Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
AAAS		ENSG00000094914	"Aladin WD repeat nucleoporin"	Q9NRG9	12	53307456-53324864	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040086	Approved		Approved	"Nuclear membrane,Centrosome,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear membrane"	"Centrosome, Cytosol"	"HPA040086: AB_10805602"	"unprognostic (1.53e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.64e-2)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (1.95e-1)"	"unprognostic (9.82e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.44e-2)"	17.0	36.3	12.3	13.8	15.0	19.1	17.1	15.2	15.6	20.3	15.1	19.1	12.3	19.1	7.2	19.3	19.9	9.4	22.7	12.9	13.7	21.7	24.6	14.0	17.6	14.3	14.1	19.2	23.9	18.0	24.8	17.4	14.8	18.4	15.1	12.3	18.5	11.7	22.6	17.3	17.7	16.8	13.7	22.2	21.6	27.3	14.0	25.2	19.4	18.5	21.6	17.8	17.9	17.2	26.1	77.3	63.2	38.0	28.6	32.2	38.9	29.8	31.3	72.6	42.1	54.0	56.7	62.2	47.4	37.3	41.9	37.6	106.4	78.8	42.1	41.0	68.1	49.7	29.9	40.7	26.4	45.5	37.9	28.1	39.4	48.9	44.6	40.4	56.6	56.2	67.6	70.6	30.4	72.8	71.2	46.1	40.0	27.7	53.1	72.1	39.3	69.4	38.2	17.5	32.8	41.3	20.2	46.9	21.0	40.2	61.2	38.8	25.5	34.9	51.1	27.4	32.9	32.5	43.5	54.7	25.6	39.6	40.5	1.0	17.7	10.7	18.4	20.2	20.8	20.0	15.9	16.8	18.8	21.8	21.7	21.4	1.1	10.5	22.5	22.6	17.4	15.2	12.3	15.0	15.2	15.6	12.9	13.7	14.3	14.1	14.8	13.7	14.0	17.2	11.7	12.8	7.8	17.9	15.1	7.4	19.0	26.2	10.2	11.8	13.2	13.0	8.2	17.2	15.4	14.7	16.7	58.4	13.7	9.3	13.7	20.4	12.5	11.9	12.9	11.7	8.4	41.2	7.3	18.3	49.5	14.9	13.3	8.9	8.2	13.1	11.0	12.0	28.5	1.7	6.6	13.1	18.3	12.4	9.3	26.2	17.7	10.6	10.6	5.6	11.6	18.0	15.5	6.6	11.4	8.9	11.0	12.8	20.8	8.1	11.2	18.5	12.6	15.5	19.7	11.0	39.7	34.2	40.5	13.1	7.4	36.5	11.4	14.9	17.2	13.0
AAGAB	"FLJ11506, p34"	ENSG00000103591	"Alpha and gamma adaptin binding protein"	Q6PD74	15	67200667-67255195	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039371, HPA040174"	Supported		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles, Cytosol"		"HPA039371: AB_10805476, HPA040174: AB_10805605"	"unprognostic (1.48e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.25e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.84e-2)"	"unprognostic (4.52e-2)"	"unprognostic (9.10e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (1.36e-4)"	"unprognostic (9.88e-2)"	"unprognostic (3.05e-1)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (1.53e-1)"	15.1	19.1	10.5	19.2	13.3	19.8	22.5	7.2	14.5	17.9	12.7	27.8	15.8	14.8	25.9	20.5	16.5	18.5	15.8	12.9	15.7	27.4	18.1	15.6	19.9	9.8	11.5	8.0	17.0	35.2	19.0	15.8	11.5	18.8	33.8	22.1	15.4	20.5	32.8	12.9	19.5	21.2	9.5	15.4	23.9	21.9	15.7	29.9	33.0	23.0	25.9	27.5	13.2	12.2	49.7	89.9	63.2	64.8	60.0	49.3	31.1	51.4	74.7	60.6	68.7	66.8	52.9	48.1	51.1	52.9	74.4	98.2	129.9	59.4	62.9	65.0	62.0	46.2	63.2	26.8	66.0	78.8	51.2	48.6	80.6	45.8	94.3	41.0	47.8	59.7	96.5	63.7	60.2	61.3	47.6	32.7	53.1	61.7	31.5	53.1	81.1	57.7	55.9	116.1	89.7	57.3	60.7	44.0	75.7	54.7	71.5	59.2	51.7	54.2	64.5	50.0	73.0	33.7	119.3	69.2	52.7	71.8	55.4	56.4	27.0	28.2	31.3	35.4	36.2	22.0	28.2	29.7	33.2	17.3	23.7	25.0	14.6	42.7	38.1	25.4	37.3	30.2	10.5	13.3	7.2	14.5	12.9	15.7	9.8	11.5	11.5	9.5	15.7	12.2	10.8	3.2	7.7	26.1	19.0	12.0	18.8	19.4	15.9	13.4	17.8	10.3	12.9	4.3	19.0	27.6	27.1	16.3	8.8	33.4	17.6	28.6	14.6	14.5	11.6	12.0	15.7	10.9	45.4	31.2	14.8	14.1	22.4	18.0	10.8	8.2	8.2	12.7	17.0	18.5	33.1	17.3	14.2	15.5	8.4	8.6	7.8	11.6	7.2	30.0	21.3	14.4	16.5	26.2	31.9	25.3	20.9	11.3	15.5	22.9	15.3	19.1	20.5	19.4	13.1	10.5	10.2	43.0	33.8	17.6	13.8	16.6	17.8	25.3	15.7	24.5
AAMP		ENSG00000127837	"Angio associated migratory cell protein"	Q13685	2	218264129-218270178	"Plasma proteins, Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017717, HPA031868"	Approved		Supported	Microtubules,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Microtubules	Cytosol	"CAB017717: , HPA031868: AB_2674078"	"unprognostic (1.57e-1)"	"unprognostic (6.12e-2)"	"unprognostic (8.11e-3)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.39e-2)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (4.94e-7)"	"unprognostic (8.94e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.23e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.09e-2)"	66.5	66.4	65.0	46.2	66.1	27.5	65.2	67.1	80.1	62.6	63.2	76.3	62.8	61.7	43.8	75.1	60.8	56.1	65.4	65.7	67.2	60.2	77.5	46.6	47.8	69.2	66.6	79.8	70.7	72.7	62.1	54.9	66.4	58.0	58.0	38.4	66.9	58.7	90.4	76.6	61.7	50.7	67.5	53.0	86.9	53.8	67.1	54.0	66.6	62.0	52.6	70.0	57.4	70.3	126.1	104.6	75.1	102.2	111.9	75.7	146.0	89.6	136.3	167.1	124.5	226.2	100.1	64.6	121.8	112.6	158.8	94.3	150.7	133.4	129.3	103.5	200.9	147.4	108.2	237.4	158.9	139.3	92.4	97.8	152.7	172.2	149.7	99.7	97.6	124.3	202.6	82.4	108.9	198.0	112.4	234.9	121.0	182.4	75.4	90.6	97.5	105.8	100.3	160.5	96.2	92.9	59.4	128.7	134.7	119.1	99.1	104.6	84.7	110.2	82.3	81.2	106.8	105.7	198.1	108.4	111.0	88.6	77.4	75.9	166.2	60.3	101.1	209.2	105.1	100.3	90.1	94.9	191.4	105.7	111.1	100.7	26.2	114.9	210.6	114.1	109.3	179.4	65.0	66.1	67.1	80.1	65.7	67.2	69.2	66.6	66.4	67.5	67.1	70.3	57.8	41.7	35.2	11.4	50.4	90.5	86.1	122.9	66.0	47.7	50.7	45.2	35.5	41.5	74.0	42.3	12.5	160.0	42.2	74.3	103.7	95.7	3.5	33.5	46.4	50.6	75.5	34.0	11.5	95.4	130.3	63.4	80.5	38.2	34.8	57.6	42.5	46.2	91.9	63.9	12.9	89.9	93.6	37.0	65.3	8.8	83.3	38.5	62.2	5.6	64.8	80.2	41.2	8.0	10.5	86.6	72.0	74.9	51.2	116.0	99.5	85.3	47.4	37.1	65.7	38.4	86.5	72.0	53.3	70.2	97.3	202.6	44.4	62.5	103.5	119.9
AATF	"BFR2, CHE-1, CHE1, DED"	ENSG00000275700	"Apoptosis antagonizing transcription factor"	Q9NY61	17	36948925-37056871	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 163.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004940, HPA075963"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoli	Nucleoplasm	"HPA004940: AB_1078075, HPA075963: "	"unprognostic (1.10e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.30e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (6.62e-5)"	"unprognostic (3.06e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (4.14e-5)"	"unprognostic (2.18e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.53e-3)"	"unprognostic (3.21e-3)"	29.8	24.4	22.2	26.3	25.6	34.7	26.6	23.6	24.9	24.6	19.8	28.3	18.5	25.6	17.5	24.4	24.7	15.4	26.1	21.0	23.2	22.1	22.5	23.4	34.1	24.0	23.4	29.5	37.5	20.3	15.9	23.2	24.5	20.3	24.0	17.3	21.0	24.1	40.8	37.1	24.2	24.5	22.8	27.1	30.0	22.9	23.5	35.3	20.4	14.2	39.2	31.2	23.4	26.8	107.2	174.2	37.0	73.8	49.3	57.0	67.3	61.2	50.4	76.0	67.3	120.3	74.3	178.2	79.5	60.5	123.4	89.9	141.8	80.0	102.6	83.4	97.3	77.1	65.6	85.8	59.4	121.9	73.4	49.5	138.7	98.4	88.4	68.2	56.6	92.3	114.4	51.7	68.6	81.6	162.4	105.0	46.0	62.8	63.3	104.0	96.7	105.6	62.6	93.7	79.0	33.8	90.9	40.8	95.5	79.6	69.6	72.3	50.4	58.1	96.2	122.5	211.9	61.3	83.1	124.2	72.2	101.9	107.1	48.9	55.2	90.2	60.0	74.0	59.6	46.8	53.9	64.0	51.0	51.0	48.1	47.7	67.5	58.1	77.7	45.5	75.7	57.2	22.2	25.6	23.6	24.9	21.0	23.2	24.0	23.4	24.5	22.8	23.5	26.8	24.5	22.4	34.6	25.1	41.2	43.7	46.3	39.7	29.6	13.4	14.7	13.1	17.8	32.9	37.8	25.8	22.9	72.9	48.5	26.4	9.8	41.6	32.0	23.4	22.9	30.1	16.1	33.7	28.5	48.1	59.8	30.3	23.0	22.0	47.5	37.4	14.6	16.9	46.8	18.5	24.6	26.4	6.1	33.9	30.3	62.0	23.6	33.4	28.4	30.0	54.9	34.3	53.5	29.1	57.7	51.1	26.3	23.3	38.4	52.1	48.8	52.0	31.1	24.0	32.9	32.3	39.0	52.5	40.8	28.2	43.9	163.9	44.3	27.4	31.9	43.6
ABCB8	"EST328128, M-ABC1, MABC1, MITOSUR"	ENSG00000197150	"ATP binding cassette subfamily B member 8"	Q9NUT2	7	151028422-151047782	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 81.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045187	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria	Nucleoplasm	"HPA045187: AB_10964281"	"unprognostic (5.29e-2)"	"unprognostic (9.17e-3)"	"unprognostic (8.28e-2)"	"unprognostic (8.32e-2)"	"unprognostic (8.63e-3)"	"prognostic favorable (5.91e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.43e-2)"	"prognostic favorable (3.34e-4)"	"unprognostic (2.26e-1)"	"prognostic favorable (5.88e-4)"	"unprognostic (7.52e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.23e-1)"	10.3	20.4	9.3	8.4	10.3	8.1	8.6	9.7	13.7	16.6	11.3	12.1	10.9	14.9	7.9	18.3	11.0	6.0	13.2	9.5	8.6	15.0	22.3	10.8	7.5	11.5	10.3	11.6	10.0	11.5	19.6	8.4	12.2	11.0	5.3	8.7	8.9	6.6	7.9	10.6	11.3	7.1	8.3	11.2	12.2	12.4	11.1	7.2	15.6	5.8	6.2	8.9	10.6	14.3	26.1	40.1	10.1	32.3	15.8	9.2	20.0	13.6	13.8	20.6	21.9	16.1	42.7	13.8	17.7	14.4	25.2	27.1	15.0	28.1	9.3	17.2	16.5	10.9	16.2	19.7	10.3	8.5	25.9	15.7	20.8	25.1	10.3	7.8	21.4	29.5	57.8	18.3	16.1	58.4	32.3	15.9	6.9	19.6	45.8	14.8	6.4	49.0	14.2	10.9	9.8	19.6	14.5	40.4	13.0	7.9	15.6	11.0	13.3	19.3	5.1	14.1	20.6	18.7	9.8	9.8	27.6	19.9	20.2	11.8	3.2	2.5	4.9	4.7	3.4	2.8	3.4	3.9	4.3	2.1	3.1	4.4	0.7	3.0	3.3	7.1	3.8	2.8	9.3	10.3	9.7	13.7	9.5	8.6	11.5	10.3	12.2	8.3	11.1	14.3	7.3	12.8	1.1	16.6	12.1	3.7	6.6	10.6	6.2	24.9	6.4	4.7	7.0	7.2	7.2	11.0	37.5	36.2	12.0	28.5	3.9	15.9	3.1	14.8	12.8	4.8	0.0	13.7	15.9	20.0	22.5	9.8	36.7	12.1	49.6	57.8	6.1	25.2	28.0	30.3	17.8	14.0	18.3	6.0	3.9	2.8	6.5	8.2	8.8	2.8	9.7	9.0	17.5	7.1	11.8	21.5	8.5	12.4	22.9	7.0	20.6	14.3	8.8	36.6	26.3	8.9	9.5	9.9	13.5	12.0	7.4	81.8	11.3	28.1	18.7	7.6
ABCE1	"OABP, RLI, RLI1, RNASEL1, RNASELI, RNS4I"	ENSG00000164163	"ATP binding cassette subfamily E member 1"	P61221	4	145098288-145129524	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Translation regulation"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012476, HPA036846"	Approved		Enhanced	Cytosol		No	No		380000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"CAB012476: , HPA036846: AB_2675346"	"unprognostic (2.22e-3)"	"unprognostic (8.11e-3)"	"prognostic favorable (8.69e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.51e-3)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (5.68e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (1.88e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.21e-1)"	30.0	21.5	11.2	33.6	12.5	27.2	33.1	13.7	16.0	20.7	10.7	22.7	20.2	24.4	16.0	35.1	22.5	22.4	24.9	12.5	14.3	23.8	39.7	18.5	40.5	12.6	11.2	29.1	29.4	27.0	10.0	28.7	14.4	19.4	27.7	14.4	24.1	16.9	28.0	25.2	17.7	28.9	13.8	26.4	20.1	26.5	11.8	34.2	26.9	30.3	42.1	40.5	15.9	18.1	117.1	61.2	89.5	62.2	74.6	107.5	89.4	124.6	86.4	145.1	101.3	95.5	105.9	187.6	39.3	109.2	77.7	75.4	132.5	157.7	193.1	108.6	82.9	106.9	44.0	80.6	98.3	244.3	81.3	80.0	108.4	153.8	213.7	74.8	157.4	139.1	219.5	136.1	156.3	70.4	234.5	82.2	74.8	177.5	142.9	124.0	107.9	135.7	108.1	79.9	111.1	55.1	74.7	124.6	89.5	66.7	74.2	98.1	105.3	143.3	89.4	101.3	152.5	120.6	209.6	199.5	87.7	214.6	163.7	2.2	10.0	0.9	12.3	13.1	25.4	13.2	15.4	16.0	19.5	13.0	21.0	18.1	0.8	16.4	13.4	10.9	18.5	14.8	11.2	12.5	13.7	16.0	12.5	14.3	12.6	11.2	14.4	13.8	11.8	18.1	56.4	25.6	18.7	15.3	55.9	59.9	109.0	38.7	45.5	37.2	35.0	30.6	24.0	17.2	45.4	25.8	20.9	39.4	44.4	9.8	39.2	39.4	40.1	29.0	61.8	53.7	20.4	47.5	24.2	28.2	45.1	50.6	35.7	23.4	32.9	50.3	21.4	32.9	41.5	42.1	27.8	22.5	24.4	22.4	40.3	15.4	46.9	34.6	19.6	12.2	33.2	18.1	33.0	18.1	37.5	39.1	10.3	34.6	58.3	112.2	8.0	39.8	28.5	34.9	32.9	71.7	47.5	92.4	79.4	65.5	59.5	26.5	47.2	98.4	36.6	72.2
ABCF1	"ABC50, EST123147"	ENSG00000204574	"ATP binding cassette subfamily F member 1"	Q8NE71	6	30571393-30597179	"Plasma proteins, Predicted intracellular proteins, Transporters"		Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 107.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017578	Approved		Enhanced	Cytosol		NA	NA		490000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA017578: AB_1844438"	"unprognostic (5.85e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-3)"	"unprognostic (4.31e-2)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (9.47e-4)"	"unprognostic (5.50e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.68e-3)"	"unprognostic (7.16e-2)"	31.6	27.5	4.5	6.7	5.0	25.5	28.3	4.4	6.4	29.6	3.5	34.0	2.0	34.3	7.4	32.4	24.6	6.8	35.0	4.3	4.9	28.1	32.6	29.9	7.4	5.1	4.8	26.2	32.7	13.5	24.7	10.5	5.0	28.3	11.4	11.1	30.4	5.4	107.0	39.9	32.3	10.2	4.5	30.7	32.4	35.0	5.3	14.7	29.3	4.1	11.3	32.4	30.0	5.6	46.2	33.5	29.4	39.7	40.0	24.5	4.2	30.1	37.6	49.0	53.6	104.8	16.4	33.8	27.1	34.3	51.9	33.3	61.7	39.5	56.2	34.2	65.2	43.0	47.6	14.5	5.5	9.4	5.6	33.6	33.7	68.6	6.4	4.0	5.6	16.9	77.2	4.5	35.3	8.5	9.3	15.5	7.5	31.2	9.4	64.5	7.5	63.3	32.2	52.4	10.2	42.9	20.1	55.3	6.6	5.0	6.1	24.4	28.2	59.0	6.9	3.8	6.2	35.7	47.5	52.8	1.3	43.3	62.2	1.7	5.5	1.5	10.1	4.7	9.3	6.2	7.2	10.2	4.7	5.1	6.3	6.3	1.8	8.0	4.9	5.4	4.1	6.1	4.5	5.0	4.4	6.4	4.3	4.9	5.1	4.8	5.0	4.5	5.3	5.6	42.5	51.3	84.4	7.2	67.9	86.2	100.3	54.2	49.5	48.9	45.5	30.1	87.3	42.9	65.2	58.8	66.7	100.3	77.5	103.3	60.7	93.9	105.0	67.0	95.4	57.2	50.7	50.9	6.8	87.6	139.4	52.6	53.5	115.2	86.9	27.0	36.0	125.4	49.5	55.5	7.4	80.6	28.5	47.4	43.0	176.4	38.8	52.1	35.6	2.8	63.2	39.3	116.4	2.0	9.2	105.9	73.8	51.9	61.8	92.1	66.2	99.0	44.0	112.9	72.3	58.7	54.3	132.5	104.2	50.2	84.8	166.1	70.5	48.2	72.3	87.1
ABCF2	"ABC28, EST133090, HUSSY-18, M-ABC1"	ENSG00000033050	"ATP binding cassette subfamily F member 2"	Q9UG63	7	151211484-151227205	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 55.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA020091, CAB020682, HPA021815, HPA030388"	Approved		Enhanced	Cytosol		NA	NA		51000	"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"CAB020682: , HPA020091: AB_1844439, HPA021815: AB_1844440, HPA030388: AB_10601558"	"unprognostic (6.80e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (9.52e-6)"	"unprognostic (1.52e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.31e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.07e-2)"	"unprognostic (7.84e-3)"	19.0	18.8	16.1	11.1	16.2	7.6	14.8	15.1	19.5	13.8	14.2	18.8	6.0	16.6	12.1	19.2	14.4	8.9	27.9	16.0	16.7	20.2	12.3	14.6	11.6	18.0	16.5	15.0	15.0	14.3	17.0	10.3	17.3	16.1	10.8	10.8	14.2	10.2	61.2	16.3	13.4	14.1	16.2	15.6	16.6	18.7	16.5	11.5	13.8	20.2	15.2	19.5	13.9	16.9	33.0	50.3	18.8	66.0	36.6	31.1	25.1	40.6	33.0	49.9	42.1	47.9	22.1	57.4	34.3	42.8	40.9	25.2	58.9	47.8	49.5	28.1	48.8	23.1	26.3	27.4	43.3	58.0	35.7	42.3	39.6	54.6	34.4	21.2	40.7	32.5	68.4	22.9	43.2	80.1	60.4	70.3	46.8	37.6	54.5	40.3	30.1	50.5	35.4	24.0	32.9	31.0	39.5	37.5	26.8	19.5	16.2	29.0	40.7	31.7	12.8	39.6	61.7	46.9	54.5	42.7	43.5	56.4	60.3	7.9	11.3	3.8	13.8	13.3	19.5	11.9	14.2	13.7	13.1	13.1	13.3	13.8	1.6	14.5	15.1	9.8	15.8	14.7	16.1	16.2	15.1	19.5	16.0	16.7	18.0	16.5	17.3	16.2	16.5	16.9	4.7	0.0	0.5	10.1	15.9	27.1	25.9	22.5	14.2	17.4	0.3	0.6	23.5	7.2	9.5	0.0	8.4	29.5	10.0	28.4	0.0	0.0	47.0	0.1	0.1	12.8	6.7	18.3	12.6	0.0	28.8	13.8	16.3	0.0	10.2	0.0	12.5	12.9	20.7	10.1	12.6	9.1	12.2	10.4	11.5	55.9	10.5	6.7	19.6	7.5	6.2	14.1	14.4	7.1	10.4	0.0	18.9	14.7	14.0	29.8	15.7	0.0	6.6	16.9	13.1	25.7	15.1	31.0	12.4	21.5	25.1	32.3	10.9	0.1	15.1	19.6
ABCF2-H2BE1		ENSG00000285292	"ABCF2-H2BE1 readthrough"	Q9UG63	7	151207837-151227166	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA020091, HPA021815, HPA030388"	Approved		Uncertain	Cytosol		NA	NA		51000	"Cluster 16: MAIT-cells - Unknown function"		"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA020091: AB_1844439, HPA021815: AB_1844440, HPA030388: AB_10601558"																		12.0	8.1	1.1	11.1	1.6	5.5	9.0	2.1	6.2	7.4	2.9	9.5	6.7	8.4	2.9	10.1	9.0	7.6	9.8	1.5	2.0	9.7	7.4	8.6	11.4	1.5	1.6	6.0	4.6	13.9		8.3	2.3	7.2	10.3	10.0	5.4	9.5	30.7	9.0	5.7	11.9	1.9	9.5	6.0	6.8	2.1	10.2	9.5	20.9	13.8	14.4		2.8	45.0	54.8	27.0	71.0	38.7	38.6	22.4	57.1	38.5	43.7	45.1	40.5	33.8	66.4	44.1	59.7	61.1	34.7	57.9	55.3	61.0	29.9	31.8	37.1	30.6	26.6	57.8	76.5	25.8	40.8	40.8	72.5	50.5	28.6	55.4	35.8	89.1	28.4	57.6	68.1	88.9	23.1	36.5	58.4	50.1	36.5	34.6	68.3	21.9	33.8	21.9	34.8	59.5	44.0	30.3	25.1	21.2	33.9	47.5	33.4	11.4	45.2	73.6	41.6	47.5	64.7	55.4	64.7	49.0	22.5	21.3	6.0	22.5	19.1	45.7	17.5	27.9	26.3	24.8	19.9	24.8	24.3	1.6	25.5	18.5	15.4	30.2	30.3	1.1	1.6	2.1	6.2	1.5	2.0	1.5	1.6	2.3	1.9	2.1	2.8	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ABT1	Esf2	ENSG00000146109	"Activator of basal transcription 1"	Q9ULW3	6	26596953-26600739	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077039			Approved	Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles		"HPA077039: AB_2732328"	"unprognostic (1.32e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.77e-1)"	"unprognostic (7.74e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.85e-2)"	"prognostic favorable (1.89e-4)"	"unprognostic (2.30e-3)"	"unprognostic (2.93e-2)"	"unprognostic (7.25e-3)"	"unprognostic (7.20e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (3.80e-4)"	9.3	8.0	6.5	9.5	6.7	23.2	9.3	7.8	7.7	8.9	6.5	10.1	10.0	10.8	6.3	13.9	9.2	5.9	8.7	6.5	6.4	8.2	13.0	7.9	15.8	6.4	6.4	9.2	9.4	8.3	7.3	10.7	6.4	8.2	6.7	4.7	9.0	6.7	9.6	14.3	11.6	5.7	6.4	14.8	9.9	8.0	6.6	13.0	7.3	7.1	10.5	9.3	9.7	6.8	23.3	11.9	16.3	28.4	8.9	9.3	23.9	13.4	13.6	20.0	19.5	21.6	10.0	33.8	30.0	11.1	15.9	14.5	19.0	19.5	11.7	18.9	38.7	22.2	11.2	40.6	14.3	30.6	21.7	12.4	17.9	15.9	9.4	9.3	17.5	26.2	39.3	22.1	11.2	23.6	35.6	39.1	16.8	14.9	15.9	21.4	13.2	35.8	12.5	18.7	21.4	17.2	8.3	21.6	32.9	8.6	20.8	24.6	15.1	15.2	11.2	12.2	27.3	25.8	40.9	30.9	7.2	37.6	23.8	76.1	41.6	53.8	66.1	40.2	63.3	66.5	63.8	66.2	39.7	70.2	67.4	60.8	37.2	57.5	41.7	37.1	76.3	88.1	6.5	6.7	7.8	7.7	6.5	6.4	6.4	6.4	6.4	6.4	6.6	6.8	22.4	16.0	15.5	3.3	41.8	59.9	35.8	65.2	34.1	16.2	23.1	22.2	7.1	21.5	31.8	11.0	2.1	96.0	50.8	16.1	41.1	39.4	39.7	12.1	14.0	31.6	34.0	26.9	4.4	38.7	97.5	21.1	16.8	17.3	29.1	17.7	25.4	21.2	42.2	15.2	4.3	25.3	50.8	21.2	22.6	81.8	27.7	22.2	16.0	2.8	32.3	22.0	78.2	3.5	4.5	35.9	19.5	23.7	29.4	31.6	27.9	24.4	21.8	17.2	19.7	15.1	23.4	29.6	41.2	28.3	59.8	109.5	44.3	24.5	29.5	33.6
ABTB2	"ABTB2A, BTBD22, DKFZP586C1619"	ENSG00000166016	"Ankyrin repeat and BTB domain containing 2"	Q8N961	11	34150987-34358010	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.1"	"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 50.3;Oligodendrocytes: 126.2;Syncytiotrophoblasts: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"eosinophil: 5.0;plasmacytoid DC: 1.6"	"Group enriched"	"Detected in many"	14	"dendritic cells: 1.6;granulocytes: 5.0"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 24.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020065, HPA030699"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Vesicles	"HPA020065: AB_1844459, HPA030699: AB_2673576"	"unprognostic (3.00e-1)"	"prognostic unfavorable (5.70e-5)"	"unprognostic (2.61e-1)"	"unprognostic (9.09e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.86e-1)"	"prognostic favorable (3.51e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.58e-2)"	2.3	13.0	7.9	2.0	12.6	2.5	2.0	18.1	6.7	8.1	1.2	3.4	8.8	6.1	4.4	4.1	4.6	2.1	12.8	5.3	8.5	9.4	11.6	2.9	2.1	24.1	16.3	2.5	2.3	0.5	3.5	3.2	16.7	4.9	2.5	2.6	6.7	4.3	16.9	6.8	7.0	2.5	12.7	0.9	2.5	2.7	15.9	2.4	2.0	7.2	2.0	3.6	5.6	20.3	5.6	16.2	6.4	1.8	1.7	0.1	6.4	3.2	2.5	2.8	5.3	4.0	4.0	0.2	5.3	4.1	16.5	10.5	3.6	3.7	2.3	0.2	8.8	0.1	9.8	17.4	1.0	8.9	1.2	0.9	2.0	5.6	2.4	10.1	0.0	0.7	1.9	0.5	1.8	13.8	0.3	10.7	8.0	8.1	8.8	1.7	3.8	6.3	10.0	13.0	8.1	6.6	8.1	24.6	6.5	4.2	5.3	3.8	0.9	3.1	0.5	9.8	5.8	0.9	0.4	0.1	7.1	2.5	9.7	0.0	0.1	5.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.0	7.9	12.6	18.1	6.7	5.3	8.5	24.1	16.3	16.7	12.7	15.9	20.3	0.7	0.0	2.3	18.9	1.1	4.7	3.2	1.3	1.2	2.1	3.0	3.3	10.0	2.8	1.1	12.9	0.0	2.7	2.5	12.2	5.9	4.6	1.2	3.4	4.5	0.9	7.2	0.0	4.0	4.5	1.1	5.8	4.6	10.7	1.3	0.3	0.0	6.8	0.8	0.0	8.9	2.3	4.1	0.8	6.1	0.3	1.2	1.2	1.8	6.5	9.3	7.5	0.0	50.3	126.2	10.5	9.1	6.0	2.1	9.3	15.5	2.0	0.3	0.6	0.0	4.3	2.4	0.5	1.1	1.0	4.8	28.3	2.9	0.4	2.9	7.5
AC012184.2		ENSG00000260537	"Novel protein, DDX19B and DDX19A readthrough"		16	70299194-70372582	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	15	"Respiratory ciliated cells: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 34.2;U-698: 35.1"									"HPA046380, HPA066668"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA046380: AB_2679645, HPA066668: "																		3.3	1.8	0.0	4.3	0.0	4.5	1.3	0.0	0.2	0.5	0.0	3.1	4.0	0.5	0.0	4.0	0.5	2.8	4.6	0.0	0.0	2.3	1.9	1.2	4.0	0.0	0.0	0.2	6.3	1.5	0.0	1.2	0.0	0.9	2.6	0.7	2.1	0.2	6.0	3.8	2.8	1.0	0.0	1.1	3.0	0.0	0.0	1.3	3.1	2.1	5.8	4.3	0.7	0.0	2.2	7.6	5.5	14.4	0.0	6.4	12.7	6.6	7.9	11.8	12.6	14.0	19.2	13.1	8.7	6.4	1.4	7.2	0.0	5.0	6.6	3.9	9.6	8.7	4.5	0.9	7.3	12.2	6.2	4.3	1.1	11.5	0.0	2.3	7.7	3.3	5.3	3.5	4.8	4.8	0.1	0.0	6.7	0.6	1.8	34.2	2.7	22.9	3.6	9.2	7.3	8.1	18.1	3.2	3.2	0.9	5.4	3.0	7.8	8.1	7.6	3.2	4.8	11.0	8.0	35.1	1.0	9.0	13.8	22.4	16.1	11.6	15.5	19.8	12.8	10.4	13.3	15.3	18.2	11.5	11.3	11.3	2.2	15.9	14.8	3.8	22.1	14.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC012488.2		ENSG00000286165	"Novel protein"		2	189661519-189667881	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	5	"brain: 2.7"	"Not detected"	"Not detected"							"Region enriched"	"Detected in single"	6	"cerebral cortex: 2.7"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 1.2;HDLM-2: 1.2"									HPA075042			Approved	Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"		"Cluster 26: Non-specific - Cell cycle regulation"		Cytosol		"HPA075042: AB_2686731"																		0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.2	2.7	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0		0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0		0.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	1.2	0.8	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.3	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.4	0.7	1.1	0.4	0.4	0.3	1.3	0.4	0.0	0.2	2.1	0.3	0.2	0.5	0.6	0.2	1.0	2.3	0.4	0.2	0.3	0.2	2.7	0.2	0.2	0.3	0.1	0.4	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC013489.1		ENSG00000173867	"Novel transcript"		15	88459501-88546585	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"granulocytes: 1.3;Respiratory ciliated cells: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"											HPA048873	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	NA			"Cluster 32: T-cells - Unknown function"		"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Microtubules	"Nucleoplasm, Cytokinetic bridge"	"HPA048873: AB_2680541"	"unprognostic (3.32e-2)"	"unprognostic (9.46e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.56e-3)"	"unprognostic (4.03e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.47e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.66e-2)"	0.4	0.4	0.6	0.2	0.6	0.4	1.1	0.7	0.7	0.4	0.9	0.5	0.3	2.2	1.0	0.3	1.0	0.5	0.8	0.5	0.9	0.7	0.8	0.5	0.4	0.6	0.6	2.2	1.0	0.7		0.5	0.7	0.6	0.6	1.3	0.4	0.7	1.4	0.3	0.4	0.9	0.6	0.7	0.4	0.4	0.7	0.5	0.7	1.2	0.5	0.3		0.8	0.3	0.6	0.5	0.8	1.2	0.6	0.6	1.0	0.7	1.0	0.7	0.6	1.1	0.9	0.7	1.2	0.7	0.6	2.1	0.6	0.9	0.3	1.0	1.0	0.5	0.8	0.4	0.8	0.7	1.0	1.1	0.7	0.8	0.4	0.5	1.2	1.0	0.9	0.1	0.4	1.0	0.5	0.6	0.7	0.2	0.4	0.7	1.2	0.6	0.8	0.6	0.4	0.9	0.4	1.4	1.0	0.7	1.5	0.8	0.7	0.5	0.9	0.9	0.5	0.9	0.6	0.9	0.7	0.5	0.0	0.5	0.3	0.7	0.9	0.8	0.9	0.9	0.8	0.8	0.7	1.0	1.1	0.0	0.9	0.6	0.6	0.8	0.9	0.6	0.6	0.7	0.7	0.5	0.9	0.6	0.6	0.7	0.6	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC026464.4		ENSG00000260914	"Novel protein"		16	69299682-69322700	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in all"		"skeletal muscle: 156.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA060092			Approved	Midbody		Yes	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	Midbody		"HPA060092: AB_2684203"	"unprognostic (2.95e-1)"	"unprognostic (4.21e-1)"			"unprognostic (7.34e-2)"	"unprognostic (8.50e-2)"		"unprognostic (1.02e-1)"	"unprognostic (2.74e-1)"		"unprognostic (3.50e-1)"	"unprognostic (4.08e-2)"	"unprognostic (6.51e-4)"	"unprognostic (1.69e-1)"		"unprognostic (2.76e-1)"	"unprognostic (5.11e-2)"	44.1	30.4	24.3	29.1	27.0	28.6	31.8	26.0	37.3	28.4	14.9	36.4	30.5	32.6	12.3	41.7	29.4	22.0	43.2	28.4	27.4	30.3	20.7	28.8	28.0	28.5	25.1	33.7	47.2	47.6	16.1	29.4	29.1	27.7	26.4	35.4	36.1	26.6	156.6	34.6	35.1	31.7	25.2	29.9	31.7	18.7	27.4	26.2	30.3	97.2	30.0	32.2	28.3	30.1	64.9	56.5	65.5	62.3	48.9	51.3	36.9	80.1	53.7	83.6	54.6	72.3	35.1	61.6	81.7	64.5	42.9	49.7	62.2	54.6	52.9	38.2	30.0	48.9	30.1	37.3	61.5	62.3	49.8	43.7	73.8	69.2	75.7	47.9	70.0	52.4	63.2	29.6	68.7	84.5	62.1	30.8	53.1	42.7	27.0	94.3	37.4	82.1	38.7	41.2	67.7	38.1	107.8	35.6	47.7	39.9	50.7	43.0	74.0	77.7	55.5	67.8	61.3	101.4	78.6	147.0	78.7	23.3	94.8	16.1	25.4	36.1	31.0	20.7	28.4	23.0	27.4	36.9	26.8	20.2	27.7	27.4	17.1	22.5	28.3	18.5	28.5	33.7	24.3	27.0	26.0	37.3	28.4	27.4	28.5	25.1	29.1	25.2	27.4	30.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC026464.6		ENSG00000272617	"Novel protein, COG8-PDF readthrough"		16	69328644-69334871	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"Cardiomyocytes: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																	NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"																					8.0	9.3	8.8	8.7	9.0	6.3	7.7	9.0	13.7	6.5	8.7	9.0	8.9	5.9	9.5	5.9	5.8	3.8	5.2	9.0	9.6	21.5	23.0	7.1	7.6	8.9	8.9	5.4	6.9	17.9	4.2	6.5	9.2	6.9	8.7	4.9	8.3	6.4	12.6	5.6	7.9	7.5	8.3	6.1	5.9	21.2	9.2	9.7	7.1	12.0	9.6	8.7	3.0	9.7	24.1	31.8	23.8	28.3	27.3	17.6	18.6	24.3	23.5	35.2	35.2	35.9	34.2	33.3	17.3	26.1	20.7	31.9	38.3	32.1	27.9	8.3	19.1	20.0	27.7	65.2	25.5	38.4	17.7	18.3	35.4	35.9	26.3	17.1	21.2	37.8	34.4	15.0	27.0	51.9	34.5	45.4	34.0	37.0	10.9	48.0	10.4	56.6	52.3	21.4	30.7	25.2	41.0	17.3	25.3	23.4	62.5	34.9	12.5	24.7	22.1	19.6	26.9	24.3	26.2	63.2	21.1	25.0	29.0	0.7	5.2	4.1	3.7	4.3	4.7	4.3	6.4	7.4	6.7	7.4	7.1	5.8	1.3	6.7	4.6	3.0	5.8	4.5	8.8	9.0	9.0	13.7	9.0	9.6	8.9	8.9	9.2	8.3	9.2	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC069544.1		ENSG00000284024	"Zinc finger and SCAN domain containing 29"		10	14838302-14846999	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 1.8;Breast myoepithelial cells: 1.5;Endometrial ciliated cells: 1.2;Endometrial stromal cells: 1.8;Glandular and luminal cells: 1.2;Granulosa cells: 2.3;Proximal tubular cells: 1.3;Theca cells: 4.3"					"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"																					4.3	4.1	2.8	6.2	2.7	8.9	6.8	6.8	4.5	5.5	1.7	5.9	5.4	5.9	3.4	6.7	3.7	6.1	3.6	3.8	3.3	3.0	3.8	3.1	8.4	2.5	2.2	7.3	5.9	5.3	3.6	7.9	2.5	5.3	6.3	10.1	3.8	4.3	2.4	7.6	5.2	4.4	2.2	5.8	6.5	6.8	2.8	9.7	5.3	4.3	7.2	6.3	2.9	3.8	13.9	9.7	15.3	14.9	9.1	7.8	15.1	12.6	5.6	15.7	20.3	16.5	10.0	21.5	6.1	7.9	8.4	14.5	24.1	12.5	20.2	11.9	14.3	22.0	20.1	10.8	11.1	8.9	13.3	5.8	10.2	25.0	11.1	7.4	9.9	13.2	25.1	16.8	18.7	12.8	18.2	8.0	13.5	8.0	6.1	15.8	13.2	14.3	8.8	6.4	12.1	14.6	11.8	13.9	12.6	9.7	9.9	10.2	8.1	16.0	16.9	18.2	12.8	9.9	12.9	19.9	8.3	13.5	7.5	2.9	1.6	1.9	1.8	2.0	2.0	2.1	1.7	1.7	1.6	2.2	2.0	2.5	1.6	3.5	2.9	2.2	1.8	1.7	2.8	2.7	6.8	4.5	3.8	3.3	2.5	2.2	2.5	2.2	2.8	3.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0	1.2	1.8	0.3	0.0	0.0	0.0	0.5	0.0	0.3	0.0	1.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	4.3	0.0	0.0
AC087721.2		ENSG00000285920	"Novel protein"		15	41284007-41380996	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 6.4;Alveolar cells type 2: 5.3;Club cells: 5.6;granulocytes: 3.8;Respiratory ciliated cells: 2.9"					"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"											"HPA042904, HPA074847"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli fibrillar center"		Yes	Yes			"Cluster 12: Non-specific - Basic cellular processes"		"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Nucleoli, Nucleoli fibrillar center"		"HPA042904: AB_2678220, HPA074847: AB_2732269"																		0.8	1.5	0.3	1.8	0.2	2.9	1.3	2.1	1.0	1.0	0.1	1.8	1.7	0.9	0.3	1.6	0.7	1.1	0.8	0.1	0.3	1.1	1.7	1.0	2.4	0.4	0.6	1.5	0.6	0.9		1.3	0.5	0.7	1.9	1.8	0.6	1.1	3.1	1.0	1.4	1.1	0.2	1.6	1.2	2.9	0.6	2.6	0.7	1.9	2.5	1.5		0.4	3.7	1.2	6.6	5.5	2.5	3.7	3.4	3.8	2.9	4.8	4.7	2.0	4.1	2.8	4.0	2.2	4.4	8.7	10.1	5.3	4.1	7.2	3.6	9.4	3.8	3.6	2.0	14.2	8.2	2.1	3.3	3.3	8.8	1.9	4.7	10.6	8.7	11.0	4.3	1.8	5.5	4.5	6.9	9.2	5.5	7.6	5.0	4.3	4.6	4.0	6.6	6.0	6.6	3.9	2.6	7.0	6.6	8.5	4.3	2.8	5.5	3.2	5.8	5.6	10.7	9.4	2.4	8.7	5.6	0.1	0.4	1.0	0.2	0.4	0.3	0.4	0.5	0.4	0.6	0.3	0.2	0.2	0.1	0.3	0.5	0.9	0.9	0.5	0.3	0.2	2.1	1.0	0.1	0.3	0.4	0.6	0.5	0.2	0.6	0.4	0.0	6.4	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0
AC091959.1		ENSG00000275740	"Novel readthrough transcript"		5	146203550-146339251	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"testis: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA035944, HPA036422"	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nuclear speckles"		"HPA035944: AB_10670672, HPA036422: AB_10669987"	"unprognostic (6.42e-2)"	"unprognostic (7.72e-4)"	"unprognostic (2.05e-2)"		"unprognostic (4.95e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.24e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.77e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.12e-2)"	0.5	0.5	0.2	1.4	0.6	2.4	0.5	1.9	0.8	1.0	0.8	0.6	1.5	0.5	0.0	1.2	1.0	0.4	0.6	0.4	1.0	0.5	0.4	0.7	1.3	0.4	0.3	1.3	0.7	0.9	0.0	0.9	0.3	0.5	0.7	0.7	0.9	0.6	0.6	0.3	1.1	1.0	0.0	0.7	0.9	6.7	0.6	1.8	1.5	0.7	1.2	0.8	0.1	0.8	7.2	11.4	5.6	5.5	1.7	1.7	5.0	8.9	5.4	10.4	10.7	12.4	5.9	8.6	5.3	4.8	6.6	5.5	8.2	7.9	8.9	16.0	4.5	10.0	5.5	1.3	1.2	12.0	9.5	2.4	1.0	9.9	6.1	1.7	3.3	3.2	13.1	5.4	3.3	3.7	9.6	0.0	5.1	3.2	7.4	9.6	10.8	4.8	0.7	9.2	5.6	3.9	12.9	2.9	4.0	1.9	9.3	1.7	6.8	5.8	6.7	6.9	8.9	6.4	14.9	13.4	6.3	6.9	6.6	18.2	7.0	14.5	10.4	7.2	11.6	10.3	9.5	8.2	7.5	12.2	10.0	9.9	10.3	10.4	12.0	10.2	9.3	7.8	0.2	0.6	1.9	0.8	0.4	1.0	0.4	0.3	0.3	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
AC092587.1		ENSG00000273155	"Novel LIPT1-MRPL30 readthrough"		2	99154998-99195298	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 1.8;Cytotrophoblasts: 1.6;Distal tubular cells: 3.9;Exocrine glandular cells: 2.2;Extravillous trophoblasts: 2.0;Hofbauer cells: 1.5;Proximal tubular cells: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in some"																	NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"				"unprognostic (5.56e-3)"	"unprognostic (2.80e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.70e-2)"	"unprognostic (8.45e-3)"	"unprognostic (3.84e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.36e-2)"	"unprognostic (3.81e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.25e-1)"	0.6	0.6	0.0	1.1	0.1	0.6	0.5	0.4	0.6	0.6	0.0	0.5	0.1	0.6	0.1	0.5	0.3	0.5	1.3	0.1	0.1	0.5	0.5	0.4	0.3	0.0	0.1	0.5	0.3	0.3	0.3	0.3	0.0	0.4	0.4	0.2	0.4	0.3	1.2	0.3	0.7	0.3	0.0	0.3	0.4	0.3	0.0	0.0	0.4	0.4	0.5	0.5	0.5	0.2	0.7	1.0	0.7	1.3	0.2	2.1	0.3	0.0	0.4	0.4	0.6	1.0	0.6	0.4	1.1	0.2	0.3	0.9	0.5	0.6	1.1	0.6	0.0	0.0	0.5	1.7	0.0	1.7	0.0	0.3	0.8	0.9	0.2	0.1	0.4	0.4	1.4	0.1	0.2	0.3	1.0	1.4	0.9	0.2	1.3	0.8	0.3	0.8	0.6	0.6	0.2	0.8	0.3	0.7	0.4	1.2	0.9	1.3	0.9	0.6	0.9	0.0	0.3	0.1	0.3	0.5	0.5	1.0	0.2	0.4	1.3	0.8	1.0	0.9	0.7	0.8	1.0	0.9	1.3	0.8	1.0	1.2	0.5	1.0	1.2	0.9	1.3	0.5	0.0	0.1	0.4	0.6	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	1.8	0.0	1.6	0.1	0.0	3.9	0.9	0.0	0.1	0.3	0.4	0.0	0.0	0.0	2.2	2.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.4	0.0	0.0
AC118553.2		ENSG00000283761	"Novel protein"		1	99970011-100083321	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 4.1;Collecting duct cells: 1.8;Respiratory ciliated cells: 5.1"					"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA073681			Approved	Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA073681: AB_2686625"																		0.1	0.1	0.0	0.0	0.3	0.2	0.0	0.1	0.2	0.2	0.5	0.2	0.2	0.2	0.1	0.6	0.2	0.1	0.1	0.2	0.3	0.3	0.2	0.7	0.0	0.3	0.2	0.3	0.0	1.0	0.0	0.2	0.4	0.2	0.3	1.0	0.2	0.5	0.1	0.1	0.1	0.4	0.1	0.0	0.2	0.4	0.2	0.7	0.1	0.3	0.2	0.6	0.1	0.3	0.5	0.7	0.9	0.2	0.0	0.6	0.8	1.3	0.5	1.3	2.7	0.5	2.0	0.1	3.3	2.0	2.7	2.1	2.6	0.9	1.7	0.9	1.3	2.2	3.7	0.1	0.2	0.5	0.5	0.0	0.8	2.5	2.2	0.7	1.6	0.3	1.8	1.2	0.7	1.2	2.3	0.1	0.1	2.1	1.1	0.5	2.0	0.9	0.7	1.1	0.6	0.7	1.1	0.6	0.5	0.8	0.6	0.1	0.5	0.8	1.3	0.7	1.4	0.7	2.9	0.3	1.0	1.0	0.3	8.4	5.1	3.5	4.4	5.2	5.0	2.8	4.5	5.2	5.8	1.9	4.2	3.6	0.8	6.7	3.2	4.6	5.9	5.0	0.0	0.3	0.1	0.2	0.2	0.3	0.3	0.2	0.4	0.1	0.2	0.3	0.3	6.4	4.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	1.3	1.8	0.0	0.0	0.6	0.0	0.0	0.2	0.0	1.2	1.3	0.4	0.0	0.0	0.0	0.7	0.0	0.4	0.0	1.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	5.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.0	0.0
ACAA2	DSAEC	ENSG00000167315	"Acetyl-CoA acyltransferase 2"	P42765	18	49782164-49813953	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1011.9"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 331.1;Hepatocytes: 810.5;Proximal tubular cells: 708.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042303	Approved		Supported	Mitochondria		NA	NA		3800000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA042303: AB_10794046"	"unprognostic (7.94e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.20e-3)"	"prognostic unfavorable (8.53e-4)"	"unprognostic (2.92e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.97e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-1)"	"prognostic favorable (1.36e-10)"	"unprognostic (1.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.26e-3)"	"unprognostic (3.41e-1)"	126.3	74.2	56.9	44.4	64.9	32.5	79.1	63.7	63.9	24.9	68.4	168.7	170.0	29.0	29.8	30.3	24.4	46.9	223.7	53.2	59.8	378.2	1011.9	48.9	36.6	65.1	61.4	34.8	54.1	35.1	34.9	29.6	64.0	26.4	109.6	31.9	20.3	34.0	165.3	28.0	165.2	44.5	62.8	33.6	37.4	37.7	64.3	39.9	55.8	236.6	31.9	41.6	28.6	64.2	3.9	70.5	110.0	97.5	129.9	69.5	57.4	35.2	52.4	53.6	41.2	146.3	58.9	61.1	73.5	117.5	56.7	4.8	176.8	21.0	51.4	190.5	50.4	45.5	79.0	171.4	62.5	0.7	78.3	91.7	6.7	84.8	26.2	44.6	90.0	87.7	42.5	54.7	147.5	81.8	2.7	89.7	101.5	24.8	26.7	150.8	233.0	217.6	177.7	2.8	163.4	130.9	2.7	76.2	5.6	82.1	45.7	60.0	48.1	49.8	60.5	67.8	36.4	112.3	139.7	157.3	35.0	85.7	47.1	53.0	87.4	96.1	99.2	106.5	123.0	43.2	58.3	88.7	103.2	36.3	50.2	73.2	8.3	120.0	108.1	50.1	76.4	112.7	56.9	64.9	63.7	63.9	53.2	59.8	65.1	61.4	64.0	62.8	64.3	64.2	28.4	38.5	47.3	11.8	31.4	3.6	14.2	15.5	11.4	6.7	25.0	25.5	189.9	234.4	23.7	55.2	4.2	36.5	48.2	331.1	295.4	148.5	71.2	7.9	33.9	30.0	40.1	53.6	1.7	45.7	56.0	47.3	23.9	7.7	45.1	63.3	41.4	810.5	109.6	1.7	4.6	73.0	24.4	64.8	18.5	153.9	48.1	50.6	19.6	13.1	57.2	62.2	106.1	4.5	8.7	101.8	161.2	37.2	41.2	9.8	226.6	708.0	26.4	29.5	19.7	42.1	34.9	51.1	42.7	11.1	4.8	27.0	52.2	93.0	144.8	9.6
ACAP2	"CENTB2, CNT-B2, KIAA0041"	ENSG00000114331	"ArfGAP with coiled-coil, ankyrin repeat and PH domains 2"	Q15057	3	195274745-195443044	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 215.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034807, HPA034808"	Supported		Approved	Endosomes		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	Endosomes		"HPA034807: AB_10669896, HPA034808: AB_10673103"	"unprognostic (9.13e-2)"	"unprognostic (1.75e-3)"	"unprognostic (7.05e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.90e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.08e-3)"	"unprognostic (7.17e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.49e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.77e-2)"	"unprognostic (8.54e-2)"	15.9	10.2	10.7	22.2	10.3	39.6	13.5	21.4	14.5	14.3	1.8	17.0	14.0	14.4	10.9	21.7	12.2	14.2	8.3	14.1	6.4	10.3	11.8	15.7	26.9	2.5	4.2	19.0	9.0	13.2	8.5	15.5	6.1	10.7	17.3	29.4	9.5	10.4	5.3	15.5	15.3	14.5	3.3	23.6	14.0	15.1	5.0	21.0	21.7	9.7	27.9	13.5	11.5	7.7	34.6	13.5	21.5	21.1	34.3	41.9	31.6	28.0	37.2	20.5	21.4	18.5	19.8	38.7	65.7	25.8	20.0	21.6	16.5	14.0	29.4	43.4	9.7	38.5	14.2	7.6	33.5	52.5	26.7	32.3	24.0	20.4	46.1	17.6	22.7	21.4	19.1	37.0	30.3	20.3	33.7	19.1	13.0	19.8	18.1	39.7	24.8	27.8	14.1	32.2	23.8	11.5	30.7	27.4	32.9	18.2	51.7	30.6	40.3	25.9	14.7	34.6	32.7	21.8	50.2	84.0	19.1	56.2	27.5	62.8	55.2	55.3	27.5	49.0	21.2	39.3	26.1	21.3	32.9	45.6	22.0	22.4	215.8	17.6	59.0	34.4	26.2	25.4	10.7	10.3	21.4	14.5	14.1	6.4	2.5	4.2	6.1	3.3	5.0	7.7	110.7	44.8	40.9	103.8	103.1	44.5	28.8	45.1	88.2	58.7	43.1	50.3	17.9	22.8	43.4	31.3	77.2	20.2	101.9	75.8	19.6	24.1	11.1	49.7	60.4	74.1	51.6	50.1	141.2	24.3	22.2	62.2	44.4	49.7	39.9	33.5	57.5	32.5	65.4	121.1	143.1	44.4	22.4	115.7	67.5	9.7	46.6	110.8	35.6	143.4	122.3	29.1	68.0	132.7	130.1	31.7	70.7	37.6	67.6	41.5	39.3	28.6	45.1	92.6	59.2	43.8	61.4	39.6	26.7	143.7	51.7	29.0	85.1	43.0	37.6	38.6
ACD	"Pip1, Ptop, Tint1, Tpp1"	ENSG00000102977	"ACD shelterin complex subunit and telomerase recruitment factor"	Q96AP0	16	67657512-67660815	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049411, HPA057660"	Approved		Enhanced	"Nuclear bodies"		NA	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear bodies"		"HPA049411: AB_2680752, HPA057660: AB_2683493"	"unprognostic (1.47e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.15e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.24e-3)"	"prognostic unfavorable (2.42e-6)"	"unprognostic (1.50e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.13e-3)"	"unprognostic (3.27e-2)"	"unprognostic (8.88e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.30e-1)"	13.0	9.9	14.2	7.3	14.4	10.1	12.9	14.4	17.7	17.1	12.0	14.8	4.2	16.4	4.0	9.1	15.6	5.2	11.2	14.6	14.2	10.8	6.7	9.9	10.1	14.6	14.2	19.9	12.4	6.3	13.7	4.7	15.0	12.2	2.3	2.7	9.4	6.3	9.8	11.4	12.1	4.6	14.1	14.9	11.2	23.7	14.6	5.5	10.0	3.2	5.6	15.5	12.2	14.6	42.1	32.3	18.4	19.2	8.3	5.8	39.5	17.1	11.3	25.0	30.3	42.0	20.3	11.6	19.4	9.4	22.5	32.7	11.3	32.8	8.2	12.6	37.4	24.9	13.4	42.4	5.8	32.5	37.6	8.3	10.0	33.7	17.7	9.4	15.9	34.3	15.7	8.1	12.6	45.2	31.8	31.8	23.5	16.3	21.5	44.1	19.8	48.0	10.5	16.6	26.3	23.1	64.0	6.7	14.5	5.3	15.8	17.9	13.8	26.6	22.4	31.9	26.1	21.7	28.6	35.9	24.7	20.5	23.3	34.5	18.2	22.8	40.2	22.2	34.1	46.4	36.7	34.8	21.0	37.7	28.5	30.3	25.9	43.5	25.8	22.9	39.5	24.7	14.2	14.4	14.4	17.7	14.6	14.2	14.6	14.2	15.0	14.1	14.6	14.6	19.4	6.4	11.9	5.5	22.3	14.4	15.9	22.6	21.6	14.7	13.7	16.0	2.8	8.6	12.6	11.0	4.2	25.1	22.5	5.5	9.8	21.3	59.3	6.6	7.7	15.4	12.5	11.6	6.2	19.6	22.8	14.1	9.7	6.8	27.9	13.6	12.8	4.7	15.5	13.5	6.1	6.4	6.1	7.6	20.6	71.4	15.2	13.4	23.2	4.7	19.3	14.3	30.9	4.0	3.6	18.4	9.2	11.7	17.0	9.9	10.2	13.2	16.1	10.8	6.6	11.8	14.8	58.1	24.1	7.1	9.7	11.4	27.0	6.9	9.0	10.0
ACIN1	"ACINUS, fSAP152, KIAA0670"	ENSG00000100813	"Apoptotic chromatin condensation inducer 1"	Q9UKV3	14	23058564-23095614	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000657	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		30000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA000657: AB_1078091"	"unprognostic (2.54e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.89e-3)"	"prognostic unfavorable (4.88e-5)"	"unprognostic (1.49e-3)"	"unprognostic (9.70e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.35e-3)"	"unprognostic (4.34e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.33e-2)"	41.5	57.7	58.3	35.0	60.2	66.7	36.6	64.3	64.6	46.1	62.7	42.6	28.6	41.5	30.1	50.9	39.3	24.3	44.1	57.5	63.4	51.3	47.5	33.8	45.2	60.9	60.6	48.7	45.1	41.4	48.5	37.2	59.9	45.8	33.2	39.0	39.1	27.8	53.0	39.5	46.0	38.9	55.7	66.4	45.3	47.6	61.6	52.8	47.1	36.5	47.4	41.9	41.3	64.4	77.1	77.6	120.0	97.7	73.3	58.5	120.2	83.8	58.8	98.9	80.0	103.8	87.8	141.8	48.4	69.7	65.0	82.6	167.4	95.6	100.7	100.2	74.3	124.5	82.9	144.8	41.8	136.6	106.4	69.0	58.0	101.5	84.8	81.0	87.9	103.4	117.2	55.1	75.7	96.5	156.1	134.6	135.1	84.6	73.3	139.7	93.0	75.8	82.9	133.3	79.7	58.6	111.2	71.7	69.1	86.7	59.2	109.0	90.7	67.3	67.3	64.7	78.5	57.9	70.2	144.0	59.9	101.8	74.8	5.3	4.0	5.1	4.2	3.5	3.2	3.8	2.9	3.2	3.4	5.4	3.8	3.7	10.8	7.5	3.2	5.5	3.5	2.6	58.3	60.2	64.3	64.6	57.5	63.4	60.9	60.6	59.9	55.7	61.6	64.4	49.8	70.5	123.0	44.4	61.6	37.3	30.2	52.7	64.9	38.1	43.4	40.8	67.9	32.9	67.2	35.0	27.1	58.0	65.0	64.4	17.6	53.4	42.5	70.5	97.6	55.5	58.3	76.2	41.0	49.3	66.8	60.3	85.1	90.1	130.6	79.4	35.0	28.8	47.1	15.2	43.6	50.1	42.7	38.1	40.8	10.9	46.0	52.5	26.6	44.0	53.4	26.1	54.6	45.8	65.6	59.4	49.7	38.4	65.4	43.5	37.7	21.6	82.6	43.3	6.6	52.4	66.9	42.1	39.2	58.5	46.5	69.2	65.2	86.1	55.8	38.4
ACOT7	"ACH1, ACT, BACH, CTE-II, hBACH, LACH1, MGC1126"	ENSG00000097021	"Acyl-CoA thioesterase 7"	O00154	1	6264269-6393767	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 128.7"	"Cell type enhanced"	"Detected in many"		"granulocytes: 137.2;Late spermatids: 160.8;Proximal enterocytes: 179.4;Proximal tubular cells: 253.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"NK-cell: 40.2;plasmacytoid DC: 35.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 35.7;NK-cells: 40.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025735, HPA025762"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		26000	"Cluster 40: NK-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA025735: AB_1844523, HPA025762: AB_1844524"	"unprognostic (3.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.33e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (2.31e-5)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.35e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (2.55e-6)"	"unprognostic (2.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.72e-2)"	11.3	20.4	72.8	18.7	72.8	14.7	9.9	56.2	108.2	17.8	16.7	32.7	55.1	18.2	5.5	35.0	11.0	8.2	17.3	75.1	107.2	47.8	22.0	17.9	22.4	96.1	88.5	11.2	9.0	3.8	65.1	10.4	128.7	12.9	21.4	24.5	11.9	6.9	5.2	27.1	56.1	23.5	46.9	20.7	19.2	38.1	83.9	28.3	6.1	4.7	19.4	18.0	23.5	68.4	117.6	100.0	96.6	104.6	21.7	35.6	36.4	98.6	50.6	142.7	85.1	347.7	37.0	142.4	70.6	80.4	110.3	113.0	156.9	263.2	53.2	126.0	136.7	75.2	74.4	124.9	88.7	88.8	59.9	32.1	49.6	118.2	139.2	38.1	81.2	174.8	62.3	29.8	76.8	136.6	187.0	94.0	48.5	116.9	228.2	219.9	110.6	95.6	80.9	44.2	52.6	149.1	88.9	134.5	317.9	47.3	47.9	41.2	133.0	129.1	75.4	129.6	158.9	24.9	110.6	202.1	81.8	153.7	80.3	0.0	0.3	0.2	7.3	1.2	1.8	2.1	5.8	6.2	5.4	0.7	2.0	3.9	0.7	40.2	0.9	35.7	8.2	5.3	72.8	72.8	56.2	108.2	75.1	107.2	96.1	88.5	128.7	46.9	83.9	68.4	3.4	6.4	16.4	9.4	4.9	31.7	16.5	24.2	12.5	46.8	4.1	7.5	9.8	8.6	14.9	9.2	10.4	20.9	14.4	45.4	15.6	22.7	95.5	4.0	6.1	19.1	4.8	26.5	38.6	7.2	29.7	11.5	19.9	7.6	137.2	13.2	8.6	16.8	30.1	47.1	38.9	110.2	36.7	4.8	85.9	160.8	3.7	13.4	39.2	5.6	15.7	12.8	8.2	22.6	21.0	23.2	41.8	7.2	9.3	9.5	179.4	253.7	7.1	24.4	0.0	6.7	17.6	37.8	28.0	26.2	29.5	17.2	21.7	13.7	51.3	19.6
ACOT9	"ACATE2, CGI-16, MT-ACT48"	ENSG00000123130	"Acyl-CoA thioesterase 9"	Q9Y305	X	23701055-23766475	"Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 192.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035533	Supported		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		7600	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA035533: AB_10696506"	"unprognostic (5.69e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-1)"	"unprognostic (9.75e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.15e-3)"	"unprognostic (6.53e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	24.1	18.8	8.0	19.5	7.5	15.8	19.8	7.5	9.5	17.7	10.3	22.0	15.5	22.5	8.4	12.1	17.3	13.6	49.3	7.2	9.1	15.5	14.5	26.1	12.7	8.0	7.5	15.1	14.0	11.7	8.8	17.8	8.6	16.1	16.4	9.6	18.6	22.1	27.6	12.5	15.8	32.3	6.9	18.4	17.7	6.2	8.5	6.3	17.4	14.2	12.5	21.3	14.7	7.5	81.5	54.0	23.1	51.4	37.2	42.0	11.7	62.7	54.3	60.7	58.4	48.5	71.4	4.1	39.1	70.5	81.8	48.3	29.6	79.9	84.2	18.8	44.6	27.4	55.0	35.6	49.9	10.8	33.3	37.5	53.6	71.5	80.5	39.6	90.3	0.6	17.7	26.7	66.7	28.4	15.2	26.1	33.9	31.8	65.3	15.7	87.6	34.4	72.8	29.8	4.5	22.1	68.4	28.3	41.6	85.5	31.9	14.0	84.7	50.7	33.8	73.3	34.7	6.4	16.1	0.5	37.4	10.5	43.6	24.7	30.2	22.2	10.2	43.5	14.1	11.1	12.6	11.3	32.4	9.9	4.0	9.4	15.8	12.3	56.2	5.4	20.8	18.6	8.0	7.5	7.5	9.5	7.2	9.1	8.0	7.5	8.6	6.9	8.5	7.5	34.6	48.1	27.3	12.1	23.0	20.1	45.9	51.8	7.4	5.3	5.6	6.7	44.3	18.6	36.8	16.5	25.0	4.0	21.5	9.7	5.9	59.6	0.8	20.8	22.9	38.7	2.4	11.2	6.1	52.5	11.4	33.4	16.8	21.6	37.3	14.8	32.9	11.8	42.4	5.0	8.6	10.3	16.2	37.1	95.4	0.4	18.0	57.3	33.8	13.1	192.3	11.9	19.6	4.5	3.1	83.4	15.0	25.6	27.7	52.4	14.6	30.3	38.0	9.9	26.3	35.2	65.1	1.6	10.4	3.5	10.7	3.0	21.2	30.4	11.2	38.2
ACTL6A	"Actl6, Arp4, BAF53A, INO80K"	ENSG00000136518	"Actin like 6A"	O96019	3	179562886-179588407	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 243.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012188, HPA018671, HPA063149"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA		18000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB012188: AB_304125, HPA018671: AB_2669914, HPA063149: "	"unprognostic (2.13e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.24e-3)"	"unprognostic (7.79e-3)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (1.89e-5)"	"unprognostic (3.36e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.13e-2)"	"prognostic unfavorable (5.44e-5)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (4.80e-5)"	"unprognostic (4.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.21e-3)"	"unprognostic (5.20e-2)"	19.7	20.4	8.3	23.5	9.8	17.8	33.0	10.1	12.4	24.6	11.0	31.1	24.7	27.6	25.9	25.3	25.0	15.6	18.6	7.9	9.5	22.3	21.8	19.0	32.0	10.4	9.8	31.9	20.6	24.3	13.1	23.5	10.8	21.3	37.8	16.3	21.3	21.4	12.3	26.8	23.8	26.3	9.4	19.9	22.3	62.5	8.9	46.0	20.5	13.9	41.4	24.8	20.7	11.9	196.4	59.5	142.2	75.7	53.4	58.0	111.7	78.1	60.2	142.3	119.8	126.6	94.8	154.0	136.8	73.5	164.7	88.7	126.3	95.7	174.6	156.7	105.0	125.5	58.2	101.9	61.0	157.4	75.2	40.7	96.1	91.5	76.6	44.5	82.5	90.7	100.1	85.1	103.6	135.6	140.1	96.8	127.6	178.0	129.5	128.7	118.0	284.4	113.4	76.2	116.9	83.2	119.1	118.5	125.2	71.2	231.5	128.8	62.5	101.0	87.1	104.1	237.8	54.6	86.5	231.3	55.6	165.0	113.5	5.7	19.3	14.7	24.5	25.5	32.4	29.2	27.8	28.5	34.1	24.1	30.2	31.3	2.6	26.7	30.1	19.3	39.1	24.3	8.3	9.8	10.1	12.4	7.9	9.5	10.4	9.8	10.8	9.4	8.9	11.9	31.1	22.4	23.1	6.2	27.1	47.2	48.0	60.4	29.0	6.1	24.5	23.9	6.7	30.0	38.1	27.6	8.4	51.2	21.6	13.4	35.2	51.1	53.5	27.1	28.8	26.7	30.5	62.3	2.8	44.7	67.5	28.1	23.4	20.8	14.5	31.0	13.6	16.8	34.9	0.0	3.8	26.7	48.8	17.1	18.7	17.7	32.3	15.4	30.2	3.7	27.1	16.7	18.6	6.6	19.0	38.8	18.8	30.1	25.8	45.4	18.2	25.8	35.6	14.9	26.3	25.0	49.0	243.2	92.1	42.7	45.9	30.6	21.6	35.1	40.4	38.5
ACTR8	"ARP8, INO80N"	ENSG00000113812	"Actin related protein 8"	Q9H981	3	53867066-53882152	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 44.3;Late spermatids: 85.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 56.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065236			Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Centrosome	"HPA065236: AB_2685442"	"unprognostic (9.05e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (2.21e-4)"	"unprognostic (2.97e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (5.11e-6)"	"unprognostic (2.24e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.68e-2)"	"prognostic favorable (7.88e-9)"	"unprognostic (3.68e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.15e-1)"	8.4	6.8	7.8	9.8	8.6	9.4	9.3	10.5	9.0	9.2	13.0	9.3	7.4	9.8	9.0	9.2	9.0	8.1	18.5	8.3	9.3	13.0	8.7	9.2	13.9	8.6	9.6	10.3	9.4	14.7	7.2	11.0	8.5	9.0	12.0	7.6	8.8	8.6	9.0	9.2	7.2	11.0	8.8	9.4	9.6	21.5	9.3	13.4	12.1	12.6	14.8	11.5	7.3	9.6	11.9	14.4	27.5	22.9	22.2	27.6	20.6	27.4	34.8	36.3	28.7	22.6	14.1	36.1	7.9	37.9	26.7	9.9	21.0	18.8	34.1	14.7	8.7	35.2	21.9	24.3	26.1	38.6	30.8	21.8	19.1	37.6	23.4	28.0	28.4	18.9	16.4	12.2	37.0	13.8	12.9	23.0	25.7	17.0	22.7	16.8	17.3	21.8	27.5	32.7	8.1	23.5	17.8	15.4	16.1	25.9	9.9	21.1	19.7	27.5	17.8	25.6	25.2	33.9	46.4	36.3	20.4	27.7	17.6	56.2	8.2	10.5	9.2	12.0	9.2	9.8	8.5	8.8	10.7	6.1	8.9	9.6	4.3	15.1	7.4	7.8	15.0	8.0	7.8	8.6	10.5	9.0	8.3	9.3	8.6	9.6	8.5	8.8	9.3	9.6	6.3	3.2	7.7	6.5	9.4	7.8	6.0	12.3	5.7	6.8	5.4	5.1	19.5	10.0	8.6	3.7	4.2	12.7	11.6	5.7	21.5	15.1	44.3	5.9	12.0	8.8	10.8	7.8	7.1	15.6	11.3	7.8	12.2	7.6	5.7	10.9	8.2	5.4	11.5	1.7	8.5	10.6	12.2	7.6	6.9	85.9	10.8	10.0	5.4	4.7	11.9	7.6	13.4	8.0	6.2	15.5	3.5	9.8	13.6	6.3	5.9	24.1	5.0	5.3	0.0	5.5	20.8	27.6	20.3	7.3	6.5	10.3	11.5	13.5	6.3	6.5
ACYP1		ENSG00000119640	"Acylphosphatase 1"	P07311	14	75053237-75069483	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Respiratory ciliated cells: 137.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034944	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		89000	"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	Nucleoplasm	"HPA034944: AB_10669898"	"prognostic favorable (1.17e-4)"	"unprognostic (3.83e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.90e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (6.14e-7)"	"unprognostic (5.48e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.37e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.74e-2)"	"unprognostic (6.69e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.32e-3)"	13.7	38.4	46.2	15.2	48.6	21.1	22.1	49.9	65.5	17.3	50.8	21.5	15.6	14.4	36.7	20.8	29.6	10.2	17.0	45.0	54.0	29.1	9.6	19.7	27.7	50.7	49.7	13.6	12.4	21.1	36.5	15.3	51.8	17.3	26.9	44.0	15.8	15.0	34.0	35.0	21.1	15.6	46.6	16.5	19.3	26.9	50.4	39.7	30.1	21.1	28.1	16.1	17.6	56.0	78.9	43.1	60.9	37.4	24.5	26.6	32.6	44.7	17.2	45.5	63.5	42.8	86.9	86.5	26.4	18.2	25.7	68.1	39.9	19.1	73.8	127.8	49.3	57.6	123.6	32.1	14.3	36.6	56.8	14.9	27.7	61.5	30.0	28.8	60.0	80.9	45.2	103.0	60.0	52.3	82.7	67.7	18.6	67.6	40.8	64.7	80.8	41.2	62.2	39.0	112.0	44.5	29.5	20.8	74.2	29.1	44.5	35.4	27.3	29.5	55.6	61.3	48.4	23.8	52.4	94.6	46.1	42.5	32.8	5.3	2.8	17.5	10.9	6.2	12.7	13.7	18.3	12.9	5.1	14.1	15.4	14.5	1.2	14.0	10.5	10.3	24.6	6.7	46.2	48.6	49.9	65.5	45.0	54.0	50.7	49.7	51.8	46.6	50.4	56.0	18.5	6.4	9.1	17.0	18.2	28.7	44.4	54.1	30.1	38.6	20.8	24.0	21.2	31.5	28.9	66.2	12.5	27.3	18.7	24.5	39.2	20.6	31.6	89.2	18.4	26.5	30.1	47.5	17.8	18.7	33.7	22.7	13.7	17.8	12.0	19.8	10.4	5.7	22.3	43.7	25.0	25.2	73.2	6.6	11.7	11.0	16.8	12.3	39.2	15.9	10.1	23.2	16.5	16.1	44.4	20.2	20.6	16.6	16.9	20.2	16.7	22.3	137.9	32.4	26.3	11.1	31.5	89.8	14.1	23.8	24.0	13.7	22.3	20.4	33.8	34.4
ADAR	"ADAR1, G1P1, IFI4"	ENSG00000160710	"Adenosine deaminase RNA specific"	P55265	1	154581695-154628013	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, mRNA processing, RNA-mediated gene silencing"	"DNA-binding, Hydrolase, RNA-binding"	"Aicardi-Goutieres syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003890, HPA051519, CAB056157"	Enhanced		Enhanced	Nucleoplasm,Nucleoli		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoli	Nucleoplasm	"CAB056157: AB_2665578, HPA003890: AB_1078103, HPA051519: AB_2681520"	"unprognostic (3.46e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.13e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (7.30e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.94e-2)"	41.9	44.7	30.4	57.2	29.9	47.1	41.1	18.0	35.1	49.4	16.3	42.9	46.4	50.2	26.3	37.9	50.3	45.6	36.1	31.5	40.0	51.7	56.1	54.6	66.1	32.1	33.8	54.9	40.6	62.8	53.9	46.5	34.8	42.8	44.4	47.9	59.4	43.0	18.8	39.9	52.8	56.6	39.2	73.5	40.3	34.4	37.8	85.2	47.1	27.6	65.0	50.5	40.0	25.5	93.2	103.1	84.4	104.8	87.4	88.5	97.8	59.5	132.7	209.8	183.4	87.8	85.3	162.6	97.7	98.7	112.4	85.4	111.9	115.5	109.8	159.1	52.3	84.9	66.2	48.4	96.7	122.8	83.8	86.2	84.7	100.4	104.1	81.2	104.5	112.4	82.4	111.6	72.0	107.8	165.0	43.3	139.7	125.5	74.6	140.1	74.2	131.2	67.6	106.1	84.8	100.2	104.4	167.9	126.2	128.1	113.4	148.2	94.3	67.5	68.5	58.8	71.5	132.9	179.0	177.6	70.2	78.4	81.0	7.8	8.1	15.0	10.8	9.9	10.2	9.0	10.6	11.2	7.8	5.8	9.8	10.0	29.1	8.6	9.4	6.3	9.1	7.4	30.4	29.9	18.0	35.1	31.5	40.0	32.1	33.8	34.8	39.2	37.8	25.5	73.3	83.3	51.2	37.5	80.5	33.3	39.4	39.9	32.5	94.5	43.6	36.6	22.1	45.8	44.0	47.8	95.9	41.2	103.0	73.3	9.8	49.2	4.2	48.9	61.0	86.7	63.1	45.2	44.8	66.9	57.8	49.1	56.6	52.4	62.1	88.6	84.9	93.8	53.5	168.2	53.2	53.9	34.6	104.1	43.9	13.1	73.7	78.0	19.6	32.8	110.2	37.9	126.7	38.2	39.7	69.6	62.7	59.0	87.5	61.1	86.7	42.5	50.0	80.2	52.6	40.1	45.2	11.4	35.0	37.9	40.3	31.5	85.6	66.5	56.2	53.8
ADAT1		ENSG00000065457	"Adenosine deaminase tRNA specific 1"	Q9BUB4	16	75596868-75623300	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 101.9;Late spermatids: 213.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040713, HPA040903"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA040713: AB_10795371, HPA040903: AB_10794071"	"unprognostic (7.71e-3)"	"unprognostic (5.35e-2)"	"unprognostic (7.62e-2)"	"unprognostic (9.00e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.65e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.14e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.60e-3)"	"unprognostic (7.21e-2)"	"unprognostic (4.92e-1)"	"unprognostic (5.58e-3)"	"unprognostic (8.27e-2)"	13.8	16.4	11.0	9.5	11.1	7.8	14.1	11.5	15.1	12.0	10.5	11.6	5.1	14.0	12.7	11.7	11.8	6.6	11.5	10.8	10.5	19.8	18.5	12.8	10.8	11.5	11.2	10.3	12.6	14.6	14.2	7.3	11.7	15.3	9.1	9.6	12.1	8.6	9.5	14.1	14.0	6.0	10.6	20.4	12.0	26.9	11.5	11.8	14.8	5.2	8.7	13.1	11.6	13.0	14.7	23.1	15.0	15.5	26.4	20.3	11.5	20.2	21.0	26.1	17.7	15.4	22.4	15.7	19.8	20.6	14.0	17.6	16.4	25.0	24.6	11.7	8.6	8.8	16.0	13.3	21.2	19.6	19.6	21.7	23.8	42.7	32.1	7.5	23.1	24.7	13.7	7.6	21.2	35.9	18.8	14.3	12.2	19.8	10.7	23.6	12.1	21.5	24.6	22.0	18.1	18.6	47.8	12.2	11.2	15.0	24.6	9.3	16.3	32.4	14.6	17.1	16.9	15.1	24.3	58.9	16.3	15.6	28.5	8.5	4.3	11.5	8.5	6.4	11.3	7.9	7.3	11.3	5.8	7.3	4.5	6.3	4.9	10.8	9.9	4.6	9.0	6.2	11.0	11.1	11.5	15.1	10.8	10.5	11.5	11.2	11.7	10.6	11.5	13.0	9.9	9.6	5.8	2.3	11.6	4.6	5.9	5.7	6.8	13.5	10.7	6.6	5.6	11.5	6.6	7.3	27.1	11.8	9.8	6.8	17.6	8.6	101.9	11.8	8.2	11.9	14.4	16.0	6.0	7.6	8.9	6.4	8.6	10.5	8.2	12.6	6.1	10.5	10.3	13.5	6.4	4.7	10.2	14.4	10.6	213.0	9.9	10.2	3.6	2.8	12.8	7.8	15.5	3.0	8.0	9.8	3.3	7.9	8.1	8.3	6.9	11.3	9.9	21.6	6.6	6.8	7.0	17.5	13.4	8.4	5.4	9.7	14.8	12.9	9.1	7.6
ADCK2	MGC20727	ENSG00000133597	"AarF domain containing kinase 2"	Q7Z695	7	140672945-140696261	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 98.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036036	Approved		Uncertain	Centrosome,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Centrosome, Cytosol"		"HPA036036: AB_10672078"	"unprognostic (2.76e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.72e-2)"	"unprognostic (5.30e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.05e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.10e-3)"	"unprognostic (6.81e-3)"	"unprognostic (9.36e-3)"	"prognostic favorable (9.75e-5)"	"unprognostic (1.89e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.13e-1)"	"unprognostic (2.13e-1)"	10.4	9.1	23.7	10.2	25.1	8.8	11.3	24.6	25.9	11.9	16.5	13.4	7.4	9.7	8.9	17.5	16.0	8.3	10.7	24.3	24.2	12.4	13.3	10.8	14.8	29.1	25.6	11.8	14.4	19.5	12.8	11.2	25.9	13.2	10.9	6.3	15.6	10.7	14.1	26.3	11.0	9.0	26.3	12.2	13.1	6.5	26.4	12.4	12.8	8.4	14.1	11.9	13.7	30.2	32.6	23.2	5.6	24.9	19.3	21.5	31.7	16.5	20.0	17.2	11.2	21.7	22.5	42.4	24.0	11.7	39.4	26.3	27.5	19.0	5.1	31.3	26.1	9.2	8.8	11.1	26.5	6.2	21.8	17.7	56.8	9.9	13.5	17.3	14.8	30.9	16.1	20.9	6.1	41.0	46.4	15.3	8.2	27.0	23.1	36.3	0.3	21.0	9.9	34.9	20.6	14.5	22.7	32.7	23.3	10.1	29.2	12.2	15.6	21.3	7.3	35.0	32.0	14.2	23.2	32.4	31.3	23.9	25.7	0.0	3.0	3.0	4.2	4.1	4.0	7.0	3.8	4.3	4.8	3.0	5.8	3.7	0.1	4.4	2.6	10.1	5.4	2.0	23.7	25.1	24.6	25.9	24.3	24.2	29.1	25.6	25.9	26.3	26.4	30.2	9.0	9.6	3.6	2.3	9.8	12.4	21.3	4.4	5.7	11.4	15.3	11.7	6.4	7.2	3.5	9.2	0.0	32.9	17.8	15.0	5.9	6.3	37.9	5.6	3.4	8.8	16.8	12.2	6.5	7.5	20.2	6.2	5.1	9.3	11.4	98.0	7.1	9.9	31.5	11.8	6.7	13.5	6.1	11.4	16.1	16.4	3.4	14.3	3.6	6.5	8.4	13.3	9.2	8.0	10.8	6.1	15.8	13.5	5.1	19.6	8.3	5.7	4.8	5.9	0.0	9.5	7.2	7.0	6.4	7.3	13.9	33.8	9.6	14.9	14.0	21.2
ADNP2	"KIAA0863, ZNF508"	ENSG00000101544	"ADNP homeobox 2"	Q6IQ32	18	80109262-80147523	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 41.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007126	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Mitochondria, Cytosol"		"HPA007126: AB_1080729"	"unprognostic (4.93e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.24e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.40e-2)"	"unprognostic (8.35e-2)"	"prognostic favorable (6.39e-5)"	"unprognostic (8.64e-2)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (9.90e-4)"	"unprognostic (5.19e-2)"	8.0	6.2	17.3	6.6	13.1	41.3	8.1	7.3	31.2	6.0	9.9	7.2	9.1	7.4	10.8	8.6	6.6	7.5	8.0	10.2	9.1	6.7	7.9	7.5	7.2	15.4	10.1	8.0	8.2	9.6	6.9	6.7	14.0	6.8	6.6	12.4	6.4	6.3	2.7	12.7	6.6	7.8	9.4	6.5	7.8	22.0	18.0	9.4	8.4	4.5	7.1	7.7	6.9	15.6	23.1	17.8	36.2	27.0	8.1	11.4	27.0	16.3	18.6	19.2	23.8	16.9	11.5	0.2	6.2	13.3	23.6	20.8	35.4	21.1	20.2	21.0	17.8	32.3	12.8	18.5	14.8	47.5	34.5	11.9	19.6	19.7	26.1	12.8	19.4	36.1	31.8	33.3	11.4	16.4	43.8	9.9	24.9	10.3	20.6	16.6	40.5	16.4	11.6	30.3	24.7	31.8	18.4	18.1	13.0	17.6	17.8	36.0	13.3	22.6	56.6	9.5	18.4	11.7	23.1	46.8	15.1	19.8	15.7	0.0	0.4	0.2	1.2	0.7	0.8	0.8	1.5	1.0	0.2	0.3	0.8	1.4	0.6	0.6	1.2	0.8	0.8	0.5	17.3	13.1	7.3	31.2	10.2	9.1	15.4	10.1	14.0	9.4	18.0	15.6	17.0	19.2	20.9	21.9	10.2	39.5	24.4	11.7	16.5	20.3	17.0	11.9	16.6	10.0	12.6	3.7	27.1	10.1	15.5	17.4	0.0	7.9	9.9	15.8	14.2	14.5	22.2	22.3	22.7	10.9	8.3	15.9	13.3	31.2	12.0	13.6	15.4	19.5	9.9	25.2	25.2	18.9	14.2	10.6	13.8	8.2	7.5	14.6	14.2	11.2	5.5	9.7	3.1	17.1	36.8	11.5	15.9	11.7	9.7	21.7	10.6	7.2	10.2	30.2	0.0	15.6	14.5	45.4	38.3	23.7	43.2	9.7	15.5	17.8	13.6	32.2
ADSL		ENSG00000239900	"Adenylosuccinate lyase"	P30566	22	40346461-40390463	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Purine biosynthesis"	Lyase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"skeletal muscle: 345.1;tongue: 242.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000525, CAB019285"	Enhanced		Enhanced	Cytosol		NA	NA		440000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"CAB019285: , HPA000525: AB_1078106"	"unprognostic (2.80e-1)"	"unprognostic (2.12e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (2.64e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.87e-3)"	"prognostic unfavorable (5.81e-8)"	"unprognostic (1.35e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.99e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.99e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.44e-2)"	29.8	33.9	10.6	31.1	11.2	40.6	33.1	12.5	13.3	30.7	12.9	36.5	22.7	34.9	21.9	29.8	33.5	20.6	47.4	10.9	10.6	33.6	32.1	22.7	46.9	10.5	11.7	33.5	45.2	29.3	22.0	30.2	10.9	23.8	35.4	10.3	25.7	22.3	345.1	22.2	28.8	41.1	10.0	33.5	28.0	29.2	10.5	50.5	29.6	242.3	48.5	36.0	25.2	10.8	98.0	110.2	88.3	124.9	62.6	89.5	106.5	82.0	85.2	187.3	138.1	189.0	51.9	279.0	73.2	102.3	84.9	67.3	203.5	137.4	187.7	75.3	197.5	126.5	98.4	166.5	134.6	423.0	96.3	97.7	76.5	161.5	169.8	91.3	138.9	127.3	153.1	114.3	136.4	105.0	130.2	131.2	152.5	121.3	119.3	195.1	203.6	198.2	118.9	67.8	58.8	54.4	106.2	54.1	170.7	78.5	76.8	134.7	91.2	93.3	173.7	85.3	168.8	109.0	212.6	218.2	80.9	149.5	97.7	29.0	47.2	19.9	35.5	55.2	49.5	34.6	76.1	48.5	68.1	33.5	58.3	45.0	4.1	48.2	49.7	34.4	81.7	62.3	10.6	11.2	12.5	13.3	10.9	10.6	10.5	11.7	10.9	10.0	10.5	10.8	10.0	12.8	10.8	9.4	28.3	18.1	18.8	48.6	23.9	16.1	14.8	15.0	30.0	30.0	20.8	3.7	37.5	85.3	15.5	13.0	7.9	61.3	44.0	5.6	9.2	21.6	13.8	54.6	11.4	43.7	78.9	21.2	21.4	5.6	36.8	8.8	28.9	25.6	60.3	6.7	10.7	24.1	24.4	44.8	26.7	25.2	24.8	22.7	12.4	1.0	41.9	45.1	19.6	9.5	9.8	33.7	15.6	14.3	52.4	21.3	21.4	19.7	12.3	18.1	26.3	38.5	20.8	61.2	82.8	35.7	15.2	33.1	32.2	8.7	37.7	14.1
AGBL5	"CCP5, FLJ21839"	ENSG00000084693	"ATP/GTP binding protein like 5"	Q8NDL9	2	27042364-27070622	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"parathyroid gland: 49.9;testis: 192.9"	"Group enriched"	"Detected in many"	6	"Early spermatids: 302.7;Late spermatids: 338.0;Spermatocytes: 156.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030981	Uncertain		Supported	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Cytokinetic bridge"	"Microtubules, Cytosol"	"HPA030981: AB_10611673"	"unprognostic (1.29e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.87e-5)"	"unprognostic (1.86e-1)"	"unprognostic (4.34e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.50e-2)"	8.8	16.7	8.4	8.0	7.4	13.6	12.4	7.8	8.2	14.4	9.5	16.2	8.8	14.0	26.0	18.3	20.8	14.3	12.7	7.3	11.3	22.5	7.2	11.2	10.7	8.3	7.8	14.4	15.0	49.9	12.5	11.2	8.9	15.2	11.5	16.3	21.2	16.5	7.1	20.5	9.9	14.6	6.1	8.5	11.8	192.9	9.1	15.6	28.5	6.5	8.6	14.9	7.3	7.5	55.0	34.7	55.4	37.2	11.6	23.0	62.9	10.9	23.5	30.9	31.9	30.2	40.5	30.3	34.0	18.9	43.4	24.6	44.8	49.4	33.9	25.9	66.8	44.5	42.0	65.7	23.6	21.6	14.4	24.4	36.7	27.1	22.0	46.9	32.8	43.5	38.9	23.8	30.3	21.5	63.2	32.3	39.4	39.4	23.7	64.5	62.9	48.0	31.9	13.6	37.1	53.6	21.5	16.7	35.0	53.9	24.9	16.3	16.4	28.6	39.2	13.8	23.9	47.7	27.2	62.4	31.8	24.4	26.1	8.8	1.8	4.5	3.3	1.1	2.5	4.6	4.1	4.6	4.1	2.3	3.6	2.2	1.1	8.5	0.7	2.3	2.8	3.8	8.4	7.4	7.8	8.2	7.3	11.3	8.3	7.8	8.9	6.1	9.1	7.5	3.6	0.0	10.1	5.2	6.3	3.3	8.3	7.2	13.6	5.7	8.6	6.7	6.7	10.0	6.8	9.2	0.0	14.7	1.8	5.9	19.6	8.3	302.7	13.0	3.9	4.9	2.4	11.6	7.9	6.0	7.9	6.4	5.6	5.8	1.3	14.1	6.4	4.1	5.2	0.0	9.1	8.4	6.1	3.1	3.5	338.0	10.5	8.0	7.2	6.5	4.9	6.8	0.0	10.1	10.1	5.0	7.6	11.3	17.1	6.0	6.3	25.0	10.7	10.0	0.0	4.2	7.0	156.8	41.2	16.3	2.7	8.3	5.0	9.4	8.6	10.5
AGGF1	"FLJ10283, GPATC7, GPATCH7, HSU84971, VG5Q"	ENSG00000164252	"Angiogenic factor with G-patch and FHA domains 1"	Q8N302	5	77029251-77065234	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"																"Secreted to blood"	NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"				"unprognostic (7.13e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (2.87e-4)"	"unprognostic (1.67e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.12e-3)"	"unprognostic (4.27e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.82e-2)"	"unprognostic (4.04e-1)"	"unprognostic (1.58e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.30e-1)"	"unprognostic (8.21e-2)"	9.8	10.5	11.0	11.5	11.1	9.2	10.5	11.2	11.8	9.1	9.5	10.5	14.1	9.1	21.4	8.7	7.7	8.6	10.0	11.1	11.3	12.9	13.7	9.4	13.6	12.0	12.0	10.6	8.1	16.0	6.1	10.9	12.1	9.7	11.5	22.3	8.6	8.8	13.0	12.5	13.3	8.9	11.0	12.6	10.1	16.2	12.4	14.4	11.0	11.1	14.1	9.4	6.6	13.1	21.6	14.5	18.4	23.2	20.8	21.5	17.9	17.7	18.8	12.9	16.3	9.6	23.2	14.4	21.7	12.4	22.6	19.2	9.9	18.1	20.0	21.9	17.2	14.6	16.8	13.2	15.6	15.6	22.8	15.3	22.0	13.3	15.3	17.4	15.9	21.4	17.7	11.9	18.5	21.6	27.3	15.7	0.0	9.0	10.4	21.5	30.2	34.1	21.9	17.1	18.5	22.5	19.0	14.7	21.9	15.8	28.3	20.1	15.2	11.6	14.6	19.1	20.5	23.5	28.6	3.3	21.1	24.5	22.0	17.5	14.0	28.9	14.8	12.6	11.8	13.2	13.6	13.8	13.0	13.5	15.8	13.2	12.7	14.9	12.6	14.3	15.8	9.7	11.0	11.1	11.2	11.8	11.1	11.3	12.0	12.0	12.1	11.0	12.4	13.1	9.0	28.9	21.7	22.5	28.2	7.1	16.9	20.4	39.3	49.2	9.2	9.0	45.0	22.8	10.0	5.5	35.5	29.5	14.0	26.6	7.9	12.8	44.5	8.5	10.2	22.9	15.0	47.1	23.6	14.5	19.9	21.6	30.5	8.6	14.0	15.3	34.2	34.0	32.1	33.7	26.0	32.3	10.2	41.1	15.6	14.0	29.2	26.6	10.6	20.6	34.1	42.2	38.1	19.1	30.1	12.3	25.5	31.6	36.5	28.2	37.3	15.3	18.0	61.7	32.9	27.2	15.5	69.8	52.0	37.9	9.8	12.9	23.2	13.8	30.1	19.7
AGL		ENSG00000162688	"Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase"	P35573	1	99850361-99924023	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Glycogen biosynthesis"	"Glycosidase, Glycosyltransferase, Hydrolase, Multifunctional enzyme, Transferase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 257.6;tongue: 212.0"	"Cell type enhanced"	"Detected in all"		"Muller glia cells: 160.5;Theca cells: 159.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028498, HPA054340"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		450000	"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA028498: AB_10600975, HPA054340: AB_2682455"	"unprognostic (2.90e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.18e-2)"	"unprognostic (6.46e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.10e-3)"	"unprognostic (7.61e-2)"	"prognostic favorable (1.73e-10)"	"unprognostic (6.38e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.13e-2)"	11.9	6.7	4.1	7.1	4.9	6.1	9.1	6.9	5.6	6.1	6.0	10.0	8.8	7.3	7.6	16.4	5.4	5.2	22.8	3.7	5.1	13.3	42.8	5.9	7.3	4.7	5.6	5.9	4.3	17.6	4.5	11.7	4.4	13.8	10.6	23.3	7.7	9.6	257.6	5.3	7.1	9.7	4.9	8.0	7.7	4.7	4.8	7.9	10.5	212.0	8.5	8.9	5.0	5.6	20.4	5.9	7.0	11.4	11.0	10.4	23.4	6.3	9.2	5.5	9.8	22.3	6.8	26.4	11.7	10.8	4.9	11.3	40.5	12.4	10.2	14.2	12.9	15.5	18.9	12.4	7.3	13.7	8.9	12.8	7.9	7.5	6.2	7.5	8.5	9.2	26.3	2.0	5.5	6.2	16.3	4.3	10.9	8.9	7.7	0.0	2.3	1.3	16.3	26.7	17.2	12.1	18.2	17.3	9.9	12.8	12.6	9.0	9.4	6.6	9.3	8.9	6.3	7.3	6.1	30.5	11.7	3.6	3.5	0.0	0.4	1.4	1.5	0.6	1.4	1.0	1.1	1.0	0.9	1.0	1.1	1.1	0.5	2.4	0.3	0.8	1.3	0.8	4.1	4.9	6.9	5.6	3.7	5.1	4.7	5.6	4.4	4.9	4.8	5.6	12.8	22.4	26.8	96.6	28.5	10.6	18.1	24.6	18.2	34.6	18.8	18.0	119.6	18.6	25.8	16.5	54.2	107.9	18.8	23.2	23.5	13.7	1.2	18.8	23.6	13.9	16.8	15.6	45.6	12.9	20.3	28.5	31.1	18.6	10.8	45.0	14.6	111.0	17.9	52.2	56.0	15.8	12.2	19.1	8.8	2.5	10.2	13.5	16.0	23.4	14.1	160.5	21.6	36.2	34.4	17.7	14.3	21.4	20.4	13.0	15.2	19.2	26.0	46.9	6.6	41.4	18.4	8.7	11.9	40.0	9.2	29.1	25.7	159.1	23.5	20.1
AGO1	"EIF2C1, hAGO1"	ENSG00000092847	"Argonaute RISC component 1"	Q9UL18	1	35869808-35930532	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Repressor, Ribonucleoprotein, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067849			Supported	"Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Cytoplasmic bodies"	Cytosol	"HPA067849: "	"unprognostic (2.35e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.27e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.71e-2)"	"prognostic unfavorable (4.57e-5)"	"unprognostic (3.61e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.60e-4)"	"unprognostic (7.52e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.57e-2)"	"unprognostic (5.77e-3)"	6.2	6.6	10.7	7.6	9.5	6.5	6.5	7.1	8.6	7.0	7.5	6.5	6.7	7.1	5.0	5.8	6.6	4.8	7.2	8.9	9.3	6.2	4.7	6.4	6.7	9.1	9.7	8.0	5.7	10.1	5.1	5.1	9.1	8.1	7.0	6.7	6.5	8.6	8.6	11.0	7.4	7.9	11.3	8.9	6.4	5.2	8.4	9.0	6.0	7.9	8.4	5.1	4.4	9.1	14.2	9.4	21.1	18.7	14.4	8.6	23.2	7.3	11.1	12.6	11.9	19.2	9.9	16.0	9.0	14.6	8.7	7.5	30.4	11.7	15.3	14.9	10.0	32.4	15.4	16.8	6.4	19.4	12.5	7.1	5.5	21.3	10.9	8.0	18.2	13.7	24.0	8.9	10.3	10.9	20.4	10.0	47.6	19.1	8.0	15.3	15.9	6.8	5.5	17.8	26.1	11.6	25.6	10.5	8.4	23.7	8.5	7.7	14.9	9.8	21.6	13.7	13.9	9.1	7.9	7.4	10.3	11.6	12.7	1.9	3.8	1.8	1.9	5.1	1.7	1.6	1.4	1.7	1.6	1.4	1.6	1.5	2.4	1.4	4.1	1.6	1.3	4.5	10.7	9.5	7.1	8.6	8.9	9.3	9.1	9.7	9.1	11.3	8.4	9.1	10.1	3.2	9.3	11.4	11.8	13.9	7.2	6.4	17.6	34.0	13.0	9.9	15.8	12.8	9.1	14.7	39.6	5.2	25.4	12.6	1.9	11.5	5.2	11.6	12.4	13.3	25.9	5.5	15.3	13.2	4.7	10.6	9.7	7.7	16.5	12.5	10.0	13.4	13.3	35.3	15.6	15.5	6.1	30.5	20.0	6.7	14.9	19.2	5.4	4.7	23.9	12.9	20.6	13.6	14.5	11.3	11.1	20.7	7.9	10.6	29.4	10.1	11.4	30.5	13.1	13.1	15.5	12.7	16.8	10.8	14.5	2.3	10.7	14.7	16.2	7.2
AGO3	"EIF2C3, FLJ12765, hAGO3"	ENSG00000126070	"Argonaute RISC catalytic component 3"	Q9H9G7	1	35930718-36072500	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing, Translation regulation"	"Endonuclease, Hydrolase, Nuclease, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 155.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA048342, HPA067849, HPA075436"	Uncertain		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Cytoplasmic bodies"	"Nucleoplasm, Cytosol"	"HPA048342: AB_2680365, HPA067849: , HPA075436: AB_2686750"	"unprognostic (4.10e-2)"	"unprognostic (7.10e-2)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (5.70e-4)"	"unprognostic (1.89e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.39e-4)"	"unprognostic (5.14e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.96e-2)"	"unprognostic (9.28e-3)"	"unprognostic (1.61e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.81e-1)"	3.6	2.8	4.5	2.6	8.4	7.4	2.9	6.9	6.9	3.3	7.4	3.0	1.4	2.9	3.2	2.7	2.7	1.9	3.4	4.6	6.9	2.5	4.3	3.5	3.0	8.5	7.2	3.7	2.9	3.3	6.2	3.5	7.4	3.2	2.0	5.1	2.5	2.2	3.2	3.8	2.5	2.7	6.8	2.8	2.8	5.6	8.0	3.3	3.2	4.4	3.1	3.0	3.0	14.0	6.6	4.4	5.5	4.4	7.5	4.6	6.7	5.2	5.4	7.9	8.4	4.9	7.2	7.2	6.5	5.4	9.1	5.3	5.9	3.8	10.5	9.9	3.7	8.8	8.3	3.7	4.0	8.5	7.2	2.2	3.4	11.4	7.2	3.1	6.8	7.4	9.8	10.2	7.0	2.5	6.5	4.6	9.6	3.4	7.8	7.5	7.4	7.1	2.5	6.2	6.7	4.2	9.4	2.3	3.3	8.3	3.5	3.5	5.4	5.5	13.9	4.9	6.4	5.6	10.5	9.9	2.8	5.4	5.4	9.8	4.3	13.2	4.9	4.1	3.1	6.5	3.1	3.4	4.8	6.4	4.4	4.3	13.0	5.4	6.1	4.2	3.4	2.3	4.5	8.4	6.9	6.9	4.6	6.9	8.5	7.2	7.4	6.8	8.0	14.0	32.2	86.6	43.2	80.6	32.6	38.7	35.9	17.8	35.3	69.1	26.1	17.8	19.1	17.2	23.0	25.8	112.6	11.8	36.6	13.2	0.0	15.8	56.0	26.6	43.0	33.8	46.7	18.7	103.8	12.2	14.8	42.3	19.9	35.6	55.9	31.6	36.8	24.7	16.4	42.1	101.1	16.0	20.3	31.7	45.1	76.7	37.9	29.7	23.2	70.3	36.9	35.2	27.8	141.8	155.9	17.3	9.1	41.3	24.7	41.1	15.0	8.8	17.5	89.6	19.7	64.4	29.9	37.5	22.1	20.0	33.5	12.9	35.3	31.0	17.5	27.9
AGPS	"ADAP-S, ADAS, ADHAPS, ADPS, ALDHPSY"	ENSG00000018510	"Alkylglycerone phosphate synthase"	O00116	2	177392746-177567024	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Cataract, Disease variant, Dwarfism, Rhizomelic chondrodysplasia punctata"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 262.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030209, HPA030210, HPA030211"	Supported		Supported	Peroxisomes	"Intracellular and membrane"	NA	NA		69000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Peroxisomes		"HPA030209: AB_10600634, HPA030210: AB_10600202, HPA030211: AB_10602195"	"unprognostic (7.10e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.79e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (8.62e-6)"	"unprognostic (1.23e-2)"	"unprognostic (7.23e-2)"	"unprognostic (5.41e-2)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (7.74e-2)"	"prognostic favorable (9.45e-4)"	"unprognostic (7.18e-2)"	"unprognostic (3.46e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.92e-2)"	14.3	9.2	4.4	15.6	6.9	19.6	13.9	7.1	6.9	14.3	4.6	20.1	11.1	14.6	6.5	12.7	9.8	11.3	10.4	4.7	6.6	18.1	19.3	13.7	11.9	8.9	7.0	7.8	11.4	18.5	3.4	13.2	8.2	7.0	21.9	6.4	8.3	8.8	11.7	4.5	13.1	21.1	7.8	8.7	9.9	16.3	6.3	16.1	12.6	12.6	12.8	14.6	5.2	11.9	43.1	36.3	23.3	19.0	32.2	33.2	33.3	29.6	21.9	34.5	34.8	70.6	34.0	58.5	59.5	45.0	46.3	47.5	64.4	45.1	47.8	51.4	16.7	77.6	56.5	75.8	31.9	82.3	63.5	28.6	28.7	58.6	44.6	33.3	75.3	42.1	44.9	26.3	45.7	0.1	59.9	22.4	33.3	42.7	30.9	47.0	65.1	32.7	60.0	65.0	22.0	31.3	66.2	5.8	43.0	58.1	0.4	35.4	70.0	29.4	61.9	26.8	64.2	28.7	59.0	23.6	29.4	43.1	11.8	2.6	3.3	5.8	1.9	4.0	2.9	1.7	3.0	2.4	3.6	1.1	2.7	1.6	1.5	2.8	3.6	0.1	4.3	2.2	4.4	6.9	7.1	6.9	4.7	6.6	8.9	7.0	8.2	7.8	6.3	11.9	20.2	16.0	13.1	29.4	10.7	10.8	6.5	15.5	12.0	11.5	19.2	6.7	20.0	20.0	13.0	14.7	2.1	14.1	15.5	25.6	13.7	20.9	262.2	25.2	17.2	14.0	19.8	20.8	53.0	23.2	20.6	23.0	18.8	25.4	64.1	16.6	11.7	31.0	31.8	15.2	61.7	30.4	16.2	30.0	31.8	41.4	14.6	28.7	14.2	56.2	36.0	12.0	21.6	45.8	83.8	23.9	17.4	13.9	14.1	3.8	15.3	46.5	21.6	7.6	6.6	16.8	16.4	41.7	22.2	16.2	9.8	7.0	19.0	22.7	26.0	6.1
AHCTF1	ELYS	ENSG00000153207	"AT-hook containing transcription factor 1"	Q8WYP5	1	246839098-246931948	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, mRNA transport, Protein transport, Translocation, Transport"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 116.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 3.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031658	Uncertain		Supported	"Nuclear membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	"Nuclear membrane"		"HPA031658: AB_10601968"	"unprognostic (3.10e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.11e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.53e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (3.49e-8)"	"unprognostic (7.65e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.52e-2)"	12.6	7.5	4.4	8.4	6.4	16.9	9.7	11.4	6.2	9.1	5.7	9.1	6.5	8.8	6.6	9.2	7.0	7.4	6.6	4.7	6.2	9.8	10.9	7.2	9.1	3.3	5.6	16.2	10.0	13.1	6.4	8.8	3.7	7.6	6.9	8.1	6.8	7.9	11.0	8.0	6.6	7.9	3.8	9.2	8.5	32.5	7.0	12.2	13.7	15.7	9.0	10.3	7.1	4.8	37.9	25.9	24.6	20.7	24.3	23.6	32.4	24.2	19.3	29.1	24.2	26.5	19.4	37.6	24.6	21.6	16.4	34.1	40.3	20.9	49.7	21.0	9.0	26.4	29.0	24.2	17.4	40.8	17.8	22.8	18.5	37.9	38.4	13.9	21.9	18.5	61.2	24.4	27.8	12.5	31.5	19.2	42.4	34.1	18.4	30.4	32.6	32.1	18.3	28.0	22.1	28.6	34.9	19.5	20.3	18.3	22.1	29.2	20.1	26.3	22.5	33.2	55.7	25.8	38.9	45.4	19.5	27.0	26.2	0.3	0.2	0.7	0.5	0.1	0.5	0.7	0.7	0.6	0.2	0.4	0.8	0.6	3.0	0.4	0.4	0.4	0.8	0.3	4.4	6.4	11.4	6.2	4.7	6.2	3.3	5.6	3.7	3.8	7.0	4.8	53.7	35.3	35.0	37.2	32.9	30.0	22.4	10.3	40.5	19.8	15.9	21.7	21.1	7.2	20.7	5.5	8.4	14.1	27.4	15.7	3.9	12.5	63.7	29.1	30.9	25.9	21.6	20.8	62.2	12.4	10.8	30.5	21.9	28.8	12.0	20.3	17.2	14.3	9.3	18.5	55.7	12.9	10.2	13.2	13.8	23.7	36.1	57.4	3.6	29.0	17.7	8.9	26.8	46.8	51.3	16.2	13.0	39.1	35.8	27.7	11.9	8.8	20.4	17.1	32.9	70.9	26.1	116.7	37.6	27.3	30.7	13.5	31.3	21.4	12.4	26.2
AIMP1	"EMAP-2, EMAPII, p43, SCYE1"	ENSG00000164022	"Aminoacyl tRNA synthetase complex interacting multifunctional protein 1"	Q12904	4	106315544-106349456	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Apoptosis, Inflammatory response, Protein biosynthesis"	"Cytokine, RNA-binding, tRNA-binding"	Leukodystrophy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017618, HPA018476"	Supported		Enhanced	Cytosol	"Secreted to blood"	NA	NA	6500000	35000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB017618: AB_2285445, HPA018476: AB_1848137"	"unprognostic (1.17e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (1.29e-3)"	"unprognostic (8.10e-2)"	"unprognostic (4.85e-2)"	"unprognostic (8.90e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.27e-2)"	32.5	33.4	23.3	31.4	25.9	60.1	44.4	25.8	32.9	32.2	25.2	42.1	39.9	34.5	35.1	37.7	32.1	32.1	34.4	23.2	25.0	40.3	35.8	29.0	38.6	25.8	25.7	42.3	32.4	37.8	25.6	30.1	25.7	33.1	41.6	36.0	35.0	35.1	65.3	29.4	37.8	32.3	24.3	33.5	34.8	23.5	24.8	35.4	38.9	50.4	39.2	40.9	30.7	27.8	66.7	46.1	47.3	60.3	51.0	78.0	68.1	80.8	69.7	73.9	87.7	81.9	97.8	109.4	61.6	79.6	50.5	61.4	69.6	86.6	98.8	62.1	47.4	64.2	63.8	134.0	101.3	147.4	75.4	62.9	100.2	74.5	117.5	56.3	64.3	68.2	120.8	58.0	82.4	58.5	99.2	78.2	51.4	94.6	46.5	81.1	86.3	101.5	94.7	60.5	72.9	56.9	52.7	158.1	86.4	61.7	75.2	107.8	50.5	87.9	73.1	66.1	105.9	71.5	98.9	110.0	74.6	112.7	97.0	60.6	54.7	55.0	42.9	61.8	51.7	57.4	54.0	43.9	58.5	55.8	55.8	51.0	7.7	51.9	73.4	74.7	72.2	34.9	23.3	25.9	25.8	32.9	23.2	25.0	25.8	25.7	25.7	24.3	24.8	27.8	87.4	70.5	55.2	18.6	72.7	50.2	147.0	166.1	50.7	49.7	71.3	87.8	95.4	82.9	130.2	66.2	35.5	124.5	58.1	83.3	156.5	121.1	79.0	75.4	83.8	60.8	73.8	66.7	17.3	126.6	144.8	66.0	48.9	130.8	79.3	64.2	61.4	109.8	109.6	25.2	20.4	144.4	116.0	90.1	53.3	19.4	99.1	68.8	32.0	16.9	117.2	56.0	74.2	24.6	38.3	118.3	93.7	85.4	40.9	141.8	146.8	166.1	105.6	45.5	59.2	77.5	128.4	127.2	74.3	66.4	50.2	150.9	68.9	74.3	142.2	173.1
AIMP2	"JTV-1, JTV1, p38, PRO0992"	ENSG00000106305	"Aminoacyl tRNA synthetase complex interacting multifunctional protein 2"	Q13155	7	6009255-6023834	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation, Protein biosynthesis"	"Developmental protein"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 154.9;tongue: 102.5"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 134.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019098, HPA020057"	Supported		Approved	Cytosol		NA	Yes		35000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA019098: AB_1852040, HPA020057: AB_1852042"	"unprognostic (1.24e-3)"	"unprognostic (1.66e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (9.29e-2)"	"unprognostic (3.41e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.13e-2)"	"unprognostic (3.96e-1)"	"prognostic favorable (1.38e-5)"	"unprognostic (7.44e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (3.09e-4)"	19.2	21.0	13.6	14.3	15.1	12.4	17.3	15.6	17.0	11.0	12.8	25.8	47.7	16.7	16.7	22.0	14.4	8.8	45.3	15.4	14.6	25.7	33.8	12.6	14.3	14.9	14.5	7.4	17.0	28.7	7.8	13.4	14.7	11.9	24.4	11.9	16.4	15.2	154.9	21.6	27.8	19.3	15.2	13.0	14.6	44.1	15.1	15.4	25.8	102.5	19.5	17.0	13.7	16.2	90.3	100.2	33.1	48.3	34.5	37.3	113.7	49.5	33.3	79.9	59.4	110.1	58.5	109.6	46.2	51.4	90.1	98.6	113.6	74.2	49.6	35.6	84.0	61.2	54.8	84.2	106.2	86.7	53.1	57.4	109.1	72.3	117.9	13.3	60.2	43.8	86.7	35.6	59.4	142.6	37.4	157.2	136.0	44.3	70.4	83.5	73.8	93.3	119.1	41.7	66.1	62.6	50.4	101.3	72.9	41.9	94.5	70.1	51.8	46.0	112.9	77.0	111.2	44.5	73.9	95.5	38.5	122.3	75.6	46.7	61.4	19.5	41.5	77.5	34.9	47.3	27.7	32.5	92.4	31.9	27.1	28.9	6.0	48.3	57.9	58.7	32.3	43.4	13.6	15.1	15.6	17.0	15.4	14.6	14.9	14.5	14.7	15.2	15.1	16.2	15.0	9.6	10.3	8.1	13.0	10.8	22.5	58.5	24.5	10.2	11.8	15.1	2.2	28.6	40.2	12.9	6.2	50.8	10.1	17.6	70.5	52.6	134.7	25.3	23.9	20.0	6.7	24.2	5.8	57.3	64.0	15.1	23.4	20.6	12.6	16.7	13.2	38.8	50.0	6.7	6.7	18.2	57.0	19.1	14.3	84.5	19.9	18.1	19.6	1.9	40.3	17.8	17.5	5.0	10.4	40.1	14.5	18.0	23.8	23.0	59.3	67.7	34.9	11.2	13.1	16.0	24.5	91.1	26.8	37.1	11.6	39.5	12.6	38.0	39.8	17.8
AKAP11	"AKAP220, DKFZp781I12161, FLJ11304, KIAA0629, PPP1R44, PRKA11"	ENSG00000023516	"A-kinase anchoring protein 11"	Q9UKA4	13	42272152-42323261	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039089	Enhanced		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 58: Brain - Synaptic function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoli, Plasma membrane, Cytosol"		"HPA039089: AB_10674279"	"unprognostic (6.43e-2)"	"prognostic unfavorable (9.26e-4)"	"unprognostic (4.91e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.02e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.49e-3)"	"unprognostic (7.44e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.10e-1)"	12.6	13.9	14.2	11.5	27.3	3.7	11.6	10.9	19.9	16.6	0.0	10.0	7.5	13.5	15.4	10.6	10.4	10.2	11.6	22.7	12.7	13.3	10.7	10.9	15.8	8.7	15.3	14.7	6.9	11.7	9.3	7.7	8.5	11.3	10.5	32.5	8.0	12.3	5.6	9.9	8.4	12.2	11.5	13.3	10.4	20.6	16.4	13.2	14.0	10.9	13.8	10.4	8.6	18.9	15.2	15.3	18.4	11.0	23.6	28.7	8.0	20.2	16.7	11.9	11.1	16.9	12.4	31.2	7.6	22.7	12.5	17.7	16.1	16.9	22.7	33.4	7.5	8.8	10.6	8.4	18.5	22.2	20.8	21.2	17.0	24.4	21.2	17.5	17.8	15.5	29.5	12.3	24.3	11.4	13.0	7.2	10.9	22.3	7.1	10.7	12.9	15.1	11.9	11.1	7.8	11.3	15.5	10.1	7.1	8.5	8.7	11.8	24.8	20.1	10.4	30.7	15.4	4.7	6.3	15.8	25.7	11.1	14.4	1.7	0.3	0.4	0.5	0.3	0.7	0.9	0.8	0.5	0.3	1.1	0.6	0.6	0.1	1.6	0.5	0.5	1.0	0.2	14.2	27.3	10.9	19.9	22.7	12.7	8.7	15.3	8.5	11.5	16.4	18.9	41.9	25.6	30.5	58.8	42.8	12.2	13.7	15.4	14.8	67.3	20.4	14.6	44.9	12.8	32.6	29.5	37.5	4.4	21.2	12.9	1.9	12.7	14.0	24.3	33.1	25.5	21.0	16.6	105.4	9.5	3.8	27.5	24.5	25.7	34.2	25.9	29.3	22.6	12.5	42.1	105.4	14.9	20.3	24.8	21.6	14.6	21.8	25.0	8.8	46.9	21.6	69.8	16.5	69.9	91.3	12.7	15.4	33.4	27.0	12.2	9.4	20.5	33.1	38.3	19.7	33.9	27.1	49.2	32.8	20.6	16.9	2.5	25.4	28.3	12.3	13.4
AKAP8L	"HAP95, NAKAP95"	ENSG00000011243	"A-kinase anchoring protein 8 like"	Q9ULX6	19	15380050-15419141	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042485, HPA042546"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nuclear speckles"		"HPA042485: AB_2678019, HPA042546: AB_2678046"	"unprognostic (9.52e-3)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (1.08e-2)"	"unprognostic (3.25e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.57e-2)"	"prognostic favorable (8.04e-4)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (1.08e-7)"	"unprognostic (2.77e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.80e-2)"	"unprognostic (2.34e-3)"	27.2	32.8	25.1	4.0	25.5	32.3	26.9	26.0	32.2	34.8	21.8	32.7	2.5	23.5	11.9	23.4	31.8	7.5	41.5	24.4	25.3	29.3	28.8	33.5	9.4	24.1	24.4	36.2	22.5	11.1	40.4	9.3	24.7	32.3	5.8	37.4	23.2	6.3	60.5	34.5	24.0	6.4	25.0	31.5	24.7	48.8	25.8	20.6	33.9	24.1	10.8	26.8	28.1	26.1	25.4	25.8	32.3	17.2	32.3	34.0	18.8	21.0	25.1	34.0	30.9	41.5	35.2	23.2	38.8	23.4	31.8	29.9	51.2	28.3	29.8	39.8	44.2	40.3	21.9	34.0	57.3	38.8	26.6	29.6	52.0	27.2	35.3	31.3	25.4	38.0	51.3	41.9	21.3	34.3	39.0	32.6	31.9	32.0	41.9	46.6	22.8	25.2	28.7	8.5	37.2	23.5	26.2	28.3	37.5	42.4	20.8	42.2	30.4	20.5	15.4	34.4	36.7	60.1	48.0	49.5	19.2	39.8	23.5	0.1	1.8	1.7	0.9	0.8	1.8	1.7	0.8	1.0	1.5	2.3	1.3	1.2	3.5	0.5	1.0	1.4	2.8	0.8	25.1	25.5	26.0	32.2	24.4	25.3	24.1	24.4	24.7	25.0	25.8	26.1	34.7	6.4	15.9	55.5	39.1	31.6	48.2	22.6	26.2	60.9	34.6	29.3	7.7	17.2	30.0	35.0	77.2	35.6	47.3	22.5	25.4	32.6	34.6	52.7	33.7	29.8	25.6	114.9	59.1	31.8	28.6	26.0	50.0	42.6	13.9	69.6	17.5	17.0	16.3	79.1	45.1	22.0	26.4	18.6	32.8	9.9	26.4	31.3	26.6	19.7	24.0	42.0	30.9	29.7	38.5	32.5	19.9	29.3	38.2	33.2	13.6	17.3	32.1	83.2	26.3	27.8	45.2	83.3	63.9	26.4	39.2	62.4	44.0	60.2	18.3	40.2
AL034430.2		ENSG00000285723	"Novel protein"		20	10420546-10420737	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"skeletal muscle: 47.7"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"													NA	NA			"Cluster 31: Non-specific - Inflammatory response"		"Cluster 26: Non-specific - Cell cycle regulation"																						25.9	8.9	0.6	14.4	2.1	18.2	0.0	0.6	9.5	0.0	7.1	14.3	31.0	2.3	0.0	0.0	0.0	0.0	8.9	4.2	0.9	6.5	17.3	5.1	3.0	0.8	1.1	1.1	11.0	9.4		3.0	4.6	6.5	0.0	21.5	6.9	0.0	47.7	0.0	21.9	0.0	0.9	7.3	9.5	12.3	1.6	0.3	0.0	0.0	0.0	2.0		2.0	77.2	33.4	72.7	62.0	0.0	0.0	22.5	111.4	8.2	2.1	0.0	4.3	70.5	42.7	37.2	7.5	77.6	86.2	0.0	0.0	0.0	3.6	16.6	116.4	23.5	135.7	1.2	131.9	36.0	6.3	0.0	6.1	0.0	19.6	0.0	35.5	17.2	58.8	0.0	9.8	94.9	62.5	79.1	54.2	21.4	49.5	161.5	41.9	0.0	35.4	16.4	31.9	96.4	135.8	165.8	27.6	52.7	56.2	68.3	41.6	73.9	48.6	85.7	51.9	76.3	98.5	27.5	86.3	50.3	52.4	33.8	41.6	17.3	43.5	18.5	26.1	20.1	24.3	39.5	24.5	20.8	21.6	22.1	18.0	41.6	67.0	25.0	25.8	0.6	2.1	0.6	9.5	4.2	0.9	0.8	1.1	4.6	0.9	1.6	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL049569.3		ENSG00000288636	"Novel  protein"		1	17005068-17011757	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"intestine: 1.3;skeletal muscle: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.6;HAP1: 11.0;hTERT-HME1: 3.9;hTERT-RPE1: 4.1;U-2197: 2.8"															NA	NA					"Cluster 26: Non-specific - Cell cycle regulation"																						0.0	0.3	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.3	0.0	1.3	0.5	0.8	0.1	1.0	0.0	0.9	0.1	0.0	0.0	0.2	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3		0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	2.2	0.3	1.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	11.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.5	3.9	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.0	0.0	0.0	2.8	0.0	0.0	0.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL662899.2		ENSG00000263020	"Novel protein"		6	31666102-31673546	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Club cells: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"							"Low region specificity"	"Detected in all"			"HPA005944, HPA048307"	Uncertain					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"			"HPA005944: AB_1847290, HPA048307: AB_2680348"	"unprognostic (7.19e-2)"	"unprognostic (4.75e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.09e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.55e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.56e-1)"	7.9	7.0	0.0	0.0	0.0	10.4	7.5	0.1	0.1	8.7	0.0	8.5	0.0	6.2	0.1	8.0	8.7	0.1	7.4	0.0	0.1	7.5	8.2	7.5	0.1	0.0	0.0	9.3	7.0	0.0	6.3	0.0	0.1	8.7	0.1	0.2	6.2	0.0	5.7	13.9	10.7	0.0	0.0	15.1	7.6	7.3	0.0	0.0	7.2	0.3	0.0	6.6	6.4	0.0	0.4	0.3	0.7	0.6	0.0	0.0	0.1	0.0	0.1	0.5	0.2	0.5	0.7	0.6	0.3	0.5	0.9	0.5	0.1	1.5	1.7	0.4	1.2	1.2	0.3	0.2	0.6	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.5	0.6	0.2	0.4	1.1	1.2	0.1	0.5	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.5	1.4	0.4	0.3	0.1	0.0	0.3	0.3	0.1	0.7	1.6	0.0	0.0	0.0	0.3	1.4	0.1	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AL672142.1		ENSG00000251184	"Novel protein"		9	128941478-128957021	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	4	"brain: 1.0;retina: 2.5;skeletal muscle: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.2;BJ: 1.9;HL-60: 1.7;RH-30: 1.9;U-138 MG: 1.4;U-698: 1.4"	"Not detected"	"Not detected"													NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 26: Non-specific - Cell cycle regulation"																						0.0	0.1	0.8	0.0	0.5	0.0	0.0	0.6	0.5	0.3	0.2	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.1	0.1	0.7	1.0	0.1	0.0	0.0	0.0	0.1	0.9	0.0	0.0	2.5	0.0	0.0	1.5	0.0	0.0	0.1	0.6	0.0	0.2	0.1	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.2	0.0	0.2	0.4	1.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.7	0.0	0.4	0.0	0.0	0.6	0.3	0.7	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.3	1.9	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.1	0.0	0.4	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.6	0.5	0.5	0.7	0.7	1.0	0.9	0.6	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALKBH2	"ABH2, MGC90512"	ENSG00000189046	"AlkB homolog 2, alpha-ketoglutarate dependent dioxygenase"	Q6NS38	12	109088188-109093631	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011198, HPA045392, HPA051976"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 15: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB011198: AB_261971, HPA045392: AB_2679309, HPA051976: AB_2681680"	"prognostic favorable (6.67e-5)"	"unprognostic (3.66e-3)"	"unprognostic (1.08e-1)"	"unprognostic (4.64e-2)"	"unprognostic (4.55e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.60e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.39e-2)"	"unprognostic (6.43e-3)"	"prognostic unfavorable (1.41e-5)"	"unprognostic (1.01e-2)"	"unprognostic (7.88e-2)"	"unprognostic (6.24e-2)"	"prognostic favorable (8.67e-4)"	22.1	14.7	17.0	13.1	18.8	8.5	22.3	17.9	18.5	19.9	15.0	16.7	7.9	21.6	9.3	18.0	20.4	8.2	14.6	17.1	18.1	15.2	31.8	12.3	16.8	18.5	18.3	21.8	19.1	6.1	9.8	7.2	18.6	15.4	9.1	4.5	15.6	11.3	25.3	27.7	15.0	13.8	17.7	15.1	16.8	11.3	18.1	11.3	15.1	12.1	14.0	19.1	18.6	20.8	35.1	58.6	33.0	74.1	22.7	30.3	52.2	22.9	15.2	23.7	26.7	62.3	24.6	53.5	22.1	13.3	11.1	25.1	55.9	23.0	13.8	48.0	50.0	26.8	35.3	57.9	30.1	37.2	23.9	31.4	48.9	22.2	56.5	28.7	9.1	50.5	40.3	31.0	16.3	61.6	34.8	74.5	45.6	36.6	59.1	30.4	32.0	57.7	31.5	48.1	33.8	58.0	24.2	77.4	50.9	12.3	47.5	22.1	9.6	26.0	28.5	25.0	34.1	43.1	54.6	119.2	22.4	31.8	42.7	2.9	8.1	1.4	12.4	11.2	21.8	27.4	18.4	17.5	8.5	27.6	27.1	16.2	1.5	16.7	7.6	21.6	15.8	10.4	17.0	18.8	17.9	18.5	17.1	18.1	18.5	18.3	18.6	17.7	18.1	20.8	23.7	9.6	6.3	4.2	15.9	50.9	52.2	19.4	42.1	3.6	25.2	44.3	6.2	12.8	16.3	9.2	2.1	17.5	12.5	3.1	15.6	26.5	12.2	7.2	27.9	17.3	8.4	10.9	3.5	24.0	25.0	20.6	14.3	8.6	6.3	9.5	6.1	21.4	9.8	5.0	3.6	11.6	18.3	8.2	11.7	5.4	26.8	6.8	26.6	3.7	4.9	11.2	7.2	6.0	7.6	24.1	5.1	17.3	13.1	46.7	7.4	20.2	10.0	7.4	0.0	44.5	26.0	7.9	32.0	35.9	60.0	5.1	12.6	24.5	14.8	25.3
ALKBH5	"FLJ20308, OFOXD1"	ENSG00000091542	"AlkB homolog 5, RNA demethylase"	Q6P6C2	17	18183078-18209954	"Enzymes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 236.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007196	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA007196: AB_1850461"	"unprognostic (1.07e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.94e-2)"	"prognostic favorable (3.75e-4)"	"unprognostic (6.54e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.68e-3)"	"prognostic unfavorable (5.69e-4)"	33.4	40.1	23.7	21.4	21.8	32.6	29.2	18.1	23.5	34.2	17.8	51.1	22.3	45.3	5.2	25.9	43.1	21.6	68.6	20.4	23.4	29.9	33.6	28.8	25.1	23.2	23.7	33.5	36.0	26.6	39.8	17.4	29.5	31.7	10.6	26.5	36.4	25.1	236.6	28.1	31.0	22.0	19.3	26.8	33.6	51.3	26.7	22.2	29.8	98.7	15.8	43.0	29.6	27.4	90.3	86.4	27.8	47.0	37.0	25.0	30.1	41.1	41.8	56.8	51.5	96.1	19.9	53.9	65.4	35.9	29.4	56.2	40.9	33.6	26.8	71.3	74.0	35.4	47.7	41.8	32.5	27.4	53.0	24.3	23.1	41.8	24.7	33.9	31.8	35.3	45.0	20.4	29.8	60.6	60.1	28.6	24.9	28.3	44.4	57.6	56.0	89.0	14.4	31.0	32.5	47.6	44.8	27.2	41.7	90.9	31.4	20.9	38.3	55.8	44.1	87.8	78.0	32.0	25.1	32.2	100.6	38.8	39.0	3.6	7.4	20.4	13.0	7.8	11.9	6.8	13.3	16.1	9.0	10.0	9.5	9.5	4.3	7.2	11.6	5.7	7.4	6.7	23.7	21.8	18.1	23.5	20.4	23.4	23.2	23.7	29.5	19.3	26.7	27.4	37.2	35.3	33.3	17.9	41.1	64.6	29.0	26.8	19.4	80.3	48.7	40.3	93.5	28.6	24.4	27.6	39.6	33.0	59.0	44.9	84.1	27.4	58.9	53.9	36.5	36.6	60.9	24.0	17.0	31.4	44.8	42.4	18.3	36.7	40.7	25.2	35.7	65.2	33.5	119.5	18.1	45.0	22.4	45.3	56.9	42.5	41.0	36.4	49.8	7.5	36.3	76.3	57.7	9.0	24.0	32.8	38.7	51.9	21.1	35.3	47.6	115.2	46.4	58.9	19.7	39.4	47.3	118.7	117.3	20.3	56.0	31.5	48.3	32.7	39.1	28.6
ALKBH8	"MGC10235, TRM9, TRMT9A"	ENSG00000137760	"AlkB homolog 8, tRNA methyltransferase"	Q96BT7	11	107502727-107565742	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Multifunctional enzyme, RNA-binding, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 25.2;Inhibitory neurons: 27.4;Oligodendrocyte precursor cells: 23.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038724, HPA038725, HPA061514"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear bodies"	Nucleoplasm	"HPA038724: AB_2676176, HPA038725: AB_10674838, HPA061514: AB_2684547"	"unprognostic (2.66e-2)"	"unprognostic (3.82e-1)"	"unprognostic (8.19e-2)"	"unprognostic (3.76e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.45e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.01e-1)"	3.1	2.9	2.4	4.0	3.0	3.3	5.0	2.6	2.8	2.9	1.7	3.0	3.2	3.8	3.2	3.1	2.9	2.8	3.8	2.4	2.6	3.9	4.5	3.6	6.0	2.2	2.6	4.4	2.3	4.1	1.7	3.3	2.5	3.5	3.6	3.3	2.9	3.3	5.1	4.6	2.6	3.6	2.2	4.6	3.3	2.8	2.3	4.6	5.2	4.7	5.9	3.5	2.8	2.3	5.4	6.5	6.6	7.2	3.6	7.9	5.4	10.2	7.5	7.4	8.0	12.1	9.7	12.6	5.8	10.0	10.2	9.6	9.9	8.5	9.6	11.4	6.6	10.6	2.5	5.6	5.3	13.7	12.6	4.9	9.2	9.5	12.0	3.8	9.3	9.9	15.2	4.1	5.9	4.9	12.4	6.8	8.7	10.5	10.6	11.1	10.2	8.7	5.9	5.8	6.0	6.7	5.9	4.4	4.5	4.0	7.2	4.1	8.8	16.1	9.6	5.3	12.9	3.8	4.3	9.7	4.5	9.0	16.1	0.0	1.1	0.3	2.2	2.1	2.1	0.9	1.6	1.9	1.7	1.9	3.0	2.6	0.0	2.8	1.5	1.0	1.8	1.1	2.4	3.0	2.6	2.8	2.4	2.6	2.2	2.6	2.5	2.2	2.3	2.3	4.4	0.0	5.3	4.6	8.5	2.0	1.7	1.5	7.4	5.7	3.2	3.0	11.2	5.7	3.5	1.8	6.2	2.3	3.0	1.3	0.0	1.9	0.4	2.4	4.6	4.2	1.2	4.6	25.2	3.3	2.7	4.3	7.7	2.3	10.1	5.1	2.9	6.6	2.8	1.7	27.4	2.8	2.0	3.8	2.2	0.2	2.8	4.1	3.6	14.0	4.7	3.0	3.1	23.1	14.3	2.7	5.2	4.1	3.8	1.3	1.3	3.6	0.8	3.8	0.0	4.0	3.0	1.8	3.2	6.9	4.1	0.8	6.6	5.2	3.5	0.6
AMMECR1		ENSG00000101935	"AMMECR nuclear protein 1"	Q9Y4X0	X	110194186-110440318	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Alport syndrome, Deafness, Disease variant, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 83.1;Excitatory neurons: 92.8;Inhibitory neurons: 108.7;Rod photoreceptor cells: 87.3;Syncytiotrophoblasts: 86.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000590, HPA051762"	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Mitochondria	"HPA000590: AB_2666037, HPA051762: AB_2681596"	"unprognostic (7.77e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.66e-3)"	"unprognostic (6.55e-2)"	"unprognostic (5.98e-2)"	"prognostic favorable (6.62e-5)"	"unprognostic (3.61e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (8.44e-4)"	"unprognostic (7.82e-2)"	3.6	2.9	1.7	3.7	1.7	13.4	3.4	1.8	2.0	2.9	8.5	3.7	3.1	2.3	2.1	7.9	3.3	2.3	1.1	1.5	1.7	3.4	3.3	2.8	4.2	1.3	1.3	5.5	2.0	2.2	2.0	7.0	1.2	2.2	3.9	14.5	2.8	1.9	1.3	7.4	3.3	2.9	1.0	3.7	3.7	1.6	1.7	4.5	2.4	1.7	5.7	4.8	4.5	1.5	20.3	9.8	7.1	3.4	7.9	11.8	7.8	13.8	12.3	11.1	16.2	15.9	14.4	12.0	6.4	18.4	9.0	9.5	22.7	15.7	11.3	8.4	10.1	16.7	21.7	3.3	19.9	13.5	6.7	6.6	27.3	12.7	22.6	6.0	8.9	5.9	47.1	34.8	8.5	17.2	6.5	4.8	32.6	17.4	19.1	13.7	7.6	21.2	18.8	16.8	11.3	5.3	23.2	22.7	19.9	8.5	5.6	13.3	4.1	7.6	4.6	22.8	12.6	7.1	8.6	18.9	11.6	27.5	25.9	0.6	0.9	0.8	1.6	0.6	2.1	1.6	3.2	2.6	1.5	2.2	2.1	1.9	0.4	0.6	2.7	0.6	2.3	1.0	1.7	1.7	1.8	2.0	1.5	1.7	1.3	1.3	1.2	1.0	1.7	1.5	4.4	0.0	9.8	17.9	11.5	9.6	3.9	10.5	5.7	35.3	7.5	4.4	4.2	8.6	8.9	3.7	52.1	27.2	9.5	8.9	23.5	9.2	0.5	10.5	7.7	9.6	15.0	83.1	92.8	12.0	9.9	12.8	13.7	13.4	2.5	14.4	19.6	8.4	7.1	1.7	108.7	11.2	12.2	7.6	3.1	2.1	12.8	7.3	3.6	21.5	9.4	7.1	14.4	35.7	19.2	11.5	3.7	17.3	8.0	9.1	10.3	10.2	10.4	87.3	13.1	6.7	8.4	2.2	6.9	17.4	26.7	86.5	13.0	34.7	10.5	15.7
ANAPC1	"APC1, MCPR, TSG24"	ENSG00000153107	"Anaphase promoting complex subunit 1"	Q9H1A4	2	111611639-111884690	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"		"Cancer-related genes, Ectodermal dysplasia, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036329, HPA036330, HPA042998"	Approved		Approved	Vesicles		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Vesicles		"HPA036329: AB_10670714, HPA036330: AB_2675065, HPA042998: AB_2678263"	"unprognostic (1.74e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (3.49e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.16e-4)"	"unprognostic (1.23e-1)"	"unprognostic (3.94e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.92e-1)"	6.4	4.8	4.1	9.5	5.1	8.3	9.2	4.8	5.1	6.9	9.8	9.9	8.3	8.0	4.9	8.1	7.8	5.8	5.8	4.7	3.6	6.2	5.6	5.4	12.1	4.1	4.1	8.4	6.3	10.4	4.6	7.7	5.1	6.4	10.5	7.9	5.4	6.2	12.2	6.8	6.5	7.6	3.7	7.8	6.6	10.2	4.0	12.6	6.3	9.4	12.4	8.4	5.8	5.2	42.4	31.0	33.1	23.9	14.9	18.4	32.6	25.0	18.8	30.3	26.5	60.4	26.6	72.7	19.9	23.0	36.0	35.4	51.0	28.4	40.4	31.7	31.9	81.6	27.6	37.1	14.3	85.0	27.4	13.8	14.3	44.9	40.8	15.4	29.5	34.9	75.8	30.8	21.5	20.2	51.9	25.5	50.3	18.3	26.1	51.1	39.4	41.1	19.1	41.6	26.2	16.0	26.2	23.9	22.8	21.8	14.1	30.1	20.9	26.5	28.5	21.7	26.9	23.0	52.5	67.1	21.5	36.9	21.9	0.0	2.1	0.6	4.2	2.2	6.1	4.0	3.8	3.6	3.9	3.1	5.4	5.2	0.4	4.8	1.9	1.8	1.8	3.3	4.1	5.1	4.8	5.1	4.7	3.6	4.1	4.1	5.1	3.7	4.0	5.2	14.5	3.2	8.2	17.0	20.3	14.3	20.5	7.6	22.2	11.2	12.1	11.8	7.5	8.6	6.0	3.7	14.6	12.2	25.4	7.2	5.9	5.9	6.6	13.5	13.4	11.0	11.4	17.9	32.5	5.9	12.7	12.0	12.2	11.7	8.2	19.2	8.6	12.8	9.0	20.2	32.6	11.1	14.2	8.4	11.8	8.6	10.2	12.2	7.2	12.2	8.8	7.7	13.4	21.6	31.3	7.1	5.4	9.4	14.4	24.6	5.6	8.8	8.2	16.0	13.1	15.9	11.5	17.3	21.0	18.0	20.2	6.7	21.2	12.2	14.5	23.4
ANAPC15	"APC15, C11orf51, DKFZP564M082, HSPC020"	ENSG00000110200	"Anaphase promoting complex subunit 15"	P60006	11	72106378-72112780	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036596	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA036596: AB_10671961"	"unprognostic (1.17e-1)"	"unprognostic (5.83e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (9.18e-2)"	"unprognostic (3.35e-2)"	"prognostic favorable (2.55e-4)"	"unprognostic (9.34e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.08e-2)"	28.9	44.2	47.0	30.0	47.5	95.9	30.0	47.8	61.1	24.3	45.8	67.1	30.7	43.4	38.3	53.2	30.4	18.3	62.2	47.2	47.7	48.8	44.0	30.0	43.5	46.4	46.8	22.4	39.2	25.4	32.8	19.2	47.2	52.0	40.6	42.8	39.9	38.8	95.2	39.6	40.1	31.9	46.4	41.2	46.5	72.0	46.3	72.6	44.7	64.3	44.3	41.6	29.5	49.0	74.0	109.4	87.5	55.8	25.5	41.2	41.4	77.1	70.1	121.3	80.2	128.8	78.4	98.8	72.9	110.3	59.0	122.6	133.4	144.0	113.9	64.0	63.3	113.1	124.9	84.5	30.2	110.8	101.3	43.2	56.2	68.9	91.6	45.4	80.7	136.7	83.3	66.6	80.0	127.2	214.5	102.9	70.9	155.3	62.3	89.6	217.4	67.2	106.1	50.5	61.9	53.8	79.0	76.5	127.0	46.8	89.6	58.6	73.4	55.5	72.9	110.5	82.8	68.0	71.5	125.3	34.0	87.8	31.7	29.7	168.5	136.3	73.3	114.2	78.0	94.5	93.4	86.3	148.8	71.4	110.9	101.5	68.4	72.4	107.4	119.1	153.0	124.1	47.0	47.5	47.8	61.1	47.2	47.7	46.4	46.8	47.2	46.4	46.3	49.0	20.1	16.0	16.5	2.9	36.1	41.8	71.2	83.5	44.3	32.9	43.2	55.6	3.9	12.8	50.6	23.9	27.1	84.7	40.5	82.9	123.3	49.4	15.4	38.8	21.3	22.8	49.6	34.1	7.1	102.7	78.8	18.3	36.7	27.8	30.4	27.2	15.0	44.1	82.8	13.5	7.3	66.2	61.1	48.5	47.5	13.4	6.8	48.0	26.6	1.0	58.8	44.1	36.0	5.5	5.2	53.1	61.4	23.0	47.1	43.8	56.2	123.6	45.6	43.3	19.7	16.0	35.3	115.9	139.9	53.8	41.1	46.7	41.1	32.3	71.5	61.7
ANAPC2	"APC2, KIAA1406"	ENSG00000176248	"Anaphase promoting complex subunit 2"	Q9UJX6	9	137174784-137188560	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 58.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018692, HPA066539"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB018692: AB_2258285, HPA066539: AB_2685688"	"unprognostic (5.20e-2)"	"unprognostic (8.86e-3)"	"unprognostic (1.43e-2)"	"prognostic favorable (8.91e-5)"	"unprognostic (2.29e-1)"	"unprognostic (2.38e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.36e-1)"	"prognostic favorable (1.07e-7)"	"unprognostic (7.41e-2)"	"prognostic favorable (3.67e-4)"	"prognostic favorable (2.87e-4)"	"unprognostic (1.35e-1)"	"unprognostic (8.46e-2)"	"unprognostic (9.88e-2)"	14.4	17.7	8.8	11.3	9.6	15.0	15.8	8.9	13.4	15.2	8.6	14.4	11.9	15.8	3.1	15.8	14.7	8.6	15.6	9.7	8.1	14.2	20.2	13.1	14.5	11.5	9.1	15.2	20.7	7.4	13.8	7.2	10.2	17.5	3.1	4.3	18.2	8.9	18.9	19.2	16.5	5.3	8.1	19.9	17.0	25.5	8.8	10.2	15.5	8.3	6.1	13.8	13.4	12.9	20.9	45.6	10.7	17.5	12.6	7.5	33.5	18.5	11.5	16.9	12.8	27.8	20.9	22.4	21.3	12.3	15.8	41.9	12.9	13.8	2.5	28.9	22.5	13.3	55.1	24.9	14.9	20.7	22.1	15.0	10.9	11.3	6.1	8.3	20.8	20.7	20.3	26.4	8.0	58.2	24.7	28.7	21.6	27.4	34.6	29.3	26.5	41.4	13.1	18.1	14.1	21.3	28.2	36.5	11.9	5.1	39.2	27.8	22.4	24.8	19.8	30.1	16.7	12.9	20.5	24.5	20.1	14.1	18.3	0.3	0.6	0.1	0.5	0.6	0.3	0.3	0.3	0.4	0.5	0.2	0.3	0.4	0.2	0.3	0.9	0.6	0.3	1.1	8.8	9.6	8.9	13.4	9.7	8.1	11.5	9.1	10.2	8.1	8.8	12.9	9.3	0.0	0.5	6.2	12.2	9.3	7.9	14.2	6.2	5.7	13.0	12.6	3.2	11.5	11.5	11.0	4.2	25.9	11.1	19.0	13.7	10.0	40.5	4.2	4.0	9.0	10.2	9.5	2.4	10.9	11.1	9.0	27.0	5.0	11.4	8.5	12.1	11.1	15.6	1.7	2.5	19.1	12.2	8.8	7.8	58.4	11.1	7.6	14.2	1.0	13.9	3.7	6.2	1.5	4.3	8.6	8.0	9.4	15.3	6.8	21.2	15.8	10.2	4.7	0.0	9.8	17.4	40.5	26.4	11.9	9.5	24.5	9.4	5.9	15.4	7.1
ANAPC7	APC7	ENSG00000196510	"Anaphase promoting complex subunit 7"	Q9UJX3	12	110372900-110403730	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 74.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009567	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"CAB009567: AB_2227137"	"unprognostic (2.49e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.35e-2)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (3.20e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (4.36e-10)"	"unprognostic (1.45e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.58e-2)"	14.4	19.0	11.8	14.0	14.3	12.6	15.7	12.7	16.1	20.1	11.8	18.8	10.6	21.4	16.7	36.2	18.0	11.4	22.7	13.0	12.9	18.6	13.3	13.7	18.0	12.3	11.7	16.7	14.1	24.9	14.7	8.5	12.4	18.5	16.2	13.2	20.5	17.5	33.8	18.0	14.5	21.1	12.4	16.6	15.7	30.1	12.1	24.0	20.2	24.9	20.7	19.0	24.8	12.8	49.7	66.8	47.8	40.9	48.8	24.6	27.4	33.9	30.6	61.1	42.2	68.5	30.8	78.6	33.5	45.8	35.2	49.1	71.8	46.5	61.8	42.0	57.8	69.3	46.0	57.3	35.5	62.5	31.6	27.0	32.7	53.0	35.0	43.6	60.1	55.2	110.7	16.4	48.7	53.0	95.6	46.7	42.0	48.1	57.6	72.8	47.2	93.1	41.4	62.5	61.8	35.4	53.2	41.2	57.3	41.9	87.1	56.0	38.2	36.3	34.1	32.6	40.6	27.4	59.5	105.6	40.5	52.6	42.9	20.2	12.1	20.5	18.2	17.2	21.7	14.3	19.6	17.7	20.1	18.7	16.1	17.5	9.3	24.3	15.9	10.9	26.1	14.4	11.8	14.3	12.7	16.1	13.0	12.9	12.3	11.7	12.4	12.4	12.1	12.8	13.1	16.0	18.4	17.6	12.9	10.1	19.6	16.5	13.1	18.5	12.8	11.6	17.5	10.0	22.6	12.9	20.9	12.4	10.7	9.2	11.7	16.9	7.6	22.8	18.6	15.7	10.8	33.6	28.1	15.2	10.1	16.9	16.3	15.3	15.8	42.5	11.7	13.4	22.4	21.9	22.6	10.8	32.6	17.9	6.6	12.7	18.3	12.5	17.8	13.1	14.7	16.1	11.3	22.6	29.3	16.2	8.9	21.8	11.4	20.0	7.3	15.0	18.4	22.9	13.1	15.9	16.2	74.1	42.2	38.3	13.4	7.3	14.0	32.4	14.9	17.5
ANKFY1	"ANKHZN, BTBD23, KIAA1255, RANK-5, ZFYVE14"	ENSG00000185722	"Ankyrin repeat and FYVE domain containing 1"	Q9P2R3	17	4163821-4263995	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024513, HPA024522, HPA065849"	Approved		Enhanced	Endosomes		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Endosomes		"HPA024513: AB_1844830, HPA024522: AB_10601453, HPA065849: AB_2685567"	"unprognostic (4.57e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.13e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.14e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.05e-1)"	13.8	16.1	18.9	13.5	25.4	16.4	12.5	23.4	19.0	15.2	15.1	25.8	11.4	18.0	10.6	13.6	15.1	11.9	11.4	17.8	23.9	11.3	13.9	15.3	14.0	27.5	23.6	19.9	9.6	19.0	12.3	14.2	25.4	12.1	13.9	13.1	13.7	12.2	14.1	19.8	13.7	14.8	25.8	15.0	13.0	5.9	22.9	20.3	14.4	11.4	12.8	14.6	13.9	28.1	20.6	47.2	31.5	21.3	41.7	31.6	20.5	22.5	23.4	35.5	35.2	21.0	13.7	17.8	18.0	34.1	19.0	32.0	29.3	24.0	31.2	9.7	29.7	17.6	34.0	19.6	23.2	10.6	20.4	33.3	24.8	25.5	18.7	19.0	21.3	17.2	17.3	16.7	24.5	16.0	15.9	11.3	13.3	16.0	16.4	23.9	21.0	9.9	18.5	27.7	10.5	16.4	31.9	15.1	20.2	24.3	17.5	13.7	27.3	22.5	11.7	31.0	30.3	5.5	4.6	5.9	27.5	21.1	27.5	1.0	3.9	1.7	2.7	6.4	2.5	0.9	1.8	1.9	2.7	0.9	1.8	1.7	1.6	1.0	7.3	1.1	1.7	2.2	18.9	25.4	23.4	19.0	17.8	23.9	27.5	23.6	25.4	25.8	22.9	28.1	14.5	28.9	24.6	43.1	8.7	12.4	8.9	12.7	13.1	24.1	12.2	13.2	4.6	8.6	13.6	18.4	29.2	11.2	15.1	13.8	1.9	9.8	4.3	13.9	20.0	15.1	12.1	6.3	59.9	9.7	9.8	15.2	18.8	12.5	3.8	21.1	24.7	19.7	20.2	26.9	60.5	10.9	6.1	24.4	7.6	3.8	14.6	19.1	17.8	39.4	18.8	9.8	19.6	36.7	46.4	13.2	6.4	19.2	7.4	15.4	11.4	7.6	22.4	30.2	6.6	25.5	11.9	12.9	12.8	17.2	11.6	6.2	15.5	16.6	12.5	14.5
ANKHD1	"FLJ10042, FLJ11979, FLJ14127, FLJ20288, KIAA1085, MASK, MASK1"	ENSG00000131503	"Ankyrin repeat and KH domain containing 1"	Q8IWZ3	5	140401814-140539856	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA008718	Approved					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"			"HPA008718: AB_1078162"	"unprognostic (1.62e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.56e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.39e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.05e-2)"	39.3	43.3	24.4	37.0	30.2	74.1	39.6	34.2	41.0	47.2	30.9	40.4	31.7	41.3	48.3	44.6	41.3	24.9	36.0	24.4	25.4	36.7	54.3	40.3	41.3	27.7	28.0	52.3	60.6	37.9	42.4	28.5	28.5	37.0	33.2	40.4	42.4	27.7	71.4	50.7	46.3	26.1	24.7	48.4	41.8	30.7	28.5	48.8	46.8	27.9	41.4	36.3	43.9	36.4	58.6	56.5	69.8	95.9	44.3	42.8	74.0	32.4	35.1	45.0	56.0	138.1	51.6	86.5	50.6	29.8	91.6	58.5	67.4	63.4	58.2	65.3	65.1	67.8	77.7	77.3	43.8	132.6	64.3	37.5	41.7	61.9	75.5	31.0	49.3	61.5	69.4	91.5	34.6	62.6	70.4	70.6	42.5	36.7	56.9	89.3	87.1	60.6	23.8	74.2	58.5	40.7	73.1	74.6	75.4	33.6	77.3	69.5	46.4	48.8	28.3	49.5	53.8	83.6	88.5	108.3	38.0	85.3	35.2	25.2	8.2	10.4	10.5	6.3	9.3	10.5	10.6	10.9	7.2	9.2	9.4	9.7	17.9	15.6	8.8	11.3	7.8	3.4	24.4	30.2	34.2	41.0	24.4	25.4	27.7	28.0	28.5	24.7	28.5	36.4	13.0	12.8	45.5	0.0	34.7	18.6	18.6	7.2	44.9	13.6	9.0	7.5	5.4	18.6	20.5	9.2	16.7	12.0	17.7	10.7	3.9	11.8	13.2	7.9	8.0	13.5	4.2	21.0	0.0	19.2	13.5	13.7	27.5	11.7	12.7	8.3	15.0	10.9	13.0	11.8	0.0	10.1	8.2	19.8	20.8	4.2	10.8	19.7	17.8	0.0	18.5	8.4	11.3	0.0	0.0	13.8	12.1	9.1	41.6	14.0	12.5	5.2	16.3	13.2	19.7	15.3	12.9	31.6	31.6	39.2	21.6	30.8	31.2	6.5	11.8	21.5
ANKRD17	"FLJ22206, GTAR, KIAA0697, MASK2, NY-BR-16"	ENSG00000132466	"Ankyrin repeat domain 17"	O75179	4	73073376-73258798	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 337.8;Inhibitory neurons: 315.8;Oligodendrocyte precursor cells: 275.0;Oligodendrocytes: 296.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045024, HPA063731"	Approved		Supported	"Nucleoplasm,Nuclear membrane"		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear membrane"	"HPA045024: AB_10964778, HPA063731: AB_2685106"	"unprognostic (3.86e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.63e-3)"	"unprognostic (3.29e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.79e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.98e-3)"	"unprognostic (9.06e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.00e-2)"	"unprognostic (4.07e-1)"	13.7	13.5	15.6	13.6	16.7	9.2	20.0	23.1	20.4	16.8	16.8	15.8	14.8	14.7	18.5	14.5	18.2	12.4	14.5	16.2	21.1	19.6	20.6	14.2	15.1	15.7	15.9	17.8	18.0	24.5	14.4	19.0	16.0	15.1	19.0	36.0	16.7	13.7	23.2	17.2	15.2	16.4	12.3	15.1	15.7	11.1	18.5	27.2	17.9	26.1	17.7	17.7	12.8	20.1	25.6	27.7	43.1	34.2	47.4	41.5	23.5	36.9	43.1	32.5	31.1	33.9	32.8	69.2	29.9	38.0	17.1	20.9	54.4	32.6	44.6	27.1	23.1	47.1	29.5	49.4	25.4	62.2	27.9	35.2	34.8	46.6	36.9	33.6	43.8	27.9	67.2	24.8	39.4	23.7	51.3	22.1	28.0	33.0	27.6	40.5	47.3	28.8	34.5	38.1	41.6	28.2	35.7	39.7	18.9	33.5	21.3	24.3	53.2	34.0	32.6	30.8	29.3	20.5	11.1	51.5	27.6	26.8	35.6	1.6	1.7	1.8	3.0	1.1	1.5	1.8	1.8	2.0	1.4	2.6	1.7	2.0	1.9	5.6	1.3	4.4	1.2	1.1	15.6	16.7	23.1	20.4	16.2	21.1	15.7	15.9	16.0	12.3	18.5	20.1	42.9	48.1	52.9	194.9	30.9	76.1	36.9	33.9	67.2	57.2	38.6	31.2	82.2	35.8	45.5	40.5	123.0	31.8	40.0	52.8	7.9	30.9	12.7	46.0	57.9	52.2	45.1	36.1	337.8	28.9	24.6	44.8	51.5	60.8	31.6	53.4	43.9	49.7	27.3	69.0	315.8	45.6	26.4	31.2	34.7	5.5	35.1	35.0	28.4	181.8	34.8	30.5	50.4	275.0	296.5	30.2	25.7	37.6	44.2	52.8	39.4	25.4	30.5	84.1	19.7	58.5	48.5	28.1	30.8	64.9	81.3	33.8	32.4	47.6	48.3	48.4
ANKRD26	"KIAA1074, THC2"	ENSG00000107890	"Ankyrin repeat domain 26"	Q9UPS8	10	26973793-27100494	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 130.6;Cone photoreceptor cells: 200.1;Excitatory neurons: 136.8;Inhibitory neurons: 185.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA040654, HPA041460"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus, Vesicles"		"HPA040654: AB_10795370, HPA041460: AB_10795120"	"unprognostic (1.92e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.86e-5)"	"unprognostic (2.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.53e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.99e-1)"	2.3	2.6	4.7	1.6	5.4	1.5	3.8	5.9	8.6	3.9	5.0	2.5	1.7	3.3	3.0	2.0	3.0	2.0	4.1	4.4	4.0	2.7	2.8	1.9	3.5	4.7	3.8	4.0	2.6	4.0	4.6	3.2	2.7	2.6	2.8	10.0	2.3	2.5	6.7	2.5	2.0	2.5	2.8	2.5	2.2	4.0	4.9	3.1	2.7	7.5	2.2	2.2	2.7	5.8	7.7	5.4	9.8	3.7	6.1	6.7	3.4	10.1	3.7	9.2	8.5	5.2	5.1	17.9	3.1	4.7	6.5	8.1	9.6	4.7	11.0	7.4	7.2	1.1	7.9	7.9	4.5	4.5	1.2	4.7	2.9	9.5	3.2	7.5	8.4	5.5	14.8	4.8	9.3	4.3	5.5	2.8	3.9	2.8	3.5	6.6	13.8	4.3	5.7	3.1	8.5	4.7	9.6	2.0	8.1	7.1	8.5	3.1	7.6	7.7	5.2	9.9	5.7	1.9	2.6	11.7	7.3	9.9	3.5	1.0	0.2	0.2	0.2	0.1	0.7	1.2	0.4	0.4	0.3	0.6	1.6	0.5	0.1	1.6	0.1	2.1	0.4	0.2	4.7	5.4	5.9	8.6	4.4	4.0	4.7	3.8	2.7	2.8	4.9	5.8	19.5	22.4	28.8	130.6	14.3	4.2	7.6	9.0	8.6	77.8	13.5	17.7	70.9	7.2	19.4	3.7	200.1	24.8	8.6	8.3	5.9	14.5	19.0	47.7	38.6	20.4	20.9	6.3	136.8	13.1	13.1	21.3	8.2	16.5	5.1	43.5	13.6	8.3	11.9	79.1	185.9	9.3	10.2	5.7	5.4	6.4	30.4	11.8	3.6	45.0	12.4	45.0	18.6	87.0	67.2	11.3	4.2	27.1	7.8	5.3	12.1	5.6	49.5	117.9	32.9	30.1	15.6	60.7	57.2	8.9	8.0	13.7	12.9	46.1	14.6	5.0
ANKRD54	LIAR	ENSG00000100124	"Ankyrin repeat domain 54"	Q6NXT1	22	37830855-37849327	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071287	Approved		Approved	Nucleoplasm,Microtubules,Midbody		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Microtubules, Midbody"	Nucleoplasm	"HPA071287: AB_2686380"	"unprognostic (5.36e-2)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.02e-1)"	"prognostic favorable (7.38e-5)"	"unprognostic (1.14e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.41e-2)"	"prognostic favorable (6.16e-4)"	"unprognostic (2.53e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.02e-3)"	8.6	18.7	22.4	5.9	20.8	6.9	9.1	22.6	23.3	13.0	28.7	16.4	7.1	12.9	7.8	14.0	23.8	6.3	12.4	23.0	26.2	14.9	15.6	8.4	6.4	22.6	24.7	17.8	18.1	11.7	19.2	5.4	21.6	13.7	6.6	6.3	13.9	11.0	12.6	11.3	8.9	9.5	22.0	9.2	10.9	30.9	26.1	10.4	13.8	8.7	7.2	14.0	10.9	20.3	18.5	18.6	15.4	23.0	19.9	11.3	8.1	24.8	19.2	41.1	25.2	11.8	7.3	17.8	10.1	16.5	13.3	16.4	19.5	14.1	19.9	14.2	39.5	9.3	17.3	28.3	17.7	17.8	20.8	10.1	14.2	22.6	13.3	10.3	25.5	13.1	11.9	12.7	19.1	19.8	17.6	21.1	4.4	24.5	16.5	20.2	18.3	11.3	23.2	6.4	26.4	14.1	20.7	18.8	30.8	7.0	19.3	28.0	15.1	24.5	25.6	12.9	18.6	13.3	11.7	14.3	20.1	15.1	17.9	3.5	4.5	2.2	5.4	5.5	5.4	3.9	5.1	4.0	5.7	5.2	5.3	2.6	2.7	10.2	9.3	5.3	2.4	3.3	22.4	20.8	22.6	23.3	23.0	26.2	22.6	24.7	21.6	22.0	26.1	20.3	8.4	12.8	14.5	11.8	14.4	15.8	11.0	12.4	12.0	18.3	16.9	15.6	8.1	24.3	12.2	18.4	29.2	20.9	14.0	19.9	39.2	17.1	6.4	47.8	12.6	10.9	9.0	12.8	9.4	14.7	17.7	12.3	12.2	8.5	9.5	23.3	13.6	12.0	13.2	26.9	9.4	14.3	12.2	12.5	10.7	7.7	18.0	8.8	10.6	2.8	9.2	18.5	17.5	13.6	8.6	11.3	15.3	21.4	8.4	11.4	19.2	22.0	48.2	23.2	6.6	13.1	13.4	65.6	42.1	12.7	17.6	16.8	13.3	25.4	20.7	9.9
ANP32A	"C15orf1, I1PP2A, LANP, MAPM, mapmodulin, PHAPI, PP32"	ENSG00000140350	"Acidic nuclear phosphoprotein 32 family member A"	P39687	15	68778535-68820897	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005231, HPA063133, HPA067561"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA		770000	"Cluster 52: Eosinophils - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Centrosome"	Cytosol	"CAB005231: AB_2289588, HPA063133: AB_2684947, HPA067561: AB_2685861"	"unprognostic (1.41e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.03e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.44e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.83e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.17e-1)"	50.8	34.7	50.2	87.3	60.5	137.0	71.6	62.3	59.1	54.0	33.3	81.0	70.8	59.1	50.7	65.8	75.1	59.8	127.9	48.8	57.3	75.1	76.4	71.0	156.2	60.0	56.5	57.8	53.7	61.4	27.5	101.5	65.4	75.4	89.0	106.0	54.0	66.8	62.4	36.1	76.9	57.0	62.7	85.5	78.9	20.8	54.3	203.0	73.6	64.5	141.2	76.4	43.6	71.0	196.4	234.7	303.2	263.2	104.2	90.9	200.5	101.0	134.3	193.5	161.8	195.3	358.0	629.8	184.5	114.5	114.2	279.9	709.5	206.6	230.8	286.6	241.2	478.6	192.7	247.8	64.5	380.8	247.4	72.9	143.1	106.3	210.2	126.6	285.9	300.0	354.5	239.1	168.2	136.1	386.1	311.6	270.1	192.5	118.2	531.7	280.7	375.3	170.5	304.5	399.8	247.8	153.7	170.8	282.7	301.1	227.2	491.4	129.0	199.0	313.5	139.3	275.2	143.8	433.9	733.8	132.2	632.1	186.7	12.9	26.4	44.9	16.8	30.6	14.2	18.7	13.8	17.8	30.0	17.9	16.5	14.9	27.2	28.8	27.5	26.8	17.2	16.0	50.2	60.5	62.3	59.1	48.8	57.3	60.0	56.5	65.4	62.7	54.3	71.0	100.2	109.0	118.0	20.2	98.1	64.7	67.7	147.0	91.0	92.2	57.3	70.6	80.0	60.1	105.4	69.9	35.5	258.2	119.7	57.1	107.6	112.5	6.7	61.2	67.7	91.8	78.5	144.2	16.8	96.1	172.4	57.5	69.3	70.1	92.4	63.6	78.1	81.8	194.1	65.6	17.4	92.1	114.0	150.1	112.6	6.3	34.8	111.6	78.2	37.5	158.9	103.7	84.5	15.6	55.4	79.8	57.0	29.7	92.6	59.7	99.3	148.0	113.7	87.2	26.3	49.9	75.1	8.8	18.2	86.4	34.9	232.5	99.5	82.5	94.7	52.0
AP1G1	"ADTG, CLAPG1"	ENSG00000166747	"Adaptor related protein complex 1 subunit gamma 1"	O43747	16	71729000-71809201	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 268.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009049, HPA041224"	Approved		Enhanced	Vesicles,Cytosol		NA	NA		62000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles	Cytosol	"CAB009049: AB_2058329, HPA041224: AB_2677370"	"unprognostic (4.84e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.90e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.22e-2)"	"unprognostic (4.30e-2)"	"prognostic favorable (2.96e-8)"	"unprognostic (1.27e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.75e-1)"	19.0	25.7	15.4	23.4	16.4	76.7	24.8	19.6	20.8	20.3	26.9	23.6	22.6	17.8	25.5	26.7	18.0	18.9	13.6	16.8	14.9	36.4	33.2	21.4	24.6	14.4	14.5	15.3	24.2	40.4	16.8	17.5	15.8	22.5	25.7	52.8	22.6	16.3	28.2	26.6	23.6	16.1	13.5	22.4	29.3	30.7	15.6	24.9	24.0	36.5	30.4	20.6	18.4	24.3	43.9	62.4	46.3	48.1	48.2	45.4	41.0	44.6	42.1	56.8	54.5	64.3	47.1	55.0	41.9	60.4	41.5	55.4	62.7	49.3	74.4	21.6	33.8	36.2	31.7	46.5	28.9	44.7	114.1	39.1	33.4	76.0	46.9	36.1	50.2	35.8	47.8	23.0	56.1	80.0	39.2	35.3	43.7	34.6	26.8	62.9	37.3	59.3	53.7	49.3	42.5	25.5	55.7	34.8	24.5	46.6	61.0	33.7	60.2	49.4	37.9	27.3	32.9	35.1	50.2	109.2	40.3	34.4	43.3	5.7	6.9	10.0	6.7	7.6	6.8	5.4	5.9	7.5	7.5	5.7	4.6	5.8	14.9	6.7	6.4	5.2	6.6	4.2	15.4	16.4	19.6	20.8	16.8	14.9	14.4	14.5	15.8	13.5	15.6	24.3	32.6	32.1	31.1	42.4	34.2	28.8	27.4	17.3	22.8	26.8	47.6	25.4	13.4	35.8	25.2	36.8	73.0	14.4	40.6	39.3	19.6	21.1	268.8	55.8	37.9	26.0	23.4	9.9	54.2	21.8	13.3	24.0	46.4	84.8	21.0	26.2	21.4	58.5	16.7	30.3	59.0	25.7	12.2	30.4	27.2	130.7	17.7	32.4	23.2	36.5	25.1	16.4	24.7	53.8	79.2	30.5	24.2	19.9	30.6	36.9	30.5	46.4	31.7	66.6	19.7	33.0	26.4	35.8	37.1	32.4	38.6	24.5	33.4	23.0	26.4	47.8
AP2B1	"ADTB2, CLAPB1"	ENSG00000006125	"Adaptor related protein complex 2 subunit beta 1"	P63010	17	35578046-35726413	"Cancer-related genes, Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 503.9;Late spermatids: 739.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017631, HPA056733, HPA067983"	Approved		Supported	Vesicles		NA	NA		380000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"CAB017631: AB_2058201, HPA056733: AB_2683219, HPA067983: AB_2732777"	"unprognostic (1.49e-2)"	"unprognostic (4.04e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.50e-1)"	"prognostic favorable (2.62e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.57e-2)"	46.4	42.4	77.0	38.2	87.8	49.2	58.3	69.9	88.7	54.1	76.6	67.6	33.5	41.7	70.7	25.1	46.7	42.3	67.6	92.1	83.5	69.0	35.0	53.4	38.6	69.8	78.6	57.2	33.2	126.4	55.0	66.8	76.8	40.9	84.0	76.1	41.9	50.1	57.5	29.9	38.8	56.0	80.3	42.0	48.4	93.5	78.7	59.7	65.1	61.0	45.5	46.8	34.4	95.0	188.8	233.9	113.7	132.0	184.4	202.8	51.6	94.3	138.9	131.0	141.1	129.0	154.6	90.5	81.1	175.3	168.8	173.2	162.5	264.8	190.8	108.6	147.0	117.7	161.8	71.0	104.7	119.3	80.8	128.9	104.3	134.5	209.3	151.2	211.4	111.8	190.6	126.9	206.9	36.9	113.7	58.7	94.2	98.9	164.5	94.3	165.1	64.7	166.2	108.3	94.4	114.1	114.5	39.6	126.9	273.3	161.5	78.5	211.5	99.3	93.4	109.8	142.1	53.0	106.1	84.7	124.1	86.9	112.5	19.6	11.8	16.7	16.0	15.3	16.9	12.1	13.9	14.3	10.7	11.9	6.3	8.0	13.3	9.6	16.8	10.7	20.5	11.0	77.0	87.8	69.9	88.7	92.1	83.5	69.8	78.6	76.8	80.3	78.7	95.0	76.5	16.0	17.0	49.3	45.9	31.1	26.3	57.4	70.6	67.6	88.9	50.9	62.5	68.6	37.4	112.2	56.3	29.7	70.7	97.4	117.4	105.0	503.9	74.5	83.7	56.8	71.3	214.7	105.5	120.2	42.8	47.1	36.2	85.4	41.2	46.5	79.9	64.5	44.1	69.0	109.8	79.4	28.5	54.3	25.9	739.2	58.7	37.2	16.0	60.0	47.3	52.6	74.2	81.4	89.0	177.9	46.6	68.4	32.1	37.4	39.4	102.5	30.4	40.9	59.2	25.3	37.6	258.8	60.0	19.6	14.6	32.8	49.2	37.3	89.8	29.1
AP3M2	"AP47B, CLA20"	ENSG00000070718	"Adaptor related protein complex 3 subunit mu 2"	P53677	8	42152946-42171673	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 70.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014876, HPA045591, HPA048380"	Approved					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"			"CAB014876: , HPA045591: AB_2679377, HPA048380: AB_2680379"	"unprognostic (5.53e-2)"	"unprognostic (2.26e-2)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (3.46e-4)"	"unprognostic (3.33e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.02e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.80e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.32e-1)"	"unprognostic (8.04e-2)"	"prognostic favorable (2.38e-4)"	9.1	11.3	26.0	8.0	27.0	11.2	8.8	18.5	27.4	9.2	14.4	8.5	7.2	10.5	13.0	7.0	16.4	10.5	14.1	27.9	25.7	12.4	4.6	12.7	12.4	22.9	21.4	9.5	6.5	22.7	13.3	20.6	24.2	10.3	8.7	41.9	6.2	11.5	8.9	12.6	7.8	9.9	20.8	10.4	7.0	23.6	26.9	8.3	13.5	10.6	10.4	9.9	8.1	21.2	20.6	20.8	18.2	21.4	16.2	15.9	4.0	23.5	23.3	22.0	25.7	11.7	24.4	12.3	14.7	13.5	24.8	23.9	28.6	14.8	28.4	17.0	26.9	23.4	17.8	8.1	14.7	10.1	13.4	14.5	25.1	24.0	13.6	30.5	15.0	35.1	28.5	11.3	20.2	9.7	30.0	11.9	20.4	25.0	14.5	28.6	34.7	13.2	16.8	24.0	25.9	18.6	14.4	7.2	26.1	18.8	21.2	6.4	9.6	13.4	19.2	20.0	10.9	9.6	19.5	11.2	18.8	1.4	37.8	2.9	1.9	1.5	7.5	2.7	9.7	4.7	15.5	8.1	4.2	3.0	14.4	5.7	2.3	7.7	2.8	6.8	5.9	5.0	26.0	27.0	18.5	27.4	27.9	25.7	22.9	21.4	24.2	20.8	26.9	21.2	16.2	12.8	3.3	16.6	13.6	17.5	20.3	8.0	9.1	35.9	6.9	7.4	17.0	1.5	9.3	14.7	39.6	7.0	21.3	2.6	5.9	12.9	59.8	15.7	11.6	18.1	3.0	10.8	26.2	7.4	4.8	11.5	6.6	11.1	3.8	12.1	18.5	4.3	6.6	35.3	33.6	3.0	16.2	2.1	10.1	70.1	5.3	6.5	37.4	14.0	13.5	19.6	11.3	15.1	16.0	16.3	1.8	9.1	17.1	8.9	0.9	6.8	18.8	37.1	19.7	8.1	15.0	26.8	45.0	6.6	19.7	2.9	41.5	11.0	4.3	15.4
AP5M1	"C14orf108, FLJ10813, mu5, MuD, MUDENG"	ENSG00000053770	"Adaptor related protein complex 5 subunit mu 1"	Q9H0R1	14	57268924-57298742	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 115.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055768, HPA057098"	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA055768: AB_2682913, HPA057098: AB_2683335"	"unprognostic (7.95e-2)"	"unprognostic (5.37e-2)"	"prognostic favorable (7.91e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.51e-3)"	"unprognostic (1.23e-1)"	"prognostic favorable (1.11e-14)"	"unprognostic (6.26e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.60e-1)"	11.5	12.1	6.5	13.2	8.7	15.4	13.8	11.9	10.2	14.3	20.1	25.7	28.8	11.7	15.3	16.3	9.8	12.1	16.5	7.2	13.5	28.5	21.1	11.7	17.0	13.2	9.0	8.3	10.0	31.5	6.6	11.0	12.1	12.3	29.5	22.5	16.7	12.6	15.5	11.2	25.2	14.0	9.0	14.4	14.9	10.5	10.0	22.2	18.4	28.3	22.8	13.3	7.5	11.0	19.0	16.1	22.3	21.5	20.2	22.6	17.8	21.0	20.7	18.5	24.5	16.1	27.8	26.7	20.4	20.7	16.5	27.6	32.1	18.5	27.8	27.9	9.4	14.8	15.3	18.7	14.0	44.9	23.6	20.9	23.8	17.6	13.3	19.2	21.0	23.2	18.4	17.6	29.8	16.6	41.6	11.2	16.9	34.6	22.4	27.9	29.4	20.3	42.7	44.1	36.4	20.0	24.3	38.9	16.3	21.8	23.8	20.4	13.5	26.3	24.9	13.9	12.0	9.7	15.9	24.1	23.2	21.1	19.8	20.5	17.8	36.4	19.1	15.4	20.8	22.8	21.0	22.0	24.9	15.9	21.4	22.9	14.9	28.6	15.3	13.2	25.6	17.9	6.5	8.7	11.9	10.2	7.2	13.5	13.2	9.0	12.1	9.0	10.0	11.0	15.4	32.1	13.1	19.2	30.7	20.1	18.8	30.5	21.6	21.0	17.8	11.6	32.6	17.2	25.3	23.9	39.6	21.5	22.6	40.6	86.1	20.9	115.1	11.5	12.9	19.0	29.9	23.4	42.3	16.2	18.9	17.0	29.0	13.1	17.7	13.4	18.9	31.1	24.5	35.3	45.6	29.0	44.7	25.6	11.5	88.1	17.7	17.9	21.4	21.5	32.1	19.3	34.0	19.1	31.0	16.6	23.7	20.3	26.8	19.9	44.8	74.4	16.2	31.3	19.7	12.7	13.4	31.5	10.7	37.8	21.5	19.3	22.3	17.2	39.6	23.7
APC	"DP2, DP2.5, DP3, PPP1R46"	ENSG00000134982	"APC regulator of WNT signaling pathway"	P25054	5	112707498-112846239	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"		"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 52.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 536.4;Bipolar cells: 196.9;Excitatory neurons: 165.8;Inhibitory neurons: 236.4;Oligodendrocyte precursor cells: 196.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013349, HPA013362"	Supported		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA013349: AB_1844913, HPA013362: "	"unprognostic (4.80e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.09e-3)"	"unprognostic (1.62e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.96e-1)"	6.9	4.6	28.4	6.2	26.0	9.1	5.7	23.1	31.0	5.7	0.1	6.7	6.2	5.6	3.3	7.7	4.3	4.9	7.2	52.8	27.4	6.2	5.7	6.2	5.6	32.1	30.7	6.6	4.1	8.5	3.9	5.1	39.0	5.2	6.2	20.0	3.8	4.1	8.5	5.7	8.5	7.5	16.0	6.1	5.0	5.1	37.9	8.5	5.9	11.8	5.9	5.4	3.6	20.9	11.3	10.1	16.8	12.2	13.4	11.3	6.7	17.9	8.5	9.7	11.5	8.2	8.9	22.0	17.0	23.1	15.5	9.0	17.4	14.6	15.9	13.2	12.2	16.8	14.9	6.2	6.6	8.4	8.6	9.3	9.8	16.6	10.8	6.8	13.6	10.2	20.9	7.2	14.3	7.8	9.6	4.2	6.0	6.1	3.6	8.1	20.8	10.7	8.9	14.1	17.0	10.1	16.9	6.5	7.1	6.8	9.1	6.7	22.8	19.6	9.5	19.5	13.6	5.6	9.5	8.2	10.8	15.3	11.2	11.8	2.5	4.9	2.9	1.3	2.4	2.8	1.5	1.9	2.1	3.1	2.4	2.4	11.4	2.9	2.4	2.7	1.5	1.0	28.4	26.0	23.1	31.0	52.8	27.4	32.1	30.7	39.0	16.0	37.9	20.9	40.6	51.3	23.6	536.4	21.9	11.2	8.9	10.1	19.9	196.9	13.1	14.9	56.6	18.6	20.1	0.0	66.7	5.4	28.9	28.6	0.0	18.7	10.5	20.1	27.6	31.2	27.5	17.4	165.8	19.5	6.5	25.9	19.4	29.7	19.0	28.7	26.7	13.9	16.3	79.1	236.4	17.2	2.0	18.9	12.4	5.5	17.7	27.8	17.8	85.3	30.7	23.4	23.7	196.6	150.8	20.3	34.7	19.5	22.9	10.4	37.2	5.1	18.0	41.5	39.5	44.1	34.0	19.2	30.4	26.5	11.6	2.9	22.4	27.1	16.0	8.9
APEX1	"APE, APE-1, APEN, APEX, APX, HAP1, REF-1, REF1"	ENSG00000100823	"Apurinic/apyrimidinic endodeoxyribonuclease 1"	P27695	14	20455191-20457772	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"	"Activator, DNA-binding, Endonuclease, Exonuclease, Hydrolase, Nuclease, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000956, HPA002564, CAB004294, CAB047307"	Supported		Supported	Nucleoplasm		Yes	No		330000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"CAB004294: AB_626685, CAB047307: , HPA000956: AB_2666158, HPA002564: AB_1078174"	"unprognostic (2.80e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.97e-2)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (7.82e-5)"	"unprognostic (4.21e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.54e-1)"	"unprognostic (7.08e-2)"	83.9	103.6	56.9	82.8	58.1	154.9	103.2	60.0	67.5	80.4	57.9	89.1	107.5	97.2	66.5	80.5	99.1	79.7	76.6	57.5	60.3	82.8	104.6	61.0	112.4	58.9	58.3	146.3	92.2	88.3	39.3	57.3	59.5	69.3	92.7	52.9	66.0	80.2	102.9	83.4	73.0	95.7	59.5	68.9	85.4	21.5	60.1	125.0	93.2	71.9	121.2	103.8	65.8	62.6	249.3	296.8	267.8	247.2	180.9	259.3	226.5	227.3	245.7	333.3	287.4	216.9	240.7	477.9	198.4	176.4	178.1	262.5	317.5	242.1	304.8	214.7	135.9	195.5	162.8	368.9	189.5	623.1	193.2	270.6	261.6	217.6	212.6	267.2	282.3	193.9	228.4	153.6	270.7	240.0	404.7	264.7	260.3	282.4	269.5	441.5	297.7	200.8	281.7	327.1	315.2	201.8	248.5	305.2	253.1	185.0	186.4	276.7	186.0	175.0	292.8	177.9	216.6	203.1	375.8	327.7	77.8	390.7	224.7	0.9	106.7	7.5	79.6	93.4	108.4	154.8	98.9	95.4	208.6	140.5	133.1	117.7	6.8	97.6	60.1	235.6	65.8	200.3	56.9	58.1	60.0	67.5	57.5	60.3	58.9	58.3	59.5	59.5	60.1	62.6	63.8	64.1	57.6	11.8	120.3	106.4	101.1	192.9	136.1	57.5	131.3	136.8	50.1	111.5	117.1	68.0	41.7	200.1	114.1	32.4	150.6	152.7	19.9	65.0	161.1	75.6	120.0	135.6	20.6	104.5	212.6	88.7	72.9	82.0	81.6	165.5	42.1	70.8	175.6	28.6	19.5	85.4	138.4	96.7	89.4	5.8	80.5	95.2	64.0	11.2	121.9	77.4	75.2	22.6	19.4	78.2	73.1	64.3	71.1	60.4	66.2	170.1	64.6	51.6	52.6	87.5	174.2	8.5	43.0	106.4	97.0	101.5	75.1	198.4	157.6	76.8
APEX2	"APE2, APEXL2, XTH2, ZGRF2"	ENSG00000169188	"Apurinic/apyrimidinic endodeoxyribonuclease 2"	Q9UBZ4	X	55000363-55009057	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair"	"DNA-binding, Endonuclease, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 52.7;Syncytiotrophoblasts: 47.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048577			Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"	Vesicles	"HPA048577: AB_2680448"	"unprognostic (2.90e-2)"	"prognostic favorable (6.17e-4)"	"unprognostic (4.32e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.62e-2)"	"prognostic unfavorable (6.13e-7)"	"unprognostic (5.89e-2)"	"unprognostic (4.87e-2)"	"prognostic favorable (5.21e-4)"	"unprognostic (7.46e-2)"	"unprognostic (3.16e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (6.63e-4)"	7.2	8.9	6.1	8.8	6.3	10.0	7.2	6.0	6.6	7.6	6.5	8.9	8.9	7.4	8.5	15.5	7.3	6.3	9.0	5.9	6.4	10.8	11.0	7.2	11.3	6.4	6.3	9.6	7.4	7.1	7.0	9.0	6.3	7.8	10.5	2.3	7.0	6.6	7.5	12.2	9.1	7.0	6.3	11.2	7.9	4.1	6.6	10.9	6.3	7.3	13.5	10.2	9.4	6.7	36.9	32.4	12.5	18.3	17.9	11.9	21.3	14.8	19.8	28.0	27.2	17.8	30.0	24.1	22.7	14.0	33.0	26.9	29.1	28.2	21.0	19.7	22.1	29.4	31.6	18.3	11.5	18.3	26.6	11.8	22.6	39.6	14.2	13.2	22.6	25.3	15.4	15.9	21.2	35.7	24.9	23.8	25.0	17.4	38.6	21.8	20.8	26.4	15.2	18.1	11.6	12.7	28.0	33.4	14.7	28.5	26.4	14.1	13.1	16.6	23.9	33.7	19.6	16.4	22.9	19.9	17.7	30.9	20.1	16.2	11.5	13.1	10.2	14.4	8.6	8.2	9.6	10.2	13.7	8.5	8.5	8.4	4.1	42.0	13.4	7.4	11.6	10.1	6.1	6.3	6.0	6.6	5.9	6.4	6.4	6.3	6.3	6.3	6.6	6.7	6.1	3.2	11.8	1.6	12.7	12.9	12.5	20.1	6.8	3.6	7.2	7.1	5.9	15.7	14.9	11.0	0.0	52.7	7.1	17.9	15.6	31.5	0.3	6.0	5.7	11.5	6.1	31.5	0.8	15.1	35.3	7.6	10.2	9.7	8.8	13.1	10.4	11.4	24.2	6.7	0.7	10.1	10.2	10.9	11.1	1.1	5.9	12.0	0.0	1.9	21.7	5.2	16.5	1.0	1.9	20.5	19.1	8.6	9.8	10.5	16.6	21.6	11.8	2.1	19.7	4.4	6.9	1.4	10.6	13.8	12.6	47.6	11.6	12.4	13.7	13.2
API5	"AAC-11, AAC11, API5L1"	ENSG00000166181	"Apoptosis inhibitor 5"	Q9BZZ5	11	43311963-43344529	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026598	Approved		Enhanced	"Nuclear speckles"		NA	NA		31000	"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA026598: AB_1844927"	"unprognostic (4.05e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.58e-3)"	"unprognostic (6.08e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.69e-3)"	"unprognostic (1.45e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (1.06e-4)"	"unprognostic (5.03e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.05e-2)"	37.6	33.1	29.2	43.4	31.1	35.3	45.7	38.5	37.4	39.3	25.9	44.3	42.8	42.1	34.5	44.6	36.6	32.4	28.2	32.0	30.6	49.1	57.7	34.8	53.5	29.2	28.5	35.1	45.9	46.6	19.0	29.9	30.8	40.4	46.6	44.1	39.0	39.5	37.1	40.0	45.5	46.6	32.8	40.3	41.1	26.8	29.9	62.1	51.4	35.9	57.2	44.2	27.6	38.6	90.2	93.0	119.4	75.2	82.7	82.4	82.9	83.8	89.4	116.3	110.2	69.4	38.8	106.4	67.2	90.2	86.9	107.7	143.2	99.7	160.6	122.4	134.9	96.5	53.0	60.8	74.8	165.6	88.9	64.2	104.6	59.0	102.9	72.4	98.9	65.8	160.3	93.9	82.1	57.0	141.2	71.1	214.6	111.1	86.0	145.2	126.3	85.3	89.5	103.8	95.5	64.2	100.7	88.7	81.4	88.4	109.1	76.6	86.5	102.0	78.3	139.8	144.5	77.5	122.7	172.1	88.8	95.0	62.3	61.3	47.3	51.5	66.5	64.5	75.1	61.7	64.8	69.3	62.1	60.4	66.3	68.7	9.9	116.3	67.3	40.0	61.4	88.4	29.2	31.1	38.5	37.4	32.0	30.6	29.2	28.5	30.8	32.8	29.9	38.6	26.4	16.0	27.3	30.0	35.9	43.8	16.6	21.6	47.3	23.8	27.8	17.8	14.4	31.5	28.0	20.2	10.4	30.4	31.8	20.1	31.3	21.3	13.6	23.5	25.8	26.2	24.0	48.0	40.2	19.7	30.4	28.3	35.2	28.2	32.3	25.9	22.1	48.0	26.3	28.6	33.5	27.5	12.2	33.6	28.8	6.5	18.6	30.0	32.0	27.2	41.7	21.1	17.5	25.1	45.4	24.9	19.8	20.3	44.2	24.0	29.4	37.3	20.8	19.0	6.6	28.9	31.1	28.4	26.6	43.1	51.9	38.9	33.8	26.6	31.4	19.2
APIP	"APIP2, CGI-29, Mmrp19"	ENSG00000149089	"APAF1 interacting protein"	Q96GX9	11	34853094-34916379	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Apoptosis, Methionine biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 187.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021188, HPA024131"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		52000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	Cytosol	"HPA021188: AB_10610977, HPA024131: AB_10602171"	"unprognostic (2.80e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.68e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (2.74e-2)"	"unprognostic (3.84e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.23e-1)"	"unprognostic (5.48e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.58e-2)"	30.4	25.4	14.7	20.7	17.1	14.4	20.7	17.3	17.1	18.0	14.2	19.9	13.6	15.0	15.0	13.8	17.2	18.5	20.0	13.9	16.3	27.0	19.4	21.2	20.2	18.7	16.4	12.3	17.2	15.8	9.1	13.3	18.4	16.8	19.5	16.8	31.7	23.6	65.6	10.0	16.3	12.3	17.1	15.5	18.8	10.7	16.0	31.3	24.6	38.3	16.3	19.1	9.6	20.9	25.1	27.3	33.5	8.3	27.7	26.8	14.5	36.8	38.0	38.9	44.4	15.6	21.3	77.1	21.7	15.5	40.3	28.8	56.1	24.9	53.3	49.9	56.3	39.5	27.8	42.6	41.2	111.3	28.9	23.6	20.6	22.1	40.7	19.1	29.8	49.8	94.2	45.2	27.6	24.2	59.7	57.7	25.1	39.6	61.7	36.4	89.1	29.6	46.8	36.3	28.5	13.6	45.0	37.2	50.2	17.4	38.9	34.3	24.1	29.2	26.9	68.1	9.0	43.9	36.1	89.4	32.2	27.3	37.2	11.3	27.3	25.4	17.2	30.0	21.3	24.5	21.1	18.8	42.7	24.3	21.4	18.3	6.7	31.4	36.8	27.2	27.2	18.4	14.7	17.1	17.3	17.1	13.9	16.3	18.7	16.4	18.4	17.1	16.0	20.9	24.7	35.3	30.1	42.4	27.9	25.0	37.5	62.7	19.4	28.8	73.8	36.2	23.1	37.1	63.0	18.4	4.2	37.2	25.5	49.5	187.9	30.2	8.0	33.4	23.9	22.8	35.5	42.5	28.4	32.4	23.4	24.4	29.6	24.8	20.3	22.0	21.0	26.0	76.5	18.5	35.2	41.3	87.5	47.1	31.8	8.3	23.9	47.6	21.4	17.8	59.4	23.1	25.7	51.3	108.8	25.4	28.4	24.8	44.2	33.0	35.0	101.7	56.8	21.6	39.5	37.8	30.1	32.4	22.3	31.4	26.3	26.4	25.8	27.1	50.1	50.4
APTX	"AOA, AOA1, AXA1, EAOH, EOAHA, FLJ20157"	ENSG00000137074	Aprataxin	Q7Z2E3	9	32886601-33025130	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Hydrolase"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064930	Supported		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nucleoli"		"HPA064930: AB_2685386"	"unprognostic (9.18e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.78e-3)"	"unprognostic (3.48e-3)"	"unprognostic (3.49e-2)"	"prognostic favorable (6.01e-5)"	"unprognostic (7.87e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.50e-2)"	9.7	14.8	14.6	7.0	14.8	11.0	10.4	14.8	20.2	9.1	13.9	10.2	8.6	8.6	7.6	14.7	8.9	4.9	9.9	14.8	15.0	13.6	15.6	9.3	8.1	14.7	14.6	8.5	9.6	12.1	7.6	7.8	15.0	9.6	11.2	8.0	9.0	6.6	9.8	15.3	8.3	8.6	14.2	8.9	9.7	14.7	15.2	9.3	7.0	6.9	11.0	10.4	9.6	15.0	36.2	26.1	18.4	17.1	19.0	17.4	25.6	24.8	26.0	28.7	31.5	35.1	12.7	27.8	14.6	21.1	18.4	19.4	33.7	32.8	35.1	39.2	11.2	17.9	32.5	37.8	24.4	29.4	15.1	23.8	36.3	32.5	37.9	16.9	26.8	20.2	27.0	24.2	26.0	15.6	24.4	43.2	33.5	24.4	29.0	21.2	14.4	21.5	25.2	21.2	15.6	11.1	21.4	18.0	15.5	17.9	23.0	11.4	17.7	16.2	21.1	29.9	25.0	11.1	21.2	27.5	23.4	23.8	13.2	3.3	14.7	13.4	12.2	15.6	15.2	16.3	12.8	14.6	17.6	16.1	16.0	12.1	5.9	23.1	21.7	15.2	17.3	16.1	14.6	14.8	14.8	20.2	14.8	15.0	14.7	14.6	15.0	14.2	15.2	15.0	14.8	19.2	29.0	31.3	16.9	16.7	23.1	32.9	22.2	15.2	17.9	17.0	14.9	21.5	23.1	9.2	10.4	27.7	15.1	12.6	29.4	25.3	55.6	19.7	18.3	13.3	16.8	20.0	27.3	28.2	27.7	15.6	19.4	18.1	16.5	17.8	8.9	21.4	18.8	13.5	29.0	15.3	34.6	14.7	9.9	48.7	13.4	15.0	14.2	15.9	19.3	18.3	15.5	23.6	43.0	31.9	6.8	10.5	28.3	24.0	13.9	31.7	25.4	16.6	13.1	13.5	20.2	42.2	26.9	25.8	21.2	27.9	15.9	20.5	16.3	23.1
ARAF	ARAF1	ENSG00000078061	"A-Raf proto-oncogene, serine/threonine kinase"	P10398	X	47561205-47571908	"Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066326	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA066326: AB_2685659"	"unprognostic (1.21e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.10e-2)"	"unprognostic (7.63e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.75e-2)"	"unprognostic (8.65e-2)"	"prognostic favorable (1.45e-6)"	"unprognostic (1.97e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.71e-2)"	37.7	41.7	17.8	36.9	20.8	102.3	36.2	19.2	21.1	34.8	22.6	40.9	37.8	36.6	21.2	32.2	35.0	32.5	50.8	17.1	18.0	44.6	55.7	39.4	40.4	22.8	20.5	39.5	59.1	51.8	27.7	31.3	20.1	40.9	33.3	15.4	45.1	34.6	136.3	36.0	39.7	31.3	18.8	46.1	46.7	12.0	21.0	38.0	39.4	85.6	31.5	36.1	30.8	20.4	49.1	69.5	29.2	46.9	43.5	34.2	39.0	40.3	42.3	58.6	54.1	57.2	58.6	29.0	32.4	54.6	49.2	67.3	51.8	56.3	34.3	53.5	61.9	29.4	74.4	30.6	61.4	58.3	85.1	45.0	56.0	56.2	49.6	39.2	45.9	36.0	55.2	55.7	40.5	83.3	42.6	64.0	41.8	41.2	77.8	39.2	38.0	65.5	34.4	46.7	32.8	25.0	43.7	39.7	24.5	47.0	74.9	43.3	44.2	38.0	42.5	76.2	41.4	71.1	49.2	22.5	50.8	65.3	31.1	48.3	47.8	61.3	44.1	57.8	40.3	32.6	38.4	40.9	55.2	37.3	33.5	40.5	37.8	38.7	67.9	40.4	41.6	50.8	17.8	20.8	19.2	21.1	17.1	18.0	22.8	20.5	20.1	18.8	21.0	20.4	13.3	16.0	29.2	7.5	25.8	15.7	25.0	29.0	18.2	5.3	15.0	9.8	25.1	34.3	22.0	18.4	10.4	33.0	26.3	43.8	23.5	29.3	1.3	11.4	10.8	17.5	31.8	22.3	5.0	34.3	30.4	16.9	39.3	15.6	16.5	13.6	24.3	42.6	28.0	13.5	5.5	35.9	40.7	26.4	21.6	4.3	17.4	25.8	33.8	4.7	43.7	18.4	32.0	8.5	8.9	26.2	41.5	17.7	27.9	20.3	44.6	27.1	11.5	9.0	19.7	15.9	18.0	8.2	10.5	17.7	16.2	44.6	26.5	12.5	32.3	24.6
ARFGAP2	"FLJ14576, IRZ, Zfp289, ZNF289"	ENSG00000149182	"ADP ribosylation factor GTPase activating protein 2"	Q8N6H7	11	47164299-47177125	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016649, HPA018152"	Enhanced		Supported	"Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"		"HPA016649: AB_1844980, HPA018152: AB_1844979"	"unprognostic (1.69e-2)"	"unprognostic (9.11e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.42e-2)"	"unprognostic (7.00e-2)"	"prognostic favorable (7.65e-7)"	"unprognostic (2.05e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.20e-2)"	38.0	51.4	62.1	36.3	63.9	82.2	41.7	63.2	68.3	42.3	57.2	49.4	40.0	43.3	35.5	60.8	49.3	32.1	58.7	62.5	60.1	47.6	76.8	40.7	51.9	65.1	61.8	44.6	69.7	48.2	38.7	39.9	61.8	51.4	39.4	38.9	56.1	41.7	115.9	78.7	43.8	38.8	60.6	51.2	55.7	30.7	63.1	49.8	47.4	81.4	50.5	44.7	43.3	70.3	55.7	36.4	54.9	43.3	45.9	37.3	51.6	51.2	48.1	64.1	48.4	41.3	45.3	91.3	32.4	58.7	40.8	82.3	47.2	74.6	40.3	45.0	46.1	77.6	85.5	50.8	53.7	107.0	84.4	56.7	82.3	33.3	71.1	46.1	60.4	65.6	111.8	67.8	58.5	102.5	50.8	87.8	43.6	98.3	48.4	78.8	94.8	116.8	60.3	79.3	53.0	47.0	58.7	81.7	38.8	26.1	126.8	78.8	48.7	55.2	43.3	50.5	68.6	58.6	60.7	78.3	38.6	81.2	56.4	108.5	69.1	92.8	74.0	77.3	66.6	59.0	57.1	66.2	65.9	63.1	63.0	63.4	41.8	69.2	98.4	35.4	71.8	108.1	62.1	63.9	63.2	68.3	62.5	60.1	65.1	61.8	61.8	60.6	63.1	70.3	23.8	35.3	45.9	25.1	46.5	22.2	31.4	22.1	29.6	73.6	30.9	25.8	13.0	20.0	41.2	31.3	114.7	64.3	40.7	38.6	25.4	38.7	2.7	20.3	26.4	29.8	45.4	47.1	16.2	36.6	47.1	29.7	34.1	27.0	60.8	44.9	31.1	44.0	36.8	74.0	15.1	35.0	38.7	33.6	25.4	6.6	34.2	28.6	28.4	15.9	58.1	51.1	71.1	13.0	23.7	39.2	45.0	26.4	31.7	26.4	41.0	26.3	34.1	115.4	39.5	33.0	28.0	24.7	35.9	30.3	26.7	91.8	43.7	40.3	36.3	34.0
ARGLU1	FLJ10154	ENSG00000134884	"Arginine and glutamate rich 1"	Q9NWB6	13	106541673-106568137	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034962, HPA056792"	Supported		Enhanced	Nucleoplasm,Mitochondria,Cytosol		No	No			"Cluster 17: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA034962: AB_10611676, HPA056792: AB_2683236"	"unprognostic (1.66e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.21e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (3.92e-5)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (2.91e-3)"	"unprognostic (2.65e-1)"	"unprognostic (2.87e-1)"	"prognostic favorable (7.34e-5)"	35.0	25.5	17.9	4.5	18.4	11.0	36.3	19.5	25.2	43.7	13.5	41.2	3.5	43.1	6.2	30.8	47.0	2.9	31.1	17.8	16.4	28.2	22.9	46.3	6.7	15.2	15.6	50.4	29.3	3.7	34.1	6.1	15.3	34.7	4.7	8.6	35.1	4.5	28.4	32.1	42.6	6.3	15.3	40.8	38.2	23.7	16.2	7.0	36.3	7.5	5.7	35.6	37.6	18.2	10.5	9.4	26.0	6.4	9.0	4.6	9.1	10.2	6.5	9.1	6.6	16.8	8.3	21.5	6.1	9.2	8.4	6.9	17.4	9.9	11.4	24.5	12.3	18.8	9.2	11.6	9.3	36.0	8.2	5.0	6.8	6.9	7.2	9.2	8.1	13.0	13.4	11.4	11.4	7.7	16.4	13.9	18.6	23.6	4.0	17.3	19.7	8.9	10.6	7.3	7.0	13.8	9.9	12.7	6.1	17.6	5.8	27.0	9.2	7.5	6.2	5.9	10.0	11.1	14.2	27.4	10.6	15.6	6.7	44.6	24.2	17.2	15.4	17.7	14.1	30.2	13.5	12.1	17.1	32.4	15.3	14.6	45.7	18.8	14.8	34.2	15.7	12.8	17.9	18.4	19.5	25.2	17.8	16.4	15.2	15.6	15.3	15.3	16.2	18.2	342.0	141.1	230.6	198.8	242.0	261.7	268.5	179.3	186.1	222.7	153.9	104.0	88.3	90.1	204.9	114.0	135.5	141.9	329.3	195.3	99.7	120.7	42.0	201.2	308.3	298.1	187.7	160.3	208.8	113.2	137.7	204.7	355.7	290.6	168.7	331.2	280.2	81.5	101.3	304.5	155.6	218.5	148.5	90.7	186.2	34.0	255.1	142.1	128.1	161.1	182.1	223.3	301.8	200.6	367.2	145.0	173.8	217.7	194.9	251.0	153.7	58.6	190.7	271.2	216.9	179.6	196.8	199.8	125.9	164.1	262.3	185.2	257.8	280.7	193.1	316.0
ARHGAP11A	KIAA0013	ENSG00000198826	"Rho GTPase activating protein 11A"	Q6P4F7	15	32615144-32639941	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.2;lymphoid tissue: 26.1"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 38.7;Extravillous trophoblasts: 23.7;Granulosa cells: 21.1;Plasma cells: 18.6;Spermatocytes: 24.7;Spermatogonia: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA040830, HPA066481"	Enhanced		Approved	Nucleoli,Cytosol		No	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	Nucleoli	"HPA040830: AB_10805830, HPA066481: "	"unprognostic (5.00e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (2.05e-4)"	"prognostic unfavorable (8.69e-4)"	"unprognostic (4.87e-2)"	"unprognostic (7.71e-2)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (3.43e-2)"	"unprognostic (1.07e-12)"	"unprognostic (7.37e-2)"	"unprognostic (5.23e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.64e-2)"	1.7	0.9	2.0	7.9	2.5	24.2	1.7	2.1	2.1	1.5	1.2	7.5	6.1	1.5	1.0	5.3	0.8	1.7	0.7	1.7	1.9	0.6	1.3	1.7	13.5	2.6	3.0	0.6	2.6	1.2	0.7	4.3	2.6	0.6	8.8	0.5	1.2	0.5	0.9	4.4	7.6	4.8	2.5	2.8	3.6	8.6	2.2	26.1	1.3	0.4	14.3	2.8	1.9	3.0	80.8	69.4	73.1	46.2	5.0	13.0	39.6	78.5	50.2	80.0	63.3	52.2	41.5	43.5	23.7	49.9	91.3	56.9	55.3	43.8	110.9	83.5	27.4	132.6	68.9	33.5	2.0	103.8	55.5	4.3	5.5	61.6	50.9	15.2	61.5	94.4	101.0	112.7	95.3	31.7	58.6	39.7	44.6	71.6	44.5	67.8	141.7	38.2	28.4	41.6	64.7	44.5	72.9	46.2	17.6	37.6	63.6	115.8	35.3	102.5	74.1	42.0	87.2	38.3	63.7	123.7	44.4	129.1	91.8	0.1	0.3	0.8	0.5	0.5	0.2	0.3	1.0	0.9	0.4	0.2	0.4	0.5	0.0	0.1	0.1	0.2	0.8	0.3	2.0	2.5	2.1	2.1	1.7	1.9	2.6	3.0	2.6	2.5	2.2	3.0	0.7	0.0	2.3	0.3	4.6	4.8	1.1	2.4	2.2	0.2	1.3	1.7	0.9	4.3	1.9	1.8	0.0	9.8	2.9	6.2	0.0	0.8	4.7	3.8	2.6	2.0	0.0	38.7	1.0	0.8	23.7	3.5	8.6	2.8	0.0	21.1	1.8	2.1	9.5	0.0	0.6	7.8	0.0	6.5	4.2	5.0	0.6	3.5	0.0	1.0	3.9	0.1	2.1	0.5	1.4	0.5	2.9	0.4	18.6	1.4	1.1	0.4	1.4	1.0	6.6	1.4	3.3	24.7	22.6	10.5	2.3	3.1	5.4	2.0	14.1	2.1
ARHGAP19	"FLJ00194, MGC14258"	ENSG00000213390	"Rho GTPase activating protein 19"	Q14CB8	10	97222173-97292673	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.3"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 13.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA035777, HPA043231"	Uncertain		Enhanced	"Plasma membrane"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane"		"HPA035777: AB_2674777, HPA043231: AB_10796791"	"unprognostic (5.88e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.00e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.97e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (7.47e-5)"	"unprognostic (1.12e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.29e-2)"	3.2	2.1	2.4	7.1	3.9	18.8	7.6	2.9	2.0	3.7	0.6	4.3	3.6	5.5	2.6	4.0	4.7	3.4	3.3	1.6	3.2	3.9	2.4	4.7	13.3	4.3	3.2	9.3	1.6	5.5	0.5	5.3	4.4	3.6	4.5	3.2	3.2	3.0	1.8	3.6	5.3	4.5	3.3	7.9	3.6	18.5	2.9	21.3	3.2	4.2	13.2	2.9	2.0	5.9	18.5	6.0	31.9	56.0	2.1	8.3	9.8	9.0	9.1	13.9	9.9	11.2	16.1	40.9	7.4	6.2	8.3	12.3	27.1	11.2	17.8	20.4	14.7	27.0	7.8	7.8	2.1	42.1	27.8	4.2	3.9	9.8	22.3	4.7	19.6	57.3	27.1	21.0	12.1	8.9	39.3	9.1	16.9	12.2	5.5	45.5	27.1	11.4	4.2	7.8	2.5	14.5	6.7	3.1	14.5	11.9	19.4	22.2	9.1	5.7	6.8	8.9	23.6	18.6	20.7	54.3	7.0	48.7	6.4	21.5	7.2	11.1	5.0	6.8	4.7	5.5	4.9	4.7	5.4	5.3	5.6	5.0	15.8	4.4	6.1	3.0	6.3	5.5	2.4	3.9	2.9	2.0	1.6	3.2	4.3	3.2	4.4	3.3	2.9	5.9	5.8	3.2	3.2	0.0	4.1	0.9	1.4	2.8	3.4	2.8	3.6	8.8	1.9	2.8	1.6	0.0	0.0	2.0	3.6	2.2	0.0	1.3	9.1	2.4	2.6	5.4	0.0	6.7	0.0	1.6	3.5	3.9	1.5	3.6	5.1	5.6	11.7	2.6	3.5	6.7	0.0	1.9	2.0	9.3	1.9	6.3	3.4	6.1	1.8	0.0	5.4	1.7	5.2	0.0	0.0	1.4	2.9	4.1	5.8	2.6	2.6	0.7	4.8	1.3	0.0	3.1	2.2	13.7	10.4	5.3	2.4	1.0	3.5	3.4	3.5	1.6
ARID1A	"B120, BAF250, BAF250a, C10rf4, C1orf4, P270, SMARCF1"	ENSG00000117713	"AT-rich interaction domain 1A"	O14497	1	26693236-26782104	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005456, CAB016334"	Supported		Enhanced	Nucleoplasm		NA	Yes			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB016334: AB_673396, HPA005456: AB_1078205"	"unprognostic (2.83e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (4.18e-4)"	"unprognostic (3.02e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.69e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.54e-2)"	16.4	16.3	10.1	22.7	9.4	37.0	16.4	12.9	24.3	16.2	0.0	18.0	15.4	20.4	15.8	22.2	18.3	14.0	17.4	6.3	35.8	13.3	16.8	16.8	25.8	20.8	6.8	20.8	23.2	19.3	14.3	18.6	9.9	15.1	15.3	20.1	19.3	14.4	21.6	20.5	20.3	17.5	3.0	24.3	19.5	16.7	17.9	46.4	22.6	17.6	23.7	18.4	17.8	9.0	53.2	49.5	68.6	71.5	19.6	18.5	32.3	24.4	21.1	32.7	23.0	36.3	34.1	74.3	20.7	31.8	20.7	31.6	60.3	26.9	37.9	92.7	22.6	63.6	33.0	24.7	16.1	95.2	19.6	21.7	18.8	38.7	27.5	18.2	28.6	52.5	77.7	81.1	21.5	25.1	80.1	36.8	72.4	34.5	22.9	82.2	45.3	42.1	20.3	35.3	62.9	50.7	42.7	35.7	29.0	37.8	10.6	53.4	50.6	34.9	33.5	32.4	39.9	38.0	54.9	34.1	21.2	59.8	31.5	0.2	1.5	1.5	1.6	1.2	2.1	1.8	1.3	2.1	1.4	1.6	1.7	1.9	3.3	2.1	1.3	2.4	0.7	1.9	10.1	9.4	12.9	24.3	6.3	35.8	20.8	6.8	9.9	3.0	17.9	9.0	49.9	60.9	40.4	99.9	66.6	73.4	21.0	32.5	90.0	68.0	77.2	61.5	33.0	38.6	35.9	38.6	52.1	36.5	56.1	46.5	1.9	35.3	23.3	48.8	59.3	46.3	47.5	56.6	47.1	37.6	40.2	35.9	35.7	72.3	61.2	68.4	49.6	65.6	51.0	74.0	59.8	50.2	28.5	89.0	47.5	9.0	38.5	73.2	40.9	89.9	86.4	30.8	53.5	78.9	116.1	49.7	36.4	41.8	48.5	50.0	32.4	16.7	36.1	42.3	52.6	38.2	47.3	44.1	52.2	101.8	94.3	36.7	57.0	45.8	52.1	43.2
ARID4A	"RBBP1, RBP-1, RBP1"	ENSG00000032219	"AT-rich interaction domain 4A"	P29374	14	58298504-58373887	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048899			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA048899: "	"unprognostic (1.57e-1)"	"unprognostic (9.39e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.70e-2)"	"prognostic favorable (1.91e-4)"	"unprognostic (2.71e-1)"	"prognostic favorable (7.82e-4)"	"unprognostic (2.08e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.72e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.11e-2)"	"unprognostic (3.52e-2)"	9.8	6.9	8.6	11.1	9.2	34.7	9.1	14.8	10.0	8.6	8.9	7.7	8.8	9.5	6.8	7.4	6.8	9.0	8.7	8.0	11.7	9.4	18.7	10.3	14.9	7.9	7.7	12.5	7.4	9.8	5.4	9.8	7.6	8.6	8.8	14.0	6.7	7.6	5.4	8.7	9.1	8.2	6.8	14.0	8.9	6.9	12.3	14.5	10.6	6.3	11.2	8.4	7.5	10.7	8.5	7.0	19.2	9.5	9.3	11.2	9.7	9.9	8.4	6.6	10.4	8.3	13.1	20.4	10.3	8.4	6.3	9.6	8.6	4.8	9.6	14.3	5.5	9.2	8.2	8.0	5.6	19.7	12.8	8.4	5.2	6.4	6.6	10.5	10.6	11.6	10.7	16.3	7.1	11.5	14.3	17.7	3.8	8.2	8.7	14.5	16.6	6.1	7.1	14.9	16.5	14.3	16.9	8.4	12.0	9.4	14.3	17.8	15.3	11.2	8.7	9.1	4.6	5.3	4.2	18.3	6.7	12.3	5.8	65.8	19.5	59.1	20.6	20.1	23.3	31.5	25.3	22.1	14.9	42.3	27.0	26.5	109.4	29.1	40.8	19.8	19.8	10.1	8.6	9.2	14.8	10.0	8.0	11.7	7.9	7.7	7.6	6.8	12.3	10.7	57.7	83.3	100.9	68.9	73.5	38.4	21.2	22.1	64.3	111.0	29.5	35.8	55.0	24.3	32.3	27.6	52.1	19.9	74.0	33.0	19.6	23.3	18.2	40.5	37.6	47.1	22.8	45.8	94.2	21.7	21.3	40.1	26.0	52.6	65.2	39.9	37.5	41.9	34.7	112.7	78.6	35.5	20.3	47.7	49.5	8.8	36.4	59.3	26.6	63.7	75.8	63.9	49.4	86.5	91.4	24.9	38.6	36.1	55.1	20.9	43.4	14.9	11.2	64.2	19.7	40.0	43.0	38.6	33.8	55.4	33.4	20.4	77.0	34.1	32.9	17.7
ARIH2	TRIAD1	ENSG00000177479	"Ariadne RBR E3 ubiquitin protein ligase 2"	O95376	3	48918821-48986382	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067381, HPA069715, HPA070963"			Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA067381: AB_2685827, HPA069715: AB_2686182, HPA070963: AB_2686329"	"unprognostic (7.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.79e-3)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.90e-2)"	"unprognostic (4.01e-2)"	"unprognostic (5.01e-2)"	"prognostic favorable (7.31e-4)"	"unprognostic (5.01e-3)"	"prognostic favorable (6.60e-4)"	"unprognostic (1.15e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.39e-2)"	20.6	22.9	21.4	16.0	24.5	23.0	19.8	24.2	23.7	21.4	24.7	29.4	11.7	24.5	33.8	19.5	21.3	15.0	53.9	21.3	23.4	22.7	21.3	19.7	20.7	22.9	22.9	20.7	24.1	24.4	26.0	18.4	23.8	23.1	17.7	32.4	18.6	21.9	100.4	16.5	21.2	24.4	22.0	24.3	22.5	27.0	22.8	26.1	22.0	79.6	21.4	23.6	17.4	27.7	40.4	39.6	37.6	53.2	54.3	29.7	52.4	46.3	53.5	56.5	62.1	42.0	35.0	84.1	21.4	49.8	82.0	23.5	77.9	47.2	68.7	57.0	48.1	85.3	51.7	34.5	48.9	63.4	39.5	31.9	70.2	70.9	94.9	32.2	43.1	38.3	68.4	54.6	50.7	27.8	65.4	25.8	64.3	43.3	59.5	23.5	42.8	70.2	32.9	54.1	16.4	44.8	47.7	56.1	45.0	44.1	28.6	43.8	41.4	34.1	49.4	52.5	74.0	72.8	148.1	103.3	37.3	51.9	43.7	53.1	34.6	39.9	44.2	32.2	30.5	28.8	28.2	37.1	32.3	34.2	29.2	37.3	25.6	25.8	20.9	29.9	35.5	39.3	21.4	24.5	24.2	23.7	21.3	23.4	22.9	22.9	23.8	22.0	22.8	27.7	37.0	35.3	31.4	54.9	50.2	50.9	51.5	27.3	68.3	57.0	35.5	35.3	74.6	32.9	44.0	29.5	87.6	36.4	76.0	31.3	29.4	33.8	15.3	33.5	48.3	38.4	16.7	76.2	50.0	43.2	36.2	40.1	42.3	38.1	45.5	42.3	28.5	44.6	26.6	57.2	59.1	26.2	14.2	32.8	35.7	11.3	41.7	44.6	30.2	38.4	45.2	42.2	95.8	42.3	128.6	42.1	23.0	43.2	85.0	78.9	20.8	34.3	30.6	82.5	26.3	51.5	48.6	165.7	89.7	59.4	54.0	53.4	66.8	37.7	31.6	67.0
ARMC1	"Arcp, FLJ10511"	ENSG00000104442	"Armadillo repeat containing 1"	Q9NVT9	8	65602458-65634217	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026085	Approved		Approved	Mitochondria		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA026085: AB_1845031"	"prognostic unfavorable (4.81e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (8.18e-2)"	"unprognostic (1.45e-2)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (4.13e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavorable (9.15e-4)"	"unprognostic (1.81e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.66e-1)"	16.6	15.4	19.0	13.5	23.8	13.1	18.4	21.0	29.0	15.2	16.4	16.4	15.6	18.6	16.4	16.8	13.2	11.9	21.6	19.7	21.7	22.0	23.2	12.4	19.3	19.8	20.9	18.8	14.9	21.0	9.0	15.0	20.4	17.8	16.6	12.5	15.7	16.9	19.2	11.5	13.7	21.6	20.4	13.9	13.6	9.4	20.8	22.3	14.7	24.6	20.3	16.8	10.8	25.6	51.3	35.6	34.2	32.0	33.1	30.1	24.8	44.7	33.2	46.5	34.2	26.5	40.3	79.0	11.2	41.0	50.7	33.4	61.9	35.9	62.9	45.0	31.7	61.3	20.6	38.9	44.1	23.4	32.0	27.8	40.9	38.3	52.5	36.6	48.5	55.3	64.5	54.7	50.6	32.9	86.9	30.7	35.7	63.6	38.9	49.9	42.6	27.9	37.2	23.8	25.3	27.3	28.5	35.4	44.3	34.6	56.9	27.2	28.5	43.8	32.1	33.8	42.5	40.3	45.2	53.2	41.5	42.8	43.7	36.3	5.6	7.4	8.3	9.3	11.4	9.8	9.9	10.2	7.2	6.9	9.9	10.1	0.7	11.5	9.2	6.4	11.4	6.5	19.0	23.8	21.0	29.0	19.7	21.7	19.8	20.9	20.4	20.4	20.8	25.6	26.6	41.7	27.7	16.0	33.0	15.8	12.1	17.5	19.4	23.7	20.7	19.4	33.4	18.6	24.5	16.5	22.9	35.0	32.9	14.4	54.8	28.3	10.4	15.9	26.9	23.7	23.4	62.7	23.9	28.1	43.9	24.4	20.4	15.3	10.8	31.5	21.4	25.6	25.0	20.2	22.7	17.0	24.4	18.9	12.6	5.7	26.1	20.6	21.4	19.7	31.6	47.3	24.7	15.1	47.7	28.0	13.0	33.4	27.2	18.9	19.9	47.7	17.6	21.9	6.6	29.0	32.2	50.7	24.5	29.9	18.5	37.6	28.0	28.1	23.4	9.1
ARMC10	"MGC3195, SVH"	ENSG00000170632	"Armadillo repeat containing 10"	Q8N2F6	7	103074881-103099759	"Predicted intracellular proteins, Predicted membrane proteins"	"Growth regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011036, HPA011057"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA011036: AB_1080139, HPA011057: AB_1080137"	"unprognostic (7.03e-3)"	"unprognostic (2.44e-1)"	"unprognostic (8.18e-2)"	"unprognostic (3.53e-1)"	"prognostic unfavorable (8.90e-6)"	"unprognostic (3.85e-3)"	"prognostic unfavorable (3.58e-4)"	"unprognostic (5.57e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.90e-2)"	"prognostic unfavorable (2.49e-6)"	"unprognostic (1.02e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.67e-2)"	20.9	22.8	11.2	9.3	11.9	7.2	18.1	10.5	12.7	22.3	12.2	19.4	9.8	17.8	17.0	21.0	18.6	11.3	16.6	11.4	11.9	24.0	24.4	15.5	10.8	10.7	11.4	24.4	24.4	17.2	11.9	10.9	11.4	18.0	12.7	13.8	16.4	15.7	18.4	25.8	12.1	14.4	13.7	12.3	19.8	12.2	11.6	13.6	17.6	8.6	11.5	21.3	19.5	15.9	30.1	25.5	16.1	28.8	30.0	28.4	15.1	19.3	22.2	14.7	17.4	13.7	34.8	57.3	42.4	18.0	43.4	25.6	20.9	23.3	20.9	19.2	22.3	19.4	10.9	7.8	31.9	55.8	21.3	19.3	40.4	18.8	30.2	45.7	33.6	29.6	45.9	32.8	26.5	58.8	38.8	43.9	36.2	54.5	26.8	22.9	15.5	69.2	37.7	20.8	16.3	25.1	30.3	43.8	35.3	26.9	17.6	26.9	23.4	22.9	23.6	52.0	31.8	47.8	77.6	42.9	25.5	50.1	30.2	0.0	2.3	3.8	1.4	3.1	2.2	2.2	2.2	2.2	3.4	3.0	2.3	2.4	0.5	2.1	1.6	3.1	2.4	1.1	11.2	11.9	10.5	12.7	11.4	11.9	10.7	11.4	11.4	13.7	11.6	15.9	30.1	25.6	17.9	12.1	31.8	78.8	60.2	7.9	54.7	24.4	53.3	56.1	17.4	34.3	12.4	27.6	14.6	45.3	41.1	17.6	66.5	19.7	12.6	31.4	32.3	28.4	15.0	51.5	20.7	15.5	52.2	35.4	33.6	23.8	17.2	37.9	30.4	37.6	46.7	8.4	18.5	32.6	6.1	38.8	39.5	8.3	33.8	32.7	46.2	14.0	28.7	38.3	25.7	20.6	44.0	23.2	20.5	34.3	41.9	87.1	21.9	97.4	10.5	28.6	32.9	28.6	37.5	15.6	35.1	67.2	104.3	45.0	31.4	31.9	41.3	71.9
ARMT1	"C6orf211, FLJ12910"	ENSG00000146476	"Acidic residue methyltransferase 1"	Q9H993	6	151452258-151470101	"Predicted intracellular proteins"	"DNA damage"	"Hydrolase, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 79.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003004, HPA005819"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		410000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA003004: AB_1078358, HPA005819: AB_1845741"	"unprognostic (5.16e-3)"	"prognostic unfavorable (7.09e-4)"	"prognostic favorable (4.14e-4)"	"unprognostic (6.39e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.78e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.22e-1)"	17.1	16.0	8.5	15.3	9.5	5.5	25.0	9.6	12.2	16.1	8.3	16.6	18.9	16.0	16.1	12.0	12.6	11.3	16.8	8.6	10.0	41.5	37.6	19.5	21.0	9.0	9.1	11.9	6.8	11.6	5.3	22.2	9.1	12.2	17.6	16.4	7.6	11.1	19.0	8.8	14.5	14.9	9.6	12.8	14.1	14.1	9.8	15.6	27.7	22.6	18.5	17.3	8.1	9.0	24.6	18.4	37.9	34.2	30.3	47.4	60.9	44.8	39.1	36.9	48.4	47.8	19.7	36.2	29.5	31.8	33.7	24.2	112.7	33.5	61.7	40.6	34.9	26.0	21.7	55.9	37.8	50.1	31.7	38.2	23.3	49.3	29.2	30.6	52.8	27.0	38.5	44.3	46.4	101.8	31.7	47.4	64.4	23.7	15.3	41.0	32.7	28.6	112.6	31.2	15.6	10.2	37.5	34.9	23.8	67.4	98.9	38.6	44.6	17.9	25.0	66.8	36.3	21.1	28.5	43.7	31.7	60.7	21.6	53.8	26.9	52.0	13.5	34.5	18.1	17.5	17.4	14.5	22.9	14.7	15.9	14.8	22.1	21.0	33.4	8.5	25.1	21.1	8.5	9.5	9.6	12.2	8.6	10.0	9.0	9.1	9.1	9.6	9.8	9.0	16.3	25.6	40.4	6.5	13.2	0.0	8.4	0.0	11.4	10.0	33.5	16.3	18.6	14.3	6.2	23.9	8.4	31.7	12.6	10.6	45.0	19.5	1.4	19.4	29.3	10.6	4.9	6.5	11.4	17.8	39.0	14.2	12.2	23.3	3.8	7.7	15.4	48.7	35.4	8.4	9.8	8.9	0.0	34.0	0.0	3.1	19.3	23.6	0.0	5.6	36.0	17.3	18.6	6.6	8.9	19.5	7.2	14.7	15.2	5.4	18.6	79.3	10.9	20.9	0.0	6.7	14.3	25.2	14.8	11.1	0.0	36.0	14.0	15.5	10.7	9.6
ARV1		ENSG00000173409	"ARV1 homolog, fatty acid homeostasis modulator"	Q9H2C2	1	230978981-231000733	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 116.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035709	Approved		Uncertain	Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA035709: AB_2674744"	"unprognostic (2.32e-1)"	"unprognostic (4.69e-2)"	"prognostic favorable (1.33e-4)"	"unprognostic (3.29e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.95e-2)"	"unprognostic (5.66e-2)"	"prognostic favorable (3.27e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.12e-2)"	"unprognostic (9.57e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.82e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.12e-3)"	10.6	18.4	23.4	10.2	24.5	13.9	19.0	26.2	32.8	12.2	25.7	24.6	16.4	9.7	22.9	15.7	14.3	16.4	30.1	24.5	25.6	25.2	26.2	15.0	14.8	25.2	24.1	11.2	17.5	33.3	20.1	11.7	25.0	16.2	25.9	29.0	22.0	15.2	21.7	17.8	17.3	13.1	25.7	13.5	17.1	31.3	25.2	15.0	21.9	24.8	15.3	15.2	11.2	27.7	40.8	43.6	20.8	25.1	29.6	26.4	20.1	19.0	34.0	33.5	38.3	16.3	31.4	11.4	22.7	21.3	20.5	32.3	40.6	25.5	39.2	30.4	55.7	36.8	28.9	22.1	30.5	53.6	27.9	28.0	25.8	18.1	20.9	21.9	22.5	34.7	53.7	30.7	22.2	14.3	22.3	16.4	27.1	43.0	27.1	25.2	32.1	33.1	47.1	33.0	21.2	32.6	22.6	26.6	57.9	5.3	46.6	46.6	13.9	13.4	8.7	23.6	45.9	47.4	44.6	28.9	36.8	45.9	36.7	9.1	8.1	8.5	10.0	12.2	13.9	18.1	11.2	12.4	10.1	11.2	13.7	13.0	2.0	12.7	21.2	14.9	15.4	9.0	23.4	24.5	26.2	32.8	24.5	25.6	25.2	24.1	25.0	25.7	25.2	27.7	13.6	16.0	31.7	10.7	12.6	12.9	22.0	75.8	11.4	18.9	14.8	15.6	32.2	21.5	38.9	29.5	2.1	37.9	12.7	15.8	60.7	24.1	52.6	12.7	10.9	12.7	7.7	58.1	20.2	40.8	14.5	14.5	11.7	9.7	17.1	14.4	15.0	17.3	24.9	38.7	25.6	18.5	34.6	13.3	5.5	22.9	9.3	13.5	24.9	8.4	9.8	33.6	7.2	8.5	19.3	21.5	11.5	16.6	14.7	11.6	17.9	32.5	27.3	20.0	0.0	11.4	15.6	116.7	21.0	20.3	15.2	15.6	11.4	22.0	26.4	20.9
ASF1B	FLJ10604	ENSG00000105011	"Anti-silencing function 1B histone chaperone"	Q9NVP2	19	14119512-14136613	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Chaperone, Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.2;testis: 32.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 36.1;Early spermatids: 36.4;Erythroid cells: 43.6;Extravillous trophoblasts: 35.4;Spermatocytes: 73.2;Spermatogonia: 87.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 60.1"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 60.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA054036, HPA069385"	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA054036: AB_2682350, HPA069385: "	"unprognostic (3.14e-1)"	"prognostic favorable (4.45e-5)"	"unprognostic (2.41e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.27e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.98e-4)"	"unprognostic (8.48e-3)"	"prognostic unfavorable (2.22e-16)"	"prognostic favorable (2.49e-4)"	"unprognostic (1.27e-1)"	"unprognostic (3.92e-2)"	"unprognostic (4.31e-2)"	0.9	1.4	0.2	5.6	0.3	11.7	1.3	0.3	0.2	2.2	0.1	7.4	5.3	1.0	0.1	10.3	0.7	0.7	0.7	0.1	0.2	1.0	1.3	2.1	12.5	0.3	0.2	0.7	0.7	0.3	0.7	3.6	0.3	0.8	7.7	0.0	1.9	0.3	0.5	3.2	6.0	2.0	0.2	6.7	3.2	32.0	0.3	23.2	0.6	0.4	14.7	1.8	3.2	0.3	64.6	25.3	37.7	28.9	3.8	3.6	16.2	33.1	28.3	63.8	79.5	26.5	31.6	59.1	30.0	17.5	26.5	38.0	41.8	24.1	49.7	54.0	26.9	55.5	48.7	18.6	0.2	39.0	35.1	0.7	1.7	35.8	12.4	7.2	25.1	44.1	50.2	83.8	31.8	75.7	80.8	34.3	17.3	69.1	56.7	77.0	56.0	51.6	20.1	28.3	46.0	16.5	39.8	29.2	17.4	10.3	22.1	41.5	10.6	36.0	21.6	91.0	56.6	43.2	46.5	80.3	28.0	71.9	36.1	0.7	6.2	1.5	1.7	8.0	0.9	1.1	1.5	2.0	1.2	0.9	0.9	1.7	60.1	1.7	8.5	0.5	5.1	3.2	0.2	0.3	0.3	0.2	0.1	0.2	0.3	0.2	0.3	0.2	0.3	0.3	1.0	0.0	0.6	0.3	5.6	2.5	2.4	4.5	1.2	0.1	4.8	8.5	1.2	1.5	1.1	0.0	0.0	36.1	3.8	11.7	0.0	1.0	36.4	2.1	1.3	2.1	1.2	43.6	0.5	1.2	35.4	4.1	23.4	2.3	4.5	9.2	0.4	0.3	21.5	0.0	0.4	9.9	8.2	5.6	5.6	29.1	0.0	5.0	1.8	1.0	2.1	0.3	4.1	0.0	0.5	1.1	2.2	0.7	20.1	1.0	2.4	0.3	0.2	0.9	0.0	1.1	3.3	73.2	87.8	8.3	1.1	10.4	5.3	3.0	20.9	2.4
ASNSD1	"FLJ20752, NBLA00058, NS3TP1"	ENSG00000138381	"Asparagine synthetase domain containing 1"	Q9NWL6	2	189661385-189670831	"Predicted intracellular proteins"	"Amino-acid biosynthesis, Asparagine biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA036132, HPA036133, HPA075042"	Approved		Approved	Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA036132: AB_2674960, HPA036133: AB_10696650, HPA075042: AB_2686731"	"unprognostic (1.32e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.15e-3)"	"prognostic favorable (4.54e-4)"	"unprognostic (8.42e-2)"	"prognostic unfavorable (8.66e-4)"	"unprognostic (5.68e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.09e-1)"	"unprognostic (6.32e-3)"	"unprognostic (8.98e-3)"	"unprognostic (8.11e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-1)"	27.1	26.1	23.1	19.2	24.5	36.9	33.5	31.8	33.5	27.9	21.3	21.1	22.5	28.6	19.6	21.3	24.0	19.7	32.2	23.6	25.5	30.5	40.4	21.9	27.1	24.2	24.0	37.6	27.1	33.2	19.1	33.7	24.5	21.6	18.3	40.2	25.2	20.8	59.6	17.5	17.7	28.1	24.6	23.0	20.4	17.5	24.1	27.9	26.3	70.5	25.1	27.4	17.1	25.9	33.1	22.0	53.5	42.5	58.9	50.4	47.2	66.4	57.1	65.7	67.5	72.5	22.6	65.3	39.0	61.9	36.4	26.5	60.2	49.2	76.6	65.4	72.5	57.5	48.5	69.2	61.4	59.9	33.2	59.9	37.2	66.3	58.9	46.5	63.3	46.9	58.6	49.6	69.6	43.2	68.8	68.9	81.0	55.3	102.4	41.3	43.4	62.4	39.0	40.2	59.5	31.2	41.7	35.0	59.1	66.7	52.3	55.9	57.0	56.6	44.5	48.1	73.4	73.7	86.5	93.4	44.1	33.9	52.7	82.8	26.1	107.6	38.8	22.7	48.6	37.2	42.3	43.3	26.7	37.2	49.4	45.3	48.9	49.1	25.2	21.4	57.6	37.3	23.1	24.5	31.8	33.5	23.6	25.5	24.2	24.0	24.5	24.6	24.1	25.9	31.3	54.5	34.9	10.1	41.1	30.0	24.4	31.2	25.0	22.4	29.7	25.9	43.7	28.6	35.6	16.5	12.5	67.2	36.1	24.1	82.2	35.7	7.0	24.8	34.9	31.1	36.0	41.7	17.2	45.3	43.3	41.8	16.8	22.8	19.0	24.6	29.6	51.9	34.1	15.2	18.9	25.2	26.4	28.0	23.7	5.6	40.7	24.5	17.8	7.5	34.7	40.5	50.4	14.6	17.6	36.5	12.0	33.8	37.9	23.0	18.7	56.7	29.4	27.0	46.0	48.7	47.9	30.3	43.8	29.4	28.4	119.9	42.7	30.9	27.7	19.3
ASPM	"ASP, Calmbp1, FLJ10517, FLJ10549, MCPH5"	ENSG00000066279	"Assembly factor for spindle microtubules"	Q8IZT6	1	197084121-197146694	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Calmodulin-binding	"Cancer-related genes, Disease variant, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 10.1;lymphoid tissue: 17.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 99.5;Granulosa cells: 121.1;Plasma cells: 44.8;Spermatocytes: 43.8;Spermatogonia: 44.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB017816			Approved	"Plasma membrane,Cytosol"		NA	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Cytosol"		"CAB017816: "	"unprognostic (3.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (3.67e-1)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (1.25e-4)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (4.67e-3)"	"unprognostic (9.29e-2)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (1.03e-1)"	"unprognostic (0.00e+0)"	"unprognostic (7.31e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.94e-2)"	"unprognostic (3.66e-2)"	0.2	0.1	0.0	3.0	0.0	10.1	0.4	0.0	0.1	0.2	0.0	1.6	2.1	0.3	0.0	1.5	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.3	5.3	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.1	1.9	0.0	0.2	0.0	0.0	2.7	1.9	0.7	0.0	0.9	1.1	3.2	0.1	17.0	0.1	0.0	5.1	0.6	0.4	0.2	44.6	22.9	39.1	23.2	1.9	5.5	14.7	35.1	23.2	32.6	25.6	16.7	31.1	45.4	12.5	27.5	13.8	40.2	33.6	12.1	39.1	41.8	25.4	33.1	56.1	12.8	0.4	51.9	20.5	0.6	1.0	26.1	15.2	7.3	31.5	32.9	41.8	50.7	29.0	16.0	40.6	10.3	17.8	24.8	6.4	30.2	55.5	31.7	7.4	11.4	20.4	29.5	50.6	20.6	9.5	20.8	26.9	12.7	28.9	20.9	20.0	34.9	61.2	13.9	21.6	26.8	14.9	11.0	42.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.0	1.1	1.3	5.8	6.1	1.5	4.0	2.2	0.1	2.4	2.4	1.1	0.0	1.3	1.8	0.0	20.0	7.8	7.7	0.0	0.3	3.9	2.9	6.2	4.3	0.0	99.5	2.0	0.0	14.8	9.8	13.3	8.1	1.3	121.1	6.4	2.2	11.6	0.0	4.8	6.8	4.1	6.4	2.4	4.5	0.6	6.4	0.0	0.0	0.9	0.7	4.1	0.0	1.0	0.5	0.2	1.5	44.8	2.0	0.4	0.4	0.8	0.3	0.0	0.6	7.0	43.8	44.7	27.1	3.4	3.7	9.1	5.7	16.9	2.1
ASTE1	HT001	ENSG00000034533	"Asteroid homolog 1"	Q2TB18	3	131013875-131027649	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 42.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037010, HPA037011"	Supported		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Endoplasmic reticulum"		"HPA037010: AB_10673629, HPA037011: AB_10696929"	"unprognostic (7.42e-2)"	"prognostic favorable (3.09e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (2.56e-1)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (4.03e-5)"	"unprognostic (2.27e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.64e-2)"	3.4	3.2	2.9	4.9	3.3	6.7	5.5	6.1	4.8	6.0	3.4	5.4	5.8	3.8	5.9	3.7	4.5	3.9	2.9	3.2	2.5	3.7	6.1	4.1	7.0	2.5	2.8	5.7	3.3	5.0	3.3	3.9	3.0	3.8	5.8	4.7	3.1	4.2	2.3	4.1	7.1	3.4	2.9	4.4	4.7	6.1	3.3	7.2	7.0	2.8	6.8	3.9	2.9	4.6	9.7	7.1	4.5	4.7	7.7	8.4	1.9	5.4	4.6	6.4	7.0	11.4	4.2	10.8	8.2	5.5	5.5	10.5	9.1	4.4	9.6	5.8	5.3	6.4	3.6	5.4	7.9	9.9	3.6	5.3	6.1	5.2	4.9	5.7	5.4	8.7	5.9	5.3	6.7	6.6	9.0	5.2	4.1	11.6	6.8	9.4	6.4	9.4	5.2	5.9	7.7	7.2	10.5	2.4	7.6	4.3	6.3	6.9	3.8	7.2	4.8	12.1	4.3	6.6	6.5	14.0	5.6	8.5	3.6	51.2	13.0	28.4	20.4	15.3	21.3	15.5	22.0	17.7	14.5	16.5	28.3	21.2	9.4	29.4	20.9	10.7	28.2	11.8	2.9	3.3	6.1	4.8	3.2	2.5	2.5	2.8	3.0	2.9	3.3	4.6	6.5	12.8	5.8	7.5	14.6	3.2	3.7	4.8	2.2	9.2	5.1	7.4	1.8	4.3	6.3	3.7	14.6	6.0	17.5	11.1	5.9	4.9	42.1	4.5	5.8	6.9	6.7	6.1	8.3	6.0	4.8	5.1	8.6	4.6	8.8	7.0	10.0	5.6	4.8	3.3	6.3	7.0	4.1	5.7	2.0	12.6	7.2	7.2	1.8	5.6	3.9	5.8	18.6	7.5	10.5	3.6	7.8	4.9	8.7	2.9	15.6	3.5	2.1	13.9	0.0	3.6	6.1	4.4	4.9	3.6	1.4	4.0	15.7	6.1	7.1	2.8
ASXL1	KIAA0978	ENSG00000171456	"ASXL transcriptional regulator 1"	Q8IXJ9	20	32358330-32439319	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Repressor"	"Cancer-related genes, Craniosynostosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064156			Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli"		"HPA064156: AB_2685200"	"unprognostic (1.49e-1)"	"unprognostic (5.97e-2)"	"unprognostic (8.36e-2)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (6.69e-2)"	"prognostic favorable (9.16e-4)"	"unprognostic (2.01e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.32e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.84e-3)"	"unprognostic (5.47e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.06e-1)"	31.6	24.6	13.4	18.1	14.4	36.9	30.5	15.0	14.4	30.6	20.2	31.6	12.2	26.8	15.6	17.2	28.6	13.7	21.8	14.1	15.6	28.7	32.8	36.0	24.0	15.8	14.2	32.3	32.9	13.1	19.2	17.3	13.8	24.8	13.2	19.7	21.0	13.3	30.1	23.2	27.8	18.4	13.8	35.0	24.7	37.2	15.1	27.4	32.0	16.4	25.0	26.4	24.2	17.1	59.2	33.6	52.7	28.2	23.6	28.6	45.6	35.4	33.0	64.1	48.6	99.8	35.2	54.4	24.5	47.3	62.2	39.5	45.3	37.8	53.2	70.6	24.1	88.9	53.6	55.7	21.6	38.5	36.1	32.4	25.1	46.1	35.6	33.3	37.4	45.3	45.2	29.1	31.9	18.4	51.7	30.3	12.9	27.7	38.9	30.8	62.1	24.8	27.1	28.4	23.7	38.2	68.9	23.5	31.7	27.9	32.7	27.0	39.9	69.1	59.4	32.3	43.2	33.9	38.6	39.3	34.0	100.2	27.8	0.1	0.6	1.0	2.6	0.5	2.5	4.8	3.6	3.9	0.8	3.3	3.5	4.0	0.5	1.5	0.6	2.7	9.0	1.5	13.4	14.4	15.0	14.4	14.1	15.6	15.8	14.2	13.8	13.8	15.1	17.1	92.3	51.3	35.5	54.9	63.3	40.0	51.8	8.6	50.7	21.4	52.9	48.6	19.8	15.7	17.9	27.6	52.1	18.0	55.2	18.8	25.4	13.5	97.8	59.4	80.1	65.6	7.2	40.8	61.4	12.6	16.5	49.8	30.5	86.2	18.3	57.7	41.0	34.7	21.3	18.5	80.3	14.1	16.2	21.2	42.2	84.9	25.4	33.5	78.2	75.9	16.7	11.6	20.6	78.4	125.9	15.6	13.7	14.7	94.6	49.6	29.9	31.7	20.8	30.7	6.6	96.7	62.7	31.0	16.1	34.6	30.5	5.9	67.2	36.4	17.5	40.5
ASXL2	"ASXH2, FLJ10898, KIAA1685"	ENSG00000143970	"ASXL transcriptional regulator 2"	Q76L83	2	25733753-25878487	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034646, HPA058040"			Enhanced	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA034646: AB_2674261, HPA058040: AB_2683586"	"unprognostic (4.78e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.68e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.75e-2)"	6.8	6.2	3.8	9.5	5.1	8.3	7.2	4.8	3.9	8.2	4.5	9.1	6.4	7.1	5.0	7.7	7.2	6.8	7.1	3.5	7.7	8.7	6.1	6.9	11.1	7.5	5.0	6.6	7.7	14.1	3.5	7.1	7.5	6.3	8.9	8.8	6.6	6.3	8.0	7.6	7.1	8.2	3.6	9.9	7.8	17.7	6.3	13.9	10.5	7.3	10.5	7.5	4.2	6.4	25.1	23.1	11.0	7.8	9.8	13.7	12.9	16.0	19.0	12.4	10.5	19.4	12.6	14.8	9.7	13.9	13.8	14.1	21.1	14.9	16.9	22.5	10.2	32.9	20.1	16.6	8.3	42.2	25.1	6.8	15.2	17.9	15.3	10.4	15.2	8.8	29.0	12.2	12.5	9.2	15.5	9.2	14.4	13.2	9.4	15.4	48.2	11.4	10.7	30.1	11.3	12.5	22.2	13.9	13.5	10.4	8.9	12.3	31.4	16.6	22.0	15.9	22.4	26.8	39.8	41.0	15.5	27.4	13.2	1.7	2.7	4.2	2.7	1.4	2.3	2.2	1.9	1.9	1.5	2.0	2.2	2.5	6.0	1.2	3.3	2.3	2.2	0.8	3.8	5.1	4.8	3.9	3.5	7.7	7.5	5.0	7.5	3.6	6.3	6.4	16.1	25.6	24.1	54.2	25.9	32.4	8.9	15.9	29.0	22.3	19.1	10.8	27.0	14.3	19.1	9.2	25.0	10.2	22.5	20.1	15.6	15.7	48.9	25.8	20.4	22.0	10.3	33.6	62.5	14.4	9.4	17.3	24.5	19.8	23.5	12.6	28.5	12.6	18.2	25.2	47.6	16.8	18.3	25.7	23.6	26.9	19.6	25.2	23.2	68.4	34.4	12.4	12.3	46.3	72.8	18.4	14.2	13.2	29.8	13.4	12.4	14.3	41.3	24.9	39.5	20.6	16.8	34.4	26.6	29.7	41.1	14.6	45.0	17.2	19.7	19.3
ATAD2B	KIAA1240	ENSG00000119778	"ATPase family AAA domain containing 2B"	Q9ULI0	2	23748664-23927123	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 93.0;Inhibitory neurons: 95.5;Oligodendrocyte precursor cells: 143.7;Oligodendrocytes: 125.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034555	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA034555: AB_10601665"	"unprognostic (2.40e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.93e-3)"	"unprognostic (5.57e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.14e-2)"	"unprognostic (7.56e-3)"	"prognostic unfavorable (2.35e-5)"	"unprognostic (2.46e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.98e-1)"	4.8	3.1	4.9	5.9	6.1	9.8	4.5	8.1	5.5	5.9	11.0	4.2	5.1	4.9	2.6	6.0	4.6	3.5	3.7	4.0	6.1	3.7	4.1	4.8	7.3	6.5	5.7	5.8	4.3	3.3	4.1	4.0	5.7	4.3	4.3	9.4	4.8	2.3	4.4	8.3	5.2	2.8	4.8	5.1	3.9	4.3	5.9	10.3	5.2	2.8	6.5	4.0	6.6	7.7	4.1	3.4	11.0	5.0	3.1	3.4	8.5	2.7	2.2	3.5	2.4	5.5	2.0	13.4	2.4	2.5	1.6	5.3	8.6	3.0	2.9	8.8	4.1	11.3	4.5	6.6	3.4	10.2	8.1	2.7	5.2	2.1	3.4	2.9	4.8	7.4	12.2	5.8	2.7	7.0	9.5	11.9	6.5	6.8	1.9	10.8	11.8	3.1	3.8	9.1	5.1	8.4	7.4	9.0	4.2	6.0	4.4	10.0	4.6	3.5	4.0	3.0	3.2	6.0	2.9	10.0	1.9	11.5	3.3	15.8	7.9	5.1	3.9	4.7	4.4	8.5	3.6	3.5	7.6	6.4	5.2	4.2	12.0	6.0	6.2	11.0	3.4	1.8	4.9	6.1	8.1	5.5	4.0	6.1	6.5	5.7	5.7	4.8	5.9	7.7	18.4	3.2	16.0	93.0	26.1	10.7	7.7	6.4	13.1	27.6	9.5	7.1	11.3	10.0	12.2	9.2	47.9	8.4	33.8	15.2	0.0	7.7	60.2	10.1	20.1	14.6	15.6	11.1	60.3	12.2	7.4	14.7	19.9	17.0	13.3	21.2	11.7	10.7	8.2	10.1	95.5	11.0	10.2	14.4	17.6	36.1	12.5	23.8	3.6	85.3	30.9	13.0	22.6	143.7	125.3	8.9	18.6	10.9	14.0	10.8	17.2	2.4	8.5	45.4	6.6	19.1	13.5	23.5	16.8	20.0	17.5	10.9	22.6	13.1	11.3	16.5
ATAD3B	"KIAA1273, TOB3"	ENSG00000160072	"ATPase family AAA domain containing 3B"	Q5T9A4	1	1471765-1497848	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"											"HPA058968, HPA064867, HPA065305"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA058968: AB_2683864, HPA064867: AB_2685375, HPA065305: AB_2685459"	"unprognostic (6.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.68e-1)"	"prognostic unfavorable (1.81e-5)"	"unprognostic (1.51e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.17e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (5.48e-9)"	"unprognostic (2.38e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.68e-1)"	9.1	10.0	5.7	3.6	5.8	5.0	8.5	5.5	9.7	9.8	5.8	9.1	2.4	7.2	0.0	12.4	9.1	0.7	8.0	5.6	5.6	13.7	15.7	8.6	3.5	5.9	5.5	10.2	9.7	0.4	13.6	1.3	5.9	11.7	0.3	0.1	7.5	0.7	6.2	10.7	9.2	0.5	5.3	14.1	8.7	10.8	6.0	2.3	9.6	0.2	0.7	9.9	8.6	6.1	13.4	0.1	3.2	21.9	1.3	1.4	29.0	20.7	4.8	20.7	15.7	47.8	38.6	16.9	6.7	7.9	13.4	21.8	28.1	13.6	4.7	16.3	29.0	12.2	32.9	31.9	5.3	20.4	14.3	4.7	0.7	35.9	1.5	0.0	7.6	7.1	37.2	3.2	8.1	5.4	26.3	28.7	44.1	9.8	51.7	21.5	6.3	12.0	6.2	7.7	15.6	13.2	14.0	18.7	20.2	2.4	2.4	7.5	7.5	4.5	12.0	32.4	23.0	12.2	18.5	45.7	17.7	35.1	5.8	0.2	0.2	0.4	0.4	1.1	0.5	0.1	0.3	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.1	5.7	5.8	5.5	9.7	5.6	5.6	5.9	5.5	5.9	5.3	6.0	6.1	8.6	6.4	22.1	17.6	9.4	26.3	7.8	5.2	10.2	16.0	9.3	7.1	5.9	8.6	7.5	9.2	20.9	15.3	12.9	17.8	1.9	7.7	3.6	10.1	7.8	8.2	7.2	7.6	13.3	7.9	40.3	8.7	23.9	10.2	11.4	16.7	4.2	7.6	12.4	13.5	12.9	13.8	6.1	4.7	12.3	3.8	4.4	7.9	10.6	8.4	5.4	5.8	1.0	4.5	8.3	11.3	9.7	3.0	22.8	14.4	6.7	2.6	8.3	17.1	6.6	8.3	10.2	5.4	10.6	11.1	23.4	17.8	9.9	15.0	20.6	10.8
ATAD5	"C17orf41, ELG1, FLJ12735, FRAG1"	ENSG00000176208	"ATPase family AAA domain containing 5"	Q96QE3	17	30831966-30895869	"Predicted intracellular proteins"	"DNA damage"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 12.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 59.3;Spermatocytes: 73.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 2.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA066823			Approved	"Nucleoplasm,Cytokinetic bridge,Centriolar satellite,Cytosol"	"Intracellular and membrane"	Yes	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cytokinetic bridge, Centriolar satellite, Cytosol"	"HPA066823: "	"unprognostic (3.12e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.36e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.28e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.79e-3)"	"unprognostic (7.24e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.19e-3)"	"unprognostic (6.30e-10)"	"unprognostic (3.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.38e-1)"	0.7	0.4	0.3	2.1	0.2	12.3	1.2	2.6	0.5	0.8	0.1	1.2	1.4	1.0	0.4	1.3	0.7	0.5	0.4	0.3	0.2	0.4	0.5	0.8	3.6	0.2	0.1	0.9	0.5	0.3	0.5	1.4	0.3	0.6	1.6	2.5	0.7	0.4	0.4	2.5	1.4	0.6	0.1	1.4	1.1	2.0	0.3	5.3	0.6	0.1	2.9	0.6	0.9	0.6	7.2	6.0	14.0	13.3	0.3	1.4	5.5	6.3	3.2	6.9	9.8	6.6	5.1	19.5	5.9	2.9	4.7	13.0	9.1	4.7	12.4	4.4	7.9	11.7	8.0	4.6	0.2	23.1	9.2	0.6	0.6	10.1	3.5	1.4	3.6	18.7	18.7	15.9	4.6	4.2	26.1	11.5	8.2	5.3	2.9	17.6	26.4	9.3	1.8	7.6	8.1	7.2	7.0	4.0	3.7	7.6	7.6	10.2	2.8	8.3	11.3	12.0	11.4	5.2	5.9	24.0	3.6	10.7	8.4	0.4	0.2	0.3	0.3	0.3	0.2	0.3	0.1	0.2	0.1	0.4	0.2	0.2	0.6	0.6	0.1	0.5	0.3	0.1	0.3	0.2	2.6	0.5	0.3	0.2	0.2	0.1	0.3	0.1	0.3	0.6	4.3	3.2	4.1	6.8	9.9	4.7	3.1	2.6	3.4	19.3	4.7	5.1	2.7	0.0	2.6	3.7	0.0	21.7	10.7	6.6	0.0	4.1	13.9	4.4	8.5	5.4	0.0	59.3	20.4	2.9	21.1	5.4	9.7	5.1	3.8	32.6	2.9	0.7	8.7	11.8	17.4	8.6	2.0	2.8	7.4	7.8	3.7	5.7	7.2	11.2	10.0	2.9	12.3	16.6	14.9	4.0	2.4	2.2	24.4	2.4	2.3	0.5	2.7	21.3	0.0	7.4	6.5	73.3	34.5	9.3	4.5	7.9	10.5	8.4	13.0	2.3
ATE1		ENSG00000107669	"Arginyltransferase 1"	O95260	10	121740424-121928492	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 137.7;Oligodendrocytes: 220.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038444, HPA057549"	Approved		Supported	Nucleoplasm		NA	NA		83000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA038444: AB_10672745, HPA057549: AB_2683463"	"unprognostic (1.37e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.75e-3)"	"unprognostic (2.40e-1)"	"unprognostic (4.67e-2)"	"unprognostic (6.65e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.52e-1)"	"unprognostic (5.69e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (3.20e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.02e-1)"	10.1	11.7	8.1	8.5	8.5	7.4	10.4	7.3	9.2	12.1	17.3	13.5	11.4	10.6	8.4	10.7	9.0	10.4	22.2	8.4	11.0	18.2	18.2	9.5	9.5	6.7	7.3	10.0	6.2	15.4	4.8	11.0	7.5	12.7	14.6	15.6	7.8	10.0	18.3	6.7	11.1	11.7	7.4	10.4	8.8	13.3	10.6	13.0	16.0	15.4	10.6	12.7	6.6	8.7	13.0	19.5	15.4	15.0	15.1	16.8	12.3	12.0	24.0	13.1	13.2	23.6	19.1	16.1	9.5	14.3	8.8	16.1	14.5	14.2	16.3	20.3	13.1	5.8	8.8	31.1	15.5	26.7	13.4	11.9	15.2	13.8	32.0	19.3	18.7	9.0	7.8	29.4	14.5	7.9	14.0	15.2	7.5	19.6	11.4	13.1	18.1	10.6	23.4	11.2	4.8	19.4	17.2	12.9	28.2	11.3	8.9	9.2	19.2	8.2	7.0	12.5	21.1	28.0	33.6	12.0	12.6	20.6	7.4	12.8	3.8	6.1	5.3	4.5	6.3	4.5	5.0	5.3	3.4	4.2	5.5	5.6	2.3	5.1	3.5	4.8	6.7	4.0	8.1	8.5	7.3	9.2	8.4	11.0	6.7	7.3	7.5	7.4	10.6	8.7	23.0	9.6	22.0	76.4	17.3	8.4	12.8	9.4	24.5	31.3	17.5	14.6	75.6	11.5	12.7	20.2	12.5	7.2	20.9	42.8	17.6	11.3	6.5	15.8	19.4	19.3	22.1	16.2	100.5	13.3	10.5	25.0	29.6	16.4	12.6	13.5	20.0	26.6	10.0	23.5	93.8	17.7	10.2	14.8	7.2	7.7	20.5	23.6	14.2	74.0	12.8	21.7	27.8	137.7	220.4	15.6	18.3	25.9	24.8	21.0	19.5	39.4	11.5	35.8	0.0	23.4	21.1	26.9	40.2	30.7	17.5	8.6	17.9	29.1	16.8	16.6
ATF7IP	"FLJ10688, p621"	ENSG00000171681	"Activating transcription factor 7 interacting protein"	Q6VMQ6	12	14365632-14502935	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016578, HPA023505"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies"		"HPA016578: AB_1845147, HPA023505: AB_1845148"	"unprognostic (2.06e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.20e-3)"	"unprognostic (2.48e-2)"	"unprognostic (5.84e-2)"	"unprognostic (8.56e-3)"	"unprognostic (7.36e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.90e-3)"	"unprognostic (2.88e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.78e-2)"	12.4	10.4	12.1	16.8	18.8	30.9	14.7	32.8	11.7	12.8	21.7	11.2	8.3	15.6	13.7	14.3	13.4	11.8	16.3	9.9	14.1	11.0	14.4	13.3	28.2	16.9	15.5	17.9	11.5	17.2	8.5	14.2	15.8	13.4	13.0	17.1	20.6	12.0	16.4	16.7	11.9	16.4	11.2	20.8	14.2	33.8	18.8	32.5	21.7	21.2	28.1	12.6	11.4	21.3	23.2	13.8	54.3	31.7	27.9	35.2	11.4	24.4	13.7	18.8	28.6	31.4	23.9	38.5	16.2	16.6	34.3	23.0	34.3	22.4	42.3	27.5	20.1	25.8	23.3	6.5	16.6	17.7	15.1	19.0	18.3	23.2	23.9	29.3	41.5	13.6	15.6	19.7	29.9	21.7	25.5	15.4	35.1	11.9	12.7	52.3	60.3	21.0	16.2	44.6	17.4	14.2	27.7	16.0	15.4	44.0	16.2	20.5	19.2	26.3	16.7	14.9	20.3	13.2	13.9	53.1	16.7	16.5	29.0	29.2	11.6	19.4	16.2	8.3	16.8	23.1	13.6	16.0	9.8	30.9	10.9	15.5	17.8	11.4	14.2	12.9	18.7	11.0	12.1	18.8	32.8	11.7	9.9	14.1	16.9	15.5	15.8	11.2	18.8	21.3	46.6	67.3	42.5	67.9	121.2	6.6	12.8	9.7	75.1	50.2	31.6	24.6	73.0	20.0	26.6	35.0	68.8	17.2	112.1	13.2	7.9	16.6	79.6	31.1	34.7	40.3	28.1	55.1	62.6	12.2	10.9	32.0	41.8	31.9	25.9	34.8	30.0	31.3	20.5	63.9	73.9	19.6	10.2	48.4	11.2	19.6	29.2	46.3	5.4	107.7	47.9	23.5	64.9	136.7	147.9	14.5	13.5	29.3	85.9	13.6	12.0	16.4	24.3	39.8	13.1	40.0	33.3	42.4	25.0	62.7	6.7	15.5	98.5	35.1	18.3	12.1
ATG9A	"APG9L1, FLJ22169"	ENSG00000198925	"Autophagy related 9A"	Q7Z3C6	2	219219380-219229717	"Predicted membrane proteins, Transporters"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 83.8;Late spermatids: 105.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059551	Uncertain		Supported	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Vesicles		"HPA059551: AB_2684060"	"unprognostic (1.53e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.46e-2)"	"unprognostic (5.04e-2)"	"unprognostic (4.80e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (2.18e-5)"	"unprognostic (8.99e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.55e-3)"	"unprognostic (4.67e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.15e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.95e-2)"	25.6	23.6	27.2	17.3	29.0	44.7	19.2	27.8	36.6	19.5	10.0	25.6	31.4	24.1	14.2	31.4	18.8	21.8	42.1	30.0	24.3	20.0	25.9	23.7	19.4	29.0	26.7	20.4	28.1	31.2	17.6	30.7	26.2	21.6	21.8	24.6	23.9	22.8	116.8	32.1	29.7	28.1	24.3	21.7	22.8	62.2	27.6	15.7	18.4	62.7	21.2	22.7	22.7	28.6	29.4	35.7	26.9	64.0	50.3	55.1	35.9	52.1	56.1	67.3	60.2	52.9	38.8	7.7	43.7	79.8	54.7	58.0	43.2	56.9	49.6	22.6	70.7	55.7	90.1	63.9	54.9	14.1	40.6	56.7	91.4	68.7	63.0	60.9	68.2	18.6	75.6	27.0	46.2	38.3	12.2	33.4	19.5	28.5	26.9	16.9	36.7	30.2	40.0	38.6	42.6	25.7	52.0	46.7	46.5	52.0	17.3	39.3	52.5	67.0	32.3	28.7	47.1	15.5	14.7	11.2	55.7	33.9	37.2	6.5	12.4	6.3	7.2	18.0	7.2	5.6	5.6	9.1	8.5	3.6	5.4	6.1	11.2	9.7	22.6	4.1	7.1	11.6	27.2	29.0	27.8	36.6	30.0	24.3	29.0	26.7	26.2	24.3	27.6	28.6	0.3	0.0	4.5	12.7	8.2	7.8	7.6	10.6	8.6	18.9	0.3	0.3	33.2	17.2	7.1	0.0	14.6	26.8	4.1	44.0	0.0	0.2	83.8	0.6	1.5	10.0	13.8	34.7	15.2	0.5	24.4	9.1	11.7	0.8	10.2	0.3	16.8	37.1	11.5	21.9	14.1	17.6	6.1	13.3	7.0	105.9	14.0	4.8	10.6	5.6	7.0	20.5	9.2	9.5	12.5	0.3	27.6	8.6	6.7	13.4	39.3	0.3	4.7	15.7	13.1	7.1	5.5	54.9	13.8	14.2	11.1	34.8	7.5	0.8	18.5	10.5
ATIC	"AICARFT, IMPCHASE, PURH"	ENSG00000138363	"5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase"	P31939	2	215311956-215349773	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Hydrolase, Multifunctional enzyme, Transferase"	"Cancer-related genes, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 171.4;Extravillous trophoblasts: 166.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013462, HPA021012"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		3900000	"Cluster 44: Non-specific - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol	"Plasma membrane"	"CAB013462: , HPA021012: AB_1845169"	"unprognostic (1.41e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.81e-2)"	"prognostic unfavorable (1.99e-7)"	"unprognostic (1.86e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.31e-3)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (8.77e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.39e-3)"	24.8	26.0	19.8	31.7	23.4	26.4	33.9	21.4	23.5	22.2	18.8	36.4	32.0	30.0	20.3	19.4	29.4	20.4	21.3	19.6	21.5	32.7	34.6	18.0	44.9	20.5	21.5	32.0	26.2	29.6	18.6	37.3	23.3	28.7	47.5	19.1	18.8	38.4	43.2	23.8	27.2	37.0	21.0	27.6	24.5	20.1	22.9	41.8	22.5	25.4	51.8	29.1	17.6	27.5	102.2	133.8	85.1	144.0	112.5	113.2	40.6	105.4	91.9	117.4	134.9	278.6	157.3	149.6	122.8	110.0	164.5	106.7	187.8	157.0	169.5	113.4	189.3	179.1	108.7	271.5	145.4	226.1	92.0	98.4	119.8	154.7	188.5	82.0	79.7	144.5	237.0	124.4	166.3	178.7	203.4	112.1	330.3	167.4	84.9	185.8	117.3	133.4	126.4	146.5	129.3	87.8	84.3	103.1	124.3	189.2	169.7	82.9	70.2	96.0	101.2	127.3	65.8	160.3	195.7	300.1	85.6	124.5	146.8	12.6	16.4	0.4	34.6	23.5	59.1	56.6	49.0	53.8	36.3	39.9	50.0	46.9	1.8	55.4	21.1	31.7	50.2	29.0	19.8	23.4	21.4	23.5	19.6	21.5	20.5	21.5	23.3	21.0	22.9	27.5	7.2	12.8	19.3	18.6	34.7	15.0	28.2	55.0	30.7	10.0	18.2	16.1	21.1	28.6	33.3	23.9	4.2	171.4	23.3	17.6	27.4	45.2	1.1	20.7	28.2	6.1	19.2	32.2	15.4	49.3	166.3	25.3	22.4	20.8	25.3	32.9	5.3	22.2	52.4	10.1	15.4	33.8	26.4	14.4	10.8	1.7	23.9	20.2	30.2	2.8	26.1	21.3	26.8	16.6	25.7	32.4	28.5	34.3	36.3	24.0	18.8	52.7	27.3	14.7	26.3	19.2	29.0	3.3	43.8	24.6	8.5	95.4	29.8	40.7	58.4	18.1
ATMIN	"ASCIZ, KIAA0431, ZNF822"	ENSG00000166454	"ATM interactor"	O43313	16	81035842-81047350	"Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 180.6;Late spermatids: 288.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054967, HPA066900"	Approved		Supported	"Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nuclear bodies"		"HPA054967: AB_2682654, HPA066900: AB_2685744"	"unprognostic (9.92e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.32e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.48e-1)"	"unprognostic (4.26e-2)"	"prognostic favorable (6.80e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.60e-1)"	15.9	12.7	18.9	11.4	19.6	7.9	14.4	18.2	23.5	13.5	14.6	12.9	12.8	13.8	18.0	18.9	11.4	11.5	14.2	19.6	21.6	19.7	17.9	10.7	13.9	19.6	21.7	14.3	16.1	27.0	13.1	20.4	22.8	17.6	13.7	10.3	12.8	14.8	16.0	17.6	12.9	13.7	17.6	12.9	12.7	22.6	21.5	15.6	20.6	17.0	15.0	14.2	12.0	18.4	26.7	22.0	28.6	33.7	30.6	21.3	42.8	17.1	24.8	15.9	8.8	14.9	14.9	20.8	21.8	25.6	18.3	25.3	28.1	14.7	20.3	13.8	15.6	14.3	13.3	17.4	28.3	24.7	21.6	22.7	24.7	15.4	24.7	26.7	16.6	20.0	22.8	12.4	22.9	42.9	19.9	18.0	33.6	16.6	16.3	34.5	13.8	12.2	25.0	27.5	22.8	29.5	54.3	16.8	14.3	23.7	28.5	22.0	22.0	20.3	20.6	19.9	16.2	19.7	31.6	50.4	18.7	16.1	19.3	0.5	0.8	0.5	1.9	0.6	1.4	1.5	2.0	1.7	0.8	1.6	1.7	1.9	0.2	1.9	0.6	1.0	2.2	0.6	18.9	19.6	18.2	23.5	19.6	21.6	19.6	21.7	22.8	17.6	21.5	18.4	38.6	9.6	19.2	10.7	11.7	12.0	16.3	10.0	10.2	24.9	20.7	16.9	18.6	20.0	15.5	23.9	20.9	42.3	25.8	21.4	11.7	12.6	180.6	13.3	37.2	19.3	11.5	7.4	16.1	14.0	38.4	17.9	15.8	22.4	16.5	15.2	22.9	21.6	29.7	13.5	17.7	13.7	6.1	23.9	6.0	288.9	19.9	14.3	14.2	3.7	19.2	32.5	12.3	8.0	16.9	18.5	11.2	19.5	15.0	15.1	19.9	20.8	7.5	16.6	13.1	24.2	18.0	28.6	25.4	17.2	15.3	30.1	15.5	21.6	16.0	18.4
ATOH8	"bHLHa21, FLJ14708, HATH6"	ENSG00000168874	"Atonal bHLH transcription factor 8"	Q96SQ7	2	85751344-85791383	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 54.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 123.8;Endothelial cells: 41.7;Hepatocytes: 39.1;Muller glia cells: 32.3"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 15.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.2;fHDF/TERT166: 6.8;hTERT-RPE1: 5.0;RH-30: 9.5;RT4: 5.6;TIME: 7.9;U-2197: 5.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA028406			Supported	Nucleoplasm		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA028406: AB_2672587"	"unprognostic (7.70e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.84e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.56e-1)"	"prognostic favorable (8.98e-6)"	"unprognostic (3.32e-2)"	"prognostic favorable (3.80e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.91e-2)"	33.8	1.8	2.1	0.3	2.2	0.0	29.9	2.7	1.6	20.9	0.5	8.8	0.2	25.9	0.2	5.6	19.4	0.4	30.6	1.5	5.1	7.3	25.1	25.6	0.8	5.7	4.9	15.0	4.2	0.2	5.4	0.3	5.3	17.4	0.4	0.6	5.2	1.9	54.7	19.9	8.9	1.3	1.6	12.2	9.4	2.1	3.1	0.2	48.5	2.0	0.1	21.7	20.6	3.3	0.0	1.1	4.1	6.2	3.0	0.4	0.0	3.4	0.5	0.8	0.3	0.0	0.0	0.0	1.1	6.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	0.1	1.6	0.0	0.0	2.1	0.0	0.0	0.0	5.0	0.6	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	9.5	0.0	0.0	5.6	3.0	1.4	0.6	0.0	0.6	0.0	0.0	0.0	7.9	1.2	0.0	5.5	0.0	0.0	0.0	0.0	0.8	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.2	2.7	1.6	1.5	5.1	5.7	4.9	5.3	1.6	3.1	3.3	123.8	9.6	18.3	10.7	0.3	2.5	8.5	11.8	0.6	0.4	0.5	0.8	13.2	5.7	17.5	1.8	0.0	0.1	0.1	1.1	0.0	11.9	13.6	5.9	5.7	41.7	4.2	0.0	0.3	2.3	0.6	11.4	1.1	20.5	1.3	5.3	5.7	39.1	3.2	0.0	0.3	2.2	6.1	3.1	4.0	25.9	3.4	4.3	1.8	5.6	0.6	32.3	0.0	14.6	3.1	1.0	5.5	0.4	0.0	4.5	0.0	0.6	2.4	1.3	0.0	12.2	11.6	3.0	2.7	0.2	1.4	0.3	0.5	0.1	1.0	2.3
ATP5MD	"bA792D24.4, DAPIT, MGC14697, USMG5"	ENSG00000173915	"ATP synthase membrane subunit DAPIT"	Q96IX5	10	103389041-103396492	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 1340.2;Ductal cells: 705.9;Exocrine glandular cells: 723.1;Pancreatic endocrine cells: 884.5;Proximal tubular cells: 1879.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044798			Supported	Mitochondria		NA	NA		55000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA044798: AB_2679091"	"unprognostic (4.41e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.59e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.57e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.66e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.03e-2)"	332.3	343.0	502.9	155.1	517.7	193.0	324.6	514.9	721.8	215.1	515.2	484.6	273.5	176.9	410.2	426.1	194.3	140.8	1229.7	526.1	539.0	546.7	587.1	215.3	180.3	501.2	501.9	157.5	321.4	519.2	309.2	157.4	506.1	254.2	449.6	245.3	234.8	236.4	1019.3	204.6	261.7	229.8	511.8	185.4	369.8	142.5	509.3	319.0	191.2	1325.5	251.0	284.7	258.9	518.0	557.8	559.4	528.4	648.2	570.2	696.0	348.3	523.2	612.7	501.0	556.6	925.2	605.3	312.4	288.9	575.3	398.6	559.4	502.2	522.7	697.9	414.7	887.3	331.8	682.1	1057.7	545.7	688.3	491.3	569.2	801.1	456.4	715.7	849.2	661.5	470.0	441.5	517.5	849.4	842.0	552.0	1167.5	397.8	830.1	959.1	355.8	326.0	495.3	1218.4	878.4	203.7	464.8	269.4	419.7	824.9	723.5	373.4	619.9	388.6	255.2	394.2	394.0	692.8	537.2	958.4	543.5	545.2	678.2	200.3	575.3	271.2	395.8	214.7	384.0	248.0	301.6	296.3	259.8	314.1	219.1	251.4	256.7	231.1	230.5	375.3	456.3	307.9	304.4	502.9	517.7	514.9	721.8	526.1	539.0	501.2	501.9	506.1	511.8	509.3	518.0	169.1	211.5	173.2	0.0	40.9	0.0	0.0	0.0	0.0	0.0	323.4	417.6	0.0	0.0	91.0	388.1	0.0	298.0	76.3	0.0	1340.2	705.9	0.0	406.0	245.4	114.5	0.0	0.0	0.0	723.1	439.4	81.8	0.0	424.5	118.6	176.9	0.0	0.0	543.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	166.4	0.0	0.0	432.6	0.0	0.0	0.0	0.0	884.5	0.0	0.0	0.0	0.0	0.0	1879.7	121.0	0.0	0.0	0.0	127.9	0.0	0.0	0.0	0.0	305.8	69.4	209.9	0.0	0.0
ATP5ME	ATP5I	ENSG00000169020	"ATP synthase membrane subunit e"	P56385	4	672436-674330	"Metabolic proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 2048.3"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 886.5;Distal tubular cells: 1729.5;Proximal tubular cells: 2485.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035010	Enhanced		Supported	Mitochondria		NA	NA		280000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA035010: AB_10669853"	"unprognostic (1.42e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.95e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.46e-3)"	"unprognostic (6.89e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.45e-3)"	360.1	412.7	940.1	212.2	960.8	312.4	277.4	981.5	1172.2	263.3	926.5	555.7	460.3	237.4	242.7	511.9	218.8	94.5	1507.7	932.5	968.9	572.0	591.7	235.6	174.6	980.1	955.6	257.5	330.9	774.8	312.8	144.8	972.5	262.0	331.4	336.4	304.8	220.4	2048.3	297.8	436.7	172.8	952.6	281.3	414.9	130.6	960.4	315.7	270.1	1688.5	223.8	293.5	323.8	998.1	542.0	560.8	781.7	599.5	622.4	544.4	390.7	561.8	445.4	407.4	359.4	525.4	548.4	299.0	472.8	612.4	683.8	361.8	668.9	924.1	241.4	249.9	1082.7	854.6	1107.9	1435.2	659.0	1118.6	368.0	721.6	533.5	472.2	491.0	665.5	503.3	608.1	756.0	314.4	464.7	904.5	972.6	1337.3	861.9	1071.7	1438.9	584.4	555.0	620.7	863.9	1053.2	667.7	530.1	401.6	525.0	620.2	502.7	590.4	695.7	580.2	348.0	340.7	308.2	730.9	739.7	1273.2	947.0	528.0	712.7	391.3	1049.3	1044.5	1188.8	742.1	920.0	776.3	1470.4	909.2	839.0	1067.0	1131.6	837.1	811.9	962.2	943.5	822.7	1179.7	1086.3	1456.6	940.1	960.8	981.5	1172.2	932.5	968.9	980.1	955.6	972.5	952.6	960.4	998.1	311.8	153.8	199.7	0.0	88.6	0.0	0.0	0.0	0.0	0.0	461.7	421.8	0.0	0.0	121.9	886.5	0.0	404.9	188.8	0.0	1729.5	467.4	0.0	468.6	315.6	125.1	0.0	0.0	0.0	692.9	335.8	139.4	0.0	484.2	122.4	311.8	0.0	0.0	676.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	201.6	0.0	0.0	278.1	0.0	0.0	0.0	0.0	509.6	0.0	0.0	50.1	0.0	0.0	2485.3	183.6	0.0	0.0	0.0	156.7	0.0	0.0	0.0	0.0	274.9	97.8	146.6	0.0	0.0
ATP5MF-PTCD1	ATP5J2-PTCD1	ENSG00000248919	"ATP5MF-PTCD1 readthrough"		7	99419749-99466197	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA020106, HPA047679"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	Mitochondria		"HPA020106: AB_2176551, HPA047679: AB_2680119"	"unprognostic (1.15e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.84e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.50e-2)"	2.8	2.8	1.2	2.8	1.0	0.0	2.3	1.1	1.8	3.3	1.1	3.7	2.7	3.0	1.6	4.7	3.3	2.0	3.7	1.0	1.2	1.7	2.7	1.8	2.6	1.3	1.4	2.5	2.5	3.6	1.7	2.5	1.3	3.7	2.1	0.5	2.5	3.5	8.9	2.7	2.2	2.5	0.9	2.3	2.7	3.4	1.2	2.3	2.3	5.5	2.5	4.1	3.3	1.1	7.7	8.2	6.8	19.1	8.1	4.8	14.6	5.1	6.2	12.8	11.6	31.5	12.3	10.0	12.6	4.9	11.9	7.3	11.6	10.6	5.4	11.2	10.9	5.8	5.0	6.5	8.5	8.0	5.7	8.2	9.4	11.5	9.3	4.7	5.3	11.5	19.5	14.9	8.3	15.7	18.5	10.2	11.9	13.2	10.5	9.9	6.3	26.6	6.7	2.4	8.7	8.8	11.0	18.0	11.0	4.5	9.2	12.5	3.3	8.9	7.8	18.7	13.8	11.7	10.8	16.0	6.5	8.9	16.3	1.3	4.0	1.2	3.3	5.4	3.4	2.1	2.7	2.8	5.6	2.4	2.8	3.6	0.3	4.5	3.2	2.7	2.2	5.0	1.2	1.0	1.1	1.8	1.0	1.2	1.3	1.4	1.3	0.9	1.2	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
ATP5PB	ATP5F1	ENSG00000116459	"ATP synthase peripheral stalk-membrane subunit b"	P24539	1	111448864-111462773	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 135.8;tongue: 131.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 346.5;Distal tubular cells: 461.8;Extravillous trophoblasts: 405.2;Hofbauer cells: 373.0;Proximal tubular cells: 434.6;Syncytiotrophoblasts: 347.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046067, HPA057347"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		170000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA046067: AB_10960850, HPA057347: AB_2683416"	"unprognostic (4.18e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.56e-2)"	"unprognostic (8.18e-2)"	"unprognostic (8.52e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.18e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.92e-1)"	"prognostic favorable (3.26e-9)"	"prognostic favorable (8.07e-4)"	"unprognostic (1.60e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.93e-1)"	19.3	15.7	10.3	11.5	12.5	15.3	18.8	14.5	27.4	17.4	3.9	51.6	28.8	16.6	16.0	26.8	23.9	16.3	109.0	12.1	10.2	40.3	40.2	13.7	24.0	13.4	12.0	19.2	18.5	33.8	7.1	21.6	14.9	22.3	33.6	28.5	29.8	18.7	135.8	15.7	19.0	17.9	9.6	15.2	22.6	15.5	12.8	15.7	31.1	131.0	22.4	21.9	7.4	14.1	55.6	17.6	44.1	36.9	35.6	34.2	34.1	57.0	68.9	67.3	54.7	31.8	29.1	84.9	52.3	45.5	14.3	56.1	69.4	79.5	65.1	61.9	33.2	76.1	21.3	21.5	26.0	98.3	70.8	30.3	40.9	69.3	66.9	17.7	60.0	11.9	78.7	33.6	46.3	35.4	153.3	30.0	34.9	19.2	90.5	41.2	143.6	34.0	54.7	26.0	37.2	13.4	49.4	72.7	55.6	12.6	54.8	46.0	50.6	32.0	49.1	59.4	61.2	41.8	44.5	172.1	70.8	77.6	60.8	3.5	15.4	7.1	14.8	10.0	12.2	12.9	15.1	13.3	16.1	15.2	16.9	10.4	4.8	9.8	9.0	9.2	15.1	44.2	10.3	12.5	14.5	27.4	12.1	10.2	13.4	12.0	14.9	9.6	12.8	14.1	73.2	67.3	83.8	0.0	31.5	0.0	0.0	0.0	0.0	0.0	112.9	155.3	0.0	0.0	57.6	125.0	0.0	346.5	56.4	0.0	461.8	237.3	0.0	132.5	111.0	58.8	0.0	0.0	0.0	196.7	405.2	57.0	0.0	125.4	89.6	82.1	0.0	0.0	373.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.8	0.0	0.0	98.8	0.0	0.0	0.0	0.0	162.6	0.0	0.0	9.8	0.0	0.0	434.6	74.3	0.0	0.0	0.0	58.0	0.0	0.0	0.0	0.0	347.7	41.8	208.0	0.0	0.0
ATP6V1F	"ATP6S14, VATF, Vma7"	ENSG00000128524	"ATPase H+ transporting V1 subunit F"	Q16864	7	128862856-128865847	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 1054.6;Hofbauer cells: 1132.8;Proximal tubular cells: 1076.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009529, HPA048700, HPA062011"	Supported					NA	NA		26000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 4: Macrophages - Innate immune response"			"CAB009529: AB_2290237, HPA048700: AB_2680498, HPA062011: AB_2684656"	"unprognostic (1.70e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.99e-2)"	"unprognostic (8.46e-3)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (6.28e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.06e-1)"	"prognostic favorable (2.49e-5)"	"unprognostic (2.20e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.36e-2)"	"unprognostic (7.33e-2)"	133.3	160.7	275.6	106.2	290.1	210.4	122.3	272.7	368.6	126.5	250.2	104.6	74.7	95.3	61.7	223.0	98.3	104.2	183.3	294.8	300.1	307.0	84.2	140.0	139.9	280.1	275.3	89.0	106.8	163.5	141.0	104.6	286.0	103.0	56.6	110.6	129.3	81.6	169.3	170.1	97.0	71.2	269.5	119.6	114.4	212.2	284.3	119.6	84.6	154.7	103.7	123.1	146.6	277.4	305.6	345.1	151.2	323.2	297.6	236.8	86.9	151.2	201.3	246.8	267.2	257.0	179.8	287.6	156.5	175.7	367.7	163.9	224.5	250.1	91.9	312.6	364.2	220.1	211.4	256.4	344.1	227.1	400.8	278.2	340.0	284.7	163.4	188.9	238.1	257.9	534.3	297.3	276.3	403.1	381.0	494.3	201.9	190.6	281.4	168.7	110.1	467.5	315.5	240.3	286.6	197.3	214.1	796.5	363.7	156.6	184.4	284.9	253.0	303.5	65.3	409.5	236.2	333.5	326.9	372.0	600.4	315.5	263.6	370.2	697.1	489.2	244.6	475.1	238.0	343.7	247.6	239.7	508.9	348.5	235.8	238.6	203.1	243.6	324.7	288.3	317.3	886.1	275.6	290.1	272.7	368.6	294.8	300.1	280.1	275.3	286.0	269.5	284.3	277.4	129.3	28.9	62.8	17.3	140.1	237.6	202.5	378.9	136.6	111.4	162.0	190.1	157.6	127.2	230.7	331.1	37.5	171.8	119.8	97.3	1054.6	241.0	574.0	128.6	96.3	163.1	113.2	63.1	27.0	222.2	289.0	155.1	78.5	131.0	275.1	114.0	124.6	112.0	1132.8	545.1	34.6	108.7	585.9	320.6	378.7	898.9	164.4	456.1	254.3	16.9	285.8	230.4	190.5	11.6	26.2	253.9	93.0	127.9	136.8	224.7	212.0	1076.3	200.2	96.4	85.5	69.7	168.9	399.6	102.0	328.4	326.6	401.4	136.3	184.5	98.9	362.7
ATR	"FRP1, MEC1, SCKL, SCKL1"	ENSG00000175054	"ATR serine/threonine kinase"	Q13535	3	142449007-142578733	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"DNA damage, DNA repair"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 93.0;Inhibitory neurons: 94.4;Microglial cells: 73.1;Oligodendrocyte precursor cells: 65.4;Oligodendrocytes: 71.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054320			Supported	"Nucleoplasm,Golgi apparatus"		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Golgi apparatus"	"HPA054320: AB_2682448"	"unprognostic (1.47e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.25e-2)"	"unprognostic (6.42e-2)"	"prognostic unfavorable (8.39e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (1.94e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.43e-1)"	3.0	8.6	0.7	4.1	1.1	1.2	3.2	0.9	1.4	3.8	3.7	2.7	1.7	3.3	2.3	3.1	3.3	3.4	2.3	1.2	1.9	3.7	3.6	2.9	4.8	1.5	1.2	2.7	3.8	5.2	3.7	3.1	1.4	3.0	2.9	2.9	3.5	2.5	2.9	2.7	3.1	3.2	1.0	4.2	2.8	5.2	1.2	4.9	5.0	1.4	4.6	4.1	2.7	1.2	28.6	13.2	7.1	7.0	9.6	13.6	8.8	14.8	8.4	10.1	9.7	6.4	6.8	19.9	14.6	10.1	14.6	16.1	10.9	12.8	15.0	7.5	7.9	11.9	8.2	4.1	4.2	20.5	5.3	9.8	4.8	9.5	10.3	5.8	11.6	8.7	8.2	7.5	9.6	7.5	13.9	2.6	7.3	15.6	9.6	11.8	12.5	13.5	6.3	11.1	5.2	5.1	28.6	8.3	8.0	7.8	12.0	5.4	14.6	10.5	4.9	12.3	15.2	10.8	7.4	18.5	13.8	6.5	8.5	0.0	0.3	0.0	0.5	0.4	1.0	0.1	0.3	0.5	0.7	0.3	0.4	0.4	0.0	1.3	0.2	0.2	0.4	0.2	0.7	1.1	0.9	1.4	1.2	1.9	1.5	1.2	1.4	1.0	1.2	1.2	11.5	6.4	10.6	39.2	22.4	4.0	7.2	8.8	14.2	14.1	9.2	6.5	7.6	5.7	10.1	3.7	37.5	7.7	14.9	3.5	0.0	5.9	16.4	18.8	18.6	10.2	7.7	14.5	93.0	4.9	3.6	8.3	14.8	10.3	1.3	16.3	7.9	7.3	6.4	8.4	94.4	4.8	14.2	9.4	4.0	8.7	6.5	12.8	10.6	73.1	12.0	6.0	9.2	65.4	71.9	6.4	1.8	7.2	23.1	8.1	1.9	6.5	25.4	23.6	0.0	14.6	9.8	50.1	18.5	14.7	4.5	5.1	15.1	13.8	7.6	6.1
ATXN1L	BOAT1	ENSG00000224470	"Ataxin 1 like"	P0C7T5	16	71845976-71885268	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Late spermatids: 263.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062596, HPA062789"			Enhanced	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA062596: AB_2684802, HPA062789: AB_2684868"	"unprognostic (1.51e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (5.33e-8)"	"unprognostic (1.61e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.30e-2)"	"prognostic unfavorable (8.42e-4)"	14.0	8.0	11.5	9.9	12.7	39.5	10.9	9.0	9.7	11.1	5.6	10.4	8.2	12.3	7.3	9.7	10.9	9.0	9.5	9.3	9.4	18.7	6.6	12.0	10.0	10.9	11.7	12.7	12.5	16.5	5.2	10.8	10.3	8.1	9.2	8.0	9.4	10.4	10.4	12.1	9.4	12.9	10.3	11.8	10.0	12.2	12.5	12.8	11.9	13.7	10.5	8.9	7.4	11.9	11.8	15.7	15.7	11.5	18.1	8.9	18.4	9.8	10.8	17.4	13.2	22.6	12.9	13.2	15.0	15.4	8.0	20.3	13.4	14.9	18.9	3.6	11.9	9.7	17.7	15.9	13.5	11.9	19.0	12.8	18.6	19.8	14.2	11.4	16.0	17.0	11.1	10.2	10.4	33.6	20.2	11.7	14.3	9.3	7.4	21.4	15.9	15.8	12.1	16.4	8.3	14.2	19.5	10.2	11.9	16.4	16.0	12.5	19.4	19.0	19.9	12.1	13.3	23.0	20.8	30.7	11.8	7.9	16.3	0.6	0.3	0.3	0.4	0.4	0.3	0.3	0.3	0.4	0.2	0.2	0.5	0.5	0.4	0.4	0.2	0.1	0.7	0.3	11.5	12.7	9.0	9.7	9.3	9.4	10.9	11.7	10.3	10.3	12.5	11.9	11.1	0.0	10.6	4.2	14.9	22.8	15.3	11.4	14.2	11.2	16.0	10.2	15.7	14.3	9.5	14.7	14.6	8.3	19.9	15.2	17.6	11.9	44.2	19.1	15.0	14.2	7.8	5.7	6.8	11.8	7.9	11.0	5.6	35.4	12.7	8.0	14.3	12.3	8.5	15.2	5.7	8.7	8.2	14.3	25.2	263.0	14.9	11.8	12.4	5.6	16.9	6.3	29.9	3.5	9.1	14.4	19.6	12.8	16.0	18.3	13.3	15.8	9.9	17.2	13.1	15.5	14.3	22.4	21.1	13.1	24.9	11.5	15.8	8.0	10.6	28.4
ATXN2	"ATX2, SCA2, TNRC13"	ENSG00000204842	"Ataxin 2"	Q99700	12	111443485-111599676	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 209.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018295, HPA020339, HPA021146"	Enhanced		Enhanced	Cytosol		NA	NA		9600	"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA018295: AB_1845130, HPA020339: AB_1845131, HPA021146: AB_1845132"	"unprognostic (3.08e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.53e-1)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (2.34e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.58e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.40e-2)"	19.6	23.5	20.5	11.2	21.9	8.0	17.5	22.8	30.3	21.6	20.8	22.8	11.2	21.7	13.9	14.2	20.4	12.0	22.2	20.5	29.9	17.5	20.1	19.7	9.5	25.2	26.0	25.9	13.8	18.6	21.9	16.3	24.5	19.4	11.6	15.7	14.5	15.6	25.8	15.6	14.9	18.3	18.6	14.1	16.3	23.2	22.7	12.8	17.1	20.8	8.9	19.6	18.3	25.8	31.0	38.0	30.3	38.2	35.9	29.0	29.4	35.8	25.9	28.8	23.4	25.2	25.7	25.8	14.2	47.7	23.8	25.5	45.0	18.2	36.0	23.3	33.9	38.2	22.8	42.4	49.7	27.1	21.4	32.4	20.1	38.0	42.6	48.0	27.8	20.2	46.8	13.1	37.2	24.7	23.2	24.2	30.1	19.4	24.6	21.8	18.6	19.2	30.1	34.5	28.7	25.2	38.5	49.3	24.7	29.1	30.9	16.5	34.9	36.9	21.6	30.4	20.6	23.4	30.0	22.5	19.0	20.9	23.5	4.5	3.6	5.8	3.9	3.4	5.2	5.1	4.9	5.3	5.0	2.7	4.1	3.6	3.5	5.6	6.4	2.7	2.2	2.8	20.5	21.9	22.8	30.3	20.5	29.9	25.2	26.0	24.5	18.6	22.7	25.8	43.0	80.1	72.6	175.3	26.7	35.3	34.3	18.4	35.9	101.0	33.6	26.3	36.6	30.0	36.6	36.8	135.5	32.5	28.9	25.6	3.9	26.0	11.1	87.2	72.2	43.9	41.4	34.9	146.7	25.3	25.4	40.0	23.9	50.3	23.5	67.2	63.5	38.1	24.5	65.6	171.8	26.7	24.4	35.9	35.9	11.9	65.6	30.6	32.0	106.8	35.1	32.6	48.4	128.7	209.6	32.6	16.0	47.4	24.2	43.0	22.7	16.9	56.0	90.4	32.9	41.5	46.6	78.0	70.7	25.7	35.2	46.9	27.4	68.7	31.5	42.2
AURKA	"AIK, ARK1, AurA, BTAK, PPP1R47, STK15, STK6, STK7"	ENSG00000087586	"Aurora kinase A"	O14965	20	56369389-56392337	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 22.1;testis: 30.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 81.6;Extravillous trophoblasts: 67.1;granulocytes: 54.1;Spermatocytes: 168.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB001454, HPA002636"	Enhanced		Approved	"Nucleoplasm,Mitotic spindle,Centrosome,Cytosol"		Yes	Yes			"Cluster 7: Monocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Centrosome"	"Mitotic spindle, Cytosol"	"CAB001454: AB_563420, HPA002636: AB_1845217"	"unprognostic (7.73e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (9.40e-5)"	"unprognostic (1.92e-1)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (4.69e-3)"	"unprognostic (2.42e-1)"	"unprognostic (6.88e-2)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.47e-8)"	"unprognostic (1.67e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.00e-2)"	"unprognostic (5.14e-2)"	1.3	2.3	1.3	10.4	1.6	15.3	2.2	2.4	1.4	1.4	0.6	10.8	11.7	1.5	0.8	7.5	1.2	2.0	5.3	0.8	1.0	2.3	5.0	2.2	20.9	1.7	1.2	8.4	2.0	1.8	0.6	8.1	1.4	1.1	12.9	3.0	1.9	1.3	8.7	3.5	9.3	4.9	1.3	5.2	4.9	30.8	1.6	20.2	1.4	8.2	22.1	2.9	2.6	1.3	179.9	127.2	84.5	61.2	4.9	10.8	106.3	145.2	66.8	339.7	142.9	361.4	124.8	58.4	96.2	59.2	176.2	142.2	152.4	96.4	360.0	52.4	57.5	102.6	128.9	229.8	2.8	140.4	140.4	5.1	10.1	117.3	104.5	26.7	80.7	93.2	121.8	45.3	146.9	182.1	85.3	108.9	78.3	145.6	129.8	62.9	163.4	65.9	56.0	46.8	73.9	39.6	200.5	228.8	94.2	77.3	137.9	86.1	47.1	149.7	145.3	83.0	208.6	62.3	78.9	100.5	80.5	80.9	127.0	0.2	3.5	4.3	1.2	5.9	1.8	2.5	2.0	1.1	3.7	0.8	0.9	0.9	2.3	1.4	3.4	0.8	4.7	1.7	1.3	1.6	2.4	1.4	0.8	1.0	1.7	1.2	1.4	1.3	1.6	1.3	2.5	0.0	2.8	0.3	7.4	1.1	1.2	5.6	0.6	1.0	4.3	6.2	5.6	1.5	2.3	3.7	2.1	34.5	8.3	8.3	1.9	4.0	33.9	2.0	2.3	3.1	6.0	81.6	1.1	4.9	67.1	7.0	13.7	3.4	54.1	12.3	3.6	2.6	17.5	1.7	1.5	10.8	2.0	3.5	7.6	16.3	1.5	11.7	0.0	1.0	12.0	3.7	3.1	1.0	2.0	5.2	2.8	0.4	10.1	2.0	5.1	4.2	1.5	2.7	6.6	2.2	7.7	168.2	30.8	8.3	1.1	8.2	8.0	8.7	15.5	1.5
AURKB	"Aik2, AIM-1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5"	ENSG00000178999	"Aurora kinase B"	Q96GD4	17	8204733-8210600	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 44.1;lymphoid tissue: 60.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 40.5;Erythroid cells: 59.3;Extravillous trophoblasts: 89.1;Granulosa cells: 24.7;Hofbauer cells: 29.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"T-reg: 7.9"	"Group enriched"	"Detected in many"	6	"B-cells: 2.5;T-cells: 7.9"	"Low cell line specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"basal ganglia: 1.3;white matter: 4.0"	"Low region specificity"	"Detected in all"			"CAB005862, HPA037708"	Enhanced		Enhanced	Nucleoplasm,Midbody		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Midbody	"CAB005862: AB_449204, HPA037708: AB_2675623"	"unprognostic (4.76e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (1.99e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.47e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.77e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.76e-2)"	"unprognostic (3.77e-1)"	1.1	1.2	0.1	14.2	0.2	44.1	1.7	0.2	0.2	3.0	0.1	11.1	12.1	1.6	0.4	18.6	0.6	1.5	0.7	0.1	0.2	0.9	2.0	2.5	36.7	0.1	0.3	0.5	0.6	0.3	0.2	8.2	0.3	0.8	11.0	0.0	2.7	0.3	5.5	9.3	11.6	3.2	0.0	12.0	4.6	1.2	0.4	60.1	0.6	0.0	36.6	3.5	5.9	0.2	196.5	130.9	191.1	93.0	4.2	6.5	73.4	91.7	49.5	186.2	170.6	171.5	57.4	193.3	46.2	37.0	77.0	139.8	140.1	62.6	153.7	84.9	231.3	115.7	78.3	146.1	0.7	62.2	109.2	3.5	2.9	109.4	67.7	18.5	86.5	123.6	73.3	73.4	82.9	92.9	225.1	87.4	119.6	63.9	57.6	149.8	176.1	80.5	41.2	38.2	41.2	59.1	81.7	36.5	61.2	56.5	63.5	41.4	33.9	74.3	75.6	67.6	243.3	53.2	37.7	147.9	35.7	92.9	153.4	0.0	0.4	0.6	0.5	0.3	0.1	1.1	1.3	2.1	0.5	2.5	0.1	0.7	0.9	0.3	0.2	0.2	7.9	0.9	0.1	0.2	0.2	0.2	0.1	0.2	0.1	0.3	0.3	0.0	0.4	0.2	0.3	0.0	0.5	0.0	7.6	4.5	1.8	6.1	0.6	0.0	1.8	2.2	1.4	0.0	2.6	0.0	0.0	40.5	1.8	13.2	0.0	0.4	0.1	0.5	1.6	3.1	0.0	59.3	0.0	0.0	89.1	5.7	6.1	2.1	4.5	24.7	6.1	0.7	29.4	0.0	0.0	10.8	0.0	5.7	7.3	0.2	0.6	5.1	1.8	0.0	0.9	0.0	3.1	0.0	0.1	0.3	2.8	0.0	15.4	1.2	1.5	0.1	0.2	0.0	0.0	0.1	4.8	1.6	7.2	11.8	2.4	9.0	4.3	1.0	22.0	2.8
AXIN1	PPP1R49	ENSG00000103126	"Axin 1"	O15169	16	287440-352723	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB012987	Approved		Supported	Nucleoli,Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoli, Vesicles"		"CAB012987: AB_2533178"	"unprognostic (3.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (3.38e-5)"	"unprognostic (1.23e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.03e-1)"	11.9	9.3	10.5	9.2	10.8	23.0	11.5	14.8	12.5	12.9	9.1	17.1	12.3	13.2	3.1	16.3	11.8	6.2	11.6	10.0	9.2	11.6	11.2	13.7	10.5	10.2	10.2	13.8	13.0	7.2	12.6	5.8	9.8	12.9	6.9	2.6	11.5	6.0	21.1	20.1	15.0	5.4	9.2	15.0	12.9	11.8	10.1	12.5	11.9	7.0	6.6	14.5	13.1	11.9	18.1	25.6	13.4	23.7	9.8	9.0	28.0	11.9	10.8	16.1	13.8	37.9	20.4	27.7	18.0	12.3	19.4	25.4	21.1	18.5	7.2	27.5	34.6	18.0	21.9	27.6	16.6	20.9	19.3	9.0	31.7	16.6	20.3	14.1	10.7	19.8	45.6	14.8	7.4	48.1	22.7	14.5	30.6	21.6	15.4	42.4	12.2	38.8	12.2	10.5	30.4	18.6	22.6	24.9	38.3	10.0	16.5	26.1	12.4	15.9	17.0	18.5	17.5	17.3	18.1	34.2	7.5	13.7	15.9	1.2	0.9	5.0	8.3	0.8	7.6	1.5	2.4	5.8	0.7	1.2	2.4	3.4	2.7	3.5	0.6	1.2	2.6	2.3	10.5	10.8	14.8	12.5	10.0	9.2	10.2	10.2	9.8	9.2	10.1	11.9	7.9	3.2	8.6	4.9	5.7	18.4	7.6	8.5	5.7	4.3	11.2	9.5	4.9	5.7	7.2	3.7	0.0	3.5	30.1	27.4	0.0	7.2	1.4	10.2	7.0	6.3	10.8	8.6	18.5	6.9	27.5	6.7	15.3	14.4	10.8	10.5	5.7	5.1	7.5	5.0	12.7	15.1	6.1	6.2	9.0	2.1	5.3	6.7	10.6	1.0	5.7	4.5	28.8	8.5	8.9	11.0	12.2	4.9	7.0	13.4	11.1	2.4	7.7	5.7	13.1	8.7	7.6	5.5	8.8	7.2	15.2	3.7	12.4	5.0	15.7	10.5
BAG4	SODD	ENSG00000156735	"BAG cochaperone 4"	O95429	8	38176533-38213301	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013716, HPA018951"	Approved					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"			"CAB013716: , HPA018951: AB_1845260"	"unprognostic (2.25e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.23e-2)"	"unprognostic (4.44e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.50e-3)"	"unprognostic (4.83e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.70e-2)"	10.3	5.7	10.8	5.9	12.5	28.6	7.8	10.8	17.8	7.3	3.3	5.5	5.8	6.7	6.8	6.7	5.2	5.5	4.9	13.6	9.0	9.6	16.8	5.7	7.3	9.0	7.5	11.0	5.2	8.0	4.6	11.4	9.0	7.5	5.8	9.6	6.7	7.8	14.4	7.3	5.6	6.0	4.8	6.5	5.5	4.3	10.0	7.5	6.8	6.8	7.6	6.3	5.6	9.8	16.3	18.4	14.9	22.7	27.8	18.5	13.8	16.5	20.3	17.6	19.4	19.0	9.5	19.5	18.1	14.2	11.9	16.4	25.0	14.4	24.2	9.0	14.0	32.8	10.6	27.3	14.0	15.3	13.4	15.5	16.1	18.4	17.7	12.1	10.1	14.0	34.8	11.5	14.7	9.7	27.3	18.0	32.5	12.7	8.2	18.9	17.7	8.9	16.1	17.8	11.4	15.6	13.7	8.9	13.5	13.4	10.7	9.0	14.4	16.3	16.9	27.6	11.1	10.4	16.5	22.9	9.7	17.4	17.2	17.1	13.9	15.1	8.2	11.6	9.7	7.5	7.2	7.9	12.5	7.4	9.3	8.6	8.7	5.6	21.3	6.5	8.4	9.4	10.8	12.5	10.8	17.8	13.6	9.0	9.0	7.5	9.0	4.8	10.0	9.8	10.6	12.8	12.4	15.3	14.7	43.1	13.2	12.7	38.1	18.9	13.1	10.8	11.1	12.8	12.1	20.2	27.1	23.5	10.8	10.4	17.6	11.0	4.0	13.5	14.6	10.9	5.4	19.4	30.6	11.6	19.0	16.2	13.7	16.0	7.6	11.4	12.8	25.5	24.5	13.5	27.5	8.9	6.1	26.7	30.8	4.4	15.2	19.4	37.4	13.1	23.9	10.4	9.2	7.5	20.8	9.1	8.3	13.2	20.6	19.2	15.3	21.1	10.9	11.8	6.6	16.1	12.7	13.3	11.5	24.0	33.8	12.2	14.8	15.7	12.0	18.7
BAP1	"hucep-6, KIAA0272, UCHL2"	ENSG00000163930	"BRCA1 associated protein 1"	Q92560	3	52401008-52410008	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 103.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004322, HPA028814, HPA028815, HPA055560"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"CAB004322: AB_626723, HPA028814: AB_10602393, HPA028815: AB_2672785, HPA055560: AB_2682850"	"unprognostic (1.52e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.41e-3)"	"unprognostic (8.53e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.64e-3)"	"unprognostic (3.30e-3)"	"prognostic favorable (3.29e-7)"	"unprognostic (6.37e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.92e-1)"	45.2	63.5	97.6	25.0	99.2	73.9	42.9	78.9	135.5	39.1	71.4	47.7	21.6	40.5	23.1	59.3	36.0	25.7	57.0	114.1	83.3	57.3	65.2	46.0	29.4	81.2	85.7	43.9	52.7	40.2	36.9	24.6	81.7	50.0	24.1	20.1	43.0	22.5	74.7	73.4	43.4	23.8	79.9	54.2	48.1	140.0	89.2	33.1	49.1	43.5	27.9	44.6	41.7	90.5	39.1	43.1	52.2	44.8	50.1	31.4	59.3	37.8	50.1	62.4	48.0	52.5	35.8	55.7	18.3	54.7	69.3	31.4	55.7	63.0	37.9	55.1	51.4	68.6	94.4	53.2	45.7	65.6	58.5	48.0	80.1	68.5	36.1	33.3	50.3	107.7	59.9	48.3	44.5	33.7	79.1	89.5	58.0	31.0	52.8	33.7	41.7	55.8	37.4	61.2	19.8	63.6	46.1	13.7	56.9	29.2	37.7	90.6	52.5	54.1	49.3	66.0	70.9	71.7	101.6	81.2	58.5	68.2	66.1	2.9	3.2	5.4	5.4	2.8	2.6	3.2	4.3	4.4	2.2	4.1	3.1	4.0	7.4	2.2	2.2	5.6	4.2	2.7	97.6	99.2	78.9	135.5	114.1	83.3	81.2	85.7	81.7	79.9	89.2	90.5	13.5	0.0	16.0	8.1	12.2	31.6	10.5	13.2	23.3	16.6	16.4	12.6	23.6	11.5	10.2	25.8	0.0	14.0	17.7	23.2	11.7	13.5	103.4	9.2	12.4	14.7	10.8	8.2	7.5	16.7	15.8	13.6	14.8	13.6	21.0	18.1	14.6	29.2	12.6	10.1	7.7	16.6	6.1	17.4	10.7	48.0	10.2	12.0	12.4	5.6	15.2	16.1	16.5	7.1	6.7	15.8	16.5	11.7	16.2	11.7	13.3	18.5	8.2	12.3	19.7	14.7	14.2	37.8	13.9	23.0	23.4	12.0	12.2	15.9	19.8	9.6
BARD1		ENSG00000138376	"BRCA1 associated RING domain 1"	Q99728	2	214725646-214809683	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 68.6;Basal prostatic cells: 62.2;Suprabasal keratinocytes: 74.4;Urothelial cells: 67.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB034106, HPA035354, HPA044864"	Enhanced		Supported	"Nucleoplasm,Nuclear speckles,Cytoplasmic bodies"		No	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Nuclear speckles"	"Cytoplasmic bodies"	"CAB034106: AB_2061237, HPA035354: AB_2674585, HPA044864: AB_2679119"	"unprognostic (4.85e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.25e-4)"	"unprognostic (1.99e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.94e-8)"	"unprognostic (3.94e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	1.8	0.6	3.0	2.7	4.6	11.4	2.9	2.2	2.7	3.1	0.2	2.9	2.3	3.3	2.6	5.1	1.9	2.0	1.5	2.3	4.1	0.8	1.0	2.5	5.5	3.8	3.2	2.3	1.6	2.3	1.2	2.3	3.9	2.9	3.6	2.0	1.9	3.6	4.2	8.8	2.1	3.9	3.9	2.6	1.9	6.6	4.1	7.0	1.4	2.3	6.6	2.1	3.8	4.2	12.3	8.8	20.2	9.3	2.7	4.0	12.0	17.3	10.6	17.8	21.8	12.0	12.2	12.6	7.6	8.5	9.5	12.7	16.5	10.5	22.7	11.5	6.4	12.5	13.8	8.7	0.9	13.9	12.7	4.7	1.1	15.0	8.1	4.5	6.1	14.7	7.9	36.0	13.7	10.7	27.9	12.5	14.3	7.9	3.7	24.7	19.8	11.2	3.9	14.0	5.8	8.8	15.0	14.7	5.3	10.9	16.3	13.4	4.7	18.0	14.0	11.7	13.6	10.2	12.6	28.0	7.6	11.3	13.4	3.9	2.0	5.8	4.6	4.0	3.2	9.7	5.4	5.5	3.6	8.2	2.4	4.0	0.3	7.3	3.8	6.9	17.1	2.3	3.0	4.6	2.2	2.7	2.3	4.1	3.8	3.2	3.9	3.9	4.1	4.2	12.3	6.4	2.2	14.7	13.0	68.6	62.2	13.0	14.2	3.3	9.9	14.1	17.4	17.2	12.7	9.2	0.0	18.2	11.3	8.2	3.9	8.0	9.2	13.3	11.9	9.6	1.2	34.5	5.5	6.9	16.0	10.0	10.2	18.0	15.2	28.2	10.0	4.2	12.5	1.7	15.4	13.1	8.2	10.1	12.2	5.7	6.2	11.2	3.6	15.9	16.6	4.4	9.2	19.6	31.7	6.5	6.5	10.1	22.0	22.9	3.2	0.7	12.3	6.8	19.7	15.4	16.9	27.6	43.4	28.6	74.4	5.1	13.4	10.5	14.7	67.2
BAZ1A	"ACF1, hACF1, WALp1, WCRF180"	ENSG00000198604	"Bromodomain adjacent to zinc finger domain 1A"	Q9NRL2	14	34752731-34875647	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 74.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 428.6;Early spermatids: 555.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 29.3"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 29.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA002730	Supported					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA002730: AB_1078269"	"unprognostic (1.49e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (4.44e-4)"	"unprognostic (4.11e-2)"	"unprognostic (3.99e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.24e-3)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (1.31e-7)"	"unprognostic (2.44e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.37e-2)"	14.4	6.0	4.7	22.5	5.8	74.6	11.7	4.5	6.4	8.5	5.0	12.5	10.4	7.6	7.3	16.6	8.9	13.5	5.7	4.8	5.6	6.8	11.9	19.3	25.2	6.3	5.6	7.8	7.1	6.2	3.6	12.7	5.9	8.8	12.9	1.7	11.5	5.8	9.7	21.6	12.4	9.0	5.1	20.2	13.1	30.8	6.6	21.7	7.7	6.4	20.7	27.9	11.2	7.0	46.4	24.1	39.7	30.5	16.9	19.6	49.2	36.7	20.0	33.6	33.6	23.9	32.8	92.1	28.0	26.3	18.7	47.0	68.4	23.8	58.2	33.4	29.5	60.0	22.6	66.9	19.9	99.6	69.8	18.2	24.2	36.3	48.1	13.5	49.3	41.2	56.4	23.0	28.5	52.9	95.3	31.3	19.1	36.4	34.1	72.4	40.9	25.7	21.0	44.2	50.4	41.2	49.6	67.4	20.2	13.5	34.5	68.7	44.6	31.0	22.7	33.6	37.2	12.7	13.5	77.1	10.0	45.9	36.0	7.6	5.7	7.7	3.5	6.2	2.5	5.3	3.6	3.9	3.4	4.7	3.6	2.9	29.3	2.7	7.1	4.2	4.2	1.5	4.7	5.8	4.5	6.4	4.8	5.6	6.3	5.6	5.9	5.1	6.6	7.0	68.5	60.9	77.9	24.5	103.5	428.6	237.6	96.9	174.2	2.6	79.7	54.0	14.7	28.6	82.8	16.5	2.1	68.6	135.4	89.2	0.0	86.8	555.2	87.5	72.3	103.8	30.5	85.2	12.2	74.7	118.0	76.1	66.3	112.1	101.6	33.1	27.8	28.6	87.9	0.0	9.4	69.9	77.3	96.7	263.7	373.0	40.4	158.7	72.9	47.8	165.8	2.4	129.8	26.7	35.8	121.7	133.6	13.5	90.5	213.2	51.6	15.3	89.2	2.0	6.6	106.8	76.1	199.9	38.7	141.8	389.6	196.9	152.1	23.8	62.1	372.5
BAZ1B	"WBSCR10, WBSCR9, WSTF"	ENSG00000009954	"Bromodomain adjacent to zinc finger domain 1B"	Q9UIG0	7	73440406-73522293	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation"	"Kinase, Transferase, Tyrosine-protein kinase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037081, CAB037158, HPA058068"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB037081: AB_477637, CAB037158: AB_477636, HPA058068: "	"unprognostic (1.17e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.16e-1)"	22.6	19.4	24.1	22.1	28.3	24.7	16.7	28.6	25.2	22.5	21.5	23.0	16.0	24.4	17.7	18.0	19.3	16.0	19.6	21.9	26.9	16.8	24.1	20.3	27.9	25.1	26.5	30.8	21.0	27.6	19.2	22.7	24.7	22.6	20.5	28.3	17.1	25.4	28.0	14.2	18.2	24.7	23.8	23.4	18.9	17.3	25.5	40.6	23.8	30.7	29.6	21.9	17.5	29.1	75.6	76.1	102.5	115.3	52.0	55.1	34.1	71.7	54.7	67.4	70.5	62.4	55.6	141.6	16.3	64.1	102.6	51.7	126.1	47.7	100.9	80.3	63.8	84.4	89.3	54.3	57.9	128.8	68.5	39.6	45.5	83.2	101.6	50.4	54.5	75.9	149.9	86.4	76.7	71.7	132.8	59.1	66.7	57.6	56.2	133.1	89.9	94.5	38.5	58.2	102.4	87.2	102.1	112.4	59.8	87.1	69.1	63.6	64.4	116.1	66.5	70.6	123.2	49.7	84.7	235.7	65.9	119.1	107.7	4.0	1.5	1.0	3.0	1.1	2.6	1.2	2.3	2.2	1.1	2.5	1.7	1.9	1.1	2.8	0.8	3.1	2.5	0.9	24.1	28.3	28.6	25.2	21.9	26.9	25.1	26.5	24.7	23.8	25.5	29.1	46.3	76.9	129.8	28.7	52.8	29.8	34.5	16.7	38.1	69.9	28.1	24.6	81.7	27.1	59.0	20.2	43.8	57.3	50.4	33.1	7.9	35.5	8.4	47.4	72.2	53.5	34.7	89.8	35.0	23.1	59.6	58.7	34.7	52.6	51.8	59.5	34.6	59.1	33.0	60.6	35.3	34.6	22.4	33.4	24.8	12.5	61.2	38.7	12.4	34.7	47.3	54.4	61.8	28.6	43.9	26.5	13.6	76.3	65.3	40.5	25.2	12.9	49.2	53.8	32.9	67.1	57.5	75.7	127.0	47.0	25.3	34.6	56.5	46.1	43.3	35.2
BBIP1	"bA348N5.3, BBIP10, BBS18, NCRNA00081"	ENSG00000214413	"BBSome interacting protein 1"	A8MTZ0	10	110898730-110919201	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"		"Bardet-Biedl syndrome, Ciliopathy, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 102.8"	"Group enriched"	"Detected in all"	4	"Early spermatids: 597.4;Late spermatids: 501.6;Spermatocytes: 399.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA055206	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA055206: AB_2682737"	"unprognostic (6.05e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.25e-3)"	"unprognostic (3.08e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.65e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.00e-2)"	"unprognostic (6.79e-3)"	"unprognostic (3.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.85e-2)"	17.6	24.9	25.8	16.0	29.9	10.1	15.5	29.8	41.2	18.7	23.7	16.6	10.3	16.6	25.3	10.5	20.0	12.3	20.4	25.3	26.9	29.8	23.5	14.1	16.4	28.8	26.9	19.5	13.8	19.0	25.6	13.8	29.0	19.2	10.7	50.1	10.5	16.2	15.5	7.3	12.4	16.0	27.2	16.7	14.3	102.8	26.6	17.8	21.7	10.1	16.6	16.2	12.9	37.2	22.1	28.9	33.0	34.0	41.4	51.0	9.8	27.2	56.4	30.9	42.7	14.4	26.9	13.3	19.2	44.9	31.4	21.5	23.9	30.1	47.5	26.9	28.6	22.0	28.3	18.9	54.4	18.9	37.0	31.8	27.1	42.4	75.7	68.9	50.3	23.7	16.5	49.8	37.0	13.9	23.8	27.0	14.0	15.3	18.1	10.5	59.7	18.8	48.6	13.9	24.9	39.6	20.7	9.1	45.4	21.1	10.4	16.9	36.5	22.3	27.2	27.3	38.2	27.9	26.0	19.9	63.4	33.5	17.6	25.5	11.2	47.6	9.7	15.0	11.5	8.2	14.5	12.0	9.5	7.2	17.6	14.9	53.6	7.8	13.0	8.4	18.8	7.4	25.8	29.9	29.8	41.2	25.3	26.9	28.8	26.9	29.0	27.2	26.6	37.2	32.3	25.6	10.0	25.8	24.2	11.2	36.2	41.4	17.1	32.3	13.9	16.3	18.5	22.8	24.3	22.0	31.3	19.3	21.4	9.5	105.7	35.8	597.4	60.4	27.1	26.4	16.9	18.3	58.8	34.5	25.6	27.7	14.3	24.4	16.5	21.0	25.4	22.1	20.0	45.4	52.6	18.4	50.8	22.4	15.8	501.6	46.6	22.4	23.2	14.0	27.1	52.4	26.8	27.6	67.5	36.0	12.0	33.8	32.2	21.6	13.5	69.4	75.7	63.8	52.6	46.0	32.7	399.5	36.5	12.5	11.9	12.3	27.2	21.0	10.0	29.7
BCCIP	"BCCIPalpha, TOK-1"	ENSG00000107949	"BRCA2 and CDKN1A interacting protein"	Q9P287	10	125823546-125853695	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038011			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA038011: AB_2675784"	"unprognostic (1.05e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.93e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.90e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.39e-2)"	"unprognostic (9.91e-2)"	40.0	35.1	37.7	38.3	39.1	62.4	52.4	41.1	43.4	31.4	42.3	37.6	32.3	31.0	54.6	38.5	33.0	26.6	48.0	37.5	38.7	55.3	67.9	27.2	49.3	38.3	38.3	42.8	47.1	41.6	24.8	32.5	39.2	42.4	41.1	55.7	58.2	28.6	77.5	31.8	31.7	31.4	38.7	29.8	42.8	48.3	39.0	50.0	39.8	63.6	48.7	55.9	30.1	40.8	225.6	114.4	126.9	141.3	70.9	77.2	105.9	117.9	112.1	142.3	131.2	188.2	146.4	156.6	72.1	108.6	107.1	121.4	219.3	167.0	197.6	145.3	148.5	157.9	97.5	210.0	89.4	219.7	96.1	79.9	98.7	170.1	178.3	108.0	137.7	145.1	177.7	78.1	122.5	134.7	142.7	220.4	98.2	188.0	170.2	134.7	133.5	94.3	126.6	106.0	67.2	68.5	88.1	142.4	149.9	102.7	76.9	96.3	93.0	65.9	116.9	98.2	215.9	79.3	94.9	233.0	129.7	112.5	52.0	30.3	68.3	41.1	56.2	86.6	77.8	76.8	63.7	61.9	75.2	71.4	71.1	64.4	11.2	68.2	94.3	65.0	75.6	48.1	37.7	39.1	41.1	43.4	37.5	38.7	38.3	38.3	39.2	38.7	39.0	40.8	21.6	64.1	67.9	16.6	46.9	66.9	59.3	60.6	58.1	24.2	32.2	27.3	80.4	28.6	67.0	23.9	22.9	41.4	28.2	16.7	78.2	52.7	14.7	37.6	36.6	30.4	25.8	47.3	21.3	44.1	38.0	43.2	40.2	33.2	27.1	33.6	23.2	50.4	35.8	16.8	21.0	23.1	42.7	28.9	22.2	9.4	37.0	29.3	23.2	11.2	36.2	30.2	28.8	22.1	25.7	45.1	19.6	31.2	57.7	51.9	22.7	62.4	74.7	25.1	26.3	47.5	37.5	105.3	117.2	57.8	52.1	33.8	38.6	28.3	33.3	55.5
BCL2L12		ENSG00000126453	"BCL2 like 12"	Q9HB09	19	49665142-49673916	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 126.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020856	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Vesicles	"Plasma membrane"	"HPA020856: AB_1845320"	"unprognostic (2.59e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.72e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.68e-2)"	"unprognostic (6.80e-3)"	"unprognostic (3.87e-3)"	"unprognostic (6.12e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (8.75e-5)"	"unprognostic (8.67e-2)"	"unprognostic (3.62e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.56e-1)"	8.5	8.5	3.8	14.7	3.9	18.2	9.5	3.9	5.1	8.3	5.0	11.9	10.5	9.9	3.2	13.4	9.5	6.5	9.4	3.6	3.8	7.8	16.6	9.6	20.6	4.4	4.2	9.7	15.5	4.5	2.7	10.3	4.1	11.3	7.3	1.7	11.7	5.0	14.0	8.5	11.9	6.8	4.1	16.7	11.7	10.1	4.1	17.3	7.6	13.5	15.8	9.6	8.7	4.3	105.2	63.7	49.8	94.8	12.6	12.6	56.9	58.2	23.3	57.2	60.6	89.2	55.4	58.4	26.7	20.2	32.4	49.7	46.3	39.4	30.7	74.1	97.4	53.1	43.5	62.0	11.4	56.6	62.2	15.5	19.0	64.3	18.2	11.5	38.7	79.2	138.8	73.3	30.8	59.1	67.6	91.8	62.4	61.8	77.4	86.6	54.3	62.7	24.8	52.0	0.9	29.4	59.5	79.0	41.8	35.6	33.0	70.3	22.8	64.1	75.2	45.5	96.4	61.2	102.4	114.3	27.2	78.0	64.3	11.0	7.4	17.0	12.5	12.2	14.6	14.8	13.2	12.3	6.5	14.6	12.8	13.1	10.9	15.8	8.6	25.9	14.4	6.3	3.8	3.9	3.9	5.1	3.6	3.8	4.4	4.2	4.1	4.1	4.1	4.3	10.2	9.6	13.1	3.3	22.1	32.2	37.4	23.3	14.2	1.0	35.2	34.2	5.0	10.0	16.5	5.5	0.0	70.3	18.2	14.6	7.9	25.7	8.3	17.0	11.5	13.2	6.7	18.5	0.2	25.8	126.3	16.2	9.2	20.1	9.5	18.9	11.0	13.1	37.6	0.0	0.2	15.7	18.3	12.6	16.1	6.4	6.5	15.5	26.6	1.0	22.1	3.5	24.7	0.0	1.6	34.5	16.6	6.0	44.3	20.5	6.5	10.4	12.6	1.2	13.1	14.0	15.1	11.6	22.3	19.7	19.5	55.7	15.7	11.7	23.3	27.7
BCL7B		ENSG00000106635	"BAF chromatin remodeling complex subunit BCL7B"	Q9BQE9	7	73536356-73557690	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Differentiation, Wnt signaling pathway"		"Allergen, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049943, HPA058069"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA049943: AB_2680963, HPA058069: AB_2683594"	"unprognostic (2.79e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.37e-2)"	"unprognostic (9.43e-2)"	"prognostic favorable (4.38e-4)"	"unprognostic (4.09e-1)"	"unprognostic (3.55e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.32e-1)"	35.6	23.8	34.9	18.7	35.0	90.0	18.5	28.1	43.5	16.3	28.3	32.6	21.8	15.5	17.4	27.5	16.6	22.5	49.5	36.5	34.1	21.9	25.1	27.4	24.4	30.6	31.2	9.0	25.6	30.3	20.9	21.7	29.7	17.8	16.4	17.7	16.0	23.5	66.0	11.1	23.6	29.8	28.3	23.0	20.6	20.5	33.4	22.4	22.1	55.8	19.4	33.4	11.4	34.3	67.8	46.9	26.7	47.8	21.5	34.0	27.1	56.1	58.9	58.0	52.9	52.0	73.8	56.7	14.0	58.7	84.7	30.4	19.4	45.7	42.7	73.9	27.5	31.5	28.7	28.0	61.3	54.3	85.3	22.8	45.0	59.5	58.7	23.9	38.4	31.7	50.6	65.0	41.6	79.5	93.0	71.2	46.5	43.0	67.7	49.2	28.6	67.6	46.5	51.8	59.7	57.9	49.6	85.0	62.3	11.3	53.0	73.3	39.6	69.8	44.7	47.9	84.1	37.0	35.9	105.2	68.7	82.8	89.0	13.7	13.3	19.7	11.4	15.8	13.8	11.7	13.1	15.3	13.5	17.6	13.7	11.1	6.5	21.2	20.3	15.9	11.4	8.3	34.9	35.0	28.1	43.5	36.5	34.1	30.6	31.2	29.7	28.3	33.4	34.3	50.4	32.1	20.7	6.8	59.8	64.6	81.9	18.7	39.3	27.5	37.4	32.1	29.5	24.3	17.5	16.5	6.2	72.5	55.9	63.3	54.8	46.7	8.0	35.4	16.8	37.3	34.6	17.9	10.3	45.8	43.6	30.4	21.9	31.6	32.4	21.5	34.2	18.1	51.0	42.1	8.8	40.6	32.6	37.5	46.4	6.7	25.7	48.3	32.0	6.5	41.1	32.4	62.8	6.0	10.0	67.9	58.3	30.5	35.7	61.6	50.4	47.0	15.7	21.8	46.0	52.4	46.7	64.1	71.6	28.7	57.7	101.8	58.3	27.3	37.6	74.1
BCLAF1	"BTF, KIAA0164"	ENSG00000029363	"BCL2 associated transcription factor 1"	Q9NYF8	6	136256627-136289851	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 135.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006484, HPA006669, HPA027770"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA		21000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA006484: AB_2667600, HPA006669: AB_1078302, HPA027770: AB_1845484"	"prognostic unfavorable (1.64e-4)"	"unprognostic (1.60e-1)"	"prognostic favorable (3.44e-4)"	"unprognostic (1.45e-1)"	"unprognostic (9.46e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.13e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.93e-2)"	"unprognostic (4.19e-3)"	24.4	22.3	14.3	26.9	17.3	135.0	32.9	23.6	18.6	21.4	19.7	29.5	18.8	23.2	24.0	24.3	21.3	14.8	16.7	15.9	19.2	21.5	27.4	24.6	28.2	11.1	12.9	24.4	25.5	33.4	18.0	21.3	12.0	21.2	28.4	34.8	21.2	20.5	27.5	21.8	21.1	28.3	14.7	24.8	27.9	21.3	16.7	35.2	30.4	24.3	32.9	23.0	19.3	19.3	82.4	70.0	162.5	136.2	50.4	42.6	82.3	153.0	94.4	100.6	106.5	100.4	54.4	172.7	92.8	117.9	112.8	78.0	183.5	101.1	125.5	95.1	114.2	213.7	96.0	110.3	58.6	362.6	131.0	58.3	49.2	142.8	88.6	37.2	90.9	77.6	193.6	82.3	107.0	97.4	145.3	40.2	120.2	55.2	72.0	130.3	203.2	76.4	76.3	155.0	137.2	94.5	150.0	71.3	60.4	60.6	66.9	71.5	125.7	79.2	116.7	95.9	151.2	69.5	134.8	227.9	47.2	113.3	94.2	32.6	27.1	42.1	32.4	33.2	32.7	36.6	29.9	28.1	42.3	32.9	37.7	34.5	57.9	49.5	35.3	24.7	25.5	24.5	14.3	17.3	23.6	18.6	15.9	19.2	11.1	12.9	12.0	14.7	16.7	19.3	165.3	205.1	178.7	68.9	174.3	68.2	118.9	99.5	104.2	129.7	86.9	71.5	88.4	65.8	131.6	57.0	210.6	111.9	173.3	86.3	33.2	96.8	12.6	157.2	173.5	117.5	118.9	134.6	80.5	65.2	99.4	138.0	128.0	169.8	156.4	130.5	74.3	60.0	74.0	102.6	82.6	106.0	93.6	92.5	88.9	13.8	122.1	121.8	69.4	56.2	136.9	91.6	118.4	63.3	93.4	77.5	81.4	109.4	197.8	128.6	83.3	42.9	147.1	139.9	111.7	259.8	130.7	102.2	129.7	121.4	71.2	128.3	174.8	154.8	101.6	123.8
BIRC5	"API4, EPR-1, survivin"	ENSG00000089685	"Baculoviral IAP repeat containing 5"	O15392	17	78214186-78225636	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation"	"Protease inhibitor, Repressor, Thiol protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.9;lymphoid tissue: 41.0;testis: 19.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 74.7;Early spermatids: 94.1;Erythroid cells: 166.7;Extravillous trophoblasts: 162.0;Spermatocytes: 191.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"T-reg: 14.1"	"Lineage enriched"	"Detected in many"	6	"T-cells: 14.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002830, CAB004270"	Enhanced		Supported	"Cytokinetic bridge"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Cytokinetic bridge"		"CAB004270: AB_628302, HPA002830: AB_1857672"	"unprognostic (8.04e-2)"	"unprognostic (3.51e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.37e-1)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (5.28e-6)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (3.56e-3)"	"unprognostic (4.53e-3)"	"unprognostic (2.87e-3)"	"unprognostic (6.67e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.77e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.16e-1)"	0.9	1.1	0.3	8.5	0.5	37.9	5.1	0.6	0.6	1.9	0.4	6.7	7.9	1.6	0.0	12.8	0.6	1.1	0.5	0.4	0.4	0.7	2.1	1.9	16.2	0.6	0.6	0.4	0.6	0.2	0.2	6.1	0.5	0.6	8.0	0.1	1.8	0.2	1.1	5.8	7.6	4.3	0.4	5.8	3.7	19.6	1.0	41.0	0.4	0.1	16.3	2.6	3.2	0.8	139.1	126.2	111.3	121.5	6.7	11.3	41.0	103.6	57.5	144.0	94.2	104.0	52.9	140.7	41.5	60.5	108.7	71.9	113.6	66.6	125.2	48.2	157.5	93.2	71.4	123.1	0.8	90.8	67.0	3.9	4.5	79.8	59.2	21.0	103.5	104.3	118.8	116.0	112.6	79.7	195.5	86.2	83.4	96.3	218.0	100.5	180.2	108.4	34.5	50.2	136.8	94.8	80.3	88.6	71.7	54.1	117.5	84.8	39.5	173.1	152.6	76.0	150.4	83.3	72.2	163.3	63.3	37.8	154.4	0.0	0.0	0.0	0.7	0.0	0.1	2.4	4.1	2.8	0.8	0.2	0.0	0.4	0.5	2.4	0.0	0.2	14.1	3.1	0.3	0.5	0.6	0.6	0.4	0.4	0.6	0.6	0.5	0.4	1.0	0.8	1.2	0.0	20.0	0.0	15.9	8.2	3.7	12.2	2.8	0.7	7.7	8.6	2.3	2.8	10.8	0.0	0.0	74.7	3.3	10.7	0.0	2.0	94.1	5.4	5.1	8.8	3.0	166.7	0.4	0.0	162.0	15.1	8.6	6.9	9.5	42.7	12.8	2.7	52.1	0.0	0.2	17.1	10.2	13.7	13.8	68.4	3.1	9.6	1.8	0.0	0.6	0.4	7.2	0.0	0.3	0.4	2.5	0.7	50.2	2.8	3.2	0.1	2.6	0.5	6.6	0.9	15.2	191.1	58.2	31.3	6.5	19.2	10.1	3.4	38.8	6.3
BIRC6	BRUCE	ENSG00000115760	"Baculoviral IAP repeat containing 6"	Q9NR09	2	32357028-32618899	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 272.0;Inhibitory neurons: 291.3;Oligodendrocytes: 361.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 9.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 9.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA074409, HPA074738"	Approved		Supported	"Golgi apparatus,Vesicles,Mitotic spindle"		Yes	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus, Vesicles"	"Mitotic spindle"	"HPA074409: , HPA074738: AB_2686710"	"unprognostic (3.38e-2)"	"unprognostic (8.13e-3)"	"unprognostic (8.88e-2)"	"unprognostic (7.06e-3)"	"unprognostic (6.69e-3)"	"unprognostic (9.01e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.49e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.61e-1)"	"unprognostic (7.32e-2)"	"unprognostic (3.37e-1)"	4.6	4.7	3.1	6.7	9.7	11.3	8.9	13.9	5.7	7.7	6.3	7.6	5.0	6.8	5.2	5.3	6.2	5.8	4.9	4.6	3.7	7.6	8.9	5.4	9.6	6.4	5.5	12.0	14.7	10.9	2.9	6.9	7.3	6.2	7.5	15.5	5.5	5.9	6.1	6.7	5.4	6.1	4.4	8.5	7.1	6.8	5.6	14.7	11.4	8.8	9.7	7.2	3.1	16.3	21.7	17.8	16.1	7.9	14.9	19.1	11.3	10.8	14.1	11.0	11.3	14.2	5.7	23.6	7.3	19.7	13.2	10.1	22.9	15.1	13.9	18.8	10.5	31.2	11.3	10.7	7.9	32.4	11.9	12.4	6.9	18.0	16.2	10.1	17.7	5.4	25.6	10.0	11.9	9.3	15.5	7.5	11.7	9.2	10.5	14.6	26.6	8.2	9.2	23.4	11.7	18.4	18.6	10.8	8.2	12.5	6.4	11.5	28.7	13.0	13.3	9.1	15.3	13.9	20.0	30.6	10.1	15.1	8.7	9.7	0.9	0.6	1.3	0.7	1.8	0.8	1.0	1.2	0.7	1.8	1.1	1.4	1.5	1.6	1.5	1.6	1.0	0.5	3.1	9.7	13.9	5.7	4.6	3.7	6.4	5.5	7.3	4.4	5.6	16.3	53.9	32.1	30.5	239.3	74.8	46.0	28.6	34.7	41.5	60.8	40.0	23.4	45.8	38.6	42.7	36.8	191.8	35.0	93.4	70.1	1.9	26.9	45.9	39.3	58.0	49.8	32.5	34.3	272.0	31.2	22.0	39.7	68.3	63.1	29.9	52.1	45.7	47.5	29.8	69.0	291.3	43.3	26.4	54.7	60.0	17.6	45.4	59.1	23.2	202.4	67.2	34.9	64.9	231.8	361.3	34.3	30.3	59.0	70.9	46.4	48.5	22.6	30.6	88.2	39.5	56.0	49.1	53.7	46.2	49.7	54.8	38.0	72.4	52.8	45.3	44.0
BLM	"BS, RECQ2, RECQL3"	ENSG00000197299	"BLM RecQ like helicase"	P54132	15	90717346-90816166	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.7;lymphoid tissue: 7.9;salivary gland: 7.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 18.3;Oligodendrocyte precursor cells: 58.3;Plasma cells: 20.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005689	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA005689: AB_1845372"	"unprognostic (2.77e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.03e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.75e-2)"	"unprognostic (9.89e-2)"	"unprognostic (6.12e-5)"	"unprognostic (2.82e-2)"	"unprognostic (4.55e-3)"	"unprognostic (5.24e-3)"	"unprognostic (1.80e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.55e-15)"	"unprognostic (6.53e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-2)"	0.3	0.2	0.9	3.6	1.1	5.7	0.5	2.3	0.9	0.1	0.3	1.4	1.0	0.4	0.4	0.6	0.3	0.3	0.3	0.8	1.1	0.1	0.1	0.4	6.4	1.2	1.4	0.1	0.2	0.0	0.6	1.2	1.1	0.1	1.7	2.4	7.8	0.0	0.5	0.4	1.6	0.4	1.0	1.6	1.1	2.2	0.9	7.9	0.3	0.1	6.2	1.0	0.2	1.0	13.0	14.4	20.4	12.6	0.1	0.9	14.6	9.4	3.2	11.1	13.4	11.7	10.1	35.1	5.9	2.6	14.1	20.4	25.7	7.1	15.1	19.1	20.5	36.4	14.8	3.9	0.0	33.7	17.3	0.3	0.1	10.6	4.7	1.3	7.9	16.9	32.7	9.9	11.0	7.4	28.3	14.5	22.2	24.9	4.2	25.4	39.1	14.7	2.3	18.9	14.6	14.7	8.5	11.5	4.8	18.1	7.2	23.4	3.7	8.6	13.6	9.6	21.0	6.4	30.4	39.5	5.6	25.8	15.7	1.7	0.6	2.6	1.6	0.8	2.6	4.6	1.4	2.1	0.7	2.3	1.0	1.1	0.7	3.1	1.0	0.7	3.2	0.9	0.9	1.1	2.3	0.9	0.8	1.1	1.2	1.4	1.1	1.0	0.9	1.0	0.9	3.2	8.9	1.0	12.9	0.3	0.5	0.5	0.6	3.6	1.3	1.0	7.9	0.0	4.2	0.0	2.1	5.5	6.9	2.2	1.9	1.0	2.7	1.3	1.3	2.0	0.0	18.3	0.7	0.7	6.8	1.8	3.6	1.7	13.3	8.1	2.2	0.6	5.7	0.0	8.6	1.3	0.0	7.7	1.3	1.6	0.0	7.7	0.0	7.5	2.7	1.7	10.3	58.3	2.6	1.2	0.3	0.4	20.6	0.7	0.2	0.0	5.4	7.1	0.0	0.9	1.7	17.1	12.9	2.2	0.6	1.0	10.2	0.7	4.0	0.4
BLMH	BH	ENSG00000108578	"Bleomycin hydrolase"	Q13867	17	30248203-30292056	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 130.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039548, HPA064307"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No		42000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA039548: AB_10805479, HPA064307: AB_2685241"	"unprognostic (6.85e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.54e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.05e-3)"	"unprognostic (6.69e-3)"	"unprognostic (1.95e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.44e-1)"	20.6	13.5	13.4	18.2	15.0	18.1	20.4	15.9	17.6	19.1	14.5	18.8	12.4	21.2	21.1	28.3	14.7	18.4	15.6	13.5	15.2	22.0	14.0	16.0	26.0	15.6	14.1	13.9	26.8	21.7	9.7	27.4	15.4	14.4	15.4	14.7	15.6	14.4	28.8	130.3	18.3	22.4	14.7	20.6	16.2	15.9	14.2	36.3	16.5	19.0	26.9	17.9	21.5	16.2	40.3	62.9	61.5	41.6	40.6	43.8	27.8	36.5	24.0	59.1	50.8	93.2	11.9	119.5	63.3	31.1	26.1	27.1	135.5	52.8	50.1	31.5	101.4	73.5	54.6	80.0	58.3	136.1	43.2	50.5	3.5	46.5	26.5	47.1	87.2	98.2	157.9	47.6	24.6	31.0	168.1	98.6	57.2	0.0	29.2	143.0	154.5	78.9	46.8	35.6	135.1	48.4	32.6	63.2	42.2	106.6	42.9	68.5	54.5	35.0	69.2	16.0	66.0	55.8	124.1	159.3	26.7	0.2	47.6	0.0	8.8	1.5	15.3	6.2	25.3	6.5	18.2	20.2	10.1	7.3	16.4	17.8	1.2	16.3	3.3	10.1	20.0	9.9	13.4	15.0	15.9	17.6	13.5	15.2	15.6	14.1	15.4	14.7	14.2	16.2	21.0	3.2	12.6	13.4	8.8	15.9	16.7	10.6	19.4	20.2	10.3	6.6	17.8	12.8	4.0	11.0	12.5	49.6	15.6	7.6	7.9	17.4	8.4	7.4	28.2	24.0	18.0	22.5	19.0	14.2	38.0	18.3	11.2	7.0	43.8	30.5	25.7	6.9	25.0	13.5	20.9	8.4	6.1	18.9	7.1	6.6	16.1	13.0	10.6	18.7	12.2	9.9	22.6	29.1	22.6	7.2	9.6	24.8	20.0	13.0	11.5	20.0	5.5	15.7	6.6	12.9	19.7	14.9	29.1	24.0	12.6	27.5	20.9	34.8	11.5	7.6
BLOC1S5	"dJ303A1.3, MU, MUTED"	ENSG00000188428	"Biogenesis of lysosomal organelles complex 1 subunit 5"	Q8TDH9	6	8013567-8064396	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 41.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB025613, HPA077525"	Uncertain		Supported	Vesicles		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"CAB025613: , HPA077525: AB_2686843"	"unprognostic (1.54e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (8.12e-4)"	"unprognostic (4.24e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.16e-2)"	"unprognostic (7.60e-3)"	6.8	7.0	3.6	6.3	4.2	3.9	10.5	3.9	4.7	8.1	3.0	6.4	4.2	7.0	6.9	6.6	6.4	6.1	6.0	3.3	4.7	15.7	11.4	5.9	9.9	4.4	4.2	9.9	4.7	9.6	3.1	6.8	4.5	6.5	5.8	5.2	4.7	9.2	6.5	6.4	5.0	6.6	4.0	7.4	6.0	3.7	3.9	15.6	10.1	8.6	10.6	6.2	5.3	4.6	6.1	7.0	14.7	18.9	15.7	18.8	9.6	6.7	9.4	9.5	9.4	13.6	5.8	21.8	43.9	8.6	10.8	5.4	10.8	5.4	13.6	20.6	11.5	13.1	4.8	25.8	13.4	23.2	14.8	8.4	13.4	9.6	14.4	14.5	17.3	17.3	27.7	3.9	13.6	6.7	26.6	15.1	7.9	14.3	9.4	21.5	17.0	33.8	17.6	5.4	13.5	7.2	6.8	10.3	21.3	26.4	12.9	11.8	7.2	15.1	10.7	8.9	5.9	16.5	37.3	19.7	6.2	17.9	15.9	16.2	9.4	18.3	11.8	12.3	15.7	18.9	15.3	15.2	16.6	17.7	15.2	15.9	2.3	19.6	6.7	7.2	15.2	11.8	3.6	4.2	3.9	4.7	3.3	4.7	4.4	4.2	4.5	4.0	3.9	4.6	18.1	12.8	6.9	0.0	14.6	6.0	8.3	6.8	8.6	7.0	7.1	9.9	7.3	0.0	7.9	25.8	2.1	12.5	15.6	5.9	35.2	9.9	7.5	11.5	12.4	10.7	1.8	7.2	0.0	8.7	9.2	10.6	7.7	19.5	16.5	14.5	0.0	0.0	7.8	6.7	0.0	6.9	2.0	0.0	6.1	7.8	9.6	11.0	3.6	0.0	10.7	13.2	12.3	0.0	0.0	10.1	3.9	12.4	7.3	8.4	6.7	41.8	7.7	8.4	0.0	12.4	9.3	5.8	14.4	8.9	7.5	8.2	12.7	22.5	6.6	7.5
BLZF1	JEM-1	ENSG00000117475	"Basic leucine zipper nuclear factor 1"	Q9H2G9	1	169367970-169396540	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 131.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 85.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025703, HPA027331, HPA067113"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA025703: AB_1845379, HPA027331: AB_1845380, HPA067113: AB_2685781"	"unprognostic (5.25e-2)"	"unprognostic (9.03e-2)"	"unprognostic (9.31e-3)"	"unprognostic (1.48e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.34e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.81e-3)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (3.28e-1)"	"unprognostic (3.06e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.18e-1)"	14.9	13.1	8.2	12.5	10.3	25.6	19.4	11.3	10.3	14.6	9.4	13.9	12.3	15.6	14.3	32.4	11.3	16.3	16.0	8.9	9.0	17.0	14.9	13.0	11.8	9.9	9.4	14.5	9.5	15.1	8.7	18.2	9.7	15.6	15.6	22.8	12.7	16.0	11.3	18.0	12.7	17.9	9.7	12.5	13.1	35.0	9.3	13.7	18.7	11.0	16.2	16.6	14.7	14.3	52.8	16.6	16.5	13.6	24.9	37.6	26.2	46.6	32.0	48.1	52.5	19.5	33.3	7.5	26.8	31.6	30.7	38.6	16.6	30.3	37.4	16.8	16.1	13.7	20.0	13.6	26.4	27.2	18.9	27.6	36.9	35.8	31.7	27.3	25.1	14.9	25.6	20.0	46.0	10.8	12.1	12.7	19.9	38.2	25.2	6.8	26.0	16.6	48.1	17.5	9.3	30.6	30.3	41.3	36.9	28.3	44.8	20.4	30.5	28.9	22.5	26.7	39.6	20.4	26.1	19.5	22.1	11.7	44.6	85.6	12.2	51.5	12.2	16.2	16.0	11.3	15.0	14.1	10.8	10.4	13.2	14.4	25.1	19.8	15.8	8.2	23.9	10.9	8.2	10.3	11.3	10.3	8.9	9.0	9.9	9.4	9.7	9.7	9.3	14.3	14.7	22.4	16.4	34.9	11.7	18.4	46.7	22.6	16.5	14.3	18.0	12.1	29.6	11.5	24.4	11.0	14.6	18.3	15.2	18.2	23.5	24.2	131.4	28.0	18.6	11.9	12.6	16.0	30.2	13.2	17.3	18.7	22.4	28.5	26.0	12.3	12.5	4.8	14.3	33.7	32.8	11.7	14.2	10.7	6.8	72.8	14.6	11.6	14.2	17.8	10.3	21.2	17.5	30.2	57.8	36.7	11.6	17.7	13.9	17.0	15.4	22.4	31.6	27.9	0.0	23.0	21.7	84.9	25.8	16.7	15.6	20.1	18.8	17.1	11.6	65.3
BMS1	"BMS1L, KIAA0187"	ENSG00000165733	"BMS1 ribosome biogenesis factor"	Q14692	10	42782795-42834937	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis"		"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036589, HPA043081"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli, Mitotic chromosome"		"HPA036589: AB_10601460, HPA043081: AB_2678305"	"unprognostic (1.46e-2)"	"unprognostic (4.31e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.25e-3)"	"prognostic unfavorable (1.06e-6)"	"unprognostic (1.47e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.16e-3)"	"unprognostic (7.03e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.43e-1)"	"unprognostic (4.82e-2)"	8.1	8.3	6.5	8.9	7.2	10.7	8.5	8.6	8.2	8.2	8.5	7.7	6.3	8.2	6.8	9.6	7.3	5.1	9.0	6.1	7.8	8.1	8.1	7.6	10.0	7.4	7.8	8.4	8.8	11.4	7.6	8.2	7.7	7.3	7.9	6.5	8.8	6.9	17.7	10.2	7.8	7.7	6.5	8.7	7.4	8.1	7.0	9.6	7.2	13.4	10.8	10.1	8.3	7.2	32.0	26.7	25.3	29.0	18.8	15.5	24.5	26.1	27.5	30.3	25.9	37.1	24.4	16.9	18.1	22.7	17.0	27.3	42.0	33.8	39.4	24.7	29.3	22.7	20.7	31.9	16.2	61.7	20.4	13.9	16.9	32.7	31.5	16.9	23.2	19.4	40.4	17.7	21.8	27.1	34.6	20.3	32.3	22.0	28.0	31.3	26.7	18.1	16.8	27.7	19.3	20.4	22.9	25.1	21.7	26.2	30.6	17.6	28.3	14.0	50.7	28.4	43.2	14.1	18.7	48.5	20.5	44.9	11.0	3.8	4.6	2.7	7.2	8.2	8.5	8.7	8.9	7.9	7.5	6.1	9.6	8.3	0.6	6.1	7.1	3.9	6.9	5.3	6.5	7.2	8.6	8.2	6.1	7.8	7.4	7.8	7.7	6.5	7.0	7.2	25.6	32.1	33.1	19.6	29.7	22.9	33.9	28.4	14.2	20.7	18.8	17.1	48.0	20.0	37.4	23.9	10.4	27.7	23.6	10.2	21.5	32.3	14.6	28.8	34.5	31.3	16.8	19.5	31.4	34.9	30.0	26.4	16.3	30.0	22.1	36.8	21.4	18.6	19.7	21.9	28.8	11.5	22.4	15.3	22.6	12.1	23.6	19.9	33.8	10.3	35.2	12.8	24.7	20.1	24.0	38.2	8.9	16.6	31.3	32.2	8.8	30.1	49.5	28.7	19.7	35.3	31.4	40.3	56.1	17.1	25.4	24.9	25.3	33.5	18.7	41.4
BOLA3		ENSG00000163170	"BolA family member 3"	Q53S33	2	74135400-74147912	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 173.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 313.2;Distal tubular cells: 352.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046393, HPA053162"	Uncertain		Supported	"Nuclear bodies,Mitochondria,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear bodies, Mitochondria"	Cytosol	"HPA046393: , HPA053162: AB_2682063"	"unprognostic (1.38e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.23e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.86e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (9.90e-5)"	"unprognostic (1.19e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.40e-1)"	35.6	39.3	52.1	22.6	54.3	40.8	31.4	58.9	66.1	20.2	55.0	46.5	33.8	24.5	25.1	31.7	20.8	11.9	101.0	52.7	56.5	59.8	33.7	23.5	22.2	57.0	53.8	16.6	44.7	56.2	29.6	14.2	56.0	25.4	37.6	35.7	39.7	23.7	117.8	16.6	28.9	22.6	54.7	21.9	41.1	15.8	53.7	24.8	28.8	173.9	21.6	27.1	24.3	55.3	102.8	134.0	44.8	46.2	81.5	78.3	113.9	92.5	54.5	104.0	72.0	176.6	45.4	67.2	79.7	82.4	99.3	53.2	107.9	135.4	95.8	126.5	172.8	85.4	88.3	269.8	76.1	167.3	39.0	62.2	96.6	100.9	124.2	45.9	79.4	144.3	183.2	73.7	116.0	163.6	136.4	123.1	66.9	196.8	198.6	88.5	120.1	132.0	138.8	106.2	70.4	40.7	68.3	106.8	123.3	62.0	62.6	102.8	42.6	83.9	142.9	93.8	185.4	67.5	135.3	92.7	87.6	131.8	73.8	14.7	14.2	3.9	68.3	29.9	75.7	45.4	92.7	72.6	37.8	44.5	79.3	68.7	3.0	51.7	33.5	65.1	91.2	40.6	52.1	54.3	58.9	66.1	52.7	56.5	57.0	53.8	56.0	54.7	53.7	55.3	54.7	9.6	29.8	8.5	33.2	22.7	44.5	111.8	43.3	29.9	82.0	109.5	313.2	44.3	50.1	84.6	16.7	54.9	42.8	125.4	352.1	93.2	20.0	67.0	46.2	45.5	76.1	138.2	14.3	111.4	167.5	48.6	58.1	61.5	25.4	31.9	36.4	113.3	113.9	26.9	15.0	128.3	83.4	32.1	28.9	10.2	32.9	32.2	99.6	3.7	59.4	61.8	62.8	7.5	7.7	95.0	70.9	46.3	76.1	50.9	85.6	266.4	51.2	52.6	19.7	39.6	64.4	66.8	80.5	101.0	16.9	22.3	45.1	83.0	176.2	52.0
BPTF	"FAC1, FALZ, NURF301"	ENSG00000171634	"Bromodomain PHD finger transcription factor"	Q12830	17	67825503-67984378	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029069, HPA048289"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA029069: AB_10602597, HPA048289: AB_2680342"	"unprognostic (1.22e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.07e-2)"	"unprognostic (9.24e-2)"	"prognostic favorable (8.46e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.56e-1)"	25.5	23.7	24.1	25.4	29.5	32.0	25.5	88.1	26.3	30.3	10.9	27.9	15.7	27.9	28.7	26.6	29.6	19.1	20.7	21.0	38.2	27.9	20.7	22.6	43.7	26.4	21.9	38.1	22.9	27.4	34.6	22.2	24.3	25.2	22.2	44.0	25.2	16.7	25.9	37.5	28.5	19.6	17.6	31.4	23.6	32.1	22.6	52.9	27.4	22.3	39.2	24.4	27.7	34.3	42.2	52.8	76.3	38.7	41.6	39.0	42.2	32.0	29.4	37.1	31.8	49.6	29.0	167.7	22.4	35.4	28.5	32.2	74.4	34.5	60.0	24.2	72.5	64.9	50.4	68.8	19.8	97.3	49.9	28.6	37.3	36.9	27.6	34.0	70.2	52.9	75.1	46.1	32.3	64.0	99.1	47.3	58.9	37.9	47.8	70.3	91.0	33.6	32.5	50.6	56.5	65.6	42.8	117.4	46.4	91.4	49.1	53.7	49.6	56.2	43.7	20.7	39.7	39.3	42.0	97.9	26.9	45.1	22.0	20.3	4.2	8.5	7.2	2.4	5.7	6.2	5.9	5.7	3.0	11.8	6.1	6.3	9.2	10.7	5.7	10.9	4.5	1.6	24.1	29.5	88.1	26.3	21.0	38.2	26.4	21.9	24.3	17.6	22.6	34.3	118.7	115.4	148.2	192.3	130.9	75.2	55.3	37.8	87.0	216.8	76.2	78.5	136.0	61.5	92.0	58.8	143.9	39.4	170.3	64.1	7.9	63.8	26.6	147.7	174.5	108.1	126.1	114.6	124.4	63.1	30.8	94.8	88.2	165.9	121.4	124.9	71.0	46.4	42.2	198.5	136.4	68.9	48.8	56.3	54.4	25.7	108.7	84.7	64.0	109.6	88.0	129.3	146.2	231.8	262.7	65.4	64.5	111.3	129.2	62.1	37.7	17.4	80.8	202.6	65.7	167.3	92.3	144.9	101.3	82.6	75.6	38.7	128.8	126.6	85.8	60.7
BRAP	"BRAP2, IMP, RNF52"	ENSG00000089234	"BRCA1 associated protein"	Q7Z569	12	111642146-111685956	"Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 67.2"	"Group enriched"	"Detected in all"	7	"Early spermatids: 319.6;Late spermatids: 380.1;Spermatocytes: 147.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040357, HPA058820"	Approved		Supported	"Nuclear membrane,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	"Nuclear membrane"	"HPA040357: AB_10967924, HPA058820: AB_2683827"	"unprognostic (7.02e-2)"	"unprognostic (2.37e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (7.65e-6)"	"unprognostic (2.14e-1)"	"unprognostic (9.24e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.57e-2)"	"unprognostic (8.08e-2)"	9.6	8.8	7.8	7.9	9.2	33.6	9.2	9.8	9.8	8.0	7.3	9.6	9.2	8.8	6.9	9.5	8.5	7.5	9.7	8.1	8.8	8.5	10.0	8.0	10.5	8.8	9.2	9.8	8.2	10.5	6.2	10.6	8.8	8.3	9.2	9.1	8.4	8.3	19.8	12.8	8.8	9.4	8.5	9.0	7.7	67.2	8.4	12.8	9.9	14.0	10.8	9.2	8.1	10.6	14.6	21.1	16.9	19.5	17.7	14.8	28.2	20.0	16.7	22.8	17.5	28.6	10.0	28.0	11.7	19.1	12.9	17.6	23.8	16.4	24.2	18.0	15.4	34.8	12.9	19.4	22.2	30.7	22.5	16.9	22.8	19.7	31.8	19.6	20.0	19.0	36.7	8.9	19.0	18.6	25.7	29.6	22.8	15.4	22.1	23.6	18.4	25.1	15.0	30.3	20.9	15.5	23.5	19.8	19.5	19.3	21.7	19.3	18.8	14.6	13.5	13.3	14.4	22.6	30.9	30.4	13.8	16.8	16.3	22.7	16.8	32.3	17.5	17.5	17.3	16.1	18.5	17.9	15.1	16.5	17.1	17.6	32.7	23.1	14.6	10.9	24.7	16.1	7.8	9.2	9.8	9.8	8.1	8.8	8.8	9.2	8.8	8.5	8.4	10.6	11.6	22.4	11.2	14.7	14.9	11.2	8.9	9.7	12.0	8.9	8.8	7.5	12.7	17.2	10.8	11.0	29.2	13.7	13.7	15.4	5.9	13.5	319.6	11.9	11.6	11.4	9.6	22.9	24.7	7.7	14.9	12.3	15.3	12.4	8.2	13.3	10.4	9.1	10.9	3.3	23.3	12.9	14.2	9.8	11.5	380.1	13.4	11.7	3.6	10.3	19.7	8.6	17.5	13.0	23.3	14.5	12.7	13.5	15.0	13.4	13.5	14.6	13.8	11.8	6.6	11.6	15.1	147.8	38.6	15.4	12.6	22.4	13.5	10.2	11.0	14.5
BRCA1	"BRCC1, FANCS, PPP1R53, RNF53"	ENSG00000012048	"BRCA1 DNA repair associated"	P38398	17	43044295-43170245	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Transferase"	"Cancer-related genes, Disease variant, Fanconi anemia, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 42.5;Granulosa cells: 38.2;Spermatocytes: 105.8;Spermatogonia: 73.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 6.8;classical monocyte: 14.7;intermediate monocyte: 4.7;myeloid DC: 10.9;neutrophil: 11.3"	"Group enriched"	"Detected in all"	6	"dendritic cells: 10.9;granulocytes: 11.3;monocytes: 14.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB001946, HPA004840, HPA034966, HPA057371"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nuclear bodies"		"CAB001946: , HPA004840: , HPA034966: AB_10795287, HPA057371: AB_2732611"	"unprognostic (7.87e-3)"	"unprognostic (6.97e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.39e-1)"	"unprognostic (5.42e-2)"	"unprognostic (7.07e-3)"	"unprognostic (1.56e-3)"	"unprognostic (4.14e-3)"	"unprognostic (9.62e-3)"	"unprognostic (2.47e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.08e-4)"	"unprognostic (1.08e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.31e-2)"	3.1	1.8	4.2	7.5	7.2	13.0	3.6	4.7	5.2	2.7	2.7	6.8	3.2	3.1	2.2	4.0	3.7	1.9	3.0	3.6	4.1	2.0	5.6	3.2	10.3	5.6	5.0	2.8	2.8	5.9	2.8	3.8	6.0	2.4	7.4	8.2	3.2	1.6	4.2	6.0	5.1	3.9	3.7	3.9	3.6	13.0	5.5	14.5	7.8	3.7	11.2	2.8	2.4	10.8	44.1	69.1	37.8	30.1	6.0	13.4	36.6	50.6	21.5	41.9	39.3	42.3	33.4	100.8	9.1	19.0	49.0	49.5	51.9	28.3	69.5	46.9	38.0	48.1	54.0	37.1	1.3	86.0	39.9	3.8	4.5	63.1	20.0	10.6	22.3	46.6	73.7	42.2	39.7	30.0	72.0	27.8	20.5	29.1	18.7	49.0	79.8	40.8	15.4	42.1	25.8	27.4	38.8	12.5	19.4	25.5	33.9	39.6	13.8	37.2	29.6	49.0	53.2	20.1	51.2	75.5	29.6	49.6	39.4	6.8	14.7	2.2	1.5	4.7	1.5	1.2	1.5	1.2	10.9	2.1	1.3	1.5	11.3	1.5	2.0	1.7	0.5	17.5	4.2	7.2	4.7	5.2	3.6	4.1	5.6	5.0	6.0	3.7	5.5	10.8	5.0	0.0	2.8	9.4	5.8	2.9	4.5	1.9	1.2	10.3	4.4	5.2	10.1	5.7	3.5	1.8	22.9	12.8	8.1	6.2	0.0	3.0	11.9	14.0	6.3	4.7	0.0	42.5	3.0	1.1	18.2	7.4	6.1	4.2	8.2	38.2	5.3	18.3	10.1	11.8	4.4	7.5	0.0	3.9	2.8	8.0	2.5	6.4	0.0	4.7	4.9	2.4	5.2	3.0	18.7	1.7	2.4	1.5	16.6	2.3	1.1	1.0	10.0	22.8	6.6	13.7	5.5	105.8	73.5	8.2	2.3	4.0	4.7	9.7	12.7	3.4
BRD3	"KIAA0043, ORFX, RING3L"	ENSG00000169925	"Bromodomain containing 3"	Q15059	9	134030305-134068535	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Theca cells: 178.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051830	Approved		Approved	"Nuclear bodies"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear bodies"		"HPA051830: AB_2681627"	"unprognostic (3.53e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.98e-1)"	"prognostic favorable (2.71e-7)"	"unprognostic (1.00e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.42e-1)"	10.6	10.3	14.2	7.3	14.7	8.2	10.2	13.0	13.6	12.9	6.4	16.1	7.9	14.6	9.4	8.6	12.5	6.9	9.5	11.6	14.6	7.8	11.0	9.2	7.5	13.9	12.6	11.6	10.7	10.1	9.2	9.0	11.7	11.8	5.6	10.6	9.6	11.6	19.3	12.6	9.6	9.0	10.4	12.4	9.9	13.0	13.5	13.4	11.8	11.5	5.8	11.8	10.3	15.9	8.5	25.3	31.4	24.6	17.1	13.8	28.7	8.4	9.5	9.2	9.3	21.2	13.7	3.2	8.7	7.7	10.4	28.7	29.4	11.7	7.2	20.1	16.5	18.2	29.1	24.1	15.3	24.1	15.7	14.8	14.1	10.6	12.0	14.9	15.2	30.0	16.7	9.3	9.5	28.4	44.9	32.2	42.0	21.9	19.2	32.8	45.3	16.1	13.1	8.9	45.8	42.3	37.7	14.1	10.1	18.7	20.3	39.6	19.5	22.3	12.3	14.6	7.6	5.0	5.6	3.0	11.2	16.4	15.1	6.6	12.9	15.8	11.4	10.1	9.6	6.9	9.1	10.2	12.9	6.7	8.6	9.1	15.0	16.3	8.6	17.1	4.6	9.4	14.2	14.7	13.0	13.6	11.6	14.6	13.9	12.6	11.7	10.4	13.5	15.9	27.6	32.1	21.9	13.1	18.3	32.4	21.2	19.8	42.1	60.9	32.8	24.3	24.3	28.6	25.7	23.9	37.5	26.0	31.8	22.6	19.6	42.7	49.2	22.9	37.9	32.1	54.0	70.1	13.4	24.4	20.5	32.4	21.9	25.3	15.9	53.2	35.7	34.0	18.7	57.2	16.8	26.6	14.2	27.9	22.8	20.7	57.2	33.6	23.2	10.3	33.6	45.6	30.9	12.5	19.3	27.7	21.4	67.4	9.1	51.0	19.2	15.7	20.1	58.0	59.2	55.8	40.0	20.7	53.1	31.9	35.7	32.7	26.4	178.7	30.8	22.3
BRD7	"BP75, CELTIX1"	ENSG00000166164	"Bromodomain containing 7"	Q9NPI1	16	50313487-50368988	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042389, CAB046458, HPA060171"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"CAB046458: AB_2066024, HPA042389: AB_2677974, HPA060171: AB_2684214"	"unprognostic (2.10e-2)"	"unprognostic (9.52e-3)"	"unprognostic (7.06e-2)"	"unprognostic (3.39e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (5.38e-4)"	"unprognostic (2.15e-1)"	"unprognostic (8.97e-2)"	"unprognostic (9.46e-2)"	"prognostic favorable (1.55e-4)"	"unprognostic (1.13e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.59e-2)"	"unprognostic (6.34e-2)"	32.6	34.1	50.8	33.6	55.8	65.9	36.0	53.4	69.4	36.0	49.2	42.8	31.1	36.8	47.0	49.3	34.3	26.7	36.4	49.5	55.3	40.3	30.6	35.3	46.6	55.4	53.4	33.3	47.8	56.0	30.8	43.1	54.8	32.7	38.5	49.6	35.0	33.1	54.4	43.4	35.1	34.5	52.4	37.4	39.5	57.0	53.3	57.2	40.1	44.3	50.0	35.5	35.6	57.6	78.4	67.8	116.4	69.7	48.2	47.7	76.6	62.8	61.7	96.9	43.8	114.3	77.5	116.1	64.2	56.0	60.4	70.7	107.6	63.3	111.1	53.2	89.1	79.0	54.2	159.2	56.7	110.0	83.5	34.9	93.2	49.9	85.5	58.8	65.6	113.0	115.8	36.2	59.9	51.0	125.2	147.0	91.5	82.0	63.5	151.8	109.2	84.8	85.6	54.5	90.0	73.1	76.3	73.2	53.6	99.0	43.9	98.5	66.8	61.3	74.4	51.0	62.0	17.0	7.1	196.9	48.1	78.5	62.2	6.2	5.1	7.6	6.4	4.4	4.9	6.1	6.4	6.0	4.1	6.2	7.1	8.7	2.9	9.8	4.1	8.5	6.9	3.0	50.8	55.8	53.4	69.4	49.5	55.3	55.4	53.4	54.8	52.4	53.3	57.6	73.7	38.5	64.4	16.0	54.6	50.7	41.1	16.9	20.5	89.0	63.4	63.8	35.7	52.9	29.6	49.7	66.7	70.6	124.6	51.1	107.6	22.3	47.4	75.1	62.9	42.0	36.0	76.4	14.6	23.0	49.5	41.3	40.2	89.1	15.2	84.3	38.6	45.8	29.9	90.9	15.8	46.6	20.3	40.3	24.5	22.5	32.6	45.9	26.6	17.8	38.4	81.2	82.4	30.2	32.7	23.9	36.4	28.2	74.2	62.2	32.0	72.3	36.7	120.6	52.6	78.4	46.5	203.6	157.2	44.8	63.2	72.4	55.7	59.3	46.1	66.6
BRF2	"BRFU, FLJ11052, TFIIIB50"	ENSG00000104221	"BRF2 RNA polymerase III transcription initiation factor subunit"	Q9HAW0	8	37843268-37849861	"Predicted intracellular proteins"	"Stress response, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019269, HPA023378"	Supported		Supported	Nucleoli		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoli		"CAB019269: , HPA023378: AB_1845446"	"unprognostic (9.85e-3)"	"unprognostic (2.74e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.35e-2)"	"unprognostic (9.68e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.41e-2)"	12.0	8.0	6.6	4.6	7.2	14.3	11.0	6.6	7.6	15.2	6.4	11.3	4.1	12.6	6.3	8.2	11.9	4.6	10.8	7.8	6.7	9.8	7.9	7.6	6.7	6.9	7.1	12.8	8.4	6.5	9.7	7.6	7.7	13.7	5.3	5.9	7.9	7.0	28.5	11.2	7.7	5.7	6.6	9.8	8.9	7.8	7.1	11.0	7.2	12.8	5.4	14.0	10.7	7.4	13.1	9.9	9.6	12.4	13.0	9.5	11.2	15.1	12.0	20.1	13.7	12.9	9.2	16.0	21.3	9.6	7.6	13.3	12.5	9.5	10.0	10.0	12.5	19.7	8.3	10.6	13.6	7.9	11.3	12.8	12.3	20.1	8.5	9.8	6.6	14.0	24.6	13.9	6.6	7.5	25.2	9.9	16.1	9.6	13.1	14.7	10.4	8.1	7.4	8.7	8.1	9.7	7.1	10.5	18.3	11.6	22.1	15.0	8.8	10.0	13.7	25.5	15.4	16.5	24.8	18.8	14.5	10.3	18.2	13.9	10.1	11.7	13.5	9.5	13.7	14.2	14.3	13.8	7.9	14.9	20.3	16.6	4.2	20.0	8.7	9.5	13.7	11.7	6.6	7.2	6.6	7.6	7.8	6.7	6.9	7.1	7.7	6.6	7.1	7.4	6.9	12.8	4.8	2.0	4.2	4.5	4.2	6.4	0.6	9.8	6.9	7.5	0.3	7.2	4.7	9.2	0.0	22.6	6.2	5.5	7.9	8.7	0.4	14.2	7.9	7.8	6.6	8.6	3.3	11.0	10.4	8.1	5.6	24.7	2.5	8.6	6.8	2.1	11.6	8.4	3.1	8.6	8.2	7.1	5.4	1.4	9.3	3.9	3.6	1.0	7.1	11.4	10.3	2.5	2.3	6.5	2.2	10.5	7.2	4.3	9.3	5.8	7.1	6.9	6.6	5.5	7.5	12.5	12.4	4.6	3.8	14.1	7.5	11.5	7.2	3.0
BRWD1	"C21orf107, DCAF19, FLJ11315, N143, WDR9"	ENSG00000185658	"Bromodomain and WD repeat domain containing 1"	Q9NSI6	21	39184176-39321559	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030943, HPA030944, HPA030945, CAB034184"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"	Cytosol	"CAB034184: AB_2243666, HPA030943: AB_2673666, HPA030944: AB_2673667, HPA030945: AB_10670161"	"unprognostic (6.00e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.39e-3)"	"unprognostic (4.94e-2)"	"unprognostic (5.01e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.82e-3)"	"unprognostic (5.45e-2)"	"unprognostic (2.58e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.56e-2)"	13.6	18.8	35.7	10.2	37.5	18.6	17.5	40.9	37.3	12.9	27.2	12.5	9.7	14.5	22.6	11.9	13.1	11.0	15.5	37.6	32.9	15.7	25.8	13.2	15.7	23.4	27.5	17.7	19.9	13.1	13.3	17.4	24.8	14.3	12.3	38.6	11.7	11.5	21.9	14.6	11.4	11.1	27.2	10.9	12.1	21.0	40.4	14.9	19.7	24.0	15.0	12.5	12.5	34.4	19.3	7.8	18.6	9.5	10.4	17.2	17.9	11.0	12.7	8.5	9.7	7.1	12.5	59.8	11.0	15.0	9.9	9.1	17.5	12.3	12.9	14.8	14.2	40.9	13.6	12.3	13.7	23.4	11.1	11.2	19.0	11.2	29.0	18.1	11.9	38.7	32.4	30.7	11.5	13.4	15.8	26.8	19.5	23.1	10.7	28.5	14.4	19.4	9.5	12.2	13.9	18.0	23.8	25.0	15.7	6.2	20.7	31.8	14.3	10.6	5.2	6.2	8.1	32.7	24.5	30.1	12.5	24.3	8.7	3.5	4.2	9.7	8.0	5.0	6.1	7.3	6.8	8.3	5.8	4.8	8.2	6.8	4.3	8.4	3.1	5.4	8.5	3.4	35.7	37.5	40.9	37.3	37.6	32.9	23.4	27.5	24.8	27.2	40.4	34.4	42.5	48.1	49.9	147.6	46.1	63.2	43.8	26.6	52.9	65.5	43.2	24.9	59.0	34.3	39.2	18.4	116.7	64.6	45.0	40.1	45.0	28.9	53.5	46.0	48.2	41.6	35.4	37.6	213.9	34.5	45.2	43.3	57.6	54.8	32.9	42.7	32.2	41.1	24.8	74.0	190.0	34.7	48.8	36.8	52.2	20.7	43.2	35.0	30.2	127.4	37.5	43.1	51.5	170.9	201.9	37.8	34.1	44.8	63.2	63.0	39.2	33.1	48.3	109.1	26.3	47.8	41.4	86.1	81.9	52.8	70.3	99.9	51.1	51.1	36.6	67.1
BRWD3	"FLJ38568, MRX93"	ENSG00000165288	"Bromodomain and WD repeat domain containing 3"	Q6RI45	X	80669503-80809877	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 69.4"	"Cancer enhanced"	"Detected in all"		"testis cancer: 8.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012802	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA012802: AB_2066662"	"unprognostic (1.13e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.17e-3)"	"unprognostic (7.04e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.18e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.75e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.35e-1)"	3.2	2.2	1.5	4.0	2.2	5.1	3.1	6.0	1.8	3.0	1.2	3.0	3.6	3.0	2.5	4.4	3.2	2.4	1.9	1.6	2.4	2.2	3.1	3.4	4.3	1.6	2.3	4.5	3.1	2.0	3.1	3.6	1.7	2.3	3.2	5.8	3.3	1.9	1.4	6.1	4.1	1.9	1.6	3.9	3.1	3.9	2.4	5.2	3.5	1.7	3.9	2.8	3.5	2.0	4.4	4.6	7.1	4.6	2.8	3.4	5.0	2.5	2.1	3.1	4.2	2.2	5.9	4.7	5.7	2.3	3.8	7.7	10.7	4.2	4.2	4.0	4.5	9.6	7.8	3.3	2.1	5.5	6.2	2.3	2.9	3.5	4.9	4.6	4.8	4.1	7.1	11.5	3.7	0.8	3.3	5.6	10.6	4.8	1.9	2.8	12.2	2.9	3.8	3.7	1.6	4.0	6.1	3.3	2.7	12.9	1.5	5.5	4.4	3.7	4.5	3.4	2.7	5.1	5.7	5.4	3.0	11.0	2.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.0	0.1	0.1	0.1	0.0	1.5	2.2	6.0	1.8	1.6	2.4	1.6	2.3	1.7	1.6	2.4	2.0	16.1	12.8	13.4	48.3	14.5	17.5	8.0	8.6	13.6	27.7	9.7	6.2	8.2	15.7	15.4	5.5	16.7	5.7	13.1	13.8	0.0	6.5	2.8	11.5	15.6	13.3	7.2	12.0	47.0	6.0	7.7	10.5	21.9	16.6	11.4	22.4	8.2	5.6	5.5	62.2	54.2	10.8	2.0	13.2	17.7	3.7	9.9	19.7	1.8	45.9	17.5	8.1	6.2	69.4	53.5	8.8	22.4	10.1	13.5	13.0	17.1	4.0	12.7	20.8	6.6	14.3	11.9	6.7	9.6	16.8	20.9	7.7	15.1	12.7	12.1	19.2
BTBD1		ENSG00000064726	"BTB domain containing 1"	Q9H0C5	15	83016423-83067252	"Predicted intracellular proteins"	"Differentiation, Myogenesis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 325.0;tongue: 230.8"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 84.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024263, HPA067671"	Enhanced		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Cytoplasmic bodies"	"Nucleoplasm, Cytosol"	"HPA024263: , HPA067671: AB_2685882"	"unprognostic (1.63e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (6.21e-7)"	"unprognostic (8.94e-3)"	"unprognostic (8.27e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.89e-2)"	36.8	26.7	39.8	24.9	41.0	36.3	28.8	40.4	48.1	24.8	26.2	33.4	32.5	24.2	25.7	30.4	31.5	28.7	107.2	41.3	43.8	37.8	34.3	23.9	36.7	40.7	41.4	23.6	17.2	46.4	22.1	24.1	38.5	30.1	35.5	28.4	21.0	24.0	325.0	16.5	29.9	26.5	44.4	25.9	23.9	58.4	46.8	35.5	37.1	230.8	34.2	36.2	18.2	46.0	45.8	43.1	37.3	37.0	57.5	98.2	19.5	64.9	88.0	54.8	60.6	27.4	46.4	91.0	78.4	73.2	45.6	56.4	82.7	52.0	64.4	73.4	67.1	77.7	62.6	39.6	67.6	74.2	82.9	80.6	45.8	37.2	55.4	71.0	82.0	35.2	70.2	49.9	117.2	24.1	55.8	38.5	52.2	39.9	47.0	57.1	94.4	45.5	55.0	106.7	64.9	46.6	75.1	61.6	111.2	50.7	46.5	61.6	82.9	61.9	46.1	86.0	91.2	50.6	84.0	88.4	66.7	123.6	43.8	1.3	2.9	5.7	3.1	3.2	2.7	2.7	2.9	4.0	5.2	3.4	3.2	3.2	1.6	2.4	4.2	2.2	3.0	1.3	39.8	41.0	40.4	48.1	41.3	43.8	40.7	41.4	38.5	44.4	46.8	46.0	24.2	16.0	5.8	30.7	22.0	15.2	13.7	9.6	13.6	9.4	11.4	6.9	84.9	8.6	18.1	11.0	6.2	8.4	23.6	20.8	17.6	14.2	35.8	19.9	16.6	16.8	23.3	18.7	36.0	10.5	13.5	15.8	18.8	14.5	17.7	11.0	17.2	11.0	18.0	11.8	38.4	10.8	14.2	23.6	24.6	24.5	8.7	21.2	12.4	37.5	22.8	11.1	9.2	32.2	28.6	15.1	19.8	11.3	22.6	11.8	15.8	15.7	24.7	8.6	6.6	21.0	15.3	46.2	14.9	16.0	12.1	8.1	18.8	22.0	18.4	18.7
BTF3L4	MGC23908	ENSG00000134717	"Basic transcription factor 3 like 4"	Q96K17	1	52056199-52090716	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067026	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		59000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA067026: AB_2685765"	"unprognostic (6.12e-2)"	"unprognostic (6.33e-2)"	"unprognostic (5.09e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (6.73e-8)"	"unprognostic (8.85e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (4.43e-6)"	"unprognostic (1.62e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.56e-2)"	44.6	51.9	28.4	30.3	29.3	61.0	43.6	28.8	36.1	31.4	28.3	25.1	14.5	36.4	30.7	36.0	36.5	23.9	40.1	28.8	33.0	35.0	40.9	26.3	36.6	31.0	31.2	52.9	38.3	42.1	31.0	37.4	31.6	29.2	23.6	31.4	29.9	24.5	70.1	35.9	18.6	34.8	30.3	28.1	27.6	34.0	31.8	49.2	43.1	59.0	40.8	42.3	29.9	39.7	99.8	23.7	113.5	59.6	60.4	76.4	117.3	96.1	96.3	108.0	115.2	43.8	50.8	92.3	93.9	68.3	127.1	56.6	111.1	75.0	137.0	64.4	77.7	105.8	41.0	65.5	163.8	118.2	70.0	79.2	101.0	100.2	140.1	89.1	86.9	75.1	81.5	57.0	98.0	42.1	82.6	69.9	202.7	76.7	51.2	53.6	132.1	109.8	105.3	78.6	89.1	100.6	112.5	102.8	141.7	124.8	92.8	124.8	64.0	60.5	65.4	78.4	114.8	98.9	176.3	89.4	52.2	90.0	77.9	70.3	74.2	70.9	29.7	78.9	40.2	49.9	42.8	31.0	72.9	49.7	49.1	38.2	31.6	49.7	70.9	34.3	62.6	64.3	28.4	29.3	28.8	36.1	28.8	33.0	31.0	31.2	31.6	30.3	31.8	39.7	60.4	35.3	22.3	17.0	76.0	107.7	91.7	153.6	65.4	43.6	81.2	75.6	44.7	52.9	82.2	69.9	33.3	111.1	45.9	18.7	168.3	106.0	115.3	82.9	83.6	55.1	52.2	114.9	30.8	80.1	137.6	77.2	44.4	73.3	22.8	128.2	56.0	81.0	129.3	38.7	32.9	33.8	120.1	127.8	92.9	25.4	72.4	87.4	78.2	27.2	86.5	62.0	49.4	29.7	39.5	72.7	26.3	55.7	58.7	135.9	23.4	162.9	75.7	33.2	59.2	73.7	106.3	97.1	31.1	108.5	160.3	145.8	56.0	114.9	34.8	106.7
BUB1B	"Bub1A, BUBR1, MAD3L, SSK1"	ENSG00000156970	"BUB1 mitotic checkpoint serine/threonine kinase B"	O60566	15	40161023-40221123	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.8;lymphoid tissue: 35.7;testis: 22.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 23.5;Spermatocytes: 79.2;Spermatogonia: 26.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA008419			Supported	Cytosol		Yes	Yes			"Cluster 24: B-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA008419: AB_1078308"	"unprognostic (4.40e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.44e-3)"	"unprognostic (9.66e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (7.43e-6)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (3.69e-3)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (1.76e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.75e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.94e-2)"	0.4	0.5	0.1	6.7	0.1	17.8	1.6	0.3	0.2	1.0	7.7	4.6	4.7	1.2	0.3	5.2	0.6	0.6	0.3	0.3	0.1	0.3	0.4	1.0	12.6	0.0	0.1	0.2	0.2	0.2	0.1	3.4	0.1	0.4	6.0	0.1	0.9	0.2	0.0	3.5	4.1	2.1	0.0	3.1	2.4	22.2	0.2	35.7	0.5	0.0	15.0	1.5	1.7	0.0	66.5	32.8	103.0	41.5	2.5	7.1	33.2	60.9	34.2	64.6	55.7	48.1	25.0	59.7	33.5	22.7	59.0	72.6	98.8	33.2	70.5	51.8	52.1	86.4	83.6	45.5	0.2	79.0	45.7	1.6	2.0	39.2	37.1	12.9	47.7	66.5	76.4	61.7	65.6	22.5	62.5	48.9	70.2	55.6	36.8	66.5	83.7	45.2	19.9	33.1	67.1	40.8	38.0	35.9	13.3	45.1	41.9	40.9	27.6	49.3	51.8	49.2	55.5	32.1	58.2	95.6	26.3	87.8	65.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.2	1.1	0.0	0.1	0.0	0.1	0.0	0.8	0.0	0.1	0.1	0.1	0.3	0.2	0.3	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.1	3.2	1.1	0.3	1.8	0.8	0.3	1.0	1.8	0.7	0.9	2.0	0.8	0.0	1.9	0.0	0.0	5.4	0.6	1.8	0.0	0.4	3.0	0.9	1.4	1.0	0.0	23.5	0.7	0.0	6.7	2.4	5.6	2.1	0.0	12.9	1.1	0.3	5.2	0.0	0.7	2.5	0.0	1.9	1.7	3.3	1.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	1.5	0.4	12.6	0.3	0.3	0.1	0.2	0.2	6.6	0.2	1.7	79.2	26.8	6.9	0.3	0.8	1.8	0.8	5.4	0.6
BUB3	BUB3L	ENSG00000154473	"BUB3 mitotic checkpoint protein"	O43684	10	123154402-123170467	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003601, CAB037075"	Supported		Supported	Nucleoplasm		NA	Yes		39000	"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB037075: AB_1078310, HPA003601: AB_1078309"	"unprognostic (7.82e-2)"	"prognostic favorable (2.04e-4)"	"unprognostic (9.07e-2)"	"unprognostic (1.83e-1)"	"unprognostic (7.93e-2)"	"unprognostic (8.60e-2)"	"prognostic unfavorable (4.45e-5)"	"unprognostic (6.04e-3)"	"unprognostic (9.41e-2)"	"unprognostic (6.30e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (3.81e-7)"	"unprognostic (8.80e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.71e-2)"	36.6	49.8	27.3	63.3	34.5	102.9	41.1	35.0	35.0	36.0	30.7	49.0	42.2	35.7	35.2	56.6	37.6	35.8	28.0	31.9	36.4	32.6	34.9	33.5	99.9	34.1	50.6	42.9	30.1	32.6	36.0	38.2	39.6	30.6	49.1	25.5	39.5	28.8	36.9	44.1	47.7	36.4	35.7	52.9	38.4	58.5	33.0	100.6	37.4	33.5	87.2	49.5	40.4	48.6	309.8	302.5	190.4	211.5	105.4	100.3	166.2	316.2	329.5	340.3	268.8	266.3	203.2	275.9	116.3	145.2	163.6	195.9	285.1	343.0	349.9	228.8	294.2	173.0	355.1	291.8	110.1	338.1	206.8	86.5	132.9	307.9	382.4	182.1	232.7	228.9	216.1	266.7	308.4	264.1	281.8	206.9	117.6	159.0	293.0	378.6	96.2	175.7	156.3	333.1	141.4	143.1	179.2	116.6	151.9	77.5	135.0	173.4	188.5	262.4	163.9	167.6	473.8	143.0	220.6	433.9	143.0	333.2	113.2	200.3	113.2	165.7	246.0	122.2	224.1	216.7	223.0	251.0	119.1	209.7	237.9	249.3	56.1	241.6	112.3	127.6	366.9	294.0	27.3	34.5	35.0	35.0	31.9	36.4	34.1	50.6	39.6	35.7	33.0	48.6	55.8	25.6	36.5	15.3	99.7	130.5	65.5	154.6	73.4	30.8	53.4	48.8	39.2	44.3	66.9	38.6	10.4	108.1	119.0	37.1	70.5	68.8	160.8	26.1	41.4	62.1	40.7	93.6	14.4	58.9	136.5	62.6	34.7	28.1	50.7	56.3	45.0	43.0	80.7	10.1	12.9	57.3	118.0	58.1	68.6	159.3	45.1	53.1	96.0	16.9	140.4	55.7	97.9	21.6	35.9	64.1	40.2	46.3	107.1	64.7	44.5	78.4	51.2	25.1	105.2	42.2	70.6	199.8	145.4	86.3	133.3	65.0	150.3	84.1	67.8	62.9
BX255925.3		ENSG00000284976	"Novel RING finger protein"		9	137217452-137219361	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 10.3;Endometrial ciliated cells: 9.0;Exocrine glandular cells: 24.4;Glandular and luminal cells: 10.1;Pancreatic endocrine cells: 33.7;Theca cells: 17.8"					"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"													NA	NA			"Cluster 52: Eosinophils - Transcription"		"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 1: Pancreatic cells - Digestion"																					3.5	8.2	14.7	5.9	15.9	14.6	3.3	13.9	19.8	3.1	11.9	6.8	13.4	2.8	3.2	14.8	4.3	4.1	3.5	13.7	13.6	2.9	2.1	3.9	7.9	16.8	15.2	1.7	11.7	3.3		2.7	15.5	7.1	3.1	3.3	13.3	4.3	3.5	15.5	11.7	2.2	14.3	6.7	17.5	8.8	15.5	6.6	2.5	1.3	5.8	3.1		18.2	11.8	18.8	10.9	14.2	5.0	4.9	42.7	13.5	7.2	13.7	9.8	17.5	13.2	17.1	9.3	4.8	10.3	41.7	6.9	9.8	2.9	19.0	19.5	10.0	52.0	15.9	8.3	14.7	32.0	6.5	9.0	15.7	4.2	3.7	6.4	16.3	24.9	14.0	4.8	32.9	13.1	42.3	19.0	26.4	64.6	32.8	14.8	20.0	5.9	11.5	14.2	16.2	12.0	14.4	11.0	3.9	37.3	22.8	7.8	21.1	24.0	34.3	16.9	11.2	20.4	14.8	12.0	16.8	16.1	0.0	0.8	1.8	0.7	1.0	1.1	0.6	0.5	0.4	0.5	0.7	0.3	0.3	1.4	0.9	0.5	2.1	0.6	2.4	14.7	15.9	13.9	19.8	13.7	13.6	16.8	15.2	15.5	14.3	15.5	18.2	1.5	6.4	2.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	10.3	8.9	0.0	0.0	0.6	3.7	0.0	0.0	1.6	0.0	5.9	5.8	0.0	9.0	3.0	0.9	0.0	0.0	0.0	24.4	0.0	0.7	0.0	10.1	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	33.7	0.0	0.0	0.0	0.0	0.0	7.7	0.7	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.1	17.8	0.0	0.0
C10orf88	"Em:AC073585.5, FLJ13490, PAAT"	ENSG00000119965	"Chromosome 10 open reading frame 88"	Q9H8K7	10	122930901-122954311	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 146.8;Late spermatids: 45.9;Spermatocytes: 52.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039681, HPA040991"	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA039681: AB_10796333, HPA040991: AB_10794432"	"unprognostic (1.54e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.42e-2)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (2.05e-5)"	"unprognostic (2.65e-2)"	"unprognostic (2.86e-1)"	"unprognostic (7.59e-3)"	"unprognostic (7.40e-3)"	"unprognostic (2.69e-2)"	"unprognostic (4.95e-2)"	"unprognostic (3.74e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.63e-2)"	2.9	4.4	4.2	4.4	4.2	1.5	4.0	4.3	6.4	3.6	3.7	3.1	3.5	3.9	4.3	3.1	2.9	2.9	3.3	4.3	4.7	3.4	3.3	2.9	5.8	4.4	4.4	4.6	2.3	4.2	2.1	4.4	4.5	3.6	3.6	6.6	2.7	2.9	4.3	3.5	3.3	3.2	4.1	3.9	3.0	10.7	4.5	5.1	4.2	4.2	4.8	3.8	1.5	4.6	6.1	6.3	7.9	7.7	5.9	8.4	6.0	9.8	11.9	10.4	12.2	5.1	5.8	6.0	4.1	7.6	9.2	6.6	8.5	4.9	15.3	10.3	7.0	6.6	5.7	5.9	8.8	7.0	10.0	6.6	9.6	9.9	13.5	14.1	10.9	7.9	6.3	6.8	17.7	3.5	7.8	7.8	4.7	5.2	5.4	7.6	9.2	1.8	6.1	3.8	4.4	9.0	5.1	4.9	11.2	8.8	4.1	4.8	8.2	7.6	4.6	7.4	12.2	6.9	6.7	7.8	8.1	9.6	6.3	1.4	1.7	3.3	2.7	0.8	3.2	3.0	3.6	3.6	2.4	3.1	3.5	3.4	0.2	3.9	1.0	2.1	5.3	2.7	4.2	4.2	4.3	6.4	4.3	4.7	4.4	4.4	4.5	4.1	4.5	4.6	4.7	3.2	4.8	9.4	5.8	6.0	2.3	6.9	6.8	9.8	3.4	3.0	4.6	5.7	6.8	0.0	6.2	5.6	7.2	2.8	11.7	5.3	146.8	4.0	7.0	4.6	4.8	6.9	10.9	3.0	5.3	6.0	3.6	6.0	2.5	4.9	2.2	2.4	4.9	6.7	11.9	3.2	6.1	3.3	2.0	45.9	4.1	4.1	3.6	6.5	3.1	6.1	5.2	13.0	16.7	4.5	1.3	5.7	2.4	2.2	2.5	5.5	5.6	9.2	6.6	5.0	5.7	52.2	14.8	5.3	4.1	3.6	5.9	3.2	3.2	1.7
C11orf58	SMAP	ENSG00000110696	"Chromosome 11 open reading frame 58"	O00193	11	16613132-16758340	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036591, HPA076406"	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA		100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Endoplasmic reticulum"	Nucleoplasm	"HPA036591: AB_10669909, HPA076406: AB_2686798"	"unprognostic (8.09e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.88e-1)"	"unprognostic (9.19e-2)"	"prognostic unfavorable (5.84e-5)"	"unprognostic (1.30e-1)"	"unprognostic (7.84e-2)"	"unprognostic (9.45e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.41e-2)"	"unprognostic (7.30e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.50e-1)"	142.2	135.1	52.2	129.5	57.8	128.3	94.5	55.3	79.7	91.5	66.5	101.8	89.9	136.1	73.8	172.3	128.0	115.6	159.9	52.0	62.7	114.9	132.9	102.9	162.9	57.6	56.0	172.0	127.8	115.1	78.7	123.9	61.3	111.7	71.7	94.2	128.6	85.3	212.2	99.8	96.5	113.8	56.8	125.8	111.7	89.6	55.4	138.2	162.1	109.6	127.9	125.1	81.3	69.1	416.1	362.9	390.3	197.0	199.5	162.3	272.8	419.2	213.0	276.2	245.5	348.0	397.7	383.1	315.2	253.7	311.4	242.3	275.0	206.9	232.8	485.8	289.9	342.7	286.8	310.1	243.4	492.8	276.2	182.3	230.6	168.9	336.6	209.7	178.4	232.6	435.2	246.5	191.1	247.8	506.5	211.7	291.1	212.7	197.6	404.3	413.6	196.0	158.6	248.7	269.8	267.4	372.4	273.4	501.4	225.0	244.4	315.7	359.5	336.7	268.2	407.1	388.0	164.0	648.6	525.2	297.2	275.3	326.1	587.6	390.4	552.8	407.8	451.9	482.3	621.9	451.4	435.0	429.7	578.9	506.9	440.6	186.9	433.9	490.1	544.7	522.0	896.2	52.2	57.8	55.3	79.7	52.0	62.7	57.6	56.0	61.3	56.8	55.4	69.1	188.3	246.8	222.5	41.8	219.8	257.1	275.3	379.8	167.9	169.5	170.9	168.4	206.4	178.7	259.1	200.5	150.1	312.2	242.8	65.6	428.4	249.7	65.6	204.2	202.0	217.3	159.2	213.7	72.5	228.1	346.8	258.2	73.4	139.8	237.3	151.3	175.6	163.8	227.0	143.0	68.6	133.2	299.1	164.3	261.0	34.3	205.9	180.1	229.5	45.0	249.9	230.5	248.2	61.3	63.5	232.3	104.3	204.2	183.0	324.1	103.4	364.6	237.0	215.7	157.8	164.9	246.8	331.6	245.7	142.5	276.6	453.5	217.3	188.2	118.7	296.6
C12orf4		ENSG00000047621	"Chromosome 12 open reading frame 4"	Q9NQ89	12	4487735-4538508	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037871	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nuclear bodies"		"HPA037871: AB_10670531"	"unprognostic (5.88e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.07e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.96e-3)"	"unprognostic (8.59e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.92e-1)"	7.5	5.4	6.6	8.9	7.6	9.2	7.3	7.7	9.1	6.6	5.6	7.0	4.3	6.6	5.3	7.1	5.5	6.5	7.4	7.8	6.0	6.0	5.9	6.7	10.1	5.6	6.3	5.3	4.7	6.2	4.7	9.6	6.0	7.4	8.1	10.0	4.9	6.6	10.5	5.9	5.1	9.4	5.9	7.9	5.7	9.2	7.0	9.2	7.9	10.8	10.2	8.6	5.0	7.6	14.6	11.0	13.4	15.9	13.1	19.5	28.4	27.6	11.4	24.9	30.3	19.5	11.8	12.4	5.6	17.9	20.5	10.6	19.0	15.9	33.6	37.1	13.0	21.5	10.3	9.6	19.0	18.7	19.4	17.4	8.8	29.9	33.4	15.6	14.4	15.1	12.8	20.9	23.5	7.0	14.9	7.9	19.8	12.6	10.4	16.0	21.1	7.9	15.3	15.1	5.3	10.4	18.9	13.6	11.9	36.4	5.7	15.9	15.0	21.6	19.9	23.8	29.3	4.8	6.8	30.2	16.0	15.1	20.4	0.0	7.5	2.8	4.2	12.7	4.6	4.7	4.1	4.3	6.6	5.2	4.5	4.0	2.4	4.4	15.1	6.9	6.9	4.3	6.6	7.6	7.7	9.1	7.8	6.0	5.6	6.3	6.0	5.9	7.0	7.6	9.8	16.0	12.0	21.5	9.2	2.9	3.0	5.5	7.4	11.8	5.2	5.3	14.3	2.8	8.9	3.7	29.2	7.4	11.4	5.2	3.9	7.6	40.9	7.3	11.8	8.2	6.0	16.0	43.0	8.2	8.5	8.1	1.5	4.4	1.3	9.7	7.5	5.4	28.2	8.4	32.4	5.3	4.1	13.3	4.7	29.9	8.1	11.4	1.8	30.0	8.5	6.8	8.2	32.6	39.2	8.3	3.2	6.8	15.5	2.2	4.6	5.4	8.6	12.3	6.6	9.7	9.6	22.0	16.2	6.4	3.3	6.2	8.2	8.0	6.0	1.9
C12orf43	"Custos, FLJ12448"	ENSG00000157895	"Chromosome 12 open reading frame 43"	Q96C57	12	121000486-121016502	"Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046148, HPA061739"	Uncertain		Supported	"Nucleoli,Golgi apparatus"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 65: Brain - Ion transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoli	"Golgi apparatus"	"HPA046148: AB_10965169, HPA061739: AB_2684597"	"unprognostic (1.51e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.24e-2)"	"prognostic unfavorable (1.29e-6)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (3.53e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-3)"	"unprognostic (9.70e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.36e-1)"	9.8	8.1	11.7	6.9	11.9	7.4	9.3	8.8	13.6	7.8	7.2	11.2	5.0	9.5	4.4	7.2	9.0	5.1	7.4	12.3	9.5	8.2	10.5	6.7	8.7	10.9	9.6	11.2	7.5	9.0	7.4	7.2	10.8	7.7	5.3	6.0	8.7	6.2	7.2	6.7	6.7	8.4	8.6	7.8	8.2	6.1	9.4	7.2	6.4	5.9	7.4	9.6	7.0	10.4	14.2	31.4	16.2	12.8	14.0	11.0	17.8	17.2	17.5	28.3	17.9	22.8	13.0	26.2	17.2	16.8	15.0	15.7	19.2	26.3	16.8	31.6	21.4	21.1	12.4	17.1	16.7	28.1	16.2	12.9	13.6	26.0	16.4	17.9	16.4	27.0	25.5	6.7	15.1	23.3	30.9	22.0	28.8	11.1	23.2	27.4	19.0	19.8	17.5	20.8	22.0	14.0	23.0	9.9	18.6	13.4	27.0	13.1	15.9	15.6	18.7	12.8	18.4	12.3	19.1	20.5	20.5	16.5	23.6	5.7	15.6	9.0	23.8	21.3	21.8	23.8	23.5	23.2	16.1	19.0	27.5	23.6	2.2	18.4	18.5	13.3	23.8	20.6	11.7	11.9	8.8	13.6	12.3	9.5	10.9	9.6	10.8	8.6	9.4	10.4	16.1	25.6	18.1	3.3	17.3	8.8	16.4	12.2	6.8	19.6	12.4	12.4	7.0	11.5	9.6	18.4	20.9	24.3	13.9	8.6	23.5	16.5	5.9	9.8	17.1	16.0	2.4	10.7	6.8	18.5	22.3	16.3	8.2	10.1	14.5	22.3	12.5	11.7	16.7	16.8	6.4	9.5	10.2	10.4	7.3	13.8	13.7	13.2	14.2	3.7	21.7	18.8	24.7	4.0	4.8	15.6	12.3	12.8	11.3	13.8	5.3	16.7	16.3	15.7	19.7	19.6	16.9	16.3	16.4	12.7	7.7	13.7	17.6	16.0	10.9	14.0
C12orf65	"FLJ38663, SPG55"	ENSG00000130921	"Chromosome 12 open reading frame 65"	Q9H3J6	12	123233385-123258079	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	RNA-binding	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 60.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057595	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		No	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"	Mitochondria	"HPA057595: "	"unprognostic (9.07e-3)"	"unprognostic (1.51e-2)"	"unprognostic (5.30e-2)"	"unprognostic (8.19e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (4.29e-9)"	"unprognostic (9.33e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.50e-2)"	"unprognostic (6.33e-3)"	"unprognostic (1.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.89e-2)"	"unprognostic (3.19e-2)"	"unprognostic (9.83e-3)"	"prognostic favorable (7.82e-5)"	7.3	12.6	16.2	10.2	16.1	9.0	8.0	23.0	19.6	13.0	13.5	10.9	11.4	12.1	13.8	9.5	11.4	8.2	15.0	16.0	13.2	12.6	14.5	8.9	18.2	12.6	12.3	17.2	8.5	10.2	19.7	7.3	14.9	13.7	8.2	15.7	16.2	9.0	13.0	13.8	11.3	7.0	8.8	12.8	10.6	16.7	14.8	60.0	12.3	12.5	13.4	10.3	11.0	18.3	28.4	20.5	20.8	39.1	12.0	11.1	13.7	22.3	16.5	25.1	18.0	21.8	15.8	36.1	20.3	8.4	23.5	20.4	25.7	12.5	25.0	29.2	22.5	44.0	20.7	18.6	26.1	20.4	19.7	14.2	33.2	18.9	35.1	37.0	17.0	53.6	45.6	13.4	16.7	12.3	46.2	39.3	13.7	25.6	31.7	35.7	25.9	33.5	22.8	13.0	40.7	18.2	24.0	8.8	23.4	16.5	18.3	24.7	14.8	23.1	27.3	23.3	24.4	22.7	28.3	32.6	17.1	26.2	28.1	85.3	12.9	50.6	53.9	14.9	67.6	83.9	72.3	71.9	21.7	73.5	96.6	78.2	11.8	63.3	16.3	36.6	73.1	33.5	16.2	16.1	23.0	19.6	16.0	13.2	12.6	12.3	14.9	8.8	14.8	18.3	46.0	41.7	47.7	9.8	54.3	45.4	36.7	29.4	59.2	34.5	23.3	50.0	52.7	14.3	18.0	25.8	14.6	41.1	56.2	16.4	60.7	20.7	22.9	12.2	24.2	27.9	9.6	37.0	13.7	10.8	22.8	41.3	23.0	11.2	15.2	24.1	18.5	33.5	14.3	45.4	15.9	20.7	28.5	9.2	24.2	6.2	37.9	19.7	24.9	7.5	26.3	35.7	44.3	14.6	10.4	13.6	17.4	42.2	42.2	22.8	19.9	39.3	14.8	36.6	13.1	42.7	33.1	115.2	59.7	40.6	36.1	10.8	63.0	43.3	20.8	8.0
C16orf70	"C16orf6, FLJ12076, lin-10, LIN10"	ENSG00000125149	"Chromosome 16 open reading frame 70"	Q9BSU1	16	67109941-67148544	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 57.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 47.9;Oligodendrocytes: 41.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041131, HPA041214"	Approved		Approved	"Nucleoli fibrillar center,Nuclear speckles,Cytosol"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nuclear speckles"	"Nucleoli fibrillar center, Cytosol"	"HPA041131: AB_10795487, HPA041214: AB_10794267"	"unprognostic (1.30e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.81e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.15e-2)"	11.3	10.0	15.6	7.6	16.6	18.1	11.1	15.5	17.4	13.2	10.8	10.2	7.3	11.2	8.9	17.8	10.6	7.5	10.3	18.5	13.6	14.0	57.3	9.8	9.2	15.7	16.1	11.1	8.3	16.1	10.9	11.8	17.0	14.4	10.1	8.1	12.0	8.5	29.7	30.4	10.0	10.8	16.2	14.7	8.6	13.8	15.6	9.2	9.0	15.3	11.7	10.5	14.6	21.4	13.7	19.3	19.0	19.9	23.6	13.9	44.5	15.4	16.6	30.7	33.3	22.1	11.7	13.9	13.3	18.2	16.9	18.0	23.7	14.9	39.7	7.1	19.7	10.6	12.2	47.4	14.5	10.9	58.0	14.1	20.6	30.2	13.9	16.6	17.3	17.5	17.5	5.8	19.4	13.6	21.2	16.6	21.5	18.4	29.4	29.5	32.2	21.9	13.4	8.2	24.5	13.2	46.2	10.7	12.0	18.7	22.0	9.0	13.4	21.5	18.4	15.5	13.5	8.8	17.3	41.3	19.4	10.9	17.5	3.2	17.4	6.1	4.4	12.2	5.9	6.9	6.6	8.1	14.6	4.5	6.8	6.3	6.2	5.9	13.6	4.8	7.2	8.9	15.6	16.6	15.5	17.4	18.5	13.6	15.7	16.1	17.0	16.2	15.6	21.4	5.1	6.4	5.9	11.1	6.6	9.1	2.5	5.1	19.4	7.4	8.7	6.7	1.3	1.5	3.2	0.0	0.0	8.8	5.0	4.9	5.9	4.4	1.6	12.9	8.5	6.2	7.2	11.1	20.4	2.9	9.5	5.1	8.6	30.6	9.5	8.7	5.0	47.9	18.6	10.1	18.5	8.4	4.1	13.5	7.8	1.6	4.7	13.2	10.6	17.8	13.3	2.7	3.1	11.1	41.6	4.8	8.6	6.4	7.5	4.6	5.4	10.3	11.0	5.9	13.1	5.3	6.4	24.7	24.8	20.5	12.1	7.0	6.7	8.2	5.7	1.3
C19orf47	FLJ36888	ENSG00000160392	"Chromosome 19 open reading frame 47"	Q8N9M1	19	40319536-40348527	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"heart muscle: 90.0;skeletal muscle: 259.4;tongue: 139.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 45.2;Late spermatids: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 29.0"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 29.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041843, HPA046309"	Enhanced		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA041843: AB_10959886, HPA046309: AB_10960266"	"prognostic favorable (6.50e-4)"	"unprognostic (1.35e-3)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (7.10e-5)"	"unprognostic (2.75e-1)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.25e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.62e-2)"	"unprognostic (5.28e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.28e-2)"	6.7	5.9	16.0	6.6	16.1	8.3	8.3	11.6	14.7	8.6	1.8	7.6	5.6	7.7	4.0	12.6	6.0	3.5	90.0	12.2	10.0	5.8	7.7	6.4	7.6	15.4	15.0	6.7	5.2	6.6	7.5	6.5	14.0	8.8	2.9	2.5	10.5	6.4	259.4	12.3	6.0	3.9	13.1	7.4	6.2	26.5	13.9	7.3	6.9	139.1	4.4	8.5	8.7	17.1	20.3	30.5	12.7	13.8	7.4	6.6	17.4	20.6	9.3	19.1	22.9	25.5	8.3	23.5	11.1	9.7	10.0	9.9	15.5	18.9	7.9	29.1	19.1	19.3	18.2	19.6	5.5	19.5	11.9	6.6	11.0	25.6	9.0	5.1	11.7	21.5	24.0	13.4	15.9	19.9	29.4	11.0	8.2	16.2	11.5	28.8	20.7	11.8	6.1	17.6	16.2	13.2	22.1	20.5	8.1	7.4	12.2	15.9	15.7	23.7	16.6	16.2	28.4	16.0	24.2	24.1	10.1	18.6	16.7	29.0	2.2	6.6	1.6	2.0	2.0	2.0	3.0	2.7	2.1	2.5	2.0	1.4	7.3	2.5	2.3	2.1	2.3	2.1	16.0	16.1	11.6	14.7	12.2	10.0	15.4	15.0	14.0	13.1	13.9	17.1	2.6	3.2	2.8	9.1	2.6	4.8	3.2	2.6	4.0	3.1	4.9	5.0	45.2	2.8	2.3	0.0	2.1	11.0	1.5	3.6	0.0	3.5	12.5	2.5	2.3	4.3	3.6	1.7	19.2	4.7	13.8	6.2	2.6	2.7	4.5	3.6	5.7	5.0	6.6	3.3	15.4	3.4	0.0	6.2	4.1	27.4	1.8	2.8	5.4	8.4	3.3	2.9	3.1	9.5	11.2	4.4	1.4	6.8	6.5	2.0	2.8	2.8	1.3	2.0	6.6	7.1	3.8	18.2	6.3	4.1	7.0	15.9	3.3	1.4	2.4	1.8
C1orf109	FLJ20508	ENSG00000116922	"Chromosome 1 open reading frame 109"	Q9NX04	1	37681570-37692249	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 50.2;Suprabasal keratinocytes: 62.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027110, HPA027127"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA027110: AB_10611813, HPA027127: AB_1845628"	"unprognostic (1.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.71e-2)"	"unprognostic (7.13e-3)"	"prognostic unfavorable (1.76e-7)"	"unprognostic (1.93e-1)"	"unprognostic (1.48e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.79e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.96e-3)"	"unprognostic (1.69e-1)"	8.8	10.7	7.7	7.3	6.8	8.0	9.7	7.1	7.5	8.9	5.9	7.2	8.2	10.2	10.0	10.1	9.8	6.9	8.3	7.0	7.5	9.2	7.8	5.5	11.9	7.0	8.1	13.4	14.6	15.0	6.1	10.4	7.6	10.6	5.6	5.3	12.3	10.1	9.7	10.5	5.7	8.2	7.9	7.7	6.9	8.3	10.3	9.1	11.4	10.0	9.7	8.1	7.9	8.2	17.7	20.1	16.9	27.8	14.5	10.4	38.5	20.9	14.7	30.7	22.6	30.8	20.8	25.0	24.4	9.2	14.2	25.3	31.5	21.2	31.3	40.3	35.1	28.3	20.7	19.5	27.9	31.6	18.0	14.2	25.7	30.4	39.8	13.4	15.7	21.6	57.2	29.5	17.7	12.1	30.9	13.9	52.9	18.1	38.0	30.2	35.4	69.0	16.4	14.9	50.8	24.4	18.4	27.9	43.1	16.9	15.7	13.9	10.6	30.7	19.3	25.0	40.8	24.0	29.0	52.0	15.4	30.4	33.0	3.5	9.7	6.9	18.9	7.9	29.9	21.2	22.8	18.3	11.6	18.7	28.8	25.0	1.9	24.8	8.8	54.1	12.5	15.0	7.7	6.8	7.1	7.5	7.0	7.5	7.0	8.1	7.6	7.9	10.3	8.2	10.9	6.4	7.9	4.2	12.9	50.2	24.1	5.9	22.8	10.1	15.6	15.1	5.5	5.7	10.8	3.7	10.4	14.9	12.2	6.7	13.7	10.5	1.5	5.8	12.8	11.5	4.2	45.3	9.5	7.3	14.0	14.4	6.1	6.2	11.4	9.6	6.4	6.6	5.4	16.8	7.2	5.1	8.2	4.4	9.0	1.0	9.9	4.8	12.4	4.7	7.3	10.4	17.5	5.0	5.0	10.2	8.1	13.9	10.9	21.3	5.5	8.9	5.6	14.6	0.0	17.5	8.5	25.7	25.5	15.5	62.1	7.9	12.0	11.9	8.3	13.2
C1orf112	FLJ10706	ENSG00000000460	"Chromosome 1 open reading frame 112"	Q9NSG2	1	169662007-169854080	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 13.5"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 30.0;Spermatocytes: 37.1;Spermatogonia: 20.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023778, HPA024451"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Mitochondria		"HPA023778: AB_1848665, HPA024451: AB_1848667"	"unprognostic (4.97e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (9.56e-5)"	"unprognostic (1.33e-1)"	"unprognostic (9.40e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.09e-1)"	"unprognostic (9.11e-3)"	"unprognostic (8.79e-2)"	"unprognostic (3.47e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.65e-8)"	"unprognostic (1.76e-1)"	"unprognostic (2.81e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.63e-1)"	1.8	1.2	0.6	3.3	0.9	9.0	2.9	1.7	0.8	2.3	0.5	2.6	1.2	2.9	1.0	2.0	1.5	1.4	1.0	0.5	0.4	1.1	2.6	1.7	6.3	1.0	0.6	2.2	1.5	13.5	1.0	3.4	0.8	1.8	4.1	5.4	1.5	2.0	0.9	2.4	1.8	2.7	0.7	2.8	1.9	10.3	0.9	11.6	1.7	1.5	7.9	3.1	1.7	1.5	32.7	17.5	21.9	11.3	3.5	4.8	32.2	21.1	10.7	30.0	30.6	19.1	27.7	29.0	9.3	7.0	10.7	26.0	27.6	14.7	34.3	16.9	16.5	27.1	23.0	14.1	1.2	35.8	11.3	1.5	1.9	22.5	5.3	3.5	12.8	16.8	44.9	48.0	24.8	7.9	31.5	10.3	28.8	22.9	12.1	23.3	24.7	19.5	4.0	16.1	16.2	16.9	13.4	22.1	6.9	20.6	21.0	18.3	9.5	24.1	19.1	17.8	28.9	12.9	20.9	30.6	9.0	26.4	24.1	2.2	0.8	1.0	0.6	1.9	0.4	1.4	0.6	0.6	1.2	1.4	0.3	0.5	0.1	2.1	2.3	0.4	0.7	0.6	0.6	0.9	1.7	0.8	0.5	0.4	1.0	0.6	0.8	0.7	0.9	1.5	1.2	0.0	3.3	4.2	4.0	1.8	2.7	2.6	1.2	4.1	1.7	1.8	0.5	0.0	1.5	0.0	6.2	9.1	1.6	1.9	0.0	2.7	8.7	0.9	2.1	2.2	0.0	3.4	9.9	3.4	9.1	2.5	2.6	1.2	4.5	9.8	2.9	3.8	6.2	1.7	9.6	1.2	6.1	3.5	2.1	4.1	2.1	3.0	3.6	30.0	1.3	2.4	0.0	13.0	13.2	3.0	0.3	3.8	5.5	1.0	0.8	0.7	2.0	6.6	6.6	1.4	2.6	37.1	20.3	2.8	1.0	3.8	3.3	2.2	2.6	2.4
C1orf174	RP13-531C17.2	ENSG00000198912	"Chromosome 1 open reading frame 174"	Q8IYL3	1	3889125-3900293	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 114.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008270, HPA065778"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA008270: AB_1845633, HPA065778: AB_2685557"	"unprognostic (4.91e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (5.84e-4)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (7.62e-4)"	"unprognostic (7.24e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.02e-2)"	"prognostic unfavorable (2.73e-6)"	"unprognostic (3.71e-2)"	"unprognostic (3.95e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.46e-2)"	11.6	12.1	8.7	10.2	9.0	13.4	11.2	9.0	10.1	10.7	9.9	13.4	6.8	11.8	9.4	13.8	10.8	8.5	10.9	9.3	9.0	13.4	18.5	10.3	11.4	9.0	8.8	11.0	14.4	6.9	7.5	10.3	9.4	10.3	6.5	4.3	11.1	6.9	15.5	9.9	12.2	7.8	9.4	15.4	12.2	13.2	8.8	13.9	11.5	14.0	11.9	12.2	11.0	9.4	27.6	15.5	23.2	22.0	20.3	12.1	15.6	23.6	13.7	21.8	22.1	24.4	43.4	21.5	28.8	18.7	31.1	27.7	27.6	17.5	23.5	39.3	25.4	56.6	14.2	33.8	11.8	39.9	29.1	13.1	9.9	24.2	15.3	17.3	18.6	27.3	45.9	22.2	14.8	21.8	44.4	30.2	28.6	36.2	32.4	32.7	42.2	20.6	15.1	16.4	23.6	19.1	22.2	30.5	35.7	23.4	14.3	24.8	20.4	29.9	23.9	52.4	25.1	7.2	7.8	39.7	15.5	42.4	10.9	61.5	26.5	50.8	43.7	50.7	38.5	25.2	29.7	34.0	31.8	23.8	27.4	35.4	22.6	29.6	33.5	17.4	32.9	23.9	8.7	9.0	9.0	10.1	9.3	9.0	9.0	8.8	9.4	9.4	8.8	9.4	20.7	9.6	7.7	4.6	21.1	21.9	13.1	17.6	19.9	11.9	15.6	12.8	3.9	22.8	15.6	5.5	8.4	59.8	46.2	11.6	27.4	22.4	114.8	14.7	16.0	16.8	11.4	28.2	5.1	19.6	61.9	16.1	14.8	13.3	36.8	21.6	13.9	15.7	31.5	11.8	7.2	15.6	16.2	17.3	14.5	20.5	17.1	20.7	14.2	4.7	20.4	13.3	50.4	6.6	13.2	17.7	15.2	19.2	17.4	18.9	15.1	20.9	11.7	12.6	13.1	16.5	17.4	32.3	32.6	21.8	17.6	26.7	24.7	21.7	19.8	12.1
C1QBP	"gC1Q-R, gC1qR, HABP1, p32, SF2p32"	ENSG00000108561	"Complement C1q binding protein"	Q07021	17	5432777-5448830	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Adaptive immunity, Apoptosis, Complement pathway, Host-virus interaction, Immunity, Innate immunity, mRNA processing, mRNA splicing, Ribosome biogenesis, Transcription, Transcription regulation"		"Cancer-related genes, Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026483	Supported		Approved	"Plasma membrane,Mitochondria"	"Secreted to blood"	NA	NA		410000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane"	Mitochondria	"HPA026483: AB_1847108"	"unprognostic (2.18e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.80e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.76e-2)"	"unprognostic (7.47e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.40e-3)"	"unprognostic (6.03e-2)"	"unprognostic (4.60e-3)"	"unprognostic (3.08e-2)"	"unprognostic (7.80e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.97e-1)"	79.3	135.4	85.5	84.1	85.7	121.2	108.7	91.5	118.3	58.4	119.6	140.3	95.9	66.4	68.3	138.6	74.5	48.7	126.3	89.5	94.3	136.4	134.5	54.7	115.7	89.6	92.3	52.7	72.9	127.7	81.3	75.8	93.2	63.9	141.6	86.7	66.2	73.1	174.2	81.3	78.4	80.9	93.1	73.5	74.3	62.5	90.7	98.5	65.1	160.1	135.6	108.4	73.9	97.3	443.8	671.0	233.0	378.0	169.8	207.7	313.7	330.4	268.5	751.4	458.8	646.8	143.7	941.8	317.8	251.3	271.3	385.8	756.7	448.9	689.8	216.6	1300.5	433.9	312.4	762.2	269.9	535.6	331.0	231.4	404.1	414.6	593.1	181.1	390.0	548.2	526.1	234.4	296.1	308.6	766.4	385.6	525.9	497.2	396.7	601.2	329.1	515.0	440.5	328.7	186.0	348.0	271.4	344.4	483.6	232.1	218.1	267.1	231.1	240.1	219.7	275.9	729.9	122.0	201.2	415.0	229.3	506.2	376.8	68.1	197.6	49.9	217.1	212.0	283.5	330.1	239.0	215.4	389.5	289.8	289.7	245.7	15.5	240.7	166.4	325.4	203.6	432.6	85.5	85.7	91.5	118.3	89.5	94.3	89.6	92.3	93.2	93.1	90.7	97.3	101.6	28.9	30.5	10.7	153.1	243.1	229.0	283.3	165.0	70.5	157.3	209.4	84.8	102.9	107.8	82.8	27.1	323.8	115.0	105.6	313.1	248.0	75.1	106.7	149.9	108.2	79.2	183.1	10.8	205.1	457.9	101.0	94.8	85.9	62.2	131.6	75.3	128.5	202.7	60.6	11.6	190.2	154.6	85.3	129.8	89.5	119.6	101.8	156.5	10.3	170.3	105.2	93.7	11.1	16.1	199.3	128.5	98.6	197.4	255.1	78.9	444.1	65.1	79.9	85.5	101.6	189.1	79.3	237.3	284.4	255.3	179.0	105.5	354.3	364.0	253.8
C2orf49	"asw, MGC5509"	ENSG00000135974	"Chromosome 2 open reading frame 49"	Q9BVC5	2	105337532-105349211	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043846, HPA060814"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Mitochondria	"HPA043846: AB_2678698, HPA060814: AB_2684372"	"unprognostic (4.19e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.06e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.57e-3)"	"unprognostic (8.75e-3)"	"unprognostic (1.89e-3)"	"unprognostic (6.51e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.94e-2)"	"prognostic unfavorable (5.06e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.04e-2)"	11.3	9.3	9.6	10.6	11.9	19.3	11.1	12.0	12.9	12.5	6.2	9.1	9.4	14.6	7.8	11.8	12.4	9.5	15.3	8.9	10.7	8.7	10.1	8.6	12.6	11.2	11.5	19.9	11.0	10.5	5.5	12.0	11.3	11.3	9.9	24.9	9.1	11.0	19.9	9.5	10.1	12.2	10.2	11.1	13.8	13.0	10.6	16.0	12.6	21.0	13.3	11.3	10.5	13.8	20.0	13.9	17.2	17.5	19.4	23.6	30.7	19.6	20.6	17.0	23.3	30.7	19.5	23.3	23.9	17.1	45.6	18.7	23.9	16.7	22.2	30.6	18.1	25.3	11.6	23.8	23.6	21.3	20.1	17.1	28.7	24.0	21.6	24.3	15.8	18.1	35.9	18.7	24.3	15.4	25.9	24.5	22.6	13.5	16.8	17.1	25.4	27.1	19.2	18.9	20.3	16.2	17.3	15.5	23.8	19.2	15.2	23.8	25.4	17.9	25.1	13.0	16.1	23.6	20.5	24.6	18.1	21.3	17.6	15.4	13.2	12.0	9.0	8.3	8.9	14.5	10.1	9.0	9.2	17.6	11.0	9.3	17.8	9.2	11.9	19.1	12.7	6.7	9.6	11.9	12.0	12.9	8.9	10.7	11.2	11.5	11.3	10.2	10.6	13.8	27.0	16.0	14.3	7.5	26.3	29.1	13.4	21.8	15.4	37.1	24.8	22.9	30.9	18.6	22.0	25.8	29.2	21.2	31.6	16.5	25.4	22.9	40.6	43.1	34.7	19.3	11.3	21.2	10.8	18.2	26.5	22.8	12.8	33.9	16.5	18.1	19.6	22.4	16.1	23.5	11.2	22.5	12.2	18.5	13.5	35.8	27.7	15.5	7.2	10.3	21.1	39.6	28.8	7.1	15.8	21.0	17.5	29.0	19.0	16.2	21.8	22.3	36.1	44.3	19.7	17.3	19.8	45.8	28.1	13.7	24.7	36.8	22.4	16.6	14.8	15.8
C4orf46	"LOC201725, RCDG1"	ENSG00000205208	"Chromosome 4 open reading frame 46"	Q504U0	4	158666675-158672255	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 49.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047287, HPA052670"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA047287: AB_2680011, HPA052670: "	"unprognostic (2.71e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.10e-2)"	"unprognostic (6.27e-5)"	"unprognostic (1.60e-1)"	"unprognostic (4.71e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.29e-2)"	"unprognostic (4.56e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.69e-2)"	"unprognostic (9.06e-3)"	2.5	2.4	1.9	4.1	2.4	14.5	2.9	2.4	2.8	2.7	1.3	3.3	3.0	5.0	2.1	2.9	2.4	2.8	3.7	1.9	1.9	1.9	1.5	2.6	6.0	2.3	2.2	4.2	2.4	1.7	1.1	4.5	2.3	2.4	4.2	9.4	1.7	2.2	2.1	2.9	2.8	4.0	2.1	3.2	2.6	12.8	2.0	10.2	4.3	6.0	5.4	2.6	2.0	2.9	16.6	9.9	23.7	35.0	10.3	10.6	11.8	27.5	18.9	31.5	27.4	8.9	14.6	29.3	4.3	14.0	11.6	9.0	20.6	14.2	40.3	40.5	10.7	44.5	10.4	11.9	3.5	33.9	23.7	6.2	5.0	25.6	11.2	10.4	22.7	29.3	19.7	72.1	43.2	8.9	65.8	29.7	16.3	10.6	13.0	47.0	13.5	13.0	9.6	8.1	12.8	38.5	12.1	10.9	10.1	11.9	9.3	26.9	12.0	48.0	22.1	27.0	23.2	16.5	22.3	37.0	12.1	29.8	18.9	2.4	1.9	1.7	1.9	1.6	1.4	1.7	1.5	1.9	2.1	1.4	2.1	2.3	0.6	3.4	2.2	1.8	1.8	1.3	1.9	2.4	2.4	2.8	1.9	1.9	2.3	2.2	2.3	2.1	2.0	2.9	10.3	3.2	1.8	1.3	7.8	24.1	5.1	5.8	14.2	7.5	6.5	5.2	7.6	1.5	3.2	1.8	4.2	9.8	8.2	2.9	7.9	3.6	0.8	7.6	10.8	6.9	7.7	11.2	1.2	3.0	11.8	14.5	4.6	15.0	7.0	8.7	5.0	2.0	9.7	10.1	1.8	5.1	6.1	10.3	25.8	1.8	4.7	7.6	19.6	0.0	18.9	6.5	5.2	1.0	6.2	3.8	3.1	6.0	18.1	6.6	3.2	2.8	3.3	28.2	6.6	7.7	10.6	49.1	15.2	30.1	15.6	3.3	9.6	2.5	5.8	7.2
C5orf22	FLJ11193	ENSG00000082213	"Chromosome 5 open reading frame 22"	Q49AR2	5	31532287-31555053	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 28.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 28.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043062	Approved		Approved	"Nuclear membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear membrane"		"HPA043062: AB_10795766"	"unprognostic (2.58e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.91e-1)"	"unprognostic (8.73e-2)"	"prognostic unfavorable (6.55e-4)"	"unprognostic (1.65e-1)"	"unprognostic (7.30e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.86e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.50e-1)"	4.3	3.7	2.0	5.6	2.9	5.8	6.5	2.4	3.0	6.0	1.6	6.7	4.6	6.0	3.4	6.5	5.9	5.6	10.2	2.4	3.2	7.6	7.0	6.6	7.3	2.3	3.2	4.1	11.0	8.2	1.4	5.7	2.9	5.9	7.6	4.8	5.4	5.3	13.7	3.9	5.9	8.2	2.4	5.1	5.2	3.6	2.5	7.2	6.6	15.1	8.7	7.0	2.8	3.0	10.0	7.2	18.4	25.3	13.0	10.7	20.9	16.2	12.2	18.1	13.4	8.7	10.7	8.2	23.4	14.7	15.7	7.3	22.2	13.4	19.2	11.8	11.9	15.7	23.9	12.6	20.9	24.3	51.8	14.6	16.6	12.2	18.9	7.4	15.4	11.5	21.2	12.9	19.6	10.3	13.1	6.1	11.0	10.1	10.7	12.2	30.7	11.7	12.7	15.5	12.3	17.1	45.1	19.9	32.9	11.6	15.9	16.4	13.0	13.6	15.5	16.7	16.4	8.7	18.7	15.0	7.9	42.5	20.7	28.0	2.5	2.4	2.6	2.9	2.8	2.9	3.4	2.8	2.4	2.4	3.2	3.4	0.9	3.8	5.2	1.4	2.1	1.5	2.0	2.9	2.4	3.0	2.4	3.2	2.3	3.2	2.9	2.4	2.5	3.0	6.0	3.2	5.3	10.1	9.6	4.5	3.3	4.0	10.8	4.1	5.6	2.8	23.5	4.3	4.9	12.9	0.0	5.3	9.2	8.8	1.9	4.3	2.9	6.9	7.3	6.2	6.7	7.2	16.5	6.0	6.2	6.4	10.2	7.6	7.6	5.5	6.1	10.2	6.4	6.7	17.7	9.2	12.2	10.7	2.5	1.7	4.7	7.7	8.8	8.4	10.7	4.8	2.1	15.1	15.5	6.8	5.7	3.4	12.8	5.1	5.9	7.9	7.9	4.9	6.6	3.9	5.6	6.1	6.5	10.3	4.0	5.3	9.5	6.3	6.9	4.3
C8orf33	FLJ20989	ENSG00000182307	"Chromosome 8 open reading frame 33"	Q9H7E9	8	145052465-145066685	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 180.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024812, HPA026104"	Approved		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Plasma membrane"		"HPA024812: AB_10599490, HPA026104: AB_10600875"	"prognostic unfavorable (2.77e-4)"	"unprognostic (6.51e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.56e-3)"	"prognostic unfavorable (8.95e-4)"	"unprognostic (4.75e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.45e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.37e-1)"	16.5	42.1	32.3	13.1	32.1	18.2	24.8	33.5	41.7	17.7	28.3	21.7	13.1	20.4	27.1	19.5	22.8	16.5	22.3	32.0	33.1	18.7	17.1	15.0	18.2	33.3	34.3	40.7	20.8	34.0	5.6	21.1	32.8	18.8	33.4	24.6	16.4	24.2	16.9	17.4	10.2	19.6	32.4	12.2	11.5	13.1	32.7	19.3	33.2	26.0	18.4	18.8	8.9	33.3	28.3	32.7	45.8	22.7	51.3	35.5	17.2	16.6	41.7	42.0	23.3	9.2	39.2	30.3	55.3	40.5	19.5	22.4	67.5	41.2	45.3	15.0	48.4	38.1	32.1	11.5	53.1	30.6	15.1	41.0	60.4	43.0	96.8	34.5	28.1	44.9	75.4	26.3	46.1	42.4	86.3	12.3	31.8	89.1	55.2	51.2	14.9	46.6	44.1	16.3	44.1	39.1	44.3	39.3	39.0	26.1	41.1	29.1	13.8	27.5	37.3	24.2	37.8	21.7	16.9	72.2	65.9	47.0	55.1	1.0	13.7	8.7	16.3	17.4	18.4	13.4	16.2	17.8	19.6	13.3	21.3	15.6	1.4	28.2	16.0	18.4	12.6	16.3	32.3	32.1	33.5	41.7	32.0	33.1	33.3	34.3	32.8	32.4	32.7	33.3	67.8	28.9	27.2	4.9	34.8	44.4	32.8	31.9	24.5	48.3	52.8	47.9	18.4	45.8	33.8	25.8	31.3	36.9	45.3	180.5	62.6	79.5	5.6	49.9	55.1	50.2	35.3	17.5	5.7	64.9	40.2	41.7	20.9	53.0	21.5	58.5	37.1	66.8	28.7	50.5	6.0	36.4	14.2	21.5	21.2	5.6	37.9	23.0	16.0	7.5	32.3	61.2	45.3	4.0	6.0	55.3	37.7	38.7	20.4	48.1	22.1	66.1	26.6	54.5	26.3	32.8	37.9	26.2	34.8	25.4	42.9	24.9	23.6	94.9	53.0	28.5
C9orf43	MGC17358	ENSG00000157653	"Chromosome 9 open reading frame 43"	Q8TAL5	9	113410054-113429690	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"testis: 45.6"	"Group enriched"	"Detected in some"	8	"Early spermatids: 114.2;Late spermatids: 226.0;Spermatocytes: 91.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021310			Approved	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA021310: AB_1845825"	"unprognostic (2.91e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.63e-1)"	"unprognostic (6.58e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.97e-2)"	"unprognostic (5.96e-3)"	"unprognostic (1.51e-1)"	"unprognostic (7.32e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.63e-1)"	0.3	1.5	0.9	0.1	1.0	1.9	0.5	0.9	1.2	0.2	0.8	0.2	0.1	0.2	1.2	0.3	0.7	0.3	0.2	0.9	1.2	1.2	1.5	0.2	0.4	1.3	1.6	0.8	0.8	0.9	1.4	0.2	1.2	0.5	0.2	1.2	0.7	0.4	0.1	0.5	0.2	0.0	1.3	0.4	0.5	45.6	1.1	0.4	0.8	0.3	0.4	0.2	0.2	1.3	0.5	0.4	0.2	0.7	0.6	0.3	0.3	0.2	0.4	0.7	0.5	0.5	0.4	1.3	0.4	0.1	1.4	0.9	0.2	0.6	0.2	1.1	0.2	1.1	0.8	0.2	0.5	0.2	0.1	0.7	1.0	0.8	1.0	0.4	0.6	1.5	0.7	1.2	0.3	1.0	0.5	0.3	0.3	0.6	1.6	0.3	0.2	0.7	0.7	0.2	1.2	0.3	1.2	0.5	0.7	0.5	1.6	0.1	0.0	1.0	0.2	0.6	1.0	0.7	1.5	2.0	0.5	0.4	0.3	0.0	0.1	0.0	0.3	0.3	0.0	0.3	0.1	0.4	0.2	0.1	0.3	0.4	0.4	0.2	0.0	0.3	0.0	0.1	0.9	1.0	0.9	1.2	0.9	1.2	1.3	1.6	1.2	1.3	1.1	1.3	0.4	0.0	0.0	4.9	1.5	0.6	0.6	0.5	1.2	1.7	0.8	0.9	0.1	0.0	1.6	0.0	0.0	0.5	0.3	0.2	1.9	0.3	114.2	3.0	0.7	0.7	0.0	0.8	0.6	0.2	0.4	0.2	0.0	0.6	0.0	0.7	0.0	0.9	0.3	0.0	0.7	0.1	0.0	0.3	0.4	226.0	2.1	0.5	0.0	0.0	0.7	1.8	0.0	0.5	1.8	0.9	0.0	1.5	1.8	0.3	0.1	0.9	6.7	2.8	0.0	0.7	0.3	91.5	17.9	0.7	0.0	0.0	0.4	0.7	0.2	0.6
C9orf85	MGC61599	ENSG00000155621	"Chromosome 9 open reading frame 85"	Q96MD7	9	71911510-71986054	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 112.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050767, HPA076627"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA050767: AB_2681229, HPA076627: "	"unprognostic (7.81e-2)"	"unprognostic (2.80e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.10e-2)"	"unprognostic (6.60e-2)"	"unprognostic (4.02e-1)"	"unprognostic (6.18e-2)"	7.5	6.6	7.5	6.4	9.0	6.0	8.9	8.2	7.8	9.2	5.0	7.8	11.9	7.3	5.7	9.9	6.5	6.8	6.2	7.0	7.2	7.1	7.9	5.0	8.7	8.5	7.6	9.5	7.8	4.9	5.9	8.4	8.2	7.2	7.5	6.3	8.9	5.0	8.7	11.2	8.2	6.3	6.5	6.7	6.8	5.4	8.2	8.5	8.5	8.4	8.0	9.8	8.4	12.9	11.6	7.5	12.6	10.4	12.7	23.4	12.8	13.8	22.0	11.1	11.0	1.5	6.4	18.5	6.9	12.1	11.7	20.1	13.4	13.6	15.4	12.9	6.5	11.3	10.3	9.5	13.9	16.7	8.5	19.2	18.2	11.4	25.2	17.5	13.8	17.1	13.8	11.8	14.5	5.7	20.4	11.8	11.6	17.8	17.6	11.6	22.4	0.5	16.3	16.7	10.1	13.9	7.0	17.8	25.0	13.8	6.0	9.6	12.1	10.2	13.3	23.7	10.6	12.0	21.7	8.5	14.0	12.6	6.5	15.1	6.6	10.6	9.9	7.5	10.5	8.7	8.4	8.5	7.3	8.6	10.2	10.8	7.6	13.0	6.8	10.5	8.4	7.4	7.5	9.0	8.2	7.8	7.0	7.2	8.5	7.6	8.2	6.5	8.2	12.9	19.2	6.4	17.0	35.6	15.7	7.6	13.6	12.8	25.6	10.9	13.9	22.9	14.0	8.6	12.6	5.5	8.4	20.3	18.4	25.2	21.5	14.2	10.8	9.4	19.7	15.0	6.6	8.2	27.4	19.9	19.0	14.1	19.9	10.8	18.4	13.7	18.5	9.7	14.8	5.0	19.2	23.4	10.2	16.1	8.9	7.5	20.8	15.2	3.6	24.4	17.7	12.5	33.0	44.2	112.1	17.8	30.6	13.2	9.5	12.7	29.3	22.8	8.4	13.0	13.1	19.3	17.3	20.6	14.6	23.2	9.8	10.8	16.2	21.9	16.8	27.0
CABLES2	"C20orf150, dJ908M14.2, ik3-2"	ENSG00000149679	"Cdk5 and Abl enzyme substrate 2"	Q9BTV7	20	62388632-62407285	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division"	Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 31.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 51.3;Late spermatids: 25.6;Spermatocytes: 21.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052138			Approved	"Nucleoplasm,Nuclear bodies,Cell Junctions"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nuclear bodies"	"Nucleoplasm, Cell Junctions"	"HPA052138: AB_2681743"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (5.26e-5)"	"unprognostic (1.45e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.37e-3)"	"unprognostic (6.05e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.09e-2)"	"prognostic unfavorable (1.24e-6)"	"unprognostic (1.99e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.94e-2)"	2.4	3.0	6.8	4.2	7.2	8.1	2.8	11.5	9.1	3.9	3.5	4.4	2.9	3.5	2.6	3.2	4.8	2.2	10.6	7.1	7.4	2.6	4.0	2.9	5.1	7.9	6.6	4.3	3.2	3.9	5.9	2.8	7.8	4.3	3.2	5.6	3.3	3.1	5.8	4.3	4.4	3.3	5.9	4.2	4.0	31.0	7.5	5.3	5.1	4.1	4.4	3.7	3.3	7.2	16.3	12.0	20.4	20.9	3.1	4.4	2.8	9.2	8.9	24.8	11.4	43.6	9.1	16.3	7.6	5.9	33.9	10.1	12.6	6.0	9.6	7.3	6.9	19.0	6.3	10.6	5.5	7.8	9.4	2.7	6.7	7.1	2.6	4.4	5.8	20.8	4.9	13.9	5.6	20.0	20.6	6.2	6.8	16.4	13.7	28.1	17.2	7.1	3.7	10.6	11.1	16.8	13.3	17.4	3.6	7.6	11.9	11.7	6.0	22.7	6.8	30.3	9.5	13.3	11.7	19.4	20.4	8.8	12.1	0.0	0.2	0.0	0.7	0.3	0.4	0.5	0.4	0.5	0.3	0.2	0.2	0.3	0.2	0.4	0.3	0.2	1.3	0.1	6.8	7.2	11.5	9.1	7.1	7.4	7.9	6.6	7.8	5.9	7.5	7.2	1.5	3.2	1.7	2.0	2.1	0.9	0.5	1.7	2.8	6.0	2.9	2.4	10.7	2.8	2.5	0.0	4.2	1.3	3.1	3.5	1.9	2.2	51.3	1.1	1.2	1.6	3.5	1.7	4.4	2.4	0.7	2.6	3.6	2.2	0.0	5.3	2.2	1.4	2.1	13.5	5.2	4.1	0.0	1.6	3.0	25.6	1.8	2.0	0.0	1.0	1.0	1.9	1.0	3.5	3.3	2.1	2.3	3.4	2.5	0.7	1.8	0.7	0.2	3.4	0.0	3.0	1.3	21.8	6.9	1.3	2.0	2.3	2.0	1.0	2.8	0.6
CACUL1	"C10orf46, CAC1, FLJ40409, MGC33215"	ENSG00000151893	"CDK2 associated cullin domain 1"	Q86Y37	10	118674167-118755249	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 237.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050611			Approved	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA050611: AB_2797238"	"unprognostic (1.48e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (1.34e-5)"	"unprognostic (3.44e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.75e-2)"	"unprognostic (8.48e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.54e-1)"	6.3	6.9	6.3	4.0	6.6	11.6	7.7	4.8	6.2	6.0	4.6	7.5	4.5	7.3	7.0	7.3	5.7	3.9	5.8	6.8	7.4	5.0	6.6	7.3	4.1	5.2	5.9	5.1	5.5	7.2	5.0	6.4	6.5	5.3	5.3	5.5	5.3	5.4	10.5	6.0	5.0	6.1	5.0	5.8	6.1	6.6	7.8	5.4	5.2	10.6	5.2	8.3	6.1	5.4	14.8	8.6	6.4	11.8	15.0	10.2	6.6	6.2	17.2	8.9	11.2	9.6	12.3	10.5	4.6	10.3	7.3	12.8	13.0	11.1	11.8	4.2	7.1	9.7	8.5	11.9	9.9	8.9	6.1	8.2	12.2	11.5	17.2	13.4	10.2	11.5	4.8	10.5	10.5	11.4	8.5	14.1	6.2	6.3	4.5	4.8	26.7	6.5	13.0	11.2	3.4	10.8	6.0	15.0	20.4	6.9	8.4	7.2	9.7	6.1	6.9	7.7	10.7	9.1	10.4	7.2	7.9	17.2	3.8	25.3	9.0	16.9	5.2	15.6	5.1	4.0	4.9	5.1	8.2	4.0	5.4	6.4	20.3	4.4	17.1	3.9	4.1	5.2	6.3	6.6	4.8	6.2	6.8	7.4	5.2	5.9	6.5	5.0	7.8	5.4	29.6	60.9	21.7	58.8	42.7	74.8	30.5	38.5	50.1	33.6	58.3	34.9	44.8	45.8	27.8	36.8	73.0	73.4	39.2	32.5	23.5	52.4	237.7	53.3	24.7	36.8	68.6	37.0	65.8	59.4	33.4	34.7	18.8	46.9	15.8	68.7	33.2	27.4	46.5	92.5	64.7	34.0	34.6	77.6	127.6	36.1	29.5	56.7	28.4	49.6	59.4	40.9	34.0	40.2	62.5	50.0	26.5	24.0	24.4	56.5	28.2	43.2	36.7	50.1	13.1	52.1	32.3	81.4	83.8	43.2	78.8	102.3	32.8	29.0	41.7	74.7
CACYBP	"S100A6BP, SIP"	ENSG00000116161	"Calcyclin binding protein"	Q9HB71	1	174999163-175012027	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 191.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025753, HPA057038"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		560000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"HPA025753: AB_1845878, HPA057038: AB_2683318"	"unprognostic (4.70e-3)"	"unprognostic (9.92e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.96e-3)"	"prognostic unfavorable (1.12e-6)"	"unprognostic (1.50e-2)"	"unprognostic (2.03e-2)"	"prognostic favorable (1.39e-5)"	"unprognostic (4.55e-2)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.79e-2)"	26.5	22.6	60.7	25.5	63.4	33.8	20.6	66.8	191.9	21.8	48.5	25.6	15.9	19.1	24.4	23.8	17.4	14.7	26.8	66.3	65.6	27.2	25.7	23.7	32.7	60.8	61.8	34.8	15.9	20.5	26.9	22.8	66.8	15.3	20.7	52.5	17.5	18.5	37.7	17.4	19.1	16.4	57.8	24.1	20.3	30.5	58.7	27.9	14.9	27.4	28.9	28.0	20.4	71.9	127.7	85.6	124.0	53.1	40.2	44.8	79.5	94.7	55.6	119.8	86.8	88.9	76.9	132.8	96.0	67.5	85.8	67.3	155.0	69.4	122.7	70.6	92.4	99.6	80.8	96.3	30.1	135.4	59.9	30.3	42.2	98.7	58.8	62.0	85.5	117.0	203.7	72.2	87.0	47.4	208.2	121.5	118.0	189.1	39.4	93.6	87.9	152.5	85.4	99.8	84.9	81.4	64.7	111.0	106.3	165.7	86.8	116.6	44.9	67.9	73.3	96.0	153.8	68.6	211.5	301.8	57.1	117.1	80.6	34.0	25.5	27.9	29.4	41.7	35.4	43.0	42.0	36.2	32.3	33.7	44.6	39.9	14.6	43.7	54.9	28.3	48.7	46.1	60.7	63.4	66.8	191.9	66.3	65.6	60.8	61.8	66.8	57.8	58.7	71.9	70.6	86.6	41.9	13.1	82.1	117.0	183.6	102.2	63.7	57.7	61.8	79.0	108.1	40.0	62.7	35.0	62.6	238.8	68.7	66.2	152.6	96.8	102.2	124.5	67.6	80.0	119.6	113.0	22.4	95.0	304.1	92.8	36.7	167.3	92.0	52.8	44.3	39.4	196.3	30.3	24.1	101.6	67.1	56.0	188.2	30.6	86.0	110.9	108.5	13.1	231.0	77.8	60.8	8.5	28.0	106.9	58.4	73.7	90.7	115.4	80.7	171.4	78.0	84.0	32.9	57.6	108.4	186.7	139.9	88.7	85.7	143.5	188.0	76.5	139.1	106.9
CAD	GATD4	ENSG00000084774	"Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase"	P27708	2	27217369-27243943	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Allosteric enzyme, Hydrolase, Ligase, Multifunctional enzyme, Transferase"	"Cancer-related genes, Congenital disorder of glycosylation, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007781, HPA065158, HPA069341"	Supported		Supported	Cytosol		NA	No		260000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"CAB007781: AB_562057, HPA065158: , HPA069341: AB_2686125"	"unprognostic (1.69e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (1.72e-11)"	"unprognostic (1.25e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.11e-2)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (6.94e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.93e-3)"	15.0	13.5	12.7	12.4	14.1	9.0	14.9	12.7	15.5	19.8	12.2	16.5	8.5	23.8	9.9	19.2	19.3	7.7	11.6	12.3	12.8	18.0	27.8	12.3	14.9	13.8	13.5	22.3	22.3	5.9	18.7	7.5	14.5	15.2	7.8	5.0	12.3	8.8	10.3	18.7	16.1	11.9	12.7	20.1	14.0	22.2	14.2	11.6	15.8	5.9	10.5	16.9	15.8	15.2	75.2	66.4	28.9	58.4	46.1	37.6	22.9	31.0	21.4	38.3	27.0	75.7	29.2	66.4	27.4	28.5	29.6	41.4	85.7	41.1	28.5	43.8	69.2	95.2	55.0	40.0	23.0	75.7	46.2	28.8	33.1	55.7	63.0	17.8	41.6	60.6	68.3	36.0	34.2	74.8	48.7	112.0	69.7	31.3	49.7	84.0	86.5	69.5	28.6	37.6	57.9	29.1	43.3	30.5	37.4	21.3	23.9	31.3	37.7	57.7	47.5	45.5	63.5	74.0	51.8	135.2	23.3	71.7	51.0	0.0	0.8	0.4	3.1	1.5	2.5	3.4	4.4	5.2	1.9	3.1	2.8	2.8	0.5	2.7	0.9	3.4	5.9	2.0	12.7	14.1	12.7	15.5	12.3	12.8	13.8	13.5	14.5	12.7	14.2	15.2	4.2	3.2	3.9	12.7	5.3	3.7	4.3	5.0	5.7	10.6	7.1	8.6	8.3	10.0	4.7	1.8	16.7	5.9	3.9	3.9	0.0	6.1	1.5	2.9	7.9	5.1	6.6	9.7	5.6	3.7	6.6	7.0	6.1	4.3	4.5	16.9	3.3	6.6	7.7	6.7	5.7	5.8	0.0	3.0	1.9	1.9	6.2	3.6	3.6	6.5	4.7	4.1	5.2	8.5	7.4	5.9	1.9	9.8	7.3	8.0	2.5	2.0	3.5	6.8	0.0	8.2	5.2	5.6	12.1	6.2	3.4	2.2	5.1	9.7	7.5	2.2
CALM3	PHKD	ENSG00000160014	"Calmodulin 3"	P0DP25	19	46601074-46610782	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"			"Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 868.1"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 1863.5;Late spermatids: 2674.8;Spermatocytes: 875.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044999	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"			"HPA044999: AB_2679177"	"unprognostic (3.39e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (4.01e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (9.10e-4)"	"unprognostic (2.72e-1)"	136.3	186.9	309.9	153.9	428.0	194.4	113.2	19.8	868.1	187.9	0.0	178.8	203.6	175.4	97.6	118.4	148.8	135.9	272.4	498.5	183.4	177.3	137.2	125.7	179.4	240.2	77.0	189.0	116.3	110.3	138.6	133.3	199.8	143.6	158.2	152.0	73.1	157.7	340.0	85.6	228.9	166.8	25.8	122.2	143.4	469.0	184.3	270.8	118.1	253.0	172.2	173.2	150.8	505.1	392.6	437.1	493.9	174.6	256.1	338.9	119.5	405.8	333.6	358.0	473.1	374.8	342.5	322.3	185.2	599.0	249.7	297.6	496.9	322.0	453.5	498.0	387.6	433.7	201.8	404.5	139.0	324.5	596.5	334.6	106.9	281.1	218.3	274.2	450.6	353.4	335.7	447.0	345.3	250.1	354.3	818.1	251.6	575.7	192.3	644.7	254.5	121.9	341.4	463.3	253.6	279.7	304.6	194.1	123.7	484.3	227.9	364.7	329.2	197.6	366.2	150.5	298.5	370.2	280.6	262.1	197.9	279.5	255.7	190.6	158.2	262.4	67.2	193.9	61.0	74.7	95.5	90.0	93.5	68.6	112.0	71.6	433.7	103.6	194.3	55.1	195.6	150.7	309.9	428.0	19.8	868.1	498.5	183.4	240.2	77.0	199.8	25.8	184.3	505.1	77.6	41.7	56.8	23.8	101.8	57.2	82.8	82.0	32.5	136.2	82.4	86.1	177.5	87.2	59.9	69.9	12.5	202.9	120.0	301.1	260.3	265.0	1863.5	101.6	76.4	88.7	122.4	318.4	114.1	221.5	545.1	112.3	89.2	82.4	106.0	130.6	125.7	106.4	760.3	89.2	89.4	178.2	59.0	307.8	112.7	2674.8	106.9	349.8	92.5	32.8	525.0	184.2	225.6	23.1	30.2	205.1	273.5	122.6	143.3	67.6	457.2	365.6	85.4	88.2	92.1	47.8	130.9	875.3	157.4	64.6	65.9	184.8	161.1	192.7	208.8	111.9
CAMSAP1	"DKFZp434F195, FLJ31228"	ENSG00000130559	"Calmodulin regulated spectrin associated protein 1"	Q5T5Y3	9	135808487-135907546	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 105.5"	"Group enriched"	"Detected in many"	6	"Cone photoreceptor cells: 339.9;Rod photoreceptor cells: 236.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020527, HPA024161"	Approved		Supported	"Mitotic spindle,Cytosol"		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Mitotic spindle, Cytosol"		"HPA020527: , HPA024161: AB_1845967"	"unprognostic (3.18e-3)"	"unprognostic (4.16e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.75e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.16e-2)"	"prognostic favorable (3.09e-5)"	"unprognostic (1.12e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.66e-3)"	6.7	7.4	12.5	5.5	12.7	10.3	5.4	12.7	12.6	9.2	2.5	7.4	3.2	7.5	5.2	20.0	7.7	5.2	7.8	14.1	9.8	5.1	4.3	6.8	5.8	8.3	9.3	10.7	7.9	6.1	8.7	5.2	8.8	6.2	3.5	105.5	7.5	6.5	32.8	10.4	4.4	6.9	5.6	5.3	5.0	18.1	11.5	11.1	4.4	17.5	6.9	7.4	11.7	11.6	15.4	22.3	36.0	25.5	8.2	7.1	17.6	12.2	10.2	13.0	9.8	19.7	13.2	7.1	17.0	15.4	16.7	30.8	19.0	13.2	9.7	24.0	10.5	10.3	24.9	9.9	12.4	18.0	14.8	9.5	16.3	16.6	22.6	12.3	14.8	15.5	21.4	15.0	17.1	27.5	16.8	11.0	20.4	18.2	15.8	32.5	29.7	17.4	12.8	18.7	39.1	38.2	15.6	11.2	17.0	11.7	15.9	14.6	18.3	24.6	19.0	18.3	20.9	7.3	14.7	19.2	16.0	12.0	14.5	1.5	0.3	0.0	0.2	0.4	0.4	0.6	0.4	0.3	0.2	0.1	0.3	0.4	0.1	0.2	0.3	0.2	0.3	0.3	12.5	12.7	12.7	12.6	14.1	9.8	8.3	9.3	8.8	5.6	11.5	11.6	6.3	6.4	3.9	31.6	5.5	22.7	17.4	10.8	9.6	34.4	11.8	9.8	14.0	4.3	15.7	3.7	339.9	12.6	5.8	4.5	0.0	11.8	13.1	41.5	13.2	8.8	12.6	6.6	37.7	8.9	3.5	6.6	8.2	32.4	6.3	20.4	7.5	8.2	10.3	16.8	34.1	4.4	10.2	8.1	13.5	15.8	5.9	11.7	12.4	25.3	12.2	19.2	4.1	27.2	35.9	15.7	3.0	6.0	11.9	14.2	2.7	4.3	37.1	236.1	13.1	16.8	11.7	24.4	34.4	35.2	31.7	5.6	6.5	15.6	4.5	24.8
CAMTA2	KIAA0909	ENSG00000108509	"Calmodulin binding transcription activator 2"	O94983	17	4967992-4987675	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 54.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027835, HPA051147"			Supported	"Nucleoplasm,Vesicles,Actin filaments,Mitochondria,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Vesicles, Actin filaments, Mitochondria, Cytosol"	"HPA027835: , HPA051147: AB_2681362"	"unprognostic (2.82e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.08e-2)"	"prognostic favorable (6.00e-8)"	"unprognostic (3.42e-2)"	"unprognostic (9.02e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.19e-1)"	15.8	15.6	10.7	13.6	15.9	10.3	15.0	5.2	36.7	14.8	0.0	19.6	10.3	17.0	4.4	14.4	14.4	8.7	17.7	24.2	3.4	16.0	12.9	18.4	9.7	10.0	4.4	14.8	17.5	19.2	26.0	7.4	8.5	15.1	10.8	10.7	13.9	11.6	38.0	17.4	19.0	14.2	0.5	21.6	18.6	14.5	7.3	10.4	17.0	27.5	9.5	16.0	13.0	18.4	13.2	23.2	4.2	6.1	27.8	19.0	8.6	12.4	13.8	11.6	10.1	5.9	3.6	15.5	11.9	19.7	9.8	13.1	16.2	19.5	6.6	21.8	20.7	9.8	13.3	6.6	15.9	5.8	40.4	13.4	24.0	10.8	17.1	14.0	19.6	11.8	16.2	13.9	11.0	8.8	10.3	3.7	0.6	15.6	9.5	8.9	4.8	6.1	13.1	13.8	5.8	5.1	7.8	14.1	3.8	7.2	12.6	5.6	25.6	9.1	5.3	9.8	20.6	6.8	8.0	5.6	22.4	11.5	9.2	0.5	1.2	0.9	1.3	1.6	1.0	0.6	0.6	1.2	0.7	0.4	0.8	1.0	3.0	0.6	4.9	1.1	0.5	1.4	10.7	15.9	5.2	36.7	24.2	3.4	10.0	4.4	8.5	0.5	7.3	18.4	15.2	3.2	11.3	11.4	9.2	6.9	3.7	11.6	8.6	14.7	11.9	8.9	8.0	12.8	6.9	11.0	10.4	5.9	9.0	16.1	1.9	7.9	30.1	5.9	12.6	10.0	11.4	7.4	17.9	11.2	9.6	12.3	20.4	11.6	13.3	14.7	16.8	15.3	8.5	35.3	15.7	13.9	20.3	16.7	10.2	54.3	10.2	13.1	3.6	4.7	14.9	6.5	12.3	9.0	9.5	10.6	13.9	9.4	9.0	6.3	20.1	15.4	6.1	11.2	13.1	7.9	14.8	7.2	6.9	8.8	10.4	12.4	11.4	14.4	12.2	4.1
CAPRIN1	"caprin-1, GPIAP1, M11S1, RNG105"	ENSG00000135387	"Cell cycle associated protein 1"	Q14444	11	34051731-34102610	"Predicted intracellular proteins"	Differentiation	"Protein synthesis inhibitor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 483.0;Late spermatids: 289.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018126, HPA063617"	Approved		Enhanced	Cytosol		NA	NA		43000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA018126: AB_1849929, HPA063617: AB_2685062"	"unprognostic (3.79e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (8.67e-8)"	"unprognostic (3.79e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.22e-1)"	45.2	30.6	26.1	42.2	28.6	70.3	56.8	25.0	30.9	56.8	21.8	48.8	46.0	52.7	30.5	47.1	61.8	41.7	44.9	28.7	28.3	49.9	39.9	43.3	42.9	26.1	26.7	60.5	47.5	59.9	21.6	53.8	27.3	45.7	60.5	58.7	38.6	53.5	45.3	30.3	41.1	66.2	32.3	40.1	42.1	123.0	26.9	77.6	53.3	54.0	62.6	58.9	31.8	36.7	134.7	168.8	245.6	137.2	180.9	182.5	117.5	168.0	175.8	202.4	188.2	154.9	80.8	211.1	104.9	213.9	169.4	173.1	311.9	204.3	244.9	134.7	155.5	174.1	153.3	131.9	109.4	282.0	122.8	164.0	109.2	129.1	236.3	174.7	204.2	153.7	228.1	103.6	211.3	114.5	243.7	55.8	114.8	155.3	150.6	191.8	339.2	93.7	120.4	263.1	155.5	147.7	202.6	101.1	88.8	150.5	183.5	104.4	205.3	172.7	116.4	167.9	190.8	110.9	175.5	238.7	117.2	116.3	191.7	25.0	33.3	13.9	18.8	39.7	27.3	19.4	20.9	23.2	39.0	17.8	21.6	21.1	13.5	30.7	43.4	18.2	28.1	31.0	26.1	28.6	25.0	30.9	28.7	28.3	26.1	26.7	27.3	32.3	26.9	36.7	42.1	35.3	43.5	37.9	46.0	77.8	45.5	51.5	68.9	38.1	63.7	43.9	55.4	24.3	37.2	64.4	18.8	46.7	47.2	46.0	31.3	56.6	483.0	90.0	116.5	52.1	71.8	79.0	37.4	60.1	60.2	54.6	65.7	132.2	17.1	63.1	39.7	46.1	57.2	25.2	38.8	51.1	54.9	75.8	72.3	289.3	47.8	57.9	39.2	37.5	57.0	36.7	35.0	44.2	53.1	71.3	40.4	72.6	83.0	72.7	42.9	47.4	49.5	32.3	39.5	40.4	64.3	201.7	74.8	93.2	72.9	45.8	46.5	53.9	65.5	77.7
CASP8AP2	"CED-4, FLASH, FLJ11208, KIAA1315, RIP25"	ENSG00000118412	"Caspase 8 associated protein 2"		6	89829894-89874436	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in single"		"brain: 2.6"	"Cell type enhanced"	"Detected in many"		"Spermatogonia: 74.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053573			Approved	"Nucleoli,Nuclear bodies"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoli, Nuclear bodies"		"HPA053573: AB_2682194"	"unprognostic (7.80e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.75e-4)"	"unprognostic (4.58e-1)"	"unprognostic (4.36e-3)"	"unprognostic (2.20e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (1.88e-5)"	"unprognostic (2.35e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.53e-1)"	0.6	0.3	0.4	0.4	1.0	0.2	0.5	2.6	1.2	0.7	0.3	0.9	0.0	0.7	0.0	0.4	0.6	0.1	0.4	0.6	0.4	0.4	0.2	0.5	0.4	0.5	0.5	0.5	0.5	0.1	0.4	0.1	0.8	0.5	0.1	0.0	0.4	0.0	0.8	0.4	0.5	0.2	0.8	0.4	0.3	0.3	0.7	0.6	0.6	0.7	0.2	0.6	0.5	1.9	0.4	1.0	1.3	1.0	0.1	0.4	0.3	2.1	0.2	0.7	0.5	0.8	0.5	2.4	0.7	1.0	0.8	0.7	2.5	0.6	0.7	3.7	3.5	4.0	3.0	0.0	0.0	2.6	1.1	0.2	0.2	1.6	0.6	0.2	0.8	1.4	4.4	1.3	0.6	0.7	1.6	0.0	0.2	0.2	1.3	3.3	3.8	0.9	0.0	3.2	1.4	0.8	1.8	0.0	0.5	0.5	0.4	1.2	1.6	0.3	0.5	1.6	1.6	0.2	2.8	1.3	0.5	1.4	1.4	14.4	1.5	5.6	6.2	2.6	5.9	5.5	7.1	6.5	1.9	6.3	5.4	5.6	3.1	12.6	2.3	4.9	6.6	2.3	0.4	1.0	2.6	1.2	0.6	0.4	0.5	0.5	0.8	0.8	0.7	1.9	27.3	32.1	14.5	26.1	26.8	0.0	9.1	0.0	13.6	19.5	13.3	16.4	47.5	7.2	11.8	7.3	6.2	20.5	21.4	12.7	3.9	15.1	5.9	9.6	22.1	21.1	2.4	35.7	32.3	12.3	15.8	21.4	11.7	13.7	15.8	31.8	9.7	6.9	12.4	35.3	33.5	11.7	0.0	11.5	0.0	4.7	23.0	16.1	0.0	33.7	26.9	18.1	34.0	23.6	38.2	9.3	10.3	25.9	14.4	13.2	11.8	7.2	13.8	25.5	19.7	30.6	25.1	47.2	74.2	15.7	0.0	10.9	24.7	16.7	14.6	9.1
CATSPER3	CACRC	ENSG00000152705	"Cation channel sperm associated 3"	Q86XQ3	5	134967907-135011696	"Predicted membrane proteins, Transporters"	"Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport"	"Calcium channel, Developmental protein, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 29.6"	"Group enriched"	"Detected in some"	5	"Early spermatids: 197.9;Late spermatids: 64.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"									NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"				"unprognostic (2.59e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.71e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.04e-2)"	"unprognostic (5.58e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.96e-3)"	0.5	0.8	0.8	0.2	0.9	0.6	0.5	0.9	1.2	0.7	1.8	0.7	0.6	0.5	0.6	0.5	1.0	0.1	0.7	0.7	0.9	1.6	1.8	0.4	0.3	1.0	0.9	0.8	1.4	0.4	0.8	0.2	0.9	0.9	0.5	2.7	0.8	0.4	3.0	0.5	0.7	0.3	0.8	0.7	0.8	29.6	0.9	0.5	0.7	1.8	0.4	0.7	0.5	0.9	0.1	1.4	0.5	0.6	0.4	0.1	0.3	0.2	0.1	2.8	0.2	0.8	1.2	0.5	0.7	0.1	0.2	0.4	0.9	0.4	0.2	0.8	1.0	0.1	0.8	0.4	0.2	0.4	0.3	0.1	0.7	0.2	1.0	0.2	0.0	0.3	0.6	0.9	0.1	0.6	0.6	0.9	0.1	1.1	0.7	0.7	0.2	0.3	1.2	0.2	0.4	0.4	0.5	0.4	0.4	0.4	0.5	0.8	0.4	0.0	0.4	0.1	0.6	0.4	0.4	0.1	0.2	0.9	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.2	0.4	1.7	0.5	0.1	0.1	1.2	0.0	0.2	0.0	0.1	0.8	0.9	0.9	1.2	0.7	0.9	1.0	0.9	0.9	0.8	0.9	0.9	0.1	0.0	0.0	21.9	0.2	0.0	0.3	0.5	0.0	0.2	0.3	0.1	1.0	1.5	0.3	0.0	0.0	0.1	0.1	0.2	0.0	0.7	197.9	0.5	0.1	0.3	0.0	0.0	6.4	1.1	0.3	0.2	0.0	0.2	0.0	0.9	0.4	0.8	0.4	0.0	7.8	0.1	2.0	0.3	0.4	64.3	1.5	0.3	0.0	7.5	0.7	1.4	0.0	9.0	7.9	0.3	0.0	0.7	0.0	0.3	0.7	1.5	0.3	2.4	0.0	0.3	0.2	4.7	1.4	0.0	0.3	0.1	0.1	0.1	0.6	0.2
CBFB	PEBP2B	ENSG00000067955	"Core-binding factor subunit beta"	Q13951	16	67028984-67101058	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 243.7;U-698: 336.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038852	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		18000	"Cluster 38: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"HPA038852: AB_10795358"	"unprognostic (1.05e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.22e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.80e-3)"	"prognostic unfavorable (2.83e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (2.89e-8)"	"unprognostic (1.03e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.20e-1)"	18.2	11.7	5.7	17.3	12.0	11.8	16.5	9.3	7.3	19.2	6.0	11.4	5.5	15.4	2.7	23.3	16.6	5.2	18.0	7.1	8.1	16.4	14.2	18.1	16.3	13.9	9.3	17.3	14.7	9.8	15.0	7.3	11.5	14.5	3.5	3.8	21.3	4.8	38.6	17.4	14.5	4.9	8.6	18.0	15.1	6.9	9.5	13.4	15.9	10.5	12.1	15.2	20.3	17.2	54.8	43.7	14.8	40.6	8.7	12.2	54.0	76.1	23.6	43.6	30.0	79.1	51.0	106.3	81.2	39.7	16.3	53.7	30.7	22.6	29.2	63.3	48.3	67.2	27.3	38.0	17.8	77.7	171.3	18.2	11.1	51.3	30.4	10.2	25.4	42.2	104.9	28.9	20.8	44.5	115.8	28.9	25.5	16.4	74.1	243.7	92.7	73.4	15.5	43.2	37.9	31.5	166.2	11.0	37.6	10.4	15.4	28.6	87.1	70.8	70.2	34.6	79.6	76.8	147.8	336.8	50.2	50.7	65.0	29.2	7.6	6.3	6.0	9.5	6.5	6.2	5.5	6.4	10.2	7.2	5.0	3.9	4.1	18.2	5.6	2.3	6.0	5.6	5.7	12.0	9.3	7.3	7.1	8.1	13.9	9.3	11.5	8.6	9.5	17.2	20.1	9.6	20.2	37.2	38.2	56.2	42.2	18.0	27.9	5.8	27.8	14.7	19.8	21.5	18.8	40.5	12.5	15.8	30.0	11.9	27.4	17.6	6.1	23.8	16.0	26.1	19.0	18.5	11.5	28.0	32.1	28.7	16.8	29.8	27.8	34.2	28.5	15.8	37.9	10.1	16.5	12.8	22.4	41.9	66.8	7.6	23.9	39.1	51.6	53.4	25.0	13.2	44.3	97.5	99.8	74.1	6.8	21.1	38.3	50.5	6.9	11.6	20.8	15.3	13.1	21.6	21.0	17.4	19.1	32.2	63.1	17.0	48.6	11.2	11.8	62.0
CBL	"c-Cbl, CBL2, RNF55"	ENSG00000110395	"Cbl proto-oncogene"	P22681	11	119206298-119313926	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 8.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004350, HPA027956"	Enhanced		Approved	Cytosol		NA	NA		67000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"CAB004350: AB_2244054, HPA027956: AB_10601094"	"unprognostic (2.52e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.10e-3)"	"unprognostic (9.75e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.03e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.21e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.85e-2)"	6.8	4.0	5.6	9.5	5.7	8.5	5.6	5.3	6.5	5.0	0.2	6.2	3.9	6.5	3.4	5.6	5.6	3.9	4.1	5.3	8.1	4.4	2.7	7.9	10.7	5.8	6.3	3.7	3.8	6.1	2.9	6.4	6.5	4.0	5.0	8.3	3.6	4.6	2.5	5.2	6.6	7.4	5.2	9.9	5.2	18.2	7.9	22.5	4.1	3.2	11.2	5.8	4.9	6.0	10.7	7.6	26.6	16.7	7.8	9.2	16.0	11.2	11.4	10.8	10.2	16.7	12.6	25.1	10.0	14.0	21.7	15.2	18.4	9.4	22.7	14.8	4.7	26.4	6.2	5.1	9.5	30.3	27.9	8.1	10.1	26.7	28.4	11.1	26.3	23.7	21.7	9.9	19.1	11.3	16.2	17.0	14.0	9.2	8.8	17.5	13.5	4.6	9.3	8.2	3.7	11.3	20.9	8.8	7.3	18.1	9.4	24.8	22.8	16.0	11.5	11.6	14.7	3.3	5.3	19.9	6.7	25.4	11.9	0.8	2.4	2.0	0.9	2.8	0.8	1.5	1.1	0.9	2.6	1.2	1.2	1.3	8.6	0.4	2.5	1.4	1.0	0.9	5.6	5.7	5.3	6.5	5.3	8.1	5.8	6.3	6.5	5.2	7.9	6.0	23.2	9.6	8.3	23.5	23.2	18.0	5.9	7.5	19.4	14.0	13.6	11.7	8.8	5.7	6.0	11.0	45.9	6.3	24.0	7.6	1.9	6.1	28.2	9.9	19.6	23.2	8.4	5.7	38.5	6.7	10.5	9.4	9.2	16.8	3.8	20.8	20.0	3.1	16.0	13.5	39.1	4.9	2.0	59.1	43.2	42.0	7.8	41.2	16.0	45.0	46.8	13.2	22.6	26.2	19.6	10.6	11.6	12.8	19.7	8.0	5.1	5.4	4.8	33.3	26.3	11.6	22.7	38.0	36.2	18.5	21.9	7.0	24.9	10.6	5.1	10.9
CBLL1	"FLJ23109, HAKAI, RNF188"	ENSG00000105879	"Cbl proto-oncogene like 1"	Q75N03	7	107743949-107761667	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021773, HPA026699"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA021773: AB_1846103, HPA026699: AB_1846104"	"unprognostic (1.90e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.79e-2)"	"unprognostic (8.16e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.96e-3)"	"unprognostic (4.28e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.12e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.71e-2)"	11.2	8.1	3.1	12.5	5.3	40.0	15.1	7.8	9.5	12.0	3.0	11.3	9.5	13.5	8.4	11.3	11.2	8.7	10.4	4.2	5.8	10.0	11.2	10.3	16.1	4.1	3.7	14.3	11.7	14.1	5.1	12.0	4.1	16.5	11.1	14.4	8.9	12.7	29.0	10.7	10.3	13.4	3.0	14.2	9.2	19.7	3.7	20.2	13.8	21.0	17.8	11.9	7.2	6.6	27.8	31.1	23.7	30.7	21.7	18.6	16.2	20.5	21.6	22.8	22.5	21.4	27.9	40.6	28.5	23.5	37.6	19.3	33.4	25.0	31.0	28.4	21.1	32.5	23.0	18.2	24.9	49.1	30.9	19.6	22.7	30.7	33.0	17.6	23.8	27.8	53.0	33.3	22.4	48.0	66.5	34.4	34.4	23.3	21.3	30.6	25.4	42.0	17.4	25.5	25.4	39.6	30.7	44.9	23.4	27.7	15.1	24.7	23.4	35.0	25.0	33.4	32.0	53.0	62.3	64.1	21.3	29.8	30.3	88.8	31.1	53.3	39.5	32.0	58.2	39.0	61.9	45.8	36.9	39.8	41.8	40.0	48.9	55.1	38.0	20.1	92.6	48.4	3.1	5.3	7.8	9.5	4.2	5.8	4.1	3.7	4.1	3.0	3.7	6.6	18.2	19.2	11.0	6.5	29.6	23.6	16.7	10.5	27.3	12.2	15.9	13.7	16.4	17.2	10.7	3.7	4.2	10.3	27.6	9.9	7.9	9.7	12.4	15.6	19.8	13.5	16.8	39.1	13.9	10.8	9.5	12.6	10.7	13.7	13.3	16.6	12.5	11.0	10.7	10.1	13.1	8.0	8.2	23.3	12.4	5.4	9.3	15.1	19.6	15.9	15.0	7.6	25.7	10.1	20.5	10.1	15.0	11.7	17.3	16.2	8.5	11.2	8.9	14.4	19.7	13.2	14.5	27.2	14.3	19.5	19.9	10.3	27.3	9.5	10.0	18.4
CBX3	HP1Hs-gamma	ENSG00000122565	"Chromobox 3"	Q13185	7	26201162-26213607	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB001973, HPA004902"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes		180000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"CAB001973: , HPA004902: AB_1850635"	"prognostic unfavorable (7.92e-4)"	"unprognostic (1.43e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.85e-2)"	"unprognostic (9.25e-3)"	"prognostic unfavorable (2.20e-8)"	"unprognostic (2.13e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.71e-3)"	"prognostic unfavorable (4.00e-4)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (4.56e-7)"	"unprognostic (7.79e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.78e-2)"	76.2	93.0	55.5	99.2	57.8	168.8	98.5	58.8	74.1	65.0	56.6	75.3	105.8	76.7	79.7	63.9	62.9	58.5	64.2	54.2	63.2	87.6	84.9	62.1	145.7	60.2	61.0	79.5	56.3	51.5	40.5	88.8	60.7	56.6	87.2	122.7	61.3	59.8	87.2	54.7	99.0	65.9	60.2	82.0	61.7	99.6	58.2	190.4	55.3	68.6	140.4	84.1	55.7	63.6	365.4	156.3	330.0	332.2	115.0	205.8	257.8	275.9	209.1	205.2	207.2	185.8	296.8	544.1	218.7	183.9	440.6	283.0	275.7	231.2	332.1	151.8	209.1	312.8	201.0	208.5	126.1	508.3	294.7	153.9	197.5	163.2	231.2	253.9	281.7	343.2	506.1	263.9	351.7	207.5	489.4	625.9	424.4	311.3	225.1	313.6	303.9	452.3	303.8	201.4	401.1	448.2	230.5	482.6	274.9	345.3	412.4	455.1	212.0	186.0	340.5	222.1	376.8	394.6	596.5	929.3	163.2	422.3	864.3	135.7	85.9	137.7	77.3	116.3	96.9	86.8	114.4	96.1	89.1	77.7	118.4	119.6	92.6	99.2	123.2	72.4	148.3	87.2	55.5	57.8	58.8	74.1	54.2	63.2	60.2	61.0	60.7	60.2	58.2	63.6	139.1	109.0	98.4	16.3	158.5	143.6	93.3	128.0	105.3	101.8	223.8	181.0	124.1	133.0	119.7	64.4	77.2	176.3	138.7	111.2	140.8	167.6	162.2	132.4	215.4	142.6	110.2	306.6	27.4	141.4	362.1	123.6	81.1	129.0	222.0	166.2	145.3	289.2	143.1	50.5	26.8	156.6	107.8	254.9	200.0	41.9	136.4	157.6	104.9	15.0	183.3	155.9	166.9	23.1	35.8	166.3	103.8	98.2	129.1	135.1	112.6	187.4	107.3	132.1	78.9	60.0	110.1	274.5	388.6	112.5	107.8	270.8	155.2	133.1	205.9	110.9
CBX5	"HP1, HP1-ALPHA, HP1Hs-alpha"	ENSG00000094916	"Chromobox 5"	P45973	12	54230942-54280133	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 102.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016699, CAB017548"	Enhanced		Enhanced	Nucleoplasm		NA	NA		22000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB017548: AB_2071368, HPA016699: AB_1850627"	"unprognostic (1.58e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.05e-3)"	"unprognostic (3.80e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.97e-3)"	"unprognostic (6.39e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.26e-2)"	"unprognostic (8.64e-2)"	8.1	14.0	20.9	12.6	22.4	17.2	13.8	14.1	19.8	10.9	102.6	10.5	7.5	9.7	15.0	9.4	16.0	8.9	20.8	19.3	37.3	17.2	8.0	9.5	18.8	18.7	25.7	18.3	9.9	25.6	19.8	12.3	22.3	11.5	10.9	22.9	8.6	11.8	13.8	17.3	8.7	10.8	24.4	10.7	10.3	25.4	39.1	31.0	23.9	7.7	21.5	7.1	8.4	28.8	33.1	96.3	147.9	68.5	19.3	41.4	34.2	50.1	35.8	41.5	42.8	37.8	102.8	91.0	65.3	49.7	49.4	27.1	106.1	31.2	70.2	144.7	23.1	80.1	108.4	13.5	15.0	42.8	32.8	20.6	20.6	71.0	62.1	46.8	46.4	82.6	92.8	87.4	69.2	57.4	137.2	44.8	118.6	13.9	11.5	133.9	82.7	50.6	43.1	30.0	73.9	113.5	93.6	21.0	10.7	58.0	80.6	71.5	61.4	69.3	59.5	26.6	59.8	22.0	25.9	169.4	44.3	43.0	74.3	1.0	5.4	4.7	6.8	6.0	5.5	11.7	7.3	6.5	9.3	14.3	7.2	6.7	0.8	7.7	8.1	21.8	10.0	4.3	20.9	22.4	14.1	19.8	19.3	37.3	18.7	25.7	22.3	24.4	39.1	28.8	39.4	38.5	50.5	33.3	46.5	46.3	42.6	46.5	40.9	120.5	59.6	55.4	138.2	55.8	47.0	82.8	45.9	58.2	32.1	25.9	105.7	61.7	117.4	53.9	58.9	49.1	27.0	102.2	28.4	59.7	56.5	69.0	22.4	37.0	30.9	81.3	38.6	37.5	38.7	183.4	38.9	37.6	48.8	22.9	35.8	58.3	64.7	25.9	35.6	23.4	44.5	68.6	36.0	46.3	40.0	45.4	14.1	80.5	49.2	41.4	11.6	63.2	79.3	64.1	32.9	70.2	67.9	221.4	80.1	40.8	32.7	26.1	40.5	83.5	44.1	29.8
CCAR1	"CARP-1, CARP1, FLJ10590"	ENSG00000060339	"Cell division cycle and apoptosis regulator 1"	Q8IX12	10	68721012-68792377	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Transcription, Transcription regulation"	"Activator, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007856, HPA048513"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Golgi apparatus"	"HPA007856: AB_1078415, HPA048513: AB_2680424"	"unprognostic (1.71e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.15e-3)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.41e-5)"	"unprognostic (1.10e-1)"	"unprognostic (3.25e-2)"	"prognostic favorable (4.05e-5)"	"unprognostic (2.89e-2)"	"unprognostic (3.21e-3)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (1.67e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.41e-2)"	17.4	21.4	14.4	20.2	16.0	23.4	17.2	21.1	25.4	15.9	15.2	17.9	16.8	16.7	16.1	20.1	14.5	16.5	15.6	13.6	17.0	18.4	19.1	15.9	30.3	16.9	14.9	19.9	20.4	15.9	14.5	21.7	16.4	17.3	22.2	20.9	18.5	13.5	20.6	23.9	19.4	16.0	13.2	21.5	17.8	14.3	16.8	29.8	18.2	17.9	28.7	21.7	17.0	19.2	64.0	64.8	73.9	49.7	31.4	30.3	57.7	56.0	47.4	59.3	40.0	87.2	50.8	74.7	29.9	39.1	29.8	49.3	78.4	44.3	64.8	51.5	48.2	60.1	46.1	54.5	35.7	96.2	67.5	30.5	54.2	50.1	61.7	36.7	48.5	37.5	83.5	46.8	58.8	46.5	64.2	60.7	74.1	49.7	58.4	74.2	44.1	44.7	52.5	48.6	42.7	36.9	55.1	89.1	57.1	57.6	60.6	58.9	48.1	36.8	46.3	40.1	61.4	32.2	45.5	78.5	30.8	63.8	35.6	6.1	14.6	14.3	16.3	13.0	14.6	14.2	11.3	15.8	21.0	17.3	13.5	14.3	3.3	10.6	15.5	13.1	18.4	11.3	14.4	16.0	21.1	25.4	13.6	17.0	16.9	14.9	16.4	13.2	16.8	19.2	50.5	35.3	85.5	61.4	69.2	37.0	49.6	54.7	66.0	51.0	36.1	40.0	65.5	41.5	49.0	46.0	58.4	73.1	62.9	44.1	23.5	68.0	28.8	55.2	68.5	54.0	46.1	61.2	49.7	78.1	83.8	49.2	45.3	62.2	67.2	76.8	39.3	40.4	49.2	55.5	51.2	55.1	30.5	47.4	36.3	14.5	53.7	49.8	21.4	41.2	65.4	36.5	66.9	47.7	66.1	77.7	34.2	50.4	61.0	45.3	36.0	18.3	49.1	68.7	65.7	53.2	62.3	128.7	77.2	50.4	37.4	109.5	61.3	83.2	67.2	49.4
CCDC137	MGC16597	ENSG00000185298	"Coiled-coil domain containing 137"	Q6PK04	17	81666737-81673904	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052637, HPA053914"	Uncertain		Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Mitotic chromosome"		"HPA052637: AB_2681894, HPA053914: AB_2682306"	"unprognostic (3.04e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (1.35e-7)"	"prognostic unfavorable (8.32e-4)"	"unprognostic (2.21e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (1.16e-7)"	"unprognostic (4.26e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.39e-1)"	8.2	9.5	13.8	12.3	13.7	17.7	7.6	13.5	17.5	10.7	14.2	9.3	11.4	7.5	5.5	23.1	7.8	6.1	6.5	13.7	13.8	10.2	10.8	7.7	16.3	14.4	14.3	6.7	8.2	7.0	6.2	7.7	14.7	11.7	5.8	2.8	9.9	6.4	7.7	22.8	10.7	6.0	13.4	15.6	8.8	10.4	14.5	11.8	7.8	4.5	11.5	9.8	13.8	14.3	38.0	62.8	21.5	35.3	13.9	13.1	35.2	41.6	19.7	53.0	30.6	55.1	22.8	33.8	22.4	21.2	36.6	47.9	34.5	43.8	30.6	19.4	51.7	51.6	30.1	48.0	20.7	46.6	37.5	19.8	26.3	47.6	26.3	14.6	37.4	41.1	53.3	19.1	28.3	34.5	45.7	56.6	46.9	32.9	59.8	55.4	34.6	24.1	19.8	29.6	45.1	57.7	41.1	87.8	37.1	28.9	58.8	48.3	27.8	82.0	53.5	34.9	65.9	53.1	28.7	36.8	30.8	42.9	48.8	2.2	7.7	11.7	11.5	9.6	6.3	10.4	8.7	8.8	7.5	13.2	9.2	8.8	3.3	13.1	11.9	12.9	9.8	5.9	13.8	13.7	13.5	17.5	13.7	13.8	14.4	14.3	14.7	13.4	14.5	14.3	17.9	22.4	17.0	5.9	29.8	31.7	22.8	19.7	74.6	6.8	17.4	13.7	6.7	15.7	20.9	12.9	2.1	25.7	31.5	19.7	19.6	25.2	1.7	26.5	32.9	20.3	7.2	37.5	4.5	21.4	41.0	16.5	29.0	29.4	19.6	28.1	15.4	11.8	24.3	18.5	4.6	17.0	14.2	12.9	11.5	1.7	13.7	16.8	16.0	4.7	24.2	13.8	37.0	4.0	5.0	35.2	16.0	13.5	25.7	40.0	12.4	15.9	21.6	9.1	6.6	13.7	22.3	30.8	44.9	57.0	34.4	20.8	29.7	22.8	22.4	24.2
CCDC138	FLJ32745	ENSG00000163006	"Coiled-coil domain containing 138"	Q96M89	2	108786757-108885477	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 10.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 154.1;Excitatory neurons: 56.5;Inhibitory neurons: 58.9;Oligodendrocytes: 48.7;Respiratory ciliated cells: 43.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049899, HPA054223"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA049899: AB_2680941, HPA054223: AB_2682420"	"unprognostic (2.34e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.22e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.24e-5)"	"unprognostic (2.89e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.56e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.77e-2)"	"unprognostic (7.06e-4)"	"unprognostic (7.88e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.69e-1)"	"unprognostic (8.93e-2)"	1.0	0.9	2.0	2.0	1.8	3.5	2.4	4.8	3.1	1.3	2.1	1.9	1.0	2.1	1.3	2.1	4.3	1.8	0.7	2.4	2.3	1.7	2.8	1.3	4.5	2.6	2.4	1.6	1.7	0.7	0.8	1.3	2.4	1.4	2.3	2.3	1.3	0.7	1.0	2.4	1.7	1.5	2.0	1.2	1.8	10.9	2.0	6.4	0.8	0.7	3.8	1.6	1.3	3.0	14.7	6.7	22.4	11.6	1.8	2.0	14.2	6.3	2.0	14.6	10.6	21.8	8.4	35.2	9.2	2.0	7.3	12.2	16.3	8.5	13.0	8.2	21.0	16.3	11.6	18.2	2.2	22.4	2.3	1.4	2.5	17.2	5.1	2.2	7.7	15.0	31.4	15.8	7.5	8.2	32.2	15.3	33.3	8.0	6.9	21.1	21.2	21.3	8.1	11.5	15.7	15.3	13.6	7.3	11.1	13.6	7.8	10.7	4.9	9.2	16.2	6.0	13.5	4.9	12.2	36.4	3.8	17.2	9.3	2.6	0.5	0.8	1.1	1.2	2.2	3.0	1.5	2.3	0.5	3.2	2.2	2.6	0.3	2.0	0.4	4.8	2.4	1.2	2.0	1.8	4.8	3.1	2.4	2.3	2.6	2.4	2.4	2.0	2.0	3.0	2.4	0.0	3.3	14.7	7.9	2.4	3.5	4.5	6.8	7.3	3.6	3.9	1.4	2.8	9.6	1.8	8.4	5.2	13.6	0.9	1.9	3.7	154.1	38.9	7.0	2.7	5.4	5.9	56.5	1.4	5.5	6.3	8.6	7.3	4.5	6.7	1.1	2.4	2.2	6.7	58.9	2.5	2.0	1.6	1.5	34.0	3.7	3.9	1.8	10.3	1.3	1.8	6.2	19.1	48.7	3.3	0.5	1.9	14.4	1.1	0.7	1.7	43.8	7.0	0.0	5.0	3.5	29.5	20.1	7.0	2.8	1.4	5.9	5.5	2.9	2.3
CCDC15	FLJ13215	ENSG00000149548	"Coiled-coil domain containing 15"	Q0P6D6	11	124954121-125041489	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 10.5"	"Group enriched"	"Detected in many"	5	"Early spermatids: 42.8;Erythroid cells: 26.3;Late spermatids: 25.8;Spermatocytes: 99.7;Spermatogonia: 34.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA040450, HPA041738"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Plasma membrane"	Cytosol	"HPA040450: AB_10794031, HPA041738: AB_10794675"	"unprognostic (2.38e-1)"	"unprognostic (3.93e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.59e-4)"	"unprognostic (2.12e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.04e-2)"	"unprognostic (9.05e-3)"	"unprognostic (3.25e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.33e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.66e-1)"	0.7	0.3	0.5	0.9	0.8	2.1	2.8	0.5	0.6	0.6	0.3	0.8	0.7	0.6	1.5	0.8	1.1	0.5	0.2	0.6	0.5	0.6	1.3	0.7	1.2	0.9	0.6	0.8	0.8	0.6	0.5	0.7	0.6	1.6	0.8	1.7	3.9	0.5	0.1	2.1	0.7	0.6	0.7	0.8	0.6	10.5	0.7	2.8	0.7	0.2	1.4	0.5	0.6	1.2	5.4	1.0	6.9	0.0	0.5	1.9	0.0	5.7	6.9	5.3	6.5	0.1	4.4	6.3	4.9	2.0	10.5	4.2	2.9	3.8	9.4	5.3	1.1	7.7	0.8	1.6	0.2	2.3	4.3	0.5	2.7	11.0	5.5	1.0	4.0	7.8	5.2	6.3	11.2	1.2	4.9	2.6	1.6	4.6	6.3	5.9	12.6	2.0	0.8	2.1	3.9	3.4	3.3	0.4	1.5	3.3	7.9	2.0	2.9	10.8	2.4	4.8	7.2	1.5	1.8	5.3	1.5	12.6	7.3	4.0	0.5	0.8	1.0	0.7	1.1	0.3	0.9	1.7	0.1	0.7	1.2	1.4	0.4	1.1	0.8	0.5	1.7	0.5	0.5	0.8	0.5	0.6	0.6	0.5	0.9	0.6	0.6	0.7	0.7	1.2	2.4	3.2	1.1	5.2	2.3	5.0	2.1	2.2	2.2	6.4	4.2	2.8	0.6	0.0	2.9	0.0	0.0	0.9	2.9	1.1	0.0	2.3	42.8	2.6	2.0	3.4	1.2	26.3	1.2	3.5	0.4	2.5	3.6	1.4	8.9	4.4	1.4	1.4	3.2	3.3	2.0	2.1	0.0	2.6	3.3	25.8	4.4	2.6	3.6	1.0	0.7	3.6	8.2	5.0	6.1	1.8	0.5	2.2	1.2	1.1	0.2	1.0	5.3	2.8	6.6	2.2	2.3	99.7	34.5	3.2	3.8	0.1	3.4	0.9	1.7	1.2
CCDC18	NY-SAR-41	ENSG00000122483	"Coiled-coil domain containing 18"	Q5T9S5	1	93179919-93278730	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.6;lymphoid tissue: 8.9;testis: 9.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 50.5;Spermatocytes: 137.2;Spermatogonia: 47.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA028035	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA028035: AB_10601795"	"unprognostic (8.79e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.89e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.49e-4)"	"unprognostic (4.36e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.44e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.64e-13)"	"unprognostic (4.94e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.44e-1)"	1.9	1.0	1.3	4.3	1.4	10.6	1.1	1.6	1.1	1.0	1.0	1.9	1.7	1.2	0.8	1.6	0.7	1.1	1.0	1.1	1.3	0.6	2.0	1.7	8.9	1.4	1.3	1.3	0.4	0.3	0.8	1.3	1.4	0.6	2.7	0.6	0.7	0.3	2.0	2.1	1.6	1.2	1.1	3.5	1.5	9.5	1.3	6.5	0.7	0.9	5.9	1.6	0.9	1.4	24.8	8.1	18.7	5.9	4.5	4.7	9.7	15.1	7.9	15.1	15.3	4.3	8.3	31.9	8.2	8.1	14.7	11.5	8.2	11.8	21.9	15.9	10.7	21.9	18.5	7.6	1.6	23.1	9.8	3.1	1.0	11.5	11.1	4.2	10.0	14.0	23.8	23.9	20.4	3.5	11.1	9.3	17.1	6.7	10.0	14.0	22.3	9.4	7.4	10.9	8.2	5.2	21.4	10.8	6.1	8.3	5.1	13.3	7.7	17.7	12.4	11.5	17.5	10.2	14.5	18.8	3.7	20.1	4.8	5.1	3.6	5.8	2.3	4.1	2.7	10.2	2.1	2.2	1.7	11.6	1.7	1.9	6.0	1.2	3.8	12.5	2.5	0.5	1.3	1.4	1.6	1.1	1.1	1.3	1.4	1.3	1.4	1.1	1.3	1.4	5.0	19.2	9.6	16.6	17.6	4.1	7.9	4.5	8.0	2.4	3.8	4.2	9.5	0.0	3.6	3.7	4.2	5.7	18.4	3.6	0.0	2.3	50.5	6.6	7.6	4.6	0.0	40.2	13.2	2.9	6.7	8.8	8.2	6.1	19.0	13.5	5.0	4.5	8.2	1.7	12.6	3.2	6.1	14.2	10.4	16.3	6.2	17.5	3.6	15.0	12.9	0.7	7.2	7.5	15.7	2.0	4.4	6.4	22.7	4.6	2.1	1.5	5.6	0.7	6.6	9.8	8.1	137.2	47.7	8.2	7.2	2.9	15.7	5.1	6.9	8.9
CCDC43	FLJ31795	ENSG00000180329	"Coiled-coil domain containing 43"	Q96MW1	17	44673069-44689779	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 73.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023078, HPA023391"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA023078: , HPA023391: AB_1846146"	"unprognostic (6.05e-2)"	"unprognostic (8.91e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (3.42e-5)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (1.89e-1)"	"unprognostic (1.14e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.11e-1)"	9.6	10.2	9.5	11.4	10.3	20.8	12.5	11.5	14.3	9.3	8.1	12.1	11.7	10.0	10.9	12.0	9.3	7.5	20.4	10.6	10.3	14.2	9.5	9.7	13.5	9.5	9.0	8.1	9.6	15.4	4.8	14.0	10.2	12.0	14.9	18.5	8.9	8.9	73.5	11.3	9.7	10.8	9.8	9.8	11.2	9.5	10.4	13.8	13.5	42.7	14.6	11.8	8.1	11.5	24.9	29.3	27.2	24.1	18.2	26.7	49.8	37.1	21.8	35.7	34.9	39.7	26.0	43.1	28.0	30.4	25.5	19.2	45.3	42.9	51.5	53.1	52.5	38.8	48.8	59.0	32.5	54.8	28.0	24.1	42.7	37.2	50.2	24.4	35.1	34.8	41.6	29.3	36.6	31.0	53.7	38.8	28.2	23.5	37.1	34.5	68.2	37.6	36.7	16.0	27.3	26.9	27.2	21.6	39.5	40.7	55.2	36.6	30.6	43.9	32.5	26.6	50.0	29.5	40.1	49.4	32.1	31.4	32.2	11.6	15.7	11.0	11.9	18.4	11.0	9.1	11.3	13.7	17.5	11.3	11.0	12.0	3.2	16.4	12.5	12.4	15.1	10.2	9.5	10.3	11.5	14.3	10.6	10.3	9.5	9.0	10.2	9.8	10.4	11.5	24.4	12.8	21.0	6.8	19.1	13.3	10.8	20.0	13.1	24.4	15.2	15.7	41.1	17.2	21.5	9.2	10.4	41.1	13.4	10.7	39.2	21.6	0.9	23.4	27.1	23.9	18.0	15.4	10.5	24.5	46.7	17.1	13.7	24.0	32.4	19.9	20.0	15.5	30.6	21.9	8.2	17.1	8.2	18.8	16.0	3.5	14.0	19.2	21.4	1.0	24.6	19.6	9.2	6.6	6.5	21.0	12.4	12.8	26.9	12.9	15.0	36.8	19.8	25.4	6.6	23.4	17.5	3.6	12.4	24.8	11.2	25.3	16.7	22.6	22.6	8.7
CCDC47	GK001	ENSG00000108588	"Coiled-coil domain containing 47"	Q96A33	17	63745255-63776351	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Chaperone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029674, HPA072573, HPA075958"	Approved		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Endoplasmic reticulum"		"HPA029674: AB_10602703, HPA072573: AB_2686535, HPA075958: "	"unprognostic (6.33e-2)"	"unprognostic (3.26e-2)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.53e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.16e-1)"	57.9	67.3	24.3	42.5	33.6	29.0	57.1	28.8	39.2	47.7	46.9	83.4	87.1	39.1	53.7	52.6	43.9	48.2	65.5	29.3	27.9	72.0	102.2	52.7	33.5	28.8	27.4	35.3	59.8	84.6	21.9	54.8	29.9	60.2	80.6	46.9	62.4	52.0	115.3	52.2	78.2	42.1	30.1	35.6	78.5	32.1	26.0	29.9	62.0	83.7	40.5	58.5	29.3	34.3	143.3	133.8	81.4	71.9	112.4	74.0	158.0	141.9	92.6	96.1	112.4	118.7	127.0	112.9	74.3	100.9	110.8	114.3	99.3	88.1	168.9	39.4	101.2	160.9	106.4	117.3	107.6	129.9	81.3	78.5	121.3	132.4	113.2	67.9	81.3	55.3	183.5	95.5	79.4	116.1	100.5	48.1	70.8	179.4	134.0	92.2	157.9	154.6	115.3	161.1	74.2	101.5	95.2	242.8	120.3	103.0	159.8	70.4	104.0	177.6	112.9	130.6	166.0	93.9	119.9	112.8	103.9	81.4	147.3	53.2	59.7	75.6	40.7	61.5	47.9	38.4	39.8	37.9	82.5	31.7	41.1	36.2	47.6	43.4	65.9	54.7	49.0	52.0	24.3	33.6	28.8	39.2	29.3	27.9	28.8	27.4	29.9	30.1	26.0	34.3	96.9	144.2	122.2	16.3	46.6	100.8	108.5	95.9	98.4	40.9	65.9	53.6	129.0	72.9	128.3	60.7	14.6	111.1	59.0	99.8	9.8	115.3	17.9	80.3	73.9	83.9	52.2	76.6	26.2	105.1	98.3	85.3	65.7	126.0	45.5	31.2	68.2	96.3	57.5	57.2	25.9	95.1	83.4	56.9	58.3	11.5	47.8	60.7	39.2	13.1	52.9	55.3	25.7	22.6	25.5	92.0	62.6	56.1	56.0	89.6	87.5	32.6	83.0	27.9	72.3	117.2	92.1	82.0	44.7	90.1	90.8	144.1	42.7	53.0	110.5	83.3
CCDC58	FLJ33273	ENSG00000160124	"Coiled-coil domain containing 58"	Q4VC31	3	122359591-122383231	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 114.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051965	Approved		Approved	Nucleoli,Mitochondria		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria	Nucleoli	"HPA051965: AB_2681676"	"unprognostic (1.51e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (5.64e-2)"	"unprognostic (6.98e-3)"	"prognostic unfavorable (2.94e-5)"	"unprognostic (2.72e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.98e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.84e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.86e-1)"	"prognostic favorable (7.29e-4)"	14.7	21.0	16.9	15.7	17.8	18.0	19.0	18.2	28.2	10.7	18.4	28.5	22.5	11.7	24.6	23.2	10.6	13.4	27.3	17.1	17.6	46.8	49.8	9.0	23.3	17.8	18.1	13.1	13.8	14.9	7.8	14.4	18.2	11.1	29.1	17.1	11.3	10.6	78.8	15.0	18.6	11.4	17.4	12.1	16.4	9.4	18.1	16.2	18.3	47.2	21.5	22.6	12.5	18.3	135.1	41.9	78.2	50.2	28.5	39.8	100.6	50.5	54.3	119.4	116.4	118.4	66.4	98.0	84.6	38.6	92.7	91.9	127.9	86.3	142.5	34.1	45.3	115.9	28.5	145.6	47.5	174.5	39.5	33.0	43.9	73.5	79.8	50.7	55.9	85.8	133.6	41.6	63.7	67.2	111.7	123.6	150.0	147.2	78.1	72.8	92.9	120.1	83.7	70.3	78.8	38.4	58.5	61.5	150.5	65.3	61.2	112.8	32.6	66.4	86.1	28.6	102.3	32.9	47.5	217.4	75.7	83.3	60.0	0.9	7.7	2.7	15.2	16.7	18.0	20.9	19.9	20.1	16.5	19.2	23.0	22.2	1.4	19.2	14.2	29.2	17.2	6.7	16.9	17.8	18.2	28.2	17.1	17.6	17.8	18.1	18.2	17.4	18.1	18.3	5.7	3.2	17.0	8.1	18.1	15.3	19.1	21.4	21.1	10.5	14.1	10.4	32.0	20.0	22.2	12.9	10.4	21.8	8.4	19.6	54.8	31.4	0.5	24.7	20.5	13.7	5.4	14.1	11.3	30.0	44.7	12.8	16.8	26.2	21.5	14.4	10.8	50.5	17.8	0.0	13.2	27.7	16.2	8.7	7.6	1.5	12.8	8.9	8.8	2.8	19.8	9.7	16.5	11.6	11.8	31.9	14.7	8.2	12.5	30.7	23.9	114.0	22.5	9.6	13.1	15.1	41.8	23.1	31.0	30.8	18.5	15.2	10.9	11.8	35.1	23.0
CCDC59	"BR22, HSPC128, TAP26"	ENSG00000133773	"Coiled-coil domain containing 59"	Q9P031	12	82223681-82358805	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038555	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Plasma membrane"	"HPA038555: AB_10669543"	"unprognostic (1.61e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (1.39e-6)"	"unprognostic (5.73e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.02e-2)"	12.9	6.3	7.1	5.2	7.4	40.3	10.9	7.8	10.3	9.2	3.7	10.0	4.2	9.2	10.9	10.6	10.0	7.0	9.0	7.1	6.5	6.5	9.7	8.0	8.8	7.4	6.1	11.3	7.8	9.6	6.7	9.6	7.0	7.0	7.5	4.7	6.7	6.7	16.0	8.5	6.0	8.0	6.1	6.3	7.4	12.3	6.9	12.5	8.6	19.3	11.1	11.1	8.7	10.2	27.2	22.9	18.9	16.0	22.5	20.1	33.1	24.0	28.5	43.4	35.3	52.9	16.0	31.0	12.0	26.0	29.9	18.3	95.3	46.7	36.4	35.7	51.3	34.3	15.1	34.6	66.7	40.3	15.7	36.1	39.0	43.5	55.9	34.6	35.9	55.8	62.8	17.1	26.9	50.6	39.6	57.1	30.4	25.6	54.4	28.4	31.9	27.6	23.4	28.4	33.8	16.4	27.4	15.6	34.6	23.1	32.3	55.0	17.6	18.0	16.3	15.1	45.7	22.7	30.2	66.2	15.7	32.8	29.0	25.9	9.2	18.3	10.7	12.6	22.0	16.4	19.0	20.9	9.9	24.1	22.2	18.7	22.3	14.9	19.0	21.4	29.5	5.9	7.1	7.4	7.8	10.3	7.1	6.5	7.4	6.1	7.0	6.1	6.9	10.2	76.6	67.3	56.3	10.1	81.7	85.8	129.9	84.9	65.4	33.7	57.3	80.1	44.3	40.0	66.5	44.1	22.9	80.0	88.2	33.1	129.1	48.7	125.8	63.1	71.5	62.0	35.8	41.2	9.4	57.5	88.3	61.5	29.6	85.0	78.6	45.8	64.2	53.9	56.8	43.7	9.9	62.5	50.8	70.9	53.8	28.4	53.4	62.0	48.0	5.6	66.9	47.2	64.9	12.1	17.2	54.8	44.0	53.8	54.7	88.1	56.1	93.0	51.5	40.6	19.7	118.1	57.8	204.9	135.2	57.6	89.9	146.8	95.6	43.5	56.7	100.6
CCDC82	FLJ23518	ENSG00000149231	"Coiled-coil domain containing 82"	Q8N4S0	11	96349241-96389956	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Early spermatids: 493.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038704, HPA070631"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA038704: AB_10674835, HPA070631: "	"unprognostic (3.04e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.94e-3)"	"unprognostic (5.94e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.42e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.31e-2)"	22.2	15.1	16.5	19.6	19.7	17.1	17.6	32.0	26.6	15.9	8.7	18.1	13.0	18.4	13.9	10.4	15.9	16.8	13.7	17.4	24.6	16.6	22.1	17.9	23.4	18.2	16.5	18.3	13.8	11.8	18.2	17.4	19.5	13.0	13.3	43.2	12.8	15.8	14.3	14.3	16.9	13.8	12.4	20.3	16.7	23.7	17.9	22.3	17.9	14.9	20.1	16.7	14.5	31.1	12.9	17.9	52.4	21.0	35.9	30.0	20.8	47.0	28.0	29.9	42.4	31.1	41.3	26.1	42.8	23.1	50.5	29.1	17.5	14.7	42.5	44.5	11.7	49.1	42.7	26.0	25.6	41.5	33.2	18.3	9.2	58.9	22.8	28.0	35.9	25.3	31.4	28.1	40.5	1.1	34.9	40.2	12.0	21.6	12.7	23.7	44.2	21.0	22.6	32.9	9.6	22.7	26.6	2.7	23.0	35.5	5.0	19.5	42.6	50.1	28.1	43.7	25.3	9.5	29.9	36.0	16.2	30.7	38.6	59.4	12.5	25.1	23.7	15.2	24.5	22.5	24.7	23.6	14.0	19.3	26.9	25.5	17.9	35.7	16.2	18.7	28.5	17.9	16.5	19.7	32.0	26.6	17.4	24.6	18.2	16.5	19.5	12.4	17.9	31.1	57.9	19.2	31.4	30.7	32.9	30.5	27.0	31.5	19.4	58.9	14.0	18.5	37.2	18.6	28.9	31.3	100.1	16.6	55.1	10.7	27.4	34.6	493.8	57.6	37.0	53.6	19.8	16.4	67.0	17.5	20.5	44.9	13.7	26.4	40.4	36.4	38.6	32.1	25.2	32.0	67.0	9.0	24.4	27.4	38.4	76.8	43.8	32.5	26.6	23.4	37.2	41.6	42.2	54.3	119.7	32.3	12.2	42.9	27.2	14.5	8.8	40.1	71.8	50.6	32.9	45.4	48.4	85.4	57.0	13.0	20.5	8.2	40.7	24.9	10.3	18.7
CCNA2	"CCN1, CCNA"	ENSG00000145386	"Cyclin A2"	P20248	4	121816444-121823883	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.6;lymphoid tissue: 46.9;retina: 31.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 47.9;Erythroid cells: 102.1;Extravillous trophoblasts: 92.8;Plasma cells: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 3.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basal ganglia: 3.4;white matter: 7.6"					"CAB000114, HPA020626"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"CAB000114: AB_563675, HPA020626: AB_1847376"	"unprognostic (4.02e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.66e-3)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.67e-2)"	"prognostic unfavorable (9.17e-5)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (3.92e-3)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (4.43e-6)"	"unprognostic (8.38e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.59e-1)"	1.5	1.2	2.5	11.4	2.5	38.6	2.5	3.5	4.7	4.3	2.5	9.8	10.1	2.5	0.6	8.4	2.2	1.8	1.3	2.3	2.4	1.5	1.6	1.8	25.0	2.8	2.7	3.8	0.8	0.6	2.7	10.5	2.6	1.9	11.5	31.7	1.8	0.8	0.7	6.7	9.9	4.0	2.6	4.6	4.4	6.2	2.6	46.9	1.2	0.5	24.4	2.9	3.9	3.5	177.1	45.3	120.5	51.8	6.4	16.3	98.8	119.7	52.8	156.7	115.6	99.4	106.5	161.2	31.7	63.8	55.0	58.0	154.2	71.1	128.0	77.8	70.8	129.7	56.0	96.9	1.5	197.0	88.0	4.2	5.3	65.1	38.7	24.7	95.4	84.3	187.9	156.9	126.1	63.8	251.8	113.1	95.5	109.9	49.8	114.1	233.5	78.2	44.8	34.6	51.0	53.8	63.1	76.0	32.4	89.8	63.7	81.9	56.5	72.7	109.3	77.4	115.9	98.0	112.3	181.9	41.5	197.6	82.4	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.9	0.6	0.4	0.0	0.0	0.2	0.1	0.8	0.1	0.0	3.1	0.9	2.5	2.5	3.5	4.7	2.3	2.4	2.8	2.7	2.6	2.6	2.6	3.5	0.8	0.0	1.1	1.6	5.7	2.8	1.5	5.5	1.8	2.9	1.9	1.8	0.8	0.0	1.6	0.0	12.5	47.9	1.9	4.9	0.0	0.7	9.6	0.6	2.7	3.3	1.2	102.1	3.3	0.2	92.8	6.3	9.2	2.1	0.0	18.1	4.2	0.9	25.3	0.0	4.1	7.7	8.2	6.9	3.6	2.1	0.9	3.6	1.8	2.8	0.2	1.2	0.0	4.5	5.2	0.5	3.1	1.2	35.5	3.3	1.8	0.2	2.5	14.2	0.0	0.9	6.0	10.3	17.7	24.0	1.3	8.5	6.3	1.4	19.9	2.1
CCNB2	HsT17299	ENSG00000157456	"Cyclin B2"	O95067	15	59105126-59125045	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 74.6;lymphoid tissue: 73.1;testis: 69.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 67.9;Early spermatids: 228.5;Erythroid cells: 123.6;Extravillous trophoblasts: 128.3;Spermatocytes: 288.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	5	"T-reg: 22.7"	"Lineage enriched"	"Detected in many"	6	"T-cells: 22.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA008873, CAB009575"	Enhanced		Enhanced	"Golgi apparatus,Cytosol"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Golgi apparatus"	"CAB009575: AB_2072392, HPA008873: AB_1078604"	"unprognostic (2.69e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (2.83e-4)"	"prognostic unfavorable (4.63e-4)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (4.48e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.96e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.98e-2)"	"unprognostic (4.44e-1)"	1.0	1.1	0.4	12.2	1.1	74.6	2.9	0.7	0.7	2.9	1.1	14.3	14.1	2.6	0.3	16.1	1.1	1.9	0.7	0.6	0.7	1.1	1.4	2.2	33.0	1.3	1.0	0.8	0.7	0.2	0.3	11.4	1.0	1.6	16.8	0.3	2.8	0.4	0.7	9.4	12.0	6.4	0.7	7.1	5.6	69.4	1.1	73.1	1.0	0.4	43.7	3.6	5.6	2.2	132.5	112.1	188.6	47.1	8.5	16.6	97.5	104.8	69.9	165.2	135.6	187.8	81.1	122.1	75.4	71.8	97.2	160.1	181.4	92.6	157.8	124.1	92.4	153.1	127.3	108.1	2.5	118.1	98.6	6.3	12.6	71.4	91.9	32.7	114.1	147.0	163.1	194.5	128.2	96.5	137.9	177.2	138.6	58.5	65.2	157.5	260.0	124.4	53.3	91.9	115.2	75.9	148.9	80.2	97.3	147.9	139.4	120.4	58.5	81.6	134.4	90.5	210.5	84.2	133.2	213.8	53.6	267.1	117.9	0.0	0.1	0.7	0.1	0.0	0.3	2.1	4.6	5.0	3.0	1.7	0.0	0.1	0.8	3.6	0.1	0.1	22.7	2.1	0.4	1.1	0.7	0.7	0.6	0.7	1.3	1.0	1.0	0.7	1.1	2.2	0.3	0.0	0.6	0.0	6.8	4.8	2.8	11.5	1.8	0.2	2.5	3.3	0.5	0.0	3.2	0.0	0.0	67.9	1.6	4.1	0.0	0.7	228.5	5.3	3.1	3.9	3.0	123.6	0.7	0.2	128.3	7.2	7.1	5.9	0.0	29.9	6.1	1.1	29.9	0.0	0.8	10.1	20.3	10.6	3.3	53.5	4.4	7.9	0.0	0.0	2.4	0.2	1.0	0.0	1.4	0.4	1.9	1.9	18.7	2.3	2.1	0.0	1.8	0.3	0.0	1.0	5.7	288.7	32.1	20.3	6.1	16.3	4.4	4.1	23.4	5.0
CCNC	CycC	ENSG00000112237	"Cyclin C"	P24863	6	99542387-99568825	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Cyclin, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010499, HPA069322"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"CAB010499: AB_2244021, HPA069322: AB_2686120"	"unprognostic (1.48e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.85e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.10e-2)"	"prognostic favorable (8.12e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.83e-2)"	31.3	32.5	15.9	27.4	17.0	33.0	47.4	26.1	19.3	29.8	26.8	30.9	42.8	21.9	58.7	41.3	18.9	42.1	23.6	17.3	17.9	54.3	74.6	25.1	39.6	17.0	16.9	16.7	62.6	47.3	22.2	35.7	17.0	34.6	30.3	27.0	70.4	23.2	22.1	32.5	35.0	21.9	17.0	24.1	41.6	17.1	18.1	32.1	60.6	17.7	43.3	34.6	19.7	18.0	86.9	29.8	45.8	99.2	39.3	53.7	126.9	61.4	78.3	75.9	97.9	118.2	53.2	177.2	69.1	51.5	69.8	60.5	72.2	91.1	109.7	45.1	91.2	101.6	44.4	97.7	67.6	118.6	35.3	51.5	55.4	55.9	67.3	52.0	82.2	102.3	151.6	62.9	68.3	53.8	43.7	98.5	64.1	53.5	47.4	75.8	76.7	71.2	105.3	101.2	72.5	43.8	35.6	67.1	69.5	65.5	46.5	117.8	60.6	38.4	51.2	47.0	92.8	42.9	69.7	134.1	69.0	87.9	55.8	40.9	20.7	16.2	21.2	22.1	39.8	29.7	25.5	20.9	23.4	25.3	27.4	21.7	3.3	28.2	16.7	23.0	29.6	30.7	15.9	17.0	26.1	19.3	17.3	17.9	17.0	16.9	17.0	17.0	18.1	18.0	37.1	44.8	32.8	25.5	58.3	75.1	99.3	58.0	50.7	42.8	60.0	31.0	16.1	81.5	57.5	23.9	22.9	110.3	45.0	32.2	84.1	127.2	45.1	36.7	27.3	46.3	43.6	23.3	64.2	186.9	93.3	33.2	38.2	43.1	32.4	31.1	36.4	53.0	41.1	25.2	56.6	38.2	67.1	37.0	52.8	45.5	22.4	32.8	58.7	24.4	41.2	64.6	40.2	52.8	40.5	133.7	27.1	25.2	120.5	158.8	37.8	128.4	37.4	42.2	19.7	26.9	40.2	62.3	21.4	60.0	67.5	176.4	38.7	42.8	46.3	147.0
CCNE2	CYCE2	ENSG00000175305	"Cyclin E2"	O96020	8	94879770-94896678	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 33.6;Oligodendrocytes: 34.5;Spermatocytes: 77.7;Spermatogonia: 26.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 5.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 101.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007825, CAB019374"	Enhanced					NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"			"CAB007825: AB_598148, CAB019374: "	"unprognostic (1.80e-2)"	"unprognostic (4.81e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (5.87e-4)"	"unprognostic (8.37e-4)"	"prognostic unfavorable (8.77e-4)"	"unprognostic (3.18e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.04e-2)"	"unprognostic (7.01e-12)"	"unprognostic (1.81e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.03e-1)"	2.0	0.6	3.7	6.9	8.3	37.0	2.2	9.0	7.7	1.7	0.3	5.4	3.6	1.8	0.1	4.7	0.6	2.4	1.4	3.2	5.4	0.5	2.3	1.8	10.9	9.9	8.1	1.5	1.8	0.5	0.6	4.3	8.8	1.2	5.7	5.2	1.8	0.2	0.7	5.9	4.3	2.2	7.4	2.3	4.0	14.5	8.0	15.1	1.7	0.7	9.6	2.1	1.5	13.4	47.2	6.2	24.0	15.0	2.9	5.4	16.5	47.3	16.6	29.4	28.9	11.3	20.6	24.5	31.4	20.3	9.1	24.4	19.4	17.5	39.5	17.4	17.5	49.5	26.6	4.2	0.2	20.2	29.0	1.4	1.1	21.4	2.1	6.4	15.5	30.1	21.7	101.5	42.5	14.2	77.8	9.7	8.1	37.4	14.1	54.1	41.7	11.7	8.1	26.4	34.8	14.5	31.8	8.4	5.9	3.0	42.0	21.2	13.0	30.7	20.2	22.9	42.8	19.1	21.1	59.3	24.8	36.1	23.1	0.0	0.2	0.1	0.8	0.2	0.3	0.3	1.1	1.3	0.7	1.0	0.3	0.6	0.6	1.5	0.1	0.0	5.2	0.6	3.7	8.3	9.0	7.7	3.2	5.4	9.9	8.1	8.8	7.4	8.0	13.4	7.5	6.4	1.7	0.7	3.0	4.2	1.6	2.3	6.8	2.9	5.9	8.9	2.5	0.0	1.9	1.8	6.2	7.2	7.2	12.3	0.0	0.2	6.9	1.3	2.7	3.5	0.0	33.6	2.3	0.2	7.8	2.6	4.1	2.9	0.0	2.1	2.5	1.3	4.4	8.4	2.6	4.0	0.0	2.5	1.9	9.0	1.2	4.8	0.0	0.0	0.0	1.0	1.0	1.5	34.5	0.2	2.4	0.4	14.6	1.1	6.3	0.1	1.1	4.7	6.6	2.6	4.3	77.7	26.2	9.5	3.8	1.9	7.5	1.2	3.3	0.8
CCNF	"FBX1, FBXO1"	ENSG00000162063	"Cyclin F"	P41002	16	2429394-2458854	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.1"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 37.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA060596, HPA070495, HPA071600"	Enhanced		Supported	Centrosome		NA	Yes			"Cluster 40: NK-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Centrosome		"HPA060596: AB_2684329, HPA070495: AB_2686273, HPA071600: AB_2686424"	"unprognostic (3.87e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.70e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (7.46e-7)"	"unprognostic (2.45e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.58e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.22e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.74e-1)"	1.4	1.0	2.5	3.8	2.1	7.3	1.9	2.9	2.7	1.3	0.0	2.0	2.8	0.8	2.0	4.0	0.8	0.8	0.6	2.4	2.0	0.6	0.7	1.0	7.4	1.5	2.0	1.0	0.8	0.5	0.8	2.5	1.3	1.6	2.0	0.8	2.1	1.1	1.3	4.8	2.1	1.1	0.8	2.2	1.6	2.7	2.6	15.1	0.7	1.3	9.6	1.7	1.5	1.7	21.0	32.4	31.3	28.9	2.2	2.9	23.8	24.1	12.2	34.2	26.1	64.6	25.6	42.3	8.0	14.1	10.2	33.1	52.2	19.6	16.4	30.9	23.4	46.1	35.3	20.4	2.3	30.4	30.7	2.0	2.5	24.1	11.7	4.4	25.5	36.5	52.0	28.5	17.6	45.6	46.1	25.0	31.2	22.6	13.2	76.2	35.1	39.5	9.5	9.3	29.8	17.0	36.0	32.8	6.4	15.6	34.3	16.6	18.1	19.1	46.7	13.5	27.1	16.4	20.9	74.5	5.6	31.8	26.9	0.0	0.3	0.0	0.7	0.1	0.4	0.6	0.4	0.9	0.1	0.4	0.3	0.4	0.0	1.3	0.3	0.5	0.5	0.6	2.5	2.1	2.9	2.7	2.4	2.0	1.5	2.0	1.3	0.8	2.6	1.7	0.9	0.0	3.9	3.3	2.7	2.8	2.7	1.4	6.2	5.3	2.4	2.0	1.9	0.0	1.6	1.8	12.5	7.0	3.7	2.4	0.0	1.2	0.9	1.0	2.7	2.2	1.2	37.5	5.7	0.6	12.2	2.2	5.6	1.0	1.3	8.9	2.5	0.9	6.1	8.4	5.6	2.6	4.1	2.4	1.6	0.0	1.8	1.5	5.4	0.0	0.8	0.9	2.1	1.0	1.0	1.1	0.3	2.6	7.2	1.9	0.9	0.2	0.3	1.6	0.0	0.8	2.7	3.9	5.7	3.5	1.1	1.9	3.4	1.7	4.7	1.6
CCT2	Cctb	ENSG00000166226	"Chaperonin containing TCP1 subunit 2"	P78371	12	69585426-69601570	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 1471.3;Spermatocytes: 625.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003197, HPA003198"	Enhanced		Supported	Cytosol		NA	NA		3500000	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"HPA003197: AB_1078425, HPA003198: AB_1078424"	"unprognostic (1.79e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.53e-1)"	"unprognostic (4.42e-2)"	"prognostic unfavorable (8.38e-4)"	"prognostic unfavorable (3.61e-9)"	"unprognostic (5.28e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.34e-2)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (6.53e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.21e-2)"	64.0	69.9	56.8	77.7	61.3	140.5	85.5	62.4	70.6	51.9	68.4	70.6	53.2	66.9	43.7	69.4	69.5	54.7	68.6	60.6	64.4	92.9	72.2	46.6	94.9	62.4	59.5	65.2	53.3	71.6	37.8	70.2	62.5	57.9	85.9	57.5	45.4	52.5	103.9	55.9	51.5	83.3	62.2	51.5	52.0	216.0	59.8	100.7	56.1	73.2	108.8	106.6	49.6	63.8	266.1	388.1	343.8	330.7	154.2	174.5	392.3	280.4	203.8	448.0	276.1	529.7	121.7	572.6	266.2	222.9	281.8	250.2	538.2	313.0	536.6	319.1	398.6	418.7	313.5	331.8	171.8	520.1	255.5	152.7	195.3	425.9	248.1	308.7	296.4	311.4	519.2	165.0	410.2	378.9	496.0	446.7	482.4	273.2	403.7	389.3	375.9	373.1	369.4	476.9	334.1	281.3	291.0	314.2	289.2	284.3	411.4	371.6	196.0	231.4	292.2	275.0	427.3	203.5	409.6	614.6	201.9	354.8	290.8	36.6	41.0	12.5	47.3	66.0	72.7	74.2	54.0	61.5	72.9	60.7	62.2	68.5	3.7	65.3	62.1	66.9	63.7	70.0	56.8	61.3	62.4	70.6	60.6	64.4	62.4	59.5	62.5	62.2	59.8	63.8	80.4	35.3	47.4	17.3	97.2	136.6	233.9	173.8	126.3	51.1	70.1	89.7	81.5	57.2	110.8	80.9	79.2	189.1	93.3	48.1	92.0	198.8	1471.3	150.9	126.5	95.3	106.2	226.4	21.5	128.4	209.1	102.1	60.6	107.1	105.4	112.3	52.5	46.2	127.1	42.1	31.3	94.4	109.9	44.3	74.9	430.3	76.7	70.5	46.2	11.2	87.7	67.9	57.7	21.6	20.6	150.7	50.8	66.5	100.7	165.8	34.4	127.4	127.5	56.6	85.5	128.4	178.3	625.4	391.5	112.1	117.3	153.4	93.9	154.1	154.8	161.9
CCT3	"Cctg, TRIC5"	ENSG00000163468	"Chaperonin containing TCP1 subunit 3"	P49368	1	156308968-156367873	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006543	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		1300000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane, Cytosol"		"HPA006543: AB_1078426"	"unprognostic (2.14e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.00e-3)"	"unprognostic (8.39e-3)"	"unprognostic (3.14e-3)"	"prognostic unfavorable (3.87e-7)"	"unprognostic (4.43e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (7.16e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.10e-1)"	85.3	122.3	121.4	103.0	125.8	79.5	119.4	132.2	176.7	77.1	139.0	95.3	87.2	93.6	77.1	106.9	119.9	67.4	100.8	125.3	135.5	114.5	108.3	60.1	123.9	129.4	126.1	113.5	82.3	120.4	65.3	93.3	129.5	86.6	112.9	135.7	74.9	89.8	134.8	93.8	83.3	137.3	132.4	67.1	80.7	120.3	130.2	129.1	87.6	120.8	148.5	136.7	70.6	143.8	432.3	562.3	324.3	311.9	352.5	261.2	419.7	388.8	315.9	617.9	378.0	611.1	396.3	689.5	442.3	337.9	392.5	395.5	1045.2	519.9	519.1	384.3	660.6	437.6	438.6	579.2	261.9	547.7	357.2	333.7	312.4	556.6	514.7	303.3	531.6	425.3	795.2	250.1	375.5	603.5	688.2	372.1	656.4	859.5	702.1	587.3	314.5	771.1	496.9	349.9	434.9	448.1	347.0	635.0	388.7	531.0	560.2	707.3	366.1	249.0	373.0	263.3	717.1	457.5	808.2	975.7	288.1	349.1	408.1	75.1	107.1	49.0	129.0	137.0	171.2	142.1	144.3	138.8	171.7	156.8	177.0	156.7	14.9	145.8	146.8	120.8	164.3	222.3	121.4	125.8	132.2	176.7	125.3	135.5	129.4	126.1	129.5	132.4	130.2	143.8	82.8	54.5	62.5	18.3	104.8	144.9	241.1	247.4	119.5	124.5	133.2	118.5	121.1	98.7	132.3	90.1	106.3	226.7	100.5	71.7	113.5	208.6	111.9	118.4	137.4	122.4	125.3	134.0	29.7	183.2	217.8	113.9	70.8	86.6	73.0	180.1	74.6	88.4	162.6	74.0	34.6	93.8	193.3	83.0	96.5	226.7	83.6	78.1	112.1	22.5	153.6	158.1	105.0	37.2	41.9	199.1	78.8	88.0	95.8	169.0	115.9	212.3	137.6	244.3	118.3	110.3	145.4	410.0	232.4	123.1	159.8	184.6	112.1	347.9	149.8	157.9
CCT4	Cctd	ENSG00000115484	"Chaperonin containing TCP1 subunit 4"	P50991	2	61868085-61888671	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029349	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		1700000	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	Nucleoplasm	"HPA029349: AB_10600800"	"prognostic unfavorable (2.03e-4)"	"unprognostic (2.80e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.74e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (9.37e-12)"	"unprognostic (1.28e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.14e-2)"	66.4	67.0	60.4	59.9	62.6	64.9	90.2	67.1	114.9	68.4	66.7	65.1	45.8	68.7	50.8	75.6	74.4	43.1	67.0	62.3	65.7	73.5	63.7	48.7	81.4	63.9	62.6	109.3	95.3	62.8	45.9	65.8	66.1	57.8	58.9	56.8	53.7	57.5	96.7	66.4	48.5	72.0	70.4	55.3	64.5	77.6	66.0	83.3	65.3	74.0	92.0	68.4	61.2	80.0	274.5	313.6	203.1	190.1	166.2	251.5	342.5	244.6	174.3	345.6	230.4	550.5	193.2	437.9	239.7	176.5	354.6	192.4	405.8	313.9	362.3	216.0	398.9	280.4	149.4	347.7	149.3	347.8	179.1	215.0	214.4	278.8	287.2	259.5	293.3	220.0	406.5	137.2	297.5	246.4	299.6	451.2	365.3	364.2	276.0	336.9	319.2	297.4	237.5	186.2	177.6	148.8	177.2	221.9	324.5	235.7	161.9	245.6	185.2	190.6	275.5	143.3	400.1	205.3	297.3	739.8	188.9	391.7	255.7	58.2	60.7	25.0	83.2	88.9	106.9	93.6	87.1	100.8	100.4	88.6	112.9	112.2	8.4	107.5	103.3	64.3	100.7	125.2	60.4	62.6	67.1	114.9	62.3	65.7	63.9	62.6	66.1	70.4	66.0	80.0	111.8	73.7	54.3	20.9	125.4	152.6	350.8	206.6	136.1	52.9	131.3	136.4	47.7	82.9	116.7	73.5	14.6	256.5	106.5	52.8	135.0	156.0	250.0	111.9	117.2	118.0	140.6	156.9	28.0	130.6	284.9	114.9	67.8	92.8	95.8	148.2	95.3	79.4	163.5	32.0	31.3	105.9	175.0	105.0	112.4	72.1	88.3	110.2	94.3	30.0	125.8	64.9	71.1	26.7	40.8	143.9	61.4	97.8	111.9	200.3	67.9	165.2	143.1	63.3	92.1	117.2	297.8	338.8	153.2	151.2	151.3	180.6	146.6	173.7	138.2	203.8
CCT6A	"CCT6, Cctz, HTR3, TCP20, TCPZ, TTCP20"	ENSG00000146731	"Chaperonin containing TCP1 subunit 6A"	P40227	7	56051685-56063989	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 1612.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042996, HPA045576, HPA049949"	Supported		Approved	Cytosol		NA	NA		3600000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA042996: AB_2678261, HPA045576: AB_2679372, HPA049949: AB_2680968"	"prognostic unfavorable (4.04e-4)"	"unprognostic (5.32e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.81e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (8.45e-4)"	"prognostic unfavorable (9.00e-10)"	"unprognostic (1.19e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.24e-2)"	"unprognostic (4.82e-2)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.78e-1)"	"unprognostic (9.44e-3)"	58.5	58.8	48.3	66.6	50.5	67.0	59.7	52.6	71.1	43.5	55.9	52.6	53.2	52.0	38.2	68.1	50.9	39.8	56.7	50.2	56.4	72.5	53.3	41.1	69.6	52.5	52.9	42.1	60.8	69.4	39.1	56.4	53.9	44.9	60.1	46.5	45.5	49.4	124.3	58.0	51.8	61.4	53.2	46.1	52.2	49.5	53.5	61.3	49.7	85.5	81.1	72.1	47.6	55.3	1612.6	357.8	211.6	322.5	145.7	181.6	243.2	293.0	165.4	284.4	227.7	407.0	196.7	487.8	222.9	192.1	511.6	333.2	438.2	339.2	390.0	276.8	328.1	306.1	337.0	363.8	157.3	444.1	240.5	157.1	191.1	287.8	284.4	224.8	283.7	221.2	682.0	121.2	325.5	199.2	346.4	392.7	449.3	356.6	466.8	315.1	213.9	284.8	321.6	302.3	280.3	282.0	259.2	440.7	272.6	321.8	324.6	341.6	238.6	194.1	372.4	651.4	617.1	146.7	321.5	596.7	194.4	389.0	658.4	21.0	69.9	34.0	57.8	87.7	77.3	65.9	59.7	63.3	96.5	50.4	59.8	64.8	8.4	77.7	103.0	54.0	68.3	81.2	48.3	50.5	52.6	71.1	50.2	56.4	52.5	52.9	53.9	53.2	53.5	55.3	94.6	89.8	106.4	13.1	83.3	108.8	201.4	175.3	91.6	60.2	77.4	83.2	114.0	65.8	187.7	47.8	27.1	199.6	93.4	56.6	88.0	263.1	22.5	209.6	121.0	129.4	102.1	163.4	19.3	274.2	264.8	97.0	88.2	133.8	131.7	123.4	71.0	66.7	148.2	38.7	23.7	94.2	124.1	83.5	79.2	19.5	70.5	104.0	58.7	19.7	206.9	80.7	80.3	18.1	22.7	245.6	66.7	90.7	106.4	184.8	65.2	146.4	190.3	60.8	59.2	99.1	136.3	115.0	219.8	160.9	109.7	199.9	91.8	189.7	138.6	145.9
CCT7	"Ccth, Nip7-1"	ENSG00000135624	"Chaperonin containing TCP1 subunit 7"	Q99832	2	73233420-73253021	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 393.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008425	Approved		Approved	Cytosol		NA	NA		1900000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA008425: AB_1078428"	"unprognostic (5.02e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (2.69e-4)"	"unprognostic (4.60e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (4.37e-3)"	"unprognostic (8.76e-2)"	"unprognostic (3.17e-1)"	"unprognostic (4.24e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.12e-2)"	113.3	150.8	104.5	108.6	109.7	93.4	111.4	114.6	110.9	109.6	118.1	113.6	84.8	123.0	117.1	119.7	133.3	69.0	162.9	109.1	114.5	111.9	114.0	83.4	126.5	109.7	109.4	140.4	114.2	134.7	97.0	101.4	114.0	115.2	123.2	83.7	92.1	110.7	252.4	103.9	88.3	147.5	112.7	98.7	106.8	162.9	110.7	153.0	87.4	241.2	158.5	120.0	101.1	120.7	396.3	641.9	361.8	393.0	259.1	211.7	460.7	348.6	311.8	573.6	359.0	1054.5	272.1	760.3	219.0	365.9	529.3	328.2	816.6	533.8	635.9	420.7	722.9	516.2	403.2	755.3	287.5	614.9	367.5	328.9	297.7	565.9	683.3	301.4	521.0	444.7	650.2	265.8	488.7	613.6	686.5	776.1	519.1	540.6	455.8	614.8	927.2	535.0	411.6	374.7	512.4	315.9	302.6	411.0	406.7	333.6	235.2	331.4	339.7	390.9	464.3	245.7	679.7	298.1	341.1	709.2	319.4	686.1	435.6	157.7	131.4	78.1	190.8	178.8	211.3	216.6	193.5	191.4	202.0	208.8	208.9	195.3	39.5	192.1	209.8	203.7	186.0	299.3	104.5	109.7	114.6	110.9	109.1	114.5	109.7	109.4	114.0	112.7	110.7	120.7	77.7	57.7	45.6	12.4	87.5	69.1	149.7	161.5	55.8	81.1	63.8	77.1	99.2	68.6	96.7	58.8	18.8	190.2	74.3	54.8	109.5	148.2	393.0	99.8	96.4	91.6	75.3	77.8	10.8	139.0	213.2	94.8	57.1	58.1	73.6	108.2	61.8	69.3	133.6	82.4	13.3	102.2	118.0	58.8	58.1	246.3	104.7	57.3	74.7	10.3	98.9	125.5	74.2	12.1	15.0	134.1	60.3	107.2	112.3	156.0	67.3	133.2	108.2	88.6	72.3	91.8	126.7	288.9	127.8	71.1	73.6	166.5	77.2	190.6	127.6	112.5
CCZ1	"C7orf28A, CCZ1A, CGI-43"	ENSG00000122674	"CCZ1 homolog, vacuolar protein trafficking and biogenesis associated"	P86791	7	5898725-5926550	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA045114, HPA050006"	Uncertain		Enhanced	Vesicles		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA045114: AB_2679219, HPA050006: AB_2680989"	"unprognostic (1.91e-1)"	"unprognostic (2.97e-3)"	"unprognostic (3.15e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.74e-3)"	"unprognostic (4.10e-1)"	"unprognostic (9.25e-3)"	"unprognostic (7.66e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.67e-2)"	"unprognostic (5.27e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.41e-1)"	32.5	55.8	10.7	12.8	10.9	26.9	30.2	12.2	13.7	28.7	12.9	31.1	13.0	29.7	9.4	40.8	25.2	10.3	31.3	11.4	10.5	27.3	27.3	26.0	15.4	10.7	10.4	23.0	27.3	29.9	24.9	12.2	10.6	24.6	16.0	12.6	32.1	11.9	43.2	30.3	26.9	13.9	10.5	31.5	29.0	22.1	11.0	20.5	25.5	13.0	16.2	31.7	28.9	11.6	52.2	29.8	30.3	27.1	41.8	35.4	15.3	15.6	30.1	23.1	25.0	9.1	27.2	42.8	4.8	40.8	61.9	27.8	16.6	26.7	26.5	16.2	37.3	18.1	30.2	16.8	38.0	13.1	7.1	40.5	42.4	15.6	19.5	42.5	57.2	25.4	52.4	29.7	38.8	26.9	16.8	56.9	39.5	26.4	28.3	36.0	13.8	28.9	21.1	38.3	23.9	31.9	15.3	36.6	13.6	57.9	26.1	21.0	27.7	28.8	57.4	18.7	25.7	13.6	24.6	58.0	9.6	30.8	41.6	3.1	1.9	2.7	1.8	2.3	1.4	1.3	2.2	2.2	1.8	1.3	1.5	1.6	3.4	3.0	2.4	1.8	4.6	0.7	10.7	10.9	12.2	13.7	11.4	10.5	10.7	10.4	10.6	10.5	11.0	11.6	30.7	3.2	23.5	15.7	26.3	45.2	30.6	21.2	9.6	59.2	29.5	20.2	11.0	24.3	24.0	31.3	62.6	45.0	47.2	38.0	31.3	61.0	6.5	18.7	18.1	35.0	29.9	26.7	20.2	71.4	35.9	26.7	11.2	21.3	15.8	21.1	76.4	17.6	35.7	23.5	20.5	30.8	50.8	39.0	61.6	4.9	37.9	27.5	46.2	8.4	80.8	41.5	72.1	15.6	28.7	74.0	30.1	36.1	14.3	26.2	40.2	21.9	32.9	69.2	78.9	19.4	32.0	40.6	34.5	11.0	54.1	34.9	32.8	38.2	34.4	33.7
CDC123	"C10orf7, D123"	ENSG00000151465	"Cell division cycle 123"	O75794	10	12195965-12250589	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037830, HPA057540"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA037830: AB_10671368, HPA057540: AB_2732614"	"unprognostic (5.35e-3)"	"unprognostic (9.06e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.75e-2)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (3.16e-7)"	"unprognostic (2.63e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.74e-2)"	"unprognostic (8.54e-2)"	"prognostic unfavorable (2.42e-6)"	"unprognostic (5.35e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.19e-2)"	44.9	40.0	38.1	53.8	44.3	73.5	45.9	40.6	46.1	43.5	39.1	54.1	37.1	39.0	46.9	50.1	42.3	34.0	61.0	41.7	41.5	42.6	55.6	35.8	69.1	40.3	38.4	31.4	29.4	42.3	33.0	50.8	40.5	35.4	58.3	29.7	31.5	39.3	49.7	44.3	39.1	53.4	41.3	45.3	35.4	35.7	40.1	65.2	41.5	52.5	81.1	63.6	34.7	43.7	155.4	187.4	148.3	157.1	125.4	136.3	117.7	137.0	94.2	194.8	205.5	274.0	186.5	259.7	123.5	153.6	116.1	157.7	237.0	223.3	172.0	176.8	206.6	199.3	142.8	266.6	162.1	151.6	159.0	131.3	118.9	214.0	126.5	98.0	206.3	320.6	224.2	114.5	178.6	135.0	208.3	133.8	221.4	223.1	76.3	195.7	111.9	234.0	173.2	86.3	72.3	140.8	139.6	165.4	152.6	120.4	180.7	179.2	200.9	107.7	127.6	167.9	166.6	112.5	233.5	320.7	135.4	155.3	69.7	133.8	99.2	242.2	103.6	117.0	108.1	158.6	114.8	115.0	139.0	170.5	93.5	99.9	233.4	121.1	129.4	116.0	143.5	167.3	38.1	44.3	40.6	46.1	41.7	41.5	40.3	38.4	40.5	41.3	40.1	43.7	48.6	32.1	35.9	18.3	51.5	54.2	49.2	162.1	39.9	28.5	28.0	32.3	56.4	24.3	75.8	35.0	6.2	120.8	55.3	25.1	86.1	91.1	7.9	26.8	39.5	49.7	20.9	36.8	33.2	82.6	138.2	46.3	26.5	26.1	49.4	36.6	34.2	37.6	101.3	26.9	27.9	31.9	105.8	25.9	34.0	10.1	41.7	37.2	46.2	21.5	79.3	43.3	45.3	19.6	23.5	84.3	34.3	45.9	44.2	46.5	30.7	73.0	62.5	29.9	39.5	32.3	59.8	50.2	41.5	46.5	74.0	77.6	51.3	72.4	47.0	50.7
CDC20	"CDC20A, p55CDC"	ENSG00000117399	"Cell division cycle 20"	Q12834	1	43358981-43363203	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 53.9;lymphoid tissue: 52.6;testis: 49.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 65.0;Early spermatids: 135.0;Erythroid cells: 96.0;Extravillous trophoblasts: 146.2;Spermatocytes: 126.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"memory B-cell: 4.2;memory CD4 T-cell: 3.2;memory CD8 T-cell: 3.5;NK-cell: 9.5;T-reg: 11.6"	"Group enriched"	"Detected in many"	9	"B-cells: 4.2;NK-cells: 9.5;T-cells: 11.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB004525, HPA045842, HPA055288"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"CAB004525: AB_628089, HPA045842: AB_2679470, HPA055288: AB_2682773"	"unprognostic (1.66e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (4.00e-8)"	"unprognostic (9.06e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (8.55e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.29e-2)"	1.6	1.5	0.6	16.2	1.1	53.9	5.2	0.8	1.3	3.5	0.4	14.8	13.7	2.3	2.5	27.2	1.7	1.2	0.9	0.7	1.1	2.3	1.7	2.5	32.6	1.3	1.1	0.7	0.6	0.2	0.3	9.7	1.1	0.8	16.0	0.2	4.4	0.7	0.3	11.3	12.2	7.3	0.8	11.7	7.0	49.1	1.7	52.6	1.7	0.2	50.8	3.3	7.0	1.3	311.9	148.2	202.8	133.4	6.9	17.6	193.5	140.3	125.0	400.0	211.4	234.5	250.9	178.3	80.1	130.1	140.6	212.8	225.3	267.9	331.5	140.8	165.6	261.4	143.6	147.3	2.1	184.3	91.4	6.0	12.4	278.2	249.6	35.1	172.2	167.5	120.2	119.3	184.0	120.4	179.2	113.5	257.2	147.0	196.9	255.8	277.9	112.9	98.5	81.3	119.2	58.9	248.1	165.8	76.6	154.9	116.3	231.7	90.2	118.9	276.2	133.7	445.0	90.6	86.7	185.7	85.2	227.6	181.6	0.0	0.1	0.0	0.3	0.0	0.0	4.2	3.2	3.5	0.9	0.9	0.1	0.3	0.7	9.5	0.0	0.2	11.6	2.8	0.6	1.1	0.8	1.3	0.7	1.1	1.3	1.1	1.1	0.8	1.7	1.3	2.1	0.0	1.1	0.0	12.2	10.5	3.8	17.6	6.2	0.5	6.4	9.7	0.7	1.5	4.8	0.0	0.0	65.0	2.8	16.9	0.0	2.2	135.0	14.6	2.4	4.5	0.0	96.0	0.2	0.4	146.2	9.3	11.7	4.6	0.0	46.5	7.9	1.3	37.4	0.0	0.0	18.5	24.4	6.2	7.5	18.5	2.8	9.3	0.0	0.0	1.8	0.3	0.0	0.0	1.6	0.7	0.5	1.9	34.4	2.7	3.2	3.1	8.3	2.9	0.0	1.0	25.4	126.5	39.8	47.3	8.4	10.7	5.1	1.6	37.5	7.4
CDC25A		ENSG00000164045	"Cell division cycle 25A"	P30304	3	48157146-48188417	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.3;lymphoid tissue: 8.8;testis: 13.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 111.2;Early spermatids: 18.3;Late spermatids: 31.8;Spermatogonia: 16.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 19.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005855, HPA008803"			Approved	"Nucleoplasm,Golgi apparatus"		NA	Yes			"Cluster 43: B-cells - Humoral immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	"Golgi apparatus"	"HPA005855: AB_1846364, HPA008803: "	"unprognostic (1.49e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.14e-1)"	"unprognostic (9.51e-2)"	"unprognostic (7.05e-7)"	"unprognostic (1.35e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.92e-3)"	"unprognostic (4.41e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	0.7	0.9	0.8	3.3	0.8	15.3	1.1	0.7	1.0	0.6	0.7	3.5	2.0	0.6	0.9	2.4	0.2	0.3	0.4	0.8	2.0	0.7	0.8	0.3	4.4	1.1	1.9	2.2	0.7	0.8	0.8	2.6	1.7	0.6	3.9	2.0	0.8	0.6	0.4	0.6	1.8	1.1	0.8	2.0	0.9	13.3	2.0	8.8	1.8	0.3	5.6	0.9	0.9	0.7	22.2	10.7	50.0	27.2	1.7	3.2	34.2	29.9	11.3	36.7	29.6	46.8	11.2	64.9	11.4	8.0	23.4	16.3	86.6	20.6	38.6	21.4	45.1	83.8	19.0	23.1	1.7	59.4	23.4	1.7	3.1	45.8	19.6	4.6	14.1	47.8	67.6	33.6	20.1	11.8	74.8	46.6	73.4	20.2	24.2	33.2	32.9	35.1	9.5	20.7	23.5	28.8	18.6	21.6	9.5	31.7	11.3	41.9	7.2	18.0	27.7	20.3	41.4	16.7	54.2	101.5	13.5	65.2	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.7	1.0	0.8	2.0	1.1	1.9	1.7	0.8	2.0	0.7	0.3	0.0	0.0	1.0	1.1	0.4	0.4	0.8	1.8	0.5	1.2	1.0	111.2	0.0	0.1	0.0	2.1	4.2	0.2	2.4	0.0	0.4	18.3	0.5	0.9	2.7	1.2	8.0	0.2	0.9	7.4	1.5	1.5	1.3	0.0	4.6	1.4	0.3	3.1	0.0	0.5	2.0	0.0	0.6	0.9	31.8	1.5	0.5	0.0	0.0	0.1	1.1	0.0	0.5	0.0	1.1	0.8	1.9	13.0	0.7	0.4	0.4	0.2	0.4	0.0	0.1	2.2	14.5	16.3	4.3	0.0	0.3	0.6	2.4	4.1	0.5
CDC7	"CDC7L1, HsCdc7, Hsk1, huCdc7"	ENSG00000097046	"Cell division cycle 7"	O00311	1	91500851-91525764	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 16.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 37.8;Erythroid cells: 23.1;Spermatocytes: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002669, HPA035831"	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"		Yes	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	"Cytokinetic bridge, Mitotic spindle"	"CAB002669: , HPA035831: AB_2674807"	"unprognostic (6.84e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.64e-2)"	"unprognostic (7.02e-3)"	"unprognostic (5.57e-2)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (3.15e-6)"	"unprognostic (6.52e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (1.89e-15)"	"unprognostic (9.44e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.39e-2)"	1.9	2.7	3.6	6.0	3.8	13.8	2.1	6.3	4.8	2.1	1.6	3.0	3.1	1.8	1.7	3.5	1.3	1.7	1.4	3.8	3.4	4.3	1.5	4.2	9.3	2.9	3.7	2.5	1.6	0.8	4.0	5.9	3.1	1.9	4.6	14.1	1.7	1.4	0.5	5.1	3.7	2.4	2.8	12.1	1.8	16.9	3.2	10.9	1.7	0.5	9.4	2.4	2.3	3.5	32.0	9.4	59.1	17.3	1.4	7.6	18.8	12.0	9.1	22.6	24.3	19.6	10.8	22.5	16.1	7.7	19.8	13.7	39.8	13.5	29.4	36.8	34.3	33.7	27.9	9.5	2.1	37.0	11.9	4.2	4.0	21.0	11.9	4.1	8.9	30.9	44.8	31.4	15.2	11.8	31.5	33.5	48.9	17.2	21.6	38.9	49.5	14.5	10.2	24.0	44.7	18.6	37.5	10.2	21.6	14.3	9.8	18.2	7.3	25.8	22.7	20.6	17.9	11.6	15.6	57.9	9.4	36.0	9.4	0.0	1.0	0.0	3.8	0.7	3.2	0.9	2.8	3.5	2.3	0.9	1.5	3.0	0.1	1.6	0.2	1.4	4.6	1.4	3.6	3.8	6.3	4.8	3.8	3.4	2.9	3.7	3.1	2.8	3.2	3.5	1.9	0.0	1.1	3.3	3.2	5.9	1.2	2.7	3.4	8.2	14.4	1.4	2.1	0.0	1.3	1.8	0.0	8.2	4.1	0.6	3.9	1.5	37.8	1.1	4.9	4.1	0.0	23.1	18.3	2.6	6.3	3.1	2.6	1.9	4.5	15.4	4.2	0.2	2.7	3.3	19.6	1.8	6.1	2.2	2.9	18.7	0.9	1.6	3.6	5.6	2.1	1.6	6.2	16.6	3.1	1.2	1.7	0.7	7.1	0.9	0.5	0.4	2.0	5.1	6.6	1.5	4.1	30.5	21.4	4.3	3.7	2.2	5.3	7.6	3.6	1.0
CDCA2	"PPP1R81, Repo-Man"	ENSG00000184661	"Cell division cycle associated 2"	Q69YH5	8	25459199-25507911	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 6.5;lymphoid tissue: 11.4;testis: 19.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 23.3;Early spermatids: 49.9;Erythroid cells: 19.0;Late spermatids: 24.2;Spermatocytes: 66.6;Spermatogonia: 27.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA026293, HPA030049"	Enhanced		Supported	Nucleoplasm		Yes	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA026293: AB_1846384, HPA030049: AB_10600862"	"unprognostic (2.12e-1)"	"unprognostic (4.75e-3)"	"prognostic favorable (9.62e-4)"	"unprognostic (2.92e-2)"	"unprognostic (9.69e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.50e-5)"	"unprognostic (1.47e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.32e-3)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (2.30e-14)"	"unprognostic (1.36e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.30e-2)"	0.2	0.0	0.0	2.6	0.0	6.5	0.6	0.1	0.0	0.2	0.1	1.9	1.6	0.3	0.0	1.4	0.1	0.3	0.3	0.0	0.1	0.0	0.1	0.2	5.3	0.2	0.2	0.0	0.0	0.0	0.0	1.2	0.2	0.1	2.2	0.1	0.2	0.0	0.0	1.1	1.8	0.8	0.0	0.8	0.9	19.4	0.3	11.4	0.1	0.1	6.7	0.6	0.3	0.1	36.5	30.2	29.4	24.2	2.3	4.5	20.2	37.7	22.6	32.9	32.4	25.7	15.8	42.6	16.0	16.2	34.6	31.6	42.9	20.0	48.5	16.2	12.0	43.2	22.4	15.2	0.6	18.4	19.4	2.5	1.0	23.5	15.8	3.3	24.5	24.5	33.6	45.8	30.6	13.9	54.5	8.7	31.0	24.1	14.5	26.3	33.4	15.2	9.2	18.7	12.0	13.3	33.3	16.1	14.3	14.7	17.4	9.4	16.6	23.9	39.3	44.7	35.6	7.1	16.5	44.4	17.7	24.3	40.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.3	0.1	0.2	0.0	1.1	0.0	2.7	1.1	0.5	1.7	0.0	0.7	0.9	0.8	23.3	0.0	0.2	0.0	0.0	7.2	0.5	1.8	0.0	0.2	49.9	0.8	1.2	1.1	0.0	19.0	0.2	0.0	13.4	2.5	4.1	1.4	0.0	8.8	1.1	0.1	4.1	0.0	0.1	1.3	0.0	2.9	0.6	24.2	1.2	2.1	0.0	0.0	0.6	0.1	2.1	0.5	0.6	0.2	0.1	0.0	15.8	0.5	0.5	1.2	0.9	0.5	13.1	0.1	2.1	66.6	27.8	10.7	0.9	1.6	2.9	1.3	3.6	0.5
CDCA3	"GRCC8, TOME-1"	ENSG00000111665	"Cell division cycle associated 3"	Q99618	12	6844793-6851292	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.5;retina: 66.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 56.3;Erythroid cells: 46.5;Extravillous trophoblasts: 74.1;Proximal enterocytes: 65.5;Spermatocytes: 71.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"T-reg: 4.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA026587			Approved	Cytosol		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA026587: AB_1846386"	"unprognostic (3.05e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.41e-2)"	"prognostic unfavorable (6.51e-5)"	"prognostic unfavorable (9.77e-5)"	"unprognostic (3.88e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.80e-3)"	"unprognostic (8.81e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.22e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.94e-2)"	1.2	2.6	0.7	7.3	0.5	16.0	1.2	1.0	1.0	4.4	0.3	6.1	20.7	2.9	0.4	9.0	1.9	1.1	2.8	0.6	0.6	1.6	1.6	1.7	17.2	0.7	0.7	4.6	1.1	0.4	8.6	4.7	0.6	3.1	7.8	66.3	2.5	0.3	0.5	6.3	18.5	3.0	0.4	4.6	3.2	21.4	0.6	30.5	1.8	0.2	23.4	2.2	4.0	0.5	106.8	88.8	81.0	45.1	4.3	6.8	95.0	71.7	46.4	119.5	83.3	142.7	86.9	64.9	8.6	54.9	86.9	71.0	53.3	55.0	117.0	97.2	60.9	56.8	58.9	81.7	0.5	41.3	47.2	3.1	3.9	63.0	34.6	27.9	50.9	44.2	47.8	36.4	116.7	94.1	60.0	46.0	86.2	75.8	62.3	57.6	68.5	34.3	40.2	36.4	12.2	23.6	61.8	53.5	18.7	87.0	21.9	38.6	22.3	52.6	67.2	35.0	117.2	19.7	21.5	104.2	25.4	53.6	92.0	0.0	0.2	0.0	0.1	0.1	0.3	0.7	0.7	0.8	0.2	0.2	0.2	0.4	0.2	0.4	0.3	1.1	4.3	0.5	0.7	0.5	1.0	1.0	0.6	0.6	0.7	0.7	0.6	0.4	0.6	0.5	0.7	0.0	0.5	0.7	4.1	2.9	1.7	5.0	2.2	12.3	1.9	2.5	1.2	1.5	1.1	0.0	56.3	29.5	0.9	6.9	0.0	1.1	12.4	1.8	2.3	1.7	1.2	46.5	0.5	0.4	74.1	5.2	4.6	2.3	4.5	15.2	3.9	1.6	19.3	6.7	0.6	11.9	4.1	4.0	3.1	6.8	1.8	3.5	0.0	1.0	1.1	1.1	1.0	0.5	0.5	0.4	4.0	0.4	19.2	1.4	65.5	0.9	0.4	18.0	6.6	0.5	8.3	71.5	14.8	12.6	1.8	8.5	4.6	1.4	17.4	2.6
CDCA5		ENSG00000146670	"Cell division cycle associated 5"	Q96FF9	11	65066300-65084164	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 53.4;lymphoid tissue: 27.6;testis: 37.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 56.5;Extravillous trophoblasts: 38.3;Late spermatids: 116.9;Spermatocytes: 50.4;Spermatogonia: 31.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"NK-cell: 2.8;T-reg: 2.0"	"Group enriched"	"Detected in many"	5	"NK-cells: 2.8;T-cells: 2.0"	"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"white matter: 1.4"	"Low region specificity"	"Detected in many"			"HPA023691, HPA076007"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA023691: AB_1846392, HPA076007: "	"unprognostic (3.14e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (8.21e-6)"	"unprognostic (1.41e-3)"	"unprognostic (7.55e-3)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (8.72e-6)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.55e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.97e-2)"	1.4	1.2	1.3	10.5	1.3	53.4	2.0	0.8	1.8	1.9	0.9	6.8	5.8	1.3	0.3	9.3	0.9	0.9	0.9	1.5	0.9	0.9	1.3	1.9	17.0	1.6	1.3	0.6	0.7	0.4	0.5	6.5	1.6	0.8	7.7	0.5	1.4	0.5	0.6	4.2	5.8	3.1	0.8	6.6	3.1	37.8	1.8	27.6	0.6	0.4	16.2	2.2	2.8	1.3	131.7	74.9	67.2	57.3	4.5	7.3	57.8	92.7	37.4	103.6	81.5	77.7	75.4	121.3	52.3	29.4	120.8	87.9	110.3	49.5	98.6	122.0	52.2	107.7	54.4	64.1	0.4	116.8	81.8	2.5	4.5	96.3	44.0	10.8	32.6	138.4	126.6	206.6	63.5	109.2	164.7	116.9	107.8	63.0	92.4	140.4	76.8	111.9	21.2	49.6	89.1	68.4	59.3	80.7	62.8	41.6	104.7	54.7	19.9	92.7	97.2	99.5	101.7	106.9	187.8	195.4	37.2	69.5	97.4	0.0	0.1	0.2	0.4	0.0	0.0	0.3	0.5	0.3	0.4	0.5	0.0	0.3	0.0	2.8	0.3	0.3	2.0	0.7	1.3	1.3	0.8	1.8	1.5	0.9	1.6	1.3	1.6	0.8	1.8	1.3	0.9	0.0	0.5	0.0	4.6	3.8	1.2	1.3	0.6	0.6	2.3	4.4	1.0	0.0	0.8	0.0	2.1	19.7	2.2	4.6	1.9	0.8	56.5	1.1	1.5	2.3	0.0	21.8	1.1	0.8	38.3	3.5	3.1	1.5	3.8	14.5	1.1	0.0	11.7	1.7	0.6	4.7	2.0	2.8	1.5	116.9	2.8	1.7	0.0	1.0	2.1	0.9	2.1	0.0	0.6	0.6	0.1	1.5	16.2	1.1	1.1	0.6	0.4	0.2	0.0	0.5	2.7	50.4	31.1	7.1	1.0	3.7	4.2	1.9	9.4	1.6
CDCA7L	"JPO2, R1, RAM2"	ENSG00000164649	"Cell division cycle associated 7 like"	Q96GN5	7	21900899-21945903	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 51.0;Spermatogonia: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 101.0;naive B-cell: 124.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"olfactory bulb: 10.1"	"HPA027169, HPA074623"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		No	Yes			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA027169: AB_1856058, HPA074623: "	"unprognostic (5.13e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (4.36e-6)"	"unprognostic (4.09e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (1.98e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.83e-3)"	5.9	1.4	3.9	15.0	9.1	51.7	15.7	5.7	5.2	8.7	17.8	17.0	10.7	13.8	5.5	11.2	11.5	8.1	25.3	3.9	3.5	2.8	4.8	14.0	37.1	6.9	4.8	21.8	13.0	1.8	1.1	4.7	3.8	7.3	19.0	5.1	9.0	7.6	6.2	18.5	13.6	11.9	5.0	13.3	17.8	18.5	7.8	49.0	29.8	3.4	31.8	6.3	8.1	9.8	84.5	27.6	26.0	0.6	14.5	17.9	0.0	65.9	58.2	51.8	73.5	11.3	75.4	173.6	21.8	59.3	102.4	51.1	41.4	69.4	103.6	0.3	28.6	42.3	83.8	7.4	21.1	111.1	0.4	35.2	12.7	40.0	116.9	54.9	104.8	133.5	58.3	0.1	41.4	34.5	146.1	46.1	153.2	17.4	36.2	141.0	94.0	119.8	15.4	14.8	96.9	79.7	30.3	19.9	29.9	34.4	45.6	54.6	43.0	57.1	68.5	101.3	83.8	90.6	63.6	223.0	55.7	154.6	54.5	1.1	2.3	43.2	2.2	3.8	0.3	101.0	6.4	3.2	14.9	124.5	30.9	12.8	3.8	3.4	4.9	75.9	9.9	12.2	3.9	9.1	5.7	5.2	3.9	3.5	6.9	4.8	3.8	5.0	7.8	9.8	1.0	19.2	31.5	7.5	51.0	27.1	23.7	6.9	17.1	1.5	12.5	20.7	38.7	11.5	19.0	0.0	2.1	0.5	30.7	8.4	3.9	8.9	7.3	5.4	2.7	4.8	10.7	21.9	0.5	6.2	0.3	13.4	18.3	5.3	8.8	14.9	1.4	4.0	10.8	13.5	1.0	26.1	8.2	15.2	3.5	5.2	4.1	7.0	8.8	1.9	1.6	2.4	1.0	15.1	8.7	3.9	7.4	2.6	20.2	14.2	1.5	0.1	4.2	2.7	13.1	6.8	12.4	4.6	63.5	9.6	7.7	0.3	5.4	8.3	23.0	6.2
CDCA8	"BOR, DasraB, FLJ12042, MESRGP"	ENSG00000134690	"Cell division cycle associated 8"	Q53HL2	1	37692481-37709719	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 33.5;lymphoid tissue: 38.8;testis: 22.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 34.1;Extravillous trophoblasts: 26.0;Spermatocytes: 76.8;Spermatogonia: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA028120, HPA028258, HPA028783, CAB040294"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Cytokinetic bridge"		Yes	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoli	"Nucleoplasm, Cytokinetic bridge"	"CAB040294: , HPA028120: AB_10670556, HPA028258: AB_10669864, HPA028783: AB_10671092"	"unprognostic (8.36e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.39e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.34e-1)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (4.93e-10)"	"unprognostic (4.30e-3)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (8.32e-4)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (6.39e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.67e-1)"	1.0	1.1	0.7	7.9	1.0	33.5	2.0	0.2	0.9	1.7	0.0	9.4	8.3	1.3	1.8	9.2	1.0	1.1	0.6	0.5	0.4	0.8	1.3	1.5	19.5	0.6	0.4	0.6	0.8	0.5	0.6	4.4	0.5	0.7	11.3	1.9	1.8	0.5	0.3	6.3	7.3	2.8	0.3	4.9	4.9	22.5	0.6	38.8	0.6	0.5	22.7	2.0	2.9	0.7	108.5	45.5	84.4	62.1	3.6	7.0	57.2	79.6	39.5	137.2	96.6	71.9	78.8	130.2	31.5	50.5	54.5	59.4	97.8	52.4	141.9	86.8	44.9	116.8	49.2	57.3	0.8	113.8	58.4	2.8	3.8	77.1	67.3	15.3	60.9	91.1	100.7	135.6	99.1	47.7	106.1	68.9	98.8	61.7	62.8	102.2	115.6	74.4	31.0	43.8	75.4	33.3	87.5	40.6	52.4	71.7	60.1	42.4	37.3	67.8	70.6	39.2	126.0	91.4	128.1	176.3	31.6	104.7	79.6	0.0	0.7	1.3	1.5	1.6	2.8	1.7	3.6	2.2	0.7	1.4	1.1	2.3	3.0	4.1	3.9	1.2	5.9	1.7	0.7	1.0	0.2	0.9	0.5	0.4	0.6	0.4	0.5	0.3	0.6	0.7	0.8	0.0	0.5	1.3	4.8	3.3	0.8	2.4	1.8	1.3	1.9	1.5	0.7	2.8	0.4	0.0	0.0	17.1	1.9	12.4	0.0	1.2	1.0	1.7	1.6	1.9	3.6	34.1	1.2	0.6	26.0	2.9	6.6	2.5	0.0	12.0	3.6	1.0	11.6	1.7	0.9	8.2	2.0	3.5	1.9	2.8	1.5	3.7	1.8	0.0	1.6	0.1	2.1	0.5	0.9	2.4	4.0	1.2	15.8	1.3	1.9	0.6	4.7	1.0	19.7	0.2	6.3	76.8	42.0	17.1	2.7	2.9	5.5	1.2	13.2	1.2
CDK1	"CDC2, CDC28A"	ENSG00000170312	"Cyclin dependent kinase 1"	P06493	10	60778331-60794852	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Host-virus interaction, Mitosis"	"Host cell receptor for virus entry, Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 53.2;lymphoid tissue: 74.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 80.9;Erythroid cells: 209.6;Extravillous trophoblasts: 144.6;Spermatocytes: 110.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 3.2;T-reg: 3.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003387, CAB003799, CAB079974"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes		51000	"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"CAB003799: AB_344898, CAB079974: , HPA003387: AB_1846356"	"unprognostic (6.34e-2)"	"prognostic favorable (8.81e-4)"	"unprognostic (1.90e-1)"	"unprognostic (6.82e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.83e-2)"	"prognostic unfavorable (1.10e-6)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (4.15e-6)"	"unprognostic (1.80e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.27e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.60e-1)"	3.8	1.8	0.9	17.0	1.0	53.2	7.4	0.9	1.5	5.2	0.9	17.6	16.3	7.1	12.2	17.5	3.7	4.3	1.4	0.9	1.0	3.1	3.2	4.7	40.6	1.2	1.2	2.3	0.8	2.5	4.1	19.4	1.1	1.7	20.8	1.3	3.2	5.2	1.4	13.2	14.5	8.0	0.9	9.0	10.1	25.1	1.4	74.0	3.6	2.2	47.5	7.1	6.9	1.0	249.9	93.5	241.1	96.0	15.4	23.6	99.0	183.8	132.7	218.8	209.0	218.9	213.7	226.2	69.6	50.6	79.6	149.9	166.2	106.8	225.8	162.3	121.1	119.4	84.4	128.1	2.8	184.5	117.6	4.7	10.4	142.1	137.0	49.6	133.3	146.2	185.1	270.3	246.9	66.3	234.0	131.1	106.6	149.3	193.1	199.7	224.5	111.3	84.3	81.4	112.7	98.7	123.5	184.9	96.3	130.0	199.9	111.5	55.4	92.8	197.9	99.1	255.8	104.9	180.8	205.6	79.9	203.5	117.6	0.0	0.0	0.0	0.3	0.1	0.2	0.5	0.7	1.3	0.3	0.4	0.2	0.7	0.0	3.2	0.1	0.9	3.4	0.9	0.9	1.0	0.9	1.5	0.9	1.0	1.2	1.2	1.1	0.9	1.4	1.0	7.7	0.0	3.2	0.3	7.1	39.8	5.4	29.9	2.8	1.1	5.3	6.1	0.8	0.0	10.2	18.4	0.0	80.9	3.6	8.9	3.9	0.8	18.7	10.8	6.2	10.5	3.0	209.6	0.4	0.0	144.6	13.3	13.3	9.4	0.0	51.5	7.5	1.3	57.2	0.0	0.2	14.6	30.5	20.5	18.1	10.4	2.1	16.5	1.8	1.9	1.0	1.0	3.1	0.0	0.1	0.4	0.7	0.7	32.1	4.3	2.2	3.0	17.6	0.7	0.0	0.5	24.6	110.0	39.6	33.8	18.6	22.0	10.3	2.1	26.6	10.4
CDK16	"FLJ16665, PCTAIRE, PCTAIRE1, PCTGAIRE, PCTK1"	ENSG00000102225	"Cyclin dependent kinase 16"	Q00536	X	47217860-47229997	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 217.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000974, HPA001366, CAB016535"	Approved		Approved	"Plasma membrane,Microtubules,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Microtubules, Cytosol"	"Plasma membrane"	"CAB016535: AB_785112, HPA000974: AB_2666162, HPA001366: AB_1079584"	"unprognostic (2.37e-3)"	"unprognostic (6.93e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.16e-3)"	"unprognostic (8.80e-2)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (2.02e-6)"	"unprognostic (2.85e-1)"	"unprognostic (5.59e-2)"	"unprognostic (7.62e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.89e-3)"	"unprognostic (2.55e-1)"	48.2	61.3	59.0	30.4	63.6	65.7	38.6	63.8	75.0	37.9	35.7	41.4	34.2	37.5	19.7	60.7	37.6	23.8	113.3	64.3	46.5	62.7	35.0	41.6	24.3	57.2	52.4	45.3	43.1	50.6	41.7	37.9	54.9	37.2	29.6	33.6	43.9	30.4	217.6	41.9	36.3	37.7	39.6	34.0	39.1	55.2	74.3	29.9	50.3	180.4	26.5	34.2	36.8	60.6	177.6	132.5	124.8	185.0	89.5	76.2	124.2	82.4	100.7	122.3	90.5	150.2	83.3	42.1	51.2	148.1	225.7	97.7	134.3	174.7	81.8	50.9	212.6	46.0	193.8	118.8	115.7	48.7	103.0	95.5	109.6	173.8	207.4	101.7	111.0	43.7	69.6	69.7	108.4	153.1	42.7	111.1	97.9	66.3	141.8	44.9	98.8	74.4	91.7	137.7	105.0	79.4	223.2	169.9	86.5	144.4	152.0	59.3	112.9	81.1	131.4	125.4	99.8	54.6	58.2	41.8	71.4	223.0	93.1	2.6	7.8	7.5	3.7	9.3	4.9	3.4	5.0	6.0	9.7	9.8	4.3	4.6	3.2	5.5	8.4	11.3	5.5	6.1	59.0	63.6	63.8	75.0	64.3	46.5	57.2	52.4	54.9	39.6	74.3	60.6	18.8	0.0	6.1	7.2	20.2	32.5	33.0	30.6	33.6	23.5	38.2	26.8	43.3	21.5	22.1	31.3	4.2	25.7	20.1	67.2	54.8	33.7	26.5	41.2	24.5	21.8	28.1	20.6	12.5	37.0	45.2	24.0	46.4	57.7	5.7	27.8	19.2	16.7	25.3	30.3	15.8	34.3	32.6	19.5	30.8	94.8	17.1	23.5	33.8	2.8	12.6	17.1	9.2	3.5	7.8	48.4	46.1	13.2	31.9	48.3	45.1	34.7	17.9	14.6	0.0	19.1	22.6	27.6	17.5	64.2	34.7	26.0	21.5	30.0	48.6	63.3
CDK5RAP2	"C48, CEP215, FLJ10867, MCPH3"	ENSG00000136861	"CDK5 regulatory subunit associated protein 2"	Q96SN8	9	120388869-120580170	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 148.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 15.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035820, HPA035821, HPA046529, CAB079753"	Approved		Enhanced	"Cell Junctions,Centrosome"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Centrosome	"Cell Junctions"	"CAB079753: AB_2665827, HPA035820: AB_10671939, HPA035821: , HPA046529: AB_2679688"	"unprognostic (7.72e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.84e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.63e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.41e-2)"	10.6	11.7	12.4	9.8	18.0	24.4	14.4	14.1	12.7	14.2	20.6	15.1	5.6	11.5	7.7	12.1	11.9	9.2	17.6	12.5	12.9	8.0	15.7	10.6	15.1	15.4	16.2	17.1	9.5	13.3	12.2	8.6	15.1	13.7	8.6	12.9	22.2	10.5	47.9	16.0	11.0	10.4	13.6	11.5	12.9	20.8	14.9	20.9	11.6	29.6	14.7	12.5	11.1	17.2	19.6	33.8	45.9	27.8	19.3	28.4	24.6	24.6	18.9	27.3	25.4	26.8	25.1	36.3	11.1	24.3	18.7	42.1	36.5	28.3	26.1	29.3	14.7	31.0	62.1	47.7	18.1	38.5	19.9	51.4	18.5	24.3	31.8	20.6	24.1	43.0	29.2	30.6	36.4	44.2	41.8	24.7	42.6	41.5	25.3	40.3	54.5	17.1	19.5	15.4	29.9	34.3	42.9	23.3	28.8	19.7	54.6	26.3	16.1	23.6	25.7	28.0	28.4	22.2	33.4	39.7	24.6	24.4	50.8	15.7	1.7	3.0	3.4	1.7	3.3	5.0	3.2	3.2	1.0	5.8	2.6	2.7	2.4	4.0	4.7	2.2	2.9	1.8	12.4	18.0	14.1	12.7	12.5	12.9	15.4	16.2	15.1	13.6	14.9	17.2	11.6	28.9	39.5	64.9	21.2	7.0	13.5	11.9	13.1	23.7	18.0	17.5	53.8	15.7	19.3	1.8	16.7	13.2	25.8	12.3	7.9	12.6	37.5	24.8	18.1	13.7	8.4	35.3	43.2	14.3	12.7	20.4	10.7	23.7	17.1	41.4	8.6	22.2	10.8	18.5	38.4	12.1	18.3	9.4	8.6	30.6	22.1	25.8	12.4	26.2	13.2	20.4	24.7	66.9	148.7	11.8	8.1	23.3	27.7	9.5	5.6	4.6	35.0	28.9	32.9	43.6	22.3	58.4	36.4	17.8	6.8	7.3	23.1	23.0	11.6	7.7
CDKN2AIPNL	"C2AIL, MGC13017"	ENSG00000237190	"CDKN2A interacting protein N-terminal like"	Q96HQ2	5	134402065-134411881	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043966	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA043966: AB_2678750"	"unprognostic (7.58e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.33e-3)"	"unprognostic (4.54e-3)"	"unprognostic (2.56e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.08e-1)"	"unprognostic (4.76e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.00e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.79e-2)"	15.5	23.7	25.8	11.0	27.2	17.0	14.2	25.8	30.6	11.4	20.0	16.8	19.2	12.3	15.6	12.8	11.7	9.4	35.5	27.8	28.2	20.9	17.3	10.8	16.6	29.4	25.2	12.7	33.0	19.7	19.3	11.4	29.3	13.9	13.9	24.3	18.3	10.4	81.7	14.9	17.4	10.0	25.2	14.5	19.2	19.7	27.8	19.0	21.0	42.9	15.8	15.7	11.8	25.7	71.2	42.1	44.1	95.4	22.5	30.5	46.1	37.8	21.5	47.2	52.1	73.1	41.8	47.1	50.3	25.5	68.0	23.0	59.2	93.0	50.8	67.4	89.5	44.1	45.0	43.8	37.8	30.8	25.8	24.5	44.6	59.4	46.3	37.9	49.7	75.3	42.4	54.3	35.4	41.2	50.6	58.2	77.6	37.3	53.1	43.0	46.5	58.3	44.2	23.9	58.7	64.5	50.8	14.1	69.1	49.3	63.1	55.2	33.4	55.8	37.0	44.7	53.7	38.8	69.2	50.2	65.2	53.7	58.7	10.5	16.7	12.4	17.8	18.2	22.7	30.1	22.9	17.7	20.2	28.1	21.7	21.6	4.6	17.8	20.9	24.2	25.3	15.2	25.8	27.2	25.8	30.6	27.8	28.2	29.4	25.2	29.3	25.2	27.8	25.7	21.3	3.2	15.6	3.3	23.7	13.5	16.6	33.6	13.6	21.9	23.9	20.2	50.7	18.6	14.1	9.2	14.6	37.8	17.4	15.3	58.7	28.6	22.0	17.3	16.4	22.7	31.0	34.5	8.8	36.3	40.4	17.2	8.6	12.3	15.2	34.7	22.1	12.6	24.6	15.2	9.1	21.2	36.7	19.4	15.4	46.1	22.1	14.2	23.2	3.7	31.3	30.1	15.5	3.5	7.0	26.0	17.4	19.9	22.6	11.9	30.0	45.4	10.7	26.8	19.7	15.6	22.4	35.1	32.3	18.6	15.3	20.2	17.6	23.5	22.9	14.4
CDKN3	"CDI1, KAP"	ENSG00000100526	"Cyclin dependent kinase inhibitor 3"	Q16667	14	54396849-54420218	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Hydrolase, Protein phosphatase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 207.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 2630.9;Late spermatids: 659.4;Spermatocytes: 606.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 18.8"	"Group enriched"	"Detected in all"	6	"NK-cells: 6.4;T-cells: 18.8"	"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005285, HPA039311, HPA058874"			Enhanced	Cytosol		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"CAB005285: AB_2078884, HPA039311: , HPA058874: AB_2683842"	"unprognostic (3.46e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.73e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.51e-3)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (2.50e-3)"	"unprognostic (2.85e-3)"	"prognostic unfavorable (7.46e-4)"	"unprognostic (5.89e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.71e-1)"	"unprognostic (7.30e-2)"	"unprognostic (7.92e-2)"	"unprognostic (4.31e-2)"	3.4	1.6	2.8	12.2	2.7	43.4	3.4	5.0	4.2	2.2	3.4	13.9	12.4	2.8	0.4	10.2	1.3	2.9	5.3	2.9	3.1	2.0	2.4	2.1	28.4	2.5	2.7	1.3	1.1	0.5	1.6	6.7	3.3	1.6	16.9	2.6	3.3	0.7	3.0	5.9	12.6	7.4	2.1	4.9	5.0	207.0	3.5	30.9	1.7	4.1	30.0	5.8	4.1	2.6	276.7	102.5	74.0	78.2	12.5	15.3	46.5	63.1	97.0	135.8	146.9	81.8	136.5	139.9	44.4	96.7	135.9	195.9	114.6	78.3	245.6	169.5	59.3	65.8	69.0	126.8	10.1	86.2	47.6	5.4	4.9	84.3	138.3	44.4	88.4	129.8	36.1	162.2	159.8	186.9	118.1	67.9	27.9	254.7	216.4	72.7	66.6	29.7	70.5	56.9	30.6	42.0	118.7	67.4	52.5	54.6	142.9	69.4	33.0	59.2	195.8	91.7	155.0	38.6	47.4	91.4	98.6	120.4	110.9	0.0	1.3	1.3	1.6	1.7	0.7	2.1	5.5	4.8	1.8	0.9	2.9	2.3	1.0	6.4	1.2	1.5	18.8	3.1	2.8	2.7	5.0	4.2	2.9	3.1	2.5	2.7	3.3	2.1	3.5	2.6	1.4	0.0	0.0	0.7	10.5	9.3	4.3	9.7	4.6	3.2	6.4	11.6	9.7	0.0	2.4	1.8	2.1	42.6	2.7	7.3	0.0	3.5	2630.9	2.7	3.5	6.8	7.8	125.5	2.5	2.4	35.0	10.2	9.2	3.5	7.0	31.3	6.1	3.1	37.7	5.0	3.9	17.9	4.1	9.8	8.8	659.4	21.5	8.9	1.8	1.0	2.9	1.7	0.0	0.0	0.2	1.9	7.2	10.5	41.0	4.0	3.4	2.8	0.2	2.9	0.0	3.0	20.5	606.9	39.8	22.5	6.5	4.1	8.3	3.9	31.2	5.3
CEBPZ	"CBF2, CTF2"	ENSG00000115816	"CCAAT enhancer binding protein zeta"	Q03701	2	37201612-37231596	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 282.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052065	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles	Nucleoplasm	"HPA052065: AB_2681715"	"unprognostic (1.64e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.00e-3)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (2.88e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (2.94e-5)"	"unprognostic (8.84e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (8.13e-4)"	"unprognostic (2.65e-2)"	"unprognostic (5.36e-2)"	"unprognostic (4.19e-2)"	"unprognostic (8.76e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.01e-2)"	21.1	27.8	10.3	18.9	11.5	31.3	26.2	15.8	12.8	17.9	11.9	19.5	17.4	20.1	19.9	20.5	17.2	16.7	15.3	9.8	11.8	25.3	27.1	19.3	24.6	10.9	11.0	23.9	20.6	22.3	10.2	23.0	11.4	19.7	20.0	24.4	16.3	15.6	36.3	17.9	18.1	16.9	10.8	19.9	17.4	38.4	11.1	24.0	22.4	24.4	24.4	26.6	12.6	14.2	61.2	46.6	46.9	26.1	45.2	48.6	39.9	57.0	39.2	47.2	50.5	74.5	45.1	111.5	49.4	33.8	64.4	51.0	122.8	58.5	60.2	71.8	53.9	104.0	47.5	60.9	35.8	105.7	44.9	37.3	56.4	62.8	63.4	31.1	43.3	27.8	114.8	49.8	48.6	31.8	61.5	82.4	153.3	81.0	43.2	48.6	76.3	84.3	45.3	56.9	49.9	80.7	47.5	57.6	65.5	67.6	41.8	45.9	35.5	45.8	52.3	41.3	79.1	55.5	62.0	88.1	40.8	95.6	51.2	34.8	16.8	16.3	23.8	21.7	30.0	29.6	24.7	23.4	17.6	30.0	31.1	26.1	6.1	26.1	22.3	25.6	21.4	14.6	10.3	11.5	15.8	12.8	9.8	11.8	10.9	11.0	11.4	10.8	11.1	14.2	73.4	86.6	82.9	15.0	91.6	107.1	109.2	64.4	83.1	45.5	50.4	54.1	34.4	47.1	81.9	49.7	43.8	54.7	93.4	36.7	107.6	56.1	282.1	56.0	87.2	60.5	44.2	66.7	15.6	62.5	37.4	67.4	52.5	67.5	73.4	44.7	43.9	76.4	35.1	43.7	19.3	56.6	44.7	37.0	36.1	43.3	60.9	44.6	21.4	15.0	54.1	57.1	63.8	18.6	21.4	54.9	30.2	50.8	67.7	79.0	30.2	89.1	54.2	95.5	52.6	94.3	68.3	186.7	99.3	56.8	101.2	45.0	87.7	62.1	64.2	80.9
CENPA	"CenH3, CENP-A"	ENSG00000115163	"Centromere protein A"	P49450	2	26764289-26801067	"Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 13.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 45.0;Extravillous trophoblasts: 33.2;Granulosa cells: 24.2;Plasma cells: 17.8;Spermatogonia: 28.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 24.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB008371, HPA073086"	Enhanced		Supported	Nucleoplasm		NA	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB008371: AB_591074, HPA073086: AB_2686569"	"unprognostic (3.94e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.29e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (2.88e-8)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (1.69e-3)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (4.21e-3)"	"unprognostic (0.00e+0)"	"unprognostic (5.74e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.07e-1)"	0.2	0.3	0.0	4.0	0.0	3.7	0.4	0.1	0.1	0.5	0.0	2.9	4.1	0.7	0.0	3.7	0.1	0.1	0.2	0.0	0.0	0.1	0.2	0.4	7.3	0.0	0.0	0.1	0.1	0.0	0.0	1.5	0.0	0.1	2.6	0.0	0.6	0.0	0.0	3.6	2.9	0.9	0.0	2.0	1.6	2.2	0.1	13.3	0.1	0.0	8.4	0.7	1.1	0.0	86.4	21.0	34.9	19.3	2.4	4.5	24.3	26.2	22.2	37.3	31.5	15.4	30.0	25.7	16.2	10.4	45.7	25.6	28.9	15.3	37.7	77.3	25.6	44.0	11.0	28.6	0.8	26.7	49.0	0.4	1.6	16.1	24.4	6.7	22.1	33.7	36.7	58.5	32.5	30.1	39.0	42.2	26.6	35.3	34.3	45.4	53.6	30.8	17.5	5.5	27.5	26.7	25.7	32.7	23.6	12.9	18.2	27.2	12.6	23.9	54.2	27.9	46.4	51.5	53.5	107.3	11.1	54.7	46.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	5.2	6.2	0.7	1.9	1.8	0.0	2.0	2.5	2.7	0.0	0.5	0.0	0.0	15.3	1.0	2.3	0.0	0.5	0.6	1.6	1.6	1.5	4.2	45.0	0.1	0.2	33.2	4.9	2.6	3.0	0.0	24.2	3.9	0.6	15.7	0.0	0.1	6.6	0.0	2.9	2.8	0.1	0.9	4.4	1.8	0.0	0.0	0.0	1.0	0.0	0.0	0.1	1.4	0.0	17.8	2.1	0.8	0.2	0.1	0.0	0.0	0.6	3.9	16.1	28.6	12.5	5.3	3.4	3.4	1.5	11.1	2.0
CENPE	"KIF10, PPP1R61"	ENSG00000138778	"Centromere protein E"	Q02224	4	103105349-103198445	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Developmental protein, Motor protein"	"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 10.0;lymphoid tissue: 9.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 75.1;Extravillous trophoblasts: 28.4;Granulosa cells: 32.0;Spermatocytes: 75.3;Spermatogonia: 51.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA011110, HPA042294"	Enhanced		Enhanced	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA011110: , HPA042294: AB_10797386"	"unprognostic (1.62e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.64e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.40e-8)"	"unprognostic (2.49e-3)"	"unprognostic (1.59e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.88e-5)"	"unprognostic (1.15e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.95e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.37e-1)"	0.4	0.2	0.4	2.7	0.4	10.0	0.6	0.3	0.5	0.4	0.4	1.8	1.5	0.6	0.0	2.0	0.2	0.8	0.2	0.3	0.6	0.2	0.5	0.8	5.6	0.5	0.5	0.1	0.1	0.3	0.0	1.4	0.9	0.3	2.0	0.4	0.3	0.2	0.0	2.0	1.7	1.1	0.3	1.2	1.1	4.1	0.5	9.2	0.2	0.6	4.9	0.8	0.6	0.5	42.6	11.8	42.2	20.5	2.7	6.2	8.4	36.7	18.2	26.9	17.9	19.6	22.2	28.6	9.2	13.7	19.2	18.2	30.3	15.1	42.2	35.9	11.3	33.5	26.8	13.6	0.4	39.9	18.6	1.8	1.1	21.7	18.0	6.0	22.9	25.2	34.4	32.5	34.8	15.6	31.5	18.9	13.8	17.0	17.9	20.9	38.5	9.3	8.0	8.4	19.3	11.5	32.9	22.9	9.0	16.0	12.9	13.9	26.1	25.8	27.2	27.2	38.6	15.9	28.6	28.8	14.2	21.7	27.8	2.9	0.0	0.3	0.0	0.2	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.3	1.5	0.2	0.6	0.0	0.4	0.4	0.3	0.5	0.3	0.6	0.5	0.5	0.9	0.3	0.5	0.5	1.4	3.2	2.2	1.0	6.6	3.6	1.5	2.9	0.0	7.6	1.8	2.7	1.9	0.0	1.3	0.0	8.4	12.7	3.9	4.7	0.0	0.5	7.7	3.5	5.7	4.2	1.2	75.1	2.0	0.0	28.4	6.5	4.6	6.9	7.0	32.0	4.2	0.9	14.1	0.0	1.9	4.3	4.1	10.4	5.7	3.5	0.9	9.6	0.0	0.0	6.0	1.3	2.1	0.5	3.1	1.8	1.4	2.6	16.0	1.4	0.8	0.3	0.3	2.6	0.0	5.7	7.4	75.3	51.0	8.3	2.8	3.6	6.6	7.0	11.6	1.9
CENPF	hcp-1	ENSG00000117724	"Centromere protein F"	P49454	1	214603195-214664571	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, DNA synthesis, Mitosis, Myogenesis"	"Developmental protein"	"Cancer-related genes, Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.8;lymphoid tissue: 33.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 84.4;Erythroid cells: 268.7;Extravillous trophoblasts: 78.8;Granulosa cells: 165.8;Spermatocytes: 107.5;Spermatogonia: 107.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA052382, HPA064308, CAB070134"	Enhanced		Supported	Nucleoplasm		Yes	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB070134: AB_2229328, HPA052382: AB_2681808, HPA064308: AB_2732711"	"unprognostic (2.80e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (2.29e-5)"	"unprognostic (1.13e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.89e-2)"	"unprognostic (4.12e-1)"	0.8	1.1	0.1	4.4	0.1	28.8	1.8	0.0	0.3	1.3	0.5	5.8	6.1	1.8	0.1	8.6	0.6	0.7	0.4	0.3	0.0	0.4	0.9	0.9	8.5	0.3	0.5	0.7	0.3	0.2	0.1	3.1	0.3	0.5	5.7	1.0	1.4	0.1	0.2	6.2	4.3	2.5	0.2	2.4	2.6	10.5	0.5	33.0	0.4	0.6	10.0	1.4	2.6	0.3	123.7	68.4	144.3	75.8	5.4	7.2	56.3	74.6	30.3	43.9	42.8	54.6	74.1	116.3	43.1	41.7	39.8	74.7	89.9	49.2	74.1	102.6	56.6	96.0	111.4	78.6	0.8	137.0	50.5	2.7	3.8	63.3	72.3	12.7	46.9	52.6	88.4	68.0	79.4	47.0	81.5	54.3	127.9	36.8	30.0	85.7	203.7	38.6	43.2	30.3	67.4	91.2	100.7	66.2	38.9	76.2	79.1	51.9	61.7	78.9	92.2	66.2	155.9	51.6	60.7	108.7	34.4	96.7	71.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.3	0.3	0.0	0.3	0.5	0.3	0.2	0.5	0.3	3.0	0.0	3.1	0.0	11.5	9.3	2.8	11.2	3.4	4.7	10.0	6.7	1.9	1.5	9.9	0.0	0.0	53.3	10.8	19.1	0.0	2.0	84.4	30.1	19.3	12.4	0.0	268.7	1.3	0.4	78.8	19.0	32.1	25.2	1.3	165.8	8.9	2.6	32.2	1.7	0.8	20.1	14.2	16.6	6.6	19.8	1.2	16.2	1.8	1.0	0.7	1.4	5.2	0.0	0.1	0.5	1.1	3.0	25.9	2.3	2.1	0.1	16.7	3.1	0.0	8.3	23.9	107.5	107.1	44.6	5.5	5.1	23.3	11.7	41.3	3.7
CENPH		ENSG00000153044	"Centromere protein H"	Q9H3R5	5	69189574-69210357	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 33.8;testis: 29.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 74.5;Spermatocytes: 222.7;Spermatogonia: 222.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA036494	Approved		Supported	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli rim"	"Mitotic chromosome"	"HPA036494: AB_10673354"	"unprognostic (1.49e-1)"	"prognostic favorable (6.86e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (5.22e-5)"	"unprognostic (6.14e-3)"	"unprognostic (6.85e-2)"	"prognostic favorable (2.50e-4)"	"unprognostic (4.21e-2)"	"unprognostic (8.80e-2)"	"prognostic unfavorable (5.11e-15)"	"unprognostic (1.17e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.20e-1)"	4.2	2.0	1.4	7.5	1.7	33.8	7.7	1.7	2.0	3.9	1.0	7.4	6.5	4.5	2.1	7.5	4.0	1.8	4.0	1.5	1.6	1.6	3.6	2.8	17.7	1.6	1.5	3.9	1.5	2.0	1.4	5.2	1.6	3.3	8.1	2.5	2.9	2.3	4.0	9.2	5.9	3.7	1.4	5.2	3.7	29.7	1.6	18.5	2.5	4.0	18.8	3.8	4.4	2.2	64.6	19.4	88.6	70.2	5.8	18.3	48.0	31.2	32.6	66.9	71.8	26.5	79.6	138.9	36.6	18.1	39.1	47.0	59.0	70.4	85.1	42.7	41.4	32.7	32.5	26.4	2.0	47.1	32.1	7.1	14.6	43.6	47.7	18.9	23.2	73.7	58.7	53.3	52.2	35.6	152.4	67.3	78.1	20.7	17.0	93.2	118.2	108.2	21.1	22.9	61.6	81.9	34.6	22.8	27.5	47.7	31.9	31.4	11.4	33.4	56.1	44.5	78.7	65.5	106.3	111.8	51.1	94.2	64.7	1.0	2.0	3.0	4.7	3.5	7.7	13.3	7.9	6.0	3.1	14.1	9.9	8.6	0.4	8.6	4.2	6.7	9.7	4.8	1.4	1.7	1.7	2.0	1.5	1.6	1.6	1.5	1.6	1.4	1.6	2.2	4.8	0.0	2.6	1.0	18.3	36.7	17.7	17.4	9.6	3.4	10.8	11.7	3.3	4.3	7.1	0.0	0.0	37.4	9.2	5.1	0.0	12.3	26.5	5.5	5.1	6.9	1.2	74.5	1.3	9.1	49.0	7.4	2.6	4.8	5.1	22.4	4.6	1.1	17.0	0.0	1.1	9.5	12.2	7.5	18.2	22.5	3.7	6.3	8.8	1.0	4.3	7.3	6.2	1.0	0.9	7.0	2.5	4.9	14.4	6.9	1.4	3.4	10.8	3.5	19.7	6.4	9.3	222.7	222.8	12.1	19.2	10.0	12.0	6.9	15.9	15.2
CENPK	"CENP-K, FKSG14, SOLT"	ENSG00000123219	"Centromere protein K"	Q9BS16	5	65517766-65563168	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.6;lymphoid tissue: 22.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 50.9;Extravillous trophoblasts: 50.6;Spermatocytes: 101.3;Spermatogonia: 75.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	Yes			"Cluster 20: T-cells - T-cell receptor"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"				"unprognostic (4.04e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.69e-4)"	"unprognostic (3.22e-3)"	"unprognostic (9.59e-3)"	"unprognostic (3.32e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.98e-2)"	"unprognostic (6.33e-15)"	"unprognostic (2.22e-1)"	"unprognostic (2.97e-1)"	"unprognostic (8.42e-2)"	"unprognostic (3.11e-1)"	1.1	0.9	0.6	10.6	0.7	24.6	3.8	1.0	0.8	1.2	1.6	9.0	8.3	1.9	0.9	5.6	2.3	1.9	0.5	0.5	0.6	0.8	1.9	2.0	14.6	1.0	0.7	0.8	0.6	1.0	0.3	5.5	1.1	1.3	11.9	0.7	1.4	0.7	0.2	8.6	8.6	3.4	0.7	4.5	5.5	13.4	1.0	22.2	1.2	0.5	12.4	2.6	2.4	1.4	65.3	41.4	85.6	29.5	4.4	12.0	40.8	69.8	26.5	58.7	73.6	35.1	97.2	39.3	25.2	23.6	59.5	39.7	33.3	35.4	92.7	45.2	28.5	42.1	50.7	33.8	1.7	50.1	36.8	5.6	5.0	56.9	27.3	10.6	56.4	42.2	31.8	57.7	59.1	21.5	85.4	56.2	41.1	18.5	17.1	52.5	81.9	43.8	38.8	34.4	35.8	28.9	53.7	22.1	28.7	31.8	40.0	36.9	20.3	44.9	46.5	31.1	82.2	30.0	51.9	83.0	41.9	74.0	49.9	3.7	0.7	2.3	9.9	1.0	14.8	4.0	21.1	12.5	1.7	7.0	28.5	20.2	1.7	10.2	1.1	1.6	23.2	10.0	0.6	0.7	1.0	0.8	0.5	0.6	1.0	0.7	1.1	0.7	1.0	1.4	2.7	0.0	3.4	0.3	11.7	23.6	8.5	14.0	4.6	1.6	6.0	7.9	0.9	0.0	8.1	0.0	0.0	28.8	18.7	5.8	1.9	3.1	27.6	25.5	4.5	5.7	0.0	50.9	3.1	1.0	50.6	6.3	9.2	7.2	2.5	22.7	3.9	1.1	22.4	0.0	2.3	14.7	8.2	1.9	12.0	17.4	1.5	5.7	1.8	11.2	1.8	0.6	7.2	2.0	1.4	2.3	2.1	1.5	14.1	2.2	1.1	0.3	7.1	1.1	0.0	2.3	9.1	101.3	75.1	17.0	8.1	6.7	20.7	3.9	15.8	11.4
CENPL	"C1orf155, dJ383J4.3, FLJ31044"	ENSG00000120334	"Centromere protein L"	Q8N0S6	1	173799550-173824720	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 9.6;testis: 9.8"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA044520	Uncertain					NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA044520: AB_10794500"	"unprognostic (8.72e-3)"	"unprognostic (2.82e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.34e-3)"	"unprognostic (7.89e-2)"	"unprognostic (7.88e-3)"	"unprognostic (6.43e-6)"	"unprognostic (8.18e-2)"	"prognostic unfavorable (2.51e-4)"	"prognostic favorable (3.60e-4)"	"unprognostic (1.78e-3)"	"unprognostic (5.00e-2)"	"unprognostic (1.46e-10)"	"unprognostic (2.16e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.09e-1)"	2.1	1.2	1.4	3.1	1.5	9.6	2.4	1.4	1.8	1.9	1.0	2.4	2.3	1.8	1.0	2.3	1.2	1.7	1.7	1.2	1.3	1.4	1.0	1.3	6.6	1.7	1.3	1.6	0.7	1.1	0.6	3.0	1.6	1.3	3.0	1.5	1.4	1.2	1.4	2.2	1.8	2.4	1.6	2.1	2.1	9.8	1.3	9.1	1.7	2.7	5.7	1.9	1.4	1.8	27.5	7.3	13.5	18.2	3.9	6.7	9.9	23.6	14.4	24.9	17.3	9.5	14.3	19.8	11.0	12.9	9.4	17.6	14.6	11.6	27.4	18.0	7.2	14.6	7.6	5.5	1.9	22.4	14.7	3.4	3.9	17.6	14.0	4.7	14.8	15.2	25.8	28.6	23.0	6.4	18.5	10.3	14.1	19.3	40.4	18.9	16.7	16.7	8.9	7.5	13.6	11.3	18.7	22.5	15.7	10.9	15.8	18.5	8.6	28.6	19.6	14.8	27.6	15.9	29.2	31.5	9.4	16.4	26.6	3.9	1.0	2.4	4.7	1.1	5.3	3.3	4.3	5.5	0.9	5.0	5.5	6.0	0.6	8.6	0.7	4.3	7.1	2.6	1.4	1.5	1.4	1.8	1.2	1.3	1.7	1.3	1.6	1.6	1.3	1.8	16.0	9.6	3.7	1.6	8.5	4.7	6.9	2.8	1.2	4.9	7.3	24.5	5.0	2.8	2.1	1.8	14.6	9.2	13.1	4.8	0.0	2.2	2.2	4.6	12.8	6.3	1.8	22.7	2.2	3.8	15.9	7.7	3.1	7.9	4.5	13.1	3.3	0.8	6.7	1.7	2.0	4.8	2.0	4.4	7.1	3.3	4.7	4.5	5.4	2.8	3.6	2.4	7.2	1.5	2.5	3.6	4.5	1.9	7.4	6.3	4.0	1.3	1.7	4.7	0.0	14.5	10.7	38.8	20.2	8.8	6.0	5.9	9.2	11.2	5.3	4.5
CENPN	"BM039, C16orf60, FLJ13607, FLJ22660"	ENSG00000166451	"Centromere protein N"	Q96H22	16	81006552-81033114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 37.4"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 64.2;Extravillous trophoblasts: 91.1;Spermatocytes: 52.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA052870			Supported	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA052870: AB_2681978"	"unprognostic (1.23e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.69e-3)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (1.90e-1)"	"unprognostic (2.36e-3)"	"prognostic unfavorable (1.46e-5)"	"unprognostic (3.02e-2)"	"prognostic unfavorable (4.86e-4)"	"unprognostic (2.34e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.41e-2)"	"unprognostic (7.99e-2)"	5.1	5.0	3.2	7.9	4.0	37.4	3.6	3.1	4.9	2.8	2.1	8.0	7.8	2.3	3.1	7.5	1.6	3.1	5.7	3.3	3.1	5.4	9.0	3.3	11.0	3.8	4.0	1.5	5.2	8.6	1.6	8.9	3.4	18.7	7.6	1.4	2.5	2.7	4.5	3.8	6.4	6.4	2.7	4.3	5.2	11.2	3.9	18.1	2.8	2.6	12.0	6.0	2.8	5.8	86.2	81.0	64.9	58.4	16.9	15.1	82.6	97.5	59.3	137.0	59.6	150.8	64.6	48.1	52.4	48.9	62.7	69.9	53.1	61.5	172.9	29.3	47.9	43.0	63.3	100.9	9.6	64.6	80.4	14.0	6.6	123.3	40.8	18.0	62.6	59.1	83.6	65.9	66.9	160.1	78.0	79.6	69.7	37.2	45.4	90.9	64.5	51.3	22.5	58.6	43.2	38.9	140.3	31.8	40.1	38.9	76.2	34.0	38.5	97.7	101.1	66.8	96.8	46.4	112.1	186.8	45.8	43.7	85.8	0.9	1.4	2.4	2.1	2.8	2.0	1.6	2.7	1.5	6.6	5.9	1.3	1.5	1.7	3.6	3.1	2.2	7.9	2.0	3.2	4.0	3.1	4.9	3.3	3.1	3.8	4.0	3.4	2.7	3.9	5.8	2.8	0.0	4.8	1.0	10.2	24.0	15.7	9.6	14.8	1.0	6.0	7.0	4.8	5.7	5.8	3.7	0.0	47.1	10.0	7.4	0.0	5.7	41.8	4.5	3.8	5.8	1.2	64.2	1.9	6.5	91.1	9.7	11.7	6.4	6.3	13.2	6.8	6.3	27.2	0.0	1.1	12.8	12.2	9.7	20.2	40.9	2.8	10.4	7.2	1.0	4.4	0.8	0.0	0.5	6.1	5.1	4.0	3.4	34.7	13.6	5.1	8.8	1.8	0.4	0.0	7.1	10.0	52.3	39.1	32.7	16.3	27.2	10.9	6.3	22.0	16.6
CENPO	"CENP-O, MGC11266"	ENSG00000138092	"Centromere protein O"	Q9BU64	2	24793136-24822376	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 11.2;Extravillous trophoblasts: 11.5;Spermatocytes: 11.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA046189			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"HPA046189: AB_2679579"	"unprognostic (1.67e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (1.79e-1)"	"unprognostic (7.48e-3)"	"prognostic unfavorable (1.73e-6)"	"unprognostic (5.56e-2)"	"unprognostic (4.02e-1)"	"unprognostic (4.81e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.63e-2)"	"prognostic unfavorable (5.71e-13)"	"unprognostic (4.23e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.96e-1)"	5.2	4.0	3.5	3.5	3.3	9.2	4.6	2.9	4.1	4.0	2.3	3.3	3.2	3.1	0.8	4.5	3.0	1.5	2.8	3.7	3.5	2.9	2.6	3.6	4.9	3.7	3.4	4.5	1.9	1.6	3.6	3.2	3.5	3.1	3.7	1.4	2.5	1.1	3.0	3.8	3.9	2.2	3.2	4.3	2.7	8.3	3.8	11.4	3.4	2.0	5.8	2.5	3.7	3.1	31.1	36.4	40.7	21.7	4.8	7.3	22.7	36.8	21.7	51.0	38.7	46.2	15.5	21.4	4.2	22.8	29.8	16.3	40.6	14.0	34.1	28.1	21.1	34.3	23.9	31.0	2.4	28.7	24.4	3.6	2.5	51.5	11.4	9.3	24.0	25.4	40.3	23.8	31.8	21.8	39.2	20.6	29.3	21.0	22.8	31.0	53.4	11.5	12.9	18.6	27.0	29.3	22.1	16.9	7.9	18.5	16.3	11.8	15.4	46.9	42.8	15.9	41.6	14.5	20.1	42.8	14.5	27.5	36.4	0.0	0.3	0.0	1.0	0.2	0.4	0.4	0.4	0.5	0.4	0.3	0.3	0.7	0.1	0.7	0.3	1.1	0.7	0.3	3.5	3.3	2.9	4.1	3.7	3.5	3.7	3.4	3.5	3.2	3.8	3.1	0.7	3.2	2.2	4.2	1.5	1.1	0.7	1.3	2.2	0.9	1.9	1.4	6.5	0.0	1.2	3.7	0.0	3.9	1.9	3.0	1.9	1.5	3.9	1.5	2.2	2.0	0.0	11.2	5.3	1.3	11.5	2.4	6.6	1.5	1.3	6.5	1.8	0.9	4.9	1.7	4.9	1.6	0.0	1.6	1.1	9.6	0.3	1.1	1.8	3.7	1.2	1.6	1.0	2.0	2.5	1.1	0.5	1.2	8.6	0.5	1.8	1.7	0.7	0.7	0.0	1.1	3.3	11.7	9.5	3.3	1.4	2.9	1.4	2.8	2.7	0.9
CENPP	"CENP-P, RP11-19J3.3"	ENSG00000188312	"Centromere protein P"	Q6IPU0	9	92325953-92620529	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 21.4"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 63.3;Excitatory neurons: 73.4;Inhibitory neurons: 70.5;Microglial cells: 94.6;Oligodendrocytes: 74.5;Suprabasal keratinocytes: 100.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021787, HPA058945"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 28: Keratinocytes - Keratinization"	Nucleoplasm	Nucleoli	"HPA021787: AB_1846524, HPA058945: AB_2683860"	"unprognostic (5.48e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.64e-2)"	"prognostic favorable (3.65e-4)"	"unprognostic (4.88e-5)"	"unprognostic (8.06e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.68e-3)"	"unprognostic (9.20e-8)"	"unprognostic (1.27e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.04e-1)"	3.4	3.0	1.7	3.5	2.1	12.3	3.0	5.6	2.1	3.8	0.8	2.4	2.8	2.9	0.7	4.4	2.0	2.8	2.8	2.0	1.5	2.0	1.8	1.9	5.6	1.7	1.4	2.2	2.1	2.4	1.8	3.1	2.0	2.3	2.7	2.4	2.2	1.5	9.0	21.4	1.9	3.0	1.0	2.7	1.8	4.5	1.8	7.1	1.4	4.5	6.4	2.3	4.0	1.8	14.2	8.7	12.0	8.8	4.9	5.3	11.7	14.6	8.2	17.9	14.3	4.0	7.9	18.5	6.7	4.7	16.5	16.8	11.6	8.0	16.6	26.3	15.1	18.6	7.2	5.7	2.6	38.2	17.0	5.8	4.5	17.3	11.1	2.5	9.2	17.5	20.8	25.2	13.8	9.0	53.4	11.6	10.1	26.6	17.9	17.9	20.3	20.0	2.7	14.1	27.8	9.6	16.8	10.5	5.4	8.7	5.6	11.4	4.4	17.4	8.7	26.6	21.2	16.7	21.6	23.9	19.5	18.9	16.1	1.8	1.8	2.6	2.6	6.4	4.7	4.6	3.0	2.3	2.3	3.6	2.7	2.7	0.5	3.5	3.3	3.0	3.5	2.0	1.7	2.1	5.6	2.1	2.0	1.5	1.7	1.4	2.0	1.0	1.8	1.8	3.7	0.0	0.5	17.3	4.5	63.3	4.0	4.5	5.2	6.2	4.0	2.7	2.1	2.8	1.3	0.0	8.4	6.2	3.3	1.6	1.9	1.7	17.5	2.4	4.2	4.4	1.2	11.2	73.4	2.3	9.2	5.8	5.6	2.3	0.0	6.4	2.5	0.9	17.1	1.7	70.5	1.5	0.0	2.1	11.7	4.7	4.4	4.0	14.2	94.6	0.5	2.8	1.0	38.2	74.5	1.1	0.4	4.9	11.9	2.8	0.4	1.8	0.3	7.8	6.6	20.8	9.2	30.2	16.2	9.8	100.9	3.8	3.6	4.4	2.6	2.7
CENPQ	"C6orf139, CENP-Q, FLJ10545"	ENSG00000031691	"Centromere protein Q"	Q7L2Z9	6	49463370-49493107	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 34.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029043, HPA046634, HPA054965"	Approved		Supported	Nucleoplasm		NA	Yes			"Cluster 37: B-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA029043: AB_2672881, HPA046634: AB_2679728, HPA054965: AB_2682653"	"unprognostic (7.39e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (2.49e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (2.21e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.76e-2)"	"prognostic favorable (6.26e-4)"	"unprognostic (2.89e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.48e-3)"	"unprognostic (8.93e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.56e-1)"	4.8	4.7	4.7	5.4	5.8	4.9	5.4	5.8	6.9	3.1	3.8	3.9	2.8	4.7	3.0	4.3	4.0	3.5	6.4	4.2	5.1	3.8	4.4	3.8	7.0	5.8	5.2	6.2	2.5	3.6	2.3	5.9	6.0	4.5	4.7	4.2	2.8	3.3	5.0	4.0	3.3	4.4	5.3	4.7	3.8	6.0	4.8	9.4	3.7	8.4	8.4	3.7	3.3	7.6	35.3	9.7	30.1	18.9	8.0	12.4	26.4	44.6	25.5	41.9	58.4	11.9	13.8	23.7	21.7	12.7	32.8	12.5	15.8	16.2	61.6	25.9	22.0	17.5	14.6	19.2	3.4	37.4	21.2	5.7	8.7	51.5	17.9	10.7	15.5	20.4	27.3	22.9	31.4	10.2	26.4	17.6	18.8	30.6	8.7	18.8	35.6	25.8	12.3	14.3	16.2	16.0	21.0	12.4	23.9	29.6	15.9	33.8	9.2	32.3	25.2	25.7	40.4	10.4	28.9	21.4	21.9	27.8	32.0	2.2	1.2	4.1	2.0	1.4	2.0	4.4	2.1	2.3	1.3	4.5	2.3	2.3	0.9	2.4	1.8	2.7	3.2	1.2	4.7	5.8	5.8	6.9	4.2	5.1	5.8	5.2	6.0	5.3	4.8	7.6	8.6	0.0	2.7	7.2	9.5	8.7	9.9	10.4	8.6	6.3	4.1	4.7	6.2	4.3	5.2	7.3	2.1	17.3	8.7	4.2	7.9	7.8	1.3	8.8	5.6	8.0	2.4	5.9	3.0	7.9	30.8	9.3	6.6	5.4	4.5	6.3	14.3	3.4	10.1	6.7	3.1	3.7	2.0	11.4	6.0	2.3	8.7	5.9	3.6	11.2	7.6	14.5	13.4	6.6	13.5	7.8	8.0	10.9	7.5	5.4	1.7	4.4	9.4	5.1	6.6	15.2	6.5	17.7	34.6	6.5	7.0	12.4	5.9	4.2	5.9	6.2
CENPW	"C6orf173, CUG2"	ENSG00000203760	"Centromere protein W"	Q5EE01	6	126340115-126348875	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 50.6;testis: 39.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 329.7;Extravillous trophoblasts: 155.9;Spermatocytes: 148.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA067285			Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA067285: AB_2685818"	"unprognostic (3.51e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.26e-3)"	"unprognostic (9.61e-3)"	"unprognostic (3.78e-1)"	"unprognostic (9.80e-3)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (1.11e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.07e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.07e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.22e-1)"	8.2	4.3	2.5	12.8	2.3	50.6	6.6	2.0	3.5	14.4	1.4	15.0	8.3	21.6	7.0	23.1	9.2	5.4	1.7	4.2	2.0	3.4	3.6	4.9	15.5	1.9	2.0	4.1	2.1	2.8	2.5	7.8	1.7	6.3	17.5	1.6	8.5	4.4	3.0	8.3	10.8	16.1	1.9	6.8	6.3	39.5	2.0	27.4	2.5	1.9	20.5	6.6	10.9	2.4	73.4	49.0	94.7	82.9	10.3	10.4	81.2	60.0	43.6	81.3	98.3	148.0	50.1	86.8	48.8	38.3	128.7	88.0	78.0	94.3	114.6	94.0	140.2	84.7	141.4	166.3	3.4	123.8	59.1	6.4	10.0	69.1	51.2	23.1	88.3	116.8	144.1	56.5	69.6	119.3	103.1	204.4	60.5	64.0	74.3	107.7	63.2	62.6	38.0	33.0	99.1	44.0	50.8	46.5	67.4	76.9	43.7	119.5	48.0	76.6	78.3	104.6	163.7	36.9	72.7	156.8	45.9	147.0	92.8	3.2	16.9	2.3	2.0	20.3	0.6	6.0	4.4	4.3	15.9	3.5	3.4	2.7	2.9	6.9	14.1	18.9	12.0	5.9	2.5	2.3	2.0	3.5	4.2	2.0	1.9	2.0	1.7	1.9	2.0	2.4	2.5	0.0	2.6	1.0	18.6	38.0	13.4	54.3	6.2	1.3	10.3	18.7	0.3	11.5	29.4	1.8	2.1	52.2	6.1	23.5	5.9	16.6	329.7	18.0	26.5	11.0	7.8	75.1	23.7	17.9	155.9	25.1	17.3	12.7	13.4	31.4	10.8	6.0	63.6	3.3	22.0	27.1	42.7	15.6	40.1	39.3	19.3	19.3	8.8	1.0	12.6	3.1	3.1	1.0	2.4	17.2	10.6	9.1	38.6	24.7	18.1	1.6	7.0	1.4	0.0	6.4	18.1	148.3	83.8	60.9	29.0	21.2	8.6	11.4	51.7	35.8
CEP104	"CFAP256, GlyBP, JBTS25, KIAA0562, ROC22, RP1-286D6.4"	ENSG00000116198	"Centrosomal protein 104"	O60308	1	3812086-3857396	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Ciliopathy, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Cone photoreceptor cells: 458.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010126	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA010126: AB_10601583"	"unprognostic (3.60e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.83e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.49e-3)"	"unprognostic (8.35e-2)"	"unprognostic (4.85e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.90e-1)"	"unprognostic (2.89e-1)"	"prognostic favorable (1.70e-5)"	"unprognostic (7.06e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.55e-1)"	9.0	9.1	7.0	6.6	11.6	3.1	6.4	9.3	7.7	6.9	12.0	8.1	5.2	7.1	4.3	7.6	7.9	6.2	7.6	5.4	7.9	11.3	8.7	7.5	7.1	10.1	11.4	7.5	8.8	14.0	8.1	6.6	10.2	7.7	6.6	9.0	7.8	8.6	9.5	7.1	7.1	9.3	7.7	6.6	7.6	9.6	10.1	8.4	9.9	6.9	8.7	8.1	6.7	9.1	13.4	10.8	8.8	11.8	20.9	15.9	6.8	14.0	11.2	19.5	12.8	8.0	11.4	15.7	17.6	14.8	14.0	12.8	20.3	13.1	23.1	22.1	15.5	15.8	12.7	10.2	13.5	15.5	13.3	8.0	13.0	17.9	28.0	13.6	16.6	17.3	19.6	15.7	18.3	6.2	22.8	6.3	6.3	18.9	20.2	14.1	12.3	17.1	12.7	7.8	22.1	8.8	21.7	23.8	15.0	10.8	10.2	8.0	19.1	14.0	6.5	23.6	11.4	13.0	20.6	22.5	7.9	17.4	5.6	0.3	0.1	1.5	0.6	0.2	0.5	0.2	0.4	0.6	0.3	0.7	0.7	0.1	0.2	0.7	0.4	0.9	0.2	0.1	7.0	11.6	9.3	7.7	5.4	7.9	10.1	11.4	10.2	7.7	10.1	9.1	13.7	25.6	25.9	15.7	14.7	15.9	14.2	9.2	12.0	24.8	12.8	9.1	14.1	12.8	13.9	25.8	458.7	16.3	18.6	16.2	7.9	26.0	74.9	34.3	14.4	15.4	11.3	10.7	23.7	19.6	24.4	12.9	12.2	18.9	10.8	12.6	8.9	18.4	13.2	58.9	24.6	13.5	4.1	14.6	7.8	91.7	12.5	14.3	19.6	12.2	21.0	13.8	22.6	12.1	34.1	24.3	11.7	20.7	23.2	19.2	16.6	18.5	28.7	55.2	19.7	19.8	16.1	63.7	23.5	15.0	20.0	11.4	17.2	18.2	12.7	13.7
CEP135	"CEP4, FLJ13621, KIAA0635"	ENSG00000174799	"Centrosomal protein 135"	Q66GS9	4	55948871-56033361	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 92.3;monocytes: 64.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"				"unprognostic (2.75e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.63e-1)"	"unprognostic (3.42e-2)"	"unprognostic (4.65e-3)"	"unprognostic (4.78e-3)"	"unprognostic (1.83e-3)"	"unprognostic (9.89e-3)"	"unprognostic (9.50e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.02e-9)"	"unprognostic (7.55e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.95e-1)"	"prognostic favorable (6.11e-5)"	2.6	1.6	1.0	7.2	1.3	10.1	2.8	2.1	1.6	3.5	1.9	2.4	3.1	7.6	2.1	2.0	3.3	3.1	1.4	1.2	1.3	4.0	1.3	3.2	10.2	1.7	1.5	5.0	1.7	2.0	1.2	5.9	1.7	2.3	3.2	3.7	1.5	1.6	0.8	3.9	3.3	5.0	1.0	5.7	2.2	6.4	2.0	9.5	2.6	1.3	7.6	2.9	2.2	1.9	8.9	4.8	13.0	12.3	2.6	5.0	5.5	8.6	6.1	7.7	9.0	5.2	9.0	23.7	6.4	3.8	6.0	4.0	13.8	5.2	14.6	6.5	8.4	8.3	7.6	4.9	2.9	15.2	12.6	3.9	4.1	9.9	7.0	3.4	6.5	11.9	15.4	11.0	8.1	5.2	21.3	9.5	8.3	4.4	4.9	15.4	6.1	4.8	5.6	6.4	9.3	9.6	7.7	5.2	6.4	7.8	6.9	9.7	6.5	10.4	17.0	12.5	15.1	5.9	4.4	15.7	5.2	11.8	13.1	9.9	2.1	2.9	3.0	2.8	2.8	3.0	3.9	2.9	1.5	5.6	5.0	3.1	4.3	4.7	3.2	5.6	2.7	1.4	1.0	1.3	2.1	1.6	1.2	1.3	1.7	1.5	1.7	1.0	2.0	1.9	16.3	6.4	12.4	7.8	30.2	9.1	8.2	6.3	7.4	12.6	5.6	6.6	8.5	2.8	9.4	7.3	10.4	20.0	27.3	5.2	3.9	9.4	92.3	23.1	14.6	18.2	5.4	28.2	10.0	5.4	16.3	11.5	3.1	13.0	14.5	38.2	12.5	1.7	10.4	26.9	10.4	5.5	6.1	12.9	11.3	19.4	5.9	19.2	5.4	19.7	64.5	4.3	32.0	8.0	13.9	15.6	6.7	8.2	16.7	5.2	3.0	10.0	17.4	24.5	6.6	16.2	11.2	57.3	38.7	6.8	6.7	9.6	20.0	34.6	5.7	6.3
CEP152	"KIAA0912, MCPH9, SCKL5"	ENSG00000103995	"Centrosomal protein 152"	O94986	15	48712928-48811146	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Disease variant, Dwarfism, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 192.5;Late spermatids: 49.5;Syncytiotrophoblasts: 46.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA039408	Approved		Supported	Nucleoplasm,Centrosome		NA	Yes			"Cluster 42: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Centrosome	Nucleoplasm	"HPA039408: AB_10795288"	"unprognostic (3.64e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.87e-4)"	"unprognostic (4.78e-2)"	"unprognostic (8.02e-3)"	"unprognostic (1.04e-2)"	"unprognostic (5.82e-2)"	"unprognostic (4.70e-3)"	"unprognostic (3.47e-2)"	"unprognostic (6.24e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.25e-1)"	2.2	1.3	1.2	3.5	1.4	16.3	1.9	2.0	1.9	1.9	2.6	2.3	2.9	1.4	0.9	2.6	1.9	1.8	2.1	1.0	0.9	2.2	1.0	2.2	4.3	1.2	1.2	2.5	2.9	1.3	0.9	4.7	1.4	1.7	3.1	1.9	2.4	0.9	1.0	3.0	2.9	1.9	0.7	2.4	2.3	9.8	1.8	5.6	2.9	0.6	3.7	1.4	2.3	1.8	8.0	6.1	12.2	15.0	2.1	3.9	7.9	13.9	5.6	10.0	12.3	13.2	6.8	18.6	5.9	4.0	14.1	18.6	13.6	5.0	14.5	16.5	8.3	30.1	34.6	7.2	1.4	25.6	13.4	1.4	3.9	11.1	6.6	3.9	7.5	19.2	18.4	21.6	8.6	4.5	18.6	23.8	7.7	9.5	6.1	22.7	16.4	22.9	3.6	7.5	14.6	9.8	10.7	8.9	4.2	13.3	6.7	12.3	6.2	24.4	12.9	18.9	15.6	9.2	10.8	21.4	7.8	36.2	17.6	2.1	1.0	1.9	0.8	1.4	0.7	0.9	0.9	0.9	0.8	1.7	1.0	1.0	1.8	1.2	1.5	1.5	1.0	0.5	1.2	1.4	2.0	1.9	1.0	0.9	1.2	1.2	1.4	0.7	1.8	1.8	3.9	6.4	2.8	22.2	9.3	3.8	4.1	2.8	4.0	1.5	2.9	3.6	3.9	4.3	1.8	3.7	2.1	31.5	6.8	7.8	0.0	4.7	192.5	6.4	5.3	6.7	3.6	29.9	14.7	6.7	8.5	9.0	7.1	5.0	8.2	20.9	6.1	3.3	7.6	0.0	8.4	8.2	4.1	7.2	6.4	49.5	23.9	8.6	1.8	16.9	6.9	2.9	10.3	6.0	7.0	7.9	3.5	27.1	15.9	3.2	9.1	1.7	8.4	3.6	6.6	6.5	5.4	24.4	10.3	7.0	3.4	46.9	9.9	3.4	10.1	4.1
CEP20	"C16orf63, DKFZp686N1651, FLJ31153, FOPNL, FOR20, PHSECRG2"	ENSG00000133393	"Centrosomal protein 20"	Q96NB1	16	15865719-15888625	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 11.2;Cardiomyocytes: 28.2;Cytotrophoblasts: 40.4;Extravillous trophoblasts: 27.1;Hofbauer cells: 21.1;Syncytiotrophoblasts: 29.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040599	Supported		Supported	Centrosome		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Centrosome		"HPA040599: AB_10794036"	"unprognostic (1.10e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.16e-3)"	"unprognostic (7.16e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.23e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.92e-1)"	"unprognostic (4.35e-2)"	"unprognostic (4.78e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.45e-3)"	16.5	19.1	7.7	12.7	7.7	14.1	19.1	8.0	16.5	17.2	8.9	14.9	13.0	13.8	1.3	27.6	15.0	13.9	16.9	7.6	9.5	17.4	19.0	13.6	24.2	8.0	8.0	18.7	18.2	8.5	14.3	9.8	8.3	15.5	13.8	10.5	14.2	11.1	45.7	17.4	12.4	8.0	8.1	13.4	15.3	31.5	8.4	15.8	32.5	5.8	15.8	17.5	17.3	8.3	43.1	45.6	16.0	3.6	35.4	43.2	2.5	23.7	26.7	23.6	27.6	24.4	6.1	31.1	30.2	6.9	43.9	33.5	39.8	3.7	49.4	33.2	29.5	4.5	10.2	12.0	29.7	9.3	34.3	4.0	53.4	5.8	36.8	7.4	39.9	70.8	85.0	5.6	7.1	33.2	28.0	34.7	38.8	29.8	3.8	6.9	37.3	4.1	3.6	13.1	14.4	1.4	2.1	30.6	51.1	33.0	4.5	5.5	14.0	4.9	3.7	47.4	83.5	11.3	38.2	53.1	42.6	72.0	36.4	38.1	14.4	7.3	12.6	15.0	16.8	15.9	15.4	15.4	16.1	15.9	16.1	14.7	4.2	19.2	13.3	18.3	16.7	14.7	7.7	7.7	8.0	16.5	7.6	9.5	8.0	8.0	8.3	8.1	8.4	8.3	11.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.0	40.4	8.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	27.1	7.8	0.0	0.0	0.0	0.0	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	29.0	1.3	0.0	0.0	0.0
CEP295	KIAA1731	ENSG00000166004	"Centrosomal protein 295"	Q9C0D2	11	93661682-93730358	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 78.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038595, HPA038596, HPA038597"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA038595: AB_2676104, HPA038596: AB_10672720, HPA038597: AB_2676106"	"unprognostic (1.35e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.66e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.73e-2)"	"unprognostic (4.08e-3)"	"unprognostic (6.03e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.54e-3)"	"unprognostic (3.73e-2)"	"unprognostic (4.99e-4)"	"unprognostic (1.34e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.18e-2)"	6.6	5.8	7.5	6.3	8.1	16.0	8.3	14.4	10.5	7.6	5.0	8.7	6.2	7.0	7.4	5.8	6.8	5.2	5.3	7.3	6.9	6.2	5.0	6.0	11.1	6.3	5.9	8.3	6.6	4.7	8.4	6.3	6.6	8.3	6.8	14.7	5.5	5.2	5.3	8.9	7.5	5.5	4.9	9.4	6.2	12.0	7.6	10.3	8.7	5.8	7.4	7.7	6.6	10.2	10.5	9.4	23.9	20.4	10.8	10.4	11.6	13.2	9.7	12.2	14.2	17.3	19.2	3.1	19.1	8.3	16.9	18.7	11.8	9.5	12.4	15.0	9.4	19.0	28.2	8.6	6.5	17.1	17.4	7.7	5.6	11.6	10.0	11.5	10.4	16.9	21.6	19.4	15.8	8.8	8.9	28.1	7.5	19.6	9.7	17.7	22.6	12.6	10.1	17.9	13.9	12.9	20.9	13.8	3.7	14.8	22.8	9.4	9.6	11.3	14.8	20.9	10.1	6.9	16.7	20.2	6.7	19.7	15.9	3.3	1.7	3.6	1.5	0.9	1.2	3.2	1.3	1.0	0.8	3.5	1.6	1.4	5.2	1.6	1.3	1.7	1.1	0.4	7.5	8.1	14.4	10.5	7.3	6.9	6.3	5.9	6.6	4.9	7.6	10.2	10.9	9.6	14.3	24.2	14.0	0.0	3.3	0.0	5.2	30.5	7.0	8.9	9.4	5.7	5.6	5.5	27.1	12.8	8.6	2.5	3.9	7.8	78.7	12.4	15.0	9.6	3.6	25.7	41.2	7.8	10.3	8.8	11.2	10.2	16.4	48.8	6.8	4.2	8.0	18.5	40.8	5.5	0.0	7.9	0.0	21.4	12.8	7.7	0.0	15.0	10.3	10.3	10.3	23.6	33.5	5.3	4.1	14.3	12.2	5.6	5.8	4.0	5.1	38.1	6.6	9.4	8.7	48.8	18.6	7.5	0.0	6.6	9.8	15.8	5.8	2.8
CEP41	"DKFZp762H1311, FLJ22445, JBTS15, TSGA14"	ENSG00000106477	"Centrosomal protein 41"	Q9BYV8	7	130393771-130442433	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"		"Autism, Autism spectrum disorder, Ciliopathy, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 47.0"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 526.8;Late spermatids: 160.6;Spermatocytes: 96.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024090	Uncertain					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA024090: AB_10966276"	"unprognostic (3.87e-2)"	"unprognostic (5.96e-2)"	"prognostic favorable (4.54e-4)"	"unprognostic (1.17e-3)"	"unprognostic (2.88e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.26e-7)"	"unprognostic (1.80e-1)"	"unprognostic (2.89e-1)"	"unprognostic (8.45e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.76e-2)"	"unprognostic (7.72e-2)"	"unprognostic (3.35e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.57e-1)"	3.8	5.2	4.9	3.5	5.0	4.2	3.6	3.6	5.6	3.5	8.8	3.0	3.2	4.3	3.7	2.6	9.4	4.6	2.0	5.3	5.2	3.3	2.7	3.2	4.7	4.8	8.1	3.5	2.2	5.1	4.7	4.5	5.2	3.2	3.6	7.7	17.8	3.6	1.6	2.4	2.2	5.3	4.7	4.2	2.8	47.0	5.3	8.6	4.1	2.3	4.9	3.2	1.4	6.4	15.9	16.5	17.6	11.4	5.1	8.9	3.6	21.0	10.4	12.4	13.9	9.8	19.3	23.1	11.3	12.3	34.4	15.2	17.6	11.3	17.2	8.0	5.0	8.4	7.2	5.2	8.5	16.7	8.0	9.7	8.6	16.2	7.2	12.0	21.9	16.7	4.8	5.3	21.5	10.7	43.2	14.7	15.7	17.4	12.6	30.3	25.7	0.7	9.1	10.3	25.4	21.0	14.0	19.9	16.3	9.9	6.1	12.8	11.0	18.4	7.2	17.6	27.3	12.2	39.9	28.8	20.7	16.4	27.8	7.9	4.6	5.9	7.5	6.9	4.9	3.6	5.4	5.7	8.3	4.5	8.4	13.9	0.8	11.2	3.3	4.0	6.3	7.4	4.9	5.0	3.6	5.6	5.3	5.2	4.8	8.1	5.2	4.7	5.3	6.4	8.7	9.6	4.1	7.2	5.0	1.8	6.4	13.5	4.6	18.1	11.6	9.0	4.4	4.3	10.1	9.2	37.5	16.2	3.8	3.1	11.7	12.9	526.8	35.9	8.9	9.6	14.4	12.4	14.5	9.2	10.9	7.8	4.6	5.3	11.4	13.3	12.8	3.4	18.7	15.2	12.5	4.7	10.2	8.9	2.2	160.6	10.5	8.0	5.4	5.6	4.0	10.2	9.2	17.1	14.2	7.0	3.7	8.2	1.9	4.0	2.0	5.2	55.5	22.0	6.6	6.3	7.4	96.0	35.0	4.1	1.6	19.2	5.8	8.7	6.3	6.5
CEP43	"FGFR1OP, FOP"	ENSG00000213066	"Centrosomal protein 43"	O95684	6	166999317-167094789	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 12.3;Cytotrophoblasts: 14.2;Extravillous trophoblasts: 16.2;Hofbauer cells: 10.3;Syncytiotrophoblasts: 6.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071876	Approved		Supported	Centrosome		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Centrosome		"HPA071876: AB_2686467"	"unprognostic (9.14e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.95e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.08e-3)"	"unprognostic (4.06e-2)"	"prognostic unfavorable (7.32e-4)"	"unprognostic (1.29e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.09e-3)"	6.9	14.8	8.8	12.6	8.3	16.7	14.3	8.3	10.0	13.5	9.2	12.4	15.9	14.9	16.9	9.0	27.0	11.2	8.9	8.1	8.3	17.4	36.3	7.3	14.8	8.7	11.4	13.0	11.3	10.5	14.1	8.4	9.4	9.4	16.9	25.4	8.8	9.1	8.5	11.6	15.8	10.4	7.7	11.1	11.3	58.4	8.4	15.7	15.5	10.4	17.7	9.2	9.3	9.4	26.1	14.3	35.3	24.2	20.3	15.1	42.7	33.0	21.9	26.4	25.3	53.1	21.6	31.0	18.3	20.2	70.3	24.0	31.4	23.3	49.3	19.5	27.0	21.4	26.7	58.2	10.8	38.4	21.6	8.4	16.8	54.2	25.2	16.4	18.5	34.5	70.9	25.8	34.2	24.0	31.1	55.8	30.2	50.0	10.9	35.3	23.9	25.7	27.8	13.8	26.2	26.2	26.9	28.6	11.7	24.6	23.5	46.7	12.2	26.1	43.7	31.6	42.1	21.8	32.3	31.4	29.4	35.4	32.7	0.4	6.5	23.5	5.1	6.1	7.6	12.1	5.8	4.8	10.7	8.4	3.4	5.5	38.8	6.3	6.7	16.4	11.7	4.9	8.8	8.3	8.3	10.0	8.1	8.3	8.7	11.4	9.4	7.7	8.4	9.4	3.3	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	14.2	3.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	16.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	6.3	1.3	0.0	0.0	0.0
CEP55	"C10orf3, CT111, FLJ10540"	ENSG00000138180	"Centrosomal protein 55"	Q53EZ4	10	93496612-93529092	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.4;testis: 21.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 29.4;Extravillous trophoblasts: 17.1;Granulosa cells: 19.8;Spermatocytes: 77.3;Spermatogonia: 17.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	8	"T-reg: 1.3"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA023430	Approved		Approved	"Plasma membrane,Midbody,Centriolar satellite"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Centriolar satellite"	Midbody	"HPA023430: AB_10960212"	"unprognostic (9.85e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.26e-2)"	"prognostic unfavorable (3.20e-9)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (0.00e+0)"	"prognostic favorable (3.15e-4)"	"unprognostic (7.86e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	1.3	0.6	0.0	7.6	0.0	5.0	1.4	0.0	0.2	1.7	0.0	7.0	6.7	1.4	0.1	7.3	0.4	1.4	0.3	0.0	0.1	0.3	0.6	1.3	14.7	0.1	0.3	0.2	0.2	0.2	0.3	3.5	0.2	0.3	8.8	0.0	1.2	0.3	0.1	4.5	6.3	5.2	0.0	2.4	4.6	21.7	0.4	27.4	0.5	0.2	15.5	3.1	2.3	0.1	208.5	81.5	53.0	67.7	5.8	12.0	29.6	112.4	78.2	103.5	106.4	87.2	108.6	55.4	48.2	72.8	69.6	115.4	64.8	54.8	123.4	167.2	33.7	21.0	49.2	29.9	0.6	36.3	46.3	2.8	3.8	110.6	133.5	30.7	97.1	89.9	19.3	101.8	118.5	48.3	96.3	54.8	20.9	64.2	58.8	41.3	86.9	30.3	47.1	25.5	21.7	30.7	86.3	26.3	64.9	40.1	68.9	36.4	61.4	65.3	90.6	90.5	186.7	45.1	66.1	66.8	51.0	134.8	59.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.3	0.2	0.0	0.4	0.1	0.2	0.0	1.3	0.0	2.7	3.6	0.9	1.9	0.0	0.0	1.8	2.0	0.4	2.8	0.2	0.0	0.0	7.7	0.9	3.3	0.0	0.6	29.4	1.7	2.0	1.5	0.0	2.5	0.5	0.2	17.1	2.3	8.2	3.6	0.0	19.8	2.2	0.3	12.9	0.0	0.3	4.5	4.1	7.0	5.1	8.2	0.3	5.1	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.3	0.0	0.4	14.8	1.1	0.4	0.0	0.2	0.0	0.0	0.5	4.5	77.3	17.3	16.1	1.3	1.5	4.3	1.6	7.9	1.7
CEP57L1	"bA487F23.2, C6orf182, MGC21731"	ENSG00000183137	"Centrosomal protein 57 like 1"	Q8IYX8	6	109095110-109174418	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 50.3;Spermatocytes: 75.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040378	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA040378: AB_10794028"	"unprognostic (5.93e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.41e-2)"	"unprognostic (4.69e-3)"	"unprognostic (3.63e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.33e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.42e-5)"	"unprognostic (2.37e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.72e-1)"	10.5	7.6	5.1	7.8	5.9	10.2	10.2	10.8	7.8	8.2	4.6	8.5	8.7	9.3	10.5	6.2	6.0	9.4	7.7	5.8	4.1	8.0	10.0	6.6	8.9	4.9	4.2	6.5	7.5	16.9	5.6	10.1	5.5	6.4	10.9	12.0	5.2	6.3	6.1	6.8	7.8	10.8	3.9	7.7	7.3	26.2	5.5	14.4	8.7	6.6	7.4	6.4	6.5	7.9	17.9	7.9	23.1	22.9	21.2	35.2	18.1	40.3	22.1	35.8	39.8	11.9	15.3	16.0	18.4	20.9	30.8	9.1	16.1	15.4	56.1	20.3	16.1	34.8	18.9	12.3	19.6	28.5	14.5	21.2	11.0	30.3	29.9	19.2	32.4	52.5	63.9	52.5	32.4	11.8	32.0	24.6	7.6	14.7	14.6	25.7	17.4	15.7	17.0	7.4	17.4	14.4	19.8	14.7	12.9	15.0	18.2	43.9	14.7	23.1	13.6	24.4	42.9	15.4	19.1	25.3	21.8	43.1	18.9	15.9	5.2	6.6	4.7	6.1	5.1	3.3	4.8	6.7	5.7	6.3	4.5	6.7	3.6	11.6	9.6	6.0	6.9	4.6	5.1	5.9	10.8	7.8	5.8	4.1	4.9	4.2	5.5	3.9	5.5	7.9	12.9	6.4	5.3	12.4	6.3	3.3	7.6	7.4	7.4	6.6	6.8	7.2	10.3	2.8	6.8	5.5	20.9	9.8	9.7	4.2	7.9	7.0	50.3	12.8	18.5	10.6	5.4	18.1	31.9	5.4	13.2	15.5	8.2	6.9	5.1	20.5	8.2	6.3	10.2	5.0	31.1	3.1	8.2	4.1	6.8	39.3	17.4	7.7	8.8	27.2	7.7	10.4	8.2	26.2	36.1	6.0	4.5	12.4	13.2	4.4	5.7	13.4	9.8	12.3	13.1	21.8	14.1	75.7	13.0	5.8	4.4	8.5	6.7	13.6	6.1	5.0
CEP78	"C9orf81, FLJ12643"	ENSG00000148019	"Centrosomal protein 78"	Q5JTW2	9	78236062-78279690	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Cone-rod dystrophy, Deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 110.5;dendritic cells: 106.8;NK-cells: 249.3;Spermatocytes: 82.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 39.1"	"Group enriched"	"Detected in many"	5	"NK-cells: 39.1;T-cells: 18.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048846	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA048846: AB_2680537"	"unprognostic (4.62e-1)"	"unprognostic (6.33e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.13e-4)"	"unprognostic (6.75e-2)"	"unprognostic (8.48e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.38e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.27e-3)"	"unprognostic (4.93e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.34e-1)"	2.2	2.9	4.3	4.6	5.0	12.3	4.3	5.9	4.4	4.1	3.8	3.5	2.8	5.6	3.2	3.5	3.4	2.4	1.6	4.2	4.7	3.6	3.5	3.4	6.2	4.6	4.5	4.3	2.5	4.3	2.7	3.9	4.6	3.1	3.9	9.2	3.3	3.4	1.6	3.5	2.9	4.7	5.1	5.0	3.0	15.1	4.3	11.5	3.7	1.7	7.7	3.2	3.0	6.2	31.7	14.5	33.3	20.5	5.4	9.4	22.3	25.6	10.1	15.1	19.1	2.7	8.4	28.9	12.7	9.2	21.4	36.9	49.6	13.7	22.5	24.3	16.6	15.4	17.1	11.4	4.9	26.0	14.6	5.2	2.9	17.1	11.1	7.5	23.4	29.4	12.2	22.4	19.8	20.3	32.6	12.8	35.2	32.7	14.0	32.2	38.4	8.4	9.0	14.0	30.4	21.1	33.7	10.6	8.4	22.7	12.6	6.9	12.5	13.3	22.6	27.5	24.7	13.1	17.8	18.4	11.8	17.6	23.0	0.7	0.8	0.7	18.3	3.4	8.9	5.0	7.9	16.0	2.3	3.4	3.9	12.8	0.5	39.1	5.5	4.2	13.1	8.3	4.3	5.0	5.9	4.4	4.2	4.7	4.6	4.5	4.6	5.1	4.3	6.2	10.3	25.6	9.2	26.1	13.7	5.1	8.1	6.9	8.0	27.1	7.6	10.5	8.9	4.3	7.2	1.8	110.5	14.0	106.8	3.9	5.9	8.4	14.1	18.7	16.9	9.0	7.7	25.7	28.6	6.7	19.5	10.3	10.2	10.4	5.1	20.6	7.1	9.0	9.6	3.3	20.5	8.0	4.1	6.1	6.1	9.9	14.9	10.0	1.8	9.4	9.7	14.7	249.3	27.2	24.6	4.7	4.1	15.1	43.7	3.7	1.0	5.1	22.1	49.4	0.0	14.8	11.3	82.1	34.2	10.0	4.8	4.0	34.0	12.3	13.2	4.0
CEP85	"CCDC21, DKFZP434L0117"	ENSG00000130695	"Centrosomal protein 85"	Q6P2H3	1	26234200-26278808	"Predicted intracellular proteins"	"Chromosome partition"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 132.9;tongue: 65.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 29.0;Oligodendrocytes: 28.8;Spermatocytes: 40.9;Spermatogonia: 34.2;Syncytiotrophoblasts: 41.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 19.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028252	Approved		Approved	"Nucleoli,Golgi apparatus,Centrosome,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoli, Golgi apparatus"	"Centrosome, Cytosol"	"HPA028252: AB_1846142"	"unprognostic (1.08e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.30e-3)"	"prognostic unfavorable (4.39e-6)"	"unprognostic (3.72e-2)"	"unprognostic (5.30e-2)"	"unprognostic (8.24e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.33e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.60e-2)"	2.8	3.5	3.9	5.3	8.3	20.8	3.8	5.6	6.7	4.1	3.7	5.4	3.4	3.2	3.2	8.6	2.7	2.7	25.5	4.3	5.9	6.0	5.8	4.7	6.9	7.1	6.8	3.3	5.0	8.8	6.1	3.2	8.9	2.9	6.0	14.1	5.3	2.4	132.9	9.8	5.2	3.7	3.7	6.3	4.7	31.1	7.1	13.6	7.8	65.9	7.8	3.2	6.2	14.3	29.6	12.5	30.2	22.6	7.3	8.9	52.5	18.8	11.5	31.9	28.5	17.4	28.2	34.3	20.1	9.2	14.6	25.5	41.0	14.4	29.9	23.5	20.9	49.7	31.9	19.4	6.6	46.2	43.8	3.8	13.7	24.9	16.4	12.8	14.5	47.7	57.4	39.9	19.2	9.8	38.7	35.2	23.0	17.4	20.8	39.8	31.3	29.7	10.4	5.5	41.4	16.7	24.5	19.8	15.7	21.5	14.5	26.4	14.3	17.1	26.7	19.3	24.7	30.0	48.4	38.9	9.8	65.2	27.5	5.0	6.4	19.2	3.5	6.1	2.8	2.6	2.6	2.7	4.9	1.8	2.2	3.5	0.6	2.3	7.4	2.1	3.6	3.6	3.9	8.3	5.6	6.7	4.3	5.9	7.1	6.8	8.9	3.7	7.1	14.3	1.0	0.0	2.2	3.6	2.7	6.9	4.0	2.5	6.2	11.2	3.7	2.9	29.0	1.5	3.7	5.5	12.5	3.4	5.1	6.9	7.9	1.7	1.0	3.4	2.3	2.0	1.8	16.8	12.8	1.3	3.9	2.3	3.6	4.9	2.5	9.1	1.4	3.1	4.8	0.0	9.9	3.7	2.0	5.0	3.7	2.9	1.5	4.3	1.8	4.7	4.0	1.8	2.1	3.0	28.8	2.7	3.4	0.4	4.4	2.5	2.3	1.1	2.0	11.1	0.0	2.4	2.3	40.9	34.2	8.6	6.1	41.7	3.4	2.3	4.5	4.5
CEP95	"CCDC45, DKFZp667E1824"	ENSG00000258890	"Centrosomal protein 95"	Q96GE4	17	64506865-64542461	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052426, HPA052428, HPA061371"	Approved		Uncertain	"Centriolar satellite,Cytosol"		NA	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol	"Centriolar satellite"	"HPA052426: AB_2681827, HPA052428: AB_2681829, HPA061371: AB_2684495"	"unprognostic (1.28e-2)"	"unprognostic (9.12e-2)"	"unprognostic (3.66e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.30e-2)"	"prognostic favorable (5.78e-4)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (6.57e-3)"	"unprognostic (7.88e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (5.76e-5)"	"unprognostic (3.48e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-3)"	8.4	6.4	8.1	11.7	10.2	42.5	17.5	20.5	10.8	12.8	15.4	11.7	13.5	23.4	15.9	9.4	16.6	13.0	8.5	8.5	8.6	10.4	11.3	11.3	20.1	10.4	10.7	25.6	14.4	10.4	6.3	9.5	10.7	14.6	14.6	40.4	9.6	11.7	9.5	23.1	11.8	12.5	8.9	14.0	13.9	19.0	8.3	18.9	21.3	6.9	16.4	9.7	7.9	16.2	18.5	10.7	26.3	22.8	8.6	15.4	23.7	9.6	10.9	12.8	16.9	14.4	11.3	28.7	6.1	13.3	13.2	25.3	21.2	15.9	24.9	7.3	15.6	27.2	28.2	30.8	21.1	28.9	15.3	18.9	19.8	14.2	30.7	18.5	10.9	29.1	31.5	21.5	12.5	21.4	40.3	23.4	14.8	20.9	14.2	31.6	46.1	21.0	16.5	28.4	14.9	28.0	11.8	22.0	30.2	39.1	20.2	25.0	12.7	27.6	23.9	11.5	13.1	23.6	18.5	31.4	11.6	21.5	19.0	0.6	2.7	2.1	2.9	2.9	7.1	3.5	3.6	4.3	3.0	3.7	5.9	4.0	0.9	2.0	2.8	2.9	3.2	1.8	8.1	10.2	20.5	10.8	8.5	8.6	10.4	10.7	10.7	8.9	8.3	16.2	14.9	41.7	26.3	44.7	29.4	16.2	25.6	14.3	40.5	29.9	17.9	20.2	17.6	14.3	29.4	3.7	45.9	9.4	25.1	18.1	7.9	18.6	58.0	45.9	28.9	13.8	7.7	26.5	47.5	11.8	10.8	23.5	18.8	44.8	29.7	31.9	13.2	8.9	8.5	18.5	56.2	13.8	8.2	10.3	12.8	18.5	20.8	16.6	12.4	23.4	15.2	21.3	15.5	42.7	46.7	14.1	10.4	21.4	21.1	15.4	20.2	6.8	53.1	84.8	13.1	41.3	21.6	38.8	27.5	28.4	20.3	6.6	23.7	23.8	19.7	21.9
CETN3	CEN3	ENSG00000153140	"Centrin 3"	O15182	5	90392257-90409766	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 130.4"	"Cell type enriched"	"Detected in all"	4	"Spermatocytes: 469.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035608, HPA063704"	Enhanced		Supported	Centrosome		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Centrosome		"HPA035608: AB_10601098, HPA063704: AB_2685097"	"unprognostic (2.08e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.18e-2)"	"unprognostic (8.77e-2)"	"unprognostic (5.03e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.35e-1)"	17.4	21.6	18.5	14.7	20.6	7.6	24.0	19.3	26.3	20.6	19.0	16.9	9.7	20.0	21.8	13.5	22.7	10.3	22.1	18.3	20.0	19.8	13.5	13.4	19.1	21.2	19.6	31.0	9.3	24.4	16.8	19.3	21.2	19.0	19.6	35.3	15.1	14.7	14.4	15.4	10.6	13.9	19.3	15.1	12.9	130.4	19.8	20.6	15.2	14.1	21.0	11.3	11.7	27.1	38.4	18.7	66.2	13.4	38.8	49.2	39.5	41.2	25.4	39.7	47.1	25.5	45.3	71.7	40.4	20.2	76.9	26.2	58.5	57.4	63.5	59.6	27.2	36.4	26.9	32.6	27.3	26.9	22.2	32.7	36.6	29.4	49.1	42.5	24.1	56.8	47.2	30.9	44.3	26.5	46.2	42.6	23.2	14.0	42.6	40.6	45.7	37.0	35.1	14.5	36.0	37.2	40.2	19.9	31.7	59.1	37.7	36.6	28.0	22.6	32.7	32.0	55.7	28.6	55.5	63.6	26.9	60.5	23.3	19.7	9.9	14.8	12.9	13.1	13.7	27.3	14.3	14.6	11.3	21.8	20.4	16.3	1.2	17.3	16.6	30.6	13.3	6.9	18.5	20.6	19.3	26.3	18.3	20.0	21.2	19.6	21.2	19.3	19.8	27.1	19.5	19.2	38.7	13.4	17.8	14.3	34.3	70.3	22.2	19.3	23.5	25.7	53.0	27.1	37.5	36.8	18.8	69.4	13.4	11.9	95.9	21.8	20.2	41.4	26.6	22.4	24.0	54.1	8.4	10.0	69.5	33.0	6.1	24.4	6.3	19.6	48.5	42.2	26.0	21.9	12.6	21.2	48.8	19.2	5.1	38.5	44.1	10.3	19.6	8.4	19.6	84.0	17.5	15.1	34.1	12.8	21.4	32.4	8.4	16.5	8.5	46.2	75.9	24.4	59.2	14.2	23.8	469.5	66.3	19.6	15.8	41.7	15.0	17.2	24.8	21.6
CFAP20DC	"C3orf67, FLJ42117, FLJ42930"	ENSG00000163689	"CFAP20 domain containing"	Q6ZVT6	3	58717365-59050084	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"esophagus: 7.9;testis: 22.1"	"Cell type enhanced"	"Detected in some"		"Extravillous trophoblasts: 1.9;Hofbauer cells: 1.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069696			Approved	"Golgi apparatus"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus"		"HPA069696: AB_2686174"	"unprognostic (4.59e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.99e-1)"	"unprognostic (4.49e-5)"	"unprognostic (1.91e-1)"	"unprognostic (9.33e-3)"	"unprognostic (1.67e-3)"	"unprognostic (3.72e-1)"	"unprognostic (2.43e-1)"	"unprognostic (6.68e-3)"	"unprognostic (8.95e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.28e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.06e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.81e-2)"	0.3	1.1	0.5	0.7	0.6	0.2	0.5	0.0	0.7	1.0	0.1	0.5	0.0	0.3	0.3	7.9	2.9	0.5	0.1	0.7	0.4	0.5	1.0	0.4	1.6	0.6	0.7	0.2	0.5	0.7	1.9	1.1	0.4	0.3	0.7	0.4	2.0	0.2	0.0	0.3	0.1	0.3	0.3	0.3	0.4	22.1	0.5	0.5	0.3	0.1	3.2	0.2	2.2	0.3	11.2	1.8	3.0	0.0	1.8	5.7	0.0	5.2	1.7	2.3	1.8	1.0	3.6	11.6	1.7	1.2	0.0	1.1	4.8	2.5	4.0	1.8	0.3	0.0	1.9	0.0	0.9	0.0	0.0	1.1	2.4	4.8	3.9	2.8	4.7	7.6	9.0	0.1	3.1	1.5	0.6	0.0	3.8	3.6	7.7	11.3	0.0	4.8	2.4	0.1	7.8	3.6	1.4	1.1	3.4	5.0	3.5	0.0	0.1	0.2	3.4	5.6	2.4	4.6	10.3	2.3	2.6	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.6	0.0	0.7	0.7	0.4	0.6	0.7	0.4	0.3	0.5	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0
CFDP1	"BCNT, CENP-29, CP27, p97, SWC5, Yeti"	ENSG00000153774	"Craniofacial development protein 1"	Q9UEE9	16	75293698-75433503	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 493.3;Paneth cells: 745.2;Proximal enterocytes: 612.2;Proximal tubular cells: 637.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041316, HPA048242"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Vesicles	"HPA041316: AB_10794371, HPA048242: AB_2680327"	"unprognostic (1.45e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.88e-1)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (9.63e-5)"	"unprognostic (5.81e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.85e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.92e-3)"	"unprognostic (1.25e-1)"	45.0	51.0	57.4	24.0	58.0	35.0	45.2	60.8	75.3	69.1	57.9	47.5	30.4	58.6	62.3	41.2	55.6	29.7	36.8	57.1	61.7	64.5	43.1	37.3	27.1	58.8	59.3	83.1	41.2	30.8	57.1	63.1	58.8	39.9	40.2	49.6	39.4	38.1	35.7	42.4	36.4	51.0	56.7	30.2	34.7	59.5	59.6	57.0	45.0	34.9	35.8	44.8	50.7	60.8	65.0	47.6	158.9	59.2	141.2	156.3	47.2	63.2	74.1	83.0	119.1	82.5	86.6	61.3	91.1	79.3	92.7	71.5	123.3	101.9	164.9	26.4	58.6	63.0	46.6	177.2	97.3	69.2	51.6	98.4	85.5	100.2	121.4	144.6	91.5	114.0	91.3	28.3	93.9	149.0	102.2	152.6	77.1	110.0	24.8	182.7	64.3	108.5	93.1	35.5	94.5	79.4	105.7	22.3	92.5	136.4	91.8	121.6	53.8	59.2	63.1	63.2	40.8	54.4	89.2	228.6	59.3	89.9	53.3	61.3	45.5	60.8	31.2	47.8	44.5	33.6	42.7	34.7	48.8	35.4	38.7	36.5	38.1	28.5	46.2	48.7	68.5	25.8	57.4	58.0	60.8	75.3	57.1	61.7	58.8	59.3	58.8	56.7	59.6	60.8	87.4	38.5	57.5	37.5	45.5	57.9	116.3	135.9	47.3	87.2	89.5	103.4	34.7	91.5	111.2	115.8	116.7	119.0	50.5	493.3	197.6	79.1	133.7	197.7	118.5	97.6	82.2	78.9	49.5	94.9	114.0	82.9	61.2	121.3	28.5	194.5	62.8	153.9	77.1	62.2	50.5	219.2	59.0	53.1	44.5	69.7	125.2	51.1	33.8	45.9	64.8	60.8	84.5	49.8	75.6	92.4	745.2	112.5	42.3	116.9	612.2	637.6	205.3	112.5	98.6	55.3	88.2	311.2	178.0	49.5	65.6	154.9	51.6	103.5	120.0	130.4
CHAF1A	"CAF-1, CAF1, CAF1B, CAF1P150, MGC71229, P150"	ENSG00000167670	"Chromatin assembly factor 1 subunit A"	Q13111	19	4402640-4445018	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, DNA replication"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 31.4"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 50.3;Spermatocytes: 94.3;Spermatogonia: 103.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 15.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 15.7;granulocytes: 4.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB015186	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"CAB015186: AB_628065"	"unprognostic (1.91e-1)"	"prognostic favorable (8.22e-5)"	"unprognostic (2.49e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.89e-3)"	"unprognostic (5.30e-3)"	"unprognostic (8.78e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.54e-2)"	"prognostic favorable (4.15e-6)"	"unprognostic (1.71e-1)"	"unprognostic (2.11e-3)"	"unprognostic (4.03e-2)"	4.9	4.4	3.5	9.7	3.0	31.4	4.8	5.6	6.6	4.7	1.3	6.9	6.5	3.9	2.0	10.2	4.0	2.7	3.9	3.7	3.0	2.4	4.1	4.0	13.4	3.4	3.1	3.7	3.9	3.3	3.7	6.2	3.0	5.8	6.6	3.4	5.5	3.0	12.2	10.8	6.7	4.1	2.4	6.9	5.1	14.5	3.1	16.3	2.9	4.1	10.5	4.7	5.6	4.1	65.8	44.0	71.8	45.3	7.0	8.5	36.7	61.2	24.8	50.5	56.7	53.5	22.8	100.4	24.7	19.6	28.6	50.3	61.6	41.5	59.8	58.1	67.2	62.9	69.4	42.7	3.5	73.7	48.8	4.8	8.6	41.5	17.7	9.4	24.0	54.9	76.8	88.0	31.3	37.8	119.2	40.7	80.1	33.5	35.6	87.2	56.8	57.2	13.1	76.7	50.6	39.2	41.6	29.1	24.5	45.2	25.7	53.9	17.5	41.3	35.9	71.1	74.9	43.7	71.0	96.3	34.7	92.8	49.9	3.8	2.3	4.7	0.5	2.3	0.4	1.6	0.6	0.1	2.1	1.0	0.5	0.4	1.2	1.2	0.4	15.7	0.9	0.9	3.5	3.0	5.6	6.6	3.7	3.0	3.4	3.1	3.0	2.4	3.1	4.1	2.3	0.0	3.9	2.0	12.5	9.7	4.6	3.5	6.2	12.1	5.1	3.6	5.7	1.5	2.6	5.5	2.1	25.3	17.3	13.9	1.9	8.5	6.7	5.3	4.2	4.6	1.8	50.3	4.1	6.7	37.9	6.1	10.7	6.5	2.5	19.3	3.3	4.8	12.1	1.7	3.6	10.7	0.0	4.8	21.4	6.7	3.1	11.8	1.8	1.9	11.5	5.2	5.2	2.5	2.9	6.8	1.7	3.8	32.5	4.1	4.6	1.8	5.0	8.4	32.9	5.7	5.5	94.3	103.8	18.7	14.9	14.6	7.7	9.4	14.6	5.9
CHAF1B	"CAF-1, CAF1, CAF1A, CAF1P60, MPHOSPH7, MPP7"	ENSG00000159259	"Chromatin assembly factor 1 subunit B"	Q13112	21	36385392-36419015	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, DNA replication, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 15.6"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 14.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA021679, CAB033604"	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB033604: AB_2229411, HPA021679: AB_1846621"	"unprognostic (2.28e-2)"	"prognostic favorable (5.44e-5)"	"prognostic favorable (7.92e-4)"	"unprognostic (1.43e-1)"	"unprognostic (3.28e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (6.14e-6)"	"unprognostic (2.14e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.27e-2)"	"unprognostic (7.66e-6)"	"unprognostic (5.89e-2)"	"unprognostic (5.00e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.36e-1)"	1.3	0.6	1.5	2.4	1.2	6.9	2.6	2.2	1.5	1.3	0.3	1.9	1.6	1.7	1.5	2.5	1.3	0.9	0.6	1.6	0.7	1.3	0.7	1.0	3.0	0.6	0.4	1.4	3.3	1.6	1.0	1.1	0.7	1.6	2.1	1.7	3.0	0.9	15.6	2.7	1.9	1.5	0.1	1.3	1.2	4.2	0.8	4.1	0.9	1.8	3.5	1.0	1.5	1.0	25.5	15.0	25.3	14.4	1.9	5.0	13.8	17.6	10.1	21.4	22.2	17.1	13.3	19.9	7.6	9.2	21.7	8.2	26.3	11.7	17.2	20.2	20.5	30.9	15.5	12.2	1.3	19.8	14.4	3.1	2.8	20.0	8.6	4.1	10.2	24.1	27.3	18.0	11.0	17.7	31.0	11.5	17.6	23.0	10.8	45.0	13.6	11.4	7.5	12.4	15.2	12.6	27.0	20.3	9.8	10.1	15.9	13.4	6.3	17.2	8.5	15.4	20.8	13.1	26.0	23.1	11.0	21.5	22.3	1.5	0.2	0.3	1.4	0.1	1.2	1.0	1.0	1.0	0.3	1.1	0.6	1.0	1.2	1.7	0.2	0.4	2.2	0.7	1.5	1.2	2.2	1.5	1.6	0.7	0.6	0.4	0.7	0.1	0.8	1.0	1.3	0.0	2.7	2.0	1.8	2.8	6.2	3.7	5.2	1.6	2.8	3.4	1.3	2.8	3.4	3.7	0.0	7.6	2.5	1.7	0.0	7.3	9.1	2.5	1.2	2.5	0.0	10.7	4.4	2.2	9.7	2.6	4.1	2.4	2.5	9.4	1.4	0.5	4.5	1.7	3.1	2.3	10.2	0.9	1.6	6.7	0.6	1.2	5.4	1.9	1.5	1.5	5.2	1.0	2.5	2.2	0.2	0.0	4.4	4.6	0.4	0.3	3.1	2.6	6.6	3.4	2.5	14.4	11.8	7.4	2.4	2.5	2.4	0.5	4.7	3.4
CHAMP1	"C13orf8, CAMP, CHAMP, ZNF828"	ENSG00000198824	"Chromosome alignment maintaining phosphoprotein 1"	Q96JM3	13	114314482-114337626	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA006623, HPA008900"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies,Midbody ring"		Yes	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies, Midbody ring"	"HPA006623: AB_1845548, HPA008900: AB_1845547"	"unprognostic (6.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.89e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.40e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.40e-1)"	9.9	7.1	3.4	9.8	3.3	14.2	9.5	6.6	5.2	8.1	3.8	8.7	10.0	8.5	8.0	6.4	9.8	7.6	6.2	3.0	4.3	8.9	15.2	8.9	15.7	2.7	3.4	12.1	15.4	9.3	3.6	9.9	3.4	10.0	9.9	9.1	8.4	9.3	7.9	9.2	8.0	10.1	2.3	9.6	7.7	6.9	2.7	16.5	10.7	9.7	17.3	7.5	4.4	3.1	36.9	15.8	56.6	24.2	20.1	30.9	24.3	38.2	32.0	35.6	39.4	23.5	22.0	75.2	15.1	30.0	22.3	23.0	41.8	30.6	52.7	29.8	50.0	49.7	21.8	20.7	22.5	73.3	28.3	30.4	18.8	27.8	27.3	12.6	17.4	25.8	32.1	20.3	46.1	14.6	48.6	21.4	43.1	45.2	20.2	48.1	26.9	26.0	27.0	22.2	27.5	32.8	22.2	49.2	36.7	39.1	28.2	61.3	19.3	19.5	30.8	20.7	23.6	25.7	27.9	80.4	38.6	42.7	38.1	7.5	3.3	4.4	3.7	4.0	4.6	5.4	3.3	3.7	3.9	5.8	2.6	3.0	0.8	3.5	6.6	12.5	2.4	2.1	3.4	3.3	6.6	5.2	3.0	4.3	2.7	3.4	3.4	2.3	2.7	3.1	11.2	9.6	9.6	3.6	13.9	3.3	6.6	7.6	10.8	12.5	11.3	10.8	5.7	11.5	4.1	12.9	4.2	14.2	18.1	9.3	13.7	11.7	1.0	8.5	14.8	10.9	10.8	24.4	6.1	11.4	18.1	11.5	10.2	8.3	10.1	13.1	13.9	21.6	21.7	15.2	7.8	12.5	6.1	20.7	7.8	1.6	11.8	13.0	12.4	7.5	18.4	8.8	17.5	4.0	8.0	10.9	7.8	11.3	17.6	13.2	12.5	17.0	7.6	10.9	6.6	11.7	10.5	10.6	20.7	13.1	3.8	7.9	11.4	12.4	11.4	3.5
CHCHD3	"FLJ20420, Mic19, MICOS19, MINOS3, PPP1R22"	ENSG00000106554	"Coiled-coil-helix-coiled-coil-helix domain containing 3"	Q9NX63	7	132784870-133082090	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"heart muscle: 125.6;skeletal muscle: 351.7;tongue: 243.0"	"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 210.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042935	Enhanced		Supported	Mitochondria		NA	NA		13000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA042935: AB_10794538"	"unprognostic (1.53e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.15e-2)"	"unprognostic (3.00e-3)"	"unprognostic (5.69e-2)"	"unprognostic (4.75e-3)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (1.39e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.69e-3)"	"unprognostic (2.04e-1)"	"prognostic favorable (1.15e-4)"	"unprognostic (4.98e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.03e-2)"	40.4	33.3	18.0	29.0	19.4	51.5	32.8	21.7	25.4	25.5	22.2	45.5	56.7	28.0	19.2	28.3	25.5	22.5	125.6	20.1	19.3	54.8	32.1	26.4	30.3	19.6	19.0	27.2	26.6	59.7	17.2	30.2	19.2	25.4	49.7	40.3	24.3	28.6	351.7	20.8	42.2	37.1	17.7	21.9	31.6	16.8	18.2	42.5	35.6	243.0	29.8	31.8	23.0	21.5	102.0	103.8	99.7	138.9	70.6	64.9	60.2	97.0	90.3	106.7	117.4	121.0	108.9	83.1	37.6	61.1	237.1	69.1	117.0	82.7	148.7	113.4	111.8	85.9	101.9	70.7	139.3	194.7	62.1	59.0	55.8	146.9	151.7	53.2	75.9	107.6	186.1	74.2	100.1	134.3	284.0	169.9	165.1	160.3	117.2	140.6	146.2	119.8	103.9	83.1	127.4	158.8	80.5	62.4	186.7	67.6	52.5	116.2	63.5	101.8	44.3	162.0	176.7	71.3	100.4	206.6	161.1	163.9	146.6	42.3	43.7	33.2	30.5	62.8	28.9	38.5	27.6	29.6	57.9	23.2	23.9	26.9	6.4	45.2	52.1	49.5	41.9	34.0	18.0	19.4	21.7	25.4	20.1	19.3	19.6	19.0	19.2	17.7	18.2	21.5	32.0	25.6	26.2	103.8	36.5	34.9	28.7	56.9	31.9	26.5	29.0	25.7	138.8	38.6	36.2	14.7	22.9	69.7	29.0	40.4	125.2	61.5	99.6	27.8	33.6	34.3	35.9	64.3	201.3	60.7	79.5	38.9	32.6	22.4	34.2	34.6	17.2	20.7	78.4	15.2	210.5	48.9	30.5	27.3	44.4	103.4	31.4	38.3	37.4	100.2	49.7	34.2	37.0	161.4	143.5	50.1	31.0	35.3	46.5	44.4	50.7	88.8	29.6	27.0	32.9	43.4	53.5	20.9	29.2	37.0	40.3	68.4	34.0	55.8	73.1	42.6
CHCHD6	"CHCM1, MGC13016, Mic25, MICOS25, PPP1R23"	ENSG00000159685	"Coiled-coil-helix-coiled-coil-helix domain containing 6"	Q9BRQ6	3	126704240-126960420	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 53.0"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 178.2;Late spermatids: 106.6;Melanocytes: 172.5;Spermatocytes: 119.7"	"Cancer enriched"	"Detected in all"	4	"melanoma: 34.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047673, HPA051975"	Approved		Supported	Mitochondria		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 4: Macrophages - Innate immune response"	Mitochondria		"HPA047673: AB_10961761, HPA051975: AB_2681679"	"unprognostic (3.94e-2)"	"prognostic favorable (7.46e-4)"	"unprognostic (6.20e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.83e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (6.76e-4)"	"unprognostic (6.47e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.11e-3)"	9.4	12.8	22.2	3.8	24.7	4.2	10.8	17.7	34.3	13.1	16.4	11.6	3.9	11.5	5.0	10.9	13.7	5.0	11.9	35.0	22.7	14.4	7.4	10.7	3.9	19.0	21.6	17.7	14.8	15.6	16.5	4.1	21.0	10.5	3.0	8.3	14.1	7.8	4.7	16.3	6.2	5.4	18.4	6.9	11.7	53.0	21.4	4.9	13.0	3.2	2.9	11.1	11.5	22.1	37.1	21.1	18.4	44.7	6.4	9.8	10.5	14.1	9.5	16.0	15.5	29.3	15.8	16.3	31.8	8.5	17.5	21.3	13.9	38.3	7.9	4.5	37.7	13.5	15.8	29.0	19.0	29.2	8.5	9.9	22.9	7.8	16.3	13.1	10.6	28.4	12.2	9.4	14.2	27.7	43.2	29.1	22.3	20.9	23.7	22.8	28.0	38.9	14.3	15.8	33.6	21.0	14.5	24.3	45.4	9.0	14.2	10.8	9.7	17.9	22.2	24.5	14.6	12.0	5.9	20.4	20.1	9.6	17.0	0.0	2.4	2.1	6.8	4.1	8.8	8.4	9.9	8.4	6.8	11.6	9.4	11.2	0.0	7.7	3.7	4.8	10.0	4.6	22.2	24.7	17.7	34.3	35.0	22.7	19.0	21.6	21.0	18.4	21.4	22.1	8.9	19.2	12.5	20.5	7.1	29.6	21.7	35.5	9.6	15.4	20.0	31.5	18.5	8.6	24.0	14.7	18.8	40.8	3.4	6.4	58.7	22.7	99.0	18.6	8.8	7.3	7.7	8.2	48.1	24.2	12.1	14.8	9.7	5.8	14.0	45.6	6.8	7.2	178.2	20.2	45.1	10.8	28.5	10.1	15.6	106.6	15.8	33.0	172.5	12.2	2.7	20.2	2.1	22.6	22.0	18.9	9.0	22.2	7.1	29.6	2.6	27.9	56.1	16.1	0.0	10.9	17.9	119.7	51.4	16.0	30.1	15.5	8.2	14.1	13.3	21.1
CHD4	"Mi-2b, Mi2-BETA"	ENSG00000111642	"Chromodomain helicase DNA binding protein 4"	Q14839	12	6570082-6614524	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA012008	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA012008: AB_1846633"	"unprognostic (6.11e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.40e-3)"	"unprognostic (8.99e-2)"	"unprognostic (3.36e-3)"	"prognostic unfavorable (6.03e-6)"	"unprognostic (2.66e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.82e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.66e-1)"	34.5	45.6	22.9	38.6	30.7	44.4	31.9	24.6	30.1	39.4	20.6	45.7	26.5	47.8	44.9	35.4	37.7	31.1	41.4	19.7	26.1	39.3	31.6	35.3	46.3	27.3	29.2	40.9	37.7	58.3	33.5	42.2	28.0	28.4	35.4	44.9	33.8	44.1	50.0	45.8	35.5	49.9	22.6	39.0	38.5	34.2	29.6	90.7	54.6	38.7	56.6	42.2	34.4	27.4	86.7	79.7	187.6	72.1	76.6	84.7	110.4	92.9	93.4	102.3	93.5	130.6	66.6	184.9	36.0	107.5	66.1	76.0	179.1	104.5	135.7	139.9	92.7	258.5	122.0	83.3	67.1	207.2	119.1	82.9	51.7	99.1	68.7	128.2	122.2	101.6	209.0	91.0	98.7	111.8	196.6	67.8	184.7	82.5	72.7	166.4	114.9	103.6	64.2	101.6	88.8	114.6	121.1	136.0	92.9	205.4	61.3	121.3	114.4	103.4	217.4	76.3	111.5	144.0	91.8	230.2	68.7	125.8	79.5	12.3	6.8	8.7	9.3	7.7	9.6	8.8	8.4	9.3	6.9	11.3	10.6	10.3	10.8	12.2	8.0	14.4	15.9	5.6	22.9	30.7	24.6	30.1	19.7	26.1	27.3	29.2	28.0	22.6	29.6	27.4	68.2	60.9	119.7	56.2	82.8	68.6	47.4	42.4	76.2	109.9	77.5	61.2	132.9	58.6	67.2	88.3	70.9	48.2	106.0	58.1	13.7	84.6	76.4	128.1	153.3	78.9	97.1	64.4	26.1	71.9	46.1	67.7	47.9	123.7	85.9	73.0	56.0	69.2	69.0	139.7	21.4	66.6	54.9	51.9	78.3	59.1	65.9	68.9	48.0	25.3	66.7	71.4	56.7	24.6	55.5	95.8	36.4	74.4	69.0	49.4	45.8	38.3	82.1	57.8	52.6	112.1	98.1	102.6	111.6	78.9	67.6	68.0	85.1	83.7	72.1	47.4
CHD8	"DUPLIN, HELSNF1, KIAA1564"	ENSG00000100888	"Chromodomain helicase DNA binding protein 8"	Q9HCK8	14	21385194-21456126	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Repressor"	"Autism, Autism spectrum disorder, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052186, HPA076133"			Enhanced	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA052186: AB_2681754, HPA076133: "	"unprognostic (3.45e-1)"	"unprognostic (9.71e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (7.31e-2)"	"unprognostic (9.22e-2)"	"prognostic favorable (8.35e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.88e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.51e-1)"	"unprognostic (8.07e-3)"	12.5	11.9	11.2	13.5	12.5	35.3	14.8	16.3	13.2	12.4	10.5	14.0	9.4	14.8	11.1	14.9	12.9	10.1	12.0	11.1	12.2	11.7	9.6	13.7	18.0	11.4	11.6	17.1	13.6	22.3	13.1	11.7	11.1	13.2	12.3	14.8	13.6	12.1	15.7	22.3	14.7	14.8	11.5	15.8	14.2	12.9	12.5	25.4	14.8	12.7	17.5	12.8	12.9	13.6	31.2	39.6	43.6	20.7	27.7	23.6	24.9	24.4	28.4	36.5	35.4	35.0	26.3	51.4	14.8	33.1	28.4	37.2	54.9	35.1	46.0	39.3	24.2	46.3	27.6	43.5	25.7	64.6	40.4	32.8	27.2	40.9	29.7	28.6	33.4	40.2	32.4	26.7	28.0	33.9	46.1	26.0	33.4	30.9	34.3	42.0	32.9	17.4	27.3	57.9	30.9	30.7	37.5	29.8	21.8	39.7	20.7	30.5	36.4	29.2	23.0	17.8	29.1	30.3	38.4	50.3	12.1	23.2	29.6	9.1	3.8	9.8	5.5	3.8	6.4	4.2	4.9	5.6	2.7	11.2	5.0	4.4	7.9	7.8	6.7	6.1	4.7	2.7	11.2	12.5	16.3	13.2	11.1	12.2	11.4	11.6	11.1	11.5	12.5	13.6	27.6	38.5	56.3	27.4	32.2	12.6	11.3	15.9	23.3	33.3	21.9	22.6	19.6	24.3	32.6	33.1	27.1	14.7	40.0	16.8	1.9	21.8	3.4	32.5	37.9	25.5	27.1	27.8	41.0	23.6	12.3	24.0	27.5	39.5	28.4	41.7	13.9	14.9	17.5	23.5	40.2	16.0	8.2	20.1	9.3	4.1	16.1	25.3	10.6	20.6	27.1	18.9	32.0	29.7	33.1	26.5	13.9	17.7	32.4	16.1	12.0	7.4	28.8	24.3	0.0	32.1	26.2	29.2	25.1	24.6	16.6	12.3	31.4	34.1	16.8	12.7
CHEK1	CHK1	ENSG00000149554	"Checkpoint kinase 1"	O14757	11	125625665-125676255	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.7;lymphoid tissue: 20.7;seminal vesicle: 29.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 32.9;Erythroid cells: 34.5;Extravillous trophoblasts: 35.6;Spermatocytes: 48.9;Spermatogonia: 49.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"T-reg: 6.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 1.7;T-cells: 6.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA044364			Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Vesicles	"HPA044364: AB_2678913"	"unprognostic (6.74e-2)"	"unprognostic (3.63e-1)"	"prognostic favorable (3.62e-4)"	"unprognostic (5.54e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.70e-6)"	"unprognostic (3.95e-3)"	"unprognostic (1.26e-3)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (3.10e-6)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (1.04e-8)"	"unprognostic (2.89e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.33e-1)"	1.6	1.3	0.7	8.2	1.0	25.7	2.6	0.6	1.3	1.7	0.5	7.9	6.8	1.7	6.7	4.1	1.1	1.7	0.9	0.7	0.9	2.2	2.1	1.3	14.9	0.7	0.8	1.8	2.0	13.2	1.7	4.8	0.8	1.6	8.7	0.7	1.5	29.8	0.6	3.6	7.3	3.4	0.6	2.2	2.6	8.9	1.2	20.7	1.0	1.3	13.9	3.3	2.1	0.8	48.5	37.0	81.1	47.4	13.5	28.9	35.7	61.1	28.7	41.6	40.1	88.0	100.3	120.7	63.5	24.9	53.7	52.6	54.2	33.2	50.1	81.4	24.8	224.2	27.2	44.7	4.3	121.1	39.6	15.7	6.0	47.6	36.0	19.9	44.7	84.1	117.3	102.7	51.4	23.8	181.3	65.0	86.1	77.1	33.2	104.7	74.4	67.2	37.9	63.2	50.5	53.6	45.2	35.4	15.2	57.3	93.9	40.6	28.4	51.0	47.3	29.6	60.8	21.9	45.4	187.5	20.5	86.6	67.6	1.7	0.2	0.0	0.4	0.1	0.2	0.7	1.6	0.4	0.6	0.3	0.4	0.3	1.1	0.3	0.1	0.7	6.2	0.4	0.7	1.0	0.6	1.3	0.7	0.9	0.7	0.8	0.8	0.6	1.2	0.8	1.1	3.2	0.5	1.6	5.5	6.2	3.9	5.8	5.2	1.7	3.9	6.0	4.6	32.9	4.1	7.3	0.0	17.3	6.0	4.5	3.9	3.4	7.8	5.5	8.0	3.5	1.8	34.5	3.3	1.1	35.6	5.3	6.1	9.9	0.0	21.1	3.6	1.2	11.1	0.0	2.5	9.2	2.0	0.0	5.2	3.1	1.5	3.2	0.0	2.8	3.2	2.8	3.1	1.5	1.6	2.9	3.9	1.2	17.7	3.1	8.0	9.4	2.5	1.7	0.0	3.1	7.8	48.9	49.8	9.5	4.8	7.8	5.1	4.8	16.7	3.0
CHEK2	"bA444G7, CDS1, CHK2, HuCds1, PP1425, RAD53"	ENSG00000183765	"Checkpoint kinase 2"	O96017	22	28687743-28742422	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001878, CAB002030"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Golgi apparatus"	"CAB002030: AB_563660, HPA001878: AB_1078514"	"unprognostic (1.54e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.49e-3)"	"unprognostic (5.08e-3)"	"unprognostic (3.33e-3)"	"unprognostic (9.62e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (7.80e-9)"	"unprognostic (2.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.27e-2)"	"unprognostic (6.79e-3)"	4.5	6.2	2.4	8.8	2.5	15.4	5.8	2.4	3.7	5.0	2.8	8.8	6.3	4.1	7.3	7.2	3.7	4.7	4.2	2.3	2.8	4.5	6.3	4.4	12.1	2.6	2.6	8.2	2.3	1.3	2.7	7.8	2.8	4.1	10.9	0.4	3.2	3.8	1.3	6.7	7.0	4.8	2.6	6.7	4.1	8.5	2.8	9.4	3.3	1.1	12.0	6.8	5.0	2.9	30.7	9.7	31.1	32.4	10.1	42.7	18.7	15.2	19.9	18.7	27.8	29.1	21.8	36.3	13.0	11.5	21.6	32.1	42.7	29.0	25.0	24.6	31.2	45.3	25.5	46.2	9.4	33.4	38.0	18.6	13.5	25.0	23.0	14.1	25.4	29.4	30.5	33.9	19.8	39.2	24.6	61.5	40.6	41.3	21.6	52.6	18.2	42.7	17.1	11.2	17.8	9.7	16.7	31.4	17.4	22.8	22.6	32.2	7.8	17.1	19.4	14.3	9.1	21.8	28.3	65.4	17.1	34.9	21.0	9.9	4.0	1.2	1.1	8.1	2.4	11.9	2.1	2.1	8.2	7.8	4.0	2.6	0.6	3.4	4.1	6.1	2.8	3.6	2.4	2.5	2.4	3.7	2.3	2.8	2.6	2.6	2.8	2.6	2.8	2.9	2.3	9.6	4.8	2.9	5.5	6.4	5.3	8.3	8.6	1.1	3.2	3.9	1.8	0.0	5.0	1.8	0.0	15.4	1.1	3.8	0.0	1.8	7.0	2.9	10.1	3.0	1.2	11.2	2.9	1.4	13.6	12.4	5.1	7.0	3.8	7.4	2.5	1.3	9.7	0.0	1.2	5.3	8.2	2.4	8.5	1.2	6.2	5.1	1.8	2.8	3.9	0.8	6.2	0.0	1.0	1.0	4.7	4.5	11.4	2.7	3.0	3.9	2.9	1.1	0.0	10.2	3.0	6.7	31.2	8.3	2.3	3.4	3.3	5.7	10.0	4.5
CHRAC1	"CHRAC15, YCL1"	ENSG00000104472	"Chromatin accessibility complex subunit 1"	Q9NRG0	8	140511311-140517154	"Predicted intracellular proteins"		"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059008			Approved	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA059008: AB_2683878"	"unprognostic (6.34e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (1.29e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (4.88e-5)"	"unprognostic (8.79e-3)"	"unprognostic (1.86e-1)"	"prognostic favorable (9.72e-4)"	"prognostic unfavorable (5.43e-4)"	"unprognostic (4.19e-1)"	"unprognostic (6.22e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.49e-1)"	15.0	11.6	11.0	16.9	14.4	28.1	12.5	11.0	12.1	12.7	7.3	16.9	16.0	15.1	11.7	21.5	13.2	16.6	15.9	9.5	9.9	16.1	14.5	14.8	24.0	14.4	13.1	13.5	18.2	16.4	8.8	15.0	12.7	11.6	16.1	4.6	13.0	11.6	27.9	19.7	18.2	18.1	10.6	12.5	15.6	14.5	12.0	21.4	20.9	25.3	26.2	17.7	11.7	18.0	53.3	25.2	23.1	22.0	22.6	38.1	17.8	22.2	32.2	31.8	38.1	32.5	37.1	54.6	32.2	27.4	25.1	32.3	28.0	22.6	43.6	42.5	30.2	77.5	33.1	37.0	21.4	26.2	39.4	19.2	32.5	23.6	45.3	17.1	30.9	33.1	58.3	50.4	28.4	61.6	91.6	27.9	17.2	46.5	43.6	54.4	24.7	43.5	32.0	21.8	31.7	26.3	31.1	20.9	39.5	12.6	40.4	29.3	29.4	37.4	65.1	46.5	47.8	24.2	34.0	66.3	45.0	61.1	29.6	10.6	20.2	25.4	18.2	26.5	17.5	20.4	15.6	17.7	22.4	24.1	16.0	13.9	24.3	20.3	30.2	22.8	15.6	16.1	11.0	14.4	11.0	12.1	9.5	9.9	14.4	13.1	12.7	10.6	12.0	18.0	32.3	16.0	29.9	4.2	45.6	38.4	39.2	28.5	29.0	7.4	26.3	18.0	14.7	20.0	25.9	14.7	2.1	24.9	45.0	23.4	43.0	27.4	20.2	25.6	31.4	29.6	21.6	28.8	2.4	36.0	49.3	27.4	19.4	44.8	32.4	13.3	31.8	22.4	25.2	6.7	2.5	23.6	24.4	30.8	51.4	31.7	29.2	37.1	19.6	6.5	43.8	26.9	43.3	4.0	14.9	38.2	20.6	25.2	26.4	35.2	29.0	33.8	13.9	11.7	72.3	34.9	31.1	75.5	58.3	34.5	48.6	24.1	42.4	15.8	22.3	35.9
CHUK	"IkBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16"	ENSG00000213341	"Component of inhibitor of nuclear factor kappa B kinase complex"	O15111	10	100188300-100229596	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001402, CAB004240, CAB018564"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB004240: AB_627784, CAB018564: AB_649197, HPA001402: AB_1079125"	"unprognostic (8.61e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.93e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.58e-2)"	"unprognostic (8.39e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (1.27e-4)"	"unprognostic (2.48e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.22e-1)"	13.5	10.3	6.6	11.7	7.6	19.6	10.8	7.1	8.3	8.4	8.3	11.9	12.8	8.8	9.1	9.7	7.5	9.0	6.8	6.4	9.2	21.0	17.0	10.2	12.7	7.3	7.5	5.6	11.5	14.0	6.5	10.5	7.6	9.6	13.3	8.0	8.8	9.0	14.2	6.9	10.8	11.8	7.7	9.9	11.2	8.3	8.7	14.3	11.1	11.7	12.6	13.6	6.4	8.7	27.7	22.9	23.0	34.4	21.6	19.3	17.6	34.3	33.5	31.3	38.0	25.9	15.9	37.2	19.7	23.5	21.8	26.7	38.7	18.2	34.9	39.8	33.5	24.7	18.0	28.7	18.4	46.2	34.8	15.5	19.1	36.2	35.0	21.8	22.7	30.1	28.5	29.9	34.6	16.7	36.9	28.4	15.0	21.8	16.5	23.7	25.5	17.0	19.9	17.6	13.7	20.3	18.6	14.2	30.9	18.0	28.5	27.8	23.9	19.6	21.9	21.5	39.7	34.9	33.7	35.7	21.3	36.9	15.8	1.0	1.2	2.1	0.9	1.9	1.5	1.6	1.1	1.6	1.4	1.0	1.3	1.5	2.8	1.8	1.3	0.8	1.2	0.5	6.6	7.6	7.1	8.3	6.4	9.2	7.3	7.5	7.6	7.7	8.7	8.7	11.4	12.8	11.5	17.9	10.8	19.8	7.1	5.1	8.0	6.3	7.3	4.8	9.2	7.2	5.9	5.5	2.1	6.5	14.1	12.2	11.7	7.1	7.6	8.9	8.6	8.4	6.0	12.0	22.7	11.8	7.8	6.5	7.7	12.7	8.2	6.2	7.1	14.4	10.6	13.5	21.3	8.0	8.2	16.9	12.7	8.0	6.2	11.7	7.2	19.7	15.6	4.5	9.2	20.6	27.7	10.4	6.0	6.0	18.5	9.6	9.5	20.0	6.4	5.0	19.7	7.8	12.0	16.4	12.9	13.2	19.0	13.8	11.1	10.1	6.6	10.6
CIAPIN1	"Anamorsin, CIAE2"	ENSG00000005194	"Cytokine induced apoptosis inhibitor 1"	Q6FI81	16	57428187-57447420	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 259.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041350, HPA042182"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	No		21000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria	Nucleoplasm	"HPA041350: AB_10796665, HPA042182: AB_10794646"	"unprognostic (1.78e-2)"	"unprognostic (9.62e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (1.41e-3)"	"unprognostic (8.15e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.48e-2)"	"unprognostic (4.70e-3)"	"unprognostic (1.62e-1)"	"prognostic favorable (4.42e-4)"	"unprognostic (5.61e-2)"	"unprognostic (3.86e-2)"	"unprognostic (8.90e-3)"	"unprognostic (1.16e-1)"	19.1	32.8	22.1	19.7	22.3	20.6	18.9	23.2	26.8	16.3	26.3	29.4	21.3	16.3	15.5	30.2	16.1	16.6	38.7	22.5	23.8	30.8	27.3	19.9	24.2	24.3	23.2	12.9	19.6	37.4	17.7	31.6	23.8	18.0	25.9	20.9	19.7	16.3	41.3	28.3	20.9	22.0	20.7	21.6	22.3	68.0	25.1	31.0	18.4	38.4	34.3	24.3	20.2	21.8	51.8	77.8	80.4	61.4	46.5	31.8	67.5	52.7	51.2	102.6	48.1	87.6	40.3	55.0	75.8	46.9	32.4	95.9	113.2	82.2	86.5	32.7	68.2	71.4	63.6	91.6	74.6	88.2	67.7	48.8	88.7	74.9	94.5	40.5	101.9	69.3	101.4	30.7	60.9	51.5	81.1	71.1	100.8	60.3	114.8	146.0	93.6	112.7	69.6	57.7	68.7	85.8	126.4	86.2	56.6	64.6	61.7	76.5	63.2	42.3	52.1	42.4	64.7	76.8	113.4	175.0	51.1	78.9	68.0	53.6	80.5	54.2	74.2	79.2	68.1	65.7	60.8	78.4	94.6	72.6	128.5	115.1	19.8	91.1	64.7	79.8	74.5	153.8	22.1	22.3	23.2	26.8	22.5	23.8	24.3	23.2	23.8	20.7	25.1	21.8	25.3	16.0	22.0	7.8	16.0	14.3	13.9	59.4	8.6	29.2	17.5	18.3	36.1	20.0	28.4	22.0	10.4	90.4	21.8	17.0	39.2	55.4	19.3	14.4	19.1	28.5	18.6	21.9	15.7	51.8	50.0	19.2	19.4	15.1	10.8	28.1	17.9	20.3	40.0	23.5	16.4	17.8	52.9	13.9	13.2	33.6	14.0	17.4	24.9	7.5	42.9	27.9	23.7	11.1	10.6	54.6	23.9	20.7	14.4	23.2	25.5	37.4	14.1	17.8	39.5	11.8	21.3	259.9	69.8	23.2	15.9	106.2	19.3	43.4	28.0	15.2
CIP2A	KIAA1524	ENSG00000163507	"Cellular inhibitor of PP2A"	Q8TCG1	3	108549864-108589644	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 7.5;lymphoid tissue: 6.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 9.6;Cytotrophoblasts: 8.0;Exocrine glandular cells: 7.3;Extravillous trophoblasts: 12.9;Granulosa cells: 25.3;Hofbauer cells: 8.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039570	Approved		Supported	"Plasma membrane,Cytosol"		NA	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Plasma membrane"	"HPA039570: AB_10796329"	"unprognostic (2.02e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.31e-3)"	"prognostic unfavorable (6.24e-5)"	"unprognostic (3.10e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.91e-7)"	"unprognostic (2.80e-3)"	"unprognostic (2.53e-3)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.18e-4)"	"unprognostic (6.85e-2)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (9.11e-3)"	"unprognostic (3.73e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.25e-1)"	1.1	1.1	0.3	3.4	0.6	7.5	1.4	0.9	0.8	0.9	0.1	1.9	1.2	1.8	0.6	1.7	0.9	1.2	0.7	0.6	0.5	1.0	0.7	1.4	6.7	0.2	0.9	1.9	0.4	0.6	0.7	2.1	0.2	1.8	2.7	2.6	0.6	0.8	0.6	1.2	1.7	1.5	0.0	2.3	1.2	5.7	0.1	6.9	1.2	0.7	5.2	2.0	0.9	0.4	42.2	12.2	33.9	21.8	1.4	3.2	13.8	31.1	14.7	36.2	41.9	15.0	18.5	27.6	10.4	11.4	27.7	20.9	11.7	11.0	65.8	8.8	11.3	33.9	17.4	11.3	0.5	21.8	23.2	1.4	2.3	28.4	11.5	5.9	16.3	12.7	21.1	44.5	36.1	8.7	26.7	19.2	35.0	15.8	20.8	30.1	31.2	15.3	11.0	11.5	16.4	21.6	22.9	9.0	12.7	19.7	15.3	15.6	12.2	37.0	41.7	11.3	38.3	10.2	12.1	46.1	16.4	23.2	38.6	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.6	0.9	0.8	0.6	0.5	0.2	0.9	0.2	0.0	0.1	0.4	1.2	9.6	1.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	1.9	1.3	0.0	0.0	2.5	3.7	0.0	8.0	1.8	0.0	1.9	2.8	0.0	2.5	2.8	2.6	0.0	0.0	0.0	7.3	12.9	3.0	0.0	2.7	3.8	25.3	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	3.1	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.4	0.0	0.0	2.4	1.5	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	1.4	1.7	5.4	0.0	0.0
CISD2	"ERIS, Miner1, NAF-1, WFS2, ZCD2"	ENSG00000145354	"CDGSH iron sulfur domain 2"	Q8N5K1	4	102868974-102892807	"Disease related genes, Human disease related genes, Predicted membrane proteins"	Autophagy		"Deafness, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 46.0"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 256.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015914	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Endoplasmic reticulum"		"HPA015914: AB_1846794"	"unprognostic (1.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.54e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.48e-3)"	"unprognostic (9.12e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.34e-1)"	11.2	19.1	2.4	5.5	2.7	6.0	9.0	3.9	3.2	9.5	4.1	11.5	1.7	9.5	5.3	12.5	8.8	4.3	10.5	2.6	3.2	17.9	46.0	10.7	5.5	2.9	2.9	8.9	20.0	5.4	12.8	3.1	3.0	9.5	3.8	6.1	12.0	1.9	7.4	9.7	10.9	3.0	2.7	14.7	11.4	6.5	3.0	4.0	13.6	1.7	3.5	9.8	10.1	4.0	16.8	5.5	5.8	7.2	14.2	15.2	3.7	12.6	4.6	5.4	8.2	6.5	27.7	12.1	10.9	12.2	12.9	8.1	28.2	10.1	24.8	10.7	4.2	10.5	3.6	6.7	10.1	18.7	16.1	5.9	15.1	23.0	17.8	5.2	9.8	6.7	22.7	21.3	14.7	4.6	16.5	5.4	11.2	5.7	4.0	6.7	5.9	22.2	13.6	5.3	13.4	7.8	7.5	12.8	12.8	6.6	8.5	4.0	4.4	15.8	17.8	21.3	7.8	16.3	23.5	24.2	11.2	5.7	12.6	4.6	2.8	5.8	2.6	2.7	2.7	2.5	2.6	2.7	2.7	2.1	1.7	2.2	2.0	4.4	3.1	3.5	3.5	2.3	2.4	2.7	3.9	3.2	2.6	3.2	2.9	2.9	3.0	2.7	3.0	4.0	24.2	25.6	26.1	10.1	65.3	85.7	45.3	131.0	60.3	33.5	61.2	51.3	27.8	58.6	70.4	77.3	20.9	74.2	52.7	52.9	72.4	101.8	12.2	39.9	41.8	35.8	43.0	256.8	17.5	77.2	131.0	39.6	39.8	48.3	57.8	24.2	26.0	159.9	110.9	30.3	22.1	94.2	146.5	93.5	128.9	6.9	23.9	66.4	69.4	12.2	78.4	36.9	45.3	17.6	25.9	74.3	88.5	33.8	194.3	63.7	82.7	203.9	63.1	33.1	32.9	22.1	41.6	41.7	36.7	56.4	90.1	56.8	54.0	33.4	68.6	53.9
CIT	"CITK, CRIK, KIAA0949, STK21"	ENSG00000122966	"Citron rho-interacting serine/threonine kinase"	O14578	12	119685791-119877320	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 87.6;Early spermatids: 72.8;Excitatory neurons: 147.0;Inhibitory neurons: 139.8;Oligodendrocyte precursor cells: 82.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019082, HPA048812, HPA075506"	Uncertain		Approved	Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA019082: AB_1846803, HPA048812: AB_2680528, HPA075506: AB_2686752"	"unprognostic (5.64e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.16e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.25e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.61e-6)"	"unprognostic (6.02e-2)"	"unprognostic (7.78e-2)"	"unprognostic (4.42e-1)"	"unprognostic (1.37e-3)"	"unprognostic (4.88e-2)"	"unprognostic (2.55e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.30e-1)"	0.7	2.2	13.5	1.6	26.2	6.3	0.6	0.0	19.9	0.9	0.0	2.1	1.2	0.4	0.0	2.5	0.5	0.5	0.6	15.2	5.4	2.5	0.3	1.8	1.5	0.2	5.0	0.3	0.2	0.1	1.6	1.4	0.4	0.5	2.5	3.4	0.8	0.2	0.5	1.6	1.9	0.9	0.9	3.0	2.2	4.8	14.2	6.8	0.6	0.3	2.3	0.5	1.3	6.6	26.2	20.6	21.7	15.3	2.4	6.3	10.4	22.0	19.1	21.8	16.6	14.5	10.3	18.4	10.0	14.2	9.3	14.6	14.4	9.5	32.1	13.6	7.5	25.7	13.2	7.1	0.3	12.7	20.6	0.9	1.2	23.7	14.8	7.3	15.5	19.9	14.5	15.2	19.5	12.2	22.4	14.0	10.4	8.7	12.5	19.3	39.8	6.3	5.0	11.1	15.5	8.4	31.9	6.5	16.0	9.6	23.2	10.6	11.5	21.9	21.4	17.2	22.7	9.9	12.6	14.2	16.8	12.5	35.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	13.5	26.2	0.0	19.9	15.2	5.4	0.2	5.0	0.4	0.9	14.2	6.6	4.1	6.4	13.0	8.5	1.2	3.3	0.7	1.0	0.6	8.2	1.8	1.5	1.8	0.0	5.6	9.2	87.6	3.5	0.6	1.1	0.0	0.2	72.8	2.4	2.1	2.7	1.8	12.8	147.0	0.8	4.8	2.2	3.1	3.6	1.3	10.5	1.1	0.7	3.6	0.0	139.8	4.4	6.1	3.7	0.8	44.1	1.2	2.0	3.6	7.5	0.0	15.4	1.0	82.4	18.7	0.2	0.1	1.2	4.1	0.4	0.8	7.5	1.7	15.2	0.0	0.6	3.3	33.2	4.2	7.7	1.3	1.0	2.2	4.3	4.4	1.0
CIZ1	"LSFR1, ZNF356"	ENSG00000148337	"CDKN1A interacting zinc finger protein 1"	Q9ULV3	9	128161251-128204383	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020380, HPA020387"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA020380: , HPA020387: AB_2670425"	"unprognostic (1.28e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (1.43e-4)"	"unprognostic (6.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.49e-3)"	"unprognostic (3.13e-3)"	"unprognostic (8.05e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.24e-1)"	"unprognostic (8.47e-3)"	57.7	38.9	36.1	28.5	37.1	55.3	48.3	36.5	46.4	60.1	19.7	68.4	34.5	53.5	24.4	46.3	47.6	33.9	46.0	36.4	33.8	31.8	21.4	38.0	35.1	35.9	31.4	69.9	70.7	35.0	33.8	28.0	34.2	40.8	26.7	26.9	44.6	33.6	90.4	65.8	41.9	36.9	26.8	35.5	51.3	56.4	36.4	35.3	37.0	42.5	29.5	57.8	50.0	40.9	72.2	85.5	70.7	67.5	71.8	85.6	69.9	55.6	82.2	99.5	56.1	79.1	60.4	84.1	46.1	93.7	82.0	102.1	55.3	59.4	53.9	76.7	64.2	80.2	106.7	51.2	82.5	75.1	91.0	83.7	104.5	109.1	91.9	71.7	68.1	52.9	199.0	70.4	60.5	169.6	98.2	76.1	61.6	96.2	87.4	83.4	74.8	86.5	45.0	48.7	88.4	68.5	123.3	85.8	73.7	31.5	89.7	96.4	72.9	105.7	74.4	120.4	105.6	81.3	99.1	80.2	74.4	49.9	115.1	2.6	2.2	2.6	2.4	3.1	2.2	2.7	2.9	3.1	2.4	3.9	3.0	2.6	0.5	4.9	2.3	2.4	4.8	1.9	36.1	37.1	36.5	46.4	36.4	33.8	35.9	31.4	34.2	26.8	36.4	40.9	15.4	3.2	12.9	14.0	19.4	23.2	23.2	12.3	21.6	25.9	16.7	17.0	10.8	18.6	11.7	18.4	29.2	23.3	23.6	20.8	13.7	26.0	77.3	10.1	19.9	18.7	22.8	31.5	20.6	44.7	28.8	22.6	25.0	14.8	9.5	25.3	18.5	6.1	22.6	16.8	19.3	19.1	16.2	20.7	18.2	79.2	34.8	17.7	19.6	19.7	19.1	19.6	16.5	11.6	15.9	28.0	15.6	31.2	25.5	15.4	31.6	18.0	8.4	25.0	13.1	23.9	19.1	37.5	26.0	23.8	24.9	20.8	18.2	15.7	25.4	20.0
CKAP2	"FLJ10749, LB1, se20-10, TMAP"	ENSG00000136108	"Cytoskeleton associated protein 2"	Q8WWK9	13	52455429-52476628	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 67.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 122.9;Granulosa cells: 88.6;Spermatocytes: 151.7;Spermatogonia: 87.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA008410, HPA027821"	Enhanced		Enhanced	"Microtubules,Mitotic spindle,Centrosome"		Yes	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Microtubules, Mitotic spindle"	Centrosome	"HPA008410: AB_1846832, HPA027821: AB_10602208"	"unprognostic (1.85e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.44e-2)"	"unprognostic (4.07e-3)"	"unprognostic (1.39e-2)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (3.38e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.69e-2)"	"unprognostic (8.30e-2)"	"unprognostic (6.60e-3)"	"prognostic unfavorable (1.90e-5)"	"unprognostic (2.01e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.36e-2)"	6.0	6.4	3.7	10.0	3.8	67.8	5.7	10.8	5.3	3.2	1.3	8.9	12.1	5.1	4.4	10.4	3.5	4.1	6.0	3.2	4.1	5.1	4.0	5.3	19.4	4.8	3.8	3.2	1.5	4.3	4.5	10.6	5.2	5.6	9.5	7.7	4.6	4.2	2.9	13.9	9.5	8.5	3.3	9.4	5.4	32.5	3.7	33.7	6.3	3.4	20.2	7.2	5.0	3.1	77.6	40.0	155.7	76.4	19.7	19.5	39.6	124.7	70.7	137.4	87.2	59.7	92.3	142.5	19.3	89.2	65.7	86.2	107.6	61.7	188.8	103.0	90.4	129.8	42.6	41.4	8.6	129.7	50.4	14.5	24.6	64.5	83.3	41.2	84.0	62.0	55.3	58.1	152.8	36.0	91.2	64.8	92.2	116.6	42.4	86.2	88.6	62.6	42.1	40.9	47.6	62.4	68.9	49.0	37.1	78.7	54.4	61.7	56.7	38.7	60.9	62.0	124.1	33.4	56.3	173.9	27.3	67.3	105.7	86.0	14.1	22.0	10.3	21.0	9.3	25.3	15.7	12.8	15.8	33.0	12.0	10.4	4.3	5.8	28.7	32.8	33.6	10.0	3.7	3.8	10.8	5.3	3.2	4.1	4.8	3.8	5.2	3.3	3.7	3.1	6.7	6.4	2.8	5.2	41.2	15.0	4.5	32.8	22.2	13.1	11.2	13.2	10.8	2.8	11.4	1.8	6.2	44.3	30.9	7.5	9.8	4.9	41.3	19.4	16.1	12.7	7.2	122.9	10.3	6.0	38.1	12.1	10.7	10.1	16.5	88.6	17.5	5.5	31.8	1.7	12.4	13.6	20.3	24.5	13.7	51.7	7.5	18.5	0.0	6.5	22.9	12.9	5.2	3.5	2.0	2.6	4.6	17.0	30.8	3.7	6.3	9.4	3.7	6.6	6.6	7.6	12.1	151.7	87.5	41.3	15.3	10.0	27.1	29.6	17.9	3.9
CKAP2L	"FLJ40629, radmis"	ENSG00000169607	"Cytoskeleton associated protein 2 like"	Q8IYA6	2	112736349-112764664	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 13.1;lymphoid tissue: 12.1;testis: 4.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 25.2;Granulosa cells: 12.5;Spermatocytes: 33.0;Spermatogonia: 35.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA039407, HPA040057, HPA070737"	Uncertain		Supported	"Microtubules,Mitotic spindle,Cytosol"		Yes	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Microtubules, Mitotic spindle"	Cytosol	"HPA039407: AB_10794091, HPA040057: AB_10794871, HPA070737: AB_2686303"	"unprognostic (2.29e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-1)"	"unprognostic (5.59e-2)"	"unprognostic (5.75e-5)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (2.49e-3)"	"unprognostic (1.91e-1)"	"unprognostic (9.57e-6)"	"unprognostic (2.42e-1)"	"unprognostic (0.00e+0)"	"unprognostic (7.37e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.49e-2)"	0.4	0.1	0.2	2.6	0.2	13.1	0.4	0.4	0.3	0.4	0.0	1.6	1.5	0.3	0.1	2.3	0.1	0.3	0.0	0.2	0.1	0.1	0.3	0.3	5.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.1	2.2	0.2	0.3	0.0	0.0	1.5	1.1	1.1	0.0	0.9	1.0	4.5	0.2	12.1	0.2	0.0	5.2	0.8	0.6	0.2	47.9	9.6	35.4	16.2	2.0	3.3	7.2	38.5	32.2	37.9	36.1	8.7	13.3	32.0	15.5	15.1	48.3	18.0	20.4	19.6	64.1	44.8	8.9	53.6	12.7	7.7	0.1	25.2	30.9	0.9	1.9	47.4	27.2	10.1	17.5	22.8	14.3	44.9	31.2	6.9	31.0	10.6	15.4	20.0	29.5	22.3	37.0	8.4	6.9	18.7	19.7	12.7	15.2	12.8	13.3	13.2	12.4	11.8	12.9	42.7	33.7	34.5	28.5	9.9	20.1	26.6	18.5	18.1	69.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.2	0.2	0.4	0.3	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.1	3.2	0.6	0.0	1.2	3.3	2.1	2.7	0.6	0.0	0.5	0.8	0.5	1.5	0.4	0.0	0.0	11.1	1.3	1.3	0.0	0.4	2.4	1.1	1.6	1.1	0.0	25.2	0.3	0.4	10.6	2.0	1.5	2.1	0.0	12.5	2.9	0.1	6.6	0.0	0.2	3.1	2.0	1.9	1.4	2.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.0	5.6	1.1	0.1	0.1	0.4	0.0	0.0	0.4	2.8	33.0	35.7	9.5	1.7	1.0	2.5	0.7	3.8	1.1
CKAP5	"ch-TOG, KIAA0097, TOG, TOGp"	ENSG00000175216	"Cytoskeleton associated protein 5"	Q14008	11	46743048-46846308	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 119.7;Spermatocytes: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039377, HPA040375"	Supported		Approved	"Nucleoli,Nucleoli rim,Plasma membrane,Centrosome"		NA	Yes		360000	"Cluster 27: Non-specific - Gene expression"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Centrosome"	"Nucleoli, Nucleoli rim"	"HPA039377: AB_10805477, HPA040375: AB_10794739"	"unprognostic (8.00e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (6.09e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.30e-3)"	"unprognostic (3.77e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.48e-1)"	"unprognostic (4.69e-2)"	12.8	30.7	15.9	15.1	19.5	25.9	14.9	30.8	24.3	11.7	5.2	18.5	12.6	15.7	12.2	13.0	11.5	12.2	21.3	21.4	18.0	11.5	45.5	10.4	18.4	21.0	17.4	27.8	9.0	21.2	12.5	17.3	22.9	15.9	17.2	57.0	9.1	13.2	37.8	13.7	12.3	19.3	17.5	11.9	16.1	33.0	20.2	36.4	9.6	28.8	18.5	13.5	10.8	24.6	104.7	95.8	212.6	90.8	48.7	73.0	48.3	117.1	69.4	107.8	114.6	76.8	33.3	104.5	41.0	76.0	117.0	116.2	144.0	62.7	134.3	102.0	107.6	176.6	80.2	78.4	35.0	139.6	76.7	37.0	34.0	60.3	125.6	56.1	79.3	97.9	129.5	103.8	89.2	71.2	127.9	39.2	114.7	78.8	73.0	131.2	210.0	98.3	34.7	63.3	96.8	83.9	149.8	56.9	57.3	88.9	103.9	39.1	64.0	106.2	92.9	180.8	176.2	59.2	137.3	158.6	66.5	64.9	105.9	4.6	4.2	4.6	6.1	6.2	5.9	6.5	4.5	6.9	6.1	6.2	5.4	5.8	0.7	8.6	6.2	3.9	5.6	3.1	15.9	19.5	30.8	24.3	21.4	18.0	21.0	17.4	22.9	17.5	20.2	24.6	13.4	25.6	23.6	32.3	17.4	8.5	11.0	17.9	16.5	19.3	11.6	12.3	65.2	12.8	18.8	9.2	37.5	19.4	11.2	13.3	9.8	12.2	119.7	19.7	21.0	16.5	12.1	32.6	61.9	7.8	15.0	27.8	29.0	18.8	37.9	55.5	11.7	8.1	18.7	13.5	63.1	16.9	16.2	17.6	5.6	50.7	19.6	19.6	7.2	30.9	16.5	16.2	16.5	32.6	51.7	13.7	15.2	29.0	26.4	14.2	9.1	9.3	30.7	25.6	19.7	18.0	21.4	107.4	59.3	24.3	11.6	11.5	16.1	83.3	19.8	9.7
CKLF	"C32, CKLF1, CKLF3, CKLF4, HSPC224, UCK-1"	ENSG00000217555	"Chemokine like factor"	Q9UBR5	16	66552563-66566251	"Predicted membrane proteins, Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 345.1;Spermatocytes: 300.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1384.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA062779			Approved	Vesicles	"Secreted to blood"	NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA062779: AB_2684867"	"unprognostic (1.64e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.97e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (2.72e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.79e-2)"	"unprognostic (8.05e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.06e-9)"	"unprognostic (2.36e-1)"	"unprognostic (2.65e-1)"	"prognostic favorable (2.22e-4)"	"unprognostic (1.07e-1)"	36.5	31.1	26.3	54.8	26.2	68.2	36.0	27.4	29.8	27.7	25.9	42.1	31.8	23.8	27.4	19.2	31.1	40.3	16.5	25.7	28.8	21.0	29.6	36.2	61.5	28.1	27.6	25.6	17.9	58.0	19.7	29.7	28.9	15.5	42.5	9.7	19.7	18.4	14.8	16.9	38.7	33.5	27.9	67.0	25.6	56.8	26.4	90.0	23.7	20.1	51.2	46.1	20.0	29.6	194.6	169.2	34.7	101.5	92.7	76.1	25.5	95.2	72.4	101.7	150.9	158.8	231.4	75.8	116.6	81.8	106.4	102.5	70.5	57.2	142.1	94.2	35.3	55.5	145.0	197.3	56.0	175.7	144.1	52.0	45.3	126.9	44.9	122.1	122.8	229.4	90.8	212.8	129.2	64.8	169.9	172.1	11.5	114.0	273.1	287.5	184.2	215.6	343.2	106.3	48.8	58.8	290.5	19.3	93.0	23.3	55.5	116.5	76.6	146.5	131.8	51.0	113.5	100.3	224.0	393.0	123.5	151.5	121.1	807.1	380.9	773.3	187.6	203.9	238.9	100.6	174.8	186.6	317.6	97.7	92.7	126.4	1384.5	187.6	199.2	161.6	236.0	401.2	26.3	26.2	27.4	29.8	25.7	28.8	28.1	27.6	28.9	27.9	26.4	29.6	65.7	19.2	49.0	0.0	68.7	27.3	24.7	84.2	12.0	8.4	80.8	94.0	1.8	87.2	50.8	57.0	0.0	54.8	109.7	57.1	17.6	141.4	67.7	34.8	21.5	52.4	33.0	63.5	0.0	130.0	117.7	38.6	21.4	17.5	345.1	17.7	67.5	38.4	247.4	1.7	0.0	73.6	61.1	138.2	238.4	31.4	49.4	244.2	40.9	0.0	157.8	28.1	188.4	0.0	0.0	224.2	51.3	30.1	94.6	10.0	95.9	83.4	79.3	9.0	32.9	24.5	38.1	300.0	77.1	30.8	23.0	17.4	192.6	23.9	79.0	25.8
CKS1B	"CKS1, ckshs1"	ENSG00000173207	"CDC28 protein kinase regulatory subunit 1B"	P61024	1	154974653-154979251	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 651.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA003424, HPA030762"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	Yes			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Mitochondria, Cytosol"	"Nucleoplasm, Vesicles"	"HPA003424: AB_2666948, HPA030762: AB_10670044"	"unprognostic (1.06e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (7.89e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.59e-2)"	"prognostic unfavorable (2.94e-5)"	"unprognostic (2.01e-3)"	"prognostic unfavorable (3.12e-5)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (6.03e-7)"	"unprognostic (3.12e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (4.87e-4)"	"unprognostic (1.37e-1)"	59.0	31.9	15.0	33.6	15.8	117.7	67.8	16.4	19.8	44.3	15.0	49.4	40.8	35.0	36.8	61.6	40.9	22.2	35.5	15.4	16.2	37.9	73.3	29.0	71.3	17.5	15.8	31.7	22.4	35.5	18.4	50.6	17.7	26.1	50.5	6.0	28.4	32.9	14.5	51.2	44.3	34.8	17.4	37.0	35.5	48.6	15.7	88.7	30.1	23.5	74.1	30.1	42.6	18.8	459.2	616.5	455.9	245.3	66.9	68.1	361.4	209.1	166.8	463.4	367.8	599.9	653.4	433.8	345.9	143.2	251.2	410.6	468.0	305.2	428.7	392.9	293.9	294.6	249.9	426.5	19.4	359.7	257.9	39.8	132.2	391.4	532.8	91.5	232.5	298.2	486.6	566.8	353.9	452.8	337.3	273.9	575.3	442.1	547.6	334.8	373.6	554.3	165.6	164.2	184.3	463.9	313.6	292.0	347.3	530.2	391.6	492.9	126.0	282.5	292.4	237.0	505.3	348.9	734.7	617.0	179.6	300.1	399.8	2.2	13.0	6.9	19.8	82.0	24.4	74.2	28.0	27.1	22.1	70.4	34.0	32.8	1.7	28.7	105.4	92.6	33.3	28.1	15.0	15.8	16.4	19.8	15.4	16.2	17.5	15.8	17.7	17.4	15.7	18.8	31.7	12.8	33.3	1.3	46.5	217.6	101.3	170.6	74.0	3.4	90.6	140.5	9.2	87.2	63.1	29.5	0.0	224.0	40.7	48.3	80.3	93.0	15.8	43.1	24.6	51.9	20.4	140.1	0.8	112.1	651.8	84.6	20.9	28.3	21.0	66.7	29.6	89.8	132.1	1.7	0.8	57.4	120.1	46.0	121.0	21.7	76.1	37.4	113.8	0.0	41.3	20.7	20.6	0.5	3.5	119.0	41.7	45.9	38.4	130.2	63.1	87.5	52.1	3.0	19.7	50.6	53.0	124.7	151.0	74.9	203.6	131.9	40.7	27.2	80.0	99.5
CKS2		ENSG00000123975	"CDC28 protein kinase regulatory subunit 2"	P33552	9	89311195-89316703	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 177.3;testis: 186.3"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 474.6;Spermatocytes: 692.7;Spermatogonia: 503.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 187.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003424, HPA030762"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Mitochondria, Cytosol"	"Nucleoplasm, Vesicles"	"HPA003424: AB_2666948, HPA030762: AB_10670044"	"unprognostic (8.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (2.51e-6)"	"unprognostic (3.57e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (6.85e-4)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (2.13e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.84e-1)"	13.6	82.9	9.6	38.5	10.0	177.3	20.1	11.9	26.9	10.1	11.8	44.1	43.3	13.0	8.8	53.2	12.1	18.7	10.3	12.7	10.3	35.6	31.2	24.0	102.8	10.5	10.1	9.4	4.2	19.8	4.8	44.3	11.0	15.0	41.0	27.9	10.8	17.8	9.4	19.9	33.1	17.6	10.6	32.6	20.4	186.3	10.8	121.1	12.8	4.8	84.7	26.5	19.9	11.3	685.9	570.1	342.6	230.6	98.7	89.1	249.5	396.1	211.4	428.1	340.0	236.1	328.6	504.9	228.4	149.1	761.4	466.5	415.5	305.1	488.2	398.1	335.5	257.5	378.9	637.5	42.4	531.7	281.2	33.0	69.2	307.2	269.1	162.9	403.2	409.1	313.2	430.6	556.0	509.1	420.7	928.3	501.6	795.5	521.5	358.4	376.4	303.7	342.8	153.5	288.4	171.7	328.7	314.9	324.5	318.4	379.7	304.2	231.4	184.1	350.3	449.6	588.2	345.9	759.2	415.3	271.3	303.1	268.5	40.8	19.5	44.1	22.6	26.5	25.3	61.3	30.4	21.9	22.5	44.7	16.3	21.8	14.5	40.9	14.8	187.9	62.7	23.6	9.6	10.0	11.9	26.9	12.7	10.3	10.5	10.1	11.0	10.6	10.8	11.3	138.6	38.5	103.9	0.3	175.7	280.2	92.1	126.1	259.0	4.1	107.2	169.0	61.3	5.7	49.9	14.7	0.0	231.1	201.1	79.4	23.5	20.1	37.3	149.7	66.4	66.1	122.3	266.9	1.2	11.2	379.4	63.1	74.9	250.2	145.0	144.7	29.3	25.0	184.6	0.0	1.9	164.9	111.9	40.5	474.6	77.0	25.7	164.3	140.5	1.9	31.0	26.1	28.8	1.0	1.1	31.1	67.1	16.6	89.3	72.1	37.6	209.7	32.8	7.3	46.0	75.2	206.5	692.7	503.6	197.5	299.1	199.5	156.0	70.3	162.7	102.1
CLINT1	"CLINT, ENTH, EPNR, KIAA0171"	ENSG00000113282	"Clathrin interactor 1"	Q14677	5	157785743-157859145	"Plasma proteins, Predicted intracellular proteins, Transporters"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"basophil: 749.5"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 749.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043280, HPA056947"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA		540000	"Cluster 46: Basophils - DNA binding"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles	Nucleoplasm	"HPA043280: AB_10793944, HPA056947: AB_2683283"	"unprognostic (1.92e-2)"	"unprognostic (6.93e-2)"	"prognostic favorable (2.95e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.19e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.88e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (3.56e-1)"	28.6	34.4	10.3	42.8	11.9	101.1	31.4	10.6	14.8	36.4	17.7	53.9	68.3	26.4	54.2	72.0	37.8	61.4	34.2	11.8	12.7	70.4	89.5	36.3	49.4	11.8	11.9	26.9	49.3	113.2	17.8	47.1	11.4	29.5	53.4	16.0	50.8	42.4	53.1	39.7	55.7	31.9	11.0	31.0	69.2	20.3	12.4	50.7	56.0	41.0	73.8	64.5	38.8	11.4	65.6	91.7	64.3	59.8	86.3	71.0	91.6	89.7	87.5	83.4	115.9	128.7	100.0	121.3	100.3	82.6	112.0	95.8	87.1	100.4	120.7	57.9	70.4	80.6	80.4	65.2	85.5	112.9	105.6	52.5	75.6	94.7	105.6	53.6	80.0	69.6	70.6	66.1	69.9	56.7	88.7	60.5	67.8	63.6	93.9	78.8	96.9	103.0	84.8	115.4	56.6	62.1	64.5	111.7	87.4	81.2	76.4	78.0	83.7	74.6	56.3	69.5	89.4	76.1	77.9	154.4	61.0	126.2	67.5	749.5	46.5	179.7	43.6	49.2	75.2	47.5	41.4	43.7	62.7	46.2	35.9	38.8	17.6	58.6	53.4	48.5	66.2	53.1	10.3	11.9	10.6	14.8	11.8	12.7	11.8	11.9	11.4	11.0	12.4	11.4	68.6	60.9	132.9	25.1	76.0	57.1	83.7	69.4	80.2	21.6	74.4	44.2	103.9	105.8	137.8	68.0	8.4	45.1	73.8	73.5	95.9	93.4	4.1	116.5	82.4	52.8	54.5	54.9	31.9	64.0	71.9	71.8	119.3	141.9	84.7	40.2	21.0	86.8	30.5	11.8	29.0	78.9	38.7	42.9	87.8	5.6	47.2	73.0	35.6	28.1	94.1	25.5	73.2	39.2	31.4	53.7	62.6	28.6	158.3	92.5	50.3	94.5	148.5	19.0	39.5	67.2	61.9	44.2	40.2	156.3	78.3	68.3	65.5	82.0	99.0	271.5
CLP1	"hClp1, HEAB"	ENSG00000172409	"Cleavage factor polyribonucleotide kinase subunit 1"	Q92989	11	57648188-57661865	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, tRNA processing"	"Kinase, Transferase"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 32.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057770	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA057770: AB_2683523"	"unprognostic (1.33e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.13e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.16e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.82e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.31e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.07e-1)"	8.9	7.4	3.1	10.1	3.6	26.1	9.2	3.9	4.4	7.1	4.4	9.0	8.7	7.7	7.6	9.2	7.3	5.9	6.5	3.3	3.3	8.0	10.1	7.3	10.8	3.3	3.1	6.8	7.4	6.8	4.4	9.2	3.7	5.6	8.6	3.2	6.7	7.1	8.2	9.0	8.4	8.9	3.4	10.0	8.1	8.4	3.3	11.2	7.2	9.3	13.1	8.6	5.0	3.7	21.2	22.2	21.0	21.6	22.3	14.4	19.7	21.4	23.2	30.1	25.8	21.4	18.4	35.1	24.3	18.9	24.2	25.9	29.2	34.5	34.2	24.3	18.0	19.4	13.5	21.7	17.7	28.5	22.2	17.4	24.0	26.9	18.6	11.9	27.7	17.4	30.4	11.9	24.9	14.8	21.8	32.9	31.8	24.3	22.2	21.7	32.1	37.5	16.5	15.0	11.1	22.3	19.1	17.2	28.7	21.7	32.7	23.2	20.0	16.0	21.7	27.7	15.9	18.6	26.4	39.3	17.3	16.3	17.3	31.2	19.0	20.0	15.9	16.4	18.9	15.6	14.1	16.4	19.0	14.3	16.4	14.9	21.7	13.6	15.9	10.8	16.2	12.3	3.1	3.6	3.9	4.4	3.3	3.3	3.3	3.1	3.7	3.4	3.3	3.7	6.1	9.6	5.1	1.0	8.5	19.4	10.7	13.4	16.5	4.3	6.0	6.2	2.4	7.2	10.5	0.0	6.2	16.5	12.7	4.8	9.8	12.9	32.5	6.7	5.7	7.3	2.4	12.2	1.9	11.7	13.9	7.4	3.1	7.1	8.2	4.9	4.2	3.5	11.0	5.0	1.8	3.2	8.2	6.0	6.9	4.1	5.6	5.8	8.8	1.0	15.0	3.3	7.2	2.5	1.4	9.8	4.7	8.6	5.9	4.7	6.2	10.1	6.4	3.1	6.6	10.4	6.9	9.4	12.0	9.3	14.5	13.5	9.7	6.5	4.6	7.8
CLSPN		ENSG00000092853	Claspin	Q9HAW4	1	35720218-35769978	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 11.3;lymphoid tissue: 7.9;retina: 6.8;testis: 5.7"	"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 101.0;Spermatocytes: 281.1;Spermatogonia: 263.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Region enriched"	"Detected in some"	6	"basal ganglia: 7.8"	"Low region specificity"	"Detected in many"			"HPA026305, HPA026312"			Enhanced	"Nucleoplasm,Golgi apparatus"		Yes	Yes			"Cluster 17: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA026305: AB_2671833, HPA026312: AB_2671837"	"unprognostic (4.75e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.54e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.18e-6)"	"unprognostic (3.99e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.63e-2)"	"unprognostic (8.71e-6)"	"unprognostic (3.23e-2)"	"unprognostic (7.61e-6)"	"prognostic favorable (4.92e-4)"	"unprognostic (5.12e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.29e-1)"	0.5	0.2	0.7	3.2	0.6	11.3	0.5	0.6	1.4	0.2	0.4	1.4	1.0	0.4	0.7	0.9	0.2	0.3	0.1	1.3	0.3	0.2	0.5	0.4	4.9	0.4	0.4	0.1	0.1	0.2	0.0	1.5	0.6	0.2	2.0	6.8	0.2	0.1	0.6	1.2	1.0	0.9	0.2	1.3	0.9	5.7	0.6	7.9	0.2	0.0	5.2	0.6	0.4	0.9	22.0	17.5	37.8	19.9	2.6	4.8	14.1	43.6	12.0	31.0	41.3	27.9	19.6	45.7	13.9	11.8	22.7	21.4	37.1	14.9	48.1	31.6	16.8	64.5	38.1	12.6	0.1	54.0	36.8	1.0	0.6	53.8	3.7	3.7	16.9	27.1	44.2	30.8	30.3	14.1	56.9	13.1	36.0	14.9	12.2	36.0	57.0	13.8	6.4	35.3	14.0	16.2	37.7	11.6	7.4	25.6	10.0	21.1	12.5	44.6	33.8	27.6	49.3	11.1	29.1	47.1	14.1	37.4	37.0	1.1	0.3	0.3	0.3	0.2	0.1	0.1	0.2	0.2	0.2	0.3	0.1	0.2	1.0	0.5	0.2	0.2	0.3	0.3	0.7	0.6	0.6	1.4	1.3	0.3	0.4	0.4	0.6	0.2	0.6	0.9	2.6	0.0	0.5	0.3	6.5	5.6	5.7	4.4	1.2	9.4	2.9	3.8	1.4	2.8	2.7	0.0	12.5	19.7	4.6	12.8	0.0	1.6	7.9	1.0	3.6	3.6	1.2	55.6	1.6	0.6	41.1	5.2	4.6	3.3	1.3	12.0	2.2	0.4	16.9	1.7	1.5	9.4	2.0	3.0	8.2	6.1	2.5	5.8	3.6	0.0	9.1	9.4	4.1	0.0	0.6	1.4	9.5	0.4	32.5	1.8	0.4	0.2	0.0	101.0	6.6	5.3	8.7	281.1	263.3	5.8	2.0	10.4	7.2	1.2	12.0	3.9
CMC2	"C16orf61, DC13, MGC45036"	ENSG00000103121	"C-X9-C motif containing 2"	Q9NRP2	16	80966448-81020270	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 263.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA006871, CAB026396"	Approved		Supported	Mitochondria		NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB026396: , HPA006871: AB_1845581"	"unprognostic (2.43e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.01e-3)"	"unprognostic (2.48e-2)"	"unprognostic (6.36e-2)"	"unprognostic (9.20e-2)"	"unprognostic (3.84e-3)"	"unprognostic (3.48e-2)"	"unprognostic (4.57e-3)"	"prognostic favorable (2.64e-5)"	"unprognostic (1.08e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.68e-1)"	22.1	24.6	47.6	14.0	50.0	45.2	17.0	49.0	60.2	17.2	41.2	22.7	19.1	12.4	16.6	20.4	11.6	17.0	68.4	48.4	50.7	43.5	44.0	24.3	22.4	47.6	47.6	13.7	27.3	30.4	26.1	16.3	47.5	34.9	16.9	16.1	14.8	12.4	54.0	15.3	20.3	15.0	48.3	21.7	27.2	47.0	51.2	30.1	16.2	33.9	17.1	20.7	17.0	54.2	74.8	103.1	76.1	43.7	25.1	25.0	44.9	73.4	33.1	64.0	32.9	71.7	49.9	33.5	53.3	35.8	62.9	52.6	52.5	42.8	84.9	50.9	63.3	51.9	68.4	78.6	40.6	43.5	85.4	21.8	23.8	77.7	43.5	29.2	57.1	83.1	124.2	43.5	63.3	140.1	68.1	138.4	45.2	59.7	62.0	84.2	41.2	43.8	50.4	35.9	64.1	37.1	110.6	39.8	87.3	39.4	78.7	39.2	32.8	57.9	82.0	56.6	75.3	45.4	107.6	193.8	44.6	55.3	69.1	33.2	28.0	37.3	28.8	29.6	27.5	39.1	36.5	30.1	31.6	34.9	25.3	29.2	12.0	44.6	34.2	45.3	64.4	18.0	47.6	50.0	49.0	60.2	48.4	50.7	47.6	47.6	47.5	48.3	51.2	54.2	41.2	35.3	38.8	48.0	54.9	97.6	75.5	53.9	48.9	31.9	48.0	50.7	204.7	42.9	36.5	47.8	54.2	44.8	78.9	29.5	158.5	34.4	95.4	44.2	33.7	36.0	38.3	55.5	88.6	38.0	62.8	45.0	42.8	45.2	95.5	37.3	25.4	86.0	51.4	30.3	62.2	42.9	59.0	70.5	84.1	168.3	24.5	59.7	65.8	14.0	33.8	29.3	51.5	48.7	74.0	39.0	31.9	29.3	83.5	69.1	48.5	166.1	31.4	16.7	59.2	33.3	47.0	263.5	121.5	65.0	102.1	38.0	84.7	55.3	44.8	74.4
CMSS1	"C3orf26, MGC4308"	ENSG00000184220	"Cms1 ribosomal small subunit homolog"	Q9BQ75	3	99817837-100181732	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 215.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042820	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoli	"Nucleoplasm, Nuclear membrane, Mitochondria"	"HPA042820: AB_10795763"	"unprognostic (1.50e-1)"	"unprognostic (8.28e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (3.15e-6)"	"unprognostic (2.13e-2)"	"unprognostic (2.39e-3)"	"prognostic unfavorable (5.92e-10)"	"unprognostic (1.50e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.83e-2)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (3.10e-4)"	"unprognostic (2.18e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.25e-1)"	"unprognostic (4.04e-2)"	24.5	33.1	23.0	15.8	21.7	20.8	23.4	26.7	30.1	22.4	17.8	21.0	8.6	21.8	9.7	15.8	20.9	10.5	28.2	21.8	20.9	20.7	15.0	15.8	17.1	22.8	20.1	23.6	26.7	21.8	24.5	11.6	19.6	16.0	11.6	24.6	14.0	13.3	69.4	17.4	12.6	13.2	17.9	13.8	16.4	30.3	21.3	16.7	14.8	29.9	15.0	24.5	18.1	21.7	116.2	51.0	50.0	72.6	34.7	40.1	51.0	53.5	28.8	93.3	77.0	64.1	37.5	126.3	90.6	28.2	82.4	68.4	70.3	60.2	120.3	66.8	66.5	99.9	32.9	53.2	62.6	137.0	51.3	28.2	56.7	71.4	116.6	30.3	65.2	100.9	63.5	78.1	67.0	78.8	110.3	126.4	73.0	109.4	126.1	49.1	81.3	134.1	57.2	27.5	139.9	58.9	52.8	42.5	125.0	47.8	51.4	84.0	18.5	73.6	207.4	43.3	109.8	56.3	121.1	244.9	49.1	149.4	124.8	1.0	11.0	2.3	22.2	27.3	32.0	57.3	32.8	30.3	23.8	55.7	41.3	42.0	4.1	28.6	25.1	62.1	33.9	18.2	23.0	21.7	26.7	30.1	21.8	20.9	22.8	20.1	19.6	17.9	21.3	21.7	26.7	6.4	19.4	48.6	41.3	62.2	37.4	45.5	26.2	32.8	43.8	40.4	41.7	42.9	23.2	62.5	18.8	41.7	25.1	8.5	97.8	42.1	165.0	21.7	56.8	38.7	15.0	30.9	154.3	47.7	56.6	44.3	9.7	19.8	62.1	47.7	24.7	61.4	27.2	127.9	132.8	14.4	16.2	7.9	45.5	215.8	50.7	18.7	37.4	58.1	12.8	28.0	19.6	114.1	116.2	35.8	4.6	58.6	36.2	82.8	1.1	87.9	22.4	27.0	26.3	67.3	50.1	163.4	146.1	21.3	66.1	21.9	30.1	54.1	22.6	27.0
CNOT1	"AD-005, CDC39, KIAA1007, NOT1, NOT1H"	ENSG00000125107	"CCR4-NOT transcription complex subunit 1"	A5YKK6	16	58519951-58629885	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Developmental protein, Repressor"	"Autism spectrum disorder, Disease variant, Holoprosencephaly, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046577, HPA049664"	Approved		Supported	Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA046577: AB_2679706, HPA049664: AB_2680844"	"unprognostic (1.30e-2)"	"unprognostic (6.86e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.39e-2)"	"unprognostic (7.11e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.43e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.52e-1)"	29.8	35.2	8.4	46.9	10.7	45.6	36.3	17.4	11.5	34.7	33.5	60.1	55.0	31.8	27.6	73.1	38.9	28.3	26.3	8.6	9.4	39.8	36.0	33.3	58.1	11.5	10.5	39.2	41.1	59.7	21.2	35.1	11.3	31.2	57.3	32.4	38.8	30.6	52.4	43.1	52.3	33.7	8.9	42.9	42.1	108.2	10.6	76.4	42.4	44.1	69.5	49.1	38.6	15.2	128.8	148.2	110.0	88.1	52.1	66.2	127.6	99.6	85.8	111.4	82.0	167.6	75.3	194.0	47.4	75.8	65.5	122.3	177.9	101.0	149.2	72.5	98.8	150.4	121.8	193.7	70.8	235.8	162.4	64.0	67.5	129.7	151.5	66.9	87.7	107.2	181.0	55.3	76.4	52.0	182.6	61.2	114.4	84.9	127.2	229.0	189.5	122.7	62.4	180.0	90.9	58.6	336.0	113.5	56.0	100.5	67.9	121.3	100.9	81.3	80.0	62.2	88.7	124.7	138.2	390.3	85.5	99.4	76.9	18.3	12.1	13.4	13.8	15.6	18.2	14.7	12.9	14.0	14.6	13.8	12.1	12.6	18.6	15.4	22.5	7.3	15.4	11.5	8.4	10.7	17.4	11.5	8.6	9.4	11.5	10.5	11.3	8.9	10.6	15.2	44.4	16.0	42.9	33.0	57.8	47.4	32.6	42.9	25.6	28.2	33.9	27.9	23.8	37.1	45.2	23.9	29.2	33.7	86.3	64.5	9.8	29.8	107.7	57.6	48.0	31.3	36.1	45.0	31.7	47.0	29.9	30.7	35.2	78.2	32.2	45.9	23.9	42.3	35.7	40.4	35.6	54.2	24.4	51.5	39.5	38.6	24.8	46.4	19.6	42.2	50.0	20.0	34.0	42.3	54.9	42.5	34.9	32.4	59.8	43.6	60.1	22.9	51.6	24.3	32.9	38.7	30.4	136.6	64.3	56.0	47.0	37.9	52.1	27.9	64.5	61.2
CNOT4	"CLONE243, NOT4, NOT4H"	ENSG00000080802	"CCR4-NOT transcription complex subunit 4"	O95628	7	135361795-135510127	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Ubl conjugation pathway"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005737	Approved					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA005737: AB_1078544"	"unprognostic (9.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (2.82e-2)"	"unprognostic (4.18e-2)"	"prognostic favorable (1.61e-4)"	"unprognostic (9.08e-2)"	"unprognostic (1.00e-2)"	"prognostic favorable (7.67e-6)"	"unprognostic (1.01e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.23e-1)"	"unprognostic (9.33e-2)"	9.2	8.9	10.3	8.2	11.0	7.9	8.3	16.2	14.0	11.3	5.9	8.7	7.4	11.1	9.1	10.1	10.4	8.9	12.5	10.7	13.7	10.0	10.4	8.7	10.1	9.4	10.6	15.4	9.2	13.4	6.5	10.7	9.4	9.5	8.4	15.4	11.4	9.4	21.7	10.2	7.7	11.0	7.7	9.5	8.1	17.6	10.2	11.9	13.6	22.2	11.5	9.0	8.7	11.2	15.4	14.3	14.3	19.3	23.3	18.4	10.3	16.9	18.3	14.1	17.4	12.4	15.4	15.2	14.3	15.6	20.0	14.2	18.3	12.8	20.0	17.3	14.1	12.6	11.9	11.0	12.9	14.4	14.5	14.2	16.0	18.1	11.1	16.2	14.7	10.7	22.4	11.8	21.0	19.2	19.8	21.2	18.9	14.1	11.9	12.7	14.1	16.6	16.6	14.0	15.1	17.7	19.7	21.7	11.6	13.2	13.5	15.8	20.0	17.0	10.0	15.9	18.5	18.1	18.2	21.5	17.2	16.4	23.2	23.7	10.5	14.6	12.4	10.8	13.6	9.8	10.4	10.4	9.4	10.7	11.1	10.5	9.4	15.8	13.1	7.5	9.7	9.2	10.3	11.0	16.2	14.0	10.7	13.7	9.4	10.6	9.4	7.7	10.2	11.2	53.9	22.4	43.0	83.9	63.0	67.7	76.3	54.0	45.5	50.6	49.7	58.2	42.7	31.5	44.3	36.8	106.3	31.5	60.9	30.0	70.5	32.9	30.7	31.3	56.7	48.3	40.7	50.9	103.7	20.7	22.5	58.4	35.2	45.1	62.6	46.1	40.0	25.0	25.5	55.5	94.0	30.2	30.5	28.1	61.0	20.7	65.3	33.4	42.7	88.1	61.0	69.1	68.0	119.6	102.8	32.4	31.2	69.2	58.9	73.0	32.0	56.2	35.4	72.4	19.7	83.8	75.3	113.4	75.7	42.1	75.7	44.6	61.6	45.9	29.3	89.4
CNOT9	"CAF40, CT129, RCD1, RCD1+, RQCD1"	ENSG00000144580	"CCR4-NOT transcription complex subunit 9"	Q92600	2	218568580-218597080	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046622	Approved		Approved	"Cytoplasmic bodies"	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Cytoplasmic bodies"		"HPA046622: AB_10962694"	"unprognostic (7.70e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.58e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (8.41e-9)"	"unprognostic (8.08e-3)"	"unprognostic (1.91e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.02e-2)"	"unprognostic (6.89e-2)"	"prognostic unfavorable (4.69e-9)"	"unprognostic (1.87e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.67e-2)"	17.2	21.9	18.3	26.0	19.7	40.2	16.6	20.8	19.4	17.8	18.9	17.7	18.1	17.6	19.4	21.4	18.8	16.1	20.1	18.7	19.4	16.3	21.0	18.2	31.3	18.6	19.2	18.7	15.8	21.0	25.2	18.0	18.6	18.4	22.6	26.1	15.1	15.0	22.4	20.5	17.3	20.2	19.4	22.6	17.1	27.0	18.9	33.6	15.4	17.1	36.2	21.8	17.6	22.1	49.9	38.2	62.2	82.2	35.2	33.8	79.8	55.5	57.4	69.6	67.4	68.2	40.4	55.4	33.7	64.3	60.9	57.2	88.1	61.6	81.4	79.8	55.6	110.6	72.1	81.1	48.9	120.2	61.7	31.0	48.5	73.1	74.2	32.7	53.1	74.0	67.1	121.1	56.3	40.0	117.2	72.8	94.5	38.4	60.4	97.8	88.7	57.1	37.1	71.5	79.2	64.8	54.5	47.5	52.2	59.1	38.1	66.5	43.2	75.5	55.8	55.3	69.0	57.6	62.6	128.3	53.7	73.1	55.0	36.9	25.6	29.1	41.5	31.7	36.4	29.9	34.0	35.4	30.4	26.6	31.8	35.0	10.5	35.5	34.0	35.1	30.8	37.9	18.3	19.7	20.8	19.4	18.7	19.4	18.6	19.2	18.6	19.4	18.9	22.1	22.1	22.4	20.7	0.0	10.0	0.0	0.0	0.0	0.0	0.0	20.4	15.1	0.0	0.0	9.9	12.9	0.0	28.4	27.1	0.0	27.4	21.2	0.0	32.2	21.2	10.3	0.0	0.0	0.0	20.7	40.7	10.9	0.0	22.4	16.4	18.9	0.0	0.0	28.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	20.7	0.0	0.0	0.0	0.0	25.6	0.0	0.0	7.0	0.0	0.0	16.1	10.2	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	28.3	11.0	16.9	0.0	0.0
CNTROB	"LIP8, PP1221"	ENSG00000170037	"Centrobin, centriole duplication and spindle assembly protein"	Q8N137	17	7932101-7949920	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 44.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023319, HPA023320, HPA023321, HPA023325"	Approved		Supported	Centrosome,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Centrosome	Cytosol	"HPA023319: AB_1852886, HPA023320: AB_1852888, HPA023321: AB_1852890, HPA023325: AB_1852892"	"unprognostic (5.73e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.26e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (9.88e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.48e-2)"	"unprognostic (8.63e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.79e-1)"	"unprognostic (2.16e-2)"	18.2	14.6	17.1	13.5	17.7	32.2	17.3	17.9	20.7	26.6	16.2	24.0	10.7	38.0	18.1	20.0	20.1	12.8	15.1	17.8	19.0	18.6	18.1	28.7	15.2	17.8	18.0	20.8	16.8	19.8	18.0	12.0	17.7	19.5	18.9	17.9	16.4	12.5	12.6	26.2	17.2	25.5	16.3	19.0	16.7	65.5	18.7	29.2	19.6	9.8	17.7	18.7	19.5	19.0	51.1	31.0	48.7	25.5	19.1	26.7	15.0	43.9	40.5	59.8	44.0	26.5	18.0	50.2	22.4	38.5	26.9	41.2	36.8	29.9	64.9	50.6	27.4	33.6	58.6	21.5	28.6	31.9	52.8	24.2	21.1	42.0	41.7	28.5	36.6	53.0	24.6	25.9	40.8	15.9	49.5	29.6	10.4	18.5	25.6	51.9	32.6	20.2	26.5	16.1	16.2	29.4	34.3	17.8	14.8	25.2	24.6	20.0	33.2	32.8	27.6	45.2	61.0	38.7	27.1	35.1	28.4	39.6	47.2	6.4	1.8	0.7	1.8	2.5	1.7	1.4	1.4	2.4	1.3	0.9	0.9	1.6	0.2	2.5	1.1	5.3	2.0	2.1	17.1	17.7	17.9	20.7	17.8	19.0	17.8	18.0	17.7	16.3	18.7	19.0	4.2	6.4	19.6	6.5	4.2	7.9	7.5	5.2	4.6	6.6	6.7	6.5	3.4	7.2	6.9	12.9	8.4	4.4	7.4	5.9	1.9	5.8	3.1	5.8	18.0	5.4	3.0	14.1	3.8	6.9	4.7	6.4	6.6	5.4	18.4	10.9	5.7	3.5	6.5	3.3	5.5	7.0	2.0	6.7	9.1	4.8	5.3	9.2	3.6	5.6	1.9	6.4	6.2	4.5	4.3	6.6	3.1	7.9	7.5	5.5	4.4	3.5	5.7	6.2	0.0	5.8	5.4	44.4	8.1	9.0	8.7	2.5	5.7	5.5	8.4	4.5
COA1	"C7orf44, FLJ10803, MITRAC15"	ENSG00000106603	"Cytochrome c oxidase assembly factor 1 homolog"	Q9GZY4	7	43608456-43729717	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA011944	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA011944: AB_1848671"	"unprognostic (1.16e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.85e-3)"	"prognostic unfavorable (7.84e-5)"	"unprognostic (2.21e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.22e-2)"	"unprognostic (5.22e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.56e-2)"	"unprognostic (5.39e-2)"	17.1	17.1	20.8	17.2	21.2	23.8	16.0	22.0	25.9	7.7	22.3	12.7	12.9	9.4	14.3	17.0	10.5	12.3	59.2	20.6	21.9	28.3	16.6	13.6	31.5	20.8	20.9	6.9	28.4	25.7	6.4	12.9	21.4	8.5	16.3	23.5	16.4	8.4	74.5	5.6	11.8	10.4	21.0	15.5	17.2	10.9	21.1	27.2	16.5	78.2	35.2	16.3	8.2	21.5	35.4	93.4	75.6	75.2	21.8	24.4	50.7	47.5	82.7	64.5	66.7	71.9	78.8	67.0	79.7	29.9	135.8	50.4	88.9	74.7	81.1	60.4	81.3	83.5	48.8	67.3	35.9	65.7	35.6	20.2	47.1	47.0	69.1	69.0	59.8	79.3	144.1	56.4	52.7	48.6	97.2	164.2	47.9	73.4	66.8	58.2	69.5	125.0	80.3	39.2	46.5	83.0	48.6	89.1	32.5	108.7	66.9	43.6	44.9	31.7	69.2	31.5	69.7	133.7	117.8	122.9	90.4	82.4	86.4	2.0	23.6	21.3	18.7	27.7	13.4	31.8	17.1	18.9	27.6	33.0	23.4	30.2	32.8	30.3	24.1	24.4	18.7	23.3	20.8	21.2	22.0	25.9	20.6	21.9	20.8	20.9	21.4	21.0	21.1	21.5	30.0	28.9	38.8	52.9	52.1	13.0	65.3	41.2	38.1	46.1	39.9	43.6	59.0	30.0	34.4	35.0	45.9	33.7	42.9	14.0	117.4	55.3	7.3	39.0	27.8	33.8	27.6	84.4	76.1	42.9	47.9	27.6	29.0	28.6	26.0	40.9	20.7	26.7	58.6	33.7	88.1	22.3	54.9	38.0	19.6	9.6	29.5	32.0	37.4	70.3	45.5	37.3	57.7	100.5	71.7	41.0	15.9	19.5	51.3	59.4	39.8	124.7	30.9	56.3	13.1	35.0	27.4	97.4	85.7	48.9	16.8	17.9	47.1	40.4	26.9	55.2
COA7	"C1orf163, FLJ12439, RESA1, SELRC1"	ENSG00000162377	"Cytochrome c oxidase assembly factor 7 (putative)"	Q96BR5	1	52684449-52698347	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028154, HPA029926"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Mitochondria"		"HPA028154: AB_10600656, HPA029926: AB_10602173"	"unprognostic (1.88e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (8.55e-4)"	"unprognostic (2.30e-2)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (7.01e-5)"	"unprognostic (1.14e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.07e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.49e-1)"	"prognostic favorable (4.35e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.52e-1)"	6.8	4.8	5.7	5.4	5.5	3.9	7.3	5.2	6.5	4.6	2.5	7.9	7.7	5.5	4.2	6.3	4.6	3.5	5.5	5.3	5.0	9.6	12.1	3.9	4.0	4.7	4.5	3.7	10.7	5.2	2.5	5.2	4.8	3.6	7.5	4.3	3.3	3.6	16.0	6.5	5.6	5.9	3.9	3.9	5.1	3.2	5.1	2.7	7.1	20.4	4.5	5.5	3.5	5.7	26.0	14.5	13.0	21.1	20.7	17.9	28.6	19.1	15.9	23.4	19.5	18.2	9.0	59.4	12.7	11.4	29.6	19.5	31.9	27.1	30.4	18.4	31.9	49.9	22.5	20.9	25.5	49.7	16.4	19.8	23.5	26.6	33.0	10.3	16.3	16.6	46.5	10.0	17.9	17.3	17.0	25.3	57.7	27.7	40.8	32.9	44.6	43.2	20.7	25.9	29.2	15.4	27.9	35.0	36.3	18.3	20.5	33.4	18.2	18.3	24.0	25.5	26.7	21.2	57.0	27.2	8.5	35.4	15.2	1.6	2.9	0.4	1.1	4.3	1.5	1.8	1.2	1.1	3.0	0.7	1.0	1.1	0.6	1.1	2.2	1.1	0.7	1.6	5.7	5.5	5.2	6.5	5.3	5.0	4.7	4.5	4.8	3.9	5.1	5.7	6.0	6.4	12.4	0.7	4.5	11.5	31.2	7.1	9.6	8.8	6.1	5.2	13.2	10.0	7.1	3.7	4.2	17.1	1.7	11.4	27.4	11.9	0.5	3.2	12.3	8.8	2.4	5.5	1.6	13.3	17.0	7.8	5.1	3.4	0.0	8.0	3.6	13.7	13.7	16.8	2.1	7.0	6.1	4.7	3.5	0.8	7.5	7.0	1.8	1.9	8.7	6.8	4.1	3.5	1.5	11.0	7.0	7.5	9.9	19.3	5.0	20.1	2.6	10.2	6.6	11.4	14.0	4.6	13.0	9.7	12.9	16.6	4.2	10.5	10.5	17.8
COG4	"COD1, DKFZP586E1519"	ENSG00000103051	"Component of oligomeric golgi complex 4"		16	70480568-70523560	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040924, HPA042539"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	Vesicles	"HPA040924: AB_2677203, HPA042539: AB_2678044"	"unprognostic (1.30e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.24e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (1.64e-5)"	"unprognostic (3.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.79e-1)"	17.8	22.0	25.3	12.8	27.2	14.2	15.7	27.8	27.0	20.2	29.0	20.3	10.5	17.4	11.1	30.1	19.7	12.8	25.7	25.3	26.5	16.9	16.9	18.3	15.4	26.9	26.3	18.8	10.6	27.9	19.0	19.8	26.6	14.4	16.6	14.5	17.1	16.5	67.7	23.8	16.3	19.2	25.9	17.9	17.4	19.2	27.7	22.3	15.9	49.4	17.7	18.5	20.7	28.3	37.3	59.9	47.1	31.3	62.6	43.7	53.0	41.0	53.7	51.0	43.9	48.3	66.7	25.0	57.7	64.9	35.5	53.4	60.8	65.3	70.9	21.5	36.7	23.1	59.8	47.5	36.7	15.3	15.0	51.9	41.9	66.1	40.6	59.7	51.7	31.6	55.9	18.1	57.6	75.9	25.1	23.4	45.2	50.4	30.9	46.8	31.2	57.4	42.3	31.0	43.9	45.5	80.7	30.5	24.3	48.0	77.9	26.4	49.7	46.3	29.1	35.3	29.8	19.1	26.2	78.0	50.7	15.8	46.1	20.6	26.4	23.8	19.7	28.8	14.4	11.8	19.3	17.9	32.8	14.6	16.9	15.7	13.8	14.4	34.4	15.2	24.4	25.1	25.3	27.2	27.8	27.0	25.3	26.5	26.9	26.3	26.6	25.9	27.7	28.3	13.6	16.0	16.0	21.9	11.0	9.1	12.1	22.6	11.4	24.5	9.2	8.0	23.3	2.8	21.1	3.7	14.6	47.7	13.1	20.8	9.8	23.4	3.1	11.9	13.0	16.8	12.6	12.6	10.9	16.0	26.8	16.5	18.8	13.4	8.8	28.7	16.8	17.8	24.7	8.4	13.0	18.0	24.4	14.1	8.9	6.7	14.6	11.1	8.8	7.5	14.7	29.3	12.3	19.6	19.1	17.6	21.0	19.2	12.3	6.3	21.7	13.8	18.5	29.9	32.9	14.0	18.6	37.5	25.7	13.1	10.7	39.0	12.9	37.3	19.4	8.9
COG8	"DOR1, FLJ22315"	ENSG00000213380	"Component of oligomeric golgi complex 8"	Q96MW5	16	69320140-69339583	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041406, HPA049429"	Approved		Supported	"Golgi apparatus"		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA041406: AB_2677459, HPA049429: AB_2680763"	"unprognostic (4.02e-2)"	"unprognostic (6.46e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (3.12e-5)"	"unprognostic (3.10e-1)"	"prognostic favorable (2.47e-7)"	"unprognostic (4.73e-2)"	"unprognostic (2.58e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.35e-2)"	9.9	14.5	19.7	8.5	23.2	6.5	11.1	23.2	24.4	9.8	24.0	10.5	10.5	10.8	14.1	9.9	13.9	7.7	11.2	19.4	19.7	13.4	15.0	10.2	11.3	21.1	20.6	13.7	14.2	19.9	12.0	7.9	21.2	10.3	9.9	7.7	13.8	10.6	18.1	16.3	10.0	10.5	20.3	10.9	11.2	20.3	20.9	12.2	13.0	15.8	11.3	9.4	7.7	28.1	13.2	28.5	18.2	26.7	30.1	21.0	19.4	16.9	18.6	23.0	18.7	26.2	19.8	23.7	18.1	23.0	12.4	24.9	29.5	24.3	19.8	11.9	26.4	17.0	19.9	35.0	21.3	21.1	14.8	25.2	23.5	25.2	14.7	22.2	22.6	20.4	35.4	5.7	16.7	38.3	19.4	31.3	32.2	17.8	20.5	35.6	12.6	33.3	23.6	11.1	26.0	31.1	37.5	15.0	17.5	18.4	35.4	17.8	20.5	16.8	14.4	15.8	14.1	31.3	27.1	36.8	17.3	18.8	19.2	41.4	19.6	20.6	17.8	19.0	19.6	13.3	19.2	18.2	18.6	19.0	17.4	16.7	15.6	22.2	17.6	10.7	19.6	16.8	19.7	23.2	23.2	24.4	19.4	19.7	21.1	20.6	21.2	20.3	20.9	28.1	3.2	9.6	9.7	1.3	9.4	4.2	10.4	5.8	5.2	18.9	7.3	6.7	0.0	24.3	10.6	11.0	18.8	15.0	5.0	12.6	1.9	7.6	17.4	6.1	6.4	7.2	12.7	5.5	1.9	8.0	9.1	7.4	7.1	4.6	7.0	9.0	15.7	28.5	9.5	11.8	2.0	11.7	20.3	7.9	3.3	4.8	12.8	3.1	5.4	1.0	8.4	12.1	10.3	2.0	2.6	5.4	9.5	15.8	9.0	9.6	19.3	15.3	10.2	19.9	13.1	15.5	6.2	9.9	13.6	7.2	4.1	9.2	8.3	5.4	16.7	7.2
COIL	"CLN80, p80-coilin"	ENSG00000121058	Coilin	P38432	17	56938199-56961050	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 98.5"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 249.2;Late spermatids: 591.1;Spermatocytes: 142.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017524, HPA027885, HPA057480, CAB069400"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	Nucleoli	"CAB017524: AB_1121780, CAB069400: , HPA027885: AB_2672421, HPA057480: "	"unprognostic (1.01e-2)"	"unprognostic (3.05e-1)"	"prognostic favorable (1.77e-4)"	"unprognostic (1.90e-2)"	"unprognostic (3.19e-2)"	"unprognostic (4.13e-3)"	"prognostic unfavorable (1.28e-4)"	"unprognostic (1.64e-1)"	"unprognostic (4.07e-3)"	"unprognostic (3.00e-3)"	"unprognostic (2.50e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.92e-1)"	"unprognostic (3.36e-2)"	"unprognostic (7.71e-2)"	7.7	7.2	6.6	8.8	6.8	19.9	12.2	9.7	8.9	9.2	7.3	9.2	10.2	10.4	11.6	9.7	9.8	7.1	8.0	6.6	7.0	8.7	13.0	7.6	12.8	6.7	6.7	11.9	8.7	12.3	6.2	13.0	7.4	9.3	10.6	12.6	9.8	7.7	11.5	9.8	10.0	8.5	6.8	10.3	9.2	98.5	6.6	13.2	12.1	9.1	13.5	9.3	8.7	8.1	25.0	18.6	37.4	14.5	12.5	14.9	25.8	17.5	16.4	26.1	27.7	25.6	21.0	29.9	34.6	14.0	19.5	14.1	25.6	20.2	37.1	36.1	32.3	48.7	17.4	29.2	13.5	41.5	28.5	13.9	24.7	19.7	21.1	15.5	22.6	17.4	42.9	24.3	24.8	31.6	32.9	26.3	22.0	27.4	18.4	15.5	45.9	23.9	18.1	24.7	31.6	31.2	11.7	11.5	30.1	21.5	41.8	40.0	16.0	30.2	22.7	14.8	23.0	35.6	47.7	34.5	15.8	22.7	18.8	22.3	13.3	17.5	15.5	12.6	17.5	27.6	17.0	16.6	13.5	25.0	19.5	18.9	8.1	16.0	17.2	16.4	18.6	10.1	6.6	6.8	9.7	8.9	6.6	7.0	6.7	6.7	7.4	6.8	6.6	8.1	21.3	12.8	21.0	6.8	26.5	18.7	39.5	34.0	21.1	35.9	21.6	22.5	14.1	22.8	28.3	14.7	37.5	42.2	26.2	12.5	13.7	30.1	249.2	22.7	23.1	26.6	23.9	17.5	8.8	27.7	32.3	23.5	18.3	19.9	22.2	20.3	22.5	23.9	22.7	25.2	10.9	16.5	16.2	16.5	10.4	591.1	42.3	12.3	3.6	10.3	19.6	28.5	34.0	9.5	13.3	23.5	17.3	30.5	15.1	32.2	16.6	23.0	22.0	52.4	13.1	24.9	21.9	142.2	46.8	20.3	22.7	29.1	23.3	17.1	20.8	29.0
COMMD4	FLJ20452	ENSG00000140365	"COMM domain containing 4"	Q9H0A8	15	75336020-75343224	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039935, HPA066957"	Uncertain		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Vesicles, Plasma membrane"	"HPA039935: , HPA066957: AB_2685754"	"unprognostic (7.77e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.57e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.60e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.07e-2)"	36.2	72.3	38.8	33.5	39.4	52.9	36.8	40.5	50.4	31.1	43.7	41.6	48.3	30.3	30.2	39.9	34.6	37.3	38.9	36.9	39.7	54.6	51.0	34.6	44.7	39.5	38.1	24.4	33.8	48.9	33.9	31.2	38.6	34.2	33.8	13.4	43.4	34.0	30.3	35.0	42.2	24.7	40.8	41.3	42.5	81.2	42.4	53.3	38.8	15.3	36.7	33.6	31.8	42.0	138.2	222.5	97.5	124.8	42.3	64.9	98.5	98.8	106.2	191.2	196.6	133.8	184.0	88.8	100.2	79.5	168.8	144.8	175.2	116.5	82.7	70.1	242.4	104.8	169.8	151.0	76.4	79.4	111.0	74.3	63.6	116.2	21.9	48.4	96.5	103.6	108.2	128.1	147.1	179.7	71.0	117.4	140.9	75.2	127.9	127.5	137.4	127.8	98.6	127.8	79.2	114.8	131.2	105.1	169.8	63.8	164.7	160.9	78.6	135.3	119.2	125.8	184.8	93.4	218.7	101.4	138.9	181.9	125.4	27.0	44.1	40.7	84.7	61.8	52.8	47.5	51.7	63.2	50.0	46.4	31.9	47.4	9.5	76.8	55.6	70.6	87.6	39.4	38.8	39.4	40.5	50.4	36.9	39.7	39.5	38.1	38.6	40.8	42.4	42.0	43.7	28.9	52.4	15.0	26.2	27.0	44.8	58.5	28.5	40.7	44.3	50.3	18.7	38.6	46.2	35.0	31.3	80.9	34.8	59.6	58.7	72.6	12.2	37.1	44.9	42.7	30.5	60.8	9.0	78.7	107.0	43.4	33.1	45.7	41.8	91.1	37.5	41.9	127.5	16.8	8.8	72.8	44.7	35.8	27.0	17.6	49.0	41.3	37.4	11.2	28.5	78.1	53.5	7.1	17.6	72.4	61.7	34.3	43.0	26.6	71.2	98.1	39.8	49.4	46.0	36.1	59.3	152.9	63.5	34.3	30.7	50.8	32.2	53.4	58.7	48.7
COPG2	2-COP	ENSG00000158623	"COPI coat complex subunit gamma 2"	Q9UBF2	7	130506238-130668748	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 50.6;Oligodendrocytes: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045712	Approved					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA045712: AB_2679428"	"unprognostic (9.48e-2)"	"unprognostic (3.31e-2)"	"unprognostic (7.98e-2)"	"unprognostic (9.40e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.50e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.23e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.23e-1)"	12.1	21.3	17.0	9.3	16.2	12.4	20.3	3.2	14.1	13.2	2.6	12.2	9.3	16.5	17.0	14.6	19.1	12.7	15.8	15.5	30.9	12.3	9.1	9.8	9.3	9.7	16.2	39.3	9.6	25.8	13.9	15.8	11.5	11.9	13.8	28.1	9.5	14.3	17.3	20.8	8.7	13.9	6.3	9.8	9.7	24.5	33.5	15.6	18.3	14.4	15.2	12.7	12.1	8.8	44.2	24.8	44.7	22.5	19.3	34.2	11.6	20.2	30.5	33.2	32.2	15.4	23.8	30.4	16.6	26.3	36.7	21.9	15.0	38.0	43.3	33.2	31.1	31.0	12.1	22.2	30.6	40.9	27.6	27.5	18.9	27.0	41.1	32.2	31.7	30.5	50.3	8.8	42.6	44.2	39.6	31.9	56.4	29.2	19.9	37.9	58.6	18.2	40.2	57.9	34.3	49.4	42.1	38.9	32.7	37.3	25.3	13.2	28.1	29.8	15.4	25.0	30.2	19.4	25.4	35.2	33.2	33.3	26.3	1.2	1.5	2.6	0.7	1.4	0.6	1.6	0.7	0.5	1.8	0.8	0.7	0.6	0.4	0.8	2.0	0.7	0.7	0.7	17.0	16.2	3.2	14.1	15.5	30.9	9.7	16.2	11.5	6.3	33.5	8.8	4.9	0.0	2.0	23.2	6.5	9.1	7.7	9.4	7.4	13.8	8.8	6.3	5.1	5.7	8.3	14.7	14.6	18.5	4.5	4.1	11.7	9.5	3.5	7.6	6.4	5.5	2.4	5.0	42.9	24.1	13.4	6.5	7.1	4.8	1.3	11.6	11.7	5.0	9.0	5.0	50.6	7.0	6.1	10.7	7.5	2.3	5.9	7.8	8.8	22.5	9.9	9.3	2.1	39.7	52.0	9.2	2.2	6.8	6.8	3.5	2.8	8.1	9.2	13.1	13.1	9.9	7.5	18.6	26.5	11.0	10.1	22.4	6.0	9.6	7.1	6.8
COPS3	"CSN3, SGN3"	ENSG00000141030	"COP9 signalosome subunit 3"	Q9UNS2	17	17246616-17281273	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 262.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021997, HPA050557"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		38000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA021997: AB_1847152, HPA050557: AB_2681176"	"unprognostic (3.35e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.84e-2)"	"unprognostic (6.29e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.91e-3)"	"unprognostic (2.11e-2)"	"unprognostic (6.37e-3)"	"prognostic unfavorable (1.56e-4)"	"prognostic unfavorable (8.65e-5)"	"unprognostic (2.04e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.03e-3)"	30.8	29.1	27.6	29.5	29.0	110.1	28.3	29.9	39.9	27.2	24.7	34.5	24.7	26.3	23.8	41.6	24.0	17.2	59.0	29.8	31.8	23.5	29.1	23.0	37.3	30.8	29.7	23.5	44.3	36.4	39.9	29.0	30.7	25.0	29.8	25.4	30.1	25.8	156.7	33.9	24.9	29.1	29.3	26.7	32.5	76.3	28.4	51.2	24.0	100.7	40.9	29.7	29.0	31.1	141.8	128.8	96.0	86.3	46.2	63.8	58.2	102.6	62.6	150.6	119.3	209.7	50.9	196.9	82.5	83.4	67.5	100.8	138.9	104.2	175.3	76.0	182.1	137.6	90.8	87.0	76.4	120.3	146.1	58.0	77.1	104.3	102.1	43.1	90.0	108.2	114.3	70.4	97.0	137.8	217.4	142.9	90.9	156.3	80.4	163.9	178.9	102.5	61.0	55.2	79.7	63.9	94.0	44.9	83.8	286.9	64.6	76.1	63.2	89.7	101.0	164.7	184.5	54.9	74.5	106.0	81.8	113.2	93.4	37.4	43.0	44.0	35.4	51.3	40.7	35.4	40.0	41.3	60.8	39.1	40.4	37.9	55.6	46.0	52.4	30.8	47.7	56.9	27.6	29.0	29.9	39.9	29.8	31.8	30.8	29.7	30.7	29.3	28.4	31.1	32.0	32.1	19.1	11.1	52.7	54.2	43.3	69.0	33.0	23.2	31.1	27.8	50.5	34.3	38.6	14.7	14.6	95.1	52.2	17.1	33.2	52.8	136.1	27.4	30.1	33.3	37.6	117.0	13.6	51.2	84.5	37.5	21.4	33.5	40.0	26.7	22.9	23.1	67.0	25.2	16.3	37.3	44.7	36.4	52.3	79.2	39.7	43.6	35.6	11.2	60.0	41.3	53.5	13.6	16.0	33.4	18.6	38.0	65.6	43.0	27.4	36.6	25.5	38.0	19.7	52.5	49.9	262.3	109.8	50.1	47.6	104.4	51.3	43.9	43.3	36.5
COPS5	"CSN5, JAB1, MOV-34, SGN5"	ENSG00000121022	"COP9 signalosome subunit 5"	Q92905	8	67043079-67083783	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 347.5;Late spermatids: 427.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004242, HPA004845, HPA051531"	Supported		Enhanced	Nucleoplasm		NA	NA		37000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB004242: AB_627835, HPA004845: AB_1078557, HPA051531: AB_2681522"	"unprognostic (1.90e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.85e-3)"	"unprognostic (2.53e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.48e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.88e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.18e-2)"	43.5	43.8	52.1	33.3	54.2	39.4	45.2	58.3	62.6	34.2	52.0	45.5	45.6	34.0	43.6	42.2	35.6	31.6	100.0	53.2	57.1	56.3	71.0	33.1	40.9	55.1	53.3	33.4	43.0	58.5	31.1	50.9	56.8	36.4	51.6	39.7	42.3	36.6	125.2	36.0	47.8	47.6	57.4	33.4	37.6	58.7	56.2	52.6	37.8	134.9	48.7	42.2	30.0	59.7	104.0	97.8	79.6	74.4	83.1	88.3	63.3	89.0	74.0	121.2	108.9	62.6	125.4	96.5	39.9	93.6	86.8	84.1	109.2	98.9	134.0	92.4	92.1	135.9	95.2	87.3	82.2	86.3	79.1	81.0	126.2	99.1	132.6	95.2	121.2	100.3	163.0	64.6	111.8	96.5	154.3	157.6	107.1	217.2	108.6	97.2	56.7	76.4	131.3	91.6	48.6	66.7	51.0	98.4	91.6	71.2	160.9	90.8	89.9	60.1	74.9	74.7	70.3	81.4	108.5	127.7	89.1	97.6	84.1	65.8	52.0	64.5	35.8	55.7	37.2	36.8	34.6	39.9	63.9	33.7	36.1	32.4	38.3	51.9	56.6	34.0	53.2	43.8	52.1	54.2	58.3	62.6	53.2	57.1	55.1	53.3	56.8	57.4	56.2	59.7	55.0	22.4	26.0	19.2	40.6	49.3	45.1	102.6	28.5	36.4	43.7	51.8	119.9	58.6	61.2	31.3	33.3	143.8	58.0	38.1	88.0	73.4	347.5	44.6	38.2	46.4	34.2	69.2	21.5	60.0	101.4	45.2	25.5	37.1	36.1	50.9	34.2	35.5	79.3	25.2	21.5	41.5	59.0	31.7	28.5	427.2	43.2	40.2	28.4	10.3	59.9	62.0	56.7	18.6	32.4	50.1	48.6	51.1	46.6	54.0	87.8	81.9	46.1	53.0	32.9	49.1	87.8	123.4	49.6	42.9	47.5	127.8	42.3	72.5	55.4	50.6
COPS7B	CSN7B	ENSG00000144524	"COP9 signalosome subunit 7B"	Q9H9Q2	2	231781671-231809254	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034675, HPA034676"	Uncertain		Supported	Nucleoplasm		NA	NA		44000	"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA034675: AB_10696360, HPA034676: AB_2674274"	"unprognostic (3.21e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.25e-3)"	"unprognostic (3.59e-3)"	"unprognostic (3.50e-1)"	"unprognostic (4.77e-2)"	"prognostic unfavorable (8.37e-6)"	"unprognostic (1.19e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.50e-6)"	"unprognostic (2.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.55e-3)"	10.8	15.6	16.5	11.3	17.6	11.7	11.3	16.3	26.3	16.7	14.3	15.1	6.9	14.2	10.6	12.7	15.1	8.1	10.8	17.0	16.4	11.9	14.6	11.6	17.8	16.0	17.4	13.8	11.5	19.8	15.5	15.0	17.3	14.9	15.1	9.4	14.1	14.9	13.6	17.0	13.3	16.7	16.2	17.5	15.9	20.5	16.8	22.9	13.9	12.8	22.3	13.9	13.8	18.4	24.8	20.9	31.7	33.5	22.1	27.8	33.9	19.8	18.6	31.5	37.3	35.9	26.6	23.4	21.2	24.3	38.1	19.5	45.6	36.1	46.8	40.3	42.3	46.2	17.9	51.4	23.8	49.1	25.0	19.4	36.2	35.2	25.8	28.6	36.4	58.2	51.7	18.6	30.2	31.8	49.7	40.0	48.5	24.8	22.0	54.6	38.8	25.6	24.2	21.1	34.2	28.5	18.6	15.8	35.4	44.9	20.1	39.6	23.6	22.9	22.1	26.8	27.7	29.9	26.9	65.0	22.0	34.2	23.4	12.6	8.4	4.6	12.3	9.9	12.1	13.3	9.6	11.4	12.5	13.3	13.1	9.4	1.8	15.8	13.7	9.8	10.5	11.5	16.5	17.6	16.3	26.3	17.0	16.4	16.0	17.4	17.3	16.2	16.8	18.4	10.6	16.0	11.3	28.1	17.1	12.4	12.2	24.0	18.2	13.8	16.7	16.5	6.7	10.0	15.2	16.5	10.4	24.2	19.7	8.6	13.7	14.1	54.6	10.7	10.1	11.1	23.3	7.6	14.8	9.3	20.5	12.3	9.7	9.0	5.7	18.1	14.6	7.9	15.1	13.5	14.3	15.7	18.3	12.7	9.7	14.9	18.0	10.1	12.4	14.0	18.6	9.5	35.0	18.1	17.8	13.7	9.5	20.3	13.5	12.5	10.4	9.9	11.4	18.3	13.1	8.3	13.5	43.3	61.4	16.5	8.1	17.8	16.5	21.1	14.3	12.1
COQ3	bA9819.1	ENSG00000132423	"Coenzyme Q3, methyltransferase"	Q9NZJ6	6	99369401-99394195	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubiquinone biosynthesis"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 51.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 42.8;Distal tubular cells: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031273, HPA031274"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Mitochondria	"HPA031273: AB_10611107, HPA031274: AB_10602176"	"unprognostic (1.81e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.48e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.40e-1)"	"unprognostic (8.77e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (6.86e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.08e-1)"	6.4	10.1	13.4	5.2	14.3	4.6	8.6	14.7	18.0	5.6	13.7	10.7	8.2	5.2	7.6	9.3	5.1	3.5	30.9	13.8	13.9	12.7	15.1	3.5	5.6	13.8	14.0	6.8	6.6	14.2	8.5	3.0	13.9	7.7	12.5	11.9	9.6	8.4	37.3	6.9	6.6	6.3	13.7	6.4	7.4	3.0	13.8	7.9	5.2	51.1	7.1	6.8	6.5	13.7	20.2	11.4	13.5	19.2	8.6	9.6	18.4	17.0	10.5	25.2	29.0	15.9	8.5	19.6	11.1	12.8	16.3	18.3	22.7	26.6	30.6	21.0	29.1	24.1	15.5	17.1	11.3	35.0	9.0	6.1	16.0	14.9	14.9	5.5	15.6	23.8	37.2	14.5	13.6	19.8	15.5	29.0	16.4	19.7	21.7	7.5	13.8	26.1	19.9	17.3	21.0	11.2	11.8	18.0	22.9	9.0	22.1	22.8	5.6	10.9	16.0	17.0	26.4	5.1	10.0	30.9	14.0	33.6	16.4	14.1	2.9	2.4	5.0	6.9	5.8	5.6	6.4	8.1	7.3	2.5	10.5	7.8	0.4	10.1	6.1	4.9	5.2	4.7	13.4	14.3	14.7	18.0	13.8	13.9	13.8	14.0	13.9	13.7	13.8	13.7	4.7	3.2	3.7	6.5	3.9	4.5	6.8	26.1	7.4	8.1	5.0	6.3	42.8	5.7	11.2	3.7	0.0	14.0	2.2	3.7	33.2	11.5	0.5	3.5	4.9	5.5	0.0	8.2	10.6	10.5	13.3	5.9	3.6	2.6	1.3	6.6	3.3	8.6	6.8	6.7	13.2	7.3	24.4	1.3	3.5	0.3	8.1	2.4	5.4	1.0	2.0	13.2	4.1	4.5	7.6	9.2	5.8	6.0	4.7	2.4	5.2	12.0	4.9	8.7	6.6	6.5	10.6	3.6	10.9	8.0	4.3	6.3	3.7	11.1	9.8	4.7
COQ4	CGI-92	ENSG00000167113	"Coenzyme Q4"	Q9Y3A0	9	128322544-128334072	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubiquinone biosynthesis"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 202.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021406, HPA042945"	Supported		Supported	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria		"HPA021406: AB_2670691, HPA042945: AB_10961047"	"unprognostic (9.15e-2)"	"prognostic favorable (2.97e-5)"	"unprognostic (2.29e-1)"	"prognostic favorable (4.93e-6)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.51e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.89e-2)"	"prognostic favorable (5.76e-6)"	"unprognostic (6.21e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.14e-3)"	23.9	52.9	33.9	21.7	35.3	19.7	28.2	32.9	43.6	31.8	43.1	35.9	76.7	24.9	19.4	62.1	51.8	21.5	39.6	34.8	37.8	62.9	63.8	25.0	24.4	33.4	33.9	30.5	64.1	45.5	53.4	17.6	33.2	41.2	23.7	22.3	47.1	28.3	31.8	56.4	54.1	15.4	32.3	27.5	39.5	22.6	34.3	20.3	51.2	22.6	22.9	31.1	34.1	36.0	36.6	54.4	31.5	36.6	22.4	31.2	58.2	31.7	20.6	40.1	28.0	48.4	46.5	48.6	28.1	24.2	31.6	99.9	27.0	38.0	14.6	25.1	50.5	18.1	112.9	52.9	38.9	51.5	27.0	37.4	45.2	33.6	36.6	21.9	32.4	40.8	121.1	31.5	26.0	106.2	60.5	38.0	37.0	75.1	60.7	60.7	45.2	91.0	49.0	36.9	58.8	40.1	64.7	71.5	41.4	13.8	92.2	18.0	43.3	38.0	35.1	56.9	43.9	53.4	50.4	38.5	47.4	25.0	28.1	22.6	31.1	19.0	44.1	36.4	39.8	39.9	39.4	44.1	39.6	34.4	31.1	38.2	3.8	35.5	37.2	63.7	34.5	29.9	33.9	35.3	32.9	43.6	34.8	37.8	33.4	33.9	33.2	32.3	34.3	36.0	21.3	22.4	29.0	25.8	31.9	28.8	47.1	75.1	47.3	29.9	60.2	65.9	43.0	42.9	48.9	57.0	27.1	90.3	36.5	70.3	142.8	56.4	15.3	139.7	39.8	25.4	31.8	36.0	23.9	63.4	47.5	32.1	35.7	42.2	36.8	37.1	30.0	77.4	49.8	30.3	26.3	65.6	57.0	26.7	23.9	27.4	30.1	24.0	40.9	8.4	27.2	37.4	27.8	17.1	28.8	46.1	66.2	30.9	60.8	32.8	185.3	202.4	161.9	53.3	26.3	27.9	33.4	47.2	31.6	79.4	50.0	47.2	32.3	69.3	85.5	58.0
COX14	"C12orf62, MGC14288"	ENSG00000178449	"Cytochrome c oxidase assembly factor COX14"	Q96I36	12	50112082-50120457	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 835.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044618, HPA062014"	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA044618: AB_10960419, HPA062014: AB_2684657"	"unprognostic (5.71e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.20e-3)"	"prognostic unfavorable (7.90e-4)"	"unprognostic (7.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.34e-2)"	"unprognostic (7.09e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.07e-3)"	124.0	106.4	96.3	47.1	101.4	66.2	105.6	110.3	129.7	63.6	120.1	92.4	83.4	46.2	130.5	68.5	54.9	62.9	238.6	94.5	105.5	143.8	145.4	62.3	74.5	102.6	99.8	52.8	62.0	127.8	88.0	54.7	102.9	67.0	77.5	60.6	84.9	80.7	247.6	49.8	84.0	58.7	102.9	66.9	76.5	32.6	104.0	54.9	87.3	276.7	62.0	74.2	47.3	110.2	78.4	168.3	32.8	79.4	169.4	105.7	60.5	61.1	92.7	98.8	89.5	156.7	109.1	69.9	171.9	78.3	82.6	79.0	57.2	87.5	91.7	78.7	236.6	154.3	140.4	139.2	65.1	112.1	133.7	123.8	129.9	67.1	76.7	100.5	96.2	83.1	70.2	153.4	109.1	193.3	93.7	170.3	51.5	116.4	211.3	77.6	52.4	176.8	155.0	149.1	91.0	51.4	92.4	177.5	195.6	72.6	115.1	103.6	75.2	55.0	58.1	92.3	50.1	106.3	199.0	93.5	77.9	105.0	30.9	258.8	197.8	172.7	146.1	194.5	155.6	213.7	186.9	167.0	190.0	188.0	176.7	173.7	67.0	153.1	178.2	247.2	224.8	214.8	96.3	101.4	110.3	129.7	94.5	105.5	102.6	99.8	102.9	102.9	104.0	110.2	91.5	60.9	120.6	11.1	108.8	124.9	91.2	212.9	87.0	68.2	169.2	192.5	524.4	161.5	138.7	222.5	22.9	191.9	111.1	320.9	565.4	131.4	7.1	117.5	58.7	99.2	156.0	69.2	13.1	170.1	122.6	90.3	81.6	88.1	65.4	64.0	88.9	397.9	219.6	47.1	16.3	214.7	187.2	152.3	110.4	22.9	129.2	117.7	149.4	6.5	181.2	111.0	111.2	7.1	22.3	116.8	262.4	109.4	93.0	129.5	492.6	835.5	157.5	67.4	105.2	51.5	130.8	51.1	56.0	121.6	159.3	127.5	112.2	115.4	227.4	118.6
COX15	CEMCOX2	ENSG00000014919	"Cytochrome c oxidase assembly homolog COX15"	Q7KZN9	10	99710868-99732127	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037727, HPA037728, HPA066096"	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA037727: AB_10672391, HPA037728: AB_10672463, HPA066096: AB_2685616"	"unprognostic (9.74e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.36e-2)"	"unprognostic (2.96e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.40e-2)"	"unprognostic (8.34e-2)"	"prognostic favorable (9.21e-6)"	"unprognostic (2.08e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.40e-2)"	15.0	31.2	12.9	9.7	13.3	6.6	13.8	12.9	16.4	16.7	14.3	17.1	12.6	15.6	14.2	18.8	15.2	10.4	21.3	12.7	12.7	21.1	23.4	11.4	13.7	12.4	12.9	19.0	16.2	14.6	16.2	10.8	13.0	14.5	16.0	15.3	14.2	11.0	34.5	14.7	15.6	10.9	12.7	17.8	16.2	12.0	13.6	13.4	13.6	27.2	16.1	19.6	15.0	14.1	22.7	50.3	19.6	42.9	28.4	22.4	15.9	16.9	22.1	25.0	23.9	37.6	30.2	42.8	26.6	15.4	15.6	32.1	44.2	25.7	26.5	19.2	21.0	25.1	23.5	39.6	30.0	33.5	22.3	23.3	23.9	27.7	40.9	36.6	26.3	36.1	27.3	29.6	24.2	24.8	24.7	27.6	21.0	22.1	22.0	30.2	29.5	27.9	24.8	16.6	16.7	26.4	29.9	16.6	29.5	15.7	61.2	13.2	22.1	12.4	17.1	18.7	25.6	25.2	36.2	28.5	22.7	53.2	10.7	19.6	12.8	12.4	7.4	15.2	8.8	12.7	8.6	8.4	13.9	11.3	8.6	8.9	7.9	8.7	18.5	5.7	9.9	9.7	12.9	13.3	12.9	16.4	12.7	12.7	12.4	12.9	13.0	12.7	13.6	14.1	11.4	22.4	8.4	32.0	14.1	6.1	10.3	13.2	12.0	14.7	14.2	11.2	25.2	14.3	15.9	14.7	10.4	23.7	9.0	16.5	29.4	17.6	1.9	14.0	15.4	10.8	17.5	9.4	18.7	15.8	20.7	9.6	11.7	14.6	2.5	21.5	7.9	27.2	17.4	13.5	23.7	13.4	6.1	27.4	8.6	1.9	10.5	14.7	12.4	12.2	18.5	13.4	13.4	16.6	26.1	13.2	11.9	10.1	9.0	7.5	16.5	24.5	27.7	15.5	0.0	11.0	9.4	10.1	9.5	12.2	9.2	22.7	10.3	35.8	16.6	9.3
COX4I1	"COX4, COX4-1"	ENSG00000131143	"Cytochrome c oxidase subunit 4I1"	P13073	16	85798633-85807068	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Oxidoreductase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002485, CAB004080"	Supported		Supported	Mitochondria		NA	NA		55000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB004080: AB_2085427, HPA002485: AB_1078559"	"unprognostic (4.73e-2)"	"unprognostic (9.14e-3)"	"unprognostic (2.65e-1)"	"unprognostic (6.18e-3)"	"unprognostic (2.47e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.97e-2)"	"unprognostic (7.82e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.29e-1)"	"prognostic favorable (2.56e-8)"	"unprognostic (4.23e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.38e-2)"	473.1	393.5	874.4	232.5	881.4	583.2	437.1	896.5	971.9	373.1	882.6	690.5	585.9	301.8	478.8	597.2	355.8	246.9	2047.0	869.5	909.5	632.7	611.2	318.6	412.8	896.4	891.1	366.2	490.4	900.7	362.1	256.7	908.6	377.1	707.7	261.2	421.2	312.3	1333.3	552.5	529.5	301.4	877.2	405.9	650.3	191.1	922.9	479.9	361.5	2063.3	538.7	422.6	420.9	881.0	433.7	677.7	460.2	616.8	823.6	761.2	785.7	379.6	771.2	702.3	346.7	1170.2	636.6	698.6	454.2	610.5	389.9	855.1	657.2	765.3	622.2	238.7	678.1	392.9	554.8	1093.8	741.9	362.9	282.0	893.1	1162.8	579.2	786.0	739.1	746.4	563.6	672.3	280.4	602.5	1510.6	730.9	1116.7	623.0	954.1	796.3	816.9	287.5	616.7	1066.7	840.2	543.2	441.1	807.4	513.2	656.2	489.6	753.2	996.6	529.9	355.5	409.5	330.7	419.0	561.4	562.5	1646.3	542.4	702.2	410.6	633.9	1373.2	805.2	700.3	1199.6	868.1	1302.9	930.5	833.2	1480.8	1231.2	1169.3	968.8	513.9	840.6	1089.3	1105.6	1106.1	2815.9	874.4	881.4	896.5	971.9	869.5	909.5	896.4	891.1	908.6	877.2	922.9	881.0	552.0	275.7	398.1	45.1	925.3	1129.4	1242.3	2031.6	1121.8	280.2	1365.2	1553.2	3479.9	1086.6	942.3	632.7	131.3	1223.1	714.3	1863.5	2752.8	1091.1	539.4	480.5	468.0	629.7	1009.6	524.6	44.0	1316.2	1094.7	591.2	813.0	575.6	521.4	554.3	660.7	1314.7	1602.3	212.0	51.7	1782.5	1125.0	1488.5	1376.5	1155.4	498.9	1010.5	1145.5	35.6	1451.7	562.9	785.8	35.7	65.5	1463.7	1950.7	357.7	726.2	1370.7	3811.3	2936.3	545.4	349.9	355.0	481.8	678.0	358.6	321.7	1721.9	1361.7	1481.9	816.5	1020.3	2147.9	1941.7
COX5A		ENSG00000178741	"Cytochrome c oxidase subunit 5A"	P20674	15	74919791-74938083	"Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 1749.5;skeletal muscle: 1609.7;tongue: 1735.8"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1645.3;Distal tubular cells: 1475.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027526	Supported					NA	NA		530000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA027526: AB_10602802"	"unprognostic (7.32e-2)"	"prognostic favorable (2.15e-4)"	"unprognostic (4.06e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.79e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.62e-2)"	"prognostic favorable (6.06e-7)"	"unprognostic (9.78e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.81e-3)"	175.6	176.7	187.1	105.1	189.5	148.5	150.8	231.1	258.1	109.8	201.3	454.2	326.9	98.2	110.7	293.0	89.3	67.8	1749.5	193.1	229.3	373.5	349.6	133.0	125.6	216.1	207.5	71.1	259.3	385.3	141.1	88.0	208.8	118.4	398.2	194.1	211.2	99.2	1609.7	169.0	269.6	95.0	194.8	150.8	306.8	217.8	220.4	150.7	141.5	1735.8	197.9	141.2	146.3	193.8	300.4	309.1	376.8	331.1	227.2	260.2	443.1	262.7	222.3	317.7	294.8	346.0	352.1	700.0	322.0	219.5	387.8	567.7	898.3	368.4	263.7	401.0	906.2	566.6	299.7	436.0	283.9	642.7	335.0	266.6	389.9	198.3	445.1	217.4	377.7	450.0	522.2	429.9	321.2	222.4	558.8	494.6	408.7	575.8	540.1	499.0	369.7	778.4	469.8	472.4	570.5	250.1	396.6	569.2	871.3	407.6	286.3	507.6	274.3	241.4	238.7	303.9	421.1	508.4	1000.3	759.0	258.2	836.1	224.5	332.4	361.5	210.2	198.1	465.6	238.6	296.4	242.4	235.7	452.9	227.3	171.6	198.0	87.4	354.9	432.7	365.2	372.6	426.4	187.1	189.5	231.1	258.1	193.1	229.3	216.1	207.5	208.8	194.8	220.4	193.8	120.7	99.3	119.6	20.5	166.6	158.2	235.3	623.6	151.4	113.4	202.6	313.4	1645.3	221.6	324.0	171.0	39.6	502.8	162.7	987.6	1475.2	407.5	1046.3	199.4	124.3	163.8	461.4	227.3	18.9	436.7	528.2	156.3	247.2	192.8	104.0	143.3	117.8	471.8	571.5	92.5	25.1	890.5	496.4	286.0	209.1	819.6	100.3	238.6	250.8	17.8	413.7	159.9	162.7	15.6	20.2	412.1	817.3	85.7	350.7	319.3	1276.3	921.7	242.7	176.8	92.1	139.6	590.9	523.0	253.6	371.3	159.0	511.0	144.2	216.5	1045.6	393.3
COX6A1	COX6A	ENSG00000111775	"Cytochrome c oxidase subunit 6A1"	P12074	12	120438090-120440737	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"		Oxidoreductase	"Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062394	Approved		Supported	Mitochondria		NA	NA		85000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA062394: AB_2684749"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-2)"	"unprognostic (5.10e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.82e-1)"	"prognostic favorable (6.50e-7)"	"unprognostic (2.53e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.48e-2)"	"unprognostic (2.63e-2)"	353.0	396.5	1004.7	203.3	1040.0	368.0	321.3	1052.0	1305.8	265.4	959.8	597.1	611.5	248.1	273.9	582.2	248.6	231.3	263.9	1030.7	1086.0	664.3	707.1	269.0	273.3	1062.6	1045.6	207.4	373.0	986.0	344.2	193.5	1075.6	282.7	443.1	392.4	373.3	244.3	59.7	372.2	481.2	230.4	995.3	262.3	493.9	224.4	1086.7	327.9	316.1	88.5	255.3	319.6	348.8	1046.6	532.7	1142.5	627.4	653.5	475.4	403.9	755.8	327.1	447.7	585.1	497.2	1388.3	528.9	1115.9	955.5	477.1	442.6	865.0	624.6	737.3	382.3	663.5	1314.3	596.5	594.9	1036.8	434.6	661.9	405.9	487.3	895.5	531.3	632.3	477.0	505.0	801.0	602.9	337.1	494.2	1528.7	965.1	1667.1	566.1	1034.6	1627.5	644.7	414.7	1044.5	945.3	1302.6	822.4	708.6	595.6	589.9	803.5	347.1	1051.4	742.9	373.0	355.0	431.9	370.9	466.8	513.0	791.3	897.5	558.7	643.2	484.9	225.6	347.3	316.4	258.9	353.6	278.9	377.1	305.3	287.3	486.9	296.9	279.3	287.3	297.9	253.7	374.0	516.7	460.6	534.3	1004.7	1040.0	1052.0	1305.8	1030.7	1086.0	1062.6	1045.6	1075.6	995.3	1086.7	1046.6	346.4	397.4	312.4	41.1	355.0	383.3	526.3	1145.7	508.2	238.3	411.3	426.7	124.4	543.3	683.0	774.3	577.6	774.8	289.0	1306.7	1481.1	659.4	207.3	487.3	239.6	311.2	515.7	348.0	26.3	661.9	701.5	304.0	437.3	425.9	272.2	263.9	266.0	971.0	779.3	146.4	38.1	861.7	980.6	376.6	426.0	136.4	302.0	377.7	524.7	19.7	583.9	440.8	332.7	23.6	56.9	726.1	1417.1	265.5	565.2	506.1	1857.6	1701.6	718.9	414.2	341.8	259.0	508.6	455.8	373.7	1155.8	388.0	927.2	341.0	399.5	1049.7	778.9
COX7A2	"COX7AL, COXVIIa-L"	ENSG00000112695	"Cytochrome c oxidase subunit 7A2"		6	75237675-75250323	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 4705.1;Late spermatids: 3873.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"				"unprognostic (8.49e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.70e-2)"	"unprognostic (2.73e-3)"	"unprognostic (7.44e-2)"	"unprognostic (1.74e-1)"	"prognostic favorable (3.43e-5)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	180.5	204.2	346.7	94.5	356.4	171.8	166.2	374.6	579.3	133.0	382.9	314.4	196.3	128.4	215.0	253.0	135.7	105.5	601.8	357.5	401.2	374.6	307.6	146.1	117.3	344.1	349.7	103.8	154.1	407.8	232.6	92.4	355.2	163.4	327.9	332.2	160.4	124.0	185.3	163.6	200.9	158.5	358.6	138.6	286.4	497.7	353.5	166.6	146.8	293.8	156.6	160.5	154.1	378.4	116.5	260.5	334.6	276.7	195.9	220.0	242.3	276.9	252.7	270.3	291.3	471.1	172.9	188.1	239.0	251.9	363.1	247.1	236.1	299.9	336.8	347.8	482.6	283.6	842.1	630.6	200.8	305.6	319.9	240.7	392.7	250.9	163.2	283.4	318.7	420.8	255.2	266.0	370.4	536.6	130.7	329.7	210.9	569.4	472.5	210.2	169.0	500.7	436.3	745.0	228.2	275.3	172.4	312.0	301.7	273.2	190.9	843.6	156.4	118.8	218.2	95.9	319.5	373.2	444.7	221.4	135.7	342.5	237.3	693.0	582.0	585.0	435.6	663.4	468.5	659.6	563.3	527.9	619.7	559.7	551.1	511.9	437.7	496.6	696.0	781.4	680.8	1055.8	346.7	356.4	374.6	579.3	357.5	401.2	344.1	349.7	355.2	358.6	353.5	378.4	370.9	304.5	371.3	15.0	391.8	553.7	624.1	2000.6	268.6	251.0	584.8	693.0	2518.6	630.5	1019.4	503.9	120.9	686.3	348.5	1504.8	2602.2	800.4	4705.1	460.2	288.0	382.5	663.0	354.3	18.9	1007.3	787.6	367.5	414.9	451.7	300.1	269.4	385.8	1485.8	870.3	154.8	22.4	1283.5	1468.9	484.8	499.6	3873.2	355.7	420.2	846.6	10.3	715.3	390.3	396.5	14.1	20.9	1157.5	1498.6	339.3	593.7	848.5	1790.7	2008.3	772.8	359.9	407.6	303.7	587.8	2905.4	230.0	627.9	626.4	818.3	381.9	336.4	1242.8	994.8
CPSF2	"CPSF100, KIAA1367"	ENSG00000165934	"Cleavage and polyadenylation specific factor 2"	Q9P2I0	14	92121969-92172145	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024238	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Vesicles	"HPA024238: AB_1847200"	"unprognostic (2.31e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.77e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (4.35e-7)"	"unprognostic (1.34e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.68e-2)"	"unprognostic (8.78e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.91e-1)"	"unprognostic (8.75e-2)"	"unprognostic (4.90e-2)"	14.8	14.5	7.3	24.9	9.7	11.5	11.8	9.3	10.1	13.7	13.0	16.1	14.7	15.0	15.0	18.3	11.7	15.0	13.1	6.8	8.9	13.6	19.7	14.7	21.0	9.5	9.2	12.6	14.9	18.2	10.7	16.7	10.6	15.6	16.8	13.9	13.6	14.1	27.1	11.1	14.4	17.8	8.5	18.6	17.4	26.0	8.5	27.3	18.3	25.6	24.8	16.6	12.3	12.2	48.1	46.9	47.0	48.6	23.9	21.1	69.5	60.7	59.0	55.1	54.3	41.4	64.9	51.3	38.9	65.1	37.2	69.2	65.2	55.2	79.2	83.3	22.4	75.4	46.1	39.5	70.5	76.3	60.6	34.7	46.2	52.5	93.8	36.5	52.2	54.5	68.8	62.9	62.1	69.6	88.3	26.8	53.3	76.8	42.3	86.0	72.7	45.9	37.5	67.1	51.7	34.7	71.7	39.9	51.1	41.9	82.9	47.4	56.3	43.9	27.7	33.4	52.4	37.6	66.2	103.0	53.0	58.9	69.7	16.6	12.9	9.3	7.8	11.7	10.4	7.6	6.9	8.4	11.3	4.0	6.1	8.6	4.4	11.1	9.8	7.3	12.1	9.5	7.3	9.7	9.3	10.1	6.8	8.9	9.5	9.2	10.6	8.5	8.5	12.2	14.2	28.9	31.8	23.2	22.9	10.3	15.2	15.1	15.9	12.7	13.4	9.5	27.1	10.0	25.5	7.3	29.2	24.0	19.8	14.6	13.7	18.0	28.2	24.3	30.0	22.9	13.8	33.0	13.6	24.0	22.7	20.0	17.3	16.8	30.4	26.2	20.7	27.2	24.8	11.8	17.5	17.3	12.2	32.9	8.8	11.2	19.0	31.1	3.6	19.7	41.2	16.9	27.8	18.6	27.9	23.8	14.0	23.0	35.4	29.9	12.5	16.3	34.1	22.7	32.9	19.6	23.2	61.7	41.3	27.2	12.8	25.3	22.8	26.6	18.2	20.2
CPSF3	"CPSF-73, CPSF73, YSH1"	ENSG00000119203	"Cleavage and polyadenylation specific factor 3"	Q9UKF6	2	9423651-9473101	"Predicted intracellular proteins"	"mRNA processing"	"Endonuclease, Hydrolase, Nuclease, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 187.6;Spermatocytes: 151.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034657	Uncertain					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA034657: AB_10669728"	"unprognostic (9.07e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (3.64e-5)"	"unprognostic (1.30e-1)"	"unprognostic (6.82e-2)"	"unprognostic (8.45e-3)"	"unprognostic (7.39e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (3.93e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.10e-2)"	14.2	15.0	10.5	18.4	11.9	23.4	16.9	11.7	13.5	14.5	12.2	17.1	13.9	13.2	23.4	16.2	14.4	11.3	11.1	10.2	11.3	15.6	19.9	12.9	26.3	11.6	10.8	10.4	12.7	14.3	10.6	16.2	12.1	12.7	19.4	11.6	11.5	13.3	15.0	19.2	13.2	16.8	11.4	15.4	13.8	50.9	12.1	32.2	16.4	12.4	30.5	16.4	11.5	13.5	35.7	79.2	85.1	74.4	46.6	54.6	89.2	56.2	60.3	67.2	63.7	100.6	64.5	112.2	51.8	49.3	61.0	61.6	96.0	66.6	81.5	73.9	70.5	95.6	37.7	94.5	40.1	92.8	61.0	49.0	44.6	84.6	61.3	38.2	55.9	71.9	117.0	46.9	64.1	78.7	96.2	121.0	125.9	89.2	54.9	92.6	107.2	94.2	59.9	52.4	46.4	110.7	55.0	41.5	63.5	71.5	40.7	63.1	42.5	53.3	46.1	54.3	70.8	56.1	80.5	118.9	62.3	95.0	57.9	32.9	34.4	23.1	22.2	39.9	23.3	25.3	20.3	23.3	50.1	23.6	20.9	22.6	5.8	38.0	38.4	33.2	36.7	30.5	10.5	11.9	11.7	13.5	10.2	11.3	11.6	10.8	12.1	11.4	12.1	13.5	7.1	6.4	12.7	3.9	15.7	10.5	10.5	26.4	8.6	12.2	7.2	6.5	11.1	8.6	19.5	5.5	8.4	39.5	19.7	9.0	19.6	22.5	187.6	14.6	15.7	11.8	12.6	36.2	9.8	22.5	43.4	13.1	8.6	14.0	8.2	19.9	6.8	14.2	26.1	21.9	9.6	11.9	26.4	20.1	9.5	33.9	11.1	20.6	19.6	10.3	36.3	18.2	16.5	8.5	13.7	16.4	7.4	12.4	15.7	6.5	9.7	18.7	18.0	20.1	6.6	12.3	38.0	151.4	43.2	16.1	8.8	27.2	13.1	26.1	15.1	8.7
CPSF6	"CFIM, CFIM68, CFIM72, HPBRII-4, HPBRII-7"	ENSG00000111605	"Cleavage and polyadenylation specific factor 6"	Q16630	12	69239569-69274358	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039973	Supported		Enhanced	"Nucleoplasm,Nuclear speckles"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear speckles"		"HPA039973: AB_10795242"	"unprognostic (1.50e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.37e-3)"	"unprognostic (5.47e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (1.91e-6)"	"unprognostic (6.82e-2)"	"unprognostic (2.91e-3)"	"unprognostic (8.57e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.20e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.41e-2)"	23.8	26.3	14.4	35.8	13.9	71.9	23.8	30.5	16.8	27.5	1.8	24.0	26.2	28.4	38.6	27.8	25.3	18.3	21.5	14.5	18.0	20.8	20.6	22.5	46.9	6.1	5.6	40.5	23.9	28.3	26.5	25.0	8.4	23.1	24.8	43.5	26.0	20.2	27.9	24.6	25.4	23.7	8.2	27.1	26.6	22.3	12.6	43.6	26.6	17.0	40.8	25.6	25.2	12.3	97.5	80.3	115.7	81.7	43.8	49.7	87.1	62.7	74.1	87.3	82.0	83.8	64.8	153.6	62.6	63.9	48.5	89.2	114.5	73.7	92.3	101.4	78.1	124.3	85.7	97.1	65.4	170.1	87.1	60.0	57.2	70.4	28.7	58.2	68.3	90.6	130.1	159.6	73.3	112.9	159.9	110.3	112.3	80.4	67.8	159.9	91.6	108.2	68.9	113.4	97.0	85.4	83.7	77.7	88.9	68.8	93.2	118.5	79.1	65.4	80.0	62.6	104.5	101.9	88.5	190.9	53.1	97.5	85.9	44.3	26.0	29.9	27.9	32.6	29.5	32.8	30.8	29.1	39.0	28.9	23.4	28.2	7.7	30.2	28.7	27.8	47.2	19.7	14.4	13.9	30.5	16.8	14.5	18.0	6.1	5.6	8.4	8.2	12.6	12.3	29.1	12.8	24.9	53.2	49.9	76.0	46.7	55.7	43.3	56.5	30.0	24.5	31.7	30.0	39.9	18.4	37.5	64.6	51.1	22.5	37.2	59.6	18.7	35.6	40.2	35.0	52.5	47.1	97.6	56.8	85.7	36.6	33.6	37.9	34.9	54.0	23.6	23.0	39.5	89.2	115.4	32.6	75.3	29.3	39.7	19.8	56.8	37.1	24.9	53.4	53.5	37.8	45.3	137.2	126.0	61.1	23.3	53.0	56.3	37.4	25.4	26.6	28.0	45.8	39.5	37.4	56.0	68.1	69.4	43.9	59.1	51.2	38.5	54.1	36.2	51.5
CPSF7	"CFIM59, FLJ12529"	ENSG00000149532	"Cleavage and polyadenylation specific factor 7"	Q8N684	11	61402641-61430031	"Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041094	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA041094: AB_10794187"	"unprognostic (6.87e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.07e-1)"	"unprognostic (9.41e-3)"	"prognostic unfavorable (9.83e-4)"	"unprognostic (5.35e-2)"	"unprognostic (2.07e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.18e-2)"	43.2	44.1	39.1	36.0	40.7	55.0	44.2	40.0	48.4	55.2	39.8	48.9	32.0	54.8	44.1	46.6	55.1	27.3	39.5	37.9	41.3	44.2	62.8	38.0	43.3	38.1	41.0	55.6	49.2	35.0	79.1	37.8	39.1	47.3	34.3	40.7	41.4	34.7	68.0	52.3	49.0	43.7	33.9	57.4	47.3	42.0	39.3	57.8	58.9	48.1	43.7	47.4	45.7	44.3	72.5	71.0	98.0	78.2	52.0	45.8	68.7	58.9	56.2	76.7	58.4	83.7	60.6	107.7	61.4	63.6	65.0	87.4	94.7	67.4	93.1	71.8	48.4	90.9	95.8	68.0	52.5	111.4	77.9	48.7	54.3	81.3	118.4	46.7	52.8	69.1	111.2	67.1	56.2	87.7	110.5	90.9	96.2	50.5	55.6	102.8	77.1	88.9	57.8	87.9	66.3	67.6	78.2	68.4	74.3	59.7	94.4	47.6	53.2	84.4	71.6	79.0	61.4	92.0	116.5	122.4	49.3	53.2	63.0	15.1	5.6	7.1	8.1	6.0	8.7	6.9	6.4	8.4	7.6	6.5	7.0	7.2	9.8	6.7	4.6	6.4	4.8	5.7	39.1	40.7	40.0	48.4	37.9	41.3	38.1	41.0	39.1	33.9	39.3	44.3	23.3	35.3	21.2	56.8	29.0	23.2	18.4	15.5	26.7	21.4	26.1	24.9	11.4	11.5	16.0	16.5	39.6	26.7	29.4	22.6	17.6	15.7	41.8	17.1	21.7	22.6	22.2	20.0	29.8	13.8	17.5	20.7	22.4	21.3	23.5	26.6	22.9	27.2	19.6	32.0	31.0	21.9	16.2	31.0	19.0	29.1	27.4	23.4	3.6	37.5	39.7	24.2	22.6	31.7	39.8	19.5	13.6	25.2	28.6	25.0	22.3	14.3	19.9	21.7	39.5	28.8	22.6	37.5	27.1	25.0	26.3	27.5	22.1	17.7	23.0	23.0
CPT2	"CPT1, CPTASE"	ENSG00000157184	"Carnitine palmitoyltransferase 2"	P23786	1	53196792-53214197	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 91.2"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 85.1;Hepatocytes: 88.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028201, HPA028202, HPA028214"	Enhanced		Approved	Nucleoplasm,Nucleoli,Mitochondria		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Mitochondria"	Nucleoli	"HPA028201: AB_10599177, HPA028202: AB_10599942, HPA028214: AB_10601958"	"unprognostic (2.43e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (5.27e-4)"	"unprognostic (6.48e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.34e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.97e-2)"	"prognostic favorable (1.46e-12)"	"unprognostic (4.00e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.95e-2)"	12.9	14.3	6.6	9.4	8.2	5.4	13.6	7.9	7.3	10.3	16.8	35.4	32.4	6.8	10.5	14.2	10.5	9.5	19.5	6.1	7.1	35.1	91.2	11.5	10.6	8.1	7.5	10.2	21.7	27.3	6.7	18.0	8.0	12.2	32.8	7.1	14.6	11.7	17.3	6.7	24.9	11.4	7.7	8.7	18.4	12.9	9.0	10.2	12.5	33.1	13.2	11.1	4.5	8.9	16.0	8.3	17.2	17.8	14.6	11.3	17.5	9.8	13.2	17.5	17.5	8.6	14.5	28.9	14.6	9.2	20.1	19.1	35.1	25.1	15.1	17.0	16.0	21.8	9.9	6.4	25.9	15.9	19.5	23.0	23.2	13.8	11.1	18.6	15.4	26.5	20.9	9.9	13.1	12.8	10.7	13.0	29.8	38.4	20.0	13.2	16.2	34.4	22.9	22.0	25.3	14.4	22.1	30.3	39.7	36.6	32.3	32.2	8.7	8.4	6.1	16.5	8.5	26.3	19.8	16.2	11.6	20.6	12.4	5.6	14.1	14.6	7.2	20.0	8.1	5.3	6.3	8.4	17.9	7.4	10.5	7.2	5.3	6.9	20.5	8.9	9.9	10.3	6.6	8.2	7.9	7.3	6.1	7.1	8.1	7.5	8.0	7.7	9.0	8.9	5.0	12.8	24.1	4.2	7.8	1.8	5.2	20.5	5.2	6.0	7.5	7.0	18.1	15.7	11.4	11.0	14.6	85.1	4.5	49.3	25.4	12.9	1.1	10.9	8.1	5.9	14.5	9.4	1.5	10.5	20.3	7.2	18.3	10.3	2.5	12.7	8.9	88.8	26.3	15.2	2.0	26.6	16.2	15.1	7.2	2.8	6.8	10.5	7.2	1.9	20.2	11.6	6.2	2.5	4.5	10.5	25.6	5.3	9.1	4.9	38.6	41.0	7.6	11.0	6.6	7.5	8.4	49.9	31.3	13.8	2.6	54.6	6.9	25.6	29.5	5.7
CRADD	RAIDD	ENSG00000169372	"CASP2 and RIPK1 domain containing adaptor with death domain"	P78560	12	93677375-93894840	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 161.3;Early spermatids: 164.5;Inhibitory neurons: 122.3;Oligodendrocyte precursor cells: 174.4;Oligodendrocytes: 287.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005337	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol	Nucleoplasm	"CAB005337: AB_2085481"	"unprognostic (1.07e-2)"	"prognostic favorable (9.06e-5)"	"unprognostic (9.65e-3)"	"unprognostic (5.51e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.10e-1)"	"unprognostic (3.79e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.89e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.18e-2)"	"prognostic favorable (4.04e-9)"	"unprognostic (2.57e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.02e-2)"	10.0	19.3	9.1	5.0	10.5	9.3	11.2	9.9	9.1	12.8	12.8	13.6	16.9	13.0	12.6	13.0	9.9	10.4	41.2	8.7	10.1	17.9	37.3	9.9	7.3	9.7	9.9	10.3	12.7	18.6	15.3	7.2	9.8	11.4	8.2	12.8	11.0	8.9	28.2	11.4	18.0	8.2	8.7	10.4	12.9	13.7	10.0	13.3	9.6	30.0	6.2	12.7	11.3	10.3	7.8	17.4	8.4	9.6	11.8	21.2	10.6	8.8	10.7	7.6	8.9	16.4	3.2	13.9	5.3	10.2	5.8	8.0	9.3	11.5	9.3	14.7	12.3	7.4	7.0	12.2	12.2	6.8	6.8	19.8	17.4	12.2	9.5	8.0	9.3	15.2	21.3	6.4	9.1	12.6	10.1	12.3	10.6	8.9	13.2	16.8	4.3	19.3	7.4	5.7	12.9	12.5	12.0	11.7	21.3	8.1	20.5	13.2	10.0	17.5	8.7	8.4	9.0	15.0	8.7	12.9	8.2	10.0	8.4	62.7	11.6	45.5	23.8	14.7	21.1	15.1	16.5	24.8	9.7	13.5	17.6	13.0	33.9	20.6	23.2	13.1	20.9	12.0	9.1	10.5	9.9	9.1	8.7	10.1	9.7	9.9	9.8	8.7	10.0	10.3	7.8	9.6	6.3	161.3	7.8	7.4	9.3	21.1	6.2	6.4	8.9	7.2	38.7	7.2	18.0	7.3	8.4	14.5	9.0	19.1	23.5	16.8	164.5	11.8	8.7	11.9	7.8	9.1	62.8	22.4	12.7	10.3	10.2	6.7	4.5	3.7	10.0	41.9	11.5	23.5	122.3	14.6	26.4	10.6	6.1	35.2	17.7	16.0	3.6	96.5	9.5	16.9	15.5	174.4	287.2	19.5	19.8	23.7	8.4	10.1	58.5	63.1	20.0	15.5	6.6	15.0	11.4	25.6	11.7	10.1	8.1	10.8	10.2	8.3	13.9	10.1
CREB1		ENSG00000118260	"CAMP responsive element binding protein 1"	P16220	2	207529737-207605988	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Differentiation, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Early spermatids: 417.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003803, HPA019150"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"CAB003803: AB_562092, HPA019150: AB_1847220"	"unprognostic (1.20e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (8.41e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.53e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.82e-3)"	"unprognostic (5.53e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.45e-2)"	13.0	8.7	10.6	15.3	11.4	22.4	14.7	17.5	11.1	15.8	11.9	11.4	10.0	15.7	10.8	15.0	13.1	14.0	11.5	10.3	10.7	12.4	11.6	13.6	22.1	10.6	9.9	17.2	8.7	15.6	6.9	18.0	10.4	13.0	14.0	17.8	8.9	12.6	6.7	11.5	10.6	16.3	9.7	17.1	12.1	32.4	9.9	28.7	18.1	14.6	25.0	16.8	9.6	15.0	24.9	20.9	38.6	15.6	22.9	22.4	21.8	15.9	23.5	26.6	26.5	21.6	22.9	15.4	19.8	21.1	29.8	19.5	34.8	20.4	37.7	25.1	13.2	29.2	18.9	23.0	18.7	27.7	20.0	16.0	16.3	21.1	31.1	25.4	34.9	28.9	20.5	22.5	30.4	16.8	41.0	16.1	27.8	24.2	13.1	31.4	22.1	20.2	25.1	24.6	27.1	23.4	21.6	16.2	18.1	35.5	16.5	30.1	18.5	21.8	22.6	22.1	20.5	19.6	27.5	36.4	25.2	25.3	22.0	33.6	28.2	28.2	27.0	29.2	23.7	36.7	25.3	26.2	34.1	34.8	30.0	20.7	56.1	45.6	34.9	18.6	38.6	26.7	10.6	11.4	17.5	11.1	10.3	10.7	10.6	9.9	10.4	9.7	9.9	15.0	46.7	19.2	18.2	47.0	52.3	70.9	47.1	33.3	34.1	38.9	25.3	18.5	26.3	17.2	29.0	12.9	33.3	29.1	35.5	25.3	23.5	23.6	417.8	19.6	39.2	47.2	32.4	54.7	56.1	20.3	24.9	35.8	18.8	21.0	43.7	41.5	35.7	15.8	29.4	40.4	51.1	28.2	30.5	48.8	75.9	47.2	26.1	35.8	44.4	68.4	60.9	42.1	33.0	66.9	70.7	26.4	27.5	29.3	29.1	56.5	22.8	19.7	18.9	40.2	39.5	37.4	40.7	44.5	29.4	33.5	57.8	18.6	42.6	19.6	25.7	62.6
CREB5	"CRE-BPA, H_GS165L15.1"	ENSG00000146592	"CAMP responsive element binding protein 5"	Q02930	7	28299321-28825894	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 165.7;Basal prostatic cells: 192.2;monocytes: 163.9;Oligodendrocyte precursor cells: 229.7;Oligodendrocytes: 734.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 5.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 198.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 198.8"	"Cell line enhanced"	"Detected in many"		"HL-60: 62.5;Karpas-707: 25.0;U-2 OS: 25.7;U-2197: 28.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA050020, HPA061622"			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	Yes			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA050020: AB_2680993, HPA061622: AB_2684569"	"unprognostic (3.59e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.90e-3)"	"unprognostic (2.01e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.91e-3)"	"unprognostic (6.61e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.52e-3)"	10.5	1.3	6.3	7.9	20.5	6.1	5.0	6.8	12.7	1.7	0.0	3.5	0.9	8.4	2.8	3.5	2.2	11.4	5.3	9.6	19.9	3.0	1.8	6.1	0.9	19.7	14.6	0.7	3.2	0.2	1.1	3.7	15.8	1.2	1.7	1.3	3.5	1.0	3.2	2.9	2.2	4.7	2.9	7.4	1.4	0.7	23.0	0.7	1.8	4.0	0.8	4.4	2.2	35.0	0.1	0.6	7.3	0.4	0.4	10.3	0.3	0.7	1.6	4.4	6.6	4.2	2.7	18.9	1.3	1.8	4.5	0.7	0.2	6.4	13.8	0.0	5.0	20.4	4.2	0.4	0.4	62.5	0.7	1.3	1.2	18.9	20.1	0.9	3.0	0.1	2.4	25.0	1.5	0.1	0.1	0.0	9.1	0.1	7.4	0.5	6.8	0.5	9.0	2.0	0.7	5.2	0.3	0.4	2.2	10.0	0.2	1.5	0.8	8.6	25.7	28.7	8.5	1.5	4.5	0.2	9.4	0.3	14.8	0.1	29.9	0.0	0.0	9.7	0.0	1.9	0.0	0.0	18.2	0.1	0.0	0.0	198.8	0.0	3.9	0.3	0.0	7.0	6.3	20.5	6.8	12.7	9.6	19.9	19.7	14.6	15.8	2.9	23.0	35.0	165.7	6.4	7.2	10.7	3.2	21.9	192.2	8.2	13.1	1.3	10.7	8.9	16.8	17.2	6.3	12.9	0.0	4.0	0.8	0.0	1.9	74.2	0.4	41.0	56.3	31.3	0.0	0.4	17.0	27.4	13.4	108.0	3.1	69.7	14.0	0.6	14.3	0.5	8.3	5.0	22.2	0.0	6.1	47.4	118.2	1.6	5.9	75.8	30.2	22.5	163.9	14.3	4.1	229.7	734.9	22.5	0.0	0.4	3.2	44.9	0.0	25.6	4.7	0.9	19.7	143.5	31.8	12.6	7.3	12.0	13.2	24.8	3.1	2.6	0.0	35.1
CREBBP	"CBP, KAT3A, RSTS, RTS"	ENSG00000005339	"CREB binding protein"	Q92793	16	3725054-3880713	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004212, HPA055861"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Nuclear bodies"	"CAB004212: AB_626817, HPA055861: AB_2682948"	"unprognostic (1.17e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.09e-2)"	"unprognostic (9.59e-3)"	"unprognostic (6.98e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.84e-1)"	"prognostic favorable (6.24e-5)"	"unprognostic (1.47e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.97e-2)"	"unprognostic (8.23e-2)"	17.4	10.6	5.8	17.1	5.2	52.9	16.8	25.4	11.5	20.9	3.7	18.8	12.5	26.5	12.4	16.5	22.4	16.6	14.4	5.9	3.1	12.0	14.3	15.9	17.6	8.9	6.8	37.3	29.7	18.5	11.3	16.9	2.9	16.1	14.1	13.8	17.2	16.2	29.6	21.0	16.4	19.6	0.4	21.0	16.3	33.2	7.9	29.1	23.3	28.9	20.7	16.6	16.5	6.4	12.3	31.0	39.3	17.4	23.5	23.1	20.4	17.4	28.9	29.2	28.2	28.2	22.4	33.7	20.1	33.3	18.7	23.2	45.7	14.2	32.9	57.5	18.5	26.6	29.2	17.9	26.0	26.9	36.5	20.7	14.2	32.5	38.9	18.0	22.3	17.0	30.9	44.8	16.0	42.0	17.9	13.0	32.3	11.7	12.7	83.4	31.1	26.1	11.2	16.2	32.6	21.5	29.5	28.7	16.8	25.3	25.6	25.9	34.7	35.5	35.2	18.4	16.0	20.8	24.3	63.7	7.2	15.8	25.6	1.9	1.1	0.9	1.7	1.5	0.8	3.7	0.8	1.3	0.7	2.1	0.8	1.1	6.7	1.4	2.9	1.5	0.8	0.9	5.8	5.2	25.4	11.5	5.9	3.1	8.9	6.8	2.9	0.4	7.9	6.4	48.1	44.8	51.6	91.1	38.3	56.2	31.0	16.0	27.3	34.2	34.4	25.7	41.2	40.0	28.0	11.0	25.0	17.4	50.1	31.2	5.9	20.9	43.0	37.2	56.4	35.7	15.0	33.4	88.7	20.3	11.3	39.5	32.1	63.5	30.4	53.1	32.5	29.5	20.9	28.6	89.8	25.3	18.3	44.0	42.8	80.2	56.5	49.0	17.8	87.1	52.5	34.5	43.3	111.6	101.2	27.5	19.5	51.1	35.6	39.8	25.2	10.9	28.2	17.6	46.0	75.8	44.9	35.1	42.2	34.6	58.8	30.8	44.2	36.2	24.6	44.2
CRLF3	"CREME9, CYTOR4"	ENSG00000176390	"Cytokine receptor like factor 3"	Q8IUI8	17	30769388-30824692	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 35.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007596	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		210000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA007596: AB_1847241"	"unprognostic (1.02e-1)"	"unprognostic (9.79e-2)"	"unprognostic (7.12e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.52e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.10e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (1.31e-7)"	"unprognostic (3.35e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.51e-2)"	7.5	4.9	3.5	21.5	3.2	20.6	7.0	10.5	4.4	7.6	0.2	7.8	6.1	5.3	2.8	12.8	4.9	7.5	4.3	4.5	2.7	4.2	5.4	9.1	35.5	1.8	1.9	4.3	4.4	7.9	4.7	12.6	2.4	4.7	7.9	9.5	5.9	3.8	3.8	11.1	9.7	6.5	1.3	23.4	6.6	10.3	3.7	33.4	4.3	4.4	32.7	11.0	8.0	3.0	11.3	12.2	7.5	15.6	13.4	10.3	11.1	10.4	10.1	19.8	20.6	13.5	7.4	36.8	15.2	13.0	19.3	19.2	12.8	8.6	23.6	17.6	23.3	15.7	9.9	10.3	7.4	21.0	11.2	6.1	11.8	16.0	13.4	7.4	19.4	32.9	40.1	37.6	12.6	6.8	46.6	21.8	14.9	18.7	7.4	20.0	24.2	22.2	13.1	9.4	5.3	12.5	10.6	16.1	11.6	15.6	12.5	10.3	10.4	11.4	13.9	18.5	25.8	15.7	14.2	24.9	10.9	16.6	12.9	53.7	57.9	139.9	37.0	59.5	39.3	46.7	52.2	42.4	43.0	46.8	99.9	75.6	117.3	40.3	72.1	22.0	63.7	84.5	3.5	3.2	10.5	4.4	4.5	2.7	1.8	1.9	2.4	1.3	3.7	3.0	10.4	0.0	12.5	17.6	50.9	22.6	8.0	5.4	16.5	17.9	7.0	4.3	4.5	2.8	4.6	7.3	14.6	18.7	36.2	9.2	5.9	5.1	13.5	6.1	8.4	10.6	3.6	46.9	54.8	5.3	17.6	7.7	13.3	9.1	22.8	5.5	8.9	4.2	16.8	6.7	56.5	3.9	8.2	26.1	25.0	21.3	6.5	26.7	5.4	42.2	39.9	4.7	47.4	38.7	38.0	9.1	3.4	4.1	25.7	8.4	2.6	5.3	8.9	25.2	13.1	9.2	7.5	27.5	27.3	11.4	27.8	45.8	47.1	5.3	4.2	7.8
CS		ENSG00000062485	"Citrate synthase"	O75390	12	56271699-56300391	"Citric acid cycle related proteins, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Tricarboxylic acid cycle"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 550.1;tongue: 600.7"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 239.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038460, HPA038461, CAB075750, CAB075751, CAB075752, CAB075753, CAB075754"	Enhanced		Enhanced	Mitochondria		NA	NA		670000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"CAB075750: AB_2665756, CAB075751: AB_2665757, CAB075752: AB_2665758, CAB075753: AB_2665759, CAB075754: AB_2665760, HPA038460: AB_2676023, HPA038461: AB_2676024"	"unprognostic (7.67e-3)"	"unprognostic (3.80e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.43e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.97e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.02e-1)"	154.2	93.6	29.2	61.7	30.0	111.0	66.3	33.7	49.9	55.4	40.5	110.1	97.7	56.4	32.2	95.6	58.3	42.4	319.3	30.9	34.6	86.6	39.0	58.0	67.2	39.4	32.0	56.0	61.5	127.6	28.9	45.7	39.4	59.0	124.1	128.9	73.7	60.5	550.1	70.5	81.2	77.5	22.5	49.0	66.5	24.4	41.0	69.4	53.0	600.7	106.1	70.2	58.2	31.6	168.9	176.8	141.6	198.2	188.4	173.8	93.3	136.9	132.0	231.1	160.6	271.2	158.2	322.9	128.2	172.6	99.3	182.1	396.8	200.8	234.9	109.3	200.2	222.9	136.1	261.4	107.3	288.4	166.6	188.2	201.6	182.4	232.0	202.2	268.6	163.7	233.2	193.7	214.7	160.8	229.8	121.9	117.5	128.0	247.8	222.3	167.1	247.6	166.2	194.6	189.3	125.2	175.2	251.7	157.7	137.5	297.6	174.3	178.3	127.1	165.3	167.4	147.4	124.5	200.4	206.2	120.4	206.4	119.5	59.6	73.3	205.7	47.0	93.0	61.9	60.6	56.5	45.1	119.3	51.8	59.2	47.9	31.3	51.6	94.0	65.6	63.4	71.2	29.2	30.0	33.7	49.9	30.9	34.6	39.4	32.0	39.4	22.5	41.0	31.6	14.5	16.0	39.5	32.3	31.6	39.0	23.5	26.9	46.7	22.8	38.3	29.7	239.9	15.7	21.5	12.9	62.6	18.5	24.1	66.9	35.2	32.5	6.6	25.1	31.5	27.2	16.9	36.0	21.5	45.1	31.3	25.8	42.3	53.5	27.9	21.3	18.9	29.7	34.3	10.1	24.6	43.9	20.3	39.4	35.0	4.8	20.2	34.6	10.6	9.4	44.8	16.7	16.5	18.6	18.8	44.6	35.7	19.9	46.7	33.1	50.4	22.0	14.9	38.3	13.1	27.8	38.2	29.7	25.8	74.8	52.1	16.8	25.8	32.0	71.3	34.5
CSNK1G1	CK1gamma1	ENSG00000169118	"Casein kinase 1 gamma 1"	Q9HCP0	15	64165525-64356173	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 35.0"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 130.6;Late spermatids: 261.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018209			Supported	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA018209: AB_1847278"	"unprognostic (9.10e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.90e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.63e-2)"	"unprognostic (3.75e-2)"	"unprognostic (7.51e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.41e-1)"	4.0	3.4	6.1	6.1	6.9	9.0	6.0	6.4	7.7	5.4	6.3	5.0	3.9	4.5	6.7	7.9	7.3	4.0	2.9	10.4	7.1	5.3	2.9	5.3	5.9	2.8	4.3	5.2	4.1	6.3	4.7	4.9	2.6	3.7	5.4	14.5	3.6	4.4	4.1	6.6	3.8	5.3	3.6	5.9	4.3	35.0	6.8	9.3	7.9	3.3	6.8	5.5	4.6	4.9	6.8	14.2	10.0	13.2	8.3	11.4	8.9	8.3	8.5	13.8	12.5	11.5	13.2	10.8	4.3	13.3	14.2	15.4	26.7	16.5	16.1	20.6	6.8	10.1	11.2	8.0	9.8	18.9	11.4	10.3	21.7	14.0	20.0	11.9	15.4	10.6	12.3	10.4	12.8	9.4	9.7	5.8	9.4	8.9	7.4	16.1	12.5	8.6	11.2	26.8	16.2	9.9	11.1	6.5	9.5	16.4	11.4	7.4	16.8	12.6	14.9	9.8	10.5	12.3	26.0	8.8	11.6	13.5	7.9	0.4	1.9	3.1	2.8	2.8	4.0	1.8	2.5	2.1	1.4	1.8	2.4	2.3	4.5	2.8	2.3	2.1	2.2	1.3	6.1	6.9	6.4	7.7	10.4	7.1	2.8	4.3	2.6	3.6	6.8	4.9	10.9	28.9	11.3	35.6	12.9	11.6	10.5	13.7	19.9	47.1	11.6	7.9	7.3	11.5	12.7	5.5	68.8	6.9	12.6	12.2	1.9	9.6	130.6	37.4	17.9	12.2	22.8	7.8	69.4	7.0	9.0	10.3	15.3	24.6	3.8	15.8	10.4	4.4	10.4	10.1	49.8	10.5	6.1	9.7	10.0	261.1	6.2	14.1	7.2	40.3	13.5	7.9	5.2	40.2	41.3	12.0	7.5	10.1	14.3	11.1	8.2	9.7	23.3	29.3	6.6	14.4	11.8	31.9	19.8	26.7	15.6	4.1	13.2	7.9	10.4	13.2
CSNK2A1	"Cka1, Cka2"	ENSG00000101266	"Casein kinase 2 alpha 1"	P68400	20	472498-543835	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB020680, HPA059206, HPA061698, CAB069395"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"CAB020680: , CAB069395: AB_1611912, HPA059206: AB_2683948, HPA061698: AB_2732667"	"unprognostic (1.19e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.44e-2)"	"unprognostic (8.28e-3)"	"unprognostic (3.62e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (4.11e-6)"	"unprognostic (4.08e-2)"	"unprognostic (3.89e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.58e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.47e-1)"	"unprognostic (9.53e-2)"	"unprognostic (7.37e-2)"	36.1	32.6	20.9	38.6	23.2	34.0	35.9	28.2	29.6	36.5	29.3	48.3	39.1	35.8	26.6	50.0	39.9	31.3	54.0	25.7	21.0	41.0	31.8	31.6	41.2	20.6	21.1	41.5	46.9	59.1	21.2	42.4	21.1	35.8	40.7	32.9	41.1	37.7	110.5	34.2	40.5	39.1	18.8	30.2	49.5	65.2	22.3	51.6	39.6	86.4	46.6	47.4	28.5	27.3	209.5	170.4	152.9	96.0	61.1	103.8	103.5	117.9	116.1	125.8	139.5	178.5	120.0	179.1	74.2	90.1	179.1	147.8	162.1	167.4	187.2	62.6	57.7	247.3	44.7	177.7	102.5	228.1	51.3	99.5	173.3	105.8	316.0	122.2	139.5	146.4	248.9	112.6	123.8	64.2	262.0	73.7	227.4	173.4	97.6	149.8	140.5	140.9	112.9	128.5	163.9	132.3	97.2	184.0	174.8	120.7	120.4	83.9	142.7	136.0	118.4	90.0	178.5	120.6	311.8	174.1	65.8	119.5	138.6	40.5	23.8	28.7	18.2	32.3	22.4	23.0	18.0	17.6	31.5	22.5	17.9	17.4	14.9	25.1	33.5	25.7	20.4	20.8	20.9	23.2	28.2	29.6	25.7	21.0	20.6	21.1	21.1	18.8	22.3	27.3	50.7	64.1	84.6	51.9	46.1	41.0	40.0	43.8	45.5	49.4	42.1	36.1	59.4	41.5	75.8	44.1	31.3	42.2	50.5	43.5	41.1	68.5	135.5	67.6	77.0	44.5	35.2	59.3	65.6	50.6	54.4	46.3	40.2	75.7	63.8	108.6	27.1	31.1	33.2	60.6	69.3	41.8	46.8	39.2	30.3	140.0	41.0	45.3	14.2	51.5	61.7	38.6	37.0	73.9	73.6	66.6	34.4	36.9	49.6	57.2	43.2	68.8	65.5	27.8	52.6	43.6	56.8	94.2	68.7	52.3	50.2	61.4	38.9	81.2	40.6	59.4
CSPP1	"CSPP, CSPP-L, FLJ22490, JBTS21"	ENSG00000104218	"Centrosome and spindle pole associated protein 1"	Q1MSJ5	8	67062417-67196778	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 165.8;Endometrial ciliated cells: 177.6;Respiratory ciliated cells: 202.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056174			Supported	"Centriolar satellite,Centrosome"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Centriolar satellite, Centrosome"		"HPA056174: "	"unprognostic (1.44e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.70e-1)"	"unprognostic (2.59e-2)"	"unprognostic (5.24e-3)"	"unprognostic (3.89e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.61e-2)"	"unprognostic (9.29e-2)"	"unprognostic (3.40e-1)"	"unprognostic (9.46e-2)"	"prognostic unfavorable (2.98e-4)"	"unprognostic (2.93e-1)"	4.1	2.9	0.8	1.5	0.7	0.8	4.4	1.5	1.3	5.4	1.4	4.1	2.2	4.3	1.8	3.4	8.4	3.1	3.7	0.6	0.6	5.5	5.4	5.8	1.4	1.0	1.1	5.6	6.0	4.3	3.3	6.0	0.9	3.6	2.8	2.1	3.6	1.6	13.5	3.6	4.0	2.6	0.7	3.3	4.4	12.8	1.2	3.9	4.6	2.8	2.0	4.1	4.1	1.0	5.7	4.9	4.6	5.9	5.3	5.6	4.9	4.9	6.3	6.5	6.9	4.6	6.6	6.5	1.1	3.3	6.9	4.4	11.4	3.4	9.1	3.6	7.2	9.3	2.3	2.9	4.5	7.7	4.0	4.4	2.9	4.2	8.2	3.9	4.1	7.9	16.1	3.0	5.9	2.1	19.1	3.2	6.1	14.8	4.9	10.4	6.9	5.4	4.9	2.6	3.0	3.0	3.1	5.9	4.7	6.3	10.8	4.4	4.1	4.7	4.7	2.1	4.2	4.6	3.2	8.6	3.6	6.1	5.6	0.6	0.1	0.2	0.5	1.0	0.6	0.5	0.4	0.5	0.4	0.8	0.8	0.3	0.0	0.3	0.3	0.4	1.0	0.3	0.8	0.7	1.5	1.3	0.6	0.6	1.0	1.1	0.9	0.7	1.2	1.0	20.9	25.6	11.8	63.3	15.0	21.2	11.1	7.6	16.5	20.5	19.4	18.7	39.8	31.5	32.4	7.3	73.0	21.8	23.6	9.6	3.9	14.8	165.8	177.6	29.1	16.6	11.4	16.6	117.5	9.7	13.7	20.2	11.2	27.7	26.0	36.8	12.1	9.3	7.4	21.9	116.1	9.6	8.2	7.2	9.4	91.0	21.5	12.5	7.2	61.8	12.9	13.6	17.5	89.0	98.1	9.8	5.3	19.5	19.4	11.0	10.8	23.0	202.3	133.2	26.3	31.7	20.4	121.6	60.1	15.3	16.2	18.5	15.9	14.6	13.6	6.9
CSTF2	CstF-64	ENSG00000101811	"Cleavage stimulation factor subunit 2"	P33240	X	100820359-100841520	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000427, CAB004680"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA		14000	"Cluster 27: Non-specific - Gene expression"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	"Nuclear bodies"	"CAB004680: AB_425385, HPA000427: AB_1078580"	"unprognostic (2.02e-2)"	"unprognostic (8.70e-3)"	"unprognostic (3.50e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.09e-2)"	"prognostic unfavorable (8.23e-6)"	"unprognostic (2.02e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.08e-3)"	"unprognostic (5.98e-3)"	"unprognostic (2.75e-1)"	"prognostic favorable (1.12e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.89e-1)"	6.3	7.2	5.7	9.9	6.0	10.5	7.7	6.7	6.3	7.0	5.0	12.0	8.6	7.5	8.2	19.2	8.1	6.4	6.1	5.9	6.4	8.0	5.3	6.3	12.5	5.4	5.4	7.1	4.7	8.9	5.3	7.2	5.3	7.5	13.1	8.5	7.9	8.4	4.5	8.4	8.2	7.6	5.3	7.0	6.6	12.7	6.6	12.0	6.7	5.1	19.9	10.0	8.4	6.3	36.0	41.7	27.5	24.9	14.7	11.4	37.2	29.6	24.0	47.6	68.0	45.4	32.1	35.6	35.2	19.1	61.2	35.1	64.2	35.3	57.2	36.5	39.9	32.8	38.8	29.8	19.4	46.9	33.8	11.3	16.5	49.8	32.6	12.7	29.0	31.3	56.2	33.7	29.2	41.9	38.4	31.8	76.8	55.7	39.9	35.8	46.3	42.3	17.5	34.4	24.1	30.4	49.1	20.5	20.4	27.6	20.5	20.3	25.8	26.2	42.3	38.1	37.8	22.8	52.3	45.9	22.5	48.6	32.4	20.0	16.1	11.1	23.4	18.9	17.9	17.4	21.1	21.8	23.3	16.9	19.0	17.8	2.6	23.9	25.8	16.7	24.2	15.3	5.7	6.0	6.7	6.3	5.9	6.4	5.4	5.4	5.3	5.3	6.6	6.3	4.1	3.2	1.1	3.9	8.2	4.2	4.6	20.7	9.6	2.2	3.1	3.0	4.9	2.8	12.9	0.0	2.1	16.7	3.6	5.9	5.9	12.5	13.3	6.3	4.9	4.6	4.2	12.8	10.4	8.3	18.4	4.3	6.1	4.3	3.8	5.5	2.5	1.5	10.8	3.3	10.8	3.7	14.2	2.5	3.7	2.4	4.7	4.3	1.8	1.0	5.9	4.5	4.1	7.1	5.7	15.4	6.7	4.1	6.2	2.0	5.4	4.0	9.9	2.9	6.6	2.7	5.7	18.8	25.5	14.4	4.1	7.7	7.1	5.0	6.4	5.0
CSTF3	CstF-77	ENSG00000176102	"Cleavage stimulation factor subunit 3"	Q12996	11	33077188-33162371	"Predicted intracellular proteins"	"mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039743, HPA040168"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA039743: AB_10795682, HPA040168: AB_10794025"	"unprognostic (2.38e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.63e-4)"	"unprognostic (3.77e-1)"	"unprognostic (4.04e-2)"	"unprognostic (4.35e-2)"	"prognostic unfavorable (8.20e-6)"	"unprognostic (1.47e-1)"	"unprognostic (1.67e-2)"	"unprognostic (6.42e-3)"	"unprognostic (9.73e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (1.61e-5)"	"unprognostic (4.64e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.01e-3)"	13.8	21.2	28.5	20.8	30.9	12.7	19.5	34.7	39.8	24.2	30.5	20.3	19.1	19.8	61.1	26.7	21.2	14.9	17.1	30.0	32.4	28.9	34.6	21.3	26.6	26.3	26.8	25.9	21.1	18.2	57.6	19.1	27.4	30.4	20.0	31.9	20.6	15.0	16.9	26.1	20.2	13.7	26.1	25.5	18.6	32.9	31.1	23.8	29.8	11.8	21.5	22.0	24.7	32.9	45.8	43.3	82.8	56.4	22.0	38.7	59.8	44.2	28.5	48.5	66.2	31.7	34.9	49.3	31.2	28.5	32.4	58.5	73.8	42.9	77.5	52.7	128.3	50.6	109.1	58.2	24.9	66.5	30.9	28.2	30.6	37.6	36.7	39.1	64.4	39.2	67.9	34.2	66.4	32.3	66.8	35.7	40.3	34.6	54.0	52.2	80.5	39.7	54.6	58.2	61.4	34.9	50.9	29.9	37.6	52.7	54.4	44.1	39.5	40.3	49.7	64.5	59.7	32.3	46.8	41.9	47.4	68.9	40.2	4.6	4.8	7.0	5.8	6.9	6.8	6.5	7.2	5.8	7.7	5.0	7.5	7.9	1.9	6.9	8.3	5.7	9.1	3.7	28.5	30.9	34.7	39.8	30.0	32.4	26.3	26.8	27.4	26.1	31.1	32.9	12.8	19.2	18.7	38.5	19.0	18.9	50.6	50.1	10.2	33.3	22.3	19.9	21.8	17.2	43.5	58.8	6.2	63.0	12.7	15.1	62.6	24.3	37.6	31.4	20.7	21.2	31.8	34.9	75.2	16.9	32.0	23.1	15.3	18.9	14.5	29.0	11.0	57.3	28.4	13.5	59.1	30.0	77.3	22.0	21.1	10.3	29.8	17.0	28.4	42.2	28.1	35.7	14.4	62.4	56.9	20.8	18.6	29.7	14.0	33.0	20.6	47.0	68.0	25.2	26.3	26.1	25.4	77.3	57.6	19.1	19.5	33.8	18.3	25.3	29.6	55.6
CTDSPL2	"FLJ10523, HSPC129"	ENSG00000137770	"CTD small phosphatase like 2"	Q05D32	15	44427622-44529038	"Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 165.5;Late spermatids: 166.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040763, HPA062198"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA040763: AB_10960989, HPA062198: AB_2684708"	"unprognostic (6.64e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.06e-1)"	"unprognostic (7.39e-3)"	"unprognostic (5.20e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.68e-3)"	"unprognostic (5.35e-2)"	"unprognostic (8.36e-3)"	"unprognostic (7.49e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.16e-1)"	9.1	7.4	2.9	12.9	3.6	20.5	14.1	12.8	5.3	14.0	3.4	10.8	10.0	17.5	7.0	12.5	11.1	11.9	9.5	3.4	4.4	10.7	10.3	10.4	19.4	3.4	2.7	19.1	11.5	11.1	4.0	15.8	3.1	10.2	11.3	15.1	9.1	10.2	5.4	8.1	12.7	13.9	3.0	13.3	9.8	21.0	2.9	25.3	15.0	9.4	19.0	12.2	6.2	6.0	28.6	14.2	57.7	29.4	9.1	19.9	31.9	29.1	25.4	37.3	46.8	29.3	26.4	30.1	27.7	20.3	20.6	39.2	33.4	19.6	42.6	30.9	16.1	37.4	34.8	17.6	12.3	65.7	33.5	15.7	14.0	25.6	33.4	15.8	28.4	37.9	44.2	34.0	26.7	12.1	78.2	23.1	31.2	30.4	20.3	86.7	80.5	28.0	19.4	38.9	26.7	38.5	36.0	28.5	16.2	21.2	38.7	57.7	24.9	46.0	49.5	44.3	49.4	19.3	79.2	93.9	22.2	50.4	36.0	7.4	10.8	9.2	10.3	11.3	9.4	10.6	9.8	9.3	13.8	10.5	10.4	11.8	7.7	15.7	8.9	8.8	14.9	9.4	2.9	3.6	12.8	5.3	3.4	4.4	3.4	2.7	3.1	3.0	2.9	6.0	34.4	19.2	35.7	26.4	25.4	24.6	14.7	14.5	27.9	23.7	24.5	21.0	23.1	11.5	31.3	12.9	10.4	18.9	40.9	16.9	17.6	12.5	165.5	18.3	35.4	27.2	9.0	16.2	41.8	14.6	18.4	30.2	11.7	29.6	36.0	26.7	20.3	13.6	14.0	30.3	41.2	13.9	20.3	22.2	20.9	166.9	20.2	22.1	16.0	49.6	23.8	19.2	39.1	50.3	65.7	17.7	10.4	13.2	24.0	18.0	17.2	14.5	19.5	31.1	26.3	30.4	34.2	23.7	31.4	19.6	21.9	14.6	31.4	21.9	15.3	16.8
CTPS1	"CTPS, GATD5"	ENSG00000171793	"CTP synthase 1"	P17812	1	40979688-41012565	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Pyrimidine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 73.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017111, HPA051322"	Enhanced		Approved	"Actin filaments,Cytosol"		NA	Yes		150000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol	"Actin filaments"	"CAB017111: , HPA051322: AB_2681441"	"unprognostic (6.60e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.14e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.04e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.09e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.89e-2)"	9.1	8.1	4.8	11.1	4.7	6.8	6.7	4.0	5.8	9.3	7.9	8.7	4.4	23.6	5.7	14.9	11.1	10.6	5.3	4.9	5.3	12.4	73.4	7.6	12.4	4.6	4.9	3.4	4.7	47.6	0.0	7.8	5.8	13.5	12.0	2.4	50.6	24.8	7.7	4.6	8.4	51.9	4.7	5.0	4.1	14.7	4.9	17.3	4.8	7.6	17.8	17.7	0.3	5.0	77.8	68.5	95.3	60.5	22.9	30.9	138.5	138.8	57.0	141.2	92.0	131.5	66.6	149.8	55.6	61.7	39.4	38.6	91.5	97.0	139.5	66.5	78.0	87.3	72.3	43.3	87.8	128.0	56.8	34.0	49.2	148.5	103.0	23.0	64.1	102.2	84.7	51.5	99.4	42.9	125.0	38.1	126.8	66.4	81.3	100.9	120.0	93.7	71.4	69.4	118.4	61.7	79.2	77.7	33.9	90.8	30.1	152.9	53.5	78.2	119.6	61.7	167.2	36.8	50.8	134.5	59.8	84.5	97.4	0.0	3.5	0.0	3.6	6.5	5.7	5.2	4.1	4.3	11.0	4.0	3.7	6.1	0.0	6.9	5.9	11.9	6.3	3.4	4.8	4.7	4.0	5.8	4.9	5.3	4.6	4.9	5.8	4.7	4.9	5.0	5.4	6.4	18.4	4.9	10.9	8.0	14.3	9.1	9.6	12.5	4.6	4.7	5.7	21.5	7.0	5.5	6.2	15.4	26.4	2.2	1.9	19.2	32.4	4.7	10.8	8.5	3.0	22.5	14.1	17.2	26.4	8.7	7.1	7.3	1.3	15.8	2.2	29.0	11.0	11.8	18.7	3.4	6.1	2.8	6.2	27.9	10.8	6.8	1.8	7.5	8.7	5.4	7.2	7.1	10.3	19.3	1.1	24.8	15.1	19.3	25.2	12.8	2.8	4.3	39.5	9.3	17.5	11.1	40.6	11.8	7.4	5.6	9.9	20.7	5.8	7.3
CTU2	"C16orf84, NCS2"	ENSG00000174177	"Cytosolic thiouridylase subunit 2"	Q2VPK5	16	88706483-88715396	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"tRNA processing"		"Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041135, HPA041894"	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA041135: AB_10794543, HPA041894: AB_10796463"	"unprognostic (4.19e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.00e-2)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (5.68e-4)"	"unprognostic (4.83e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.74e-1)"	9.7	9.6	8.8	5.0	8.7	6.2	8.8	7.9	13.8	10.2	6.5	9.9	4.2	11.6	2.0	8.7	9.5	3.5	11.8	9.1	7.5	9.7	12.5	7.9	6.1	9.6	8.1	10.5	11.3	3.6	11.3	3.2	8.5	8.8	1.6	1.4	8.0	3.7	19.1	8.7	7.6	3.4	7.5	9.4	9.6	10.9	8.2	4.0	10.3	5.4	3.4	9.9	8.1	10.5	14.9	22.9	8.8	19.4	7.3	7.5	21.8	15.2	11.4	16.6	8.1	27.2	14.0	21.7	19.8	9.8	7.8	14.7	14.8	14.9	4.5	6.8	44.6	14.9	9.8	27.8	12.4	15.1	10.8	8.5	10.8	13.1	13.9	6.0	14.1	13.1	56.5	6.3	6.3	40.0	42.0	34.9	13.7	12.9	36.9	33.0	6.6	23.4	5.8	5.8	29.0	14.0	24.2	4.6	9.7	5.3	13.8	15.6	15.9	17.5	22.1	19.2	16.8	19.4	10.5	61.7	15.1	32.1	19.6	1.1	5.5	0.0	7.3	6.9	6.0	5.5	6.6	7.3	6.8	5.8	6.4	5.5	0.4	7.5	6.0	6.4	4.1	4.2	8.8	8.7	7.9	13.8	9.1	7.5	9.6	8.1	8.5	7.5	8.2	10.5	6.5	0.0	4.4	2.3	10.0	13.8	12.2	7.8	5.2	12.5	7.3	7.2	2.5	10.0	7.8	1.8	6.2	11.0	15.7	8.4	11.7	8.8	12.1	4.0	7.1	6.6	5.4	3.8	2.9	13.6	16.2	8.6	11.2	4.9	0.0	9.9	3.6	6.7	9.9	13.5	2.3	7.1	4.1	1.9	4.0	7.0	8.1	6.7	5.4	1.0	5.0	4.4	7.2	0.5	2.7	8.9	8.2	9.8	15.5	17.2	9.6	7.8	4.7	8.7	0.0	8.9	11.1	25.6	25.7	6.5	10.7	8.1	9.5	10.8	10.5	8.9
CUL1		ENSG00000055130	"Cullin 1"	Q13616	7	148697914-148801110	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 466.3;Late spermatids: 567.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002676, HPA064584"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA		220000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Nucleoli	"CAB002676: , HPA064584: AB_2685294"	"unprognostic (3.59e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.23e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.06e-3)"	"unprognostic (9.45e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.40e-1)"	"unprognostic (7.24e-3)"	33.2	27.3	19.6	29.4	20.9	15.5	30.2	20.4	26.5	28.1	22.2	38.9	23.0	29.8	28.8	30.6	29.4	23.2	35.9	22.1	23.0	21.6	45.1	26.3	39.0	20.4	21.2	30.9	20.6	36.3	25.6	32.7	20.4	27.3	24.5	52.1	26.1	30.1	88.8	28.8	27.3	32.2	21.8	30.0	29.7	95.1	21.3	30.3	27.4	74.6	35.6	34.9	26.6	21.7	79.9	61.6	59.5	93.6	46.6	51.6	72.8	64.8	77.7	65.8	61.4	64.5	53.9	109.6	49.5	65.9	104.4	52.5	87.0	59.9	76.4	72.8	71.9	65.2	39.6	64.5	50.5	74.8	58.9	40.0	58.5	45.9	46.0	59.9	71.3	52.8	100.8	78.2	72.2	76.4	64.1	81.0	111.6	68.6	58.8	78.7	52.3	106.3	54.2	55.4	83.3	61.0	74.5	92.3	51.4	69.9	29.0	57.5	56.6	44.1	15.4	87.7	75.8	70.4	54.2	96.7	94.3	82.5	66.2	15.5	17.0	14.1	16.5	18.3	21.8	17.3	18.9	21.2	26.6	15.0	22.4	18.5	1.4	27.9	18.5	6.7	18.5	20.0	19.6	20.9	20.4	26.5	22.1	23.0	20.4	21.2	20.4	21.8	21.3	21.7	24.0	35.3	40.9	41.4	26.0	27.9	31.1	19.5	22.2	33.4	13.8	17.5	29.2	12.8	32.2	9.2	29.2	66.6	19.1	12.0	17.6	28.1	466.3	20.4	23.4	25.1	15.6	23.1	76.3	26.2	77.1	29.9	19.4	21.9	23.4	31.6	18.5	41.5	29.8	21.9	89.5	19.7	22.4	18.5	16.8	567.7	21.8	25.7	28.4	60.9	51.7	32.7	37.0	52.8	74.3	28.5	15.0	30.5	25.3	29.8	11.7	13.5	33.6	48.9	32.9	30.3	38.9	59.6	34.0	20.6	25.4	73.2	26.5	24.1	18.8	21.7
CUL3		ENSG00000036257	"Cullin 3"	Q13618	2	224470150-224585397	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, ER-Golgi transport, Mitosis, Transport, Ubl conjugation pathway"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 224.8"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 309.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002678	Supported					NA	NA		65000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"			"CAB002678: "	"unprognostic (1.22e-2)"	"unprognostic (2.35e-1)"	"unprognostic (7.05e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.16e-2)"	"unprognostic (4.86e-3)"	"unprognostic (2.16e-2)"	"unprognostic (8.74e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.87e-2)"	30.6	33.6	26.7	36.3	28.2	62.5	40.6	30.4	34.7	35.3	31.0	38.2	36.1	33.6	41.8	54.2	28.7	32.8	39.0	28.6	30.2	49.4	52.4	31.2	55.5	25.9	26.0	33.2	34.3	56.5	25.2	37.1	26.2	33.4	39.4	46.3	36.1	28.6	112.6	54.1	34.2	33.5	27.0	33.8	35.5	224.8	26.6	48.4	45.7	81.8	75.7	40.6	36.5	31.1	61.7	61.3	87.8	72.6	71.9	62.7	82.7	73.9	74.3	72.6	67.7	72.7	60.2	67.0	44.5	76.1	70.3	53.6	99.8	85.0	112.0	66.5	54.5	95.9	61.3	100.7	87.6	95.1	69.3	62.6	68.9	67.7	74.0	72.2	74.3	61.9	90.2	67.0	96.9	104.5	88.5	91.5	90.4	100.9	38.0	76.5	109.8	50.0	108.5	141.0	79.9	58.6	51.1	73.7	85.7	124.5	58.6	79.3	66.2	77.2	58.5	52.1	74.1	69.2	55.3	115.3	59.9	58.2	83.7	9.4	2.8	7.6	3.5	3.5	4.6	5.3	3.9	5.4	3.0	6.5	4.7	5.2	6.6	8.7	4.2	3.6	7.6	1.7	26.7	28.2	30.4	34.7	28.6	30.2	25.9	26.0	26.2	27.0	26.6	31.1	48.3	51.3	69.6	92.1	73.9	28.3	67.8	25.1	20.5	48.5	40.8	34.7	39.9	30.0	49.7	27.6	29.2	25.7	85.3	46.7	35.2	20.2	211.2	58.9	66.9	35.2	40.9	30.9	86.7	24.9	17.8	35.0	32.6	76.2	38.0	37.1	28.5	39.6	20.7	60.6	93.4	39.2	20.3	43.2	28.3	309.7	27.4	45.2	24.9	95.5	39.4	48.4	28.8	107.1	126.4	34.5	39.3	27.4	58.1	59.8	43.8	43.2	38.7	41.3	52.6	71.8	41.5	116.4	50.7	35.7	32.7	39.5	61.2	40.1	34.0	90.1
CWC22	"EIF4GL, fSAPb, KIAA1604, NCM"	ENSG00000163510	"CWC22 spliceosome associated protein homolog"	Q9HCG8	2	179944876-180007297	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036748	Approved		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear speckles"	Cytosol	"HPA036748: AB_10669913"	"unprognostic (1.90e-1)"	"unprognostic (7.10e-2)"	"unprognostic (7.30e-2)"	"unprognostic (6.14e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (7.42e-4)"	"unprognostic (3.15e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.84e-2)"	"unprognostic (4.80e-2)"	"prognostic unfavorable (7.76e-5)"	"unprognostic (1.74e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.44e-3)"	12.7	10.2	7.1	13.1	7.8	16.0	15.0	13.5	10.1	14.1	7.1	11.9	10.1	16.9	10.4	12.5	12.0	12.1	10.1	7.6	7.2	13.4	16.8	11.5	18.5	6.4	6.9	19.3	9.2	13.5	8.2	14.5	7.0	12.5	11.8	12.4	10.2	10.9	13.6	11.0	10.4	13.9	7.1	14.7	11.0	9.0	7.0	21.8	16.0	14.5	18.2	14.1	12.1	8.9	19.1	11.2	31.6	21.1	22.7	26.7	24.1	24.5	28.7	29.4	28.7	25.9	23.1	36.7	21.6	17.9	25.6	20.5	30.4	23.1	44.2	33.0	26.2	49.1	15.1	35.4	22.0	69.6	26.2	17.5	27.1	37.4	49.8	19.3	22.3	25.2	54.6	21.9	19.7	18.9	36.5	34.7	48.8	22.5	18.3	32.8	38.9	27.7	20.2	23.5	21.6	28.8	20.3	15.9	28.5	33.8	11.8	42.2	19.0	25.1	21.2	16.8	25.7	19.2	21.5	44.3	22.6	27.2	26.1	49.7	13.3	31.4	16.1	16.7	16.3	17.4	17.3	19.5	13.9	14.5	21.1	16.7	22.0	16.0	13.3	8.6	16.5	11.5	7.1	7.8	13.5	10.1	7.6	7.2	6.4	6.9	7.0	7.1	7.0	8.9	38.0	19.2	33.8	20.5	38.0	19.1	29.2	16.9	22.2	19.5	12.9	19.8	26.6	22.8	27.0	11.0	25.0	18.3	36.5	11.8	9.8	23.4	1.6	24.2	31.9	27.2	15.6	14.9	35.8	19.1	17.5	32.5	19.9	25.1	27.3	24.7	16.8	12.8	13.7	13.5	28.4	16.4	14.2	20.6	12.1	2.4	23.3	24.2	3.6	15.0	31.6	17.3	30.9	35.2	35.1	18.7	17.6	18.4	20.8	16.8	15.7	20.3	34.4	19.1	46.0	40.3	25.1	22.8	21.3	14.1	18.6	24.8	32.5	18.6	15.6	19.5
CWC27	"NY-CO-10, SDCCAG-10, SDCCAG10"	ENSG00000153015	"CWC27 spliceosome associated cyclophilin"	Q6UX04	5	64768930-65018750	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"			"Disease variant, Dwarfism, Mental retardation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 255.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020344, HPA024149, HPA065809"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA020344: AB_1856644, HPA024149: AB_1856645, HPA065809: AB_2685561"	"unprognostic (1.71e-1)"	"unprognostic (6.47e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.91e-2)"	"unprognostic (4.00e-3)"	"prognostic unfavorable (5.27e-6)"	"unprognostic (1.58e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.74e-1)"	"unprognostic (7.45e-3)"	13.4	13.0	13.6	13.0	14.6	20.5	13.4	16.7	18.4	12.6	10.7	14.3	9.8	15.5	12.3	11.8	11.8	11.2	18.9	13.1	15.5	14.1	10.2	10.7	15.4	14.5	13.7	18.2	9.0	16.9	8.8	14.6	14.4	13.9	15.0	14.0	10.5	12.3	22.2	11.5	10.1	14.3	13.5	12.8	11.1	17.2	14.1	21.7	13.9	26.4	16.0	13.2	11.5	15.4	32.7	21.4	37.5	69.9	31.4	38.2	41.8	33.5	27.7	36.7	38.2	36.0	40.3	48.0	57.0	35.0	41.2	20.2	39.8	60.5	66.2	40.4	32.4	36.2	35.6	30.3	48.0	38.3	23.5	25.6	45.7	46.3	58.3	32.3	39.4	53.9	35.8	30.8	36.8	32.6	53.5	34.7	30.4	16.9	25.6	49.0	50.4	50.3	35.0	28.0	44.4	19.6	40.8	16.4	39.7	35.5	35.9	55.5	32.9	21.4	37.8	34.6	54.2	23.9	33.1	46.5	40.1	65.9	38.8	13.2	13.1	9.6	13.6	13.2	16.8	17.5	15.3	17.4	16.9	13.2	16.2	16.9	2.7	20.4	10.2	13.8	18.0	10.4	13.6	14.6	16.7	18.4	13.1	15.5	14.5	13.7	14.4	13.5	14.1	15.4	24.2	9.6	26.2	64.3	26.0	16.4	27.7	37.5	13.6	31.4	17.4	20.3	63.6	18.6	23.2	14.7	14.6	44.0	16.8	11.6	21.5	44.1	255.6	21.0	27.2	27.2	29.9	37.8	114.1	33.1	54.5	25.1	13.7	20.2	19.6	40.7	16.4	11.4	33.0	20.2	110.3	17.0	40.7	17.1	15.2	57.9	38.5	22.3	14.2	61.8	33.6	34.2	36.0	103.0	103.2	40.4	16.0	36.1	21.0	22.1	13.3	24.4	28.6	51.3	32.9	31.3	33.6	74.2	28.3	20.6	20.0	30.8	26.2	30.7	28.6	23.8
CWF19L1	"FLJ10998, hDrn1"	ENSG00000095485	"CWF19 like cell cycle control factor 1"	Q69YN2	10	100232298-100267680	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA036889, HPA036890"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Golgi apparatus"		"HPA036889: AB_10670928, HPA036890: AB_10696789"	"unprognostic (2.76e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (3.04e-1)"	"unprognostic (9.17e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.50e-3)"	"unprognostic (5.61e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.10e-1)"	8.1	6.9	5.9	11.4	6.3	18.8	11.6	7.5	7.6	7.9	5.1	7.2	6.8	8.2	5.7	6.9	8.7	6.7	7.4	5.9	6.5	7.8	8.2	7.5	16.4	6.0	5.8	10.3	8.0	9.0	6.1	9.0	6.3	6.8	8.6	10.3	8.6	6.5	10.1	11.2	8.1	9.3	6.3	11.8	6.6	14.3	6.0	14.8	8.1	10.2	16.9	8.5	6.6	8.4	29.1	18.8	18.7	29.2	9.1	10.8	20.7	17.2	23.8	37.5	30.6	21.5	22.6	30.5	19.4	16.6	16.3	27.9	42.2	24.9	39.6	19.4	20.8	17.5	15.8	20.6	15.8	44.7	19.6	15.2	10.4	28.0	26.2	14.2	26.6	30.8	20.7	26.8	21.9	18.3	36.2	32.4	14.7	15.0	23.2	12.6	29.2	21.2	15.0	16.5	9.4	16.8	20.6	10.3	26.0	12.6	37.3	19.1	18.6	15.8	21.5	18.3	32.8	23.9	29.6	17.9	20.1	39.1	11.4	10.0	17.0	22.7	12.8	15.9	16.3	14.0	13.3	14.4	14.9	13.0	14.9	15.0	9.6	18.1	14.7	6.8	17.7	13.8	5.9	6.3	7.5	7.6	5.9	6.5	6.0	5.8	6.3	6.3	6.0	8.4	8.0	19.2	10.8	14.0	16.2	4.5	7.7	6.8	4.6	9.5	4.8	3.9	8.0	5.7	11.3	5.5	4.2	10.4	13.5	4.3	7.9	6.0	23.6	6.8	6.4	8.3	4.2	11.2	26.8	7.7	11.0	6.7	4.6	6.3	17.7	8.3	7.5	5.9	9.5	10.1	24.3	4.2	10.2	13.1	5.7	5.3	6.8	11.3	8.8	14.0	15.5	5.1	19.6	18.6	24.0	7.2	6.7	4.1	11.3	5.3	4.5	6.2	12.5	12.3	0.0	8.4	6.9	18.4	12.2	5.8	7.7	10.9	12.8	6.7	5.3	4.4
CXorf56	FLJ22965	ENSG00000018610	"Chromosome X open reading frame 56"	Q9H5V9	X	119538149-119565409	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038245, HPA038617, HPA064831"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Centrosome	"HPA038245: AB_10672407, HPA038617: AB_10674691, HPA064831: AB_2685364"	"prognostic unfavorable (3.45e-4)"	"unprognostic (3.88e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.03e-3)"	"unprognostic (8.92e-2)"	"unprognostic (7.74e-3)"	"unprognostic (6.38e-3)"	"unprognostic (3.89e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.68e-3)"	"unprognostic (9.26e-3)"	"unprognostic (4.68e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.90e-1)"	11.6	9.8	8.2	7.6	8.6	16.2	12.5	8.3	9.2	10.1	7.1	10.0	7.7	11.6	9.0	9.4	9.9	6.1	10.5	8.2	9.4	11.6	8.8	8.8	10.7	7.9	7.9	13.7	8.8	11.7	7.2	10.2	8.7	8.8	8.7	11.5	9.9	8.8	13.0	12.3	9.0	8.7	8.0	9.8	9.0	6.7	9.3	11.5	11.8	13.2	11.6	9.3	9.0	9.7	27.3	26.2	16.8	19.8	17.9	12.5	22.9	17.1	15.4	22.3	20.7	23.4	26.7	41.3	43.2	16.9	53.9	16.9	40.1	21.0	30.5	24.8	30.3	14.9	25.2	16.2	13.8	41.3	22.1	14.7	17.9	29.1	24.0	14.2	16.3	24.0	32.2	25.4	11.1	40.5	24.8	24.7	27.3	33.4	28.4	23.9	19.0	29.9	15.8	19.8	12.1	22.0	35.9	19.3	25.3	18.0	15.0	17.9	20.4	16.9	12.0	31.2	39.6	21.9	42.7	42.0	14.2	39.7	20.3	5.0	10.3	13.9	9.0	12.6	8.2	10.9	7.7	9.5	9.5	15.6	7.9	7.7	4.8	6.4	11.9	8.7	10.4	9.4	8.2	8.6	8.3	9.2	8.2	9.4	7.9	7.9	8.7	8.0	9.3	9.7	2.6	3.2	13.9	1.6	10.6	6.2	8.0	4.8	5.7	15.7	4.8	5.0	13.4	7.2	5.4	3.7	6.2	20.5	3.5	8.3	21.5	9.2	1.3	8.7	10.3	7.5	8.5	10.3	9.4	6.6	20.1	5.3	4.1	10.5	17.2	7.7	6.8	6.4	10.1	8.4	10.8	6.0	8.2	12.9	8.3	1.2	9.6	6.5	12.4	2.8	17.1	15.8	6.2	7.5	6.8	6.8	6.5	11.3	7.8	5.2	9.8	13.2	6.8	11.3	13.1	9.5	11.1	5.4	10.0	6.5	5.8	35.6	9.2	7.6	7.9	8.6
CYB561D1	"FLJ39035, FLJ44753"	ENSG00000174151	"Cytochrome b561 family member D1"	Q8N8Q1	1	109494052-109502932	"Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027028	Uncertain					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 31: Skin - Epidermis development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA027028: AB_1847365"	"unprognostic (2.15e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (4.68e-4)"	"unprognostic (4.53e-4)"	"unprognostic (1.32e-1)"	"unprognostic (3.45e-1)"	"unprognostic (5.29e-2)"	"prognostic favorable (5.16e-6)"	"unprognostic (4.30e-1)"	"prognostic favorable (2.22e-4)"	"unprognostic (1.20e-3)"	"unprognostic (2.75e-1)"	"unprognostic (4.95e-3)"	"unprognostic (5.82e-2)"	4.8	7.3	6.3	8.0	6.0	8.4	5.3	7.9	7.0	3.9	4.4	6.2	5.6	4.7	11.1	7.1	5.1	3.9	4.2	7.1	4.6	6.8	2.9	5.8	11.0	4.8	5.4	6.8	11.1	8.5	8.0	3.1	4.8	4.5	5.8	4.3	6.1	6.0	6.8	17.8	9.0	5.1	4.4	8.7	7.3	2.7	5.6	7.8	7.8	3.6	10.3	4.7	3.5	5.8	9.4	5.4	3.9	4.5	13.1	9.4	9.9	8.0	6.1	9.0	6.4	5.2	4.0	8.3	8.2	10.3	5.7	10.4	5.1	6.4	5.8	6.9	4.7	5.4	8.6	4.3	6.2	11.6	16.8	10.2	15.8	8.7	4.5	5.5	6.3	8.1	3.6	3.7	5.8	11.7	4.1	6.2	1.8	6.9	8.2	6.9	15.6	3.3	8.2	15.6	5.7	5.1	9.1	8.9	8.6	5.4	5.9	6.3	8.5	8.8	10.2	12.0	6.6	4.3	3.3	4.0	8.9	9.4	9.9	2.5	2.4	3.6	3.7	2.6	3.3	2.5	3.9	3.4	1.7	2.5	4.9	3.4	6.7	5.6	2.9	1.9	3.1	2.5	6.3	6.0	7.9	7.0	7.1	4.6	4.8	5.4	4.8	4.4	5.6	5.8	2.5	0.0	4.7	2.3	7.1	2.3	1.7	2.9	1.8	7.7	4.2	2.3	3.7	7.2	4.4	3.7	2.1	2.5	5.3	10.6	0.0	3.3	0.0	2.6	3.0	2.6	4.2	0.4	10.4	8.0	1.1	2.9	4.6	3.0	1.3	3.7	0.7	2.2	1.3	3.3	6.4	2.9	2.0	4.1	3.2	0.4	2.5	2.5	1.8	3.7	3.7	2.4	28.8	3.5	9.1	5.8	0.8	4.1	3.5	1.9	10.2	2.6	4.3	6.4	0.0	5.6	2.2	0.9	2.0	3.4	3.0	1.1	8.3	1.9	3.5	2.5
CYB5B	CYB5-M	ENSG00000103018	"Cytochrome b5 type B"	O43169	16	69424619-69466264	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 318.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007893	Approved		Approved	"Endoplasmic reticulum,Centriolar satellite,Cytosol"		NA	NA		99000	"Cluster 44: Non-specific - Transcription"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"	"Centriolar satellite, Cytosol"	"HPA007893: AB_1847369"	"unprognostic (1.13e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (2.51e-4)"	"unprognostic (2.87e-3)"	"unprognostic (4.35e-3)"	"unprognostic (3.87e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.10e-1)"	"prognostic favorable (6.38e-5)"	"unprognostic (9.69e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.30e-2)"	60.2	318.0	52.3	51.4	53.9	20.9	50.4	46.0	69.9	45.8	43.6	92.6	69.5	49.3	72.8	59.3	58.2	45.4	58.0	56.9	51.2	71.9	83.8	54.1	68.8	50.7	48.1	44.0	40.1	77.7	28.6	73.8	50.6	47.6	116.0	49.4	36.3	48.3	65.8	45.8	67.8	61.6	44.7	49.6	49.3	38.6	52.3	74.3	54.1	78.2	76.9	80.4	38.2	48.4	186.2	576.4	232.9	144.9	105.1	139.3	99.5	162.3	224.1	266.0	249.2	406.1	221.3	168.0	159.3	157.9	216.0	214.5	224.4	235.0	300.0	90.2	85.5	81.2	97.1	479.1	154.7	169.1	172.4	120.9	116.3	315.9	149.6	111.8	254.7	190.5	133.6	78.4	165.2	241.2	278.9	204.1	173.5	171.4	78.4	260.0	128.7	184.3	359.3	208.7	135.7	69.7	431.6	82.0	142.2	119.0	159.0	133.2	115.9	152.2	124.5	102.2	145.5	94.7	227.0	516.6	157.0	138.0	180.0	121.1	57.6	71.5	103.8	80.0	85.0	68.8	76.9	81.8	69.8	63.1	62.8	75.5	17.1	96.4	59.7	124.2	134.6	105.6	52.3	53.9	46.0	69.9	56.9	51.2	50.7	48.1	50.6	44.7	52.3	48.4	36.2	44.8	46.8	44.7	47.2	49.8	49.2	84.0	66.0	22.8	28.6	26.0	25.0	30.0	51.4	62.5	6.2	159.8	66.7	112.7	78.2	66.2	18.8	56.4	33.3	61.7	23.4	38.7	40.9	70.4	94.1	38.4	27.5	87.7	60.2	36.6	43.9	54.9	64.8	30.3	30.4	76.6	83.4	30.1	57.5	22.7	44.4	33.4	62.2	24.4	55.8	63.0	96.8	23.6	39.4	70.5	78.8	44.4	28.1	34.9	75.9	62.9	49.5	31.6	46.0	22.2	36.5	48.1	46.6	44.9	42.3	59.8	54.1	84.8	61.6	50.4
CYB5D1	FLJ32499	ENSG00000182224	"Cytochrome b5 domain containing 1"	Q6P9G0	17	7857746-7862282	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 71.9;Endometrial ciliated cells: 45.5;Late spermatids: 42.6;Respiratory ciliated cells: 47.3;Skeletal myocytes: 41.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA021632	Uncertain		Approved	"Nucleoli,Golgi apparatus"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoli, Golgi apparatus"		"HPA021632: AB_1847368"	"unprognostic (1.99e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.10e-3)"	"unprognostic (2.34e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.04e-4)"	"unprognostic (2.38e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.27e-3)"	"unprognostic (1.79e-2)"	17.2	13.0	8.6	5.5	9.4	7.8	12.1	9.6	9.7	10.2	16.0	9.4	6.2	10.1	15.2	8.2	26.4	8.7	15.0	9.0	10.1	17.9	12.6	8.3	4.8	10.0	10.8	13.0	11.4	10.8	16.6	6.6	9.0	11.3	7.1	30.0	10.3	11.6	10.6	9.6	6.3	8.7	9.3	6.0	8.8	8.8	11.5	7.5	21.3	13.6	5.4	7.4	7.8	8.0	24.6	17.9	8.5	22.4	14.8	13.0	5.0	12.5	12.2	13.0	12.4	11.3	4.6	10.5	8.6	10.0	7.6	21.3	18.9	16.1	19.4	7.1	21.9	6.9	24.6	16.3	6.7	12.4	4.7	11.2	19.9	22.8	20.2	8.0	14.0	25.3	5.2	7.0	7.3	10.7	19.5	5.0	10.7	16.0	18.2	13.2	3.9	10.7	20.4	4.7	11.4	7.6	19.9	10.8	11.6	8.5	12.6	5.0	9.9	9.9	8.7	17.8	15.9	3.7	9.7	5.8	20.8	6.7	6.5	0.3	0.9	0.0	1.0	0.7	1.1	1.2	0.8	0.5	1.2	0.5	2.1	1.1	0.9	0.6	0.4	0.5	0.8	0.7	8.6	9.4	9.6	9.7	9.0	10.1	10.0	10.8	9.0	9.3	11.5	8.0	21.8	12.8	19.5	5.9	4.5	5.1	6.7	4.9	1.8	4.8	22.2	18.4	0.3	7.2	11.0	5.5	20.9	4.2	7.7	5.0	13.7	4.2	71.9	45.5	16.3	14.7	6.0	0.8	6.8	3.1	2.7	13.2	13.3	27.2	10.8	4.6	6.8	8.3	3.9	1.7	5.9	8.5	4.1	1.6	4.3	42.6	4.7	29.1	5.4	2.8	0.3	6.7	0.0	0.5	2.2	7.7	4.5	3.8	5.1	7.8	4.5	11.9	47.3	20.3	6.6	41.9	7.5	4.4	2.7	8.5	6.1	2.6	4.4	2.9	8.3	2.5
CYB5RL	LOC606495	ENSG00000215883	"Cytochrome b5 reductase like"	Q6IPT4	1	54169651-54200036	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA042671, HPA060463"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA042671: AB_2678107, HPA060463: AB_2684286"	"unprognostic (2.03e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.90e-4)"	"unprognostic (6.45e-3)"	"unprognostic (9.75e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.08e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.86e-1)"	2.1	4.4	1.6	1.4	1.8	2.3	2.5	1.7	2.0	2.4	2.7	2.5	2.7	2.7	2.5	2.3	2.8	2.2	3.4	1.7	1.2	2.5	2.9	1.8	2.6	1.4	1.4	4.4	4.2	2.9	3.7	1.6	1.4	2.4	2.8	2.7	3.7	1.7	4.1	3.8	2.1	2.5	1.2	3.1	3.1	1.4	1.5	1.7	3.1	4.1	2.6	2.0	1.9	1.8	3.6	4.7	6.3	6.6	5.0	4.8	2.2	2.8	4.0	5.3	5.7	4.4	3.9	6.0	3.2	1.9	12.1	3.3	10.1	2.9	6.0	6.8	4.1	6.8	8.0	4.7	3.8	5.8	3.4	2.6	3.8	6.3	2.8	3.7	4.7	5.3	7.5	2.8	3.9	4.3	5.9	3.2	6.4	4.1	3.7	9.3	7.8	5.6	2.4	4.0	9.3	4.6	1.9	6.3	5.7	5.1	4.4	4.4	2.1	4.0	3.3	6.0	5.0	4.3	7.1	8.5	4.5	12.2	6.3	0.7	0.4	0.4	0.2	0.9	0.1	0.2	0.3	0.1	0.4	0.3	0.2	0.2	0.5	0.8	0.2	0.4	0.1	0.3	1.6	1.8	1.7	2.0	1.7	1.2	1.4	1.4	1.4	1.2	1.5	1.8	1.6	0.0	7.2	1.3	1.3	0.1	1.1	0.9	0.0	4.0	2.3	2.4	5.1	2.8	3.0	3.7	4.2	1.9	0.4	1.1	7.9	3.0	0.1	3.6	2.0	6.1	2.4	6.1	2.4	4.2	2.3	2.4	1.1	2.1	2.5	4.8	3.9	2.9	5.3	0.0	2.2	1.2	4.1	1.6	0.4	1.0	1.5	1.2	0.0	2.8	1.2	1.9	4.1	2.5	3.1	1.4	0.8	1.9	2.0	0.8	1.4	2.7	5.9	4.0	0.0	2.6	1.4	1.2	5.1	0.8	0.9	0.3	1.6	2.9	2.3	0.9
CYCS	"CYC, HCS"	ENSG00000172115	"Cytochrome c, somatic"	P99999	7	25118656-25125260	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Electron transport, Respiratory chain, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 799.8"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 1663.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004222, CAB005126, CAB018597"	Enhanced		Supported	Mitochondria		NA	NA		170000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria		"CAB004222: AB_627385, CAB005126: AB_2090472, CAB018597: AB_627383"	"unprognostic (3.06e-2)"	"unprognostic (3.39e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (2.81e-4)"	"unprognostic (4.44e-2)"	"unprognostic (7.04e-3)"	"unprognostic (5.67e-2)"	"unprognostic (6.22e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (1.30e-5)"	"unprognostic (1.18e-1)"	"unprognostic (4.94e-2)"	"unprognostic (8.75e-3)"	"unprognostic (7.04e-2)"	86.0	115.6	65.8	89.2	70.4	85.0	59.2	79.8	101.7	45.3	87.6	263.6	150.1	42.3	41.5	105.9	43.0	52.9	476.8	72.1	82.8	174.6	115.7	54.3	63.8	71.0	72.9	48.1	38.5	226.2	57.0	43.0	69.4	54.3	238.8	153.9	58.0	60.1	483.7	47.6	120.1	91.1	70.2	48.0	108.1	61.1	83.4	74.0	74.6	799.8	89.4	119.8	60.1	71.7	336.4	185.1	195.0	273.7	108.7	83.1	199.6	314.4	128.0	229.2	264.5	307.4	222.2	383.8	152.9	138.5	678.3	385.8	396.5	295.0	401.2	115.0	179.1	318.6	208.9	218.7	170.2	739.0	271.1	111.2	257.5	230.9	492.9	99.4	209.5	232.2	597.1	397.9	246.0	155.1	408.6	284.4	365.1	746.3	343.0	282.1	235.3	364.5	360.9	322.5	392.6	190.3	164.5	689.0	267.9	338.7	359.5	436.6	152.8	209.3	383.3	329.8	591.8	401.4	507.3	860.5	281.0	526.4	606.7	65.3	56.2	42.8	68.0	106.0	82.5	102.5	62.2	71.6	105.7	90.0	58.6	70.2	8.2	73.3	96.8	81.5	87.5	83.0	65.8	70.4	79.8	101.7	72.1	82.8	71.0	72.9	69.4	70.2	83.4	71.7	244.3	83.3	118.6	42.4	337.6	689.8	818.3	698.5	237.9	163.1	210.6	179.6	770.0	144.4	314.2	183.9	77.2	192.6	304.4	827.5	1663.0	278.3	496.4	154.8	120.2	183.3	384.9	162.6	53.2	216.0	351.0	257.3	287.5	197.5	212.6	68.7	81.0	210.8	353.0	132.9	64.6	522.5	502.5	141.5	715.2	161.8	90.1	329.2	590.5	16.9	245.8	220.9	197.8	17.1	24.2	303.8	570.5	93.6	358.7	551.9	392.8	638.6	146.1	195.2	138.1	294.7	962.3	423.1	211.1	402.7	715.2	349.3	349.7	146.9	600.2	884.1
CYREN	"C7orf49, FLJ22450, FLJ27285, MGC5242, MRI, MRI-2"	ENSG00000122783	"Cell cycle regulator of NHEJ"	Q9BWK5	7	135092363-135170795	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 69.1;Distal tubular cells: 72.4;Ductal cells: 51.0;Extravillous trophoblasts: 65.6;Hofbauer cells: 41.3;Proximal tubular cells: 47.3;Syncytiotrophoblasts: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA020060	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"			"HPA020060: AB_2290651"	"unprognostic (3.32e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.92e-3)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (8.89e-3)"	"unprognostic (2.92e-2)"	"unprognostic (3.21e-3)"	"unprognostic (8.39e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.60e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.69e-1)"	16.2	20.1	11.8	15.4	15.7	16.5	16.2	15.0	13.1	16.4	18.9	14.5	13.7	18.5	16.6	18.6	21.1	11.6	15.9	11.5	13.1	30.1	14.1	13.9	19.3	18.7	14.6	18.3	21.0	26.2	16.3	20.6	17.4	15.4	13.9	6.6	22.5	22.8	33.4	13.6	13.6	18.1	13.8	17.2	18.5	13.9	14.6	19.5	15.0	18.9	23.7	16.6	14.8	18.9	59.9	62.7	29.4	46.0	24.9	23.7	49.1	38.3	38.8	49.0	38.1	40.1	42.0	48.3	42.2	39.2	52.1	32.8	42.2	69.6	31.6	62.1	27.1	32.0	34.2	37.2	35.4	64.0	37.4	27.6	68.4	38.3	44.0	22.5	21.2	37.4	117.5	31.9	40.3	60.4	60.6	44.0	67.8	50.5	46.1	44.1	36.4	64.1	57.1	35.4	34.7	53.4	43.4	37.7	42.5	32.1	30.0	57.4	18.4	43.8	24.6	39.0	66.3	56.8	69.8	65.8	60.7	62.5	90.9	32.2	27.5	27.9	12.3	24.5	13.4	18.3	10.8	16.7	30.3	19.4	15.8	15.9	6.1	27.2	24.1	25.8	5.4	20.9	11.8	15.7	15.0	13.1	11.5	13.1	18.7	14.6	17.4	13.8	14.6	18.9	12.2	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	15.2	13.8	0.0	0.0	0.0	31.3	0.0	69.1	9.9	0.0	72.4	51.0	0.0	11.8	13.4	6.3	0.0	0.0	0.0	35.4	65.6	8.0	0.0	25.6	0.0	17.0	0.0	0.0	41.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	32.0	0.0	0.0	0.0	0.0	34.7	0.0	0.0	2.2	0.0	0.0	47.3	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	46.7	4.3	17.8	0.0	0.0
DACH2		ENSG00000126733	"Dachshund family transcription factor 2"	Q96NX9	X	86148451-86832604	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.1;epididymis: 3.6;fallopian tube: 3.7"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 27.0;Granulosa cells: 14.3;Inhibitory neurons: 31.3;Oligodendrocyte precursor cells: 71.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HAP1: 6.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA000258, HPA001367"	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA000258: AB_1078618, HPA001367: "	"unprognostic (5.73e-3)"		"unprognostic (3.22e-1)"	"unprognostic (1.54e-6)"	"unprognostic (3.66e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.34e-1)"	"unprognostic (7.71e-2)"	"unprognostic (6.48e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.74e-3)"	"unprognostic (5.01e-3)"	"unprognostic (2.63e-2)"	0.2	0.1	4.4	0.0	5.0	0.0	0.1	1.3	5.8	0.3	1.4	0.1	0.2	0.3	3.6	0.0	3.7	0.0	0.0	5.7	7.0	1.0	0.0	0.1	0.0	3.7	3.6	0.5	0.2	0.0	0.5	0.0	3.9	0.4	0.0	2.0	0.5	0.1	0.0	0.0	0.3	0.0	2.0	0.0	0.4	0.0	8.1	0.0	0.1	0.0	0.0	0.3	0.0	3.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	5.0	1.3	5.8	5.7	7.0	3.7	3.6	3.9	2.0	8.1	3.0	0.4	0.0	0.0	4.6	0.0	0.4	0.1	0.0	0.0	2.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	27.0	0.0	0.0	0.1	0.0	0.0	0.0	14.3	0.0	0.0	0.1	3.3	31.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	4.2	0.0	71.4	4.3	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1
DAGLB	"DAGLBETA, KCCR13L"	ENSG00000164535	"Diacylglycerol lipase beta"	Q8NCG7	7	6409126-6484190	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069377			Supported	"Nucleoplasm,Plasma membrane"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Nucleoplasm	"HPA069377: AB_2686132"	"unprognostic (2.39e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.13e-3)"	"unprognostic (1.42e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (7.18e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-2)"	7.3	15.6	9.9	6.7	9.9	15.0	6.6	7.3	11.1	7.0	5.9	6.7	7.6	5.8	3.6	8.0	5.9	6.4	5.6	11.2	8.8	4.9	7.9	9.3	7.4	9.7	7.7	7.9	6.9	7.0	4.3	8.7	8.0	5.3	5.0	3.4	7.7	4.5	13.3	12.4	7.6	5.8	8.4	8.5	7.1	5.5	8.1	8.1	7.5	7.0	6.7	5.8	7.3	10.7	21.6	23.9	10.9	14.3	16.1	12.5	8.4	29.8	21.3	26.6	28.7	13.6	24.4	12.3	12.5	15.4	64.8	32.4	17.8	16.7	15.2	5.8	11.7	6.6	26.9	9.4	17.3	18.8	10.1	11.3	27.2	17.9	17.5	10.7	11.7	15.6	18.2	6.1	15.9	16.2	6.7	26.9	39.6	11.3	18.5	57.4	12.7	25.5	16.8	8.1	13.5	8.4	17.7	26.7	5.3	17.2	19.0	34.7	14.4	22.4	41.9	28.1	13.9	6.2	11.2	10.4	11.3	28.9	28.2	10.8	22.8	22.0	6.2	21.3	5.5	8.2	4.8	4.1	28.6	4.7	11.4	6.7	10.2	3.9	19.5	5.0	4.3	12.2	9.9	9.9	7.3	11.1	11.2	8.8	9.7	7.7	8.0	8.4	8.1	10.7	6.5	9.6	12.6	5.9	7.9	16.8	3.6	6.2	12.0	4.5	5.7	5.7	3.1	4.3	5.0	5.5	2.1	5.1	4.8	12.2	0.0	7.0	0.4	10.3	6.8	9.0	2.4	13.3	13.8	6.2	8.9	5.4	19.4	19.9	3.8	5.5	8.9	8.0	17.2	0.0	9.2	5.8	6.1	16.1	17.4	1.7	6.2	16.3	5.4	26.2	15.8	1.4	7.2	2.5	6.5	12.2	8.0	2.2	5.0	5.7	10.6	1.6	3.8	4.3	0.0	4.0	5.0	8.5	7.1	9.4	13.4	12.4	6.7	7.4	7.6	4.3
DAP3	"bMRP-10, DAP-3, DKFZp686G12159, MGC126058, MGC126059, MRP-S29, MRPS29"	ENSG00000132676	"Death associated protein 3"	P51398	1	155687960-155739010	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	Apoptosis	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023687	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Mitochondria"		"HPA023687: AB_1847472"	"unprognostic (2.60e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (1.80e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (4.14e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-1)"	57.0	63.6	32.5	54.7	34.9	66.7	66.2	33.6	38.8	43.3	32.5	55.7	58.7	46.0	52.3	54.5	41.9	38.6	88.1	36.1	37.5	63.1	88.2	44.6	69.3	36.1	35.8	38.1	69.3	49.4	42.4	41.2	38.9	50.7	61.4	71.9	53.3	49.4	129.9	60.1	47.6	53.2	32.1	51.3	59.1	42.3	37.1	80.8	48.9	89.4	78.6	58.4	45.3	41.6	144.9	91.9	73.5	116.7	105.9	133.0	180.0	118.8	124.8	119.4	103.8	170.7	172.4	204.1	235.0	97.3	76.5	143.1	110.3	103.7	129.8	128.6	80.4	124.7	80.5	156.5	144.5	173.3	106.4	112.1	145.8	152.2	199.4	93.3	119.2	185.2	274.5	141.2	125.6	192.0	152.6	200.9	130.1	225.2	146.9	124.2	92.1	218.9	142.5	136.0	84.9	150.4	113.9	331.9	211.6	135.1	206.4	279.8	102.8	100.5	106.1	126.0	202.6	152.9	245.9	235.3	100.2	151.6	132.7	65.4	110.5	61.6	110.1	134.2	179.0	141.5	155.8	133.9	152.0	121.1	192.5	167.5	47.8	136.0	128.0	99.1	173.1	162.1	32.5	34.9	33.6	38.8	36.1	37.5	36.1	35.8	38.9	32.1	37.1	41.6	31.8	44.8	43.6	34.0	59.2	54.9	67.2	94.2	52.9	28.2	54.6	43.8	106.2	51.5	68.3	16.5	20.9	76.2	45.0	33.2	66.5	79.8	19.0	44.9	40.5	38.1	25.7	63.8	52.7	78.6	98.5	41.3	35.7	38.7	62.1	34.9	33.2	57.4	77.8	13.5	57.4	41.9	59.0	59.4	62.9	15.3	32.3	53.0	35.6	30.9	83.7	22.2	55.6	26.7	47.1	73.8	30.8	25.2	52.4	81.7	41.7	78.0	61.2	46.4	13.1	33.7	45.1	48.3	29.3	51.1	63.1	141.6	66.4	73.3	62.5	73.5
DARS2	"FLJ10514, mtAspRS"	ENSG00000117593	"Aspartyl-tRNA synthetase 2, mitochondrial"	Q6PI48	1	173824653-173858808	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026506, HPA026528"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Mitochondria	Nucleoplasm	"HPA026506: AB_1847482, HPA026528: AB_1847483"	"unprognostic (3.14e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.05e-3)"	"unprognostic (4.10e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (1.74e-4)"	"unprognostic (3.30e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.73e-3)"	8.8	9.8	3.1	7.6	3.5	5.4	7.5	3.7	4.3	7.1	11.5	14.6	8.7	4.3	4.7	6.4	5.2	4.8	8.4	3.1	3.8	19.9	13.5	5.7	9.2	3.3	3.6	4.4	5.7	15.5	2.9	7.6	3.4	5.3	15.4	5.2	5.2	5.0	5.6	3.4	10.4	5.6	3.5	6.2	9.3	6.2	3.9	10.6	7.6	13.5	12.0	6.7	4.1	3.7	74.8	50.5	26.3	18.7	24.0	34.2	38.6	32.3	30.0	49.2	37.0	47.5	68.2	41.6	45.2	27.2	31.3	77.5	86.6	56.5	66.7	48.6	41.5	35.2	22.7	31.8	24.0	30.9	30.8	23.2	25.3	50.9	44.5	15.4	49.8	30.5	74.7	31.0	39.6	19.9	38.8	16.1	60.2	83.0	63.2	44.3	40.6	78.2	43.7	24.9	40.4	34.2	36.3	79.6	51.3	47.0	84.5	39.7	21.2	22.9	35.3	32.6	52.5	21.7	60.4	46.3	13.3	33.3	51.5	3.9	4.4	3.3	3.8	7.0	5.4	6.0	3.4	3.2	6.4	4.4	3.8	2.6	0.2	3.5	5.0	2.5	3.9	3.5	3.1	3.5	3.7	4.3	3.1	3.8	3.3	3.6	3.4	3.5	3.9	3.7	3.7	3.2	3.1	7.2	5.7	1.8	4.1	3.1	6.2	2.3	3.3	2.5	12.6	4.3	4.2	5.5	0.0	9.7	3.1	4.8	7.9	3.9	2.5	3.9	4.9	4.5	4.2	9.4	5.3	2.7	16.0	3.9	7.1	4.5	5.7	4.5	1.8	5.4	10.3	3.3	6.5	5.2	0.0	4.4	2.2	1.5	3.1	5.1	1.8	8.4	5.6	2.9	3.1	4.0	5.1	3.8	1.9	1.5	7.1	2.6	5.9	7.1	3.0	2.7	0.0	6.2	4.0	8.9	7.1	8.0	1.6	4.2	4.4	9.2	7.2	2.9
DAXX	DAP6	ENSG00000204209	"Death domain associated protein"	Q9UER7	6	33318558-33323016	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Transcription, Transcription regulation"	"Chaperone, Chromatin regulator, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 111.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002224, HPA008736, HPA008797, CAB025546, HPA065779"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nuclear bodies"		"CAB002224: AB_563688, CAB025546: , HPA008736: AB_1078625, HPA008797: AB_2797218, HPA065779: AB_2685558"	"prognostic favorable (6.05e-4)"	"unprognostic (2.90e-1)"	"unprognostic (9.66e-2)"	"unprognostic (4.04e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.46e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (6.32e-7)"	"unprognostic (2.43e-1)"	"unprognostic (5.37e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.04e-1)"	27.5	33.6	6.4	4.0	6.2	8.1	25.3	5.0	12.0	28.4	2.9	27.9	8.1	27.8	18.9	30.8	28.6	7.2	22.3	6.8	5.8	23.2	25.0	24.0	8.7	6.9	5.9	23.8	23.1	19.3	22.1	7.9	5.5	25.1	10.8	5.2	24.2	9.3	35.4	28.8	30.4	10.6	4.8	44.3	25.0	36.7	6.7	23.5	24.2	12.5	27.3	27.2	25.9	9.0	20.8	0.1	38.0	15.6	16.0	16.0	30.1	27.4	76.7	61.5	43.6	1.6	11.8	58.5	14.8	33.3	65.5	11.8	0.3	46.1	62.5	29.9	39.6	52.0	29.9	39.9	26.5	37.0	17.0	27.0	32.5	25.8	31.0	22.7	15.5	16.2	39.1	21.2	32.1	23.2	29.7	54.1	1.2	0.2	9.1	35.2	5.6	41.8	11.7	1.6	49.7	20.2	0.0	0.9	22.7	14.8	17.5	0.5	22.9	26.3	29.1	0.5	0.3	35.4	58.3	66.4	23.3	23.0	27.7	24.1	22.5	47.3	55.6	28.9	54.9	58.8	48.3	61.3	28.2	56.8	44.5	49.6	22.9	62.9	35.1	27.0	59.0	70.5	6.4	6.2	5.0	12.0	6.8	5.8	6.9	5.9	5.5	4.8	6.7	9.0	18.4	6.4	22.8	5.2	45.3	58.5	23.5	36.2	48.3	19.2	25.8	19.4	7.9	18.6	27.6	12.9	18.8	25.2	41.3	23.3	23.5	38.5	15.7	14.5	54.8	23.9	21.0	27.1	3.7	38.3	35.9	25.2	16.8	23.6	37.9	12.9	16.4	14.5	24.3	15.2	3.8	21.2	12.2	17.2	42.5	7.6	17.7	19.7	24.9	6.5	48.8	29.9	52.5	5.0	4.6	45.4	21.8	23.3	38.7	31.8	20.3	14.4	15.6	111.1	13.1	18.7	19.9	63.8	41.5	45.9	60.9	24.8	42.8	24.1	22.0	35.7
DAZL	"DAZH, DAZL1, DAZLA, MGC26406, SPGYLA"	ENSG00000092345	"Deleted in azoospermia like"	Q92904	3	16586792-16670306	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Translation regulation"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	79	"testis: 79.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 64.1;Late spermatids: 41.2;Spermatocytes: 257.9;Spermatogonia: 143.1"	"Cancer enriched"	"Detected in single"	51	"testis cancer: 13.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"HAP1: 18.8"									"HPA019777, HPA047113"	Enhanced					NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA019777: AB_1847495, HPA047113: AB_2679936"	"unprognostic (5.61e-2)"	"unprognostic (5.27e-3)"	"unprognostic (2.80e-1)"			"unprognostic (5.85e-2)"		"unprognostic (2.32e-3)"	"unprognostic (2.60e-2)"	"unprognostic (6.34e-2)"	"unprognostic (4.91e-2)"	"unprognostic (9.69e-2)"		"unprognostic (7.79e-2)"	"unprognostic (2.04e-1)"		"unprognostic (3.47e-1)"	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.4	79.6	0.0	0.0	0.0	0.1	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	41.2	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	257.9	143.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0
DBF4B	"ASKL1, chifb, DRF1, FLJ13087, ZDBF1B"	ENSG00000161692	"DBF4 zinc finger B"	Q8NFT6	17	44708608-44752264	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 30.0;Horizontal cells: 30.3;Oligodendrocytes: 30.9;Spermatocytes: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA048465, HPA077959"	Approved		Supported	Nucleoplasm,Vesicles		NA	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA048465: AB_2680405, HPA077959: "	"unprognostic (2.44e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.37e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.53e-4)"	"unprognostic (7.61e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.08e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.23e-6)"	"unprognostic (1.50e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.39e-1)"	0.9	0.7	1.1	1.2	1.1	2.0	1.3	1.2	1.8	1.5	0.5	1.9	0.6	1.9	3.5	1.4	1.8	0.7	0.8	1.1	1.0	1.6	0.6	0.8	1.5	1.1	1.0	1.7	0.9	0.8	1.7	0.9	1.1	2.3	1.2	2.9	1.1	1.3	0.6	2.0	1.5	1.5	0.8	1.6	1.3	5.1	1.2	1.9	2.7	0.4	1.3	1.6	1.3	1.2	3.7	7.7	5.7	4.2	0.5	1.1	4.9	3.9	1.7	8.1	7.9	3.3	3.1	5.5	2.1	1.3	7.2	3.6	5.0	1.7	9.3	9.2	8.2	7.0	6.2	4.3	0.2	4.8	5.9	0.5	0.6	4.4	1.4	1.8	4.1	9.3	8.9	5.6	4.4	4.0	7.1	2.9	2.5	7.7	4.0	6.2	6.6	2.3	1.8	2.2	3.1	3.4	3.8	1.2	2.9	6.1	3.9	3.1	1.8	2.8	5.2	3.6	7.2	2.6	3.5	7.2	2.1	4.1	4.3	0.0	0.1	0.4	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.1	0.1	1.1	1.1	1.2	1.8	1.1	1.0	1.1	1.0	1.1	0.8	1.2	1.2	2.1	0.0	1.1	15.0	4.0	0.6	2.6	1.2	1.2	30.0	1.5	1.3	1.1	0.0	2.1	5.5	12.5	4.2	5.8	0.6	0.0	0.3	8.1	2.0	2.2	2.8	4.2	5.5	11.4	0.8	1.4	2.3	1.5	1.1	3.8	9.6	3.3	0.3	1.4	30.3	11.0	0.3	0.0	1.3	3.1	7.4	1.2	2.5	5.4	5.6	1.4	7.2	2.1	7.5	30.9	0.2	0.2	3.0	3.4	2.0	0.7	0.5	1.9	15.7	0.0	4.5	2.0	35.7	16.5	1.9	0.1	1.4	1.4	5.3	1.1	2.3
DBR1		ENSG00000138231	"Debranching RNA lariats 1"	Q9UK59	3	138160988-138174921	"Predicted intracellular proteins"	"mRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035365	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA035365: AB_10611956"	"unprognostic (1.20e-1)"	"unprognostic (3.72e-2)"	"unprognostic (8.48e-3)"	"unprognostic (2.04e-2)"	"unprognostic (2.83e-1)"	"unprognostic (9.40e-2)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (2.33e-1)"	"unprognostic (5.24e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.33e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (5.37e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.79e-2)"	6.6	6.7	4.4	6.7	5.1	15.3	7.6	5.4	4.8	6.2	5.8	6.4	5.3	7.4	8.2	6.6	6.5	5.6	6.0	4.2	5.1	7.2	6.1	7.7	9.0	5.1	4.8	8.2	7.3	7.4	5.6	5.6	5.4	6.7	6.2	5.1	7.0	6.1	6.7	7.6	7.2	6.9	5.4	9.6	11.3	3.0	4.8	9.7	8.2	6.5	9.0	6.2	5.5	5.9	24.5	9.9	17.7	19.7	9.6	9.0	18.4	14.2	10.4	15.1	18.2	16.9	10.6	22.3	26.4	12.9	22.8	17.8	20.6	7.0	19.7	19.2	17.1	24.2	12.3	13.9	11.8	31.5	20.5	12.4	11.6	14.0	13.1	8.9	12.6	19.1	16.0	4.7	15.4	18.9	31.2	18.5	20.4	18.9	11.4	19.3	20.1	20.4	13.2	23.6	17.1	22.0	38.0	13.1	21.1	14.4	24.6	25.5	11.9	12.6	8.8	23.6	16.7	7.1	10.5	46.6	8.2	22.4	16.8	4.2	7.1	13.3	8.4	9.7	11.1	7.0	9.6	8.1	8.6	7.4	9.6	10.7	2.9	8.4	8.4	5.2	8.4	6.2	4.4	5.1	5.4	4.8	4.2	5.1	5.1	4.8	5.4	5.4	4.8	5.9	7.5	6.4	12.9	6.5	8.2	5.2	3.4	6.2	6.2	5.9	6.9	11.9	6.1	7.2	5.9	9.2	0.0	11.3	14.7	4.7	9.8	10.8	0.1	6.1	9.8	6.7	6.0	16.2	4.2	9.0	8.6	8.6	9.2	9.5	5.7	8.7	6.1	6.9	10.4	6.7	4.8	6.6	6.1	16.7	4.8	0.5	8.7	10.2	3.6	8.4	9.0	8.0	6.2	8.5	7.8	8.2	5.6	8.2	7.0	3.7	3.9	5.3	5.5	5.1	0.0	10.0	8.7	4.3	2.1	5.6	4.1	4.5	12.9	6.5	7.3	2.9
DCAF1	"KIAA0800, MGC102804, VPRBP"	ENSG00000145041	"DDB1 and CUL4 associated factor 1"	Q9Y4B6	3	51395867-51500002	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 53.4"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 17.9;Granulosa cells: 13.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036142, HPA052445, HPA053203"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA036142: AB_10669666, HPA052445: AB_2681835, HPA053203: AB_2682080"	"unprognostic (7.51e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.15e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.21e-2)"	"prognostic favorable (7.45e-5)"	"unprognostic (5.49e-2)"	"unprognostic (5.00e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.64e-1)"	11.4	11.3	7.6	11.7	8.8	15.9	11.2	11.2	9.4	9.4	9.8	11.0	7.9	10.3	9.4	10.6	8.9	7.4	9.5	7.8	9.3	11.0	11.5	10.0	14.8	8.4	8.8	10.3	10.4	18.9	8.6	10.3	8.6	9.7	10.9	19.7	11.3	9.6	27.9	13.5	11.4	9.2	8.0	11.3	10.3	53.4	8.5	18.6	14.6	16.1	15.9	11.2	10.0	9.0	19.9	23.9	22.8	20.7	20.1	15.9	21.6	21.8	16.2	23.1	22.5	26.4	18.8	48.1	11.7	17.2	35.3	17.1	43.3	19.5	29.6	33.7	21.5	41.2	32.4	22.8	14.7	54.4	28.7	10.6	22.2	29.8	21.6	15.0	18.2	26.1	24.5	30.3	18.3	20.3	41.8	22.0	24.0	23.5	26.0	17.5	24.4	32.0	18.0	30.5	11.8	21.0	24.1	22.0	13.2	16.7	15.0	22.8	22.9	18.8	25.1	31.4	33.9	20.5	29.7	48.2	21.9	36.6	15.7	2.5	3.0	2.4	6.5	3.3	7.4	5.1	5.6	5.6	4.8	4.9	6.0	5.1	0.7	5.8	5.0	3.8	6.7	4.9	7.6	8.8	11.2	9.4	7.8	9.3	8.4	8.8	8.6	8.0	8.5	9.0	11.1	3.2	10.6	0.0	3.6	0.0	0.0	0.0	0.0	0.0	11.3	9.4	0.0	0.0	6.8	3.7	0.0	7.6	9.7	0.0	1.9	7.0	0.0	11.2	10.3	5.6	0.0	0.0	0.0	6.7	5.7	3.0	0.0	17.9	6.3	13.1	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	2.6	0.0	0.0	0.0	0.0	7.5	0.0	0.0	2.8	0.0	0.0	6.1	5.1	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	10.5	5.0	7.4	0.0	0.0
DCAF17	"C2orf37, FLJ13096"	ENSG00000115827	"DDB1 and CUL4 associated factor 17"	Q5H9S7	2	171434217-171485052	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"		"Deafness, Diabetes mellitus, Hypotrichosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 56.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053339, HPA055040"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA053339: AB_2682119, HPA055040: AB_2682680"	"unprognostic (1.60e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.98e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.27e-1)"	"prognostic unfavorable (7.10e-4)"	"unprognostic (2.79e-2)"	3.9	4.5	5.2	5.4	6.6	3.4	6.4	6.6	6.1	6.1	4.3	5.6	4.5	6.2	6.3	4.4	4.6	3.8	3.5	5.1	5.7	5.6	4.5	3.8	7.2	5.5	5.2	7.1	5.0	6.0	3.8	5.3	5.8	5.0	4.6	13.9	4.3	4.5	3.9	7.2	4.7	4.6	5.5	6.4	4.4	5.7	6.9	7.8	10.2	4.3	6.0	5.6	5.4	10.6	8.5	6.9	8.9	10.6	11.0	11.7	13.6	7.3	7.5	7.3	6.8	8.3	5.5	24.4	5.4	9.1	5.5	8.2	9.1	9.0	9.9	11.4	6.2	11.3	6.2	15.0	11.2	16.2	7.9	9.2	11.6	9.3	20.7	8.6	8.0	7.6	17.9	8.2	10.1	5.2	17.9	14.9	13.2	6.2	4.3	13.4	11.7	13.4	6.2	7.6	7.8	11.3	6.9	5.8	7.4	8.3	4.5	8.3	9.6	8.4	7.6	4.8	6.4	12.4	18.3	20.5	8.9	8.2	8.8	1.1	1.3	0.5	2.3	1.5	3.4	1.3	1.8	1.7	1.0	1.8	2.0	2.5	0.0	1.1	1.3	0.8	1.8	1.6	5.2	6.6	6.6	6.1	5.1	5.7	5.5	5.2	5.8	5.5	6.9	10.6	5.8	0.0	7.5	17.9	8.9	4.7	4.7	4.2	8.6	10.1	7.8	6.0	5.0	7.2	3.1	7.3	12.5	6.5	6.0	4.4	9.8	4.8	2.2	6.2	10.7	5.2	10.2	6.9	18.0	3.9	5.7	5.8	8.2	4.9	3.8	8.2	2.5	7.7	5.6	8.4	23.5	4.5	6.1	8.4	4.6	3.6	6.2	5.0	3.6	15.0	4.4	8.8	5.2	24.6	56.5	6.6	2.0	6.0	6.4	6.3	5.5	6.2	6.1	15.2	0.0	6.7	7.2	13.5	17.1	8.7	5.1	5.6	7.5	9.0	4.3	5.0
DCAF7	"HAN11, SWAN-1, WDR68"	ENSG00000136485	"DDB1 and CUL4 associated factor 7"	P61962	17	63550477-63594279	"Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022948, HPA022962"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA022948: AB_1858820, HPA022962: AB_1858821"	"unprognostic (7.75e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.79e-2)"	"unprognostic (3.38e-2)"	"prognostic favorable (3.49e-4)"	"unprognostic (2.40e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.95e-2)"	"unprognostic (4.18e-2)"	12.4	13.6	23.3	22.6	23.1	9.0	15.5	20.1	21.0	19.8	17.8	23.9	25.9	16.7	18.8	17.5	19.3	16.7	18.1	22.2	23.0	26.5	14.3	21.6	29.1	22.7	22.7	16.5	18.4	37.4	12.4	26.7	22.8	21.9	25.7	29.9	18.1	23.3	13.3	14.0	25.0	18.9	24.9	25.4	20.8	14.8	23.6	37.2	22.1	15.3	32.4	22.3	12.8	23.2	33.2	46.4	79.6	51.0	26.9	22.2	20.9	32.6	28.7	35.3	29.7	34.2	35.2	61.2	25.7	32.7	36.9	34.7	67.0	45.8	45.0	23.7	42.7	79.9	29.3	40.3	27.7	89.7	44.4	18.6	29.7	20.6	46.8	42.5	55.8	50.9	85.7	27.8	45.3	40.9	97.7	43.0	25.9	57.5	61.7	77.1	94.5	34.9	51.4	49.7	76.4	141.0	29.4	56.2	38.9	70.0	41.5	72.1	59.3	58.0	26.4	29.6	54.4	28.9	39.6	32.2	33.0	57.1	35.2	10.9	11.3	12.6	11.2	13.1	9.0	8.1	7.7	8.7	10.6	8.3	6.9	7.5	4.7	8.9	16.2	7.8	5.9	8.6	23.3	23.1	20.1	21.0	22.2	23.0	22.7	22.7	22.8	24.9	23.6	23.2	28.5	44.8	45.9	30.3	57.4	31.4	30.5	49.8	46.7	55.4	29.3	25.1	30.8	38.6	38.1	68.0	77.2	51.7	49.0	47.2	23.5	50.1	95.5	30.5	38.0	43.1	72.0	62.6	42.3	45.2	47.7	33.8	31.1	30.1	60.2	67.1	48.9	40.2	55.4	65.6	41.1	49.0	52.9	64.3	45.2	27.6	35.1	61.9	26.6	43.1	72.9	53.1	69.0	36.2	40.5	55.0	41.2	38.0	45.0	45.3	67.7	52.0	43.7	54.0	59.2	23.2	35.8	96.5	35.0	51.6	34.8	21.6	53.1	49.8	57.2	47.6
DCLRE1A	"hSNM1, KIAA0086, PSO2, SNM1"	ENSG00000198924	"DNA cross-link repair 1A"	Q6PJP8	10	113834725-113854383	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036907	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA036907: AB_10673626"	"unprognostic (1.22e-1)"	"unprognostic (7.55e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (5.74e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.07e-1)"	"unprognostic (6.34e-2)"	2.1	3.8	3.9	3.9	4.2	4.6	5.2	4.2	5.5	4.0	4.1	4.3	4.1	2.9	5.5	3.3	4.1	2.8	4.4	4.2	4.3	6.0	9.8	3.6	5.3	3.8	3.9	5.3	7.4	8.4	2.9	4.2	4.0	5.9	5.2	8.0	5.0	4.0	3.6	3.7	4.0	3.2	3.8	4.0	5.2	4.7	4.1	5.0	5.1	3.3	5.3	3.2	1.9	4.1	15.8	13.0	19.3	19.7	2.5	4.2	11.0	9.4	9.5	12.5	14.3	10.2	21.1	12.2	10.4	4.8	9.7	12.9	18.6	8.2	16.1	24.2	16.0	20.7	8.0	13.1	8.2	21.9	18.8	2.8	9.8	10.5	18.5	8.3	7.7	16.3	24.1	12.9	7.1	9.4	10.6	8.8	9.4	12.5	6.9	6.1	23.0	8.0	8.3	7.3	8.4	13.9	5.4	9.2	13.8	13.2	11.0	10.5	6.8	7.2	14.1	9.8	15.6	14.9	18.2	18.6	10.7	31.5	10.5	1.3	0.3	0.7	2.8	0.2	1.8	0.6	1.2	1.9	1.1	0.3	0.8	1.4	0.1	1.0	0.5	0.4	3.2	1.2	3.9	4.2	4.2	5.5	4.2	4.3	3.8	3.9	4.0	3.8	4.1	4.1	0.9	6.4	4.1	4.9	1.3	0.6	0.6	2.8	0.6	4.2	2.9	1.9	9.6	5.7	3.6	1.8	0.0	3.0	2.0	2.2	7.9	1.9	0.7	2.9	1.8	1.6	3.5	6.5	4.9	1.1	1.8	2.5	1.5	2.0	1.3	3.6	1.8	7.7	3.2	6.7	4.7	2.5	4.1	3.8	0.6	0.5	1.5	10.3	0.0	2.8	3.6	3.9	2.1	8.0	4.1	1.6	2.3	1.5	3.0	1.3	1.6	3.7	5.1	3.9	0.0	1.7	1.2	6.0	5.4	2.5	0.6	0.7	3.1	2.4	3.4	0.7
DCLRE1C	"A-SCID, ARTEMIS, FLJ11360, SCIDA, SNM1C"	ENSG00000152457	"DNA cross-link repair 1C"	Q96SD1	10	14897359-14954432	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Adaptive immunity, DNA damage, DNA recombination, DNA repair, Immunity"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 62.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069295			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Golgi apparatus"	"HPA069295: AB_2686112"	"unprognostic (8.42e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.36e-2)"	"prognostic favorable (1.30e-4)"	"unprognostic (8.02e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (7.98e-4)"	"unprognostic (1.91e-1)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (9.03e-8)"	"unprognostic (2.43e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.45e-3)"	4.2	3.3	2.2	8.0	3.2	14.0	6.1	5.7	3.4	4.5	3.7	4.3	5.2	4.4	3.8	7.1	3.7	4.0	2.3	2.2	2.2	3.5	2.6	4.9	14.1	2.8	2.7	4.5	3.1	3.8	2.2	4.4	3.1	4.0	5.2	4.9	4.5	3.7	3.0	6.9	5.4	3.9	2.5	10.4	5.9	1.9	2.9	12.3	5.5	2.7	12.8	5.4	5.1	3.7	16.2	7.8	6.9	13.8	6.4	8.2	6.6	9.7	5.3	13.0	13.5	8.9	13.4	21.7	3.8	7.6	9.2	13.7	7.6	5.1	10.9	13.4	8.0	16.7	8.9	6.0	5.1	10.0	18.4	6.6	4.8	12.7	5.3	8.2	7.4	13.9	10.5	17.4	8.6	7.4	14.9	9.9	4.7	14.4	3.5	17.2	9.2	12.1	6.5	6.0	3.6	6.9	10.7	10.2	27.5	5.3	12.8	18.5	6.0	8.3	11.6	17.1	10.8	9.9	19.1	21.5	8.1	10.5	11.8	27.4	13.9	20.0	12.1	18.9	14.5	25.1	14.1	15.0	20.9	28.1	12.2	13.2	13.2	11.0	17.5	22.4	11.9	8.9	2.2	3.2	5.7	3.4	2.2	2.2	2.8	2.7	3.1	2.5	2.9	3.7	6.6	3.2	6.9	17.9	27.6	17.3	20.8	10.9	5.7	24.8	7.8	4.3	4.4	11.5	26.1	14.7	62.6	15.1	21.8	10.9	3.9	9.9	26.8	8.5	8.6	8.2	6.7	22.7	12.4	11.1	21.9	10.2	7.1	13.1	6.3	14.1	10.4	1.9	10.2	32.0	10.6	7.3	10.2	19.8	20.6	2.3	12.5	13.3	19.6	16.9	21.8	10.4	35.0	12.5	11.9	14.9	15.5	11.3	13.4	21.5	12.3	2.7	22.3	47.9	19.7	18.1	11.9	13.9	18.5	7.3	21.2	5.1	14.8	12.4	8.6	41.4
DCP1A	"HSA275986, SMAD4IP1, SMIF"	ENSG00000272886	"Decapping mRNA 1A"	Q9NPI6	3	53283429-53347586	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Nonsense-mediated mRNA decay"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013202	Approved		Supported	"Cytoplasmic bodies"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Cytoplasmic bodies"		"HPA013202: AB_1857287"	"unprognostic (2.10e-1)"	"unprognostic (7.61e-2)"	"prognostic favorable (9.01e-4)"	"unprognostic (9.79e-3)"	"unprognostic (7.68e-2)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (3.25e-5)"	"unprognostic (2.90e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.37e-2)"	"unprognostic (7.33e-3)"	"unprognostic (9.14e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.95e-1)"	9.3	8.2	4.3	8.7	4.9	29.9	8.9	11.3	6.8	8.5	5.5	8.5	6.1	11.7	5.8	7.9	9.1	8.2	8.0	4.6	4.9	6.0	6.4	7.7	10.3	4.6	4.6	14.9	6.3	10.3	6.3	10.2	4.8	7.9	8.4	8.6	6.1	6.9	9.5	7.4	7.3	10.4	4.1	9.2	6.8	8.2	5.2	14.2	8.7	9.5	9.8	9.0	7.0	6.3	8.3	8.3	19.4	15.8	13.1	13.5	26.3	9.5	12.5	20.5	19.0	24.7	14.5	18.9	3.7	12.0	12.3	6.8	25.3	9.7	17.8	16.9	11.3	18.5	11.8	12.9	11.4	23.0	24.6	10.7	9.4	18.5	15.0	12.6	15.1	13.2	16.4	20.2	10.1	5.0	30.6	11.2	13.1	8.6	12.1	14.0	12.9	13.2	8.6	18.2	10.1	16.7	16.3	10.7	14.3	14.4	7.0	17.8	16.3	9.8	14.1	10.3	14.5	12.9	11.9	21.9	12.0	12.8	17.8	46.9	25.0	43.0	41.0	25.5	50.4	38.9	41.4	47.8	27.1	48.7	49.6	46.8	26.0	54.3	52.3	31.4	30.9	38.5	4.3	4.9	11.3	6.8	4.6	4.9	4.6	4.6	4.8	4.1	5.2	6.3	28.6	28.9	30.7	26.4	43.6	57.5	48.5	32.4	48.9	27.5	32.7	25.5	26.4	15.7	24.7	7.3	47.9	41.1	34.5	25.5	3.9	29.2	10.8	21.5	33.4	33.5	51.8	20.2	43.4	35.1	52.3	33.6	18.3	34.0	36.8	34.8	24.7	13.2	19.9	28.6	40.5	27.6	24.4	27.6	48.9	26.3	24.8	29.2	10.6	20.6	35.2	18.3	30.9	40.7	44.2	45.0	19.6	25.9	31.8	48.4	22.3	13.5	14.2	30.3	13.1	39.2	32.5	12.8	19.1	27.4	41.2	64.0	39.1	27.7	27.9	62.1
DCP2	NUDT20	ENSG00000172795	"Decapping mRNA 2"	Q8IU60	5	112976702-113022195	"Enzymes, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011677, HPA057676"	Approved		Approved	"Nucleoplasm,Cell Junctions,Cytoplasmic bodies"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytoplasmic bodies"	"Cell Junctions"	"CAB011677: AB_731858, HPA057676: AB_2683500"	"unprognostic (2.76e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.86e-3)"	"prognostic unfavorable (4.84e-4)"	"unprognostic (1.87e-1)"	"unprognostic (3.64e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.30e-2)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (8.39e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.25e-2)"	"unprognostic (5.75e-2)"	4.6	4.0	5.9	8.1	6.0	14.0	6.9	9.8	5.7	6.0	6.6	3.9	3.7	4.3	3.4	4.1	4.7	3.5	3.4	5.9	7.2	4.8	4.7	6.9	12.6	5.5	4.9	6.7	3.3	3.1	3.7	12.1	5.8	4.4	4.1	7.4	5.3	3.5	4.8	5.8	5.1	3.3	4.5	10.2	4.0	3.8	8.5	17.9	3.7	3.9	12.3	4.4	5.2	5.1	6.4	5.6	24.1	19.0	4.5	5.3	37.0	6.7	4.3	7.2	9.8	25.0	13.1	32.2	8.5	3.2	5.6	7.9	27.6	7.1	8.8	9.0	11.0	29.5	4.6	9.9	5.4	20.1	15.3	4.8	5.3	8.4	9.0	6.9	12.5	24.8	22.7	12.0	6.1	8.1	29.6	19.6	20.8	4.0	2.9	27.0	22.7	12.2	10.5	15.4	5.6	11.4	8.3	8.8	11.3	24.1	25.3	24.4	7.7	7.8	13.9	4.4	8.8	8.8	19.8	23.6	4.7	26.0	6.3	14.0	4.9	3.7	3.0	6.1	4.2	3.8	3.7	3.0	5.1	2.5	3.4	3.7	9.4	3.5	7.3	2.9	4.3	2.6	5.9	6.0	9.8	5.7	5.9	7.2	5.5	4.9	5.8	4.5	8.5	5.1	30.0	19.2	16.8	16.0	50.7	27.8	19.9	22.3	31.9	24.7	43.5	26.4	12.4	8.6	24.1	20.2	79.2	66.7	65.0	11.6	19.6	11.2	24.3	21.7	38.1	28.9	16.2	41.9	25.5	11.8	49.6	25.7	17.3	25.7	19.6	66.7	28.5	7.0	31.7	28.6	34.1	8.9	20.3	78.1	41.5	53.8	19.0	57.4	26.6	56.2	90.7	36.9	35.0	26.7	28.8	17.3	10.6	10.9	27.1	33.3	13.8	14.4	22.7	34.6	6.6	16.5	32.3	36.6	29.5	20.0	26.6	64.4	50.1	52.0	13.1	48.8
DCTN5	"MGC3248, p25"	ENSG00000166847	"Dynactin subunit 5"	Q9BTE1	16	23641466-23677472	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042003, HPA063710"	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA042003: AB_10796468, HPA063710: AB_2685101"	"unprognostic (5.90e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.28e-2)"	"prognostic unfavorable (4.02e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.36e-2)"	"unprognostic (6.78e-2)"	"unprognostic (9.28e-2)"	"prognostic favorable (4.48e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.55e-2)"	13.9	11.3	14.6	18.1	18.1	41.5	14.2	10.4	18.3	13.6	3.8	19.2	20.8	14.8	12.0	25.2	13.6	14.2	14.7	17.2	13.0	21.0	10.7	14.0	22.1	11.4	13.6	12.0	15.9	19.8	8.5	20.9	11.1	14.1	24.9	21.5	12.8	14.0	13.9	14.1	22.2	21.7	11.4	15.1	16.7	20.6	12.8	20.9	18.8	14.2	32.2	20.6	10.9	12.9	30.0	58.5	56.0	46.9	39.0	28.9	39.2	51.9	32.1	32.9	39.3	66.5	40.3	42.1	41.2	54.8	34.6	30.6	93.4	50.2	40.5	48.1	37.1	51.9	67.2	93.9	26.5	63.7	38.4	24.3	35.3	40.5	42.8	36.5	52.8	52.0	100.7	31.6	53.3	82.4	49.4	18.4	66.3	43.3	25.5	59.8	48.6	45.9	26.2	62.6	46.8	48.5	45.6	36.7	30.5	49.0	51.2	53.2	71.8	44.0	20.0	34.9	36.6	42.6	68.6	66.2	42.0	31.4	48.8	14.3	16.6	20.3	15.5	14.0	17.1	13.9	14.2	17.0	17.5	10.5	12.0	14.3	7.3	22.0	22.0	12.4	19.0	17.2	14.6	18.1	10.4	18.3	17.2	13.0	11.4	13.6	11.1	11.4	12.8	12.9	19.7	16.0	26.2	12.1	19.1	14.7	14.5	12.9	22.8	52.1	15.5	14.5	27.1	15.7	15.6	20.2	91.8	32.9	16.1	36.2	11.7	23.8	23.2	11.9	22.4	22.5	22.1	27.6	13.4	25.2	36.3	16.3	20.9	20.8	27.8	37.3	17.2	14.2	28.4	52.2	13.2	18.9	12.2	19.1	11.4	23.4	13.1	17.1	7.2	6.5	34.4	32.3	30.9	11.1	12.0	45.7	19.4	18.0	17.4	14.4	31.9	23.3	11.2	45.0	13.1	22.4	18.1	70.4	30.6	20.9	14.2	48.2	18.7	17.9	26.2	22.0
DCUN1D1	"DCUN1L1, RP42, SCCRO, SCRO, Tes3"	ENSG00000043093	"Defective in cullin neddylation 1 domain containing 1"	Q96GG9	3	182938074-182985953	"Predicted intracellular proteins"	"Ubl conjugation pathway"		Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"testis: 246.2"	"Cell type enriched"	"Detected in all"	5	"Late spermatids: 13031.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035911	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		130000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA035911: AB_10673489"	"unprognostic (2.13e-1)"	"unprognostic (2.36e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.44e-3)"	"unprognostic (6.06e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.34e-2)"	"unprognostic (9.25e-3)"	"unprognostic (4.98e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.12e-1)"	"unprognostic (5.01e-2)"	"unprognostic (3.52e-1)"	14.7	12.3	10.5	12.3	13.9	22.4	13.0	13.2	16.3	11.6	4.0	14.0	13.7	12.9	9.4	18.1	10.4	12.8	15.7	10.0	10.6	19.2	31.5	10.6	15.4	11.0	12.3	12.4	10.2	12.0	8.4	12.6	13.0	13.6	13.1	11.3	11.0	13.9	34.5	14.4	14.4	15.4	11.6	12.5	11.4	246.2	12.0	13.6	17.7	38.1	17.5	14.9	10.2	18.3	54.3	23.5	31.0	13.1	32.4	30.8	26.3	33.9	37.8	37.4	36.2	34.9	39.0	63.6	72.5	32.2	56.4	29.4	27.6	28.5	49.8	52.2	14.3	61.1	17.2	14.8	20.2	36.6	44.3	23.3	32.6	22.3	20.7	28.3	26.7	38.0	20.6	32.6	27.9	28.8	36.2	19.0	25.3	40.4	21.7	27.9	32.4	41.6	27.5	37.6	22.4	22.3	59.7	41.9	33.1	32.6	86.0	29.0	25.6	22.9	22.2	31.7	40.3	26.5	53.3	64.0	29.0	33.8	33.8	10.2	8.5	16.3	6.7	9.2	6.6	6.4	5.6	6.6	10.0	4.1	6.2	6.8	13.7	10.5	6.2	7.5	7.4	5.5	10.5	13.9	13.2	16.3	10.0	10.6	11.0	12.3	13.0	11.6	12.0	18.3	23.5	22.4	29.5	54.2	22.3	43.3	26.0	28.3	23.3	13.2	26.6	15.4	32.5	21.5	30.1	47.8	10.4	18.8	36.3	29.1	37.2	28.3	2437.8	24.0	29.9	23.7	26.9	98.1	52.7	30.5	18.7	29.0	18.3	26.3	29.8	22.1	17.9	52.6	28.6	18.5	40.9	19.6	30.5	45.9	54.2	13031.2	86.6	39.5	12.4	30.0	45.9	18.1	20.6	37.7	91.9	31.9	24.1	64.3	20.2	42.0	27.3	42.3	24.0	22.6	78.9	35.9	37.4	124.6	58.7	25.7	42.5	20.0	27.1	15.3	20.7	43.6
DCUN1D4	KIAA0276	ENSG00000109184	"Defective in cullin neddylation 1 domain containing 4"	Q92564	4	51843000-51916837	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 111.9;Oligodendrocytes: 131.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036483, HPA036484"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles	Nucleoplasm	"HPA036483: AB_10670719, HPA036484: AB_10671843"	"unprognostic (3.16e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.47e-3)"	"unprognostic (1.61e-3)"	"unprognostic (3.88e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.93e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.40e-1)"	14.0	17.8	14.5	7.3	14.1	2.8	9.8	14.4	20.3	13.3	8.1	15.0	5.9	13.6	11.5	10.4	12.7	11.4	12.1	13.4	17.3	14.9	28.9	9.1	7.5	16.0	16.2	16.0	9.1	9.5	15.7	6.9	17.2	12.0	8.5	15.7	13.4	16.9	11.8	7.7	9.7	17.3	14.2	9.4	13.3	17.0	18.9	6.5	13.2	11.4	6.1	16.9	10.9	16.4	10.6	18.9	25.5	36.7	25.6	27.5	9.8	31.1	23.2	18.0	15.9	11.8	12.1	8.1	20.1	35.2	23.5	11.2	31.0	19.8	27.8	4.9	9.5	13.8	14.9	28.7	54.9	20.4	17.9	25.1	23.7	19.6	17.9	27.0	19.2	7.4	15.6	5.9	35.3	15.2	24.1	13.6	14.5	21.1	15.1	11.4	12.2	4.4	23.1	12.4	14.4	15.6	13.1	17.8	28.9	13.9	18.4	12.3	28.8	24.0	19.7	19.7	25.7	11.1	18.1	7.3	16.6	18.8	14.4	6.8	3.6	8.8	5.7	3.3	8.5	3.6	6.4	6.5	2.5	2.4	6.0	6.8	1.4	3.7	2.4	1.5	3.2	4.4	14.5	14.1	14.4	20.3	13.4	17.3	16.0	16.2	17.2	14.2	18.9	16.4	13.1	6.4	14.1	86.2	9.7	37.2	19.2	16.5	16.5	23.3	18.1	11.7	40.6	14.3	13.2	16.5	16.7	5.0	9.8	14.9	13.7	10.6	76.3	10.7	16.1	17.9	6.7	11.8	90.9	12.2	8.5	23.1	21.9	10.0	13.3	18.9	17.2	35.8	8.2	30.3	88.6	7.2	12.2	7.3	18.4	111.9	14.9	7.2	32.0	51.5	5.3	14.9	15.5	69.4	131.4	13.3	10.9	25.9	6.3	17.2	8.9	24.1	18.1	17.8	0.0	13.4	20.8	24.6	25.5	17.3	33.2	3.4	11.1	12.4	8.9	15.0
DDB1		ENSG00000167986	"Damage specific DNA binding protein 1"	Q16531	11	61299451-61342596	"Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 352.3;Rod photoreceptor cells: 451.4;Syncytiotrophoblasts: 389.4;Theca cells: 303.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032821, HPA045174, HPA068456"	Approved		Enhanced	Nucleoplasm		NA	NA		440000	"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"CAB032821: AB_639050, HPA045174: AB_2679242, HPA068456: AB_2685992"	"unprognostic (3.45e-1)"	"unprognostic (8.38e-2)"	"prognostic favorable (7.09e-4)"	"unprognostic (1.21e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.33e-2)"	"unprognostic (9.74e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.42e-3)"	"unprognostic (3.11e-1)"	"prognostic favorable (1.51e-8)"	"unprognostic (3.44e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.25e-3)"	52.8	164.8	30.2	44.0	32.5	47.2	59.0	29.5	30.2	61.3	42.5	50.0	53.2	48.0	79.7	49.7	78.3	39.9	65.1	31.9	36.4	64.8	55.9	43.1	47.0	31.8	33.5	89.3	42.5	232.1	44.5	129.7	36.9	56.6	52.3	162.5	54.1	70.9	133.1	60.6	49.9	61.9	31.9	41.9	44.4	69.1	33.5	81.2	65.0	125.1	66.6	58.6	39.2	36.1	160.3	168.1	159.0	142.2	151.4	139.2	237.8	140.9	193.6	174.4	129.2	188.7	130.7	237.6	126.8	203.4	107.4	141.4	245.5	177.5	188.0	115.7	131.3	128.0	144.3	192.0	109.4	182.7	112.6	169.1	121.7	174.0	146.2	123.5	195.7	86.0	278.4	119.9	158.9	194.7	238.4	77.4	214.5	104.3	146.3	197.9	198.5	254.3	119.7	177.3	140.3	143.0	154.6	183.8	145.9	144.8	226.0	85.6	150.9	120.9	113.6	138.2	106.4	139.5	157.0	194.7	134.9	103.7	121.1	38.4	43.6	36.5	46.7	47.1	61.1	35.8	42.0	47.3	60.5	30.5	37.8	43.3	4.6	46.4	45.3	34.2	49.6	54.6	30.2	32.5	29.5	30.2	31.9	36.4	31.8	33.5	36.9	31.9	33.5	36.1	34.2	28.9	69.9	46.4	48.8	52.6	53.6	61.1	51.2	87.0	52.0	39.9	105.6	34.3	54.5	53.3	352.3	283.5	57.5	45.0	17.6	43.9	15.7	46.6	40.8	48.1	74.2	102.3	27.8	42.4	130.1	50.6	46.4	51.3	30.9	102.7	45.0	67.4	75.5	87.5	31.6	55.4	44.7	45.3	33.5	18.8	85.1	38.3	42.7	30.0	61.1	64.4	71.1	24.1	31.0	52.6	36.4	62.1	65.4	55.7	63.2	46.7	64.4	451.4	32.9	51.5	44.5	114.0	120.9	52.3	59.8	389.4	46.0	303.8	60.0	57.1
DDI2	MGC14844	ENSG00000197312	"DNA damage inducible 1 homolog 2"	Q5TDH0	1	15617458-15669044	"Plasma proteins, Predicted intracellular proteins"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 82.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA043119, HPA043225"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		630000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Cytosol"		"HPA043119: AB_2678326, HPA043225: AB_2678369"	"unprognostic (1.93e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.04e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.31e-3)"	"unprognostic (8.31e-3)"	"unprognostic (1.02e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.51e-3)"	"unprognostic (7.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.63e-2)"	"unprognostic (3.77e-2)"	10.8	6.0	3.4	6.3	3.9	10.7	10.2	4.3	4.6	8.1	4.6	6.4	7.9	8.7	6.6	15.8	6.0	5.1	6.8	4.1	3.7	7.9	21.8	7.8	8.6	4.0	3.8	5.8	7.0	10.2	3.9	7.4	4.1	10.0	6.6	10.2	10.2	5.3	26.8	10.9	7.1	6.4	3.5	6.9	5.8	3.0	3.8	7.7	6.4	11.7	9.7	7.9	10.4	5.3	11.4	6.5	11.6	12.1	15.5	12.2	11.2	7.0	5.3	6.0	5.2	16.1	10.1	28.4	8.0	7.7	4.4	11.8	25.4	11.3	10.1	13.2	17.0	22.3	10.7	15.8	6.6	29.8	10.8	12.1	13.1	11.3	12.0	7.5	12.4	18.2	36.5	10.2	7.5	7.6	17.3	9.8	11.1	16.8	5.3	16.1	16.3	16.8	8.5	9.4	14.1	7.8	13.1	20.9	19.2	12.9	10.9	7.7	10.9	8.6	7.4	9.8	8.6	9.5	12.4	22.3	6.7	21.4	6.9	0.3	0.8	0.1	1.1	0.7	0.9	0.8	0.8	0.8	0.8	1.1	0.8	1.1	0.2	0.7	0.5	1.8	0.8	0.5	3.4	3.9	4.3	4.6	4.1	3.7	4.0	3.8	4.1	3.5	3.8	5.3	8.9	9.6	21.0	6.2	18.1	15.3	14.0	11.7	23.3	25.6	23.4	11.6	28.0	15.7	24.6	3.7	14.6	22.6	22.8	16.5	1.9	7.7	1.7	40.7	25.2	17.5	15.0	82.9	12.8	7.7	19.2	16.7	14.8	39.1	1.3	13.7	15.7	61.7	15.1	35.3	15.1	21.3	22.4	27.1	6.8	1.0	12.8	17.6	16.0	10.3	16.8	8.2	6.2	8.5	17.6	16.4	9.4	6.8	10.9	24.9	28.1	20.5	33.0	41.3	6.6	14.7	11.3	11.1	9.1	38.6	20.2	40.2	13.6	8.6	20.4	13.8
DDIAS	"C11orf82, FLJ25416, FLJ38838, noxin"	ENSG00000165490	"DNA damage induced apoptosis suppressor"	Q8IXT1	11	82899975-82958277	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 7.9;testis: 10.8"	"Cell type enhanced"	"Detected in many"		"Plasma cells: 8.2;Spermatocytes: 17.2;Spermatogonia: 18.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038540, HPA038541"	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Cytosol"		"HPA038540: AB_10672648, HPA038541: AB_2676071"	"unprognostic (2.53e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.32e-2)"	"unprognostic (3.86e-6)"	"unprognostic (4.65e-3)"	"unprognostic (1.01e-3)"	"unprognostic (8.24e-3)"	"unprognostic (2.04e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.11e-16)"	"unprognostic (7.17e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.13e-2)"	0.9	0.4	0.6	3.3	0.9	7.9	2.1	0.9	1.0	0.7	0.4	1.8	1.6	1.2	1.0	2.9	0.5	0.7	0.5	0.8	0.4	0.4	1.2	3.4	4.4	0.8	0.8	0.5	0.9	0.1	0.1	1.9	0.7	0.5	2.2	0.5	0.8	0.4	1.0	2.2	1.5	1.8	0.5	2.9	0.9	10.8	0.8	5.3	0.4	0.9	6.2	3.5	0.9	1.8	13.6	22.6	21.0	15.2	1.9	3.1	15.3	25.4	10.5	26.8	31.0	22.4	16.2	16.1	36.1	5.7	21.6	24.7	36.0	15.5	36.8	30.7	19.7	23.1	10.6	9.1	0.2	28.6	19.7	0.7	1.4	33.8	15.6	2.3	12.8	20.5	23.9	27.0	23.9	19.6	27.0	23.2	25.1	36.5	24.4	20.0	40.5	20.6	5.7	23.3	15.6	21.5	15.2	15.6	5.7	20.2	16.5	11.7	6.0	26.7	35.9	71.1	30.4	15.4	44.3	56.4	8.4	20.2	26.3	0.7	10.3	4.1	0.5	7.9	0.2	1.1	0.3	0.7	4.5	1.7	0.6	0.4	5.5	2.2	8.5	1.4	0.5	3.2	0.6	0.9	0.9	1.0	0.8	0.4	0.8	0.8	0.7	0.5	0.8	1.8	0.3	0.0	0.0	0.0	4.3	0.0	0.6	0.0	1.8	0.0	1.1	1.1	0.9	1.5	0.0	0.0	0.0	2.7	1.0	0.6	0.0	0.9	4.2	1.0	0.6	0.8	0.0	6.5	0.6	0.6	5.5	0.8	1.1	1.2	0.0	2.5	0.7	0.7	2.5	0.0	0.3	0.7	0.0	6.4	0.0	1.9	0.3	3.5	0.0	1.9	4.5	0.0	4.1	0.5	0.6	0.5	0.1	0.7	8.2	0.7	0.3	0.3	0.0	0.0	0.0	0.8	1.1	17.2	18.2	5.4	0.0	0.3	1.5	0.5	1.6	0.9
DDX1	DBP-RB	ENSG00000079785	"DEAD-box helicase 1"	Q92499	2	15591178-15634346	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, mRNA processing, Transcription, Transcription regulation, tRNA processing"	"Activator, DNA-binding, Exonuclease, Helicase, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 362.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012280, HPA034502, HPA034503"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		86000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"CAB012280: , HPA034502: AB_10794321, HPA034503: AB_10795025"	"unprognostic (9.94e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.07e-2)"	"unprognostic (8.36e-3)"	"unprognostic (9.28e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (9.09e-9)"	"unprognostic (2.55e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.81e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.03e-1)"	"prognostic favorable (9.69e-4)"	"unprognostic (3.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.20e-3)"	52.8	53.4	32.6	39.0	33.5	37.8	61.7	36.1	44.2	49.9	39.6	54.3	45.0	45.4	48.0	56.5	42.4	31.7	97.6	33.8	37.1	76.7	62.0	38.9	35.3	36.8	32.6	45.7	59.0	89.5	46.7	50.9	36.0	44.6	58.0	55.5	52.9	47.8	157.9	50.3	46.0	56.5	34.7	33.8	50.5	42.5	35.3	47.0	62.3	134.2	46.8	48.4	41.0	36.3	84.1	127.1	172.3	126.2	148.1	125.5	193.3	176.8	142.6	165.1	135.9	203.0	80.7	221.8	80.4	202.8	120.9	118.8	245.5	166.8	170.7	94.6	154.3	244.5	150.6	241.8	110.2	204.5	102.3	101.2	105.9	140.6	129.6	100.8	151.0	98.4	253.4	61.8	161.9	112.2	110.3	126.7	221.0	205.6	104.4	125.0	276.8	152.6	178.9	161.9	136.6	169.3	124.3	118.0	154.8	123.2	83.6	77.5	133.7	132.1	139.8	84.2	197.2	84.5	169.3	296.2	120.5	153.7	128.4	32.4	34.5	20.3	31.0	42.0	33.2	28.6	35.8	37.0	38.8	30.5	39.9	35.8	3.0	38.5	42.0	30.1	38.1	34.1	32.6	33.5	36.1	44.2	33.8	37.1	36.8	32.6	36.0	34.7	35.3	36.3	41.3	80.1	57.6	25.8	34.9	40.3	57.2	96.4	31.9	58.9	50.3	41.5	362.7	67.2	78.6	90.1	52.1	112.1	29.0	43.7	142.8	112.3	23.1	49.2	69.6	57.2	52.1	64.2	52.1	120.3	108.5	67.0	28.5	51.2	57.0	49.3	47.5	123.0	53.4	45.4	48.6	69.8	83.4	30.3	19.7	19.5	72.7	28.1	49.8	29.0	41.2	60.1	55.6	45.8	49.0	107.2	52.4	78.2	32.8	31.3	74.5	170.2	80.6	75.9	59.2	51.3	94.6	174.0	76.8	30.0	42.3	80.2	30.7	73.5	74.1	36.6
DDX19A	"DDX19L, FLJ11126"	ENSG00000168872	"DEAD-box helicase 19A"	Q9NUU7	16	70346861-70373383	"Enzymes, Predicted intracellular proteins, Transporters"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA045252, HPA066668"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA045252: AB_10961128, HPA066668: "	"unprognostic (3.11e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.07e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (2.38e-4)"	"prognostic unfavorable (8.05e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.68e-3)"	20.1	19.1	11.3	14.2	12.0	12.6	17.6	12.5	12.6	16.3	12.6	21.4	10.3	20.8	14.1	19.8	17.2	16.0	22.9	11.1	12.4	17.5	21.8	15.6	19.1	12.2	12.2	21.7	17.3	24.8	11.9	23.6	12.6	15.4	15.0	12.6	14.5	20.8	58.4	16.4	14.0	26.9	12.1	15.2	16.9	7.4	12.7	21.0	20.3	38.5	20.5	22.3	14.5	12.5	36.5	39.9	42.4	43.8	60.8	41.7	39.6	45.8	46.7	70.0	54.1	60.9	27.5	60.4	41.8	49.2	34.1	41.6	75.3	45.2	60.4	20.0	41.1	31.7	32.0	75.5	55.0	56.9	26.3	51.0	31.7	65.3	49.8	35.1	46.3	43.5	77.6	15.6	42.6	53.0	62.2	47.8	68.6	43.6	24.6	79.2	27.9	84.8	42.3	23.0	35.1	45.8	115.3	25.4	35.6	43.8	47.4	35.5	31.0	49.0	39.2	31.4	43.9	44.6	70.5	132.7	32.8	50.8	50.5	9.3	8.6	4.7	7.3	8.0	6.7	5.3	6.4	7.2	10.5	5.8	7.0	7.4	0.8	7.1	7.6	5.9	6.0	7.0	11.3	12.0	12.5	12.6	11.1	12.4	12.2	12.2	12.6	12.1	12.7	12.5	14.8	16.0	20.7	15.3	19.1	9.9	21.2	8.6	14.8	35.0	10.4	11.0	18.0	22.8	17.5	11.0	33.3	23.0	12.7	8.2	9.8	14.7	3.2	14.7	18.6	15.6	14.4	21.0	23.4	13.8	16.3	16.0	7.1	15.2	17.7	18.0	12.5	19.5	14.0	23.5	25.7	10.1	2.0	14.2	9.5	2.0	26.1	11.2	10.6	2.8	19.2	15.6	27.8	8.5	10.9	14.0	9.5	12.4	19.8	23.0	8.7	13.3	12.8	32.3	26.3	14.7	15.1	14.7	15.7	16.3	10.2	17.2	16.3	18.0	13.6	16.0
DDX19B	"DBP5, DDX19"	ENSG00000157349	"DEAD-box helicase 19B"	Q9UMR2	16	70289663-70335305	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 207.8;Spermatocytes: 101.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037229, CAB037284, HPA046380, HPA066668"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB037229: AB_1840791, CAB037284: AB_1840792, HPA046380: AB_2679645, HPA066668: "	"unprognostic (2.91e-2)"	"unprognostic (5.37e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.33e-2)"	"unprognostic (4.07e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.32e-2)"	26.9	20.5	8.2	14.8	8.3	29.5	23.8	13.5	9.2	15.7	9.4	18.9	18.9	16.3	13.2	18.6	16.6	15.2	17.7	7.9	8.4	20.5	40.0	19.2	22.1	8.4	8.4	15.7	21.0	19.0	14.4	14.8	8.6	16.1	23.3	19.4	19.0	17.5	31.7	32.3	19.5	20.1	8.3	18.1	22.1	45.9	8.3	23.0	20.0	23.0	25.7	20.0	16.2	9.8	5.3	31.8	44.3	40.3	23.9	31.6	38.0	25.3	36.0	54.6	56.6	67.7	38.5	41.9	23.5	32.2	22.3	31.2	0.2	14.7	56.1	17.7	28.5	25.0	20.0	56.5	51.4	53.7	22.9	39.3	28.0	41.5	31.2	22.5	42.5	12.7	25.1	17.3	33.7	37.1	0.1	77.0	27.6	19.9	13.1	73.9	23.8	59.9	33.2	29.5	29.0	37.1	60.0	13.7	33.1	19.3	30.5	47.1	25.8	25.8	22.6	21.6	23.6	37.6	20.7	96.4	8.7	41.1	33.8	80.6	46.4	42.0	46.5	61.1	45.0	45.8	41.3	50.6	44.6	45.3	36.4	35.1	8.7	52.6	40.2	14.2	77.8	54.6	8.2	8.3	13.5	9.2	7.9	8.4	8.4	8.4	8.6	8.3	8.3	9.8	16.7	12.8	21.8	7.5	21.4	9.4	16.5	20.3	11.4	18.4	12.4	11.2	8.0	14.3	20.8	11.0	12.5	19.7	19.5	25.4	31.3	42.3	207.8	10.6	8.1	19.6	22.0	8.6	11.7	66.1	24.4	16.7	13.7	10.6	11.4	13.8	12.5	15.5	29.3	10.1	12.4	18.4	16.2	21.0	21.6	46.7	20.8	17.1	3.6	6.5	33.6	17.0	28.8	7.5	11.0	45.8	35.3	15.8	13.2	28.6	49.3	23.5	24.4	17.9	13.1	9.7	13.7	101.7	7.4	9.2	10.4	31.6	19.0	13.9	22.2	20.4
DDX20	"DP103, GEMIN3"	ENSG00000064703	"DEAD-box helicase 20"	Q9UHI6	1	111754832-111775602	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 52.8"	"Group enriched"	"Detected in all"	5	"Early spermatids: 738.2;Late spermatids: 718.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005516, CAB015427"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB015427: AB_629518, HPA005516: AB_1849612"	"unprognostic (3.71e-2)"	"unprognostic (5.25e-2)"	"prognostic favorable (9.85e-5)"	"unprognostic (8.73e-2)"	"unprognostic (2.51e-2)"	"unprognostic (7.09e-2)"	"prognostic unfavorable (6.35e-6)"	"unprognostic (1.17e-1)"	"unprognostic (5.87e-2)"	"unprognostic (7.46e-3)"	"unprognostic (4.21e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.23e-1)"	"unprognostic (1.30e-2)"	4.6	3.6	0.8	1.3	0.7	2.3	4.3	0.4	0.9	4.2	0.3	3.9	0.5	4.8	0.9	3.3	4.5	1.6	3.6	0.8	0.7	3.0	2.6	3.2	3.0	0.7	0.8	4.3	3.6	2.5	1.9	2.4	0.5	3.0	1.9	0.8	3.3	2.5	8.8	3.6	4.3	2.8	0.5	4.8	3.8	52.8	0.6	3.7	3.2	1.8	4.2	4.0	3.3	1.3	7.0	3.8	7.1	7.3	4.7	5.0	7.0	3.3	9.1	16.3	18.6	5.8	4.5	17.7	5.2	6.4	3.9	5.8	13.5	9.4	18.2	7.3	9.2	7.4	3.2	3.0	4.6	8.4	6.1	3.0	10.4	9.2	12.2	2.4	12.8	7.2	10.8	5.9	12.0	6.5	11.8	0.9	14.1	5.2	8.5	11.3	12.7	5.3	4.8	5.2	11.7	9.5	6.7	7.0	12.7	5.7	7.0	8.5	3.5	7.9	8.2	13.2	8.6	1.2	5.3	12.3	7.5	8.1	18.5	14.9	6.2	6.0	8.2	5.6	10.7	9.3	9.1	8.4	6.8	9.1	10.6	8.6	3.4	9.1	6.6	3.5	10.0	6.9	0.8	0.7	0.4	0.9	0.8	0.7	0.7	0.8	0.5	0.5	0.6	1.3	8.5	12.8	9.4	6.8	13.0	10.8	9.7	6.0	9.6	14.3	6.5	6.6	7.7	5.7	10.0	5.5	2.1	10.2	9.4	2.9	3.9	9.5	738.2	8.1	12.0	9.3	4.2	5.9	7.4	6.9	7.5	6.9	5.1	5.4	7.6	12.3	5.7	5.9	9.3	6.7	7.7	5.8	8.2	7.2	7.0	718.9	16.4	7.3	1.8	3.7	7.5	6.9	6.2	3.0	3.6	6.3	2.3	13.2	9.0	5.2	3.0	7.6	11.8	10.4	6.6	9.7	11.7	121.7	26.3	7.0	7.2	5.1	11.1	14.0	6.6	5.5
DDX21	"GURDB, RH-II/GU"	ENSG00000165732	"DExD-box helicase 21"	Q9NR30	10	68956170-68985068	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, rRNA processing, Transcription"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 589.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036592, HPA036593"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No		40000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA036592: AB_10673625, HPA036593: AB_2675208"	"unprognostic (3.04e-1)"	"unprognostic (6.81e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (3.12e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.33e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.74e-3)"	55.9	27.9	7.9	52.7	8.8	103.5	36.2	8.9	9.3	22.0	7.7	26.5	25.5	25.2	13.4	40.3	24.0	32.4	21.9	7.4	9.7	30.0	42.1	31.5	50.0	10.8	10.1	20.1	45.7	24.5	12.9	38.0	11.0	19.0	32.0	8.1	20.5	17.5	47.9	30.1	21.8	28.4	10.7	30.2	26.4	22.5	8.8	33.6	25.1	26.9	51.0	81.7	23.5	11.3	194.4	112.5	64.5	199.7	56.7	74.4	135.6	129.8	104.3	163.8	138.3	366.7	128.8	289.5	77.8	108.2	77.2	168.1	250.4	161.8	217.5	90.7	176.1	203.2	76.9	153.3	121.2	488.9	184.7	76.8	205.2	196.2	324.5	76.1	121.3	106.8	393.8	140.5	116.8	88.1	192.9	106.1	176.3	91.8	236.8	170.1	105.3	143.0	108.2	102.7	132.5	141.6	116.6	254.8	155.5	76.8	144.9	101.1	125.6	95.5	136.0	129.8	230.7	160.4	228.2	418.2	79.3	362.4	66.5	7.6	10.9	20.4	8.7	17.1	15.9	14.0	11.4	11.8	13.0	12.3	10.6	11.8	4.9	9.4	21.2	12.1	9.2	7.5	7.9	8.8	8.9	9.3	7.4	9.7	10.8	10.1	11.0	10.7	8.8	11.3	199.4	102.5	141.6	8.1	243.7	550.2	346.2	103.8	174.2	25.9	159.9	113.7	74.2	94.4	144.1	71.7	41.7	80.8	139.5	134.0	72.4	141.2	50.8	116.7	260.7	196.7	86.7	98.6	18.5	187.8	151.8	162.2	120.8	201.8	168.5	57.1	104.2	215.3	112.4	25.2	16.0	202.7	67.1	154.5	266.8	19.7	89.5	199.1	124.5	12.2	138.1	25.8	64.9	13.6	18.2	222.9	77.7	77.1	148.9	465.3	59.9	128.2	72.8	29.8	26.3	302.6	174.9	105.5	114.8	224.8	589.7	137.5	159.6	99.4	210.7	375.5
DDX28	"FLJ11282, MDDX28"	ENSG00000182810	"DEAD-box helicase 28"	Q9NUL7	16	68020916-68023232	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis"	"Helicase, Hydrolase, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 99.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041911, HPA053585"	Approved		Supported	Nucleoli,Mitochondria,Cytosol		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Mitochondria, Cytosol"	Nucleoli	"HPA041911: AB_10794161, HPA053585: AB_2682200"	"unprognostic (8.11e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.10e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.69e-2)"	"unprognostic (8.46e-2)"	"unprognostic (9.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.63e-2)"	"unprognostic (8.14e-3)"	"unprognostic (8.53e-2)"	"prognostic favorable (2.07e-10)"	"unprognostic (1.58e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.47e-1)"	5.8	10.0	3.9	4.8	4.1	16.8	5.6	4.0	4.3	3.9	4.0	5.7	3.9	6.0	5.1	8.2	5.0	2.8	8.3	4.1	4.7	6.4	8.7	4.3	7.7	4.0	3.9	5.5	5.6	7.0	3.6	4.7	4.3	3.5	4.3	1.6	5.0	3.5	15.4	9.7	7.0	3.7	4.0	9.0	6.3	9.7	4.1	5.6	4.0	7.7	6.4	5.5	4.3	4.1	10.2	14.7	7.1	8.5	9.5	5.3	16.5	6.9	9.8	16.4	11.6	14.4	15.5	37.6	10.2	8.3	9.0	17.9	10.1	16.1	9.6	5.1	16.7	13.6	7.4	14.9	12.8	21.7	14.1	10.3	17.2	13.5	12.4	5.7	9.2	24.9	24.5	5.7	7.4	22.4	22.9	30.0	17.2	10.2	10.7	22.1	6.6	40.3	11.6	11.4	14.8	9.9	27.6	7.8	15.3	8.0	14.9	23.1	7.0	7.3	6.3	10.6	11.2	12.8	16.9	36.7	9.0	16.4	10.1	24.0	22.3	27.4	17.0	22.4	18.7	14.3	15.6	18.5	20.8	19.0	24.2	18.2	7.2	21.5	23.4	10.2	16.0	20.8	3.9	4.1	4.0	4.3	4.1	4.7	4.0	3.9	4.3	4.0	4.1	4.1	4.4	6.4	6.8	0.7	10.9	9.2	14.2	11.7	8.0	5.6	4.8	4.3	4.1	8.6	8.3	3.7	0.0	27.9	4.0	2.9	13.7	12.0	6.6	5.4	4.4	5.7	4.8	9.5	0.9	9.7	12.5	4.4	5.1	5.4	3.8	8.0	6.8	11.6	17.1	3.3	1.0	3.5	6.1	8.5	3.1	4.0	5.0	6.8	7.2	0.0	13.3	7.5	25.7	0.5	1.4	7.4	4.2	3.4	4.2	5.7	2.0	19.7	5.3	4.3	13.1	4.4	9.4	22.7	14.1	6.7	10.7	99.9	7.6	12.5	6.1	8.8
DDX31	"FLJ13633, FLJ14578, FLJ23349, PPP1R25"	ENSG00000125485	"DEAD-box helicase 31"	Q9H8H2	9	132592997-132670401	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 26.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020891			Supported	"Nucleoli,Golgi apparatus,Vesicles"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoli	"Golgi apparatus, Vesicles"	"HPA020891: "	"unprognostic (5.71e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.91e-2)"	"unprognostic (5.79e-2)"	"unprognostic (9.94e-2)"	"prognostic unfavorable (1.68e-7)"	"unprognostic (1.34e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.90e-2)"	"unprognostic (9.57e-3)"	"unprognostic (4.57e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.03e-1)"	3.9	3.8	3.3	5.3	3.9	4.2	6.3	8.8	3.2	4.8	4.0	3.9	3.1	4.5	5.0	5.7	5.2	3.6	3.3	2.8	3.7	6.0	5.5	4.5	6.6	5.1	3.8	9.9	5.8	5.4	4.2	3.5	5.7	5.4	4.7	3.2	8.2	4.3	6.1	8.4	4.2	4.2	2.9	4.8	4.0	6.0	3.6	5.5	13.8	4.2	7.2	5.2	4.9	4.7	12.4	22.2	10.8	14.4	12.4	11.1	20.4	12.9	12.2	19.2	14.5	24.9	24.1	29.9	11.2	11.7	20.8	33.5	32.8	14.6	15.4	18.4	12.3	16.4	19.5	13.1	14.9	29.7	12.8	9.9	19.5	19.7	27.5	7.5	12.7	22.1	30.6	11.4	16.1	26.3	20.6	15.9	26.2	35.4	22.2	21.4	19.3	34.6	17.5	11.4	18.8	13.5	23.4	20.2	18.0	12.2	42.8	8.4	11.1	32.5	15.0	18.7	19.8	5.5	18.8	23.5	12.0	18.2	25.2	0.0	1.1	1.2	3.1	1.6	2.4	2.1	2.9	2.4	2.5	2.7	3.6	2.7	0.2	2.0	1.1	1.6	2.0	1.7	3.3	3.9	8.8	3.2	2.8	3.7	5.1	3.8	5.7	2.9	3.6	4.7	3.3	6.4	6.0	16.6	7.2	5.6	4.5	3.0	9.1	4.3	5.9	8.1	4.4	0.0	10.2	7.3	4.2	5.7	4.7	3.6	1.9	6.2	4.1	3.9	6.6	3.6	24.6	1.7	9.7	5.4	6.8	4.4	4.1	4.6	1.3	6.1	2.9	4.1	5.2	1.7	13.9	5.8	6.1	2.9	1.8	3.0	18.0	2.9	1.8	5.6	4.5	1.7	8.2	26.7	17.1	5.9	1.2	13.2	5.7	5.8	0.7	7.1	5.7	3.7	0.0	4.1	3.4	14.0	13.7	8.8	6.3	3.0	5.0	5.7	6.1	3.5
DDX39A	"BAT1L, DDX39, DDXL, URH49"	ENSG00000123136	"DExD-box helicase 39A"	O00148	19	14408798-14419383	"Enzymes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 147.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 308.4;Late spermatids: 283.3;Spermatocytes: 307.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055334	Approved		Approved	"Nuclear speckles"		NA	NA		200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear speckles"		"HPA055334: AB_2682787"	"unprognostic (1.31e-1)"	"prognostic favorable (6.86e-4)"	"unprognostic (2.41e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.87e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.09e-2)"	"prognostic unfavorable (1.50e-10)"	"unprognostic (1.55e-3)"	"unprognostic (8.57e-2)"	"unprognostic (3.92e-1)"	"unprognostic (7.38e-3)"	28.2	21.6	17.1	49.6	20.7	105.5	24.7	21.9	23.0	22.1	18.0	26.4	28.6	21.9	8.7	39.3	18.2	13.6	24.9	17.0	18.6	21.0	21.9	25.1	76.2	21.9	19.8	14.9	15.7	10.2	15.5	18.1	22.0	16.8	20.2	4.7	19.0	8.8	20.7	24.4	33.8	15.1	19.0	55.7	27.2	147.8	20.5	80.4	20.5	12.7	65.1	25.9	22.7	25.2	198.8	175.9	87.8	147.2	32.4	22.4	73.5	84.8	48.0	176.1	105.7	183.3	98.7	375.0	87.5	71.1	101.0	114.8	215.7	135.9	74.3	129.0	127.3	408.5	201.0	133.1	55.1	225.1	164.0	30.1	30.6	113.1	47.0	25.4	89.1	134.4	253.4	150.3	95.7	270.9	375.4	320.1	147.9	208.8	280.4	248.9	139.7	212.0	62.5	179.6	181.5	98.2	64.3	127.8	98.6	54.3	138.0	216.5	83.1	144.5	92.7	245.7	192.6	156.0	313.0	399.3	167.1	232.2	148.9	33.2	92.8	29.6	120.1	107.9	106.2	132.5	96.0	96.3	131.1	125.8	83.1	90.1	27.0	84.1	94.3	82.7	153.0	135.5	17.1	20.7	21.9	23.0	17.0	18.6	21.9	19.8	22.0	19.0	20.5	25.2	55.6	16.0	21.4	4.9	90.0	76.0	43.6	53.0	50.1	10.5	30.0	24.8	10.9	21.5	27.4	5.5	0.0	60.6	75.1	60.5	37.2	55.3	308.4	26.6	30.6	53.0	25.7	88.1	3.1	67.2	117.9	33.3	87.7	44.5	93.0	32.7	26.0	12.9	90.5	11.8	3.5	55.4	26.4	48.6	85.2	283.3	26.4	62.7	49.8	4.7	56.7	16.2	50.4	4.0	9.2	53.5	42.7	18.8	115.6	44.5	41.7	26.0	21.1	4.9	19.7	24.8	62.0	307.5	95.4	69.4	71.0	59.9	78.7	32.1	63.8	34.2
DDX3X	"DBX, DDX14, DDX3, HLP2"	ENSG00000215301	"DEAD-box helicase 3 X-linked"	O00571	X	41333348-41364472	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Chromosome partition, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation, Translation regulation"	"DNA-binding, Helicase, Hydrolase, RNA-binding"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 887.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001648, HPA005631, HPA059585"	Supported	Supported	Approved	Nucleoplasm,Cytosol		NA	NA		260000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	Nucleoplasm	"HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059585: AB_2684073"	"unprognostic (2.42e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.01e-3)"	"unprognostic (1.66e-1)"	"unprognostic (8.12e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.95e-1)"	"unprognostic (4.77e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.93e-2)"	164.7	123.2	28.7	113.3	29.9	146.1	99.8	31.9	37.3	102.4	38.8	85.6	80.7	123.4	39.1	107.6	108.8	111.0	96.4	27.0	36.0	110.5	130.6	103.5	118.7	33.6	29.8	108.1	76.9	133.0	52.5	107.3	34.2	68.7	75.8	81.9	72.9	64.8	126.9	91.2	81.6	145.1	32.4	103.2	84.4	43.0	30.9	169.6	104.3	112.5	111.5	153.3	97.7	34.7	230.5	225.6	236.3	122.3	273.6	211.1	136.4	150.6	239.3	167.1	132.3	238.8	141.4	2.5	103.9	185.8	212.4	149.4	292.2	235.0	248.3	130.2	232.9	132.6	237.6	152.1	140.5	253.8	236.4	159.1	150.9	278.4	270.3	204.1	258.3	131.5	258.4	134.5	158.9	157.8	163.0	83.2	212.2	121.3	114.2	187.8	223.3	182.6	143.7	279.1	147.1	220.0	352.3	184.3	194.3	248.9	158.9	172.4	224.5	159.6	166.3	178.7	188.2	153.6	194.0	215.7	161.5	156.1	151.5	50.8	39.0	30.7	23.3	35.3	33.5	21.0	23.3	26.3	34.7	13.0	25.4	25.3	54.0	30.7	39.4	11.7	24.8	37.8	28.7	29.9	31.9	37.3	27.0	36.0	33.6	29.8	34.2	32.4	30.9	34.7	466.5	86.6	150.0	66.9	280.1	264.3	160.5	63.7	191.8	77.1	295.1	237.6	158.0	81.5	96.5	58.8	131.3	94.6	415.2	231.1	43.0	64.3	370.6	261.1	237.7	238.5	183.7	113.0	43.8	85.6	95.1	191.8	178.9	290.1	165.5	180.6	144.2	174.5	123.1	60.6	47.1	161.4	71.2	208.7	269.1	887.5	66.5	319.0	128.1	47.8	112.2	90.0	79.3	44.7	63.1	114.1	156.7	62.8	241.8	145.0	234.9	87.3	102.5	127.1	72.3	351.4	210.1	30.6	57.7	212.6	333.4	172.9	342.4	144.8	129.1	225.8
DDX42	"RHELP, RNAHP, SF3b125, SF3B8"	ENSG00000198231	"DEAD-box helicase 42"	Q86XP3	17	63773603-63819317	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023447, HPA023571, HPA025941"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"HPA023447: AB_1847560, HPA023571: AB_1847561, HPA025941: AB_1847562"	"unprognostic (3.46e-1)"	"unprognostic (7.11e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (9.26e-4)"	"unprognostic (3.02e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.55e-2)"	43.5	32.6	27.4	30.5	29.4	37.3	42.7	26.2	29.7	38.5	21.6	42.9	31.3	42.4	39.0	32.6	44.0	30.2	35.3	25.8	30.8	30.0	34.8	35.8	40.6	29.9	30.1	54.7	54.4	39.9	29.2	36.5	28.9	39.3	36.4	39.3	47.3	40.7	59.2	39.6	33.5	43.1	29.0	37.2	37.1	39.8	30.7	40.1	34.2	42.7	47.1	39.5	30.6	26.5	87.4	89.9	79.2	81.3	78.2	62.7	85.0	83.4	74.6	74.7	72.9	84.7	55.9	120.8	32.0	94.3	62.4	68.2	90.3	74.3	98.5	35.9	59.1	91.0	92.0	104.2	77.1	106.9	59.7	80.3	69.2	67.9	81.6	63.5	75.2	61.6	103.2	49.7	77.0	71.3	102.8	59.3	75.8	69.4	47.4	88.7	135.8	62.3	68.2	101.3	49.5	93.9	63.2	112.3	74.1	110.7	77.2	87.1	80.5	109.9	67.0	45.3	99.4	55.6	47.9	109.5	56.4	58.1	58.9	1.9	2.2	6.9	3.7	2.2	4.2	2.8	3.0	3.7	2.9	5.3	3.6	3.7	2.0	4.5	4.3	1.8	2.1	1.9	27.4	29.4	26.2	29.7	25.8	30.8	29.9	30.1	28.9	29.0	30.7	26.5	41.5	80.1	60.4	24.2	34.7	31.2	24.4	24.5	48.9	40.9	37.0	38.0	49.5	30.0	49.0	36.8	37.5	33.3	29.3	27.0	13.7	30.4	9.2	64.9	68.0	41.8	40.7	33.0	33.6	27.1	24.4	42.2	32.1	72.0	30.4	82.1	30.0	34.5	23.2	50.5	30.3	37.8	28.5	32.7	26.1	12.7	48.7	29.6	14.2	21.5	55.5	46.6	32.0	18.1	26.7	41.1	25.3	50.4	36.7	39.0	26.5	23.5	65.5	46.7	39.5	63.2	51.8	68.5	63.1	52.7	29.7	27.4	32.7	71.3	33.8	32.4
DDX46	"FLJ25329, KIAA0801, Prp5, PRPF5"	ENSG00000145833	"DEAD-box helicase 46"	Q7L014	5	134758771-134855133	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036554, HPA057501"	Supported		Supported	"Nucleoli fibrillar center,Nuclear speckles"		NA	NA		13000	"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	"Nucleoli fibrillar center"	"HPA036554: AB_10673621, HPA057501: AB_2683449"	"unprognostic (1.88e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (9.01e-6)"	"unprognostic (7.00e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.05e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.02e-2)"	"unprognostic (9.70e-3)"	"unprognostic (4.36e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.64e-2)"	"unprognostic (4.50e-2)"	16.5	14.6	7.6	23.9	8.8	23.1	17.7	16.1	10.8	16.3	11.4	17.3	17.0	19.8	12.3	17.5	15.0	13.4	13.4	6.8	11.2	18.8	17.7	15.8	25.6	10.0	8.4	18.5	20.8	18.4	11.1	15.7	9.2	15.5	20.7	18.0	16.8	12.1	35.2	19.4	18.7	17.6	5.4	20.6	20.0	16.3	10.0	32.1	18.7	22.9	26.6	18.2	15.6	10.3	87.1	78.0	54.4	71.1	20.8	23.2	75.0	56.8	43.7	58.8	65.6	119.2	61.7	108.9	47.7	38.3	62.3	52.5	80.9	54.2	68.7	73.8	73.3	131.0	84.7	48.5	18.0	120.5	67.8	21.0	28.9	62.1	34.8	24.9	47.3	85.9	113.6	45.3	44.1	41.5	104.2	46.9	75.2	50.1	34.8	89.7	142.0	54.8	32.0	73.9	64.2	61.3	79.4	37.2	42.7	63.0	58.3	68.0	59.0	61.8	43.2	47.9	114.0	35.6	103.2	140.2	42.8	112.0	40.0	55.6	31.9	48.2	30.7	29.2	28.0	38.1	30.4	31.3	25.3	43.4	30.9	31.5	55.9	32.3	27.5	38.5	29.7	17.8	7.6	8.8	16.1	10.8	6.8	11.2	10.0	8.4	9.2	5.4	10.0	10.3	102.4	76.9	131.5	35.9	123.6	113.8	121.5	102.7	68.9	131.5	80.6	79.4	69.3	64.3	94.9	103.0	83.4	133.7	142.3	91.3	56.7	100.5	53.4	111.4	155.8	104.7	92.2	90.6	38.7	107.9	160.4	85.1	69.3	115.9	101.2	122.3	76.8	113.1	94.4	121.1	41.2	112.4	63.1	119.3	113.2	26.7	111.9	103.4	56.9	21.5	178.5	79.9	194.7	28.1	57.6	130.7	62.6	113.2	134.7	139.5	79.2	84.1	74.5	176.0	98.6	114.9	115.2	246.3	275.7	81.0	137.0	157.2	131.8	114.5	112.7	144.1
DDX50	"GU2, GUB, MGC3199, RH-II/GuB"	ENSG00000107625	"DExD-box helicase 50"	Q9BQ39	10	68901286-68946847	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037388, HPA037389, HPA058196"	Approved		Enhanced	Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoli		"HPA037388: AB_10671752, HPA037389: AB_2675450, HPA058196: AB_2683635"	"unprognostic (2.05e-1)"	"unprognostic (3.36e-1)"	"unprognostic (9.90e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.02e-1)"	21.5	16.9	12.3	19.0	12.4	17.3	25.5	14.6	13.9	24.5	14.2	25.1	13.1	27.3	18.1	19.9	22.5	17.4	18.6	12.5	13.5	19.1	16.3	15.9	27.7	12.1	12.2	30.4	20.9	23.1	21.9	22.1	12.3	19.7	17.9	23.3	15.8	22.5	20.9	17.7	16.3	27.3	12.5	19.7	17.5	25.8	13.3	30.6	25.7	20.7	27.4	23.7	20.0	14.0	48.3	30.6	53.8	67.0	45.4	58.6	33.5	50.2	56.7	45.7	42.5	69.3	41.3	62.4	29.4	45.7	27.9	41.5	53.4	38.0	58.0	54.6	38.5	33.6	30.0	31.0	45.6	71.7	40.5	45.9	38.2	43.7	120.7	79.3	37.3	52.8	60.8	37.5	57.0	39.7	67.6	67.7	31.3	46.7	67.3	58.0	60.6	11.4	35.5	28.7	36.9	50.2	36.5	43.0	57.1	50.2	50.6	45.3	32.0	35.1	40.0	39.5	69.5	49.7	47.6	52.8	37.6	72.8	20.9	9.2	10.6	15.0	18.5	16.7	22.9	16.8	22.8	19.4	14.0	17.1	24.1	21.9	3.4	20.6	13.6	12.4	21.8	15.0	12.3	12.4	14.6	13.9	12.5	13.5	12.1	12.2	12.3	12.5	13.3	14.0	27.8	19.2	21.7	21.2	50.5	11.9	35.4	34.6	36.5	44.2	21.1	23.1	27.4	30.0	31.5	20.2	39.6	40.6	36.0	11.4	56.7	28.7	80.3	25.2	41.6	30.3	16.2	29.5	37.5	25.1	39.3	32.2	22.4	22.8	43.0	30.3	23.2	16.2	23.2	37.0	36.4	19.2	26.4	21.6	9.1	20.0	36.4	21.3	12.4	22.5	41.2	22.7	51.5	28.1	29.5	22.8	14.3	39.1	46.3	30.1	11.1	41.3	26.7	55.1	19.7	35.8	53.5	72.8	58.4	31.7	14.3	41.2	40.8	35.4	21.4	20.7
DDX52	ROK1	ENSG00000278053	"DExD-box helicase 52"	Q9Y2R4	17	37609739-37643446	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 245.1;Glandular and luminal cells: 360.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056173	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli"		"HPA056173: AB_2683056"	"unprognostic (1.05e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (9.41e-4)"	"unprognostic (4.26e-2)"	"unprognostic (9.96e-3)"	"unprognostic (6.77e-2)"	"prognostic unfavorable (2.44e-6)"	"unprognostic (5.10e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.95e-2)"	"unprognostic (5.58e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.28e-1)"	1.8	2.5	1.6	1.0	1.6	4.2	1.7	2.3	2.0	2.0	2.1	2.2	2.0	2.2	3.9	3.1	1.6	1.8	1.8	1.6	1.7	2.6	2.8	1.8	2.1	1.7	1.6	1.5	2.9	2.2	1.4	1.7	1.9	1.7	2.2	2.1	1.9	1.7	2.5	2.8	3.3	1.8	1.4	2.0	2.4	1.8	1.7	1.5	1.3	1.8	2.1	2.4	1.9	2.2	4.7	10.2	1.0	9.4	5.2	4.6	4.0	6.3	5.4	8.1	7.7	6.6	1.7	2.8	4.2	4.3	1.5	4.4	10.5	7.2	11.0	6.5	12.8	5.9	6.6	4.6	5.1	7.8	3.1	4.5	7.6	5.5	6.3	4.1	9.4	2.7	0.9	1.7	4.7	1.6	11.9	4.3	5.4	2.6	0.8	7.3	8.4	4.9	9.9	5.8	6.6	5.5	7.5	1.8	5.2	5.0	3.3	6.1	6.7	6.6	4.2	3.6	7.3	2.2	3.8	4.9	5.3	4.6	5.2	0.9	0.5	0.7	0.8	0.7	0.6	0.6	0.8	0.6	0.4	0.6	0.7	0.9	0.4	0.8	0.4	1.2	0.5	0.2	1.6	1.6	2.3	2.0	1.6	1.7	1.7	1.6	1.9	1.4	1.7	2.2	28.5	41.7	19.7	17.3	29.4	34.5	33.9	41.2	26.2	34.0	25.4	22.7	33.3	18.6	41.4	27.6	33.3	35.4	47.4	28.7	35.2	76.6	245.1	105.8	77.7	32.3	26.3	42.7	19.4	52.3	31.1	28.1	29.6	360.4	27.3	40.8	28.5	37.2	26.1	47.1	19.3	30.1	34.6	25.8	12.6	97.8	24.5	24.1	17.8	19.7	53.8	26.0	33.0	29.7	23.0	56.8	20.5	24.0	25.4	35.8	35.7	40.2	32.0	36.0	26.3	26.7	34.1	29.6	56.0	33.4	33.2	25.0	30.3	43.7	46.8	49.5
DDX54	"APR-5, DP97, MGC2835"	ENSG00000123064	"DEAD-box helicase 54"	Q8TDD1	12	113157173-113185479	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028244, HPA070786"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli, Golgi apparatus"		"HPA028244: AB_10603885, HPA070786: AB_2686311"	"unprognostic (1.61e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.57e-2)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (2.23e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.24e-1)"	19.6	21.7	7.4	28.9	8.6	38.8	18.7	8.0	9.7	20.0	12.0	17.9	26.8	21.4	5.6	24.0	21.1	13.3	17.8	7.4	7.3	16.2	20.8	17.0	28.5	8.9	8.1	23.2	30.3	20.7	8.4	16.8	9.3	16.2	11.4	7.3	19.7	15.8	53.9	24.7	21.0	13.5	7.7	21.5	21.8	9.2	9.2	21.3	19.0	20.4	16.5	19.9	18.2	9.0	82.7	84.0	30.8	57.1	20.2	24.1	79.3	43.8	40.3	58.3	31.9	87.1	39.0	105.8	49.7	36.8	43.4	59.8	55.0	56.8	22.0	61.3	67.7	64.0	45.1	60.3	35.3	107.5	72.1	39.8	44.1	56.7	34.7	47.7	48.4	63.2	94.2	37.1	30.4	75.8	93.0	152.4	72.1	57.6	59.2	68.2	45.6	107.8	31.7	84.3	39.8	36.0	61.8	93.4	39.9	25.2	80.4	82.6	36.3	49.2	54.8	59.1	92.7	53.3	66.4	119.5	43.4	59.0	52.9	13.0	11.3	2.9	12.6	16.7	13.1	12.4	11.5	12.6	14.5	11.3	11.6	12.9	0.6	13.1	11.7	10.9	10.1	12.7	7.4	8.6	8.0	9.7	7.4	7.3	8.9	8.1	9.3	7.7	9.2	9.0	19.1	32.1	29.8	6.5	39.4	17.3	35.9	26.4	34.7	20.5	28.2	24.3	14.5	21.5	24.1	12.9	2.1	63.9	30.6	29.2	25.4	44.5	1.2	23.3	21.8	25.7	28.2	33.4	5.9	49.9	57.2	23.2	26.0	28.5	25.3	35.6	17.9	38.2	38.6	26.9	4.3	31.5	24.4	35.9	20.9	2.4	29.5	22.3	12.4	6.5	29.5	26.8	51.5	2.0	4.8	43.0	33.4	24.0	35.0	52.9	49.3	50.5	12.8	18.1	6.6	28.7	24.9	14.8	20.1	39.5	19.6	72.4	33.3	56.8	43.8	38.0
DDX56	NOH61	ENSG00000136271	"DEAD-box helicase 56"	Q9NY93	7	44565804-44575051	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019749, CAB037320"	Uncertain		Supported	"Nucleoli,Mitotic chromosome"		Yes	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	"Mitotic chromosome"	"CAB037320: , HPA019749: AB_1847579"	"unprognostic (3.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.08e-3)"	"unprognostic (2.12e-3)"	"prognostic unfavorable (1.38e-5)"	"unprognostic (5.17e-2)"	"unprognostic (2.76e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.01e-3)"	"prognostic unfavorable (8.41e-7)"	"unprognostic (2.60e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.90e-2)"	21.3	21.8	24.8	21.5	25.6	16.6	17.1	25.5	29.0	19.2	25.3	18.6	20.8	15.4	17.3	25.9	27.2	15.8	20.3	25.1	25.3	16.2	30.1	15.7	29.4	25.6	25.2	22.1	28.2	27.1	7.9	20.1	25.7	18.2	15.7	7.3	24.6	20.2	27.4	32.2	16.4	21.2	25.2	19.5	20.8	10.4	25.2	24.5	23.5	21.5	27.1	28.4	7.3	26.0	69.5	118.8	32.0	70.0	36.6	40.3	62.3	60.9	43.7	107.6	83.9	139.2	90.7	109.8	65.0	59.4	143.5	111.4	70.9	97.5	38.5	45.9	99.2	64.3	90.9	86.1	59.9	77.0	66.4	57.9	78.8	105.8	82.2	35.5	62.0	55.8	150.2	42.8	78.3	103.7	67.3	104.4	108.8	127.8	103.6	70.7	54.3	76.7	69.8	65.4	68.8	90.6	64.2	199.4	58.9	21.3	120.6	105.5	52.4	71.0	86.0	52.6	155.1	88.7	135.0	167.1	75.2	115.1	146.1	36.3	50.8	21.1	37.6	66.3	47.7	48.3	40.9	41.6	63.8	55.0	49.2	38.7	3.6	63.2	67.7	34.8	44.9	59.7	24.8	25.6	25.5	29.0	25.1	25.3	25.6	25.2	25.7	25.2	25.2	26.0	21.5	16.0	29.0	13.1	22.8	17.1	23.9	45.1	21.1	26.6	18.4	14.7	12.3	11.5	40.3	22.0	14.6	57.0	19.1	29.0	27.4	39.4	41.4	21.0	21.1	26.4	18.5	35.8	6.1	32.3	48.5	24.6	30.5	20.6	28.5	35.3	16.8	30.1	35.4	6.7	8.0	24.9	38.7	13.2	17.5	37.5	21.1	17.9	14.2	3.7	28.8	22.4	23.7	6.6	6.2	37.5	18.8	19.9	18.2	24.8	37.2	63.0	31.8	26.9	13.1	22.4	25.1	36.2	25.6	30.1	19.9	47.2	23.6	40.3	36.8	21.3
DEK	D6S231E	ENSG00000124795	"DEK proto-oncogene"	P35659	6	18223860-18264548	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015226, HPA054505, HPA057799"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"CAB015226: , HPA054505: AB_2682508, HPA057799: AB_2683530"	"unprognostic (6.35e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.04e-3)"	"unprognostic (1.40e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.02e-3)"	"prognostic unfavorable (9.65e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.61e-3)"	"unprognostic (6.49e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (3.45e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.78e-1)"	50.8	43.0	17.3	82.4	20.1	158.6	63.1	29.6	25.4	48.1	19.8	74.8	76.9	74.2	29.9	65.4	45.6	49.0	61.0	17.3	18.3	46.0	68.0	53.2	125.5	19.5	20.4	61.4	40.3	43.3	19.3	67.7	20.8	56.2	74.2	46.3	37.3	56.1	116.0	49.8	86.8	63.9	18.2	63.8	58.7	22.1	19.5	116.8	102.3	73.4	112.8	59.3	43.0	26.1	450.1	118.6	330.9	276.6	68.9	118.4	184.2	347.4	210.9	338.9	457.1	190.7	165.5	504.2	390.2	181.8	269.1	251.1	260.7	196.2	591.3	346.5	221.3	305.7	179.9	260.0	70.3	499.2	238.2	58.2	98.1	238.2	198.2	164.7	170.9	188.1	392.9	0.6	236.5	156.2	380.3	222.1	208.6	177.4	131.8	471.7	459.7	299.8	184.2	239.6	196.1	183.8	328.9	290.5	224.6	218.4	277.8	212.7	168.7	382.7	220.0	223.9	474.1	32.4	77.0	540.3	95.0	251.3	380.8	116.2	78.2	41.8	69.6	74.9	83.1	66.3	72.5	78.0	72.9	56.1	55.6	55.7	93.4	70.9	92.9	49.0	75.2	67.8	17.3	20.1	29.6	25.4	17.3	18.3	19.5	20.4	20.8	18.2	19.5	26.1	149.7	121.8	130.8	16.3	126.2	271.2	189.8	128.8	146.3	70.3	143.3	161.3	218.8	161.5	112.0	79.1	81.3	284.2	174.5	156.7	82.2	172.0	17.4	118.8	157.7	156.6	88.5	448.8	10.4	173.1	235.4	159.6	85.1	170.6	111.2	195.1	105.7	125.1	190.9	26.9	18.6	188.1	67.1	185.3	300.7	26.2	189.5	219.1	101.4	31.9	263.3	136.2	212.1	26.2	37.1	136.9	117.3	191.5	44.0	252.9	140.0	129.5	89.0	138.8	210.4	189.1	197.0	87.2	220.7	169.9	233.6	108.6	189.1	138.6	232.5	209.2
DENND10	FAM45A	ENSG00000119979	"DENN domain containing 10"	Q8TCE6	10	119104086-119137984	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 36.5;Cytotrophoblasts: 53.8;Extravillous trophoblasts: 27.7;Hofbauer cells: 56.0;Syncytiotrophoblasts: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041159			Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Centrosome, Cytosol"		"HPA041159: AB_10793871"	"unprognostic (1.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.64e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.20e-2)"	16.7	14.3	18.7	14.0	20.2	32.4	14.0	18.7	23.6	14.2	17.4	17.9	12.6	13.3	16.7	20.5	11.4	12.7	15.5	18.8	19.2	26.1	31.1	12.6	13.1	19.8	18.9	20.9	9.4	18.0	2.9	15.6	19.8	13.4	14.4	10.6	10.9	10.6	17.6	18.7	15.2	13.2	19.8	14.1	14.2	7.3	19.3	13.1	19.9	11.1	14.6	14.8	9.3	21.7	23.7	24.9	38.6	45.5	75.9	59.1	15.9	32.3	85.9	29.4	30.1	23.7	35.8	16.1	12.8	41.4	33.8	42.2	25.7	28.0	27.0	29.2	24.1	3.8	11.5	32.9	75.4	11.0	10.3	63.7	31.5	20.9	32.6	75.0	36.1	16.8	7.8	22.9	42.0	20.0	17.2	48.5	23.6	22.1	14.6	17.0	40.6	14.3	38.6	25.9	6.9	27.7	21.7	30.2	67.5	36.1	24.9	48.5	36.6	23.3	12.3	28.9	19.4	23.0	10.0	17.7	35.9	54.7	11.2	44.9	26.6	55.6	6.9	31.8	6.6	3.9	10.9	10.0	16.6	3.6	5.7	7.1	40.0	6.1	36.4	5.0	20.4	11.6	18.7	20.2	18.7	23.6	18.8	19.2	19.8	18.9	19.8	19.8	19.3	21.7	9.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.5	0.0	0.0	0.0	0.0	53.8	11.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	27.7	9.0	0.0	0.0	0.0	0.0	0.0	0.0	56.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	45.3	1.7	0.0	0.0	0.0
DENR	"DRP, DRP1, SMAP-3"	ENSG00000139726	"Density regulated re-initiation and release factor"	O43583	12	122752824-122771064	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 227.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021783	Approved		Approved	Cytosol		NA	NA		200000	"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA021783: AB_2670820"	"unprognostic (3.65e-2)"	"unprognostic (7.00e-2)"	"unprognostic (5.69e-2)"	"unprognostic (7.33e-3)"	"unprognostic (6.62e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (1.58e-7)"	"unprognostic (2.23e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.02e-3)"	"prognostic unfavorable (8.57e-6)"	"unprognostic (1.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.35e-1)"	25.4	22.6	19.0	27.0	19.6	27.5	29.6	15.3	23.6	22.2	15.1	25.5	26.7	23.7	22.1	32.5	21.7	22.1	24.4	19.4	20.2	25.5	27.6	18.8	36.2	16.8	21.6	19.2	21.2	59.0	17.1	31.6	19.5	28.0	26.0	16.5	28.4	24.8	60.2	29.6	25.0	24.5	15.2	28.0	23.3	14.6	18.9	38.9	29.8	44.7	35.5	30.0	20.4	16.7	113.1	62.1	77.7	80.1	48.7	71.9	67.6	100.5	56.1	87.6	60.6	86.9	40.6	99.9	103.4	72.5	66.6	84.0	93.8	89.5	117.6	90.9	67.3	122.8	36.2	63.8	63.5	139.6	97.4	62.8	86.9	79.3	107.4	81.6	86.4	109.7	129.8	35.8	94.8	74.9	137.7	134.1	159.2	67.2	128.4	120.6	91.2	63.7	85.3	99.9	89.3	63.4	139.2	40.8	107.3	79.1	129.5	78.1	82.2	81.2	95.9	91.7	102.1	58.8	145.8	160.4	76.4	100.1	90.9	227.9	35.0	58.1	38.8	53.3	45.3	45.5	41.9	39.4	47.3	41.4	48.5	43.4	42.2	47.3	69.9	42.1	49.2	44.5	19.0	19.6	15.3	23.6	19.4	20.2	16.8	21.6	19.5	15.2	18.9	16.7	43.4	70.5	40.1	31.0	59.8	71.9	65.9	55.4	59.7	37.7	66.2	69.8	66.3	45.8	47.7	47.8	41.7	73.0	60.8	40.9	64.6	68.6	17.9	67.7	83.5	51.4	84.8	53.8	39.0	61.8	130.3	48.3	40.8	70.7	43.1	50.4	42.1	54.3	57.4	55.5	36.2	53.6	44.7	50.1	42.4	8.0	50.4	49.3	26.6	25.3	60.2	47.3	75.2	48.2	31.3	88.0	44.6	45.9	47.9	73.2	40.3	67.3	49.5	35.9	19.7	46.2	62.5	120.3	136.8	72.8	64.9	60.6	54.7	47.3	58.8	51.3
DEPDC1B	"BRCC3, XTP1"	ENSG00000035499	"DEP domain containing 1B"	Q8WUY9	5	60596912-60700190	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.1;gallbladder: 21.0;lymphoid tissue: 20.7;testis: 12.6"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 18.6;Erythroid cells: 23.8;Extravillous trophoblasts: 21.6;Spermatocytes: 37.2;Syncytiotrophoblasts: 46.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"T-reg: 3.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA038255, HPA072558"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA038255: AB_10669521, HPA072558: AB_2686534"	"unprognostic (1.38e-1)"	"unprognostic (1.99e-2)"	"prognostic favorable (2.42e-4)"	"prognostic unfavorable (8.55e-4)"	"unprognostic (2.23e-1)"	"unprognostic (7.93e-2)"	"prognostic unfavorable (3.08e-4)"	"prognostic unfavorable (6.93e-5)"	"unprognostic (2.13e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.11e-16)"	"unprognostic (1.00e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.62e-2)"	0.3	0.2	0.4	3.9	0.7	11.1	0.9	0.5	0.5	0.6	0.1	4.1	6.0	0.6	0.0	2.5	0.2	21.0	0.1	0.3	0.6	2.9	0.4	0.4	9.1	1.2	0.5	0.2	0.1	0.0	0.0	7.5	1.4	0.2	5.5	0.1	0.5	0.1	0.0	2.1	6.4	0.9	0.6	1.6	1.4	12.6	0.6	20.7	1.2	0.0	9.7	1.0	1.1	1.5	61.0	20.3	60.5	37.2	1.3	1.9	66.2	16.1	10.9	27.7	35.8	34.0	37.5	34.6	38.5	5.0	36.0	19.8	49.2	36.1	36.9	49.5	35.5	43.3	22.7	42.6	1.0	36.7	40.3	1.2	3.7	9.0	12.9	5.4	26.1	36.3	31.4	45.8	24.7	38.0	59.8	31.9	44.7	13.0	32.6	65.4	49.2	29.4	22.8	29.9	33.6	15.4	37.7	13.4	17.7	27.0	24.9	28.8	12.1	11.7	34.2	9.5	41.6	23.0	43.3	68.0	14.7	53.2	33.3	1.5	0.1	0.9	0.2	0.0	0.2	0.4	1.0	0.7	0.3	0.0	0.1	0.1	0.0	0.6	0.0	0.0	3.2	0.4	0.4	0.7	0.5	0.5	0.3	0.6	1.2	0.5	1.4	0.6	0.6	1.5	0.2	0.0	1.8	0.0	1.9	4.7	1.0	1.5	0.0	0.1	0.5	0.8	0.1	18.6	0.3	0.0	0.0	7.4	1.1	3.1	0.0	0.3	1.9	3.3	1.4	0.9	0.0	23.8	5.5	0.2	21.6	1.1	2.6	11.7	3.8	5.2	0.0	0.3	6.4	0.0	1.7	2.3	0.0	1.6	2.9	2.4	0.3	1.9	0.0	4.7	0.1	0.2	0.0	2.0	7.0	0.9	5.8	0.0	15.9	0.7	3.7	1.0	0.1	0.1	6.6	0.3	1.4	37.2	12.7	5.8	2.0	46.9	4.5	0.6	7.9	0.9
DEPDC4	"DEP.4, FLJ33505"	ENSG00000166153	"DEP domain containing 4"	Q8N2C3	12	100203669-100267079	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"testis: 3.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 13.7;Late spermatids: 19.2"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA039323	Uncertain		Approved	Microtubules		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Microtubules		"HPA039323: AB_10674283"	"unprognostic (8.89e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.33e-2)"	"unprognostic (3.62e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.53e-1)"	"unprognostic (9.09e-4)"	"unprognostic (5.02e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.37e-2)"	0.2	0.3	0.2	0.3	0.2	0.6	0.8	0.2	0.6	0.3	0.0	0.6	1.2	0.4	0.5	0.7	0.4	0.4	0.3	0.2	0.6	1.7	1.3	0.3	0.3	0.3	0.2	0.7	0.7	0.5	0.5	0.7	0.2	0.7	0.8	0.4	0.7	1.0	0.2	0.4	0.5	0.2	0.3	0.2	0.6	3.9	0.2	0.6	0.5	0.2	0.3	0.3	0.3	0.3	1.3	1.8	3.4	0.9	0.1	0.4	2.1	1.8	1.2	3.7	2.2	2.9	0.7	1.4	1.1	0.9	1.1	2.0	2.9	1.5	4.0	1.5	3.2	4.9	0.8	3.3	0.4	1.6	1.9	0.3	0.9	1.3	0.3	0.7	0.9	2.5	2.9	0.6	1.7	1.3	1.0	2.9	1.6	1.6	1.9	2.0	3.4	3.3	1.7	0.8	0.9	2.0	1.0	1.4	1.1	2.0	2.8	1.7	0.2	2.5	1.0	1.0	1.4	1.5	1.7	3.0	0.7	1.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.6	0.2	0.6	0.3	0.2	0.2	0.3	0.2	0.3	0.5	0.0	4.4	6.2	0.7	0.9	1.4	1.8	3.4	2.1	1.0	1.5	0.9	0.0	2.2	5.5	4.2	3.5	0.2	0.5	5.9	0.6	13.7	0.9	0.9	0.7	0.0	2.1	3.3	1.3	2.0	3.6	0.0	0.9	0.0	1.1	0.4	1.1	1.1	0.0	3.4	0.5	0.0	0.3	1.1	19.2	1.2	0.5	1.8	1.0	0.1	1.3	0.0	3.5	6.5	0.5	0.3	0.0	0.2	0.6	1.4	5.3	1.8	4.8	0.0	1.4	1.2	8.0	6.2	0.7	0.3	1.2	0.7	2.4	1.5	0.9
DERPC		ENSG00000286140	"DERPC proline and glycine rich nuclear protein"	P0CG12	16	69118010-69132151	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA051872, HPA065522"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"		"Cluster 26: Non-specific - Cell cycle regulation"		Nucleoplasm		"HPA051872: AB_2681647, HPA065522: AB_2685503"																		6.7	10.6	13.3	15.3	12.7	9.3	13.3	12.1	14.2	11.7	13.1	10.2	6.6	8.8	25.9	11.6	16.0	10.8	8.9	12.4	12.4	10.4	10.5	9.0	17.8	13.6	12.5	16.3	10.2	11.7		18.8	12.4	10.2	10.6	9.8	9.5	13.7	2.1	13.2	7.2	11.3	13.2	10.2	6.1	11.0	13.3	17.6	10.0	10.1	18.4	13.0		13.1	15.9	13.1	50.5	39.4	29.0	27.4	24.8	15.3	25.8	54.2	37.6	23.2	50.3	15.8	19.1	27.4	30.5	22.9	62.0	44.9	34.4	7.4	10.8	25.3	8.3	14.4	27.4	16.3	28.7	22.0	41.3	33.1	23.4	35.1	44.2	25.2	25.9	13.1	41.0	11.9	36.5	39.8	51.6	43.8	12.1	65.0	14.6	40.3	35.7	8.6	31.2	28.9	21.8	19.8	38.5	37.3	34.3	69.6	10.9	34.5	20.3	17.2	22.3	9.6	15.3	46.2	31.4	27.6	45.4	2.4	5.3	3.2	2.8	6.0	4.0	2.6	2.7	2.6	5.5	3.1	2.6	3.3	1.3	4.0	6.3	5.1	4.0	4.2	13.3	12.7	12.1	14.2	12.4	12.4	13.6	12.5	12.4	13.2	13.3	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DESI2	"C1orf121, CGI-146, DESI-2, FAM152A, FLJ21998, PNAS-4, PPPDE1"	ENSG00000121644	"Desumoylating isopeptidase 2"	Q9BSY9	1	244653103-244709033	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 171.8;Spermatocytes: 192.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049950			Approved	Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA049950: AB_2680969"	"unprognostic (1.13e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.95e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (4.52e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.27e-2)"	"unprognostic (9.49e-2)"	17.1	13.6	7.7	13.6	10.7	17.1	14.0	13.0	8.4	18.4	13.1	16.4	16.0	22.7	13.6	16.2	13.3	17.8	16.4	7.4	7.9	11.8	12.8	23.2	17.9	7.7	8.0	13.6	9.3	13.9	7.1	18.6	7.4	14.4	18.2	16.2	11.1	15.6	24.1	15.2	13.3	22.3	8.1	11.7	15.6	54.8	8.3	19.7	23.3	23.6	19.1	18.4	12.0	8.1	68.1	24.3	47.0	40.8	52.8	54.8	61.7	40.8	65.9	36.9	33.9	43.8	31.0	121.8	53.8	47.7	21.5	29.5	58.1	43.1	50.5	43.1	53.6	31.0	17.5	33.0	46.2	52.8	36.1	38.4	57.3	49.3	61.6	35.6	52.8	52.8	48.4	63.7	56.2	11.7	49.6	28.0	109.0	62.7	67.7	36.9	71.9	46.0	28.4	27.6	42.5	57.2	55.4	26.4	47.7	37.7	27.6	39.0	59.7	41.7	45.4	57.4	68.5	69.4	94.1	69.8	33.8	55.7	78.0	2.5	1.7	5.6	2.1	2.1	2.1	5.2	2.2	3.0	2.7	2.7	2.9	2.8	1.4	2.2	2.3	2.4	3.2	0.7	7.7	10.7	13.0	8.4	7.4	7.9	7.7	8.0	7.4	8.1	8.3	8.1	32.7	86.6	60.4	17.9	31.0	55.3	41.3	23.0	38.7	43.2	21.5	26.3	22.1	27.1	25.5	18.4	20.9	29.8	36.1	28.1	21.5	19.8	171.8	32.0	39.6	36.2	15.6	21.7	18.4	33.4	40.0	44.2	28.5	25.0	7.0	28.7	25.7	21.5	23.8	40.4	23.1	19.0	26.4	23.3	27.1	101.5	34.8	27.2	16.0	18.7	25.5	23.8	28.8	35.7	26.9	34.3	28.6	51.9	34.5	69.5	17.0	16.5	17.6	25.1	39.5	41.7	50.2	192.7	105.4	42.4	41.3	43.2	31.2	38.4	25.4	55.5
DFFA	"DFF-45, DFF1, DFF45, ICAD"	ENSG00000160049	"DNA fragmentation factor subunit alpha"	O00273	1	10456522-10472529	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002679, HPA018859, HPA019938, HPA025230"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		8700	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Cytosol"		"CAB002679: , HPA018859: AB_1847622, HPA019938: AB_1847625, HPA025230: AB_1847623"	"unprognostic (1.23e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (1.55e-1)"	"unprognostic (9.24e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (1.57e-9)"	"unprognostic (1.21e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.88e-1)"	13.3	12.6	15.0	12.0	18.0	6.5	12.6	19.7	16.5	11.1	14.2	11.3	12.1	11.7	9.8	16.7	13.0	10.8	12.1	14.9	17.2	16.8	13.2	11.3	12.4	17.4	18.7	15.3	11.4	18.0	9.2	20.1	17.5	11.8	12.2	12.2	10.9	12.3	12.3	10.9	11.1	16.1	16.1	10.7	12.1	9.8	18.3	13.3	12.3	13.9	16.2	14.4	10.1	18.3	37.8	36.8	31.0	35.4	25.7	24.3	15.1	52.5	33.6	53.4	39.6	88.4	48.4	79.9	33.1	44.5	29.7	30.3	60.5	62.2	53.7	31.9	41.8	39.9	37.6	35.8	41.8	49.3	25.4	30.5	30.6	84.4	67.4	29.1	41.3	39.3	72.6	17.6	38.4	48.0	48.8	22.2	27.2	28.3	42.4	41.3	37.1	40.1	48.5	28.6	36.5	35.6	48.9	42.1	58.0	26.6	27.0	17.0	43.4	24.9	34.0	46.4	35.0	21.6	32.5	114.3	26.5	45.7	38.5	1.8	11.2	8.6	15.2	9.1	11.7	16.6	10.3	13.5	10.6	15.8	10.7	13.0	1.4	17.5	12.3	12.4	16.2	10.5	15.0	18.0	19.7	16.5	14.9	17.2	17.4	18.7	17.5	16.1	18.3	18.3	26.9	44.8	34.3	3.3	23.5	34.4	39.0	43.8	30.1	21.1	20.5	25.0	23.7	32.9	36.6	18.4	108.4	91.1	22.8	12.6	37.2	46.5	32.0	22.4	31.6	34.0	34.2	15.6	6.5	39.1	64.9	25.1	20.9	23.8	24.7	35.6	31.4	31.0	41.8	20.2	8.3	17.3	28.5	22.9	13.8	73.2	30.1	17.0	10.6	3.7	37.4	23.3	28.8	5.0	6.9	49.1	10.6	32.4	19.3	48.1	25.0	57.8	26.0	34.0	19.7	29.9	26.9	35.7	28.4	32.0	40.6	66.4	18.5	43.9	27.9	38.9
DGUOK	dGK	ENSG00000114956	"Deoxyguanosine kinase"	Q16854	2	73926826-73958961	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease variant, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034766, HPA057246"	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA034766: AB_10669850, HPA057246: AB_2683381"	"unprognostic (3.40e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.10e-3)"	"unprognostic (5.07e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.84e-2)"	"prognostic unfavorable (8.69e-7)"	"unprognostic (3.86e-1)"	"unprognostic (2.21e-2)"	"unprognostic (5.98e-2)"	"prognostic favorable (7.47e-4)"	20.8	30.0	37.1	20.3	39.2	27.1	28.1	36.5	48.4	23.0	36.8	25.0	17.7	23.1	34.4	21.8	31.3	19.4	23.0	38.5	42.8	24.6	30.5	17.7	36.8	37.9	37.7	30.0	16.3	11.0	41.3	21.5	39.1	24.5	29.1	34.5	19.8	22.5	17.1	26.5	20.2	21.9	37.9	25.9	21.0	32.8	38.8	36.3	22.6	17.7	40.9	22.2	20.9	38.8	45.1	72.5	74.4	67.9	47.8	53.8	37.1	29.3	56.0	66.7	61.1	91.2	51.5	83.0	27.4	42.1	74.1	34.7	85.4	57.1	79.3	47.1	53.6	65.8	25.4	107.5	70.5	62.1	66.0	49.7	51.3	50.4	58.9	48.6	48.3	91.4	67.2	37.0	78.8	54.4	59.6	101.2	76.7	60.5	53.9	73.8	73.1	59.7	55.8	49.6	85.0	82.6	27.9	28.2	77.1	35.5	34.0	34.8	45.3	43.3	68.8	37.8	52.6	32.3	31.4	86.1	62.2	65.9	95.1	129.8	70.9	138.7	62.3	87.3	72.4	108.5	77.0	69.6	81.6	114.5	98.6	79.6	56.4	79.4	84.7	91.3	79.9	91.3	37.1	39.2	36.5	48.4	38.5	42.8	37.9	37.7	39.1	37.9	38.8	38.8	72.5	32.1	42.8	14.7	103.4	74.2	138.7	249.6	88.2	52.3	85.0	128.1	19.1	78.6	108.6	60.7	6.2	159.4	89.7	58.9	84.1	102.6	12.3	82.3	69.1	74.1	113.1	67.1	17.5	149.1	165.4	88.3	40.2	82.6	57.6	87.4	76.1	69.9	90.9	52.2	21.1	100.1	158.7	88.3	112.3	15.1	93.5	80.2	110.3	15.9	151.9	89.5	118.4	12.5	27.2	173.0	88.1	86.9	70.2	146.2	88.2	119.7	87.2	40.4	92.1	55.3	89.3	105.3	129.4	88.3	83.3	124.5	101.4	124.5	104.9	142.9
DHFR		ENSG00000228716	"Dihydrofolate reductase"	P00374	5	80626226-80654983	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Methotrexate resistance, One-carbon metabolism"	"Oxidoreductase, RNA-binding"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 145.8;Spermatocytes: 132.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037129, HPA051465"	Uncertain		Approved	Mitochondria		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Mitochondria		"CAB037129: AB_439683, HPA051465: AB_2681494"	"unprognostic (1.44e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.91e-3)"	"unprognostic (3.27e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.19e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.09e-1)"	25.2	5.3	15.3	20.7	16.5	54.3	12.0	15.8	21.9	8.0	13.3	21.4	24.5	8.6	7.0	14.1	7.4	8.5	7.2	13.8	15.5	21.3	60.1	7.5	41.5	16.6	16.6	6.6	3.2	9.1	6.3	14.4	16.6	8.9	25.3	10.3	6.8	9.5	19.6	9.8	25.1	12.0	16.5	10.3	12.2	18.5	15.8	60.7	8.2	25.8	39.5	10.3	5.7	17.7	98.1	66.6	164.8	122.7	30.7	32.0	60.6	76.5	58.1	130.2	149.0	63.8	114.6	196.9	32.5	44.6	106.0	67.0	214.4	98.6	208.5	88.2	132.1	94.8	104.5	59.5	6.6	111.7	40.3	22.3	9.9	116.9	13.0	22.2	63.9	142.0	108.3	146.7	133.5	98.2	276.5	44.9	83.6	48.3	38.5	176.7	323.3	194.1	75.1	61.5	134.3	93.7	107.9	49.9	54.6	83.5	98.5	108.6	38.5	41.0	62.0	116.0	148.3	68.2	146.6	210.3	91.5	222.1	107.7	0.2	0.3	0.2	0.5	0.6	0.2	0.5	0.6	0.8	0.5	0.5	0.5	0.6	0.8	0.5	0.5	0.8	0.9	0.6	15.3	16.5	15.8	21.9	13.8	15.5	16.6	16.6	16.6	16.5	15.8	17.7	4.1	6.4	11.7	4.9	21.4	6.9	6.5	6.0	4.0	3.5	8.9	8.9	13.0	4.3	6.1	14.7	2.1	35.2	7.4	19.3	9.8	7.4	7.4	10.8	7.7	7.7	4.9	145.8	7.3	3.7	47.3	12.0	11.7	8.0	2.5	22.0	10.0	48.3	44.7	3.3	7.2	19.1	4.1	18.9	4.4	6.4	14.0	12.8	0.0	4.7	7.1	14.5	13.4	3.5	6.0	4.7	10.3	16.1	60.9	2.9	26.6	40.0	6.9	3.2	13.1	9.0	12.5	132.2	49.8	21.2	5.5	13.3	11.8	12.3	38.1	12.1
DHODH		ENSG00000102967	"Dihydroorotate dehydrogenase (quinone)"	Q02127	16	72008588-72027664	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Pyrimidine biosynthesis"	Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"liver: 105.9"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 124.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010123, HPA011942"	Approved		Enhanced	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 15: Hepatocytes - Hemostasis"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA010123: AB_1847648, HPA011942: AB_1847649"	"unprognostic (4.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.81e-1)"	7.4	4.8	3.1	4.2	3.6	3.9	5.8	3.7	3.7	4.0	3.7	5.4	3.9	5.4	2.8	4.2	6.1	2.3	13.8	2.9	2.5	8.0	105.9	3.9	4.2	3.4	3.3	4.9	4.2	6.2	2.5	2.7	3.3	4.0	5.8	3.2	5.4	4.5	10.0	4.5	3.1	5.7	2.1	4.1	4.1	3.6	3.4	3.9	4.1	8.1	5.5	3.9	3.4	5.2	12.5	25.7	6.9	12.1	3.8	5.0	13.9	10.5	4.2	15.6	11.6	20.4	11.1	27.8	13.6	5.7	8.6	12.5	13.7	11.4	18.2	6.0	13.3	15.4	12.6	20.3	10.6	21.4	10.8	4.9	11.3	18.6	19.7	4.7	11.3	18.3	23.9	4.4	9.7	32.7	20.2	17.0	15.9	21.1	10.0	24.9	9.6	29.4	9.4	7.8	8.5	10.2	14.1	14.8	6.8	8.7	13.0	10.3	5.1	14.1	8.3	13.1	15.2	8.8	18.7	46.3	7.1	22.4	12.8	6.1	8.4	1.0	9.4	8.8	12.9	12.0	8.5	9.3	14.5	11.7	11.7	12.6	2.1	10.1	6.3	13.5	8.0	7.2	3.1	3.6	3.7	3.7	2.9	2.5	3.4	3.3	3.3	2.1	3.4	5.2	6.3	3.2	13.1	1.6	7.1	5.6	7.8	11.2	6.8	5.6	6.6	7.1	14.8	15.7	5.5	7.3	4.2	12.3	6.9	1.6	5.9	10.3	2.9	3.8	6.3	9.1	1.2	7.8	2.0	5.1	12.4	7.4	2.6	3.2	8.2	10.2	5.3	124.1	7.9	3.3	2.3	6.6	10.2	6.0	3.1	3.6	2.8	3.3	12.4	1.0	3.8	5.2	8.2	4.0	4.4	5.9	2.4	2.2	4.6	11.2	1.0	20.8	8.1	5.2	0.0	9.7	9.1	6.8	8.1	5.0	3.8	2.9	4.3	13.5	6.7	4.2
DHX15	"DBP1, DDX15, HRH2, PRP43, PRPF43, PrPp43p"	ENSG00000109606	"DEAH-box helicase 15"	O43143	4	24517441-24584554	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047047	Approved		Enhanced	"Nuclear speckles"		NA	NA		130000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"HPA047047: AB_2679916"	"unprognostic (4.46e-3)"	"unprognostic (2.47e-2)"	"prognostic favorable (5.74e-4)"	"unprognostic (3.35e-1)"	"unprognostic (5.30e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.53e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.60e-2)"	"unprognostic (8.68e-3)"	"unprognostic (7.77e-3)"	"unprognostic (2.51e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.41e-3)"	40.3	35.7	17.0	51.2	23.2	78.5	50.7	30.5	22.6	41.3	29.4	48.8	36.8	44.5	30.2	43.9	38.5	35.6	33.3	18.4	20.9	45.7	44.7	37.1	60.2	20.9	20.3	43.8	47.7	52.1	21.6	55.0	22.0	39.5	57.9	40.1	37.7	35.9	43.0	42.1	37.9	48.0	20.8	40.0	44.7	33.5	20.2	79.8	40.0	42.2	70.9	65.6	34.7	29.0	135.0	129.1	209.4	104.6	100.6	97.4	124.7	153.0	133.9	157.8	155.5	132.0	158.5	245.4	91.8	126.2	183.7	109.8	272.1	184.1	243.7	90.6	129.0	213.3	134.7	107.3	59.2	222.3	140.9	82.2	108.4	154.3	103.1	100.8	133.9	113.4	203.4	96.2	181.3	101.3	293.7	148.2	228.4	133.4	115.8	190.4	245.3	114.6	187.1	190.2	179.0	111.9	118.7	112.8	109.1	149.0	123.8	113.7	123.5	132.8	87.5	101.6	181.4	72.1	130.2	289.3	89.1	177.9	161.8	57.5	29.6	28.5	28.8	30.8	39.7	28.7	32.0	33.7	39.0	29.9	33.2	32.2	13.9	37.1	38.5	25.8	38.6	28.5	17.0	23.2	30.5	22.6	18.4	20.9	20.9	20.3	22.0	20.8	20.2	29.0	51.2	76.9	57.4	40.1	53.4	98.7	68.3	58.0	56.3	30.2	50.1	36.7	28.1	35.8	70.6	27.6	22.9	72.7	44.9	79.8	37.2	59.3	32.6	61.7	53.2	53.6	60.5	58.9	51.4	41.8	69.7	55.5	79.5	97.3	57.0	47.4	42.8	48.4	44.7	26.9	50.8	69.3	36.7	46.9	53.2	16.5	39.4	50.2	48.0	49.6	48.0	24.4	34.0	61.3	99.1	57.1	41.2	40.3	51.0	73.1	33.2	34.8	55.6	32.1	26.3	59.6	69.4	72.9	46.3	60.4	100.0	88.2	49.3	34.0	71.2	89.4
DHX16	"DBP2, DDX16, Prp2, PRPF2"	ENSG00000204560	"DEAH-box helicase 16"	O60231	6	30653119-30673006	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"	"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 92.7;Spermatocytes: 86.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051455	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA051455: AB_2681491"	"unprognostic (7.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.58e-2)"	"unprognostic (1.24e-2)"	"unprognostic (9.77e-3)"	"unprognostic (4.42e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.73e-3)"	24.3	28.2	5.4	13.8	6.3	11.3	26.0	6.3	6.8	27.7	8.3	29.5	18.8	25.5	8.6	27.2	26.6	11.3	26.6	5.3	6.0	34.9	36.5	25.4	18.1	6.3	5.9	26.2	35.0	16.0	28.6	10.5	6.4	30.1	10.3	14.4	32.0	12.8	45.0	28.8	37.5	12.5	5.2	40.3	28.3	46.8	6.6	17.1	38.2	17.6	12.7	24.8	26.8	6.4	31.9	17.9	20.3	38.7	26.8	15.7	27.0	33.0	30.7	47.6	44.3	35.8	15.9	25.5	24.2	31.1	39.6	34.0	47.0	24.1	35.5	35.4	15.5	27.2	25.5	17.9	21.4	65.9	40.4	17.6	22.7	47.3	30.1	16.5	16.9	36.9	44.4	29.3	26.7	29.0	22.4	20.8	21.4	20.9	12.1	38.5	17.4	28.2	18.4	24.0	27.9	19.7	30.8	37.4	32.0	20.3	29.5	24.7	11.8	31.2	21.3	27.4	46.3	29.9	49.9	20.2	15.7	36.8	40.4	10.5	11.2	18.6	7.4	14.7	9.5	7.7	9.1	7.9	11.1	5.9	7.4	5.8	11.4	14.8	16.4	9.8	7.4	7.5	5.4	6.3	6.3	6.8	5.3	6.0	6.3	5.9	6.4	5.2	6.6	6.4	13.0	22.4	20.9	4.6	16.9	10.8	11.7	11.3	16.5	13.9	10.0	9.9	14.6	10.0	20.2	5.5	39.6	19.2	14.4	18.3	9.8	15.7	92.7	25.2	18.0	11.8	6.0	14.9	4.3	18.6	20.1	11.6	26.5	15.8	42.3	11.1	8.6	9.7	13.9	5.0	4.1	14.6	8.2	12.6	12.8	49.3	14.3	14.4	5.4	5.6	20.3	11.6	15.5	2.5	5.2	22.9	23.1	12.4	22.1	9.3	18.0	9.8	31.4	51.1	19.7	16.2	19.2	86.9	32.6	14.7	10.7	19.2	19.5	11.4	12.8	9.5
DHX30	"DDX30, FLJ11214, KIAA0890"	ENSG00000132153	"DExH-box helicase 30"	Q7L2E3	3	47802909-47850195	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Ribosome biogenesis"	"Helicase, Hydrolase, RNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034806	Supported		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria	Cytosol	"HPA034806: AB_10601364"	"unprognostic (2.00e-1)"	"unprognostic (8.37e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.42e-2)"	"prognostic favorable (1.37e-6)"	"unprognostic (4.12e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.22e-1)"	22.6	24.6	23.7	17.1	23.3	22.2	22.9	21.4	26.3	26.4	24.8	26.8	16.2	27.6	10.4	23.6	24.8	14.9	28.8	23.5	22.4	26.8	25.2	21.3	20.1	24.0	23.5	27.9	24.1	28.9	32.1	17.5	24.6	26.6	10.9	12.7	21.6	18.2	37.1	27.6	22.3	15.9	20.3	27.3	25.2	54.2	23.8	23.3	24.8	21.0	14.3	25.2	22.8	24.2	21.9	52.3	54.5	56.2	24.6	20.2	35.3	39.0	33.4	65.1	46.5	56.9	42.6	66.4	32.0	37.0	51.2	30.3	73.7	52.1	23.1	49.6	86.1	59.6	76.0	58.6	40.7	56.0	58.3	33.0	33.4	68.1	49.7	28.4	44.0	57.5	82.0	40.6	31.8	57.1	82.2	59.3	60.7	30.2	84.0	44.6	30.6	62.2	32.0	53.6	41.6	61.6	39.6	54.1	31.1	25.0	38.5	58.8	32.2	40.6	51.0	46.7	73.9	56.2	75.3	61.8	42.8	48.3	49.9	14.1	10.7	7.8	16.2	10.6	12.4	10.4	12.4	16.3	13.9	8.7	11.7	12.7	1.6	9.6	11.6	7.9	15.3	14.7	23.7	23.3	21.4	26.3	23.5	22.4	24.0	23.5	24.6	20.3	23.8	24.2	31.1	38.5	46.7	30.7	34.7	18.1	25.7	38.7	39.3	49.0	34.6	35.6	38.1	32.9	34.1	51.5	43.8	41.7	33.1	37.6	66.5	37.8	129.5	59.2	31.7	32.4	40.1	38.5	32.8	36.3	22.8	26.7	42.3	33.2	23.5	40.7	27.5	50.8	35.9	58.9	36.6	25.8	40.7	29.6	17.6	123.8	24.8	24.4	19.6	13.1	32.5	46.3	28.8	22.1	28.7	46.0	41.0	30.1	39.9	28.6	40.5	83.5	49.9	52.8	32.9	27.3	28.6	145.4	50.2	33.5	19.9	29.6	29.7	36.6	38.5	26.3
DHX33	"DDX33, DKFZp762F2011, FLJ21972"	ENSG00000005100	"DEAH-box helicase 33"	Q9H6R0	17	5440917-5468982	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 81.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073875	Supported		Supported	Nucleoli		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoli		"HPA073875: AB_2686638"	"unprognostic (4.96e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (1.03e-1)"	"unprognostic (4.66e-1)"	"unprognostic (3.55e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.37e-2)"	6.2	5.9	5.5	6.3	5.8	4.4	7.0	5.1	6.0	5.4	3.9	5.3	4.8	6.4	4.1	6.2	5.8	4.1	4.5	5.7	4.9	5.2	7.8	4.4	6.0	4.9	5.2	5.6	6.7	7.6	3.9	6.3	4.8	5.4	5.6	6.4	5.6	5.4	8.0	6.9	5.0	5.9	5.0	6.0	5.5	4.5	5.7	5.2	5.1	5.6	5.9	6.5	5.4	5.5	19.0	27.7	17.4	31.1	7.2	14.4	21.6	18.4	11.4	27.6	22.1	17.6	8.1	46.7	12.5	15.1	11.0	22.0	35.4	28.7	35.3	15.0	34.1	18.5	22.4	30.0	14.1	24.9	15.9	12.2	17.3	29.8	40.4	8.3	20.9	22.0	24.9	22.3	15.5	13.4	25.5	13.6	38.5	12.5	14.0	33.5	25.5	25.3	12.8	14.7	15.1	21.7	19.2	16.4	28.0	14.6	12.8	12.9	19.5	19.0	20.2	15.3	39.6	8.3	9.5	23.5	13.6	29.1	27.7	0.2	0.9	0.5	0.5	0.4	0.5	0.7	0.6	0.3	0.4	0.8	0.6	0.6	0.6	0.8	0.3	0.9	0.4	0.2	5.5	5.8	5.1	6.0	5.7	4.9	4.9	5.2	4.8	5.0	5.7	5.5	11.4	12.8	8.6	6.5	8.6	21.0	15.3	8.6	19.9	15.6	18.3	15.7	16.3	17.2	9.9	7.3	20.9	8.3	10.2	8.5	1.9	9.3	81.8	7.6	23.3	16.2	9.1	23.3	14.5	15.3	10.1	13.7	10.7	12.7	3.8	21.0	13.2	28.1	6.3	13.5	15.2	10.9	2.0	16.9	8.7	11.3	7.8	9.9	14.2	6.5	6.8	13.3	9.2	11.6	13.0	12.1	5.1	9.8	10.4	20.9	5.9	5.9	6.1	10.5	0.0	25.1	11.5	10.6	15.7	22.0	19.9	5.1	6.6	19.7	11.9	14.9
DHX36	"DDX36, KIAA1488, MLEL1, RHAU"	ENSG00000174953	"DEAH-box helicase 36"	Q9H2U1	3	154272546-154324487	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Antiviral defense, Differentiation, Immunity, Innate immunity, Transcription, Transcription regulation, Translation regulation, Transport"	"Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 547.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035398, HPA035399"	Approved		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA035398: , HPA035399: AB_10670115"	"unprognostic (8.04e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.50e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.03e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.09e-2)"	"unprognostic (5.27e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.37e-1)"	17.7	14.4	5.6	17.3	8.6	16.3	16.4	8.9	7.3	13.9	6.3	12.0	12.6	18.3	11.6	14.8	14.4	15.5	16.9	5.6	8.1	18.6	20.0	13.7	21.7	7.0	7.5	19.0	16.0	29.1	14.9	19.0	7.2	17.3	13.7	17.0	11.7	16.4	58.9	12.0	12.8	17.1	6.9	15.2	16.0	34.4	6.9	21.7	23.1	31.6	20.5	17.2	11.0	10.0	63.8	42.6	56.6	32.7	26.1	36.3	28.1	40.6	40.5	45.2	53.5	43.7	49.7	61.3	64.0	35.8	41.7	40.1	53.8	34.4	70.6	59.3	35.6	44.5	34.8	25.0	44.2	62.7	37.4	41.3	28.5	48.6	59.1	24.5	39.4	37.3	42.6	34.3	42.2	31.0	52.2	13.7	75.4	33.6	40.5	53.4	47.6	88.8	32.1	44.4	52.7	56.1	42.3	44.4	59.7	38.3	45.5	31.5	44.9	47.1	29.6	44.6	82.1	63.6	43.9	87.5	38.1	32.2	51.1	1.2	1.5	1.8	3.7	1.5	2.3	2.6	3.2	2.5	1.3	3.1	2.9	3.1	0.6	2.6	3.5	3.3	3.1	0.6	5.6	8.6	8.9	7.3	5.6	8.1	7.0	7.5	7.2	6.9	6.9	10.0	95.6	57.7	92.9	45.4	123.6	92.9	146.6	56.6	81.4	152.2	61.8	62.6	60.8	67.2	83.5	60.7	129.3	138.0	179.3	43.8	39.2	71.2	547.0	73.4	147.9	82.0	92.0	68.5	53.5	62.8	69.9	97.6	66.8	104.2	103.8	86.7	72.8	80.5	62.0	154.8	60.2	57.4	73.2	73.7	85.2	335.5	110.6	83.0	53.4	37.5	88.5	86.4	113.3	59.3	55.4	66.5	49.9	121.5	97.6	132.2	40.4	54.4	52.3	128.6	78.9	130.6	88.8	197.4	135.1	65.3	83.1	370.1	152.0	114.2	58.1	128.4
DHX37	"DDX37, Dhr1, KIAA1517, MGC2695, MGC4322"	ENSG00000150990	"DEAH-box helicase 37"	Q8IY37	12	124946825-124989131	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Helicase, Hydrolase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047607	Approved		Approved	"Nuclear membrane"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear membrane"		"HPA047607: AB_2680101"	"unprognostic (1.83e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (9.54e-10)"	"unprognostic (2.38e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.16e-2)"	"unprognostic (8.28e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.73e-1)"	4.3	3.2	2.9	6.8	3.4	8.8	3.6	3.0	3.6	3.5	1.4	3.4	4.4	3.8	1.3	4.7	3.4	2.8	3.6	2.9	2.5	3.3	3.0	2.8	7.4	4.1	3.6	4.5	6.6	2.6	1.6	2.9	3.4	3.3	1.6	0.5	4.3	2.6	10.8	4.0	3.8	2.5	3.0	5.2	3.9	2.6	3.2	4.6	3.2	4.9	3.9	5.0	3.6	4.3	17.3	45.5	5.2	21.9	6.7	6.6	27.4	13.8	7.3	19.5	11.6	44.7	9.4	37.5	24.6	11.4	19.7	21.9	19.8	15.6	4.5	32.7	38.2	23.0	13.8	23.7	13.4	27.7	30.5	8.8	10.8	24.3	4.0	7.2	10.0	17.4	44.4	7.5	7.5	23.9	29.5	28.5	39.2	15.1	36.4	31.4	11.0	21.5	8.6	22.6	17.6	11.1	14.0	16.3	16.0	5.1	19.3	19.5	13.1	16.1	20.2	20.0	27.6	31.6	33.2	44.0	15.1	22.2	27.2	0.0	1.5	0.0	1.6	1.7	1.4	1.8	1.3	1.6	1.4	1.4	0.9	1.4	0.0	0.9	0.8	1.1	0.7	1.4	2.9	3.4	3.0	3.6	2.9	2.5	4.1	3.6	3.4	3.0	3.2	4.3	5.5	3.2	5.2	3.3	10.3	4.2	3.4	2.8	4.0	3.5	6.2	5.3	3.8	2.8	4.1	0.0	0.0	4.1	6.7	8.8	3.9	4.8	1.7	5.3	9.6	5.7	9.0	5.0	3.0	6.2	6.0	4.8	8.2	7.8	6.3	9.3	2.2	6.2	5.4	13.5	2.0	7.1	6.1	7.2	2.5	2.0	5.3	4.9	0.0	1.9	6.6	2.2	6.2	3.0	4.0	9.0	2.2	2.6	9.2	4.9	2.8	4.7	4.1	2.1	6.6	7.1	3.8	1.5	5.6	8.0	4.0	2.9	7.7	5.9	9.3	4.0
DHX38	"DDX38, hPrp16, KIAA0224, PRP16, PRPF16"	ENSG00000140829	"DEAH-box helicase 38"	Q92620	16	72093613-72112912	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041347, HPA041604"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA041347: AB_10796571, HPA041604: AB_2677577"	"unprognostic (2.38e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.32e-3)"	"unprognostic (8.50e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.28e-3)"	"unprognostic (4.20e-3)"	"unprognostic (2.68e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.40e-2)"	25.8	18.7	22.4	22.8	24.4	39.7	23.8	22.2	24.7	25.1	25.9	24.8	19.6	25.5	10.7	24.2	23.8	15.0	27.0	21.5	21.6	19.6	24.0	23.9	27.8	23.2	23.2	30.6	20.2	22.9	19.3	18.6	22.5	20.9	16.1	13.2	21.1	14.4	39.9	27.6	27.3	17.6	22.2	30.4	22.5	21.3	23.5	24.2	22.8	21.4	23.1	23.7	22.9	25.0	38.5	55.0	39.4	21.9	33.4	25.8	51.1	33.6	32.6	49.1	37.8	66.4	37.5	50.5	29.2	50.9	27.0	48.6	46.3	45.8	38.0	25.3	50.0	38.7	48.9	92.5	30.8	46.9	66.7	35.6	41.2	66.1	47.4	25.9	42.9	35.7	58.9	22.9	30.6	112.8	43.9	53.1	49.7	23.9	30.9	55.8	27.1	49.9	24.0	35.6	35.6	38.9	43.8	20.3	24.5	22.5	36.8	38.4	49.4	46.6	40.8	34.8	37.3	56.2	47.6	96.7	43.9	32.1	37.5	7.1	6.2	7.1	11.3	8.3	9.8	8.1	6.8	8.2	6.2	6.0	7.4	7.9	6.4	8.8	5.1	5.5	8.6	5.5	22.4	24.4	22.2	24.7	21.5	21.6	23.2	23.2	22.5	22.2	23.5	25.0	22.5	25.6	34.3	13.7	24.4	12.2	11.0	9.5	20.5	30.7	12.0	13.6	8.6	20.0	22.0	14.7	16.7	15.0	33.3	28.5	0.0	14.5	9.0	19.3	23.0	22.3	30.5	16.8	6.7	20.6	14.3	17.1	28.1	23.6	43.0	24.0	15.0	13.6	14.9	30.3	6.1	24.8	6.1	15.2	13.9	11.0	28.9	20.3	8.8	5.6	16.9	17.9	19.6	8.0	11.1	23.7	17.1	25.2	22.4	12.7	21.1	8.6	19.0	35.3	19.7	25.6	19.1	25.5	17.8	18.5	12.8	20.4	28.2	20.6	23.4	12.6
DHX9	"DDX9, LKP, RHA"	ENSG00000135829	"DExH-box helicase 9"	Q08211	1	182839347-182887982	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, DNA replication, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, mRNA processing, mRNA splicing, mRNA transport, RNA-mediated gene silencing, Transcription, Transcription regulation, Transcription termination, Translation regulation, Transport"	"Activator, DNA-binding, Helicase, Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011819, HPA028050, HPA055684"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA		360000	"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Nucleoli	"CAB011819: AB_777725, HPA028050: AB_10603564, HPA055684: AB_2682885"	"unprognostic (8.14e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (9.98e-2)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (2.76e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.53e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.99e-1)"	38.7	30.5	13.6	47.4	15.8	131.4	53.2	19.0	19.7	43.7	17.0	40.2	32.6	49.4	33.0	32.2	45.9	31.1	28.5	13.1	16.0	49.9	36.9	38.6	56.9	15.2	13.6	52.8	30.5	68.2	21.1	44.6	16.3	39.6	47.1	66.5	32.5	44.3	30.3	31.1	36.3	50.8	16.6	40.9	34.5	50.4	14.6	88.7	48.0	37.7	70.2	54.0	30.0	25.5	165.7	158.8	223.0	122.3	113.7	87.8	219.2	143.5	130.3	203.6	137.0	175.8	124.2	264.3	133.7	129.6	121.7	138.8	342.6	155.2	225.7	108.3	169.5	176.4	121.0	119.6	62.5	258.3	115.0	78.6	75.8	200.4	53.4	91.6	161.7	132.9	281.8	91.9	165.1	142.3	263.6	61.1	282.8	173.9	96.8	236.0	208.0	151.0	127.0	187.8	160.0	183.2	203.2	125.0	83.2	186.4	148.4	140.9	127.6	125.3	138.8	128.9	195.9	93.6	167.2	305.0	79.0	137.0	174.5	7.7	21.3	16.1	23.4	22.5	26.2	20.5	19.8	21.1	29.9	16.6	21.6	23.7	8.0	20.0	19.7	14.2	20.1	21.2	13.6	15.8	19.0	19.7	13.1	16.0	15.2	13.6	16.3	16.6	14.6	25.5	43.6	41.7	74.1	59.1	54.5	53.7	61.2	42.7	38.7	59.6	43.3	38.9	43.9	30.0	60.8	51.5	52.1	50.9	70.2	38.6	19.6	49.0	26.8	79.2	67.4	50.7	53.8	74.5	49.4	50.8	47.5	48.0	37.8	109.8	44.9	67.7	36.0	28.0	40.8	28.6	55.5	40.9	30.5	35.4	35.1	45.8	60.3	44.7	30.2	55.3	55.9	42.7	42.2	55.3	70.3	52.3	28.0	47.0	52.4	48.3	35.4	38.0	67.7	77.1	39.5	73.9	54.1	69.9	68.2	51.7	47.2	49.5	59.2	60.9	54.4	55.4
DIABLO	"DFNA64, DIABLO-S, FLJ10537, FLJ25049, SMAC"	ENSG00000184047	"Diablo IAP-binding mitochondrial protein"	Q9NR28	12	122207663-122227456	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 31.3;Plasma cells: 29.2;Squamous epithelial cells: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001825, CAB003857, CAB016688"	Supported		Enhanced	Mitochondria		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"CAB003857: AB_365498, CAB016688: AB_1615783, HPA001825: AB_1857247"	"unprognostic (3.67e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.40e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (6.68e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.40e-1)"	23.8	34.3	29.8	17.3	30.8	32.5	25.3	33.7	36.8	21.4	30.4	28.7	21.7	27.0	36.1	30.8	23.3	18.0	30.3	28.7	32.0	34.5	39.6	21.2	21.0	32.0	31.4	27.8	27.7	32.2	41.4	25.8	32.1	21.9	24.5	27.5	28.9	19.5	37.4	25.4	26.9	20.5	33.6	24.3	26.6	53.2	31.0	26.9	25.8	34.5	24.9	32.0	24.5	33.4	49.0	94.7	65.4	44.7	45.9	44.6	50.2	49.5	48.3	56.9	50.8	82.4	24.9	59.2	45.4	45.2	42.4	47.4	72.2	59.3	67.0	51.1	56.4	65.2	36.6	76.7	65.3	71.0	25.9	62.2	41.3	67.3	100.1	64.4	66.8	57.9	75.9	24.5	56.1	72.4	58.6	103.8	52.9	69.5	88.0	52.3	65.2	65.4	64.4	74.7	61.7	62.6	66.1	26.2	54.8	73.3	87.9	49.2	46.0	43.7	53.6	50.0	45.4	52.8	95.5	84.3	55.8	53.6	58.8	43.3	39.8	39.8	39.9	41.4	37.8	46.3	36.4	37.2	48.3	36.4	35.6	36.1	17.9	45.5	40.1	37.5	46.3	42.0	29.8	30.8	33.7	36.8	28.7	32.0	32.0	31.4	32.1	33.6	31.0	33.4	0.2	0.0	0.6	7.2	19.7	5.0	5.9	7.6	31.3	7.3	0.0	0.0	1.3	10.0	3.3	0.0	4.2	11.3	3.0	8.2	0.0	0.2	6.3	0.0	0.0	3.8	7.3	20.4	14.5	0.0	10.8	7.7	25.5	0.0	4.5	0.0	5.3	2.9	6.5	3.3	14.1	8.8	8.2	3.3	3.6	4.6	5.6	7.1	3.6	3.7	2.7	7.6	9.2	9.0	15.1	0.2	11.9	3.4	29.2	3.9	16.8	0.1	1.7	11.1	6.6	2.6	4.9	19.2	16.3	30.4	4.8	13.4	13.2	0.0	9.9	3.9
DICER1	"Dicer, HERNA, K12H4.8-LIKE, KIAA0928, MNG1"	ENSG00000100697	"Dicer 1, ribonuclease III"	Q9UPY3	14	95086228-95158010	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, RNA-mediated gene silencing"	"Endonuclease, Helicase, Hydrolase, Nuclease, RNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 418.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000694, CAB068185"	Approved		Supported	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"CAB068185: AB_2665650, HPA000694: AB_1078661"	"unprognostic (2.97e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.75e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.96e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.52e-3)"	"unprognostic (5.73e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.22e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.04e-3)"	"unprognostic (3.74e-2)"	15.6	7.9	6.7	14.0	22.5	10.8	15.1	12.3	11.4	13.3	7.4	13.0	7.5	12.7	8.3	15.0	12.4	8.7	9.9	7.2	14.0	10.7	12.8	14.9	11.0	19.1	16.0	14.3	12.6	11.5	10.6	18.7	18.5	12.5	10.9	19.3	12.4	10.1	19.2	13.0	11.6	11.5	11.6	12.1	10.1	13.2	20.3	8.5	14.7	16.2	12.0	12.7	14.5	39.4	18.6	19.4	40.7	12.0	7.2	14.5	26.4	15.5	10.7	11.3	11.1	25.4	12.5	20.9	16.1	16.0	10.4	21.2	31.6	13.9	20.5	35.9	14.6	36.5	10.1	16.0	6.7	22.6	18.0	12.2	10.1	12.3	20.8	8.0	16.1	15.7	15.7	16.6	16.9	21.8	24.1	6.8	9.3	11.0	10.2	16.0	31.9	12.2	8.2	30.9	31.9	16.4	16.2	13.4	15.2	19.2	18.0	12.4	16.4	8.1	14.4	14.0	16.9	18.9	31.7	31.4	8.0	14.5	13.1	1.4	1.1	0.8	0.3	1.4	0.7	0.7	0.6	0.4	0.8	0.7	0.5	0.3	3.9	0.5	3.2	0.4	0.7	0.4	6.7	22.5	12.3	11.4	7.2	14.0	19.1	16.0	18.5	11.6	20.3	39.4	69.4	54.5	53.7	88.8	45.7	27.4	49.5	29.9	40.5	98.2	50.7	29.1	36.4	41.5	47.3	46.0	56.3	46.6	36.9	44.0	5.9	33.4	23.3	37.4	54.2	52.0	46.1	33.4	99.7	23.1	22.8	45.6	33.1	50.1	12.0	35.5	42.1	60.1	48.8	107.7	112.2	29.7	24.4	104.2	24.8	15.5	54.3	82.3	23.2	81.5	84.6	33.5	33.0	109.1	418.6	33.2	28.0	52.6	39.2	62.5	27.1	25.9	38.6	73.8	32.9	64.3	41.9	45.5	56.1	63.0	27.6	25.7	31.7	35.9	33.9	62.1
DIS3L	"DIS3L1, FLJ38088, KIAA1955, MGC4562"	ENSG00000166938	"DIS3 like exosome 3'-5' exoribonuclease"	Q8TF46	15	66293217-66333898	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041805	Approved		Supported	"Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"	Centrosome	"HPA041805: AB_10796783"	"unprognostic (2.57e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.99e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.86e-1)"	"unprognostic (3.42e-3)"	"unprognostic (2.66e-1)"	"unprognostic (6.18e-2)"	"unprognostic (9.58e-2)"	"unprognostic (3.40e-1)"	11.0	11.8	7.9	6.2	9.8	7.6	9.3	8.9	8.6	10.3	7.7	11.1	5.1	11.1	9.5	7.5	9.6	5.5	12.7	8.0	9.1	8.3	11.0	5.9	7.6	8.7	9.4	11.1	12.8	15.8	10.0	5.4	9.6	8.7	6.0	11.4	8.9	9.0	23.2	7.4	7.7	8.8	8.8	8.7	9.0	9.8	8.9	7.8	11.0	28.3	7.2	9.6	8.1	12.2	14.0	32.6	10.6	14.1	12.2	16.4	12.4	9.5	11.1	14.3	13.2	17.6	10.1	51.6	10.3	13.4	14.9	23.3	25.7	9.2	9.2	12.0	24.1	26.7	25.1	20.1	9.5	27.7	10.1	6.9	9.7	4.5	14.8	9.7	13.1	17.7	18.6	12.6	14.4	12.3	13.8	17.3	15.4	12.7	20.0	18.3	42.1	30.0	5.7	18.9	17.1	15.7	22.3	7.6	11.4	10.0	10.6	21.8	14.4	18.7	16.8	7.4	18.7	10.1	36.9	24.0	6.4	35.9	7.8	8.5	5.1	4.3	7.6	6.1	10.2	6.5	7.7	10.0	8.5	7.8	8.8	7.3	0.6	11.7	13.2	6.7	8.0	6.7	7.9	9.8	8.9	8.6	8.0	9.1	8.7	9.4	9.6	8.8	8.9	12.2	7.1	6.4	16.2	22.5	14.6	4.2	5.5	4.0	17.1	15.6	9.4	7.6	30.3	15.7	7.1	3.7	4.2	17.0	9.6	5.0	5.9	6.5	7.1	8.3	14.6	10.2	3.0	24.2	11.4	3.5	4.5	12.4	10.7	7.3	16.5	25.1	7.1	19.2	9.6	10.1	17.2	10.6	8.2	12.3	7.8	9.9	19.9	10.1	1.8	13.1	14.4	17.7	12.3	22.6	23.1	3.3	5.1	20.3	18.4	4.8	5.4	9.8	8.1	23.2	19.7	9.5	10.1	28.5	17.2	12.1	5.4	3.7	16.0	16.5	14.0	3.8
DLD	"DLDH, E3, GCSL, LAD, OGDC-E3"	ENSG00000091140	"Dihydrolipoamide dehydrogenase"	P09622	7	107891162-107931730	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 357.0"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 356.2;Distal tubular cells: 226.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044849	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA		10000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA044849: AB_2679111"	"unprognostic (2.01e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.01e-3)"	"unprognostic (9.27e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.43e-2)"	"unprognostic (7.35e-2)"	"prognostic favorable (7.58e-9)"	"unprognostic (4.08e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.18e-1)"	108.7	98.9	22.7	42.1	23.7	54.0	49.0	27.1	29.1	36.3	35.6	109.0	81.8	45.3	21.2	94.1	34.3	48.5	264.1	23.1	29.5	153.3	112.8	39.3	50.1	27.1	27.4	30.0	49.2	136.7	27.8	43.1	26.6	45.7	99.3	35.0	50.2	50.3	295.0	38.9	71.9	67.7	24.9	38.4	80.5	31.3	25.7	43.2	64.2	357.0	67.5	66.1	32.7	23.4	171.4	134.5	74.8	127.9	104.6	91.4	88.4	96.5	80.8	110.6	86.2	159.5	95.5	165.9	159.6	103.0	177.7	110.9	150.2	135.8	166.1	111.1	88.4	116.9	175.6	116.7	80.3	194.7	116.0	104.8	97.6	116.4	63.4	72.3	134.0	137.0	298.5	119.7	121.8	188.1	161.8	138.9	87.4	206.0	98.2	113.1	117.8	225.9	151.8	250.8	92.3	99.9	156.3	262.1	143.9	149.9	100.5	165.8	87.9	120.7	97.3	238.1	149.4	89.3	187.1	114.6	115.0	204.1	130.2	132.7	63.9	136.0	46.9	81.6	49.4	37.8	46.8	46.8	87.2	38.5	47.9	50.5	39.9	68.1	116.9	29.9	49.0	64.2	22.7	23.7	27.1	29.1	23.1	29.5	27.1	27.4	26.6	24.9	25.7	23.4	26.7	28.9	20.7	14.7	26.3	31.4	42.7	124.7	31.3	47.1	24.0	19.2	356.2	51.5	70.5	79.1	22.9	110.2	27.3	56.1	226.9	69.3	10.2	27.6	26.2	32.2	30.6	53.9	23.9	55.9	62.7	36.3	36.7	28.0	26.6	35.3	26.0	86.8	69.2	21.9	25.3	44.1	114.0	41.0	26.5	7.3	23.3	37.5	37.4	15.9	62.2	36.0	38.1	21.1	16.7	42.6	51.4	42.2	30.7	24.3	60.0	178.9	55.5	45.5	26.3	28.4	44.8	55.2	51.5	48.0	32.4	108.4	29.5	73.7	78.7	39.2
DLGAP5	"DLG1, DLG7, HURP, KIAA0008"	ENSG00000126787	"DLG associated protein 5"	Q15398	14	55148112-55191608	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 29.7;lymphoid tissue: 42.0;testis: 17.4"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 92.6;Extravillous trophoblasts: 23.1;Plasma cells: 22.1;Spermatocytes: 68.1;Spermatogonia: 31.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"T-reg: 5.4"	"Lineage enriched"	"Detected in many"	5	"T-cells: 5.4"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA005546	Enhanced		Supported	"Centriolar satellite,Cytosol"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Centriolar satellite, Cytosol"		"HPA005546: AB_1078677"	"unprognostic (2.24e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.19e-3)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.52e-6)"	"prognostic unfavorable (7.85e-4)"	"unprognostic (6.15e-3)"	"unprognostic (3.55e-1)"	"prognostic unfavorable (9.94e-6)"	"unprognostic (4.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.06e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.93e-2)"	0.8	0.3	1.4	8.1	0.9	29.7	1.4	0.4	1.8	0.8	0.6	5.5	5.0	1.3	0.1	5.2	0.4	0.8	0.2	1.0	1.7	0.2	0.7	0.7	17.9	0.7	1.0	0.2	0.1	0.2	0.0	4.1	0.8	0.2	6.7	0.1	0.8	0.1	0.1	3.1	4.6	2.7	0.3	2.6	3.0	17.4	1.1	42.0	0.4	0.0	18.7	2.0	1.5	3.8	144.8	56.8	140.6	63.7	3.3	13.4	43.8	80.3	52.7	115.3	109.3	45.9	75.8	82.1	44.2	46.9	47.4	85.6	91.5	64.0	150.5	101.9	45.7	84.4	49.9	39.3	0.4	82.7	49.3	2.8	2.2	54.8	27.0	18.9	129.0	82.5	70.5	79.8	109.3	69.2	105.0	42.7	72.6	63.3	57.3	80.8	137.9	39.0	37.9	45.2	71.7	40.7	84.8	31.7	30.8	60.6	71.6	31.6	49.6	52.4	133.3	50.6	94.6	19.4	44.9	108.9	35.9	59.6	83.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.9	1.4	0.3	0.0	0.2	0.1	0.2	1.0	0.0	0.0	5.4	0.7	1.4	0.9	0.4	1.8	1.0	1.7	0.7	1.0	0.8	0.3	1.1	3.8	0.1	0.0	0.5	0.0	4.4	1.1	0.7	3.3	0.0	0.0	1.2	0.9	0.4	0.0	1.3	0.0	0.0	11.6	1.4	3.2	0.0	0.4	19.7	7.2	2.6	2.4	0.0	92.6	0.3	0.0	23.1	4.2	7.7	4.5	0.0	15.8	3.9	0.5	10.5	0.0	0.3	3.6	8.2	4.1	1.6	6.0	0.9	3.7	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.2	0.2	1.2	22.1	0.6	0.3	0.1	1.3	0.0	6.6	0.0	3.8	68.1	31.7	11.6	0.4	1.9	4.0	0.9	6.9	1.4
DNA2	"DNA2L, KIAA0083"	ENSG00000138346	"DNA replication helicase/nuclease 2"	P51530	10	68414064-68472121	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, Endonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease"	"Disease variant, Dwarfism, Mental retardation, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 8.1"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 33.2;Excitatory neurons: 14.1;Inhibitory neurons: 15.5;Oligodendrocytes: 18.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"NK-cell: 1.8"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 1.8"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA037487, HPA057526"	Approved		Supported	Mitochondria		No	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Mitochondria		"HPA037487: AB_10672493, HPA057526: AB_2683456"	"unprognostic (1.79e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.37e-3)"	"unprognostic (4.60e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.50e-5)"	"unprognostic (3.36e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.29e-4)"	"unprognostic (1.09e-10)"	"unprognostic (3.43e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.23e-2)"	1.3	0.9	1.9	2.8	2.1	4.6	1.8	2.5	3.6	1.4	1.0	2.3	2.1	1.1	0.9	1.9	0.9	0.9	1.8	1.8	1.9	2.6	4.2	1.8	5.2	2.3	1.9	1.2	1.6	0.4	1.5	1.6	2.4	1.9	2.8	5.3	1.6	0.4	1.6	1.8	3.2	1.1	1.6	2.1	1.9	2.9	2.1	8.1	1.0	0.9	4.2	1.4	1.4	3.2	25.6	13.0	29.0	20.7	3.2	2.2	20.4	12.4	10.3	17.4	21.2	31.1	16.1	26.1	4.6	3.8	6.7	15.2	16.8	6.5	20.7	16.2	12.6	15.8	8.5	12.3	0.9	27.7	16.4	1.8	2.6	12.3	3.6	4.5	7.9	17.0	23.6	22.8	10.1	9.0	42.8	19.8	20.5	10.9	24.0	33.1	20.0	8.4	7.5	11.7	13.1	15.7	16.9	21.4	4.2	20.1	16.5	11.6	3.4	6.6	20.5	8.5	23.8	11.5	13.9	38.3	5.7	26.1	8.9	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.1	0.0	1.8	0.0	0.0	0.1	0.0	1.9	2.1	2.5	3.6	1.8	1.9	2.3	1.9	2.4	1.6	2.1	3.2	1.0	6.4	1.1	4.9	1.3	2.3	0.9	1.7	2.8	2.5	2.3	1.4	10.5	2.8	1.1	1.8	6.2	3.9	2.2	1.7	0.0	0.8	2.2	2.0	1.4	2.0	1.2	33.2	14.1	0.9	4.8	2.0	2.6	2.8	0.0	6.0	0.7	4.6	2.2	0.0	15.5	1.8	0.0	1.3	0.7	3.7	0.6	1.5	0.0	4.7	0.5	0.5	2.1	5.5	18.4	0.7	0.1	0.7	7.4	2.5	2.4	0.6	0.8	4.3	0.0	2.4	1.1	9.1	12.2	4.7	1.7	1.2	1.6	0.7	3.7	1.0
DNAAF5	"CILD18, FLJ20397, FLJ25564, FLJ31671, FLJ39381, HEATR2"	ENSG00000164818	"Dynein axonemal assembly factor 5"	Q86Y56	7	726699-786475	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020243	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA020243: AB_1848750"	"unprognostic (9.77e-2)"	"unprognostic (9.53e-3)"	"unprognostic (2.55e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.22e-3)"	"prognostic unfavorable (8.42e-4)"	"prognostic unfavorable (3.83e-4)"	"unprognostic (8.07e-3)"	"unprognostic (2.02e-1)"	"unprognostic (7.59e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.47e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.70e-3)"	8.4	8.7	7.8	6.7	7.1	7.6	8.5	11.8	8.7	10.3	12.1	11.3	7.4	12.7	4.8	11.6	14.1	5.1	11.9	6.9	7.3	8.3	9.0	6.9	6.5	7.7	10.1	10.6	10.9	7.9	13.0	6.5	6.8	7.9	5.7	4.0	11.5	8.0	24.1	9.1	9.2	6.3	8.3	7.3	9.4	7.8	9.4	6.2	9.1	9.5	5.0	10.5	9.1	8.3	83.1	64.3	18.8	44.0	12.1	13.3	47.2	16.8	16.0	20.5	19.4	64.5	42.8	50.5	23.9	17.7	49.0	49.2	35.0	42.2	15.7	8.6	59.5	12.4	37.4	47.2	16.6	38.1	21.7	16.1	17.8	25.8	19.0	13.7	28.1	25.2	80.0	10.3	15.0	81.5	22.7	34.1	69.3	27.4	50.5	41.4	6.1	34.8	24.3	34.5	39.3	65.1	27.5	66.9	19.9	21.4	59.1	31.5	23.7	11.4	40.1	39.4	38.4	19.9	25.5	29.0	25.1	39.2	60.8	0.0	0.7	0.6	0.8	1.1	1.3	0.6	1.3	1.8	1.1	1.4	1.2	0.9	0.0	1.3	0.8	1.7	0.3	0.8	7.8	7.1	11.8	8.7	6.9	7.3	7.7	10.1	6.8	8.3	9.4	8.3	7.1	19.2	9.1	6.2	3.8	0.0	6.1	0.0	6.8	6.3	8.3	7.1	13.1	4.3	4.3	9.2	27.1	8.0	5.7	4.9	15.6	6.4	0.7	28.2	13.9	7.8	3.6	9.7	12.5	4.2	13.2	7.8	11.7	15.3	0.0	17.6	6.8	8.5	5.8	10.1	10.4	7.4	0.0	7.5	0.0	1.7	7.2	4.8	0.0	7.5	2.4	8.6	2.1	10.6	8.9	9.6	4.1	8.6	6.0	5.1	6.4	11.1	8.0	15.0	0.0	11.4	6.1	7.2	17.4	10.8	0.0	4.5	3.5	12.0	9.1	4.2
DNAJA1	"dj-2, hdj-2, HSJ2, HSPF4, NEDD7"	ENSG00000086061	"DnaJ heat shock protein family (Hsp40) member A1"	P31689	9	33025273-33039907	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 438.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001306, CAB033665"	Approved		Supported	Microtubules,Cytosol		NA	Yes		160000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 65: Brain - Ion transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	Microtubules	"CAB033665: AB_2094242, HPA001306: AB_1079043"	"unprognostic (3.11e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.88e-2)"	"unprognostic (5.58e-2)"	"prognostic favorable (5.39e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (3.40e-4)"	"unprognostic (3.27e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.70e-2)"	102.6	134.7	143.9	83.9	154.7	148.8	65.8	147.4	438.9	83.7	142.7	61.9	44.5	81.0	80.4	51.7	102.7	83.6	72.9	154.1	159.8	114.6	216.9	94.4	80.6	147.7	152.8	83.5	59.7	105.2	80.7	108.3	160.9	85.8	63.5	78.2	61.0	64.7	47.3	43.8	50.1	87.2	155.3	72.0	67.7	135.0	164.6	95.7	66.0	61.5	89.1	130.7	57.3	174.0	255.6	447.5	353.7	123.6	240.2	155.1	202.4	256.5	205.9	451.2	348.2	299.2	115.0	259.5	191.6	175.4	254.9	113.1	515.7	154.7	386.1	368.2	150.2	208.3	537.3	382.7	115.1	242.5	234.2	96.1	156.1	170.4	53.9	218.4	273.6	110.9	330.5	109.7	262.0	208.6	407.7	530.3	345.3	254.2	308.2	294.7	126.6	132.9	254.1	148.8	223.8	243.5	345.4	220.6	120.0	262.5	103.5	231.5	236.1	160.0	273.1	184.6	346.2	69.9	233.3	271.7	209.9	208.3	140.9	154.1	140.8	160.9	93.3	202.0	111.1	127.5	116.8	105.7	127.8	119.7	119.6	113.4	176.2	117.8	268.3	213.4	110.4	209.9	143.9	154.7	147.4	438.9	154.1	159.8	147.7	152.8	160.9	155.3	164.6	174.0	1110.8	214.7	154.9	7.8	368.7	264.6	942.8	245.3	327.8	209.3	307.8	513.5	187.7	95.8	257.7	82.8	208.5	274.0	619.1	287.9	172.1	247.7	536.4	549.2	348.2	427.8	391.1	198.9	16.2	181.1	341.6	392.8	188.6	526.1	424.7	127.6	133.2	129.6	231.1	121.1	16.7	327.3	213.6	156.0	497.4	222.2	99.1	402.3	284.6	22.5	243.7	150.5	91.6	8.0	22.5	189.8	334.7	94.8	195.8	393.8	134.7	178.1	417.8	161.7	105.2	391.1	476.0	492.7	209.4	238.5	265.4	464.9	678.9	179.2	273.3	636.8
DNAJA2	"CPR3, DNAJ, DNJ3, HIRIP4"	ENSG00000069345	"DnaJ heat shock protein family (Hsp40) member A2"	O60884	16	46955362-46973674	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049789, HPA060538"	Approved		Approved	"Nucleoli,Intermediate filaments,Cytosol"		NA	NA		67000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Cytosol"	"Intermediate filaments"	"HPA049789: AB_2680883, HPA060538: AB_2684315"	"unprognostic (7.68e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.77e-2)"	"unprognostic (3.67e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (2.81e-4)"	"unprognostic (1.03e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.41e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (1.19e-9)"	"unprognostic (9.22e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.69e-2)"	20.7	25.2	30.5	14.2	32.6	23.9	19.7	33.9	40.5	17.9	32.2	21.3	20.0	22.0	28.6	21.5	17.4	16.4	36.0	32.3	31.9	28.0	36.0	16.6	19.7	29.8	30.2	22.0	17.0	29.2	16.4	19.9	30.5	21.8	19.0	29.5	17.1	20.6	37.1	21.1	20.5	17.0	31.0	22.7	19.2	24.9	31.2	20.3	22.2	38.7	21.4	21.6	18.2	30.5	23.1	26.9	26.6	22.8	35.7	34.1	40.3	29.4	35.4	43.4	20.5	23.7	23.6	37.1	23.2	31.9	18.6	35.0	43.0	30.2	49.8	8.8	36.0	27.2	12.8	50.7	42.7	41.7	36.3	36.5	34.6	25.2	23.7	37.9	30.4	14.7	31.7	12.0	37.0	25.4	30.1	57.5	40.6	21.1	39.6	34.3	48.7	44.1	52.7	24.1	36.1	23.1	34.9	52.1	33.4	26.1	20.3	32.2	31.6	25.4	16.0	18.5	25.1	29.3	21.7	49.0	26.9	35.5	21.8	13.1	10.3	13.5	9.8	12.7	12.9	11.3	13.2	11.2	9.4	8.4	12.9	13.1	10.7	12.8	11.3	6.7	17.2	9.7	30.5	32.6	33.9	40.5	32.3	31.9	29.8	30.2	30.5	31.0	31.2	30.5	64.3	51.3	35.9	11.8	78.4	126.9	75.1	56.4	101.3	38.8	37.5	28.4	100.3	40.0	48.2	40.5	18.8	85.2	76.1	67.6	90.1	73.4	93.3	86.9	76.8	52.2	52.0	49.4	16.6	62.2	72.5	66.2	54.0	72.1	53.9	52.7	31.1	54.9	56.5	37.0	15.3	55.6	52.9	42.5	86.4	56.8	50.1	65.1	72.9	12.2	72.3	60.5	45.3	10.1	11.0	71.2	64.2	59.0	70.7	61.6	83.3	111.4	67.6	43.7	52.6	63.4	99.4	177.7	106.0	111.1	120.5	172.4	89.6	131.4	62.6	87.3
DNAJA3	"hTid-1, TID1"	ENSG00000103423	"DnaJ heat shock protein family (Hsp40) member A3"	Q96EY1	16	4425805-4456775	"Predicted intracellular proteins"	Apoptosis	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016095, HPA040875, HPA044229"	Approved		Supported	Vesicles,Mitochondria		NA	NA		16000	"Cluster 22: NK-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Vesicles	"CAB016095: AB_668801, HPA040875: AB_2677183, HPA044229: AB_2678865"	"unprognostic (5.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.86e-3)"	"unprognostic (2.91e-2)"	"unprognostic (4.17e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.27e-2)"	"prognostic favorable (1.79e-4)"	"unprognostic (4.17e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.92e-1)"	18.9	44.3	15.7	11.8	16.3	6.4	18.3	17.5	18.7	19.9	15.3	25.2	17.5	18.6	6.8	27.8	18.0	8.1	43.6	16.0	16.8	26.7	65.7	15.8	13.3	16.5	16.1	20.7	26.5	23.9	20.2	12.3	17.2	18.7	12.6	8.7	20.2	12.4	90.5	22.7	21.2	10.4	16.6	19.3	23.9	23.6	17.5	11.5	18.7	48.3	11.9	23.8	20.5	16.8	26.4	53.7	16.1	33.1	20.5	18.8	34.6	34.2	22.9	45.1	36.1	40.2	38.7	50.2	32.9	20.3	31.3	38.4	55.7	39.7	24.8	42.2	35.8	25.4	48.8	40.4	50.8	47.5	24.4	22.6	46.6	40.0	66.1	20.5	20.4	36.7	63.1	39.7	27.8	60.9	39.6	33.8	35.6	48.2	43.2	51.5	27.6	92.7	32.5	28.0	43.7	17.3	38.2	77.6	62.0	13.7	46.7	38.3	22.2	35.8	24.5	80.1	44.4	38.5	56.6	69.7	17.9	45.0	39.8	1.4	5.3	3.2	10.3	8.7	12.4	12.1	9.6	9.8	7.6	10.0	12.9	10.4	0.8	11.1	6.9	5.4	10.8	10.5	15.7	16.3	17.5	18.7	16.0	16.8	16.5	16.1	17.2	16.6	17.5	16.8	10.9	12.8	8.1	11.4	23.7	15.7	18.5	12.6	25.0	23.0	14.8	10.8	36.3	14.3	13.0	25.8	10.4	42.8	8.2	17.9	45.0	21.8	62.6	8.9	13.5	13.3	17.5	18.7	19.4	12.2	34.3	13.6	18.8	10.0	12.7	17.9	8.9	46.1	16.6	23.5	20.4	17.5	16.2	10.1	7.0	30.5	19.3	10.0	21.4	6.5	15.2	18.5	16.5	10.6	15.2	13.9	15.5	22.2	19.9	28.9	21.5	25.9	9.2	23.2	13.1	14.2	14.2	50.5	33.7	23.5	16.9	28.5	17.5	29.8	32.7	16.7
DNAJB11	"EDJ, ERdj3, HEDJ"	ENSG00000090520	"DnaJ heat shock protein family (Hsp40) member B11"	Q9UBS4	3	186567403-186585800	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Chaperone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010814, HPA017051"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		100000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA010814: AB_1078691, HPA017051: AB_1847792"	"unprognostic (4.29e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.86e-2)"	"unprognostic (6.52e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.05e-3)"	"prognostic unfavorable (3.44e-9)"	"unprognostic (1.27e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.82e-1)"	36.1	26.3	17.3	51.5	18.8	50.1	28.2	20.1	19.8	30.3	21.0	38.9	35.2	31.5	36.7	33.2	28.7	28.1	42.9	17.9	20.1	33.0	81.8	35.8	34.5	21.1	19.8	20.5	62.3	31.7	27.0	46.2	20.2	23.3	37.2	16.1	34.3	23.1	22.9	23.9	38.4	30.9	19.3	41.7	37.8	27.1	20.0	30.7	53.2	15.8	36.5	40.6	26.1	21.6	154.5	60.5	87.5	150.5	69.6	53.1	142.4	166.5	98.5	138.6	145.9	187.0	100.5	109.4	326.7	113.3	199.6	139.1	96.0	88.0	135.6	123.7	81.7	97.8	57.0	128.8	150.8	116.8	149.0	46.6	85.5	78.0	130.6	76.4	116.7	59.0	55.8	263.9	93.6	117.4	77.6	85.7	83.1	211.8	76.3	78.1	96.8	187.8	87.7	66.4	73.3	101.3	108.2	181.4	123.2	103.2	209.3	177.6	89.5	76.6	97.1	100.7	244.5	202.9	159.0	175.8	102.3	141.6	169.8	37.4	37.3	39.8	44.0	45.9	37.2	37.2	22.9	36.5	46.2	21.8	21.8	29.2	17.2	50.2	35.4	84.8	33.9	38.4	17.3	18.8	20.1	19.8	17.9	20.1	21.1	19.8	20.2	19.3	20.0	21.6	42.2	19.2	20.9	12.1	78.1	145.3	212.5	104.3	48.9	22.9	38.3	22.7	152.0	67.2	61.4	14.7	18.8	88.7	75.0	93.5	3.9	109.2	41.5	58.2	44.9	63.6	142.1	37.6	10.8	85.7	173.0	63.3	41.3	77.5	54.7	29.4	61.1	105.0	149.4	23.5	11.6	122.8	67.1	65.3	130.3	10.8	31.4	59.4	103.2	14.0	33.3	48.5	63.8	12.1	24.5	86.9	88.2	25.9	251.1	136.6	74.6	18.9	47.3	28.4	65.7	63.7	61.3	190.6	100.7	51.1	112.2	195.1	61.7	28.4	106.8	155.8
DNAJC11	FLJ10737	ENSG00000007923	"DnaJ heat shock protein family (Hsp40) member C11"	Q9NVH1	1	6634168-6701924	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023707, HPA028705"	Uncertain		Supported	Mitochondria		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA023707: , HPA028705: AB_10603662"	"unprognostic (3.74e-2)"	"unprognostic (3.19e-2)"	"unprognostic (4.06e-2)"	"unprognostic (6.05e-3)"	"unprognostic (9.55e-2)"	"unprognostic (6.65e-2)"	"unprognostic (4.38e-3)"	"unprognostic (6.10e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.63e-5)"	"unprognostic (6.30e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.04e-1)"	16.9	28.3	15.8	19.1	16.3	14.5	16.3	14.5	20.0	15.2	11.9	28.6	27.2	17.2	12.7	24.2	15.5	12.5	37.2	17.7	15.1	54.5	28.8	13.6	19.0	17.9	16.5	18.7	19.0	24.5	12.7	17.7	18.1	15.4	31.7	16.5	17.1	13.8	44.0	20.3	23.3	17.6	13.5	23.3	21.7	16.5	17.8	15.4	14.6	35.9	18.5	18.6	16.2	17.7	44.5	41.5	47.6	44.3	40.5	28.6	44.7	42.6	36.5	82.7	58.9	51.2	61.7	70.0	41.2	49.2	35.3	58.1	82.9	69.1	72.1	40.0	57.6	71.0	84.1	51.4	40.7	85.4	37.6	42.3	19.0	74.8	48.7	29.2	39.6	52.2	92.6	29.7	42.3	35.5	53.6	45.1	49.9	60.2	71.9	60.0	41.7	50.9	53.0	37.3	64.9	46.0	49.3	98.2	55.4	39.9	39.1	44.6	40.5	48.9	26.1	40.9	51.7	34.5	40.7	91.2	48.1	93.5	25.0	10.2	9.6	3.4	8.7	12.8	8.8	7.5	6.2	9.4	12.1	8.4	6.6	5.2	0.3	10.0	14.4	5.3	7.6	9.2	15.8	16.3	14.5	20.0	17.7	15.1	17.9	16.5	18.1	13.5	17.8	17.7	11.9	9.6	11.8	17.3	9.7	19.6	4.4	9.1	4.6	18.5	8.6	9.8	9.7	2.8	9.7	12.9	29.2	21.4	5.3	33.4	35.2	14.2	14.9	8.6	13.1	9.3	14.6	25.2	28.6	13.7	22.8	10.3	23.0	10.5	5.1	27.4	5.0	14.1	16.7	20.2	35.8	22.9	14.2	8.2	24.2	9.3	8.1	9.6	28.4	18.7	8.4	11.8	6.2	15.6	23.3	11.1	19.6	4.5	13.3	6.5	37.2	32.4	12.0	17.7	6.6	11.8	13.7	17.0	11.6	14.5	18.3	23.8	8.9	24.9	36.4	5.3
DNAJC19	"Pam18, Tim14, TIMM14"	ENSG00000205981	"DnaJ heat shock protein family (Hsp40) member C19"	Q96DA6	3	180983709-180989774	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Translocation, Transport"	Chaperone	Cardiomyopathy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 471.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037782	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA037782: AB_10672611"	"unprognostic (4.52e-2)"	"unprognostic (3.55e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.01e-2)"	"prognostic favorable (8.53e-5)"	"unprognostic (6.19e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.66e-1)"	"unprognostic (3.33e-1)"	"unprognostic (4.20e-3)"	22.7	44.1	26.1	11.1	27.1	10.8	26.4	27.2	39.7	19.4	28.8	27.5	21.4	18.9	33.0	22.9	21.3	11.8	73.4	27.2	28.0	50.2	48.9	14.7	16.3	26.4	29.3	26.5	27.9	34.7	30.9	14.2	26.3	22.6	17.7	27.2	28.1	18.2	65.8	15.0	18.1	11.8	27.6	18.5	26.2	11.6	26.8	20.7	25.6	77.8	13.4	23.5	18.4	28.1	53.9	14.0	38.8	29.6	45.6	27.0	35.4	30.2	18.2	29.1	25.5	49.0	26.2	23.0	63.9	25.5	70.9	26.8	37.8	36.5	35.9	36.5	49.1	27.0	24.5	48.3	48.9	64.9	27.5	25.9	29.8	24.4	43.0	37.9	34.0	55.2	42.8	35.8	23.0	44.2	48.5	54.6	51.2	75.9	44.8	31.4	26.9	69.6	43.3	24.8	38.7	20.6	30.8	75.8	82.3	44.0	85.2	45.2	16.8	18.5	27.1	26.3	54.4	47.7	60.7	80.1	19.0	49.9	22.9	33.6	20.4	31.5	33.3	22.3	39.8	34.7	38.5	34.7	28.6	29.8	39.8	40.6	4.4	26.8	27.3	36.4	35.0	30.8	26.1	27.1	27.2	39.7	27.2	28.0	26.4	29.3	26.3	27.6	26.8	28.1	68.3	38.5	52.5	11.1	66.3	56.6	68.6	105.4	56.9	31.7	138.6	183.0	151.7	120.1	70.1	77.3	14.6	116.6	67.4	57.9	471.6	83.9	9.1	57.4	50.4	61.4	45.2	48.8	18.7	109.3	111.2	71.7	30.1	42.7	110.7	79.7	68.6	167.0	68.0	48.8	20.5	90.7	91.6	35.5	59.8	13.2	85.1	42.8	74.7	9.4	58.6	91.4	74.2	13.0	21.4	79.9	66.1	72.6	47.7	91.5	101.0	216.8	58.7	67.6	85.5	80.3	108.8	82.1	56.3	73.9	60.1	68.7	68.4	121.4	86.7	69.2
DNAJC2	"MPHOSPH11, MPP11, ZRF1, ZUO1, zuotin"	ENSG00000105821	"DnaJ heat shock protein family (Hsp40) member C2"	Q99543	7	103312289-103344830	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chaperone, Chromatin regulator"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 248.5;Spermatocytes: 238.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 61.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020454	Approved		Supported	Cytosol		NA	Yes			"Cluster 42: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA020454: AB_1859492"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.13e-3)"	"unprognostic (1.63e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (1.11e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.28e-1)"	15.7	13.4	10.2	12.2	10.7	42.0	13.4	12.7	19.2	13.1	10.5	11.9	14.7	12.8	9.7	13.8	12.1	9.8	13.5	10.5	10.4	16.4	15.7	11.2	16.8	10.0	10.7	15.7	13.4	9.0	12.6	11.9	10.3	12.3	11.9	8.7	12.6	7.7	32.5	13.6	11.9	7.4	9.3	12.2	12.9	31.3	11.4	12.3	12.7	12.7	13.2	18.8	12.8	11.8	52.7	38.1	21.4	38.7	16.1	22.6	41.6	35.1	25.8	38.5	28.6	52.9	37.2	74.9	53.7	24.4	55.2	35.5	57.5	25.7	58.4	40.6	43.4	55.1	38.7	47.3	28.6	97.9	41.2	19.6	21.9	44.9	39.4	16.2	25.6	27.8	128.3	46.2	32.0	83.8	95.0	102.1	75.9	56.8	57.0	59.7	43.0	70.1	22.8	24.8	40.6	38.7	47.7	66.2	39.7	39.6	28.1	49.8	30.8	37.5	59.9	83.3	68.1	48.9	67.8	146.0	27.3	97.9	47.6	61.3	9.0	9.3	10.9	10.3	12.1	11.7	10.9	11.7	9.4	13.7	12.5	12.5	3.6	16.4	15.3	11.2	12.8	5.9	10.2	10.7	12.7	19.2	10.5	10.4	10.0	10.7	10.3	9.3	11.4	11.8	31.3	25.6	47.0	10.7	46.1	64.6	78.7	37.3	35.3	27.1	26.3	36.6	32.3	22.8	50.2	22.0	41.7	43.7	45.9	31.1	35.2	45.0	248.5	43.8	50.1	39.6	35.3	29.9	24.7	46.0	75.5	41.0	42.8	44.2	53.7	50.1	18.5	30.6	39.6	21.9	17.9	39.0	26.4	24.5	41.3	37.3	39.4	37.8	19.6	13.1	42.9	19.3	44.3	24.1	20.6	50.2	32.9	31.2	36.9	79.2	36.4	31.0	43.4	29.0	39.5	63.7	64.8	238.7	131.9	33.5	62.1	55.4	43.2	58.3	51.9	91.5
DNAJC7	"TPR2, TTC2"	ENSG00000168259	"DnaJ heat shock protein family (Hsp40) member C7"	Q99615	17	41976421-42021376	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023015, HPA052395"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		22000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA023015: AB_1847804, HPA052395: AB_2681811"	"unprognostic (3.21e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.47e-3)"	"unprognostic (8.40e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.31e-3)"	"prognostic unfavorable (3.35e-4)"	"unprognostic (7.71e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.37e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.93e-3)"	41.7	50.5	122.8	43.5	126.4	40.4	39.6	125.0	204.0	39.5	124.2	46.5	37.3	28.3	50.5	66.7	33.8	26.2	85.3	126.8	128.6	65.4	67.0	38.9	53.4	127.6	127.1	43.0	54.9	54.5	55.2	35.9	127.2	37.4	45.4	49.2	39.2	25.0	99.8	48.2	38.1	27.6	124.1	45.1	49.1	46.0	125.5	56.5	38.2	73.0	67.7	40.7	41.3	128.1	99.2	129.6	130.8	100.1	68.5	106.5	120.0	103.6	98.8	139.7	110.6	143.5	93.9	142.0	118.2	113.2	118.4	140.6	192.3	127.9	169.7	123.6	220.1	102.6	116.0	189.7	100.8	185.0	102.7	92.4	82.3	131.5	104.4	101.5	114.8	122.4	160.7	98.9	122.2	66.5	210.8	155.0	139.4	92.3	87.1	124.0	175.4	123.6	116.9	104.8	117.7	104.7	84.9	243.6	126.1	128.7	139.3	177.8	110.3	80.1	105.0	100.1	163.3	72.0	159.4	122.9	103.0	124.0	97.1	49.7	55.9	35.9	30.9	57.8	35.2	39.6	36.3	36.1	57.7	41.9	33.4	32.6	19.8	49.4	59.8	98.5	43.8	38.8	122.8	126.4	125.0	204.0	126.8	128.6	127.6	127.1	127.2	124.1	125.5	128.1	62.2	35.3	38.3	39.2	87.1	65.4	94.4	107.8	37.5	80.5	46.7	43.4	57.6	61.5	54.0	66.2	135.5	108.6	139.0	81.1	115.4	107.6	108.3	83.7	77.8	71.8	111.4	52.4	33.9	132.5	103.8	50.9	38.7	70.6	57.0	105.5	71.4	56.4	102.4	63.9	37.3	63.4	67.1	102.1	99.6	52.3	67.4	94.6	48.0	34.7	166.5	100.0	121.5	36.7	142.0	125.2	62.1	61.3	79.7	77.4	79.2	155.8	61.7	143.5	46.0	78.9	78.5	104.7	111.9	49.3	68.8	126.8	81.9	127.2	79.1	94.6
DNAJC8	SPF31	ENSG00000126698	"DnaJ heat shock protein family (Hsp40) member C8"	O75937	1	28199456-28233029	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026275, HPA026283"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA026275: AB_2671823, HPA026283: AB_10600907"	"unprognostic (1.42e-1)"	"unprognostic (2.44e-2)"	"unprognostic (5.71e-2)"	"prognostic favorable (6.95e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (2.54e-1)"	"unprognostic (3.07e-3)"	"unprognostic (9.57e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.50e-2)"	"prognostic favorable (2.39e-4)"	"unprognostic (4.84e-2)"	32.1	29.2	21.7	27.8	22.5	30.1	31.2	22.8	27.6	27.2	21.3	27.4	20.9	31.6	22.9	25.2	22.6	20.2	38.4	22.6	24.3	28.2	27.3	21.9	40.3	22.7	22.8	28.2	25.2	23.2	13.6	30.6	23.1	21.7	23.0	26.2	23.0	22.8	41.2	21.6	23.6	31.0	21.8	26.7	29.0	13.8	22.1	42.7	26.2	29.9	42.2	28.1	23.4	22.9	76.6	38.9	58.9	68.4	70.6	57.8	53.0	61.7	77.2	122.6	111.7	41.2	60.1	87.0	62.4	69.4	60.2	45.3	88.4	61.1	128.6	68.5	65.9	112.0	54.0	73.1	63.5	111.8	88.3	44.3	53.6	77.0	40.6	57.2	82.5	70.6	106.4	59.3	90.6	44.5	84.6	77.3	107.6	47.1	44.2	96.0	87.7	84.4	78.1	62.3	21.1	55.1	81.8	33.2	74.4	43.2	49.7	89.9	63.4	54.4	58.4	123.1	93.9	55.5	78.9	138.3	72.9	133.4	75.8	64.2	53.6	53.1	60.4	53.6	61.6	60.5	54.5	60.2	59.8	59.6	54.3	54.8	28.6	57.1	60.0	61.3	66.3	91.8	21.7	22.5	22.8	27.6	22.6	24.3	22.7	22.8	23.1	21.8	22.1	22.9	133.2	76.9	91.4	9.4	119.4	129.8	148.3	181.2	80.8	96.0	66.6	87.1	149.6	78.6	116.2	106.7	25.0	188.7	156.7	56.4	270.1	150.9	55.3	100.9	127.5	127.9	46.0	128.7	19.5	98.1	159.7	132.4	48.9	106.1	141.0	93.8	93.5	77.9	181.2	69.0	16.6	58.1	111.9	71.9	146.3	40.3	120.5	121.1	103.2	21.5	153.5	167.4	183.4	19.6	23.4	117.3	68.2	144.0	74.6	121.1	65.2	199.3	87.8	103.1	85.5	108.0	144.9	153.1	91.7	74.7	110.2	224.1	132.7	98.8	76.7	112.3
DNAJC9	"JDD1, SB73"	ENSG00000213551	"DnaJ heat shock protein family (Hsp40) member C9"	Q8WXX5	10	73183362-73247255	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 91.9"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 173.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035215, HPA035216"	Supported		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		39000	"Cluster 44: Non-specific - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Plasma membrane"	"HPA035215: AB_10603663, HPA035216: AB_2674522"	"unprognostic (4.18e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.67e-3)"	"unprognostic (3.45e-1)"	"unprognostic (6.83e-3)"	"unprognostic (2.43e-3)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (6.20e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.91e-1)"	"prognostic unfavorable (7.07e-5)"	"unprognostic (5.61e-2)"	"unprognostic (3.08e-3)"	"unprognostic (6.49e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.56e-1)"	9.2	10.6	17.1	17.6	17.5	91.9	15.4	19.2	21.5	11.2	15.4	16.0	14.6	12.8	12.4	16.9	9.7	6.9	8.6	16.9	17.0	10.0	13.4	9.6	28.2	16.4	16.5	15.3	8.7	10.2	10.6	17.6	16.9	11.4	18.0	25.1	11.3	11.2	11.5	17.7	13.9	11.8	15.7	14.8	12.2	12.4	17.0	35.8	8.4	13.1	32.3	11.5	11.9	17.6	135.0	77.3	93.8	68.4	16.1	19.3	45.7	101.5	59.4	101.1	106.1	130.8	89.4	86.9	33.5	43.6	43.7	83.1	92.9	67.5	118.1	98.5	63.8	188.3	79.4	93.4	14.8	173.1	71.0	14.8	33.2	107.1	93.4	36.4	66.2	112.1	168.3	103.0	81.4	118.4	155.0	124.7	36.3	64.4	215.1	114.2	85.1	47.6	52.9	61.5	44.3	73.4	73.5	114.5	52.9	43.7	62.1	76.8	48.0	65.2	118.3	71.3	168.0	45.0	70.6	141.8	64.8	162.9	45.9	23.9	3.7	29.1	25.5	10.7	29.2	32.8	31.3	28.2	6.5	28.3	30.3	26.9	4.5	24.8	10.9	20.3	36.8	18.0	17.1	17.5	19.2	21.5	16.9	17.0	16.4	16.5	16.9	15.7	17.0	17.6	17.3	9.6	12.3	11.1	39.5	47.7	34.1	31.9	33.0	26.1	21.5	24.8	2.7	17.2	24.8	9.2	8.4	107.8	44.6	18.3	21.5	31.5	80.4	15.9	14.0	20.6	12.0	173.8	11.8	31.4	111.4	17.6	12.2	19.0	42.3	26.0	13.9	9.8	61.9	15.2	12.8	25.6	54.9	10.9	19.6	43.3	14.0	17.4	32.0	6.5	23.0	29.5	32.0	7.5	6.5	44.1	16.7	20.3	49.7	27.6	18.2	16.3	21.9	43.2	26.3	17.7	28.3	28.7	65.4	38.2	43.5	58.0	45.2	19.7	38.0	37.5
DNMT1	"CXXC9, DNMT, MCMT"	ENSG00000130816	"DNA methyltransferase 1"	P26358	19	10133342-10231286	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Deafness, Disease variant, FDA approved drug targets, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 388.1;Spermatocytes: 229.6;Syncytiotrophoblasts: 323.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002694, CAB005876"	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"CAB005876: AB_731983, HPA002694: AB_1847810"	"unprognostic (3.51e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.62e-1)"	"unprognostic (7.59e-3)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (2.90e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.81e-3)"	"unprognostic (1.73e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.46e-1)"	7.1	3.9	0.9	16.9	2.9	23.1	7.0	11.7	3.1	9.1	0.0	6.9	6.6	7.3	3.1	7.7	6.5	6.2	4.8	2.1	6.6	3.0	3.9	7.8	26.2	3.8	4.5	5.6	3.6	4.3	4.5	26.0	5.7	4.5	6.8	7.5	5.6	4.6	5.3	7.9	7.9	8.8	0.3	8.1	6.3	12.4	3.3	20.6	6.3	5.0	24.9	7.3	6.4	10.6	77.0	40.6	49.5	45.8	24.6	24.0	138.8	52.4	43.9	77.5	74.9	50.6	40.8	138.3	33.8	30.0	38.6	46.6	68.4	44.2	68.4	57.5	100.9	181.5	39.5	27.1	9.6	91.5	73.4	11.5	9.3	68.5	24.1	18.4	39.9	37.6	75.0	82.8	63.3	37.6	109.2	50.4	87.5	38.3	76.6	117.1	67.9	77.2	21.5	49.3	64.5	41.5	58.2	26.2	16.5	33.6	28.9	42.2	31.8	111.3	42.2	73.0	84.4	49.6	69.5	166.8	35.0	68.5	87.1	20.3	21.2	5.9	29.8	22.0	25.1	14.2	22.8	20.4	19.3	20.0	25.5	20.5	4.6	42.6	13.8	31.9	21.9	12.6	0.9	2.9	11.7	3.1	2.1	6.6	3.8	4.5	5.7	0.3	3.3	10.6	36.4	6.4	26.5	12.7	38.0	29.6	20.7	26.8	21.1	86.7	32.6	29.6	14.6	7.2	28.2	22.0	56.3	388.1	54.4	29.0	13.7	26.0	46.1	48.1	42.0	38.9	15.7	109.6	17.6	14.3	73.2	33.6	33.6	60.3	37.2	43.6	25.0	14.8	76.8	65.6	22.6	25.5	38.7	31.4	47.8	50.8	28.0	57.9	14.2	15.0	52.5	32.2	123.6	14.6	20.1	21.1	11.3	28.6	73.4	16.3	4.5	9.3	42.8	50.2	13.1	22.6	32.8	229.6	145.3	41.6	22.4	323.7	70.4	38.7	43.1	16.6
DNTTIP2	"ERBP, HSU15552, TdIF2"	ENSG00000067334	"Deoxynucleotidyltransferase terminal interacting protein 2"	Q5QJE6	1	93866284-93879918	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044502, HPA053707"	Supported		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA044502: AB_10960277, HPA053707: AB_2682236"	"unprognostic (2.95e-3)"	"unprognostic (3.84e-2)"	"unprognostic (6.21e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.92e-2)"	"prognostic unfavorable (1.90e-6)"	"unprognostic (7.94e-2)"	"unprognostic (5.57e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.80e-5)"	"unprognostic (2.59e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.06e-2)"	5.0	3.7	4.9	3.5	5.2	15.3	5.0	10.3	6.7	3.5	5.6	3.4	2.7	4.0	6.3	4.4	3.5	4.5	4.5	5.5	5.4	4.2	5.0	3.7	5.5	4.8	4.9	4.3	3.4	3.8	2.1	4.6	5.1	3.7	3.6	4.2	2.9	3.0	8.9	5.5	2.7	3.7	3.8	4.5	3.6	4.5	5.3	4.3	4.7	5.0	5.2	6.5	2.8	6.8	14.3	6.6	7.2	7.8	6.9	6.2	11.1	9.4	6.6	11.0	9.4	7.3	6.1	18.8	12.2	9.9	13.8	7.7	11.9	11.2	15.6	11.4	6.6	15.4	11.3	11.0	7.2	17.4	5.3	6.8	11.9	11.9	9.8	5.5	7.9	6.0	18.6	6.0	15.1	6.3	12.2	11.3	14.2	6.3	10.6	7.0	15.6	7.2	11.3	10.8	8.7	7.7	9.8	14.4	10.5	9.2	6.2	12.6	7.7	8.8	9.2	10.2	15.9	6.4	9.3	15.3	5.1	13.6	5.9	9.7	5.7	11.6	6.4	8.3	7.7	8.2	5.8	5.8	5.1	8.4	5.3	6.9	8.0	9.6	8.5	3.5	6.4	6.8	4.9	5.2	10.3	6.7	5.5	5.4	4.8	4.9	5.1	3.8	5.3	6.8	98.9	57.7	78.2	3.6	66.7	54.4	163.0	57.9	43.3	33.9	27.5	38.9	73.0	11.5	91.2	12.9	58.4	52.0	110.2	17.3	21.5	74.3	53.8	85.1	72.0	74.2	8.4	20.6	6.8	60.3	44.4	54.3	38.2	122.4	119.4	36.6	25.7	19.4	38.1	20.2	7.7	14.5	46.8	29.5	72.1	11.0	25.7	75.8	23.2	8.4	52.1	29.2	48.4	3.5	7.2	88.6	20.1	25.9	50.1	96.7	17.2	19.6	85.1	34.4	19.7	90.7	79.0	62.8	65.9	40.0	50.6	55.8	87.7	44.4	23.1	112.0
DOHH	"HLRC1, MGC4293"	ENSG00000129932	"Deoxyhypusine hydroxylase"	Q9BU89	19	3490821-3500674	"Enzymes, Predicted intracellular proteins"	"Hypusine biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041953, HPA076271"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA041953: AB_10795386, HPA076271: "	"unprognostic (1.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.63e-2)"	"prognostic favorable (2.24e-4)"	"unprognostic (3.66e-1)"	"unprognostic (2.01e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.26e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (3.58e-4)"	"unprognostic (9.87e-3)"	"unprognostic (1.14e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.76e-3)"	7.5	8.8	15.6	4.4	18.9	8.9	6.8	18.9	18.3	6.2	9.9	8.2	17.8	7.6	0.5	11.0	6.7	1.2	12.6	14.7	15.2	11.1	10.9	6.4	3.2	20.6	19.2	6.5	8.5	2.5	8.4	2.2	18.8	7.5	1.0	1.3	6.9	2.1	18.9	10.5	11.5	1.3	16.5	7.9	8.7	8.1	17.6	2.1	5.9	2.2	1.6	8.3	6.9	24.0	18.6	22.4	3.1	7.1	1.6	2.0	15.0	17.4	3.6	8.0	6.5	31.9	7.6	15.3	13.2	2.4	7.5	19.3	4.6	6.1	1.5	21.5	24.5	15.1	13.3	37.7	6.7	20.7	19.9	2.3	5.7	8.2	3.3	2.8	4.3	15.6	34.1	16.4	3.7	22.3	20.3	23.3	19.1	7.1	29.2	25.4	7.6	21.3	5.3	11.1	20.0	15.5	12.7	10.8	18.4	1.3	15.0	11.0	9.9	10.9	14.4	29.0	31.7	21.9	17.4	20.1	12.4	46.6	12.7	1.2	6.7	2.4	7.6	8.1	9.4	11.1	10.1	14.9	11.0	16.5	14.1	12.3	0.4	10.0	8.9	14.1	13.2	5.9	15.6	18.9	18.9	18.3	14.7	15.2	20.6	19.2	18.8	16.5	17.6	24.0	9.5	6.4	2.2	2.0	15.5	23.6	22.6	13.2	12.5	17.2	12.4	10.0	7.7	11.5	7.1	5.5	10.4	30.9	7.6	27.9	21.5	22.2	8.6	10.9	7.9	13.2	13.1	23.2	4.9	21.3	29.9	13.6	16.3	7.8	13.4	10.5	11.7	10.0	21.6	25.2	5.1	17.6	24.4	7.9	9.3	23.8	14.0	9.3	19.6	1.9	16.9	12.7	15.5	4.5	30.0	24.7	17.2	15.1	16.0	28.4	10.8	28.9	4.6	12.4	0.0	16.2	13.6	12.6	12.7	14.5	27.6	34.8	12.1	13.6	27.2	18.7
DOLK	"DK1, KIAA1094, TMEM15"	ENSG00000175283	"Dolichol kinase"	Q9UPQ8	9	128945530-128947603	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Kinase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 33.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066767, HPA068706"			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA066767: AB_2732751, HPA068706: AB_2732118"	"unprognostic (6.35e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.30e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.81e-3)"	"unprognostic (8.90e-3)"	"unprognostic (3.26e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.83e-2)"	"prognostic favorable (5.53e-4)"	"unprognostic (3.20e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (6.88e-5)"	"unprognostic (6.13e-3)"	9.6	14.3	6.6	6.3	6.3	1.5	7.8	6.7	6.7	7.4	8.6	7.5	7.6	9.3	13.5	8.6	8.9	7.9	10.5	6.5	7.1	9.1	10.5	9.1	6.8	6.9	7.6	6.7	14.5	16.8	5.9	9.3	7.3	10.0	6.6	4.4	12.0	10.0	6.7	9.9	7.5	9.4	6.5	8.0	10.6	14.5	7.6	5.1	7.8	7.1	6.6	8.6	5.9	6.8	11.7	42.5	14.8	22.0	42.6	22.2	20.0	23.7	38.1	28.5	21.0	33.7	17.9	6.4	12.3	34.6	40.3	80.3	20.3	29.6	14.7	10.7	17.8	8.0	27.4	24.5	43.0	8.8	13.5	31.1	27.0	30.8	16.8	16.7	28.1	9.1	19.7	10.0	31.3	56.9	7.3	7.3	19.0	33.0	26.0	7.2	19.5	25.1	25.7	17.3	13.5	15.1	31.4	25.6	14.1	13.7	44.8	11.4	23.6	25.6	9.2	32.5	19.8	9.4	25.0	6.4	24.2	8.0	19.9	2.7	15.4	6.9	11.2	15.3	10.1	11.8	9.9	12.3	16.6	12.5	12.8	13.2	2.2	13.0	21.2	9.3	16.8	10.5	6.6	6.3	6.7	6.7	6.5	7.1	6.9	7.6	7.3	6.5	7.6	6.8	8.5	6.4	4.1	2.9	2.6	1.8	3.6	13.9	4.6	9.1	4.4	4.3	3.5	10.0	10.9	7.3	8.4	25.6	3.5	5.2	0.0	15.7	15.1	5.9	7.2	9.2	1.2	3.6	1.2	14.2	16.4	8.1	5.1	3.6	1.3	7.5	16.1	9.2	13.5	5.0	2.2	3.5	12.2	5.2	2.7	3.7	12.2	2.9	3.6	1.9	2.8	10.7	5.2	2.5	1.7	11.1	7.5	6.0	1.5	4.4	7.5	9.0	11.4	7.1	0.0	7.0	15.7	33.8	15.1	3.3	1.3	18.2	2.3	15.8	5.7	2.1
DOLPP1	LSFR2	ENSG00000167130	"Dolichyldiphosphatase 1"	Q86YN1	9	129081111-129090438	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 29.1;Proximal enterocytes: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019179	Approved		Approved	"Vesicles,Intermediate filaments"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"	Vesicles	"Intermediate filaments"	"HPA019179: AB_1847827"	"unprognostic (1.32e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.89e-1)"	"unprognostic (6.12e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.18e-1)"	"unprognostic (3.10e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.37e-3)"	"unprognostic (7.59e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.34e-2)"	5.6	11.4	12.2	6.3	13.4	8.1	5.8	13.0	13.8	6.6	8.7	15.5	26.2	5.3	6.0	19.2	5.5	5.8	4.6	12.1	12.5	6.0	22.4	5.0	6.6	13.3	13.4	5.2	10.4	8.7	6.2	7.6	14.3	8.5	12.5	3.8	9.9	4.7	4.9	10.5	22.6	5.3	13.1	7.8	10.8	8.1	13.5	10.1	5.4	4.8	6.6	6.0	8.3	15.2	8.7	33.6	31.4	29.6	10.3	9.1	36.2	20.9	12.2	39.3	22.0	42.9	28.4	16.7	18.2	13.0	30.2	61.8	32.6	17.8	16.6	19.9	20.6	22.0	22.3	34.5	18.8	23.0	26.4	9.5	24.4	25.5	20.3	8.9	17.5	30.7	37.3	16.2	11.4	44.7	26.5	24.8	27.4	64.7	28.2	30.8	25.3	31.2	14.2	14.1	35.9	24.2	27.1	24.1	9.4	18.4	44.8	15.0	14.5	33.5	16.4	33.4	29.0	20.3	41.6	25.3	15.3	4.6	22.8	7.9	8.2	12.6	10.2	10.5	25.2	11.4	12.6	12.6	10.5	7.7	12.5	11.9	1.7	11.2	11.0	15.8	13.6	8.9	12.2	13.4	13.0	13.8	12.1	12.5	13.3	13.4	14.3	13.1	13.5	15.2	3.1	6.4	6.3	4.2	3.9	2.3	3.0	6.9	1.2	3.7	7.3	5.2	2.1	10.0	6.3	1.8	6.2	18.8	2.8	29.1	1.9	7.1	0.5	3.9	5.0	3.4	3.6	13.0	3.1	9.6	14.2	3.9	10.2	5.4	5.7	3.8	5.3	18.3	7.5	3.3	4.4	10.1	6.1	2.9	1.9	0.5	2.1	2.7	5.4	1.0	4.2	8.6	6.2	3.5	6.4	6.6	16.2	4.1	6.7	3.8	42.0	4.1	3.2	3.7	0.0	3.1	4.0	6.3	9.7	11.0	4.0	16.4	4.4	8.1	13.5	4.1
DONSON	"B17, C21orf60, C2TA, DKFZP434M035"	ENSG00000159147	"DNA replication fork stabilization factor DONSON"	Q9NYP3	21	33559542-33588706	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 57.3;Erythroid cells: 42.1;Spermatocytes: 62.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039558, HPA049033"	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cell Junctions"	Cytosol	"HPA039558: AB_2676570, HPA049033: AB_2680608"	"unprognostic (9.90e-3)"	"unprognostic (1.01e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (8.22e-4)"	"unprognostic (4.00e-2)"	"unprognostic (5.93e-3)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.25e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.77e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.83e-2)"	5.5	2.9	5.8	5.5	6.5	10.9	4.1	7.9	7.5	8.5	4.2	5.2	5.4	5.7	2.4	5.0	7.0	5.5	4.4	5.4	6.5	3.9	7.9	4.6	10.5	6.7	6.2	10.8	3.4	5.6	5.5	6.6	6.7	4.8	6.3	13.3	3.5	3.4	4.4	8.5	6.1	4.5	5.7	3.6	4.9	21.2	6.5	10.6	3.5	4.8	9.2	4.7	6.2	8.6	67.9	15.5	34.8	30.4	10.7	18.5	23.9	53.7	23.2	41.2	45.1	41.9	19.7	40.5	13.9	28.3	30.6	20.0	43.6	20.2	45.1	36.5	36.5	73.8	34.9	41.5	8.1	39.0	18.2	13.9	5.7	44.4	11.1	13.1	25.1	19.8	67.0	65.2	35.4	14.7	34.0	17.2	35.9	34.8	17.3	33.2	68.4	41.3	21.3	19.0	36.0	14.8	82.1	25.3	23.1	17.1	34.9	19.4	16.4	38.0	25.3	28.6	37.7	56.8	58.1	59.3	22.1	52.1	43.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	6.5	7.9	7.5	5.4	6.5	6.7	6.2	6.7	5.7	6.5	8.6	6.3	3.2	1.9	10.4	4.8	8.2	8.1	3.1	5.2	2.8	5.6	5.7	3.9	7.2	2.3	3.7	10.4	13.2	7.8	3.0	1.9	3.3	57.3	3.0	6.6	8.0	1.2	42.1	9.7	4.7	27.9	6.9	7.1	4.4	8.2	7.5	7.5	6.2	8.9	6.7	11.2	4.2	6.1	3.4	6.3	25.3	10.2	5.5	7.2	4.7	4.0	2.1	4.1	7.5	12.7	3.9	2.5	13.9	19.3	5.7	2.9	4.4	2.8	3.6	0.0	4.4	7.6	62.3	33.5	7.6	9.8	16.6	7.6	3.0	6.8	9.2
DPF2	"BAF45d, REQ, ubi-d4"	ENSG00000133884	"Double PHD fingers 2"	Q92785	11	65333852-65354262	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020880, HPA056786"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA020880: AB_1847845, HPA056786: AB_2683235"	"unprognostic (2.06e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.40e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (2.04e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.93e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.34e-1)"	21.2	21.0	41.3	14.2	45.1	24.7	21.6	43.6	43.3	35.0	35.2	36.1	13.1	37.6	22.8	23.1	31.3	14.7	34.2	39.5	42.2	20.8	16.8	19.5	22.3	43.1	43.7	40.9	20.5	19.7	20.1	17.6	42.8	28.6	13.8	17.6	21.1	25.8	38.6	19.3	24.3	27.8	43.7	29.7	24.2	37.7	43.0	37.6	22.5	29.2	24.5	34.2	24.1	48.7	29.9	36.4	45.9	40.5	39.7	39.8	25.5	25.0	35.1	53.5	38.6	36.0	34.8	39.5	40.8	34.0	46.6	31.2	52.2	31.9	37.7	47.6	23.1	50.4	24.6	37.7	61.1	47.0	36.5	35.0	30.4	48.4	86.6	40.1	43.3	47.0	48.7	51.0	35.2	47.3	60.0	49.3	51.6	31.9	37.4	65.1	29.9	46.8	34.0	24.1	29.9	27.3	32.1	45.7	47.0	29.7	59.0	26.2	25.8	35.2	31.3	38.9	25.9	62.7	78.8	51.1	21.6	30.6	40.4	186.4	75.4	141.1	79.7	70.8	87.0	102.0	76.9	78.4	76.2	109.1	78.6	71.9	161.5	125.8	83.0	70.6	107.3	108.4	41.3	45.1	43.6	43.3	39.5	42.2	43.1	43.7	42.8	43.7	43.0	48.7	19.2	6.4	10.1	14.0	35.7	22.7	21.8	41.7	23.9	42.2	20.1	24.9	12.7	27.1	24.2	33.1	47.9	27.2	42.0	11.5	19.6	21.2	5.2	18.3	29.5	24.2	17.4	32.8	18.5	17.4	22.9	27.2	15.3	18.5	16.5	31.8	24.3	13.3	19.5	30.3	19.9	16.8	32.6	17.5	33.8	12.3	58.7	16.9	19.6	15.0	30.0	22.8	35.0	24.1	32.3	19.3	8.6	53.4	21.6	22.6	23.7	22.0	19.3	50.5	32.9	28.8	32.2	60.2	63.5	15.4	23.2	26.5	30.6	28.7	17.9	19.7
DPY30	"Cps25, HDPY-30, Saf19"	ENSG00000162961	"Dpy-30 histone methyltransferase complex regulatory subunit"	Q9C005	2	31867809-32039805	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 388.8;Respiratory ciliated cells: 396.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043761	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		29000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Golgi apparatus"	"HPA043761: AB_10960501"	"unprognostic (2.76e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.57e-3)"	"unprognostic (4.14e-3)"	"unprognostic (1.91e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.75e-2)"	"prognostic unfavorable (4.26e-4)"	"unprognostic (2.70e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.49e-1)"	40.2	75.2	66.9	34.3	68.6	31.4	61.3	72.1	84.4	53.2	73.6	50.9	43.4	38.3	78.3	60.2	90.5	42.4	46.7	68.4	73.6	79.1	84.8	44.1	51.8	71.6	71.5	42.7	48.1	58.3	50.9	43.9	73.6	57.3	46.4	33.3	64.6	47.0	48.8	49.7	44.4	37.4	73.2	36.1	46.8	22.6	69.1	52.3	81.6	45.4	49.3	51.8	50.0	77.5	201.8	136.8	100.8	78.1	86.7	128.8	134.9	102.1	90.8	81.2	79.5	197.2	158.3	123.2	102.2	90.8	148.3	79.9	93.1	118.6	88.1	146.4	149.5	110.8	89.7	225.5	76.5	114.3	66.8	87.4	135.6	87.4	76.9	109.1	130.4	55.1	132.5	85.3	125.6	219.4	128.8	228.9	139.2	184.3	140.5	104.0	118.9	155.7	144.2	137.1	162.5	115.9	101.2	141.1	143.6	118.2	98.3	82.1	100.5	73.9	119.1	69.2	125.4	99.9	161.3	166.2	77.6	123.2	91.7	177.6	101.0	150.8	95.5	99.9	116.5	165.9	133.5	119.4	100.5	135.6	118.1	112.0	117.3	105.8	112.8	91.5	200.3	130.6	66.9	68.6	72.1	84.4	68.4	73.6	71.6	71.5	73.6	73.2	69.1	77.5	65.7	51.3	61.5	10.1	61.7	98.0	107.7	233.5	53.5	17.9	110.5	135.1	71.3	80.1	140.8	103.0	0.0	190.2	41.0	84.2	283.7	114.3	64.5	388.8	59.7	62.9	92.1	55.5	16.0	117.2	252.4	63.1	44.4	107.3	46.9	65.1	63.1	102.7	123.5	21.9	17.7	107.6	175.0	65.4	67.2	18.5	72.4	58.7	65.8	13.1	106.8	50.8	55.6	13.6	26.7	125.7	117.8	88.0	40.6	130.5	138.4	296.7	396.4	26.8	85.5	52.4	108.4	65.7	57.4	72.0	122.6	138.7	67.3	67.7	109.0	127.5
DR1	"NC2-BETA, NC2B, NCB2"	ENSG00000117505	"Down-regulator of transcription 1"	Q01658	1	93345907-93369493	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050785, HPA055308"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA050785: AB_2681237, HPA055308: AB_2682779"	"unprognostic (1.46e-1)"	"unprognostic (9.62e-2)"	"prognostic favorable (4.79e-4)"	"unprognostic (1.03e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (9.95e-7)"	"unprognostic (8.70e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.44e-2)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (2.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.97e-1)"	"unprognostic (1.60e-1)"	21.8	18.9	9.8	28.8	9.6	59.1	16.8	12.5	9.3	17.7	23.7	18.2	27.2	21.0	11.1	30.0	14.2	23.1	27.0	8.7	10.8	21.8	20.4	19.6	43.3	9.9	9.8	15.9	18.8	16.9	12.1	32.0	9.5	17.1	16.3	14.1	19.5	14.0	50.4	29.4	22.4	19.2	10.3	27.0	30.2	55.7	10.5	47.7	18.7	42.9	30.8	27.3	22.6	10.5	97.1	29.8	46.8	60.6	42.3	47.9	57.5	76.5	46.6	50.9	54.0	34.9	34.1	101.9	86.4	56.7	69.3	50.1	56.7	53.0	74.6	86.4	53.0	85.8	58.7	38.4	67.3	102.1	60.6	33.7	62.4	71.2	102.2	53.1	45.9	60.0	90.0	95.7	61.0	29.8	97.6	32.1	78.1	33.4	72.1	83.5	103.2	104.0	36.3	58.0	45.3	57.6	65.1	59.7	80.6	42.2	42.2	79.4	72.1	91.5	73.0	90.7	116.0	54.9	65.6	105.5	26.3	80.3	38.2	95.2	46.2	82.1	35.3	52.7	39.2	36.9	38.8	40.4	55.9	31.5	38.6	37.8	62.8	35.5	47.4	45.4	57.1	41.3	9.8	9.6	12.5	9.3	8.7	10.8	9.9	9.8	9.5	10.3	10.5	10.5	36.2	28.9	22.1	10.1	43.5	171.3	38.0	38.7	47.3	32.0	29.1	24.1	33.9	22.8	27.9	36.8	25.0	74.5	84.6	42.8	45.0	31.4	183.1	18.4	33.7	37.5	20.8	59.3	8.4	27.7	73.6	34.3	38.2	24.2	48.9	19.7	29.3	27.6	53.0	50.5	8.7	42.6	10.2	50.8	82.8	106.2	28.3	55.2	44.4	15.0	68.0	16.0	69.0	7.5	10.8	52.9	25.9	26.4	31.9	51.6	29.8	40.7	17.6	25.3	32.9	27.7	42.0	163.2	41.2	69.4	160.5	109.9	59.8	26.2	26.9	79.2
DRG1	NEDD3	ENSG00000185721	"Developmentally regulated GTP binding protein 1"	Q9Y295	22	31399604-31530634	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 160.2"	"Group enriched"	"Detected in all"	5	"Early spermatids: 798.4;Late spermatids: 651.5;Spermatocytes: 469.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001218	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No		22000	"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA001218: AB_1078704"	"unprognostic (4.94e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.17e-3)"	"unprognostic (5.26e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (7.71e-4)"	"unprognostic (3.68e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.32e-3)"	"unprognostic (8.69e-3)"	"unprognostic (1.55e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.25e-1)"	31.4	32.6	22.6	21.4	23.9	32.3	35.1	27.0	31.6	27.3	22.8	24.7	22.6	27.8	38.7	27.4	32.7	19.5	44.6	23.7	24.6	35.9	37.9	20.9	29.2	23.9	23.7	35.0	34.1	38.4	18.6	35.7	25.0	25.0	30.0	30.1	30.5	28.8	100.5	23.7	21.3	34.1	24.5	20.1	24.2	160.2	22.7	40.4	34.5	85.1	38.3	30.8	20.6	26.4	80.3	61.3	73.9	63.3	64.4	75.2	61.5	70.2	81.7	125.7	104.4	100.3	38.3	111.2	38.6	86.9	60.3	64.5	128.5	82.8	134.4	52.0	152.0	71.9	64.9	99.6	91.4	174.2	65.1	65.6	60.9	103.7	152.9	64.6	87.5	61.6	93.9	48.1	97.2	88.0	75.7	88.4	62.1	114.0	65.9	98.7	118.9	97.3	82.1	68.6	80.8	50.4	78.5	79.8	107.2	70.8	59.7	77.2	50.6	57.7	79.3	59.1	81.3	67.2	78.5	108.6	57.0	77.7	77.4	25.0	43.3	46.0	34.3	49.7	39.6	53.6	36.6	43.0	45.2	39.4	40.5	39.8	9.8	46.7	37.5	39.6	50.9	47.0	22.6	23.9	27.0	31.6	23.7	24.6	23.9	23.7	25.0	24.5	22.7	26.4	22.0	19.2	15.4	3.9	29.4	38.6	40.8	77.2	29.6	18.7	27.2	27.2	52.4	35.8	37.6	27.6	25.0	126.4	20.6	22.5	64.6	56.4	798.4	23.7	24.4	34.4	11.4	37.8	10.3	45.4	104.5	33.2	21.4	21.1	33.7	27.1	35.7	36.9	60.4	15.2	11.2	31.0	48.8	31.1	24.0	651.5	35.8	22.9	17.8	7.5	39.2	27.6	33.0	9.5	11.1	42.7	27.0	37.2	27.1	48.7	42.9	60.3	28.7	18.4	59.2	35.4	36.1	469.3	92.1	33.1	32.1	117.1	25.5	26.2	41.0	45.3
DSN1	"C20orf172, dJ469A13.2, hKNL-3, KNL3, MIS13"	ENSG00000149636	"DSN1 component of MIS12 kinetochore complex"	Q9H410	20	36751791-36773818	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 49.8;Spermatocytes: 115.5;Spermatogonia: 75.1;Syncytiotrophoblasts: 47.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002813, HPA030627"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Kinetochore,Cytosol"		Yes	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nucleoli fibrillar center, Nuclear bodies, Kinetochore, Cytosol"	"HPA002813: AB_1078343, HPA030627: AB_2732460"	"unprognostic (3.60e-2)"	"prognostic favorable (4.49e-4)"	"unprognostic (5.22e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.00e-1)"	"unprognostic (4.64e-2)"	"prognostic unfavorable (4.16e-5)"	"unprognostic (3.93e-1)"	"unprognostic (9.35e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.66e-2)"	"prognostic unfavorable (1.54e-5)"	"unprognostic (6.92e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.84e-1)"	5.9	9.9	4.2	7.5	4.2	14.3	8.6	3.9	4.5	5.0	5.2	9.2	6.8	4.4	9.3	7.9	4.1	4.4	5.1	4.3	4.4	4.8	9.1	6.3	12.8	4.0	3.9	4.3	4.3	5.5	3.5	8.8	4.1	6.5	10.8	10.7	5.9	6.3	4.0	8.0	7.8	6.3	3.9	9.6	7.3	23.3	4.1	16.4	5.1	4.8	14.3	4.4	4.7	4.7	36.7	29.1	35.7	29.5	14.0	18.0	24.7	42.9	35.1	63.9	70.2	52.5	44.4	39.3	27.4	23.0	69.1	45.8	33.3	32.7	60.3	18.2	22.7	78.3	26.2	36.1	3.0	46.2	34.0	7.0	9.4	43.7	13.8	10.4	31.5	42.4	30.9	33.7	41.7	25.3	59.2	34.5	16.8	63.3	55.1	46.1	109.4	28.4	16.2	20.5	37.8	16.9	52.9	53.7	25.8	26.3	55.9	30.5	16.4	60.1	35.0	56.9	46.1	27.3	39.1	46.4	49.8	40.8	42.6	53.4	6.4	14.5	7.4	11.0	8.4	14.6	8.1	10.3	7.1	18.4	10.1	9.0	11.9	11.1	10.1	46.9	12.2	6.7	4.2	4.2	3.9	4.5	4.3	4.4	4.0	3.9	4.1	3.9	4.1	4.7	6.5	6.4	4.4	1.6	10.3	5.0	11.4	7.6	3.4	8.0	8.7	7.6	5.4	2.8	8.6	5.5	29.2	49.8	9.8	9.2	7.9	6.8	10.6	5.5	5.9	8.1	2.4	22.1	6.3	6.4	30.4	8.4	20.9	9.4	3.8	21.8	7.9	6.2	14.7	6.7	4.4	13.6	4.1	6.3	4.6	8.0	8.7	6.7	1.8	5.6	7.4	6.0	7.2	3.0	3.6	5.1	5.4	7.5	22.9	7.1	7.7	3.6	8.2	17.5	0.0	5.3	8.2	115.5	75.1	12.3	7.2	47.5	7.7	6.9	13.6	11.0
DTL	"CDT2, DCAF2, L2DTL, RAMP"	ENSG00000143476	"Denticleless E3 ubiquitin protein ligase homolog"	Q9NZJ0	1	212035553-212107400	"Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA replication, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 14.6;intestine: 4.7;lymphoid tissue: 14.2;placenta: 3.9;testis: 13.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 25.3;Erythroid cells: 36.2;Extravillous trophoblasts: 16.2;Spermatocytes: 53.2;Spermatogonia: 20.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 2.0"	"Lineage enriched"	"Detected in single"	8	"T-cells: 2.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028016, HPA032023, HPA032031"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA028016: AB_10611958, HPA032023: AB_2674114, HPA032031: AB_2674119"	"unprognostic (7.61e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.14e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (8.96e-3)"	"unprognostic (2.45e-3)"	"unprognostic (8.83e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (1.71e-9)"	"unprognostic (5.93e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.82e-1)"	0.6	0.2	0.0	4.1	0.0	14.6	1.9	0.0	0.1	0.6	0.0	3.3	2.3	1.1	0.1	1.9	0.4	0.4	0.1	0.0	0.0	0.1	1.2	1.4	5.6	0.0	0.1	0.1	0.1	0.5	0.2	3.9	0.0	0.4	4.7	0.0	0.4	0.1	0.1	2.1	3.0	1.9	0.0	2.5	1.3	13.7	0.1	14.2	0.5	0.0	6.4	1.2	0.7	0.0	34.1	28.1	48.0	23.6	2.9	5.8	23.3	41.3	25.5	38.1	56.1	17.6	29.0	25.2	15.4	16.1	25.0	25.8	62.5	34.9	54.7	31.4	30.9	40.7	33.6	21.5	0.1	54.1	25.3	2.5	1.2	62.2	32.4	6.8	17.7	44.7	49.1	51.1	44.4	13.5	75.3	24.3	56.6	25.2	32.9	57.2	84.0	49.2	11.6	22.9	29.6	46.0	39.2	37.5	17.6	47.7	32.0	24.1	9.7	38.2	28.6	40.5	47.8	18.4	30.5	57.7	19.1	35.5	37.8	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.3	0.5	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	2.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	2.3	2.3	0.4	1.7	0.0	0.0	1.3	1.3	7.0	1.5	0.9	0.0	0.0	12.8	1.4	1.5	0.0	0.4	25.3	0.4	1.3	5.2	0.0	36.2	0.2	0.0	16.2	2.4	3.1	1.0	0.0	11.4	0.7	0.4	4.7	0.0	0.3	3.3	0.0	0.3	0.8	12.4	1.2	2.2	0.0	1.0	0.2	0.0	0.0	0.0	0.1	0.6	0.4	0.0	12.8	0.2	0.6	0.0	0.1	0.0	0.0	0.2	2.7	53.2	20.8	5.6	1.7	1.5	2.6	1.6	5.2	0.7
DTNBP1	"BLOC1S8, DBND, Dysbindin, HPS7, My031"	ENSG00000047579	"Dystrobrevin binding protein 1"	Q96EV8	6	15522807-15663058	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction"		"Albinism, Hermansky-Pudlak syndrome, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 127.0"	"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 173.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028053, HPA029615, HPA029616"	Approved		Enhanced	Microtubules,Midbody		Yes	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Microtubules	Midbody	"HPA028053: AB_10599296, HPA029615: AB_10599945, HPA029616: AB_10602413"	"unprognostic (2.83e-1)"	"prognostic favorable (2.82e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (8.72e-4)"	"prognostic favorable (6.34e-5)"	"unprognostic (1.36e-1)"	"unprognostic (4.28e-3)"	"unprognostic (2.21e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.81e-3)"	"unprognostic (1.09e-2)"	16.2	9.3	40.8	17.6	60.1	16.7	14.8	35.1	46.6	13.2	32.5	26.0	11.8	13.5	18.3	11.3	11.6	12.6	21.5	42.8	45.7	18.0	8.6	14.7	29.3	40.2	41.9	11.0	11.9	21.0	11.5	14.9	40.8	13.8	16.4	127.0	13.7	14.8	26.8	13.6	17.4	17.8	38.0	22.1	17.1	12.0	44.3	21.4	13.2	16.0	30.9	19.8	12.5	37.8	30.6	12.9	10.9	23.7	15.5	17.8	16.6	15.3	20.0	36.0	32.4	17.6	13.7	42.9	40.5	21.8	29.6	10.4	21.8	16.3	32.6	27.3	28.9	30.2	15.4	25.7	27.3	30.6	24.8	16.9	24.7	18.5	26.8	16.6	32.2	29.0	29.3	10.2	22.1	35.9	31.9	48.7	7.7	25.4	18.6	37.7	21.2	33.4	33.7	31.7	22.1	9.5	12.1	28.4	36.4	25.1	20.6	19.4	15.2	20.5	13.4	21.2	28.6	27.7	57.3	30.9	9.5	27.1	39.5	11.1	10.1	14.4	19.5	12.4	13.1	24.8	16.5	17.2	11.0	31.3	15.5	12.6	11.6	49.3	9.0	30.8	12.1	11.5	40.8	60.1	35.1	46.6	42.8	45.7	40.2	41.9	40.8	38.0	44.3	37.8	23.2	12.8	11.3	35.3	42.6	29.1	16.5	12.5	11.4	47.2	14.3	13.1	29.3	15.7	11.4	14.7	58.4	41.4	29.6	18.6	37.2	37.5	50.5	16.3	9.8	31.7	13.8	5.5	36.3	35.8	17.9	16.9	14.3	14.5	54.6	54.1	20.0	6.0	54.8	25.2	38.6	17.5	8.2	18.5	32.4	26.6	10.2	22.1	37.4	39.4	29.8	55.2	64.9	26.7	36.3	26.5	12.1	15.4	20.2	12.9	27.2	81.6	13.0	173.4	6.6	12.3	20.8	22.3	18.3	8.6	22.0	16.7	29.1	11.0	19.2	12.0
DTWD2	FLJ33977	ENSG00000169570	"DTW domain containing 2"	Q8NBA8	5	118836074-118988547	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 70.4;Inhibitory neurons: 61.8;Oligodendrocyte precursor cells: 49.3;Oligodendrocytes: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA053173, HPA054864"	Approved		Approved	"Nuclear bodies"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear bodies"		"HPA053173: AB_2682068, HPA054864: AB_2682629"	"unprognostic (1.66e-1)"	"unprognostic (1.60e-1)"	"prognostic favorable (3.16e-4)"	"unprognostic (4.80e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.77e-3)"	"unprognostic (5.15e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (6.09e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.59e-1)"	3.1	3.3	1.3	2.3	1.3	1.2	3.6	2.3	1.8	5.1	2.2	3.3	3.2	2.6	2.3	4.2	2.3	3.2	6.5	1.2	0.8	6.5	4.5	2.4	2.3	1.1	1.4	1.7	3.0	4.7	0.8	1.8	1.2	3.4	3.3	3.4	3.2	2.7	10.5	3.3	2.7	3.2	1.0	3.0	2.7	2.4	1.3	2.0	9.1	6.3	2.3	2.9	1.3	1.4	4.3	2.6	3.6	5.3	2.0	1.0	3.6	3.9	2.7	5.5	6.3	1.8	3.2	3.6	6.9	3.4	2.6	4.8	6.0	4.4	6.9	1.2	4.2	4.9	4.3	2.9	1.7	5.9	6.1	1.5	7.4	2.4	2.4	3.2	1.8	6.4	3.8	5.5	3.7	4.2	4.9	3.6	3.8	3.1	1.4	2.0	3.3	1.9	7.0	6.2	1.8	3.3	3.9	4.2	5.4	2.9	9.7	3.9	2.2	6.9	5.1	2.3	5.7	3.8	6.6	2.8	4.0	3.5	3.4	0.9	0.3	0.1	0.2	0.3	0.3	0.4	0.3	0.3	0.3	0.6	0.4	0.4	0.6	0.5	0.3	0.5	0.1	0.4	1.3	1.3	2.3	1.8	1.2	0.8	1.1	1.4	1.2	1.0	1.3	1.4	2.7	9.6	3.6	33.6	5.7	2.8	2.7	3.9	8.6	12.0	5.4	2.8	11.7	8.6	4.7	7.3	16.7	2.7	3.7	4.0	9.8	2.9	12.8	4.2	1.9	2.0	4.2	12.6	70.4	8.3	1.1	3.0	9.7	3.6	0.0	4.5	1.8	5.6	3.9	20.2	61.8	2.0	4.1	2.6	2.5	20.3	2.5	4.5	7.2	21.5	4.6	7.3	4.1	49.3	43.9	1.9	5.2	2.2	8.0	2.1	3.7	12.1	3.1	9.1	0.0	4.5	2.8	12.7	17.4	10.0	3.7	0.7	2.8	7.3	3.4	3.4
DTYMK	"CDC8, TMPK, TYMK"	ENSG00000168393	"Deoxythymidylate kinase"	P23919	2	241675747-241686944	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 108.6;Extravillous trophoblasts: 149.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042593, HPA042719"	Approved		Approved	Mitochondria		NA	NA		7000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Mitochondria		"HPA042593: AB_10959590, HPA042719: AB_10960633"	"unprognostic (1.90e-1)"	"unprognostic (6.95e-2)"	"unprognostic (4.14e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (1.44e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.60e-2)"	"unprognostic (6.94e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (7.13e-2)"	"unprognostic (6.81e-2)"	"unprognostic (5.07e-2)"	"unprognostic (9.19e-2)"	12.2	16.0	15.6	15.6	17.1	37.0	11.8	16.2	19.8	11.2	16.5	15.1	13.2	10.8	6.1	19.1	10.2	8.6	10.6	14.5	15.0	14.9	18.8	9.7	24.8	16.8	16.0	8.2	9.5	7.5	5.0	11.1	16.1	11.1	12.2	4.3	9.8	7.4	8.1	18.8	14.0	13.4	15.3	17.2	13.3	8.2	16.8	24.1	8.7	6.4	19.2	10.6	11.2	17.2	102.6	112.3	93.6	120.1	30.2	33.3	103.2	82.1	63.2	110.8	125.6	54.8	120.1	48.3	24.6	66.8	126.8	84.4	87.8	102.2	56.7	118.8	104.6	103.9	88.3	105.1	26.3	69.1	83.1	23.7	27.3	102.7	42.4	32.1	104.8	74.4	123.6	38.4	114.1	112.6	132.2	125.0	100.7	113.1	94.2	111.4	139.8	71.8	62.3	59.5	115.0	74.0	53.4	81.5	67.9	27.0	74.2	120.0	66.5	147.5	110.4	99.0	152.5	47.3	49.1	144.6	122.4	112.2	184.9	20.5	26.2	17.4	30.4	46.7	29.6	35.6	28.5	32.6	19.7	36.7	28.1	25.0	4.2	32.6	37.1	38.5	42.1	28.5	15.6	17.1	16.2	19.8	14.5	15.0	16.8	16.0	16.1	15.3	16.8	17.2	28.9	9.6	5.8	8.1	21.4	15.2	17.7	47.7	16.5	19.1	36.3	44.8	11.0	24.3	22.2	25.8	2.1	79.5	24.0	22.9	21.5	39.6	2.1	17.6	25.0	29.2	14.4	108.6	3.3	34.1	149.1	26.9	25.5	22.3	15.2	52.3	23.9	22.3	84.9	5.0	4.7	35.7	36.7	17.0	13.9	2.1	16.4	21.7	23.2	5.6	39.3	23.0	38.1	6.0	9.2	33.7	10.6	19.2	37.6	21.7	12.7	37.7	12.9	17.4	26.3	21.4	31.2	27.5	63.4	32.6	11.9	27.5	17.4	28.2	52.2	19.5
DUS2	"DUS2L, FLJ20399, SMM1"	ENSG00000167264	"Dihydrouridine synthase 2"	Q9NX74	16	67987746-68079320	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Oxidoreductase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 118.1;Late spermatids: 94.1;Spermatocytes: 53.1;Syncytiotrophoblasts: 61.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA042560, HPA043528"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA042560: AB_10965170, HPA043528: AB_10959753"	"unprognostic (2.21e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.23e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.23e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.18e-1)"	"prognostic favorable (3.50e-5)"	"unprognostic (1.44e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.81e-1)"	5.8	6.8	5.2	12.6	5.8	9.6	5.8	6.8	7.5	6.1	4.6	8.6	5.7	5.3	4.9	12.2	5.1	5.5	6.1	5.3	6.1	5.9	9.2	6.8	18.8	6.8	5.8	4.8	4.4	7.5	4.9	9.9	6.6	5.4	8.4	5.3	5.9	5.0	9.6	10.8	10.4	7.9	5.0	15.9	6.4	27.5	6.4	7.6	5.4	8.9	20.2	7.0	7.4	7.8	17.1	25.5	11.0	17.1	8.8	14.8	20.4	16.1	15.6	33.4	23.7	27.5	29.9	39.7	14.3	17.0	9.8	22.8	26.6	28.5	25.5	6.1	16.0	13.4	15.6	20.6	14.9	15.1	18.4	14.5	21.9	27.5	26.8	12.8	21.3	29.9	16.1	6.5	16.0	24.9	16.0	22.5	12.2	16.9	13.5	26.8	12.5	28.3	18.4	11.8	13.0	11.3	31.8	12.3	7.1	14.1	25.1	8.4	11.7	14.8	13.3	12.9	13.6	18.4	24.5	36.6	10.6	19.7	8.8	12.1	29.2	89.9	9.5	25.8	9.2	56.9	6.5	10.3	21.9	48.4	9.4	8.5	27.8	21.3	37.7	8.6	13.5	17.2	5.2	5.8	6.8	7.5	5.3	6.1	6.8	5.8	6.6	5.0	6.4	7.8	2.5	9.6	4.6	6.8	17.1	2.7	2.0	12.8	4.6	3.9	2.4	2.2	2.6	4.3	6.2	7.3	8.4	29.2	6.0	5.7	5.9	10.4	118.1	1.7	3.5	5.3	4.2	3.0	7.2	5.4	17.3	3.8	4.6	2.6	7.0	7.2	9.3	7.9	13.4	15.2	8.0	5.5	6.1	11.9	2.3	94.1	3.7	6.2	3.6	2.8	13.5	4.5	9.2	5.5	7.3	9.5	3.6	7.9	7.7	3.4	4.2	10.8	4.1	2.9	6.6	3.4	4.7	53.1	15.0	5.2	2.6	61.4	4.2	10.0	6.0	2.1
DUS4L	"DUS4, PP35"	ENSG00000105865	"Dihydrouridine synthase 4 like"	O95620	7	107563484-107578523	"Predicted intracellular proteins"	"tRNA processing"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044301	Approved		Approved	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA044301: AB_10967460"	"unprognostic (7.95e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.29e-2)"	"unprognostic (9.21e-3)"	"unprognostic (7.74e-3)"	"unprognostic (6.72e-3)"	1.5	1.9	1.1	0.5	1.2	0.4	1.5	1.2	1.5	1.6	0.9	1.4	0.6	1.5	1.7	1.7	1.3	0.6	2.7	1.1	1.2	2.7	2.0	1.0	0.8	1.2	1.2	1.8	1.7	1.2	1.5	0.6	1.3	1.5	0.8	1.0	1.6	0.5	1.7	1.5	1.3	0.5	1.2	1.3	1.6	2.3	1.1	0.7	1.6	1.1	0.8	1.7	1.5	1.4	4.1	1.6	1.6	1.0	0.5	1.0	2.3	0.9	1.4	1.7	1.5	2.1	3.6	4.6	2.1	0.6	4.6	1.2	1.7	2.4	2.3	1.2	1.3	1.2	0.9	2.6	1.6	3.0	0.2	1.2	3.5	1.6	5.7	1.8	2.4	3.9	5.4	1.7	2.7	3.0	4.3	5.8	2.8	3.3	3.4	2.3	1.7	5.3	3.2	2.1	1.6	4.4	1.9	4.2	3.6	2.3	1.9	2.6	1.7	2.5	2.0	1.8	2.6	3.0	3.8	4.9	2.3	4.3	2.9	0.0	0.1	0.0	0.1	0.2	0.2	0.2	0.4	0.1	0.2	0.1	0.3	0.4	0.0	0.1	0.1	0.1	0.2	0.1	1.1	1.2	1.2	1.5	1.1	1.2	1.2	1.2	1.3	1.2	1.1	1.4	4.5	6.4	3.9	4.6	7.6	5.1	11.0	5.6	10.2	10.0	8.6	10.2	9.2	5.7	6.6	11.0	4.2	9.1	4.5	3.3	7.9	13.3	32.8	11.3	7.2	4.6	9.6	5.0	3.5	16.2	8.8	4.6	5.1	11.0	13.4	10.2	4.2	9.3	6.7	3.3	5.1	5.0	10.2	5.0	3.7	24.9	4.4	5.6	3.6	5.6	5.2	15.4	11.3	4.5	9.7	15.7	6.8	3.8	5.6	8.1	7.7	17.3	15.3	9.8	13.1	3.4	5.7	12.4	11.0	11.2	4.0	3.7	6.7	7.6	6.3	6.9
DUSP12	"DUSP1, YVH1"	ENSG00000081721	"Dual specificity phosphatase 12"	Q9UNI6	1	161749758-161757238	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008840	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA008840: AB_1847884"	"unprognostic (3.51e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (1.99e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.25e-3)"	"unprognostic (9.52e-2)"	"unprognostic (2.42e-3)"	"prognostic unfavorable (1.55e-7)"	"unprognostic (1.17e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.42e-1)"	13.3	9.6	12.1	9.1	12.5	30.9	14.1	14.3	14.6	13.8	12.1	12.9	7.6	14.3	8.9	10.3	12.5	6.7	9.4	12.0	12.4	14.4	9.4	11.4	13.8	12.2	12.2	13.6	13.6	8.2	9.5	11.2	12.3	11.0	10.5	13.2	10.9	9.5	7.4	10.9	12.4	11.0	12.3	14.1	11.5	6.7	12.0	11.7	12.1	7.3	13.0	13.1	11.5	13.3	32.6	28.2	33.1	21.7	17.2	18.5	30.4	25.9	33.7	39.2	29.9	42.1	28.2	19.9	25.7	31.9	24.4	22.7	26.0	32.0	38.0	25.5	22.0	17.8	27.7	28.4	36.4	38.6	17.1	25.4	34.6	34.1	61.0	22.2	27.6	27.2	31.7	20.9	28.3	30.0	22.7	43.2	52.1	35.2	43.1	32.2	32.0	32.9	22.2	39.3	20.6	43.6	21.9	36.2	44.1	36.2	31.3	43.6	19.3	33.3	30.8	26.3	55.6	35.3	31.0	47.0	20.3	38.1	33.3	32.0	16.9	13.7	18.4	19.5	22.9	19.2	20.8	17.8	22.0	20.0	19.6	21.8	6.8	28.4	12.2	10.0	19.5	12.9	12.1	12.5	14.3	14.6	12.0	12.4	12.2	12.2	12.3	12.3	12.0	13.3	22.9	19.2	12.8	8.1	25.5	13.6	14.4	25.9	25.6	15.9	13.4	16.1	5.0	8.6	15.6	7.3	8.4	21.7	26.4	4.8	21.5	22.2	4.2	7.4	13.7	18.4	11.3	16.2	11.9	24.3	22.7	17.3	11.7	7.2	18.3	18.7	18.5	8.2	20.5	10.1	14.8	9.8	8.2	20.6	16.2	1.2	8.7	15.4	10.6	10.3	22.1	15.8	33.0	12.1	14.4	21.2	6.5	17.7	27.5	17.1	8.6	18.5	7.0	19.6	0.0	13.2	24.5	13.9	12.6	18.2	13.1	17.6	23.5	16.4	12.1	12.0
DYNLL1	"DLC1, DLC8, DNCL1, hdlc1, LC8, PIN"	ENSG00000088986	"Dynein light chain LC8-type 1"	P63167	12	120469850-120498493	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Transcription, Transcription regulation, Transport"	"Activator, Motor protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 4098.6;Respiratory ciliated cells: 2679.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039954			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	Yes		890000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA039954: AB_2676771"	"unprognostic (1.94e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.88e-2)"	"unprognostic (5.63e-2)"	"unprognostic (7.09e-2)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (4.41e-3)"	"unprognostic (4.64e-2)"	"unprognostic (6.17e-3)"	"unprognostic (1.61e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (7.97e-7)"	"unprognostic (4.91e-2)"	"unprognostic (2.80e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.62e-1)"	268.6	261.9	912.5	186.7	967.7	126.8	268.0	895.2	1292.9	354.2	894.7	325.8	162.8	319.4	322.3	719.9	544.2	242.7	257.5	975.4	944.7	352.6	238.4	222.6	241.6	896.1	898.5	247.0	225.1	228.2	309.7	259.2	914.2	225.9	327.4	181.3	245.4	264.6	85.6	626.7	206.3	390.1	935.1	185.2	244.5	360.3	909.7	306.5	176.1	163.9	357.8	389.8	474.4	1001.2	721.6	811.4	779.2	600.8	677.1	713.6	250.8	968.0	451.6	785.6	466.7	770.8	472.3	400.6	510.3	945.1	753.0	629.6	949.3	818.3	781.0	528.3	617.9	390.4	532.9	1062.5	676.2	412.8	620.5	436.2	863.0	584.6	477.5	855.7	831.8	421.5	502.0	446.1	1056.8	960.1	541.4	894.8	642.2	917.7	935.7	543.0	403.0	499.2	1143.1	659.8	535.2	392.0	789.3	677.7	926.6	812.6	673.6	595.3	635.2	592.3	502.1	525.6	852.2	264.0	562.8	404.6	656.8	645.1	776.6	516.6	291.9	384.2	200.6	303.3	155.3	310.4	207.2	211.7	281.8	219.0	132.0	165.7	50.1	282.9	334.8	461.6	373.5	353.0	912.5	967.7	895.2	1292.9	975.4	944.7	896.1	898.5	914.2	935.1	909.7	1001.2	810.1	195.5	101.9	79.3	341.4	922.2	359.1	1275.0	356.8	138.4	800.0	949.4	170.8	303.1	764.6	399.1	83.4	524.6	484.1	689.9	1113.2	691.2	1407.2	1842.5	528.5	541.9	480.8	332.9	111.2	538.9	897.4	538.5	240.5	488.1	316.7	611.9	521.9	499.0	732.1	85.8	62.8	801.6	1121.0	329.4	706.1	4098.6	516.6	466.3	595.9	42.2	701.6	164.0	248.2	47.3	156.4	754.9	798.6	701.8	234.9	304.7	533.4	1125.0	2679.6	193.5	368.1	440.7	1016.3	961.5	721.4	1005.4	1610.1	1006.6	396.6	586.3	498.2	389.6
E2F1	"RBBP3, RBP3"	ENSG00000101412	"E2F transcription factor 1"	Q01094	20	33675477-33686385	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 25.0;Granulosa cells: 11.4;Spermatogonia: 32.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000329, HPA008003, CAB019308, HPA029735"	Enhanced		Supported	Nucleoplasm,Centrosome		NA	Yes			"Cluster 22: NK-cells - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Centrosome"		"CAB000329: AB_627476, CAB019308: , HPA008003: AB_1847936, HPA029735: AB_2673176"	"unprognostic (7.46e-2)"	"prognostic favorable (9.22e-6)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (4.33e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (3.83e-5)"	"unprognostic (1.25e-2)"	"unprognostic (8.23e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavorable (4.18e-4)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (8.99e-5)"	"unprognostic (1.05e-2)"	"unprognostic (7.50e-2)"	"prognostic favorable (1.62e-4)"	"unprognostic (1.91e-1)"	1.8	5.5	7.1	5.6	7.1	34.3	1.6	5.2	9.2	1.8	3.9	3.8	3.2	1.2	0.2	5.7	1.3	0.7	1.4	6.1	5.6	0.9	1.8	3.7	8.7	7.6	6.4	3.5	1.0	1.3	0.6	2.4	6.5	1.9	3.9	0.7	1.9	0.9	1.6	4.7	4.1	2.8	7.0	5.0	3.7	10.4	6.9	10.7	0.8	0.8	6.9	2.4	2.5	8.3	48.1	45.4	52.0	40.5	5.2	3.6	39.3	45.0	21.4	55.9	46.7	81.1	48.0	87.3	44.2	20.2	67.7	35.4	25.3	23.8	24.8	26.4	36.5	71.6	71.9	47.7	0.4	34.0	43.6	2.8	1.4	30.6	5.4	5.7	14.6	54.4	19.3	60.0	34.9	42.3	72.8	71.6	15.6	47.9	64.6	71.4	140.7	36.2	9.6	28.7	76.7	54.1	54.6	37.6	22.7	14.8	47.3	42.4	7.9	65.0	37.7	45.8	64.8	58.1	42.0	72.6	54.1	20.0	39.3	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.4	1.0	0.1	0.1	0.1	7.1	7.1	5.2	9.2	6.1	5.6	7.6	6.4	6.5	7.0	6.9	8.3	1.1	0.0	1.1	0.7	3.6	2.9	1.7	0.5	0.0	2.3	3.1	4.3	0.4	0.0	1.4	0.0	0.0	5.0	2.9	2.4	0.0	0.9	1.0	0.3	1.0	1.6	0.0	25.0	1.5	0.2	9.6	3.0	7.7	1.2	0.0	11.4	0.7	0.8	4.4	0.0	0.5	4.6	2.0	0.6	2.1	3.1	2.1	3.1	1.8	1.0	0.1	1.5	1.0	1.0	3.4	0.6	0.5	1.2	9.7	0.5	1.4	0.1	0.2	2.3	0.0	1.0	3.0	7.5	32.9	3.7	1.7	1.8	3.3	1.2	7.0	3.5
E2F4	E2F-4	ENSG00000205250	"E2F transcription factor 4"	Q16254	16	67192155-67198918	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cilium biogenesis/degradation, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 174.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054128			Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA054128: AB_2682392"	"unprognostic (1.74e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.39e-3)"	"unprognostic (1.05e-3)"	"unprognostic (7.50e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.04e-2)"	"unprognostic (8.44e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.17e-1)"	43.5	39.6	27.9	39.7	27.2	98.2	38.3	26.5	31.0	35.3	27.1	43.8	32.1	41.2	22.2	47.4	36.7	23.5	39.6	27.4	29.2	38.2	32.0	38.0	48.5	28.7	27.7	33.1	36.1	29.1	39.2	44.0	28.2	36.5	32.0	9.9	29.8	27.6	50.5	34.0	44.3	31.8	27.9	54.7	40.6	32.9	28.2	42.5	33.6	30.0	43.4	42.0	34.1	27.9	67.3	53.2	44.4	54.3	63.5	54.6	158.6	49.1	72.7	88.5	84.8	94.6	71.5	82.7	58.1	52.3	60.7	95.8	69.2	69.2	57.4	35.2	73.4	55.9	31.9	97.5	76.7	110.9	113.0	64.8	53.9	70.4	77.9	33.2	77.8	62.9	107.1	26.8	47.2	115.0	127.9	90.8	109.1	71.7	47.4	152.7	92.8	109.7	41.8	50.9	53.6	63.9	134.2	49.6	58.2	35.2	50.6	109.7	56.0	62.4	58.9	46.1	78.2	65.6	62.0	215.0	73.3	75.5	60.7	1.2	11.8	10.9	8.4	10.7	7.0	6.1	7.7	9.9	14.6	6.6	6.1	5.5	7.5	8.7	8.1	6.3	3.9	7.7	27.9	27.2	26.5	31.0	27.4	29.2	28.7	27.7	28.2	27.9	28.2	27.9	36.2	12.8	16.5	14.7	31.2	41.6	33.9	18.0	10.8	22.3	20.9	16.3	15.1	22.8	13.4	12.9	4.2	116.1	35.1	26.7	19.6	30.2	50.5	16.0	24.4	36.2	22.8	174.7	13.9	37.2	82.8	25.5	36.7	19.4	27.3	25.4	30.0	10.2	44.7	21.9	12.3	23.6	22.4	23.8	29.0	84.9	27.1	30.1	14.2	11.2	41.5	14.3	55.6	10.6	12.2	35.8	19.3	23.7	39.7	56.8	21.4	13.4	9.5	19.2	46.0	20.0	26.9	37.9	45.3	25.8	45.9	79.8	36.7	31.4	30.2	37.9
E2F8	FLJ23311	ENSG00000129173	"E2F transcription factor 8"	A0AVK6	11	19224063-19241620	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.2;lymphoid tissue: 11.8;skeletal muscle: 12.6"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 34.1;Gastric mucus-secreting cells: 10.2;Plasma cells: 9.7;Squamous epithelial cells: 10.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA064882, HPA076614"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA064882: AB_2685381, HPA076614: "	"unprognostic (5.62e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.17e-2)"	"unprognostic (6.99e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.29e-5)"	"unprognostic (1.94e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.41e-1)"	"unprognostic (7.29e-4)"	"unprognostic (1.16e-2)"	"unprognostic (9.13e-8)"	"unprognostic (1.02e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.81e-1)"	"unprognostic (4.28e-3)"	0.3	0.1	0.0	2.8	0.0	14.2	0.5	0.1	0.1	1.0	0.0	4.0	3.8	0.4	0.0	4.9	0.9	0.4	2.1	0.0	0.0	0.1	0.3	0.3	7.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.4	5.1	0.0	0.9	0.2	12.6	3.0	3.0	0.6	0.0	1.3	5.6	1.7	0.0	11.8	0.1	0.4	7.3	1.8	1.3	0.1	23.3	7.2	7.1	9.8	0.4	1.1	31.7	13.0	3.7	15.3	16.4	25.4	7.8	23.5	5.5	4.3	9.0	20.2	17.2	1.6	13.5	15.9	14.9	8.0	4.1	7.1	0.0	12.7	19.2	0.3	0.1	3.1	1.0	0.9	21.0	17.2	17.6	22.1	6.3	11.6	25.8	16.6	6.9	26.3	10.1	26.9	12.8	16.0	6.6	16.8	6.0	7.0	5.5	11.3	1.3	4.0	7.7	13.7	4.2	7.3	9.0	18.3	11.8	7.7	16.2	30.6	9.0	24.4	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	1.1	0.1	1.3	0.0	0.0	0.3	0.1	3.8	0.0	0.5	0.0	0.0	0.9	0.8	2.5	0.0	0.0	0.4	3.3	0.8	0.8	1.2	34.1	0.1	0.0	1.7	1.0	10.2	3.3	0.0	3.1	0.0	0.0	2.4	0.0	0.0	3.9	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	1.2	0.0	9.7	0.1	0.4	0.2	5.6	0.0	0.0	1.5	0.9	4.0	3.1	10.0	0.3	0.3	2.2	0.5	6.3	0.9
EARS2	"KIAA1970, MSE1, mtGlnRS"	ENSG00000103356	"Glutamyl-tRNA synthetase 2, mitochondrial"	Q5JPH6	16	23520754-23557731	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043289, HPA043633"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA043289: AB_10963932, HPA043633: AB_10959901"	"unprognostic (3.10e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.20e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.99e-2)"	"prognostic unfavorable (7.20e-4)"	"unprognostic (8.09e-2)"	"prognostic favorable (3.16e-6)"	"unprognostic (2.48e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.29e-2)"	3.7	7.6	3.3	1.2	3.5	1.5	4.0	2.7	4.0	2.9	3.6	3.7	1.1	3.7	3.0	5.2	3.0	1.0	5.3	3.3	3.6	4.9	9.9	3.1	1.8	3.3	2.5	3.3	5.6	4.8	3.5	2.5	2.6	3.0	2.3	1.9	4.6	1.4	4.2	5.6	2.9	2.0	1.5	3.3	4.1	3.8	3.5	2.5	4.3	3.8	2.4	3.3	3.3	3.2	2.6	8.3	2.4	4.8	2.9	3.8	3.9	3.2	3.1	3.6	2.4	5.0	2.9	4.8	2.6	3.3	1.8	2.9	9.6	6.4	4.7	2.9	7.7	2.4	5.3	7.1	2.4	3.4	2.1	3.2	4.4	2.4	4.7	4.5	1.4	5.2	7.0	2.5	2.6	5.5	2.1	2.3	7.5	4.4	2.8	4.1	4.5	8.0	5.5	3.8	5.0	4.1	2.1	5.0	2.7	6.3	5.9	3.0	2.3	3.1	2.1	3.1	3.4	5.1	3.7	3.4	4.1	4.0	4.3	0.1	0.8	0.0	1.0	1.5	1.6	0.8	1.4	1.1	1.7	1.0	1.3	1.1	0.4	1.8	1.1	1.6	1.7	1.3	3.3	3.5	2.7	4.0	3.3	3.6	3.3	2.5	2.6	1.5	3.5	3.2	1.8	9.6	5.9	5.2	3.8	2.2	4.0	4.0	4.0	3.8	6.2	4.7	11.6	2.8	2.9	3.7	2.1	15.1	2.3	2.5	5.9	7.0	2.9	3.3	4.9	3.2	5.4	9.4	8.3	3.5	12.3	4.3	4.1	3.4	5.7	6.5	3.6	11.4	7.1	8.4	7.9	4.3	2.0	3.2	2.5	2.5	2.5	3.4	5.4	3.7	5.3	2.6	4.1	4.0	4.7	3.7	1.7	1.9	8.8	4.9	1.6	8.6	5.3	3.9	0.0	2.7	3.4	5.8	9.8	6.5	3.0	11.4	3.3	12.6	6.2	3.2
EBNA1BP2	"EBP2, NOBP, P40"	ENSG00000117395	"EBNA1 binding protein 2"	Q99848	1	43164175-43270936	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026512, HPA028277"	Approved		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No		38000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA026512: AB_1847954, HPA028277: AB_10603664"	"unprognostic (9.30e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.03e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (7.64e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.11e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.10e-3)"	"unprognostic (3.04e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.33e-2)"	35.1	38.8	30.3	35.2	31.1	34.3	39.5	28.8	33.5	30.0	32.5	35.4	23.6	35.5	55.7	46.5	43.5	21.7	37.1	31.1	31.0	55.7	126.6	27.7	35.9	29.3	28.5	27.3	36.1	45.6	48.9	33.1	30.0	29.0	36.5	19.6	34.5	31.0	51.9	36.8	24.5	35.0	29.6	24.8	33.4	44.4	31.8	30.5	41.4	28.6	39.8	52.5	34.5	31.1	325.0	180.2	66.0	192.7	52.1	58.3	142.6	219.4	107.8	338.7	210.5	215.2	192.5	211.0	167.9	157.0	157.2	218.2	144.5	200.9	360.5	101.2	146.5	144.8	160.9	188.5	95.7	248.7	106.8	47.6	197.4	248.6	197.3	64.2	185.5	145.2	220.3	67.8	165.1	172.8	190.0	152.0	290.8	209.5	165.0	139.2	150.4	235.5	123.7	135.0	132.0	139.9	127.3	228.6	219.0	105.6	94.5	136.1	147.6	128.7	248.9	211.4	360.7	102.9	219.7	262.7	107.6	258.7	265.2	19.7	45.4	24.9	52.3	54.1	55.2	61.5	52.8	54.5	68.7	68.5	48.3	48.3	3.9	59.6	53.3	65.6	60.5	43.6	30.3	31.1	28.8	33.5	31.1	31.0	29.3	28.5	30.0	29.6	31.8	31.1	38.0	35.3	39.5	5.9	36.9	123.0	91.6	78.0	40.5	26.3	50.6	62.1	32.0	52.9	52.5	31.3	6.2	102.2	23.3	34.0	90.1	144.5	163.5	56.8	47.3	51.0	24.1	45.0	5.6	124.4	135.1	51.5	33.1	31.6	50.7	35.1	27.8	148.3	63.3	15.2	3.8	49.7	48.8	22.5	24.7	94.9	33.2	28.9	55.2	3.7	41.4	55.7	35.0	6.0	4.9	135.3	25.8	38.4	53.1	179.3	29.4	135.9	81.3	29.5	39.5	55.0	68.1	92.6	97.8	54.2	99.4	84.3	26.8	57.8	66.2	95.3
ECT2	ARHGEF31	ENSG00000114346	"Epithelial cell transforming 2"	Q9H8V3	3	172750682-172821474	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Neurogenesis, Protein transport, Transport"	"Guanine-nucleotide releasing factor"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6;Spermatocytes: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA036363, HPA053261"			Enhanced	Nucleoplasm,Cytosol		No	Yes			"Cluster 1: Neutrophils - Mixed function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA036363: AB_2732472, HPA053261: AB_2682094"	"unprognostic (3.83e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.22e-3)"	"unprognostic (4.49e-2)"	"unprognostic (5.02e-3)"	"prognostic unfavorable (6.82e-6)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.24e-5)"	"unprognostic (2.44e-2)"	"prognostic unfavorable (1.19e-5)"	"unprognostic (1.08e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.33e-1)"	3.6	3.3	2.1	8.2	1.9	19.8	7.5	3.4	3.4	8.1	1.4	11.5	9.3	4.4	1.8	8.9	3.3	5.3	3.2	2.4	1.4	4.3	2.6	5.2	10.5	2.1	1.7	1.3	2.9	3.6	1.2	8.8	2.7	3.2	15.8	12.5	5.6	2.6	2.1	7.1	7.6	7.5	0.7	4.3	9.4	15.9	2.3	23.3	3.9	2.7	11.4	6.9	4.2	3.5	192.0	133.6	103.2	54.0	10.6	21.8	51.6	81.5	67.5	121.4	116.9	74.7	196.9	47.2	122.1	48.8	116.0	81.8	84.2	53.1	164.3	67.8	46.6	29.6	70.0	38.5	4.6	46.2	32.8	7.1	9.0	72.2	73.2	34.0	53.0	68.6	31.3	67.2	97.2	67.6	47.5	34.6	84.4	156.7	72.0	33.7	101.1	60.7	92.2	43.7	68.6	44.1	104.5	117.4	42.2	51.5	195.4	34.1	46.5	58.5	55.7	79.6	174.9	32.8	47.2	88.2	51.6	39.7	78.0	6.0	2.0	0.7	1.0	1.7	1.1	1.4	1.4	0.9	1.6	1.3	0.6	0.9	6.3	0.7	0.7	1.6	2.5	0.7	2.1	1.9	3.4	3.4	2.4	1.4	2.1	1.7	2.7	0.7	2.3	3.5	6.7	6.4	3.2	4.2	3.8	19.5	4.9	6.2	9.1	3.4	10.1	6.5	3.6	5.7	5.7	3.7	64.6	12.0	2.9	10.7	0.0	9.5	3.3	20.1	6.6	7.7	4.8	25.2	6.5	9.2	14.9	6.0	17.9	20.5	0.0	17.9	5.3	2.9	7.3	0.0	2.5	13.5	10.2	4.7	6.3	2.8	0.9	5.1	7.2	15.0	2.8	3.1	2.1	3.0	4.9	20.7	3.8	1.5	9.6	12.8	1.5	3.7	11.0	16.3	0.0	2.9	5.2	42.6	30.4	16.9	12.8	3.8	4.1	3.3	13.5	8.8
EDC3	"FLJ21128, hYjeF_N2-15q23, LSM16, YJDC, YJEFN2"	ENSG00000179151	"Enhancer of mRNA decapping 3"	Q96F86	15	74630558-74696292	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		RNA-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Early spermatids: 117.2;Late spermatids: 192.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040650, HPA044206, HPA066137"	Uncertain		Supported	"Cytoplasmic bodies"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Cytoplasmic bodies"		"HPA040650: AB_2677061, HPA044206: AB_2678857, HPA066137: AB_2685625"	"unprognostic (4.22e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (7.80e-5)"	"unprognostic (3.06e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.81e-1)"	"unprognostic (4.81e-2)"	12.8	8.7	14.3	11.7	15.6	7.9	13.8	18.1	16.6	13.0	15.6	12.4	10.4	15.2	11.0	15.5	16.4	10.2	10.5	14.0	15.3	12.9	11.2	10.5	15.1	15.2	15.0	18.6	10.5	13.4	11.9	12.4	14.9	14.3	13.8	11.8	10.3	10.8	14.8	15.3	12.3	17.0	12.7	12.9	11.5	34.8	15.0	18.5	13.1	11.5	18.1	13.0	10.7	18.6	24.9	20.8	39.0	34.9	24.6	22.5	35.7	26.1	30.5	42.4	40.6	58.9	30.2	39.6	24.1	35.8	39.2	50.6	99.0	40.4	29.5	33.7	54.3	41.0	46.9	30.8	29.4	47.8	24.4	23.0	36.9	36.8	39.0	26.8	38.9	45.7	59.3	30.4	30.5	39.8	32.8	26.7	39.2	34.0	22.9	40.8	42.7	40.0	19.4	42.7	42.5	38.8	38.8	33.5	41.8	51.8	34.6	34.6	24.3	36.7	20.3	22.2	38.4	31.9	65.2	44.3	29.1	46.6	29.5	6.1	5.8	4.6	9.6	5.9	10.3	8.3	6.8	7.9	6.8	6.3	6.9	7.5	1.9	13.7	5.0	6.7	8.5	7.1	14.3	15.6	18.1	16.6	14.0	15.3	15.2	15.0	14.9	12.7	15.0	18.6	10.8	6.4	7.8	21.9	7.2	4.7	5.0	7.6	9.6	9.7	6.8	6.2	6.3	8.6	6.7	7.3	0.0	9.7	8.4	7.0	3.9	11.4	117.2	10.2	7.5	9.6	15.6	7.8	19.5	8.1	12.1	7.9	9.7	9.4	4.5	10.2	8.2	8.2	7.6	5.0	18.0	6.8	8.2	7.1	2.4	192.2	9.0	4.6	8.8	17.8	11.5	5.2	11.3	18.6	19.0	9.5	11.1	6.4	14.0	7.6	6.6	5.8	11.3	6.3	13.1	4.6	6.8	12.8	16.3	7.7	2.8	9.3	7.4	7.6	6.0	8.1
EDC4	"Ge-1, HEDLS, RCD-8"	ENSG00000038358	"Enhancer of mRNA decapping 4"	Q6P2E9	16	67873052-67884499	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Alveolar cells type 2: 24.8;Excitatory neurons: 14.2;Gastric mucus-secreting cells: 15.3;Inhibitory neurons: 12.6;Oligodendrocytes: 13.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041164, HPA043038"	Supported		Enhanced	"Nucleoplasm,Cytoplasmic bodies"		NA	NA		9700	"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Cytoplasmic bodies"	Nucleoplasm	"HPA041164: AB_2677339, HPA043038: AB_2678281"	"unprognostic (1.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (7.61e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.10e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.13e-2)"	"unprognostic (7.69e-3)"	"unprognostic (1.17e-1)"	10.1	11.8	36.3	11.9	36.2	24.4	10.6	36.0	42.2	11.6	34.0	15.5	13.7	12.9	9.6	12.1	13.2	12.1	17.0	34.7	34.8	12.2	10.9	10.8	16.3	34.3	34.5	15.8	18.1	13.6	14.0	10.8	34.4	11.3	11.2	8.5	11.3	10.2	21.9	16.1	14.1	9.7	33.0	13.7	15.8	18.3	34.1	20.6	10.9	11.3	16.0	13.1	10.5	37.0	23.8	33.6	22.0	19.9	19.6	14.8	43.6	21.1	17.8	42.4	33.9	55.2	22.4	38.2	22.6	29.1	17.9	32.4	43.1	17.2	21.3	14.8	54.6	27.2	21.9	29.5	23.7	33.2	29.8	20.3	23.2	42.7	19.8	24.9	32.8	28.3	48.2	7.1	25.4	36.5	44.9	83.6	21.8	15.9	18.4	66.1	26.1	42.3	17.0	17.7	38.5	20.8	56.0	15.9	15.8	17.3	29.4	45.2	21.5	17.7	24.7	16.3	28.6	34.9	22.2	94.7	13.6	39.4	16.3	0.7	5.8	4.2	8.9	6.2	7.9	5.6	7.6	8.4	6.0	4.1	7.5	5.4	2.6	8.3	10.9	4.2	11.2	6.6	36.3	36.2	36.0	42.2	34.7	34.8	34.3	34.5	34.4	33.0	34.1	37.0	0.6	22.4	24.8	8.5	4.8	0.0	0.3	0.2	7.4	1.2	0.3	0.4	1.5	0.0	3.2	0.0	4.2	0.2	1.1	1.6	0.0	0.4	0.0	1.0	1.1	2.1	1.2	8.8	14.2	0.0	0.4	2.6	15.3	1.3	3.8	0.8	1.4	0.2	0.4	0.0	12.6	0.4	0.0	0.3	0.3	0.2	0.3	4.5	0.0	11.2	0.0	0.7	1.0	8.5	13.6	0.3	1.2	0.0	8.3	0.2	2.0	0.1	4.4	1.2	6.6	1.0	0.9	0.2	0.2	8.3	0.1	0.0	5.5	0.8	0.4	0.1
EDF1	"CFAP280, EDF-1"	ENSG00000107223	"Endothelial differentiation related factor 1"	O60869	9	136862119-136866308	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	"Activator, Calmodulin-binding, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 2662.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035642	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 22: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"HPA035642: AB_10611959"	"unprognostic (2.07e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.58e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.65e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.15e-1)"	305.1	423.1	401.9	234.1	403.4	299.6	315.7	408.4	511.3	359.2	392.1	355.4	494.2	280.8	211.9	462.9	281.6	192.2	519.3	404.5	420.1	430.0	668.7	279.5	273.3	415.5	412.3	394.2	715.5	289.9	395.9	202.8	412.2	430.3	206.9	105.1	497.8	230.7	497.6	407.3	486.4	162.7	401.3	309.8	399.1	179.5	405.5	231.3	396.3	321.6	242.2	286.6	343.4	418.0	496.0	646.9	355.3	361.3	342.6	358.5	693.9	555.9	370.3	438.7	339.8	528.1	335.9	429.6	503.5	484.3	392.3	585.0	277.0	424.5	159.7	467.6	338.4	300.4	784.0	727.5	680.2	518.7	394.9	357.4	533.8	344.9	396.9	408.1	426.7	382.7	443.0	540.6	379.7	1071.4	465.6	818.8	375.6	761.1	548.0	404.2	517.5	875.8	592.2	515.4	450.8	433.3	579.8	807.6	587.1	231.9	781.1	715.8	526.6	477.5	363.8	524.5	528.0	311.5	555.7	366.6	625.8	305.7	448.8	290.4	378.6	327.2	351.6	334.9	388.7	430.9	373.6	364.9	379.2	400.3	328.8	343.7	149.3	396.7	282.8	621.6	471.0	544.4	401.9	403.4	408.4	511.3	404.5	420.1	415.5	412.3	412.2	401.3	405.5	418.0	375.9	227.6	290.8	27.1	357.5	522.1	601.8	717.4	314.1	139.5	530.5	691.1	336.9	480.4	421.8	314.5	39.6	683.0	405.4	1157.4	1154.3	668.1	148.4	266.8	317.2	365.7	443.4	277.0	19.1	1274.9	768.6	332.7	349.7	320.2	291.1	386.5	404.8	822.2	571.2	94.2	20.8	1032.8	376.4	394.7	535.9	292.1	581.6	323.0	526.5	15.9	787.1	352.5	460.3	23.1	39.0	1103.5	1413.9	426.5	409.6	625.2	2662.5	1566.5	314.5	155.6	276.1	389.0	469.0	238.7	237.4	408.3	620.3	1127.5	377.8	364.3	764.7	682.5
EDRF1	"C10orf137, DKFZp586F1019, FLJ21617"	ENSG00000107938	"Erythroid differentiation regulatory factor 1"	Q3B7T1	10	125719515-125764143	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 145.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031820			Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Centrosome, Cytosol"	"HPA031820: AB_10600753"	"unprognostic (2.10e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.64e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.84e-4)"	"unprognostic (4.76e-3)"	"unprognostic (8.67e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.63e-3)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (3.16e-5)"	"unprognostic (3.44e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.68e-3)"	4.1	4.0	2.0	6.1	2.7	21.8	5.6	5.3	2.9	5.6	2.7	4.0	5.0	7.4	4.9	4.7	4.6	4.1	5.1	2.9	2.0	3.6	2.8	4.2	9.7	1.7	1.7	8.0	7.2	4.3	2.9	5.7	2.3	6.8	5.2	4.6	12.3	4.1	5.7	5.1	4.5	5.2	1.5	5.4	4.7	15.1	1.7	9.4	5.2	5.1	8.2	4.4	3.3	4.1	12.6	11.7	15.4	16.5	7.2	10.0	7.8	14.8	13.6	16.3	18.5	15.7	10.4	16.5	6.9	9.6	9.5	15.3	22.6	4.7	18.0	10.3	18.3	12.0	12.5	8.9	9.6	17.0	12.1	6.5	6.0	16.2	8.1	15.6	7.8	8.9	11.1	11.2	10.6	5.3	16.9	11.8	20.6	7.7	10.2	14.0	13.2	9.7	6.5	7.2	7.6	14.9	10.7	5.9	10.1	13.9	10.3	6.8	5.4	8.8	9.6	12.4	17.1	15.0	11.4	26.1	9.3	8.8	5.0	5.9	2.3	1.4	2.7	2.0	3.4	3.1	2.2	2.5	3.0	2.3	2.2	2.8	2.9	2.9	1.3	2.9	3.1	1.4	2.0	2.7	5.3	2.9	2.9	2.0	1.7	1.7	2.3	1.5	1.7	4.1	12.4	12.8	9.7	26.1	19.1	5.9	5.7	5.1	15.4	23.9	9.3	8.4	12.9	8.6	9.0	11.0	33.3	6.7	28.5	5.1	0.0	4.3	145.1	11.2	14.6	9.5	4.2	7.6	40.9	7.2	6.0	12.1	17.3	27.2	20.3	24.7	7.5	7.0	4.1	20.2	31.7	7.5	4.1	7.7	4.2	61.5	21.1	9.2	7.2	22.5	12.2	9.1	13.4	22.1	36.2	8.3	4.9	19.9	27.1	6.6	7.1	2.7	8.6	24.4	6.6	13.0	11.0	26.8	21.4	10.6	8.2	4.5	20.1	18.5	7.3	5.2
EEF1AKMT2	"C10orf138, Efm4, METTL10"	ENSG00000203791	"EEF1A lysine methyltransferase 2"	Q5JPI9	10	124748149-124791887	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 29.1;Distal tubular cells: 66.5;Extravillous trophoblasts: 29.8;Proximal tubular cells: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA050138	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear bodies, Vesicles, Cytosol"	"HPA050138: AB_2681030"	"unprognostic (1.64e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.75e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.29e-3)"	"unprognostic (9.04e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (3.90e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (9.09e-2)"	4.8	3.8	3.0	2.1	3.3	3.6	5.3	4.8	4.2	4.6	3.0	3.7	1.8	4.0	4.6	4.0	3.8	2.1	4.1	3.1	3.0	4.9	5.2	3.3	2.5	2.8	3.1	5.5	4.4	4.5	4.3	2.7	2.8	4.3	3.8	2.5	5.1	2.8	4.0	5.0	3.5	2.6	2.7	3.5	3.7	5.6	2.8	3.3	5.1	3.3	3.1	3.4	4.2	3.6	12.6	3.3	4.8	8.0	3.1	8.0	3.1	5.8	7.6	7.4	6.5	4.3	7.1	8.4	3.0	4.7	2.5	3.8	6.8	4.2	11.5	7.0	2.5	6.8	4.2	3.9	6.0	10.9	4.1	3.9	3.9	4.1	9.9	6.2	4.7	7.0	7.6	9.3	9.3	3.7	5.2	8.5	5.9	4.6	4.8	2.3	5.7	2.6	4.6	2.7	1.5	3.8	3.7	6.2	8.7	3.3	5.4	8.5	5.8	2.7	2.9	4.5	8.8	4.3	3.7	6.8	4.9	5.7	3.9	0.8	1.0	1.6	1.6	1.1	2.5	1.9	1.6	2.0	1.2	1.3	2.2	1.6	0.1	4.4	0.8	1.5	1.9	1.1	3.0	3.3	4.8	4.2	3.1	3.0	2.8	3.1	2.8	2.7	2.8	3.6	23.2	3.2	11.3	0.0	8.9	0.0	0.0	0.0	0.0	0.0	20.5	22.4	0.0	0.0	2.5	11.0	0.0	29.1	13.4	0.0	66.5	20.0	0.0	11.4	11.8	7.5	0.0	0.0	0.0	20.4	29.8	10.4	0.0	10.5	2.5	17.8	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	11.4	0.0	0.0	0.0	0.0	19.8	0.0	0.0	2.8	0.0	0.0	30.5	3.6	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	17.1	7.1	14.7	0.0	0.0
EEF1AKMT4		ENSG00000284753	"EEF1A lysine methyltransferase 4"	P0DPD7	3	184249672-184258759	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 9.9;Breast myoepithelial cells: 11.7;Distal tubular cells: 15.6;Ductal cells: 14.7;Exocrine glandular cells: 15.3;Pancreatic endocrine cells: 9.2;Proximal tubular cells: 21.2"					"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062215			Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"		"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"		"HPA062215: AB_2684714"																		2.4	3.0	1.0	4.1	1.0	5.0	4.3	3.9	1.6	3.1	1.3	5.6	5.3	1.6	1.4	6.1	1.8	2.2	2.0	0.9	1.7	2.9	14.0	2.0	4.3	1.4	1.2	0.7	12.7	4.8		6.0	1.3	1.9	5.3	0.4	6.6	2.0	2.3	5.3	3.4	3.2	1.2	2.0	3.8	11.4	1.4	4.5	7.2	5.4	5.0	6.2		1.0	50.8	29.9	5.1	17.3	9.9	6.8	41.2	6.4	12.5	10.0	9.4	56.9	7.9	63.7	40.2	7.2	41.8	19.5	31.1	32.2	5.6	23.8	36.9	17.1	18.1	36.8	12.1	43.8	12.8	8.5	39.0	10.8	19.1	3.3	8.2	20.8	33.0	54.7	4.8	84.2	18.6	54.9	11.7	71.0	52.1	32.6	7.0	53.4	11.8	11.2	26.8	9.7	10.8	95.1	24.6	9.2	76.0	21.4	5.8	7.5	11.5	22.4	30.2	33.1	74.5	64.6	7.0	74.9	10.0	0.0	22.9	2.5	8.0	19.1	8.8	8.8	8.4	7.8	19.4	6.5	5.8	9.2	0.5	7.3	13.3	17.5	15.5	10.9	1.0	1.0	3.9	1.6	0.9	1.7	1.4	1.2	1.3	1.2	1.4	1.0	3.8	0.0	2.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	9.9	11.7	0.0	0.0	3.1	7.3	0.0	0.0	1.7	0.0	15.6	14.7	0.0	1.8	3.5	2.1	0.0	0.0	0.0	15.3	0.0	1.5	0.0	2.0	1.3	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.8	0.0	0.0	21.2	1.5	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	1.0	6.7	0.0	0.0
EEF1AKNMT	"CGI-01, DFNM1, FEAT, KIAA0859, METTL13"	ENSG00000010165	"EEF1A lysine and N-terminal methyltransferase"	Q8N6R0	1	171781660-171814023	"Disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 8.1;Cytotrophoblasts: 16.9;Extravillous trophoblasts: 22.3;Hofbauer cells: 17.5;Syncytiotrophoblasts: 9.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044498, HPA053705"	Approved		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA044498: AB_10960884, HPA053705: AB_2682235"	"unprognostic (1.05e-2)"	"unprognostic (3.68e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.78e-1)"	"unprognostic (4.40e-1)"	"prognostic unfavorable (5.68e-4)"	"unprognostic (1.86e-1)"	"unprognostic (3.12e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.65e-1)"	"unprognostic (4.12e-1)"	"unprognostic (6.86e-3)"	"unprognostic (7.49e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.13e-1)"	10.5	12.6	8.0	11.3	8.6	8.2	11.1	9.4	8.3	10.5	8.2	10.7	12.1	10.2	18.6	9.8	12.1	7.1	9.4	7.8	8.4	10.0	10.4	9.6	13.8	9.1	8.3	11.0	10.0	10.6	5.4	9.0	8.3	9.4	11.4	6.2	10.2	10.4	16.4	11.2	11.2	11.5	8.7	11.3	10.0	13.0	8.9	13.2	9.3	13.1	14.2	10.1	8.5	9.2	27.3	63.3	16.7	17.2	23.1	20.7	44.7	33.5	26.2	39.5	30.7	48.2	27.5	49.5	39.3	22.9	26.0	27.3	51.3	26.8	31.2	32.4	29.1	34.3	33.0	21.3	17.0	46.2	33.4	18.5	24.5	41.1	17.7	18.1	23.9	26.6	69.7	16.6	30.3	20.7	36.9	31.3	63.6	54.0	84.1	33.3	21.9	45.8	22.7	27.7	27.3	37.5	25.3	56.8	31.0	40.3	42.0	39.8	19.8	26.6	24.4	27.6	40.0	42.7	51.2	56.7	20.2	31.5	24.5	1.6	8.0	3.0	8.3	7.7	9.6	8.4	8.3	7.1	7.7	6.1	7.4	10.0	2.3	10.5	7.1	8.9	6.7	7.5	8.0	8.6	9.4	8.3	7.8	8.4	9.1	8.3	8.3	8.7	8.9	9.2	1.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	16.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	22.3	3.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	9.6	0.3	0.0	0.0	0.0
EEF1E1	"AIMP3, P18"	ENSG00000124802	"Eukaryotic translation elongation factor 1 epsilon 1"	O43324	6	8073360-8102559	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 244.3;Late spermatids: 231.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA027901, HPA057866"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		18000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA027901: AB_10611960, HPA057866: AB_2683547"	"unprognostic (9.39e-3)"	"prognostic favorable (3.16e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.42e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (1.55e-7)"	"unprognostic (1.79e-1)"	"unprognostic (5.67e-2)"	"prognostic favorable (3.24e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-1)"	15.5	29.6	26.6	21.5	26.4	57.8	26.5	33.5	33.4	14.9	24.2	18.4	12.0	19.3	26.3	22.6	15.0	13.6	19.1	27.0	31.5	50.6	20.3	13.8	31.7	30.7	34.6	14.7	28.3	31.3	23.9	17.3	31.6	17.8	20.9	25.4	20.0	18.2	22.8	12.3	12.7	19.2	26.7	16.4	23.0	57.5	30.5	25.9	20.6	24.7	31.2	26.4	13.9	30.0	129.5	67.1	104.8	71.9	35.0	56.5	63.6	105.7	67.0	94.4	97.0	111.8	52.5	140.9	229.3	69.8	169.8	51.9	122.3	123.9	156.8	79.6	160.6	113.9	92.0	196.4	63.9	228.2	79.2	47.4	113.5	117.4	116.2	66.4	136.2	113.8	283.3	35.9	91.2	54.0	98.0	183.2	95.8	123.9	107.8	117.9	61.0	221.0	156.3	98.5	156.7	48.0	45.6	100.5	131.9	141.5	79.7	75.7	70.2	77.0	76.7	70.7	156.3	58.4	290.7	199.3	43.1	95.8	126.0	16.2	22.2	14.2	25.7	31.8	36.8	42.9	34.4	34.8	61.2	46.9	38.1	39.5	2.3	30.7	25.5	26.8	45.8	29.3	26.6	26.4	33.5	33.4	27.0	31.5	30.7	34.6	31.6	26.7	30.5	30.0	31.9	16.0	30.0	0.0	39.7	65.9	61.4	99.1	60.3	34.4	43.1	54.1	23.5	21.5	63.4	60.7	10.4	78.7	23.5	11.8	140.8	67.9	244.3	59.0	31.0	34.1	40.1	43.5	0.0	89.0	76.6	30.8	32.1	71.0	15.8	45.4	24.3	30.0	49.7	30.3	0.0	36.6	75.3	31.1	33.4	231.1	26.4	31.3	42.7	0.0	32.6	44.7	29.9	0.0	0.0	69.0	12.9	23.7	48.0	81.3	7.5	186.7	45.9	21.8	13.1	32.8	38.9	131.2	92.2	59.3	76.1	32.3	34.1	69.9	42.0	44.8
EFCAB10		ENSG00000185055	"EF-hand calcium binding domain 10"	A6NFE3	7	105565120-105600875	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 29.7;testis: 23.5"	"Group enriched"	"Detected in some"	11	"Early spermatids: 205.9;Endometrial ciliated cells: 138.5;Late spermatids: 78.7;Respiratory ciliated cells: 243.9;Spermatocytes: 96.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA019751	Uncertain					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA019751: AB_1848011"	"unprognostic (1.20e-1)"	"unprognostic (2.24e-3)"	"unprognostic (8.96e-2)"	"unprognostic (4.76e-3)"	"unprognostic (4.11e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.58e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.42e-3)"	"unprognostic (6.87e-2)"	"unprognostic (3.07e-9)"	"unprognostic (2.13e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.67e-2)"	0.5	0.5	1.0	0.6	2.0	2.4	0.5	1.7	1.3	1.6	11.1	0.6	0.5	1.0	0.2	0.8	29.7	0.2	0.5	1.7	2.3	0.9	1.0	3.2	0.8	5.4	6.9	0.9	1.4	0.0	2.1	0.2	3.8	0.9	0.3	1.3	0.8	0.0	1.2	1.1	0.7	0.0	3.8	1.1	0.6	23.5	3.0	0.1	0.7	0.0	0.1	0.5	0.6	2.4	1.4	3.8	2.0	1.3	0.3	0.1	0.8	1.8	0.0	0.0	0.1	0.7	0.9	1.9	1.6	0.0	0.3	0.5	0.0	0.0	0.0	0.7	3.4	0.9	3.0	2.1	0.2	1.2	1.2	0.1	0.0	0.0	0.0	1.2	0.0	0.9	2.8	1.5	0.0	2.9	1.3	2.5	3.4	0.9	1.4	0.9	2.1	4.1	0.2	0.8	1.8	2.5	1.1	3.9	0.6	2.5	0.7	1.4	1.0	1.9	1.3	4.0	1.2	2.1	2.7	1.7	1.1	1.9	0.9	1.0	0.3	0.2	0.4	0.2	0.4	0.3	0.4	0.3	0.1	0.6	0.6	0.5	0.3	0.3	0.2	0.4	0.3	0.1	1.0	2.0	1.7	1.3	1.7	2.3	5.4	6.9	3.8	3.8	3.0	2.4	0.1	0.0	4.4	0.3	0.2	0.0	0.1	11.8	0.0	0.7	0.2	0.3	0.3	0.0	13.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	205.9	138.5	1.2	0.3	0.0	0.0	3.4	0.0	0.1	0.3	0.0	2.2	0.0	0.1	0.0	0.0	0.1	0.0	2.1	0.0	6.1	0.0	0.0	78.7	2.5	0.4	0.0	0.0	0.0	0.1	0.0	1.5	0.7	0.0	0.0	1.5	0.8	0.2	0.0	0.5	243.9	0.2	0.0	0.6	3.5	96.3	2.5	0.0	0.0	0.1	0.5	0.1	0.0	0.1
EFTUD2	"SNRNP116, Snrp116, Snu114, U5-116KD"	ENSG00000108883	"Elongation factor Tu GTP binding domain containing 2"	Q15029	17	44849948-44899445	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022021	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		94000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Vesicles, Cytosol"	"HPA022021: AB_1848032"	"unprognostic (4.28e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (2.71e-6)"	"unprognostic (6.94e-2)"	"unprognostic (4.52e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.11e-3)"	"unprognostic (5.19e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.62e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.53e-2)"	23.6	30.7	26.7	31.3	27.2	37.4	22.4	24.6	28.0	17.6	27.9	26.5	21.6	19.4	18.8	33.1	25.0	16.3	35.3	28.0	26.3	26.1	26.2	22.6	35.5	25.6	26.1	17.6	24.0	27.9	13.2	28.6	26.4	17.8	28.8	15.5	22.5	18.6	65.8	28.5	22.8	23.5	25.1	29.8	22.5	27.5	27.3	41.0	21.2	38.3	46.5	28.8	20.3	26.6	88.7	173.6	82.8	134.9	61.9	60.9	97.1	68.7	91.4	169.6	146.0	134.6	73.9	152.1	79.0	87.1	130.3	98.6	181.5	120.2	196.2	153.9	150.8	150.9	100.9	144.5	68.2	179.9	107.5	66.5	67.4	157.2	85.0	65.2	149.1	134.8	189.6	57.8	98.0	88.2	182.3	118.6	85.7	206.8	143.1	126.1	168.1	132.0	97.0	97.8	135.7	81.1	67.7	49.5	73.9	120.6	131.6	112.2	91.4	126.5	97.4	77.7	176.3	60.2	81.4	150.0	101.6	98.4	132.0	42.7	84.3	85.9	37.2	81.6	41.7	32.3	32.9	36.1	82.8	31.3	28.8	32.2	13.0	44.2	85.0	35.5	35.2	70.7	26.7	27.2	24.6	28.0	28.0	26.3	25.6	26.1	26.4	25.1	27.3	26.6	11.3	0.0	14.0	11.1	18.1	11.7	12.2	15.1	13.6	14.7	14.1	11.8	21.1	22.8	15.3	18.4	33.3	34.5	14.0	15.6	3.9	29.4	12.5	17.8	17.9	21.4	10.8	24.8	17.5	26.7	30.9	14.0	18.3	18.8	19.7	22.6	21.8	22.4	38.5	26.9	17.2	13.4	16.2	30.1	17.5	6.5	12.8	26.2	5.4	12.2	46.7	12.0	21.6	6.0	15.5	27.7	12.0	9.1	20.3	14.5	15.9	13.2	17.4	18.0	19.7	14.8	14.8	28.2	43.3	16.0	14.6	27.2	16.3	21.4	22.2	12.5
EHMT1	"bA188C12.1, EHMT1-IT1, Eu-HMTase1, FLJ12879, FLJ40292, KIAA1876, KMT1D"	ENSG00000181090	"Euchromatic histone lysine methyltransferase 1"	Q9H9B1	9	137618992-137870016	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 167.0;Plasma cells: 170.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060022, HPA074729"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Nuclear bodies"		"HPA060022: AB_2684190, HPA074729: "	"unprognostic (1.18e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-2)"	"prognostic favorable (6.56e-4)"	"unprognostic (1.03e-1)"	"prognostic favorable (8.91e-4)"	"unprognostic (5.87e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.18e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.55e-3)"	"unprognostic (2.01e-2)"	"unprognostic (6.58e-3)"	"unprognostic (4.24e-1)"	"unprognostic (7.12e-3)"	"unprognostic (7.75e-2)"	17.7	18.3	11.0	22.3	12.0	30.5	18.2	16.0	12.3	17.0	13.8	19.3	18.8	21.5	9.7	19.1	18.1	14.0	13.5	8.6	8.3	11.0	14.4	15.8	29.6	10.7	10.2	19.9	14.9	13.8	12.9	15.0	11.1	16.2	13.1	13.7	18.4	13.9	31.4	19.3	19.6	15.1	4.4	25.9	18.2	40.5	12.7	22.9	19.6	15.0	21.2	18.3	16.2	19.9	26.7	52.3	57.4	53.2	23.9	24.6	48.1	34.5	21.4	24.7	20.2	34.7	32.5	81.6	32.7	26.0	29.9	56.2	34.8	37.8	19.2	45.3	24.7	34.4	54.2	22.4	20.9	52.9	39.5	22.6	25.9	29.9	28.9	18.1	41.3	30.1	52.6	27.5	17.9	61.9	62.5	26.3	56.0	42.1	34.8	79.3	49.5	47.2	20.7	47.7	50.6	41.1	65.4	45.4	15.3	40.6	51.1	42.0	39.0	28.9	29.5	44.8	33.2	17.2	52.0	67.0	21.3	27.6	32.0	19.5	16.2	21.2	18.0	14.3	11.3	16.4	15.6	15.6	12.9	23.0	14.9	13.5	28.8	17.3	15.6	23.3	14.2	9.7	11.0	12.0	16.0	12.3	8.6	8.3	10.7	10.2	11.1	4.4	12.7	19.9	34.3	19.2	19.2	130.6	64.9	17.5	23.4	26.9	32.5	39.7	30.5	26.7	31.5	25.8	24.7	22.0	52.1	23.8	36.9	24.4	3.9	24.1	86.8	29.3	44.8	29.9	28.1	31.7	74.4	21.0	21.8	27.6	45.3	40.6	18.9	55.8	18.9	41.7	19.7	50.5	76.4	22.2	10.2	25.8	18.1	167.0	35.8	26.9	12.4	71.2	31.2	19.7	51.5	64.3	104.0	25.4	30.3	37.6	170.6	34.9	20.7	14.3	22.6	46.8	13.1	34.7	28.5	80.4	51.9	35.3	20.2	26.5	38.9	81.3	23.8	28.8
EID2	"CRI2, EID-2, MGC20452"	ENSG00000176396	"EP300 interacting inhibitor of differentiation 2"	Q8N6I1	19	39538707-39540161	"Predicted intracellular proteins"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 48.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045477	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA045477: AB_10959785"	"unprognostic (5.91e-2)"	"unprognostic (6.37e-3)"	"prognostic favorable (9.73e-4)"	"unprognostic (5.93e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.52e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.43e-1)"	"unprognostic (6.88e-3)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.51e-1)"	10.5	17.9	13.3	8.8	14.5	6.4	8.5	13.3	19.5	7.7	11.9	9.1	6.8	11.0	8.1	9.2	8.4	6.2	10.1	14.3	15.6	12.6	10.8	8.4	9.1	13.8	11.8	8.4	7.8	12.6	13.0	14.3	14.1	9.0	6.6	15.7	7.7	8.0	11.1	7.4	9.0	9.8	12.5	9.5	8.8	9.0	12.8	14.2	8.3	10.4	8.4	7.8	6.5	12.6	25.0	33.4	31.1	21.2	24.7	15.3	4.6	29.3	22.0	22.5	23.2	21.2	7.7	25.4	23.5	20.6	15.1	10.5	29.0	21.3	29.0	24.6	36.5	11.4	19.1	25.5	24.5	19.9	16.1	18.0	13.3	18.7	14.4	17.8	26.6	49.0	18.8	17.2	19.8	16.5	29.0	17.5	17.4	30.1	14.0	26.6	29.7	11.9	28.9	22.8	29.0	20.6	31.8	12.6	21.0	20.9	17.1	12.9	19.2	14.3	51.0	19.1	22.3	26.9	33.8	32.1	13.3	18.5	11.8	0.0	0.4	0.7	0.8	0.5	0.8	0.5	1.0	1.0	0.5	0.5	1.0	1.4	0.1	0.3	0.5	0.5	0.2	0.4	13.3	14.5	13.3	19.5	14.3	15.6	13.8	11.8	14.1	12.5	12.8	12.6	16.4	19.2	9.2	2.6	7.3	10.1	4.5	2.4	6.2	23.9	11.2	15.6	19.1	17.2	4.0	14.7	10.4	48.9	14.0	6.5	1.9	5.2	3.2	18.3	23.3	14.4	7.2	4.2	7.4	5.0	5.3	10.0	5.1	12.4	1.3	14.4	13.2	12.9	10.8	26.9	8.0	5.3	0.0	8.1	6.5	1.3	10.2	7.8	8.8	3.7	7.5	31.1	12.3	5.0	8.6	6.2	7.4	13.2	7.2	5.3	5.9	9.5	5.5	20.7	6.6	9.7	12.7	11.3	8.8	5.2	7.5	19.4	11.3	25.2	7.5	2.6
EID2B	"EID-3, FLJ38944"	ENSG00000176401	"EP300 interacting inhibitor of differentiation 2B"	Q96D98	19	39530987-39532852	"Predicted intracellular proteins"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 30.1;Horizontal cells: 32.0;NK-cells: 27.8;Rod photoreceptor cells: 30.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA064185	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 62: Horizontal cells - Visual perception"			"HPA064185: AB_2685207"	"unprognostic (1.15e-1)"	"unprognostic (8.53e-3)"	"unprognostic (6.41e-3)"	"unprognostic (1.08e-3)"	"unprognostic (4.00e-1)"	"unprognostic (7.08e-2)"	"unprognostic (9.92e-4)"	"unprognostic (2.45e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.29e-1)"	"prognostic favorable (2.57e-4)"	"unprognostic (6.80e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.20e-2)"	2.4	3.6	7.2	2.0	6.9	1.2	2.0	7.8	7.1	3.9	4.5	3.7	1.3	4.1	2.6	1.1	4.1	1.2	3.0	6.4	9.4	2.6	1.0	2.2	3.1	5.1	5.7	5.1	1.4	1.8	10.3	1.1	5.8	2.9	0.9	9.4	1.3	2.0	2.1	1.0	2.5	1.5	4.7	3.3	1.9	5.2	8.1	2.5	3.6	1.2	1.5	3.0	2.3	5.5	2.0	4.1	4.6	5.1	2.9	2.7	1.0	3.1	2.4	5.0	4.5	0.6	1.3	4.0	1.7	1.9	2.5	0.6	2.3	2.1	3.7	6.3	6.3	1.8	5.3	2.5	2.5	1.8	3.1	2.7	1.5	2.8	1.4	1.9	2.2	8.9	2.0	5.6	2.5	1.8	3.6	3.1	1.2	0.7	2.2	4.6	4.2	2.0	2.5	0.6	6.3	3.9	6.1	0.2	2.5	1.8	0.5	1.0	1.5	3.7	6.6	3.6	4.1	4.0	6.1	3.0	2.0	4.3	2.0	0.4	1.9	3.9	2.8	2.1	2.7	3.6	3.5	4.1	2.4	3.1	6.5	4.3	0.6	4.6	2.2	2.4	2.4	2.1	7.2	6.9	7.8	7.1	6.4	9.4	5.1	5.7	5.8	4.7	8.1	5.5	3.9	6.4	1.1	3.9	8.5	1.5	1.3	3.5	1.8	30.1	1.6	2.7	5.5	7.2	6.3	9.2	25.0	3.0	6.4	0.2	11.7	4.0	1.8	5.3	6.0	4.3	6.1	4.6	9.0	3.0	1.2	6.3	2.0	0.7	4.5	9.1	3.3	1.8	3.7	32.0	9.2	0.5	4.1	4.1	5.3	1.2	15.2	4.6	8.8	4.7	5.5	23.2	27.8	3.0	5.5	1.8	1.3	11.3	5.6	0.6	0.2	4.9	10.8	30.2	13.1	3.5	5.3	22.1	8.8	0.5	0.6	0.8	7.8	8.0	0.1	0.4
EIF1AX	"eIF-1A, eIF-4C, EIF1A, EIF4C"	ENSG00000173674	"Eukaryotic translation initiation factor 1A X-linked"	P47813	X	20124525-20141838	"Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002561	Uncertain	Supported	Approved	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA002561: AB_1078724"	"unprognostic (1.91e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.26e-3)"	"unprognostic (7.13e-3)"	"unprognostic (2.22e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.02e-3)"	"unprognostic (2.82e-2)"	"unprognostic (4.73e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.23e-3)"	"unprognostic (7.81e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.52e-1)"	61.2	42.9	27.1	47.9	29.2	61.6	58.2	36.8	38.3	45.1	23.0	46.5	43.9	57.9	28.5	49.7	42.2	26.7	47.4	27.9	29.3	58.0	62.0	35.0	44.5	29.3	28.9	66.9	50.6	46.6	19.8	40.1	28.3	36.2	31.6	45.3	49.9	30.8	80.0	42.1	37.3	49.6	32.2	33.7	45.7	30.4	30.4	41.4	48.4	50.4	33.9	42.6	49.2	35.7	233.3	128.4	96.9	129.8	92.5	124.8	78.8	202.6	73.9	108.3	84.9	186.2	108.2	215.5	132.2	134.9	101.4	97.6	172.8	175.9	167.8	88.8	284.5	95.7	148.9	160.1	64.5	257.8	129.5	59.1	105.2	167.4	260.2	71.4	153.3	68.9	252.3	117.6	107.9	113.2	160.3	160.6	252.1	97.5	211.0	129.8	222.3	232.0	85.1	127.7	112.1	124.9	215.0	165.8	139.0	138.8	134.6	108.0	88.3	130.8	81.6	430.8	153.6	79.9	163.3	255.7	89.5	116.1	101.2	36.3	41.0	27.4	47.8	46.5	64.1	69.0	54.4	57.2	41.2	66.4	62.6	52.8	10.7	64.5	47.1	68.1	47.6	52.6	27.1	29.2	36.8	38.3	27.9	29.3	29.3	28.9	28.3	32.2	30.4	35.7	205.4	105.8	116.7	22.2	167.5	474.9	354.9	172.6	178.2	164.0	226.5	212.2	100.2	161.5	154.5	115.8	93.8	191.4	231.5	131.6	187.9	213.6	450.5	210.5	310.1	161.2	167.2	135.2	40.5	230.4	453.8	208.6	107.6	321.9	164.0	140.7	137.4	329.9	196.3	102.6	43.2	213.5	120.1	137.9	230.1	132.2	144.1	157.3	154.7	35.6	118.2	181.3	68.0	23.6	48.0	251.0	140.1	145.2	176.7	469.7	152.2	301.4	93.2	140.4	144.7	288.6	213.9	52.9	101.1	245.4	570.1	227.0	170.5	149.6	288.5	377.0
EIF2AK1	"HRI, KIAA1369"	ENSG00000086232	"Eukaryotic translation initiation factor 2 alpha kinase 1"	Q9BQI3	7	6022247-6059175	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Protein synthesis inhibitor, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Cytotrophoblasts: 219.1;Erythroid cells: 422.0;Syncytiotrophoblasts: 371.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016496, CAB022082, HPA061675"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	Cytosol	"CAB022082: , HPA016496: AB_1848057, HPA061675: AB_2684583"	"unprognostic (7.15e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.70e-2)"	"unprognostic (9.69e-3)"	"prognostic unfavorable (6.99e-4)"	"unprognostic (2.36e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.06e-2)"	27.2	39.4	28.1	27.7	28.9	105.9	35.9	30.6	36.1	29.0	34.9	48.8	37.1	25.0	37.4	30.4	31.0	23.8	33.8	28.1	30.6	43.8	65.1	30.3	35.2	30.5	28.9	29.3	44.3	78.0	25.9	52.3	31.6	35.0	47.3	29.0	46.8	24.2	38.3	33.3	37.2	23.8	29.1	26.6	49.1	19.5	29.8	43.6	39.3	34.4	40.4	27.2	22.4	33.7	144.5	90.5	71.2	108.8	66.4	59.6	92.4	73.0	66.8	64.2	80.8	83.7	96.2	112.5	77.4	81.3	115.5	100.4	93.1	67.1	82.2	69.8	140.3	115.9	91.6	127.3	54.3	100.8	102.0	48.1	82.8	60.7	64.9	67.7	69.4	88.1	189.0	106.8	61.4	146.5	55.6	128.6	88.5	84.6	99.7	120.0	74.6	134.0	82.3	70.3	87.3	156.5	139.3	186.6	63.8	98.6	141.0	122.4	65.9	37.0	134.2	65.3	78.2	106.5	114.8	115.6	73.9	129.8	108.7	11.1	6.9	17.3	8.2	5.5	5.6	12.3	6.5	9.3	6.9	9.5	7.5	6.6	3.7	10.2	6.2	6.0	8.9	4.8	28.1	28.9	30.6	36.1	28.1	30.6	30.5	28.9	31.6	29.1	29.8	33.7	23.1	38.5	43.7	14.4	42.8	23.8	34.9	34.3	41.5	29.7	52.5	34.9	49.6	45.8	37.7	44.1	16.7	219.1	52.5	57.1	66.5	55.0	8.8	59.5	42.3	27.5	38.5	422.0	21.8	44.8	82.1	29.7	64.7	48.1	20.8	44.9	21.0	63.2	53.8	32.0	21.9	68.7	54.9	39.0	29.9	16.1	34.5	65.2	24.9	13.1	62.8	46.4	70.0	19.1	26.9	53.0	47.0	37.6	60.1	43.3	47.5	66.1	48.3	26.5	13.1	32.0	26.0	33.7	34.5	45.5	22.4	371.0	38.0	57.1	52.7	32.3
EIF2B3	"EIF-2B, EIF2Bgamma"	ENSG00000070785	"Eukaryotic translation initiation factor 2B subunit gamma"	Q9NR50	1	44850522-44986722	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024213, HPA024218, HPA024219"	Supported		Supported	Vesicles,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Vesicles, Cytosol"		"HPA024213: AB_1848067, HPA024218: AB_1848068, HPA024219: AB_1848069"	"unprognostic (2.12e-2)"	"unprognostic (7.49e-2)"	"unprognostic (4.37e-3)"	"unprognostic (5.14e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.45e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (4.55e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.98e-2)"	"unprognostic (7.80e-2)"	"unprognostic (5.69e-3)"	"unprognostic (2.73e-2)"	23.6	27.2	11.4	11.6	10.9	10.9	21.9	13.2	15.6	18.7	10.1	17.5	8.6	17.0	12.5	17.4	16.3	9.6	40.6	11.2	11.6	15.4	24.7	13.5	14.3	11.9	12.1	18.2	16.9	30.0	15.8	9.7	12.8	15.0	13.4	19.0	25.1	13.7	77.0	17.6	10.7	19.4	11.0	14.9	14.2	19.3	11.2	13.3	12.5	48.0	14.5	17.7	17.1	14.0	35.4	26.9	30.9	25.5	36.3	43.1	36.2	56.1	42.2	56.5	52.9	39.0	20.7	90.6	39.9	43.2	45.0	20.6	65.3	48.6	69.5	32.5	58.1	44.3	29.3	38.4	46.2	71.2	24.3	29.3	25.8	61.0	69.9	26.5	52.8	30.1	106.1	31.6	62.3	23.1	69.7	30.2	42.0	38.8	52.7	54.7	51.3	65.7	28.7	15.7	53.2	20.5	55.1	63.8	37.4	40.7	24.7	32.8	28.3	35.9	42.9	53.4	73.7	31.6	37.9	68.9	27.9	59.5	43.1	1.6	23.4	3.9	18.6	37.2	22.8	14.8	18.3	21.1	37.0	18.9	22.9	23.6	2.1	25.5	33.1	25.3	17.6	21.4	11.4	10.9	13.2	15.6	11.2	11.6	11.9	12.1	12.8	11.0	11.2	14.0	13.9	6.4	22.0	24.8	15.8	13.8	19.0	33.0	10.8	15.1	15.8	16.8	79.2	15.7	24.9	5.5	20.9	25.1	12.1	4.5	29.4	18.9	26.1	17.0	23.0	14.4	3.6	15.3	39.9	15.8	22.6	22.6	13.7	11.5	25.9	21.1	3.9	22.6	24.8	21.9	44.5	7.0	20.3	10.7	11.2	11.3	26.4	15.4	17.8	26.2	30.1	21.7	10.3	29.1	35.7	13.7	6.9	25.2	22.6	17.1	5.7	23.1	34.2	21.8	26.3	19.7	45.4	45.5	23.6	17.1	14.9	14.9	13.5	40.4	9.4	13.9
EIF2B4	"DKFZP586J0119, EIF-2B, EIF2B, EIF2Bdelta"	ENSG00000115211	"Eukaryotic translation initiation factor 2B subunit delta"	Q9UI10	2	27364352-27370457	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 196.4;Late spermatids: 299.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032234, HPA039993, HPA068855"	Approved		Approved	"Nuclear membrane,Actin filaments"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear membrane"	"Actin filaments"	"CAB032234: AB_668909, HPA039993: AB_2676790, HPA068855: "	"unprognostic (2.26e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.00e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.63e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (3.64e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.56e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (5.46e-8)"	"unprognostic (1.79e-1)"	"unprognostic (1.70e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.67e-2)"	21.4	24.8	23.3	15.2	24.3	10.7	20.7	24.0	23.8	21.3	22.5	31.7	14.6	21.0	16.9	27.8	20.3	13.4	28.0	23.2	23.7	18.2	21.5	18.1	17.2	24.4	24.3	19.8	31.4	20.4	20.3	18.8	24.0	25.4	18.4	19.3	24.6	20.8	51.8	29.3	18.4	22.8	23.2	18.6	24.7	38.1	24.4	18.9	18.1	35.2	22.9	24.1	21.4	24.1	38.7	59.8	44.3	34.6	58.4	42.7	48.4	41.0	43.7	55.7	37.3	89.2	16.9	49.7	38.7	48.7	46.6	27.6	62.5	50.8	36.2	37.4	40.7	61.7	39.3	104.5	51.1	58.2	23.0	41.3	51.1	69.2	51.6	40.4	53.3	37.2	59.5	24.9	53.0	35.2	28.8	61.7	49.1	59.8	38.9	52.9	69.9	43.2	50.0	32.7	34.3	37.4	34.1	53.8	42.6	39.6	31.3	23.4	52.8	40.1	47.0	35.4	49.7	50.9	65.7	74.7	33.9	47.9	38.6	56.6	53.9	38.8	32.1	48.1	44.6	31.1	31.6	32.6	52.5	25.3	30.2	32.9	7.7	30.8	52.2	38.6	43.8	43.2	23.3	24.3	24.0	23.8	23.2	23.7	24.4	24.3	24.0	23.2	24.4	24.1	19.9	12.8	14.8	9.8	17.5	35.9	18.9	32.0	15.4	22.6	28.0	18.7	33.0	14.3	27.0	22.0	66.7	40.9	27.8	23.4	19.6	29.0	196.4	22.3	23.9	19.9	24.0	8.2	6.6	33.4	25.0	24.6	14.8	17.6	31.6	16.9	25.7	34.4	24.3	10.1	6.5	24.8	28.5	20.7	28.0	299.6	23.3	16.5	23.2	2.8	29.5	23.2	16.5	6.0	8.8	26.7	27.1	24.8	28.4	21.2	23.0	27.6	24.9	58.9	19.7	17.0	34.9	71.5	38.9	14.5	34.8	46.1	24.3	23.8	20.5	14.4
EIF2S1	"EIF-2alpha, EIF2, EIF2A"	ENSG00000134001	"Eukaryotic translation initiation factor 2 subunit alpha"	P05198	14	67360328-67386516	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011663, HPA064885"	Supported		Enhanced	Cytosol		NA	NA		210000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB011663: AB_2096478, HPA064885: AB_2685382"	"unprognostic (1.86e-2)"	"unprognostic (8.33e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.46e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.78e-3)"	"prognostic unfavorable (4.73e-7)"	"unprognostic (4.14e-3)"	"unprognostic (4.49e-1)"	"unprognostic (1.68e-2)"	"prognostic unfavorable (4.97e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.65e-1)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (7.11e-4)"	28.3	24.5	12.5	29.9	14.0	25.0	25.7	15.1	17.8	18.1	10.4	25.0	21.5	19.4	19.6	38.8	15.8	21.5	28.7	14.6	14.1	24.5	35.3	18.4	30.4	13.7	12.7	17.1	26.3	22.9	9.4	26.3	13.6	22.1	26.7	21.2	18.3	22.3	49.4	23.7	21.5	27.0	13.8	19.8	19.8	33.4	13.5	27.9	27.9	40.6	33.5	39.1	19.0	16.6	265.7	86.4	59.8	92.3	56.4	63.4	127.8	115.5	68.3	127.4	110.7	101.6	92.2	118.7	57.0	87.4	85.7	100.4	139.1	110.3	192.7	86.9	51.9	76.9	80.0	70.4	59.2	82.7	71.9	52.4	62.6	113.9	172.5	49.8	105.4	73.8	132.6	89.6	127.3	131.3	113.7	64.7	61.1	157.9	142.9	85.7	99.0	84.6	78.2	120.0	85.9	60.7	83.0	96.5	91.1	52.3	164.5	70.8	81.3	167.4	180.7	82.0	124.4	77.0	90.4	180.7	97.1	145.3	110.2	51.4	50.6	33.0	47.4	71.0	58.4	55.4	54.5	51.7	70.1	45.8	50.3	51.5	6.9	58.6	62.8	48.0	64.3	70.7	12.5	14.0	15.1	17.8	14.6	14.1	13.7	12.7	13.6	13.8	13.5	16.6	64.1	28.9	40.2	17.3	44.1	142.8	88.2	77.2	37.5	22.1	32.0	30.1	92.8	30.0	55.8	22.0	12.5	78.7	38.0	23.3	70.5	89.6	81.0	34.6	48.9	60.3	13.1	64.2	21.7	63.0	104.7	51.2	34.1	44.8	35.5	35.7	26.4	39.8	70.4	37.0	20.9	30.6	61.1	37.9	51.3	33.4	31.1	40.7	51.6	15.9	61.3	32.2	36.0	15.1	23.8	70.8	18.3	40.6	56.7	79.9	26.6	65.1	35.0	35.2	26.3	60.7	85.9	204.9	96.3	49.7	130.4	93.4	46.1	57.9	39.7	79.1
EIF2S3	"EIF2, EIF2G, EIF2gamma"	ENSG00000130741	"Eukaryotic translation initiation factor 2 subunit gamma"	P41091	X	24054946-24078810	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Hydrolase, Initiation factor"	"Disease variant, Epilepsy, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											CAB012471	Approved					NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"			"CAB012471: AB_873547"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.46e-3)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.66e-3)"	"unprognostic (6.94e-3)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (5.44e-6)"	"unprognostic (4.88e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-1)"	65.5	51.8	31.9	71.8	33.5	76.2	82.9	35.7	35.4	78.0	42.5	67.2	66.4	83.8	45.0	62.5	79.9	53.3	57.1	31.4	33.0	69.6	74.6	50.7	113.3	35.9	32.2	131.3	94.8	49.6	30.1	46.4	35.7	51.7	66.3	46.9	69.7	41.7	66.7	71.8	53.0	74.3	35.8	72.1	66.7	18.6	34.8	97.6	69.9	51.8	111.6	66.4	65.6	41.4	261.0	256.0	110.3	182.7	113.5	235.5	73.2	142.3	127.4	114.8	130.6	290.8	174.3	449.5	141.0	104.9	251.9	165.1	344.7	271.3	140.8	147.8	203.7	177.2	467.8	164.3	126.2	304.0	219.4	206.9	169.2	129.6	269.7	152.9	166.2	176.0	275.4	176.0	127.7	124.8	170.6	278.8	268.2	118.1	146.5	169.5	215.2	271.4	155.4	241.5	60.2	130.8	232.3	224.7	239.8	205.5	289.6	205.1	140.2	97.1	66.7	177.3	125.3	156.6	322.4	240.9	120.9	193.1	113.7	64.4	141.1	27.9	84.9	151.9	147.8	156.0	148.8	113.9	123.9	120.6	187.5	156.6	51.2	106.3	132.6	97.4	124.2	127.2	31.9	33.5	35.7	35.4	31.4	33.0	35.9	32.2	35.7	35.8	34.8	41.4	76.5	44.8	54.5	48.0	187.6	126.6	98.0	51.8	145.1	25.3	128.4	91.2	49.1	74.4	49.0	40.5	25.0	59.6	127.5	35.2	111.6	67.9	0.5	67.3	109.4	67.5	44.9	92.5	19.0	57.6	122.1	72.3	78.5	90.9	100.8	84.6	84.3	58.8	89.1	20.2	20.1	65.0	32.6	138.9	91.9	3.5	67.7	109.7	55.2	36.5	134.5	30.4	78.2	23.6	31.4	59.5	68.9	61.3	99.3	70.2	72.3	135.2	40.6	33.3	72.3	85.0	87.4	10.2	21.9	130.7	151.2	71.0	117.9	76.2	100.4	92.9
EIF3B	"EIF3S9, PRT1"	ENSG00000106263	"Eukaryotic translation initiation factor 3 subunit B"	P55884	7	2354086-2380745	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017562, HPA048983"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		180000	"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoplasm	"CAB017562: AB_2246341, HPA048983: AB_2680588"	"unprognostic (1.50e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.92e-2)"	"unprognostic (9.45e-3)"	"prognostic unfavorable (2.20e-4)"	"prognostic unfavorable (4.41e-9)"	"unprognostic (4.64e-3)"	"unprognostic (3.68e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.47e-1)"	"prognostic unfavorable (9.66e-6)"	"unprognostic (2.38e-1)"	"unprognostic (7.54e-2)"	"unprognostic (9.00e-2)"	"unprognostic (6.18e-3)"	59.3	54.8	29.4	49.5	31.5	88.8	55.1	31.8	31.7	49.6	31.4	74.3	39.5	55.3	28.4	78.2	53.3	34.8	55.1	31.2	32.1	44.7	60.4	42.2	58.9	33.4	32.6	51.0	83.1	39.6	37.9	51.9	33.6	50.3	44.6	17.7	63.4	42.9	155.2	82.9	48.9	52.5	32.6	56.6	59.1	60.8	32.0	53.5	37.0	65.8	64.6	69.4	53.3	35.2	510.8	253.3	102.9	280.4	113.5	102.4	254.4	174.5	130.2	193.8	180.5	334.4	193.2	293.9	139.8	186.2	273.5	269.9	287.1	229.0	212.5	88.6	334.6	224.8	240.8	227.0	159.2	277.0	159.8	127.5	147.9	210.1	219.2	101.8	157.9	133.9	580.9	133.2	179.7	358.4	134.7	306.9	322.6	176.2	224.4	163.3	208.3	304.2	123.4	228.9	233.9	174.9	184.5	403.4	102.8	178.8	270.0	301.3	169.0	149.0	326.9	231.7	319.4	145.7	210.6	295.6	169.3	303.9	372.5	2.1	7.2	4.0	7.5	7.2	9.4	6.5	7.0	8.2	8.0	6.1	8.4	8.5	0.6	16.9	6.6	8.2	9.5	4.8	29.4	31.5	31.8	31.7	31.2	32.1	33.4	32.6	33.6	32.6	32.0	35.2	43.3	25.6	64.1	19.6	35.9	64.2	55.6	25.4	34.1	37.9	74.0	62.4	37.4	30.0	38.8	27.6	64.6	64.9	52.6	49.0	3.9	35.5	11.6	37.1	57.0	50.9	47.8	56.8	20.1	62.6	63.4	47.6	48.9	48.1	17.1	77.0	63.5	67.0	47.4	52.2	19.5	63.0	14.2	39.5	32.3	23.3	43.8	34.3	16.0	8.4	32.6	45.6	38.1	15.6	19.9	70.9	28.9	37.2	42.3	68.8	33.6	31.0	27.4	44.3	26.3	69.2	48.5	34.4	39.4	63.5	78.3	82.6	34.7	119.4	77.0	50.6
EIF3I	"eIF3-beta, eIF3-p36, EIF3S2, TRIP-1"	ENSG00000084623	"Eukaryotic translation initiation factor 3 subunit I"	Q13347	1	32221077-32245397	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA029939, HPA029940"	Enhanced		Approved	Cytosol		NA	NA		70000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA029939: AB_10611109, HPA029940: AB_10600878"	"unprognostic (4.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.82e-2)"	"prognostic favorable (2.14e-4)"	"unprognostic (3.86e-2)"	"unprognostic (2.32e-2)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (9.26e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (4.81e-6)"	"unprognostic (1.80e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.47e-2)"	123.4	146.6	69.2	109.3	70.2	103.5	164.5	76.9	87.3	126.4	78.7	137.2	96.4	104.4	162.3	154.7	141.7	93.7	127.0	68.6	71.8	123.8	152.8	99.6	134.0	72.8	71.2	154.1	134.8	141.9	78.3	116.2	73.3	113.2	163.5	52.5	127.2	120.4	247.3	119.8	91.0	144.9	72.7	84.7	118.8	48.9	73.6	164.5	131.8	220.5	187.1	158.0	107.1	79.0	404.3	293.3	207.4	463.5	326.9	427.2	209.3	301.3	514.2	517.2	401.5	317.1	418.3	533.0	320.7	514.0	315.9	265.9	498.6	549.9	667.0	234.4	348.1	288.9	245.8	362.7	352.5	559.1	295.4	413.1	471.2	528.0	569.5	363.4	478.8	363.8	699.1	223.4	502.4	276.3	469.3	370.2	624.2	445.4	339.4	344.1	356.3	509.0	515.9	300.9	325.6	343.4	276.6	351.7	562.1	366.6	282.9	270.7	286.4	333.2	360.3	523.8	653.5	377.7	495.7	487.4	365.2	419.6	440.2	113.8	196.6	93.7	164.4	206.7	180.4	182.1	171.8	160.5	235.8	164.9	148.4	140.5	15.2	183.0	162.0	177.0	219.6	299.8	69.2	70.2	76.9	87.3	68.6	71.8	72.8	71.2	73.3	72.7	73.6	79.0	136.9	51.3	76.7	6.8	114.5	136.6	227.6	275.6	84.8	38.0	123.6	114.7	41.9	87.2	136.4	51.5	10.4	300.8	118.2	90.1	133.1	295.4	60.8	79.2	114.2	163.5	138.6	69.0	6.8	272.8	341.4	125.6	71.9	85.1	115.3	120.3	89.6	77.1	224.1	13.5	8.2	184.0	148.5	108.1	131.5	29.5	172.4	108.8	144.1	5.6	190.8	69.9	112.3	7.1	10.7	284.4	115.6	139.2	107.5	173.9	125.9	216.2	99.2	41.8	92.1	108.0	338.3	76.5	76.6	121.8	141.4	342.3	115.1	192.3	213.5	219.9
EIF3M	"FLJ29030, GA17, hfl-B5, PCID1, TANGO7"	ENSG00000149100	"Eukaryotic translation initiation factor 3 subunit M"	Q7L2H7	11	32583798-32606264	"Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031063	Approved		Approved	Cytosol		NA	NA		130000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA031063: AB_10602128"	"unprognostic (4.40e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.64e-2)"	"unprognostic (7.16e-2)"	"unprognostic (3.18e-1)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (1.28e-9)"	"unprognostic (5.79e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.83e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.89e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.10e-2)"	"unprognostic (6.42e-2)"	96.9	105.0	49.5	72.4	53.0	141.4	135.1	51.9	71.6	89.6	51.1	80.6	77.1	96.5	106.6	95.0	146.4	70.8	86.1	52.0	56.1	112.7	108.4	60.1	122.7	52.3	49.5	162.9	131.6	64.7	49.4	79.8	51.5	71.3	98.4	43.3	78.6	82.3	103.1	102.5	60.2	98.3	52.7	71.1	88.0	74.3	51.7	131.2	107.6	82.4	146.6	113.6	79.5	55.9	173.6	219.0	171.0	218.8	222.7	318.2	251.5	176.1	242.7	264.5	255.6	284.5	124.1	445.6	118.1	201.6	226.7	214.1	301.1	319.4	328.2	151.4	372.3	201.2	164.5	303.4	322.1	473.9	276.4	287.4	355.1	178.8	434.6	221.5	301.3	234.6	403.8	151.2	293.8	204.1	238.3	494.4	188.4	230.8	334.2	192.0	430.7	209.9	291.4	321.4	131.3	203.0	125.2	233.5	279.9	187.0	259.3	279.6	142.1	164.6	188.0	353.0	540.2	183.5	248.8	324.0	148.2	284.3	166.1	71.9	211.7	65.7	99.7	189.3	137.6	144.9	136.9	127.3	258.4	117.9	141.1	129.9	24.8	142.3	142.8	154.8	156.5	186.0	49.5	53.0	51.9	71.6	52.0	56.1	52.3	49.5	51.5	52.7	51.7	55.9	82.7	83.3	66.4	19.2	147.5	212.9	256.2	372.8	189.0	44.7	112.9	132.3	41.1	81.5	168.0	60.7	20.9	261.8	127.8	47.1	131.0	187.3	154.9	76.4	168.8	106.3	72.4	148.5	23.8	250.7	284.0	121.9	103.0	104.3	158.4	123.6	98.6	73.3	197.1	10.1	23.5	132.3	156.6	250.6	209.6	55.2	133.9	153.6	110.3	12.2	283.6	70.0	131.8	20.1	21.6	171.8	87.4	120.4	132.4	212.0	86.3	220.6	87.6	42.5	72.3	140.1	254.9	109.4	72.6	159.5	225.0	243.0	154.1	228.3	169.9	252.9
EIF4A1	"DDX2A, EIF-4A, EIF4A"	ENSG00000161960	"Eukaryotic translation initiation factor 4A1"	P60842	17	7572824-7579006	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Helicase, Hydrolase, Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 1342.5;Basal respiratory cells: 1913.6;Langerhans cells: 1330.1;Suprabasal keratinocytes: 1233.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011689, HPA068286"	Uncertain		Approved	Cytosol		NA	NA		4100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB011689: AB_732122, HPA068286: AB_2685968"	"unprognostic (1.49e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.12e-3)"	"unprognostic (7.25e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.19e-3)"	"prognostic unfavorable (1.76e-8)"	"unprognostic (1.91e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.13e-2)"	500.5	373.3	110.2	296.5	113.4	416.2	354.2	118.1	129.6	287.0	116.7	260.6	199.7	290.3	196.6	566.2	307.9	229.5	229.7	112.7	123.9	274.2	328.3	339.0	286.3	128.9	119.1	302.8	360.5	150.4	190.2	301.9	125.9	219.2	289.5	118.5	268.6	168.7	281.2	375.5	228.9	316.6	122.9	291.4	313.2	159.8	131.2	309.3	171.4	122.4	385.2	506.9	321.6	131.5	1048.3	1396.3	914.1	833.9	802.7	931.9	852.4	977.9	1104.0	1770.4	1356.8	1420.1	457.7	1428.7	735.7	1032.2	774.7	907.6	1962.5	1505.4	1890.2	468.1	1454.0	799.3	854.7	1597.9	1226.2	826.4	771.9	1244.8	763.3	1491.8	1510.3	1055.1	1351.6	784.4	831.1	284.9	1294.2	1092.6	865.0	704.8	789.1	1068.6	952.6	802.1	691.1	682.2	1249.8	939.1	481.2	934.2	883.0	585.6	1273.8	679.4	651.5	625.1	976.1	930.2	649.9	603.8	2010.9	276.0	425.7	921.2	1000.8	999.3	1045.7	318.5	1639.1	408.1	463.4	1377.5	755.2	469.1	493.1	497.9	1905.9	412.2	477.7	488.1	157.1	658.5	1076.3	727.7	682.0	2945.6	110.2	113.4	118.1	129.6	112.7	123.9	128.9	119.1	125.9	122.9	131.2	131.5	212.3	115.4	239.6	0.0	139.7	1342.5	678.5	1913.6	173.0	113.5	191.0	183.4	6.8	104.4	799.6	73.5	116.7	345.6	185.8	100.5	152.6	295.4	32.4	120.7	171.6	286.1	116.1	139.6	0.0	231.4	370.5	299.2	129.5	165.0	149.1	237.5	154.2	63.8	212.1	106.0	0.0	117.3	767.0	160.4	1330.1	42.0	160.9	206.7	725.7	0.0	133.3	120.7	119.4	0.0	0.0	313.9	123.3	109.1	134.7	342.8	151.8	174.0	446.1	119.4	151.2	374.4	871.4	71.5	102.8	154.0	1233.4	636.9	224.2	197.1	135.9	474.6
EIF4A3	"DDX48, EIF4AIII, Fal1, KIAA0111"	ENSG00000141543	"Eukaryotic translation initiation factor 4A3"	P38919	17	80134369-80147151	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, rRNA processing, Translation regulation, Transport"	"Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021878	Supported		Supported	Nucleoplasm		NA	NA		280000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA021878: AB_1848090"	"unprognostic (7.24e-2)"	"unprognostic (7.33e-3)"	"prognostic favorable (3.57e-5)"	"unprognostic (1.29e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (1.68e-5)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (3.71e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.64e-2)"	"unprognostic (9.78e-3)"	"unprognostic (5.81e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.91e-3)"	65.8	81.4	19.0	49.1	21.1	185.8	44.2	21.5	27.2	51.2	22.8	44.3	38.6	46.6	38.8	81.9	54.7	40.1	38.0	22.3	21.0	45.1	42.6	44.0	67.0	19.9	19.5	66.5	37.0	58.5	41.1	52.9	20.3	38.7	47.5	32.3	42.4	32.6	37.3	64.8	38.9	42.6	22.7	47.6	41.4	42.8	20.0	78.2	37.0	34.9	74.7	83.4	55.1	24.7	237.2	208.9	140.5	103.8	105.5	63.2	114.4	119.3	91.0	177.7	141.4	223.7	110.3	221.4	67.9	112.9	126.4	152.2	194.9	136.2	195.0	71.5	192.3	142.5	159.3	244.3	103.1	253.8	133.4	98.7	68.7	149.5	119.4	71.8	147.2	128.7	189.8	140.2	105.3	178.9	224.8	132.8	145.0	223.8	190.0	168.5	282.7	172.2	85.8	196.5	186.1	100.1	170.9	334.2	151.9	130.1	219.3	166.7	100.5	108.7	138.6	159.9	200.3	104.4	86.2	403.2	88.0	158.7	113.3	126.1	167.0	137.4	101.1	174.6	131.2	142.4	128.2	119.4	200.0	119.8	116.9	115.2	98.7	132.9	143.4	326.0	158.2	232.6	19.0	21.1	21.5	27.2	22.3	21.0	19.9	19.5	20.3	22.7	20.0	24.7	117.9	41.7	48.0	6.8	135.1	283.1	273.4	212.9	107.0	23.3	77.0	109.2	61.5	38.6	107.8	29.5	16.7	140.1	165.7	75.4	64.6	85.6	33.2	132.9	109.2	70.5	60.3	24.4	4.1	115.2	225.1	144.3	149.4	248.2	92.6	42.6	32.2	27.0	108.5	6.7	4.3	83.2	89.5	63.4	255.0	12.1	67.1	199.6	103.2	10.3	67.9	48.6	23.7	5.5	7.6	86.6	83.1	49.7	118.6	96.0	47.9	65.0	61.4	32.5	85.5	109.7	207.8	99.4	123.2	77.6	299.1	261.9	138.4	98.0	77.7	252.5
EIF4E	"EIF4E1, EIF4EL1, EIF4F"	ENSG00000151247	"Eukaryotic translation initiation factor 4E"	P06730	4	98879276-98929133	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"	"Autism, Autism spectrum disorder, Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 927.0;Late spermatids: 2284.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004077, CAB016316, HPA068358"	Supported		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA		450000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Cytosol, Cytoplasmic bodies"	Nucleoplasm	"CAB004077: AB_823488, CAB016316: AB_627502, HPA068358: "	"unprognostic (3.07e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.53e-3)"	"unprognostic (7.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.03e-5)"	"unprognostic (6.55e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.10e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.28e-1)"	38.0	37.4	27.4	37.7	28.5	57.4	35.6	32.5	34.6	28.5	20.9	45.1	35.9	30.5	38.0	51.7	31.7	31.3	37.5	27.8	34.3	47.4	43.3	27.0	44.6	29.2	31.1	29.1	27.0	45.1	17.0	35.9	29.2	31.4	52.2	54.0	31.2	30.7	39.2	24.2	34.4	39.4	36.2	31.5	35.8	62.6	31.4	53.2	52.6	48.1	58.0	54.4	29.8	34.3	101.1	85.2	139.8	96.5	73.4	74.2	87.3	184.6	105.3	137.0	100.5	111.0	122.7	194.7	59.4	104.4	94.3	49.0	181.9	124.9	158.9	133.5	56.2	135.6	52.7	105.8	62.6	199.3	104.8	54.5	78.3	104.8	82.9	81.5	108.3	97.6	226.6	95.2	120.0	82.9	189.2	110.6	115.0	189.2	72.2	119.7	94.4	90.0	122.0	85.3	123.3	80.3	85.5	188.4	65.4	93.3	89.9	85.9	86.5	110.0	121.6	96.9	153.7	71.4	185.4	179.4	99.7	102.7	127.1	39.5	34.7	59.3	38.2	42.1	44.4	50.0	43.2	40.2	39.6	43.6	47.3	47.3	26.3	54.3	54.8	33.5	46.5	50.3	27.4	28.5	32.5	34.6	27.8	34.3	29.2	31.1	29.2	36.2	31.4	34.3	45.2	32.1	42.2	29.7	93.1	362.1	227.5	202.2	149.7	87.9	81.6	41.1	27.5	55.8	106.0	60.7	35.5	105.3	56.2	140.5	256.3	88.9	927.0	76.1	84.0	77.8	64.6	192.8	45.2	67.4	150.0	87.1	80.0	119.0	51.4	28.0	40.0	77.1	121.1	85.8	45.0	77.4	227.9	61.9	327.6	2284.9	50.7	122.1	193.9	25.3	69.8	82.0	57.7	35.2	50.9	83.8	107.1	49.2	113.0	191.1	83.2	189.2	76.8	64.7	52.6	78.7	151.7	98.7	87.1	171.2	370.9	119.0	82.2	39.8	97.3	224.3
EIF4E2	"4EHP, EIF4EL3, IF4e"	ENSG00000135930	"Eukaryotic translation initiation factor 4E family member 2"	O60573	2	232550674-232583644	"Predicted intracellular proteins"	"Protein biosynthesis, RNA-mediated gene silencing, Translation regulation"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 302.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019253, HPA077074"			Enhanced	Mitochondria,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria	Cytosol	"HPA019253: AB_1848092, HPA077074: "	"unprognostic (3.44e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (1.42e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.36e-2)"	"unprognostic (7.74e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.38e-2)"	40.8	35.9	27.8	52.4	29.0	58.3	43.0	29.2	34.3	35.4	26.9	67.4	50.6	41.6	36.9	51.9	33.2	42.8	38.3	28.1	29.2	63.9	93.2	45.2	49.2	30.4	28.7	33.6	40.8	36.2	24.5	56.9	31.5	34.8	77.2	34.4	38.8	31.8	153.1	50.2	52.5	56.1	27.1	42.5	51.1	42.2	29.5	41.9	36.2	62.5	61.9	47.3	34.3	31.1	104.9	99.5	108.7	79.3	83.4	110.2	161.9	144.9	88.3	101.9	107.8	109.8	100.3	109.0	39.0	151.6	116.7	88.6	128.2	131.2	128.9	98.6	122.0	146.6	97.4	149.9	98.8	213.0	130.7	103.1	98.1	105.5	78.5	102.8	172.1	53.0	139.0	34.7	118.7	201.4	83.1	171.0	174.3	124.1	83.5	73.2	231.7	72.3	209.6	133.2	98.7	135.5	77.0	86.6	95.3	117.2	81.3	145.3	148.6	88.3	114.9	96.6	106.1	67.3	71.0	139.8	100.0	109.4	78.9	299.2	205.7	194.4	63.6	220.0	51.4	62.2	65.8	67.7	179.3	60.5	55.1	56.1	132.1	70.7	205.9	70.9	114.7	155.5	27.8	29.0	29.2	34.3	28.1	29.2	30.4	28.7	31.5	27.1	29.5	31.1	37.2	41.7	57.3	11.8	40.1	38.0	78.2	127.4	31.3	19.8	41.5	49.3	36.9	65.8	85.4	35.0	18.8	142.0	53.6	109.1	74.3	164.5	129.6	45.6	63.1	46.9	66.0	50.7	20.0	151.5	204.3	60.2	48.9	68.6	43.7	47.2	50.0	119.9	125.4	20.2	19.3	111.3	120.1	90.8	87.5	302.4	38.2	72.6	30.2	10.3	135.8	29.3	51.5	12.1	29.7	159.8	109.3	38.7	51.8	96.8	139.1	170.8	58.8	22.3	26.3	38.8	118.5	68.4	56.0	59.7	51.1	182.5	42.7	92.3	87.9	120.4
EIF4ENIF1	"2610509L04Rik, 4E-T, Clast4, FLJ21601"	ENSG00000184708	"Eukaryotic translation initiation factor 4E nuclear import factor 1"	Q9NRA8	22	31436977-31496108	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, RNA-mediated gene silencing, Translation regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 54.6;Late spermatids: 98.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001619, HPA002078"	Enhanced		Enhanced	Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"HPA001619: AB_1078727, HPA002078: AB_1078728"	"unprognostic (1.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.30e-2)"	"unprognostic (4.95e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.80e-1)"	"prognostic favorable (1.57e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.32e-2)"	"unprognostic (2.45e-2)"	12.5	11.9	14.3	10.4	14.8	14.3	11.9	19.7	17.3	15.9	11.4	19.4	11.4	15.0	13.0	14.0	13.8	7.8	13.2	15.3	15.0	12.3	8.4	12.1	12.6	13.6	14.7	15.0	10.5	16.7	10.8	13.6	14.3	13.5	11.5	18.0	12.1	13.2	20.2	15.7	11.8	12.1	11.6	12.3	12.3	34.7	13.8	12.9	13.5	14.5	14.9	15.6	14.3	17.3	19.8	11.6	29.4	16.0	16.1	14.2	11.7	13.7	16.8	21.4	19.8	13.4	7.0	25.3	7.9	20.7	14.3	19.1	26.9	12.5	19.7	20.2	27.0	10.3	20.0	15.4	16.7	41.0	17.9	16.6	16.9	15.8	17.8	19.5	18.4	14.8	25.4	27.0	20.3	22.4	27.8	20.3	13.5	18.3	9.5	31.1	24.5	26.0	21.7	14.7	22.6	20.9	18.9	15.4	14.5	19.4	16.4	16.1	20.5	14.3	18.6	14.4	15.5	19.3	20.4	25.1	13.7	14.8	17.1	1.3	2.4	1.2	3.4	3.0	3.5	4.8	1.8	3.3	2.2	2.0	1.8	3.2	2.0	1.0	8.1	4.4	1.4	1.9	14.3	14.8	19.7	17.3	15.3	15.0	13.6	14.7	14.3	11.6	13.8	17.3	8.4	12.8	15.2	23.2	10.6	7.4	7.3	6.2	15.4	18.0	9.6	8.9	22.7	10.0	8.5	12.9	12.5	9.8	13.8	8.6	9.8	8.9	54.6	8.0	12.8	10.2	12.0	12.4	21.0	6.4	5.5	8.1	12.2	13.0	6.3	23.1	11.0	8.9	8.0	18.5	20.5	10.8	8.2	9.5	6.2	98.9	14.6	7.5	7.2	13.1	14.5	8.1	14.4	20.1	20.2	10.2	3.6	15.4	10.3	10.7	5.7	9.4	6.3	13.7	6.6	11.8	11.0	38.7	13.3	10.7	10.5	6.7	8.2	9.0	8.1	8.0
EIF4G1	"EIF4F, EIF4G, p220, PARK18"	ENSG00000114867	"Eukaryotic translation initiation factor 4 gamma 1"	Q04637	3	184314495-184335358	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding, Translational shunt"	"Cancer-related genes, Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 348.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014774, HPA028487, HPA043866"	Approved		Enhanced	Cytosol		NA	NA		330000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB014774: , HPA028487: AB_10602219, HPA043866: AB_2678705"	"unprognostic (4.14e-3)"	"unprognostic (2.10e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavorable (7.99e-4)"	"unprognostic (4.27e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.55e-3)"	"unprognostic (7.06e-3)"	"unprognostic (2.42e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.33e-3)"	86.2	91.8	24.8	75.7	22.2	84.0	69.0	17.9	22.2	66.6	34.1	81.8	62.0	71.3	32.7	126.8	59.6	50.9	90.8	23.3	29.8	53.9	113.0	74.2	55.7	38.5	36.1	57.5	96.2	99.3	57.4	59.4	32.4	62.2	56.5	22.3	93.1	59.2	348.3	116.7	67.2	74.7	24.4	58.2	79.9	64.8	37.4	49.1	71.3	177.0	63.2	76.0	85.3	16.6	559.0	232.3	173.1	205.7	196.9	192.5	322.5	298.6	204.1	315.4	238.8	486.5	173.7	348.4	381.9	367.6	358.5	292.7	322.6	365.8	230.5	375.1	345.8	321.3	226.1	206.4	173.4	321.4	212.2	199.6	206.8	292.4	268.8	152.8	278.3	128.8	239.6	267.2	205.7	403.4	219.7	105.3	368.9	241.3	180.8	221.7	183.4	281.9	156.8	331.8	197.7	174.6	258.1	415.6	187.6	144.6	445.2	206.5	364.1	227.2	228.9	297.3	567.9	203.8	263.2	629.0	260.5	271.4	258.3	8.3	16.0	6.7	11.7	14.4	10.8	7.7	7.8	9.6	12.8	9.2	6.9	7.6	5.6	8.7	21.0	18.1	6.0	12.7	24.8	22.2	17.9	22.2	23.3	29.8	38.5	36.1	32.4	24.4	37.4	16.6	63.9	76.9	72.6	23.8	41.7	59.1	78.2	58.0	70.6	24.2	69.3	46.2	109.4	50.1	72.3	62.5	14.6	64.0	37.6	135.5	13.7	98.8	151.6	53.0	67.1	69.3	55.7	82.7	10.8	135.3	74.8	64.5	75.4	85.6	48.0	163.8	43.5	152.8	66.8	21.9	12.9	97.2	50.8	40.8	39.9	202.7	73.0	48.9	33.8	14.0	53.0	23.2	30.9	4.0	10.1	149.0	69.0	56.1	112.9	96.8	77.0	45.4	51.4	23.2	78.9	81.6	78.9	24.8	41.4	120.7	91.8	79.6	46.0	94.8	108.4	95.6
EIF4G2	"DAP5, NAT1, p97"	ENSG00000110321	"Eukaryotic translation initiation factor 4 gamma 2"	P78344	11	10797050-10808940	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005163, HPA006773, HPA016965"	Approved		Enhanced	Cytosol		NA	NA		48000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB005163: AB_638994, HPA006773: AB_1848099, HPA016965: AB_1848100"	"unprognostic (1.10e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.92e-2)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (6.18e-5)"	"unprognostic (1.25e-1)"	"unprognostic (7.84e-3)"	"unprognostic (5.42e-2)"	"unprognostic (7.07e-2)"	"unprognostic (2.63e-1)"	"prognostic favorable (1.67e-4)"	"unprognostic (1.02e-2)"	"unprognostic (2.08e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.74e-1)"	307.1	259.9	177.4	278.4	178.0	516.4	213.7	182.9	197.9	281.1	260.2	329.2	217.0	310.5	310.1	372.0	265.0	290.0	377.9	165.0	195.9	321.8	288.7	312.8	286.6	190.0	226.5	247.1	259.6	368.6	160.2	406.4	196.9	276.2	318.6	258.5	231.1	305.5	456.4	299.5	216.3	395.9	186.5	249.5	245.4	226.4	193.0	384.8	349.7	372.4	369.3	430.0	203.0	191.1	933.5	715.1	958.4	527.9	668.2	712.0	668.4	848.9	841.7	713.1	483.6	790.1	1064.3	525.7	474.1	1029.4	545.2	537.8	1048.1	781.0	970.8	820.1	489.0	676.3	427.7	607.2	580.2	1041.8	545.9	582.3	601.0	444.6	577.3	657.1	830.2	483.5	527.8	570.5	935.1	481.8	691.7	377.9	702.1	646.8	756.0	690.3	563.8	336.1	630.7	1328.3	357.9	584.6	966.5	658.7	516.7	640.7	561.1	474.5	805.5	916.1	614.8	793.4	711.4	281.5	841.5	766.9	531.5	600.2	998.7	343.1	331.3	498.6	212.1	382.2	277.0	251.3	237.3	250.1	304.6	212.9	205.8	212.9	244.6	262.4	422.3	162.3	295.9	767.1	177.4	178.0	182.9	197.9	165.0	195.9	190.0	226.5	196.9	186.5	193.0	191.1	306.7	323.7	284.4	48.6	273.6	633.2	372.0	213.4	285.1	128.1	236.0	196.0	382.6	198.8	243.4	147.1	123.0	321.8	289.0	422.3	244.6	325.2	163.7	213.4	247.1	302.9	247.8	169.1	48.1	368.1	373.7	250.1	263.5	269.3	199.5	271.3	209.9	209.0	272.2	164.9	53.8	279.7	191.2	240.1	417.9	152.0	208.8	312.7	250.8	54.4	279.7	197.3	224.6	36.7	53.3	582.5	260.6	240.7	262.0	307.1	205.6	329.5	225.3	142.8	131.5	328.1	363.1	203.6	197.6	320.3	630.1	1056.1	267.7	281.2	289.0	518.3
EIF5A	"EIF-5A, EIF5A1, MGC104255, MGC99547"	ENSG00000132507	"Eukaryotic translation initiation factor 5A"	P63241	17	7306999-7312463	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein biosynthesis, Protein transport, Translocation, Transport"	"Elongation factor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005042, HPA061298, HPA074052"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB005042: AB_562281, HPA061298: AB_2684472, HPA074052: "	"unprognostic (3.72e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.80e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (9.04e-4)"	"unprognostic (4.10e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.64e-2)"	"unprognostic (8.25e-2)"	"prognostic unfavorable (1.63e-5)"	"unprognostic (3.53e-1)"	"unprognostic (2.79e-1)"	"unprognostic (6.01e-2)"	"unprognostic (7.65e-2)"	317.2	309.3	82.3	138.3	83.8	221.5	240.7	85.5	99.0	222.7	77.8	247.5	113.0	206.2	85.8	575.9	188.1	73.7	316.1	87.8	89.8	241.7	495.6	244.5	135.0	87.7	86.4	161.2	295.0	79.7	166.7	96.4	93.0	189.1	125.7	47.6	230.9	65.6	572.1	407.8	207.5	106.1	86.5	227.4	226.7	201.7	92.3	122.5	181.6	160.3	154.4	221.3	281.8	88.6	838.2	958.6	275.8	570.6	220.8	270.2	427.1	546.2	360.7	730.1	501.6	583.6	343.3	749.7	350.9	451.4	300.3	572.3	610.0	777.8	665.9	466.2	987.2	477.9	710.1	750.6	388.6	324.0	431.7	302.5	374.9	587.8	736.0	259.1	501.4	232.0	673.8	192.2	527.3	496.2	388.6	523.3	525.8	477.2	498.0	412.0	320.5	732.4	464.6	393.8	340.5	431.8	330.0	469.4	360.8	212.3	327.2	258.4	427.7	567.6	379.5	326.2	896.4	168.8	229.9	443.6	515.1	527.2	642.2	146.8	137.6	102.0	157.4	193.1	187.5	154.5	153.1	137.2	215.9	149.1	139.6	144.6	62.0	195.1	186.5	225.0	156.7	200.3	82.3	83.8	85.5	99.0	87.8	89.8	87.7	86.4	93.0	86.5	92.3	88.6	180.1	54.5	37.9	6.2	241.9	349.0	67.9	226.5	378.5	88.3	258.8	138.7	77.8	125.8	72.7	62.5	14.6	324.3	200.3	316.0	74.3	317.3	153.8	136.4	255.2	176.6	150.6	456.1	6.8	239.8	633.8	199.6	172.8	187.8	138.4	87.3	105.7	236.4	296.8	50.5	7.0	317.4	83.4	133.6	283.1	112.9	100.6	151.9	263.3	4.7	245.0	122.2	216.3	2.0	11.5	322.0	223.7	81.3	386.7	507.1	229.3	127.1	41.3	65.0	92.1	160.7	262.1	200.4	82.6	572.0	313.7	428.4	179.3	290.7	384.7	207.0
ELP1	"DYS, IKAP, IKBKAP, IKI3, TOT1"	ENSG00000070061	"Elongator complex protein 1"	O95163	9	108866898-108934328	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, tRNA processing"		"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 12.8;Alveolar cells type 2: 18.8;Collecting duct cells: 14.7;Exocrine glandular cells: 21.1;Theca cells: 24.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	8	"basophil: 36.6"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 36.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021340, HPA049677, HPA050686"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	Nucleoplasm	"CAB021340: , HPA049677: AB_2680847, HPA050686: AB_2681216"	"prognostic unfavorable (1.57e-4)"	"unprognostic (8.71e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.27e-2)"	"unprognostic (4.98e-2)"	13.6	39.7	5.8	6.5	6.2	6.5	13.6	6.9	8.1	21.5	8.4	17.5	5.8	17.1	9.5	13.0	19.9	6.7	18.2	5.9	7.8	14.4	18.4	15.2	9.6	6.6	6.5	29.9	17.6	29.3	38.1	6.8	7.9	18.0	8.1	24.8	14.8	8.3	15.7	15.9	15.9	8.9	5.9	18.2	15.5	12.0	6.9	9.5	20.1	11.4	8.8	15.5	18.3	6.3	15.6	26.7	19.7	12.8	21.7	21.1	21.1	23.4	15.1	20.8	16.9	31.5	9.2	31.0	12.0	20.2	27.5	35.7	40.7	29.8	25.8	28.6	26.6	15.2	38.2	63.3	18.6	28.7	13.7	18.7	19.1	34.5	26.7	18.0	20.9	33.6	43.1	17.9	22.9	25.3	21.2	13.6	32.1	41.0	34.4	20.7	31.9	18.3	17.3	16.1	26.6	23.9	27.8	23.3	15.7	22.4	33.3	14.1	15.4	10.4	16.2	26.0	25.1	15.5	47.2	13.8	20.0	20.2	19.1	36.6	1.4	2.8	2.9	2.2	4.4	2.2	3.4	4.6	2.4	1.2	3.1	4.0	0.2	4.5	3.3	1.6	2.6	2.1	5.8	6.2	6.9	8.1	5.9	7.8	6.6	6.5	7.9	5.9	6.9	6.3	7.3	12.8	18.8	0.0	2.9	0.0	0.0	0.0	0.0	0.0	7.7	7.0	0.0	0.0	3.1	14.7	0.0	6.9	5.8	0.0	0.0	5.8	0.0	9.9	10.6	4.7	0.0	0.0	0.0	21.1	6.2	3.8	0.0	9.6	2.5	11.4	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	7.6	0.0	0.0	2.7	0.0	0.0	6.3	6.6	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	5.6	2.8	24.4	0.0	0.0
ELP5	"C17orf81, DERP6"	ENSG00000170291	"Elongator acetyltransferase complex subunit 5"	Q8TE02	17	7251416-7259940	"Predicted intracellular proteins"	"Transcription, Transcription regulation, tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 171.6"	"Group enriched"	"Detected in all"	4	"Early spermatids: 405.3;Late spermatids: 699.6;Spermatocytes: 226.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023279, HPA052411"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA023279: AB_1847613, HPA052411: "	"unprognostic (3.73e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.39e-3)"	"unprognostic (7.72e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.70e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.83e-3)"	"unprognostic (1.60e-2)"	"prognostic favorable (2.62e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.30e-2)"	30.6	47.9	21.1	10.0	22.0	14.1	26.7	22.0	23.8	30.0	22.0	36.4	11.5	31.8	12.8	27.9	28.7	9.3	59.7	21.0	21.8	39.6	57.1	22.7	16.7	21.7	21.6	33.7	28.0	19.9	39.7	10.4	21.6	35.4	10.8	18.9	26.1	11.8	57.3	21.2	31.2	17.8	21.2	35.0	29.0	171.6	21.9	22.9	29.3	77.9	16.9	30.9	24.8	21.6	22.4	61.7	27.3	24.9	46.8	36.8	11.9	19.5	23.1	30.7	28.2	62.0	14.3	44.0	21.1	31.3	53.7	16.4	69.6	46.1	22.0	27.4	98.2	40.7	20.5	57.3	23.2	29.2	15.4	26.2	34.0	21.0	41.1	19.4	26.5	54.9	28.6	11.5	48.4	37.5	74.4	55.4	22.5	23.4	42.5	63.0	30.6	23.9	34.5	20.7	13.3	26.4	38.0	11.5	30.9	27.0	16.3	20.9	30.4	17.6	20.6	34.1	31.7	13.3	19.4	51.8	32.0	28.1	23.3	28.6	30.7	16.1	32.3	37.8	41.0	39.3	28.9	30.1	37.4	39.5	30.2	35.9	5.3	38.7	26.1	45.9	44.7	28.6	21.1	22.0	22.0	23.8	21.0	21.8	21.7	21.6	21.6	21.2	21.9	21.6	30.4	9.6	11.7	10.7	38.3	22.0	47.7	47.8	27.9	21.5	27.8	36.6	64.3	12.8	39.9	46.0	20.9	36.1	45.1	29.7	97.8	38.3	405.3	20.5	28.1	26.5	41.6	14.1	9.4	13.6	78.1	28.6	9.7	21.5	7.0	30.1	18.2	24.2	41.4	28.6	9.7	37.0	57.0	13.5	28.8	699.6	34.2	22.8	21.4	10.3	29.0	32.7	29.9	10.6	10.5	19.3	32.9	33.1	26.7	73.5	46.9	107.0	23.1	33.6	39.5	27.1	35.9	226.4	40.8	21.0	21.7	57.9	29.9	29.0	46.5	51.6
ELP6	"C3orf75, FLJ20211, TMEM103"	ENSG00000163832	"Elongator acetyltransferase complex subunit 6"	Q0PNE2	3	47495640-47513712	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation, tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046358, HPA064545"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	Centrosome	"HPA046358: AB_10961011, HPA064545: AB_2685282"	"unprognostic (2.00e-3)"	"unprognostic (2.27e-1)"	"unprognostic (7.41e-3)"	"unprognostic (2.41e-2)"	"unprognostic (2.67e-1)"	"unprognostic (8.62e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.07e-2)"	"unprognostic (5.38e-2)"	"prognostic favorable (3.42e-6)"	"unprognostic (1.54e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.29e-2)"	13.5	27.0	21.3	14.3	22.8	11.5	15.8	23.6	23.6	14.5	24.3	16.2	15.2	17.2	23.1	15.5	16.9	14.7	19.6	21.0	21.6	17.5	21.3	12.1	21.9	22.8	22.2	21.7	14.8	21.1	15.1	14.4	22.7	19.4	13.9	8.7	16.4	17.7	35.6	16.6	13.4	18.0	22.2	15.7	15.7	21.1	22.9	24.6	19.3	29.0	20.5	16.0	13.3	23.7	37.6	36.4	45.3	46.8	34.9	32.0	26.5	43.4	29.7	54.2	48.6	35.1	38.4	68.7	27.1	37.6	51.3	22.1	43.6	62.5	33.0	39.9	34.4	62.6	55.5	40.4	38.5	49.1	38.5	34.9	33.2	61.4	38.3	31.5	47.3	58.8	67.1	21.7	54.1	44.0	59.8	56.7	55.1	35.4	57.9	29.2	22.3	42.2	38.4	33.9	40.3	40.9	36.9	29.8	25.8	36.0	40.8	41.1	32.8	57.3	41.9	28.9	56.9	44.8	63.5	64.9	28.4	58.8	58.4	19.7	20.4	15.1	31.8	18.9	25.2	33.4	29.4	32.9	25.9	35.2	28.3	28.9	2.8	35.3	13.7	33.9	38.5	25.6	21.3	22.8	23.6	23.6	21.0	21.6	22.8	22.2	22.7	22.2	22.9	23.7	19.3	6.4	12.3	8.8	24.9	8.4	15.2	35.7	19.4	21.7	20.3	22.4	23.0	24.3	20.0	33.1	14.6	44.0	27.8	16.0	60.7	28.1	8.3	15.3	19.4	22.6	17.4	30.3	9.4	23.6	39.6	23.4	17.9	14.0	22.2	56.3	30.0	28.5	28.6	38.7	11.9	15.0	40.7	14.5	8.3	14.5	23.0	17.4	16.0	9.4	21.7	43.7	48.4	5.5	11.7	21.3	12.7	30.5	23.1	10.9	22.9	51.1	15.7	26.0	6.6	14.2	22.6	47.2	22.4	15.6	8.4	26.8	23.9	58.4	21.7	10.4
EMC8	"C16orf2, C16orf4, COX4NB, FAM158B, NOC4"	ENSG00000131148	"ER membrane protein complex subunit 8"	O43402	16	85771758-85799608	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 230.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049476	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Endoplasmic reticulum"	"Golgi apparatus"	"HPA049476: AB_2680784"	"unprognostic (2.69e-1)"	"unprognostic (2.62e-2)"	"unprognostic (4.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavorable (8.49e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.91e-3)"	"prognostic favorable (6.39e-4)"	"unprognostic (9.06e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-1)"	13.5	12.9	13.9	8.3	14.7	17.4	12.7	14.7	13.6	9.7	13.2	12.5	10.6	12.7	7.2	13.1	9.2	6.3	19.5	13.9	13.9	13.8	12.8	9.3	10.1	14.8	14.3	8.2	10.9	11.0	10.2	9.3	13.8	9.9	8.7	7.1	9.9	8.7	20.8	10.5	10.5	9.3	15.1	10.9	11.7	12.2	14.8	10.3	9.6	12.5	9.5	11.7	9.4	16.0	29.8	34.1	21.3	19.5	22.6	21.6	41.4	28.7	28.4	46.9	20.8	54.7	33.5	25.6	32.5	29.1	21.0	33.3	32.0	30.1	41.5	10.9	45.7	21.1	17.3	50.3	34.2	21.7	13.7	23.8	20.1	35.7	41.5	20.2	27.1	30.9	48.6	9.6	29.2	50.7	34.5	61.4	42.5	27.4	43.3	50.0	17.4	21.8	29.9	20.7	35.9	21.4	52.8	17.1	33.9	18.9	33.9	38.1	23.8	28.1	28.7	24.9	37.1	26.6	27.3	102.8	24.1	41.3	30.2	17.9	18.1	25.6	10.9	19.2	12.7	11.1	11.8	14.8	24.2	15.6	14.7	14.4	7.5	19.2	19.5	17.8	12.3	12.3	13.9	14.7	14.7	13.6	13.9	13.9	14.8	14.3	13.8	15.1	14.8	16.0	60.1	6.4	8.6	10.4	25.0	61.3	30.1	28.9	25.0	33.7	26.7	26.0	19.9	15.7	18.5	25.8	12.5	48.5	25.0	28.8	60.7	46.9	230.2	37.1	28.3	33.6	46.6	21.5	6.1	42.1	60.7	26.2	18.8	40.9	9.5	25.1	23.6	23.3	47.0	15.2	7.8	27.4	26.4	28.0	38.0	55.0	24.8	27.1	28.4	8.4	41.9	27.8	27.8	8.0	12.2	50.0	27.2	31.6	33.3	51.1	29.1	46.5	12.5	18.6	26.3	22.5	28.9	54.2	56.5	33.5	54.6	51.0	22.4	37.0	35.6	41.9
EME1	"FLJ31364, MMS4L, SLX2A"	ENSG00000154920	"Essential meiotic structure-specific endonuclease 1"	Q96AY2	17	50373220-50381483	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.4;epididymis: 6.3;testis: 5.7"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 4.6;Extravillous trophoblasts: 4.8;Granulosa cells: 4.5;Spermatocytes: 13.2;Spermatogonia: 9.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	33	"basophil: 18.6"	"Lineage enriched"	"Detected in single"	33	"granulocytes: 18.6"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016127, HPA052188"	Supported		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear bodies, Cytosol"		"CAB016127: AB_2278026, HPA052188: "	"unprognostic (3.81e-1)"	"unprognostic (7.72e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.94e-5)"	"unprognostic (2.87e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.37e-3)"	"unprognostic (2.83e-3)"	"unprognostic (0.00e+0)"	"unprognostic (9.82e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.71e-1)"	"unprognostic (3.41e-1)"	0.5	0.3	0.2	1.7	0.3	4.4	0.6	0.1	0.4	0.5	0.0	0.9	0.8	0.4	6.3	1.1	0.3	0.3	0.2	0.1	0.1	0.2	0.4	0.4	2.3	0.3	0.2	0.5	0.2	0.1	0.1	1.4	0.3	0.2	1.3	0.4	0.5	0.1	0.2	1.1	0.7	0.6	0.1	0.9	0.5	5.7	0.3	3.3	0.2	0.0	2.6	0.4	0.5	0.4	13.9	20.0	26.2	13.7	1.2	2.6	18.8	14.2	5.4	19.3	17.7	31.7	11.0	11.0	18.3	5.7	12.0	10.7	24.5	11.3	27.3	21.7	19.3	26.3	23.3	14.8	0.1	10.9	8.4	0.5	0.8	22.3	9.2	2.6	4.5	31.2	16.3	25.6	11.6	15.2	25.0	13.9	15.1	14.2	13.6	25.5	50.7	15.4	4.3	5.6	10.1	20.2	8.7	4.8	8.1	20.9	16.8	12.3	3.1	24.8	14.9	16.6	19.7	16.0	17.4	10.5	7.8	12.2	15.6	18.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.2	0.3	0.1	0.4	0.1	0.1	0.3	0.2	0.3	0.1	0.3	0.4	0.1	0.0	1.1	0.3	0.8	0.1	0.3	0.5	0.6	1.5	0.5	0.3	0.4	0.0	0.7	0.0	0.0	4.6	0.5	0.6	0.0	0.3	0.5	0.8	0.7	0.4	0.0	3.8	0.1	0.0	4.8	0.8	2.0	0.5	0.0	4.5	0.0	0.3	2.2	0.0	0.1	0.9	0.0	0.0	1.4	0.6	0.6	0.8	0.0	0.0	1.0	0.5	1.0	0.0	0.3	0.1	0.0	0.0	2.5	0.1	0.1	0.0	0.9	0.3	0.0	0.6	1.0	13.2	9.1	1.5	0.1	1.1	0.5	0.6	1.3	0.2
EMSY	C11orf30	ENSG00000158636	"EMSY transcriptional repressor, BRCA2 interacting"	Q7Z589	11	76444923-76553025	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012234, HPA050777"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB012234: AB_449325, HPA050777: AB_2681232"	"unprognostic (1.69e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.66e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.70e-2)"	"unprognostic (8.47e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.64e-2)"	"unprognostic (8.74e-2)"	6.8	5.8	4.6	7.7	7.5	13.1	8.7	15.3	8.6	8.1	6.9	7.6	5.2	10.0	7.6	6.1	8.6	6.4	9.0	4.9	8.0	7.3	5.6	9.0	8.9	6.0	5.9	11.4	8.8	9.8	5.7	12.2	6.7	7.7	8.7	17.8	7.1	7.7	9.3	5.7	6.6	10.1	4.3	7.9	6.6	8.7	6.3	13.3	8.2	12.6	8.4	7.3	7.4	12.3	8.6	11.9	26.8	16.5	9.9	9.8	11.8	13.5	13.3	17.3	18.9	20.3	11.5	11.7	12.7	14.7	14.3	16.8	21.9	13.0	26.6	18.7	8.2	18.2	18.5	8.8	6.3	20.0	15.8	8.9	8.5	19.8	16.3	11.0	15.8	19.6	12.9	20.0	14.1	22.8	26.9	12.0	11.7	26.9	15.6	17.1	49.2	16.4	12.0	10.0	16.7	7.3	19.0	12.8	4.1	16.5	25.9	12.2	11.9	16.2	21.8	42.0	9.6	11.1	12.8	33.1	5.4	12.0	12.1	11.9	3.5	7.5	4.5	3.3	4.3	4.3	4.3	5.5	2.6	4.9	3.9	3.7	7.3	3.6	2.7	4.2	4.7	3.0	4.6	7.5	15.3	8.6	4.9	8.0	6.0	5.9	6.7	4.3	6.3	12.3	14.0	16.0	7.8	0.0	15.1	0.0	7.5	0.0	17.1	19.7	12.1	10.2	0.0	2.8	6.2	12.9	35.5	15.6	14.0	4.8	13.7	6.2	1.8	13.7	14.0	10.7	7.3	13.5	0.0	4.3	7.7	9.2	10.2	10.1	2.5	17.2	12.8	7.3	8.6	15.2	0.0	12.0	0.0	7.9	0.0	2.0	11.5	9.0	0.0	0.0	7.3	8.9	14.4	0.0	0.0	5.9	4.4	12.4	20.1	14.1	8.4	10.1	6.6	22.8	13.1	11.5	10.6	25.8	12.3	15.0	0.0	21.1	13.3	12.3	8.1	11.7
ENOPH1	"E1, MASA, mtnC"	ENSG00000145293	"Enolase-phosphatase 1"	Q9UHY7	4	82430590-82461177	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004985, HPA044607"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA		240000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Nuclear bodies"	"CAB004985: AB_426046, HPA044607: AB_2679019"	"unprognostic (6.64e-3)"	"unprognostic (3.05e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.68e-3)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (9.99e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.30e-3)"	"unprognostic (3.68e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.52e-3)"	"unprognostic (3.52e-2)"	17.0	24.2	61.3	21.2	70.0	26.6	26.2	69.8	102.7	20.7	52.3	21.1	20.3	16.7	35.9	23.5	16.5	14.7	18.7	60.0	66.6	33.5	22.1	18.3	29.0	70.5	67.4	19.8	23.5	34.1	20.6	29.1	69.1	26.6	23.9	42.0	19.2	18.0	18.1	21.8	18.5	17.9	68.1	22.2	22.3	10.6	65.9	30.8	28.6	18.7	31.6	21.9	17.8	80.1	56.6	36.6	64.3	40.4	38.3	37.6	69.7	63.7	42.6	57.2	50.6	67.3	61.3	110.8	64.8	49.0	62.6	29.8	86.1	81.3	103.3	67.2	39.2	67.1	33.7	91.0	62.0	113.3	56.0	36.5	84.9	59.7	70.6	41.4	58.8	69.2	88.3	60.1	76.1	73.2	125.8	67.6	59.2	141.8	28.8	88.1	98.2	61.0	94.7	55.5	90.5	55.2	36.2	109.7	86.3	57.3	49.4	54.5	43.3	70.9	52.8	71.2	85.7	67.5	62.4	138.5	45.9	69.5	97.5	5.8	13.9	7.2	21.8	17.1	27.1	20.2	25.9	25.0	20.5	16.9	29.4	24.2	1.2	24.7	14.9	22.4	30.4	20.6	61.3	70.0	69.8	102.7	60.0	66.6	70.5	67.4	69.1	68.1	65.9	80.1	24.6	16.0	10.5	9.4	31.8	68.6	40.8	47.3	30.7	36.6	22.9	19.8	13.5	18.6	27.5	12.9	16.7	86.7	24.7	10.7	88.0	48.1	7.7	15.2	14.2	25.6	29.3	24.6	18.5	25.7	61.3	22.4	15.3	19.5	38.1	15.3	17.9	10.8	57.7	28.6	21.4	24.8	61.1	23.2	27.9	5.1	26.4	23.1	39.2	6.5	35.6	62.8	29.9	15.1	37.9	41.1	11.1	24.0	28.0	52.6	17.7	56.2	18.8	37.7	13.1	16.4	23.8	9.0	24.9	37.8	64.1	46.7	34.3	27.5	26.7	39.9
ENTR1	"NY-CO-3, SDCCAG3"	ENSG00000165689	"Endosome associated trafficking regulator 1"	Q96C92	9	136401922-136410614	"Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 20.4;Breast glandular cells: 15.7;Breast myoepithelial cells: 21.5;Endometrial stromal cells: 22.5;Granulosa cells: 18.7;Hofbauer cells: 18.2;Pancreatic endocrine cells: 18.3;Theca cells: 24.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029303	Approved					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"			"HPA029303: AB_10602222"	"unprognostic (8.94e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.20e-1)"	"unprognostic (8.84e-3)"	"unprognostic (6.35e-2)"	"unprognostic (8.97e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.44e-3)"	"prognostic unfavorable (8.50e-5)"	"unprognostic (1.88e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.23e-2)"	19.5	18.0	11.5	14.2	12.4	10.5	18.0	12.5	13.7	18.9	13.9	21.4	14.3	17.3	4.2	20.7	17.9	10.9	17.0	11.5	11.6	17.8	46.9	16.6	21.0	13.0	11.9	18.5	25.4	7.9	13.5	8.6	12.8	17.9	9.0	5.1	15.1	8.6	26.8	22.0	20.7	11.0	11.5	27.7	19.8	33.2	14.2	10.9	17.4	10.6	13.2	21.3	18.3	14.6	39.0	47.7	30.4	63.6	29.8	27.7	61.6	36.2	21.1	36.6	23.2	61.2	29.3	32.8	29.4	28.6	45.3	94.0	57.5	42.0	21.4	63.7	39.0	28.5	87.3	42.4	41.1	46.0	31.1	25.9	59.5	35.1	74.1	19.1	28.8	49.3	66.9	23.6	33.8	72.2	19.6	48.1	107.4	101.5	49.3	36.7	33.2	130.8	30.2	31.7	60.3	49.4	38.6	61.2	60.5	23.1	88.2	50.7	31.0	55.5	33.1	72.9	71.6	18.1	36.1	48.9	47.6	56.5	56.5	0.0	0.6	1.0	0.6	0.2	1.9	2.3	1.0	0.8	0.3	1.2	1.1	1.3	0.4	1.0	0.6	0.9	1.1	0.5	11.5	12.4	12.5	13.7	11.5	11.6	13.0	11.9	12.8	11.5	14.2	14.6	20.4	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	15.7	21.5	0.0	0.0	0.0	9.2	0.0	4.3	12.8	0.0	0.0	9.3	0.0	10.9	22.5	4.9	0.0	0.0	0.0	13.6	6.0	6.2	0.0	11.7	0.0	18.7	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	3.1	0.0	0.0	9.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	2.9	5.0	24.0	0.0	0.0
EPC1	Epl1	ENSG00000120616	"Enhancer of polycomb homolog 1"	Q9H2F5	10	32267751-32378798	"Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 149.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028931			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"		"HPA028931: "	"unprognostic (6.94e-2)"	"unprognostic (3.03e-2)"	"unprognostic (9.93e-2)"	"unprognostic (9.43e-2)"	"unprognostic (5.73e-2)"	"prognostic favorable (6.40e-4)"	"unprognostic (1.80e-2)"	"unprognostic (3.83e-3)"	"unprognostic (7.43e-2)"	"unprognostic (5.55e-2)"	"prognostic favorable (6.02e-4)"	"unprognostic (4.40e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-3)"	14.4	9.6	12.5	13.9	13.7	149.7	19.4	21.2	14.5	17.5	12.0	15.9	11.5	20.6	15.8	11.1	14.8	12.8	11.9	12.4	12.0	11.9	13.8	14.7	21.5	12.4	12.7	23.4	14.4	14.6	10.3	11.7	13.0	15.0	16.1	19.3	15.0	10.3	22.7	13.8	12.9	16.8	12.5	18.6	13.9	14.4	12.4	31.9	16.8	23.4	17.6	15.2	14.1	16.2	12.0	9.6	21.4	17.9	10.6	14.1	12.4	12.2	6.9	15.6	12.8	10.7	15.1	21.8	8.0	13.6	8.2	12.1	12.1	10.4	10.8	15.9	19.4	18.0	13.5	19.2	11.4	14.1	24.7	12.9	15.8	9.3	7.3	13.9	12.8	18.3	18.8	27.7	12.6	12.9	21.5	10.1	5.3	11.4	8.4	27.7	18.3	11.2	12.1	10.9	18.7	17.8	11.4	8.3	20.1	11.8	8.6	18.7	11.6	9.3	22.7	7.8	10.6	11.3	12.2	35.6	10.0	21.1	8.4	65.8	15.3	36.3	18.9	10.2	16.0	27.4	16.9	15.0	9.1	30.9	17.5	16.1	46.8	13.4	13.2	27.4	21.1	7.7	12.5	13.7	21.2	14.5	12.4	12.0	12.4	12.7	13.0	12.5	12.4	16.2	103.8	41.7	50.9	133.2	166.8	28.6	85.0	54.0	78.6	101.4	69.6	84.3	32.4	52.9	49.2	40.5	68.8	34.9	182.6	55.5	9.8	51.5	11.8	54.1	86.7	70.1	98.6	74.9	108.0	43.6	40.7	71.8	58.1	65.8	85.4	74.9	58.5	35.8	35.2	114.4	106.7	63.9	50.8	55.7	46.8	13.1	94.8	84.4	40.9	134.0	75.4	57.3	148.3	161.9	131.8	49.9	52.3	68.1	139.4	71.6	50.4	20.5	44.1	85.8	98.6	134.9	82.5	77.8	58.3	62.9	24.9	46.1	175.3	56.5	51.0	72.4
EPRS1	"EARS, EPRS, GLUPRORS, PARS, QARS, QPRS"	ENSG00000136628	"Glutamyl-prolyl-tRNA synthetase 1"	P07814	1	219968600-220046530	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Aminoacyl-tRNA synthetase, Ligase, Multifunctional enzyme, RNA-binding"	"Disease variant, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 22.3;Cardiomyocytes: 84.7;Cytotrophoblasts: 40.8;Extravillous trophoblasts: 59.3;Hofbauer cells: 42.6;Syncytiotrophoblasts: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026490, HPA030052"	Enhanced		Enhanced	Cytosol		NA	NA		360000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA026490: AB_1855979, HPA030052: AB_10601466"	"prognostic unfavorable (7.25e-4)"	"unprognostic (1.19e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.13e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (2.62e-4)"	28.8	24.7	18.1	34.4	19.6	26.6	35.7	22.8	24.8	30.5	17.6	36.1	27.7	25.6	25.2	30.6	26.2	20.6	31.8	17.7	21.8	31.6	27.9	24.3	36.5	21.6	20.5	34.7	49.0	54.5	22.5	23.8	22.9	23.6	39.0	43.8	83.4	26.4	52.2	28.9	29.7	32.5	22.4	27.4	35.9	20.5	21.7	34.8	43.0	55.9	42.5	30.4	18.6	27.8	125.9	78.4	55.7	152.3	114.9	126.7	138.0	160.1	111.7	102.1	113.4	93.3	98.1	239.3	86.7	170.4	41.3	130.3	140.9	129.4	136.2	117.9	88.9	130.2	97.6	80.2	125.1	217.6	106.7	92.1	161.7	130.3	161.6	84.8	113.4	113.2	228.0	182.9	100.8	61.8	94.7	53.1	107.4	146.8	159.6	98.5	98.0	236.2	92.8	54.4	128.6	101.3	93.7	152.6	166.5	78.9	141.2	235.1	101.1	48.3	88.1	149.6	151.1	122.8	150.1	197.1	111.4	153.9	156.4	8.8	17.8	10.0	19.7	24.6	27.8	21.0	19.7	22.1	23.2	18.5	22.0	22.9	0.6	22.5	22.1	7.6	20.8	17.2	18.1	19.6	22.8	24.8	17.7	21.8	21.6	20.5	22.9	22.4	21.7	27.8	22.3	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	84.7	0.0	0.0	0.0	0.0	40.8	14.1	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	59.3	17.1	0.0	0.0	0.0	0.0	0.0	0.0	42.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	36.5	2.6	0.0	0.0	0.0
ERAL1	HERA-B	ENSG00000132591	"Era like 12S mitochondrial rRNA chaperone 1"	O75616	17	28855010-28861061	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis"	"RNA-binding, rRNA-binding"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021425, HPA024423"	Supported		Enhanced	Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	Mitochondria	Cytosol	"HPA021425: AB_1848228, HPA024423: AB_1848229"	"unprognostic (1.03e-1)"	"unprognostic (9.16e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.55e-1)"	"unprognostic (8.37e-3)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (8.20e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.57e-3)"	"unprognostic (5.76e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.79e-2)"	20.3	32.5	47.6	17.5	47.7	18.5	23.4	48.4	61.7	20.9	44.7	25.8	22.0	22.1	22.7	28.8	26.2	15.1	41.0	48.0	48.0	29.2	41.2	18.3	22.0	47.9	47.3	25.6	23.6	36.2	18.9	24.5	48.1	21.0	28.1	16.9	22.6	23.9	52.7	26.3	19.9	26.5	47.7	21.0	26.3	17.9	48.4	23.8	19.2	51.8	29.6	22.1	20.6	48.9	50.4	96.2	55.9	63.1	59.1	40.6	53.4	40.1	56.2	117.1	95.9	94.5	31.7	64.1	47.0	68.8	87.9	55.2	102.0	90.0	97.5	63.6	119.8	52.2	60.6	95.8	75.5	63.0	45.7	53.5	78.1	95.3	89.3	46.1	97.2	80.4	104.4	39.9	66.4	78.7	66.1	98.4	50.6	91.8	46.0	59.7	87.6	83.4	71.3	56.1	58.6	47.1	64.5	155.6	51.6	82.2	110.0	71.8	39.7	48.1	53.1	52.9	84.6	32.0	62.3	69.9	51.4	54.4	49.1	25.5	34.2	14.4	32.2	44.6	24.2	38.9	26.9	23.5	54.9	36.3	30.8	32.2	2.6	42.8	31.6	28.7	32.1	30.8	47.6	47.7	48.4	61.7	48.0	48.0	47.9	47.3	48.1	47.7	48.4	48.9	12.4	6.4	2.8	5.9	14.0	8.0	12.7	33.9	12.0	10.9	14.9	18.3	8.0	17.2	13.9	11.0	6.2	69.1	9.9	13.4	37.2	28.1	1.0	11.1	14.0	14.4	21.6	20.4	7.2	21.6	55.2	15.8	19.9	13.3	5.1	24.8	14.3	21.7	35.6	11.8	7.8	15.0	26.4	8.5	6.7	5.4	14.3	12.4	10.6	3.7	66.6	16.4	9.2	5.5	4.3	21.1	12.9	15.8	29.2	15.1	20.0	33.3	9.7	9.0	19.7	11.0	15.6	22.3	21.7	25.4	11.6	51.7	10.4	25.0	26.6	9.9
ERC1	"CAST2, ELKS, KIAA1081, MGC12974, RAB6IP2"	ENSG00000082805	"ELKS/RAB6-interacting/CAST family member 1"	Q8IUD2	12	990509-1495933	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 292.3;Horizontal cells: 185.1;Inhibitory neurons: 487.0;Microglial cells: 213.6;Oligodendrocyte precursor cells: 230.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019513, HPA019523, HPA024130"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Vesicles, Plasma membrane"	"HPA019513: AB_1856012, HPA019523: AB_1856013, HPA024130: AB_1856014"	"unprognostic (2.41e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.50e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.75e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.01e-1)"	"unprognostic (7.37e-2)"	"prognostic unfavorable (7.01e-4)"	10.4	9.7	12.2	6.8	14.4	7.3	8.0	38.1	12.8	8.9	8.0	11.8	3.5	9.0	4.8	11.8	8.2	7.5	13.9	15.2	18.5	9.2	6.5	7.3	4.8	13.7	14.8	10.5	7.6	15.4	8.1	11.8	13.7	9.5	6.2	7.0	8.4	12.1	9.4	9.4	5.8	12.9	11.9	5.8	7.2	7.5	17.7	7.9	13.4	9.0	5.3	13.4	9.0	12.6	8.2	20.1	10.3	7.1	27.8	22.2	14.2	25.0	20.0	17.0	15.3	17.7	10.0	12.5	3.4	33.2	16.8	13.3	22.1	19.7	23.1	25.9	11.6	30.3	20.1	9.3	21.1	16.1	6.9	18.7	17.0	30.0	55.6	20.7	22.3	7.9	9.6	23.9	12.9	9.2	5.2	3.5	16.8	8.1	9.7	9.9	38.9	3.8	16.9	14.2	6.3	12.3	38.8	9.3	13.9	37.6	9.3	7.0	39.6	29.6	29.0	21.6	24.0	6.4	13.1	18.1	19.2	9.4	12.9	1.5	3.1	2.3	1.7	1.2	2.4	12.7	2.7	2.7	2.7	5.6	3.8	2.7	2.4	1.4	4.8	3.4	2.8	0.7	12.2	14.4	38.1	12.8	15.2	18.5	13.7	14.8	13.7	11.9	17.7	12.6	36.9	25.6	25.1	155.4	21.2	21.0	25.6	9.4	29.0	39.2	13.2	14.1	56.4	17.2	17.4	20.2	47.9	34.1	12.6	12.7	1.9	20.3	34.3	31.2	43.4	34.6	30.0	7.6	292.3	13.4	18.0	32.3	23.9	53.9	14.5	59.2	24.3	17.3	12.4	185.1	487.0	11.9	2.0	12.6	16.5	35.2	24.8	17.0	14.2	213.6	18.4	34.8	6.2	230.7	171.1	18.5	10.3	30.9	39.1	30.8	6.1	4.1	13.2	33.4	19.7	35.5	33.1	18.5	28.8	33.8	27.4	78.7	15.8	18.7	10.3	29.4
ERCC6L	"FLJ20105, PICH, RAD26L"	ENSG00000186871	"ERCC excision repair 6 like, spindle assembly checkpoint helicase"	Q2NKX8	X	72204657-72239027	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 3.2;lymphoid tissue: 3.6"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 3.4;Granulosa cells: 2.5;Spermatocytes: 2.1;Spermatogonia: 2.4;Squamous epithelial cells: 2.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	4	"NK-cell: 1.7"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.7"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050492	Approved		Uncertain	Nucleoplasm,Centrosome,Cytosol		No	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Centrosome	"Nucleoplasm, Cytosol"	"HPA050492: AB_2681145"	"prognostic unfavorable (1.80e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.76e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.23e-6)"	"unprognostic (8.63e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.68e-5)"	"unprognostic (4.61e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.97e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.41e-2)"	0.1	0.1	0.1	1.3	0.2	3.2	0.4	0.8	0.2	0.4	0.1	0.9	0.7	0.2	0.2	1.1	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.1	2.3	0.1	0.0	0.3	0.1	0.0	0.1	0.5	0.1	0.1	1.1	0.5	0.3	0.0	0.1	0.6	0.6	0.3	0.0	0.5	0.7	0.8	0.2	3.6	0.1	0.0	2.7	0.2	0.4	0.6	19.0	16.3	14.6	9.3	1.0	1.7	8.0	19.8	9.1	17.0	17.7	13.3	11.6	30.5	7.3	7.2	23.0	15.2	27.8	14.8	30.1	17.5	20.2	10.5	5.5	7.9	0.0	20.7	14.2	0.2	0.9	23.7	4.4	2.8	9.6	15.1	14.1	7.3	17.6	14.8	19.8	12.1	26.6	18.3	24.8	16.4	26.2	5.4	4.4	11.5	12.0	8.6	14.7	9.8	3.6	11.8	7.5	4.6	6.0	11.4	18.3	21.8	13.1	5.7	9.4	25.9	8.1	14.1	11.7	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.1	1.7	0.1	0.1	0.4	0.1	0.1	0.2	0.8	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.6	0.1	0.0	0.0	0.0	0.9	0.3	0.2	0.5	0.0	0.0	0.3	0.6	0.5	1.5	0.2	0.0	0.0	1.1	0.9	0.6	0.0	0.0	0.3	0.9	0.8	0.3	0.0	3.4	0.9	0.0	1.7	0.5	0.0	0.5	0.0	2.5	0.0	0.0	1.0	0.0	0.7	0.4	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	1.7	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.4	2.1	2.4	2.4	0.1	0.4	0.3	0.2	0.9	0.1
ERCC8	"CKN1, CSA"	ENSG00000049167	"ERCC excision repair 8, CSA ubiquitin ligase complex subunit"	Q13216	5	60866454-60945073	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"		"Cockayne syndrome, Deafness, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 47.3;Excitatory neurons: 51.8;Inhibitory neurons: 47.9;Oligodendrocyte precursor cells: 44.2;Oligodendrocytes: 57.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029328			Approved	"Nuclear speckles"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear speckles"		"HPA029328: AB_2673000"	"unprognostic (5.45e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.56e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.68e-2)"	"unprognostic (4.96e-2)"	"unprognostic (2.10e-3)"	"unprognostic (9.68e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.23e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.75e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.31e-3)"	"unprognostic (7.19e-2)"	3.4	3.1	2.3	1.6	2.4	2.0	3.1	3.1	3.2	2.5	1.5	2.6	1.7	3.0	1.4	2.8	2.4	1.9	3.2	2.3	1.7	4.0	3.2	2.2	1.6	1.9	1.8	2.7	2.7	3.0	2.5	2.1	2.1	2.2	2.4	2.7	2.7	2.1	3.0	2.4	2.2	2.3	1.4	2.6	2.5	4.1	2.0	2.8	2.9	2.9	2.2	2.5	2.6	2.9	4.8	4.9	7.3	9.5	6.0	4.2	8.2	7.6	6.4	8.9	9.2	6.9	8.6	7.3	9.4	4.2	14.4	4.0	10.6	7.4	11.1	7.6	6.0	5.3	7.3	7.7	5.0	4.9	4.5	6.5	6.5	6.1	7.5	3.3	9.9	8.8	8.0	4.2	5.2	8.1	6.9	8.0	6.5	2.8	3.1	11.0	9.6	9.1	4.7	5.9	6.1	11.3	8.6	3.6	6.5	7.6	11.2	3.6	3.8	3.8	7.4	7.6	10.1	5.5	11.9	12.7	5.9	10.1	8.3	0.5	4.2	0.9	3.1	3.4	2.5	2.7	2.4	2.8	7.1	1.8	2.8	3.2	0.7	2.2	1.4	3.5	3.3	2.1	2.3	2.4	3.1	3.2	2.3	1.7	1.9	1.8	2.1	1.4	2.0	2.9	3.4	3.2	4.6	28.4	6.6	2.9	3.1	6.9	9.6	0.0	4.9	5.5	4.1	7.2	3.3	16.5	0.0	7.7	4.2	1.6	15.6	5.0	47.3	4.3	7.2	3.9	0.0	10.5	51.8	5.2	9.2	5.2	5.1	3.1	5.7	8.1	3.9	5.0	6.4	0.0	47.9	3.8	4.1	7.1	5.5	11.2	4.7	6.5	7.2	20.6	7.9	0.0	6.2	44.2	57.4	5.2	2.2	3.0	11.1	3.8	2.0	7.1	6.3	0.0	0.0	4.0	4.6	22.5	9.2	10.4	4.3	3.4	6.5	8.9	4.4	3.5
ERMN	"ERMIN, JN, KIAA1189"	ENSG00000136541	Ermin	Q8TAM6	2	157318631-157327713	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"brain: 498.6;choroid plexus: 136.2"	"Cell type enriched"	"Detected in some"	51	"Oligodendrocytes: 290.9"	"Cancer enriched"	"Detected in some"	4	"glioma: 9.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HAP1: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038295, HPA038296"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"	Cytosol	"HPA038295: AB_10805353, HPA038296: AB_10796217"	"unprognostic (7.89e-2)"	"unprognostic (9.06e-3)"	"unprognostic (2.71e-2)"	"prognostic favorable (6.93e-6)"	"unprognostic (1.06e-1)"	"unprognostic (2.02e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.46e-3)"	"unprognostic (2.84e-2)"	"unprognostic (7.96e-2)"	"unprognostic (9.97e-3)"	"unprognostic (5.76e-2)"	0.7	0.2	212.4	2.3	342.3	18.8	0.5	312.8	386.9	0.5	136.2	0.7	0.5	0.4	0.1	0.4	0.4	0.8	0.3	208.7	266.4	0.5	0.5	2.4	3.3	408.3	313.2	0.2	0.3	0.0	0.4	0.1	391.8	0.3	0.9	0.6	1.7	0.3	0.4	0.7	3.8	0.3	266.5	4.7	1.3	0.5	300.8	1.6	0.4	0.0	3.0	0.7	0.3	498.6	0.1	0.3	0.3	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.2	1.3	0.0	1.9	0.0	0.3	25.3	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.7	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	3.5	0.4	0.2	0.7	2.3	0.2	0.1	0.5	0.0	0.4	0.5	0.0	1.0	0.4	0.5	0.0	0.1	0.0	0.3	0.6	1.2	0.0	0.2	0.1	0.3	0.6	3.4	2.5	0.6	1.7	0.9	0.9	0.5	0.3	0.3	0.4	0.2	0.2	0.1	0.1	0.1	0.1	0.3	0.3	0.3	0.6	0.5	0.2	0.3	0.2	0.1	212.4	342.3	312.8	386.9	208.7	266.4	408.3	313.2	391.8	266.5	300.8	498.6	0.1	0.0	1.3	1.6	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	1.3	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.4	0.0	0.2	0.0	0.8	0.2	0.0	1.2	0.9	0.1	0.0	2.2	0.0	1.9	1.1	0.0	3.1	2.0	290.9	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.5	2.7	0.0	0.0	0.0
ESCO2	"EFO2, RBS"	ENSG00000171320	"Establishment of sister chromatid cohesion N-acetyltransferase 2"	Q56NI9	8	27771949-27812640	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.0;intestine: 11.0;lymphoid tissue: 8.5;testis: 5.7"	"Group enriched"	"Detected in many"	4	"Erythroid cells: 44.6;Spermatocytes: 62.0;Spermatogonia: 80.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA027243, HPA053679"			Supported	"Nucleoplasm,Golgi apparatus,Cell Junctions"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Golgi apparatus"	"Cell Junctions"	"HPA027243: AB_2672175, HPA053679: AB_2682227"	"unprognostic (7.86e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (5.13e-3)"	"unprognostic (9.50e-2)"	"unprognostic (8.67e-3)"	"unprognostic (7.30e-4)"	"unprognostic (5.24e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.51e-4)"	"unprognostic (2.23e-1)"	"unprognostic (1.65e-14)"	"unprognostic (6.65e-3)"	"unprognostic (5.32e-1)"	"unprognostic (5.85e-2)"	"unprognostic (4.06e-1)"	0.5	0.4	0.0	2.7	0.2	6.0	1.2	0.4	0.2	0.5	0.0	3.7	11.0	0.6	0.0	2.4	0.2	0.6	0.2	0.0	0.0	0.1	0.7	0.4	4.6	0.0	0.0	0.1	1.0	0.3	0.0	1.1	0.1	0.3	4.3	0.5	0.3	0.1	0.0	1.1	7.9	0.7	0.0	0.8	2.5	5.7	0.0	8.5	0.3	0.2	5.7	0.8	0.5	0.2	54.6	39.9	17.9	22.0	2.3	3.9	10.2	31.6	12.9	27.8	32.5	14.2	10.7	21.0	16.6	8.3	24.7	29.2	22.0	8.5	43.6	15.8	9.2	24.4	16.2	15.3	0.3	12.5	21.4	0.7	0.9	17.0	4.2	3.0	11.6	15.2	20.0	30.0	17.7	10.5	49.8	5.9	12.2	29.9	13.4	21.7	53.0	14.8	9.6	31.9	8.0	11.7	15.5	19.6	7.9	6.5	13.2	14.1	5.2	17.9	37.0	36.2	25.7	4.0	11.1	25.2	10.2	20.5	25.2	0.0	0.2	0.1	0.0	0.4	0.0	0.4	0.2	0.2	0.6	0.0	0.1	0.1	0.2	0.3	0.1	0.0	1.3	0.3	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	4.7	0.0	2.4	2.3	0.6	2.1	1.8	1.2	1.5	1.7	1.2	0.0	3.3	0.0	4.2	4.6	1.3	8.2	0.0	0.4	5.4	1.3	2.6	1.0	1.2	44.6	0.3	0.0	6.6	3.2	5.6	3.1	1.3	11.4	1.4	1.5	5.4	0.0	0.4	4.4	2.0	2.5	3.5	0.8	1.8	3.2	0.0	1.0	0.5	0.1	4.1	1.0	0.9	0.1	1.5	0.0	11.5	0.6	15.1	0.1	1.6	2.0	6.6	0.8	2.3	62.0	80.0	6.8	0.6	1.0	3.1	1.8	8.0	1.4
ESPL1	"ESP1, KIAA0165, SEPA"	ENSG00000135476	"Extra spindle pole bodies like 1, separase"	Q14674	12	53268299-53293638	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Chromosome partition"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.5;esophagus: 15.4;lymphoid tissue: 10.7"	"Cell type enhanced"	"Detected in many"		"Ionocytes: 22.4;Proximal enterocytes: 22.6;Squamous epithelial cells: 7.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB012185, HPA073188"	Approved		Supported	Nucleoplasm,Vesicles		NA	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Vesicles	"CAB012185: AB_304056, HPA073188: "	"unprognostic (1.57e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (5.32e-5)"	"unprognostic (2.91e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (2.01e-5)"	"prognostic unfavorable (7.14e-4)"	"unprognostic (1.59e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.18e-2)"	"unprognostic (7.42e-13)"	"prognostic favorable (7.10e-4)"	"unprognostic (2.39e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.42e-1)"	0.4	0.2	0.0	2.4	0.0	8.5	0.5	0.0	0.0	3.5	0.0	1.5	3.9	0.2	0.0	15.4	0.2	0.4	0.1	0.0	0.0	0.9	0.6	0.4	4.4	0.0	0.0	0.1	0.1	0.0	0.0	1.1	0.0	0.1	1.4	0.0	2.0	0.1	0.0	2.6	4.3	0.7	0.0	1.0	0.9	6.2	0.1	10.7	0.1	0.0	4.9	0.6	5.9	0.0	27.8	23.6	27.6	21.1	0.6	1.9	17.5	15.9	8.6	28.8	19.2	15.8	22.7	49.9	9.5	6.8	17.4	20.2	32.6	9.9	14.3	13.7	32.8	30.6	24.1	11.1	0.1	19.5	25.2	0.6	0.6	15.5	7.6	2.8	15.4	22.2	42.6	41.0	9.1	29.2	30.6	16.4	22.5	14.5	12.9	29.3	30.2	21.4	4.2	11.6	18.9	15.8	11.9	20.4	10.1	13.0	36.9	12.7	8.2	14.5	27.2	11.9	25.5	32.5	29.7	31.9	8.2	19.0	27.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.3	0.6	0.9	0.3	0.5	0.6	0.0	1.0	1.3	0.9	0.0	0.4	3.7	0.0	1.9	0.6	2.7	0.0	0.2	0.8	0.2	0.8	1.0	3.5	1.3	0.7	0.0	2.3	1.1	3.6	0.7	0.0	4.4	0.7	6.8	2.6	0.0	0.4	2.7	22.4	0.6	2.1	1.2	0.0	1.3	0.0	1.0	0.0	0.0	0.0	0.0	0.5	1.5	1.3	0.4	2.1	0.4	22.6	6.6	0.2	0.0	0.0	0.4	0.9	5.5	4.1	7.4	0.6	0.3	0.4	0.1	2.8	0.4
EWSR1	EWS	ENSG00000182944	"EWS RNA binding protein 1"	Q01844	22	29268009-29300525	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Calmodulin-binding, Repressor, RNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004230, HPA051771, HPA062953"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli rim"		No	No		59000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nucleoli rim"	"CAB004230: AB_675526, HPA051771: AB_2681602, HPA062953: AB_2684910"	"unprognostic (1.96e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (1.27e-6)"	"unprognostic (1.33e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.71e-2)"	"unprognostic (7.04e-2)"	"unprognostic (9.30e-2)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (7.33e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.50e-3)"	84.8	102.2	63.2	93.2	64.7	172.3	80.3	70.3	69.5	87.9	61.2	90.5	88.0	105.1	61.9	99.0	86.0	56.1	101.7	64.7	63.7	88.0	85.0	76.8	120.1	67.4	64.7	86.8	79.1	98.0	64.1	70.2	63.6	78.4	84.4	111.2	76.5	77.3	140.0	88.0	92.6	86.9	59.7	101.0	84.3	135.5	63.9	183.0	77.2	79.9	126.8	88.1	86.2	71.8	307.7	239.7	327.6	249.1	166.0	136.0	218.2	188.1	301.3	309.9	264.5	270.3	154.5	428.0	114.1	294.3	234.9	238.9	471.5	392.6	313.7	287.5	341.6	323.9	218.8	262.7	246.5	499.5	219.3	211.1	162.5	259.1	413.0	152.2	244.2	201.1	248.3	186.0	233.8	310.6	505.9	185.8	221.1	261.4	182.8	348.1	317.2	253.3	288.0	328.2	261.4	247.7	236.3	258.5	195.9	216.2	170.9	261.0	246.3	184.4	198.2	115.1	272.3	236.2	205.5	387.4	169.9	220.6	224.4	203.9	201.1	182.6	195.2	283.5	199.5	169.4	181.3	194.4	227.5	191.3	175.8	170.9	148.1	216.9	293.0	122.0	244.0	314.2	63.2	64.7	70.3	69.5	64.7	63.7	67.4	64.7	63.6	59.7	63.9	71.8	77.5	102.5	106.8	68.6	130.8	69.5	145.2	153.2	108.1	72.4	63.8	46.6	68.0	87.2	127.2	64.4	75.0	141.0	91.3	92.4	66.5	121.7	165.4	96.3	88.1	88.3	80.9	102.0	55.8	107.6	133.5	85.4	117.2	115.2	121.0	88.5	71.7	71.7	99.3	82.4	60.8	110.9	136.3	69.7	94.0	32.7	61.5	91.9	81.8	47.8	110.9	72.8	122.6	49.8	67.6	116.5	106.4	62.1	156.6	97.4	79.4	72.6	128.9	84.9	52.6	93.1	141.4	209.6	107.5	105.5	58.5	152.4	121.4	84.9	110.2	115.1
EXO1	"HEX1, hExoI"	ENSG00000174371	"Exonuclease 1"	Q9UQ84	1	241847967-241895148	"Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, Immunity, Meiosis"	"DNA-binding, Endonuclease, Excision nuclease, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 17.3;lymphoid tissue: 11.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 9.3;Erythroid cells: 7.4;Extravillous trophoblasts: 16.7;Plasma cells: 11.8;Spermatocytes: 9.3;Spermatogonia: 9.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA053079, HPA069738"			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"HPA053079: AB_2682037, HPA069738: AB_2732140"	"unprognostic (6.33e-3)"	"unprognostic (8.54e-3)"	"unprognostic (9.47e-3)"	"prognostic unfavorable (8.21e-4)"	"unprognostic (2.43e-1)"	"unprognostic (6.34e-2)"	"prognostic unfavorable (6.94e-7)"	"unprognostic (1.84e-3)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.40e-2)"	"unprognostic (4.81e-3)"	"unprognostic (9.40e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.72e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.57e-1)"	0.5	0.3	0.2	3.3	0.2	17.3	1.2	0.1	0.7	0.5	0.1	3.2	2.9	0.8	0.0	2.5	0.3	0.4	0.2	0.3	0.1	0.3	0.5	0.6	5.8	0.1	0.2	0.2	0.3	0.7	0.1	3.3	0.2	0.2	3.7	0.0	0.5	0.2	0.1	1.8	2.5	1.2	0.2	1.5	1.6	5.7	0.3	11.1	0.4	0.0	6.4	1.2	0.8	0.4	41.3	26.8	43.4	28.6	2.7	6.7	36.5	53.4	17.7	46.7	50.5	33.9	22.5	44.3	25.3	12.6	25.1	40.0	55.5	22.5	54.8	69.5	48.4	41.5	28.8	17.3	1.0	59.8	29.4	1.7	1.1	46.8	12.5	5.7	14.7	43.4	84.6	57.0	37.8	19.0	65.9	33.6	60.4	49.7	26.0	46.2	40.5	47.5	9.6	25.6	48.1	60.9	34.8	27.9	19.5	20.2	25.8	36.6	5.5	44.9	39.5	42.7	72.9	41.5	59.0	71.3	15.6	48.1	54.9	0.8	0.2	0.0	0.2	0.0	0.0	0.3	0.2	0.2	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.9	0.3	0.2	0.2	0.1	0.7	0.3	0.1	0.1	0.2	0.2	0.2	0.3	0.4	0.2	0.0	0.0	0.3	0.7	0.8	0.1	0.7	0.0	0.0	0.3	0.5	2.3	0.0	0.1	0.0	0.0	5.3	0.2	1.2	0.0	0.1	9.3	0.3	0.4	0.7	0.0	7.4	1.0	0.0	16.7	0.9	1.1	0.5	0.0	4.6	0.4	0.0	3.3	0.0	2.9	0.5	0.0	0.3	0.8	2.1	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.1	0.0	0.0	11.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	9.3	9.8	2.7	0.1	4.0	0.8	0.8	1.9	0.3
EXOC5	"SEC10, SEC10L1, SEC10P"	ENSG00000070367	"Exocyst complex component 5"	O00471	14	57200507-57268905	"Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 130.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060837	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA060837: AB_2684375"	"unprognostic (2.95e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.82e-2)"	"unprognostic (6.84e-2)"	"unprognostic (5.05e-2)"	"unprognostic (3.38e-1)"	"unprognostic (9.47e-3)"	"unprognostic (2.82e-2)"	"unprognostic (9.14e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.38e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.98e-2)"	9.0	6.3	4.9	6.6	6.2	5.1	5.1	6.4	6.5	4.5	7.5	4.8	5.6	4.7	4.9	6.5	4.5	4.7	5.2	5.3	6.4	7.7	8.4	6.6	7.2	6.2	7.5	4.6	3.7	6.9	3.4	7.7	7.4	5.6	4.5	9.8	5.4	4.9	5.7	5.6	5.9	6.4	5.5	7.9	5.7	11.1	6.0	8.7	7.4	5.9	6.6	5.7	3.7	8.4	21.7	13.4	26.3	13.4	17.4	17.1	20.1	33.1	15.6	12.3	14.3	12.6	13.4	31.9	19.6	17.9	12.5	17.3	16.3	13.5	19.1	37.7	9.6	20.4	9.9	9.6	16.1	25.2	25.7	10.3	14.0	12.1	13.5	16.2	22.6	22.4	19.9	23.5	25.0	9.8	34.2	5.7	14.2	12.4	23.8	23.9	38.7	11.8	15.4	17.7	20.4	17.5	26.8	10.7	16.4	22.1	19.9	12.2	24.9	26.7	29.9	17.1	16.5	12.0	15.9	26.7	24.5	14.1	17.5	6.8	5.1	6.1	4.8	5.5	5.9	5.6	4.9	5.2	6.3	5.8	5.4	4.7	2.8	6.3	5.2	3.2	6.3	6.8	4.9	6.2	6.4	6.5	5.3	6.4	6.2	7.5	7.4	5.5	6.0	8.4	32.1	25.6	18.6	34.3	26.7	22.6	23.1	18.8	22.2	32.2	23.4	13.2	28.3	21.5	24.2	14.7	29.2	17.4	24.2	17.1	17.6	18.6	130.7	29.4	32.5	35.7	34.6	34.7	56.2	17.3	19.4	27.5	21.9	23.2	34.9	20.6	45.0	38.6	21.6	63.9	56.5	17.0	32.6	31.5	34.1	108.6	23.6	31.4	21.4	38.4	34.3	28.6	23.7	49.3	71.9	25.2	10.8	35.7	27.7	24.7	11.1	41.1	29.4	30.2	19.7	31.1	33.9	128.6	53.2	32.8	30.0	18.7	26.0	34.6	15.3	20.1
EXOSC10	"p2, p3, p4, PM-Scl, PM/Scl-100, PMSCL2, RRP6, Rrp6p"	ENSG00000171824	"Exosome component 10"	Q01780	1	11066618-11099869	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, rRNA processing"	"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028470, HPA028484, CAB037141"	Supported		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"CAB037141: AB_532315, HPA028470: AB_10599180, HPA028484: AB_10611250"	"unprognostic (1.23e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.88e-2)"	"unprognostic (6.37e-2)"	"prognostic unfavorable (2.49e-6)"	"unprognostic (3.36e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.49e-2)"	"unprognostic (2.52e-2)"	"unprognostic (7.68e-3)"	"unprognostic (3.43e-1)"	"unprognostic (9.03e-2)"	"prognostic favorable (5.27e-4)"	"unprognostic (1.33e-1)"	31.8	21.4	18.3	25.9	18.4	39.4	30.8	23.1	22.2	32.5	14.7	27.6	20.7	28.7	23.9	27.3	26.4	19.2	20.3	17.7	15.9	21.8	20.0	24.3	31.1	17.2	15.2	35.8	24.0	25.2	26.1	26.1	16.6	25.3	27.6	35.4	25.4	21.0	33.3	37.0	26.1	27.5	13.7	27.4	26.1	23.4	17.9	32.7	23.3	22.6	34.2	24.6	28.4	19.1	66.4	41.5	84.9	33.0	44.3	48.7	48.5	63.8	46.8	109.8	99.1	61.6	94.1	66.3	40.3	61.0	48.8	64.2	95.0	71.2	100.1	74.9	95.0	96.5	80.5	63.2	43.4	79.5	73.7	38.4	60.2	108.1	63.1	40.9	69.4	58.0	103.2	59.3	61.4	37.4	78.5	73.1	56.5	50.3	49.1	79.8	72.2	58.1	64.8	33.3	54.5	53.3	68.8	58.9	77.0	59.4	51.5	72.1	63.6	58.2	60.4	53.0	76.2	35.7	60.0	130.0	59.4	116.2	71.5	57.7	32.0	26.6	36.2	41.5	43.0	36.4	37.7	36.7	37.9	36.5	31.9	35.4	6.2	49.3	51.2	19.3	39.4	43.3	18.3	18.4	23.1	22.2	17.7	15.9	17.2	15.2	16.6	13.7	17.9	19.1	18.4	28.9	18.3	17.0	26.1	13.3	14.3	19.8	26.2	14.9	11.0	23.6	6.4	12.8	29.2	5.5	47.9	26.5	18.8	16.4	9.8	25.0	16.4	14.3	21.0	20.1	9.0	28.0	20.3	31.9	34.3	17.2	31.1	19.2	20.2	26.2	13.9	11.1	24.7	21.9	24.3	16.5	22.4	15.1	14.1	7.1	29.5	18.7	12.4	9.4	24.0	6.1	28.8	30.2	15.2	30.2	9.4	23.0	26.8	8.5	12.7	8.8	27.3	34.8	13.1	18.4	17.6	21.9	20.8	28.7	13.4	22.7	21.2	19.7	20.1	10.0
EXOSC2	"hRrp4p, p7, RRP4, Rrp4p"	ENSG00000130713	"Exosome component 2"	Q13868	9	130693721-130704894	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Deafness, Disease variant, Dwarfism, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021756, HPA021790"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli"		"HPA021756: AB_2670809, HPA021790: AB_1848320"	"unprognostic (8.19e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (4.36e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (8.33e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.73e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.41e-1)"	9.1	8.2	8.6	13.8	8.7	9.9	12.6	8.9	11.1	8.9	8.6	10.3	7.7	12.8	6.8	10.0	12.8	5.6	8.8	8.9	8.9	9.7	13.0	6.7	13.0	8.5	8.6	14.8	9.9	11.5	3.2	9.2	8.4	9.3	11.9	10.6	7.1	9.0	15.0	8.4	8.3	12.9	8.9	8.3	8.2	4.1	8.6	14.6	8.4	12.0	15.8	10.1	8.6	9.3	39.9	79.7	46.6	41.2	16.8	18.9	34.0	58.6	28.1	57.4	44.1	64.4	33.7	79.0	31.2	31.8	62.9	71.0	75.8	58.8	62.9	46.9	36.7	63.1	75.2	45.3	31.3	96.7	39.9	24.0	21.7	80.8	94.1	21.1	41.6	52.3	70.1	33.1	41.0	70.3	68.2	27.3	57.8	109.3	51.0	52.3	85.8	85.5	27.5	36.4	28.6	31.8	68.3	51.4	31.1	32.8	53.5	34.1	25.5	56.1	43.5	50.2	83.3	16.8	71.4	117.2	40.0	55.0	44.7	1.7	7.3	6.0	10.0	8.3	10.6	11.6	10.2	8.9	10.4	10.0	11.1	9.4	1.6	16.5	5.7	7.1	10.1	7.7	8.6	8.7	8.9	11.1	8.9	8.9	8.5	8.6	8.4	8.9	8.6	9.3	7.6	6.4	20.5	3.6	13.5	10.6	12.6	7.7	8.0	12.4	6.1	8.3	8.7	4.3	5.7	3.7	6.2	19.1	10.6	6.0	5.9	13.4	1.4	3.8	11.4	8.0	1.2	23.5	5.3	11.3	22.8	9.8	5.1	4.5	12.7	14.0	7.1	10.7	12.8	5.0	5.2	7.9	4.1	2.5	5.7	1.7	8.4	7.8	7.2	1.9	5.4	14.7	13.4	4.5	4.0	8.3	2.7	7.9	13.7	14.2	5.0	10.4	6.7	15.0	6.6	11.7	10.2	5.8	10.9	10.6	8.4	8.3	10.1	11.9	10.0	8.1
EXOSC9	"p5, p6, PM/Scl-75, PMSCL1, RRP45, Rrp45p"	ENSG00000123737	"Exosome component 9"	Q06265	4	121801318-121817021	"Disease related genes, Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 154.0;Spermatocytes: 170.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041838, HPA048257, CAB070171"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoli	Nucleoplasm	"CAB070171: AB_11026964, HPA041838: AB_10794492, HPA048257: AB_2680331"	"unprognostic (7.36e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (7.89e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.25e-2)"	"unprognostic (9.85e-3)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (3.28e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.21e-2)"	14.7	14.3	9.2	16.7	9.9	37.9	14.4	10.5	15.3	11.9	8.4	11.7	9.3	12.9	14.4	12.3	12.9	8.1	15.7	9.4	9.9	11.8	16.0	13.6	25.8	9.3	9.2	12.9	11.2	14.7	11.0	14.1	9.3	10.4	12.6	9.9	11.9	9.3	21.6	13.9	12.0	10.2	9.0	15.8	11.7	43.4	9.2	32.8	10.1	18.6	21.1	14.8	11.9	10.4	66.3	29.9	76.7	44.4	10.7	20.6	39.2	83.7	45.4	114.6	84.5	32.5	53.2	113.9	20.1	50.5	35.7	23.2	83.1	38.1	95.6	51.1	39.9	56.8	43.4	43.0	26.0	98.5	51.1	16.1	20.1	77.8	20.3	23.7	56.0	72.6	102.2	42.3	110.0	38.9	154.6	78.6	42.7	25.2	34.7	80.6	134.4	52.4	41.4	21.0	51.3	53.7	28.8	45.5	52.3	38.9	38.2	64.2	35.2	50.4	76.5	44.4	80.9	63.0	49.7	132.5	52.4	67.8	34.2	15.8	14.5	23.4	17.6	21.1	18.5	20.7	20.9	25.4	17.9	22.4	22.1	22.6	3.8	14.4	21.3	15.9	24.9	14.0	9.2	9.9	10.5	15.3	9.4	9.9	9.3	9.2	9.3	9.0	9.2	10.4	20.4	44.8	19.1	4.9	20.8	12.7	15.5	31.7	18.8	10.7	6.7	10.7	13.2	17.2	25.4	3.7	10.4	31.4	21.5	5.7	1.9	23.7	154.0	10.9	15.6	17.6	6.0	27.0	10.4	30.5	31.3	15.8	7.7	11.8	31.0	25.4	10.0	5.5	24.5	16.8	8.8	9.8	28.5	11.9	10.1	21.8	13.1	16.3	8.8	11.2	22.2	15.3	16.5	6.6	10.9	20.2	9.2	10.9	22.9	8.4	6.5	8.5	16.8	17.7	6.6	23.4	21.8	170.4	62.8	14.1	14.8	10.9	26.2	16.5	11.6	12.1
EYA3	DKFZp686C132	ENSG00000158161	"EYA transcriptional coactivator and phosphatase 3"	Q99504	1	27970344-28088637	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 80.2;Oligodendrocytes: 80.5;Spermatocytes: 98.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052432, HPA062889"	Uncertain		Supported	Nucleoplasm		Yes	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA052432: AB_2681831, HPA062889: AB_2684895"	"unprognostic (3.57e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.74e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (5.11e-4)"	"unprognostic (1.39e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.13e-2)"	"unprognostic (8.98e-2)"	"prognostic favorable (3.15e-6)"	"unprognostic (5.17e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.60e-2)"	"unprognostic (6.11e-2)"	4.7	4.8	7.4	8.2	7.0	5.2	7.1	8.8	7.9	7.4	9.6	5.7	5.9	6.1	6.4	9.9	6.2	4.3	6.4	6.5	7.6	11.6	6.0	5.9	9.4	7.1	7.1	6.4	6.5	8.3	7.6	7.7	7.2	6.1	6.2	10.5	5.6	5.4	7.1	9.0	6.3	5.5	6.4	7.2	5.5	11.4	7.6	9.4	9.3	8.3	14.4	7.1	6.1	7.9	16.3	6.6	13.1	9.7	14.9	11.6	7.3	11.8	11.0	13.2	12.9	6.4	9.5	25.5	12.3	7.8	4.9	15.3	24.4	9.5	15.6	13.4	13.5	28.2	14.4	11.6	8.8	27.9	25.2	7.0	8.3	14.6	9.7	11.3	17.0	9.0	26.9	9.6	11.9	7.0	18.0	18.5	27.5	12.6	8.6	13.2	24.9	16.8	15.3	8.8	14.9	8.2	12.6	7.6	11.0	10.5	6.2	7.3	16.6	15.9	8.4	15.1	9.4	13.9	15.2	22.0	11.5	26.7	7.0	5.7	6.8	7.3	7.5	6.9	6.7	5.2	5.8	5.4	8.3	4.6	4.9	5.6	6.4	7.1	6.1	5.1	5.4	1.9	7.4	7.0	8.8	7.9	6.5	7.6	7.1	7.1	7.2	6.4	7.6	7.9	12.6	9.6	10.8	46.4	17.5	17.8	11.3	10.0	9.6	18.3	12.0	7.1	9.2	12.8	7.9	25.8	16.7	13.0	10.6	8.2	15.6	13.5	80.2	13.6	13.2	12.9	20.4	9.9	66.0	8.9	14.4	11.6	16.8	15.3	12.0	15.8	14.6	8.7	9.7	18.5	58.8	9.1	12.2	13.3	46.1	39.1	10.2	14.6	12.4	39.4	12.9	8.1	10.3	45.2	80.5	14.5	10.9	6.0	13.7	12.0	13.8	18.0	5.7	20.6	13.1	11.1	8.4	98.7	50.6	10.7	22.9	10.9	15.8	9.6	10.5	11.7
FAAP24	"C19orf40, FLJ46828, MGC32020"	ENSG00000131944	"FA core complex associated protein 24"	Q9BTP7	19	32972209-32978229	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 14.6;Spermatocytes: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041168	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Vesicles	"HPA041168: AB_10960496"	"unprognostic (1.18e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (6.52e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.58e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.82e-3)"	"unprognostic (3.54e-2)"	"prognostic unfavorable (4.00e-7)"	"unprognostic (4.37e-3)"	"unprognostic (5.30e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.15e-1)"	1.7	1.4	0.8	2.6	0.7	3.5	1.8	1.2	1.1	1.0	1.1	1.7	1.8	1.3	2.4	1.8	1.4	2.3	0.7	0.8	0.6	1.2	1.4	1.4	3.1	1.4	0.6	2.5	0.9	0.4	0.8	1.6	1.0	4.8	2.5	0.5	1.2	1.1	0.5	2.8	2.2	1.5	0.4	2.4	1.4	6.2	0.9	2.6	1.8	0.2	3.5	1.5	1.2	2.2	6.0	15.0	5.7	9.3	3.2	6.3	4.9	7.7	8.2	14.5	18.8	10.3	9.7	7.0	11.2	3.2	11.4	4.2	11.7	5.9	11.5	19.4	5.4	15.3	5.8	7.6	1.7	5.2	7.5	3.5	3.5	9.0	5.3	2.3	5.9	11.2	8.2	7.1	11.1	6.7	11.6	7.1	2.6	8.7	6.7	10.2	5.1	3.9	2.9	3.6	5.9	4.9	8.7	9.9	6.1	6.2	6.6	13.7	3.5	14.2	6.6	6.2	7.2	5.5	12.4	9.6	10.1	11.9	9.6	15.3	5.7	8.8	3.2	6.9	3.8	6.4	4.0	4.9	3.6	6.2	3.6	5.2	13.9	7.1	7.8	6.9	5.6	3.2	0.8	0.7	1.2	1.1	0.8	0.6	1.4	0.6	1.0	0.4	0.9	2.2	1.7	3.2	1.1	0.0	3.0	0.0	3.3	0.0	1.8	1.5	3.9	3.6	0.5	2.8	1.3	3.7	2.1	11.1	6.5	1.2	1.9	1.6	7.2	4.4	3.0	2.1	1.2	7.4	0.0	8.0	14.6	3.1	0.5	6.3	1.3	7.1	3.6	0.4	8.2	5.0	0.0	2.4	0.0	5.1	0.0	12.3	3.4	3.5	0.0	0.0	7.0	0.6	2.1	0.0	0.0	4.2	2.4	3.4	2.6	3.2	3.5	1.0	0.0	1.0	0.0	2.7	2.2	22.6	8.3	2.7	0.0	5.1	2.5	5.8	2.7	2.6
FAF1	"CGI-03, hFAF1, HFAF1s, UBXD12, UBXN3A"	ENSG00000185104	"Fas associated factor 1"	Q9UNN5	1	50437028-50960267	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 202.4;Excitatory neurons: 296.7;Inhibitory neurons: 278.9;Microglial cells: 177.1;Oligodendrocyte precursor cells: 269.9;Oligodendrocytes: 424.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018253, CAB072814"	Approved		Supported	Nucleoplasm		NA	NA		12000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"CAB072814: , HPA018253: AB_1848351"	"unprognostic (1.52e-1)"	"unprognostic (1.25e-2)"	"unprognostic (6.49e-3)"	"unprognostic (4.69e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (1.87e-5)"	"unprognostic (2.51e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.82e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.01e-3)"	"unprognostic (6.42e-3)"	18.2	16.8	21.0	9.2	22.0	21.0	18.5	21.8	27.5	18.9	18.7	23.7	12.4	18.2	11.7	23.1	15.7	8.7	34.9	22.3	22.1	21.5	23.6	14.9	13.1	21.5	21.5	19.9	26.2	23.2	20.6	10.6	22.0	18.5	12.7	19.6	18.1	16.3	67.9	28.1	16.4	13.4	21.8	14.0	18.2	47.8	21.2	22.2	18.3	37.6	14.1	21.4	18.7	25.9	37.4	27.1	23.1	39.3	22.4	21.1	33.9	35.5	32.1	53.9	48.8	30.4	26.0	59.9	25.7	30.5	47.5	27.2	37.3	33.1	45.9	40.1	33.5	49.9	33.5	31.6	36.4	54.3	28.5	19.8	29.4	57.0	69.4	27.8	29.5	44.5	58.9	0.2	28.1	15.0	56.6	43.0	30.6	49.3	19.2	52.1	50.7	0.0	54.9	33.1	0.3	28.6	32.3	64.9	56.4	32.0	20.4	64.1	18.2	30.4	37.3	37.8	0.2	45.1	50.6	69.3	0.0	77.6	35.7	1.1	2.1	4.9	4.0	2.7	5.5	2.5	3.6	4.0	3.6	4.2	4.3	2.8	0.7	4.3	3.5	2.9	6.1	1.6	21.0	22.0	21.8	27.5	22.3	22.1	21.5	21.5	22.0	21.8	21.2	25.9	17.9	6.4	18.2	202.4	26.9	21.4	38.5	27.8	33.6	19.9	16.9	16.9	43.9	11.5	27.2	16.5	27.1	14.2	18.0	13.1	29.4	8.8	75.1	15.1	15.6	14.2	11.4	44.6	296.7	11.6	28.2	16.0	29.0	16.9	5.7	19.2	10.4	18.2	11.4	16.8	278.9	17.8	6.1	13.6	18.0	117.2	11.1	15.4	16.0	177.1	8.9	20.0	15.5	269.9	424.4	8.5	9.7	10.9	35.4	18.3	20.0	28.3	32.7	33.0	6.6	26.2	20.3	36.9	15.6	37.9	28.1	15.3	27.9	19.6	21.6	34.1
FAM120A	"C9orf10, KIAA0183, OSSA"	ENSG00000048828	"Family with sequence similarity 120A"	Q9NZB2	9	93451685-93566112	"Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019734, HPA055800"	Approved		Enhanced	Cytosol		NA	NA		12000	"Cluster 35: T-regs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA019734: AB_1848369, HPA055800: AB_2682925"	"unprognostic (5.92e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (5.03e-4)"	"unprognostic (3.36e-1)"	"unprognostic (2.33e-2)"	"unprognostic (8.93e-2)"	"unprognostic (5.84e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.71e-3)"	"prognostic favorable (1.08e-7)"	"unprognostic (8.16e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.00e-2)"	48.1	47.8	26.7	59.7	30.8	49.9	37.8	25.8	27.0	45.0	55.0	74.4	59.0	39.2	36.0	46.6	50.8	42.3	60.9	26.0	24.2	47.7	55.7	42.0	56.5	32.6	29.3	39.1	57.9	87.3	26.8	60.3	28.8	42.7	69.1	30.6	56.2	40.8	81.7	41.9	58.4	50.9	25.3	49.0	69.3	17.4	30.3	45.5	49.0	71.4	45.6	53.4	33.0	28.7	179.7	145.4	32.0	92.8	93.7	116.6	100.3	123.2	107.8	92.9	68.0	47.5	108.2	116.1	68.9	156.2	73.7	188.8	86.5	144.3	71.1	117.0	62.8	63.8	126.1	75.3	104.6	109.0	83.5	114.3	87.2	105.7	166.3	90.9	133.7	81.0	74.4	94.9	101.3	202.8	108.2	61.4	41.2	212.7	134.3	62.1	85.6	97.4	112.3	107.2	85.8	52.5	139.5	166.4	86.0	31.4	91.0	70.6	140.6	99.6	71.6	123.8	136.4	74.2	78.6	44.8	107.9	96.6	90.9	3.1	6.6	5.2	4.9	7.5	4.1	4.4	4.3	4.8	6.1	3.5	3.0	4.4	13.1	4.3	9.3	3.9	8.3	4.1	26.7	30.8	25.8	27.0	26.0	24.2	32.6	29.3	28.8	25.3	30.3	28.7	64.0	44.8	93.9	67.9	42.7	102.2	49.6	56.6	70.6	30.0	86.5	49.0	112.3	77.2	75.2	75.4	50.1	73.8	49.2	164.3	21.5	50.1	26.1	77.5	76.2	64.9	91.8	60.2	92.1	74.7	104.9	60.5	123.8	92.3	48.8	66.1	63.1	186.6	71.0	40.4	62.5	176.8	36.7	146.4	78.6	9.8	66.8	103.4	53.4	80.6	111.0	35.7	35.0	64.3	80.9	86.4	92.0	65.5	60.8	125.8	81.0	75.7	87.8	33.7	39.5	63.5	68.6	12.3	12.4	91.1	114.2	103.4	49.3	94.4	177.2	109.0
FAM133B	MGC40405	ENSG00000234545	"Family with sequence similarity 133 member B"	Q5BKY9	7	92560758-92590393	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066175, HPA069513"			Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoli	Nucleoplasm	"HPA066175: AB_2685629, HPA069513: AB_2686143"	"unprognostic (5.54e-2)"	"unprognostic (4.42e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.87e-3)"	"unprognostic (8.56e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.73e-3)"	"unprognostic (9.01e-3)"	"unprognostic (3.16e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.38e-2)"	14.4	13.7	21.5	12.7	23.5	35.5	16.2	25.6	43.1	15.8	20.5	13.6	13.4	14.3	22.4	13.6	13.2	9.8	11.1	21.5	20.6	13.0	16.6	11.1	16.6	22.1	21.8	16.7	15.8	11.8	12.5	10.6	23.1	13.7	11.9	9.5	13.2	11.1	16.2	14.4	13.2	10.8	21.1	14.0	13.1	8.2	23.3	17.3	14.0	15.1	14.6	13.6	14.3	26.8	24.5	12.1	34.5	55.4	20.8	22.8	20.0	29.1	29.9	26.4	32.5	21.1	27.6	43.5	26.5	19.0	22.7	19.9	28.5	17.5	40.0	22.4	37.5	35.2	20.6	43.9	20.5	36.8	27.6	14.6	17.8	20.4	24.5	21.0	16.1	31.6	46.0	50.4	29.9	30.8	58.8	59.2	50.0	22.6	16.8	42.9	36.9	34.0	26.7	27.5	35.1	31.7	26.3	29.3	32.1	32.9	27.7	26.6	19.8	28.7	46.6	37.4	30.5	12.1	14.4	76.3	18.8	48.5	39.6	15.9	13.8	14.0	12.7	15.0	18.5	30.3	16.4	17.2	13.7	23.4	19.5	17.3	5.8	15.2	11.4	31.2	21.0	7.7	21.5	23.5	25.6	43.1	21.5	20.6	22.1	21.8	23.1	21.1	23.3	26.8	157.6	57.7	64.3	23.8	146.2	114.3	196.1	130.7	84.2	83.7	120.3	113.2	27.8	184.5	87.9	88.3	75.0	61.7	258.3	126.9	99.7	93.3	47.8	174.1	167.5	89.3	137.3	119.5	28.0	87.0	62.0	99.6	59.1	294.0	87.0	76.3	109.9	120.9	72.4	55.5	27.1	118.7	95.6	121.2	155.1	19.2	102.6	116.5	76.5	27.2	112.5	104.8	121.5	27.6	57.8	89.2	122.3	88.8	139.3	126.1	84.2	98.1	55.1	73.8	52.6	207.3	107.0	100.9	115.7	75.4	104.8	70.6	151.7	78.5	113.3	137.9
FAM204A	"bA319I23.1, C10orf84, FLJ13188"	ENSG00000165669	"Family with sequence similarity 204 member A"	Q9H8W3	10	118297925-118342328	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038182, HPA062025"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA038182: AB_10669519, HPA062025: AB_2684663"	"unprognostic (1.60e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.45e-2)"	"unprognostic (8.52e-3)"	"unprognostic (4.47e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.13e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (8.59e-4)"	"unprognostic (5.55e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.76e-3)"	27.9	19.3	15.7	22.5	16.9	54.4	31.4	13.4	23.6	22.2	11.5	27.5	20.9	26.6	32.2	26.1	20.0	21.8	35.3	17.1	16.1	27.7	29.0	25.0	27.4	15.8	14.8	28.4	24.8	30.3	14.1	20.9	14.8	20.7	24.1	15.9	25.3	22.1	36.7	18.7	18.5	26.5	15.0	24.8	21.7	49.2	16.0	28.4	29.3	27.6	27.9	25.8	17.1	15.8	56.4	24.9	40.2	56.2	39.1	42.4	22.8	43.6	81.4	61.6	55.4	29.4	51.2	39.7	26.3	47.2	27.7	47.3	34.0	45.5	55.6	62.8	42.0	33.0	23.4	26.2	58.4	86.7	44.9	29.4	54.8	45.3	94.3	51.7	53.3	50.2	35.3	45.5	51.6	31.5	53.6	80.1	28.6	24.7	22.0	45.2	77.7	29.3	56.0	28.2	25.8	40.5	29.9	27.7	66.8	19.6	44.0	61.7	37.4	32.2	30.1	28.8	67.4	32.4	31.0	57.0	62.8	92.2	33.3	73.5	57.5	70.4	36.9	64.2	39.0	50.6	41.8	34.4	59.6	35.2	35.6	41.8	32.0	34.4	69.3	43.0	51.5	57.1	15.7	16.9	13.4	23.6	17.1	16.1	15.8	14.8	14.8	15.0	16.0	15.8	71.9	60.9	55.7	54.5	66.0	55.6	63.0	60.9	63.7	38.8	61.0	67.4	78.6	52.9	47.3	44.1	73.0	39.5	84.8	30.2	135.0	85.5	255.8	62.5	79.4	67.8	41.9	59.5	49.9	113.7	49.8	72.4	41.8	60.3	68.4	140.6	64.6	49.8	62.4	33.7	48.3	56.0	63.1	69.4	76.2	132.0	76.4	73.0	60.5	27.2	77.2	62.5	92.7	53.3	45.4	95.3	68.9	70.0	62.9	54.6	35.4	115.7	44.2	55.4	26.3	73.7	78.3	258.5	170.3	55.6	50.6	30.6	62.8	62.6	48.4	61.6
FAM216A	"C12orf24, HSU79274"	ENSG00000204856	"Family with sequence similarity 216 member A"	Q8WUB2	12	110468415-110490385	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 15.5;testis: 59.4"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 54.7;Spermatocytes: 215.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038286	Enhanced		Approved	"Actin filaments"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Actin filaments"		"HPA038286: AB_2675931"	"unprognostic (7.91e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.02e-3)"	"unprognostic (3.04e-1)"	"unprognostic (2.76e-1)"	"prognostic unfavorable (4.49e-5)"	"unprognostic (8.49e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.04e-3)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (4.18e-10)"	"unprognostic (7.60e-2)"	"unprognostic (4.35e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.05e-1)"	3.4	7.5	9.4	6.6	9.6	4.1	3.8	12.9	15.5	4.8	4.7	3.6	1.1	5.8	2.0	3.2	4.5	4.3	9.1	9.7	12.7	3.0	3.2	2.1	7.4	10.4	9.4	7.0	2.0	5.5	5.2	3.6	10.3	3.9	2.2	8.8	1.7	4.4	3.3	1.4	3.2	6.0	8.9	3.9	2.3	59.4	11.1	7.3	3.2	4.3	4.5	4.8	3.2	9.7	31.1	25.8	21.6	28.5	13.7	25.9	3.5	57.3	14.4	63.9	28.3	27.5	8.5	101.2	13.1	24.2	18.1	19.9	38.1	33.3	77.9	30.0	72.8	49.9	17.6	23.4	22.8	68.3	39.1	25.1	7.8	32.5	71.6	47.8	20.5	39.5	63.1	26.7	48.4	11.2	50.4	106.4	64.6	13.6	41.9	24.4	29.6	68.9	24.7	0.9	77.4	27.5	24.4	18.4	14.2	7.8	43.6	49.2	18.9	22.4	7.5	19.9	58.8	41.7	38.9	79.7	31.7	61.0	37.7	0.9	3.6	1.0	1.9	3.1	3.7	7.3	3.7	3.6	4.5	8.2	9.3	5.6	2.9	2.8	2.6	2.4	2.4	3.9	9.4	9.6	12.9	15.5	9.7	12.7	10.4	9.4	10.3	8.9	11.1	9.7	2.4	0.0	1.5	7.8	9.6	1.7	6.0	8.7	7.4	11.6	3.0	7.5	20.1	0.0	3.6	3.7	2.1	0.7	1.4	0.1	0.0	4.1	38.6	3.2	17.5	4.4	1.2	17.2	20.4	0.9	3.0	10.8	1.1	0.7	10.2	6.6	3.9	3.4	8.1	13.5	21.6	0.1	2.0	4.4	2.1	54.7	9.6	3.7	3.6	5.6	4.2	4.2	6.2	14.1	8.9	2.8	0.0	5.7	3.9	8.0	0.1	4.4	5.1	5.1	13.1	8.4	9.3	215.9	21.6	5.1	2.0	0.5	3.6	12.2	0.4	1.5
FAM72A	"LMPIP, MGC57827, p17, RP11-312O7.1, UGENE"	ENSG00000196550	"Family with sequence similarity 72 member A"	Q5TYM5	1	206186179-206204414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 10.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 29.5;Kupffer cells: 18.2;Late spermatids: 30.2;Spermatocytes: 28.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	Yes			"Cluster 7: Monocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles	"Plasma membrane, Cytosol"	"HPA043271: AB_2678402, HPA067321: "	"unprognostic (3.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.20e-5)"	"unprognostic (3.61e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.01e-5)"	"unprognostic (7.70e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.58e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.44e-16)"	"unprognostic (1.82e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.89e-1)"	4.0	3.1	2.6	5.9	2.9	8.4	3.6	9.1	3.1	1.3	1.0	2.2	3.1	0.9	0.4	2.5	1.8	2.7	1.2	3.1	4.0	1.3	2.0	2.6	10.9	5.4	4.4	1.1	1.4	1.6	0.8	3.5	5.8	1.1	2.3	0.2	1.0	0.7	0.6	5.9	2.9	2.0	4.1	6.3	1.5	7.1	4.8	8.6	0.9	1.0	7.5	1.5	1.5	4.7	21.1	16.4	17.7	7.7	2.6	3.1	21.1	14.6	6.3	17.1	12.7	9.9	31.1	54.2	12.3	3.8	18.8	24.7	20.9	8.1	20.2	29.5	16.3	24.3	16.4	13.9	1.8	42.9	27.0	4.4	1.4	15.1	26.7	5.1	10.7	45.7	50.1	36.7	10.7	12.9	26.9	38.3	32.1	15.1	22.1	29.5	30.6	41.4	9.8	3.2	17.7	10.2	10.6	9.7	9.3	20.1	20.5	23.2	5.5	13.5	15.5	17.7	24.9	29.1	44.8	48.4	11.1	34.9	18.8	0.0	5.9	0.0	0.7	8.0	0.2	1.7	1.4	1.4	4.6	0.5	0.1	0.3	1.0	0.6	4.8	1.9	2.9	2.1	2.6	2.9	9.1	3.1	3.1	4.0	5.4	4.4	5.8	4.1	4.8	4.7	5.9	0.0	1.5	0.0	2.4	1.8	0.4	1.2	1.2	0.3	0.8	0.6	1.5	0.0	0.9	0.0	0.0	0.8	3.7	4.9	0.0	1.0	29.5	1.5	1.5	8.4	0.0	0.4	0.1	0.8	3.8	1.8	0.5	0.7	0.0	0.3	7.1	0.4	9.4	0.0	0.2	3.6	0.0	18.2	5.8	30.2	0.0	6.9	3.6	0.0	9.6	0.6	2.1	0.0	0.1	0.6	0.0	0.0	1.6	0.4	1.3	0.3	2.1	0.2	0.0	0.9	2.2	28.0	4.1	2.0	1.0	0.7	1.4	0.8	1.6	0.8
FAM72B	RP11-439A17.6	ENSG00000188610	"Family with sequence similarity 72 member B"	Q86X60	1	121167646-121185539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.2;lymphoid tissue: 10.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 7.3;Early spermatids: 11.3;Erythroid cells: 5.9;Hepatic stellate cells: 6.4;Spermatocytes: 17.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	Yes			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Vesicles	"Plasma membrane, Cytosol"	"HPA043271: AB_2678402, HPA067321: "	"unprognostic (8.53e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.25e-3)"	"unprognostic (4.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.26e-4)"	"unprognostic (8.22e-5)"	"unprognostic (1.30e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.36e-4)"	"unprognostic (2.46e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.39e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.30e-2)"	0.8	0.6	1.2	3.7	1.0	6.2	0.8	2.0	1.1	0.5	1.3	1.1	1.3	0.5	0.4	1.6	0.4	1.0	0.3	1.2	1.2	0.4	0.4	0.6	8.1	1.6	1.4	0.4	0.2	0.7	0.2	1.4	1.6	0.2	1.2	0.1	0.4	0.2	0.1	1.9	1.1	0.7	1.3	2.0	1.0	2.3	1.3	10.3	0.3	0.2	6.6	0.8	0.7	1.4	28.6	10.3	16.5	8.2	1.6	2.4	13.3	14.7	6.2	16.8	14.1	0.1	14.5	62.9	19.9	2.7	16.4	17.1	23.1	8.3	25.9	41.1	17.3	27.2	12.0	12.5	1.0	47.7	23.2	1.3	0.9	13.0	26.5	4.2	10.3	51.0	36.1	37.3	12.4	12.1	24.1	39.1	31.6	14.9	20.6	35.8	35.8	28.7	6.7	3.2	18.0	10.4	11.1	8.6	8.6	16.9	11.4	36.5	3.6	13.8	23.5	27.3	26.6	32.6	44.1	61.3	12.4	50.8	32.6	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.4	0.3	1.2	1.0	2.0	1.1	1.2	1.2	1.6	1.4	1.6	1.3	1.3	1.4	1.3	0.0	0.0	0.0	1.6	1.0	0.1	0.2	0.0	0.0	0.3	0.6	0.4	0.0	0.1	0.0	0.0	0.8	0.1	7.3	0.0	0.2	11.3	0.2	0.4	2.5	0.0	5.9	0.1	0.2	2.3	0.6	1.1	0.2	0.0	0.5	6.4	0.0	1.1	0.0	0.3	4.9	0.0	1.9	2.8	3.0	0.6	1.6	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.1	2.3	0.0	2.5	0.0	2.1	0.0	0.7	0.0	0.0	0.3	0.9	17.0	3.1	3.5	1.0	0.1	1.2	0.2	3.6	0.0
FAM76B	MGC33371	ENSG00000077458	"Family with sequence similarity 76 member B"	Q5HYJ3	11	95768953-95790409	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 39.5"	"Group enriched"	"Detected in many"	7	"Early spermatids: 261.6;Late spermatids: 372.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036608	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA036608: AB_2675215"	"unprognostic (8.17e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.90e-3)"	"prognostic unfavorable (7.17e-5)"	"unprognostic (1.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.43e-1)"	"prognostic favorable (2.72e-4)"	5.8	5.0	1.1	12.5	1.6	39.5	5.2	4.2	2.3	4.2	1.7	4.9	9.2	6.8	1.6	4.0	3.9	5.3	4.0	1.2	1.0	3.1	8.2	5.0	17.1	1.9	1.8	5.5	6.1	3.7	2.3	6.7	1.8	4.7	5.1	5.3	4.7	3.3	3.9	5.8	6.4	4.5	1.1	8.4	5.9	17.7	1.8	14.2	5.5	3.7	17.6	4.9	3.7	3.4	8.0	6.0	22.1	12.0	3.6	3.6	18.4	13.4	6.4	9.6	11.0	22.4	15.3	29.8	16.5	6.4	12.5	15.0	13.1	4.5	10.1	16.1	9.5	35.0	10.9	11.8	9.2	25.0	19.3	4.7	7.3	11.1	9.9	6.3	9.3	17.5	21.1	16.1	5.5	5.8	28.0	29.9	12.3	8.5	5.4	30.0	16.5	17.7	7.3	8.8	9.3	26.3	16.3	9.1	10.1	7.4	12.1	10.9	9.5	13.4	14.1	15.8	12.3	8.8	19.7	45.5	3.2	23.8	19.2	0.1	1.9	3.5	3.3	2.0	2.7	1.8	3.0	3.4	1.3	1.5	2.7	4.1	5.7	3.3	1.9	4.8	5.2	1.8	1.1	1.6	4.2	2.3	1.2	1.0	1.9	1.8	1.8	1.1	1.8	3.4	27.9	6.4	16.5	14.7	41.5	13.8	12.5	8.4	22.8	16.1	17.0	16.4	12.9	8.6	14.0	5.5	27.1	8.5	28.9	10.5	0.0	7.7	261.6	23.2	23.4	19.2	20.4	34.1	18.7	7.5	10.1	14.9	15.3	18.3	10.8	21.0	15.4	19.8	8.3	11.8	15.9	14.0	4.1	18.0	18.0	372.1	17.1	20.0	16.0	13.1	17.7	12.4	19.6	16.6	30.1	9.1	16.0	15.4	16.2	12.5	10.3	2.4	12.3	15.1	26.3	17.6	21.3	31.8	20.9	14.4	16.1	7.7	26.4	15.0	10.8	10.7
FAM83D	"C20orf129, CHICA, dJ616B8.3"	ENSG00000101447	"Family with sequence similarity 83 member D"	Q9H4H8	20	38926312-38953106	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 84.7;intestine: 83.1;smooth muscle: 95.3"	"Group enriched"	"Detected in many"	4	"Basal squamous epithelial cells: 44.9;Erythroid cells: 72.6;Extravillous trophoblasts: 67.5;Squamous epithelial cells: 71.7;Syncytiotrophoblasts: 152.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"B-cells: 1.1;NK-cells: 1.1;T-cells: 2.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA049333, HPA060854"			Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	Yes			"Cluster 26: Non-specific - Mitochondria"	"Cluster 37: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Mitotic spindle"	"Microtubules, Cytokinetic bridge, Cytosol"	"HPA049333: AB_2680717, HPA060854: "	"unprognostic (7.90e-3)"	"unprognostic (4.34e-2)"	"unprognostic (6.41e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (5.44e-6)"	"prognostic unfavorable (9.69e-4)"	"unprognostic (2.21e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.73e-5)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (1.81e-14)"	"unprognostic (2.57e-3)"	"unprognostic (5.74e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.87e-2)"	1.6	1.8	0.8	7.2	1.6	23.3	1.1	0.9	1.4	4.1	0.2	83.1	8.4	1.0	1.6	84.7	1.0	13.6	1.0	0.9	0.5	5.7	3.7	5.2	4.5	0.5	0.4	0.5	0.4	0.2	0.4	3.4	0.5	16.2	8.6	0.2	7.8	1.7	0.2	10.2	34.7	95.3	0.5	1.9	44.9	5.0	0.5	6.6	1.0	0.2	12.2	27.0	17.1	0.9	112.2	67.3	52.0	44.0	5.8	6.5	93.6	49.3	30.2	94.7	57.4	103.4	49.7	28.3	47.6	32.1	73.4	93.1	71.8	83.9	87.9	9.4	28.6	32.6	50.7	75.2	4.7	14.6	16.5	3.3	4.2	54.6	31.4	11.4	52.7	12.3	29.6	39.5	54.4	59.7	22.7	21.3	43.2	64.4	85.1	21.8	96.0	15.6	27.6	28.0	24.3	40.2	143.0	117.4	20.6	48.1	73.6	14.9	25.4	62.4	76.4	71.6	110.1	12.0	19.6	29.0	28.1	21.2	46.7	0.0	0.0	0.0	0.2	0.1	0.9	0.6	1.0	1.1	0.0	1.1	1.1	1.4	0.0	1.1	0.1	0.0	2.0	0.5	0.8	1.6	0.9	1.4	0.9	0.5	0.5	0.4	0.5	0.5	0.5	0.9	3.9	0.0	1.3	0.3	2.3	2.3	5.8	7.0	44.9	0.0	2.8	9.0	0.8	1.5	18.0	0.0	0.0	17.3	6.3	6.5	0.0	0.1	0.5	1.1	1.6	2.2	1.8	72.6	3.7	0.0	67.5	2.7	18.3	2.1	0.0	8.2	1.8	5.7	4.8	0.0	1.2	6.0	4.1	1.6	0.5	0.6	0.3	2.6	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.1	6.0	0.0	12.5	1.6	1.7	8.3	4.5	0.0	19.7	0.3	4.0	15.7	18.3	71.7	1.8	152.6	5.2	0.3	10.2	4.1
FAM98B	FLJ38426	ENSG00000171262	"Family with sequence similarity 98 member B"	Q52LJ0	15	38454127-38487710	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008320, HPA008502"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA		20000	"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Vesicles"		"HPA008320: AB_1848419, HPA008502: AB_1848420"	"unprognostic (1.05e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	12.7	11.4	9.5	12.8	10.2	9.8	12.9	16.4	12.6	9.7	7.2	15.4	9.6	13.3	9.0	9.0	8.1	7.0	12.4	10.8	10.9	13.1	7.8	8.1	13.8	9.4	9.7	11.2	6.1	19.3	6.4	12.0	10.0	12.1	11.6	19.8	6.3	10.0	13.8	8.8	10.0	9.5	10.1	11.2	9.5	8.5	9.6	28.6	11.7	16.3	13.3	11.9	7.0	12.6	30.7	16.2	77.7	40.0	14.1	25.7	37.9	38.6	28.2	37.4	37.5	35.8	14.4	21.1	41.4	32.2	37.9	31.8	47.4	39.5	52.2	21.8	25.7	62.6	33.9	27.8	20.4	59.8	34.6	23.9	24.1	33.3	38.5	27.4	38.9	45.7	45.6	25.7	36.0	13.8	50.7	31.8	42.0	34.8	22.3	53.3	42.0	17.7	32.8	39.9	47.8	48.9	42.5	27.0	19.8	34.6	33.0	36.6	32.7	42.1	51.5	28.2	44.0	47.6	46.1	78.3	23.1	38.9	44.8	2.3	0.5	1.4	2.8	0.4	2.4	1.6	2.8	2.3	0.6	1.9	3.4	2.6	0.4	2.2	0.6	1.4	1.9	0.4	9.5	10.2	16.4	12.6	10.8	10.9	9.4	9.7	10.0	10.1	9.6	12.6	17.9	16.0	21.4	16.3	16.8	14.7	12.7	14.1	14.2	36.8	15.2	11.6	48.9	12.8	18.1	16.5	16.7	30.6	16.4	11.0	7.9	16.4	3.4	19.1	21.5	16.9	12.6	16.6	22.5	19.8	22.4	16.6	16.8	17.0	13.3	18.4	16.8	13.1	12.6	20.2	20.5	22.6	12.2	15.8	12.2	2.5	12.5	10.9	5.4	18.7	21.4	18.5	21.6	12.1	23.8	14.3	9.8	17.0	18.2	12.4	11.1	12.7	18.8	27.9	6.6	21.5	16.2	27.2	17.1	19.7	14.8	21.5	15.3	14.7	19.3	14.1
FANCA	"FA-H, FAA, FACA, FAH, FANCH"	ENSG00000187741	"FA complementation group A"	O15360	16	89737549-89816657	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 20.2;testis: 21.6"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 44.1;Spermatogonia: 38.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA063236			Supported	Nucleoplasm		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA063236: AB_2684966"	"unprognostic (5.99e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.36e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.45e-4)"	"unprognostic (9.21e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.82e-3)"	"unprognostic (8.48e-4)"	"unprognostic (7.82e-10)"	"unprognostic (3.67e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.62e-1)"	1.4	1.9	1.7	6.7	1.9	20.2	1.9	2.4	3.3	2.1	1.5	5.5	5.2	1.2	0.8	6.6	2.0	1.2	1.6	1.8	1.2	2.9	6.1	3.4	12.5	1.4	1.1	1.4	1.9	1.4	1.9	4.1	1.5	1.7	6.2	1.0	2.1	0.6	0.7	5.2	5.6	2.1	1.1	6.7	3.6	21.6	1.5	8.1	1.7	0.6	13.5	2.2	2.7	1.9	23.2	34.8	40.8	35.7	2.6	5.2	31.2	28.2	15.3	46.5	19.5	30.6	37.3	56.2	12.9	9.8	15.5	34.7	27.7	21.1	48.8	13.4	46.5	16.6	49.1	63.4	1.7	17.1	17.5	1.7	2.2	37.8	12.0	6.6	14.9	28.0	40.9	16.9	24.6	53.6	34.6	73.7	26.5	31.5	21.3	61.4	32.8	10.3	11.8	21.5	36.3	19.7	41.9	12.3	5.4	23.3	22.4	30.4	11.1	37.0	38.9	20.9	30.0	15.1	19.0	56.3	17.5	37.8	36.1	2.5	7.4	9.9	4.2	8.5	3.0	7.0	2.4	3.7	6.2	4.6	0.6	2.6	9.4	8.2	9.2	0.4	9.2	4.2	1.7	1.9	2.4	3.3	1.8	1.2	1.4	1.1	1.5	1.1	1.5	1.9	1.5	0.0	1.1	0.7	9.6	3.4	1.6	2.6	0.0	8.1	3.0	2.0	2.9	0.0	3.5	16.5	10.4	16.0	12.3	5.1	1.9	2.0	5.9	2.8	3.5	2.1	1.8	20.8	10.0	1.6	9.9	3.3	9.2	3.4	2.5	19.0	5.3	4.7	8.8	3.3	5.7	8.1	2.0	4.1	3.1	4.1	1.5	6.8	0.0	1.0	3.0	1.1	21.6	3.0	1.7	1.9	1.7	0.0	21.1	1.3	6.6	10.4	6.4	7.7	0.0	2.7	3.5	44.1	38.5	3.8	1.8	25.3	9.3	6.8	11.4	2.6
FANCB	"FAAP95, FAB, FLJ34064"	ENSG00000181544	"FA complementation group B"	Q8NB91	X	14835961-14873069	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Fanconi anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 3.4;brain: 3.8"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 12.4;Oligodendrocytes: 33.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA003124	Uncertain					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA003124: AB_1078813"	"unprognostic (3.49e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.16e-2)"	"unprognostic (8.42e-3)"	"unprognostic (7.99e-2)"	"unprognostic (2.42e-2)"	"unprognostic (4.05e-5)"	"unprognostic (6.93e-3)"	"unprognostic (1.77e-3)"	"unprognostic (7.70e-3)"	"unprognostic (2.76e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-11)"	"unprognostic (4.46e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.96e-2)"	0.2	0.1	2.1	0.7	3.3	3.4	0.5	1.2	1.6	0.3	0.0	0.3	0.2	0.3	0.1	0.4	0.2	0.1	0.1	0.8	1.0	0.1	0.1	0.2	1.2	1.7	2.2	0.4	0.1	0.1	0.0	0.8	1.8	0.2	0.5	0.0	0.2	0.1	0.1	0.3	0.2	0.3	1.5	0.4	0.2	0.2	3.1	1.4	0.2	0.1	1.3	0.3	0.3	3.8	7.3	5.0	4.8	3.9	0.3	1.1	1.7	11.2	3.0	8.8	9.9	3.5	5.3	10.6	1.9	4.4	6.6	7.0	11.3	4.1	15.0	5.1	5.9	4.1	7.9	1.7	0.1	5.8	3.3	0.1	0.4	9.0	2.0	0.9	4.4	3.5	7.3	7.2	5.2	3.5	5.7	3.2	6.1	3.0	7.1	5.1	11.4	5.2	0.8	2.6	3.1	3.5	5.7	2.4	3.2	11.2	3.6	2.0	1.8	6.7	3.7	14.5	6.8	1.8	3.9	7.2	3.0	4.1	14.3	0.3	0.2	0.2	0.2	0.1	0.1	0.7	0.1	0.3	0.2	0.5	0.1	0.1	0.4	0.4	0.1	0.2	0.4	0.2	2.1	3.3	1.2	1.6	0.8	1.0	1.7	2.2	1.8	1.5	3.1	3.8	1.9	3.2	0.5	1.0	5.2	1.7	1.1	1.5	0.6	3.0	1.6	3.3	0.4	0.0	1.8	0.0	0.0	7.0	6.2	0.9	0.0	1.2	0.4	2.1	2.7	1.9	0.0	5.0	6.3	1.5	12.4	2.0	1.5	2.3	3.8	6.6	1.4	0.3	3.6	3.3	4.8	0.8	4.1	0.3	1.8	0.6	1.2	2.7	0.0	2.8	1.0	0.4	3.1	3.0	33.1	0.7	0.1	1.2	6.5	0.7	0.2	0.4	1.2	0.5	0.0	2.4	2.3	5.2	4.2	3.8	1.0	3.8	4.1	0.7	1.8	1.5
FANCC	"FA3, FAC, FACC"	ENSG00000158169	"FA complementation group C"	Q00597	9	95099054-95426796	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 24.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 178.6;Hepatocytes: 42.6;Late spermatids: 87.8;Microglial cells: 49.6;Oligodendrocytes: 48.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"basophil: 8.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 8.8"	"Cell line enhanced"	"Detected in all"		"RH-30: 47.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017793, HPA030771"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"CAB017793: , HPA030771: AB_2673604"	"unprognostic (1.48e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.26e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.37e-1)"	"unprognostic (8.00e-3)"	"unprognostic (3.19e-2)"	"prognostic favorable (6.03e-6)"	"unprognostic (2.35e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.71e-2)"	2.6	1.7	1.7	3.1	2.4	3.3	3.4	8.9	2.7	4.1	1.7	4.0	5.5	3.2	1.1	3.5	2.8	3.7	2.7	1.8	2.3	6.8	24.6	4.0	2.7	3.9	2.3	2.3	4.4	1.5	3.5	3.1	3.2	3.5	4.3	2.4	3.0	1.5	3.6	5.9	6.2	2.1	1.7	2.3	3.6	9.5	2.4	4.2	3.1	1.2	2.6	3.0	3.2	3.9	21.5	14.6	18.7	16.9	2.0	5.4	11.7	8.1	5.7	14.1	13.9	16.2	9.3	12.7	6.4	7.2	10.6	25.5	21.1	8.5	8.4	12.9	10.1	9.8	16.6	9.6	2.7	11.6	11.3	4.9	3.8	11.1	5.4	3.9	8.4	10.1	14.9	5.7	10.3	17.1	9.7	5.8	9.6	23.2	8.9	17.3	47.1	7.0	6.4	6.8	26.2	13.1	18.9	7.4	4.2	8.2	6.9	8.6	4.0	13.0	17.1	14.5	14.1	5.9	12.0	6.8	6.6	9.8	15.9	8.8	0.3	0.0	0.9	0.6	0.9	0.6	0.4	0.9	0.3	0.6	0.7	0.7	0.1	0.1	1.3	0.9	0.4	0.5	1.7	2.4	8.9	2.7	1.8	2.3	3.9	2.3	3.2	1.7	2.4	3.9	3.0	3.2	2.2	9.4	2.2	2.5	2.7	1.2	2.8	6.1	3.5	3.7	1.9	5.7	2.3	0.0	4.2	3.0	2.7	3.3	1.9	4.4	178.6	3.5	5.5	4.3	0.0	3.0	22.1	4.1	5.0	3.3	2.0	4.7	5.7	3.9	5.0	42.6	2.0	10.1	13.8	4.0	0.0	3.5	1.3	87.8	6.5	1.6	1.8	49.6	2.8	2.1	1.0	32.2	48.9	3.1	1.0	2.2	4.4	3.0	5.6	8.9	1.0	4.5	0.0	4.1	2.3	19.4	13.2	4.0	2.7	2.3	2.1	4.5	4.7	2.5
FANCG	"FAG, XRCC9"	ENSG00000221829	"FA complementation group G"	O15287	9	35073835-35079942	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 20.6;Spermatogonia: 20.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008105, HPA045335"	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	Yes			"Cluster 41: Basophils - Cellular respiration"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Cytosol"	Nucleoli	"CAB008105: AB_2231542, HPA045335: AB_2679292"	"unprognostic (9.41e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.83e-3)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (8.92e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.27e-3)"	"unprognostic (9.01e-2)"	"unprognostic (5.62e-2)"	"prognostic unfavorable (2.38e-7)"	"unprognostic (1.14e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.10e-1)"	3.4	3.1	2.8	5.1	2.8	12.4	4.5	3.6	3.8	5.1	2.1	4.3	4.9	4.2	2.3	5.9	5.8	3.3	1.9	2.7	2.7	3.9	2.9	3.3	7.7	2.8	2.7	6.2	6.3	4.7	3.0	4.5	2.7	3.9	4.0	2.4	4.3	4.1	2.3	6.5	4.6	4.5	2.5	5.5	4.1	6.4	2.7	12.2	4.0	1.7	6.9	3.5	4.6	3.4	34.7	40.7	30.4	28.3	6.4	10.2	25.0	23.6	16.3	44.9	42.5	20.1	21.2	33.4	15.8	7.7	33.1	20.5	25.3	22.0	17.6	38.7	14.8	24.5	45.5	13.2	1.8	24.5	26.9	8.1	4.1	39.5	18.2	8.0	23.8	40.7	15.7	44.3	23.5	31.5	43.2	34.5	32.5	26.4	30.1	43.8	35.2	23.1	10.9	14.6	14.4	26.1	15.7	22.3	8.3	13.4	28.4	17.2	13.4	21.0	42.8	28.3	33.1	12.4	24.0	20.6	19.2	18.5	30.1	10.5	0.7	6.7	6.1	2.2	5.3	5.6	4.8	4.6	1.9	5.4	3.6	3.8	1.1	7.8	2.0	4.2	8.2	3.1	2.8	2.8	3.6	3.8	2.7	2.7	2.8	2.7	2.7	2.5	2.7	3.4	3.2	3.2	4.6	6.8	4.9	4.5	6.1	3.9	10.2	4.7	5.9	5.0	1.5	2.8	3.3	3.7	4.2	15.0	4.1	3.0	3.9	4.9	0.4	2.3	3.8	4.4	1.8	11.6	3.0	2.3	20.6	5.1	1.5	3.6	14.0	10.3	4.2	1.1	7.7	5.0	3.3	4.1	2.0	1.3	4.7	0.6	3.4	2.3	3.6	1.0	2.8	4.0	3.1	0.5	4.1	1.9	2.4	4.1	14.1	4.4	3.5	2.3	1.3	3.1	0.0	3.0	3.9	14.7	20.7	8.5	2.6	6.6	4.9	2.8	6.7	5.2
FANCI	"FLJ10719, KIAA1794"	ENSG00000140525	"FA complementation group I"	Q9NVI1	15	89243945-89317261	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage, DNA repair"	DNA-binding	"Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 31.4;lymphoid tissue: 44.2;testis: 32.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 48.6;Spermatocytes: 69.5;Spermatogonia: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"basophil: 23.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA039972, HPA040379"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA039972: AB_10673265, HPA040379: AB_2676951"	"unprognostic (6.88e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (6.82e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.59e-3)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (2.71e-13)"	"unprognostic (2.40e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.12e-1)"	3.2	2.1	1.6	13.0	1.3	31.4	6.0	3.8	2.5	3.3	0.0	10.5	6.0	4.7	1.1	8.1	3.4	3.0	1.7	1.7	0.7	1.7	2.9	3.4	23.9	1.2	0.9	3.8	3.0	3.0	0.6	11.3	1.7	3.6	12.4	5.4	2.8	2.0	0.8	8.0	7.3	6.9	0.6	6.0	6.7	32.6	1.3	44.2	2.0	0.8	26.6	5.4	3.7	1.7	108.2	122.4	127.8	86.1	10.8	16.0	78.5	101.4	58.3	123.6	150.5	96.8	95.4	198.8	53.4	33.8	79.3	143.9	196.8	69.0	116.2	127.8	123.5	197.2	176.7	45.8	1.7	146.0	96.3	8.6	6.8	87.1	44.4	17.6	51.7	120.2	139.2	142.3	83.5	61.5	150.9	49.6	101.1	70.3	44.5	130.6	187.1	84.6	28.5	196.8	93.9	80.8	105.2	73.3	46.7	85.7	81.2	64.8	35.4	103.2	103.8	94.9	155.8	93.3	209.5	151.9	38.5	125.7	104.7	23.4	2.3	3.0	4.7	3.0	2.8	3.5	4.7	6.5	2.2	3.6	3.3	5.6	3.1	5.1	4.3	4.1	11.8	3.1	1.6	1.3	3.8	2.5	1.7	0.7	1.2	0.9	1.7	0.6	1.3	1.7	2.6	3.2	1.5	3.6	3.8	4.2	2.6	4.0	0.6	2.4	2.9	2.7	3.9	0.0	3.3	1.8	0.0	17.0	3.9	4.2	0.0	2.0	7.9	5.0	3.7	3.0	1.2	48.6	7.0	2.9	18.3	3.9	5.6	4.5	2.5	14.9	6.8	0.8	8.1	1.7	5.8	5.9	0.0	3.0	3.8	7.9	3.4	4.8	1.8	1.9	3.3	11.6	1.0	9.0	6.9	2.5	1.2	1.5	13.9	2.0	1.3	1.0	6.3	1.9	6.6	3.6	4.0	69.5	60.2	9.2	2.4	12.4	8.1	2.5	9.1	2.8
FANCM	"FAAP250, KIAA1596"	ENSG00000187790	"FA complementation group M"	Q8IYD8	14	45135930-45200890	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Early spermatids: 65.5;Late spermatids: 206.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055144			Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA055144: AB_2682715"	"unprognostic (8.40e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.99e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.13e-2)"	1.9	1.6	0.8	2.2	1.6	5.6	2.8	1.9	2.2	2.0	0.3	1.6	1.3	2.4	2.2	1.9	1.6	1.8	1.3	1.0	0.9	1.8	1.5	1.7	3.3	1.0	0.8	2.9	1.1	1.5	0.8	1.9	1.2	1.6	1.8	2.8	1.4	1.9	1.6	2.6	1.2	1.9	0.7	2.3	1.4	7.6	1.1	4.1	1.5	2.3	2.6	1.5	1.5	1.2	8.2	7.0	8.1	7.5	6.4	3.5	6.5	10.3	4.1	8.1	10.1	11.3	6.2	10.6	5.8	2.6	4.5	10.6	9.5	4.4	11.0	7.6	5.4	5.1	7.8	6.4	1.1	13.0	6.1	2.2	1.6	8.1	5.1	1.8	7.1	6.6	9.1	8.9	6.9	8.1	9.5	9.2	3.2	6.3	11.6	9.0	12.7	4.5	3.4	5.8	7.3	1.9	9.4	7.6	4.0	5.1	8.0	6.0	5.6	11.8	11.0	10.6	8.1	4.4	8.7	10.3	2.3	7.9	7.0	6.6	0.7	2.5	2.0	2.0	1.1	4.3	1.3	0.7	0.6	2.0	2.0	1.7	1.0	1.1	0.9	1.7	1.0	0.6	0.8	1.6	1.9	2.2	1.0	0.9	1.0	0.8	1.2	0.7	1.1	1.2	6.5	0.0	3.1	9.8	8.3	2.7	1.1	1.9	4.6	6.3	3.9	2.4	8.3	1.5	3.1	1.8	2.1	7.6	5.6	1.7	0.0	2.2	65.5	3.5	5.8	5.1	0.0	12.8	21.0	2.7	3.5	4.6	5.1	3.0	1.3	9.4	5.7	1.7	3.5	3.3	15.6	1.6	4.1	3.8	2.9	206.1	9.0	4.0	3.6	18.7	5.9	4.8	3.1	20.1	22.7	2.4	0.8	5.3	8.4	0.8	1.5	1.9	1.1	6.9	6.6	4.7	6.0	26.5	14.0	4.4	1.8	2.3	5.6	9.5	3.2	0.7
FARSB	"FARSLB, FRSB, PheHB"	ENSG00000116120	"Phenylalanyl-tRNA synthetase subunit beta"	Q9NSD9	2	222566899-222656092	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036677, HPA036678, HPA061398"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		28000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA036677: AB_2675242, HPA036678: AB_10673504, HPA061398: AB_2684504"	"unprognostic (9.95e-3)"	"unprognostic (1.86e-3)"	"unprognostic (7.02e-2)"	"unprognostic (7.42e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (6.45e-10)"	"unprognostic (8.89e-3)"	"unprognostic (4.51e-2)"	"unprognostic (3.63e-2)"	"unprognostic (5.25e-3)"	"unprognostic (6.25e-2)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (1.36e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (1.25e-4)"	12.8	10.9	9.5	7.6	10.0	8.0	12.8	10.4	11.3	13.1	6.5	14.7	9.1	13.5	6.5	20.7	11.9	3.9	16.7	10.2	10.7	11.8	14.1	9.4	7.4	9.6	9.4	14.3	15.6	8.0	13.2	5.0	10.8	11.2	11.1	10.0	10.4	6.1	31.9	14.9	10.8	8.1	8.4	9.7	13.9	13.5	9.9	7.7	9.7	13.2	8.3	13.1	13.7	9.4	31.1	17.8	20.7	27.2	18.0	26.3	31.0	31.0	19.2	29.4	23.9	45.3	16.6	15.3	22.7	22.6	24.7	25.8	39.7	34.7	43.0	22.8	20.7	35.1	18.9	28.8	27.9	51.9	14.0	17.6	27.0	33.9	51.2	10.5	28.3	26.4	53.5	30.3	36.1	28.9	31.2	29.2	26.6	37.0	22.0	30.2	49.4	49.8	24.5	19.9	33.4	11.2	12.9	22.4	27.6	24.7	20.9	21.3	15.8	25.5	21.1	37.8	38.5	14.8	15.5	54.5	20.8	34.0	27.2	0.5	7.6	1.2	9.6	9.4	14.3	15.1	12.8	11.9	14.4	12.7	16.4	14.2	0.9	17.4	11.3	7.2	12.5	13.7	9.5	10.0	10.4	11.3	10.2	10.7	9.6	9.4	10.8	8.4	9.9	9.4	10.2	6.4	6.4	21.2	25.2	12.4	19.5	32.7	19.4	17.9	16.3	18.0	28.6	5.7	18.5	22.0	4.2	37.0	7.5	18.1	35.2	24.7	57.5	17.3	15.8	13.3	20.9	24.2	50.2	30.4	43.3	18.0	32.6	18.6	5.1	21.8	7.5	17.8	27.4	3.3	56.7	19.9	20.3	10.1	9.7	73.1	15.2	11.8	7.2	26.2	11.3	13.2	15.5	38.7	38.2	22.8	11.3	19.9	27.3	18.1	9.9	31.0	16.8	19.5	6.6	17.6	34.4	67.4	33.7	28.8	14.2	22.2	16.9	24.3	45.8	14.3
FBH1	"Fbx18, FBXO18, FLJ14590"	ENSG00000134452	"F-box DNA helicase 1"	Q8NFZ0	10	5890203-5937594	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 22.4;Distal tubular cells: 21.5;Granulosa cells: 23.6;Syncytiotrophoblasts: 32.0;Theca cells: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002844	Supported					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"			"HPA002844: AB_1078829"	"unprognostic (3.14e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.35e-3)"	"unprognostic (4.42e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.98e-3)"	"prognostic unfavorable (7.73e-7)"	"unprognostic (1.89e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.69e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.54e-2)"	28.7	38.8	17.5	22.8	20.3	24.6	26.8	17.7	19.1	32.4	25.7	30.4	24.6	34.3	21.3	24.0	36.4	23.0	44.5	17.2	18.0	25.2	28.8	27.6	27.6	17.7	18.2	30.7	21.9	28.5	26.1	26.6	18.0	28.6	24.2	14.8	24.3	25.8	30.3	30.4	29.7	30.1	17.8	35.3	27.6	24.7	19.2	40.2	25.2	27.4	27.2	28.8	27.1	19.0	31.8	34.0	31.3	34.4	70.4	46.3	28.1	35.9	24.6	34.8	38.8	40.4	28.3	29.6	23.0	52.5	16.7	46.3	42.6	38.2	31.3	32.2	31.5	28.6	27.3	34.8	48.2	14.2	26.4	58.2	36.4	44.2	19.4	44.0	59.7	39.7	50.9	30.4	37.3	48.1	34.5	20.9	14.3	54.7	18.9	37.6	14.8	49.9	34.0	25.5	17.7	26.6	36.8	33.1	50.8	35.7	33.7	28.5	37.9	22.1	24.7	59.1	28.1	30.9	26.1	16.3	29.8	20.7	15.8	0.0	2.1	3.3	1.9	1.7	1.3	3.0	2.0	2.5	2.0	4.1	2.5	1.8	1.3	4.6	1.3	4.0	6.2	1.7	17.5	20.3	17.7	19.1	17.2	18.0	17.7	18.2	18.0	17.8	19.2	19.0	22.4	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	15.6	16.1	0.0	0.0	0.0	7.3	0.0	20.3	9.3	0.0	21.5	16.8	0.0	11.4	19.0	7.1	0.0	0.0	0.0	15.1	19.4	9.8	0.0	14.9	0.0	23.6	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	10.3	0.0	0.0	0.0	0.0	18.3	0.0	0.0	3.2	0.0	0.0	20.9	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	32.0	4.4	27.9	0.0	0.0
FBL	"FIB, FLRN, Nop1, RNU3IP1"	ENSG00000105202	Fibrillarin	P22087	19	39834458-39846379	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, Ribonucleoprotein, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 747.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001514, HPA049546, HPA077724"	Supported		Supported	"Nucleoli fibrillar center"		NA	NA		79000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoli fibrillar center"		"CAB001514: AB_367009, HPA049546: AB_2680811, HPA077724: "	"prognostic favorable (1.65e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.32e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (5.56e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.09e-3)"	"unprognostic (4.69e-2)"	"unprognostic (8.81e-2)"	"prognostic unfavorable (4.52e-6)"	"unprognostic (4.04e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-1)"	130.3	86.7	30.0	66.3	31.0	124.9	147.8	28.4	34.0	186.5	28.8	112.1	52.2	136.9	61.2	191.5	145.3	32.8	72.8	27.5	28.4	93.3	73.4	88.2	99.2	30.6	29.4	255.1	155.9	50.1	66.0	42.9	30.2	109.9	85.6	23.3	110.5	48.2	127.6	221.8	113.4	67.3	30.0	130.8	104.8	77.2	31.1	103.0	89.5	57.2	157.3	125.6	156.2	31.5	248.5	510.6	208.0	237.2	82.6	140.5	125.0	137.5	122.8	237.6	225.9	301.8	142.8	555.9	125.9	119.7	72.0	98.3	308.2	295.4	290.8	101.2	405.3	225.2	181.9	276.8	106.5	528.3	169.1	114.2	105.9	190.3	395.0	107.4	184.2	239.5	361.8	228.0	133.2	340.3	468.9	232.7	206.4	353.8	156.1	256.3	209.7	282.5	131.4	282.1	280.2	163.2	133.5	210.9	87.7	116.2	107.1	190.6	99.8	112.3	177.2	156.8	324.8	155.5	176.1	374.1	113.4	341.6	105.2	2.7	41.8	6.4	70.6	36.3	101.7	83.5	73.9	70.3	74.8	84.5	100.6	97.3	3.2	92.5	40.5	78.1	58.3	71.6	30.0	31.0	28.4	34.0	27.5	28.4	30.6	29.4	30.2	30.0	31.1	31.5	45.9	32.1	48.1	2.3	166.6	350.3	323.8	150.2	200.9	18.8	168.3	177.3	37.5	105.8	77.4	40.5	25.0	130.7	118.9	88.5	74.3	108.8	361.1	43.4	97.9	105.4	92.8	129.3	2.7	190.9	283.2	84.2	65.7	53.7	95.9	139.0	105.7	54.1	104.8	15.2	2.6	170.0	46.8	104.3	169.8	747.7	118.1	66.5	97.8	2.8	135.8	33.3	151.4	1.0	4.1	94.5	95.6	78.6	102.8	266.6	59.1	78.7	43.7	24.9	72.3	193.9	122.8	41.7	83.4	201.8	330.7	121.6	123.3	157.3	265.3	240.1
FBXO45	Fbx45	ENSG00000174013	"F-box protein 45"	P0C2W1	3	196568611-196589059	"Predicted intracellular proteins"	"Neurogenesis, Ubl conjugation pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040730	Uncertain		Approved	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA040730: AB_10959311"	"unprognostic (7.17e-3)"	"unprognostic (1.14e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (7.61e-5)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.13e-2)"	"unprognostic (9.48e-3)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.16e-5)"	"prognostic unfavorable (4.93e-5)"	"unprognostic (5.18e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.65e-1)"	5.1	4.2	10.7	6.1	11.5	13.9	7.3	11.8	14.8	4.5	6.8	6.9	5.3	4.7	3.0	8.9	3.6	4.4	3.6	11.0	10.9	3.7	6.9	4.5	6.7	10.7	10.9	5.0	4.6	7.2	3.1	5.4	10.4	5.1	7.0	8.2	4.0	4.3	13.8	12.7	5.1	5.0	11.6	5.1	5.5	12.2	11.5	8.8	3.7	11.5	10.0	6.8	5.0	11.7	45.5	8.5	17.6	22.4	11.6	11.4	20.9	19.7	9.0	15.3	15.6	23.9	15.1	19.1	33.1	12.8	22.8	19.0	33.9	22.5	28.1	27.7	15.3	34.8	15.5	15.1	11.1	46.9	17.1	5.8	24.9	17.3	31.8	8.0	16.9	30.5	42.4	39.2	17.2	45.3	27.5	21.9	27.4	40.3	32.5	23.1	23.0	46.2	12.9	18.3	35.6	24.4	21.4	36.8	23.5	15.4	63.3	31.1	16.8	17.7	19.1	25.7	53.8	38.3	68.5	52.6	15.4	59.6	17.3	1.3	0.9	1.1	0.8	0.9	1.4	0.5	0.8	0.5	1.2	0.8	0.8	0.9	0.4	0.6	1.1	1.4	1.6	0.4	10.7	11.5	11.8	14.8	11.0	10.9	10.7	10.9	10.4	11.6	11.5	11.7	10.2	12.8	4.1	6.5	6.6	9.8	10.2	5.6	4.6	20.1	10.5	7.7	10.8	4.3	4.2	3.7	14.6	2.6	11.5	7.9	0.0	4.4	15.5	8.0	12.9	8.0	17.4	6.1	13.8	7.7	4.6	7.8	10.7	8.8	1.3	6.9	7.9	9.9	5.8	13.5	15.0	8.2	4.1	9.1	11.0	18.9	5.6	7.6	5.4	8.4	8.3	9.3	4.1	6.6	12.4	8.3	4.8	6.4	8.0	14.8	4.0	3.4	6.8	10.7	0.0	10.5	7.5	32.4	24.4	9.4	13.5	1.9	8.2	7.1	9.8	14.5
FBXO5	"EMI1, FBX5, Fbxo31"	ENSG00000112029	"F-box protein 5"	Q9UKT4	6	152970519-152983579	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 44.1;lymphoid tissue: 27.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 36.0;Extravillous trophoblasts: 30.5;Spermatocytes: 32.3;Spermatogonia: 26.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB008106, HPA029048"	Approved		Supported	Nucleoplasm		NA	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB008106: AB_828450, HPA029048: AB_10602132"	"unprognostic (1.22e-2)"	"unprognostic (7.21e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.24e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.43e-8)"	"unprognostic (2.46e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.89e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.25e-9)"	"prognostic favorable (8.65e-4)"	"unprognostic (1.20e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.51e-1)"	3.1	3.1	1.5	7.3	1.6	44.1	4.5	2.6	2.1	4.0	1.9	5.0	4.6	5.3	4.5	3.7	3.0	2.6	1.8	1.4	1.7	3.1	4.4	3.4	14.9	1.6	1.6	4.1	3.0	2.3	2.1	6.3	1.7	3.0	5.1	3.3	2.7	2.9	0.9	4.3	4.3	5.0	1.6	5.5	4.6	3.9	1.8	27.3	4.4	2.6	14.6	4.0	3.0	2.0	33.7	17.2	70.8	48.1	5.3	10.8	22.6	79.9	35.5	58.7	65.6	35.6	19.8	81.6	23.9	21.3	39.7	31.4	56.4	26.7	70.0	44.2	50.6	82.3	24.1	38.7	10.2	74.4	48.6	7.7	4.9	39.8	30.9	14.3	27.3	42.3	88.2	74.5	53.9	25.7	85.2	47.6	41.5	25.8	25.0	71.0	56.8	52.8	20.8	18.0	46.1	47.9	56.6	30.2	15.6	24.7	21.8	68.7	20.6	43.9	57.4	51.1	94.8	24.9	29.5	120.4	31.9	54.3	54.2	0.0	1.9	0.0	2.8	2.5	4.0	5.1	4.7	5.2	3.7	5.0	4.6	4.8	0.0	7.1	3.2	4.3	6.6	2.5	1.5	1.6	2.6	2.1	1.4	1.7	1.6	1.6	1.7	1.6	1.8	2.0	6.0	0.0	1.1	1.3	9.8	9.9	3.7	4.0	7.4	3.2	5.7	5.2	1.8	2.8	3.9	1.8	6.2	15.2	13.5	2.6	3.9	3.0	0.4	2.3	10.5	5.7	4.8	36.0	1.0	1.6	30.5	9.1	7.7	4.0	2.5	16.6	5.0	1.9	7.9	1.7	0.9	6.1	2.0	3.2	6.1	0.1	4.4	5.3	1.8	1.9	4.2	4.1	9.2	1.5	2.1	1.5	0.5	6.0	24.7	3.6	1.5	3.6	1.9	3.6	13.1	8.6	8.9	32.3	26.1	10.2	5.3	5.9	7.9	8.0	6.3	2.0
FBXW2	"FBW2, Fwd2, Md6"	ENSG00000119402	"F-box and WD repeat domain containing 2"	Q9UKT8	9	120751978-120793416	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 177.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067878	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA067878: AB_2685913"	"unprognostic (1.08e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.06e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.88e-3)"	"prognostic favorable (1.38e-6)"	"unprognostic (1.66e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.83e-2)"	23.7	21.7	10.0	21.0	10.3	37.4	20.1	10.5	10.6	21.7	11.7	18.0	16.7	19.9	15.4	21.3	16.5	14.7	23.5	11.8	10.9	18.0	22.2	23.1	22.1	9.5	10.5	16.9	18.5	22.7	13.0	17.4	9.4	18.4	19.8	15.2	19.0	18.8	16.1	21.4	16.0	22.7	9.5	22.5	18.7	17.7	12.2	26.3	19.9	21.7	25.3	22.4	16.7	11.4	30.1	37.3	27.5	46.5	50.7	41.4	25.4	39.5	45.1	42.7	41.3	29.8	35.4	44.9	20.4	51.8	43.1	64.4	39.9	39.4	53.0	60.6	17.2	29.1	64.8	43.5	28.6	65.6	38.6	30.3	47.9	47.2	50.0	40.1	50.8	45.7	39.4	47.5	37.4	48.2	47.3	19.6	41.0	50.8	35.3	36.1	43.8	45.1	29.5	33.5	21.9	33.0	55.3	40.6	29.5	32.2	66.5	18.7	38.1	36.3	28.9	59.3	49.6	34.1	74.2	38.5	38.4	28.7	38.1	15.3	12.0	17.2	17.3	11.4	13.1	10.0	12.3	16.3	11.0	6.2	10.0	13.8	12.4	15.5	13.7	9.6	13.0	9.8	10.0	10.3	10.5	10.6	11.8	10.9	9.5	10.5	9.4	9.5	12.2	11.4	32.3	25.6	56.9	17.3	17.6	22.7	26.4	27.3	13.1	20.0	23.5	16.6	21.9	12.8	28.7	11.0	12.5	18.5	50.9	27.1	21.5	27.1	38.8	14.5	22.7	31.9	27.6	24.0	34.0	34.0	29.2	23.2	28.1	17.8	15.8	27.2	33.5	33.9	25.2	33.7	29.0	19.0	28.5	25.0	30.0	177.2	26.4	21.7	48.0	23.4	38.0	16.5	36.0	27.6	37.0	32.5	19.4	35.7	24.5	34.9	22.7	24.7	21.0	25.1	6.6	20.4	36.1	40.5	53.7	21.9	32.0	17.8	31.2	31.0	23.2	28.1
FBXW5	"DKFZP434B205, Fbw5, MGC20962"	ENSG00000159069	"F-box and WD repeat domain containing 5"	Q969U6	9	136940435-136944738	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 251.8"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 581.9;Late spermatids: 1900.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046615	Approved		Approved	Mitochondria		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"HPA046615: AB_10965648"	"unprognostic (1.11e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.56e-2)"	"prognostic favorable (1.02e-4)"	"unprognostic (4.26e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.22e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.64e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.51e-3)"	"unprognostic (3.23e-2)"	"prognostic favorable (4.74e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.13e-1)"	54.7	58.1	27.6	23.3	23.0	28.7	47.4	23.4	32.4	36.2	23.4	73.9	42.9	44.1	9.4	70.8	33.9	17.7	117.1	34.7	23.5	54.3	132.4	37.5	22.1	27.0	27.2	29.1	75.7	19.0	41.1	15.5	28.3	56.3	13.4	3.9	54.8	26.9	188.7	42.6	59.3	17.2	24.3	47.6	65.0	251.8	33.0	24.7	42.5	66.0	17.6	59.4	41.5	23.7	39.2	65.5	14.9	36.7	36.6	23.6	85.7	40.6	27.5	27.7	15.3	42.9	48.8	27.0	46.0	42.0	21.5	48.0	13.6	35.3	4.6	35.4	47.2	22.9	88.8	46.8	40.0	34.2	55.2	26.9	31.0	25.4	21.1	21.9	28.9	19.5	46.0	42.7	21.3	98.3	26.2	36.4	26.7	48.1	70.6	28.7	22.5	46.3	24.5	37.9	30.9	30.0	49.0	52.8	54.4	5.7	60.3	52.4	55.8	39.5	35.1	75.1	35.1	33.6	45.1	17.0	55.0	29.7	30.5	62.8	62.1	88.0	97.7	74.3	75.3	39.2	73.9	83.3	59.6	31.1	32.0	53.7	32.9	55.4	61.2	98.8	96.8	72.8	27.6	23.0	23.4	32.4	34.7	23.5	27.0	27.2	28.3	24.3	33.0	23.7	61.3	19.2	45.4	13.1	40.7	28.7	44.5	129.0	26.7	29.9	50.1	48.8	86.9	50.1	72.8	23.9	16.7	68.3	108.0	336.5	74.3	111.7	581.9	29.1	27.5	53.6	67.3	36.8	15.9	148.1	132.9	38.9	98.4	38.6	28.6	116.2	46.1	113.3	88.0	60.6	15.3	153.7	65.1	62.6	49.3	1900.7	51.6	69.2	69.4	8.4	124.9	59.1	83.4	11.1	17.1	132.5	238.0	71.1	59.4	84.6	420.9	134.1	43.5	37.3	59.2	33.5	59.0	224.3	47.4	47.1	35.9	101.4	66.6	49.4	127.6	70.0
FEN1	"FEN-1, MF1, RAD2"	ENSG00000168496	"Flap structure-specific endonuclease 1"	P39748	11	61792911-61797238	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 46.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 87.5;Extravillous trophoblasts: 70.9;Spermatocytes: 61.0;Spermatogonia: 62.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002262, HPA006748"	Enhanced		Enhanced	Nucleoplasm,Nucleoli		NA	Yes		160000	"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"CAB002262: AB_563729, HPA006748: AB_1848494"	"unprognostic (1.82e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (3.39e-6)"	"unprognostic (1.50e-2)"	"unprognostic (9.82e-2)"	"prognostic favorable (7.85e-4)"	"unprognostic (2.82e-3)"	"unprognostic (5.86e-2)"	"prognostic unfavorable (5.73e-6)"	"prognostic favorable (9.46e-4)"	"unprognostic (1.10e-1)"	"unprognostic (4.49e-3)"	"unprognostic (4.04e-2)"	5.9	10.4	7.8	21.3	7.8	39.5	10.2	10.9	9.9	6.2	9.6	15.5	11.2	6.3	7.1	14.2	5.7	4.3	6.6	8.0	7.7	5.8	9.9	5.6	34.0	10.0	8.3	3.9	6.8	5.6	8.3	12.9	10.7	6.2	16.1	17.4	6.1	5.9	13.1	9.6	11.4	8.9	6.8	12.8	8.4	19.1	9.1	46.0	4.8	9.6	37.4	8.1	4.9	8.1	154.6	139.7	149.3	81.3	14.9	18.0	94.9	133.3	76.1	160.9	181.4	123.4	112.8	222.6	100.3	57.3	150.5	158.3	214.3	117.7	163.3	117.8	117.6	117.6	187.7	127.3	11.0	184.7	115.4	12.7	15.8	148.1	39.0	23.3	63.1	122.1	181.3	155.1	136.0	195.4	259.7	165.4	165.3	120.3	134.7	173.8	173.7	228.9	64.4	144.7	170.0	140.7	89.6	115.0	79.1	70.1	167.4	127.1	43.2	141.5	178.1	182.3	134.6	120.4	204.3	228.9	98.4	121.9	124.6	24.7	6.7	14.2	16.2	12.9	16.8	14.4	12.3	15.1	8.0	14.8	14.0	13.8	2.7	20.0	12.9	24.5	25.2	10.3	7.8	7.8	10.9	9.9	8.0	7.7	10.0	8.3	10.7	6.8	9.1	8.1	2.7	0.0	2.2	0.3	14.0	10.3	5.2	18.2	7.4	23.8	7.4	7.4	5.8	5.7	7.7	0.0	12.5	53.0	15.9	6.7	7.9	17.3	21.7	4.2	5.5	5.5	4.8	87.5	2.0	12.2	70.9	8.6	7.1	6.3	0.0	18.6	1.1	7.2	25.7	15.2	2.4	8.0	18.3	5.4	6.8	14.4	5.6	6.2	5.4	0.0	12.4	31.3	13.4	1.5	3.1	12.2	9.4	7.2	45.3	6.5	3.7	5.7	6.4	23.3	0.0	6.8	12.2	61.0	62.1	11.3	6.1	30.9	11.0	9.0	22.0	5.2
FIGNL1		ENSG00000132436	"Fidgetin like 1"	Q6PIW4	7	50444128-50542535	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 27.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA055542	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"			"HPA055542: AB_2682841"	"unprognostic (4.62e-2)"	"unprognostic (8.76e-2)"	"unprognostic (3.99e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.73e-2)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (3.15e-1)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (3.62e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.79e-2)"	"prognostic unfavorable (9.54e-7)"	"unprognostic (1.86e-1)"	"unprognostic (6.32e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.68e-2)"	4.5	4.1	4.0	8.4	4.9	8.7	8.8	6.2	5.3	5.4	1.6	6.2	6.8	8.5	4.7	9.0	4.8	4.5	3.9	4.3	4.2	3.5	4.7	3.3	10.3	4.4	3.9	11.3	2.7	3.8	2.5	5.2	4.9	5.9	6.4	9.7	3.8	4.4	6.5	8.6	6.3	9.9	3.9	7.7	4.2	7.2	4.4	10.2	3.7	8.0	13.3	3.6	4.9	5.7	12.9	25.8	33.0	36.1	7.4	13.3	21.1	43.8	22.3	46.0	50.9	40.6	28.5	49.1	22.9	13.1	38.3	43.6	35.3	21.9	73.0	42.0	26.5	21.8	53.7	14.2	4.5	52.5	33.4	6.1	10.7	30.4	15.6	7.3	48.8	22.1	51.5	30.0	35.3	19.1	32.1	38.8	30.2	48.6	30.4	29.8	28.5	17.9	14.3	32.7	37.6	29.2	16.3	35.5	16.6	15.4	34.8	17.4	19.0	0.1	19.2	55.9	36.4	50.5	56.5	38.1	14.7	47.2	73.4	0.0	1.1	0.8	1.7	2.0	3.0	3.4	2.0	3.4	1.2	4.0	3.0	2.9	0.6	3.8	6.1	1.2	4.1	1.5	4.0	4.9	6.2	5.3	4.3	4.2	4.4	3.9	4.9	3.9	4.4	5.7	3.4	0.0	0.5	3.9	7.8	4.1	1.9	3.2	8.6	10.8	4.3	3.9	17.2	2.8	2.3	1.8	6.2	7.0	6.0	1.7	3.9	3.0	1.1	3.3	5.6	4.4	0.0	17.9	11.0	1.2	9.8	5.7	2.6	6.0	2.5	21.3	3.9	2.1	4.6	10.1	7.6	1.3	4.1	2.9	4.2	1.4	11.5	2.9	3.6	4.7	4.4	6.0	7.2	6.6	11.1	2.3	2.8	9.4	8.6	0.7	1.5	2.2	0.8	14.9	0.0	6.0	4.3	27.6	20.4	7.7	3.0	1.4	5.5	9.9	4.0	1.2
FIP1L1	"DKFZp586K0717, FIP1"	ENSG00000145216	"Factor interacting with PAPOLA and CPSF1"	Q6UN15	4	53377641-53460862	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"mRNA processing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA037475, HPA058202"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA037475: AB_10696933, HPA058202: AB_2683636"	"unprognostic (3.80e-1)"	"unprognostic (5.46e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.40e-1)"	"unprognostic (7.18e-2)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.87e-1)"	"unprognostic (9.00e-3)"	"unprognostic (1.14e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.07e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.66e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.39e-1)"	19.1	15.7	5.8	14.8	5.9	31.8	17.0	11.3	8.7	18.4	1.2	14.3	11.7	17.9	12.7	15.9	16.0	11.0	13.0	4.9	9.9	13.3	13.7	14.2	20.2	4.8	5.1	22.0	9.7	16.4	9.7	21.1	4.9	12.3	15.1	17.0	14.7	11.4	25.8	17.9	14.4	15.9	4.6	14.8	14.4	31.4	7.0	29.4	14.6	11.7	23.3	17.5	16.2	8.7	43.7	29.5	51.8	32.6	36.4	31.9	63.5	52.8	64.0	45.1	35.0	43.2	37.8	79.5	42.6	47.2	44.4	26.7	55.6	37.9	55.8	27.0	31.0	60.0	25.5	40.7	51.2	95.4	53.6	31.2	35.6	51.6	49.8	42.0	32.3	47.7	71.3	34.3	34.1	33.3	88.5	44.4	35.9	53.7	28.8	79.2	22.0	36.9	33.9	34.7	40.8	41.5	37.6	40.3	65.1	47.0	25.2	33.6	33.9	44.2	39.7	39.9	67.2	43.3	27.8	100.8	38.4	59.2	84.3	45.2	23.3	51.4	32.5	25.0	38.8	34.8	33.0	32.9	31.9	32.3	36.6	32.3	28.3	50.7	37.0	46.5	45.9	33.1	5.8	5.9	11.3	8.7	4.9	9.9	4.8	5.1	4.9	4.6	7.0	8.7	36.1	25.6	25.4	47.0	50.4	38.7	46.6	41.5	30.1	41.2	24.0	25.4	14.4	21.5	34.1	27.6	18.8	58.7	54.0	26.9	37.2	45.8	10.3	37.6	51.1	33.4	36.6	29.2	78.8	34.9	52.2	41.9	29.6	41.6	49.4	40.0	28.5	21.2	33.2	77.4	78.7	27.0	32.6	19.8	24.6	15.2	66.8	32.2	32.0	60.9	41.3	48.6	29.9	137.7	91.4	36.9	33.3	53.4	40.3	36.5	25.2	23.3	44.8	30.3	39.5	38.9	46.9	118.5	87.6	31.8	34.1	86.3	49.8	56.8	29.4	38.5
FKBP15	"FKBP133, KIAA0674, PPP1R76, WAFL"	ENSG00000119321	"FKBP prolyl isomerase 15"	Q5T1M5	9	113161006-113221318	"Predicted intracellular proteins"	"Endocytosis, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 61.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 23.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007979	Approved		Approved	Nucleoli,Cytosol		NA	NA		9800	"Cluster 14: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoli	Cytosol	"HPA007979: AB_1848615"	"unprognostic (2.81e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.68e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (3.44e-2)"	"unprognostic (5.62e-3)"	17.8	14.8	7.0	17.0	10.5	13.1	15.3	8.7	8.9	17.0	8.1	15.0	9.6	14.8	8.5	16.2	14.7	8.3	14.9	7.8	8.8	12.2	15.2	23.9	15.9	12.5	9.4	14.9	13.4	12.0	15.4	14.2	11.6	14.9	10.2	12.5	17.1	7.3	18.1	20.3	16.7	10.9	8.7	31.0	14.1	5.9	10.9	11.0	15.7	7.6	13.5	16.3	16.4	15.4	13.4	13.2	9.4	8.8	15.6	14.8	12.1	16.6	20.8	15.6	14.2	8.1	13.3	21.7	7.1	18.6	31.2	30.0	10.4	14.0	15.3	16.6	7.1	8.8	16.3	8.0	12.7	18.7	20.9	15.0	13.8	16.1	17.4	18.3	15.1	13.3	10.9	13.4	15.7	19.2	13.8	9.7	8.8	17.4	10.6	12.5	19.1	7.5	11.2	12.2	8.0	8.1	19.5	15.5	8.5	11.6	17.7	6.2	19.9	18.4	6.9	19.2	16.9	12.2	13.0	9.4	19.7	10.3	14.9	2.5	11.3	1.8	3.2	13.9	2.7	1.8	1.9	2.0	7.9	3.1	2.4	1.9	6.4	4.4	23.3	3.3	2.0	4.7	7.0	10.5	8.7	8.9	7.8	8.8	12.5	9.4	11.6	8.7	10.9	15.4	11.1	16.0	26.7	23.5	14.9	5.7	6.2	9.6	11.4	13.7	7.0	5.6	15.4	7.2	14.3	14.7	27.1	13.8	17.3	9.7	1.9	12.7	1.2	13.4	13.9	12.5	4.8	14.7	25.1	13.6	12.4	14.7	11.7	10.0	11.4	13.3	17.2	9.3	61.3	11.8	25.0	8.6	8.2	58.4	13.6	1.7	16.8	57.5	7.2	27.2	31.2	8.0	18.6	21.1	30.1	17.3	8.1	15.8	8.8	6.1	9.2	5.4	15.9	16.1	19.7	10.0	9.2	7.1	10.5	11.1	4.1	12.2	14.9	14.5	8.2	10.5
FKBPL	"DIR1, NG7, WISp39"	ENSG00000204315	"FKBP prolyl isomerase like"	Q9UIM3	6	32128707-32130288	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 51.2;Squamous epithelial cells: 34.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043478, HPA060158"	Approved		Approved	"Nucleoplasm,Mitotic spindle"		Yes	No			"Cluster 17: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Mitotic spindle"	"HPA043478: AB_2678500, HPA060158: AB_2684213"	"unprognostic (1.80e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.67e-2)"	"unprognostic (8.22e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (8.46e-4)"	"unprognostic (1.30e-1)"	"unprognostic (8.96e-2)"	"unprognostic (5.79e-2)"	"unprognostic (7.32e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.13e-1)"	3.3	4.2	2.9	2.0	2.5	2.8	4.0	2.2	3.2	3.8	2.2	4.1	1.6	3.1	6.1	10.7	4.3	1.6	2.9	2.6	2.4	4.0	5.2	3.2	3.1	2.9	2.4	3.2	5.5	4.0	2.9	1.7	2.6	3.2	3.4	1.8	6.4	1.1	4.5	9.8	3.6	3.6	2.1	4.7	6.1	6.2	2.5	5.5	5.6	4.4	1.1	2.9	5.1	3.6	0.0	0.9	8.1	13.8	11.6	8.2	3.4	5.4	6.1	10.0	9.7	17.5	7.3	0.0	1.8	9.3	13.1	4.2	11.3	10.5	6.9	0.0	13.7	0.0	11.9	10.2	6.5	0.0	6.6	8.0	5.6	19.3	6.1	7.3	10.6	15.8	11.9	15.0	10.2	6.0	6.9	5.9	6.0	16.1	3.0	0.0	5.0	13.6	10.4	1.5	15.3	1.0	5.5	9.6	10.2	2.4	16.8	11.8	4.7	14.3	4.1	7.5	13.3	7.7	1.5	5.7	5.6	7.1	9.1	6.6	1.8	0.5	0.7	2.5	0.7	2.1	1.1	1.3	1.9	0.5	1.0	1.0	2.6	3.4	0.8	1.6	0.3	1.5	2.9	2.5	2.2	3.2	2.6	2.4	2.9	2.4	2.6	2.1	2.5	3.6	8.8	6.4	5.9	0.3	7.8	11.2	4.7	6.7	51.2	2.9	11.5	8.5	2.0	7.2	6.2	1.8	0.0	9.9	6.1	9.3	5.9	8.1	4.2	11.6	6.1	9.6	6.0	19.8	0.7	6.7	13.3	5.6	6.1	8.1	2.5	12.4	5.0	3.3	5.0	10.1	0.6	7.0	8.2	2.8	8.8	5.5	2.8	4.2	7.2	1.0	3.7	7.3	3.1	0.0	0.5	6.0	6.2	3.4	7.7	5.2	10.3	9.9	3.2	4.9	0.0	5.4	17.4	11.1	8.8	34.1	10.2	14.1	6.8	14.9	6.5	4.1
FMC1-LUC7L2	C7orf55-LUC7L2	ENSG00000269955	"FMC1-LUC7L2 readthrough"		7	139341360-139422599	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 26.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA045663, HPA051631"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA045663: AB_2679410, HPA051631: AB_2681558"	"unprognostic (2.54e-1)"	"unprognostic (5.27e-2)"			"unprognostic (3.21e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.68e-2)"		"unprognostic (4.48e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.42e-3)"		16.8	17.7	2.4	8.8	4.4	6.4	16.1	3.8	9.8	15.8	3.7	20.2	11.0	21.8	1.1	13.4	18.2	2.7	21.9	2.3	3.9	15.0	19.3	14.8	6.2	4.9	3.0	20.4	12.3	12.3	14.1	6.9	4.1	15.3	4.0	13.9	18.1	8.6	56.9	13.3	16.0	6.7	3.5	12.7	16.5	11.7	3.2	14.1	24.7	30.5	4.9	17.7	14.9	4.6	32.6	46.2	55.1	31.7	23.3	16.2	20.8	25.2	17.0	29.9	23.8	36.5	35.8	36.5	44.3	18.6	40.1	25.5	59.7	21.3	9.4	25.2	6.3	48.6	45.9	27.8	21.7	60.2	38.2	12.7	15.3	28.8	18.4	16.9	20.9	19.1	62.1	47.4	18.7	45.6	88.9	3.2	44.5	44.2	9.7	57.5	41.6	48.5	4.8	22.3	45.7	47.5	33.9	26.4	33.8	10.4	20.2	25.1	24.0	21.5	20.2	22.5	38.8	44.4	40.3	70.5	39.9	37.8	40.1	14.6	15.7	22.3	22.2	16.1	21.3	22.2	21.3	23.0	22.8	23.0	23.9	21.7	5.6	24.6	20.4	17.9	25.8	16.4	2.4	4.4	3.8	9.8	2.3	3.9	4.9	3.0	4.1	3.5	3.2	4.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FN3KRP	"FLJ12171, FN3KL"	ENSG00000141560	"Fructosamine 3 kinase related protein"	Q9HA64	17	82716706-82730328	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 100.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056172, HPA065831"	Approved		Approved	Nucleoplasm		NA	NA		44000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA056172: AB_2683055, HPA065831: AB_2685565"	"unprognostic (1.37e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.25e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.84e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.71e-2)"	23.2	22.1	40.6	13.3	43.7	18.8	19.7	43.3	41.3	23.4	35.1	22.9	15.3	23.1	19.4	20.4	20.4	16.6	16.1	41.1	41.7	23.9	29.3	16.3	18.5	42.5	41.6	32.1	19.3	18.4	17.2	21.8	43.2	20.8	18.0	17.8	22.2	23.2	11.4	23.6	19.4	22.1	42.9	20.9	20.6	13.7	41.7	16.6	16.7	10.6	22.8	19.7	20.7	48.3	31.4	122.3	33.6	44.5	15.9	30.3	27.2	56.9	31.8	54.5	44.3	64.9	21.8	25.6	37.0	46.6	50.5	35.3	30.1	43.5	48.7	17.2	54.3	42.6	66.2	77.5	28.3	30.7	23.2	27.8	50.9	51.7	28.1	33.4	39.8	35.9	42.5	15.8	70.7	59.8	58.8	45.2	15.2	68.7	53.5	44.0	83.4	40.3	38.9	58.7	27.6	58.1	93.7	42.7	47.3	57.4	69.8	43.6	34.8	103.3	35.9	74.2	85.3	32.1	37.8	64.8	48.1	38.2	49.0	32.0	21.9	30.6	29.6	24.7	29.5	23.9	28.8	28.8	18.2	24.8	32.5	24.3	3.4	32.1	13.8	36.0	29.7	26.0	40.6	43.7	43.3	41.3	41.1	41.7	42.5	41.6	43.2	42.9	41.7	48.3	14.3	12.8	11.1	5.5	13.9	15.0	26.0	26.0	15.4	18.1	13.3	15.6	6.9	25.8	15.3	11.0	8.4	100.3	20.0	12.2	23.5	20.6	2.0	10.7	13.0	14.8	7.8	31.2	7.6	11.1	45.3	18.1	13.3	22.3	13.3	18.6	10.8	12.1	33.8	3.3	6.7	15.4	22.4	11.2	11.3	4.2	28.3	12.8	23.2	6.5	20.9	36.1	17.5	5.0	11.8	17.8	15.9	31.6	27.6	15.5	11.1	28.2	10.0	18.5	13.1	13.6	20.9	18.3	36.2	18.0	15.3	62.5	17.2	22.3	15.6	24.0
FNBP4	KIAA1014	ENSG00000109920	"Formin binding protein 4"	Q8N3X1	11	47716494-47767443	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039485, HPA040029"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA039485: AB_2676536, HPA040029: AB_2676808"	"unprognostic (2.49e-2)"	"unprognostic (3.95e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.13e-3)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (5.58e-3)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.60e-2)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (6.35e-4)"	"prognostic unfavorable (1.91e-8)"	"unprognostic (3.54e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.58e-1)"	"prognostic favorable (7.23e-5)"	38.0	34.4	5.8	12.1	6.1	19.6	36.6	9.9	7.4	46.7	8.4	35.4	8.9	38.9	9.4	33.8	40.6	8.2	29.9	5.7	6.8	29.5	31.3	39.1	15.9	5.9	6.2	48.8	39.2	7.5	29.2	9.6	5.8	36.3	8.8	14.9	32.7	8.2	51.0	40.5	42.8	9.0	5.3	50.6	31.6	16.5	6.4	14.0	42.8	7.0	14.2	34.2	40.2	7.8	10.6	8.5	17.7	12.5	10.0	11.6	12.0	12.3	12.7	11.1	12.9	8.4	14.0	23.2	6.0	14.0	9.3	21.2	15.8	10.0	16.4	18.2	24.1	17.5	28.1	14.3	14.1	19.5	16.6	14.2	16.4	9.7	22.0	16.2	13.1	14.1	19.2	19.2	10.7	9.7	30.0	22.6	16.7	9.4	7.8	21.2	16.8	12.9	10.9	12.8	7.9	13.1	18.5	15.2	10.5	13.2	12.3	9.1	14.4	13.1	13.8	19.0	17.3	18.6	13.4	26.1	9.5	11.9	9.1	3.8	2.1	3.4	3.7	1.5	2.9	5.1	2.6	2.6	1.3	5.4	2.7	2.9	2.0	1.8	2.2	5.6	3.9	0.9	5.8	6.1	9.9	7.4	5.7	6.8	5.9	6.2	5.8	5.3	6.4	7.8	65.0	51.3	71.7	82.6	114.7	70.9	112.5	45.9	112.7	95.1	57.0	49.0	38.2	27.1	63.6	25.8	108.4	48.9	122.0	46.1	5.9	39.9	5.5	94.3	121.9	59.7	36.5	59.1	86.7	37.8	37.4	70.6	89.2	165.4	57.6	95.5	48.2	27.0	28.4	67.3	93.6	46.5	34.6	37.2	58.3	8.0	89.5	59.2	39.2	71.2	62.1	28.1	83.4	100.5	108.3	50.8	39.4	62.1	102.4	120.8	36.6	11.3	60.5	103.2	46.0	70.5	61.6	37.3	28.1	96.0	69.9	82.9	105.7	93.4	42.6	168.0
FOXK1	IMAGE:5164497	ENSG00000164916	"Forkhead box K1"	P85037	7	4682295-4771442	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Host-virus interaction, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 113.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017998, HPA018864"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA017998: AB_1849077, HPA018864: AB_1849079"	"unprognostic (3.05e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (2.54e-6)"	"unprognostic (2.34e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.66e-3)"	"unprognostic (4.96e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.72e-1)"	6.3	11.3	6.9	4.2	7.1	9.5	5.7	1.4	8.9	7.1	0.0	9.8	3.0	9.1	2.1	7.5	7.6	2.3	7.5	9.2	5.2	6.0	4.8	8.6	4.0	9.2	6.6	7.7	6.5	2.7	12.5	3.0	7.6	5.9	2.6	3.6	4.6	4.0	11.0	9.7	5.8	4.8	5.9	6.3	6.3	9.2	8.7	4.0	4.9	4.8	3.4	6.9	7.4	7.5	11.8	14.8	9.4	18.6	9.0	6.8	11.6	5.3	4.6	3.7	4.2	14.8	13.0	19.9	6.0	8.5	11.9	18.9	10.2	12.9	3.7	5.8	6.3	9.4	16.1	8.4	8.8	11.7	10.3	13.0	7.1	8.9	12.3	6.0	7.2	7.5	20.5	4.3	4.5	13.5	4.5	20.9	14.1	4.8	7.4	16.7	9.4	12.7	5.4	17.2	8.4	10.6	8.0	17.2	6.2	7.2	9.6	15.4	22.4	6.4	20.1	10.0	11.4	11.9	10.5	12.9	8.6	13.4	10.3	0.9	0.9	0.4	1.7	1.6	2.5	1.2	1.7	1.7	1.1	1.1	1.8	1.8	0.5	1.6	1.6	0.9	0.9	1.4	6.9	7.1	1.4	8.9	9.2	5.2	9.2	6.6	7.6	5.9	8.7	7.5	15.7	32.1	17.5	25.5	16.8	33.4	15.2	31.9	12.0	18.0	15.7	15.2	12.9	8.6	14.4	14.7	22.9	13.6	26.0	11.4	5.9	10.6	44.7	17.8	20.4	17.2	13.1	3.6	42.0	15.2	4.0	18.6	9.7	25.1	7.6	29.5	16.1	11.6	10.6	23.5	35.2	11.3	12.2	17.5	17.9	113.2	19.3	11.4	16.0	30.9	21.4	10.3	54.6	25.1	58.2	19.7	9.6	28.6	6.0	29.1	8.1	15.5	14.7	13.9	19.7	17.6	25.3	19.1	20.4	15.3	50.0	4.0	19.3	17.9	17.9	21.5
FOXK2	"ILF, ILF1"	ENSG00000141568	"Forkhead box K2"	Q01167	17	82519713-82644662	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027523, HPA073491"	Approved		Supported	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Vesicles, Mitochondria"	"HPA027523: AB_10601013, HPA073491: "	"unprognostic (2.39e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.05e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.24e-6)"	"unprognostic (3.35e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.80e-3)"	"unprognostic (2.24e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.52e-2)"	14.0	24.0	10.7	12.6	13.2	8.0	12.1	14.7	16.3	14.2	1.2	18.1	9.3	19.7	9.8	20.2	13.2	10.0	17.1	12.4	10.5	12.7	13.1	14.2	12.5	5.8	7.1	14.7	15.4	20.0	17.7	15.7	6.3	13.3	9.4	11.6	12.1	12.5	43.0	18.8	12.1	16.4	3.0	11.6	14.7	28.1	9.4	18.4	15.4	28.4	11.9	15.5	13.4	12.7	48.4	50.4	46.3	50.9	26.2	28.5	31.0	27.6	31.6	47.4	47.9	49.1	30.1	40.7	19.6	34.4	52.3	27.6	49.7	32.0	44.4	28.3	47.9	42.3	32.7	49.4	41.0	47.3	27.2	27.2	57.2	50.4	56.8	29.2	48.9	43.7	57.7	40.7	26.3	28.8	81.8	30.4	26.5	39.7	38.2	53.0	39.4	34.2	21.7	40.1	76.2	56.1	27.4	69.0	65.1	48.8	48.7	54.3	38.3	62.2	43.2	42.2	56.6	46.7	45.1	53.5	33.4	39.0	33.4	1.5	1.0	1.2	1.4	0.7	1.1	1.5	1.1	1.4	1.2	1.0	0.8	0.9	0.1	1.6	0.9	2.0	1.3	0.6	10.7	13.2	14.7	16.3	12.4	10.5	5.8	7.1	6.3	3.0	9.4	12.7	21.5	51.3	27.1	23.5	11.5	37.2	8.0	10.6	10.2	19.2	17.7	15.7	19.5	7.2	16.2	14.7	12.5	11.9	19.3	15.6	3.9	8.7	15.6	19.4	22.4	14.9	10.9	7.8	44.6	10.7	8.8	13.2	14.3	26.7	2.5	22.1	10.8	13.4	20.0	47.1	39.6	12.6	8.2	17.3	22.0	24.1	9.3	19.2	12.4	20.6	13.9	12.3	6.2	33.2	49.1	11.4	12.4	13.2	13.3	13.6	12.2	7.1	13.9	16.7	0.0	19.8	16.6	15.0	10.3	17.0	43.0	9.7	11.6	30.6	13.0	10.7
FOXM1	"FKHL16, HFH-11, HNF-3, INS-1, MPHOSPH2, MPP2, TGT3, trident"	ENSG00000111206	"Forkhead box M1"	Q08050	12	2857680-2877174	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.0;lymphoid tissue: 32.2;testis: 21.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 22.4;Erythroid cells: 18.7;Extravillous trophoblasts: 18.2;Late spermatids: 25.5;Plasma cells: 19.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			CAB017832	Uncertain		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli, Nucleoli rim"	Cytosol	"CAB017832: "	"unprognostic (3.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavorable (1.95e-6)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (1.01e-2)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (6.09e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.80e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.94e-1)"	1.9	1.1	0.4	9.4	0.5	25.0	1.8	0.8	0.8	1.7	0.2	10.5	9.7	1.7	0.2	11.1	0.8	1.5	0.5	0.8	0.3	0.7	1.2	1.8	11.3	0.4	0.9	0.3	0.4	0.4	0.1	6.1	0.6	0.7	12.5	1.1	1.9	0.8	0.6	6.4	8.8	7.5	0.1	3.1	5.2	21.4	1.0	32.2	0.9	0.3	15.2	3.0	3.2	0.6	133.0	129.5	101.3	92.2	14.2	19.0	129.2	84.0	80.4	165.2	147.2	166.9	114.8	84.5	17.7	119.8	188.5	100.2	153.1	76.1	160.0	159.8	80.3	94.7	121.6	71.6	2.0	79.2	75.0	9.9	8.3	154.4	106.1	39.1	117.8	96.8	55.6	184.9	130.5	122.6	108.3	36.8	225.6	136.1	95.4	77.3	149.8	44.1	38.1	82.7	56.3	89.1	106.7	90.4	46.6	189.4	87.1	87.8	48.0	134.3	200.5	160.4	300.4	24.7	44.3	122.1	63.1	74.3	147.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.5	0.8	0.8	0.8	0.3	0.4	0.9	0.6	0.1	1.0	0.6	0.1	0.0	1.3	0.7	2.4	2.9	1.3	1.0	1.2	2.0	1.7	1.3	0.5	1.5	0.8	1.8	4.2	7.1	0.8	6.6	1.9	0.2	22.4	1.2	2.1	2.5	0.0	18.7	1.1	0.0	18.2	3.2	10.2	2.4	0.0	15.4	3.6	0.8	9.1	5.0	0.6	7.5	2.0	4.2	1.2	25.5	0.9	2.4	0.0	0.0	1.1	0.6	1.0	0.5	1.0	0.3	0.3	0.7	19.9	1.0	1.4	0.4	0.2	4.0	0.0	1.2	3.0	15.0	9.9	10.2	1.4	1.9	3.3	0.9	12.9	1.9
FRA10AC1	C10orf4	ENSG00000148690	"FRA10A associated CGG repeat 1"	Q70Z53	10	93667883-93702592	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 151.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039204	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA039204: AB_10794426"	"unprognostic (3.21e-3)"	"unprognostic (1.61e-1)"	"unprognostic (5.03e-2)"	"unprognostic (9.91e-2)"	"unprognostic (9.24e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.89e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.13e-1)"	9.2	8.6	18.4	6.3	20.0	7.0	8.6	19.6	24.5	10.5	14.1	10.2	5.9	10.7	8.4	6.5	10.1	5.3	11.8	17.8	19.1	8.4	8.3	6.4	8.3	18.8	18.6	12.2	10.3	8.3	10.2	5.9	19.2	9.0	6.4	12.3	12.4	7.5	12.2	9.8	6.6	6.8	18.6	7.2	7.8	10.5	19.5	7.3	9.1	12.7	7.3	8.9	8.5	20.5	15.9	11.6	10.7	29.4	14.3	17.1	6.9	13.4	9.5	7.3	8.4	5.3	12.9	11.9	9.7	8.9	11.6	19.1	13.0	10.0	11.5	22.4	14.4	8.9	9.0	12.0	20.1	17.5	5.8	11.7	5.9	7.9	18.8	23.1	15.3	13.6	13.0	14.3	13.1	7.6	16.2	17.9	8.5	8.3	11.1	10.6	13.4	5.1	8.8	5.5	10.5	10.0	6.8	6.1	28.1	11.1	24.2	14.2	15.9	5.3	9.5	4.4	15.6	11.5	16.2	11.6	13.5	28.4	3.9	4.7	2.7	5.6	4.4	3.1	6.0	5.7	6.5	5.9	2.2	6.3	7.8	6.7	2.0	4.0	4.1	3.6	5.5	1.4	18.4	20.0	19.6	24.5	17.8	19.1	18.8	18.6	19.2	18.6	19.5	20.5	39.6	16.0	45.4	28.1	25.5	20.6	29.6	37.7	32.5	36.2	24.1	43.6	109.7	34.3	28.9	14.7	22.9	29.0	18.7	13.4	37.2	35.2	75.8	29.0	35.8	35.1	43.0	24.6	44.2	43.7	21.0	37.1	21.4	24.6	25.3	34.5	29.6	77.1	19.6	50.5	45.6	51.7	20.3	20.0	14.6	26.2	30.7	18.4	16.0	34.7	26.9	47.9	29.9	44.7	48.2	36.0	16.1	28.2	19.0	32.5	14.8	43.1	23.7	33.0	13.1	57.2	43.0	151.3	69.0	20.3	22.3	14.1	23.1	33.6	25.3	21.8
FTSJ3	SPB1	ENSG00000108592	"FtsJ RNA 2'-O-methyltransferase 3"	Q8IY81	17	63819433-63830012	"Metabolic proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055544, HPA062628"	Supported		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA055544: AB_2682843, HPA062628: AB_2684813"	"unprognostic (1.33e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.60e-2)"	"unprognostic (7.82e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (1.27e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.10e-1)"	"unprognostic (3.43e-1)"	20.7	20.7	11.8	18.2	12.4	15.8	18.0	12.3	12.7	20.4	12.0	20.5	14.2	20.2	17.2	19.0	18.8	15.1	20.8	11.3	12.0	23.3	18.8	14.8	20.9	12.6	12.1	22.3	15.7	20.6	12.4	13.1	12.5	18.7	18.0	8.8	17.7	18.1	28.8	23.9	18.4	22.6	12.3	21.0	17.8	15.2	12.3	21.0	17.2	14.6	23.8	20.1	18.7	12.7	63.0	97.0	36.8	52.5	57.9	49.5	57.0	61.4	44.7	68.8	54.2	81.4	40.9	83.4	24.7	36.2	36.0	42.6	69.3	58.4	87.8	14.4	69.2	75.0	68.6	76.6	42.2	95.9	52.5	35.1	45.3	106.9	51.2	34.9	58.2	50.2	75.9	33.1	46.5	105.5	84.9	31.1	99.4	70.2	97.7	74.6	100.9	58.6	44.8	56.3	33.9	132.5	72.3	60.9	43.1	72.7	58.0	31.8	52.7	50.9	71.6	57.4	115.1	79.5	120.9	81.4	45.6	62.6	50.3	4.5	11.4	7.0	11.0	13.0	14.5	9.6	11.6	14.5	13.6	8.6	9.2	11.5	2.5	13.9	10.1	10.3	15.1	10.0	11.8	12.4	12.3	12.7	11.3	12.0	12.6	12.1	12.5	12.3	12.3	12.7	16.2	32.1	30.2	4.2	17.3	13.8	13.6	16.1	26.7	6.6	10.6	12.6	27.7	18.6	25.7	14.7	10.4	16.0	19.4	15.7	13.7	28.0	8.8	23.5	27.5	25.1	12.7	20.8	2.0	33.8	17.0	18.4	11.2	24.1	24.1	17.5	14.3	19.9	14.2	3.3	2.0	12.0	16.2	13.8	9.3	17.8	24.2	16.3	8.8	1.9	19.3	16.0	15.5	1.5	3.8	30.6	14.0	19.2	18.6	10.6	15.5	29.8	24.3	9.3	46.0	21.0	20.5	11.7	15.7	20.8	12.8	16.3	18.6	15.7	21.1	9.5
FUBP3	FBP3	ENSG00000107164	"Far upstream element binding protein 3"	Q96I24	9	130578965-130638352	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047658, HPA058392"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		63000	"Cluster 15: NK-cells - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	Cytosol	"HPA047658: AB_2680114, HPA058392: AB_2683703"	"unprognostic (1.23e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.67e-3)"	"unprognostic (2.12e-2)"	"unprognostic (2.29e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (3.12e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.23e-2)"	"prognostic favorable (4.39e-5)"	"unprognostic (2.15e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.23e-2)"	29.9	23.6	20.4	20.9	23.7	12.4	21.5	22.2	25.3	23.3	16.4	26.1	21.4	30.4	20.5	24.8	21.8	20.4	26.7	19.4	21.0	22.9	40.4	21.3	21.9	24.2	22.5	24.9	22.9	33.7	17.5	28.5	23.8	26.6	20.9	20.2	23.7	24.7	16.0	22.1	22.4	27.0	21.5	22.9	22.5	17.0	22.1	25.8	41.5	13.6	20.9	22.8	22.6	24.5	47.3	42.4	61.1	50.8	43.2	48.7	76.8	67.1	59.0	51.9	40.3	62.0	42.3	45.8	34.5	63.4	45.7	80.3	51.5	56.1	61.1	51.2	45.7	50.3	66.8	46.1	59.2	76.4	54.5	47.6	44.1	54.5	51.1	43.8	43.7	37.2	82.1	27.5	54.7	63.3	59.3	38.8	78.2	74.4	54.5	52.6	75.4	61.7	45.6	49.2	39.5	66.4	70.5	51.8	44.4	45.7	71.0	57.9	55.4	93.9	44.4	63.5	78.4	25.1	44.8	57.9	52.8	33.0	68.2	0.0	2.1	1.2	2.4	2.5	3.6	2.3	2.6	2.9	3.1	1.6	3.1	2.7	0.5	4.0	2.0	2.7	2.3	1.5	20.4	23.7	22.2	25.3	19.4	21.0	24.2	22.5	23.8	21.5	22.1	24.5	26.1	19.2	20.6	45.4	19.5	33.4	20.6	17.6	24.5	26.2	23.0	13.6	20.4	20.0	15.2	16.5	14.6	28.3	18.1	21.1	29.4	19.0	5.1	18.0	24.3	23.9	21.7	20.2	49.4	18.9	31.8	25.0	20.9	26.2	7.6	26.6	26.4	52.0	26.7	32.0	54.1	17.2	20.3	25.4	20.4	9.6	20.5	17.6	37.4	30.0	18.1	59.1	12.3	41.2	56.9	25.7	17.0	27.8	22.8	28.3	15.5	35.9	22.8	28.0	13.1	29.3	29.9	16.8	12.4	31.4	40.9	45.8	19.4	20.7	17.7	26.0
FUS	"ALS6, FUS1, hnRNP-P2, HNRNPP2, TLS"	ENSG00000089280	"FUS RNA binding protein"	P35637	16	31180138-31191605	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008784, CAB033036, CAB058691"	Supported		Supported	Nucleoplasm		NA	NA		480000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB033036: AB_2105208, CAB058691: AB_2665583, HPA008784: AB_1849181"	"unprognostic (3.06e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.86e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.03e-2)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (2.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.12e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.27e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-2)"	88.6	47.6	43.6	102.9	48.6	98.9	65.1	50.6	59.2	85.3	27.2	72.5	59.5	102.0	40.9	58.5	99.2	38.8	70.4	46.9	48.6	83.6	54.3	64.8	97.9	44.3	43.0	134.2	57.3	85.0	47.2	58.3	46.9	59.1	62.8	59.4	60.0	70.4	98.6	53.8	62.6	98.1	45.7	69.3	59.4	69.1	44.8	174.1	58.6	86.0	113.2	87.5	63.2	52.1	386.6	337.2	492.6	292.9	128.3	101.7	429.3	504.1	253.1	319.6	238.3	440.7	254.9	579.6	359.3	310.7	349.4	173.0	563.6	421.0	284.3	341.5	304.7	486.6	224.6	445.3	222.7	529.7	348.5	222.4	99.8	437.5	258.9	120.1	295.7	419.6	537.6	204.7	357.0	483.0	446.2	475.5	649.0	307.7	402.0	677.0	535.9	350.1	344.0	265.6	279.1	478.9	344.5	255.7	267.8	314.9	291.8	597.5	276.3	371.5	365.5	242.1	520.5	181.4	350.4	779.0	204.4	364.2	460.9	12.3	38.2	52.8	53.6	67.3	49.9	29.1	36.5	45.9	41.7	35.2	40.3	43.9	35.0	37.3	59.3	50.3	31.0	27.4	43.6	48.6	50.6	59.2	46.9	48.6	44.3	43.0	46.9	45.7	44.8	52.1	414.6	102.5	121.2	58.1	470.7	144.8	345.7	201.0	507.6	272.6	209.8	223.8	102.1	112.9	156.3	104.8	131.3	299.3	488.8	266.8	68.4	183.6	130.8	201.0	366.1	278.4	212.1	188.2	75.4	154.8	398.5	309.0	222.8	309.7	229.7	445.0	174.2	59.1	208.5	201.9	85.9	229.5	132.2	148.4	270.7	51.2	307.3	282.7	165.4	94.6	185.4	230.8	341.9	117.6	122.2	175.7	219.4	215.5	266.6	245.4	205.4	69.7	115.4	266.3	164.3	584.4	344.2	221.0	237.1	443.6	154.3	295.1	518.2	327.9	232.6	281.2
FUT10		ENSG00000172728	"Fucosyltransferase 10"	Q6P4F1	8	33370824-33473146	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Astrocytes: 140.0;Early spermatids: 248.8;Late spermatids: 334.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053970, HPA058655"	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Endoplasmic reticulum, Golgi apparatus"		"HPA053970: AB_2682327, HPA058655: AB_2683789"	"unprognostic (6.02e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.85e-3)"	"unprognostic (6.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.80e-2)"	"unprognostic (5.40e-3)"	"unprognostic (6.07e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.10e-3)"	"unprognostic (2.76e-4)"	"unprognostic (3.06e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.87e-3)"	"unprognostic (6.01e-3)"	1.9	2.2	4.3	1.0	4.7	0.8	3.4	4.2	4.2	4.0	2.0	2.5	2.5	3.1	1.2	1.9	3.3	1.8	1.7	3.0	3.3	3.1	2.0	2.4	1.8	4.3	5.5	5.2	2.6	5.1	1.3	3.5	3.3	2.2	2.7	5.2	2.7	2.1	0.6	3.2	2.6	2.9	2.7	1.5	2.3	1.5	4.8	2.9	2.8	1.2	2.2	2.2	2.2	2.5	2.4	4.5	6.8	8.3	10.8	10.8	3.4	4.3	7.1	4.2	5.4	6.3	3.6	2.7	5.1	5.8	3.5	5.9	10.4	4.1	4.1	5.8	3.8	8.6	3.6	7.0	4.9	1.9	2.9	8.0	7.0	1.1	5.4	8.8	8.6	4.4	8.0	3.2	3.9	1.4	6.6	2.8	9.1	6.4	3.0	4.8	5.1	1.4	6.1	5.4	2.4	2.3	2.5	3.7	5.1	7.0	3.8	1.9	6.6	3.2	1.4	8.1	3.6	1.3	2.2	1.8	2.0	5.4	3.4	0.4	0.6	0.7	1.3	0.2	1.4	1.0	0.7	1.2	1.3	0.3	0.8	0.8	0.4	1.6	0.2	0.7	1.7	0.6	4.3	4.7	4.2	4.2	3.0	3.3	4.3	5.5	3.3	2.7	4.8	2.5	4.5	3.2	2.0	140.0	2.5	2.7	2.7	3.4	4.0	2.9	3.7	3.8	2.5	2.8	3.2	3.7	10.4	12.0	3.0	1.5	1.9	4.5	248.8	2.8	5.7	3.8	3.6	3.8	16.3	4.0	7.0	5.8	6.1	3.0	5.7	10.1	5.3	3.6	3.4	3.3	20.2	3.2	4.1	2.2	1.8	334.2	6.8	2.2	1.8	29.0	3.0	29.9	5.2	44.2	16.4	4.0	1.0	4.9	5.0	1.4	5.3	3.0	2.0	11.0	0.0	5.7	4.6	7.0	2.7	5.5	1.7	6.0	2.6	6.5	3.6	1.3
FXN	"CyaY, FA, FARR, FRDA, X25"	ENSG00000165060	Frataxin	Q16595	9	69035751-69079076	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Heme biosynthesis, Ion transport, Iron storage, Iron transport, Transport"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 69.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022164, HPA068304"	Supported		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Mitochondria	Cytosol	"CAB022164: , HPA068304: AB_2685970"	"unprognostic (3.38e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.37e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.74e-2)"	10.3	20.1	8.9	7.8	9.2	29.1	10.1	9.7	8.9	9.3	11.7	10.4	7.4	12.1	12.1	9.5	10.2	5.3	27.0	9.0	10.4	12.9	46.3	7.1	9.8	9.8	10.2	17.6	15.1	22.2	8.1	9.1	9.8	10.2	12.3	4.1	11.7	13.6	25.5	5.2	7.7	13.3	9.5	12.6	10.1	10.7	9.9	5.4	10.4	19.8	10.4	12.3	7.9	10.4	27.0	22.1	34.2	17.0	15.7	23.1	34.3	18.6	16.3	28.0	21.2	11.8	16.6	45.9	14.0	19.5	28.8	28.6	41.8	42.6	34.9	53.9	47.5	66.2	14.1	87.2	26.7	48.7	27.7	25.7	33.7	27.8	29.9	9.6	37.7	28.0	50.3	43.9	26.1	25.6	14.0	21.0	47.5	53.1	42.8	32.7	24.0	32.0	32.2	21.5	26.9	12.1	19.2	12.5	20.7	24.3	14.1	14.4	22.7	18.0	32.0	24.1	27.6	11.6	11.4	27.8	8.5	39.7	18.5	8.1	39.9	0.4	48.6	45.4	37.5	36.3	48.0	48.4	42.8	22.7	61.6	59.8	1.9	60.8	36.2	33.2	43.3	49.5	8.9	9.2	9.7	8.9	9.0	10.4	9.8	10.2	9.8	9.5	9.9	10.4	11.0	3.2	11.5	13.1	19.9	9.7	19.8	36.6	14.8	6.8	16.9	20.8	38.2	10.0	10.5	14.7	4.2	39.9	14.9	4.9	21.5	17.5	2.4	11.7	22.5	16.9	7.2	56.1	14.2	14.7	22.3	14.7	14.3	8.7	7.0	15.4	11.0	69.0	33.4	0.0	18.6	15.3	18.3	22.1	16.1	6.3	15.8	13.9	17.8	9.4	18.3	7.6	28.8	6.6	10.8	15.0	3.7	13.2	42.0	17.1	5.8	27.2	7.4	1.6	13.1	10.1	19.8	5.1	32.3	29.8	8.1	14.6	17.1	27.9	17.5	14.1
FXR2	FMR1L2	ENSG00000129245	"FMR1 autosomal homolog 2"	P51116	17	7591230-7614897	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 120.9"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 63.9;Rod photoreceptor cells: 55.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011205, HPA022997"	Supported		Supported	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"CAB011205: AB_476964, HPA022997: AB_1849208"	"unprognostic (9.57e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.15e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.50e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.49e-6)"	"unprognostic (2.79e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.64e-1)"	"unprognostic (7.79e-2)"	"unprognostic (7.67e-2)"	19.7	27.9	31.5	11.4	34.3	9.8	17.4	36.5	37.9	21.2	26.9	26.7	13.9	21.7	11.6	20.9	20.1	10.9	66.0	33.2	40.0	22.2	20.6	19.2	14.1	41.1	40.9	20.4	16.2	30.7	33.0	15.5	43.4	21.6	11.5	37.7	19.9	18.2	120.9	22.5	17.4	17.1	33.4	16.8	19.9	27.4	37.2	20.8	17.1	84.4	15.1	23.3	19.4	34.9	36.6	48.3	43.8	45.7	36.7	25.0	33.7	54.2	45.1	77.2	53.2	27.2	11.9	33.8	34.8	37.2	34.1	40.1	58.2	24.8	51.4	39.1	62.4	19.6	42.2	15.9	35.7	0.2	39.8	23.5	35.8	58.8	56.4	43.3	27.1	26.9	35.4	11.6	38.8	18.6	26.9	19.3	26.2	18.9	25.8	37.9	26.6	21.3	28.2	13.0	26.1	47.2	37.3	24.3	37.8	41.3	25.3	14.5	24.3	36.0	22.5	24.0	64.8	19.0	18.6	15.5	41.3	15.8	48.0	2.6	0.8	2.5	0.9	1.0	1.3	0.5	1.5	1.9	1.3	0.9	1.2	1.3	2.1	1.0	0.6	0.9	1.8	0.8	31.5	34.3	36.5	37.9	33.2	40.0	41.1	40.9	43.4	33.4	37.2	34.9	10.3	32.1	17.9	10.7	7.7	11.5	15.4	7.9	2.8	46.9	10.4	8.3	41.7	8.6	9.5	16.5	31.3	15.9	15.1	12.0	1.9	11.6	1.8	11.1	9.2	10.5	9.6	15.6	10.3	9.3	11.5	10.8	10.7	11.0	2.5	12.9	15.0	11.7	9.1	63.9	12.0	10.1	10.2	7.3	9.7	2.7	9.6	7.1	0.0	3.7	7.4	23.3	16.5	8.5	12.4	17.6	12.5	15.4	6.3	15.4	15.5	8.9	7.6	55.8	6.6	14.2	17.7	22.9	28.2	8.7	14.3	17.1	7.6	14.6	7.4	10.3
FYTTD1	"DKFZp761B1514, UIF"	ENSG00000122068	"Forty-two-three domain containing 1"	Q96QD9	3	197737179-197787596	"Predicted intracellular proteins"	"mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054474, HPA074880"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nuclear speckles"		"HPA054474: , HPA074880: "	"unprognostic (3.61e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.88e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (2.33e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.69e-2)"	"unprognostic (9.57e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.04e-3)"	"unprognostic (8.74e-2)"	"unprognostic (8.49e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.15e-1)"	29.7	20.9	12.1	27.1	12.6	39.2	26.6	16.1	14.6	24.8	9.1	19.9	16.7	30.4	19.6	43.9	19.1	24.4	41.3	12.1	14.9	25.7	28.9	23.6	32.4	12.4	13.9	27.5	36.4	28.7	12.6	33.5	13.0	25.1	21.6	33.8	18.2	28.8	92.6	27.1	19.3	34.9	12.8	26.3	18.2	41.1	13.3	34.1	29.6	67.0	37.7	33.6	16.9	14.9	104.5	22.6	43.7	41.7	50.1	55.3	13.4	50.0	50.8	75.4	61.4	35.3	34.8	66.4	177.1	59.3	40.0	36.7	55.5	51.0	79.8	14.5	24.9	99.8	32.9	16.1	48.9	75.1	46.5	40.0	64.6	40.8	58.3	52.1	60.4	36.8	45.9	139.0	67.6	86.9	82.2	18.1	9.6	45.1	41.2	74.9	53.6	47.4	54.8	67.3	82.4	35.7	76.8	60.0	56.4	31.8	141.2	39.1	54.0	38.5	38.1	49.0	53.6	83.5	137.2	79.3	40.8	106.4	40.6	59.2	26.9	26.5	32.4	31.8	40.7	20.0	30.7	35.9	29.9	18.9	33.4	32.2	8.5	64.6	31.0	16.9	30.2	45.7	12.1	12.6	16.1	14.6	12.1	14.9	12.4	13.9	13.0	12.8	13.3	14.9	60.6	35.3	27.2	14.7	78.5	82.3	46.6	24.3	42.7	35.1	47.0	34.4	109.7	25.8	30.1	47.8	31.3	24.4	63.9	19.0	90.1	35.5	21.7	27.3	58.9	55.2	56.4	25.2	23.7	36.1	27.5	53.7	30.1	42.6	66.6	29.4	36.4	50.7	38.0	45.4	19.6	23.7	28.5	48.6	67.8	18.3	32.0	54.8	51.6	22.5	108.6	41.8	82.4	19.6	23.0	34.3	16.5	37.2	65.4	74.5	17.1	51.1	44.6	45.2	39.5	45.8	63.1	96.3	90.7	54.0	91.1	50.1	60.7	51.9	20.0	63.6
G2E3	"FLJ20333, KIAA1333, PHF7B"	ENSG00000092140	"G2/M-phase specific E3 ubiquitin protein ligase"	Q7L622	14	30559158-30620064	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 42.3"	"Group enriched"	"Detected in all"	6	"Early spermatids: 722.5;Late spermatids: 233.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001601	Uncertain		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	Yes			"Cluster 18: Basophils - Vesicular transport"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	"Golgi apparatus, Vesicles"	"HPA001601: AB_1079198"	"unprognostic (4.75e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.86e-2)"	"unprognostic (9.10e-2)"	"unprognostic (3.99e-2)"	"unprognostic (5.44e-6)"	"unprognostic (1.17e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.12e-2)"	4.8	3.2	2.1	6.4	7.0	10.0	6.4	11.6	5.5	6.4	0.7	5.6	5.0	6.3	3.7	6.2	4.8	3.8	4.8	2.4	5.6	4.5	5.2	4.5	9.1	3.1	2.5	6.1	5.2	5.6	2.7	6.3	2.7	5.1	5.3	13.8	4.9	4.6	3.0	5.9	4.9	6.2	1.0	6.3	5.3	42.3	7.0	14.3	6.6	3.9	8.9	4.9	3.9	9.6	37.9	15.6	33.7	16.1	11.2	15.0	30.5	31.9	12.9	20.2	22.9	17.1	20.5	32.9	10.9	18.4	15.9	29.7	36.4	18.8	42.2	25.7	15.7	19.6	17.1	31.0	10.3	34.0	22.5	8.1	7.4	15.1	34.9	18.3	22.9	22.5	21.2	24.2	29.0	21.9	22.6	9.6	31.2	27.5	32.7	21.4	0.0	8.2	10.5	22.3	28.4	19.9	27.7	16.0	7.9	20.5	19.1	12.5	17.3	19.7	21.9	16.9	21.9	14.1	47.7	38.8	5.4	16.6	29.2	20.2	6.5	12.9	7.6	8.5	10.1	9.2	7.4	6.3	5.6	9.9	9.2	7.8	5.9	6.5	11.3	6.8	6.6	4.1	2.1	7.0	11.6	5.5	2.4	5.6	3.1	2.5	2.7	1.0	7.0	9.6	22.6	19.2	9.0	17.9	32.9	21.9	22.5	11.8	26.7	34.9	13.0	10.8	10.0	12.8	13.6	5.5	25.0	17.8	23.0	9.0	9.8	8.9	722.5	13.9	26.6	17.0	13.8	42.7	45.3	7.1	22.7	20.6	14.3	14.1	17.1	23.3	13.2	7.5	14.2	35.3	38.4	14.7	14.2	13.9	12.4	233.9	16.4	16.5	8.8	24.4	16.2	15.5	32.0	41.7	43.1	10.7	9.4	14.3	14.4	22.5	5.6	12.0	10.9	33.4	52.6	18.0	18.6	69.8	42.7	20.7	25.4	10.0	24.9	11.9	12.4	20.6
G3BP1	"G3BP, HDH-VIII"	ENSG00000145907	"G3BP stress granule assembly factor 1"	Q13283	5	151771045-151812911	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Immunity, Innate immunity, Transport"	"DNA-binding, Endonuclease, Helicase, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004052, CAB037068"	Supported		Supported	Cytosol		NA	NA		280000	"Cluster 13: T-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 28: Keratinocytes - Keratinization"	Cytosol		"CAB037068: AB_1840864, HPA004052: AB_1849348"	"unprognostic (1.31e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.28e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (3.33e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.88e-2)"	52.3	46.8	32.9	60.2	36.1	27.5	54.1	42.8	44.6	42.0	41.0	47.8	34.8	42.5	33.1	54.8	51.0	38.8	51.0	30.7	36.1	57.1	69.0	36.1	78.3	34.5	35.7	62.5	30.4	41.5	16.5	58.2	35.8	41.3	50.6	18.3	31.8	37.3	112.2	43.4	33.9	47.8	35.0	46.7	40.3	65.5	38.6	66.0	42.6	92.1	85.7	66.3	31.9	43.3	204.9	267.0	177.0	96.3	253.2	119.2	232.4	204.1	190.6	290.6	348.6	413.7	310.3	384.7	307.0	188.0	231.6	210.9	319.7	395.6	333.7	122.5	173.8	232.9	201.1	334.8	128.8	281.6	163.9	123.4	186.7	243.7	232.2	98.7	209.7	140.9	191.3	173.3	254.5	179.7	273.9	142.4	231.4	146.0	209.6	254.3	235.1	187.2	163.1	290.5	195.2	132.0	200.8	307.0	319.3	169.2	246.3	174.7	238.2	202.0	239.7	187.3	364.0	104.9	171.3	305.0	132.2	229.6	337.8	132.2	102.3	84.7	189.2	135.4	255.3	168.8	215.6	186.7	141.0	160.0	201.8	193.2	37.8	203.7	134.1	134.7	249.2	287.2	32.9	36.1	42.8	44.6	30.7	36.1	34.5	35.7	35.8	35.0	38.6	43.3	88.9	19.2	41.4	32.7	112.0	239.5	101.3	82.4	148.0	37.1	74.8	60.7	62.3	44.3	66.2	64.4	16.7	94.0	91.7	47.3	78.2	69.6	49.6	80.6	104.4	112.1	50.2	96.1	25.7	53.0	94.6	98.0	70.3	87.2	73.6	73.8	76.8	169.4	78.2	57.2	30.6	59.4	50.8	81.2	195.0	30.1	65.0	73.3	87.2	37.5	83.7	54.3	45.3	29.7	45.3	59.2	42.9	57.2	89.3	160.0	33.5	80.0	74.2	36.6	39.5	111.6	90.7	58.0	89.3	155.6	256.4	67.3	99.6	72.2	78.5	98.0
G3BP2	KIAA0660	ENSG00000138757	"G3BP stress granule assembly factor 2"	Q9UN86	4	75641849-75724589	"Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018304, HPA018425"	Enhanced		Enhanced	Cytosol		NA	NA		47000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA018304: AB_1849350, HPA018425: AB_1849352"	"unprognostic (2.42e-2)"	"unprognostic (5.79e-2)"	"unprognostic (8.70e-3)"	"unprognostic (2.23e-1)"	"unprognostic (6.98e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.83e-2)"	"unprognostic (3.79e-1)"	"unprognostic (7.38e-2)"	"unprognostic (7.88e-2)"	"prognostic favorable (6.65e-5)"	"unprognostic (3.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.99e-2)"	37.6	41.5	32.6	50.9	35.6	69.2	50.3	24.2	48.5	47.2	12.9	61.7	52.4	45.1	32.1	49.5	55.2	49.7	47.8	33.7	51.7	67.5	65.3	46.0	60.2	26.0	28.8	32.0	42.2	56.0	28.2	38.4	32.4	77.8	58.0	46.8	37.0	49.2	115.1	25.5	62.6	55.0	24.0	48.0	47.5	60.5	40.0	66.5	74.6	119.5	61.2	65.8	25.8	30.0	96.8	96.6	160.5	131.1	134.8	136.6	54.1	141.6	144.6	96.2	101.5	128.5	137.1	197.1	125.5	120.1	87.0	68.8	170.1	176.0	136.6	111.4	66.2	185.7	95.7	141.7	119.8	188.4	146.2	109.9	144.4	114.6	122.8	129.1	172.1	114.9	140.9	139.2	150.7	63.0	218.4	63.1	154.1	140.3	36.3	159.8	199.2	96.3	112.3	125.8	124.1	141.1	105.7	151.0	201.9	165.7	75.1	90.9	178.5	95.3	76.5	107.7	81.7	136.2	133.9	195.2	135.5	122.9	122.7	83.1	36.2	62.4	50.0	47.8	76.4	35.1	48.1	55.8	41.1	28.2	46.9	51.5	30.8	59.6	64.1	18.5	44.1	64.1	32.6	35.6	24.2	48.5	33.7	51.7	26.0	28.8	32.4	24.0	40.0	30.0	72.8	54.5	100.7	26.1	126.3	89.0	81.7	53.2	114.4	61.4	71.8	55.2	79.1	20.0	81.0	53.3	50.1	36.4	133.0	92.2	41.1	59.0	213.8	84.7	57.8	69.8	135.4	43.9	70.6	68.9	49.3	56.7	65.2	80.0	105.7	76.7	51.0	77.7	45.7	70.7	74.9	107.9	50.8	75.9	131.3	228.8	26.4	86.1	60.5	30.9	85.3	29.3	53.5	36.7	59.1	94.8	66.6	39.9	117.7	84.5	88.3	104.1	85.8	69.1	19.7	57.2	91.9	63.2	74.8	79.8	77.7	41.3	186.2	99.5	75.6	88.3
GABARAPL2	"ATG8, ATG8C, GATE-16, GATE16, GEF2"	ENSG00000034713	"GABA type A receptor associated protein like 2"	P60520	16	75566375-75577881	"Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036726	Uncertain		Uncertain	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA036726: AB_10672476"	"unprognostic (3.29e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.30e-2)"	"unprognostic (7.00e-2)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (2.58e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.95e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.33e-2)"	"prognostic favorable (5.95e-8)"	"unprognostic (3.11e-3)"	"unprognostic (3.84e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.85e-1)"	129.2	166.9	269.1	68.0	278.1	101.6	122.3	297.7	310.8	105.9	237.2	118.5	67.1	101.3	158.1	91.9	106.0	84.1	279.9	259.7	294.9	153.8	113.6	111.3	94.7	280.8	278.4	108.7	81.4	209.5	169.0	113.8	289.2	113.7	81.4	201.4	100.8	102.2	262.9	135.0	90.1	98.6	306.0	112.0	99.7	78.3	282.4	102.1	124.5	186.7	98.9	95.3	104.8	320.2	103.4	85.9	142.7	67.7	217.1	189.9	72.6	118.2	169.9	158.0	176.4	79.8	129.1	148.1	143.0	135.3	95.2	86.6	107.6	110.6	193.9	64.8	208.7	86.9	72.2	119.1	118.2	84.1	151.3	132.0	153.5	133.3	98.6	143.0	130.5	130.5	130.3	58.4	160.2	145.7	125.4	161.0	85.8	114.5	95.8	139.4	69.0	179.6	166.2	66.4	167.7	175.5	184.7	43.7	177.4	113.3	140.1	130.4	119.5	67.9	104.7	100.0	64.5	166.2	172.8	310.6	163.6	80.6	102.6	345.1	148.8	370.8	128.4	140.3	163.0	215.0	135.2	146.8	176.8	199.0	121.4	114.6	502.5	115.3	157.0	274.1	208.1	241.5	269.1	278.1	297.7	310.8	259.7	294.9	280.8	278.4	289.2	306.0	282.4	320.2	341.0	86.6	136.2	30.7	163.9	274.9	278.8	311.4	141.7	247.9	196.5	236.2	361.4	145.8	212.5	174.7	45.9	251.3	188.5	201.5	686.7	183.9	48.2	209.6	112.8	270.1	277.8	457.6	37.0	175.4	120.6	203.5	80.5	162.4	110.1	85.9	239.8	128.5	223.9	307.9	39.6	156.4	297.0	169.6	428.8	59.7	243.5	197.2	257.9	21.5	404.6	491.0	145.2	27.6	63.6	223.6	237.0	261.1	137.5	306.1	195.7	552.4	263.0	208.1	157.8	182.1	187.9	288.1	219.9	136.6	273.9	390.1	159.3	182.5	121.2	328.6
GABPA	"E4TF1-60, E4TF1A, NFT2, NRF2, NRF2A"	ENSG00000154727	"GA binding protein transcription factor subunit alpha"	Q06546	21	25734570-25772460	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003258, CAB004411, HPA028791"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB004411: AB_627648, HPA003258: AB_1078928, HPA028791: AB_10602598"	"unprognostic (5.50e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.07e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (3.97e-5)"	"unprognostic (1.62e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.73e-3)"	17.0	13.8	6.8	14.1	9.4	16.0	14.9	7.9	10.2	14.6	7.2	12.5	12.9	18.3	15.1	11.3	12.4	13.4	12.9	6.2	7.1	13.8	19.3	13.3	20.4	7.5	7.6	18.1	10.2	15.3	6.7	24.5	8.1	12.4	13.8	11.5	10.4	10.3	10.6	10.3	13.4	15.3	7.6	18.7	11.8	15.0	7.6	22.1	21.2	16.5	19.5	12.9	10.0	10.3	22.2	9.2	25.8	18.2	25.4	33.9	20.0	17.5	18.7	13.7	13.5	11.4	18.2	45.7	13.4	19.7	13.9	9.7	28.5	17.2	22.7	27.6	26.8	32.9	11.9	10.7	17.1	35.3	21.2	25.1	16.3	18.5	17.2	22.9	25.6	24.9	30.8	27.5	23.2	11.0	37.9	15.1	35.9	23.6	12.5	31.1	37.5	28.7	15.9	14.3	16.0	21.1	30.9	19.5	22.0	15.5	17.2	26.8	26.5	16.9	15.5	18.7	14.8	22.2	20.3	40.3	17.2	26.5	21.1	8.8	4.7	7.4	4.3	5.5	5.8	5.6	5.1	5.3	4.7	5.4	5.9	5.2	5.5	6.7	4.3	2.6	5.8	4.4	6.8	9.4	7.9	10.2	6.2	7.1	7.5	7.6	8.1	7.6	7.6	10.3	43.2	9.6	12.0	14.0	20.7	11.6	12.2	7.0	15.4	7.6	13.0	10.8	9.1	14.3	11.8	22.0	0.0	18.1	18.4	19.0	3.9	7.6	13.2	12.0	22.6	26.3	9.0	11.6	21.0	8.1	12.4	23.7	12.2	14.8	6.3	21.1	27.8	18.7	12.7	13.5	19.6	11.1	6.1	19.0	10.1	3.6	17.7	16.7	7.2	22.5	16.0	23.2	10.3	21.1	43.4	7.9	10.2	22.2	15.3	11.9	11.4	10.4	9.3	10.2	19.7	26.1	18.4	34.0	19.5	12.6	12.6	25.2	19.2	14.2	11.3	14.4
GABPB1	"E4TF1-47, GABPB, GABPB2"	ENSG00000104064	"GA binding protein transcription factor subunit beta 1"	Q06547	15	50275389-50355408	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019653, HPA067444"	Supported		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	Yes			"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Cytoplasmic bodies"	"HPA019653: AB_1849370, HPA067444: AB_2685842"	"unprognostic (7.79e-3)"	"unprognostic (2.42e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.33e-2)"	"unprognostic (3.99e-2)"	"unprognostic (3.25e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.54e-3)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (3.18e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.93e-3)"	14.1	7.5	5.5	13.6	6.1	34.7	11.5	11.1	7.1	8.5	5.8	9.0	7.6	10.4	9.5	8.0	8.6	9.2	7.1	5.7	5.7	7.4	13.9	9.3	18.8	6.2	5.2	8.2	7.4	9.8	4.7	14.3	6.3	9.6	10.7	8.1	8.5	6.9	7.4	8.2	7.9	10.0	5.3	11.9	8.8	16.1	5.8	24.8	9.6	8.1	20.1	16.8	6.9	9.2	25.4	28.6	41.0	32.0	10.6	14.8	54.7	32.5	25.5	37.6	32.9	48.9	20.3	33.0	19.3	26.9	29.7	40.8	37.2	27.9	47.5	46.1	22.2	39.2	29.3	33.7	25.3	37.9	29.1	19.7	26.8	35.3	45.6	21.0	66.9	35.6	36.6	40.4	25.4	58.1	56.5	34.1	28.2	27.8	19.2	68.6	29.8	31.7	22.9	31.7	38.9	32.0	29.0	27.0	33.4	38.9	23.5	37.1	32.1	34.2	28.3	60.4	58.9	28.6	42.0	57.8	21.1	34.5	35.2	44.5	16.2	32.7	19.8	20.1	26.5	31.6	19.4	21.4	22.4	26.4	17.7	20.5	16.1	27.3	15.7	17.7	27.9	20.2	5.5	6.1	11.1	7.1	5.7	5.7	6.2	5.2	6.3	5.3	5.8	9.2	18.2	9.6	11.2	10.7	80.0	47.2	126.7	15.1	23.9	43.1	10.1	9.4	17.7	24.3	7.2	7.3	35.5	43.2	47.3	11.4	3.9	12.2	79.5	8.3	11.9	38.0	50.4	38.7	13.9	7.6	50.5	33.2	23.9	10.9	47.0	8.6	41.7	30.6	37.0	37.0	12.3	24.9	12.2	73.4	22.3	33.3	57.8	42.2	19.6	15.9	54.0	32.4	120.5	22.1	19.1	14.6	21.6	38.4	58.7	89.3	21.4	8.4	8.7	45.8	26.3	64.0	32.5	28.9	34.0	32.7	35.8	55.4	77.2	6.7	27.8	116.6
GAPVD1	"DKFZP434C212, KIAA1521"	ENSG00000165219	"GTPase activating protein and VPS9 domains 1"	Q14C86	9	125261794-125367207	"Predicted intracellular proteins"	Endocytosis	"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029386, HPA029387, HPA074882"	Uncertain		Enhanced	"Plasma membrane,Cytosol"		NA	NA		46000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane"	Cytosol	"HPA029386: AB_10599604, HPA029387: AB_10600311, HPA074882: "	"unprognostic (8.43e-3)"	"unprognostic (3.84e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.43e-2)"	"unprognostic (4.04e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.31e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.54e-3)"	"unprognostic (2.77e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.82e-2)"	12.3	9.8	8.1	12.2	11.1	23.0	12.0	11.7	9.4	12.2	13.1	10.3	8.0	11.1	9.8	17.0	10.7	10.3	9.7	8.4	8.8	13.0	11.2	15.7	12.6	9.8	8.9	12.1	10.6	18.7	8.2	18.4	10.0	10.5	9.8	16.5	9.3	12.4	19.1	14.7	9.2	13.3	10.1	12.7	9.6	26.8	9.7	14.1	18.9	18.7	15.0	12.2	10.1	14.2	22.8	23.2	21.8	20.0	26.2	28.6	30.5	25.0	28.9	29.0	24.2	37.0	15.9	30.2	13.3	31.9	28.7	44.9	46.2	25.8	31.1	28.1	27.1	34.6	53.1	18.4	30.1	41.4	56.0	20.1	25.2	34.6	27.2	18.7	35.0	23.8	68.8	16.3	24.3	33.2	31.2	18.0	21.6	41.2	26.2	27.2	47.6	29.1	16.2	23.2	28.8	18.9	36.9	32.6	20.0	21.7	40.9	20.9	36.1	19.9	14.3	35.7	27.2	20.7	42.3	29.9	24.1	22.9	26.4	25.6	15.9	19.6	13.0	15.4	12.7	10.0	13.5	14.6	15.4	9.5	13.3	14.3	19.5	15.2	19.8	5.8	11.8	11.3	8.1	11.1	11.7	9.4	8.4	8.8	9.8	8.9	10.0	10.1	9.7	14.2	30.0	109.0	58.0	35.6	28.3	31.9	18.2	23.0	32.5	29.9	21.0	17.5	66.8	14.3	34.8	27.6	52.1	42.3	20.7	16.6	9.8	16.2	58.3	35.7	30.7	26.8	12.6	77.0	68.4	19.3	23.7	26.2	18.3	31.4	15.8	27.6	21.4	15.2	27.6	35.3	69.7	15.9	10.2	25.4	28.5	17.7	23.0	30.5	17.8	51.5	31.2	22.8	18.6	45.2	62.7	22.3	13.9	24.0	26.5	20.0	15.4	16.1	57.2	39.1	19.7	27.8	32.0	85.6	34.5	32.3	36.9	67.0	28.3	32.5	17.0	29.8
GAR1	NOLA1	ENSG00000109534	"GAR1 ribonucleoprotein"	Q9NY12	4	109815510-109824740	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059098	Supported		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA059098: AB_2683904"	"unprognostic (9.72e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (2.64e-5)"	"unprognostic (1.01e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.17e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.08e-3)"	14.7	16.4	10.0	13.5	10.1	31.7	15.9	9.8	13.0	12.3	10.1	16.0	11.3	13.7	11.4	23.0	13.3	6.4	12.7	10.0	10.3	20.1	16.5	9.6	13.5	10.1	10.1	15.5	14.7	9.3	11.8	11.5	10.3	12.2	15.2	7.1	13.2	8.0	12.2	23.2	13.2	11.7	9.9	15.5	12.9	15.1	10.3	13.8	10.7	6.6	16.0	16.3	13.5	10.6	45.7	65.5	34.3	49.7	19.3	26.8	34.1	47.1	24.1	35.3	30.1	100.6	60.2	103.5	27.5	38.9	39.5	22.2	68.8	47.7	66.5	31.2	68.3	57.7	57.1	113.1	46.6	150.8	35.2	27.0	49.5	48.6	37.6	27.9	44.5	48.1	146.8	34.6	50.0	121.7	78.5	115.4	59.5	78.4	68.7	58.0	57.2	41.2	55.3	79.3	51.2	55.7	26.3	80.6	46.2	29.5	25.1	48.4	39.3	38.5	51.1	27.2	61.4	42.0	70.7	132.2	26.3	69.7	43.2	7.5	4.0	2.9	6.1	6.7	6.5	8.4	5.9	6.2	6.3	7.9	6.7	6.2	0.7	7.3	6.3	6.8	6.8	2.6	10.0	10.1	9.8	13.0	10.0	10.3	10.1	10.1	10.3	9.9	10.3	10.6	25.2	3.2	17.0	4.6	29.0	57.9	40.9	42.7	27.3	11.9	36.3	37.2	13.8	14.3	33.1	16.5	14.6	69.9	23.4	18.5	25.4	49.2	1.3	54.0	39.9	30.9	18.6	62.1	6.6	53.8	65.8	24.7	30.1	36.9	19.0	38.1	18.2	19.6	35.8	5.0	6.3	40.7	10.2	13.3	17.2	4.3	22.1	16.0	17.8	5.6	16.1	39.2	17.5	5.5	7.4	49.5	22.7	18.8	24.7	68.5	14.5	40.4	35.6	9.3	6.6	35.2	27.7	45.0	38.3	40.2	60.0	87.8	24.8	44.6	46.1	40.6
GATAD2A	p66alpha	ENSG00000167491	"GATA zinc finger domain containing 2A"	Q86YP4	19	19385826-19508931	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006759, HPA024373"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA006759: AB_1079549, HPA024373: AB_1849522"	"unprognostic (1.07e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.64e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.86e-1)"	"unprognostic (9.04e-3)"	"unprognostic (9.53e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.62e-3)"	"unprognostic (4.69e-2)"	"unprognostic (3.06e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.30e-2)"	"unprognostic (9.84e-2)"	16.7	15.1	13.1	23.6	14.0	32.6	15.4	11.0	12.6	13.6	17.1	19.5	22.8	14.8	8.7	22.0	12.3	14.4	12.3	16.7	13.5	16.1	17.1	21.7	19.8	17.6	14.4	11.4	21.6	15.1	14.9	17.8	14.3	10.7	11.3	8.4	15.5	11.0	17.9	30.0	24.8	8.3	14.4	22.2	17.8	33.0	14.8	19.5	14.7	6.9	13.6	15.1	16.4	12.7	60.7	50.8	46.5	69.3	18.9	19.7	97.5	46.7	31.6	47.7	45.4	92.8	62.6	117.9	69.5	47.1	31.6	49.6	43.6	41.5	27.6	40.6	47.7	87.1	49.4	51.8	46.2	97.6	72.1	31.3	30.2	49.9	40.0	15.8	48.2	66.9	141.1	37.1	28.1	68.5	115.9	38.7	98.3	55.8	45.9	121.9	46.6	54.9	24.9	79.0	87.7	48.9	40.4	48.6	57.5	30.2	44.0	40.3	94.9	89.9	43.3	106.8	88.5	46.1	62.9	125.3	56.2	80.9	53.7	4.6	2.9	3.2	3.2	1.5	1.9	2.3	1.9	2.7	1.3	1.5	1.4	1.6	7.8	2.7	3.3	3.0	1.3	2.3	13.1	14.0	11.0	12.6	16.7	13.5	17.6	14.4	14.3	14.4	14.8	12.7	35.7	12.8	19.2	24.5	24.1	55.7	22.3	14.2	26.2	16.1	33.5	21.5	13.5	24.3	15.4	14.7	18.8	23.7	66.3	53.4	13.7	21.9	21.8	43.9	42.8	31.4	15.6	21.0	14.9	30.6	36.8	21.9	29.0	69.5	17.1	22.1	29.3	27.9	27.7	23.5	21.4	28.9	24.4	27.3	42.1	18.5	15.5	27.7	32.0	35.6	28.5	18.2	53.5	17.1	21.6	46.4	28.8	13.9	19.5	24.1	30.2	29.9	15.8	18.3	19.7	40.5	25.8	18.4	41.4	39.5	55.5	36.7	39.3	28.2	32.2	28.2
GATC	"15E1.2, FLJ37000"	ENSG00000257218	"Glutamyl-tRNA amidotransferase subunit C"	O43716	12	120446444-120463749	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	Ligase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 22: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"				"unprognostic (2.10e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.04e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.46e-2)"	"prognostic unfavorable (4.21e-5)"	"unprognostic (1.68e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.10e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.92e-2)"	10.0	10.3	11.6	8.4	13.2	7.5	12.0	15.2	15.1	11.1	10.2	10.2	11.7	8.3	10.9	8.7	7.7	7.3	6.6	12.1	12.6	15.3	16.4	8.6	10.2	13.2	12.9	9.9	37.8	13.0	7.9	9.2	13.6	8.6	10.7	12.8	10.5	7.9	8.5	9.5	10.2	7.7	12.8	9.2	9.6	4.6	13.1	11.9	11.6	8.0	11.8	10.0	8.3	15.8	12.7	40.7	19.4	22.6	23.4	23.1	13.8	16.1	15.0	17.5	12.9	37.9	9.3	25.2	17.6	14.7	15.5	20.4	30.7	17.6	17.1	19.4	28.7	24.1	25.3	25.4	25.8	23.4	13.6	21.7	18.8	13.7	24.4	24.0	24.8	23.4	33.3	12.9	17.9	20.0	26.3	25.8	12.3	19.0	25.7	17.6	22.5	33.9	20.7	21.5	35.7	17.3	28.8	15.1	21.0	15.3	26.8	12.9	21.9	14.6	13.5	19.8	12.6	18.4	32.6	32.5	19.8	14.5	23.5	7.0	5.3	4.0	6.1	3.6	5.9	6.2	4.7	3.6	3.9	5.9	4.3	5.0	3.7	4.7	5.5	6.2	5.4	5.4	11.6	13.2	15.2	15.1	12.1	12.6	13.2	12.9	13.6	12.8	13.1	15.8	14.8	3.2	19.1	11.4	13.0	9.4	20.6	4.4	16.5	17.6	13.4	12.4	6.2	18.6	13.8	18.4	16.7	13.3	16.4	18.3	11.7	17.8	3.2	14.6	19.5	17.2	27.0	10.1	14.0	24.4	12.3	12.5	11.2	18.2	24.1	17.6	18.5	22.8	11.3	18.5	12.8	15.5	6.1	14.9	4.2	1.9	14.6	14.6	3.6	4.7	18.5	12.0	11.3	13.6	13.6	29.4	14.1	20.3	13.9	25.8	19.8	22.4	7.5	14.1	6.6	20.0	12.0	11.7	8.0	15.3	9.9	14.9	12.6	11.7	19.3	22.0
GATD3B		ENSG00000280071	"Glutamine amidotransferase like class 1 domain containing 3B"	A0A0B4J2D5	21	5079294-5128413	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 17.6;Ductal cells: 6.9;Hofbauer cells: 8.0;monocytes: 7.8;Proximal tubular cells: 31.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA018517	Uncertain		Approved	Centrosome,Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	Centrosome	"HPA018517: AB_2669899"	"unprognostic (4.87e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.96e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.67e-4)"	"unprognostic (1.88e-2)"	"unprognostic (6.80e-2)"	"unprognostic (4.25e-1)"	"unprognostic (2.84e-2)"	53.8	77.8	82.0	34.9	87.3	31.7	48.6	88.9	90.2	40.9	76.0	55.1	71.8	36.9	27.5	59.4	44.4	41.2	195.5	78.2	87.4	141.7	239.9	34.5	53.8	89.0	86.3	66.6	52.7	61.9	54.8	40.2	90.2	43.9	57.5	32.2	60.1	33.4	208.0	40.6	51.3	32.4	83.9	48.2	50.1	33.0	89.9	35.9	55.1	225.6	28.1	40.0	41.1	85.5	55.8	52.7	57.1	98.7	42.8	38.3	23.7	0.0	4.5	1.9	2.9	7.0	54.8	2.6	61.9	62.9	51.7	38.8	77.2	34.7	1.1	36.8	32.8	217.2	60.1	47.6	41.7	94.8	39.7	80.4	69.6	28.3	57.1	39.5	64.4	66.1	86.6	51.2	34.9	118.5	94.4	103.6	110.9	150.0	80.5	190.1	43.1	223.3	72.4	49.8	48.5	96.4	76.7	138.9	52.0	28.4	146.2	131.4	19.7	27.7	39.0	2.5	33.7	80.7	79.2	37.6	64.9	192.0	20.7	87.3	110.4	60.4	102.2	123.5	101.4	153.3	129.7	107.0	147.7	167.1	124.6	95.2	21.7	136.1	167.7	96.3	145.3	190.3	82.0	87.3	88.9	90.2	78.2	87.4	89.0	86.3	90.2	83.9	89.9	85.5	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.6	1.1	0.0	0.0	0.0	0.0	0.0	2.9	1.4	0.0	17.6	6.9	0.0	1.1	1.9	0.7	0.0	0.0	0.0	5.0	3.2	0.3	0.0	2.0	0.0	0.5	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	7.8	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.7	0.0	0.0	31.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	3.4	0.7	1.9	0.0	0.0
GCSH		ENSG00000140905	"Glycine cleavage system protein H"	P23434	16	81081945-81096395	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 553.4;Extravillous trophoblasts: 1476.4;Proximal tubular cells: 655.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA041368, HPA057079"	Supported		Approved	Vesicles	"Intracellular and membrane"	NA	NA		50000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Vesicles		"HPA041368: AB_10804001, HPA057079: "	"unprognostic (4.09e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.47e-3)"	"unprognostic (2.55e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.96e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.80e-2)"	"prognostic favorable (6.26e-6)"	"unprognostic (1.12e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.31e-2)"	"unprognostic (6.47e-2)"	28.7	20.1	58.9	6.9	66.5	6.3	24.2	62.9	113.8	18.2	50.8	16.0	7.2	17.5	68.9	15.5	19.8	11.7	38.1	55.8	60.9	78.2	118.9	10.8	6.7	60.1	66.0	18.4	19.7	31.0	14.3	26.0	61.1	18.7	13.0	15.6	15.6	16.7	59.3	10.1	9.5	11.8	61.7	6.3	17.5	7.4	63.7	10.4	96.4	63.6	9.3	18.3	15.2	67.8	63.6	28.3	82.4	37.0	40.4	30.9	175.5	35.9	26.4	43.3	20.6	37.0	57.2	17.2	32.3	15.9	31.9	33.3	64.5	36.5	71.6	4.7	86.7	21.8	34.9	114.6	45.7	70.3	24.1	32.0	47.8	26.8	53.7	13.0	22.3	45.1	86.3	3.4	42.9	67.7	45.9	138.8	113.0	49.6	57.5	72.7	44.1	25.5	98.4	56.4	43.7	45.3	53.3	32.9	70.8	63.9	48.3	33.2	19.8	27.6	49.3	44.0	37.8	14.7	31.8	102.1	18.2	41.3	22.6	3.6	1.3	1.3	2.8	2.1	4.6	3.5	2.6	4.0	3.9	2.5	4.4	5.9	1.7	7.0	1.7	10.8	2.2	2.4	58.9	66.5	62.9	113.8	55.8	60.9	60.1	66.0	61.1	61.7	63.7	67.8	31.1	3.2	5.9	16.3	24.8	29.1	94.6	73.6	52.3	43.7	97.9	115.6	12.9	44.3	31.4	80.9	37.5	553.4	13.8	15.3	295.4	70.0	32.4	34.8	128.3	31.9	26.4	71.1	12.6	42.5	1476.4	61.6	31.1	55.2	36.3	38.5	33.2	352.0	118.8	38.7	11.9	34.3	67.1	19.7	34.6	19.5	140.8	18.8	85.4	4.7	17.7	215.8	19.6	19.6	35.2	42.3	17.8	141.1	51.7	123.9	13.7	655.9	20.0	45.7	32.9	46.2	50.2	20.7	77.3	78.4	27.1	228.8	16.3	114.5	49.4	69.8
GDI2	RABGDIB	ENSG00000057608	"GDP dissociation inhibitor 2"	P50395	10	5765223-5842132	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049290, HPA057668"	Supported		Approved	Cytosol		NA	NA		53000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"HPA049290: AB_2680700, HPA057668: AB_2683498"	"unprognostic (1.08e-2)"	"unprognostic (8.33e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (9.26e-4)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (7.56e-7)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.74e-2)"	"unprognostic (6.97e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.68e-2)"	125.1	111.5	62.4	151.6	70.0	126.6	138.1	76.0	90.3	120.6	66.8	152.9	175.4	96.3	115.3	131.1	96.8	112.6	86.8	59.3	70.7	146.0	241.1	98.3	217.5	85.8	72.7	116.9	165.1	91.3	59.6	135.5	82.6	88.8	160.7	69.1	97.7	92.2	107.0	107.6	160.2	124.1	80.9	138.7	108.6	74.3	65.1	149.1	114.1	99.7	239.2	145.5	81.7	95.4	343.4	245.8	341.1	241.2	298.2	347.5	191.4	325.0	170.8	287.3	312.0	351.8	287.3	553.2	198.2	340.5	88.1	320.8	368.3	289.3	288.0	212.2	174.7	380.0	152.0	428.4	276.9	252.1	230.7	292.6	235.8	249.6	148.9	324.0	400.6	340.1	398.5	203.4	331.6	291.1	390.9	208.0	242.5	355.1	159.3	466.7	181.9	389.8	330.7	250.1	138.0	210.0	257.5	468.5	358.3	289.9	382.3	299.0	342.0	142.3	243.4	420.3	282.2	180.0	314.8	526.5	212.0	275.5	130.0	154.9	280.8	169.0	109.9	347.8	136.4	210.7	136.9	121.6	329.1	204.2	124.8	119.3	138.4	177.5	445.1	146.1	181.5	416.8	62.4	70.0	76.0	90.3	59.3	70.7	85.8	72.7	82.6	80.9	65.1	95.4	101.5	25.6	83.8	31.0	208.1	161.7	131.3	144.8	145.7	37.1	124.5	81.8	76.6	107.2	109.0	57.0	18.8	252.1	148.5	156.6	133.1	185.7	29.5	69.1	138.0	125.4	118.4	177.1	27.7	212.2	312.0	151.5	109.6	84.3	132.5	121.7	121.3	145.9	284.5	92.5	32.1	184.7	91.6	354.2	302.8	40.4	152.2	255.7	149.4	36.5	485.8	75.0	97.9	34.7	49.2	158.1	141.9	141.8	151.3	129.2	271.0	194.1	63.0	36.8	111.7	96.1	125.8	126.2	119.3	177.6	165.1	247.4	120.1	136.9	213.5	131.9
GEMIN4	"DKFZP434B131, DKFZP434D174, HC56, HCAP1, HHRF-1, p97"	ENSG00000179409	"Gem nuclear organelle associated protein 4"	P57678	17	744421-753999	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 148.3;Late spermatids: 157.2;Spermatocytes: 57.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065699, HPA067891"	Uncertain		Supported	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear bodies, Cytosol"		"HPA065699: AB_2685534, HPA067891: AB_2685918"	"unprognostic (1.85e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.60e-1)"	"unprognostic (7.41e-3)"	"unprognostic (2.00e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.89e-2)"	"unprognostic (8.67e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.74e-2)"	"unprognostic (8.56e-3)"	12.4	7.7	3.0	8.2	3.0	15.5	12.3	10.5	6.2	13.4	5.9	9.5	8.0	12.1	5.7	14.8	12.3	13.0	11.2	2.9	3.3	4.9	8.6	9.8	13.6	2.3	2.4	15.6	9.7	6.3	5.7	6.6	2.6	14.4	6.3	3.4	11.7	8.2	13.9	38.9	9.8	8.5	2.1	10.0	14.5	48.9	3.1	13.2	15.6	10.1	12.3	11.8	12.4	2.6	44.8	77.8	25.5	38.3	15.8	19.9	31.7	25.0	17.4	44.4	39.1	44.5	23.6	77.9	32.5	21.6	23.6	55.4	48.3	47.0	35.3	29.6	72.3	28.0	40.9	25.1	11.3	30.1	36.8	19.3	23.3	36.5	25.6	15.4	25.3	44.9	39.6	31.7	24.0	31.7	49.8	17.0	24.7	37.4	33.0	53.1	12.1	36.6	18.9	32.5	26.4	21.4	25.7	26.1	11.7	18.2	27.8	21.7	20.2	27.3	24.6	35.6	61.4	5.3	12.4	44.8	23.5	41.9	31.8	1.6	7.0	0.3	7.9	9.6	13.6	11.8	8.6	8.4	9.3	12.3	10.1	10.2	0.9	8.7	11.6	5.2	6.0	10.0	3.0	3.0	10.5	6.2	2.9	3.3	2.3	2.4	2.6	2.1	3.1	2.6	2.9	16.0	6.7	1.3	8.5	20.4	14.3	6.6	9.1	2.9	4.6	4.7	38.4	4.3	8.5	0.0	0.0	8.4	4.4	3.1	3.9	7.5	148.3	2.6	3.9	5.8	1.2	3.0	1.2	6.4	8.3	6.4	7.7	2.9	1.3	11.1	4.6	5.2	5.4	5.0	1.5	7.0	8.2	3.9	5.7	157.2	11.5	2.6	5.4	1.0	4.8	2.4	2.1	0.0	0.5	8.4	1.8	6.8	4.3	7.4	2.3	2.2	4.4	1.4	0.0	6.2	6.4	57.0	11.2	8.7	16.1	4.0	3.2	7.4	8.7	9.8
GEMIN5		ENSG00000082516	"Gem nuclear organelle associated protein 5"	Q8TEQ6	5	154887411-154938211	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Protein biosynthesis, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037392, HPA037393"	Uncertain		Enhanced	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Nuclear bodies"	"HPA037392: AB_2675453, HPA037393: AB_10672489"	"unprognostic (1.14e-2)"	"unprognostic (2.81e-3)"	"unprognostic (5.41e-3)"	"prognostic unfavorable (6.23e-5)"	"unprognostic (5.44e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (9.91e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.61e-2)"	"unprognostic (9.38e-2)"	"unprognostic (5.11e-2)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.40e-3)"	"unprognostic (5.01e-2)"	8.3	4.4	5.0	5.0	5.9	3.3	8.2	5.4	5.6	5.9	5.0	5.4	3.3	6.2	4.6	5.3	6.1	3.4	6.7	5.1	5.4	4.7	6.0	4.3	6.5	5.2	5.2	8.4	5.5	6.4	4.4	4.8	5.4	5.8	4.6	4.1	4.6	5.9	12.3	7.3	4.0	6.9	5.2	5.6	4.3	6.0	5.4	7.5	5.3	10.2	7.3	6.8	5.0	6.9	17.2	25.0	15.9	37.0	16.8	14.2	20.4	16.4	9.9	28.0	20.6	41.6	15.0	45.0	20.2	15.7	28.8	17.8	47.7	29.8	38.0	9.0	22.3	27.3	15.6	25.2	9.3	48.0	15.2	10.7	13.6	38.9	23.2	10.1	23.2	10.7	43.9	10.7	21.2	23.6	26.0	19.2	22.3	13.4	19.4	33.3	31.2	37.4	11.6	11.6	20.9	14.4	18.9	20.7	13.3	15.7	24.6	11.0	14.2	25.1	18.0	19.1	37.2	10.7	17.5	34.5	10.7	38.8	22.6	0.0	1.9	1.7	2.4	2.3	3.9	3.4	2.2	2.2	2.6	2.7	3.2	3.5	0.1	2.8	2.2	1.9	2.2	2.1	5.0	5.9	5.4	5.6	5.1	5.4	5.2	5.2	5.4	5.2	5.4	6.9	6.7	0.0	6.4	6.8	8.4	10.3	6.7	5.3	10.2	6.3	5.2	5.0	15.0	1.5	12.3	3.7	0.0	4.4	5.0	1.9	0.0	5.7	3.4	4.3	9.5	8.4	1.2	8.8	19.1	4.2	4.4	11.1	5.1	4.8	1.3	15.6	4.6	9.2	4.5	16.8	20.5	3.9	0.0	14.4	2.6	4.1	10.8	4.5	7.2	11.2	6.0	7.0	5.2	15.1	19.3	3.4	1.1	13.2	4.5	7.0	2.6	4.5	2.5	4.3	0.0	11.5	8.6	11.7	16.1	8.2	15.9	2.1	5.6	15.6	4.7	4.9
GEMIN6	FLJ23459	ENSG00000152147	"Gem nuclear organelle associated protein 6"	Q8WXD5	2	38751534-38785002	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 164.5;Spermatocytes: 87.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035726, HPA035727"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nuclear bodies"		"HPA035726: AB_10669528, HPA035727: AB_2674753"	"unprognostic (1.97e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.82e-3)"	"unprognostic (3.10e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (2.47e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.67e-2)"	6.5	10.1	7.7	7.7	8.2	3.6	8.3	8.2	10.9	6.7	8.2	6.9	9.0	6.5	10.3	7.1	9.0	5.5	6.0	7.7	7.6	12.5	13.8	5.3	10.8	7.7	7.8	9.8	6.8	7.5	6.2	7.4	8.1	5.6	8.5	6.1	6.1	5.2	13.1	5.4	7.8	8.7	7.4	7.9	7.2	19.6	8.0	8.1	6.7	7.0	12.4	7.7	5.8	10.5	38.8	31.2	21.3	24.9	27.3	23.8	36.4	32.4	16.1	28.1	23.3	33.1	18.1	52.8	36.3	16.8	39.4	18.1	33.5	31.6	40.7	45.5	42.3	34.4	17.9	54.4	18.7	29.0	17.2	16.3	22.9	37.6	18.5	19.2	29.9	14.1	35.9	17.9	28.4	27.4	35.1	37.0	36.6	45.4	37.0	24.1	37.6	28.9	25.8	13.4	26.6	41.9	8.3	31.1	25.3	24.7	16.0	9.8	16.4	27.1	34.6	21.4	49.1	36.7	77.4	50.6	21.8	43.0	27.7	3.1	24.3	7.8	19.6	28.6	21.7	32.4	20.3	20.3	24.0	29.5	24.4	25.5	3.6	26.3	26.6	17.7	31.3	22.4	7.7	8.2	8.2	10.9	7.7	7.6	7.7	7.8	8.1	7.4	8.0	10.5	11.8	12.8	24.0	1.0	18.7	8.3	10.3	31.5	7.4	6.9	13.9	21.1	9.1	14.3	22.3	11.0	4.2	29.7	7.5	7.5	29.4	22.2	164.5	28.6	21.3	14.9	1.2	18.5	1.7	17.8	37.8	16.1	16.8	8.3	12.6	19.0	16.8	33.5	26.4	11.8	1.8	10.7	6.1	19.5	15.5	29.0	20.5	15.0	10.6	1.9	23.4	9.2	15.5	1.5	1.2	19.1	11.4	11.3	13.3	10.7	21.2	68.5	32.6	7.9	19.7	10.7	15.7	87.8	18.3	16.1	11.5	7.3	12.5	30.5	17.7	7.7
GEMIN7	FLJ13956	ENSG00000142252	"Gem nuclear organelle associated protein 7"	Q9H840	19	45079195-45091518	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052075			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Cytosol"		"HPA052075: AB_2681718"	"unprognostic (3.32e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.60e-1)"	"unprognostic (7.00e-2)"	"prognostic unfavorable (5.86e-5)"	"unprognostic (7.78e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (9.64e-11)"	"unprognostic (7.01e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (8.00e-4)"	16.2	17.0	16.7	15.3	16.4	23.4	15.8	17.8	19.0	15.3	19.3	20.2	21.1	12.5	9.3	29.6	12.7	10.5	21.7	17.1	17.2	22.7	32.3	15.5	26.8	17.4	17.8	9.5	16.7	10.1	21.9	12.7	17.5	18.3	14.2	8.0	19.0	7.2	35.1	23.5	23.9	10.8	16.9	37.1	24.0	6.0	18.0	11.8	12.5	16.4	19.4	18.5	19.2	17.8	48.3	62.6	36.0	44.4	27.0	27.8	27.8	36.2	26.3	54.1	60.0	38.3	30.1	47.8	24.3	31.3	30.0	29.5	52.6	43.0	32.6	38.4	68.6	52.8	29.2	50.4	37.6	42.7	30.3	41.9	34.8	30.3	21.8	27.7	53.4	28.5	56.3	48.7	21.5	71.2	41.2	44.2	33.9	73.2	32.3	48.6	16.6	62.4	41.4	34.9	35.6	24.9	28.3	60.3	32.8	28.9	40.9	44.9	29.1	20.0	38.0	13.1	48.4	50.3	80.6	77.7	32.1	42.7	32.8	32.8	33.5	37.1	70.5	28.2	67.6	67.3	51.1	65.3	47.4	57.8	39.4	51.1	18.3	74.6	20.5	54.1	48.4	46.4	16.7	16.4	17.8	19.0	17.1	17.2	17.4	17.8	17.5	16.9	18.0	17.8	7.5	19.2	12.1	5.2	23.0	18.1	12.4	27.3	8.0	5.8	14.9	14.5	9.9	21.5	18.4	3.7	0.0	37.9	19.3	12.7	21.5	36.7	1.5	5.9	9.7	13.2	13.2	15.3	7.5	33.7	57.2	13.0	27.0	7.5	3.8	7.9	16.4	19.9	34.7	1.7	8.1	19.8	22.4	18.8	15.4	3.1	14.3	14.2	12.4	8.4	63.3	8.0	48.4	10.1	4.1	44.5	19.7	6.4	42.1	15.9	27.8	26.0	5.1	4.6	6.6	7.3	11.9	4.9	8.3	20.0	23.7	25.9	12.4	13.8	25.0	12.1
GEN1	"FLJ40869, Gen"	ENSG00000178295	"GEN1 Holliday junction 5' flap endonuclease"	Q17RS7	2	17753858-17788946	"Predicted intracellular proteins"	"DNA damage, DNA repair"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA020078, HPA021141"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA020078: AB_2670352, HPA021141: AB_2670599"	"unprognostic (2.25e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.52e-2)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (8.64e-2)"	"unprognostic (1.67e-3)"	"unprognostic (7.90e-4)"	"unprognostic (4.53e-2)"	"unprognostic (1.70e-3)"	"unprognostic (8.60e-3)"	"unprognostic (8.04e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.89e-12)"	"unprognostic (3.97e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.49e-3)"	1.6	1.8	1.1	4.8	1.0	15.1	3.2	0.7	1.2	2.3	15.4	5.2	3.2	1.8	9.3	5.6	1.4	4.4	2.3	1.5	1.7	1.7	8.6	2.0	10.8	2.1	2.4	0.9	2.2	1.1	3.0	3.9	1.8	2.7	6.9	2.5	5.6	2.7	1.7	7.5	4.5	1.4	1.7	5.1	3.0	8.5	1.6	5.4	1.9	1.5	11.8	1.5	3.7	1.8	29.4	15.0	14.0	9.9	3.2	4.1	23.9	21.3	6.7	9.9	9.6	19.6	13.0	27.4	8.2	7.3	10.4	18.4	16.4	12.8	13.7	21.4	9.1	15.7	16.3	9.5	1.9	20.2	17.0	3.1	4.7	16.8	7.7	3.0	8.0	13.7	21.0	19.6	16.4	14.1	15.2	16.4	9.5	9.4	6.8	17.7	36.3	10.9	5.6	19.6	15.3	20.8	11.5	14.3	7.5	9.5	9.8	10.6	10.7	22.4	9.8	12.2	21.8	13.1	26.0	45.1	9.6	18.3	16.0	0.1	0.4	0.3	0.3	0.3	0.2	1.7	0.3	0.6	0.6	0.7	0.4	0.4	0.1	0.4	0.4	0.6	0.5	0.3	1.1	1.0	0.7	1.2	1.5	1.7	2.1	2.4	1.8	1.7	1.6	1.8	3.6	6.4	3.6	12.1	16.9	2.8	2.7	5.2	5.7	5.7	4.5	3.0	4.4	1.5	8.1	3.7	12.5	4.4	6.9	9.3	0.0	2.1	4.6	4.9	8.5	4.0	1.8	15.3	14.1	2.3	4.8	4.2	17.3	6.6	1.3	14.5	2.2	5.4	3.8	3.3	13.0	7.3	0.0	3.1	1.0	3.7	1.8	4.0	1.8	6.5	2.9	3.8	1.0	12.5	11.0	2.9	4.0	0.7	11.2	3.2	5.3	2.5	5.0	3.6	6.6	15.0	5.3	14.2	11.4	8.1	1.8	3.3	3.7	8.0	7.2	2.9
GET4	"C7orf20, CEE, CGI-20, H_NH1244M04.5, TRC35"	ENSG00000239857	"Guided entry of tail-anchored proteins factor 4"	Q7L5D6	7	876554-896436	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 36.7;Oligodendrocytes: 15.8;Plasma cells: 37.2;Squamous epithelial cells: 23.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019765	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Mitotic chromosome,Cytosol"		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	"Nucleoli, Mitotic chromosome"	"HPA019765: AB_1845750"	"unprognostic (2.80e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.66e-4)"	"unprognostic (9.86e-2)"	"unprognostic (8.64e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.93e-2)"	"unprognostic (9.47e-2)"	25.0	98.0	28.9	12.5	33.7	31.6	26.8	29.7	37.0	28.1	19.1	33.5	20.8	25.5	21.1	43.7	32.1	11.4	33.1	28.8	31.1	68.8	98.4	25.5	15.8	36.1	33.4	34.3	46.1	13.7	70.7	20.5	36.0	37.8	8.8	16.4	28.8	12.3	56.3	46.9	33.6	7.7	29.1	37.5	41.5	79.0	34.0	14.4	34.3	21.9	10.4	31.3	28.9	45.6	78.8	38.1	25.8	38.4	13.2	9.1	81.7	21.2	14.9	26.5	26.6	103.4	95.1	28.5	21.7	12.4	73.7	48.7	29.3	23.3	11.5	11.6	50.9	15.8	31.5	59.5	29.1	27.1	28.1	13.8	27.6	23.4	15.1	19.9	21.1	32.5	103.6	25.7	15.2	59.7	20.8	65.2	93.3	46.1	56.0	43.0	4.5	30.8	23.8	45.4	46.7	50.5	19.5	71.2	32.2	31.5	54.2	47.8	21.4	19.6	43.6	45.7	29.5	38.5	25.9	37.5	20.1	46.2	50.3	22.3	28.5	32.4	23.9	27.6	23.3	24.3	26.4	24.1	29.4	24.5	25.2	27.0	21.9	27.7	35.3	33.3	26.9	24.8	28.9	33.7	29.7	37.0	28.8	31.1	36.1	33.4	36.0	29.1	34.0	45.6	0.3	0.0	3.1	14.7	10.6	1.0	0.3	0.2	14.8	0.8	1.1	0.9	0.6	0.0	2.2	0.0	4.2	1.1	0.7	2.3	0.0	0.9	4.0	2.0	1.1	1.5	0.0	9.2	9.1	0.7	0.7	3.8	36.7	2.8	1.3	1.2	0.0	0.4	0.6	8.4	9.1	2.8	0.0	0.6	0.8	2.7	0.0	6.1	0.0	4.7	0.5	0.2	0.0	10.1	15.8	0.8	1.0	0.0	37.2	0.4	3.6	1.1	2.1	1.4	0.0	0.8	1.8	0.6	1.1	23.5	1.0	1.6	9.9	0.8	1.7	0.8
GFM1	"EFGM, EGF1, GFM, mtEF-G1"	ENSG00000168827	"G elongation factor mitochondrial 1"	Q96RP9	3	158644527-158695581	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034764, HPA034765, HPA061405"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria	Nucleoplasm	"HPA034764: AB_2674320, HPA034765: AB_10669849, HPA061405: AB_2684505"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.48e-3)"	"unprognostic (4.48e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.75e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.36e-2)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (2.79e-1)"	"prognostic favorable (1.16e-7)"	"unprognostic (1.62e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.32e-2)"	"unprognostic (8.78e-2)"	26.7	25.0	12.3	21.7	13.2	24.1	27.8	18.1	21.3	14.1	16.8	30.1	24.9	17.2	20.8	24.1	13.4	17.5	39.0	13.0	15.5	43.7	49.6	18.8	20.7	14.5	13.2	12.7	26.4	40.1	12.0	25.7	15.3	19.6	31.5	46.4	21.0	21.9	63.0	15.2	19.8	20.9	13.7	16.4	23.9	23.5	14.1	16.6	32.1	60.2	20.7	23.5	12.9	15.7	92.2	55.9	25.5	32.0	41.8	30.6	34.2	42.6	49.8	75.9	57.4	73.2	58.7	73.9	54.7	39.2	32.0	55.9	62.5	47.8	84.3	40.6	33.7	56.1	34.6	34.3	48.6	76.7	35.9	37.3	55.7	43.8	41.0	17.6	50.2	43.0	71.7	50.3	67.9	56.9	49.6	30.6	55.7	97.0	29.8	49.8	28.0	132.6	51.0	38.3	48.9	42.8	63.8	96.1	79.1	19.9	132.1	60.0	28.0	46.4	21.0	69.4	74.1	82.7	61.4	138.9	41.8	65.0	52.4	18.9	19.3	13.8	22.2	27.2	28.6	17.0	19.3	23.0	23.3	16.4	22.1	23.9	3.0	25.4	22.0	11.2	17.4	18.4	12.3	13.2	18.1	21.3	13.0	15.5	14.5	13.2	15.3	13.7	14.1	15.7	31.4	19.2	19.0	17.0	26.1	21.5	26.0	20.9	20.5	57.3	23.0	11.9	54.8	22.8	18.9	12.9	31.3	31.6	20.1	22.2	11.7	19.9	15.4	12.4	20.2	36.6	19.3	29.0	39.8	25.0	17.6	20.9	22.4	14.8	19.0	17.7	22.5	61.6	29.0	15.2	43.9	24.5	30.5	20.4	21.5	7.6	22.7	21.7	17.8	18.7	33.8	27.3	16.5	22.6	43.3	20.3	10.5	17.0	19.2	21.7	22.1	37.9	25.1	51.6	13.1	21.5	23.4	34.4	31.6	20.1	21.0	30.8	22.3	41.4	28.9	22.0
GFOD2	"FLJ23802, MGC11335"	ENSG00000141098	"Glucose-fructose oxidoreductase domain containing 2"	Q3B7J2	16	67674531-67719339	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040939, HPA041112"	Uncertain		Supported	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA040939: AB_10796564, HPA041112: AB_10794541"	"unprognostic (9.80e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.16e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.93e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.22e-2)"	"prognostic favorable (5.95e-4)"	"unprognostic (1.17e-1)"	"prognostic favorable (8.66e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.87e-2)"	"unprognostic (9.64e-2)"	12.5	12.2	13.4	6.9	13.8	16.6	12.6	27.4	14.8	17.6	13.4	11.8	11.7	10.8	5.5	33.5	13.0	7.9	7.2	13.0	13.9	12.4	40.8	9.3	8.7	11.3	12.9	6.4	8.9	12.0	13.2	14.7	13.6	10.9	9.3	8.1	12.7	7.3	9.2	16.7	9.2	9.2	8.8	18.5	8.0	11.1	12.6	8.1	10.3	7.1	12.9	10.9	26.3	11.5	15.8	25.1	15.1	31.0	14.9	11.3	18.1	12.7	16.5	23.3	23.9	21.5	13.9	26.6	11.8	14.8	12.6	19.4	15.6	14.9	19.3	16.2	20.1	6.7	14.5	30.4	11.4	11.0	12.5	9.1	16.9	31.0	9.2	11.7	34.5	26.9	14.1	4.9	13.2	33.0	18.2	13.4	20.7	9.4	13.8	28.7	8.9	20.8	14.5	21.5	30.4	18.4	31.6	10.5	9.6	8.7	15.9	7.3	26.4	17.8	18.1	16.3	13.0	13.2	19.8	29.0	11.1	15.8	13.3	0.5	4.8	5.2	4.4	2.9	7.2	6.3	7.7	7.9	4.8	7.0	6.6	5.3	9.0	5.9	3.1	5.4	9.2	3.7	13.4	13.8	27.4	14.8	13.0	13.9	11.3	12.9	13.6	8.8	12.6	11.5	36.1	0.0	8.4	8.5	7.7	22.9	15.8	8.1	15.9	13.7	21.7	12.4	5.3	15.7	10.9	11.0	14.6	10.3	10.6	23.8	5.9	21.1	89.6	22.5	10.9	33.8	43.2	56.6	18.3	11.6	24.1	10.4	3.6	8.7	4.5	12.2	31.1	46.7	6.6	21.9	16.8	17.0	16.2	7.5	10.0	29.9	8.7	4.6	8.8	6.5	5.2	12.0	11.3	8.5	7.3	15.8	14.2	11.3	9.1	12.4	20.6	13.0	24.5	11.0	6.6	11.9	11.4	19.9	14.8	10.1	27.3	22.2	10.3	9.3	18.3	21.3
GGA3	KIAA0154	ENSG00000125447	"Golgi associated, gamma adaptin ear containing, ARF binding protein 3"	Q9NZ52	17	75236599-75262363	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022945, HPA024645"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA022945: AB_1849639, HPA024645: AB_2671629"	"unprognostic (9.16e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (8.26e-4)"	"unprognostic (1.20e-1)"	"unprognostic (4.60e-3)"	"prognostic unfavorable (2.77e-6)"	"unprognostic (6.33e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.30e-2)"	"unprognostic (4.63e-3)"	"unprognostic (4.90e-3)"	"prognostic unfavorable (3.41e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.28e-2)"	"unprognostic (9.68e-3)"	11.7	9.8	9.0	13.0	8.4	15.7	10.8	7.7	11.4	12.3	4.3	12.4	11.5	10.8	9.8	17.0	10.2	11.4	12.8	8.4	6.7	11.1	11.6	13.0	17.5	8.9	7.6	15.3	12.3	9.1	9.0	14.6	7.6	10.1	11.7	6.7	12.3	7.8	22.7	15.7	15.0	11.8	6.8	19.6	13.0	11.5	7.8	12.8	9.9	10.5	19.0	11.6	12.2	9.4	16.9	21.1	19.5	11.9	21.5	17.9	22.8	18.5	13.3	24.9	21.2	24.8	18.4	21.4	8.2	16.4	19.9	10.6	13.8	8.0	25.7	15.1	21.4	34.3	19.2	19.6	10.3	32.5	24.3	14.1	19.7	13.6	23.5	13.2	26.5	16.1	37.8	19.1	17.7	17.4	42.5	9.6	13.8	19.6	14.9	16.9	28.0	14.3	17.1	18.4	14.0	23.9	18.5	33.2	14.9	27.3	25.3	17.4	29.6	25.7	18.7	17.4	19.9	19.8	15.1	27.5	20.8	23.0	17.2	5.1	6.8	2.9	5.5	5.9	5.1	3.9	4.9	4.2	6.4	4.7	4.3	4.6	7.3	8.4	5.8	6.6	5.4	6.0	9.0	8.4	7.7	11.4	8.4	6.7	8.9	7.6	7.6	6.8	7.8	9.4	9.5	35.3	21.0	13.4	15.5	2.5	4.9	5.2	8.0	8.1	8.8	7.6	12.6	4.3	9.6	0.0	10.4	10.3	21.2	14.3	5.9	5.2	27.6	10.5	13.6	10.2	0.0	4.6	20.6	7.0	11.0	7.7	21.9	14.7	10.1	12.4	9.7	10.4	12.5	6.7	20.2	10.0	6.1	19.2	7.1	30.1	9.3	19.4	12.4	16.9	20.3	5.9	10.3	18.1	21.2	11.6	9.1	10.1	11.0	8.2	9.5	3.5	10.2	8.9	0.0	7.7	6.1	8.1	6.9	7.8	5.3	13.0	12.2	7.0	12.8	8.5
GINS1	"KIAA0186, PSF1"	ENSG00000101003	"GINS complex subunit 1"	Q14691	20	25407673-25452628	"Disease related genes, Predicted intracellular proteins"	"DNA replication"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 7.3;testis: 9.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 60.2;Erythroid cells: 14.7;Extravillous trophoblasts: 17.9;Late spermatids: 21.9;Spermatocytes: 14.2;Spermatogonia: 19.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051185	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA051185: AB_2681378"	"unprognostic (6.10e-3)"	"unprognostic (2.58e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.74e-3)"	"unprognostic (2.00e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (4.61e-7)"	"unprognostic (5.86e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (5.42e-11)"	"unprognostic (5.24e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.55e-1)"	0.7	0.6	0.9	3.2	0.8	3.4	1.6	1.8	1.0	1.0	0.4	3.2	3.0	1.4	0.7	4.3	0.8	0.8	0.5	0.8	0.5	1.1	1.2	0.5	5.3	0.4	0.5	0.9	0.5	0.6	0.2	2.9	0.6	0.8	3.9	0.8	0.8	0.4	0.5	3.7	2.9	2.0	0.3	1.5	2.0	9.0	0.6	7.3	0.6	0.0	5.9	1.3	1.5	0.9	43.6	38.8	46.5	30.4	2.6	3.5	46.7	18.9	9.1	35.5	37.2	33.7	42.1	53.3	21.0	7.9	26.4	49.0	40.9	34.4	40.7	14.3	14.2	36.7	13.8	41.3	0.9	48.5	16.2	1.7	2.0	33.8	6.9	4.7	19.1	30.1	36.1	33.9	21.2	47.0	75.1	36.0	31.8	30.0	20.0	53.1	53.6	35.7	13.6	28.8	19.4	20.3	19.3	45.3	16.7	26.0	42.9	24.2	8.7	27.7	29.9	18.2	35.1	13.6	41.1	42.0	7.4	46.8	32.0	0.2	0.2	0.1	0.3	0.2	0.1	0.5	0.2	0.1	0.5	0.3	0.1	0.3	0.2	0.4	0.2	0.5	0.8	0.2	0.9	0.8	1.8	1.0	0.8	0.5	0.4	0.5	0.6	0.3	0.6	0.9	0.2	0.0	0.6	1.3	1.5	3.2	1.0	1.5	1.8	1.8	1.1	1.3	0.4	0.0	1.6	1.8	0.0	8.2	0.2	1.9	0.0	1.1	60.2	0.5	1.3	1.1	1.2	14.7	6.4	0.7	17.9	2.0	3.6	1.3	1.3	6.8	0.7	0.7	5.9	0.0	3.7	2.5	0.0	1.6	0.8	21.9	0.6	1.2	0.0	1.0	0.0	1.3	0.0	4.0	1.6	0.4	0.6	1.2	8.9	0.6	0.4	2.1	1.7	0.2	0.0	0.5	1.4	14.2	19.7	5.4	1.4	2.5	0.8	2.0	5.5	0.8
GINS4	"MGC14799, SLD5"	ENSG00000147536	"GINS complex subunit 4"	Q9BRT9	8	41529218-41545030	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 6.2"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 17.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024663, HPA026580"	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Centrosome	"HPA024663: AB_1857224, HPA026580: AB_1857225"	"unprognostic (7.74e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.25e-3)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.70e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.71e-3)"	"unprognostic (8.01e-3)"	"unprognostic (4.03e-3)"	"unprognostic (1.50e-2)"	"unprognostic (4.34e-4)"	"unprognostic (1.79e-1)"	"unprognostic (3.67e-5)"	"unprognostic (2.40e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.11e-1)"	"unprognostic (3.22e-1)"	0.8	0.8	0.9	4.0	1.2	5.9	1.8	1.5	1.1	0.9	0.9	2.1	1.6	1.4	0.7	1.7	0.8	1.5	0.7	0.9	0.9	0.6	1.4	0.7	5.1	1.4	1.0	1.1	0.9	0.6	0.2	2.6	1.2	0.7	3.0	0.8	0.8	0.5	0.5	2.1	1.7	1.5	0.5	1.7	1.3	2.9	1.0	6.2	1.3	0.1	6.0	1.2	0.8	2.3	20.3	28.3	39.4	17.9	2.4	3.1	16.4	28.1	16.9	28.8	33.6	26.4	17.3	28.1	11.2	14.3	21.6	15.0	32.1	23.4	41.9	10.4	17.8	40.8	20.6	17.9	0.6	8.9	20.2	1.7	1.1	47.2	10.4	6.6	14.4	33.0	20.3	9.0	20.4	13.8	37.6	10.1	22.0	21.5	15.4	34.4	36.8	11.8	10.3	19.1	12.2	9.5	20.3	8.8	8.1	19.9	22.8	9.9	10.0	19.3	28.9	36.1	28.8	10.6	16.4	33.0	13.8	20.9	48.3	1.5	0.7	0.3	1.5	0.7	0.9	1.2	2.5	1.0	0.3	2.8	1.5	1.0	1.9	1.4	0.3	2.9	3.7	1.0	0.9	1.2	1.5	1.1	0.9	0.9	1.4	1.0	1.2	0.5	1.0	2.3	1.3	0.0	1.1	0.7	6.4	2.8	2.8	2.3	1.2	4.0	2.1	4.3	0.8	0.0	1.3	9.2	2.1	9.1	5.6	3.7	0.0	1.8	0.9	2.0	2.3	1.9	3.5	9.9	0.2	1.8	12.4	3.5	4.1	3.7	1.3	17.5	1.1	0.5	4.8	0.0	0.7	4.0	4.1	1.8	9.4	0.6	1.2	5.7	0.0	0.0	9.6	1.7	3.1	0.0	2.5	2.1	0.3	2.2	9.2	1.2	0.5	0.9	0.3	2.5	0.0	3.6	5.9	9.6	11.8	2.5	1.1	5.9	6.9	9.0	6.0	1.6
GIT1		ENSG00000108262	"GIT ArfGAP 1"	Q9Y2X7	17	29573475-29594054	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 122.3"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 97.8;Late spermatids: 99.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004059, HPA004186"	Enhanced		Supported	"Focal adhesion sites,Mitochondria,Cytosol"		NA	NA		36000	"Cluster 15: NK-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Focal adhesion sites, Cytosol"	Mitochondria	"HPA004059: AB_1078966, HPA004186: AB_1078967"	"unprognostic (3.66e-1)"	"unprognostic (4.46e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (2.54e-6)"	"unprognostic (3.00e-3)"	"unprognostic (2.79e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.48e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.69e-1)"	30.2	13.5	79.4	18.0	89.3	14.4	29.9	29.1	122.3	22.0	14.9	20.5	17.9	20.9	7.6	28.6	22.5	15.5	28.9	101.2	38.0	18.4	7.6	34.8	21.3	42.5	45.3	21.3	21.9	18.0	23.7	21.1	39.7	21.3	10.1	12.1	19.0	14.4	31.9	34.2	20.5	12.9	31.7	22.3	19.1	88.8	51.8	23.1	23.2	18.5	15.2	21.6	23.6	62.1	49.7	80.9	39.1	69.9	30.4	19.1	45.3	23.9	23.4	28.2	25.1	33.1	18.0	37.3	37.3	31.5	50.5	79.5	41.6	61.4	14.4	48.3	49.7	26.9	39.8	29.8	37.0	34.4	21.3	23.4	69.2	32.4	50.5	40.0	53.0	48.6	22.3	31.2	20.5	50.9	109.0	45.7	29.2	49.9	19.2	81.7	52.3	55.6	25.8	26.7	82.0	70.0	33.8	77.2	117.7	27.9	38.0	45.0	66.2	26.7	38.2	59.3	49.0	25.8	39.3	41.5	43.9	29.0	45.9	0.1	1.6	1.4	1.9	2.5	0.9	0.7	1.9	2.1	2.2	0.6	1.6	1.1	0.5	2.4	1.8	1.8	1.3	1.8	79.4	89.3	29.1	122.3	101.2	38.0	42.5	45.3	39.7	31.7	51.8	62.1	54.6	3.2	1.5	21.9	9.5	27.1	6.7	9.2	10.2	15.5	12.6	16.3	8.7	4.3	4.9	5.5	10.4	5.1	17.3	19.2	1.9	7.5	97.8	9.4	16.8	30.8	14.9	1.7	16.8	9.4	8.0	9.7	11.2	10.5	1.3	17.9	22.5	4.0	8.3	11.8	14.1	13.8	8.2	9.5	18.9	99.2	14.3	10.6	8.8	15.9	7.4	13.3	9.2	12.5	16.9	9.5	11.5	10.5	8.7	13.4	17.2	6.1	9.8	10.2	13.1	17.3	9.5	30.5	11.5	14.4	28.1	3.6	12.4	8.6	14.6	8.3
GLE1	"GLE1L, hGLE1, LCCS1"	ENSG00000119392	"GLE1 RNA export mediator"	Q53GS7	9	128504719-128542288	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 77.0;Late spermatids: 58.1;Spermatocytes: 51.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041689, HPA043538, HPA061560"	Supported		Supported	"Nuclear membrane,Nucleoli"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear membrane"	Nucleoli	"HPA041689: AB_2677617, HPA043538: AB_2678539, HPA061560: AB_2684560"	"unprognostic (8.74e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (7.49e-4)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.00e-2)"	"prognostic favorable (7.04e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.99e-3)"	"unprognostic (5.64e-2)"	11.6	14.0	9.2	15.7	9.2	15.1	15.7	12.4	11.3	13.0	13.4	17.4	16.2	11.6	10.8	16.4	14.1	7.8	14.9	8.9	8.8	14.1	16.3	12.3	20.4	8.7	9.2	16.2	9.5	17.6	14.1	9.2	8.6	11.8	18.3	16.5	11.1	12.4	22.5	19.1	15.8	12.9	8.4	15.2	12.9	32.0	9.3	25.9	13.3	12.4	22.2	12.8	12.3	8.9	29.6	54.5	26.2	44.9	25.3	25.5	34.6	29.2	24.9	40.2	28.4	36.8	20.1	59.6	23.0	33.0	38.6	101.4	45.9	41.7	34.5	56.9	29.8	30.6	57.8	34.6	28.5	49.9	38.8	18.1	39.7	45.6	48.5	22.3	22.9	54.7	44.7	51.0	46.7	68.6	49.5	35.2	22.2	79.1	46.7	49.8	64.2	79.0	27.3	26.1	30.9	23.1	71.3	42.7	25.9	21.1	78.9	34.9	17.0	42.5	28.1	50.2	41.2	50.9	131.9	45.9	39.9	37.5	46.8	40.0	21.1	24.4	22.1	26.0	18.1	13.4	17.2	20.0	22.1	20.5	15.2	17.7	18.0	27.4	27.5	13.0	22.3	19.8	9.2	9.2	12.4	11.3	8.9	8.8	8.7	9.2	8.6	8.4	9.3	8.9	4.0	9.6	9.0	11.1	11.4	6.5	5.3	10.4	8.6	7.6	8.8	7.6	13.0	5.7	7.2	7.3	8.4	16.1	6.9	13.2	5.9	11.7	77.0	12.2	7.4	3.6	5.4	12.0	14.0	6.2	11.7	7.6	10.2	9.4	9.5	10.9	4.6	14.2	15.7	10.1	15.5	12.7	8.2	15.1	5.7	58.1	10.2	13.5	3.6	10.3	20.0	8.9	15.5	18.1	15.5	8.3	8.0	6.4	13.4	6.1	16.3	13.7	12.6	8.6	13.1	7.7	7.3	51.3	25.5	14.4	6.8	13.3	12.1	7.1	14.1	5.4
GLOD4	"C17orf25, CGI-150, HC71"	ENSG00000167699	"Glyoxalase domain containing 4"	Q9HC38	17	757097-783390	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA021623, HPA023246, HPA023248"	Enhanced		Approved	Cytosol		NA	NA		3500000	"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA021623: AB_1844365, HPA023246: AB_1844366, HPA023248: AB_1844367"	"unprognostic (2.82e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.88e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.13e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.96e-2)"	"prognostic favorable (2.18e-6)"	"unprognostic (6.21e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.02e-1)"	42.5	46.8	27.4	33.5	31.0	22.5	34.5	25.4	33.3	28.4	33.4	71.3	80.5	31.6	33.6	42.9	44.9	32.6	37.3	30.6	36.4	75.7	67.7	31.5	46.9	27.8	27.9	39.9	40.5	37.6	23.2	36.7	28.8	37.8	48.3	25.6	39.5	27.3	39.8	44.3	72.7	31.9	28.3	36.8	85.3	19.4	35.3	35.2	47.4	23.0	40.0	41.5	22.4	27.5	121.1	106.8	120.9	67.1	52.0	51.5	73.8	94.4	57.6	75.0	56.7	87.4	84.0	142.9	100.2	42.8	69.7	85.5	106.6	60.1	78.0	105.4	91.2	69.0	55.7	115.5	51.6	72.1	87.5	36.2	81.9	75.5	66.0	47.7	70.4	116.9	115.1	90.4	80.2	73.9	124.1	55.3	88.7	118.8	36.3	122.7	49.0	65.9	74.5	81.2	54.8	91.8	74.8	53.6	124.6	75.3	66.6	75.2	92.2	71.0	56.8	99.9	120.4	50.3	100.0	89.1	83.6	79.5	75.9	26.1	51.8	48.7	68.1	64.1	73.2	70.0	81.0	82.2	45.9	75.4	68.9	75.7	7.1	64.0	70.4	47.2	99.1	75.9	27.4	31.0	25.4	33.3	30.6	36.4	27.8	27.9	28.8	28.3	35.3	27.5	52.2	57.7	35.2	11.4	48.5	47.9	40.4	91.1	40.5	39.6	39.2	36.3	30.9	54.3	70.4	101.2	29.2	104.5	43.2	39.3	178.1	77.3	34.0	44.0	34.3	43.8	28.9	54.7	12.7	57.4	85.9	41.5	71.4	40.8	40.4	42.1	31.1	58.8	82.3	13.5	13.6	52.0	97.6	30.1	26.5	63.3	38.8	40.8	67.6	7.5	61.7	39.8	44.3	10.1	13.2	58.7	52.0	46.6	27.5	39.4	110.5	186.1	66.8	38.7	46.0	30.3	45.8	23.5	32.9	53.6	54.8	69.1	53.3	57.2	63.7	39.3
GLRX3	"bA500G10.4, GLRX4, GRX3, GRX4, PICOT, TXNL2"	ENSG00000108010	"Glutaredoxin 3"	O76003	10	130136391-130184521	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 280.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028941	Approved					NA	NA		350000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA028941: AB_10601015"	"unprognostic (7.11e-3)"	"unprognostic (4.02e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.39e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (9.03e-6)"	"unprognostic (9.29e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.08e-3)"	"prognostic unfavorable (9.24e-6)"	"unprognostic (4.01e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.11e-1)"	36.0	44.6	24.3	40.5	25.7	38.0	35.2	25.9	30.9	29.8	26.9	32.9	35.9	29.4	28.4	58.4	25.3	28.6	54.3	25.5	28.4	37.7	42.9	28.4	54.5	27.6	26.9	24.0	35.4	36.1	21.2	40.9	28.4	27.1	38.7	27.8	32.3	29.5	53.5	41.4	31.3	40.8	25.8	27.1	33.4	64.4	26.5	39.6	32.6	55.1	63.0	49.8	38.0	26.9	209.9	134.2	126.8	195.3	84.0	130.8	136.5	149.9	148.3	182.5	153.5	234.4	164.5	157.8	94.2	118.3	160.4	133.7	170.8	179.5	198.0	123.6	145.7	84.0	87.2	201.9	108.8	163.9	80.8	85.4	205.0	167.2	227.3	164.2	147.3	116.8	190.1	72.4	201.1	103.0	119.4	239.8	146.7	121.5	142.8	161.3	131.8	59.8	179.5	114.1	62.4	84.7	85.8	93.2	194.2	139.2	69.2	103.0	111.6	96.2	96.4	130.7	219.2	52.7	87.4	316.0	201.6	88.9	59.5	25.7	45.2	21.5	40.6	58.8	48.2	52.1	45.1	45.4	70.3	37.8	34.4	41.7	7.3	59.1	51.8	44.8	76.7	49.5	24.3	25.7	25.9	30.9	25.5	28.4	27.6	26.9	28.4	25.8	26.5	26.9	47.6	41.7	28.1	20.9	38.4	82.8	90.1	167.1	32.5	24.1	42.1	40.5	61.5	40.0	74.4	27.6	14.6	122.9	47.3	38.3	62.6	160.1	252.7	39.6	43.4	57.0	34.0	44.6	24.7	147.7	162.2	48.3	28.5	38.7	42.5	47.7	43.2	36.2	113.2	42.1	24.6	50.7	77.3	44.6	54.2	138.9	40.7	46.1	49.8	15.0	72.9	37.9	47.4	22.1	22.5	150.2	32.3	50.4	41.0	115.2	58.7	100.7	58.3	25.1	19.7	41.2	95.1	280.9	188.1	62.7	99.0	163.1	41.8	49.7	64.7	100.5
GLYR1	"BM045, HIBDL, N-PAC, NP60"	ENSG00000140632	"Glyoxylate reductase 1 homolog"	Q49A26	16	4803203-4847288	"Predicted intracellular proteins"		"DNA-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017022, HPA048226, HPA050136"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"CAB017022: , HPA048226: AB_2680320, HPA050136: AB_2681028"	"unprognostic (4.72e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.19e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.47e-3)"	"prognostic favorable (8.74e-7)"	"unprognostic (3.34e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.86e-1)"	34.4	35.0	26.9	43.4	27.9	43.4	27.7	21.2	27.7	31.7	35.9	46.0	43.3	30.1	24.6	37.7	45.4	30.4	41.7	29.3	26.5	46.9	38.3	32.8	41.7	24.2	26.1	24.9	35.8	60.4	31.5	33.7	22.8	40.2	43.9	41.9	43.5	37.5	44.1	33.6	40.4	37.2	22.5	39.2	44.7	20.3	26.6	45.7	40.2	37.8	43.2	36.5	26.9	22.4	43.2	47.5	76.4	47.9	66.1	52.5	73.4	80.0	59.0	59.6	50.7	66.7	75.5	69.8	74.0	74.2	49.0	47.3	96.4	67.0	53.4	114.0	59.4	72.4	57.7	47.7	37.3	117.6	129.6	50.2	52.3	56.3	41.5	57.6	77.2	65.0	122.8	58.8	65.6	69.8	96.6	64.8	91.0	65.0	35.2	123.5	59.9	86.5	73.4	64.0	93.1	47.1	86.4	80.7	37.1	83.1	90.3	123.9	86.1	41.1	46.0	186.2	50.3	49.0	73.1	145.5	29.3	57.9	85.5	10.3	14.1	7.8	9.0	12.7	8.0	6.2	6.0	8.9	9.7	9.6	6.2	5.6	28.1	7.0	20.8	10.8	6.5	8.2	26.9	27.9	21.2	27.7	29.3	26.5	24.2	26.1	22.8	22.5	26.6	22.4	28.6	38.5	47.3	35.6	29.9	19.1	18.7	17.1	19.4	36.8	30.3	23.6	42.3	28.6	37.3	31.3	29.2	28.0	31.1	54.9	66.5	24.4	11.3	58.2	36.7	28.1	46.3	45.6	43.6	19.4	31.6	23.0	26.0	43.0	31.6	27.4	26.7	53.0	32.0	45.4	37.0	41.2	18.3	39.3	23.9	10.3	24.2	35.9	21.4	32.8	54.5	25.0	28.8	28.6	35.8	29.2	38.8	16.1	26.5	29.0	38.9	54.7	73.3	42.6	19.7	24.6	36.1	21.9	24.5	23.4	24.2	35.7	26.1	28.1	38.8	21.3
GMNN	Gem	ENSG00000112312	"Geminin DNA replication inhibitor"	O75496	6	24774931-24786099	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle"	"DNA replication inhibitor"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 231.4"	"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 184.8;Paneth cells: 300.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011458, CAB047327, CAB047328, HPA049977, HPA054597"	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 25: Pancreas - Digestion"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"CAB011458: AB_2110946, CAB047327: , CAB047328: , HPA049977: AB_2680978, HPA054597: AB_2682538"	"unprognostic (1.37e-1)"	"unprognostic (3.43e-3)"	"unprognostic (3.91e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.90e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.23e-3)"	"prognostic favorable (4.13e-4)"	"prognostic unfavorable (9.77e-4)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (7.82e-5)"	"unprognostic (2.25e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.63e-2)"	"unprognostic (5.90e-3)"	10.1	7.7	16.9	17.2	18.2	68.9	24.2	19.5	23.7	11.1	13.5	41.6	17.8	10.6	5.8	16.6	16.5	7.9	8.0	14.7	20.2	24.6	18.2	8.9	30.4	17.0	20.2	14.6	231.4	8.4	11.1	16.5	17.8	41.5	44.4	16.3	8.7	24.9	7.4	40.3	16.1	12.5	16.4	19.1	22.6	37.4	19.8	37.4	10.8	14.3	23.7	28.4	13.9	15.5	110.9	64.2	159.2	66.2	22.2	23.5	106.0	106.0	55.9	124.4	135.5	125.1	38.8	110.1	131.3	34.4	91.3	63.3	139.4	78.1	133.0	41.2	145.4	151.5	109.3	207.4	20.7	119.1	53.1	19.1	25.1	75.9	29.5	25.8	62.2	84.6	193.9	56.9	88.9	86.3	224.9	128.2	87.3	89.6	50.2	128.9	124.4	141.2	53.5	94.6	127.3	78.3	47.5	77.4	95.2	89.1	81.3	72.0	30.9	75.7	76.8	88.3	182.6	62.8	207.6	210.3	23.1	220.9	111.2	5.5	5.2	17.1	4.4	6.9	5.6	9.2	8.5	6.9	7.6	4.6	6.1	6.9	3.0	5.9	5.0	9.4	15.9	5.6	16.9	18.2	19.5	23.7	14.7	20.2	17.0	20.2	17.8	16.4	19.8	15.5	24.0	6.4	15.6	8.8	17.0	33.0	28.4	57.4	18.8	9.5	51.0	52.5	12.1	18.6	68.1	44.1	2.1	83.2	19.9	72.6	9.8	113.6	94.8	84.8	30.6	18.4	25.9	66.2	3.5	112.3	136.3	17.7	12.2	184.8	13.3	36.4	13.9	17.4	54.0	11.8	5.3	66.3	10.2	10.7	13.2	28.0	9.6	15.2	23.2	5.6	12.6	30.9	6.2	5.5	3.2	31.8	300.5	10.9	41.6	25.6	20.8	20.6	25.2	13.7	19.7	8.0	21.9	158.8	58.8	26.8	63.5	48.7	19.1	30.4	156.5	30.1
GMPS	GATD7	ENSG00000163655	"Guanine monophosphate synthase"	P49915	3	155870650-155944020	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"GMP biosynthesis, Purine biosynthesis"	Ligase	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 100.3"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 272.7;Late spermatids: 193.6;Spermatocytes: 171.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046630			Approved	Cytosol		No	No		50000	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA046630: AB_2679727"	"unprognostic (3.89e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (5.54e-5)"	"unprognostic (2.30e-1)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (8.73e-7)"	"unprognostic (1.71e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.79e-2)"	18.8	20.7	7.2	20.0	7.7	44.6	24.1	22.7	11.0	21.2	7.9	19.7	15.8	20.6	16.0	22.1	17.1	14.0	17.9	6.8	8.5	15.9	22.6	18.2	27.0	7.8	6.8	17.0	26.4	23.1	11.5	20.8	8.3	17.4	22.5	10.1	20.9	17.5	20.0	25.0	16.7	23.4	6.3	19.2	18.0	100.3	8.0	32.3	20.3	16.7	29.4	23.3	19.9	8.8	241.0	93.1	123.0	101.1	49.0	77.0	118.9	99.8	91.6	128.2	128.8	170.5	156.2	171.7	116.1	77.1	98.1	114.6	105.7	104.2	175.0	101.1	81.8	183.2	63.7	92.8	55.9	188.5	68.7	57.3	62.9	99.4	150.5	68.2	79.9	91.3	131.7	63.8	96.8	160.1	153.9	99.4	118.5	130.4	68.3	149.2	145.8	207.5	66.3	103.5	73.3	68.0	111.0	156.0	101.8	83.9	163.6	122.3	56.9	84.4	68.5	121.0	204.3	88.8	58.5	288.5	84.8	137.4	77.0	23.7	16.1	11.5	24.7	20.2	29.1	16.0	23.6	22.3	26.1	11.6	23.3	22.3	2.2	29.3	29.5	14.2	27.1	17.5	7.2	7.7	22.7	11.0	6.8	8.5	7.8	6.8	8.3	6.3	8.0	8.8	23.8	19.2	20.2	19.6	21.5	39.9	47.4	43.9	22.8	22.0	19.5	18.5	16.4	15.7	28.4	7.3	2.1	44.1	21.6	8.3	25.4	33.8	272.7	14.3	37.5	29.9	7.2	68.5	40.9	29.5	56.2	32.4	19.9	18.4	28.6	34.0	22.1	11.6	29.9	21.9	41.6	19.7	26.4	18.5	27.1	193.6	23.0	25.2	23.2	22.5	31.7	17.8	30.9	30.2	31.6	21.3	11.9	24.8	21.9	50.6	17.8	22.8	17.3	8.7	19.7	28.6	65.2	171.2	65.5	29.0	38.2	30.8	30.4	63.2	26.8	42.4
GNG5		ENSG00000174021	"G protein subunit gamma 5"	P63218	1	84498325-84506581	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB032623, HPA043651"	Approved					NA	NA		37000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"CAB032623: AB_2109919, HPA043651: AB_2678600"	"unprognostic (1.82e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.75e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (3.23e-5)"	"unprognostic (1.59e-1)"	"unprognostic (9.28e-2)"	"unprognostic (8.93e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.72e-3)"	"unprognostic (1.64e-1)"	"unprognostic (6.51e-2)"	"unprognostic (3.44e-2)"	"unprognostic (4.22e-2)"	132.0	93.4	51.8	77.3	56.2	176.7	114.2	54.3	76.1	106.5	58.6	143.2	110.4	99.9	69.2	148.9	97.0	56.4	278.2	51.3	56.7	189.5	165.4	159.8	77.5	57.5	55.1	78.1	118.5	62.6	71.9	75.5	58.0	96.5	100.2	19.0	108.5	56.3	266.5	104.8	112.7	67.3	54.9	148.9	142.2	96.4	54.9	102.8	106.8	164.1	94.0	100.5	102.6	55.7	205.2	82.4	218.6	189.3	143.5	161.9	263.4	194.6	130.3	230.2	241.5	107.4	123.8	127.8	179.9	184.6	346.3	105.2	127.3	183.3	195.1	165.2	200.7	264.4	83.9	213.9	245.7	184.7	96.9	148.0	223.5	228.0	139.9	132.3	247.1	146.8	249.0	194.2	222.9	55.5	268.7	405.3	287.7	139.7	255.2	171.0	271.4	151.2	301.7	100.2	66.2	212.6	141.0	186.6	395.0	169.1	133.6	240.4	193.7	179.0	213.3	264.5	250.4	213.0	157.3	192.4	104.8	240.5	169.2	512.9	447.6	425.3	192.8	568.4	154.7	286.4	204.1	190.5	428.5	226.8	163.6	177.5	879.6	218.7	655.9	461.8	269.9	426.7	51.8	56.2	54.3	76.1	51.3	56.7	57.5	55.1	58.0	54.9	54.9	55.7	327.9	266.0	231.9	15.7	150.2	278.6	316.7	478.4	224.8	3.4	286.2	398.1	1037.7	303.1	364.7	277.7	6.2	405.2	248.3	668.3	716.1	413.6	777.6	344.8	218.5	296.1	210.0	277.0	2.0	486.0	486.6	213.9	209.5	342.8	174.8	216.1	280.6	382.0	599.6	18.5	1.2	405.6	319.4	371.5	463.1	122.3	181.1	417.2	249.1	15.9	564.4	430.9	241.0	3.0	4.0	631.1	639.7	195.6	322.0	496.2	571.6	724.9	312.3	16.7	131.5	195.4	271.3	206.8	133.7	367.5	261.0	311.7	171.1	134.1	421.0	541.2
GNL2	"HUMAUANTIG, Ngp-1, Nog2, Nug2"	ENSG00000134697	"G protein nucleolar 2"	Q13823	1	37566816-37595937	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027163, HPA060026"	Approved		Enhanced	"Nucleoli,Nucleoli rim"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Nucleoli rim"		"HPA027163: AB_10601655, HPA060026: AB_2684191"	"unprognostic (1.38e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.61e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (5.86e-9)"	"unprognostic (2.28e-1)"	"unprognostic (7.80e-2)"	"prognostic favorable (7.89e-4)"	"unprognostic (1.01e-2)"	"unprognostic (8.19e-2)"	"prognostic unfavorable (2.90e-11)"	"unprognostic (3.36e-2)"	"unprognostic (7.33e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.87e-1)"	27.8	22.4	11.1	24.8	12.1	49.9	30.4	12.5	13.5	21.7	13.1	22.8	17.8	22.8	24.4	26.4	20.1	19.4	21.6	10.9	12.1	19.2	31.6	22.7	26.5	13.0	12.0	20.4	20.8	20.9	19.3	23.5	12.7	18.2	25.5	11.7	23.2	14.2	50.6	29.5	18.7	24.4	12.1	19.6	21.9	30.2	13.5	26.1	16.0	29.0	32.7	35.2	21.2	14.1	66.5	33.5	63.9	66.4	49.8	57.1	102.9	98.6	68.5	89.3	90.4	92.6	75.2	107.8	62.7	73.5	50.8	60.6	105.1	80.5	121.1	62.6	83.5	108.4	66.4	74.5	66.5	143.3	73.7	36.2	72.6	122.4	144.3	42.7	65.2	47.1	146.8	74.6	87.3	58.2	77.7	85.9	165.8	48.2	65.9	81.8	114.7	121.8	75.0	70.7	76.9	71.1	74.2	73.4	73.1	93.8	52.7	82.5	53.0	59.1	83.9	127.2	138.6	69.9	67.8	185.8	68.3	113.2	77.3	23.2	28.1	24.4	22.5	36.3	26.0	28.1	21.0	24.6	39.8	21.1	21.9	21.2	2.8	33.5	35.3	29.0	28.2	21.7	11.1	12.1	12.5	13.5	10.9	12.1	13.0	12.0	12.7	12.1	13.5	14.1	18.5	16.0	48.1	6.5	29.7	63.3	84.3	37.2	27.3	8.8	17.5	14.5	21.9	12.8	63.3	7.3	10.4	37.2	27.8	18.2	27.4	52.9	54.0	27.2	31.0	28.1	17.3	17.7	6.4	62.3	49.4	40.8	23.9	29.7	48.1	29.5	11.0	18.3	32.0	6.7	5.3	27.3	24.4	17.9	29.6	13.5	23.9	27.7	8.8	8.4	31.7	21.1	25.7	3.5	5.7	51.5	21.9	19.2	32.4	68.3	15.7	18.8	54.4	9.6	0.0	44.8	34.8	46.7	45.6	29.5	52.8	46.1	28.3	20.6	27.5	56.5
GNL3	"C77032, E2IG3, MGC800, NS"	ENSG00000163938	"G protein nucleolar 3"	Q9BVP2	3	52681156-52694497	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020770, HPA036742, HPA036743"	Enhanced		Enhanced	"Nucleoli rim,Nuclear bodies,Mitotic chromosome"		Yes	No		13000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli rim"	"Nuclear bodies, Mitotic chromosome"	"CAB020770: , HPA036742: AB_2675282, HPA036743: AB_2675283"	"unprognostic (4.40e-1)"	"unprognostic (9.30e-2)"	"unprognostic (4.10e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (1.46e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.67e-3)"	"prognostic unfavorable (6.11e-4)"	"prognostic unfavorable (5.69e-5)"	"unprognostic (1.33e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.06e-2)"	47.2	47.1	17.1	42.1	17.0	27.4	68.8	18.4	24.4	38.8	18.7	40.0	38.8	33.8	25.6	65.0	28.2	28.0	29.6	17.9	19.4	33.4	50.3	29.7	51.5	17.9	17.7	35.8	60.7	27.1	35.9	36.4	17.8	46.7	46.0	16.0	46.4	26.3	78.2	39.1	29.6	32.2	16.9	34.0	41.0	26.8	17.9	35.9	28.6	42.9	64.9	92.3	41.3	19.1	110.4	79.1	114.4	125.3	105.6	105.1	178.1	133.0	101.5	135.4	100.6	121.3	80.8	255.4	42.2	100.1	104.6	78.2	189.1	125.1	180.5	156.3	134.6	196.8	139.0	189.3	218.1	283.7	138.0	96.1	216.5	147.8	224.1	90.3	107.8	99.7	214.8	136.2	93.8	77.7	170.6	162.1	195.6	153.4	151.2	99.3	93.0	315.0	108.9	153.9	81.4	105.6	82.1	190.5	193.6	101.7	74.7	155.8	86.6	92.8	100.0	139.2	281.7	147.6	252.0	387.0	96.9	203.5	148.4	1.2	15.2	3.3	19.9	16.7	34.1	28.7	26.8	24.1	26.1	23.9	30.4	29.4	1.8	26.1	12.9	40.7	18.8	20.2	17.1	17.0	18.4	24.4	17.9	19.4	17.9	17.7	17.8	16.9	17.9	19.1	34.6	22.4	48.2	5.2	84.3	163.7	146.0	111.9	77.4	19.0	72.6	46.4	51.3	25.8	144.9	12.9	10.4	73.2	78.5	42.8	41.1	105.1	54.4	44.7	76.5	53.4	47.8	51.5	11.6	104.6	117.5	92.9	47.9	53.0	63.1	47.5	23.2	41.9	40.9	21.9	11.1	71.7	67.1	24.2	77.6	28.2	51.9	43.0	78.2	5.6	59.5	17.7	38.1	7.1	9.4	99.9	34.4	34.3	122.3	126.1	19.1	47.2	56.5	14.8	6.6	106.2	79.1	37.9	74.4	59.4	153.7	90.3	63.0	74.5	85.8	135.7
GNPAT	"DAP-AT, DAPAT, DHAPAT"	ENSG00000116906	"Glyceronephosphate O-acyltransferase"	O15228	1	231241207-231277973	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Cataract, Disease variant, Dwarfism, Rhizomelic chondrodysplasia punctata"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 119.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (8.87e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.56e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.07e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (8.29e-6)"	"unprognostic (5.69e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.48e-2)"	"unprognostic (2.68e-1)"	22.4	26.9	21.6	20.5	24.0	17.3	21.7	23.9	28.2	18.3	25.2	30.0	30.0	20.3	23.7	22.1	27.9	18.2	44.9	22.0	23.5	25.7	30.9	18.7	23.6	24.1	22.5	22.5	29.5	22.6	17.9	19.4	23.3	22.8	24.8	17.0	26.4	20.9	101.9	23.6	28.1	26.4	23.6	18.5	26.9	32.0	23.2	27.5	20.8	84.1	25.8	21.5	17.0	26.1	39.8	43.6	60.4	46.1	48.7	71.4	40.7	32.9	37.1	34.1	39.1	56.1	48.3	57.0	40.4	49.5	35.9	41.9	40.6	44.7	50.0	64.8	37.2	41.2	41.4	81.7	49.4	70.9	31.4	50.1	53.8	35.5	39.6	44.5	81.2	56.0	61.1	53.3	71.7	13.1	63.6	41.0	97.1	112.0	49.5	68.7	81.0	66.9	42.7	29.2	40.0	57.1	55.2	30.7	49.1	23.8	53.7	110.7	42.8	34.5	32.1	50.5	83.3	68.2	93.6	65.1	49.8	58.8	65.3	34.1	36.4	37.3	23.7	37.1	27.2	35.1	30.6	31.3	36.4	37.7	26.4	24.4	14.3	26.9	50.3	17.2	37.9	29.8	21.6	24.0	23.9	28.2	22.0	23.5	24.1	22.5	23.3	23.6	23.2	26.1	17.7	25.6	20.8	19.9	32.3	13.5	19.5	23.1	16.5	23.3	14.9	12.6	55.8	30.0	21.2	27.6	39.6	25.3	20.1	16.4	17.6	41.5	70.3	21.5	19.4	21.4	28.2	13.2	18.9	43.4	19.2	19.5	21.4	14.1	11.4	30.1	19.2	26.9	27.4	11.8	18.6	21.0	22.4	24.8	18.3	119.2	25.4	21.8	12.4	15.9	38.7	22.7	26.8	17.1	29.2	40.2	30.3	26.7	30.1	24.9	41.7	28.0	30.8	24.2	19.7	16.5	22.4	50.9	31.5	18.8	13.9	12.4	24.5	19.7	30.1	19.0
GOLGA1	"golgin-97, MGC33154"	ENSG00000136935	"Golgin A1"	Q92805	9	124878275-124948492	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013065, HPA044329, HPA050555"	Supported		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus"		"CAB013065: AB_221447, HPA044329: AB_2678897, HPA050555: AB_2681174"	"unprognostic (5.44e-2)"	"unprognostic (9.35e-2)"	"unprognostic (6.92e-2)"	"prognostic favorable (2.21e-4)"	"unprognostic (9.34e-2)"	"unprognostic (4.43e-1)"	"unprognostic (4.40e-2)"	"unprognostic (6.03e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.03e-3)"	"unprognostic (3.06e-1)"	"unprognostic (6.28e-3)"	"unprognostic (4.05e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.52e-2)"	8.7	9.4	5.4	8.7	7.0	5.9	7.8	5.8	6.3	8.0	7.1	10.8	10.1	8.8	5.9	9.9	7.7	7.6	10.2	5.1	5.9	6.8	9.5	7.5	7.6	6.1	6.4	8.0	10.8	9.1	8.0	5.6	6.9	8.3	9.3	37.7	8.4	8.3	13.2	10.8	9.6	8.6	6.1	8.5	8.7	15.2	6.8	5.3	8.2	9.6	7.4	10.4	8.1	9.0	8.4	14.7	8.6	9.1	14.7	13.0	11.0	13.5	14.3	14.0	10.2	9.7	9.6	5.6	6.5	15.0	10.8	21.2	7.1	11.4	10.2	8.0	7.0	5.9	20.5	12.9	16.9	7.1	13.7	8.8	8.1	13.5	16.3	9.9	12.7	7.0	9.8	9.4	10.0	17.5	5.1	8.0	3.2	19.7	13.5	3.2	12.7	12.3	7.0	11.3	5.0	9.5	16.2	13.0	8.5	7.6	25.1	5.0	14.8	13.0	7.2	16.8	12.6	11.4	19.6	6.5	16.3	7.4	13.8	8.1	3.4	4.3	4.2	3.5	3.4	3.0	2.6	4.5	3.3	3.5	2.7	2.5	7.6	3.2	2.8	4.6	2.7	1.3	5.4	7.0	5.8	6.3	5.1	5.9	6.1	6.4	6.9	6.1	6.8	9.0	11.8	6.4	14.4	32.3	8.1	2.0	4.2	5.8	6.2	16.3	10.2	10.2	21.0	7.2	10.8	5.5	64.6	6.8	11.5	11.7	3.9	9.5	16.2	10.4	13.6	10.0	5.4	5.0	31.7	8.9	4.9	7.8	10.7	8.8	15.8	14.6	10.8	14.8	6.6	18.5	31.4	9.7	12.2	7.3	4.2	9.8	5.9	9.3	8.8	20.6	10.1	15.2	9.2	27.2	34.3	9.0	2.7	9.1	11.1	4.5	7.8	6.1	17.8	38.0	6.6	15.4	12.3	50.1	21.4	11.0	4.3	8.6	9.1	10.9	8.8	4.0
GON4L	"FLJ20203, GON-4, GON4, YARP"	ENSG00000116580	"Gon-4 like"	Q3T8J9	1	155749659-155859400	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 160.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA006986, HPA057305, HPA074504"	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nuclear bodies"		"HPA006986: AB_1080620, HPA057305: AB_2683408, HPA074504: AB_2686696"	"unprognostic (3.16e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (4.19e-4)"	"unprognostic (9.85e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.49e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.12e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.26e-2)"	"unprognostic (5.83e-2)"	11.3	7.6	4.7	10.7	4.9	9.5	11.4	7.6	5.9	10.1	6.3	10.9	7.4	10.7	10.4	8.3	9.7	7.4	8.4	4.4	4.5	8.9	7.9	10.5	12.3	4.4	6.1	10.1	10.1	10.8	9.5	10.0	4.3	9.9	9.2	14.0	9.5	9.1	12.4	11.4	11.2	10.5	3.5	12.6	9.4	9.0	5.2	14.3	11.3	8.1	12.1	10.0	9.4	5.9	13.7	11.1	21.2	13.0	13.0	16.2	13.2	12.0	14.7	15.4	14.9	13.2	12.2	15.7	13.0	15.8	7.7	15.3	15.9	14.1	17.6	14.7	11.1	15.3	14.0	7.3	12.2	18.6	14.0	14.4	12.2	17.0	15.9	15.7	18.5	17.0	20.3	5.8	13.2	13.5	16.2	11.1	23.4	16.7	12.6	14.8	13.2	17.7	11.2	16.1	11.8	19.8	14.3	14.4	11.6	21.0	16.2	22.2	20.5	12.4	10.1	12.7	15.4	23.9	16.9	25.6	10.8	11.0	14.0	3.5	2.6	2.4	3.6	2.0	2.4	2.1	2.4	2.5	2.7	4.0	2.4	2.2	5.7	4.5	1.8	2.9	2.5	1.8	4.7	4.9	7.6	5.9	4.4	4.5	4.4	6.1	4.3	3.5	5.2	5.9	52.3	16.0	36.1	52.5	41.8	12.1	20.6	18.6	17.6	67.2	25.0	26.2	22.1	17.2	27.7	20.2	131.3	27.1	41.6	25.5	9.8	23.5	18.8	29.5	40.0	42.2	32.4	36.4	45.0	18.1	23.8	28.8	37.8	37.5	38.1	40.8	29.3	13.8	19.7	77.4	40.3	23.5	16.2	23.8	19.1	11.7	35.1	27.0	16.0	28.1	40.2	39.2	80.3	26.2	27.6	24.0	20.6	27.4	38.5	26.9	23.2	14.0	19.8	160.7	39.5	38.8	30.6	54.7	40.5	18.3	17.5	45.0	47.9	50.1	22.6	24.0
GOT2	"KAT4, KATIV, KYAT4, mitAAT"	ENSG00000125166	"Glutamic-oxaloacetic transaminase 2"	P00505	16	58707131-58734342	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Lipid transport, Transport"	"Aminotransferase, Transferase"	"Cancer-related genes, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 698.4;tongue: 726.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 341.9;Hepatocytes: 176.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018139, HPA058537"	Enhanced				"Intracellular and membrane"	NA	NA		2800000	"Cluster 13: T-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA018139: AB_1849903, HPA058537: "	"unprognostic (1.50e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.73e-3)"	"unprognostic (2.63e-3)"	"unprognostic (3.02e-2)"	"prognostic unfavorable (1.61e-4)"	"prognostic favorable (5.75e-5)"	"unprognostic (1.12e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.00e-1)"	"prognostic favorable (2.90e-9)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.22e-1)"	19.6	73.9	52.4	27.4	55.9	21.1	36.3	62.5	66.9	34.1	129.4	57.6	37.4	36.5	66.3	66.9	46.7	24.1	313.2	57.9	59.3	88.0	321.4	25.2	35.6	60.6	51.0	29.4	33.2	98.6	46.7	24.7	62.5	59.0	65.0	91.4	47.7	65.7	698.4	41.1	35.7	46.7	50.1	28.5	54.9	28.9	58.7	35.9	42.6	726.8	57.0	57.0	45.1	61.0	137.2	182.4	93.8	114.8	66.6	59.8	122.0	101.4	108.8	197.6	107.7	158.9	120.1	302.3	117.3	114.6	86.5	195.5	203.2	199.2	250.1	83.1	182.0	81.4	92.1	179.3	84.2	132.3	71.9	58.4	110.9	125.2	108.2	112.4	201.8	141.9	167.0	30.6	102.2	122.5	164.0	128.0	127.7	90.8	338.0	177.8	142.7	291.1	187.9	197.7	148.2	107.6	195.2	208.5	74.8	84.2	105.5	42.7	82.3	71.4	129.3	56.2	132.4	69.9	68.6	247.4	76.7	130.9	73.8	4.6	20.6	7.4	28.3	16.9	43.7	26.5	33.1	34.1	34.7	22.3	30.1	28.4	1.8	30.2	18.4	30.0	48.7	31.2	52.4	55.9	62.5	66.9	57.9	59.3	60.6	51.0	62.5	50.1	58.7	61.0	15.1	9.6	15.8	11.8	19.8	32.0	37.0	39.4	34.1	34.5	27.5	16.3	341.9	22.8	22.5	36.8	77.2	42.6	11.8	42.6	56.7	50.8	4.0	30.4	20.0	23.8	20.5	39.3	24.7	42.5	38.8	21.1	30.1	25.4	14.5	37.5	23.2	176.1	39.1	20.2	27.1	33.5	26.4	17.0	15.1	8.1	18.0	13.5	24.9	5.6	12.7	16.1	8.2	11.6	17.6	40.3	13.3	22.6	39.2	38.2	27.6	63.2	17.5	48.9	0.0	15.2	24.0	11.9	15.0	68.9	30.0	23.7	17.4	36.4	54.4	69.6
GPATCH4	"DKFZP434F1735, FLJ20249, GPATC4"	ENSG00000160818	"G-patch domain containing 4"		1	156594301-156601496	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in all"		"skeletal muscle: 79.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028323, HPA054319"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA028323: AB_10601017, HPA054319: AB_2682447"	"unprognostic (2.80e-2)"	"unprognostic (4.61e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (3.17e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.33e-3)"	"unprognostic (9.60e-2)"	"unprognostic (6.39e-3)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.03e-2)"	"unprognostic (6.80e-2)"	24.5	19.5	12.1	16.7	12.4	10.6	18.9	8.7	17.3	14.9	8.0	19.8	8.9	19.9	9.1	21.7	16.6	6.8	23.0	11.5	12.4	26.5	21.4	14.9	16.8	12.5	13.0	15.0	19.6	15.6	10.1	9.6	12.8	19.2	13.0	2.9	16.3	10.6	79.0	17.3	16.2	14.3	9.9	18.6	19.3	13.1	11.7	11.8	14.4	31.9	19.0	22.8	16.1	14.7	54.6	67.6	31.2	46.3	28.1	20.4	44.0	66.0	27.8	53.3	30.7	74.9	44.8	131.6	55.0	47.8	34.3	38.7	68.9	59.4	54.5	38.2	65.2	82.1	65.2	57.3	26.2	174.9	48.3	25.0	51.1	96.9	79.3	13.1	36.6	44.0	135.5	31.8	40.7	96.2	82.0	39.8	138.9	92.5	71.4	72.9	52.1	96.3	35.0	58.4	50.4	75.8	59.6	146.7	41.6	31.9	46.2	89.3	52.8	50.7	66.0	53.4	121.1	57.8	69.5	169.9	45.7	89.7	79.7	0.1	9.4	0.1	20.9	17.9	20.4	29.1	21.2	24.0	17.5	30.7	24.1	25.1	0.4	19.0	22.0	11.1	15.7	12.6	12.1	12.4	8.7	17.3	11.5	12.4	12.5	13.0	12.8	9.9	11.7	14.7	17.0	32.1	38.3	5.2	36.0	73.7	65.9	32.5	26.2	7.7	23.8	25.4	27.2	25.8	33.4	16.5	8.4	35.6	19.5	26.5	25.4	51.9	12.9	19.1	53.7	32.5	37.0	42.9	6.4	57.1	53.0	29.0	23.0	20.1	57.7	24.3	18.5	46.9	37.4	8.4	4.6	26.1	10.2	13.6	21.3	11.4	26.8	19.0	23.2	2.8	18.8	6.9	23.7	1.5	3.3	53.0	17.5	26.7	23.8	92.5	7.8	34.3	14.9	6.4	32.9	66.0	45.4	47.4	44.3	33.5	62.7	15.5	26.3	38.6	43.6	51.5
GPATCH8	"GPATC8, KIAA0553"	ENSG00000186566	"G-patch domain containing 8"	Q9UKJ3	17	44395281-44503430	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 312.1;Inhibitory neurons: 287.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044380	Approved		Approved	"Nuclear speckles,Mitochondria"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles"	Mitochondria	"HPA044380: AB_10965696"	"unprognostic (3.37e-1)"	"unprognostic (5.90e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.07e-3)"	"unprognostic (2.13e-2)"	"unprognostic (5.86e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.84e-3)"	"unprognostic (8.47e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.91e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.49e-1)"	10.5	9.2	12.0	11.3	13.3	18.3	11.0	15.0	14.0	10.6	9.3	8.9	11.1	14.5	11.8	9.4	11.1	8.8	8.9	11.8	12.5	9.0	7.0	10.7	15.7	12.9	12.9	17.3	8.0	14.4	0.4	13.1	12.7	9.5	10.4	30.1	9.3	10.2	33.4	15.5	11.0	12.5	12.1	13.1	8.8	10.8	13.0	20.8	11.0	13.8	15.4	9.8	0.8	13.5	22.0	12.8	22.8	18.9	17.5	20.2	23.1	16.7	21.1	18.3	19.2	19.0	13.9	31.1	10.9	23.7	15.8	16.7	23.3	19.3	27.2	25.7	20.8	26.5	15.5	22.5	20.9	25.7	20.3	22.9	20.5	20.9	27.2	18.4	20.2	19.4	20.1	18.7	16.8	10.0	33.7	9.9	16.0	12.5	16.2	27.1	25.8	21.7	16.0	10.6	15.9	19.3	16.6	10.6	20.9	27.0	13.9	17.3	22.5	18.0	12.6	19.3	23.4	20.1	17.9	29.2	16.8	14.1	19.3	8.2	6.1	4.9	9.4	6.0	8.7	8.6	8.2	7.8	6.5	7.1	7.5	7.3	4.6	10.3	13.6	8.0	4.1	5.2	12.0	13.3	15.0	14.0	11.8	12.5	12.9	12.9	12.7	12.1	13.0	13.5	38.8	22.4	32.5	148.5	64.6	48.7	53.1	52.0	47.8	72.7	28.8	22.7	40.5	30.0	46.0	25.8	123.0	42.4	76.6	25.2	9.8	32.8	19.6	38.7	63.3	38.8	38.8	50.1	312.1	24.5	39.3	48.4	23.9	56.5	42.4	44.6	44.3	19.4	23.0	146.4	287.3	20.3	36.7	36.2	42.3	7.6	63.0	38.6	23.2	108.7	42.5	43.5	161.7	172.9	204.1	34.7	24.7	43.2	58.1	45.3	30.2	14.6	29.8	125.3	52.6	68.6	51.2	93.1	74.2	33.7	46.9	53.4	69.8	43.1	25.4	56.8
GPR107	"FLJ20998, KIAA1624, LUSTR1, RP11-88G17"	ENSG00000148358	"G protein-coupled receptor 107"	Q5VW38	9	130053426-130140169	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031704	Supported		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"	Nucleoplasm	"HPA031704: AB_10601018"	"prognostic unfavorable (3.56e-5)"	"unprognostic (7.48e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.35e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (1.87e-5)"	"unprognostic (4.10e-2)"	"unprognostic (5.83e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.34e-3)"	18.9	17.3	21.0	15.1	22.1	12.2	20.3	21.9	21.3	20.1	24.4	21.3	11.6	18.8	15.3	18.7	22.0	16.1	18.3	19.5	23.9	20.5	13.0	20.3	11.0	23.4	25.3	17.9	18.8	28.7	16.6	23.3	25.6	23.6	22.6	26.3	18.3	19.9	17.8	22.7	12.9	23.2	21.8	13.4	16.7	17.3	23.5	14.3	34.9	17.0	14.2	15.8	14.2	23.8	29.7	42.0	39.6	31.7	42.4	44.6	39.9	45.9	52.5	37.9	37.5	40.6	39.5	16.4	33.4	52.1	44.5	73.0	30.7	28.6	32.3	24.7	20.3	17.0	49.1	23.8	40.9	36.2	24.4	37.5	44.3	38.1	38.7	44.1	35.9	19.0	25.0	15.8	33.6	36.6	19.4	14.7	26.8	60.0	31.7	18.3	58.7	25.9	32.1	40.2	13.6	30.7	59.8	42.8	33.1	34.9	75.0	19.3	42.9	48.1	25.1	40.3	35.3	9.8	35.6	15.2	43.5	17.0	46.9	1.5	2.8	1.9	0.7	3.4	1.0	1.0	0.7	0.8	1.8	1.0	0.5	1.2	3.3	0.9	3.6	1.1	0.7	1.3	21.0	22.1	21.9	21.3	19.5	23.9	23.4	25.3	25.6	21.8	23.5	23.8	14.8	25.6	19.3	47.7	8.0	6.4	5.1	14.8	5.2	16.9	17.8	12.2	23.0	14.3	16.4	16.5	39.6	15.4	11.4	20.7	0.0	13.4	6.5	23.7	19.3	14.3	9.6	4.6	32.7	17.6	19.2	16.2	16.8	26.4	6.3	17.9	24.3	11.6	15.1	18.5	39.7	19.4	6.1	17.0	17.6	5.7	19.0	13.8	14.2	22.5	15.6	11.0	9.2	38.2	48.6	21.9	15.9	19.2	11.2	13.2	9.3	6.5	24.5	15.5	0.0	16.3	15.3	16.2	11.5	12.2	10.9	26.7	10.4	13.5	18.4	10.9
GPR137	"C11orf4, GPR137A, TM7SF1L1"	ENSG00000173264	"G protein-coupled receptor 137"	Q96N19	11	64270062-64289500	"Predicted intracellular proteins, Predicted membrane proteins"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 203.8"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 193.1;Late spermatids: 573.0;Spermatocytes: 175.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 14.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062871	Uncertain		Approved	"Nucleoplasm,Nucleoli,Actin filaments"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli"	"Actin filaments"	"HPA062871: AB_2684889"	"unprognostic (2.25e-1)"	"unprognostic (4.21e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.29e-3)"	"unprognostic (6.37e-2)"	"prognostic unfavorable (5.34e-4)"	"unprognostic (5.68e-2)"	"unprognostic (1.83e-2)"	"unprognostic (7.61e-3)"	"prognostic favorable (6.18e-4)"	"unprognostic (4.95e-2)"	"unprognostic (8.66e-3)"	"unprognostic (3.67e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.41e-1)"	20.6	32.6	54.4	16.4	50.9	13.7	19.6	49.4	63.8	24.5	42.5	22.6	12.2	23.6	12.6	28.9	22.3	15.0	29.1	52.8	44.3	34.0	33.9	19.4	14.9	55.3	50.5	18.7	16.2	23.2	26.5	15.6	56.2	29.1	7.5	11.8	23.7	14.8	16.8	22.5	19.5	10.4	45.9	24.5	27.4	203.8	56.2	10.6	30.8	15.9	12.8	26.7	21.4	48.2	22.0	50.2	18.6	49.5	34.9	19.9	69.6	25.5	24.3	31.0	18.4	38.0	31.6	22.7	42.4	24.1	51.9	44.3	28.8	17.1	9.7	73.0	27.9	22.7	53.7	22.5	21.6	15.0	40.9	24.8	25.0	27.5	19.0	20.8	16.3	28.4	20.6	56.2	19.1	56.9	16.8	40.5	22.5	20.4	49.9	31.0	18.0	37.5	20.0	30.3	27.2	32.6	30.0	44.6	30.6	21.4	46.0	6.3	23.1	69.1	46.8	53.3	18.7	41.9	84.9	20.5	50.0	12.3	44.9	1.9	2.8	5.1	2.3	2.5	2.9	2.7	2.0	1.7	3.0	3.8	2.1	1.8	14.0	1.9	2.1	3.0	1.6	1.4	54.4	50.9	49.4	63.8	52.8	44.3	55.3	50.5	56.2	45.9	56.2	48.2	13.0	3.2	11.2	12.7	15.0	14.4	18.5	21.8	19.4	14.1	16.2	13.3	5.3	20.0	13.7	12.9	12.5	49.6	9.5	26.2	15.6	39.0	193.1	14.4	14.8	15.8	16.2	14.7	9.3	26.6	69.7	13.4	15.3	10.0	2.5	10.3	11.4	10.8	23.2	20.2	9.0	16.8	14.2	15.4	14.5	573.0	19.3	11.5	14.2	6.5	16.4	38.9	11.3	4.5	11.2	30.8	14.6	16.1	13.4	26.7	31.5	19.6	18.6	9.1	26.3	8.7	14.1	175.0	55.9	16.9	15.2	119.6	10.8	16.6	15.1	23.3
GPR75	WI-31133	ENSG00000119737	"G protein-coupled receptor 75"	O95800	2	53852912-53859967	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.7"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 1.2;Cone photoreceptor cells: 2.1;Gastric mucus-secreting cells: 2.0;Glandular and luminal cells: 1.9"	"Cancer enriched"	"Detected in many"	5	"glioma: 4.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"				"unprognostic (1.88e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.77e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.96e-2)"	"unprognostic (5.27e-3)"	"unprognostic (8.31e-3)"	"unprognostic (2.59e-3)"	"unprognostic (4.71e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.07e-4)"	"unprognostic (1.10e-1)"	"unprognostic (3.97e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.38e-1)"	"unprognostic (5.75e-2)"	1.1	1.5	10.5	1.1	9.6	1.4	2.1	6.5	3.4	0.9	0.0	0.7	0.3	1.4	0.8	0.9	1.3	1.3	0.8	5.2	10.7	0.5	2.7	1.0	1.0	9.7	17.7	2.0	1.3	3.3	2.0	0.4	8.2	1.5	0.6	7.7	1.9	1.3	1.1	0.9	0.9	1.6	5.5	1.4	1.0	0.7	16.8	1.1	2.0	0.7	0.7	0.9	0.7	2.3	1.6	1.7	2.4	2.2	0.8	0.5	3.2	1.3	0.8	1.5	1.4	4.4	0.7	3.4	1.1	1.8	1.3	2.4	2.9	2.4	2.3	2.9	1.9	3.9	2.8	2.4	0.5	2.2	2.6	1.1	0.7	3.8	0.7	0.8	1.2	1.2	2.3	0.9	1.3	1.2	1.0	1.7	3.2	0.4	1.9	1.7	2.2	0.6	0.8	2.4	1.4	2.1	1.1	0.9	0.6	2.5	0.8	0.7	3.2	2.6	2.5	2.1	3.7	0.7	0.5	1.0	2.4	2.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	10.5	9.6	6.5	3.4	5.2	10.7	9.7	17.7	8.2	5.5	16.8	2.3	0.3	0.0	0.0	0.0	0.1	0.6	0.2	0.2	1.2	0.2	0.6	0.4	0.3	0.0	0.2	0.0	2.1	0.1	0.9	0.1	0.0	0.0	0.2	0.6	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.3	2.0	1.9	0.0	0.2	0.4	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.4	0.0	0.7	0.3	0.1	0.2	1.0	0.9	0.0	0.3	0.1	0.1	0.2
GPR89A	UNQ192	ENSG00000117262	"G protein-coupled receptor 89A"	B7ZAQ6	1	145607988-145670650	"Predicted membrane proteins"	"Ion transport, Protein transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA076096			Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Endoplasmic reticulum"		"HPA076096: AB_2686777"	"unprognostic (1.19e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.51e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.99e-3)"	"unprognostic (8.14e-2)"	"unprognostic (4.61e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.02e-5)"	"unprognostic (1.42e-1)"	"unprognostic (3.70e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.21e-1)"	5.9	6.7	6.0	3.7	6.0	4.1	14.1	8.6	7.0	11.9	6.2	8.7	9.8	6.4	6.9	5.9	7.6	8.2	7.0	6.3	7.3	31.2	24.7	5.7	5.7	7.3	7.5	4.2	12.9	11.7	3.4	7.1	8.4	9.5	11.8	4.3	6.9	7.2	6.7	4.7	11.6	9.7	6.5	3.3	8.5	14.8	6.9	8.1	10.6	8.7	8.0	8.3	2.3	6.9	20.7	11.6	18.0	9.7	35.1	34.3	19.2	23.0	25.8	29.3	33.2	27.6	24.4	13.4	13.2	26.0	14.3	20.2	19.9	22.4	25.8	21.5	15.5	9.8	15.8	14.2	29.3	30.5	6.7	36.4	26.5	21.9	28.6	12.7	21.9	16.2	23.7	30.2	40.6	29.7	13.1	11.5	23.5	36.3	25.4	15.5	21.0	48.7	24.8	12.6	7.0	15.4	30.7	36.8	16.6	30.1	32.4	20.0	9.6	27.1	6.5	24.0	23.2	15.2	33.2	17.4	20.6	16.4	20.2	3.7	5.8	7.1	9.2	5.7	9.5	6.0	7.1	9.9	8.1	3.0	7.3	6.5	1.1	9.3	7.6	6.5	8.2	5.0	6.0	6.0	8.6	7.0	6.3	7.3	7.3	7.5	8.4	6.5	6.9	6.9	6.1	22.4	5.9	16.0	13.7	7.6	10.1	17.7	15.4	6.9	10.2	6.3	13.9	14.3	13.2	14.7	12.5	20.1	12.1	6.5	0.0	13.6	13.6	4.8	6.0	6.5	13.7	24.4	29.0	20.2	21.2	9.1	12.8	5.6	5.7	5.1	7.9	9.2	9.3	3.3	24.3	11.2	20.3	5.1	4.0	8.6	9.6	7.3	10.6	7.5	9.0	7.5	17.5	14.1	19.7	17.1	6.0	7.2	20.9	8.5	24.3	13.7	8.0	6.9	13.1	7.3	8.2	45.4	24.6	10.1	8.5	16.1	14.6	6.3	10.9	5.7
GRSF1		ENSG00000132463	"G-rich RNA sequence binding factor 1"	Q12849	4	70815783-70839897	"Predicted intracellular proteins"	"mRNA processing, tRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 275.2"	"Cell type enhanced"	"Detected in all"		"monocytes: 301.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036984, HPA036985"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	Mitochondria		"HPA036984: AB_2675415, HPA036985: AB_10672785"	"unprognostic (1.45e-3)"	"unprognostic (1.82e-2)"	"prognostic favorable (1.47e-5)"	"unprognostic (8.63e-2)"	"unprognostic (6.73e-2)"	"unprognostic (4.15e-3)"	"prognostic unfavorable (8.29e-5)"	"unprognostic (1.94e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.68e-2)"	"unprognostic (8.05e-2)"	"prognostic favorable (2.72e-9)"	"unprognostic (6.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (9.65e-3)"	38.0	61.2	38.4	36.9	37.7	23.7	37.7	42.5	47.1	36.3	58.9	54.6	43.1	32.5	34.0	42.0	43.0	35.2	80.7	41.0	44.5	55.8	54.4	35.5	47.4	40.3	42.3	38.4	62.0	48.8	21.5	43.8	41.6	39.9	62.7	25.4	83.9	35.3	275.2	32.0	41.3	40.0	40.7	34.6	50.8	32.8	40.9	76.0	45.7	155.0	53.7	50.3	25.8	46.1	116.9	78.1	90.0	94.5	93.5	108.1	128.3	138.2	87.3	102.3	83.5	80.5	117.1	167.6	102.9	143.7	53.0	43.4	161.3	108.6	135.9	91.3	52.8	88.4	75.2	112.4	115.1	130.8	48.7	91.9	102.2	103.6	71.6	123.0	106.9	91.9	102.6	94.7	144.2	124.9	217.4	92.0	96.3	127.1	80.9	88.2	139.8	71.6	126.1	144.0	93.4	84.0	65.3	183.6	234.3	104.7	79.8	63.3	98.4	95.1	99.7	79.4	88.7	78.1	66.2	106.4	78.6	83.6	94.5	12.7	17.4	7.7	10.1	12.3	12.2	7.4	14.6	15.5	28.1	6.1	14.4	12.6	2.0	20.0	15.2	27.2	13.3	8.4	38.4	37.7	42.5	47.1	41.0	44.5	40.3	42.3	41.6	40.7	40.9	46.1	27.8	32.1	36.6	19.6	38.0	50.0	53.7	32.9	48.3	18.2	37.7	28.3	135.5	40.0	30.4	27.6	25.0	106.2	57.4	52.9	74.3	70.3	7.6	53.8	40.4	33.0	69.0	41.2	35.1	61.3	141.3	41.2	65.2	44.5	17.2	60.2	35.0	50.9	63.2	28.6	30.5	73.5	36.7	66.3	53.7	6.7	34.8	45.4	62.2	24.4	301.5	23.8	41.2	21.6	28.0	60.1	46.7	39.1	58.7	65.9	47.1	74.1	27.6	19.6	19.7	38.4	46.2	35.0	61.8	69.7	50.4	77.2	45.1	99.0	89.3	67.0
GRWD1	"GRWD, RRB1, WDR28"	ENSG00000105447	"Glutamate rich WD repeat containing 1"	Q9BQ67	19	48445841-48457022	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042643, HPA055680"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA042643: AB_10795510, HPA055680: AB_2682884"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.46e-1)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.71e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.69e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.07e-2)"	16.0	13.7	6.3	14.0	5.8	14.0	14.4	7.0	6.9	13.7	7.2	11.5	13.1	16.1	4.2	18.2	13.0	8.6	13.6	6.2	6.7	13.0	16.3	10.9	16.0	6.9	7.4	13.7	18.6	13.0	8.6	11.4	7.4	12.2	6.5	3.7	12.7	8.9	28.4	17.5	10.9	8.6	5.6	14.1	13.8	7.4	8.7	11.5	11.8	14.5	10.6	14.6	13.5	7.3	58.3	148.9	25.0	47.3	20.2	19.8	21.6	44.9	20.8	62.2	51.8	84.0	42.4	83.4	37.8	28.7	35.0	48.8	62.7	67.9	24.9	63.8	86.5	78.2	48.6	60.4	23.0	71.9	47.8	23.8	37.0	58.9	29.4	14.3	31.5	43.8	107.3	50.1	27.0	59.1	75.1	180.1	68.1	63.8	43.2	92.9	28.3	58.5	26.4	70.4	56.2	32.1	51.3	71.0	22.4	15.4	34.6	36.5	35.2	57.9	49.1	25.9	107.1	50.6	126.8	78.3	19.7	64.8	69.0	0.3	24.8	3.3	41.5	40.7	46.4	44.4	37.1	41.0	40.9	44.8	42.6	40.3	2.0	41.6	32.4	29.7	36.3	37.4	6.3	5.8	7.0	6.9	6.2	6.7	6.9	7.4	7.4	5.6	8.7	7.3	17.3	3.2	17.5	1.0	26.8	46.3	31.7	18.6	23.3	13.4	16.0	13.7	7.1	14.3	14.3	12.9	0.0	41.4	15.1	14.4	23.5	29.0	3.8	13.1	20.5	19.1	19.2	28.8	1.6	18.2	39.7	18.1	13.3	14.3	19.7	16.8	13.6	18.5	24.4	21.9	3.9	14.5	14.2	11.1	14.3	19.4	17.1	11.4	28.4	2.8	25.3	6.1	19.6	3.0	2.6	22.4	6.5	12.4	28.5	24.2	6.8	18.8	16.8	15.7	19.7	22.7	20.4	9.4	34.3	20.5	40.6	35.0	17.9	26.3	17.1	24.0
GSAP	"LOC54103, PION"	ENSG00000186088	"Gamma-secretase activating protein"	A4D1B5	7	77310751-77416349	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 76.9;NK-cells: 110.2;Oligodendrocyte precursor cells: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 12.5;U-937: 17.0"	"Region enhanced"	"Detected in all"		"cerebellum: 15.5"	"Low region specificity"	"Detected in all"			HPA023994			Approved	Vesicles		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 64: Macrophages - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA023994: AB_1855386"	"prognostic favorable (3.36e-4)"	"unprognostic (3.70e-1)"	"unprognostic (8.55e-3)"	"unprognostic (4.53e-3)"	"unprognostic (6.80e-3)"	"unprognostic (3.52e-3)"	"unprognostic (4.36e-2)"	"unprognostic (7.18e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.98e-3)"	"unprognostic (2.07e-3)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (3.61e-1)"	"unprognostic (1.82e-2)"	"unprognostic (9.49e-2)"	"prognostic favorable (4.15e-5)"	5.3	5.3	2.5	10.9	2.2	9.4	5.9	1.8	3.4	3.7	3.2	5.0	2.6	4.0	3.8	3.1	6.4	7.9	4.9	2.4	4.1	6.3	16.4	18.4	13.1	3.6	2.9	3.6	5.4	11.8	7.4	3.8	3.0	5.4	4.7	10.9	4.7	5.1	2.0	4.4	7.5	3.8	2.8	18.7	7.8	1.9	4.2	6.1	8.3	3.9	13.0	5.9	2.3	4.1	3.8	2.0	0.0	0.0	0.5	2.4	0.4	2.3	7.7	1.2	3.2	0.6	5.4	0.8	0.2	0.1	4.3	1.8	0.1	1.9	3.4	2.5	1.6	4.1	0.2	10.7	3.3	0.3	0.0	0.9	7.0	6.2	12.5	9.2	0.5	0.0	0.1	0.3	10.5	2.1	0.0	8.2	0.6	6.0	2.7	0.0	0.2	0.2	6.9	3.2	0.2	5.7	2.5	1.2	6.3	0.5	2.3	3.4	0.0	2.0	1.4	0.2	7.1	1.5	0.1	1.4	8.8	17.0	1.6	0.0	13.3	1.4	8.5	12.7	5.2	18.6	2.8	6.0	16.3	16.4	3.6	6.1	1.7	16.7	9.4	0.4	0.1	8.2	2.5	2.2	1.8	3.4	2.4	4.1	3.6	2.9	3.0	2.8	4.2	4.1	15.2	76.9	60.8	29.0	53.3	5.2	11.6	19.3	13.6	17.0	12.5	9.8	8.5	11.5	22.8	3.7	16.7	3.2	60.5	0.7	25.4	8.5	0.1	10.2	1.6	9.2	5.4	4.4	28.2	6.2	0.7	4.9	9.7	15.8	13.3	9.8	3.3	17.2	9.7	20.2	51.9	6.1	10.2	38.2	23.3	0.2	5.3	46.5	8.8	42.2	30.8	41.6	110.2	72.4	12.7	6.8	4.6	3.8	15.4	20.0	1.4	12.0	9.8	20.9	6.6	9.8	3.2	2.5	1.5	8.6	4.5	1.6	22.8	2.0	4.6	17.2
GSPT1	"eRF3a, ETF3A, GST1"	ENSG00000103342	"G1 to S phase transition 1"	P15170	16	11868128-11916082	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Protein biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052488, HPA074588"	Approved		Approved	Vesicles,Cytosol		NA	NA		210000	"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	Vesicles	"HPA052488: AB_2681849, HPA074588: "	"unprognostic (4.13e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (2.10e-5)"	"unprognostic (1.64e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (7.94e-4)"	"unprognostic (2.38e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.65e-1)"	"prognostic favorable (3.06e-5)"	"unprognostic (3.47e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.61e-3)"	"unprognostic (3.13e-2)"	60.8	57.5	22.3	49.5	24.7	76.3	46.0	24.4	33.3	42.0	27.4	56.0	33.8	34.5	46.6	67.9	30.1	35.2	53.4	23.9	24.5	53.6	76.3	47.7	55.4	25.0	23.1	33.3	62.2	62.7	27.5	50.0	26.2	47.8	59.6	35.3	41.0	41.8	127.0	43.5	34.3	46.9	25.0	40.2	49.8	68.7	23.1	56.3	57.7	97.8	82.0	85.7	39.6	29.3	220.1	212.9	116.1	161.0	164.2	169.3	167.5	238.0	245.9	187.1	185.4	153.1	197.8	295.7	303.9	207.5	130.1	164.3	297.8	220.3	312.9	142.4	153.6	202.0	163.1	325.5	137.9	258.7	103.5	133.5	170.0	212.0	288.3	122.4	210.4	146.2	331.7	148.7	220.0	211.2	219.8	134.0	232.9	163.0	120.1	256.4	200.5	345.6	184.7	189.3	186.4	99.6	342.0	256.3	144.2	164.3	222.4	122.6	163.3	206.8	129.5	151.5	190.3	146.6	233.2	253.8	145.4	258.1	128.5	1.4	5.8	7.7	6.3	11.1	8.8	7.9	8.1	7.7	7.0	6.5	8.2	8.1	1.9	7.2	9.9	3.8	10.5	4.3	22.3	24.7	24.4	33.3	23.9	24.5	25.0	23.1	26.2	25.0	23.1	29.3	69.4	76.9	160.2	39.5	92.3	242.2	232.0	47.1	170.8	47.7	95.0	61.6	123.4	57.2	69.1	86.5	50.1	76.1	94.5	88.1	103.7	58.9	94.9	109.0	95.6	74.4	66.6	328.5	61.6	63.4	118.3	77.2	81.1	153.9	24.7	93.2	43.5	77.9	75.2	52.2	47.0	107.2	32.6	60.8	116.3	51.6	47.8	80.9	64.0	35.6	50.1	43.6	25.7	38.7	42.9	73.0	66.9	47.4	166.2	271.0	38.3	120.3	52.7	41.5	59.2	94.6	123.0	138.3	83.5	198.5	257.7	102.1	132.1	128.1	114.1	270.4
GSTCD	FLJ13273	ENSG00000138780	"Glutathione S-transferase C-terminal domain containing"	Q8NEC7	4	105708778-105847725	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 120.2;Late spermatids: 52.4;Oligodendrocyte precursor cells: 53.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046160, HPA061782"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA046160: AB_10961048, HPA061782: AB_2797265"	"unprognostic (4.10e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.06e-3)"	"unprognostic (4.44e-3)"	"unprognostic (6.44e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.84e-3)"	"unprognostic (4.30e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.38e-2)"	"unprognostic (5.46e-2)"	"unprognostic (8.67e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.32e-2)"	"unprognostic (7.02e-2)"	2.6	2.4	1.7	3.8	2.1	5.3	5.5	3.8	2.1	3.6	5.7	3.7	2.6	3.6	2.7	5.0	4.3	3.6	2.3	1.6	2.0	4.4	2.5	2.6	4.6	2.0	2.3	2.9	3.2	3.5	2.3	3.7	2.0	3.9	4.0	7.3	2.2	3.5	2.1	3.3	3.0	4.1	1.7	2.8	3.3	10.8	1.9	4.7	5.3	2.7	5.2	2.4	2.2	3.2	11.2	10.0	22.2	19.5	5.8	7.4	16.6	15.5	7.9	18.6	16.6	9.2	21.0	13.2	7.7	6.5	10.8	8.9	25.8	16.0	26.3	19.9	7.2	10.7	9.5	12.6	2.5	20.7	7.4	4.0	8.0	17.2	13.1	7.0	11.6	13.2	22.0	11.7	16.0	9.1	21.9	7.7	12.2	16.4	11.5	14.9	13.1	7.4	20.4	8.0	18.0	8.1	11.9	17.2	6.6	19.5	15.3	8.3	8.8	13.8	14.4	8.6	12.2	4.4	10.1	7.4	8.6	10.4	19.4	0.7	0.8	0.4	0.9	1.1	1.0	1.0	0.8	0.3	1.0	1.1	0.9	1.5	5.5	1.4	1.4	1.3	0.1	0.7	1.7	2.1	3.8	2.1	1.6	2.0	2.0	2.3	2.0	1.7	1.9	3.2	5.8	6.4	3.9	32.7	5.2	2.5	3.6	2.4	2.2	22.3	10.4	4.8	3.3	8.6	1.9	9.2	27.1	6.1	2.6	5.6	3.9	5.8	120.2	7.7	8.1	4.6	4.2	12.8	32.0	5.0	8.1	5.0	6.6	9.9	2.5	9.3	3.6	8.0	7.7	21.9	32.2	4.4	2.0	5.1	3.1	52.4	8.4	4.2	5.4	9.4	4.2	7.3	3.1	53.8	35.4	6.8	1.3	4.5	7.1	3.8	1.7	5.0	2.4	21.4	0.0	5.4	4.9	11.2	7.5	6.4	4.3	3.3	2.9	6.3	6.1	2.0
GTF2B	TFIIB	ENSG00000137947	"General transcription factor IIB"	Q00403	1	88852633-88891944	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061626	Supported		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear bodies"		"HPA061626: AB_2684570"	"prognostic favorable (4.81e-4)"	"unprognostic (5.21e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.37e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.06e-3)"	"unprognostic (3.74e-2)"	25.3	26.4	14.8	18.8	15.7	62.2	28.3	16.4	24.0	22.9	17.7	22.6	17.9	21.8	30.3	26.3	22.7	23.8	15.7	15.5	16.5	22.9	32.6	22.0	28.9	15.5	15.9	26.3	23.3	22.7	20.3	25.2	15.7	18.1	23.1	17.9	22.9	16.3	23.1	28.3	23.9	20.7	16.2	28.7	23.0	16.3	15.1	40.2	21.2	18.5	31.3	31.5	23.7	17.0	40.0	13.6	34.6	18.8	49.8	34.4	42.9	32.1	39.4	44.1	46.4	17.9	24.3	45.5	37.8	28.0	53.3	22.0	36.8	32.1	38.3	42.8	34.3	48.6	21.2	32.1	31.9	56.8	28.7	30.0	32.1	38.2	21.7	33.4	25.1	41.1	43.1	33.6	47.0	12.6	54.9	46.7	28.8	35.4	29.3	34.4	46.8	34.2	47.0	47.2	26.7	22.4	28.5	35.4	57.8	30.7	15.9	51.1	22.3	19.2	24.0	35.0	38.8	35.1	29.9	62.6	12.8	48.8	16.7	91.2	49.3	82.1	45.9	57.1	53.2	57.8	52.1	50.5	62.5	48.2	62.9	53.9	99.7	54.9	60.4	40.5	70.1	50.9	14.8	15.7	16.4	24.0	15.5	16.5	15.5	15.9	15.7	16.2	15.1	17.0	106.6	6.4	29.7	13.7	114.9	46.3	75.4	63.3	58.6	14.6	39.7	104.9	12.3	21.5	45.6	11.0	2.1	74.0	122.3	39.1	39.2	49.2	22.9	53.9	28.4	30.3	20.3	51.1	22.7	38.6	60.0	53.0	41.8	29.8	48.9	30.2	16.8	17.6	40.5	18.5	21.4	30.5	52.9	32.3	42.5	7.9	36.4	93.4	28.4	22.5	40.3	30.7	33.0	18.1	25.2	49.9	70.5	29.3	74.3	27.8	26.9	47.4	55.2	18.5	13.1	86.6	65.0	24.2	29.0	40.1	50.0	150.1	122.8	34.5	22.7	79.4
GTF2E1	"FE, TFIIE-A"	ENSG00000153767	"General transcription factor IIE subunit 1"	P29083	3	120742637-120783069	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB009884, HPA056359, HPA066881"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB009884: AB_2279381, HPA056359: AB_2683106, HPA066881: AB_2685740"	"unprognostic (3.19e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.23e-1)"	"unprognostic (4.36e-3)"	"unprognostic (2.62e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.38e-2)"	"unprognostic (9.34e-3)"	"unprognostic (5.10e-2)"	"unprognostic (8.29e-3)"	"unprognostic (4.94e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.97e-1)"	5.2	7.7	4.2	6.6	4.9	4.4	5.1	4.6	5.5	4.9	7.9	5.0	4.6	4.6	4.5	4.2	4.2	3.7	5.1	4.4	4.8	4.3	5.0	4.9	9.1	5.0	4.7	5.7	4.5	4.6	2.9	6.6	4.9	4.6	5.8	5.6	4.2	5.6	7.0	3.6	4.2	5.7	4.5	7.7	4.7	9.9	4.9	8.3	5.5	9.3	9.0	5.5	4.2	5.4	13.7	18.7	23.0	14.1	16.9	7.8	20.0	9.0	8.2	13.8	14.7	22.5	9.6	22.3	15.3	6.8	10.7	16.1	21.4	11.8	19.2	15.6	5.0	28.7	12.8	19.0	13.1	26.1	16.8	10.4	12.6	10.3	14.5	9.4	21.4	18.9	20.4	11.3	14.8	15.6	21.6	13.2	22.0	13.1	17.2	17.7	27.0	16.6	13.8	8.6	4.9	15.1	13.5	11.6	12.6	20.6	14.7	19.8	18.9	12.9	14.0	4.1	10.2	9.9	11.8	31.5	13.5	26.0	12.5	18.0	7.2	11.6	6.6	11.2	8.3	9.3	8.1	9.5	8.7	7.3	8.6	8.4	5.0	10.8	10.5	4.1	10.2	7.6	4.2	4.9	4.6	5.5	4.4	4.8	5.0	4.7	4.9	4.5	4.9	5.4	4.1	3.2	4.4	3.3	6.8	1.9	3.0	4.1	3.4	5.3	4.6	1.8	4.9	8.6	6.3	7.3	0.0	9.0	4.7	3.8	5.9	5.1	7.7	8.1	6.0	5.4	1.2	5.5	3.8	4.4	8.4	3.8	3.1	6.1	12.7	9.1	7.5	5.3	9.2	16.8	4.0	3.2	6.1	8.3	2.2	2.9	2.1	7.0	3.6	8.4	12.5	5.5	14.4	4.5	7.2	4.9	2.5	4.9	5.3	3.3	3.4	5.9	5.1	4.4	0.0	3.5	3.9	14.3	22.8	2.8	2.6	8.8	5.7	9.7	3.9	3.1
GTF2H4	"P52, TFB2, TFIIH"	ENSG00000213780	"General transcription factor IIH subunit 4"	Q92759	6	30908207-30914106	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 12.5;Gastric mucus-secreting cells: 9.7;granulocytes: 7.0;Plasma cells: 9.2;Squamous epithelial cells: 13.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA074336			Supported	"Nuclear speckles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA074336: AB_2686679"	"unprognostic (7.05e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.79e-4)"	"unprognostic (7.42e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.66e-4)"	"unprognostic (7.74e-3)"	"prognostic unfavorable (4.08e-4)"	"unprognostic (1.22e-1)"	"unprognostic (9.53e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.07e-2)"	12.6	11.1	5.4	6.6	6.6	4.7	11.4	6.2	7.0	12.8	4.8	12.0	1.8	12.8	1.9	14.4	10.6	2.2	9.3	5.6	6.3	14.6	21.5	10.1	5.6	5.2	5.8	12.2	11.0	6.8	13.4	3.5	4.9	10.5	4.0	1.1	8.6	3.5	13.2	9.7	10.4	1.9	6.0	11.9	12.4	11.9	6.3	8.7	13.5	3.8	3.7	11.7	11.7	8.1	20.5	15.0	15.9	16.5	16.0	11.6	17.7	3.3	5.3	5.8	9.6	14.9	9.1	12.3	8.0	21.1	11.1	16.6	10.7	21.4	10.6	18.6	2.5	10.0	11.5	13.8	10.1	0.0	17.0	18.5	20.5	9.8	0.0	10.3	6.1	9.1	35.2	11.3	11.4	25.0	22.5	16.9	18.5	10.4	6.1	28.5	0.0	11.8	20.7	11.4	9.2	4.5	0.8	11.5	8.8	9.8	16.2	13.7	6.8	15.5	21.5	16.4	28.6	11.1	13.1	9.3	8.9	16.8	7.0	1.8	1.1	0.9	0.8	1.2	0.3	1.3	1.2	1.3	2.5	0.6	1.2	2.2	0.0	1.1	0.6	1.2	2.1	0.3	5.4	6.6	6.2	7.0	5.6	6.3	5.2	5.8	4.9	6.0	6.3	8.1	0.6	0.0	0.0	4.2	4.0	0.4	0.1	0.4	12.5	0.7	1.1	0.8	0.0	1.5	0.1	0.0	2.1	0.4	0.5	0.4	1.9	0.6	0.1	1.1	1.0	1.8	0.0	4.2	4.6	0.6	0.4	1.4	9.7	1.0	7.0	0.8	0.7	1.1	0.3	0.0	3.3	0.0	0.0	1.2	1.2	0.0	0.9	1.5	1.8	1.9	0.3	0.5	0.0	3.5	2.8	0.0	1.2	0.7	9.2	0.1	0.1	0.9	0.8	0.3	0.0	0.4	1.9	1.4	0.4	13.8	1.0	0.3	3.5	0.4	0.6	0.1
GTF2I	"BAP-135, BTKAP1, DIWS, IB291, SPIN, TFII-I, WBSCR6"	ENSG00000263001	"General transcription factor IIi"	P78347	7	74650231-74760692	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004595, HPA026638"	Supported		Enhanced	Nucleoplasm		NA	NA		55000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB004595: AB_628345, HPA026638: AB_1857959"	"unprognostic (3.47e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.28e-1)"	"prognostic favorable (6.35e-6)"	"unprognostic (7.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.88e-2)"	61.2	75.3	32.5	48.2	36.4	32.7	52.2	36.7	35.7	57.5	64.7	41.9	52.8	57.5	41.3	54.9	66.9	47.0	51.2	32.3	31.5	70.9	57.6	52.3	56.7	31.2	33.7	64.4	49.8	106.0	42.9	56.1	31.6	64.2	39.9	82.8	69.4	54.1	84.2	62.9	48.0	61.5	31.0	47.6	67.6	25.4	35.1	70.6	118.0	56.8	68.8	49.4	38.8	46.4	136.4	110.4	222.6	219.9	120.6	106.7	46.3	83.7	76.9	90.5	89.6	76.9	161.6	165.4	33.7	104.1	121.6	116.3	221.1	101.3	116.2	126.4	115.9	85.6	128.0	107.7	72.3	159.5	126.9	98.8	84.7	68.8	70.0	132.6	123.3	55.2	165.3	80.0	110.9	126.8	133.7	147.5	243.6	286.9	67.1	146.0	77.5	133.1	118.7	232.2	185.5	236.3	153.0	226.5	78.7	185.8	116.4	105.2	111.7	123.6	66.8	62.8	108.8	90.2	83.3	256.2	70.9	95.8	126.6	20.4	10.0	17.4	11.3	7.3	16.6	22.1	14.6	16.7	14.6	24.1	17.8	17.4	4.1	21.3	6.6	23.0	8.7	9.7	32.5	36.4	36.7	35.7	32.3	31.5	31.2	33.7	31.6	31.0	35.1	46.4	118.5	80.1	60.6	55.8	80.3	60.2	83.3	136.3	125.7	276.4	140.7	113.7	30.3	210.1	106.3	119.5	283.5	112.6	101.5	46.0	56.7	155.4	37.1	368.7	201.3	98.2	112.5	91.7	68.6	83.0	64.4	78.8	117.8	321.8	13.3	246.1	115.3	101.0	80.3	250.7	74.1	71.0	73.2	106.7	53.7	39.8	152.8	76.0	55.2	46.9	122.3	200.9	101.0	102.5	98.1	132.5	70.6	193.0	81.4	117.6	150.6	110.2	233.3	184.3	85.5	96.8	87.8	34.1	51.9	145.8	91.9	72.2	60.5	172.7	63.9	124.3
GTF3C2	"KIAA0011, TFIIIC110"	ENSG00000115207	"General transcription factor IIIC subunit 2"	Q8WUA4	2	27325849-27357034	"Predicted intracellular proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 61.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA008274, HPA035836"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA008274: , HPA035836: AB_10601813"	"unprognostic (1.76e-1)"	"unprognostic (9.64e-2)"	"unprognostic (9.89e-2)"	"prognostic unfavorable (8.25e-5)"	"unprognostic (1.33e-1)"	"unprognostic (4.88e-2)"	"prognostic unfavorable (1.21e-8)"	"unprognostic (1.57e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.59e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.97e-2)"	"unprognostic (3.00e-1)"	18.7	25.6	19.5	23.2	20.8	23.5	21.1	26.2	27.6	19.0	23.5	25.3	22.4	19.8	23.7	34.5	24.4	15.3	23.2	19.9	20.8	23.3	21.1	19.7	26.6	21.2	18.7	20.7	30.7	33.1	20.0	19.6	20.0	20.1	27.7	25.2	25.2	18.5	28.7	32.2	24.2	23.3	17.2	26.8	24.3	26.0	22.0	30.4	29.4	18.5	33.5	23.2	21.4	28.1	86.2	75.7	62.5	60.6	36.2	35.2	91.2	30.8	41.8	39.8	33.7	56.3	53.7	75.1	54.1	43.0	40.8	50.6	93.2	59.2	38.0	59.5	81.0	63.3	48.5	76.0	33.0	69.7	60.6	44.4	52.3	45.4	58.4	38.0	51.8	50.4	90.1	54.9	38.8	70.4	64.9	50.7	118.2	69.0	47.6	79.1	69.2	83.9	56.8	63.9	58.0	101.5	33.1	78.6	57.7	52.8	42.2	39.3	39.6	48.2	52.4	36.9	58.1	60.2	71.9	169.4	48.1	55.4	53.8	29.6	18.2	14.5	14.3	15.0	15.1	13.3	12.6	15.2	15.6	11.4	12.4	12.2	8.4	13.3	19.2	9.8	8.5	19.7	19.5	20.8	26.2	27.6	19.9	20.8	21.2	18.7	20.0	17.2	22.0	28.1	7.9	19.2	22.1	11.8	17.5	9.8	9.8	11.9	18.2	11.3	13.9	11.6	11.7	14.3	14.9	5.5	22.9	19.3	12.9	22.2	9.8	16.6	54.9	13.6	10.9	10.3	3.5	24.8	17.3	22.8	23.6	10.0	17.3	14.6	18.3	16.2	10.0	11.1	16.1	10.1	16.2	17.6	12.2	18.4	7.6	61.9	9.3	12.1	5.4	16.9	18.3	8.9	12.3	14.1	18.9	21.5	9.0	7.9	18.6	13.0	16.0	11.8	14.8	18.0	6.6	9.7	11.8	9.1	16.4	19.4	12.6	20.0	13.7	11.8	15.1	14.4
GTF3C4	"KAT12, TFIIIC90"	ENSG00000125484	"General transcription factor IIIC subunit 4"	Q9UKN8	9	132670035-132694953	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Transcription	"Acyltransferase, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069369			Supported	Nucleoplasm,Mitochondria		No	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Mitochondria	"HPA069369: AB_2686130"	"unprognostic (7.02e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.10e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.77e-1)"	"unprognostic (1.92e-2)"	"prognostic favorable (2.99e-4)"	"unprognostic (1.65e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.54e-2)"	4.9	4.4	4.3	4.6	5.0	6.9	8.4	9.2	4.3	7.3	3.6	5.3	3.9	6.6	5.5	6.7	6.6	5.2	5.8	4.5	5.2	6.0	5.3	5.7	5.0	3.4	4.8	10.3	6.1	9.4	3.2	6.4	3.7	6.2	5.4	5.5	7.3	5.7	5.8	9.8	3.6	6.2	3.6	4.5	5.8	8.3	5.6	8.1	9.5	8.0	6.6	5.0	3.8	3.8	15.2	21.7	25.8	22.5	12.3	14.4	20.0	15.1	18.4	19.6	14.4	25.4	10.9	22.7	9.8	18.6	18.1	33.8	39.8	23.6	21.1	15.4	19.1	19.0	28.9	10.8	12.8	28.6	12.4	11.4	17.6	20.4	26.1	11.6	16.8	15.1	32.7	11.4	14.0	24.6	17.8	13.3	33.1	22.2	21.4	17.6	31.1	20.6	14.3	12.5	36.3	24.6	25.9	25.8	15.9	15.8	35.4	12.1	17.8	32.9	18.7	15.1	21.6	4.9	12.3	25.1	13.5	17.8	20.7	0.0	0.3	0.2	0.5	0.3	0.4	0.5	0.4	0.6	0.2	0.4	0.5	0.5	0.3	0.5	0.2	0.5	0.4	0.2	4.3	5.0	9.2	4.3	4.5	5.2	3.4	4.8	3.7	3.6	5.6	3.8	9.9	19.2	11.5	2.3	7.8	30.7	6.9	6.9	21.6	15.5	19.1	14.7	14.6	1.5	6.7	3.7	14.6	7.5	9.0	6.6	7.9	8.3	6.5	21.5	26.2	11.6	13.1	8.2	3.2	6.3	7.5	13.0	8.6	17.7	1.3	17.1	10.0	8.6	6.3	20.2	3.1	8.1	10.2	7.6	9.3	3.7	19.0	6.3	3.6	1.9	7.1	11.9	7.2	1.0	2.1	5.8	7.0	19.2	10.7	11.6	3.8	6.6	16.2	16.9	0.0	18.8	10.9	16.7	13.8	22.1	40.1	6.4	8.8	18.2	9.0	6.4
GTF3C5	"TFiiiC2-63, TFIIIC63, TFIIICepsilon"	ENSG00000148308	"General transcription factor IIIC subunit 5"	Q9Y5Q8	9	133030675-133058503	"Predicted intracellular proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA067063, HPA069805"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA067063: AB_2685773, HPA069805: AB_2686201"	"unprognostic (1.07e-2)"	"unprognostic (1.78e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.97e-3)"	"unprognostic (4.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.45e-3)"	"unprognostic (4.55e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.73e-2)"	26.5	33.6	26.3	20.6	30.4	42.4	29.1	35.1	35.8	36.2	23.9	28.8	26.4	31.7	22.3	39.0	32.0	17.5	39.1	26.9	27.5	27.5	32.9	23.7	27.7	28.1	28.6	44.6	33.6	24.5	36.0	24.6	29.0	34.3	19.2	13.7	29.1	20.7	47.9	38.6	30.3	21.6	26.2	32.1	28.5	29.4	28.5	44.5	28.6	32.3	25.3	29.2	33.2	36.6	44.1	77.5	67.3	63.3	35.9	32.5	93.2	42.0	45.4	78.6	55.4	83.5	71.8	72.7	38.7	47.1	63.2	103.9	79.8	76.3	40.2	74.9	69.1	86.8	90.3	78.7	55.9	66.2	176.0	45.0	49.9	83.5	57.7	38.0	69.1	235.1	112.5	66.0	42.1	142.1	107.9	92.4	87.5	100.6	79.7	113.9	69.5	89.2	52.4	50.2	80.4	59.7	71.2	73.4	43.8	38.1	96.5	95.6	46.0	92.0	71.3	59.1	71.8	25.8	57.3	78.0	44.8	49.8	62.4	54.2	16.0	22.5	15.8	18.9	23.0	14.6	16.3	20.7	17.2	13.6	18.1	16.4	9.5	20.7	16.3	16.6	19.4	17.8	26.3	30.4	35.1	35.8	26.9	27.5	28.1	28.6	29.0	26.2	28.5	36.6	16.0	9.6	19.0	17.3	21.0	12.4	16.5	21.7	30.7	14.2	25.2	21.6	29.3	14.3	17.2	16.5	8.4	42.1	20.0	30.4	29.4	25.5	3.4	16.2	15.4	16.4	14.4	22.3	9.0	30.3	38.4	19.7	18.3	19.9	16.5	50.1	18.5	17.2	22.5	15.2	7.9	15.9	34.6	15.7	9.9	4.3	17.4	15.8	16.0	8.4	14.8	18.8	15.5	6.0	16.6	27.2	25.4	21.4	17.4	13.9	27.3	11.7	14.6	20.8	46.0	17.2	19.4	20.5	31.9	26.1	16.6	41.6	17.6	34.0	25.7	19.4
GTF3C6	"bA397G5.3, C6orf51, TFIIIC35"	ENSG00000155115	"General transcription factor IIIC subunit 6"	Q969F1	6	110958706-110967890	"Predicted intracellular proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056179, HPA061345"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Nuclear bodies"	"HPA056179: AB_2683058, HPA061345: AB_2684485"	"unprognostic (6.98e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.04e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (7.27e-6)"	"unprognostic (2.08e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.89e-1)"	"unprognostic (5.42e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.42e-3)"	"unprognostic (9.31e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.14e-2)"	53.2	55.0	71.5	53.5	73.6	53.5	47.1	73.7	114.9	42.0	73.4	66.9	52.3	30.8	45.8	44.8	45.2	57.8	86.6	70.8	76.3	76.2	51.3	33.9	55.8	72.4	72.6	28.2	30.8	65.3	37.1	32.5	72.7	94.6	65.4	39.0	38.3	41.6	231.2	31.1	46.7	48.7	72.9	33.6	49.8	61.9	72.3	49.7	40.2	168.0	58.1	61.1	27.5	74.9	85.8	154.0	166.5	155.7	59.9	121.9	145.4	143.8	105.1	131.9	109.2	229.0	74.7	121.1	137.8	132.9	30.4	38.6	141.1	120.0	145.5	175.9	205.3	234.2	145.9	347.5	113.4	360.9	190.8	121.4	103.3	115.2	112.8	89.7	155.2	154.3	281.7	79.4	246.8	166.5	198.6	371.4	169.9	109.6	121.0	183.2	95.6	109.7	221.5	214.7	105.4	148.5	107.0	16.8	133.0	98.6	58.7	244.2	163.0	38.2	112.0	260.5	232.3	51.7	127.2	235.9	39.7	208.1	191.3	112.6	116.9	71.0	104.2	170.7	117.9	164.1	130.0	131.0	158.3	133.7	100.9	118.9	18.5	116.2	141.1	173.4	292.4	167.5	71.5	73.6	73.7	114.9	70.8	76.3	72.4	72.6	72.7	72.9	72.3	74.9	58.0	70.5	47.1	12.7	67.1	30.3	70.9	169.2	34.1	37.6	85.3	90.4	279.1	203.0	99.5	104.8	16.7	94.6	75.0	138.8	305.2	190.4	169.1	119.1	82.0	66.0	109.8	86.9	4.9	293.0	251.1	66.4	47.9	167.8	54.4	71.2	55.6	94.5	284.6	26.9	6.7	98.6	144.5	79.8	50.1	223.9	65.0	104.5	55.2	6.5	172.4	133.2	81.4	7.1	13.4	210.8	125.2	68.4	78.3	126.9	118.9	404.7	74.9	37.0	65.7	63.5	88.1	153.1	105.8	72.5	29.7	90.4	72.3	120.2	121.4	117.8
GTPBP10	"DKFZP686A10121, FLJ38242, OBGH2"	ENSG00000105793	"GTP binding protein 10"	A4D1E9	7	90335223-90391453	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021076	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"			"HPA021076: AB_1850411"	"unprognostic (2.74e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.56e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.44e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (6.76e-5)"	"unprognostic (8.34e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.72e-3)"	8.5	7.2	3.2	8.9	3.2	6.5	10.6	5.3	5.7	7.0	1.9	8.8	8.8	7.6	6.4	8.2	6.3	5.6	10.1	3.0	4.3	12.5	18.7	5.7	11.0	3.3	2.8	8.6	7.6	8.1	4.5	6.1	4.0	6.9	9.6	7.2	6.1	5.3	12.3	6.8	7.1	7.1	3.9	7.3	10.7	11.3	3.5	12.7	9.8	10.0	9.7	9.5	5.6	4.3	33.9	21.1	14.1	21.3	17.1	15.3	23.2	21.2	13.9	19.5	15.4	31.1	25.0	42.2	34.6	14.5	41.6	21.3	32.4	28.3	25.3	26.5	16.6	17.4	12.8	16.4	16.3	51.0	14.9	18.3	12.1	32.4	64.3	15.5	11.5	35.0	64.8	30.1	17.6	34.6	35.8	14.5	17.4	30.8	25.5	22.7	41.3	35.2	14.3	18.4	17.4	16.3	27.2	41.3	41.2	20.1	20.0	21.9	21.1	27.3	31.9	48.9	41.2	22.6	30.7	59.3	20.5	35.4	29.5	23.6	5.3	9.4	6.3	7.4	10.9	11.7	10.2	7.7	6.4	9.2	10.8	10.2	5.1	7.8	4.5	5.7	13.3	5.6	3.2	3.2	5.3	5.7	3.0	4.3	3.3	2.8	4.0	3.9	3.5	4.3	11.0	12.8	21.1	21.5	17.6	5.9	8.5	13.5	9.6	12.6	9.8	11.0	14.3	7.2	17.0	16.5	14.6	7.6	9.7	6.2	13.7	8.7	21.8	8.8	12.1	9.4	9.6	12.8	29.7	15.8	7.2	10.8	10.2	8.9	12.0	12.7	8.6	14.3	6.4	5.0	35.5	7.4	14.2	7.5	6.0	4.4	9.3	7.4	7.2	42.2	7.4	11.2	9.2	36.7	50.8	10.2	4.9	9.4	7.4	8.4	7.8	21.8	15.3	12.4	6.6	18.9	10.5	26.2	18.9	12.0	6.1	6.7	15.5	15.6	9.1	8.4
GTPBP4	"CRFG, FLJ10686, FLJ10690, NGB, NOG1"	ENSG00000107937	"GTP binding protein 4"	Q9BZE4	10	988434-1019932	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039618, HPA056468"	Uncertain		Supported	"Nuclear membrane,Nucleoli,Nucleoli rim"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nucleoli, Nucleoli rim"	"Nuclear membrane"	"HPA039618: AB_10795292, HPA056468: AB_2683141"	"unprognostic (2.11e-3)"	"unprognostic (3.10e-3)"	"unprognostic (7.77e-3)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (3.72e-2)"	"unprognostic (8.91e-3)"	"prognostic unfavorable (8.85e-12)"	"unprognostic (9.06e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (2.38e-5)"	"unprognostic (7.90e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.67e-2)"	15.6	19.6	8.0	12.6	8.5	26.9	12.8	8.6	8.7	8.4	9.4	9.5	8.6	11.0	8.8	11.4	9.2	7.9	11.1	8.8	9.5	9.4	10.9	8.5	13.9	9.1	9.4	9.8	11.9	10.3	7.8	10.2	9.1	9.0	10.8	8.9	7.8	8.4	26.6	9.5	8.2	12.2	9.5	9.4	9.2	21.0	9.4	12.0	9.8	14.8	15.6	18.3	8.7	10.1	57.0	49.4	37.1	34.9	27.9	31.1	27.3	52.3	18.8	62.6	53.3	73.2	43.3	87.0	15.2	45.5	21.3	43.6	77.4	52.0	71.2	41.8	50.9	94.7	35.3	45.4	44.5	41.3	47.1	43.1	42.7	72.7	51.6	25.5	34.7	62.9	98.3	33.5	60.1	57.0	62.0	40.3	56.2	77.9	33.8	59.3	35.5	57.6	37.9	37.4	19.3	57.3	37.3	44.7	66.3	36.7	61.8	42.3	32.4	30.3	16.4	71.5	65.2	45.0	86.9	103.5	33.9	43.5	24.9	18.2	9.6	3.6	12.4	16.2	14.3	12.0	11.7	12.6	12.9	11.2	12.7	12.5	1.5	18.4	13.3	8.6	16.6	8.9	8.0	8.5	8.6	8.7	8.8	9.5	9.1	9.4	9.1	9.5	9.4	10.1	36.2	57.7	74.3	5.9	41.8	62.7	100.0	52.8	35.3	26.1	28.1	27.4	32.6	21.5	83.5	29.5	18.8	50.3	37.4	18.4	33.2	57.7	70.9	46.8	51.9	49.2	22.1	37.4	9.3	44.1	54.9	48.9	33.6	78.8	66.9	40.1	20.0	27.5	34.7	23.5	8.9	29.9	40.7	26.0	24.4	20.9	24.8	33.1	23.2	8.4	39.5	26.5	22.6	6.0	10.2	72.2	17.3	29.3	37.0	84.7	10.6	25.6	55.8	32.7	19.7	58.5	51.4	88.7	84.9	47.0	67.2	95.4	37.5	57.7	32.6	102.6
GTSE1	"B99, GTSE-1"	ENSG00000075218	"G2 and S-phase expressed 1"	Q9NYZ3	22	46296870-46330810	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 11.2;lymphoid tissue: 19.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 52.2;Extravillous trophoblasts: 31.2;Granulosa cells: 27.1;Spermatocytes: 73.6;Spermatogonia: 27.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA029457			Approved	"Plasma membrane,Centrosome"		Yes	Yes			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Centrosome	"Plasma membrane"	"HPA029457: "	"unprognostic (1.97e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.59e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (1.90e-10)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (1.09e-1)"	"unprognostic (8.37e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (3.49e-3)"	"unprognostic (0.00e+0)"	"unprognostic (6.52e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.85e-2)"	0.6	0.6	0.2	5.1	0.2	11.2	0.5	0.5	0.3	0.7	0.2	2.4	4.1	0.8	0.0	3.6	0.2	0.5	0.3	0.2	0.3	0.3	0.4	0.6	9.2	0.4	0.3	0.2	0.2	0.1	0.1	2.6	0.4	0.2	2.6	0.1	0.7	0.1	0.1	2.5	2.9	1.2	0.1	2.4	1.9	7.2	0.5	19.6	0.2	0.2	8.7	1.0	1.2	0.4	59.5	27.6	53.2	42.2	1.1	3.0	25.5	50.3	23.5	71.7	58.8	29.3	21.9	55.7	13.0	19.4	32.8	30.3	48.0	12.7	45.7	33.7	52.0	37.4	38.9	22.8	0.1	67.5	43.8	0.6	1.0	30.9	15.6	7.5	31.2	39.7	29.0	67.8	43.4	33.1	60.9	33.0	37.2	24.2	30.7	59.6	59.7	36.3	11.7	10.7	27.5	37.5	48.1	30.7	21.5	23.8	26.2	25.8	25.1	40.6	75.8	33.4	53.7	38.6	19.7	56.3	25.8	32.2	60.5	0.0	0.0	0.3	0.3	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.5	0.3	0.0	0.4	0.3	0.2	0.2	0.2	0.5	0.3	0.2	0.3	0.4	0.3	0.4	0.1	0.5	0.4	1.1	0.0	0.0	0.7	7.0	2.8	1.1	2.1	0.6	0.7	2.8	3.4	1.6	0.0	0.5	0.0	0.0	19.2	6.8	7.6	0.0	0.9	5.6	2.1	4.7	3.9	1.2	52.2	0.3	0.2	31.2	5.1	16.8	4.3	0.0	27.1	6.4	1.2	19.9	0.0	0.5	9.4	2.0	7.5	4.0	3.9	0.3	4.7	0.0	0.0	0.1	0.4	0.0	0.5	0.1	0.8	0.2	0.7	19.1	1.8	0.5	0.5	0.2	0.3	6.6	2.6	5.4	73.6	27.8	11.7	2.6	1.5	5.0	1.2	13.8	1.6
GUF1	FLJ13220	ENSG00000151806	"GUF1 homolog, GTPase"	Q8N442	4	44678420-44700928	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	Hydrolase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003934, HPA024222"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria"		"HPA003934: AB_1079034, HPA024222: AB_2671488"	"unprognostic (1.32e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.65e-3)"	"unprognostic (7.56e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.56e-3)"	"unprognostic (7.38e-3)"	"prognostic favorable (2.66e-6)"	"unprognostic (4.98e-3)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.65e-5)"	"unprognostic (5.40e-2)"	5.2	4.1	2.5	3.9	3.2	6.3	5.2	4.3	3.6	3.5	0.6	5.7	4.6	4.8	3.8	5.2	4.1	2.7	6.1	3.3	2.5	6.9	7.1	3.1	4.7	1.6	1.9	4.9	3.7	4.3	2.4	3.7	1.9	4.9	5.9	6.7	4.0	3.5	15.8	5.0	6.3	3.5	2.4	4.8	7.9	5.9	2.2	4.4	5.3	17.0	4.6	3.9	3.8	4.4	11.9	6.0	10.9	13.9	4.4	9.0	24.0	16.1	8.2	16.2	12.4	10.5	8.3	25.8	12.3	7.7	14.9	9.2	18.7	18.2	18.2	8.7	12.2	30.7	5.3	7.2	14.3	33.4	12.7	9.2	8.1	12.1	10.5	7.6	11.8	15.0	31.7	4.9	13.2	5.9	19.1	7.0	7.0	8.5	13.8	13.5	22.5	11.0	4.8	4.6	14.8	11.1	10.1	4.2	11.2	8.4	6.8	9.6	11.7	11.0	12.7	14.8	19.1	17.9	17.4	18.3	11.9	19.7	9.6	0.5	2.2	2.3	2.0	2.9	2.6	2.1	2.1	1.8	2.1	1.7	1.9	2.0	0.0	2.3	1.9	2.3	3.6	1.9	2.5	3.2	4.3	3.6	3.3	2.5	1.6	1.9	1.9	2.4	2.2	4.4	7.2	6.4	9.5	9.8	11.6	4.0	9.6	6.0	5.2	10.5	9.8	7.5	22.8	7.2	9.1	7.3	2.1	13.1	10.1	11.5	13.7	10.3	2.0	12.0	14.3	8.1	11.4	14.9	20.3	10.2	17.6	9.7	18.3	8.8	1.3	16.6	7.9	13.9	12.1	11.8	19.5	12.4	4.1	11.7	5.4	2.9	5.6	9.0	7.2	9.4	9.2	9.2	14.4	18.6	19.0	16.4	6.6	7.2	13.9	9.8	11.3	12.2	16.7	10.3	0.0	6.8	10.0	12.3	14.6	14.9	7.1	13.4	9.5	18.9	13.3	10.6
H2AZ1	"H2A.Z, H2AFZ, H2AZ"	ENSG00000164032	"H2A.Z variant histone 1"	P0C0S5	4	99948086-99950355	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 621.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 211.4;Cytotrophoblasts: 625.4;Extravillous trophoblasts: 1438.5;Hofbauer cells: 711.2;Syncytiotrophoblasts: 403.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022549, HPA057236"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB022549: , HPA057236: AB_2683377"	"unprognostic (1.21e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.03e-3)"	"unprognostic (7.60e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.74e-3)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (2.29e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.99e-3)"	"unprognostic (9.70e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (2.16e-6)"	"unprognostic (3.02e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.52e-1)"	104.6	88.6	104.7	193.5	115.0	621.6	120.9	112.0	156.8	116.8	114.4	206.7	149.4	156.0	99.2	220.9	105.5	110.5	98.8	108.9	113.5	137.5	104.4	137.9	348.0	103.2	105.5	130.2	88.3	79.2	110.5	146.0	106.9	123.6	193.6	123.7	122.5	114.6	127.5	140.1	155.3	207.2	110.6	161.6	155.3	150.3	107.4	545.3	88.9	121.7	385.4	165.3	129.5	113.6	1249.7	864.3	1753.9	911.2	354.8	314.7	581.6	1287.6	930.7	1319.4	1229.9	897.5	1422.2	2205.2	451.5	666.0	862.3	442.9	1558.6	1268.1	1566.7	956.4	1088.7	1130.4	974.2	1029.1	212.4	2028.8	914.6	235.3	549.6	1004.5	561.1	369.3	1322.2	1313.0	1133.0	1293.1	1558.8	1751.0	1710.7	1697.0	1013.0	1402.9	822.1	1443.6	1279.6	928.0	741.0	750.1	1142.6	875.9	796.4	1507.4	1509.1	608.7	772.0	1550.7	686.7	841.6	1589.0	578.0	1674.1	736.1	1208.3	2671.0	939.8	1348.6	1342.7	780.2	689.8	1375.4	351.5	788.5	393.9	493.8	580.9	475.6	590.8	419.7	533.4	437.6	1482.5	453.8	1053.0	379.0	868.9	1555.4	104.7	115.0	112.0	156.8	108.9	113.5	103.2	105.5	106.9	110.6	107.4	113.6	211.4	0.0	0.0	0.0	35.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	130.2	0.0	0.0	0.0	0.0	625.4	147.1	0.0	0.0	0.0	0.0	0.0	0.0	49.0	0.0	0.0	0.0	0.0	1438.5	78.5	0.0	0.0	0.0	0.0	0.0	0.0	711.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.2	0.0	0.0	0.0	0.0	403.2	39.0	0.0	0.0	0.0
H4C2	"H4/I, H4FI, HIST1H4B"	ENSG00000278705	"H4 clustered histone 2"	P62805	6	26026815-26027252	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 87.0"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	6	"cerebellum: 87.0"	"Immune cell enriched"	"Detected in many"	6	"neutrophil: 43.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 43.0"	"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in many"							HPA042201	Supported					NA	NA		25000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"			"HPA042201: AB_2677898"	"unprognostic (1.16e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.31e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.52e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.69e-3)"	"unprognostic (4.39e-2)"	"unprognostic (3.17e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.58e-2)"	0.3	0.0	5.5	0.0	4.2	1.9	0.2	87.0	12.2	0.5	9.6	0.2	0.1	0.1	0.0	0.1	0.4	0.0	0.1	2.5	8.2	0.2	0.4	0.2	0.6	5.2	9.1	0.2	0.1	0.0	0.1	0.1	13.8	0.2	0.0	0.2	0.4	0.0	0.2	0.1	0.1	0.0	7.0	0.2	0.2	0.2	15.2	2.0	0.4	0.0	0.1	0.1	0.2	6.2	0.9	0.0	0.1	1.8	0.0	0.0	0.0	1.4	0.1	0.8	0.5	0.3	0.2	0.7	0.2	0.3	0.5	0.2	0.4	0.0	0.5	0.3	1.9	2.4	1.2	1.1	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	2.6	0.2	1.4	2.4	1.9	0.4	0.4	0.3	1.7	0.8	1.5	0.0	0.6	0.5	0.3	0.2	1.0	0.0	0.0	0.2	1.2	0.0	0.5	1.2	1.0	1.8	1.4	1.5	1.2	0.7	0.7	0.9	0.0	0.9	1.3	1.7	1.2	1.5	2.7	1.8	1.3	0.7	6.7	1.4	0.8	43.0	0.3	2.4	2.3	1.3	0.5	5.5	4.2	87.0	12.2	2.5	8.2	5.2	9.1	13.8	7.0	15.2	6.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
HACD3	"B-ind1, HSPC121, PTPLAD1"	ENSG00000074696	"3-hydroxyacyl-CoA dehydratase 3"	Q9P035	15	65530418-65578349	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014837, HPA060347"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Endoplasmic reticulum"		"HPA014837: AB_1855914, HPA060347: AB_2684260"	"unprognostic (1.51e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.57e-1)"	"prognostic favorable (3.09e-5)"	"unprognostic (3.44e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.04e-2)"	23.1	84.1	56.1	18.5	57.1	17.3	74.4	64.6	67.5	40.2	73.2	30.0	28.9	29.9	43.0	19.2	32.4	34.1	11.8	54.3	87.8	79.6	119.1	30.3	18.8	68.3	79.6	47.8	29.8	61.5	44.2	37.2	87.2	41.6	34.3	54.0	28.6	34.3	6.9	27.7	29.2	28.1	70.0	21.2	68.7	34.6	88.3	29.0	70.8	7.8	20.3	43.0	17.8	75.8	88.9	194.4	211.3	106.2	130.3	78.0	99.8	95.9	82.4	106.6	119.6	149.9	129.1	110.8	81.8	104.7	132.6	237.9	344.4	80.1	94.8	61.9	191.8	88.1	88.7	165.3	65.9	110.6	64.9	80.3	58.7	73.3	52.5	102.7	105.5	65.1	117.5	40.8	174.3	105.6	82.5	86.0	180.6	235.3	65.4	91.8	178.9	125.0	152.1	151.2	126.8	111.9	103.6	114.9	110.5	197.5	117.1	57.9	84.2	134.4	117.6	66.9	134.9	79.1	251.2	154.5	89.7	105.8	82.6	8.5	7.5	2.5	31.7	11.2	36.1	23.7	28.6	30.2	13.2	22.2	33.0	32.9	1.0	23.2	12.7	17.4	24.6	22.7	56.1	57.1	64.6	67.5	54.3	87.8	68.3	79.6	87.2	70.0	88.3	75.8	63.6	64.1	64.8	84.5	18.7	0.0	60.5	0.0	76.2	121.3	94.8	64.5	9.9	62.9	27.9	176.6	100.1	189.1	23.8	6.1	25.4	71.3	107.2	62.8	76.2	51.8	43.7	67.3	57.5	46.3	124.4	62.7	73.4	39.8	16.4	127.0	42.1	165.2	51.2	139.7	97.1	26.3	0.0	23.1	0.0	32.5	87.3	22.2	0.0	29.0	5.2	89.8	16.5	57.8	66.7	32.1	18.2	88.4	28.9	71.5	28.3	56.2	36.5	83.7	78.9	40.9	41.9	156.9	110.3	54.3	0.0	113.1	22.3	136.2	45.1	78.7
HARBI1	"C11orf77, FLJ32675"	ENSG00000180423	"Harbinger transposase derived 1"	Q96MB7	11	46602861-46617909	"Predicted intracellular proteins"		"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 70.9;Late spermatids: 73.0;Spermatocytes: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038671, HPA045457"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Cytosol"		"HPA038671: AB_10675947, HPA045457: AB_2679332"	"unprognostic (1.29e-1)"	"unprognostic (6.82e-2)"	"unprognostic (7.76e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.23e-5)"	"unprognostic (2.10e-1)"	"unprognostic (1.66e-2)"	"unprognostic (9.58e-2)"	"unprognostic (3.15e-1)"	"unprognostic (6.34e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.13e-1)"	2.0	2.6	2.6	2.4	4.5	5.6	2.4	3.3	4.2	2.3	2.3	3.0	2.6	1.7	3.4	2.3	2.1	2.0	2.5	2.7	3.1	2.9	3.3	2.2	3.4	3.5	3.5	1.4	2.4	2.2	2.5	2.8	3.6	2.2	3.4	2.7	2.8	1.9	2.6	3.2	2.8	3.0	2.8	2.4	4.0	12.1	4.0	4.2	2.7	2.0	3.4	2.6	1.5	7.3	3.3	5.3	4.3	4.1	8.4	5.1	5.1	4.7	4.5	6.3	8.0	3.7	3.7	5.8	2.9	3.9	7.1	6.3	4.6	4.1	5.9	6.7	5.5	5.9	3.9	4.2	9.8	5.5	7.6	6.5	10.7	4.2	8.2	2.4	4.0	6.2	9.4	7.0	5.3	7.1	6.8	2.3	11.8	10.8	6.4	4.5	6.1	10.3	4.8	3.9	4.1	3.4	5.6	5.9	6.8	5.7	9.9	4.7	3.8	6.3	4.9	8.4	4.3	6.6	7.7	6.3	4.8	3.2	6.6	21.9	7.6	10.9	9.6	10.3	6.7	4.7	7.6	7.0	6.4	6.6	7.2	8.0	11.2	6.9	9.8	8.3	10.2	4.4	2.6	4.5	3.3	4.2	2.7	3.1	3.5	3.5	3.6	2.8	4.0	7.3	1.0	0.0	1.3	1.3	2.2	1.0	2.7	4.0	1.8	3.5	2.5	1.8	2.3	1.5	4.4	0.0	2.1	4.9	1.5	2.1	5.9	4.1	70.9	4.7	2.2	1.4	1.2	13.5	1.5	2.2	3.4	1.7	2.0	4.7	0.0	1.6	1.8	2.8	3.3	3.3	1.5	2.2	8.2	3.3	0.8	73.0	3.1	1.7	1.8	0.0	4.2	2.9	1.0	0.5	4.6	3.0	0.8	1.9	3.4	1.6	3.4	3.5	6.1	3.7	0.0	2.1	2.0	25.2	13.5	1.7	2.7	9.3	2.2	2.2	1.7	2.3
HASPIN	GSG2	ENSG00000177602	"Histone H3 associated protein kinase"	Q8TF76	17	3723903-3726699	"Enzymes, Predicted intracellular proteins"	"Cell cycle"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.0;lymphoid tissue: 5.3;testis: 7.3"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.2;Extravillous trophoblasts: 3.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA027422, HPA030698"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA027422: AB_10601812, HPA030698: AB_2673575"	"unprognostic (1.15e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.05e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.01e-4)"	"unprognostic (1.57e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.75e-3)"	"unprognostic (3.82e-3)"	"unprognostic (0.00e+0)"	"unprognostic (5.65e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.73e-1)"	0.2	0.1	0.0	1.8	0.2	6.0	0.4	0.0	0.1	0.2	0.2	1.1	1.5	0.2	0.1	1.3	0.3	0.2	0.1	0.0	0.0	0.1	0.1	1.4	4.2	0.1	0.1	0.1	0.2	0.0	0.0	0.6	0.1	0.3	1.0	0.0	0.4	0.0	0.6	0.7	1.8	0.4	0.0	1.7	0.9	7.3	0.2	5.3	0.3	0.1	5.1	0.3	0.5	0.2	11.3	12.2	11.1	12.5	0.7	1.4	9.3	10.2	7.8	19.7	19.3	9.6	4.6	27.7	5.7	5.7	7.9	18.0	20.1	9.9	18.7	0.1	16.7	13.8	9.9	5.8	0.5	8.1	13.7	0.9	0.8	14.9	9.2	2.4	9.1	21.6	12.4	23.7	10.1	5.9	16.4	4.8	9.8	8.7	8.3	16.8	13.9	7.4	3.0	7.8	4.4	6.5	8.9	6.1	3.5	9.6	6.1	7.5	4.7	8.7	9.9	9.8	18.1	4.5	5.4	13.4	5.1	11.5	10.7	0.1	0.1	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.2	0.0	0.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0
HAT1	KAT1	ENSG00000128708	"Histone acetyltransferase 1"	O14929	2	171922448-171983686	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036788, CAB037191"	Supported		Supported	Nucleoplasm		NA	NA		27000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"CAB037191: AB_477070, HPA036788: AB_10672267"	"unprognostic (1.76e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.39e-3)"	"unprognostic (8.24e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (5.72e-5)"	"unprognostic (2.71e-2)"	"unprognostic (9.08e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.23e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.69e-2)"	27.7	27.0	14.3	33.5	15.5	59.8	41.4	15.9	19.2	26.8	15.3	27.7	19.9	24.6	16.7	26.6	24.4	24.6	31.4	13.1	16.2	32.2	30.2	25.7	48.7	15.0	14.6	23.2	30.0	37.9	16.9	30.6	15.5	29.0	30.7	28.8	32.8	24.0	67.7	23.8	21.7	29.3	16.1	27.7	23.6	20.1	15.5	50.7	32.8	50.8	47.5	39.0	19.6	17.3	132.4	61.5	106.6	98.8	55.2	56.8	75.2	133.9	88.9	144.4	149.9	144.3	88.2	147.0	85.0	81.5	122.7	101.3	116.7	109.5	220.5	83.5	115.8	131.1	91.5	131.0	26.7	165.5	77.9	34.2	62.2	191.0	63.6	45.5	92.6	100.4	136.5	93.1	166.5	91.8	131.1	148.3	89.0	158.9	63.9	102.8	134.4	99.4	85.3	130.2	67.8	55.4	112.4	62.4	118.1	81.5	86.4	164.5	47.5	129.8	99.2	109.5	137.1	40.9	100.5	173.8	87.6	117.8	113.8	47.6	35.3	53.7	32.8	42.0	40.6	35.5	34.9	34.0	27.4	30.7	33.9	37.6	40.3	44.6	59.2	14.3	49.2	34.0	14.3	15.5	15.9	19.2	13.1	16.2	15.0	14.6	15.5	16.1	15.5	17.3	55.6	35.3	28.9	13.7	49.7	74.2	117.7	129.7	46.1	24.2	36.4	42.3	49.5	25.8	66.2	27.6	33.3	77.5	43.5	19.0	82.2	45.2	70.3	33.1	32.3	43.2	14.3	103.1	28.6	46.5	83.1	43.7	15.8	28.9	40.6	30.7	28.9	20.1	51.8	28.6	45.3	20.9	111.9	29.5	36.3	14.7	30.7	34.5	32.0	16.9	28.8	53.4	43.3	21.6	28.0	27.8	21.0	36.9	50.8	52.0	18.2	46.0	65.4	42.0	39.5	43.8	51.3	65.7	67.5	28.8	52.7	58.3	49.0	43.9	29.4	64.1
HAUS1	"CCDC5, FLJ40084, HEI-C, HsT1461"	ENSG00000152240	"HAUS augmin like complex subunit 1"	Q96CS2	18	46104378-46128333	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 111.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040601, HPA040652"	Supported		Supported	Centrosome,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	Centrosome	"HPA040601: AB_10794743, HPA040652: AB_10793966"	"unprognostic (1.74e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.13e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (1.39e-1)"	"unprognostic (4.76e-3)"	"prognostic favorable (1.55e-4)"	"unprognostic (3.75e-1)"	"prognostic unfavorable (6.76e-4)"	"unprognostic (5.97e-3)"	"unprognostic (5.40e-2)"	"unprognostic (9.79e-3)"	"unprognostic (3.66e-2)"	"unprognostic (7.96e-2)"	14.3	11.0	7.2	18.4	7.2	37.8	18.9	7.3	10.2	13.7	9.0	18.5	14.3	17.0	38.7	14.5	13.4	16.9	11.8	7.0	7.8	13.0	13.7	12.2	35.6	7.5	7.6	26.4	11.4	14.3	10.7	17.8	7.8	10.4	22.1	9.5	10.5	12.9	7.2	10.1	14.3	16.8	8.0	14.6	13.0	16.2	7.3	41.4	13.3	13.2	39.5	16.2	11.9	8.1	72.8	43.6	157.3	86.9	38.8	59.4	42.5	68.4	65.7	105.5	104.4	43.2	39.5	136.4	40.5	48.3	49.8	74.6	94.0	56.4	115.1	77.7	64.2	99.2	40.7	82.0	32.5	184.2	59.7	28.6	21.6	64.6	33.3	45.6	115.1	91.5	72.4	39.8	94.2	41.9	150.0	87.7	101.1	33.0	24.9	144.6	112.4	98.4	85.4	49.9	74.3	77.2	64.3	22.3	52.9	60.7	33.3	89.0	67.9	62.8	42.1	27.9	73.4	43.5	73.2	130.6	39.9	157.0	74.0	11.1	46.5	36.7	40.3	45.4	45.0	79.4	53.0	48.9	58.3	64.8	38.1	45.0	4.9	55.9	35.8	62.5	99.9	55.4	7.2	7.2	7.3	10.2	7.0	7.8	7.5	7.6	7.8	8.0	7.3	8.1	20.6	12.8	12.2	3.3	26.5	17.5	15.8	47.8	16.5	6.1	16.4	18.7	10.1	15.7	33.0	14.7	4.2	58.7	22.0	11.1	17.6	38.2	7.5	15.9	18.3	29.4	12.1	53.9	4.2	42.3	111.7	25.1	7.1	14.5	29.8	31.3	23.2	6.9	50.9	11.8	4.8	24.1	28.5	33.6	24.7	12.4	22.7	25.8	21.4	4.7	45.8	21.5	37.0	8.0	5.2	31.8	12.4	25.9	21.9	8.1	14.3	24.7	29.3	8.7	19.7	15.9	20.2	50.8	55.8	15.3	15.5	23.7	23.9	20.7	26.8	12.9
HAUS3	"C4orf15, dgt3, IT1, MGC4701"	ENSG00000214367	"HAUS augmin like complex subunit 3"	Q68CZ6	4	2078998-2242276	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040649, HPA048190"	Approved		Uncertain	"Microtubules,Cytokinetic bridge,Mitotic spindle,Mitochondria"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria	"Microtubules, Cytokinetic bridge, Mitotic spindle"	"HPA040649: AB_2677060, HPA048190: AB_2680308"	"unprognostic (4.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.30e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.57e-3)"	"unprognostic (7.63e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.81e-3)"	"unprognostic (2.79e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.40e-2)"	"prognostic favorable (4.78e-5)"	9.6	8.6	3.5	7.5	3.5	27.5	8.9	9.0	4.6	8.1	1.9	8.3	6.5	7.3	4.9	8.0	7.2	4.2	5.8	3.4	3.2	6.2	7.4	9.0	10.2	3.4	3.4	7.3	10.5	4.0	5.6	6.5	3.3	8.5	5.3	5.8	8.5	4.5	7.4	8.9	9.2	4.7	2.3	12.0	9.0	10.7	3.4	8.6	7.4	4.6	8.3	7.1	7.7	4.3	9.8	4.7	14.2	13.0	5.5	8.5	12.8	14.3	6.0	12.7	10.6	9.5	12.5	18.9	6.5	5.7	14.3	9.3	11.9	7.2	15.9	6.8	6.9	12.5	13.1	7.0	4.5	11.6	11.2	4.3	10.2	11.0	5.8	6.6	10.3	8.8	22.0	21.2	12.5	5.4	19.6	19.5	11.2	8.5	12.3	13.9	12.4	10.4	6.3	6.7	18.4	10.0	10.1	7.6	8.4	10.5	15.7	7.8	8.5	18.1	7.8	11.1	17.0	11.2	10.6	16.9	8.8	16.8	12.0	9.6	4.2	12.2	7.9	5.8	10.1	5.5	8.2	8.9	3.8	9.1	9.5	8.9	4.7	10.7	6.9	6.8	12.0	6.6	3.5	3.5	9.0	4.6	3.4	3.2	3.4	3.4	3.3	2.3	3.4	4.3	15.5	3.2	4.8	0.0	15.8	12.6	5.0	6.4	15.4	11.9	9.3	8.8	5.8	7.2	10.3	3.7	12.5	7.3	24.0	3.9	1.9	7.4	11.8	8.9	11.8	9.4	7.2	23.1	0.0	5.7	11.7	9.6	4.6	8.3	13.3	12.1	6.8	3.7	7.2	25.2	0.0	6.4	12.2	5.4	9.3	6.4	9.9	10.4	12.4	0.0	7.9	6.5	16.5	0.0	0.0	5.3	1.8	8.6	22.5	5.1	5.8	2.6	5.4	12.5	0.0	12.3	17.7	34.4	25.3	10.5	7.7	5.1	26.5	10.1	5.8	3.0
HAUS4	"C14orf94, FLJ20424"	ENSG00000092036	"HAUS augmin like complex subunit 4"	Q9H6D7	14	22946228-22957161	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029803	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"			"HPA029803: AB_10601428"	"unprognostic (8.47e-3)"	"unprognostic (3.52e-1)"	"unprognostic (6.47e-2)"	"unprognostic (7.59e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.32e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.87e-2)"	"unprognostic (7.70e-2)"	"unprognostic (8.66e-2)"	"unprognostic (3.00e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (2.24e-4)"	29.3	24.8	12.8	29.2	13.8	63.5	39.7	12.9	15.6	33.7	14.4	32.3	28.1	26.2	22.2	30.5	31.0	26.4	26.5	11.8	13.6	26.0	32.2	31.7	40.7	15.2	14.2	52.8	45.2	27.6	14.5	22.4	15.0	26.1	30.2	10.4	33.2	26.4	19.1	39.3	30.6	24.3	13.9	37.7	32.0	12.9	13.8	30.8	27.7	22.9	36.7	29.0	31.7	15.6	77.0	51.2	55.5	56.9	42.0	50.4	86.6	36.5	48.2	39.3	56.1	37.0	88.5	146.2	17.2	22.3	29.2	75.5	31.2	44.9	34.5	39.8	23.0	48.1	35.8	90.2	37.7	63.3	77.8	35.7	84.7	17.5	50.9	48.2	71.1	82.0	35.8	71.2	41.6	58.1	69.8	56.7	29.9	59.3	50.9	66.3	68.8	57.0	35.2	40.7	22.5	37.1	52.7	54.0	34.0	24.1	47.8	50.2	39.3	36.2	46.3	26.3	33.6	74.6	67.9	67.1	16.7	70.6	20.9	8.7	79.5	17.7	15.7	54.1	20.8	38.2	29.1	22.2	101.3	33.0	40.2	32.0	100.8	23.7	34.7	28.5	43.2	46.0	12.8	13.8	12.9	15.6	11.8	13.6	15.2	14.2	15.0	13.9	13.8	15.6	4.9	22.4	6.8	16.0	13.4	12.4	5.9	8.7	29.6	1.0	13.7	11.0	1.3	11.5	7.5	1.8	0.0	12.4	3.4	9.6	5.9	17.6	0.6	2.3	3.9	7.5	7.8	42.2	3.7	27.3	13.8	8.3	16.3	3.7	3.8	4.9	8.9	4.4	17.3	0.0	6.1	20.9	2.0	29.1	13.0	0.5	5.6	17.3	5.4	15.9	33.4	6.2	3.1	7.5	8.9	18.4	18.7	4.1	21.5	3.4	26.3	8.0	9.6	0.5	0.0	3.3	6.2	3.1	6.1	32.0	11.1	8.2	10.9	1.2	35.2	5.9
HAUS5	"dgt5, KIAA0841"	ENSG00000249115	"HAUS augmin like complex subunit 5"	O94927	19	35612735-35625355	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 55.4;Spermatogonia: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067250	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA067250: AB_2685812"	"unprognostic (9.24e-3)"	"prognostic favorable (7.68e-4)"	"unprognostic (4.18e-2)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.24e-3)"	"prognostic unfavorable (2.77e-6)"	"unprognostic (2.64e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (4.15e-8)"	"unprognostic (2.09e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.22e-1)"	4.0	5.1	6.2	3.9	6.3	5.6	4.8	7.2	10.7	7.7	6.0	3.6	1.6	5.2	2.2	6.5	6.1	1.6	4.0	6.1	6.1	5.7	5.1	3.8	6.0	6.4	6.2	10.4	6.2	1.8	5.0	1.8	6.5	4.7	2.2	4.0	4.4	1.2	7.5	5.3	5.3	2.5	6.2	7.7	4.2	10.9	6.2	4.1	4.7	1.2	4.9	4.2	5.5	7.0	6.7	5.1	14.0	5.2	1.9	2.9	1.6	7.0	2.1	4.4	6.0	3.4	5.1	14.1	6.1	2.5	2.8	4.1	9.1	4.2	9.8	10.3	7.8	16.2	7.7	3.2	1.9	12.5	3.4	2.9	2.4	3.2	5.0	4.1	3.9	14.2	9.0	12.1	5.3	6.0	16.9	5.2	3.7	8.1	5.9	12.3	12.6	6.5	3.6	4.2	4.3	3.4	6.6	5.7	4.2	8.7	7.3	10.3	3.7	3.2	9.1	5.0	5.4	6.5	5.3	13.5	4.8	10.5	4.1	0.8	0.8	0.2	3.1	1.8	3.0	3.4	2.9	2.2	1.9	2.3	3.0	2.5	0.4	4.2	1.0	1.5	2.3	1.1	6.2	6.3	7.2	10.7	6.1	6.1	6.4	6.2	6.5	6.2	6.2	7.0	5.8	0.0	5.6	8.5	10.3	6.0	5.7	5.0	9.6	5.4	6.2	6.6	4.1	7.2	2.8	14.7	8.4	10.9	6.5	3.5	3.9	4.2	15.1	6.2	5.9	5.8	2.4	10.1	3.3	3.5	10.8	6.2	6.1	4.5	7.0	12.2	5.7	3.9	4.7	3.3	6.3	2.9	2.0	0.6	7.0	7.9	5.3	3.9	5.4	1.9	2.5	3.7	6.2	5.0	9.5	4.2	2.1	6.8	11.2	2.2	0.6	1.3	13.1	4.3	0.0	5.1	5.8	55.4	30.3	7.2	5.7	7.3	7.8	4.3	4.8	3.7
HAUS8	"HICE1, MGC20533, NY-SAR-48"	ENSG00000131351	"HAUS augmin like complex subunit 8"	Q9BT25	19	17049729-17075625	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 40.4;Spermatogonia: 47.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039406	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA039406: AB_10794090"	"unprognostic (1.14e-1)"	"prognostic favorable (9.54e-4)"	"unprognostic (8.73e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.34e-2)"	"unprognostic (8.35e-13)"	"unprognostic (7.46e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.17e-3)"	3.5	4.6	1.1	7.5	1.1	11.5	3.3	1.6	1.4	2.0	0.9	5.6	5.1	2.8	2.5	3.0	2.2	2.7	2.9	1.1	1.3	2.1	4.6	3.1	14.6	1.3	1.2	2.5	1.9	2.5	1.8	5.4	1.2	2.3	5.0	1.0	2.7	2.7	3.4	3.8	4.6	2.8	1.0	6.9	3.6	10.7	1.3	9.5	2.4	2.6	14.3	3.5	1.9	1.3	29.8	19.2	28.5	29.5	5.2	5.0	58.1	29.5	14.7	44.4	44.0	29.9	19.0	59.8	29.7	12.9	12.7	28.3	29.2	14.7	33.4	34.6	32.6	37.3	20.1	20.7	2.9	24.9	34.2	1.5	3.9	27.8	9.2	4.7	17.8	27.4	31.8	27.5	24.9	37.6	42.2	28.5	29.5	34.0	36.7	38.5	29.8	24.7	10.5	21.2	26.7	16.1	27.8	17.0	15.5	18.2	19.5	21.5	11.2	27.8	18.7	48.6	40.4	14.9	21.3	40.6	15.2	47.5	25.2	0.2	5.1	5.6	5.4	15.0	5.9	12.0	6.4	7.0	3.6	11.0	8.6	5.7	3.3	7.7	14.2	4.4	11.1	5.1	1.1	1.1	1.6	1.4	1.1	1.3	1.3	1.2	1.2	1.0	1.3	1.3	3.2	3.2	2.8	1.0	12.0	6.6	13.5	10.2	6.2	2.9	4.4	5.2	4.5	7.2	5.1	1.8	2.1	25.1	6.2	8.5	5.9	7.2	12.6	3.7	5.9	3.8	0.0	18.1	2.0	7.8	25.4	7.8	1.5	4.6	4.5	7.8	4.6	4.2	12.1	1.7	2.3	7.9	14.2	8.5	12.1	3.2	5.9	12.2	10.6	2.8	6.4	2.6	5.2	2.0	3.2	7.0	3.0	3.8	4.4	5.5	5.3	3.0	3.5	6.3	6.6	4.2	6.1	40.4	47.0	4.7	4.5	9.9	7.5	5.6	6.5	5.1
HDDC3	"MESH1, MGC45386"	ENSG00000184508	"HD domain containing 3"	Q8N4P3	15	90929968-90935196	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040895	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 22: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA040895: AB_10795494"	"unprognostic (1.03e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.65e-1)"	13.0	13.1	15.5	7.9	15.1	10.4	9.2	15.0	20.0	6.5	13.9	11.2	10.3	4.3	8.2	5.9	10.4	4.6	13.3	15.1	14.8	12.1	11.4	6.4	8.2	15.1	14.8	6.5	20.0	15.7	8.0	7.0	14.7	7.0	9.1	7.1	20.7	5.8	13.3	7.7	11.9	3.9	15.3	9.3	9.7	4.5	16.1	7.4	9.8	14.6	9.2	5.5	5.5	15.7	12.7	15.7	5.3	6.4	11.8	11.8	9.0	8.5	11.4	7.7	11.5	7.7	25.5	24.2	8.5	7.0	6.1	19.3	11.1	19.3	6.3	30.4	24.4	30.5	6.0	17.7	23.9	11.6	14.1	10.5	30.1	13.9	24.8	12.2	17.0	19.5	24.6	20.7	6.9	19.1	16.1	10.0	4.3	47.2	15.6	13.2	2.1	38.2	15.8	13.2	13.3	8.5	7.1	19.2	21.4	11.0	29.2	30.5	9.8	4.7	10.5	8.1	10.9	33.5	41.4	16.7	17.5	22.4	14.3	10.1	20.1	8.5	23.3	27.4	30.1	35.1	30.0	26.3	27.4	31.4	34.6	25.5	4.7	31.5	26.7	44.0	31.9	25.6	15.5	15.1	15.0	20.0	15.1	14.8	15.1	14.8	14.7	15.3	16.1	15.7	42.8	28.9	7.4	5.9	23.5	5.6	14.1	22.5	6.8	13.8	27.8	30.1	1.1	44.3	21.6	16.5	4.2	48.2	19.1	18.1	76.3	42.3	4.6	18.8	12.4	19.0	19.9	34.3	4.8	56.5	33.0	12.7	13.7	18.6	7.0	14.3	15.7	41.4	45.9	15.2	5.2	32.9	12.2	15.1	10.9	4.3	14.3	19.6	14.2	1.9	36.3	39.9	34.0	1.0	3.9	28.4	30.2	11.7	31.7	14.7	59.7	71.5	20.6	38.8	6.6	13.2	11.5	29.6	38.4	17.2	8.4	24.2	21.4	21.7	33.0	13.5
HDHD5	CECR5	ENSG00000069998	"Haloacid dehalogenase like hydrolase domain containing 5"	Q9BXW7	22	17137511-17165287	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 43.0;Ductal cells: 35.2;Extravillous trophoblasts: 42.2;Granulosa cells: 37.0;Hofbauer cells: 42.3;Proximal tubular cells: 41.1;Theca cells: 55.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005548	Approved		Approved	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA005548: AB_1078497"	"unprognostic (4.04e-2)"	"unprognostic (5.04e-2)"	"unprognostic (4.54e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.04e-3)"	"unprognostic (7.35e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.98e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.21e-3)"	17.4	29.7	15.0	13.2	15.3	16.5	17.3	15.4	15.7	12.9	16.7	21.5	26.5	14.6	6.8	21.7	13.6	9.8	45.0	15.4	14.8	19.8	40.5	12.6	14.5	15.4	14.9	12.2	20.9	17.5	11.6	8.1	14.6	15.5	14.1	5.7	18.6	10.0	46.9	23.0	17.2	11.4	14.8	19.3	19.9	15.9	15.9	13.6	10.1	55.7	12.0	16.5	14.1	15.0	64.0	41.5	30.5	41.5	17.7	10.8	38.8	17.9	19.6	47.1	50.2	61.1	23.3	103.9	29.3	21.6	23.0	44.0	38.7	42.0	21.8	31.6	56.7	0.0	30.7	0.0	29.4	47.6	23.5	26.1	51.1	21.0	23.1	26.4	33.3	67.4	31.0	26.2	24.9	62.1	84.2	97.2	46.6	97.9	36.7	47.4	45.8	26.3	32.2	34.7	61.4	46.5	34.9	49.9	54.3	23.9	50.1	58.5	29.1	39.7	29.4	28.2	31.3	41.3	48.5	77.8	32.0	0.1	34.2	12.3	86.2	4.7	28.4	56.7	35.6	24.6	26.4	25.8	74.5	23.6	34.3	29.3	4.5	30.7	31.4	30.9	29.7	48.0	15.0	15.3	15.4	15.7	15.4	14.8	15.4	14.9	14.6	14.8	15.9	15.0	21.5	6.4	2.8	0.0	3.6	0.0	0.0	0.0	0.0	0.0	23.9	22.4	0.0	0.0	5.0	5.5	0.0	26.5	9.3	0.0	43.0	35.2	0.0	8.4	14.9	9.2	0.0	0.0	0.0	28.2	42.2	7.7	0.0	11.5	5.1	37.0	0.0	0.0	42.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	5.2	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.5	0.0	0.0	41.1	1.5	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	15.7	3.4	55.8	0.0	0.0
HEATR1	"BAP28, FLJ10359, UTP10"	ENSG00000119285	"HEAT repeat containing 1"	Q9H583	1	236549005-236604516	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046917, HPA062200"	Approved		Enhanced	"Nucleoli fibrillar center,Mitochondria"		NA	NA		470000	"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoli fibrillar center"	Mitochondria	"HPA046917: AB_2679863, HPA062200: AB_2684709"	"unprognostic (2.61e-1)"	"unprognostic (1.44e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.34e-3)"	"unprognostic (7.18e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (5.82e-2)"	"unprognostic (4.15e-2)"	"unprognostic (3.80e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (8.08e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.27e-2)"	"unprognostic (4.00e-2)"	8.5	5.6	3.3	11.1	4.1	12.7	9.8	4.6	4.0	6.8	3.3	6.2	5.6	8.7	6.5	7.3	7.0	5.5	4.4	3.5	3.7	5.4	5.5	5.2	12.9	3.7	3.3	9.4	8.7	7.9	3.4	7.7	3.8	6.2	7.5	4.8	6.2	6.4	6.6	10.4	6.2	8.0	3.7	8.5	6.2	14.4	4.2	10.1	7.9	5.7	13.5	10.8	6.7	6.5	35.2	41.4	21.2	32.3	29.1	32.5	47.4	27.7	17.8	31.2	27.7	41.8	29.0	57.3	30.4	25.8	19.3	41.5	48.7	29.7	42.0	29.0	56.0	40.7	28.3	36.1	26.1	73.5	25.2	26.7	26.2	47.2	40.5	14.9	36.3	25.9	93.8	18.8	31.5	18.8	35.1	20.1	84.9	44.8	16.9	38.6	30.6	53.8	19.9	34.9	19.9	44.1	33.5	23.7	28.3	14.1	28.2	27.2	34.7	31.2	29.5	40.6	69.4	35.4	47.2	65.5	27.8	40.2	47.4	1.6	3.3	1.0	6.0	4.2	5.6	9.1	5.9	6.6	4.0	6.5	8.1	7.8	0.4	5.7	4.2	5.2	5.3	2.3	3.3	4.1	4.6	4.0	3.5	3.7	3.7	3.3	3.8	3.7	4.2	6.5	13.3	3.2	12.8	19.6	21.8	19.8	16.3	8.3	26.2	12.4	9.8	7.6	4.2	7.2	11.7	5.5	18.8	8.1	15.0	3.6	3.9	8.9	10.5	8.4	26.3	12.4	4.2	12.6	35.1	8.5	10.8	15.2	8.6	11.3	32.9	23.4	10.4	9.7	7.5	6.7	30.4	6.2	4.1	11.3	7.5	2.7	14.0	11.7	1.8	26.2	9.6	3.0	9.2	36.2	34.1	12.0	4.3	10.1	19.0	15.7	3.3	5.6	11.5	9.6	0.0	19.4	11.8	29.3	30.1	19.3	16.9	4.9	18.1	15.6	11.1	12.0
HECTD3	FLJ21156	ENSG00000126107	"HECT domain E3 ubiquitin protein ligase 3"	Q5T447	1	45002540-45011324	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 33.7;Proximal enterocytes: 44.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027467	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"			"HPA027467: AB_10600710"	"unprognostic (1.86e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.14e-5)"	"unprognostic (1.74e-2)"	"unprognostic (2.92e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.47e-1)"	"unprognostic (8.39e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.35e-1)"	"prognostic favorable (1.85e-6)"	"unprognostic (3.19e-1)"	22.8	24.5	19.7	12.3	21.2	15.0	20.0	20.9	20.6	17.1	18.7	33.2	47.2	18.1	16.0	26.4	13.8	12.3	17.0	20.4	20.7	19.6	30.5	14.0	16.5	22.2	20.5	19.5	37.0	26.7	11.9	14.2	22.3	14.8	26.2	7.4	34.1	15.6	39.9	27.9	40.4	14.8	19.8	20.1	22.6	13.6	20.9	12.7	17.0	24.0	14.4	20.4	18.9	22.6	22.1	19.8	12.4	20.1	42.5	26.5	24.3	20.6	31.2	22.3	25.2	28.7	6.8	10.3	17.1	34.1	50.0	20.2	29.7	21.5	20.0	19.3	22.8	16.6	28.4	24.9	37.2	13.0	26.8	28.6	36.5	38.4	14.8	23.2	50.4	17.8	38.0	11.3	28.9	18.8	16.6	10.6	17.1	24.9	29.6	19.5	22.7	15.0	33.2	25.7	29.7	12.4	27.9	47.8	25.5	31.1	15.5	12.0	38.0	25.7	20.4	32.2	23.9	14.4	18.3	5.8	41.3	14.0	12.9	10.7	8.0	8.0	7.3	10.9	6.3	6.0	6.1	6.5	7.3	3.3	5.0	6.1	2.8	4.0	6.3	5.5	6.7	6.5	19.7	21.2	20.9	20.6	20.4	20.7	22.2	20.5	22.3	19.8	20.9	22.6	6.9	3.2	8.2	7.2	5.6	3.8	2.2	3.1	8.6	5.2	8.5	6.2	6.0	8.6	5.8	5.5	6.2	7.1	9.2	33.7	1.9	10.3	1.2	4.0	7.5	7.0	2.4	20.6	5.4	15.5	14.2	7.0	21.4	8.1	6.3	6.4	6.4	14.1	13.6	6.7	5.0	15.1	0.0	15.3	2.9	2.3	14.6	7.8	3.6	4.7	10.2	3.1	5.2	2.0	4.7	13.2	28.1	9.8	9.1	2.8	44.8	6.9	1.4	6.2	6.6	4.5	6.7	4.5	7.4	9.7	6.1	6.0	7.1	13.5	14.9	2.3
HELLS	"LSH, Nbla10143, PASG, SMARCA6"	ENSG00000119969	"Helicase, lymphoid specific"	Q9NRZ9	10	94501434-94613905	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	"Developmental protein, Helicase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.3;lymphoid tissue: 15.9"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 182.0;Spermatogonia: 173.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 16.1"	"Region enhanced"	"Detected in many"		"cerebellum: 5.5"	"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 36.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004491, HPA063242"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		No	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB004491: AB_627895, HPA063242: AB_2684968"	"unprognostic (1.94e-1)"	"prognostic favorable (1.36e-4)"	"unprognostic (9.85e-2)"	"unprognostic (3.38e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.76e-5)"	"unprognostic (7.59e-3)"	"unprognostic (7.03e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.05e-2)"	"unprognostic (9.45e-5)"	"unprognostic (9.93e-13)"	"unprognostic (2.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.03e-2)"	1.1	1.2	0.8	6.4	0.3	16.3	3.0	5.5	1.2	3.2	1.3	4.3	2.9	2.9	1.4	5.9	1.7	2.0	0.7	0.4	1.3	2.5	1.8	1.7	12.4	0.8	0.8	2.6	1.2	1.4	3.0	4.1	1.0	2.1	5.1	1.1	1.9	1.0	0.3	5.3	3.9	2.2	0.9	4.3	3.7	12.8	0.9	15.9	1.1	0.2	12.6	3.6	3.2	1.5	57.7	55.4	70.6	90.1	2.9	6.4	37.4	42.9	27.8	34.4	54.6	70.3	45.5	70.0	16.7	15.5	29.1	56.3	40.9	34.9	50.7	68.5	45.5	37.3	56.3	58.0	1.7	71.2	31.6	3.6	2.0	42.1	20.0	9.4	24.0	46.0	20.7	43.5	43.1	54.9	75.2	35.6	73.4	42.3	24.1	70.3	62.1	16.3	24.2	72.2	28.4	22.8	50.3	14.5	7.8	59.0	60.9	23.1	17.2	38.4	19.4	35.4	52.4	22.3	47.6	74.5	19.0	42.8	17.9	0.3	0.7	0.0	7.0	1.5	2.4	18.8	11.4	9.4	2.3	23.2	5.2	7.7	1.0	10.2	1.0	36.8	19.7	2.3	0.8	0.3	5.5	1.2	0.4	1.3	0.8	0.8	1.0	0.9	0.9	1.5	4.7	9.6	3.9	0.0	19.7	21.5	11.5	12.6	13.1	16.4	10.0	15.0	1.0	12.8	12.6	22.0	0.0	46.3	13.2	26.2	3.9	9.0	2.0	9.3	16.4	8.1	10.8	50.5	3.3	6.2	43.4	13.0	17.9	16.3	5.7	60.6	5.7	3.6	15.1	6.7	5.4	17.8	8.2	2.2	10.3	5.3	9.0	7.3	1.8	9.4	5.7	4.3	1.0	4.5	6.6	4.7	1.8	5.7	37.5	3.7	1.7	1.6	6.3	11.4	19.7	10.5	16.4	182.0	173.9	22.9	9.9	11.1	15.7	16.5	30.9	11.7
HERC1	"p532, p619"	ENSG00000103657	"HECT and RLD domain containing E3 ubiquitin protein ligase family member 1"	Q15751	15	63608618-63833948	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Transport, Ubl conjugation pathway"	"Guanine-nucleotide releasing factor, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 458.8;Inhibitory neurons: 338.0;Oligodendrocytes: 201.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049749	Uncertain					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA049749: AB_2680866"	"unprognostic (9.72e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.80e-1)"	"unprognostic (2.35e-1)"	"prognostic favorable (4.87e-5)"	"unprognostic (1.53e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.89e-3)"	"prognostic favorable (3.66e-4)"	"unprognostic (1.24e-1)"	"prognostic favorable (1.36e-6)"	"unprognostic (2.87e-1)"	"unprognostic (3.36e-2)"	"unprognostic (9.04e-3)"	"unprognostic (3.94e-1)"	10.5	7.4	8.6	10.3	10.1	27.4	12.7	14.1	20.3	13.0	5.2	11.8	5.3	10.8	6.5	8.1	7.6	9.6	15.2	9.3	0.0	9.1	9.1	10.6	13.7	1.7	0.3	18.5	8.4	22.7	8.8	10.3	1.8	8.6	9.2	18.3	8.8	10.3	30.4	12.1	9.9	12.4	0.0	15.2	10.2	11.5	0.0	25.6	14.0	29.3	12.8	9.2	7.9	22.7	13.5	17.1	19.1	6.6	33.3	21.1	6.4	10.3	13.4	10.7	12.3	10.9	5.3	19.8	9.3	19.8	9.7	14.5	31.2	9.0	14.6	15.4	9.6	42.5	26.4	7.8	5.3	31.6	25.1	15.3	8.5	15.1	14.5	9.3	22.7	13.3	44.0	8.6	9.4	21.7	11.3	6.5	9.3	10.4	8.7	12.2	20.6	11.6	4.4	32.9	17.0	8.4	18.2	12.5	10.5	23.0	6.1	12.7	23.6	13.6	12.6	11.9	13.6	9.4	17.4	13.3	7.8	23.3	4.9	24.4	3.8	8.7	4.9	3.4	3.7	5.9	5.5	4.6	3.4	9.5	5.5	5.4	13.5	2.9	6.7	7.5	7.8	1.8	8.6	10.1	14.1	20.3	9.3	0.0	1.7	0.3	1.8	0.0	0.0	22.7	66.0	6.4	39.5	113.0	44.2	14.9	10.6	16.1	17.1	65.3	19.7	17.1	64.8	17.2	19.9	22.0	66.7	8.8	66.1	11.4	1.9	11.0	28.7	13.5	24.0	44.5	10.2	47.5	458.8	14.1	15.1	28.5	34.7	17.8	50.6	36.5	47.2	21.0	16.2	85.8	338.0	13.1	10.2	43.2	27.4	14.3	27.7	39.2	19.6	137.7	36.0	29.9	35.0	160.4	201.5	11.7	14.7	39.9	44.9	12.7	12.5	15.7	16.6	55.0	6.6	34.4	36.0	43.5	31.3	17.1	15.3	8.9	61.1	31.9	14.4	12.1
HIBCH		ENSG00000198130	"3-hydroxyisobutyryl-CoA hydrolase"	Q6NVY1	2	190189735-190344193	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Branched-chain amino acid catabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 230.2;Proximal tubular cells: 376.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036540, HPA036541, HPA067080"	Enhanced		Enhanced	Mitochondria		NA	NA		74000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA036540: AB_10673355, HPA036541: AB_2675182, HPA067080: "	"unprognostic (3.60e-3)"	"unprognostic (3.88e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.36e-3)"	"unprognostic (3.38e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.88e-1)"	"prognostic favorable (1.22e-4)"	"unprognostic (7.32e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (1.04e-10)"	"unprognostic (1.34e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.18e-3)"	34.0	60.1	40.6	17.4	49.2	14.5	28.5	40.5	60.3	33.4	51.0	37.5	55.9	28.1	29.1	34.9	22.5	22.3	28.7	40.7	47.7	142.2	129.0	13.9	20.5	43.9	43.1	18.6	27.2	58.2	19.1	18.6	44.9	25.5	40.9	38.4	20.9	23.2	49.2	58.7	33.9	18.3	45.0	17.8	25.6	21.7	43.3	16.8	31.7	38.5	21.9	23.7	26.6	72.6	23.5	16.1	37.0	23.8	29.9	27.6	16.9	23.1	11.4	20.8	22.1	46.8	20.2	33.3	36.1	18.1	17.0	44.4	33.2	30.7	29.5	47.0	25.1	44.5	37.7	41.4	10.7	31.8	16.7	19.8	17.8	24.3	4.8	32.3	31.6	30.4	55.2	30.3	20.8	18.2	34.3	33.6	11.1	30.2	30.2	42.4	24.8	83.8	43.8	68.4	27.9	24.0	18.0	27.2	66.8	47.2	32.0	21.3	26.5	22.8	20.8	16.1	15.8	18.7	45.2	30.9	20.7	27.4	18.6	27.8	11.9	26.4	19.5	14.2	21.3	43.5	21.8	21.0	20.9	34.7	22.9	29.6	6.0	32.0	11.3	26.7	37.0	12.7	40.6	49.2	40.5	60.3	40.7	47.7	43.9	43.1	44.9	45.0	43.3	72.6	23.3	22.4	25.8	129.3	29.8	56.0	131.4	74.9	34.1	35.3	39.1	24.1	28.6	42.9	51.3	36.8	102.2	53.6	18.8	53.5	115.4	27.4	230.2	48.0	21.4	33.3	37.8	13.0	46.4	29.4	22.3	27.7	29.6	39.3	10.2	41.1	89.3	117.4	35.3	25.2	51.5	31.4	71.2	15.7	11.7	62.9	34.8	15.9	46.2	52.5	14.1	35.5	39.1	104.0	141.1	15.6	26.6	45.5	23.3	27.9	32.4	376.2	47.6	50.5	39.5	29.9	26.2	18.0	29.4	45.5	40.6	20.0	30.7	61.7	62.7	67.8
HIF1AN	"DKFZp762F1811, FIH1, FLJ20615, FLJ22027"	ENSG00000166135	"Hypoxia inducible factor 1 subunit alpha inhibitor"	Q9NWT6	10	100529072-100559998	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 41.6;tongue: 40.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048742, HPA065302, CAB069903"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB069903: AB_10000508, HPA048742: AB_2680507, HPA065302: AB_2685458"	"unprognostic (4.07e-2)"	"unprognostic (7.75e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.07e-3)"	"unprognostic (8.82e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.24e-2)"	6.5	8.1	6.9	7.8	6.5	6.2	6.5	6.1	7.3	6.2	5.7	7.5	7.2	7.3	7.2	7.5	6.8	6.3	12.3	6.6	6.0	7.5	5.4	5.7	7.8	6.7	7.5	10.3	8.1	12.1	6.5	6.0	6.5	7.5	6.6	9.8	6.5	8.3	41.6	10.1	7.2	7.4	6.0	6.8	6.5	13.9	7.0	9.3	5.5	40.8	9.6	7.1	5.4	6.5	13.8	14.4	19.0	19.1	28.8	11.9	16.3	14.4	34.4	20.9	24.5	22.3	11.5	14.8	12.8	21.7	15.4	15.9	16.9	13.0	22.6	16.5	10.2	14.2	12.8	17.2	14.9	17.1	17.9	11.7	12.9	20.4	22.2	29.4	11.9	19.5	6.3	8.1	23.9	14.4	18.3	11.2	6.2	11.6	6.9	13.2	23.4	7.2	14.6	18.2	7.2	11.9	12.4	7.6	13.7	15.8	25.7	9.2	10.1	10.6	13.8	10.6	14.7	10.9	11.8	11.1	17.6	13.8	8.1	13.7	7.6	15.3	7.7	10.7	7.7	7.9	8.0	7.3	7.2	6.4	7.6	7.8	8.0	9.1	13.0	2.6	9.8	8.4	6.9	6.5	6.1	7.3	6.6	6.0	6.7	7.5	6.5	6.0	7.0	6.5	7.9	0.0	6.5	11.8	16.7	11.0	11.5	16.4	13.1	17.9	12.3	8.9	40.7	14.3	11.7	11.0	16.7	27.8	16.5	15.5	9.8	17.3	21.5	9.0	11.3	12.1	13.2	16.0	12.2	13.9	17.6	10.9	11.2	8.7	6.3	20.0	8.2	10.9	14.3	25.2	11.2	12.0	8.2	18.5	6.8	49.3	11.1	10.1	3.6	11.2	23.4	15.0	27.8	11.1	12.8	17.7	11.3	12.0	11.2	11.4	20.1	20.5	11.6	23.1	6.6	12.0	16.1	48.2	26.6	11.4	11.6	32.7	14.0	14.8	13.3	10.3
HJURP	"DKFZp762E1312, FAKTS, hFLEG1, URLC9"	ENSG00000123485	"Holliday junction recognition protein"	Q8NCD3	2	233833416-233854566	"Predicted intracellular proteins"	"Cell cycle"	"Chaperone, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.4;lymphoid tissue: 30.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 17.4;Erythroid cells: 38.3;Extravillous trophoblasts: 16.1;Granulosa cells: 14.8;Spermatocytes: 37.5;Spermatogonia: 16.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.2"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA008436, HPA027261"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitochondria"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli, Nucleoli rim"	Mitochondria	"HPA008436: AB_1850757, HPA027261: AB_2672184"	"unprognostic (5.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (3.37e-5)"	"prognostic unfavorable (2.46e-4)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (7.72e-5)"	"unprognostic (7.60e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.42e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.74e-2)"	0.6	0.6	0.0	5.5	0.1	47.4	1.1	0.1	0.2	0.8	0.1	3.9	4.1	0.9	0.2	5.6	0.3	0.5	0.3	0.1	0.1	0.4	0.8	1.4	12.6	0.1	0.3	0.2	0.2	0.1	0.1	3.0	0.1	0.4	5.2	0.1	1.0	0.1	0.2	3.6	3.8	1.9	0.0	4.1	2.4	11.1	0.3	30.4	0.3	0.0	12.0	1.4	2.0	0.2	54.5	73.6	68.4	32.7	2.6	5.4	42.8	79.5	37.9	55.2	59.9	51.3	57.6	17.1	9.0	31.4	98.0	61.7	54.9	40.9	72.6	40.0	21.6	65.5	61.4	50.9	0.3	54.1	43.2	1.8	1.5	45.1	30.9	15.7	35.5	51.3	56.6	40.8	103.0	55.3	76.4	59.7	58.9	42.2	49.1	58.4	103.0	30.3	28.6	32.3	39.4	24.7	45.8	34.2	31.7	31.0	25.7	42.1	26.0	59.6	64.6	44.3	87.2	38.6	32.7	67.9	35.7	39.3	151.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.4	0.0	1.2	0.4	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.1	0.0	0.3	0.2	0.2	0.0	0.5	0.0	2.9	1.3	0.5	1.9	0.0	0.0	0.7	0.5	1.2	0.0	2.1	0.0	0.0	8.2	0.5	5.6	0.0	0.2	17.4	0.3	1.3	1.1	0.0	38.3	0.0	0.0	16.1	2.0	5.1	1.3	0.0	14.8	2.2	0.3	7.1	0.0	0.0	3.5	0.0	3.0	2.9	9.0	0.6	3.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	11.4	1.0	0.5	0.1	0.1	0.0	0.0	0.1	1.9	37.5	16.3	8.9	0.9	1.5	2.3	0.3	7.6	0.9
HMGN1	"FLJ27265, FLJ31471, HMG14, MGC104230, MGC117425"	ENSG00000205581	"High mobility group nucleosome binding domain 1"	P05114	21	39342315-39349647	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012260, HPA048694"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"CAB012260: AB_304786, HPA048694: AB_2680496"	"unprognostic (4.49e-2)"	"unprognostic (5.52e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.21e-3)"	"unprognostic (8.50e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.46e-3)"	"unprognostic (5.68e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.24e-2)"	"prognostic unfavorable (8.74e-7)"	"unprognostic (3.20e-1)"	"unprognostic (3.72e-2)"	"unprognostic (3.84e-2)"	"unprognostic (8.98e-3)"	56.1	73.7	54.1	120.5	52.3	202.4	121.4	52.0	63.7	115.8	54.6	126.0	121.3	78.8	187.6	124.8	100.2	72.9	39.1	53.3	58.7	114.4	100.8	72.5	219.1	57.1	57.5	72.9	92.2	132.1	73.8	111.6	55.7	93.2	136.2	245.5	97.1	75.2	16.2	82.5	133.6	65.3	57.2	100.9	113.2	64.8	56.4	238.7	117.2	26.3	294.9	114.2	73.8	58.5	517.7	135.9	450.3	316.3	74.5	131.1	299.7	266.6	191.8	261.0	233.0	262.6	420.6	1161.6	246.8	223.7	309.8	106.5	317.4	377.9	336.1	459.5	317.7	883.6	225.7	355.8	187.0	768.2	291.3	167.4	349.9	260.2	350.6	222.4	363.6	513.6	680.2	191.6	436.7	686.7	780.2	691.0	798.0	682.3	237.8	853.2	224.7	466.0	469.5	308.3	386.3	362.2	582.8	364.1	356.0	183.1	479.5	807.5	239.6	127.2	128.7	94.0	279.7	235.6	394.8	690.7	179.4	882.9	341.4	103.7	76.4	282.5	138.0	68.9	153.5	228.9	175.2	143.7	216.5	205.8	195.2	172.2	53.8	174.5	67.7	294.9	221.5	231.4	54.1	52.3	52.0	63.7	53.3	58.7	57.1	57.5	55.7	57.2	56.4	58.5	169.9	93.0	139.7	55.2	420.4	278.5	532.0	674.9	233.9	265.1	650.7	412.6	56.1	307.4	349.0	285.1	331.5	599.2	405.1	306.8	737.6	479.9	642.8	304.4	287.3	223.3	345.2	275.6	34.9	350.5	970.7	196.6	221.7	309.2	219.9	277.8	135.7	176.2	533.9	240.6	55.1	442.1	514.7	176.1	389.6	180.6	175.8	279.6	243.7	45.0	415.1	427.8	358.4	96.5	68.8	381.0	307.4	200.1	335.9	684.7	327.8	625.4	226.8	1301.8	32.9	122.0	179.5	81.9	149.1	399.7	313.7	602.1	326.1	289.2	537.1	699.9
HMGXB4	"HMG2L1, THC211630"	ENSG00000100281	"HMG-box containing 4"	Q9UGU5	22	35257452-35295807	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Wnt signaling pathway"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000725, HPA076681"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA000725: AB_1079073, HPA076681: "	"unprognostic (2.22e-1)"	"unprognostic (1.12e-1)"	"prognostic favorable (3.24e-5)"	"unprognostic (4.81e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (4.79e-4)"	"unprognostic (2.85e-2)"	"unprognostic (8.25e-3)"	"unprognostic (6.67e-3)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.62e-1)"	"unprognostic (8.71e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.54e-2)"	7.9	4.7	5.1	7.8	6.5	23.4	8.1	6.5	7.2	6.7	3.7	6.6	6.4	11.6	3.7	8.6	7.6	7.0	6.5	5.3	5.8	4.1	5.1	5.6	7.5	5.9	5.3	14.0	7.0	8.2	2.2	9.0	5.8	7.4	7.4	8.5	6.7	6.2	7.2	6.7	6.7	9.5	4.9	6.3	5.0	7.9	6.1	11.3	6.7	7.2	7.7	8.6	5.3	8.2	22.6	4.9	37.6	17.6	9.3	16.4	9.9	22.3	31.6	22.1	20.1	4.3	8.9	27.5	10.2	23.3	13.4	13.0	14.9	18.3	26.2	23.3	18.6	24.6	6.5	5.3	11.2	56.8	25.1	15.8	14.0	18.5	14.2	13.3	16.8	21.0	19.7	21.6	17.1	11.0	35.1	15.1	15.7	15.6	14.2	25.3	32.5	10.7	13.8	17.5	22.1	23.0	19.6	15.6	16.5	10.6	9.6	16.1	13.3	20.1	41.9	24.1	19.5	26.1	25.5	34.8	17.1	15.9	31.7	34.5	12.5	16.9	13.4	14.8	11.7	10.4	13.1	14.3	9.8	13.3	8.4	9.6	19.0	9.6	13.8	10.8	12.1	5.9	5.1	6.5	6.5	7.2	5.3	5.8	5.9	5.3	5.8	4.9	6.1	8.2	30.6	12.8	18.5	18.3	30.9	20.9	52.3	33.3	16.5	60.6	26.0	25.1	14.4	34.3	29.7	27.6	35.5	48.0	30.1	31.5	29.4	40.4	14.7	22.2	35.5	32.4	16.9	56.6	17.7	29.3	54.5	34.8	27.5	31.9	52.1	51.9	36.8	24.1	31.8	67.3	20.5	31.9	28.5	26.4	17.6	12.7	53.7	29.1	8.8	7.5	32.1	21.0	34.0	17.1	31.5	35.3	27.4	56.8	21.2	58.1	26.4	21.0	15.6	73.5	39.5	46.4	32.9	67.0	82.9	28.0	22.6	64.7	30.4	33.1	32.3	57.8
HMMR	"CD168, RHAMM"	ENSG00000072571	"Hyaluronan mediated motility receptor"	O75330	5	163460203-163491941	"CD markers, FDA approved drug targets, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 20.6;lymphoid tissue: 27.3;testis: 27.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 86.2;Erythroid cells: 133.3;Extravillous trophoblasts: 55.1;Late spermatids: 60.9;Spermatocytes: 100.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.5"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB002433, HPA040025, HPA043926, HPA061524"	Enhanced		Enhanced	Microtubules,Centrosome,Cytosol		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Microtubules	"Centrosome, Cytosol"	"CAB002433: AB_564080, HPA040025: AB_2676805, HPA043926: , HPA061524: AB_2684551"	"unprognostic (3.53e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.38e-3)"	"unprognostic (8.88e-3)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (5.52e-4)"	"prognostic unfavorable (1.93e-7)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (5.68e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (3.71e-5)"	"unprognostic (1.02e-1)"	"unprognostic (0.00e+0)"	"unprognostic (1.65e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.77e-2)"	0.8	0.7	0.2	10.1	0.3	20.6	2.1	0.3	0.4	1.1	0.1	6.6	7.4	0.8	0.2	4.0	0.5	0.9	0.8	0.2	0.2	0.7	1.7	0.9	18.1	0.5	0.3	0.2	0.3	0.9	0.2	6.2	0.4	0.5	8.8	0.8	0.8	0.2	1.2	4.2	6.5	2.9	0.3	2.9	3.6	27.5	0.7	27.3	0.7	0.4	17.7	2.2	1.4	0.5	77.0	47.2	94.5	50.8	5.0	9.0	70.3	71.4	34.9	88.0	78.9	96.8	145.1	127.5	66.0	22.2	118.5	86.3	112.4	69.0	148.6	116.1	34.4	76.7	32.3	48.4	1.4	68.7	67.3	2.4	4.1	82.8	64.0	14.7	50.6	85.7	73.2	101.0	93.2	28.5	72.3	38.8	81.9	51.2	51.6	78.0	126.3	63.9	34.8	20.4	78.8	43.8	106.3	32.8	38.6	45.1	97.3	54.5	32.9	63.2	52.4	50.6	97.2	53.7	96.3	102.4	41.4	104.2	61.1	0.2	0.2	0.0	0.1	0.1	0.3	0.3	0.3	0.1	0.2	0.2	0.1	0.2	0.1	0.5	0.0	0.6	1.5	0.2	0.2	0.3	0.3	0.4	0.2	0.2	0.5	0.3	0.4	0.3	0.7	0.5	0.4	0.0	1.1	1.3	6.0	2.5	1.8	4.5	2.8	0.6	3.2	3.7	2.5	4.3	3.2	0.0	0.0	37.3	2.3	5.3	0.0	0.8	86.2	3.8	3.1	3.1	1.2	133.3	0.6	0.2	55.1	4.6	11.7	5.7	0.0	21.6	5.3	3.8	22.2	0.0	0.4	7.8	6.1	8.8	2.7	60.9	2.1	7.6	0.0	0.0	2.3	0.1	1.0	0.5	1.2	0.2	0.3	0.7	22.9	1.5	1.3	2.6	2.8	1.0	6.6	0.6	3.8	100.9	23.3	14.1	1.4	4.5	5.2	1.6	15.6	3.0
HNRNPA1	"ALS20, hnRNP-A1, HNRPA1"	ENSG00000135486	"Heterogeneous nuclear ribonucleoprotein A1"	P09651	12	54280193-54287088	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transport"	"Ribonucleoprotein, RNA-binding"	"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001609, HPA001666, HPA005812, HPA007185, CAB010894"	Supported		Enhanced	Nucleoplasm		NA	NA		9300000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"CAB010894: AB_261962, HPA001609: AB_2666383, HPA001666: AB_1850836, HPA005812: AB_2667441, HPA007185: AB_2667768"	"unprognostic (1.38e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.51e-2)"	"unprognostic (6.88e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.54e-3)"	531.6	410.2	339.5	528.1	362.6	1087.9	640.6	348.2	424.9	750.3	326.5	542.3	447.5	625.3	474.8	510.3	589.2	214.7	391.4	320.7	363.0	501.4	277.0	380.6	685.7	363.3	348.2	1410.2	556.7	359.8	327.2	447.9	364.8	458.9	445.9	261.2	398.9	409.6	437.4	506.3	436.4	382.1	380.9	434.1	431.0	168.9	343.9	1010.9	396.3	174.4	824.8	513.7	580.9	372.6	1246.7	815.8	2072.5	1717.3	550.5	1057.0	1204.0	911.9	1405.6	1311.7	1153.1	1225.4	1306.6	3183.8	983.8	671.8	354.7	1045.9	1486.5	1393.4	1425.5	1216.4	1041.7	1700.0	1156.1	2250.0	320.4	2712.4	1078.2	845.2	568.3	642.9	1056.1	868.7	1408.6	1474.7	1930.7	1215.3	968.2	1244.6	2969.1	2880.9	2571.8	844.0	675.9	2911.7	1588.9	1574.1	1239.4	1395.0	1260.4	1739.0	758.0	1675.2	1392.3	1031.6	1010.9	1744.5	1063.1	781.6	1164.2	820.6	1395.1	1185.7	1349.3	2249.7	572.5	1646.7	744.0	140.4	423.5	165.9	572.8	513.1	893.3	576.5	746.2	657.5	704.5	501.8	851.2	810.1	41.0	823.3	437.7	556.5	683.4	1333.2	339.5	362.6	348.2	424.9	320.7	363.0	363.3	348.2	364.8	380.9	343.9	372.6	372.4	304.5	521.4	20.9	1018.9	1416.1	1039.8	1252.9	900.9	254.1	745.1	541.3	166.2	697.7	612.0	294.3	93.8	2076.2	900.8	407.3	739.6	1296.2	181.5	304.7	706.7	624.8	824.0	1032.4	16.5	2124.2	2894.5	600.5	458.7	400.7	528.9	790.7	562.2	183.1	1006.9	109.4	18.3	1130.9	459.8	863.9	1048.2	115.6	1050.7	609.2	588.7	21.5	1374.4	411.0	1304.9	23.1	34.1	1162.7	731.2	741.8	702.2	696.8	693.2	838.6	288.3	195.2	453.6	714.5	704.1	217.0	338.1	1030.6	1261.9	2178.8	958.6	690.9	1543.8	897.8
HNRNPC	HNRPC	ENSG00000092199	"Heterogeneous nuclear ribonucleoprotein C"	P07910	14	21209136-21269494	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005223, HPA051075, CAB075755, CAB075756"	Supported		Enhanced	Nucleoplasm		NA	NA		1200000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB005223: AB_2117508, CAB075755: AB_2665761, CAB075756: AB_2665762, HPA051075: AB_2681335"	"unprognostic (1.92e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.21e-3)"	"prognostic unfavorable (7.72e-5)"	"unprognostic (8.66e-3)"	"unprognostic (5.96e-3)"	"prognostic favorable (1.19e-4)"	"unprognostic (3.31e-3)"	"unprognostic (5.30e-3)"	"prognostic unfavorable (7.29e-5)"	"unprognostic (7.36e-2)"	"unprognostic (3.73e-3)"	"unprognostic (2.28e-3)"	"unprognostic (5.42e-2)"	286.9	309.2	274.1	319.5	290.1	540.3	328.5	283.9	332.6	307.8	248.8	266.7	232.3	318.9	311.9	318.3	328.5	246.4	269.5	275.3	289.2	372.9	334.4	251.8	497.7	287.2	275.4	427.3	237.7	257.8	237.7	342.0	299.0	249.6	290.9	407.3	225.9	247.9	288.2	260.1	255.2	265.9	295.2	306.5	232.3	193.7	276.6	557.8	259.2	244.0	496.0	374.6	278.6	327.1	1076.2	832.7	1277.7	748.5	754.8	704.7	910.2	673.2	764.3	1034.3	900.6	799.4	787.6	1935.6	414.1	772.1	656.8	775.6	1611.4	1035.4	1389.0	1236.1	918.1	992.8	614.2	1241.4	920.6	1495.2	762.6	731.8	854.2	756.5	1781.1	897.8	1078.4	957.7	1483.6	787.1	829.5	1020.0	1713.7	1435.2	1351.4	990.3	770.1	1375.0	1073.9	925.3	1159.7	956.9	699.0	665.5	838.5	760.9	786.4	1057.3	725.2	1332.6	783.1	388.9	698.2	473.8	972.8	708.8	1144.4	1873.6	370.6	1215.3	794.1	480.2	515.1	516.9	419.0	450.9	544.5	531.4	494.0	451.2	716.3	467.0	552.1	478.2	810.8	471.0	439.4	460.5	575.7	1220.5	274.1	290.1	283.9	332.6	275.3	289.2	287.2	275.4	299.0	295.2	276.6	327.1	172.7	153.8	233.9	69.5	307.2	536.2	583.9	512.2	331.8	169.8	259.9	191.5	137.9	173.0	393.2	275.8	198.1	612.6	309.4	134.0	283.7	315.0	169.0	365.1	352.2	257.5	224.0	389.9	74.3	216.6	746.8	287.1	197.2	555.6	415.9	281.3	174.2	233.9	388.5	116.1	79.2	276.0	260.4	293.8	500.1	76.5	270.0	325.7	208.1	99.3	341.9	157.9	227.6	97.5	112.2	210.7	151.1	230.9	293.6	531.5	135.0	370.8	381.9	296.1	151.2	285.1	282.6	391.5	249.0	315.5	539.9	874.9	339.1	311.8	318.0	590.3
HNRNPD	"AUF1, HNRPD"	ENSG00000138668	"Heterogeneous nuclear ribonucleoprotein D"	Q14103	4	82352498-82374503	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004911	Supported		Enhanced	Nucleoplasm		NA	NA		1100000	"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA004911: AB_1078250"	"unprognostic (9.60e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.75e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.31e-2)"	147.4	114.7	61.9	207.3	61.6	377.7	155.5	83.7	89.1	167.3	68.4	153.6	169.8	176.6	137.1	155.5	152.0	98.7	122.7	60.7	81.0	144.2	140.6	129.0	290.2	61.0	61.7	180.6	146.7	134.1	117.0	167.8	59.2	138.6	164.4	188.1	147.1	125.4	169.7	151.8	177.2	140.1	54.1	184.6	164.6	97.7	61.6	335.1	122.8	103.4	310.7	159.8	145.7	69.2	661.7	257.5	1073.5	344.2	138.9	179.1	508.9	506.2	384.6	566.7	484.9	461.1	565.7	1332.6	357.1	343.3	301.9	318.2	863.8	376.6	883.9	250.1	450.8	957.4	345.2	630.7	282.1	1283.9	475.2	221.0	164.7	459.6	459.5	290.2	521.2	637.3	1076.0	446.6	487.7	254.3	1569.2	887.2	897.8	487.2	236.1	1149.2	1089.0	556.7	478.0	394.8	540.9	583.3	496.5	426.0	262.2	497.0	319.7	504.9	443.7	435.3	595.3	339.7	661.7	472.5	403.1	1516.3	334.6	651.6	508.9	26.1	11.3	12.4	13.3	12.5	15.1	20.3	16.2	17.0	13.5	13.9	17.5	14.6	13.6	14.1	14.1	23.6	19.7	7.2	61.9	61.6	83.7	89.1	60.7	81.0	61.0	61.7	59.2	54.1	61.6	69.2	152.4	102.5	143.5	63.6	128.0	261.3	227.8	139.0	111.0	128.4	124.6	121.9	202.6	125.8	149.0	112.2	62.6	299.7	163.4	71.6	70.5	204.3	35.3	136.2	218.9	162.3	146.6	182.6	65.3	210.6	355.2	134.7	98.4	204.5	92.3	191.5	114.9	114.4	156.6	107.7	72.9	158.9	85.5	125.6	172.7	21.8	124.8	134.5	90.7	63.7	169.3	187.8	130.7	84.9	105.8	157.4	56.7	102.3	151.0	208.3	91.3	80.9	115.7	118.8	111.7	185.5	154.5	106.7	133.7	147.0	229.7	272.0	133.6	149.1	169.3	228.8
HNRNPDL	"HNRPDL, JKTBP, laAUF1, LGMD1G"	ENSG00000152795	"Heterogeneous nuclear ribonucleoprotein D like"	O14979	4	82422565-82430462	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056820, HPA063147"	Supported		Enhanced	Nucleoplasm		NA	NA		330000	"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA056820: AB_2683246, HPA063147: AB_2684950"	"unprognostic (1.41e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.30e-3)"	"unprognostic (7.19e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.46e-1)"	"unprognostic (5.56e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.03e-2)"	267.9	192.7	133.9	221.1	162.3	404.9	259.1	143.9	214.8	288.6	126.4	296.5	151.4	283.6	157.2	209.6	275.4	147.3	229.0	137.8	162.8	220.1	181.2	292.4	247.8	161.6	155.2	368.8	248.8	111.9	231.2	161.5	163.9	218.2	153.2	210.6	200.3	155.8	395.5	232.4	246.1	205.0	140.4	243.2	233.4	119.5	153.1	199.1	245.4	168.8	188.5	233.3	266.4	197.4	405.2	208.8	762.2	151.9	282.0	152.2	249.8	426.5	460.4	371.3	351.5	289.2	324.8	745.8	263.5	467.3	191.2	306.5	582.9	395.3	433.5	165.3	421.1	432.9	354.2	524.9	133.0	745.8	309.1	271.1	112.3	417.2	370.3	294.6	299.6	467.5	572.4	300.4	365.7	169.3	701.6	519.6	526.6	363.9	244.4	624.1	615.1	342.2	437.2	259.4	322.5	556.0	265.6	339.6	262.3	344.7	354.3	418.2	253.4	371.2	462.1	246.3	519.7	351.6	363.7	828.3	325.4	428.8	320.2	44.5	36.8	32.3	60.4	59.6	49.9	63.3	54.0	56.7	29.1	61.4	74.6	66.0	15.3	42.9	77.8	46.8	46.0	51.3	133.9	162.3	143.9	214.8	137.8	162.8	161.6	155.2	163.9	140.4	153.1	197.4	314.7	272.4	281.3	104.8	486.6	659.0	612.1	364.2	429.6	223.4	287.0	304.9	201.0	150.2	359.4	152.6	106.3	520.8	472.3	128.1	297.4	338.3	57.7	294.3	410.9	296.7	236.0	260.7	163.9	255.8	629.2	361.5	271.7	432.2	387.7	319.8	127.1	132.7	326.5	176.7	152.9	225.5	240.1	218.2	452.0	50.7	212.5	344.3	311.3	80.6	339.0	303.9	272.9	143.7	298.8	231.5	131.1	202.8	480.6	556.8	173.0	300.2	288.2	188.3	164.3	602.9	397.0	161.8	391.4	433.0	554.2	521.0	488.0	238.7	241.1	478.6
HNRNPH1	"hnRNPH, HNRPH1"	ENSG00000169045	"Heterogeneous nuclear ribonucleoprotein H1"	P31943	5	179614178-179634784	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000914, HPA001359, HPA016884, CAB032820"	Supported		Enhanced	Nucleoplasm		NA	NA		2800000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB032820: AB_2248257, HPA000914: AB_2666143, HPA001359: AB_1079076, HPA016884: AB_1856444"	"unprognostic (9.01e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.45e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (7.85e-4)"	"prognostic unfavorable (3.29e-7)"	"unprognostic (7.99e-2)"	"unprognostic (6.22e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.65e-3)"	"unprognostic (8.64e-3)"	"prognostic unfavorable (3.46e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.72e-3)"	115.8	108.5	83.6	103.2	88.9	242.9	90.4	100.4	99.6	134.4	95.6	109.5	73.3	120.3	67.9	112.7	109.5	71.4	93.0	84.6	88.2	159.3	137.1	102.5	175.0	86.2	86.0	148.4	123.5	99.2	95.5	91.3	86.1	117.5	79.2	162.9	92.5	84.1	142.1	110.5	137.4	102.9	82.8	209.3	105.0	121.2	88.1	210.8	130.8	84.3	166.6	115.6	112.0	88.6	425.0	432.1	496.0	291.0	155.8	135.0	391.5	227.3	188.7	472.0	271.1	519.4	222.0	618.0	205.4	235.2	297.1	227.0	517.8	345.3	552.9	582.8	322.2	335.5	497.3	528.4	196.1	426.0	295.5	104.7	249.1	379.8	230.0	182.6	247.1	293.8	494.4	281.7	279.8	338.5	724.8	371.1	534.9	249.0	226.8	660.7	507.2	368.3	180.4	485.0	431.5	364.3	410.7	232.7	421.8	344.6	275.7	567.1	250.5	415.3	304.2	184.8	556.0	252.0	674.2	723.6	213.0	405.1	501.6	55.7	44.8	46.5	61.4	73.2	82.6	63.4	65.8	66.4	67.9	52.1	81.5	86.8	9.1	62.9	57.6	87.3	83.1	38.9	83.6	88.9	100.4	99.6	84.6	88.2	86.2	86.0	86.1	82.8	88.1	88.6	374.3	115.4	238.0	80.6	263.0	775.3	182.3	89.2	202.1	118.0	332.7	242.1	136.4	165.8	125.5	156.3	131.3	158.3	419.8	183.0	78.2	97.1	151.3	178.7	246.3	237.8	255.2	189.8	81.8	124.1	181.8	241.7	128.0	258.9	247.3	178.6	189.5	225.3	108.2	70.7	85.8	213.7	81.4	186.2	621.4	86.6	111.6	224.0	334.4	104.9	148.3	93.4	110.2	148.8	121.8	105.2	153.0	117.4	269.3	200.4	142.7	75.4	95.9	166.0	184.1	306.3	253.2	189.1	120.6	181.0	718.0	192.5	311.9	87.4	266.4	191.5
HNRNPH3	"2H9, HNRPH3"	ENSG00000096746	"Heterogeneous nuclear ribonucleoprotein H3"	P31942	10	68331174-68343193	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038264			Supported	Nucleoplasm		NA	NA		650000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA038264: AB_10697246"	"unprognostic (1.72e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (6.17e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.81e-3)"	"unprognostic (2.75e-3)"	"unprognostic (7.70e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.06e-3)"	71.8	65.3	80.6	65.7	82.6	101.8	58.8	81.2	96.6	79.4	69.1	74.4	56.4	92.5	44.5	55.1	72.1	44.1	67.2	76.4	82.4	84.2	56.7	63.5	79.1	85.8	83.7	109.7	44.7	54.4	55.0	83.2	87.2	59.9	63.7	81.1	47.7	60.2	92.2	63.2	64.6	68.0	86.4	63.9	59.2	69.1	81.4	98.1	75.1	66.9	78.2	68.6	69.2	87.5	233.2	220.5	343.4	107.6	131.8	81.0	221.6	199.1	104.2	183.2	150.0	379.3	200.7	364.7	106.8	132.5	145.2	151.9	280.2	192.8	280.9	226.4	148.2	282.9	194.1	231.7	115.4	326.9	149.4	53.6	172.7	209.0	368.0	151.0	142.8	191.2	356.8	122.7	205.2	323.6	291.3	350.6	229.2	169.0	258.6	239.6	288.2	119.0	148.3	189.7	155.0	168.5	211.9	144.2	221.7	195.4	153.7	164.5	154.6	170.9	284.8	89.8	273.4	147.6	213.7	368.2	94.1	159.0	135.1	22.7	18.6	37.6	17.0	21.2	18.1	16.2	20.4	20.2	21.6	16.2	25.7	21.6	23.8	22.3	26.0	17.6	20.2	13.4	80.6	82.6	81.2	96.6	76.4	82.4	85.8	83.7	87.2	86.4	81.4	87.5	133.6	102.5	117.3	33.6	111.1	325.8	275.5	99.9	113.3	114.2	83.2	102.6	115.5	64.3	114.5	73.5	95.9	149.6	111.7	71.6	60.7	89.6	29.0	108.2	138.9	125.7	107.7	127.9	39.8	83.8	202.2	143.6	69.3	162.5	141.1	111.5	75.0	39.6	95.5	87.5	41.9	80.2	73.2	69.5	153.2	21.1	96.3	97.1	129.9	50.6	105.7	107.8	75.2	51.8	84.6	76.8	99.7	120.4	97.9	214.3	84.6	72.0	115.2	146.7	131.5	150.0	174.6	277.3	164.5	89.7	266.8	191.8	128.5	90.8	84.4	215.1
HNRNPK	"CSBP, HNRPK, TUNP"	ENSG00000165119	"Heterogeneous nuclear ribonucleoprotein K"	P61978	9	83968083-83980616	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, Ribonucleoprotein, RNA-binding"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004435, HPA007644, CAB016225, HPA044105"	Supported		Enhanced	Nucleoplasm		NA	NA		7100000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB004435: AB_627734, CAB016225: , HPA007644: AB_1079077, HPA044105: AB_2678812"	"unprognostic (4.84e-2)"	"unprognostic (4.69e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.42e-3)"	"unprognostic (2.78e-2)"	"unprognostic (9.83e-3)"	"prognostic unfavorable (6.68e-5)"	"unprognostic (3.46e-3)"	"unprognostic (8.11e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.85e-3)"	"unprognostic (2.81e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.23e-3)"	"unprognostic (6.50e-2)"	"unprognostic (4.59e-1)"	"unprognostic (2.82e-1)"	283.6	308.1	186.1	326.2	197.1	637.3	265.3	202.4	236.6	264.5	227.4	270.2	287.0	297.0	227.3	276.8	269.7	243.8	275.8	188.8	220.3	279.2	346.8	240.4	401.9	203.1	187.8	317.5	247.4	350.8	198.2	325.8	203.0	251.3	277.5	342.2	242.2	251.4	315.3	256.1	282.9	287.6	205.7	298.3	250.1	183.4	194.4	548.5	297.2	312.9	423.7	351.2	230.7	241.0	926.1	624.2	1048.4	625.7	492.2	540.7	840.0	634.1	785.0	778.2	726.4	527.0	641.2	1087.2	425.8	671.1	673.8	689.5	1061.5	772.9	941.8	753.7	624.2	765.1	511.9	754.6	648.7	958.6	726.5	554.6	577.4	665.6	876.1	583.7	806.1	605.5	792.8	541.4	776.4	809.0	1198.4	652.1	934.7	929.3	599.3	1030.2	835.0	727.6	760.3	747.6	677.1	802.6	669.6	703.8	645.5	721.8	698.6	801.6	665.8	537.9	631.7	552.7	844.2	564.7	795.5	784.6	514.3	762.6	779.5	582.0	438.9	559.2	302.2	419.8	378.9	347.8	346.6	348.7	457.5	324.4	354.8	327.2	546.1	477.9	429.1	270.8	457.4	1012.5	186.1	197.1	202.4	236.6	188.8	220.3	203.1	187.8	203.0	205.7	194.4	241.0	354.7	205.1	270.0	58.4	398.4	506.0	540.7	421.5	313.0	180.9	281.6	203.3	195.0	230.2	322.4	263.0	89.6	585.3	379.9	288.1	395.2	448.2	43.4	326.2	329.0	331.7	387.0	447.9	45.9	368.3	738.5	323.4	233.9	384.2	336.8	300.0	260.9	356.6	388.4	156.5	51.2	379.2	307.2	352.9	412.9	45.4	334.6	333.4	327.3	58.1	448.9	362.5	338.8	71.9	116.2	397.0	282.7	321.2	281.0	353.3	260.0	416.7	308.1	182.6	276.1	340.9	479.7	345.9	241.7	309.5	448.7	728.5	368.6	334.9	406.9	453.2
HNRNPL	HNRPL	ENSG00000104824	"Heterogeneous nuclear ribonucleoprotein L"	P14866	19	38836370-38852347	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016326, HPA051748, HPA052661"	Supported		Enhanced	Nucleoplasm		NA	NA		420000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB016326: AB_627736, HPA051748: AB_2681588, HPA052661: AB_2681905"	"unprognostic (5.33e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.67e-3)"	"unprognostic (8.99e-3)"	"unprognostic (4.90e-3)"	"prognostic unfavorable (3.25e-6)"	"unprognostic (1.45e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (9.69e-4)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (1.96e-11)"	"unprognostic (2.17e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.39e-2)"	112.5	108.5	43.8	69.7	46.1	195.1	110.3	49.4	47.4	114.0	42.9	115.2	72.7	119.9	48.0	134.4	97.6	37.4	100.2	41.8	44.5	96.6	98.8	117.7	84.2	47.0	42.9	103.8	87.5	67.7	70.6	57.6	47.5	81.5	76.4	53.2	99.8	45.7	125.7	142.3	113.4	79.9	47.2	113.5	104.3	83.7	46.9	128.8	101.7	57.3	114.5	101.9	111.6	59.4	293.6	214.8	256.4	157.9	94.8	108.7	257.7	233.3	138.9	187.1	177.4	229.9	189.7	436.8	196.2	130.5	152.1	167.0	299.6	228.9	270.7	354.4	231.0	349.9	128.3	205.9	101.2	334.0	228.2	122.7	106.9	187.1	182.1	108.8	209.4	186.7	353.7	200.0	197.6	216.0	347.7	202.9	307.6	186.6	185.6	440.8	296.4	271.7	212.1	203.8	218.6	226.0	225.1	157.7	90.0	172.2	213.4	176.7	207.1	194.9	238.1	184.2	349.4	224.0	312.5	473.1	128.4	293.1	220.0	1.2	1.9	1.2	2.6	3.0	2.0	1.7	2.0	1.7	2.6	2.2	2.0	1.7	1.9	1.8	2.5	5.1	2.6	1.1	43.8	46.1	49.4	47.4	41.8	44.5	47.0	42.9	47.5	47.2	46.9	59.4	62.2	22.4	53.8	40.1	105.1	35.4	52.1	18.0	135.5	76.7	63.6	47.6	22.9	31.5	29.1	22.0	64.6	42.9	100.0	59.0	7.9	37.4	15.9	61.2	64.8	48.7	62.9	83.3	38.0	44.1	35.3	57.0	91.7	88.4	39.3	33.8	43.5	63.0	27.4	33.7	39.0	70.4	12.2	63.7	35.1	11.7	28.3	60.3	26.6	31.9	42.4	39.0	48.4	31.2	56.3	44.1	45.6	22.6	123.0	55.6	55.4	23.9	25.5	78.7	19.7	64.1	59.0	25.5	22.1	117.6	47.5	52.3	95.0	42.4	70.2	41.9
HNRNPM	"CEAR, HNRNPM4, HNRPM, HNRPM4, HTGR1, NAGR1"	ENSG00000099783	"Heterogeneous nuclear ribonucleoprotein M"	P52272	19	8444767-8489114	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016113, HPA024344"	Supported		Enhanced	Nucleoplasm		NA	NA		440000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB016113: AB_627739, HPA024344: AB_1850879"	"unprognostic (2.12e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.52e-3)"	"prognostic unfavorable (1.80e-6)"	"unprognostic (2.44e-1)"	"unprognostic (2.59e-2)"	"unprognostic (6.91e-3)"	"unprognostic (4.70e-3)"	"unprognostic (7.34e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.73e-1)"	97.2	83.9	55.6	126.3	63.0	230.9	94.4	66.0	63.8	104.4	61.4	108.3	98.4	113.8	57.1	126.4	92.5	54.4	89.1	51.6	61.0	92.4	89.4	90.6	141.3	60.7	59.1	121.9	84.1	90.5	71.5	87.5	60.8	76.6	91.9	127.7	93.0	75.4	148.6	106.5	100.8	88.0	57.2	110.5	90.9	78.1	59.8	166.3	93.2	62.1	156.0	93.2	101.5	69.3	477.5	315.7	580.8	236.3	131.4	145.2	373.7	279.3	208.5	340.3	256.9	452.4	141.4	697.4	363.4	254.3	242.4	286.3	603.3	349.4	425.1	437.5	501.0	620.1	312.2	439.8	136.3	640.0	317.4	150.5	173.4	289.2	119.9	100.0	309.7	256.3	632.3	193.6	273.3	324.3	617.2	556.8	505.1	258.2	381.1	687.8	508.1	330.5	179.6	452.9	320.7	356.8	469.5	250.4	278.8	276.8	299.0	378.4	362.9	294.5	357.4	313.6	529.2	285.4	560.8	791.4	221.7	511.4	329.1	21.3	78.4	48.0	91.2	93.4	91.7	69.6	79.0	91.6	86.6	61.4	84.3	83.0	20.0	86.0	71.8	86.3	87.6	94.5	55.6	63.0	66.0	63.8	51.6	61.0	60.7	59.1	60.8	57.2	59.8	69.3	157.1	128.2	189.0	48.6	154.1	166.3	204.8	240.8	105.9	199.6	143.8	125.1	92.1	118.7	240.8	117.7	70.9	272.8	170.3	95.5	97.8	237.4	13.2	150.6	194.7	164.3	190.4	211.5	43.3	273.1	304.4	141.7	76.0	190.2	267.4	136.3	111.4	148.5	174.4	138.0	46.5	154.6	138.4	127.2	139.8	18.3	113.4	137.7	110.3	59.0	212.5	186.1	219.4	60.8	79.8	202.2	102.9	142.1	118.7	92.7	77.8	106.0	193.1	213.6	210.4	194.1	231.2	182.3	150.6	106.3	137.0	262.4	168.7	125.4	183.3	131.3
HNRNPR	"hnRNP-R, HNRPR"	ENSG00000125944	"Heterogeneous nuclear ribonucleoprotein R"	O43390	1	23303771-23344336	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011687, HPA026092"	Supported		Enhanced	Nucleoplasm		NA	NA		470000	"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB011687: AB_2295532, HPA026092: AB_1850885"	"unprognostic (1.86e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.70e-2)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (2.29e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.28e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.14e-2)"	"unprognostic (4.12e-1)"	51.1	47.9	18.4	48.7	21.6	56.6	49.0	26.0	22.9	55.0	22.3	44.7	33.6	66.1	25.8	54.9	52.6	29.0	40.4	18.1	22.2	43.8	27.2	47.6	58.0	20.2	19.6	61.6	34.0	42.3	33.9	50.0	21.6	35.0	43.2	40.2	46.7	31.8	55.9	51.2	46.7	44.7	20.1	41.9	38.9	31.0	19.2	71.9	43.5	27.7	60.0	48.3	50.1	26.8	161.7	103.9	200.9	123.5	70.0	73.6	103.6	102.7	118.0	178.3	123.0	73.2	113.4	202.3	52.1	141.4	88.9	89.5	211.0	143.9	208.5	142.3	161.4	192.5	131.0	121.9	68.4	224.2	125.1	74.8	86.7	141.5	113.4	73.3	112.9	153.0	185.4	139.9	119.2	98.3	268.3	71.6	111.6	105.3	103.4	196.9	186.5	144.1	96.5	88.7	137.3	132.6	141.8	116.0	88.7	109.5	98.6	102.6	121.0	102.6	133.4	123.8	129.5	81.3	149.0	276.8	71.9	200.7	117.7	21.7	35.9	44.9	49.0	47.2	51.7	41.4	45.0	47.7	45.8	41.6	48.0	45.5	12.8	53.9	48.1	30.0	58.4	46.6	18.4	21.6	26.0	22.9	18.1	22.2	20.2	19.6	21.6	20.1	19.2	26.8	112.0	118.6	109.1	29.0	132.7	127.6	207.1	139.0	95.6	127.8	89.1	78.0	72.3	84.4	138.0	88.3	43.8	253.0	125.8	60.2	92.0	126.6	22.9	110.5	183.8	129.3	116.4	150.4	28.6	126.5	274.4	135.3	92.2	146.2	172.0	171.4	61.8	73.1	106.6	126.2	32.6	107.8	138.4	77.7	92.4	17.2	120.9	98.8	83.6	36.5	147.7	159.9	112.3	63.3	60.6	125.2	64.1	116.6	144.3	208.5	59.6	76.9	114.5	111.1	85.5	159.1	170.2	170.4	148.3	136.4	129.9	206.7	136.5	157.3	116.8	182.4
HNRNPU	"C1orf199, FLJ30202, FLJ37978, HNRNPU-AS1, HNRPU, NCRNA00201, SAF-A"	ENSG00000153187	"Heterogeneous nuclear ribonucleoprotein U"	Q00839	1	244840638-244864560	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Cell division, Differentiation, Host-virus interaction, Mitosis, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor, Ribonucleoprotein, RNA-binding"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011532, HPA041057, HPA058707"	Supported		Enhanced	Nucleoplasm		NA	NA		2100000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"CAB011532: AB_732983, HPA041057: AB_2677278, HPA058707: AB_2683796"	"unprognostic (1.38e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (8.88e-5)"	"unprognostic (2.26e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.87e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.62e-1)"	110.3	111.9	123.7	76.1	132.5	177.5	100.9	131.8	139.8	101.6	122.3	93.3	65.5	103.0	121.3	99.9	106.6	62.7	92.7	122.5	123.5	129.9	105.6	80.7	98.3	125.7	127.9	134.5	99.4	109.6	88.2	96.0	127.3	92.2	84.2	126.3	86.8	79.5	116.5	91.9	94.5	76.7	129.8	103.0	95.0	90.2	127.6	141.2	103.6	61.6	115.5	97.0	86.8	144.6	308.9	242.9	311.8	249.4	160.5	136.4	307.9	215.2	138.2	193.3	171.1	234.0	198.6	481.9	195.6	183.0	185.4	235.3	424.4	244.0	304.5	204.8	280.2	417.4	203.4	360.7	168.8	482.7	242.9	156.2	143.9	211.6	220.1	169.8	200.4	296.9	553.0	174.0	264.3	221.2	517.8	497.8	545.5	227.4	217.2	510.6	392.7	261.9	314.3	222.9	260.6	257.5	339.2	220.4	280.9	226.8	305.2	531.7	244.5	192.6	283.7	207.0	384.3	283.4	332.9	458.6	156.8	403.1	282.2	23.0	14.4	20.6	18.0	12.9	19.2	22.6	22.0	22.1	15.8	21.8	25.5	21.5	20.6	19.8	15.0	31.3	21.3	10.1	123.7	132.5	131.8	139.8	122.5	123.5	125.7	127.9	127.3	129.8	127.6	144.6	269.6	326.9	375.8	67.9	271.9	271.2	416.4	137.1	277.2	149.5	254.3	166.5	186.8	118.7	281.4	193.1	183.5	202.2	323.4	163.7	97.8	215.5	389.9	283.4	530.1	248.6	198.1	269.4	61.8	180.9	259.5	267.1	202.9	429.8	363.6	375.3	133.2	121.9	184.5	141.3	65.2	208.0	109.9	223.7	268.6	481.9	153.7	402.7	122.7	45.9	251.4	151.4	228.6	67.8	107.7	188.9	141.8	142.6	331.6	215.8	141.4	133.2	240.1	213.7	144.7	317.0	364.3	194.9	162.7	292.7	239.2	252.7	310.6	379.9	234.6	288.1
HNRNPUL1	"E1B-AP5, E1BAP5, FLJ12944, HNRPUL1"	ENSG00000105323	"Heterogeneous nuclear ribonucleoprotein U like 1"	Q9BUJ2	19	41262496-41307787	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046290, CAB046477, HPA049475"	Enhanced		Enhanced	Nucleoplasm		NA	NA		26000	"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB046477: AB_2120664, HPA046290: AB_2679616, HPA049475: AB_2680783"	"unprognostic (5.52e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.39e-1)"	"unprognostic (4.29e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.94e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.59e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.66e-1)"	"unprognostic (8.05e-2)"	"unprognostic (2.39e-1)"	85.7	65.9	53.2	89.1	62.4	176.2	75.0	64.3	63.8	78.0	58.9	85.7	81.3	85.0	49.1	81.4	82.8	58.0	75.7	52.9	58.9	48.3	52.5	75.0	102.4	63.9	56.3	116.3	71.7	64.7	58.3	48.8	60.6	59.6	73.1	91.2	84.7	66.7	92.7	93.2	78.7	79.0	53.1	86.4	73.5	79.8	56.1	140.0	69.9	75.6	109.6	75.2	72.1	66.0	284.3	371.2	216.5	200.4	104.3	124.0	82.2	163.1	194.1	207.1	187.8	218.7	213.2	250.1	112.3	206.4	116.8	91.2	208.1	191.3	234.6	248.5	172.9	272.9	168.8	170.4	121.0	259.5	244.3	132.9	116.8	185.8	171.6	186.5	195.7	187.1	203.1	233.8	185.9	217.0	341.0	151.8	165.0	270.8	126.7	219.0	171.6	142.3	149.0	298.8	171.2	154.2	363.3	212.6	95.4	147.7	163.7	290.2	188.4	231.6	218.6	105.4	318.3	264.3	184.5	238.4	147.5	210.8	311.6	13.2	6.2	11.0	11.9	6.7	18.1	8.8	14.4	12.4	7.3	9.0	9.9	7.9	13.5	12.6	7.9	13.7	10.9	5.7	53.2	62.4	64.3	63.8	52.9	58.9	63.9	56.3	60.6	53.1	56.1	66.0	57.0	80.1	69.6	14.7	105.4	56.2	42.9	35.9	71.7	63.2	69.0	58.5	64.1	52.9	36.1	31.3	73.0	50.1	151.9	51.4	45.0	65.1	51.6	52.7	76.8	57.7	76.7	129.4	13.9	62.2	58.8	67.7	55.5	54.2	58.9	78.8	60.3	43.0	63.6	48.8	16.2	66.4	30.5	102.4	76.5	73.9	86.3	92.3	35.6	16.9	81.1	70.8	93.7	21.6	22.2	68.6	39.4	71.5	152.2	48.6	49.5	29.5	49.9	97.3	78.9	74.7	70.3	113.6	108.9	99.1	60.2	53.4	134.2	60.3	73.6	43.6
HP1BP3	HP1-BP74	ENSG00000127483	"Heterochromatin protein 1 binding protein 3"	Q5SSJ5	1	20740266-20787323	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028215, HPA054295"	Supported		Supported	"Nuclear speckles"		NA	Yes		30000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear speckles"		"HPA028215: AB_10601021, HPA054295: AB_2682440"	"unprognostic (3.90e-3)"	"unprognostic (6.83e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.25e-3)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (1.97e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.50e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.43e-2)"	87.9	78.9	62.2	76.2	75.1	141.7	80.1	69.6	76.5	143.6	62.1	107.9	71.3	116.5	63.0	94.8	96.7	75.3	75.7	64.5	66.6	83.5	66.5	84.1	91.4	68.1	64.4	135.6	74.4	98.1	60.9	85.9	67.5	81.3	88.2	96.4	83.0	74.3	113.9	86.9	93.8	100.3	61.3	89.2	83.1	54.5	68.7	134.5	106.3	78.7	90.3	93.9	114.2	107.6	207.3	106.1	261.6	157.5	152.3	172.8	157.3	230.2	182.4	156.7	163.1	97.6	232.0	208.2	113.4	176.6	108.4	171.9	136.7	125.5	199.8	306.5	124.7	296.2	230.5	85.4	98.1	209.7	181.7	135.1	90.6	159.0	208.5	193.0	160.5	245.1	169.9	251.8	180.1	64.2	323.5	93.0	69.3	152.6	126.3	250.4	255.0	219.2	113.6	66.6	175.0	180.0	279.8	112.9	181.2	132.9	117.3	138.7	196.4	176.2	164.2	180.7	139.2	144.0	194.2	246.7	150.2	213.0	204.0	102.4	55.3	202.6	57.1	45.0	59.7	70.8	61.9	62.1	52.2	58.4	80.4	54.5	66.1	63.3	54.9	59.5	71.6	49.0	62.2	75.1	69.6	76.5	64.5	66.6	68.1	64.4	67.5	61.3	68.7	107.6	129.4	150.6	156.2	96.9	112.1	130.4	137.4	81.6	159.9	117.8	116.6	108.7	161.4	94.4	94.5	104.8	54.2	87.6	144.7	105.6	154.6	87.0	40.8	85.3	184.6	136.8	103.7	214.6	98.3	93.4	70.7	161.9	98.8	128.2	137.8	131.8	129.2	101.0	72.6	80.8	93.7	113.4	83.4	100.7	104.1	22.3	172.7	116.9	113.8	130.2	111.2	119.5	127.7	142.7	189.9	113.0	90.1	162.5	162.0	124.6	91.7	110.7	54.6	97.6	157.8	145.2	148.3	141.3	110.1	201.8	134.5	92.9	151.9	116.2	115.3	118.4
HROB	"C17orf53, MCM8IP, MGC3130"	ENSG00000125319	"Homologous recombination factor with OB-fold"	Q8N3J3	17	44141906-44162476	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, DNA synthesis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 9.3;testis: 11.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.3;Cytotrophoblasts: 3.4;Extravillous trophoblasts: 8.6;Hofbauer cells: 2.9;Syncytiotrophoblasts: 1.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023004, HPA023393, HPA024430"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	Yes			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Cytosol"		"HPA023004: AB_1853877, HPA023393: AB_1853878, HPA024430: AB_1853879"	"unprognostic (1.72e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (8.08e-4)"	"unprognostic (1.59e-1)"	"unprognostic (7.37e-2)"	"prognostic unfavorable (3.46e-4)"	"prognostic unfavorable (9.39e-4)"	"unprognostic (1.90e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.66e-4)"	"unprognostic (2.86e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.06e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.65e-2)"	"unprognostic (8.40e-2)"	1.5	0.4	0.1	1.1	0.1	9.3	1.4	0.4	0.3	0.9	0.0	0.9	0.9	0.8	0.1	2.7	0.5	0.2	0.7	0.1	0.2	0.4	0.6	0.6	1.6	0.3	0.2	0.8	0.3	0.4	0.4	0.9	0.3	0.7	1.0	0.3	0.7	0.3	0.9	1.7	0.9	0.7	0.1	1.3	0.6	11.4	0.2	2.3	0.3	0.2	1.9	0.6	1.2	0.3	8.9	11.1	8.3	7.6	0.6	2.3	9.8	6.7	5.9	12.8	13.9	11.3	5.4	9.4	5.8	5.8	13.3	7.5	10.9	10.5	11.1	10.6	14.0	6.0	10.1	7.7	0.3	6.6	7.3	1.9	1.6	15.7	7.7	1.5	5.3	10.2	13.8	11.6	6.2	6.7	15.7	10.2	5.6	4.0	10.8	10.0	13.2	11.6	3.0	7.0	5.1	2.9	4.1	4.0	3.4	9.4	8.1	7.7	2.4	12.1	9.5	8.3	9.9	6.7	12.2	8.0	5.7	5.1	7.1	0.0	0.2	0.2	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.1	0.9	0.4	0.1	0.1	0.1	0.4	0.3	0.1	0.2	0.3	0.2	0.3	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0
HS2ST1	KIAA0448	ENSG00000153936	"Heparan sulfate 2-O-sulfotransferase 1"	Q7LGA3	1	86914635-87109982	"Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 160.9;Excitatory neurons: 126.1;Inhibitory neurons: 130.1;Oligodendrocyte precursor cells: 95.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA043069, HPA043603, HPA075001"	Supported		Approved	Mitochondria	"Intracellular and membrane"	No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria		"HPA043069: AB_10964127, HPA043603: AB_10963432, HPA075001: AB_2686726"	"unprognostic (1.04e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.28e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (7.20e-2)"	"unprognostic (5.34e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.45e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.63e-2)"	"unprognostic (5.07e-2)"	"unprognostic (3.24e-1)"	"unprognostic (7.58e-2)"	8.0	25.7	11.5	9.4	13.8	3.8	8.1	8.0	12.2	10.5	13.2	9.3	9.7	9.1	9.9	7.0	6.7	10.6	7.0	11.9	11.4	13.8	17.2	8.2	11.8	10.1	11.0	12.7	10.1	13.4	6.6	8.3	8.1	9.5	9.0	19.3	6.7	9.9	4.4	8.2	9.3	7.8	8.8	12.7	8.3	9.3	12.2	10.6	12.9	4.7	11.6	9.4	5.9	8.4	24.4	20.4	59.0	38.5	31.9	92.3	20.4	23.3	30.5	19.2	21.2	78.1	30.6	53.3	22.1	16.4	33.2	14.5	27.2	19.5	30.8	42.1	22.2	64.0	21.0	63.0	13.4	33.6	31.0	38.2	17.0	31.0	25.6	30.4	28.8	29.7	44.6	27.4	28.1	8.6	33.8	20.2	19.8	26.5	12.9	41.2	55.7	11.6	23.5	50.3	12.6	19.0	30.6	26.2	27.2	15.2	17.2	15.2	25.7	24.0	29.8	42.2	29.7	25.1	19.9	49.7	14.8	23.6	25.0	6.2	1.1	1.0	1.3	0.6	1.6	1.1	1.5	1.5	0.7	2.8	1.4	0.9	1.2	1.1	2.8	0.7	0.9	1.0	11.5	13.8	8.0	12.2	11.9	11.4	10.1	11.0	8.1	8.8	12.2	8.4	13.0	16.0	12.4	160.9	14.2	16.6	8.6	9.3	19.9	10.9	11.9	7.6	12.8	14.3	15.2	20.2	4.2	8.2	5.7	13.5	13.7	18.2	5.5	7.1	23.6	13.8	23.4	12.2	126.1	11.5	9.3	16.9	11.2	8.0	19.0	74.2	18.2	28.9	37.7	8.4	130.1	12.5	18.3	12.8	13.5	3.8	6.8	15.3	12.4	53.4	8.2	28.8	5.2	95.0	54.5	11.3	7.7	20.3	24.0	7.3	17.6	18.3	11.2	17.7	0.0	21.1	16.8	10.1	15.0	12.8	15.8	4.4	12.9	77.4	13.5	7.1
HSBP1		ENSG00000230989	"Heat shock factor binding protein 1"	O75506	16	83807978-83819737	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		12000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"				"unprognostic (3.27e-2)"	"unprognostic (9.23e-2)"	"unprognostic (2.22e-1)"	"prognostic favorable (5.73e-4)"	"unprognostic (1.85e-2)"	"unprognostic (3.74e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (2.96e-4)"	"unprognostic (2.00e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.84e-3)"	"unprognostic (4.39e-2)"	"unprognostic (9.48e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.70e-2)"	19.6	34.4	34.3	20.5	33.9	12.6	18.7	35.3	39.4	20.4	36.1	20.9	24.9	16.0	12.2	40.4	19.3	8.4	38.4	33.1	37.4	35.2	19.1	18.2	10.3	36.3	34.9	21.6	18.9	32.4	21.8	18.7	36.4	16.6	15.2	21.9	29.7	10.8	40.7	12.5	22.2	13.0	37.2	17.1	21.8	32.9	36.8	19.5	25.1	32.1	14.9	21.1	21.0	38.5	69.1	91.8	124.6	57.5	50.5	44.7	57.9	97.5	47.4	67.6	31.6	77.4	65.7	46.7	96.9	80.3	65.8	66.2	88.3	64.3	60.3	16.8	101.5	35.8	70.9	105.8	41.6	54.3	58.2	44.7	47.1	72.0	39.7	58.1	43.4	35.1	87.8	13.7	52.0	173.4	44.2	65.1	103.8	76.9	67.5	59.7	94.3	22.6	104.4	62.4	85.6	79.7	166.5	34.5	46.9	63.6	119.1	62.9	75.8	86.1	69.8	55.0	70.4	44.6	52.6	186.3	67.5	63.6	96.1	60.9	118.0	158.5	23.4	159.9	25.8	69.1	28.5	26.7	96.2	48.6	26.0	25.0	157.1	31.4	158.1	71.9	43.7	132.7	34.3	33.9	35.3	39.4	33.1	37.4	36.3	34.9	36.4	37.2	36.8	38.5	159.3	157.0	124.8	21.5	79.9	194.6	236.1	694.7	157.1	89.1	239.1	250.3	712.8	140.2	465.6	252.0	20.9	391.1	76.7	233.9	659.3	410.6	364.4	484.6	161.7	183.1	238.9	78.0	16.0	335.7	482.0	231.5	116.2	202.1	68.5	214.2	141.7	161.2	427.1	109.4	23.8	274.7	547.3	223.2	177.0	241.1	219.6	260.9	304.1	15.0	242.4	236.9	76.2	17.6	33.7	440.2	291.0	143.0	90.8	318.7	259.7	562.7	858.5	90.3	118.3	154.1	220.4	685.0	243.5	279.3	207.7	285.4	58.9	282.5	234.4	376.1
HSD17B10	"17b-HSD10, ABAD, CAMR, ERAB, HADH2, MHBD, MRPP2, MRXS10, SDR5C1"	ENSG00000072506	"Hydroxysteroid 17-beta dehydrogenase 10"	Q99714	X	53431258-53434370	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Steroid metabolism, tRNA processing"	Oxidoreductase	"Disease variant, FDA approved drug targets, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 444.0;Proximal tubular cells: 427.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001432	Approved					NA	NA		290000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA001432: AB_1078740"	"unprognostic (1.27e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (2.60e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.37e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.64e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.95e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.92e-1)"	"unprognostic (9.51e-2)"	71.1	110.7	63.5	52.5	67.5	64.8	62.7	70.0	64.7	58.1	64.6	62.8	58.0	62.0	56.2	111.6	55.4	33.4	103.8	62.0	68.4	99.1	261.3	48.4	59.4	70.4	68.2	67.1	74.8	73.4	66.1	37.2	67.8	50.7	62.9	12.7	55.0	46.0	90.5	90.0	50.3	62.0	66.6	52.0	66.4	21.5	69.1	60.1	66.4	81.6	76.3	56.3	59.8	69.2	121.9	203.1	97.2	181.3	93.4	41.0	146.5	73.7	72.9	192.0	125.3	210.3	101.8	205.8	65.6	84.9	124.2	124.5	316.1	148.7	104.3	164.1	177.7	97.1	283.6	177.0	156.3	185.1	145.5	87.6	138.9	148.7	82.8	41.6	142.2	181.2	141.6	158.1	90.3	426.7	165.3	277.0	269.9	163.0	259.5	166.2	179.2	364.9	149.3	132.2	171.1	225.1	211.7	250.2	138.6	123.0	263.3	169.8	64.2	81.7	129.7	171.9	113.4	128.3	194.1	256.5	113.4	384.9	123.2	54.2	127.8	40.4	84.8	125.1	87.2	98.8	78.0	84.1	176.7	111.4	64.4	67.9	10.5	98.7	94.5	96.5	114.8	126.6	63.5	67.5	70.0	64.7	62.0	68.4	70.4	68.2	67.8	66.6	69.1	69.2	42.8	48.1	37.3	4.9	61.8	86.4	90.2	150.8	44.9	11.8	72.5	74.9	62.0	107.2	70.2	101.2	4.2	173.2	55.0	73.8	283.7	131.5	1.6	26.1	64.7	58.3	104.6	71.3	2.5	135.4	228.1	72.0	28.1	51.9	56.5	75.3	56.4	444.0	136.8	13.5	3.3	78.2	99.7	73.9	98.6	5.7	78.3	65.4	96.0	3.7	118.7	61.3	89.6	6.6	6.2	101.9	54.1	94.8	83.3	74.6	78.5	427.8	31.5	13.2	78.9	63.1	117.9	23.6	56.3	91.3	116.2	151.6	62.4	104.1	103.0	83.7
HSDL1	SDR12C3	ENSG00000103160	"Hydroxysteroid dehydrogenase like 1"	Q3SXM5	16	84122141-84145192	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 45.4;Rod photoreceptor cells: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045745			Supported	"Vesicles,Intermediate filaments,Mitochondria"		No	No			"Cluster 34: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria	"Vesicles, Intermediate filaments"	"HPA045745: AB_2679440"	"unprognostic (2.16e-1)"	"unprognostic (4.32e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.80e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (1.25e-2)"	"unprognostic (7.43e-2)"	"unprognostic (3.39e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.66e-1)"	"prognostic favorable (4.20e-7)"	"unprognostic (2.30e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.14e-2)"	7.5	15.4	14.3	7.1	14.6	4.4	11.9	10.9	13.0	10.6	10.7	7.4	6.2	13.2	10.5	7.8	12.6	7.1	15.7	14.0	18.3	10.8	5.1	9.1	9.0	15.0	14.8	22.0	4.9	15.1	11.9	9.1	18.6	9.8	6.9	34.3	7.3	11.1	20.7	8.0	5.7	10.8	9.5	8.0	6.4	13.2	17.0	14.1	26.8	30.5	9.2	7.3	7.1	10.2	11.1	12.6	57.4	19.8	20.7	14.5	14.6	13.8	13.1	17.0	8.9	14.5	18.8	22.7	24.7	12.4	18.8	7.6	31.1	12.1	26.9	4.9	18.9	10.9	7.9	32.5	21.0	17.1	19.2	11.0	20.0	24.1	15.4	21.9	20.9	30.6	23.0	28.2	34.3	27.3	37.8	17.4	29.5	6.4	13.3	36.7	20.4	8.4	16.6	12.0	27.1	20.2	35.0	5.6	39.0	28.5	34.4	10.2	17.5	19.2	22.9	13.9	11.3	44.1	38.1	36.9	22.8	12.3	18.2	21.2	5.0	11.1	3.8	3.4	5.0	5.0	4.1	4.6	2.8	7.5	5.3	5.6	5.5	4.3	6.3	0.0	5.4	4.4	14.3	14.6	10.9	13.0	14.0	18.3	15.0	14.8	18.6	9.5	17.0	10.2	8.9	12.8	16.4	7.8	8.2	4.8	4.6	6.4	8.6	20.2	10.2	8.3	16.7	1.5	8.6	3.7	14.6	6.9	4.4	3.7	5.9	7.9	38.5	11.4	10.5	7.7	9.5	5.7	12.4	6.7	6.6	7.7	3.6	11.0	1.3	38.6	9.3	4.1	12.2	45.4	15.8	3.7	4.1	6.9	3.5	12.2	5.9	10.4	5.4	11.2	6.1	28.4	5.2	15.6	13.0	6.8	2.5	10.1	10.1	5.2	3.9	8.0	13.7	44.2	0.0	8.0	7.8	35.8	30.1	8.8	7.0	8.8	6.6	12.7	4.5	4.8
HSP90AA1	"FLJ31884, Hsp89, Hsp90, HSP90N, HSPC1, HSPCA"	ENSG00000080824	"Heat shock protein 90 alpha family class A member 1"	P07900	14	102080742-102139699	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Stress response"	"Chaperone, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 2527.6"	"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 12150.7;Urothelial cells: 5781.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002058	Approved		Supported	Cytosol		NA	NA		71000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB002058: "	"prognostic unfavorable (5.59e-4)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-2)"	"unprognostic (9.25e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.05e-3)"	"prognostic unfavorable (3.09e-5)"	"unprognostic (7.79e-3)"	"unprognostic (5.71e-2)"	"unprognostic (7.81e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.65e-2)"	"prognostic favorable (1.18e-5)"	"unprognostic (1.04e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.12e-1)"	362.9	439.5	1188.2	299.3	1221.3	459.2	438.6	1272.5	2527.6	282.1	1284.0	289.7	191.3	239.6	318.6	262.0	560.3	363.7	460.6	1213.8	1334.7	452.4	380.5	376.1	321.9	1283.8	1324.0	350.4	273.5	421.8	355.5	420.6	1351.6	348.4	311.1	1127.6	371.1	319.5	405.8	224.8	244.2	306.2	1216.2	217.6	297.5	541.9	1274.3	404.8	223.3	434.9	376.7	406.5	232.8	1639.1	1348.6	1832.2	1142.0	794.2	678.0	567.7	1512.1	1466.0	709.0	1779.5	994.1	1123.6	1245.6	1671.5	1323.1	960.7	1164.7	1471.2	3319.0	1452.5	3215.8	1227.4	1091.9	1291.8	1029.3	1444.3	334.9	1936.9	950.0	539.4	604.6	1140.3	416.2	1107.1	998.6	1764.9	1818.9	838.8	1634.1	1850.8	2087.7	891.1	1191.0	2500.5	1709.3	1968.2	1550.2	715.1	1030.3	1738.2	1497.0	1077.2	1860.4	1389.6	848.2	1903.9	1790.2	765.2	708.2	1234.6	786.5	1860.0	2826.4	783.5	2534.1	2402.7	1167.3	1182.5	1521.0	184.4	87.6	112.1	195.4	128.5	254.9	128.4	162.4	202.2	104.9	127.8	119.2	174.8	57.5	252.6	124.9	208.0	177.8	113.5	1188.2	1221.3	1272.5	2527.6	1213.8	1334.7	1283.8	1324.0	1351.6	1216.2	1274.3	1639.1	1571.4	1137.8	696.7	255.6	934.0	1340.7	12150.7	814.1	748.4	1185.6	1215.2	1173.1	2257.3	684.9	1020.6	513.1	2103.8	1415.1	1091.2	905.8	342.4	1210.5	662.9	2972.0	1350.8	1163.8	947.3	1502.3	158.9	867.6	1909.7	1632.5	788.5	2209.5	916.4	1026.8	341.3	554.4	1348.0	723.5	216.2	992.2	703.9	618.8	3110.7	442.6	732.0	2305.3	1300.2	267.0	773.6	1548.1	356.3	96.5	435.3	779.9	1021.6	722.9	1227.4	3791.1	552.2	896.4	2827.3	3623.6	618.0	1112.4	1974.9	3800.9	2142.4	830.1	1113.7	2050.2	3196.2	972.6	1028.8	5781.1
HSPA14	"HSP70-4, HSP70L1"	ENSG00000187522	"Heat shock protein family A (Hsp70) member 14"	Q0VDF9	10	14838306-14871741	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 223.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046180	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA046180: AB_2679571"	"unprognostic (5.84e-3)"	"unprognostic (5.85e-3)"	"unprognostic (5.73e-2)"	"unprognostic (6.40e-3)"	"unprognostic (7.98e-3)"	"prognostic favorable (5.73e-4)"	"prognostic unfavorable (3.70e-8)"	"unprognostic (2.20e-1)"	"unprognostic (9.60e-2)"	"prognostic favorable (9.16e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.17e-3)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (7.27e-2)"	"unprognostic (2.27e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.90e-1)"	8.9	9.2	9.2	14.7	9.5	42.8	13.3	13.5	12.4	8.5	7.8	14.7	13.1	9.2	11.1	11.0	7.1	8.9	11.4	10.0	9.5	10.2	11.8	8.8	19.4	8.3	8.2	7.9	11.5	8.2	8.8	10.1	8.6	8.8	17.8	10.3	10.1	8.9	21.4	13.3	12.5	9.7	8.6	12.0	9.4	30.9	9.1	18.6	10.3	16.6	19.1	13.0	8.0	10.2	54.0	38.9	33.7	30.7	15.7	21.7	43.6	27.8	14.6	47.5	37.9	52.1	38.9	66.8	21.6	25.7	23.5	43.1	55.3	32.8	49.7	28.2	56.0	62.1	33.0	30.4	13.4	43.6	39.9	15.9	15.0	38.9	11.4	11.8	24.3	53.8	54.3	53.6	35.4	37.3	65.7	30.4	34.9	55.2	20.7	50.3	43.8	53.9	24.7	27.2	19.1	23.5	31.3	43.1	35.8	32.0	49.0	57.6	13.6	19.8	27.7	77.8	45.1	36.6	85.4	67.8	39.6	56.3	11.4	15.8	12.3	13.3	13.7	18.0	14.9	15.1	14.0	17.2	13.4	14.5	11.7	14.6	6.1	17.8	15.8	14.7	20.3	10.7	9.2	9.5	13.5	12.4	10.0	9.5	8.3	8.2	8.6	8.6	9.1	10.2	8.2	6.4	3.3	7.2	18.7	26.3	20.5	37.9	30.7	16.6	7.8	5.8	19.3	14.3	21.2	3.7	6.2	36.2	17.5	16.2	1.9	4.2	53.9	6.7	8.7	12.1	6.0	20.4	21.8	3.9	65.6	16.2	18.3	8.9	10.2	7.4	11.7	12.6	22.8	6.7	19.5	17.0	26.4	11.6	20.3	14.6	14.0	12.1	14.2	10.3	9.0	17.6	23.7	14.6	15.9	4.7	19.9	12.4	33.3	24.4	15.2	2.0	12.5	13.7	13.1	23.3	33.1	223.8	71.4	25.7	26.1	48.7	21.5	8.0	21.2	22.2
HSPA4	"HS24/P52, HSPH2"	ENSG00000170606	"Heat shock protein family A (Hsp70) member 4"	P34932	5	133052013-133106449	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Stress response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010023, CAB025529"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		14000000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"CAB025529: , HPA010023: AB_1851206"	"unprognostic (2.54e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.52e-3)"	"prognostic unfavorable (4.13e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.41e-1)"	31.3	36.9	33.8	41.0	37.2	35.6	26.9	38.1	63.7	26.6	52.0	31.8	26.6	27.5	29.3	62.0	26.8	27.8	50.8	39.8	43.8	44.3	47.2	26.3	47.4	37.6	41.0	21.3	29.7	43.5	24.0	37.7	45.0	26.3	34.7	104.0	27.9	26.9	57.7	26.1	26.0	35.3	38.4	28.7	26.6	62.8	40.3	40.2	39.7	41.7	60.9	48.4	23.7	48.2	160.8	215.8	147.6	241.7	137.5	114.6	267.3	171.0	127.8	162.1	199.2	408.0	163.2	264.4	175.2	165.8	382.6	138.9	259.4	282.9	232.7	122.9	148.3	195.4	136.5	225.7	109.6	122.6	163.8	115.1	117.3	209.7	136.3	92.9	157.2	126.5	207.9	79.6	179.8	141.4	173.5	91.0	202.4	123.8	98.7	156.6	180.4	140.2	146.7	207.4	117.0	96.0	163.4	84.4	234.6	273.5	124.3	118.5	139.0	146.8	210.8	127.1	206.1	90.7	215.2	199.9	125.5	198.7	149.2	29.5	22.6	24.9	18.1	35.8	21.5	34.2	16.6	19.0	27.7	42.0	17.1	16.2	14.7	22.9	27.1	10.5	18.0	18.5	33.8	37.2	38.1	63.7	39.8	43.8	37.6	41.0	45.0	38.4	40.3	48.2	30.5	64.1	47.0	12.4	74.8	41.8	116.8	25.5	52.9	58.9	30.3	26.8	113.1	28.6	47.3	22.0	54.2	67.3	38.5	42.9	27.4	48.4	68.7	54.7	48.5	40.8	47.2	46.9	24.2	49.9	66.1	45.3	38.2	46.1	54.6	66.9	19.6	32.9	64.3	35.3	24.8	34.4	36.7	28.2	40.9	31.9	23.3	50.7	30.2	21.5	55.0	60.1	22.6	18.6	24.2	50.1	24.9	25.9	66.5	61.5	27.7	49.7	60.7	152.4	26.3	41.8	85.1	107.4	101.0	71.7	41.8	87.2	58.2	68.0	39.4	69.7
HSPA4L	"APG-1, HSPH3, Osp94"	ENSG00000164070	"Heat shock protein family A (Hsp70) member 4 like"	O95757	4	127781821-127840733	"Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 108.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 436.6;Late spermatids: 901.8;Spermatocytes: 203.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.1"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"HAP1: 82.3"	"Low region specificity"	"Detected in all"							"CAB034450, HPA039149, HPA061446"	Enhanced		Approved	Centrosome,Cytosol		NA	NA		1000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Centrosome, Cytosol"		"CAB034450: AB_2119823, HPA039149: AB_2676366, HPA061446: AB_2684520"	"unprognostic (6.66e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.33e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.40e-2)"	"unprognostic (3.28e-1)"	"prognostic favorable (3.80e-9)"	"unprognostic (8.53e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.99e-2)"	"prognostic unfavorable (6.78e-4)"	1.3	11.3	12.0	1.0	10.5	3.0	3.5	21.7	30.6	3.5	13.5	2.6	2.3	1.0	1.2	13.7	7.0	3.7	6.4	10.6	32.7	13.3	7.4	1.5	0.3	15.2	17.7	3.8	4.0	11.1	8.0	2.9	21.5	4.1	3.5	26.9	5.7	4.9	1.5	8.4	1.2	3.0	12.9	0.9	2.1	108.7	17.7	4.0	3.9	3.6	4.7	2.8	7.7	15.9	20.6	26.5	14.0	22.1	9.5	9.5	16.2	9.1	3.7	8.6	9.5	19.7	9.2	0.1	16.4	2.6	7.0	4.7	82.3	32.9	11.7	38.7	24.7	11.0	33.5	23.7	3.5	42.3	17.9	8.7	29.7	5.7	20.3	8.9	11.3	9.4	19.8	12.2	10.9	14.9	13.6	3.7	3.3	21.5	21.6	0.1	1.5	2.0	29.1	9.2	25.7	9.4	16.4	28.2	1.5	8.3	21.7	7.1	3.2	3.0	0.1	3.7	22.1	23.6	29.3	6.4	11.7	28.3	9.4	0.6	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	12.0	10.5	21.7	30.6	10.6	32.7	15.2	17.7	21.5	12.9	17.7	15.9	2.7	3.2	9.3	17.6	1.1	28.4	91.9	31.3	40.9	57.7	7.7	9.4	18.1	12.8	27.6	9.2	104.3	10.0	0.8	3.4	19.6	6.8	436.6	17.8	1.6	6.8	18.4	0.0	47.1	2.9	2.1	8.1	2.6	5.2	15.8	2.5	1.8	9.7	1.2	40.4	70.4	3.5	24.4	2.5	9.7	901.8	10.2	4.7	8.8	7.5	3.0	16.6	2.1	19.6	9.3	2.8	0.3	9.8	0.4	26.2	0.3	24.6	52.0	66.8	0.0	18.7	12.5	203.1	13.5	47.5	42.5	16.7	4.2	2.8	5.3	65.2
HSPA8	"HSC70, HSC71, HSP73, HSPA10"	ENSG00000109971	"Heat shock protein family A (Hsp70) member 8"	P11142	11	123057489-123063230	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Stress response, Transcription, Transcription regulation"	"Chaperone, Hydrolase, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 2455.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002056, HPA052504"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	Yes		140000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Vesicles	"CAB002056: , HPA052504: AB_2681854"	"unprognostic (2.28e-3)"	"unprognostic (1.19e-3)"	"prognostic favorable (6.14e-6)"	"unprognostic (1.75e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.70e-2)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (9.65e-3)"	"unprognostic (3.82e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.22e-1)"	"prognostic favorable (3.81e-4)"	"unprognostic (2.53e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.74e-1)"	"unprognostic (7.16e-2)"	539.8	604.9	456.3	542.1	498.1	442.4	448.9	591.6	887.9	326.6	571.4	435.8	506.9	367.3	614.7	554.2	498.5	508.6	892.4	535.1	614.9	850.5	763.2	480.1	685.0	564.8	564.2	421.4	1238.1	593.8	501.9	487.1	620.0	411.2	525.8	531.5	404.1	439.8	1519.0	224.4	453.5	508.4	554.2	520.3	676.7	395.0	559.8	628.6	422.6	1508.5	879.6	866.0	302.4	656.8	1369.6	2077.3	1370.5	1176.5	1259.4	1337.4	1775.6	2730.9	1550.4	3373.2	2004.8	3151.7	1787.3	2318.5	1614.6	1591.9	2337.3	1835.9	4091.6	1027.2	3323.5	1955.4	605.9	2570.4	881.5	1532.0	347.5	2418.0	1757.1	721.8	1594.5	1045.0	320.7	1753.4	1845.6	321.7	2727.8	1147.0	2704.5	1235.5	2507.0	1761.3	2063.2	3463.3	1874.0	2214.4	962.2	1281.3	1665.1	1008.4	1371.8	1023.9	1980.4	2110.5	763.6	1491.1	1837.1	901.9	1767.0	1621.1	1246.1	1404.5	2402.7	740.6	1985.0	1890.9	1791.1	3316.9	1970.0	517.7	592.3	587.8	1245.4	1159.8	1499.6	1009.2	1441.8	1366.1	656.1	752.2	1367.5	1326.5	201.8	1110.7	1255.0	465.5	1761.7	3439.4	456.3	498.1	591.6	887.9	535.1	614.9	564.8	564.2	620.0	554.2	559.8	656.8	795.5	192.3	228.2	72.5	576.3	282.3	2455.6	315.3	507.6	206.7	454.5	380.1	396.3	278.8	352.8	130.6	127.2	926.1	740.3	513.1	528.3	589.0	49.8	404.1	380.1	512.8	519.8	551.7	33.4	628.8	1032.6	609.7	366.0	366.5	434.8	633.8	249.9	223.9	810.9	181.7	45.6	511.1	303.2	359.8	1060.8	58.2	222.4	590.6	528.3	35.6	530.9	307.4	639.5	28.1	50.3	513.8	552.1	270.0	573.6	779.5	823.0	1002.2	465.7	278.1	243.3	416.3	893.1	248.9	419.2	590.6	284.6	1512.1	1123.5	430.3	632.0	1171.5
HSPA9	"GRP75, HSPA9B, mot-2, mthsp75, PBP74"	ENSG00000113013	"Heat shock protein family A (Hsp70) member 9"	P38646	5	138553756-138575675	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Chaperone	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000898, CAB005219"	Supported		Supported	Mitochondria		NA	NA		3600000	"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB005219: AB_647720, HPA000898: AB_1079032"	"prognostic unfavorable (2.93e-4)"	"unprognostic (1.86e-1)"	"prognostic favorable (4.53e-4)"	"unprognostic (3.73e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.06e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.85e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.78e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.29e-1)"	88.6	226.3	10.3	51.5	15.1	98.8	72.4	25.4	26.0	60.3	28.8	80.3	61.2	67.0	33.9	87.8	56.5	38.3	179.5	10.9	19.6	112.1	194.2	62.5	43.6	19.6	20.7	80.0	79.8	169.4	71.4	46.5	23.8	56.4	56.5	48.8	78.9	46.7	288.9	77.5	64.3	44.2	21.6	54.7	91.8	50.1	17.8	44.6	91.3	193.6	55.7	73.8	65.6	29.1	196.0	276.6	111.4	231.0	138.1	94.3	274.7	198.3	196.7	255.4	268.6	579.4	194.4	419.3	263.7	150.8	382.0	158.6	334.0	314.1	298.2	219.7	177.9	230.5	209.0	270.4	360.4	229.0	201.3	142.6	317.7	299.5	494.8	78.7	128.0	167.8	280.4	297.5	134.7	220.6	206.7	82.9	182.5	191.6	173.3	252.1	188.8	302.4	192.8	267.4	150.1	112.4	242.5	338.5	630.7	269.0	230.5	200.5	117.7	204.1	126.5	174.9	313.5	324.6	300.5	378.6	249.6	301.4	202.6	11.8	31.3	10.7	39.8	34.9	46.2	31.7	30.6	36.8	42.0	22.4	34.1	33.9	4.3	28.3	38.8	17.9	31.3	53.6	10.3	15.1	25.4	26.0	10.9	19.6	19.6	20.7	23.8	21.6	17.8	29.1	63.0	99.3	123.8	43.1	101.7	87.8	228.6	157.2	84.8	88.2	83.4	63.8	337.3	70.1	153.8	99.3	83.4	194.7	114.7	80.8	223.0	151.4	12.1	90.1	98.4	83.1	73.0	75.1	41.1	106.1	132.9	109.6	73.9	126.6	167.8	86.1	43.5	175.9	133.9	99.3	48.4	95.4	148.5	54.1	76.4	12.6	67.4	100.1	83.6	25.3	92.3	92.5	43.3	27.6	43.3	93.8	66.0	72.6	102.3	131.1	85.8	231.3	119.7	89.3	46.0	134.3	136.2	52.5	91.4	93.2	73.9	175.5	130.7	157.9	150.7	141.2
HSPE1-MOB4		ENSG00000270757	"HSPE1-MOB4 readthrough"		2	197500413-197550726	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 2.6;Astrocytes: 1.6;Excitatory neurons: 1.5;Inhibitory neurons: 1.7;Oligodendrocytes: 1.6;Respiratory ciliated cells: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA038755, HPA044125, HPA048272"	Approved					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"			"HPA038755: AB_2676190, HPA044125: AB_2678822, HPA048272: AB_2680336"	"unprognostic (7.69e-3)"	"unprognostic (4.73e-2)"	"unprognostic (2.53e-2)"		"unprognostic (9.15e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.50e-1)"	"unprognostic (4.76e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.12e-1)"	"unprognostic (3.52e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.26e-2)"	6.0	19.1	2.9	11.2	3.3	2.0	5.1	3.6	5.4	4.6	3.7	5.1	7.8	5.5	0.0	10.6	4.4	1.7	7.5	3.3	3.5	4.8	4.2	4.6	5.5	3.2	3.2	3.6	4.3	3.7	3.7	7.5	3.5	2.9	3.1	6.4	7.1	2.2	11.6	4.8	4.8	2.4	3.9	5.6	4.4	3.3	3.1	6.8	4.3	3.6	6.8	5.1	6.0	4.0	16.1	8.0	33.1	8.3	12.5	7.5	16.3	28.6	7.0	12.6	9.0	13.5	16.7	14.1	22.2	10.4	24.0	16.7	20.9	4.6	17.0	23.3	4.3	19.4	11.7	8.0	12.2	18.4	24.3	8.0	8.3	15.6	8.8	13.6	7.1	13.0	12.5	8.7	12.2	16.4	21.3	13.2	18.8	16.5	12.4	15.6	12.4	16.5	15.1	28.4	14.4	10.7	13.0	18.9	24.4	27.1	14.5	29.2	14.3	15.9	18.0	19.7	24.4	12.1	24.8	24.3	22.4	8.9	23.7	34.1	13.6	15.6	14.2	16.3	13.9	15.8	16.3	15.8	16.7	12.7	15.6	17.3	17.7	19.6	15.4	11.8	21.9	16.2	2.9	3.3	3.6	5.4	3.3	3.5	3.2	3.2	3.5	3.9	3.1	4.0	0.0	9.6	2.6	1.6	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0
HTD2		ENSG00000255154	"Hydroxyacyl-thioester dehydratase type 2"	P86397	3	58306262-58320193	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 44.1"	"Cell type enhanced"	"Detected in some"		"Club cells: 1.3;granulocytes: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066812, HPA077228"	Approved		Supported	Nucleoli,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 60: Granulocytes - Receptor signaling"	Mitochondria	Nucleoli	"HPA066812: AB_2685727, HPA077228: "	"unprognostic (1.95e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.19e-3)"	"unprognostic (1.11e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.33e-2)"	7.7	7.2	4.3	6.5	5.0	7.2	8.7	7.3	5.5	6.8	4.7	8.9	12.1	8.4	5.9	8.7	7.8	6.8	12.5	4.8	5.6	11.1	15.2	5.7	6.8	3.6	4.6	12.1	7.4	12.0	5.7	6.7	4.6	7.1	9.1	9.2	7.4	8.6	44.1	7.9	8.7	7.6	4.3	7.2	7.0	7.4	4.5	6.6	10.4	37.8	8.0	6.9	4.9	5.5	10.4	7.1	10.9	8.7	11.6	11.2	15.1	13.8	10.2	17.0	14.4	15.9	7.7	19.9	4.0	10.1	12.8	8.7	18.5	12.6	16.8	11.0	13.1	13.7	16.1	13.9	11.3	16.7	11.4	15.1	15.1	17.3	11.4	11.0	14.6	14.3	12.2	19.9	11.1	6.4	11.2	8.9	17.2	10.2	17.3	7.2	7.2	14.7	12.5	13.8	7.0	10.5	8.4	9.4	17.2	12.1	10.9	15.9	8.1	14.5	10.8	14.3	17.2	15.4	27.6	15.7	12.7	11.9	9.8	17.9	19.2	29.2	19.7	23.7	21.5	28.1	20.0	25.2	20.2	27.6	27.5	21.3	13.6	24.9	20.4	24.5	15.6	15.7	4.3	5.0	7.3	5.5	4.8	5.6	3.6	4.6	4.6	4.3	4.5	5.5	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.3	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HUWE1	"Ib772, KIAA0312, UREB1"	ENSG00000086758	"HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1"	Q7Z6Z7	X	53532096-53686728	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Differentiation, DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Granulosa cells: 507.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002548, CAB022718"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		73000	"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Cytosol"		"CAB022718: , HPA002548: AB_1080489"	"unprognostic (4.73e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.64e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.89e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.45e-1)"	37.7	46.1	55.6	21.1	57.4	26.7	37.4	57.6	69.6	39.8	42.0	49.4	17.6	45.6	52.6	48.4	40.7	18.5	57.1	62.6	61.3	45.2	41.8	36.1	26.6	58.7	67.8	54.0	45.9	43.2	54.2	24.0	73.2	38.4	22.7	40.0	38.9	28.6	101.0	59.3	40.2	28.8	49.1	42.5	45.5	43.0	65.1	41.2	42.9	58.1	30.3	44.6	40.2	57.2	166.8	100.4	64.0	45.4	109.2	64.8	78.5	48.8	62.6	50.2	52.3	77.0	52.2	86.6	32.3	89.4	90.4	77.8	145.6	81.8	68.3	125.6	64.6	69.1	91.9	60.5	100.2	104.5	40.6	62.4	59.8	120.8	137.6	49.7	88.3	66.4	70.3	54.5	66.3	102.4	57.0	58.2	87.7	45.4	71.3	52.0	87.9	52.8	84.0	113.3	53.1	38.4	137.7	60.5	44.1	118.7	87.0	50.1	113.8	46.0	65.8	66.5	62.9	47.3	50.2	73.1	49.2	100.1	67.6	2.8	2.3	4.3	3.3	1.9	4.0	2.4	3.1	3.5	3.3	2.4	2.2	2.2	1.9	3.5	3.8	3.5	2.9	1.9	55.6	57.4	57.6	69.6	62.6	61.3	58.7	67.8	73.2	49.1	65.1	57.2	41.4	51.3	46.1	70.2	41.9	30.1	32.6	30.4	44.9	57.8	37.0	35.6	110.4	37.1	35.4	40.5	50.1	31.0	40.0	29.2	1.9	42.8	28.6	45.6	59.8	38.3	47.6	47.7	94.4	35.4	34.8	38.6	57.1	69.6	22.1	507.7	32.9	48.1	24.8	82.4	85.8	28.1	18.3	31.4	30.8	32.8	28.3	34.1	26.6	59.0	43.7	22.6	35.0	83.9	95.3	49.3	20.5	39.1	50.9	44.1	27.1	14.7	35.7	33.3	13.1	69.6	56.4	34.5	44.6	53.3	41.6	37.9	46.7	114.1	31.7	42.0
HYPK	"C15orf63, FLJ20431, HSPC136"	ENSG00000242028	"Huntingtin interacting protein K"	Q9NX55	15	43796142-43804427	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 54.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055252	Uncertain		Supported	Nucleoplasm,Microtubules		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Microtubules	"HPA055252: AB_2682759"	"unprognostic (2.89e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.55e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.39e-3)"	"unprognostic (6.52e-7)"	"unprognostic (2.05e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.78e-4)"	8.9	9.8	13.8	5.9	13.8	4.9	6.5	16.6	22.0	5.0	13.8	5.0	3.7	4.3	5.1	4.2	6.0	2.9	8.5	13.8	15.0	6.5	14.2	7.6	6.5	14.7	15.2	6.2	9.4	6.2	5.6	3.6	14.7	6.8	3.8	8.6	5.5	4.3	19.2	6.1	5.1	4.9	13.4	5.5	5.8	7.9	14.2	6.1	5.2	14.7	7.7	8.3	4.3	15.4	13.5	36.8	17.3	19.5	11.6	11.5	6.5	21.8	13.1	18.9	12.6	23.7	7.4	19.8	25.9	16.7	17.8	23.1	30.3	24.9	14.3	17.3	37.3	26.4	64.6	34.0	17.8	30.4	16.3	10.1	24.2	21.3	18.1	9.3	14.7	20.9	40.5	16.9	17.2	33.5	19.2	33.9	19.5	48.6	40.9	15.4	12.6	22.4	17.7	26.5	33.9	24.7	20.7	31.1	13.3	10.6	23.7	19.5	13.3	22.6	11.8	24.2	55.8	20.5	40.6	46.2	15.1	33.1	26.8	16.8	25.7	22.1	25.0	37.7	26.4	30.0	26.8	26.7	23.5	31.4	29.9	27.9	9.4	26.7	47.7	39.8	27.5	23.5	13.8	13.8	16.6	22.0	13.8	15.0	14.7	15.2	14.7	13.4	14.2	15.4	11.3	6.4	14.5	0.0	11.1	30.0	15.0	8.1	13.6	11.2	14.4	11.9	0.7	8.6	12.1	7.3	54.2	6.6	8.2	6.4	9.8	6.5	2.4	7.2	9.6	10.7	10.7	9.5	0.0	8.4	4.4	12.5	26.0	7.7	8.8	4.5	6.4	6.5	3.9	13.5	0.0	11.6	8.2	4.4	26.2	1.1	5.0	9.1	23.2	0.0	4.7	4.9	6.2	0.0	0.0	6.8	4.7	2.2	11.3	14.8	7.2	10.4	15.4	28.5	0.0	23.2	11.8	3.9	4.7	19.4	37.4	4.9	10.4	9.1	9.4	11.1
IARS2	FLJ10326	ENSG00000067704	"Isoleucyl-tRNA synthetase 2, mitochondrial"	Q9NSE4	1	220094132-220148041	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Cataract, Deafness, Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024212, HPA024594, HPA024596"	Enhanced		Enhanced	Mitochondria		NA	NA		35000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA024212: AB_1851363, HPA024594: AB_1851368, HPA024596: AB_1851370"	"unprognostic (2.15e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (2.42e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (9.24e-5)"	"unprognostic (9.48e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.87e-2)"	"unprognostic (6.27e-3)"	55.8	49.8	19.9	33.3	21.1	18.3	41.8	23.5	25.4	35.3	37.8	54.2	43.4	31.8	31.4	47.9	41.4	30.5	60.0	20.0	21.8	65.5	83.8	31.0	38.8	22.7	22.2	39.0	33.6	80.5	16.0	40.7	25.0	36.1	54.8	34.8	40.0	37.5	92.9	40.5	40.4	39.4	21.6	28.4	39.1	30.1	22.3	31.8	39.7	85.7	43.1	35.6	30.0	22.9	137.2	125.6	70.7	69.9	104.2	104.4	169.6	81.4	86.9	87.9	70.7	121.7	138.8	125.6	107.1	101.4	68.0	129.3	99.0	101.5	100.9	87.5	119.3	62.6	94.6	137.8	64.6	100.4	64.9	76.0	101.3	95.4	97.6	84.7	86.9	79.9	156.9	70.7	116.7	75.9	79.8	72.0	92.1	106.2	82.1	69.5	140.7	202.2	126.2	90.4	38.0	106.6	123.2	188.2	130.3	80.6	218.5	111.9	89.8	86.1	71.6	117.0	138.4	60.0	98.9	90.8	91.3	77.3	97.6	33.8	24.6	22.8	23.0	27.7	30.8	23.6	24.9	30.3	29.2	18.3	27.8	25.6	4.7	28.3	22.3	10.6	29.9	26.7	19.9	21.1	23.5	25.4	20.0	21.8	22.7	22.2	25.0	21.6	22.3	22.9	66.4	35.3	38.0	15.7	30.7	20.1	28.6	44.1	34.7	28.6	40.1	39.4	144.3	22.8	42.9	29.5	25.0	79.0	31.5	54.2	11.7	47.7	20.0	63.8	48.3	43.7	36.2	29.6	17.3	65.4	55.5	37.0	32.1	44.3	19.6	41.3	37.5	99.6	45.9	20.2	22.7	55.4	28.5	51.0	11.2	6.8	37.3	35.9	19.6	15.0	46.1	34.6	27.8	16.6	31.5	67.4	44.9	42.5	33.1	34.1	38.4	36.1	62.0	35.5	46.0	46.3	39.0	44.6	44.1	63.5	26.6	71.7	31.0	54.4	69.9	27.6
ICE2	"BRCC1, FLJ11896, NARG2"	ENSG00000128915	"Interactor of little elongation complex ELL subunit 2"	Q659A1	15	60419609-60479160	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 34.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040058			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"		"HPA040058: AB_10795686"	"unprognostic (3.80e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.59e-3)"	"unprognostic (8.78e-3)"	"unprognostic (2.71e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.39e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.74e-2)"	5.5	5.5	3.0	6.2	4.0	5.5	8.4	4.5	3.2	5.0	5.8	4.8	4.4	8.0	5.5	6.6	6.4	6.5	5.3	2.6	3.2	6.5	7.0	4.9	9.1	3.9	3.3	9.9	6.3	34.6	4.2	7.9	4.2	6.6	7.1	4.8	6.0	5.4	4.4	5.0	5.4	6.4	3.4	7.7	5.3	6.8	3.2	12.7	9.3	5.1	9.8	6.1	3.6	6.7	14.7	25.5	21.1	20.3	15.6	16.9	11.0	8.5	13.1	13.3	14.4	20.0	10.6	25.5	18.3	9.2	25.2	27.2	28.3	11.4	18.3	30.9	12.6	25.8	17.4	11.8	8.4	28.8	17.6	8.5	13.6	11.0	19.7	17.7	22.2	24.9	39.9	23.3	16.7	6.3	22.9	7.6	26.3	26.8	17.1	27.1	16.7	22.4	10.7	18.0	23.8	22.8	12.0	12.2	15.1	24.8	19.7	14.6	10.5	18.4	16.0	15.8	26.5	11.0	31.6	37.7	12.1	32.4	17.4	4.0	4.5	5.3	5.7	6.3	9.7	7.6	7.0	7.6	5.9	10.5	9.3	9.1	0.7	4.2	5.8	4.9	8.1	6.0	3.0	4.0	4.5	3.2	2.6	3.2	3.9	3.3	4.2	3.4	3.2	6.7	32.5	19.2	19.6	34.6	30.6	0.0	20.4	0.0	16.5	31.3	24.4	27.7	20.2	15.7	17.3	20.2	39.6	22.7	32.4	8.8	21.5	12.2	15.5	25.6	27.5	25.1	19.2	28.0	39.9	10.4	14.9	21.1	25.0	21.8	29.8	70.6	29.6	20.6	14.0	30.3	42.6	16.1	0.0	16.8	0.0	17.4	25.4	21.1	0.0	49.6	25.3	19.6	25.7	49.3	83.6	14.6	13.7	17.7	15.9	23.0	11.6	18.1	19.7	33.3	0.0	31.4	17.5	22.1	34.8	21.3	0.0	14.6	31.3	39.3	19.4	19.2
IDH3A		ENSG00000166411	"Isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha"	P50213	15	78131498-78171945	"Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 99.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 144.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041465, HPA062971"	Supported		Enhanced	Mitochondria		No	No		110000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA041465: AB_10794377, HPA062971: AB_2684913"	"unprognostic (2.33e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.76e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.42e-1)"	"prognostic favorable (6.49e-8)"	"unprognostic (1.40e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.39e-2)"	22.6	25.1	11.5	19.9	12.6	9.7	9.6	17.0	14.7	12.4	21.4	26.2	36.6	13.7	7.8	17.0	11.0	9.0	62.5	14.8	13.2	16.8	14.2	11.9	17.1	13.0	13.1	10.8	13.0	54.7	6.9	12.1	15.2	13.9	26.7	26.2	16.2	16.1	79.4	15.8	36.0	17.1	10.1	15.3	11.9	16.9	14.3	35.0	11.2	99.7	24.8	17.7	11.1	14.8	43.8	58.5	10.4	36.5	25.5	26.1	22.6	50.8	24.5	40.6	30.5	41.6	25.8	91.6	36.8	29.9	59.9	64.2	98.2	39.3	37.0	40.7	32.2	35.7	62.4	19.2	21.8	69.8	48.8	19.9	23.6	39.4	41.2	19.3	25.7	32.0	46.4	35.9	26.0	41.4	51.4	17.4	12.9	25.2	21.8	29.3	44.4	28.1	33.4	58.3	41.4	15.8	58.2	82.1	47.1	19.1	32.7	37.4	26.4	47.6	43.9	63.1	83.1	41.5	99.9	48.8	33.2	64.9	37.7	16.9	27.9	8.3	15.1	52.9	16.4	27.7	14.7	13.5	43.5	32.6	15.2	16.4	15.5	17.3	54.8	144.4	17.7	23.2	11.5	12.6	17.0	14.7	14.8	13.2	13.0	13.1	15.2	10.1	14.3	14.8	18.0	9.6	16.5	22.9	30.6	56.0	58.7	51.4	33.0	35.1	10.9	12.6	17.5	14.3	22.6	25.8	37.5	38.3	63.0	69.0	82.2	26.1	52.2	19.9	13.4	17.5	19.2	9.4	45.9	17.9	40.4	21.2	11.7	9.2	27.3	14.5	10.8	22.4	26.5	26.9	53.3	37.6	69.2	24.9	28.6	23.4	20.8	26.4	26.6	12.2	16.0	29.3	12.3	19.6	17.9	21.5	37.9	23.7	33.2	40.6	49.6	48.1	38.2	34.6	13.1	23.8	25.5	45.7	26.2	28.4	41.2	68.4	17.7	37.2	56.0	42.0
IKZF5	"FLJ22973, Pegasus, ZNFN1A5"	ENSG00000095574	"IKAROS family zinc finger 5"	Q9H5V7	10	122990807-123008812	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015297, HPA051574"			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA015297: AB_1855183, HPA051574: AB_2681538"	"unprognostic (2.42e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.68e-1)"	"unprognostic (9.14e-3)"	"unprognostic (5.43e-2)"	"unprognostic (2.99e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.98e-3)"	"unprognostic (4.17e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.15e-2)"	8.3	8.5	8.7	7.3	11.5	34.0	12.2	10.2	15.1	8.8	5.9	7.6	6.6	9.3	9.7	7.2	8.4	6.1	7.1	8.3	10.3	8.7	12.2	8.2	11.1	10.4	10.4	13.9	11.1	9.3	10.1	8.1	11.2	8.3	7.1	13.6	8.4	6.0	9.7	11.3	8.5	7.1	10.0	9.2	7.9	10.5	9.8	10.5	10.0	9.4	9.6	7.3	8.4	17.7	7.5	3.7	7.3	12.5	11.5	10.5	7.9	6.2	13.3	8.1	9.8	6.0	8.6	18.8	4.5	7.6	4.4	10.1	13.0	9.3	11.9	10.6	11.5	12.1	6.0	9.0	7.6	14.8	10.6	8.3	12.5	9.7	20.8	11.1	9.0	12.3	16.9	12.2	8.8	5.5	13.6	16.1	6.7	5.6	5.1	10.9	9.1	10.8	6.7	5.1	7.9	7.1	5.1	6.3	12.2	5.8	5.2	9.3	9.3	5.8	4.9	8.6	10.1	11.4	6.6	17.6	7.4	25.5	3.5	6.0	4.1	5.7	5.8	5.3	6.8	4.0	5.3	5.7	4.5	4.7	7.2	8.4	4.0	6.7	5.6	3.1	7.5	4.3	8.7	11.5	10.2	15.1	8.3	10.3	10.4	10.4	11.2	10.0	9.8	17.7	11.2	12.8	13.1	8.8	16.0	32.2	11.0	7.2	20.5	12.7	23.8	15.0	15.6	8.6	11.3	5.5	14.6	5.8	20.5	7.7	9.8	5.1	8.6	12.0	13.2	11.5	18.0	12.4	10.9	5.3	5.7	15.6	7.7	20.7	17.1	11.3	9.7	15.7	6.5	11.8	13.0	9.2	4.1	10.6	11.4	3.7	13.4	11.0	16.0	17.8	8.9	9.0	17.5	13.0	30.9	4.7	4.9	10.5	14.2	16.1	7.4	11.4	10.9	14.1	13.1	14.3	11.6	22.8	22.3	20.4	32.4	14.4	19.3	7.0	6.7	11.9
ILF2	NF45	ENSG00000143621	"Interleukin enhancer binding factor 2"	Q12905	1	153661788-153671028	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007484	Supported		Supported	Nucleoplasm		No	No		3400000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA007484: AB_1079137"	"unprognostic (1.97e-3)"	"unprognostic (8.68e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.75e-3)"	"unprognostic (9.70e-2)"	"prognostic unfavorable (5.71e-8)"	"unprognostic (2.64e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (2.61e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.09e-1)"	81.4	84.2	42.3	81.5	44.1	158.1	100.7	45.9	51.1	75.4	51.2	80.5	57.4	75.6	85.7	99.1	77.5	61.0	71.3	43.5	47.9	97.6	69.0	76.1	97.7	44.8	44.9	75.4	79.7	101.7	75.3	86.1	46.1	63.5	91.3	43.4	84.3	61.2	114.6	90.0	63.3	79.2	46.8	78.1	76.9	101.2	44.6	189.7	88.7	85.9	132.4	105.8	69.5	50.6	323.3	244.7	420.1	297.8	173.1	162.4	336.2	233.5	263.6	411.9	294.5	362.1	254.3	441.5	349.5	233.6	198.8	239.3	508.8	248.3	394.6	242.0	328.9	330.5	182.2	310.0	158.6	521.0	234.7	149.6	139.7	314.4	339.1	171.7	389.3	256.0	423.5	203.4	347.2	424.3	702.8	215.4	607.5	468.5	366.2	502.1	367.2	418.3	194.8	304.0	379.5	350.2	272.3	336.1	272.3	392.0	367.2	442.7	239.5	210.7	266.4	191.6	391.8	348.6	522.6	882.9	177.2	314.1	327.2	168.7	158.1	118.1	147.4	156.0	188.0	198.7	169.8	160.3	219.2	165.0	190.7	164.8	14.8	218.5	129.7	212.2	212.6	357.3	42.3	44.1	45.9	51.1	43.5	47.9	44.8	44.9	46.1	46.8	44.6	50.6	101.4	57.7	68.5	6.8	102.1	197.9	220.9	238.0	129.7	38.0	113.5	112.1	62.2	70.1	130.4	38.6	27.1	215.3	99.0	54.2	131.0	209.9	73.9	81.6	84.4	114.0	106.8	113.0	9.4	156.4	259.3	110.8	50.4	103.0	94.4	107.0	49.2	31.5	124.8	28.6	10.5	87.2	164.8	54.9	117.4	33.1	60.0	74.0	112.1	9.4	112.9	82.8	61.8	10.6	17.1	145.4	63.5	65.8	125.4	139.9	45.5	201.6	80.7	36.3	65.7	102.4	124.2	360.3	159.9	119.1	158.8	260.4	101.4	144.9	110.9	181.0
ILF3	"DRBP76, MPHOSPH4, MPP4, MPP4110, NF110, NF110b, NF90, NF90a, NF90c, NF90ctv, NFAR-1, NFAR-2, NFAR110, NFAR90, TCP110"	ENSG00000129351	"Interleukin enhancer binding factor 3"	Q12906	19	10654261-10692417	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Transcription, Transcription regulation"	"DNA-binding, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001897	Supported		Enhanced	Nucleoplasm,Nucleoli,Mitochondria		No	No		1600000	"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli, Mitochondria"		"HPA001897: AB_1078703"	"unprognostic (2.39e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.53e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.11e-3)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (3.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.38e-2)"	"prognostic unfavorable (9.65e-4)"	"unprognostic (7.57e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.20e-2)"	49.2	58.5	31.6	79.4	31.5	179.5	49.8	44.2	37.5	60.8	38.5	56.0	52.0	64.5	40.9	60.4	61.1	31.9	49.0	31.4	37.9	43.1	32.1	50.5	82.9	30.6	32.8	76.5	52.6	55.5	53.8	47.8	29.7	52.4	44.8	69.5	54.0	48.8	83.6	58.7	56.1	49.8	29.4	61.7	47.8	78.9	35.4	97.3	61.6	58.2	72.3	56.1	52.1	42.8	285.9	226.7	359.5	330.9	76.5	104.0	208.9	178.1	149.6	291.8	226.5	261.8	160.8	353.2	172.1	160.8	178.0	248.9	392.5	240.7	260.9	227.2	349.5	459.3	206.9	247.5	109.2	334.8	219.5	99.0	105.0	232.1	257.4	111.1	253.1	201.7	400.0	269.4	172.3	233.8	558.1	534.0	433.3	149.2	246.2	405.2	342.2	244.2	116.3	297.1	395.1	286.7	229.0	179.4	131.6	161.6	152.2	212.0	205.2	237.6	224.2	249.3	356.5	228.9	339.7	431.4	132.8	351.6	262.2	20.2	18.1	10.2	24.4	14.1	20.6	19.3	20.2	22.3	22.8	22.9	19.5	20.2	2.7	21.3	21.2	25.1	20.6	11.8	31.6	31.5	44.2	37.5	31.4	37.9	30.6	32.8	29.7	29.4	35.4	42.8	63.6	99.3	133.9	34.3	106.2	86.2	110.0	64.2	104.7	95.4	77.5	64.3	69.7	60.1	98.8	42.3	85.5	90.0	100.0	78.4	27.4	89.0	21.2	89.8	105.7	77.4	114.0	124.3	24.4	80.4	111.1	94.8	101.9	121.4	96.8	145.9	36.8	47.9	71.4	94.2	34.0	85.6	50.8	55.0	68.3	21.0	76.4	75.8	39.2	24.4	66.0	69.2	92.7	31.7	28.9	88.2	55.6	62.4	124.9	144.6	38.8	47.2	82.9	103.6	32.9	100.3	80.1	137.2	120.6	113.8	77.0	70.9	103.5	140.8	111.7	94.9
ILKAP	"DKFZP434J2031, FLJ10181, PPM1O"	ENSG00000132323	"ILK associated serine/threonine phosphatase"	Q9H0C8	2	238170402-238203708	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004752, HPA056099"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA004752: AB_1851753, HPA056099: AB_2797255"	"unprognostic (1.50e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.78e-2)"	"unprognostic (9.75e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (1.60e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.37e-3)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (9.89e-6)"	"unprognostic (6.24e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.20e-1)"	20.5	17.4	24.3	15.1	25.6	29.0	19.5	26.5	26.9	26.2	22.3	30.8	14.6	25.1	15.3	23.2	23.4	8.7	24.2	23.8	24.9	26.0	26.2	18.6	20.5	24.9	24.2	24.5	20.6	13.1	26.5	12.9	24.1	25.2	12.9	13.0	17.3	14.5	41.4	22.4	23.3	16.1	23.9	25.9	21.4	23.1	24.6	17.9	23.9	18.3	18.1	26.6	21.8	27.4	40.5	25.6	36.9	36.3	28.1	18.6	37.9	41.5	27.9	40.9	35.4	23.7	20.9	25.8	10.5	30.1	48.8	33.8	48.1	34.4	41.2	46.6	49.8	66.7	26.0	52.7	43.3	43.7	50.3	19.6	23.3	43.6	43.6	20.2	31.1	34.0	52.4	16.1	35.4	48.1	43.4	58.0	34.8	37.4	25.9	52.6	75.6	23.7	30.4	18.8	54.1	26.7	28.2	29.6	68.9	27.9	23.3	43.7	28.9	39.7	36.7	53.5	45.1	28.6	31.4	46.7	32.5	47.3	34.3	43.4	19.8	27.1	28.2	25.6	25.4	24.7	24.9	26.4	27.7	24.0	28.8	22.9	7.3	24.8	21.4	20.9	30.7	23.0	24.3	25.6	26.5	26.9	23.8	24.9	24.9	24.2	24.1	23.9	24.6	27.4	27.7	12.8	22.0	43.8	35.4	27.0	29.1	30.8	25.0	28.9	19.4	21.6	23.1	17.2	19.6	25.8	29.2	41.2	51.5	22.4	43.0	27.9	8.1	17.1	20.6	21.5	19.1	64.2	37.7	28.5	43.7	26.7	29.0	16.1	33.7	43.5	22.1	19.2	34.4	38.7	33.2	24.0	16.2	17.0	22.0	12.6	28.3	24.0	30.2	25.3	34.0	25.1	57.7	36.7	72.2	24.8	16.2	29.3	33.6	29.7	24.1	33.4	19.3	28.6	32.9	29.2	47.4	54.4	70.8	29.2	28.7	40.4	36.6	23.0	27.4	23.5
IMMT	"HMP, Mic60, MICOS60, MINOS2, P87, P89"	ENSG00000132305	"Inner membrane mitochondrial protein"	Q16891	2	86143932-86195472	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 288.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 223.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022439, HPA036164, HPA036165"	Supported		Enhanced	Mitochondria		NA	NA		220000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB022439: , HPA036164: AB_2674979, HPA036165: AB_2674980"	"unprognostic (3.83e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (5.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.10e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (3.51e-6)"	"unprognostic (2.06e-3)"	"unprognostic (6.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.82e-1)"	41.3	82.4	30.3	34.9	31.8	40.3	36.5	33.1	39.0	30.2	41.9	57.4	57.4	35.0	27.6	43.4	30.9	27.1	174.8	31.9	34.5	80.9	65.0	32.5	44.3	35.3	34.2	28.1	48.5	90.2	36.0	36.7	35.1	29.4	58.1	42.4	37.9	35.1	200.9	38.0	46.6	38.9	29.8	44.8	56.0	49.2	32.6	52.3	35.5	288.9	47.1	41.5	33.8	32.8	115.6	111.2	99.2	45.6	93.7	88.3	101.5	80.5	85.6	108.0	98.7	160.7	89.1	175.7	78.9	87.7	87.7	83.4	128.9	118.4	131.8	71.4	105.9	139.0	65.6	192.0	95.7	135.9	91.1	100.6	84.0	101.7	119.5	67.2	124.7	99.7	138.4	96.7	105.1	99.0	135.6	140.8	117.8	175.1	88.2	89.9	211.2	158.7	122.5	128.3	119.3	89.0	82.9	124.0	126.3	77.4	70.7	94.6	93.6	76.0	83.6	112.0	101.8	76.6	104.1	119.9	86.9	158.8	94.4	12.1	29.2	12.2	23.5	34.0	20.7	15.9	20.6	19.3	32.9	13.7	18.3	22.3	3.8	20.8	33.2	17.2	23.2	25.4	30.3	31.8	33.1	39.0	31.9	34.5	35.3	34.2	35.1	29.8	32.6	32.8	29.3	54.5	49.2	31.3	42.1	23.3	34.9	51.6	30.1	40.9	21.6	19.7	223.0	24.3	57.3	40.5	33.3	94.9	49.6	57.9	133.1	59.9	152.4	26.5	34.0	38.3	56.0	76.1	41.6	52.8	73.9	36.3	39.8	26.8	48.0	55.6	35.7	64.2	70.9	23.5	46.5	46.2	38.7	49.4	28.3	158.9	27.7	48.9	17.8	26.2	80.6	30.2	52.5	29.1	44.1	43.3	36.3	36.9	56.4	28.6	59.8	92.6	41.8	42.5	6.6	39.7	58.2	100.7	54.6	41.1	24.9	98.5	45.6	118.6	68.0	33.6
INCENP	FLJ31633	ENSG00000149503	"Inner centromere protein"	Q9NQS7	11	62123998-62153169	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 20.9"	"Cell type enhanced"	"Detected in many"		"Squamous epithelial cells: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"basophil: 1.2;NK-cell: 1.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.2;NK-cells: 1.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013292, HPA051339, HPA070550"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Kinetochore,Midbody"		Yes	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear bodies, Kinetochore"	"Nucleoplasm, Midbody"	"CAB013292: AB_2533405, HPA051339: AB_2732566, HPA070550: AB_2686279"	"unprognostic (6.31e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.65e-3)"	"unprognostic (7.35e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (1.25e-4)"	"prognostic unfavorable (8.58e-4)"	"unprognostic (1.63e-2)"	"unprognostic (4.37e-2)"	"prognostic unfavorable (5.76e-5)"	"unprognostic (1.74e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.17e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.78e-3)"	3.1	2.5	2.7	7.5	1.1	20.9	2.8	6.2	3.0	4.6	0.0	4.8	6.8	3.0	8.1	14.0	3.5	2.2	2.8	2.9	0.5	2.4	1.9	3.0	11.6	1.6	0.8	3.8	3.1	3.1	1.5	4.1	1.3	2.5	3.6	3.4	6.1	2.9	4.2	7.9	5.7	3.4	0.1	5.5	4.5	6.4	0.5	17.8	5.1	3.4	8.2	2.8	5.5	1.2	74.3	69.4	51.6	45.5	6.8	8.4	28.1	47.6	21.2	44.4	28.3	37.0	50.7	70.0	36.2	16.0	46.2	72.6	52.2	28.4	31.8	60.5	36.6	45.7	68.0	29.6	2.7	53.5	62.1	4.3	6.5	41.3	23.6	6.8	25.8	50.2	48.8	57.6	25.3	59.7	85.0	43.3	56.2	28.0	34.4	79.3	66.4	53.4	12.0	35.8	40.1	42.2	46.8	30.8	27.9	19.8	48.2	19.4	28.5	41.8	51.9	59.8	50.0	29.7	48.3	75.8	23.5	34.7	50.6	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	2.7	1.1	6.2	3.0	2.9	0.5	1.6	0.8	1.3	0.1	0.5	1.2	1.2	3.2	2.3	1.3	3.4	5.6	0.8	1.0	2.8	2.4	1.1	0.6	1.3	0.0	3.7	0.0	0.0	4.2	4.2	5.4	0.0	1.9	1.0	2.0	2.1	1.5	0.0	10.9	3.3	2.5	7.1	1.9	9.2	2.7	3.8	5.7	0.0	0.7	4.2	0.0	2.5	3.4	0.0	0.9	1.6	0.5	2.8	3.3	3.6	1.0	5.0	1.5	3.1	2.0	1.5	2.2	1.6	1.5	10.9	1.2	1.3	0.3	2.6	2.3	0.0	1.9	4.3	6.5	7.8	15.1	3.3	2.2	3.7	1.9	4.8	1.1
ING3	"Eaf4, FLJ20089, MEAF4, p47ING3"	ENSG00000071243	"Inhibitor of growth family member 3"	Q9NXR8	7	120950763-120977216	"Disease related genes, Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"bone marrow: 80.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004762, HPA067388, HPA067575"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA004762: , HPA067388: AB_2685831, HPA067575: AB_2685863"	"unprognostic (1.35e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.26e-2)"	"unprognostic (7.09e-3)"	"unprognostic (4.07e-2)"	"unprognostic (5.18e-2)"	"unprognostic (8.04e-3)"	"unprognostic (2.86e-1)"	"unprognostic (6.90e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.64e-2)"	9.3	7.7	3.8	9.9	4.5	80.5	10.1	11.3	5.5	8.3	3.3	9.1	8.2	10.8	10.5	7.4	9.7	8.5	8.5	3.5	4.5	9.7	9.2	10.9	14.9	4.2	4.7	8.9	8.5	7.7	6.0	15.1	4.7	8.0	11.8	7.6	8.6	7.7	4.7	4.6	7.6	13.0	4.8	15.5	9.7	8.1	4.2	18.6	11.5	8.4	13.5	8.5	5.0	5.7	19.3	5.6	24.8	14.0	9.2	7.3	8.3	12.9	10.1	18.1	21.1	7.3	21.6	31.3	5.7	11.3	19.0	9.2	24.1	9.9	20.7	22.1	42.2	22.5	21.2	4.3	12.6	43.8	25.5	5.4	5.0	16.0	11.3	8.7	28.7	19.1	51.0	48.4	17.5	6.7	36.0	26.0	29.9	10.9	10.4	17.6	17.7	25.7	18.4	19.4	22.4	24.1	13.3	26.9	14.0	15.3	6.1	17.0	10.4	18.5	6.8	40.0	23.7	22.2	15.1	46.0	9.3	28.9	15.6	44.0	28.0	26.4	20.1	30.8	19.9	21.7	20.3	18.7	23.4	24.3	20.4	18.6	50.7	30.6	32.3	17.7	27.1	14.8	3.8	4.5	11.3	5.5	3.5	4.5	4.2	4.7	4.7	4.8	4.2	5.7	27.1	19.2	18.4	24.5	37.7	7.6	20.4	17.6	9.1	23.3	16.3	14.4	14.2	11.5	14.0	7.3	4.2	38.8	31.7	19.6	21.5	12.6	7.2	21.5	20.1	24.7	12.0	27.0	14.5	18.0	22.0	19.5	16.8	28.3	33.7	21.8	21.4	14.3	17.9	26.9	21.5	18.7	22.4	35.8	16.6	4.3	13.7	23.4	16.0	18.7	24.3	17.6	27.8	22.6	24.3	15.5	17.7	9.8	26.8	14.0	17.7	12.8	13.5	19.8	19.7	26.9	25.9	16.6	15.3	12.0	11.2	45.7	28.6	25.7	15.4	18.7
ING5	"FLJ23842, p28ING5"	ENSG00000168395	"Inhibitor of growth family member 5"	Q8WYH8	2	241687085-241729478	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 21.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042685	Approved					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"			"HPA042685: AB_10797507"	"unprognostic (1.87e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.65e-3)"	"unprognostic (9.15e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.07e-3)"	"prognostic unfavorable (2.86e-5)"	"unprognostic (8.25e-2)"	"unprognostic (2.30e-2)"	"unprognostic (7.87e-2)"	"prognostic favorable (1.60e-4)"	"unprognostic (2.15e-1)"	"unprognostic (5.88e-2)"	"unprognostic (8.43e-2)"	"unprognostic (5.01e-2)"	"unprognostic (5.90e-2)"	"unprognostic (4.74e-3)"	12.4	11.3	16.7	8.9	17.1	12.1	12.6	20.5	18.2	19.4	15.3	13.8	9.6	15.0	15.8	13.8	18.8	7.3	12.6	16.4	16.6	14.8	17.1	12.2	12.9	14.7	13.9	25.2	24.0	10.7	24.6	7.9	15.5	21.9	9.1	10.1	19.8	9.8	14.3	18.7	15.4	8.1	11.7	15.7	16.8	9.7	15.5	12.0	23.2	9.5	10.8	14.4	16.2	18.0	12.0	10.9	24.4	14.9	18.5	21.1	30.4	13.2	10.5	13.0	10.4	11.5	11.6	12.0	4.6	12.4	14.0	17.7	22.9	11.8	15.8	12.9	21.6	28.7	17.2	35.0	15.7	30.6	18.2	18.1	18.7	12.8	20.8	15.2	14.4	19.9	28.1	8.0	12.4	20.2	24.6	42.5	28.6	20.5	8.0	42.9	30.1	11.0	12.2	19.2	31.4	19.0	7.0	13.7	18.8	16.0	9.4	20.3	10.2	17.3	18.7	11.2	14.5	17.7	6.7	33.8	12.4	18.4	13.0	21.5	4.0	8.8	2.5	3.2	3.0	3.3	4.2	3.4	2.3	3.7	4.6	3.1	3.9	2.5	3.5	3.7	5.8	2.8	16.7	17.1	20.5	18.2	16.4	16.6	14.7	13.9	15.5	11.7	15.5	18.0	13.4	44.8	33.7	25.1	25.4	9.4	34.6	10.0	21.1	14.7	24.6	26.4	13.9	14.3	19.5	18.4	14.6	20.4	21.3	15.1	31.3	9.3	26.7	23.4	31.6	12.4	8.4	11.3	24.2	10.1	15.3	17.6	13.3	25.1	15.8	22.9	13.6	12.3	7.2	15.2	22.6	16.7	16.2	7.7	7.0	10.4	17.1	11.6	8.8	4.7	8.8	16.3	6.2	18.6	26.9	8.9	9.4	11.3	20.1	26.4	11.6	17.7	11.5	18.8	19.7	22.5	17.4	7.5	11.9	18.1	14.2	17.4	19.9	17.3	15.6	17.7
INTS14	"C15orf44, DKFZP564O1664, VWA9"	ENSG00000138614	"Integrator complex subunit 14"	Q96SY0	15	65578753-65611289	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 40.5;Extravillous trophoblasts: 30.5;Syncytiotrophoblasts: 49.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040255, HPA040651"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nuclear bodies,Mitochondria"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear bodies, Mitochondria"	"Nuclear membrane"	"HPA040255: AB_10805710, HPA040651: AB_10796559"	"unprognostic (2.92e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.06e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.30e-1)"	12.5	15.8	13.2	14.2	15.8	18.0	22.3	14.7	16.6	20.9	18.2	21.8	14.1	18.1	27.4	16.1	24.2	19.6	13.4	13.5	14.8	21.3	21.1	15.6	22.7	14.5	14.9	18.4	17.7	22.9	16.3	19.2	14.6	19.1	23.6	13.1	16.2	19.8	9.9	18.0	17.2	18.8	14.8	18.9	18.1	18.9	15.8	25.4	23.2	13.6	24.3	23.6	13.6	17.7	26.4	46.7	46.1	36.8	25.2	31.4	29.5	28.4	36.5	46.4	42.5	42.2	61.2	42.9	38.9	35.6	38.5	52.0	99.4	47.6	40.5	37.8	60.2	37.5	32.2	46.4	50.0	38.7	46.2	30.6	46.9	35.1	53.7	34.1	50.8	64.8	52.2	24.3	33.4	41.7	44.3	41.2	33.8	66.2	25.6	37.5	38.8	49.0	36.7	48.6	33.1	26.3	34.2	34.5	49.5	39.2	32.3	44.0	25.2	31.8	33.2	28.8	45.6	23.9	48.4	58.1	32.1	70.0	38.1	25.7	11.0	6.2	19.8	12.7	22.3	19.3	20.3	22.6	19.8	14.8	21.1	19.2	1.2	23.8	9.5	17.9	30.8	16.6	13.2	15.8	14.7	16.6	13.5	14.8	14.5	14.9	14.6	14.8	15.8	17.7	12.2	22.4	10.9	0.0	3.8	0.0	0.0	0.0	0.0	0.0	13.0	11.0	0.0	0.0	5.6	12.9	0.0	40.5	7.7	0.0	21.5	18.2	0.0	12.8	11.8	6.8	0.0	0.0	0.0	15.4	30.5	6.7	0.0	12.6	7.6	22.5	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	9.3	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.5	0.0	0.0	15.1	10.9	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	49.8	4.8	24.0	0.0	0.0
INTS5	"INT5, KIAA1698"	ENSG00000185085	"Integrator complex subunit 5"	Q6P9B9	11	62646848-62653302	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046181, HPA056915"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA046181: , HPA056915: AB_2683276"	"unprognostic (2.87e-1)"	"unprognostic (9.51e-2)"	"unprognostic (9.11e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.71e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.97e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.09e-2)"	"prognostic favorable (8.44e-5)"	"unprognostic (7.08e-3)"	"unprognostic (2.97e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.35e-2)"	8.3	9.3	5.5	8.0	5.7	5.4	8.5	5.7	6.0	10.1	5.5	9.1	7.8	11.4	5.3	12.1	12.9	5.8	8.1	5.7	5.4	8.6	12.6	7.7	10.6	6.0	5.6	10.2	10.3	8.8	6.6	6.0	5.8	9.2	5.8	2.8	11.7	6.9	13.9	12.4	8.8	8.3	5.5	10.5	9.5	6.1	5.8	8.3	7.8	8.3	9.2	9.1	8.7	5.8	17.5	21.1	12.2	11.4	23.5	17.1	11.4	14.2	14.4	18.7	13.4	15.1	19.0	33.1	25.0	18.0	15.5	26.7	24.6	32.9	9.0	20.8	17.1	17.2	15.8	10.2	21.2	19.0	15.7	19.9	25.3	20.1	17.1	14.2	18.8	14.5	26.6	18.9	16.3	35.8	22.0	22.1	18.7	20.7	26.4	22.2	16.5	39.9	14.3	11.3	16.4	13.8	15.9	22.0	22.2	8.6	31.3	12.9	15.7	17.8	13.6	27.6	12.9	26.5	21.9	23.8	20.5	14.3	17.2	4.3	5.3	3.9	6.4	3.5	10.1	4.1	5.9	5.7	5.5	5.0	6.9	6.4	1.9	7.7	4.1	5.5	4.6	6.3	5.5	5.7	5.7	6.0	5.7	5.4	6.0	5.6	5.8	5.5	5.8	5.8	5.0	3.2	7.8	2.3	8.8	2.2	7.1	8.2	4.6	7.5	6.6	6.3	3.1	7.2	9.3	3.7	0.0	14.0	10.7	4.8	11.7	12.0	6.4	5.7	5.0	6.9	6.7	2.5	2.0	10.6	9.3	5.2	4.1	4.4	8.9	6.7	9.7	11.5	8.7	10.1	2.1	7.9	8.2	7.0	3.1	8.9	6.5	4.3	0.0	1.9	12.6	10.4	8.2	2.0	1.0	9.7	2.2	7.9	7.3	8.5	8.7	10.2	13.2	3.8	13.1	5.1	8.6	10.8	11.3	5.4	4.1	19.8	6.8	9.1	7.6	5.9
INTS7	"C1orf73, DKFZP434B168, INT7"	ENSG00000143493	"Integrator complex subunit 7"	Q9NVH2	1	211940399-212035557	"Predicted intracellular proteins"	"DNA damage"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 35.6;Oligodendrocytes: 46.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072611			Supported	"Nuclear bodies"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear bodies"		"HPA072611: AB_2732204"	"unprognostic (1.25e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.63e-2)"	"unprognostic (4.26e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.66e-3)"	"unprognostic (2.80e-3)"	"unprognostic (1.37e-2)"	"unprognostic (9.80e-2)"	"unprognostic (4.46e-1)"	"prognostic unfavorable (1.42e-5)"	"unprognostic (2.48e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.44e-2)"	5.5	5.1	5.4	6.3	7.1	7.9	6.7	5.8	8.5	5.1	5.3	6.3	5.8	4.6	6.6	8.2	4.5	4.5	4.7	5.3	5.7	4.4	11.1	5.1	9.1	6.0	6.1	4.3	4.7	2.7	5.6	5.8	6.8	5.5	7.6	7.8	4.2	3.1	5.4	7.6	5.4	7.1	5.5	6.0	5.3	21.4	5.7	13.6	6.6	8.5	10.2	6.4	5.5	9.0	31.1	27.2	21.4	17.1	15.3	16.7	25.7	24.9	15.8	29.2	36.8	25.8	26.4	36.0	13.1	18.1	22.7	27.9	32.2	20.0	24.2	34.8	27.5	31.3	27.9	19.0	16.6	56.3	27.9	14.9	24.1	46.8	35.4	13.8	17.7	19.5	46.8	31.2	24.3	18.1	45.6	16.1	39.2	21.3	26.8	27.9	39.7	53.0	16.9	23.2	36.1	28.2	32.4	34.7	20.6	24.7	28.9	26.7	12.6	23.7	25.5	22.0	37.5	13.5	24.3	42.8	21.0	22.8	27.2	12.6	7.3	6.1	8.7	7.5	7.3	9.4	8.7	10.4	10.9	10.9	5.2	6.4	0.8	22.2	10.0	7.6	15.0	7.6	5.4	7.1	5.8	8.5	5.3	5.7	6.0	6.1	6.8	5.5	5.7	9.0	2.4	0.0	12.0	9.1	7.3	9.9	8.2	4.6	10.8	8.5	5.9	3.7	4.9	5.7	4.6	3.7	4.2	10.5	6.9	6.7	1.9	5.1	35.0	5.1	4.9	4.6	1.2	11.6	20.4	7.0	7.9	5.7	6.6	4.5	4.5	8.1	4.6	10.8	5.5	5.0	24.5	5.6	6.1	4.7	5.1	35.6	5.0	3.8	1.8	19.7	6.2	4.2	10.3	34.7	46.6	5.5	1.9	6.8	9.1	4.2	4.4	3.3	6.2	5.6	0.0	5.4	4.5	31.5	18.8	9.9	11.9	6.8	6.7	17.7	8.3	3.9
IPO7	"Imp7, RANBP7"	ENSG00000205339	"Importin 7"	O95373	11	9384652-9448127	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019002, HPA056590"	Approved	Approved	Supported	Nucleoplasm,Cytosol		NA	NA		220000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA019002: AB_1856059, HPA056590: AB_2683180"	"unprognostic (1.92e-1)"	"prognostic unfavorable (4.98e-4)"	"unprognostic (9.50e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (1.19e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (8.38e-6)"	"unprognostic (3.06e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.90e-3)"	37.9	29.1	24.1	31.3	25.7	22.7	40.4	27.3	30.7	35.7	27.5	34.6	27.2	33.9	29.2	37.9	31.3	31.8	50.4	23.2	28.0	41.4	38.5	28.9	30.1	27.6	27.4	33.1	33.8	38.9	13.0	41.1	27.3	32.1	34.1	47.8	33.3	33.2	110.3	25.3	26.0	43.4	26.8	22.9	25.6	12.7	27.4	31.8	54.0	93.4	34.8	51.8	22.8	29.9	148.7	110.8	130.6	104.4	129.4	165.7	104.4	176.0	112.4	127.1	136.4	99.1	132.6	138.1	62.5	136.3	115.5	113.5	187.5	136.7	210.7	66.3	154.5	114.3	118.8	100.1	80.7	177.0	83.3	106.7	144.8	84.0	195.6	129.5	152.8	46.7	174.7	80.5	167.9	60.3	107.5	86.3	129.0	136.3	130.2	111.4	205.5	63.0	105.3	137.5	51.7	101.5	78.6	153.5	129.1	103.2	70.7	87.6	120.9	155.6	107.4	162.0	190.9	23.2	95.3	93.6	102.0	93.6	86.4	0.1	1.5	0.3	1.4	2.6	2.7	1.9	1.5	2.0	3.2	1.4	1.9	1.7	0.7	3.5	3.8	1.4	1.5	1.0	24.1	25.7	27.3	30.7	23.2	28.0	27.6	27.4	27.3	26.8	27.4	29.9	41.3	67.3	71.5	19.6	46.4	144.0	103.3	44.8	68.9	40.1	65.5	42.4	131.9	25.8	59.7	35.0	58.4	52.8	39.7	27.2	33.2	34.2	4.6	55.9	92.5	55.7	31.1	50.9	43.9	42.2	63.8	58.0	47.4	99.5	37.9	56.5	25.0	46.8	35.3	35.3	49.7	38.8	32.6	48.0	92.2	7.1	28.0	56.6	39.2	17.8	39.2	31.8	13.4	28.1	44.9	45.5	32.9	35.7	47.6	150.6	26.5	45.7	48.4	39.8	13.1	96.2	71.0	21.6	19.8	82.2	147.9	36.7	37.7	49.0	50.9	127.4
IQGAP3		ENSG00000183856	"IQ motif containing GTPase activating protein 3"	Q86VI3	1	156525405-156572604	"Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.5"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 11.2;Late spermatids: 26.6;Undifferentiated cells: 7.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA030142, HPA030143"	Uncertain		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	Yes				"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA030142: AB_10600108, HPA030143: AB_10601104"	"unprognostic (9.99e-3)"	"unprognostic (5.24e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.69e-3)"	"prognostic unfavorable (8.94e-6)"	"unprognostic (1.86e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.35e-3)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.46e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.30e-2)"	"unprognostic (6.81e-2)"	0.7	0.7	0.2	2.2	0.4	15.5	0.6	0.0	0.6	1.1	0.2	4.1	6.6	0.5	1.1	5.2	0.2	0.7	0.4	0.5	0.1	0.6	0.6	1.6	1.6	0.9	0.4	0.1	0.2	0.1	0.1	2.8	0.9	0.4	5.0	0.0	1.0	0.1	0.3	3.7	5.7	2.9	0.0	0.8	4.6	3.8	0.6	3.4	0.2	0.0	2.2	0.9	2.1	0.4	59.2	28.4	25.6	18.1	1.6	4.0	12.4	43.1	28.3	41.0	36.6	32.4	52.5	5.2	15.6	25.2	21.6	54.6	17.5	22.1	36.3	0.1	15.7	7.8	62.6	16.1	0.2	9.7	0.1	1.2	2.5	34.3	50.0	10.0	24.1	12.5	16.1	8.1	30.2	31.2	5.7	13.7	18.6	57.7	28.0	18.9	28.8	6.1	10.4	20.3	16.3	25.2	38.7	44.9	14.9	29.8	35.8	25.6	16.8	36.8	43.7	30.4	51.4	4.0	2.1	2.4	12.4	15.1	42.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.2	0.4	0.0	0.6	0.5	0.1	0.9	0.4	0.9	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.4	1.3	0.1	0.4	0.6	0.0	1.4	1.3	1.0	2.8	0.1	0.0	0.0	2.2	0.1	3.9	0.0	0.3	6.5	0.5	0.7	0.6	1.2	6.5	0.7	0.0	3.6	0.9	11.2	1.4	0.0	4.4	2.5	0.4	3.9	0.0	0.2	3.7	0.0	1.3	6.1	26.6	0.3	1.9	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.5	0.4	0.8	0.4	0.0	0.0	0.0	0.0	1.4	6.4	2.6	3.6	1.0	0.8	0.2	0.3	7.4	0.4
IREB2	IRP2	ENSG00000136381	"Iron responsive element binding protein 2"	P48200	15	78437431-78501453	"Disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032885, HPA040371, HPA068982"	Uncertain		Approved	"Cell Junctions,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Cell Junctions"	Cytosol	"CAB032885: AB_2126703, HPA040371: AB_2676945, HPA068982: AB_2686064"	"unprognostic (1.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.54e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.51e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-2)"	"unprognostic (9.40e-2)"	17.1	25.2	7.5	18.2	7.7	27.7	18.8	16.3	9.3	15.2	8.4	17.4	17.9	17.9	11.8	15.2	14.6	14.9	12.5	7.4	10.5	18.3	23.1	14.9	22.8	7.0	7.2	22.0	11.4	17.8	8.2	21.8	7.1	16.5	20.3	19.4	10.6	15.4	18.8	14.4	18.4	16.1	7.0	24.8	16.4	15.1	9.5	29.7	28.7	23.5	20.9	13.4	11.7	8.8	19.9	34.9	52.8	33.2	45.5	29.7	35.5	33.3	26.0	29.7	26.9	34.6	33.8	73.1	22.1	28.0	20.3	37.8	124.7	33.2	26.1	23.4	43.0	63.6	35.0	24.4	23.8	69.4	65.7	31.5	22.4	22.9	27.7	30.2	35.4	42.6	67.9	25.4	25.5	29.7	42.8	35.2	69.1	24.1	12.4	49.6	53.0	20.8	32.4	54.2	31.7	47.3	45.1	31.4	35.7	59.2	29.5	59.7	28.9	30.3	20.8	16.8	29.2	31.5	74.8	41.7	21.8	63.1	22.2	3.8	2.5	2.0	2.4	3.3	3.1	2.7	2.6	2.4	3.5	2.6	2.5	3.5	2.8	3.0	2.6	4.0	2.3	1.4	7.5	7.7	16.3	9.3	7.4	10.5	7.0	7.2	7.1	7.0	9.5	8.8	24.3	22.4	40.7	33.0	37.5	14.1	16.6	19.3	14.8	55.6	23.1	18.4	24.9	25.8	26.1	23.9	66.7	35.0	56.2	45.3	0.0	19.9	18.1	19.3	38.2	26.6	31.9	42.3	52.3	19.6	23.7	27.7	32.1	21.2	17.7	66.2	38.9	41.8	26.1	79.1	55.6	31.0	18.3	61.3	18.4	10.8	32.9	37.7	14.2	28.1	52.9	22.4	54.6	50.3	49.0	26.3	49.8	30.5	28.5	33.7	49.1	19.6	25.7	51.1	6.6	29.5	23.2	33.9	29.6	24.5	18.6	30.6	33.9	56.3	36.0	29.6
IRF3		ENSG00000126456	"Interferon regulatory factor 3"	Q14653	19	49659569-49665875	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004895, CAB013018"	Approved		Supported	Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB013018: AB_2533904, HPA004895: AB_1851887"	"unprognostic (5.75e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.59e-1)"	"unprognostic (9.17e-2)"	"unprognostic (9.60e-2)"	"unprognostic (7.85e-3)"	"unprognostic (7.91e-2)"	"unprognostic (6.98e-2)"	"unprognostic (5.52e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.85e-3)"	"prognostic unfavorable (1.56e-7)"	"unprognostic (1.61e-2)"	"unprognostic (4.98e-1)"	"unprognostic (3.47e-2)"	"prognostic favorable (3.61e-4)"	32.9	33.7	27.9	20.8	27.4	24.9	33.8	27.4	36.0	46.5	27.8	39.0	18.8	37.0	10.2	37.3	39.7	19.5	31.8	26.4	27.4	46.3	42.4	39.7	42.6	28.3	27.2	44.1	36.6	12.1	37.0	21.1	28.7	46.7	11.4	5.8	34.7	22.8	18.0	43.5	53.0	14.4	27.9	73.9	38.3	16.0	29.7	29.9	43.0	9.4	24.2	40.2	41.1	28.2	82.2	88.3	30.1	44.7	22.6	35.3	68.1	35.1	52.8	59.8	77.7	62.6	93.8	47.7	39.4	32.9	49.8	66.2	32.5	91.0	26.1	66.0	57.6	44.7	33.8	58.2	25.5	33.1	43.9	33.9	63.6	79.2	23.8	30.5	47.9	60.9	50.4	50.7	32.3	79.9	53.4	94.2	36.0	82.3	80.7	60.8	29.4	83.8	43.7	69.2	16.7	21.7	64.5	69.6	35.9	29.5	30.6	64.4	33.6	35.0	32.7	26.7	46.0	69.4	76.9	47.9	40.1	77.2	35.7	25.4	27.6	50.3	58.6	29.3	52.8	37.8	57.1	55.0	22.0	37.9	49.5	45.2	35.1	46.3	36.0	30.2	81.0	39.5	27.9	27.4	27.4	36.0	26.4	27.4	28.3	27.2	28.7	27.9	29.7	28.2	42.5	25.6	33.9	16.0	51.3	54.2	35.6	58.4	29.0	33.0	40.1	39.2	7.9	35.8	51.9	40.5	29.2	78.2	57.6	83.6	19.6	39.4	3.7	30.4	29.5	33.1	44.9	40.0	3.9	46.5	92.0	30.4	76.0	37.0	77.3	33.8	38.6	25.7	39.0	16.8	5.6	70.5	46.8	32.2	29.9	8.9	41.0	33.9	30.2	10.3	71.1	37.9	122.6	7.1	10.8	46.8	60.0	35.7	70.4	26.7	74.8	25.8	45.4	47.7	32.9	23.1	28.2	13.7	15.9	23.2	45.6	49.3	69.2	30.9	63.8	30.1
ISG20L2	FLJ12671	ENSG00000143319	"Interferon stimulated exonuclease gene 20 like 2"	Q9H9L3	1	156721891-156728766	"Predicted intracellular proteins"	"Ribosome biogenesis"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 95.7"	"Group enriched"	"Detected in all"	30	"Early spermatids: 816.3;Late spermatids: 2897.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028005, HPA054285"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA028005: AB_2126319, HPA054285: "	"unprognostic (1.67e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (3.52e-1)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (6.15e-5)"	"unprognostic (1.02e-1)"	"unprognostic (9.55e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.40e-1)"	"unprognostic (8.17e-2)"	"prognostic unfavorable (4.80e-5)"	"unprognostic (5.11e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.82e-3)"	"unprognostic (2.32e-1)"	12.0	10.5	6.2	11.4	6.1	16.7	10.7	8.3	8.1	10.7	4.9	12.5	9.2	12.9	7.5	18.5	11.5	9.0	10.2	6.9	6.2	11.8	13.5	10.0	14.9	6.1	6.0	13.8	11.7	9.3	9.1	11.9	5.8	11.3	12.3	6.6	11.3	8.0	9.8	14.6	12.0	12.4	5.6	13.3	12.2	95.7	6.0	12.2	9.7	6.6	17.0	15.3	12.4	6.3	29.8	22.6	19.1	20.5	19.4	14.2	29.5	20.4	17.9	26.3	18.2	30.2	21.3	56.7	24.3	15.3	11.9	39.2	47.0	32.2	19.9	28.4	30.6	30.9	16.4	17.8	18.9	73.7	32.3	14.3	32.4	24.6	24.7	17.1	24.2	23.9	49.5	25.4	17.0	40.4	31.8	21.3	62.9	60.3	38.0	37.5	22.3	35.9	19.6	23.8	40.4	48.5	24.8	69.8	21.3	27.8	44.5	45.8	16.2	15.2	22.4	18.8	41.9	33.9	56.3	70.3	13.8	37.1	20.2	28.2	8.7	17.2	8.5	11.0	9.8	7.2	6.5	8.7	8.2	8.6	6.6	7.7	15.1	12.1	12.4	5.5	6.7	6.1	6.2	6.1	8.3	8.1	6.9	6.2	6.1	6.0	5.8	5.6	6.0	6.3	16.4	28.9	43.4	4.9	43.6	52.9	40.4	18.9	46.7	22.4	30.5	23.6	10.1	18.6	29.1	7.3	25.0	34.9	57.7	32.0	17.6	21.2	816.3	21.7	22.8	24.9	31.8	29.8	13.5	17.3	37.5	24.2	26.0	38.5	27.8	22.7	21.4	18.6	21.3	23.5	9.8	32.3	10.2	28.4	38.0	2897.0	29.2	33.2	23.2	2.8	21.6	19.8	36.0	6.0	6.3	23.6	16.7	25.9	38.4	38.0	33.8	13.9	19.5	20.5	26.3	30.2	24.5	48.0	27.3	41.7	60.7	37.5	51.5	23.4	31.5	45.8
IST1	"CHMP8, KIAA0174"	ENSG00000182149	"IST1 factor associated with ESCRT-III"	P53990	16	71845996-71931199	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041802, HPA054532"	Approved		Supported	Vesicles		NA	NA		270000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA041802: AB_10794491, HPA054532: AB_2682517"	"unprognostic (2.15e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.04e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.11e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (4.55e-4)"	"unprognostic (1.64e-2)"	"unprognostic (7.88e-3)"	"unprognostic (8.43e-3)"	"prognostic favorable (8.88e-4)"	47.7	44.1	43.2	38.8	49.7	81.0	50.5	46.2	50.6	49.0	43.9	68.3	52.4	55.9	42.4	50.5	61.4	46.8	50.4	42.9	45.3	68.7	37.9	50.0	64.3	47.2	47.6	60.0	46.9	90.4	57.2	60.1	47.1	45.7	62.9	32.4	52.0	45.8	64.1	52.5	52.0	60.8	45.5	50.6	52.5	47.4	46.1	62.2	59.4	80.8	81.6	53.0	44.3	53.8	57.0	81.9	113.3	73.2	110.7	77.9	95.7	70.0	87.1	95.2	98.9	90.1	77.1	80.5	84.2	81.2	67.7	83.8	112.0	74.2	120.4	53.7	54.1	68.1	46.8	146.9	83.8	66.9	91.9	92.7	100.8	85.5	81.6	94.8	120.6	74.8	94.5	28.7	99.5	94.9	87.4	55.6	129.7	92.7	50.6	135.7	62.0	99.1	78.5	81.8	85.0	63.3	77.2	40.3	63.9	138.2	73.7	82.2	60.7	71.8	70.9	44.5	55.9	75.0	145.5	226.7	60.7	59.2	88.6	234.9	195.1	243.5	158.7	185.4	172.6	179.1	150.6	166.9	180.1	178.5	159.6	150.1	300.0	193.7	185.1	124.9	244.9	293.9	43.2	49.7	46.2	50.6	42.9	45.3	47.2	47.6	47.1	45.5	46.1	53.8	59.7	48.1	51.8	39.8	57.1	70.1	41.2	49.8	39.9	29.2	69.1	50.0	43.9	60.1	48.1	46.0	25.0	56.7	68.4	130.6	35.2	47.1	18.4	50.0	52.8	55.4	75.4	30.7	35.5	41.7	44.3	48.1	42.3	70.1	61.4	55.1	61.1	40.8	53.4	21.9	41.6	76.3	46.8	81.1	73.8	22.5	41.0	57.2	42.7	38.4	75.9	22.2	51.5	34.2	59.7	58.1	88.4	47.8	45.2	51.5	82.2	52.4	56.2	30.3	59.2	45.3	44.4	52.4	57.3	34.4	70.0	65.7	51.8	31.3	57.6	66.4
ITFG2	"FGGAP1, MDS028"	ENSG00000111203	"Integrin alpha FG-GAP repeat containing 2"	Q969R8	12	2812622-2859791	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038664, HPA038665"	Uncertain		Uncertain	"Endoplasmic reticulum"		NA	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Endoplasmic reticulum"		"HPA038664: AB_10672722, HPA038665: AB_2676138"	"unprognostic (5.70e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.46e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.36e-2)"	"unprognostic (5.05e-3)"	"unprognostic (8.40e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.24e-1)"	"unprognostic (5.89e-1)"	"unprognostic (4.35e-2)"	"unprognostic (7.43e-2)"	12.8	15.6	6.0	11.4	8.1	14.4	14.0	10.2	8.1	17.7	10.7	14.2	12.4	18.7	14.5	13.1	17.1	8.9	12.1	5.9	9.2	16.4	12.2	15.0	15.9	7.7	7.9	28.9	22.1	28.1	14.1	14.5	8.1	13.9	15.0	8.1	17.9	15.6	8.3	11.7	14.5	13.4	6.2	19.6	16.1	5.1	8.0	18.1	26.7	9.7	15.8	14.7	14.9	11.8	7.3	10.6	11.9	9.7	10.2	11.6	11.0	15.9	9.0	18.9	13.8	22.7	17.6	16.5	4.4	15.0	9.4	9.1	18.5	15.9	14.1	14.7	10.6	23.1	12.7	9.1	18.8	21.7	12.0	15.7	18.4	17.3	26.4	15.5	13.1	15.6	12.8	17.3	10.9	21.9	31.3	12.6	24.6	16.5	8.0	15.6	13.3	9.5	11.3	12.3	5.7	18.3	19.5	17.1	7.2	16.2	10.6	9.9	13.4	12.4	7.4	12.0	30.8	2.2	1.4	25.0	8.0	12.4	12.8	4.0	16.6	8.4	19.2	22.2	18.0	25.8	14.7	19.0	19.6	24.2	19.8	18.6	1.9	23.4	35.6	14.6	13.2	16.5	6.0	8.1	10.2	8.1	5.9	9.2	7.7	7.9	8.1	6.2	8.0	11.8	11.1	12.8	17.9	12.7	35.9	3.3	9.8	9.3	10.2	39.8	16.5	15.6	17.1	18.6	12.1	12.9	64.6	28.1	27.6	13.0	11.7	9.2	46.3	13.0	19.1	10.5	9.5	17.9	13.6	7.2	8.9	15.0	23.0	13.2	6.3	18.7	12.1	11.3	13.4	32.0	15.2	15.2	8.2	12.0	5.1	12.1	16.8	11.0	1.8	8.4	16.8	10.0	42.2	10.1	25.8	7.2	14.4	13.2	19.6	9.1	20.5	6.1	8.7	56.0	6.6	11.7	16.9	13.2	20.0	14.3	4.0	17.4	24.3	22.2	19.5	5.9
ITGB3BP	"CENPR, HSU37139, NRIF3, TAP20"	ENSG00000142856	"Integrin subunit beta 3 binding protein"	Q13352	1	63440770-63593721	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 200.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA028463	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA028463: AB_10601435"	"unprognostic (4.98e-2)"	"unprognostic (5.88e-3)"	"unprognostic (6.28e-3)"	"unprognostic (3.96e-2)"	"unprognostic (4.58e-1)"	"prognostic favorable (4.32e-4)"	"prognostic unfavorable (7.24e-5)"	"unprognostic (2.68e-2)"	"unprognostic (7.89e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.97e-3)"	"prognostic unfavorable (8.45e-6)"	"unprognostic (1.34e-2)"	"unprognostic (5.24e-2)"	"unprognostic (7.34e-3)"	"unprognostic (6.14e-2)"	6.8	11.5	2.3	7.9	2.3	11.9	15.0	2.5	4.6	7.8	3.7	10.7	8.0	8.8	15.9	9.0	9.3	10.8	4.4	2.2	2.5	12.6	6.4	7.2	18.0	2.5	2.4	14.1	10.1	18.2	5.3	10.1	2.5	8.7	10.1	2.8	7.8	6.2	2.5	9.1	6.0	5.6	2.4	8.9	8.0	20.6	2.3	20.2	13.5	4.4	16.4	10.1	8.3	2.6	63.6	32.9	35.9	28.6	8.6	25.2	32.3	30.3	18.7	51.6	63.4	18.2	29.0	57.4	22.6	7.3	26.2	44.3	28.2	30.8	63.7	43.4	74.2	43.9	41.3	35.1	9.2	60.4	27.6	6.5	22.4	29.9	23.5	24.3	26.6	34.5	51.5	74.6	7.3	27.8	66.4	57.0	45.5	24.1	38.2	42.5	61.4	84.7	34.8	19.4	46.1	28.8	34.7	20.0	50.4	53.0	19.9	20.0	16.1	17.9	26.1	36.6	46.2	37.1	64.1	54.4	30.0	75.4	27.7	14.2	4.0	1.4	6.5	3.2	11.3	15.9	10.2	10.6	5.1	15.4	11.3	10.2	1.1	15.6	3.9	8.8	12.2	6.7	2.3	2.3	2.5	4.6	2.2	2.5	2.5	2.4	2.5	2.4	2.3	2.6	22.0	9.6	13.9	24.2	40.9	33.9	56.3	49.8	34.7	10.7	35.9	43.7	11.5	28.6	38.2	25.8	10.4	45.9	19.3	10.1	29.4	42.2	100.8	45.2	22.1	21.6	17.4	40.0	23.6	34.3	56.3	28.6	20.4	21.1	23.5	40.7	23.9	9.7	30.0	6.7	23.6	18.1	42.7	21.0	26.1	121.4	21.5	18.9	21.4	15.0	23.7	21.2	30.9	18.6	31.0	24.8	4.1	25.9	30.7	13.7	6.0	39.1	54.3	15.8	32.9	18.2	21.9	200.5	54.4	30.8	32.7	19.2	26.6	13.6	31.9	35.8
ITPA	"C20orf37, dJ794I6.3, HLC14-06-P"	ENSG00000125877	"Inosine triphosphatase"	Q9BY32	20	3208868-3223870	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022824, HPA073963"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		120000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 37: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA022824: AB_1851960, HPA073963: "	"unprognostic (1.58e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (2.54e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.94e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.84e-1)"	26.2	37.1	16.7	21.2	17.5	26.4	25.0	16.9	20.0	24.8	18.2	25.3	27.0	24.0	13.0	43.9	29.9	16.7	20.8	18.2	16.8	34.2	28.2	22.4	27.6	17.0	16.5	21.2	21.9	24.2	13.0	19.8	17.0	20.3	19.2	6.9	26.4	16.1	26.5	33.6	23.2	18.5	17.3	27.0	27.1	12.3	18.0	24.8	33.5	15.1	21.4	24.1	25.7	18.5	118.2	91.1	44.0	49.1	29.7	42.7	30.9	50.9	72.4	65.9	58.8	75.0	106.6	52.5	46.9	48.7	65.7	101.9	62.3	79.8	46.6	32.9	91.6	123.9	39.1	117.6	55.5	54.5	41.4	41.5	60.3	64.4	40.9	28.6	52.5	39.5	88.7	34.2	62.6	55.2	66.0	156.5	77.2	132.1	89.6	61.4	60.7	135.0	96.7	39.2	67.4	80.9	41.4	154.0	106.3	19.3	60.1	94.2	37.9	76.5	42.4	51.7	116.0	52.0	68.4	94.2	32.9	102.8	83.0	32.8	61.5	22.9	47.7	78.2	41.7	48.9	43.6	49.0	74.5	50.2	32.4	39.5	3.4	64.5	56.9	70.7	61.0	48.0	16.7	17.5	16.9	20.0	18.2	16.8	17.0	16.5	17.0	17.3	18.0	18.5	29.4	22.4	47.0	15.3	38.0	40.1	50.5	93.2	56.9	20.4	48.8	58.3	9.8	34.3	59.3	44.1	14.6	74.4	45.9	37.5	58.7	104.2	2.7	51.8	64.4	29.4	27.5	24.6	12.0	105.1	128.2	41.8	48.4	60.9	42.5	49.7	29.3	32.1	116.6	5.0	9.2	53.1	54.9	42.4	54.0	3.7	31.1	49.0	40.9	5.6	90.3	21.0	41.2	14.1	21.5	102.2	59.9	22.2	34.5	53.5	51.6	94.5	37.9	24.5	19.7	35.4	45.0	16.8	17.6	58.8	49.2	56.2	47.2	53.3	79.9	66.0
IWS1	"DKFZp761G0123, FLJ10006, FLJ14655, FLJ32319"	ENSG00000163166	"Interacts with SUPT6H, CTD assembly factor 1"	Q96ST2	2	127436207-127526886	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035719, HPA061866"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA035719: AB_10669527, HPA061866: AB_2684628"	"unprognostic (3.11e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.27e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.32e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.10e-2)"	"unprognostic (9.01e-2)"	"unprognostic (9.81e-2)"	24.2	18.5	26.7	23.2	32.3	31.5	22.2	30.3	37.8	23.1	30.1	24.8	23.4	22.9	23.8	22.9	21.3	18.9	48.4	26.8	32.2	30.1	40.2	22.5	28.8	30.7	32.1	18.0	21.6	23.8	24.8	26.5	32.0	23.3	23.8	26.5	22.7	19.3	76.0	21.6	24.4	21.9	27.7	27.6	23.1	23.2	31.5	31.2	20.7	62.0	28.4	25.8	23.4	40.4	52.0	34.5	68.4	45.0	51.0	42.4	71.4	73.9	50.0	67.2	55.9	81.6	38.8	48.7	38.2	59.3	51.4	41.9	66.7	58.2	79.4	50.7	45.4	68.1	50.6	92.9	60.2	78.2	54.5	42.0	43.6	71.5	64.0	35.7	58.0	60.3	72.8	37.0	64.3	48.3	77.7	63.4	92.2	43.0	46.8	68.9	53.5	44.9	67.6	62.0	53.4	34.7	52.9	65.9	60.3	73.4	29.6	53.5	66.4	66.3	50.4	40.4	43.8	28.6	33.6	64.5	36.6	54.2	45.0	3.6	13.2	18.5	9.7	14.8	11.8	11.4	11.1	11.8	13.0	15.1	10.5	11.0	13.9	15.0	17.3	11.8	11.0	9.5	26.7	32.3	30.3	37.8	26.8	32.2	30.7	32.1	32.0	27.7	31.5	40.4	23.1	112.2	74.3	35.3	36.6	15.7	55.3	22.8	23.9	27.9	16.9	15.7	77.4	21.5	53.5	16.5	27.1	40.0	33.5	35.1	19.6	38.6	13.2	38.5	39.8	28.9	28.1	30.7	21.9	25.5	56.3	41.9	32.1	36.8	42.3	42.3	20.7	25.7	27.1	21.9	27.8	25.7	30.5	16.4	25.4	8.5	39.1	29.2	10.6	25.3	40.1	26.4	46.4	25.6	105.0	41.9	28.0	31.6	37.5	53.8	25.1	19.1	44.6	44.7	32.9	29.3	35.6	69.8	52.0	24.1	17.0	92.8	37.4	34.6	26.9	77.2
JMJD6	"KIAA0585, PTDSR, PTDSR1"	ENSG00000070495	"Jumonji domain containing 6, arginine demethylase and lysine hydroxylase"	Q6NYC1	17	76712832-76726799	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Dioxygenase, Oxidoreductase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 121.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004548, HPA059156"	Supported		Supported	Nucleoplasm		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB004548: AB_628185, HPA059156: AB_2683934"	"unprognostic (1.26e-1)"	"unprognostic (6.27e-2)"	"unprognostic (8.06e-2)"	"unprognostic (9.46e-2)"	"unprognostic (5.95e-2)"	"unprognostic (4.14e-3)"	"prognostic unfavorable (5.75e-6)"	"unprognostic (4.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.56e-2)"	"prognostic favorable (5.71e-4)"	"unprognostic (5.66e-2)"	"prognostic unfavorable (7.59e-7)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.86e-2)"	"unprognostic (3.82e-1)"	30.3	27.0	14.2	17.0	16.3	121.7	19.6	19.2	29.5	20.2	15.3	32.3	15.4	19.4	7.4	18.8	22.4	18.7	41.2	14.3	16.5	18.3	18.5	26.8	15.7	16.2	16.2	27.6	18.0	11.0	22.4	16.2	16.2	19.9	10.3	29.5	15.2	10.7	38.2	15.6	18.4	16.0	14.6	21.1	24.4	17.8	16.9	13.4	16.6	28.1	12.8	23.9	20.4	20.8	39.0	53.3	18.0	23.5	22.6	19.4	17.6	34.7	26.8	49.6	47.6	53.6	18.7	25.3	14.9	37.6	72.6	28.8	57.3	17.3	47.2	18.6	45.9	37.3	37.5	54.4	36.8	19.7	55.0	23.9	26.8	54.2	18.2	31.6	41.6	13.8	57.1	45.2	37.0	24.4	34.7	28.4	15.9	37.3	62.4	27.1	33.6	39.2	16.6	12.1	31.1	31.1	30.2	43.7	43.7	30.4	39.5	28.6	27.7	56.7	33.3	29.9	65.8	50.6	28.8	23.4	55.7	17.4	32.5	50.8	28.6	40.2	24.7	37.8	24.0	20.5	28.4	28.2	25.9	13.0	23.3	22.2	23.3	14.6	39.4	22.4	31.0	20.1	14.2	16.3	19.2	29.5	14.3	16.5	16.2	16.2	16.2	14.6	16.9	20.8	44.1	25.6	22.9	9.1	29.3	83.2	79.9	46.1	67.2	16.5	30.8	42.8	30.5	14.3	29.2	9.2	50.1	29.0	96.5	33.1	17.6	28.1	30.3	39.1	29.6	36.0	39.4	13.0	6.6	27.4	52.9	37.9	33.1	58.6	65.2	18.6	28.2	10.2	32.7	6.7	7.4	32.0	24.4	19.5	79.2	12.5	16.1	52.4	58.7	3.7	26.9	11.8	21.6	7.1	7.9	29.6	32.1	17.7	50.0	38.5	40.8	7.9	20.5	35.4	13.1	32.7	69.2	59.6	27.2	48.8	73.6	30.5	80.4	29.9	31.3	60.2
JPT2	"C16orf34, FLJ13092, HN1L, KIAA1426, L11"	ENSG00000206053	"Jupiter microtubule associated homolog 2"	Q9H910	16	1678256-1702280	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 99.3;Ductal cells: 90.1;Endometrial ciliated cells: 107.3;Extravillous trophoblasts: 205.9;Glandular and luminal cells: 77.5;Pancreatic endocrine cells: 78.9;Syncytiotrophoblasts: 168.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041888, HPA041908"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		76000	"Cluster 22: NK-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane, Cytosol"		"HPA041888: AB_10793937, HPA041908: AB_10794160"	"unprognostic (1.49e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.30e-3)"	"prognostic favorable (7.85e-4)"	"unprognostic (3.60e-1)"	"unprognostic (2.37e-2)"	"prognostic unfavorable (9.14e-4)"	"unprognostic (1.10e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.12e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.22e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.78e-2)"	21.2	17.0	12.7	18.6	21.1	11.3	36.4	33.2	19.8	39.5	14.1	32.7	21.9	21.1	17.9	47.7	63.4	13.6	20.3	12.0	16.3	48.8	41.1	20.0	19.9	58.0	27.8	19.8	29.6	20.9	15.1	48.1	46.9	47.9	30.5	4.6	26.6	18.2	17.5	31.3	24.2	19.5	28.4	12.8	28.2	18.1	25.6	35.5	27.7	14.0	31.3	31.2	25.9	51.7	148.1	147.5	168.4	93.9	23.9	39.3	151.9	143.6	44.8	117.7	99.8	194.5	188.3	94.6	107.8	71.1	116.4	141.9	223.5	194.2	135.7	77.2	135.2	78.4	80.2	111.4	36.7	93.5	44.8	28.1	121.6	116.4	149.6	64.9	75.7	85.4	187.5	37.0	68.6	169.5	117.1	46.6	185.3	164.4	112.0	212.7	159.3	136.2	186.2	82.5	156.1	85.6	214.9	205.3	66.5	161.1	250.3	59.6	87.9	113.9	201.1	54.8	141.1	31.5	136.3	198.8	35.8	71.5	170.5	2.1	3.7	4.1	5.2	3.3	7.2	4.8	5.8	4.2	2.8	7.6	6.3	5.4	0.3	6.8	1.7	6.6	5.8	4.4	12.7	21.1	33.2	19.8	12.0	16.3	58.0	27.8	46.9	28.4	25.6	51.7	11.9	25.6	10.6	0.0	2.7	0.0	0.0	0.0	0.0	0.0	33.3	23.4	0.0	0.0	12.4	9.2	0.0	99.3	4.5	0.0	43.0	90.1	0.0	107.3	19.2	8.5	0.0	0.0	0.0	25.6	205.9	7.4	0.0	77.5	2.5	23.4	0.0	0.0	41.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	28.4	0.0	0.0	0.0	0.0	78.9	0.0	0.0	1.2	0.0	0.0	26.0	27.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	168.7	3.6	18.9	0.0	0.0
KARS1	"DFNB89, KARS, KARS2"	ENSG00000065427	"Lysyl-tRNA synthetase 1"	Q15046	16	75627474-75648643	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, Transferase"	"Charcot-Marie-Tooth disease, Deafness, Disease variant, Neurodegeneration, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"Cardiomyocytes: 90.7;Cytotrophoblasts: 122.7;Extravillous trophoblasts: 143.3;Hofbauer cells: 89.5;Syncytiotrophoblasts: 110.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041345, HPA041550"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		82000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Plasma membrane"	"HPA041345: AB_10795589, HPA041550: AB_10794520"	"unprognostic (1.56e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.39e-2)"	"prognostic unfavorable (8.84e-6)"	"unprognostic (6.24e-3)"	"unprognostic (8.97e-3)"	"unprognostic (1.18e-1)"	"unprognostic (9.11e-3)"	"unprognostic (8.71e-3)"	"unprognostic (8.46e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.13e-1)"	68.5	49.6	45.5	71.6	47.3	86.1	83.0	46.9	63.2	60.3	50.6	75.8	62.4	53.9	75.1	72.5	69.5	50.4	96.0	45.6	48.3	72.2	76.8	53.1	88.3	46.9	47.5	74.9	86.5	76.7	51.5	62.2	46.8	55.2	85.6	69.6	79.6	60.6	213.4	67.3	62.6	69.6	46.8	57.6	66.2	98.9	47.4	96.6	65.3	186.8	107.8	92.1	55.0	48.1	164.2	187.0	133.5	185.4	140.1	140.3	262.4	135.0	164.9	290.2	217.0	332.8	209.0	292.4	145.4	180.8	138.4	229.4	272.0	246.7	314.4	86.0	139.8	161.4	153.1	348.5	255.8	245.5	174.1	166.4	173.8	257.4	414.6	147.7	240.0	253.5	273.4	68.5	222.5	378.0	254.1	262.2	284.3	238.4	135.9	329.2	120.0	358.4	235.4	136.3	200.2	162.9	339.5	122.8	152.2	144.8	166.1	229.2	133.8	159.8	164.9	123.6	196.7	145.1	178.6	696.6	139.5	206.5	199.7	88.6	112.7	130.0	110.7	155.7	202.6	109.5	137.1	132.0	135.7	91.6	126.6	117.1	24.9	127.6	163.1	85.7	155.5	160.5	45.5	47.3	46.9	63.2	45.6	48.3	46.9	47.5	46.8	46.8	47.4	48.1	14.2	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.7	0.0	0.0	0.0	0.0	122.7	10.1	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	143.3	14.4	0.0	0.0	0.0	0.0	0.0	0.0	89.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	110.0	2.1	0.0	0.0	0.0
KBTBD2	"BKLHD1, DKFZP566C134"	ENSG00000170852	"Kelch repeat and BTB domain containing 2"	Q8IY47	7	32868172-32894131	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021133	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Cluster 5: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA021133: AB_1852093"	"unprognostic (1.01e-1)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (3.17e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (5.69e-4)"	"unprognostic (3.96e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.80e-3)"	"unprognostic (5.05e-1)"	"unprognostic (6.79e-3)"	"unprognostic (3.81e-3)"	"unprognostic (1.42e-2)"	"unprognostic (8.69e-2)"	"unprognostic (2.96e-1)"	26.4	16.4	23.0	21.7	25.2	54.6	20.9	27.3	24.9	17.2	21.4	16.9	15.9	20.8	10.7	16.1	15.6	25.2	20.3	21.0	24.8	15.3	21.5	22.5	25.6	27.2	25.8	16.4	11.8	17.1	15.0	25.8	27.2	16.3	19.6	25.9	14.4	15.0	57.6	16.3	17.6	23.6	26.3	27.0	14.8	18.1	26.5	30.5	18.6	40.3	24.0	22.0	17.3	28.8	38.3	18.8	47.5	23.5	28.1	28.0	17.1	33.4	33.9	31.2	37.6	18.7	28.6	31.9	22.6	34.7	52.3	27.5	24.5	26.2	39.2	12.6	17.6	27.1	30.6	24.4	28.9	29.3	34.2	30.1	26.9	34.0	32.9	28.9	34.9	28.6	50.3	46.2	46.4	31.4	24.3	47.9	38.6	26.5	17.7	23.4	41.6	26.7	27.6	22.3	24.9	46.4	21.5	29.1	38.6	39.6	20.7	49.5	30.5	29.6	38.7	28.3	46.5	37.5	39.3	57.6	28.8	34.9	77.0	14.5	6.4	21.4	10.9	12.2	9.2	7.1	5.4	9.7	5.6	9.8	4.2	6.9	39.2	10.7	14.6	2.9	7.6	4.1	23.0	25.2	27.3	24.9	21.0	24.8	27.2	25.8	27.2	26.3	26.5	28.8	67.2	28.9	23.9	24.5	27.0	40.4	15.7	13.4	44.3	14.6	20.4	15.6	18.4	20.0	22.1	1.8	10.4	6.9	41.4	18.1	0.0	11.8	7.7	21.6	23.1	48.7	14.9	25.2	21.0	12.2	8.7	22.2	17.9	33.8	43.7	20.4	36.8	14.6	13.3	8.4	20.5	14.0	4.1	24.6	23.1	6.2	13.1	32.5	24.9	34.7	13.0	8.7	15.5	29.7	36.8	16.8	10.3	6.0	25.2	17.1	10.5	5.1	7.3	8.9	19.7	26.4	21.1	19.1	8.8	25.9	36.1	7.5	28.4	10.8	11.4	18.5
KBTBD4	"BKLHD4, FLJ10450, HSPC252"	ENSG00000123444	"Kelch repeat and BTB domain containing 4"	Q9NVX7	11	47572197-47578976	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037792, HPA037793"	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Vesicles, Cytosol"	"HPA037792: AB_10671633, HPA037793: AB_2675671"	"unprognostic (5.52e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.36e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.73e-3)"	"unprognostic (2.78e-1)"	"unprognostic (4.04e-2)"	"unprognostic (7.22e-2)"	"prognostic favorable (2.70e-7)"	"unprognostic (4.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.25e-2)"	10.2	13.9	5.8	4.6	6.2	8.7	10.0	7.2	6.2	10.0	6.4	12.8	4.2	13.2	8.8	9.2	10.6	4.6	10.6	5.9	5.8	9.9	8.3	8.3	6.4	5.5	5.7	10.9	8.4	12.4	13.0	4.3	5.6	8.5	6.2	7.4	10.3	6.7	24.3	13.1	10.5	6.7	5.7	10.9	10.4	14.5	5.7	7.9	9.3	11.0	8.4	11.3	8.3	6.0	5.0	11.8	13.0	10.2	7.8	10.6	3.7	9.0	11.8	12.8	11.2	4.0	9.8	9.6	4.8	11.6	9.2	8.5	7.5	13.3	10.9	12.6	10.7	7.2	15.9	5.7	5.8	15.3	14.5	9.6	9.1	5.4	6.9	8.8	13.4	6.7	5.4	7.6	10.2	13.1	11.2	4.6	6.4	14.0	7.6	10.2	17.0	5.4	13.8	11.9	17.2	11.0	7.7	10.4	6.5	4.3	17.4	4.8	10.7	7.9	8.4	12.1	9.0	10.3	20.3	14.2	11.5	4.2	8.8	11.6	4.6	11.7	12.5	3.8	13.8	11.6	9.8	11.4	5.9	10.9	10.6	11.4	8.3	13.5	4.1	2.5	12.8	10.4	5.8	6.2	7.2	6.2	5.9	5.8	5.5	5.7	5.6	5.7	5.7	6.0	6.2	6.4	3.6	3.3	9.6	4.8	6.2	16.4	7.4	14.0	6.9	4.4	0.1	8.6	11.3	11.0	8.4	12.3	9.7	6.9	23.5	13.9	14.5	10.2	5.2	9.0	7.2	9.5	5.7	13.7	7.3	5.8	1.5	4.6	10.8	6.8	7.5	8.8	8.1	13.5	6.6	4.0	20.3	4.1	2.9	18.3	5.0	4.3	1.8	3.7	11.4	24.9	10.3	2.5	4.6	9.0	2.9	9.4	5.8	4.1	6.3	10.9	18.8	12.1	13.1	6.9	6.0	23.7	20.1	4.0	4.5	14.1	10.2	7.6	5.4	4.6
KBTBD6	DKFZp547E1912	ENSG00000165572	"Kelch repeat and BTB domain containing 6"	Q86V97	13	41127569-41132802	"Predicted intracellular proteins"	"Unfolded protein response"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA046861, HPA048914"	Uncertain					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA046861: AB_2679843, HPA048914: AB_2680554"	"unprognostic (6.21e-2)"	"unprognostic (2.07e-3)"	"unprognostic (3.55e-1)"	"unprognostic (1.68e-3)"	"unprognostic (4.25e-3)"	"unprognostic (9.16e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.87e-2)"	"unprognostic (9.85e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.40e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.41e-1)"	2.8	6.1	11.2	3.1	11.4	5.5	5.9	9.8	11.8	5.3	5.9	2.9	2.6	5.6	3.2	2.8	8.3	2.0	6.5	10.5	15.2	5.1	3.7	2.4	4.1	8.8	10.1	5.9	3.5	4.8	6.5	3.6	10.1	4.8	2.1	4.3	3.3	4.2	2.8	3.2	2.3	2.9	8.3	3.2	2.7	5.4	14.9	5.1	5.2	4.2	4.6	2.6	2.6	9.3	3.6	6.9	12.8	16.2	15.0	11.4	4.0	7.5	7.4	8.7	7.4	9.6	4.1	4.8	4.5	6.4	5.6	10.7	20.8	9.4	13.7	4.5	22.0	9.9	9.2	11.2	7.9	7.3	3.7	9.8	9.6	6.2	13.3	7.6	6.3	7.6	8.3	2.7	11.4	5.2	8.9	7.3	9.6	7.9	8.1	6.9	12.2	3.1	8.9	7.8	5.1	11.4	10.4	10.5	7.6	4.4	7.2	9.9	7.0	4.5	5.3	4.5	6.3	2.0	1.9	6.8	6.8	7.8	8.7	3.6	1.6	0.4	1.8	1.2	2.0	1.1	2.8	2.3	1.6	1.3	3.3	3.5	0.8	1.4	2.9	1.1	1.7	1.4	11.2	11.4	9.8	11.8	10.5	15.2	8.8	10.1	10.1	8.3	14.9	9.3	3.8	9.6	4.2	4.6	3.7	3.2	3.3	4.7	3.4	20.6	7.6	6.9	14.6	5.7	2.4	7.3	10.4	4.2	4.3	1.2	7.9	2.6	5.0	3.9	9.5	5.2	3.0	2.5	9.9	1.8	7.6	6.8	2.0	3.5	0.0	8.2	13.6	8.2	1.7	18.5	18.0	2.1	0.0	2.2	3.7	2.9	8.7	2.0	8.8	2.8	2.2	8.0	3.1	12.1	10.6	1.5	0.5	11.7	2.6	3.4	1.1	8.6	2.2	11.1	6.6	11.1	5.9	7.8	9.7	3.2	3.4	2.9	5.1	10.7	3.2	2.4
KDM5C	"DXS1272E, JARID1C, MRX13, SMCX, XE169"	ENSG00000126012	"Lysine demethylase 5C"	P41229	X	53191321-53225422	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038244, HPA046147"			Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA038244: AB_2675911, HPA046147: AB_2679555"	"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.10e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.08e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.05e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.00e-1)"	22.3	29.0	19.2	28.2	19.7	34.8	22.7	23.0	21.7	35.5	22.2	25.5	26.0	35.5	14.8	35.2	33.2	17.1	22.7	19.6	20.1	21.1	24.1	27.2	33.4	19.8	19.0	39.9	26.4	33.8	31.4	23.8	19.0	23.8	15.4	24.6	29.4	18.5	51.0	34.2	28.2	26.9	16.8	30.9	25.8	13.5	20.9	44.2	27.6	25.5	26.5	25.9	35.4	20.8	45.3	60.4	63.6	49.0	43.2	39.1	45.2	27.7	32.2	36.8	34.0	41.3	28.9	41.8	35.0	36.7	103.2	39.5	72.6	59.1	27.8	31.6	107.9	40.6	66.7	29.6	52.9	48.5	77.6	31.0	42.8	72.0	87.7	52.3	55.2	34.2	80.8	27.2	27.3	57.9	35.9	55.4	54.1	23.3	56.3	40.1	37.8	45.9	23.5	42.6	47.6	61.4	84.0	76.8	32.2	58.4	53.9	42.3	37.8	40.6	35.0	36.9	27.2	39.0	34.2	31.5	52.6	56.9	30.8	0.9	1.2	0.8	1.6	1.1	1.4	1.2	1.0	1.6	0.9	0.8	1.2	0.8	1.4	0.8	1.2	1.3	1.3	1.2	19.2	19.7	23.0	21.7	19.6	20.1	19.8	19.0	19.0	16.8	20.9	20.8	17.6	12.8	14.9	33.0	17.8	12.1	10.5	12.1	14.8	24.7	19.7	15.0	10.0	11.5	15.2	7.3	25.0	13.1	21.2	32.2	3.9	15.0	0.8	28.2	25.2	17.7	31.2	17.2	36.1	21.9	15.1	14.2	21.4	35.7	13.3	25.5	15.0	25.5	14.4	25.2	37.0	25.8	16.2	18.2	8.8	2.6	14.6	17.1	14.2	27.2	14.9	9.8	16.5	31.2	49.2	26.4	26.3	15.8	17.0	17.9	22.1	5.8	16.4	16.9	0.0	17.2	16.8	10.3	15.8	16.2	15.9	20.8	18.0	22.6	18.9	21.6
KHDRBS1	"FLJ34027, p62, Sam68"	ENSG00000121774	"KH RNA binding domain containing, signal transduction associated 1"	Q07666	1	32013868-32060850	"Predicted intracellular proteins"	"Cell cycle, mRNA processing, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005355, HPA051280, HPA056813"	Supported		Enhanced	Nucleoplasm		NA	NA		110000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB005355: AB_631869, HPA051280: AB_2681417, HPA056813: AB_2683240"	"unprognostic (1.31e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.55e-2)"	"prognostic unfavorable (3.68e-5)"	"unprognostic (5.01e-2)"	"unprognostic (2.51e-3)"	"unprognostic (4.03e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.91e-3)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.03e-2)"	59.8	47.4	36.3	67.0	38.8	93.3	61.7	44.7	37.4	59.5	34.8	62.9	62.3	82.6	47.2	57.3	70.3	48.6	56.8	36.6	39.7	54.0	50.6	52.1	94.1	40.7	38.7	110.6	50.9	61.7	38.3	63.7	38.1	55.1	57.3	58.5	45.2	55.8	45.9	57.3	59.2	65.6	44.1	64.0	52.3	42.2	37.2	112.2	63.8	40.6	96.7	62.2	47.6	46.7	204.6	121.0	272.6	201.6	92.5	115.4	159.5	120.7	152.1	221.5	185.5	136.2	178.1	302.9	131.5	153.5	128.4	139.2	221.9	165.1	225.6	181.7	188.8	191.1	111.8	188.0	121.5	256.2	123.8	127.6	92.7	168.9	132.8	145.6	212.6	183.1	251.0	136.5	172.6	132.6	379.2	218.7	277.0	127.3	144.3	300.1	230.2	257.7	156.0	203.7	185.7	241.7	175.7	148.8	157.2	192.9	177.3	183.7	160.5	143.9	154.5	155.3	205.9	140.3	163.5	296.0	149.2	202.3	112.1	5.8	5.7	5.9	7.8	8.9	11.7	9.9	9.2	8.2	7.8	8.0	9.8	9.5	5.0	8.0	7.5	8.9	9.3	3.0	36.3	38.8	44.7	37.4	36.6	39.7	40.7	38.7	38.1	44.1	37.2	46.7	130.6	38.5	77.4	40.8	181.9	147.6	200.3	58.8	183.2	94.8	111.1	109.9	104.4	97.2	89.8	69.9	50.1	192.7	131.9	87.9	84.1	96.2	24.7	122.5	154.4	125.7	117.8	131.6	46.0	103.1	234.5	132.4	103.5	127.0	128.1	224.5	99.6	64.6	120.8	63.9	48.1	101.1	28.5	141.9	148.4	21.7	111.2	139.2	108.5	36.5	142.6	142.6	105.0	43.7	59.6	107.1	76.2	124.1	141.8	136.4	74.5	123.8	93.3	89.3	92.1	140.4	157.9	198.2	122.7	173.8	130.6	173.5	161.7	138.7	152.0	167.1
KHSRP	"FBP2, FUBP2, KSRP"	ENSG00000088247	"KH-type splicing regulatory protein"	Q92945	19	6413102-6424811	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034739, HPA056518"	Supported		Enhanced	Nucleoplasm		NA	NA		710000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA034739: AB_10601582, HPA056518: AB_2683162"	"unprognostic (2.16e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.27e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.56e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.84e-2)"	78.3	90.9	39.2	44.8	37.0	63.9	73.6	35.0	44.6	109.8	14.0	90.2	53.8	121.7	17.0	111.3	105.3	27.5	62.5	39.3	32.0	66.8	89.9	73.5	52.1	35.8	34.4	120.7	89.5	24.7	77.5	44.0	32.6	75.7	34.2	41.0	75.1	33.1	100.5	93.7	88.4	36.3	31.1	79.6	81.8	106.5	35.5	53.8	83.4	26.0	45.7	94.5	91.5	44.1	302.1	128.6	148.0	139.2	62.0	67.0	216.8	103.7	84.0	147.2	148.3	259.2	77.2	286.8	187.3	76.7	82.8	162.6	203.5	104.5	162.2	2.6	240.3	209.2	94.9	158.2	86.0	204.9	186.2	74.9	47.6	108.3	117.0	65.8	124.0	138.6	328.7	142.5	95.7	146.9	290.7	182.3	264.3	78.9	187.9	284.3	124.5	206.5	73.0	143.9	152.5	160.7	133.8	119.7	144.3	121.7	118.5	222.4	111.4	108.0	160.9	230.4	230.9	257.1	306.8	279.8	107.3	298.1	130.9	1.6	2.7	2.1	2.2	3.1	2.5	2.4	2.6	2.9	2.9	3.2	1.5	1.6	1.9	1.3	2.8	4.8	1.9	1.7	39.2	37.0	35.0	44.6	39.3	32.0	35.8	34.4	32.6	31.1	35.5	44.1	39.8	9.6	17.5	9.1	27.9	58.8	23.6	18.7	33.6	44.6	50.9	49.7	12.8	41.5	23.5	31.3	50.1	41.8	35.7	46.5	5.9	28.0	84.2	38.5	52.4	32.7	57.6	41.8	12.3	30.9	47.5	33.8	21.9	51.9	18.4	41.8	41.4	44.0	38.9	50.5	12.9	50.5	10.2	42.9	44.2	24.4	50.7	32.0	26.6	12.2	26.7	37.9	15.5	11.1	19.1	32.9	34.9	46.3	33.8	36.9	36.0	23.0	17.4	57.4	26.3	39.7	29.9	92.1	57.3	48.8	72.5	40.0	22.9	34.6	60.4	32.1
KIAA0586	"JBTS23, Talpid3"	ENSG00000100578	KIAA0586	Q9BVV6	14	58427385-58551297	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 81.3;Early spermatids: 142.0;Late spermatids: 108.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000846, HPA050249"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA000846: AB_2234167, HPA050249: "	"unprognostic (1.90e-1)"	"unprognostic (7.85e-2)"	"unprognostic (2.98e-2)"	"unprognostic (6.88e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.76e-3)"	"unprognostic (4.82e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.65e-2)"	"prognostic favorable (7.20e-4)"	"unprognostic (8.10e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.13e-1)"	5.0	5.1	4.6	4.8	4.9	5.4	5.7	6.0	7.1	5.1	4.5	4.9	3.3	4.3	6.2	5.0	4.3	4.9	4.7	4.3	4.9	4.0	6.5	4.2	7.4	4.9	5.1	6.0	4.0	6.1	7.1	3.7	5.0	5.1	6.0	7.9	4.2	4.6	5.8	5.2	4.4	6.3	4.7	5.4	3.9	16.4	4.7	12.4	4.9	6.1	7.1	5.6	4.8	6.5	21.1	14.0	20.2	9.7	16.4	15.6	8.7	17.3	16.3	15.1	15.7	6.0	11.3	23.4	11.4	14.8	6.2	12.3	19.1	10.9	24.8	16.8	6.9	17.9	11.1	18.2	11.2	27.6	15.3	10.5	4.6	11.2	17.7	7.2	19.9	22.3	18.0	12.4	28.4	13.5	16.9	11.4	8.7	10.7	22.8	20.5	23.5	14.6	10.9	8.8	11.1	8.4	18.4	12.3	8.9	10.8	14.7	14.4	18.8	23.4	18.4	12.9	14.5	7.4	9.5	19.0	16.2	21.8	13.7	13.2	2.0	5.0	7.0	2.1	5.6	6.3	6.6	5.3	2.6	6.8	8.5	6.1	2.0	9.7	3.2	3.3	7.1	2.6	4.6	4.9	6.0	7.1	4.3	4.9	4.9	5.1	5.0	4.7	4.7	6.5	17.9	12.8	14.5	29.4	20.9	3.2	6.1	6.2	12.5	30.5	10.1	9.8	14.1	7.2	9.3	9.2	81.3	7.5	20.1	5.9	5.9	6.5	142.0	18.5	19.6	13.9	10.7	22.1	52.0	5.2	8.4	14.5	16.8	11.0	21.5	15.2	9.3	4.7	9.5	32.0	56.7	8.5	10.2	7.9	2.8	108.1	10.2	10.8	8.8	27.2	10.6	17.0	14.4	47.3	73.9	5.9	3.0	12.0	20.6	4.3	4.3	7.7	20.0	51.0	0.0	19.7	12.3	61.6	23.9	12.4	4.5	4.8	24.4	15.7	7.3	3.3
KIAA0753	"MNR, OFIP"	ENSG00000198920	KIAA0753	Q2KHM9	17	6578147-6640711	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			Ciliopathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 90.9;Excitatory neurons: 46.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"							"HPA023057, HPA023494"	Enhanced		Approved	Centrosome,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Centrosome, Cytosol"		"HPA023057: AB_1852338, HPA023494: AB_1852339"	"unprognostic (3.72e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.93e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.01e-3)"	"unprognostic (1.82e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.47e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.77e-3)"	4.9	5.7	6.8	4.6	6.8	3.5	7.3	3.8	7.3	8.4	10.5	7.1	3.5	8.5	11.0	7.1	10.1	5.2	4.1	7.2	6.6	8.7	3.7	5.3	5.0	4.3	4.9	10.1	5.6	14.0	8.8	5.3	3.6	7.7	6.9	10.8	5.7	8.3	2.1	5.7	5.4	8.4	3.4	7.6	6.5	16.6	6.0	8.5	9.0	2.7	5.1	6.4	6.4	5.5	19.9	16.1	19.4	13.2	7.2	11.9	7.7	10.5	10.0	15.1	14.0	11.1	4.8	7.9	7.1	10.4	9.9	18.4	17.8	10.1	23.9	8.1	15.1	4.3	14.8	8.7	12.0	6.9	9.3	7.1	12.9	13.7	13.0	15.5	11.8	9.1	9.9	1.0	12.3	5.9	7.7	6.2	11.8	9.7	8.1	11.1	6.8	2.5	13.9	12.9	7.3	12.7	13.2	3.9	8.9	12.5	6.5	4.5	11.1	13.1	6.7	7.6	16.8	1.8	2.6	2.8	9.8	4.5	10.6	0.0	0.7	0.6	0.5	0.7	0.6	0.8	0.5	0.5	0.4	0.4	0.3	0.3	1.9	0.4	0.4	0.6	0.4	0.2	6.8	6.8	3.8	7.3	7.2	6.6	4.3	4.9	3.6	3.4	6.0	5.5	5.4	6.4	12.3	25.8	3.4	3.2	2.9	2.6	4.6	3.8	5.9	5.2	3.6	7.2	8.3	0.0	16.7	2.4	2.9	5.2	0.0	4.1	90.9	13.2	9.5	5.7	7.2	3.0	46.6	3.8	1.1	6.3	9.7	5.8	1.3	12.9	3.9	2.1	2.5	10.1	29.2	3.9	4.1	3.1	0.6	15.4	4.4	3.2	0.0	25.3	2.8	2.1	2.1	27.2	14.7	3.9	4.9	3.4	5.6	3.6	2.2	2.9	29.3	12.1	0.0	5.9	5.4	15.1	7.8	5.0	2.4	1.2	3.1	9.3	4.4	2.7
KIAA1841		ENSG00000162929	KIAA1841	Q6NSI8	2	61065871-61138034	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 11.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 56.3;Excitatory neurons: 91.2;Inhibitory neurons: 78.5;Oligodendrocytes: 63.8;Respiratory ciliated cells: 58.0;Rod photoreceptor cells: 45.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051240	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nucleoli"		"HPA051240: AB_2681401"	"unprognostic (1.01e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-2)"	"unprognostic (5.71e-8)"	"unprognostic (1.13e-1)"	"unprognostic (5.06e-3)"	"unprognostic (7.53e-2)"	"unprognostic (6.09e-2)"	"unprognostic (8.92e-2)"	"unprognostic (7.85e-6)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.25e-1)"	2.4	1.6	3.2	1.8	3.7	1.1	1.8	4.1	6.2	4.2	1.2	3.2	2.6	1.8	2.2	1.6	3.4	1.3	2.5	3.4	3.3	1.2	1.0	3.6	1.5	5.2	3.2	1.0	1.6	1.3	3.3	1.6	5.7	4.2	3.7	11.2	1.4	1.3	1.8	3.9	2.8	2.4	2.2	1.4	2.5	3.7	5.2	2.5	1.8	2.2	1.6	1.5	1.8	6.1	5.1	10.9	12.5	5.3	6.5	7.7	4.3	10.1	2.2	4.8	4.4	3.4	3.2	2.1	2.6	7.5	9.8	6.3	8.2	3.3	6.7	10.0	3.0	2.2	6.9	8.8	3.5	2.5	2.0	3.7	4.9	8.8	3.1	5.3	7.1	3.0	2.1	1.7	13.5	0.4	2.1	1.7	3.9	5.9	2.5	6.7	10.5	0.5	5.4	10.6	7.5	4.7	11.8	2.6	3.4	9.1	1.8	2.7	9.4	7.8	3.1	6.5	6.8	1.0	3.1	3.0	5.6	1.8	5.5	0.4	0.5	1.8	0.4	0.7	0.4	0.5	0.4	0.2	0.5	0.1	0.0	0.3	1.3	0.5	1.0	0.3	1.5	0.2	3.2	3.7	4.1	6.2	3.4	3.3	5.2	3.2	5.7	2.2	5.2	6.1	12.9	6.4	5.8	26.1	1.5	2.5	3.2	4.4	1.8	14.5	3.5	2.8	7.0	2.8	11.6	3.7	56.3	1.1	4.5	7.5	0.0	3.8	4.0	22.4	8.3	8.0	7.7	5.5	91.2	6.2	2.7	8.0	14.8	4.5	1.3	18.6	7.1	0.9	5.8	8.4	78.5	5.3	4.1	5.9	5.3	2.6	3.7	5.2	3.6	22.5	9.1	5.1	7.2	19.1	63.8	9.2	8.4	1.9	2.0	4.0	4.7	0.8	58.0	45.4	0.0	4.4	7.5	10.5	20.7	4.8	3.3	0.4	4.0	0.9	4.7	2.7
KIF11	"Eg5, HKSP, KNSL1, TRIP5"	ENSG00000138160	"Kinesin family member 11"	P52732	10	92574105-92655395	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.4;lymphoid tissue: 37.9"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 39.1;Granulosa cells: 20.7;Spermatocytes: 38.0;Spermatogonia: 23.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA006916, HPA010093, HPA010568, CAB017617"	Enhanced		Supported	"Mitotic spindle,Cytosol"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Mitotic spindle"	"CAB017617: AB_2131098, HPA006916: AB_1848033, HPA010093: AB_2668281, HPA010568: AB_1848034"	"unprognostic (1.53e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (8.19e-7)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (6.59e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.35e-3)"	"unprognostic (7.23e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.01e-1)"	1.1	0.7	0.5	8.5	0.7	19.4	2.5	0.4	0.6	1.4	0.5	6.3	5.5	1.8	1.0	6.7	1.0	1.2	0.6	0.5	0.5	1.0	1.1	1.3	17.5	0.6	0.6	0.6	0.5	0.7	0.3	3.9	0.6	1.0	7.4	0.8	1.3	0.7	0.2	6.0	5.3	2.5	0.5	2.9	3.9	11.6	0.4	37.9	1.6	0.3	18.5	2.3	2.3	0.6	103.1	45.2	100.6	94.5	7.3	10.5	24.2	72.6	62.8	78.8	78.1	39.6	67.2	111.1	36.5	34.4	32.9	72.0	72.1	36.5	92.4	68.3	41.3	70.5	41.4	42.4	1.4	116.0	63.0	3.6	3.3	61.4	55.9	18.3	50.0	46.1	51.2	126.4	61.1	41.4	99.3	65.8	40.3	42.5	30.7	106.6	98.8	40.2	21.0	30.1	30.0	42.9	56.4	25.9	29.2	34.1	67.9	37.6	28.6	35.7	51.3	37.1	96.9	35.4	58.3	113.4	29.5	82.3	50.3	0.8	0.0	0.1	0.0	0.3	0.3	0.6	0.4	0.4	0.2	0.1	0.1	0.2	0.2	1.0	0.1	0.1	1.1	0.2	0.5	0.7	0.4	0.6	0.5	0.5	0.6	0.6	0.6	0.5	0.4	0.6	0.4	0.0	2.0	1.3	3.5	2.9	1.1	1.6	3.4	1.0	1.8	1.8	1.7	1.5	2.5	1.8	0.0	6.7	2.3	2.9	1.9	0.5	16.3	3.4	4.3	2.0	0.0	39.1	2.1	0.6	11.4	4.7	9.2	4.9	0.0	20.7	2.2	0.4	8.2	0.0	1.8	4.3	4.1	4.6	3.4	4.4	0.9	4.0	0.0	0.0	1.0	0.7	2.1	2.5	1.1	0.2	0.4	0.7	15.2	0.8	0.5	0.6	3.7	0.4	0.0	1.7	3.7	38.0	23.4	12.6	3.3	1.5	4.5	2.5	8.0	1.7
KIF14	KIAA0042	ENSG00000118193	"Kinesin family member 14"	Q15058	1	200551497-200620751	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein"	"Ciliopathy, Disease variant, Meckel syndrome, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.5;lymphoid tissue: 10.9"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 27.1;Granulosa cells: 13.2;Spermatocytes: 22.8;Spermatogonia: 16.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038061, HPA058220"	Uncertain		Supported	"Midbody ring,Cytosol"		Yes	Yes			"Cluster 18: Basophils - Vesicular transport"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Midbody ring"	"HPA038061: AB_10669515, HPA058220: AB_2683642"	"unprognostic (1.84e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-3)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (8.47e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.54e-5)"	"unprognostic (2.31e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.28e-3)"	"unprognostic (3.31e-1)"	"unprognostic (8.14e-2)"	"unprognostic (7.44e-2)"	0.2	0.2	0.1	2.0	0.0	6.5	0.3	0.2	0.3	0.2	0.1	0.9	1.2	0.3	0.0	1.0	0.0	0.2	0.0	0.1	0.1	0.0	0.3	0.2	3.2	0.1	0.2	0.0	0.0	0.0	0.0	0.9	0.1	0.0	1.2	0.1	0.1	0.0	0.0	1.0	1.1	0.6	0.0	0.6	0.6	2.5	0.1	10.9	0.1	0.0	3.2	0.4	0.3	0.1	29.7	17.3	26.8	15.0	0.8	3.0	14.8	20.0	11.7	18.7	16.8	10.5	15.1	18.0	7.0	9.6	11.6	23.0	21.6	13.3	26.7	22.1	11.3	28.8	24.8	10.3	0.1	45.5	15.7	0.6	0.6	20.9	17.8	4.0	13.5	26.3	44.0	22.6	23.5	12.1	26.9	14.2	22.6	8.7	15.0	24.3	35.4	22.8	6.3	8.3	12.7	14.0	28.3	9.5	11.0	19.8	12.9	11.6	11.1	14.7	17.3	16.2	35.3	8.2	8.9	25.8	8.6	24.0	30.5	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	1.0	0.0	0.0	0.0	1.9	2.4	1.0	1.1	0.6	2.3	1.5	1.9	0.8	0.0	0.9	0.0	2.1	4.2	0.6	2.5	0.0	0.2	4.1	3.7	2.2	1.6	0.0	27.1	1.1	0.0	7.7	3.3	10.2	5.0	2.5	13.2	2.5	0.9	5.4	0.0	0.9	5.2	0.0	2.9	1.9	2.5	0.6	2.3	0.0	0.0	0.4	0.5	0.0	0.5	0.8	0.3	0.0	0.7	11.3	1.2	0.2	0.1	1.4	0.8	6.6	1.4	2.1	22.8	16.3	8.3	0.9	1.4	2.3	0.7	4.3	1.9
KIF15	"HKLP2, KNSL7, NY-BR-62"	ENSG00000163808	"Kinesin family member 15"	Q9NS87	3	44761721-44873376	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 5.0;lymphoid tissue: 9.2;testis: 7.3"	"Group enriched"	"Detected in many"	4	"Early spermatids: 177.5;Late spermatids: 78.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA035516, HPA035517, HPA061469"	Approved					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA035516: AB_2674664, HPA035517: AB_10671935, HPA061469: "	"unprognostic (2.26e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (3.12e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.17e-3)"	"unprognostic (6.68e-7)"	"unprognostic (1.35e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.14e-4)"	"unprognostic (2.72e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.38e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.58e-1)"	0.2	0.1	0.1	1.2	0.1	5.0	0.4	0.2	0.2	0.3	0.0	1.4	1.4	0.3	0.0	1.1	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.2	2.2	0.1	0.1	0.1	0.0	0.0	0.0	0.7	0.1	0.2	1.6	0.1	0.2	0.1	0.0	0.8	1.4	0.4	0.1	0.4	0.8	7.3	0.1	9.2	0.0	0.0	2.2	0.3	0.4	0.1	7.5	3.9	17.6	12.8	1.2	1.4	3.9	8.6	5.3	10.8	9.0	6.6	7.2	13.8	2.8	3.1	4.0	6.3	10.1	4.7	13.1	11.6	2.3	14.9	7.7	8.4	0.1	15.6	6.6	0.3	0.2	7.3	7.1	1.6	8.6	18.4	9.3	17.2	8.2	3.9	30.0	5.7	18.2	9.7	7.0	11.9	19.0	7.9	2.4	4.9	8.2	7.8	14.2	4.6	2.9	4.6	7.7	11.7	4.8	10.4	8.5	8.8	11.5	7.2	12.7	17.3	5.5	16.3	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	2.6	1.6	1.9	0.4	0.9	0.0	0.1	0.5	0.8	1.8	0.0	0.7	0.0	2.1	3.3	0.8	2.5	0.0	0.8	177.5	1.3	1.7	1.2	0.0	28.0	3.2	0.0	5.9	1.9	5.1	1.4	0.0	12.3	0.0	0.2	3.5	0.0	3.8	2.6	0.0	1.6	1.4	78.0	0.0	1.8	0.0	0.0	0.3	0.7	1.0	3.0	4.7	0.5	0.1	0.4	9.7	0.5	0.5	0.1	0.2	0.0	0.0	0.4	1.9	20.2	14.7	6.0	1.0	0.7	3.1	1.1	5.3	0.5
KIF18A	"DKFZP434G2226, PPP1R99"	ENSG00000121621	"Kinesin family member 18A"	Q8NI77	11	28020619-28108156	"Predicted intracellular proteins"	"Protein transport, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 8.2;lymphoid tissue: 9.6;testis: 13.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 43.1;Spermatocytes: 78.7;Spermatogonia: 28.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 4.1;memory B-cell: 1.0;NK-cell: 1.4;T-reg: 1.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA039312, HPA039484"	Approved		Supported	"Microtubules,Cytokinetic bridge"		Yes	Yes			"Cluster 41: Basophils - Cellular respiration"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Microtubules, Cytokinetic bridge"		"HPA039312: AB_10794087, HPA039484: AB_10795252"	"unprognostic (3.79e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.09e-3)"	"unprognostic (3.80e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.34e-7)"	"unprognostic (2.43e-3)"	"unprognostic (2.04e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.72e-4)"	"unprognostic (4.41e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.88e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.50e-1)"	0.2	0.1	0.0	1.9	0.1	8.2	0.7	0.0	0.1	0.7	0.1	1.6	1.5	0.5	0.3	1.4	0.3	0.5	0.0	0.1	0.1	0.3	0.3	1.0	4.7	0.1	0.1	0.1	0.1	0.1	0.1	1.5	0.1	0.3	2.0	0.6	0.3	0.4	0.2	1.2	1.4	0.8	0.1	0.7	0.6	13.7	0.2	9.6	1.1	0.1	4.6	0.7	0.5	0.1	27.9	27.4	27.2	19.0	0.9	3.7	9.1	28.3	13.2	44.2	46.0	9.2	11.0	23.3	10.0	14.7	24.1	27.2	23.4	11.1	61.4	23.4	14.2	15.2	17.8	11.8	2.1	22.6	13.4	6.8	1.4	15.5	18.1	7.8	17.2	19.0	24.6	20.0	25.2	14.8	23.1	16.7	13.4	18.0	11.1	17.8	65.0	11.6	12.5	8.0	16.3	12.6	23.7	11.1	7.8	16.5	23.8	6.9	10.1	35.0	27.2	33.2	37.4	7.9	19.8	23.4	21.0	16.5	25.2	4.1	0.0	0.3	0.1	0.2	0.3	1.0	0.4	0.2	0.3	0.4	0.3	0.1	0.0	1.4	0.0	0.3	1.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	1.2	3.2	0.0	0.0	4.7	2.3	1.3	1.4	1.2	0.3	1.3	2.9	0.5	0.0	2.2	0.0	6.2	4.6	2.8	1.9	0.0	0.6	43.1	3.4	2.5	1.1	1.8	15.4	0.2	0.9	7.1	5.4	1.5	3.4	4.5	9.7	1.4	0.0	2.2	0.0	0.1	1.9	0.0	1.6	1.4	8.7	0.6	1.4	0.0	1.0	1.1	0.7	1.0	0.5	0.9	0.5	0.1	0.4	5.1	0.2	0.2	0.6	1.7	1.9	0.0	2.5	1.9	78.7	28.3	4.3	1.0	1.6	3.9	2.7	3.6	0.5
KIF18B		ENSG00000186185	"Kinesin family member 18B"	Q86Y91	17	44924709-44947773	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 12.7;lymphoid tissue: 14.4"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 9.0;Extravillous trophoblasts: 3.8;Granulosa cells: 5.9;Oligodendrocyte precursor cells: 7.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"white matter: 1.4"	"Low region specificity"	"Detected in many"			HPA024205	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Microtubule ends,Cytosol"		Yes	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Microtubule ends"	"Nuclear bodies, Cytosol"	"HPA024205: AB_1852472"	"unprognostic (1.88e-1)"	"unprognostic (9.92e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.17e-1)"	"unprognostic (7.27e-3)"	"prognostic unfavorable (2.44e-6)"	"unprognostic (3.34e-3)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (8.18e-2)"	"unprognostic (0.00e+0)"	"unprognostic (4.69e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.68e-2)"	0.4	0.4	0.3	3.8	0.4	12.7	0.2	0.7	0.3	0.9	0.3	2.0	2.7	0.4	0.0	5.1	0.2	0.4	0.3	0.3	0.4	0.2	0.4	0.8	5.7	0.5	1.1	0.1	0.1	0.0	0.1	1.9	0.6	0.2	1.7	0.1	0.7	0.0	0.4	3.0	2.5	1.1	0.3	2.9	1.5	2.9	0.6	14.4	0.2	0.0	4.7	0.6	1.6	0.5	31.5	41.7	35.3	32.8	0.8	3.0	28.1	25.8	10.3	34.6	26.9	34.0	27.4	28.3	10.9	10.8	21.5	34.0	25.1	11.3	17.9	56.6	36.4	35.4	51.7	22.1	0.0	30.0	30.2	0.7	0.6	29.7	12.2	4.7	17.9	29.2	28.1	48.0	18.2	25.9	60.0	31.1	25.4	30.4	28.9	43.5	51.8	19.2	5.8	16.7	26.2	24.7	18.0	16.1	9.8	17.0	30.2	21.6	11.2	49.9	48.0	28.8	56.8	15.1	15.7	34.4	16.3	22.9	33.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.3	0.4	0.7	0.3	0.3	0.4	0.5	1.1	0.6	0.3	0.6	0.5	0.1	0.0	0.0	0.0	0.9	0.4	0.1	0.2	0.0	0.5	0.5	0.4	2.6	0.0	0.0	0.0	0.0	2.4	0.4	1.9	0.0	0.0	0.0	0.3	0.8	0.6	0.0	9.0	0.3	0.0	3.8	1.4	1.5	0.5	0.0	5.9	0.4	0.3	2.3	0.0	0.3	1.6	0.0	2.2	1.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	7.1	0.1	0.1	0.0	0.0	2.1	0.2	0.3	0.0	0.0	0.3	0.0	0.2	0.8	1.1	2.9	2.5	0.4	0.8	1.3	0.3	3.2	0.3
KIF20B	"CT90, KRMP1, MPHOSPH1, MPP1"	ENSG00000138182	"Kinesin family member 20B"	Q96Q89	10	89701590-89774939	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.2;lymphoid tissue: 9.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 89.2;Spermatocytes: 165.4;Spermatogonia: 96.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA050214	Supported		Supported	"Nucleoplasm,Cytokinetic bridge,Midbody,Cytosol"		Yes	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytokinetic bridge"	"Midbody, Cytosol"	"HPA050214: AB_2681053"	"unprognostic (2.13e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.39e-2)"	"unprognostic (8.95e-5)"	"unprognostic (3.32e-3)"	"unprognostic (2.01e-2)"	"unprognostic (8.14e-2)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (3.06e-6)"	"unprognostic (4.22e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.51e-2)"	"unprognostic (6.43e-2)"	1.3	0.7	0.3	4.5	1.0	10.2	2.5	2.4	0.4	1.5	0.1	3.2	3.6	2.3	0.4	3.3	1.2	1.3	0.9	0.3	0.3	1.3	1.3	1.5	8.0	0.5	0.3	2.7	0.7	1.1	0.2	2.4	0.6	1.3	4.0	1.1	1.0	0.9	0.4	2.5	3.4	2.2	0.4	3.3	2.5	6.9	0.6	9.8	1.8	0.7	7.5	1.6	0.7	0.6	84.8	17.0	24.3	21.7	4.7	8.0	20.2	33.8	30.9	34.8	36.3	22.6	38.1	32.5	10.4	17.3	13.0	41.8	27.3	18.9	46.4	39.5	18.6	33.1	30.5	19.5	1.4	57.1	26.3	3.4	2.8	33.7	33.9	12.2	22.8	17.0	32.2	36.5	31.3	14.6	33.6	10.8	25.0	13.8	16.1	23.1	47.8	14.3	10.7	11.2	7.7	13.9	24.4	11.0	12.2	17.3	28.5	16.3	17.9	22.2	22.1	29.1	55.3	10.1	29.5	43.2	21.1	49.4	16.8	13.1	2.4	4.2	5.5	4.1	6.8	13.0	7.4	6.1	1.3	16.0	8.6	8.0	0.2	3.0	4.5	5.2	9.5	2.2	0.3	1.0	2.4	0.4	0.3	0.3	0.5	0.3	0.6	0.4	0.6	0.6	11.5	3.2	13.5	2.3	36.4	17.7	6.2	20.8	6.8	14.3	8.3	8.5	8.7	1.5	10.7	0.0	10.4	21.4	32.3	8.8	3.9	6.9	13.1	10.6	13.2	11.0	1.2	89.2	8.1	4.7	38.1	13.2	14.8	12.9	44.4	37.2	9.3	4.4	20.7	13.5	9.5	8.6	16.2	21.0	17.9	10.5	8.1	17.1	5.4	23.4	11.3	7.5	24.7	9.0	9.1	4.1	5.7	8.6	51.4	3.7	8.9	3.2	6.6	9.8	6.6	16.9	17.1	165.4	96.7	26.1	14.1	5.2	34.2	12.9	25.5	5.2
KIF23	"KNSL5, MKLP-1, MKLP1"	ENSG00000137807	"Kinesin family member 23"	Q02241	15	69414246-69448427	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 21.6;lymphoid tissue: 15.9"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 24.2;Erythroid cells: 42.3;Extravillous trophoblasts: 32.4;Granulosa cells: 22.4;Spermatocytes: 70.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 4.6"	"Group enriched"	"Detected in many"	13	"granulocytes: 4.6;monocytes: 1.2;T-cells: 1.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB010414, HPA045208, HPA068831"	Uncertain		Enhanced	"Nucleoplasm,Midbody ring,Mitotic spindle"		Yes	Yes			"Cluster 49: Eosinophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Midbody ring, Mitotic spindle"	"CAB010414: AB_631959, HPA045208: AB_2679254, HPA068831: AB_2686045"	"unprognostic (1.29e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.57e-2)"	"prognostic unfavorable (8.62e-4)"	"unprognostic (1.86e-1)"	"unprognostic (7.99e-3)"	"prognostic unfavorable (3.18e-5)"	"unprognostic (1.43e-3)"	"unprognostic (4.25e-3)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (3.69e-5)"	"unprognostic (5.85e-3)"	"unprognostic (0.00e+0)"	"unprognostic (1.15e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.17e-2)"	1.0	1.5	0.3	5.7	0.2	21.6	1.4	0.2	0.3	1.5	1.4	4.1	3.9	2.0	0.1	5.3	0.9	1.3	0.6	0.3	0.2	4.6	0.5	1.5	7.9	0.2	0.3	0.7	0.5	0.4	0.1	6.4	0.3	0.9	5.0	0.2	1.1	1.2	0.1	3.7	3.8	4.2	0.2	2.2	2.0	10.6	0.3	15.9	0.3	0.2	9.8	1.8	2.1	0.2	100.7	81.5	64.2	59.0	3.7	7.3	36.3	105.3	57.0	154.8	120.6	50.2	72.4	56.8	31.4	53.1	78.6	110.5	121.6	39.5	158.7	52.9	60.2	55.3	78.8	30.7	2.1	55.6	48.3	3.3	4.2	71.8	60.5	19.4	52.0	46.9	36.0	70.2	95.4	44.1	31.2	28.2	71.6	35.5	33.2	37.0	133.8	31.2	39.3	49.7	32.5	25.3	120.4	51.9	44.9	74.5	50.6	25.3	34.5	90.0	120.8	62.0	157.6	26.3	74.3	48.4	31.5	72.2	78.0	0.0	1.2	4.6	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.6	0.0	1.2	0.3	0.3	0.2	0.2	0.3	0.3	0.2	0.2	0.3	0.3	0.2	0.3	0.2	0.4	0.0	0.5	0.0	2.3	1.9	3.7	4.2	0.0	0.2	1.8	2.8	0.8	5.7	4.7	7.3	2.1	24.2	1.4	3.3	3.9	1.8	13.3	13.1	3.6	2.2	1.8	42.3	1.8	0.0	32.4	5.8	3.6	8.7	2.5	22.4	3.9	0.3	8.1	0.0	1.0	3.1	0.0	2.8	3.4	4.8	0.9	3.2	0.0	1.0	8.1	0.2	0.0	0.0	0.2	0.4	0.4	1.9	6.8	1.6	0.8	0.9	3.6	0.1	6.6	0.4	8.2	70.8	20.9	11.3	1.0	2.5	4.2	3.6	8.6	3.3
KIF24	"bA571F15.4, C9orf48, FLJ10933, FLJ43884"	ENSG00000186638	"Kinesin family member 24"	Q5T7B8	9	34252381-34311371	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 11.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 32.3;Early spermatids: 28.9;Late spermatids: 41.6;Spermatocytes: 14.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	19	"basophil: 2.8"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 2.8"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA020643	Uncertain					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA020643: AB_2131749"	"unprognostic (2.68e-1)"	"prognostic favorable (1.33e-4)"	"unprognostic (9.44e-2)"	"unprognostic (3.82e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.40e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.40e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.50e-1)"	0.2	0.6	0.7	0.9	1.0	2.1	0.7	0.6	0.7	0.6	4.4	0.9	0.6	0.6	1.4	0.9	3.2	0.4	0.5	0.8	0.8	0.9	0.3	0.6	1.3	1.9	2.3	0.4	0.5	1.5	1.0	0.6	1.3	0.4	1.0	0.4	0.3	0.5	0.7	0.9	0.6	0.7	1.5	0.3	0.6	11.1	0.8	3.9	1.2	0.6	1.6	0.3	0.4	0.8	9.8	6.4	7.5	6.2	0.6	1.0	2.8	5.3	3.4	7.0	8.4	3.1	3.0	7.6	1.6	2.5	4.5	4.5	7.6	4.6	7.2	4.9	3.3	3.5	10.7	1.9	0.2	7.2	5.3	0.4	0.9	9.1	3.8	1.3	3.2	5.3	3.6	6.0	3.9	4.0	8.7	6.7	3.0	4.5	3.8	8.0	4.6	2.1	2.9	2.5	3.5	3.4	6.5	3.3	0.9	2.9	3.6	3.5	2.6	6.5	7.1	5.1	6.5	1.7	2.9	4.1	4.4	3.5	8.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	1.0	0.6	0.7	0.8	0.8	1.9	2.3	1.3	1.5	0.8	0.8	0.3	0.0	1.1	32.3	0.7	0.4	0.2	0.7	0.6	0.3	0.7	1.1	0.9	1.5	1.6	1.8	0.0	0.6	0.3	0.7	0.0	0.4	28.9	8.2	0.8	0.4	0.0	3.0	7.2	0.2	1.0	0.7	2.0	0.8	0.0	1.5	0.0	0.0	0.7	0.0	3.5	0.8	2.0	0.3	0.3	41.6	0.9	0.4	0.0	3.7	0.1	0.2	0.0	10.1	9.2	0.2	0.0	1.9	2.1	0.1	0.3	0.4	11.0	0.4	0.0	0.5	0.4	14.5	6.9	1.0	0.9	0.3	0.3	0.8	0.7	0.1
KIF2A	"HK2, KIF2"	ENSG00000068796	"Kinesin family member 2A"	O00139	5	62306162-62391025	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis"	"Developmental protein, Motor protein"	"Cancer-related genes, Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004715, HPA004716"	Approved		Enhanced	Nucleoplasm,Nucleoli,Centrosome		Yes	No		300000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Nucleoli, Centrosome"		"HPA004715: AB_2667215, HPA004716: AB_1079211"	"unprognostic (2.40e-2)"	"unprognostic (3.43e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (2.74e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (5.45e-4)"	"prognostic unfavorable (3.17e-6)"	"unprognostic (8.77e-3)"	"unprognostic (4.69e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (3.81e-5)"	"unprognostic (3.53e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.58e-1)"	11.9	7.7	15.6	23.2	20.7	12.8	10.8	15.5	17.7	19.5	0.0	13.8	11.5	12.0	6.3	12.5	17.6	12.9	6.2	17.4	23.0	8.0	5.3	9.8	32.8	17.9	17.5	12.9	10.2	12.3	8.5	16.9	18.4	9.9	14.7	42.7	6.9	11.4	4.8	5.9	15.9	13.1	14.6	18.4	9.6	49.1	16.1	43.6	12.6	6.8	28.9	20.2	7.2	28.0	47.3	46.9	81.4	67.3	28.8	39.6	65.2	51.2	38.5	54.6	67.5	53.1	49.6	111.9	53.3	41.9	67.2	29.1	61.3	37.7	72.5	116.8	44.2	113.8	41.2	27.8	34.7	65.3	42.9	30.5	26.6	50.1	47.5	33.1	49.1	66.5	86.6	66.7	46.9	36.1	104.4	33.1	42.6	12.0	31.9	78.3	59.6	65.3	25.4	55.4	68.0	55.9	67.0	27.9	34.7	55.3	37.6	38.5	39.8	31.9	52.2	40.5	51.3	64.8	94.9	114.1	36.4	74.5	39.8	10.4	4.6	4.7	29.2	5.0	35.3	13.5	29.8	32.7	6.2	10.5	26.3	29.0	7.8	23.2	3.3	9.6	42.3	17.7	15.6	20.7	15.5	17.7	17.4	23.0	17.9	17.5	18.4	14.6	16.1	28.0	30.8	16.0	14.1	54.5	44.1	16.8	41.4	20.1	39.3	45.5	17.9	23.9	9.4	4.3	20.5	20.2	104.3	20.3	73.4	23.1	13.7	37.5	113.8	103.3	47.2	21.4	21.0	42.3	56.7	30.9	22.6	28.2	20.4	43.4	17.7	25.6	19.6	4.4	15.4	52.2	64.5	7.9	14.2	12.9	22.1	130.7	13.1	83.6	12.4	26.2	104.9	28.0	76.2	119.6	156.0	26.6	26.1	13.2	47.8	42.7	13.5	18.7	49.2	92.9	26.3	33.1	25.4	118.9	42.8	34.3	9.5	43.9	77.9	48.9	11.0	56.1
KIF2C	"CT139, KNSL6, MCAK"	ENSG00000142945	"Kinesin family member 2C"	Q99661	1	44739818-44767767	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 33.0;lymphoid tissue: 37.4;testis: 76.5"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 1860.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"white matter: 2.1"	"Not detected"	"Not detected"			"HPA006219, HPA079172"	Enhanced		Supported	Nucleoplasm,Midbody,Centrosome		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Centrosome"	Midbody	"HPA006219: AB_2667540, HPA079172: "	"unprognostic (3.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (3.07e-7)"	"unprognostic (7.49e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.66e-1)"	"prognostic unfavorable (6.86e-4)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.41e-1)"	0.7	0.8	0.7	7.0	0.7	33.0	1.6	2.3	0.7	1.8	1.1	6.2	5.5	1.8	0.7	7.3	0.9	1.3	1.3	0.6	1.1	0.8	0.7	1.3	16.4	1.1	0.9	0.6	0.5	1.3	0.4	5.4	1.4	0.8	7.6	0.8	1.3	0.7	0.9	6.0	5.1	3.2	0.9	3.7	3.5	76.5	0.8	37.4	1.1	0.7	19.2	2.1	2.7	0.8	119.7	45.8	99.6	79.8	5.3	11.6	66.6	86.9	62.1	175.0	151.3	77.6	84.2	136.2	41.3	43.2	121.7	55.2	102.8	59.6	158.2	89.1	44.4	162.1	83.3	65.5	0.6	121.5	71.8	2.7	5.8	125.0	60.3	16.5	57.6	95.4	130.4	113.1	112.4	46.5	127.5	72.9	97.1	58.4	56.5	101.1	149.3	86.4	29.6	42.8	68.3	48.5	116.1	81.6	71.5	71.9	47.2	90.7	34.7	62.9	124.2	69.0	155.6	59.4	65.0	195.3	40.3	115.4	123.9	0.0	0.0	0.0	0.9	0.0	0.0	0.6	1.7	1.2	0.1	0.1	0.3	0.2	0.0	2.0	0.1	0.8	2.9	0.5	0.7	0.7	2.3	0.7	0.6	1.1	1.1	0.9	1.4	0.9	0.8	0.8	0.1	0.0	0.5	1.6	1.3	1.8	0.5	2.4	0.0	1.0	0.9	0.9	1.6	0.0	1.7	1.8	2.1	12.2	1.9	2.9	1.9	0.3	461.1	1.2	1.4	1.6	0.0	34.5	0.8	0.4	23.4	3.2	3.1	2.1	0.0	13.0	2.9	0.2	9.2	0.0	1.0	3.5	0.0	1.9	1.5	1860.6	9.3	3.4	0.0	1.0	4.3	0.4	0.0	0.5	0.2	0.1	0.2	6.8	7.8	0.8	0.3	0.2	0.3	0.2	6.6	0.8	3.4	60.6	36.8	4.6	0.4	3.7	2.7	0.8	7.4	0.7
KIF4A	"FLJ12530, FLJ12655, FLJ14204, FLJ20631, HSA271784, KIF4, KIF4-G1, MRX100"	ENSG00000090889	"Kinesin family member 4A"	O95239	X	70290104-70420886	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"DNA-binding, Motor protein"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 11.2;lymphoid tissue: 12.6"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 18.6;Erythroid cells: 29.5;Extravillous trophoblasts: 11.5;Granulosa cells: 12.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA034745, HPA034746, HPA061583"	Approved		Supported	Nucleoplasm,Midbody		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Midbody"		"HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: AB_2684564"	"unprognostic (8.17e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.46e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (7.37e-6)"	"unprognostic (2.18e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (9.44e-6)"	"unprognostic (3.79e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.47e-1)"	0.3	0.3	0.3	3.2	0.2	11.2	0.7	0.1	0.3	0.6	0.3	3.7	3.1	0.8	0.0	3.6	1.5	0.5	0.2	0.2	0.5	0.2	0.5	0.5	5.5	0.9	0.7	0.1	0.1	0.1	0.5	2.3	0.6	0.1	4.5	0.6	0.5	0.1	0.1	2.2	3.3	1.3	0.7	2.4	1.7	1.5	0.6	12.6	0.2	0.0	6.6	0.9	1.1	0.2	60.2	41.1	61.0	30.1	2.9	5.1	24.0	44.7	23.8	59.7	51.6	46.7	34.3	36.7	27.4	22.1	46.2	35.1	66.6	24.2	66.8	42.5	33.4	41.7	50.1	33.4	0.7	46.7	27.8	1.7	1.5	49.6	28.2	7.3	37.0	27.7	53.8	79.1	57.0	38.7	43.0	23.1	61.7	63.8	43.2	47.1	82.2	34.6	14.5	23.4	40.1	33.5	72.9	30.5	18.6	30.6	24.5	18.1	26.0	39.3	50.6	42.6	54.1	22.6	41.7	52.0	20.8	50.4	60.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.2	0.1	0.3	0.2	0.5	0.9	0.7	0.6	0.7	0.6	0.2	0.1	0.0	0.5	1.3	1.3	1.8	0.3	1.4	0.6	0.2	1.1	0.8	0.4	1.5	0.2	0.0	0.0	7.0	0.9	2.2	0.0	0.0	0.4	18.6	1.5	1.3	1.2	29.5	1.9	0.0	11.5	2.1	3.1	1.6	0.0	12.2	1.1	0.1	5.3	0.0	1.9	4.6	2.0	1.3	0.7	0.8	0.0	1.4	0.0	0.0	0.2	3.1	0.0	2.0	0.7	0.1	0.1	0.0	8.2	0.4	0.3	0.1	0.4	0.0	0.0	0.2	2.9	8.7	5.4	7.2	0.3	1.8	1.8	1.3	6.6	0.5
KIF9	MGC104186	ENSG00000088727	"Kinesin family member 9"	Q9HAQ2	3	47228395-47283451	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 64.4"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 690.3;Endometrial ciliated cells: 398.0;Respiratory ciliated cells: 359.0;Spermatocytes: 328.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022031, HPA022033, HPA030429"	Approved					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA022031: AB_1852502, HPA022033: AB_1852504, HPA030429: AB_10601921"	"unprognostic (1.93e-2)"	"unprognostic (6.37e-2)"	"prognostic favorable (2.26e-4)"	"unprognostic (1.17e-3)"	"unprognostic (8.86e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.80e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.94e-2)"	"unprognostic (4.59e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (5.95e-6)"	"unprognostic (4.21e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.23e-1)"	6.5	7.4	9.3	3.1	10.1	11.8	10.6	8.8	14.4	7.6	23.1	9.1	6.1	7.9	20.5	5.8	26.3	6.4	14.1	10.1	9.8	26.8	6.0	8.6	2.6	12.0	12.9	5.0	12.7	10.1	16.4	3.7	11.4	7.7	8.1	18.7	8.9	4.8	9.4	8.4	5.6	4.5	11.0	5.7	9.3	64.4	10.0	2.3	21.0	5.7	3.1	6.8	5.4	9.5	19.4	21.7	7.6	19.1	3.6	8.7	6.2	5.9	6.1	8.8	7.8	8.4	23.0	12.8	7.3	7.6	11.8	12.0	22.6	15.3	8.7	6.6	14.6	11.9	16.5	26.9	3.4	25.3	3.8	4.5	15.3	12.8	9.6	7.4	19.0	13.5	26.5	5.1	6.6	15.5	13.7	37.6	21.7	44.4	30.5	8.6	5.3	18.3	36.7	10.9	10.8	19.9	6.8	13.0	21.8	3.9	8.4	17.6	9.0	5.1	11.0	8.3	13.6	4.4	19.7	16.1	18.9	25.1	11.3	2.5	3.6	2.1	1.5	2.6	3.0	3.5	1.4	2.3	5.7	0.6	1.7	1.9	6.3	3.5	2.3	3.3	1.0	1.3	9.3	10.1	8.8	14.4	10.1	9.8	12.0	12.9	11.4	11.0	10.0	9.5	34.5	19.2	18.4	4.2	6.7	20.1	53.7	44.3	20.5	7.2	61.4	74.5	28.2	38.6	51.9	64.4	35.5	10.7	7.5	23.8	109.5	45.5	690.3	398.0	17.8	29.3	58.9	20.0	16.6	32.7	11.1	12.1	34.1	38.5	29.1	11.3	17.9	20.7	9.2	5.0	10.3	40.1	52.9	7.2	7.1	160.6	14.0	8.0	16.0	2.8	3.8	17.2	3.1	2.5	3.2	26.0	15.7	13.2	5.7	37.6	15.1	198.1	359.0	44.0	13.1	42.2	16.7	328.8	37.3	17.2	20.2	8.2	7.8	21.8	37.8	37.4
KIFBP	"DKFZP586B0923, KBP, KIAA1279, KIF1BP, TTC20"	ENSG00000198954	"Kinesin family binding protein"	Q96EK5	10	68988803-69043544	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Hirschsprung disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 9.5;Cardiomyocytes: 40.7;Cytotrophoblasts: 21.7;Extravillous trophoblasts: 19.5;Fibroblasts: 8.7;Hofbauer cells: 16.7;Syncytiotrophoblasts: 8.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035538, HPA035539"	Uncertain					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"			"HPA035538: AB_10601130, HPA035539: AB_2674676"	"unprognostic (4.28e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.64e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.23e-3)"	"unprognostic (3.72e-2)"	"unprognostic (3.52e-2)"	"unprognostic (7.74e-2)"	"unprognostic (6.23e-3)"	"unprognostic (8.74e-2)"	"prognostic favorable (2.60e-4)"	"unprognostic (5.19e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.04e-1)"	19.9	22.1	21.3	6.7	24.4	1.3	11.2	24.4	32.5	14.0	19.7	11.9	6.4	12.5	15.9	12.2	11.8	12.6	37.3	24.6	23.8	19.5	13.8	9.9	6.7	23.9	22.2	12.3	8.5	33.8	13.6	14.8	24.5	16.6	10.3	25.7	9.8	17.3	30.4	8.7	8.1	15.3	25.7	7.5	11.4	16.2	22.7	7.6	19.2	43.3	9.2	15.2	9.3	28.1	49.1	36.9	33.3	36.1	48.3	42.5	0.2	63.2	58.0	63.4	71.9	40.4	24.7	0.1	20.7	57.3	39.5	40.2	57.0	37.9	63.6	27.5	48.8	9.5	22.0	24.0	32.4	13.3	11.5	26.4	30.4	42.3	37.7	60.5	46.6	15.1	13.1	14.0	78.4	23.3	13.0	15.8	20.7	25.4	84.1	15.5	27.7	7.2	67.4	12.4	25.0	18.1	36.0	48.9	34.8	32.2	60.3	10.2	46.3	28.0	25.7	24.6	64.0	2.8	0.3	9.0	35.9	19.8	15.7	1.8	4.3	2.4	7.3	7.5	8.8	5.1	8.4	7.2	5.5	4.1	9.6	7.8	1.6	6.9	12.9	2.8	8.0	5.0	21.3	24.4	24.4	32.5	24.6	23.8	23.9	22.2	24.5	25.7	22.7	28.1	9.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.7	0.0	0.0	0.0	0.0	21.7	3.5	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	19.5	8.7	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	8.3	0.9	0.0	0.0	0.0
KIFC1	"HSET, KNSL2"	ENSG00000237649	"Kinesin family member C1"	Q9BW19	6	33391823-33409896	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 39.7;lymphoid tissue: 47.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 32.0;Erythroid cells: 62.3;Extravillous trophoblasts: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"T-reg: 1.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			"HPA055997, HPA062674"	Enhanced		Approved	Centrosome		NA	Yes			"Cluster 40: NK-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Centrosome		"HPA055997: AB_2683001, HPA062674: AB_2684829"	"unprognostic (7.33e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (7.07e-8)"	"unprognostic (6.34e-3)"	"unprognostic (9.36e-3)"	"unprognostic (8.58e-2)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (1.83e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.17e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.52e-1)"	1.1	1.1	0.2	10.6	0.3	39.7	2.2	0.3	1.2	2.5	0.4	8.0	8.8	1.8	0.2	11.7	0.8	1.5	0.6	0.7	0.3	0.8	1.0	2.3	24.6	0.4	0.7	2.0	0.7	0.3	0.6	5.5	0.5	0.9	8.2	0.4	2.1	0.2	0.2	9.8	8.1	4.1	0.2	5.3	4.7	12.3	0.6	47.5	0.7	0.4	24.9	2.7	3.9	0.5	133.5	47.9	120.6	124.2	5.2	8.1	64.0	82.5	48.4	122.6	104.6	80.6	53.3	120.2	38.3	41.5	102.0	88.1	87.1	60.7	79.7	114.3	60.3	93.9	71.6	73.5	0.5	96.0	75.7	2.5	4.7	73.2	38.8	13.8	64.2	87.5	76.0	112.3	81.0	86.2	125.7	103.2	47.5	67.6	48.4	129.7	110.7	61.4	38.4	42.8	100.1	57.2	54.3	91.9	44.1	51.3	78.7	105.4	32.2	74.6	104.6	56.2	128.9	58.2	132.4	126.1	18.8	94.8	101.0	0.4	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.6	0.2	0.2	0.0	0.0	0.0	1.0	0.3	0.0	1.6	0.5	0.2	0.3	0.3	1.2	0.7	0.3	0.4	0.7	0.5	0.2	0.6	0.5	0.4	0.0	2.5	1.0	4.1	5.6	1.5	4.6	2.2	0.4	2.8	2.2	0.5	0.0	1.9	0.0	0.0	18.7	3.7	8.8	0.0	0.7	32.0	2.7	1.9	2.4	0.0	62.3	0.3	0.0	39.6	4.2	4.1	6.1	1.3	15.0	1.8	0.3	14.3	0.0	0.3	8.0	2.0	2.4	9.8	12.0	0.3	4.7	3.6	1.0	3.1	0.3	0.0	1.0	0.6	0.3	2.1	0.7	12.0	0.9	2.1	0.7	0.8	0.5	0.0	2.5	7.5	13.9	9.6	14.4	3.7	6.7	5.7	0.6	12.1	3.1
KIN	"KIN17, Rts2"	ENSG00000151657	"Kin17 DNA and RNA binding protein"	O60870	10	7750962-7787993	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, DNA replication, Host-virus interaction, mRNA processing, Stress response"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016339, HPA038700"			Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB016339: AB_627860, HPA038700: AB_2676159"	"unprognostic (4.33e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.17e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.40e-3)"	"prognostic unfavorable (1.44e-7)"	"unprognostic (3.98e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.65e-1)"	"prognostic favorable (3.23e-5)"	2.1	2.4	1.9	2.6	1.9	3.1	2.6	4.4	2.5	2.8	1.8	2.2	2.4	3.3	2.8	2.0	2.4	2.1	2.1	1.8	1.8	2.3	3.3	2.2	3.4	1.7	1.8	3.0	2.7	2.0	2.6	3.0	1.9	2.5	2.2	3.4	2.5	2.1	2.8	3.4	2.4	2.1	1.4	2.8	2.5	2.1	2.0	2.4	2.9	2.2	2.7	2.1	2.4	2.6	4.3	2.7	4.1	2.5	3.3	3.9	3.3	3.8	1.7	4.5	4.8	5.2	4.2	3.3	1.9	2.3	1.4	4.0	3.5	2.3	5.1	3.8	4.0	5.2	2.7	5.1	4.6	1.9	4.1	3.3	2.5	3.4	2.2	3.7	3.4	4.1	5.3	3.1	3.5	3.9	3.8	2.9	3.9	4.5	1.6	4.8	2.9	3.1	3.8	2.3	1.7	3.8	3.0	2.9	6.2	3.8	5.5	3.8	2.5	2.9	3.2	5.1	3.1	4.0	4.7	4.1	3.6	2.9	2.0	15.9	3.9	7.1	3.7	4.3	3.7	5.9	3.3	3.1	3.0	5.4	3.6	3.8	8.8	4.9	4.1	5.8	3.0	1.5	1.9	1.9	4.4	2.5	1.8	1.8	1.7	1.8	1.9	1.4	2.0	2.6	31.5	35.3	27.2	12.1	20.7	17.3	14.6	31.3	13.6	54.8	17.2	20.1	13.0	20.0	24.8	18.4	39.6	36.7	32.0	20.4	13.7	32.9	5.7	21.7	28.4	25.6	23.3	30.3	17.4	21.5	23.8	24.0	14.3	27.9	16.4	22.9	21.0	11.9	32.1	63.9	14.8	20.3	18.3	16.9	22.8	6.2	27.7	21.8	16.0	11.2	30.7	28.7	38.1	13.0	19.4	21.2	23.6	30.9	18.1	18.9	18.2	16.9	26.0	54.7	13.1	27.8	29.7	29.1	19.0	12.1	14.3	38.4	25.7	30.1	14.7	17.3
KLHDC4	DKFZp434G0522	ENSG00000104731	"Kelch domain containing 4"	Q8TBB5	16	87696485-87765992	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 61.6;Late spermatids: 79.9;NK-cells: 77.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 112.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041665	Approved		Approved	"Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoli	"Mitotic chromosome"	"HPA041665: AB_10796352"	"unprognostic (2.96e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.28e-3)"	"unprognostic (3.54e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.61e-3)"	"unprognostic (6.40e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.87e-1)"	"prognostic favorable (1.14e-4)"	"unprognostic (3.84e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.88e-1)"	"prognostic favorable (1.69e-4)"	10.6	10.8	7.6	11.6	7.2	13.3	10.7	11.7	9.0	11.8	5.2	14.0	8.9	11.6	4.4	11.9	12.0	6.7	8.9	7.8	7.7	14.0	14.6	11.4	16.1	7.6	7.0	12.2	18.4	10.3	13.1	5.4	7.4	13.2	10.9	6.2	11.8	7.8	12.5	11.9	13.7	7.1	6.3	19.8	14.0	12.5	7.3	15.6	13.1	6.4	13.4	11.5	12.9	7.1	16.6	29.7	14.8	22.8	6.0	7.9	23.3	15.1	14.5	24.8	11.6	43.9	23.3	25.6	19.6	12.1	8.8	26.6	23.1	20.0	18.0	4.2	24.9	15.0	20.6	29.4	14.9	14.3	14.8	3.6	10.7	21.9	25.0	12.4	20.8	42.5	48.3	13.4	17.1	72.0	32.7	40.3	25.5	18.9	21.8	31.3	17.3	15.3	15.0	19.2	22.5	21.4	31.9	16.4	7.8	12.6	25.8	22.0	13.4	13.1	23.3	7.1	29.5	63.2	23.4	112.0	13.2	35.2	9.7	0.0	7.8	5.9	18.3	10.8	16.2	7.8	7.2	14.1	6.0	7.7	7.3	11.3	0.6	25.7	16.0	8.0	6.8	8.7	7.6	7.2	11.7	9.0	7.8	7.7	7.6	7.0	7.4	6.3	7.3	7.1	8.4	0.0	16.8	11.1	14.7	4.6	10.9	6.8	12.5	17.8	12.7	9.9	9.9	14.3	14.2	9.2	27.1	14.4	36.1	16.5	11.7	12.3	61.6	8.9	6.0	8.8	24.0	16.0	9.1	16.7	9.4	9.0	19.4	11.4	3.8	17.7	12.1	13.3	13.3	11.8	10.1	15.9	8.2	13.3	6.1	79.9	6.5	9.9	8.8	7.5	10.2	6.5	77.2	7.1	9.2	13.1	9.3	7.5	35.9	15.1	13.8	25.1	9.0	18.0	0.0	16.7	8.5	22.8	11.8	8.6	6.7	11.9	25.5	11.6	21.8	16.5
KLHL12	C3IP1	ENSG00000117153	"Kelch like family member 12"	Q53G59	1	202891116-202928636	"Predicted intracellular proteins"	"ER-Golgi transport, Transport, Ubl conjugation pathway, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 140.7;Late spermatids: 88.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA071324			Supported	"Vesicles,Centriolar satellite"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Vesicles, Centriolar satellite"		"HPA071324: AB_2686389"	"unprognostic (1.69e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.86e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.35e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.11e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.20e-3)"	"unprognostic (6.22e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.87e-2)"	13.3	15.8	26.4	14.6	26.8	18.8	17.3	24.7	27.8	13.8	23.9	19.4	14.5	14.9	22.7	15.8	18.4	12.3	20.4	27.5	29.8	21.8	16.2	15.0	19.0	24.6	26.5	17.7	16.3	21.2	15.2	15.6	27.6	19.3	23.4	24.6	13.7	13.6	14.3	13.5	14.8	17.3	24.6	17.1	16.0	44.8	28.5	20.4	19.8	18.3	22.4	14.2	13.1	26.4	20.4	24.5	30.2	34.3	46.2	34.2	35.6	24.1	28.0	29.7	27.0	23.3	33.0	57.8	18.5	27.7	29.8	25.8	40.5	33.8	32.3	29.9	17.6	20.1	19.5	23.6	33.4	42.3	31.7	33.0	43.0	25.7	56.1	23.5	26.8	56.9	51.5	36.7	41.3	28.0	35.6	20.4	43.4	25.8	18.3	36.5	52.8	37.0	26.1	25.7	22.5	25.8	29.9	27.6	33.2	54.7	49.2	29.4	22.0	29.0	20.2	7.1	21.7	26.4	22.5	48.0	28.6	29.9	28.3	7.5	10.1	15.6	6.9	12.3	10.2	7.1	6.9	8.3	10.5	6.7	7.3	7.9	10.1	8.3	13.2	6.1	11.1	9.2	26.4	26.8	24.7	27.8	27.5	29.8	24.6	26.5	27.6	24.6	28.5	26.4	7.0	6.4	11.5	12.7	13.3	5.4	9.4	8.9	6.2	11.2	8.5	5.7	16.6	12.8	9.2	16.5	12.5	11.9	9.3	17.6	23.5	12.1	140.7	8.6	7.8	7.8	10.8	15.8	14.9	8.9	12.1	9.3	5.6	7.4	3.8	15.0	8.6	7.8	17.2	5.0	19.3	13.2	6.1	15.9	5.6	88.1	8.4	12.9	5.4	14.0	16.8	11.3	10.3	11.1	18.6	11.4	10.1	8.2	9.3	8.7	11.6	15.9	8.2	10.2	6.6	6.9	7.6	26.0	44.9	9.2	6.7	11.1	11.5	9.5	12.5	7.2
KLHL18	"FLJ13703, KIAA0795"	ENSG00000114648	"Kelch like family member 18"	O94889	3	47282917-47346816	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035027, HPA035028"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	"Nuclear bodies"	"HPA035027: AB_10602340, HPA035028: AB_10669899"	"unprognostic (1.96e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (1.22e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.05e-1)"	"unprognostic (9.60e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.88e-3)"	"unprognostic (3.13e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.67e-1)"	5.9	6.2	6.5	6.2	6.9	15.9	4.6	5.9	7.7	5.7	3.9	5.8	4.4	5.3	5.1	8.7	4.6	5.4	6.2	6.8	6.3	6.1	3.7	6.2	6.9	4.9	6.0	3.9	5.5	7.2	6.0	5.5	5.1	5.1	4.6	20.2	4.4	6.2	6.7	13.8	5.6	6.6	5.5	8.8	4.9	6.3	6.7	5.1	7.0	5.6	7.5	6.7	6.7	6.3	11.6	14.6	11.1	16.5	12.0	8.6	7.9	15.6	8.1	15.5	12.6	15.6	7.0	22.6	8.6	13.1	14.2	7.0	33.7	16.5	15.9	18.0	11.3	33.3	20.9	14.3	12.3	17.9	14.7	10.0	12.5	22.4	20.8	8.7	17.5	12.1	41.0	9.2	12.6	9.6	13.7	10.3	20.4	9.4	29.2	9.4	7.3	13.2	14.6	21.6	7.6	10.1	10.9	13.2	7.9	11.3	7.8	9.7	18.4	14.3	14.8	16.6	19.9	10.3	21.9	19.5	9.2	20.5	15.4	6.1	12.1	3.7	2.0	10.7	2.9	3.8	1.6	3.9	7.8	2.4	1.3	2.0	4.9	1.3	18.6	2.0	1.7	5.7	6.5	6.9	5.9	7.7	6.8	6.3	4.9	6.0	5.1	5.5	6.7	6.3	19.6	12.8	13.7	13.1	24.4	11.3	10.6	8.1	12.0	65.2	17.4	13.0	62.1	4.3	7.5	3.7	20.9	10.6	26.1	15.2	21.5	15.5	3.0	15.5	24.8	16.1	9.5	21.7	24.2	14.8	11.9	9.3	12.2	27.5	36.1	11.0	14.3	19.7	29.6	13.5	23.0	11.1	4.1	28.8	14.9	3.5	5.9	26.7	0.0	18.7	22.4	13.9	8.2	15.1	17.4	17.7	10.6	8.2	12.0	9.3	9.8	28.2	6.3	54.2	6.6	19.5	13.5	13.9	14.8	14.8	21.0	14.1	20.8	15.4	10.3	13.0
KLHL36	"C16orf44, FLJ12543"	ENSG00000135686	"Kelch like family member 36"	Q8N4N3	16	84648511-84667686	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023423	Approved		Approved	Cytosol		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA023423: AB_10962985"	"unprognostic (6.50e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.90e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.59e-2)"	"prognostic favorable (9.81e-5)"	"unprognostic (3.79e-3)"	"prognostic favorable (5.52e-10)"	"unprognostic (3.48e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.67e-3)"	9.3	6.4	7.2	6.1	5.8	13.4	7.7	4.2	7.0	5.7	10.0	7.0	6.8	6.6	2.1	8.9	6.8	3.9	9.8	9.0	4.9	6.9	11.3	8.6	7.7	6.4	4.4	8.7	11.4	8.9	6.1	4.6	3.6	6.6	3.2	1.9	7.6	5.3	5.1	8.1	9.0	4.0	3.9	9.3	8.4	13.8	5.9	4.3	8.8	4.5	4.9	8.2	7.1	4.0	18.9	19.9	5.0	11.9	5.4	8.8	18.9	13.9	9.7	5.8	2.8	17.3	12.7	13.2	18.2	11.3	5.9	20.6	5.5	13.4	4.0	8.1	8.0	4.4	6.7	10.9	7.2	5.4	12.2	8.4	11.2	6.7	8.3	8.6	8.7	4.3	14.3	2.1	6.0	28.7	0.8	8.3	7.6	8.1	8.2	18.1	5.8	6.3	11.1	17.2	5.9	4.4	16.6	4.7	8.8	6.0	17.7	16.6	16.9	7.6	12.9	8.2	8.7	7.1	10.2	22.7	10.3	7.3	22.2	3.5	2.7	6.3	3.2	1.7	2.8	4.5	5.9	4.7	3.7	3.7	6.9	5.0	3.2	2.3	2.0	3.4	3.4	2.8	7.2	5.8	4.2	7.0	9.0	4.9	6.4	4.4	3.6	3.9	5.9	4.0	18.5	19.2	16.2	8.5	24.6	15.9	45.3	23.9	15.9	25.8	23.3	15.7	26.5	32.9	16.8	22.0	35.5	23.7	19.3	28.3	5.9	24.5	41.4	13.8	12.3	19.6	18.6	6.5	11.8	14.5	11.7	20.9	16.3	21.4	7.0	22.7	19.2	21.9	19.3	26.9	10.6	23.3	26.4	21.2	17.6	14.7	23.3	18.0	21.4	15.9	22.4	10.5	18.6	7.5	8.5	22.8	20.0	25.2	10.8	56.0	37.0	28.1	16.3	23.0	32.9	21.7	24.9	21.7	6.1	19.3	17.6	19.3	26.8	12.8	21.3	39.8
KLHL7	"KLHL6, RP42, SBBI26"	ENSG00000122550	"Kelch like family member 7"	Q8IXQ5	7	23105758-23177914	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 50.8"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 560.6;Late spermatids: 242.7;Oligodendrocyte precursor cells: 168.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029491, HPA029492"	Uncertain		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA029491: AB_10599605, HPA029492: AB_10600881"	"unprognostic (1.24e-2)"	"unprognostic (4.45e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (3.78e-1)"	"unprognostic (6.10e-2)"	"unprognostic (6.41e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (8.98e-5)"	"unprognostic (2.46e-2)"	"unprognostic (3.55e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.27e-2)"	9.5	18.8	12.8	7.0	13.3	12.4	13.0	16.3	15.9	10.5	12.1	9.2	7.8	11.5	12.2	9.0	9.7	9.7	50.8	12.5	13.1	11.9	10.4	7.7	8.3	12.6	12.7	11.8	7.7	10.8	7.3	8.6	12.3	10.1	7.9	14.9	8.5	8.1	9.1	10.9	6.9	10.5	12.2	8.0	6.3	42.2	13.4	12.4	9.2	9.7	9.1	8.7	9.4	14.7	24.7	20.7	55.7	66.3	26.8	23.2	20.3	21.3	31.5	30.7	35.6	25.3	17.5	24.1	16.8	26.2	50.5	26.2	21.5	15.0	25.8	6.4	15.5	15.9	16.7	32.9	20.0	32.5	12.0	20.7	19.1	35.2	28.8	24.2	39.6	29.4	28.3	25.5	50.7	28.4	27.3	51.3	77.0	16.7	24.5	23.7	31.2	22.2	29.2	21.0	33.5	32.5	46.2	22.7	23.3	33.9	18.9	16.9	17.0	25.7	26.6	56.9	25.7	39.9	35.3	58.6	17.0	33.8	31.5	44.1	15.3	67.2	13.0	17.9	13.7	9.2	13.8	12.3	11.1	11.9	10.1	10.0	14.4	9.5	15.8	8.0	16.7	12.6	12.8	13.3	16.3	15.9	12.5	13.1	12.6	12.7	12.3	12.2	13.4	14.7	12.1	22.4	5.5	45.7	13.0	23.6	18.2	13.0	18.2	23.7	12.3	13.5	101.2	8.6	11.3	9.2	29.2	20.7	14.4	5.7	11.7	17.7	560.6	18.3	16.7	15.8	10.8	25.6	74.5	17.6	27.1	19.8	10.2	13.2	21.5	16.3	13.2	7.0	19.7	37.0	75.2	7.6	14.2	16.0	17.2	242.7	16.8	12.6	12.4	35.6	13.4	30.3	8.2	168.9	45.6	19.4	1.9	20.7	12.3	11.5	7.4	13.5	18.8	16.3	6.6	14.3	17.9	83.7	19.7	24.6	33.8	23.7	17.2	12.1	7.0	24.0
KLHL8	KIAA1378	ENSG00000145332	"Kelch like family member 8"	Q9P2G9	4	87160103-87240314	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 60.4"	"Cell type enriched"	"Detected in all"	4	"Muller glia cells: 216.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013856, HPA017762"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA013856: AB_1852594, HPA017762: AB_2669660"	"unprognostic (2.93e-2)"	"unprognostic (4.91e-3)"	"unprognostic (3.44e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.46e-3)"	"unprognostic (3.27e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.46e-1)"	"prognostic favorable (1.53e-5)"	"unprognostic (4.24e-3)"	"unprognostic (3.05e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.57e-3)"	6.7	7.3	4.6	6.1	4.7	3.1	9.4	7.0	4.8	8.7	1.9	8.0	7.8	6.8	60.4	4.8	5.4	4.9	4.6	4.1	5.6	12.0	11.2	5.2	5.8	4.1	5.4	6.0	5.2	8.5	3.6	4.2	3.6	5.5	8.9	27.2	7.1	7.4	13.7	4.0	7.6	6.6	4.7	6.3	4.2	4.3	5.9	8.5	18.9	9.7	4.8	6.0	4.2	5.0	9.9	8.5	15.1	6.8	13.5	9.8	8.1	12.4	6.6	8.1	9.5	13.8	7.3	14.3	9.8	9.2	6.6	4.1	16.2	12.2	17.4	13.7	10.1	17.4	6.0	8.1	11.5	28.9	10.5	12.4	8.6	12.4	12.4	7.9	9.7	10.6	22.8	12.7	8.5	10.9	34.8	14.4	3.8	22.1	3.4	12.9	12.9	8.7	13.7	10.1	31.6	11.0	8.1	19.6	9.2	5.6	6.8	21.0	9.2	10.2	12.6	10.9	10.4	18.7	13.1	25.1	7.7	13.5	11.4	2.0	12.2	7.6	2.9	9.2	4.6	3.2	2.2	2.4	10.4	3.5	4.0	4.0	8.6	8.4	9.8	2.6	0.9	5.0	4.6	4.7	7.0	4.8	4.1	5.6	4.1	5.4	3.6	4.7	5.9	5.0	9.5	3.2	22.9	29.4	14.3	13.8	10.8	10.1	13.6	22.8	11.1	7.7	15.4	5.7	11.6	44.1	41.7	4.1	12.1	21.4	11.7	5.2	4.0	8.3	21.4	12.8	9.0	12.4	44.6	4.5	6.9	10.4	3.1	9.8	7.6	16.8	8.6	20.0	9.7	23.5	41.5	10.8	4.1	38.8	12.0	3.5	9.6	23.3	10.6	24.4	22.1	216.0	11.3	47.3	35.7	4.9	12.2	8.2	6.4	13.8	14.5	19.2	10.1	47.0	13.1	20.1	9.2	32.5	22.5	12.9	14.8	23.8	9.9	4.4	15.2	11.4
KMT2C	"HALR, KIAA1506, MLL3"	ENSG00000055609	"Lysine methyltransferase 2C"	Q8NEZ4	7	152134922-152436641	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 363.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 15.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074736			Approved	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA074736: AB_2686709"	"unprognostic (7.75e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.23e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (8.01e-6)"	"unprognostic (1.78e-1)"	"unprognostic (3.83e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.64e-1)"	12.7	11.2	16.7	7.3	25.7	16.4	12.9	16.7	15.7	15.3	5.5	13.1	5.7	14.3	13.7	14.1	11.9	7.7	10.2	13.0	18.9	8.9	10.4	12.7	8.1	25.3	19.4	16.8	18.5	12.4	12.1	10.3	20.6	9.3	7.6	21.7	14.2	9.0	25.9	17.6	12.8	7.5	12.2	12.2	15.2	13.4	19.1	16.1	14.6	16.9	9.5	11.3	12.7	28.6	13.4	6.1	11.6	11.7	19.0	13.9	10.2	4.7	6.4	5.0	5.5	10.9	4.7	22.4	8.9	11.3	9.2	5.2	14.3	7.5	9.2	12.7	6.5	14.0	7.3	4.5	8.9	22.9	12.8	6.6	9.1	7.1	8.2	7.2	8.4	9.7	22.5	15.0	11.7	12.7	14.8	11.1	6.8	8.5	7.9	9.5	12.3	8.4	5.8	10.9	19.6	12.8	13.4	15.8	6.3	10.6	4.6	15.7	12.8	8.0	4.4	9.0	8.9	15.3	7.7	22.4	10.7	14.7	8.4	6.1	3.0	4.4	1.9	2.7	1.6	6.9	2.0	1.5	1.4	3.9	1.9	1.4	15.2	2.2	2.6	3.7	1.3	0.8	16.7	25.7	16.7	15.7	13.0	18.9	25.3	19.4	20.6	12.2	19.1	28.6	62.4	76.9	71.9	292.8	75.0	89.1	38.3	31.5	62.0	89.0	59.6	35.2	65.8	44.3	72.4	46.0	173.0	38.0	61.9	61.7	5.9	37.6	32.1	94.4	92.1	58.9	67.9	55.5	180.7	33.1	51.7	58.3	89.2	200.5	65.2	52.8	56.7	46.0	33.7	80.8	172.2	53.5	42.7	54.7	79.6	17.3	67.4	90.5	42.7	202.4	77.1	57.7	59.8	299.6	363.2	37.6	49.0	60.2	90.3	53.6	36.3	14.7	46.9	73.0	26.3	83.0	55.5	42.3	33.9	80.9	96.3	127.2	76.8	54.8	39.1	61.4
KMT2E	"HDCMC04P, MLL5"	ENSG00000005483	"Lysine methyltransferase 2E (inactive)"	Q8IZD2	7	105014190-105115019	"Disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Growth arrest, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042866, HPA056125"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nuclear bodies"	"HPA042866: , HPA056125: AB_2683044"	"unprognostic (1.05e-1)"	"unprognostic (6.33e-2)"	"unprognostic (6.49e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.98e-3)"	"unprognostic (2.03e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.53e-2)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (3.80e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.06e-1)"	23.0	16.4	17.6	28.8	23.6	69.9	22.5	53.6	26.1	28.9	11.6	29.0	22.7	33.4	22.1	22.7	24.8	24.5	21.1	16.9	25.9	18.7	16.4	27.9	31.4	19.0	19.2	43.8	22.8	23.1	11.5	26.8	17.7	24.9	28.5	40.5	25.5	23.0	15.0	30.3	22.3	26.8	14.4	33.4	26.7	18.6	17.1	35.6	27.4	22.9	33.0	27.9	14.3	34.4	35.7	24.8	49.3	43.5	29.3	34.5	12.3	24.3	38.2	21.0	25.5	19.0	30.1	28.8	24.7	30.0	27.7	26.2	27.1	25.7	35.0	45.8	17.4	27.0	31.6	19.2	28.1	39.7	34.8	24.2	23.3	28.6	30.6	38.6	40.2	32.3	39.9	76.9	28.7	26.5	62.1	35.0	17.9	19.1	19.1	53.4	30.3	33.5	23.0	34.5	28.8	36.1	35.7	32.3	20.2	32.8	13.6	23.5	47.2	50.0	33.1	57.5	26.4	61.6	50.8	63.5	34.3	29.5	36.3	246.8	73.2	173.1	118.3	56.2	114.6	153.9	109.7	103.0	53.8	152.0	106.0	100.0	290.3	89.9	94.4	103.2	101.5	71.7	17.6	23.6	53.6	26.1	16.9	25.9	19.0	19.2	17.7	14.4	17.1	34.4	169.3	141.1	158.4	108.4	283.5	146.6	115.5	119.2	118.4	236.4	93.4	81.5	102.9	85.8	124.6	115.8	252.3	40.5	278.0	138.0	35.2	82.2	27.0	77.8	89.3	205.6	100.0	90.5	160.2	68.1	50.4	128.8	91.7	112.4	247.9	78.2	119.2	33.6	60.4	185.1	148.9	96.4	89.5	91.8	348.4	27.3	141.1	152.2	140.5	148.9	147.5	104.1	255.4	189.0	236.2	80.7	102.9	131.7	223.1	149.7	82.6	32.4	78.3	297.5	124.9	136.7	168.3	100.0	76.4	86.1	134.7	65.3	278.3	58.2	115.4	159.9
KNL1	"AF15Q14, CASC5, CT29, D40, hKNL-1, hSpc105, KIAA1570, MCPH4, PPP1R55, Spc7"	ENSG00000137812	"Kinetochore scaffold 1"	Q8NG31	15	40594020-40664342	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes, Disease variant, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 5.3;lymphoid tissue: 7.4;testis: 16.9"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 8.5;Extravillous trophoblasts: 11.3;Granulosa cells: 22.8;Hofbauer cells: 7.1;Proximal tubular cells: 11.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA026624, HPA049647"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		Yes	Yes			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"HPA026624: AB_10601696, HPA049647: AB_2680840"	"unprognostic (5.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.59e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.59e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.06e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.20e-4)"	"unprognostic (2.22e-2)"	"unprognostic (1.93e-12)"	"unprognostic (3.07e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.45e-2)"	"unprognostic (7.36e-2)"	0.2	0.1	0.1	1.9	0.0	5.3	0.3	0.2	0.2	0.2	0.2	1.3	1.6	0.3	0.2	1.0	0.1	0.3	0.1	0.1	0.1	0.5	0.7	0.4	3.6	0.1	0.3	0.0	0.0	0.3	0.0	1.3	0.1	0.1	1.4	0.2	0.2	0.0	0.0	0.8	1.7	0.7	0.0	0.6	0.9	16.9	0.3	7.4	0.3	0.1	3.4	0.5	0.2	0.1	19.1	9.3	18.0	13.8	0.5	2.6	8.6	20.5	8.1	16.0	13.1	11.6	7.2	11.9	6.1	9.3	12.0	21.9	17.6	9.7	16.3	21.4	5.0	35.5	15.5	3.9	0.0	26.2	17.8	0.5	0.4	10.8	6.4	2.1	13.8	20.9	22.9	19.2	18.3	6.1	23.5	6.1	9.4	11.3	9.5	21.2	25.8	5.9	2.6	15.6	15.9	7.7	17.7	10.6	2.1	5.9	11.1	9.0	13.1	18.7	16.3	21.9	11.7	7.5	27.9	22.3	7.6	18.5	18.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.3	0.5	0.0	0.1	0.1	0.1	0.1	0.0	0.6	0.0	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.3	0.1	0.0	0.3	0.1	0.3	0.0	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.1	1.1	0.0	0.0	1.8	1.8	0.0	8.5	2.6	0.0	1.9	0.2	0.0	3.5	3.5	1.9	0.0	0.0	0.0	0.6	11.3	4.2	0.0	2.9	0.0	22.8	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.1	0.0	0.0	11.5	0.7	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	3.7	1.9	1.7	0.0	0.0
KNSTRN	"C15orf23, FLJ14502, kinastrin, SKAP, TRAF4AF1"	ENSG00000128944	"Kinetochore localized astrin (SPAG5) binding protein"	Q9Y448	15	40382721-40394246	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 63.6;thyroid gland: 53.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 328.2;Late spermatids: 600.1;Spermatocytes: 145.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA042027	Enhanced		Enhanced	"Plasma membrane,Mitotic spindle,Centriolar satellite"		Yes	Yes			"Cluster 51: Monocytes - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Mitotic spindle, Centriolar satellite"	"Plasma membrane"	"HPA042027: AB_10797378"	"unprognostic (2.35e-3)"	"unprognostic (6.83e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.23e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.47e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (3.43e-5)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (7.88e-9)"	"unprognostic (1.70e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.52e-2)"	8.0	6.2	6.3	8.1	7.1	14.1	14.3	7.7	8.6	5.1	4.5	7.9	9.2	6.4	12.3	9.1	5.7	4.4	7.4	7.2	6.2	7.2	12.0	5.8	14.5	6.2	6.2	5.1	5.0	8.4	5.6	10.7	6.5	6.8	10.4	9.0	10.3	7.2	12.2	6.7	6.2	10.2	5.9	7.1	10.2	63.6	6.1	25.6	53.1	12.4	16.1	5.6	5.6	7.7	103.4	47.5	92.7	61.0	20.1	30.9	48.1	69.9	54.0	141.0	123.3	102.6	44.2	39.7	34.8	47.3	112.1	115.7	100.0	64.8	126.5	70.8	48.8	117.7	107.4	65.2	18.9	63.8	58.6	16.1	36.5	71.3	70.6	34.5	80.3	97.6	86.3	66.8	120.0	52.2	55.6	51.2	58.6	87.7	71.2	56.4	69.7	45.7	49.7	42.3	89.9	62.5	58.3	63.3	15.1	55.8	66.5	45.3	41.6	67.5	68.8	69.7	98.3	56.5	98.6	70.5	41.8	84.0	56.5	13.2	17.6	17.4	7.9	24.3	6.8	9.5	5.7	7.0	18.4	11.2	5.4	5.5	9.7	9.8	47.8	12.7	9.4	7.1	6.3	7.1	7.7	8.6	7.2	6.2	6.2	6.2	6.5	5.9	6.1	7.7	2.4	9.6	1.1	2.6	4.1	2.2	2.9	7.6	3.4	8.2	4.2	3.4	7.3	1.5	5.4	0.0	8.4	25.2	2.5	1.9	3.9	8.5	328.2	5.9	4.9	3.7	2.4	34.3	5.1	9.3	40.8	5.2	5.6	4.4	1.3	16.9	3.6	8.0	21.6	5.0	4.9	5.3	14.2	9.8	2.0	600.1	9.0	8.2	3.6	4.7	8.0	8.5	6.2	2.0	4.3	12.3	0.5	7.2	12.6	4.9	2.8	5.8	7.2	8.5	0.0	3.7	6.5	145.7	19.2	7.0	1.4	21.1	5.1	8.5	6.4	3.0
KPNA1	"IPOA5, NPI-1, RCH2, SRP1"	ENSG00000114030	"Karyopherin subunit alpha 1"	P52294	3	122421902-122514945	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 221.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053627, HPA063426"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA053627: AB_2682211, HPA063426: AB_2685013"	"unprognostic (6.23e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (1.82e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.02e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.77e-3)"	"unprognostic (7.89e-3)"	"unprognostic (5.22e-2)"	"unprognostic (9.09e-2)"	"unprognostic (5.43e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.77e-1)"	20.2	18.4	10.0	19.8	10.6	11.4	11.9	10.6	15.0	14.1	6.7	15.5	13.0	13.6	15.1	21.8	12.9	12.1	20.3	11.6	10.7	16.1	32.0	13.0	15.7	11.2	10.2	10.6	18.8	19.2	9.0	15.9	11.2	15.1	15.4	28.6	12.4	16.3	74.4	13.5	13.6	23.0	11.6	12.3	14.5	20.6	10.7	15.5	17.9	41.0	20.6	22.1	11.4	12.6	75.1	43.4	73.2	37.2	46.6	51.2	23.2	56.5	47.5	60.4	54.4	52.6	35.6	54.1	50.6	62.4	47.8	38.3	58.2	48.2	88.9	14.8	22.1	66.6	37.1	29.5	27.3	59.8	29.5	35.7	61.0	43.7	60.9	29.5	67.3	28.8	47.6	30.5	55.8	34.6	43.7	14.1	31.8	52.5	46.2	44.1	60.8	34.8	26.2	51.8	50.4	30.3	60.5	32.6	50.1	56.9	43.2	34.8	57.9	37.7	41.2	18.7	44.1	29.1	31.8	99.9	52.7	40.9	39.1	27.1	19.3	18.8	17.4	19.5	18.6	15.8	15.2	19.3	25.4	12.7	15.4	15.8	41.5	21.2	29.3	7.9	17.6	18.2	10.0	10.6	10.6	15.0	11.6	10.7	11.2	10.2	11.2	11.6	10.7	12.6	27.9	16.0	31.8	53.5	31.9	41.4	22.2	15.8	28.5	30.1	24.2	12.3	31.1	22.8	32.9	14.7	31.3	21.2	31.5	18.6	13.7	23.2	120.1	35.0	26.1	27.6	16.3	49.2	107.2	33.4	25.9	26.1	19.4	29.5	38.7	18.6	22.5	50.2	23.3	20.2	81.7	19.7	18.3	27.9	47.4	221.8	22.4	30.0	17.8	61.8	31.5	22.2	26.8	59.8	91.7	35.1	19.8	24.8	36.6	34.5	18.6	23.1	44.8	47.4	13.1	25.4	32.1	42.1	18.0	27.1	45.5	24.9	31.3	19.6	14.0	27.5
KPNA2	"IPOA1, QIP2, RCH1, SRP1alpha"	ENSG00000182481	"Karyopherin subunit alpha 2"	P52292	17	68035636-68047364	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 209.1"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 863.9;Extravillous trophoblasts: 279.7;Spermatocytes: 552.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB015460, HPA041270"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes		160000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"CAB015460: AB_831493, HPA041270: AB_2677385"	"unprognostic (2.78e-2)"	"unprognostic (1.54e-1)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.16e-3)"	"prognostic unfavorable (2.12e-10)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (3.34e-2)"	"unprognostic (7.59e-2)"	"unprognostic (3.72e-3)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (1.26e-13)"	"unprognostic (3.07e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (2.19e-4)"	25.9	15.9	18.9	45.2	19.3	99.2	15.2	18.7	23.3	17.4	15.7	30.7	26.1	17.6	25.7	41.4	10.8	19.4	23.9	20.8	24.7	16.2	23.1	17.9	72.1	19.1	20.5	6.5	10.0	10.6	15.6	43.8	22.2	8.2	35.8	22.2	15.4	11.6	14.8	21.0	23.3	34.6	20.5	28.3	19.0	209.1	20.0	94.7	10.9	16.7	104.9	38.6	17.7	22.7	556.0	712.3	667.1	264.4	95.7	93.9	421.1	467.9	372.9	758.1	587.9	499.5	250.4	514.4	146.7	273.4	375.1	297.4	753.8	359.4	870.7	203.8	437.5	446.5	311.7	482.7	101.9	387.6	294.3	58.1	69.3	426.0	267.2	105.8	746.8	211.0	360.8	346.0	686.1	517.3	484.4	249.8	451.4	455.2	365.8	271.5	605.1	280.6	304.0	250.0	262.2	286.3	269.5	839.1	291.9	609.6	495.6	196.9	288.6	416.7	506.2	290.6	647.3	291.5	451.9	504.7	203.0	334.9	458.0	30.1	31.0	12.7	24.1	46.5	19.2	45.8	18.8	27.3	56.2	39.6	13.3	21.5	0.9	43.9	39.6	41.4	37.7	31.3	18.9	19.3	18.7	23.3	20.8	24.7	19.1	20.5	22.2	20.5	20.0	22.7	41.0	12.8	31.0	6.2	49.4	109.7	32.2	73.7	43.3	20.1	39.8	45.5	13.8	7.2	39.7	18.4	8.4	128.3	96.4	27.7	15.6	31.4	863.9	70.8	55.1	48.6	42.9	70.9	8.5	25.5	279.7	64.9	31.1	68.0	44.4	68.2	21.8	17.2	126.0	32.0	7.3	27.6	97.6	42.9	132.1	266.6	19.3	60.0	53.4	3.7	72.1	31.2	18.6	6.6	5.9	20.7	11.9	14.7	60.3	27.6	9.3	31.2	22.7	20.0	32.9	52.4	74.1	552.9	185.2	61.3	88.5	118.9	79.8	28.0	49.3	24.2
KPNA4	"IPOA3, MGC12217, MGC26703, QIP1, SRP3"	ENSG00000186432	"Karyopherin subunit alpha 4"	O00629	3	160495007-160565571	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 124.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034336, HPA043154, HPA045500"	Enhanced		Enhanced	Nucleoplasm		NA	NA		110000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB034336: AB_2281054, HPA043154: AB_2678343, HPA045500: AB_2679351"	"unprognostic (1.58e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (8.59e-4)"	"unprognostic (7.56e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (6.24e-7)"	"unprognostic (7.71e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (1.20e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.48e-1)"	20.2	8.1	4.4	12.0	5.4	15.2	11.1	7.2	10.8	11.1	2.7	16.9	8.8	12.7	8.5	16.5	9.0	9.7	23.3	5.8	7.3	11.1	12.2	11.0	10.4	6.2	5.5	9.0	13.2	11.0	6.3	11.9	6.5	11.6	8.5	13.2	10.5	12.4	124.6	11.3	9.8	13.5	5.9	11.2	12.1	12.2	5.5	11.2	10.3	59.8	12.0	14.3	11.8	6.9	103.4	29.9	20.0	32.7	30.3	27.8	39.7	70.7	39.6	41.0	33.0	38.5	32.1	52.6	73.8	59.9	52.5	45.8	27.4	38.2	50.2	77.0	20.5	52.8	15.2	9.0	37.7	49.3	33.8	22.0	18.5	38.5	76.6	27.5	53.9	26.5	44.2	33.5	45.5	13.8	38.0	17.7	53.9	33.7	31.4	33.9	41.6	50.4	21.9	22.9	23.3	24.8	60.8	29.7	55.7	22.8	33.7	14.4	72.9	39.4	36.0	37.3	87.9	80.4	50.4	96.3	30.9	45.4	31.6	7.7	2.3	2.9	1.8	3.5	2.5	2.3	1.6	2.6	1.7	1.5	1.3	2.0	4.2	4.0	5.7	1.5	2.7	1.8	4.4	5.4	7.2	10.8	5.8	7.3	6.2	5.5	6.5	5.9	5.5	6.9	70.5	38.5	25.1	40.1	62.8	123.6	87.3	24.3	60.3	58.6	59.4	48.1	158.8	30.0	38.4	11.0	79.2	26.1	54.5	65.0	35.2	36.5	24.3	71.2	63.2	60.7	28.7	38.1	48.5	37.7	25.3	55.1	45.9	92.1	31.6	57.6	37.5	34.7	39.2	53.8	52.9	38.1	28.5	47.9	97.2	18.4	33.8	80.0	44.4	49.6	43.2	57.5	28.8	45.8	69.2	77.4	44.3	34.6	65.2	86.5	32.0	40.2	40.6	69.6	32.9	102.4	67.4	38.2	25.3	85.3	126.0	40.6	60.6	36.1	43.7	104.4
KPNA6	"FLJ11249, IPOA7, KPNA7, MGC17918"	ENSG00000025800	"Karyopherin subunit alpha 6"	O60684	1	32108056-32176563	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 294.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018863	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA018863: AB_1852632"	"unprognostic (8.58e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.30e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (9.28e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.51e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.57e-2)"	14.2	15.4	12.8	11.0	13.9	20.5	13.1	12.4	15.1	15.4	12.7	17.7	8.8	17.1	12.8	18.8	14.2	8.8	22.0	13.8	17.2	13.8	15.8	15.1	11.1	15.7	16.3	13.4	13.4	24.6	14.3	16.6	18.2	13.9	13.0	17.1	13.4	14.3	39.3	18.5	12.5	17.8	12.0	12.0	14.8	20.2	14.6	12.8	13.5	23.7	14.8	15.6	15.6	14.5	32.0	24.8	21.6	28.0	32.5	28.4	25.3	25.2	29.5	36.0	34.5	27.8	33.9	26.5	29.1	45.6	21.6	26.7	33.5	38.5	45.6	27.0	18.4	27.4	36.4	22.6	28.7	30.4	21.5	28.9	35.8	44.6	42.3	30.3	38.1	20.5	27.0	23.7	34.4	17.5	24.6	17.3	50.5	20.6	18.3	24.5	31.0	21.7	31.4	28.9	20.7	17.4	45.8	27.1	25.0	52.6	19.2	15.9	44.5	33.1	22.7	43.8	36.6	16.9	20.7	20.3	36.3	27.8	32.4	3.2	7.4	7.2	7.7	9.1	7.5	5.3	6.5	6.0	6.0	6.1	7.4	7.2	4.2	3.8	9.9	6.7	7.3	5.3	12.8	13.9	12.4	15.1	13.8	17.2	15.7	16.3	18.2	12.0	14.6	14.5	27.9	41.7	41.5	33.0	36.1	63.6	36.9	37.6	22.2	48.6	44.7	26.7	32.7	37.1	32.4	29.5	58.4	45.4	42.4	29.5	17.6	36.2	294.2	41.0	44.6	40.4	46.1	52.8	62.5	31.6	41.6	35.7	25.5	49.3	13.9	31.3	36.0	77.3	30.4	52.2	58.4	36.0	24.4	36.8	44.8	65.2	34.2	29.3	24.9	30.0	41.4	29.0	47.4	40.7	54.3	46.1	26.4	40.6	24.1	56.7	25.3	33.2	48.2	44.7	32.9	53.1	36.7	78.7	56.2	31.2	85.1	135.7	31.7	31.8	35.6	59.0
KRIT1	"CAM, CCM1"	ENSG00000001631	"KRIT1 ankyrin repeat containing"	O00522	7	92198969-92246166	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Angiogenesis		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 177.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA049606	Supported		Uncertain	Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Vesicles		"HPA049606: AB_2680832"	"unprognostic (8.12e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.93e-2)"	"unprognostic (4.10e-3)"	"unprognostic (1.06e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.18e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.04e-1)"	11.4	13.6	6.5	16.2	8.9	8.5	11.8	15.8	11.3	13.1	11.7	12.1	14.5	17.1	14.1	13.3	14.0	15.7	18.9	7.4	9.5	14.1	12.1	10.7	14.7	6.7	6.9	20.3	15.9	23.8	11.4	13.6	7.9	12.1	12.6	16.3	14.1	11.2	16.3	14.0	12.2	14.1	5.7	14.7	13.7	18.8	7.8	19.4	22.4	17.5	15.8	13.6	10.8	14.2	27.6	22.0	26.8	27.4	21.2	15.9	19.6	25.5	18.3	12.0	12.3	18.8	31.1	25.9	24.6	14.8	25.9	24.1	21.9	12.7	18.5	23.0	31.4	25.2	26.6	13.2	15.2	34.9	34.5	22.3	21.8	15.0	16.9	20.7	16.2	21.8	51.4	40.5	18.9	30.7	40.6	26.0	26.6	22.4	16.3	28.4	35.5	34.1	10.8	30.9	27.4	33.5	27.7	38.3	22.9	28.2	22.0	20.6	25.1	37.3	28.2	46.9	18.3	25.6	31.1	50.4	19.5	29.6	34.4	13.4	5.5	5.4	6.5	4.0	6.6	10.8	7.5	9.5	5.6	8.5	9.5	8.3	2.2	12.0	2.9	7.6	7.7	3.3	6.5	8.9	15.8	11.3	7.4	9.5	6.7	6.9	7.9	5.7	7.8	14.2	40.6	16.0	34.3	47.0	38.9	19.9	25.7	27.3	40.5	43.7	35.5	34.3	27.6	20.0	26.8	42.3	33.3	37.3	39.2	22.0	46.9	24.0	29.7	30.0	44.1	36.2	20.4	29.2	76.9	24.2	30.0	39.7	35.7	27.9	36.7	49.4	44.6	29.7	19.3	28.6	92.6	23.1	20.3	22.1	16.2	19.5	51.3	23.4	7.2	35.6	29.9	39.9	41.2	46.8	115.4	22.1	33.1	54.2	38.0	22.4	32.2	36.3	36.9	53.1	39.5	43.8	36.8	177.1	90.1	43.1	25.1	28.0	33.0	41.8	23.7	20.5
KRR1	"HRB2, RIP-1"	ENSG00000111615	"KRR1 small subunit processome component homolog"	Q13601	12	75490863-75511636	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043433, HPA051690"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA043433: AB_10960988, HPA051690: AB_2681574"	"unprognostic (2.77e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.71e-2)"	"unprognostic (6.01e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.12e-2)"	15.2	14.2	6.5	15.6	7.0	43.9	16.7	9.3	10.4	11.6	7.6	12.5	12.1	15.0	9.0	16.0	9.8	10.0	11.8	6.9	8.2	16.2	20.4	11.5	19.0	6.6	7.3	15.0	10.7	20.3	8.0	14.5	7.0	13.2	10.9	16.0	19.3	9.8	23.5	12.7	10.3	10.9	7.4	12.6	12.7	12.0	7.5	17.9	14.9	22.7	18.0	15.9	9.8	8.2	59.4	48.1	29.2	27.1	21.8	20.1	54.1	51.0	31.7	38.5	24.8	35.7	30.7	62.2	40.3	23.9	39.0	30.5	39.1	43.0	42.4	52.0	39.9	60.9	25.0	41.8	26.4	107.0	37.1	21.3	35.8	44.8	41.7	39.1	26.6	57.4	67.7	19.8	38.2	39.2	63.1	30.8	43.6	32.4	42.4	49.9	56.1	37.4	42.6	73.6	35.4	29.6	48.0	33.7	59.5	27.9	56.2	42.9	34.4	36.2	24.1	37.7	53.2	38.8	52.3	39.0	19.6	37.0	66.2	13.3	3.2	13.2	13.1	6.5	16.4	23.0	18.3	15.0	5.5	20.6	18.6	17.9	1.5	12.9	5.5	15.3	18.2	7.6	6.5	7.0	9.3	10.4	6.9	8.2	6.6	7.3	7.0	7.4	7.5	8.2	62.9	70.5	49.2	13.4	64.0	49.1	104.3	70.3	48.9	56.4	41.1	50.5	25.6	24.3	55.7	40.5	33.3	68.5	86.4	18.7	58.7	50.9	5.4	52.5	63.8	46.7	18.0	55.8	25.3	49.0	55.7	48.2	21.4	62.6	38.0	41.3	31.1	40.9	29.5	74.0	24.3	25.7	46.8	24.2	21.3	7.6	52.5	30.0	12.4	6.5	42.4	66.4	66.9	19.1	16.3	42.8	28.1	53.4	37.9	45.6	19.2	47.0	42.3	55.5	13.1	79.2	50.2	72.6	61.1	46.8	44.3	70.5	65.4	59.6	29.3	63.2
LARP1	"KIAA0731, Lar1, LARP, Lhp1, MGC19556"	ENSG00000155506	"La ribonucleoprotein 1, translational regulator"	Q6PKG0	5	154712843-154817605	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015222, HPA051397, HPA054819"	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA		12000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Endoplasmic reticulum, Cytosol"		"CAB015222: , HPA051397: AB_2681467, HPA054819: AB_2682612"	"unprognostic (1.44e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.95e-2)"	"unprognostic (3.08e-3)"	"unprognostic (2.72e-2)"	"unprognostic (3.34e-3)"	"unprognostic (4.12e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.83e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.83e-1)"	42.5	50.0	30.9	36.5	28.4	37.0	36.4	12.2	44.8	38.4	15.8	38.4	33.8	43.6	37.4	51.6	39.9	29.3	48.6	34.3	25.8	40.0	36.7	34.8	41.1	26.7	40.3	45.0	103.0	70.3	39.8	37.9	47.2	31.3	34.6	32.1	57.4	32.9	78.8	45.4	37.7	38.7	5.4	35.7	44.0	38.2	27.6	42.1	53.8	46.4	44.8	38.0	40.0	37.4	93.3	140.3	107.6	124.1	93.3	73.1	103.1	99.0	101.8	114.7	110.0	218.1	116.8	252.2	128.0	127.5	168.5	92.9	196.1	185.9	135.7	83.4	94.1	187.1	143.8	106.1	117.6	250.6	81.2	91.2	108.4	144.5	185.2	66.4	103.9	114.0	149.2	180.2	111.9	102.9	156.5	100.0	107.3	89.8	60.5	158.8	97.5	120.5	74.1	120.7	180.7	93.5	132.2	215.4	112.3	112.9	126.0	119.0	130.4	140.3	83.0	106.2	170.3	136.8	126.0	219.5	92.1	134.8	99.1	2.2	2.4	0.7	2.6	3.0	3.3	2.5	3.0	3.0	2.4	3.3	2.5	2.6	1.4	5.9	5.6	3.9	2.1	1.7	30.9	28.4	12.2	44.8	34.3	25.8	26.7	40.3	47.2	5.4	27.6	37.4	37.6	44.8	33.8	67.9	37.2	78.3	39.7	38.0	34.7	64.4	45.1	33.0	104.4	50.1	33.7	40.5	37.5	43.7	35.3	45.1	29.4	42.2	14.4	70.1	70.6	48.8	43.9	73.4	72.0	82.5	35.2	46.2	46.9	65.5	17.2	63.2	47.8	66.9	57.9	87.5	92.5	49.6	18.3	53.3	42.6	12.1	69.6	43.6	37.4	46.9	49.1	26.5	33.0	47.7	69.5	62.1	37.7	80.1	47.3	75.2	53.0	50.1	46.5	38.7	13.1	63.6	39.4	56.2	40.5	54.6	84.5	23.9	34.6	71.6	68.8	53.6
LARP4	PP13296	ENSG00000161813	"La ribonucleoprotein 4"	Q71RC2	12	50392383-50480004	"Predicted intracellular proteins"	"Protein biosynthesis"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039306, HPA039673"	Approved		Enhanced	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	"Nucleoli fibrillar center"	"HPA039306: AB_10805362, HPA039673: AB_10795110"	"unprognostic (4.41e-3)"	"unprognostic (4.11e-2)"	"unprognostic (2.01e-2)"	"unprognostic (8.50e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.93e-3)"	"unprognostic (9.08e-2)"	"unprognostic (8.94e-2)"	"unprognostic (8.51e-3)"	"unprognostic (1.91e-2)"	"unprognostic (3.14e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.99e-3)"	17.4	27.7	9.5	16.2	12.6	14.0	14.6	16.4	10.8	14.1	23.8	15.3	16.7	10.5	11.7	18.9	9.3	12.9	16.3	8.8	13.9	29.0	62.1	13.5	15.6	13.2	14.4	9.4	16.5	21.8	8.8	18.3	14.0	13.9	14.4	20.3	15.9	11.3	26.4	11.2	13.1	11.7	12.2	12.5	17.2	14.9	13.0	15.9	20.0	37.0	15.5	21.5	9.0	17.3	43.9	61.0	40.1	29.6	36.6	30.2	67.9	52.9	31.5	51.3	40.8	120.5	50.2	102.9	63.9	33.2	47.5	41.1	88.2	36.1	67.3	64.3	35.9	83.9	56.1	43.6	34.0	93.9	47.5	27.6	33.9	60.9	65.1	33.9	45.9	37.2	122.8	47.4	48.0	39.3	77.7	31.6	58.2	28.5	52.9	56.6	63.6	61.0	27.8	65.1	47.2	27.7	94.0	48.3	54.9	37.0	42.1	37.4	66.9	34.0	50.2	39.7	50.4	45.9	134.7	90.3	47.0	37.9	28.9	8.2	8.7	6.0	8.1	9.6	7.5	8.6	7.0	4.5	11.7	8.6	8.2	6.7	4.4	8.2	12.1	10.0	7.6	7.7	9.5	12.6	16.4	10.8	8.8	13.9	13.2	14.4	14.0	12.2	13.0	17.3	35.9	48.1	44.7	31.0	26.8	71.0	33.8	23.1	59.7	41.0	34.0	25.1	47.8	22.8	27.7	29.5	87.6	27.4	22.0	29.1	9.8	19.7	8.6	52.9	50.4	28.6	24.0	33.0	38.9	24.0	17.3	31.0	38.7	57.5	19.7	27.9	21.0	129.0	27.3	18.5	45.5	25.8	20.3	33.0	26.6	25.4	14.9	23.0	26.6	24.4	27.6	18.4	13.4	26.7	40.4	27.0	16.1	19.2	56.4	44.3	20.3	54.7	33.0	54.0	6.6	42.2	36.8	37.4	42.5	52.2	74.3	34.2	22.0	34.4	27.5	33.2
LARP4B	"KIAA0217, LARP5"	ENSG00000107929	"La ribonucleoprotein 4B"	Q92615	10	806914-931705	"Predicted intracellular proteins, Predicted membrane proteins"	"Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036566, HPA042738"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA036566: AB_10673624, HPA042738: AB_2678137"	"unprognostic (3.02e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.77e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.13e-3)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (8.95e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.54e-2)"	14.3	19.9	13.1	17.2	13.3	18.5	13.6	15.3	17.4	13.4	20.9	17.0	19.4	13.1	10.3	25.2	13.3	12.8	22.2	16.4	14.9	13.8	13.0	20.2	22.1	16.0	12.0	13.0	16.5	17.1	12.7	15.1	15.6	16.2	15.6	14.5	16.8	12.3	38.7	22.3	18.5	10.9	12.1	19.4	21.9	18.9	13.2	16.0	22.2	22.3	19.7	15.9	16.7	14.1	50.0	42.7	21.7	24.5	19.0	19.1	32.2	33.0	15.7	35.6	34.2	58.1	56.4	59.9	12.0	33.0	10.6	51.6	38.5	28.0	30.5	38.1	27.9	51.6	29.5	33.9	31.3	37.3	42.5	21.2	31.7	36.8	20.4	19.9	24.8	28.8	65.5	39.3	28.9	50.9	53.0	33.8	23.2	49.5	16.5	36.1	18.7	41.5	28.6	38.5	21.4	30.2	32.5	62.5	25.4	21.1	59.3	35.6	34.4	27.6	7.2	87.8	34.2	39.2	51.2	58.3	30.5	30.0	17.6	11.4	8.2	9.7	5.4	9.0	5.7	4.2	6.0	6.2	7.3	5.2	5.7	6.0	8.0	5.4	7.9	8.3	6.1	3.9	13.1	13.3	15.3	17.4	16.4	14.9	16.0	12.0	15.6	12.1	13.2	14.1	23.7	51.3	62.1	59.4	22.4	30.3	15.6	16.2	23.9	20.5	21.6	15.4	43.5	28.6	30.7	23.9	27.1	17.2	24.6	38.5	5.9	17.4	14.7	42.0	24.5	21.2	13.8	22.7	87.7	16.3	13.2	19.4	44.9	43.4	7.6	31.0	14.6	19.1	21.5	23.5	84.1	35.1	18.3	34.7	25.3	7.1	17.4	30.3	17.8	83.4	33.4	15.7	14.4	65.9	71.6	33.2	27.2	24.0	25.5	27.0	32.5	16.2	33.4	22.4	26.3	23.4	18.3	27.8	23.8	28.8	42.6	46.2	20.7	26.1	34.7	35.6
LARS2	"KIAA0028, LEURS, MGC26121, mtLeuRS"	ENSG00000011376	"Leucyl-tRNA synthetase 2, mitochondrial"	Q15031	3	45388561-45554726	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 28.7;Excitatory neurons: 35.4;Inhibitory neurons: 37.8;Oligodendrocyte precursor cells: 22.6;Oligodendrocytes: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035951, HPA045450, HPA066085"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	Nucleoplasm	"HPA035951: AB_10672997, HPA045450: AB_2679328, HPA066085: AB_2685612"	"unprognostic (3.89e-1)"	"unprognostic (3.89e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (3.02e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-3)"	"unprognostic (9.19e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.86e-1)"	"unprognostic (4.98e-1)"	"unprognostic (4.37e-2)"	"prognostic favorable (1.32e-11)"	"unprognostic (2.81e-1)"	"unprognostic (5.74e-2)"	"unprognostic (9.90e-2)"	"unprognostic (9.07e-2)"	3.3	4.7	9.5	3.4	10.3	2.4	3.9	10.1	11.7	3.7	9.2	6.9	3.9	4.6	4.3	4.2	4.5	3.0	5.5	9.3	10.5	7.5	8.1	2.9	4.3	9.5	10.2	3.8	2.4	12.3	3.7	4.2	9.5	4.3	6.9	4.2	3.6	4.2	6.2	3.6	2.9	4.4	9.2	3.2	3.6	2.2	11.5	6.9	4.5	6.4	4.8	5.0	3.7	8.5	6.3	11.2	10.7	9.3	11.8	13.0	11.1	11.6	15.7	24.7	16.2	20.3	8.8	13.8	8.9	18.0	18.2	5.8	49.0	30.4	16.0	9.5	12.7	12.9	13.6	18.4	12.1	20.9	4.4	19.0	16.8	26.0	12.5	13.1	14.9	19.5	25.1	5.5	19.0	9.7	21.1	11.6	28.4	15.0	21.9	8.9	9.8	16.9	23.6	18.8	7.6	9.7	17.3	7.9	11.8	13.5	14.6	14.7	9.1	12.1	8.3	8.5	12.3	5.3	12.3	15.4	14.0	16.9	9.5	0.0	0.6	0.6	1.2	0.9	1.5	1.0	0.7	1.1	1.2	0.5	0.8	1.0	0.3	1.9	0.8	1.0	0.6	0.7	9.5	10.3	10.1	11.7	9.3	10.5	9.5	10.2	9.5	9.2	11.5	8.5	3.9	0.0	2.0	28.7	4.8	1.1	1.5	1.8	3.4	5.5	3.2	2.8	9.0	1.5	1.8	5.5	4.2	5.0	3.5	4.4	5.9	2.9	0.6	7.6	5.7	4.2	4.8	5.2	35.4	2.7	5.2	3.2	6.6	4.9	1.3	9.8	2.2	7.7	5.4	1.7	37.8	4.5	0.0	2.9	1.3	1.2	1.2	2.6	1.8	19.7	2.3	4.0	2.1	22.6	25.2	3.2	7.0	2.2	5.0	1.9	2.6	2.4	2.9	4.7	0.0	3.1	2.9	0.7	2.4	4.8	1.3	2.9	3.2	8.3	6.8	1.7
LAS1L	"FLJ12525, Las1"	ENSG00000001497	"LAS1 like ribosome biogenesis factor"	Q9Y4W2	X	65438549-65534810	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"rRNA processing"		"Disease variant, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 148.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044431, HPA061463"	Supported		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA044431: AB_10965695, HPA061463: AB_2684530"	"unprognostic (9.71e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.15e-3)"	"unprognostic (2.83e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.06e-2)"	"unprognostic (6.00e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.00e-3)"	"unprognostic (1.53e-1)"	21.5	19.1	36.9	11.4	37.8	16.0	21.2	35.6	53.7	27.1	34.0	26.4	5.8	23.1	6.8	20.0	25.5	6.3	18.6	34.8	34.8	19.1	19.6	17.4	13.1	36.3	37.1	29.9	21.2	12.2	17.5	8.9	36.8	22.7	8.1	9.4	18.8	11.9	19.3	25.4	18.5	10.3	38.1	22.5	20.0	33.6	37.1	12.8	20.5	6.3	14.0	24.2	21.4	37.8	44.1	63.6	36.3	28.5	12.4	16.1	29.1	28.5	14.9	42.8	36.4	30.4	31.3	95.0	31.3	17.8	28.7	31.3	63.9	39.6	50.6	25.6	52.3	32.2	53.2	32.4	16.6	95.9	26.8	17.8	28.7	40.5	25.6	15.1	26.0	46.1	80.3	71.3	25.5	51.8	62.4	53.6	52.6	49.8	63.1	56.2	67.4	79.9	24.7	17.9	24.6	32.9	51.3	26.0	20.1	25.8	19.5	44.6	22.2	26.4	50.9	73.2	44.4	23.7	37.7	94.6	28.1	92.5	13.6	17.7	17.7	11.2	20.1	24.0	21.3	23.9	18.6	23.5	24.2	26.4	23.2	19.8	2.0	22.9	19.3	19.1	21.7	21.0	36.9	37.8	35.6	53.7	34.8	34.8	36.3	37.1	36.8	38.1	37.1	37.8	15.5	12.8	22.3	23.2	21.6	18.2	21.4	24.8	9.1	34.9	12.7	13.6	9.2	21.5	27.0	3.7	29.2	32.8	13.3	6.9	15.6	27.9	58.0	17.5	20.0	17.2	16.7	18.1	19.6	26.6	31.4	16.8	11.7	12.9	18.3	26.0	8.9	14.8	16.3	45.4	17.7	9.4	18.3	8.5	13.4	148.2	17.4	11.7	10.6	8.4	18.1	16.1	12.3	13.0	12.5	21.4	7.7	15.4	26.3	23.5	10.2	14.3	26.7	34.2	13.1	21.8	22.8	24.1	19.1	17.8	18.6	17.8	17.5	22.3	14.1	14.8
LBR	"DHCR14B, TDRD18"	ENSG00000143815	"Lamin B receptor"	Q14739	1	225401502-225428925	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"DNA-binding, Oxidoreductase, Receptor"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 248.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062236	Enhanced		Supported	"Nuclear membrane"		NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nuclear membrane"		"HPA062236: AB_2684721"	"unprognostic (2.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (7.30e-4)"	"unprognostic (3.60e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.45e-1)"	"unprognostic (8.32e-2)"	"unprognostic (2.78e-1)"	28.6	9.1	8.8	53.2	9.7	95.7	17.1	9.3	11.9	27.3	9.2	61.4	40.7	47.0	44.4	29.7	31.8	21.7	10.0	8.5	10.1	19.4	47.3	19.2	81.6	12.0	9.8	19.4	16.9	5.6	6.5	27.6	11.2	23.8	46.2	5.3	11.1	36.7	9.8	13.8	39.9	41.4	10.2	41.5	28.2	20.5	9.5	105.5	11.8	12.8	70.7	32.3	23.0	13.1	122.2	42.0	154.9	69.3	64.8	39.7	77.3	31.2	39.2	65.0	69.0	87.2	207.2	248.4	66.6	32.8	38.6	88.8	114.2	32.9	98.5	142.2	107.1	61.4	40.4	81.5	39.9	274.7	105.5	34.3	21.3	58.9	52.0	33.1	82.9	117.4	189.6	164.6	44.4	16.3	254.9	156.6	140.6	121.8	14.2	164.9	141.4	234.0	75.6	52.7	40.6	53.4	52.7	39.6	26.6	68.2	53.3	181.0	50.5	17.6	91.7	49.3	115.9	56.6	83.0	274.5	24.3	120.5	61.2	83.6	44.3	67.3	43.6	31.6	50.9	39.0	43.5	48.8	38.4	39.5	42.4	52.9	211.4	41.3	25.2	21.5	61.9	69.8	8.8	9.7	9.3	11.9	8.5	10.1	12.0	9.8	11.2	10.2	9.5	13.1	98.1	28.9	36.4	13.4	86.4	27.0	33.4	17.3	21.6	4.5	11.9	11.0	8.5	48.6	34.4	31.3	6.2	40.5	98.3	33.4	5.9	23.6	1.2	31.5	31.0	53.1	27.0	248.9	10.5	19.8	23.9	29.0	29.0	53.9	10.1	24.0	48.5	73.6	44.4	11.8	14.3	43.0	12.2	88.5	18.1	3.4	33.8	71.7	26.6	19.7	56.0	11.6	82.4	37.2	34.1	20.6	24.6	32.4	74.0	32.9	19.3	26.0	26.0	10.4	39.5	13.9	46.6	21.0	26.7	68.4	35.5	11.1	81.3	13.2	73.8	36.7
LCLAT1	"AGPAT8, ALCAT1, FLJ37965, LYCAT"	ENSG00000172954	"Lysocardiolipin acyltransferase 1"	Q6UWP7	2	30447226-30644225	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 67.3;Inhibitory neurons: 86.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031880, HPA049217"	Uncertain		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"	Cytosol	"HPA031880: AB_10610002, HPA049217: AB_2680678"	"unprognostic (6.60e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.52e-3)"	"unprognostic (4.10e-1)"	"prognostic unfavorable (9.67e-4)"	"prognostic unfavorable (8.72e-4)"	"unprognostic (2.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.11e-3)"	"unprognostic (2.85e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.93e-3)"	"unprognostic (1.10e-1)"	4.2	4.9	6.1	5.0	6.7	9.9	5.3	10.8	9.3	6.7	3.4	7.8	12.3	7.2	9.8	5.1	6.1	6.2	11.3	5.3	7.8	9.5	8.6	5.1	5.4	2.9	3.3	4.9	5.9	6.3	3.2	4.3	3.1	7.8	7.9	10.6	4.6	7.0	9.6	6.6	9.5	8.7	0.8	5.3	5.3	8.3	7.0	6.4	10.9	4.1	5.4	4.9	3.7	10.2	16.9	21.6	11.3	19.3	2.6	5.7	16.3	11.8	11.7	12.3	10.3	21.8	19.0	10.5	10.7	18.4	15.2	18.3	38.8	16.0	12.1	13.6	13.0	19.4	12.8	21.6	12.0	28.1	14.3	4.6	12.4	13.0	18.0	8.0	8.7	6.0	18.3	9.5	9.6	12.8	16.1	16.5	12.5	13.6	12.4	15.6	22.9	21.8	9.7	24.7	13.1	20.5	26.4	17.4	15.7	7.7	12.6	9.5	10.0	22.1	18.2	12.4	18.9	7.0	16.2	23.2	22.7	20.1	17.3	15.9	2.3	5.0	5.2	3.8	6.2	7.5	8.3	6.7	2.8	9.7	11.7	11.5	7.2	4.6	3.6	2.0	4.2	3.0	6.1	6.7	10.8	9.3	5.3	7.8	2.9	3.3	3.1	0.8	7.0	10.2	6.5	9.6	6.9	27.1	11.4	7.1	5.0	8.4	6.8	15.5	6.9	5.3	20.1	18.6	8.7	14.7	27.1	5.2	6.7	10.4	0.0	7.7	3.9	12.0	7.0	7.7	13.1	10.3	67.3	16.4	5.3	6.7	3.1	9.4	3.8	11.6	8.6	21.5	6.1	15.2	86.8	14.3	0.0	5.7	3.9	1.4	5.6	3.4	5.4	45.0	2.4	7.9	5.2	50.8	37.3	12.9	8.6	9.1	5.2	5.4	21.4	12.1	16.6	18.2	6.6	10.9	16.3	13.9	21.0	7.9	6.7	1.9	9.1	10.9	17.0	4.7
LEMD3	MAN1	ENSG00000174106	"LEM domain containing 3"	Q9Y2U8	12	65169583-65248355	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"		DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025078, HPA076986"	Uncertain		Supported	"Nuclear membrane"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear membrane"		"HPA025078: AB_10601908, HPA076986: AB_2686821"	"unprognostic (2.10e-2)"	"unprognostic (6.83e-3)"	"unprognostic (1.63e-3)"	"unprognostic (1.76e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.68e-3)"	"unprognostic (7.22e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.16e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (2.30e-4)"	"unprognostic (4.37e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.72e-1)"	9.3	7.3	6.6	10.5	8.0	20.8	10.6	12.2	9.4	8.6	6.9	10.4	9.6	12.2	8.8	8.1	9.3	6.9	7.2	8.5	6.3	9.6	9.5	9.3	13.5	6.0	6.9	11.9	9.8	14.7	5.3	7.2	6.4	9.4	10.0	16.6	9.3	7.7	8.7	8.0	9.4	8.3	6.9	11.4	9.7	15.6	6.9	13.6	10.6	9.6	12.3	8.9	8.1	7.7	19.7	10.9	17.1	17.2	11.8	13.6	11.7	22.4	12.0	11.0	9.5	13.7	12.4	53.2	14.1	13.9	8.5	25.8	18.5	16.0	15.9	12.8	21.4	21.7	10.2	10.5	9.0	33.4	15.1	9.9	16.9	13.1	17.6	15.5	13.1	14.6	28.9	24.6	15.6	11.5	17.5	17.3	23.5	8.9	11.1	40.6	16.8	26.8	13.8	21.4	17.8	10.9	22.5	22.7	14.0	16.4	22.6	26.0	18.1	13.4	14.3	12.7	15.7	17.5	17.7	32.3	11.2	16.1	16.8	1.0	0.7	1.4	1.5	0.6	2.0	1.8	2.0	2.0	1.0	1.9	1.9	2.1	0.8	1.6	0.9	2.1	1.9	0.7	6.6	8.0	12.2	9.4	8.5	6.3	6.0	6.9	6.4	6.9	6.9	7.7	21.7	38.5	21.0	29.7	29.0	32.1	19.4	10.4	14.8	20.1	15.3	11.3	14.7	8.6	13.5	11.0	18.8	8.0	32.7	20.2	0.0	10.3	2.1	16.3	18.0	17.4	14.9	16.8	50.0	13.1	4.6	18.5	13.3	19.8	22.2	12.5	14.6	13.3	6.5	16.8	58.2	13.7	12.2	13.7	16.4	3.2	15.8	16.4	17.8	49.6	16.1	20.3	17.5	53.3	52.7	14.6	14.5	12.4	23.6	18.9	7.8	4.3	19.3	21.5	6.6	23.5	19.2	43.3	35.3	17.6	39.1	14.4	21.9	13.7	11.8	22.9
LETM1	SLC55A1	ENSG00000168924	"Leucine zipper and EF-hand containing transmembrane protein 1"	O95202	4	1811479-1856156	"Human disease related genes, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 116.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011029, HPA011100"	Supported		Supported	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA011029: AB_1852804, HPA011100: AB_1852802"	"unprognostic (1.16e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.85e-2)"	"unprognostic (5.04e-2)"	"unprognostic (5.48e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (1.37e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.77e-4)"	"prognostic favorable (8.90e-4)"	"unprognostic (8.06e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.42e-1)"	13.6	16.3	14.3	7.9	13.7	7.7	10.8	11.7	14.6	8.2	10.8	20.3	13.9	8.4	3.2	23.8	8.0	4.5	19.6	13.4	13.2	13.3	16.4	8.9	7.0	12.7	13.5	9.2	12.5	11.4	8.8	4.9	11.9	8.4	10.7	4.5	9.6	4.2	18.7	15.9	11.7	5.1	12.2	10.7	13.8	14.5	15.0	25.7	10.7	10.9	7.9	8.4	10.6	11.6	22.9	38.1	11.6	36.1	17.4	12.2	20.7	22.1	10.7	21.8	16.9	35.5	24.7	37.5	15.4	23.3	34.0	22.7	29.8	31.2	13.2	25.1	31.1	38.4	30.9	25.6	22.6	39.3	30.3	19.9	22.0	24.9	21.8	10.1	19.0	22.6	51.5	22.9	15.3	25.1	57.3	44.7	30.5	24.7	43.2	32.4	16.2	21.9	17.0	31.3	29.5	26.0	25.2	31.5	13.3	10.0	29.7	20.3	28.8	24.8	14.8	21.1	37.3	19.8	32.7	29.3	22.0	33.8	20.2	3.9	3.7	2.0	5.8	5.0	5.7	4.2	4.9	4.9	4.1	3.6	3.2	4.6	0.5	5.9	5.1	12.9	4.2	2.1	14.3	13.7	11.7	14.6	13.4	13.2	12.7	13.5	11.9	12.2	15.0	11.6	12.2	16.0	11.5	15.0	19.2	40.0	40.7	13.4	8.0	19.4	19.7	10.5	23.3	11.5	14.0	27.6	33.3	17.5	24.9	116.1	31.3	25.5	32.2	9.1	19.4	16.7	15.6	20.4	14.3	31.3	22.6	17.0	32.1	14.7	10.2	17.9	16.1	33.3	21.5	15.2	12.4	29.5	12.2	18.4	19.8	45.1	20.2	13.0	19.6	4.7	13.9	12.7	28.8	9.5	13.2	42.4	52.7	16.6	17.8	58.8	48.8	46.1	5.6	28.4	13.1	23.8	16.1	54.2	44.4	25.2	51.1	15.2	16.7	21.9	53.2	48.4
LHX2	"hLhx2, LH-2"	ENSG00000106689	"LIM homeobox 2"	P50458	9	124001670-124033301	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 99.8;choroid plexus: 48.5;retina: 34.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 68.6;Early spermatids: 43.1;Muller glia cells: 254.6"	"Group enriched"	"Detected in many"	5	"cervical cancer: 3.2;glioma: 10.7;melanoma: 3.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 23.2;GAMG: 17.9;HAP1: 23.5;HeLa: 15.5;NTERA-2: 28.5;U-138 MG: 14.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA000838		Supported	Approved	Nucleoplasm		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA000838: AB_2666109"	"unprognostic (3.60e-3)"	"prognostic favorable (9.52e-4)"	"unprognostic (3.52e-1)"	"unprognostic (9.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.12e-2)"	"unprognostic (6.37e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.59e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.32e-2)"	"unprognostic (4.66e-15)"	"unprognostic (1.72e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.77e-1)"	0.1	0.1	77.8	0.2	78.1	0.0	0.2	48.5	99.8	0.0	48.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	88.1	51.2	0.3	6.7	0.0	0.3	49.5	52.7	0.2	0.0	0.0	9.8	3.4	50.2	0.0	0.1	34.1	0.1	0.0	0.0	6.1	0.2	0.0	48.3	0.1	0.0	3.0	54.9	0.1	0.0	0.0	0.2	0.1	0.0	73.9	0.0	7.2	0.2	23.2	0.0	0.3	2.6	0.7	0.3	1.8	0.2	7.8	0.0	0.2	3.0	1.4	17.9	0.2	23.5	0.0	0.9	0.0	5.0	0.0	15.5	0.4	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	12.1	0.0	0.2	28.5	0.0	7.0	6.5	0.1	0.0	0.0	0.1	9.2	0.1	5.7	0.0	0.0	0.2	8.0	3.1	0.0	14.6	0.6	4.2	1.1	0.4	5.0	0.0	0.8	3.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	77.8	78.1	48.5	99.8	88.1	51.2	49.5	52.7	50.2	48.3	54.9	73.9	0.1	0.0	0.0	68.6	0.2	0.0	0.0	0.0	0.0	3.2	0.1	0.3	0.6	0.0	0.0	0.0	2.1	0.1	0.0	0.1	0.0	0.0	43.1	0.1	0.0	0.3	0.0	0.0	20.6	0.0	8.9	0.1	0.0	0.0	0.0	0.1	3.9	0.0	4.0	8.4	2.5	0.0	0.0	0.0	0.3	21.7	0.0	0.1	0.0	1.9	0.0	254.6	0.0	5.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.4	0.2	4.2	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0
LIAS	LAS	ENSG00000121897	"Lipoic acid synthetase"	O43766	4	39459004-39485109	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 86.0;Late spermatids: 100.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018842, HPA019076"	Approved	Supported	Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Mitochondria	"HPA018842: AB_1852864, HPA019076: AB_1852866"	"unprognostic (3.61e-1)"	"unprognostic (1.89e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.19e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.46e-3)"	"unprognostic (3.80e-2)"	"prognostic favorable (4.11e-7)"	"unprognostic (9.41e-3)"	"unprognostic (2.35e-1)"	"unprognostic (5.45e-2)"	"unprognostic (6.98e-2)"	5.4	7.5	5.9	3.0	6.5	6.6	5.7	7.6	9.8	5.1	5.9	6.4	5.5	4.6	5.3	6.7	6.1	3.6	11.1	6.2	6.7	8.7	8.6	2.9	5.1	6.3	6.4	10.0	6.8	6.5	4.0	3.3	6.8	4.1	6.4	5.4	4.3	3.1	27.2	5.7	5.2	5.2	5.5	3.6	6.3	9.8	6.2	4.3	4.2	21.0	4.2	5.8	4.7	8.3	5.7	4.5	5.4	5.2	11.5	11.4	4.8	6.6	3.7	6.1	4.1	6.8	7.8	20.8	7.3	2.5	15.2	4.9	15.9	9.1	8.0	2.4	4.0	8.8	2.3	7.0	10.4	19.1	5.5	10.8	14.6	7.1	22.4	13.4	7.0	12.7	21.1	5.2	7.5	3.6	10.9	24.9	7.3	15.3	14.2	9.1	15.2	12.9	7.1	2.9	6.0	4.8	3.8	4.9	22.5	7.6	5.6	8.8	2.6	4.7	10.6	6.3	15.5	9.9	15.8	14.3	7.2	22.2	4.0	2.5	6.4	3.9	5.7	7.6	12.7	10.0	8.1	8.0	6.2	7.6	16.2	11.6	3.4	7.7	5.6	5.5	5.7	4.7	5.9	6.5	7.6	9.8	6.2	6.7	6.3	6.4	6.8	5.5	6.2	8.3	11.0	9.6	12.6	14.0	12.9	9.7	11.6	17.4	12.0	25.8	15.7	17.3	20.1	17.2	12.7	18.4	10.4	24.0	22.6	12.9	21.5	13.2	86.0	11.2	15.8	10.3	18.1	12.4	11.9	6.4	18.2	10.4	9.2	10.3	17.7	19.0	11.4	19.0	17.5	10.1	18.8	13.5	18.3	13.5	7.8	100.1	10.2	11.4	1.8	6.5	17.6	15.4	16.5	14.6	22.9	10.3	10.1	12.4	5.8	6.6	18.3	32.6	14.1	26.7	0.0	10.8	20.5	64.9	25.1	13.7	9.2	9.6	14.2	19.0	18.4	8.8
LIN9	TGS	ENSG00000183814	"Lin-9 DREAM MuvB core complex component"	Q5TKA1	1	226231149-226309869	"Predicted intracellular proteins"	"Cell cycle, DNA synthesis"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 20.2;Spermatocytes: 36.3;Spermatogonia: 18.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030241	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA030241: AB_10601542"	"unprognostic (9.90e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.82e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.42e-2)"	"unprognostic (3.51e-5)"	"unprognostic (2.80e-2)"	"unprognostic (9.84e-3)"	"unprognostic (2.65e-2)"	"unprognostic (3.59e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.09e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.26e-2)"	1.8	1.6	0.9	2.8	1.0	6.6	3.5	3.5	1.6	1.8	0.6	3.2	4.1	3.2	1.6	3.2	2.4	1.5	12.8	0.9	0.7	2.1	1.4	2.5	5.0	0.6	0.8	5.0	2.0	2.2	0.6	4.0	0.7	2.1	3.9	1.8	2.0	1.9	3.6	3.4	3.9	2.8	0.7	2.6	3.0	9.7	0.7	8.1	2.2	3.5	4.8	1.9	1.7	1.1	15.9	10.0	16.2	11.6	1.5	3.8	31.2	11.4	7.3	20.2	18.1	10.8	20.0	15.0	14.1	5.3	8.9	14.4	15.9	6.1	18.0	14.4	28.1	9.4	12.2	7.7	1.4	18.6	9.7	1.5	4.3	10.5	10.6	4.9	10.0	13.7	33.5	17.8	12.3	5.8	19.5	12.0	26.0	20.1	18.2	18.7	27.5	19.4	6.6	8.2	14.2	19.9	20.3	23.6	14.7	10.0	13.4	23.8	4.8	11.4	16.3	15.7	29.4	8.2	20.2	31.0	6.6	16.7	27.2	4.1	1.0	1.1	1.2	1.3	1.9	2.2	1.9	2.7	0.5	1.6	3.4	2.6	0.2	1.7	2.8	0.6	2.8	1.0	0.9	1.0	3.5	1.6	0.9	0.7	0.6	0.8	0.7	0.7	0.7	1.1	3.1	9.6	5.1	3.3	3.3	3.3	1.4	2.8	3.4	1.2	2.1	2.2	15.7	1.5	2.2	0.0	0.0	13.0	2.8	1.6	1.9	2.3	20.2	2.0	3.4	3.1	2.4	16.4	11.1	3.3	6.9	3.3	2.0	1.6	1.3	4.3	2.2	1.4	2.8	3.3	8.7	2.5	0.0	3.5	1.1	4.0	4.4	1.9	0.0	6.5	0.4	1.9	2.1	10.1	4.7	2.8	3.8	4.5	6.4	1.2	2.0	1.7	3.7	1.0	0.0	3.0	4.5	36.3	18.7	5.1	1.8	15.5	2.8	1.9	4.9	1.5
LINC00634		ENSG00000205704	"Long intergenic non-protein coding RNA 634"		22	41952174-41958933	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	9	"brain: 33.2;choroid plexus: 10.7"	"Group enriched"	"Detected in some"	35	"Astrocytes: 5.2;Excitatory neurons: 4.0;Inhibitory neurons: 3.6;Oligodendrocyte precursor cells: 3.5;Oligodendrocytes: 1.6"	"Cancer enriched"	"Detected in single"	13	"glioma: 5.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 2.9;SCLC-21H: 2.7"									HPA029815			Approved	"Nuclear speckles,Cytosol"		NA	NA					"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nuclear speckles"	Cytosol	"HPA029815: AB_10601803"	"unprognostic (1.42e-1)"	"unprognostic (8.80e-4)"	"unprognostic (3.93e-4)"	"unprognostic (9.78e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.72e-4)"	"unprognostic (6.59e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.11e-6)"	"unprognostic (5.40e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.17e-1)"	0.0	2.1	27.4	0.0	25.9	0.1	0.0	16.3	33.2	0.0	10.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	30.2	22.6	0.0	0.0	0.0	0.0	19.0	23.6	0.0	0.0	0.0		0.0	17.9	0.1	0.0	2.4	0.0	0.3	0.0	0.0	0.0	0.0	15.6	0.0	0.2	1.0	30.1	0.0	0.0	0.0	0.1	0.0		21.9	0.3	0.0	1.3	1.3	0.0	0.7	0.8	0.0	0.0	0.2	0.3	0.4	1.0	2.4	0.1	0.0	0.9	0.2	0.0	0.0	0.0	0.9	2.1	0.1	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.6	0.6	0.0	0.0	2.5	0.1	1.5	0.0	0.6	1.0	1.4	0.3	0.3	2.0	2.9	0.5	0.1	0.0	0.1	2.7	1.8	0.1	0.1	0.3	0.2	0.3	0.0	0.0	0.2	1.1	0.0	0.3	0.8	1.7	2.4	0.0	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.4	25.9	16.3	33.2	30.2	22.6	19.0	23.6	17.9	15.6	30.1	21.9	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LMNB2	LMN2	ENSG00000176619	"Lamin B2"	Q03252	19	2427638-2456959	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 220.2;Extravillous trophoblasts: 81.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022593, HPA047863, HPA062477"	Enhanced		Supported	"Nuclear membrane"		NA	NA		110000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear membrane"		"CAB022593: , HPA047863: AB_2680189, HPA062477: AB_2684776"	"unprognostic (3.92e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.05e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (2.53e-3)"	"prognostic unfavorable (5.88e-4)"	"unprognostic (1.96e-1)"	"unprognostic (3.09e-3)"	"prognostic unfavorable (9.53e-5)"	"prognostic unfavorable (9.34e-5)"	"prognostic favorable (3.98e-4)"	"unprognostic (4.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.53e-2)"	9.7	10.1	8.9	15.3	8.6	17.3	7.7	11.5	9.8	11.9	6.4	13.1	10.9	11.9	2.4	32.1	10.7	3.4	10.6	8.5	10.1	9.5	6.0	11.2	12.8	8.7	9.0	13.4	8.1	3.6	12.3	14.6	8.4	9.8	6.2	3.5	9.1	4.9	14.9	10.6	12.2	5.5	8.0	12.3	10.4	10.9	10.5	23.1	8.7	5.2	10.5	10.0	12.4	8.0	181.5	114.0	80.8	105.7	17.3	27.2	107.5	119.2	57.7	117.7	88.8	152.0	75.6	83.5	47.8	55.9	68.1	185.6	72.4	84.8	60.0	102.4	86.3	66.4	40.3	119.8	20.9	93.5	64.6	24.5	21.4	63.4	49.7	22.0	60.9	76.2	117.8	51.9	56.4	105.4	107.9	51.8	154.0	97.8	98.6	150.1	102.4	70.0	33.7	89.8	118.7	68.8	99.6	65.6	39.6	44.7	65.9	95.7	85.1	112.5	116.6	174.8	180.6	45.6	41.8	83.5	91.3	88.5	148.3	0.0	0.6	0.8	1.0	0.6	1.6	0.4	1.1	1.0	0.8	0.9	1.1	1.3	0.0	0.9	2.1	3.5	0.4	0.6	8.9	8.6	11.5	9.8	8.5	10.1	8.7	9.0	8.4	8.0	10.5	8.0	8.6	3.2	4.2	2.6	9.4	20.6	14.8	7.9	10.2	8.2	8.8	8.1	5.7	2.8	5.3	5.5	8.4	30.4	9.7	17.5	9.8	7.0	220.2	7.7	14.9	12.7	6.0	19.6	3.0	11.8	81.6	14.3	14.3	11.7	4.5	31.4	8.2	2.7	21.2	13.5	3.9	15.1	6.1	6.8	18.2	31.4	9.3	10.3	1.8	3.7	12.2	9.4	11.3	2.0	3.3	12.7	9.1	7.9	25.5	24.4	12.7	4.9	5.7	10.8	13.1	14.3	11.2	8.6	15.0	30.0	20.0	13.8	11.4	12.0	23.1	19.2
LMTK2	"AATYK2, BREK, cprk, KIAA1079, KPI-2, KPI2, LMR2, PPP1R100"	ENSG00000164715	"Lemur tyrosine kinase 2"	Q8IWU2	7	98106862-98209638	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 50.7;Excitatory neurons: 114.9;Inhibitory neurons: 69.0;Oligodendrocyte precursor cells: 52.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 25.2"	"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010657, HPA041836"	Uncertain		Approved	"Nuclear speckles,Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles, Centriolar satellite"	"Plasma membrane, Cytosol"	"HPA010657: AB_1079259, HPA041836: AB_2677698"	"unprognostic (7.36e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.96e-1)"	"prognostic unfavorable (8.03e-4)"	"unprognostic (1.23e-1)"	"unprognostic (4.65e-1)"	"prognostic favorable (1.12e-7)"	"unprognostic (1.88e-1)"	"unprognostic (3.92e-1)"	"unprognostic (2.16e-2)"	"unprognostic (6.38e-3)"	3.5	7.0	4.2	3.9	6.2	13.8	3.6	0.0	25.2	4.9	0.0	9.7	8.8	3.9	3.9	9.5	4.1	4.2	12.4	6.0	0.0	6.6	6.2	6.6	3.6	2.1	0.5	5.0	14.8	10.7	7.0	3.1	1.8	5.1	8.0	8.2	7.9	4.0	11.1	9.0	9.8	3.7	0.0	4.6	6.5	5.2	1.2	4.9	5.8	7.0	4.8	5.8	6.2	8.7	12.5	14.5	11.0	11.4	5.8	4.6	10.2	5.1	5.5	4.9	5.9	11.5	11.1	6.5	14.3	6.5	18.6	13.4	12.8	7.8	7.6	9.4	9.0	4.4	13.0	11.6	7.0	8.0	7.6	3.2	10.5	10.1	13.6	4.9	7.4	7.4	11.8	13.4	4.5	16.9	8.5	4.8	13.4	17.1	7.0	9.2	7.5	13.0	8.2	21.7	7.8	15.7	10.2	18.4	7.4	11.0	5.1	3.2	9.2	10.2	16.6	20.5	11.7	5.9	11.2	12.8	6.8	6.2	12.3	0.5	0.1	0.1	0.2	0.0	0.1	0.1	0.2	0.2	0.1	0.2	0.3	0.4	1.4	0.1	0.3	0.2	0.2	0.1	4.2	6.2	0.0	25.2	6.0	0.0	2.1	0.5	1.8	0.0	1.2	8.7	6.0	28.9	17.0	28.7	7.8	9.7	4.3	6.2	14.8	14.2	5.5	3.9	22.4	15.7	11.8	1.8	14.6	2.8	7.5	50.7	1.9	6.1	1.1	13.2	7.6	5.7	12.0	8.4	114.9	9.1	1.9	5.4	21.4	26.4	2.5	5.3	2.5	8.4	2.2	6.7	69.0	14.7	4.1	1.6	2.3	2.0	1.8	3.2	1.8	16.9	2.8	6.1	7.2	52.3	29.6	10.3	23.8	4.5	12.9	8.8	14.0	3.0	15.8	10.6	0.0	8.6	5.7	6.9	6.3	15.5	10.9	3.0	8.6	2.7	14.7	20.5
LONRF3	"FLJ22612, RNF127"	ENSG00000175556	"LON peptidase N-terminal domain and ring finger 3"	Q496Y0	X	118974614-119018355	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 16.9;Gastric mucus-secreting cells: 17.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 3.8"	"Lineage enriched"	"Detected in single"	7	"T-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"GAMG: 12.2;K-562: 13.8;OE19: 15.2;PC-3: 16.0;SiHa: 14.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050422, HPA061162"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Plasma membrane"	"HPA050422: AB_2681122, HPA061162: AB_2732658"	"unprognostic (1.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.21e-1)"	"unprognostic (8.01e-2)"	"prognostic unfavorable (4.32e-4)"	"unprognostic (4.29e-2)"	"unprognostic (2.31e-3)"	"unprognostic (6.34e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.27e-3)"	3.3	3.3	1.2	1.9	1.1	4.5	1.4	6.6	2.8	1.5	0.0	3.5	2.3	1.9	1.2	1.4	2.0	2.4	2.3	3.3	1.0	2.8	12.7	6.4	0.8	0.9	1.9	1.6	7.0	0.7	0.9	0.8	1.0	1.9	4.3	2.8	4.8	2.4	8.8	0.7	2.0	1.5	1.5	0.6	4.0	1.7	2.0	0.3	8.2	3.9	1.0	3.6	0.7	1.1	5.0	6.9	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.7	6.0	0.0	3.5	0.0	12.2	0.0	1.3	0.0	0.1	0.1	3.7	6.6	11.8	6.9	3.7	5.7	0.7	0.0	0.0	0.0	0.0	2.1	1.7	0.5	13.8	0.0	0.9	5.5	0.0	2.3	0.0	15.2	16.0	0.0	3.1	0.0	4.2	2.1	0.2	0.0	14.5	0.4	11.8	0.1	0.0	4.5	0.3	0.1	0.2	0.0	7.9	1.4	6.3	0.0	3.2	5.4	3.4	0.0	0.4	0.0	2.4	0.0	3.8	0.0	1.1	0.8	0.0	0.0	0.5	0.8	0.5	0.0	0.0	0.0	0.4	0.3	1.2	1.1	6.6	2.8	3.3	1.0	0.9	1.9	1.0	1.5	2.0	1.1	2.2	6.4	13.4	7.8	0.4	1.5	16.9	0.2	1.8	3.3	0.8	1.9	4.4	0.0	6.1	1.8	0.0	0.5	5.3	11.2	1.9	3.0	1.6	4.4	6.4	3.3	1.2	0.4	1.8	4.3	0.0	8.0	17.3	13.0	6.3	0.1	2.2	4.1	2.7	1.7	6.0	4.6	0.0	4.7	7.7	1.0	0.9	9.5	3.6	9.4	0.5	3.7	2.1	3.5	0.2	5.2	8.8	1.5	1.3	7.2	1.6	1.5	0.3	0.3	0.0	9.9	2.0	2.4	4.6	1.6	0.1	0.4	2.7	0.2	3.7	12.5
LRR1	"LRR-1, MGC20689, PPIL5"	ENSG00000165501	"Leucine rich repeat protein 1"	Q96L50	14	49598761-49614672	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 29.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 129.5;Spermatocytes: 151.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA065703, HPA069364"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Vesicles"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"	Vesicles	"HPA065703: AB_2685537, HPA069364: AB_2686129"	"unprognostic (2.73e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.85e-2)"	"unprognostic (9.34e-2)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (7.34e-2)"	"unprognostic (2.50e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (4.90e-7)"	"unprognostic (6.86e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.04e-2)"	5.7	5.5	1.6	9.1	1.7	22.6	5.6	1.7	2.1	3.0	1.6	12.2	9.6	3.7	2.4	6.7	3.3	3.6	3.2	1.5	1.6	3.1	6.1	4.2	14.0	1.8	1.7	2.4	4.3	2.9	1.2	4.0	1.8	3.2	10.0	3.2	4.1	3.4	4.0	4.7	10.1	6.1	1.7	7.5	4.6	29.1	1.8	23.2	3.4	4.8	13.3	5.4	3.5	1.9	66.5	39.3	34.2	38.4	15.1	10.6	38.2	35.0	30.8	72.5	68.7	38.4	49.1	60.9	25.1	22.9	23.2	41.7	42.2	29.8	64.1	56.5	31.3	27.4	29.4	24.6	8.5	64.5	34.2	6.9	11.3	33.9	19.4	9.2	35.8	49.2	29.3	45.4	49.2	55.2	87.2	60.1	22.5	31.7	53.0	54.8	56.2	41.4	25.4	27.1	36.9	21.7	33.1	35.3	25.4	12.1	49.9	49.6	13.1	50.6	83.1	24.8	44.4	23.6	35.9	69.0	23.6	47.7	42.9	22.4	14.2	25.4	10.1	22.7	13.5	16.1	13.3	14.8	15.0	12.6	10.8	12.3	8.2	11.1	16.9	17.7	15.7	10.5	1.6	1.7	1.7	2.1	1.5	1.6	1.8	1.7	1.8	1.7	1.8	1.9	6.4	3.2	6.5	2.0	12.1	15.6	5.7	12.0	4.6	3.8	6.5	5.6	3.6	5.7	9.3	3.7	2.1	12.6	9.2	11.8	1.9	16.8	129.5	3.4	5.3	8.9	4.8	48.4	0.9	22.7	34.2	7.8	6.6	2.9	14.5	9.5	6.8	6.6	21.6	1.7	1.1	11.0	12.2	10.4	19.2	41.6	7.5	11.5	10.6	2.8	16.7	8.1	13.4	1.0	2.0	14.1	3.7	3.4	31.3	11.2	8.7	7.5	4.3	5.2	6.6	5.5	8.0	151.7	14.0	8.8	14.9	7.7	10.5	7.5	14.5	7.0
LRRC40	FLJ20331	ENSG00000066557	"Leucine rich repeat containing 40"	Q9H9A6	1	70144805-70205579	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026564	Approved		Approved	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli		"HPA026564: AB_2250054"	"unprognostic (9.39e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (4.54e-4)"	"unprognostic (6.42e-2)"	"unprognostic (6.65e-3)"	"unprognostic (3.94e-2)"	"unprognostic (7.69e-3)"	"unprognostic (9.90e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.50e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.95e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.12e-1)"	9.7	8.4	5.7	9.0	6.6	16.3	11.0	8.3	8.4	7.7	2.3	9.0	14.6	10.3	6.5	9.5	5.4	8.4	11.7	7.0	6.3	14.1	23.6	8.2	13.2	4.6	4.8	8.3	7.1	6.8	3.5	12.0	5.1	8.6	9.7	9.9	5.6	6.9	7.4	7.7	13.5	11.2	5.3	9.3	6.9	11.9	5.3	14.0	8.2	10.0	12.6	9.8	5.1	6.8	26.4	10.9	42.1	33.3	15.1	16.6	25.4	25.0	18.2	37.0	45.4	16.0	14.5	35.4	21.4	19.6	36.6	19.0	100.0	22.3	50.2	28.5	20.0	26.8	18.6	25.9	19.0	35.4	6.2	13.8	12.7	24.7	24.6	17.1	21.7	22.2	33.6	16.7	31.7	6.8	42.8	27.4	55.5	17.3	22.5	33.8	43.5	22.9	34.1	16.0	21.5	21.7	30.2	29.9	28.6	29.6	14.3	19.8	27.2	26.0	20.8	39.7	28.7	14.0	14.4	57.2	21.0	36.6	27.3	5.4	4.6	5.5	5.5	6.0	7.3	7.2	5.8	5.3	6.0	6.7	6.8	5.8	0.7	7.6	5.8	4.6	7.8	4.5	5.7	6.6	8.3	8.4	7.0	6.3	4.6	4.8	5.1	5.3	5.3	6.8	13.9	12.8	12.6	22.2	15.1	12.9	7.8	10.5	17.1	16.4	6.9	6.0	10.4	8.6	9.2	14.7	6.2	16.9	23.2	6.9	11.7	12.7	1.3	6.0	12.1	11.3	23.3	17.2	41.1	8.9	13.3	12.7	5.1	10.8	15.2	11.3	13.2	21.4	11.9	15.2	40.1	6.5	20.3	11.7	12.1	3.0	10.2	9.4	5.4	15.9	13.4	7.6	8.2	22.6	30.9	9.2	4.1	10.1	11.7	5.1	13.2	24.1	6.4	12.5	19.7	12.9	12.9	25.1	28.3	11.7	11.1	7.3	15.8	10.4	8.1	5.0
LRRC57	FLJ36812	ENSG00000180979	"Leucine rich repeat containing 57"	Q8N9N7	15	42537820-42548802	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 60.5;Rod photoreceptor cells: 87.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA040894	Approved		Approved	Mitochondria,Cytosol		NA	NA		26000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Mitochondria, Cytosol"		"HPA040894: AB_10794996"	"unprognostic (8.99e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.77e-2)"	"unprognostic (4.16e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.73e-2)"	"prognostic favorable (2.15e-4)"	"unprognostic (7.45e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.05e-2)"	7.7	7.3	4.8	5.5	4.6	22.0	7.5	4.8	8.5	7.3	3.3	9.3	6.5	7.7	5.5	9.6	8.3	5.3	6.9	6.1	3.1	8.0	6.1	8.6	6.6	3.6	3.4	8.6	7.3	14.0	6.0	7.9	4.1	6.6	10.7	14.9	8.0	5.8	6.0	9.6	8.1	7.3	3.2	6.7	7.8	5.7	3.7	9.6	7.0	6.9	7.4	6.8	8.6	5.4	14.7	11.0	19.5	13.8	16.5	12.7	9.7	20.5	11.2	14.7	15.4	23.3	11.0	6.8	13.8	16.9	16.5	22.7	13.2	16.7	14.7	12.8	12.2	27.7	23.6	10.7	14.7	17.8	15.0	14.0	22.8	13.2	17.1	10.1	23.7	17.3	21.9	14.5	13.6	6.6	9.8	7.5	4.6	26.6	8.5	15.1	19.6	10.5	9.8	24.4	9.8	11.9	24.8	16.3	11.8	12.7	16.1	19.6	24.3	16.5	11.4	17.5	15.5	11.9	36.4	29.0	8.9	16.4	21.0	36.9	9.7	32.0	7.4	14.6	9.3	5.8	7.2	7.2	10.2	7.1	5.8	7.3	12.2	16.9	19.3	5.9	8.5	6.9	4.8	4.6	4.8	8.5	6.1	3.1	3.6	3.4	4.1	3.2	3.7	5.4	16.3	9.6	10.8	6.8	10.4	5.7	13.6	6.5	6.8	13.6	9.6	8.1	11.1	15.7	7.3	9.2	60.5	11.6	18.8	16.4	13.7	10.9	18.7	13.5	13.8	17.3	12.5	15.8	17.1	9.8	19.3	12.7	9.2	13.2	14.5	10.2	19.2	7.5	14.1	20.2	8.8	13.1	6.1	14.2	4.8	20.0	9.6	13.1	7.2	7.5	21.9	21.1	20.6	11.6	8.3	15.2	15.9	16.1	8.4	12.4	15.2	8.4	14.8	87.4	6.6	16.9	10.1	7.8	6.4	11.4	5.5	15.9	11.3	18.4	12.2	12.8
LRRC58		ENSG00000163428	"Leucine rich repeat containing 58"	Q96CX6	3	120324509-120349354	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057574	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA057574: AB_2683474"	"unprognostic (7.87e-3)"	"unprognostic (6.84e-3)"	"unprognostic (3.20e-1)"	"unprognostic (2.67e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.98e-4)"	"unprognostic (4.41e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.73e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (1.06e-1)"	10.6	22.8	8.4	8.8	11.9	9.0	12.0	11.0	9.3	9.0	9.5	7.7	7.5	10.2	8.3	9.2	6.6	7.4	5.5	7.1	8.6	14.9	11.2	7.4	10.2	11.8	11.3	14.6	10.3	13.7	4.1	9.6	12.6	9.7	7.5	7.2	8.5	8.6	5.0	10.9	7.4	9.7	10.8	9.1	7.3	4.5	9.7	12.2	14.2	5.8	8.8	7.4	6.5	14.8	52.6	18.1	12.2	15.6	27.5	26.1	19.3	18.5	16.0	19.2	23.8	17.0	15.8	34.1	22.4	19.9	27.3	22.4	22.7	18.1	36.5	13.3	14.0	36.5	23.5	19.9	18.5	59.8	18.0	19.3	22.7	23.4	29.9	12.4	11.5	21.5	21.0	42.6	20.9	23.9	47.2	19.1	12.3	23.1	32.8	10.4	32.6	22.1	14.6	19.1	15.6	20.6	32.4	21.9	46.2	8.5	24.1	26.7	17.2	32.0	35.7	21.7	23.5	36.3	44.9	70.6	32.2	44.2	27.4	1.4	2.7	1.1	1.9	2.4	2.7	2.5	2.3	2.4	2.6	2.3	3.5	2.7	1.5	1.6	1.9	2.9	2.6	1.9	8.4	11.9	11.0	9.3	7.1	8.6	11.8	11.3	12.6	10.8	9.7	14.8	26.0	73.7	59.9	18.3	30.8	50.9	20.7	15.9	32.5	32.3	34.0	25.8	17.3	24.3	29.0	18.4	56.3	17.3	33.3	17.9	11.7	22.0	7.8	24.4	48.8	24.1	16.8	34.3	23.8	31.0	28.2	50.0	18.3	27.0	35.4	33.9	27.1	43.0	28.7	25.2	27.1	24.3	12.2	49.0	33.9	7.3	55.9	34.4	33.8	14.0	42.3	46.5	30.9	25.1	34.8	28.8	18.6	73.0	33.0	37.0	24.8	39.6	32.3	26.5	26.3	52.7	33.9	19.5	22.8	31.2	57.0	13.5	28.7	94.6	32.3	17.5
LRRTM3		ENSG00000198739	"Leucine rich repeat transmembrane neuronal 3"	Q86VH5	10	66926036-67101551	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 2.6;brain: 4.8;ovary: 2.7;pituitary gland: 3.4"	"Group enriched"	"Detected in some"	22	"Early spermatids: 164.0;Excitatory neurons: 485.6;Inhibitory neurons: 577.7;Late spermatids: 178.7;Oligodendrocyte precursor cells: 601.7;Oligodendrocytes: 253.5"	"Cancer enriched"	"Detected in single"	7	"glioma: 2.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.4;HAP1: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA070444, HPA078598"			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies"	"HPA070444: , HPA078598: "					"unprognostic (1.21e-2)"					"unprognostic (4.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.02e-2)"		"unprognostic (1.15e-4)"	"unprognostic (8.11e-2)"		"unprognostic (4.77e-1)"	0.1	2.6	2.7	0.0	3.1	0.0	0.0	1.0	4.8	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.9	0.7	0.0	0.0	0.2	0.0	0.0	0.6	2.7	1.0	0.0	3.4	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.1	1.0	4.8	3.9	0.7	0.0	0.6	0.0	0.1	1.0	3.4	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	164.0	0.0	0.2	0.2	0.0	0.0	485.6	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	577.7	0.0	0.0	0.0	0.0	178.7	8.7	0.1	0.0	8.4	0.0	0.4	0.0	601.7	253.5	0.1	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.3	2.5	1.5	0.0	0.0	0.0	0.0	5.7	0.0	0.0
LSG1	FLJ11301	ENSG00000041802	"Large 60S subunit nuclear export GTPase 1"	Q9H089	3	194640791-194672463	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037704, HPA037705"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 60: Granulocytes - Receptor signaling"	"Nuclear bodies, Cytosol"	Nucleoplasm	"HPA037704: AB_10672912, HPA037705: AB_2675621"	"unprognostic (5.72e-3)"	"unprognostic (9.38e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (3.21e-7)"	"unprognostic (4.63e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.86e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.07e-1)"	14.9	12.8	13.2	15.8	13.8	28.1	15.8	13.9	15.9	12.8	14.0	15.1	17.2	15.2	19.8	15.9	14.5	12.6	14.0	13.1	14.5	16.6	21.7	12.8	18.7	14.7	16.4	14.2	15.5	16.8	11.1	17.2	15.8	14.6	18.1	14.0	13.8	13.9	23.0	19.3	14.9	14.5	14.0	15.4	13.6	14.4	14.4	17.2	15.5	18.9	21.3	18.2	14.3	15.4	55.6	36.0	21.2	35.3	32.3	17.8	43.1	31.0	30.1	42.9	37.6	47.9	25.1	43.1	93.5	29.4	75.5	39.5	68.2	35.0	52.1	56.3	32.5	46.8	38.4	27.6	22.9	51.1	42.4	17.3	31.5	44.4	41.7	16.0	47.1	29.4	39.5	46.2	36.0	76.6	46.3	30.8	57.7	73.5	65.6	56.2	35.0	49.3	23.7	46.9	40.5	27.9	39.9	38.2	40.0	39.7	90.3	32.9	36.5	32.4	37.3	46.2	66.6	50.6	71.1	97.7	26.2	64.7	52.4	3.5	10.1	13.6	15.3	13.2	17.1	16.6	12.5	13.9	17.2	14.3	14.4	12.9	1.3	21.0	8.9	9.0	15.4	10.6	13.2	13.8	13.9	15.9	13.1	14.5	14.7	16.4	15.8	14.0	14.4	15.4	25.0	19.2	29.6	10.4	22.5	16.2	13.4	8.9	25.0	18.3	12.1	11.9	17.2	18.6	27.9	9.2	12.5	25.1	21.2	14.0	5.9	23.3	12.0	22.1	24.5	23.7	7.8	16.2	10.5	22.4	19.4	17.7	21.9	24.0	53.7	21.9	11.7	14.0	13.0	15.2	8.3	14.2	12.2	4.4	10.2	8.9	15.5	15.5	12.4	8.4	14.0	18.2	12.3	12.5	12.2	19.7	8.0	14.7	23.8	11.5	10.8	9.7	34.3	18.6	19.7	22.1	14.6	26.4	35.7	30.5	16.1	28.5	24.0	23.2	17.6	9.0
LSM11	FLJ38273	ENSG00000155858	"LSM11, U7 small nuclear RNA associated"	P83369	5	157743712-157760709	"Predicted intracellular proteins"	"mRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 26.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039587	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA039587: AB_10796330"	"unprognostic (3.99e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.38e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.61e-3)"	"unprognostic (9.68e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.89e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.11e-2)"	"unprognostic (3.01e-2)"	2.0	2.1	3.6	1.9	3.8	1.7	2.2	3.8	4.8	4.3	0.2	6.4	2.3	5.3	1.5	2.2	3.1	2.3	1.2	4.0	2.3	1.3	1.3	1.8	2.1	2.7	3.0	3.4	1.9	1.8	2.2	2.1	3.0	4.3	2.6	7.1	1.8	4.7	1.4	2.2	2.3	3.3	3.0	1.6	2.3	4.1	2.7	1.8	1.2	1.4	2.1	9.8	3.5	3.0	3.2	2.3	6.2	6.6	2.7	3.5	5.4	4.3	1.9	3.6	4.7	6.9	3.1	7.0	4.9	2.5	2.5	3.7	8.1	4.7	3.9	5.0	7.6	2.9	8.6	4.4	1.0	8.7	3.5	1.6	3.1	4.3	4.4	4.0	5.9	5.7	5.5	3.7	3.9	3.0	4.9	5.1	1.8	2.6	6.9	7.7	7.7	2.9	1.8	2.9	3.6	5.7	2.8	3.8	3.8	4.5	3.2	5.3	4.2	6.9	2.7	4.1	6.9	3.0	2.0	6.9	2.8	8.9	3.1	0.4	0.1	0.0	0.2	0.1	0.3	0.1	0.3	0.2	0.1	0.1	0.2	0.2	0.1	0.4	0.0	0.0	0.2	0.1	3.6	3.8	3.8	4.8	4.0	2.3	2.7	3.0	3.0	3.0	2.7	3.0	3.6	6.4	4.1	2.3	2.7	3.6	3.5	1.3	2.2	26.1	3.3	2.5	2.2	1.5	3.1	3.7	6.2	2.1	4.7	3.1	0.0	1.7	10.6	0.8	3.7	3.2	3.0	1.3	11.7	0.9	4.8	3.6	2.0	1.6	1.3	5.5	3.9	2.2	2.2	8.4	11.8	2.0	0.0	4.2	5.7	15.7	1.5	2.6	0.0	1.0	3.5	2.2	4.1	1.5	2.4	1.8	6.2	4.1	2.4	3.7	2.1	1.5	1.9	7.8	0.0	4.3	9.1	10.5	10.9	1.9	4.3	1.2	2.8	2.1	5.5	4.0
LSM12	FLJ30656	ENSG00000161654	"LSM12 homolog"	Q3MHD2	17	44034328-44067619	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 267.0;Late spermatids: 568.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA051934	Approved		Approved	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA051934: AB_2681666"	"unprognostic (3.42e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.98e-2)"	"unprognostic (8.04e-2)"	"unprognostic (3.87e-3)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (7.49e-5)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (1.18e-7)"	"unprognostic (8.91e-3)"	"unprognostic (2.79e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.18e-2)"	20.0	21.9	20.0	16.9	20.5	29.6	18.6	19.9	24.7	16.1	18.4	19.7	17.2	17.5	25.0	28.1	15.1	15.5	22.6	20.8	23.5	20.8	29.3	16.8	20.8	20.9	22.5	15.4	23.9	21.5	14.2	23.0	20.6	16.8	23.6	31.3	18.1	15.4	37.1	16.7	16.9	20.4	19.6	17.2	19.9	24.0	21.6	19.9	18.2	23.7	24.8	22.8	17.4	21.0	47.4	51.3	35.7	56.3	45.9	49.4	65.2	52.3	51.6	65.5	65.3	59.2	50.5	78.6	36.8	59.8	51.9	37.9	75.7	67.7	97.7	59.5	78.5	54.5	38.7	72.6	42.4	95.6	55.9	44.4	53.8	61.3	88.0	42.7	57.1	50.2	81.0	56.6	44.8	46.5	91.4	53.1	52.8	46.7	72.5	57.3	69.8	76.2	61.4	68.5	49.6	32.9	42.4	45.3	55.9	74.0	94.5	62.5	51.8	82.7	49.0	45.1	86.5	44.4	48.3	83.6	70.2	66.9	64.0	43.8	61.7	28.3	48.3	80.3	54.0	46.7	53.5	51.8	70.7	41.0	46.9	46.6	32.6	47.1	78.4	71.9	58.2	61.2	20.0	20.5	19.9	24.7	20.8	23.5	20.9	22.5	20.6	19.6	21.6	21.0	37.9	16.0	17.5	4.6	32.0	50.3	44.0	36.7	42.1	41.4	58.4	44.6	19.3	27.1	27.4	16.5	87.6	48.0	50.4	43.9	43.0	62.7	267.0	57.2	51.2	35.5	39.9	45.8	13.3	101.6	94.0	37.2	28.5	52.3	7.6	39.6	28.9	48.6	43.8	35.3	14.3	46.5	26.4	38.0	64.4	568.8	35.1	44.6	33.8	14.0	50.1	35.4	39.1	8.0	14.8	85.2	38.5	31.6	48.0	76.7	30.3	58.4	22.7	63.1	26.3	35.5	57.9	59.7	70.0	50.5	48.9	83.7	37.8	63.7	48.5	78.6
LSM14A	"C19orf13, DKFZP434D1335, FAM61A, RAP55, RAP55A"	ENSG00000257103	"LSM14A mRNA processing body assembly factor"	Q8ND56	19	34172504-34229288	"Predicted intracellular proteins"	"Translation regulation"	"Developmental protein, Repressor, Ribonucleoprotein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017961	Approved		Supported	"Cytosol,Cytoplasmic bodies"		NA	NA		18000	"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	"Cytoplasmic bodies"	Cytosol	"HPA017961: AB_1845610"	"unprognostic (2.38e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.62e-3)"	"unprognostic (5.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.56e-1)"	43.9	38.5	26.4	27.5	26.2	72.0	42.0	28.0	39.2	46.2	29.4	49.4	24.8	47.8	31.7	41.2	40.6	22.7	36.4	25.5	26.0	37.7	37.6	37.7	46.5	26.1	27.1	51.7	32.9	33.8	30.4	37.5	26.4	36.5	29.2	52.8	36.4	32.3	74.2	47.1	38.2	33.0	28.3	36.7	32.8	33.1	26.1	50.7	45.9	43.7	40.8	44.2	41.8	27.7	66.0	46.1	62.9	49.7	33.4	42.9	20.4	24.7	39.5	43.9	42.9	50.2	27.7	107.9	28.9	46.7	14.7	17.6	57.0	42.7	70.8	71.5	10.4	102.2	30.0	50.5	58.7	82.1	34.6	39.4	63.0	33.3	47.8	56.1	63.3	36.3	56.6	44.8	45.6	32.0	64.8	62.2	59.9	61.0	7.5	42.7	44.1	40.7	58.4	32.9	52.8	40.8	56.7	85.2	61.5	56.2	54.8	102.0	38.7	66.3	25.6	25.5	53.1	43.3	59.0	78.6	42.0	57.5	40.4	16.5	9.3	18.9	11.4	12.1	15.2	11.9	13.4	12.8	10.9	8.0	14.3	12.7	8.1	17.8	14.6	5.2	13.4	11.1	26.4	26.2	28.0	39.2	25.5	26.0	26.1	27.1	26.4	28.3	26.1	27.7	64.3	25.6	42.8	81.9	118.7	123.9	70.2	64.6	86.0	92.3	68.1	50.0	70.6	61.5	58.4	58.8	20.9	161.2	108.2	39.0	68.4	77.7	65.6	54.3	64.2	75.5	57.2	100.4	68.0	54.1	176.6	70.1	37.8	57.0	62.1	64.6	63.9	50.6	67.0	62.2	70.1	52.7	73.2	63.7	96.7	75.5	126.2	73.5	67.6	85.3	137.2	104.3	232.8	92.0	113.4	59.6	40.2	127.2	80.2	110.0	49.9	88.0	47.6	78.8	78.9	64.2	78.8	194.9	151.6	75.4	131.6	137.4	101.5	69.2	51.4	71.7
LSM2	"C6orf28, G7b, YBL026W"	ENSG00000204392	"LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated"	Q9Y333	6	31797396-31806966	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052805, HPA066718"	Supported		Enhanced	Nucleoplasm		NA	NA		97000	"Cluster 32: T-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA052805: , HPA066718: AB_2685710"	"unprognostic (1.69e-1)"	"unprognostic (7.78e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.36e-3)"	"unprognostic (6.14e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (5.59e-9)"	"unprognostic (2.23e-1)"	"unprognostic (8.48e-2)"	"unprognostic (4.49e-2)"	"unprognostic (9.59e-2)"	38.6	34.3	19.0	19.3	21.8	32.7	37.9	20.6	21.4	44.8	17.4	43.0	23.6	45.0	19.3	39.0	36.9	18.1	32.3	19.4	19.1	43.8	27.6	31.6	36.6	22.8	19.6	37.6	37.2	20.5	30.1	22.5	21.7	29.7	27.8	7.2	25.2	16.3	43.9	37.0	33.6	27.7	24.5	43.5	34.6	26.7	22.9	45.1	30.1	20.9	39.3	39.9	35.6	23.7	91.1	42.5	84.9	103.7	43.8	61.9	58.4	50.1	38.5	85.2	75.1	56.9	37.6	50.3	66.8	50.1	79.8	36.2	109.3	101.1	76.9	72.4	85.0	83.6	27.3	60.1	55.7	80.6	39.7	47.1	47.3	78.6	80.4	40.6	90.3	102.0	127.5	63.0	60.7	73.3	132.3	168.4	56.8	75.0	77.6	73.4	40.5	123.4	69.5	31.6	66.6	55.6	56.0	58.8	101.7	44.7	61.6	68.7	20.1	47.6	74.5	54.1	85.1	53.2	109.9	88.2	26.8	123.3	76.7	29.1	31.3	15.9	36.9	37.7	45.2	3.7	51.6	33.6	35.4	4.1	45.6	30.1	8.7	13.8	25.1	30.9	29.9	57.5	19.0	21.8	20.6	21.4	19.4	19.1	22.8	19.6	21.7	24.5	22.9	23.7	82.9	22.4	23.6	4.6	95.2	58.2	63.7	104.9	56.3	30.9	108.2	177.2	14.9	60.1	48.5	55.2	6.2	143.5	58.5	36.5	113.5	104.5	20.1	38.8	61.2	90.2	54.0	121.8	5.9	137.1	218.8	58.0	46.9	49.2	82.6	119.9	72.8	59.7	143.2	30.3	6.0	93.9	73.2	67.9	76.8	26.0	49.7	56.6	92.5	3.7	99.3	53.3	109.2	9.5	19.8	94.0	55.7	49.2	91.5	78.2	40.8	113.3	24.2	28.3	46.0	70.7	71.4	66.9	176.5	90.8	64.2	69.0	77.8	101.3	113.6	58.6
LTN1	"C21orf10, C21orf98, FLJ11053, KIAA0714, LISTERIN, RNF160, ZNF294"	ENSG00000198862	"Listerin E3 ubiquitin protein ligase 1"	O94822	21	28928144-28992956	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 213.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029143, CAB034164, HPA055604"	Uncertain		Enhanced	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"CAB034164: AB_2180094, HPA029143: AB_10671360, HPA055604: AB_2682859"	"unprognostic (3.67e-2)"	"unprognostic (7.07e-2)"	"unprognostic (7.78e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.42e-2)"	"unprognostic (3.66e-3)"	"unprognostic (5.38e-2)"	"unprognostic (5.40e-2)"	"unprognostic (9.98e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.22e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.52e-1)"	7.7	8.4	4.5	9.3	7.8	16.5	12.4	7.0	6.2	9.3	5.3	9.2	8.8	10.7	10.2	9.1	7.0	7.4	7.7	4.1	6.6	8.3	11.0	7.4	12.0	6.1	5.9	10.1	9.4	9.9	3.9	18.6	6.7	12.7	10.6	11.6	10.1	8.1	9.5	9.4	9.0	9.1	6.2	10.3	11.0	13.6	6.1	11.3	12.1	11.2	10.5	8.3	5.9	13.1	20.4	8.6	17.5	7.9	14.6	19.9	17.7	16.8	13.6	14.2	19.4	12.1	16.5	13.3	8.0	15.1	12.2	10.2	18.8	13.8	25.5	15.7	13.0	39.8	11.9	9.7	11.0	13.3	14.8	13.9	12.1	20.1	16.6	13.9	15.2	9.5	33.0	31.0	16.4	6.3	8.6	12.9	25.1	16.8	10.1	11.4	34.9	28.0	16.0	17.3	9.5	19.7	19.3	14.5	17.0	16.3	14.8	18.6	20.2	12.4	22.9	16.8	14.3	25.1	25.1	18.5	19.3	28.3	15.0	12.6	4.9	7.9	6.3	7.6	5.2	5.8	4.2	4.2	4.9	5.1	4.5	3.4	8.6	7.0	10.7	3.1	5.0	2.6	4.5	7.8	7.0	6.2	4.1	6.6	6.1	5.9	6.7	6.2	6.1	13.1	42.1	16.0	22.6	36.6	30.7	30.2	26.3	22.8	30.7	28.4	22.8	17.4	25.8	12.8	24.0	11.0	33.3	19.3	26.8	18.4	1.9	14.4	213.7	21.6	45.9	27.5	22.7	18.7	47.1	14.0	18.8	30.3	38.2	36.2	27.8	24.2	14.3	19.7	13.2	42.1	54.8	18.9	22.4	18.1	13.2	73.1	26.8	23.5	12.4	25.3	28.2	44.9	18.6	53.8	90.8	20.2	14.2	21.1	43.9	31.5	16.6	16.9	22.6	30.5	13.1	29.3	28.6	46.8	23.9	30.1	32.0	29.8	30.5	34.3	20.8	29.8
LUC7L2	"CGI-59, CGI-74, FLJ10657, H_NH0792N18.3, hLuc7B2, LUC7B2"	ENSG00000146963	"LUC7 like 2, pre-mRNA splicing factor"	Q9Y383	7	139340359-139423457	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051631	Approved		Approved	Nucleoplasm		NA	NA		28000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA051631: AB_2681558"	"unprognostic (1.07e-3)"	"unprognostic (2.71e-2)"	"unprognostic (8.26e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.00e-2)"	"unprognostic (4.54e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.48e-3)"	"unprognostic (3.54e-1)"	"unprognostic (2.20e-2)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (1.23e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.28e-3)"	38.6	32.2	43.0	29.9	43.4	79.4	46.5	45.0	63.4	51.9	37.0	40.4	26.0	40.4	39.7	44.4	46.7	33.0	40.8	41.2	49.4	42.5	49.0	34.2	49.5	42.2	41.8	50.8	46.0	40.3	26.1	36.6	42.4	46.4	35.2	43.6	38.1	37.1	62.3	49.3	37.3	35.5	38.6	40.0	40.6	35.8	43.4	62.7	60.8	41.4	53.6	41.9	45.2	52.9	65.7	37.4	79.3	73.6	53.0	43.6	58.0	74.4	71.6	71.5	74.6	41.4	61.2	108.5	43.4	60.7	44.6	46.3	96.5	75.7	100.7	51.1	94.7	92.5	56.1	41.9	44.8	150.2	75.4	38.6	93.6	67.3	81.9	49.5	58.5	56.1	119.5	57.1	78.6	62.5	180.4	140.9	65.2	87.6	53.1	107.7	77.7	98.7	81.9	72.7	68.2	65.2	82.0	82.5	75.5	59.3	55.8	59.1	56.0	54.7	31.8	61.1	68.3	86.5	88.0	230.1	60.5	143.8	74.3	10.7	9.4	17.9	17.7	14.3	19.8	16.0	17.3	18.6	12.8	14.9	21.3	18.3	8.7	16.3	17.1	13.2	19.0	12.3	43.0	43.4	45.0	63.4	41.2	49.4	42.2	41.8	42.4	38.6	43.4	52.9	53.5	54.5	56.8	0.0	63.0	0.0	74.8	0.0	72.8	54.0	54.4	45.1	0.0	35.8	39.6	38.6	52.1	77.0	48.5	16.5	54.8	45.1	18.7	31.4	43.1	46.8	21.9	102.9	0.0	38.5	74.3	48.2	57.1	32.8	60.5	37.7	42.1	58.5	43.9	43.7	0.0	29.0	0.0	42.5	0.0	8.5	53.1	41.9	0.0	0.0	46.4	46.7	43.3	0.0	0.1	34.9	18.7	67.7	68.6	62.0	34.6	40.8	37.2	49.2	59.2	54.9	45.6	74.1	68.7	51.5	0.1	82.4	63.7	43.0	28.0	56.2
LYAR	"ZC2HC2, ZLYAR"	ENSG00000145220	"Ly1 antibody reactive"	Q9NX58	4	4267701-4290154	"Predicted intracellular proteins, Transcription factors"	"Immunity, Innate immunity, rRNA processing, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"testis: 102.1"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 223.1;NK-cells: 197.8;Spermatocytes: 718.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035880, HPA035881"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA035880: , HPA035881: AB_10669980"	"unprognostic (2.81e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.22e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (3.20e-5)"	"unprognostic (1.08e-3)"	"unprognostic (2.92e-2)"	"prognostic favorable (8.82e-4)"	"unprognostic (5.05e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (4.36e-10)"	"unprognostic (4.94e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.72e-1)"	14.8	8.4	7.8	19.8	8.4	20.4	11.2	8.2	13.0	10.0	7.1	10.8	8.8	9.1	5.7	15.9	10.4	8.2	15.6	8.0	9.0	8.8	10.4	11.8	24.3	9.0	8.6	12.4	9.6	5.3	8.4	11.1	8.9	7.8	10.1	11.1	7.3	6.7	21.2	9.2	9.3	9.0	7.9	18.7	7.9	102.1	8.5	12.8	6.7	11.7	17.8	18.8	10.8	9.3	59.9	30.8	26.7	39.3	22.9	26.0	46.1	53.2	18.1	53.7	37.1	97.1	75.6	158.9	37.5	23.0	86.2	37.0	100.6	55.4	69.8	28.6	74.8	159.2	29.5	109.0	38.7	184.4	41.4	20.5	34.4	61.8	103.9	13.9	47.2	89.1	217.9	51.2	37.8	60.5	63.4	236.6	134.0	62.1	99.2	96.2	48.6	76.4	24.4	40.7	63.4	27.4	29.0	31.0	55.8	34.0	32.3	54.4	44.7	53.3	42.7	70.2	169.1	36.2	59.1	250.4	36.5	154.7	44.2	37.3	26.4	24.4	73.5	26.8	85.5	21.7	48.2	80.3	19.5	15.0	22.1	47.9	7.6	30.3	39.2	14.3	25.4	30.2	7.8	8.4	8.2	13.0	8.0	9.0	9.0	8.6	8.9	7.9	8.5	9.3	29.1	16.0	23.5	6.8	26.9	120.1	59.2	19.9	27.9	10.1	15.7	32.9	20.9	14.3	25.6	1.8	8.4	47.7	128.9	11.5	9.8	24.9	223.1	17.7	29.4	32.3	10.7	46.3	3.6	19.8	55.6	31.9	9.7	12.7	21.5	31.5	14.3	11.2	35.8	15.2	4.2	16.1	4.1	30.4	34.0	113.4	34.2	44.7	21.4	2.8	35.2	14.1	197.8	6.0	9.3	30.0	11.4	26.7	36.1	117.5	3.0	7.4	19.2	30.2	39.5	34.4	27.9	718.6	36.6	36.0	115.8	20.2	135.3	46.8	28.9	64.1
LYRM4	"C6orf149, CGI-203, ISD11"	ENSG00000214113	"LYR motif containing 4"	Q9HD34	6	5103629-5260950	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA030362	Approved		Supported	"Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	"Nuclear bodies"		"HPA030362: AB_10601546"	"unprognostic (2.41e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.68e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.30e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.85e-3)"	"unprognostic (4.58e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.79e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.76e-1)"	"unprognostic (9.80e-2)"	"unprognostic (5.23e-1)"	16.9	18.8	22.8	14.6	22.5	19.0	19.0	21.4	31.0	16.2	24.0	14.7	7.7	18.1	18.1	13.4	19.1	11.2	20.5	22.3	22.1	14.5	13.6	12.1	22.9	22.7	21.7	27.1	19.4	15.9	20.4	14.2	22.3	12.3	16.2	15.9	13.0	10.2	14.4	17.1	10.4	16.6	22.3	15.9	14.1	16.0	21.8	20.8	19.5	11.0	21.8	16.9	14.2	24.1	28.9	27.4	41.1	32.0	41.3	60.1	37.1	27.1	44.0	36.9	38.0	57.8	19.2	44.7	51.7	35.8	51.6	25.4	58.9	34.2	41.0	79.4	45.9	19.7	20.9	77.4	25.9	52.2	19.2	47.9	53.1	33.1	43.3	34.9	35.8	42.4	64.3	15.2	32.1	15.6	49.6	70.5	39.6	45.9	42.1	49.2	30.8	82.2	38.6	23.4	55.2	35.6	23.8	14.6	65.5	58.6	39.8	44.7	29.5	39.2	26.3	32.9	44.8	22.4	82.4	42.7	19.0	36.6	54.2	1.9	18.8	2.1	11.7	19.8	15.6	31.3	17.5	13.3	34.4	26.2	26.6	24.6	4.3	23.6	17.5	23.0	19.1	17.6	22.8	22.5	21.4	31.0	22.3	22.1	22.7	21.7	22.3	22.3	21.8	24.1	75.6	25.6	16.2	28.4	45.0	73.5	55.6	80.9	25.0	16.4	51.9	48.4	29.1	28.6	33.9	18.4	8.4	49.5	23.0	12.3	31.3	44.1	38.8	26.0	29.3	40.3	32.3	32.0	103.4	43.8	72.2	37.6	11.2	19.0	41.3	39.6	41.7	35.9	65.2	11.8	57.4	26.5	32.6	46.8	93.0	91.7	46.3	31.7	69.4	32.8	74.2	45.1	23.7	80.4	50.8	34.1	15.3	35.3	32.6	108.9	7.2	90.0	26.6	16.8	32.9	32.2	34.8	79.4	78.7	32.1	82.8	47.2	29.5	43.9	38.6	63.5
LZIC	MGC15436	ENSG00000162441	"Leucine zipper and CTNNBIP1 domain containing"	Q8WZA0	1	9922113-9943407	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 304.7;Spermatocytes: 191.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028184, HPA058614"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		160000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA028184: AB_10602706, HPA058614: AB_2683779"	"unprognostic (1.56e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.26e-2)"	"unprognostic (8.37e-2)"	"prognostic unfavorable (2.47e-5)"	"unprognostic (2.89e-1)"	"unprognostic (3.79e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.56e-5)"	"unprognostic (1.19e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.95e-2)"	20.6	18.1	20.2	18.8	24.4	19.4	25.5	24.8	23.4	24.3	16.2	28.5	29.0	25.9	16.2	22.9	23.7	18.1	29.6	19.8	21.2	28.9	30.4	17.0	21.9	24.0	24.1	35.0	13.4	29.2	12.3	22.3	24.2	21.9	27.6	25.9	20.9	19.8	27.3	20.1	27.1	24.8	24.2	15.8	16.7	66.9	21.6	30.0	24.6	27.5	23.8	18.1	15.3	28.4	43.0	27.8	52.5	37.2	32.0	51.9	23.3	38.1	32.1	52.8	50.9	34.6	73.4	51.6	42.3	48.1	33.3	31.9	49.7	55.1	78.7	48.5	33.5	75.7	34.9	57.9	30.7	69.7	37.5	34.3	77.0	74.1	69.2	37.6	41.8	67.4	95.6	28.7	49.1	30.5	57.3	33.8	26.6	53.7	44.5	60.7	69.4	41.9	28.5	19.2	26.1	41.2	46.6	20.2	91.2	49.9	33.5	35.1	38.6	36.5	49.6	52.4	40.8	23.2	57.5	87.4	37.3	101.7	49.6	34.9	25.1	40.3	20.5	29.5	17.8	18.4	20.6	20.1	24.8	20.4	20.1	21.2	25.6	23.2	33.2	38.0	29.3	17.5	20.2	24.4	24.8	23.4	19.8	21.2	24.0	24.1	24.2	24.2	21.6	28.4	34.3	6.4	17.3	6.8	20.7	12.7	21.9	24.1	17.6	12.0	22.6	27.3	57.4	10.0	15.9	7.3	6.2	26.9	26.9	25.9	49.0	27.0	304.7	34.7	36.4	19.9	9.1	24.0	11.1	21.2	45.7	27.8	13.3	27.0	30.4	27.2	14.3	23.9	42.7	42.1	14.8	18.1	10.2	22.6	15.7	91.6	26.4	34.9	14.2	14.0	36.8	45.6	20.6	13.6	23.8	22.6	27.8	27.4	22.4	27.6	41.7	53.0	27.4	18.0	19.7	26.6	31.1	191.3	86.2	29.2	16.8	34.5	26.8	21.4	22.5	21.6
MAD2L1	"HSMAD2, MAD2"	ENSG00000164109	"Mitotic arrest deficient 2 like 1"	Q13257	4	120055623-120066858	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.9;lymphoid tissue: 5.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 81.8;Extravillous trophoblasts: 119.2;Spermatocytes: 127.8;Spermatogonia: 76.2"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003348	Uncertain		Approved	Nucleoplasm		NA	Yes			"Cluster 20: T-cells - T-cell receptor"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA003348: AB_10603014"	"unprognostic (4.08e-3)"	"unprognostic (7.31e-2)"	"unprognostic (5.17e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.54e-2)"	"prognostic unfavorable (5.15e-5)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (6.74e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.20e-3)"	"unprognostic (3.87e-3)"	"prognostic unfavorable (3.07e-11)"	"unprognostic (3.06e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.70e-2)"	0.3	0.4	0.5	2.1	0.6	5.9	1.2	0.8	0.7	0.5	0.2	2.2	1.8	0.7	0.3	1.6	1.4	0.4	0.5	0.5	0.5	0.4	0.5	0.4	4.0	0.4	0.4	0.5	0.2	0.4	0.1	1.4	0.5	0.6	2.6	1.0	0.3	0.5	0.2	1.0	1.9	0.8	0.4	0.8	0.9	2.3	0.4	5.7	0.4	0.2	3.6	0.7	0.5	0.6	27.2	11.6	26.9	17.5	2.8	3.4	11.5	21.0	11.8	21.5	16.5	15.7	16.3	39.6	6.8	7.6	9.5	7.1	27.1	16.1	30.0	18.8	18.8	22.0	10.5	14.9	0.8	36.3	12.0	1.9	2.3	14.6	9.1	5.4	12.6	16.4	26.7	22.0	11.4	12.0	35.0	15.6	18.3	14.1	13.0	17.8	35.9	16.2	8.7	10.3	28.4	20.1	10.5	12.8	6.5	12.9	8.4	13.0	7.8	14.2	16.1	14.6	27.0	20.1	23.2	25.7	13.3	18.4	19.1	0.9	0.1	0.1	0.4	0.1	0.6	0.5	1.2	1.0	0.1	0.4	1.1	1.1	0.3	0.9	0.2	0.7	1.3	0.5	0.5	0.6	0.8	0.7	0.5	0.5	0.4	0.4	0.5	0.4	0.4	0.6	2.4	0.0	1.3	1.0	11.5	17.3	7.3	23.5	4.0	9.7	7.2	8.3	3.4	1.5	6.0	7.3	2.1	52.0	7.6	7.5	0.0	3.4	2.4	31.3	6.0	5.4	1.8	81.8	1.3	1.5	119.2	13.7	8.6	7.8	15.2	34.6	3.9	2.9	27.9	20.2	1.2	13.7	36.7	7.3	13.4	4.8	4.7	6.1	8.8	0.0	3.1	12.3	5.2	0.5	1.0	1.6	3.7	1.5	33.1	5.0	3.7	7.2	12.9	3.8	13.1	7.3	14.9	127.8	76.2	26.0	8.9	10.8	20.1	11.9	29.2	8.7
MAGOH	"MAGOH1, MAGOHA"	ENSG00000162385	"Mago homolog, exon junction complex subunit"	P61326	1	53226900-53238518	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015425, HPA043036, HPA047754"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB015425: AB_629914, HPA043036: AB_2678279, HPA047754: AB_2680148"	"prognostic favorable (1.85e-4)"	"unprognostic (2.61e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.59e-1)"	"unprognostic (6.34e-3)"	"unprognostic (3.07e-3)"	"unprognostic (2.18e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.46e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (1.45e-5)"	"unprognostic (2.01e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.60e-2)"	"unprognostic (6.75e-3)"	51.4	48.5	36.5	59.0	36.5	141.1	51.8	37.8	47.1	41.0	38.4	61.2	53.1	57.2	59.0	48.1	55.9	37.9	43.3	36.6	38.1	53.6	76.4	44.8	85.0	37.5	37.1	49.2	43.8	50.4	34.9	67.9	37.9	39.9	55.5	34.4	44.5	37.4	43.8	42.9	55.2	50.7	37.5	55.2	46.8	32.3	36.8	101.7	51.7	42.5	86.3	62.1	38.9	38.1	207.8	101.0	169.4	150.2	88.1	56.9	197.6	152.3	92.0	202.4	204.5	233.2	97.1	293.5	168.8	93.1	248.4	125.9	228.3	136.7	242.3	197.1	249.6	266.1	127.4	253.3	141.4	459.3	143.3	62.7	95.3	184.4	150.6	77.7	136.8	260.8	279.6	63.8	109.9	169.3	377.2	316.0	310.0	171.1	218.4	256.1	323.2	154.5	109.1	208.3	142.7	115.7	202.0	161.2	250.1	206.8	85.1	330.2	122.0	122.6	167.7	170.7	354.9	93.6	184.8	453.4	109.4	289.5	127.0	31.5	34.8	53.9	49.3	51.9	48.1	47.4	46.9	51.5	50.0	42.9	42.6	44.9	41.9	52.9	50.2	58.6	54.2	32.7	36.5	36.5	37.8	47.1	36.6	38.1	37.5	37.1	37.9	37.5	36.8	38.1	134.5	51.3	47.6	10.1	93.5	144.4	121.3	231.6	99.0	31.0	62.1	85.9	50.6	60.1	106.9	57.0	14.6	206.9	123.5	47.0	178.1	96.2	44.9	123.9	83.7	89.6	54.4	90.9	13.0	84.9	195.4	83.5	46.9	102.2	83.6	78.4	57.8	44.2	116.0	23.5	12.4	89.2	130.2	47.8	103.2	16.1	75.5	80.0	81.8	7.5	102.5	67.2	84.5	10.6	15.1	87.4	70.9	68.1	62.6	92.3	69.0	152.0	100.4	36.4	59.2	93.9	148.1	90.0	67.9	82.7	120.8	241.9	107.6	89.5	87.1	92.1
MAK16	"MAK16L, RBM13"	ENSG00000198042	"MAK16 homolog"	Q9BXY0	8	33485182-33501262	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044417, HPA050574"	Uncertain		Approved	Nucleoli,Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Vesicles"		"HPA044417: AB_2678935, HPA050574: AB_2681181"	"unprognostic (2.10e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.48e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.00e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (8.04e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.47e-1)"	9.9	6.2	4.7	9.3	4.8	9.2	8.9	5.1	5.7	6.6	4.1	5.7	5.4	7.2	5.1	8.0	5.9	6.5	7.0	4.5	6.4	7.2	9.0	5.6	11.1	5.3	6.3	7.5	9.3	5.9	4.5	7.8	5.8	6.1	6.5	4.0	5.6	5.6	8.4	7.4	5.0	7.7	5.3	6.5	5.4	5.6	5.5	8.8	8.5	8.0	10.8	12.2	5.1	6.0	14.1	19.3	13.2	30.6	15.2	18.1	19.9	25.0	16.2	26.4	24.6	28.5	12.0	49.7	23.8	22.1	22.5	18.3	45.6	27.8	35.0	10.8	12.3	46.9	13.2	25.6	22.9	19.3	27.4	19.1	24.8	34.8	40.4	9.4	19.6	33.5	59.5	27.5	22.0	16.1	68.9	22.4	71.4	34.4	13.2	23.9	20.1	22.2	22.2	23.7	33.6	26.7	15.5	21.1	30.4	16.2	14.7	19.5	17.8	24.9	19.3	32.6	28.9	13.8	16.4	50.4	15.3	39.7	27.0	0.0	2.4	0.6	3.2	5.0	3.6	2.0	3.2	2.8	2.9	2.5	4.0	4.3	0.4	4.4	7.9	3.0	2.6	2.3	4.7	4.8	5.1	5.7	4.5	6.4	5.3	6.3	5.8	5.3	5.5	6.0	12.8	16.0	9.7	3.6	12.8	15.6	15.2	5.6	13.1	5.1	7.9	9.0	12.9	10.0	11.3	9.2	2.1	11.5	7.8	3.9	7.9	10.6	1.8	9.8	19.8	12.7	1.8	15.8	5.8	7.8	15.8	15.8	8.2	10.5	9.5	10.8	5.3	7.3	8.7	10.1	6.0	6.7	6.1	5.3	4.7	1.3	9.0	7.8	1.8	2.8	7.7	2.9	10.3	7.1	4.7	11.5	5.0	7.5	12.1	15.3	4.1	10.2	10.5	5.1	6.6	17.6	14.4	13.8	19.2	12.7	14.9	7.5	9.9	13.8	7.4	12.3
MAP1S	"BPY2IP1, C19orf5, FLJ10669, MAP8, VCY2IP1"	ENSG00000130479	"Microtubule associated protein 1S"	Q66K74	19	17719242-17734513	"Predicted intracellular proteins"	Apoptosis	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 82.9"	"Group enriched"	"Detected in all"	4	"Early spermatids: 98.1;Late spermatids: 293.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050934, HPA054637"	Approved		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	"Nucleoplasm, Nucleoli, Cell Junctions"	"HPA050934: AB_2681281, HPA054637: AB_2682552"	"unprognostic (8.47e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.23e-2)"	"prognostic unfavorable (5.29e-4)"	"unprognostic (2.53e-1)"	"unprognostic (6.17e-2)"	"unprognostic (4.39e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (6.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.65e-2)"	20.5	13.9	48.2	8.7	51.9	11.2	19.1	36.8	82.9	18.9	30.1	21.5	7.7	24.8	5.4	11.9	19.2	7.9	18.8	51.4	40.5	15.4	12.4	23.5	9.0	44.7	41.1	21.6	15.6	5.4	22.0	9.7	43.3	17.4	2.4	2.8	19.7	6.5	32.4	12.2	17.7	3.6	39.2	18.3	20.1	74.7	40.6	6.1	16.1	5.4	3.9	21.6	14.6	47.7	30.1	43.2	12.4	16.9	10.4	15.4	34.0	18.3	8.8	10.9	12.3	61.3	16.0	17.3	33.8	11.4	12.8	15.3	10.5	14.5	4.6	21.8	61.1	15.1	36.3	39.2	22.1	16.8	20.9	16.7	8.3	16.7	10.5	7.9	22.6	12.5	24.2	9.5	6.0	39.0	20.8	42.0	28.7	17.1	50.8	33.3	10.2	17.5	14.8	43.4	23.0	26.5	10.7	14.8	18.9	9.0	9.9	17.8	37.3	19.7	18.2	40.7	27.2	18.1	23.3	17.4	23.7	26.7	25.1	18.5	22.6	25.9	15.7	22.2	15.1	15.7	12.3	15.6	25.9	15.5	10.1	13.9	31.4	13.0	17.9	21.2	12.2	19.0	48.2	51.9	36.8	82.9	51.4	40.5	44.7	41.1	43.3	39.2	40.6	47.7	11.1	3.2	7.5	4.2	14.7	10.3	14.0	13.1	13.1	11.1	12.3	8.6	5.5	15.7	12.1	3.7	8.4	21.7	14.0	30.9	3.9	22.2	98.1	12.9	11.5	18.5	20.4	3.8	8.4	17.2	16.9	12.3	19.4	26.9	10.2	12.0	20.7	4.8	26.1	40.4	5.5	16.6	12.2	18.7	25.1	293.2	22.4	20.7	1.8	2.8	17.4	8.1	8.2	4.5	7.1	24.2	15.8	31.6	8.8	14.9	19.0	5.9	6.2	6.3	13.1	7.7	13.0	25.9	21.4	5.4	3.3	33.8	11.3	8.1	18.3	13.7
MAPKAP1	"MGC2745, MIP1, SIN1"	ENSG00000119487	"MAPK associated protein 1"	Q9BPZ7	9	125437393-125707234	"Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029091, HPA029092"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA029091: AB_10599732, HPA029092: AB_10601568"	"unprognostic (6.65e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.94e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.08e-2)"	"prognostic favorable (7.23e-6)"	"unprognostic (1.66e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.27e-2)"	42.9	47.1	43.4	36.7	48.6	34.7	32.8	39.2	45.6	36.4	44.9	47.3	30.4	29.1	35.9	44.0	29.2	28.0	69.7	44.3	41.6	48.0	46.0	30.1	34.8	47.8	46.2	26.1	36.9	53.3	19.2	30.2	41.9	30.3	38.5	42.9	42.1	36.1	103.7	26.2	32.6	46.2	43.2	28.8	36.2	42.0	51.6	36.6	47.4	76.4	37.9	39.4	31.6	40.9	87.4	97.1	64.3	68.3	86.7	82.2	107.9	108.6	110.0	82.0	57.2	97.9	94.9	89.1	65.9	151.6	89.7	119.1	99.5	126.9	110.8	101.8	41.1	64.3	111.9	95.1	97.3	116.0	72.1	80.9	114.6	117.0	121.7	91.2	123.0	85.8	103.6	67.7	176.4	180.3	87.5	46.8	102.4	204.3	122.0	72.4	152.0	119.3	90.2	62.3	77.9	76.7	109.7	100.9	70.0	86.6	115.8	67.1	79.7	115.3	76.1	140.5	182.5	86.1	225.2	89.9	165.5	52.5	127.6	4.4	6.1	5.7	4.3	6.0	5.9	8.2	4.7	4.8	4.9	7.4	4.1	7.1	19.1	5.8	5.6	7.2	5.8	2.5	43.4	48.6	39.2	45.6	44.3	41.6	47.8	46.2	41.9	43.2	51.6	40.9	22.3	12.8	17.0	64.6	33.5	15.8	30.2	15.3	25.6	25.6	30.6	24.1	68.3	22.8	27.5	14.7	41.7	35.4	31.7	28.9	54.8	48.3	80.2	26.2	42.6	27.1	9.6	22.3	82.6	65.6	50.9	27.0	32.1	29.3	17.7	31.2	19.6	34.5	50.7	32.0	80.1	20.8	22.4	29.5	23.4	116.9	19.0	37.3	23.2	59.0	55.1	30.1	35.0	97.0	96.4	59.2	20.1	17.7	32.3	45.2	27.2	84.6	14.6	26.2	6.6	29.1	33.0	75.4	71.4	29.1	19.5	50.9	29.5	38.4	27.6	37.8
MAPKAPK5	"MK5, PRAK"	ENSG00000089022	"MAPK activated protein kinase 5"	Q8IW41	12	111842228-111902222	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004546, HPA015515"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"CAB004546: AB_627910, HPA015515: AB_1853569"	"unprognostic (6.45e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.09e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (2.98e-8)"	"unprognostic (1.88e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.20e-1)"	"unprognostic (6.03e-2)"	"unprognostic (3.39e-2)"	"unprognostic (9.41e-2)"	"unprognostic (3.25e-2)"	18.1	20.8	12.6	17.9	14.4	27.1	20.4	14.9	15.0	15.2	15.7	28.2	25.5	15.7	20.7	17.2	16.1	12.2	16.7	15.3	14.3	20.3	19.4	17.5	20.7	12.3	12.4	18.1	20.4	21.4	11.6	20.3	11.8	17.0	30.7	27.2	17.4	15.6	30.4	20.1	28.2	18.9	11.3	15.6	18.0	15.9	12.9	23.2	19.3	25.3	19.3	18.5	14.4	13.8	32.4	42.1	40.0	33.7	28.2	28.4	60.6	31.7	38.1	47.7	32.7	54.8	25.9	48.6	22.9	37.7	28.4	31.6	53.1	33.2	44.4	32.6	29.0	43.4	29.5	44.2	34.1	55.1	29.4	30.2	46.7	45.6	53.7	36.0	35.6	43.4	61.0	18.7	35.3	36.4	55.2	86.6	56.9	79.1	29.4	53.7	29.1	46.9	37.9	46.2	49.0	41.4	36.1	60.5	46.3	36.2	49.1	62.0	31.2	26.8	27.2	27.9	40.4	37.8	50.1	57.4	32.7	39.4	38.9	1.1	3.3	2.3	4.2	2.4	2.2	3.5	2.7	3.0	2.2	3.1	4.2	3.1	1.6	2.9	8.8	2.6	4.8	1.8	12.6	14.4	14.9	15.0	15.3	14.3	12.3	12.4	11.8	11.3	12.9	13.8	16.9	3.2	23.1	12.1	22.3	20.5	22.3	12.5	21.1	47.0	18.3	14.0	20.1	22.8	15.4	3.7	41.7	29.9	32.4	34.1	13.7	28.2	17.2	14.2	17.3	16.0	36.6	15.8	24.6	29.6	33.3	19.4	20.9	15.2	2.5	22.3	14.6	13.4	19.9	23.5	22.3	47.3	14.2	21.2	17.7	7.3	15.5	15.0	8.8	14.0	27.8	19.6	25.7	15.6	21.8	36.3	27.4	17.7	21.6	37.5	63.6	21.8	12.0	36.4	19.7	22.6	19.8	30.7	40.3	23.6	21.3	30.1	22.2	22.5	32.3	32.3
MAPRE1	EB1	ENSG00000101367	"Microtubule associated protein RP/EB family member 1"	Q15691	20	32819954-32850405	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003600, CAB009337, CAB019391"	Supported		Enhanced	"Centriolar satellite,Cytosol"		NA	NA		11000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Centriolar satellite, Cytosol"		"CAB009337: AB_2141629, CAB019391: , HPA003600: AB_1079309"	"unprognostic (3.74e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.68e-1)"	"unprognostic (4.48e-3)"	"unprognostic (2.98e-3)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (6.33e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.24e-2)"	"unprognostic (5.99e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.76e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.59e-3)"	66.7	44.5	41.2	69.7	46.7	192.7	48.3	45.3	45.5	45.9	41.9	69.0	39.7	61.0	52.9	62.7	44.8	57.4	58.2	37.0	50.0	54.1	30.4	50.6	75.8	48.0	52.5	37.8	40.4	38.3	24.3	66.8	47.9	56.0	58.0	16.1	32.7	70.6	34.1	34.7	41.2	91.3	47.7	57.7	43.9	54.4	47.5	88.0	74.1	39.7	69.3	83.1	37.8	47.0	179.7	161.4	176.6	102.0	93.5	84.3	250.7	171.3	106.3	261.0	191.0	470.0	161.9	271.2	167.4	154.8	265.6	159.9	213.1	191.6	283.7	92.4	83.1	523.3	105.0	253.2	98.7	190.6	222.8	91.6	94.1	213.8	141.7	89.3	165.0	151.4	240.0	150.6	232.4	111.0	263.0	166.2	127.6	182.7	147.5	174.4	312.8	145.9	143.0	121.8	109.7	115.3	307.2	134.3	179.4	160.6	194.3	140.0	147.5	291.9	157.7	147.3	224.7	131.5	194.5	289.6	154.9	428.3	166.0	256.8	125.8	262.1	100.1	150.8	104.0	75.1	94.1	92.9	97.4	81.8	94.6	104.3	139.7	111.1	170.6	89.5	107.1	185.6	41.2	46.7	45.3	45.5	37.0	50.0	48.0	52.5	47.9	47.7	47.5	47.0	71.6	19.2	30.2	8.1	67.0	132.8	194.4	48.1	62.0	11.1	54.7	42.3	36.5	25.8	44.5	55.2	8.4	108.0	82.0	67.6	84.1	68.8	90.2	43.5	44.7	64.8	71.5	52.8	7.8	78.3	130.0	61.4	40.8	60.9	115.4	45.7	39.3	14.9	107.0	10.1	8.5	43.6	36.7	94.6	121.2	76.6	35.8	99.5	71.2	12.2	120.5	36.5	92.7	7.5	12.6	75.0	40.5	64.3	71.1	115.3	32.6	74.3	39.4	11.5	65.7	61.5	102.8	72.1	62.1	65.2	110.8	169.2	89.8	76.6	44.4	123.1
MARCHF5	"FLJ20445, MARCH-V, MARCH5, MITOL, RNF153"	ENSG00000198060	"Membrane associated ring-CH-type finger 5"	Q9NX47	10	92291167-92353964	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 23.8;Cardiomyocytes: 28.6;Cytotrophoblasts: 39.2;Extravillous trophoblasts: 44.0;Hofbauer cells: 34.9;Syncytiotrophoblasts: 65.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056596			Supported	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria		"HPA056596: AB_2683181"	"unprognostic (4.00e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.10e-2)"	"unprognostic (5.47e-3)"	"unprognostic (2.33e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.24e-2)"	"unprognostic (9.77e-2)"	"unprognostic (5.50e-3)"	"unprognostic (4.02e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.53e-1)"	"unprognostic (2.85e-2)"	13.6	14.0	9.1	7.7	9.6	17.3	15.0	9.1	11.9	12.2	10.4	9.8	11.3	13.3	12.6	19.3	10.1	10.7	12.8	9.6	9.4	15.1	20.1	10.4	9.0	9.0	9.4	14.0	9.2	12.5	7.0	7.8	8.8	15.1	10.1	8.8	13.7	7.8	18.2	9.8	11.6	10.7	9.6	8.9	10.5	8.8	9.3	12.5	17.2	16.1	9.8	10.7	12.2	9.7	28.0	14.8	28.7	33.1	19.2	19.8	14.8	24.5	26.7	29.8	30.4	10.0	19.6	16.2	16.5	24.1	13.0	22.4	20.3	20.5	42.5	12.3	23.9	13.1	13.6	23.7	23.2	21.1	12.4	20.4	27.0	19.7	40.9	39.6	26.6	17.0	14.5	19.7	24.2	17.7	18.7	24.1	6.7	18.1	22.1	20.0	29.4	9.8	30.8	17.8	13.3	24.5	21.3	15.5	26.7	13.7	27.1	16.1	26.0	13.9	15.3	15.3	34.0	19.9	16.2	14.2	12.7	28.7	9.5	4.2	6.0	7.0	5.1	7.5	5.2	5.2	5.7	5.5	6.9	4.5	5.7	5.5	12.2	5.0	6.7	4.6	5.9	5.0	9.1	9.6	9.1	11.9	9.6	9.4	9.0	9.4	8.8	9.6	9.3	9.7	23.8	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6	0.0	0.0	0.0	0.0	39.2	12.9	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	44.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	34.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	65.3	2.8	0.0	0.0	0.0
MASTL	"FLJ14813, Gwl, THC2"	ENSG00000120539	"Microtubule associated serine/threonine kinase like"	Q96GX5	10	27154824-27187953	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 24.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027175, HPA054273"	Approved		Enhanced	Nucleoplasm		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA027175: AB_1853591, HPA054273: AB_2682433"	"unprognostic (4.10e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.14e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.52e-6)"	"unprognostic (2.19e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (4.81e-5)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (1.71e-6)"	"unprognostic (1.55e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.79e-1)"	5.0	3.9	1.7	6.2	1.9	18.7	5.3	2.3	2.3	3.8	2.1	4.1	4.4	3.9	4.5	5.9	3.0	3.9	2.5	1.9	2.0	3.9	4.9	4.0	8.9	2.0	2.0	3.4	3.3	6.0	3.1	6.5	2.1	3.1	5.2	2.7	4.1	3.0	2.3	6.0	4.3	4.5	1.6	4.6	4.7	6.5	2.0	10.4	4.7	2.2	7.1	4.5	4.3	2.3	29.4	22.0	43.8	15.5	6.2	9.1	25.4	43.3	18.0	68.4	83.8	26.7	27.2	22.4	16.1	18.4	33.5	26.8	27.9	16.0	48.2	20.2	26.5	26.9	14.5	15.5	3.8	10.4	19.8	5.6	7.5	41.6	7.9	9.0	14.7	18.2	21.1	49.9	41.5	17.9	34.8	11.2	32.0	15.9	8.9	22.2	71.9	18.9	17.4	10.6	19.2	26.8	26.0	17.6	19.1	28.1	17.2	21.4	12.6	17.0	36.3	44.0	37.4	5.9	10.3	34.7	18.3	31.1	14.8	0.2	1.8	1.7	0.7	1.7	1.1	1.1	0.9	0.7	1.0	1.6	0.9	0.8	2.3	1.0	1.8	1.1	1.6	0.8	1.7	1.9	2.3	2.3	1.9	2.0	2.0	2.0	2.1	1.6	2.0	2.3	4.3	6.4	7.8	2.6	7.4	11.0	4.9	4.4	4.0	1.7	4.2	4.8	3.0	2.8	7.0	1.8	0.0	8.6	10.1	7.0	0.0	4.0	3.0	9.7	5.3	4.6	4.2	7.8	4.3	2.5	24.9	7.3	6.1	17.9	12.7	6.9	2.5	2.5	5.8	3.3	4.3	3.7	4.1	7.8	19.3	1.7	3.1	11.3	0.0	3.7	5.1	1.8	3.1	3.5	4.9	4.4	2.9	2.6	7.1	5.0	2.8	1.9	4.0	1.0	0.0	3.8	5.3	14.9	14.1	10.9	9.9	6.2	11.6	5.4	4.5	6.6
MATR3		ENSG00000280987	"Matrin 3"		5	139273752-139331671	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA036564, HPA036565"	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm		"HPA036564: AB_10669907, HPA036565: AB_10673623"	"unprognostic (3.08e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.69e-9)"	"unprognostic (1.10e-1)"	"unprognostic (9.33e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.51e-2)"	"unprognostic (9.91e-10)"	"unprognostic (2.91e-2)"	"unprognostic (9.21e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.89e-2)"	10.5	13.5	14.6	24.4	14.6	25.1	31.1	9.9	24.5	9.7	5.5	22.4	16.2	15.3	34.0	17.8	19.2	9.6	30.6	15.4	12.9	10.2	9.7	8.4	36.1	18.4	10.9	14.3	7.5	8.3	2.2	10.3	18.8	15.5	29.3	11.8	26.4	8.6	41.2	20.4	12.1	14.8	13.9	19.9	17.7	18.6	13.5	17.4	9.7	38.4	33.7	14.7	2.8	21.2	81.0	58.9	30.2	162.9	65.9	79.7	58.6	42.8	36.4	69.4	87.0	101.7	71.7	284.8	60.7	61.2	45.0	91.2	257.9	136.3	120.5	48.7	125.6	190.2	100.3	89.8	57.6	176.9	67.9	93.7	95.4	79.6	90.7	38.6	78.9	103.7	143.2	50.3	74.0	31.7	98.5	53.4	122.7	35.4	38.8	199.0	92.8	125.1	40.3	55.7	92.6	56.5	49.4	60.7	113.6	77.3	57.0	71.1	56.3	52.8	78.5	43.7	63.7	23.3	33.6	153.2	45.8	148.1	61.6	0.1	0.8	0.1	0.5	1.2	1.3	3.4	1.7	2.4	3.2	2.0	2.6	1.7	0.2	0.9	0.4	0.1	1.4	1.2	14.6	14.6	9.9	24.5	15.4	12.9	18.4	10.9	18.8	13.9	13.5	21.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
MBOAT1	"dJ434O11.1, LPEAT1, MGC44669, OACT1"	ENSG00000172197	"Membrane bound O-acyltransferase domain containing 1"	Q6ZNC8	6	20099684-20212469	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 18.8;Langerhans cells: 25.2;Oligodendrocytes: 41.5;Respiratory ciliated cells: 19.1;Suprabasal keratinocytes: 15.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 42.2;HEL: 40.6;T-47d: 31.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (1.26e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.85e-3)"	"unprognostic (3.88e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.57e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.62e-3)"	"prognostic unfavorable (9.15e-4)"	"unprognostic (2.90e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.24e-2)"	7.3	3.3	1.4	6.0	3.6	11.1	12.5	4.6	2.4	13.3	1.9	19.2	13.8	14.2	5.8	10.5	21.7	8.4	5.9	1.1	2.1	6.1	4.5	7.4	5.4	7.4	3.8	12.5	5.8	5.7	2.4	4.0	6.3	9.3	18.9	1.2	8.1	5.3	1.9	6.8	16.4	8.4	4.6	7.3	15.2	1.4	4.1	2.7	7.6	2.2	5.2	8.6	10.9	9.4	4.5	4.7	8.3	6.6	0.9	2.7	0.6	7.1	2.0	4.4	5.1	2.3	19.0	0.0	14.5	6.8	3.9	42.2	7.6	3.6	6.3	11.3	4.5	40.6	7.9	0.1	5.5	10.6	11.9	1.2	3.6	1.9	8.1	2.3	2.4	7.1	5.4	7.2	1.0	4.7	6.3	10.1	2.1	4.4	2.3	2.0	9.1	25.0	5.9	8.7	0.4	5.3	1.4	8.6	9.0	15.9	31.2	5.3	2.0	6.0	4.2	3.6	3.4	9.7	20.9	0.1	0.6	7.9	7.9	39.9	27.6	66.8	3.9	33.3	20.2	2.6	9.1	7.2	15.1	1.6	2.6	2.6	34.4	4.4	41.1	18.5	13.5	7.9	1.4	3.6	4.6	2.4	1.1	2.1	7.4	3.8	6.3	4.6	4.1	9.4	1.3	3.2	0.5	0.3	1.7	11.0	0.9	3.5	4.6	0.0	2.4	1.3	0.4	0.0	6.6	0.0	0.0	0.1	3.7	3.5	1.9	2.7	0.0	4.7	3.1	2.5	0.0	8.4	1.1	1.2	0.1	6.4	18.8	7.5	0.0	1.9	1.1	0.0	1.5	0.0	0.5	2.0	2.0	1.0	25.2	0.0	0.3	4.4	8.8	6.5	4.5	1.3	0.0	0.0	41.5	1.5	7.7	0.0	1.5	0.8	5.5	0.0	19.1	0.1	0.0	1.0	3.6	0.0	0.1	5.4	15.5	0.3	6.4	10.4	3.0	1.8
MCM10	"CNA43, DNA43, PRO2249"	ENSG00000065328	"Minichromosome maintenance 10 replication initiation factor"	Q7L590	10	13161558-13211110	"Predicted intracellular proteins"	"DNA damage, DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 9.2;lymphoid tissue: 8.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 11.8;Erythroid cells: 23.5;Extravillous trophoblasts: 20.9;Plasma cells: 15.3;Spermatocytes: 15.8;Spermatogonia: 12.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045899, HPA071952"	Approved		Supported	Nucleoplasm,Nucleoli		Yes	Yes			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli"		"HPA045899: AB_10960529, HPA071952: AB_2686477"	"unprognostic (9.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.41e-1)"	"unprognostic (6.58e-3)"	"unprognostic (1.78e-8)"	"unprognostic (2.42e-3)"	"unprognostic (3.51e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.78e-4)"	"unprognostic (7.81e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.87e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.05e-1)"	1.2	0.1	0.0	3.3	0.1	9.2	0.8	0.1	0.2	0.4	0.1	1.7	1.5	0.4	0.1	1.9	0.2	0.2	0.1	0.0	0.0	0.1	0.7	0.3	4.8	0.0	0.1	0.2	0.1	0.2	0.1	2.1	0.1	0.1	2.2	0.1	0.3	0.0	0.5	1.1	1.2	0.8	0.0	1.0	0.8	1.5	0.2	8.1	0.3	0.1	4.5	0.6	0.6	0.1	38.0	42.0	48.6	36.9	1.6	2.9	21.2	38.7	5.9	42.7	44.0	41.3	26.4	56.7	17.1	9.9	15.7	43.3	69.0	22.8	39.2	29.7	32.9	70.9	17.6	27.7	0.0	36.6	30.8	0.6	0.8	43.3	4.0	3.5	14.0	45.0	85.2	37.6	23.4	34.0	87.7	15.7	28.9	36.3	10.3	68.3	43.0	34.6	9.8	13.7	9.7	36.6	31.3	22.0	5.9	25.2	27.7	24.9	8.6	27.0	50.3	41.0	42.4	11.7	49.0	74.3	17.2	39.6	21.5	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.9	0.3	0.1	0.1	0.7	0.4	0.1	0.1	0.0	0.4	0.4	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	1.7	0.0	0.0	0.0	1.8	1.7	0.4	0.8	0.0	0.0	0.8	0.5	2.4	0.0	0.8	0.0	0.0	11.8	0.8	2.4	0.0	0.4	1.0	0.3	1.2	1.4	0.0	23.5	0.4	0.2	20.9	1.8	1.1	1.0	0.0	7.2	0.0	0.2	5.3	0.0	0.4	1.2	2.0	0.6	0.4	1.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.1	0.4	15.3	0.2	0.2	0.0	0.0	0.0	0.0	0.4	6.4	15.8	12.9	3.6	0.4	3.4	1.2	0.8	3.1	0.4
MCM2	"BM28, CCNL1, cdc19, CDCL1, D3S3194, DFNA70, KIAA0030"	ENSG00000073111	"Minichromosome maintenance complex component 2"	P49736	3	127598410-127622436	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 67.7;lymphoid tissue: 37.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 63.3;Erythroid cells: 65.6;Extravillous trophoblasts: 28.8;Spermatogonia: 25.9;Syncytiotrophoblasts: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB000303, HPA031450, HPA031495, HPA031496"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes		120000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB000303: AB_322519, HPA031450: , HPA031495: AB_2673904, HPA031496: AB_2673905"	"unprognostic (2.43e-1)"	"prognostic favorable (4.66e-4)"	"unprognostic (4.44e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (1.51e-7)"	"unprognostic (8.43e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.82e-1)"	3.1	3.4	2.0	16.4	1.9	67.7	6.2	2.5	1.9	5.3	0.6	9.2	8.1	5.0	2.4	11.0	7.6	2.5	6.4	1.9	1.8	3.4	6.3	3.4	26.8	2.3	1.9	6.4	3.0	3.7	2.4	17.0	2.6	5.0	10.2	3.5	4.7	2.8	9.4	10.6	8.6	5.3	2.0	9.6	5.7	12.3	2.0	37.6	4.8	5.8	26.0	4.2	5.4	2.4	133.6	110.3	122.4	102.1	7.0	14.4	110.5	65.2	42.3	129.9	146.9	177.7	84.7	136.0	65.2	32.3	113.6	105.6	204.8	76.1	79.1	127.2	127.1	227.4	134.8	131.1	4.4	214.3	102.4	8.2	8.4	86.1	13.1	15.3	40.6	160.7	116.0	123.7	47.4	169.0	229.0	156.2	172.5	108.3	90.7	242.4	165.1	203.3	26.9	97.9	143.0	106.8	175.8	48.9	16.7	45.7	111.9	165.3	20.3	104.2	87.9	128.4	91.7	127.1	163.5	362.6	73.2	159.7	41.0	0.0	0.6	0.3	4.4	1.4	5.5	9.7	3.9	5.4	2.9	8.1	3.6	4.7	0.9	6.5	0.4	3.7	11.2	3.5	2.0	1.9	2.5	1.9	1.9	1.8	2.3	1.9	2.6	2.0	2.0	2.4	1.2	3.2	2.0	0.7	8.5	4.6	2.6	4.6	2.2	2.5	4.1	5.3	8.3	0.0	3.9	0.0	0.0	63.3	1.8	4.8	0.0	5.3	0.9	5.2	3.5	2.9	3.6	65.6	0.3	1.9	28.8	4.2	6.6	4.8	1.3	18.8	1.4	1.7	18.2	0.0	0.4	8.2	0.0	1.6	3.2	0.7	1.8	2.7	1.8	0.0	9.2	2.1	0.0	0.0	0.7	2.1	1.7	1.5	20.5	0.8	1.1	0.8	7.4	2.1	0.0	2.6	4.1	8.1	25.9	7.1	3.0	33.5	6.3	3.8	13.8	2.3
MCM3		ENSG00000112118	"Minichromosome maintenance complex component 3"	P25205	6	52264014-52284881	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 122.7;Erythroid cells: 92.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002162, HPA004789, HPA004790"	Supported		Supported	Nucleoplasm		NA	Yes		150000	"Cluster 35: T-regs - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB002162: AB_564115, HPA004789: AB_1079336, HPA004790: AB_1079335"	"unprognostic (9.14e-2)"	"prognostic favorable (1.89e-4)"	"unprognostic (2.37e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (4.40e-5)"	"unprognostic (1.01e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (3.13e-5)"	"unprognostic (1.34e-2)"	24.3	15.9	12.8	41.5	13.6	55.5	29.1	13.7	13.7	27.5	13.4	32.9	19.6	30.8	23.8	33.4	29.2	16.4	25.4	11.9	12.7	27.5	18.8	21.4	68.8	14.1	13.6	31.9	17.0	28.9	10.8	40.0	14.1	19.7	39.3	19.3	19.2	30.7	16.0	32.2	29.3	37.0	14.5	31.3	24.1	21.1	14.0	81.1	18.3	17.7	78.5	28.1	24.5	13.9	187.9	121.7	208.0	196.9	43.9	39.4	136.1	135.8	103.7	226.6	230.3	251.6	99.2	202.8	132.5	79.7	147.8	145.4	277.4	165.9	226.9	230.0	261.4	383.6	233.2	358.2	11.8	381.7	150.8	23.7	38.1	166.6	46.2	55.6	117.3	240.4	318.1	452.9	118.3	123.8	386.9	293.5	173.1	369.8	84.8	338.3	317.0	271.2	101.1	195.8	210.3	160.5	142.2	81.1	125.3	289.4	159.7	266.9	60.5	153.5	163.6	160.8	206.4	132.9	163.5	356.4	132.2	323.8	184.0	30.5	18.3	27.3	50.0	31.3	42.8	47.7	49.9	50.3	30.0	41.2	47.6	51.2	2.6	55.0	18.3	19.0	71.6	46.9	12.8	13.6	13.7	13.7	11.9	12.7	14.1	13.6	14.1	14.5	14.0	13.9	24.3	22.4	12.3	3.3	26.4	19.2	20.0	24.9	12.5	16.1	14.1	17.1	19.9	7.2	19.2	22.0	4.2	122.7	18.6	10.9	13.7	30.9	1.1	9.6	16.7	30.9	7.3	92.6	2.5	20.2	63.6	22.3	15.8	15.1	37.4	48.3	15.0	10.5	36.0	0.0	2.1	20.4	8.2	10.1	7.5	3.6	27.1	12.1	7.2	8.4	12.5	17.8	34.0	2.5	6.1	17.3	10.5	21.1	37.6	10.9	7.3	7.5	17.0	16.0	6.6	16.8	27.9	22.5	64.0	24.5	10.1	27.4	26.0	19.0	37.1	13.9
MCM4	"CDC21, CDC54, hCdc21, MGC33310, P1-Cdc21"	ENSG00000104738	"Minichromosome maintenance complex component 4"	P33991	8	47960185-47978160	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 63.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 153.2;Erythroid cells: 60.8;Late spermatids: 77.9;Spermatocytes: 65.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004497, HPA004873, HPA031052"	Enhanced		Enhanced	Nucleoplasm		NA	Yes		140000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB004497: AB_627916, HPA004873: AB_1079337, HPA031052: AB_2673712"	"unprognostic (4.55e-2)"	"unprognostic (3.16e-3)"	"prognostic favorable (2.19e-4)"	"prognostic unfavorable (2.84e-5)"	"unprognostic (7.71e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (1.12e-3)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (3.53e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.40e-1)"	6.5	8.8	4.8	21.7	4.8	63.2	16.0	5.7	5.2	7.7	1.8	17.7	13.3	6.9	4.6	22.4	9.7	5.6	14.5	5.2	3.5	8.2	9.2	6.3	38.7	3.6	4.2	7.1	5.5	7.7	4.1	18.3	3.9	5.6	21.3	12.3	8.8	4.9	13.4	24.2	16.7	9.2	4.2	8.1	10.6	41.6	4.8	47.0	6.5	15.8	41.8	11.8	10.9	5.2	184.0	139.6	188.1	83.2	20.7	36.6	102.8	122.6	99.8	178.5	190.3	156.6	181.1	229.8	70.3	72.1	119.2	143.2	278.7	128.2	199.8	64.2	190.4	371.8	133.3	169.2	5.4	189.7	82.0	20.3	24.1	147.8	54.3	28.6	72.0	136.8	216.2	167.0	129.9	155.6	435.5	141.5	241.2	246.5	54.2	266.6	159.6	139.2	64.9	168.1	209.0	97.8	325.6	133.6	46.3	117.7	154.9	110.5	45.1	138.1	125.4	144.5	131.9	54.7	104.6	347.2	114.8	185.7	131.5	2.3	1.8	1.1	4.0	3.1	2.0	3.9	3.8	5.4	3.9	1.6	3.3	2.7	0.1	4.1	3.5	1.5	10.2	3.6	4.8	4.8	5.7	5.2	5.2	3.5	3.6	4.2	3.9	4.2	4.8	5.2	3.3	0.0	6.3	3.3	6.5	21.7	11.1	9.0	13.6	12.2	9.0	7.7	25.1	1.5	8.4	5.5	10.4	36.7	5.8	12.1	3.9	8.0	153.2	11.0	7.9	6.7	6.7	60.8	5.0	6.0	40.2	10.6	11.2	13.4	1.3	24.9	2.2	3.2	12.3	16.8	5.7	13.9	4.1	2.9	6.5	77.9	5.3	7.9	3.6	1.9	2.4	7.0	3.1	4.0	2.9	4.5	4.8	3.0	22.3	7.7	5.6	3.0	13.1	16.7	0.0	9.5	11.4	65.8	39.9	19.1	19.0	29.8	9.0	11.7	26.2	9.7
MCM5	CDC46	ENSG00000100297	"Minichromosome maintenance complex component 5"	P33992	22	35400134-35425431	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 138.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 147.8;Erythroid cells: 96.6;monocytes: 137.7;Syncytiotrophoblasts: 82.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000101, HPA000845, HPA052880"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes		44000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB000101: AB_2235163, HPA000845: AB_1079338, HPA052880: AB_2681979"	"unprognostic (6.71e-2)"	"prognostic favorable (2.81e-6)"	"unprognostic (5.29e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (1.78e-4)"	"prognostic unfavorable (3.95e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.53e-1)"	15.2	7.1	5.8	49.1	10.4	138.7	14.4	8.3	7.4	14.5	5.8	20.2	19.6	16.3	3.3	25.1	13.7	9.6	8.9	5.8	7.0	9.1	14.9	14.8	70.1	10.3	7.7	25.6	12.6	10.3	5.3	25.2	9.6	10.2	16.7	2.3	13.9	9.6	13.3	17.6	28.3	12.2	8.1	47.3	17.9	20.6	9.0	58.9	12.1	8.0	53.6	12.7	15.6	12.3	213.0	147.5	115.7	118.8	11.0	22.2	100.6	138.1	71.2	199.4	188.3	98.9	102.4	137.9	78.8	70.5	83.6	103.8	116.0	108.3	64.4	112.7	212.6	198.3	141.5	203.7	3.9	414.0	172.4	12.3	9.7	120.0	32.4	18.4	88.7	124.5	124.0	201.2	76.9	172.7	341.8	137.9	154.9	143.4	86.7	379.6	164.8	173.0	39.4	120.1	88.2	94.8	188.3	75.4	41.8	60.9	78.8	155.6	54.1	201.3	153.1	127.2	145.4	111.9	150.2	265.2	130.9	153.5	157.6	66.5	59.8	43.4	49.5	69.6	35.8	127.5	43.1	53.1	77.8	106.1	34.0	39.0	28.4	65.5	81.2	88.8	96.6	77.1	5.8	10.4	8.3	7.4	5.8	7.0	10.3	7.7	9.6	8.1	9.0	12.3	8.1	6.4	7.3	1.3	49.5	10.6	13.6	12.1	8.6	1.5	9.2	10.8	3.5	8.6	6.0	7.3	0.0	147.8	30.4	12.0	5.9	19.8	2.8	6.2	4.1	11.8	3.5	96.6	0.3	12.7	77.1	11.2	18.8	9.0	15.2	65.7	13.2	5.3	53.1	1.7	0.4	16.6	4.1	24.0	29.4	5.1	10.8	28.4	7.2	7.5	137.7	5.7	13.4	3.0	6.0	11.0	8.6	6.0	49.3	4.0	6.5	5.7	4.8	3.7	19.7	8.8	14.5	16.1	58.8	14.9	6.3	82.2	19.4	8.5	34.6	9.8
MCM6	Mis5	ENSG00000076003	"Minichromosome maintenance complex component 6"	Q14566	2	135839626-135876443	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 48.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 40.1;Erythroid cells: 50.5;Spermatogonia: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004818, CAB009577"	Enhanced		Enhanced	Nucleoplasm		NA	Yes		33000	"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB009577: AB_2266309, HPA004818: AB_1079339"	"unprognostic (6.73e-2)"	"unprognostic (6.68e-3)"	"unprognostic (1.22e-3)"	"unprognostic (3.60e-3)"	"unprognostic (8.98e-2)"	"unprognostic (4.34e-2)"	"prognostic unfavorable (5.70e-7)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (2.36e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (8.29e-12)"	"unprognostic (2.84e-1)"	"unprognostic (9.02e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.68e-1)"	10.0	5.3	4.7	20.7	5.1	35.6	11.6	6.3	6.4	10.2	3.5	12.8	11.7	10.0	5.1	11.1	7.9	6.8	5.3	5.0	5.1	6.4	9.5	7.8	34.4	4.4	4.6	11.3	3.9	4.6	3.0	12.6	4.7	6.9	15.6	3.2	6.0	8.3	8.1	10.5	13.2	11.8	4.8	9.9	8.2	14.6	5.4	48.5	4.5	7.6	38.0	9.6	8.9	5.5	104.4	62.8	133.8	85.7	28.2	36.5	52.3	73.9	55.8	84.3	93.0	129.3	77.7	181.0	52.9	54.0	36.9	60.4	136.7	67.6	89.5	93.6	94.4	179.9	85.0	40.9	13.1	218.4	76.9	21.7	8.6	61.7	18.9	16.8	58.1	139.8	130.8	147.9	62.6	106.3	268.6	159.6	120.9	91.3	62.1	131.1	159.9	165.7	42.3	90.3	83.7	71.3	97.6	45.9	47.0	95.2	53.1	135.4	29.0	58.3	48.0	63.4	56.8	87.8	153.7	234.2	81.4	163.5	70.9	9.2	1.6	1.1	8.1	4.7	7.6	6.1	11.1	9.9	5.2	4.7	9.9	12.4	0.9	9.1	4.5	10.6	16.1	6.3	4.7	5.1	6.3	6.4	5.0	5.1	4.4	4.6	4.7	4.8	5.4	5.5	6.4	0.0	2.7	3.9	10.3	6.6	4.1	5.4	7.4	3.3	4.2	5.8	4.6	2.8	5.4	3.7	0.0	40.1	28.2	3.0	0.0	7.2	3.2	2.5	8.9	8.3	2.4	50.5	3.5	6.6	28.0	13.3	9.7	7.1	9.5	27.2	8.9	3.0	24.4	3.3	3.4	11.7	0.0	4.7	3.5	2.1	9.3	9.6	5.4	3.7	3.2	2.4	4.1	2.0	2.8	3.9	4.9	17.0	27.6	1.6	2.4	0.9	3.0	0.5	0.0	7.2	10.0	26.6	40.4	10.2	4.1	10.7	22.0	9.6	15.4	2.7
MCM7	"CDC47, MCM2, PPP1R104"	ENSG00000166508	"Minichromosome maintenance complex component 7"	P33993	7	100092728-100101940	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 180.8;lymphoid tissue: 156.4"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 132.9;Erythroid cells: 173.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002163, HPA003898, CAB016312"	Enhanced		Enhanced	Nucleoplasm		NA	Yes		150000	"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB002163: AB_564113, CAB016312: AB_627235, HPA003898: AB_1853632"	"unprognostic (1.87e-1)"	"prognostic favorable (1.28e-4)"	"unprognostic (1.36e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (2.18e-4)"	"unprognostic (2.08e-2)"	"unprognostic (5.79e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.34e-3)"	"unprognostic (3.83e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.38e-1)"	22.9	14.2	56.4	50.2	61.7	180.8	32.0	51.4	70.4	17.4	45.8	45.3	38.7	29.7	13.1	31.2	25.6	18.2	17.0	48.8	50.5	13.7	26.3	23.0	82.4	58.5	59.8	37.0	24.1	15.1	8.9	35.0	55.1	20.4	50.8	10.6	21.3	22.2	25.7	44.9	41.3	32.3	55.1	29.4	27.4	49.4	55.6	156.4	20.4	28.5	88.5	21.6	11.9	60.8	310.1	359.5	399.9	306.7	28.7	35.5	214.4	195.7	165.5	374.9	407.7	281.9	335.2	469.2	184.6	112.0	321.6	252.5	439.3	241.6	303.9	238.6	498.1	274.7	251.9	248.9	18.9	553.6	226.2	30.1	43.4	306.9	179.6	61.8	154.0	295.1	542.2	444.6	200.8	786.2	940.1	442.9	361.9	295.2	236.4	572.5	517.7	651.6	92.3	221.5	253.4	397.0	264.9	294.3	104.9	217.9	126.2	314.4	81.0	198.1	346.7	379.8	411.1	200.3	311.8	875.0	135.9	463.1	354.3	3.7	4.0	4.3	14.1	7.5	10.9	9.1	10.3	13.2	9.3	15.0	11.2	10.5	1.4	15.9	13.3	11.3	17.2	11.6	56.4	61.7	51.4	70.4	48.8	50.5	58.5	59.8	55.1	55.1	55.6	60.8	23.2	9.6	17.9	6.2	34.5	46.7	28.5	25.7	37.0	9.4	30.8	36.3	9.6	11.5	13.3	3.7	14.6	132.9	32.5	42.3	9.8	28.2	54.7	11.8	16.3	23.8	17.4	173.6	4.0	26.2	102.7	22.8	40.8	19.8	24.1	67.3	10.4	10.3	40.4	6.7	4.0	48.8	18.3	10.4	22.2	32.0	21.1	17.6	19.6	3.7	14.1	11.1	18.6	12.1	11.7	16.7	22.8	15.4	59.8	20.8	19.0	11.5	18.0	12.5	13.1	30.7	46.0	90.0	79.8	41.3	35.4	72.0	29.4	14.9	79.0	22.9
MCM8	"C20orf154, dJ967N21.5, MGC119522, MGC119523, MGC12866, MGC4816, REC"	ENSG00000125885	"Minichromosome maintenance 8 homologous recombination repair factor"	Q9UJA3	20	5950652-5998977	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 71.8;Spermatogonia: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"											"HPA045141, HPA066433"			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA045141: AB_2679230, HPA066433: "	"unprognostic (6.55e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.90e-1)"	"unprognostic (5.78e-2)"	"prognostic unfavorable (9.30e-8)"	"unprognostic (5.21e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (6.74e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.47e-1)"	2.9	2.9	3.0	4.6	4.1	10.2	2.8	6.8	4.4	4.0	4.2	3.9	3.6	3.1	2.1	3.7	3.2	1.7	3.3	3.1	3.4	2.4	1.8	2.4	7.5	2.9	3.1	2.6	3.1	2.0	1.6	3.3	3.1	3.6	3.2	5.3	2.9	1.8	6.9	4.7	3.7	2.1	2.6	3.6	3.3	13.4	3.1	9.0	2.4	4.6	6.5	3.4	3.6	5.8	48.6	33.0	27.7	30.3	4.6	6.6	27.4	38.1	12.3	26.6	32.0	35.4	27.6	48.3	11.3	10.2	51.5	50.9	46.1	25.7	47.9	13.4	21.5	49.3	16.8	27.9	0.9	56.6	7.4	2.5	3.8	47.2	17.6	5.3	12.3	28.7	56.7	45.8	27.1	12.3	27.6	30.0	40.3	25.3	21.6	34.8	50.9	18.6	5.0	15.3	21.6	23.2	40.0	36.3	22.5	28.6	27.1	16.4	9.6	51.5	43.2	28.2	56.8	20.1	53.8	82.2	9.6	33.5	43.4	1.0	0.1	0.4	0.4	0.1	0.7	0.3	0.2	0.4	0.0	0.3	0.2	0.4	0.4	0.4	0.2	0.4	0.5	0.1	3.0	4.1	6.8	4.4	3.1	3.4	2.9	3.1	3.1	2.6	3.1	5.8	3.3	0.0	4.4	1.6	6.0	2.3	3.0	1.9	4.6	7.3	2.1	2.8	10.3	7.2	2.4	12.9	16.7	7.2	4.2	5.8	0.0	1.9	8.5	4.9	3.5	4.2	4.2	14.9	3.7	2.8	6.3	5.0	3.1	5.4	1.3	24.4	2.9	1.9	4.5	6.7	2.9	4.0	6.1	2.8	4.6	3.2	3.7	3.7	1.8	2.8	0.3	3.7	8.2	3.5	6.6	3.6	3.9	3.0	9.2	3.3	4.7	2.4	4.0	11.5	6.6	5.7	4.8	71.8	37.1	5.0	2.6	4.0	6.0	3.0	6.3	2.2
MCM9	"C6orf61, dJ329L24.3, FLJ20170, MCMDC1, MGC35304"	ENSG00000111877	"Minichromosome maintenance 9 homologous recombination repair factor"	Q9NXL9	6	118813442-118935162	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 32.0;Microglial cells: 40.3;Oligodendrocyte precursor cells: 35.7;Oligodendrocytes: 39.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031137	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA031137: AB_10602027"	"unprognostic (3.11e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.61e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.95e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.79e-2)"	5.7	4.4	2.5	5.7	3.3	12.7	7.0	2.4	2.9	6.8	3.5	5.1	4.9	5.3	10.2	6.5	5.8	3.7	3.4	2.2	2.5	6.6	5.0	5.2	7.5	3.2	3.2	5.1	6.9	5.3	4.6	7.0	3.1	6.8	5.7	4.1	7.5	4.7	2.6	6.5	5.8	4.2	2.8	6.3	4.9	5.7	3.0	8.0	8.0	2.1	7.1	5.8	6.9	3.7	4.2	6.5	10.3	11.8	4.2	4.8	7.3	3.9	7.1	5.4	6.8	5.2	6.7	12.1	4.5	6.2	3.9	12.5	7.1	4.7	7.2	7.5	10.1	11.4	9.5	5.5	3.0	11.7	7.3	5.2	5.7	6.0	7.3	3.7	5.5	8.0	12.9	6.3	4.2	9.4	10.0	9.4	4.7	7.3	3.1	8.3	7.0	4.2	5.4	7.9	8.5	6.0	6.9	5.7	3.7	2.9	7.3	15.8	6.0	4.3	3.7	2.9	5.7	7.8	7.2	13.9	5.5	8.7	5.6	4.3	2.6	4.4	2.2	2.7	1.8	1.5	1.4	2.3	2.9	1.4	1.7	1.6	2.9	4.8	1.7	2.1	3.5	2.1	2.5	3.3	2.4	2.9	2.2	2.5	3.2	3.2	3.1	2.8	3.0	3.7	6.6	6.4	6.7	32.0	10.8	2.9	3.8	2.9	7.4	3.5	6.4	4.1	6.0	2.8	4.4	7.3	10.4	11.8	7.6	7.2	3.9	3.0	2.9	7.4	6.0	6.3	7.2	4.6	16.8	2.8	3.4	5.0	9.2	6.9	7.0	8.1	2.9	3.9	3.5	1.7	15.2	6.0	6.1	5.5	2.8	2.6	3.7	7.4	0.0	40.3	6.3	1.6	11.3	35.7	39.7	2.7	5.6	4.1	10.9	3.9	6.8	3.3	10.6	5.6	0.0	5.7	5.8	6.3	4.6	8.6	2.0	7.3	9.8	4.7	4.1	4.3
MCMBP	"C10orf119, FLJ13081, MCM-BP"	ENSG00000197771	"Minichromosome maintenance complex binding protein"	Q9BTE3	10	119829404-119892556	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013792, HPA038481"	Uncertain		Enhanced	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cell Junctions, Cytosol"	"CAB013792: , HPA038481: AB_10794620"	"unprognostic (1.26e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.31e-3)"	"unprognostic (5.61e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (7.32e-2)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (2.23e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.87e-2)"	30.5	14.2	9.1	16.7	10.5	10.0	26.1	12.9	11.9	23.8	9.7	25.9	13.3	26.7	10.8	25.0	23.7	12.1	18.2	9.4	10.4	16.1	18.6	24.9	18.9	11.3	10.2	22.2	17.0	16.1	11.0	25.3	11.5	15.2	16.6	12.3	20.5	13.7	30.1	25.6	19.6	18.3	11.5	19.5	20.3	11.8	9.9	20.7	17.5	15.9	19.7	25.1	24.1	12.4	54.4	28.6	49.6	40.3	24.0	27.1	27.0	49.2	55.9	62.2	63.3	42.5	32.9	69.7	20.3	34.8	20.7	46.8	65.1	46.8	74.1	46.0	50.3	34.7	20.8	38.3	35.7	71.3	80.6	24.1	25.8	47.4	60.7	27.6	38.9	37.5	35.3	43.9	41.7	28.5	77.4	52.6	33.3	34.7	26.5	49.8	104.0	30.8	29.0	30.0	25.0	28.7	32.9	33.1	39.3	33.0	20.4	50.2	34.3	26.5	24.1	29.8	56.3	36.1	37.7	71.1	35.5	46.1	16.2	9.8	2.3	1.4	2.0	4.2	2.0	2.0	2.0	1.9	3.2	0.9	2.0	2.2	3.0	1.8	2.5	1.5	1.9	1.1	9.1	10.5	12.9	11.9	9.4	10.4	11.3	10.2	11.5	11.5	9.9	12.4	39.0	16.0	16.5	11.8	26.2	42.8	35.0	12.3	24.5	11.4	18.1	14.2	18.6	25.8	15.6	20.2	4.2	40.5	35.4	23.7	13.7	11.7	4.6	18.8	31.7	38.3	10.8	25.0	14.0	13.7	52.6	27.4	12.2	26.2	18.3	18.2	26.7	25.6	38.5	32.0	17.3	20.8	12.2	35.5	35.0	6.2	30.1	35.9	23.2	15.0	34.2	18.3	26.8	17.6	25.3	15.8	11.9	22.6	28.0	32.8	15.6	18.7	12.5	18.3	19.7	32.8	27.4	42.5	68.7	29.9	42.8	39.7	31.6	12.7	29.1	29.1
MCPH1	"BRIT1, FLJ12847"	ENSG00000147316	"Microcephalin 1"	Q8NEM0	8	6406596-6648508	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 107.5;Inhibitory neurons: 94.3;Oligodendrocyte precursor cells: 78.4;Oligodendrocytes: 79.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008238, HPA012064, CAB012177"	Supported		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nuclear bodies"		"CAB012177: AB_303207, HPA008238: AB_1853655, HPA012064: "	"unprognostic (1.00e-1)"	"unprognostic (2.17e-2)"	"prognostic favorable (8.52e-4)"	"unprognostic (6.45e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.79e-2)"	"unprognostic (5.55e-3)"	"unprognostic (4.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.94e-1)"	5.7	3.7	1.9	2.9	2.1	12.3	5.7	2.9	2.4	5.7	2.2	5.0	2.4	5.7	2.5	4.7	5.2	2.5	4.3	1.9	1.9	4.3	3.8	4.4	4.7	1.9	1.9	5.4	5.1	3.3	3.8	4.0	1.9	4.6	2.8	3.3	5.9	2.7	9.8	5.2	4.6	3.4	1.7	4.7	4.7	6.1	2.1	5.5	4.6	3.9	4.2	5.4	5.1	2.7	4.5	3.9	7.0	4.9	3.4	6.1	5.9	6.7	5.8	8.3	6.2	5.0	3.3	8.7	1.8	5.5	7.6	5.1	8.9	6.3	9.8	3.6	4.9	11.1	3.9	6.7	5.6	5.6	8.4	5.8	6.4	5.7	8.1	5.8	6.2	9.2	13.7	8.5	6.4	2.9	15.1	6.1	12.0	8.2	3.9	8.9	6.6	5.3	4.8	8.2	4.8	6.4	4.9	5.2	7.4	7.7	4.5	7.8	5.2	6.4	3.5	2.1	6.4	3.9	5.7	12.7	5.9	6.4	9.0	1.6	2.1	8.7	3.1	2.5	4.1	4.0	2.7	3.7	2.1	4.4	3.4	3.7	0.3	4.3	3.2	2.8	3.0	2.1	1.9	2.1	2.9	2.4	1.9	1.9	1.9	1.9	1.9	1.7	2.1	2.7	21.3	3.2	16.1	50.6	28.3	4.6	14.5	7.1	10.8	13.4	9.7	9.0	13.7	10.0	17.7	14.7	16.7	10.9	28.2	4.6	3.9	10.9	46.6	20.0	21.2	15.6	0.0	17.9	107.5	10.5	10.6	14.2	14.8	25.9	19.7	15.5	11.4	6.9	7.0	30.3	94.3	6.1	2.0	12.2	2.7	30.6	12.2	12.1	0.0	69.3	14.2	13.1	19.6	78.4	79.5	10.4	7.8	13.2	27.0	9.7	6.3	8.7	25.6	10.6	6.6	20.2	13.8	29.5	12.6	10.9	6.0	12.3	23.5	12.8	7.2	10.1
MCTS1	MCT-1	ENSG00000232119	"MCTS1 re-initiation and release factor"	Q9ULC4	X	120594010-120621159	"Predicted intracellular proteins"	"Cell cycle, DNA damage, Growth regulation, Protein biosynthesis, Transcription, Transcription regulation"	"Initiation factor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001045			Supported	"Plasma membrane,Cytosol"		NA	NA		160000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol	"Plasma membrane"	"HPA001045: "	"prognostic unfavorable (1.38e-4)"	"unprognostic (1.44e-1)"	"unprognostic (4.50e-1)"	"unprognostic (9.37e-3)"	"unprognostic (7.29e-2)"	"prognostic unfavorable (3.27e-5)"	"unprognostic (2.94e-3)"	"unprognostic (9.59e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (4.35e-5)"	"unprognostic (1.95e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-1)"	28.1	31.1	5.5	3.9	5.6	3.9	26.4	5.7	7.0	24.5	4.3	25.9	4.6	19.7	6.3	38.9	19.3	3.0	32.9	6.0	6.0	35.9	40.7	20.8	5.5	5.2	5.0	17.0	39.5	4.9	34.3	3.9	5.2	20.4	5.2	5.5	26.8	3.7	28.5	24.1	23.9	3.1	5.0	28.9	30.5	11.9	5.4	6.7	21.5	6.4	6.7	22.6	24.4	5.7	13.9	8.2	8.2	9.9	16.2	19.2	9.9	13.8	11.9	15.2	17.0	6.6	15.8	18.6	14.3	18.3	23.6	9.6	18.0	17.7	23.4	9.7	8.5	6.3	11.3	6.4	15.6	13.6	10.3	14.1	14.2	14.9	14.2	12.6	19.5	11.0	14.5	10.8	21.9	13.5	11.3	17.5	10.3	27.9	15.7	10.5	7.6	19.2	17.7	6.4	11.0	10.0	8.5	15.2	9.0	10.1	9.1	10.6	16.5	13.3	6.4	14.3	20.7	7.5	12.5	22.2	14.3	18.8	12.9	3.4	5.0	3.5	3.5	5.9	5.6	6.1	4.6	4.4	6.5	4.9	4.2	4.3	2.3	4.9	5.9	8.4	6.1	4.1	5.5	5.6	5.7	7.0	6.0	6.0	5.2	5.0	5.2	5.0	5.4	5.7	53.5	19.2	22.9	13.1	65.4	32.2	65.5	108.4	27.9	14.5	49.3	46.9	80.8	42.9	63.5	46.0	8.4	97.0	52.0	71.3	129.1	87.4	54.4	53.1	55.6	49.9	55.7	22.5	28.2	88.5	182.0	48.5	50.0	43.9	52.0	50.4	51.4	84.4	132.6	15.2	25.5	111.0	71.2	81.7	43.2	88.7	42.0	60.4	62.2	10.3	67.6	27.0	39.1	15.1	25.3	92.7	83.7	27.8	92.0	52.6	118.2	153.5	57.4	21.0	39.5	25.3	66.1	17.7	15.0	50.4	34.5	112.9	46.5	90.0	82.2	75.3
MCTS2P	"MCTS2, psiMCT-1"	ENSG00000101898	"MCTS family member 2, pseudogene"		20	31547412-31548081	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											HPA001045			Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"		"Cluster 26: Non-specific - Cell cycle regulation"		Cytosol	"Plasma membrane"	"HPA001045: "	"unprognostic (1.71e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.17e-3)"	"unprognostic (6.04e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.81e-2)"	"unprognostic (3.90e-4)"	"unprognostic (6.59e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.20e-1)"	0.9	0.6	0.2	1.6	0.3	1.5	2.2	0.7	1.3	1.0	0.3	1.6	1.0	1.0	0.5	1.3	1.4	0.6	0.6	0.3	0.4	1.0	0.7	0.8	1.8	0.2	0.5	2.5	0.7	1.7		1.5	0.4	1.2	1.1	1.4	0.8	0.9	0.6	0.6	0.5	1.4	0.1	0.8	1.3	1.3	0.4	2.3	1.6	0.7	2.7	2.1		0.4	8.8	0.0	7.6	7.2	2.2	5.4	0.0	3.2	5.1	10.3	4.3	0.2	4.1	13.3	0.1	4.4	3.8	11.1	0.1	15.0	12.4	0.2	10.1	20.2	2.4	2.3	3.1	17.4	10.7	3.8	7.2	4.1	7.4	3.3	4.2	8.0	9.7	4.6	3.8	3.2	16.0	2.8	0.2	23.1	7.9	8.4	25.4	4.7	3.4	1.0	10.9	10.4	3.4	9.1	3.0	5.6	4.9	7.2	5.5	5.2	11.4	4.0	8.2	3.4	4.7	10.0	6.2	11.9	6.5	0.0	0.3	0.1	0.3	0.2	0.7	0.4	0.4	0.5	0.8	0.5	0.7	0.6	0.0	0.8	0.1	0.4	0.1	0.3	0.2	0.3	0.7	1.3	0.3	0.4	0.2	0.5	0.4	0.1	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MCUR1	"C6orf79, CCDC90A, FLJ20958"	ENSG00000050393	"Mitochondrial calcium uniporter regulator 1"	Q96AQ8	6	13786557-13814568	"Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 81.6"	"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 238.5;Rod photoreceptor cells: 293.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078654	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA078654: "	"unprognostic (1.82e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.19e-3)"	"unprognostic (8.62e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.01e-3)"	"unprognostic (2.16e-1)"	"unprognostic (4.83e-2)"	"prognostic favorable (5.51e-4)"	"unprognostic (3.40e-1)"	"unprognostic (5.77e-2)"	"prognostic favorable (3.32e-4)"	"unprognostic (5.86e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.39e-1)"	9.7	5.4	20.2	7.2	21.0	7.1	10.0	19.6	32.6	7.8	18.5	10.8	19.1	7.0	13.1	10.0	4.6	5.5	12.2	20.9	21.3	22.6	9.2	8.6	6.6	21.0	20.8	3.9	12.6	9.0	5.9	8.7	22.0	6.4	9.7	81.6	9.1	7.6	19.3	18.3	16.5	5.1	20.0	7.6	6.4	4.8	22.5	8.1	16.0	15.8	9.4	6.2	7.7	19.7	23.4	6.9	34.4	34.6	19.8	17.0	21.8	21.0	19.9	22.4	23.4	24.0	11.3	31.6	41.0	15.1	35.2	10.2	21.5	17.7	25.4	21.2	13.1	32.3	12.2	24.0	19.4	32.4	12.6	11.9	16.9	29.1	20.9	16.7	8.1	38.7	24.4	16.3	15.8	9.7	40.1	49.0	22.2	59.9	9.0	29.2	30.3	45.2	27.4	14.2	22.0	24.9	14.0	35.4	58.1	53.1	13.2	14.6	11.5	33.5	18.8	24.2	29.3	20.0	71.9	45.4	15.6	19.0	46.4	4.2	1.3	0.3	1.5	1.2	1.8	1.9	2.1	2.2	3.2	1.7	1.6	1.5	0.8	1.7	1.7	2.0	1.3	2.9	20.2	21.0	19.6	32.6	20.9	21.3	21.0	20.8	22.0	20.0	22.5	19.7	40.5	16.0	25.0	13.1	33.2	44.7	24.2	16.9	39.3	48.0	62.8	54.1	43.6	28.6	15.1	57.0	120.9	45.3	27.2	75.0	138.9	27.4	48.9	29.3	83.5	38.7	15.6	62.9	16.7	31.7	66.9	30.5	7.1	31.3	7.0	16.7	28.2	72.4	91.6	26.9	11.5	49.6	24.4	34.7	80.2	6.8	22.1	60.1	51.6	10.3	36.6	50.4	25.7	7.5	13.4	29.2	91.3	27.1	80.7	60.2	161.6	238.5	11.2	293.7	19.7	20.7	34.5	13.1	52.4	47.3	57.4	86.2	21.0	31.0	37.5	31.1
MDC1	"Em:AB023051.5, KIAA0170, NFBD1"	ENSG00000137337	"Mediator of DNA damage checkpoint 1"	Q14676	6	30699807-30717447	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Spermatocytes: 74.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"NK-cell: 3.2"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 3.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006915	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Focal adhesion sites"		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	"Focal adhesion sites"	"HPA006915: AB_1853669"	"unprognostic (8.52e-2)"	"unprognostic (4.32e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.09e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.99e-1)"	"unprognostic (4.39e-3)"	"unprognostic (3.23e-1)"	11.3	7.0	2.7	8.6	3.2	13.0	10.9	4.1	5.2	12.4	3.3	11.0	4.9	13.7	8.5	6.2	12.3	4.6	9.5	2.4	4.1	8.2	9.7	9.5	10.2	4.5	3.3	16.8	10.8	8.6	12.8	7.4	3.5	10.1	6.9	14.1	9.1	8.2	11.0	9.4	10.9	8.9	2.0	11.3	8.4	28.2	3.4	14.5	16.4	5.8	11.3	10.7	9.3	3.6	36.7	11.1	47.4	34.8	6.3	10.0	23.0	14.8	10.0	25.2	21.3	22.7	8.5	37.7	17.5	17.0	23.5	20.2	63.0	28.6	34.9	29.9	65.6	43.4	28.7	12.5	4.1	27.1	16.9	7.9	9.2	48.6	27.3	9.0	11.5	25.7	61.0	36.7	19.1	14.7	14.6	20.0	20.6	8.4	7.8	33.2	24.7	37.4	11.0	10.7	39.9	23.2	11.5	26.2	13.5	29.1	21.8	16.8	13.8	24.8	26.4	19.2	26.3	19.3	21.6	34.5	7.8	63.9	34.3	0.1	0.1	0.1	0.6	0.1	0.3	0.4	0.4	0.5	0.1	0.7	0.5	0.5	0.0	3.2	0.1	0.7	0.0	0.3	2.7	3.2	4.1	5.2	2.4	4.1	4.5	3.3	3.5	2.0	3.4	3.6	9.7	16.0	13.0	10.1	13.4	4.5	5.5	5.6	15.9	11.5	6.8	8.6	7.6	7.2	5.7	5.5	8.4	7.9	11.0	2.5	3.9	5.3	4.7	8.0	8.7	9.7	6.7	14.5	8.3	6.2	11.4	11.2	4.1	13.7	17.1	12.8	6.1	12.0	6.7	5.0	8.1	3.3	12.2	6.0	5.7	3.9	7.8	7.3	1.8	11.2	5.9	10.6	14.4	12.5	9.9	5.2	1.1	6.0	16.9	2.9	1.2	3.0	8.0	17.1	13.1	16.2	8.3	74.5	18.0	8.7	3.7	1.9	12.1	7.7	6.0	1.9
MDH2		ENSG00000146701	"Malate dehydrogenase 2"	P40926	7	76048051-76067508	"Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 697.1;tongue: 601.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019714, HPA019716, HPA019848, HPA026720"	Enhanced		Enhanced	Mitochondria		No	No		14000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA019714: AB_1853678, HPA019716: AB_1853680, HPA019848: AB_1853683, HPA026720: AB_1853685"	"unprognostic (3.20e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.55e-3)"	"unprognostic (8.94e-2)"	"unprognostic (6.45e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.70e-2)"	"prognostic favorable (1.49e-5)"	"unprognostic (8.57e-2)"	"unprognostic (9.64e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.66e-1)"	76.9	163.4	68.0	51.4	73.6	71.9	73.9	62.1	83.9	67.4	81.3	118.7	112.7	69.2	34.7	144.9	66.8	38.0	367.5	73.5	69.9	121.7	215.5	60.7	62.4	66.7	61.4	64.1	118.3	90.5	70.7	45.2	67.0	67.3	80.3	40.2	98.8	56.8	697.1	119.5	94.4	60.0	56.3	75.6	103.2	60.2	64.1	60.4	62.3	601.9	66.2	85.6	82.4	66.6	176.5	278.4	99.2	250.7	110.3	121.2	172.0	113.9	145.8	159.4	143.2	246.2	204.7	261.3	51.1	151.1	172.6	174.4	256.3	170.0	112.7	192.1	368.3	144.6	138.7	229.9	135.2	229.3	144.6	153.7	149.7	155.2	229.3	124.9	150.9	160.5	466.3	149.4	149.7	389.6	206.4	402.1	222.8	306.6	344.3	164.3	121.7	379.9	149.9	225.5	247.4	226.9	114.6	567.5	247.0	124.9	323.4	260.0	117.7	160.0	151.6	175.5	232.7	166.5	148.1	290.8	138.6	289.1	249.1	95.4	129.9	63.3	102.4	148.8	107.1	122.2	113.7	111.2	176.0	110.2	109.0	102.6	34.0	107.4	164.2	157.2	156.6	175.8	68.0	73.6	62.1	83.9	73.5	69.9	66.7	61.4	67.0	56.3	64.1	66.6	98.8	51.3	65.9	7.8	110.2	135.9	190.8	437.9	118.4	68.0	151.8	165.5	486.2	135.8	217.3	115.8	18.8	328.1	104.9	242.3	448.0	269.8	263.7	108.0	97.9	96.8	169.7	97.2	13.0	333.1	334.0	112.6	111.1	104.8	54.5	150.9	88.5	246.6	248.1	72.3	15.0	280.6	288.9	132.6	113.5	161.5	99.4	117.6	181.5	9.4	171.4	85.7	126.7	8.0	12.8	255.0	252.1	99.3	149.8	197.3	433.3	466.3	139.0	67.3	85.5	114.7	150.9	157.8	65.3	256.6	166.1	294.8	105.4	233.4	372.7	234.7
MDN1	"KIAA0301, Rea1"	ENSG00000112159	"Midasin AAA ATPase 1"	Q9NU22	6	89642498-89819794	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 82.5;Inhibitory neurons: 79.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"K-562: 24.7;NTERA-2: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029666, HPA029667, HPA029668, HPA029669"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoli, Cytosol"	"Nucleoplasm, Intermediate filaments"	"HPA029666: AB_10600888, HPA029667: AB_10696207, HPA029668: AB_10669868, HPA029669: AB_10670429"	"unprognostic (2.00e-1)"	"unprognostic (4.46e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.14e-3)"	"unprognostic (3.46e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.54e-3)"	"unprognostic (6.28e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.09e-2)"	4.2	4.6	3.4	1.9	3.6	4.2	4.3	4.4	3.3	4.5	1.7	4.4	1.2	5.6	2.1	4.9	5.0	1.2	4.9	3.1	3.3	4.4	9.1	3.9	2.6	3.3	3.1	7.6	5.9	3.0	4.6	1.2	3.7	3.6	1.8	3.0	3.9	1.5	8.3	7.1	5.0	1.7	2.2	4.5	4.6	6.5	3.3	2.8	6.0	3.4	2.5	4.2	4.3	5.7	4.2	4.1	4.1	3.8	6.6	6.3	4.1	2.8	2.1	3.1	3.8	9.4	1.5	12.5	3.1	2.9	3.3	3.6	10.7	3.8	5.5	4.9	7.1	13.5	5.6	6.1	2.5	17.7	3.2	3.9	3.1	8.3	7.6	1.9	5.6	5.6	24.7	2.9	3.1	5.0	2.8	6.6	22.7	3.4	3.5	5.5	7.8	3.1	2.7	5.8	7.5	3.3	3.9	2.3	2.5	5.4	1.6	7.7	7.2	2.1	3.8	2.8	6.5	3.3	3.9	5.9	2.8	9.8	3.7	3.2	0.3	0.6	0.7	0.2	0.6	1.0	1.0	0.8	0.2	1.3	1.3	1.0	0.0	1.1	0.3	3.0	0.4	0.1	3.4	3.6	4.4	3.3	3.1	3.3	3.3	3.1	3.7	2.2	3.3	5.7	13.2	28.9	19.1	55.2	19.2	29.3	8.2	6.0	30.7	24.4	14.0	11.0	39.2	11.5	16.9	14.7	25.0	5.5	25.2	6.6	0.0	6.3	7.5	20.1	21.9	15.0	7.7	58.5	82.5	8.1	7.2	13.3	19.4	25.2	6.3	26.4	6.4	48.5	6.6	18.5	79.5	7.7	6.1	6.3	9.5	4.3	7.2	8.6	12.4	33.7	6.6	8.0	9.2	35.7	74.8	6.9	3.7	8.6	26.0	18.1	4.7	2.5	12.9	18.7	0.0	33.1	12.7	37.5	50.1	26.1	30.1	3.4	19.4	17.4	10.3	8.5
MEAF6	"C1orf149, CENP-28, Eaf6, FLJ11730, NY-SAR-91"	ENSG00000163875	"MYST/Esa1 associated factor 6"	Q9HAF1	1	37489993-37514766	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029599			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 35: Glandular cells - Unknown function"	"Nuclear bodies"	Nucleoplasm	"HPA029599: AB_10599996"	"unprognostic (4.95e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.41e-3)"	"unprognostic (4.36e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.75e-3)"	"unprognostic (2.87e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.68e-3)"	"unprognostic (3.57e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.93e-2)"	"unprognostic (5.12e-3)"	"unprognostic (2.19e-1)"	37.9	31.4	28.8	18.7	30.5	28.4	39.0	23.9	38.5	42.3	23.5	45.2	19.7	36.7	32.0	37.3	35.6	26.9	25.8	30.5	38.4	32.9	29.5	32.9	29.0	25.9	29.6	41.7	38.9	52.4	67.6	20.9	29.8	66.5	20.3	18.8	43.1	45.1	43.3	46.5	31.8	26.4	23.8	26.7	35.5	38.8	34.2	50.5	31.0	25.1	28.0	41.6	38.7	28.1	56.3	11.2	36.0	37.5	42.3	57.9	32.8	49.0	51.8	57.4	47.4	24.0	48.2	45.9	52.4	41.8	39.0	30.4	47.6	43.0	44.5	75.8	55.6	67.4	17.6	44.5	46.1	59.4	46.2	37.6	72.0	53.7	78.5	31.2	49.5	58.7	89.1	36.4	46.2	23.4	61.9	39.5	69.7	36.4	49.3	60.4	53.4	65.0	42.7	26.6	68.2	38.9	61.8	35.2	73.3	23.0	41.1	41.3	39.4	47.3	36.1	58.5	39.4	58.1	88.0	83.7	43.4	77.8	33.4	108.4	71.1	123.0	97.7	61.3	100.3	102.2	87.6	95.8	73.4	101.8	86.0	79.7	33.3	80.3	70.3	62.3	109.9	114.4	28.8	30.5	23.9	38.5	30.5	38.4	25.9	29.6	29.8	23.8	34.2	28.1	71.4	64.1	47.2	30.0	102.9	211.8	179.3	158.5	84.2	44.0	115.7	81.8	28.1	107.2	98.1	108.5	22.9	88.6	94.0	23.0	223.0	96.0	47.0	127.2	53.3	59.4	70.2	83.5	34.1	63.0	58.3	74.2	47.9	89.7	54.3	67.5	75.3	59.9	88.9	20.2	28.9	60.3	146.5	66.3	125.5	103.2	75.8	61.5	131.6	9.4	81.4	71.2	115.4	28.6	36.9	64.2	35.8	81.6	59.4	251.4	52.8	184.2	174.7	42.5	46.0	52.4	79.2	143.7	197.5	91.8	246.6	53.8	111.6	56.5	52.3	120.4
MED10	"L6, MGC5309, NUT2, TRG20"	ENSG00000133398	"Mediator complex subunit 10"	Q9BTT4	5	6371874-6378571	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA042795, HPA054188"			Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA042795: AB_10796679, HPA054188: AB_2682410"	"unprognostic (2.33e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-3)"	"prognostic unfavorable (2.65e-5)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (3.26e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.92e-3)"	"unprognostic (4.32e-2)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (3.85e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.14e-1)"	26.3	20.6	33.3	22.3	34.8	55.5	23.8	32.5	39.2	19.0	28.6	35.5	19.6	20.3	24.1	27.0	19.9	20.5	31.3	36.5	38.7	21.9	22.7	20.4	35.5	33.8	35.2	20.5	27.1	22.2	18.2	20.9	37.4	21.0	12.6	8.5	21.6	22.3	34.0	27.0	23.9	20.2	33.8	23.4	24.4	17.6	36.1	26.7	20.0	20.2	22.8	26.4	22.3	36.1	55.0	59.8	23.5	43.9	36.3	40.2	66.7	67.9	61.1	70.6	51.7	91.4	43.5	70.8	53.3	57.5	101.7	40.3	40.7	50.3	63.6	116.6	46.6	47.0	94.0	46.5	111.9	56.7	39.8	46.1	65.1	66.7	95.4	43.6	57.5	39.9	69.8	41.3	55.3	68.7	84.2	86.2	40.2	38.0	154.4	47.6	41.6	29.6	48.6	57.3	44.7	66.3	128.8	53.1	106.2	29.2	36.9	50.6	63.5	70.6	77.7	65.5	73.5	65.5	70.1	102.4	63.4	89.5	53.8	127.4	42.3	94.6	75.0	47.1	92.6	98.2	93.9	81.8	36.5	88.6	101.7	85.7	31.6	76.1	52.0	67.5	93.1	109.2	33.3	34.8	32.5	39.2	36.5	38.7	33.8	35.2	37.4	33.8	36.1	36.1	108.3	22.4	21.7	11.1	96.7	92.0	87.8	142.0	58.1	68.0	49.8	68.8	46.9	34.3	56.3	46.0	29.2	81.9	116.2	38.6	58.7	103.2	5.5	43.5	50.5	74.7	44.2	46.3	28.3	92.0	78.5	67.9	35.2	50.8	51.4	58.0	75.7	23.0	64.5	74.0	18.8	56.2	95.6	30.7	61.9	11.8	70.2	44.4	62.2	13.1	96.9	55.1	133.9	12.5	21.0	148.4	52.2	45.1	72.5	108.0	68.7	51.9	53.1	49.1	32.9	51.1	71.5	63.7	83.8	53.4	70.5	79.4	105.8	68.0	45.8	88.6
MED14	"CRSP150, CRSP2, CSRP, CXorf4, EXLM1, RGR1, TRAP170"	ENSG00000180182	"Mediator complex subunit 14"	O60244	X	40648305-40735858	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064182			Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA064182: AB_2685204"	"unprognostic (5.21e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.16e-1)"	"unprognostic (7.95e-3)"	"unprognostic (4.38e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.89e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.64e-1)"	10.8	10.2	11.7	12.5	13.4	22.4	9.8	13.3	15.9	11.8	15.2	14.3	17.9	11.2	20.4	13.9	9.7	9.6	14.5	11.7	13.2	11.3	15.1	11.0	17.3	13.0	12.1	13.1	12.0	18.7	10.7	13.2	13.5	11.0	14.7	19.2	9.6	9.4	60.7	16.5	13.9	10.1	10.8	11.1	12.4	5.1	14.3	24.9	14.6	33.4	18.6	14.2	12.6	16.0	44.3	21.4	33.8	30.0	14.7	19.0	6.9	17.1	21.3	24.1	30.6	19.8	21.4	25.4	11.4	21.8	51.7	32.7	57.8	27.1	35.9	23.3	43.5	25.7	25.8	18.1	15.8	27.2	25.4	13.7	16.3	35.3	30.5	28.5	29.5	16.6	17.7	24.1	25.5	22.8	25.1	24.2	37.5	27.9	24.7	12.6	36.1	25.6	23.3	20.2	21.6	19.2	40.6	18.3	19.2	62.7	26.8	16.1	26.9	24.5	25.6	31.1	21.2	22.4	24.6	25.2	23.7	18.4	18.1	1.9	1.5	2.8	1.9	3.2	2.2	1.6	1.8	1.8	2.5	1.5	2.0	1.6	0.8	3.5	1.8	1.3	1.8	1.2	11.7	13.4	13.3	15.9	11.7	13.2	13.0	12.1	13.5	10.8	14.3	16.0	12.6	16.0	12.0	36.9	17.5	23.7	11.7	8.4	11.4	16.5	13.9	9.8	14.1	11.5	12.1	12.9	18.8	6.3	22.2	24.0	5.9	8.4	0.8	16.9	14.8	12.9	20.4	8.4	30.9	10.0	5.4	11.3	29.6	21.6	10.8	21.5	8.2	20.9	9.3	18.5	35.6	19.0	8.2	15.6	17.4	1.0	8.7	17.3	12.4	27.2	16.0	6.3	12.3	41.7	63.5	13.9	15.0	8.6	23.8	17.6	19.1	9.2	6.8	16.3	26.3	12.7	14.2	20.5	7.7	18.7	30.3	6.6	16.7	12.5	17.2	27.3
MED22	"Med24, SRB6, SURF5"	ENSG00000148297	"Mediator complex subunit 22"	Q15528	9	133338312-133348131	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020391, HPA063694"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA020391: AB_1857668, HPA063694: AB_2685093"	"unprognostic (2.62e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.53e-2)"	"unprognostic (5.56e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (5.16e-6)"	"unprognostic (4.99e-3)"	"unprognostic (3.23e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (6.46e-4)"	"unprognostic (3.99e-1)"	"prognostic favorable (3.76e-11)"	"unprognostic (9.25e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.62e-1)"	14.1	20.4	7.1	6.2	7.1	4.9	14.0	7.3	7.2	22.1	6.3	24.6	5.2	23.2	2.8	15.6	20.4	3.4	22.2	6.8	6.8	19.5	12.1	15.1	6.3	8.4	7.2	21.4	14.8	6.7	16.7	4.4	7.3	21.7	2.9	2.8	14.3	7.4	13.3	14.3	17.6	5.6	7.5	21.9	15.7	10.2	6.9	4.6	19.2	3.3	5.0	23.2	16.2	7.1	10.0	11.5	17.7	12.7	3.8	6.5	20.5	11.9	8.3	14.5	9.6	25.4	9.1	20.0	6.9	8.5	12.6	19.4	13.3	11.5	6.0	15.7	7.7	10.6	28.8	6.9	6.4	13.7	10.5	5.0	9.0	13.0	8.6	6.8	7.0	11.5	15.7	9.3	6.9	13.8	19.5	11.4	24.8	12.4	13.8	26.4	14.1	18.4	6.0	7.2	14.3	11.6	13.8	17.4	10.4	7.1	19.7	4.7	9.5	18.7	13.0	13.0	15.8	6.4	9.4	19.4	10.8	10.6	15.8	1.1	1.5	2.6	0.7	1.2	0.9	1.1	0.8	0.9	1.1	1.5	0.9	0.7	2.3	0.6	2.2	1.5	0.7	1.1	7.1	7.1	7.3	7.2	6.8	6.8	8.4	7.2	7.3	7.5	6.9	7.1	6.4	22.4	11.7	4.6	8.3	8.3	10.6	4.0	4.0	13.6	6.9	5.2	9.9	7.2	3.1	16.5	0.0	6.1	12.8	8.8	3.9	5.8	1.9	3.7	6.7	8.4	6.7	3.8	3.0	5.3	5.1	11.2	6.1	6.2	7.6	8.4	6.4	4.3	7.8	13.5	3.3	6.5	4.1	7.2	8.3	2.8	11.8	8.3	1.8	3.7	5.6	9.6	5.2	3.0	5.3	8.1	2.1	16.6	6.8	8.4	8.3	5.2	1.7	12.1	26.3	14.8	15.2	13.2	13.7	5.2	6.5	5.5	5.8	5.9	5.9	4.7
MED6	NY-REN-28	ENSG00000133997	"Mediator complex subunit 6"	O75586	14	70581257-70600690	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030764, HPA069039"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA030764: AB_2673601, HPA069039: AB_2686070"	"unprognostic (1.65e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (2.23e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.15e-2)"	13.0	14.9	13.3	14.0	13.3	21.6	17.2	22.5	17.3	14.8	10.6	13.2	11.8	14.8	17.7	17.2	15.0	12.2	14.6	12.6	13.8	11.5	16.8	13.0	24.3	10.3	11.6	19.0	11.2	12.2	12.1	15.3	10.8	11.2	13.0	22.0	12.3	12.4	23.2	18.6	12.2	14.4	10.1	15.0	12.4	13.7	12.9	24.3	14.8	22.6	26.5	16.4	13.9	13.3	81.0	43.5	56.1	24.2	29.6	32.0	44.9	39.6	42.7	60.8	60.3	43.8	48.9	60.9	22.7	34.6	36.0	37.9	67.5	41.0	64.4	44.0	35.7	44.8	31.6	59.5	36.0	39.5	34.4	36.1	47.2	43.1	39.7	26.7	48.1	45.8	42.3	37.4	45.2	60.3	56.7	53.2	41.9	56.7	53.7	46.5	51.9	32.0	37.8	42.4	37.9	40.3	41.8	44.3	47.0	32.6	69.2	49.1	37.7	49.7	71.2	24.8	37.3	39.2	63.7	85.8	43.1	34.1	34.7	19.1	16.2	24.6	17.6	18.9	20.9	17.9	23.1	20.3	18.5	20.2	21.3	21.7	15.8	22.6	22.9	13.9	23.4	14.1	13.3	13.3	22.5	17.3	12.6	13.8	10.3	11.6	10.8	10.1	12.9	13.3	36.7	19.2	25.7	16.0	48.7	19.4	34.2	50.3	28.5	73.5	23.0	21.1	7.4	12.8	34.5	18.4	79.2	39.1	49.4	13.9	5.9	30.3	7.6	22.7	24.9	27.6	22.1	22.5	27.1	23.1	44.3	30.1	24.5	30.5	46.3	29.5	25.4	15.0	26.2	26.9	24.2	14.0	20.3	19.2	15.4	6.3	27.1	21.4	17.8	16.9	30.4	38.5	47.4	18.6	18.6	27.2	19.5	29.3	41.6	38.3	22.5	14.1	37.2	97.7	26.3	28.0	26.4	25.3	37.7	23.5	20.0	49.0	44.7	25.2	14.8	39.2
METAP1	"KIAA0094, MAP1A, MetAP1A"	ENSG00000164024	"Methionyl aminopeptidase 1"	P53582	4	98995659-99062809	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 1627.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025485, HPA037997, HPA037998"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		8900	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB025485: , HPA037997: AB_2675777, HPA037998: AB_2675778"	"unprognostic (1.79e-1)"	"unprognostic (3.39e-1)"	"prognostic favorable (7.22e-4)"	"unprognostic (1.58e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (3.08e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.28e-5)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (5.50e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.15e-3)"	"prognostic favorable (9.31e-4)"	14.8	9.5	10.2	20.5	11.6	25.1	28.7	10.5	13.8	24.0	8.8	31.8	24.1	25.7	43.7	52.3	24.3	15.1	41.1	11.2	10.0	24.7	24.0	15.6	24.9	9.5	10.1	14.0	19.5	14.0	11.6	16.9	9.4	29.2	33.5	11.3	23.1	29.7	33.8	28.7	23.4	25.7	9.2	17.6	19.6	51.6	10.6	41.9	18.8	28.7	31.2	34.5	30.8	10.4	57.6	55.9	47.7	51.7	37.2	59.1	52.9	80.3	51.5	67.1	63.7	62.9	83.3	84.1	31.3	65.5	40.3	56.1	84.8	80.5	92.9	59.2	39.9	75.6	37.8	68.2	40.2	103.6	60.8	42.8	57.5	57.0	60.4	52.4	56.3	46.9	60.0	49.7	73.2	44.0	90.9	49.3	58.7	97.7	44.3	58.9	74.5	45.4	109.2	73.6	64.7	38.5	27.0	82.5	32.8	53.1	31.6	39.3	46.1	53.9	68.0	49.9	70.9	35.5	53.5	66.2	46.5	51.9	54.8	19.1	11.6	5.7	17.7	14.6	23.1	16.0	18.0	17.6	14.9	11.4	17.4	15.8	2.9	17.7	14.7	7.2	17.7	14.1	10.2	11.6	10.5	13.8	11.2	10.0	9.5	10.1	9.4	9.2	10.6	10.4	16.1	41.7	14.6	20.2	19.8	42.4	47.5	26.2	51.2	5.2	21.0	24.9	57.0	17.2	19.5	14.7	2.1	24.4	17.4	36.7	13.7	28.4	330.3	45.4	30.0	17.3	7.8	24.2	22.6	29.4	70.5	15.3	22.4	60.9	3.8	16.9	12.8	21.4	17.2	3.3	15.0	23.3	24.4	20.2	16.2	1627.3	19.3	17.4	16.0	14.0	13.9	10.6	25.7	17.6	22.3	28.0	30.8	22.6	17.8	34.4	25.3	31.6	17.2	3.7	26.3	11.5	21.7	15.7	41.6	54.3	38.8	7.7	23.6	18.1	36.2	46.9
METTL16	"METT10D, MGC3329"	ENSG00000127804	"Methyltransferase like 16"	Q86W50	17	2405562-2511891	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020352, HPA059798"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA020352: AB_1853828, HPA059798: AB_2684128"	"unprognostic (4.94e-3)"	"unprognostic (2.86e-2)"	"unprognostic (2.29e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.46e-1)"	"prognostic favorable (3.06e-4)"	"unprognostic (5.35e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.68e-2)"	6.8	6.2	4.4	6.6	6.2	8.8	7.8	5.1	5.2	7.2	4.3	6.0	5.3	9.5	5.7	5.9	9.1	4.9	7.2	4.0	4.4	6.3	3.8	7.0	8.3	4.7	5.2	12.3	7.5	10.1	4.5	4.2	4.9	7.4	5.8	7.7	6.6	7.0	6.6	6.4	5.2	8.5	5.0	6.9	4.7	5.4	4.8	10.4	9.3	7.4	8.3	6.4	5.3	7.9	9.0	25.3	12.7	12.9	9.7	12.1	12.3	11.8	9.6	12.4	10.3	34.5	6.1	28.1	11.9	10.1	13.3	12.5	30.2	15.3	16.8	11.0	20.7	14.2	21.2	16.0	10.8	13.3	11.0	10.2	14.0	17.3	24.9	8.5	13.0	16.1	19.1	14.8	8.4	11.0	19.1	7.8	14.9	10.9	10.1	31.8	13.8	12.7	9.2	8.3	6.8	11.4	16.7	9.3	9.0	13.5	11.9	8.6	10.2	11.6	7.3	16.3	16.3	8.3	11.3	19.4	15.5	11.1	15.8	1.6	2.1	0.8	3.5	1.4	4.4	3.5	3.3	3.4	1.5	2.9	4.9	3.7	0.0	1.3	1.0	2.0	2.3	1.4	4.4	6.2	5.1	5.2	4.0	4.4	4.7	5.2	4.9	5.0	4.8	7.9	17.5	12.8	33.5	19.2	25.7	11.5	21.4	12.6	9.6	28.7	14.9	14.1	15.8	15.7	25.8	7.3	45.9	8.9	19.3	11.8	13.7	9.9	20.8	18.8	21.7	13.9	20.4	6.3	20.9	10.8	9.1	18.9	15.3	15.0	24.7	25.5	17.5	9.2	10.4	26.9	21.6	13.7	10.2	10.0	5.9	7.6	14.9	11.6	8.8	17.8	13.7	20.2	30.9	23.6	42.2	9.7	6.3	12.8	14.5	20.1	23.2	9.0	26.3	37.4	6.6	28.0	21.3	11.8	16.7	14.7	12.8	6.0	25.5	28.7	16.8	17.0
METTL17	"FLJ20859, METT11D1"	ENSG00000165792	"Methyltransferase like 17"	Q9H7H0	14	20989973-20997035	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002955, HPA059802"	Uncertain		Enhanced	Nucleoplasm	"Intracellular and membrane"	No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA002955: AB_2144183, HPA059802: AB_2684129"	"unprognostic (1.90e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.02e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.29e-2)"	11.9	32.2	11.0	11.1	11.5	26.6	12.2	12.3	16.1	14.1	13.2	20.6	17.6	12.8	11.2	22.4	13.0	10.3	23.7	10.7	11.1	20.0	19.7	11.7	18.0	12.0	10.9	13.8	18.8	19.4	9.6	12.2	11.6	12.3	21.7	8.0	15.6	13.8	21.3	16.1	21.5	14.2	12.0	23.3	17.6	18.6	12.0	21.7	13.6	29.2	19.3	12.2	14.6	12.3	37.5	48.0	41.8	16.1	25.3	12.2	32.0	22.3	32.8	69.1	58.2	34.3	44.9	85.8	24.4	29.1	43.7	54.0	57.5	48.5	49.6	32.5	44.7	41.8	27.5	56.6	31.5	71.5	42.8	23.4	41.7	35.1	27.8	23.0	27.9	70.5	40.4	38.6	33.8	24.9	48.9	72.2	49.6	62.7	56.2	56.8	42.9	48.2	37.5	34.4	30.2	36.5	30.0	43.9	24.8	31.1	29.4	60.0	15.5	22.4	72.0	25.1	30.2	28.7	49.8	62.1	15.5	46.0	29.3	28.8	8.1	8.6	11.7	9.8	7.0	13.9	12.7	13.2	16.8	10.8	12.4	11.7	0.1	10.7	5.5	11.1	11.5	6.9	11.0	11.5	12.3	16.1	10.7	11.1	12.0	10.9	11.6	12.0	12.0	12.3	11.2	9.6	17.7	21.9	33.6	18.9	17.9	21.2	46.1	37.5	16.5	16.4	5.4	21.5	17.9	11.0	43.8	30.8	23.0	19.3	5.9	20.4	49.2	11.8	16.2	13.5	12.2	26.9	9.7	15.4	17.4	17.7	36.2	11.1	29.7	22.0	11.7	24.2	18.1	21.9	9.3	24.0	16.2	11.3	12.4	10.2	33.5	16.3	3.6	6.5	19.8	23.4	26.8	8.5	11.0	13.8	32.5	21.4	33.6	11.0	27.9	18.0	21.4	53.1	13.1	14.6	17.0	23.4	17.3	40.6	17.8	12.7	27.6	29.0	35.6	24.8
METTL18	"AsTP2, C1orf156, HPM1, MGC9084"	ENSG00000171806	"Methyltransferase like 18"	O95568	1	169792529-169794963	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035314	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Cytosol	"HPA035314: AB_10601146"	"unprognostic (6.63e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.39e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (3.65e-1)"	"unprognostic (3.06e-2)"	"unprognostic (3.03e-2)"	"prognostic favorable (3.28e-4)"	5.6	5.3	5.4	6.2	5.7	4.0	10.5	6.5	6.8	5.8	5.7	6.5	5.2	6.0	8.7	5.2	7.5	4.8	6.1	5.0	5.5	7.4	6.2	5.5	14.1	5.4	5.5	9.2	4.9	22.4	3.4	6.0	5.7	6.8	6.2	7.3	6.3	5.9	4.3	6.2	6.0	5.0	5.8	8.8	7.3	6.5	5.5	10.3	9.0	6.9	11.6	5.6	3.8	6.7	13.0	7.5	11.6	8.3	6.6	12.2	8.6	5.9	6.9	7.8	6.6	9.6	20.7	22.2	16.2	7.7	10.8	14.5	11.5	13.6	9.9	14.0	9.9	15.9	6.6	8.0	13.7	16.9	7.2	5.6	14.2	7.5	8.1	7.6	14.2	16.8	17.1	10.8	10.1	6.3	18.0	11.1	14.9	27.7	18.7	13.0	12.0	16.8	11.7	12.9	8.6	13.4	13.2	14.4	18.2	17.1	19.3	18.1	6.7	9.3	9.0	9.9	13.8	19.8	27.6	29.9	7.1	13.4	9.9	18.2	9.5	23.1	24.8	10.6	31.7	21.6	27.1	28.8	10.0	24.2	31.8	30.9	5.5	24.0	6.6	7.7	34.5	18.3	5.4	5.7	6.5	6.8	5.0	5.5	5.4	5.5	5.7	5.8	5.5	6.7	5.8	3.2	4.6	1.0	9.5	1.5	6.1	10.8	1.8	7.4	4.6	5.2	5.0	2.8	8.5	5.5	0.0	13.7	4.5	3.7	25.4	12.1	16.9	3.7	5.1	8.3	3.0	8.6	1.4	8.0	5.5	5.5	2.0	2.8	7.0	13.4	7.5	2.9	7.7	6.7	1.9	3.6	10.2	5.9	3.2	5.4	6.2	3.7	5.4	2.8	2.6	12.0	14.4	1.5	4.0	5.3	5.7	5.3	2.5	3.1	5.7	11.6	10.9	8.5	0.0	6.1	6.5	16.7	10.2	2.4	0.9	11.5	10.1	10.0	5.5	4.2
METTL21A	"FAM119A, HCA557b, HSPA-KMT, LOC151194"	ENSG00000144401	"Methyltransferase like 21A"	Q8WXB1	2	207580631-207625928	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Paneth cells: 114.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034712	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"HPA034712: AB_10670160"	"unprognostic (1.41e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (1.87e-5)"	"unprognostic (4.80e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.47e-3)"	"unprognostic (6.65e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (5.43e-4)"	"unprognostic (5.01e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.05e-1)"	11.1	9.0	18.9	10.8	20.3	22.7	7.9	24.8	24.6	8.9	14.7	9.4	8.2	9.7	7.9	6.7	7.9	7.0	13.7	17.7	19.9	11.2	23.7	9.0	16.5	20.1	19.2	11.1	8.8	9.9	9.9	12.5	20.1	8.4	8.9	16.0	8.6	6.5	21.9	9.2	8.8	7.6	15.1	16.2	12.1	7.6	21.6	17.6	12.4	8.8	15.0	8.5	6.8	27.6	18.4	16.8	27.4	20.8	11.9	12.4	53.0	10.1	12.3	15.9	16.0	32.3	28.6	26.2	21.5	7.7	27.8	10.4	39.6	13.2	13.1	15.3	27.1	30.9	26.7	53.6	21.0	40.7	30.0	11.1	17.2	7.9	13.2	19.5	18.1	43.3	45.0	15.1	10.6	29.7	41.2	69.4	45.5	24.9	11.8	30.1	11.4	38.2	23.0	15.3	32.3	26.5	21.8	7.4	21.6	37.8	10.3	59.4	9.3	13.8	30.6	12.9	17.8	22.3	29.8	54.1	22.6	31.5	20.9	32.8	28.6	54.8	9.5	29.0	16.0	54.2	14.4	13.7	24.1	44.8	26.8	17.4	10.4	16.9	45.6	30.0	12.7	16.6	18.9	20.3	24.8	24.6	17.7	19.9	20.1	19.2	20.1	15.1	21.6	27.6	30.8	16.0	25.3	16.0	55.0	15.9	38.1	25.7	5.7	22.0	16.6	16.4	23.8	21.5	23.1	11.0	8.4	35.5	24.3	17.1	29.4	27.9	31.4	12.5	10.1	24.6	5.4	42.5	20.6	25.1	31.3	16.9	18.3	8.5	46.3	17.7	20.7	12.3	29.9	18.5	17.6	16.3	69.2	22.2	93.7	45.6	9.9	32.8	44.4	44.0	29.7	17.4	16.5	20.6	25.9	23.8	114.4	7.5	16.6	48.1	8.9	23.4	23.3	20.3	13.1	9.6	16.0	24.8	19.1	9.3	12.6	10.5	23.0	15.6	18.6	19.6
METTL2B	"FLJ11350, METL, METTL2"	ENSG00000165055	"Methyltransferase like 2B"	Q6P1Q9	7	128476729-128506602	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (2.56e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.81e-3)"	"unprognostic (9.91e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.36e-2)"	"unprognostic (3.40e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.46e-2)"	"unprognostic (8.38e-2)"	"unprognostic (5.67e-2)"	7.1	7.0	3.2	3.3	3.6	3.2	6.3	5.3	4.9	5.6	1.6	6.4	2.5	6.5	5.2	7.7	5.6	1.9	7.9	2.5	3.7	6.9	10.0	5.2	3.8	3.0	3.1	5.7	7.7	2.8	5.3	3.7	3.1	5.4	4.2	6.3	6.1	2.5	11.4	7.9	5.6	3.4	1.5	5.8	6.3	3.8	3.7	2.7	4.8	3.6	4.2	6.0	5.6	5.1	9.1	11.6	8.5	14.6	6.1	6.9	5.6	8.1	4.6	7.5	6.2	11.5	10.7	8.5	3.0	8.0	13.6	9.9	13.2	7.7	10.8	8.2	12.0	10.6	15.7	9.4	9.7	13.1	7.4	6.1	8.8	9.6	8.9	7.1	8.6	11.1	18.8	6.8	9.4	9.2	17.8	18.3	12.9	9.4	10.6	7.4	8.0	8.5	11.3	8.7	7.4	13.7	7.1	33.0	9.6	10.1	8.7	9.1	9.7	9.2	3.7	9.5	16.7	10.7	10.3	20.5	18.8	15.3	11.7	2.7	1.7	1.1	2.1	1.4	1.4	1.3	1.9	1.7	1.2	2.2	1.9	2.4	1.8	1.7	1.4	1.9	1.6	1.3	3.2	3.6	5.3	4.9	2.5	3.7	3.0	3.1	3.1	1.5	3.7	5.1	20.5	12.8	23.5	7.8	14.7	16.4	22.4	14.0	15.4	31.8	10.6	8.0	11.5	10.0	19.9	12.9	39.6	21.8	14.5	11.6	5.9	18.6	1.6	13.9	17.8	16.6	8.4	15.3	13.4	17.9	13.4	15.7	10.7	14.4	18.3	17.3	9.3	12.7	10.7	37.0	14.3	15.7	18.3	7.3	9.1	1.9	14.6	10.2	8.8	9.4	18.4	23.2	17.5	9.5	13.2	19.3	8.0	15.8	19.0	24.1	9.1	15.2	28.8	34.7	6.6	28.6	14.7	15.5	15.7	11.8	18.8	24.4	16.7	19.4	18.3	23.2
METTL5	HSPC133	ENSG00000138382	"Methyltransferase like 5"	Q9NRN9	2	169810081-169824931	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038223	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Cytosol	"HPA038223: AB_10672509"	"unprognostic (2.55e-2)"	"unprognostic (8.41e-2)"	"unprognostic (4.73e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.25e-3)"	"prognostic unfavorable (6.64e-5)"	"unprognostic (2.78e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (3.06e-8)"	"unprognostic (8.53e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.95e-2)"	"unprognostic (6.87e-3)"	51.1	39.5	41.3	27.7	42.5	34.0	50.2	41.0	57.0	30.4	36.1	53.7	29.4	29.4	63.0	36.6	29.2	25.1	65.5	41.9	45.2	38.5	46.9	24.1	35.4	41.0	42.5	25.7	54.1	36.7	30.2	30.7	42.4	32.5	42.2	30.5	47.1	32.1	92.9	32.7	33.0	36.6	43.7	26.4	43.0	24.3	45.1	30.8	37.7	73.5	38.4	42.3	31.5	45.0	97.1	52.5	74.6	83.1	66.9	99.6	122.6	80.1	74.8	95.4	76.1	164.2	111.2	122.8	95.0	66.0	126.8	98.5	103.0	167.9	133.3	95.3	73.8	185.8	40.6	181.8	90.9	235.9	87.6	73.6	220.2	121.2	147.7	99.4	90.0	165.8	176.0	99.9	123.1	93.8	113.7	190.5	101.4	125.5	98.5	113.7	70.0	190.6	167.0	87.5	90.5	67.6	51.5	80.2	146.0	84.2	75.7	104.6	62.2	103.4	84.5	65.4	104.3	97.0	158.8	206.3	86.3	113.7	95.3	45.5	26.0	21.1	39.9	32.5	61.5	65.0	54.8	53.9	32.0	56.3	56.5	52.3	7.7	45.3	31.8	49.5	57.8	34.8	41.3	42.5	41.0	57.0	41.9	45.2	41.0	42.5	42.4	43.7	45.1	45.0	67.1	12.8	28.8	6.8	49.1	38.6	88.9	105.2	47.8	24.8	64.0	111.4	83.1	50.1	65.4	44.1	16.7	96.1	43.2	36.1	111.6	115.6	3.9	61.0	34.8	48.6	60.6	70.9	10.8	146.2	117.4	43.8	24.5	43.1	46.3	35.1	46.4	49.5	77.2	23.5	11.0	66.7	59.0	36.9	33.3	8.7	50.4	35.9	55.2	9.4	53.7	51.6	53.5	7.1	13.2	149.7	48.8	60.2	48.1	92.5	72.2	115.8	61.3	23.0	52.6	47.2	66.5	49.2	97.4	56.2	40.9	39.1	47.6	48.4	69.3	89.2
METTL8	"FLJ13984, TIP"	ENSG00000123600	"Methyltransferase like 8"		2	171317405-171434802	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"B-cells: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035421	Uncertain		Approved	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	Cytosol		"HPA035421: AB_10670116"	"unprognostic (3.13e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (1.76e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.43e-4)"	"unprognostic (2.94e-3)"	"unprognostic (7.29e-2)"	"unprognostic (6.52e-3)"	"unprognostic (4.83e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (6.75e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.59e-3)"	3.6	2.8	2.8	3.2	4.7	3.6	3.7	2.5	3.9	3.4	1.8	5.3	2.2	3.0	2.1	8.6	2.4	2.8	2.5	2.6	1.9	3.1	3.6	2.0	3.5	2.7	2.4	2.2	1.7	2.1	1.2	2.6	2.9	3.9	5.2	1.6	2.1	4.0	3.6	6.8	3.6	6.4	2.0	3.3	2.1	4.2	2.8	2.1	1.8	2.3	3.9	5.2	3.8	4.0	10.3	7.4	5.0	13.0	11.7	14.1	19.1	12.8	9.8	11.1	10.0	13.8	13.5	25.1	9.5	8.1	8.2	10.0	17.7	19.4	13.9	10.8	9.9	15.0	6.5	25.0	11.1	17.0	9.1	12.5	24.7	16.0	28.1	2.6	18.6	10.9	26.7	4.1	9.7	13.5	14.3	4.8	16.9	8.3	8.8	7.0	15.4	21.9	9.1	6.8	12.2	5.1	14.5	11.4	9.2	6.6	9.4	7.0	13.8	11.4	6.1	7.6	7.5	3.6	13.0	15.0	7.2	15.9	11.2	0.5	2.1	0.5	3.4	2.7	4.4	3.4	4.4	3.3	2.1	5.1	1.9	2.1	0.7	3.7	1.6	6.7	4.8	2.5	2.8	4.7	2.5	3.9	2.6	1.9	2.7	2.4	2.9	2.0	2.8	4.0	8.1	6.4	6.1	25.1	72.3	25.5	10.7	18.3	27.9	8.4	10.6	9.1	8.2	14.3	14.1	3.7	2.1	15.5	13.1	8.4	11.7	7.6	13.3	4.0	19.2	8.2	6.7	16.2	28.7	6.2	21.2	14.9	6.1	6.1	6.3	18.5	7.5	10.6	11.8	11.8	33.0	5.7	12.2	9.8	10.2	4.1	14.0	11.9	10.6	17.8	11.4	6.3	7.2	29.1	48.2	8.8	5.3	16.1	24.2	20.4	9.8	18.3	6.4	9.2	6.6	10.8	10.8	11.8	21.3	32.8	26.7	12.9	18.3	23.0	13.7	10.0
MFAP1	AMP	ENSG00000140259	"Microfibril associated protein 1"	P55081	15	43804492-43824690	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 147.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015583, HPA042370"	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Centrosome	"HPA015583: , HPA042370: AB_10796904"	"unprognostic (1.05e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.28e-2)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (4.08e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.02e-2)"	"prognostic favorable (1.04e-9)"	"unprognostic (1.66e-2)"	"unprognostic (9.68e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.54e-2)"	15.9	24.0	17.5	17.6	18.0	12.9	21.4	21.3	23.2	16.6	19.7	17.1	14.5	18.8	23.4	22.2	18.4	14.9	22.1	17.7	19.3	23.7	18.1	15.2	26.6	18.3	19.3	24.8	15.3	33.2	14.5	23.2	18.7	22.8	18.1	25.0	17.0	17.7	26.3	20.5	15.0	19.1	17.7	17.1	16.8	19.3	18.5	24.4	24.7	23.2	32.4	20.6	17.5	19.1	40.1	41.0	69.4	46.0	57.9	36.3	42.7	63.1	43.8	50.3	58.2	64.1	25.6	42.8	58.7	39.4	50.9	70.8	62.5	51.7	58.9	72.9	37.6	103.7	71.6	48.5	45.4	62.3	53.2	34.1	55.3	48.0	43.3	48.0	49.8	48.3	95.8	35.7	60.9	30.0	51.1	47.0	49.2	74.2	35.4	73.9	69.6	27.6	52.0	59.0	43.8	43.0	55.6	47.0	27.0	55.2	70.7	39.5	47.4	50.6	35.8	56.3	51.7	43.5	112.2	91.8	42.5	58.4	37.9	42.5	25.5	56.9	35.3	34.8	34.7	35.0	35.1	33.6	32.6	28.3	35.7	35.0	22.6	50.5	29.1	26.8	44.1	26.3	17.5	18.0	21.3	23.2	17.7	19.3	18.3	19.3	18.7	17.7	18.5	19.1	30.4	35.3	30.2	5.2	32.8	30.3	59.6	50.1	35.9	41.8	22.4	28.8	31.0	25.8	43.2	51.5	6.2	94.6	33.2	27.4	56.7	44.2	6.2	43.1	39.9	35.6	11.3	32.0	9.0	29.4	55.0	29.8	21.4	39.4	46.3	37.6	20.7	18.8	35.4	32.0	8.6	24.4	38.7	20.7	20.5	6.3	28.0	25.5	26.6	5.6	30.6	51.5	33.0	2.0	8.2	26.8	27.1	35.7	20.6	39.3	22.1	42.9	60.0	35.2	19.7	35.9	41.7	49.7	84.8	28.1	27.7	147.4	33.6	39.4	21.3	50.6
MGME1	"bA504H3.4, C20orf72, DDK1"	ENSG00000125871	"Mitochondrial genome maintenance exonuclease 1"	Q9BQP7	20	17969018-17991122	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"	"Disease variant, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040913	Approved		Supported	Mitochondria		NA	Yes			"Cluster 2: Granulocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Mitochondria		"HPA040913: AB_10962835"	"unprognostic (5.81e-3)"	"unprognostic (5.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.29e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.44e-2)"	"prognostic unfavorable (6.98e-8)"	"unprognostic (5.31e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavorable (1.13e-7)"	"unprognostic (2.04e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.70e-2)"	"unprognostic (6.89e-2)"	6.5	14.4	7.5	11.7	8.2	16.0	18.4	8.0	9.7	7.3	7.9	11.4	13.4	5.2	10.4	13.1	6.2	7.3	10.8	7.2	7.5	12.8	14.4	7.7	19.9	8.6	8.1	5.9	8.8	7.8	4.7	12.8	8.7	7.5	13.4	7.8	9.0	7.4	21.3	34.2	11.9	6.7	8.3	17.7	9.3	10.7	7.9	19.8	11.9	12.1	20.8	8.9	9.5	9.3	44.7	51.0	41.0	38.7	16.5	29.0	54.9	36.8	27.1	34.8	47.4	63.4	44.7	53.4	20.3	16.4	39.6	64.9	43.1	55.1	52.7	19.9	34.7	34.7	29.6	97.2	12.3	22.9	56.2	17.6	37.3	52.3	27.4	16.3	28.2	26.0	48.0	33.3	70.7	33.4	40.5	29.9	36.3	26.8	44.0	30.5	91.4	50.8	30.1	32.3	31.6	26.1	26.1	62.8	57.7	33.2	59.7	15.5	22.8	59.1	48.1	29.8	40.3	24.6	59.6	45.3	15.2	17.3	44.7	57.5	15.2	44.6	8.1	14.9	10.9	21.0	10.5	10.9	12.6	24.2	7.5	6.9	14.4	16.7	15.0	19.5	17.1	8.4	7.5	8.2	8.0	9.7	7.2	7.5	8.6	8.1	8.7	8.3	7.9	9.3	10.6	0.0	10.0	19.9	24.6	46.4	15.7	12.7	40.9	7.9	19.9	39.4	12.6	15.7	11.9	7.3	8.4	22.9	21.0	14.3	39.2	13.1	9.8	11.2	15.6	11.9	7.2	52.6	3.1	10.2	25.9	8.1	5.1	13.3	48.0	25.5	20.0	9.9	31.4	8.4	2.9	12.1	6.1	34.4	15.4	5.5	8.4	18.8	21.4	9.4	16.4	11.4	28.8	17.6	12.6	10.4	10.6	5.7	13.2	12.3	31.0	26.5	5.9	10.0	13.1	10.3	10.8	38.6	47.0	20.5	46.9	18.1	14.9	27.1	19.0	12.8
MIEF1	"FLJ20232, L0R8F8, MiD51, SMCR7L"	ENSG00000100335	"Mitochondrial elongation factor 1"	Q9NQG6	22	39499432-39518132	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 266.3;Late spermatids: 377.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061059			Approved	"Intermediate filaments,Mitochondria"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Intermediate filaments, Mitochondria"		"HPA061059: "	"unprognostic (5.35e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.86e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.85e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.24e-1)"	"unprognostic (6.65e-2)"	"prognostic favorable (3.96e-5)"	"unprognostic (1.53e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.30e-1)"	9.6	8.1	10.9	7.9	10.4	12.8	8.4	10.9	10.4	6.3	8.5	9.5	12.0	7.6	6.8	9.3	7.1	5.5	8.8	10.2	9.9	13.1	16.3	7.4	11.2	10.4	11.5	7.7	9.5	10.9	5.1	8.6	11.1	6.9	9.3	8.3	9.8	8.1	8.4	7.9	10.4	6.8	10.8	9.2	8.2	17.1	11.4	9.5	8.4	9.3	11.7	7.3	6.3	10.3	16.0	15.9	16.5	26.6	15.5	17.0	19.5	15.0	17.4	16.7	15.0	25.9	8.1	44.4	12.2	15.7	10.9	20.0	37.6	20.4	20.1	18.8	36.3	18.1	22.4	26.2	30.1	63.7	23.1	22.3	24.3	14.7	30.7	16.1	17.9	14.5	32.5	23.4	16.7	11.0	20.5	17.8	15.4	32.5	17.2	27.7	23.4	44.6	19.0	18.8	15.3	12.7	16.6	27.6	42.8	17.3	12.3	22.7	17.8	15.7	22.1	14.0	18.6	42.2	47.5	43.9	18.1	28.0	24.7	0.4	5.6	4.7	5.2	6.2	6.4	4.8	5.0	5.1	6.0	4.7	5.4	5.1	0.4	6.8	6.2	3.3	4.7	6.3	10.9	10.4	10.9	10.4	10.2	9.9	10.4	11.5	11.1	10.8	11.4	10.3	10.9	12.8	18.7	7.5	13.6	19.5	16.0	11.4	10.8	19.0	13.6	12.1	19.3	20.0	8.6	16.5	25.0	19.6	17.0	22.0	25.4	13.1	266.3	5.2	14.3	13.1	9.7	14.7	7.4	13.8	19.8	10.4	8.2	8.9	9.5	14.2	16.8	49.8	15.8	6.7	8.3	11.5	24.4	20.7	20.5	377.2	15.5	12.2	16.0	9.4	19.0	18.7	7.2	2.0	8.9	17.6	7.6	13.9	29.1	23.4	21.9	27.8	8.9	15.2	0.0	14.1	10.2	20.4	28.0	16.2	23.0	13.0	10.8	14.7	20.7	19.1
MIGA2	"C9orf54, FAM73B, FLJ00199, FLJ14596"	ENSG00000148343	"Mitoguardin 2"	Q7L4E1	9	129036621-129072082	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 18.7;Theca cells: 22.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041363	Approved		Approved	"Cell Junctions,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol	"Cell Junctions"	"HPA041363: AB_10794664"	"unprognostic (2.10e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.90e-2)"	"prognostic favorable (3.04e-6)"	"unprognostic (1.12e-2)"	"unprognostic (1.44e-3)"	"unprognostic (8.57e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.15e-3)"	6.7	13.6	7.5	5.3	7.6	12.6	5.8	8.4	8.1	6.2	5.1	11.8	15.2	7.2	2.9	11.9	6.7	3.9	17.3	7.0	8.4	7.8	7.8	4.8	4.6	10.4	8.3	6.8	4.7	6.6	8.1	1.6	9.1	9.3	3.1	2.3	7.3	6.9	9.8	10.1	14.0	4.3	7.0	7.0	10.1	4.6	9.1	4.4	9.2	7.7	3.6	9.3	6.3	7.6	4.8	9.7	2.9	14.9	7.9	4.1	6.5	8.4	6.3	9.5	6.0	8.4	9.8	7.2	3.7	6.6	8.3	22.3	4.0	6.3	1.4	6.6	5.9	5.2	20.4	6.3	8.7	6.0	11.5	5.8	4.9	8.6	4.4	3.1	6.6	6.7	7.7	2.9	5.2	12.7	6.0	12.3	6.7	11.4	13.9	12.2	8.7	12.0	5.0	9.2	9.3	6.6	9.4	14.7	5.2	1.7	10.6	6.4	6.7	6.1	7.0	10.4	6.5	4.0	6.2	6.7	8.7	4.7	7.4	7.2	1.5	1.4	1.5	1.6	3.3	1.2	1.1	2.0	1.6	1.3	1.1	0.7	2.5	0.6	0.9	2.2	1.0	1.2	7.5	7.6	8.4	8.1	7.0	8.4	10.4	8.3	9.1	7.0	9.1	7.6	7.1	3.2	7.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	7.1	7.2	0.0	0.0	3.1	7.3	0.0	3.3	8.1	0.0	1.9	5.4	0.0	4.2	4.4	1.8	0.0	0.0	0.0	4.7	2.6	2.4	0.0	7.3	0.0	18.7	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	3.6	0.0	0.0	0.0	0.0	5.8	0.0	0.0	1.8	0.0	0.0	4.5	2.9	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	5.6	3.0	22.1	0.0	0.0
MIOS	"FLJ20323, MIO, Sea4, Yulink"	ENSG00000164654	"Meiosis regulator for oocyte development"	Q9NXC5	7	7566875-7608932	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 85.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042928, HPA052223"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"HPA042928: AB_10795610, HPA052223: AB_2681768"	"unprognostic (8.09e-3)"	"unprognostic (1.25e-2)"	"unprognostic (6.93e-2)"	"prognostic favorable (6.51e-4)"	"unprognostic (3.42e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (9.14e-4)"	"unprognostic (5.03e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.09e-1)"	"prognostic favorable (3.28e-6)"	"unprognostic (1.03e-1)"	"unprognostic (1.10e-2)"	"unprognostic (7.67e-3)"	"unprognostic (2.72e-1)"	10.0	9.5	7.0	15.2	6.6	18.8	14.5	12.1	8.7	12.3	26.8	11.3	8.8	9.9	10.4	22.9	10.8	9.9	11.9	5.7	9.3	12.6	17.3	11.7	22.4	6.7	7.4	13.3	17.3	28.1	8.9	11.6	6.1	21.7	13.0	18.8	13.5	11.2	85.5	18.1	9.3	12.2	6.7	15.3	13.4	19.2	7.2	16.2	9.3	51.1	29.9	13.9	14.3	8.2	42.4	18.8	21.8	26.4	17.1	35.9	18.3	32.9	26.8	20.6	20.6	23.2	16.5	37.1	9.9	19.7	55.3	37.6	23.1	24.2	27.0	14.8	19.5	9.5	22.5	16.1	24.3	40.1	10.2	30.9	29.0	18.3	46.2	20.1	18.2	12.4	47.2	29.4	88.0	29.1	9.2	17.0	45.3	21.3	19.8	27.4	33.4	36.3	19.0	21.3	23.0	37.2	17.7	49.1	19.3	40.5	26.7	35.1	15.7	31.3	33.2	17.4	27.7	25.9	30.9	33.2	27.6	23.0	37.2	0.0	5.4	8.8	4.3	9.9	3.6	10.1	4.6	4.2	7.6	8.8	6.0	4.9	0.6	5.4	5.0	4.5	5.1	4.0	7.0	6.6	12.1	8.7	5.7	9.3	6.7	7.4	6.1	6.7	7.2	8.2	8.2	9.6	11.9	18.6	30.3	12.1	14.8	6.6	15.4	8.2	13.2	10.8	18.2	12.8	9.2	7.3	12.5	16.8	12.2	9.0	17.6	11.7	38.5	22.7	11.4	7.5	4.2	15.6	22.9	17.5	8.7	9.3	16.3	18.6	9.5	15.4	6.8	17.0	15.5	11.8	21.0	7.2	4.1	22.7	12.2	57.9	5.9	18.4	7.2	27.2	10.1	9.4	13.4	23.1	18.2	14.1	11.3	7.5	19.4	24.9	6.7	11.3	11.0	17.0	13.1	13.1	9.3	36.0	30.4	24.8	18.9	21.2	15.3	15.3	11.1	19.7
MIS12	"hMIS12, KNTC2AP, MGC2488, MTW1"	ENSG00000167842	"MIS12 kinetochore complex component"	Q9H081	17	5486285-5490814	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 117.7;Late spermatids: 235.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044482	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA044482: AB_10963834"	"unprognostic (3.86e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.34e-3)"	"unprognostic (3.41e-2)"	"prognostic favorable (8.00e-4)"	"unprognostic (4.13e-3)"	"unprognostic (3.00e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.11e-3)"	"unprognostic (3.65e-2)"	11.9	11.3	10.2	16.1	12.6	17.6	15.5	11.0	12.3	12.1	10.6	12.1	12.2	13.6	31.7	10.1	13.3	10.1	9.7	9.6	10.5	13.8	16.3	10.9	21.5	11.7	11.7	11.9	14.8	10.6	13.8	10.7	12.7	12.0	14.0	28.1	11.0	12.9	13.6	10.4	13.9	13.1	10.7	18.2	11.7	15.0	11.1	26.1	18.8	12.9	21.2	13.3	8.8	15.8	19.0	21.8	45.4	28.7	18.5	18.4	23.4	26.9	20.1	40.6	36.2	20.4	14.0	47.7	22.9	14.4	19.7	42.2	36.9	25.3	41.3	28.0	24.9	26.7	42.1	24.0	32.6	15.7	31.0	18.4	38.3	34.9	54.3	19.4	21.4	36.8	29.9	46.5	26.0	11.9	34.8	15.6	25.6	24.6	19.4	31.6	44.2	23.0	16.3	19.3	15.7	30.8	28.3	13.2	30.0	32.8	20.0	13.1	14.2	25.8	20.7	22.6	34.0	22.1	21.6	26.8	23.2	22.6	23.9	6.5	8.5	6.6	14.6	9.8	15.5	11.9	12.3	14.4	9.7	9.2	15.5	14.8	4.4	16.1	13.8	12.9	8.8	10.3	10.2	12.6	11.0	12.3	9.6	10.5	11.7	11.7	12.7	10.7	11.1	15.8	13.6	12.8	15.3	14.0	21.0	12.9	25.8	9.7	19.4	14.4	15.4	12.3	7.6	14.3	12.3	5.5	14.6	13.1	18.7	16.5	23.5	10.4	117.7	11.0	13.1	14.2	21.4	16.8	7.0	7.1	12.7	12.8	10.2	10.3	32.4	11.7	10.0	13.0	10.1	5.0	7.2	20.7	18.3	9.9	17.2	235.3	5.9	9.9	10.6	6.5	7.3	19.9	17.5	7.1	22.2	9.9	19.8	9.4	23.7	19.8	7.9	7.6	13.9	22.1	19.7	16.7	12.2	27.2	11.5	11.7	18.0	21.9	19.5	11.3	13.4	20.6
MIS18A	"B28, C21orf45, C21orf46, FASP1, hMis18alpha"	ENSG00000159055	"MIS18 kinetochore protein A"	Q9NYP9	21	32268228-32279049	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 109.9;Spermatogonia: 86.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA018286, HPA020585"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"HPA018286: AB_1845693, HPA020585: AB_1845694"	"unprognostic (1.19e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.45e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.39e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.28e-1)"	4.3	5.4	4.3	7.5	4.3	16.9	7.6	5.0	5.6	4.1	3.9	9.5	8.3	6.6	6.3	8.5	5.7	3.2	3.6	4.6	4.2	6.3	6.1	3.7	11.1	4.1	4.0	9.6	4.2	4.0	3.0	7.5	4.0	5.4	10.6	4.2	5.2	3.9	3.2	8.3	9.1	4.9	4.0	6.0	6.7	21.4	4.0	16.4	3.7	2.4	12.1	4.9	5.1	4.7	63.6	15.5	43.8	42.2	6.5	11.2	67.0	32.6	16.8	31.5	27.1	31.0	34.2	69.0	23.6	12.5	37.8	21.1	43.3	24.8	37.6	39.7	48.3	79.3	16.8	40.4	4.3	68.7	25.8	4.9	10.6	26.5	18.9	10.3	22.4	68.9	93.9	56.3	31.1	43.5	79.0	61.9	90.7	43.7	45.0	68.1	65.4	64.4	22.1	21.4	52.4	25.8	49.9	41.7	30.9	31.3	50.8	41.4	13.2	39.2	72.6	30.9	34.1	30.3	51.8	86.8	25.0	108.9	36.4	4.6	7.7	13.0	14.3	10.6	14.4	30.0	15.7	16.6	7.4	29.6	21.4	15.7	2.5	16.9	19.8	20.0	23.5	9.3	4.3	4.3	5.0	5.6	4.6	4.2	4.1	4.0	4.0	4.0	4.0	4.7	8.4	19.2	8.9	1.6	9.5	15.6	7.7	16.9	9.1	9.2	15.0	17.5	5.3	11.5	10.9	11.0	4.2	36.8	11.2	5.6	13.7	13.2	7.5	16.6	12.8	8.4	6.1	22.9	6.8	12.3	53.1	12.4	5.1	15.0	3.8	29.7	12.5	7.4	16.6	8.4	5.2	21.1	14.2	6.3	6.2	7.4	10.5	6.5	5.4	2.8	7.8	10.1	18.6	5.5	6.5	10.8	6.2	10.1	13.9	5.6	3.0	17.2	10.6	7.3	19.7	16.1	12.0	109.9	86.0	20.1	14.8	14.6	7.8	16.5	20.0	5.9
MKI67	"MIB-1, PPP1R105"	ENSG00000148773	"Marker of proliferation Ki-67"	P46013	10	128096659-128126423	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 46.3;lymphoid tissue: 52.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 232.9;Extravillous trophoblasts: 86.1;Granulosa cells: 87.0;Plasma cells: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB000058, HPA000451, HPA001164, CAB068198"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli rim"	"Mitotic chromosome"	"CAB000058: AB_2142367, CAB068198: AB_2665702, HPA000451: AB_1079186, HPA001164: AB_1079187"	"unprognostic (2.54e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.37e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (3.61e-6)"	"unprognostic (7.16e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (9.47e-5)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.61e-1)"	0.9	0.7	0.0	8.5	0.1	46.3	1.7	0.0	0.1	1.2	0.2	8.1	6.2	1.0	0.0	10.0	0.3	0.9	0.3	0.1	0.1	0.4	0.8	1.4	14.9	0.1	1.0	0.2	0.2	0.1	0.1	4.1	0.6	0.4	9.2	0.0	1.4	0.1	0.0	6.6	5.8	2.6	0.0	4.8	4.2	2.3	0.9	52.7	0.4	0.1	16.4	1.8	2.8	0.3	204.6	101.5	103.2	73.6	4.3	8.7	32.1	75.7	55.3	70.3	62.3	83.9	82.3	152.6	21.3	51.9	46.4	120.7	109.3	56.8	104.7	161.8	53.1	131.0	79.4	52.7	0.1	186.0	68.0	2.0	2.5	72.2	73.2	17.2	69.8	69.5	61.2	142.1	70.5	80.9	111.7	56.6	41.3	52.7	45.7	82.2	135.1	20.3	25.6	56.2	35.9	38.9	107.1	38.0	17.3	33.9	31.4	39.3	65.0	37.0	73.6	53.0	206.8	64.2	54.9	177.2	30.7	83.3	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	1.0	0.6	0.0	0.9	0.3	0.6	0.0	5.4	0.0	16.0	6.4	1.6	5.3	0.6	0.0	3.9	3.2	1.6	1.5	5.3	0.0	0.0	30.6	7.4	25.0	0.0	0.8	4.2	2.3	10.2	6.7	6.7	232.9	0.0	0.0	86.1	13.5	34.7	13.2	1.3	87.0	5.7	1.7	42.1	0.0	0.0	22.4	2.0	12.9	13.7	0.9	0.3	16.6	3.6	0.0	0.2	0.0	8.2	0.0	0.0	0.1	3.0	0.4	107.4	4.6	2.6	0.1	1.6	0.0	0.0	0.5	13.6	8.1	24.1	50.4	3.0	7.8	23.0	2.7	47.1	4.8
MLH1	"COCA2, FCC2, HNPCC, HNPCC2"	ENSG00000076242	"MutL homolog 1"	P40692	3	36993350-37050846	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013294, HPA052707, HPA060714, CAB070868"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB013294: AB_2533406, CAB070868: , HPA052707: AB_2681923, HPA060714: AB_2684348"	"unprognostic (1.26e-2)"	"unprognostic (3.88e-3)"	"unprognostic (2.36e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (8.24e-5)"	"unprognostic (3.36e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.63e-3)"	"unprognostic (2.10e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.86e-2)"	15.6	17.9	7.3	17.4	8.0	22.1	15.4	7.1	9.1	17.4	7.6	17.4	12.0	16.3	14.0	14.3	14.9	11.1	35.4	6.9	8.3	16.0	19.1	15.8	21.9	8.6	7.4	15.1	16.6	22.4	22.7	14.8	7.6	16.2	14.5	9.6	12.1	14.0	49.1	13.4	13.4	19.2	7.1	18.8	15.5	25.4	7.7	28.4	19.2	42.2	24.3	17.2	14.0	9.0	37.1	56.7	66.7	0.2	25.9	34.5	30.7	54.7	44.4	64.1	62.3	43.4	40.1	92.2	25.0	44.1	33.6	24.7	65.2	45.8	68.5	42.2	32.1	68.1	42.3	54.9	23.2	81.9	40.5	28.4	29.0	54.8	57.8	21.9	37.6	55.0	86.0	32.0	66.2	27.6	81.0	22.2	49.4	38.4	31.6	4.6	90.6	40.2	35.1	39.3	14.2	36.1	52.1	56.9	32.7	33.3	79.9	55.6	28.8	46.0	50.5	44.0	65.9	29.1	93.7	88.1	37.8	71.9	45.7	12.6	12.5	15.1	12.7	22.6	9.8	11.3	7.7	11.4	14.3	9.7	8.4	9.6	2.6	7.8	29.2	5.9	15.0	11.0	7.3	8.0	7.1	9.1	6.9	8.3	8.6	7.4	7.6	7.1	7.7	9.0	10.8	25.6	15.8	22.9	18.5	7.1	12.4	18.7	7.4	18.5	9.6	9.7	41.8	12.8	15.8	11.0	10.4	33.4	16.0	6.1	19.6	14.6	31.3	12.5	11.3	10.7	5.4	19.0	18.5	14.7	26.9	14.4	12.2	9.5	7.6	13.0	13.6	14.9	20.1	3.3	21.6	8.6	16.2	16.3	8.9	13.2	11.1	13.8	8.8	10.3	18.2	15.9	11.3	27.2	31.3	9.3	7.4	13.9	22.1	6.4	5.3	12.9	16.5	18.1	13.1	10.0	14.0	58.6	29.3	9.3	5.5	20.0	15.9	14.8	8.4	6.5
MMACHC	"cblC, DKFZP564I122"	ENSG00000132763	"Metabolism of cobalamin associated C"	Q9Y4U1	1	45500300-45513382	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Oxidoreductase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 17.4"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027394, HPA027399, HPA027402"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA027394: AB_10601669, HPA027399: AB_10601987, HPA027402: AB_2672255"	"unprognostic (3.34e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.03e-3)"	"unprognostic (3.14e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.16e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.61e-3)"	"unprognostic (2.08e-3)"	"unprognostic (8.83e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.58e-2)"	2.0	3.1	3.3	1.7	5.3	1.2	3.5	5.1	4.2	2.9	2.3	3.7	3.3	1.7	3.0	2.8	3.5	1.3	6.9	3.4	5.1	3.5	17.4	1.2	1.8	4.1	5.6	3.5	2.9	5.5	1.3	1.5	3.9	2.0	4.4	2.1	5.0	2.4	10.8	2.0	2.4	2.3	3.5	1.6	2.3	4.3	5.6	2.2	2.3	6.6	2.0	1.7	1.5	6.0	7.7	3.9	6.6	10.0	6.1	3.7	8.1	5.9	3.9	10.5	9.4	8.3	4.7	12.0	7.4	4.9	2.0	6.2	12.3	14.0	9.6	3.3	11.4	9.4	6.5	9.2	5.8	13.5	3.3	5.3	7.8	11.6	12.6	3.7	5.1	12.5	10.8	6.7	8.1	8.2	9.1	4.3	10.9	8.8	8.9	11.1	2.7	13.2	6.2	6.0	10.5	5.4	8.8	14.5	19.3	4.9	8.3	4.6	2.3	7.3	9.9	8.3	3.3	9.9	8.5	6.9	5.3	6.4	6.9	2.3	0.5	0.5	0.5	0.8	0.8	0.7	0.7	0.4	0.6	0.6	1.3	0.6	0.9	0.8	2.7	1.3	0.4	0.4	3.3	5.3	5.1	4.2	3.4	5.1	4.1	5.6	3.9	3.5	5.6	6.0	1.1	3.2	5.5	1.6	2.1	0.1	1.8	0.8	5.7	1.3	2.7	1.5	9.8	4.3	2.2	1.8	0.0	3.7	0.6	2.8	5.9	1.3	1.0	3.6	4.8	1.5	4.2	4.8	2.6	1.4	4.3	3.6	7.1	3.2	2.5	2.9	2.5	22.9	3.3	3.3	2.7	3.2	2.0	3.2	0.9	1.2	1.8	2.7	0.0	0.0	0.6	1.4	3.1	1.5	5.3	1.8	2.3	1.5	10.4	1.7	2.0	4.6	1.2	5.2	0.0	5.0	2.4	7.4	2.1	11.5	0.1	2.7	2.4	3.9	5.8	1.8
MMS19	"CIAO4, hMMS19, MET18, MMS19L"	ENSG00000155229	"MMS19 homolog, cytosolic iron-sulfur assembly component"	Q96T76	10	97458324-97498794	"Predicted intracellular proteins"	"Chromosome partition, DNA damage, DNA repair, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051936, HPA056299"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA051936: AB_2681668, HPA056299: AB_2683091"	"unprognostic (8.57e-2)"	"unprognostic (2.38e-3)"	"unprognostic (9.34e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (4.40e-1)"	"unprognostic (1.99e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.06e-3)"	"unprognostic (6.79e-2)"	"unprognostic (6.49e-2)"	"unprognostic (4.06e-1)"	"unprognostic (3.51e-2)"	"prognostic unfavorable (3.39e-4)"	25.9	23.3	45.1	14.9	47.1	16.4	27.0	45.7	66.4	27.7	45.3	26.1	14.2	24.6	18.3	32.8	24.8	13.1	39.3	47.6	44.0	37.3	24.0	25.1	22.3	44.7	44.2	30.3	30.6	17.1	35.7	20.6	45.2	23.5	17.5	28.8	26.7	15.8	38.0	44.4	28.4	17.8	43.4	33.4	27.9	47.2	45.8	25.8	23.5	29.2	22.7	25.6	30.3	44.9	39.1	36.5	43.3	61.1	41.4	49.9	26.3	30.7	61.6	45.8	53.5	48.9	49.7	59.9	32.5	42.1	30.4	43.5	71.5	82.7	43.1	26.3	54.5	32.0	30.5	51.8	31.3	42.7	29.9	41.5	35.7	40.7	86.3	88.8	78.2	44.7	45.5	32.8	45.1	35.1	40.5	77.3	24.6	39.0	29.8	32.1	33.0	27.1	55.0	27.9	17.8	29.5	17.8	23.4	48.3	53.7	47.9	37.8	45.0	21.1	26.0	14.2	35.6	29.5	35.0	34.6	31.5	62.3	17.3	10.5	6.1	4.6	5.4	6.6	9.3	6.0	7.2	6.8	8.5	5.0	8.7	7.1	1.2	5.7	5.2	6.3	7.2	6.3	45.1	47.1	45.7	66.4	47.6	44.0	44.7	44.2	45.2	43.4	45.8	44.9	9.4	22.4	16.0	21.2	10.0	10.5	6.2	11.3	12.5	10.6	9.2	11.2	18.0	12.8	8.2	5.5	18.8	13.7	13.4	8.7	11.7	11.1	9.6	5.6	12.1	13.0	10.2	11.6	32.8	8.1	18.8	9.9	16.8	9.0	3.8	12.8	15.4	14.4	12.4	10.1	29.7	14.6	4.1	12.6	9.6	7.4	15.5	9.0	14.2	7.5	15.6	6.4	6.2	27.6	38.6	9.7	4.1	11.3	10.7	6.1	9.1	6.7	7.6	22.2	13.1	9.1	8.8	22.2	28.5	12.7	11.5	8.8	9.7	9.7	13.1	4.9
MMS22L	"C6orf167, dJ39B17.2"	ENSG00000146263	"MMS22 like, DNA repair protein"	Q6ZRQ5	6	97142161-97283217	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 67.8;Oligodendrocytes: 52.3;Spermatocytes: 56.9;Spermatogonia: 45.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA067042			Supported	Nucleoplasm		NA	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA067042: AB_2685768"	"unprognostic (3.61e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.00e-5)"	"unprognostic (9.63e-2)"	"unprognostic (5.81e-3)"	"unprognostic (8.21e-3)"	"unprognostic (9.39e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.34e-6)"	"unprognostic (3.48e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.29e-1)"	1.1	1.1	0.7	2.0	1.8	7.0	2.3	1.3	1.2	1.6	0.7	1.6	1.2	1.5	0.5	1.7	1.4	1.0	0.7	0.7	1.0	0.8	0.9	1.1	3.4	2.1	1.4	1.4	1.3	1.4	0.5	2.0	1.8	1.3	2.3	2.4	1.0	0.8	0.6	2.9	1.6	1.5	1.2	1.4	1.1	6.8	1.5	5.2	1.1	0.5	3.4	1.3	1.1	2.4	7.5	8.2	13.5	14.8	2.2	4.0	10.6	15.0	6.9	13.8	20.1	11.4	8.6	16.4	9.0	5.7	16.0	13.4	17.1	8.3	27.4	14.1	12.7	16.7	11.3	7.2	1.3	25.8	11.3	2.2	4.3	19.5	9.0	2.8	6.0	15.2	23.1	25.6	13.1	8.9	9.5	10.4	5.2	12.1	6.1	15.8	12.8	5.8	5.9	9.7	7.7	6.6	9.8	4.9	4.0	7.6	7.6	15.7	4.5	14.0	13.3	11.8	20.8	3.2	10.3	18.3	8.0	16.0	15.7	0.5	0.4	0.9	0.6	0.7	1.0	0.5	0.9	1.0	1.1	0.7	0.8	1.1	0.4	0.6	1.6	1.2	0.9	0.4	0.7	1.8	1.3	1.2	0.7	1.0	2.1	1.4	1.8	1.2	1.5	2.4	5.9	3.2	8.6	16.6	9.7	9.2	5.8	4.0	4.0	11.6	6.1	6.2	4.2	5.7	6.9	3.7	41.7	12.5	14.6	3.3	1.9	2.9	67.8	4.4	6.1	6.5	1.2	26.3	11.3	4.1	11.2	6.1	7.7	2.8	7.6	24.0	10.8	3.1	6.4	3.3	7.7	8.4	8.2	7.5	6.0	17.2	9.9	6.8	7.2	36.5	6.4	6.1	6.2	22.6	52.3	3.0	2.0	5.7	13.1	2.9	5.4	0.8	6.1	31.9	6.6	7.9	5.1	56.9	45.8	7.1	8.2	3.6	9.6	5.2	10.3	3.0
MMUT	"MCM, MUT"	ENSG00000146085	"Methylmalonyl-CoA mutase"	P22033	6	49430360-49463253	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Isomerase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 199.0"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 62.5;Cytotrophoblasts: 26.5;Extravillous trophoblasts: 13.3;Hofbauer cells: 12.4;Syncytiotrophoblasts: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035971, HPA035972"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		150000	"Cluster 27: Non-specific - Gene expression"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Mitochondria	"HPA035971: AB_10696648, HPA035972: AB_2674895"	"unprognostic (1.34e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.57e-2)"	"unprognostic (9.89e-2)"	"prognostic favorable (8.71e-13)"	"unprognostic (5.38e-2)"	"unprognostic (3.78e-1)"	"unprognostic (6.01e-3)"	"unprognostic (1.91e-1)"	19.8	23.3	12.1	11.5	13.2	8.6	18.4	14.2	16.2	14.0	19.3	22.6	27.1	15.2	15.6	17.9	13.9	14.2	31.0	12.1	13.5	50.6	199.0	12.5	11.8	13.0	12.7	24.2	24.6	31.1	11.7	13.2	13.2	20.8	21.5	17.2	18.7	15.8	23.6	15.0	20.1	14.9	14.1	9.4	20.1	14.6	13.3	12.2	19.2	36.1	11.2	13.0	11.9	16.3	23.9	8.3	24.6	28.8	47.8	45.1	13.6	20.9	27.3	21.6	31.7	9.7	12.1	21.9	16.3	22.4	32.6	13.3	27.6	14.8	30.2	18.9	20.0	11.7	17.5	25.4	34.8	15.1	10.8	27.4	21.6	22.0	25.4	19.3	21.1	23.4	21.6	25.6	25.7	15.0	17.9	14.9	10.5	25.0	6.0	15.8	30.8	30.7	24.9	22.6	22.7	15.8	23.0	16.3	35.7	25.6	14.2	23.9	15.4	20.0	14.6	27.4	28.7	10.0	12.2	18.8	28.1	17.6	17.9	16.0	6.5	11.4	6.4	8.8	8.2	7.6	7.7	8.1	7.8	6.9	9.6	7.2	3.8	12.5	14.7	5.5	10.9	5.8	12.1	13.2	14.2	16.2	12.1	13.5	13.0	12.7	13.2	14.1	13.3	16.3	6.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.5	0.0	0.0	0.0	0.0	26.5	2.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	13.3	5.3	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	33.4	0.6	0.0	0.0	0.0
MNS1	"FLJ11222, SPATA40"	ENSG00000138587	"Meiosis specific nuclear structural 1"	Q8NEH6	15	56421544-56465137	"Human disease related genes, Predicted intracellular proteins"	Meiosis		"Disease variant, Heterotaxy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 21.2;testis: 48.2"	"Group enriched"	"Detected in many"	5	"Early spermatids: 504.6;Endometrial ciliated cells: 256.5;Respiratory ciliated cells: 232.5;Spermatocytes: 249.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039975, HPA040382"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nuclear speckles"		"HPA039975: AB_10793858, HPA040382: AB_10794740"	"unprognostic (7.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.07e-2)"	"unprognostic (2.25e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.05e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.12e-3)"	"unprognostic (8.20e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (7.71e-2)"	1.9	1.4	2.6	1.6	2.4	4.6	3.1	10.1	2.9	3.5	12.3	1.9	2.3	3.6	1.3	2.7	21.2	3.3	2.5	2.2	2.4	10.5	1.9	3.4	1.3	7.2	6.8	4.0	2.4	0.6	3.5	1.6	5.1	2.3	2.0	4.7	2.0	1.7	1.0	1.4	2.1	1.3	6.1	1.4	2.2	48.2	2.7	5.6	2.9	1.1	1.2	1.3	2.5	3.9	32.1	7.4	3.8	11.3	3.1	6.7	0.7	7.6	4.4	8.8	18.6	10.5	15.0	17.8	9.4	3.2	12.8	12.3	4.7	4.4	17.9	0.0	1.9	22.9	8.8	1.8	1.1	7.9	2.4	2.7	0.2	17.9	2.6	3.7	1.6	6.8	5.2	0.0	7.6	4.2	0.3	9.8	1.2	16.4	4.3	15.0	22.6	0.2	8.7	6.1	29.5	8.9	12.7	3.8	13.6	0.9	9.1	12.1	0.7	12.0	13.6	11.6	18.8	3.6	11.9	0.3	13.4	18.3	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.4	10.1	2.9	2.2	2.4	7.2	6.8	5.1	6.1	2.7	3.9	0.7	0.0	4.7	1.0	0.8	3.3	8.8	9.3	1.8	10.5	4.7	8.3	6.0	4.3	28.3	35.0	25.0	1.8	0.2	3.7	11.7	10.9	504.6	256.5	7.8	2.0	1.2	3.0	4.9	1.9	3.9	14.0	5.1	7.2	0.0	11.0	6.8	0.4	7.0	15.2	3.7	4.5	10.2	1.0	5.5	60.8	12.8	2.0	0.0	0.0	0.8	12.4	0.0	1.5	2.8	1.2	0.1	8.6	0.5	3.0	0.3	12.3	232.5	32.6	0.0	21.6	6.5	249.6	25.0	7.1	1.4	0.5	1.0	6.4	6.0	3.5
MOBP		ENSG00000168314	"Myelin associated oligodendrocyte basic protein"	Q13875	3	39467198-39529479	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 918.8"	"Cell type enriched"	"Detected in some"	14	"Oligodendrocytes: 1607.0"	"Cancer enriched"	"Detected in single"	63	"glioma: 4.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	50	"HAP1: 18.6"	"Low region specificity"	"Detected in all"							HPA035152	Enhanced		Supported	"Cytoplasmic bodies"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Cytoplasmic bodies"		"HPA035152: AB_10603020"	"unprognostic (1.76e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.53e-2)"	"unprognostic (7.35e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.60e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.04e-5)"	"unprognostic (2.28e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-2)"	0.2	0.1	366.9	0.1	539.9	0.0	0.1	443.3	488.6	0.2	112.1	0.7	0.0	0.5	0.0	0.0	1.5	0.1	0.2	308.8	382.8	0.3	0.1	0.7	0.0	836.4	490.3	0.8	0.1	2.5	0.4	0.0	714.6	0.1	0.2	0.2	0.3	0.0	0.2	0.2	0.1	0.1	565.7	0.0	0.1	5.5	519.1	0.0	0.1	0.0	0.0	0.3	0.1	918.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	366.9	539.9	443.3	488.6	308.8	382.8	836.4	490.3	714.6	565.7	519.1	918.8	0.1	0.0	0.0	3.3	0.0	0.6	0.1	0.0	0.0	0.1	0.2	0.3	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	105.1	1.5	0.1	0.2	0.0	0.0	6.1	0.0	0.0	0.2	0.0	0.8	11.4	40.9	0.0	0.0	0.0	0.0	3.8	0.2	0.0	0.0	1.6	113.0	1.5	0.2	0.0	1.0	0.0	0.2	0.0	4.0	1607.0	0.1	0.4	0.7	0.0	0.1	0.0	0.0	1.1	0.4	0.0	0.1	0.5	41.8	6.1	0.0	0.4	0.0	0.1	0.0	0.4	0.0
MON1B	"HSRG1, KIAA0872, SAND2"	ENSG00000103111	"MON1 homolog B, secretory trafficking associated"	Q7L1V2	16	77190835-77202398	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046285	Approved		Approved	Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"HPA046285: AB_10959467"	"unprognostic (1.73e-2)"	"unprognostic (9.99e-2)"	"unprognostic (9.97e-2)"	"prognostic favorable (6.90e-4)"	"unprognostic (1.94e-1)"	"unprognostic (7.72e-2)"	"unprognostic (5.64e-3)"	"unprognostic (3.71e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (9.42e-5)"	"unprognostic (2.21e-2)"	"unprognostic (3.62e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.75e-1)"	12.9	9.6	19.3	17.2	25.5	15.7	9.0	20.8	18.9	11.1	9.4	15.6	16.3	10.6	12.0	13.2	10.8	13.2	10.5	18.1	19.1	10.6	12.4	12.6	18.3	24.9	24.0	8.8	13.7	17.5	8.3	8.1	21.2	19.7	13.1	21.0	13.9	10.2	11.4	13.6	16.0	9.7	20.6	15.2	13.7	5.6	22.6	15.3	19.7	7.7	15.5	11.8	7.1	23.0	14.8	35.7	15.0	15.5	16.0	15.9	20.5	14.6	17.4	13.0	13.9	20.9	22.4	26.9	24.1	11.9	23.3	29.8	15.7	14.5	11.5	19.6	17.9	19.0	12.7	20.5	22.4	20.9	52.5	15.7	28.5	19.3	17.2	14.0	24.5	24.7	25.6	9.0	11.3	29.9	26.3	24.6	15.5	19.9	9.6	34.0	10.3	30.4	14.9	11.9	22.4	18.8	25.5	10.2	17.6	10.7	23.3	30.6	26.2	16.2	18.5	18.4	13.0	30.0	21.4	72.9	28.7	21.4	20.3	17.8	9.7	16.6	9.5	16.3	9.8	6.0	7.6	8.8	8.3	7.0	5.6	7.2	21.7	10.3	11.1	4.7	9.9	9.0	19.3	25.5	20.8	18.9	18.1	19.1	24.9	24.0	21.2	20.6	22.6	23.0	19.4	38.5	34.8	1.6	17.3	7.5	10.0	12.7	8.0	15.0	16.6	14.4	12.6	12.8	19.8	14.7	18.8	10.5	16.9	42.3	3.9	14.0	17.8	13.1	15.6	20.7	24.0	16.2	1.9	19.5	12.4	12.6	21.9	20.0	12.7	17.4	19.6	28.4	13.2	8.4	3.0	27.9	10.2	32.0	7.8	14.1	9.0	18.7	8.8	4.7	26.1	21.5	26.8	3.0	5.0	20.0	18.7	10.1	13.8	21.0	23.8	11.7	14.6	23.5	19.7	21.6	11.0	10.4	5.3	14.6	9.5	16.8	17.2	10.9	23.5	18.8
MORC2	"AC004542.C22.1, KIAA0852, ZCW3, ZCWCC1"	ENSG00000133422	"MORC family CW-type zinc finger 2"	Q9Y6X9	22	30925130-30968774	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Lineage enriched"	"Detected in all"	5	"T-cells: 16.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000436, HPA077137"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA000436: AB_1079404, HPA077137: "	"unprognostic (3.43e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.44e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.56e-3)"	"unprognostic (2.89e-3)"	"unprognostic (4.63e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (6.54e-8)"	"unprognostic (5.64e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.02e-2)"	"unprognostic (6.66e-3)"	15.6	14.4	6.6	7.0	6.7	6.6	16.6	8.5	8.3	20.6	6.6	20.7	5.3	18.1	6.8	17.0	18.7	5.3	19.2	6.6	6.5	16.7	26.9	14.6	9.0	6.6	6.9	20.0	20.1	7.4	16.6	7.5	6.7	21.8	5.9	5.8	14.8	7.7	26.8	19.5	15.6	7.7	6.4	19.5	16.2	45.2	7.0	8.0	15.6	10.2	7.3	21.2	18.5	7.3	19.2	12.2	20.2	23.3	21.4	18.3	15.5	15.6	12.9	16.1	16.7	17.5	10.2	26.9	11.7	14.3	9.4	17.2	17.7	6.9	18.2	15.5	23.8	20.5	12.4	15.3	15.6	18.1	19.8	15.3	12.1	15.1	18.9	12.0	14.0	9.5	26.3	19.0	17.2	23.7	16.2	17.9	23.0	23.9	12.6	31.5	12.8	22.9	12.5	19.1	20.5	17.2	18.8	21.9	8.8	19.6	16.2	21.2	16.3	17.8	18.7	14.3	12.3	15.0	19.0	22.2	10.3	9.1	13.3	0.8	1.6	1.0	12.0	2.9	10.0	2.3	15.1	9.6	1.6	2.1	15.2	11.0	0.3	1.8	3.3	3.2	16.5	5.2	6.6	6.7	8.5	8.3	6.6	6.5	6.6	6.9	6.7	6.4	7.0	7.3	8.7	0.0	4.6	14.0	4.5	7.4	7.3	3.9	6.2	7.9	8.8	9.1	4.6	2.8	6.2	11.0	10.4	8.4	5.9	6.0	3.9	7.3	30.8	6.1	7.8	7.3	9.0	8.6	9.5	8.0	11.4	6.2	4.1	6.0	1.3	8.9	5.7	8.8	5.4	13.5	11.7	4.8	6.1	3.8	4.1	10.3	7.8	4.5	7.2	10.3	2.8	4.1	6.2	11.1	8.8	11.7	4.1	10.1	3.2	11.6	4.6	3.7	3.8	10.4	19.7	7.7	7.7	26.6	24.1	6.0	9.2	6.3	7.8	7.0	7.3	5.6
MPDU1	"CDGIf, Lec35, PQLC5, SL15, SLC66A5"	ENSG00000129255	"Mannose-P-dolichol utilization defect 1"	O75352	17	7583529-7592789	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Transport		"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 157.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014845	Uncertain		Supported	"Endoplasmic reticulum,Mitochondria"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Endoplasmic reticulum"	Mitochondria	"HPA014845: AB_1854072"	"unprognostic (1.96e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.70e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.34e-3)"	"unprognostic (9.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.93e-1)"	31.9	41.1	33.0	32.8	34.1	63.3	39.2	35.5	34.5	33.3	41.9	65.5	53.3	17.4	33.5	37.7	32.0	35.7	20.4	31.7	34.2	72.2	107.0	33.3	30.7	34.3	33.9	10.9	39.7	57.4	15.6	37.1	33.7	33.7	69.6	25.4	33.6	18.4	21.3	29.0	48.5	28.7	34.2	28.4	54.5	14.5	36.2	25.9	35.7	21.3	38.0	43.2	21.9	34.9	51.0	111.8	75.9	54.1	83.8	74.4	50.5	81.1	104.6	142.4	98.6	58.0	85.0	28.8	54.8	128.1	65.0	98.4	102.2	134.3	116.6	63.8	118.8	55.7	65.8	98.7	101.0	49.3	89.8	77.9	105.2	133.4	76.4	64.7	105.8	84.9	87.1	38.6	151.6	70.1	35.9	48.4	85.2	107.4	55.8	81.6	56.4	60.7	145.1	52.1	45.8	90.1	104.4	75.9	34.4	59.5	83.8	50.1	76.5	67.5	36.9	36.8	111.2	20.3	34.6	27.0	97.1	62.3	103.5	16.8	44.2	14.0	16.9	73.1	12.8	18.1	16.1	22.1	52.4	16.5	15.4	18.3	6.5	17.4	69.1	48.5	26.4	24.9	33.0	34.1	35.5	34.5	31.7	34.2	34.3	33.9	33.7	34.2	36.2	34.9	30.1	9.6	23.0	5.5	30.4	10.7	34.9	51.0	22.2	18.1	34.7	22.7	5.1	34.3	31.0	23.9	12.5	111.5	26.5	106.8	35.2	62.7	3.2	22.2	23.3	28.2	37.2	96.8	4.5	76.1	93.8	27.5	53.5	28.1	14.5	28.6	25.0	49.7	79.7	16.8	5.6	68.9	40.7	30.5	23.6	5.7	17.1	46.1	24.9	4.7	35.9	28.5	21.6	6.6	9.3	69.7	76.8	6.4	38.5	37.1	78.0	48.0	20.3	23.3	26.3	30.6	24.7	22.9	26.4	20.7	12.6	157.6	26.0	37.1	77.1	40.9
MPHOSPH6	MPP6	ENSG00000135698	"M-phase phosphoprotein 6"	Q99547	16	82147798-82170224	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003674, HPA026948"	Approved		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Nucleoli"		"CAB003674: , HPA026948: AB_1854077"	"unprognostic (2.58e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.97e-3)"	"prognostic unfavorable (4.36e-5)"	"unprognostic (2.00e-2)"	"unprognostic (2.29e-3)"	"prognostic favorable (3.41e-5)"	"unprognostic (7.52e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (3.05e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.43e-2)"	19.8	21.3	26.7	25.5	26.8	20.0	72.5	29.6	32.8	23.6	19.1	22.7	13.8	25.8	22.4	36.2	15.9	16.5	13.9	26.7	28.3	17.8	15.9	18.7	24.7	22.1	24.7	13.4	9.0	16.2	21.3	24.4	23.1	15.3	24.9	31.6	26.0	13.0	18.0	40.1	15.9	22.8	21.7	16.7	15.7	14.1	27.5	20.7	11.6	17.5	26.2	34.7	21.0	28.4	67.8	36.2	79.0	38.9	37.7	52.7	43.5	71.1	84.7	60.6	29.3	58.5	38.4	55.2	42.0	39.2	44.7	69.2	76.2	73.6	80.8	41.3	49.9	44.5	31.2	106.5	37.5	111.9	65.9	33.6	64.7	36.2	102.8	30.5	70.6	75.7	106.2	15.3	93.4	54.8	86.5	131.2	72.4	83.4	49.5	105.5	36.6	36.5	55.3	69.8	54.1	23.3	119.6	52.5	53.6	32.4	92.2	68.6	56.0	56.5	56.3	50.2	51.3	22.4	58.0	217.9	51.0	89.9	73.2	26.1	38.3	36.9	38.2	46.5	48.5	35.6	38.7	39.9	44.9	29.2	41.1	38.8	4.9	33.1	33.8	27.2	44.3	28.3	26.7	26.8	29.6	32.8	26.7	28.3	22.1	24.7	23.1	21.7	27.5	28.4	13.2	19.2	38.3	20.5	22.9	38.7	40.3	123.9	19.4	14.5	74.3	50.0	31.5	14.3	66.2	20.2	10.4	56.9	23.0	21.7	50.9	45.2	6.5	13.9	18.5	19.3	9.0	23.1	38.5	28.1	46.1	31.4	15.8	22.0	18.3	21.9	20.0	19.0	49.6	20.2	35.6	20.7	40.7	29.1	42.7	7.5	11.1	55.9	32.0	12.2	56.0	61.1	34.0	29.7	17.1	56.4	28.4	10.1	22.3	38.6	12.2	46.5	32.7	24.5	19.7	15.4	30.1	36.9	57.5	30.6	54.0	32.8	27.4	26.3	34.0	48.1
MPP6	"p55T, PALS2, VAM-1"	ENSG00000105926	"Membrane palmitoylated protein 6"	Q9NZW5	7	24573268-24694193	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.1;testis: 25.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 74.1;Excitatory neurons: 140.1;Inhibitory neurons: 146.6;Spermatocytes: 71.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 8.3"	"Group enriched"	"Detected in many"	4	"B-cells: 8.3;dendritic cells: 2.9;T-cells: 2.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019085, HPA020456"	Enhanced					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA019085: AB_1858713, HPA020456: AB_1858714"	"unprognostic (2.79e-1)"	"unprognostic (3.49e-1)"	"unprognostic (7.84e-2)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (8.85e-5)"	"unprognostic (2.18e-3)"	"unprognostic (3.80e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.69e-1)"	"prognostic favorable (3.05e-5)"	"unprognostic (1.94e-1)"	"unprognostic (8.51e-2)"	"prognostic unfavorable (5.28e-4)"	"unprognostic (1.88e-3)"	3.8	2.7	10.0	3.4	16.0	3.1	4.1	3.9	14.2	1.7	0.0	1.6	3.5	1.9	1.1	3.0	2.6	19.1	1.6	20.0	24.1	8.6	9.4	1.9	4.9	10.2	17.2	9.4	7.7	0.4	1.5	0.8	8.5	2.6	1.4	2.5	2.8	1.2	9.2	2.3	4.5	3.1	9.5	2.0	2.5	25.0	20.8	4.3	6.0	3.2	4.9	1.9	2.9	12.8	24.4	14.2	15.2	22.7	16.6	11.8	11.1	18.1	10.0	12.3	15.5	42.6	18.1	43.1	14.4	11.1	32.1	15.0	26.7	21.6	24.4	17.1	21.5	7.1	23.6	10.4	12.9	29.2	5.0	12.3	9.1	14.7	26.1	9.0	19.6	25.3	46.7	16.5	14.3	9.7	18.9	7.7	83.9	11.5	22.6	22.9	26.5	23.1	17.2	33.1	11.8	48.4	20.8	20.4	6.3	30.3	10.3	4.2	18.8	8.0	33.7	25.0	34.8	62.4	6.8	83.8	14.3	10.9	30.1	0.2	0.1	0.1	1.9	0.8	1.2	5.7	0.9	2.2	0.2	8.3	2.3	2.0	0.2	1.0	0.0	2.9	0.8	0.4	10.0	16.0	3.9	14.2	20.0	24.1	10.2	17.2	8.5	9.5	20.8	12.8	0.8	6.4	3.2	74.1	16.9	11.1	16.2	6.3	15.9	2.5	13.0	8.5	5.6	47.1	5.0	5.5	43.8	2.9	8.3	0.8	3.9	36.2	31.9	1.3	9.5	3.0	3.0	8.0	140.1	18.0	2.1	13.2	3.6	3.3	0.0	53.3	2.9	16.0	1.4	3.3	146.6	9.2	2.0	1.8	2.9	30.1	5.3	1.8	1.8	8.4	1.6	1.8	3.1	30.7	4.2	12.6	25.0	7.2	9.7	20.5	26.3	31.0	1.0	5.9	0.0	34.7	16.0	71.7	24.1	9.4	8.8	0.5	10.9	6.8	6.3	10.2
MRE11	"ATLD, MRE11A"	ENSG00000020922	"MRE11 homolog, double strand break repair nuclease"	P49959	11	94415570-94493885	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Meiosis"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 28.9;Cytotrophoblasts: 39.2;Granulosa cells: 34.1;Syncytiotrophoblasts: 28.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002691, CAB004081"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB004081: AB_2145100, HPA002691: AB_1079409"	"unprognostic (5.59e-3)"	"unprognostic (4.35e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (7.14e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.66e-3)"	"unprognostic (6.96e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.06e-3)"	9.1	6.1	3.4	11.7	3.7	22.6	13.9	6.8	3.4	8.8	6.0	7.6	6.8	11.7	8.9	7.1	7.9	7.3	5.0	3.3	3.5	6.0	6.4	7.7	12.6	5.1	4.4	11.1	7.5	5.6	3.1	12.1	3.8	9.3	11.5	6.3	7.8	7.3	5.0	15.6	7.7	9.9	4.0	12.7	7.3	8.3	4.4	14.3	7.4	5.4	16.1	8.5	7.4	6.7	21.5	21.5	39.9	5.0	13.1	18.2	22.8	29.4	19.0	25.9	30.6	39.4	43.3	55.8	47.0	15.3	32.5	40.1	33.7	22.1	34.1	37.5	20.0	48.7	31.5	22.7	6.0	32.7	33.6	12.8	13.4	33.7	21.0	11.7	23.0	26.8	34.9	35.6	20.9	15.5	33.2	30.5	13.0	49.3	23.3	29.0	35.3	28.1	16.8	29.6	14.1	19.8	40.6	26.0	8.6	33.2	43.4	19.3	16.9	38.7	28.6	33.9	21.5	8.8	33.2	54.4	10.4	50.3	31.5	5.7	8.0	6.5	8.2	10.0	8.3	6.4	6.0	8.9	11.6	6.9	5.1	8.4	3.8	8.6	8.4	8.7	8.8	6.7	3.4	3.7	6.8	3.4	3.3	3.5	5.1	4.4	3.8	4.0	4.4	6.7	23.6	28.9	14.3	0.0	6.3	0.0	0.0	0.0	0.0	0.0	12.5	13.7	0.0	0.0	9.3	9.2	0.0	39.2	20.8	0.0	3.9	11.4	0.0	19.5	22.2	8.4	0.0	0.0	0.0	8.1	15.8	8.9	0.0	16.3	17.7	34.1	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	8.8	0.0	0.0	6.1	0.0	0.0	6.5	11.7	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	28.0	7.2	16.8	0.0	0.0
MRM2	"FJH1, FTSJ2, RRMJ2"	ENSG00000122687	"Mitochondrial rRNA methyltransferase 2"	Q9UI43	7	2234195-2242205	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, Transferase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 59.7;Distal tubular cells: 31.3;Extravillous trophoblasts: 37.0;Hofbauer cells: 35.8;Syncytiotrophoblasts: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019826, HPA049622"	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"			"HPA019826: AB_2670282, HPA049622: AB_2680834"	"unprognostic (8.05e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.50e-3)"	"prognostic unfavorable (5.21e-6)"	"unprognostic (8.49e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.27e-1)"	"unprognostic (9.99e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.48e-1)"	9.3	12.8	12.7	12.1	13.3	6.1	13.0	13.5	15.7	9.2	14.2	10.7	10.8	8.2	11.5	11.5	10.8	6.7	14.1	12.5	13.2	12.6	17.3	11.0	17.8	13.9	13.2	11.7	8.0	13.3	6.9	13.7	13.5	10.0	10.8	8.0	10.1	12.0	21.7	11.2	9.1	9.1	14.0	12.8	9.7	10.7	13.4	12.2	8.5	12.6	18.3	10.4	7.9	14.0	62.2	39.9	34.2	25.2	21.3	22.3	24.8	35.3	35.5	45.3	43.9	56.7	29.8	57.5	15.8	27.4	37.5	48.0	49.3	40.0	49.0	22.2	37.9	36.6	37.0	35.0	25.8	54.3	34.5	19.1	34.2	30.4	35.4	19.6	20.2	35.3	59.3	33.0	35.6	73.4	17.1	68.7	94.9	38.6	38.0	34.1	42.5	45.1	31.9	46.4	31.2	44.3	28.9	81.1	34.1	44.8	70.0	81.6	15.1	27.4	64.2	53.8	56.0	29.1	43.4	59.0	31.7	55.9	85.2	17.2	49.1	32.9	28.0	57.1	33.9	52.1	29.9	32.1	71.8	48.8	36.9	32.1	3.7	47.8	48.9	37.8	36.5	40.4	12.7	13.3	13.5	15.7	12.5	13.2	13.9	13.2	13.5	14.0	13.4	14.0	11.3	22.4	19.8	0.0	5.1	0.0	0.0	0.0	0.0	0.0	15.0	19.6	0.0	0.0	8.1	11.0	0.0	59.7	6.6	0.0	31.3	24.1	0.0	7.7	14.3	6.0	0.0	0.0	0.0	19.9	37.0	7.2	0.0	6.7	11.4	15.9	0.0	0.0	35.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	11.9	0.0	0.0	0.0	0.0	24.5	0.0	0.0	0.9	0.0	0.0	20.4	9.5	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	37.1	3.6	28.8	0.0	0.0
MRM3	"FLJ10581, HC90, RMTL1, RNMTL1"	ENSG00000171861	"Mitochondrial rRNA methyltransferase 3"	Q9HC36	17	782353-792509	"Metabolic proteins, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 27.1;Distal tubular cells: 19.6;Ductal cells: 18.9;Exocrine glandular cells: 18.4;Extravillous trophoblasts: 24.6;Proximal tubular cells: 20.0;Syncytiotrophoblasts: 19.6;Theca cells: 28.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022534, HPA023031, HPA023292"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA022534: AB_1856386, HPA023031: AB_1856387, HPA023292: AB_1856388"	"unprognostic (1.66e-1)"	"unprognostic (5.83e-3)"	"unprognostic (6.72e-2)"	"prognostic favorable (2.81e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (8.20e-2)"	"unprognostic (3.72e-3)"	"unprognostic (8.47e-2)"	"prognostic favorable (3.00e-4)"	"unprognostic (3.82e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.42e-2)"	9.3	12.9	7.9	6.8	8.4	17.6	8.7	9.9	9.2	6.7	9.7	9.7	7.8	7.6	5.2	11.6	8.0	4.8	17.3	8.2	7.9	9.7	20.5	6.0	10.4	8.2	8.7	8.7	19.6	9.1	6.2	6.9	8.6	7.5	7.5	4.3	9.5	6.0	29.4	14.7	8.2	6.6	7.7	9.9	13.0	18.6	8.6	8.3	7.0	18.7	9.3	8.6	7.2	8.3	26.4	53.9	11.3	19.8	16.2	13.8	22.5	13.6	12.8	27.3	22.8	31.8	12.0	47.3	14.1	10.6	13.1	21.7	33.0	12.0	24.8	16.2	55.9	18.3	30.6	27.9	16.7	15.8	16.0	16.7	16.2	29.0	23.9	13.6	20.7	28.3	31.3	20.1	14.5	28.5	27.5	20.8	16.9	19.3	28.2	33.1	7.9	25.3	18.2	14.2	15.1	17.6	19.8	16.6	26.5	9.0	20.6	14.2	16.6	14.6	11.2	21.0	38.3	8.0	11.8	18.9	18.3	22.1	20.0	12.5	24.6	14.7	25.0	20.6	27.0	38.2	27.1	30.8	25.8	38.4	32.8	28.4	1.8	32.7	21.1	20.8	31.9	26.8	7.9	8.4	9.9	9.2	8.2	7.9	8.2	8.7	8.6	7.7	8.6	8.3	11.3	6.4	1.1	0.0	4.2	0.0	0.0	0.0	0.0	0.0	9.8	10.4	0.0	0.0	1.3	5.5	0.0	27.1	7.6	0.0	19.6	18.9	0.0	8.3	8.0	5.1	0.0	0.0	0.0	18.4	24.6	4.1	0.0	8.8	3.8	15.6	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.5	0.0	0.0	20.0	0.7	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	19.6	4.4	28.9	0.0	0.0
MRPL1	BM022	ENSG00000169288	"Mitochondrial ribosomal protein L1"	Q9BYD6	4	77862830-77952785	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA043656	Supported		Approved	Mitochondria		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA043656: AB_2678601"	"unprognostic (9.03e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.88e-1)"	"unprognostic (4.52e-2)"	"unprognostic (5.29e-3)"	"unprognostic (4.69e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.14e-3)"	"unprognostic (8.79e-2)"	"unprognostic (2.22e-2)"	"prognostic favorable (3.35e-5)"	"unprognostic (7.63e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.13e-2)"	"unprognostic (9.17e-3)"	19.4	17.7	17.1	17.4	17.7	26.9	24.4	16.8	20.9	16.5	15.7	28.3	19.5	18.6	21.0	20.5	17.0	11.8	41.7	17.9	18.2	38.1	33.8	13.1	23.6	17.3	17.1	19.0	14.1	21.4	8.1	21.4	17.9	16.0	29.4	14.5	19.3	15.0	67.3	14.6	18.6	21.4	17.1	15.0	17.8	8.8	17.8	19.3	17.7	67.6	24.2	19.8	9.2	17.7	40.5	26.2	47.3	40.7	36.6	47.4	41.2	44.6	28.6	57.4	39.3	55.0	71.6	71.4	53.9	37.1	35.8	32.8	71.1	82.5	75.6	47.6	37.6	61.1	27.6	60.4	47.5	126.2	28.3	37.7	76.7	51.2	53.0	37.8	70.4	50.1	90.3	24.1	73.6	46.0	76.0	84.9	52.0	92.0	34.3	90.7	60.6	41.1	113.3	43.2	52.1	25.9	36.1	88.7	84.5	38.0	43.7	61.0	41.9	37.5	54.3	37.7	65.1	21.1	28.1	74.6	31.9	71.8	49.3	9.0	11.5	7.0	20.6	19.0	20.6	27.8	22.2	23.1	22.1	25.5	26.8	29.5	1.7	23.2	16.9	18.0	25.8	15.4	17.1	17.7	16.8	20.9	17.9	18.2	17.3	17.1	17.9	17.1	17.8	17.7	40.1	25.6	35.7	22.5	45.7	12.7	17.1	68.6	13.6	24.6	31.6	37.2	122.1	57.2	33.5	33.1	18.8	72.7	75.5	22.2	135.0	46.0	15.5	33.9	40.9	34.9	47.9	34.9	45.9	36.7	51.9	27.5	18.8	38.5	42.4	38.7	40.7	134.3	47.7	25.2	39.7	60.5	61.1	25.1	12.7	9.3	31.1	23.5	16.0	35.6	34.1	26.7	64.9	45.2	47.7	28.3	24.9	33.4	38.6	14.7	36.0	144.8	20.6	42.4	39.5	31.4	45.9	21.1	48.0	23.1	12.8	34.9	65.8	61.7	70.9	15.5
MRPL15	"HSPC145, L15mt, MRP-L15, MRP-L7, RPML7"	ENSG00000137547	"Mitochondrial ribosomal protein L15"	Q9P015	8	54135241-54148514	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 291.2;tongue: 279.4"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 248.4;Syncytiotrophoblasts: 198.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044425	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA044425: AB_10969629"	"unprognostic (5.67e-3)"	"unprognostic (8.89e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (9.30e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.06e-2)"	42.5	34.4	33.2	36.4	34.1	25.1	49.3	37.0	50.5	32.6	38.7	70.8	58.6	28.6	27.7	48.8	35.6	29.0	169.6	33.5	38.3	83.8	89.2	26.5	42.9	36.6	35.7	30.5	29.2	83.4	18.6	49.6	35.8	27.5	67.5	63.1	41.4	29.0	291.2	38.5	50.6	45.4	33.8	27.3	38.4	14.7	38.3	38.1	35.2	279.4	57.4	64.1	26.3	33.0	164.1	118.9	98.0	122.6	76.1	110.5	125.8	128.4	93.0	173.3	150.2	134.1	197.1	253.9	170.3	112.1	164.4	161.5	206.2	165.5	190.4	109.9	109.5	165.8	62.4	168.5	114.5	92.0	168.9	103.3	167.4	159.5	165.6	74.7	366.7	89.4	208.2	80.8	251.3	156.1	262.4	177.3	206.2	313.9	60.8	169.5	63.6	136.3	210.8	147.1	56.5	83.7	66.8	204.0	167.0	97.4	195.2	96.6	129.6	95.8	111.7	139.5	151.5	94.6	128.4	207.1	88.8	137.8	153.4	40.1	93.8	27.3	50.7	123.4	63.8	100.6	64.8	68.4	141.1	76.6	59.0	56.9	3.3	54.0	115.7	88.9	79.8	85.8	33.2	34.1	37.0	50.5	33.5	38.3	36.6	35.7	35.8	33.8	38.3	33.0	28.0	25.6	14.4	9.4	33.1	23.6	40.7	114.5	19.4	28.2	25.0	37.2	120.9	55.8	50.4	36.8	29.2	160.3	17.6	38.7	248.4	103.2	18.7	34.0	34.4	34.8	18.0	31.7	10.9	70.9	155.2	32.8	23.9	39.2	25.4	37.9	26.4	59.2	106.1	25.2	12.4	52.5	75.3	44.5	22.9	4.3	24.8	37.9	33.8	7.5	56.5	37.4	20.6	11.1	6.0	97.5	34.3	22.6	35.3	33.9	66.8	127.0	32.1	58.8	13.1	32.1	70.1	14.8	34.3	37.3	34.4	198.9	19.7	91.3	78.3	41.8
MRPL20	FLJ10024	ENSG00000242485	"Mitochondrial ribosomal protein L20"	Q9BYC9	1	1401909-1407293	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047074	Supported		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA047074: AB_10964064"	"unprognostic (4.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.64e-1)"	111.5	120.2	144.2	81.8	156.1	72.1	110.0	144.3	178.5	86.5	148.7	126.7	83.6	89.7	135.0	117.2	90.2	68.5	189.8	146.7	154.3	140.9	152.7	86.7	100.4	152.4	154.1	84.2	136.6	100.6	117.3	68.6	147.2	110.9	86.9	59.6	131.9	90.3	277.2	97.7	91.3	75.4	158.1	100.2	116.8	60.5	168.6	71.8	102.3	160.9	102.5	107.6	87.6	158.1	216.1	204.2	149.7	152.8	113.4	122.7	110.6	188.3	143.8	240.7	171.1	244.9	255.4	228.5	256.8	162.9	111.4	133.8	247.6	203.8	185.9	199.0	350.3	247.0	369.0	244.8	156.5	367.3	152.7	143.9	76.8	184.8	196.4	138.4	181.1	213.8	254.6	131.8	204.8	216.3	285.2	279.2	155.8	249.6	409.1	186.0	138.3	291.3	189.9	142.8	265.4	218.5	179.2	369.9	288.7	124.7	158.8	268.0	155.2	144.9	170.0	219.6	236.2	200.6	313.5	450.5	224.2	296.4	103.7	124.6	191.2	146.5	164.8	190.1	183.7	189.3	181.9	163.3	198.2	177.2	204.1	199.0	89.2	163.1	150.8	289.2	175.0	219.6	144.2	156.1	144.3	178.5	146.7	154.3	152.4	154.1	147.2	158.1	168.6	158.1	97.5	67.3	115.5	19.9	120.3	130.3	134.8	206.8	99.0	77.8	153.0	171.4	255.2	145.8	166.0	161.8	35.5	234.5	129.2	138.6	530.2	232.6	39.3	153.1	121.8	118.4	138.2	152.7	13.7	325.9	265.0	113.6	87.7	126.3	106.2	92.7	131.0	384.0	220.6	50.5	13.8	185.5	177.0	139.7	111.0	30.7	107.8	117.9	138.7	11.2	200.8	279.3	183.4	9.5	20.8	261.8	167.4	110.9	163.3	254.8	194.1	543.9	146.9	107.7	65.7	121.8	135.7	131.7	202.7	179.9	157.7	226.2	109.2	121.9	216.1	170.2
MRPL22	"HSPC158, MRP-L25, RPML25"	ENSG00000082515	"Mitochondrial ribosomal protein L22"	Q9NWU5	5	154941073-154969411	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047063	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA047063: AB_2679919"	"unprognostic (9.17e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.56e-2)"	"unprognostic (5.42e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.01e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.54e-1)"	"unprognostic (2.69e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.29e-2)"	23.9	38.4	18.4	20.3	18.4	40.9	26.3	20.0	27.9	20.7	17.7	28.4	26.1	20.5	26.0	30.8	18.9	15.4	46.3	18.5	19.0	37.5	49.3	19.6	28.5	19.5	18.8	18.1	30.3	31.2	23.8	24.2	19.7	19.4	28.0	17.0	24.8	19.3	38.5	23.6	22.9	20.0	18.7	26.2	27.1	29.4	18.8	28.2	23.3	34.5	27.1	24.6	21.6	19.6	68.5	65.8	57.1	79.7	43.7	55.0	67.9	47.6	55.9	93.9	118.3	191.5	82.8	93.7	82.9	40.1	100.0	61.2	83.2	90.0	99.8	32.2	94.3	36.1	64.1	110.1	57.1	81.5	47.2	36.5	59.4	63.4	76.9	41.8	161.8	84.6	55.2	81.9	58.8	100.8	74.1	78.3	43.5	74.0	50.6	67.4	49.6	97.9	93.1	50.9	65.4	24.3	62.5	89.1	104.9	41.0	130.2	71.3	47.5	57.7	57.5	51.1	89.3	43.4	57.5	104.4	57.9	99.7	55.4	35.9	49.0	44.1	47.5	59.7	48.7	72.3	51.5	51.3	66.6	61.5	47.7	54.6	19.8	64.0	60.4	51.9	75.1	62.4	18.4	18.4	20.0	27.9	18.5	19.0	19.5	18.8	19.7	18.7	18.8	19.6	55.2	25.6	28.1	11.1	52.2	63.9	54.4	191.6	43.9	28.1	45.9	67.9	213.2	64.3	95.6	60.7	27.1	144.6	37.9	46.6	223.0	114.9	56.2	49.6	44.4	69.2	49.6	64.0	13.0	127.1	132.6	64.7	27.0	41.3	45.0	56.2	51.4	85.2	99.3	32.0	11.8	65.6	79.3	33.2	57.1	29.3	66.2	35.7	51.6	2.8	61.3	35.9	56.7	11.1	20.1	113.9	83.4	75.2	71.1	47.2	68.1	203.7	89.0	27.1	32.9	48.5	86.7	167.7	67.0	50.3	65.8	78.5	48.4	122.2	78.5	54.6
MRPL3	"MRL3, RPML3"	ENSG00000114686	"Mitochondrial ribosomal protein L3"	P09001	3	131462212-131502983	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043665, HPA060132"	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA043665: AB_2678606, HPA060132: AB_2684209"	"unprognostic (1.75e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.61e-3)"	"unprognostic (7.83e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (4.33e-7)"	"unprognostic (1.54e-1)"	"unprognostic (8.23e-2)"	"prognostic favorable (1.36e-4)"	"prognostic unfavorable (3.51e-6)"	"unprognostic (2.05e-3)"	"unprognostic (6.40e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.29e-1)"	46.2	44.3	22.9	45.1	24.2	32.0	65.4	23.0	28.7	47.0	29.4	60.8	48.7	40.8	71.6	51.0	59.3	34.9	48.6	24.2	28.0	75.2	65.6	29.9	51.4	22.9	23.8	47.9	61.1	80.9	38.2	39.6	24.9	45.7	65.9	33.8	57.5	48.1	78.6	34.5	41.3	50.4	25.6	29.8	46.7	51.1	25.6	53.1	64.2	78.0	60.9	65.8	35.0	26.9	263.1	108.9	119.8	135.0	110.5	142.4	216.4	139.7	122.6	177.0	156.7	241.4	148.5	212.3	184.3	140.8	138.9	168.5	205.9	200.8	269.6	138.4	160.1	197.2	112.3	204.8	129.2	399.8	121.7	112.7	163.6	136.4	241.0	96.1	116.4	159.7	183.3	113.0	148.2	200.1	201.3	199.6	255.2	278.6	193.7	79.4	153.8	326.3	176.3	182.1	194.1	130.5	125.4	141.4	206.3	100.0	165.5	211.6	105.8	127.2	132.5	181.6	196.8	107.0	116.0	380.4	135.6	189.6	178.6	12.8	79.0	19.7	58.7	105.9	91.2	71.9	71.9	70.2	147.5	76.3	82.7	75.1	4.5	98.3	80.5	51.5	77.1	124.6	22.9	24.2	23.0	28.7	24.2	28.0	22.9	23.8	24.9	25.6	25.6	26.9	32.5	25.6	26.9	22.5	54.4	45.9	89.0	106.8	49.5	28.3	54.2	52.8	35.7	37.1	63.8	31.3	8.4	100.2	37.6	26.6	152.6	115.7	86.4	39.0	58.6	31.6	30.1	57.2	38.3	101.9	135.4	53.3	42.8	65.2	28.6	55.1	31.1	50.7	65.9	30.3	30.3	76.2	67.1	54.1	37.3	24.2	55.6	51.5	42.7	19.7	55.5	35.6	49.4	33.7	30.3	92.4	31.9	51.6	72.9	97.8	47.4	167.2	38.9	21.9	32.9	59.8	54.2	149.3	85.4	67.6	47.5	63.9	42.5	95.0	81.3	84.0
MRPL30	"MRP-L28, RPML28"	ENSG00000185414	"Mitochondrial ribosomal protein L30"	Q8TCC3	2	99181152-99199561	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA047255	Approved					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"			"HPA047255: AB_2680002"	"unprognostic (1.94e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.77e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.60e-3)"	"unprognostic (2.53e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.50e-3)"	"unprognostic (2.84e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.72e-1)"	9.9	12.5	4.0	5.0	4.1	3.4	9.3	4.8	4.5	10.0	2.8	9.8	7.1	9.8	4.1	14.6	8.0	4.0	16.7	4.3	4.1	12.4	13.6	6.0	5.2	3.2	3.3	9.6	11.3	7.4	7.2	5.1	3.4	8.6	6.8	6.0	9.9	5.6	29.6	10.6	8.1	5.3	3.2	7.1	10.1	4.0	4.1	7.4	7.0	21.1	7.0	9.3	10.1	4.3	30.7	8.5	14.4	10.6	9.6	15.7	14.3	12.7	11.1	15.3	12.3	23.3	7.4	22.8	7.7	11.3	9.2	15.1	25.9	30.8	24.9	14.8	21.3	23.4	10.9	25.3	13.0	19.8	8.2	13.6	10.6	12.3	23.1	11.8	26.3	12.3	36.3	14.2	14.8	10.8	29.0	16.6	15.6	10.2	24.5	28.1	28.4	19.9	17.7	17.5	20.2	20.3	9.8	21.4	29.3	14.5	17.1	16.4	13.0	20.7	11.2	10.8	15.6	17.2	22.7	33.7	14.2	17.3	22.1	3.1	4.7	3.2	3.5	4.9	3.6	4.6	2.7	5.1	4.0	4.2	3.6	3.4	1.5	3.8	3.1	3.8	4.3	3.3	4.0	4.1	4.8	4.5	4.3	4.1	3.2	3.3	3.4	3.2	4.1	4.3	15.9	9.6	7.5	11.8	16.2	0.6	12.7	1.0	20.5	9.4	14.0	15.7	27.3	15.7	6.7	11.0	6.2	22.5	15.1	15.4	35.2	23.3	3.0	16.9	28.1	11.5	13.8	16.6	18.9	24.7	25.3	13.6	13.7	20.2	6.3	15.1	14.3	25.8	19.9	16.8	17.3	19.5	2.0	19.7	0.5	2.4	22.4	14.9	1.8	11.2	24.2	9.8	21.6	9.0	17.2	29.7	11.9	22.6	19.1	9.0	20.6	34.6	5.3	9.3	0.0	10.8	12.3	7.5	13.8	22.9	0.9	13.4	14.4	17.9	19.8	10.3
MRPL32	"bMRP-59b, HSPC283, L32mt, MRP-L32"	ENSG00000106591	"Mitochondrial ribosomal protein L32"	Q9BYC8	7	42932376-42948958	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA048965	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA048965: AB_2680576"	"unprognostic (1.15e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.90e-3)"	"unprognostic (2.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.64e-2)"	"unprognostic (8.22e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.05e-3)"	"unprognostic (4.09e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.21e-2)"	44.7	71.4	35.8	32.3	37.1	28.4	41.8	36.5	42.8	29.4	46.1	47.4	46.7	33.4	57.2	38.7	38.5	42.1	74.1	36.8	39.7	82.5	120.3	28.7	39.2	36.9	36.7	45.4	52.1	53.0	26.3	34.6	36.8	57.3	45.7	15.9	46.2	34.7	53.6	26.9	39.5	34.4	36.4	29.8	43.7	25.5	36.8	36.9	42.2	66.3	43.3	55.2	27.5	37.8	67.9	94.3	63.3	99.7	97.0	79.9	72.8	101.9	74.2	84.3	95.9	116.3	71.7	145.3	95.8	59.4	141.3	150.3	98.6	112.0	99.1	94.2	116.6	70.7	75.4	128.5	142.2	121.4	66.8	91.8	84.0	62.6	109.2	72.7	106.0	97.6	132.5	73.4	108.1	104.4	83.2	207.1	160.9	160.2	139.3	81.3	73.6	150.4	188.2	138.7	77.4	69.1	82.4	224.2	89.0	92.2	126.3	90.4	93.4	72.5	117.3	77.3	143.6	120.9	215.1	160.4	55.0	156.6	157.9	181.9	89.7	147.1	77.8	101.6	104.3	154.6	114.1	102.3	95.9	122.9	120.3	113.9	18.3	102.9	91.0	94.3	160.6	117.9	35.8	37.1	36.5	42.8	36.8	39.7	36.9	36.7	36.8	36.4	36.8	37.8	53.3	54.5	39.8	6.2	47.8	131.5	88.5	191.2	55.2	20.5	68.7	87.4	93.3	70.1	92.7	58.8	8.4	110.9	47.6	46.1	180.0	111.5	8.3	50.8	70.5	68.7	46.8	44.4	16.5	101.0	98.4	61.5	38.7	57.4	64.0	43.5	57.8	104.1	61.8	16.8	14.1	64.2	101.7	40.6	50.2	8.4	52.8	34.1	64.0	5.6	57.7	16.3	35.0	11.6	17.1	97.6	55.4	50.8	43.8	103.1	77.4	211.7	70.1	23.2	52.6	73.1	113.5	34.3	72.5	65.2	109.4	89.6	45.4	117.4	104.6	105.1
MRPL35		ENSG00000132313	"Mitochondrial ribosomal protein L35"	Q9NZE8	2	86199355-86213790	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 135.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043482	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA043482: AB_10959449"	"unprognostic (3.68e-2)"	"unprognostic (6.24e-2)"	"unprognostic (9.14e-3)"	"unprognostic (1.68e-2)"	"unprognostic (9.38e-3)"	"unprognostic (7.72e-2)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (9.81e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.66e-1)"	"prognostic favorable (9.96e-6)"	"unprognostic (1.94e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.52e-3)"	25.0	29.7	19.6	24.7	22.0	20.5	25.3	21.2	26.1	18.9	18.8	55.5	57.9	17.8	13.6	31.2	21.9	19.9	83.8	20.1	21.9	47.5	46.1	15.5	35.6	19.7	19.6	17.3	19.7	45.9	12.0	20.9	20.9	19.1	58.7	23.2	24.3	25.1	69.4	14.3	43.3	30.1	20.5	21.6	32.2	16.2	21.7	29.1	19.9	113.5	40.0	32.2	18.0	21.2	83.4	35.8	53.6	55.0	55.1	51.6	77.2	71.5	51.5	88.0	64.9	31.4	69.1	154.1	79.0	61.6	70.9	71.2	109.3	64.2	98.1	89.0	51.0	88.5	25.9	80.5	44.7	143.0	68.0	38.6	75.0	95.4	46.4	42.3	81.4	82.6	111.4	66.1	82.0	50.2	82.0	97.3	56.2	107.0	46.4	71.4	143.1	129.8	90.6	60.2	45.2	43.7	66.1	106.8	116.8	37.5	43.7	57.0	62.2	70.4	85.9	89.8	112.6	49.9	157.4	170.0	61.7	150.1	65.6	30.4	36.0	19.0	21.4	48.4	24.0	45.2	31.9	28.0	41.9	41.4	37.4	29.7	5.1	23.5	50.8	42.2	40.4	32.4	19.6	22.0	21.2	26.1	20.1	21.9	19.7	19.6	20.9	20.5	21.7	21.2	17.3	22.4	15.0	7.2	17.5	7.1	20.3	67.4	11.4	21.9	17.0	20.1	135.9	18.6	42.2	18.4	31.3	49.2	15.0	46.7	97.8	42.0	3.7	22.0	28.3	19.2	26.5	35.1	11.6	43.0	49.7	19.8	23.4	22.1	21.0	21.9	15.7	52.9	65.3	23.5	12.7	31.4	48.8	23.8	6.1	5.0	12.8	23.7	10.6	12.2	32.1	21.5	19.6	5.0	11.5	41.8	29.5	17.7	29.5	17.3	52.6	82.8	24.9	25.4	26.3	17.2	47.2	14.6	26.3	29.0	8.5	27.0	14.6	38.1	56.3	25.2
MRPL37	"MRP-L2, RPML2"	ENSG00000116221	"Mitochondrial ribosomal protein L37"	Q9BZE1	1	54184041-54225464	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025767, HPA025826, HPA025951"	Supported		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Mitochondria		"HPA025767: AB_1854105, HPA025826: AB_1854106, HPA025951: AB_1854107"	"unprognostic (2.00e-1)"	"unprognostic (6.81e-2)"	"prognostic favorable (6.99e-4)"	"unprognostic (1.71e-3)"	"unprognostic (8.24e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (6.45e-5)"	"unprognostic (2.49e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.07e-1)"	"prognostic favorable (9.25e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.62e-1)"	"unprognostic (7.67e-3)"	44.7	73.8	28.6	32.4	30.6	67.4	41.5	35.5	37.2	36.1	42.7	50.7	51.5	34.7	26.9	65.8	38.2	25.5	86.3	31.5	29.8	55.4	108.1	30.2	41.1	32.5	30.3	41.0	67.7	47.2	20.8	31.5	33.2	33.8	53.5	21.8	41.3	29.8	167.9	56.2	41.0	41.6	27.4	34.6	49.2	31.4	30.8	41.2	28.5	154.2	51.3	37.9	40.5	28.7	168.3	94.9	84.6	114.5	83.4	110.9	150.5	111.2	103.5	194.0	167.7	190.7	75.4	226.1	98.2	125.3	184.8	131.6	168.2	164.6	150.6	111.1	211.7	194.8	186.9	194.8	142.9	233.3	87.1	123.2	138.7	201.8	156.5	108.7	176.1	174.2	219.2	66.1	140.2	123.3	161.7	226.4	173.5	134.4	208.2	175.3	171.7	191.6	110.8	123.4	166.3	77.6	153.8	261.4	214.0	110.6	113.2	260.7	88.5	123.6	112.2	157.7	227.1	83.1	126.0	175.5	161.1	234.2	119.9	53.0	103.4	45.4	67.5	91.8	79.1	120.4	81.9	76.1	120.4	105.1	82.0	72.8	5.6	94.0	88.7	101.5	116.4	126.6	28.6	30.6	35.5	37.2	31.5	29.8	32.5	30.3	33.2	27.4	30.8	28.7	24.0	22.4	18.7	3.9	33.4	34.7	43.8	84.6	45.5	8.9	46.3	57.0	71.3	55.8	43.1	18.4	2.1	118.0	15.5	36.6	80.3	81.2	31.0	25.7	23.2	30.3	33.1	103.3	7.5	96.3	145.8	37.3	41.8	33.1	14.5	40.6	37.5	156.5	87.0	6.7	8.4	53.0	52.9	43.6	25.6	57.5	26.1	30.9	23.2	4.7	53.1	9.2	24.7	4.5	5.4	69.0	41.1	28.6	72.2	54.2	73.8	105.2	29.4	8.7	13.1	28.8	34.3	23.6	50.4	79.6	37.4	73.9	24.5	57.2	86.0	55.2
MRPL39	"C21orf92, FLJ20451, L39mt, MGC104174, MGC3400, MRP-L5, MSTP003, PRED22, PRED66, RPML5"	ENSG00000154719	"Mitochondrial ribosomal protein L39"	Q9NYK5	21	25585656-25607517	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 241.5;Spermatocytes: 103.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018331	Approved		Supported	Mitochondria		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA018331: AB_1854111"	"unprognostic (3.81e-3)"	"unprognostic (5.34e-2)"	"unprognostic (8.55e-3)"	"unprognostic (4.61e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.32e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (5.84e-4)"	"unprognostic (7.48e-2)"	"unprognostic (7.32e-3)"	"unprognostic (9.81e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.45e-2)"	"unprognostic (6.89e-2)"	23.1	35.6	18.2	19.7	19.6	22.7	26.7	22.1	28.7	16.7	18.4	29.2	25.5	18.0	41.7	26.5	20.4	13.5	51.4	18.3	19.2	40.4	55.3	15.3	34.2	18.7	18.1	17.6	25.2	71.0	13.4	26.2	19.8	20.0	32.1	21.5	21.8	17.8	58.6	20.3	23.1	22.0	19.0	17.6	22.9	54.7	18.2	24.9	20.1	56.7	37.3	22.3	18.8	21.6	89.6	43.0	60.1	38.1	29.7	42.9	92.3	56.1	50.0	77.0	64.7	85.2	49.2	97.9	30.9	35.4	69.8	25.5	128.5	76.4	85.9	49.1	66.3	100.1	43.0	91.4	34.6	102.4	31.7	34.8	66.7	76.3	62.2	42.7	58.2	99.6	112.3	78.4	77.1	56.0	67.5	55.5	95.6	88.9	65.4	77.8	97.0	103.1	80.6	35.7	37.9	36.3	51.6	94.5	76.3	42.3	68.3	57.6	36.4	40.8	61.0	43.9	69.6	54.9	74.6	121.9	61.2	109.1	62.5	41.9	16.9	20.7	37.0	30.3	46.9	62.0	45.0	42.3	31.0	49.1	43.9	39.3	2.8	36.7	21.6	43.2	56.4	18.6	18.2	19.6	22.1	28.7	18.3	19.2	18.7	18.1	19.8	19.0	18.2	21.6	18.3	25.6	10.5	9.8	17.6	20.0	20.3	71.0	7.4	20.4	14.0	23.5	78.2	10.0	36.2	25.8	10.4	46.8	14.1	8.7	31.3	36.0	241.5	20.9	12.7	22.2	7.8	22.3	11.4	33.8	41.7	19.4	7.1	11.8	15.2	11.3	18.9	19.8	30.8	10.1	11.7	11.4	30.5	10.6	15.7	37.0	14.9	11.3	19.6	9.4	17.1	19.0	11.3	9.5	13.2	26.5	9.3	23.3	13.6	13.2	20.4	46.8	41.8	15.0	46.0	18.1	25.4	103.0	29.4	10.7	16.9	36.9	14.9	25.7	20.1	17.3
MRPL42	"HSPC204, MRP-L31, MRPL31, MRPS32, PTD007, RPML31"	ENSG00000198015	"Mitochondrial ribosomal protein L42"	Q9Y6G3	12	93467514-93516214	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 397.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039398	Approved		Supported	"Plasma membrane,Mitochondria"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane, Mitochondria"		"HPA039398: AB_10673529"	"unprognostic (9.32e-2)"	"unprognostic (4.18e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (7.49e-4)"	"unprognostic (6.13e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.45e-2)"	"unprognostic (4.92e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (8.12e-4)"	15.7	26.7	6.8	8.8	8.3	13.9	14.9	11.6	9.0	15.7	9.9	16.9	13.5	14.5	10.9	19.3	14.2	8.1	17.2	7.9	9.8	21.4	20.4	12.8	12.2	7.5	8.3	14.3	13.8	23.4	15.4	11.3	8.6	15.9	16.8	6.1	14.0	10.5	12.0	14.9	13.5	13.8	6.3	10.8	15.9	14.4	7.7	19.2	14.0	14.4	14.9	16.6	16.6	11.7	30.5	42.3	53.5	33.8	25.5	36.8	36.5	43.0	33.0	45.4	32.9	51.8	11.6	49.9	16.3	32.1	29.8	22.4	61.5	48.0	74.3	50.6	40.5	45.0	26.8	61.9	41.9	74.0	21.3	31.0	44.4	48.4	60.5	42.2	46.5	53.0	61.3	19.0	54.0	36.1	67.2	49.3	65.1	52.8	55.9	48.1	25.5	40.4	49.2	77.0	39.8	32.0	36.0	39.3	41.3	42.0	35.5	33.4	29.1	26.5	22.1	21.3	49.6	31.2	49.0	46.1	12.2	45.7	41.5	21.0	14.4	20.4	14.7	21.2	18.9	25.9	19.4	16.6	16.4	23.7	21.3	21.8	8.3	27.0	20.4	11.2	28.1	16.3	6.8	8.3	11.6	9.0	7.9	9.8	7.5	8.3	8.6	6.3	7.7	11.7	55.0	28.9	35.5	13.4	59.9	67.3	97.6	131.6	50.1	34.9	48.7	38.1	82.6	42.9	82.5	46.0	60.5	96.7	41.4	38.2	213.2	86.2	397.6	87.5	61.3	48.7	93.2	66.7	16.2	77.4	133.1	54.5	48.9	48.6	58.4	50.7	32.9	48.4	54.0	47.1	22.1	66.8	107.8	34.1	47.9	165.0	51.6	32.6	60.5	6.5	35.2	22.1	54.6	20.1	20.3	89.8	49.9	56.1	59.8	109.8	44.9	146.5	96.7	41.6	52.6	42.3	59.8	230.5	66.6	59.7	75.0	95.5	51.7	100.1	82.1	115.4
MRPL47	"CGI-204, NCM1"	ENSG00000136522	"Mitochondrial ribosomal protein L47"	Q9HD33	3	179588285-179604649	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 399.7;Spermatocytes: 301.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037553, HPA047779"	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA037553: AB_10671375, HPA047779: AB_2680154"	"unprognostic (6.37e-2)"	"prognostic favorable (6.44e-4)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (3.15e-4)"	"unprognostic (1.53e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.84e-2)"	27.2	34.8	30.6	24.0	31.7	48.8	27.2	34.2	41.1	19.4	34.2	32.1	23.7	23.0	22.8	31.8	18.9	18.5	54.9	29.4	34.7	44.4	35.5	20.1	30.0	32.0	31.8	16.6	17.4	33.9	24.0	22.2	32.6	20.6	31.8	26.6	21.1	18.9	52.5	21.5	22.6	24.7	33.3	24.3	26.2	53.1	32.6	33.3	21.0	56.9	30.4	32.0	21.7	34.2	128.6	48.6	83.0	76.7	51.5	53.5	95.2	73.2	65.1	112.3	93.2	198.6	51.8	104.7	140.6	62.5	137.2	94.5	103.5	76.9	120.5	121.0	90.9	99.8	46.1	112.5	99.8	182.2	54.2	49.6	65.7	83.4	84.7	53.1	77.2	95.9	59.5	81.4	88.1	98.9	98.4	168.4	144.3	115.4	114.6	102.7	81.1	175.3	120.4	79.6	71.8	83.5	80.7	128.6	151.2	61.9	198.6	136.6	61.6	60.7	87.4	77.1	204.5	102.1	182.4	229.3	70.7	147.4	75.8	38.2	32.4	44.2	31.7	43.8	32.2	35.1	35.1	34.7	48.4	31.8	30.4	31.7	8.5	41.5	54.4	41.9	48.9	35.8	30.6	31.7	34.2	41.1	29.4	34.7	32.0	31.8	32.6	33.3	32.6	34.2	45.3	22.4	21.7	5.5	51.4	74.9	82.0	179.7	38.7	20.2	36.4	33.4	89.7	54.3	78.6	57.0	10.4	100.0	61.2	46.3	258.2	112.3	399.7	72.8	56.0	55.5	54.9	62.9	7.1	115.9	109.6	51.8	36.2	50.0	56.4	34.0	44.3	62.5	99.3	10.1	9.2	52.8	105.8	42.4	55.7	95.4	42.9	53.5	48.0	4.7	80.3	43.4	39.1	7.1	12.4	118.7	53.6	49.2	54.6	72.6	45.2	201.7	85.5	26.0	59.2	57.9	68.2	301.2	54.0	52.2	70.5	104.1	57.8	102.3	71.9	83.8
MRPL58	"DS-1, ICT1"	ENSG00000167862	"Mitochondrial ribosomal protein L58"	Q14197	17	75012670-75021261	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Ribosomal proteins"	"Protein biosynthesis"	"Hydrolase, Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 60.1;Distal tubular cells: 56.7;Ductal cells: 50.9;Exocrine glandular cells: 60.3;Hofbauer cells: 48.1;Pancreatic endocrine cells: 53.7;Proximal tubular cells: 121.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003634, HPA076987"	Approved		Supported	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	"Nucleoplasm, Plasma membrane"	"HPA003634: AB_1851388, HPA076987: "	"unprognostic (2.04e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.94e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.79e-3)"	"unprognostic (4.98e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.71e-1)"	22.7	36.3	22.1	18.0	22.8	22.8	24.6	24.4	23.0	17.1	31.9	25.9	19.1	19.4	18.2	32.1	17.5	13.1	49.1	21.9	23.6	34.7	47.2	16.3	24.4	23.4	22.6	14.2	27.4	25.0	14.0	19.3	23.4	18.6	22.8	11.2	21.8	18.6	79.0	28.4	21.7	18.8	23.3	21.6	26.0	10.5	22.9	18.3	18.7	50.3	23.8	24.5	19.9	24.5	81.1	111.4	36.5	42.1	38.3	37.9	50.5	46.7	50.7	95.7	80.7	86.3	49.5	56.0	37.3	46.8	58.9	56.3	75.6	80.7	100.2	28.1	87.7	43.8	50.5	72.2	72.5	92.5	28.8	40.9	37.8	63.3	101.0	32.3	73.8	57.0	71.7	39.9	54.8	100.9	80.7	63.4	27.5	125.3	147.1	41.2	64.8	81.2	71.1	58.5	33.5	64.1	40.3	72.5	92.9	46.7	97.5	75.6	31.6	50.8	56.0	54.3	89.7	41.0	34.8	63.2	58.5	102.5	43.5	26.6	41.2	21.4	30.8	40.9	27.1	33.8	38.0	31.4	55.3	29.3	27.8	31.1	4.0	42.2	36.1	37.2	67.2	42.5	22.1	22.8	24.4	23.0	21.9	23.6	23.4	22.6	23.4	23.3	22.9	24.5	18.8	32.1	8.7	0.0	4.3	0.0	0.0	0.0	0.0	0.0	22.5	32.8	0.0	0.0	8.1	25.8	0.0	60.1	11.4	0.0	56.7	50.9	0.0	29.3	18.3	8.4	0.0	0.0	0.0	60.3	40.5	8.9	0.0	19.0	1.3	22.3	0.0	0.0	48.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	15.0	0.0	0.0	0.0	0.0	53.7	0.0	0.0	0.8	0.0	0.0	121.1	21.1	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	29.1	7.4	43.5	0.0	0.0
MRPS15	FLJ11564	ENSG00000116898	"Mitochondrial ribosomal protein S15"	P82914	1	36455718-36464384	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 287.3"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 776.7;Late spermatids: 2209.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028100, HPA028134, HPA067137"	Supported		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Mitochondria		"HPA028100: AB_10600216, HPA028134: AB_10600890, HPA067137: AB_2685787"	"unprognostic (2.05e-2)"	"unprognostic (6.98e-2)"	"unprognostic (7.57e-2)"	"unprognostic (4.53e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (2.20e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (7.83e-4)"	"unprognostic (8.48e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.39e-1)"	77.3	68.9	54.1	37.4	55.7	81.7	62.4	58.5	70.4	38.8	61.8	63.7	41.1	42.5	62.6	70.9	37.1	30.2	133.8	54.8	59.8	82.0	122.1	47.4	45.4	57.9	56.8	33.2	63.2	77.0	46.3	45.0	58.3	45.1	50.7	21.0	58.1	37.8	287.3	53.0	41.6	40.0	54.4	41.3	68.7	151.2	58.1	44.1	40.0	196.9	47.9	54.2	43.0	56.0	162.3	88.7	94.4	115.8	91.9	132.6	233.9	88.3	126.1	214.3	195.7	157.9	169.3	148.8	140.0	117.3	128.1	138.9	139.5	223.3	192.3	97.4	177.0	152.5	104.1	175.2	171.6	190.2	103.2	123.1	196.1	191.2	153.7	82.5	178.0	109.5	168.1	114.0	134.5	112.2	184.7	203.8	169.8	137.2	154.2	140.4	165.6	218.6	193.0	135.1	139.4	77.0	122.2	153.9	236.0	139.7	95.1	129.0	84.3	119.7	126.8	149.0	189.4	113.2	169.1	211.3	136.1	128.1	170.8	18.7	78.9	22.3	61.8	89.7	77.3	72.5	70.3	71.2	122.0	73.5	65.6	64.4	5.3	64.5	61.2	83.6	87.8	90.7	54.1	55.7	58.5	70.4	54.8	59.8	57.9	56.8	58.3	54.4	58.1	56.0	50.6	38.5	52.0	10.1	57.2	65.4	70.3	119.6	55.8	23.2	85.6	79.9	136.7	65.8	74.7	71.7	14.6	245.9	49.2	84.8	322.9	132.8	776.7	53.2	58.6	62.6	66.0	118.2	8.7	162.4	260.3	61.7	69.3	75.4	42.5	71.1	62.4	140.6	153.8	13.5	8.7	97.7	85.5	81.1	68.9	2209.2	62.7	75.7	56.9	4.7	86.7	31.3	56.7	5.5	7.2	143.1	64.2	74.4	108.4	128.8	118.3	361.6	50.3	23.5	65.7	56.3	103.2	502.4	76.0	107.0	80.4	281.6	59.0	113.1	127.2	118.3
MRPS18B	"C6orf14, HSPC183, MRPS18-2, PTD017"	ENSG00000204568	"Mitochondrial ribosomal protein S18B"	Q9Y676	6	30617840-30626395	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043485, HPA050334"	Supported		Supported	"Cell Junctions,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Cell Junctions"	"HPA043485: AB_2678506, HPA050334: AB_2681091"	"unprognostic (8.18e-3)"	"unprognostic (1.14e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.20e-2)"	"unprognostic (7.40e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.40e-2)"	"prognostic favorable (3.99e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.39e-2)"	37.2	52.0	43.6	27.6	45.7	20.3	61.0	46.8	44.3	41.1	43.2	52.3	49.8	31.3	57.6	39.3	62.5	27.4	108.1	40.5	44.1	77.9	99.8	39.4	43.6	46.0	45.2	63.0	47.0	74.0	29.2	38.4	46.2	32.0	62.3	41.6	58.0	42.4	180.2	45.1	39.4	38.1	45.2	39.3	44.4	22.0	46.1	43.7	54.1	229.0	63.6	33.0	29.4	48.2	112.7	68.3	51.1	73.5	72.9	101.8	92.6	39.8	92.6	122.8	75.5	117.7	51.8	112.6	91.5	61.7	91.3	86.1	115.0	109.9	122.0	68.7	122.9	107.9	45.1	124.2	67.2	105.7	45.4	88.8	139.4	99.5	273.8	82.7	72.4	104.7	171.3	107.7	112.2	83.1	70.6	111.4	40.6	86.1	81.8	91.2	69.8	220.7	114.8	49.5	111.3	38.4	34.7	147.1	163.0	46.0	190.6	58.4	39.6	79.2	80.8	47.3	70.8	89.5	114.1	99.2	38.3	154.6	121.7	79.2	72.4	42.5	77.0	94.4	104.7	153.5	104.3	86.3	79.8	140.3	129.6	103.5	7.2	120.3	101.4	74.3	108.1	108.4	43.6	45.7	46.8	44.3	40.5	44.1	46.0	45.2	46.2	45.2	46.1	48.2	59.4	60.9	56.1	7.2	58.4	36.8	65.9	114.0	58.6	47.4	56.6	73.0	175.5	117.2	75.0	47.8	64.6	121.2	43.7	39.1	193.7	103.8	54.2	37.5	42.8	59.4	31.3	45.4	6.0	92.1	124.9	47.4	39.3	30.8	37.4	53.1	61.8	121.6	81.4	43.7	7.9	59.5	75.3	53.2	30.4	37.4	70.2	39.7	60.5	1.9	80.0	46.9	70.0	4.5	14.4	69.5	49.9	44.8	56.8	53.2	89.6	201.6	60.4	69.4	52.6	50.0	53.0	29.6	57.4	61.7	44.9	96.5	43.9	144.4	85.3	50.1
MRPS2	CGI-91	ENSG00000122140	"Mitochondrial ribosomal protein S2"	Q9Y399	9	135499984-135504673	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029487, HPA057261"	Approved		Supported	Mitochondria		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Mitochondria		"HPA029487: , HPA057261: AB_2683385"	"unprognostic (3.18e-3)"	"unprognostic (9.42e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.55e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.63e-3)"	"unprognostic (3.83e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.81e-2)"	"unprognostic (7.58e-2)"	"prognostic favorable (6.96e-9)"	"unprognostic (2.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.24e-1)"	32.6	56.9	30.7	14.7	31.3	23.2	30.8	30.3	37.9	29.2	34.9	35.4	23.0	29.6	12.9	37.7	35.7	15.8	67.0	31.2	30.2	46.1	79.7	22.0	21.0	29.9	31.3	34.9	45.8	32.2	26.4	16.8	31.1	33.1	17.3	7.7	31.3	21.2	75.5	39.1	28.1	15.2	29.7	32.0	39.3	17.0	33.1	16.2	25.8	50.4	17.7	33.8	28.8	30.8	59.9	98.4	35.3	48.0	39.1	43.5	60.0	43.0	39.0	71.7	53.0	149.0	55.4	75.4	57.2	40.1	75.8	132.6	88.9	101.4	27.7	46.2	137.4	37.4	96.1	101.8	68.4	76.6	44.3	58.6	77.6	78.3	55.6	45.7	67.9	74.2	125.1	54.3	42.3	185.8	73.9	133.7	80.2	110.8	153.9	81.3	57.3	159.5	59.9	50.8	104.9	55.2	58.8	110.9	63.2	23.6	92.4	60.5	42.4	52.3	58.4	90.3	78.8	58.9	124.5	84.1	53.0	69.2	49.1	8.4	28.4	13.6	30.0	27.5	34.5	34.4	30.1	32.4	29.1	34.3	32.4	32.9	2.4	28.7	24.0	25.1	41.8	26.4	30.7	31.3	30.3	37.9	31.2	30.2	29.9	31.3	31.1	29.7	33.1	30.8	23.8	12.8	14.1	4.9	32.5	44.7	38.8	55.0	33.0	22.2	37.3	51.7	31.2	42.9	31.6	12.9	6.2	71.3	19.0	21.5	72.4	50.7	14.7	27.8	34.2	32.6	21.7	41.4	4.6	38.6	65.8	27.9	21.4	77.7	8.2	37.9	21.8	46.5	42.5	25.2	5.9	37.9	28.5	17.6	15.4	32.5	24.2	21.0	19.6	1.9	31.7	24.8	20.6	4.0	4.5	39.9	27.1	23.0	38.6	48.6	36.3	84.5	14.7	17.0	32.9	27.1	29.4	13.3	21.5	47.1	45.7	37.4	23.4	77.5	55.7	35.5
MRPS22	"C3orf5, GIBT, GK002, MRP-S22"	ENSG00000175110	"Mitochondrial ribosomal protein S22"	P82650	3	139005806-139357223	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006083, HPA007830"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA006083: AB_1854122, HPA007830: AB_1854123"	"unprognostic (8.38e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.04e-2)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (5.22e-3)"	"unprognostic (5.45e-3)"	"unprognostic (4.85e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.49e-3)"	"prognostic unfavorable (1.55e-5)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (3.22e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.40e-1)"	25.5	55.6	23.1	20.7	24.2	37.9	25.2	27.2	31.5	21.9	22.2	35.0	37.0	20.2	19.3	37.4	20.5	17.3	61.3	23.4	27.3	38.0	57.4	17.0	22.8	24.9	23.4	22.6	32.0	31.7	13.7	25.6	26.0	17.1	31.9	17.9	22.0	20.2	83.0	21.8	33.1	23.9	25.8	17.0	25.0	35.4	24.4	23.5	22.8	77.3	24.4	27.3	21.6	27.4	101.2	40.4	40.0	44.5	49.1	41.7	79.1	58.9	72.3	97.1	80.7	130.0	68.3	66.5	106.9	67.1	98.9	109.9	64.6	76.5	96.4	39.0	64.1	105.2	35.8	97.2	56.2	99.3	58.1	45.2	59.6	58.3	61.8	49.2	61.0	76.2	149.2	41.7	61.2	72.4	51.9	85.9	64.4	102.3	73.3	65.0	61.3	98.9	75.0	61.4	43.4	40.4	94.2	141.4	154.6	37.0	97.1	93.7	47.5	42.4	42.3	82.4	55.9	66.3	38.5	119.5	56.9	70.6	42.3	42.8	38.4	36.1	34.9	53.4	43.0	40.3	37.5	39.4	45.8	36.1	41.0	38.9	9.2	38.1	53.6	29.7	47.6	36.3	23.1	24.2	27.2	31.5	23.4	27.3	24.9	23.4	26.0	25.8	24.4	27.4	30.7	19.2	13.4	8.8	21.8	22.8	29.7	63.3	19.4	19.9	15.3	18.0	50.3	25.8	33.3	18.4	14.6	62.9	24.9	26.5	68.4	47.5	84.3	19.9	30.5	26.6	15.6	31.2	8.7	60.3	48.0	27.7	16.3	22.0	27.3	24.9	18.2	38.9	48.6	20.2	13.8	26.5	32.6	21.9	16.1	14.3	23.3	22.5	16.0	4.7	38.0	21.8	24.7	10.1	10.1	42.0	27.1	23.7	38.4	16.6	45.4	59.4	35.5	26.2	39.5	32.2	39.1	102.2	51.4	34.8	20.5	75.4	24.7	74.1	46.5	31.2
MRPS27	KIAA0264	ENSG00000113048	"Mitochondrial ribosomal protein S27"	Q92552	5	72219403-72320646	"Predicted intracellular proteins, Ribosomal proteins"	"Translation regulation"	"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 101.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071751	Approved		Supported	Nucleoli,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria	Nucleoli	"HPA071751: AB_2686442"	"unprognostic (3.05e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.14e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-2)"	"unprognostic (7.20e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.22e-3)"	"unprognostic (5.07e-2)"	"unprognostic (3.26e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.27e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.95e-2)"	25.5	36.1	23.8	21.8	25.3	18.9	31.8	23.6	27.8	27.0	33.8	26.2	20.4	25.8	27.6	32.4	31.3	19.0	55.5	25.0	23.1	30.5	38.5	17.5	36.9	24.6	24.1	39.5	27.1	32.7	20.9	21.2	24.6	25.2	31.5	17.7	22.4	30.3	58.7	31.7	22.0	26.9	24.5	25.9	25.7	15.1	25.0	30.7	35.6	89.1	41.9	29.7	26.0	24.1	49.7	65.2	56.8	94.4	73.1	93.5	73.0	46.7	66.4	86.9	69.7	81.9	68.5	128.2	63.8	54.8	94.9	54.0	111.8	166.1	93.6	48.6	69.2	66.0	71.3	91.1	72.7	58.4	49.0	88.1	68.7	91.3	101.5	79.0	94.2	92.2	67.2	37.5	73.0	59.7	87.8	70.4	65.7	35.8	40.4	92.0	94.4	131.5	80.7	52.4	87.5	46.7	78.5	63.8	58.5	52.2	97.8	69.9	54.1	35.3	51.8	50.3	85.2	37.7	61.0	89.1	60.9	94.6	57.0	15.5	23.4	8.1	24.9	27.5	37.1	36.1	30.6	30.4	44.2	32.1	35.2	37.9	3.2	43.3	23.0	16.6	34.6	31.5	23.8	25.3	23.6	27.8	25.0	23.1	24.6	24.1	24.6	24.5	25.0	24.1	13.9	9.6	11.7	32.7	27.6	20.4	22.3	21.6	23.3	11.4	26.5	22.2	101.9	7.2	15.6	11.0	16.7	41.5	18.6	9.1	25.4	20.5	2.2	16.1	21.8	17.2	16.2	36.8	43.9	17.3	48.2	18.8	17.9	12.1	7.6	29.3	15.7	34.8	24.8	10.1	38.4	21.0	8.2	28.6	13.3	4.4	19.0	15.0	10.6	30.0	31.4	15.3	17.5	38.7	51.1	14.9	15.3	25.2	16.8	13.5	10.7	28.8	12.6	13.2	13.1	18.2	17.6	10.3	18.7	32.3	17.6	28.9	21.2	30.4	31.4	14.8
MRPS33	CGI-139	ENSG00000090263	"Mitochondrial ribosomal protein S33"	Q9Y291	7	141002610-141015228	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 354.1;Proximal tubular cells: 386.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030425	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA030425: AB_10602030"	"unprognostic (9.83e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.03e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.66e-2)"	"unprognostic (4.55e-3)"	"unprognostic (6.94e-3)"	"unprognostic (4.26e-1)"	"unprognostic (9.80e-3)"	"unprognostic (1.16e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.52e-2)"	37.7	64.4	43.9	27.5	46.9	25.0	58.5	46.4	68.8	30.3	47.7	65.3	50.1	25.5	79.1	46.3	35.1	22.4	114.5	45.3	48.0	72.7	83.7	20.8	41.0	46.6	45.9	35.2	67.6	81.2	49.1	24.4	48.0	36.6	69.8	29.4	50.0	31.2	173.7	35.9	44.5	26.5	46.8	30.9	44.3	45.3	45.4	41.9	51.7	171.5	43.5	36.9	30.2	47.8	79.0	110.5	61.8	65.7	77.1	104.9	67.6	69.5	68.7	65.1	73.2	67.6	104.9	107.7	100.0	67.3	140.9	50.5	69.5	102.6	89.3	96.6	83.1	67.8	20.6	130.8	93.8	98.3	39.2	99.8	103.0	100.8	89.4	73.3	53.9	108.4	113.3	84.0	128.2	124.8	110.1	153.3	129.3	140.0	125.6	28.4	48.5	186.1	114.9	99.8	111.7	88.2	93.7	93.2	145.5	65.3	79.4	90.8	41.8	56.6	38.4	137.5	75.8	128.3	155.7	126.8	125.3	99.8	95.1	13.0	47.6	37.9	48.9	68.7	61.9	85.4	85.5	61.1	79.5	66.8	98.3	83.5	4.9	79.8	60.5	93.8	77.3	61.2	43.9	46.9	46.4	68.8	45.3	48.0	46.6	45.9	48.0	46.8	45.4	47.8	30.3	38.5	43.6	11.1	54.6	42.6	72.1	207.7	51.2	27.1	101.1	104.6	333.5	82.9	96.5	114.0	31.3	145.4	39.5	96.9	354.1	101.0	136.8	124.2	60.1	42.8	89.7	46.3	8.9	136.8	133.0	55.3	50.0	70.6	48.2	71.4	42.5	221.8	114.1	57.2	9.1	148.3	109.9	59.8	38.1	41.0	57.8	45.7	76.5	8.4	97.4	47.8	51.5	9.0	18.0	95.6	80.6	42.5	88.9	67.1	199.0	386.1	122.5	32.9	19.7	41.0	57.1	157.7	50.8	84.4	45.7	116.8	49.6	82.8	202.3	79.0
MRPS7	"MRP-S, RP-S7, RPMS7"	ENSG00000125445	"Mitochondrial ribosomal protein S7"	Q9Y2R9	17	75261674-75266376	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 454.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022522, HPA023007"	Supported		Approved	Mitochondria		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"HPA022522: AB_1854131, HPA023007: AB_1854132"	"unprognostic (1.24e-1)"	"unprognostic (4.74e-2)"	"prognostic favorable (1.12e-4)"	"unprognostic (5.82e-3)"	"unprognostic (3.62e-2)"	"unprognostic (5.05e-3)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.95e-2)"	"unprognostic (8.56e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.15e-1)"	44.3	58.4	55.5	38.1	55.9	32.9	41.2	60.0	61.9	28.7	59.0	49.9	48.9	28.3	24.4	58.5	39.2	27.1	129.0	55.1	59.3	66.1	64.6	32.4	41.3	57.2	57.5	29.2	39.0	76.6	36.0	40.8	57.6	34.1	48.2	47.3	41.1	35.7	201.3	32.6	40.0	33.8	57.8	39.5	47.5	29.9	59.8	33.6	35.9	212.3	43.6	42.6	35.0	56.3	113.8	188.6	78.8	57.6	63.9	35.7	139.4	73.3	60.9	137.4	101.1	209.8	93.5	96.4	66.4	79.8	91.4	104.5	122.3	135.8	82.2	50.8	173.5	131.8	133.6	201.3	62.5	134.3	69.6	60.0	131.8	108.6	109.6	69.2	177.3	117.8	130.1	93.3	91.1	203.5	151.8	104.7	85.4	157.7	176.2	100.7	229.5	145.2	128.4	124.6	135.8	122.8	93.8	249.9	150.0	83.9	188.4	108.7	72.2	124.0	125.3	68.2	155.7	97.9	61.5	106.6	89.5	88.3	96.9	43.2	155.1	48.2	115.7	161.6	124.2	140.2	112.0	126.0	172.0	128.1	128.6	120.7	11.0	130.5	138.5	164.9	141.6	236.0	55.5	55.9	60.0	61.9	55.1	59.3	57.2	57.5	57.6	57.8	59.8	56.3	44.1	51.3	48.3	12.1	69.3	39.5	75.1	148.1	37.0	65.8	56.5	63.0	77.8	70.1	74.3	57.0	98.0	192.9	63.3	94.1	230.9	112.9	139.2	50.9	43.2	55.6	47.5	61.4	11.8	104.1	175.3	50.2	55.5	43.5	39.3	68.6	45.3	91.7	148.8	47.1	14.0	84.3	77.3	60.0	35.6	454.3	48.4	52.6	42.7	3.7	107.0	85.6	73.2	9.5	11.3	89.8	69.3	39.9	87.7	85.3	129.2	219.3	81.0	114.4	59.2	40.8	73.0	60.5	68.5	68.5	41.9	137.9	53.8	110.0	133.8	77.4
MRRF	RRF	ENSG00000148187	"Mitochondrial ribosome recycling factor"	Q96E11	9	122264603-122331337	"Predicted intracellular proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 210.0;Late spermatids: 191.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047177, HPA049987"	Supported		Approved	"Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Microtubules, Cytokinetic bridge"		"HPA047177: AB_2679970, HPA049987: AB_2680984"	"unprognostic (8.38e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.40e-2)"	"unprognostic (6.06e-3)"	"unprognostic (3.64e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.89e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.01e-2)"	"prognostic favorable (2.14e-8)"	"unprognostic (3.89e-2)"	"unprognostic (4.05e-1)"	"unprognostic (8.02e-2)"	"unprognostic (8.88e-3)"	18.9	19.3	10.4	12.1	10.7	14.2	19.3	11.7	13.3	13.9	15.3	25.1	23.7	10.1	13.1	25.5	11.4	8.8	28.2	10.6	11.3	23.4	24.3	13.3	14.0	11.4	10.9	11.3	18.3	23.2	12.5	9.0	11.3	14.7	28.6	14.5	15.3	10.6	40.6	22.1	18.5	10.1	10.6	15.6	14.4	18.1	11.3	13.8	16.3	32.1	20.4	16.9	16.4	11.5	34.7	45.8	25.6	43.0	35.7	32.5	48.7	33.7	43.0	44.5	26.0	55.0	40.6	75.0	16.7	27.0	35.5	99.3	74.1	78.8	36.3	25.2	30.3	25.6	53.4	30.5	23.6	72.3	32.7	30.5	52.7	40.0	70.8	22.4	50.4	29.6	44.2	27.8	45.1	55.1	36.2	23.6	30.0	86.0	45.7	26.8	48.8	79.7	76.6	34.8	30.3	19.9	36.2	58.3	27.9	24.3	62.8	18.2	27.1	19.5	29.6	51.0	42.0	19.1	50.1	33.0	36.8	42.4	22.8	4.7	17.5	6.0	13.3	29.0	14.2	15.6	13.3	12.5	29.8	12.7	13.8	16.5	2.0	22.9	31.3	12.9	16.3	11.1	10.4	10.7	11.7	13.3	10.6	11.3	11.4	10.9	11.3	10.6	11.3	11.5	22.7	3.2	9.1	21.9	18.8	15.4	22.1	30.3	26.2	13.2	20.1	17.3	21.8	18.6	17.8	14.7	12.5	29.0	10.8	21.4	35.2	36.0	210.0	16.2	15.7	22.5	7.8	29.3	28.6	29.5	49.2	11.1	23.9	12.1	24.7	14.5	14.3	19.2	30.4	5.0	39.1	22.0	18.3	17.0	16.5	191.7	9.6	16.0	14.2	20.6	18.3	6.3	11.3	22.1	31.0	24.0	20.6	7.5	19.4	18.1	41.2	37.3	16.2	23.5	19.7	15.1	11.7	30.2	16.6	32.5	22.4	37.1	12.3	31.1	33.9	22.7
MRTO4	"C1orf33, dJ657E11.4, MRT4"	ENSG00000053372	"MRT4 homolog, ribosome maturation factor"	Q9UKD2	1	19251805-19260128	"Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026446	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nuclear membrane"	Nucleoli	"HPA026446: AB_10601441"	"unprognostic (3.99e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.94e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.22e-2)"	"prognostic unfavorable (1.56e-8)"	"unprognostic (7.46e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (4.11e-8)"	"unprognostic (5.87e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.23e-2)"	18.9	18.5	17.0	16.8	17.1	13.4	20.2	14.8	17.9	13.0	13.7	13.5	16.8	15.8	12.9	23.7	17.6	8.9	14.4	17.4	16.1	17.9	20.3	11.1	20.0	15.8	16.0	17.0	23.4	12.5	8.9	12.1	16.1	12.9	16.5	7.2	12.3	10.5	22.7	17.4	19.5	16.7	15.4	13.8	15.5	14.0	16.1	14.8	11.1	11.4	22.8	21.4	14.1	16.4	90.9	65.9	51.1	67.0	24.2	38.6	44.7	69.0	38.9	116.7	76.1	92.9	92.0	133.6	56.7	60.5	50.4	70.1	142.7	104.6	114.0	47.4	109.6	98.4	55.4	80.8	30.3	133.4	38.7	34.0	69.8	131.6	69.6	31.7	66.1	59.0	151.1	42.3	68.9	68.0	106.3	96.5	65.0	95.6	95.4	99.3	62.7	100.5	64.8	31.3	82.9	59.2	54.0	73.0	75.4	37.6	50.8	76.5	44.2	61.9	77.5	97.6	118.0	33.8	64.3	178.2	61.2	172.4	102.5	1.4	11.6	1.3	11.4	12.7	22.9	23.1	13.7	15.9	17.6	19.7	18.4	16.7	1.4	16.6	10.2	19.7	10.6	11.4	17.0	17.1	14.8	17.9	17.4	16.1	15.8	16.0	16.1	15.4	16.1	16.4	30.0	6.4	14.5	6.2	31.2	37.3	59.1	45.8	42.7	20.4	23.6	37.7	10.3	38.6	26.4	7.3	10.4	50.4	14.9	15.7	41.1	61.8	23.3	19.1	46.8	32.1	21.6	31.3	8.4	55.0	69.9	29.5	19.4	21.1	26.0	36.8	15.4	16.3	47.1	15.2	7.3	25.4	36.7	13.3	18.2	36.5	23.0	21.0	19.6	1.9	32.0	25.7	16.5	4.5	4.3	57.5	17.0	20.3	29.0	57.4	6.0	37.9	15.8	16.4	19.7	44.8	35.9	55.6	49.7	48.2	33.5	26.0	18.6	58.1	34.8	36.7
MSH2	"COCA1, HNPCC, HNPCC1"	ENSG00000095002	"MutS homolog 2"	P43246	2	47403067-47663146	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"testis cancer: 46.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009572, HPA066845, CAB070867"	Approved		Supported	Nucleoplasm,Vesicles		NA	Yes		28000	"Cluster 48: NK-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Vesicles	"CAB009572: AB_2144828, CAB070867: , HPA066845: AB_2732752"	"unprognostic (2.35e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.89e-3)"	"prognostic unfavorable (4.44e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.31e-3)"	"prognostic unfavorable (1.72e-9)"	"unprognostic (1.77e-1)"	"unprognostic (7.09e-3)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (5.38e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.74e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.48e-1)"	8.1	7.5	8.3	12.8	10.5	15.7	15.7	14.6	10.6	9.7	12.2	11.9	7.8	11.7	14.0	9.5	12.4	5.8	10.1	9.6	9.0	8.2	6.7	8.1	23.7	8.6	8.0	8.7	6.5	14.8	6.2	11.6	9.5	8.6	15.0	34.9	8.5	7.7	7.1	11.1	9.3	8.8	8.5	10.8	8.1	16.2	7.9	32.6	15.8	7.2	25.0	7.9	6.4	8.9	114.3	35.3	103.3	57.9	7.3	21.2	64.3	62.9	33.3	80.9	76.9	72.3	50.1	141.2	84.6	23.8	56.6	49.8	78.6	37.4	122.3	68.1	55.8	99.3	42.3	65.6	7.7	97.7	34.9	12.3	11.2	68.1	19.0	19.1	45.2	3.9	165.1	34.0	63.1	44.2	119.6	75.4	195.7	69.3	45.1	151.1	182.2	84.4	35.8	57.3	85.9	91.6	58.4	49.2	48.0	83.6	46.9	38.8	18.7	55.5	70.9	57.1	74.6	20.8	63.4	180.1	33.1	72.5	35.4	3.0	1.3	4.9	8.0	4.4	9.3	6.7	7.7	10.3	2.5	7.9	12.6	13.1	1.0	14.2	3.9	3.4	11.8	6.5	8.3	10.5	14.6	10.6	9.6	9.0	8.6	8.0	9.5	8.5	7.9	8.9	14.7	9.6	11.5	18.6	13.0	8.3	7.9	14.4	8.6	17.4	7.5	7.1	15.6	5.7	12.6	9.2	45.9	19.9	14.2	6.6	3.9	11.5	17.8	21.0	11.3	13.4	3.5	54.1	59.9	8.4	20.7	12.2	7.1	18.8	12.0	28.2	5.0	1.6	11.4	11.8	58.0	12.1	14.2	4.1	4.6	22.8	5.3	5.1	8.8	16.9	5.5	22.6	17.5	35.7	54.7	7.3	5.0	6.4	12.4	2.8	5.4	4.5	23.3	41.1	0.0	9.8	9.0	56.5	50.8	9.3	6.5	5.1	12.8	24.3	13.5	3.8
MSH3	"DUP, MRP1"	ENSG00000113318	"MutS homolog 3"	P20585	5	80654652-80876815	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 95.1;Inhibitory neurons: 98.9;Oligodendrocytes: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036081			Approved	"Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear bodies"		"HPA036081: AB_10673229"	"unprognostic (1.91e-1)"	"unprognostic (7.61e-2)"	"prognostic favorable (5.90e-5)"	"unprognostic (2.95e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.70e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.91e-1)"	"prognostic favorable (1.77e-4)"	"unprognostic (5.15e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.29e-1)"	9.4	4.6	1.8	4.3	2.4	5.0	5.5	1.6	2.0	6.6	1.5	6.0	6.0	5.2	5.3	5.0	7.0	5.7	4.9	1.7	2.0	12.5	11.4	4.2	4.9	1.7	2.0	5.3	5.2	8.8	3.3	4.3	1.7	5.2	6.2	3.7	4.5	5.2	5.1	5.1	5.6	5.1	2.2	4.1	5.0	3.9	2.5	7.1	10.8	4.7	6.1	6.3	3.9	2.0	12.4	15.0	11.7	13.1	6.6	12.3	16.6	12.2	11.8	13.6	16.7	10.0	15.6	22.2	14.0	15.3	12.8	10.4	15.6	20.5	17.3	14.2	13.9	8.4	13.4	9.9	6.8	9.9	8.5	10.9	9.5	15.8	16.6	13.8	12.9	7.9	12.1	12.9	16.1	11.9	19.0	4.7	9.0	4.8	7.7	13.2	24.2	16.4	15.2	13.0	11.6	13.9	10.4	11.5	13.0	14.4	15.2	9.4	12.4	7.8	9.5	6.2	23.0	8.7	15.6	21.6	12.2	16.8	10.2	0.7	2.9	1.9	3.3	3.4	3.8	3.4	3.5	3.6	3.3	2.2	2.6	2.6	1.7	3.1	4.6	2.8	4.8	2.4	1.8	2.4	1.6	2.0	1.7	2.0	1.7	2.0	1.7	2.2	2.5	2.0	16.7	35.3	9.3	66.9	18.1	10.5	12.3	12.4	12.5	25.8	19.4	12.8	17.6	8.6	14.3	14.7	14.6	18.9	18.7	18.2	15.6	12.4	14.6	28.4	20.2	12.0	14.5	17.0	95.1	10.3	12.9	15.9	31.6	18.9	8.2	19.9	10.0	20.1	11.5	21.9	98.9	13.2	8.2	13.0	7.0	17.2	13.7	16.3	3.6	72.1	19.9	22.5	19.6	71.9	92.3	10.6	9.6	25.9	22.0	6.5	16.8	43.6	65.4	28.3	19.7	20.2	14.7	24.7	25.5	22.3	10.1	13.1	25.4	14.7	17.4	10.7
MTDH	"3D3, AEG-1, LYRIC"	ENSG00000147649	Metadherin	Q86UE4	8	97644184-97730260	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010932, HPA015104, CAB068204, CAB068205"	Supported		Enhanced	"Endoplasmic reticulum"		NA	NA		300000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB068204: AB_2665655, CAB068205: AB_2665654, HPA010932: AB_1079422, HPA015104: AB_1854173"	"unprognostic (1.01e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.05e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.08e-2)"	"prognostic unfavorable (7.76e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (5.36e-4)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (3.84e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.40e-1)"	53.3	41.4	18.6	56.0	26.7	109.9	39.0	26.2	24.5	52.6	27.2	51.3	51.2	50.1	33.7	52.2	41.1	41.2	35.7	17.2	21.2	40.8	89.6	40.7	59.3	28.3	23.2	50.7	30.4	53.4	13.4	28.9	28.6	44.7	47.5	44.8	29.3	41.4	60.2	27.0	52.2	62.5	25.9	41.6	48.1	39.6	23.3	65.9	62.7	50.6	61.0	56.3	22.7	37.1	191.5	96.4	61.1	84.7	97.3	102.7	30.7	167.8	139.0	104.2	79.4	59.9	137.0	173.5	181.5	164.6	114.1	121.6	150.3	115.2	143.6	189.5	79.9	320.0	97.5	69.6	118.2	170.5	142.4	78.6	109.3	128.1	282.2	97.3	119.3	126.2	215.5	300.2	108.4	77.6	286.0	43.2	38.9	160.9	113.0	187.2	73.0	255.4	64.5	108.6	92.3	69.2	118.3	101.3	132.0	58.6	158.0	105.1	126.8	146.7	52.7	135.8	123.6	166.1	196.4	174.5	134.3	194.5	130.9	57.0	71.5	38.1	35.7	49.2	49.7	71.6	51.1	52.8	87.0	51.4	51.9	45.7	10.1	51.4	54.6	112.2	33.3	31.9	18.6	26.7	26.2	24.5	17.2	21.2	28.3	23.2	28.6	25.9	23.3	37.1	185.1	128.2	109.2	69.2	294.6	261.7	233.0	178.9	194.1	0.0	166.1	150.7	109.9	201.6	146.1	141.6	0.0	10.0	231.7	140.5	25.4	230.9	267.4	156.0	269.9	185.1	121.8	205.7	96.4	231.7	98.6	227.2	156.5	178.5	137.1	183.1	164.6	438.0	267.5	0.0	97.0	249.9	146.5	258.7	273.9	163.5	195.4	266.5	184.9	86.2	258.2	0.0	195.7	110.6	141.8	241.8	137.8	216.3	675.9	374.7	160.8	99.2	87.2	0.0	223.5	237.8	334.5	162.1	129.6	249.8	314.8	13.7	200.3	285.6	251.6	315.0
MTERF4	"MGC61716, MTERFD2"	ENSG00000122085	"Mitochondrial transcription termination factor 4"	Q7Z6M4	2	241072169-241102332	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA027097	Uncertain		Supported	Mitochondria,Cytosol		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	"Mitochondria, Cytosol"		"HPA027097: AB_10603879"	"unprognostic (4.58e-2)"	"unprognostic (3.66e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.99e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.20e-2)"	"prognostic favorable (3.48e-4)"	"unprognostic (2.28e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.13e-1)"	15.4	15.7	8.7	22.7	10.6	23.8	21.8	17.5	14.5	21.8	6.7	18.2	16.1	25.3	16.1	19.4	19.0	14.2	17.3	9.1	10.3	15.7	20.4	17.0	38.8	9.1	8.3	27.9	17.5	16.2	15.3	14.2	9.6	33.8	19.9	29.4	19.8	18.1	54.4	17.6	22.0	20.1	6.4	22.0	18.3	10.2	9.1	25.1	34.7	41.8	30.8	14.8	16.0	12.7	17.2	14.9	29.7	16.4	38.2	17.5	22.1	27.4	31.5	25.8	36.0	10.5	23.2	24.7	10.0	31.0	30.8	17.6	41.0	38.5	33.8	35.4	28.9	32.2	30.5	46.5	25.5	40.2	23.3	29.0	37.8	30.2	35.6	32.8	30.2	32.4	29.4	10.5	31.9	24.0	28.2	26.4	33.7	35.5	25.8	27.7	33.1	14.1	24.8	31.5	26.2	22.9	20.3	26.8	20.7	19.5	19.6	19.4	39.3	23.4	23.0	27.3	25.7	28.0	7.9	61.2	19.8	24.1	21.4	8.3	10.8	24.9	18.6	10.5	22.7	32.3	29.1	26.8	12.3	31.8	46.0	36.7	3.4	18.1	8.7	9.1	32.5	22.1	8.7	10.6	17.5	14.5	9.1	10.3	9.1	8.3	9.6	6.4	9.1	12.7	20.7	12.8	27.7	40.8	45.6	0.0	20.3	0.0	15.9	0.0	19.8	23.9	19.8	27.1	13.0	20.2	0.0	30.2	34.1	12.1	41.1	24.1	49.2	11.7	19.1	22.4	10.9	22.9	31.2	24.6	28.2	18.6	14.3	12.0	11.4	37.9	20.0	30.6	24.8	0.0	28.8	20.7	0.0	24.5	0.0	61.0	23.3	17.0	0.0	25.3	31.6	0.0	42.2	33.2	39.8	23.7	20.7	26.4	44.8	22.0	43.4	51.4	17.5	0.0	39.5	22.7	18.4	59.0	34.3	23.4	0.0	23.7	37.0	42.9	17.2	17.1
MTFP1	"HSPC242, MTP18"	ENSG00000242114	"Mitochondrial fission process 1"	Q9UDX5	22	30425623-30429054	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 69.7;Exocrine glandular cells: 52.2;Plasma cells: 43.5;Undifferentiated cells: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077396			Approved	Mitochondria		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA077396: AB_2686837"	"unprognostic (2.19e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.12e-1)"	"unprognostic (6.20e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.52e-3)"	"unprognostic (8.98e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.40e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.66e-2)"	12.9	15.6	8.7	10.1	9.1	14.2	11.6	11.1	9.9	8.3	16.8	17.1	16.8	3.8	15.1	19.8	3.4	8.1	26.2	9.0	10.2	38.9	31.9	11.9	16.5	9.9	9.7	5.0	19.0	21.8	8.1	11.4	9.3	13.5	12.9	23.4	10.1	4.9	26.2	7.6	13.4	4.7	9.1	20.9	19.7	4.0	10.8	7.8	8.5	19.3	14.8	13.7	7.6	8.6	91.9	69.5	23.8	37.1	5.1	4.1	27.2	8.6	8.2	51.3	78.5	33.6	52.4	99.5	25.3	6.0	41.3	46.5	74.0	77.6	34.7	56.2	96.5	26.7	38.6	64.9	14.8	66.7	52.7	7.6	25.7	31.4	47.4	15.7	43.5	45.1	51.2	35.5	16.3	109.5	63.3	71.8	41.5	82.9	73.2	85.6	23.1	87.3	61.0	24.8	40.6	44.5	19.9	90.6	35.6	16.9	28.8	31.4	18.4	55.9	72.4	27.6	26.3	17.8	15.5	86.1	22.4	75.9	23.7	0.2	14.3	0.1	49.2	17.1	65.5	34.0	39.6	42.3	20.3	23.7	41.7	48.2	1.8	14.0	11.6	10.5	36.0	25.6	8.7	9.1	11.1	9.9	9.0	10.2	9.9	9.7	9.3	9.1	10.8	8.6	5.3	6.4	3.0	3.9	21.7	5.6	1.8	12.0	6.2	0.0	10.1	3.7	4.4	7.2	6.7	3.7	0.0	13.4	14.8	33.2	15.6	69.7	0.1	1.9	1.4	5.8	8.4	9.2	0.8	52.2	30.4	2.5	20.9	2.6	9.5	0.4	5.0	11.1	17.6	0.0	2.7	28.1	2.0	10.3	9.6	0.2	0.6	6.4	3.6	1.0	36.6	0.0	10.3	0.5	0.3	40.3	13.8	0.4	43.5	3.5	28.3	11.8	1.9	0.0	0.0	1.5	5.1	0.6	2.1	16.5	5.5	16.8	29.6	0.7	45.3	2.2
MTHFD1L	"DKFZP586G1517, FLJ21145, FTHFSDC1"	ENSG00000120254	"Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like"	Q6UB35	6	150865679-151101887	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"One-carbon metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 84.0;Extravillous trophoblasts: 166.5;Granulosa cells: 86.9;Microglial cells: 126.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"dendritic cells: 1.1;T-cells: 1.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015006, HPA029040, HPA029041, HPA050052, HPA074911"	Approved		Enhanced	Mitochondria		NA	NA		89000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Mitochondria		"HPA015006: AB_1854178, HPA029040: AB_2672879, HPA029041: AB_2672880, HPA050052: AB_2680998, HPA074911: AB_2686723"	"unprognostic (3.66e-2)"	"prognostic unfavorable (1.68e-5)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (7.28e-4)"	"unprognostic (3.25e-1)"	"prognostic unfavorable (5.10e-4)"	"prognostic unfavorable (8.33e-5)"	"unprognostic (6.35e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (8.69e-5)"	12.5	12.2	7.1	11.4	6.7	13.2	7.9	25.1	7.4	7.1	8.3	7.4	3.2	8.4	6.2	6.7	7.1	5.9	11.5	6.4	9.8	12.7	5.6	19.5	11.1	11.5	10.1	14.6	10.7	6.8	9.2	14.3	11.0	5.5	7.9	7.5	3.2	7.0	1.3	6.0	5.2	10.0	11.6	9.2	6.0	9.9	8.4	8.6	10.9	0.5	10.8	12.8	4.2	15.4	40.6	35.1	44.9	110.0	11.5	40.0	108.4	63.0	68.3	62.1	75.7	71.8	37.4	152.3	41.1	96.9	36.8	42.7	72.4	61.8	76.8	63.4	65.3	62.7	60.4	66.1	72.4	115.7	9.8	47.7	76.9	60.6	109.8	55.5	105.5	81.6	150.9	76.2	65.0	86.1	57.1	23.9	45.5	40.7	32.1	67.2	33.2	67.1	42.1	19.6	44.1	32.5	83.9	36.7	53.0	40.6	11.5	79.5	80.6	41.4	90.6	91.9	90.5	62.3	63.5	154.0	68.8	105.7	54.0	0.0	0.2	0.0	0.2	0.3	0.4	0.2	0.6	0.7	1.1	0.3	0.5	0.6	0.0	0.3	0.3	0.5	1.8	0.2	7.1	6.7	25.1	7.4	6.4	9.8	11.5	10.1	11.0	11.6	8.4	15.4	6.9	0.0	1.7	47.7	6.9	6.5	8.0	15.7	1.8	0.0	3.3	4.1	2.4	1.5	9.8	14.7	0.0	25.8	1.4	2.6	7.9	9.0	44.9	11.3	18.4	10.7	1.2	5.0	84.0	18.1	166.5	14.4	8.2	22.2	0.0	86.9	6.1	1.7	24.9	0.0	73.8	3.0	46.8	3.0	13.3	6.2	0.6	13.8	35.6	126.5	2.4	0.0	2.1	60.8	59.3	19.2	1.4	7.9	14.0	31.3	0.9	15.2	5.3	0.0	0.0	8.7	13.1	0.5	6.8	2.3	3.4	73.6	4.0	42.9	4.0	35.1
MTHFS	HsT19268	ENSG00000136371	"Methenyltetrahydrofolate synthetase"	P49914	15	79833585-79897379	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 253.4"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 205.5;monocytes: 150.8;Proximal tubular cells: 201.6;Syncytiotrophoblasts: 253.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 134.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 134.1;monocytes: 49.1"	"Low cell line specificity"	"Detected in many"											"HPA008067, HPA054177"	Approved		Supported	Cytosol		NA	NA		13000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 62: Liver - Hemostasis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA008067: AB_1078882, HPA054177: AB_2682405"	"unprognostic (4.57e-2)"	"unprognostic (9.76e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (8.52e-4)"	"unprognostic (9.13e-3)"	"prognostic favorable (1.29e-6)"	"unprognostic (1.34e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.18e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.76e-1)"	"prognostic favorable (2.04e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.90e-1)"	21.9	19.8	8.0	4.6	8.2	5.0	19.0	9.6	12.7	9.9	6.9	12.0	13.7	9.0	10.3	10.1	9.4	7.0	19.0	8.0	9.2	53.1	253.4	17.8	6.4	8.7	9.3	8.6	32.8	26.3	21.5	8.3	9.1	19.5	6.4	5.9	13.6	5.5	20.2	6.2	14.5	6.2	8.8	14.9	19.5	12.1	8.7	10.6	15.9	11.1	10.8	12.4	9.9	9.1	12.6	35.8	5.0	2.6	15.8	12.0	11.9	8.8	13.0	16.4	10.5	34.5	22.4	15.1	25.1	15.5	15.0	19.5	31.9	10.7	15.4	14.7	28.4	14.8	22.9	39.8	25.3	7.8	0.8	17.5	27.8	8.1	23.0	19.6	7.4	16.0	28.8	12.0	17.4	36.0	10.2	36.1	15.6	51.4	17.0	10.8	17.2	25.8	35.1	34.3	8.9	4.8	25.1	14.2	43.8	20.0	17.3	13.0	3.3	5.7	11.1	3.6	7.1	6.8	20.2	17.8	3.3	25.9	6.2	17.5	25.7	73.5	9.4	35.3	12.4	13.5	13.7	12.9	12.3	11.1	16.5	12.6	134.1	17.8	49.1	13.3	15.7	19.1	8.0	8.2	9.6	12.7	8.0	9.2	8.7	9.3	9.1	8.8	8.7	9.1	11.3	19.2	44.0	0.0	20.7	10.7	9.9	63.0	35.9	0.0	25.5	32.5	0.7	58.6	34.3	22.0	0.0	68.1	10.1	10.0	64.6	55.8	2.2	11.9	7.8	10.5	17.6	36.6	0.0	75.7	37.1	13.5	39.8	11.0	8.8	7.2	21.8	205.5	45.7	0.0	0.0	18.7	24.4	22.1	34.8	3.8	13.7	29.3	21.4	0.0	150.8	0.0	35.0	0.0	0.0	75.3	35.9	15.8	13.3	13.3	101.7	201.6	29.9	0.0	13.1	8.4	10.5	6.7	8.5	21.1	8.1	253.8	22.2	9.2	24.9	7.7
MTHFSD	FLJ12998	ENSG00000103248	"Methenyltetrahydrofolate synthetase domain containing"	Q2M296	16	86530178-86555235	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041333	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Vesicles"		"HPA041333: AB_10795006"	"unprognostic (4.09e-2)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (9.88e-5)"	"unprognostic (2.66e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.24e-2)"	"unprognostic (3.29e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.77e-1)"	"unprognostic (5.85e-3)"	7.2	8.2	5.3	8.7	6.5	6.3	10.4	6.3	6.2	9.2	7.6	8.7	7.4	9.6	10.6	10.1	13.0	8.4	7.9	5.2	5.1	7.6	7.9	8.3	11.7	6.4	6.2	11.5	9.9	11.8	9.3	8.1	6.4	10.2	10.5	6.6	11.0	8.1	11.3	12.7	8.6	8.3	6.1	10.6	9.7	17.7	6.4	10.6	11.0	8.3	11.7	8.9	8.8	9.6	15.7	14.6	14.2	12.3	11.8	18.0	17.0	15.3	11.1	19.0	9.4	13.0	25.8	14.2	16.3	13.4	10.2	21.4	15.8	15.0	17.7	9.4	12.8	12.9	20.0	12.0	16.0	10.1	6.9	11.4	23.4	24.4	20.9	16.4	11.5	20.5	26.9	0.0	13.9	19.8	12.6	15.0	9.3	12.9	18.3	38.6	8.0	11.2	11.1	9.4	13.8	9.5	34.7	6.8	12.6	14.1	34.5	10.3	11.9	18.3	15.7	12.2	15.1	11.1	14.7	41.6	16.7	15.8	18.2	5.9	4.8	2.4	4.7	3.5	5.0	4.6	5.2	4.9	6.0	3.4	4.2	5.0	1.9	6.3	4.3	2.7	4.5	4.8	5.3	6.5	6.3	6.2	5.2	5.1	6.4	6.2	6.4	6.1	6.4	9.6	6.4	6.4	5.9	10.4	6.4	1.1	2.7	4.2	1.2	0.0	6.8	7.1	4.4	2.8	4.7	5.5	0.0	7.9	5.6	7.2	11.7	5.2	35.6	7.4	5.9	4.6	4.2	7.4	6.6	4.2	4.5	4.5	2.6	4.9	4.5	9.4	5.7	3.4	6.1	0.0	7.1	5.3	2.0	5.5	2.0	18.8	6.5	4.3	3.6	3.7	4.7	0.0	6.2	5.5	13.5	3.6	3.6	8.2	4.1	2.6	5.3	4.4	8.2	0.0	6.6	2.2	5.5	11.4	4.0	4.5	1.4	7.7	3.8	5.7	5.5	2.0
MTMR8	FLJ20126	ENSG00000102043	"Myotubularin related protein 8"	Q96EF0	X	64268081-64395452	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 8.6;Inhibitory neurons: 11.3;Microglial cells: 18.7;Oligodendrocyte precursor cells: 16.1;Oligodendrocytes: 12.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 4.7;JURKAT: 4.7;NTERA-2: 4.2;U-2197: 3.7"					"Low region specificity"	"Detected in all"									NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (1.73e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.22e-2)"	"unprognostic (8.20e-2)"	0.3	0.5	0.2	0.6	0.3	0.5	0.4	0.5	0.2	0.8	1.3	1.2	0.5	0.8	0.7	0.9	2.3	0.5	0.2	0.1	0.5	0.6	0.2	0.5	0.9	0.4	0.5	0.9	0.3	0.6	0.2	0.1	0.4	0.7	1.4	0.9	0.4	1.3	0.2	0.3	0.6	0.7	0.2	0.7	1.2	0.2	0.5	1.0	0.4	0.2	1.1	0.7	0.5	0.2	0.0	0.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	1.0	4.7	0.6	0.0	0.0	0.0	2.6	0.5	1.1	0.0	1.1	1.5	0.2	0.0	0.0	3.3	1.9	0.0	0.6	0.0	0.2	0.0	0.0	4.7	3.4	3.3	0.0	0.2	1.7	0.6	4.2	1.3	0.4	2.6	0.0	1.1	0.2	0.7	0.0	0.4	0.0	0.1	0.0	0.8	0.9	1.6	0.0	0.0	1.0	3.7	0.0	0.0	0.4	2.9	0.0	0.0	0.0	0.1	0.2	0.0	1.2	0.5	1.1	1.2	1.2	0.8	0.0	1.3	1.5	1.3	0.3	0.3	0.6	0.1	0.7	0.6	0.2	0.3	0.5	0.2	0.1	0.5	0.4	0.5	0.4	0.2	0.5	0.2	0.7	0.0	0.0	3.6	3.0	0.4	1.2	0.5	3.4	0.0	0.1	0.1	0.7	0.0	0.3	0.0	0.0	0.3	1.0	0.6	0.0	1.0	0.0	2.3	0.2	0.6	0.0	0.4	8.6	0.2	0.2	0.5	3.1	0.6	0.0	0.4	0.0	0.0	0.2	0.0	11.3	0.2	2.0	0.3	0.3	0.0	0.6	0.4	0.0	18.7	0.0	0.0	1.0	16.1	12.7	0.2	1.4	0.7	0.4	0.1	0.3	0.4	0.0	0.0	0.0	0.3	0.4	0.0	0.3	0.8	0.1	0.3	1.4	0.6	0.8	1.1
MTPAP	"FLJ10486, PAPD1, SPAX4, TENT6"	ENSG00000107951	"Mitochondrial poly(A) polymerase"	Q9NVV4	10	30309801-30374448	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, Transcription"	"Nucleotidyltransferase, RNA-binding, Transferase"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 36.8"	"Cell type enriched"	"Detected in many"	7	"Early spermatids: 240.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038620, HPA058232"	Approved		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Mitochondria		"HPA038620: AB_10673015, HPA058232: AB_2683646"	"unprognostic (2.76e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (4.20e-6)"	"unprognostic (1.16e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.56e-2)"	"unprognostic (9.02e-2)"	"unprognostic (6.28e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.39e-2)"	8.9	7.4	4.9	10.3	4.8	36.8	9.7	12.6	6.7	6.1	3.1	9.6	10.6	9.0	6.2	8.3	6.6	5.2	8.8	4.8	4.3	9.6	10.6	6.3	10.7	3.4	3.5	8.2	10.0	8.4	2.7	9.6	3.9	7.2	11.0	7.1	8.0	4.9	13.2	8.4	9.0	9.1	3.2	9.3	7.1	5.1	3.6	9.2	10.2	12.0	10.3	8.1	5.2	6.2	26.0	25.3	15.8	23.0	15.2	14.2	20.6	17.6	6.2	17.7	18.4	27.0	35.4	36.9	12.3	11.7	16.3	29.7	31.1	20.7	21.6	18.7	24.0	37.3	23.7	27.5	16.0	24.6	28.2	14.3	19.0	19.9	11.7	9.8	19.6	34.0	41.2	28.1	13.5	21.8	29.8	21.8	10.8	19.5	13.3	29.6	27.9	34.4	16.2	17.1	25.9	20.8	16.0	16.4	24.7	14.8	15.8	15.6	18.7	18.4	23.8	26.0	19.8	6.2	16.3	50.8	15.9	44.5	6.6	27.4	25.2	27.3	21.7	35.0	23.0	20.8	20.4	21.1	33.0	17.1	21.6	22.0	4.2	25.1	27.9	17.3	23.1	13.1	4.9	4.8	12.6	6.7	4.8	4.3	3.4	3.5	3.9	3.2	3.6	6.2	12.2	9.6	7.4	9.1	11.2	25.2	13.9	7.4	4.6	0.0	9.8	9.8	16.7	15.7	9.2	3.7	0.0	13.1	13.9	8.1	19.6	9.6	240.7	9.9	14.8	12.9	4.2	16.6	12.7	9.1	12.0	12.7	7.7	12.5	5.1	18.8	12.5	14.6	14.7	0.0	14.5	15.6	6.1	15.8	13.6	34.3	12.2	10.8	8.8	8.4	14.8	0.0	5.2	4.5	14.4	8.9	5.2	16.6	5.3	14.1	8.7	14.2	8.6	0.0	13.1	14.7	10.8	25.3	19.5	11.4	24.9	11.5	8.8	12.6	18.4	16.6
MTREX	"Dob1, fSAP118, KIAA0052, Mtr4, SKIV2L2"	ENSG00000039123	"Mtr4 exosome RNA helicase"	P42285	5	55307989-55425579	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, mRNA processing, mRNA splicing, rRNA processing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 42.3;Endometrial stromal cells: 44.0;Exocrine glandular cells: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037379	Supported		Supported	Nucleoplasm		NA	NA		13000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA037379: AB_10601713"	"unprognostic (7.71e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.08e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.11e-1)"	20.4	22.7	10.2	21.9	11.5	18.5	22.0	17.4	12.7	22.5	14.4	17.7	24.6	22.1	14.1	19.1	17.8	19.8	24.3	9.7	11.2	20.8	19.6	16.7	25.9	11.1	10.8	20.1	21.2	26.6	17.2	18.9	11.5	21.6	19.9	17.8	18.9	14.7	29.9	20.8	24.1	13.8	11.4	19.2	20.9	23.4	10.3	21.9	25.8	22.5	21.8	21.0	19.8	14.9	40.9	49.2	38.4	39.9	32.8	35.0	49.5	33.4	28.3	39.7	50.1	57.1	51.2	79.3	37.4	33.1	52.9	28.5	76.8	50.3	59.9	14.2	53.2	51.6	45.4	45.9	31.3	33.4	44.8	27.5	31.3	42.9	51.6	33.6	35.1	29.7	60.9	45.0	37.9	35.8	32.3	36.5	38.4	16.8	46.6	39.5	44.1	33.9	41.3	56.9	42.0	28.8	40.4	24.5	35.4	42.4	52.5	44.8	33.2	10.0	27.5	28.4	62.0	31.5	33.6	59.0	27.0	69.5	40.8	3.6	5.0	5.4	7.2	4.7	6.9	6.1	5.7	6.8	6.4	6.4	6.1	6.2	1.3	4.5	7.9	6.7	5.6	4.1	10.2	11.5	17.4	12.7	9.7	11.2	11.1	10.8	11.5	11.4	10.3	14.9	27.6	32.1	42.3	0.0	10.1	0.0	0.0	0.0	0.0	0.0	22.3	13.8	0.0	0.0	21.7	20.2	0.0	25.0	24.6	0.0	11.7	32.0	0.0	28.2	44.0	10.0	0.0	0.0	0.0	40.7	21.5	16.2	0.0	26.2	25.2	30.8	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	13.9	0.0	0.0	0.0	0.0	35.7	0.0	0.0	8.3	0.0	0.0	22.3	26.2	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	34.9	11.6	31.7	0.0	0.0
MTRF1L	"HMRF1L, mtRF1a"	ENSG00000112031	"Mitochondrial translational release factor 1 like"	Q9UGC7	6	152987362-153002709	"Predicted intracellular proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036367	Uncertain					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA036367: AB_10670715"	"prognostic unfavorable (4.82e-4)"	"unprognostic (4.64e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.56e-3)"	"unprognostic (4.21e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.01e-3)"	"unprognostic (4.80e-3)"	"unprognostic (2.88e-1)"	"unprognostic (3.82e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.84e-1)"	6.8	6.2	8.4	5.8	10.3	7.1	4.6	12.6	10.3	4.8	13.0	7.6	8.2	4.0	5.9	5.4	3.6	5.1	11.4	8.3	9.6	10.1	7.7	4.6	6.6	9.7	9.5	4.2	6.2	8.6	3.8	5.5	11.0	5.1	6.2	10.3	5.5	5.5	17.9	7.7	6.2	6.7	9.4	5.4	5.7	4.6	9.7	4.8	7.6	21.9	5.8	6.0	3.5	10.7	7.8	8.9	14.8	20.4	16.1	8.5	14.7	13.9	13.4	12.8	18.6	15.4	6.1	14.0	10.7	14.3	22.0	11.7	21.3	12.3	18.5	16.0	14.7	14.0	12.8	20.9	13.9	14.3	14.4	13.4	14.1	16.2	17.9	12.4	18.4	15.3	22.4	8.8	15.4	12.8	10.8	12.1	8.9	17.2	13.1	10.3	11.0	11.2	19.2	13.7	15.6	19.6	18.1	12.9	10.3	16.4	8.6	15.6	12.8	10.2	16.3	17.3	18.2	15.6	15.7	14.8	19.6	10.7	13.1	10.3	3.5	7.1	3.2	5.2	2.8	3.3	3.4	2.9	3.7	2.4	3.1	3.5	3.4	3.3	6.9	2.7	4.0	4.0	8.4	10.3	12.6	10.3	8.3	9.6	9.7	9.5	11.0	9.4	9.7	10.7	29.9	12.8	16.4	11.8	19.9	33.9	24.2	14.5	20.5	0.0	13.8	11.4	28.0	8.6	13.7	18.4	0.0	15.7	15.7	26.3	25.4	34.1	59.8	15.2	22.8	34.5	17.3	14.9	13.0	26.7	24.3	23.6	14.3	20.3	18.4	17.7	62.8	17.6	17.1	0.0	13.2	12.9	12.2	21.2	15.4	54.5	20.2	23.5	16.0	9.4	31.2	0.0	21.6	11.1	11.8	34.0	22.9	25.6	24.0	21.2	27.9	39.2	6.8	0.0	39.5	23.7	30.0	43.4	13.8	29.1	32.7	19.7	16.5	33.8	17.9	23.4
MVD	MPD	ENSG00000167508	"Mevalonate diphosphate decarboxylase"	P53602	16	88651935-88663161	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 147.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041404, HPA048250"	Uncertain		Approved	"Cell Junctions,Cytosol"		NA	NA		170000	"Cluster 15: NK-cells - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	"Cell Junctions"	"HPA041404: AB_2677457, HPA048250: AB_2680329"	"unprognostic (1.67e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.42e-1)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.89e-1)"	"unprognostic (9.56e-2)"	"unprognostic (9.26e-3)"	"unprognostic (8.33e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.19e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.00e-2)"	20.3	51.1	24.2	15.7	27.5	7.0	16.4	26.2	37.5	30.5	19.3	32.3	35.1	20.3	2.2	77.8	13.5	4.9	22.8	24.7	27.8	28.8	78.8	31.0	12.3	32.4	27.8	19.6	25.3	8.3	18.9	6.3	39.3	23.5	4.2	3.4	25.1	6.5	27.2	52.3	26.6	5.7	24.0	24.6	31.5	42.3	24.7	7.0	21.1	8.3	6.8	17.6	36.9	25.6	50.6	34.2	52.4	33.1	18.1	38.7	29.5	25.1	26.0	17.7	14.6	86.1	119.7	24.4	39.8	15.7	63.7	72.8	25.0	133.1	4.9	15.7	38.3	17.8	18.2	127.0	35.9	11.6	11.8	30.9	24.6	46.6	13.5	8.7	18.0	58.0	51.7	13.1	10.2	115.9	39.3	56.6	61.5	17.7	31.3	40.2	15.0	62.3	49.8	33.0	52.2	17.9	62.0	13.3	18.5	11.4	67.8	51.3	39.0	14.7	29.8	27.2	14.2	34.9	17.6	83.2	17.9	55.7	25.7	5.6	12.6	2.4	26.8	13.7	20.4	16.1	18.0	17.9	15.0	22.6	13.2	16.6	1.8	28.3	15.4	28.0	20.4	15.4	24.2	27.5	26.2	37.5	24.7	27.8	32.4	27.8	39.3	24.0	24.7	25.6	17.2	25.6	48.2	22.2	21.5	15.2	12.9	106.3	4.0	27.2	26.5	14.1	16.7	21.5	56.9	20.2	6.2	20.2	79.6	117.5	25.4	30.8	61.6	17.7	10.0	15.8	32.9	26.5	23.4	62.3	29.2	15.5	41.8	26.5	16.5	27.4	20.7	147.2	38.6	23.5	17.0	75.3	32.6	25.5	21.6	96.2	8.1	20.3	21.4	6.5	32.2	16.5	55.6	11.1	14.5	30.0	79.4	9.1	46.3	20.1	47.1	22.6	21.5	18.1	6.6	7.0	20.7	50.8	13.0	13.8	21.6	48.8	36.3	35.5	65.2	20.6
MYBBP1A	"FLJ37886, P160, PAP2, Pol5"	ENSG00000132382	"MYB binding protein 1a"	Q9BQG0	17	4538897-4555386	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Ribosome biogenesis, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005466	Supported		Supported	Nucleoli,Vesicles		No	No		47000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Vesicles	"HPA005466: AB_2667327"	"unprognostic (8.06e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.01e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.61e-4)"	"unprognostic (3.88e-3)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (8.12e-4)"	"unprognostic (9.70e-2)"	12.3	11.0	3.8	13.4	3.8	11.4	15.9	1.3	7.6	13.3	0.8	11.9	9.6	14.6	4.6	17.0	15.2	6.2	11.0	5.0	4.2	9.8	10.8	11.4	13.8	5.2	4.9	14.1	24.4	6.7	12.7	5.2	3.5	17.1	5.1	3.8	18.9	10.1	27.9	22.0	12.9	7.3	2.1	14.0	12.4	8.1	3.4	7.4	11.2	8.0	8.7	14.9	13.8	3.8	60.1	90.0	11.9	56.2	15.4	17.1	40.8	39.8	17.5	39.5	30.8	67.1	24.4	80.4	47.2	23.9	19.8	74.2	50.1	61.3	19.0	40.3	133.8	38.8	58.3	62.2	25.2	45.5	34.7	25.7	34.6	58.8	29.1	11.0	26.6	45.0	64.2	37.1	18.2	51.4	54.2	19.5	56.0	19.1	48.0	69.8	19.7	54.0	9.8	45.5	25.5	48.5	40.8	29.7	28.2	8.6	27.5	19.1	34.3	35.1	31.5	32.7	118.6	32.1	26.5	34.4	32.5	53.9	45.3	0.0	1.9	0.3	2.8	1.6	3.4	2.9	2.3	3.1	2.9	1.7	2.5	2.8	0.1	2.4	3.4	2.1	1.0	2.7	3.8	3.8	1.3	7.6	5.0	4.2	5.2	4.9	3.5	2.1	3.4	3.8	13.4	9.6	14.5	4.6	13.1	12.9	6.8	7.1	12.0	8.2	12.9	14.4	4.1	8.6	13.3	3.7	12.5	2.9	5.8	9.2	0.0	7.7	0.5	6.7	15.3	17.0	11.4	7.2	11.3	12.7	5.4	10.2	10.7	8.5	5.1	12.2	8.6	7.8	6.5	10.1	6.1	8.0	4.1	4.5	6.8	0.6	5.6	6.3	3.6	7.5	3.8	3.8	6.2	3.5	6.5	8.2	4.5	12.0	13.7	13.9	4.6	3.2	12.2	6.2	6.6	10.8	12.9	2.6	11.1	12.8	11.9	1.1	9.7	13.8	12.4	6.2
MYBPC1	ssMyBP-C	ENSG00000196091	"Myosin binding protein C1"	Q00872	12	101568353-101686028	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell adhesion"	"Actin-binding, Muscle protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	87	"skeletal muscle: 11290.5;tongue: 5207.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 34.6;Breast glandular cells: 102.4;Breast myoepithelial cells: 81.4;Cardiomyocytes: 64.7;Skeletal myocytes: 184.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 33.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"HAP1: 6.8"	"Group enriched"	"Detected in many"	9	"cerebellum: 39.6;olfactory bulb: 10.6"	"Region enhanced"	"Detected in many"		"thalamus: 6.9"	"HPA021004, HPA027614"	Enhanced					NA	NA		240000		"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 37: Myocytes - Muscle contraction"			"HPA021004: AB_1854232, HPA027614: AB_10602711"	"prognostic favorable (4.76e-5)"	"unprognostic (7.72e-2)"	"unprognostic (1.09e-1)"		"unprognostic (1.81e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.63e-2)"	"unprognostic (8.67e-2)"	"unprognostic (2.93e-1)"	"unprognostic (9.98e-3)"	"unprognostic (2.56e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.10e-2)"	"unprognostic (7.96e-2)"	"unprognostic (6.13e-2)"	"unprognostic (5.55e-3)"	1.5	0.3	55.5	0.1	66.5	0.0	63.7	60.4	71.6	1.9	36.3	4.5	0.1	0.2	1.1	94.7	0.8	0.3	1.8	50.1	59.5	0.3	0.7	0.7	0.0	52.3	64.5	0.5	1.1	0.0	0.3	0.0	55.0	83.5	0.8	0.0	48.4	0.3	11290.5	6.1	7.4	0.0	49.4	0.4	1.3	3.4	68.4	2.6	1.2	5207.7	4.0	0.3	0.7	49.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.5	66.5	60.4	71.6	50.1	59.5	52.3	64.5	55.0	49.4	68.4	49.9	1.3	0.0	0.0	34.6	0.3	0.0	2.2	0.0	0.0	0.0	102.4	81.4	64.7	0.0	0.0	0.0	0.0	0.0	0.6	2.7	0.0	0.0	16.5	0.1	0.1	1.2	0.0	0.0	5.3	0.0	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.2	0.0	0.8	0.3	23.7	0.6	1.2	1.8	1.0	0.0	0.0	0.0	0.5	0.5	0.1	1.6	0.4	0.0	16.3	0.3	0.1	0.0	0.0	0.0	184.6	2.7	1.4	1.4	0.0	0.0	0.0	0.7	0.0	0.3	2.9
MYNN	"SBBIZ1, ZBTB31, ZNF902"	ENSG00000085274	Myoneurin	Q9NPC7	3	169773396-169789716	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045149	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA045149: AB_10960839"	"unprognostic (7.13e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.77e-1)"	"unprognostic (8.25e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.34e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.36e-3)"	6.0	5.3	3.4	6.5	4.1	14.8	9.7	7.2	4.5	7.9	4.4	5.7	5.1	10.3	6.3	7.1	6.8	6.2	5.8	3.1	3.4	6.8	7.9	6.4	8.7	3.0	3.5	10.0	7.3	8.4	3.6	7.1	3.3	7.2	7.0	15.3	6.3	6.3	7.9	7.8	6.8	8.4	3.5	7.9	7.0	9.9	3.4	7.6	8.5	10.8	9.8	7.4	5.5	5.2	13.1	6.0	6.9	13.6	14.2	12.2	8.7	8.6	12.4	13.0	14.3	7.3	13.1	19.7	15.3	9.4	10.3	10.2	12.5	10.9	17.2	17.7	9.8	18.4	9.1	7.2	12.0	17.1	12.9	10.8	13.9	7.9	22.8	10.5	11.7	8.6	7.9	18.9	13.0	11.0	10.1	8.8	10.4	16.1	6.6	11.1	9.7	21.4	8.6	22.1	9.6	11.3	10.4	23.5	14.8	9.0	29.0	12.5	8.7	11.9	5.4	11.1	16.6	21.6	16.4	26.8	9.5	10.6	11.7	22.2	4.8	11.2	7.3	5.2	10.0	8.1	8.4	7.1	5.5	7.9	10.0	7.7	6.7	10.8	4.5	5.5	9.1	7.7	3.4	4.1	7.2	4.5	3.1	3.4	3.0	3.5	3.3	3.5	3.4	5.2	25.8	28.9	21.6	10.7	25.2	41.3	31.1	21.4	46.7	9.0	14.9	12.1	14.7	14.3	20.3	11.0	22.9	14.6	20.1	9.8	13.7	10.4	46.3	15.8	14.8	20.3	14.3	14.5	15.6	9.4	17.0	16.6	19.4	20.3	7.6	12.7	11.4	7.3	8.2	10.1	15.0	8.4	20.3	7.5	14.0	12.6	17.1	12.3	16.0	13.1	12.7	13.3	19.6	12.5	14.0	9.9	9.4	18.8	31.6	18.1	12.2	12.3	18.3	31.7	6.6	15.7	14.7	34.9	18.8	27.3	38.4	20.8	25.5	12.0	9.6	25.7
MYO19	"FLJ22865, MYOHD1"	ENSG00000278259	"Myosin XIX"	Q96H55	17	36495636-36543435	"Predicted intracellular proteins"		"Actin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 81.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021415, HPA059715"	Approved		Enhanced	Mitochondria,Cytosol		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Mitochondria	Cytosol	"HPA021415: AB_2266815, HPA059715: AB_2684111"	"unprognostic (3.12e-1)"	"unprognostic (2.38e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.89e-3)"	"prognostic unfavorable (8.33e-6)"	"unprognostic (1.07e-3)"	"unprognostic (1.39e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.70e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.17e-2)"	7.8	5.5	2.3	7.1	2.6	13.1	8.0	2.3	3.0	11.3	3.5	11.7	13.0	7.3	5.2	22.1	7.5	4.9	5.6	2.3	2.4	13.5	11.1	7.8	5.7	3.0	2.4	6.8	13.2	17.0	9.5	6.4	3.2	7.9	14.6	2.1	15.4	3.9	8.5	24.2	13.0	7.2	2.2	8.4	14.4	9.6	2.9	6.4	9.4	4.5	10.0	7.3	14.5	3.1	41.6	47.3	21.7	25.1	10.1	12.5	32.5	34.0	27.0	53.2	57.9	42.6	46.4	21.9	15.6	23.3	20.0	66.5	48.0	38.3	36.8	18.9	24.0	30.6	58.8	29.4	8.4	36.5	40.0	6.9	20.2	41.6	40.8	13.5	22.2	29.7	46.5	24.2	28.2	28.9	25.3	29.4	23.9	44.1	20.4	32.8	30.7	28.4	27.7	32.3	37.9	18.5	44.9	31.7	15.4	30.3	55.2	17.6	15.9	32.8	41.1	47.5	65.3	19.8	41.4	21.3	22.8	24.7	44.5	0.5	0.6	0.4	1.1	0.4	0.9	0.6	0.7	1.1	1.2	0.5	0.6	1.2	0.0	1.4	0.2	0.6	0.6	0.4	2.3	2.6	2.3	3.0	2.3	2.4	3.0	2.4	3.2	2.2	2.9	3.1	13.1	9.6	12.0	23.8	12.3	29.6	12.3	14.4	23.9	18.4	11.0	12.3	4.4	17.2	8.6	5.5	35.5	12.0	9.6	24.4	1.9	10.7	81.4	10.6	12.7	10.6	10.8	24.6	25.8	13.3	21.6	9.6	23.9	16.7	2.5	20.4	6.8	9.5	10.9	3.3	36.4	23.5	14.2	7.9	10.1	20.8	12.5	7.8	3.6	10.3	11.0	3.9	15.5	22.6	24.4	16.4	13.9	9.8	19.4	26.4	23.0	4.4	6.4	24.8	0.0	13.3	9.0	19.7	19.4	29.1	23.4	7.3	13.0	9.9	32.5	16.3
MYOM1		ENSG00000101605	"Myomesin 1"	P52179	18	3066807-3219968	"Predicted intracellular proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	23	"heart muscle: 412.8;skeletal muscle: 845.6;tongue: 435.6"	"Cell type enriched"	"Detected in many"	15	"Cardiomyocytes: 1346.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"HAP1: 13.5;HMC-1: 3.5;HSkMC: 6.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA014305, HPA049193"	Enhanced					NA	NA		33000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA014305: AB_1854257, HPA049193: AB_2680670"	"unprognostic (2.51e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.19e-3)"	"unprognostic (8.01e-3)"	"unprognostic (8.94e-2)"	"unprognostic (4.31e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.62e-1)"	15.1	2.2	7.5	1.3	9.0	0.6	4.1	7.8	6.4	3.0	3.4	14.1	1.9	6.4	2.9	14.1	6.8	14.6	412.8	5.7	11.5	1.5	24.7	1.5	1.3	11.1	12.0	2.9	11.5	0.4	1.6	1.6	11.3	12.4	2.4	2.0	5.3	4.5	845.6	1.6	4.6	11.9	8.6	0.9	3.2	5.7	8.0	0.8	2.8	435.6	0.7	7.6	2.4	8.6	0.0	0.1	0.2	0.0	0.7	0.7	0.3	0.4	0.5	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.0	13.5	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.0	3.5	6.2	0.3	0.2	0.0	0.3	0.0	0.2	0.0	0.4	0.2	0.0	0.2	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.1	0.3	0.0	0.1	0.2	0.0	0.5	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.4	0.1	0.2	0.0	0.6	0.0	0.2	7.5	9.0	7.8	6.4	5.7	11.5	11.1	12.0	11.3	8.6	8.0	8.6	1.2	0.0	0.5	49.0	1.7	1.7	2.3	0.7	0.0	2.1	1.0	0.8	1346.0	27.1	1.2	0.0	2.1	0.9	2.7	7.4	0.0	0.6	11.7	1.1	0.4	12.0	0.0	0.8	3.5	6.3	0.1	27.4	6.6	1.0	0.0	3.4	2.5	19.1	0.3	1.7	7.1	0.7	4.1	1.3	2.1	14.1	2.1	1.3	0.0	7.5	1.5	0.2	2.1	24.6	13.5	1.5	88.9	4.1	0.1	0.8	0.5	0.3	2.1	1.6	6.6	24.6	40.8	4.4	5.4	0.1	1.3	2.2	1.3	1.3	0.6	0.6
MYSM1	KIAA1915	ENSG00000162601	"Myb like, SWIRM and MPN domains 1"	Q5VVJ2	1	58643440-58700077	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Immunity, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, DNA-binding, Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 106.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054291, HPA057306"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Nucleoli	"HPA054291: AB_2682438, HPA057306: "	"unprognostic (2.95e-3)"	"unprognostic (3.64e-2)"	"unprognostic (3.20e-2)"	"unprognostic (8.68e-2)"	"unprognostic (2.08e-2)"	"prognostic favorable (5.09e-5)"	"unprognostic (8.12e-3)"	"unprognostic (9.63e-3)"	"unprognostic (5.72e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.44e-2)"	11.2	7.5	4.0	4.4	3.9	12.5	12.0	4.3	5.9	11.9	4.2	11.8	5.4	10.6	6.2	10.0	10.2	3.1	10.5	4.1	3.9	7.2	8.0	10.1	6.3	3.9	3.7	13.2	12.1	5.9	8.7	4.4	3.9	9.6	4.4	8.4	11.8	4.1	10.0	10.5	12.6	3.6	3.7	11.4	9.9	4.4	3.9	5.3	11.5	3.1	4.9	9.3	11.1	4.4	10.1	2.6	5.0	6.7	6.0	7.2	10.5	5.9	5.6	5.1	3.9	5.3	4.2	10.3	1.8	3.8	4.8	7.4	7.7	2.1	11.0	6.2	4.3	11.3	2.1	5.1	7.4	19.6	9.7	5.4	5.9	7.5	3.8	6.1	1.2	4.2	12.6	6.3	6.8	2.6	7.8	16.3	11.4	3.5	3.5	7.3	16.4	6.1	4.6	3.8	5.8	6.6	4.4	9.4	13.9	9.0	3.1	10.6	4.9	9.3	4.6	6.4	11.3	10.8	5.8	13.9	5.8	13.7	11.6	0.9	0.3	0.1	0.3	0.4	0.2	0.4	0.3	0.3	0.1	0.3	0.5	0.4	1.0	0.1	0.5	0.4	0.4	0.1	4.0	3.9	4.3	5.9	4.1	3.9	3.9	3.7	3.9	3.7	3.9	4.4	36.5	22.4	33.7	47.7	26.0	19.1	22.8	13.5	30.7	19.5	25.6	21.0	28.2	10.0	35.1	11.0	25.0	8.4	36.6	22.1	15.6	8.8	3.9	22.1	34.8	25.4	16.2	14.1	87.4	9.4	5.7	20.8	19.9	36.9	56.3	30.1	23.9	16.3	11.3	18.5	58.2	17.0	24.4	13.9	14.2	6.3	12.8	22.2	8.8	35.6	21.3	12.7	22.6	58.3	106.9	12.7	13.1	17.3	29.5	19.3	19.2	8.8	21.2	27.8	26.3	28.8	21.5	15.5	20.6	25.0	18.5	11.4	30.8	22.0	18.5	26.4
NAA15	"FLJ13340, NARG1, NATH, TBDN100"	ENSG00000164134	"N-alpha-acetyltransferase 15, NatA auxiliary subunit"	Q9BXJ9	4	139301505-139420033	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Developmental protein"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023589, HPA050661"	Approved		Supported	"Nuclear bodies,Cytosol"		NA	NA		140000	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Nuclear bodies"	"HPA023589: AB_1854311, HPA050661: AB_2681208"	"unprognostic (6.25e-3)"	"unprognostic (5.95e-2)"	"unprognostic (7.80e-3)"	"unprognostic (8.45e-2)"	"unprognostic (2.88e-1)"	"unprognostic (8.67e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (2.16e-2)"	"unprognostic (9.20e-3)"	"unprognostic (1.07e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.99e-2)"	"unprognostic (8.65e-2)"	"unprognostic (7.37e-3)"	"unprognostic (2.12e-1)"	"unprognostic (8.28e-3)"	"unprognostic (1.58e-1)"	9.1	8.9	6.5	11.4	7.3	16.4	9.9	12.4	8.3	7.3	7.3	8.4	7.6	8.9	6.0	12.5	7.1	7.0	10.0	6.5	6.7	7.5	10.9	6.4	14.5	7.3	6.8	7.9	7.8	9.7	5.8	10.6	7.7	8.3	9.1	9.2	6.2	7.2	17.0	9.3	7.0	8.7	6.9	8.5	7.9	13.1	6.9	13.4	9.0	16.3	15.5	14.5	7.7	10.5	44.7	32.1	30.4	49.2	21.7	26.4	37.3	42.2	27.6	39.9	30.6	45.3	38.2	91.1	25.3	35.0	34.6	28.1	80.5	51.7	57.2	42.8	29.6	49.0	29.6	29.8	23.0	90.5	30.5	18.7	31.0	50.4	39.1	21.1	40.5	35.2	92.1	38.7	42.9	35.6	86.8	26.8	50.7	83.4	25.0	53.4	40.9	47.0	31.8	37.2	39.3	30.8	28.2	45.7	28.8	30.6	27.8	35.2	35.0	38.3	27.0	36.7	48.7	46.5	89.0	88.7	32.9	64.6	37.4	4.2	3.4	1.1	5.0	3.9	5.9	4.8	5.3	5.9	4.7	5.3	5.1	5.8	2.6	4.5	3.9	4.0	5.5	2.1	6.5	7.3	12.4	8.3	6.5	6.7	7.3	6.8	7.7	6.9	6.9	10.5	28.4	48.1	33.8	28.4	39.7	93.4	69.6	20.7	29.0	34.0	28.1	15.7	46.9	22.8	32.3	20.2	20.9	39.9	22.8	14.4	15.6	28.1	9.0	40.3	38.9	31.5	15.6	34.5	44.0	19.5	50.8	32.9	21.4	40.5	34.8	35.7	16.8	28.1	32.5	40.4	45.9	20.8	18.3	24.1	35.0	11.3	25.4	27.8	28.4	29.0	26.6	27.7	32.0	42.3	57.6	26.5	16.2	29.0	23.4	53.8	10.2	16.4	34.0	36.3	32.9	69.0	47.4	90.0	59.7	44.0	99.3	41.7	31.7	32.1	32.5	70.2
NAA16	"FLJ22054, MGC40612, NARG1L, PRO2435"	ENSG00000172766	"N-alpha-acetyltransferase 16, NatA auxiliary subunit"	Q6N069	13	41311267-41377030	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 23.5;pancreas: 20.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039761, HPA040157"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA039761: AB_10795112, HPA040157: AB_10793917"	"unprognostic (2.09e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.66e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.36e-2)"	"unprognostic (7.94e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.34e-2)"	3.2	2.7	1.8	5.0	2.1	23.5	3.9	4.9	2.2	5.0	1.6	2.8	4.3	6.3	2.7	4.2	4.3	3.5	2.4	1.5	2.4	3.1	2.9	3.7	6.5	1.8	2.0	5.9	20.5	3.5	1.9	3.8	2.0	4.7	3.2	5.9	3.9	3.8	4.4	4.1	4.1	3.7	1.1	4.5	4.8	7.5	2.2	5.9	3.7	4.5	4.0	3.9	3.5	3.4	7.3	6.0	14.9	10.8	5.1	6.5	5.7	8.9	7.4	8.6	7.5	7.1	5.6	12.1	4.1	7.2	3.5	10.0	7.7	5.7	10.5	7.5	15.5	15.0	6.3	7.2	5.5	16.8	9.7	4.5	4.2	3.6	6.8	5.8	8.6	11.7	6.8	6.5	5.6	6.0	17.5	4.8	12.6	10.1	8.1	12.9	6.1	10.1	6.8	6.6	5.0	11.6	8.0	7.7	3.3	8.6	4.7	9.3	6.2	5.8	4.9	9.3	7.0	4.5	5.4	14.0	7.5	7.2	7.1	4.4	1.5	3.1	2.3	0.8	2.1	1.0	2.6	2.4	0.8	1.6	4.5	4.7	0.8	3.4	1.2	1.6	2.0	1.3	1.8	2.1	4.9	2.2	1.5	2.4	1.8	2.0	2.0	1.1	2.2	3.4	15.0	9.6	16.7	34.0	19.6	17.7	21.9	9.5	18.8	27.9	10.3	10.2	12.0	10.0	12.4	9.2	14.6	8.8	20.2	5.6	1.9	12.5	17.9	17.2	26.7	16.7	7.7	15.4	53.5	20.5	7.8	18.8	19.9	22.1	3.8	18.9	13.6	8.7	19.1	38.7	66.9	5.5	4.1	8.5	11.7	26.3	30.1	14.3	14.2	45.0	12.0	11.3	21.6	68.9	57.1	13.1	6.9	19.9	28.3	20.0	7.3	7.0	17.3	33.6	19.7	17.0	24.7	39.2	28.8	17.0	14.6	2.9	31.7	17.1	9.7	21.2
NAA25	"C12orf30, FLJ13089"	ENSG00000111300	"N-alpha-acetyltransferase 25, NatB auxiliary subunit"	Q14CX7	12	112026689-112108796	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 146.0;Oligodendrocytes: 109.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039322	Approved		Supported	"Golgi apparatus,Cytosol"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus, Cytosol"		"HPA039322: AB_10697548"	"unprognostic (1.26e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.91e-2)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (1.91e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (5.53e-5)"	"unprognostic (9.09e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.34e-2)"	"prognostic unfavorable (1.32e-8)"	"unprognostic (2.44e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.34e-2)"	"unprognostic (9.18e-2)"	5.5	6.1	4.6	6.0	5.0	9.8	6.8	6.4	8.1	6.8	8.5	6.8	3.9	5.5	4.3	7.6	5.8	3.7	5.6	5.3	5.1	4.6	5.6	4.9	6.6	5.6	4.7	7.0	6.9	5.9	4.3	5.3	7.7	5.4	4.2	14.8	4.9	4.4	14.9	7.5	4.8	5.4	3.6	5.3	4.9	5.1	4.9	6.0	5.7	9.9	6.9	6.4	6.7	8.0	16.7	16.1	14.8	11.9	8.1	14.0	17.9	15.3	12.4	18.3	12.4	16.2	8.6	28.9	14.4	12.3	10.5	19.2	32.8	13.0	25.1	16.6	22.9	23.6	15.9	15.0	13.2	34.0	13.7	12.1	15.9	21.3	21.8	15.5	16.1	12.6	35.3	3.7	16.7	13.5	19.6	24.9	22.1	34.2	18.6	21.5	15.2	19.7	14.0	27.0	19.1	10.5	16.9	19.8	15.0	14.0	19.3	13.4	13.7	15.2	13.6	17.0	21.3	15.0	30.4	33.0	19.4	14.7	15.5	0.0	1.7	0.5	2.4	1.9	3.7	2.5	3.0	2.3	3.5	2.8	4.2	4.1	0.0	1.6	2.5	3.7	2.5	1.6	4.6	5.0	6.4	8.1	5.3	5.1	5.6	4.7	7.7	3.6	4.9	8.0	16.1	9.6	16.2	44.1	23.3	66.7	34.5	17.1	22.8	38.9	18.9	12.4	23.5	12.8	26.5	7.3	146.0	25.6	20.4	10.1	3.9	15.3	26.5	15.1	23.9	17.4	16.2	17.0	71.6	19.4	21.6	17.8	15.8	14.8	20.3	20.7	15.4	19.4	14.0	23.5	68.0	11.9	28.5	15.4	25.2	8.6	17.4	16.5	16.0	30.0	83.8	13.0	12.3	48.2	109.6	17.4	7.5	12.8	15.7	61.5	7.4	4.7	25.0	67.7	6.6	28.7	22.7	31.5	29.5	28.5	70.2	22.6	15.3	20.0	14.7	48.1
NAA40	"FLJ13848, NAT11"	ENSG00000110583	"N-alpha-acetyltransferase 40, NatD catalytic subunit"	Q86UY6	11	63938959-63957319	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 102.6;Late spermatids: 130.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037816, HPA056142"	Uncertain		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA037816: AB_10672289, HPA056142: "	"unprognostic (3.52e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.88e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (1.43e-7)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.29e-3)"	"unprognostic (3.42e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.25e-2)"	3.3	8.9	5.1	3.9	5.1	2.5	4.4	4.5	5.7	4.0	5.7	5.2	5.7	3.0	3.3	6.7	6.8	3.6	9.5	5.3	4.9	9.1	3.8	3.6	7.5	5.6	5.3	2.7	6.5	15.1	10.4	6.7	5.2	4.2	4.7	7.2	6.6	4.0	4.7	2.7	5.7	3.1	5.0	8.8	4.8	15.3	5.2	10.0	6.1	8.5	7.3	4.2	3.6	5.0	15.5	17.3	21.7	11.8	6.0	5.9	13.8	11.3	12.0	27.3	19.1	14.8	19.3	9.5	13.6	10.2	18.9	13.7	18.3	8.2	20.1	12.5	11.2	13.0	11.1	16.9	7.9	20.9	10.8	6.0	7.4	17.0	4.6	10.6	18.0	16.1	22.4	6.9	12.9	11.8	22.3	16.3	20.2	14.3	11.8	21.9	19.5	12.1	18.5	11.8	28.7	15.1	17.7	15.2	9.2	15.8	25.1	9.2	11.6	15.1	18.3	8.9	9.3	8.3	5.6	16.5	9.2	8.9	11.9	2.3	0.5	2.7	6.9	0.4	2.4	2.7	1.8	3.3	2.7	2.4	1.1	2.6	0.1	5.2	0.2	3.5	0.5	2.3	5.1	5.1	4.5	5.7	5.3	4.9	5.6	5.3	5.2	5.0	5.2	5.0	4.3	3.2	4.8	12.1	8.1	2.8	2.0	4.5	10.8	30.9	11.5	7.0	14.8	5.7	9.4	18.4	33.3	9.6	12.1	13.6	0.0	5.7	46.3	20.0	7.4	7.6	17.5	7.4	14.3	5.4	12.8	4.8	6.1	8.5	1.3	14.3	9.7	5.2	9.5	102.6	15.6	6.1	10.2	10.3	5.3	130.5	4.7	7.3	1.8	15.0	4.4	8.6	17.5	11.6	10.1	5.9	3.5	7.2	12.2	2.1	10.6	4.1	22.5	23.9	0.0	4.3	4.4	27.4	16.5	6.5	2.8	4.1	8.9	10.4	7.3	1.8
NABP2	"hSSB1, MGC2731, OBFC2B, SOSS-B1, SSB1"	ENSG00000139579	"Nucleic acid binding protein 2"	Q9BQ15	12	56222015-56229854	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 243.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044615, HPA057213"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA044615: AB_10795884, HPA057213: AB_2683371"	"unprognostic (1.45e-1)"	"prognostic favorable (8.35e-6)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (7.44e-6)"	"unprognostic (4.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.96e-3)"	"unprognostic (6.52e-2)"	"unprognostic (4.72e-2)"	"prognostic unfavorable (2.69e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.01e-2)"	21.7	39.4	31.6	17.9	34.3	18.8	20.7	33.5	39.5	21.2	28.9	27.1	23.0	23.6	19.0	21.7	21.2	14.9	23.3	31.8	33.4	25.8	23.1	15.4	20.1	33.2	33.2	24.5	34.6	21.8	24.9	8.4	33.0	20.5	19.4	24.8	17.3	18.0	59.2	21.1	23.0	16.2	32.2	18.0	23.5	24.4	35.4	17.5	19.6	32.2	19.6	25.5	18.5	34.5	74.8	75.9	70.3	78.4	30.8	33.1	13.8	43.5	36.6	63.0	37.9	45.8	65.7	56.3	85.8	41.1	44.6	57.8	66.5	56.1	48.0	107.1	64.1	94.7	49.2	36.0	32.4	67.9	89.0	28.6	44.5	75.4	60.3	53.5	41.9	69.0	50.1	94.9	46.2	67.4	94.1	78.6	51.8	45.0	74.3	83.2	65.2	84.9	31.3	30.4	89.1	65.6	69.0	86.3	62.5	11.2	98.9	60.8	29.8	43.8	41.3	92.0	81.2	64.2	104.5	36.1	81.0	63.9	82.9	33.0	15.6	14.9	26.5	22.7	29.6	26.4	21.9	23.9	21.4	21.2	13.4	22.4	3.0	42.7	25.9	21.6	34.3	16.6	31.6	34.3	33.5	39.5	31.8	33.4	33.2	33.2	33.0	32.2	35.4	34.5	17.2	16.0	18.9	5.2	17.5	18.6	18.5	25.0	21.1	15.3	22.5	27.1	9.6	31.5	12.0	23.9	2.1	28.4	13.6	27.3	49.0	36.7	88.4	11.3	17.1	20.7	18.0	30.3	6.7	70.8	40.0	20.6	13.7	13.4	17.7	17.6	22.9	22.5	31.2	15.2	6.6	27.5	16.2	17.7	20.3	243.5	23.6	16.0	32.0	1.9	27.6	35.8	33.0	2.5	6.4	38.4	22.7	34.3	30.9	13.3	41.6	43.1	11.6	14.8	19.7	23.2	22.9	20.2	25.0	22.1	17.0	15.2	20.1	23.0	37.9	15.1
NAE1	"APP-BP1, APPBP1, ula-1"	ENSG00000159593	"NEDD8 activating enzyme E1 subunit 1"	Q13564	16	66802875-66873256	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatogonia: 219.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041178, HPA042041"	Enhanced		Approved	Nucleoplasm,Microtubules,Centrosome		NA	NA		100000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Microtubules, Centrosome"	"HPA041178: AB_10964773, HPA042041: AB_10964772"	"unprognostic (3.22e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (3.92e-8)"	"unprognostic (2.31e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.12e-3)"	"unprognostic (5.34e-2)"	"unprognostic (3.85e-2)"	"unprognostic (7.09e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (9.44e-5)"	"unprognostic (1.97e-1)"	23.9	28.3	26.0	26.0	26.0	38.8	32.5	28.8	29.6	23.0	27.1	31.9	32.4	32.9	35.2	30.3	26.8	24.2	29.7	25.5	27.1	26.5	28.6	22.5	36.1	25.8	26.1	35.6	27.3	41.5	22.6	28.4	27.1	28.8	35.3	33.9	25.9	26.7	35.0	33.1	33.2	30.3	27.0	22.2	21.6	47.1	27.1	35.0	32.3	33.0	31.6	28.6	22.1	30.3	107.6	81.1	140.4	139.4	55.1	78.9	116.9	79.9	80.3	115.6	139.8	99.5	80.9	118.1	89.1	60.4	74.8	105.6	107.7	96.5	162.0	43.8	122.1	83.9	53.6	153.9	63.2	157.3	100.7	64.0	69.6	92.8	80.7	61.0	82.5	141.2	201.9	40.3	89.9	37.5	165.7	177.7	196.2	83.4	144.6	175.7	167.8	157.7	89.1	92.6	151.3	110.6	239.5	50.7	94.7	86.0	54.2	105.2	64.7	80.2	80.1	84.7	93.9	75.3	125.3	423.8	72.3	103.0	99.7	2.8	6.0	13.4	27.3	5.8	34.9	18.2	29.0	30.1	8.2	14.4	31.0	31.4	2.7	17.1	6.5	12.2	27.4	18.3	26.0	26.0	28.8	29.6	25.5	27.1	25.8	26.1	27.1	27.0	27.1	30.3	29.2	32.1	32.2	23.5	30.1	33.0	66.6	87.2	17.1	52.0	28.4	31.4	30.7	18.6	53.4	31.3	12.5	101.3	33.9	28.0	39.2	70.0	4.6	27.7	23.2	30.7	22.9	38.9	41.3	60.2	70.9	38.4	20.9	22.9	35.4	55.9	19.2	21.3	28.6	50.5	40.7	33.3	67.1	10.4	13.5	14.3	48.7	16.2	49.8	17.8	25.7	68.4	51.5	33.2	39.8	65.0	114.3	54.2	32.0	68.8	34.7	48.2	44.8	35.9	19.7	41.0	63.7	145.4	219.3	33.6	32.1	52.4	36.9	49.4	42.5	49.5
NANP	"C20orf147, dJ694B14.3, HDHD4, MGC26833"	ENSG00000170191	"N-acetylneuraminic acid phosphatase"	Q8TBE9	20	25612935-25624014	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA050342	Uncertain		Approved	"Nuclear membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nuclear membrane"		"HPA050342: AB_2681098"	"unprognostic (8.72e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.42e-3)"	"unprognostic (6.01e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (9.01e-6)"	"unprognostic (3.20e-1)"	"unprognostic (3.75e-2)"	"unprognostic (7.70e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.42e-2)"	3.3	3.8	1.4	2.6	1.4	3.4	3.0	2.8	1.4	2.3	1.7	2.1	2.9	2.3	2.4	2.8	2.1	2.5	2.5	1.3	1.8	4.4	4.8	2.4	2.0	1.3	1.5	2.7	3.2	2.8	1.5	2.6	1.4	2.3	2.5	2.9	2.1	1.9	1.7	2.0	2.0	2.8	1.1	1.9	2.3	2.8	1.7	4.9	3.0	3.7	2.4	2.9	1.9	1.4	14.2	8.5	6.7	9.4	10.7	11.0	9.5	7.1	13.9	9.3	11.8	7.4	9.7	4.9	7.9	13.6	11.0	8.9	10.6	10.7	17.9	1.7	5.9	13.3	3.8	20.1	9.1	10.0	3.7	9.9	5.1	10.7	13.6	5.1	8.2	17.8	11.1	8.5	11.7	8.0	19.4	4.8	4.8	12.6	12.6	9.3	14.1	6.4	5.7	7.7	12.6	5.2	8.0	12.7	8.7	6.6	5.3	8.5	6.8	14.5	10.9	13.6	10.2	4.3	4.1	12.4	4.3	22.7	9.1	0.3	2.3	0.9	1.3	2.4	2.0	0.6	0.9	1.0	3.3	0.6	0.8	1.4	0.3	2.2	1.4	0.7	0.8	1.1	1.4	1.4	2.8	1.4	1.3	1.8	1.3	1.5	1.4	1.1	1.7	1.4	3.6	3.2	1.5	4.2	1.9	5.9	5.8	4.6	2.8	4.5	3.0	2.3	2.8	5.7	3.6	7.3	0.0	4.1	5.2	1.7	13.7	5.2	0.3	2.0	4.7	4.4	3.0	16.0	3.3	4.2	2.1	4.9	4.6	2.0	5.7	3.4	3.6	5.3	4.6	6.7	3.6	2.3	6.1	4.1	4.8	0.8	3.1	2.8	5.4	1.9	2.4	5.5	9.2	2.5	2.3	4.8	2.0	2.6	3.5	5.1	1.8	8.2	2.1	7.3	0.0	4.6	3.4	5.5	11.3	2.6	5.1	1.9	1.9	7.4	2.2	3.1
NAP1L1	"MGC23410, MGC8688, NAP1, NAP1L, NRP"	ENSG00000187109	"Nucleosome assembly protein 1 like 1"	P55209	12	76036585-76084735	"Plasma proteins, Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028861	Approved		Uncertain	Microtubules		NA	NA		10000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Microtubules		"HPA028861: AB_10603880"	"unprognostic (1.51e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.57e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.69e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.29e-9)"	"unprognostic (1.67e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.24e-3)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (6.14e-13)"	"unprognostic (5.59e-2)"	"unprognostic (3.07e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.15e-1)"	270.7	293.7	240.6	215.5	261.7	337.4	248.4	224.3	295.7	341.7	182.2	255.2	76.7	274.1	172.3	156.9	260.9	217.2	250.2	207.8	239.1	155.4	113.2	320.7	456.3	249.6	239.0	602.9	137.4	125.5	175.6	201.9	257.8	228.5	123.5	199.8	193.1	211.0	378.2	142.5	175.1	190.2	285.6	278.3	158.5	127.7	254.0	341.4	178.1	144.9	386.7	253.7	244.1	275.2	765.7	575.6	1061.5	673.3	667.4	1066.2	596.5	479.3	655.2	724.9	532.1	633.5	278.5	1791.9	521.0	601.8	305.7	496.1	636.3	763.4	892.0	570.1	627.7	667.6	407.6	646.4	950.1	1075.1	624.2	748.0	810.0	502.4	842.5	1778.1	891.6	640.5	995.1	379.3	1162.6	366.2	1380.9	868.2	1214.7	278.7	529.9	1071.8	1053.2	748.8	640.6	421.8	455.7	654.4	400.9	580.4	1180.9	818.0	860.4	765.8	704.5	561.5	635.1	403.2	687.9	472.7	601.0	1115.1	343.2	552.1	371.0	6.9	114.4	183.5	95.1	350.0	192.7	248.1	218.5	154.4	226.1	205.7	250.8	207.1	28.1	153.6	732.5	165.3	242.4	225.4	240.6	261.7	224.3	295.7	207.8	239.1	249.6	239.0	257.8	285.6	254.0	275.2	184.6	166.7	227.5	77.4	506.6	459.2	637.5	478.4	352.3	158.1	308.0	327.8	453.8	197.3	271.3	136.1	79.2	523.7	313.5	39.7	238.7	360.5	225.9	333.6	833.9	340.2	247.1	254.9	181.9	281.7	460.0	386.6	66.8	198.3	435.9	345.2	260.9	125.6	428.1	252.4	149.0	160.6	195.3	546.8	738.3	249.5	709.3	644.0	403.8	93.7	839.2	372.8	241.0	92.5	109.3	397.4	61.3	832.8	183.4	601.2	9.7	266.6	341.6	127.0	374.7	457.2	448.4	350.7	159.2	268.7	337.6	417.0	408.4	353.4	182.9	430.0
NAP1L4	NAP2	ENSG00000205531	"Nucleosome assembly protein 1 like 4"	Q99733	11	2944431-2992377	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011567	Approved		Supported	Nucleoplasm		NA	NA		3100000	"Cluster 46: Basophils - DNA binding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB011567: AB_776638"	"unprognostic (1.61e-1)"	"prognostic favorable (9.77e-4)"	"unprognostic (8.99e-2)"	"unprognostic (9.64e-3)"	"unprognostic (2.96e-3)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (1.68e-7)"	"unprognostic (1.80e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.55e-4)"	"unprognostic (1.54e-1)"	39.6	43.5	44.3	36.1	59.2	50.3	41.3	53.0	178.1	46.7	70.3	60.3	20.1	45.4	17.3	79.6	41.2	32.5	111.4	41.3	52.1	63.7	56.2	40.5	65.7	57.2	53.8	42.9	38.0	63.5	61.4	36.8	60.2	51.9	34.2	38.6	66.4	32.1	146.1	49.0	53.8	39.1	52.2	59.0	56.6	87.4	56.4	78.8	44.6	110.7	75.8	61.9	52.1	72.2	82.8	59.9	81.7	65.7	83.9	92.4	37.7	159.8	104.1	145.4	132.5	129.7	208.4	149.5	95.3	98.0	15.1	140.0	21.9	136.3	166.8	159.2	57.5	106.7	151.4	168.2	57.7	93.0	110.5	77.8	65.1	78.6	59.1	12.0	88.9	77.6	139.3	150.7	128.0	74.5	206.4	4.2	199.8	98.9	75.2	101.4	98.1	117.0	12.2	131.7	121.4	104.3	80.5	118.1	78.3	82.5	7.3	7.4	67.8	112.5	104.4	152.4	13.8	79.3	136.5	201.5	8.4	66.0	75.3	67.5	22.9	32.6	42.3	24.0	39.9	24.7	51.9	53.0	27.2	28.4	45.7	52.1	14.5	57.6	30.4	25.0	70.5	48.0	44.3	59.2	53.0	178.1	41.3	52.1	57.2	53.8	60.2	52.2	56.4	72.2	53.6	44.8	49.8	56.2	64.3	70.1	67.4	76.9	83.1	80.4	54.6	48.3	200.4	42.9	69.0	75.4	45.9	103.8	99.4	37.2	97.8	78.7	97.0	107.7	65.9	55.4	45.4	168.7	36.9	50.4	109.2	56.6	54.0	91.1	74.6	100.6	43.5	50.0	47.3	65.6	56.6	41.4	67.1	30.8	44.7	142.6	48.1	49.7	35.6	38.4	65.3	67.5	95.8	60.8	125.3	74.1	26.8	50.0	100.7	76.1	39.8	76.9	92.6	68.1	46.0	58.8	64.7	166.1	129.0	102.3	66.9	91.3	123.8	79.7	55.1	83.7
NAT10	"FLJ10774, FLJ12179, hALP, KIAA1709, Kre33, NET43"	ENSG00000135372	"N-acetyltransferase 10"	Q9H0A0	11	34105617-34147670	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB035546, HPA057576, HPA071628"	Approved		Enhanced	Nucleoli,Midbody		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoli	Midbody	"CAB035546: , HPA057576: AB_2683475, HPA071628: AB_2686426"	"unprognostic (3.04e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (1.07e-4)"	"prognostic unfavorable (9.61e-8)"	"unprognostic (1.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (8.83e-5)"	"unprognostic (1.24e-1)"	"unprognostic (7.18e-2)"	"unprognostic (9.55e-2)"	"unprognostic (8.69e-2)"	20.6	24.2	16.0	17.3	15.4	20.4	19.6	14.7	17.4	20.1	14.0	17.0	10.2	20.0	13.7	25.7	19.2	9.4	18.4	15.1	15.4	19.5	22.3	14.9	23.4	14.3	13.6	23.1	25.3	16.8	17.5	15.1	14.7	19.4	15.5	16.3	16.7	12.2	24.8	28.9	17.5	15.5	12.6	22.8	18.7	22.0	15.6	19.4	17.2	12.5	27.5	20.3	20.5	16.9	40.0	55.5	29.3	62.0	34.2	30.2	33.6	38.8	28.5	48.4	38.4	62.6	22.6	127.6	28.3	33.0	41.8	59.5	110.5	59.4	59.5	35.9	70.2	58.0	44.5	58.9	31.0	147.3	40.7	31.1	40.0	31.5	88.3	22.8	37.4	60.6	128.6	43.5	40.8	76.0	120.5	65.7	41.9	69.3	65.7	89.3	98.0	53.7	27.8	68.5	43.1	32.6	52.3	54.9	23.6	28.2	55.0	41.0	30.5	42.8	34.0	63.7	72.8	47.0	61.0	120.3	43.3	60.0	43.4	0.7	8.3	2.8	11.7	13.7	15.5	12.2	12.6	13.4	15.5	10.6	12.7	13.2	0.9	15.0	12.9	11.6	12.0	9.1	16.0	15.4	14.7	17.4	15.1	15.4	14.3	13.6	14.7	12.6	15.6	16.9	8.5	6.4	20.7	10.4	12.7	12.2	11.3	6.9	12.5	12.2	8.8	10.2	12.6	7.2	15.1	14.7	12.5	18.1	8.0	5.8	5.9	9.2	6.1	10.1	18.3	10.9	7.2	21.0	22.8	9.6	13.4	14.5	5.6	12.2	5.1	17.3	5.7	7.5	12.0	11.8	21.7	8.9	4.1	5.5	4.4	3.4	9.3	8.5	1.8	6.5	12.9	5.3	7.2	11.6	16.0	8.7	3.5	13.2	9.8	14.8	3.7	5.8	10.6	11.0	13.1	19.6	8.4	20.5	21.6	13.1	13.8	14.4	11.0	19.7	14.3	7.6
NAT9	DKFZP564C103	ENSG00000109065	"N-acetyltransferase 9 (putative)"	Q9BTE0	17	74770529-74776367	"Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021820, HPA057149"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA021820: AB_1847958, HPA057149: AB_2683350"	"unprognostic (7.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.25e-5)"	"unprognostic (1.27e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.41e-1)"	"prognostic favorable (3.21e-5)"	"unprognostic (6.50e-3)"	"prognostic unfavorable (6.26e-6)"	"prognostic favorable (7.80e-4)"	"unprognostic (8.50e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.03e-3)"	18.2	57.5	24.0	11.4	24.6	13.5	18.1	25.8	27.6	23.3	25.0	17.3	8.0	18.7	23.2	16.3	21.5	8.9	19.4	23.6	24.2	25.1	29.9	17.6	13.6	25.2	24.9	31.0	25.2	18.0	29.4	14.2	25.2	27.7	9.8	11.5	17.1	12.5	16.4	16.0	15.8	11.1	24.4	20.8	19.3	20.9	24.5	13.7	24.4	11.0	11.3	21.7	18.2	25.6	20.9	30.0	18.7	17.2	29.9	37.4	22.3	39.5	34.2	40.7	35.1	51.3	22.8	57.4	14.7	31.2	26.2	22.8	25.6	42.9	25.9	12.0	37.0	37.0	24.6	46.2	34.9	19.1	22.9	34.2	31.9	40.5	61.2	33.7	44.7	36.2	46.8	17.6	30.2	19.9	38.9	15.6	14.5	40.5	42.8	25.6	55.7	33.4	29.2	33.5	27.0	35.7	16.5	48.1	78.0	25.5	44.4	24.7	26.2	47.0	37.7	20.4	37.5	24.1	9.4	32.0	19.4	12.9	30.5	20.4	16.2	7.4	9.2	24.0	18.9	20.7	16.7	13.8	19.9	30.5	28.5	21.1	4.2	16.7	13.9	15.2	9.8	12.0	24.0	24.6	25.8	27.6	23.6	24.2	25.2	24.9	25.2	24.4	24.5	25.6	15.3	6.4	14.5	15.7	22.6	35.1	41.7	25.9	12.5	39.5	24.7	18.9	5.6	5.7	16.4	18.4	47.9	23.3	20.3	14.5	7.9	14.9	5.5	7.6	13.3	14.3	26.4	10.3	24.4	19.5	19.2	17.3	17.3	13.1	1.3	33.0	9.3	9.9	18.0	45.4	20.2	17.7	20.3	14.1	21.0	4.0	29.5	16.8	10.6	5.6	20.7	11.3	18.6	15.6	16.4	18.3	17.0	17.0	15.8	43.7	11.8	14.5	13.5	46.4	6.6	15.1	16.1	20.5	26.4	9.0	29.7	22.2	14.3	23.7	20.8	39.0
NBPF19		ENSG00000271383	"NBPF member 19"	A0A087WUL8	1	149475338-149556361	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 73.1;Paneth cells: 123.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	Microtubules,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	Microtubules	"HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (7.92e-3)"	"unprognostic (9.12e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.36e-3)"	"unprognostic (5.59e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.20e-4)"	"unprognostic (3.54e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.92e-5)"	"unprognostic (1.10e-1)"	"unprognostic (3.32e-1)"	"unprognostic (8.93e-2)"	"unprognostic (4.61e-2)"	38.1	9.0	11.7	31.4	5.4	55.7	28.7	3.7	35.0	25.8	37.6	19.1	10.6	28.8	24.4	24.6	29.5	16.7	10.2	9.7	3.4	14.3	18.9	27.3	30.2	5.9	10.2	48.8	33.7	17.4	3.8	14.9	8.2	24.8	21.7	57.6	20.6	15.5	15.0	63.4	13.4	30.4	0.4	36.8	13.2	28.6	19.9	33.5	20.7	18.2	26.6	19.1	9.2	7.8	62.9	16.4	33.8	18.0	65.9	55.4	16.0	29.8	22.4	20.2	19.4	14.7	21.9	18.1	7.0	45.4	26.7	27.8	47.8	27.6	30.9	32.6	26.8	51.6	49.1	5.2	13.1	51.9	18.0	38.5	12.1	58.7	73.5	27.6	13.3	25.1	12.7	27.6	43.3	45.9	28.3	31.1	30.7	17.6	25.4	25.5	35.7	29.1	12.5	30.0	2.8	7.1	71.5	23.9	13.0	47.7	44.7	70.4	80.2	40.7	30.5	23.9	46.9	23.1	14.5	54.9	45.6	35.4	12.4	15.1	22.2	7.8	8.9	8.6	6.1	3.3	5.0	3.3	4.4	7.1	6.5	8.6	24.0	9.3	7.1	16.1	2.1	2.4	11.7	5.4	3.7	35.0	9.7	3.4	5.9	10.2	8.2	0.4	19.9	7.8	2.3	51.3	59.2	61.0	12.9	0.0	18.5	0.0	19.4	8.1	13.9	7.6	22.4	2.8	9.9	3.7	27.1	1.5	24.4	2.6	1.9	21.2	57.8	13.9	13.0	2.6	1.2	12.8	7.6	6.2	7.1	14.0	4.6	23.2	20.2	9.2	2.2	7.3	6.6	3.3	6.7	3.1	0.0	40.9	0.0	8.0	32.3	43.8	0.0	12.2	73.1	16.6	36.0	22.1	0.6	10.0	123.8	30.1	17.1	6.8	6.3	0.5	11.7	48.7	19.7	15.9	12.4	30.4	6.2	33.9	0.0	1.4	26.3	2.8	6.0	11.5
NCAPD2	"CAP-D2, CNAP1, hCAP-D2, KIAA0159"	ENSG00000010292	"Non-SMC condensin I complex subunit D2"	Q15021	12	6493356-6531955	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 76.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 48.0;Late spermatids: 34.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012423, HPA036947, HPA037363"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	Yes		34000	"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Nucleoplasm, Nucleoli"	"CAB012423: , HPA036947: AB_10671367, HPA037363: AB_10672483"	"unprognostic (1.51e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.84e-2)"	"prognostic unfavorable (1.79e-8)"	"unprognostic (2.73e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.41e-3)"	"unprognostic (4.53e-1)"	"prognostic unfavorable (1.13e-7)"	"unprognostic (4.80e-3)"	"unprognostic (1.18e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.75e-2)"	8.3	7.4	7.3	21.5	11.4	35.5	10.9	9.9	8.3	10.2	7.4	17.9	17.0	10.7	10.6	15.9	11.2	9.8	7.6	7.2	8.0	7.4	4.8	10.6	38.1	11.0	10.0	8.0	7.7	11.3	5.5	17.5	11.7	9.4	20.4	11.1	11.8	10.2	7.9	21.9	16.0	13.4	8.4	16.1	12.1	18.2	10.2	76.8	11.3	10.2	44.8	10.1	9.3	13.9	125.3	99.3	134.6	97.9	29.9	28.4	159.2	76.1	69.8	138.3	109.1	123.5	150.8	135.8	24.2	63.2	126.7	128.6	188.0	105.4	194.1	214.1	92.8	112.2	113.8	79.4	12.5	145.0	96.5	20.5	31.6	112.4	107.8	61.9	89.9	94.0	71.0	63.4	104.7	79.6	162.2	73.8	207.5	129.9	78.2	153.7	260.6	77.7	39.5	64.1	54.0	61.9	121.5	64.9	44.3	189.1	27.0	101.7	51.0	94.1	149.6	60.8	168.4	45.3	51.7	181.0	55.7	92.2	126.1	11.0	1.7	3.7	7.1	2.8	5.3	5.1	6.4	7.3	3.4	3.5	7.3	7.3	1.4	8.1	2.2	4.1	8.3	3.9	7.3	11.4	9.9	8.3	7.2	8.0	11.0	10.0	11.7	8.4	10.2	13.9	4.3	6.4	7.4	4.9	11.0	3.6	3.8	4.4	17.1	3.7	4.7	6.9	4.1	5.7	3.4	1.8	8.4	13.5	8.9	7.3	0.0	4.5	18.3	5.3	6.3	5.4	1.2	48.0	5.6	3.7	17.8	6.4	7.1	5.8	3.8	20.0	8.9	3.3	10.1	5.0	5.0	9.9	6.1	16.4	4.4	34.3	5.9	10.8	0.0	2.8	9.5	11.8	15.5	2.5	17.8	5.3	4.6	6.0	22.6	4.1	6.0	2.4	4.2	8.4	0.0	4.2	5.2	21.3	13.7	19.3	3.4	6.3	12.0	6.1	14.7	4.1
NCAPG	"CAP-G, FLJ12450, hCAP-G, YCG1"	ENSG00000109805	"Non-SMC condensin I complex subunit G"	Q9BPX3	4	17810979-17844865	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.9;lymphoid tissue: 15.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 59.3;Extravillous trophoblasts: 26.6;Plasma cells: 20.4;Spermatocytes: 63.7;Spermatogonia: 24.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"white matter: 1.6"	"Low region specificity"	"Detected in all"			HPA039613	Uncertain					NA	Yes		9500	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA039613: AB_10805481"	"unprognostic (5.23e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.59e-3)"	"prognostic unfavorable (8.28e-4)"	"unprognostic (4.22e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (3.13e-6)"	"unprognostic (1.18e-3)"	"unprognostic (1.63e-2)"	"unprognostic (6.70e-2)"	"prognostic unfavorable (7.65e-5)"	"unprognostic (3.44e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.94e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.07e-1)"	0.7	0.5	0.1	4.1	0.1	13.9	0.9	0.5	0.1	0.7	0.2	3.0	3.8	0.6	0.0	3.5	0.2	0.9	0.3	0.0	0.2	0.2	0.7	0.6	8.7	0.6	1.2	0.2	0.2	0.1	0.1	3.0	0.7	0.3	2.4	0.3	0.7	0.0	0.2	3.5	3.2	1.0	1.2	2.1	1.9	5.6	0.3	15.8	0.3	0.1	8.7	1.2	1.0	0.2	45.1	28.3	63.8	42.2	4.0	7.8	23.1	56.8	22.2	55.0	55.8	36.3	26.8	66.8	11.3	16.0	47.6	19.9	54.5	22.1	74.8	30.5	27.0	53.6	37.3	29.8	0.2	38.4	20.3	1.5	1.5	40.7	18.6	8.8	27.9	28.9	53.1	74.1	55.0	13.4	44.1	36.9	32.8	26.1	27.9	42.8	57.4	28.0	16.6	13.9	50.0	29.7	51.2	10.9	15.7	27.2	25.6	21.3	23.2	52.5	23.6	30.0	78.9	23.2	23.3	56.1	21.7	39.1	35.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.4	0.1	0.1	0.5	0.1	0.0	0.2	0.6	1.2	0.7	1.2	0.3	0.2	0.3	0.0	1.1	0.0	3.3	2.4	0.6	1.9	1.2	0.2	0.6	0.6	0.2	0.0	0.8	0.0	0.0	11.7	1.6	2.9	0.0	0.1	15.8	0.9	1.9	1.7	1.8	59.3	0.2	0.0	26.6	3.8	7.1	2.3	1.3	14.2	2.2	0.5	9.5	0.0	0.4	3.1	2.0	2.6	2.9	9.5	0.6	3.7	1.8	1.0	0.7	0.3	3.1	0.5	0.5	0.2	0.1	0.0	20.4	0.4	0.2	0.0	0.0	0.2	0.0	0.2	4.3	63.7	24.3	11.0	1.1	2.2	3.7	0.7	5.6	1.3
NCAPG2	"CAP-G2, FLJ20311, hCAP-G2, LUZP5, MTB"	ENSG00000146918	"Non-SMC condensin II complex subunit G2"	Q86XI2	7	158631169-158704804	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 24.4;lymphoid tissue: 27.9"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026631, HPA049637"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear speckles"	"HPA026631: AB_1845983, HPA049637: "	"unprognostic (2.73e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (7.94e-4)"	"unprognostic (1.66e-1)"	"prognostic favorable (1.91e-4)"	"prognostic unfavorable (3.00e-5)"	"unprognostic (5.33e-3)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (8.50e-4)"	"unprognostic (5.19e-2)"	"prognostic unfavorable (4.06e-5)"	"unprognostic (2.58e-3)"	"unprognostic (1.28e-1)"	"unprognostic (8.21e-2)"	"unprognostic (7.37e-2)"	3.7	2.5	2.0	8.8	2.2	24.4	5.4	2.5	2.1	4.0	1.3	6.9	4.4	4.3	2.1	6.9	3.0	2.9	2.9	2.2	2.1	2.6	4.1	3.1	12.4	2.0	1.7	3.1	2.2	4.6	3.5	5.9	2.1	2.8	7.6	2.8	3.5	2.8	3.4	6.8	5.8	4.8	1.6	4.6	5.6	14.8	1.8	27.9	3.2	4.1	13.8	4.0	3.9	2.4	103.9	53.7	64.1	41.8	9.5	15.4	25.3	74.3	47.4	89.0	99.0	48.5	52.0	64.0	45.0	30.3	95.1	51.7	53.7	33.8	117.2	68.4	40.4	57.2	64.8	38.8	4.2	72.2	62.3	6.8	3.7	73.1	21.0	16.2	50.4	72.9	71.9	91.6	82.8	111.4	119.2	48.8	63.7	58.8	43.3	69.7	67.8	60.6	22.6	45.9	69.6	54.5	91.6	35.0	20.2	40.4	31.4	46.5	25.9	60.6	45.9	166.2	120.6	61.3	48.2	77.2	64.6	89.6	118.5	5.9	0.9	1.1	5.2	1.2	7.5	1.6	5.2	3.6	2.3	1.0	1.6	1.8	0.7	5.2	5.1	1.1	7.2	2.2	2.0	2.2	2.5	2.1	2.2	2.1	2.0	1.7	2.1	1.6	1.8	2.4	3.6	6.4	1.5	3.9	4.1	4.0	2.1	2.8	1.8	3.9	3.7	3.3	4.8	2.8	4.6	1.8	0.0	6.7	5.1	3.4	0.0	2.3	15.1	4.0	4.6	4.3	0.0	19.6	10.7	3.3	10.4	4.5	4.1	5.9	1.3	12.6	2.9	2.6	7.3	8.4	7.2	2.9	2.0	3.8	5.2	7.2	2.8	4.4	1.8	3.7	2.7	2.1	2.1	10.1	10.7	2.3	0.4	4.1	11.0	1.1	0.3	1.3	6.0	2.8	6.6	4.3	5.7	48.2	18.5	6.1	2.0	2.6	4.9	5.0	5.7	3.0
NCAPH	"BRRN1, CAP-H, hCAP-H"	ENSG00000121152	"Non-SMC condensin I complex subunit H"	Q15003	2	96335766-96377091	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 35.2;lymphoid tissue: 37.4;testis: 35.4"	"Cell type enhanced"	"Detected in many"		"Plasma cells: 26.3;Spermatocytes: 89.3;Spermatogonia: 29.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"T-reg: 6.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.8;T-cells: 6.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA002647, HPA003008"	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	Nucleoplasm	"HPA002647: AB_1078300, HPA003008: AB_1078301"	"unprognostic (5.52e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.92e-1)"	"unprognostic (7.51e-2)"	"prognostic unfavorable (9.53e-6)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (1.50e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.16e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.00e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.30e-2)"	1.2	0.7	0.3	9.9	0.4	35.2	1.8	0.9	0.9	1.3	0.1	7.7	5.6	0.9	0.2	6.3	0.5	1.6	0.4	0.3	0.2	0.4	1.0	1.1	20.3	0.1	0.0	0.3	0.3	0.5	0.2	5.2	0.3	0.4	9.3	1.8	1.5	0.2	0.3	4.7	6.2	2.8	0.0	3.7	3.6	35.4	0.1	37.4	0.4	0.1	22.0	2.6	2.0	0.3	134.1	52.0	115.1	60.6	3.9	6.1	80.8	58.7	40.3	115.1	118.4	93.5	71.5	121.0	41.8	26.6	106.2	57.2	100.2	39.6	117.2	110.0	63.4	123.7	49.3	74.5	0.7	112.2	101.3	1.8	4.2	89.1	35.9	10.2	46.6	89.7	89.5	88.8	53.0	59.5	183.8	104.2	85.9	57.6	56.6	133.4	106.7	95.5	23.6	49.6	71.2	52.3	34.8	46.5	19.9	42.4	36.6	80.0	24.1	83.5	126.3	76.9	101.9	44.4	70.1	134.0	33.7	111.5	95.3	3.8	0.0	0.2	0.8	0.9	0.1	0.9	1.2	1.0	0.4	0.9	0.0	0.4	0.3	0.1	0.0	0.0	6.2	0.5	0.3	0.4	0.9	0.9	0.3	0.2	0.1	0.0	0.3	0.0	0.1	0.3	4.9	0.0	0.0	0.0	3.5	0.6	0.7	1.9	1.2	0.4	1.0	0.8	0.5	0.0	1.6	0.0	8.4	9.4	2.0	2.1	0.0	0.5	5.9	1.7	0.9	1.8	0.0	16.4	0.4	0.0	16.3	1.8	4.1	1.2	1.3	5.5	1.4	0.4	8.5	0.0	0.3	2.8	0.0	3.8	3.7	4.9	0.9	2.2	1.8	0.0	0.2	8.5	0.0	0.5	1.0	0.2	0.1	0.4	26.3	0.7	0.4	0.0	1.6	2.3	0.0	0.2	3.5	89.3	29.4	8.8	0.9	1.9	5.1	0.6	5.7	1.1
NCAPH2	"384D8-2, CAP-H2, hCAP-H2"	ENSG00000025770	"Non-SMC condensin II complex subunit H2"	Q6IBW4	22	50508224-50524780	"Predicted intracellular proteins"	"DNA condensation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 111.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067932, HPA069056"	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cytokinetic bridge"	"HPA067932: AB_2685926, HPA069056: AB_2686076"	"unprognostic (2.01e-1)"	"prognostic favorable (2.24e-8)"	"unprognostic (3.65e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (2.92e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.26e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.00e-1)"	25.7	21.9	32.9	24.5	33.6	78.8	26.9	32.7	39.2	31.8	25.4	29.3	17.7	29.8	12.4	30.3	30.0	13.0	36.7	32.0	30.9	26.6	27.6	28.2	27.6	32.6	29.0	37.6	40.7	16.7	38.6	17.1	28.7	28.4	11.7	15.5	25.7	16.6	30.7	32.6	28.4	14.7	27.5	33.2	30.2	52.3	28.5	29.6	28.9	19.3	20.2	25.9	26.9	33.5	60.7	32.1	53.8	57.1	15.8	18.4	71.6	45.8	31.6	81.8	89.5	67.2	41.4	68.8	25.5	32.9	45.5	47.1	49.0	44.2	23.5	40.3	82.8	39.8	86.7	63.6	19.1	90.3	69.5	16.1	27.6	64.4	22.2	12.2	26.2	59.4	51.5	132.5	33.4	83.9	61.7	109.9	39.3	34.9	37.9	103.3	71.0	77.2	23.8	40.6	35.6	47.5	36.7	55.4	44.3	16.5	37.5	86.7	17.6	64.2	80.5	54.4	72.3	67.7	45.8	110.1	48.8	45.7	62.3	11.9	9.8	18.2	18.7	11.6	22.9	16.0	19.4	19.1	8.0	14.2	19.9	17.3	11.4	13.9	14.4	11.8	19.3	15.5	32.9	33.6	32.7	39.2	32.0	30.9	32.6	29.0	28.7	27.5	28.5	33.5	10.1	22.4	24.5	12.1	15.9	18.9	23.8	17.5	6.2	18.3	11.5	12.6	19.6	15.7	10.4	9.2	4.2	36.3	15.5	24.6	15.6	16.6	36.8	8.5	7.5	12.9	13.1	31.5	8.6	23.5	55.1	13.8	14.8	14.5	17.1	16.3	8.9	10.6	19.3	8.4	8.8	18.8	6.1	7.9	16.3	111.5	17.4	9.2	12.4	3.7	16.2	14.7	18.6	3.0	8.2	17.3	13.5	17.3	26.6	15.2	18.4	9.5	5.9	16.1	19.7	17.8	16.9	36.2	39.7	10.9	18.5	31.5	15.9	7.6	22.6	18.2
NCBP2	"Cbc2, CBP20, NIP1"	ENSG00000114503	"Nuclear cap binding protein subunit 2"	P52298	3	196935402-196942594	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, RNA-mediated gene silencing, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044850, HPA062483"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA044850: AB_10961012, HPA062483: AB_2684779"	"unprognostic (1.82e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.12e-3)"	"unprognostic (3.17e-1)"	"unprognostic (5.13e-3)"	"prognostic unfavorable (2.37e-7)"	"unprognostic (2.86e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (4.75e-4)"	"prognostic unfavorable (2.27e-4)"	"unprognostic (3.28e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.30e-2)"	"unprognostic (5.04e-3)"	38.3	44.0	40.3	38.7	41.4	17.2	36.0	39.7	46.6	34.5	38.6	35.4	29.4	32.6	41.1	29.0	30.1	28.8	31.3	41.5	45.8	41.7	30.1	27.1	43.5	42.7	42.1	35.7	25.7	38.2	26.0	33.9	42.3	36.4	35.2	46.2	24.4	35.5	38.6	27.2	27.8	33.8	43.6	34.2	29.6	25.8	43.8	49.9	37.7	38.6	42.2	45.6	26.1	43.1	144.3	44.6	105.5	131.8	118.6	102.8	74.1	106.1	80.9	66.4	69.7	99.5	51.2	97.0	229.7	76.3	85.4	84.6	136.1	113.0	104.7	50.8	85.0	125.2	55.3	87.5	103.9	146.4	85.3	84.1	101.2	48.7	134.1	99.5	104.3	103.2	71.6	99.7	113.7	165.5	111.3	88.4	134.5	137.2	139.5	86.9	78.6	92.9	99.3	101.9	57.3	153.1	63.8	126.4	189.4	85.4	279.1	112.4	97.5	67.1	71.4	85.0	193.0	155.6	149.4	162.1	93.8	162.5	103.2	9.9	37.7	20.9	37.5	44.5	56.6	53.2	46.2	44.8	40.1	43.5	52.8	48.1	4.0	43.1	47.0	32.2	45.0	40.4	40.3	41.4	39.7	46.6	41.5	45.8	42.7	42.1	42.3	43.6	43.8	43.1	38.5	25.6	43.5	9.1	71.1	52.5	83.6	55.9	36.5	55.7	48.9	36.8	40.5	25.8	51.6	42.3	58.4	59.1	58.9	44.0	97.8	64.3	116.2	39.5	66.6	50.2	45.0	35.1	12.8	49.8	81.8	47.1	30.5	35.9	52.6	54.7	30.0	31.1	65.4	45.4	14.0	44.9	54.9	54.1	60.7	66.2	37.6	38.6	32.0	2.8	68.2	91.0	51.5	10.6	10.4	69.1	45.9	51.6	42.0	81.9	37.0	82.5	44.6	60.3	26.3	40.9	51.3	52.9	59.5	33.5	44.8	53.2	49.8	58.8	52.1	84.2
NCBP2AS2	"HIAR, KRASIM, NCBP2-AS2"	ENSG00000270170	"NCBP2 antisense 2 (head to head)"	Q69YL0	3	196942674-196943543	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 50.3;Cytotrophoblasts: 53.1;dendritic cells: 22.6;Extravillous trophoblasts: 42.3;Hofbauer cells: 43.0;Syncytiotrophoblasts: 34.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"				"unprognostic (3.48e-1)"	"unprognostic (4.33e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.74e-3)"	"unprognostic (4.77e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.61e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.67e-1)"	"unprognostic (5.07e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (8.92e-4)"	"unprognostic (4.19e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.66e-3)"	19.0	22.6	32.7	9.7	32.3	38.4	18.8	33.7	33.7	12.6	27.2	31.6	15.9	21.7	13.2	22.5	16.2	6.0	27.9	31.7	34.9	24.9	23.5	14.9	13.9	32.0	31.8	11.5	21.9	20.1	21.4	9.6	33.0	18.7	16.6	13.1	19.8	13.0	45.1	29.5	23.9	10.2	31.2	23.7	23.8	14.0	32.4	18.2	16.9	35.2	10.5	20.7	16.3	32.3	52.7	15.3	26.0	31.3	20.5	18.7	50.0	24.4	16.8	33.2	22.1	29.7	18.7	49.1	87.8	18.3	25.9	41.0	42.8	21.6	26.0	17.5	64.1	39.0	19.3	49.0	23.1	36.4	23.5	30.8	39.4	19.4	24.0	15.1	21.7	45.7	39.7	38.1	14.5	93.9	45.8	65.7	56.9	58.8	74.0	40.7	22.7	60.9	28.0	29.7	59.9	68.0	26.1	39.4	61.3	26.8	80.9	41.4	16.5	15.3	45.4	24.5	52.2	57.1	71.4	119.5	18.0	62.3	20.7	87.4	120.6	116.5	91.6	97.9	99.2	98.3	115.7	106.5	110.0	123.3	141.8	115.3	47.6	127.2	89.7	129.0	118.3	109.7	32.7	32.3	33.7	33.7	31.7	34.9	32.0	31.8	33.0	31.2	32.4	32.3	10.8	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.3	0.0	0.0	0.0	0.0	53.1	22.6	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	42.3	10.4	0.0	0.0	0.0	0.0	0.0	0.0	43.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	34.3	2.9	0.0	0.0	0.0
NCL	"C23, Nsr1"	ENSG00000115053	Nucleolin	P19338	2	231453531-231483641	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004210, HPA023981, HPA071110"	Supported		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No		1400000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"CAB004210: AB_670270, HPA023981: AB_1854688, HPA071110: "	"unprognostic (1.91e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.72e-3)"	"prognostic unfavorable (1.41e-6)"	"unprognostic (3.74e-2)"	"unprognostic (4.31e-3)"	"unprognostic (9.78e-2)"	"unprognostic (6.70e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.42e-2)"	212.0	192.8	128.8	226.0	146.3	301.4	228.7	129.1	139.6	180.0	114.1	183.6	160.7	205.2	150.2	228.8	173.2	132.2	164.3	115.9	152.3	166.2	218.5	147.4	289.7	148.8	141.5	258.2	209.0	258.9	115.9	203.4	140.4	155.4	219.2	147.1	157.0	160.9	350.9	197.1	157.4	201.0	137.9	176.3	164.7	126.2	142.1	347.0	198.4	228.2	329.0	271.1	169.1	143.9	718.3	691.8	715.7	640.1	485.7	592.0	823.0	790.4	497.2	690.8	628.2	1227.4	521.4	1083.7	608.6	651.0	892.6	719.5	1614.4	1059.9	1284.7	554.6	644.0	1587.3	605.9	1749.5	544.0	1930.4	632.7	513.5	613.2	872.3	1019.6	394.9	834.2	770.5	1745.4	378.6	760.5	1176.4	1443.2	1086.7	1202.0	728.7	435.9	1290.8	1452.0	918.4	583.8	959.9	749.0	502.0	555.8	704.5	706.9	625.7	476.8	985.3	686.3	611.4	626.7	714.5	1063.7	624.3	554.5	1885.9	467.2	1173.1	685.2	27.3	95.6	62.5	136.5	100.3	152.8	113.5	118.4	121.9	130.6	111.9	130.3	114.2	16.8	177.8	121.7	102.0	102.3	151.0	128.8	146.3	129.1	139.6	115.9	152.3	148.8	141.5	140.4	137.9	142.1	143.9	286.2	291.7	411.7	8.1	468.9	459.9	633.8	241.0	644.9	145.0	315.2	303.8	320.9	147.3	401.6	195.0	47.9	386.9	596.2	215.0	230.9	294.4	20.6	348.7	669.8	291.1	200.0	419.2	9.3	254.4	444.6	370.9	292.0	421.8	451.7	262.7	130.6	242.0	239.5	80.8	10.4	319.6	156.6	133.7	231.1	32.2	217.2	281.8	165.4	10.3	268.9	199.6	346.1	14.1	14.9	268.0	153.9	159.9	543.5	651.1	120.1	277.6	250.3	141.0	151.2	548.9	442.0	433.3	532.4	707.9	441.4	379.0	454.0	442.6	380.6	449.1
NCLN	"NET59, NICALIN"	ENSG00000125912	Nicalin	Q969V3	19	3185563-3209575	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Theca cells: 115.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006625	Approved		Approved	"Nucleoplasm,Lipid droplets"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Lipid droplets"	Nucleoplasm	"HPA006625: AB_1079453"	"unprognostic (4.32e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.19e-4)"	"unprognostic (8.55e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (2.15e-4)"	"unprognostic (9.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.26e-3)"	"prognostic unfavorable (8.37e-5)"	"prognostic favorable (8.82e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.38e-2)"	25.8	62.4	19.7	16.2	18.5	33.3	22.3	18.6	25.2	23.1	13.9	36.5	31.1	25.9	4.3	31.0	23.4	6.9	28.0	22.2	15.7	29.5	59.8	33.1	12.7	20.4	18.8	22.0	53.6	11.0	23.5	7.5	18.6	28.9	8.7	3.5	22.9	8.0	29.2	25.8	35.8	8.6	17.4	42.8	29.7	21.8	21.1	8.6	24.4	10.5	6.6	26.3	21.7	17.5	70.8	74.2	21.6	60.3	20.3	15.4	55.4	84.5	33.2	57.5	45.5	103.6	36.8	43.3	67.0	49.4	37.8	87.2	24.7	57.1	12.7	57.4	61.3	31.7	46.2	73.2	41.1	56.8	51.3	29.0	36.2	46.4	24.7	15.2	31.7	41.7	84.1	41.4	25.6	59.3	48.9	64.1	59.3	43.2	63.6	77.8	23.2	71.9	36.5	42.6	45.3	47.1	31.1	56.2	50.3	10.3	38.3	61.9	47.6	45.4	45.8	77.3	100.4	59.0	58.1	36.0	51.1	71.5	72.7	1.4	13.4	9.8	7.1	13.1	5.8	5.4	4.3	7.9	9.2	4.5	4.6	6.2	7.6	4.8	5.6	18.8	4.2	9.6	19.7	18.5	18.6	25.2	22.2	15.7	20.4	18.8	18.6	17.4	21.1	17.5	15.3	16.0	14.7	12.1	19.8	8.3	9.4	18.2	5.7	15.1	15.6	11.9	10.2	15.7	14.8	11.0	10.4	20.4	26.0	71.0	3.9	31.0	15.0	11.3	15.6	14.3	12.6	12.4	13.6	37.4	49.3	14.9	30.5	17.4	15.9	31.1	12.8	43.8	39.3	23.5	14.6	41.2	14.2	18.8	9.2	49.1	9.3	18.1	14.2	8.4	19.2	5.8	14.4	9.0	10.3	35.8	45.3	9.1	51.7	22.0	75.7	11.7	10.5	13.2	13.1	11.8	16.9	13.6	20.1	12.4	12.5	17.0	12.0	115.1	72.7	14.2
NCR3LG1	"B7-H6, DKFZp686O24166"	ENSG00000188211	"Natural killer cell cytotoxicity receptor 3 ligand 1"	Q68D85	11	17351800-17377341	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 7.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 32.2;Inhibitory neurons: 29.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"cerebellum: 4.7;cerebral cortex: 4.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HL-60: 53.8;K-562: 30.8"									HPA024137	Uncertain					NA	NA		21000		"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA024137: AB_1859534"	"unprognostic (1.23e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.03e-5)"	"unprognostic (6.24e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.36e-1)"	"prognostic favorable (4.21e-12)"	"unprognostic (7.88e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.52e-3)"	"unprognostic (1.36e-1)"	1.1	0.5	0.3	1.1	0.5	1.9	0.5	4.7	4.7	0.6	3.7	3.4	4.5	1.0	0.4	0.7	1.4	0.9	1.0	0.3	0.6	2.5	0.4	1.1	0.5	0.1	0.0	1.2	0.8	7.5	1.7	0.4	0.1	0.6	5.1	1.9	0.8	0.6	0.4	0.8	3.3	1.0	0.0	0.6	1.3	2.3	0.0	1.3	2.6	0.1	0.7	1.1	0.5	0.7	3.9	1.3	8.8	1.2	3.0	8.1	0.6	2.8	5.2	3.8	9.0	7.3	1.5	22.4	0.4	3.1	1.2	4.0	14.4	3.6	3.1	3.9	23.8	20.6	10.0	7.2	12.5	53.8	0.9	6.7	1.8	5.3	12.8	1.6	4.2	8.1	30.8	0.1	1.2	0.4	5.2	4.7	0.5	14.4	2.1	1.7	4.6	0.3	3.1	1.4	9.3	3.5	3.1	0.7	2.5	0.1	2.1	11.9	6.1	0.7	1.2	2.3	1.6	2.4	4.5	25.1	3.9	17.6	1.8	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	4.7	4.7	0.3	0.6	0.1	0.0	0.1	0.0	0.0	0.7	0.8	0.0	2.0	8.1	1.4	2.5	2.1	2.1	5.2	7.2	1.9	0.4	0.8	2.8	1.7	1.8	2.1	0.1	3.1	6.8	0.0	2.3	13.6	2.3	3.2	1.6	1.8	1.3	32.2	0.9	0.0	4.0	5.6	3.2	0.0	1.5	3.6	0.5	0.9	5.0	29.3	6.6	0.0	1.6	13.6	2.5	0.6	4.4	3.6	4.7	0.4	1.4	2.1	8.5	1.7	1.2	5.4	0.4	0.8	1.8	4.1	1.1	5.3	1.1	0.0	3.1	1.9	0.7	1.1	4.1	3.7	1.5	1.6	5.6	7.5	0.9
NDC1	"FLJ10407, NET3, TMEM48"	ENSG00000058804	"NDC1 transmembrane nucleoporin"	Q9BTX1	1	53765478-53838463	"Metabolic proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069751, HPA070882"	Approved		Supported	"Nuclear membrane,Plasma membrane,Actin filaments"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear membrane"	"Plasma membrane, Actin filaments"	"HPA069751: AB_2686189, HPA070882: AB_2686320"	"unprognostic (2.51e-1)"	"unprognostic (1.93e-1)"	"prognostic favorable (4.48e-5)"	"unprognostic (6.96e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.36e-3)"	"prognostic unfavorable (7.52e-7)"	"unprognostic (3.46e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (3.58e-4)"	"unprognostic (9.27e-2)"	"unprognostic (6.22e-3)"	"unprognostic (3.00e-3)"	"unprognostic (4.38e-2)"	"unprognostic (9.24e-2)"	"unprognostic (6.07e-2)"	5.4	5.2	3.4	9.5	3.5	8.4	11.1	3.6	4.1	5.7	3.6	11.9	8.9	6.5	7.4	7.7	7.5	4.6	4.5	3.6	3.4	6.9	7.8	4.7	15.7	3.2	3.3	5.9	4.7	9.5	1.7	8.0	3.3	4.8	14.2	6.0	4.2	5.2	4.3	7.3	8.2	7.1	3.5	5.6	6.4	7.5	3.5	14.2	6.8	5.2	18.4	7.1	4.2	3.9	61.6	31.2	42.8	43.7	15.5	15.5	49.3	40.9	31.0	63.8	51.1	47.5	40.4	119.0	26.2	18.6	51.2	72.0	73.2	43.3	89.8	29.8	50.9	58.5	42.9	40.5	14.3	95.3	31.9	9.4	17.0	62.9	37.5	18.6	39.1	44.2	67.7	16.9	35.6	22.2	47.2	38.2	101.0	52.2	49.9	52.0	68.4	66.0	29.8	41.7	25.4	32.2	36.5	71.5	35.9	45.3	55.3	50.2	22.7	32.9	32.6	45.5	74.9	17.9	48.8	84.7	27.3	71.6	42.2	0.0	2.3	1.5	3.0	5.0	4.7	3.6	2.8	2.7	2.6	2.8	5.3	4.1	0.1	3.1	3.3	2.3	3.4	2.4	3.4	3.5	3.6	4.1	3.6	3.4	3.2	3.3	3.3	3.5	3.5	3.9	4.4	6.4	6.3	12.4	8.7	10.1	6.4	9.0	12.0	4.5	10.1	6.3	8.1	4.3	5.4	5.5	2.1	11.5	5.9	7.9	0.0	8.5	2.3	5.0	5.6	6.1	0.0	19.4	13.8	9.1	20.2	6.3	8.6	4.6	7.6	21.5	5.3	7.1	11.8	3.3	11.0	10.3	16.2	8.2	8.9	2.1	2.8	7.1	7.2	13.1	4.7	3.3	3.1	11.6	19.4	7.0	5.8	3.4	20.1	8.9	2.9	4.5	5.5	2.9	6.6	6.3	15.7	11.8	14.3	18.2	8.5	6.8	6.7	4.3	18.2	6.5
NDC80	"HEC, HEC1, hsNDC80, KNTC2, TID3"	ENSG00000080986	"NDC80 kinetochore complex component"	O14777	18	2571557-2616635	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 31.2;lymphoid tissue: 29.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 63.4;Spermatocytes: 82.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 7.2;granulocytes: 8.3;T-cells: 11.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA066330			Supported	Nucleoplasm,Centrosome		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Centrosome	"HPA066330: AB_2685661"	"unprognostic (1.96e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (2.53e-8)"	"unprognostic (1.16e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.86e-2)"	"unprognostic (3.19e-3)"	"unprognostic (7.74e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.69e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.71e-1)"	1.8	0.9	1.4	9.6	1.3	31.2	2.5	2.2	1.7	2.7	0.1	7.0	5.9	4.3	2.1	5.6	1.2	2.5	1.2	1.0	0.6	1.2	1.6	1.5	20.5	1.9	0.6	0.8	0.9	0.5	0.1	10.4	2.9	5.3	9.8	0.7	1.1	14.0	0.9	7.9	6.2	5.0	0.4	5.5	3.8	15.1	1.2	29.2	1.6	0.6	19.3	3.2	4.6	2.5	80.3	17.7	86.5	38.6	4.5	9.8	44.5	91.7	49.1	117.7	99.7	49.2	44.0	86.6	40.4	35.9	49.7	47.9	98.2	39.9	123.6	32.2	24.6	68.8	49.5	38.1	1.5	133.2	55.1	5.1	3.7	67.8	47.8	12.0	54.3	52.8	56.8	107.1	104.0	36.2	65.1	57.2	44.9	51.6	25.3	71.0	88.6	69.7	31.0	38.0	69.3	31.4	84.4	21.7	32.7	34.0	36.7	52.4	33.2	75.7	168.1	60.7	123.2	46.5	78.6	116.0	33.5	60.8	65.8	3.5	0.6	2.5	1.8	0.4	1.7	7.2	3.2	3.8	0.2	5.3	2.0	2.0	8.3	1.7	0.5	1.3	11.3	1.3	1.4	1.3	2.2	1.7	1.0	0.6	1.9	0.6	2.9	0.4	1.2	2.5	2.8	0.0	0.6	0.3	5.8	2.3	0.7	3.8	0.6	0.0	0.6	0.9	15.8	0.0	2.4	0.0	0.0	15.5	4.8	2.1	0.0	0.9	22.0	1.3	3.7	1.9	0.0	63.4	0.6	0.4	21.7	6.8	2.6	2.1	0.0	20.8	5.7	0.5	11.5	0.0	0.5	2.8	8.2	3.2	2.4	7.6	7.5	1.7	0.0	1.0	0.4	0.0	7.2	0.5	0.5	0.3	0.1	23.3	14.1	0.4	0.4	0.2	1.4	0.0	19.7	0.6	6.8	82.8	21.1	4.2	0.6	2.1	8.7	9.8	6.2	1.5
NDE1	"FLJ20101, NDE, nudE"	ENSG00000072864	"NudE neurodevelopment protein 1"	Q9NXR1	16	15643267-15734691	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis"	"Developmental protein"	Lissencephaly	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 105.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"granulocytes: 21.8;monocytes: 11.7;NK-cells: 8.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024075	Approved					NA	Yes			"Cluster 14: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA024075: AB_1854336"	"unprognostic (1.09e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.84e-1)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (9.92e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.55e-2)"	"unprognostic (3.70e-3)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (8.19e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.93e-2)"	9.2	5.8	12.1	13.0	23.6	25.6	9.4	22.5	15.6	14.6	6.9	25.0	7.5	11.6	2.6	17.7	11.1	9.8	10.6	11.2	16.1	6.3	4.2	11.1	20.4	30.0	24.5	7.5	4.0	4.0	3.1	10.0	26.5	14.2	7.3	2.0	12.2	5.1	7.3	27.6	12.9	10.7	17.0	12.5	10.1	11.1	21.3	23.4	6.3	7.9	20.9	15.3	19.8	43.2	37.0	33.0	34.2	39.9	11.4	18.6	10.4	15.4	21.0	30.4	34.5	18.3	58.3	21.9	24.0	23.2	16.7	34.5	25.3	47.3	20.8	33.7	16.0	24.6	35.3	51.7	16.3	33.3	37.2	6.6	28.9	28.8	52.0	16.9	40.6	27.9	20.5	80.5	26.6	43.9	43.0	30.5	30.5	26.5	14.3	64.8	32.3	34.8	11.6	24.1	17.0	21.0	27.5	40.7	27.6	25.9	42.8	34.3	12.5	26.9	17.6	43.2	36.1	17.4	13.1	38.1	27.5	43.0	55.0	5.1	4.7	15.0	3.0	3.8	1.7	3.3	3.0	1.3	3.4	1.9	1.8	2.0	21.8	8.5	11.7	3.1	3.3	3.9	12.1	23.6	22.5	15.6	11.2	16.1	30.0	24.5	26.5	17.0	21.3	43.2	11.7	3.2	4.4	11.1	36.1	26.0	32.7	19.0	24.5	7.0	9.5	10.4	2.0	4.3	8.9	5.5	6.2	3.9	25.0	9.6	0.0	4.5	46.9	17.1	23.1	11.6	4.2	49.0	2.1	5.3	5.3	11.8	19.4	15.0	10.8	15.5	8.6	1.7	10.1	3.3	2.4	7.4	2.0	15.8	11.0	58.5	15.8	19.3	12.4	22.5	53.0	7.4	50.4	9.5	105.5	7.1	4.2	6.0	16.6	26.3	4.6	1.9	13.3	6.5	6.6	6.9	9.5	13.8	10.0	18.8	30.7	2.5	28.3	9.8	10.2	21.6
NDOR1	"bA350O14.9, CIAE1, NR1"	ENSG00000188566	"NADPH dependent diflavin oxidoreductase 1"	Q9UHB4	9	137205685-137217009	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 13.4;Oligodendrocytes: 10.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024504	Approved		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Nucleoplasm, Intermediate filaments"	"HPA024504: AB_1854338"	"unprognostic (1.67e-1)"	"unprognostic (1.44e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.41e-2)"	"unprognostic (5.89e-3)"	"unprognostic (5.99e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.61e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.69e-3)"	"unprognostic (2.05e-1)"	"unprognostic (4.30e-2)"	"unprognostic (6.74e-3)"	6.5	8.2	8.7	9.8	9.6	17.2	6.9	7.9	12.5	8.1	5.4	8.4	9.6	7.8	2.0	8.3	7.9	4.6	6.6	8.3	7.1	9.0	7.1	8.6	11.5	10.7	9.0	7.0	8.9	4.0	8.2	4.0	10.2	9.6	2.9	3.9	8.6	5.2	4.0	9.5	10.6	3.7	7.9	14.2	8.7	10.5	9.9	8.9	10.1	1.5	5.4	7.8	7.2	12.9	14.2	21.2	13.8	21.8	5.7	5.6	42.7	20.4	9.1	19.1	13.0	21.6	16.3	19.9	15.6	7.7	15.3	52.1	10.0	14.3	3.8	25.9	16.3	17.6	59.7	11.6	9.6	19.9	36.2	7.8	9.7	21.6	7.9	5.3	8.9	25.9	29.2	20.6	7.0	25.8	21.0	35.8	22.5	12.9	26.0	38.0	16.5	28.2	6.0	12.4	17.6	17.5	16.8	17.0	10.6	6.1	27.2	22.8	12.0	35.3	22.9	41.7	23.2	12.5	26.8	20.7	15.4	18.1	20.7	1.1	2.1	3.1	1.3	2.2	1.1	0.5	1.2	1.2	1.7	1.0	0.6	0.6	2.9	0.7	1.7	1.1	1.8	1.5	8.7	9.6	7.9	12.5	8.3	7.1	10.7	9.0	10.2	7.9	9.9	12.9	1.4	0.0	2.6	13.4	3.9	0.5	0.7	1.0	5.2	0.4	1.5	1.3	1.6	1.5	1.6	3.7	0.0	4.5	1.4	3.3	1.9	1.1	0.8	1.3	1.9	1.8	2.4	1.3	8.6	1.1	3.5	1.6	5.1	2.1	1.3	2.0	1.1	0.8	2.5	0.0	7.5	1.9	2.0	3.2	1.3	1.1	0.6	2.7	1.8	6.5	5.4	0.1	5.2	3.5	10.5	1.6	1.5	0.4	6.9	0.7	2.6	1.2	0.3	0.9	0.0	0.9	1.4	1.9	1.2	3.2	0.3	3.7	3.8	1.6	2.2	0.8
NDUFA12	"B17.2, DAP13"	ENSG00000184752	"NADH:ubiquinone oxidoreductase subunit A12"	Q9UI09	12	94897055-95003748	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 558.6;tongue: 563.1"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 2159.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039903	Supported		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria	Cytosol	"HPA039903: AB_10795516"	"unprognostic (2.76e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.85e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.27e-2)"	100.2	94.1	158.6	73.9	162.8	93.2	77.1	168.9	228.1	67.8	159.8	148.6	109.3	66.8	87.1	89.8	77.8	52.9	361.8	161.3	172.6	133.8	143.7	70.3	92.5	166.4	162.1	64.7	59.6	159.5	73.5	79.5	164.1	74.7	143.9	106.8	75.3	77.8	558.6	74.2	101.5	98.4	162.6	97.6	87.7	58.9	165.1	108.9	89.6	563.1	122.0	81.0	73.0	161.1	255.3	281.1	223.6	160.8	183.3	171.8	165.8	118.8	178.5	258.5	234.6	347.6	125.8	293.7	68.8	187.6	141.1	188.2	236.1	278.4	296.7	254.8	282.9	241.2	218.6	358.8	186.3	344.0	285.3	183.0	352.4	215.7	266.9	270.4	222.2	246.0	235.2	130.4	260.8	381.1	238.6	533.6	167.0	313.7	484.0	179.9	189.4	335.2	262.5	393.9	213.2	128.5	201.3	287.3	164.6	193.9	287.2	226.9	243.5	134.1	134.0	195.0	204.2	207.5	349.9	443.7	80.6	293.6	211.2	643.9	420.5	228.2	354.8	512.5	336.4	482.8	479.5	429.9	576.2	415.5	631.9	455.9	62.0	464.6	506.6	355.5	570.8	814.8	158.6	162.8	168.9	228.1	161.3	172.6	166.4	162.1	164.1	162.6	165.1	161.1	213.5	73.7	68.4	26.8	81.3	108.6	163.9	364.5	71.2	67.4	87.9	171.7	2159.0	135.8	168.3	108.5	64.6	254.0	127.9	172.0	620.3	162.0	240.0	110.3	98.9	206.0	85.3	86.5	19.6	163.9	254.5	172.6	67.2	100.7	58.3	103.5	109.2	149.1	192.3	37.0	29.0	171.8	244.1	103.6	161.9	122.1	97.6	111.1	160.1	13.1	203.5	141.6	199.8	20.6	22.3	234.6	228.8	133.5	98.8	123.8	229.9	338.3	134.7	130.5	105.2	120.8	291.2	156.3	109.8	127.9	127.7	209.6	120.2	181.9	219.2	182.0
NDUFA2	B8	ENSG00000131495	"NADH:ubiquinone oxidoreductase subunit A2"	O43678	5	140638740-140647771	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 1052.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035933	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA035933: AB_10669661"	"unprognostic (4.48e-1)"	"prognostic favorable (6.53e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.15e-2)"	"unprognostic (5.39e-3)"	"unprognostic (4.01e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.39e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.18e-2)"	"unprognostic (3.78e-2)"	"unprognostic (9.96e-2)"	"unprognostic (4.22e-1)"	"unprognostic (1.30e-3)"	76.1	127.9	131.0	52.3	131.3	96.0	67.3	139.0	156.1	49.2	139.8	81.0	90.2	43.8	79.0	73.5	50.3	45.8	197.3	129.8	137.1	144.9	145.1	53.3	66.1	133.3	131.0	54.9	81.5	99.8	79.1	47.3	133.3	68.7	60.9	51.8	102.2	46.8	283.8	52.4	86.1	31.6	135.8	72.6	90.8	79.7	134.9	78.1	64.2	233.0	48.2	55.5	51.3	142.3	131.1	202.5	91.3	195.9	113.6	84.5	117.8	76.6	69.0	99.4	120.4	328.1	149.5	125.4	191.2	65.9	122.9	103.7	88.4	153.9	57.1	120.6	226.6	80.1	170.6	248.3	67.7	138.7	102.6	100.6	116.6	65.4	47.5	84.3	101.2	111.8	86.9	194.4	93.1	204.9	168.4	285.9	97.5	152.8	203.6	144.7	110.4	212.7	167.5	146.4	119.6	99.4	104.7	292.2	221.8	81.9	269.7	216.3	70.1	113.9	84.8	96.3	125.9	214.2	339.4	190.1	132.3	152.8	65.0	195.0	304.6	311.5	133.1	270.1	137.4	222.0	141.1	143.0	258.1	178.0	127.0	135.6	255.8	156.8	219.9	273.3	205.6	322.8	131.0	131.3	139.0	156.1	129.8	137.1	133.3	131.0	133.3	135.8	134.9	142.3	138.4	109.0	125.4	10.4	127.5	97.8	116.4	311.1	105.3	87.4	182.2	203.5	314.4	200.1	199.7	244.6	37.5	294.1	168.0	499.6	815.9	187.8	526.6	194.5	114.1	115.8	193.2	222.2	6.5	220.4	231.0	115.9	122.9	171.9	92.5	121.2	169.6	516.1	291.9	53.8	7.7	337.9	258.4	251.3	144.6	435.1	165.0	168.0	190.3	5.6	265.1	227.3	211.2	5.5	12.9	194.7	474.4	153.4	151.8	153.8	682.9	1052.3	207.9	113.0	118.3	104.8	139.0	182.7	237.0	165.8	117.1	222.5	124.3	196.1	367.5	164.4
NDUFA5	"B13, CI-13kB, CI-13KD-B, NUFM, UQOR13"	ENSG00000128609	"NADH:ubiquinone oxidoreductase subunit A5"	Q16718	7	123536997-123557904	"Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 403.3"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 717.3;Distal tubular cells: 1070.2;Proximal tubular cells: 667.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043175	Supported					NA	NA		81000	"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA043175: AB_10793992"	"prognostic favorable (8.47e-5)"	"unprognostic (4.00e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.20e-2)"	"prognostic favorable (3.99e-9)"	"unprognostic (3.39e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.73e-3)"	55.2	129.2	94.7	34.1	99.9	34.8	68.8	94.2	130.1	51.3	93.4	78.5	77.6	47.5	71.5	51.0	51.8	47.0	215.7	100.5	108.4	175.3	114.9	44.4	40.0	92.4	97.6	42.2	41.2	170.1	58.3	39.7	98.5	72.8	73.3	127.1	75.6	63.1	285.1	27.2	72.7	46.9	92.6	35.4	77.4	38.3	94.4	52.8	136.6	403.3	42.5	57.8	33.5	91.6	65.9	41.8	76.3	76.6	64.5	58.6	39.5	57.4	63.1	46.8	61.1	47.1	58.2	108.6	54.8	58.8	91.0	60.7	83.9	75.2	74.3	89.6	71.7	68.8	85.9	78.1	62.7	140.5	56.4	58.6	65.9	45.3	47.3	84.1	68.4	75.4	213.9	104.9	84.4	45.5	127.3	162.1	100.3	154.3	107.0	69.2	75.0	146.6	129.5	63.7	144.9	86.3	76.1	286.2	90.3	102.5	65.6	104.7	53.1	58.9	31.7	262.0	88.5	111.2	109.4	116.4	112.7	106.2	75.7	57.8	26.2	31.5	38.2	48.7	55.4	53.6	48.6	44.9	37.1	41.6	52.5	54.0	9.2	52.7	54.8	40.0	55.8	60.4	94.7	99.9	94.2	130.1	100.5	108.4	92.4	97.6	98.5	92.6	94.4	91.6	99.2	102.5	100.4	38.2	108.7	112.5	146.2	280.3	74.6	183.6	113.0	100.8	717.3	102.9	160.6	165.5	83.4	160.6	105.6	119.0	1070.2	132.2	359.6	123.4	91.1	91.8	138.0	91.1	65.2	89.6	156.8	110.5	108.6	128.6	88.7	59.2	66.0	170.6	109.6	127.9	48.5	168.6	295.0	67.2	92.5	77.5	90.1	94.9	202.7	19.7	65.7	264.6	77.2	32.2	29.2	86.2	130.9	112.1	82.0	107.1	210.2	667.6	158.6	214.7	118.3	97.4	133.7	179.0	99.0	94.7	110.2	158.4	102.3	116.9	172.2	147.0
NDUFAF2	"B17.2L, mimitin, MMTN, NDUFA12L"	ENSG00000164182	"NADH:ubiquinone oxidoreductase complex assembly factor 2"	Q8N183	5	60945177-61154531	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Chaperone	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA048082, HPA054776"	Supported		Enhanced	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 47: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA048082: AB_2680254, HPA054776: AB_2682598"	"unprognostic (7.28e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.46e-3)"	"unprognostic (2.41e-2)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (2.56e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.76e-2)"	"unprognostic (8.40e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (1.79e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.66e-2)"	42.7	39.2	34.8	23.3	35.7	18.0	38.5	34.6	56.0	34.7	33.0	48.3	21.0	31.6	17.5	36.4	31.3	17.0	57.7	34.8	37.5	37.4	32.2	24.9	19.7	36.2	37.9	37.7	35.7	31.2	45.1	14.5	37.3	31.9	26.2	22.0	25.8	23.0	80.2	22.6	24.9	25.9	34.4	18.3	35.9	31.2	35.4	13.0	23.0	46.5	18.8	43.4	33.4	35.0	109.0	51.9	41.6	129.1	80.7	113.8	70.3	129.8	71.1	85.2	103.7	99.4	84.0	150.8	127.5	91.2	141.2	44.2	72.6	113.8	103.6	66.0	104.3	52.1	95.7	99.4	115.6	72.5	26.2	59.7	119.2	74.9	226.0	53.9	74.7	64.0	79.5	76.3	90.9	89.6	64.2	108.0	35.3	41.2	135.0	77.3	115.1	192.7	83.1	46.1	84.8	33.0	74.7	72.7	136.0	35.8	86.1	40.4	68.6	55.5	82.8	125.3	134.2	46.0	73.2	170.8	75.9	123.2	66.3	0.4	18.3	2.4	17.3	19.1	21.1	23.0	22.3	21.1	32.1	15.2	18.6	20.1	0.8	27.1	15.8	11.0	31.7	12.2	34.8	35.7	34.6	56.0	34.8	37.5	36.2	37.9	37.3	34.4	35.4	35.0	40.8	12.8	28.0	23.8	32.8	60.5	64.6	62.2	34.1	27.9	47.9	59.8	87.6	45.8	39.6	38.6	12.5	20.8	18.7	29.8	93.9	55.1	175.7	41.8	95.1	35.8	24.7	28.8	62.2	56.6	49.2	60.4	28.5	40.3	20.3	27.2	31.8	94.6	51.4	42.1	68.8	59.3	40.7	29.5	59.1	22.2	76.7	29.0	44.4	40.3	24.7	34.0	22.6	61.9	71.3	69.8	52.2	62.1	29.0	144.1	32.2	151.4	25.9	29.1	26.3	55.2	60.1	108.4	73.9	63.0	63.6	14.2	34.0	48.5	65.7	71.1
NDUFAF4	"bA22L21.1, C6orf66, HRPAP20, HSPC125, My013"	ENSG00000123545	"NADH:ubiquinone oxidoreductase complex assembly factor 4"	Q9P032	6	96889315-96897891	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction"	Calmodulin-binding	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 168.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046560	Uncertain		Supported	Mitochondria		NA	Yes			"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA046560: AB_10966700"	"prognostic unfavorable (1.31e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.89e-1)"	"unprognostic (7.53e-3)"	"unprognostic (6.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.20e-3)"	"unprognostic (6.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.31e-1)"	5.7	7.9	13.3	3.4	14.7	2.2	7.0	16.8	21.4	6.4	10.4	7.4	4.9	5.5	4.7	5.4	4.4	4.5	25.6	14.7	15.6	12.6	9.3	3.2	4.7	14.9	14.5	7.8	5.5	10.1	2.5	4.8	15.6	7.2	7.5	9.8	6.2	9.6	23.2	4.8	4.4	5.6	12.3	4.9	4.7	4.6	16.6	5.3	7.4	31.1	4.7	7.8	3.7	13.7	2.2	6.1	10.5	14.3	10.3	5.9	5.6	6.0	5.6	8.8	6.6	8.4	3.7	20.6	10.7	5.6	8.4	4.4	24.7	9.3	8.5	14.5	19.5	23.0	3.2	7.4	11.2	24.4	9.2	5.7	14.2	7.6	7.7	4.4	6.9	14.3	21.0	13.6	13.9	7.0	15.7	13.1	20.1	11.3	10.0	7.4	5.9	10.7	14.6	6.0	17.9	8.4	3.1	10.7	17.5	10.2	3.3	16.1	5.8	4.6	3.5	16.2	9.9	3.1	5.4	20.0	6.2	18.1	6.9	0.2	1.8	0.5	4.0	3.6	5.3	5.1	5.2	5.4	3.3	5.4	7.6	6.9	0.3	3.0	2.3	3.8	5.9	3.2	13.3	14.7	16.8	21.4	14.7	15.6	14.9	14.5	15.6	12.3	16.6	13.7	31.9	9.6	19.8	9.8	43.2	108.8	74.4	82.6	60.9	15.1	28.5	48.1	126.9	25.8	37.3	23.9	0.0	49.6	27.9	23.5	168.3	37.7	3.3	19.2	18.3	30.7	39.3	23.3	18.5	27.6	47.6	34.4	33.6	15.9	20.3	42.5	26.0	51.8	53.9	26.9	17.8	44.3	67.1	18.3	33.7	6.2	26.1	20.2	55.2	11.2	19.7	20.7	24.7	8.0	13.1	21.4	19.7	24.8	40.6	63.7	24.2	118.0	16.6	16.6	26.3	57.8	49.1	42.3	63.7	63.1	96.7	32.8	34.3	43.4	58.1	46.4
NDUFB3	B12	ENSG00000119013	"NADH:ubiquinone oxidoreductase subunit B3"	O43676	2	201071433-201085750	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 704.3;tongue: 727.7"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1711.2;Distal tubular cells: 1064.4;Proximal tubular cells: 780.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034596	Enhanced					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA034596: AB_10602712"	"unprognostic (5.38e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.46e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (7.24e-4)"	"unprognostic (1.41e-3)"	"unprognostic (6.29e-2)"	"unprognostic (8.81e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.40e-3)"	"unprognostic (9.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.27e-2)"	119.4	114.4	151.2	88.9	152.7	79.7	105.5	165.7	227.5	69.9	161.9	185.7	136.7	46.4	132.2	98.4	66.1	66.3	389.3	151.5	165.1	247.1	195.3	63.5	103.7	158.2	155.4	46.2	54.7	219.3	57.8	78.0	158.1	77.1	174.6	140.8	100.8	75.8	704.3	52.0	127.9	73.8	157.2	61.6	115.5	83.1	158.2	143.4	96.0	727.7	128.8	95.4	53.7	160.6	180.1	148.9	227.5	122.0	226.3	207.0	183.1	224.8	160.1	171.9	200.3	347.2	211.3	144.4	249.8	211.4	261.9	154.5	209.6	287.7	269.4	294.5	460.6	349.0	363.8	394.8	141.2	500.9	170.5	180.1	223.6	203.3	119.2	211.3	250.3	259.2	311.1	240.3	313.1	234.4	313.8	459.8	129.9	392.4	536.7	215.6	200.4	388.0	380.6	278.7	209.5	150.1	176.0	153.2	258.2	353.2	150.7	373.0	227.3	144.8	179.7	150.9	222.8	174.5	435.3	452.6	246.0	284.4	172.6	205.2	135.4	159.4	116.1	205.3	129.2	148.8	132.7	135.7	177.3	117.3	115.2	140.9	267.3	141.6	213.3	211.8	183.1	109.6	151.2	152.7	165.7	227.5	151.5	165.1	158.2	155.4	158.1	157.2	158.2	160.6	95.3	80.1	57.7	18.9	100.9	78.1	100.0	433.7	66.6	52.9	101.7	128.1	1711.2	141.5	205.1	187.6	12.5	254.6	83.5	473.9	1064.4	247.0	218.1	191.6	93.9	101.9	146.4	113.8	13.2	201.7	208.9	103.4	118.7	135.2	78.0	61.0	86.7	260.5	288.2	32.0	14.7	299.0	248.2	121.6	107.1	59.9	95.4	126.8	168.9	10.3	292.9	184.6	116.4	7.5	19.9	177.3	411.0	101.5	135.2	72.5	496.3	780.3	229.2	92.0	92.1	82.3	125.4	270.0	89.7	169.2	91.9	157.6	89.7	113.9	322.1	132.9
NDUFB5	"CI-SGDH, MGC12314, SGDH"	ENSG00000136521	"NADH:ubiquinone oxidoreductase subunit B5"	O43674	3	179604690-179627647	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 241.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005640	Enhanced		Supported	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA005640: AB_1079461"	"unprognostic (6.76e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.38e-1)"	"unprognostic (7.35e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.46e-2)"	"unprognostic (5.96e-3)"	"unprognostic (4.83e-2)"	"unprognostic (7.11e-2)"	"prognostic favorable (3.32e-5)"	"unprognostic (3.05e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.95e-1)"	61.0	88.4	35.6	29.0	38.5	19.5	47.8	39.4	57.3	37.7	52.8	64.0	75.1	30.2	15.6	56.7	33.4	28.8	217.0	38.4	40.0	93.5	74.0	34.4	36.1	37.1	36.6	41.9	52.3	66.6	40.2	27.0	37.4	32.6	36.1	22.7	43.7	20.2	241.4	43.6	57.0	22.3	35.4	46.3	63.8	42.2	39.8	31.4	41.6	166.9	24.8	46.2	41.5	38.9	96.5	23.2	51.2	66.8	52.3	66.0	75.6	58.5	42.0	48.1	50.7	79.8	53.4	72.7	193.4	32.7	119.5	89.9	48.9	47.4	38.9	182.5	43.1	90.4	31.2	44.8	52.3	97.9	64.0	64.9	60.7	31.2	51.0	61.0	62.8	62.1	71.2	98.7	51.8	68.8	55.8	60.5	80.2	138.7	80.8	64.2	63.3	205.1	82.5	46.8	41.1	62.4	34.9	169.9	126.7	36.2	265.9	151.2	64.5	46.6	47.8	61.7	139.9	158.0	193.6	122.5	75.8	91.7	67.9	94.6	104.5	49.9	43.8	127.8	64.5	90.2	60.0	51.6	145.5	67.2	59.8	62.9	18.9	48.1	154.8	81.0	84.0	105.6	35.6	38.5	39.4	57.3	38.4	40.0	37.1	36.6	37.4	35.4	39.8	38.9	113.6	48.1	48.5	17.3	90.2	85.1	115.2	374.4	73.4	45.9	121.0	138.6	362.3	88.6	164.3	88.3	33.3	234.0	54.5	115.9	508.7	132.5	162.6	118.4	79.0	89.2	117.5	75.3	16.1	105.7	150.0	87.1	77.5	62.9	93.8	120.1	105.7	118.3	253.5	40.4	22.6	196.0	266.5	261.3	133.0	28.9	81.1	133.6	135.2	15.9	180.0	107.2	70.0	19.6	25.8	81.5	163.4	70.0	75.0	89.8	293.5	462.8	157.9	73.4	72.3	87.1	98.5	265.7	128.3	105.9	88.7	230.0	72.9	257.4	268.8	163.4
NDUFS3	CI-30	ENSG00000213619	"NADH:ubiquinone oxidoreductase core subunit S3"	O75489	11	47565336-47584562	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 292.3"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 405.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004484, CAB034894"	Enhanced		Supported	"Nuclear bodies,Mitochondria"		NA	NA		14000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Nuclear bodies"	"CAB034894: AB_2151118, HPA004484: AB_1079464"	"unprognostic (2.18e-1)"	"unprognostic (7.42e-3)"	"unprognostic (1.75e-1)"	"unprognostic (5.01e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.13e-2)"	"unprognostic (6.40e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.75e-3)"	"unprognostic (7.73e-2)"	"prognostic favorable (2.61e-6)"	"unprognostic (2.77e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.17e-3)"	52.4	91.3	47.4	16.5	52.6	44.1	50.7	55.6	50.2	43.5	59.4	97.5	53.8	49.7	26.2	78.7	42.6	18.1	210.3	49.3	51.9	94.2	96.2	40.5	25.5	48.8	49.3	37.3	56.7	53.6	67.5	17.6	49.4	44.0	52.7	23.5	60.9	27.5	292.3	66.2	69.4	26.6	50.3	55.5	81.4	48.2	54.7	33.8	49.7	194.2	33.3	51.4	52.0	47.7	37.7	68.7	59.8	62.9	48.8	52.3	48.2	35.0	60.3	84.6	80.4	103.6	65.1	81.8	34.8	49.7	63.0	64.9	81.7	61.8	69.4	44.2	137.2	49.5	90.6	106.5	49.7	121.5	62.1	50.1	46.6	32.0	52.2	37.5	55.3	69.2	73.7	57.1	57.7	118.6	87.0	164.9	83.6	109.6	97.7	100.7	81.8	68.7	76.4	60.2	63.9	47.1	43.4	76.9	83.5	35.2	84.4	118.2	37.0	49.3	56.4	57.0	80.4	61.2	93.5	91.8	50.1	94.9	51.3	38.3	69.3	48.9	43.2	79.8	46.4	60.6	45.2	47.5	83.3	59.2	42.4	46.0	18.4	45.6	66.7	89.3	61.3	90.3	47.4	52.6	55.6	50.2	49.3	51.9	48.8	49.3	49.4	50.3	54.7	47.7	54.7	54.5	42.6	23.5	54.6	65.6	67.4	217.5	62.6	45.6	60.2	72.5	176.9	81.5	108.5	69.9	41.7	122.0	70.8	183.1	405.0	113.0	132.3	56.8	58.6	60.0	84.7	73.8	12.7	111.3	116.5	60.8	81.1	40.5	57.7	67.1	58.5	126.3	195.9	60.6	14.5	162.8	173.0	66.9	59.3	63.2	67.4	62.8	119.2	7.5	83.9	117.9	58.7	12.5	13.1	91.7	109.3	69.2	69.8	53.0	257.8	297.0	109.7	59.5	105.2	55.5	154.8	85.5	74.7	115.3	75.9	89.1	55.5	128.3	210.7	85.3
NEK2	"NEK2A, NLK1, PPP1R111, RP67"	ENSG00000117650	"NIMA related kinase 2"	P51955	1	211658657-211675630	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 17.9;lymphoid tissue: 19.2;testis: 67.1"	"Group enriched"	"Detected in many"	4	"Early spermatids: 76.1;Spermatocytes: 244.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 5.7"	"Low region specificity"	"Detected in all"			"CAB017530, HPA064967"	Enhanced		Supported	Nucleoplasm,Centrosome		NA	Yes			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Centrosome"		"CAB017530: AB_1126558, HPA064967: AB_2685393"	"unprognostic (1.28e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (9.47e-6)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.09e-3)"	"unprognostic (8.49e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.21e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.71e-1)"	0.7	0.4	0.5	5.3	0.4	17.9	1.5	0.9	0.6	1.1	0.6	5.9	7.4	1.3	0.5	4.4	2.2	0.8	0.4	0.5	0.3	0.3	0.7	0.7	9.0	0.4	0.2	0.4	0.1	0.1	0.0	3.2	0.3	2.5	7.6	1.5	0.8	0.2	0.4	4.3	6.9	2.0	0.2	1.7	2.7	67.1	0.6	19.2	0.4	0.2	10.6	1.3	1.6	0.9	86.0	60.5	45.3	32.6	2.6	4.5	49.7	32.4	30.1	55.4	47.5	32.3	81.7	45.1	15.2	25.2	35.1	44.5	39.9	24.2	69.6	69.5	33.2	21.6	51.4	44.2	0.4	43.2	28.3	1.4	2.9	42.9	45.9	13.4	36.3	45.2	59.9	76.9	56.0	23.6	47.3	28.8	43.0	55.0	30.5	46.2	69.2	68.7	19.7	24.2	41.0	45.0	46.6	51.5	39.3	38.4	79.4	25.1	19.0	27.6	54.1	54.8	88.3	31.6	62.6	59.6	24.1	32.6	46.8	1.2	0.1	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.0	0.4	0.3	0.2	0.7	1.5	0.1	0.2	1.6	0.3	0.5	0.4	0.9	0.6	0.5	0.3	0.4	0.2	0.3	0.2	0.6	0.9	0.1	0.0	0.5	0.3	1.7	2.9	0.7	3.8	0.6	11.3	1.9	2.2	0.5	0.0	2.9	0.0	0.0	9.4	0.8	1.9	0.0	0.2	76.1	15.2	0.7	0.8	0.0	39.6	0.8	0.2	14.1	1.4	5.6	1.5	0.0	3.6	3.6	0.7	5.8	3.3	0.0	3.2	10.2	2.5	1.1	39.0	2.5	2.1	0.0	0.0	0.0	1.6	2.1	0.0	0.1	0.0	2.5	0.7	5.4	0.7	2.1	0.1	5.2	1.8	6.6	0.0	1.5	244.2	26.1	8.6	1.7	1.4	2.0	0.9	9.5	1.4
NEK4	"NRK2, pp12301, STK2"	ENSG00000114904	"NIMA related kinase 4"	P51957	3	52708444-52770946	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 46.0"	"Cell type enhanced"	"Detected in all"		"Spermatocytes: 75.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015750, HPA058543"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA015750: AB_1854367, HPA058543: AB_2732623"	"unprognostic (1.32e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (2.69e-5)"	"unprognostic (9.65e-3)"	"unprognostic (3.42e-1)"	"unprognostic (6.64e-2)"	"unprognostic (8.75e-3)"	"unprognostic (2.27e-1)"	"unprognostic (7.85e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.74e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.51e-2)"	"unprognostic (8.39e-2)"	6.3	8.2	6.1	7.4	6.7	7.0	9.4	9.1	7.4	8.5	8.6	7.3	6.5	8.7	8.9	6.7	13.6	6.2	6.1	5.9	7.8	9.7	10.8	6.7	8.3	6.8	8.9	13.3	8.1	11.5	7.3	7.6	6.3	7.7	8.2	16.9	7.3	9.0	8.0	3.5	5.6	8.1	6.9	7.2	9.6	46.0	7.8	9.5	13.5	6.1	9.4	7.9	4.9	5.9	19.9	15.2	20.5	16.2	18.2	13.1	22.1	13.9	18.6	25.3	25.4	13.5	14.4	20.4	6.4	13.6	27.9	9.2	25.2	16.3	33.8	20.4	10.6	16.0	18.4	17.3	11.4	39.4	15.4	8.1	14.8	32.5	21.5	13.5	9.6	17.4	20.2	16.1	16.1	17.1	21.4	14.4	17.7	20.9	14.9	18.5	17.8	15.1	14.3	28.3	15.0	9.0	29.1	17.7	14.1	15.7	16.5	23.4	8.9	16.9	17.1	27.3	26.0	17.8	27.9	19.7	19.3	18.2	18.7	13.6	9.8	5.0	3.5	6.1	3.7	2.8	3.0	3.6	5.2	3.5	3.6	3.1	1.4	4.0	4.2	2.6	2.6	5.2	6.1	6.7	9.1	7.4	5.9	7.8	6.8	8.9	6.3	6.9	7.8	5.9	6.2	12.8	8.2	19.2	11.8	4.1	5.3	3.4	4.6	14.1	10.6	6.2	4.6	2.8	11.6	5.5	12.5	7.0	4.8	6.5	9.8	7.0	20.7	24.0	10.6	7.3	4.8	13.3	30.5	9.6	8.1	7.8	12.8	9.9	7.6	14.0	6.8	14.5	8.2	6.7	29.4	9.3	6.1	16.8	4.6	19.5	14.6	10.4	1.8	7.5	14.0	19.4	10.3	16.6	19.3	8.5	2.9	12.4	10.6	5.3	5.4	17.1	22.4	18.9	6.6	12.6	7.3	75.9	27.9	6.9	4.1	6.7	5.8	11.8	9.1	5.2
NELFB	"COBRA1, KIAA1182, NELF-B"	ENSG00000188986	"Negative elongation factor complex member B"		9	137255327-137273542	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020259	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA020259: AB_1847072"	"unprognostic (2.56e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.14e-2)"	"unprognostic (3.27e-1)"	"unprognostic (4.06e-1)"	"unprognostic (5.58e-3)"	"unprognostic (7.74e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.03e-3)"	"unprognostic (6.46e-2)"	"prognostic favorable (4.31e-6)"	"unprognostic (6.74e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.04e-2)"	25.7	24.5	40.1	21.8	36.4	23.9	25.1	33.6	52.1	28.8	28.0	29.5	23.9	24.9	6.9	34.6	23.2	15.7	37.1	38.5	35.0	32.8	30.2	25.0	27.4	41.4	40.1	28.2	37.4	18.2	20.6	18.5	36.4	30.5	11.5	7.6	29.6	16.1	36.3	36.2	26.6	13.0	36.4	31.5	30.3	28.4	40.0	21.6	24.0	21.2	16.7	29.0	27.9	35.3	50.4	79.5	41.1	53.1	34.8	24.8	62.1	42.0	28.4	48.0	33.9	84.7	56.9	70.2	60.8	40.0	56.3	96.0	41.0	47.8	14.0	68.2	64.9	45.4	97.9	69.7	35.3	66.5	54.2	29.7	47.2	44.3	25.8	28.9	45.0	46.9	77.8	57.7	28.6	116.8	51.0	106.2	67.2	88.8	92.9	83.6	76.1	114.7	27.1	43.9	60.8	57.2	56.7	59.7	40.6	21.4	79.3	79.7	59.9	71.1	56.1	113.4	65.9	32.1	55.2	59.1	56.9	47.4	64.6	1.1	3.3	5.5	4.3	2.8	2.9	3.5	3.6	3.3	2.9	3.5	3.3	3.5	1.9	4.0	2.7	4.7	4.3	2.2	40.1	36.4	33.6	52.1	38.5	35.0	41.4	40.1	36.4	36.4	40.0	35.3	31.6	6.4	17.9	16.6	11.7	14.9	11.8	12.7	5.7	19.7	21.8	20.6	12.4	17.2	14.1	23.9	18.8	24.3	24.7	40.0	13.7	27.9	3.7	14.7	18.1	19.8	28.2	13.0	8.9	38.5	27.8	17.4	13.3	21.8	18.4	39.1	20.3	19.5	26.5	43.7	8.4	37.2	12.2	14.0	15.6	5.6	23.3	17.6	7.2	11.2	37.7	33.8	22.6	9.5	11.7	33.5	18.7	20.7	13.8	18.9	29.2	13.9	9.9	17.1	39.5	15.5	20.6	10.7	23.6	12.6	13.9	15.6	15.4	35.0	31.5	13.5
NEMF	"FLJ10051, NY-CO-1, SDCCAG1"	ENSG00000165525	"Nuclear export mediator factor"	O60524	14	49782083-49852821	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004160	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		830000	"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA004160: AB_1079884"	"unprognostic (9.92e-2)"	"unprognostic (6.03e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.15e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.12e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (3.61e-1)"	"unprognostic (2.36e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.81e-2)"	16.5	13.8	9.5	18.0	13.0	42.1	14.7	18.1	14.7	16.2	5.9	13.6	10.0	16.2	13.5	22.5	12.2	13.2	17.7	7.9	10.6	14.9	11.9	13.8	17.9	11.8	11.6	15.2	15.2	24.8	10.3	18.2	11.9	16.0	14.5	14.7	14.6	15.8	23.0	14.3	13.6	15.7	10.9	15.5	14.1	10.7	10.7	16.3	18.5	21.5	17.9	18.0	11.6	18.4	34.3	39.2	35.9	24.1	37.3	31.0	32.1	42.0	28.3	27.6	27.3	23.2	35.3	13.3	32.0	35.7	21.2	47.5	34.1	26.7	42.2	38.9	22.7	38.7	40.3	29.1	23.8	50.7	33.4	26.8	19.6	29.9	27.2	36.3	39.8	23.8	47.3	36.2	37.7	30.6	31.2	17.9	21.9	28.6	36.8	32.6	35.5	20.8	33.7	44.8	23.6	22.2	41.6	40.4	39.2	37.2	37.6	31.1	47.2	39.2	34.4	26.6	28.9	24.5	47.6	40.9	14.7	23.9	35.5	76.4	38.9	45.8	45.7	36.9	44.8	83.7	47.1	44.4	33.9	86.7	55.6	59.1	61.3	47.8	54.4	79.7	46.1	20.3	9.5	13.0	18.1	14.7	7.9	10.6	11.8	11.6	11.9	10.9	10.7	18.4	66.2	41.7	76.7	65.3	81.1	34.4	67.4	81.6	29.6	92.1	31.7	43.1	97.2	34.3	74.4	44.1	100.1	85.8	78.4	51.8	37.2	57.0	13.9	52.2	60.1	65.2	54.0	57.0	75.7	39.1	58.1	53.0	41.8	60.7	89.3	68.0	49.6	28.1	58.9	131.2	80.7	48.9	71.2	48.7	57.0	13.1	65.9	57.9	24.9	62.8	79.4	54.8	82.4	56.8	99.5	46.4	68.5	67.4	50.0	66.1	59.4	29.9	82.4	90.0	72.3	65.7	70.7	83.0	58.3	32.5	34.1	108.4	66.9	64.1	54.6	88.6
NF1		ENSG00000196712	"Neurofibromin 1"	P21359	17	31094927-31382116	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"		"GTPase activation"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 254.0;Excitatory neurons: 325.3;Inhibitory neurons: 412.5;Oligodendrocyte precursor cells: 428.2;Oligodendrocytes: 317.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045502	Uncertain		Approved	Mitochondria		No	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA045502: AB_2679352"	"unprognostic (6.69e-2)"	"unprognostic (8.73e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.70e-1)"	7.4	8.4	8.9	7.1	10.7	3.4	11.5	13.2	12.2	10.0	1.6	8.5	6.8	10.2	10.0	6.1	9.0	8.0	11.3	9.7	11.7	12.0	9.4	7.3	7.7	11.7	9.2	13.5	10.4	15.9	7.8	12.4	9.1	9.5	8.8	20.9	9.1	9.5	8.1	7.4	7.5	8.7	8.2	7.1	8.2	10.0	11.8	13.5	19.5	10.6	7.8	10.4	6.8	14.4	15.8	20.3	24.2	13.1	20.1	25.8	12.2	13.4	24.1	19.5	21.8	18.4	10.5	15.2	3.8	25.1	22.9	26.8	22.2	18.7	32.6	7.5	14.1	13.4	18.8	9.5	14.2	24.4	10.6	20.7	11.8	20.8	25.1	21.8	9.5	15.7	19.8	14.8	18.8	12.4	20.4	8.8	7.1	9.7	6.8	15.8	36.8	12.3	14.7	22.5	10.0	14.9	25.4	8.3	13.8	16.8	25.0	15.3	14.1	15.3	21.5	18.8	5.1	13.2	6.9	16.3	12.6	10.0	16.2	4.4	0.3	0.6	1.5	0.1	1.0	1.4	2.8	2.5	0.4	1.2	2.0	2.0	0.7	0.7	0.3	0.4	5.9	0.6	8.9	10.7	13.2	12.2	9.7	11.7	11.7	9.2	9.1	8.2	11.8	14.4	30.9	32.1	31.1	254.0	18.3	38.6	48.1	38.9	31.9	62.7	33.7	24.9	43.9	41.5	29.8	40.5	137.6	57.5	23.8	37.8	23.5	27.1	210.4	27.4	39.4	35.8	19.8	9.7	325.3	22.5	26.6	39.1	39.3	45.8	10.8	44.0	33.2	35.7	22.5	70.7	412.5	24.3	38.7	27.6	34.1	94.6	37.3	28.2	21.4	215.5	20.9	47.5	21.6	428.2	317.4	33.3	43.0	50.4	30.8	54.2	32.1	28.6	36.9	62.8	46.0	51.9	43.3	30.5	28.7	19.8	34.0	49.3	19.8	36.1	27.4	64.5
NFATC2IP	"ESC2, FLJ14639, NIP45, RAD60"	ENSG00000176953	"Nuclear factor of activated T cells 2 interacting protein"	Q8NCF5	16	28950807-28967097	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053587			Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA053587: AB_2682202"	"unprognostic (6.01e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.90e-1)"	"unprognostic (7.09e-2)"	"unprognostic (8.82e-3)"	"unprognostic (1.15e-2)"	"unprognostic (8.95e-2)"	"unprognostic (5.80e-2)"	"unprognostic (5.32e-2)"	"prognostic unfavorable (5.23e-4)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (8.00e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.25e-1)"	"unprognostic (5.94e-2)"	20.9	16.6	10.4	27.6	10.5	48.6	21.7	15.6	11.0	25.2	9.9	30.6	21.1	23.3	14.4	29.0	24.5	14.3	20.9	11.0	9.1	26.0	27.9	25.8	36.6	11.1	10.6	24.1	22.7	20.0	15.0	15.5	11.1	23.9	32.2	26.6	24.3	15.5	25.7	32.5	36.9	22.8	9.8	45.4	25.9	30.3	12.1	34.3	22.0	15.8	38.5	26.0	23.5	11.7	38.6	27.2	36.5	36.7	21.7	22.8	46.0	36.7	27.6	42.1	53.7	32.0	47.0	41.1	27.0	26.4	25.6	44.8	44.3	40.3	56.9	35.0	32.4	37.5	81.2	39.8	13.9	34.1	55.0	16.1	32.1	45.9	27.6	20.8	34.3	40.9	34.4	49.5	37.8	47.9	44.9	60.2	35.9	30.9	32.0	77.0	32.4	37.5	30.2	34.2	28.0	20.0	24.7	37.7	14.4	29.6	39.1	25.2	38.1	46.3	26.1	36.5	28.1	36.5	51.5	49.7	25.6	55.5	27.8	5.0	1.5	1.8	1.9	2.0	1.8	1.5	1.4	2.3	0.9	1.5	2.3	2.0	1.1	2.8	1.2	3.2	2.4	0.7	10.4	10.5	15.6	11.0	11.0	9.1	11.1	10.6	11.1	9.8	12.1	11.7	40.9	35.3	52.2	15.7	43.1	31.7	23.0	19.1	33.0	63.1	29.4	25.7	17.4	21.5	29.8	29.5	100.1	30.1	69.8	51.3	19.6	21.9	6.3	28.3	43.6	35.1	40.9	77.2	21.3	22.9	30.5	23.3	50.0	37.6	36.7	69.5	38.9	26.0	23.2	43.7	27.0	63.1	18.3	38.8	32.2	7.6	29.5	37.8	23.2	26.2	56.7	15.3	57.7	19.6	18.2	44.6	31.6	20.3	55.4	40.4	40.7	17.8	21.7	84.5	39.5	26.7	26.6	95.0	92.2	35.7	30.3	26.1	51.4	38.3	53.0	42.1
NFU1	"CGI-33, HIRIP5, NifU, NIFUC"	ENSG00000169599	"NFU1 iron-sulfur cluster scaffold"	Q9UMS0	2	69396113-69437628	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 189.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035826	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 38: Heart - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoplasm	"HPA035826: AB_2674803"	"unprognostic (4.49e-3)"	"unprognostic (5.62e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.87e-1)"	66.8	46.3	36.8	22.5	39.3	33.4	56.8	40.0	56.0	35.6	37.4	51.4	31.3	35.9	51.9	27.9	35.3	29.0	110.4	37.5	40.9	64.2	39.5	31.8	30.0	40.2	39.7	38.0	39.9	43.3	45.1	38.1	41.4	34.3	38.1	56.9	41.2	36.5	140.8	22.3	33.4	33.1	39.9	31.0	43.8	34.6	39.0	22.8	41.9	120.2	29.5	44.8	31.1	42.0	59.3	59.2	56.1	55.5	70.4	75.4	61.6	61.0	62.0	59.0	47.8	114.7	56.9	42.4	30.0	57.0	85.6	25.4	63.7	64.2	79.5	77.8	62.3	43.5	38.2	102.0	70.1	73.7	59.2	58.4	37.2	67.5	41.2	56.0	65.6	41.8	80.1	41.8	99.1	11.9	39.1	119.0	53.9	62.9	64.3	42.6	85.5	15.6	83.5	57.6	45.9	34.3	35.2	32.2	92.5	57.6	40.8	49.4	67.8	71.3	47.1	52.2	80.8	53.8	48.4	23.1	54.2	74.7	55.8	20.2	13.6	25.5	15.9	18.6	15.6	21.7	16.3	18.9	12.4	25.1	16.9	18.6	4.3	18.0	28.5	25.0	24.8	12.3	36.8	39.3	40.0	56.0	37.5	40.9	40.2	39.7	41.4	39.9	39.0	42.0	30.6	32.1	22.5	9.8	37.0	16.2	35.9	96.7	21.1	23.9	33.2	29.6	92.3	37.1	42.6	38.6	12.5	113.9	34.1	34.6	189.8	56.9	111.0	40.0	27.1	34.9	53.3	25.7	15.4	60.9	70.5	30.9	20.4	25.3	58.3	21.6	33.5	32.0	82.6	18.5	18.8	47.7	57.0	35.8	24.0	34.2	34.8	30.2	39.2	10.3	66.8	55.6	46.4	21.1	27.1	50.3	39.7	36.9	25.4	28.8	56.3	163.0	58.9	33.4	46.0	36.9	44.1	82.9	60.4	18.8	14.9	61.3	33.3	42.7	46.3	35.4
NHLRC2	"DKFZp779F115, FLJ20147, FLJ25621, FLJ33312, MGC45492"	ENSG00000196865	"NHL repeat containing 2"	Q8NBF2	10	113854661-113917194	"Disease related genes, Predicted intracellular proteins"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038493, HPA057564"	Approved		Approved	Nucleoplasm		NA	NA		120000	"Cluster 14: Monocytes - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA038493: AB_10672519, HPA057564: AB_2683469"	"unprognostic (7.09e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.74e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.88e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.52e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.68e-2)"	5.9	5.6	4.4	4.9	5.1	4.2	6.2	5.8	5.2	7.0	7.6	6.5	5.4	6.2	6.9	4.7	5.7	4.1	16.5	3.5	4.3	5.4	8.7	6.6	5.9	5.1	4.8	7.2	7.9	10.5	5.3	6.4	5.1	8.8	5.8	10.1	6.7	4.8	10.6	7.0	6.2	5.2	4.2	7.2	6.4	3.8	4.6	4.6	7.6	7.5	5.5	6.2	6.2	6.0	10.8	6.8	13.1	10.8	4.7	8.4	8.3	7.4	8.8	6.3	6.9	4.7	10.3	5.8	5.2	7.5	5.5	9.4	10.8	6.1	10.7	7.0	5.4	6.2	5.7	6.7	7.1	8.9	6.8	5.8	7.4	7.0	14.4	12.2	7.7	4.1	7.4	6.5	8.6	5.0	5.1	6.9	3.9	6.6	3.4	4.7	18.8	3.4	7.8	5.9	3.4	6.9	5.8	7.3	9.1	6.1	5.3	6.6	9.9	7.5	7.6	4.8	11.3	4.4	2.3	5.7	6.2	14.0	5.1	0.9	0.5	0.7	0.6	0.4	0.6	0.6	0.4	0.7	0.6	0.6	0.4	0.5	0.3	0.6	0.9	0.8	0.5	0.3	4.4	5.1	5.8	5.2	3.5	4.3	5.1	4.8	5.1	4.2	4.6	6.0	22.4	19.2	21.3	40.5	13.7	7.9	13.1	8.9	11.4	20.8	15.2	9.7	74.4	18.6	18.8	36.8	14.6	16.8	8.3	8.5	7.9	10.9	5.4	15.6	24.1	19.4	10.3	27.6	45.5	12.3	12.9	19.3	16.3	14.4	10.8	23.3	19.2	28.2	10.1	28.6	34.7	15.8	10.2	17.6	6.7	8.6	18.0	13.7	7.2	44.0	13.2	20.6	13.4	58.3	55.2	11.1	15.4	26.4	9.1	17.3	12.4	11.8	8.9	25.7	65.7	29.1	19.1	16.0	11.4	9.9	8.4	18.2	10.9	18.7	12.3	14.1
NIF3L1	"ALS2CR1, CALS-7, MDS015"	ENSG00000196290	"NGG1 interacting factor 3 like 1"	Q9GZT8	2	200889327-200903938	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 90.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036335, HPA036336, HPA061466"	Supported		Approved	Vesicles		NA	NA		9800000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles		"HPA036335: AB_10696654, HPA036336: AB_2675068, HPA061466: AB_2684532"	"unprognostic (6.61e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (9.52e-5)"	"unprognostic (2.48e-2)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (2.51e-6)"	"unprognostic (1.94e-1)"	"unprognostic (8.53e-3)"	"unprognostic (6.75e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.65e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.04e-3)"	"unprognostic (8.61e-2)"	13.2	19.2	14.1	15.2	15.8	11.0	24.3	15.7	23.8	17.7	13.7	21.8	16.5	15.9	26.3	16.7	22.5	13.2	21.5	14.9	14.8	24.3	22.9	15.6	26.5	15.3	13.8	21.4	15.5	27.0	9.7	19.1	16.2	17.2	28.0	32.7	19.8	19.8	23.5	21.6	15.7	19.1	15.6	18.1	20.1	18.5	14.1	26.5	19.4	30.6	32.4	17.1	12.7	17.5	39.5	42.1	66.9	41.3	29.8	37.1	45.9	42.6	45.4	88.6	71.3	66.1	44.7	31.8	40.2	36.5	64.1	42.7	96.8	56.0	94.6	42.4	90.8	47.4	73.6	70.9	27.0	56.8	31.3	31.7	52.3	58.6	55.8	39.9	29.9	65.6	70.2	31.4	52.7	51.4	69.9	71.1	79.1	44.7	73.5	41.1	37.1	61.6	46.8	40.6	42.3	49.5	36.6	36.8	51.9	94.4	36.5	50.5	15.6	42.2	39.8	38.3	39.0	28.4	58.3	68.4	41.4	45.6	41.6	70.1	23.0	30.7	27.8	34.9	29.1	31.4	31.8	35.3	28.8	23.7	35.4	29.1	7.8	33.6	31.1	29.8	32.0	24.2	14.1	15.8	15.7	23.8	14.9	14.8	15.3	13.8	16.2	15.6	14.1	17.5	6.0	0.0	7.0	2.6	11.7	3.7	7.7	43.1	12.5	90.5	6.9	9.3	13.9	10.0	26.5	5.5	14.6	34.3	8.0	7.5	15.6	20.3	16.2	10.2	9.3	7.0	1.8	23.2	6.2	18.2	35.6	9.8	9.7	7.8	9.5	12.7	6.8	9.3	17.2	18.5	5.7	10.5	26.4	7.3	2.2	6.5	16.1	9.5	5.4	5.6	17.2	18.8	8.2	2.5	5.7	13.2	9.2	19.2	23.9	6.3	10.1	21.3	24.9	27.4	6.6	7.2	14.5	30.9	24.4	12.9	8.2	22.6	10.0	11.1	11.4	6.2
NIFK	"hNIFK, MKI67IP, Nopp34"	ENSG00000155438	"Nucleolar protein interacting with the FHA domain of MKI67"	Q9BYG3	2	121726945-121736911	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015382, HPA035735, HPA035736, CAB075728, CAB075729"	Supported		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"CAB015382: AB_2142390, CAB075728: AB_2665734, CAB075729: AB_2665735, HPA035735: AB_2674758, HPA035736: AB_2674759"	"unprognostic (3.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.49e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (1.21e-1)"	"unprognostic (4.15e-3)"	"prognostic unfavorable (2.92e-6)"	"unprognostic (7.74e-3)"	"unprognostic (4.63e-2)"	"unprognostic (3.21e-2)"	"unprognostic (6.02e-3)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (5.01e-11)"	"unprognostic (1.72e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-1)"	29.3	24.8	18.1	31.9	18.6	31.5	37.3	18.7	21.8	25.4	17.9	24.8	25.1	28.5	21.9	34.6	27.5	25.1	22.9	19.3	18.7	25.7	34.1	17.9	47.2	18.5	17.8	36.5	32.6	17.9	16.7	25.6	18.4	24.6	25.6	23.0	17.9	17.8	38.3	34.5	20.1	24.8	19.1	22.3	22.5	21.8	18.3	32.9	25.2	18.3	42.4	43.3	24.5	20.1	118.4	37.6	68.8	68.3	57.9	80.6	90.2	90.6	75.2	105.0	113.2	105.9	55.0	152.4	111.4	66.9	93.1	72.9	149.4	116.4	153.4	101.3	85.7	155.0	44.5	92.9	82.6	141.1	81.7	80.6	126.7	137.4	184.4	48.7	75.9	60.3	174.5	73.9	90.5	58.2	109.5	140.9	175.3	132.4	122.5	102.5	80.7	191.2	92.1	72.4	88.1	91.8	56.6	105.1	200.7	62.2	52.0	123.1	45.7	72.8	123.5	85.6	129.3	87.5	150.6	182.1	55.7	143.9	101.5	41.8	54.2	28.8	59.2	65.3	83.4	73.6	72.3	68.6	72.1	74.8	84.5	79.4	4.0	81.5	62.5	64.0	68.9	75.1	18.1	18.6	18.7	21.8	19.3	18.7	18.5	17.8	18.4	19.1	18.3	20.1	51.1	44.8	25.9	8.1	56.3	98.4	128.9	87.0	81.4	25.8	51.2	88.8	21.5	24.3	62.2	14.7	12.5	74.9	62.7	18.9	46.9	64.2	23.7	43.8	126.9	47.7	28.1	41.8	8.2	45.2	90.6	68.7	32.6	39.9	54.5	47.9	26.0	33.2	54.4	13.5	7.2	41.3	42.7	34.5	32.8	8.0	57.5	39.0	23.2	10.3	59.1	48.0	54.6	13.0	8.0	51.5	28.4	45.1	33.3	107.0	18.4	58.4	41.9	45.8	39.5	72.7	54.3	81.1	83.9	79.3	101.4	48.8	52.5	97.7	60.5	125.2
NIN		ENSG00000100503	Ninein	Q8N4C6	14	50719763-50831162	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 43.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 240.5;Muller glia cells: 150.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"basophil: 31.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005939, HPA070691"	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Centrosome"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli, Nucleoli rim, Centrosome"	Nucleoplasm	"HPA005939: AB_2667474, HPA070691: AB_2686296"	"unprognostic (1.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.31e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.06e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.58e-2)"	"unprognostic (7.66e-3)"	11.2	4.4	10.1	19.9	10.8	43.2	8.9	9.5	15.0	7.2	0.0	8.3	4.8	7.7	2.8	12.9	10.5	8.9	18.2	10.4	0.9	6.7	5.7	9.5	25.9	0.0	1.3	9.7	7.2	9.0	8.9	16.8	0.0	6.9	8.6	19.1	5.4	5.4	6.0	12.9	7.1	10.3	0.0	16.2	9.3	5.2	3.0	19.9	7.7	7.4	23.7	13.6	5.7	7.5	29.1	21.6	42.4	36.8	16.7	26.8	20.4	26.5	22.1	21.4	18.0	14.7	14.6	48.5	17.7	35.5	19.9	32.5	34.2	16.3	45.3	34.7	10.4	25.1	13.2	12.3	9.8	41.6	57.5	18.4	11.4	37.2	14.9	13.3	34.6	25.9	6.6	26.3	31.8	36.8	22.6	14.0	6.4	10.1	23.6	37.1	81.6	5.7	20.1	42.9	18.6	22.2	34.0	9.6	25.1	10.2	21.2	39.3	50.9	55.2	74.3	20.5	29.0	18.6	12.1	34.3	14.4	32.8	30.4	31.9	2.9	24.0	3.9	2.5	3.3	8.9	2.4	6.2	2.0	6.2	5.1	4.7	9.6	2.9	2.1	7.7	2.5	1.4	10.1	10.8	9.5	15.0	10.4	0.9	0.0	1.3	0.0	0.0	3.0	7.5	34.0	6.4	7.7	100.2	85.6	18.4	9.1	10.2	18.8	13.3	13.3	10.9	68.0	14.3	27.1	11.0	62.6	12.4	102.7	8.7	3.9	7.3	22.2	17.3	28.5	26.7	12.6	29.0	240.5	4.2	11.3	32.9	7.7	14.9	31.6	3.9	21.8	4.4	22.7	6.7	110.4	5.7	20.3	46.8	42.2	10.4	8.4	61.3	23.2	63.7	63.2	150.2	57.7	105.6	75.1	5.2	6.2	9.4	48.1	16.5	3.2	7.3	29.4	21.0	32.9	44.9	24.1	0.2	4.3	20.1	21.0	9.7	56.2	21.8	6.9	15.5
NIP7	"CGI-37, FLJ10296, HSPC031, KD93"	ENSG00000132603	"Nucleolar pre-rRNA processing protein NIP7"	Q9Y221	16	69337996-69343106	"Predicted intracellular proteins"	"Ribosome biogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040856, HPA059850"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA040856: AB_2677171, HPA059850: AB_2684142"	"unprognostic (2.14e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.76e-1)"	"unprognostic (8.02e-2)"	"unprognostic (6.47e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.04e-3)"	"unprognostic (1.37e-3)"	"unprognostic (5.72e-2)"	"unprognostic (3.86e-2)"	"prognostic unfavorable (6.69e-5)"	"unprognostic (6.99e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.33e-2)"	17.9	14.1	7.1	17.9	7.5	26.2	16.0	7.8	8.1	11.4	9.6	16.6	14.4	11.3	14.2	17.2	12.1	12.9	7.7	7.8	7.3	13.2	17.2	10.6	23.6	7.7	7.3	7.4	10.3	11.4	5.2	14.5	8.1	9.8	16.1	3.5	8.5	8.9	8.7	12.7	12.0	14.1	7.6	13.1	11.5	12.3	8.1	21.4	11.2	9.8	26.9	24.9	8.6	8.5	57.9	39.7	31.2	43.0	44.0	38.5	48.8	52.7	40.6	87.8	62.7	66.7	61.6	105.5	57.1	48.3	36.5	60.1	63.7	80.0	112.5	28.9	51.2	53.8	27.0	83.6	42.6	118.1	34.0	42.2	63.1	83.1	88.7	25.7	50.5	60.7	115.1	17.5	62.3	69.8	78.6	81.9	94.4	50.9	47.7	108.6	34.3	95.7	54.6	38.8	41.3	57.8	107.8	31.0	59.8	35.0	44.3	72.4	43.5	63.5	54.7	49.5	97.0	54.4	45.0	250.2	37.9	69.4	63.4	16.7	12.7	9.8	28.4	14.9	29.9	28.9	25.2	33.3	22.8	21.1	23.3	30.1	4.3	24.8	21.4	20.7	28.9	16.9	7.1	7.5	7.8	8.1	7.8	7.3	7.7	7.3	8.1	7.6	8.1	8.5	28.2	3.2	12.7	3.9	33.7	53.7	58.1	34.6	45.5	8.8	21.7	18.3	5.5	14.3	21.1	20.2	16.7	33.2	33.2	14.7	21.5	35.9	43.8	24.5	32.0	28.3	3.0	37.9	5.1	26.1	36.5	24.0	11.2	23.2	17.7	20.5	18.2	12.1	24.8	11.8	4.5	12.7	30.5	12.2	19.2	41.4	17.1	14.7	19.6	1.9	18.3	9.2	35.0	3.0	6.4	37.5	16.6	17.3	15.6	46.2	14.6	28.9	25.6	8.1	13.1	35.2	25.9	40.7	43.8	43.0	52.6	25.6	33.2	36.2	20.8	42.2
NLE1	"FLJ10458, NLE"	ENSG00000073536	"Notchless homolog 1"	Q9NVX2	17	35128730-35142304	"Predicted intracellular proteins"	"Notch signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018807	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Nucleoplasm	"HPA018807: AB_1848658"	"unprognostic (9.19e-2)"	"unprognostic (8.40e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (8.64e-8)"	"unprognostic (8.67e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (6.39e-4)"	7.3	7.4	5.0	5.8	5.0	6.2	8.8	5.1	5.3	7.4	3.4	5.6	4.0	6.8	2.9	8.4	7.4	3.1	4.2	5.0	4.5	6.5	7.3	4.6	6.8	4.7	4.0	12.0	23.7	3.9	4.2	4.9	4.0	6.0	4.0	2.5	7.6	4.6	8.0	6.8	5.1	4.1	3.5	6.2	7.6	4.4	5.0	6.6	5.1	3.5	5.4	7.4	5.8	4.6	15.9	36.8	12.5	22.7	6.9	11.4	19.6	14.0	12.7	24.4	19.3	26.1	14.8	34.9	18.6	12.0	18.0	21.0	26.8	35.6	15.1	5.6	44.2	14.9	18.2	33.2	10.3	29.9	12.0	12.9	19.0	25.6	38.3	10.7	15.5	33.9	42.4	12.7	14.6	22.1	47.1	25.5	23.6	13.5	16.6	37.6	20.9	38.5	14.3	14.8	25.6	14.8	13.1	13.4	17.1	11.1	32.4	22.4	14.5	13.3	18.3	13.0	47.4	9.8	7.8	29.1	9.3	24.9	25.8	0.1	2.2	0.0	4.0	2.4	6.2	3.4	3.8	4.2	3.4	4.6	5.2	3.5	0.3	1.8	1.2	0.8	2.1	2.2	5.0	5.0	5.1	5.3	5.0	4.5	4.7	4.0	4.0	3.5	5.0	4.6	4.7	3.2	1.1	0.3	8.6	8.7	8.6	7.4	9.6	4.7	12.3	14.0	2.6	10.0	3.7	3.7	2.1	12.1	2.4	3.9	0.0	8.9	1.0	2.1	5.4	5.0	4.9	8.8	1.3	15.4	20.9	7.4	6.6	2.8	3.8	9.4	5.3	6.6	7.6	1.7	1.5	8.1	2.0	4.6	2.6	5.4	4.1	2.8	1.8	1.0	3.8	1.9	2.1	1.0	0.7	8.5	3.6	4.9	5.1	8.6	3.4	7.1	2.8	3.1	0.0	6.5	7.2	4.2	6.5	12.5	10.1	4.9	4.1	9.2	13.4	5.5
NME1	"NDPKA, NM23, NM23-H1"	ENSG00000239672	"NME/NM23 nucleoside diphosphate kinase 1"	P15531	17	51153559-51162428	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Endocytosis, Neurogenesis, Nucleotide metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008467, CAB040571, HPA041113"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		21000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB040571: , HPA008467: AB_1079492, HPA041113: AB_2677305"	"unprognostic (2.24e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.48e-3)"	"unprognostic (5.96e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.33e-3)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (4.54e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.07e-9)"	"unprognostic (9.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.46e-2)"	63.6	84.4	79.3	74.7	81.6	77.0	63.1	78.7	102.2	38.2	79.0	60.1	38.8	49.7	46.8	91.0	48.6	20.8	37.7	88.0	92.0	65.4	83.2	41.3	73.9	83.9	78.4	33.6	67.8	52.8	47.4	39.2	82.4	38.7	77.6	218.4	50.7	30.4	35.6	57.5	33.1	66.3	76.5	48.5	41.8	25.3	81.0	61.1	41.3	20.9	95.8	72.2	48.9	80.1	483.6	833.1	285.9	444.8	118.6	183.7	479.7	355.3	227.3	652.2	489.7	656.9	288.1	754.2	372.4	304.1	272.4	252.1	542.5	553.3	553.4	398.4	729.3	504.9	605.8	975.9	237.1	575.8	243.8	177.8	341.7	493.1	458.6	120.6	404.6	247.8	739.0	270.0	392.8	720.4	715.2	647.1	390.7	957.5	739.3	446.9	587.6	751.3	511.5	320.2	418.6	461.1	188.1	521.0	385.3	246.2	554.0	419.6	279.5	476.9	452.2	307.0	774.4	374.0	840.9	956.3	286.2	480.4	385.8	1.1	55.0	2.1	47.2	77.1	69.3	96.4	50.3	53.8	134.0	67.6	54.3	60.4	1.7	69.6	48.6	84.8	49.1	68.4	79.3	81.6	78.7	102.2	88.0	92.0	83.9	78.4	82.4	76.5	81.0	80.1	53.1	32.1	30.5	0.0	71.3	132.4	97.5	198.8	88.8	283.3	98.8	118.1	34.2	65.8	92.3	71.7	285.7	180.0	25.4	54.2	150.6	211.3	34.2	40.2	107.2	85.1	89.7	81.8	0.0	201.5	269.7	85.0	64.2	37.2	45.7	113.5	27.8	123.3	207.1	40.4	0.0	107.4	101.7	25.7	88.9	93.7	61.2	48.9	129.9	0.0	47.2	105.6	27.8	0.0	0.0	194.0	50.5	58.6	113.8	170.6	12.2	195.2	42.0	323.7	13.1	83.0	182.9	22.7	98.8	139.4	133.1	88.5	38.0	215.5	157.7	98.2
NME6	"IPIA-ALPHA, NM23-H6"	ENSG00000172113	"NME/NM23 nucleoside diphosphate kinase 6"	O75414	3	48290722-48301685	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Nucleotide metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017909	Approved		Approved	Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Vesicles		"HPA017909: AB_1854530"	"unprognostic (7.31e-3)"	"unprognostic (1.87e-1)"	"unprognostic (8.19e-3)"	"unprognostic (2.09e-2)"	"unprognostic (8.52e-2)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (2.17e-7)"	"unprognostic (1.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.98e-1)"	"prognostic favorable (3.18e-5)"	"unprognostic (1.98e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.50e-2)"	8.7	7.7	6.3	10.4	6.4	8.1	12.1	9.2	6.3	10.2	8.7	11.6	13.2	9.3	8.5	12.1	14.8	8.9	13.5	7.1	6.5	11.1	10.3	10.2	12.2	5.9	6.3	12.4	11.6	12.4	6.0	14.2	5.7	9.5	11.5	7.6	10.9	8.7	17.7	10.0	10.4	12.4	4.9	9.6	11.5	6.2	6.4	9.4	12.2	17.2	13.7	9.6	9.0	6.3	30.0	19.1	24.3	18.3	18.2	23.4	22.1	27.2	18.3	37.5	27.3	30.5	26.5	30.1	14.0	20.5	36.5	10.1	21.9	27.2	24.1	36.1	21.3	17.9	24.1	26.6	25.7	24.3	20.7	19.7	33.8	34.4	42.9	19.3	19.8	21.1	33.9	23.6	14.0	13.9	21.4	11.3	22.3	19.5	23.3	12.7	22.9	25.3	21.2	23.6	7.7	12.7	19.8	21.0	26.1	17.8	23.9	22.5	22.1	8.3	33.0	21.2	39.4	27.0	40.9	26.1	16.3	31.9	18.4	47.3	33.4	76.4	40.9	36.0	36.6	43.5	37.4	35.2	39.9	38.0	28.1	27.2	37.3	40.4	42.1	34.5	33.5	25.1	6.3	6.4	9.2	6.3	7.1	6.5	5.9	6.3	5.7	4.9	6.4	6.3	13.1	28.9	20.7	2.3	16.4	5.0	8.5	18.2	9.6	11.9	14.1	13.6	10.4	15.7	19.4	9.2	14.6	49.5	18.4	8.2	39.2	24.8	2.6	16.1	17.5	12.8	4.2	8.0	2.5	30.1	41.6	12.4	11.7	11.8	10.1	22.8	7.9	7.9	34.4	10.1	3.2	10.8	12.2	9.3	9.7	1.7	11.8	13.7	16.0	1.9	23.4	17.6	18.6	2.5	2.7	31.3	8.3	7.2	10.8	12.8	16.6	16.4	30.6	11.5	13.1	7.7	12.2	9.3	15.0	12.4	4.1	19.7	14.7	15.1	12.8	7.1
NOB1	"ART-4, MST158, NOB1P, PSMD8BP1"	ENSG00000141101	"NIN1 (RPN12) binding protein 1 homolog"	Q9ULX3	16	69741871-69754926	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041522, HPA049430, HPA067411"	Approved		Approved	"Focal adhesion sites,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Cytosol	"Focal adhesion sites"	"HPA041522: , HPA049430: AB_2680764, HPA067411: "	"unprognostic (5.11e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.15e-1)"	"unprognostic (8.61e-3)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (4.21e-5)"	"prognostic unfavorable (8.16e-4)"	"unprognostic (3.26e-2)"	"unprognostic (3.04e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.16e-1)"	33.3	51.8	13.5	23.2	18.6	31.1	32.2	14.7	17.3	29.2	18.1	25.1	31.5	28.4	14.0	41.8	43.4	24.3	18.5	13.9	13.4	23.7	24.5	20.6	37.0	15.2	13.9	54.5	90.1	17.7	15.3	20.5	15.2	24.9	19.1	7.0	31.1	19.2	36.6	42.5	23.2	20.1	13.9	27.3	37.1	12.8	15.3	26.5	30.8	20.2	30.1	31.5	31.7	14.9	58.7	125.9	29.0	82.7	63.2	98.6	57.5	46.1	63.6	84.0	75.9	143.5	93.5	129.9	69.9	51.2	44.2	84.9	80.3	102.6	49.4	33.0	93.6	50.8	57.5	186.6	111.3	95.0	40.9	125.5	85.8	96.9	122.6	78.0	71.7	77.0	117.2	39.2	42.5	152.8	119.6	187.9	89.2	64.9	73.8	130.5	30.1	164.6	62.5	56.5	75.0	37.1	144.8	50.1	73.8	25.5	54.4	84.0	55.3	56.8	51.8	52.6	76.0	63.9	52.7	230.1	57.0	85.3	64.2	0.3	37.9	5.7	41.5	32.5	58.1	47.0	50.3	38.5	51.3	53.9	53.3	49.0	1.9	65.7	26.5	26.8	68.2	46.7	13.5	18.6	14.7	17.3	13.9	13.4	15.2	13.9	15.2	13.9	15.3	14.9	31.3	3.2	18.8	4.6	36.2	60.0	75.1	84.7	87.6	10.2	52.3	69.7	5.7	24.3	47.2	20.2	0.0	71.9	22.5	14.2	41.1	47.9	10.7	22.0	42.5	39.9	10.2	37.6	6.9	85.9	82.6	35.8	23.4	26.5	16.5	68.5	32.5	14.8	36.2	5.0	6.7	36.9	36.7	30.7	24.1	7.1	36.7	19.6	21.4	2.8	35.7	11.6	35.0	6.0	5.7	46.9	25.1	42.5	24.8	72.0	35.3	37.4	17.1	5.4	26.3	47.2	30.5	18.1	33.4	64.0	59.7	47.5	30.7	77.4	63.2	67.8
NOC2L	"DKFZP564C186, NET15, NET7, NIR, PPP1R112"	ENSG00000188976	"NOC2 like nucleolar associated transcriptional repressor"	Q9Y3T9	1	944203-959309	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044258, HPA062195"	Approved		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No		310000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA044258: AB_10961284, HPA062195: AB_2684707"	"unprognostic (3.18e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.54e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.20e-3)"	"unprognostic (8.62e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.52e-1)"	26.7	23.6	17.1	23.0	17.1	30.1	26.4	16.8	21.2	29.5	14.3	28.0	17.9	30.3	10.3	47.3	27.7	14.1	32.8	18.1	18.5	27.1	33.7	23.6	23.1	18.5	17.0	26.0	35.6	21.2	24.4	15.8	19.5	26.8	11.6	9.6	26.5	16.0	73.0	45.0	25.2	15.0	15.1	28.0	28.4	36.0	17.6	20.1	24.3	26.4	15.9	32.7	31.7	18.5	112.8	110.4	19.8	129.5	34.5	31.0	70.2	82.3	38.9	114.4	62.1	148.5	110.5	126.3	113.3	56.0	94.0	102.2	147.6	122.8	49.2	79.2	161.5	67.0	141.2	132.0	77.4	151.1	63.8	50.3	35.0	125.3	84.3	35.3	56.4	44.6	190.8	58.2	51.6	182.1	98.7	92.6	112.0	82.3	128.8	120.0	81.5	155.9	53.6	47.4	136.0	133.0	109.3	166.3	105.1	30.3	74.8	81.1	64.1	68.3	95.9	75.2	143.0	97.6	112.5	225.7	84.3	209.1	57.7	21.3	30.9	22.2	23.9	46.4	31.3	23.9	23.3	23.4	36.8	19.3	23.3	18.6	2.8	34.5	57.5	23.6	19.9	31.7	17.1	17.1	16.8	21.2	18.1	18.5	18.5	17.0	19.5	15.1	17.6	18.5	21.5	16.0	23.1	12.4	42.7	69.3	90.8	42.9	47.8	54.6	33.4	34.7	4.5	28.6	29.8	36.8	62.6	63.7	24.7	27.4	17.6	49.9	10.2	34.8	40.9	27.8	30.0	23.8	12.6	46.2	65.5	29.9	28.1	36.9	13.9	36.4	24.7	24.0	39.6	45.4	12.4	27.6	36.7	24.6	29.2	10.3	29.5	24.4	24.9	12.2	35.7	20.6	60.8	9.5	10.6	39.2	21.4	21.4	42.6	71.9	22.9	19.6	27.1	77.0	32.9	41.2	34.6	43.0	83.9	47.4	82.0	58.8	36.6	51.8	53.1	69.3
NOC3L	"AD24, C10orf117, FAD24, FLJ12820"	ENSG00000173145	"NOC3 like DNA replication regulator"	Q8WTT2	10	94333226-94362959	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063958, HPA067638, HPA070981"			Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA063958: AB_2685160, HPA067638: AB_2685876, HPA070981: AB_2686331"	"unprognostic (1.29e-1)"	"unprognostic (2.25e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.58e-2)"	"unprognostic (6.49e-3)"	"unprognostic (3.34e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.93e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.30e-1)"	8.6	9.0	5.1	9.5	6.5	3.6	11.2	5.9	5.9	6.7	5.9	5.2	5.4	8.5	6.4	9.0	6.2	5.7	5.3	4.6	5.8	7.2	9.9	5.2	13.1	6.5	6.4	8.2	5.3	9.1	4.3	8.9	6.5	7.4	6.3	6.2	5.3	6.5	9.4	9.3	5.4	7.1	6.4	11.4	5.5	10.4	5.8	7.5	11.1	10.4	13.2	10.3	6.4	7.1	38.4	20.6	13.6	44.1	13.9	22.4	16.1	29.9	23.6	40.2	46.3	35.1	26.4	41.3	21.4	15.0	20.6	26.9	39.2	18.0	64.6	28.3	29.3	28.1	16.6	22.6	27.8	45.0	12.2	13.0	17.3	42.5	42.2	26.2	18.1	15.1	44.2	20.3	40.0	12.9	28.5	33.2	28.9	22.3	22.4	12.5	31.3	22.8	23.7	11.7	9.7	24.1	21.4	10.7	33.9	15.2	27.6	17.1	17.7	25.6	25.9	23.4	50.9	19.1	40.8	56.8	23.4	42.6	19.5	0.1	2.6	0.6	4.3	4.3	5.4	14.4	4.4	5.5	4.6	12.8	5.7	5.2	0.1	8.2	5.0	4.1	4.3	3.3	5.1	6.5	5.9	5.9	4.6	5.8	6.5	6.4	6.5	6.4	5.8	7.1	33.5	19.2	13.7	11.4	38.0	23.7	32.7	17.0	33.0	20.7	16.4	20.7	22.5	14.3	31.8	22.0	8.4	21.1	17.7	5.1	25.4	20.6	3.9	20.3	50.1	26.1	5.4	26.7	11.7	13.8	15.1	27.0	10.2	17.0	29.2	26.9	11.7	12.9	13.2	13.5	15.5	8.1	12.2	17.0	11.9	5.0	18.3	15.0	12.4	11.2	23.3	20.5	20.6	19.6	23.6	15.3	3.4	24.8	26.3	34.1	1.7	22.7	21.1	20.9	13.1	37.8	23.7	64.0	64.5	25.5	21.7	15.2	17.3	44.5	10.7	19.1
NOL10	"FLJ14075, PQBP5"	ENSG00000115761	"Nucleolar protein 10"	Q9BSC4	2	10570754-10689987	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 189.3;Late spermatids: 163.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035286, HPA043075"	Approved		Supported	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoli		"HPA035286: AB_2674552, HPA043075: AB_10794652"	"unprognostic (6.53e-3)"	"unprognostic (1.61e-1)"	"unprognostic (6.84e-2)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (1.43e-7)"	"unprognostic (1.25e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (7.51e-5)"	"unprognostic (2.43e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.87e-2)"	12.6	14.8	6.6	10.1	8.0	16.2	11.3	10.2	8.2	9.6	5.1	10.8	8.1	9.3	11.0	13.7	7.8	6.6	11.2	7.5	7.1	13.7	14.4	9.0	10.3	6.2	6.6	9.1	16.0	12.1	8.3	10.9	6.1	10.0	10.6	6.2	12.9	8.6	19.4	13.1	9.0	8.8	6.3	9.6	11.7	13.1	7.3	9.9	10.2	11.9	11.7	12.3	10.7	8.8	19.7	33.2	18.6	32.6	22.1	24.2	34.9	33.1	25.8	36.9	27.5	37.5	24.0	45.4	19.5	32.1	30.8	24.5	43.8	38.7	43.6	32.2	33.8	43.8	20.3	46.6	28.0	52.8	23.9	22.6	28.7	40.7	39.1	16.7	25.5	25.0	59.4	28.5	33.9	38.2	36.4	37.4	49.7	51.8	28.8	32.0	49.2	41.4	26.1	30.6	31.6	34.3	24.2	39.4	29.1	20.2	20.8	20.4	24.2	33.8	41.1	33.6	53.9	37.9	63.7	52.4	28.1	49.7	41.5	1.5	3.9	2.2	4.0	5.2	5.9	4.8	4.2	4.2	4.9	3.7	3.2	4.8	0.5	4.8	5.9	3.1	6.0	2.8	6.6	8.0	10.2	8.2	7.5	7.1	6.2	6.6	6.1	6.3	7.3	8.8	22.2	16.0	16.7	31.6	17.1	33.0	29.9	17.2	17.1	13.0	16.3	12.8	19.2	11.5	16.1	12.9	12.5	32.7	16.4	9.9	15.6	27.5	189.3	8.9	19.5	22.9	11.4	19.8	72.9	24.1	33.7	20.2	13.3	17.8	14.0	20.2	12.5	12.2	15.4	16.8	57.6	12.4	18.3	9.8	13.0	163.0	17.1	12.2	8.8	36.5	23.8	13.9	20.6	54.3	54.2	19.0	7.0	16.6	22.1	30.3	10.6	17.0	7.3	16.7	13.1	36.4	22.5	26.4	42.1	17.8	34.2	29.6	17.7	30.4	18.3	22.3
NOL11	DKFZP586L0724	ENSG00000130935	"Nucleolar protein 11"	Q9H8H0	17	67717931-67744531	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022010	Supported		Supported	Nucleoli		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli		"HPA022010: AB_2267158"	"unprognostic (6.81e-2)"	"unprognostic (2.85e-2)"	"prognostic favorable (1.00e-6)"	"unprognostic (3.07e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.55e-2)"	"prognostic unfavorable (2.59e-6)"	"unprognostic (1.37e-2)"	"unprognostic (1.25e-3)"	"unprognostic (4.77e-3)"	"unprognostic (8.74e-2)"	"unprognostic (4.41e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.11e-1)"	12.4	8.2	5.0	14.4	5.5	20.8	16.3	9.6	13.0	14.8	6.1	14.8	12.2	15.0	12.7	14.9	14.5	12.7	12.3	5.0	5.3	15.5	18.9	9.8	22.9	5.8	5.4	14.8	14.4	15.6	3.3	17.8	5.9	11.9	15.5	10.3	9.4	11.3	15.5	11.9	10.9	15.6	5.8	12.6	10.2	11.5	5.8	19.7	15.2	17.0	24.5	18.4	6.0	8.9	54.3	63.4	45.7	29.6	21.1	25.3	52.2	37.1	28.6	71.0	58.5	53.5	36.2	86.5	26.8	36.4	47.1	38.4	112.9	54.0	105.7	26.8	92.7	57.9	36.3	48.3	24.7	74.8	34.0	19.8	34.2	52.7	36.9	20.7	67.8	39.1	96.6	25.8	58.8	49.2	89.1	29.6	50.6	61.0	74.4	63.6	101.4	59.8	31.0	57.6	39.4	37.8	32.8	84.7	40.3	63.3	60.5	44.0	26.5	64.3	44.7	21.7	75.7	16.2	45.5	93.7	26.4	54.8	37.6	12.8	6.3	4.6	9.7	7.6	10.4	10.6	10.2	11.9	8.9	13.0	16.4	11.9	0.8	13.1	7.7	6.5	11.8	9.4	5.0	5.5	9.6	13.0	5.0	5.3	5.8	5.4	5.9	5.8	5.8	8.9	25.5	28.9	18.6	10.4	33.7	33.4	38.9	30.5	27.9	21.9	15.8	11.8	18.6	21.5	27.8	9.2	14.6	45.4	33.8	13.1	11.7	23.5	1.7	17.1	28.9	26.0	27.5	24.2	11.3	17.8	37.1	25.0	20.4	18.7	24.1	31.9	16.8	25.3	20.3	25.2	11.4	16.8	26.4	11.8	11.8	4.3	20.8	15.7	17.8	8.4	19.5	15.8	21.6	13.0	16.3	16.6	9.2	19.2	17.4	24.9	12.2	28.6	24.8	32.7	6.6	25.9	21.8	30.2	35.0	26.8	33.2	33.0	32.0	27.0	21.9	25.4
NOL6	"bA311H10.1, FLJ21959, MGC14896, MGC14921, MGC20838, Nrap, UTP22"	ENSG00000165271	"Nucleolar protein 6"	Q9H6R4	9	33461353-33473930	"Predicted intracellular proteins, Predicted membrane proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055891, HPA061002"	Supported		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoli	Nucleoplasm	"HPA055891: AB_2682959, HPA061002: AB_2684410"	"unprognostic (2.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (4.83e-5)"	"unprognostic (7.37e-3)"	"unprognostic (8.26e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (9.49e-4)"	"unprognostic (4.09e-1)"	19.0	22.0	15.6	13.5	15.5	19.9	17.8	14.3	17.6	19.8	14.5	15.3	8.7	19.5	9.3	29.7	17.1	8.0	20.5	16.5	14.4	21.4	27.0	18.1	14.3	15.2	14.6	19.3	28.4	13.6	24.3	12.1	15.1	23.5	11.8	6.8	17.3	10.1	31.0	27.9	16.2	13.7	13.9	23.5	18.0	28.8	15.8	13.8	17.3	12.0	16.0	22.9	20.6	15.6	37.5	52.3	20.0	45.6	30.5	20.6	33.6	41.2	30.8	46.7	39.3	57.8	13.5	65.3	18.3	46.4	20.7	25.7	58.8	59.1	49.5	41.5	23.9	33.8	62.9	33.1	29.8	78.2	47.0	23.7	48.0	62.9	60.9	19.7	31.6	23.5	54.8	24.5	38.1	33.1	43.3	77.1	71.4	42.0	47.6	36.9	19.9	33.5	36.7	44.1	23.3	31.8	34.0	43.9	14.9	21.3	17.7	44.1	34.7	28.2	38.5	36.6	72.7	22.9	34.4	54.5	25.3	40.6	33.4	0.0	3.0	0.2	3.6	5.9	4.1	2.8	2.7	3.6	5.0	2.2	3.3	3.2	0.1	2.8	6.3	2.7	3.0	2.7	15.6	15.5	14.3	17.6	16.5	14.4	15.2	14.6	15.1	13.9	15.8	15.6	4.8	3.2	12.9	5.2	5.7	20.0	6.6	3.7	4.0	6.5	6.7	6.5	6.6	4.3	8.6	3.7	6.2	4.2	5.4	3.8	3.9	6.3	30.4	7.1	7.7	6.5	10.2	5.7	11.6	4.0	6.1	4.8	9.2	13.6	3.8	7.3	4.2	8.8	5.0	3.3	7.3	5.6	2.0	1.6	4.0	22.0	5.9	3.4	5.4	4.7	3.8	4.2	4.1	6.0	5.9	5.7	2.1	6.0	4.8	10.6	2.4	3.0	6.0	3.8	0.0	6.9	4.5	2.7	5.6	9.5	25.9	3.0	4.9	7.0	7.2	9.5
NOL7	"C6orf90, dJ223E5.2, NOP27, PQBP3, RARG-1"	ENSG00000225921	"Nucleolar protein 7"	Q9UMY1	6	13615335-13632739	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029185	Supported		Supported	"Nucleoli,Mitotic chromosome,Mitochondria"		Yes	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Mitotic chromosome"	Mitochondria	"HPA029185: AB_10601274"	"unprognostic (8.76e-2)"	"unprognostic (8.94e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.75e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.57e-1)"	"unprognostic (4.64e-2)"	"prognostic favorable (3.64e-5)"	"unprognostic (1.26e-1)"	"unprognostic (2.03e-2)"	"unprognostic (8.04e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.79e-2)"	44.3	43.9	29.5	21.7	30.8	29.5	42.0	32.2	34.0	37.5	28.2	44.8	26.8	37.7	23.4	38.2	35.5	16.6	48.2	28.7	31.1	58.5	37.9	32.2	25.8	30.9	31.4	40.7	48.9	40.2	35.9	21.1	31.0	35.1	19.8	16.6	38.0	19.2	44.5	36.9	36.4	16.0	30.8	37.8	37.9	41.7	30.7	15.2	37.1	17.1	20.3	41.4	34.9	33.8	71.7	37.2	31.7	42.7	26.9	26.1	74.4	71.8	29.3	48.4	44.4	60.0	24.9	97.8	137.4	34.4	57.7	46.5	46.9	42.4	47.8	57.5	105.0	91.2	36.3	104.0	45.4	112.0	61.4	25.5	41.5	42.5	24.2	29.8	33.6	45.5	135.7	22.2	44.7	38.1	70.6	147.6	42.1	37.0	74.1	74.4	46.8	140.5	57.9	21.7	92.5	60.3	40.9	88.0	94.9	36.2	53.6	42.8	65.7	48.0	51.9	57.8	108.3	66.2	123.2	100.2	30.7	70.7	75.6	34.5	59.6	82.1	59.2	76.4	68.2	104.0	84.7	71.4	73.2	87.8	90.7	69.0	27.4	61.9	82.9	91.4	96.0	67.9	29.5	30.8	32.2	34.0	28.7	31.1	30.9	31.4	31.0	30.8	30.7	33.8	103.1	93.0	73.5	10.4	112.5	90.8	117.3	151.0	50.1	62.1	78.9	97.0	214.9	68.6	112.0	57.0	22.9	137.4	71.5	72.7	123.3	188.7	202.3	105.8	95.0	109.2	37.1	89.4	14.0	261.2	153.8	90.9	58.1	91.6	90.6	67.0	61.1	61.8	115.1	48.8	17.1	97.8	130.2	52.6	81.8	38.9	82.6	78.5	101.4	8.4	119.7	124.2	78.2	13.6	19.0	175.0	94.3	79.4	138.8	121.7	81.2	163.6	135.6	61.7	65.7	92.5	119.4	186.3	112.9	70.8	90.5	155.3	99.5	99.2	91.0	117.2
NOL8	"C9orf34, FLJ20736, Nop132"	ENSG00000198000	"Nucleolar protein 8"	Q76FK4	9	92297358-92325636	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044440, HPA062922"	Uncertain		Supported	"Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoli	"Mitotic chromosome"	"HPA044440: AB_10963212, HPA062922: "	"unprognostic (3.44e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.73e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (1.85e-1)"	"unprognostic (6.16e-3)"	"unprognostic (5.17e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (4.69e-2)"	"unprognostic (5.38e-2)"	"unprognostic (4.58e-1)"	"unprognostic (5.53e-2)"	8.6	5.8	4.2	8.0	5.8	6.8	10.0	5.0	5.3	8.2	5.2	8.6	6.0	9.8	7.4	8.7	7.4	6.5	6.8	4.1	5.3	7.2	5.5	6.9	12.0	5.6	5.4	11.2	7.1	12.6	3.2	7.6	5.6	7.4	8.3	5.8	7.8	8.5	6.3	7.2	5.9	9.9	4.6	9.8	6.2	6.1	6.0	12.6	10.5	6.2	12.6	8.6	5.1	7.1	18.9	27.1	13.4	24.2	28.5	24.3	19.8	19.7	14.9	20.9	18.7	11.2	18.5	54.2	16.3	20.1	33.8	39.9	43.5	25.8	22.3	36.3	21.4	37.1	25.9	22.4	20.3	63.2	30.5	24.0	23.5	22.0	31.6	16.7	23.7	16.3	60.7	17.1	22.5	29.7	42.7	24.8	21.4	28.4	26.8	29.8	37.9	23.0	10.6	13.4	23.0	12.3	25.3	25.1	18.0	17.3	9.5	21.2	24.9	18.3	14.0	26.7	25.0	17.7	37.5	26.7	18.5	37.4	26.6	18.9	8.3	11.3	11.4	10.8	15.8	13.0	11.3	11.8	12.1	12.9	13.3	11.7	3.1	13.2	15.7	10.2	13.8	7.1	4.2	5.8	5.0	5.3	4.1	5.3	5.6	5.4	5.6	4.6	6.0	7.1	25.4	19.2	33.4	15.7	33.8	13.0	18.4	15.3	21.1	17.9	14.7	20.6	28.4	14.3	19.8	11.0	10.4	19.5	37.7	10.1	15.6	23.5	13.9	17.9	46.2	23.9	9.0	37.6	12.1	12.9	20.1	25.8	23.9	20.8	52.4	30.6	16.1	11.5	26.5	28.6	12.5	16.9	6.1	17.7	12.1	9.4	32.0	23.9	10.6	18.7	34.5	12.4	43.3	15.6	25.9	16.1	11.2	23.7	36.5	23.3	10.3	15.8	21.2	17.7	6.6	29.3	21.5	73.3	50.2	25.4	15.9	14.6	30.1	33.4	20.3	12.2
NOLC1	"KIAA0035, NOPP130, NOPP140, P130, Srp40"	ENSG00000166197	"Nucleolar and coiled-body phosphoprotein 1"	Q14978	10	102152176-102163871	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032654, HPA037366, HPA050388"	Supported		Enhanced	"Nucleoli fibrillar center"		No	Yes		44000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli fibrillar center"		"CAB032654: AB_2152006, HPA037366: AB_10670930, HPA050388: AB_2681109"	"unprognostic (3.23e-1)"	"unprognostic (5.58e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.13e-2)"	"unprognostic (8.89e-2)"	"unprognostic (7.03e-3)"	"unprognostic (2.36e-3)"	"unprognostic (7.34e-3)"	"unprognostic (3.43e-1)"	"unprognostic (3.74e-1)"	"unprognostic (5.64e-3)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (9.19e-5)"	"unprognostic (3.15e-2)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (8.25e-5)"	"unprognostic (7.68e-2)"	36.5	23.9	10.7	41.9	12.3	37.2	32.3	14.6	20.5	27.1	4.5	31.8	21.8	30.3	18.7	33.3	34.4	29.0	24.0	12.6	18.2	21.4	37.5	24.9	43.1	10.9	14.4	34.4	38.4	42.9	14.6	38.3	11.9	31.5	39.1	38.0	26.3	26.6	45.3	21.9	22.8	33.8	10.8	27.6	27.4	19.3	12.2	54.2	37.6	46.4	55.7	64.2	19.6	18.3	202.1	175.1	98.2	209.0	84.7	66.0	166.6	108.5	87.8	150.1	130.5	302.1	132.4	401.5	118.1	69.5	73.9	225.1	285.0	236.1	173.3	127.0	194.8	267.9	143.6	200.3	112.0	389.8	122.8	86.3	169.8	158.3	328.7	94.5	96.5	194.3	286.6	172.6	102.6	170.3	373.7	95.0	196.5	150.7	137.1	277.3	261.6	233.3	100.2	123.5	148.3	141.9	103.5	124.1	144.5	95.6	207.5	99.3	79.3	67.7	93.5	81.3	256.9	165.5	254.4	442.4	110.5	422.7	60.7	2.4	12.5	11.6	20.4	14.4	24.9	16.6	16.1	19.2	16.2	12.1	18.5	22.6	1.3	17.3	17.2	12.4	13.0	17.9	10.7	12.3	14.6	20.5	12.6	18.2	10.9	14.4	11.9	10.8	12.2	18.3	47.8	60.9	74.7	6.2	47.6	120.4	112.6	37.7	101.9	20.8	52.6	48.0	35.3	20.0	68.2	16.5	14.6	49.2	29.1	28.3	25.4	42.2	29.0	38.5	56.3	47.3	27.6	56.8	8.8	23.1	62.7	63.9	43.3	73.1	44.2	28.6	16.8	23.4	27.1	10.1	7.9	38.3	18.3	11.2	46.0	9.7	23.0	26.8	26.6	4.7	22.9	15.1	32.0	2.5	6.8	48.8	21.0	21.1	62.3	89.5	10.2	19.9	56.6	20.0	6.6	85.8	58.9	32.1	53.5	103.3	117.5	48.6	44.5	40.1	49.1	100.5
NONO	"NMT55, NRB54, P54, P54NRB, PPP1R114"	ENSG00000147140	"Non-POU domain containing octamer binding"	Q15233	X	71254814-71301522	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022069, HPA054094, HPA054559"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Nuclear speckles"		NA	NA		450000	"Cluster 44: Non-specific - Transcription"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center, Nuclear speckles"	"CAB022069: , HPA054094: AB_2682376, HPA054559: AB_2682522"	"unprognostic (2.39e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (9.29e-4)"	"unprognostic (8.87e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.02e-3)"	"unprognostic (9.34e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.29e-3)"	"unprognostic (6.79e-2)"	"unprognostic (5.73e-3)"	"unprognostic (2.76e-2)"	"unprognostic (3.04e-2)"	106.4	147.2	58.6	96.4	57.7	115.3	109.2	71.5	64.9	116.8	64.4	101.3	86.2	130.2	107.9	111.9	115.4	100.7	81.2	55.3	69.9	103.3	121.5	103.2	136.5	60.3	61.5	197.9	164.8	114.8	97.1	99.1	60.5	97.0	101.2	70.2	106.8	89.6	99.1	112.2	102.0	113.5	59.2	109.5	114.3	55.2	68.5	255.5	116.0	86.1	165.2	116.8	102.6	61.0	421.2	539.7	595.3	344.4	251.2	238.5	345.3	330.9	319.2	459.3	388.5	413.4	312.9	481.4	379.9	320.5	309.7	310.5	949.5	299.4	488.1	383.9	605.7	394.8	498.4	398.0	212.3	547.7	338.7	272.0	206.0	473.1	305.7	370.5	382.0	342.1	535.3	509.0	406.2	413.9	756.0	466.8	771.3	433.9	365.2	660.0	657.3	414.0	345.9	426.1	431.7	519.4	467.8	299.1	392.5	354.9	271.4	354.0	343.9	268.0	438.6	402.9	400.1	297.3	503.2	516.0	216.8	627.1	433.8	107.5	117.3	91.1	107.9	120.0	119.9	107.4	107.9	106.4	118.7	107.2	115.1	115.6	50.8	119.6	140.7	101.1	128.0	178.1	58.6	57.7	71.5	64.9	55.3	69.9	60.3	61.5	60.5	59.2	68.5	61.0	72.9	76.9	81.1	16.3	97.2	126.3	99.9	105.8	116.7	62.3	111.4	83.6	63.5	90.1	99.8	44.1	41.7	132.3	103.6	52.0	56.7	147.8	11.8	81.6	137.8	95.4	139.8	144.6	16.2	111.4	179.9	93.9	71.4	104.8	88.0	135.9	83.9	128.3	112.6	53.8	20.7	105.6	95.6	153.2	107.7	15.9	106.6	95.0	56.9	13.1	132.0	84.8	96.8	19.6	22.8	110.7	75.4	127.9	115.2	94.9	89.0	121.0	71.1	50.3	65.7	78.7	127.8	45.7	66.5	137.3	122.3	130.1	108.5	163.7	117.2	103.0
NOP14	"C4orf9, NOL14, RES4-25, UTP2"	ENSG00000087269	"NOP14 nucleolar protein"	P78316	4	2937933-2963406	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039596, HPA055652"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoli	Nucleoplasm	"HPA039596: AB_2676590, HPA055652: AB_2682876"	"unprognostic (4.70e-2)"	"unprognostic (6.47e-2)"	"prognostic favorable (3.93e-5)"	"unprognostic (7.32e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (9.10e-4)"	"unprognostic (2.41e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.77e-2)"	17.5	15.7	4.6	18.4	5.9	22.9	16.5	11.2	5.1	13.2	6.9	13.7	12.4	13.2	6.0	18.3	12.2	9.3	13.0	4.3	5.8	11.5	19.0	12.4	23.4	5.5	5.4	19.2	24.6	11.1	11.0	12.1	5.6	11.6	12.7	7.1	13.9	9.0	41.7	22.3	13.6	11.5	4.6	15.2	15.4	7.7	6.1	15.7	15.5	14.6	19.7	19.8	14.6	6.8	52.7	43.8	25.6	52.9	33.6	37.9	44.6	47.4	33.5	48.2	39.6	57.5	54.1	148.0	32.8	38.7	35.1	35.5	71.1	61.5	51.6	28.4	67.8	117.8	40.5	52.6	44.3	129.3	49.2	38.6	54.2	54.7	49.5	23.9	41.3	44.6	108.7	50.9	37.0	37.7	137.4	94.4	66.6	48.0	70.7	87.8	38.7	49.3	24.1	83.2	52.6	30.9	39.4	28.8	37.9	23.0	55.0	50.3	51.7	40.3	23.3	49.6	88.3	37.9	65.8	124.8	41.9	93.6	42.6	1.0	2.1	0.4	2.8	2.4	4.9	2.1	3.4	4.3	2.5	3.5	4.1	3.1	0.2	3.2	1.6	3.1	2.5	2.1	4.6	5.9	11.2	5.1	4.3	5.8	5.5	5.4	5.6	4.6	6.1	6.8	13.3	19.2	30.5	3.6	22.2	25.9	23.4	11.6	27.9	9.6	12.2	12.2	20.2	12.8	23.9	1.8	14.6	16.8	21.0	11.8	11.7	19.5	2.6	13.6	27.8	16.5	9.0	22.3	4.7	24.0	18.4	16.3	20.9	16.4	20.8	25.9	8.6	24.3	11.0	20.2	5.7	11.6	4.1	7.0	12.1	2.6	12.5	14.6	0.0	3.7	15.3	6.3	10.3	3.0	4.7	21.3	6.5	9.8	28.1	27.1	5.1	14.1	12.0	7.7	13.1	23.3	19.7	11.8	19.1	32.5	32.5	11.5	24.1	38.5	17.0	21.4
NOP16	"HSPC111, HSPC185, LOC51491"	ENSG00000048162	"NOP16 nucleolar protein"	Q9Y3C1	5	176383938-176388927	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 202.1;Suprabasal keratinocytes: 205.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA036506, HPA058147"	Approved		Enhanced	Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli		"HPA036506: AB_10672223, HPA058147: AB_2683620"	"unprognostic (4.55e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (1.19e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (5.75e-6)"	"unprognostic (1.05e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.76e-1)"	32.9	24.3	17.6	23.7	17.4	24.8	21.6	17.4	18.1	15.2	15.0	22.1	18.0	14.0	10.7	43.6	15.5	12.5	29.0	17.9	17.2	25.1	31.7	14.1	26.8	17.1	16.9	15.6	21.5	15.3	10.6	15.7	17.4	14.1	18.8	4.8	14.8	12.0	70.9	29.8	16.3	14.5	16.3	17.3	19.9	15.1	17.6	16.6	11.6	30.6	29.9	44.6	21.1	18.2	85.2	135.1	30.3	134.2	49.6	53.3	122.1	70.2	42.4	103.1	89.4	190.7	85.6	145.6	91.6	53.4	101.0	76.5	162.7	242.7	74.5	184.5	115.8	77.7	103.5	159.5	98.7	156.5	80.4	51.8	113.5	98.3	126.1	31.5	79.2	64.4	155.5	69.6	78.9	261.2	121.8	208.7	111.9	127.9	170.3	95.5	44.7	152.1	101.2	75.9	96.0	76.5	41.1	165.1	94.3	28.8	71.9	110.8	68.4	76.9	75.9	68.8	177.1	85.7	122.4	165.1	58.0	218.7	67.2	7.6	51.9	9.5	52.9	86.5	69.4	81.9	58.5	56.7	78.9	85.4	62.6	65.2	4.4	80.0	45.9	97.1	44.1	44.7	17.6	17.4	17.4	18.1	17.9	17.2	17.1	16.9	17.4	16.3	17.6	18.2	21.8	6.4	19.6	2.3	34.4	202.1	145.6	66.4	114.4	3.7	37.2	35.3	35.6	25.8	48.8	1.8	4.2	46.2	17.3	31.8	37.2	53.6	11.0	13.8	30.6	37.6	20.9	20.8	3.1	53.6	60.3	43.3	53.0	20.2	26.6	15.1	12.1	36.9	38.1	0.0	2.9	32.3	32.6	8.3	46.4	5.5	19.6	17.1	56.9	1.9	20.8	4.9	4.1	3.0	1.7	56.4	18.0	14.7	23.8	134.2	20.1	72.6	16.5	3.0	6.6	90.5	46.1	38.4	32.1	112.9	205.3	38.3	22.2	35.9	57.7	116.6
NOP56	"NOL5A, SCA36"	ENSG00000101361	"NOP56 ribonucleoprotein"	O00567	20	2652593-2658393	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"	Ribonucleoprotein	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049918, CAB075757"	Supported		Enhanced	"Nucleoli fibrillar center"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli fibrillar center"		"CAB075757: AB_2665763, HPA049918: AB_2680952"	"unprognostic (2.82e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.59e-7)"	"unprognostic (2.63e-2)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (7.11e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.87e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (1.04e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.42e-1)"	41.4	31.3	39.9	42.6	39.7	60.4	37.1	38.8	59.7	30.9	35.3	33.8	28.8	39.9	34.7	37.1	50.7	26.3	30.9	41.1	45.8	29.8	30.5	25.9	53.5	40.4	40.6	49.7	38.6	27.1	31.5	37.4	43.4	31.1	39.9	21.0	27.1	35.6	43.2	38.4	28.1	52.0	39.9	37.7	25.9	28.3	45.4	51.9	33.4	29.2	62.2	52.4	28.4	44.4	152.8	147.3	108.4	108.0	122.8	89.8	184.2	150.4	97.3	198.3	134.9	204.3	122.2	330.5	82.7	104.2	117.7	253.3	287.5	221.4	196.6	93.5	171.4	195.0	76.0	225.3	125.9	179.4	91.3	123.6	137.2	254.8	260.4	78.2	117.4	153.1	215.7	151.2	138.1	103.1	317.8	214.1	233.8	270.9	180.9	257.2	156.2	188.5	120.8	146.7	115.5	101.1	171.0	193.4	302.8	115.7	167.6	152.7	91.6	170.2	115.9	132.6	227.2	91.9	186.0	274.0	45.9	209.4	128.5	5.1	23.2	18.9	33.0	26.4	41.1	35.8	35.9	36.6	23.6	32.4	34.0	34.0	1.8	33.6	19.8	41.1	33.4	24.8	39.9	39.7	38.8	59.7	41.1	45.8	40.4	40.6	43.4	39.9	45.4	44.4	75.0	44.8	59.8	14.0	89.3	96.4	103.6	76.4	88.2	39.5	62.9	78.6	39.0	42.9	100.1	23.9	62.6	117.5	132.2	71.8	25.4	78.2	8.0	64.6	100.6	73.3	72.3	93.2	24.6	86.5	124.2	87.5	44.4	48.5	79.1	97.5	52.5	40.9	86.9	50.5	24.1	81.2	54.9	46.8	45.9	14.0	57.2	57.5	30.2	12.2	64.9	32.8	80.3	18.1	21.5	75.6	34.6	54.9	79.6	92.0	38.7	53.8	81.2	37.6	26.3	110.0	141.5	50.3	185.9	89.1	81.7	56.5	102.6	99.4	110.0	58.0
NOP58	"HSPC120, NOP5"	ENSG00000055044	"NOP58 ribonucleoprotein"	Q9Y2X3	2	202265736-202303661	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018472, HPA021062"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA018472: AB_1854564, HPA021062: AB_1854565"	"unprognostic (1.56e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (1.97e-6)"	"unprognostic (6.64e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (9.86e-4)"	"unprognostic (4.52e-3)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (3.38e-9)"	"unprognostic (1.79e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.60e-1)"	36.0	35.1	33.5	43.9	33.6	76.3	43.7	38.8	58.4	29.5	33.4	30.4	28.2	32.2	33.4	37.8	31.6	23.6	25.1	33.4	36.3	32.8	40.7	26.4	60.3	32.3	33.3	37.4	37.8	24.8	30.2	32.6	32.6	29.5	35.8	28.1	26.5	23.1	41.8	30.7	29.7	27.3	32.6	33.9	29.6	24.9	34.8	41.9	27.1	21.5	59.8	43.3	30.2	35.3	126.4	86.0	85.1	106.8	62.0	55.6	199.2	118.5	62.9	89.1	82.9	191.5	110.9	193.1	95.4	72.5	111.6	114.0	170.1	144.7	158.4	75.0	152.5	233.6	133.3	193.7	91.5	234.7	108.6	72.1	85.3	124.6	284.6	48.6	81.2	112.3	260.4	144.1	113.4	131.4	215.1	258.7	212.9	139.4	146.5	179.5	128.3	257.1	107.1	148.5	130.5	95.8	109.0	156.6	140.8	136.2	106.4	181.8	70.3	113.5	133.8	102.5	206.0	115.7	226.1	274.8	84.2	163.7	138.5	13.4	24.0	7.4	37.2	35.6	55.0	56.1	53.1	51.2	37.4	45.0	57.5	58.9	2.3	52.1	28.3	53.1	58.0	32.5	33.5	33.6	38.8	58.4	33.4	36.3	32.3	33.3	32.6	32.6	34.8	35.3	56.3	109.0	116.2	22.2	111.6	85.8	150.5	98.0	78.0	28.1	53.8	70.2	82.7	37.1	116.8	40.5	41.7	78.1	87.1	35.7	29.4	59.9	39.2	59.6	75.9	62.3	35.2	65.2	39.0	67.8	96.9	82.6	51.0	97.0	137.3	47.7	32.2	46.1	47.7	25.2	47.5	61.5	61.1	23.2	43.5	11.1	43.2	51.5	24.9	20.6	59.6	18.8	35.0	20.6	27.0	50.3	17.3	29.7	118.6	89.9	18.3	37.8	70.6	44.2	26.3	112.2	116.8	70.4	58.4	77.5	74.7	68.0	124.1	45.4	79.6	94.6
NPDC1	"CAB-, CAB1, DKFZp586J0523"	ENSG00000107281	"Neural proliferation, differentiation and control 1"	Q9NQX5	9	137039463-137046179	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 397.0;Endothelial cells: 307.2;Enteroendocrine cells: 281.6;Hepatic stellate cells: 406.2;Intestinal goblet cells: 589.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 146.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 12.3;MAIT T-cell: 14.7;memory CD4 T-cell: 19.0;memory CD8 T-cell: 18.9;T-reg: 15.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 19.0"	"Cell line enhanced"	"Detected in many"		"MCF7: 138.4;RPMI-8226: 132.8;T-47d: 140.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008189	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		240000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	Cytosol	"HPA008189: AB_1854584"	"unprognostic (6.94e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (2.01e-5)"	"prognostic favorable (6.19e-5)"	"unprognostic (2.06e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (2.40e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.20e-2)"	"unprognostic (8.84e-2)"	129.5	45.7	140.8	12.2	128.1	3.4	133.0	110.6	181.3	130.5	55.0	93.1	23.4	121.6	4.3	53.7	148.6	24.9	149.1	143.3	143.1	75.9	23.7	115.4	13.0	138.9	142.3	68.2	81.2	23.0	266.0	21.1	131.3	260.5	13.4	9.2	137.4	35.1	34.0	56.4	72.1	16.9	120.7	145.2	126.2	35.3	142.9	2.9	68.4	12.4	3.9	97.9	90.5	114.7	33.6	41.9	10.1	67.1	23.7	23.8	2.8	68.7	23.0	16.9	6.7	17.1	18.5	30.3	50.7	28.6	4.6	122.4	8.6	20.5	1.6	25.0	40.4	13.6	123.7	12.9	33.3	11.9	0.3	16.5	31.9	8.7	17.9	43.1	43.6	13.2	0.7	0.8	3.5	138.4	1.0	1.1	21.1	111.0	68.1	19.9	0.0	132.8	28.6	22.7	77.2	50.0	18.4	65.3	46.5	3.6	140.1	17.9	73.9	12.4	21.6	84.1	21.0	0.1	0.4	1.4	17.7	1.2	10.5	0.0	0.6	0.9	12.3	0.1	14.7	0.1	19.0	18.9	1.1	0.0	0.5	3.1	0.0	0.2	0.1	3.4	15.9	3.3	140.8	128.1	110.6	181.3	143.3	143.1	138.9	142.3	131.3	120.7	142.9	114.7	397.0	0.0	7.7	64.3	3.4	23.6	77.6	15.0	31.3	97.5	174.0	139.7	18.3	71.4	19.8	29.5	16.7	1.1	5.5	122.2	0.0	52.5	1.8	39.0	27.7	307.2	281.6	19.3	71.7	66.0	1.3	61.2	153.9	101.3	0.0	9.2	406.2	1.9	22.2	62.2	64.7	589.1	18.3	21.0	20.0	6.9	161.2	6.6	30.2	37.5	3.0	38.5	1.0	38.2	39.0	33.0	106.0	145.6	1.4	234.9	37.5	0.7	7.5	62.0	39.5	23.9	38.9	2.8	19.0	15.9	23.7	1.8	12.3	9.1	98.1	103.1
NPM3		ENSG00000107833	"Nucleophosmin/nucleoplasmin 3"	O75607	10	101781325-101783413	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036295, HPA036296"	Approved		Approved	"Nucleoli,Actin filaments,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	"Nucleoli, Actin filaments, Cytosol"		"HPA036295: AB_10671244, HPA036296: AB_10672083"	"unprognostic (3.41e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (1.00e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.69e-2)"	"unprognostic (9.58e-2)"	12.7	19.5	9.9	18.5	10.2	27.2	19.0	7.8	10.4	19.6	9.6	15.5	8.3	17.2	10.1	26.6	15.3	9.8	8.4	9.6	11.6	16.4	12.3	10.2	23.3	8.4	8.5	20.6	30.3	16.4	12.4	16.3	8.6	13.4	19.3	1.1	15.1	8.2	13.3	16.7	10.7	19.9	8.5	14.8	13.1	17.1	11.6	20.3	11.1	10.1	25.9	20.9	16.7	9.3	94.8	117.2	34.2	226.2	76.5	80.0	36.1	50.0	75.7	75.8	64.4	126.5	117.1	154.8	91.0	56.0	41.6	99.2	192.6	211.8	59.3	66.1	199.8	124.5	50.5	206.0	86.1	286.6	87.4	69.6	100.8	105.2	417.0	39.0	100.6	187.1	156.9	83.7	63.3	173.8	121.0	371.8	60.7	131.1	89.1	93.3	179.2	158.0	75.0	45.8	70.0	45.1	31.2	72.5	144.7	41.8	94.4	59.0	40.1	30.0	95.8	44.8	94.1	36.0	39.9	179.7	41.9	263.4	31.8	0.0	2.8	0.0	3.6	4.0	6.5	4.0	5.9	6.9	6.4	4.8	9.5	9.8	0.1	8.1	0.8	8.3	2.6	5.1	9.9	10.2	7.8	10.4	9.6	11.6	8.4	8.5	8.6	8.5	11.6	9.3	5.1	3.2	5.0	1.0	15.3	62.7	79.6	121.4	28.5	1.4	55.5	54.4	2.9	28.6	32.0	36.8	0.0	91.4	15.6	16.3	78.2	54.0	8.9	7.3	22.1	21.6	24.2	17.9	2.7	41.2	90.6	29.7	13.7	10.5	16.5	19.6	15.0	19.0	68.6	0.0	2.0	33.1	46.8	21.1	69.9	10.9	28.0	18.0	30.2	1.9	14.7	2.5	18.6	1.5	1.0	34.2	12.7	23.7	19.1	118.5	3.1	61.6	16.4	2.0	6.6	47.9	21.6	46.5	91.3	21.3	49.9	60.7	18.5	29.0	46.9	62.8
NPRL3	"C16orf35, CGTHBA, HS-40, MARE, NPR3, RMD11"	ENSG00000103148	"NPR3 like, GATOR1 complex subunit"	Q12980	16	84271-138677	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"GTPase activation"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 134.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011741	Uncertain		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol		"HPA011741: AB_1845577"	"unprognostic (1.34e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.87e-2)"	"unprognostic (6.18e-3)"	"unprognostic (9.50e-2)"	"unprognostic (7.28e-2)"	"unprognostic (4.85e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.15e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.73e-1)"	9.6	10.4	17.5	7.2	18.2	19.1	8.5	16.7	22.2	10.1	15.7	6.5	7.3	10.5	5.2	9.3	12.1	6.3	8.9	17.7	18.0	8.0	10.0	7.8	9.4	17.1	18.1	12.9	10.9	12.7	11.7	6.6	16.9	8.8	4.8	7.1	11.0	7.1	15.5	9.9	5.6	7.2	15.5	8.3	6.8	9.4	18.2	7.0	11.0	10.3	6.6	6.5	8.2	18.2	14.5	29.0	12.6	32.2	33.7	16.9	19.8	17.2	16.8	21.3	16.6	46.6	25.6	26.5	22.5	25.5	13.8	17.0	20.5	29.7	12.3	29.2	16.0	38.8	17.3	34.2	31.1	15.9	25.6	20.7	22.2	28.4	24.9	16.0	20.3	21.1	38.6	24.6	19.1	51.2	17.6	12.3	11.9	10.0	20.8	30.1	10.8	37.9	21.6	12.2	26.9	17.1	22.8	30.1	14.3	6.5	22.2	11.1	19.2	32.9	18.2	20.0	13.3	25.9	14.7	37.7	1.1	19.2	18.3	0.0	2.4	0.3	3.0	2.2	3.2	2.0	2.6	2.5	3.5	2.0	2.5	2.9	0.2	2.0	3.1	2.6	2.9	2.2	17.5	18.2	16.7	22.2	17.7	18.0	17.1	18.1	16.9	15.5	18.2	18.2	10.4	12.8	11.7	30.0	22.2	9.4	17.6	15.7	14.8	58.1	16.6	16.8	9.0	12.8	9.2	11.0	66.7	24.6	20.4	6.8	23.5	16.4	31.0	11.8	18.1	13.0	9.6	134.5	29.7	8.9	35.2	17.3	15.8	9.4	3.8	49.2	15.7	10.2	19.7	55.5	30.8	11.7	10.2	14.2	6.4	73.8	22.7	12.8	12.4	15.9	16.4	29.5	79.3	21.1	40.4	11.4	6.6	19.5	14.0	23.3	8.0	23.9	11.0	57.2	6.6	15.6	14.9	62.2	43.0	16.0	5.5	15.3	18.8	28.2	14.4	10.4
NRDC	"hNRD1, hNRD2, NRD1"	ENSG00000078618	"Nardilysin convertase"	O43847	1	51789191-51878937	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 267.3"	"Group enriched"	"Detected in many"	9	"Early spermatids: 597.7;Late spermatids: 1672.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053661			Approved	Nucleoplasm		NA	NA		58000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA053661: AB_2682221"	"unprognostic (1.22e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (5.49e-6)"	"unprognostic (1.42e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (2.12e-9)"	"unprognostic (2.75e-1)"	"unprognostic (2.35e-2)"	"unprognostic (9.54e-2)"	"unprognostic (5.53e-3)"	48.2	36.8	33.3	48.2	33.9	48.5	34.2	33.6	42.3	31.1	37.2	32.5	32.3	31.1	20.2	40.4	29.7	31.0	58.5	34.4	35.5	26.5	55.7	34.3	43.8	35.2	34.6	32.6	40.1	60.9	32.8	40.2	37.8	38.6	35.3	48.1	28.7	30.5	267.3	51.4	31.4	38.4	33.6	40.9	35.2	95.6	36.5	54.9	33.1	182.0	46.7	36.5	28.4	38.1	166.8	91.0	94.2	133.4	98.9	145.5	106.8	165.6	143.9	116.6	123.5	65.6	65.3	108.3	84.7	128.4	157.6	95.1	136.5	127.9	156.2	127.7	66.1	129.5	125.4	62.9	97.9	114.4	95.4	117.2	102.1	169.7	160.0	105.0	125.7	113.1	174.7	71.7	153.4	62.9	105.0	45.2	161.5	71.8	97.4	101.6	106.4	122.6	92.8	94.7	86.5	65.2	148.0	124.8	94.5	185.7	79.3	152.5	102.4	103.8	94.2	114.2	146.0	103.9	168.4	100.1	120.8	146.6	120.1	44.5	33.8	50.0	23.2	35.1	23.3	23.2	21.5	26.0	33.7	15.6	20.9	22.7	67.8	29.8	28.3	27.5	26.9	33.1	33.3	33.9	33.6	42.3	34.4	35.5	35.2	34.6	37.8	33.6	36.5	38.1	43.5	35.3	69.0	0.0	58.9	0.0	46.3	0.0	38.7	73.3	38.2	31.0	0.0	28.6	34.7	27.6	81.3	56.8	94.3	11.1	31.3	48.1	597.7	63.1	78.8	39.4	18.2	85.8	0.0	64.0	45.5	40.1	56.6	55.4	35.3	74.6	30.4	59.9	44.3	62.2	0.0	19.5	0.0	44.6	0.0	1672.1	66.2	72.5	0.0	0.0	70.3	45.9	55.6	0.0	0.0	57.6	13.7	59.0	126.1	41.9	30.1	19.6	59.0	71.8	59.2	64.5	38.2	39.0	28.1	57.7	0.0	82.5	52.8	65.9	21.6	42.3
NRM	NRM29	ENSG00000137404	Nurim	Q8IXM6	6	30688047-30691420	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 60.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA072545, HPA073982"			Enhanced	"Nuclear membrane"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear membrane"		"HPA072545: AB_2686532, HPA073982: AB_2686649"	"unprognostic (2.09e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.44e-1)"	"prognostic unfavorable (3.52e-8)"	"unprognostic (3.95e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.51e-1)"	7.6	4.7	0.4	0.6	0.4	1.7	6.1	0.4	0.4	13.0	0.3	6.7	0.2	13.5	0.3	8.8	8.2	0.3	5.3	0.4	0.4	4.4	2.9	7.8	1.0	0.5	0.4	8.1	5.2	0.3	1.7	0.9	0.4	4.8	0.5	0.3	4.2	0.9	2.1	8.1	6.5	1.1	0.4	7.3	3.9	10.9	0.5	1.5	4.8	0.5	1.1	6.9	9.1	0.4	3.0	2.8	5.2	3.7	0.8	2.8	0.6	1.5	2.9	4.7	4.2	3.1	2.1	5.1	1.0	3.1	2.1	4.6	2.9	5.0	1.3	7.1	1.5	3.1	4.0	4.0	1.0	2.4	4.6	1.7	1.8	4.6	1.7	1.6	3.7	4.1	2.8	4.5	3.2	2.7	3.9	2.6	1.1	3.3	1.7	9.2	3.5	6.2	2.1	1.5	1.9	1.7	1.7	2.1	1.0	1.6	3.4	2.4	1.5	4.3	2.3	2.4	2.8	1.6	3.3	1.8	0.6	6.5	5.6	0.3	1.6	0.1	0.4	0.5	0.3	1.8	0.4	0.6	1.4	1.7	0.2	0.2	0.6	0.4	0.2	1.6	0.3	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.5	0.4	0.4	0.4	0.5	0.4	12.1	3.2	2.0	0.7	12.9	9.8	6.3	9.6	5.7	1.7	3.0	7.5	1.9	12.8	4.9	1.8	2.1	23.0	5.1	1.6	3.9	12.2	13.5	1.0	8.4	12.3	1.2	9.2	0.3	5.6	28.1	9.0	1.5	2.7	12.7	5.0	4.6	1.0	17.6	3.3	0.4	3.4	2.0	20.5	18.9	60.1	5.6	12.8	3.6	1.0	25.6	1.2	7.2	0.5	0.3	4.8	0.5	6.0	5.5	1.7	0.5	1.0	0.4	1.9	6.6	7.3	11.6	4.4	2.1	14.6	6.3	5.1	9.9	3.9	6.3	4.3
NSD2	"KMT3G, MMSET, WHSC1"	ENSG00000109685	"Nuclear receptor binding SET domain protein 2"	O96028	4	1871393-1982207	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 20.3;Granulosa cells: 69.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015801, CAB068246, CAB068247"	Enhanced		Supported	Nucleoplasm		No	No			"Cluster 17: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"CAB068246: AB_2665690, CAB068247: AB_2665689, HPA015801: AB_1858830"	"unprognostic (3.70e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (3.24e-2)"	"unprognostic (6.22e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (9.25e-3)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (3.89e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.15e-2)"	10.1	8.4	12.7	16.5	13.0	54.9	9.9	23.6	15.2	9.4	0.8	19.6	18.6	10.7	7.3	13.6	8.4	8.3	15.8	11.8	11.5	9.8	8.3	12.6	25.4	9.8	8.6	7.7	13.5	12.0	13.8	12.2	12.0	9.7	22.5	28.5	11.6	8.4	16.7	11.6	18.3	12.4	4.4	14.1	12.5	37.2	12.6	59.8	17.4	13.7	24.3	9.7	9.2	14.9	124.0	58.6	168.3	71.2	17.5	26.5	44.2	98.2	85.4	115.2	128.8	44.6	141.4	117.5	31.4	78.0	158.5	50.2	114.4	74.3	195.0	58.3	47.7	151.3	81.7	25.5	18.6	89.5	74.9	9.9	19.8	101.2	89.9	60.1	92.2	123.4	81.7	132.2	95.8	42.1	243.3	99.7	68.8	60.1	77.1	137.8	106.7	42.9	45.4	57.4	115.6	82.7	78.4	29.2	31.7	71.4	68.9	52.2	64.9	109.0	87.4	72.8	188.1	54.1	72.9	113.7	66.0	81.9	108.0	4.0	1.1	1.3	1.0	0.8	1.1	0.9	1.5	1.2	1.2	1.7	1.1	0.8	3.4	1.2	0.5	2.1	2.9	0.7	12.7	13.0	23.6	15.2	11.8	11.5	9.8	8.6	12.0	4.4	12.6	14.9	12.6	12.8	18.4	0.0	4.1	0.0	0.0	0.0	0.0	0.0	15.3	9.1	0.0	0.0	8.1	12.9	0.0	15.7	7.2	0.0	3.9	10.4	0.0	13.0	11.7	6.3	0.0	0.0	0.0	7.1	10.0	6.0	0.0	20.3	2.5	69.3	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	5.7	0.0	0.0	0.0	0.0	11.4	0.0	0.0	4.9	0.0	0.0	4.0	7.3	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	3.4	5.2	3.7	0.0	0.0
NSL1	"C1orf48, DC8, DKFZP566O1646, MIS14"	ENSG00000117697	"NSL1 component of MIS12 kinetochore complex"	Q96IY1	1	212726153-212791782	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA045761, HPA053721"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA045761: AB_2679444, HPA053721: AB_2682240"	"unprognostic (1.47e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.78e-2)"	"unprognostic (8.22e-3)"	"unprognostic (3.55e-1)"	"unprognostic (4.78e-2)"	"unprognostic (6.09e-3)"	"unprognostic (3.44e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.10e-3)"	"unprognostic (2.59e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.66e-2)"	16.7	14.5	13.8	19.4	16.9	19.1	11.2	17.1	17.5	12.8	15.0	13.3	17.5	14.5	8.0	15.3	13.9	15.0	24.9	13.4	14.9	16.0	19.3	12.5	27.0	18.0	14.9	16.8	12.5	13.9	11.0	17.6	17.5	12.8	10.1	12.6	13.9	10.0	22.5	8.8	17.5	13.1	17.3	19.4	11.7	13.5	14.8	22.7	15.0	15.6	16.7	13.6	10.1	21.3	39.7	44.3	45.0	43.3	18.9	19.5	59.4	32.5	22.1	38.7	33.2	37.3	42.2	55.6	29.4	18.7	21.6	28.4	35.6	29.9	20.1	102.9	33.6	37.0	31.2	61.8	21.7	62.5	34.9	20.2	14.6	39.6	19.8	17.8	28.8	62.9	83.0	45.7	24.6	23.1	80.6	24.6	82.9	20.6	32.8	69.2	68.1	61.5	31.3	19.8	41.1	57.0	46.0	22.3	55.7	33.3	65.6	44.9	33.3	39.4	34.1	36.4	54.5	26.4	76.3	73.8	33.7	42.2	50.7	21.8	49.3	63.1	35.9	62.3	43.0	59.0	38.8	39.2	55.6	47.4	46.7	41.9	49.6	45.3	64.3	53.8	51.2	60.7	13.8	16.9	17.1	17.5	13.4	14.9	18.0	14.9	17.5	17.3	14.8	21.3	39.4	16.0	20.7	25.5	43.5	14.8	21.2	51.4	31.3	34.1	22.8	26.8	22.4	31.5	28.1	18.4	14.6	64.0	40.9	14.7	43.0	32.2	29.2	19.9	29.0	32.0	21.7	50.7	50.2	21.1	62.2	28.9	13.3	15.1	15.2	31.6	29.6	27.9	61.6	33.7	50.1	14.1	30.5	68.2	28.5	15.2	34.8	44.6	19.6	33.7	56.0	37.1	35.0	36.2	68.9	22.7	15.9	32.7	26.7	10.5	32.5	58.5	25.6	32.7	59.2	30.2	32.6	48.7	65.5	22.7	16.2	20.9	36.6	27.0	18.5	10.3
NSMCE4A	"bA500G22.3, C10orf86, FLJ20003, NSE4A"	ENSG00000107672	"NSE4 homolog A, SMC5-SMC6 complex component"	Q9NXX6	10	121957091-121975217	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA037459, HPA038412, HPA044872"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 4: Stomach - Digestion"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA037459: AB_10696932, HPA038412: AB_2676005, HPA044872: AB_2679124"	"unprognostic (1.16e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (2.72e-5)"	"unprognostic (3.16e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.44e-3)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (1.64e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.01e-3)"	27.3	20.6	9.3	14.6	11.8	20.2	27.4	10.8	13.3	23.0	9.3	37.0	24.7	23.4	12.4	19.2	22.8	14.4	21.2	9.5	10.0	15.6	25.2	16.9	23.8	10.9	10.8	22.7	30.0	15.1	11.2	14.1	10.9	24.8	21.0	10.7	24.4	16.5	20.6	19.4	26.8	17.7	10.4	23.3	29.5	4.9	10.6	21.5	21.1	8.4	19.7	30.0	20.8	13.2	43.4	51.9	55.0	49.0	18.9	24.7	40.3	23.7	42.3	40.0	55.2	40.5	32.8	57.2	17.9	18.9	22.0	36.7	32.5	26.0	31.5	69.0	76.3	37.5	17.0	76.5	16.0	43.2	25.5	16.9	19.4	23.5	37.9	22.4	42.8	51.5	35.1	40.3	22.6	35.1	78.2	62.8	28.7	30.7	40.4	66.9	42.4	61.2	27.7	35.4	14.9	29.1	27.0	18.1	38.2	22.0	20.0	40.3	35.3	15.8	28.0	26.8	49.6	53.0	60.6	88.0	19.7	57.5	17.3	0.3	31.5	19.5	29.6	38.3	34.4	50.6	39.5	38.7	33.1	46.6	41.4	33.6	2.9	41.7	38.5	51.5	48.3	36.5	9.3	11.8	10.8	13.3	9.5	10.0	10.9	10.8	10.9	10.4	10.6	13.2	49.3	22.4	33.1	9.4	35.5	17.0	45.0	47.0	23.9	20.3	30.4	34.3	23.1	30.0	31.8	12.9	33.3	56.4	40.0	35.8	35.2	28.0	0.7	16.8	15.4	33.9	21.6	26.1	5.3	61.2	38.0	25.9	28.5	17.0	11.4	34.6	18.5	33.3	35.6	26.9	5.4	35.1	46.8	20.0	19.2	1.6	35.4	22.4	21.4	7.5	48.6	33.3	40.2	7.5	17.4	30.4	37.0	33.4	36.3	41.9	36.8	39.2	21.6	37.4	26.3	27.1	31.3	6.7	16.6	35.5	21.6	66.2	29.3	39.6	44.8	47.9
NSUN5	"FLJ10267, NOL1R, NSUN5A, p120(NOL1), WBSCR20, WBSCR20A, Ynl022cL"	ENSG00000130305	"NOP2/Sun RNA methyltransferase 5"	Q96P11	7	73302516-73308826	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, RNA-binding, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020536, HPA045590, HPA046867"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"		"HPA020536: AB_1858789, HPA045590: AB_2679376, HPA046867: AB_2679847"	"unprognostic (3.94e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (3.96e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.85e-2)"	13.9	11.6	9.8	9.7	11.3	33.4	14.1	11.7	12.9	15.3	9.1	18.6	8.9	18.7	3.2	17.7	15.5	4.2	17.7	9.8	10.9	17.4	16.2	12.1	14.2	12.8	10.8	13.0	24.0	6.6	12.8	6.1	11.7	15.5	4.3	3.2	14.6	6.3	37.9	19.7	17.7	6.2	11.6	24.4	16.3	20.7	11.0	13.0	13.6	8.1	9.4	18.6	14.7	13.3	34.7	46.4	12.3	29.3	4.8	6.3	48.4	15.3	9.1	23.6	25.3	63.0	24.3	55.3	10.6	7.7	34.6	28.9	23.7	15.2	8.1	36.6	57.0	20.7	35.8	36.4	20.0	45.9	26.0	8.3	25.7	20.0	17.3	5.2	3.1	40.4	71.0	12.7	10.8	83.2	39.3	91.6	52.1	24.9	34.9	48.9	9.5	79.8	10.1	17.1	33.2	54.6	27.9	72.5	36.4	12.8	47.9	37.1	5.3	0.2	34.8	34.7	11.1	49.6	73.8	80.8	0.5	65.6	2.5	23.7	21.5	24.0	19.6	19.6	15.7	32.2	22.3	20.4	25.0	46.2	31.0	26.5	27.4	26.8	14.8	31.5	26.9	23.2	9.8	11.3	11.7	12.9	9.8	10.9	12.8	10.8	11.7	11.6	11.0	13.3	11.1	6.4	7.4	14.4	38.2	17.0	20.0	32.8	14.8	27.5	23.0	25.0	20.4	27.1	21.3	36.8	12.5	37.7	27.3	18.3	37.2	35.8	17.4	18.1	12.7	8.9	3.6	19.1	9.2	33.0	48.9	17.2	21.4	15.5	26.6	50.5	5.3	21.0	36.6	32.0	9.3	18.3	26.4	21.0	10.8	21.6	29.2	20.2	21.4	3.7	39.9	13.2	36.0	10.1	12.1	29.1	20.5	20.7	24.9	12.6	28.4	25.1	21.8	23.1	6.6	20.8	16.8	64.2	56.7	15.1	21.3	21.8	24.9	16.2	23.1	14.3
NSUN6	"ARL5B-AS1, FLJ23743, NOPD1"	ENSG00000241058	"NOP2/Sun RNA methyltransferase 6"	Q8TEA1	10	18545561-18659285	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 61.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045902	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 15: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus"		"HPA045902: AB_10962354"	"unprognostic (7.34e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.10e-3)"	"unprognostic (9.50e-2)"	"unprognostic (4.92e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.63e-2)"	"prognostic favorable (8.42e-4)"	"unprognostic (1.60e-1)"	"unprognostic (2.45e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (5.55e-5)"	"unprognostic (2.23e-1)"	"unprognostic (7.53e-3)"	"unprognostic (3.18e-2)"	"unprognostic (2.00e-3)"	6.4	12.2	13.6	7.5	14.3	12.4	9.3	16.0	15.9	9.0	13.5	6.1	8.6	9.6	12.2	5.7	8.7	6.0	8.6	14.0	14.1	10.6	61.1	6.5	11.3	13.8	14.8	12.7	12.0	7.8	17.2	6.5	14.7	10.5	8.4	12.9	8.4	5.6	4.5	9.1	8.7	6.1	13.9	9.8	8.5	17.5	13.8	11.8	12.0	4.8	10.9	9.1	7.6	17.6	7.5	6.3	16.6	12.3	8.1	11.1	7.2	10.3	2.5	8.4	11.3	12.0	11.2	17.0	4.3	4.0	5.9	11.0	17.1	10.8	10.8	16.6	13.9	17.8	8.8	14.5	8.3	8.1	11.6	8.6	10.3	8.0	5.5	8.3	3.9	20.0	25.1	16.1	8.2	4.2	18.6	9.3	8.5	14.8	4.8	13.1	8.6	17.4	6.3	9.1	8.9	11.0	8.7	9.0	7.3	11.3	5.8	6.4	6.7	7.0	8.1	12.8	7.6	9.9	11.0	18.8	5.0	14.5	4.3	1.5	3.5	2.8	4.4	4.7	7.0	8.0	6.3	5.6	2.9	6.1	7.8	6.7	1.6	5.3	8.2	4.0	10.5	2.5	13.6	14.3	16.0	15.9	14.0	14.1	13.8	14.8	14.7	13.9	13.8	17.6	75.4	9.6	15.1	57.8	34.9	28.7	17.1	11.0	30.1	33.2	32.4	34.7	8.1	18.6	13.6	9.2	22.9	10.1	39.6	19.5	5.9	10.0	19.7	23.6	38.9	37.5	14.5	20.8	43.5	12.7	8.0	19.2	40.2	49.0	17.7	32.0	26.7	86.6	7.4	25.2	45.0	24.5	18.3	24.2	52.4	12.7	25.7	28.5	12.4	23.4	15.3	15.3	17.5	43.7	57.6	11.1	20.0	17.0	31.0	10.1	40.2	10.9	14.5	28.9	13.1	20.1	19.1	49.5	21.8	21.3	26.7	6.7	31.0	26.7	18.7	14.2
NT5DC1	"dJ486I3.1, MGC24302, NT5C2L1"	ENSG00000178425	"5'-nucleotidase domain containing 1"	Q5TFE4	6	116100851-116249497	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 117.6"	"Cell type enriched"	"Detected in all"	4	"Oligodendrocytes: 429.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030352, HPA079264"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		140000	"Cluster 37: B-cells - Transcription"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA030352: AB_2154066, HPA079264: "	"unprognostic (1.30e-1)"	"unprognostic (2.92e-1)"	"prognostic favorable (2.61e-4)"	"unprognostic (1.14e-1)"	"unprognostic (3.13e-2)"	"unprognostic (7.80e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.61e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (7.49e-7)"	"unprognostic (1.41e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.79e-1)"	"unprognostic (9.63e-2)"	19.5	24.0	11.4	12.7	24.6	10.0	19.2	22.7	15.0	10.4	117.6	19.8	29.5	9.1	22.4	16.5	20.6	15.7	25.9	11.0	16.3	28.2	42.6	16.7	21.4	24.1	20.9	13.2	22.2	23.8	9.6	8.3	24.1	28.3	19.9	11.2	22.7	16.6	21.5	10.7	26.8	11.3	21.0	13.5	21.6	10.6	19.3	14.5	28.3	23.2	22.4	15.8	9.4	40.9	24.7	20.3	17.7	23.7	19.2	11.6	31.0	17.7	40.3	27.4	32.2	29.4	24.8	50.3	37.4	15.9	29.7	38.7	12.1	28.1	23.8	78.4	26.7	21.0	16.7	31.0	20.9	46.8	1.9	21.7	22.2	17.6	15.0	59.2	24.7	30.0	26.6	27.5	34.8	25.3	9.0	16.3	16.2	54.1	27.0	52.3	48.3	27.2	25.5	29.2	11.8	17.6	37.9	28.7	26.5	19.4	26.6	9.3	21.6	12.3	20.8	23.7	35.6	40.2	59.2	39.8	29.3	31.0	22.4	14.5	18.2	33.2	20.2	10.5	31.4	41.3	29.8	25.4	24.6	30.1	28.2	24.3	12.9	23.1	12.7	12.4	32.4	19.7	11.4	24.6	22.7	15.0	11.0	16.3	24.1	20.9	24.1	21.0	19.3	40.9	15.4	64.1	45.7	62.3	37.9	26.1	37.9	66.5	29.6	14.0	30.3	23.6	44.2	25.8	44.5	18.4	27.1	41.6	24.9	19.1	64.6	39.6	19.8	32.9	10.7	21.7	26.5	16.2	96.1	40.8	30.4	14.0	26.5	19.0	23.5	16.2	33.5	49.3	31.8	45.4	70.1	30.6	30.5	29.2	14.2	8.3	19.0	18.5	19.6	54.4	49.6	19.8	10.3	29.7	429.4	28.8	19.6	20.7	25.3	28.0	54.6	57.4	76.7	20.2	32.9	29.2	23.9	17.2	28.5	27.4	21.5	25.6	23.8	18.3	35.9	31.5
NTMT1	"AD-003, C9orf32, HOMT1A, METTL11A, NRMT, NRMT1"	ENSG00000148335	"N-terminal Xaa-Pro-Lys N-methyltransferase 1"	Q9BV86	9	129608884-129636135	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 391.4;Late spermatids: 761.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020092, HPA058420"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA020092: AB_1853831, HPA058420: AB_2683713"	"unprognostic (4.74e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-3)"	"unprognostic (4.17e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.63e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.11e-3)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.50e-3)"	26.4	68.6	20.6	19.3	21.7	24.5	22.1	23.6	27.0	22.5	22.4	23.2	18.3	19.6	15.9	20.2	18.9	19.9	67.9	21.0	23.1	31.5	41.6	22.8	20.2	22.5	23.8	19.8	31.1	22.4	23.4	19.6	22.5	22.7	11.2	6.3	22.4	16.7	98.9	25.1	19.5	13.7	21.3	29.7	24.9	93.3	22.9	16.1	17.9	84.3	16.0	23.9	20.0	24.1	57.8	117.2	47.9	82.2	30.0	44.6	50.2	107.6	63.5	108.1	92.8	96.6	74.0	74.8	53.7	78.5	76.7	110.1	101.8	96.4	66.8	56.3	50.9	31.2	106.3	100.4	96.3	63.3	45.0	47.0	48.6	113.5	56.0	34.2	60.1	64.1	116.5	54.2	57.5	194.1	72.0	85.6	62.6	105.4	96.6	66.8	55.8	150.4	43.7	32.4	96.5	48.5	53.1	97.3	74.7	30.2	81.4	32.4	41.8	129.1	64.5	118.7	115.3	41.2	53.7	115.2	59.0	64.4	75.0	32.9	49.7	39.2	43.7	55.1	43.7	43.2	43.5	46.5	49.2	50.4	43.9	36.3	13.6	30.6	70.9	52.8	44.5	36.4	20.6	21.7	23.6	27.0	21.0	23.1	22.5	23.8	22.5	21.3	22.9	24.1	35.6	3.2	13.9	5.9	45.9	99.8	85.7	50.3	16.5	18.3	33.4	33.8	4.1	20.0	35.7	22.0	22.9	72.6	23.1	49.7	97.8	60.5	391.4	21.4	29.8	38.3	20.3	23.4	6.4	55.9	86.8	41.1	21.9	23.2	30.4	20.5	20.0	52.7	67.0	42.1	6.5	44.0	42.7	27.6	80.3	761.6	35.1	34.3	55.2	3.7	33.1	23.3	25.7	4.5	9.2	69.2	29.9	24.8	41.0	105.7	84.5	89.6	22.5	23.6	26.3	34.1	58.8	129.2	43.2	19.2	99.3	135.6	38.3	39.2	48.4	70.7
NUCKS1	NUCKS	ENSG00000069275	"Nuclear casein kinase and cyclin dependent kinase substrate 1"	Q9H1E3	1	205712822-205750182	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062351, HPA063843"	Supported		Supported	Nucleoplasm,Nucleoli		No	No		13000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Nucleoli	"HPA062351: AB_2684745, HPA063843: AB_2685134"	"unprognostic (1.68e-1)"	"unprognostic (3.92e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.93e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.16e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.82e-3)"	"unprognostic (7.45e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.57e-2)"	63.3	57.2	88.6	43.3	98.3	33.4	72.8	86.2	102.7	70.8	53.7	52.5	29.5	83.4	62.0	54.4	71.8	46.7	98.3	80.7	88.8	70.4	104.2	48.7	61.2	93.8	87.8	108.9	41.2	96.1	39.0	49.6	94.1	71.7	48.1	81.4	46.8	71.1	113.7	51.4	33.2	69.8	94.6	56.5	43.0	25.8	87.9	97.4	98.1	101.6	60.7	47.8	45.2	115.8	223.5	134.6	354.2	140.8	96.0	131.7	166.1	157.3	161.3	215.6	172.6	74.4	250.0	246.1	89.0	154.2	68.2	160.0	272.6	131.9	245.7	118.6	135.8	160.3	113.2	81.8	70.6	255.0	54.9	105.1	116.9	128.6	221.7	115.6	171.4	156.3	261.9	76.7	170.7	258.1	233.2	128.0	363.0	88.9	99.4	239.1	436.4	141.1	121.4	135.4	146.9	270.9	232.2	183.3	127.5	272.4	280.3	189.9	172.8	164.5	144.8	190.0	282.8	69.9	88.0	192.6	112.8	140.5	226.2	5.6	3.2	3.9	9.1	4.9	8.8	5.6	8.3	8.0	4.6	6.9	10.1	10.7	0.6	10.7	4.2	7.3	5.5	3.8	88.6	98.3	86.2	102.7	80.7	88.8	93.8	87.8	94.1	94.6	87.9	115.8	258.4	214.7	283.4	73.4	179.5	258.1	277.4	212.9	282.9	356.2	221.2	229.7	412.4	318.8	241.8	303.5	73.0	301.5	174.5	125.5	385.4	202.5	61.3	227.0	410.3	254.5	179.0	324.2	85.9	171.5	381.3	356.5	131.0	299.5	215.4	329.0	258.5	668.2	264.1	316.3	88.7	219.2	116.0	216.8	266.4	52.6	512.0	164.0	174.3	71.2	162.1	546.9	195.7	56.8	126.2	117.2	113.2	485.2	128.2	295.3	49.4	384.5	187.8	200.2	315.5	458.0	358.1	70.0	104.1	321.4	243.9	177.2	190.5	443.9	265.1	220.8
NUDC		ENSG00000090273	"Nuclear distribution C, dynein complex regulator"	Q9Y266	1	26900238-26946871	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 642.2;Respiratory ciliated cells: 635.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027183, HPA028105"	Enhanced		Enhanced	Cytosol		NA	NA		140000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA027183: AB_10600086, HPA028105: AB_10601988"	"unprognostic (1.40e-1)"	"unprognostic (1.74e-2)"	"unprognostic (5.61e-2)"	"unprognostic (6.52e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (1.21e-6)"	"unprognostic (1.11e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.10e-2)"	62.6	140.1	108.3	37.7	111.2	51.7	64.2	113.6	124.2	69.3	118.7	97.8	35.8	70.1	70.0	59.7	93.9	28.4	106.7	110.1	115.8	79.8	116.0	63.7	42.3	109.5	110.5	74.5	81.4	53.1	75.4	40.8	110.7	72.1	31.5	48.6	54.5	57.0	126.1	67.1	52.7	41.8	108.6	63.3	85.3	86.7	110.5	47.5	63.2	60.6	42.3	80.0	61.7	120.2	204.2	208.1	106.9	149.2	83.5	74.6	121.2	159.2	97.3	209.4	153.5	192.3	137.8	169.5	137.1	109.6	154.2	156.2	229.5	209.8	160.7	132.1	238.0	210.9	207.7	333.7	147.2	224.9	149.2	80.6	134.5	252.7	161.8	90.9	156.4	194.9	306.1	92.3	143.5	175.9	227.3	289.9	281.2	264.8	266.4	234.7	135.5	172.4	180.1	79.2	177.4	133.1	173.3	109.0	149.1	99.8	106.5	137.0	155.5	148.7	178.1	188.3	207.4	184.0	311.9	202.0	160.4	312.7	170.9	184.4	138.8	141.1	152.7	150.2	154.5	176.7	154.1	145.4	140.7	185.9	150.7	154.9	95.4	147.4	155.1	163.2	163.5	168.0	108.3	111.2	113.6	124.2	110.1	115.8	109.5	110.5	110.7	108.6	110.5	120.2	111.8	134.6	116.1	12.4	93.6	154.1	329.0	187.2	82.0	93.3	85.1	85.9	166.5	137.2	169.8	110.3	52.1	203.3	89.2	91.3	262.2	285.0	85.6	473.8	105.4	120.6	131.4	99.3	16.1	317.4	206.7	128.9	105.5	113.4	147.6	104.5	95.3	642.2	147.5	111.0	16.5	123.1	128.1	70.2	132.1	132.7	135.8	83.7	151.2	11.2	115.3	181.1	86.5	10.1	19.2	309.7	79.7	153.1	77.5	277.7	76.3	200.1	635.8	105.7	111.7	129.1	174.6	246.4	249.7	70.9	148.5	162.7	128.9	91.1	129.1	200.1
NUDT21	"CFIM25, CPSF5"	ENSG00000167005	"Nudix hydrolase 21"	O43809	16	56429133-56452199	"Predicted intracellular proteins"	"Differentiation, mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 445.9;Late spermatids: 230.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019863, HPA074228"	Uncertain		Supported	"Nuclear bodies,Centriolar satellite"		NA	NA		12000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nuclear bodies"	"Centriolar satellite"	"HPA019863: AB_2670299, HPA074228: AB_2686675"	"unprognostic (4.95e-2)"	"unprognostic (4.42e-2)"	"unprognostic (4.25e-3)"	"unprognostic (1.31e-1)"	"unprognostic (5.85e-3)"	"unprognostic (1.29e-2)"	"unprognostic (8.80e-3)"	"unprognostic (6.87e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.76e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.27e-2)"	29.5	32.0	23.4	37.7	27.1	64.4	39.4	27.0	28.7	39.7	19.9	39.3	49.3	39.2	27.4	39.9	35.9	28.4	31.4	28.9	32.2	42.6	37.0	27.7	56.7	20.7	22.5	55.8	32.3	40.2	22.0	38.5	25.3	29.6	40.1	36.0	30.5	32.1	28.0	25.0	34.7	34.7	22.6	34.5	34.0	71.0	22.6	58.3	37.7	37.9	65.7	39.7	26.0	26.9	143.8	79.3	144.3	116.8	78.0	110.0	131.1	96.2	112.2	135.9	94.7	167.7	146.6	193.5	98.5	90.5	84.8	129.8	190.2	116.8	206.0	67.2	78.5	126.6	73.0	146.2	63.6	183.0	124.8	65.5	83.4	113.7	80.3	78.2	127.5	145.8	137.5	69.1	111.2	88.1	195.5	130.1	178.9	106.6	133.0	286.2	196.3	165.4	94.5	121.9	161.1	107.2	184.0	88.0	77.6	99.2	107.6	106.5	74.8	107.4	153.3	93.1	104.1	103.1	120.0	364.7	71.4	117.9	100.1	32.0	24.9	32.9	28.0	26.1	27.7	22.8	29.4	26.1	25.8	20.9	27.1	27.4	27.2	25.5	29.2	19.9	49.6	22.2	23.4	27.1	27.0	28.7	28.9	32.2	20.7	22.5	25.3	22.6	22.6	26.9	30.7	28.9	37.8	23.8	45.5	60.9	52.9	78.4	47.8	19.5	46.3	34.3	39.3	27.1	54.4	42.3	18.8	63.8	29.1	29.2	66.5	63.4	445.9	32.9	40.2	45.2	31.1	69.9	26.5	86.5	90.6	45.8	25.0	38.7	35.5	35.9	48.9	39.1	67.2	35.3	27.9	57.7	20.3	58.8	50.5	230.2	44.7	42.7	37.4	13.1	61.1	25.6	18.6	18.1	34.6	62.5	36.0	41.0	70.0	60.3	49.2	78.3	47.7	24.2	39.5	33.9	59.6	217.4	96.9	67.4	60.0	68.3	49.7	39.5	64.0	70.1
NUDT3	DIPP	ENSG00000272325	"Nudix hydrolase 3"	O95989	6	34279679-34392669	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA047027, HPA055953"	Uncertain		Approved	Cytosol		NA	NA		87000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA047027: AB_2679907, HPA055953: AB_2682984"	"unprognostic (2.42e-1)"	"prognostic favorable (5.29e-4)"	"unprognostic (9.63e-3)"	"unprognostic (4.74e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.41e-3)"	"unprognostic (4.21e-2)"	"unprognostic (4.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.63e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.24e-2)"	12.8	12.9	72.7	11.4	65.3	12.0	14.7	41.2	73.1	17.2	33.8	10.4	9.0	13.2	30.1	12.3	17.3	9.2	20.7	64.9	55.9	18.0	12.1	13.3	13.7	60.8	59.6	19.7	10.5	29.9	5.7	10.4	59.0	12.8	10.9	43.1	11.4	17.5	70.8	13.4	9.4	13.0	64.5	16.5	9.8	7.6	73.7	11.4	25.3	51.8	14.9	9.4	7.4	59.5	11.0	8.0	20.9	41.2	13.7	22.9	8.7	7.9	13.2	8.0	5.7	9.7	7.2	37.3	10.5	14.3	5.1	9.2	11.0	21.3	14.7	14.5	15.2	42.9	10.4	20.7	13.0	41.5	21.7	20.8	18.8	9.0	16.8	9.9	23.2	20.1	42.5	14.0	12.6	11.4	28.7	48.1	13.4	32.5	7.3	24.7	17.4	39.2	18.2	22.7	29.3	32.4	17.5	24.4	32.1	6.0	23.6	28.2	25.7	15.6	5.7	14.1	17.4	11.7	28.7	27.9	9.7	40.1	25.4	1.4	3.9	9.2	2.1	4.1	2.4	2.2	2.1	1.9	4.4	3.0	1.9	2.2	2.8	1.4	4.2	2.1	1.6	1.8	72.7	65.3	41.2	73.1	64.9	55.9	60.8	59.6	59.0	64.5	73.7	59.5	36.6	16.0	26.7	0.0	41.4	59.9	72.2	32.4	51.8	117.0	30.5	27.9	47.5	62.9	25.0	42.3	118.9	34.7	28.2	16.1	13.7	19.2	4.1	25.0	38.6	67.0	49.1	40.8	0.0	28.5	32.0	36.4	19.4	37.2	13.9	30.3	109.6	56.1	76.0	169.9	0.0	29.0	22.4	107.1	79.2	8.1	37.6	65.2	53.4	0.0	90.1	137.4	42.2	0.0	0.0	27.9	16.0	63.2	22.8	90.1	25.3	24.4	46.4	126.6	59.2	68.1	35.0	45.6	83.9	58.4	60.2	19.6	26.5	32.8	31.8	64.7
NUDT5	"hYSAH1, YSA1H"	ENSG00000165609	"Nudix hydrolase 5"	Q9UKK9	10	12165330-12196144	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019827	Approved		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA		1500000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles	"Nucleoplasm, Centrosome"	"HPA019827: AB_1854704"	"unprognostic (2.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.77e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.39e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.97e-2)"	"prognostic unfavorable (7.14e-12)"	"unprognostic (1.61e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.12e-2)"	"unprognostic (3.68e-2)"	35.1	32.4	23.0	30.6	26.4	24.1	26.7	27.5	30.5	24.6	29.5	32.0	27.5	14.3	23.7	40.7	24.6	18.4	14.9	23.4	26.0	36.3	88.8	26.0	39.3	27.3	24.9	18.0	25.9	33.1	35.5	31.1	27.4	21.0	36.0	27.4	25.1	14.0	6.2	33.2	25.4	17.6	25.0	34.2	22.6	13.1	25.4	53.5	27.8	7.6	47.4	28.9	27.8	31.8	136.4	98.0	114.6	107.1	107.5	105.6	100.8	96.9	61.5	111.9	119.1	142.5	125.9	134.2	82.4	79.2	70.0	133.1	162.0	150.6	102.1	110.8	160.8	111.9	114.3	209.3	112.0	77.1	75.2	111.7	88.4	122.3	61.7	86.3	144.9	209.4	153.5	88.9	103.2	123.8	143.5	87.0	100.4	215.0	60.1	128.0	42.4	157.2	106.0	46.1	56.6	82.3	117.4	90.8	142.2	132.0	155.9	77.9	91.6	47.0	90.6	134.3	121.9	74.3	141.6	179.3	99.7	97.3	36.0	29.6	60.8	115.2	69.9	65.7	80.4	72.7	73.9	82.6	87.6	64.6	50.4	68.4	163.8	57.4	52.2	149.2	123.4	71.6	23.0	26.4	27.5	30.5	23.4	26.0	27.3	24.9	27.4	25.0	25.4	31.8	42.1	25.6	55.1	23.2	43.8	43.0	57.8	121.2	28.5	21.1	28.6	30.7	4.5	32.9	72.3	23.9	16.7	82.6	49.8	35.0	74.3	82.2	35.3	61.1	44.4	42.6	38.3	43.5	34.6	82.9	150.6	40.3	33.1	31.9	31.7	41.4	41.7	131.8	128.7	21.9	38.2	41.2	79.3	41.8	32.2	11.7	39.4	39.7	30.2	12.2	85.0	37.4	62.8	34.2	41.2	73.8	35.2	29.0	66.1	33.7	52.6	130.6	103.9	25.5	32.9	21.2	40.1	20.2	33.6	52.4	60.5	58.1	49.7	54.4	57.4	46.9
NUF2	"CDCA1, CT106, NUF2R"	ENSG00000143228	"NUF2 component of NDC80 kinetochore complex"	Q9BZD4	1	163266576-163355764	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 28.4;lymphoid tissue: 26.0;testis: 53.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 60.8;Spermatocytes: 208.2;Spermatogonia: 40.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"T-reg: 4.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA059692, HPA076604"			Supported	Nucleoplasm,Kinetochore,Cytosol		Yes	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Kinetochore, Cytosol"	"HPA059692: AB_2684103, HPA076604: "	"unprognostic (9.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.32e-3)"	"unprognostic (6.20e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (1.04e-5)"	"prognostic unfavorable (9.16e-4)"	"prognostic unfavorable (4.83e-4)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (9.75e-4)"	"unprognostic (3.70e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.79e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.96e-2)"	0.8	0.6	0.5	6.9	0.8	28.4	1.2	0.5	0.8	1.0	0.4	4.2	4.3	1.1	0.3	5.8	0.4	1.0	0.3	0.6	0.6	0.3	0.7	0.9	18.2	0.9	0.8	0.4	0.2	0.6	0.2	4.7	0.9	0.4	5.3	1.5	0.9	0.3	0.1	4.1	4.3	2.3	0.7	3.6	2.6	53.5	0.8	26.0	0.5	0.2	16.7	1.8	1.8	1.0	90.8	30.8	80.5	33.9	2.5	8.1	43.6	55.9	39.3	88.9	77.3	23.7	77.7	77.4	45.5	22.6	37.0	51.6	49.6	21.0	111.5	81.4	35.6	30.3	34.8	34.4	0.3	53.0	60.2	1.0	2.0	45.0	31.6	16.8	41.1	74.5	58.1	103.9	85.0	17.6	97.3	70.6	43.9	66.1	47.0	65.0	70.3	68.4	25.3	12.4	59.9	68.9	29.9	32.2	30.6	49.7	49.3	109.5	29.4	65.9	73.8	50.1	115.1	73.9	111.5	148.9	22.0	42.9	74.7	1.4	0.1	1.3	1.2	0.0	0.5	0.6	1.8	1.2	0.2	0.7	1.2	1.0	0.4	1.8	0.1	0.3	4.3	0.4	0.5	0.8	0.5	0.8	0.6	0.6	0.9	0.8	0.9	0.7	0.8	1.0	0.5	0.0	0.5	1.3	5.3	5.9	1.9	4.2	1.2	1.2	1.3	2.7	0.9	0.0	3.3	0.0	0.0	21.7	3.6	2.6	0.0	0.8	17.7	2.5	2.5	1.8	0.0	60.8	1.1	0.2	29.7	3.4	5.6	3.0	4.5	18.3	3.3	0.4	14.0	0.0	1.4	3.3	0.0	5.2	3.6	21.4	2.5	3.1	0.0	1.0	0.9	2.0	6.2	0.5	3.6	0.2	0.1	2.2	17.8	0.8	0.9	0.2	0.7	2.3	6.6	0.9	4.2	208.2	40.3	10.6	2.4	4.0	5.0	1.7	9.0	3.8
NUFIP1	"NUFIP, Rsa1"	ENSG00000083635	"Nuclear FMR1 interacting protein 1"	Q9UHK0	13	44939249-44989471	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 63.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029958, HPA029959"	Approved		Enhanced	Nucleoplasm,Nucleoli		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA029958: AB_10598911, HPA029959: AB_10602308"	"unprognostic (2.01e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.98e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.91e-2)"	"unprognostic (9.74e-3)"	"unprognostic (4.52e-1)"	"unprognostic (3.95e-2)"	"unprognostic (3.73e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.31e-1)"	"unprognostic (5.24e-2)"	3.2	3.7	3.2	2.8	3.4	7.9	4.6	2.9	4.6	3.6	2.1	2.6	2.8	4.5	5.5	3.3	3.5	2.4	2.5	3.3	3.0	4.0	4.1	2.3	3.7	2.6	3.2	4.3	3.8	4.0	1.8	3.0	2.9	3.4	3.0	2.6	3.3	3.2	4.8	3.4	2.4	4.0	2.9	3.0	2.8	5.5	3.1	3.6	3.9	3.9	3.8	4.2	2.6	3.9	7.4	5.7	9.5	7.9	6.4	6.6	11.3	8.6	7.4	15.6	9.9	15.6	11.5	21.5	7.0	8.0	9.4	11.3	17.9	12.2	20.2	6.6	14.0	16.4	3.7	14.0	10.5	21.3	6.4	6.9	11.0	10.5	15.8	6.0	7.9	10.9	13.3	3.5	11.1	8.5	17.8	13.4	22.5	19.5	9.3	17.3	9.0	13.1	9.5	6.3	5.2	11.5	7.3	9.9	9.6	8.9	7.5	11.8	6.0	7.9	6.8	10.3	11.9	4.8	7.9	26.7	8.9	14.8	11.4	0.0	2.6	0.8	2.5	2.6	4.7	4.0	2.9	2.8	3.4	4.1	4.5	3.4	0.2	5.9	1.8	4.5	1.7	1.8	3.2	3.4	2.9	4.6	3.3	3.0	2.6	3.2	2.9	2.9	3.1	3.9	11.3	6.4	12.2	6.2	10.5	15.4	11.8	16.7	23.9	7.8	9.8	16.3	4.5	4.3	15.4	5.5	12.5	15.7	11.7	4.2	17.6	14.0	37.2	14.0	21.7	10.9	5.4	14.5	19.2	16.7	15.9	11.9	7.7	18.6	17.7	14.1	7.1	9.7	10.8	8.4	16.9	5.3	12.2	3.4	5.5	63.2	10.8	7.9	8.8	7.5	6.9	9.7	7.2	16.6	14.4	10.8	1.6	11.3	5.0	8.6	3.2	14.8	6.6	6.8	6.6	20.3	15.6	27.1	31.6	14.3	16.6	8.8	9.9	15.7	8.4	7.1
NUMA1		ENSG00000137497	"Nuclear mitotic apparatus protein 1"	Q14980	11	72002864-72080693	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019841, HPA019859, HPA029912"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes		62000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA019841: AB_1854708, HPA019859: AB_1854709, HPA029912: AB_10602811"	"unprognostic (1.60e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.47e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.74e-3)"	"unprognostic (5.91e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.51e-2)"	"prognostic favorable (7.92e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.39e-1)"	55.2	59.9	27.8	51.1	45.6	69.6	67.1	37.4	40.5	75.4	36.2	77.7	59.6	111.2	43.3	67.9	82.7	62.7	47.6	24.0	33.0	49.9	29.8	65.4	57.9	40.4	34.3	112.3	68.8	98.6	42.1	60.8	41.9	111.4	54.5	46.2	78.1	85.6	82.5	93.8	61.9	86.7	28.4	56.8	59.0	42.4	36.0	79.3	73.9	54.8	53.2	75.2	65.9	83.4	64.4	80.0	97.2	66.4	85.1	88.2	48.8	85.0	97.2	86.4	74.6	83.9	115.5	86.7	72.0	104.0	61.6	134.2	89.7	85.8	78.0	89.9	43.1	105.8	130.4	64.1	69.1	81.1	74.0	94.0	55.7	84.1	84.3	133.0	74.0	76.7	63.4	101.1	59.4	124.2	105.6	45.2	61.2	122.3	57.6	127.9	170.0	67.6	64.2	98.6	117.3	166.6	134.9	123.5	123.6	42.3	166.4	47.1	103.0	90.6	69.9	130.1	56.9	64.8	69.7	120.0	61.1	38.0	53.0	3.7	4.1	1.9	6.4	2.3	4.7	3.4	4.0	5.0	3.5	5.8	4.9	3.6	2.8	5.0	4.4	8.2	5.2	6.0	27.8	45.6	37.4	40.5	24.0	33.0	40.4	34.3	41.9	28.4	36.0	83.4	52.4	41.7	41.3	42.7	36.6	25.9	30.1	25.3	74.0	60.7	62.3	63.4	5.7	34.3	32.2	53.3	73.0	25.5	42.6	56.3	17.6	27.9	31.9	55.5	48.5	44.9	47.4	43.3	27.5	32.1	13.4	41.9	57.6	92.8	31.0	84.7	37.9	23.6	28.7	52.2	34.0	68.3	32.6	32.1	24.9	17.8	69.0	36.3	19.6	33.7	26.8	51.8	53.5	27.6	58.9	30.9	31.2	50.8	40.8	29.6	57.0	26.9	35.4	59.8	39.5	64.3	36.9	14.8	21.4	51.9	28.1	45.0	44.8	44.2	52.2	26.0
NUP107	NUP84	ENSG00000111581	"Nucleoporin 107"	P57740	12	68686951-68745809	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 89.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031679			Uncertain	"Nucleoplasm,Nuclear membrane,Centrosome"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Nuclear membrane, Centrosome"	"HPA031679: AB_2673992"	"unprognostic (2.89e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.10e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.32e-2)"	"prognostic unfavorable (3.12e-9)"	"unprognostic (4.03e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (1.28e-6)"	"unprognostic (3.43e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.96e-1)"	15.4	11.1	5.0	17.9	6.3	24.0	17.8	8.2	6.0	12.9	6.3	13.0	10.3	16.7	14.3	10.7	13.5	9.3	11.4	4.6	5.0	10.6	11.8	12.8	25.8	5.6	5.7	16.3	9.3	11.8	6.8	13.8	5.5	12.0	16.2	14.7	10.3	12.2	11.7	15.8	12.9	14.0	5.4	15.8	11.0	20.9	5.5	25.6	10.3	12.1	25.5	12.4	10.7	7.6	53.1	66.8	77.8	56.7	22.6	28.6	84.1	56.6	32.4	83.0	68.9	67.6	43.7	96.3	53.7	27.2	36.9	59.4	88.4	41.7	109.8	90.8	65.6	110.1	46.2	57.4	14.2	97.9	35.6	15.2	19.4	66.5	43.2	29.0	50.3	54.9	133.7	67.3	52.8	64.3	81.3	85.2	85.8	20.3	64.6	81.9	93.6	57.8	36.1	55.3	45.7	46.9	62.7	46.5	34.4	60.4	69.8	46.7	31.1	45.0	45.8	53.0	69.9	29.2	62.2	115.2	34.7	70.2	54.2	10.5	9.2	14.4	17.7	12.5	23.4	18.7	17.5	19.3	10.2	18.7	21.5	19.5	2.4	30.5	23.2	8.1	20.0	11.8	5.0	6.3	8.2	6.0	4.6	5.0	5.6	5.7	5.5	5.4	5.5	7.6	18.3	12.8	17.7	13.7	38.1	17.3	18.4	28.1	25.0	23.8	12.5	11.4	13.5	12.8	18.9	9.2	18.8	30.7	30.3	12.2	11.7	22.8	45.3	12.6	18.2	20.6	8.5	64.4	23.8	17.6	30.8	19.6	16.3	10.2	15.8	35.6	15.4	7.0	17.5	13.5	20.1	12.6	42.7	13.9	16.2	9.6	38.8	18.3	19.6	15.9	27.0	16.7	36.0	21.6	34.3	22.1	9.9	21.8	22.9	19.4	10.5	6.4	21.9	29.6	13.1	18.4	18.2	89.4	51.9	18.7	17.6	14.1	27.0	24.5	16.8	12.5
NUP153	HNUP153	ENSG00000124789	"Nucleoporin 153"	P49790	6	17615035-17706925	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport, Viral penetration into host nucleus, Virus entry into host cell"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027896, HPA027897, HPA027898, HPA027899"	Supported		Enhanced	"Nuclear membrane"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nuclear membrane"		"HPA027896: AB_10611243, HPA027897: AB_10601108, HPA027898: AB_10601682, HPA027899: "	"unprognostic (2.49e-1)"	"unprognostic (5.37e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.20e-3)"	"unprognostic (3.36e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.53e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.95e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.40e-2)"	"unprognostic (8.69e-2)"	16.5	10.3	5.4	18.2	6.1	45.6	16.7	12.5	7.4	15.2	10.1	12.8	10.1	17.0	11.6	16.2	15.0	14.9	11.2	6.2	6.3	13.1	23.4	13.9	23.9	6.1	7.1	18.6	13.2	17.9	9.2	18.9	6.4	12.0	13.1	15.7	12.0	13.1	25.1	15.9	12.8	14.4	6.3	17.8	11.6	26.7	6.8	25.2	13.8	19.5	27.6	18.7	14.5	9.7	55.6	27.2	57.7	50.8	24.9	29.3	57.8	42.3	39.3	61.8	65.7	45.5	24.9	104.3	69.7	37.7	51.9	39.4	68.1	41.0	99.0	56.2	52.7	55.6	29.4	47.0	18.6	81.0	50.2	31.0	32.5	64.9	46.5	23.6	37.0	34.5	131.7	32.5	41.9	29.5	60.5	50.1	45.6	20.8	29.5	80.1	74.2	97.9	27.3	53.1	64.6	37.5	36.0	58.3	36.2	90.5	37.8	29.0	34.8	63.2	36.2	30.2	66.7	41.8	63.8	102.8	15.6	36.8	76.1	1.2	1.3	3.2	2.8	1.2	3.7	1.7	3.5	3.4	1.9	2.1	2.1	2.1	3.4	3.0	1.8	1.1	1.7	1.3	5.4	6.1	12.5	7.4	6.2	6.3	6.1	7.1	6.4	6.3	6.8	9.7	28.9	19.2	23.2	39.8	31.4	76.3	37.9	11.1	51.2	14.2	32.5	18.7	14.3	11.5	11.9	16.5	16.7	20.9	24.0	19.4	1.9	8.8	27.3	69.3	56.8	23.3	20.9	44.0	53.0	6.0	21.7	31.8	23.4	91.0	3.8	17.7	13.6	30.7	17.5	16.8	48.8	13.6	12.2	15.6	36.7	19.6	17.4	27.5	21.4	47.8	12.7	7.2	20.6	37.2	50.5	13.4	7.0	14.7	27.9	41.7	10.1	9.8	23.4	12.7	13.1	55.1	26.4	30.4	22.3	51.8	79.3	23.9	35.8	11.7	16.8	35.1
NUP188	KIAA0169	ENSG00000095319	"Nucleoporin 188"	Q5SRE5	9	128947699-129007096	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Cataract, Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 45.9;Spermatocytes: 52.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061750, HPA063942"	Approved		Uncertain	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA061750: AB_2684602, HPA063942: AB_2685156"	"unprognostic (4.64e-1)"	"unprognostic (6.91e-3)"	"unprognostic (2.36e-1)"	"prognostic favorable (5.20e-5)"	"unprognostic (9.50e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.78e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.81e-3)"	"unprognostic (3.53e-3)"	13.1	15.5	9.5	16.2	10.9	21.4	11.9	13.1	10.0	15.6	10.0	14.8	7.5	13.1	8.0	23.7	11.9	9.4	13.6	9.0	9.7	10.4	9.9	16.7	18.0	11.4	11.1	11.4	12.0	13.1	14.9	11.8	11.8	13.5	11.5	13.7	13.9	9.8	15.7	21.4	13.4	13.9	9.3	16.8	13.6	56.6	10.9	27.3	12.6	10.3	20.4	16.1	15.6	11.7	33.6	62.6	50.8	69.7	37.7	37.2	45.4	45.9	35.9	82.1	54.4	76.3	26.2	58.2	16.7	50.7	52.9	96.6	115.2	56.8	61.0	47.1	55.5	51.9	113.3	60.8	23.9	89.6	50.2	26.0	26.3	86.5	43.8	24.1	47.8	74.1	116.0	40.3	58.8	84.6	77.3	36.5	68.2	63.8	59.4	69.9	109.8	59.2	25.5	37.3	71.2	34.3	118.8	44.7	17.1	37.2	49.3	32.7	39.0	67.7	48.2	69.2	83.5	34.1	67.9	76.9	39.5	56.3	51.2	8.2	4.8	1.7	7.5	8.9	9.7	4.9	6.4	7.4	6.8	4.3	6.4	7.0	0.6	5.4	5.2	2.9	8.3	6.8	9.5	10.9	13.1	10.0	9.0	9.7	11.4	11.1	11.8	9.3	10.9	11.7	9.6	0.0	12.6	15.7	10.4	6.5	6.6	6.4	5.7	16.2	7.6	7.6	3.5	10.0	5.9	5.5	45.9	8.0	8.6	6.0	1.9	6.1	14.5	7.9	13.2	9.4	9.1	8.6	11.3	6.5	6.5	9.5	9.7	12.2	6.3	24.0	11.0	5.0	8.4	20.2	13.1	7.2	6.1	4.7	6.1	5.7	9.6	8.1	1.8	12.2	5.3	6.8	9.2	12.5	13.0	9.0	2.3	11.7	8.3	10.1	3.3	2.5	6.3	24.4	26.3	18.2	7.1	52.9	37.8	13.6	11.2	8.6	9.4	12.5	7.4	8.2
NUP205	"C7orf14, KIAA0225"	ENSG00000155561	"Nucleoporin 205"	Q92621	7	135557917-135648757	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		24000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"				"unprognostic (3.64e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.66e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (1.90e-7)"	"unprognostic (2.33e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.27e-2)"	"unprognostic (7.53e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.22e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.35e-2)"	7.5	6.7	2.0	13.1	3.3	10.7	11.5	6.7	2.6	8.9	3.8	10.0	8.0	10.7	7.2	11.0	10.4	6.4	4.9	1.7	3.1	8.0	6.6	8.4	15.0	2.7	2.7	11.8	6.1	15.1	5.2	11.0	3.2	8.7	12.3	14.8	11.8	9.0	8.0	9.6	8.3	12.7	2.6	10.3	9.0	11.6	3.2	21.8	8.4	8.0	17.3	9.9	6.9	4.4	66.4	52.8	69.5	68.2	16.2	26.6	45.4	41.0	31.5	62.4	69.1	55.1	46.8	84.2	31.7	24.6	63.0	50.1	88.5	46.0	80.1	41.9	63.3	48.9	52.1	25.1	12.2	96.5	37.0	14.5	20.5	61.4	40.8	21.9	47.3	58.9	115.6	39.1	47.6	45.0	105.0	29.4	107.0	51.6	46.3	77.6	64.6	66.6	18.8	52.4	69.3	70.4	67.8	54.8	31.8	52.4	31.6	36.5	38.6	51.0	25.3	62.7	79.5	28.7	57.2	112.3	51.7	74.3	70.1	1.6	1.3	0.4	2.4	3.1	2.8	2.3	2.9	2.5	3.0	2.1	2.3	2.7	0.5	2.9	1.7	1.9	2.9	1.4	2.0	3.3	6.7	2.6	1.7	3.1	2.7	2.7	3.2	2.6	3.2	4.4	7.9	12.8	13.4	24.8	15.3	13.0	6.8	10.3	11.4	6.3	8.6	5.2	5.3	7.2	10.6	16.5	12.5	13.1	7.5	8.2	3.9	7.8	0.9	7.4	8.1	9.3	9.1	21.3	22.7	9.6	9.3	9.4	13.3	8.4	8.2	18.5	7.9	10.7	10.3	5.0	24.1	10.4	6.1	14.1	11.7	2.4	8.1	12.2	10.6	17.8	11.4	4.9	3.1	26.2	23.3	11.9	6.4	7.5	17.4	10.3	3.9	4.6	12.4	9.7	0.0	12.6	8.2	14.5	10.8	14.8	15.5	7.7	11.9	6.1	10.9	9.4
NUP35	MP44	ENSG00000163002	"Nucleoporin 35"	Q8NFH5	2	183117513-183161680	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"Early spermatids: 151.6;Late spermatids: 424.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018401, HPA018410, HPA018441"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"	"Plasma membrane"	"HPA018401: AB_1854719, HPA018410: AB_1854721, HPA018441: AB_1854720"	"unprognostic (6.18e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.58e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.91e-2)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (3.95e-1)"	"unprognostic (6.21e-3)"	"prognostic favorable (3.45e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.78e-3)"	"unprognostic (6.78e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.96e-2)"	7.7	8.9	5.9	6.9	7.3	4.6	13.1	8.9	7.8	8.5	5.0	7.6	6.3	8.1	7.7	8.7	8.9	6.9	6.2	6.1	5.9	10.2	14.4	5.9	9.1	5.5	5.9	10.4	10.2	8.9	6.3	7.8	5.5	7.8	9.1	9.0	8.4	7.0	7.4	9.0	6.5	8.9	6.6	5.7	7.2	24.2	5.5	10.4	8.2	8.7	11.0	9.2	8.0	6.4	19.7	19.7	32.5	20.5	11.8	11.5	23.2	23.0	18.8	35.3	33.5	37.6	24.7	34.6	22.0	12.4	40.9	17.4	45.4	26.7	57.8	29.6	27.8	32.6	16.4	43.9	8.2	23.6	21.8	8.2	13.8	29.9	28.9	7.9	20.8	20.5	28.7	25.3	27.8	23.7	28.7	29.1	57.9	31.6	61.9	34.3	25.2	25.0	34.0	24.7	29.4	20.3	21.6	26.6	26.0	24.4	17.0	16.2	10.6	28.6	19.7	23.3	26.5	16.4	38.3	37.9	19.3	16.8	39.2	0.0	4.1	1.4	4.9	5.5	8.6	7.2	6.3	6.0	3.2	6.5	7.5	6.7	0.2	5.6	6.6	3.1	6.7	4.1	5.9	7.3	8.9	7.8	6.1	5.9	5.5	5.9	5.5	6.6	5.5	6.4	9.6	9.6	6.8	6.5	10.3	26.0	20.7	17.5	12.5	10.8	9.3	8.9	4.7	14.3	13.8	16.5	18.8	23.6	8.5	3.3	11.7	15.5	151.6	5.3	8.1	10.2	3.6	12.6	11.5	12.7	20.2	10.8	5.1	6.4	8.2	8.1	12.8	12.6	8.4	6.7	12.0	7.5	16.2	4.4	9.9	424.7	9.6	3.6	21.4	2.8	5.0	11.4	7.2	17.1	12.8	11.1	5.1	8.2	7.5	12.8	4.2	14.5	6.9	19.1	13.1	18.7	11.6	39.8	21.1	11.3	27.4	9.4	11.5	9.0	9.6	11.2
NUP37	"FLJ22618, MGC5585"	ENSG00000075188	"Nucleoporin 37"	Q8NFH4	12	102073103-102120120	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056300, HPA073708"	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"HPA056300: AB_2683092, HPA073708: AB_2686629"	"unprognostic (1.42e-3)"	"unprognostic (5.39e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (6.72e-4)"	"prognostic unfavorable (7.70e-6)"	"unprognostic (2.48e-3)"	"unprognostic (2.37e-3)"	"unprognostic (7.77e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.67e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.64e-1)"	11.3	14.2	4.1	17.1	4.4	22.7	19.5	5.1	7.8	12.8	2.4	20.1	13.0	11.9	21.5	18.9	19.0	10.9	17.6	4.8	4.5	15.2	13.0	11.6	28.1	3.5	2.8	12.1	8.7	17.4	5.9	16.9	3.4	13.7	23.8	10.9	11.7	13.8	17.5	13.4	14.9	17.7	2.4	12.0	12.9	15.1	4.3	25.7	16.4	15.5	33.5	17.7	9.6	6.3	105.5	74.5	64.2	29.6	51.7	68.4	144.6	64.8	61.0	99.8	68.0	97.4	55.5	70.1	45.4	50.9	68.9	76.2	113.5	101.2	124.4	98.5	65.2	75.6	37.2	86.4	66.0	107.5	22.8	53.4	43.5	78.3	57.3	66.7	83.3	91.2	135.5	25.8	93.9	71.6	79.9	87.9	63.4	96.8	117.2	51.9	92.0	52.8	79.0	76.1	33.6	24.0	49.8	52.7	50.3	72.1	90.7	61.7	27.2	35.7	39.4	51.0	91.1	38.5	78.9	119.4	41.9	86.1	61.8	67.8	24.0	28.3	21.4	29.3	23.2	31.2	25.7	21.9	30.2	28.2	23.0	26.1	7.0	23.9	24.9	25.3	45.4	22.5	4.1	4.4	5.1	7.8	4.8	4.5	3.5	2.8	3.4	2.4	4.3	6.3	12.3	6.4	14.3	8.8	22.6	11.3	20.9	63.8	17.1	8.0	10.5	11.7	9.5	14.3	28.2	16.5	8.4	68.1	17.7	9.1	25.4	24.0	2.9	21.6	17.6	17.2	6.0	38.7	5.8	20.0	92.3	19.9	12.2	11.8	7.6	21.2	13.6	10.0	35.6	3.3	7.3	16.0	22.4	15.2	8.4	6.3	19.6	13.5	7.2	5.6	20.5	18.9	13.4	11.1	12.6	17.2	10.6	18.8	34.1	10.7	11.5	24.6	39.3	20.1	19.7	8.6	18.3	49.0	42.4	25.5	9.5	40.2	18.8	31.9	26.5	16.8
NUP43	"bA350J20.1, FLJ13287"	ENSG00000120253	"Nucleoporin 43"	Q8NFH3	6	149724315-149749665	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 78.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027126, HPA027291, HPA028500"	Enhanced		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA027126: AB_10599301, HPA027291: AB_10601851, HPA028500: AB_10602287"	"prognostic unfavorable (2.08e-4)"	"unprognostic (3.02e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.29e-1)"	"unprognostic (8.19e-3)"	"prognostic unfavorable (7.13e-7)"	"unprognostic (5.14e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.74e-2)"	"unprognostic (6.25e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.60e-2)"	8.4	8.6	6.2	11.4	7.5	6.2	13.6	7.2	6.9	9.7	6.5	9.4	8.7	9.8	7.5	9.5	8.2	6.4	10.8	5.6	6.6	9.9	9.6	8.0	15.9	6.6	6.6	9.1	12.2	8.9	5.6	11.4	6.9	10.3	9.7	9.8	8.8	9.2	14.2	13.5	10.9	9.4	6.6	13.6	9.8	7.9	6.5	12.8	11.1	11.6	17.0	9.0	9.1	8.3	21.1	34.9	31.1	49.6	20.0	23.7	48.9	36.3	20.3	34.0	43.0	49.5	19.5	61.4	36.6	20.2	32.1	33.5	54.6	31.6	58.3	27.8	38.2	70.9	35.5	49.6	13.4	73.2	44.1	15.3	16.4	49.9	33.1	13.0	27.5	34.6	71.4	33.6	29.6	20.7	52.2	30.4	28.3	24.1	21.0	50.2	43.2	20.6	23.2	28.9	12.9	21.2	43.4	27.1	14.2	25.6	28.7	30.9	21.3	28.3	30.2	41.2	53.9	20.5	43.3	63.9	25.2	49.3	40.5	2.9	4.9	3.4	3.5	5.4	3.8	4.3	4.2	3.5	2.6	6.2	4.3	5.5	1.9	3.7	4.8	5.0	4.9	2.2	6.2	7.5	7.2	6.9	5.6	6.6	6.6	6.6	6.9	6.6	6.5	8.3	5.8	3.2	7.8	9.1	11.5	7.9	5.5	4.7	2.8	11.9	4.5	5.0	14.3	11.5	5.2	3.7	6.2	10.9	11.3	4.7	3.9	9.0	33.3	4.3	8.7	5.7	10.2	7.6	4.8	7.8	12.2	6.4	6.1	6.0	0.0	12.8	8.2	4.4	7.8	6.7	5.1	6.9	2.0	11.9	6.9	78.9	10.2	6.5	8.8	9.4	15.1	10.5	9.2	11.1	17.4	6.6	2.3	10.5	8.7	6.2	3.9	5.4	4.2	9.5	13.1	6.9	22.1	7.1	9.2	5.5	8.5	6.6	7.6	7.4	8.4	6.7
NUP50	NPAP60L	ENSG00000093000	"Nucleoporin 50"	Q9UKX7	22	45163925-45188017	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047162, HPA048328"	Enhanced		Enhanced	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA047162: AB_2679963, HPA048328: AB_2680360"	"unprognostic (2.64e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.46e-3)"	"unprognostic (5.83e-3)"	"unprognostic (4.94e-2)"	"unprognostic (4.94e-2)"	"unprognostic (7.22e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.97e-2)"	"prognostic favorable (4.06e-4)"	"unprognostic (1.43e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.63e-2)"	14.1	14.8	8.6	23.3	9.9	54.4	13.5	11.9	12.1	14.3	11.2	18.7	16.6	10.1	18.7	20.5	18.1	14.3	7.2	10.7	10.2	13.7	23.5	14.6	33.7	8.1	8.3	13.9	15.9	15.8	6.7	15.5	7.8	12.2	16.7	10.9	11.7	13.4	7.8	19.0	16.3	11.4	8.0	25.5	24.2	29.8	9.2	46.6	15.2	12.7	35.3	19.3	12.3	9.7	75.8	35.5	67.1	43.7	31.0	31.8	70.9	61.9	41.1	46.9	47.1	77.6	32.9	82.7	28.1	41.0	35.1	52.0	83.4	50.5	67.3	44.3	87.4	72.6	54.8	47.7	32.2	193.7	73.7	38.8	34.1	60.1	45.2	22.7	52.4	71.4	76.5	84.3	49.0	50.8	88.2	50.5	50.4	50.0	36.3	91.8	40.7	58.0	37.0	72.5	41.7	40.4	61.5	37.9	74.0	50.9	23.6	50.3	48.3	99.1	88.6	51.6	52.7	58.4	51.3	119.0	37.1	49.2	70.4	55.1	39.1	80.5	20.3	40.2	27.8	19.5	24.5	23.5	25.5	18.1	28.4	19.6	92.7	30.6	24.2	13.9	25.8	34.2	8.6	9.9	11.9	12.1	10.7	10.2	8.1	8.3	7.8	8.0	9.2	9.7	42.7	9.6	27.9	6.2	32.7	85.5	51.9	26.4	48.3	14.6	26.2	16.3	10.8	22.8	29.6	33.1	12.5	22.6	47.5	34.2	13.7	18.9	46.3	56.3	34.7	29.7	17.4	72.4	16.4	20.9	39.8	21.8	59.1	47.3	34.7	23.9	33.2	38.5	28.1	13.5	15.3	24.4	20.3	47.5	32.8	83.3	14.6	33.4	24.9	11.2	56.9	11.1	42.2	11.6	12.5	29.8	33.5	13.9	49.0	60.8	16.9	22.8	50.0	16.3	26.3	15.9	17.1	45.9	44.3	60.6	89.4	56.6	47.1	23.5	26.3	95.3
NUP54		ENSG00000138750	"Nucleoporin 54"	Q7Z3B4	4	76114659-76148444	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035929, HPA058122"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA035929: AB_10671236, HPA058122: AB_2683613"	"unprognostic (6.70e-2)"	"unprognostic (3.51e-2)"	"prognostic favorable (8.80e-4)"	"unprognostic (3.02e-1)"	"unprognostic (3.58e-2)"	"unprognostic (4.24e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (1.51e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.49e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.65e-3)"	17.5	13.1	6.4	15.8	7.1	35.0	23.4	11.9	9.3	22.4	6.2	19.2	16.5	23.5	18.8	18.1	20.0	15.8	12.2	6.6	7.7	15.2	22.2	16.1	22.1	6.4	6.4	24.3	16.6	15.7	7.5	24.4	6.6	18.5	20.6	12.4	14.7	18.4	12.7	19.3	16.0	20.4	7.1	16.6	16.3	21.8	6.3	28.7	20.6	14.2	24.5	21.7	15.0	9.2	42.6	14.2	52.3	37.1	44.2	40.8	45.0	42.1	61.1	62.1	63.1	36.9	58.4	64.4	34.5	42.3	33.4	27.5	57.0	47.6	76.5	42.5	31.1	38.5	19.1	36.7	41.1	75.8	44.1	37.4	33.6	48.8	50.7	27.1	52.8	41.4	67.1	38.9	44.4	35.9	81.0	39.9	81.3	51.2	14.2	61.6	81.0	25.0	37.3	39.1	31.7	26.6	38.6	45.2	35.4	39.5	18.7	47.2	35.5	48.2	43.0	58.8	52.8	25.1	10.0	60.8	35.1	44.5	44.0	10.1	8.8	9.3	13.3	10.7	18.4	9.7	14.0	13.1	12.9	10.9	14.7	14.1	4.1	26.6	12.6	9.5	14.9	8.5	6.4	7.1	11.9	9.3	6.6	7.7	6.4	6.4	6.6	7.1	6.3	9.2	26.1	22.4	16.7	25.5	31.3	35.2	42.8	29.4	32.5	13.8	18.8	19.3	11.8	14.3	17.8	11.0	20.9	41.3	30.5	13.5	29.4	25.1	12.5	24.9	31.6	23.7	14.4	35.7	42.8	27.7	47.5	26.8	17.3	34.4	24.1	23.0	19.2	13.6	21.7	8.4	42.0	20.8	16.2	16.4	24.2	7.4	27.4	20.2	17.8	18.7	28.6	12.8	35.0	34.2	54.2	19.2	17.1	25.9	30.5	34.1	14.4	20.4	19.2	22.2	32.9	24.8	26.5	46.8	39.9	30.2	29.1	39.1	31.8	21.6	24.4	36.1
NUP85	"FLJ12549, NUP75"	ENSG00000125450	"Nucleoporin 85"	Q9BW27	17	75205659-75235758	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061910, HPA062595"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA061910: AB_2684634, HPA062595: AB_2684801"	"unprognostic (2.30e-1)"	"unprognostic (5.10e-2)"	"unprognostic (5.12e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (1.73e-7)"	"unprognostic (3.46e-1)"	"unprognostic (1.09e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (3.32e-6)"	"unprognostic (1.03e-3)"	"unprognostic (2.16e-1)"	"unprognostic (9.10e-3)"	"unprognostic (2.11e-1)"	20.9	12.9	15.2	18.6	15.7	20.8	20.0	21.8	17.0	21.5	15.4	18.7	15.8	20.8	16.1	20.5	20.9	11.6	16.4	15.6	14.7	18.9	22.1	18.7	26.5	15.8	15.1	20.8	18.7	12.1	12.7	19.0	16.0	18.9	21.0	11.2	16.7	14.3	16.7	23.9	20.5	19.6	14.9	25.3	16.9	22.2	15.3	33.2	18.0	14.1	27.0	17.9	19.5	17.0	66.5	74.0	53.4	37.3	20.3	31.5	74.0	47.3	37.4	108.5	101.7	63.2	61.4	61.1	26.6	41.1	70.5	55.9	88.8	50.6	96.1	19.3	70.1	51.0	83.3	56.3	16.6	52.8	40.7	30.3	30.5	76.1	32.8	24.9	84.7	49.0	63.3	38.1	53.8	73.0	100.2	64.8	40.0	82.2	67.4	68.9	115.1	55.5	42.1	47.5	40.6	38.5	58.2	73.7	42.5	59.4	83.3	59.1	30.8	80.2	74.4	52.5	76.3	23.6	21.0	79.2	41.4	47.3	50.6	8.1	24.9	21.5	16.1	22.6	22.9	16.1	17.5	15.9	20.5	21.5	17.0	12.8	8.2	16.7	16.5	22.5	16.6	17.3	15.2	15.7	21.8	17.0	15.6	14.7	15.8	15.1	16.0	14.9	15.3	17.0	13.2	6.4	12.5	7.2	13.9	6.1	8.9	19.1	6.2	7.8	10.3	7.5	9.0	8.6	15.0	7.3	10.4	23.0	11.7	9.1	7.9	16.0	3.7	11.1	13.6	15.0	7.7	16.2	13.5	19.4	22.1	13.8	9.7	10.3	11.4	13.0	21.0	23.1	23.0	6.7	9.9	11.0	16.2	13.3	7.2	3.9	14.3	13.7	8.8	10.3	15.8	4.8	22.6	3.5	10.6	18.3	7.5	9.8	8.6	7.9	8.8	11.7	11.8	8.8	32.9	7.9	19.2	24.9	29.3	7.3	7.1	12.7	10.9	7.4	13.3	8.0
NUP88	MGC8530	ENSG00000108559	"Nucleoporin 88"	Q99567	17	5360963-5419676	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 146.0;Spermatocytes: 147.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002209, HPA021816"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB002209: AB_564128, HPA021816: AB_1854725"	"unprognostic (3.46e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.38e-2)"	"unprognostic (3.94e-1)"	"unprognostic (4.72e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.04e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.44e-2)"	11.8	12.0	4.2	16.3	3.8	20.8	15.2	7.5	6.0	10.8	3.3	13.2	9.9	10.4	16.4	12.1	12.4	8.0	12.2	3.9	3.9	15.2	27.3	9.4	26.4	4.1	4.0	8.5	10.2	15.3	9.0	10.9	4.3	11.5	19.3	9.6	13.2	10.3	31.2	12.9	11.7	13.7	3.6	14.8	12.3	49.3	3.8	24.1	14.6	21.6	32.9	15.1	9.0	4.2	46.2	50.0	44.0	33.3	18.3	20.0	40.2	35.8	29.0	58.7	52.0	41.5	17.8	88.6	13.3	33.1	38.1	43.5	73.6	39.6	74.7	22.7	48.6	40.0	42.7	32.5	24.8	31.8	34.6	14.3	28.2	43.7	71.3	24.5	41.0	34.3	42.3	22.2	46.5	24.3	46.7	23.4	41.2	46.4	23.9	44.1	48.5	38.7	30.7	22.3	17.5	33.9	44.0	20.4	28.1	33.7	22.9	37.3	26.8	26.4	28.3	27.1	66.9	15.0	19.4	39.5	31.3	36.3	37.4	5.4	7.6	4.3	12.4	12.2	12.3	39.1	13.3	15.0	10.9	35.7	14.3	15.9	0.9	21.1	14.3	12.2	17.6	11.5	4.2	3.8	7.5	6.0	3.9	3.9	4.1	4.0	4.3	3.6	3.8	4.2	6.9	12.8	17.8	10.1	38.0	22.2	31.5	13.5	14.2	13.3	8.9	6.2	10.7	11.5	18.1	16.5	16.7	30.1	19.3	15.2	11.7	27.9	146.0	26.1	15.0	11.5	13.8	28.6	22.9	25.4	24.8	12.2	15.3	47.2	7.6	14.9	9.3	16.5	11.4	10.1	20.4	10.1	14.2	7.9	12.3	38.0	15.2	10.6	3.6	11.2	19.4	7.8	26.8	13.0	17.8	23.3	15.4	10.9	9.4	21.7	9.9	7.5	11.5	11.0	13.1	19.5	20.5	147.5	61.8	15.8	17.0	36.0	17.9	13.6	17.6	42.8
NUP93	KIAA0095	ENSG00000102900	"Nucleoporin 93"	Q8N1F7	16	56730118-56850286	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017937	Uncertain					NA	NA		38000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA017937: AB_1854726"	"unprognostic (6.31e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.85e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.78e-3)"	"prognostic unfavorable (1.72e-6)"	"unprognostic (9.18e-2)"	"unprognostic (9.35e-3)"	"unprognostic (5.22e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.68e-2)"	"unprognostic (3.74e-2)"	17.9	13.9	13.2	21.3	17.4	52.7	15.5	6.8	23.9	15.3	0.2	17.7	9.9	16.9	12.4	22.3	15.3	12.4	14.2	30.6	10.7	12.8	9.3	15.3	27.7	10.7	9.3	14.9	14.2	14.8	10.8	19.1	9.9	17.7	18.1	31.7	12.2	12.7	20.0	21.6	14.5	19.5	8.3	24.2	15.2	39.8	11.4	34.1	34.3	14.2	30.3	17.1	16.1	11.5	71.3	84.5	71.6	81.0	25.9	34.8	81.0	58.7	48.2	156.2	100.1	119.4	66.1	107.7	60.4	54.9	54.2	120.6	143.3	90.1	149.8	34.0	81.3	72.6	64.7	97.3	35.0	96.7	82.8	29.3	35.7	104.2	64.7	31.6	90.8	95.3	87.8	22.3	72.3	52.4	136.2	81.1	92.1	44.2	95.4	163.9	129.4	108.9	53.1	47.8	66.6	44.1	159.1	54.6	47.3	77.4	43.0	57.9	55.3	68.1	74.0	57.8	67.5	35.0	60.7	190.2	47.4	88.5	67.5	19.3	49.9	195.7	38.9	77.2	45.2	45.4	28.3	40.9	60.9	45.4	28.7	41.0	11.8	51.8	77.5	28.7	39.7	47.4	13.2	17.4	6.8	23.9	30.6	10.7	10.7	9.3	9.9	8.3	11.4	11.5	11.3	6.4	12.3	17.6	13.4	12.0	13.6	20.7	6.2	68.6	9.0	7.6	11.8	1.5	20.2	9.2	10.4	21.1	9.4	8.6	11.7	24.6	11.7	10.9	8.8	16.5	4.9	33.2	51.1	25.5	31.7	12.8	13.7	10.6	17.2	22.3	10.8	7.2	26.6	38.7	49.4	11.2	24.4	17.8	23.8	7.7	23.3	17.3	16.0	33.7	30.3	11.7	8.2	18.1	22.1	21.4	7.2	13.5	8.1	16.5	3.6	11.0	13.0	20.8	13.1	11.4	27.9	54.6	62.2	14.3	16.1	10.3	13.5	22.3	15.3	18.0
NUP98	"NUP96, Nup98-96, Nup98-Nup96"	ENSG00000110713	"Nucleoporin 98 and 96 precursor"	P52948	11	3671083-3797792	"Cancer-related genes, Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 118.7;Late spermatids: 158.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (1.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.41e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.71e-3)"	"unprognostic (3.40e-1)"	"unprognostic (4.08e-3)"	"unprognostic (6.47e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.83e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.21e-1)"	22.9	14.7	7.2	25.1	8.4	76.0	25.3	15.1	12.4	21.8	13.8	21.1	17.8	22.2	20.7	23.1	20.8	21.6	20.8	7.2	8.8	19.3	31.9	23.4	27.6	9.8	10.5	28.4	24.0	25.7	16.7	25.6	8.3	21.9	23.6	23.2	23.3	22.3	41.9	21.2	17.7	23.4	7.1	21.9	17.6	78.4	9.1	34.4	29.1	31.0	30.6	32.7	18.6	12.7	81.2	63.7	51.7	54.5	54.7	46.1	44.5	57.9	67.7	78.3	69.9	69.4	97.4	80.6	26.0	68.6	77.1	85.5	90.0	56.1	105.6	56.7	67.0	86.4	51.7	48.1	46.1	111.1	67.5	51.9	37.6	41.8	75.2	33.7	61.9	88.3	109.3	60.6	82.5	33.2	110.2	36.3	64.5	87.8	48.4	65.9	62.6	37.8	43.4	63.4	46.8	31.5	83.4	64.9	38.1	52.0	40.5	43.4	45.9	59.9	51.1	67.5	53.0	37.0	67.0	83.5	41.0	46.5	64.4	40.5	11.7	23.3	15.0	15.0	15.1	12.8	14.7	13.5	14.3	10.8	16.1	14.4	35.2	9.7	9.5	3.9	20.1	13.3	7.2	8.4	15.1	12.4	7.2	8.8	9.8	10.5	8.3	7.1	9.1	12.7	24.7	28.9	25.2	32.7	37.4	49.8	36.3	12.6	34.7	14.9	28.2	24.5	19.5	22.8	20.1	7.3	16.7	22.2	41.6	18.8	3.9	12.2	118.7	32.1	30.4	22.5	21.5	42.5	43.6	11.8	17.5	22.7	42.3	62.0	18.3	16.3	15.7	23.6	16.8	15.2	43.7	15.1	6.1	19.8	51.1	158.6	17.1	29.3	16.0	25.3	24.9	11.1	12.3	31.7	44.4	13.2	16.1	14.3	36.3	25.1	11.8	9.0	16.6	14.1	32.9	36.9	23.2	56.2	31.0	30.3	50.4	46.5	44.5	13.7	19.5	32.5
NUSAP1	"ANKT, BM037, FLJ13421, LNP, PRO0310p1, Q0310, SAPL"	ENSG00000137804	"Nucleolar and spindle associated protein 1"	Q9BXS6	15	41320794-41381050	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 88.6;lymphoid tissue: 101.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 266.7;Extravillous trophoblasts: 121.2;Granulosa cells: 93.3;Spermatocytes: 99.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"basophil: 10.7;T-reg: 7.7"	"Group enriched"	"Detected in many"	15	"granulocytes: 10.7;T-cells: 7.7"	"Low cell line specificity"	"Detected in many"											"HPA042904, HPA074847"	Supported		Approved	"Nucleoplasm,Nucleoli,Nucleoli fibrillar center"		Yes	Yes			"Cluster 34: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli, Nucleoli fibrillar center"		"HPA042904: AB_2678220, HPA074847: AB_2732269"	"unprognostic (1.19e-1)"	"unprognostic (9.53e-3)"	"unprognostic (1.65e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.74e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.14e-1)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (8.49e-3)"	"prognostic unfavorable (6.82e-14)"	"unprognostic (4.76e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.22e-1)"	1.8	14.1	0.2	7.8	0.2	88.6	1.5	0.3	0.4	3.6	0.3	6.1	7.0	1.1	0.1	17.7	1.1	1.0	1.1	0.2	0.2	2.6	5.0	3.8	28.7	0.3	0.4	4.4	1.3	0.0	0.6	6.5	0.3	1.1	8.0	0.1	3.6	0.6	5.4	9.4	7.4	2.7	0.2	7.8	4.5	10.9	0.3	101.5	0.9	0.1	31.5	1.9	6.4	0.3	146.0	38.3	165.1	64.6	3.5	5.9	37.0	107.4	74.6	138.9	130.6	58.4	67.0	63.5	42.5	44.4	99.1	107.6	104.2	46.2	132.4	98.5	62.3	149.6	102.0	50.7	0.2	67.3	57.2	0.9	1.3	69.1	37.3	21.7	72.0	104.2	70.1	237.5	105.7	30.7	147.5	82.2	59.8	139.8	55.0	136.5	156.5	67.5	42.4	29.3	85.7	55.2	129.8	88.5	25.7	46.0	106.2	76.1	33.7	89.9	104.8	101.5	206.2	81.3	145.8	200.5	42.1	163.6	171.2	10.7	0.1	0.5	0.1	0.0	0.0	0.3	0.5	0.5	0.3	0.6	0.0	0.3	0.2	0.4	0.0	0.3	7.7	0.5	0.2	0.2	0.3	0.4	0.2	0.2	0.3	0.4	0.3	0.2	0.3	0.3	1.9	0.0	1.5	1.3	14.2	38.5	10.3	21.2	31.9	0.9	9.9	13.7	1.1	17.2	5.0	0.0	0.0	72.2	13.4	14.4	3.9	2.3	33.2	10.7	11.6	7.3	3.0	266.7	1.4	0.5	121.2	14.6	25.5	21.8	7.0	93.3	10.8	3.9	36.7	0.0	1.5	15.5	24.4	13.8	22.7	14.6	0.3	17.5	3.6	1.9	6.1	1.9	4.1	1.0	1.3	1.5	0.4	1.9	57.2	5.3	2.6	5.4	1.1	1.0	0.0	2.8	12.1	99.6	59.9	69.5	24.9	19.3	22.9	38.8	30.0	10.3
NUTF2	"NTF2, PP15"	ENSG00000102898	"Nuclear transport factor 2"	P61970	16	67846923-67872567	"Plasma proteins, Predicted intracellular proteins"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 336.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040915, HPA040956"	Supported					NA	NA		2300000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA040915: AB_10794073, HPA040956: AB_10796233"	"unprognostic (1.74e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.41e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.08e-3)"	"unprognostic (1.56e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.33e-2)"	"unprognostic (5.17e-3)"	"unprognostic (9.80e-2)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (1.79e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.45e-1)"	57.1	53.7	86.4	36.5	86.6	42.0	49.8	88.8	93.4	47.4	75.3	57.9	27.4	60.7	49.4	53.7	47.9	26.6	74.7	88.4	96.6	50.8	51.5	49.9	47.8	96.2	99.6	42.4	56.9	41.6	43.0	49.8	99.2	44.6	42.6	17.2	40.5	32.5	93.4	58.7	42.8	58.0	90.7	41.4	45.9	56.6	88.3	57.4	39.3	79.2	53.3	57.9	45.2	91.7	149.0	174.8	186.9	212.2	92.8	94.1	249.9	118.8	102.8	165.4	134.1	222.3	152.5	169.2	107.7	161.3	95.9	130.3	235.4	176.2	179.3	65.9	225.5	114.2	73.6	357.5	124.0	161.6	83.1	123.4	114.1	152.9	190.7	91.0	175.5	127.7	164.2	59.1	173.6	301.8	257.3	311.1	318.9	152.4	117.6	228.2	121.5	254.2	218.9	128.5	169.6	164.4	266.4	109.5	93.6	174.5	161.0	137.3	147.4	140.3	168.3	104.2	144.0	94.8	131.0	367.5	92.9	113.0	147.8	47.8	64.0	27.4	61.0	95.7	70.1	52.7	64.9	60.3	81.5	51.8	48.8	55.9	17.9	71.9	88.3	78.7	72.8	101.8	86.4	86.6	88.8	93.4	88.4	96.6	96.2	99.6	99.2	90.7	88.3	91.7	67.6	57.7	20.2	4.9	58.6	68.2	79.5	136.5	64.9	15.9	62.8	53.7	38.7	27.1	58.5	49.7	2.1	208.2	62.4	66.2	137.0	196.5	9.9	71.4	66.1	71.9	98.3	126.4	6.9	105.1	336.1	57.6	60.6	52.7	39.3	65.1	28.2	22.5	149.4	20.2	7.4	69.1	89.5	32.4	83.6	20.8	33.2	75.2	58.7	4.7	130.2	26.5	69.0	4.0	8.3	198.8	93.3	42.9	86.2	166.0	96.5	124.1	53.7	7.6	13.1	48.5	187.5	54.6	82.0	88.7	87.7	183.5	62.9	62.1	95.6	114.5
NVL	NVL2	ENSG00000143748	"Nuclear VCP like"	O15381	1	224227334-224330189	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028207, HPA028219, HPA028224, HPA028654"	Supported		Enhanced	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoli		"HPA028207: AB_10601382, HPA028219: AB_2672526, HPA028224: AB_2672529, HPA028654: AB_2672714"	"unprognostic (1.50e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (5.77e-5)"	"prognostic favorable (2.95e-4)"	"unprognostic (4.43e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (4.10e-11)"	"unprognostic (1.67e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.37e-1)"	7.0	7.7	5.5	8.7	5.7	9.8	10.7	7.8	7.5	9.5	6.5	9.1	6.3	9.0	7.7	7.2	8.8	5.6	5.9	5.3	6.4	8.7	6.1	8.0	12.5	5.4	5.3	10.6	8.8	9.5	10.3	13.0	5.6	9.0	10.6	12.8	7.4	7.9	6.5	15.7	8.2	8.1	4.7	10.4	7.2	6.6	5.6	13.0	10.2	5.2	12.1	8.8	8.9	7.5	28.8	15.8	31.2	25.2	11.5	16.6	31.6	22.0	16.5	30.6	27.0	23.4	23.4	39.6	22.5	14.7	11.7	26.1	37.3	22.2	31.5	30.5	47.0	16.4	25.5	11.3	20.3	39.1	28.8	13.5	16.9	26.8	28.5	14.3	19.2	23.0	48.9	23.8	19.1	21.3	30.6	18.3	47.5	20.0	26.1	34.2	37.3	24.8	17.8	19.2	27.5	22.9	34.2	53.1	31.9	25.6	24.3	32.1	19.8	23.2	14.9	27.1	42.9	15.6	33.3	39.3	15.1	30.2	24.8	13.9	7.8	8.4	11.5	11.8	11.7	13.5	11.8	9.1	8.7	9.0	9.9	10.0	0.8	11.9	16.4	9.0	9.3	7.8	5.5	5.7	7.8	7.5	5.3	6.4	5.4	5.3	5.6	4.7	5.6	7.5	10.2	22.4	23.1	21.2	14.3	5.2	4.6	7.8	4.0	14.5	7.9	8.3	10.5	7.2	12.2	1.8	10.4	21.5	12.6	26.9	13.7	9.5	10.1	10.0	11.6	9.3	4.2	7.2	32.1	8.4	14.0	9.3	5.6	7.3	16.4	13.4	4.6	4.5	10.7	10.1	31.0	12.6	10.2	6.5	5.7	3.1	9.6	8.1	5.4	26.2	8.7	9.7	15.5	24.6	43.0	7.0	23.4	10.9	12.3	3.7	7.0	8.1	16.7	20.4	0.0	8.5	10.1	17.5	11.3	7.3	4.5	18.3	12.9	11.4	14.7	3.7
NXF1	"DKFZp667O0311, Mex67, TAP"	ENSG00000162231	"Nuclear RNA export factor 1"	Q9UBU9	11	62792123-62806302	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016327, HPA061593"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB016327: AB_627608, HPA061593: AB_2684565"	"unprognostic (2.45e-2)"	"unprognostic (1.15e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.68e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.21e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.64e-1)"	"prognostic favorable (4.08e-4)"	"unprognostic (4.33e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.25e-2)"	90.2	103.4	57.2	47.9	56.8	204.6	81.8	61.6	71.9	100.1	66.8	106.0	39.4	94.6	55.2	80.2	86.8	51.8	78.0	57.3	59.0	100.3	130.0	82.0	69.9	56.6	57.2	97.3	98.3	63.8	136.7	58.9	56.1	107.2	45.6	49.9	77.3	57.8	75.7	110.6	96.1	66.6	55.2	143.8	97.1	59.5	58.2	75.5	123.1	41.5	56.1	83.1	78.8	59.9	44.6	48.5	82.8	56.5	69.6	50.2	50.2	67.5	60.5	89.0	52.6	66.8	35.1	70.0	39.1	54.4	35.7	54.1	89.9	42.3	80.2	55.5	61.3	52.9	82.1	56.4	52.8	66.3	73.6	74.5	59.9	65.6	31.5	66.5	58.9	60.7	69.3	50.7	64.4	61.1	81.3	85.1	50.4	54.8	41.6	77.5	46.0	74.6	61.7	51.7	43.6	36.5	66.4	52.8	49.8	59.9	60.3	57.9	60.3	51.2	41.5	64.6	61.3	61.4	56.8	70.2	39.6	55.2	52.1	7.6	21.3	23.5	18.9	26.0	20.5	16.0	18.4	18.5	23.6	12.8	19.6	18.4	16.1	20.2	23.6	18.3	24.0	17.1	57.2	56.8	61.6	71.9	57.3	59.0	56.6	57.2	56.1	55.2	58.2	59.9	53.2	38.5	45.3	14.7	40.2	83.4	27.0	29.4	42.7	13.2	45.9	74.7	24.6	21.5	23.4	22.0	31.3	50.4	44.1	42.2	9.8	17.6	32.6	30.4	36.8	36.8	31.6	17.7	11.0	12.3	25.9	35.1	43.3	51.7	49.9	19.8	26.0	18.6	28.6	5.0	13.0	35.9	22.4	33.8	43.2	12.3	36.7	62.5	32.0	11.2	21.8	12.7	21.6	7.1	10.1	14.7	28.6	25.9	29.7	22.0	24.0	10.2	18.6	17.2	26.3	48.6	40.4	28.2	19.9	53.4	70.0	99.2	42.3	15.4	30.4	15.2
ODC1	ODC	ENSG00000115758	"Ornithine decarboxylase 1"	P11926	2	10439968-10448327	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Polyamine biosynthesis"	"Decarboxylase, Lyase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 560.8;Late spermatids: 834.9;Prostatic glandular cells: 412.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001536, CAB035996"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane, Cytosol"		"CAB035996: , HPA001536: AB_1079521"	"unprognostic (2.33e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.25e-3)"	"unprognostic (5.21e-3)"	"unprognostic (4.22e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (3.07e-5)"	"unprognostic (3.06e-2)"	"unprognostic (4.18e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.04e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.86e-2)"	47.2	23.2	31.0	69.3	31.5	172.9	33.0	30.5	32.2	33.5	48.5	64.8	32.4	66.0	49.2	29.4	56.3	43.7	55.9	29.9	33.0	132.2	92.1	52.4	111.0	32.4	33.0	54.8	61.8	99.6	92.5	20.0	30.6	91.1	72.0	46.2	27.0	55.1	163.3	29.2	41.6	71.2	34.1	42.9	51.5	133.3	34.0	77.1	58.5	73.5	149.1	113.6	26.9	35.7	166.8	130.6	177.1	211.4	31.1	92.4	410.1	234.6	114.9	216.3	99.9	697.3	75.4	870.2	114.6	143.6	208.6	30.2	549.1	265.5	261.2	334.0	231.5	398.1	212.2	429.9	250.8	680.1	91.8	62.5	70.5	490.1	608.3	111.4	176.3	237.6	674.2	274.3	121.7	109.0	680.1	267.3	324.9	228.3	418.8	478.5	556.0	586.3	130.9	119.5	246.6	209.9	293.6	88.8	121.8	135.7	60.0	300.5	124.7	174.4	362.6	227.9	511.7	128.0	416.1	780.8	156.7	443.6	109.9	0.0	1.5	3.0	2.9	2.9	3.3	14.8	4.1	4.8	3.4	15.0	2.8	4.5	0.5	1.4	1.8	12.2	4.4	3.2	31.0	31.5	30.5	32.2	29.9	33.0	32.4	33.0	30.6	34.1	34.0	35.7	78.2	44.8	161.4	7.5	228.9	58.0	123.7	48.8	19.4	36.8	53.2	68.3	55.1	81.5	33.9	40.5	31.3	1.5	188.1	77.7	72.4	50.6	560.8	90.9	66.2	52.2	271.0	111.3	7.5	27.6	70.0	63.2	204.4	127.6	58.9	103.8	14.6	50.3	46.8	6.7	4.1	234.1	22.4	32.1	22.4	834.9	15.5	191.8	23.2	8.4	22.1	126.3	37.0	4.5	2.4	28.6	64.5	11.3	287.4	412.4	31.6	154.1	21.9	77.4	0.0	223.0	79.9	186.5	75.8	52.2	87.5	3.4	133.0	30.2	180.5	142.2
ODF2	"CT134, ODF84"	ENSG00000136811	"Outer dense fiber of sperm tails 2"	Q5BJF6	9	128455186-128501292	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"testis: 317.6"	"Cell type enriched"	"Detected in all"	4	"Late spermatids: 8228.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001874, HPA048841"	Enhanced		Supported	Vesicles,Centrosome		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Centrosome	Vesicles	"HPA001874: AB_1079522, HPA048841: AB_2680536"	"unprognostic (4.54e-3)"	"unprognostic (9.91e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.57e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.28e-2)"	"prognostic unfavorable (1.72e-4)"	"unprognostic (1.93e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.65e-2)"	14.3	11.8	9.6	22.1	9.8	31.1	14.2	17.9	13.5	20.4	40.1	15.7	10.3	21.9	11.0	12.4	22.6	13.2	14.4	11.1	10.7	14.1	16.4	14.4	25.6	13.4	16.1	15.1	13.2	15.3	30.8	15.9	11.6	16.1	15.1	14.9	12.9	14.7	8.9	19.3	13.7	20.5	9.7	20.5	13.7	317.6	11.7	34.8	13.2	5.3	26.6	17.0	14.4	9.9	44.2	52.2	85.3	97.7	33.3	39.6	68.6	72.3	33.7	58.9	30.8	51.8	31.6	78.6	26.7	59.2	45.7	112.7	62.9	43.1	59.4	52.2	29.3	69.8	84.9	43.8	19.3	76.2	84.5	32.8	26.9	62.6	43.9	36.5	52.0	58.8	83.9	42.9	56.3	134.9	81.5	92.7	33.4	89.7	37.2	73.6	82.0	60.9	30.7	33.6	51.2	43.6	67.8	64.0	22.9	38.3	59.8	54.8	49.9	73.1	44.6	84.9	71.7	79.6	123.9	55.9	33.4	68.4	64.8	21.6	9.2	10.3	11.4	13.4	13.6	8.2	10.2	12.2	8.8	7.0	7.2	9.3	3.0	12.0	17.8	8.3	8.1	10.1	9.6	9.8	17.9	13.5	11.1	10.7	13.4	16.1	11.6	9.7	11.7	9.9	14.2	6.4	6.8	9.8	14.4	16.7	16.7	7.4	19.9	9.8	11.2	9.5	10.6	11.5	8.5	7.3	10.4	13.1	13.7	4.6	11.7	10.6	1914.4	39.4	16.3	18.3	3.6	29.8	18.5	9.0	16.8	14.0	10.2	13.4	19.6	10.1	8.2	9.6	12.4	8.4	16.6	10.9	12.2	10.2	14.9	8228.0	42.6	12.9	10.6	12.2	11.1	8.6	9.2	14.1	9.8	7.4	3.2	33.8	16.1	16.1	3.0	6.9	46.6	8.9	13.1	11.1	16.7	268.1	58.3	13.8	13.2	33.2	16.8	11.4	7.6	12.9
OGFOD1	"FLJ10826, KIAA1612, TPA1"	ENSG00000087263	"2-oxoglutarate and iron dependent oxygenase domain containing 1"	Q8N543	16	56451521-56479104	"Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003215, HPA003722"	Approved	Approved	Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm	Cytosol	"HPA003215: AB_1078881, HPA003722: "	"unprognostic (1.13e-1)"	"unprognostic (4.52e-2)"	"unprognostic (3.80e-3)"	"unprognostic (2.86e-2)"	"unprognostic (2.48e-3)"	"prognostic unfavorable (6.65e-4)"	"prognostic unfavorable (7.02e-4)"	"unprognostic (5.51e-2)"	"unprognostic (6.87e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.59e-2)"	"unprognostic (7.49e-2)"	"unprognostic (7.20e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.84e-2)"	9.6	12.3	5.2	8.8	6.5	3.9	9.5	5.5	7.3	10.4	4.1	7.7	8.8	9.8	7.6	19.4	10.6	6.7	14.5	5.3	7.2	9.3	9.1	8.0	8.9	6.5	6.3	8.1	5.7	12.0	6.1	9.2	6.5	8.4	9.6	9.6	6.4	9.5	31.5	6.3	5.1	16.7	5.1	7.5	6.1	9.5	6.3	10.5	10.2	23.5	14.5	9.1	5.7	9.0	25.4	27.4	25.7	32.5	28.6	34.5	26.0	39.1	29.9	52.4	38.5	34.5	16.5	44.7	19.0	29.3	21.7	34.9	57.2	25.5	57.3	14.1	29.6	32.4	21.6	32.8	21.4	34.9	36.2	23.2	29.0	38.7	31.2	23.1	45.3	29.3	44.3	8.2	46.2	15.6	27.4	19.2	45.0	19.8	47.2	51.2	41.0	51.9	22.9	16.7	20.4	24.1	46.3	29.0	25.2	26.9	26.4	30.1	28.9	28.1	23.2	22.9	36.7	18.0	37.1	67.5	22.9	26.5	22.7	13.4	4.6	4.5	7.7	6.4	10.1	7.1	9.5	9.4	6.4	5.6	10.7	8.4	1.5	8.5	8.6	6.8	9.0	5.9	5.2	6.5	5.5	7.3	5.3	7.2	6.5	6.3	6.5	5.1	6.3	9.0	8.9	3.2	16.0	9.8	14.1	17.7	13.8	11.2	17.6	11.3	13.1	10.7	21.4	20.0	15.0	9.2	10.4	18.3	11.7	5.8	25.4	13.7	22.2	11.6	20.0	12.2	2.4	19.6	14.4	14.1	20.5	22.3	12.2	19.1	45.7	13.0	9.7	17.6	12.0	13.5	16.6	7.9	4.1	6.9	10.2	15.6	12.2	10.9	10.6	4.7	16.1	13.6	10.3	9.0	14.5	17.4	5.5	15.8	16.1	11.0	4.6	13.8	8.0	15.2	13.1	16.7	19.0	26.0	29.6	21.2	18.9	11.6	18.4	19.1	10.6	9.0
OGFOD3	"C17orf101, FLJ22222"	ENSG00000181396	"2-oxoglutarate and iron dependent oxygenase domain containing 3"	Q6PK18	17	82389210-82418637	"Predicted intracellular proteins, Predicted membrane proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052099	Uncertain		Approved	Nucleoplasm		NA	NA		9700	"Cluster 26: Non-specific - Mitochondria"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"HPA052099: AB_2681725"	"unprognostic (1.12e-2)"	"unprognostic (5.85e-2)"	"unprognostic (9.66e-2)"	"unprognostic (9.69e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.41e-2)"	"unprognostic (7.15e-2)"	"unprognostic (8.05e-3)"	"unprognostic (2.95e-1)"	"prognostic favorable (5.72e-4)"	"unprognostic (7.43e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.02e-1)"	14.6	19.6	4.3	9.0	4.7	10.1	14.0	6.1	6.9	14.2	9.7	13.5	9.9	16.0	6.4	12.5	13.3	8.1	24.0	3.8	4.3	15.4	20.5	13.7	8.4	5.3	4.5	14.6	25.7	15.3	22.0	8.9	4.6	15.5	5.4	2.7	18.9	10.2	24.3	13.0	11.1	5.7	3.7	11.4	15.8	8.5	4.1	5.4	19.0	9.0	5.4	14.4	11.5	5.1	23.0	28.6	9.4	31.5	17.8	22.4	16.1	22.9	21.4	23.5	24.0	30.8	30.9	15.7	17.8	18.0	23.9	16.9	8.1	19.4	9.7	12.5	24.5	23.6	22.6	39.7	15.9	27.8	27.0	18.1	14.0	10.9	9.3	17.1	24.8	17.2	30.4	12.0	6.9	21.7	19.1	29.1	8.9	24.3	33.5	12.4	18.0	24.4	13.5	21.3	20.2	40.1	39.4	36.1	18.8	7.9	21.4	36.2	19.4	44.0	27.3	17.5	30.0	20.9	2.0	14.6	27.5	15.9	23.2	0.2	13.8	4.5	6.5	12.9	7.4	13.6	9.4	13.0	23.6	11.9	11.1	9.3	1.6	7.0	8.5	12.3	3.9	8.0	4.3	4.7	6.1	6.9	3.8	4.3	5.3	4.5	4.6	3.7	4.1	5.1	13.9	25.6	16.5	3.3	21.6	11.3	23.8	27.1	13.1	23.1	26.0	29.7	18.6	18.6	19.1	22.0	10.4	37.9	12.7	19.8	9.8	27.3	28.2	23.1	17.0	18.4	28.8	21.8	6.3	31.4	59.2	25.3	19.4	16.8	9.5	20.8	8.9	28.0	37.1	30.3	7.7	24.0	12.2	22.4	16.4	45.7	20.8	19.9	14.2	3.7	27.1	12.4	34.0	8.5	6.9	20.1	32.4	18.8	53.1	35.1	42.3	27.8	18.2	16.1	6.6	30.2	23.1	16.1	10.3	19.9	12.8	31.7	15.9	27.0	28.6	28.1
OIP5	"CT86, hMIS18beta, MIS18B"	ENSG00000104147	"Opa interacting protein 5"	O43482	15	41309273-41332591	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.3;skeletal muscle: 10.3;testis: 20.9"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 45.9;Extravillous trophoblasts: 24.0;Spermatocytes: 110.6;Spermatogonia: 56.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA052271, HPA059602"	Enhanced		Supported	"Nuclear speckles,Vesicles"		NA	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear speckles"	Vesicles	"HPA052271: AB_2681780, HPA059602: AB_2684079"	"unprognostic (5.17e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.94e-2)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (1.79e-4)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (9.34e-5)"	"unprognostic (5.51e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.84e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.86e-2)"	0.6	1.7	0.1	3.3	0.2	10.3	1.2	1.2	0.4	0.9	0.2	4.1	3.5	0.8	0.3	3.8	0.4	0.6	1.5	0.2	0.2	0.3	1.2	0.5	5.8	0.2	0.4	1.5	0.3	0.1	0.1	2.3	0.4	0.5	3.9	0.7	0.8	0.6	10.3	3.3	3.9	1.1	0.1	1.7	1.5	20.9	0.2	9.1	0.4	0.8	5.2	0.7	1.3	0.5	33.7	17.8	34.3	24.9	1.7	2.1	32.4	20.0	9.3	24.5	26.1	31.8	16.2	19.8	17.0	7.7	37.8	51.0	35.7	16.1	19.2	42.4	40.1	42.4	49.8	33.6	0.4	46.5	22.1	0.7	3.2	13.8	14.5	5.2	21.1	40.8	59.4	37.3	16.5	16.3	27.1	34.8	30.9	50.4	37.9	32.9	28.4	30.5	11.1	15.4	53.7	17.5	33.7	34.3	9.6	13.7	33.7	26.3	10.0	24.5	37.3	24.6	36.6	17.0	83.2	71.1	7.1	56.5	35.9	0.0	0.4	0.5	0.2	0.7	0.8	1.0	0.7	0.8	0.7	1.2	1.3	0.8	0.0	1.2	0.4	4.1	3.1	0.8	0.1	0.2	1.2	0.4	0.2	0.2	0.2	0.4	0.4	0.1	0.2	0.5	0.2	0.0	0.5	1.0	2.7	4.1	0.9	3.6	1.2	0.0	1.1	2.2	0.2	0.0	1.8	0.0	0.0	15.0	1.7	2.3	0.0	0.4	12.0	1.9	0.6	0.9	0.0	45.9	2.2	0.4	24.0	1.7	5.1	1.1	1.3	5.2	0.0	0.8	7.5	0.0	2.1	3.0	8.2	2.2	1.8	10.8	0.9	1.2	0.0	0.0	0.6	1.1	2.1	1.5	2.5	0.2	0.5	1.2	10.9	0.4	0.9	0.3	0.0	0.3	6.6	1.0	1.1	110.6	56.8	8.3	2.4	3.8	1.2	2.1	7.6	0.9
OLA1	"GTPBP9, PTD004"	ENSG00000138430	"Obg like ATPase 1"	Q9NTK5	2	174072447-174248599	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035790, HPA041443"	Approved		Enhanced	Cytosol		NA	NA		3300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA035790: AB_10601977, HPA041443: AB_2677483"	"unprognostic (3.30e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.08e-3)"	"prognostic unfavorable (9.73e-8)"	"unprognostic (6.51e-3)"	"unprognostic (7.66e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.13e-3)"	"unprognostic (4.32e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.62e-2)"	"unprognostic (9.75e-2)"	42.2	44.3	39.7	38.2	42.7	53.7	57.3	42.5	48.9	34.3	30.0	48.0	50.1	34.7	38.8	58.1	38.0	35.1	57.4	44.5	43.8	56.4	43.0	23.5	47.9	38.0	36.6	31.1	56.3	44.1	27.4	42.0	40.1	41.1	52.7	42.5	36.3	33.6	105.6	52.0	45.7	37.0	38.0	24.6	35.2	48.8	40.7	58.3	59.7	93.1	53.3	48.3	31.0	39.1	181.4	84.1	134.9	225.5	70.1	152.2	243.0	142.1	142.8	194.2	147.1	200.9	104.4	246.5	138.9	114.5	143.9	139.9	165.3	164.6	227.3	113.7	142.5	231.3	76.4	209.9	135.3	264.3	90.2	134.8	200.6	206.3	217.4	177.4	174.5	88.0	256.8	82.3	170.3	116.6	241.4	272.9	159.1	193.9	273.0	180.4	217.8	170.7	245.1	192.0	218.3	124.7	96.8	141.6	206.2	142.2	101.2	220.6	127.5	127.1	161.4	128.5	210.8	76.2	207.3	190.5	124.6	180.0	115.4	18.1	24.9	7.4	16.2	24.2	23.4	17.9	18.6	20.8	37.1	16.4	21.5	21.2	2.1	26.1	20.0	22.5	25.3	22.7	39.7	42.7	42.5	48.9	44.5	43.8	38.0	36.6	40.1	38.0	40.7	39.1	43.2	35.3	33.0	57.5	49.0	62.7	73.5	92.4	76.8	47.3	86.0	83.8	68.3	47.1	57.0	31.3	35.5	153.7	47.7	44.6	103.7	145.1	267.8	37.1	55.2	47.8	70.7	92.5	132.6	105.3	112.8	53.0	60.1	43.1	41.2	73.3	29.3	25.8	97.3	33.7	129.8	79.6	65.1	59.6	54.4	99.5	40.4	55.9	32.0	65.6	83.1	60.3	52.5	101.6	101.8	112.8	51.8	51.1	56.3	84.2	78.4	141.7	36.1	35.9	26.3	69.7	92.3	104.8	35.9	113.7	64.1	105.9	55.9	94.6	107.6	79.3
OPA1	"FLJ12460, KIAA0567, MGM1, NPG, NTG"	ENSG00000198836	"OPA1 mitochondrial dynamin like GTPase"	O60313	3	193593144-193697811	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Apoptosis, Sensory transduction, Vision"	Hydrolase	"Cardiomyopathy, Deafness, Disease variant, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 135.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036926, HPA036927"	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA		10000	"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Mitochondria"		"HPA036926: AB_10671247, HPA036927: AB_2675388"	"unprognostic (2.10e-2)"	"unprognostic (9.23e-3)"	"unprognostic (7.98e-2)"	"prognostic unfavorable (8.61e-4)"	"unprognostic (1.62e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (8.44e-5)"	"unprognostic (3.48e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (2.92e-1)"	"unprognostic (4.75e-1)"	"unprognostic (4.50e-3)"	"unprognostic (3.21e-1)"	15.0	12.0	14.3	7.6	17.4	25.6	12.8	15.2	19.5	10.4	9.4	18.9	16.8	10.9	9.1	14.6	8.1	10.2	39.3	18.6	17.4	18.3	20.9	8.5	11.8	16.4	15.4	8.4	10.1	23.1	3.8	11.7	16.8	12.3	16.6	9.6	11.7	13.3	24.2	11.9	13.8	13.5	12.4	9.3	14.6	6.3	15.2	12.7	13.9	44.5	12.4	13.0	5.1	13.7	58.9	18.8	18.2	20.2	15.8	25.0	19.3	27.5	26.2	30.0	29.0	45.2	19.3	38.6	58.1	27.0	27.3	37.3	32.7	31.7	53.5	46.5	25.7	67.9	16.7	23.1	24.9	55.8	29.8	28.4	27.6	30.0	40.9	18.5	26.2	15.7	28.4	37.0	30.2	46.5	21.9	30.9	25.8	33.9	59.9	27.8	40.1	41.6	22.7	36.1	39.8	24.2	41.8	46.3	29.5	14.1	60.3	43.5	26.3	27.7	20.8	29.3	58.7	33.1	41.3	74.0	30.5	43.7	28.4	9.7	7.3	7.1	5.8	8.2	5.5	6.8	5.5	5.6	7.8	5.1	5.6	6.0	2.7	4.7	17.3	4.0	6.6	5.2	14.3	17.4	15.2	19.5	18.6	17.4	16.4	15.4	16.8	12.4	15.2	13.7	24.8	16.0	24.0	72.1	27.5	15.9	16.4	17.4	24.5	19.5	20.9	13.5	135.2	22.8	20.1	18.4	31.3	19.0	24.6	31.4	17.6	19.3	7.7	20.3	25.2	23.8	23.4	86.3	106.8	24.0	14.9	24.6	31.1	26.1	19.6	25.6	14.3	39.1	17.9	21.9	106.7	20.6	10.2	25.6	14.7	13.5	15.8	28.1	21.4	58.1	22.9	14.6	11.3	87.4	98.1	28.9	12.1	14.7	29.3	18.7	24.6	34.1	19.6	23.4	6.6	21.3	26.2	15.1	16.6	34.3	22.4	17.9	22.3	28.2	26.7	22.1
ORC1	"HSORC1, ORC1L, PARC1"	ENSG00000085840	"Origin recognition complex subunit 1"	Q13415	1	52372829-52404423	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 29.0;lymphoid tissue: 11.6"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 5.5;Early spermatids: 5.6;Erythroid cells: 14.1;Extravillous trophoblasts: 9.9;Plasma cells: 6.3;Spermatogonia: 6.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 15.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 3.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA027439, HPA027450"	Approved		Supported	Nucleoplasm		NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA027439: , HPA027450: AB_10602041"	"unprognostic (3.28e-1)"	"unprognostic (4.42e-3)"	"prognostic favorable (1.74e-5)"	"unprognostic (1.29e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (3.77e-3)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (3.86e-2)"	"unprognostic (2.70e-3)"	"unprognostic (8.39e-2)"	"unprognostic (1.25e-10)"	"unprognostic (4.56e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.57e-2)"	0.4	0.6	0.2	3.5	0.1	29.0	1.1	0.6	0.2	0.6	0.0	3.4	1.7	0.6	0.1	2.7	0.3	0.4	0.2	0.1	0.2	0.5	0.6	0.6	6.7	0.3	0.0	0.5	0.3	0.3	0.3	1.9	0.2	0.4	4.0	1.0	0.6	0.1	0.5	2.0	2.3	0.9	0.0	2.0	1.0	5.2	0.2	11.6	0.3	0.1	7.7	0.9	1.0	0.3	19.3	20.8	33.0	21.7	0.8	2.7	31.8	13.5	12.2	38.9	40.0	25.8	10.7	44.2	11.6	8.5	17.8	25.9	48.9	16.9	33.8	19.0	28.1	53.2	30.2	25.8	0.2	71.9	29.2	1.4	0.8	38.1	4.3	2.7	11.7	27.6	63.0	20.9	12.8	14.4	56.9	34.0	73.1	11.7	29.5	60.2	51.3	43.1	6.8	25.0	18.5	15.6	31.0	18.8	10.3	30.5	10.2	28.7	5.4	15.8	22.5	24.9	34.0	10.9	31.1	54.4	15.6	52.6	19.5	0.0	0.1	0.0	0.2	0.1	0.2	0.2	0.4	0.4	0.6	0.8	0.1	0.3	0.4	3.4	0.2	0.0	1.2	0.3	0.2	0.1	0.6	0.2	0.1	0.2	0.3	0.0	0.2	0.0	0.2	0.3	0.6	0.0	0.0	0.3	1.7	0.9	0.3	0.4	1.2	0.7	0.7	1.1	0.5	0.0	0.1	0.0	0.0	5.5	0.7	1.2	0.0	0.3	5.6	0.5	0.6	0.5	0.0	14.1	0.7	0.2	9.9	0.7	0.5	0.6	0.0	2.8	0.0	0.2	2.9	0.0	0.7	1.3	0.0	0.3	0.4	3.8	0.6	0.6	0.0	1.0	0.3	0.2	0.0	0.5	0.5	0.2	0.8	0.4	6.3	0.2	0.2	3.9	0.1	0.9	0.0	0.6	0.7	4.1	6.5	2.5	1.1	1.8	1.1	0.9	3.7	0.4
ORC2	ORC2L	ENSG00000115942	"Origin recognition complex subunit 2"	Q13416	2	200908977-200963680	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 107.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003693, HPA073881"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB003693: AB_425574, HPA073881: AB_2686640"	"unprognostic (3.04e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.89e-1)"	"unprognostic (8.12e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.37e-3)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (8.42e-4)"	"unprognostic (6.18e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.63e-3)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (9.67e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.31e-3)"	5.9	4.9	2.8	6.7	3.1	5.7	8.0	7.6	4.6	5.8	4.6	7.2	9.1	6.0	6.0	5.8	5.1	4.3	8.8	2.7	3.3	5.6	5.2	4.9	8.5	2.4	2.6	6.8	6.9	7.2	5.1	5.6	2.6	6.4	6.8	7.8	7.1	5.8	6.7	8.4	7.7	4.8	1.4	6.5	7.0	20.8	2.6	9.4	8.3	6.0	8.4	5.4	5.8	5.0	17.8	12.3	13.9	13.9	5.6	9.5	23.4	18.1	11.4	16.3	16.1	26.3	14.2	11.2	12.6	10.7	18.3	14.3	30.6	20.6	24.7	24.9	28.2	26.1	22.1	32.4	11.0	20.7	17.7	8.9	12.0	16.7	20.4	12.8	19.1	18.3	42.5	13.3	14.6	16.9	29.1	19.5	33.6	17.2	29.6	20.6	14.1	16.3	17.2	14.1	22.0	16.5	15.9	14.0	10.4	27.2	10.0	10.2	14.7	14.2	14.6	12.3	18.3	9.4	24.1	17.9	11.3	19.9	13.6	0.3	2.5	3.9	3.2	1.0	4.3	5.5	4.5	3.2	2.1	4.6	5.7	4.1	1.2	3.2	1.9	4.9	3.3	1.6	2.8	3.1	7.6	4.6	2.7	3.3	2.4	2.6	2.6	1.4	2.6	5.0	12.9	9.6	18.5	30.7	16.5	19.1	9.0	7.7	23.9	14.6	12.3	7.6	18.0	14.3	14.8	9.2	25.0	20.6	17.5	12.8	7.9	10.0	56.0	11.5	14.1	12.7	4.2	26.7	54.6	12.3	18.5	10.0	14.8	13.3	10.8	27.5	13.2	10.9	8.9	6.7	61.4	13.1	4.1	7.0	7.1	11.6	12.2	7.0	10.6	24.4	11.4	7.0	20.6	41.7	55.9	10.5	9.0	8.2	16.3	9.7	15.2	9.1	12.1	14.9	19.7	13.1	9.1	107.2	22.1	16.1	15.5	10.8	14.7	6.9	14.7	8.4
ORC4	"HsORC4, ORC4L, Orc4p"	ENSG00000115947	"Origin recognition complex subunit 4"	O43929	2	147930396-148021604	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015124, HPA064562"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Nucleoli"		"CAB015124: AB_2157883, HPA064562: AB_2685287"	"unprognostic (5.04e-2)"	"unprognostic (6.56e-2)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (8.28e-2)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (4.98e-8)"	"unprognostic (5.55e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.81e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.19e-1)"	"prognostic favorable (4.10e-6)"	"unprognostic (2.49e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.95e-3)"	9.7	11.2	11.5	10.1	13.1	19.3	14.6	21.6	16.3	9.0	8.7	12.6	12.0	12.0	11.0	10.6	14.2	9.7	11.6	12.8	10.8	20.5	12.8	9.3	10.9	9.6	7.9	16.7	8.2	16.2	7.6	10.1	10.0	12.1	13.8	19.7	13.4	10.3	15.0	9.3	11.4	11.5	7.6	8.9	9.4	15.5	10.9	15.7	15.6	10.9	11.9	10.2	6.6	14.4	22.8	19.3	37.2	20.4	14.2	13.9	39.9	25.2	21.3	31.3	31.0	47.9	22.6	29.3	26.8	15.1	27.7	22.4	43.4	25.2	32.4	20.6	36.1	40.2	19.0	32.8	18.8	25.9	14.5	11.9	29.4	34.0	13.9	23.3	21.4	27.5	38.8	14.9	21.2	23.8	20.1	20.9	42.3	18.9	28.0	21.6	24.9	26.5	34.5	46.3	35.0	27.4	22.6	24.7	30.1	33.6	18.9	12.2	15.5	23.5	23.2	17.3	23.4	14.7	37.9	27.5	19.1	20.0	14.6	24.1	13.1	18.3	13.6	17.5	13.9	14.1	12.9	13.9	16.4	14.5	13.4	13.5	18.8	19.3	14.0	8.3	15.1	11.7	11.5	13.1	21.6	16.3	12.8	10.8	9.6	7.9	10.0	7.6	10.9	14.4	21.5	83.3	62.5	53.5	26.0	26.0	21.8	47.1	27.3	48.7	20.3	24.0	25.9	11.5	66.1	12.9	39.6	40.3	27.3	21.7	45.0	31.6	34.0	47.9	17.6	23.8	22.9	46.5	88.4	17.2	48.2	27.7	14.3	26.1	45.5	28.3	19.2	17.1	23.8	53.8	91.4	18.9	28.5	18.8	20.7	15.7	22.4	19.7	21.4	34.7	22.0	33.8	24.7	69.9	71.3	18.3	15.4	21.4	12.8	24.4	23.2	55.4	85.8	37.5	32.9	23.2	31.5	61.2	26.8	22.6	24.9	32.7	25.6	16.9	21.8	20.6
ORC5	"ORC5L, Orc5p, ORC5T, PPP1R117"	ENSG00000164815	"Origin recognition complex subunit 5"	O43913	7	104126341-104208047	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 54.4;Inhibitory neurons: 48.8;Oligodendrocytes: 55.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019730	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA019730: AB_10696205"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.72e-2)"	"unprognostic (4.77e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.47e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.83e-2)"	"unprognostic (6.52e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.53e-2)"	"unprognostic (7.73e-2)"	9.7	9.8	10.5	7.8	11.5	5.8	13.2	14.3	12.5	10.2	7.8	12.0	8.4	10.8	13.7	10.6	8.9	6.6	6.3	11.2	10.5	10.4	17.4	6.4	12.2	10.3	10.0	10.7	14.5	10.1	7.5	9.5	9.7	16.9	12.8	14.1	8.9	10.6	9.0	11.6	7.5	10.9	9.3	9.0	10.3	19.3	11.6	13.3	10.2	7.9	13.4	11.0	10.0	11.2	37.1	39.2	21.2	38.1	21.8	21.5	18.8	31.0	30.8	34.2	28.5	25.9	23.7	55.4	26.9	19.5	37.9	33.1	42.4	29.9	40.8	32.3	30.5	20.2	19.1	24.8	30.8	37.9	16.5	22.3	27.9	39.4	36.2	14.4	32.8	30.1	65.0	29.3	30.8	52.6	52.4	38.7	23.2	48.6	37.9	21.6	38.0	53.4	26.4	26.4	28.9	23.5	30.2	58.7	41.3	16.5	19.7	28.4	19.2	32.8	36.0	51.8	41.6	33.7	75.8	69.3	22.2	49.7	39.8	14.2	10.6	8.4	20.2	12.7	26.5	24.0	21.6	23.9	12.3	18.7	25.7	28.9	1.4	20.6	10.9	11.4	18.4	13.7	10.5	11.5	14.3	12.5	11.2	10.5	10.3	10.0	9.7	9.3	11.6	11.2	6.7	3.2	7.2	22.2	11.2	4.5	3.6	11.4	10.8	6.6	6.6	5.7	6.2	8.6	9.8	3.7	0.0	22.1	2.6	4.4	1.9	10.3	5.7	3.8	9.8	9.1	5.4	12.8	54.4	9.0	14.3	8.6	9.7	4.5	5.1	11.6	4.6	9.7	8.8	3.3	48.8	8.9	6.1	4.8	4.2	5.7	6.2	6.0	1.8	35.6	7.8	3.4	7.2	31.2	55.9	7.4	5.4	7.9	13.9	4.9	5.9	7.2	12.9	12.5	0.0	4.1	10.9	40.1	24.6	12.6	8.5	10.5	9.5	10.3	8.1	2.0
OSBPL11	"FLJ13012, FLJ13164, ORP-11, ORP11"	ENSG00000144909	"Oxysterol binding protein like 11"	Q9BXB4	3	125528858-125595497	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 57.3;tongue: 80.1"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 74.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039144			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Golgi apparatus"		"HPA039144: AB_10794086"	"unprognostic (1.14e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.57e-3)"	"unprognostic (9.73e-3)"	"unprognostic (6.38e-2)"	"unprognostic (6.56e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.25e-2)"	"unprognostic (9.84e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.13e-1)"	10.0	5.4	11.6	10.9	13.3	7.0	6.0	8.6	10.5	6.3	4.4	8.2	6.8	7.6	5.6	8.4	5.7	6.5	6.6	9.1	15.2	8.5	28.9	14.0	13.1	11.0	14.1	5.5	3.7	13.3	3.9	10.9	12.6	5.6	8.1	6.0	4.2	7.7	57.3	7.5	6.2	8.8	9.9	15.4	5.2	10.3	12.3	12.4	7.4	80.1	12.2	8.4	4.9	12.3	21.2	10.9	20.4	11.7	22.4	12.0	27.5	15.6	11.9	18.7	21.3	21.3	7.2	34.2	19.2	12.5	15.5	15.5	22.7	13.3	24.7	9.6	10.2	15.6	12.5	14.0	12.6	11.9	20.8	9.7	15.8	15.6	13.6	7.5	13.8	16.2	16.5	15.0	17.1	12.2	24.4	5.8	28.8	15.1	10.0	21.1	11.8	40.4	15.5	12.6	4.6	12.4	18.9	10.6	16.3	13.9	11.2	6.1	14.8	15.2	13.9	22.4	12.2	9.8	11.1	41.5	10.7	4.1	14.9	16.5	12.3	3.1	2.1	12.1	1.8	4.3	1.3	2.2	14.9	3.3	1.4	1.6	18.2	2.5	10.1	6.2	2.9	4.5	11.6	13.3	8.6	10.5	9.1	15.2	11.0	14.1	12.6	9.9	12.3	12.3	14.4	9.6	14.4	33.3	16.0	9.9	7.3	3.9	10.8	18.7	12.1	11.6	9.4	7.2	9.9	9.2	12.5	12.4	22.8	29.1	5.9	8.5	1.3	34.5	13.7	9.7	4.2	9.4	14.8	6.9	10.3	9.4	6.6	24.3	3.8	10.6	10.8	37.6	26.6	8.4	18.6	6.0	0.0	74.0	27.5	4.0	6.5	40.3	12.4	38.4	48.6	12.2	13.4	15.1	18.1	11.4	21.3	7.2	10.5	7.8	10.7	9.7	8.9	33.8	6.6	18.0	10.5	13.0	18.6	9.2	15.8	23.1	11.1	5.3	9.5	10.4
OSBPL9		ENSG00000117859	"Oxysterol binding protein like 9"	Q96SU4	1	51577179-51798427	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 216.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027378, HPA027397"	Supported	Approved	Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	Vesicles	"HPA027378: AB_1854816, HPA027397: AB_1854817"	"unprognostic (5.99e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.11e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.58e-1)"	"unprognostic (8.36e-3)"	"unprognostic (8.61e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.95e-2)"	"unprognostic (3.37e-1)"	27.5	38.1	17.9	18.1	23.8	30.1	32.6	26.3	23.5	25.5	28.3	20.8	17.4	31.1	31.0	17.7	23.3	17.6	37.0	17.6	23.9	42.8	60.8	27.5	25.9	25.0	21.8	30.5	33.3	60.0	21.1	21.8	26.6	27.8	19.1	53.5	22.0	22.4	70.0	19.6	21.7	24.2	23.0	27.2	34.3	28.4	22.2	21.8	24.7	35.2	33.0	23.7	24.7	32.2	66.3	31.7	69.0	11.2	38.1	17.9	90.7	30.1	50.8	54.9	60.0	53.0	46.6	105.8	54.4	34.1	120.9	26.9	59.2	57.4	76.9	71.9	41.9	77.4	62.7	104.7	36.9	81.7	35.5	44.7	55.0	56.8	31.4	66.8	68.9	52.1	154.4	31.1	26.7	45.4	20.3	92.5	97.0	26.8	15.1	58.2	102.8	110.5	74.0	47.4	31.8	45.2	22.4	79.6	93.7	154.7	38.0	82.8	22.9	11.6	51.2	17.2	58.1	80.2	52.5	120.4	39.3	32.8	23.0	52.7	12.2	30.5	20.1	9.9	28.9	32.6	19.7	20.8	25.0	23.9	21.0	22.2	16.9	16.3	9.4	23.2	20.5	16.4	17.9	23.8	26.3	23.5	17.6	23.9	25.0	21.8	26.6	23.0	22.2	32.2	32.5	80.1	56.8	75.4	39.2	17.7	33.8	25.7	34.1	102.0	34.2	33.0	47.9	38.6	50.5	46.0	41.7	89.2	30.4	20.5	125.2	47.6	40.7	36.3	46.3	30.1	29.8	35.7	64.8	47.8	50.2	48.6	54.0	52.9	33.6	75.7	18.2	61.7	40.1	26.9	113.0	18.3	38.7	22.7	16.0	38.3	62.4	25.3	65.8	63.7	50.1	43.8	29.9	62.8	216.4	41.9	14.3	50.0	81.4	38.5	26.4	59.7	32.1	35.3	46.0	36.9	62.9	32.3	18.9	26.9	18.9	75.5	32.0	52.2	21.2	27.4
OXSM	"CEM1, FASN2D, FLJ20604, KS"	ENSG00000151093	"3-oxoacyl-ACP synthase, mitochondrial"	Q9NWU1	3	25782917-25794534	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 59.5;Spermatocytes: 48.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021293, HPA021300, HPA021337"	Enhanced		Approved	Mitochondria,Cytosol		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Mitochondria, Cytosol"		"HPA021293: AB_1848772, HPA021300: AB_1848774, HPA021337: AB_1848776"	"unprognostic (2.20e-2)"	"unprognostic (3.28e-1)"	"prognostic favorable (1.35e-4)"	"prognostic favorable (5.51e-4)"	"unprognostic (1.01e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (4.18e-9)"	"unprognostic (1.79e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.73e-2)"	6.1	11.0	3.1	5.5	3.4	4.0	9.3	3.5	4.6	4.9	5.3	11.1	9.4	4.6	13.9	8.5	6.8	3.9	12.9	3.3	3.6	13.7	22.0	4.9	7.9	3.3	3.3	4.9	10.5	10.0	5.8	5.9	3.4	5.9	12.3	10.2	10.1	5.9	14.6	7.7	7.8	5.2	3.5	7.9	8.2	11.7	3.5	7.1	8.6	15.6	8.8	5.5	5.3	3.4	11.0	18.1	3.8	10.5	10.7	11.6	10.9	8.6	12.4	15.8	11.2	13.8	12.9	20.4	11.5	8.0	9.2	11.3	15.7	16.6	14.9	12.3	16.0	22.5	15.2	16.9	13.1	18.4	13.7	11.0	20.4	12.7	13.3	10.3	13.8	18.9	23.5	16.0	13.7	16.6	13.6	14.4	0.7	8.8	20.6	17.8	9.9	33.7	23.3	6.8	5.4	9.7	13.8	23.6	18.3	6.0	25.5	16.9	8.5	10.0	11.9	13.1	12.7	15.1	18.8	6.6	13.9	16.0	10.4	2.1	5.1	3.7	8.6	6.0	10.1	7.9	8.8	10.8	8.4	8.9	10.2	10.7	0.8	11.4	6.8	8.8	6.0	6.3	3.1	3.4	3.5	4.6	3.3	3.6	3.3	3.3	3.4	3.5	3.5	3.4	5.9	0.0	9.4	3.9	9.3	3.1	5.9	23.0	4.0	6.5	8.7	13.2	13.3	10.0	12.0	11.0	4.2	19.5	7.1	5.4	11.7	13.5	59.5	7.8	7.2	4.9	2.4	2.1	4.5	6.8	16.9	5.9	4.6	6.4	10.1	13.0	7.5	17.4	8.5	5.0	5.1	9.8	14.2	3.8	3.2	15.1	7.2	6.8	5.4	1.0	5.2	9.1	6.2	3.5	3.8	7.5	8.9	4.1	7.8	6.5	10.6	18.4	9.2	7.4	0.0	5.3	5.8	48.0	12.6	7.2	4.4	14.1	5.9	19.2	8.8	3.6
PA2G4		ENSG00000170515	"Proliferation-associated 2G4"	Q9UQ80	12	56104537-56113910	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation, Translation regulation"	"Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB011711, CAB012428, HPA016484"	Supported		Approved	Cytosol		NA	NA		2300000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"CAB011711: AB_732060, CAB012428: , HPA016484: AB_1854912"	"unprognostic (5.53e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.87e-1)"	"unprognostic (6.03e-3)"	"prognostic unfavorable (6.31e-7)"	"unprognostic (4.25e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (4.59e-7)"	"unprognostic (1.17e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.67e-2)"	78.4	59.6	46.7	89.3	50.4	132.9	76.2	50.7	58.0	64.8	43.0	78.7	74.1	64.7	48.2	132.5	64.7	43.7	76.9	48.6	51.8	62.1	72.8	62.5	96.6	49.4	48.3	71.2	75.1	83.7	36.3	69.2	51.0	53.2	90.5	38.3	63.9	55.4	144.0	106.1	69.7	68.4	49.8	61.2	65.5	63.1	48.9	123.4	61.4	92.5	120.7	105.3	76.9	57.2	429.6	374.8	248.9	275.5	112.5	169.8	499.6	441.3	209.7	530.9	293.8	464.7	307.5	850.8	291.2	209.6	155.9	343.5	574.2	493.1	510.9	243.9	517.6	659.1	242.5	400.4	219.7	898.8	232.4	172.5	247.2	460.2	410.8	218.1	327.3	292.0	812.8	380.7	294.7	383.5	700.8	496.2	410.9	264.5	460.9	569.3	449.8	577.2	272.0	315.7	372.8	225.6	290.5	451.6	275.0	183.1	488.7	343.5	264.8	256.3	364.7	300.3	495.5	234.4	345.1	822.1	232.3	532.6	340.9	34.3	87.0	54.6	129.9	96.0	174.7	98.0	136.8	141.3	102.1	81.3	129.7	131.2	13.8	151.5	82.0	98.6	170.9	155.9	46.7	50.4	50.7	58.0	48.6	51.8	49.4	48.3	51.0	49.8	48.9	57.2	135.7	54.5	91.2	9.8	136.3	368.5	244.7	187.4	224.8	56.2	151.9	165.7	37.3	118.7	161.3	130.6	18.8	232.0	163.1	123.4	193.7	235.8	530.6	127.1	218.4	154.2	93.3	552.1	12.8	249.1	321.7	139.5	112.7	142.2	170.9	103.7	107.8	197.5	208.6	33.7	13.0	159.0	99.7	124.2	127.8	238.9	132.0	126.2	129.9	6.5	155.4	117.1	178.2	10.6	14.8	269.3	100.8	126.7	163.5	360.7	118.6	264.7	103.6	48.8	144.7	188.1	191.7	344.6	110.9	295.2	362.7	193.5	176.2	132.2	254.1	242.7
PABPN1	"OPMD, PAB2, PABP2"	ENSG00000100836	"Poly(A) binding protein nuclear 1"	Q86U42	14	23321289-23326185	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"							HPA000637	Supported		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	"Nuclear speckles"	"HPA000637: AB_1079553"	"unprognostic (5.11e-3)"	"unprognostic (2.65e-2)"	"unprognostic (7.20e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.95e-3)"	"prognostic favorable (9.66e-4)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (2.41e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.25e-3)"	133.2	178.7	187.0	86.4	183.9	136.9	127.7	193.4	249.3	165.6	184.5	184.1	107.6	176.0	130.3	151.0	175.6	63.4	138.1	185.8	196.6	187.7	194.8	130.0	103.9	186.0	182.2	176.3	138.8	101.0	199.0	79.7	181.6	179.4	101.5	126.6	130.4	85.8	131.5	136.9	167.8	97.4	175.6	174.3	159.3	230.1	186.3	147.6	189.8	94.1	116.5	146.3	144.0	190.4	127.2	133.9	298.3	216.6	125.5	143.1	191.4	120.4	121.6	168.4	157.4	168.0	223.0	229.7	67.0	157.0	180.6	186.4	337.7	169.7	230.7	195.2	116.7	173.5	208.1	435.5	145.2	273.5	220.2	157.1	164.7	125.0	149.1	240.9	188.1	196.0	164.5	174.6	159.8	239.6	296.1	334.5	328.6	151.2	149.3	289.1	114.8	136.2	196.1	256.2	205.6	159.9	161.4	143.2	129.6	196.9	114.2	196.3	153.2	112.1	153.8	110.4	161.8	207.3	153.0	276.5	51.4	221.4	138.7	15.7	7.6	8.5	6.0	5.8	4.9	7.4	6.1	5.5	6.1	9.3	7.5	7.0	10.0	10.1	7.2	13.8	7.6	2.5	187.0	183.9	193.4	249.3	185.8	196.6	186.0	182.2	181.6	175.6	186.3	190.4	66.3	35.3	49.4	0.0	83.3	157.8	84.4	74.0	158.2	120.1	110.2	89.5	14.3	77.2	51.2	126.9	146.0	70.0	102.5	85.5	13.7	52.6	55.6	71.8	80.8	75.0	161.4	94.2	0.0	57.2	67.4	72.4	68.8	78.6	24.1	169.3	66.0	121.6	63.2	77.4	0.0	107.2	54.9	84.7	119.0	45.9	81.1	85.5	53.4	0.0	104.4	55.8	65.9	0.0	0.0	59.2	91.6	59.8	102.2	88.7	88.9	40.3	49.8	80.2	72.3	57.5	85.0	41.8	33.3	187.4	179.9	62.8	67.3	107.6	108.1	114.6
PAFAH1B1	"LIS1, MDCR, MDS, NudF, PAFAH"	ENSG00000007168	"Platelet activating factor acetylhydrolase 1b regulatory subunit 1"	P43034	17	2593210-2685615	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Lipid degradation, Lipid metabolism, Mitosis, Neurogenesis, Transport"	"Developmental protein"	"Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 640.0;Late spermatids: 1864.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004489, HPA020036"	Approved		Supported	Centrosome		NA	NA		860000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Centrosome		"CAB004489: AB_627889, HPA020036: AB_1854925"	"unprognostic (1.54e-3)"	"unprognostic (6.84e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.19e-3)"	"unprognostic (3.17e-2)"	"unprognostic (6.36e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.89e-3)"	"unprognostic (5.80e-2)"	"prognostic favorable (3.16e-4)"	"unprognostic (3.31e-1)"	"unprognostic (3.51e-1)"	"unprognostic (7.45e-2)"	"unprognostic (5.58e-2)"	34.8	32.2	35.5	27.2	43.1	4.0	32.6	31.5	46.5	38.3	6.7	46.4	30.5	43.9	26.9	38.0	36.7	31.8	51.1	46.2	47.4	41.4	30.0	37.3	30.9	41.3	38.4	35.4	26.3	56.4	38.4	32.4	48.1	32.6	32.8	47.2	32.4	38.6	87.7	42.1	36.5	44.4	30.2	31.0	34.6	55.7	36.7	41.5	43.9	73.2	38.8	35.7	37.8	38.0	51.3	53.3	81.8	28.4	66.9	74.1	27.3	76.5	67.1	56.3	53.0	69.7	18.7	64.5	63.5	100.3	27.4	53.5	74.4	59.8	80.6	50.9	48.4	56.4	48.8	27.3	69.3	37.5	66.4	68.8	73.5	58.8	58.1	71.7	58.1	51.8	38.8	32.7	84.8	21.1	58.3	28.6	36.7	30.5	27.0	39.5	67.6	30.0	62.5	30.5	37.4	62.0	63.0	34.5	65.5	51.8	36.5	30.1	84.9	71.5	17.1	57.1	61.0	24.7	32.1	28.8	60.4	33.7	66.2	2.6	1.7	3.4	4.7	2.5	5.2	2.9	4.1	3.3	2.5	2.4	4.9	3.8	2.6	3.6	3.8	1.5	5.1	2.4	35.5	43.1	31.5	46.5	46.2	47.4	41.3	38.4	48.1	30.2	36.7	38.0	73.7	121.8	92.2	90.8	82.7	118.7	114.8	74.3	63.2	102.4	52.1	42.9	136.3	30.0	101.6	35.0	50.1	56.4	117.2	77.4	35.2	77.2	640.0	82.2	95.5	77.2	34.1	45.9	178.1	56.3	76.7	74.7	87.7	100.9	93.7	45.1	43.2	32.3	60.2	102.6	161.8	43.7	57.0	46.3	77.0	1864.4	64.0	77.6	56.9	104.9	90.3	60.7	97.9	115.1	193.5	100.8	61.5	56.8	91.7	91.6	76.9	55.0	80.7	65.8	46.0	84.5	133.0	256.8	78.1	69.7	132.6	129.6	92.7	54.7	39.2	122.4
PAICS	"ADE2H1, AIRC, PAIS"	ENSG00000128050	"Phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase"	P22234	4	56435741-56464578	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Decarboxylase, Ligase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 157.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035895, HPA041538"	Approved		Approved	Cytosol		Yes	No		490000	"Cluster 30: Non-specific - Translation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA035895: AB_10669660, HPA041538: AB_2677540"	"unprognostic (2.59e-3)"	"unprognostic (7.90e-3)"	"unprognostic (3.84e-3)"	"unprognostic (2.88e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.82e-3)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (8.07e-3)"	"unprognostic (1.23e-2)"	"prognostic favorable (8.44e-4)"	"unprognostic (1.48e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (5.85e-5)"	"unprognostic (7.11e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (2.16e-1)"	24.5	40.2	22.7	40.1	26.7	46.8	54.6	28.3	25.0	29.3	21.6	42.8	32.1	29.7	22.1	36.3	35.4	17.8	19.7	20.3	27.8	42.7	109.7	14.1	51.3	26.0	30.1	30.7	21.7	39.5	17.7	45.9	26.1	31.0	54.7	30.4	26.4	25.8	32.4	37.6	30.8	35.7	25.6	18.3	20.7	29.5	26.8	56.4	32.4	24.1	64.5	37.4	25.4	27.2	239.3	175.3	354.3	220.6	74.3	166.1	304.0	201.7	145.1	282.5	276.0	280.5	275.7	548.0	228.3	136.0	154.1	143.6	565.5	293.0	480.8	110.4	198.8	298.7	259.5	313.4	141.8	537.1	127.6	141.9	207.9	301.0	225.0	155.7	235.4	308.6	524.7	198.5	246.8	159.3	621.5	267.2	407.5	454.8	216.5	496.2	151.7	361.5	268.4	164.5	378.8	226.4	198.6	273.7	124.3	287.2	181.2	169.8	127.7	222.6	290.1	221.8	419.0	139.1	128.2	571.1	234.8	385.2	251.0	6.0	5.2	0.4	5.2	8.7	15.0	17.8	14.4	9.2	15.3	11.0	17.4	15.5	1.1	15.9	6.9	17.0	11.2	8.7	22.7	26.7	28.3	25.0	20.3	27.8	26.0	30.1	26.1	25.6	26.8	27.2	16.4	22.4	22.9	17.0	35.7	56.6	71.9	66.0	54.1	27.4	35.8	37.5	23.3	50.1	32.3	33.1	6.2	134.4	15.3	20.5	37.2	45.0	69.4	15.2	49.1	25.1	24.7	80.8	9.1	26.3	157.5	34.2	15.3	23.3	21.0	69.1	13.2	78.7	51.5	28.6	14.6	41.0	34.6	16.1	17.2	10.6	29.8	16.1	17.8	6.5	20.2	14.0	6.2	13.0	12.2	27.4	18.6	23.3	48.1	81.7	15.9	47.7	17.9	24.6	0.0	31.3	29.2	40.0	50.3	53.1	50.4	54.6	16.8	66.4	69.7	48.9
PAK1IP1	"bA421M1.5, FLJ20624, hPIP1, MAK11, PIP1, WDR84"	ENSG00000111845	"PAK1 interacting protein 1"	Q9NWT1	6	10694972-10709782	"Predicted intracellular proteins"	"Ribosome biogenesis"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030111, HPA030112"	Supported		Supported	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli		"HPA030111: AB_2732454, HPA030112: AB_10603125"	"unprognostic (9.41e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (1.35e-6)"	"unprognostic (7.23e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (7.02e-8)"	"unprognostic (8.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.10e-1)"	13.5	10.3	5.6	7.6	5.7	10.6	12.4	5.7	8.1	9.3	5.5	8.4	4.2	10.3	7.2	16.3	8.4	5.2	9.6	5.7	6.2	9.3	11.3	7.3	7.8	5.7	6.0	8.0	9.6	5.7	6.7	7.0	5.9	37.8	7.3	4.9	9.2	5.7	15.2	8.8	7.1	8.1	5.8	8.2	7.8	5.7	5.9	7.0	7.5	9.7	9.6	11.5	9.9	6.9	35.3	13.7	17.2	29.9	21.3	19.4	24.9	22.4	18.7	33.7	32.9	30.2	15.4	35.6	54.9	19.4	41.4	18.4	35.8	29.2	48.1	20.9	23.3	19.4	12.4	35.2	31.1	54.5	24.3	17.9	25.2	32.6	55.3	11.1	22.9	19.2	60.2	10.0	28.3	21.2	27.4	49.5	37.4	32.7	24.1	27.9	22.4	55.0	24.4	21.0	25.7	22.4	16.8	42.7	51.1	28.9	18.9	19.6	19.6	26.9	19.5	29.2	56.4	23.3	68.7	38.9	11.0	36.3	51.7	2.0	8.1	2.9	9.4	12.4	9.6	10.0	8.3	9.4	11.7	7.2	11.1	13.5	0.4	9.9	10.3	13.7	5.9	6.8	5.6	5.7	5.7	8.1	5.7	6.2	5.7	6.0	5.9	5.8	5.9	6.9	22.6	19.2	12.3	8.8	18.5	66.4	54.2	47.3	30.1	13.2	18.6	28.3	18.6	17.2	35.0	11.0	4.2	24.9	24.8	10.3	19.6	43.3	12.4	26.0	35.0	24.1	5.4	31.1	9.9	26.9	32.0	32.0	14.8	34.3	35.5	16.6	15.0	21.7	36.6	13.5	10.9	12.7	42.7	16.1	12.6	8.4	21.5	18.2	12.4	6.5	22.1	12.0	12.3	9.5	12.5	31.3	7.7	20.7	18.2	56.5	5.1	27.0	17.7	11.8	6.6	40.9	31.4	27.3	44.2	29.3	49.9	17.5	16.3	23.1	24.0	28.6
PAK2	"PAK65, PAKgamma"	ENSG00000180370	"P21 (RAC1) activated kinase 2"	Q13177	3	196739857-196832647	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Growth regulation, Host-virus interaction"	"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB007794	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		1700000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Vesicles"		"CAB007794: AB_562363"	"unprognostic (1.03e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.18e-3)"	"unprognostic (1.85e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.36e-4)"	"prognostic unfavorable (9.58e-4)"	"unprognostic (1.30e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.39e-1)"	31.8	18.1	21.2	34.6	24.9	28.1	19.5	25.0	21.7	21.1	19.8	25.6	23.0	21.9	16.0	26.5	20.5	23.8	24.0	19.5	24.6	22.1	33.8	26.3	40.9	26.7	23.4	19.8	18.5	32.6	8.4	33.3	27.7	20.1	26.6	17.4	14.5	18.9	28.3	16.6	22.5	27.0	24.8	43.5	20.9	15.1	23.0	45.1	19.7	25.9	39.4	34.1	16.0	34.1	140.7	49.1	67.6	49.8	47.1	61.9	100.0	69.1	57.0	73.7	66.8	117.5	70.1	89.4	192.7	70.8	75.1	70.2	72.5	66.2	113.6	39.9	35.2	132.2	52.1	92.5	95.0	130.2	122.0	49.6	53.1	66.2	139.2	78.1	74.3	97.3	65.0	107.5	72.9	146.7	124.8	67.2	40.5	74.7	73.4	112.4	38.6	80.9	64.8	96.7	39.6	44.7	92.8	64.7	52.7	51.9	227.0	92.6	76.9	60.9	33.6	64.3	103.1	72.5	138.9	216.4	50.4	127.6	59.1	37.3	20.0	48.0	10.9	23.2	14.7	11.2	12.7	12.6	25.4	11.3	9.1	10.9	47.6	12.2	21.2	9.3	20.7	14.9	21.2	24.9	25.0	21.7	19.5	24.6	26.7	23.4	27.7	24.8	23.0	34.1	164.9	80.1	40.2	37.9	142.8	97.4	89.2	41.8	96.2	42.6	59.7	47.5	59.3	62.9	45.1	82.8	52.1	50.3	135.1	69.6	33.2	71.5	57.1	107.9	112.6	104.0	44.9	72.3	32.2	59.0	101.4	68.9	58.1	96.1	148.8	70.9	66.0	138.6	104.3	55.5	38.9	46.4	57.0	160.5	115.9	75.5	60.9	169.6	33.8	46.9	183.2	63.7	140.1	37.2	61.3	100.4	52.1	45.5	100.0	149.4	58.2	85.2	76.4	45.0	39.5	86.0	75.9	24.5	43.0	103.2	86.2	34.9	139.1	96.3	51.0	124.1
PALB2	"FANCN, FLJ21816"	ENSG00000083093	"Partner and localizer of BRCA2"	Q86YC2	16	23603160-23641310	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Fanconi anemia, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 30.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB014895, HPA057000"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"CAB014895: , HPA057000: AB_2683307"	"unprognostic (1.11e-1)"	"unprognostic (5.67e-3)"	"prognostic favorable (2.83e-5)"	"unprognostic (1.43e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.00e-3)"	"unprognostic (5.18e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (2.35e-5)"	"unprognostic (2.05e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.21e-1)"	5.8	5.6	6.2	4.4	6.5	3.5	6.4	9.8	10.7	7.1	6.2	6.1	6.5	5.6	5.6	10.1	5.4	3.3	4.7	6.2	6.1	7.9	9.9	4.8	6.3	6.0	6.2	6.2	6.0	5.8	5.1	3.8	6.2	5.3	5.3	8.6	6.0	4.0	5.4	9.0	7.0	4.0	5.7	7.8	5.7	9.8	6.6	6.4	5.3	4.8	6.9	6.6	7.2	7.0	17.3	13.1	15.4	10.8	12.6	9.4	13.9	12.0	18.4	19.7	23.6	11.2	17.3	18.2	8.7	8.6	15.0	15.2	13.9	19.8	23.4	10.8	8.1	11.2	18.2	31.8	11.7	20.5	17.3	11.2	20.3	18.7	20.7	10.9	10.6	17.1	23.4	9.4	17.2	17.4	21.2	21.3	34.3	12.5	7.6	24.2	18.9	24.7	15.2	15.2	11.2	11.3	12.5	13.5	16.7	13.4	12.9	13.9	7.7	23.1	8.7	11.2	13.2	11.2	19.0	18.3	15.4	14.8	14.3	6.4	1.8	1.8	2.1	2.3	2.6	1.8	2.4	2.7	2.0	1.4	2.6	2.1	0.1	2.1	4.5	1.5	1.7	1.1	6.2	6.5	9.8	10.7	6.2	6.1	6.0	6.2	6.2	5.7	6.6	7.0	4.7	12.8	4.2	8.5	5.1	0.9	3.5	5.4	2.2	4.8	4.0	3.7	4.8	2.8	8.2	3.7	4.2	2.9	3.8	2.4	3.9	5.8	6.8	2.3	5.1	4.8	1.2	4.6	7.4	5.0	2.0	4.4	4.1	2.6	5.1	7.7	3.3	4.7	3.7	1.7	8.0	3.4	2.0	5.0	1.5	3.6	4.7	5.1	1.8	5.6	8.4	4.8	5.2	7.1	5.9	8.6	2.5	6.4	4.2	5.3	4.6	5.4	8.3	7.5	6.6	4.7	3.0	30.0	17.7	5.4	2.7	1.2	3.7	6.9	4.8	4.1
PAPOLG	FLJ12972	ENSG00000115421	"Poly(A) polymerase gamma"	Q9BWT3	2	60756253-60802086	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017795, HPA035349, HPA035350"	Approved		Enhanced	Nucleoplasm		No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB017795: , HPA035349: AB_2674583, HPA035350: AB_2674584"	"unprognostic (1.83e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.39e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.72e-4)"	"unprognostic (2.49e-1)"	"unprognostic (6.97e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.62e-2)"	3.7	3.0	2.2	2.2	2.3	1.4	3.4	3.2	3.1	4.2	1.7	3.2	1.3	4.1	1.2	3.5	3.2	1.4	3.1	2.3	2.3	2.5	2.3	3.2	3.0	2.5	2.1	4.9	3.5	1.7	3.1	2.0	2.5	2.6	1.5	4.0	3.8	1.2	4.2	3.7	3.6	1.5	1.9	4.1	3.4	3.5	2.6	3.7	6.2	1.7	2.5	3.2	4.1	3.0	1.8	1.5	3.4	2.0	3.1	3.7	2.4	1.5	1.9	1.4	1.2	2.4	1.3	2.6	1.7	1.3	1.4	2.8	3.7	1.8	2.3	4.0	2.1	4.0	1.7	1.7	1.9	4.4	2.4	2.2	2.5	1.7	3.7	2.9	2.6	2.6	3.2	1.9	1.4	1.4	5.0	3.6	5.3	2.9	1.1	3.4	4.9	2.7	1.9	1.4	1.6	2.4	2.2	2.7	1.9	3.2	1.3	2.7	2.4	1.8	1.8	1.3	1.7	2.4	1.5	5.4	2.2	4.8	1.4	3.7	0.8	1.5	1.3	1.0	1.7	1.1	1.2	1.2	0.7	1.4	1.7	1.5	2.2	1.4	1.2	0.8	2.2	0.8	2.2	2.3	3.2	3.1	2.3	2.3	2.5	2.1	2.5	1.9	2.6	3.0	11.5	12.8	12.2	13.1	13.9	12.5	13.5	4.6	12.0	6.8	8.4	8.6	7.9	7.2	8.8	9.2	25.0	6.0	21.0	6.9	3.9	4.8	4.7	6.1	13.2	10.9	2.4	13.3	29.5	4.3	4.6	11.0	6.6	6.6	13.3	14.6	11.7	5.0	7.4	5.0	24.8	5.7	10.2	10.4	22.7	4.3	7.5	17.8	12.4	25.3	12.0	5.1	8.2	19.1	22.1	4.9	6.0	8.6	12.7	15.4	4.3	3.5	7.1	10.3	26.3	9.3	11.3	30.3	17.3	13.2	15.9	8.8	20.8	10.6	4.0	16.2
PARG		ENSG00000227345	"Poly(ADP-ribose) glycohydrolase"	Q86W56	10	49818279-49970203	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021819, HPA053007"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Vesicles, Cytosol"	"HPA021819: AB_1854974, HPA053007: AB_2682014"	"unprognostic (5.77e-3)"	"unprognostic (6.74e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.57e-5)"	"unprognostic (1.21e-1)"	"unprognostic (3.97e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.06e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.13e-1)"	5.3	6.5	3.7	6.2	3.8	3.2	7.1	7.5	4.8	6.1	1.4	7.3	8.8	6.1	4.7	7.0	5.8	5.4	8.5	4.0	4.3	12.7	6.9	5.2	9.1	3.6	3.2	5.4	4.0	8.9	4.3	7.7	4.0	6.7	7.8	5.8	5.3	6.3	12.0	7.3	7.0	6.3	3.0	6.9	6.4	7.8	3.7	9.1	6.7	9.0	9.0	6.2	5.2	4.3	15.3	9.5	20.0	17.8	11.2	13.6	14.9	13.6	17.2	17.0	16.1	9.8	15.2	10.5	10.7	13.3	7.8	17.7	17.3	10.2	19.8	15.5	16.6	11.6	7.7	13.2	13.8	16.5	8.9	8.4	21.0	12.3	22.4	13.4	10.6	14.0	18.8	11.1	14.9	9.2	18.0	20.0	22.4	10.5	26.8	21.1	20.7	13.9	16.1	8.4	16.0	19.7	10.6	21.6	17.1	21.2	23.8	10.9	10.0	11.5	12.4	11.8	15.9	10.4	16.2	21.9	18.9	18.8	8.8	6.1	2.5	1.4	2.3	2.2	3.2	3.0	3.0	2.8	2.7	2.9	3.7	3.5	1.3	3.9	3.5	2.9	2.8	2.3	3.7	3.8	7.5	4.8	4.0	4.3	3.6	3.2	4.0	3.0	3.7	4.3	8.2	9.6	15.3	22.2	12.2	6.1	5.2	4.3	12.0	13.9	9.5	7.4	28.6	14.3	9.2	12.9	27.1	7.7	8.9	10.4	9.8	7.3	6.1	17.7	14.8	11.1	6.6	12.8	42.5	6.5	6.2	12.0	11.2	11.8	14.5	17.0	6.8	13.6	9.7	5.0	37.9	10.0	2.0	12.0	4.3	4.6	7.5	11.6	3.6	35.6	12.4	7.3	24.7	26.7	41.4	8.1	3.7	8.2	9.9	5.3	8.7	40.3	21.5	20.7	0.0	11.3	12.0	17.1	13.3	13.8	6.0	4.7	12.0	20.0	11.2	4.4
PARK7	"DJ-1, DJ1, GATD2"	ENSG00000116288	"Parkinsonism associated deglycase"	Q99497	1	7954291-7985505	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, DNA damage, DNA repair, Fertilization, Inflammatory response, Stress response"	"Chaperone, Hydrolase, Protease, RNA-binding"	"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004190, CAB005870"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		35000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"CAB005870: AB_444361, HPA004190: AB_1079566"	"unprognostic (6.88e-3)"	"unprognostic (7.50e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.68e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.96e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.43e-2)"	249.4	373.6	283.5	213.7	290.0	205.0	235.7	292.9	403.4	201.1	327.7	252.5	145.8	212.2	278.0	161.0	203.2	162.9	388.0	285.5	296.6	311.0	397.6	181.6	269.2	289.6	286.0	234.2	308.5	387.6	283.6	174.1	291.7	234.9	194.9	273.8	240.9	185.6	771.4	127.1	170.5	199.1	295.2	188.2	234.2	139.6	288.1	217.9	286.3	541.8	249.7	226.5	171.2	299.7	537.0	452.5	467.1	523.2	459.8	442.6	218.4	476.7	434.4	450.4	360.3	419.9	549.4	633.1	534.2	505.1	328.6	367.1	483.2	625.3	579.3	574.5	526.2	683.0	678.6	674.5	403.8	662.9	418.6	421.3	262.4	459.8	547.4	359.2	478.2	340.1	676.8	471.7	633.0	485.0	474.3	868.7	376.1	653.6	465.4	366.7	598.0	888.7	714.7	269.7	527.7	447.4	470.4	728.0	798.4	370.1	414.9	503.7	459.3	412.8	344.6	395.5	539.5	452.8	788.4	938.8	551.5	1002.9	606.4	298.4	590.2	394.0	484.7	553.7	459.2	483.6	478.2	577.3	717.4	374.6	406.8	466.8	202.5	551.1	456.9	1378.2	874.4	1060.8	283.5	290.0	292.9	403.4	285.5	296.6	289.6	286.0	291.7	295.2	288.1	299.7	243.6	131.4	157.1	23.2	211.8	208.9	402.4	677.7	200.9	196.2	342.0	381.8	453.3	257.4	318.5	248.3	79.2	553.0	382.3	131.1	851.0	504.3	32.1	272.1	263.9	241.7	238.0	177.1	19.5	478.4	612.1	302.3	146.3	195.9	206.5	291.2	183.1	368.1	435.1	186.7	22.9	279.6	484.2	204.5	304.5	53.6	358.2	258.9	359.3	21.5	605.4	816.4	327.5	18.1	36.0	378.9	186.9	378.7	269.7	523.4	227.1	941.5	327.8	235.5	276.1	277.8	342.6	288.2	302.2	220.4	143.8	469.6	244.4	535.3	312.2	433.1
PARL	"PRO2207, PSARL, PSARL1, RHBDS1"	ENSG00000175193	"Presenilin associated rhomboid like"	Q9H300	3	183829271-183884933	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA019545	Approved		Approved	Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA019545: AB_1855796"	"unprognostic (2.10e-1)"	"unprognostic (1.53e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.17e-2)"	"unprognostic (5.76e-2)"	"unprognostic (9.55e-2)"	"unprognostic (3.17e-3)"	"unprognostic (8.97e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.28e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.11e-5)"	38.4	35.8	46.5	26.6	48.2	33.8	40.3	47.4	66.2	33.8	50.7	47.7	29.2	31.9	57.7	36.7	30.2	19.7	54.1	46.6	48.2	39.6	45.0	28.4	32.0	47.7	48.7	31.7	49.9	39.7	32.0	25.5	47.4	37.1	41.9	32.7	40.5	30.3	54.9	37.1	34.7	29.7	47.2	36.2	42.6	26.7	47.6	34.5	31.4	51.6	33.8	38.9	31.5	48.4	115.1	55.6	39.7	33.0	38.8	42.1	80.2	39.2	59.4	80.5	65.0	172.0	59.0	47.8	90.0	56.7	73.5	49.2	64.1	68.0	90.0	71.6	76.1	73.9	35.5	96.9	57.3	73.9	61.6	60.0	85.4	58.0	70.7	38.5	59.0	82.4	42.6	45.0	69.2	131.0	148.3	194.3	105.5	100.6	53.3	64.7	72.8	92.0	79.0	97.6	37.9	52.0	47.6	162.9	107.8	48.1	159.2	143.5	31.8	29.3	63.0	60.9	108.2	89.2	65.7	116.0	56.6	75.1	35.5	97.5	143.1	133.4	51.3	107.8	60.9	62.4	57.3	59.9	132.4	59.1	68.7	54.2	41.3	67.1	83.3	79.7	73.7	116.1	46.5	48.2	47.4	66.2	46.6	48.2	47.7	48.7	47.4	47.2	47.6	48.4	30.3	22.4	19.7	17.9	37.6	30.3	54.9	93.5	26.7	35.9	31.8	31.5	41.2	35.8	44.5	31.3	31.3	58.9	38.4	24.4	117.4	63.9	24.0	15.2	18.3	30.2	33.7	23.3	23.4	84.7	49.0	35.1	28.1	13.7	69.8	33.1	33.2	30.4	77.7	33.7	24.1	42.0	77.3	56.2	55.7	9.7	28.9	57.5	42.7	33.7	79.3	55.9	50.4	17.1	28.0	60.3	35.1	27.1	42.3	55.4	47.3	86.0	30.5	51.1	6.6	44.8	96.6	47.8	47.4	40.2	30.0	42.1	40.9	49.0	49.2	58.8
PARN	DAN	ENSG00000140694	"Poly(A)-specific ribonuclease"	O95453	16	14435700-14632728	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	"Exonuclease, Hydrolase, Nuclease, RNA-binding"	"Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006314, CAB011673, HPA012010"	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"CAB011673: AB_778216, HPA006314: AB_1079567, HPA012010: AB_1854976"	"unprognostic (2.54e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (2.99e-3)"	"unprognostic (5.07e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.09e-2)"	16.6	20.2	10.8	13.9	12.1	9.2	15.9	11.7	11.4	17.2	12.0	19.3	11.8	19.1	24.7	15.6	16.0	13.4	14.8	10.6	14.0	12.7	16.4	14.2	21.2	11.7	11.9	16.4	16.5	21.1	16.3	15.6	11.9	16.1	16.8	7.0	15.3	17.1	16.8	17.9	16.1	18.0	11.3	15.7	16.2	18.1	12.6	21.6	20.6	9.7	23.4	19.3	16.0	13.5	28.0	39.9	17.6	22.9	32.9	33.2	20.3	24.4	32.4	29.8	28.3	21.9	28.7	56.2	63.1	32.3	25.3	30.4	46.7	32.3	41.0	42.9	29.4	28.8	24.2	53.2	35.5	46.0	36.2	32.5	38.5	32.0	43.1	25.5	22.5	32.6	28.5	29.9	32.5	44.9	36.7	33.1	26.0	28.2	16.7	56.2	36.1	57.1	23.1	17.1	18.7	16.9	53.4	29.6	36.3	28.6	31.6	28.0	21.2	31.5	15.8	16.4	26.9	32.5	31.0	63.5	34.6	30.8	35.8	8.9	8.0	15.8	8.6	13.2	7.7	16.0	10.4	12.4	13.6	9.4	14.2	14.4	6.2	15.0	15.6	8.3	19.1	7.1	10.8	12.1	11.7	11.4	10.6	14.0	11.7	11.9	11.9	11.3	12.6	13.5	18.0	32.1	39.1	37.9	26.2	7.1	7.8	9.7	21.6	13.0	13.4	14.0	22.3	7.2	11.8	11.0	8.4	29.2	24.7	13.6	11.7	14.2	14.1	15.2	20.5	15.2	14.9	20.4	48.0	12.9	23.2	19.5	21.9	21.7	2.5	19.2	11.7	15.6	14.8	8.4	48.2	14.3	6.1	14.2	5.8	6.3	21.1	18.2	10.6	54.4	35.8	10.3	52.5	38.2	72.4	15.2	10.6	17.7	23.0	7.1	12.2	10.8	19.2	10.8	19.7	13.1	15.0	70.5	70.5	20.0	8.2	22.4	21.5	20.1	13.4	4.8
PARP1	"ADPRT, ARTD1, PARP, PPOL"	ENSG00000143799	"Poly(ADP-ribose) polymerase 1"	P09874	1	226360210-226408154	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"DNA-binding, Glycosyltransferase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 469.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000147, CAB003839, CAB003840, HPA045168, CAB075726, CAB075727"	Supported	Supported	Enhanced	Nucleoplasm,Nucleoli		NA	NA		150000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Nucleoli	"CAB000147: AB_430876, CAB003839: AB_365493, CAB003840: AB_562187, CAB075726: AB_2665732, CAB075727: AB_2665733, HPA045168: AB_2679240"	"unprognostic (2.02e-1)"	"unprognostic (9.40e-2)"	"unprognostic (7.44e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.29e-1)"	"unprognostic (9.22e-2)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (2.20e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (2.38e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.64e-1)"	32.0	26.4	33.9	63.9	41.9	29.4	29.5	46.2	33.2	26.2	20.6	43.5	29.3	30.2	19.8	31.3	28.9	20.4	55.1	30.3	36.2	22.4	37.1	27.4	125.5	48.4	39.7	27.5	50.8	94.7	38.0	58.2	47.7	40.7	37.2	44.9	28.9	46.4	94.5	21.1	36.8	45.6	41.9	57.7	29.6	40.5	40.9	64.6	28.4	70.2	150.8	38.7	24.6	58.1	182.4	108.9	295.4	209.3	75.9	61.3	137.1	101.3	119.1	178.2	144.9	175.4	98.1	559.3	147.2	80.9	77.9	135.1	411.6	132.4	144.4	204.1	396.6	216.2	135.9	114.5	44.6	372.2	93.3	61.7	50.5	144.2	101.3	49.3	140.5	132.2	346.9	291.8	94.1	99.6	114.7	110.0	476.2	290.5	165.1	334.2	484.5	533.4	76.4	144.5	264.0	229.2	165.2	190.3	100.1	205.3	159.6	225.8	99.3	93.3	140.9	120.6	235.1	110.9	151.8	472.6	78.2	125.7	214.3	11.1	11.7	12.3	31.2	20.5	45.3	72.2	37.3	36.7	28.2	69.9	28.2	32.5	2.2	22.0	42.3	16.2	49.3	25.7	33.9	41.9	46.2	33.2	30.3	36.2	48.4	39.7	47.7	41.9	40.9	58.1	33.4	54.5	73.6	13.7	169.1	72.3	83.9	56.4	51.2	96.1	58.8	43.3	115.0	44.3	69.8	57.0	141.8	469.2	53.8	27.7	72.4	88.9	34.1	53.3	66.5	62.0	75.0	100.5	16.5	107.0	111.7	49.8	37.8	55.2	122.1	116.2	34.2	69.4	139.6	90.9	17.5	50.0	57.0	47.8	35.7	20.5	40.0	48.3	62.2	16.9	76.9	80.1	95.8	10.1	31.9	48.5	24.2	35.0	186.9	82.8	25.6	48.5	56.4	118.1	46.0	58.7	48.0	88.8	199.6	77.2	48.2	137.6	85.0	103.5	61.9	41.7
PARP11	"ARTD11, C12orf6"	ENSG00000111224	"Poly(ADP-ribose) polymerase family member 11"	Q9NR21	12	3791047-3873448	"Metabolic proteins, Predicted intracellular proteins"	"Differentiation, mRNA transport, Protein transport, Spermatogenesis, Translocation, Transport"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 61.5;Granulosa cells: 72.0;Late spermatids: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026895	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA026895: AB_1854980"	"unprognostic (9.58e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.87e-2)"	3.4	5.0	2.7	5.0	2.9	3.2	5.3	2.0	2.9	4.2	2.0	3.6	3.7	6.5	5.4	3.1	4.1	4.0	2.3	2.5	3.4	3.9	4.5	3.8	10.2	3.4	3.2	8.2	2.5	7.8	1.8	3.2	3.3	8.6	4.1	3.3	4.0	4.2	1.8	2.2	3.7	5.2	2.8	6.2	3.3	9.4	3.5	10.4	9.1	2.9	9.4	5.0	1.9	3.5	2.7	2.3	14.0	2.3	4.4	7.2	4.1	3.3	5.5	5.6	5.7	8.7	2.2	8.0	2.0	6.4	6.6	2.2	4.8	4.8	9.0	16.1	4.9	12.0	0.0	6.5	5.1	8.1	4.4	5.9	3.8	4.4	12.4	0.0	4.4	15.3	3.1	6.5	8.1	4.0	4.2	3.1	5.2	2.9	0.3	8.3	9.8	1.8	2.6	6.3	0.9	2.9	3.1	2.8	4.2	15.1	0.5	7.1	8.5	4.9	4.8	7.3	4.4	3.1	7.3	11.7	4.6	4.4	1.2	20.3	8.9	9.2	7.4	7.4	10.0	10.0	8.3	5.5	8.9	8.8	9.2	7.5	8.5	7.7	6.1	7.8	3.7	6.2	2.7	2.9	2.0	2.9	2.5	3.4	3.4	3.2	3.3	2.8	3.5	3.5	8.6	9.6	9.5	16.0	18.3	1.9	4.4	6.7	7.4	10.6	5.7	4.1	3.8	2.8	4.5	1.8	2.1	4.2	17.7	2.6	0.0	3.4	61.5	2.1	9.6	5.3	3.6	12.0	30.8	3.1	1.6	8.4	1.1	1.9	14.7	72.0	6.8	4.1	7.1	3.3	30.8	4.7	2.0	9.8	5.8	45.1	10.5	9.7	1.8	18.7	10.3	5.4	17.5	32.6	18.8	3.3	7.6	8.6	3.7	6.6	2.6	4.1	6.0	6.4	6.6	7.0	9.8	9.9	10.9	3.6	1.8	2.6	15.0	8.9	5.0	3.4
PARP16	"ARTD15, C15orf30, FLJ20509, FLJ25281, pART15"	ENSG00000138617	"Poly(ADP-ribose) polymerase family member 16"	Q8N5Y8	15	65234460-65300618	"Metabolic proteins, Predicted membrane proteins"	"Unfolded protein response"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 33.0;Spermatogonia: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017081	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA017081: AB_10963218"	"unprognostic (1.17e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.82e-2)"	"unprognostic (6.37e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.41e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.61e-2)"	6.6	9.8	5.0	4.7	4.8	6.0	8.8	7.0	5.6	12.6	4.4	10.2	6.2	8.7	5.1	7.5	9.7	4.3	4.9	4.9	4.9	6.2	13.2	5.1	7.0	4.8	4.8	11.9	7.5	8.2	5.5	6.0	4.9	8.4	6.4	5.1	7.2	6.2	3.8	8.1	7.1	6.8	4.7	6.5	7.9	4.8	4.9	10.0	6.4	3.9	8.2	10.0	9.1	5.1	6.0	6.3	6.5	10.4	5.3	4.9	2.8	2.8	7.1	7.0	7.3	4.5	5.4	18.9	7.3	3.5	15.3	9.4	30.3	3.7	5.0	7.3	11.3	3.1	6.5	6.3	9.1	8.7	5.6	6.1	6.0	2.0	7.2	10.6	6.4	17.9	7.6	7.1	5.9	6.8	19.0	8.8	2.8	29.7	8.2	33.5	11.8	14.3	5.0	5.3	10.8	7.2	8.3	7.5	6.8	5.1	8.7	7.5	2.7	8.5	6.5	4.7	3.9	13.3	16.5	24.2	7.0	12.5	4.2	19.9	3.9	12.2	12.6	6.0	14.0	8.5	11.9	12.8	5.2	11.1	14.7	10.9	15.0	12.5	6.5	4.4	10.8	6.9	5.0	4.8	7.0	5.6	4.9	4.9	4.8	4.8	4.9	4.7	4.9	5.1	3.7	3.2	3.1	10.1	9.6	5.2	6.0	3.9	9.6	12.1	5.0	4.7	4.1	7.2	3.4	3.7	0.0	12.5	9.1	3.4	0.0	5.8	0.8	1.5	4.7	4.5	1.8	3.0	14.0	9.1	5.7	7.0	11.7	2.7	0.0	6.5	2.9	6.0	3.8	3.3	18.3	4.9	4.1	2.5	1.7	1.9	9.9	4.3	3.6	11.2	4.3	7.3	9.2	10.6	13.4	5.3	2.5	7.9	9.8	3.2	7.1	4.0	2.6	33.0	6.6	4.3	4.5	1.6	28.6	4.6	4.3	5.5	9.0	6.3	5.4	3.0
PARP2	"ADPRTL2, ARTD2"	ENSG00000129484	"Poly(ADP-ribose) polymerase 2"	Q9UGN5	14	20343615-20357904	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052003	Approved		Supported	Nucleoplasm,Nucleoli		NA	Yes			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Nucleoli	"HPA052003: AB_2681689"	"unprognostic (3.93e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.40e-2)"	"unprognostic (7.30e-2)"	"prognostic unfavorable (6.48e-4)"	"unprognostic (1.97e-2)"	"unprognostic (4.43e-2)"	"unprognostic (9.35e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.37e-3)"	"unprognostic (2.83e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.89e-2)"	17.7	21.1	21.1	10.7	22.0	26.8	17.5	21.4	31.4	18.1	16.4	19.3	12.8	20.9	17.8	14.6	17.5	10.0	17.1	22.5	21.0	15.5	17.2	13.5	14.5	19.5	18.9	22.9	17.9	11.1	21.0	12.9	19.8	13.9	14.0	26.4	14.2	13.4	32.4	19.2	14.2	15.8	19.0	16.5	16.3	23.8	19.8	11.9	16.7	27.1	17.9	13.8	15.3	22.1	55.5	39.5	59.7	45.3	19.4	18.4	43.4	60.2	32.5	74.8	91.8	36.8	51.3	40.4	26.5	19.0	64.8	50.1	78.3	27.5	87.8	32.4	38.3	37.2	46.6	63.3	17.3	77.9	20.4	12.5	23.0	45.5	51.1	20.5	38.5	48.0	39.2	53.4	52.3	33.5	40.1	33.0	33.0	62.8	60.0	49.7	79.7	26.5	30.0	28.2	41.3	28.3	65.3	36.8	17.9	37.4	34.2	25.8	26.6	45.3	68.1	31.5	48.1	49.3	67.7	53.4	19.0	33.3	51.4	1.9	5.0	0.5	8.9	4.8	11.7	6.8	8.4	7.9	5.5	4.1	9.0	8.6	0.1	7.6	2.6	5.6	5.3	4.8	21.1	22.0	21.4	31.4	22.5	21.0	19.5	18.9	19.8	19.0	19.8	22.1	12.1	25.6	6.5	7.2	9.5	6.5	10.5	16.1	18.8	29.2	7.4	10.0	14.0	5.7	19.9	7.3	12.5	25.8	10.2	4.5	7.9	12.8	9.3	9.9	13.3	11.0	4.8	30.3	17.6	8.7	22.2	11.6	7.7	11.3	8.2	18.4	6.8	10.1	11.9	30.3	15.5	5.0	14.2	4.6	5.1	9.8	11.5	6.6	8.8	9.4	4.2	20.7	6.2	6.0	9.3	10.1	4.5	17.0	19.1	4.5	5.3	7.4	28.0	23.2	6.6	9.8	18.5	20.9	41.5	11.3	4.8	14.9	6.2	16.7	7.4	7.0
PARPBP	"C12orf48, FLJ20641, PARI"	ENSG00000185480	"PARP1 binding protein"	Q9NWS1	12	102120183-102197520	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 9.3;lymphoid tissue: 7.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 20.0;Spermatogonia: 17.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039677	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA039677: AB_10673426"	"unprognostic (7.84e-3)"	"unprognostic (1.34e-2)"	"unprognostic (4.54e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.30e-5)"	"unprognostic (2.52e-3)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.83e-1)"	"unprognostic (5.61e-8)"	"unprognostic (3.50e-3)"	"unprognostic (2.34e-1)"	"unprognostic (9.16e-3)"	"unprognostic (6.14e-2)"	0.8	0.6	0.2	3.1	0.2	9.3	1.8	0.3	0.4	1.2	0.1	3.0	2.3	1.2	0.5	3.6	0.6	1.1	0.4	0.3	0.4	0.8	0.6	0.6	4.2	0.3	0.4	0.7	0.2	0.3	0.2	2.3	0.3	1.0	3.8	0.2	0.9	0.9	0.4	1.9	2.7	1.7	0.3	1.2	1.8	3.9	0.3	7.5	0.5	0.3	5.1	1.9	1.1	0.3	13.5	27.2	23.6	13.7	3.8	3.4	16.7	19.9	11.0	32.0	27.9	14.8	10.4	25.4	11.4	7.8	16.2	14.5	38.5	11.7	34.2	25.7	22.6	31.9	15.7	13.9	1.1	33.5	9.1	3.3	2.8	22.3	14.4	8.3	21.6	18.9	31.0	15.3	21.1	10.7	30.5	31.1	31.7	17.8	26.6	20.4	38.9	16.7	10.3	21.1	15.9	14.7	13.8	16.6	11.8	24.0	27.1	12.1	8.5	16.5	15.7	20.2	25.3	11.3	24.8	22.8	11.4	33.7	22.4	2.6	0.4	1.0	0.5	0.6	0.1	1.1	0.9	0.8	0.7	0.7	0.5	0.6	0.0	0.5	0.4	0.7	1.8	0.7	0.2	0.2	0.3	0.4	0.3	0.4	0.3	0.4	0.3	0.3	0.3	0.3	1.1	0.0	0.0	2.9	4.3	3.7	1.5	3.6	0.6	1.9	2.4	2.4	0.7	1.5	2.5	1.8	0.0	11.3	2.3	1.5	5.9	1.6	2.5	3.0	11.6	2.5	1.8	20.0	4.1	1.3	13.9	4.8	6.1	3.0	5.7	15.0	2.2	0.1	6.5	3.3	5.3	3.1	10.2	5.7	4.3	2.6	1.2	3.1	0.0	3.7	1.7	0.2	2.1	3.5	4.1	1.2	0.8	0.4	14.2	0.7	1.3	1.8	1.4	0.9	0.0	1.1	2.8	16.0	17.7	9.8	1.6	3.6	4.1	9.3	7.8	1.6
PARS2	DKFZp727A071	ENSG00000162396	"Prolyl-tRNA synthetase 2, mitochondrial"	Q7L3T8	1	54756898-54764523	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 9.8;Early spermatids: 11.0;Spermatocytes: 10.5;Spermatogonia: 11.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028308, HPA028314, HPA028518"	Uncertain		Approved	"Nucleoli fibrillar center,Mitochondria"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoli fibrillar center, Mitochondria"		"HPA028308: AB_2672553, HPA028314: AB_10603981, HPA028518: AB_2672653"	"unprognostic (1.95e-1)"	"unprognostic (1.10e-1)"	"prognostic favorable (1.26e-5)"	"unprognostic (1.93e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.79e-3)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (6.48e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (1.24e-6)"	"unprognostic (2.72e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.64e-2)"	1.3	2.9	2.5	1.9	3.0	0.2	2.7	2.8	3.1	2.7	3.0	4.0	2.7	2.5	3.2	2.7	4.4	1.6	3.0	2.6	2.6	4.2	3.4	1.4	2.0	2.5	2.7	4.8	2.3	4.7	2.1	2.5	2.7	2.3	3.6	2.0	3.3	2.8	4.4	2.9	2.1	2.0	2.7	1.8	2.5	4.8	2.7	2.6	2.9	5.5	2.4	2.1	2.0	3.0	4.4	7.2	4.6	6.0	5.5	4.6	10.3	3.7	4.5	6.4	4.6	8.3	2.8	7.7	5.6	3.3	9.3	6.9	8.3	5.8	4.7	5.0	7.5	7.4	4.0	6.2	8.5	4.3	2.5	5.0	8.8	8.3	7.4	5.5	4.8	8.4	13.2	1.0	4.9	4.6	6.1	5.7	10.6	8.3	9.1	4.6	9.0	9.0	5.4	3.2	4.7	4.8	5.3	6.9	9.7	8.7	3.9	5.5	2.6	4.8	4.9	6.8	4.7	7.3	6.6	3.0	3.6	5.1	2.8	1.2	5.3	4.5	4.8	7.7	5.9	4.9	5.3	5.3	7.3	5.5	7.8	5.3	0.5	7.4	10.7	5.9	8.2	5.0	2.5	3.0	2.8	3.1	2.6	2.6	2.5	2.7	2.7	2.7	2.7	3.0	0.6	0.0	1.1	0.3	1.0	0.6	0.9	2.0	1.8	2.6	1.3	1.9	1.5	2.8	1.8	0.0	0.0	7.0	0.2	2.4	9.8	4.5	11.0	1.1	1.4	0.8	0.0	0.0	0.9	2.8	3.9	1.3	1.5	0.6	0.0	2.9	0.0	2.3	3.1	5.0	1.1	2.8	0.0	1.2	0.3	6.8	3.7	0.8	0.0	2.8	1.1	3.2	0.0	0.5	1.6	1.9	1.5	3.0	0.3	1.8	1.5	6.5	1.0	1.9	0.0	1.3	1.1	10.5	11.5	2.0	1.0	3.3	0.7	5.1	3.5	0.8
PAX5	BSAP	ENSG00000196092	"Paired box 5"	Q02548	9	36833269-37034268	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"lymphoid tissue: 39.7"	"Cell type enriched"	"Detected in some"	29	"B-cells: 91.3"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"midbrain: 6.5"	"Group enriched"	"Detected in some"	43	"memory B-cell: 39.0;naive B-cell: 26.0"	"Lineage enriched"	"Detected in single"	52	"B-cells: 39.0"	"Group enriched"	"Detected in some"	9	"Daudi: 66.6;REH: 194.1;U-698: 87.1"	"Region enriched"	"Detected in single"	11	"midbrain: 3.9"	"Low region specificity"	"Detected in all"			"CAB026269, CAB026869, HPA056394, HPA068498"	Enhanced	Supported	Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	"Nucleoli fibrillar center, Vesicles, Cytosol"	"CAB026269: , CAB026869: , HPA056394: AB_2683116, HPA068498: AB_2685997"	"unprognostic (4.69e-4)"	"unprognostic (3.83e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.15e-1)"	"unprognostic (8.96e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.01e-1)"	0.3	0.1	0.4	14.9	0.3	9.4	0.1	0.5	0.5	0.0	0.2	0.8	0.5	0.2	0.1	0.2	0.0	0.8	0.2	0.3	0.6	0.1	0.2	0.3	39.7	1.1	6.5	0.0	0.0	0.0	0.2	0.1	4.1	0.3	0.8	0.5	1.0	0.0	3.1	0.0	6.6	0.0	0.8	18.7	1.6	0.6	1.9	2.8	0.2	0.0	36.2	1.1	0.0	0.3	0.1	0.3	5.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	66.6	0.1	0.0	0.1	0.2	0.1	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.0	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.5	0.1	0.3	1.9	0.3	0.4	194.1	0.4	0.3	0.0	0.0	13.2	2.9	0.1	0.7	0.0	0.0	0.0	7.5	0.2	0.0	0.2	0.1	0.0	0.2	0.1	87.1	0.0	1.5	0.1	0.7	0.0	0.1	0.0	0.1	0.1	39.0	0.0	0.0	0.1	26.0	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.7	0.4	0.3	0.5	0.5	0.3	0.6	1.1	6.5	4.1	0.8	1.9	0.3	0.0	0.0	0.0	0.7	91.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.4	0.6	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.4	0.0	0.0	0.5	0.1	0.0	0.3	0.0	3.1	0.0	0.9	0.0	0.0	0.2	0.5	0.0	0.0	0.3	0.0	0.1	0.0	2.7	0.4	0.0	0.1	0.0	0.1	0.0	0.8	0.1	0.6	0.2	0.2	0.0	0.0	2.0	0.0	0.0	0.3
PBK	"CT84, FLJ14385, Nori-3, SPK, TOPK"	ENSG00000168078	"PDZ binding kinase"	Q96KB5	8	27809624-27838082	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 22.8;testis: 70.3"	"Group enriched"	"Detected in many"	5	"Early spermatids: 364.9;Spermatocytes: 436.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 282.8"	"Group enriched"	"Detected in many"	4	"basal ganglia: 4.7;white matter: 13.9"	"Not detected"	"Not detected"			"HPA005753, HPA050656"	Enhanced	Supported	Approved	Cytosol		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA005753: AB_1855018, HPA050656: AB_2681205"	"unprognostic (7.17e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.04e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (8.29e-5)"	"unprognostic (3.65e-3)"	"unprognostic (7.38e-2)"	"unprognostic (2.88e-3)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.18e-12)"	"unprognostic (9.61e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.68e-2)"	1.1	0.6	0.1	6.6	0.1	9.1	2.3	0.0	0.1	1.1	0.0	8.9	8.4	1.2	0.0	6.6	0.6	0.7	0.2	0.1	0.1	0.4	1.1	0.7	12.8	0.1	0.3	0.2	0.4	0.2	0.0	5.1	0.2	0.4	10.1	0.0	0.9	0.0	0.2	4.8	8.1	2.7	0.1	1.5	3.6	70.3	0.3	22.8	0.5	0.1	12.4	1.6	2.1	0.1	282.8	94.2	94.4	57.9	8.3	15.7	36.9	129.5	63.0	133.2	112.3	33.7	51.2	156.4	43.3	51.7	150.2	76.4	87.6	44.7	145.7	35.8	48.0	35.0	64.6	49.2	0.6	25.7	54.1	4.4	36.0	62.6	32.8	24.3	68.5	75.9	54.3	100.6	160.4	34.5	87.7	29.1	15.6	80.1	80.0	54.4	126.9	41.2	51.2	44.9	36.1	53.2	48.2	56.0	75.0	26.2	58.0	37.3	40.6	85.6	207.3	111.5	141.5	15.4	39.4	70.1	54.0	43.4	188.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.3	0.1	0.2	0.0	0.0	0.0	4.2	8.9	2.8	10.8	0.0	0.0	2.9	2.4	0.5	2.8	2.6	0.0	0.0	29.8	1.3	5.5	0.0	0.6	364.9	2.5	2.2	2.4	0.0	61.7	0.1	0.0	49.3	6.7	6.6	3.5	0.0	13.5	5.7	1.7	5.0	0.0	0.1	9.4	6.1	1.9	1.6	76.8	8.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	3.0	14.0	2.0	1.5	0.3	0.1	0.0	6.6	0.1	5.8	436.4	38.1	9.4	2.4	6.7	1.9	2.4	18.7	3.8
PCGF6	"MBLR, RNF134"	ENSG00000156374	"Polycomb group ring finger 6"	Q9BYE7	10	103302796-103351144	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 76.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"				"unprognostic (7.73e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.72e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.44e-2)"	"prognostic unfavorable (4.54e-9)"	"unprognostic (5.14e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.57e-3)"	"unprognostic (4.53e-2)"	7.3	4.7	2.8	5.0	3.0	4.5	6.3	3.2	5.3	6.9	2.5	7.8	4.4	7.5	3.3	4.4	6.0	4.3	5.4	2.8	3.0	4.4	11.6	4.0	5.6	3.0	2.9	5.5	6.6	4.3	3.3	4.7	3.3	4.8	4.3	2.6	4.1	5.2	10.9	4.1	4.7	7.5	3.2	4.3	5.1	8.9	2.9	5.8	3.8	6.9	5.0	6.2	5.3	3.5	29.8	11.6	16.3	33.7	7.3	12.2	15.3	19.9	20.0	21.0	16.9	14.7	10.6	22.4	9.1	18.3	9.3	16.2	18.5	14.8	21.5	15.1	34.2	20.2	11.6	19.3	17.7	29.9	9.4	16.3	13.5	19.1	23.7	12.1	13.5	19.2	30.1	13.6	14.9	22.1	21.3	32.0	16.4	8.6	16.4	23.4	24.3	11.7	7.0	12.3	5.8	14.5	14.8	7.5	21.8	8.7	8.0	19.4	10.5	15.8	19.1	17.8	34.5	14.9	19.9	30.5	13.5	32.3	6.9	5.4	1.9	1.4	2.3	2.3	3.4	1.7	3.1	2.9	2.7	2.6	3.7	3.2	0.2	3.6	1.7	2.5	4.1	1.7	2.8	3.0	3.2	5.3	2.8	3.0	3.0	2.9	3.3	3.2	2.9	3.5	10.5	3.2	3.6	12.7	8.9	9.6	5.6	5.9	12.0	12.4	6.4	7.2	5.5	10.0	4.4	11.0	12.5	14.6	9.4	4.1	11.7	7.4	7.9	5.4	12.7	11.1	4.2	15.6	23.9	7.3	20.3	12.8	5.1	4.2	3.8	10.7	10.8	12.2	8.7	6.7	21.3	4.8	2.0	8.8	7.0	5.3	10.2	7.9	8.8	7.5	7.0	6.8	15.5	17.6	11.8	5.7	4.6	7.2	11.1	8.1	4.9	12.4	5.0	13.2	6.6	5.5	12.7	76.2	39.3	15.3	8.8	4.5	11.5	12.8	7.3	4.1
PCNA		ENSG00000132646	"Proliferating cell nuclear antigen"	P12004	20	5114953-5126626	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Host-virus interaction"	DNA-binding	"Cancer-related genes, Deafness, Disease variant, Dwarfism, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 383.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000148, HPA030521, HPA030522, HPA030523"	Enhanced		Enhanced	Nucleoplasm		No	Yes		170000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB000148: AB_628110, HPA030521: AB_10600218, HPA030522: AB_10602096, HPA030523: AB_10602199"	"unprognostic (5.21e-2)"	"prognostic favorable (1.86e-5)"	"unprognostic (2.96e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.17e-1)"	"unprognostic (5.60e-3)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.78e-2)"	"prognostic unfavorable (3.03e-6)"	"unprognostic (2.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.11e-3)"	"unprognostic (7.46e-2)"	31.2	47.2	23.2	85.2	26.0	383.2	51.0	26.8	29.7	41.5	26.8	89.0	70.7	38.1	30.9	81.2	39.1	34.8	30.6	23.0	24.4	43.7	55.3	37.5	168.8	25.1	24.0	37.7	32.8	42.4	25.1	69.8	26.0	32.2	93.7	94.1	40.3	38.3	27.9	62.8	72.9	47.9	26.8	54.0	53.9	62.3	23.3	219.9	42.0	26.8	137.3	51.0	42.3	30.0	769.1	591.4	585.0	253.7	136.1	126.6	409.5	491.6	288.3	453.7	640.0	465.3	594.2	773.4	155.7	177.5	395.2	558.8	350.7	594.4	413.2	231.7	386.8	543.7	207.8	1098.3	57.8	753.7	233.0	92.6	138.2	387.2	91.7	95.3	263.3	503.6	493.9	631.2	449.7	278.3	1450.6	829.3	439.9	592.0	322.9	787.9	514.1	622.5	208.5	441.1	500.8	339.4	345.1	524.6	351.9	213.9	371.2	378.0	177.2	324.3	373.3	461.5	572.0	317.2	981.6	1313.9	145.9	707.4	426.2	5.0	23.2	18.5	36.5	23.3	45.7	33.5	45.7	37.1	32.6	29.2	41.6	37.3	7.7	43.6	24.7	29.9	48.1	36.7	23.2	26.0	26.8	29.7	23.0	24.4	25.1	24.0	26.0	26.8	23.3	30.0	32.4	44.8	26.0	2.9	40.6	67.7	44.4	121.4	44.3	42.1	27.5	45.2	14.5	21.5	60.5	58.8	27.1	171.5	44.3	42.9	60.7	51.6	176.0	30.2	21.4	34.8	19.9	189.0	4.3	39.6	175.6	38.7	21.9	27.7	22.7	53.1	29.6	27.1	96.7	32.0	5.9	53.9	75.3	24.2	33.4	109.1	36.1	32.7	37.4	3.7	47.6	74.0	23.7	4.0	13.5	28.3	20.3	40.3	56.6	23.3	33.3	46.1	44.1	97.1	52.6	29.2	46.1	149.1	101.1	65.5	49.7	66.4	48.6	29.6	84.5	40.4
PCNP		ENSG00000081154	"PEST proteolytic signal containing nuclear protein"	Q8WW12	3	101574180-101594465	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035011, HPA063861"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No		38000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Nuclear bodies"	"HPA035011: AB_10601386, HPA063861: "	"unprognostic (4.34e-2)"	"unprognostic (9.65e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.08e-3)"	"unprognostic (7.67e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.00e-5)"	"unprognostic (1.91e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.32e-2)"	"unprognostic (2.05e-1)"	47.0	47.6	42.6	43.5	45.3	58.7	53.5	48.6	69.1	48.2	54.5	47.8	38.8	53.8	52.6	48.1	43.8	41.0	57.7	43.1	50.6	51.9	49.6	41.0	57.3	43.7	43.9	69.7	33.3	50.0	39.3	50.5	44.0	47.6	45.2	58.3	42.5	49.1	66.5	39.0	36.1	53.4	45.8	39.8	34.8	28.4	45.8	58.0	49.8	66.4	57.5	50.7	40.0	52.9	135.0	71.1	105.2	82.9	96.1	136.8	113.4	90.0	126.3	94.1	105.1	85.8	73.1	139.4	66.5	100.0	92.8	71.4	138.0	119.6	196.9	102.6	76.6	151.1	84.9	103.4	73.6	141.1	72.1	82.4	115.5	78.0	109.6	134.8	129.6	64.1	143.7	82.6	117.2	55.8	123.8	120.2	162.4	110.8	113.9	71.8	93.2	110.0	123.7	76.7	136.1	108.0	83.4	82.0	132.6	119.3	76.7	105.4	81.5	86.5	113.8	44.1	97.1	62.1	100.2	174.0	84.1	150.9	107.4	58.3	22.4	38.6	22.1	27.0	29.1	29.8	28.9	26.9	23.9	24.1	29.1	27.3	20.2	36.4	36.0	18.9	35.9	40.9	42.6	45.3	48.6	69.1	43.1	50.6	43.7	43.9	44.0	45.8	45.8	52.9	94.9	60.9	101.4	25.5	124.2	232.6	235.2	171.7	126.9	89.5	90.3	65.8	111.5	75.8	106.2	64.4	39.6	120.3	75.0	46.6	266.1	130.3	30.1	89.1	80.4	111.0	81.9	195.9	50.4	95.0	205.7	126.9	55.5	114.6	102.6	53.8	90.3	51.7	90.3	97.6	51.3	70.8	187.2	87.3	242.1	15.0	130.8	105.0	250.8	39.4	131.0	128.4	102.0	36.2	49.1	111.2	51.6	134.6	77.8	207.5	72.2	182.6	85.8	90.5	131.5	110.8	170.3	105.7	70.1	100.6	238.5	235.9	125.1	60.9	78.8	196.3
PDCD10	"CCM3, TFAR15"	ENSG00000114209	"Programmed cell death 10"	Q9BUL8	3	167683298-167734939	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Angiogenesis, Apoptosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027095	Approved					NA	NA		190000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA027095: AB_1855101"	"unprognostic (3.39e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (9.34e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.89e-4)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (4.98e-3)"	"unprognostic (2.41e-2)"	"unprognostic (9.95e-3)"	"prognostic unfavorable (5.22e-5)"	"unprognostic (3.08e-2)"	"prognostic favorable (5.88e-4)"	"unprognostic (1.98e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.14e-1)"	"unprognostic (5.58e-2)"	34.4	30.4	24.0	39.2	27.1	61.7	41.3	28.4	34.3	24.9	22.6	50.9	48.7	27.3	29.1	50.4	24.4	29.5	35.9	25.6	28.0	43.5	36.4	31.4	53.0	26.9	25.6	25.6	25.7	41.5	21.9	44.4	27.3	31.0	48.7	20.3	31.4	24.7	21.8	27.6	43.4	30.3	27.9	33.1	41.3	44.1	25.9	50.9	37.9	29.6	52.6	50.2	32.3	32.2	133.1	49.3	61.6	39.6	56.7	62.1	67.7	78.5	82.7	89.8	89.9	92.3	153.3	107.5	150.0	73.2	156.5	86.0	73.1	91.1	108.0	172.2	52.9	164.8	59.3	61.1	80.3	109.8	93.0	47.9	92.7	56.9	92.6	64.3	73.3	89.1	129.6	105.2	82.1	117.2	88.4	67.7	79.3	119.3	67.9	51.3	46.9	157.9	112.7	53.5	58.9	52.1	75.2	80.8	148.5	76.8	149.0	92.4	70.5	63.5	41.2	68.9	113.5	113.4	170.9	187.6	75.3	114.6	53.2	224.8	81.7	196.5	82.4	107.0	100.1	136.2	111.2	100.2	79.4	136.4	92.0	95.3	175.0	107.1	138.9	73.2	181.9	133.8	24.0	27.1	28.4	34.3	25.6	28.0	26.9	25.6	27.3	27.9	25.9	32.2	103.3	44.8	42.6	18.6	74.8	108.1	91.0	227.1	69.4	20.2	49.1	57.4	71.1	32.9	120.9	33.1	6.2	106.2	76.9	100.1	105.7	101.4	76.0	58.8	48.3	69.8	34.6	123.3	48.0	122.0	112.3	52.9	62.7	61.4	62.7	34.8	45.3	41.5	91.2	20.2	33.8	75.4	120.1	53.8	73.6	33.5	49.7	89.0	49.8	27.2	100.5	52.9	88.6	19.1	49.7	121.7	103.0	39.5	51.2	97.2	72.0	123.5	92.8	24.1	32.9	37.9	128.4	119.5	103.7	66.6	129.0	103.0	77.9	38.9	55.9	122.7
PDCD11	"ALG-4, KIAA0185, NFBP, RRP5"	ENSG00000148843	"Programmed cell death 11"	Q14690	10	103396626-103446294	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 61.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017924, CAB026472"	Approved		Supported	"Nucleoli rim,Vesicles"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoli rim"	Vesicles	"CAB026472: , HPA017924: AB_10601045"	"unprognostic (1.34e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.94e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.25e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.28e-2)"	"unprognostic (5.59e-2)"	8.1	7.8	4.1	10.0	4.8	7.5	9.4	4.5	4.6	8.7	4.5	7.7	5.9	9.9	5.9	11.7	9.0	4.4	7.5	4.4	4.7	9.8	9.1	7.3	11.0	4.4	4.5	10.4	11.6	8.5	6.4	7.5	4.6	8.0	7.9	6.1	7.2	6.2	15.8	15.5	7.7	9.1	4.1	9.5	7.3	14.8	5.1	11.9	6.9	8.1	11.8	9.9	8.4	5.0	27.4	39.8	27.2	77.0	23.3	20.9	30.5	29.6	20.7	29.2	23.7	54.7	26.3	74.9	20.5	21.4	18.0	48.0	70.6	37.1	32.5	34.8	47.5	43.7	26.0	44.2	27.7	88.0	28.7	21.8	33.3	44.8	101.3	21.0	31.6	19.4	71.5	32.7	28.4	30.9	44.5	49.9	55.9	21.7	37.9	44.3	39.0	34.1	18.1	26.6	18.2	34.1	19.9	23.2	32.6	26.4	22.8	24.8	34.5	21.5	27.0	29.0	55.9	41.2	61.8	69.5	19.0	83.3	16.2	0.1	2.8	0.9	3.2	2.6	5.2	3.4	3.1	2.7	2.8	2.2	2.7	3.2	0.3	2.1	2.3	3.3	2.3	2.5	4.1	4.8	4.5	4.6	4.4	4.7	4.4	4.5	4.6	4.1	5.1	5.0	8.8	12.8	14.1	5.9	13.6	16.4	9.3	10.8	8.0	15.0	18.6	15.6	14.6	20.0	17.4	9.2	29.2	12.8	18.1	9.6	13.7	23.6	61.2	12.6	25.4	14.4	9.5	14.9	11.8	15.8	15.8	14.0	5.6	11.7	18.9	18.5	8.9	24.5	10.9	6.7	9.3	12.9	4.1	7.7	5.2	19.6	11.1	10.7	10.6	8.4	9.8	4.9	9.2	7.5	7.6	29.1	4.9	10.1	9.6	17.9	4.4	8.2	20.2	13.8	6.6	16.8	11.0	27.5	30.7	14.0	16.9	8.2	11.6	19.0	19.9	8.7
PDCL3	VIAF1	ENSG00000115539	"Phosducin like 3"	Q9H2J4	2	100562993-100576739	"Predicted intracellular proteins"	"Angiogenesis, Apoptosis"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018469, HPA027094"	Approved		Enhanced	Nucleoplasm,Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA018469: AB_1855116, HPA027094: AB_10601387"	"unprognostic (1.34e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.32e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (6.07e-5)"	"unprognostic (1.44e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (2.55e-5)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.22e-2)"	"prognostic favorable (4.23e-4)"	20.8	22.0	19.1	27.1	21.6	22.9	23.0	21.6	24.3	18.9	16.6	27.3	17.0	24.1	37.2	36.8	22.5	21.3	30.6	18.4	21.3	28.4	18.5	18.4	25.3	21.8	24.7	21.1	11.4	23.4	10.5	23.4	21.7	27.0	28.9	21.1	16.9	23.2	58.8	36.8	17.3	38.6	20.8	17.0	17.6	22.8	22.1	22.4	21.4	34.3	34.0	33.1	17.5	22.2	41.8	58.7	59.9	52.2	19.3	27.4	67.5	51.3	32.5	92.9	58.1	74.2	25.5	68.6	74.0	62.3	122.3	34.2	76.0	50.2	74.0	110.6	65.8	72.0	31.8	89.7	50.8	77.3	73.2	29.8	92.0	82.0	52.3	24.2	58.9	52.8	61.1	43.8	70.7	74.6	75.8	117.7	77.9	45.6	86.6	72.5	63.2	48.0	58.2	98.7	55.9	49.6	41.0	54.7	59.0	48.6	42.3	53.0	45.8	56.4	60.1	44.8	72.2	26.4	54.1	68.3	34.4	90.5	45.7	82.3	64.8	80.2	63.1	124.4	72.8	92.5	95.0	70.4	114.9	78.1	97.7	75.4	7.0	93.9	161.7	64.0	113.6	87.3	19.1	21.6	21.6	24.3	18.4	21.3	21.8	24.7	21.7	20.8	22.1	22.2	37.4	19.2	25.2	1.6	39.5	65.6	36.6	79.2	52.9	13.0	24.8	36.2	40.9	18.6	46.1	14.7	6.2	70.8	61.5	16.0	60.7	50.6	37.0	38.9	26.6	30.2	19.8	21.7	2.3	39.1	51.2	22.6	19.4	34.6	92.9	25.4	12.5	17.0	59.7	11.8	2.0	24.0	89.5	17.8	80.7	14.3	14.6	54.4	35.6	3.7	104.3	19.7	40.2	2.0	4.5	31.8	18.6	33.4	27.7	33.2	19.7	77.9	28.1	16.5	52.6	23.8	54.1	5.5	66.9	63.2	57.5	52.4	91.8	24.5	31.3	32.4
PDE12	"2'-PDE, 3635, DKFZp667B1218"	ENSG00000174840	"Phosphodiesterase 12"	Q6L8Q7	3	57556274-57566848	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043171	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"			"HPA043171: AB_10794654"	"unprognostic (2.79e-1)"	"unprognostic (3.18e-1)"	"prognostic favorable (2.85e-5)"	"unprognostic (2.39e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.58e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (9.88e-3)"	"prognostic favorable (3.63e-8)"	"unprognostic (6.97e-3)"	"unprognostic (1.32e-1)"	"unprognostic (7.85e-2)"	"unprognostic (2.62e-1)"	7.6	8.6	4.1	8.3	4.6	13.9	6.0	5.1	4.4	5.2	4.7	7.2	9.1	5.7	3.9	9.0	4.2	7.1	5.7	4.3	5.2	8.0	10.6	5.5	8.9	3.9	3.9	4.7	9.8	9.2	4.4	7.3	3.5	6.3	6.7	7.3	5.9	6.4	8.4	4.9	7.2	6.9	4.2	7.1	7.2	4.2	3.9	7.0	7.2	7.9	8.1	8.6	4.9	6.2	19.5	18.8	11.5	21.3	14.6	10.3	20.8	16.1	15.3	17.8	15.8	24.9	12.9	31.6	5.9	14.6	23.7	12.5	24.8	16.8	14.5	14.7	12.7	23.5	15.4	19.3	16.6	31.1	23.5	14.2	11.3	21.5	19.0	9.3	15.6	16.1	19.4	22.3	16.3	15.0	28.0	10.2	17.8	15.1	32.0	10.5	9.4	23.0	14.4	22.3	10.2	16.0	17.3	20.2	17.4	9.1	15.0	17.6	19.3	14.7	13.7	28.1	26.4	21.9	34.2	27.4	17.3	24.1	22.2	20.6	9.3	8.7	10.9	12.7	12.3	6.7	10.2	11.3	10.2	11.4	12.4	12.4	2.3	14.9	13.8	5.3	13.5	10.2	4.1	4.6	5.1	4.4	4.3	5.2	3.9	3.9	3.5	4.2	3.9	6.2	15.9	25.6	21.9	32.0	20.0	36.8	18.5	13.2	14.8	21.0	17.9	10.0	10.8	22.8	14.8	31.3	12.5	19.0	23.9	17.9	5.9	10.0	1.3	15.5	19.3	14.6	12.5	20.4	50.8	9.8	11.3	14.6	12.8	21.7	19.7	12.8	13.6	27.8	15.0	26.9	49.0	10.8	10.2	18.5	16.8	1.3	10.5	16.1	12.4	26.2	15.8	18.3	17.5	47.7	56.6	9.0	9.8	12.4	20.4	18.6	14.8	16.5	8.9	31.1	6.6	32.7	15.1	18.6	10.3	21.7	39.6	20.5	19.2	19.7	19.5	19.1
PDHX	"DLDBP, E3BP, OPDX, PDX1, proX"	ENSG00000110435	"Pyruvate dehydrogenase complex component X"	O00330	11	34915829-35020591	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 138.6;tongue: 125.2"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 115.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038484, HPA038485"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Plasma membrane"	Mitochondria	"HPA038484: AB_10669645, HPA038485: AB_10669540"	"unprognostic (1.60e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.34e-3)"	"unprognostic (3.56e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (1.83e-5)"	"unprognostic (2.24e-1)"	"unprognostic (8.28e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.82e-1)"	23.5	21.6	16.5	12.2	19.9	7.4	16.6	21.6	21.9	13.3	9.4	22.8	20.1	14.2	13.3	17.2	10.0	12.3	77.8	21.1	14.5	21.5	31.0	12.7	11.9	16.6	17.2	11.7	21.5	21.0	15.4	24.4	16.5	18.9	20.6	27.1	20.4	16.0	138.6	14.6	15.0	17.8	13.4	11.1	23.1	27.8	19.7	13.2	14.3	125.2	14.8	15.0	11.7	21.1	20.4	54.3	29.9	11.9	20.7	25.5	28.5	38.9	30.1	40.3	38.9	69.3	18.8	27.2	24.7	31.4	49.1	39.4	58.9	31.9	41.1	25.8	47.2	26.9	54.6	82.3	45.0	50.7	30.7	25.6	37.9	23.2	31.5	23.8	31.1	23.9	57.9	25.4	33.1	35.7	32.2	29.9	25.2	54.2	30.5	27.0	53.5	23.8	62.1	54.7	32.0	23.3	33.8	48.1	52.2	29.3	54.8	29.9	21.0	30.4	35.5	32.3	42.7	24.4	53.3	35.7	23.9	24.2	32.5	14.0	19.4	17.5	15.4	21.4	14.3	18.8	14.4	12.7	27.5	16.0	17.2	12.6	3.9	22.1	34.6	7.4	22.1	14.7	16.5	19.9	21.6	21.9	21.1	14.5	16.6	17.2	16.5	13.4	19.7	21.1	9.0	35.3	24.6	34.3	14.5	26.0	21.4	26.7	15.4	25.8	15.1	11.4	115.3	20.0	26.0	5.5	29.2	62.9	9.0	14.4	64.6	21.4	52.6	15.1	12.2	13.0	9.0	13.5	85.4	14.3	34.9	20.6	16.3	16.6	5.7	16.5	11.7	23.6	26.4	20.2	80.3	17.2	42.7	18.6	13.6	54.0	10.8	14.7	21.4	24.4	23.2	21.0	9.2	40.2	53.4	16.7	15.9	13.5	14.1	22.4	15.0	30.7	19.8	26.7	0.0	14.5	18.8	57.2	36.1	17.9	25.4	83.0	13.4	27.5	20.0	19.7
PDP2	"KIAA1348, PPM2B, PPM2C2"	ENSG00000172840	"Pyruvate dehyrogenase phosphatase catalytic subunit 2"	Q9P2J9	16	66878589-66895754	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019950, HPA062059"	Approved		Approved	Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	Mitochondria		"HPA019950: AB_1855156, HPA062059: AB_2684671"	"unprognostic (8.42e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.90e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (9.75e-7)"	"unprognostic (1.89e-1)"	"unprognostic (5.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (6.15e-2)"	6.0	2.6	3.6	1.8	4.6	1.5	3.6	6.9	5.2	2.0	7.7	3.8	5.4	2.6	3.4	3.7	3.4	2.0	1.8	3.6	4.3	9.2	8.6	3.4	2.6	6.2	4.6	7.4	4.5	6.1	3.0	4.0	6.8	3.8	4.1	5.0	3.6	2.6	2.5	2.1	3.2	2.1	3.5	2.0	3.0	3.8	5.7	2.5	9.3	4.1	3.0	2.1	2.2	4.3	9.8	11.7	7.1	14.1	18.7	9.6	8.9	5.0	19.2	11.3	17.0	23.9	6.7	13.5	6.9	6.9	10.8	12.1	20.8	11.3	10.9	3.2	10.5	6.8	5.9	15.9	10.1	8.8	11.5	7.4	8.3	16.1	16.6	12.3	4.9	14.9	13.3	9.5	10.3	6.3	17.1	6.2	8.4	6.5	14.7	16.7	9.9	21.4	6.0	10.3	14.3	8.0	15.9	6.5	6.0	5.5	8.7	4.3	4.6	7.0	9.2	4.2	7.5	16.6	16.9	13.4	9.5	6.9	7.0	1.1	0.2	1.2	3.8	0.1	3.1	1.0	1.8	3.2	0.8	2.1	2.6	3.0	0.7	4.2	0.1	0.5	0.6	1.3	3.6	4.6	6.9	5.2	3.6	4.3	6.2	4.6	6.8	3.5	5.7	4.3	2.5	9.6	22.9	8.1	3.1	5.2	6.4	1.3	6.2	9.6	5.8	4.2	5.1	8.6	3.1	9.2	14.6	12.8	3.3	13.3	7.9	3.4	0.2	3.5	3.2	3.3	3.6	0.8	8.8	2.9	2.2	4.1	3.1	4.3	6.3	14.4	7.1	20.5	2.4	5.0	7.6	4.2	2.0	1.3	0.4	2.4	3.1	1.2	3.6	3.7	0.4	8.1	7.2	4.5	4.3	3.4	6.6	4.5	4.5	8.9	7.4	9.9	1.2	6.7	0.0	5.9	2.7	12.6	5.7	8.0	2.4	3.6	3.4	4.0	5.5	6.5
PDPR	PDP3	ENSG00000090857	"Pyruvate dehydrogenase phosphatase regulatory subunit"	Q8NCN5	16	70114332-70162537	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 54.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048092, HPA070386"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Mitochondria		"HPA048092: AB_2680261, HPA070386: AB_2686263"	"unprognostic (8.30e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.91e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.04e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.90e-1)"	"prognostic favorable (8.36e-4)"	"unprognostic (8.85e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.24e-2)"	11.5	12.6	10.7	8.1	13.3	15.9	11.3	14.7	11.4	13.1	9.8	14.5	9.1	14.1	11.9	8.1	12.8	6.7	14.7	10.7	11.4	16.3	8.6	9.6	11.1	11.8	12.4	13.5	12.3	10.2	10.4	9.0	11.8	10.9	11.8	12.1	10.3	9.6	23.2	12.2	13.7	15.1	10.6	15.4	12.0	19.1	12.5	15.8	13.0	13.6	12.5	13.8	9.8	13.9	6.9	19.4	17.9	33.0	32.6	20.9	12.1	11.1	19.4	17.4	13.1	25.1	13.4	14.4	19.1	35.8	16.1	26.7	26.4	24.1	20.3	3.5	9.1	35.8	12.7	17.6	9.3	39.9	27.9	28.0	22.6	25.1	23.0	25.2	18.7	26.6	24.6	6.6	15.3	20.8	25.3	23.3	27.8	4.9	10.0	49.0	18.5	14.9	13.8	16.3	8.3	12.3	30.2	6.2	8.2	24.2	24.4	12.4	10.9	20.4	27.3	17.6	17.9	15.4	17.9	50.9	9.1	13.8	13.5	1.6	1.5	1.4	1.4	1.5	2.0	0.9	1.1	1.3	1.6	1.5	1.3	1.5	1.1	0.9	1.5	1.5	1.3	1.0	10.7	13.3	14.7	11.4	10.7	11.4	11.8	12.4	11.8	10.6	12.5	13.9	12.6	22.4	18.2	18.6	13.0	2.8	4.9	3.5	18.2	21.6	14.2	12.1	19.2	17.2	9.1	1.8	31.3	7.7	16.0	12.1	5.9	5.3	54.4	13.7	16.0	17.4	4.9	17.4	18.0	6.7	7.8	16.1	11.7	17.1	18.3	23.9	17.2	11.2	16.4	32.0	20.3	10.0	4.1	17.8	3.5	20.8	10.8	15.7	7.2	10.3	12.2	11.2	15.5	9.5	13.9	6.8	6.1	16.6	11.7	10.3	11.6	4.4	12.7	20.8	19.7	22.7	11.5	10.8	15.4	11.1	1.8	4.9	11.9	12.7	14.5	4.6
PDS5A	"KIAA0648, PIG54, SCC-112"	ENSG00000121892	"PDS5 cohesin associated factor A"	Q29RF7	4	39822863-39977956	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036661, HPA036662"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA036661: AB_2675233, HPA036662: AB_10696783"	"unprognostic (4.18e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.62e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.09e-2)"	"unprognostic (9.97e-3)"	"unprognostic (2.97e-1)"	"unprognostic (6.67e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.81e-2)"	19.4	16.2	13.3	23.2	15.0	29.4	24.3	19.7	18.1	20.6	17.0	23.0	19.7	19.9	20.2	25.8	15.9	16.5	14.5	13.4	13.9	22.0	33.4	22.7	33.2	15.1	13.6	23.6	21.0	29.7	10.6	22.9	15.5	18.5	23.9	20.9	20.1	15.9	17.7	24.3	19.4	19.4	14.2	21.4	20.6	14.0	14.2	42.0	28.5	19.6	34.7	22.8	15.9	23.5	54.8	40.0	50.3	53.4	47.5	47.5	40.2	43.4	40.9	50.1	49.6	39.2	60.2	106.6	46.5	51.6	79.5	29.4	86.9	50.5	71.7	36.1	33.2	73.1	47.6	41.3	47.5	90.2	60.1	31.5	55.9	53.3	78.2	44.5	64.7	62.1	88.0	43.8	52.0	38.5	113.2	78.8	28.6	51.4	26.7	104.3	89.6	38.9	48.2	54.6	69.5	41.2	59.9	40.7	39.0	37.5	41.4	78.7	61.5	56.4	58.6	41.2	74.3	37.0	69.7	112.3	40.1	90.6	45.3	2.3	1.2	1.9	2.3	1.6	3.0	2.0	2.2	2.5	1.8	2.5	2.6	2.1	0.4	3.0	1.1	2.2	2.0	1.0	13.3	15.0	19.7	18.1	13.4	13.9	15.1	13.6	15.5	14.2	14.2	23.5	36.2	86.6	70.3	75.7	52.3	56.6	37.0	29.3	51.8	32.7	42.6	30.1	40.5	32.9	45.8	22.0	60.5	32.4	50.8	39.2	7.9	22.0	9.7	34.9	50.0	40.7	30.5	69.6	120.5	25.8	39.1	36.8	41.3	52.8	29.1	45.1	40.0	58.2	30.9	13.5	115.3	36.3	28.5	46.6	54.5	10.0	32.9	44.6	46.2	119.9	38.7	13.3	42.2	98.5	138.0	38.9	28.2	33.1	52.8	53.7	28.5	27.4	25.5	27.9	32.9	36.3	31.1	44.2	48.5	66.9	68.2	38.7	49.9	30.9	40.4	59.6
PDS5B	"APRIN, AS3, CG008, FLJ23236, KIAA0979"	ENSG00000083642	"PDS5 cohesin associated factor B"	Q9NTI5	13	32586452-32778019	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 185.5;Inhibitory neurons: 222.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039513, HPA040015"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA039513: AB_10671999, HPA040015: AB_10671047"	"unprognostic (3.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.25e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.98e-2)"	"unprognostic (3.29e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.29e-2)"	"unprognostic (5.47e-2)"	"unprognostic (9.62e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.91e-2)"	11.8	8.1	3.8	9.4	6.2	23.3	12.6	7.6	14.3	18.5	0.0	13.5	6.1	19.0	13.2	7.1	12.8	7.8	7.4	7.5	8.3	9.8	9.6	10.9	13.3	0.7	0.4	15.9	7.5	9.3	9.8	10.1	0.0	12.8	8.2	11.1	8.5	9.8	11.4	10.4	10.6	11.7	0.3	13.4	9.8	12.1	0.9	20.9	10.4	8.0	10.7	10.2	11.4	10.5	12.4	7.3	32.7	17.6	15.3	11.0	9.2	20.5	13.7	17.1	17.1	10.1	20.2	45.0	7.2	10.1	17.2	16.1	23.9	12.9	20.2	36.1	9.0	40.7	13.1	14.2	9.0	37.6	24.0	8.6	6.4	14.3	12.8	11.2	13.1	17.8	14.4	29.6	15.8	15.9	45.3	28.2	24.2	25.9	8.9	45.7	45.2	15.5	11.0	10.2	8.5	20.4	23.6	23.0	9.2	19.7	22.2	24.8	26.0	16.3	15.7	11.8	12.4	9.0	10.7	37.4	7.0	25.1	24.1	3.0	2.7	4.0	3.0	2.4	3.5	3.4	3.5	3.2	3.5	4.5	3.4	3.3	3.3	2.8	3.3	2.3	2.8	1.6	3.8	6.2	7.6	14.3	7.5	8.3	0.7	0.4	0.0	0.3	0.9	10.5	50.3	16.0	30.2	86.8	33.9	28.9	23.8	14.6	34.1	42.3	24.3	17.0	26.7	21.5	24.6	27.6	25.0	24.9	35.9	17.4	5.9	14.8	14.5	24.2	79.7	42.2	31.8	22.9	185.5	16.0	18.5	46.4	19.4	19.9	23.5	55.3	23.9	28.0	18.5	47.1	222.6	21.8	16.2	39.0	38.1	13.7	67.1	31.3	35.6	131.2	39.4	15.8	34.0	154.8	155.1	14.7	17.9	62.4	43.8	23.4	15.9	12.9	31.3	20.8	72.3	46.9	51.4	49.5	60.6	17.0	29.3	6.2	37.1	41.8	21.1	17.0
PELP1	MNAR	ENSG00000141456	"Proline, glutamate and leucine rich protein 1"	Q8IZL8	17	4669774-4704337	"Predicted intracellular proteins"	Transcription	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053966, HPA056028, HPA060760"	Supported		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Nucleoli"		"HPA053966: AB_2682325, HPA056028: AB_2683013, HPA060760: AB_2684355"	"unprognostic (8.81e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.81e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (2.72e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.31e-2)"	"prognostic favorable (4.07e-5)"	"unprognostic (2.20e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.31e-1)"	"unprognostic (8.32e-2)"	"unprognostic (5.15e-2)"	14.2	17.8	34.9	13.4	34.1	10.9	14.9	29.9	33.1	19.9	21.2	18.3	11.8	21.5	6.2	19.5	19.8	8.8	23.1	33.4	30.7	16.8	17.7	13.1	16.3	34.2	33.3	21.9	17.5	15.5	23.5	11.4	33.8	20.5	7.5	8.7	15.3	12.2	46.8	18.7	17.4	10.8	31.8	20.5	17.5	32.8	33.6	12.5	17.2	18.1	12.0	19.5	17.0	33.9	41.8	89.8	34.8	55.3	26.5	19.5	77.9	29.6	20.5	40.1	42.7	88.1	30.0	100.0	44.4	23.4	28.5	62.6	65.1	46.3	22.6	52.1	93.2	44.6	45.1	72.0	34.2	36.4	57.5	23.9	28.2	49.5	41.3	20.7	30.2	52.9	54.7	42.6	22.4	57.2	68.9	42.7	57.3	40.2	29.7	71.7	30.8	49.3	28.2	31.2	34.8	46.5	50.8	36.9	39.4	33.1	44.6	24.3	30.7	30.9	43.5	47.3	57.9	22.7	42.5	41.6	34.9	37.1	40.6	0.2	0.7	2.0	0.9	1.0	0.9	0.8	0.9	0.7	0.8	1.3	0.9	1.3	0.2	1.3	1.2	1.1	0.6	0.7	34.9	34.1	29.9	33.1	33.4	30.7	34.2	33.3	33.8	31.8	33.6	33.9	10.4	22.4	30.1	11.1	18.5	14.8	14.8	15.7	21.1	24.0	13.5	12.4	22.6	8.6	20.9	9.2	16.7	30.9	15.3	11.8	1.9	15.9	64.7	16.6	17.3	13.7	12.6	14.1	10.6	14.6	28.3	16.6	16.8	17.6	30.9	21.1	5.0	10.6	16.9	35.3	13.0	18.6	12.2	6.0	20.4	27.0	9.3	10.4	10.6	5.6	65.1	10.7	5.2	5.0	11.5	11.4	11.7	19.2	23.6	19.3	8.3	4.7	22.3	17.8	6.6	16.8	14.8	31.3	67.5	20.0	16.3	21.2	17.4	16.6	21.9	13.0
PES1	"NOP7, PES"	ENSG00000100029	"Pescadillo ribosomal biogenesis factor 1"	O00541	22	30576625-30607083	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040210, HPA062439, HPA066670"	Supported		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA040210: AB_2676885, HPA062439: AB_2684764, HPA066670: AB_2685700"	"unprognostic (1.82e-1)"	"unprognostic (5.88e-2)"	"unprognostic (5.59e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.23e-3)"	"prognostic unfavorable (1.84e-9)"	"unprognostic (3.29e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.46e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.42e-1)"	33.3	41.0	26.3	29.2	28.6	35.5	32.2	26.7	30.5	31.8	27.1	29.6	21.7	35.5	21.2	43.6	29.4	20.2	28.8	26.9	26.2	38.7	48.2	26.2	32.3	27.1	27.2	34.2	57.3	30.1	21.8	21.5	27.6	32.9	19.6	9.2	29.3	21.5	48.8	45.3	28.2	22.5	25.8	34.4	35.7	40.0	27.0	23.8	27.1	20.0	27.3	35.0	31.9	30.0	132.2	146.6	53.0	113.7	59.9	58.4	81.6	84.7	69.6	141.6	110.0	170.6	55.2	177.2	74.4	97.0	110.3	89.4	163.9	153.5	103.1	76.4	159.8	85.9	80.8	149.0	149.3	209.6	86.8	82.7	94.7	148.3	147.3	68.3	93.0	62.4	144.6	69.9	87.7	164.3	102.6	209.8	103.1	128.3	106.7	129.0	91.7	173.3	78.9	88.7	91.4	94.6	84.2	94.6	117.8	42.0	66.8	106.1	74.2	165.9	126.1	85.3	145.1	88.1	81.0	178.6	116.2	94.9	109.0	7.5	24.9	6.4	18.9	29.8	23.2	20.2	17.4	18.1	26.8	20.0	19.4	18.0	0.9	20.0	22.3	23.2	14.3	29.3	26.3	28.6	26.7	30.5	26.9	26.2	27.1	27.2	27.6	25.8	27.0	30.0	23.6	3.2	18.9	4.9	17.4	22.6	23.4	32.7	22.2	6.5	14.1	12.2	3.8	24.3	22.1	25.8	8.4	34.9	7.8	19.6	25.4	48.0	44.4	11.7	13.8	23.2	23.4	24.6	4.3	43.9	40.0	15.4	22.4	10.6	18.3	24.4	27.8	22.8	38.4	3.3	4.3	22.4	22.4	27.8	12.6	14.3	19.9	21.2	21.4	2.8	29.0	13.5	16.5	6.6	5.1	38.7	16.2	20.3	28.3	26.4	31.3	55.1	24.6	8.9	19.7	23.2	20.7	28.7	20.9	25.9	22.9	28.5	13.5	19.9	29.7	15.1
PFAS	"FGARAT, GATD8, KIAA0361, PURL"	ENSG00000178921	"Phosphoribosylformylglycinamidine synthase"	O15067	17	8247618-8270491	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 49.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022140, HPA022886"	Enhanced		Approved	Vesicles		NA	NA		670000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA022140: AB_1855232, HPA022886: AB_1855233"	"unprognostic (1.90e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.19e-3)"	"unprognostic (2.59e-1)"	"unprognostic (6.40e-2)"	"prognostic unfavorable (9.19e-4)"	"unprognostic (3.19e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.08e-3)"	"unprognostic (9.51e-3)"	"unprognostic (3.63e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.88e-3)"	"unprognostic (3.85e-1)"	8.4	9.9	4.7	7.8	5.1	9.8	8.2	6.2	5.8	7.8	2.8	6.7	4.8	9.0	2.6	8.4	8.0	2.8	6.3	5.1	3.3	11.0	10.1	5.8	9.8	3.9	3.9	9.7	10.3	5.6	5.5	5.2	4.6	6.9	5.6	5.8	6.4	4.7	6.4	6.8	7.7	6.8	3.3	11.0	7.8	7.8	3.9	7.5	7.8	3.2	8.2	7.6	6.2	6.0	15.6	67.0	33.8	50.2	12.1	10.0	38.7	19.4	7.4	35.1	26.4	32.9	13.7	69.8	30.8	11.4	12.4	35.1	78.5	25.6	25.8	30.6	64.0	40.0	63.2	41.9	10.4	32.9	28.3	9.5	6.2	40.5	25.5	9.9	29.5	36.6	54.8	10.1	13.7	23.0	58.1	28.4	55.7	8.5	29.9	86.0	35.2	32.6	16.1	25.5	20.4	31.7	24.1	15.3	22.2	17.9	15.3	14.9	20.9	19.2	25.0	35.7	49.0	11.8	23.5	33.7	21.0	45.4	32.9	20.2	5.1	12.7	6.8	4.5	8.7	14.8	8.8	7.9	4.4	16.7	10.9	8.6	49.1	5.2	3.7	12.9	5.0	2.3	4.7	5.1	6.2	5.8	5.1	3.3	3.9	3.9	4.6	3.3	3.9	6.0	2.9	0.0	7.9	3.9	6.0	2.4	1.7	1.9	1.8	8.1	4.5	3.7	4.3	1.5	4.1	3.7	6.2	5.2	3.2	2.1	0.0	3.7	2.1	2.4	5.9	3.6	0.0	9.2	5.8	3.0	4.3	4.0	5.6	3.7	1.3	9.7	2.5	4.2	4.6	1.7	5.4	3.5	2.0	2.5	1.4	1.1	5.3	3.4	3.6	4.7	4.5	1.6	4.1	6.6	3.9	1.9	4.9	1.5	5.3	2.9	0.8	2.7	5.1	7.3	0.0	5.1	3.2	5.6	8.8	3.9	2.0	3.1	3.3	7.7	6.2	1.4
PFN1		ENSG00000108518	"Profilin 1"	P07737	17	4945652-4949061	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 5241.0;monocytes: 4824.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037134, CAB037140"	Enhanced		Approved	Cytosol		NA	NA		660000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"CAB037134: AB_1079599, CAB037140: AB_1079598"	"unprognostic (1.07e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.65e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.01e-3)"	"unprognostic (7.83e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.40e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (3.62e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.28e-1)"	573.1	365.8	278.0	1133.4	302.0	1613.0	397.0	323.2	333.0	393.7	289.2	970.2	764.0	734.4	346.4	582.7	500.9	372.7	343.8	281.8	301.5	460.9	661.6	559.2	1357.9	347.3	325.4	247.7	246.4	311.3	198.9	581.1	348.6	419.4	808.4	71.8	346.9	601.4	337.9	449.8	772.9	1034.7	315.2	910.8	675.1	116.2	366.2	1197.6	269.2	238.7	1440.0	842.6	425.0	355.2	3019.5	4276.8	1461.5	1205.2	778.8	977.1	1972.7	2416.8	1970.4	2568.6	1923.7	1684.1	1181.1	2476.9	1892.0	2542.0	1453.6	1825.4	1383.6	3040.5	2049.6	3560.1	2355.1	2516.6	2034.3	2225.8	2144.0	1630.4	5006.0	1152.4	1331.9	1957.6	1939.8	1477.6	2361.3	1646.4	1488.6	1736.7	3150.5	1815.0	2469.9	3448.0	2095.2	1474.7	2297.3	2451.9	2035.1	1494.6	2491.7	1909.8	564.0	1586.2	1910.5	1180.9	1679.7	1226.8	1121.0	1359.7	2731.7	2136.6	1675.1	1512.3	3969.3	931.3	1070.7	1799.3	1834.4	1949.7	3316.4	8100.1	8206.3	13914.4	9850.0	10858.8	6780.3	5722.0	8185.7	9586.6	9920.0	4970.0	5238.0	7604.7	9387.0	9112.1	13547.4	7809.7	11245.6	23570.1	278.0	302.0	323.2	333.0	281.8	301.5	347.3	325.4	348.6	315.2	366.2	355.2	561.8	112.2	176.1	12.1	1070.6	1806.0	873.2	3658.3	1003.3	25.0	767.4	914.1	147.6	457.5	1020.0	741.2	0.0	1911.0	1725.6	1733.8	992.0	1866.6	19.7	313.4	546.1	806.6	603.7	713.5	7.1	1625.2	5241.0	599.9	733.4	422.7	486.5	291.2	637.5	754.3	4094.2	38.7	6.4	1399.7	1452.6	1434.3	2934.8	31.0	263.8	1854.7	873.4	21.5	4824.7	99.8	3216.3	9.0	37.2	2933.5	1585.7	375.0	927.8	1238.2	1472.2	1671.2	559.4	17.8	506.2	282.3	1838.4	97.4	355.4	1170.1	1513.5	1682.8	1804.7	410.7	1355.5	1177.9
PGAM5	"BXLBv68, MGC5352"	ENSG00000247077	"PGAM family member 5, mitochondrial serine/threonine protein phosphatase"	Q96HS1	12	132710819-132722734	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Necrosis	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036978, HPA036979, CAB068215"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB068215: AB_2665674, HPA036978: AB_10964347, HPA036979: AB_10960559"	"unprognostic (9.57e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.13e-6)"	"unprognostic (3.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.92e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.53e-2)"	10.5	17.7	13.0	17.0	12.7	16.3	9.7	12.7	17.0	9.8	10.1	16.1	15.2	10.9	6.6	23.9	12.4	8.7	20.0	19.0	12.5	14.3	28.9	9.3	21.2	9.3	9.7	7.2	25.8	10.7	9.9	10.7	10.1	9.4	11.3	6.0	15.5	11.5	33.2	17.1	13.2	11.3	7.9	12.8	13.3	16.5	10.8	14.8	11.6	19.0	16.1	15.6	11.8	11.3	72.2	134.3	28.2	79.5	19.4	15.6	66.1	37.4	22.0	59.1	33.0	168.6	40.2	92.3	67.2	31.2	30.4	61.2	132.9	67.5	24.1	47.3	106.7	110.7	61.6	89.2	44.0	105.8	61.8	19.4	48.8	69.0	73.6	19.3	43.6	73.4	143.3	36.9	23.5	128.5	144.5	105.7	108.0	61.8	94.4	109.4	31.2	73.3	38.4	97.4	102.8	58.0	62.2	86.1	38.9	22.2	108.9	57.5	38.2	29.9	65.5	60.6	89.9	77.2	124.8	133.5	38.8	85.3	51.1	4.9	1.1	0.3	1.1	1.2	1.8	1.7	1.3	1.3	1.0	1.7	1.3	1.7	0.9	1.6	1.7	3.3	1.1	0.8	13.0	12.7	12.7	17.0	19.0	12.5	9.3	9.7	10.1	7.9	10.8	11.3	6.6	3.2	6.1	3.9	8.9	11.5	16.7	2.6	2.2	9.5	7.8	5.5	15.1	15.7	1.5	5.5	14.6	7.6	11.9	11.7	5.9	5.8	14.5	6.3	6.3	7.0	13.1	5.0	5.1	7.9	14.4	4.9	4.1	9.3	0.0	7.1	5.7	22.4	7.3	6.7	3.9	8.9	2.0	6.9	5.8	20.6	5.9	4.7	3.6	1.9	5.3	4.4	3.1	2.0	2.3	7.5	6.9	6.8	9.7	19.5	5.2	11.5	4.5	12.9	6.6	8.0	6.4	15.1	10.1	10.8	17.3	6.2	7.4	9.2	15.7	16.1
PGAP2	"CWH43-N, FRAG1, MRT17, MRT21"	ENSG00000148985	"Post-GPI attachment to proteins 2"	Q9UHJ9	11	3797724-3826371	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"GPI-anchor biosynthesis"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"epididymis: 216.2"	"Group enriched"	"Detected in all"	4	"Cytotrophoblasts: 74.9;Early spermatids: 147.6;Late spermatids: 296.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063099	Approved		Approved	Microtubules		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Microtubules		"HPA063099: AB_2684940"	"unprognostic (1.94e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.18e-2)"	"unprognostic (5.13e-2)"	"unprognostic (6.06e-2)"	"prognostic unfavorable (7.49e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.44e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.66e-3)"	"unprognostic (4.13e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.67e-2)"	8.9	14.9	16.4	6.4	17.5	9.5	11.5	15.9	18.2	13.7	17.0	13.9	18.4	8.3	216.2	34.9	19.2	7.6	21.7	16.6	16.3	13.9	30.9	16.2	10.4	17.8	16.6	11.2	28.9	17.6	15.1	14.2	17.2	16.7	13.3	9.2	18.4	33.4	11.4	48.0	16.0	7.6	16.3	11.3	14.1	28.5	17.3	13.1	19.4	9.5	13.5	10.9	18.8	20.9	27.1	36.3	17.2	15.8	15.2	28.9	27.3	10.9	9.4	15.6	14.2	31.1	46.6	29.0	12.3	8.0	9.4	44.1	27.6	30.2	15.5	35.5	30.9	17.7	14.7	38.4	10.7	23.0	22.0	22.8	41.9	11.6	39.3	10.2	18.0	38.4	38.4	41.8	16.6	39.9	28.0	19.3	32.4	56.7	21.5	44.0	2.0	27.8	30.0	31.6	22.7	22.5	19.7	52.0	12.3	20.1	43.2	9.6	16.5	9.9	9.2	23.8	6.8	26.2	31.3	21.6	12.9	15.3	19.1	3.0	6.4	5.9	9.1	9.2	11.0	11.4	13.2	11.3	9.7	12.7	17.3	11.8	18.2	10.7	9.2	6.6	13.3	8.8	16.4	17.5	15.9	18.2	16.6	16.3	17.8	16.6	17.2	16.3	17.3	20.9	8.4	12.8	10.6	7.5	10.6	31.7	15.1	23.3	33.6	14.1	19.2	18.0	13.7	11.5	13.0	12.9	22.9	74.9	5.2	11.4	1.9	15.6	147.6	11.7	6.6	9.0	3.0	13.2	15.4	21.3	18.4	7.6	10.2	14.7	8.8	13.4	3.6	14.6	16.0	3.3	19.1	10.5	10.2	5.0	8.0	296.8	8.7	5.5	5.4	4.7	8.9	9.3	8.2	10.6	23.0	14.2	9.3	6.8	12.2	9.1	39.8	10.2	15.2	9.5	6.6	11.0	7.2	17.7	21.6	31.1	28.6	29.3	9.4	11.8	20.1	13.0
PGM2	FLJ10983	ENSG00000169299	"Phosphoglucomutase 2"	Q96G03	4	37826660-37862937	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Muller glia cells: 334.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040676	Uncertain		Approved	"Intermediate filaments"		NA	NA		1700000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"	"Intermediate filaments"		"HPA040676: AB_2677076"	"unprognostic (3.11e-2)"	"unprognostic (1.01e-2)"	"prognostic favorable (2.14e-5)"	"unprognostic (2.29e-1)"	"unprognostic (3.94e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.09e-3)"	"unprognostic (5.32e-2)"	"unprognostic (7.02e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.22e-2)"	"unprognostic (6.72e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.97e-2)"	"unprognostic (1.02e-1)"	8.2	11.2	3.2	9.5	3.2	10.1	8.8	4.6	4.5	10.9	4.5	9.8	7.6	10.1	4.9	36.6	7.9	11.3	5.6	4.9	3.1	8.0	14.8	6.9	10.0	3.4	3.0	6.9	4.4	8.4	3.0	11.7	3.6	7.8	9.0	18.2	7.7	5.2	1.2	17.5	7.8	13.7	3.5	8.3	6.1	5.3	3.1	10.2	9.7	1.9	22.7	18.9	16.4	3.7	27.4	9.5	14.6	16.6	10.2	12.4	19.8	32.6	18.9	27.8	26.4	18.0	19.2	38.0	15.5	17.8	34.9	13.8	36.0	32.0	65.1	23.0	21.0	40.1	15.2	12.3	23.2	44.2	26.5	17.0	36.0	22.0	18.6	16.2	41.6	31.2	53.6	6.2	24.3	15.6	49.8	49.6	17.3	19.2	15.5	35.8	23.1	14.8	15.7	52.3	31.8	10.8	17.5	23.3	12.0	19.5	21.5	45.4	37.0	19.7	24.9	27.3	67.1	14.0	38.4	40.3	10.9	56.2	32.9	19.8	27.5	67.2	9.8	22.4	11.5	9.4	8.0	11.1	31.9	5.5	7.7	9.8	33.6	28.1	18.2	7.1	14.9	17.0	3.2	3.2	4.6	4.5	4.9	3.1	3.4	3.0	3.6	3.5	3.1	3.7	16.9	0.0	8.2	5.2	13.8	14.7	14.3	32.9	17.6	7.8	12.6	6.9	4.5	14.3	23.1	3.7	0.0	31.9	11.9	10.6	5.9	16.0	0.9	9.0	12.7	22.9	7.2	8.0	8.3	11.8	37.8	10.3	5.6	14.7	12.7	56.4	42.5	9.7	37.9	6.7	5.6	9.2	4.1	24.4	15.2	2.0	8.4	24.5	5.4	4.7	46.1	334.1	13.4	8.0	0.9	14.5	6.7	9.8	10.5	17.7	6.9	10.4	9.8	16.0	13.1	5.8	23.8	0.6	2.1	42.5	32.1	79.8	14.7	19.8	12.9	20.4
PHF23	"FLJ16355, MGC2941"	ENSG00000040633	"PHD finger protein 23"	Q9BUL5	17	7235029-7239722	"Disease related genes, Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052410	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 28: Keratinocytes - Keratinization"	Nucleoplasm		"HPA052410: AB_2681822"	"unprognostic (1.76e-2)"	"unprognostic (6.12e-2)"	"unprognostic (4.72e-2)"	"unprognostic (6.44e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.40e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.48e-2)"	22.0	39.6	21.3	24.5	21.0	10.1	19.1	21.6	25.1	22.3	20.7	24.2	22.8	23.6	23.3	35.3	20.2	20.2	18.0	22.7	23.1	22.5	26.3	18.3	30.4	25.4	30.3	19.0	17.9	24.3	20.8	23.0	25.1	24.0	17.7	15.2	19.1	22.8	22.6	19.3	21.4	22.9	21.8	28.4	19.7	24.8	23.1	36.7	24.3	21.9	34.2	29.1	23.3	22.9	49.6	78.1	85.2	56.0	54.4	54.7	33.4	65.8	72.2	78.5	66.7	42.5	34.2	72.5	39.7	71.2	55.4	46.6	81.1	54.1	64.6	73.7	67.4	54.6	51.5	47.8	87.5	26.4	82.7	75.9	51.5	68.4	45.6	82.3	75.6	34.8	61.1	17.4	92.7	37.9	45.7	53.5	80.7	35.7	34.3	61.5	41.5	35.4	83.9	27.4	28.0	89.0	47.0	37.9	75.2	50.9	46.0	30.7	69.5	69.0	47.9	41.2	82.8	32.0	35.2	37.6	62.0	42.9	60.6	23.1	8.2	15.5	16.2	6.6	13.9	12.0	12.3	17.9	9.3	15.6	10.0	12.5	15.9	10.7	9.5	16.7	11.2	7.9	21.3	21.0	21.6	25.1	22.7	23.1	25.4	30.3	25.1	21.8	23.1	22.9	22.3	6.4	9.2	2.0	21.9	84.1	22.7	21.6	56.9	13.6	36.5	17.7	18.7	15.7	17.2	22.0	6.2	32.1	31.2	24.0	39.2	39.2	19.8	20.2	25.7	26.0	18.6	33.6	3.7	21.5	21.0	20.0	8.6	22.1	17.7	15.2	17.5	13.8	37.0	16.8	2.8	18.5	26.4	20.9	40.3	24.8	24.8	20.8	33.8	4.7	37.3	14.5	35.0	3.5	2.5	35.1	26.0	17.3	23.7	28.9	16.6	30.1	11.4	11.0	39.5	14.8	29.1	30.9	22.4	39.2	83.3	76.8	21.3	30.5	16.5	27.1
PHF6	"BFLS, BORJ, CENP-31, KIAA1823, MGC14797"	ENSG00000156531	"PHD finger protein 6"	Q8IWS0	X	134373312-134428791	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant, Epilepsy, Hypotrichosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 149.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001023	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Nucleoli"		"HPA001023: AB_1079606"	"unprognostic (2.38e-3)"	"unprognostic (8.21e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.04e-3)"	"unprognostic (6.03e-3)"	"unprognostic (5.20e-3)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (1.81e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (9.96e-4)"	"unprognostic (1.09e-1)"	"unprognostic (5.96e-2)"	"unprognostic (4.84e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.29e-2)"	6.7	18.0	6.6	14.2	7.9	8.4	10.8	10.3	9.3	8.3	6.2	9.1	8.9	9.7	32.7	8.2	7.9	6.6	6.7	7.1	8.4	10.2	7.7	6.8	25.3	8.3	7.8	33.3	9.5	16.3	6.2	9.3	8.4	9.2	10.3	12.0	13.2	11.0	5.0	8.3	8.8	8.1	8.6	13.3	9.3	9.2	7.7	20.8	13.2	6.8	29.8	8.6	7.1	11.5	28.2	22.9	98.7	40.8	17.9	22.9	18.7	27.6	22.1	29.1	35.6	13.9	28.5	45.1	61.8	16.9	28.3	24.6	69.4	31.3	48.6	37.2	32.1	44.3	37.7	16.1	19.2	44.2	23.3	15.3	23.2	31.7	39.2	29.1	41.1	43.1	32.6	21.8	35.8	18.7	71.3	21.8	30.1	38.3	31.0	69.6	36.0	34.5	30.7	33.8	34.1	39.9	21.2	19.3	29.5	29.0	18.0	24.0	31.5	26.8	19.2	34.0	42.9	11.1	27.3	60.5	17.7	51.4	34.3	5.9	6.3	4.1	8.0	6.6	8.7	18.7	8.2	7.3	9.5	12.4	9.6	8.2	2.6	11.0	8.4	11.7	9.1	5.5	6.6	7.9	10.3	9.3	7.1	8.4	8.3	7.8	8.4	8.6	7.7	11.5	25.5	22.4	18.4	13.1	42.7	13.0	14.3	28.7	22.2	22.4	17.5	20.3	16.3	11.5	17.8	16.5	18.8	11.8	27.1	9.9	23.5	14.2	3.7	13.0	29.1	18.7	11.4	31.3	27.8	13.8	7.6	17.2	14.8	18.7	24.6	149.5	20.0	15.2	15.1	18.5	23.4	12.5	10.2	15.5	10.2	3.1	20.8	20.2	7.2	29.0	25.3	27.9	21.6	33.2	46.7	14.4	18.7	15.4	23.1	12.3	9.5	19.8	16.5	19.7	26.3	21.0	21.9	10.3	22.0	25.7	11.5	4.7	22.6	69.3	17.7	11.5
PHKA2	"PHK, PYK"	ENSG00000044446	"Phosphorylase kinase regulatory subunit alpha 2"	P46019	X	18892298-18984114	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	Calmodulin-binding	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 42.7;Hepatocytes: 57.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002912	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA002912: AB_10961321"	"unprognostic (3.90e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.25e-5)"	"unprognostic (2.07e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.82e-1)"	"prognostic favorable (7.68e-4)"	"unprognostic (7.51e-2)"	"prognostic unfavorable (1.55e-5)"	"unprognostic (2.05e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.16e-2)"	"prognostic favorable (2.96e-5)"	12.7	9.6	4.6	6.8	6.3	15.0	7.6	6.6	5.5	9.0	6.9	6.8	12.5	10.5	6.5	6.3	9.9	8.1	12.6	5.6	5.4	6.7	34.3	6.4	7.7	6.9	5.6	16.8	15.2	8.1	12.8	10.5	6.7	9.7	6.5	10.6	9.5	7.1	7.8	8.8	10.1	6.2	5.5	9.3	8.6	9.7	6.0	12.6	10.1	14.3	7.4	6.2	8.1	7.3	11.3	10.6	6.1	10.2	8.2	7.5	16.6	4.9	4.1	7.1	7.7	11.3	7.3	13.3	3.6	6.4	11.2	10.3	11.0	12.8	7.6	6.5	11.2	15.9	17.6	13.8	5.8	15.2	19.7	12.6	8.3	8.7	12.5	11.8	7.4	13.8	5.3	8.0	5.0	12.0	16.0	25.2	7.5	5.2	11.2	12.4	12.5	14.9	4.6	5.0	5.2	8.0	14.8	15.3	6.8	20.3	18.9	8.8	13.2	9.6	5.3	10.3	7.6	7.6	6.7	10.1	5.4	8.1	5.2	4.3	3.2	7.2	2.0	3.8	2.1	1.6	1.7	1.5	2.1	1.7	1.9	1.9	5.4	3.0	2.5	1.1	2.3	1.9	4.6	6.3	6.6	5.5	5.6	5.4	6.9	5.6	6.7	5.5	6.0	7.3	6.1	9.6	12.9	27.7	5.7	6.5	5.4	6.0	8.6	11.1	8.0	7.4	20.1	12.8	5.1	9.2	10.4	16.8	3.4	9.6	0.0	7.5	7.2	6.4	11.8	7.3	4.2	14.5	15.2	5.1	17.5	5.3	4.1	7.2	1.3	42.7	20.3	57.4	8.0	5.0	19.9	7.4	4.1	18.9	3.8	5.3	7.5	10.5	5.4	13.1	8.3	17.0	7.2	16.6	16.9	6.3	12.6	7.9	7.4	6.9	12.4	4.8	4.1	13.3	0.0	7.4	5.9	7.9	7.9	8.6	4.7	10.5	7.4	12.1	10.7	3.6
PI4K2B	"FLJ11105, PI4KIIB, PIK42B"	ENSG00000038210	"Phosphatidylinositol 4-kinase type 2 beta"	Q8TCG2	4	25160663-25279204	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 57.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004099	Enhanced		Supported	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA004099: AB_1855353"	"unprognostic (1.02e-1)"	"unprognostic (6.34e-3)"	"prognostic favorable (9.64e-5)"	"unprognostic (2.75e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.68e-2)"	"unprognostic (7.54e-2)"	"unprognostic (7.75e-2)"	"unprognostic (5.06e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.07e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.47e-2)"	7.9	8.9	3.4	14.0	3.9	14.1	16.5	3.6	4.5	11.4	5.8	18.7	39.0	8.0	5.8	16.7	8.7	8.3	4.5	3.2	4.1	12.9	57.9	16.5	18.1	4.3	3.6	5.2	9.5	7.7	3.4	12.0	4.5	11.4	20.4	4.9	23.5	7.9	2.4	13.1	31.6	9.1	4.5	13.5	22.7	12.1	3.7	19.7	24.1	4.8	18.9	14.3	8.1	5.3	33.8	9.9	16.7	14.6	18.2	33.9	31.3	50.8	48.6	48.4	58.1	14.0	37.7	86.3	11.5	45.3	37.5	14.7	37.3	24.6	41.7	28.9	12.2	30.4	23.3	26.1	14.2	61.9	21.0	21.6	17.9	18.6	19.2	12.9	28.0	27.0	20.7	76.2	37.0	18.8	58.3	39.7	23.6	40.5	13.6	34.4	58.1	47.5	32.2	32.2	28.9	6.2	24.5	17.1	12.0	17.0	25.7	27.3	33.8	31.8	8.4	18.3	32.5	76.3	49.5	77.4	34.5	45.4	30.6	5.3	1.1	3.4	1.5	1.2	1.0	1.4	1.5	1.5	0.8	1.2	1.2	1.4	1.7	0.9	0.9	1.5	3.5	0.6	3.4	3.9	3.6	4.5	3.2	4.1	4.3	3.6	4.5	4.5	3.7	5.3	5.6	6.4	18.5	21.5	14.9	15.0	15.8	9.9	8.0	2.1	8.4	5.3	0.0	5.7	12.2	9.2	0.0	21.6	6.7	20.2	5.9	5.5	1.0	10.0	3.4	7.1	8.4	25.7	8.7	7.1	12.6	6.1	16.3	8.5	0.0	3.5	6.8	40.4	10.3	1.7	13.7	13.7	8.2	15.4	13.9	1.0	4.4	8.6	5.4	11.2	10.3	0.7	4.1	30.2	20.1	5.8	8.2	4.5	27.4	14.1	16.8	20.3	10.4	3.4	0.0	5.3	7.2	9.6	10.3	18.3	15.6	13.5	10.3	4.4	13.9	18.2
PIAS1	"DDXBP1, GBP, GU/RH-II, ZMIZ3"	ENSG00000033800	"Protein inhibitor of activated STAT 1"	O75925	15	68054309-68198603	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 248.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005743, CAB012304"	Supported		Approved	Microtubules		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Microtubules		"CAB012304: AB_777265, HPA005743: "	"unprognostic (1.36e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.75e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.10e-3)"	"unprognostic (6.93e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.28e-2)"	10.2	10.2	5.6	14.1	7.0	23.2	11.7	11.9	9.4	15.3	5.7	12.0	12.0	14.7	13.9	15.1	14.0	12.7	11.5	7.6	8.3	10.8	9.7	14.9	18.2	4.8	4.9	22.7	11.3	12.5	6.5	12.9	4.9	15.5	11.1	21.3	10.4	17.7	12.4	12.6	12.3	13.6	4.7	15.3	12.7	20.6	6.9	24.9	18.8	16.3	17.6	14.1	10.8	7.0	13.1	17.6	27.9	13.6	16.4	16.8	8.4	19.6	19.8	21.1	23.6	14.7	19.2	24.6	13.1	16.5	13.5	35.5	41.5	10.7	22.7	14.2	15.5	29.6	17.3	16.3	10.7	29.0	23.0	15.2	30.5	13.7	12.4	16.2	15.1	14.1	20.7	18.3	16.3	10.7	24.1	15.0	15.8	14.4	9.9	21.2	26.8	24.1	13.8	16.4	23.3	9.8	13.1	12.1	13.4	25.4	10.7	26.9	13.5	18.3	19.3	10.6	14.6	13.6	19.2	26.2	11.4	30.2	13.7	33.8	31.4	41.9	18.7	23.9	19.3	20.8	18.7	19.8	30.7	19.5	22.3	19.6	70.8	19.2	25.7	16.7	21.5	27.3	5.6	7.0	11.9	9.4	7.6	8.3	4.8	4.9	4.9	4.7	6.9	7.0	38.7	109.0	58.4	106.7	91.5	38.0	58.2	29.4	132.1	72.2	30.3	25.1	28.3	45.8	35.9	12.9	106.3	35.5	61.3	35.2	21.5	32.5	67.1	23.5	48.2	42.0	27.6	41.0	165.7	22.6	20.4	37.5	43.8	27.2	56.3	30.6	40.0	34.9	45.8	48.8	136.6	30.2	14.2	102.4	38.8	33.4	123.6	62.6	21.4	248.3	104.9	57.8	56.7	120.1	126.2	25.5	25.0	113.6	59.3	48.3	38.1	20.0	25.0	64.8	32.9	47.7	31.6	66.7	45.4	51.1	33.0	36.0	67.6	22.6	22.4	64.5
PIGA	GPI3	ENSG00000165195	"Phosphatidylinositol glycan anchor biosynthesis class A"	P37287	X	15319452-15335554	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 83.5;Suprabasal keratinocytes: 55.0;Urothelial cells: 62.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 22.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001174	Approved					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"			"HPA001174: AB_2666220"	"unprognostic (1.15e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.99e-3)"	"unprognostic (2.24e-2)"	"unprognostic (7.37e-3)"	"unprognostic (3.93e-3)"	"prognostic unfavorable (7.64e-4)"	"unprognostic (1.85e-3)"	"unprognostic (5.97e-3)"	"unprognostic (2.24e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.18e-2)"	2.1	2.9	2.2	2.9	2.7	9.2	3.1	2.0	3.6	2.8	0.8	3.7	1.9	3.0	3.5	5.1	2.8	3.7	2.0	1.6	1.8	3.8	4.5	6.7	3.5	2.8	2.7	2.4	4.0	3.3	0.6	3.6	2.2	2.7	3.7	4.5	4.6	1.7	1.3	1.4	2.4	2.5	2.2	2.0	2.8	2.6	2.3	4.0	4.4	1.3	4.7	10.3	1.9	5.8	14.5	8.3	9.1	5.0	2.6	2.8	7.0	3.7	5.7	7.4	7.3	9.2	6.5	6.6	2.9	2.9	9.0	5.8	14.3	11.4	12.6	6.1	9.5	5.5	11.0	5.8	4.5	8.8	2.9	3.3	8.1	10.0	16.0	2.4	5.0	5.2	6.4	7.0	5.1	9.2	9.0	3.4	4.7	5.5	8.2	3.0	12.4	10.7	5.6	9.4	6.2	9.4	6.9	6.8	14.4	8.7	6.6	7.4	4.2	6.2	2.4	14.0	7.3	5.4	7.2	9.9	9.4	5.6	7.9	22.9	3.8	4.3	2.6	6.3	3.7	3.0	4.1	2.6	3.9	2.1	3.8	2.9	5.2	1.8	8.6	2.6	4.1	2.7	2.2	2.7	2.0	3.6	1.6	1.8	2.8	2.7	2.2	2.2	2.3	5.8	6.4	19.2	83.5	6.8	7.2	29.6	41.9	10.6	13.6	3.5	13.2	10.5	6.9	5.7	20.1	3.7	0.0	6.3	7.4	8.4	11.7	7.6	5.4	30.8	9.8	7.9	10.7	9.3	2.2	5.8	10.2	12.7	17.9	45.6	33.6	3.0	3.6	4.4	8.8	3.3	2.0	5.0	2.0	8.4	43.4	4.4	3.1	18.1	28.4	2.8	3.6	4.2	4.1	1.0	7.7	8.3	5.1	3.0	5.5	32.0	2.1	6.6	19.8	3.0	13.1	10.6	16.3	2.7	3.7	35.5	55.0	28.0	11.7	2.9	6.0	62.2
PIGM	GPI-MT-I	ENSG00000143315	"Phosphatidylinositol glycan anchor biosynthesis class M"	Q9H3S5	1	160024953-160031990	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA047418	Uncertain					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"			"HPA047418: AB_2680039"	"unprognostic (1.55e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.89e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.85e-2)"	"prognostic favorable (3.27e-4)"	"unprognostic (2.63e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.01e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.50e-1)"	3.2	4.2	3.0	4.0	4.8	1.8	5.2	4.6	3.7	4.1	3.3	3.8	4.4	3.6	6.0	3.4	3.9	3.3	2.6	3.2	4.0	4.0	5.2	3.6	4.3	5.7	4.3	4.0	7.8	6.7	3.6	3.4	5.3	6.1	4.3	8.1	6.3	4.1	1.4	5.5	4.8	3.2	4.7	4.2	4.6	3.5	4.4	4.9	6.1	1.7	4.0	3.0	2.6	8.6	5.8	5.2	6.1	9.1	8.0	6.5	2.0	8.6	5.4	5.6	5.1	2.8	10.3	4.1	6.9	5.6	4.8	11.5	6.9	6.9	7.0	8.7	7.2	9.3	6.8	4.2	4.9	12.1	7.0	6.0	4.5	6.6	5.0	4.8	4.7	8.9	5.1	7.5	6.5	9.8	7.9	6.4	6.5	10.9	7.4	2.3	6.4	18.0	6.1	7.9	8.7	13.5	9.4	11.0	6.9	5.8	20.7	14.4	6.7	7.3	6.4	11.1	5.3	13.5	16.0	0.2	6.7	6.1	8.3	8.9	12.4	5.3	6.7	10.4	6.9	5.1	6.7	5.3	7.7	4.8	8.4	6.7	2.2	8.9	13.8	9.1	7.8	7.3	3.0	4.8	4.6	3.7	3.2	4.0	5.7	4.3	5.3	4.7	4.4	8.6	10.0	12.8	19.8	7.5	7.7	4.2	4.7	6.4	17.1	16.1	14.1	9.0	5.3	17.2	13.2	16.5	10.4	7.6	5.0	7.3	1.9	13.3	6.7	5.5	12.5	10.0	12.6	14.1	5.7	18.5	3.2	11.9	7.1	8.1	5.1	9.6	15.4	22.2	7.3	16.8	5.5	12.8	2.0	14.5	5.0	3.9	8.4	9.2	8.8	4.7	12.3	27.9	9.2	12.5	23.1	12.0	5.3	9.1	11.2	8.1	10.1	6.6	10.2	13.6	19.7	10.7	8.6	29.3	8.1	17.0	4.5	1.8	7.3	11.0	12.1	3.7
PIGT		ENSG00000124155	"Phosphatidylinositol glycan anchor biosynthesis class T"	Q969N2	20	45416084-45456934	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (6.06e-2)"	"unprognostic (4.60e-3)"	"unprognostic (7.63e-2)"	"unprognostic (6.00e-2)"	"unprognostic (6.18e-3)"	"unprognostic (6.68e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.70e-2)"	"unprognostic (3.32e-1)"	"prognostic favorable (2.51e-4)"	"unprognostic (5.48e-2)"	"unprognostic (7.60e-2)"	"unprognostic (9.21e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.43e-2)"	57.4	51.9	30.7	39.4	38.9	70.8	52.7	41.2	37.5	65.5	44.6	75.8	49.9	69.6	89.5	37.7	61.2	48.3	113.5	29.9	37.2	47.1	48.9	45.3	26.6	41.0	38.1	46.1	65.0	105.4	48.9	48.5	38.9	39.5	77.2	13.0	48.2	55.6	61.2	46.0	54.3	69.7	37.6	36.5	62.1	38.1	38.8	25.8	57.0	51.8	27.4	57.0	42.8	47.6	79.0	95.3	35.8	138.7	218.0	152.9	68.5	90.4	172.8	126.8	99.7	179.9	123.6	47.1	122.0	142.9	108.4	152.4	43.6	124.8	67.8	25.2	53.5	49.0	80.8	100.9	99.9	93.5	203.1	117.3	117.0	99.9	108.6	179.4	109.3	39.2	65.0	163.8	107.4	165.3	44.8	74.7	29.4	227.5	162.1	38.0	107.6	168.0	102.5	51.1	60.2	77.0	177.7	173.2	88.7	61.4	150.6	169.8	96.5	301.4	138.1	57.1	128.8	93.9	144.0	30.0	190.7	74.7	140.9	58.9	77.9	66.3	57.4	83.2	43.6	27.2	41.0	53.8	92.2	28.1	35.7	41.8	30.7	57.6	79.2	71.4	61.6	83.1	30.7	38.9	41.2	37.5	29.9	37.2	41.0	38.1	38.9	37.6	38.8	47.6	41.9	41.7	29.5	9.1	43.9	30.0	46.4	86.8	13.6	21.0	43.7	31.4	169.2	41.5	63.7	44.1	14.6	62.1	58.9	106.1	13.7	107.5	31.8	45.2	32.3	46.0	65.5	24.2	7.6	114.5	73.9	94.2	44.9	59.2	33.6	58.5	39.7	41.5	76.8	38.7	9.8	145.3	85.5	49.6	42.6	81.4	60.6	44.3	88.9	4.7	39.8	25.8	37.0	6.0	27.1	79.5	61.8	56.1	69.2	40.7	103.8	26.1	46.2	15.6	65.7	39.4	47.2	88.4	96.9	23.5	27.8	52.1	43.4	47.9	111.6	57.7
PIGW	"FLJ37433, Gwt1"	ENSG00000277161	"Phosphatidylinositol glycan anchor biosynthesis class W"	Q7Z7B1	17	36534987-36539310	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Acyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023499			Approved	"Plasma membrane"		No	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane"		"HPA023499: "	"unprognostic (4.96e-3)"	"unprognostic (3.84e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.39e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.71e-2)"	"unprognostic (8.14e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.88e-1)"	4.5	3.8	1.0	3.9	1.1	2.7	3.9	1.4	1.5	3.2	1.8	4.3	2.6	4.2	2.0	7.4	3.4	1.9	3.7	1.0	1.5	6.5	6.5	3.7	3.8	1.5	1.2	2.5	4.7	2.6	4.0	2.0	1.5	3.3	3.6	1.8	5.0	1.3	8.2	5.8	4.3	2.6	1.1	4.4	4.5	2.8	1.4	2.1	4.1	3.4	3.5	3.6	4.3	1.3	10.8	15.2	9.0	9.2	4.9	4.2	15.0	11.6	6.2	12.2	9.3	11.7	12.2	19.9	3.8	7.9	14.9	15.7	16.5	8.0	16.1	11.3	23.3	14.7	7.3	11.0	3.8	32.2	17.2	5.2	9.6	12.5	5.4	2.5	7.9	6.3	26.9	9.5	8.9	10.1	16.4	11.2	16.5	7.5	13.0	15.3	24.0	18.8	7.6	11.6	20.7	16.7	21.0	8.6	9.3	8.4	27.8	4.7	10.4	21.7	29.1	20.8	26.1	8.8	32.8	22.0	5.2	18.0	19.6	0.8	1.7	0.3	2.0	2.7	2.8	1.5	2.6	2.1	3.5	2.9	3.2	3.1	0.4	2.6	3.5	2.1	1.6	2.2	1.0	1.1	1.4	1.5	1.0	1.5	1.5	1.2	1.5	1.1	1.4	1.3	3.6	3.2	3.1	1.6	4.6	3.4	9.5	4.6	12.5	2.2	4.3	2.9	1.6	10.0	4.2	0.0	0.0	6.1	5.4	2.9	7.9	6.8	0.2	2.4	3.6	4.7	1.2	12.6	2.0	6.4	6.7	3.8	5.1	2.7	0.0	2.3	1.1	6.0	4.5	3.3	2.6	4.0	0.0	3.3	2.2	0.6	2.8	3.5	0.0	0.0	3.1	4.2	1.0	1.5	2.5	7.1	3.6	2.2	4.9	10.2	1.0	4.9	2.8	3.1	0.0	3.7	3.6	3.4	7.4	9.4	6.8	4.1	3.1	3.5	5.6	5.3
PIGX	FLJ20522	ENSG00000163964	"Phosphatidylinositol glycan anchor biosynthesis class X"	Q8TBF5	3	196639775-196736007	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 87.5"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 87.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029409, HPA073301"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA029409: AB_10610280, HPA073301: "	"unprognostic (8.83e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (2.14e-1)"	"unprognostic (2.42e-3)"	"unprognostic (9.25e-2)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (7.45e-5)"	"unprognostic (1.91e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.01e-1)"	10.5	10.3	14.4	10.4	15.6	9.0	9.9	14.7	16.7	7.5	19.5	10.8	9.1	8.3	12.4	10.3	7.9	8.3	9.6	15.2	16.7	12.2	8.2	7.2	7.1	15.1	15.8	6.8	9.0	19.6	12.7	8.3	14.8	12.8	10.1	17.4	9.9	10.5	17.1	10.4	9.1	11.2	16.0	6.8	7.6	6.0	16.2	11.6	9.2	14.1	10.9	8.7	7.6	16.7	39.4	18.7	21.4	18.1	22.7	15.3	12.6	18.1	20.7	19.3	20.5	13.7	25.6	20.3	63.6	15.4	25.1	22.2	19.5	16.6	23.1	18.6	19.6	21.0	12.8	12.6	19.2	20.6	34.6	15.1	25.7	17.1	15.7	16.3	12.7	36.5	11.7	38.6	21.0	30.1	59.2	32.1	12.8	30.7	18.3	31.1	27.6	29.5	24.6	11.5	24.4	29.2	31.8	23.9	29.7	16.9	71.8	20.3	8.2	18.1	9.2	25.6	29.5	57.0	70.4	41.1	20.7	26.9	21.5	39.6	7.5	87.5	3.3	10.8	3.0	4.6	3.1	4.6	7.7	5.5	3.7	3.2	18.8	8.7	11.6	3.3	4.4	4.1	14.4	15.6	14.7	16.7	15.2	16.7	15.1	15.8	14.8	16.0	16.2	16.7	14.2	19.2	16.3	13.7	16.4	17.1	30.1	5.5	31.9	34.9	28.3	19.2	12.6	21.5	8.4	29.5	47.9	21.4	31.6	20.8	35.2	7.9	30.5	17.2	23.5	16.9	15.7	15.8	17.7	5.6	20.9	22.0	9.2	17.9	12.0	19.3	17.5	16.6	20.1	33.7	23.7	17.0	8.2	21.4	25.4	22.7	28.0	18.1	21.4	15.9	25.0	50.0	32.0	12.1	14.5	5.2	12.5	35.0	20.1	33.8	27.1	32.5	10.2	39.1	26.3	23.6	28.1	27.1	36.0	29.3	15.9	11.6	21.2	22.7	25.7	23.0
PIK3CA	PI3K	ENSG00000121879	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha"	P42336	3	179148114-179240093	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Angiogenesis, Lipid metabolism, Phagocytosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 126.7;Inhibitory neurons: 122.0;Oligodendrocyte precursor cells: 130.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009985, CAB017804"	Approved		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol	Mitochondria	"CAB017804: , HPA009985: AB_1079610"	"unprognostic (1.81e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.69e-3)"	"unprognostic (6.49e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.57e-3)"	"unprognostic (5.21e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.82e-2)"	14.7	7.9	3.1	8.1	3.7	12.4	8.5	9.7	8.3	8.7	0.3	6.7	4.2	8.3	4.8	7.9	5.7	8.4	9.5	3.7	3.6	8.2	7.1	7.9	9.2	5.1	4.2	10.3	4.3	11.5	3.4	11.1	5.1	7.3	5.8	12.4	4.5	7.1	7.1	5.5	5.3	8.9	2.3	8.8	5.8	6.1	3.7	13.7	7.9	13.0	9.2	8.6	5.8	6.4	19.9	6.5	9.6	9.2	22.7	27.7	6.5	10.8	16.5	10.9	16.0	5.1	13.0	16.1	21.7	10.8	14.1	5.9	8.4	9.8	16.5	32.0	6.2	22.4	5.2	4.4	10.7	13.1	12.6	16.8	10.6	12.4	15.0	13.4	15.8	12.9	10.6	17.3	18.9	6.9	10.9	8.5	8.0	8.8	7.8	13.9	10.0	16.7	8.5	10.0	5.2	9.9	13.1	10.8	16.1	9.1	19.0	11.1	21.1	10.4	6.5	18.1	13.3	9.3	13.8	29.0	11.3	9.6	5.4	1.3	1.2	0.4	1.2	1.0	0.8	1.5	0.8	0.6	0.8	1.6	1.0	0.8	2.2	0.7	0.9	0.9	0.8	0.3	3.1	3.7	9.7	8.3	3.7	3.6	5.1	4.2	5.1	2.3	3.7	6.4	31.3	32.1	26.8	60.7	28.3	14.7	17.9	11.2	2.2	27.9	14.4	15.2	18.5	5.7	15.9	7.3	31.3	10.2	17.9	8.7	1.9	10.7	2.0	14.1	21.7	25.6	2.4	9.2	126.7	13.9	6.1	23.5	8.6	21.6	31.6	19.9	33.5	21.9	11.1	38.7	122.0	10.3	14.2	23.5	24.3	3.4	32.6	20.9	14.2	75.9	24.5	17.4	18.6	130.2	84.2	16.9	10.8	39.5	15.1	34.6	9.5	14.8	20.1	27.1	26.3	25.7	28.6	11.8	10.2	9.8	14.9	8.8	19.9	19.6	9.2	32.0
PIK3R4	"p150, VPS15"	ENSG00000196455	"Phosphoinositide-3-kinase regulatory subunit 4"	Q99570	3	130678934-130746829	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036032, HPA036033"	Approved		Approved	Vesicles,Microtubules		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Vesicles	Microtubules	"HPA036032: AB_10610281, HPA036033: AB_2674911"	"unprognostic (7.50e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.68e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.02e-3)"	"unprognostic (7.26e-2)"	"prognostic favorable (4.40e-6)"	"unprognostic (8.25e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.05e-1)"	8.8	8.5	3.7	7.8	4.2	8.9	10.0	5.2	4.9	9.4	5.6	8.2	7.5	10.1	7.9	8.0	9.1	7.2	7.6	4.1	4.5	10.5	21.2	9.6	9.4	3.2	3.6	12.4	6.9	17.6	6.1	9.7	3.8	9.8	8.1	16.5	7.6	9.6	7.3	7.8	8.0	10.4	3.8	10.0	7.5	11.4	3.2	11.4	13.1	8.6	10.4	9.0	6.5	7.1	20.7	12.9	18.5	13.4	26.6	21.1	12.8	15.0	17.9	20.2	23.3	16.7	17.1	24.2	18.4	15.2	16.1	28.7	30.7	23.3	31.6	14.7	11.3	19.7	13.8	11.7	12.2	30.3	9.5	14.7	16.4	21.7	13.6	12.6	19.0	13.8	23.3	11.9	18.1	18.1	24.9	9.2	23.3	18.6	12.4	17.2	21.4	21.9	13.2	16.7	17.0	12.4	21.6	13.4	15.3	21.5	18.6	13.1	15.2	15.5	13.3	17.6	12.2	13.8	13.5	31.2	17.0	11.3	14.7	9.7	5.3	7.0	6.3	6.0	9.3	5.6	5.7	4.7	6.9	3.5	6.6	6.0	4.4	8.5	6.6	2.4	6.8	5.3	3.7	4.2	5.2	4.9	4.1	4.5	3.2	3.6	3.8	3.8	3.2	7.1	8.3	6.4	8.7	18.6	8.8	3.8	3.9	5.7	10.8	8.1	5.7	4.7	7.7	8.6	9.6	11.0	14.6	5.6	7.2	5.5	1.9	5.0	4.4	8.9	7.5	8.9	3.0	9.2	28.5	5.8	3.4	6.9	13.3	9.9	9.5	9.5	7.5	18.2	5.9	5.0	30.3	6.8	8.2	6.4	2.6	3.1	9.6	7.3	5.4	20.6	7.1	9.0	6.2	22.1	32.9	6.6	4.3	11.7	6.9	4.8	6.2	4.2	12.6	12.6	6.6	8.9	6.2	17.0	13.9	9.5	4.4	4.2	7.5	9.6	6.1	3.4
PINX1	"FLJ20565, Gno1, LPTL, LPTS, MGC8850, Pxr1"	ENSG00000254093	"PIN2 (TERF1) interacting telomerase inhibitor 1"	Q96BK5	8	10764961-10839884	"Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 20.0;Extravillous trophoblasts: 13.0;Hofbauer cells: 16.1;Syncytiotrophoblasts: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023139, HPA023146"	Uncertain		Supported	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoli	"Nucleoplasm, Mitochondria"	"HPA023139: AB_1855384, HPA023146: "	"unprognostic (4.01e-1)"	"prognostic favorable (2.45e-5)"	"unprognostic (7.80e-3)"	"unprognostic (3.35e-2)"	"unprognostic (4.10e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.40e-2)"	"unprognostic (9.73e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.37e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.08e-2)"	9.9	7.7	7.2	8.9	8.4	9.1	9.9	8.9	8.9	9.7	6.1	9.9	6.2	9.3	4.5	12.1	8.8	4.0	8.2	7.4	7.1	11.6	11.7	8.0	11.5	7.2	7.1	9.8	9.0	6.1	6.4	7.2	7.4	8.1	6.1	12.0	7.3	4.2	13.5	14.4	7.7	8.5	7.0	9.3	8.2	9.7	7.4	13.0	8.2	9.3	11.1	10.2	10.5	7.7	14.5	18.9	20.1	19.2	16.6	13.5	23.1	21.5	9.7	23.2	15.6	20.0	12.4	38.5	7.4	11.7	28.3	28.6	51.4	39.9	29.8	15.7	15.3	16.2	13.3	22.0	18.8	17.4	9.7	11.3	24.9	18.3	34.0	8.2	32.7	25.8	52.3	23.1	22.9	17.1	57.7	21.8	46.3	62.6	21.0	46.5	24.5	35.2	17.5	17.5	16.6	17.3	14.5	17.0	48.3	24.3	18.1	21.7	20.0	13.9	30.3	18.0	28.1	10.3	29.0	71.2	14.4	32.6	32.1	1.9	8.4	6.1	14.6	10.7	18.9	12.9	12.8	15.6	11.1	10.8	17.1	13.5	0.5	12.5	9.9	8.6	16.1	10.4	7.2	8.4	8.9	8.9	7.4	7.1	7.2	7.1	7.4	7.0	7.4	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	13.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	48.2	0.0	0.0	0.0	0.0
PITHD1	"C1orf128, HT014, TXNL1CL"	ENSG00000057757	"PITH domain containing 1"	Q9GZP4	1	23778418-23788232	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016936	Uncertain					NA	NA		640000	"Cluster 30: Non-specific - Translation"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA016936: AB_2067141"	"unprognostic (2.11e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.69e-3)"	"unprognostic (6.75e-2)"	"unprognostic (1.18e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.39e-1)"	"unprognostic (9.93e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.21e-2)"	"unprognostic (5.70e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.38e-1)"	42.2	49.8	102.6	28.3	105.5	100.6	42.6	94.4	120.5	49.3	75.9	43.1	28.1	36.8	55.1	70.0	38.6	24.5	44.6	107.8	125.0	39.7	52.9	35.4	45.9	105.8	110.0	43.3	43.2	124.3	48.3	37.8	131.4	49.0	40.8	47.5	42.8	38.1	78.5	70.3	37.2	37.7	97.5	44.5	46.3	53.1	106.1	142.5	36.5	54.9	52.6	40.3	57.9	112.6	49.9	27.6	44.6	84.4	66.9	48.2	33.5	70.5	51.2	61.1	47.2	43.9	55.4	132.8	58.7	64.7	25.1	55.8	89.4	55.4	61.5	67.6	68.8	124.1	83.9	61.2	40.3	128.8	45.7	39.1	69.8	47.9	67.2	55.0	53.3	79.8	185.9	68.1	72.2	38.1	82.3	71.1	57.9	79.5	67.0	89.3	49.3	87.4	56.7	34.6	105.0	42.3	50.2	74.8	90.7	47.0	45.7	56.8	47.8	41.9	54.4	86.3	60.4	58.8	64.6	153.1	73.3	140.7	65.9	20.4	22.0	49.4	36.6	29.5	40.7	53.3	42.2	42.8	22.7	48.2	51.2	49.1	22.5	43.0	35.6	35.3	39.2	33.7	102.6	105.5	94.4	120.5	107.8	125.0	105.8	110.0	131.4	97.5	106.1	112.6	59.6	9.6	19.6	15.3	66.3	129.1	48.0	30.6	68.9	65.2	58.9	66.9	39.9	35.8	21.4	22.0	22.9	97.6	116.7	31.8	52.8	38.4	12.3	46.8	30.7	46.6	32.9	162.9	24.6	33.9	63.1	50.5	42.3	35.8	24.1	34.6	33.2	37.5	78.0	104.3	24.4	42.6	42.7	37.4	64.3	16.3	42.9	51.5	120.9	9.4	63.5	118.3	61.8	9.5	21.7	36.4	28.8	57.6	46.3	61.9	28.7	48.9	11.9	41.0	78.9	52.3	47.1	139.3	116.4	86.5	134.7	116.4	80.1	66.9	44.1	34.6
PITPNB	VIB1B	ENSG00000180957	"Phosphatidylinositol transfer protein beta"	P48739	22	27851669-27920134	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000528	Uncertain		Approved	Vesicles,Cytosol		NA	NA		300000	"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Vesicles	"HPA000528: AB_1079622"	"unprognostic (9.29e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (5.28e-4)"	"unprognostic (1.34e-1)"	"unprognostic (7.52e-3)"	"unprognostic (4.78e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.56e-3)"	"unprognostic (2.42e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.26e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.64e-1)"	42.2	27.1	27.9	33.3	30.4	21.6	33.0	30.9	34.1	31.7	22.6	53.1	21.9	31.5	28.6	52.5	29.3	35.4	35.8	32.2	31.6	25.2	56.9	32.1	34.6	29.5	31.8	30.0	28.3	24.0	22.5	49.2	30.5	27.5	30.1	18.1	24.7	37.0	21.3	30.3	28.1	44.2	29.1	27.7	35.3	19.4	31.9	33.4	24.8	21.7	41.1	54.2	36.6	30.5	94.1	39.8	71.5	53.8	62.3	74.7	54.5	88.8	77.4	95.5	91.7	63.4	43.1	64.7	46.0	86.0	70.5	96.6	103.0	88.7	133.2	111.1	97.4	66.1	62.0	58.5	66.9	152.5	102.6	67.2	85.0	115.7	119.6	62.9	94.4	44.8	95.3	130.5	88.5	50.0	64.9	74.7	54.4	97.8	52.1	81.6	112.9	95.6	79.1	87.6	83.6	104.7	60.8	72.7	75.7	75.9	39.4	53.7	93.2	94.9	138.9	72.9	94.2	53.0	66.7	125.2	81.6	74.1	82.2	36.0	18.6	18.6	30.9	21.7	34.0	35.2	29.7	32.3	24.9	30.9	28.4	28.0	16.7	27.4	21.2	22.2	40.8	26.0	27.9	30.4	30.9	34.1	32.2	31.6	29.5	31.8	30.5	29.1	31.9	30.5	97.0	28.9	32.4	57.8	44.3	96.0	128.9	40.8	65.4	24.1	37.4	33.4	57.8	35.8	48.4	31.3	14.6	39.7	45.9	26.1	37.2	49.0	21.4	55.4	72.5	62.4	25.2	15.8	51.8	50.2	52.3	65.9	32.6	79.8	21.5	37.0	30.7	45.8	27.3	32.0	45.7	26.7	24.4	23.6	42.2	6.9	32.0	35.1	26.6	68.4	55.6	17.4	48.4	60.8	67.0	66.7	21.1	48.2	54.2	97.5	17.2	29.6	22.8	16.1	26.3	57.9	76.7	44.0	35.4	60.9	82.1	48.6	42.3	46.9	24.0	112.9
PJA1	"FLJ11830, RNF70"	ENSG00000181191	"Praja ring finger ubiquitin ligase 1"	Q8NG27	X	69160851-69165521	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 160.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 74.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HAP1: 99.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000595	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA000595: AB_1079826"	"unprognostic (3.40e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.58e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.26e-3)"	"unprognostic (4.61e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.84e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.44e-5)"	"unprognostic (1.49e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.10e-1)"	22.9	14.5	46.8	8.7	50.5	3.6	19.4	37.2	78.0	19.9	33.0	15.4	6.4	16.4	160.0	12.3	16.0	11.1	15.0	47.1	48.9	19.2	9.4	13.8	10.0	38.9	41.7	25.8	14.5	38.7	28.1	17.3	40.6	15.3	7.6	17.6	10.6	32.4	7.9	14.6	11.1	16.0	40.1	13.3	14.0	26.4	49.0	10.0	22.7	8.8	12.1	17.4	15.1	43.5	27.3	19.6	62.9	43.7	21.3	22.5	18.7	17.8	22.0	16.7	22.3	17.1	25.8	4.4	26.7	28.1	39.2	24.0	99.0	34.9	21.2	20.2	33.0	8.1	16.0	10.9	25.7	4.9	14.4	23.1	23.6	28.6	17.0	15.8	19.0	13.2	7.8	3.0	16.9	14.1	2.1	8.4	43.4	23.1	32.0	20.0	28.2	6.9	23.4	22.6	46.4	30.7	28.6	4.9	22.2	50.1	7.7	7.0	17.8	13.9	22.6	41.7	8.3	0.0	0.2	9.1	15.3	13.1	19.4	6.6	6.8	2.1	29.6	9.2	34.3	16.4	26.1	27.5	7.3	22.8	26.5	31.3	2.3	30.0	6.5	8.9	17.5	19.4	46.8	50.5	37.2	78.0	47.1	48.9	38.9	41.7	40.6	40.1	49.0	43.5	4.7	16.0	4.8	2.9	9.7	41.0	19.4	30.8	23.9	16.8	5.0	6.2	7.1	4.3	14.8	3.7	8.4	35.6	5.9	1.0	15.6	24.9	74.7	3.9	10.4	6.6	5.4	10.8	8.1	11.7	15.3	18.2	7.1	5.8	4.5	27.9	6.8	1.7	7.0	5.0	8.3	3.6	6.1	2.9	9.9	32.7	27.1	5.7	5.4	2.8	2.9	30.6	14.4	5.0	3.7	18.0	1.7	19.5	7.7	17.0	0.5	6.5	4.4	6.1	6.6	9.4	16.3	1.4	1.5	11.2	29.5	20.8	11.2	27.0	2.6	22.5
PLAAT5	"HRASLS5, HRLP5, iNAT, PLAAT-5"	ENSG00000168004	"Phospholipase A and acyltransferase 5"	Q96KN8	11	63461404-63491194	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"adipose tissue: 16.5;pancreas: 13.6;testis: 53.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.6;Syncytiotrophoblasts: 1.0"	"Cancer enhanced"	"Detected in many"		"breast cancer: 3.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	64	"basophil: 5.4;eosinophil: 16.4"	"Lineage enriched"	"Detected in single"	97	"granulocytes: 16.4"	"Group enriched"	"Detected in some"	5	"HAP1: 11.4;NB-4: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042493			Uncertain	"Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA042493: AB_10797499"	"unprognostic (3.16e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.83e-3)"	"unprognostic (4.24e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (7.11e-3)"	"unprognostic (2.14e-1)"	"unprognostic (6.66e-2)"	"unprognostic (9.46e-2)"	"unprognostic (8.89e-3)"	"unprognostic (3.15e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.04e-5)"	"unprognostic (1.52e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.57e-3)"	"unprognostic (4.50e-4)"	16.5	0.2	1.2	0.3	0.9	0.1	3.3	0.7	0.8	0.1	0.0	0.7	0.2	0.5	0.2	0.8	0.9	0.6	0.6	1.0	1.3	0.1	0.0	0.6	0.1	1.5	0.5	0.6	13.6	0.0	0.0	0.0	1.0	0.4	0.2	0.5	0.8	1.3	0.1	0.2	0.3	1.4	1.1	0.1	0.5	53.4	0.8	0.0	0.1	0.1	0.0	0.5	0.1	3.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.4	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.9	0.7	0.8	1.0	1.3	1.5	0.5	1.0	1.1	0.8	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0
PLCB3		ENSG00000149782	"Phospholipase C beta 3"	Q01970	11	64251530-64269150	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 113.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 52.3;Proximal enterocytes: 161.7;Undifferentiated cells: 65.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009257, HPA039279, HPA043907"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		210000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Golgi apparatus"	"CAB009257: AB_654079, HPA039279: AB_2676425, HPA043907: AB_2678726"	"unprognostic (1.30e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.35e-2)"	"unprognostic (6.23e-3)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (2.44e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (4.31e-5)"	"unprognostic (5.04e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.88e-2)"	12.8	19.1	6.8	9.7	7.3	7.4	11.2	8.2	8.0	19.7	7.0	22.8	113.8	17.8	3.6	35.3	16.5	7.1	11.5	6.5	7.3	11.7	6.4	15.6	4.4	9.2	7.6	15.8	8.6	10.0	5.8	10.3	8.1	13.1	12.5	1.4	13.5	10.4	6.7	20.3	101.6	11.4	7.7	14.5	14.7	9.5	9.2	3.9	10.3	4.2	5.3	13.8	18.8	7.7	45.2	24.9	24.0	36.0	24.6	18.9	23.8	35.3	26.4	29.5	17.9	22.1	33.5	3.2	20.8	44.4	25.4	75.9	27.2	33.0	10.1	21.8	15.1	35.1	54.9	16.7	17.0	8.6	22.3	16.0	21.5	32.1	23.6	32.2	43.5	13.4	17.6	3.8	37.9	54.5	10.9	17.9	38.8	56.9	26.9	23.5	54.0	13.3	18.2	46.8	6.4	26.4	52.0	64.4	25.2	14.8	33.9	16.4	76.4	27.1	32.0	62.7	23.2	4.6	2.4	3.6	44.8	19.9	25.5	0.0	0.4	0.0	0.2	0.4	0.2	0.0	0.2	0.1	0.4	0.0	0.1	0.1	0.2	0.1	0.4	1.2	0.0	0.1	6.8	7.3	8.2	8.0	6.5	7.3	9.2	7.6	8.1	7.7	9.2	7.7	11.2	3.2	7.9	7.5	1.8	13.0	6.0	6.4	6.2	1.2	6.1	4.6	3.3	8.6	6.3	16.5	0.0	9.2	8.3	52.3	1.9	7.8	1.3	3.5	8.7	13.2	2.4	7.8	0.6	7.7	19.1	7.6	28.5	7.1	5.7	20.2	18.2	3.4	9.8	3.3	0.9	46.2	12.2	10.1	13.5	1.4	9.9	8.8	8.8	8.4	22.1	4.7	2.1	1.5	0.6	17.3	23.8	12.4	2.6	7.4	161.7	4.0	2.8	1.1	26.3	6.0	9.8	3.1	8.3	19.4	11.8	14.6	2.7	6.8	65.5	8.3
PLD6		ENSG00000179598	"Phospholipase D family member 6"	Q8N2A8	17	17200995-17206333	"Metabolic proteins, Predicted membrane proteins"	"Differentiation, Lipid degradation, Lipid metabolism, Meiosis, Spermatogenesis"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 32.4;Spermatogonia: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 5.8;NK-cells: 6.3;T-cells: 11.9"	"Cell line enhanced"	"Detected in many"		"HAP1: 41.2;REH: 31.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA049345	Approved					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA049345: AB_2680722"	"unprognostic (1.71e-1)"	"unprognostic (6.80e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.95e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.83e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (1.05e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.24e-1)"	4.6	4.1	11.5	1.4	10.8	2.0	3.8	10.7	11.4	7.6	10.3	9.0	1.7	3.5	5.0	1.6	5.7	2.2	5.2	10.9	12.1	2.9	5.9	2.8	3.0	10.3	14.6	7.9	5.0	5.7	8.1	1.8	14.0	5.6	1.7	3.6	3.2	4.4	5.2	4.5	3.2	2.4	8.7	4.3	4.5	21.2	13.1	1.6	3.3	1.4	2.2	4.3	4.4	11.1	7.1	5.4	0.2	6.0	2.3	0.9	0.3	2.2	3.6	4.0	2.4	6.3	2.0	15.4	3.3	2.2	2.4	1.9	41.2	1.2	3.8	9.7	12.0	14.9	4.2	11.3	10.2	11.2	6.0	2.0	4.4	2.4	9.7	4.5	1.0	7.1	13.5	0.4	4.6	9.0	8.3	15.8	0.1	8.0	7.4	31.5	3.1	11.3	3.7	0.5	23.4	9.7	2.8	3.9	7.2	4.3	3.8	17.8	1.1	0.1	0.3	9.0	4.5	1.9	7.5	0.1	4.8	11.4	8.6	0.4	0.4	0.2	2.9	0.3	9.9	5.8	11.3	6.0	0.1	4.8	11.9	5.5	0.5	6.3	0.2	1.5	9.4	4.1	11.5	10.8	10.7	11.4	10.9	12.1	10.3	14.6	14.0	8.7	13.1	11.1	0.6	3.2	3.3	4.6	3.3	5.5	4.5	1.7	9.6	4.5	2.2	3.9	7.2	1.5	1.9	1.8	0.0	5.5	0.5	0.5	1.9	1.4	7.1	7.5	1.5	0.8	1.2	3.4	6.0	0.7	1.3	2.8	1.5	3.4	1.3	3.3	1.8	2.1	2.7	6.7	9.8	2.0	6.1	0.6	1.7	2.7	4.4	0.8	3.6	2.8	0.7	6.5	0.0	3.0	7.1	1.0	0.1	4.9	10.1	5.9	0.8	1.4	6.0	1.3	0.0	1.4	1.5	32.4	23.7	1.3	1.6	0.8	3.6	5.6	1.5	1.2
PLK1	PLK	ENSG00000166851	"Polo like kinase 1"	P53350	16	23677656-23690367	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.0;lymphoid tissue: 43.9;testis: 33.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 32.3;Early spermatids: 123.7;Erythroid cells: 38.3;Extravillous trophoblasts: 55.9;Spermatocytes: 79.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"T-reg: 5.6"	"Lineage enriched"	"Detected in many"	5	"T-cells: 5.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA051638, HPA053229"	Approved					NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA051638: AB_2681561, HPA053229: AB_2682084"	"unprognostic (7.21e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.98e-3)"	"unprognostic (4.97e-3)"	"unprognostic (9.56e-2)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (2.70e-7)"	"prognostic unfavorable (2.28e-5)"	"unprognostic (2.55e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (4.12e-4)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.33e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.26e-2)"	1.4	1.5	2.3	13.4	2.3	32.0	1.5	2.5	3.2	2.3	2.0	9.6	10.4	1.2	0.4	13.9	1.0	1.4	1.0	2.3	2.1	1.4	1.9	1.9	27.8	2.3	2.3	1.3	1.1	0.2	1.2	6.4	2.2	1.2	10.1	1.2	2.4	0.3	1.0	5.7	9.2	4.0	2.0	9.1	6.2	33.1	2.5	43.9	0.9	0.4	30.0	2.8	4.0	2.8	199.9	207.5	166.2	90.9	5.2	11.7	92.8	111.0	74.5	172.5	127.0	184.3	131.0	99.1	56.3	76.5	90.1	112.8	229.5	93.5	206.1	139.5	128.0	125.2	163.4	257.1	1.7	147.5	133.7	4.8	5.2	124.7	125.2	21.6	127.9	127.5	200.7	133.9	134.8	187.8	139.8	151.4	189.5	82.1	103.5	217.2	111.7	160.0	49.3	43.9	94.3	65.3	126.8	88.9	55.8	94.4	114.4	92.1	65.1	82.7	102.7	79.9	194.1	93.2	156.8	173.6	69.3	127.7	137.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.8	0.3	0.3	0.0	0.0	0.0	0.4	0.9	0.0	0.0	5.6	1.4	2.3	2.3	2.5	3.2	2.3	2.1	2.3	2.3	2.2	2.0	2.5	2.8	0.6	3.2	0.0	3.3	7.6	1.3	1.2	6.5	0.0	1.4	1.7	2.3	0.6	0.0	1.4	0.0	4.2	32.3	0.4	5.5	0.0	0.8	123.7	3.4	1.3	2.5	0.0	38.3	3.1	0.8	55.9	4.7	10.2	1.8	1.3	19.9	3.3	1.1	20.8	0.0	2.3	7.3	4.1	6.9	3.2	13.9	1.2	7.2	0.0	2.8	0.4	1.1	0.0	1.5	2.3	1.2	0.3	0.7	23.0	2.0	1.5	0.1	1.3	1.3	0.0	2.3	6.1	79.5	13.5	12.2	1.8	3.8	2.5	1.2	17.9	2.0
PLK4	"Sak, STK18"	ENSG00000142731	"Polo like kinase 4"	O00444	4	127880893-127899224	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 22.6;lymphoid tissue: 14.4;testis: 22.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 65.9;Late spermatids: 87.5;Spermatocytes: 53.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017327, HPA035026, HPA043198"	Approved		Supported	Centrosome,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Centrosome, Cytosol"		"HPA017327: AB_2669584, HPA035026: AB_10602080, HPA043198: AB_2732504"	"unprognostic (2.44e-1)"	"unprognostic (4.24e-2)"	"prognostic favorable (7.46e-5)"	"unprognostic (2.18e-1)"	"unprognostic (3.79e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.06e-5)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (1.44e-3)"	"unprognostic (5.66e-2)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.22e-11)"	"unprognostic (2.29e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.93e-2)"	1.0	1.1	0.4	4.9	0.5	22.6	2.0	0.2	0.7	0.9	0.1	3.5	2.8	1.5	0.6	3.2	1.3	1.1	0.5	0.5	0.6	0.6	0.8	0.9	7.4	0.5	0.5	1.0	0.4	0.6	0.2	3.6	0.4	0.9	4.3	2.1	0.9	0.9	0.1	2.3	2.9	1.8	0.4	1.6	2.0	22.6	0.6	14.4	0.9	0.7	7.3	1.3	1.4	0.4	26.1	12.1	44.3	22.9	1.5	4.2	20.1	24.9	17.6	32.4	33.3	17.0	26.1	34.9	9.0	13.9	26.3	16.7	31.6	19.9	49.6	27.4	13.1	31.6	20.0	16.0	0.5	45.2	35.9	1.4	2.0	29.7	13.6	5.9	25.3	26.3	37.5	45.2	27.6	18.2	69.9	20.1	20.7	26.3	13.6	36.0	30.9	12.1	10.8	16.4	24.4	20.0	15.8	14.2	7.6	18.7	11.5	19.3	11.0	25.3	24.4	17.4	31.4	23.1	27.4	49.0	13.0	33.7	28.7	0.0	0.1	0.4	0.4	0.2	0.3	0.1	0.5	0.5	0.2	0.2	0.1	0.6	0.0	0.4	0.1	0.1	1.2	0.2	0.4	0.5	0.2	0.7	0.5	0.6	0.5	0.5	0.4	0.4	0.6	0.4	1.6	0.0	0.6	0.0	1.6	1.7	0.9	1.7	1.2	1.8	1.0	0.9	0.9	0.0	0.6	1.8	0.0	6.0	1.9	2.0	0.0	0.6	65.9	4.7	1.0	1.0	2.4	19.6	0.8	0.4	12.9	1.6	4.1	2.0	1.3	7.5	0.4	0.5	3.7	0.0	0.8	3.3	6.1	1.3	0.6	87.5	2.8	1.5	0.0	1.0	1.2	1.1	1.0	1.0	1.2	0.1	0.5	0.4	8.7	0.7	0.5	0.6	3.7	0.8	0.0	0.4	3.6	53.5	13.4	6.8	0.9	3.8	2.1	0.8	4.5	1.7
PMM2	"CDG1, CDG1a, CDGS, PMI, PMI1"	ENSG00000140650	"Phosphomannomutase 2"	O15305	16	8788823-8849325	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	8	"basophil: 210.5"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 210.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040852, HPA063649"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		21000	"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA040852: AB_10794069, HPA063649: AB_2685074"	"unprognostic (8.62e-3)"	"unprognostic (8.00e-3)"	"prognostic favorable (1.04e-4)"	"unprognostic (3.58e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.14e-3)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (8.97e-6)"	"unprognostic (1.22e-1)"	"unprognostic (2.50e-2)"	"unprognostic (6.89e-2)"	"unprognostic (5.02e-2)"	18.5	18.3	3.3	15.1	4.6	6.4	16.7	3.3	4.2	13.7	8.4	26.0	25.0	10.6	11.9	29.0	10.7	10.6	13.2	3.8	3.5	16.7	51.8	13.8	13.7	3.6	3.7	7.5	36.5	10.2	12.1	15.5	3.5	14.2	26.0	1.5	22.6	7.4	9.7	16.2	21.3	12.5	3.5	14.0	19.6	4.5	3.9	9.6	11.3	5.9	14.2	21.7	15.7	3.6	26.1	56.5	12.3	32.7	21.8	33.7	27.4	39.8	47.3	38.8	41.6	42.5	31.5	41.0	16.3	69.4	20.2	35.1	25.3	48.5	39.2	30.7	29.0	13.6	33.0	73.8	40.4	36.9	31.6	50.4	33.7	41.1	37.9	18.1	40.1	24.5	18.9	39.6	26.0	68.3	37.9	33.9	52.8	60.0	35.8	47.2	27.4	82.8	43.5	45.0	23.5	43.7	32.7	71.4	23.9	19.5	46.4	31.7	47.7	27.8	31.5	76.6	39.5	48.2	43.3	51.5	23.4	45.5	38.0	210.5	16.5	3.2	7.9	13.0	11.7	9.5	7.0	10.2	12.1	7.8	7.7	7.5	26.5	6.2	8.4	10.9	5.7	10.9	3.3	4.6	3.3	4.2	3.8	3.5	3.6	3.7	3.5	3.5	3.9	3.6	16.5	16.0	24.1	12.7	18.4	3.8	11.6	7.7	14.8	4.7	10.6	9.5	3.1	4.3	28.8	0.0	14.6	8.9	11.9	11.2	9.8	16.3	0.9	15.9	32.0	11.7	7.7	9.0	29.3	28.5	11.9	16.6	23.9	38.5	22.8	12.9	2.5	12.8	5.5	1.7	26.1	21.2	2.0	4.7	1.7	0.9	6.2	10.4	1.8	21.5	9.6	2.5	9.2	22.6	21.6	23.3	9.7	2.2	49.5	12.6	12.3	17.4	16.8	9.0	0.0	13.5	9.8	2.0	4.2	27.0	4.1	10.7	16.0	13.1	12.6	14.9
PMPCA	"Alpha-MPP, CLA1, INPP5E, KIAA0123, SCAR2"	ENSG00000165688	"Peptidase, mitochondrial processing subunit alpha"	Q10713	9	136410641-136423761	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"			"Disease variant, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021648, HPA063735"	Supported		Enhanced	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA021648: AB_1855491, HPA063735: AB_2685108"	"unprognostic (9.80e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.19e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.32e-2)"	"prognostic favorable (8.00e-5)"	"unprognostic (9.47e-3)"	"prognostic favorable (2.14e-6)"	"unprognostic (4.27e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.54e-2)"	29.2	58.1	27.0	20.6	27.6	31.4	27.1	27.0	34.6	29.2	36.8	32.2	24.8	26.8	10.4	34.5	27.5	17.9	73.2	28.0	27.3	37.3	110.8	25.4	27.1	27.1	27.6	29.3	28.8	26.9	38.8	20.8	27.9	31.8	15.3	8.8	28.4	16.1	69.2	37.6	30.6	15.3	25.6	38.2	35.3	37.8	27.9	21.4	29.4	50.0	17.0	28.0	27.8	26.7	48.7	87.7	41.8	84.5	30.8	45.0	63.2	49.3	39.6	67.2	48.9	101.1	56.5	67.4	50.5	50.3	36.2	110.2	77.9	72.0	30.0	97.2	92.8	54.6	113.2	123.6	53.9	71.7	44.9	66.3	48.9	52.6	27.0	38.2	58.0	61.2	140.2	43.4	42.6	132.1	68.1	90.1	85.4	86.2	82.2	83.0	59.1	149.9	46.3	33.9	85.4	56.1	66.6	92.9	58.6	28.6	127.6	95.5	48.2	47.8	50.7	39.8	63.8	26.2	37.4	73.5	62.9	61.3	43.9	37.4	50.5	36.5	53.2	51.9	51.4	52.5	49.0	57.2	61.7	48.8	57.9	50.2	11.9	67.2	51.5	31.4	52.7	62.2	27.0	27.6	27.0	34.6	28.0	27.3	27.1	27.6	27.9	25.6	27.9	26.7	17.3	16.0	26.7	14.7	24.2	27.5	40.2	65.0	27.9	24.7	19.3	15.2	35.9	15.7	32.8	22.0	22.9	103.1	22.5	28.0	49.0	32.9	24.6	25.6	23.5	21.7	20.8	23.5	13.8	30.7	50.4	23.7	21.9	26.2	24.7	44.2	19.6	57.2	37.8	18.5	11.4	24.2	44.7	19.2	14.6	15.8	19.0	17.4	16.0	6.5	21.0	22.9	14.4	8.5	8.0	31.6	20.9	22.6	26.6	22.6	25.6	46.9	22.6	27.4	39.5	22.4	27.9	37.7	42.4	23.2	26.9	103.8	21.7	77.0	38.6	28.5
PMPCB	"MPPB, MPPP52"	ENSG00000105819	"Peptidase, mitochondrial processing subunit beta"	O75439	7	103297435-103329511	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040674, HPA074168"	Approved		Enhanced	Mitochondria		No	No		19000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA040674: AB_10961998, HPA074168: AB_2686671"	"prognostic favorable (2.79e-4)"	"unprognostic (3.11e-1)"	"unprognostic (7.18e-3)"	"unprognostic (3.03e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.67e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.42e-3)"	"prognostic favorable (2.95e-8)"	"unprognostic (2.59e-2)"	"unprognostic (9.79e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.39e-2)"	30.8	42.0	16.9	22.3	18.2	53.5	32.5	18.9	22.1	33.3	24.7	33.4	38.0	29.9	26.2	27.7	29.3	25.1	44.9	18.8	18.1	47.4	46.1	22.6	36.4	16.5	16.6	35.4	41.1	39.7	22.4	25.8	17.6	31.5	33.2	25.4	30.6	28.1	34.8	33.2	32.4	26.3	17.2	28.2	35.8	26.7	17.4	30.2	33.4	38.2	33.9	29.3	28.4	19.9	30.2	42.8	49.9	69.4	28.5	57.1	38.0	26.7	45.6	54.3	62.8	47.7	33.7	76.9	41.7	47.9	58.0	37.5	59.7	43.2	49.2	26.4	69.4	26.4	74.0	61.6	35.0	35.0	30.6	53.4	40.5	41.8	39.6	51.3	28.8	55.9	52.5	77.9	48.5	71.1	59.2	82.0	59.2	60.4	52.4	42.7	34.3	79.4	50.3	54.2	62.2	76.5	37.3	108.6	55.8	49.5	45.3	49.1	24.9	48.3	57.9	85.1	52.3	57.4	79.9	61.8	35.7	59.3	38.2	16.7	19.3	13.2	18.3	21.4	20.1	25.9	21.1	18.5	24.7	19.3	26.1	21.7	5.7	17.9	19.7	12.6	30.2	22.3	16.9	18.2	18.9	22.1	18.8	18.1	16.5	16.6	17.6	17.2	17.4	19.9	32.0	32.1	36.9	27.1	54.5	36.7	68.2	123.2	51.8	31.6	41.3	37.3	70.4	41.5	70.7	27.6	22.9	125.6	55.9	35.8	72.4	75.6	106.3	38.4	37.0	37.1	27.1	65.8	36.8	73.2	61.3	42.5	35.7	35.0	60.2	49.9	31.1	53.7	54.6	23.5	33.9	48.1	75.3	49.4	30.7	24.0	51.9	42.4	26.6	18.7	92.5	35.8	58.7	35.7	44.4	59.7	45.4	49.7	56.1	35.2	60.4	127.5	58.2	37.9	65.7	48.6	73.5	125.4	56.4	47.1	37.5	124.9	55.9	63.3	59.1	62.2
PMS1	"MLH2, PMSL1"	ENSG00000064933	"PMS1 homolog 1, mismatch repair system component"	P54277	2	189784085-189877629	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 48.4"	"Group enriched"	"Detected in many"	6	"Early spermatids: 474.4;Late spermatids: 570.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031013			Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nuclear bodies"		"HPA031013: AB_2673696"	"unprognostic (1.03e-1)"	"unprognostic (1.58e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (2.38e-6)"	"unprognostic (5.31e-2)"	"unprognostic (1.60e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (1.86e-6)"	"unprognostic (1.29e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.92e-2)"	"prognostic favorable (3.73e-4)"	9.2	9.0	9.6	12.0	8.2	12.1	11.6	14.7	9.7	10.8	7.6	7.7	7.4	13.3	15.7	6.3	9.7	8.3	7.0	7.8	10.0	6.3	7.7	8.0	13.7	7.5	8.2	11.9	8.3	7.3	9.8	8.7	8.7	9.5	9.1	18.4	9.9	10.2	9.4	11.5	8.4	10.2	7.2	13.2	13.0	48.4	9.5	8.0	10.6	6.6	10.7	7.4	7.5	11.4	13.8	11.8	29.9	23.8	16.1	24.3	26.6	25.3	12.3	21.2	25.4	19.6	18.1	39.7	14.0	10.6	15.1	19.2	29.9	18.7	29.5	30.3	17.4	39.5	24.1	30.3	22.5	23.3	17.3	15.6	18.4	19.3	39.7	18.8	22.4	27.6	34.0	20.8	26.1	9.7	27.6	32.2	31.6	14.1	27.6	31.9	19.5	38.8	20.9	19.6	27.8	19.3	18.5	12.5	19.6	36.2	13.4	20.1	17.3	22.8	15.4	14.7	23.2	16.6	21.9	34.4	13.1	20.4	14.7	2.9	6.4	3.7	13.6	4.2	13.3	14.4	10.1	15.5	6.4	15.9	10.6	13.0	3.0	12.0	5.2	10.0	10.8	4.8	9.6	8.2	14.7	9.7	7.8	10.0	7.5	8.2	8.7	7.2	9.5	11.4	18.5	16.0	14.4	45.1	22.7	6.9	8.9	12.9	21.6	30.8	13.7	14.6	16.3	10.0	15.8	5.5	8.4	16.4	18.7	3.6	0.0	7.6	474.4	17.3	26.6	14.8	12.0	10.9	68.6	8.0	11.7	18.5	13.7	11.7	13.3	27.7	8.2	9.6	9.2	10.1	80.2	7.3	16.2	16.0	5.1	570.1	21.8	14.9	7.2	43.1	9.8	11.2	22.6	80.9	64.8	6.4	4.3	19.5	30.1	7.5	4.9	6.1	27.0	28.0	13.1	16.3	15.0	25.3	25.9	19.3	7.0	5.2	20.9	22.2	11.1	4.3
PNO1	"KHRBP1, RRP20"	ENSG00000115946	"Partner of NOB1 homolog"	Q9NRX1	2	68157888-68176238	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056928			Supported	Nucleoplasm,Nucleoli		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Nucleoplasm	"HPA056928: "	"unprognostic (1.81e-3)"	"unprognostic (4.83e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (5.88e-2)"	"unprognostic (1.66e-3)"	"prognostic unfavorable (3.04e-8)"	"unprognostic (5.82e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.13e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.74e-2)"	"unprognostic (7.66e-2)"	15.1	14.2	6.4	12.1	8.0	19.5	11.6	7.0	11.8	7.6	6.9	9.7	7.6	9.8	11.2	11.1	8.8	9.9	10.2	12.0	7.3	14.1	12.6	8.6	12.6	6.7	6.9	7.0	12.7	12.5	7.1	12.7	6.8	10.0	9.1	19.0	7.1	10.8	20.1	9.1	6.7	11.5	6.7	8.2	8.8	8.9	6.9	8.1	12.5	12.6	12.2	19.8	7.6	7.4	37.8	40.1	18.5	30.5	22.5	18.3	46.0	34.7	23.0	39.1	27.8	77.9	21.9	51.4	28.5	23.6	54.0	31.6	60.6	41.9	61.3	35.2	40.6	49.7	17.4	58.2	34.6	40.2	22.4	24.1	30.2	39.4	45.0	11.3	29.1	32.7	69.7	27.3	35.7	27.4	39.9	38.1	52.0	68.7	43.1	33.3	45.2	54.8	29.8	31.7	32.7	24.0	26.1	32.4	57.8	29.7	22.9	22.4	21.2	44.2	48.0	40.1	97.9	21.6	33.1	78.1	36.3	59.1	62.1	0.9	12.6	2.8	12.2	18.1	19.1	19.2	13.8	14.4	16.8	14.5	16.0	14.6	2.4	15.0	13.0	11.8	16.0	21.3	6.4	8.0	7.0	11.8	12.0	7.3	6.7	6.9	6.8	6.7	6.9	7.4	23.7	16.0	13.2	3.3	29.9	83.2	62.8	29.5	25.6	22.7	18.6	18.4	11.9	18.6	36.2	7.3	12.5	39.5	20.2	7.9	19.6	36.7	33.5	28.7	37.7	25.5	17.3	21.4	10.6	29.8	43.5	28.3	9.7	20.9	31.6	13.6	12.5	15.8	26.0	18.5	9.0	12.1	30.5	10.4	38.7	7.7	12.5	20.7	12.4	4.7	18.9	21.0	14.4	7.1	10.4	29.1	5.8	16.6	27.8	56.6	4.6	34.7	28.6	51.3	6.6	40.4	29.6	28.9	41.7	21.0	56.1	47.6	25.7	20.5	20.2	37.6
PNPT1	"DFNB70, old-35, OLD35, PNPase"	ENSG00000138035	"Polyribonucleotide nucleotidyltransferase 1"	Q8TCS8	2	55634061-55693863	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, Transport"	"Exonuclease, Hydrolase, Nuclease, Nucleotidyltransferase, RNA-binding, Transferase"	"Deafness, Disease variant, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033424, HPA034602, HPA034603"	Supported		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	Mitochondria	Cytosol	"CAB033424: AB_2299801, HPA034602: AB_2674243, HPA034603: AB_10603130"	"unprognostic (9.09e-2)"	"unprognostic (7.40e-2)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (3.40e-2)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (1.95e-7)"	"unprognostic (1.88e-1)"	"unprognostic (5.93e-3)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (5.44e-5)"	"unprognostic (2.19e-2)"	"unprognostic (2.11e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.21e-1)"	6.7	5.9	5.4	4.0	7.0	7.4	5.7	6.4	7.7	5.2	6.4	5.7	3.3	6.4	4.5	4.6	5.7	3.0	6.6	4.8	6.5	5.6	5.2	5.0	4.3	6.9	6.0	4.8	7.8	4.9	5.0	2.9	7.1	4.4	5.2	5.5	5.0	3.2	11.5	5.9	5.3	4.2	5.7	6.2	5.8	3.2	6.3	3.4	5.2	5.9	3.3	5.6	4.5	9.0	9.0	4.3	6.5	2.9	4.7	7.8	8.4	12.2	7.7	19.8	13.1	13.5	4.2	17.9	5.4	5.8	6.2	7.1	8.3	10.1	9.5	6.3	16.3	10.2	5.9	7.0	11.8	25.0	6.4	8.6	6.9	8.4	7.0	4.7	6.4	7.3	11.5	4.2	8.0	4.4	15.4	17.9	15.5	9.3	8.1	15.2	10.9	16.6	8.6	5.2	15.2	9.6	4.4	14.3	17.0	5.6	3.8	11.4	6.4	4.6	3.9	4.2	13.5	18.9	1.3	3.8	9.2	21.1	8.3	3.3	3.4	4.0	4.2	2.8	2.4	3.1	1.7	4.1	1.3	5.6	3.4	3.9	3.4	2.2	2.7	4.1	1.4	2.9	5.4	7.0	6.4	7.7	4.8	6.5	6.9	6.0	7.1	5.7	6.3	9.0	25.1	48.1	57.0	23.8	21.6	24.2	23.1	17.5	29.0	41.3	12.6	11.2	25.6	15.7	46.8	20.2	58.4	19.9	14.2	7.7	9.8	18.6	25.6	27.9	28.9	24.4	10.2	17.4	48.4	16.0	23.3	25.3	14.8	14.3	58.7	21.8	11.7	14.7	15.4	30.3	48.1	12.8	26.4	12.2	17.7	4.8	17.4	26.7	16.0	17.8	16.5	23.9	13.4	34.2	97.7	15.8	11.4	18.4	23.1	26.0	7.6	19.8	38.5	58.6	26.3	31.7	22.3	43.4	20.7	25.7	20.2	12.3	24.7	58.2	18.6	17.6
PNRC2		ENSG00000189266	"Proline rich nuclear receptor coactivator 2"	Q9NPJ4	1	23956839-23963462	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027820, HPA045837"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Golgi apparatus"	"HPA027820: AB_10602147, HPA045837: AB_2679467"	"prognostic favorable (6.02e-4)"	"unprognostic (5.99e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.10e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.45e-3)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.44e-2)"	"prognostic favorable (4.05e-4)"	82.7	82.5	49.5	80.6	52.1	141.0	78.5	53.4	62.0	69.6	56.1	98.1	99.5	87.4	68.6	62.8	58.3	80.5	75.2	49.6	51.9	99.6	66.8	76.0	137.0	52.6	50.7	79.3	52.2	94.3	34.8	103.3	54.4	70.5	92.2	56.2	55.0	56.9	49.8	46.1	84.2	71.8	50.9	87.5	81.9	33.7	51.9	133.5	122.2	63.6	109.5	100.1	51.4	57.8	107.8	42.0	179.5	124.9	121.5	110.7	68.6	116.7	103.7	132.7	106.1	122.7	132.5	291.7	111.5	74.8	49.9	93.5	121.6	101.8	146.7	208.6	78.7	277.5	131.8	130.2	103.3	272.1	122.3	83.9	125.8	109.2	101.0	86.8	130.3	148.4	239.6	159.5	79.0	87.5	169.4	103.3	243.8	101.7	76.5	189.7	116.7	125.0	134.8	113.8	107.4	93.5	101.0	85.7	123.7	130.9	93.6	168.6	105.3	85.6	82.2	84.6	75.4	133.7	164.8	197.6	58.0	259.0	89.8	230.8	112.7	126.8	103.5	115.0	108.8	129.1	112.5	112.2	109.1	131.1	124.9	106.8	74.2	108.6	112.2	77.4	129.4	178.3	49.5	52.1	53.4	62.0	49.6	51.9	52.6	50.7	54.4	50.9	51.9	57.8	119.0	185.9	109.2	11.4	122.5	13.3	231.7	2.0	99.0	33.6	110.5	109.6	84.8	58.6	62.2	62.5	18.8	129.8	104.7	160.5	238.7	90.5	6.9	86.0	96.1	97.3	100.4	157.0	7.9	127.8	101.4	128.7	66.3	130.9	76.5	84.1	86.7	30.0	68.6	20.2	6.4	109.3	0.0	82.3	10.9	14.2	78.9	109.0	1.8	13.1	81.8	66.9	127.7	6.0	11.8	119.2	157.7	81.3	48.8	187.6	90.3	112.0	56.1	28.7	46.0	104.3	104.5	21.2	24.4	97.8	12.6	141.7	104.0	203.9	110.2	314.0
POC1A	"DKFZP434C245, WDR51A"	ENSG00000164087	"POC1 centriolar protein A"	Q8NBT0	3	52075226-52154690	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Dwarfism, Hypotrichosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 12.8;testis: 17.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 47.9;Extravillous trophoblasts: 33.8;Late spermatids: 73.4;Spermatocytes: 40.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040600	Approved					NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA040600: AB_10672837"	"unprognostic (2.68e-1)"	"unprognostic (7.17e-2)"	"prognostic favorable (1.78e-4)"	"unprognostic (5.08e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.41e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (3.89e-2)"	"prognostic unfavorable (9.43e-7)"	"unprognostic (9.90e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.32e-2)"	1.4	4.1	1.5	4.0	1.5	11.1	2.2	1.4	1.8	1.5	1.1	5.9	4.8	1.0	1.0	4.7	1.7	1.1	1.4	1.7	1.6	2.1	5.2	1.9	5.4	1.9	1.6	0.7	0.9	1.1	0.7	4.1	1.8	1.3	6.0	0.4	1.3	1.0	1.5	2.6	4.0	2.9	1.5	2.8	2.8	17.6	1.6	12.8	1.0	1.0	7.0	2.0	1.8	1.8	30.1	25.2	25.0	33.5	5.1	6.5	33.9	30.0	28.7	62.8	48.7	22.1	31.0	31.3	8.8	23.9	48.6	18.3	38.0	33.9	45.3	26.0	16.0	21.4	26.3	23.9	1.4	24.5	13.0	3.6	7.3	49.6	25.9	8.7	29.0	46.2	18.8	32.9	37.5	23.8	45.6	44.2	19.1	33.7	41.0	19.6	19.7	30.0	14.2	21.0	11.6	16.7	24.0	23.7	18.3	26.0	29.2	45.7	9.7	28.6	27.6	46.3	49.3	27.8	49.1	26.6	19.2	42.6	29.1	0.0	1.6	0.0	1.2	2.2	0.1	0.9	0.8	0.4	1.9	0.5	0.7	0.4	0.5	1.4	1.6	1.9	2.6	1.1	1.5	1.5	1.4	1.8	1.7	1.6	1.9	1.6	1.8	1.5	1.6	1.8	0.9	0.0	1.3	0.3	2.5	1.7	1.6	4.7	0.0	0.7	2.1	2.2	0.7	0.0	1.4	1.8	0.0	21.8	0.9	4.4	0.0	1.8	47.9	4.5	1.0	2.9	1.8	15.6	2.3	3.0	33.8	3.4	2.0	1.5	0.0	11.3	1.8	4.2	12.9	1.7	1.4	5.4	0.0	2.6	3.4	73.4	1.2	2.6	1.8	1.9	2.7	0.8	1.0	0.0	2.7	2.1	2.2	0.4	12.9	1.3	3.0	3.2	4.2	0.0	0.0	1.1	3.4	40.1	21.2	4.9	1.8	7.5	1.6	4.4	8.4	2.1
POLA1	"NSX, p180, POLA"	ENSG00000101868	"DNA polymerase alpha 1, catalytic subunit"	P09884	X	24693873-24996986	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"DNA replication, Host-virus interaction"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Disease variant, Dwarfism, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 38.5;Excitatory neurons: 42.3;Inhibitory neurons: 65.7;Microglial cells: 57.1;Oligodendrocyte precursor cells: 59.3;Oligodendrocytes: 97.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002947, CAB012274"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"CAB012274: , HPA002947: AB_1079652"	"unprognostic (6.92e-2)"	"unprognostic (4.43e-3)"	"unprognostic (3.27e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (4.80e-5)"	"unprognostic (1.87e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.48e-2)"	"unprognostic (8.41e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.08e-1)"	3.7	2.0	1.9	4.8	2.5	7.3	5.1	2.2	1.8	4.3	0.8	4.1	2.4	4.2	1.4	3.9	3.7	2.1	3.5	1.3	1.9	2.9	2.0	3.1	6.8	2.3	2.3	5.8	2.8	3.4	1.8	5.6	2.4	3.1	5.2	3.7	3.0	3.5	4.9	4.0	3.5	4.8	2.2	3.5	3.7	2.6	2.1	11.9	3.1	3.1	7.7	3.7	3.8	2.6	32.7	24.6	30.3	24.1	5.2	6.5	6.9	23.6	12.7	25.0	28.3	20.4	17.0	41.1	7.7	9.6	23.4	26.0	59.7	18.7	33.6	21.1	24.8	31.0	42.8	13.5	2.4	41.6	15.5	4.1	3.6	31.2	8.4	5.8	13.0	20.8	28.7	20.0	16.8	22.4	45.2	7.2	30.7	20.3	19.1	39.0	81.5	30.7	7.1	21.1	27.9	16.7	28.1	11.2	11.6	33.0	25.7	11.5	10.1	21.3	14.9	42.4	22.6	11.6	18.1	32.7	12.4	18.3	24.9	0.0	0.2	0.2	0.6	1.4	0.8	1.0	0.8	1.0	0.7	0.4	0.4	0.5	0.0	0.8	0.2	0.2	0.9	0.5	1.9	2.5	2.2	1.8	1.3	1.9	2.3	2.3	2.4	2.2	2.1	2.6	5.8	9.6	6.5	38.5	5.2	2.8	4.6	1.8	5.7	3.9	4.7	4.3	11.8	0.0	7.2	1.8	2.1	6.1	3.2	2.5	3.9	3.2	0.2	3.2	4.7	6.3	4.2	24.2	42.3	3.0	4.9	4.6	4.6	3.8	9.5	8.3	3.3	3.4	4.4	1.7	65.7	4.2	4.1	4.4	1.5	1.7	6.2	4.5	0.0	57.1	3.7	4.8	5.2	59.3	97.7	1.4	1.2	3.4	8.6	2.0	2.3	1.6	6.1	7.4	6.6	9.2	6.0	6.4	4.5	5.5	2.3	2.3	4.9	5.0	4.2	2.4
POLA2	FLJ21662	ENSG00000014138	"DNA polymerase alpha 2, accessory subunit"	Q14181	11	65261920-65305589	"Metabolic proteins, Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 23.2;Spermatocytes: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA037570	Supported		Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA037570: AB_10672280"	"unprognostic (2.28e-1)"	"prognostic favorable (4.61e-4)"	"unprognostic (1.67e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.20e-2)"	"unprognostic (3.18e-2)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (1.14e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (4.09e-8)"	"unprognostic (1.60e-3)"	"unprognostic (8.26e-2)"	"unprognostic (8.16e-2)"	"unprognostic (6.25e-3)"	3.3	2.6	1.9	5.3	2.9	6.9	3.5	4.8	3.3	4.5	1.7	5.3	3.6	5.0	3.3	4.5	3.8	1.8	2.9	1.9	1.5	3.5	3.7	3.5	10.0	4.5	2.8	5.1	3.3	3.2	1.9	2.1	3.7	3.0	4.9	3.6	4.2	3.1	3.1	5.1	4.2	4.1	3.1	5.7	3.8	5.2	2.6	15.9	3.3	3.4	13.2	3.2	3.2	7.0	32.6	21.9	47.3	20.4	3.7	3.6	19.5	25.6	15.9	64.4	43.3	6.9	24.0	48.1	20.4	11.0	35.5	18.9	38.8	25.1	61.1	21.3	14.7	32.4	39.4	10.4	0.9	33.5	25.6	3.7	2.9	47.4	8.5	10.3	14.6	20.2	30.2	25.3	44.4	34.9	62.6	13.2	38.6	16.1	16.2	33.4	29.9	40.7	14.1	21.8	32.5	18.1	14.9	15.9	7.9	29.7	28.6	14.1	3.9	25.4	18.7	19.8	16.0	12.0	14.7	45.0	14.9	18.8	33.7	10.0	5.2	2.3	3.8	3.2	4.5	3.9	4.2	4.2	7.4	3.9	3.5	3.1	1.4	3.8	1.7	5.9	4.6	5.3	1.9	2.9	4.8	3.3	1.9	1.5	4.5	2.8	3.7	3.1	2.6	7.0	2.6	0.0	3.4	1.0	5.1	1.7	4.2	5.7	2.2	2.2	3.0	2.3	2.9	7.2	3.7	5.5	2.1	15.6	4.3	3.0	3.9	5.3	2.7	1.8	2.9	3.7	3.0	23.2	4.3	3.4	19.0	7.7	5.6	2.5	0.0	11.0	5.3	2.1	9.7	3.3	3.6	3.5	2.0	2.8	3.7	4.0	7.5	5.3	0.0	12.2	8.0	2.2	5.2	1.5	8.7	4.9	2.2	7.5	10.4	3.4	1.7	2.0	3.2	5.4	6.6	19.6	5.0	23.7	17.7	4.3	1.4	7.3	5.5	4.0	6.3	3.7
POLD2		ENSG00000106628	"DNA polymerase delta 2, accessory subunit"	P49005	7	44114680-44124358	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 288.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026745	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA026745: AB_1855520"	"unprognostic (9.09e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.50e-3)"	"unprognostic (4.94e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.01e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.44e-3)"	48.4	58.8	48.9	35.0	46.7	44.6	44.4	46.4	53.8	53.4	52.0	39.0	32.4	47.3	14.0	86.6	75.8	18.5	86.8	46.5	47.6	51.6	113.5	36.2	36.9	49.0	49.3	59.3	73.4	62.0	53.0	27.1	49.3	46.8	28.9	22.6	46.6	30.1	118.8	59.9	32.9	32.4	46.9	35.9	48.0	48.7	56.7	46.2	40.6	77.5	33.4	48.2	54.3	45.6	162.2	209.3	114.1	240.5	99.5	105.5	112.9	97.2	97.5	130.6	97.4	178.0	151.4	371.1	121.2	141.1	261.0	218.3	188.9	265.6	84.4	105.9	222.1	82.2	216.3	152.3	112.8	253.4	96.1	96.8	159.6	202.4	195.1	136.3	110.7	245.8	305.4	173.2	146.3	262.7	310.5	476.0	180.0	231.0	203.0	206.4	153.4	528.9	114.0	102.7	225.0	176.2	121.5	430.6	83.7	73.5	249.7	321.6	88.0	171.7	215.8	213.3	310.5	269.3	430.3	359.1	154.1	252.7	248.6	1.7	41.2	10.4	51.6	38.9	77.3	82.2	61.7	52.5	70.8	80.2	81.4	60.5	3.3	44.9	38.8	112.7	54.1	69.7	48.9	46.7	46.4	53.8	46.5	47.6	49.0	49.3	49.3	46.9	56.7	45.6	25.6	6.4	31.8	11.8	35.3	49.3	83.0	111.8	42.7	41.6	57.1	62.7	58.2	44.3	54.1	29.5	31.3	69.9	24.3	31.0	103.7	71.9	108.9	53.5	52.4	33.6	41.9	52.2	5.0	59.5	84.1	49.3	40.2	24.9	26.6	65.6	19.2	95.6	46.8	53.8	5.1	53.6	30.5	14.4	26.6	288.0	41.7	15.0	49.8	4.7	13.0	58.1	18.6	5.0	7.8	44.5	25.0	53.4	38.0	127.6	10.0	95.2	69.7	52.0	19.7	55.4	78.6	48.2	52.4	70.5	60.5	35.4	25.7	103.9	81.5	71.3
POLD3	"KIAA0039, P66, P68, PPP1R128"	ENSG00000077514	"DNA polymerase delta 3, accessory subunit"	Q15054	11	74493851-74669117	"Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA058846	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 14: Monocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA058846: AB_2683833"	"unprognostic (3.68e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.49e-1)"	"prognostic unfavorable (9.17e-4)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (5.48e-4)"	"unprognostic (3.99e-3)"	"unprognostic (1.54e-3)"	"unprognostic (9.21e-3)"	"prognostic unfavorable (7.90e-6)"	"unprognostic (7.92e-3)"	"unprognostic (2.65e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.23e-1)"	7.9	6.2	6.1	14.6	6.0	10.1	11.1	6.0	7.3	10.6	7.6	17.2	15.7	16.5	12.0	12.9	16.3	14.9	8.9	5.9	6.1	44.5	7.1	11.5	14.5	4.9	5.6	16.0	11.4	7.8	4.6	11.5	5.6	8.3	17.9	14.9	6.8	10.1	7.7	11.6	14.4	15.3	5.1	11.4	15.4	19.6	5.5	15.7	15.0	12.5	15.2	12.7	7.5	7.4	32.2	28.6	43.6	29.8	13.2	22.5	30.9	42.7	23.9	43.7	37.0	37.8	40.8	45.7	30.9	20.5	25.3	41.2	36.3	28.0	54.6	34.5	23.3	29.1	44.3	12.8	9.5	56.4	25.3	10.0	17.3	51.1	27.3	13.8	17.1	39.8	26.7	35.5	25.6	25.3	63.4	25.3	26.4	95.3	29.1	60.0	109.4	37.9	20.2	30.6	29.0	19.5	50.7	25.3	49.7	26.2	29.5	35.7	16.4	42.9	30.8	48.8	34.2	24.8	56.6	102.4	24.5	35.1	33.2	7.3	22.6	15.9	9.2	18.5	9.1	10.1	11.7	8.2	17.7	8.0	11.6	9.6	19.4	10.8	19.0	5.2	13.7	13.0	6.1	6.0	6.0	7.3	5.9	6.1	4.9	5.6	5.6	5.1	5.5	7.4	14.8	12.8	20.0	13.1	9.7	5.9	7.0	11.4	12.5	12.3	10.5	12.8	7.8	7.2	17.7	9.2	8.4	19.7	11.1	17.9	5.9	17.2	28.3	24.8	17.1	14.2	5.4	24.2	20.1	32.1	26.7	13.1	16.8	14.4	19.0	20.9	8.2	4.9	15.6	23.5	15.3	12.7	12.2	12.9	7.2	23.1	12.5	16.9	3.6	15.0	25.3	15.3	9.2	6.6	18.7	17.4	13.4	8.6	11.4	11.4	10.7	39.1	45.2	19.1	6.6	13.7	12.4	60.3	37.7	11.2	5.4	13.0	11.8	10.0	19.9	10.5
POLDIP3	"KIAA1649, PDIP3, PDIP46, SKAR"	ENSG00000100227	"DNA polymerase delta interacting protein 3"	Q9BY77	22	42583721-42614962	"Predicted intracellular proteins"	"mRNA transport, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 129.3;Late spermatids: 469.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018419, HPA048790"	Approved		Enhanced	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear speckles"	"Cytoplasmic bodies"	"HPA018419: AB_1856928, HPA048790: AB_2680522"	"unprognostic (2.00e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.05e-3)"	"prognostic favorable (7.79e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.16e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.48e-1)"	"unprognostic (5.96e-2)"	"prognostic favorable (3.36e-4)"	"unprognostic (3.73e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.19e-1)"	25.9	36.5	51.7	26.3	56.0	68.2	33.3	52.5	54.9	43.2	45.5	36.7	25.8	40.5	34.7	42.6	53.2	24.0	34.4	50.2	51.1	40.6	33.2	36.3	36.2	59.2	54.1	91.1	35.9	34.4	35.6	32.6	53.3	41.3	29.3	30.1	37.7	33.4	34.9	39.1	31.8	35.4	50.6	38.6	44.4	30.8	54.1	48.6	37.6	34.5	46.4	34.8	34.3	58.1	43.7	43.7	96.3	45.4	42.7	48.7	61.7	49.0	41.1	73.6	54.6	51.6	29.5	73.3	30.8	58.2	34.9	49.5	101.0	55.8	57.1	35.6	74.9	58.4	50.8	53.6	39.5	91.9	57.5	33.8	62.5	54.1	56.0	61.4	52.5	54.1	63.7	47.0	58.8	48.5	76.3	65.3	53.5	56.4	40.5	96.5	87.7	49.5	61.4	27.9	31.5	27.2	59.6	51.1	53.0	56.2	47.4	67.4	48.3	46.7	56.0	31.8	50.1	45.3	59.5	67.1	37.8	56.0	67.4	23.3	36.9	29.8	30.9	34.8	32.0	26.9	27.3	26.3	41.9	26.2	29.7	27.1	21.2	28.6	30.9	21.5	31.0	38.7	51.7	56.0	52.5	54.9	50.2	51.1	59.2	54.1	53.3	50.6	54.1	58.1	15.8	19.2	15.1	10.4	28.6	19.6	23.7	13.1	22.2	30.1	23.0	20.6	13.3	17.2	16.0	20.2	20.9	36.5	23.1	22.9	21.5	29.1	129.3	22.9	20.7	18.9	19.2	25.6	7.1	24.9	39.7	23.2	21.4	23.4	24.1	18.8	16.1	19.0	22.2	25.2	8.8	15.8	16.2	25.7	17.9	469.0	21.8	19.9	19.6	18.7	40.3	23.6	22.6	11.6	17.4	26.4	21.2	24.8	24.5	37.2	19.2	20.3	19.5	17.1	46.0	19.3	18.5	33.0	34.5	22.9	17.6	52.1	23.0	22.6	19.0	28.6
POLE2	DPE2	ENSG00000100479	"DNA polymerase epsilon 2, accessory subunit"	P56282	14	49643555-49688422	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 21.0;Spermatogonia: 24.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"							HPA027555	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA027555: AB_10610282"	"unprognostic (1.42e-1)"	"unprognostic (6.57e-3)"	"unprognostic (3.53e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.99e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.32e-3)"	"unprognostic (1.10e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.37e-3)"	"unprognostic (5.13e-11)"	"unprognostic (9.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.50e-3)"	0.9	0.9	0.5	5.1	0.3	18.2	3.0	0.5	0.6	2.1	0.0	3.8	2.5	2.5	0.7	3.7	1.0	0.9	0.6	0.2	0.2	0.7	3.1	1.2	5.1	0.2	0.4	1.0	0.8	0.7	0.5	3.0	0.2	1.4	4.5	3.0	1.0	0.7	0.5	3.5	3.6	2.3	0.3	1.5	2.1	4.1	0.2	5.5	0.9	0.9	6.2	1.4	1.9	0.6	37.2	18.6	34.3	16.3	1.7	9.9	18.2	20.4	10.4	31.9	36.7	19.3	27.5	23.6	11.6	11.6	17.5	22.3	35.3	12.8	36.9	27.4	19.6	35.4	20.6	23.9	0.8	41.2	14.6	2.8	0.8	18.5	2.9	4.1	19.0	30.5	30.9	14.3	31.6	32.7	43.6	28.4	20.2	30.9	42.6	35.9	31.7	21.0	11.6	20.6	24.8	14.3	20.5	11.9	6.7	16.5	24.5	15.8	6.7	5.3	38.5	21.4	16.9	10.7	22.7	52.7	9.8	30.1	20.9	0.0	0.0	0.2	0.2	0.0	0.1	0.3	0.2	0.4	0.1	0.2	0.0	0.2	0.0	0.9	0.0	0.2	0.7	0.1	0.5	0.3	0.5	0.6	0.2	0.2	0.2	0.4	0.2	0.3	0.2	0.6	2.0	3.2	0.5	4.2	2.4	4.8	2.1	1.9	2.2	0.8	1.5	1.1	1.2	1.5	1.3	0.0	0.0	9.1	1.0	2.2	0.0	1.3	1.2	0.8	2.6	1.5	1.2	21.0	9.5	1.5	10.6	2.7	1.1	1.5	0.0	4.3	5.0	5.5	5.5	0.0	11.9	2.8	0.0	1.9	1.6	0.8	1.5	1.1	1.8	7.5	1.0	2.0	4.1	12.1	11.5	0.8	0.5	3.0	5.7	1.9	1.1	1.2	0.9	3.1	0.0	2.1	7.4	5.3	24.4	6.0	3.7	3.4	1.7	1.8	4.7	1.5
POLE3	"CHARAC17, CHRAC17, CHRAC2, p17, Ybl1"	ENSG00000148229	"DNA polymerase epsilon 3, accessory subunit"	Q9NRF9	9	113407235-113410675	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		DNA-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA047945	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA047945: AB_2680218"	"unprognostic (9.55e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.18e-1)"	25.4	32.9	20.3	34.9	20.9	113.5	31.7	24.7	24.2	25.8	17.3	29.6	25.4	25.2	26.0	39.7	28.2	18.0	26.4	21.2	19.7	23.6	38.1	23.7	53.6	21.9	19.6	22.6	27.4	26.7	11.2	26.6	21.5	23.0	32.8	16.4	27.2	22.8	79.1	37.3	26.3	27.8	20.8	33.0	24.9	41.1	19.8	55.1	21.8	56.4	56.7	28.5	24.8	21.5	85.0	103.3	71.2	107.6	39.8	35.3	62.5	110.3	56.0	122.1	95.6	96.5	75.0	305.5	66.9	65.0	74.5	141.4	140.3	121.4	112.0	58.8	84.7	158.9	97.7	99.5	42.4	333.5	92.2	40.5	82.2	106.3	135.5	44.3	86.0	152.7	225.7	165.6	85.9	215.1	230.6	178.4	92.1	180.7	184.8	232.4	296.3	171.8	53.4	79.8	153.8	88.7	160.2	100.0	89.4	43.0	149.7	148.1	71.3	90.0	122.3	115.2	191.2	86.0	301.5	407.4	82.2	193.5	110.1	77.4	85.4	90.4	83.8	87.0	104.2	86.3	78.9	79.8	83.3	82.4	84.8	79.3	17.5	77.4	71.6	83.6	102.0	135.2	20.3	20.9	24.7	24.2	21.2	19.7	21.9	19.6	21.5	20.8	19.8	21.5	37.2	38.5	30.2	2.0	61.4	93.8	30.8	37.0	66.0	15.0	51.9	49.9	43.6	21.5	35.8	31.3	6.2	60.7	73.9	28.9	43.0	35.7	5.1	45.4	53.7	33.9	24.6	101.6	4.7	45.4	62.5	37.6	22.4	44.1	57.5	41.4	25.7	43.1	49.3	13.5	3.9	36.9	28.5	36.5	66.4	16.4	35.8	44.7	40.9	1.9	60.3	29.9	48.4	3.5	3.6	37.6	13.9	42.5	67.8	36.0	18.3	34.4	35.5	18.3	13.1	47.9	45.7	40.2	93.1	87.6	94.9	34.9	65.5	36.3	42.5	22.6
POLQ	POLH	ENSG00000051341	"DNA polymerase theta"	O75417	3	121431427-121546641	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.0;lymphoid tissue: 4.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 16.4;Excitatory neurons: 9.5;Granulosa cells: 12.6;Inhibitory neurons: 7.8;Plasma cells: 12.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 2.5"	HPA053359			Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA053359: "	"unprognostic (1.59e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (5.46e-5)"	"unprognostic (2.70e-1)"	"unprognostic (6.23e-3)"	"unprognostic (3.09e-5)"	"unprognostic (8.55e-3)"	"unprognostic (1.09e-4)"	"unprognostic (2.86e-1)"	"unprognostic (5.59e-5)"	"unprognostic (2.06e-3)"	"unprognostic (0.00e+0)"	"prognostic favorable (1.04e-4)"	"unprognostic (1.76e-1)"	"unprognostic (6.01e-2)"	"unprognostic (5.76e-2)"	0.1	0.2	0.0	1.6	0.1	6.0	0.4	1.0	0.2	0.2	0.0	1.2	1.2	0.2	0.0	2.0	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.2	2.8	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	2.0	0.0	0.3	0.0	0.0	1.4	0.9	0.4	0.0	0.8	0.5	2.2	0.0	4.5	0.0	0.0	2.3	0.3	0.5	0.0	18.2	12.1	10.2	7.2	0.9	1.2	9.2	8.5	3.2	9.7	12.9	9.8	6.6	21.5	3.7	4.6	11.7	14.0	12.2	5.4	16.4	6.3	6.7	13.8	8.0	6.1	0.1	15.1	12.1	0.2	0.4	8.9	5.4	1.7	4.9	7.9	9.3	15.9	10.3	7.1	13.7	8.8	9.7	5.5	5.9	11.4	12.2	7.6	3.1	10.3	5.5	5.0	9.8	5.2	3.4	8.8	4.8	14.8	3.8	8.6	11.2	3.4	11.1	8.0	6.9	21.8	4.1	11.0	6.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	1.6	0.7	0.9	0.5	0.6	0.0	0.9	0.6	0.6	1.6	0.0	2.0	0.0	0.0	3.1	0.6	1.6	0.0	0.1	0.4	0.9	1.0	0.5	0.0	16.4	9.5	0.0	3.3	1.2	4.6	1.0	0.0	12.6	0.0	0.2	2.3	0.0	7.8	1.6	2.0	1.3	1.2	0.7	0.3	1.7	0.0	1.0	0.6	0.4	0.0	1.5	1.3	0.2	1.2	0.0	12.2	0.5	0.2	0.1	2.4	0.2	0.0	0.1	1.0	6.8	3.4	4.9	0.1	0.3	1.8	0.9	3.2	0.8
POLR1A	"DKFZP586M0122, FLJ21915, RPA1, RPA190, RPO1-4"	ENSG00000068654	"RNA polymerase I subunit A"	O95602	2	86020216-86106155	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010145, HPA031513, HPA049700"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments"		No	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoli fibrillar center"	"Nucleoplasm, Intermediate filaments"	"CAB010145: AB_675814, HPA031513: AB_2673916, HPA049700: AB_2680856"	"unprognostic (1.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (3.70e-9)"	"unprognostic (1.06e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (4.31e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (8.41e-4)"	"unprognostic (7.20e-2)"	5.4	5.7	3.7	5.8	4.0	4.9	4.5	3.1	4.7	4.9	4.0	4.9	4.1	8.2	3.0	6.0	5.2	2.9	5.8	3.9	3.6	4.6	5.0	4.0	4.6	3.4	3.6	5.2	5.2	7.1	4.9	5.0	3.3	4.5	5.0	3.5	3.9	5.1	10.8	5.5	3.8	6.9	2.7	3.8	4.5	6.2	4.4	6.2	4.5	7.4	4.9	5.2	4.2	4.3	18.5	41.1	18.0	34.7	17.2	13.7	25.9	16.6	10.9	23.2	14.4	51.9	14.2	41.9	17.2	17.0	22.7	20.9	46.6	24.4	20.6	17.6	24.0	36.2	18.0	35.1	12.1	34.8	18.7	10.5	15.0	34.6	26.7	8.8	18.2	19.0	48.8	10.3	16.2	16.4	25.8	15.1	32.7	24.4	26.8	30.7	39.5	19.6	10.5	29.7	27.7	14.6	18.3	23.8	12.7	12.3	14.0	12.0	29.3	28.0	22.2	24.3	33.8	14.5	15.3	35.7	14.6	29.3	25.3	0.5	0.4	0.0	0.7	0.6	0.9	0.5	0.3	0.6	0.4	0.6	0.3	0.4	0.1	0.5	0.5	0.7	0.1	0.4	3.7	4.0	3.1	4.7	3.9	3.6	3.4	3.6	3.3	2.7	4.4	4.3	4.9	3.2	9.1	13.4	8.8	4.2	4.9	5.3	12.0	12.4	6.2	5.5	11.1	8.6	4.7	9.2	16.7	6.3	7.2	5.1	3.9	6.0	3.0	5.4	13.8	6.5	9.6	10.9	19.7	4.9	5.4	7.7	8.2	6.9	6.3	11.0	4.2	8.3	12.5	11.8	18.1	6.7	2.0	3.1	3.5	1.7	6.2	5.5	5.4	6.5	3.3	4.2	6.2	20.1	18.2	6.6	3.0	5.3	10.1	9.1	3.5	3.4	5.2	9.7	0.0	14.3	6.2	5.0	7.2	13.4	2.7	3.8	7.5	12.4	10.4	4.0
POLR1B	"FLJ10816, FLJ21921, RPA135, RPA2, Rpo1-2"	ENSG00000125630	"RNA polymerase I subunit B"	Q9H9Y6	2	112541915-112579818	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 181.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037528			Supported	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoli fibrillar center"	Cytosol	"HPA037528: AB_10671627"	"unprognostic (1.66e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (2.71e-5)"	"unprognostic (2.07e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.56e-2)"	5.7	4.6	2.9	5.6	3.0	4.1	8.2	3.5	3.1	5.3	3.8	5.5	4.4	4.7	4.4	8.1	6.7	3.7	4.1	2.8	3.5	8.1	10.7	4.1	9.3	2.6	2.7	6.3	8.1	11.9	4.4	5.6	2.5	5.0	6.2	5.2	3.8	4.7	7.5	5.2	3.8	5.3	2.6	6.7	4.3	8.4	3.1	7.2	10.7	6.4	10.8	7.9	3.6	3.4	21.1	21.6	11.2	28.2	13.9	13.2	24.0	15.1	11.9	24.0	21.5	48.8	12.5	46.1	22.9	9.8	18.8	29.5	56.1	30.6	28.4	22.3	30.9	26.5	21.4	37.1	14.2	43.6	18.1	12.7	21.6	25.4	39.6	9.8	19.9	10.2	55.0	16.8	13.2	17.5	20.5	29.7	66.3	29.5	42.8	30.9	21.3	54.1	17.2	19.2	34.3	29.1	12.1	34.7	19.7	13.8	16.3	15.6	15.9	14.6	23.2	13.7	21.8	24.3	44.4	40.9	11.0	28.8	13.1	0.4	8.0	3.3	10.0	8.3	21.5	11.4	9.9	10.7	14.2	11.6	12.4	12.5	0.8	15.3	6.5	3.5	15.2	9.6	2.9	3.0	3.5	3.1	2.8	3.5	2.6	2.7	2.5	2.6	3.1	3.4	4.8	16.0	5.9	4.6	8.5	15.0	4.7	4.1	9.6	3.6	4.2	3.7	6.4	7.2	5.8	9.2	2.1	3.4	6.5	2.0	5.9	3.9	181.9	3.5	7.6	5.8	3.6	5.9	8.8	4.6	2.8	3.5	8.6	4.2	5.1	6.5	1.4	9.4	3.8	1.7	9.2	3.8	0.0	4.3	3.7	40.9	3.1	3.8	1.8	3.7	4.5	4.3	8.2	7.5	8.1	3.8	5.8	3.0	6.4	6.2	1.2	5.1	3.2	2.9	0.0	5.1	3.5	10.3	7.9	12.7	17.2	0.5	6.2	6.8	5.5	3.9
POLR1E	"FLJ13390, FLJ13970, PAF53, PRAF1, RPA49"	ENSG00000137054	"RNA polymerase I subunit E"	Q9GZS1	9	37485948-37503697	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022527, HPA052400"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA022527: AB_1854924, HPA052400: AB_2681815"	"prognostic favorable (2.27e-4)"	"unprognostic (2.09e-1)"	"unprognostic (9.90e-3)"	"unprognostic (1.10e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.09e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.23e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.24e-2)"	20.8	15.3	9.4	14.6	9.7	13.1	24.0	9.7	9.0	22.7	7.0	17.9	8.5	24.3	14.8	13.9	20.0	12.6	18.4	8.8	10.6	8.4	29.7	11.9	19.3	9.0	9.5	42.4	27.9	11.5	9.4	8.3	9.4	14.0	10.9	8.9	18.0	17.4	19.1	15.7	10.9	22.5	10.2	10.9	15.0	9.1	9.6	17.0	13.7	10.5	21.6	17.9	17.0	10.4	58.5	53.7	29.0	46.2	53.2	67.8	18.9	50.6	19.5	51.2	45.0	46.4	18.9	84.1	23.8	58.5	34.9	23.8	71.5	60.0	64.2	81.9	33.6	40.4	68.0	33.3	39.7	78.2	27.5	72.7	20.9	100.4	85.7	32.2	26.5	46.0	107.5	36.0	45.6	28.0	54.5	26.8	51.7	39.7	43.5	47.8	26.7	40.5	26.7	21.4	41.3	33.9	33.7	26.7	43.8	23.8	26.0	51.4	18.3	60.3	91.9	52.3	102.2	19.5	29.6	87.7	20.8	48.8	51.2	0.0	3.5	2.2	14.2	6.0	22.7	10.1	13.5	14.5	5.6	11.5	16.6	14.7	1.1	13.1	5.2	3.9	8.0	7.5	9.4	9.7	9.7	9.0	8.8	10.6	9.0	9.5	9.4	10.2	9.6	10.4	7.2	0.0	8.4	1.6	20.4	28.3	23.7	10.9	21.1	7.0	13.2	15.2	8.6	14.3	7.4	0.0	4.2	15.6	20.0	4.3	7.9	13.8	5.6	5.4	20.1	7.1	1.8	15.4	1.8	21.6	21.4	16.1	8.6	6.7	8.8	14.0	3.9	18.7	7.4	3.3	2.4	7.7	6.1	10.3	8.0	10.7	14.9	8.1	5.4	3.7	9.2	9.2	12.3	1.5	2.1	14.1	3.0	15.1	28.3	23.6	3.1	5.9	4.1	6.9	0.0	22.1	15.9	20.6	23.5	14.0	17.8	8.3	23.7	31.9	11.9	12.7
POLR1G	"A34.5, ASE-1, CAST, CD3EAP, PAF49, RPA34"	ENSG00000117877	"RNA polymerase I subunit G"	O15446	19	45406644-45410737	"Predicted intracellular proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 15.8;Extravillous trophoblasts: 26.3;Hofbauer cells: 11.5;Syncytiotrophoblasts: 7.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 14.5"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 14.5"	"Cell line enhanced"	"Detected in all"		"U-251 MG: 200.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041664, HPA041734"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"	Mitochondria	"HPA041664: AB_10795693, HPA041734: AB_10794489"	"unprognostic (1.03e-1)"	"unprognostic (8.98e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.46e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavorable (4.79e-9)"	"unprognostic (1.62e-3)"	"unprognostic (3.21e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.26e-2)"	"unprognostic (6.29e-9)"	"unprognostic (1.02e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.53e-2)"	3.2	2.4	2.9	3.3	3.0	2.1	3.1	4.1	4.3	2.4	1.1	2.5	2.4	2.7	1.4	4.3	3.0	2.8	3.5	2.9	2.4	2.7	2.6	2.0	3.5	3.4	2.6	3.5	3.8	2.9	1.9	2.2	3.6	2.2	2.1	2.7	2.8	1.9	6.7	4.4	1.9	3.0	1.1	2.1	1.8	1.8	3.4	2.1	2.3	4.5	4.0	4.1	2.4	3.8	31.4	29.0	5.3	20.6	7.5	6.5	20.3	15.3	5.2	26.2	15.1	32.5	21.5	48.3	14.8	11.3	20.6	29.5	46.4	43.0	18.4	22.1	28.7	24.3	11.0	23.9	12.8	25.3	8.9	9.4	27.3	38.2	20.7	7.0	19.2	16.0	63.0	8.9	25.6	37.0	18.7	9.3	37.0	34.6	27.3	25.1	19.5	32.2	10.5	22.7	30.8	9.6	30.9	40.6	6.4	10.6	19.9	15.4	18.2	36.5	36.7	20.4	200.5	16.1	74.0	51.6	16.8	37.6	25.9	1.5	2.7	0.3	1.4	3.5	3.1	2.7	2.0	2.2	4.2	3.0	2.9	3.5	1.3	3.3	2.8	14.5	1.3	2.0	2.9	3.0	4.1	4.3	2.9	2.4	3.4	2.6	3.6	1.1	3.4	3.8	3.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	15.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	26.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	7.7	0.1	0.0	0.0	0.0
POLR1H	"A12.2, HTEX-6, hZR14, RPA12, tctex-6, ZNRD1"	ENSG00000066379	"RNA polymerase I subunit H"	Q9P1U0	6	30058899-30064909	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 14.6;B-cells: 17.6;Cardiomyocytes: 15.2;Cytotrophoblasts: 28.2;dendritic cells: 20.5;Extravillous trophoblasts: 43.0;Hofbauer cells: 35.3;Syncytiotrophoblasts: 17.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055074, HPA077979"	Supported		Supported	"Nucleoli fibrillar center"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli fibrillar center"		"HPA055074: AB_2682690, HPA077979: AB_2732366"	"unprognostic (4.94e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.88e-2)"	"unprognostic (8.55e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.96e-1)"	"unprognostic (9.52e-3)"	"unprognostic (5.18e-1)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (2.17e-7)"	"unprognostic (2.57e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.97e-2)"	"prognostic favorable (2.75e-5)"	26.0	26.2	5.0	4.3	5.0	2.6	22.4	4.7	9.6	24.4	5.1	22.4	16.8	22.7	4.7	29.3	21.7	1.1	23.7	5.2	6.2	32.3	24.4	19.7	2.9	5.5	5.6	25.4	30.0	2.4	18.0	5.8	5.4	21.1	14.2	4.3	16.8	2.7	25.4	23.0	24.7	4.0	5.4	33.2	26.3	30.5	5.3	13.1	17.5	7.7	3.3	23.0	22.1	5.2	17.9	5.4	20.5	40.9	5.7	5.9	6.9	7.2	19.4	19.9	18.7	23.0	9.3	16.2	7.3	8.1	10.4	10.8	37.4	27.7	25.4	2.0	43.1	24.6	13.7	31.0	36.4	33.8	8.1	22.5	13.1	20.4	49.0	6.4	32.3	25.1	60.8	8.3	15.5	29.9	22.9	67.5	0.0	29.9	28.1	18.1	26.5	30.2	11.5	23.7	12.5	20.0	10.0	19.5	10.4	9.8	19.1	30.4	7.3	19.5	8.0	0.0	23.1	9.7	10.7	20.4	3.4	33.1	25.4	22.1	5.3	4.4	6.5	3.9	6.7	4.9	6.0	6.1	6.3	4.3	6.6	5.1	4.0	5.1	3.9	4.9	7.8	4.0	5.0	5.0	4.7	9.6	5.2	6.2	5.5	5.6	5.4	5.4	5.3	5.2	14.6	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	28.2	20.5	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	43.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	35.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	17.6	4.4	0.0	0.0	0.0
POLR2B	RPB2	ENSG00000047315	"RNA polymerase II subunit B"	P30876	4	56977722-57031158	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037506	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA037506: AB_10672597"	"unprognostic (9.88e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.83e-3)"	"unprognostic (7.51e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.24e-3)"	"unprognostic (3.51e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (7.17e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.35e-2)"	28.2	29.1	11.8	38.3	14.0	34.1	34.1	21.0	17.6	32.9	16.9	34.7	32.6	34.9	26.5	30.0	32.9	30.2	48.1	14.2	16.0	35.7	30.0	27.7	49.9	14.1	11.8	31.6	28.3	50.3	17.8	32.9	15.4	32.5	36.3	36.8	30.6	32.4	64.7	28.0	30.9	38.3	12.8	36.5	31.1	39.8	12.8	61.2	37.6	56.7	51.3	42.4	19.8	17.6	78.9	64.3	110.5	98.2	89.3	80.3	61.2	94.6	101.3	98.3	91.1	82.9	80.1	126.5	86.1	94.3	71.4	52.2	140.5	77.2	139.8	54.2	66.3	96.9	70.0	71.5	102.2	156.0	100.6	86.8	76.1	114.3	68.5	81.0	119.5	95.0	145.4	100.0	115.9	56.8	142.3	60.5	92.0	101.5	77.9	105.9	75.7	68.4	66.8	90.7	95.3	106.8	67.5	120.3	89.6	90.7	65.8	88.3	91.2	74.4	95.2	75.8	132.2	77.3	75.5	172.8	82.4	83.1	92.4	51.9	17.0	22.8	27.7	17.0	29.5	27.9	26.6	28.8	22.2	18.9	25.9	30.8	14.4	26.5	19.8	17.6	30.9	19.8	11.8	14.0	21.0	17.6	14.2	16.0	14.1	11.8	15.4	12.8	12.8	17.6	39.5	28.9	52.0	26.8	61.5	41.3	60.9	60.3	39.9	45.5	31.5	26.5	35.7	35.8	56.3	36.8	43.8	49.2	77.1	36.9	19.6	60.9	5.9	53.4	52.7	39.5	29.9	50.5	31.1	55.0	30.7	42.8	59.1	45.8	58.2	36.8	30.7	30.8	29.1	45.4	32.0	36.9	50.8	45.8	36.8	8.8	57.5	42.5	44.4	33.7	74.3	26.7	115.4	23.6	40.4	54.0	36.2	38.0	50.5	59.4	36.6	32.7	80.6	49.0	72.3	46.5	45.7	74.0	63.6	32.7	39.9	41.0	75.2	46.2	35.4	74.6
POLR2C	RPB3	ENSG00000102978	"RNA polymerase II subunit C"	P19387	16	57462660-57472009	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040919, HPA041826"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA040919: AB_10795483, HPA041826: AB_10793935"	"unprognostic (2.10e-2)"	"unprognostic (4.42e-2)"	"unprognostic (7.52e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (2.90e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.60e-2)"	"unprognostic (6.63e-2)"	"prognostic favorable (3.03e-6)"	"unprognostic (2.29e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.43e-3)"	35.1	41.6	49.9	30.4	51.2	43.9	39.6	52.3	60.3	36.8	49.4	36.0	33.1	39.2	67.1	31.2	47.0	31.3	52.1	51.0	52.0	59.8	62.3	47.7	38.7	50.5	51.0	54.3	45.1	55.1	46.9	39.5	51.8	40.4	40.0	59.3	39.0	45.9	74.2	34.5	31.8	40.6	52.4	30.8	36.4	25.4	50.4	47.7	40.8	61.4	44.9	39.1	31.2	54.5	59.3	94.0	81.2	72.7	72.7	62.9	67.6	75.4	84.9	126.0	82.3	121.7	74.7	65.8	86.4	89.3	75.6	60.5	111.9	83.5	134.2	30.2	77.0	51.1	53.5	142.0	81.8	95.0	94.4	57.8	66.4	96.7	88.7	66.6	74.8	90.0	90.2	37.3	81.6	78.6	106.9	98.6	118.4	72.1	138.0	151.4	94.4	120.5	99.7	56.7	102.5	117.4	122.9	69.8	81.4	74.0	51.6	85.2	54.4	76.3	76.3	56.8	89.0	82.2	76.2	135.0	75.3	79.5	102.5	79.8	38.3	70.3	44.6	37.8	49.2	52.4	50.6	42.8	38.1	48.4	60.4	57.4	96.9	64.6	49.5	31.2	54.9	60.5	49.9	51.2	52.3	60.3	51.0	52.0	50.5	51.0	51.8	52.4	50.4	54.5	49.5	25.6	43.0	11.1	49.2	31.0	46.0	51.3	30.1	81.6	39.4	52.5	11.0	41.5	31.9	27.6	56.3	78.8	49.8	38.2	92.0	62.9	5.6	25.0	25.4	39.0	38.2	35.6	13.3	65.8	80.8	40.5	15.8	22.3	61.0	46.1	23.2	25.1	41.2	52.2	13.9	34.5	48.8	22.9	30.3	8.4	51.6	22.7	40.9	8.4	49.1	102.7	58.7	8.0	9.6	59.5	44.6	51.9	40.0	43.9	63.8	120.4	29.4	93.9	46.0	30.0	49.1	50.4	66.4	30.0	30.0	92.9	52.9	49.0	38.4	43.5
POLR2D	RPB4	ENSG00000144231	"RNA polymerase II subunit D"	O15514	2	127843553-127858155	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 74.3"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 170.2;Spermatocytes: 86.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034694, HPA046092"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear speckles"		"HPA034694: AB_2674284, HPA046092: AB_10963049"	"unprognostic (3.57e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (8.91e-4)"	"unprognostic (2.51e-1)"	"unprognostic (7.95e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (3.66e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.38e-1)"	12.3	10.4	7.2	14.4	9.8	32.4	11.9	9.6	8.3	9.4	7.3	12.0	9.7	10.3	8.0	12.3	10.6	8.4	10.0	7.5	8.7	8.8	19.2	10.2	19.7	8.0	8.9	15.0	14.7	10.4	8.3	15.9	8.3	9.5	14.7	8.1	8.4	9.2	29.3	11.3	9.3	15.0	8.4	12.8	9.4	74.3	8.1	28.3	9.1	27.1	26.9	15.3	8.4	11.0	63.4	40.6	73.9	51.9	26.8	29.2	59.0	59.1	27.9	69.6	61.9	92.0	50.9	97.7	49.6	40.0	39.8	32.7	107.0	51.2	107.3	57.7	58.3	96.6	37.9	85.4	31.4	104.9	51.6	20.8	37.8	93.3	53.2	19.3	46.1	70.4	137.1	84.8	40.4	50.1	105.0	47.5	103.6	65.9	46.4	99.3	77.8	88.0	23.1	42.6	45.7	60.9	39.9	48.9	50.7	54.7	54.6	71.4	47.0	60.1	84.4	34.4	69.0	99.4	173.4	173.0	52.4	51.2	60.5	9.9	22.8	17.3	26.3	31.7	25.0	22.8	21.0	23.2	29.9	20.2	27.6	23.7	7.3	25.8	35.0	19.5	20.6	21.3	7.2	9.8	9.6	8.3	7.5	8.7	8.0	8.9	8.3	8.4	8.1	11.0	10.9	3.2	11.7	2.6	22.0	10.8	22.0	7.6	15.9	15.1	9.8	6.2	10.4	11.5	10.1	12.9	8.4	33.0	23.4	7.6	11.7	20.3	70.8	13.2	16.1	12.5	8.4	31.1	4.7	17.5	31.0	15.2	9.7	10.4	18.4	23.1	11.4	17.0	21.7	33.7	5.2	11.9	8.2	11.1	14.1	170.2	17.7	13.3	8.8	2.8	23.4	13.2	16.5	2.5	7.5	18.4	8.4	18.4	46.6	26.2	10.2	11.1	6.8	13.7	13.1	18.5	15.5	86.1	48.9	19.3	10.1	26.7	17.1	31.5	14.0	18.9
POLR2E	"hRPB25, hsRPB5, RPABC1, RPB5, XAP4"	ENSG00000099817	"RNA polymerase II, I and III subunit E"	P19388	19	1086574-1095380	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Host-virus interaction, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063030, HPA068992"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm		"HPA063030: AB_2684926, HPA068992: AB_2686065"	"unprognostic (2.52e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.03e-3)"	"unprognostic (3.03e-2)"	"prognostic favorable (3.21e-6)"	"unprognostic (3.22e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.72e-3)"	"unprognostic (4.77e-2)"	30.8	16.7	25.5	16.3	22.9	15.4	18.1	23.0	28.9	13.0	16.0	18.7	13.7	12.8	14.4	22.8	17.3	7.9	14.6	25.9	23.5	23.6	41.1	17.0	18.6	28.1	24.7	14.0	13.2	20.3	12.2	10.3	28.6	12.5	19.5	17.5	14.8	12.1	16.4	16.2	17.0	16.7	23.4	19.3	15.9	13.0	26.6	13.8	17.0	22.6	26.6	14.0	11.2	24.1	33.6	30.8	41.6	33.4	55.6	34.5	19.5	24.2	34.1	39.5	23.1	36.1	11.9	27.5	10.7	72.1	6.1	26.5	79.1	26.9	73.1	29.2	23.9	36.3	36.2	33.9	22.3	54.3	26.4	25.5	17.5	27.7	51.0	40.6	36.7	14.7	42.3	31.0	44.3	27.6	30.0	17.1	33.6	23.9	23.1	31.9	40.7	27.0	39.5	38.3	21.0	23.9	40.2	27.8	17.5	37.2	29.5	24.7	49.9	19.6	21.7	36.0	28.4	47.6	70.9	50.9	32.3	34.6	23.2	24.2	50.2	29.5	25.5	33.7	26.5	18.2	23.2	26.0	44.3	19.6	18.5	18.4	25.2	28.7	38.7	31.2	24.5	38.4	25.5	22.9	23.0	28.9	25.9	23.5	28.1	24.7	28.6	23.4	26.6	24.1	67.7	32.1	63.0	8.1	80.1	104.3	83.9	152.1	59.7	55.7	80.9	82.9	78.2	60.1	79.9	55.2	41.7	234.3	67.4	103.1	174.1	156.7	21.0	64.0	64.4	77.8	70.6	77.4	13.0	141.1	264.1	95.1	66.3	57.2	71.0	74.9	68.9	96.6	259.7	55.5	13.9	91.8	107.8	93.6	221.7	37.8	69.3	103.7	99.6	6.5	361.7	78.1	103.0	4.5	10.6	162.5	84.6	62.1	93.8	111.7	163.1	188.4	72.3	48.9	26.3	50.5	96.9	125.4	82.5	104.1	109.7	234.6	73.4	110.6	130.5	106.9
POLR2F	"HRBP14.4, RPB6"	ENSG00000100142	"RNA polymerase II, I and III subunit F"	P61218	22	37952607-38041915	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in single"	4	"melanoma: 1.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000827, CAB009882"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"		"CAB009882: AB_2299942, HPA000827: AB_1079834"	"unprognostic (8.27e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.73e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.87e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.11e-4)"	"unprognostic (9.08e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.90e-1)"	"unprognostic (7.86e-2)"	52.5	61.1	73.4	34.6	92.3	38.9	50.8	77.5	90.2	59.5	56.9	64.9	37.7	53.2	24.8	58.7	50.2	19.5	91.8	74.2	91.2	58.2	118.6	41.6	31.0	87.9	83.9	60.9	47.5	76.5	62.7	30.2	82.6	47.7	28.7	16.8	56.1	39.6	111.0	45.8	42.3	28.8	75.3	36.4	57.6	48.8	86.8	36.7	54.7	68.4	26.3	53.1	52.7	123.7	150.7	176.2	120.6	128.7	141.1	81.7	109.4	138.0	81.0	141.4	130.5	210.0	51.8	117.4	99.1	120.3	138.3	106.4	166.9	135.7	67.1	143.0	303.7	107.3	181.3	289.1	125.9	213.6	67.0	112.4	99.8	186.3	72.1	71.2	118.7	130.4	208.9	93.7	101.9	220.2	168.4	258.2	174.3	175.4	134.7	162.3	110.4	134.5	77.4	94.8	180.6	67.2	129.5	88.9	215.3	69.6	62.9	144.3	110.5	119.8	173.9	150.4	158.1	106.0	178.0	247.9	122.4	107.9	138.4	118.9	92.9	140.8	83.8	90.4	78.5	95.8	71.9	81.8	86.3	71.3	63.1	63.7	122.8	113.7	78.5	123.3	103.4	85.3	73.4	92.3	77.5	90.2	74.2	91.2	87.9	83.9	82.6	75.3	86.8	123.7	82.6	38.5	85.9	9.4	73.2	204.3	113.9	205.4	63.7	26.7	133.8	168.7	0.3	101.5	122.5	121.4	25.0	243.5	70.5	148.7	193.7	160.0	117.0	96.0	117.2	94.8	117.2	109.6	9.9	159.5	303.4	97.4	58.1	82.4	90.0	90.0	98.6	304.4	178.5	28.6	10.7	143.1	116.0	94.2	102.9	42.0	159.7	65.9	225.9	2.8	102.3	99.4	111.2	9.5	99.0	182.4	152.9	151.2	65.7	137.3	196.6	306.5	114.3	33.3	157.8	90.1	197.1	237.0	241.0	106.0	224.3	211.9	82.4	82.7	145.7	121.2
POLR2H	RPB8	ENSG00000163882	"RNA polymerase II, I and III subunit H"	P52434	3	184361718-184368596	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037745, HPA055813"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA037745: AB_10672914, HPA055813: AB_2797254"	"unprognostic (3.21e-1)"	"unprognostic (4.96e-3)"	"unprognostic (3.61e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.72e-2)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (8.82e-3)"	"unprognostic (2.84e-1)"	"unprognostic (4.02e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.27e-3)"	"prognostic unfavorable (1.65e-10)"	"unprognostic (1.34e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.93e-3)"	41.6	60.6	50.4	32.5	51.0	31.1	42.2	53.5	60.1	48.8	51.8	54.4	57.6	36.3	39.7	52.1	39.8	30.0	34.8	50.7	49.9	77.5	63.8	37.6	41.1	50.8	50.6	40.2	52.1	35.5	32.9	34.9	50.9	42.9	57.8	14.6	44.2	26.3	37.3	37.8	55.5	35.0	49.8	41.9	51.2	32.3	51.3	39.8	48.3	30.0	40.8	43.4	41.5	52.9	225.2	77.3	81.7	121.4	89.0	62.8	101.2	82.8	86.3	110.8	141.6	199.6	104.6	126.0	201.7	65.0	168.4	88.8	147.4	148.7	98.1	124.4	194.7	121.4	89.8	126.2	80.1	129.3	67.9	81.6	83.3	72.6	129.8	99.4	116.3	124.6	95.3	81.0	89.0	265.6	128.7	172.3	89.0	279.0	159.3	74.3	74.9	171.2	133.9	100.3	122.8	87.3	69.7	214.0	126.9	78.6	267.9	102.4	61.5	52.5	82.9	70.9	224.3	161.7	181.3	237.3	83.4	136.2	71.5	8.3	17.6	15.9	26.8	30.7	32.9	32.9	31.6	29.1	34.0	33.9	45.8	34.8	1.3	29.8	19.2	34.7	36.7	21.6	50.4	51.0	53.5	60.1	50.7	49.9	50.8	50.6	50.9	49.8	51.3	52.9	45.1	38.5	43.8	23.8	39.4	113.4	74.1	113.7	61.5	22.0	70.1	77.0	17.4	47.1	70.2	44.1	16.7	103.2	45.8	132.8	140.8	73.0	21.0	62.3	62.3	57.9	55.7	53.8	12.9	91.2	146.0	52.8	53.5	83.7	31.1	50.4	43.2	58.5	61.4	25.2	15.8	80.2	93.6	21.4	57.5	14.3	46.0	29.9	51.6	9.4	29.0	26.7	32.0	8.5	11.5	97.6	90.9	27.8	52.1	139.7	94.5	150.5	55.1	24.9	39.5	48.0	69.6	92.9	111.0	66.0	74.2	122.3	38.0	71.6	83.1	92.5
POLR3B	"C128, FLJ10388, RPC2"	ENSG00000013503	"RNA polymerase III subunit B"	Q9NW08	12	106357748-106510198	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	"Nucleotidyltransferase, Transferase"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 24.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036466	Supported		Approved	"Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA036466: AB_10671842"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.36e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.09e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (8.73e-2)"	"unprognostic (9.24e-2)"	4.5	8.7	3.1	4.8	4.4	5.2	5.0	4.3	4.6	4.7	3.7	5.3	4.2	4.6	5.2	8.6	5.1	3.6	5.8	3.4	2.9	6.8	9.0	4.7	4.1	2.2	2.3	7.5	4.9	11.1	2.4	6.7	2.3	5.6	5.7	6.2	4.7	4.0	6.5	11.0	3.4	5.4	2.7	3.3	5.4	6.1	3.2	4.7	6.0	8.3	5.6	4.9	4.3	3.6	16.2	7.6	16.4	7.8	13.9	13.1	22.9	21.9	13.0	15.2	11.6	14.0	4.4	20.6	7.7	14.2	5.6	14.8	19.5	19.2	18.5	16.6	13.1	15.7	10.1	12.0	9.2	26.1	17.0	11.7	13.4	15.1	17.3	10.3	11.5	9.8	24.5	6.5	11.2	12.0	19.1	8.7	17.8	11.9	28.5	11.6	9.8	13.5	8.6	21.8	17.3	9.6	13.6	18.2	13.4	10.8	17.0	7.9	11.0	8.3	10.0	13.6	13.1	8.1	22.4	30.3	3.8	15.9	9.2	5.6	2.0	1.5	2.0	2.2	2.7	2.1	2.2	2.2	2.6	1.3	3.0	1.9	1.3	2.1	2.2	0.9	2.7	1.7	3.1	4.4	4.3	4.6	3.4	2.9	2.2	2.3	2.3	2.7	3.2	3.6	2.4	0.0	9.2	14.4	4.7	1.8	1.7	4.5	4.6	6.0	3.4	3.7	10.3	2.8	7.0	5.5	6.2	11.0	3.8	3.8	1.9	5.1	7.1	3.9	7.0	3.3	4.2	3.8	22.3	4.6	9.3	4.4	9.2	3.9	5.1	4.8	3.6	11.0	3.1	3.3	24.1	5.6	2.0	1.6	0.3	5.2	3.7	2.4	3.6	9.4	1.0	2.4	2.1	17.1	22.4	3.8	1.1	4.9	4.9	1.5	1.7	3.4	7.2	7.2	6.6	6.9	4.1	16.5	10.9	8.9	3.0	7.4	4.1	7.2	5.1	1.2
POLR3C	"C82, RPC3, RPC62"	ENSG00000186141	"RNA polymerase III subunit C"	Q9BUI4	1	145824088-145844402	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	16	"Early spermatids: 288.2;Late spermatids: 574.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027508, HPA027516"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA027508: AB_10600091, HPA027516: AB_10600894"	"unprognostic (1.43e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (6.87e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (5.48e-4)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.46e-1)"	"prognostic unfavorable (1.85e-5)"	"unprognostic (2.34e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.38e-1)"	16.9	8.5	5.0	10.5	5.3	14.7	15.1	8.7	6.5	14.1	4.6	12.0	8.0	13.4	9.3	11.1	12.3	10.9	10.1	5.5	4.9	10.3	10.7	9.7	14.1	4.6	4.6	16.0	14.6	11.9	6.3	10.4	5.1	9.6	11.2	7.9	12.4	8.3	14.7	15.9	11.8	13.1	4.7	12.6	11.3	24.8	5.3	15.3	11.4	10.3	15.6	13.0	12.2	6.5	29.9	23.7	19.0	17.6	23.0	29.3	19.8	30.6	31.5	36.2	34.9	32.6	16.4	51.6	28.9	37.2	19.5	31.6	30.6	30.5	34.9	22.7	24.9	27.9	26.5	17.6	42.1	58.4	35.2	29.3	18.9	42.4	61.7	20.8	21.8	22.0	36.3	30.9	35.6	37.2	27.7	22.1	29.0	29.3	29.7	30.1	23.6	34.1	19.7	20.6	18.2	26.4	26.0	37.5	36.7	28.5	29.5	49.6	26.7	34.0	27.4	19.6	41.9	42.9	48.1	58.8	12.4	28.4	28.3	63.0	31.7	31.9	22.5	36.9	29.5	30.4	24.2	23.3	33.9	33.8	25.1	22.7	2.7	34.0	27.0	35.6	23.3	26.1	5.0	5.3	8.7	6.5	5.5	4.9	4.6	4.6	5.1	4.7	5.3	6.5	12.6	6.4	10.8	12.1	15.6	5.0	8.3	8.8	13.1	3.6	5.5	5.2	23.8	2.8	10.1	3.7	4.2	11.7	18.5	3.5	11.7	14.8	288.2	7.8	7.3	11.2	4.2	19.1	13.0	21.3	12.5	11.0	9.2	7.5	8.2	6.9	9.3	5.2	14.3	1.7	12.4	7.5	8.2	12.6	6.2	574.5	10.2	9.4	1.8	10.3	13.3	5.1	10.3	14.1	12.9	16.5	6.8	14.7	12.2	8.4	8.9	12.8	8.1	3.8	19.7	11.0	9.9	26.1	22.5	10.9	4.3	9.6	13.4	11.1	8.5	9.5
POLR3D	"BN51T, C53, RPC4, TSBN51"	ENSG00000168495	"RNA polymerase III subunit D"	P05423	8	22245133-22254601	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061331, HPA067875, HPA068461, HPA069089"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA061331: AB_2684480, HPA067875: AB_2685912, HPA068461: AB_2685993, HPA069089: AB_2686081"	"unprognostic (2.33e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.38e-3)"	"unprognostic (9.33e-3)"	"unprognostic (1.24e-1)"	"unprognostic (8.02e-2)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (2.02e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.27e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (9.15e-6)"	"unprognostic (1.15e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (2.12e-4)"	15.0	11.9	3.4	4.4	3.3	6.5	10.6	3.0	3.9	14.1	3.8	11.3	2.5	10.4	3.3	15.2	11.3	4.1	14.1	3.0	3.6	11.7	10.0	11.1	4.7	3.7	3.6	14.9	17.5	4.0	13.7	6.6	3.6	12.8	4.5	4.0	10.6	3.8	32.8	11.2	8.6	5.8	3.5	11.4	10.6	19.3	3.9	3.4	10.6	8.3	4.3	15.1	14.4	4.3	5.1	10.7	11.0	7.8	10.0	16.6	11.3	18.9	9.1	10.7	8.7	10.5	3.6	27.8	10.2	12.5	8.9	9.1	16.9	9.2	11.0	6.9	9.4	20.7	10.5	11.2	13.6	5.0	9.5	13.8	12.9	13.4	21.8	13.1	8.9	14.9	28.9	9.5	8.7	7.2	22.2	10.4	18.9	13.0	9.0	14.7	12.2	18.0	6.1	6.0	7.8	24.2	8.5	5.9	17.7	11.9	5.4	8.0	13.0	9.4	9.1	18.8	11.4	17.0	22.7	18.9	9.2	10.1	14.0	0.1	1.4	0.3	1.8	1.1	2.5	2.4	2.3	2.6	1.6	2.2	3.0	1.9	0.1	2.9	1.6	3.5	1.8	1.3	3.4	3.3	3.0	3.9	3.0	3.6	3.7	3.6	3.6	3.5	3.9	4.3	15.0	9.6	6.5	4.6	15.8	19.5	43.6	21.2	13.6	12.8	15.2	14.5	10.9	4.3	13.3	11.0	16.7	16.2	18.5	6.9	11.7	20.2	42.7	11.6	37.7	15.6	21.5	10.3	2.4	11.8	33.2	21.3	12.8	14.8	18.4	18.7	11.7	3.8	13.7	3.3	2.8	19.1	12.2	8.8	8.2	40.5	15.8	8.6	8.8	1.0	13.4	4.5	14.4	2.5	3.5	22.5	6.7	12.8	20.5	52.3	6.7	12.6	11.2	12.2	19.7	22.1	21.3	44.2	52.0	12.1	19.2	27.0	15.0	25.1	12.3	41.8
POLR3E	"C37, FLJ10509, RPC5, SIN"	ENSG00000058600	"RNA polymerase III subunit E"	Q9NVU0	16	22297375-22335101	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 62.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041419, HPA041477"	Approved		Enhanced	Nucleoplasm		Yes	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041419: AB_2677468, HPA041477: AB_10796345"	"unprognostic (3.09e-2)"	"unprognostic (8.59e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.42e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (8.14e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.96e-2)"	"unprognostic (8.19e-3)"	"unprognostic (3.41e-2)"	12.2	17.0	2.8	6.6	4.5	7.8	12.0	4.3	3.7	10.7	16.1	12.9	6.3	12.7	2.4	13.0	11.8	4.5	15.4	4.1	4.4	8.4	13.3	10.2	5.3	4.8	5.5	11.3	16.1	10.7	12.8	4.6	4.5	11.3	3.0	3.1	12.2	8.2	62.6	14.8	10.0	4.9	3.7	8.9	14.2	11.2	4.2	8.5	12.8	15.5	5.7	12.0	10.4	5.3	21.1	29.0	6.9	19.5	12.1	9.7	27.5	16.1	6.1	9.4	4.2	36.3	14.8	41.7	21.8	11.1	7.9	18.7	35.6	20.6	7.6	28.7	52.3	21.0	31.8	70.9	15.1	34.4	23.0	8.7	19.5	22.1	25.8	3.5	25.9	17.1	63.1	17.0	10.9	34.5	33.6	11.8	37.5	20.2	22.8	45.0	16.7	54.2	8.0	12.4	28.9	20.6	15.6	29.2	14.0	4.2	17.2	16.3	17.3	11.0	12.4	9.2	18.3	23.6	45.6	40.3	11.1	23.0	21.1	0.0	4.7	2.8	8.6	4.8	9.1	7.4	9.1	8.7	7.7	6.0	8.4	7.3	0.5	7.4	4.5	4.4	10.0	6.9	2.8	4.5	4.3	3.7	4.1	4.4	4.8	5.5	4.5	3.7	4.2	5.3	9.4	3.2	14.7	14.4	20.3	32.5	23.0	10.9	12.5	24.0	16.4	19.7	18.9	11.5	13.4	18.4	31.3	25.2	27.3	8.9	5.9	12.0	34.9	21.0	13.3	13.3	15.0	10.5	12.8	12.8	20.2	14.1	13.7	28.5	27.9	23.1	8.9	11.1	13.1	20.2	16.3	13.7	10.2	10.1	22.2	20.9	12.5	11.0	14.2	11.2	9.7	10.4	21.6	18.6	17.9	15.0	11.7	9.1	26.0	28.5	13.6	11.8	16.6	40.9	13.1	21.0	12.2	19.7	16.1	16.5	39.6	28.3	30.3	20.5	16.2	26.3
POLR3F	"C34, RPC39, RPC6"	ENSG00000132664	"RNA polymerase III subunit F"	Q9H1D9	20	18467389-18484646	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 42.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049441, HPA050173, HPA072298"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA049441: AB_2680768, HPA050173: AB_2681042, HPA072298: AB_2686510"	"unprognostic (4.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.39e-2)"	"prognostic unfavorable (8.87e-9)"	"unprognostic (1.80e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.20e-1)"	"prognostic favorable (6.48e-4)"	"unprognostic (3.04e-1)"	"unprognostic (4.01e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.88e-3)"	"unprognostic (4.98e-3)"	6.6	6.5	10.1	6.4	10.9	9.8	9.5	13.1	12.6	6.1	9.7	5.2	5.0	8.0	9.5	7.0	6.8	5.7	9.8	11.1	10.5	8.5	6.4	6.2	7.3	10.1	10.0	8.2	6.0	7.6	3.2	7.5	10.5	7.0	6.1	21.2	5.7	6.6	10.9	7.4	4.4	7.2	9.9	6.3	5.5	9.1	9.9	6.9	11.0	9.5	7.2	6.9	3.0	10.9	12.9	12.6	14.9	15.9	9.5	11.7	22.7	19.0	13.2	23.8	19.3	14.0	12.1	12.0	10.0	14.2	21.3	20.0	20.8	21.2	27.2	8.1	11.0	8.5	7.1	18.6	12.4	22.8	11.9	10.6	14.0	32.2	18.0	13.1	12.9	9.4	19.4	11.7	19.0	15.8	17.3	21.1	17.2	14.3	29.1	11.8	29.4	12.7	13.0	9.1	27.3	17.2	13.9	24.2	32.2	14.0	13.6	15.5	10.1	26.0	13.4	16.2	27.8	11.2	38.0	11.7	10.7	11.0	19.5	0.4	3.0	1.3	2.7	3.7	4.5	3.1	3.6	2.7	3.7	1.7	3.5	3.6	0.8	3.7	3.0	2.7	3.7	2.7	10.1	10.9	13.1	12.6	11.1	10.5	10.1	10.0	10.5	9.9	9.9	10.9	7.3	9.6	4.8	9.8	8.0	8.9	3.7	5.7	10.2	18.3	6.6	5.8	8.3	2.8	5.1	1.8	10.4	10.7	8.5	3.5	9.8	8.8	42.7	8.5	6.7	9.0	6.7	8.2	21.7	6.8	12.1	7.0	4.6	4.8	5.7	8.8	7.1	4.6	7.6	11.8	19.4	4.4	4.1	9.2	6.7	7.7	6.2	5.9	5.4	10.3	10.4	17.5	12.3	15.1	13.0	7.7	1.9	10.1	9.0	4.3	2.9	12.2	11.3	19.3	13.1	8.3	8.3	28.1	22.9	8.4	11.4	7.3	8.0	11.3	4.3	3.2
POLR3G	"C31, RPC32, RPC7"	ENSG00000113356	"RNA polymerase III subunit G"	O15318	5	90471748-90514557	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 24.8;Inhibitory neurons: 21.2;Oligodendrocytes: 70.8;Spermatogonia: 26.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 84.5"									"CAB010109, HPA052658, HPA074330"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB010109: AB_2165718, HPA052658: AB_2681904, HPA074330: "	"unprognostic (4.31e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.18e-1)"	"unprognostic (3.42e-2)"	"unprognostic (4.19e-6)"	"unprognostic (2.17e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.21e-14)"	"unprognostic (3.86e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.53e-2)"	"unprognostic (8.17e-5)"	1.8	0.6	3.5	2.4	4.5	3.0	2.0	6.3	5.9	1.3	0.7	1.6	1.8	1.5	4.7	4.3	1.2	1.3	1.8	3.6	6.0	0.9	2.2	1.6	4.7	5.7	4.4	1.9	2.4	2.0	0.9	1.8	6.8	1.7	1.5	3.3	2.3	0.5	3.0	4.3	1.4	0.8	1.9	1.8	1.2	4.5	4.2	0.8	3.2	0.8	1.9	2.0	1.7	6.3	24.1	13.0	18.8	5.3	5.9	8.2	7.7	11.9	4.3	19.8	16.8	9.0	18.8	63.7	4.2	5.3	20.0	11.6	20.8	23.2	69.2	29.6	19.6	26.2	8.1	15.1	9.5	19.4	6.2	6.7	8.1	32.7	25.8	4.6	27.2	26.5	35.8	6.4	8.3	13.2	19.1	14.1	78.1	4.0	63.2	16.5	7.4	40.2	5.9	3.2	22.0	6.4	3.7	9.6	35.1	7.7	5.4	6.2	29.1	10.3	21.2	13.2	48.3	13.5	36.7	50.0	22.1	23.7	84.5	3.3	0.2	0.2	1.5	0.4	0.7	1.7	0.5	0.9	0.4	0.9	1.1	1.2	0.7	2.9	1.5	1.0	0.2	0.3	3.5	4.5	6.3	5.9	3.6	6.0	5.7	4.4	6.8	1.9	4.2	6.3	3.2	6.4	2.2	11.8	2.8	3.6	1.6	1.5	1.8	3.0	2.8	3.7	5.2	0.0	0.7	1.8	8.4	0.8	0.7	0.9	3.9	2.4	4.5	1.6	2.3	2.0	6.7	8.8	24.8	4.4	5.4	3.8	0.5	1.2	7.0	1.6	4.6	2.6	1.7	3.3	21.2	1.4	0.0	0.3	0.3	1.0	0.3	1.2	1.8	5.6	0.0	1.1	1.0	14.6	70.8	4.1	3.0	1.2	5.4	6.1	0.4	1.5	3.0	0.8	0.0	1.1	1.8	7.2	26.6	6.3	8.5	0.8	1.7	6.5	2.0	0.8
POLR3K	"C11, RPC11"	ENSG00000161980	"RNA polymerase III subunit K"	Q9Y2Y1	16	46407-53608	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 183.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005891	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA005891: AB_1079653"	"unprognostic (3.00e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.53e-1)"	"unprognostic (7.16e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.03e-3)"	"unprognostic (9.06e-2)"	"unprognostic (7.40e-2)"	"unprognostic (5.72e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.36e-3)"	"unprognostic (2.68e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.53e-2)"	"unprognostic (9.63e-2)"	6.9	10.4	12.5	13.1	13.0	11.6	7.0	12.3	13.5	6.4	11.0	8.1	8.3	6.8	7.3	8.7	7.4	5.2	10.3	12.6	12.8	8.2	9.0	6.5	18.4	11.8	11.9	7.1	6.9	12.3	6.1	6.7	12.5	8.0	7.6	5.1	8.4	6.8	20.5	5.3	8.5	6.7	11.5	11.9	8.4	2.6	13.6	13.1	9.5	12.6	16.3	8.8	5.8	13.2	36.1	60.9	37.7	39.4	15.2	9.4	30.3	50.2	16.0	43.4	28.7	79.4	38.2	93.1	37.1	17.7	17.3	35.0	88.5	23.0	31.0	56.5	82.1	68.2	44.5	56.6	11.6	62.1	64.3	9.2	20.4	48.3	24.3	9.9	21.7	40.9	99.0	29.0	28.4	89.9	75.1	41.2	62.3	44.8	57.4	89.9	43.7	96.7	25.0	25.7	55.1	32.5	34.7	63.2	30.8	15.9	37.2	55.2	20.9	28.1	34.5	37.8	61.6	18.5	47.5	183.8	12.1	45.1	42.5	30.5	36.3	93.2	40.4	54.7	42.1	114.6	51.3	46.5	34.4	109.9	45.8	42.6	27.7	41.2	51.8	70.2	87.6	53.1	12.5	13.0	12.3	13.5	12.6	12.8	11.8	11.9	12.5	11.5	13.6	13.2	23.3	3.2	11.3	2.0	31.8	33.3	19.9	34.4	17.6	16.4	29.7	33.8	28.9	18.6	30.3	18.4	4.2	42.5	28.2	17.6	49.0	34.0	0.7	21.6	15.6	20.0	18.0	38.3	5.1	35.0	51.1	16.9	9.2	14.9	22.2	29.7	20.7	27.5	43.7	10.1	4.6	21.8	71.2	15.1	24.3	1.8	21.1	23.2	23.2	3.7	44.1	23.5	34.0	1.0	3.4	37.0	16.2	16.6	28.1	29.6	17.1	43.4	30.6	10.8	13.1	12.0	25.2	4.5	18.9	23.4	44.2	12.9	23.1	58.8	29.3	22.1
POM121C		ENSG00000272391	"POM121 transmembrane nucleoporin C"	A8CG34	7	75416786-75486299	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA043809, HPA049817"	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear membrane"		"HPA043809: AB_2678680, HPA049817: AB_2680896"	"unprognostic (9.11e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.84e-3)"	"unprognostic (2.03e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.00e-2)"	14.9	14.0	3.5	15.5	3.8	28.9	14.2	8.0	9.3	13.8	2.4	14.2	12.0	16.6	9.0	15.9	14.1	12.0	13.9	7.0	4.9	13.1	13.2	12.9	18.2	2.2	3.1	18.7	18.1	16.8	13.4	16.4	2.0	13.0	12.9	26.3	14.3	11.5	19.6	17.7	14.0	15.1	0.3	15.5	14.0	12.5	5.2	17.6	16.7	10.7	19.9	14.3	14.3	5.5	41.8	34.1	46.3	89.0	17.1	19.0	30.4	29.7	27.3	23.7	22.8	41.2	26.5	73.4	12.0	32.6	37.2	36.7	39.6	36.7	38.9	49.9	55.1	36.4	39.6	27.8	22.5	97.0	49.5	16.2	22.8	36.3	26.8	34.5	24.6	29.9	103.8	39.8	38.9	41.8	59.5	49.3	36.9	32.0	38.4	53.0	30.7	37.6	13.1	56.0	51.4	67.4	34.3	54.0	23.8	41.5	47.1	34.2	27.4	57.4	30.6	42.2	62.3	42.4	54.4	88.2	37.3	49.1	53.9	0.2	0.4	0.5	1.1	0.5	1.0	0.8	0.9	0.3	0.3	1.0	0.5	0.6	1.2	0.9	0.3	1.1	0.2	0.6	3.5	3.8	8.0	9.3	7.0	4.9	2.2	3.1	2.0	0.3	5.2	5.5	23.1	35.3	26.2	29.4	27.8	18.0	11.8	13.4	33.6	30.7	21.3	23.4	12.6	21.5	21.4	12.9	68.8	13.4	27.2	12.3	5.9	11.8	2.1	14.2	21.3	20.7	28.7	33.9	59.2	17.1	10.2	21.0	31.6	18.3	7.6	28.6	16.8	15.1	12.0	25.2	60.2	17.4	14.2	16.4	15.8	3.8	18.0	21.7	7.2	35.6	17.1	21.3	37.0	28.1	45.6	18.8	8.0	15.4	37.8	24.6	10.0	9.6	18.7	29.4	13.1	26.1	17.4	19.2	12.4	32.9	18.5	17.0	34.0	22.0	17.0	19.7
POMP	"C13orf12, HSPC014, UMP1"	ENSG00000132963	"Proteasome maturation protein"	Q9Y244	13	28659104-28678959	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Chaperone	"Ichthyosis, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026995	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear speckles"		"HPA026995: AB_1845546"	"unprognostic (2.00e-1)"	"unprognostic (3.56e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.15e-1)"	"unprognostic (8.58e-2)"	"prognostic unfavorable (2.05e-5)"	"unprognostic (2.71e-3)"	"unprognostic (2.50e-2)"	"unprognostic (9.90e-2)"	"unprognostic (4.35e-2)"	"unprognostic (4.83e-2)"	"unprognostic (4.93e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.70e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.03e-2)"	"unprognostic (9.81e-2)"	78.9	71.6	77.5	62.9	78.5	66.4	66.7	82.1	101.1	45.1	77.8	66.6	57.0	44.4	78.9	68.7	43.4	46.2	126.3	78.1	83.6	94.1	110.9	65.6	65.4	82.2	83.4	32.9	46.6	51.7	41.7	100.3	83.2	46.6	66.3	56.2	45.1	50.7	175.6	48.5	58.4	57.2	83.6	61.2	54.9	70.0	81.0	64.6	51.4	114.6	70.1	74.0	46.9	86.3	103.4	124.9	129.9	153.1	145.3	161.3	120.3	232.1	203.8	225.5	179.5	245.7	228.7	181.7	136.3	178.6	241.7	150.3	170.7	179.3	307.5	137.7	131.9	171.7	130.1	191.1	203.0	209.6	136.0	131.2	181.9	162.5	149.5	122.3	181.6	139.7	222.2	72.5	291.5	182.5	178.4	295.6	226.1	319.0	146.1	169.6	199.3	122.2	259.6	160.7	152.1	117.1	104.0	147.4	162.2	161.5	103.1	238.5	166.2	108.7	111.2	172.3	195.5	61.5	118.5	255.3	129.2	139.8	243.6	146.4	155.3	101.7	99.9	210.8	88.7	136.4	101.6	113.2	190.8	137.6	71.8	101.9	135.1	95.3	213.9	223.4	132.3	165.2	77.5	78.5	82.1	101.1	78.1	83.6	82.2	83.4	83.2	83.6	81.0	86.3	527.4	131.4	114.2	17.3	218.5	409.8	345.1	1106.2	124.1	110.1	194.3	229.9	806.2	204.5	523.9	239.1	54.2	660.4	255.5	410.0	600.7	566.3	1156.6	266.7	235.8	486.2	228.7	271.5	23.4	699.5	974.0	281.8	128.9	293.0	207.3	181.6	434.1	538.7	780.7	97.6	22.4	315.0	585.9	431.0	673.7	533.7	201.0	407.1	300.6	29.0	612.6	294.7	228.6	13.6	26.1	755.1	414.0	233.6	228.1	443.5	491.8	922.5	472.8	121.8	322.1	193.8	494.6	625.5	240.3	230.1	416.3	972.4	202.7	234.7	335.5	494.3
POMT1	LGMD2K	ENSG00000130714	"Protein O-mannosyltransferase 1"	Q9Y6A1	9	131502789-131523806	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 64.5;Spermatocytes: 71.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065252			Uncertain	"Golgi apparatus"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus"		"HPA065252: AB_2685445"	"unprognostic (2.00e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.67e-1)"	"unprognostic (7.97e-2)"	"unprognostic (5.35e-3)"	"unprognostic (1.14e-1)"	"unprognostic (9.76e-3)"	"unprognostic (2.84e-1)"	"prognostic favorable (3.90e-5)"	"unprognostic (8.36e-2)"	"prognostic favorable (4.68e-5)"	"unprognostic (2.41e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.12e-1)"	15.7	20.9	16.6	7.6	16.7	6.6	16.2	18.4	21.0	21.1	15.0	24.8	9.0	17.1	7.2	15.2	18.4	9.3	24.5	25.5	16.0	25.5	24.4	15.6	8.3	16.0	16.2	25.6	25.9	15.5	31.3	9.7	16.5	28.4	6.5	8.1	20.1	8.7	32.9	17.5	19.9	7.1	14.2	22.2	20.4	63.7	16.9	7.1	19.0	13.4	5.4	16.5	17.1	15.5	9.8	17.4	10.5	26.4	19.3	13.5	24.5	12.1	17.0	21.3	14.1	15.8	14.7	2.5	16.9	26.4	8.6	24.1	17.3	16.6	5.9	16.2	21.6	4.2	28.5	7.8	23.1	13.1	10.5	10.8	10.0	12.3	5.0	17.6	15.1	16.4	13.4	15.6	23.2	27.6	15.8	25.2	6.7	9.6	21.1	15.7	13.8	24.6	18.1	1.5	15.0	14.1	25.1	26.8	13.0	5.8	31.4	17.7	20.9	13.8	2.2	28.6	10.3	7.3	7.0	5.2	8.7	29.1	13.0	0.0	2.8	3.4	5.2	3.0	7.7	1.9	5.0	5.3	4.0	2.6	4.8	3.6	0.6	3.2	2.9	2.4	5.2	4.0	16.6	16.7	18.4	21.0	25.5	16.0	16.0	16.2	16.5	14.2	16.9	15.5	5.9	9.6	16.0	18.6	7.1	4.5	4.9	7.2	5.7	13.2	7.8	8.6	9.7	10.0	8.7	12.9	8.4	20.8	6.5	12.9	1.9	10.7	64.5	9.6	7.3	8.0	7.8	1.3	21.5	6.7	12.9	9.0	9.2	9.9	2.5	15.1	11.0	10.1	10.8	21.9	25.9	8.4	10.2	5.4	5.9	33.0	8.7	5.6	5.4	15.9	7.5	12.3	5.2	18.6	11.1	8.1	6.0	10.1	6.8	4.9	14.2	7.5	6.8	16.6	6.6	7.5	7.2	71.6	9.6	5.7	3.0	17.5	9.0	6.2	9.1	2.6
POP1		ENSG00000104356	"POP1 homolog, ribonuclease P/MRP subunit"	Q99575	8	98117293-98159835	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066194			Supported	Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli		"HPA066194: AB_2732742"	"prognostic unfavorable (2.54e-4)"	"unprognostic (9.42e-2)"	"unprognostic (5.96e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.46e-2)"	"prognostic unfavorable (1.26e-6)"	"prognostic unfavorable (9.88e-4)"	"unprognostic (4.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (5.97e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.96e-1)"	2.1	1.6	1.7	3.5	1.5	1.5	2.1	3.4	2.3	1.4	1.2	1.9	1.5	1.7	1.4	3.0	1.8	1.3	1.6	1.3	1.2	2.0	1.9	1.6	3.6	1.1	1.4	2.9	1.7	1.7	1.5	1.2	1.1	1.5	4.8	2.4	1.4	1.3	1.7	3.0	1.6	1.8	0.8	2.1	1.9	3.1	1.6	2.6	1.5	1.2	4.4	2.5	1.5	1.8	21.9	12.9	13.8	12.8	4.8	3.3	9.1	18.3	15.2	18.7	13.8	13.4	13.8	15.3	25.6	12.9	9.0	14.3	40.3	18.2	18.9	11.1	17.0	30.0	10.2	9.2	2.1	16.4	18.4	2.8	3.3	20.8	8.2	5.7	14.8	7.2	17.0	13.5	17.7	17.4	23.8	8.3	10.4	25.1	17.6	19.4	7.5	11.0	13.5	11.5	32.8	7.7	8.4	14.2	6.4	7.9	19.2	6.0	18.4	16.3	11.6	20.8	36.5	13.3	13.6	32.7	12.8	17.3	14.6	9.4	5.1	3.9	7.4	5.7	6.0	4.9	5.4	5.0	5.0	8.1	6.8	6.5	0.8	3.8	2.9	6.2	4.9	2.1	1.7	1.5	3.4	2.3	1.3	1.2	1.1	1.4	1.1	0.8	1.6	1.8	2.3	3.2	3.9	10.7	4.7	3.7	8.2	3.8	4.0	7.0	2.5	2.3	3.9	0.0	3.8	5.5	0.0	4.1	4.1	2.7	5.9	8.8	13.8	2.4	6.4	4.2	0.0	5.0	17.7	5.9	3.4	5.8	6.6	2.9	1.3	5.9	1.8	5.4	3.4	1.7	19.0	1.7	2.0	2.4	0.8	3.0	5.3	3.3	0.0	3.7	7.9	2.7	10.3	8.5	11.0	7.8	1.0	4.5	5.2	4.8	1.1	8.5	2.6	9.5	6.6	4.0	6.1	7.7	19.1	9.8	2.4	3.0	4.4	6.1	3.9	5.1
PPAT	"GPAT, PRAT"	ENSG00000128059	"Phosphoribosyl pyrophosphate amidotransferase"	Q06203	4	56393362-56435615	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Allosteric enzyme, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 66.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036091, HPA036092"	Approved		Approved	"Midbody ring"		Yes	No		11000	"Cluster 27: Non-specific - Gene expression"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Midbody ring"		"HPA036091: AB_2674936, HPA036092: AB_10603132"	"unprognostic (5.11e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (5.15e-5)"	"unprognostic (1.38e-1)"	"unprognostic (4.37e-3)"	"prognostic unfavorable (1.14e-8)"	"unprognostic (6.74e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.88e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (8.34e-4)"	"unprognostic (1.41e-1)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (1.09e-1)"	2.8	6.1	3.8	5.4	4.0	5.6	7.1	3.7	4.7	4.3	3.6	3.9	4.0	4.6	3.4	4.5	4.4	3.0	2.3	4.1	4.0	6.0	6.1	2.2	8.4	3.4	4.0	7.4	5.9	3.9	2.5	6.7	4.3	3.9	4.8	4.4	5.6	3.1	2.9	4.3	3.2	3.6	3.7	4.3	3.5	8.6	4.1	8.3	5.9	2.9	8.0	6.7	2.6	4.2	23.1	19.0	38.0	18.7	12.2	15.7	31.0	25.2	11.1	20.4	21.6	38.1	27.5	80.6	33.4	11.9	19.0	16.8	74.0	25.4	40.7	21.1	32.8	32.6	22.6	42.2	18.4	65.0	19.5	13.6	19.4	29.0	32.4	12.6	21.8	32.5	83.5	43.3	23.2	20.9	80.6	49.1	50.6	52.0	22.4	67.2	24.9	56.9	34.2	16.2	64.0	31.2	20.1	36.3	23.0	35.4	24.5	13.8	15.3	21.2	36.6	21.4	45.0	32.2	34.5	82.9	23.6	40.7	20.1	4.7	1.8	0.9	3.8	2.7	5.9	7.4	5.1	5.2	2.5	6.1	7.7	7.1	0.5	10.2	3.9	3.2	4.3	3.5	3.8	4.0	3.7	4.7	4.1	4.0	3.4	4.0	4.3	3.7	4.1	4.2	4.8	0.0	5.5	16.6	10.7	31.0	16.0	5.6	28.5	8.4	10.1	9.7	3.8	4.3	8.0	3.7	2.1	29.7	10.3	1.5	9.8	3.7	2.6	5.5	14.1	7.8	4.2	14.9	22.9	2.7	25.2	9.4	4.1	6.9	7.0	66.2	5.3	7.1	7.9	38.7	15.8	4.3	4.1	1.6	6.0	2.6	7.8	5.2	8.8	5.6	3.1	6.4	2.1	5.5	9.1	3.3	2.7	5.7	15.3	15.0	0.8	12.7	6.2	4.7	0.0	9.3	10.8	16.4	27.5	18.3	31.8	7.7	10.7	21.9	9.0	8.7
PPFIA2		ENSG00000139220	"PTPRF interacting protein alpha 2"	O75334	12	81257975-81759553	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 51.3;retina: 50.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 806.6;Inhibitory neurons: 641.1;Oligodendrocyte precursor cells: 609.7;Oligodendrocytes: 409.8;Rod photoreceptor cells: 195.9"	"Group enriched"	"Detected in some"	4	"glioma: 0.8;prostate cancer: 1.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 29.8;hTERT-RPE1: 5.0;SCLC-21H: 10.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 58: Brain - Synaptic function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (4.31e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.82e-2)"	"unprognostic (6.78e-5)"	"unprognostic (4.69e-3)"	"unprognostic (2.13e-1)"	"unprognostic (6.67e-2)"	"unprognostic (7.10e-2)"	"unprognostic (8.92e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.76e-1)"	"unprognostic (9.84e-2)"	"unprognostic (3.27e-3)"	"unprognostic (2.45e-2)"	"unprognostic (4.88e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.06e-3)"	1.8	5.8	21.1	0.3	24.0	0.0	1.0	0.0	47.2	4.1	0.0	1.1	0.3	2.3	0.6	0.6	2.5	1.7	0.6	51.3	10.3	0.9	0.2	0.8	0.1	1.2	5.3	1.1	0.5	0.1	4.6	0.0	2.4	1.4	1.4	50.1	0.5	3.2	0.3	0.7	0.6	2.1	0.7	0.2	0.9	6.2	3.8	0.1	0.9	0.1	0.1	1.2	2.2	17.6	0.0	0.0	2.7	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	29.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.7	0.0	0.1	0.0	1.4	0.0	10.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.7	0.0	2.0	0.0	0.0	0.0	0.9	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.1	24.0	0.0	47.2	51.3	10.3	1.2	5.3	2.4	0.7	3.8	17.6	0.6	0.0	1.1	136.8	0.0	0.4	0.0	0.0	0.0	107.8	0.0	0.9	0.6	0.0	0.0	0.0	89.6	0.0	0.0	0.1	1.9	0.0	140.3	0.7	16.0	0.7	16.3	0.0	806.6	0.0	0.0	2.3	0.0	0.4	0.0	0.1	0.0	0.0	0.1	48.8	641.1	0.2	0.0	0.0	0.5	61.5	0.0	0.0	0.0	11.2	0.0	12.6	0.0	609.7	409.8	0.0	0.0	16.6	0.0	0.3	0.0	0.1	0.0	195.9	0.0	2.4	8.6	6.5	2.4	0.0	0.6	0.1	0.0	0.2	0.0	0.1
PPIA	CYPA	ENSG00000196262	"Peptidylprolyl isomerase A"	P62937	7	44796680-44824564	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Host-virus interaction"	"Isomerase, Rotamase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB004655, HPA058345"	Uncertain				"Secreted to blood"	NA	NA		230000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"			"CAB004655: AB_425607, HPA058345: AB_2683685"	"unprognostic (3.10e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.86e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavorable (2.27e-6)"	"unprognostic (1.12e-3)"	"unprognostic (3.30e-2)"	"unprognostic (3.92e-2)"	"unprognostic (8.68e-3)"	"unprognostic (2.52e-1)"	"unprognostic (6.35e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.16e-1)"	1148.4	1085.6	1707.2	714.4	1757.6	1052.9	1368.0	1733.9	2245.6	943.7	1718.8	1352.6	603.7	854.8	981.6	2149.0	771.3	548.8	781.6	1785.4	1791.4	1412.8	1318.6	1099.2	1067.1	1857.4	1728.1	799.5	967.7	1286.3	670.1	805.9	1860.7	766.1	1196.0	496.7	1020.3	782.9	566.1	1516.0	953.4	943.4	1767.2	1134.4	896.7	366.0	1742.4	2333.2	884.9	517.9	1647.3	1339.3	1208.7	1822.8	2141.8	3020.1	3731.1	2509.6	2798.6	4154.8	1115.0	3173.6	4588.0	5531.3	5393.2	3414.3	3127.1	4614.1	1893.1	3828.8	6554.2	3209.5	4495.7	5727.5	5062.6	2674.3	3204.3	1883.6	3911.6	4682.5	2255.3	3890.0	2246.2	3103.5	3820.5	3988.9	4295.5	2888.1	5717.2	3277.9	3933.2	3789.6	5790.6	3665.7	4667.5	7562.4	4612.9	7628.9	3689.2	3554.4	2050.1	5969.7	8018.9	4215.4	2548.3	2218.7	2500.5	7185.8	2493.3	4091.8	4303.8	5202.3	2587.0	2865.0	3656.5	2027.1	4050.5	3861.7	6522.3	9409.0	2614.0	4314.6	4455.2	475.6	1239.3	594.8	1421.6	1449.2	1534.2	2104.8	1500.3	1491.1	2196.1	1769.5	1217.2	1394.4	133.3	1349.0	1374.8	2618.5	2085.4	3631.4	1707.2	1757.6	1733.9	2245.6	1785.4	1791.4	1857.4	1728.1	1860.7	1767.2	1742.4	1822.8	713.8	794.9	759.9	37.2	1037.1	866.6	867.8	1097.5	1878.1	94.3	1226.2	1628.0	47.6	526.1	743.6	603.2	18.8	852.7	1067.7	658.4	1414.6	1172.4	78.2	539.3	770.8	719.7	529.6	1120.3	57.3	1218.7	1683.7	672.4	820.1	862.1	622.1	650.0	669.7	766.9	1582.1	111.0	50.4	1003.5	587.9	1110.0	786.1	81.4	582.2	988.1	691.9	41.2	1283.2	221.6	995.9	27.2	79.8	1222.6	715.0	613.1	1215.3	922.1	831.6	1636.8	481.4	101.5	394.4	588.7	942.7	366.7	246.1	2608.3	990.4	609.2	924.5	1157.5	1262.6	947.0
PPIL1	CYPL1	ENSG00000137168	"Peptidylprolyl isomerase like 1"	Q9Y3C6	6	36854827-36874803	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 58.7;Extravillous trophoblasts: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062916			Supported	Nucleoli		NA	NA		21000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoli		"HPA062916: AB_2684904"	"unprognostic (3.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (2.01e-1)"	"unprognostic (3.37e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (6.58e-2)"	"unprognostic (5.49e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.15e-2)"	12.4	21.7	20.3	19.1	21.9	11.4	18.4	22.6	27.3	15.0	23.8	14.7	13.2	15.7	19.1	17.0	23.0	10.7	42.8	20.0	25.2	18.9	21.5	10.5	21.9	22.0	22.0	17.7	14.3	21.7	12.0	22.3	23.3	16.8	17.6	29.1	19.5	17.6	18.5	9.5	11.3	22.9	24.1	9.5	12.9	23.2	22.2	18.6	33.2	20.7	24.6	20.5	8.0	22.8	69.2	50.0	111.2	78.5	19.7	31.5	77.5	60.9	41.0	82.7	70.0	89.7	39.7	87.7	75.5	41.9	105.5	55.4	135.1	92.7	96.2	81.3	114.6	102.7	33.6	147.7	53.5	89.3	40.8	24.7	48.7	62.3	118.9	31.8	75.5	79.1	202.4	48.0	63.3	71.2	101.9	69.8	92.3	108.5	57.9	79.4	100.2	92.0	63.2	53.5	140.0	68.5	41.8	51.4	102.5	83.5	76.3	100.2	44.0	66.7	69.0	58.5	98.8	57.0	145.2	153.0	23.7	183.7	139.4	1.6	4.8	1.3	14.7	6.2	19.7	10.3	12.1	13.9	9.2	7.4	13.4	15.9	1.2	7.3	3.4	7.8	10.2	9.8	20.3	21.9	22.6	27.3	20.0	25.2	22.0	22.0	23.3	24.1	22.2	22.8	5.7	6.4	7.5	2.9	10.8	3.1	18.6	12.2	5.7	16.9	9.0	10.5	45.8	8.6	8.3	5.5	4.2	58.7	6.6	3.3	23.5	25.7	32.0	10.3	14.2	12.3	3.6	22.7	6.5	20.3	72.3	12.2	7.7	7.7	10.8	16.3	5.0	8.2	30.1	16.8	8.6	11.4	4.1	3.3	3.6	11.7	6.8	6.4	7.2	1.9	9.2	41.0	11.3	7.5	5.4	22.1	5.5	12.4	15.0	13.5	3.3	17.1	13.5	15.5	6.6	6.1	12.8	25.7	51.0	10.6	4.5	25.3	9.2	21.1	11.9	8.6
PPIL3	CyPJ	ENSG00000240344	"Peptidylprolyl isomerase like 3"	Q9H2H8	2	200870907-200889303	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040765, HPA062187"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA		120000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Nucleoli	"HPA040765: AB_2677125, HPA062187: AB_2684706"	"unprognostic (8.96e-3)"	"unprognostic (6.07e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.69e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.31e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.40e-2)"	"prognostic favorable (1.19e-4)"	"unprognostic (5.23e-2)"	"unprognostic (6.60e-2)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (1.14e-1)"	"unprognostic (5.96e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.87e-2)"	13.0	16.4	15.2	19.8	14.9	35.1	25.4	17.0	22.3	15.7	13.9	19.0	14.6	20.2	28.4	18.6	22.5	13.0	18.2	14.6	16.8	18.4	21.9	15.0	32.2	15.7	15.5	35.4	12.1	14.0	14.9	17.7	16.8	15.1	19.5	25.8	17.1	18.2	18.0	18.0	18.1	12.4	15.4	17.5	19.0	21.1	15.5	30.1	20.8	11.1	32.5	16.2	12.5	18.2	19.9	18.3	53.0	23.5	42.5	90.8	17.5	32.0	35.3	37.1	37.2	13.0	37.5	19.5	32.0	35.4	41.9	24.6	19.3	38.1	33.2	41.4	43.8	84.0	48.3	90.6	21.3	79.7	39.8	32.7	37.7	30.3	47.1	62.0	25.3	38.4	67.4	46.3	46.3	32.4	61.7	67.2	32.9	19.8	28.9	23.3	30.5	29.1	49.6	30.4	22.2	21.1	31.3	29.9	51.7	62.3	24.6	36.9	34.2	51.4	28.8	31.2	26.2	45.5	51.0	94.2	39.6	36.2	33.7	36.2	17.5	19.7	17.5	16.4	25.5	35.2	20.9	17.7	30.9	26.7	25.3	27.6	4.5	31.8	23.1	25.6	30.3	14.6	15.2	14.9	17.0	22.3	14.6	16.8	15.7	15.5	16.8	15.4	15.5	18.2	12.5	0.0	11.5	16.0	33.6	31.7	43.1	71.5	37.5	12.0	23.7	28.2	18.5	15.7	30.4	16.5	10.4	50.3	24.8	9.7	56.7	26.0	44.1	16.1	21.4	16.2	9.5	25.5	19.3	16.1	51.6	22.1	16.3	13.4	26.0	17.2	13.6	19.4	47.0	3.3	18.1	25.3	48.8	32.1	59.1	9.5	36.7	26.8	28.4	9.4	30.2	23.1	37.0	15.1	19.7	18.2	18.1	28.2	24.5	15.9	25.4	59.7	28.7	11.9	19.7	18.2	39.6	45.7	22.6	34.5	46.3	30.8	31.1	8.9	29.4	35.6
PPM1G	"PP2CG, PP2Cgamma"	ENSG00000115241	"Protein phosphatase, Mg2+/Mn2+ dependent 1G"	O15355	2	27381195-27409591	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 233.9"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 1540.4;Late spermatids: 3492.8;Spermatocytes: 793.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035530, HPA035531"	Enhanced		Enhanced	Nucleoplasm		NA	NA		19000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA035530: AB_10670021, HPA035531: AB_10610283"	"unprognostic (7.50e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.15e-2)"	"prognostic unfavorable (3.14e-7)"	"unprognostic (9.36e-3)"	"unprognostic (7.73e-2)"	"prognostic favorable (6.08e-5)"	"unprognostic (3.74e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.83e-2)"	46.0	49.6	34.7	45.1	35.1	73.5	43.6	35.4	37.8	38.4	36.9	48.3	39.9	45.6	26.1	62.6	39.0	28.0	44.9	35.0	37.0	40.7	45.3	40.6	59.6	35.4	36.0	34.9	53.0	41.4	43.4	37.6	35.3	36.0	51.3	20.0	45.1	38.8	95.7	41.2	43.0	44.9	35.1	47.1	47.8	233.9	36.0	64.9	36.8	53.0	75.3	47.0	39.6	35.3	302.0	243.1	174.0	134.8	108.7	88.0	160.6	182.8	119.8	214.8	170.9	377.7	154.4	352.7	130.9	130.9	181.8	160.3	296.4	205.6	191.4	148.4	241.1	343.6	172.9	404.0	97.9	343.5	139.2	95.7	116.9	219.2	175.1	101.7	209.1	171.1	293.3	106.0	165.5	269.4	256.7	370.5	254.1	207.1	173.1	261.1	365.0	185.3	145.9	206.4	233.2	264.0	164.4	178.9	135.9	137.4	99.4	111.3	169.5	159.3	192.6	141.6	281.8	229.0	277.0	545.5	124.8	275.6	122.5	67.3	41.5	59.0	57.5	52.3	56.8	44.7	61.1	60.3	65.4	37.9	45.1	47.4	20.9	55.0	71.4	91.9	88.9	48.0	34.7	35.1	35.4	37.8	35.0	37.0	35.4	36.0	35.3	35.1	36.0	35.3	72.9	64.1	51.3	9.8	76.7	81.1	88.7	71.9	83.6	40.8	63.1	59.3	37.9	52.9	63.7	69.9	29.2	93.9	114.2	81.0	33.2	135.7	1540.4	102.7	75.8	80.8	80.7	119.6	19.5	139.3	163.8	56.6	69.3	89.8	59.1	76.1	40.4	44.7	85.4	48.8	21.1	78.9	54.9	59.7	75.7	3492.8	70.2	68.2	24.9	17.8	127.3	69.7	112.3	17.1	15.9	156.7	52.7	71.1	137.8	152.1	52.6	61.4	61.8	41.7	46.0	54.9	80.5	793.3	298.9	108.7	80.6	53.1	89.7	123.7	106.4	122.6
PPP1CB	"MP, PP-1B, PP1B, PP1beta, PP1c, PPP1beta"	ENSG00000213639	"Protein phosphatase 1 catalytic subunit beta"	P62140	2	28751640-28802940	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism"	"Hydrolase, Protein phosphatase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 985.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022558, HPA065425, CAB069426"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		3800000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB022558: , CAB069426: , HPA065425: AB_2685489"	"unprognostic (2.90e-1)"	"unprognostic (5.03e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (6.52e-6)"	"unprognostic (3.47e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.56e-1)"	"unprognostic (2.26e-2)"	90.9	75.2	55.8	74.7	73.5	119.1	110.5	55.6	74.9	148.6	67.8	109.2	84.8	138.4	104.0	245.7	113.5	103.1	185.2	54.3	73.8	84.4	70.5	73.3	60.4	73.9	61.2	92.7	76.2	126.9	45.9	74.8	74.5	149.1	92.9	70.8	114.6	123.4	386.0	73.7	76.0	159.7	71.8	65.8	81.7	47.6	63.5	71.3	78.8	262.8	91.1	118.0	104.1	88.2	186.0	114.6	391.1	121.7	130.8	121.0	227.0	97.7	110.6	92.2	91.0	102.6	106.9	147.5	119.2	101.5	102.7	111.4	112.6	129.9	109.8	235.9	58.2	111.3	130.1	111.5	284.3	127.8	50.5	93.5	181.3	100.1	207.8	97.4	113.8	77.0	103.6	140.4	123.3	93.2	136.9	110.3	128.3	141.8	89.8	132.2	344.9	112.7	304.3	220.6	106.7	131.3	151.4	166.2	136.2	111.4	80.4	70.6	137.6	122.6	134.6	89.3	119.0	100.4	171.0	299.8	130.1	135.0	93.5	72.4	59.4	84.9	39.8	96.7	50.8	38.6	59.3	46.8	65.4	31.6	51.8	58.8	103.6	61.4	115.2	49.8	74.3	52.8	55.8	73.5	55.6	74.9	54.3	73.8	73.9	61.2	74.5	71.8	63.5	88.2	172.2	93.0	80.6	59.4	147.8	492.1	176.7	101.5	64.9	62.4	208.0	117.0	352.1	112.9	124.1	310.8	27.1	129.6	210.4	324.5	244.6	297.0	514.0	330.2	245.7	129.3	283.0	200.2	68.5	210.5	202.1	147.8	78.5	258.9	146.6	91.2	137.8	108.7	114.7	163.2	71.8	144.2	111.9	182.6	985.1	406.2	196.7	238.1	336.2	59.0	137.9	116.6	55.6	64.3	68.4	236.8	181.3	302.0	100.9	364.9	106.6	227.4	213.3	65.2	631.1	225.8	264.8	55.2	66.6	135.6	458.0	392.9	237.7	65.8	154.4	498.9
PPP1CC	"PP1C, PP1gamma"	ENSG00000186298	"Protein phosphatase 1 catalytic subunit gamma"	P36873	12	110719680-110742939	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 639.3;Late spermatids: 923.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022645	Uncertain					NA	NA		2800000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"			"CAB022645: "	"unprognostic (1.51e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.29e-2)"	"unprognostic (7.26e-2)"	"prognostic unfavorable (2.75e-6)"	"unprognostic (6.55e-2)"	"unprognostic (4.11e-2)"	"unprognostic (6.91e-2)"	"unprognostic (4.96e-3)"	"unprognostic (5.72e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.18e-1)"	63.3	64.9	58.8	76.8	61.7	103.6	72.5	67.1	69.7	59.4	53.2	110.5	193.2	66.7	57.5	92.0	59.2	57.2	91.5	56.1	66.5	60.4	64.4	53.6	139.0	60.0	62.7	90.3	74.0	68.4	41.5	53.2	60.5	58.5	108.4	125.0	71.6	55.2	157.7	60.7	147.7	76.8	59.8	73.4	73.5	142.3	62.7	107.7	54.9	175.8	131.4	86.3	53.6	65.7	221.0	130.2	217.5	160.0	128.9	176.6	166.0	124.1	183.1	201.0	159.6	223.8	109.0	341.7	91.2	133.8	125.8	122.5	295.3	162.7	278.9	200.2	198.9	221.7	93.0	230.4	105.1	285.5	184.4	112.4	130.5	152.8	135.2	213.2	236.4	190.3	225.1	90.0	186.6	91.7	232.8	318.3	343.6	144.0	190.8	224.9	150.2	216.9	129.6	164.2	174.7	140.3	137.2	162.4	246.7	190.5	254.6	219.9	106.1	102.2	168.8	139.1	158.0	140.4	157.4	291.2	96.2	203.8	159.2	38.3	33.3	54.7	13.2	26.3	12.8	31.7	23.8	18.8	32.8	27.4	19.8	16.4	27.8	14.9	35.0	12.8	25.4	24.3	58.8	61.7	67.1	69.7	56.1	66.5	60.0	62.7	60.5	59.8	62.7	65.7	71.3	35.3	32.2	27.7	163.4	209.2	124.0	89.6	150.8	203.2	77.6	63.6	138.5	78.6	52.4	36.8	68.8	136.5	61.3	103.9	93.9	75.7	639.3	43.9	72.1	88.8	85.0	131.3	17.9	125.9	204.6	129.6	74.5	47.9	58.4	87.8	62.2	43.4	132.7	102.6	29.9	109.8	93.6	161.3	111.8	923.3	89.8	88.9	128.1	30.0	96.0	91.8	57.7	34.7	34.3	88.3	144.0	138.8	234.3	159.7	305.2	94.6	28.9	110.5	111.7	75.9	133.8	314.6	51.7	161.1	210.0	132.2	106.5	121.8	164.8	156.3
PPP1R10	"CAT53, FB19, p99, PNUTS"	ENSG00000204569	"Protein phosphatase 1 regulatory subunit 10"	Q96QC0	6	30600413-30618612	"Predicted intracellular proteins"		"DNA-binding, Protein phosphatase inhibitor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"basophil: 7.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025501, HPA047248, HPA056756"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear bodies"	"CAB025501: , HPA047248: AB_2679996, HPA056756: AB_2683227"	"unprognostic (1.68e-1)"	"prognostic favorable (4.84e-4)"	"unprognostic (1.21e-1)"	"unprognostic (9.31e-3)"	"unprognostic (6.31e-2)"	"unprognostic (9.57e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.25e-1)"	"prognostic favorable (9.74e-5)"	"unprognostic (2.72e-1)"	"unprognostic (8.02e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.74e-2)"	20.9	27.5	0.2	12.0	0.1	1.0	15.8	0.2	1.3	23.3	0.1	21.8	8.9	21.2	1.1	23.1	22.0	10.7	14.6	0.5	0.4	22.8	33.6	17.4	5.0	1.2	1.3	22.8	28.0	4.8	26.3	5.0	0.6	22.8	6.4	5.2	20.1	7.9	23.0	21.1	21.0	7.0	0.3	25.1	25.2	21.7	0.3	10.1	22.9	1.2	5.6	22.5	21.8	0.2	9.1	20.0	30.9	16.8	17.0	2.2	8.9	15.9	7.0	5.6	23.3	5.0	9.7	11.5	9.6	16.0	10.5	23.6	24.3	35.7	9.7	13.1	0.0	19.8	14.1	0.2	7.6	16.3	27.3	14.2	4.0	28.0	30.9	13.2	9.7	3.9	18.4	3.7	14.4	5.4	5.5	2.4	9.1	1.9	2.3	25.4	39.3	19.8	1.4	8.0	19.3	9.1	29.5	28.3	8.8	13.0	13.8	21.8	2.6	12.7	9.0	18.5	10.7	26.9	5.1	11.3	15.8	19.9	15.8	7.9	1.2	2.0	0.9	2.1	1.6	2.9	0.4	1.7	3.3	0.7	0.5	1.1	1.0	1.0	0.8	1.2	1.9	0.4	0.2	0.1	0.2	1.3	0.5	0.4	1.2	1.3	0.6	0.3	0.3	0.2	243.9	32.1	40.3	20.5	152.7	69.8	64.9	41.1	167.9	72.7	165.1	163.8	59.1	28.6	34.2	27.6	131.3	44.0	178.9	120.5	35.2	27.2	32.0	138.2	103.8	102.6	71.3	30.5	26.1	23.0	21.8	103.2	107.0	151.4	44.9	143.0	38.2	33.6	33.1	35.3	27.0	102.2	54.9	35.5	70.6	11.3	46.3	123.4	37.4	30.0	46.4	59.0	72.1	21.1	29.7	29.8	58.3	30.1	140.1	51.9	88.1	40.3	46.9	102.2	32.9	211.5	114.9	45.9	23.4	125.7	77.9	88.5	144.1	99.9	77.0	34.5
PPP1R8	"ard-1, ARD1, NIPP-1, NIPP1, PRO2047"	ENSG00000117751	"Protein phosphatase 1 regulatory subunit 8"	Q12972	1	27830782-27851676	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein phosphatase inhibitor, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027406, HPA027417, HPA027452"	Enhanced		Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"	Nucleoplasm	"HPA027406: AB_1854488, HPA027417: AB_1854489, HPA027452: AB_1854490"	"unprognostic (5.61e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.42e-3)"	"unprognostic (3.76e-2)"	"unprognostic (2.00e-2)"	"unprognostic (9.09e-3)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (4.82e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.16e-2)"	"unprognostic (9.16e-2)"	"unprognostic (6.26e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.91e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.58e-2)"	24.0	17.1	23.7	23.8	26.3	38.8	27.2	26.0	27.8	25.1	20.8	23.3	19.6	28.4	21.3	26.1	26.7	20.8	23.8	22.9	25.1	19.6	21.5	21.1	35.5	25.0	25.0	33.0	20.7	25.2	15.8	25.2	25.7	21.0	25.1	28.0	18.9	25.7	25.3	23.2	21.4	30.6	26.0	25.9	19.7	24.0	24.2	41.0	25.2	37.0	36.4	29.5	20.5	30.5	57.8	40.0	85.3	55.8	52.6	54.7	48.9	60.5	63.3	101.5	81.6	45.2	64.5	81.9	41.6	69.3	39.5	50.9	101.3	56.6	73.2	69.3	61.7	107.2	53.3	67.2	52.9	99.9	73.0	48.0	60.7	92.4	81.8	45.4	61.3	68.9	92.4	54.3	61.2	37.6	109.6	58.6	105.9	50.7	46.2	88.4	70.5	78.2	54.9	52.2	59.5	54.0	74.5	57.5	73.4	43.5	50.5	61.7	50.9	49.6	45.3	78.9	57.2	50.0	82.2	102.8	48.5	127.6	65.0	17.2	9.1	8.5	12.4	9.5	14.3	9.8	9.7	13.7	8.8	9.9	10.5	10.2	5.4	14.3	11.4	6.7	10.8	13.2	23.7	26.3	26.0	27.8	22.9	25.1	25.0	25.0	25.7	26.0	24.2	30.5	11.3	16.0	10.0	2.9	21.3	17.3	21.4	33.4	7.4	22.0	12.0	9.8	13.4	8.6	24.2	5.5	2.1	47.6	19.6	15.4	31.3	30.6	33.7	9.8	15.2	17.8	11.5	20.6	8.4	25.9	41.2	17.1	12.2	11.1	26.0	16.8	19.6	20.2	26.3	8.4	8.6	15.0	28.5	18.0	11.5	30.0	23.9	14.1	10.6	4.7	35.6	21.5	25.7	10.6	16.0	31.9	14.7	17.0	14.3	24.6	14.3	25.7	18.1	16.9	26.3	16.2	20.0	35.4	43.2	16.5	14.1	43.9	17.4	28.8	16.2	21.2
PPP2R3C	"C14orf10, FLJ20644, G4-1, G5PR"	ENSG00000092020	"Protein phosphatase 2 regulatory subunit B''gamma"	Q969Q6	14	35085467-35122517	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cone-rod dystrophy, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 489.7;Late spermatids: 233.5;Spermatocytes: 239.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040835, HPA058834"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA040835: AB_10794152, HPA058834: AB_2683831"	"unprognostic (1.41e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.32e-3)"	"unprognostic (5.33e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.10e-3)"	"unprognostic (3.05e-1)"	"unprognostic (7.85e-2)"	"unprognostic (9.48e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.15e-3)"	"unprognostic (8.55e-2)"	"unprognostic (8.29e-2)"	19.9	15.5	23.5	23.9	25.0	42.8	17.1	24.4	41.6	18.1	23.3	18.6	21.0	16.2	16.4	12.5	14.0	18.6	22.9	23.8	25.6	14.4	16.1	17.7	31.0	25.3	24.4	15.9	10.2	17.0	17.6	18.8	25.6	17.1	20.3	15.4	13.5	14.1	24.9	7.1	22.5	21.0	24.9	24.4	16.2	71.6	24.4	26.4	12.4	25.7	25.9	22.3	10.4	27.5	41.2	21.8	41.7	33.9	32.4	54.5	29.6	33.0	32.0	41.0	48.0	18.1	32.2	47.2	13.4	33.9	15.5	17.6	20.0	13.8	60.5	47.8	19.3	26.2	11.9	65.2	43.3	51.2	51.7	41.9	14.4	29.0	19.7	24.0	55.7	26.2	25.7	46.3	57.4	28.4	46.4	43.1	37.1	27.4	24.3	50.2	27.1	32.8	15.8	24.1	39.9	37.5	41.7	27.6	57.8	19.9	17.9	57.0	47.9	41.3	17.3	36.0	34.9	44.8	52.4	92.8	22.8	47.9	48.1	66.5	41.6	86.9	23.4	52.5	27.0	31.0	24.8	29.5	36.1	33.1	22.0	26.9	76.9	33.1	42.7	16.3	40.8	34.0	23.5	25.0	24.4	41.6	23.8	25.6	25.3	24.4	25.6	24.9	24.4	27.5	35.5	16.0	24.7	32.7	40.2	11.5	23.3	31.7	9.6	15.9	18.8	14.7	26.3	17.2	25.8	20.2	4.2	19.4	48.1	29.1	33.2	31.2	489.7	23.1	28.1	33.8	31.2	69.7	28.3	36.1	26.2	26.5	19.9	21.7	33.7	31.3	34.6	22.8	61.3	8.4	30.4	26.8	32.6	49.7	36.3	233.5	28.3	42.6	28.4	24.4	71.5	28.7	46.4	36.2	58.8	49.2	22.3	30.5	37.4	24.8	37.8	43.2	25.1	21.5	32.9	24.0	43.1	239.2	58.6	19.6	13.5	34.8	45.2	36.2	24.6	30.5
PPP2R5E	"B56E, B56epsilon"	ENSG00000154001	"Protein phosphatase 2 regulatory subunit B'epsilon"	Q16537	14	63371364-63543377	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 283.4;Horizontal cells: 262.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006034, CAB072342"	Approved		Supported	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"CAB072342: , HPA006034: AB_1079670"	"unprognostic (1.58e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (2.26e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.62e-2)"	"prognostic favorable (4.16e-4)"	"unprognostic (1.23e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.22e-2)"	12.7	12.5	9.5	13.5	11.0	14.5	12.5	10.3	11.1	14.6	7.2	17.0	10.7	14.9	10.2	19.8	11.7	12.0	15.7	11.4	11.1	14.7	15.8	12.7	15.4	7.4	7.6	12.6	10.9	17.5	6.6	16.0	7.9	12.7	20.0	26.7	9.2	12.6	17.8	11.8	12.3	15.0	7.6	14.3	12.0	14.3	10.4	19.2	20.2	16.5	17.0	17.1	9.8	7.8	90.5	26.0	46.7	22.1	31.6	37.0	44.5	37.1	30.4	39.5	39.1	33.1	35.4	39.6	22.1	38.1	29.3	36.2	48.1	34.4	67.8	36.2	11.8	25.7	18.1	27.7	33.7	41.7	30.4	27.1	37.7	38.8	42.7	28.8	40.2	39.8	33.3	41.9	43.8	60.2	41.8	18.7	35.3	37.7	46.8	41.9	47.8	30.1	38.2	68.1	26.5	51.6	47.7	39.1	25.0	40.1	57.4	20.8	37.8	61.7	68.6	31.7	33.0	15.2	24.4	50.9	28.4	26.3	42.7	1.4	1.3	1.3	2.0	1.4	1.9	1.1	2.2	2.5	1.2	1.7	1.7	1.9	1.0	4.5	1.9	1.9	1.4	0.6	9.5	11.0	10.3	11.1	11.4	11.1	7.4	7.6	7.9	7.6	10.4	7.8	52.1	89.8	55.5	54.2	52.8	80.4	56.9	34.0	60.3	65.0	49.3	27.8	61.7	44.3	35.3	22.0	64.6	27.2	54.8	55.0	29.4	46.4	283.4	65.1	57.2	52.5	27.1	41.2	110.4	47.7	41.5	44.8	33.1	74.6	24.1	48.6	41.0	45.1	29.8	262.5	131.6	51.6	28.5	38.7	49.0	46.6	43.8	42.3	37.4	59.0	49.7	38.4	61.8	93.5	91.8	41.4	48.1	43.2	55.9	58.5	24.9	41.2	41.6	81.2	26.3	51.5	71.1	74.9	22.5	63.1	91.6	30.6	57.0	47.8	70.2	46.9
PPP4R2		ENSG00000163605	"Protein phosphatase 4 regulatory subunit 2"	Q9NY27	3	72996803-73069198	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA034695, HPA039837, HPA073758"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA034695: AB_10671231, HPA039837: AB_2676707, HPA073758: AB_2686632"	"unprognostic (4.60e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.98e-3)"	"unprognostic (5.62e-2)"	"unprognostic (8.86e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.13e-3)"	"unprognostic (1.87e-2)"	"unprognostic (2.86e-3)"	"unprognostic (1.67e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.35e-1)"	27.2	23.2	16.9	26.8	22.9	101.2	22.7	22.6	25.3	27.9	21.7	26.9	24.7	24.7	19.0	23.0	27.7	23.3	25.8	17.3	17.7	23.6	53.6	18.0	26.3	19.7	19.1	22.9	23.0	25.4	11.0	28.6	21.5	18.3	23.8	24.4	20.7	15.7	25.8	16.7	22.3	18.8	18.9	21.6	21.4	27.1	20.1	36.2	24.8	24.8	25.8	24.0	15.3	38.7	33.6	38.5	80.9	48.2	41.7	35.9	48.8	66.2	46.7	59.0	61.3	56.1	39.8	63.3	37.3	39.7	56.0	23.6	63.6	36.8	76.0	96.6	23.8	71.1	43.6	67.8	45.8	105.7	70.6	40.9	53.6	71.3	58.3	40.9	41.4	62.9	63.6	70.6	49.5	49.3	88.3	45.8	74.8	50.0	31.8	82.0	45.9	58.9	50.0	89.4	18.1	47.7	77.3	49.9	62.1	57.9	45.9	58.7	47.0	52.4	62.4	61.3	57.3	43.1	97.4	125.5	36.9	79.9	60.4	7.9	5.9	14.8	12.5	3.4	13.8	6.9	12.9	13.1	5.1	7.8	11.1	10.0	21.3	11.3	5.7	18.0	17.6	4.3	16.9	22.9	22.6	25.3	17.3	17.7	19.7	19.1	21.5	18.9	20.1	38.7	56.8	57.7	32.4	19.2	58.5	117.1	110.1	115.8	69.4	50.1	53.2	55.5	54.7	47.1	74.0	27.6	14.6	74.8	62.8	72.4	19.6	63.4	58.1	86.3	76.0	61.9	53.8	61.0	45.6	53.1	72.0	61.6	38.2	142.7	30.9	49.1	40.4	76.4	43.1	50.5	34.8	55.5	77.3	39.2	78.1	12.7	53.4	61.6	56.9	41.2	52.6	53.9	54.6	42.3	101.8	71.4	58.3	48.5	69.7	115.7	44.3	45.8	64.0	39.0	39.5	73.9	60.4	100.6	77.1	54.6	109.1	138.3	69.4	59.1	54.5	128.1
PPRC1	"KIAA0595, MGC74642, PRC"	ENSG00000148840	"PPARG related coactivator 1"	Q5VV67	10	102132994-102150333	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038511, HPA057571"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA038511: AB_10672521, HPA057571: AB_2683472"	"unprognostic (2.27e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.96e-2)"	"unprognostic (4.29e-3)"	"unprognostic (6.31e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.86e-1)"	"prognostic unfavorable (6.71e-7)"	"unprognostic (8.65e-2)"	"unprognostic (4.22e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.93e-2)"	31.0	19.2	10.3	13.1	10.9	19.0	19.3	9.8	10.7	20.3	12.0	23.2	8.1	21.8	8.1	25.2	21.7	11.9	19.2	10.2	12.0	21.2	19.4	26.3	13.7	11.7	11.4	25.0	24.9	9.4	17.9	13.4	11.2	19.2	8.2	5.1	16.3	8.0	28.8	29.2	16.1	14.2	10.3	19.8	20.4	14.2	11.2	11.0	16.0	12.1	13.7	21.0	20.2	11.5	30.7	44.3	27.0	54.5	23.6	24.2	34.7	26.7	35.9	37.9	31.2	51.1	34.1	66.4	21.8	40.5	23.8	56.7	55.4	52.8	32.6	27.5	43.4	63.5	33.9	48.7	31.4	50.6	26.3	31.9	46.9	44.3	82.8	24.9	23.9	26.5	48.0	38.4	29.9	52.4	40.5	70.0	46.6	29.0	26.7	55.9	38.6	28.2	32.7	30.1	18.6	26.9	23.3	25.2	32.7	25.9	40.8	26.4	26.1	30.1	38.0	30.9	61.2	31.8	24.3	59.6	33.8	61.7	15.4	0.0	1.2	0.1	1.8	1.3	2.3	1.5	1.4	2.3	2.6	1.8	1.7	2.1	0.0	4.1	1.3	1.0	0.9	1.3	10.3	10.9	9.8	10.7	10.2	12.0	11.7	11.4	11.2	10.3	11.2	11.5	16.4	28.9	13.2	6.5	13.4	44.4	33.1	6.1	48.9	4.7	17.5	12.4	9.1	8.6	9.5	5.5	4.2	7.6	9.2	7.9	1.9	8.0	1.1	16.3	16.1	15.6	8.4	10.7	6.8	9.6	12.9	13.7	32.1	31.3	10.8	9.5	6.8	7.2	8.7	1.7	6.2	11.2	6.1	5.3	15.9	2.4	6.2	9.7	8.8	2.8	3.9	2.2	9.2	5.5	5.3	14.0	5.8	6.4	21.4	26.0	2.8	2.4	3.8	4.1	6.6	35.6	18.2	6.3	14.8	36.0	43.5	5.1	10.8	7.8	11.4	30.0
PPTC7	TA-PP2C	ENSG00000196850	"Protein phosphatase targeting COQ7"	Q8NI37	12	110533245-110583318	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 140.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039335, HPA040614"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane, Cytosol"		"HPA039335: AB_10805474, HPA040614: AB_10795526"	"unprognostic (2.44e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (1.43e-5)"	"prognostic unfavorable (6.76e-4)"	"unprognostic (1.09e-1)"	"prognostic favorable (4.48e-5)"	"unprognostic (5.34e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.83e-1)"	18.8	25.5	6.9	16.1	7.3	52.3	13.4	12.1	11.1	15.5	8.3	15.7	13.4	14.3	6.4	21.6	11.3	15.0	40.0	6.5	14.1	21.5	21.0	15.6	20.7	12.7	12.4	13.1	13.2	30.6	8.4	10.7	12.1	12.3	16.7	15.6	17.8	13.4	88.7	21.5	13.2	16.1	9.2	15.2	11.9	14.0	13.0	18.4	11.6	140.0	18.4	19.0	19.1	7.4	24.3	13.6	11.4	12.0	27.8	24.3	16.3	10.9	14.3	11.7	11.7	15.4	9.3	42.2	11.1	10.8	16.7	23.0	23.1	25.3	23.5	30.9	19.1	37.5	14.4	16.7	26.3	41.8	29.6	21.0	40.7	16.6	48.4	17.4	22.5	28.8	28.3	11.7	19.2	6.3	37.2	35.7	16.1	13.0	25.0	30.7	15.3	25.8	48.7	26.7	18.4	14.2	20.6	28.2	24.4	11.0	13.4	22.1	25.9	10.7	11.5	32.8	18.6	33.5	40.0	46.7	18.0	22.6	21.4	0.0	0.6	0.5	0.8	0.5	0.8	0.4	0.6	0.6	0.4	0.7	0.7	0.6	2.1	0.6	0.4	0.5	0.5	0.2	6.9	7.3	12.1	11.1	6.5	14.1	12.7	12.4	12.1	9.2	13.0	7.4	14.1	22.4	28.3	16.0	35.7	91.9	53.1	33.9	56.9	8.6	20.2	12.8	105.4	12.8	36.0	9.2	14.6	7.5	28.2	36.7	17.6	7.7	29.7	34.4	20.4	22.3	16.8	7.8	15.5	8.2	8.4	26.1	12.8	63.3	23.5	8.6	15.4	29.5	17.4	13.5	19.8	15.2	30.5	28.3	97.6	33.2	11.5	30.8	33.8	21.5	31.9	4.8	20.6	19.1	11.7	14.6	15.1	9.8	28.2	57.3	16.5	13.1	35.4	23.8	13.1	22.8	22.4	15.9	24.1	57.1	104.3	6.7	28.7	8.2	17.2	77.5
PPWD1	KIAA0073	ENSG00000113593	"Peptidylprolyl isomerase domain and WD repeat containing 1"	Q96BP3	5	65563236-65587549	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019353, HPA019360"	Enhanced		Supported	"Nuclear bodies"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nuclear bodies"		"HPA019353: AB_1855668, HPA019360: AB_1855669"	"unprognostic (3.31e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.85e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (1.37e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.84e-3)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (6.72e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-2)"	15.0	12.1	12.3	18.2	14.6	27.6	17.2	16.5	16.4	17.3	13.4	14.7	13.4	19.0	17.8	13.5	16.1	15.7	13.5	12.4	13.2	13.0	15.5	14.9	30.0	13.6	12.8	22.9	14.0	15.5	14.7	19.6	13.4	15.0	19.2	14.7	12.7	13.7	13.2	22.2	17.1	13.2	12.9	22.6	14.4	18.1	13.0	32.9	16.3	15.6	26.0	13.7	15.2	18.5	36.5	23.6	35.1	35.2	30.6	36.9	38.8	34.5	25.3	36.5	45.5	37.8	35.4	41.5	28.5	24.3	49.1	32.3	38.4	35.5	49.8	35.7	32.3	26.0	40.0	31.1	25.9	23.9	26.4	29.2	15.3	35.5	25.5	27.0	32.3	31.6	35.3	28.8	28.8	35.8	40.0	31.6	24.7	15.2	13.3	35.4	46.7	35.1	21.2	29.5	18.1	14.8	34.8	14.5	33.1	26.8	21.5	30.8	24.9	20.2	29.2	22.4	52.9	17.1	26.3	45.5	22.3	35.8	21.4	35.0	15.1	31.6	26.1	19.3	32.0	25.8	29.1	29.9	21.2	19.1	36.1	31.0	14.3	26.5	24.0	11.8	38.1	23.4	12.3	14.6	16.5	16.4	12.4	13.2	13.6	12.8	13.4	12.9	13.0	18.5	25.1	28.9	22.4	28.1	36.0	12.4	14.9	15.4	18.2	14.2	9.1	12.8	19.8	7.2	22.1	11.0	8.4	27.7	27.0	6.9	9.8	8.7	76.8	16.4	28.7	20.7	9.6	21.5	37.2	7.7	14.4	21.1	15.8	13.8	11.4	32.6	18.9	6.0	11.8	6.7	46.8	14.9	8.2	16.4	11.9	41.7	20.2	15.2	14.2	23.4	22.6	11.8	23.7	42.3	67.1	8.9	14.7	18.8	29.4	6.6	10.0	7.9	17.8	20.9	6.6	19.9	17.8	32.5	33.7	13.2	11.8	25.2	35.4	15.8	11.4	9.0
PRC1	ASE1	ENSG00000198901	"Protein regulator of cytokinesis 1"	O43663	15	90966040-90995629	"Predicted intracellular proteins"	"Cell cycle, Cell division"		Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 89.9;testis: 55.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 142.9;Extravillous trophoblasts: 68.3;Spermatocytes: 136.4;Spermatogonia: 74.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 34.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 34.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034521, HPA048816"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Microtubules,Cytokinetic bridge,Midbody"		Yes	Yes			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Microtubules, Cytokinetic bridge, Midbody"	Nucleoplasm	"HPA034521: AB_10670169, HPA048816: "	"unprognostic (1.14e-1)"	"unprognostic (3.98e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.24e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (2.76e-5)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.92e-2)"	7.4	6.2	6.4	10.0	6.1	89.9	6.4	10.3	8.4	8.1	5.0	16.3	10.6	5.7	2.3	37.6	6.0	3.0	6.9	5.6	4.9	5.6	4.8	9.0	16.9	4.8	5.2	8.1	8.9	2.6	3.6	15.3	5.2	4.9	16.5	4.9	9.5	1.5	4.1	20.1	13.0	9.4	4.9	12.5	11.7	55.0	4.2	43.0	4.3	2.3	24.9	4.8	13.7	5.6	167.9	199.9	164.8	113.6	16.8	28.7	87.5	237.8	139.3	257.2	195.3	134.6	158.5	65.5	91.4	151.9	156.9	220.9	188.8	101.2	240.6	118.7	206.4	135.6	263.5	123.5	4.1	71.4	109.0	7.7	12.8	145.8	146.9	56.6	146.4	100.5	114.0	132.4	241.1	144.4	66.9	98.5	66.6	216.4	84.9	69.7	205.1	86.3	115.3	123.6	151.2	118.9	225.4	121.9	82.7	112.3	149.1	127.1	91.2	168.2	146.0	140.5	345.1	43.5	127.7	80.0	74.5	162.0	265.3	34.4	0.6	2.9	0.6	0.1	0.4	1.1	1.3	1.3	2.4	0.5	1.2	0.4	0.4	3.0	0.3	2.6	8.0	1.0	6.4	6.1	10.3	8.4	5.6	4.9	4.8	5.2	5.2	4.9	4.2	5.6	2.5	0.0	3.1	1.3	6.8	16.6	6.6	8.0	2.2	6.4	3.4	4.3	3.2	0.0	7.6	3.7	0.0	45.5	2.8	16.5	0.0	3.2	41.5	4.5	4.0	4.7	5.4	142.9	5.0	2.9	68.3	7.2	16.3	6.8	8.9	13.2	9.3	2.1	21.5	3.3	5.2	17.0	10.2	8.7	15.0	15.4	3.7	5.2	3.6	1.9	5.5	3.8	4.1	2.0	1.7	2.3	3.2	1.9	17.5	5.9	2.0	0.1	3.2	4.6	6.6	7.4	10.9	136.4	74.2	38.0	14.2	14.6	6.8	0.4	24.1	6.7
PRDX1	"NKEFA, PAGA"	ENSG00000117450	"Peroxiredoxin 1"	Q06830	1	45510914-45542732	"Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 2690.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004682, HPA007730"	Approved		Approved	Mitochondria		NA	NA		110000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"CAB004682: AB_437046, HPA007730: AB_1855204"	"unprognostic (1.28e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.68e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.39e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.89e-4)"	277.8	362.9	642.4	290.2	667.1	86.7	454.3	700.7	747.3	314.1	627.0	326.7	501.4	255.3	459.4	945.8	306.3	297.4	542.9	613.0	700.8	785.5	841.2	340.2	371.4	712.1	706.3	255.5	122.7	214.6	210.0	353.3	711.6	256.0	327.1	347.3	348.6	307.2	571.4	296.5	402.1	329.3	713.5	265.8	355.5	143.7	671.4	262.8	802.3	477.7	603.3	393.2	375.3	766.6	1028.1	1743.7	735.2	942.9	828.4	701.9	1459.3	1134.8	1144.1	1183.0	964.3	932.3	429.2	899.1	1125.9	1237.6	1448.6	967.6	1640.2	1101.3	1193.0	696.9	1266.4	678.6	2042.8	2484.7	361.0	793.6	848.9	610.4	813.6	1201.7	283.8	657.7	1409.7	1044.0	1271.8	292.7	1225.2	829.4	1053.7	772.5	2339.8	2241.0	1867.3	1863.6	934.0	1177.7	2211.5	872.4	987.5	495.1	1035.3	2524.2	73.3	2157.3	760.6	631.1	1208.1	474.8	1071.9	1034.4	1541.5	206.1	1220.5	1678.2	791.4	537.9	278.7	469.3	325.6	111.6	155.7	367.1	205.4	253.8	246.8	209.3	293.9	221.6	150.3	166.6	12.1	123.8	407.5	195.9	438.2	416.3	642.4	667.1	700.7	747.3	613.0	700.8	712.1	706.3	711.6	713.5	671.4	766.6	530.7	522.4	259.0	48.3	330.1	607.3	1115.3	1161.1	745.0	161.3	387.0	510.9	54.9	397.5	685.2	617.9	104.3	1258.6	151.5	339.3	946.9	1015.7	19.7	662.7	281.2	437.8	174.5	304.2	15.5	442.8	1773.2	462.0	500.0	435.5	325.3	463.2	326.3	875.2	1467.4	206.9	17.1	295.0	545.3	366.9	980.7	44.2	498.6	534.8	581.7	12.2	545.7	416.4	62.8	24.1	90.5	804.4	384.9	410.7	612.8	1100.9	995.0	2690.9	919.1	402.2	309.0	279.0	982.6	84.5	329.2	1346.9	528.6	1114.9	270.9	499.4	398.8	1462.7
PRIM1		ENSG00000198056	"DNA primase subunit 1"	P49642	12	56731296-56752374	"Predicted intracellular proteins"	"DNA replication, Transcription"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 28.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 56.4;Spermatocytes: 118.2;Spermatogonia: 107.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040010	Uncertain					NA	Yes			"Cluster 24: B-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA040010: AB_10805599"	"unprognostic (3.04e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.61e-2)"	"prognostic unfavorable (2.40e-8)"	"unprognostic (4.68e-2)"	"unprognostic (2.73e-3)"	"unprognostic (1.82e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.98e-3)"	"unprognostic (3.94e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.35e-2)"	"unprognostic (6.53e-2)"	3.7	3.2	2.0	7.0	2.8	28.2	9.9	5.5	2.8	3.7	1.2	7.9	4.5	5.0	4.2	4.4	5.3	2.9	2.3	1.9	2.0	3.0	7.5	4.9	12.3	2.5	2.2	8.9	6.1	6.1	2.1	4.8	2.6	3.6	11.2	8.3	3.9	3.9	4.6	7.8	7.7	5.8	2.0	6.9	5.4	14.4	2.3	18.8	5.0	5.6	14.4	3.8	3.1	4.3	43.0	37.9	52.1	29.2	5.1	9.1	57.8	34.7	28.7	62.1	59.8	42.0	54.4	83.0	27.4	15.8	26.0	40.4	60.3	39.9	68.8	40.7	40.4	106.2	22.6	36.8	1.2	129.3	43.2	4.2	7.2	55.8	22.1	8.8	22.6	92.1	105.5	123.8	35.4	33.6	76.8	54.4	53.5	32.0	47.1	85.0	81.4	70.9	15.0	35.4	51.0	46.0	41.4	20.6	19.9	36.2	67.2	52.8	10.9	32.2	70.7	33.1	46.4	45.1	94.5	45.3	19.4	55.4	40.9	2.5	1.9	4.4	9.1	4.0	9.5	11.3	11.2	8.5	3.9	12.2	14.0	10.7	1.0	6.8	7.1	7.5	10.0	5.3	2.0	2.8	5.5	2.8	1.9	2.0	2.5	2.2	2.6	2.0	2.3	4.3	6.9	6.4	6.8	4.6	10.4	3.8	10.7	10.0	4.6	5.1	7.0	7.2	3.2	2.8	6.1	7.3	6.2	14.9	8.7	2.5	0.0	5.8	6.2	4.1	3.9	6.4	1.2	56.4	5.7	7.2	27.0	5.4	5.6	3.3	3.8	10.0	5.7	4.7	11.8	20.2	10.6	4.6	2.0	8.1	3.1	4.3	7.2	6.5	3.6	2.8	7.9	5.7	8.2	8.0	7.8	2.7	2.2	4.9	9.7	2.2	2.0	2.5	6.0	12.7	13.1	8.2	8.8	118.2	107.2	5.1	4.0	4.5	12.8	3.0	9.4	5.0
PRKCI	"DXS1179E, PKCI"	ENSG00000163558	"Protein kinase C iota"	P41743	3	170222424-170305977	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026574, HPA038635"	Approved		Supported	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Microtubules, Cytokinetic bridge"	"HPA026574: AB_1855428, HPA038635: AB_2676124"	"unprognostic (2.26e-1)"	"unprognostic (6.75e-2)"	"unprognostic (4.57e-2)"	"prognostic unfavorable (3.93e-6)"	"unprognostic (1.59e-1)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (2.52e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (5.32e-3)"	"prognostic favorable (3.10e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.73e-2)"	6.7	5.0	2.0	6.9	2.4	2.6	10.4	2.0	3.2	12.7	0.3	12.4	11.6	11.0	8.2	15.1	15.9	11.4	6.9	3.4	1.1	13.5	7.3	16.6	4.6	0.4	0.2	13.6	7.0	13.0	3.1	10.9	0.5	17.3	13.1	6.2	17.5	12.7	6.2	6.9	10.8	11.0	0.2	5.2	34.5	12.5	0.9	10.9	24.5	9.8	10.4	16.1	6.2	1.1	81.6	20.2	20.0	21.6	17.3	23.9	32.2	20.4	29.9	26.4	28.3	29.7	38.6	24.7	65.3	28.8	36.4	37.3	37.9	40.0	44.8	18.2	23.5	22.9	24.3	16.6	27.9	20.9	10.0	21.8	27.5	22.6	35.1	42.8	20.9	13.3	25.8	19.8	27.4	28.0	30.5	8.5	42.3	86.4	22.1	21.8	30.7	41.2	42.3	24.4	31.5	25.8	44.1	57.7	20.0	29.5	63.0	14.5	22.4	27.5	21.1	26.0	34.3	33.9	34.9	35.2	19.8	16.4	11.0	0.0	0.6	0.4	1.1	0.6	1.7	0.9	1.5	2.0	0.8	1.2	1.6	0.9	0.3	2.6	0.5	0.8	1.1	0.7	2.0	2.4	2.0	3.2	3.4	1.1	0.4	0.2	0.5	0.2	0.9	1.1	17.6	73.7	82.1	23.2	5.8	57.1	49.5	39.8	30.7	16.4	29.0	19.7	16.2	24.3	45.3	49.7	14.6	30.2	15.0	29.0	25.4	16.5	8.4	42.0	29.7	20.5	29.3	10.5	77.2	22.0	26.6	32.2	59.7	72.3	8.8	20.4	17.5	17.7	10.0	15.2	55.2	28.3	50.8	18.6	26.8	6.8	23.3	11.6	17.8	22.5	12.7	8.8	6.2	33.2	33.5	55.2	18.6	28.6	29.4	99.4	18.7	20.4	31.9	9.4	19.7	23.7	18.7	15.8	20.6	38.5	63.6	20.7	14.8	14.3	28.5	80.1
PRMT1	"ANM1, HCP1, HRMT1L2"	ENSG00000126457	"Protein arginine methyltransferase 1"	Q99873	19	49675786-49689029	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 444.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022550, HPA069769, HPA072136"	Supported		Supported	Nucleoplasm		NA	NA		8500	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB022550: , HPA069769: AB_2686193, HPA072136: AB_2686490"	"unprognostic (1.88e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.84e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (8.04e-5)"	"unprognostic (3.43e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.19e-3)"	"unprognostic (2.21e-1)"	"unprognostic (3.66e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.10e-2)"	79.7	102.2	62.5	76.2	63.2	65.0	76.7	68.1	74.7	107.0	59.4	87.2	55.1	115.4	44.5	90.7	109.7	49.8	149.2	65.7	71.1	77.9	61.8	76.5	94.0	66.5	65.2	106.7	66.3	65.6	101.1	65.3	68.8	77.1	45.5	71.3	67.6	73.9	242.6	74.8	71.8	74.0	66.3	91.6	69.4	78.4	71.3	79.6	70.9	163.2	84.5	92.6	81.6	68.7	262.5	584.9	396.5	481.7	105.4	118.7	208.4	163.7	283.1	461.8	394.0	439.5	202.2	425.9	119.0	193.4	181.1	188.0	337.3	345.8	200.1	333.7	580.5	311.5	156.4	484.6	256.8	378.7	214.2	166.7	169.3	259.2	369.0	154.8	277.1	338.3	334.0	293.2	182.5	394.1	493.2	467.0	420.5	324.9	375.6	344.8	319.9	388.8	264.0	540.9	440.0	342.4	188.9	193.2	103.4	126.9	146.8	220.6	173.9	269.9	262.5	125.4	398.6	280.0	457.4	429.3	165.7	271.0	289.8	25.0	76.8	37.5	104.0	93.8	129.6	198.9	95.4	111.0	131.5	171.6	105.2	103.3	14.8	162.3	71.9	158.9	97.7	132.5	62.5	63.2	68.1	74.7	65.7	71.1	66.5	65.2	68.8	66.3	71.3	68.7	169.7	3.2	10.3	15.7	112.4	207.0	228.7	444.9	123.5	228.9	71.3	96.8	17.2	40.0	117.3	44.1	106.3	195.6	74.4	45.1	127.2	204.0	5.4	88.9	124.5	167.8	115.2	38.3	9.8	135.2	177.5	101.7	51.5	87.5	54.7	154.2	109.6	22.1	104.1	129.5	15.8	74.5	227.9	27.0	125.7	19.4	104.1	52.9	112.1	15.9	149.4	119.3	57.7	14.6	20.2	125.6	45.6	89.1	117.8	263.0	35.2	87.5	62.8	168.7	92.1	89.7	236.3	66.8	121.8	94.9	158.8	235.2	76.8	200.7	105.0	183.2
PRMT3	HRMT1L3	ENSG00000185238	"Protein arginine methyltransferase 3"	O60678	11	20387558-20509338	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 54.2;Excitatory neurons: 55.5;Inhibitory neurons: 66.9;Oligodendrocytes: 63.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007832, CAB022083"	Uncertain					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB022083: , HPA007832: AB_1855721"	"unprognostic (2.08e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.57e-2)"	"unprognostic (8.97e-2)"	"prognostic unfavorable (2.81e-5)"	"unprognostic (2.01e-1)"	"unprognostic (9.92e-2)"	"unprognostic (9.78e-2)"	"prognostic unfavorable (3.17e-5)"	"unprognostic (9.15e-2)"	"unprognostic (7.22e-2)"	"unprognostic (8.86e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.11e-2)"	5.0	7.4	4.5	8.1	5.4	8.6	9.6	5.0	8.3	5.1	3.7	6.5	7.6	7.7	3.8	8.2	8.5	5.4	9.7	5.2	5.3	6.9	5.4	4.7	7.8	5.4	5.0	8.1	6.7	11.1	2.6	6.9	5.5	6.1	7.7	7.7	6.5	5.7	10.2	6.2	5.9	7.3	5.0	5.5	6.6	4.3	4.8	9.9	19.8	7.7	8.8	8.0	4.6	7.9	26.5	31.4	18.9	17.4	11.8	19.5	36.1	17.9	15.5	24.5	18.5	25.9	7.2	55.8	12.8	14.1	22.4	34.0	27.2	25.6	37.7	26.1	26.4	26.9	25.5	23.3	24.0	48.8	11.4	16.3	26.3	16.1	54.6	10.3	19.7	19.8	61.1	15.3	15.6	26.7	38.6	16.6	26.7	45.1	27.8	27.9	42.3	46.3	23.8	20.2	18.9	24.8	31.0	28.5	23.2	20.3	30.1	14.1	13.3	19.8	17.3	32.7	34.2	9.1	9.7	58.3	15.7	34.1	39.0	3.8	5.1	4.4	4.4	6.1	7.7	5.3	5.5	4.9	9.8	4.9	6.0	5.2	1.3	10.7	5.2	2.0	3.6	3.9	4.5	5.4	5.0	8.3	5.2	5.3	5.4	5.0	5.5	5.0	4.8	7.9	5.5	9.6	5.1	54.2	11.8	6.0	7.7	6.7	15.9	3.8	6.5	4.2	11.8	4.3	5.7	0.0	2.1	11.4	5.0	3.2	9.8	6.9	3.1	6.0	8.2	5.5	7.8	29.2	55.5	5.1	11.0	8.9	11.2	5.5	5.7	8.0	2.9	4.3	6.5	6.7	66.9	7.3	14.2	5.3	3.6	1.0	6.5	10.9	3.6	35.6	6.7	5.6	2.1	41.7	63.2	5.1	2.2	6.4	8.9	9.5	3.5	5.9	5.8	6.6	0.0	7.8	6.7	13.7	9.6	18.7	5.8	7.3	7.0	12.5	7.6	5.7
PRMT5	"HRMT1L5, SKB1, SKB1Hs"	ENSG00000100462	"Protein arginine methyltransferase 5"	O14744	14	22920525-22929408	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005525, CAB012459, HPA064708"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		45000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Cytosol"		"CAB012459: , HPA005525: AB_1079679, HPA064708: AB_2685330"	"unprognostic (8.34e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.19e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.56e-3)"	"prognostic unfavorable (1.82e-4)"	"prognostic unfavorable (4.77e-5)"	"unprognostic (3.64e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (4.69e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.04e-2)"	"unprognostic (6.28e-2)"	"prognostic unfavorable (1.04e-4)"	27.6	31.0	19.9	27.9	21.6	21.7	34.9	21.0	25.9	33.3	24.4	38.4	24.0	36.9	30.6	49.0	44.6	19.4	35.1	20.9	21.8	37.0	28.3	23.2	26.6	20.2	22.2	45.3	32.9	47.3	24.5	30.6	22.0	27.9	35.6	30.8	27.7	33.3	65.8	34.4	23.3	35.5	20.4	26.3	29.2	30.3	21.6	33.1	37.9	42.1	34.3	31.4	33.5	22.8	161.7	169.2	114.2	112.9	62.3	67.7	125.6	104.1	91.6	192.7	156.6	159.2	160.1	171.3	83.2	88.5	108.3	135.8	246.4	212.8	213.9	98.5	119.3	104.5	108.3	256.3	111.4	221.7	85.7	69.3	113.2	143.1	264.8	72.7	91.0	128.5	160.0	91.7	108.5	171.4	151.3	102.9	103.1	160.8	221.8	176.0	140.3	122.7	98.8	110.7	126.0	79.8	125.7	132.3	65.5	94.3	91.3	82.6	70.9	75.1	103.1	103.0	145.9	116.6	246.0	207.2	46.1	109.2	116.0	3.0	31.3	0.4	14.2	31.7	22.9	30.6	19.0	23.0	42.8	27.9	24.4	20.4	7.7	19.8	25.1	25.9	17.6	29.1	19.9	21.6	21.0	25.9	20.9	21.8	20.2	22.2	22.0	20.4	21.6	22.8	8.5	19.2	15.1	5.5	11.4	26.5	26.5	33.8	15.4	10.8	13.9	15.4	1.1	28.6	19.4	7.3	8.4	41.7	8.6	11.1	23.5	32.0	2.3	18.5	21.4	12.3	6.1	24.4	6.1	27.0	33.4	16.7	12.8	12.6	7.0	21.9	10.4	15.1	19.6	16.8	5.8	17.5	20.3	4.4	11.7	3.7	16.4	8.0	26.6	0.0	11.8	18.2	3.1	5.5	4.0	92.8	12.7	21.1	12.4	23.6	7.4	24.6	31.1	11.2	6.6	25.9	19.5	43.1	47.3	20.3	27.8	33.4	8.2	27.5	21.1	17.9
PROSER1	"bA50D16.2, C13orf23, FLJ12661"	ENSG00000120685	"Proline and serine rich 1"	Q86XN7	13	39009865-39038089	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034225, HPA055687"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB034225: AB_1564157, HPA055687: AB_2682886"	"unprognostic (6.75e-3)"	"unprognostic (9.56e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.81e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.73e-3)"	"unprognostic (5.98e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.93e-1)"	"unprognostic (9.31e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.95e-1)"	9.0	7.7	4.7	11.1	5.1	25.5	9.1	7.0	6.2	7.6	4.4	12.8	10.6	9.0	9.0	11.6	7.2	6.0	8.9	4.8	4.3	9.0	9.5	12.2	13.4	6.7	5.2	6.9	15.5	5.7	7.7	21.0	5.9	10.6	13.7	9.9	13.6	6.2	10.1	15.8	12.4	7.8	5.1	12.8	10.9	12.7	5.0	14.0	10.0	7.2	14.6	8.5	9.4	6.9	16.0	12.2	37.3	25.9	12.5	10.0	59.1	14.8	13.0	14.6	15.5	39.0	24.3	37.1	11.7	14.5	19.7	26.9	40.5	26.6	23.8	56.6	33.1	54.7	13.4	27.1	28.5	57.7	32.4	13.3	31.4	23.2	52.3	9.0	24.2	41.9	27.6	21.8	15.7	27.8	35.2	30.6	55.8	31.4	13.0	36.6	39.6	23.3	14.6	24.6	21.0	24.2	10.4	26.8	21.7	28.9	28.8	32.9	22.2	8.4	13.5	16.7	18.9	20.2	22.6	39.7	13.6	31.5	16.8	4.6	1.9	0.4	2.8	1.6	3.1	2.0	2.8	3.0	2.2	1.4	2.4	2.6	0.5	4.2	2.5	2.5	1.7	2.7	4.7	5.1	7.0	6.2	4.8	4.3	6.7	5.2	5.9	5.1	5.0	6.9	9.5	3.2	15.3	13.7	11.7	7.0	5.2	4.6	8.0	11.7	8.4	7.6	6.2	5.7	5.6	0.0	8.4	19.3	19.4	12.7	1.9	7.3	16.8	9.0	9.4	10.0	11.4	6.3	16.8	13.5	18.5	6.4	11.2	12.1	12.0	12.5	8.6	6.0	10.4	16.8	12.7	16.3	0.0	16.3	8.0	5.6	6.5	9.9	5.4	12.2	9.9	4.5	13.4	14.1	27.3	15.0	19.2	4.9	16.9	11.2	6.5	3.6	6.0	9.5	0.0	7.8	7.2	14.0	11.6	10.5	7.2	26.8	11.5	5.2	14.8	8.1
PRPF18	hPrp18	ENSG00000165630	"Pre-mRNA processing factor 18"	Q99633	10	13586939-13630859	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 105.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA037599, HPA047950"	Supported		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"	Cytosol	"HPA037599: AB_10795137, HPA047950: AB_2680221"	"unprognostic (5.82e-2)"	"unprognostic (7.86e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.20e-2)"	"unprognostic (3.00e-2)"	"unprognostic (6.36e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.93e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.63e-1)"	14.6	15.9	8.4	14.4	9.7	43.0	19.6	12.2	10.4	12.8	8.9	16.0	16.9	14.0	28.1	15.8	11.7	15.5	14.3	8.5	10.8	20.7	21.9	14.9	18.2	8.7	8.7	12.9	17.0	18.7	10.7	17.4	8.7	14.3	18.1	10.1	14.3	13.0	23.2	14.3	16.5	15.1	8.6	13.6	15.0	18.8	9.1	25.0	23.6	22.2	19.7	16.4	12.3	10.1	29.5	21.7	18.9	16.4	25.9	24.7	23.5	33.6	16.6	35.9	34.2	20.8	43.8	24.4	18.3	31.1	16.3	23.8	25.1	27.8	41.3	36.3	24.9	28.4	18.5	16.3	30.7	22.6	32.9	19.4	44.3	31.3	15.4	21.9	35.3	35.0	29.9	32.1	33.1	30.5	42.2	15.6	17.8	29.0	10.7	29.8	22.8	30.6	23.9	12.6	13.2	32.7	26.6	18.8	29.1	23.0	29.0	36.6	30.2	22.2	26.1	36.5	25.5	31.2	35.8	34.8	32.8	27.9	15.4	27.2	27.3	36.5	27.7	25.1	24.0	26.9	24.8	23.9	27.4	25.8	26.4	32.6	40.3	39.7	37.4	23.3	33.5	16.8	8.4	9.7	12.2	10.4	8.5	10.8	8.7	8.7	8.7	8.6	9.1	10.1	24.5	19.2	22.4	14.7	32.8	45.6	24.0	35.7	25.0	13.5	22.6	15.0	9.4	30.0	32.9	22.0	10.4	30.5	28.7	21.1	41.1	30.9	29.8	27.5	22.8	21.1	12.6	25.9	27.0	29.1	40.4	18.9	19.4	22.0	27.1	10.5	16.4	28.4	26.0	21.9	25.3	21.8	46.8	20.7	18.0	16.5	17.7	19.4	24.9	18.7	29.7	20.2	36.0	28.1	29.3	33.7	28.9	13.2	27.1	16.2	30.2	50.6	31.8	21.7	19.7	20.8	18.3	105.8	41.1	17.1	46.9	41.7	33.2	11.6	19.0	25.8
PRPF38A	"FLJ14936, Prp38"	ENSG00000134748	"Pre-mRNA processing factor 38A"	Q8NAV1	1	52404602-52420836	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053099, HPA058407"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA053099: AB_2682044, HPA058407: AB_2683709"	"unprognostic (1.29e-1)"	"unprognostic (6.12e-2)"	"prognostic favorable (7.16e-4)"	"unprognostic (1.34e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.15e-3)"	"prognostic unfavorable (3.83e-5)"	"unprognostic (3.83e-2)"	"unprognostic (7.84e-3)"	"unprognostic (7.06e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.69e-2)"	"prognostic unfavorable (7.41e-5)"	"unprognostic (6.54e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.82e-1)"	9.0	8.1	11.8	10.7	12.2	19.3	13.3	16.2	14.2	12.1	10.5	11.2	8.4	14.1	9.8	9.5	11.4	7.1	7.4	11.3	12.3	10.4	7.9	9.7	15.7	12.2	12.5	17.3	7.9	8.9	9.6	9.9	12.1	10.1	12.1	17.6	8.4	9.0	6.7	11.4	10.7	9.0	11.6	11.2	8.2	8.9	11.8	21.1	12.2	8.1	15.0	8.7	10.3	13.5	17.6	8.5	29.8	14.3	11.5	11.3	17.6	11.8	8.0	19.1	18.3	15.5	8.5	36.2	12.0	8.1	14.8	12.8	42.6	12.8	24.7	19.8	32.4	48.7	31.1	16.3	14.2	54.8	17.2	8.7	11.2	20.9	20.0	14.5	16.3	25.9	45.4	9.2	11.5	9.9	42.5	32.8	36.6	18.6	19.7	41.3	44.8	30.3	16.9	10.4	19.7	24.0	23.8	19.3	23.8	20.0	13.6	43.8	12.9	10.8	16.2	16.3	23.5	17.4	26.6	35.7	15.9	47.0	14.0	12.3	6.2	8.9	7.4	7.1	10.2	7.2	8.3	9.1	7.9	6.5	11.3	8.8	4.8	11.1	7.5	4.3	8.9	5.7	11.8	12.2	16.2	14.2	11.3	12.3	12.2	12.5	12.1	11.6	11.8	13.5	37.5	41.7	32.1	8.5	49.1	53.0	92.7	48.8	33.6	35.9	34.4	32.1	29.9	22.8	41.1	16.5	93.8	60.5	52.6	69.9	35.2	36.9	84.6	36.8	34.3	47.6	35.8	44.6	6.7	29.4	77.9	33.8	20.4	31.6	60.1	43.1	34.6	19.3	40.0	25.2	7.2	42.7	32.6	35.8	40.0	18.6	25.7	34.4	30.2	1.9	40.4	49.4	70.0	7.1	7.4	27.0	49.1	33.4	47.3	47.0	61.2	34.9	28.3	47.8	52.6	53.8	33.2	109.8	55.1	38.1	56.0	103.4	57.6	44.7	62.2	67.9
PRPF39	"FLJ11128, FLJ20666"	ENSG00000185246	"Pre-mRNA processing factor 39"	Q86UA1	14	45084107-45116282	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001176, HPA078403"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA001176: AB_2171026, HPA078403: "	"unprognostic (1.79e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.91e-2)"	"unprognostic (6.75e-3)"	"prognostic unfavorable (3.84e-5)"	"unprognostic (9.51e-3)"	"prognostic unfavorable (6.51e-4)"	"prognostic favorable (8.48e-4)"	"unprognostic (4.34e-3)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (5.02e-3)"	"unprognostic (1.83e-1)"	"unprognostic (9.04e-2)"	"unprognostic (8.93e-2)"	"prognostic favorable (2.99e-4)"	4.8	4.0	1.4	0.7	1.6	2.7	4.8	1.3	2.0	5.5	0.2	5.1	1.5	5.2	1.7	3.9	6.3	1.3	3.7	1.1	1.0	5.6	3.4	3.2	1.5	1.3	0.7	5.5	4.4	1.7	4.1	1.7	1.5	3.5	1.0	2.0	4.4	1.5	7.6	4.8	4.3	1.5	0.2	3.8	5.1	3.0	1.0	1.8	3.6	1.7	1.2	5.3	4.3	2.2	7.8	8.5	7.0	3.4	2.7	2.4	7.0	6.2	3.4	4.9	4.3	5.1	5.2	4.9	6.2	4.5	3.6	5.1	9.0	4.1	7.3	8.9	6.2	6.8	11.5	4.8	3.2	6.5	1.9	1.5	2.5	2.7	3.2	2.6	3.5	6.2	9.8	5.2	5.4	7.0	7.2	3.1	6.5	5.2	8.9	9.5	6.0	6.3	2.8	10.4	6.8	1.8	2.9	3.9	4.9	3.5	3.7	5.2	7.8	4.3	4.0	3.1	8.3	5.1	12.9	11.2	1.8	6.6	2.4	5.2	2.7	4.7	4.5	4.9	6.4	5.6	4.0	4.7	4.9	5.0	5.2	6.1	2.1	4.3	5.2	2.0	5.4	3.2	1.4	1.6	1.3	2.0	1.1	1.0	1.3	0.7	1.5	0.2	1.0	2.2	14.3	25.6	22.5	21.2	18.2	27.3	15.6	6.5	18.8	19.5	10.6	7.4	14.9	7.2	13.5	7.3	14.6	12.1	21.5	7.0	9.8	8.5	1.3	9.2	19.5	12.8	9.6	15.8	36.6	9.3	10.6	15.5	12.2	11.2	16.4	16.7	10.8	7.5	7.5	16.8	37.1	9.1	6.1	5.1	14.6	4.9	14.9	9.5	14.2	25.3	8.4	10.8	5.2	31.2	55.5	8.0	6.6	14.7	19.1	14.2	14.2	5.4	6.1	24.2	6.6	13.5	16.7	11.6	11.8	18.3	25.3	12.0	19.7	13.4	9.2	10.0
PRPF4	"HPRP4, HPRP4P, PRP4, Prp4p, SNRNP60"	ENSG00000136875	"Pre-mRNA processing factor 4"	O43172	9	113275642-113294009	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021794, HPA022248"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"		"HPA021794: AB_1855772, HPA022248: AB_1855773"	"unprognostic (1.70e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (9.35e-4)"	"unprognostic (1.95e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.14e-2)"	"unprognostic (5.00e-2)"	"unprognostic (6.76e-3)"	"unprognostic (2.18e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.57e-2)"	11.6	14.7	9.2	15.2	9.5	15.1	13.4	10.3	10.9	11.2	8.6	11.1	9.9	13.5	19.4	14.9	12.3	10.3	11.0	9.4	9.5	15.4	16.2	9.4	15.6	8.9	8.9	14.8	14.4	25.4	12.2	12.5	9.2	13.3	12.3	13.1	11.2	11.1	18.1	14.6	9.8	13.2	9.0	11.6	10.3	11.6	9.1	16.9	10.2	15.2	17.6	16.7	11.3	9.6	36.6	61.3	40.3	44.4	27.8	28.6	40.4	56.1	28.1	60.2	44.2	60.4	33.4	76.5	32.5	30.3	62.2	81.8	84.9	48.8	66.2	54.2	32.1	39.1	50.4	43.7	25.2	68.0	34.2	20.7	32.7	63.1	59.9	22.6	28.9	41.8	67.5	40.9	51.2	57.3	65.1	47.9	63.9	94.2	66.5	59.4	95.9	51.4	26.0	28.9	52.7	35.5	82.9	44.0	26.0	32.0	68.3	35.0	29.8	49.1	37.3	63.0	72.4	52.1	153.1	73.3	37.6	42.9	63.8	27.4	16.2	16.1	14.7	19.4	17.1	17.1	14.4	13.3	20.4	17.4	14.5	14.6	5.2	18.4	24.6	13.4	14.6	14.8	9.2	9.5	10.3	10.9	9.4	9.5	8.9	8.9	9.2	9.0	9.1	9.6	15.7	9.6	18.4	6.8	23.7	15.7	17.6	10.4	18.8	22.9	12.7	14.6	12.9	12.8	15.2	18.4	18.8	27.7	26.6	5.8	25.4	18.6	17.2	17.5	24.7	12.6	17.5	20.0	8.6	16.9	34.5	16.4	10.2	21.9	19.0	21.5	6.4	9.9	18.4	28.6	8.3	13.0	10.2	13.5	17.8	13.0	11.5	20.5	5.4	2.8	27.3	22.7	18.6	4.0	5.7	15.5	9.6	10.9	15.7	20.6	8.1	16.9	14.3	24.1	0.0	16.9	17.5	28.6	21.0	21.4	18.8	21.5	20.0	24.7	14.0	16.9
PRPS1	"CMTX5, DFN2, DFNX1"	ENSG00000147224	"Phosphoribosyl pyrophosphate synthetase 1"	P60891	X	107628428-107651993	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Nucleotide biosynthesis"	"Kinase, Transferase"	"Charcot-Marie-Tooth disease, Deafness, Disease variant, Gout, Mental retardation, Neurodegeneration, Neuropathy, Non-syndromic deafness, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043760, HPA051269"	Uncertain		Approved	Vesicles		NA	NA		320000	"Cluster 13: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Vesicles		"HPA043760: AB_2678656, HPA051269: "	"unprognostic (4.47e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.19e-3)"	"unprognostic (2.30e-3)"	"unprognostic (2.56e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.25e-2)"	22.9	28.0	33.7	30.2	35.0	58.0	21.0	32.4	36.4	20.0	59.3	19.0	11.0	23.7	14.8	13.7	25.9	13.9	22.2	33.7	39.6	27.6	51.5	21.5	42.7	35.4	39.1	30.2	21.7	27.2	23.2	14.6	37.6	21.3	17.9	30.2	16.3	17.4	49.1	12.3	16.7	29.5	34.2	26.2	15.5	13.4	35.2	52.0	44.1	37.9	45.7	23.6	15.2	34.4	93.5	128.9	56.4	69.9	32.7	26.5	18.6	253.2	55.8	146.0	122.6	55.5	36.6	156.9	111.7	94.9	104.1	36.6	176.0	53.8	148.3	79.9	150.9	84.2	140.0	100.3	28.8	153.1	55.6	28.2	30.6	90.2	56.2	96.7	52.3	108.2	137.4	183.5	69.0	51.0	101.2	113.6	213.5	77.2	141.4	117.6	96.3	125.4	60.7	54.2	96.2	52.5	131.5	77.6	57.3	106.4	36.0	61.7	31.2	93.2	45.0	108.3	109.1	61.8	115.1	172.7	50.1	163.6	61.6	8.8	8.9	22.6	26.0	14.3	30.8	29.3	31.7	32.2	11.4	31.0	36.1	30.7	4.7	28.5	15.7	16.3	35.5	21.1	33.7	35.0	32.4	36.4	33.7	39.6	35.4	39.1	37.6	34.2	35.2	34.4	21.0	6.4	10.0	4.6	44.2	31.1	18.4	13.2	12.0	28.4	8.3	9.4	12.1	15.7	12.6	16.5	4.2	8.8	29.3	3.0	25.4	18.3	1.2	11.5	13.3	18.1	16.2	52.2	4.8	20.2	11.5	22.2	10.2	5.7	26.6	13.2	14.6	57.5	35.3	15.2	10.0	6.5	6.1	18.6	34.8	3.9	14.0	16.8	26.6	6.5	24.9	20.0	27.8	3.5	4.8	19.1	3.7	17.0	35.7	16.2	1.5	29.4	27.1	14.1	0.0	18.1	30.7	3.6	10.9	10.8	22.3	1.8	45.0	19.7	8.0	9.7
PRR11	FLJ11029	ENSG00000068489	"Proline rich 11"	Q96HE9	17	59155732-59206709	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.1;lymphoid tissue: 20.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 26.3;Extravillous trophoblasts: 22.3;Granulosa cells: 14.4;Kupffer cells: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 9.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA023923, HPA052376"	Uncertain		Approved	"Endoplasmic reticulum"		Yes	Yes			"Cluster 14: Monocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Endoplasmic reticulum"		"HPA023923: AB_1855783, HPA052376: AB_2681803"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (2.15e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (1.35e-7)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (7.22e-3)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.56e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.55e-3)"	1.3	0.7	1.8	6.5	2.0	18.1	1.8	4.3	2.7	1.2	1.1	4.6	6.5	1.7	0.5	3.8	1.4	1.4	1.0	2.0	1.3	0.6	1.4	2.3	10.3	2.3	1.5	1.4	0.5	0.3	0.0	4.3	2.2	0.8	5.6	1.7	0.6	0.7	1.2	3.1	5.0	3.6	1.1	3.3	2.4	1.8	2.3	20.6	1.3	0.4	12.0	2.0	0.6	3.7	105.3	56.9	84.5	24.8	2.4	16.0	31.7	66.7	41.9	69.1	54.2	68.4	78.7	80.2	65.9	52.7	56.2	40.7	67.0	73.9	145.0	99.3	39.1	86.4	58.8	50.3	0.6	88.7	32.5	4.0	5.3	81.9	109.0	17.1	77.2	57.9	48.6	76.7	72.8	95.2	80.7	26.1	31.9	52.0	82.5	67.3	135.7	45.9	20.0	32.4	34.5	45.4	61.7	18.4	29.2	38.0	54.4	34.1	57.8	146.4	157.3	73.5	117.8	48.8	108.2	73.6	34.5	47.4	150.1	1.7	2.1	2.3	0.6	4.0	0.2	1.1	0.5	0.7	2.6	0.6	0.3	0.5	2.1	0.5	9.5	1.1	1.4	0.8	1.8	2.0	4.3	2.7	2.0	1.3	2.3	1.5	2.2	1.1	2.3	3.7	4.5	0.0	1.7	3.3	3.1	1.9	2.0	1.5	0.0	2.0	0.8	1.5	2.0	1.5	1.6	0.0	0.0	6.2	1.4	2.0	0.0	0.4	0.9	1.4	1.9	3.6	4.9	26.3	1.6	0.5	22.3	2.9	2.6	2.2	2.5	14.4	4.2	0.3	7.8	1.7	1.8	5.0	0.0	18.6	6.3	0.4	0.9	7.8	1.8	2.8	8.4	0.9	4.1	2.0	3.4	0.9	0.7	2.2	9.7	1.1	0.5	0.5	0.6	3.2	0.0	2.9	3.3	2.6	5.1	5.5	1.3	2.1	3.3	1.3	8.4	1.7
PRR14L	"C22orf30, MGC50372"	ENSG00000183530	"Proline rich 14 like"	Q5THK1	22	31676256-31750140	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062645	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA062645: AB_2684817"	"unprognostic (2.87e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.10e-2)"	"unprognostic (8.86e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.10e-1)"	"unprognostic (4.90e-2)"	"prognostic favorable (3.00e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.95e-1)"	"unprognostic (7.48e-2)"	"unprognostic (4.14e-3)"	3.8	3.6	3.1	5.4	4.1	8.6	5.6	5.8	3.8	4.5	8.5	6.3	4.3	4.3	4.2	5.7	5.1	3.3	3.2	3.5	2.4	4.3	4.2	4.5	6.9	2.0	2.1	6.9	4.1	6.6	4.7	5.3	1.9	4.0	7.0	4.9	4.2	3.7	2.8	6.9	4.7	5.0	0.6	5.6	5.9	5.5	3.7	7.6	5.3	4.6	7.2	4.8	4.0	6.5	11.4	10.8	11.6	11.5	10.4	9.7	12.0	6.1	7.2	9.4	8.7	9.9	4.1	12.9	5.8	12.0	7.0	11.0	22.9	9.1	9.7	17.3	9.7	7.8	9.7	8.0	8.8	24.3	16.2	8.7	9.0	13.0	11.2	8.1	13.3	10.1	12.0	8.3	9.9	10.8	8.6	7.7	13.4	16.3	4.1	12.8	18.5	7.4	7.8	12.8	16.0	9.4	14.2	8.5	7.8	13.6	7.5	9.6	12.7	5.7	11.4	7.7	8.4	12.8	16.4	9.5	8.9	11.7	8.9	9.1	4.3	5.4	2.9	5.1	2.6	3.5	1.8	2.4	3.3	3.1	2.6	2.8	8.1	2.9	11.8	3.7	2.7	1.8	3.1	4.1	5.8	3.8	3.5	2.4	2.0	2.1	1.9	0.6	3.7	6.5	18.1	22.4	20.3	31.0	18.1	7.5	13.4	18.5	16.5	11.9	16.0	12.3	22.2	10.0	28.7	11.0	20.9	19.0	21.1	29.5	9.8	19.3	7.4	25.9	27.3	16.2	10.2	14.3	48.0	17.1	14.2	15.6	25.0	24.4	26.6	56.6	11.7	18.4	14.6	15.2	38.8	19.4	10.2	21.3	9.2	5.9	14.9	21.2	1.8	35.6	24.7	12.1	20.6	21.6	46.7	24.6	13.9	8.2	12.4	19.3	20.3	11.9	23.2	11.7	13.1	21.9	15.6	14.0	18.4	19.9	9.7	22.2	14.4	27.9	18.5	20.3
PRRC2C	"BAT2D1, BAT2L2, KIAA1096, XTP2"	ENSG00000117523	"Proline rich coiled-coil 2C"	Q9Y520	1	171485551-171593511	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025766, HPA028659"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA025766: AB_1845277, HPA028659: AB_10600786"	"unprognostic (4.16e-1)"	"unprognostic (2.40e-2)"	"unprognostic (6.66e-3)"	"unprognostic (8.71e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.19e-3)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (7.76e-6)"	"unprognostic (7.03e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.34e-2)"	30.9	21.0	26.8	33.3	25.8	72.5	32.7	32.1	35.0	34.0	19.0	27.0	21.6	30.2	37.5	36.7	29.7	26.2	22.7	22.9	34.2	28.8	31.1	35.8	44.8	27.5	27.1	34.3	28.9	33.8	25.7	34.2	27.6	28.2	31.9	34.5	30.3	27.1	25.7	39.7	34.0	25.4	20.3	36.0	28.9	29.3	26.4	49.6	27.8	23.7	43.4	38.5	34.4	30.7	84.9	64.3	88.1	58.4	61.0	70.5	65.2	47.8	67.7	54.8	49.7	99.1	59.0	123.9	73.1	70.4	44.3	73.8	96.5	76.1	83.8	70.1	51.4	94.2	51.2	69.5	63.3	154.4	73.8	68.6	57.1	92.7	137.3	49.3	80.9	66.6	126.8	66.6	63.0	40.3	92.8	65.2	116.8	67.5	110.5	69.3	65.5	60.7	77.8	93.3	56.7	58.3	72.6	85.4	56.0	115.8	58.2	107.0	101.6	61.9	57.0	60.7	100.4	55.5	63.4	175.3	39.4	74.7	56.7	2.2	1.3	0.7	1.3	1.2	1.3	1.7	1.2	1.2	0.6	2.0	1.1	1.3	3.4	2.5	1.4	2.0	1.0	0.6	26.8	25.8	32.1	35.0	22.9	34.2	27.5	27.1	27.6	20.3	26.4	30.7	233.8	298.1	224.7	81.0	272.5	167.0	270.8	107.5	198.6	164.6	105.4	104.6	115.7	133.0	198.3	86.5	139.7	204.0	325.0	190.0	25.4	174.0	63.9	228.0	246.7	214.5	165.1	139.0	101.5	151.3	210.1	189.1	157.0	378.3	263.2	132.8	130.3	119.0	128.9	138.0	108.6	162.3	57.0	142.8	183.0	36.5	139.1	211.0	96.0	91.8	227.9	120.4	269.8	87.9	143.2	223.1	145.2	96.3	281.8	294.3	99.6	40.1	132.1	170.4	78.9	218.1	184.2	247.7	160.8	178.0	145.9	476.8	317.3	178.5	168.5	335.5
PSKH1		ENSG00000159792	"Protein serine kinase H1"	P11801	16	67893254-67929676	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053927, HPA062763"	Approved		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear speckles, Cytosol"		"HPA053927: AB_2682312, HPA062763: "	"unprognostic (2.57e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.88e-1)"	"unprognostic (5.79e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.66e-2)"	"unprognostic (9.85e-3)"	"unprognostic (8.32e-2)"	"prognostic favorable (4.28e-10)"	"unprognostic (1.46e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.15e-2)"	"unprognostic (3.90e-3)"	14.3	18.6	12.8	9.6	14.5	5.2	14.0	12.2	13.5	13.5	19.5	18.2	13.7	19.3	10.0	16.9	18.7	10.1	17.6	11.2	11.5	20.5	16.5	12.7	10.6	15.0	14.9	19.4	26.3	32.9	13.2	7.6	13.4	15.1	10.8	4.0	18.1	12.7	15.3	13.8	15.7	15.7	13.2	12.8	21.4	21.8	13.6	12.0	15.0	13.5	8.5	16.5	9.5	14.9	13.0	22.7	25.2	28.1	38.4	19.3	16.3	15.2	23.0	15.8	14.0	17.2	18.2	12.2	22.7	25.7	12.7	19.2	14.7	15.6	5.3	4.8	16.4	13.9	16.8	22.0	26.3	13.4	8.0	35.7	26.7	18.8	19.6	21.3	23.3	22.5	21.6	5.1	16.7	28.7	18.3	8.6	24.2	14.0	13.9	27.7	9.7	25.3	18.6	16.0	21.8	26.0	47.3	12.8	15.8	9.9	23.5	23.9	20.8	17.7	6.2	15.0	7.7	15.3	8.7	26.2	21.4	8.8	19.9	0.0	2.0	1.9	2.0	2.2	1.4	1.5	1.5	2.0	2.1	1.2	1.2	1.7	1.0	2.1	1.5	1.5	0.8	1.7	12.8	14.5	12.2	13.5	11.2	11.5	15.0	14.9	13.4	13.2	13.6	14.9	5.5	0.0	3.6	4.6	2.9	1.1	3.1	5.2	2.2	11.1	5.3	4.6	2.3	7.2	3.8	5.5	6.2	6.2	3.0	11.5	11.7	6.0	14.4	5.8	6.5	5.2	10.8	3.0	4.6	7.4	4.8	5.4	5.1	4.8	6.3	13.0	5.3	10.3	4.8	6.7	6.1	6.2	10.2	6.3	1.6	22.1	4.7	2.9	5.4	3.7	4.8	11.0	3.1	5.5	9.2	7.6	4.5	7.9	3.0	3.6	10.0	8.1	4.9	6.9	13.1	6.3	6.1	6.7	6.1	5.4	1.6	5.9	3.8	10.7	7.4	2.2
PSMA2	"HC3, MU, PMSA2"	ENSG00000106588	"Proteasome 20S subunit alpha 2"	P25787	7	42916828-42932185	"Enzymes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 439.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA008188	Uncertain					NA	NA		61000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"			"HPA008188: AB_1855819"	"unprognostic (9.40e-3)"	"unprognostic (2.08e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.01e-2)"	"unprognostic (9.25e-2)"	"prognostic favorable (6.73e-5)"	"unprognostic (1.77e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.38e-2)"	"unprognostic (4.24e-2)"	100.7	113.4	53.7	89.0	54.1	120.2	100.1	55.7	82.8	71.2	56.4	90.9	104.3	75.6	83.1	110.0	70.5	49.4	119.2	52.5	56.6	117.0	319.5	85.9	101.4	55.6	54.5	66.4	91.0	71.0	63.8	78.9	55.5	91.1	86.8	42.2	76.0	58.2	227.5	86.9	96.7	67.3	58.6	94.1	104.8	56.1	55.4	137.5	67.4	120.1	108.8	92.4	77.0	62.8	202.8	212.5	243.4	296.4	128.1	142.1	181.1	174.7	202.8	274.9	292.3	316.5	322.2	371.5	301.7	155.5	431.6	273.3	254.3	242.4	314.2	270.3	202.3	189.8	279.1	337.1	137.3	325.8	197.7	131.7	172.7	211.7	125.7	196.1	265.1	226.0	389.8	219.4	223.5	235.9	295.0	634.9	482.4	331.3	259.9	282.1	235.5	364.3	268.2	271.6	196.8	199.1	189.5	429.9	200.9	328.3	312.4	375.6	189.9	161.0	295.3	174.5	348.6	282.6	470.3	611.1	276.0	406.0	468.9	278.5	185.4	351.9	133.9	193.4	156.9	195.4	163.3	157.9	199.8	175.2	146.0	155.2	93.1	160.7	210.0	225.0	240.8	363.3	53.7	54.1	55.7	82.8	52.5	56.6	55.6	54.5	55.5	58.6	55.4	62.8	92.2	89.8	100.5	11.1	100.6	0.1	89.3	0.2	41.5	32.4	125.2	121.4	0.0	123.0	66.8	95.6	22.9	293.3	141.3	130.3	170.2	348.6	23.9	42.3	41.5	93.2	154.9	126.9	15.3	380.0	300.1	67.2	23.9	37.6	166.0	27.5	122.8	204.8	193.5	28.6	16.0	199.8	0.0	173.5	0.3	19.1	79.2	94.1	0.0	12.2	439.1	85.3	153.5	17.1	27.9	314.5	166.9	84.7	72.6	97.8	332.7	301.5	58.3	46.6	131.5	55.3	74.4	125.8	115.6	44.3	0.0	279.1	81.8	39.1	252.8	98.2
PSMB1	"HC5, PMSB1"	ENSG00000008018	"Proteasome 20S subunit beta 1"	P20618	6	170535120-170553307	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 1197.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029635, HPA029637, CAB033911"	Enhanced		Supported	Nucleoplasm		NA	NA		15000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB033911: AB_2268890, HPA029635: AB_10599738, HPA029637: AB_10601793"	"unprognostic (2.78e-2)"	"unprognostic (3.10e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.39e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.76e-6)"	"unprognostic (3.63e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.45e-3)"	"unprognostic (9.62e-2)"	214.3	191.2	127.8	138.1	131.9	206.8	186.4	129.8	150.7	146.1	131.9	175.9	147.4	174.9	279.4	175.2	157.1	114.5	222.3	127.7	139.0	179.7	308.6	158.3	175.8	129.2	127.5	136.6	153.1	169.2	151.8	173.8	133.2	130.9	166.9	98.5	141.7	151.3	355.2	192.2	149.1	164.3	137.6	165.7	156.8	114.3	132.9	180.5	142.4	239.2	206.8	168.8	143.4	143.0	309.8	284.9	396.2	514.9	347.3	271.2	421.6	288.3	422.7	471.6	478.5	628.9	259.3	449.1	366.2	390.0	430.8	303.7	446.0	459.8	488.7	460.2	502.1	384.4	277.6	799.6	406.3	455.8	327.1	311.5	277.6	455.6	293.1	322.4	409.9	278.1	774.3	373.2	436.9	835.1	343.5	633.0	362.7	558.1	387.9	326.9	314.1	571.6	495.1	183.6	394.5	321.6	277.1	424.5	231.5	351.1	290.9	648.4	313.3	190.4	304.8	466.9	543.2	315.8	454.8	565.8	443.7	510.9	417.5	258.4	431.9	290.2	265.2	416.1	313.5	386.4	306.0	290.7	523.1	305.7	288.1	279.8	249.3	408.2	384.4	297.4	442.6	652.5	127.8	131.9	129.8	150.7	127.7	139.0	129.2	127.5	133.2	137.6	132.9	143.0	242.7	112.2	148.5	19.9	182.1	217.2	351.4	750.7	117.8	120.2	168.2	236.3	232.3	208.8	335.5	141.6	41.7	876.6	175.0	222.0	401.1	498.3	332.4	224.6	190.2	243.8	165.3	223.9	23.5	651.4	790.8	245.5	109.6	215.1	189.5	226.1	168.8	349.8	394.3	119.5	25.1	251.6	417.1	165.3	222.3	81.9	256.3	207.3	231.3	20.6	364.5	237.8	206.0	19.6	43.3	525.5	240.1	235.9	253.4	334.9	327.6	537.0	310.0	135.9	190.7	181.2	500.2	247.8	196.3	153.3	215.8	1197.8	182.1	283.7	276.7	365.4
PSMB2	HC7-I	ENSG00000126067	"Proteasome 20S subunit beta 2"	P49721	1	35599541-35641526	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026322, HPA026324"	Approved		Enhanced	Nucleoplasm		NA	NA		9700000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA026322: AB_1855821, HPA026324: AB_1855822"	"unprognostic (3.54e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.63e-3)"	"unprognostic (6.93e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (3.49e-7)"	"unprognostic (2.81e-2)"	"unprognostic (5.23e-2)"	"unprognostic (3.34e-3)"	"unprognostic (7.87e-2)"	"unprognostic (4.45e-1)"	"prognostic unfavorable (2.80e-6)"	"unprognostic (1.65e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.93e-2)"	26.4	29.3	10.0	13.9	10.3	21.7	25.0	9.7	11.6	23.6	9.4	24.3	12.9	26.9	11.5	31.8	21.9	9.1	27.3	10.6	10.4	22.6	45.9	25.6	15.8	9.9	9.7	21.0	25.2	11.3	19.6	15.2	11.0	20.0	12.7	12.1	22.3	10.8	63.1	30.9	23.2	13.4	9.9	25.4	24.2	15.6	9.5	20.5	18.7	14.8	16.7	22.9	23.9	11.8	68.8	42.4	45.5	32.2	23.3	27.9	55.5	31.8	36.6	63.2	51.1	51.6	79.3	68.8	71.3	37.6	38.6	41.2	59.3	53.4	54.5	54.5	54.1	63.4	44.5	50.1	41.4	66.1	34.7	30.4	33.4	77.0	36.8	25.9	50.8	54.1	76.6	37.7	41.9	30.7	85.5	50.1	59.3	29.7	44.0	52.3	47.5	48.7	45.3	35.9	39.8	30.1	36.0	34.5	52.1	50.3	24.9	29.3	35.2	32.0	37.5	30.9	76.5	31.8	55.0	66.9	49.9	70.4	55.6	20.5	23.6	18.2	19.6	30.3	19.9	22.3	19.3	20.6	26.4	18.5	14.0	17.3	8.8	23.6	35.4	27.4	26.3	26.1	10.0	10.3	9.7	11.6	10.6	10.4	9.9	9.7	11.0	9.9	9.5	11.8	110.8	64.1	68.9	6.2	80.4	111.1	145.2	298.5	50.7	48.0	65.8	95.1	59.8	67.2	145.0	66.2	16.7	406.6	83.6	72.4	144.8	286.2	118.0	95.4	78.8	115.9	98.3	78.7	20.8	227.3	341.0	101.3	61.2	75.9	35.4	109.6	85.6	158.1	222.6	58.9	20.9	96.9	187.2	92.7	70.3	22.8	100.6	94.1	76.5	15.9	184.1	68.4	87.6	17.1	23.4	252.0	76.6	91.4	141.7	186.0	108.5	221.7	126.8	50.4	92.1	66.8	291.4	224.4	144.0	80.4	111.5	442.1	81.4	123.9	111.7	178.9
PSMB3	"HC10-II, MGC4147"	ENSG00000277791	"Proteasome 20S subunit beta 3"	P49720	17	38752741-38764225	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042775, HPA048147"	Approved					NA	NA		25000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA042775: AB_2678158, HPA048147: AB_2680285"	"unprognostic (1.86e-1)"	"unprognostic (4.84e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.80e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.14e-3)"	"unprognostic (5.46e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (1.71e-6)"	"unprognostic (4.44e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.42e-3)"	"unprognostic (6.03e-2)"	95.7	139.3	65.9	95.7	70.8	138.7	92.9	68.2	76.1	83.0	67.4	105.6	82.5	90.6	101.8	110.9	81.4	73.0	154.2	74.4	80.3	120.7	187.3	101.8	137.0	70.0	73.2	59.3	78.1	86.2	81.4	90.9	70.6	85.6	106.1	42.4	84.1	66.6	201.7	99.0	90.3	92.7	69.4	122.0	93.8	53.2	76.1	106.3	87.6	119.5	132.5	102.8	83.0	80.1	246.1	457.3	168.8	277.2	180.9	158.6	237.1	167.6	265.8	563.8	489.1	486.3	324.1	279.5	276.3	228.8	371.1	401.6	279.3	294.3	301.1	373.6	500.2	184.2	226.6	562.5	96.5	289.3	278.1	151.0	184.6	393.5	131.1	132.9	289.3	283.1	301.2	320.4	246.2	319.6	461.1	457.0	250.6	278.8	328.3	261.1	383.3	446.2	312.1	253.4	216.8	145.7	191.8	157.3	201.3	243.8	360.1	356.6	173.1	138.0	269.5	308.9	421.1	202.1	367.2	397.7	285.2	294.8	242.0	227.2	323.7	150.4	176.6	271.4	118.1	148.5	145.2	154.4	274.5	114.6	93.0	94.9	569.6	142.8	209.6	352.6	176.1	372.0	65.9	70.8	68.2	76.1	74.4	80.3	70.0	73.2	70.6	69.4	76.1	80.1	146.2	76.9	124.5	8.8	142.0	199.6	203.6	517.8	79.1	66.7	100.9	105.8	328.0	104.4	281.6	176.6	25.0	434.0	141.4	215.0	406.9	362.1	51.5	140.6	123.8	185.5	133.4	156.4	8.6	497.7	428.3	160.8	100.9	117.7	154.0	110.0	118.9	247.6	416.7	30.3	7.8	207.1	368.2	161.5	266.5	48.2	149.5	231.8	200.9	7.5	309.8	167.5	179.2	3.0	12.6	401.0	242.9	145.9	205.1	189.9	219.9	642.6	274.9	72.2	124.9	110.2	507.6	152.2	76.7	114.0	201.5	504.2	154.0	186.7	224.7	239.9
PSMB6	"DELTA, Y"	ENSG00000142507	"Proteasome 20S subunit beta 6"	P28072	17	4796144-4798502	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023312, HPA063656"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		1400000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA023312: AB_1855828, HPA063656: AB_2685078"	"unprognostic (2.71e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.32e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.47e-2)"	"prognostic unfavorable (5.93e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.27e-2)"	"unprognostic (5.66e-2)"	92.7	107.8	130.1	82.2	133.7	126.9	107.0	138.1	141.2	92.6	137.4	116.3	76.9	101.9	150.9	140.6	99.2	68.3	201.6	132.8	138.1	134.8	184.6	86.2	90.1	135.7	134.1	63.7	99.3	173.3	82.5	119.8	138.7	84.8	118.3	62.6	100.0	114.2	358.6	114.9	77.0	135.3	136.0	90.4	103.8	76.6	133.5	147.4	88.7	339.5	140.5	110.6	89.2	140.3	279.8	478.2	251.6	216.4	209.9	188.1	289.7	144.1	300.1	431.3	336.0	358.7	220.5	215.0	277.9	348.1	246.5	273.8	388.0	404.4	418.0	281.9	409.7	128.0	315.3	422.7	242.0	133.5	194.4	178.3	305.1	377.4	355.7	241.5	426.5	335.8	199.4	316.6	336.1	331.8	237.4	221.8	214.1	356.2	328.2	261.9	178.7	284.6	326.6	185.3	146.9	179.9	206.6	158.9	148.6	261.4	194.5	147.2	205.1	210.8	158.9	286.4	355.2	130.8	191.8	132.9	301.3	242.1	259.3	410.6	603.3	343.2	347.5	589.9	355.9	668.6	373.1	384.0	624.9	640.8	319.8	329.3	210.5	424.4	549.4	585.5	556.2	817.2	130.1	133.7	138.1	141.2	132.8	138.1	135.7	134.1	138.7	136.0	133.5	140.3	156.3	134.6	113.3	8.5	118.3	229.2	184.1	410.8	112.1	65.5	124.6	153.4	454.8	141.5	253.9	134.3	16.7	587.3	142.8	178.0	358.1	321.6	245.2	110.9	108.1	164.7	148.4	183.7	7.6	349.9	418.2	171.5	105.5	116.0	105.2	156.1	99.6	235.4	346.3	32.0	7.2	173.0	311.3	111.7	272.1	52.9	109.6	159.8	236.5	4.7	298.9	183.4	109.2	9.0	16.9	351.3	163.4	123.0	244.7	191.7	188.6	564.6	193.3	81.3	111.7	119.8	486.8	175.1	84.7	178.6	277.2	664.5	125.9	172.6	177.7	217.3
PSMB9	"beta1i, LMP2, PSMB6i, RING12"	ENSG00000240065	"Proteasome 20S subunit beta 9"	P28065	6	32844136-32859851	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 160.9"	"Cell type enhanced"	"Detected in many"		"monocytes: 323.0;NK-cells: 495.4;Proximal enterocytes: 318.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 27.7;Daudi: 40.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015180, HPA042818, HPA053280"	Enhanced		Supported	Cytosol		NA	NA		340000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB015180: AB_2172368, HPA042818: AB_2678186, HPA053280: AB_2682098"	"unprognostic (1.09e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.18e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.68e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.87e-3)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (2.65e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.96e-3)"	"unprognostic (5.99e-2)"	47.0	31.1	4.8	18.4	4.9	6.9	41.4	4.3	5.5	28.8	2.6	38.4	10.2	26.8	2.3	25.7	25.9	4.7	31.6	4.8	5.6	36.3	37.4	60.2	26.2	7.6	4.9	18.1	12.1	1.5	14.0	3.4	5.9	26.5	8.7	1.3	20.3	5.0	11.9	27.7	78.1	5.7	5.7	160.9	26.5	4.9	5.1	15.0	28.7	3.8	22.2	23.6	30.8	5.8	5.5	0.3	0.0	0.2	3.4	8.5	3.0	0.7	11.5	17.3	27.7	0.0	3.1	40.8	1.3	2.9	14.3	10.0	0.2	5.8	2.6	9.3	0.1	17.6	0.7	0.8	17.3	1.8	2.2	2.1	0.3	7.0	1.0	3.3	2.7	10.1	1.4	12.8	1.9	1.0	16.1	8.0	0.0	0.0	0.8	19.0	1.2	7.4	2.1	2.5	0.0	0.0	1.0	2.1	10.7	0.0	4.4	10.3	0.0	2.5	1.6	14.7	1.2	11.3	23.9	9.3	7.5	6.8	4.0	92.7	30.3	75.6	56.1	55.8	45.9	59.7	45.1	55.9	26.6	45.3	41.0	49.6	96.3	61.5	60.9	20.5	61.0	46.2	4.8	4.9	4.3	5.5	4.8	5.6	7.6	4.9	5.9	5.7	5.1	5.8	258.6	41.7	51.1	1.3	197.2	72.5	37.4	155.6	30.1	2.4	25.3	47.0	7.3	50.1	64.8	25.8	0.0	1.5	216.2	88.0	19.6	116.6	1.3	28.9	47.5	146.5	33.5	29.9	0.0	115.6	6.6	45.1	34.1	42.6	77.3	20.0	119.6	26.6	117.2	0.0	0.1	148.0	99.7	126.8	155.7	2.1	29.2	145.2	35.6	8.4	323.0	22.7	495.4	0.5	8.3	67.8	150.3	15.8	136.1	40.4	318.5	40.5	133.7	1.7	32.9	23.1	50.8	1.5	7.4	21.0	58.7	1.4	241.8	45.3	110.6	39.1
PSMC2	"MSS1, Nbla10058, S7"	ENSG00000161057	"Proteasome 26S subunit, ATPase 2"	P35998	7	103328570-103370346	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 231.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019238, HPA049621"	Supported		Supported	"Cytosol,Cytoplasmic bodies"		NA	NA		190000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Cytosol, Cytoplasmic bodies"		"HPA019238: AB_1855834, HPA049621: AB_2680833"	"unprognostic (4.00e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.57e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.08e-2)"	"unprognostic (6.08e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.71e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.41e-1)"	34.1	33.6	19.6	31.7	21.6	32.0	25.6	23.7	29.5	26.2	24.3	26.2	25.2	23.5	27.8	27.2	23.1	22.0	35.9	20.5	22.9	39.9	54.2	23.5	29.6	22.5	21.0	21.2	16.5	41.4	16.1	30.9	22.3	27.1	22.8	22.3	23.8	26.4	87.2	27.6	24.5	29.6	24.3	22.4	29.5	25.8	21.7	42.4	29.2	77.1	33.5	34.3	17.7	24.8	133.5	78.3	84.4	98.2	93.0	69.7	58.5	102.5	97.9	123.7	122.7	92.7	97.3	100.1	199.2	94.7	168.1	71.0	109.2	76.6	128.7	153.3	68.0	90.5	57.9	57.8	65.2	149.0	84.9	55.3	50.2	122.5	38.9	60.9	89.8	70.4	190.1	98.2	104.2	135.8	165.0	74.2	98.7	109.6	95.2	73.8	108.4	93.8	80.6	64.2	65.3	64.9	97.6	123.9	89.6	92.9	56.6	73.3	91.5	80.9	106.6	174.6	153.8	98.9	274.8	191.3	118.1	143.7	138.5	140.0	53.4	52.7	44.7	81.6	51.5	47.5	51.1	47.9	75.3	40.6	46.3	47.3	7.3	58.4	98.2	42.3	93.3	74.2	19.6	21.6	23.7	29.5	20.5	22.9	22.5	21.0	22.3	24.3	21.7	24.8	36.2	48.1	29.5	18.3	33.8	39.8	41.4	131.8	24.5	36.0	23.5	27.2	61.8	40.0	73.9	27.6	14.6	172.2	34.4	22.5	66.5	113.9	118.9	32.3	33.9	48.5	8.4	64.6	27.9	96.4	110.6	49.7	27.5	24.9	56.4	35.5	34.2	48.5	134.6	26.9	25.1	36.9	93.6	48.5	40.4	33.2	58.4	46.1	32.0	15.9	62.4	69.5	40.2	21.1	32.8	87.3	38.5	64.3	45.0	34.7	36.9	88.8	52.5	49.1	59.2	43.7	105.2	96.3	47.2	23.6	42.9	231.8	39.5	49.1	32.0	42.9
PSMC6	p42	ENSG00000100519	"Proteasome 26S subunit, ATPase 6"	P62333	14	52707178-52728590	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042823	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		300000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA042823: AB_2678188"	"unprognostic (2.38e-2)"	"unprognostic (2.72e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.14e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.13e-2)"	"unprognostic (4.67e-1)"	43.4	48.4	38.8	47.3	39.2	44.1	58.1	41.2	54.0	44.0	37.4	52.2	50.0	47.6	49.2	65.1	49.2	36.5	78.7	39.8	42.1	65.9	87.1	39.6	55.4	41.1	41.0	51.0	43.7	59.9	5.5	54.9	42.0	45.3	54.3	60.1	37.9	45.6	118.1	44.6	46.6	56.8	41.5	38.8	46.5	31.4	41.0	56.3	54.3	106.7	67.0	57.2	7.9	44.1	182.0	115.0	135.4	99.0	92.4	95.8	146.0	139.3	133.1	220.8	165.1	142.6	143.5	156.8	169.8	121.6	111.5	134.0	173.9	121.9	230.6	151.2	74.5	115.0	91.3	153.5	111.0	164.9	106.8	71.8	118.4	112.1	111.6	120.1	141.2	77.4	174.2	64.7	161.8	163.2	129.5	111.8	108.7	170.1	153.8	108.4	237.2	70.7	144.6	178.5	96.0	71.2	123.8	76.5	122.3	120.8	156.4	117.0	108.9	121.2	171.0	95.8	145.2	45.6	127.0	175.8	79.1	110.5	112.9	77.5	62.4	67.0	51.2	71.9	59.5	63.4	62.7	56.4	73.9	56.4	59.6	59.0	52.7	55.6	73.0	38.5	85.4	75.4	38.8	39.2	41.2	54.0	39.8	42.1	41.1	41.0	42.0	41.5	41.0	44.1	81.2	70.5	58.9	23.5	74.2	86.2	141.9	187.1	50.1	65.5	55.3	51.3	76.6	62.9	140.6	57.0	68.8	162.2	69.4	73.5	135.0	131.0	30.4	92.8	75.3	78.2	70.4	85.2	37.4	106.9	139.9	72.1	38.7	96.3	67.7	68.7	50.0	84.4	92.1	62.2	39.0	58.9	109.9	71.3	67.9	19.9	67.1	61.4	80.0	20.6	90.9	64.6	52.5	38.2	46.7	116.2	46.2	65.5	64.0	85.2	72.5	140.2	116.4	107.6	72.3	66.5	130.6	63.4	82.8	48.9	72.0	237.5	65.0	79.7	73.4	116.6
PSMD11	"MGC3844, p44.5, Rpn6, S9"	ENSG00000108671	"Proteasome 26S subunit, non-ATPase 11"	O00231	17	32444379-32483319	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 308.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042275, HPA067433"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		95000	"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA042275: AB_10794793, HPA067433: AB_2685838"	"unprognostic (1.16e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (6.33e-6)"	"unprognostic (2.64e-2)"	"unprognostic (3.97e-1)"	"unprognostic (8.10e-2)"	"unprognostic (5.88e-2)"	"unprognostic (9.17e-3)"	"prognostic unfavorable (5.73e-6)"	"unprognostic (9.39e-3)"	"unprognostic (6.65e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.17e-2)"	26.9	26.5	25.6	29.4	26.4	34.5	22.6	24.6	29.5	22.8	20.3	27.3	27.2	28.8	23.1	36.3	21.8	22.7	37.0	26.0	25.6	30.1	37.7	24.3	30.2	27.0	25.3	20.6	25.9	35.0	18.5	34.1	28.1	25.0	32.0	23.8	23.3	21.8	96.0	33.8	23.2	35.0	24.4	24.0	22.9	34.2	25.9	38.4	21.6	58.6	39.1	34.0	24.8	31.2	127.0	136.8	98.4	106.2	65.4	48.4	103.8	71.5	90.0	151.9	122.0	139.9	111.5	99.1	110.7	77.0	145.9	143.0	114.5	98.5	147.8	50.9	81.2	81.0	68.7	108.3	63.3	95.5	81.6	43.7	51.0	134.3	91.8	49.0	108.7	87.0	155.5	110.9	90.8	78.0	143.1	57.4	134.5	67.4	68.8	89.2	127.2	132.4	75.2	92.2	86.3	58.8	89.8	63.4	71.0	100.3	154.2	45.1	77.8	84.3	99.5	105.6	166.5	62.2	105.0	129.1	122.5	74.8	145.2	48.3	41.2	26.7	40.2	41.8	44.2	36.3	39.1	40.6	46.6	34.2	34.5	36.4	19.1	47.7	45.6	38.2	51.5	45.6	25.6	26.4	24.6	29.5	26.0	25.6	27.0	25.3	28.1	24.4	25.9	31.2	62.7	48.1	31.5	36.6	56.3	126.9	108.7	116.3	44.9	44.5	47.8	40.8	71.9	41.5	78.0	25.8	31.3	178.2	57.8	87.5	80.3	117.8	205.4	45.8	46.2	69.7	48.8	100.8	36.0	107.3	146.1	63.8	43.8	59.9	45.7	79.8	55.3	107.0	92.3	37.0	36.4	58.7	77.3	48.4	72.6	48.0	49.0	61.1	26.6	15.9	77.5	63.1	40.2	33.2	55.6	117.2	48.0	48.5	79.3	131.9	66.4	120.6	52.6	43.3	52.6	68.0	189.7	152.7	98.4	85.3	117.5	308.9	54.8	52.0	67.6	109.5
PSMD12	"p55, Rpn5"	ENSG00000197170	"Proteasome 26S subunit, non-ATPase 12"	O00232	17	67337916-67366605	"Disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023119	Approved		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA		73000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Microtubules	"Nucleoplasm, Cytosol"	"HPA023119: AB_1855845"	"unprognostic (6.06e-2)"	"unprognostic (3.16e-2)"	"prognostic favorable (4.39e-4)"	"unprognostic (1.35e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.97e-3)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.28e-2)"	"unprognostic (3.72e-2)"	"prognostic favorable (6.32e-4)"	"unprognostic (2.63e-1)"	"unprognostic (7.32e-3)"	"prognostic unfavorable (4.73e-6)"	"unprognostic (1.52e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-1)"	14.8	13.9	11.2	11.4	12.2	12.5	11.9	15.0	19.4	9.4	9.7	10.4	8.2	10.5	10.9	12.5	7.6	9.7	13.7	12.6	17.2	14.9	28.0	9.4	10.8	17.8	17.8	9.1	15.6	14.8	7.6	11.0	18.9	10.7	11.6	8.9	10.0	7.7	35.8	10.3	8.7	11.3	12.9	9.4	11.2	14.4	16.0	12.1	10.3	29.1	15.1	14.7	8.0	12.5	63.8	38.5	29.2	32.2	21.9	26.3	40.6	44.2	27.9	47.8	42.0	40.4	27.4	36.6	28.0	35.9	37.4	37.0	51.1	45.1	70.7	17.8	38.5	43.2	29.9	41.1	28.6	44.7	25.0	29.6	29.4	45.3	35.2	21.2	47.6	27.8	57.4	21.0	45.0	43.5	41.0	42.6	35.7	30.0	50.1	20.9	75.6	32.5	36.1	52.0	28.0	40.6	32.9	62.6	45.2	34.1	45.0	36.9	49.5	50.5	34.4	38.6	81.4	21.4	35.2	30.5	59.8	46.5	29.9	14.0	9.9	8.9	8.7	16.7	12.3	8.0	11.5	9.9	10.3	8.9	10.1	10.7	7.3	10.9	19.6	7.0	12.1	8.7	11.2	12.2	15.0	19.4	12.6	17.2	17.8	17.8	18.9	12.9	16.0	12.5	59.6	48.1	58.8	9.8	37.9	112.3	119.5	109.0	43.3	40.8	37.9	33.0	108.1	25.8	97.7	46.0	25.0	88.3	47.9	29.7	70.5	80.7	158.1	99.1	62.3	73.8	32.9	67.3	21.0	78.7	88.8	64.0	33.1	125.3	50.6	39.9	41.0	84.1	56.0	92.5	22.0	28.6	65.1	44.7	90.6	197.0	46.3	50.6	48.0	10.3	59.8	58.6	37.0	14.6	15.0	84.9	22.7	44.0	58.2	93.4	26.0	77.2	68.1	44.6	26.3	78.6	146.8	126.2	108.0	52.9	94.8	123.0	53.8	53.8	34.1	123.2
PSMD14	"pad1, POH1, Rpn11"	ENSG00000115233	"Proteasome 26S subunit, non-ATPase 14"	O00487	2	161308425-161411717	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002114, HPA003828"	Approved		Supported	Nucleoplasm		NA	NA		26000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA002114: AB_1855850, HPA003828: AB_2667057"	"unprognostic (3.50e-3)"	"unprognostic (1.48e-1)"	"unprognostic (9.61e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.61e-3)"	"prognostic unfavorable (2.66e-8)"	"unprognostic (3.11e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.90e-3)"	"unprognostic (9.84e-3)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (3.10e-6)"	"unprognostic (2.86e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.66e-1)"	35.2	38.3	38.6	39.7	40.0	38.8	36.4	42.5	47.5	26.2	36.7	35.2	29.1	24.7	30.1	40.7	27.3	23.7	44.6	40.7	43.3	44.4	48.4	26.9	37.8	42.1	41.7	14.5	25.6	51.1	21.4	42.0	43.7	31.0	41.0	37.9	20.8	29.9	98.0	33.2	26.4	39.6	43.8	22.9	27.2	38.7	41.1	49.7	34.7	76.0	52.0	42.5	19.6	46.6	170.3	145.8	158.8	140.8	113.9	97.0	194.2	173.6	168.2	246.1	198.6	216.2	140.2	200.2	258.0	128.7	144.3	126.5	176.8	185.6	244.6	210.3	133.1	200.8	110.8	245.9	139.7	196.7	113.8	74.4	138.8	277.4	256.8	94.0	185.5	117.1	222.1	139.6	207.7	164.1	145.0	148.0	220.5	124.3	218.2	123.6	154.4	196.0	218.6	145.0	138.4	101.3	117.8	131.7	167.5	131.4	90.2	124.3	147.2	162.7	152.4	111.6	193.8	82.5	242.7	186.7	174.1	129.6	182.2	47.4	48.2	25.2	65.3	69.6	68.7	64.2	69.4	71.0	75.4	57.4	55.4	66.5	4.9	70.2	56.2	74.5	83.7	73.3	38.6	40.0	42.5	47.5	40.7	43.3	42.1	41.7	43.7	43.8	41.1	46.6	40.1	51.3	38.2	35.3	49.4	49.5	48.1	146.8	25.0	43.7	40.2	36.2	89.8	52.9	80.3	23.9	18.8	159.5	60.4	47.7	90.1	124.3	82.5	52.4	51.8	49.9	52.5	56.2	64.0	118.3	154.6	48.1	29.6	58.4	51.2	59.0	31.8	125.3	104.7	47.1	56.1	53.5	118.0	41.1	40.0	36.0	27.7	46.1	48.0	25.3	61.1	87.7	44.3	50.3	64.6	155.0	48.0	34.3	60.2	57.0	36.5	106.1	55.4	60.6	32.9	36.6	64.5	137.0	77.7	34.3	56.0	220.3	47.8	63.6	64.5	50.8
PSMD7	"MOV34, P40, Rpn8, S12"	ENSG00000103035	"Proteasome 26S subunit, non-ATPase 7"	P51665	16	74296814-74306288	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 596.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019379, HPA049824, HPA056069"	Enhanced		Enhanced	Nucleoplasm		NA	NA		190000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB019379: , HPA049824: AB_2680899, HPA056069: AB_2683025"	"unprognostic (4.75e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.95e-2)"	"unprognostic (7.62e-2)"	"prognostic unfavorable (6.64e-5)"	"prognostic unfavorable (7.71e-6)"	"unprognostic (1.97e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.91e-2)"	"unprognostic (9.34e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.06e-3)"	"unprognostic (7.04e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-2)"	68.9	78.8	51.6	52.1	52.9	126.7	57.5	54.5	69.3	50.1	50.9	75.8	47.3	59.5	59.3	85.8	44.0	41.2	124.8	53.0	54.2	57.3	75.1	52.6	62.3	54.3	54.1	37.8	49.0	49.0	41.7	70.2	55.6	68.3	65.4	47.3	59.7	59.2	265.8	85.5	55.6	62.4	54.3	56.5	58.0	42.0	55.0	71.9	42.0	159.5	71.2	73.1	62.2	56.7	140.1	226.2	170.6	89.0	120.1	122.1	209.8	191.6	166.2	236.2	212.7	301.9	189.8	190.1	207.7	156.7	103.2	176.3	135.0	175.1	215.4	113.3	146.3	147.2	169.1	235.9	156.0	241.3	241.3	112.4	176.3	213.4	213.0	106.0	207.0	119.2	222.2	82.1	153.5	345.4	147.0	232.1	184.9	145.0	113.8	198.8	106.9	251.6	125.1	207.3	106.9	119.3	185.7	70.4	114.9	130.5	148.7	166.6	187.5	137.5	116.0	152.5	146.5	174.6	241.4	560.2	186.6	174.1	145.2	152.4	163.6	193.4	133.2	176.2	130.5	149.7	131.8	141.2	201.9	110.5	126.6	131.2	98.7	139.5	187.4	172.2	168.2	187.8	51.6	52.9	54.5	69.3	53.0	54.2	54.3	54.1	55.6	54.3	55.0	56.7	74.4	67.3	59.4	16.6	84.2	104.4	183.5	167.8	64.3	59.6	47.0	47.5	53.3	57.2	114.9	46.0	8.4	337.1	69.5	120.4	80.3	158.5	153.8	76.3	80.6	96.2	85.5	121.0	22.7	190.9	229.8	87.7	67.8	80.3	103.9	76.7	66.0	147.6	188.5	57.2	21.3	100.1	122.1	75.1	91.2	25.3	56.5	95.1	99.6	9.4	119.5	86.0	81.4	15.6	25.7	164.0	104.1	65.5	121.4	259.6	93.9	109.4	88.1	59.9	92.1	68.4	186.1	184.2	88.7	103.6	129.3	596.1	86.2	114.0	110.3	197.8
PSME3	"Ki, PA28-gamma, PA28G, REG-GAMMA"	ENSG00000131467	"Proteasome activator subunit 3"	P61289	17	42824385-42843760	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 253.8;Late spermatids: 143.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008388, HPA012510"	Supported		Enhanced	Nucleoplasm		NA	NA		460000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"CAB008388: AB_592552, HPA012510: AB_1855752"	"unprognostic (4.22e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.30e-3)"	"prognostic unfavorable (5.41e-5)"	"unprognostic (6.02e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.17e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.41e-3)"	"unprognostic (1.02e-1)"	46.9	45.2	27.9	43.4	29.1	51.7	40.3	27.9	32.1	32.6	27.0	43.6	38.0	39.8	28.1	67.3	33.8	29.3	52.0	30.2	29.7	49.7	41.8	36.2	49.2	28.2	35.0	25.4	43.8	49.9	25.2	36.2	29.2	31.2	45.3	34.6	42.1	35.7	80.8	50.7	39.6	41.6	27.9	37.5	46.7	46.4	30.6	43.1	39.5	50.1	57.8	61.9	39.0	26.7	153.1	211.4	124.3	125.3	97.6	101.7	158.6	199.6	134.3	238.7	168.6	180.7	116.5	224.8	137.0	155.3	134.9	142.1	186.2	180.9	268.2	114.6	159.0	131.1	114.8	151.1	111.0	306.1	139.6	97.4	116.1	187.5	175.8	66.3	140.4	123.8	220.7	75.3	154.4	75.8	268.0	101.1	166.0	227.8	114.1	171.4	228.0	173.8	115.4	217.8	140.4	139.5	113.5	92.2	140.6	174.1	193.2	111.0	131.2	187.0	132.9	156.0	259.8	119.7	217.5	316.3	133.6	156.9	181.9	52.0	78.1	73.6	55.2	86.6	59.6	51.4	44.2	54.4	75.7	49.4	41.5	47.6	101.5	66.3	74.9	41.6	59.4	87.5	27.9	29.1	27.9	32.1	30.2	29.7	28.2	35.0	29.2	27.9	30.6	26.7	15.1	19.2	19.3	5.9	29.2	30.2	38.1	34.6	35.3	13.2	26.9	18.4	35.1	22.8	28.2	29.5	14.6	43.6	21.2	31.1	27.4	58.7	253.8	24.4	24.5	21.1	24.7	30.3	10.5	52.9	71.4	21.6	31.6	31.1	22.2	19.2	18.9	28.0	49.5	13.5	10.6	25.2	44.7	30.8	21.3	143.8	15.5	29.6	16.0	4.7	42.6	17.0	24.7	11.1	7.3	63.6	26.8	19.9	38.5	58.8	28.5	43.3	23.9	18.5	19.7	17.7	35.9	43.8	41.5	49.0	47.2	76.2	22.6	25.3	30.7	52.7
PSME3IP1	"C16orf94, FAM192A, NIP30, PIP30"	ENSG00000172775	"Proteasome activator subunit 3 interacting protein 1"	Q9GZU8	16	57152466-57186116	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 82.3;Cytotrophoblasts: 56.7;Extravillous trophoblasts: 59.5;Hofbauer cells: 64.6;Syncytiotrophoblasts: 53.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054382, HPA059652"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Vesicles	"HPA054382: AB_2682469, HPA059652: AB_2684095"	"unprognostic (1.69e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.20e-3)"	"unprognostic (4.69e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.19e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.87e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.56e-3)"	48.8	50.2	80.5	72.9	93.9	151.0	66.7	85.8	99.0	52.4	83.8	75.4	67.6	54.1	64.7	63.5	54.1	47.3	59.2	78.4	89.7	66.3	62.6	57.6	94.8	91.7	87.3	54.6	55.3	76.7	65.3	56.0	87.3	64.7	87.5	75.2	55.2	50.3	79.0	90.3	76.1	52.3	87.9	93.3	62.6	96.8	85.8	85.0	71.5	66.0	96.5	53.3	56.1	103.7	119.3	148.6	163.6	109.8	70.3	86.2	153.4	138.3	102.3	166.3	107.1	141.3	122.5	179.2	150.6	105.8	84.2	155.9	114.4	137.9	167.1	80.3	92.1	125.0	141.6	148.3	101.0	154.8	170.8	86.6	134.8	158.2	127.4	101.8	121.0	134.4	170.1	56.5	110.8	88.2	169.4	143.2	105.1	88.0	111.3	205.6	236.9	174.5	113.1	96.4	116.3	133.9	250.2	105.2	92.7	113.0	87.1	105.9	120.2	122.0	102.3	90.2	103.7	133.2	113.1	228.6	125.0	109.7	119.6	170.3	78.3	124.1	47.6	93.0	46.8	83.1	45.8	44.7	90.0	77.8	47.0	49.1	107.6	57.1	123.4	62.4	69.2	68.1	80.5	93.9	85.8	99.0	78.4	89.7	91.7	87.3	87.3	87.9	85.8	103.7	16.9	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	82.3	0.0	0.0	0.0	0.0	56.7	10.2	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	59.5	16.8	0.0	0.0	0.0	0.0	0.0	0.0	64.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	53.1	1.5	0.0	0.0	0.0
PSME4	"KIAA0077, PA200"	ENSG00000068878	"Proteasome activator subunit 4"	Q14997	2	53864069-53970993	"Predicted intracellular proteins"	"Differentiation, DNA damage, DNA repair, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 59.8"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 238.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060922	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA060922: AB_2684386"	"unprognostic (2.77e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.00e-2)"	"prognostic unfavorable (8.99e-4)"	"unprognostic (7.26e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (4.84e-4)"	"unprognostic (4.76e-2)"	"unprognostic (6.67e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.80e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.89e-1)"	7.4	8.6	5.3	8.1	8.8	16.1	12.1	5.7	7.4	15.4	11.1	9.8	5.9	16.1	6.2	8.8	8.0	11.9	16.9	6.4	7.1	7.0	16.6	8.0	11.1	7.1	7.0	6.7	7.9	8.3	6.8	8.5	6.4	10.0	8.4	8.9	14.5	7.4	59.8	7.2	7.1	15.0	5.0	9.5	10.6	33.6	8.1	10.7	14.4	45.2	12.2	13.2	8.1	12.6	28.0	18.3	27.6	8.5	9.1	19.4	18.1	29.1	25.6	29.3	23.6	28.3	10.6	38.7	26.1	29.4	14.1	18.1	32.1	23.5	52.7	29.4	18.8	59.8	18.3	38.5	11.7	32.1	17.1	14.8	14.2	33.1	26.6	12.1	30.4	10.1	48.1	24.0	26.3	10.9	19.5	15.4	26.7	13.7	15.4	22.8	41.9	25.3	15.7	27.1	20.6	23.1	18.2	23.9	14.8	17.4	18.1	12.7	39.6	25.5	21.4	19.7	27.0	17.1	16.6	24.9	20.1	26.4	16.1	0.5	0.1	0.5	0.7	0.3	0.4	0.6	0.4	0.4	0.3	0.9	0.5	0.7	0.4	0.6	0.2	0.4	0.3	0.1	5.3	8.8	5.7	7.4	6.4	7.1	7.1	7.0	6.4	5.0	8.1	12.6	20.0	16.0	35.0	58.1	33.1	75.8	72.4	37.4	60.9	20.6	40.0	19.6	63.5	20.0	45.4	22.0	45.9	16.1	51.0	20.1	3.9	20.8	99.7	60.0	49.6	27.3	40.6	28.8	100.3	37.1	12.8	27.2	41.3	97.0	28.5	34.9	18.5	34.3	19.5	25.2	83.5	19.5	30.5	28.7	47.7	92.5	21.1	35.1	28.4	71.2	28.0	15.7	36.0	64.3	238.5	43.6	9.3	10.5	61.3	92.5	8.7	10.3	39.0	27.8	13.1	48.9	26.5	36.0	18.0	79.3	66.1	29.7	42.6	14.0	18.8	107.3
PSPC1	"FLJ10955, PSP1"	ENSG00000121390	"Paraspeckle component 1"	Q8WXF1	13	19674752-19783019	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 173.4;Inhibitory neurons: 164.7;Spermatocytes: 171.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038904	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA038904: AB_10673291"	"unprognostic (2.13e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.14e-3)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (1.13e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.69e-3)"	"unprognostic (3.04e-3)"	"unprognostic (2.92e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.61e-2)"	"prognostic favorable (1.46e-4)"	"unprognostic (7.72e-2)"	10.9	13.0	11.5	13.2	11.5	53.7	16.2	12.8	13.9	12.5	9.9	14.9	12.4	14.8	21.7	14.0	16.2	12.1	11.1	11.8	10.6	12.2	8.9	9.9	20.8	12.1	9.0	13.7	9.5	9.5	10.3	13.8	10.6	11.0	15.5	17.4	10.0	8.3	20.9	14.4	12.4	12.6	8.7	11.1	12.0	25.0	10.5	23.1	12.2	12.7	21.9	20.4	10.0	15.8	50.5	20.4	46.6	23.3	18.9	19.8	60.3	26.1	34.0	48.3	43.6	68.4	27.8	67.8	27.7	27.9	25.4	24.6	54.7	32.2	50.0	28.9	27.3	76.4	14.1	83.1	37.4	55.3	46.7	31.6	6.5	29.8	32.9	19.2	41.7	65.9	42.8	26.1	43.2	54.1	65.5	52.8	65.5	27.3	28.0	43.7	46.8	34.6	50.8	74.6	42.7	22.0	35.8	59.1	23.1	44.9	34.5	56.6	25.1	28.9	27.7	28.0	25.4	22.5	14.5	115.1	13.2	32.7	35.2	14.8	21.3	14.5	11.8	22.7	12.0	23.3	15.1	11.0	19.1	22.5	15.4	11.2	16.9	11.9	18.1	20.9	21.8	15.7	11.5	11.5	12.8	13.9	11.8	10.6	12.1	9.0	10.6	8.7	10.5	15.8	21.0	19.2	29.5	79.3	36.4	33.3	24.9	16.4	23.3	43.2	24.6	21.0	28.6	21.5	18.9	16.5	58.4	70.0	41.0	16.4	21.5	31.3	17.4	40.0	33.9	24.0	25.2	23.1	173.4	34.1	104.7	25.1	25.5	39.4	9.5	28.0	23.9	11.1	27.2	30.3	164.7	20.0	12.2	25.7	25.3	21.4	31.4	27.7	19.6	92.8	45.2	25.5	27.8	115.6	156.4	26.8	22.2	26.7	31.8	16.5	16.1	23.8	25.9	69.1	32.9	27.2	27.4	171.5	75.4	24.0	34.1	80.4	38.9	48.1	27.2	26.2
PSPH	PSP	ENSG00000146733	"Phosphoserine phosphatase"	P78330	7	56011051-56051604	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 107.6;Early spermatids: 149.8;Late spermatids: 211.5;Proximal tubular cells: 91.7"	"Cancer enhanced"	"Detected in all"		"glioma: 41.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020376, HPA029515"	Approved		Approved	Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA020376: AB_1855867, HPA029515: AB_10601492"	"prognostic unfavorable (2.30e-4)"	"unprognostic (7.80e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.66e-3)"	"prognostic unfavorable (2.75e-5)"	"unprognostic (1.74e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.45e-2)"	"prognostic favorable (3.77e-4)"	"unprognostic (3.78e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.90e-3)"	"unprognostic (9.05e-3)"	4.7	9.4	11.0	3.7	12.4	3.7	3.9	11.8	10.8	4.7	13.3	4.8	4.2	4.9	5.2	8.7	16.1	5.9	8.1	11.0	11.0	10.0	6.8	3.5	5.1	12.3	12.9	8.2	6.7	6.6	9.4	3.7	11.7	6.4	4.4	4.4	4.5	6.4	4.6	4.2	4.1	5.1	12.2	3.9	6.2	7.1	12.1	5.8	7.0	6.0	5.9	5.2	5.7	16.1	130.1	37.6	23.1	93.0	18.9	25.3	16.7	32.5	18.5	18.7	32.7	34.7	23.5	62.9	21.0	29.4	44.5	26.9	52.6	26.9	19.0	48.1	27.9	17.9	11.1	62.2	44.4	18.6	26.8	31.8	50.2	27.7	32.6	25.1	17.7	61.2	44.4	42.4	26.4	17.3	27.7	48.3	38.0	47.5	52.1	35.9	14.4	39.8	17.2	6.8	43.6	49.8	23.5	14.9	68.9	20.9	44.8	41.4	14.5	15.1	24.8	45.5	30.3	26.9	53.0	72.8	21.9	39.9	49.7	2.5	6.2	5.9	3.1	4.4	2.3	5.4	3.0	3.8	9.6	6.1	4.5	4.1	2.9	4.7	7.1	9.3	4.0	4.8	11.0	12.4	11.8	10.8	11.0	11.0	12.3	12.9	11.7	12.2	12.1	16.1	2.1	3.2	1.5	11.4	5.2	6.8	16.9	20.5	8.6	5.2	8.3	5.8	13.1	11.5	11.4	5.5	2.1	12.8	4.5	2.4	107.6	8.6	149.8	62.9	5.4	4.2	4.8	7.2	9.3	8.0	7.5	9.9	3.1	9.4	1.3	16.5	5.0	9.8	9.5	1.7	9.8	5.0	4.1	4.4	5.8	211.5	8.4	4.3	7.2	0.0	5.7	46.8	2.1	7.1	13.8	7.1	3.5	6.0	10.1	6.5	3.1	91.7	28.3	3.1	13.1	5.1	20.0	30.1	22.5	7.6	8.5	4.7	3.9	16.1	7.3	7.7
PSRC1	DDA3	ENSG00000134222	"Proline and serine rich coiled-coil 1"	Q6PGN9	1	109279556-109283186	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 101.5;choroid plexus: 47.9;retina: 41.6"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 30.1;Oligodendrocytes: 95.2;Peritubular cells: 44.8;Rod photoreceptor cells: 71.0"	"Cancer enriched"	"Detected in all"	4	"glioma: 50.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 12.0"	"Group enriched"	"Detected in many"	11	"dendritic cells: 5.4;granulocytes: 7.1;monocytes: 12.0"	"Low cell line specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"amygdala: 3.5;cerebral cortex: 7.7;hippocampal formation: 5.7;white matter: 3.4"	"Low region specificity"	"Detected in all"			HPA056561			Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol	Nucleoplasm	"HPA056561: AB_2683175"	"unprognostic (1.14e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.42e-3)"	"unprognostic (6.78e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.76e-2)"	"prognostic unfavorable (1.36e-9)"	"unprognostic (3.51e-2)"	"unprognostic (6.21e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (9.43e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-1)"	2.0	1.9	64.7	3.8	84.0	7.9	2.4	76.5	84.1	5.1	47.9	3.9	4.3	3.1	2.6	7.6	3.5	3.0	3.0	69.7	71.2	2.7	4.5	5.3	3.6	78.0	79.9	3.3	1.5	3.2	4.2	4.0	83.0	5.5	2.7	41.6	2.4	4.5	0.9	5.2	4.5	3.9	67.9	3.9	3.4	13.3	74.1	14.2	2.3	0.9	4.3	3.2	5.8	101.5	56.0	28.2	112.9	55.1	4.4	8.7	31.0	43.1	34.7	57.6	55.1	43.7	22.7	28.2	15.4	21.4	27.1	38.9	61.4	35.4	48.1	11.0	29.6	17.7	40.5	36.2	5.0	19.0	19.3	10.0	3.3	22.8	16.2	21.5	28.7	32.9	40.9	12.5	46.8	50.5	29.2	12.9	46.9	25.4	31.8	44.4	108.7	9.5	19.6	14.4	47.2	27.3	24.3	36.8	43.6	40.8	22.3	18.0	14.9	35.4	57.9	25.1	72.5	9.7	6.9	9.8	28.6	44.9	100.9	0.0	12.0	1.9	0.6	4.8	0.4	0.0	0.7	0.2	5.4	0.0	0.4	0.3	7.1	0.3	2.7	0.0	0.7	3.4	64.7	84.0	76.5	84.1	69.7	71.2	78.0	79.9	83.0	67.9	74.1	101.5	0.7	0.0	3.9	9.8	0.5	2.0	1.8	2.3	0.6	6.7	2.1	5.6	1.3	1.5	0.5	1.8	25.0	17.6	1.0	2.0	0.0	0.9	1.1	0.5	3.2	2.3	0.0	0.8	19.3	0.9	30.1	4.4	0.5	1.1	1.3	12.9	2.9	1.2	10.9	3.3	3.8	3.9	4.1	4.4	1.8	2.6	5.9	4.9	1.8	2.8	2.2	10.0	0.0	18.1	95.2	0.5	0.6	44.8	0.6	1.0	0.6	2.9	0.9	71.0	0.0	5.5	4.7	5.0	1.5	6.5	1.1	2.9	1.5	1.1	5.4	1.3
PTBP1	"HNRNP-I, HNRPI, pPTB, PTB, PTB-1, PTB2, PTB3, PTB4"	ENSG00000011304	"Polypyrimidine tract binding protein 1"	P26599	19	797075-812327	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013507	Supported		Supported	Nucleoplasm		NA	NA		4500000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB013507: AB_2533082"	"unprognostic (2.82e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.01e-2)"	"unprognostic (6.22e-2)"	"prognostic unfavorable (2.71e-4)"	"unprognostic (4.06e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.47e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.41e-2)"	"unprognostic (7.91e-3)"	"unprognostic (4.28e-2)"	"unprognostic (8.31e-2)"	"unprognostic (3.72e-2)"	101.5	84.7	29.9	104.7	33.4	138.2	94.9	33.5	34.9	92.7	51.7	95.9	91.4	90.5	48.9	137.7	86.9	54.0	64.7	29.9	33.6	111.8	123.5	102.3	90.1	38.1	35.5	99.5	100.8	66.4	80.9	79.0	36.7	86.3	56.0	11.8	90.7	45.6	35.2	123.8	96.6	49.7	34.4	117.2	86.0	45.5	36.2	91.9	98.0	19.7	79.2	80.3	101.5	34.8	517.8	377.1	242.8	224.3	70.1	90.3	385.1	299.7	128.8	230.2	169.2	394.1	243.6	428.0	192.5	188.9	88.0	299.8	342.7	260.0	239.3	433.8	361.2	352.9	362.6	429.8	141.8	479.4	355.1	83.5	179.0	265.5	164.2	84.4	232.2	201.3	523.0	223.0	385.6	434.8	610.4	258.5	446.4	190.2	245.2	648.8	182.0	254.2	140.4	467.5	272.9	317.4	358.4	213.4	174.8	168.5	228.9	286.4	335.4	247.5	286.9	306.0	557.4	238.0	500.7	591.2	153.2	357.7	307.9	12.9	32.5	23.1	31.8	38.6	32.3	23.7	26.3	30.0	36.0	23.7	25.1	26.2	13.4	33.5	36.7	22.3	29.1	38.3	29.9	33.4	33.5	34.9	29.9	33.6	38.1	35.5	36.7	34.4	36.2	34.8	99.8	41.7	66.9	11.8	88.7	76.7	91.8	47.0	84.8	19.6	114.5	91.9	39.1	82.9	44.3	47.8	35.5	116.5	96.1	134.3	35.2	73.3	22.3	62.2	62.2	92.1	101.1	87.7	12.4	87.5	172.7	70.4	70.3	80.5	90.8	92.0	74.6	87.9	78.7	33.7	12.1	145.0	36.7	60.6	62.7	20.6	79.9	75.1	39.2	20.6	59.8	29.9	59.8	10.1	12.9	99.4	107.5	65.8	90.0	90.5	89.9	46.9	49.9	21.3	59.2	74.8	71.1	40.5	54.3	97.2	82.0	133.4	89.7	68.7	144.9	100.7
PTDSS1	"KIAA0024, PSS1, PSSA"	ENSG00000156471	"Phosphatidylserine synthase 1"	P48651	8	96261902-96336995	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 10.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016852	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	"Endoplasmic reticulum"	Nucleoplasm	"HPA016852: AB_1855878"	"unprognostic (1.44e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.89e-3)"	"unprognostic (7.48e-2)"	"unprognostic (5.68e-3)"	"prognostic unfavorable (1.08e-5)"	"prognostic unfavorable (9.83e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.29e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.55e-2)"	1.6	2.2	1.6	3.4	2.0	4.9	3.1	1.2	2.6	3.5	0.8	3.4	4.1	2.1	2.8	3.7	2.5	3.1	7.2	1.8	1.0	3.7	4.6	2.6	5.6	0.5	0.6	3.6	2.7	8.0	0.6	4.6	1.3	1.9	2.9	0.9	2.0	3.5	2.9	3.2	3.2	3.6	0.2	2.6	1.4	1.9	2.0	3.6	4.5	3.0	5.2	2.6	1.1	1.4	14.9	11.6	2.0	5.5	4.2	8.5	3.4	10.6	15.5	10.6	7.5	4.6	4.2	24.9	9.5	10.5	2.1	6.0	14.1	11.1	16.1	12.5	10.3	24.5	19.8	2.5	4.3	17.8	8.1	7.2	10.9	14.4	10.2	2.7	7.0	7.6	12.5	12.3	9.7	4.4	14.0	3.0	3.1	5.1	11.1	10.9	10.1	18.8	5.7	12.5	8.6	3.5	3.9	3.4	1.4	2.3	8.2	6.3	11.8	9.1	5.5	6.3	12.3	2.5	13.3	11.8	5.7	19.3	7.5	10.5	2.6	1.5	1.7	1.6	2.5	1.7	2.8	2.2	4.0	2.2	2.5	1.8	0.9	3.2	1.7	1.2	1.7	6.7	1.6	2.0	1.2	2.6	1.8	1.0	0.5	0.6	1.3	0.2	2.0	1.4	12.4	19.2	9.1	8.8	50.5	31.6	18.9	22.6	42.7	10.2	22.9	18.4	94.5	14.3	15.6	11.0	10.4	78.4	23.6	11.9	1.9	20.5	60.1	6.6	9.1	22.9	5.4	38.3	29.3	44.9	54.1	18.0	14.8	9.3	32.4	17.6	34.2	32.1	45.9	5.0	29.2	17.1	10.2	45.3	31.5	52.2	23.3	36.0	19.6	15.9	39.3	4.7	29.9	21.1	8.7	23.9	11.9	25.9	45.5	21.4	16.6	19.0	5.2	4.7	0.0	13.8	15.8	12.1	18.8	33.1	33.5	80.9	34.3	14.6	34.8	16.3
PTGES2	"C9orf15, FLJ14038"	ENSG00000148334	"Prostaglandin E synthase 2"	Q9H7Z7	9	128120693-128128462	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Cardiomyocytes: 700.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020631, HPA020733"	Approved		Approved	Mitochondria		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA020631: AB_1855887, HPA020733: AB_2670508"	"unprognostic (1.23e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.33e-2)"	"prognostic favorable (5.83e-7)"	"unprognostic (2.10e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-1)"	18.1	49.8	31.6	15.6	33.9	6.5	16.0	29.1	45.8	18.1	32.4	30.6	27.5	21.6	4.0	35.3	17.6	11.4	95.0	35.6	33.0	36.4	37.7	14.8	17.6	31.5	31.5	16.1	37.6	35.2	41.4	9.7	32.1	24.6	9.2	10.0	26.1	16.8	117.9	20.9	23.8	7.5	27.3	21.1	29.6	14.5	31.5	11.9	23.5	78.7	9.7	22.3	22.0	31.7	46.1	114.0	15.5	54.4	13.5	12.8	47.9	30.7	20.6	48.6	24.9	86.9	75.6	43.5	45.7	15.9	36.9	108.8	22.5	47.1	6.5	28.3	62.3	21.0	92.7	79.5	41.0	42.1	39.5	18.6	32.3	39.5	26.9	14.2	31.6	47.8	50.2	26.4	16.7	130.0	56.9	75.6	42.7	58.7	113.9	39.6	26.5	111.6	32.8	33.1	69.1	45.6	47.3	86.3	34.2	6.7	78.7	23.5	34.0	46.3	50.2	62.8	63.1	48.9	25.5	38.3	39.1	33.2	44.5	1.4	3.3	0.7	3.1	3.7	3.8	3.8	2.2	3.5	4.3	2.7	2.4	3.0	0.6	2.7	1.8	5.8	3.1	1.9	31.6	33.9	29.1	45.8	35.6	33.0	31.5	31.5	32.1	27.3	31.5	31.7	18.8	16.0	6.4	10.4	32.0	22.9	38.1	32.7	25.0	37.8	34.2	36.3	700.2	51.5	25.9	23.9	20.9	82.1	30.8	86.1	146.8	74.6	2.1	12.7	20.9	29.4	45.1	13.2	15.5	51.8	62.1	32.7	46.4	17.3	14.7	31.9	13.9	37.8	57.6	37.0	15.8	62.2	46.8	25.3	43.6	4.8	30.7	30.8	56.9	3.7	105.7	21.9	38.1	12.1	7.2	57.6	60.4	21.8	45.4	68.0	93.4	99.3	9.3	44.8	19.7	17.8	37.2	3.6	45.6	48.3	24.6	66.6	25.6	84.1	105.5	52.9
PTGES3	"cPGES, p23, TEBP"	ENSG00000110958	"Prostaglandin E synthase 3"	Q15185	12	56663341-56688408	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034319, HPA038672, HPA038673"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		660000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 65: Brain - Ion transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"CAB034319: AB_2175206, HPA038672: AB_10697395, HPA038673: AB_10670786"	"prognostic unfavorable (2.15e-5)"	"unprognostic (2.60e-1)"	"unprognostic (8.67e-3)"	"unprognostic (7.07e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-3)"	"prognostic unfavorable (4.44e-6)"	"unprognostic (4.33e-3)"	"unprognostic (3.64e-2)"	"prognostic favorable (4.36e-4)"	"unprognostic (2.73e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.07e-1)"	141.7	128.0	198.0	137.2	210.0	150.2	171.2	217.0	454.6	168.2	185.5	169.9	151.7	172.9	159.0	161.3	217.6	114.9	122.8	195.5	215.6	180.5	218.6	133.9	157.2	214.9	213.0	250.0	121.9	133.7	111.7	164.9	218.5	141.6	172.8	118.0	124.0	147.6	208.6	123.5	155.4	138.8	213.0	125.0	117.1	135.0	204.3	167.2	162.3	158.5	185.0	158.7	145.8	278.0	616.6	528.8	416.5	249.8	300.2	270.3	634.3	392.8	298.5	494.5	366.9	452.5	629.6	676.0	588.5	338.3	331.7	385.4	790.0	514.2	621.8	509.8	529.8	529.7	309.5	524.4	219.4	637.9	367.2	197.0	367.3	375.1	450.3	468.5	518.1	425.7	866.0	628.2	490.4	385.3	636.5	602.1	714.7	538.3	609.3	549.2	392.3	914.4	436.8	473.2	538.4	313.8	401.7	570.1	355.8	546.5	658.3	526.9	314.0	294.7	341.8	358.3	552.8	262.8	777.5	540.4	321.1	516.7	543.8	141.1	166.1	107.1	130.9	261.6	172.3	172.3	170.6	156.7	160.2	127.0	167.3	147.7	64.7	132.2	346.2	135.3	191.6	316.1	198.0	210.0	217.0	454.6	195.5	215.6	214.9	213.0	218.5	213.0	204.3	278.0	265.8	179.5	137.1	39.5	251.0	386.6	826.7	248.5	272.6	128.3	208.5	197.1	166.0	178.7	161.4	189.4	77.2	457.2	245.6	246.5	373.7	310.4	42.5	493.7	221.5	242.1	261.3	452.0	43.4	214.8	676.3	268.7	143.2	291.3	234.2	224.5	188.8	187.0	349.9	112.7	41.3	295.9	201.4	209.5	363.6	107.9	238.9	261.7	282.8	47.8	283.3	244.1	178.2	38.7	71.4	220.8	207.1	213.3	299.8	657.6	218.9	343.8	345.5	128.0	144.7	185.1	337.7	558.4	348.4	350.4	377.6	566.0	359.3	219.0	358.9	556.3
PTRH2	"BIT1, CFAP37, CGI-147, PTH2"	ENSG00000141378	"Peptidyl-tRNA hydrolase 2"	Q9Y3E5	17	59674636-59707626	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	Apoptosis	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012897	Supported		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA012897: AB_1855949"	"unprognostic (2.26e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (6.38e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.59e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.01e-8)"	"unprognostic (5.43e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.49e-2)"	20.8	25.9	24.3	17.3	25.1	14.5	27.6	25.0	31.9	19.7	23.6	24.1	15.3	18.8	48.5	18.1	18.4	18.2	14.5	25.1	26.1	18.5	45.7	14.7	19.0	25.9	26.1	16.9	19.5	18.6	14.1	18.6	26.7	20.7	27.5	10.2	15.9	18.6	25.0	15.7	13.2	22.9	24.8	17.5	16.1	19.5	24.9	17.3	16.2	20.9	24.1	44.0	11.8	27.4	75.9	142.9	44.3	40.8	84.8	72.6	47.4	70.6	63.8	60.7	89.0	94.1	57.7	54.1	105.0	60.9	101.1	73.3	98.4	93.8	89.4	104.2	133.2	96.7	72.3	176.2	129.4	86.0	52.5	82.0	120.9	93.9	108.5	42.8	102.5	37.4	111.3	58.2	92.4	187.9	74.2	71.2	38.0	194.5	113.4	39.1	74.8	80.7	103.7	109.2	57.9	74.2	36.7	39.6	91.5	50.7	93.1	61.1	67.2	77.8	77.8	47.1	77.9	73.6	91.9	82.3	50.7	54.4	60.4	6.1	69.0	2.9	22.7	67.4	30.9	43.1	26.3	25.7	50.0	33.1	37.4	27.0	29.0	34.8	86.0	59.4	34.0	37.9	24.3	25.1	25.0	31.9	25.1	26.1	25.9	26.1	26.7	24.8	24.9	27.4	21.4	16.0	13.6	5.5	18.7	36.7	50.1	48.1	27.9	4.1	17.1	22.4	15.4	11.5	51.6	11.0	4.2	26.8	13.0	8.9	11.7	27.2	22.1	23.4	33.1	22.5	6.7	17.9	9.8	25.6	25.0	29.7	17.3	24.1	22.8	12.8	12.8	31.5	16.9	8.4	9.1	10.3	22.4	9.7	17.2	12.0	17.4	14.6	14.2	2.8	11.4	7.2	13.4	7.5	11.5	28.8	12.3	9.8	24.8	35.1	10.0	16.5	33.3	3.4	13.1	25.4	32.2	33.4	13.3	21.3	35.7	31.7	12.6	22.4	16.7	37.5
PUM1	"KIAA0099, PUMH1"	ENSG00000134644	"Pumilio RNA binding family member 1"	Q14671	1	30931506-31065991	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Translation regulation"	RNA-binding	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027424, HPA027449"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Cytosol	Nucleoplasm	"HPA027424: AB_10602918, HPA027449: AB_2672281"	"unprognostic (1.26e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.44e-2)"	"unprognostic (3.19e-3)"	"unprognostic (4.42e-2)"	"prognostic favorable (7.62e-8)"	"unprognostic (1.57e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.74e-1)"	27.8	26.0	33.4	22.5	34.3	52.0	31.9	37.5	37.8	28.0	28.5	26.7	22.5	32.2	29.3	25.7	35.0	22.7	28.6	33.7	42.5	28.7	25.9	25.6	26.2	27.0	30.0	40.3	27.5	39.3	19.2	32.4	28.0	27.3	29.4	38.4	30.3	28.0	46.1	32.7	22.6	31.6	27.8	25.7	26.3	18.4	45.5	35.1	34.9	38.3	26.1	27.1	26.0	31.5	33.7	43.7	70.4	44.7	54.1	46.5	48.2	39.3	47.9	40.3	45.5	46.0	56.6	39.3	40.2	53.8	25.2	48.2	58.3	43.4	51.4	33.2	50.8	42.8	50.7	56.0	37.9	52.6	39.2	50.0	53.3	53.5	56.1	52.8	55.6	36.9	60.0	36.1	46.5	28.1	51.6	37.8	72.2	42.0	30.2	53.1	48.0	42.3	58.7	50.0	58.0	44.0	54.5	41.7	47.6	77.6	42.1	39.3	58.5	33.2	29.8	44.7	39.7	28.8	28.3	42.5	29.7	38.3	43.0	44.1	31.3	24.8	31.0	30.3	31.7	23.9	27.5	30.3	32.0	21.1	31.0	32.0	19.6	37.9	34.5	18.5	35.9	31.0	33.4	34.3	37.5	37.8	33.7	42.5	27.0	30.0	28.0	27.8	45.5	31.5	66.6	73.7	58.8	85.2	56.9	90.2	53.8	41.2	56.3	54.6	63.2	58.7	80.7	61.5	46.3	36.8	79.2	52.6	66.4	56.4	23.5	44.0	32.2	139.8	98.0	61.5	104.7	34.3	87.0	36.4	42.4	56.8	55.0	154.6	18.3	105.1	43.2	61.0	34.0	33.7	87.5	65.6	24.4	78.3	49.8	21.5	72.1	50.4	17.8	102.1	56.6	41.6	69.0	111.6	101.7	58.1	45.0	80.5	41.7	84.6	28.8	49.2	42.7	59.2	32.9	81.6	65.5	36.4	24.4	62.9	93.6	78.0	50.5	63.6	75.8	95.5
PUS7	FLJ20485	ENSG00000091127	"Pseudouridine synthase 7"	Q96PZ0	7	105439661-105522271	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"tRNA processing"	Isomerase	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 43.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024116	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA024116: AB_1848754"	"unprognostic (3.07e-1)"	"unprognostic (1.52e-3)"	"unprognostic (9.03e-2)"	"unprognostic (4.94e-2)"	"unprognostic (8.91e-2)"	"unprognostic (7.95e-2)"	"prognostic unfavorable (4.89e-6)"	"unprognostic (2.86e-2)"	"prognostic unfavorable (7.58e-5)"	"unprognostic (1.87e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (1.03e-8)"	"unprognostic (2.76e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (6.28e-4)"	"unprognostic (4.90e-2)"	7.1	3.5	3.6	5.5	3.9	3.2	7.4	4.7	4.1	5.9	3.0	5.3	4.0	5.6	3.0	7.7	5.2	3.2	4.8	3.6	3.2	4.4	6.3	4.6	4.3	3.5	3.2	4.3	6.0	6.5	2.7	5.1	3.6	4.4	5.7	2.3	4.7	3.9	11.0	7.8	3.4	6.5	3.0	2.8	4.2	4.6	3.1	3.0	7.6	4.8	5.3	7.2	6.2	4.1	32.1	18.2	18.0	29.4	13.6	14.9	19.9	14.7	13.0	25.5	20.9	24.5	12.7	17.5	24.7	15.6	22.0	25.0	33.0	17.9	39.6	12.9	26.4	26.2	17.2	25.8	16.1	42.1	9.9	15.2	20.9	21.5	27.9	9.5	27.2	16.2	59.8	14.6	17.9	39.8	48.4	39.4	44.6	39.5	23.6	29.1	26.5	81.5	31.0	23.3	30.2	28.5	29.3	53.0	21.3	20.5	19.2	9.9	16.6	37.4	25.1	49.3	32.5	11.0	24.4	46.9	13.1	35.7	33.1	0.0	0.8	0.2	0.9	2.0	2.1	2.0	1.3	1.0	1.2	1.3	1.1	1.2	0.1	1.4	2.0	0.0	0.9	0.7	3.6	3.9	4.7	4.1	3.6	3.2	3.5	3.2	3.6	3.0	3.1	4.1	8.5	6.4	9.0	13.1	4.8	13.4	13.9	5.0	13.1	4.0	8.2	6.5	3.8	1.5	6.0	1.8	2.1	5.6	2.8	3.6	1.9	9.5	1.7	7.0	14.3	10.4	7.2	8.4	43.2	7.2	10.2	8.6	8.6	5.5	11.4	4.3	4.2	5.1	4.4	0.0	27.9	4.1	2.0	2.8	6.0	1.8	4.1	3.3	0.0	11.2	4.0	1.5	3.1	8.5	23.8	7.6	3.2	1.9	6.7	18.3	1.0	5.6	4.3	3.2	0.0	14.3	10.4	1.8	9.7	13.7	9.8	3.4	3.9	15.6	8.0	8.2
PYCR2	P5CR2	ENSG00000143811	"Pyrroline-5-carboxylate reductase 2"	Q96C36	1	225919877-225924340	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis"	Oxidoreductase	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA056873	Approved		Approved	Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	Mitochondria		"HPA056873: AB_2683263"	"unprognostic (1.11e-1)"	"unprognostic (8.08e-2)"	"prognostic unfavorable (5.02e-5)"	"unprognostic (2.91e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.20e-3)"	"unprognostic (1.56e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.07e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.42e-6)"	"unprognostic (9.69e-2)"	"unprognostic (2.61e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.16e-3)"	38.0	71.7	53.2	35.8	62.4	47.3	35.8	68.1	54.2	46.4	51.8	39.6	22.3	48.5	26.4	32.3	44.7	22.4	62.3	50.4	61.3	40.2	40.3	38.2	47.2	69.0	61.2	47.9	47.2	42.0	57.0	28.5	66.0	39.6	18.3	34.0	39.6	40.9	66.8	28.3	34.4	25.7	68.6	49.5	38.9	34.4	59.2	43.9	30.0	49.1	33.9	50.3	33.3	72.5	72.6	59.6	35.0	59.1	38.8	40.0	73.2	74.8	46.3	49.7	44.1	77.2	58.3	126.1	156.6	55.0	39.1	81.6	50.5	58.6	28.3	154.6	107.5	120.6	60.2	81.5	59.8	107.9	189.1	38.8	72.3	56.1	64.1	44.1	47.8	103.7	178.4	81.6	50.9	60.5	135.8	120.9	196.0	112.8	80.4	120.2	79.0	263.6	65.2	58.3	44.0	56.7	62.4	48.7	161.0	27.9	62.3	202.0	40.3	38.4	46.5	82.9	104.4	129.9	156.2	127.4	60.7	80.6	109.3	38.4	19.6	39.6	45.5	29.2	47.8	34.4	43.8	42.4	31.3	41.9	74.9	62.4	13.3	67.9	26.3	59.2	44.0	45.1	53.2	62.4	68.1	54.2	50.4	61.3	69.0	61.2	66.0	68.6	59.2	72.5	28.0	19.2	22.8	11.4	31.6	14.8	64.6	53.4	8.0	15.6	24.3	21.2	47.6	20.0	24.8	35.0	14.6	90.6	39.1	12.9	49.0	50.0	8.2	92.8	25.6	26.7	26.5	58.7	4.6	34.0	46.3	23.7	10.2	31.8	38.7	74.9	21.0	16.6	40.0	13.5	5.8	17.8	57.0	20.4	19.8	8.8	38.2	31.5	33.8	8.4	46.4	46.9	46.4	5.5	29.3	29.1	15.8	37.6	23.1	42.1	18.3	35.8	55.4	42.7	26.3	19.8	24.4	40.1	46.2	9.4	12.8	41.7	34.9	44.9	16.1	40.4
QRSL1	"DKFZP564C1278, FLJ10989, FLJ12189, FLJ13447, GatA"	ENSG00000130348	"Glutaminyl-tRNA amidotransferase subunit QRSL1"	Q9H0R6	6	106629578-106668417	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	Ligase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"memory B-cell: 86.4;naive B-cell: 71.0"	"Lineage enriched"	"Detected in all"	7	"B-cells: 86.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029585, HPA029587"	Approved		Approved	Vesicles,Centrosome		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	Vesicles	Centrosome	"HPA029585: AB_10599823, HPA029587: AB_10602311"	"unprognostic (1.86e-3)"	"unprognostic (5.58e-2)"	"unprognostic (6.19e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (8.36e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.46e-1)"	5.0	5.7	4.0	8.6	5.2	6.4	7.4	4.7	5.0	4.8	5.8	8.2	7.8	6.3	6.1	5.7	5.4	4.8	10.1	4.1	4.5	9.3	7.8	4.6	15.9	4.6	4.5	5.6	6.0	9.4	4.3	5.7	5.0	5.3	9.1	8.4	6.1	5.6	19.4	5.9	8.9	5.8	4.1	10.5	6.7	6.6	4.5	8.2	9.2	21.3	15.5	5.7	4.9	7.4	9.0	9.1	12.3	17.8	7.8	9.7	17.3	10.0	10.2	13.1	13.0	10.7	7.1	29.7	8.9	11.2	13.5	15.5	18.6	12.1	16.4	14.2	14.1	14.5	9.7	11.1	12.2	33.2	12.5	9.6	18.6	14.0	20.6	9.9	9.5	18.4	26.8	9.4	11.0	10.1	10.7	16.1	12.9	15.6	10.5	28.9	15.8	7.5	14.3	10.2	10.7	11.0	8.0	18.4	15.3	10.7	12.1	25.3	9.3	9.2	7.6	10.0	15.7	5.4	8.3	17.2	12.6	22.1	14.0	5.0	6.4	1.0	6.4	9.6	6.3	86.4	7.1	5.6	10.7	71.0	6.6	6.4	1.6	7.0	13.0	8.5	8.5	5.7	4.0	5.2	4.7	5.0	4.1	4.5	4.6	4.5	5.0	4.1	4.5	7.4	9.0	19.2	12.5	20.2	64.6	4.0	8.4	12.8	6.2	14.9	10.3	6.1	24.8	7.2	9.3	11.0	16.7	21.5	12.3	11.0	17.6	15.4	15.5	28.2	12.0	10.8	17.4	13.7	14.6	18.4	23.0	9.9	15.3	14.8	18.9	15.3	8.2	14.6	12.9	3.3	18.9	11.2	14.2	12.4	6.1	8.4	8.4	10.0	8.8	12.2	18.3	9.9	19.6	22.6	26.5	14.2	8.3	9.1	13.2	9.3	12.2	19.5	19.9	19.1	0.0	10.0	10.0	25.6	14.2	12.2	5.4	12.3	14.3	21.1	18.7	8.9
QSOX2	"DKFZp762A2013, QSCN6L1, SOXN"	ENSG00000165661	"Quiescin sulfhydryl oxidase 2"	Q6ZRP7	9	136206333-136245812	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012716, HPA017280"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA		9600000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA012716: AB_2173315, HPA017280: AB_2669565"	"unprognostic (7.29e-2)"	"unprognostic (7.35e-3)"	"unprognostic (6.23e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.10e-3)"	"unprognostic (4.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.06e-3)"	"unprognostic (5.96e-2)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (9.64e-6)"	"unprognostic (1.23e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.10e-2)"	7.5	7.6	7.3	11.2	7.6	15.9	5.9	12.9	8.1	7.3	5.9	6.7	5.1	8.3	10.6	5.3	8.6	4.6	7.6	7.3	7.6	7.5	8.6	7.0	17.5	7.3	7.6	9.5	18.8	8.1	32.3	4.9	6.9	6.4	5.4	12.3	5.9	3.7	5.6	11.1	11.8	6.7	6.0	15.7	7.1	10.8	8.0	8.1	11.7	3.4	14.6	6.3	5.8	7.3	14.7	35.0	28.6	38.2	15.8	19.0	35.9	18.3	20.4	34.9	31.9	26.4	31.1	22.6	29.5	24.7	64.1	46.7	34.2	26.5	28.0	33.5	17.2	12.1	59.8	29.3	22.5	36.4	17.8	15.3	26.3	34.8	41.8	15.4	25.9	23.3	29.8	59.1	18.8	25.0	13.6	24.2	34.0	44.2	22.3	24.8	37.1	37.2	12.0	13.1	30.5	23.1	28.9	22.6	15.9	18.5	16.3	21.1	15.0	42.2	30.4	35.1	42.6	20.9	29.9	49.7	28.3	18.9	40.5	0.4	0.0	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.0	1.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	7.3	7.6	12.9	8.1	7.3	7.6	7.3	7.6	6.9	6.0	8.0	7.3	8.8	9.6	7.9	13.7	17.7	5.7	2.8	2.2	1.8	24.4	2.3	2.9	4.3	0.0	4.4	5.5	18.8	1.3	5.8	1.6	1.9	3.4	6.7	5.7	7.4	6.6	16.3	14.5	10.1	4.0	2.8	5.2	4.1	5.6	1.3	7.1	2.9	4.4	2.3	5.0	11.1	3.8	0.0	3.7	8.2	7.3	5.9	3.3	0.0	8.4	4.3	2.6	4.1	6.0	10.7	3.4	0.7	7.2	5.4	7.9	0.9	2.3	9.0	8.8	6.6	9.2	4.7	19.4	24.2	1.8	11.5	1.0	5.1	7.3	3.9	3.6
R3HCC1	DKFZp564N123	ENSG00000104679	"R3H domain and coiled-coil containing 1"	Q9Y3T6	8	23270120-23296279	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 113.2;Rod photoreceptor cells: 115.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023073, HPA023153"	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol	Nucleoplasm	"HPA023073: AB_1855987, HPA023153: AB_2237834"	"unprognostic (5.80e-2)"	"unprognostic (4.70e-3)"	"prognostic favorable (4.08e-4)"	"unprognostic (7.46e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.26e-2)"	"unprognostic (8.49e-3)"	"unprognostic (1.02e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.92e-1)"	"prognostic favorable (8.66e-4)"	"unprognostic (7.65e-2)"	"prognostic favorable (6.80e-5)"	"unprognostic (1.22e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.18e-1)"	"unprognostic (3.43e-1)"	20.5	21.9	41.2	15.2	52.7	29.0	19.6	53.7	43.8	23.4	36.4	33.6	19.7	23.9	14.8	16.1	22.5	16.2	33.1	39.9	42.3	20.1	28.2	16.7	22.5	60.9	49.8	27.2	42.8	29.0	22.6	13.7	63.6	22.7	15.3	62.7	35.7	19.9	54.5	22.5	20.4	22.2	49.3	20.2	28.4	30.8	48.6	20.3	17.6	31.5	18.8	22.2	17.8	73.7	38.2	48.7	36.7	35.9	15.2	20.6	25.2	24.7	23.4	41.0	29.7	35.0	17.6	38.1	25.6	30.2	28.0	28.3	38.9	45.8	27.5	24.7	41.6	35.7	33.4	29.2	36.0	24.7	25.6	24.8	35.5	35.0	16.4	30.1	31.7	42.9	41.8	31.0	24.3	33.1	55.6	43.8	29.8	40.4	35.8	37.9	44.8	22.8	20.3	41.9	47.2	41.1	28.1	32.8	41.8	25.0	30.3	29.2	27.4	37.9	31.8	32.2	51.1	23.8	22.2	39.3	29.5	34.3	48.5	38.4	50.5	82.5	64.8	44.1	56.5	56.5	52.7	55.0	56.7	42.1	40.5	47.0	31.3	59.5	50.3	52.9	61.5	51.4	41.2	52.7	53.7	43.8	39.9	42.3	60.9	49.8	63.6	49.3	48.6	73.7	25.2	25.6	14.7	4.9	15.5	14.9	16.5	35.9	10.2	28.0	22.8	32.9	24.1	24.3	20.5	5.5	27.1	18.8	19.8	17.9	56.7	32.3	36.4	15.2	17.0	21.1	19.2	17.9	5.1	50.9	21.3	25.4	20.9	10.2	22.8	24.7	20.0	21.6	30.2	18.5	5.0	21.5	22.4	18.2	12.3	113.2	17.7	16.2	21.4	5.6	18.8	59.3	42.2	4.5	9.5	37.0	22.1	21.8	34.7	11.4	41.7	38.5	22.0	115.7	13.1	19.9	31.1	49.8	32.4	13.6	16.2	7.7	18.3	30.7	22.8	13.6
RAB14	"FBP, RAB-14"	ENSG00000119396	"RAB14, member RAS oncogene family"	P61106	9	121178133-121223014	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026419, CAB037066"	Approved		Supported	Vesicles		NA	NA		2700000	"Cluster 14: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Vesicles		"CAB037066: AB_1841128, HPA026419: AB_1855996"	"unprognostic (1.30e-3)"	"unprognostic (3.12e-2)"	"unprognostic (9.01e-2)"	"unprognostic (7.18e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.90e-2)"	"unprognostic (3.05e-2)"	"unprognostic (9.71e-3)"	"prognostic favorable (1.79e-8)"	"unprognostic (1.38e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.09e-1)"	39.0	38.7	37.5	35.6	39.7	66.5	42.1	40.3	47.7	37.8	32.6	42.8	39.9	35.6	34.2	63.2	34.0	30.7	32.4	38.4	40.9	50.0	82.8	49.2	41.1	39.6	39.9	35.9	27.6	45.8	28.9	43.1	40.5	38.8	42.4	45.5	34.6	38.1	39.4	56.4	38.9	33.4	40.8	38.3	44.3	33.8	40.2	35.2	43.8	38.9	49.5	43.9	40.8	46.8	53.8	53.7	66.9	56.3	76.2	82.5	52.6	74.8	59.6	56.6	44.7	42.6	57.0	51.2	42.5	72.0	49.2	100.1	48.1	55.8	63.6	44.4	31.7	55.7	69.0	43.9	52.6	60.1	63.8	53.0	98.5	58.2	63.4	62.5	81.2	47.1	42.8	45.6	85.6	50.8	58.5	48.1	39.7	104.8	59.9	45.8	72.3	60.4	62.3	76.0	58.9	34.4	89.0	78.0	53.8	47.1	82.1	46.8	76.0	60.1	43.9	75.3	53.0	40.8	82.6	52.3	56.6	51.9	80.7	34.4	29.4	33.5	22.4	41.5	22.4	24.6	20.9	24.7	31.4	23.4	24.6	25.0	31.8	26.5	43.7	19.0	29.3	24.0	37.5	39.7	40.3	47.7	38.4	40.9	39.6	39.9	40.5	40.8	40.2	46.8	102.6	160.3	103.9	23.5	64.4	157.9	78.2	84.8	97.3	93.8	70.7	58.8	39.2	62.9	96.2	62.5	37.5	85.2	79.6	95.1	86.1	81.3	41.9	80.7	89.8	84.5	60.3	44.4	42.5	64.4	83.0	68.7	64.7	94.4	77.2	58.1	61.1	113.6	91.0	94.2	38.0	59.8	95.6	89.9	105.4	36.2	51.9	80.7	110.3	44.0	84.8	100.5	49.4	38.2	59.0	80.7	52.9	56.4	50.2	81.0	63.2	103.3	86.8	62.0	59.2	64.0	105.6	112.9	113.6	120.0	202.4	116.2	74.3	82.5	64.0	106.0
RAB21	KIAA0118	ENSG00000080371	"RAB21, member RAS oncogene family"	Q9UL25	12	71754863-71800286	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 497.9;Late spermatids: 807.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA016988, CAB037048"	Approved					NA	NA		13000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"			"CAB037048: AB_1841130, HPA016988: AB_1855998"	"unprognostic (4.38e-2)"	"unprognostic (1.49e-2)"	"unprognostic (8.57e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.43e-2)"	"unprognostic (5.68e-2)"	"prognostic favorable (5.39e-8)"	"unprognostic (1.75e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.91e-2)"	"unprognostic (6.31e-2)"	6.1	7.4	6.1	3.8	7.3	8.0	5.0	6.4	7.5	5.2	4.7	5.3	3.7	4.9	3.9	5.8	4.4	4.5	11.5	5.5	6.5	8.3	6.1	6.5	4.5	7.4	7.2	5.1	3.9	6.5	5.4	5.3	6.9	5.0	3.5	3.5	4.2	4.4	14.2	6.5	4.0	4.3	7.2	4.6	4.3	2.5	6.6	4.6	5.9	7.6	4.2	5.3	5.4	8.2	6.0	4.6	4.7	3.8	7.5	4.8	8.1	8.3	4.9	5.6	3.8	5.6	2.8	9.3	9.5	7.4	3.3	5.1	8.5	5.8	8.8	7.5	3.9	8.6	3.3	6.2	7.7	9.5	5.0	5.6	8.9	6.2	9.6	8.6	3.9	5.1	6.0	5.3	8.6	5.5	7.7	6.3	7.0	3.4	6.9	7.4	5.2	6.7	8.4	8.3	4.7	3.8	10.4	9.8	6.2	5.8	7.7	6.1	6.1	7.3	2.9	11.7	6.2	6.8	7.0	7.1	3.8	5.4	5.3	0.8	0.3	0.5	0.4	0.3	0.4	0.4	0.4	0.3	0.2	0.4	0.4	0.4	1.2	0.4	0.3	0.5	0.3	0.1	6.1	7.3	6.4	7.5	5.5	6.5	7.4	7.2	6.9	7.2	6.6	8.2	93.7	28.9	56.5	17.9	60.7	119.6	78.4	29.6	32.5	45.4	66.1	45.1	179.9	48.6	31.6	47.8	79.2	39.4	96.5	60.4	13.7	22.5	497.9	48.0	56.6	73.1	49.6	21.0	24.9	20.8	38.0	66.6	30.1	109.0	24.1	22.1	48.5	62.3	42.7	52.2	31.9	35.8	20.3	55.7	168.9	807.6	36.1	88.9	55.2	17.8	41.5	41.9	36.0	33.7	47.5	34.2	40.7	41.8	47.8	97.7	44.4	62.5	20.0	37.3	26.3	90.9	81.2	19.2	16.6	56.1	160.1	83.5	59.8	35.5	41.2	117.7
RAB35	H-ray	ENSG00000111737	"RAB35, member RAS oncogene family"	Q15286	12	120095099-120117502	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054146	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"			"HPA054146: AB_2682399"	"unprognostic (3.15e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (6.46e-6)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (1.16e-1)"	"unprognostic (5.84e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.13e-2)"	"unprognostic (4.84e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.49e-1)"	27.6	18.4	16.7	27.8	17.6	36.2	23.8	15.3	19.8	26.1	10.8	24.6	21.1	27.0	8.5	39.7	23.9	17.7	22.1	18.2	16.7	19.4	19.1	21.9	28.3	16.3	16.9	20.3	16.1	13.6	16.9	21.5	16.7	19.5	14.8	9.6	21.7	14.5	22.0	36.0	22.9	20.1	14.7	31.3	22.4	10.9	18.0	26.7	15.0	17.6	25.1	25.5	28.4	16.0	52.8	58.8	33.8	34.1	33.6	34.7	44.3	47.0	33.8	46.1	29.7	64.7	26.2	40.2	58.6	60.9	35.2	46.0	45.9	50.0	29.6	66.0	50.7	74.2	33.4	44.2	34.2	52.3	67.3	38.2	38.7	61.7	42.7	42.4	50.3	23.8	62.5	25.4	33.0	54.8	54.6	68.3	38.0	31.4	56.9	42.4	28.3	52.5	28.3	61.2	35.8	41.4	55.9	28.3	34.1	33.0	63.0	45.3	62.2	44.7	47.3	45.5	61.9	51.1	62.7	70.3	45.4	45.6	40.2	3.0	7.3	14.6	6.9	8.2	5.8	3.9	4.6	7.2	6.7	3.9	2.5	3.8	14.1	6.5	11.8	3.8	6.9	6.6	16.7	17.6	15.3	19.8	18.2	16.7	16.3	16.9	16.7	14.7	18.0	16.0	22.1	19.2	17.1	5.9	15.1	29.7	18.9	11.4	8.0	9.3	13.0	8.4	6.6	14.3	10.5	9.2	0.0	28.1	28.6	23.7	37.2	21.6	8.6	11.3	14.9	22.7	12.6	10.5	6.5	18.3	25.7	15.6	22.4	17.2	19.6	9.1	22.5	8.7	36.6	15.2	6.0	19.3	2.0	21.8	28.1	3.4	11.5	21.5	12.4	5.6	24.8	10.8	27.8	1.0	5.9	27.9	20.6	15.4	12.6	20.0	17.1	12.9	10.3	7.1	6.6	9.5	15.3	7.3	8.0	16.0	34.7	48.2	23.5	13.4	15.7	20.2
RAB3GAP2	"DKFZP434D245, KIAA0839, RAB3-GAP150, SPG69"	ENSG00000118873	"RAB3 GTPase activating non-catalytic protein subunit 2"	Q9H2M9	1	220148293-220272453	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Cataract, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026273, HPA027299"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol	"Plasma membrane"	"HPA026273: AB_1856007, HPA027299: AB_1856008"	"prognostic unfavorable (3.05e-4)"	"unprognostic (2.80e-3)"	"unprognostic (1.76e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.40e-2)"	"unprognostic (7.00e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.56e-1)"	10.1	9.0	6.3	9.6	6.7	10.2	11.2	11.4	7.8	8.7	23.5	8.8	7.8	9.4	8.4	9.0	7.0	7.9	9.3	7.3	9.3	11.7	10.0	8.6	12.6	6.7	6.9	9.6	8.6	18.6	6.2	11.5	9.0	8.5	8.3	18.1	9.2	7.9	8.7	7.9	7.8	9.3	5.7	9.2	9.4	6.6	7.5	13.1	12.8	12.2	14.4	9.1	6.0	9.1	21.3	15.8	18.9	14.3	21.2	25.1	21.4	21.4	20.3	18.9	22.2	14.7	17.3	26.4	14.8	20.9	14.3	19.9	19.8	16.4	21.8	22.1	12.9	20.6	21.5	13.8	27.9	29.8	20.3	20.0	18.4	18.5	28.5	21.2	17.6	11.4	36.2	16.6	21.6	6.0	23.0	10.5	40.8	11.4	9.3	12.5	26.0	23.7	16.1	17.3	18.8	22.7	22.2	21.4	35.3	20.3	22.4	28.0	25.7	20.6	9.6	14.4	23.2	14.6	19.2	22.8	17.7	24.6	24.8	10.0	2.8	5.6	4.8	3.6	5.9	4.8	4.7	6.2	3.8	3.8	4.1	4.9	1.8	2.8	3.9	2.4	6.0	3.3	6.3	6.7	11.4	7.8	7.3	9.3	6.7	6.9	9.0	5.7	7.5	9.1	28.5	41.7	21.9	60.7	30.4	11.6	13.6	15.8	17.6	57.9	18.9	16.3	34.8	32.9	23.4	25.8	68.8	18.5	30.6	23.8	5.9	17.4	4.3	21.4	27.7	22.3	35.4	18.7	106.8	16.7	13.5	23.4	20.4	28.5	19.6	40.8	28.9	24.2	25.4	42.1	105.1	22.1	16.2	29.0	9.4	2.8	18.0	22.2	14.2	68.4	25.2	39.8	26.8	82.0	81.5	21.7	14.2	25.9	24.7	21.0	19.4	14.9	17.2	50.5	6.6	24.1	20.4	17.7	13.6	17.5	9.8	23.1	27.1	23.6	19.3	13.2
RAB8A	"MEL, RAB8"	ENSG00000167461	"RAB8A, member RAS oncogene family"	P61006	19	16111889-16134234	"Predicted intracellular proteins"	"Autophagy, Cilium biogenesis/degradation, Protein transport, Transport"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041945			Approved	"Nucleoplasm,Plasma membrane"		No	No		4800000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 9: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Plasma membrane"		"HPA041945: "	"unprognostic (1.10e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (6.56e-5)"	"unprognostic (6.60e-2)"	"unprognostic (7.25e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (9.99e-2)"	21.3	24.5	17.4	40.4	17.5	61.3	18.7	19.5	17.6	24.6	20.7	37.4	58.5	18.5	18.9	25.9	27.8	22.0	11.5	17.2	19.1	20.8	51.5	28.6	44.3	21.1	19.5	21.5	23.4	17.7	15.3	25.0	21.6	21.7	32.8	8.7	30.7	21.2	7.0	27.5	58.7	22.8	20.3	40.4	32.4	15.4	19.0	34.3	16.3	8.1	45.1	25.9	21.2	23.3	94.2	62.6	50.5	43.0	42.7	36.7	77.9	56.0	48.8	74.2	76.8	76.1	105.7	66.1	61.9	58.6	63.5	60.6	71.2	69.1	50.9	132.6	39.9	135.9	57.1	75.6	46.7	119.4	129.3	36.6	37.6	69.5	32.1	38.9	63.5	65.0	64.4	97.0	63.4	111.6	100.1	113.7	63.3	114.3	100.5	111.6	56.2	115.6	58.2	71.9	46.9	45.3	56.6	68.0	35.9	34.2	53.8	44.2	61.7	61.4	39.2	119.2	96.6	51.4	113.4	97.3	58.7	121.5	67.0	244.5	278.6	315.0	164.3	387.5	145.7	190.5	143.3	147.5	247.5	190.0	112.5	131.7	292.2	225.9	485.1	177.8	150.9	514.1	17.4	17.5	19.5	17.6	17.2	19.1	21.1	19.5	21.6	20.3	19.0	23.3	47.2	25.6	29.1	2.3	70.2	47.7	47.4	53.5	31.3	15.2	37.0	34.7	3.0	17.2	35.7	31.3	14.6	95.7	97.9	115.9	82.2	70.7	31.0	33.7	29.7	37.3	30.4	47.5	4.2	51.5	98.6	36.3	29.6	45.0	48.7	36.2	26.0	50.3	88.9	6.7	3.5	55.3	48.8	50.6	81.5	19.0	27.7	100.9	33.8	2.8	124.8	34.9	131.8	3.0	8.8	76.8	90.0	24.8	96.5	30.7	130.7	62.6	35.4	13.9	32.9	22.0	38.1	33.3	23.4	30.4	52.6	79.6	64.8	43.4	52.0	38.4
RABEP1	"neurocrescin, RAB5EP, rabaptin-5, RABPT5"	ENSG00000029725	"Rabaptin, RAB GTPase binding effector protein 1"	Q15276	17	5282265-5386340	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Endocytosis, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004549, HPA019669, HPA024235, HPA024691"	Supported		Supported	Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Vesicles		"CAB004549: AB_628192, HPA019669: AB_1856019, HPA024235: AB_1856020, HPA024691: AB_1856021"	"unprognostic (3.22e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.75e-3)"	"unprognostic (1.64e-1)"	"unprognostic (8.25e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.73e-2)"	"prognostic favorable (6.43e-4)"	"unprognostic (1.14e-1)"	"unprognostic (6.09e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.00e-3)"	30.1	23.6	39.1	23.2	45.8	17.1	43.9	41.0	49.3	22.2	32.0	21.1	16.5	26.8	25.1	18.5	16.7	21.7	32.4	37.9	46.7	23.5	32.8	19.5	33.5	43.1	44.8	21.7	18.0	48.0	19.7	30.8	44.2	31.0	20.7	58.2	22.7	21.8	68.5	16.3	18.9	27.5	43.5	28.3	24.0	18.8	43.7	37.3	25.8	52.4	40.3	23.1	15.2	50.7	45.5	57.5	59.6	33.3	60.9	60.5	31.2	58.3	44.5	61.8	58.5	51.4	19.7	98.3	46.0	61.2	35.0	35.9	87.8	50.0	86.4	60.7	75.0	60.9	73.1	39.4	56.4	41.3	37.9	47.2	33.3	59.6	76.5	37.7	54.4	49.9	52.3	48.3	54.2	32.7	66.1	30.4	26.8	25.8	24.9	61.2	70.8	32.4	30.6	43.1	25.3	39.4	52.4	52.8	49.5	52.3	95.9	17.2	46.9	53.1	24.2	52.6	69.6	26.9	31.0	52.4	41.2	62.3	37.5	14.9	21.1	22.4	25.0	22.7	21.9	80.4	19.5	24.0	22.6	96.7	24.6	21.5	30.4	22.6	50.9	35.0	20.0	16.6	39.1	45.8	41.0	49.3	37.9	46.7	43.1	44.8	44.2	43.5	43.7	50.7	36.4	35.3	45.1	57.5	53.8	24.0	30.1	17.0	25.6	51.5	87.3	46.0	91.1	14.3	32.9	18.4	39.6	39.7	47.2	18.6	41.1	30.4	7.6	19.8	55.5	37.9	16.3	58.3	123.7	23.8	35.0	38.5	23.4	25.3	12.6	47.0	34.2	31.7	89.8	35.3	115.9	17.1	30.5	32.1	38.2	6.0	33.8	36.5	30.2	90.9	32.8	89.7	63.8	78.4	114.1	28.3	65.5	28.2	28.2	52.8	16.5	38.1	19.0	52.5	26.3	34.3	47.7	82.2	75.7	25.5	20.3	25.9	34.4	61.2	18.9	33.6
RABEPK	"bA65N13.1, RAB9P40"	ENSG00000136933	"Rab9 effector protein with kelch motifs"	Q7Z6M1	9	125200542-125234161	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 85.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023920, HPA067106"	Supported		Uncertain	"Plasma membrane"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 15: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Plasma membrane"		"HPA023920: AB_1856023, HPA067106: "	"unprognostic (8.72e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.70e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.47e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.25e-2)"	"unprognostic (2.69e-1)"	17.4	15.0	27.9	14.6	30.0	11.6	16.4	27.3	32.5	16.4	25.5	17.7	11.5	15.1	16.9	16.1	15.4	10.6	14.5	27.2	28.9	14.7	58.7	12.2	13.9	28.5	28.6	13.1	14.3	14.9	19.7	11.9	28.6	14.0	14.8	15.7	10.7	13.0	15.0	16.6	11.4	16.4	27.9	12.8	13.5	16.1	29.7	14.8	11.7	13.6	13.8	17.3	15.3	29.2	24.6	57.2	21.3	39.2	34.0	41.0	39.4	33.3	32.5	38.7	30.6	68.6	24.0	73.5	29.1	45.5	38.2	64.8	54.2	41.3	38.0	42.6	45.1	32.6	52.7	105.2	30.4	62.3	21.7	30.0	49.0	55.3	59.1	23.5	41.8	45.3	71.8	20.6	37.5	66.8	44.5	42.2	43.0	96.7	51.2	62.0	41.2	81.5	31.4	18.8	50.3	25.5	34.3	23.8	39.2	21.1	48.3	26.5	36.1	26.7	26.3	61.8	58.8	27.4	65.5	51.2	34.3	40.1	40.7	27.8	19.6	23.2	24.0	16.6	22.1	23.8	34.4	23.6	21.6	20.6	38.2	28.2	27.9	23.0	17.3	20.6	38.8	23.8	27.9	30.0	27.3	32.5	27.2	28.9	28.5	28.6	28.6	27.9	29.7	29.2	9.9	0.0	11.3	13.1	9.9	14.5	17.2	23.4	28.5	12.1	9.1	11.2	9.5	10.0	8.5	5.5	8.4	36.1	7.8	8.7	25.4	13.9	85.2	8.6	11.9	13.1	2.4	13.5	25.2	13.3	32.2	17.4	10.2	8.5	5.1	10.4	10.0	54.8	20.9	13.5	24.0	11.9	10.2	7.7	10.8	19.2	16.1	7.4	8.8	6.5	31.6	12.0	14.4	9.0	17.2	10.0	4.9	18.8	16.8	24.9	9.2	23.2	8.0	17.1	0.0	13.5	13.5	7.0	11.2	20.0	12.9	12.7	13.0	13.1	15.9	15.6
RABGAP1	"GAPCenA, TBC1D11"	ENSG00000011454	"RAB GTPase activating protein 1"	Q9Y3P9	9	122940833-123104866	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 179.1;Oligodendrocytes: 147.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064860, HPA072273"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA064860: AB_2685372, HPA072273: AB_2686504"	"prognostic unfavorable (8.09e-4)"	"unprognostic (3.45e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.90e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.19e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.76e-1)"	"prognostic favorable (6.06e-6)"	"unprognostic (1.39e-1)"	"unprognostic (2.75e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.05e-2)"	22.5	15.5	27.3	16.9	28.8	7.3	21.6	23.8	31.6	21.9	19.4	39.7	12.2	28.8	25.4	31.7	21.9	19.0	26.3	28.0	27.8	19.9	11.7	19.3	19.5	27.3	29.8	23.8	16.3	31.3	16.8	21.4	28.0	29.4	22.7	24.9	24.3	30.2	34.5	23.6	17.2	31.7	26.1	18.4	21.6	21.8	27.1	19.6	39.2	30.7	19.4	26.0	21.8	30.2	19.5	25.7	39.6	33.0	44.8	36.2	24.5	20.0	35.8	30.3	28.2	29.9	18.6	26.6	15.6	31.3	40.4	64.7	25.6	25.0	32.4	25.1	15.4	20.8	40.4	22.9	38.3	17.2	17.5	35.2	37.6	26.1	29.3	43.5	34.8	26.2	18.3	19.9	36.9	43.3	22.5	13.5	14.6	55.7	19.6	36.7	72.3	23.0	25.2	21.3	22.3	17.2	35.7	31.9	18.6	29.5	60.7	9.4	26.9	25.6	15.1	28.3	20.3	19.3	33.9	27.7	24.0	8.7	22.9	3.4	1.3	1.8	0.9	2.1	0.7	1.1	0.9	0.9	1.1	1.4	1.6	1.1	2.1	0.8	1.0	1.5	1.2	0.5	27.3	28.8	23.8	31.6	28.0	27.8	27.3	29.8	28.0	26.1	27.1	30.2	47.2	25.6	50.8	115.2	26.6	18.0	23.0	20.8	40.5	44.9	26.7	26.4	46.9	11.5	31.9	11.0	50.1	25.5	26.0	24.9	3.9	11.8	15.4	31.5	30.3	33.1	16.9	17.0	179.1	14.5	8.7	22.9	18.3	47.7	14.0	34.2	27.1	15.4	15.9	57.2	129.7	16.7	24.4	28.6	14.4	17.5	40.7	25.1	14.2	78.7	35.9	33.6	33.0	101.0	147.7	13.0	18.6	51.6	11.9	39.7	11.7	10.1	30.6	34.6	85.5	31.0	51.4	73.8	37.4	27.6	17.3	41.6	16.4	22.5	21.6	27.8
RABGGTB		ENSG00000137955	"Rab geranylgeranyltransferase subunit beta"	P53611	1	75786197-75795086	"Enzymes, Predicted intracellular proteins"		"Prenyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA026585, HPA027167, HPA030793"	Approved	Supported	Approved	Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA026585: AB_1856026, HPA027167: AB_1856027, HPA030793: "	"unprognostic (4.83e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.45e-2)"	"unprognostic (9.02e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (9.80e-5)"	"unprognostic (9.62e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.23e-1)"	"unprognostic (6.95e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (6.05e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.77e-2)"	"unprognostic (3.89e-1)"	37.5	56.5	41.0	20.3	44.9	18.3	41.4	44.7	52.8	31.4	40.4	33.9	33.3	24.6	23.6	35.2	28.1	21.4	49.6	40.0	44.8	75.9	67.2	29.0	26.9	44.8	43.6	38.1	67.7	37.5	25.1	31.5	44.8	27.5	29.3	41.2	32.0	23.0	79.7	21.7	24.9	23.0	47.1	29.1	33.9	15.3	43.6	30.6	30.5	84.0	31.3	37.3	30.4	47.9	74.8	40.2	68.6	31.4	85.2	108.8	43.8	99.5	68.2	91.6	70.4	97.3	17.6	68.2	101.3	55.7	146.0	46.0	178.3	77.7	133.8	67.1	48.3	58.0	66.5	158.0	106.6	74.8	32.9	67.5	165.1	84.3	95.4	125.6	75.8	59.7	96.9	65.7	109.9	30.8	61.5	81.4	64.5	53.3	78.0	49.2	114.5	29.9	69.9	41.7	43.5	39.1	24.1	123.6	231.0	58.8	26.1	69.8	77.5	59.6	67.0	142.1	199.5	41.9	127.1	46.4	67.5	60.3	27.0	8.4	7.2	4.7	7.7	11.3	9.3	9.5	7.7	7.2	12.3	5.9	9.4	9.3	1.1	6.3	8.1	11.3	7.7	4.0	41.0	44.9	44.7	52.8	40.0	44.8	44.8	43.6	44.8	47.1	43.6	47.9	35.3	35.3	44.3	12.7	83.3	127.7	59.4	132.6	66.0	22.6	58.5	45.6	71.1	72.9	86.0	27.6	20.9	45.9	65.7	38.6	103.7	44.9	1.6	36.1	42.5	45.8	89.8	41.6	17.1	51.8	60.3	48.6	57.6	40.4	70.5	26.5	41.7	68.6	61.2	32.0	17.8	62.2	75.3	61.3	91.4	4.4	32.3	54.8	58.7	9.4	52.0	36.5	32.0	14.6	21.9	44.1	46.0	33.4	78.8	84.8	58.4	206.5	45.8	22.3	6.6	40.1	59.8	20.1	14.0	73.6	142.9	53.5	60.2	37.5	69.6	88.7
RACGAP1	MgcRacGAP	ENSG00000161800	"Rac GTPase activating protein 1"	Q9H0H5	12	49976923-50033136	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Ion transport, Spermatogenesis, Transport"	"Developmental protein, GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 38.9;lymphoid tissue: 43.0;testis: 45.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 55.7;Extravillous trophoblasts: 49.4;Spermatocytes: 79.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025859, HPA039427, HPA043912"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB025859: , HPA039427: AB_2676503, HPA043912: AB_2678728"	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.82e-2)"	"prognostic unfavorable (1.86e-6)"	"unprognostic (1.15e-3)"	"unprognostic (3.07e-3)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (4.12e-6)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (3.98e-8)"	"unprognostic (3.13e-2)"	"unprognostic (4.94e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.15e-1)"	5.0	2.5	5.5	13.7	8.2	38.9	7.1	6.9	6.3	5.2	3.2	16.7	10.5	5.3	1.5	21.3	4.4	6.4	2.8	5.0	6.0	9.2	4.7	6.2	23.9	6.7	7.1	2.4	2.7	5.8	1.4	14.0	6.5	3.3	18.7	5.3	4.8	3.4	4.9	14.4	11.6	12.5	5.5	6.5	9.8	45.5	7.6	43.0	3.3	4.8	30.2	7.7	8.0	7.0	193.0	174.5	135.8	86.8	24.8	29.7	113.0	195.0	97.0	207.3	140.3	174.6	144.7	107.5	86.0	108.3	99.9	127.1	137.7	93.6	219.9	203.0	85.4	137.9	165.8	58.1	8.4	146.1	109.0	16.2	17.2	140.7	111.4	60.3	71.7	96.4	101.6	159.6	197.0	136.8	122.5	72.6	96.2	108.9	112.9	113.9	163.5	78.3	54.9	95.7	113.9	97.5	161.7	102.7	53.0	68.8	199.7	64.8	64.9	136.2	119.1	86.8	144.7	83.3	225.2	126.6	67.7	97.0	81.1	24.1	3.2	4.7	6.5	4.1	5.7	8.2	7.9	9.2	2.8	4.3	4.6	6.1	0.7	11.0	2.6	1.8	19.1	5.8	5.5	8.2	6.9	6.3	5.0	6.0	6.7	7.1	6.5	5.5	7.6	7.0	2.0	6.4	6.4	2.9	4.2	12.9	2.5	4.9	6.2	1.5	4.8	5.1	1.5	2.8	3.3	5.5	4.2	21.8	4.4	3.1	19.6	1.9	15.2	2.2	3.1	2.7	0.0	55.7	7.5	2.2	49.4	5.9	7.7	4.0	2.5	14.2	5.3	2.7	13.1	1.7	8.0	5.7	20.3	11.3	8.0	17.7	1.5	7.1	1.8	1.0	4.5	2.7	6.2	6.0	12.3	2.0	1.0	3.8	10.9	2.8	1.1	2.1	2.3	0.8	13.1	3.1	5.5	79.6	32.2	19.5	12.9	8.6	6.9	2.2	11.6	2.9
RAD17	"CCYC, RAD17Sp, Rad24"	ENSG00000152942	"RAD17 checkpoint clamp loader component"	O75943	5	69369293-69414801	"Predicted intracellular proteins"	"Cell cycle, DNA damage"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 121.6;Spermatocytes: 172.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 70.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004551, HPA005448"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"CAB004551: AB_628195, HPA005448: AB_1079738"	"unprognostic (1.25e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.28e-3)"	"unprognostic (2.21e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.04e-2)"	"unprognostic (7.75e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.59e-2)"	"unprognostic (5.74e-2)"	"prognostic favorable (5.79e-6)"	"unprognostic (1.02e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.24e-2)"	9.6	11.5	6.3	8.5	6.8	8.0	11.7	7.3	8.8	9.7	7.2	10.8	4.8	10.1	8.1	9.5	9.1	5.4	12.5	7.1	7.9	16.1	13.4	8.2	19.4	6.8	7.3	10.3	16.5	12.9	16.2	8.2	6.9	9.6	9.3	16.5	10.7	8.5	13.3	9.9	11.7	5.6	6.5	13.3	11.8	41.2	7.2	14.8	11.1	8.3	13.0	9.5	8.9	7.9	16.2	7.0	21.7	25.7	0.0	0.2	26.5	15.7	19.8	21.0	29.5	16.9	17.3	70.7	16.6	9.1	41.9	7.4	21.8	9.1	32.3	0.0	11.8	17.3	17.0	16.9	25.3	0.5	21.7	15.1	14.9	15.6	15.2	0.0	18.4	18.3	16.9	21.0	26.7	0.0	32.2	11.8	13.4	6.7	8.8	27.7	19.8	15.9	25.1	14.5	22.7	15.8	14.4	4.5	0.6	22.8	21.2	21.1	5.6	0.0	19.1	9.8	10.3	26.9	44.6	24.4	21.3	33.7	14.2	1.4	2.3	4.0	4.3	2.9	4.2	7.5	3.9	4.6	3.4	5.5	5.4	4.7	0.9	6.5	1.4	1.7	5.8	2.5	6.3	6.8	7.3	8.8	7.1	7.9	6.8	7.3	6.9	6.5	7.2	7.9	17.5	32.1	17.9	20.2	20.2	5.5	6.5	10.3	12.0	17.9	13.6	15.1	33.5	8.6	19.9	5.5	20.9	18.0	20.5	9.5	25.4	12.8	121.6	19.4	23.7	13.9	15.1	24.4	16.5	12.9	17.3	11.5	12.8	16.0	30.9	20.2	10.8	12.6	10.1	6.7	17.8	11.1	14.2	10.4	4.3	72.3	14.3	11.9	5.4	11.2	15.6	20.8	16.5	23.1	28.1	12.2	7.5	10.9	31.7	9.3	11.1	24.3	29.3	45.4	6.6	20.1	16.5	172.7	70.1	12.5	5.8	14.1	17.2	16.7	10.8	6.4
RAD18	RNF73	ENSG00000070950	"RAD18 E3 ubiquitin protein ligase"	Q9NS91	3	8775402-8963773	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006716, HPA006724, HPA008752"	Supported	Approved	Enhanced	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 2: Granulocytes - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nuclear bodies"		"HPA006716: AB_2667650, HPA006724: AB_2667655, HPA008752: AB_2668129"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.73e-2)"	"unprognostic (6.15e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (2.01e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (3.73e-4)"	"prognostic unfavorable (3.65e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.89e-2)"	2.7	2.3	1.2	3.3	1.5	5.2	5.3	1.3	1.7	3.2	0.5	3.8	10.1	2.8	1.9	3.4	2.3	3.1	1.8	1.5	0.9	1.6	2.7	2.7	4.6	1.6	1.0	2.8	1.7	2.0	1.3	3.0	1.5	3.2	4.9	2.6	3.2	1.6	1.3	4.5	6.5	2.8	1.2	3.5	2.2	2.9	1.1	5.8	3.7	1.0	4.4	2.5	2.9	2.3	16.2	15.2	12.3	7.4	3.0	6.4	14.9	25.0	8.5	23.5	16.1	13.7	10.1	19.8	4.7	14.2	13.8	5.6	13.1	13.0	23.8	12.2	17.2	16.9	16.1	8.2	1.9	22.7	13.9	2.4	4.6	23.3	15.7	6.3	7.7	17.1	18.2	19.0	20.9	18.6	22.9	15.9	17.2	12.7	28.5	18.0	13.6	15.6	6.9	12.2	5.1	11.5	11.2	10.5	8.2	9.7	11.0	9.8	6.4	19.4	10.5	16.8	21.7	9.6	16.1	43.7	14.3	24.5	14.6	6.4	1.6	5.1	1.5	1.7	2.8	1.9	2.1	2.7	2.0	1.9	2.2	1.6	0.7	2.8	1.1	3.6	3.0	0.8	1.2	1.5	1.3	1.7	1.5	0.9	1.6	1.0	1.5	1.2	1.1	2.3	5.7	16.0	9.8	6.2	7.7	11.1	7.5	6.4	5.7	4.6	7.3	11.7	2.2	4.3	7.5	3.7	2.1	9.0	8.6	5.2	1.9	9.6	4.2	4.0	5.8	4.6	1.8	7.2	20.9	8.2	12.4	6.8	3.6	4.9	13.9	14.8	6.1	3.1	7.1	3.3	15.7	6.5	2.0	5.2	5.6	3.0	4.1	4.6	3.6	14.0	7.1	3.2	8.2	16.1	14.3	10.2	4.3	2.6	8.7	6.4	4.0	3.1	4.1	2.3	6.6	4.3	6.9	26.2	14.0	6.0	11.8	6.7	7.5	9.3	6.3	3.6
RAD51	"BRCC5, FANCR, HsRad51, HsT16930, RAD51A, RECA"	ENSG00000051180	"RAD51 recombinase"	Q06609	15	40694774-40732340	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.7;testis: 24.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 35.3;Extravillous trophoblasts: 67.2;Spermatocytes: 53.6;Spermatogonia: 24.8;Syncytiotrophoblasts: 25.3"	"Cancer enhanced"	"Detected in all"		"testis cancer: 19.9"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010381, HPA039310"	Enhanced		Supported	"Nucleoli rim,Cytosol"		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoli rim"	Cytosol	"CAB010381: AB_2253533, HPA039310: AB_2676434"	"prognostic unfavorable (7.94e-4)"	"unprognostic (7.20e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.72e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (9.33e-4)"	"unprognostic (3.40e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.53e-3)"	"unprognostic (0.00e+0)"	"unprognostic (2.26e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.94e-2)"	0.9	0.6	0.4	5.5	0.5	10.5	1.9	1.7	0.7	1.0	0.6	8.3	3.2	1.2	0.4	4.2	0.7	1.3	0.6	0.4	0.5	0.5	1.3	1.1	11.0	0.4	0.3	0.6	1.4	0.5	0.2	6.8	0.5	0.8	9.1	0.3	1.0	0.3	1.0	3.1	4.1	2.4	0.1	2.4	1.8	24.3	0.3	15.7	0.6	0.5	13.3	1.7	1.5	0.5	33.8	16.1	33.4	16.3	4.4	7.8	31.1	54.9	16.5	43.3	43.8	35.4	22.1	20.4	26.8	20.9	18.9	67.7	56.6	22.1	42.3	39.0	22.2	47.7	28.2	30.4	0.4	37.9	28.5	1.7	2.9	30.0	13.5	6.4	22.5	48.5	59.6	55.8	36.6	28.5	54.4	43.6	35.2	69.2	19.0	61.0	49.0	30.7	15.4	45.3	15.4	27.0	23.6	41.4	8.5	39.2	27.0	39.4	9.9	32.8	22.2	48.7	27.2	12.0	65.1	59.8	16.3	78.0	33.5	1.3	0.6	1.7	2.4	1.3	0.6	1.7	2.5	3.2	1.0	1.1	0.6	1.2	1.2	1.8	1.4	0.9	5.9	1.2	0.4	0.5	1.7	0.7	0.4	0.5	0.4	0.3	0.5	0.1	0.3	0.5	0.0	0.0	0.0	0.3	1.9	3.6	1.5	2.0	0.0	0.8	0.1	0.0	0.9	0.0	1.0	0.0	0.0	35.3	1.4	3.0	0.0	0.0	5.7	0.2	0.2	1.0	0.0	16.0	1.6	0.0	67.2	1.3	2.0	0.2	0.0	0.6	2.2	0.2	12.7	0.0	1.2	5.3	2.0	1.6	1.7	5.3	0.6	0.5	0.0	1.0	0.3	0.3	2.1	0.5	0.6	0.1	5.0	0.7	8.2	0.9	1.0	0.0	0.1	0.0	0.0	0.5	0.9	53.6	24.8	3.9	1.6	25.3	1.2	0.1	8.0	2.1
RAD51AP1	PIR51	ENSG00000111247	"RAD51 associated protein 1"	Q96B01	12	4538798-4560047	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Meiosis"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.9;lymphoid tissue: 14.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 33.4;Erythroid cells: 47.8;Extravillous trophoblasts: 34.1;Hofbauer cells: 40.8;Late spermatids: 68.1;Spermatocytes: 35.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 6.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051499			Approved	Nucleoplasm		Yes	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA051499: AB_2681508"	"unprognostic (1.03e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (9.42e-4)"	"unprognostic (6.30e-2)"	"unprognostic (5.25e-3)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (2.15e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.29e-3)"	"prognostic unfavorable (1.22e-5)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (4.44e-15)"	"unprognostic (2.68e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.88e-2)"	"unprognostic (3.75e-2)"	0.9	0.8	0.3	4.8	0.4	16.9	2.7	0.4	0.7	0.9	0.3	5.2	5.2	1.2	0.6	3.2	1.0	1.1	0.5	0.3	0.3	0.8	1.8	1.4	8.9	0.4	0.4	0.5	0.4	0.6	0.3	3.8	0.4	1.3	6.5	1.5	1.0	1.0	0.5	3.2	4.8	1.9	0.4	3.4	2.7	6.3	0.4	14.4	1.0	0.6	7.9	1.7	1.3	0.5	37.5	13.0	45.3	22.7	2.7	5.7	53.0	48.2	21.2	52.6	68.9	35.4	35.4	48.6	7.0	10.4	24.7	23.1	31.8	14.5	80.0	38.7	27.0	61.4	21.6	24.8	0.6	56.6	29.9	1.2	1.5	31.6	30.4	7.5	21.4	33.0	39.2	54.4	33.7	13.6	46.5	20.5	110.4	36.3	14.4	46.0	54.3	19.2	16.1	18.3	15.1	16.6	35.9	27.7	11.6	45.5	11.3	32.6	9.5	35.5	36.5	38.8	52.4	7.8	10.0	93.3	13.3	40.0	29.4	0.0	0.5	0.7	0.1	2.3	0.5	3.1	0.4	1.0	0.4	3.4	0.1	0.2	0.0	1.4	2.0	6.9	1.0	0.6	0.3	0.4	0.4	0.7	0.3	0.3	0.4	0.4	0.4	0.4	0.4	0.5	1.4	0.0	0.5	0.7	6.1	5.2	2.3	6.6	1.2	3.1	3.4	5.7	1.4	2.8	4.5	0.0	4.2	20.3	11.3	5.7	0.0	3.0	33.4	3.3	2.9	2.9	2.4	47.8	2.7	2.7	34.1	5.2	6.1	3.6	1.3	22.6	2.5	1.2	40.8	0.0	1.1	6.4	16.2	6.2	5.6	68.1	1.2	10.1	0.0	3.7	6.8	2.7	3.1	0.5	2.4	1.5	0.8	1.5	15.5	1.0	1.2	1.5	0.9	4.8	0.0	2.4	4.2	35.9	25.0	10.0	2.6	4.7	4.6	2.0	14.6	2.7
RAD51B	"hREC2, R51H2, RAD51L1, REC2"	ENSG00000182185	"RAD51 paralog B"	O15315	14	67819779-68730218	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"Astrocytes: 150.8;Microglial cells: 263.3;Oligodendrocyte precursor cells: 157.3;Oligodendrocytes: 375.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB016191, HPA051869"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear bodies"	Nucleoplasm	"CAB016191: AB_2238209, HPA051869: AB_2681644"	"unprognostic (9.10e-3)"	"unprognostic (5.45e-2)"	"unprognostic (4.92e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.42e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.08e-1)"	"unprognostic (6.80e-3)"	"unprognostic (1.47e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.49e-2)"	"unprognostic (6.79e-2)"	"unprognostic (8.13e-3)"	3.1	2.3	3.0	2.9	5.7	7.3	5.5	3.8	3.3	5.8	5.8	3.0	1.1	4.4	9.0	3.7	3.9	4.3	1.7	3.4	3.7	2.7	2.1	2.7	4.8	5.7	4.7	6.3	2.1	4.9	2.0	4.1	5.7	2.5	2.6	3.0	13.1	2.3	1.2	4.2	2.4	4.4	4.3	2.6	2.6	1.8	5.0	5.9	2.5	1.2	4.3	3.6	4.5	7.3	15.3	5.9	6.5	3.9	5.9	10.0	4.0	7.6	5.8	8.2	10.5	4.2	20.1	18.6	4.8	4.7	9.4	13.4	4.1	12.1	11.1	8.4	4.2	8.9	5.4	3.3	3.2	7.6	8.6	5.1	9.0	9.4	9.9	3.8	7.4	13.5	7.3	8.4	6.7	11.9	14.9	2.7	3.8	14.6	5.9	16.6	7.7	6.8	6.3	4.3	4.4	2.9	6.0	2.2	13.1	7.6	10.1	6.8	2.0	9.9	9.6	7.8	6.3	4.0	4.4	14.9	5.5	13.1	5.7	17.4	5.7	5.7	8.1	4.8	6.6	14.2	7.6	8.6	6.5	11.8	9.4	8.9	0.7	8.5	4.7	6.4	9.4	4.5	3.0	5.7	3.8	3.3	3.4	3.7	5.7	4.7	5.7	4.3	5.0	7.3	5.1	0.0	1.1	150.8	13.3	6.6	5.1	6.4	5.7	1.8	8.4	5.1	1.6	0.0	4.0	1.8	8.4	5.4	3.5	1.1	3.9	1.9	3.0	5.3	3.7	4.5	4.8	4.6	21.5	1.4	6.7	4.2	3.1	3.6	4.5	6.8	1.8	0.8	6.5	1.7	22.0	3.8	2.0	3.4	3.5	1.9	3.7	4.2	8.8	263.3	6.8	5.8	3.1	157.3	375.2	1.0	0.6	4.5	8.9	2.4	2.7	1.8	8.4	6.0	0.0	3.6	7.0	6.2	3.2	5.6	7.0	4.0	7.0	4.4	1.8	4.6
RAD54B	RDH54	ENSG00000197275	"RAD54 homolog B"	Q9Y620	8	94371960-94475115	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 7.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 29.0;Cone photoreceptor cells: 27.1;Excitatory neurons: 45.8;Inhibitory neurons: 19.0;Oligodendrocyte precursor cells: 39.7;Oligodendrocytes: 25.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 1.9"	"Group enriched"	"Detected in many"	10	"B-cells: 1.0;T-cells: 1.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA007087	Enhanced					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA007087: AB_1856040"	"unprognostic (1.68e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.31e-2)"	"unprognostic (8.84e-3)"	"unprognostic (4.15e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.56e-8)"	"unprognostic (1.96e-2)"	"unprognostic (1.77e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.04e-12)"	"unprognostic (5.86e-2)"	"unprognostic (5.23e-1)"	"unprognostic (9.08e-2)"	"unprognostic (6.68e-5)"	0.6	0.7	1.3	1.7	2.0	2.0	1.9	2.1	2.1	2.4	1.7	1.5	1.4	1.1	2.1	1.4	5.0	0.7	0.6	1.2	1.6	0.8	1.4	0.7	2.7	1.6	1.9	1.0	0.8	0.7	1.2	1.4	1.6	1.6	2.1	7.0	0.8	2.0	0.3	1.8	1.2	1.1	1.3	0.9	1.5	3.6	1.7	4.2	1.1	0.3	3.0	1.2	0.9	1.6	20.5	15.7	20.9	11.2	1.6	2.5	11.0	16.2	8.9	22.7	23.1	8.1	14.8	14.5	25.3	4.3	11.7	12.7	18.7	7.7	24.6	17.5	11.9	23.2	8.1	7.7	1.5	8.4	8.5	0.8	1.8	11.7	14.9	4.5	8.3	14.7	16.6	8.9	24.6	10.6	28.5	5.7	13.5	23.4	14.4	7.1	21.3	8.7	8.9	9.8	12.0	8.0	11.6	2.8	9.7	17.9	14.9	6.1	5.8	14.8	7.6	16.7	18.1	4.5	12.2	7.8	7.7	15.9	15.4	0.0	0.0	0.0	0.5	0.0	1.9	0.7	0.9	0.4	0.0	1.0	0.8	1.1	0.0	0.1	0.1	0.0	0.6	0.3	1.3	2.0	2.1	2.1	1.2	1.6	1.6	1.9	1.6	1.3	1.7	1.6	0.5	0.0	0.5	29.0	1.7	0.4	0.9	1.7	1.2	9.1	1.1	1.1	1.8	1.5	0.6	3.7	27.1	2.0	0.5	0.7	1.9	0.8	0.3	11.5	1.6	1.3	1.2	3.8	45.8	0.8	3.2	1.3	3.1	5.6	0.0	3.3	3.3	2.0	1.5	0.0	19.0	1.1	0.0	0.6	0.6	0.4	3.4	0.9	0.0	9.4	0.6	4.4	1.0	39.7	25.9	0.7	0.4	2.2	3.9	0.4	0.2	1.4	3.3	17.5	0.0	1.0	1.7	9.4	13.1	3.7	0.6	0.3	2.6	3.0	2.3	0.7
RAD54L	"hHR54, hRAD54, RAD54A"	ENSG00000085999	"RAD54 like"	Q92698	1	46246461-46278480	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.4;testis: 15.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 7.2;Extravillous trophoblasts: 9.4;Glandular and luminal cells: 8.0;Spermatocytes: 12.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.1"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA028954, HPA051537"	Approved		Enhanced	Nucleoplasm		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA028954: AB_2672840, HPA051537: AB_2681525"	"unprognostic (2.12e-2)"	"prognostic favorable (6.67e-4)"	"unprognostic (5.12e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.08e-2)"	"unprognostic (9.75e-6)"	"unprognostic (3.91e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.77e-4)"	"unprognostic (5.58e-2)"	"unprognostic (1.11e-16)"	"unprognostic (6.76e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.74e-1)"	0.5	0.7	3.0	4.1	3.8	8.7	1.0	4.3	3.9	1.3	2.1	3.2	2.0	0.7	0.1	5.4	0.4	0.5	0.7	2.9	2.5	1.4	0.5	1.2	5.5	3.2	3.0	0.5	0.5	0.3	0.4	3.4	3.8	1.0	4.6	0.4	0.9	0.4	1.2	2.3	2.8	1.7	2.8	2.8	1.5	15.6	3.1	15.4	1.8	0.0	8.3	0.8	1.8	3.7	22.2	16.1	46.8	29.1	3.3	2.4	43.9	25.8	11.3	42.8	43.3	33.3	14.2	42.5	19.1	11.0	38.5	22.2	44.6	14.5	36.8	23.7	43.0	53.0	49.7	32.1	0.1	54.0	29.3	1.6	1.2	42.1	12.5	6.9	13.5	49.7	38.2	41.7	23.1	20.4	68.9	60.0	42.5	19.4	25.2	52.8	26.8	19.0	9.4	17.5	22.4	16.3	18.4	25.2	5.7	38.0	9.1	37.7	5.7	43.9	26.1	23.6	43.7	17.6	10.6	46.9	11.5	35.1	18.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.1	0.2	3.0	3.8	4.3	3.9	2.9	2.5	3.2	3.0	3.8	2.8	3.1	3.7	0.0	0.0	0.0	1.0	0.7	0.3	0.7	0.5	1.8	0.0	0.5	0.5	0.8	0.0	0.1	0.0	0.0	4.3	0.4	1.8	0.0	0.3	2.7	2.3	0.8	0.5	0.0	7.2	2.8	0.0	9.4	1.1	0.5	8.0	4.5	5.6	0.4	0.0	2.6	0.0	1.1	1.3	0.0	0.3	0.3	0.7	0.0	0.4	0.0	0.0	0.0	0.0	1.0	1.0	2.9	0.3	0.1	0.0	4.7	0.4	0.4	0.0	0.1	0.0	0.0	0.4	4.0	12.4	5.6	3.1	0.3	1.6	1.1	0.2	2.9	1.0
RAD54L2	"ARIP4, KIAA0809, SRISNF2L"	ENSG00000164080	"RAD54 like 2"	Q9Y4B4	3	51541144-51668667	"Enzymes, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035004, HPA039992, HPA077351"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA035004: AB_10671930, HPA039992: AB_2676789, HPA077351: "	"unprognostic (1.46e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.71e-5)"	"unprognostic (3.72e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.63e-2)"	4.6	4.8	5.6	3.7	6.1	6.1	4.6	6.5	5.6	4.8	2.9	5.8	2.5	5.6	4.2	4.0	4.6	2.7	4.4	5.0	5.2	4.0	7.8	4.9	4.2	5.5	5.7	5.3	5.3	3.8	4.5	4.8	5.5	4.4	3.4	7.5	4.5	3.9	7.1	5.5	5.0	4.1	5.3	5.2	5.2	5.0	6.3	6.2	4.6	5.3	5.2	4.8	4.3	6.2	6.6	5.1	12.8	12.7	7.0	5.0	6.7	5.5	7.8	7.4	6.9	9.1	3.8	17.4	1.5	9.7	7.8	5.0	20.5	6.8	9.1	9.2	4.6	14.9	11.5	6.0	6.4	16.8	8.5	5.8	5.4	11.3	10.9	4.6	8.3	14.8	10.3	9.1	5.9	5.1	15.0	7.6	10.2	3.2	5.5	6.9	9.9	2.3	3.8	8.4	5.2	10.0	8.7	8.2	5.7	7.7	5.4	9.9	10.9	7.7	8.9	8.0	10.8	9.8	10.7	16.8	8.3	9.2	10.0	3.1	2.2	2.2	3.3	2.6	3.5	1.8	2.9	2.8	2.3	2.9	1.9	2.3	0.9	3.0	3.5	2.3	2.9	2.2	5.6	6.1	6.5	5.6	5.0	5.2	5.5	5.7	5.5	5.3	6.3	6.2	10.8	9.6	14.4	31.3	11.3	9.2	8.6	6.7	3.4	33.8	8.7	8.0	11.0	15.7	7.8	9.2	31.3	19.3	12.2	7.7	1.9	9.3	7.5	9.5	12.0	15.1	16.3	3.8	54.9	10.4	8.7	9.6	9.2	19.8	18.3	14.2	10.4	21.9	8.9	47.1	54.3	8.1	4.1	9.1	8.4	3.1	15.2	9.4	14.2	26.2	13.2	9.1	30.9	42.7	42.3	13.9	9.7	17.0	11.3	12.4	4.6	4.4	9.5	29.9	13.1	17.1	11.6	43.9	36.4	5.5	8.9	29.7	12.5	10.1	7.9	12.5
RAI1	"DKFZP434A139, KIAA1820, MGC12824, SMCR, SMS"	ENSG00000108557	"Retinoic acid induced 1"	Q7Z5J4	17	17681458-17811453	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023898, HPA054906"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA023898: AB_10971089, HPA054906: AB_2682637"	"unprognostic (7.57e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (2.61e-2)"	"unprognostic (5.29e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.28e-2)"	6.8	10.5	5.9	7.4	5.2	4.9	9.3	5.7	13.0	17.2	1.4	13.1	6.3	16.4	3.4	11.6	15.1	7.4	12.7	3.9	2.4	9.2	5.3	10.8	5.8	4.9	0.4	15.9	10.1	10.2	18.0	4.6	1.2	16.1	2.7	8.9	15.3	9.5	5.7	12.5	8.4	6.3	0.1	11.8	10.9	6.4	0.8	7.1	14.5	1.8	4.3	15.6	14.4	4.3	29.3	39.0	24.2	20.0	3.2	6.5	4.2	9.9	10.5	8.1	7.9	20.4	12.1	9.4	13.3	12.9	6.9	33.8	8.5	19.7	3.4	9.3	19.0	17.2	24.4	10.4	10.5	6.9	10.4	7.5	9.4	7.4	11.0	9.6	10.1	11.8	7.5	7.5	4.2	25.9	14.7	6.7	1.7	15.1	11.4	34.2	18.9	13.4	6.6	34.6	16.8	30.0	15.6	13.6	32.2	27.8	18.3	8.6	19.6	12.8	16.3	20.7	14.1	6.6	1.6	5.9	12.5	8.4	35.7	0.0	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.0	0.6	0.3	0.7	0.0	0.2	5.9	5.2	5.7	13.0	3.9	2.4	4.9	0.4	1.2	0.1	0.8	4.3	6.1	12.8	20.5	24.8	4.7	12.1	10.8	11.7	12.0	28.7	14.1	10.2	4.0	11.5	14.0	14.7	22.9	0.1	10.0	4.8	0.0	18.4	2.5	9.4	9.6	11.0	11.4	4.6	37.3	9.0	0.8	8.0	12.8	10.5	14.0	7.7	15.4	6.2	2.4	23.5	35.9	7.1	4.1	3.5	8.7	4.9	6.8	4.5	8.8	14.0	5.9	6.8	7.2	26.2	17.1	13.5	2.5	6.0	1.7	11.6	2.2	1.8	7.3	13.1	6.6	5.0	7.6	1.2	11.7	10.5	8.8	0.4	6.8	12.4	8.5	12.9
RAN	"ARA24, Gsp1, TC4"	ENSG00000132341	"RAN, member RAS oncogene family"	P62826	12	130872037-130877678	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Host-virus interaction, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA063353			Enhanced	Nucleoplasm		No	No		4000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA063353: "	"unprognostic (2.22e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.39e-3)"	"prognostic unfavorable (9.99e-8)"	"unprognostic (2.81e-3)"	"unprognostic (1.28e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (7.86e-5)"	"prognostic unfavorable (1.46e-7)"	"unprognostic (6.55e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.62e-1)"	"unprognostic (3.16e-2)"	285.3	333.2	207.7	340.1	222.3	406.0	220.5	212.1	265.0	193.6	204.5	269.1	177.8	207.6	238.1	445.6	180.6	148.9	256.9	220.6	260.3	249.0	208.2	225.9	416.4	207.2	213.3	180.7	192.9	210.6	180.1	243.0	231.0	149.7	266.6	213.3	200.4	155.5	415.0	231.2	220.0	250.1	228.5	255.9	223.4	308.6	236.5	577.6	166.8	383.7	480.6	380.9	244.7	230.2	1391.5	1850.5	1580.8	921.6	707.0	868.2	1219.5	1770.2	926.2	1695.1	1163.1	2003.5	1434.2	2260.7	1169.3	1290.0	1067.9	877.0	2327.1	1854.5	1830.8	766.9	1831.5	1331.9	1318.9	2068.9	864.1	2347.9	1100.3	821.9	1129.3	1470.6	2111.6	1119.9	1671.0	1593.5	2013.6	656.5	1686.3	1688.2	2306.9	2810.1	1857.8	1429.2	2936.2	1773.9	1347.2	1274.4	1608.2	2377.1	1441.5	875.0	1018.5	920.7	1334.4	1299.9	1817.9	1666.5	1157.6	975.6	1495.0	998.8	1694.1	905.2	1605.1	3245.4	1002.2	1410.7	1390.4	285.0	398.0	275.5	501.5	489.3	614.6	726.4	682.5	581.4	531.7	593.3	611.5	585.9	80.7	500.4	481.0	506.9	768.0	1005.0	207.7	222.3	212.1	265.0	220.6	260.3	207.2	213.3	231.0	228.5	236.5	230.2	321.3	182.7	141.5	18.6	337.4	635.3	693.4	702.0	406.3	155.3	239.0	316.0	112.6	165.8	310.5	169.2	37.5	734.2	273.6	157.0	387.4	642.1	90.2	212.9	280.8	306.2	201.9	540.9	27.8	452.8	1266.0	379.6	181.0	201.3	194.0	273.1	143.8	181.6	624.5	139.7	25.8	300.5	349.9	171.7	424.1	148.1	213.4	239.7	332.6	9.4	417.0	287.5	219.4	19.6	23.5	596.4	189.1	230.9	418.2	954.8	167.2	423.2	214.3	141.6	164.3	286.0	600.8	746.4	571.6	578.0	547.0	613.1	332.3	451.9	403.6	621.0
RANBP2	"ADANE, ANE1, NUP358"	ENSG00000153201	"RAN binding protein 2"	P49792	2	108719482-108785809	"Cancer-related genes, Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway"	"RNA-binding, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018437, HPA023960, CAB034063, HPA049497, HPA051675, HPA067564"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Vesicles"		NA	NA		160000	"Cluster 38: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nuclear membrane"	"Nucleoplasm, Vesicles"	"CAB034063: AB_2176784, HPA018437: AB_2620151, HPA023960: AB_2671385, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862"	"unprognostic (2.51e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.30e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.23e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.62e-2)"	"unprognostic (8.74e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.53e-1)"	20.3	24.3	8.6	16.3	11.6	42.1	19.7	14.4	17.1	18.1	20.3	15.6	13.4	17.7	20.5	14.3	14.6	13.7	14.9	11.8	9.4	18.1	17.4	14.0	18.6	9.2	8.1	24.4	20.2	30.1	21.5	16.5	9.5	20.9	15.2	26.5	16.4	17.2	30.3	17.2	13.4	15.2	8.6	15.0	17.6	21.3	8.2	23.3	28.4	23.6	18.0	16.9	12.1	12.2	40.5	24.2	34.1	31.0	38.7	34.5	32.9	35.5	28.0	28.7	25.1	60.7	18.9	63.2	26.8	37.2	35.3	33.1	58.9	36.9	41.5	38.9	28.5	65.9	30.3	43.2	22.5	77.9	21.3	29.1	27.5	44.9	34.7	28.3	44.5	27.1	71.9	34.0	38.4	22.3	34.8	31.6	43.0	20.3	28.7	32.3	52.3	30.7	25.3	49.6	49.4	22.6	31.5	26.7	34.7	20.4	17.2	35.4	53.5	29.8	39.6	21.2	40.2	27.9	44.4	55.8	23.1	34.4	23.5	5.4	2.6	2.7	3.7	1.7	4.1	2.7	3.0	3.4	2.2	2.7	2.9	3.3	3.9	2.2	3.6	2.6	2.7	1.4	8.6	11.6	14.4	17.1	11.8	9.4	9.2	8.1	9.5	8.6	8.2	12.2	54.5	76.9	85.3	48.6	91.5	55.7	34.5	39.1	61.5	51.2	34.1	25.8	103.9	38.6	63.0	58.8	73.0	28.8	96.1	28.9	1.9	34.7	77.3	83.6	65.3	55.7	106.4	50.5	125.5	50.9	17.5	56.5	68.3	142.1	84.9	52.2	31.4	56.6	47.9	32.0	92.2	59.5	44.7	44.9	80.7	32.9	38.5	114.0	48.0	55.3	57.0	20.0	34.0	44.2	80.0	41.5	29.9	56.1	118.4	44.1	28.8	15.6	67.0	40.5	46.0	56.9	59.0	78.3	65.4	53.3	67.8	40.6	104.8	25.3	38.3	38.7
RANBP9	RanBPM	ENSG00000010017	"RAN binding protein 9"	Q96S59	6	13621498-13711835	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 113.6;Excitatory neurons: 132.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033767, HPA050007, HPA076784"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"CAB033767: AB_2176959, HPA050007: AB_2680990, HPA076784: "	"unprognostic (3.59e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.78e-1)"	"prognostic favorable (9.97e-4)"	"unprognostic (1.30e-1)"	"unprognostic (4.61e-2)"	"unprognostic (5.87e-3)"	"prognostic favorable (2.47e-4)"	"unprognostic (1.61e-1)"	"unprognostic (6.74e-2)"	"unprognostic (3.51e-1)"	"unprognostic (7.19e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.49e-1)"	"unprognostic (3.09e-1)"	21.8	20.3	23.3	16.7	25.2	57.3	18.3	22.2	32.4	28.3	21.5	27.5	13.2	20.6	22.2	69.1	15.3	24.6	20.0	25.5	22.6	18.7	26.4	17.9	18.5	20.3	24.3	19.7	17.4	24.1	16.7	20.0	22.7	21.3	18.0	21.0	24.3	17.2	60.5	27.7	15.5	23.5	22.0	15.1	17.9	106.4	21.7	29.7	16.5	39.5	30.8	21.6	38.2	25.4	38.1	16.3	38.7	39.3	51.9	47.8	41.0	45.6	51.6	47.2	49.5	24.8	21.9	33.4	73.0	54.0	35.7	20.3	30.5	26.8	64.6	58.0	27.5	33.6	29.9	45.9	71.7	53.0	24.5	48.7	33.8	56.0	45.9	37.4	39.0	58.3	73.3	26.2	53.1	38.5	62.1	42.0	17.1	36.2	22.6	49.1	30.2	47.1	37.7	43.2	47.9	33.7	36.9	66.3	67.0	73.4	35.6	44.6	38.3	42.3	30.2	34.7	47.4	63.5	82.3	44.9	19.4	32.8	80.1	0.3	0.5	1.8	0.7	0.7	1.4	0.7	1.5	0.7	0.5	0.7	1.3	0.9	0.8	1.2	0.8	0.8	3.6	0.4	23.3	25.2	22.2	32.4	25.5	22.6	20.3	24.3	22.7	22.0	21.7	25.4	17.2	19.2	30.5	58.1	12.5	24.9	7.8	13.5	13.1	25.1	23.3	15.0	40.1	12.8	19.2	18.4	14.6	17.9	22.3	21.7	1.9	8.2	113.6	23.5	21.8	24.0	13.2	11.6	132.9	10.8	9.1	19.8	10.2	29.6	10.1	19.5	16.8	18.3	18.0	6.7	78.3	14.5	12.2	28.0	32.3	99.9	15.8	21.8	17.8	73.1	14.9	22.8	15.5	74.9	75.6	16.6	7.3	24.8	18.3	15.5	12.2	11.4	19.8	17.5	6.6	16.5	18.5	85.4	41.9	19.3	26.1	28.5	22.9	14.3	12.0	17.7
RANGRF	"HSPC165, HSPC236, MOG1, RANGNRF"	ENSG00000108961	"RAN guanine nucleotide release factor"	Q9HD47	17	8288654-8290092	"Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 435.1;Late spermatids: 1448.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057280, HPA057888"	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 35: T-regs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA057280: AB_2683393, HPA057888: AB_2683549"	"unprognostic (2.87e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.41e-2)"	"prognostic favorable (1.65e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (4.39e-4)"	"unprognostic (1.43e-1)"	"unprognostic (6.34e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.13e-2)"	28.3	27.6	40.9	18.8	42.4	20.5	29.2	39.9	43.8	47.4	40.6	38.1	15.8	36.9	31.9	15.7	35.1	16.9	41.6	40.6	42.5	44.2	18.6	25.3	33.0	40.6	41.3	36.3	15.1	43.8	32.7	22.7	41.1	35.5	15.9	34.8	13.1	27.6	24.1	19.4	28.1	27.1	41.4	33.3	39.0	78.4	43.1	34.0	25.1	26.0	32.3	34.7	23.3	41.0	52.8	59.5	41.0	42.7	30.0	41.0	35.4	29.7	59.9	75.3	72.7	30.4	20.3	98.4	31.7	35.9	29.7	58.0	77.7	39.3	53.7	71.2	97.6	46.6	45.0	46.6	72.9	30.7	66.2	39.6	75.1	66.4	66.4	38.9	65.5	93.4	21.2	27.1	48.9	1.3	91.7	98.4	29.7	29.8	22.7	81.1	32.0	61.8	44.4	21.3	15.7	45.2	23.5	36.2	65.0	25.9	2.8	28.3	36.3	16.4	29.5	33.0	58.4	47.5	40.0	121.4	35.1	60.8	24.1	17.2	47.6	81.5	68.2	50.7	64.4	74.7	82.8	78.1	51.5	82.0	72.3	61.6	5.9	70.1	41.0	67.8	129.9	57.5	40.9	42.4	39.9	43.8	40.6	42.5	40.6	41.3	41.1	41.4	43.1	41.0	21.2	9.6	26.1	6.2	35.8	18.1	24.3	23.5	25.0	26.2	31.4	36.2	4.7	12.8	17.5	25.8	12.5	93.2	25.4	9.4	68.4	25.5	435.1	19.0	18.8	26.0	19.8	15.4	6.2	18.3	46.4	25.3	14.8	19.3	27.8	19.0	23.9	17.3	49.3	20.2	9.0	17.4	26.4	16.4	19.2	1448.8	28.3	18.9	17.8	1.9	29.5	33.6	58.7	3.0	9.5	21.1	21.2	31.6	37.5	22.9	14.3	66.7	14.3	38.4	19.7	16.3	34.0	180.6	23.0	10.6	19.6	112.9	35.6	28.1	21.8	16.1
RBAK	ZNF769	ENSG00000146587	"RB associated KRAB zinc finger"	Q9NYW8	7	5045821-5069487	"Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071231			Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA071231: AB_2686370"	"unprognostic (2.82e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.04e-1)"	"unprognostic (4.32e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.67e-2)"	"unprognostic (5.91e-2)"	"unprognostic (6.84e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.66e-2)"	"unprognostic (6.12e-3)"	"unprognostic (5.75e-2)"	4.3	3.8	4.1	4.4	4.0	3.7	5.8	6.7	5.4	4.7	3.7	4.6	4.5	5.2	4.7	5.8	4.4	3.7	4.3	3.8	4.5	4.4	6.5	4.0	6.4	4.5	5.0	4.8	5.5	6.9	3.9	4.5	4.4	4.7	4.9	8.4	4.6	4.7	4.2	6.0	5.1	4.4	4.2	5.1	5.0	2.9	4.8	5.6	5.5	6.1	6.7	4.1	4.6	4.8	8.9	6.7	9.2	17.0	6.6	6.1	7.5	5.5	4.3	5.3	6.3	8.3	5.4	10.5	4.5	6.4	10.0	10.8	10.4	8.5	8.2	2.3	7.4	7.7	9.2	6.9	7.0	12.9	8.9	5.9	9.9	5.3	11.8	7.7	5.3	6.1	16.2	3.7	6.7	15.7	3.2	11.9	14.5	3.0	7.0	5.3	14.9	7.7	6.1	11.3	9.4	15.4	7.7	12.6	11.5	11.7	7.7	15.3	4.5	6.3	10.0	7.3	9.1	11.4	9.7	9.2	6.3	9.5	8.2	0.0	0.2	0.4	0.5	0.4	0.7	0.3	0.4	0.3	0.3	0.3	0.5	0.4	0.0	0.5	0.1	0.4	0.3	0.1	4.1	4.0	6.7	5.4	3.8	4.5	4.5	5.0	4.4	4.2	4.8	4.8	7.4	0.0	8.2	0.0	6.5	4.2	3.4	4.7	5.2	8.2	6.1	3.9	13.4	7.2	7.3	0.0	10.4	2.8	7.9	5.1	1.9	5.9	1.1	7.5	10.1	6.1	4.9	11.6	0.0	5.8	2.2	6.7	8.6	6.9	5.7	11.7	7.9	5.3	3.7	21.9	0.0	5.6	2.0	8.2	4.0	1.4	8.1	5.2	3.6	0.0	5.7	6.0	5.2	0.0	0.0	6.0	3.8	8.6	6.7	5.9	5.6	3.7	8.8	8.2	0.0	8.8	7.0	5.0	3.2	7.5	7.0	1.9	6.4	9.1	6.1	4.2
RBBP4	"lin-53, NURF55, RbAp48"	ENSG00000162521	"RB binding protein 4, chromatin remodeling factor"	Q09028	1	32651142-32686211	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB006264, HPA060710, HPA060724"	Supported		Enhanced	Nucleoplasm		NA	NA		150000	"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB006264: AB_425651, HPA060710: AB_2684347, HPA060724: AB_2684350"	"unprognostic (1.18e-3)"	"unprognostic (1.79e-3)"	"unprognostic (2.96e-3)"	"unprognostic (1.82e-2)"	"prognostic favorable (9.23e-4)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (1.89e-6)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (1.57e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.36e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.88e-2)"	32.0	38.8	19.9	33.5	21.8	34.8	38.5	24.7	21.1	40.3	21.5	33.3	27.0	42.4	35.1	32.1	45.5	25.3	31.7	18.7	21.8	31.9	30.6	28.8	62.9	21.4	21.1	46.9	38.5	34.0	31.1	34.6	23.0	30.0	45.9	56.2	38.3	30.7	42.9	33.2	35.7	42.1	22.9	32.7	37.1	75.5	21.3	58.0	45.8	21.1	91.5	35.2	31.2	30.1	68.8	59.1	166.2	120.1	49.9	47.4	66.7	55.3	44.9	103.0	99.7	85.5	135.6	206.9	54.8	61.4	62.7	42.9	184.7	53.6	110.0	80.9	88.3	194.3	112.0	111.9	72.3	183.9	79.9	52.2	66.8	78.1	50.3	83.6	77.2	139.8	138.0	142.1	89.0	48.0	239.4	57.6	185.4	67.0	67.8	228.3	173.8	181.0	72.4	143.4	156.7	94.7	122.1	41.9	83.8	161.3	71.9	83.3	64.3	63.8	61.6	80.4	70.2	113.4	128.0	229.5	75.2	146.9	99.3	79.1	99.9	68.5	74.4	99.8	77.4	79.6	69.8	75.2	115.0	60.1	61.2	67.3	24.8	87.7	95.4	95.7	77.9	151.8	19.9	21.8	24.7	21.1	18.7	21.8	21.4	21.1	23.0	22.9	21.3	30.1	61.6	41.7	53.7	32.3	115.8	71.5	68.3	76.8	120.1	106.1	105.2	57.3	22.2	77.2	59.1	73.5	143.9	129.2	132.0	55.4	84.1	84.7	26.3	51.2	89.0	65.7	97.1	201.4	38.0	58.3	87.6	81.3	70.3	71.6	49.4	93.3	64.6	76.5	80.6	106.0	41.5	83.9	79.3	78.8	74.3	17.5	79.6	80.8	49.8	22.5	90.7	77.4	91.6	44.2	49.7	76.1	42.1	88.4	201.8	59.5	44.3	65.9	50.5	109.2	98.6	47.6	76.9	154.2	88.8	132.5	77.4	85.5	95.4	79.5	86.9	58.7
RBBP5	"RBQ3, SWD1"	ENSG00000117222	"RB binding protein 5, histone lysine methyltransferase complex subunit"	Q15291	1	205086142-205122015	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049042, HPA058085"	Uncertain		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Nucleoli"		"HPA049042: AB_2680610, HPA058085: AB_2683600"	"unprognostic (8.72e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.75e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.78e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.88e-2)"	6.3	8.2	4.7	7.2	5.3	9.5	7.9	6.4	6.4	7.8	2.7	7.0	7.1	8.1	7.5	7.0	7.5	6.1	6.4	5.7	5.3	12.4	11.0	6.6	11.3	3.4	3.8	9.5	8.2	9.4	6.1	6.5	3.8	6.9	8.0	9.8	7.6	6.9	8.7	8.5	6.7	7.1	4.3	9.3	6.7	6.1	4.5	13.2	9.8	9.9	12.8	7.5	5.2	6.4	16.3	16.9	16.0	19.0	21.8	12.5	17.3	15.2	12.9	19.0	18.8	17.9	19.1	25.3	11.3	11.1	15.5	18.2	26.9	10.1	22.4	21.6	14.5	21.2	16.4	14.6	14.1	26.9	16.6	10.1	12.9	17.6	15.0	12.7	15.4	17.9	41.6	25.2	16.0	15.0	26.1	11.3	26.1	14.2	27.9	22.9	33.9	31.6	13.2	11.7	25.0	20.1	21.3	22.3	19.2	19.0	24.2	14.9	11.8	15.6	16.6	23.1	20.2	12.2	18.3	30.6	13.9	16.5	24.5	22.0	4.9	7.9	8.0	6.4	8.5	7.8	7.4	8.1	5.4	6.2	7.1	8.7	11.6	8.2	8.3	6.0	8.1	3.5	4.7	5.3	6.4	6.4	5.7	5.3	3.4	3.8	3.8	4.3	4.5	6.4	14.7	19.2	12.2	11.4	31.0	26.9	9.7	5.9	15.9	14.5	18.9	14.6	7.1	8.6	13.4	22.0	29.2	9.1	25.2	15.8	9.8	12.1	7.3	13.1	14.0	13.2	12.1	23.1	19.9	11.6	10.7	13.5	9.7	21.0	13.9	25.6	17.2	21.8	10.9	16.8	15.7	14.0	10.2	15.6	25.9	3.2	12.8	17.9	19.6	8.4	15.6	12.6	15.5	14.6	21.2	13.6	9.8	16.1	25.9	13.5	14.7	28.8	13.2	18.3	19.7	21.9	14.1	10.2	20.4	14.6	33.8	10.8	27.9	12.6	15.8	13.4
RBBP6	"P2P-R, PACT, SNAMA"	ENSG00000122257	"RB binding protein 6, ubiquitin ligase"	Q7Z6E9	16	24537693-24572863	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA replication, Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 143.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032866, HPA041725, HPA043544"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"		"CAB032866: AB_2177791, HPA041725: AB_2677639, HPA043544: AB_2678543"	"unprognostic (1.04e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.83e-2)"	27.1	25.0	22.9	21.1	23.8	143.6	25.9	33.1	29.9	27.8	21.7	31.5	15.0	33.6	26.3	23.2	32.4	25.5	23.9	22.8	23.5	24.3	26.8	27.9	29.7	24.2	22.8	38.8	22.2	21.8	28.1	31.7	24.4	26.0	20.4	51.1	21.4	19.9	29.7	34.6	26.0	24.1	23.9	29.4	25.6	45.5	24.4	26.6	27.2	25.7	23.5	25.3	24.7	27.7	35.4	18.4	42.5	44.4	31.9	32.9	45.9	28.1	26.1	25.1	27.3	20.5	28.3	49.6	20.3	24.4	28.7	33.3	46.2	24.8	41.9	26.9	35.7	41.9	57.1	58.6	24.7	57.5	23.7	28.8	33.7	33.2	38.9	28.6	36.9	42.2	54.5	43.8	29.7	36.5	45.5	51.2	48.7	24.0	17.3	62.8	42.5	43.3	24.7	31.7	33.4	28.5	39.7	35.1	52.3	47.0	27.4	49.7	32.3	31.0	22.8	27.0	30.8	37.7	40.9	60.9	25.1	36.5	26.1	7.1	1.2	2.0	2.0	2.0	2.2	2.0	2.1	1.5	0.9	1.7	1.8	2.0	2.5	3.5	1.1	3.7	1.7	0.6	22.9	23.8	33.1	29.9	22.8	23.5	24.2	22.8	24.4	23.9	24.4	27.7	139.1	86.6	115.3	47.3	125.7	100.7	103.5	40.8	223.1	67.1	145.6	160.8	147.0	44.3	56.5	27.6	100.1	46.3	88.9	71.5	25.4	48.8	307.5	109.8	123.7	93.7	82.0	83.1	52.5	47.6	57.6	127.1	121.8	203.1	51.3	127.8	64.2	59.5	38.4	62.2	53.4	76.0	28.5	53.5	70.2	41.9	72.4	101.5	62.2	54.4	54.0	53.1	52.5	61.3	58.7	56.4	32.8	58.6	173.7	99.9	54.5	23.9	52.0	61.4	52.6	247.0	112.9	100.3	45.8	161.0	101.7	101.5	110.2	105.3	69.3	111.9
RBBP7	RbAp46	ENSG00000102054	"RB binding protein 7, chromatin remodeling factor"	Q16576	X	16839283-16870362	"Predicted intracellular proteins"	"DNA replication, Transcription, Transcription regulation"	"Chaperone, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 440.4;Syncytiotrophoblasts: 532.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037084, HPA060710, HPA060724"	Supported		Enhanced	Nucleoplasm		NA	NA		140000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"CAB037084: AB_477448, HPA060710: AB_2684347, HPA060724: AB_2684350"	"unprognostic (5.18e-1)"	"unprognostic (3.29e-2)"	"unprognostic (6.68e-3)"	"unprognostic (1.09e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (5.55e-4)"	"unprognostic (3.64e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.00e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (2.43e-4)"	"unprognostic (5.65e-2)"	47.1	280.4	28.9	57.0	35.7	99.8	63.8	27.7	39.8	133.1	40.1	73.0	55.0	90.5	293.7	67.1	96.3	49.8	86.5	32.0	31.0	60.9	56.7	42.9	89.8	29.4	25.9	132.8	46.8	194.2	42.5	96.4	28.8	81.9	73.0	61.4	62.1	166.4	132.8	61.2	57.2	101.0	30.1	47.7	64.4	94.5	27.4	88.7	57.9	90.0	106.5	67.9	51.7	34.2	298.0	219.5	159.5	212.2	99.8	116.6	103.0	143.7	144.7	207.7	233.9	128.6	190.4	328.0	215.2	141.6	236.3	153.1	291.5	214.4	275.2	186.2	400.6	138.9	247.7	153.1	83.8	212.1	160.3	91.3	77.8	240.6	174.9	133.3	211.9	134.6	141.5	167.2	166.9	200.2	236.1	194.0	181.7	141.5	199.5	204.3	295.3	386.7	151.9	197.6	149.3	110.7	271.9	128.3	133.9	225.8	426.8	126.5	99.0	99.5	102.1	265.7	162.8	116.6	178.6	429.3	127.7	140.8	123.3	50.9	45.3	62.3	85.1	79.5	82.6	92.0	70.6	89.4	63.6	80.0	73.3	82.9	18.2	89.2	111.7	74.1	72.1	77.2	28.9	35.7	27.7	39.8	32.0	31.0	29.4	25.9	28.8	30.1	27.4	34.2	52.0	51.3	65.0	18.6	69.5	74.8	105.7	98.0	33.6	31.4	53.5	51.1	105.1	42.9	80.8	55.2	29.2	440.4	89.8	41.9	78.2	87.3	14.5	55.0	58.0	50.7	60.7	70.2	26.6	74.3	170.8	87.7	44.9	54.8	57.7	101.8	41.4	36.4	109.3	25.2	20.7	57.4	81.4	33.5	39.6	31.2	113.7	43.7	83.6	16.9	60.4	79.4	72.1	46.3	24.7	75.7	39.0	187.3	89.6	75.3	48.6	64.2	63.8	43.6	138.1	73.8	134.3	109.9	121.1	52.5	61.1	532.2	67.8	81.9	79.3	74.2
RBBP8	"COM1, CtIP, RIM, SCKL2"	ENSG00000101773	"RB binding protein 8, endonuclease"	Q99708	18	22798261-23026488	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 125.9;Spermatocytes: 116.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 36.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039890, HPA052946"	Approved		Supported	Nucleoplasm		NA	Yes			"Cluster 51: Monocytes - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA039890: AB_10794756, HPA052946: AB_2681996"	"unprognostic (1.55e-3)"	"unprognostic (4.10e-3)"	"unprognostic (7.89e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (7.21e-4)"	"unprognostic (2.29e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.04e-2)"	"prognostic favorable (1.71e-5)"	"unprognostic (3.91e-3)"	"unprognostic (2.42e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.48e-1)"	10.1	8.7	6.8	10.0	6.8	18.2	29.4	9.2	11.3	20.9	41.6	14.5	9.3	20.1	23.4	22.1	28.0	12.7	7.0	7.4	9.2	42.2	14.4	13.5	14.0	6.3	7.3	6.4	18.5	22.1	17.5	8.5	6.4	10.8	12.9	6.2	19.5	23.3	2.3	28.5	12.9	16.4	6.2	7.6	13.1	28.7	8.5	32.4	18.2	3.5	17.3	18.3	18.0	7.3	32.9	24.8	36.0	41.9	18.2	19.4	28.2	44.2	31.1	40.3	56.5	45.7	36.3	95.4	19.9	27.9	38.5	67.3	41.2	89.9	78.5	68.3	33.2	41.8	32.0	44.0	22.2	151.5	43.7	13.9	86.0	61.0	105.3	23.6	16.6	65.7	25.0	69.2	41.6	49.1	112.8	50.6	34.2	60.1	41.5	57.6	65.9	58.9	117.4	34.7	84.1	39.8	74.1	22.4	39.0	20.5	129.1	39.4	12.0	107.2	49.3	52.4	78.0	92.9	108.4	105.3	49.1	72.2	58.8	17.0	6.5	3.9	1.2	24.0	0.5	6.6	1.7	2.1	8.2	5.3	0.9	1.5	2.4	7.9	36.7	8.1	4.7	3.8	6.8	6.8	9.2	11.3	7.4	9.2	6.3	7.3	6.4	6.2	8.5	7.3	13.1	35.3	42.8	10.1	22.9	27.4	44.7	125.9	76.8	4.3	22.6	72.6	10.4	35.8	41.9	29.5	4.2	12.7	25.0	14.5	43.0	30.5	17.7	56.0	19.5	14.2	7.7	37.0	20.3	33.0	9.4	13.2	23.0	67.3	66.1	22.3	5.7	16.4	11.7	1.7	15.5	9.3	16.2	11.4	23.5	14.5	6.5	27.5	23.2	8.4	9.0	2.1	4.1	9.5	2.7	44.9	8.6	5.3	53.8	37.5	17.5	26.1	28.2	7.9	0.0	20.4	14.0	116.6	83.4	36.2	19.7	15.2	13.6	9.8	14.9	45.5
RBBP9	Bog	ENSG00000089050	"RB binding protein 9, serine hydrolase"	O75884	20	18486540-18497225	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 9.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015830, HPA049005"	Approved		Supported	Nucleoplasm		NA	NA		40000	"Cluster 38: Basophils - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA015830: AB_1845410, HPA049005: AB_2680597"	"unprognostic (1.17e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.21e-2)"	7.2	10.3	5.3	6.6	5.8	3.3	9.5	6.2	5.9	13.4	8.2	6.3	6.7	7.6	6.6	7.7	5.8	9.5	5.4	4.5	5.8	17.7	25.7	8.5	7.1	5.7	5.9	6.9	5.4	15.9	5.4	5.5	5.7	8.6	7.5	8.1	8.8	8.8	3.5	11.0	6.5	7.9	5.6	5.6	7.2	3.8	6.6	7.3	24.3	3.9	9.1	8.3	4.6	6.6	12.2	14.1	12.8	18.2	8.9	14.6	13.0	13.7	13.3	17.4	17.7	10.2	10.8	15.2	5.5	9.6	12.1	13.5	10.2	22.5	20.7	4.6	12.5	8.0	4.3	31.4	5.6	11.8	4.7	7.6	8.7	14.3	8.4	8.7	22.2	12.5	5.1	11.6	15.2	6.9	12.2	8.1	8.5	16.9	26.4	11.9	38.0	9.6	15.7	13.2	10.9	18.7	18.2	21.8	9.7	8.7	17.6	3.2	12.8	29.0	9.5	18.5	12.3	13.1	34.5	10.4	11.4	5.5	9.5	9.3	2.0	0.6	1.9	2.5	2.9	2.2	2.3	1.4	2.1	1.7	2.0	1.6	0.3	1.8	2.0	0.4	3.0	2.0	5.3	5.8	6.2	5.9	4.5	5.8	5.7	5.9	5.7	5.6	6.6	6.6	6.7	22.4	18.3	3.9	5.5	7.4	3.4	7.7	10.2	4.3	7.8	4.6	8.1	4.3	9.3	11.0	0.0	3.3	5.8	5.1	15.6	5.9	5.1	4.9	6.5	6.6	5.4	2.5	3.4	2.8	4.0	5.5	6.6	6.2	0.0	6.2	6.1	17.9	5.7	3.3	4.9	3.6	4.1	6.8	5.2	1.6	5.3	4.4	5.4	1.0	5.9	8.6	3.1	5.0	4.7	4.7	2.5	7.2	4.3	3.3	9.2	21.3	10.5	6.8	0.0	5.7	5.7	1.3	4.1	8.5	6.1	2.5	6.1	7.3	6.4	3.8
RBL1	"cp107, p107, PRB1"	ENSG00000080839	"RB transcriptional corepressor like 1"	P28749	20	36996349-37095997	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 23.3;Inhibitory neurons: 22.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA054962, HPA056525"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA054962: AB_2682652, HPA056525: AB_2683165"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.70e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.25e-5)"	"unprognostic (6.91e-2)"	"unprognostic (7.19e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.23e-2)"	"prognostic unfavorable (2.52e-6)"	"unprognostic (3.15e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.26e-1)"	2.0	1.6	1.2	4.8	2.6	14.5	2.8	8.3	1.8	2.3	0.7	2.8	2.4	2.8	1.3	2.9	1.9	2.0	1.8	1.0	1.9	1.6	1.4	2.2	7.3	2.0	1.9	4.4	2.4	2.6	1.1	3.4	2.2	2.0	3.5	4.0	1.5	1.4	6.9	3.1	2.5	2.8	1.4	3.4	2.7	3.1	2.0	8.8	2.7	7.9	6.7	2.0	2.2	3.4	24.8	15.8	19.4	13.1	4.9	6.4	12.4	28.2	12.6	23.9	24.6	16.8	13.5	27.5	7.9	11.8	14.0	23.8	17.5	18.2	39.7	9.7	9.4	27.2	18.1	14.3	3.0	35.3	18.2	3.0	2.5	31.6	11.1	4.0	13.6	17.9	20.1	25.8	13.7	10.5	33.1	11.7	5.7	12.5	15.3	21.3	57.7	20.9	5.5	12.2	4.6	11.5	30.8	17.6	8.2	6.2	11.3	25.3	9.1	42.0	15.9	38.9	24.8	8.6	16.4	27.7	30.2	24.4	21.1	0.9	0.7	1.4	2.7	0.8	2.3	3.0	3.0	2.5	1.3	2.1	3.2	2.7	0.3	2.2	1.2	3.0	4.5	0.9	1.2	2.6	8.3	1.8	1.0	1.9	2.0	1.9	2.2	1.4	2.0	3.4	3.5	6.4	11.0	10.4	8.7	2.4	1.5	1.7	4.0	5.9	2.5	1.7	2.9	1.5	6.1	0.0	2.1	5.9	6.5	1.8	0.0	1.8	1.5	2.2	4.3	3.3	1.2	23.3	14.7	1.1	5.1	4.6	2.6	2.9	8.8	9.0	2.2	1.4	4.5	3.3	22.8	1.9	0.0	3.0	3.2	0.6	2.1	6.8	1.8	6.5	4.7	3.1	7.2	19.6	18.5	0.9	3.6	3.0	14.1	0.8	1.0	0.7	0.9	12.2	6.6	8.5	4.1	17.5	8.7	5.3	1.3	3.8	11.7	6.4	3.5	0.9
RBM12	"HRIHFB2091, KIAA0765, SWAN"	ENSG00000244462	"RNA binding motif protein 12"	Q9NTZ6	20	35648925-35664956	"Disease related genes, Predicted intracellular proteins"		RNA-binding	"Disease variant, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043258, HPA043621"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA043258: AB_2678395, HPA043621: AB_2678584"	"unprognostic (8.94e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.04e-3)"	"unprognostic (7.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.19e-2)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (7.96e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.47e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.67e-1)"	"unprognostic (3.29e-1)"	"unprognostic (4.44e-1)"	"unprognostic (3.92e-1)"	"unprognostic (6.87e-2)"	24.5	20.2	2.6	28.7	3.5	30.2	22.6	23.2	8.0	18.2	7.6	24.5	20.3	28.6	12.4	23.4	26.6	23.7	18.4	2.9	9.6	17.7	18.5	22.9	39.9	4.1	4.1	39.0	19.9	25.2	13.9	30.2	3.7	23.4	24.1	27.4	19.3	19.3	19.2	17.6	20.2	28.5	0.9	27.0	22.2	23.0	6.2	50.6	23.0	17.2	44.8	36.4	17.0	10.4	87.9	57.6	121.3	74.5	29.1	57.0	74.5	47.7	56.1	65.5	64.0	80.4	60.3	157.5	51.8	96.0	68.3	60.7	144.8	121.9	83.3	74.8	52.2	132.0	56.6	54.2	50.0	145.1	67.9	82.0	61.7	75.2	49.7	41.8	73.9	84.0	128.1	73.9	58.0	64.3	172.8	40.8	88.4	56.7	59.2	104.2	149.0	77.0	47.0	142.2	63.9	82.9	85.1	66.0	64.3	99.2	85.1	52.4	104.9	54.8	81.0	54.3	71.7	79.7	93.4	165.3	48.3	55.3	72.9	6.7	10.5	8.9	11.7	11.6	13.6	12.2	10.4	13.7	12.7	11.5	10.7	9.8	7.5	9.9	9.8	8.1	10.1	11.5	2.6	3.5	23.2	8.0	2.9	9.6	4.1	4.1	3.7	0.9	6.2	10.4	22.6	25.6	24.1	0.0	28.7	29.6	23.8	17.4	19.4	15.8	19.4	19.3	22.5	17.2	19.2	3.7	27.1	21.5	35.8	17.1	1.9	14.9	4.8	20.7	24.0	18.7	24.6	25.2	0.0	17.8	18.5	22.6	11.2	24.9	26.6	31.5	20.0	14.0	18.5	8.4	0.0	20.4	20.3	24.6	20.6	4.8	14.6	25.7	16.0	0.0	23.7	13.5	21.6	0.0	0.0	21.0	14.6	16.6	22.9	18.5	15.0	9.8	25.3	14.4	6.6	28.0	22.6	15.1	17.4	21.8	29.5	17.5	29.7	18.7	19.8	27.8
RBM17	"MGC14439, SPF45"	ENSG00000134453	"RNA binding motif protein 17"	Q96I25	10	6089034-6117457	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037477, HPA037478"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA037477: AB_10671372, HPA037478: AB_2675494"	"unprognostic (8.55e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.11e-3)"	"unprognostic (6.23e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (4.57e-8)"	"unprognostic (3.78e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.44e-1)"	"unprognostic (8.32e-2)"	"prognostic unfavorable (4.31e-5)"	"unprognostic (1.82e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.01e-2)"	72.4	47.0	46.3	75.3	51.6	139.5	64.4	47.2	53.5	50.2	40.1	57.6	63.8	63.5	38.7	51.9	55.3	52.6	60.8	46.9	52.3	54.6	44.6	78.0	87.4	53.5	49.5	54.7	62.9	45.5	35.8	75.7	52.7	41.5	65.2	41.6	49.9	39.4	95.4	47.0	70.5	60.4	47.3	77.6	51.6	61.9	52.5	87.7	63.3	72.1	85.4	63.5	49.4	52.4	195.9	113.0	141.1	122.7	76.5	69.4	175.5	128.4	58.0	130.2	139.8	184.7	151.2	234.1	89.3	94.4	48.5	188.1	130.3	136.4	138.6	233.7	132.1	199.3	120.4	158.5	96.7	110.0	93.6	71.7	104.0	132.4	72.4	67.9	159.6	168.1	219.0	112.1	84.1	223.6	198.8	66.2	90.3	227.8	81.3	211.4	79.9	120.8	93.5	117.3	60.5	78.9	124.1	110.1	99.0	119.5	146.3	111.3	97.3	76.9	153.4	169.0	138.1	110.2	135.6	386.7	72.0	140.3	51.7	79.7	78.2	102.6	71.6	79.0	75.2	101.8	71.8	73.4	69.9	110.2	71.8	68.1	38.7	77.8	62.3	77.0	101.1	59.8	46.3	51.6	47.2	53.5	46.9	52.3	53.5	49.5	52.7	47.3	52.5	52.4	152.3	89.8	56.0	24.8	107.7	129.2	97.4	72.7	108.7	71.3	68.5	85.3	86.0	65.8	68.1	66.2	50.1	125.6	83.3	80.8	90.1	92.0	90.2	74.7	99.5	123.9	72.7	100.5	42.2	70.9	188.5	89.5	58.6	83.9	96.8	79.7	69.7	65.3	98.8	92.5	41.4	87.1	63.1	73.6	128.6	26.3	66.2	93.9	51.6	38.4	161.5	77.9	96.8	23.6	40.7	88.0	86.4	60.5	153.8	122.3	79.8	75.7	41.3	62.2	72.3	115.6	117.4	266.4	233.3	114.4	108.7	97.0	97.4	78.9	106.5	112.6
RBM22	"Cwc2, FLJ10290, fSAP47, ZC3H16"	ENSG00000086589	"RNA binding motif protein 22"	Q9NW64	5	150690792-150701077	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001634	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA001634: AB_1079746"	"unprognostic (1.94e-1)"	"unprognostic (1.17e-3)"	"unprognostic (6.86e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.04e-2)"	"prognostic unfavorable (5.50e-6)"	"unprognostic (7.08e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.58e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (7.29e-2)"	"unprognostic (2.37e-1)"	"unprognostic (7.82e-2)"	"unprognostic (9.87e-3)"	20.3	15.8	18.8	19.3	21.1	64.5	22.2	21.8	28.5	21.3	17.4	22.5	19.7	23.5	19.8	16.8	25.4	22.7	20.9	18.9	19.7	21.8	21.3	22.7	29.2	21.0	18.9	30.7	18.1	23.9	10.9	22.6	20.6	17.7	23.4	23.6	16.4	19.6	27.3	18.8	19.0	21.3	20.3	26.7	19.1	11.6	19.6	41.6	22.2	34.3	32.3	26.1	16.0	26.0	34.9	37.3	56.0	66.2	37.2	34.3	79.4	35.0	39.1	68.4	75.7	61.3	50.7	51.7	54.5	33.6	65.1	36.1	73.0	63.3	71.0	57.6	55.6	41.4	35.1	26.3	35.4	74.4	47.0	29.1	50.1	56.5	37.0	30.2	48.9	41.7	44.3	50.7	43.2	41.3	68.4	50.6	33.8	42.2	37.6	69.8	46.4	45.9	34.0	35.6	52.4	39.1	39.3	64.4	65.2	33.4	67.2	64.9	33.0	55.5	43.7	24.3	64.4	46.8	56.0	74.2	44.0	66.3	42.6	27.0	30.6	51.8	33.9	36.7	38.2	37.9	31.4	32.5	36.5	35.9	33.2	31.8	52.8	43.8	46.9	19.7	37.4	33.4	18.8	21.1	21.8	28.5	18.9	19.7	21.0	18.9	20.6	20.3	19.6	26.0	69.4	28.9	28.2	8.5	51.3	26.0	52.9	33.9	42.1	33.3	29.3	25.9	28.2	27.1	35.9	16.5	25.0	54.9	56.6	34.2	25.4	36.3	8.4	48.4	44.1	50.5	25.9	34.9	7.4	34.3	43.6	39.3	24.5	101.6	63.4	37.3	27.8	16.6	44.3	30.3	7.6	33.2	44.7	31.1	30.3	3.6	43.2	45.8	23.2	6.5	48.5	35.9	58.7	7.5	13.7	29.1	37.1	45.5	32.1	25.6	29.4	22.5	23.1	19.0	32.9	40.2	37.6	32.0	28.5	22.8	21.7	72.7	56.9	34.4	33.4	39.4
RBM23	"CAPERbeta, FLJ10482, RNPC4"	ENSG00000100461	"RNA binding motif protein 23"	Q86U06	14	22893204-22919182	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			HPA004144	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Intermediate filaments"	Nucleoplasm	"HPA004144: AB_1079747"	"unprognostic (5.93e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.73e-3)"	"unprognostic (2.29e-1)"	"prognostic favorable (8.06e-9)"	"unprognostic (4.41e-2)"	"unprognostic (3.06e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.81e-1)"	31.8	37.9	35.8	34.1	38.5	53.2	40.7	55.0	42.0	46.0	48.4	38.3	30.7	53.4	39.3	39.6	59.4	39.1	33.6	35.8	42.9	44.2	40.7	42.0	44.8	38.6	38.5	57.9	39.2	83.2	40.6	46.7	37.0	39.0	41.7	52.2	38.0	40.1	29.1	36.3	37.3	45.9	37.7	45.4	39.2	31.3	43.4	57.9	54.5	40.7	50.6	43.5	37.7	45.0	55.9	86.3	86.6	45.4	46.5	39.6	36.1	59.9	81.3	114.0	88.8	39.6	66.6	93.0	45.8	55.8	54.8	77.3	98.3	50.3	92.2	73.1	81.2	43.7	65.8	2.8	72.9	84.6	68.9	51.0	68.3	65.8	43.4	63.4	64.4	45.5	56.5	58.3	56.6	71.1	93.8	38.0	38.7	84.8	80.3	80.1	71.8	56.6	44.0	78.0	59.5	66.3	89.8	68.8	38.6	56.6	50.8	49.6	59.8	19.3	33.3	47.5	56.1	55.1	77.0	87.6	32.4	48.2	71.7	40.1	47.7	50.7	37.1	37.0	25.1	29.3	26.3	32.2	49.5	34.7	31.5	28.2	136.6	59.7	49.7	24.6	30.0	32.0	35.8	38.5	55.0	42.0	35.8	42.9	38.6	38.5	37.0	37.7	43.4	45.0	36.8	44.8	48.3	12.1	82.3	18.4	44.7	28.4	27.9	66.4	38.7	35.9	24.3	68.6	42.7	33.1	116.7	53.0	53.8	48.8	45.0	36.3	9.5	55.1	36.8	39.5	65.4	54.1	13.5	33.5	48.0	32.0	36.7	41.4	70.9	27.2	53.2	37.2	31.5	50.5	16.1	39.3	20.3	54.9	33.6	11.9	35.4	40.4	16.0	19.7	70.8	52.4	102.0	18.6	15.3	39.7	55.1	28.2	42.2	29.1	57.3	33.1	64.0	164.2	32.9	47.8	32.1	52.0	64.3	22.0	21.0	101.4	64.0	28.1	42.3	27.8
RBM25	"fSAP94, NET52, RNPC7, S164, Snu71"	ENSG00000119707	"RNA binding motif protein 25"	P49756	14	73058532-73123899	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003025, HPA070713"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA003025: AB_1079748, HPA070713: AB_2686302"	"unprognostic (1.15e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.85e-2)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (4.22e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (8.09e-4)"	"prognostic unfavorable (4.26e-4)"	"unprognostic (6.98e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.73e-1)"	31.4	23.2	14.7	36.0	16.2	72.6	30.7	21.5	20.9	28.7	17.2	28.9	23.4	31.4	22.7	28.9	29.5	21.2	22.2	14.5	19.3	20.8	21.2	30.3	40.0	14.9	13.7	31.1	33.2	22.7	25.3	26.7	16.1	22.5	24.0	41.9	31.4	19.8	41.1	33.3	29.9	23.2	12.5	29.7	27.7	28.5	15.9	36.4	29.3	21.9	33.4	28.1	29.8	20.7	97.8	55.6	86.9	66.6	38.1	44.6	76.5	78.4	54.6	59.5	65.2	74.5	61.2	116.7	40.5	54.0	45.1	72.3	100.9	47.2	101.6	73.8	53.3	98.2	43.2	57.7	24.1	87.5	60.0	32.4	33.3	69.7	56.7	51.1	60.0	42.4	102.7	47.6	65.2	73.3	114.4	51.1	73.8	59.6	60.1	97.4	94.8	57.1	49.0	67.4	58.5	55.8	98.5	64.4	35.0	52.2	92.7	37.9	77.2	87.5	85.5	47.3	79.7	50.2	96.0	141.5	39.1	61.3	61.2	17.4	17.2	16.6	19.9	19.2	18.7	22.3	15.8	16.9	18.2	23.7	16.6	17.6	20.3	27.2	17.5	28.7	19.2	11.7	14.7	16.2	21.5	20.9	14.5	19.3	14.9	13.7	16.1	12.5	15.9	20.7	177.8	230.8	319.9	94.7	226.2	227.4	194.3	109.8	198.6	253.8	136.2	139.2	131.5	77.2	191.8	92.0	268.9	151.8	268.4	137.5	17.6	111.0	71.1	160.4	295.6	170.2	155.2	149.3	115.4	122.6	183.5	185.1	146.8	223.2	247.8	183.3	95.3	98.3	113.1	180.0	99.3	146.3	54.9	110.8	180.8	29.2	157.8	169.9	81.8	71.2	176.9	131.2	155.5	84.9	134.1	132.9	111.0	137.7	233.2	236.5	86.3	32.9	137.0	263.0	72.3	234.2	213.4	213.8	212.9	196.7	236.7	185.4	242.9	161.0	162.5	235.1
RBM27	"ARRS1, KIAA1311, Psc1, ZC3H20"	ENSG00000091009	"RNA binding motif protein 27"	Q9P2N5	5	146203605-146289223	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA035944, HPA036422"	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear speckles"		"HPA035944: AB_10670672, HPA036422: AB_10669987"	"unprognostic (8.18e-2)"	"unprognostic (3.17e-1)"	"unprognostic (6.04e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.04e-3)"	"prognostic unfavorable (8.58e-4)"	"unprognostic (4.73e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.49e-2)"	"unprognostic (5.51e-2)"	"unprognostic (6.67e-3)"	"unprognostic (4.09e-3)"	7.3	5.4	4.1	8.4	4.2	19.5	9.4	7.0	4.9	8.3	4.0	7.8	7.5	9.3	8.0	7.3	7.4	5.9	7.0	3.9	4.8	8.0	10.6	6.7	11.7	3.5	4.5	10.9	6.0	8.9	3.6	9.2	4.0	7.6	8.3	9.4	6.3	6.4	7.2	7.2	7.3	7.6	4.3	9.4	8.6	10.1	4.6	12.6	10.9	9.2	11.3	9.3	5.9	4.9	15.0	12.1	15.3	24.8	13.1	12.5	17.7	10.9	12.3	15.7	17.2	21.3	18.9	31.7	8.4	12.5	21.5	15.3	23.1	25.2	27.7	24.3	10.2	21.7	12.9	14.9	14.4	34.3	24.1	11.7	13.0	16.9	29.9	12.1	14.2	14.9	24.3	18.7	15.0	13.5	25.0	17.4	21.2	16.5	13.6	22.2	23.7	21.9	16.0	16.6	19.1	13.1	22.5	21.7	17.8	15.6	25.3	18.7	13.5	16.6	17.6	12.5	17.8	17.7	18.1	36.6	12.5	24.7	15.7	1.7	0.8	1.6	1.4	1.3	1.6	1.2	1.4	1.6	1.1	1.4	1.8	1.5	1.2	1.8	1.5	1.3	1.5	0.7	4.1	4.2	7.0	4.9	3.9	4.8	3.5	4.5	4.0	4.3	4.6	4.9	12.7	16.0	17.6	20.5	13.1	66.2	9.5	52.6	6.2	11.2	13.0	8.6	17.3	5.7	32.3	14.7	10.4	9.2	17.6	10.1	1.9	7.8	32.4	15.1	11.8	15.7	10.8	11.8	32.2	6.8	8.3	17.0	11.2	13.9	22.1	12.2	11.4	12.1	11.2	15.2	31.4	13.8	30.5	20.4	40.6	6.6	11.5	14.1	19.6	28.1	16.9	8.4	12.3	28.6	43.8	11.5	8.7	14.7	7.3	17.4	9.9	7.9	36.8	8.7	0.0	16.5	24.1	31.4	13.2	12.0	62.1	9.7	15.7	9.8	12.5	19.7
RBM28	FLJ10377	ENSG00000106344	"RNA binding motif protein 28"	Q9NW13	7	128297685-128343908	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 93.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019058, HPA026672, HPA031519"	Enhanced		Supported	Nucleoli		NA	No			"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoli		"HPA019058: AB_1856118, HPA026672: AB_1856119, HPA031519: AB_2673920"	"unprognostic (2.34e-1)"	"unprognostic (1.87e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (2.72e-11)"	"unprognostic (6.83e-2)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (7.20e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.45e-3)"	"unprognostic (7.15e-3)"	"unprognostic (3.05e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.04e-1)"	17.6	13.0	6.1	14.9	9.2	12.2	14.6	7.6	8.6	12.5	7.2	12.2	10.3	12.8	6.3	11.8	11.4	8.2	20.3	6.6	9.2	8.5	15.2	10.6	14.9	7.6	7.7	14.9	12.4	10.5	13.5	11.2	7.9	10.3	9.3	10.4	10.1	7.7	29.6	13.6	9.2	10.7	6.1	10.8	11.9	16.3	8.7	11.3	12.6	17.6	12.5	12.2	11.6	13.1	56.2	60.5	35.9	103.0	25.1	15.9	49.0	50.3	20.7	44.6	48.0	50.7	47.9	74.0	26.8	23.0	64.8	37.0	53.2	42.6	57.4	37.1	51.0	74.4	43.0	47.1	22.3	94.7	63.9	18.1	27.4	59.4	35.5	16.8	41.9	40.3	141.6	42.0	35.1	45.2	68.3	54.0	68.5	38.5	47.0	53.4	42.8	70.7	21.8	37.5	40.0	48.4	65.0	107.2	34.8	42.6	27.6	28.7	40.4	64.4	33.6	57.7	61.9	42.8	39.5	126.0	42.4	78.2	70.8	3.8	11.0	4.6	12.6	9.2	8.7	12.8	10.7	11.6	11.5	13.4	9.7	11.1	9.7	12.3	8.1	14.1	7.4	5.8	6.1	9.2	7.6	8.6	6.6	9.2	7.6	7.7	7.9	6.1	8.7	13.1	22.7	16.0	31.4	33.3	23.2	16.2	17.1	16.2	24.5	54.9	16.3	17.8	28.8	10.0	27.7	12.9	93.8	20.8	27.5	9.1	25.4	22.3	2.5	21.3	50.3	25.3	11.4	20.4	13.1	22.9	26.5	25.7	21.4	22.5	36.7	30.3	9.7	14.8	19.1	40.4	17.6	14.9	14.2	12.9	10.2	3.3	27.7	17.9	5.4	7.5	18.9	18.6	37.0	18.6	15.3	18.7	8.2	20.7	17.7	19.0	8.1	16.7	17.1	56.1	6.6	51.3	26.4	42.6	44.7	19.1	14.5	18.6	24.4	34.6	16.4	14.8
RBM34	KIAA0117	ENSG00000188739	"RNA binding motif protein 34"	P42696	1	235131183-235161283	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA028606	Approved		Supported	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoli	"Nucleoplasm, Mitotic chromosome"	"HPA028606: AB_10601494"	"unprognostic (4.53e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.32e-2)"	"unprognostic (6.57e-4)"	"unprognostic (2.98e-2)"	"unprognostic (5.65e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.69e-8)"	"unprognostic (8.50e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.73e-2)"	"unprognostic (7.09e-4)"	12.2	10.3	11.7	15.0	12.5	35.5	17.0	12.1	13.7	10.0	12.3	12.4	17.9	11.5	15.6	13.9	10.9	12.2	15.5	11.8	12.6	17.1	14.8	11.9	23.2	13.3	12.5	12.8	13.1	9.2	8.7	13.2	13.1	12.0	14.1	6.3	19.9	7.4	19.7	18.2	15.8	11.6	13.1	12.7	14.3	21.3	12.5	16.3	15.6	12.3	20.6	15.7	9.6	13.5	28.6	20.9	23.8	28.8	17.9	33.3	52.8	29.3	24.6	29.4	30.1	26.9	33.7	49.4	29.9	21.0	22.1	40.5	29.0	28.9	28.2	44.4	47.8	35.7	17.0	20.1	35.1	60.4	34.5	28.0	33.2	26.5	19.6	26.5	26.8	50.5	54.5	23.7	38.7	18.0	49.9	48.3	65.3	43.8	15.8	48.0	23.2	57.3	29.5	22.7	26.2	47.1	39.2	27.0	66.4	17.0	55.2	63.5	21.0	26.2	23.0	36.1	59.9	27.8	47.5	47.4	30.8	38.0	40.8	113.9	36.0	44.1	46.1	42.5	55.6	74.1	53.0	59.8	37.2	54.5	49.0	57.4	18.3	58.2	46.4	59.5	77.5	51.5	11.7	12.5	12.1	13.7	11.8	12.6	13.3	12.5	13.1	13.1	12.5	13.5	4.3	19.2	12.8	12.1	11.9	3.2	10.0	7.3	10.2	2.6	6.3	3.7	3.4	7.2	9.1	3.7	10.4	6.2	19.3	4.1	5.9	6.6	7.2	3.2	5.1	6.9	7.8	3.8	10.6	6.2	4.5	10.3	4.6	6.0	23.4	8.0	6.1	3.6	3.3	0.0	11.5	2.7	8.2	5.4	3.2	7.9	4.1	7.1	3.6	15.9	9.4	4.0	23.7	10.1	11.9	8.6	9.6	5.7	10.2	5.3	5.3	12.8	10.7	5.7	0.0	5.0	4.4	7.1	5.3	8.0	3.8	6.2	16.2	3.3	4.5	7.7
RBM39	"CAPER, CAPERalpha, CC1.3, fSAP59, HCC1, RNPC2"	ENSG00000131051	"RNA binding motif protein 39"	Q14498	20	35701347-35742312	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001591	Supported		Supported	"Nucleoplasm,Nuclear speckles,Microtubules,Centriolar satellite"		NA	NA		19000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear speckles"	"Microtubules, Centriolar satellite"	"HPA001591: AB_1079749"	"unprognostic (1.37e-2)"	"unprognostic (4.97e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.09e-2)"	"unprognostic (3.47e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.55e-3)"	"unprognostic (4.56e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.04e-2)"	"unprognostic (7.65e-3)"	"prognostic unfavorable (2.78e-5)"	"unprognostic (1.88e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.28e-3)"	70.1	55.8	18.4	37.7	17.6	172.0	44.6	33.5	28.0	57.8	22.2	56.0	35.1	54.5	9.2	62.3	61.4	40.8	57.3	16.5	25.0	52.2	47.7	62.2	42.3	24.2	24.0	71.1	41.2	27.3	50.0	40.9	19.4	50.2	16.9	49.5	53.4	22.3	70.3	51.2	46.9	19.2	16.0	56.4	49.7	34.3	16.9	51.1	54.2	33.1	24.1	50.7	62.1	26.5	98.8	87.6	77.0	78.5	48.8	53.8	78.8	131.0	50.6	59.6	60.2	109.3	78.5	137.5	90.6	38.9	67.9	91.2	122.3	67.9	66.5	94.6	96.7	174.6	80.7	101.2	23.4	158.6	99.9	14.4	97.6	68.9	38.4	63.7	57.8	46.4	195.5	117.6	46.3	72.2	194.5	87.9	103.2	87.5	96.8	104.9	136.2	91.7	41.5	56.2	77.9	63.4	91.1	94.7	78.4	109.3	70.6	94.6	91.4	100.8	92.5	90.5	115.8	71.6	164.3	204.0	64.7	123.2	79.2	250.9	120.4	197.5	104.7	111.1	103.6	131.1	91.5	97.6	111.8	140.5	85.7	82.1	427.7	127.2	102.2	160.9	114.7	95.7	18.4	17.6	33.5	28.0	16.5	25.0	24.2	24.0	19.4	16.0	16.9	26.5	302.0	233.9	280.9	144.3	441.7	616.4	521.0	283.0	284.0	258.5	339.1	295.4	189.2	191.6	267.6	200.5	316.9	375.2	624.9	278.1	189.8	203.8	48.1	359.2	496.0	299.7	295.3	214.2	130.1	186.0	389.6	337.9	254.9	540.8	525.8	304.4	215.3	202.1	199.8	220.4	120.9	331.3	215.7	207.7	469.5	41.9	262.5	335.5	270.3	129.3	274.3	208.7	400.6	136.2	160.5	221.3	254.8	214.4	391.0	453.6	271.8	150.6	248.0	386.5	164.3	504.0	410.2	263.5	228.1	215.8	586.9	561.6	490.8	218.2	282.8	532.1
RBM48	"C7orf64, DKFZp564O0523, HSPC304"	ENSG00000127993	"RNA binding motif protein 48"	Q5RL73	7	92528773-92540481	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021777, HPA025306"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA021777: AB_1845763, HPA025306: AB_1845764"	"unprognostic (2.79e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.81e-2)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (2.86e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.59e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.51e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.43e-2)"	"unprognostic (8.04e-2)"	8.3	8.6	8.2	5.6	9.4	14.1	8.2	10.1	12.1	9.0	6.5	8.0	5.3	8.2	4.8	7.6	8.4	3.8	10.0	8.5	7.5	7.4	9.0	6.4	8.4	9.0	7.7	9.8	8.5	4.6	7.5	4.6	9.1	8.2	4.6	6.5	8.3	3.3	13.5	8.0	9.0	3.7	7.3	11.3	8.0	8.9	8.5	6.5	8.4	7.0	6.4	7.3	8.3	12.1	5.5	4.0	6.8	11.1	6.5	7.3	5.4	6.5	5.2	6.4	6.1	4.9	6.9	8.0	11.8	4.4	9.9	6.2	6.6	4.6	7.9	7.8	9.4	5.3	12.0	5.8	5.2	10.2	7.1	5.2	8.5	7.2	6.5	8.9	6.9	10.1	11.5	13.1	6.9	5.6	12.1	10.1	6.1	6.9	5.8	6.5	6.1	9.8	5.9	5.9	7.6	9.9	5.7	11.6	8.6	8.3	3.7	8.5	4.4	11.7	6.3	9.1	8.9	8.6	11.1	13.3	5.3	8.6	11.0	67.8	12.4	30.3	23.2	16.3	25.7	28.5	25.1	23.7	12.3	28.7	32.1	27.3	19.2	26.2	13.3	14.3	25.7	16.0	8.2	9.4	10.1	12.1	8.5	7.5	9.0	7.7	9.1	7.3	8.5	12.1	13.5	12.8	7.5	8.1	23.5	8.5	13.2	11.9	12.5	12.7	8.7	7.7	16.7	5.7	10.9	3.7	0.0	10.9	18.8	6.9	7.9	9.2	9.4	9.5	12.3	13.8	0.0	8.6	20.5	6.0	5.8	11.7	6.6	12.9	30.4	11.9	7.9	3.7	6.2	11.8	15.8	4.0	14.2	6.8	6.4	5.9	5.9	8.1	5.4	5.6	9.8	11.5	26.8	11.1	34.3	5.5	6.2	6.4	16.6	10.5	7.0	9.6	7.8	13.2	13.1	15.0	13.7	24.0	15.5	9.9	11.4	15.3	18.9	8.4	5.7	11.8
RBMX	"hnRNP-G, HNRNPG, RNMX"	ENSG00000147274	"RNA binding motif protein X-linked"	P38159	X	136848004-136880764	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription"	"Activator, Repressor, Ribonucleoprotein, RNA-binding"	"Cancer-related genes, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057707	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"HPA057707: AB_2683508"	"unprognostic (1.53e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.12e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.62e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (5.16e-6)"	"unprognostic (5.59e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.68e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.65e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.64e-3)"	81.0	57.0	35.7	80.8	39.3	172.5	119.7	40.5	39.7	108.8	36.9	82.9	77.8	142.0	85.9	64.5	116.5	68.2	72.2	33.9	36.2	77.7	66.5	71.8	117.8	40.7	36.4	242.9	86.8	76.6	48.9	80.4	40.8	83.9	101.6	82.0	68.5	82.1	126.2	69.6	75.5	118.2	38.8	89.1	71.8	34.8	35.1	210.8	92.5	103.9	145.6	89.1	77.9	51.9	235.0	250.2	448.6	201.0	109.6	184.3	261.2	227.7	246.3	308.4	324.6	268.8	228.3	422.9	229.2	163.9	193.3	152.9	481.9	238.3	353.6	184.2	226.8	324.6	240.9	289.9	95.9	358.0	285.6	152.5	113.1	240.6	333.6	236.3	252.7	392.0	296.6	210.3	254.4	297.9	526.3	240.5	285.7	248.1	207.0	430.9	300.2	262.0	229.6	275.2	260.8	281.7	181.9	162.4	213.8	263.6	186.8	237.7	161.7	173.5	188.0	121.7	294.8	149.2	214.9	444.3	123.9	256.7	242.6	131.6	158.5	90.6	142.1	192.8	199.7	194.5	184.8	170.4	175.6	187.4	231.9	192.5	25.3	173.9	178.9	106.4	203.9	302.6	35.7	39.3	40.5	39.7	33.9	36.2	40.7	36.4	40.8	38.8	35.1	51.9	112.1	112.2	139.0	55.2	223.0	151.9	209.0	151.6	128.1	112.4	229.8	208.0	100.5	153.0	167.3	88.3	95.9	187.2	200.3	80.1	154.6	157.2	10.9	83.5	147.4	130.5	202.9	195.7	33.2	148.8	269.4	156.6	75.4	84.3	268.8	212.7	204.5	119.3	117.0	92.5	41.2	170.9	81.4	223.2	112.2	10.5	171.8	109.0	96.0	27.2	176.9	99.4	157.6	57.3	56.5	108.0	99.1	133.2	124.0	108.2	140.0	120.3	123.3	137.9	92.1	159.7	161.6	33.8	81.2	94.6	122.3	111.5	195.5	135.0	216.4	157.4
RCC1L	WBSCR16	ENSG00000274523	"RCC1 like"	Q96I51	7	75027122-75074228	"Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor, RNA-binding, rRNA-binding"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 56.0;Distal tubular cells: 49.0;Extravillous trophoblasts: 42.3;Granulosa cells: 46.2;Proximal tubular cells: 37.0;Syncytiotrophoblasts: 54.5;Theca cells: 53.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052184, HPA060643"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"		"HPA052184: AB_2681752, HPA060643: AB_2684335"	"unprognostic (9.73e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.87e-2)"	"prognostic unfavorable (4.88e-4)"	"unprognostic (8.91e-2)"	"unprognostic (3.34e-3)"	"unprognostic (7.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.28e-3)"	"unprognostic (6.35e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.43e-1)"	27.4	46.3	19.6	17.3	21.4	14.0	25.2	19.5	22.5	24.0	22.9	35.0	19.0	28.2	6.8	30.7	21.9	12.7	53.1	18.5	19.6	40.1	59.8	20.2	18.7	21.4	20.2	28.8	28.8	18.2	27.2	15.4	19.3	30.6	10.3	5.3	22.8	17.5	103.1	22.0	23.2	12.7	20.8	25.3	28.8	21.6	22.0	12.4	25.9	45.9	12.7	32.0	23.1	20.5	44.8	59.2	34.8	54.0	24.5	19.8	45.3	42.9	30.5	36.1	29.5	64.6	53.5	47.2	18.9	34.8	46.9	51.9	29.8	28.8	15.0	52.0	47.7	35.1	41.5	61.3	34.6	56.6	53.7	24.7	23.1	31.4	24.9	24.2	32.4	7.7	113.8	29.5	28.3	92.8	1.5	84.6	80.0	53.2	52.1	24.5	27.4	98.6	31.5	38.9	34.5	55.3	57.1	119.0	54.4	24.3	83.8	58.3	35.8	46.9	38.5	40.7	56.5	32.4	26.7	73.6	35.8	58.3	63.6	3.5	2.3	1.4	4.2	3.1	3.4	3.6	4.6	3.7	3.3	4.2	4.3	5.3	0.8	4.6	2.3	3.3	3.7	1.7	19.6	21.4	19.5	22.5	18.5	19.6	21.4	20.2	19.3	20.8	22.0	20.5	15.9	0.0	7.3	0.0	5.9	0.0	0.0	0.0	0.0	0.0	15.2	15.5	0.0	0.0	2.5	22.0	0.0	56.0	13.0	0.0	49.0	24.3	0.0	11.7	17.7	8.0	0.0	0.0	0.0	20.6	42.3	10.5	0.0	13.8	5.1	46.2	0.0	0.0	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	17.1	0.0	0.0	0.0	0.0	18.1	0.0	0.0	1.8	0.0	0.0	37.0	2.9	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	54.5	6.6	53.8	0.0	0.0
RCHY1	"ARNIP, CHIMP, DKFZp586C1620, PIRH2, PRO1996, RNF199, ZCHY, ZNF363"	ENSG00000163743	"Ring finger and CHY zinc finger domain containing 1"	Q96PM5	4	75479037-75514764	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030338, HPA030339"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Nucleoplasm, Vesicles"	"HPA030338: , HPA030339: AB_10603232"	"unprognostic (1.53e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (9.09e-4)"	"unprognostic (1.90e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.19e-2)"	"unprognostic (7.87e-3)"	"unprognostic (5.82e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.45e-3)"	"unprognostic (4.60e-2)"	"prognostic favorable (3.62e-5)"	"unprognostic (1.69e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (7.89e-5)"	8.6	7.0	9.5	7.9	10.2	17.0	16.8	12.6	13.0	9.0	7.7	12.1	8.7	9.6	6.9	7.2	11.9	6.8	16.8	9.4	10.6	16.2	12.3	10.0	9.5	8.9	10.4	14.5	8.3	12.6	5.8	10.0	9.9	10.9	13.2	14.8	12.9	10.1	16.5	5.6	8.6	11.6	9.9	11.5	8.9	13.6	10.7	12.7	18.9	23.6	12.6	7.6	4.7	10.7	9.8	5.0	14.6	13.8	15.1	13.1	8.4	6.5	15.1	13.2	15.4	13.8	11.9	16.2	12.0	9.4	13.1	5.8	37.6	11.5	19.9	13.4	12.3	21.2	9.2	17.9	13.0	28.9	11.2	12.2	14.1	15.2	14.2	15.9	27.0	20.8	19.9	16.2	30.9	15.8	26.7	11.5	24.5	26.9	8.7	14.2	34.4	13.9	20.4	16.7	22.6	12.4	10.7	24.8	28.2	15.9	14.0	12.9	10.8	8.6	8.5	7.8	11.1	17.0	13.0	22.8	10.5	20.2	14.0	27.5	9.2	9.7	4.3	5.7	7.6	4.6	5.4	5.2	8.0	2.1	3.9	5.5	4.0	5.5	5.6	4.1	5.7	4.7	9.5	10.2	12.6	13.0	9.4	10.6	8.9	10.4	9.9	9.9	10.7	10.7	22.2	19.2	10.3	28.4	25.4	40.7	32.3	47.1	39.3	35.0	38.5	25.9	56.8	24.3	23.5	23.9	20.9	31.6	31.2	21.9	68.4	30.3	37.3	11.9	17.1	22.3	13.8	21.8	31.2	22.5	23.2	24.6	21.9	17.3	5.1	23.8	25.4	23.0	19.0	23.5	32.3	23.4	38.7	37.5	26.8	59.8	22.4	27.4	28.4	22.5	23.9	32.0	24.7	31.7	41.0	26.5	22.6	25.2	19.7	36.6	24.6	69.4	13.5	21.7	32.9	20.9	27.3	72.8	41.7	28.1	31.0	33.8	32.9	35.2	27.6	26.3
RCOR1	"COREST, KIAA0071, RCOR"	ENSG00000089902	"REST corepressor 1"	Q9UKL0	14	102592649-102730561	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 117.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001956, HPA049327, HPA054241"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB001956: , HPA049327: AB_2680715, HPA054241: AB_2682426"	"unprognostic (1.98e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.01e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.05e-3)"	"unprognostic (7.23e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (3.72e-4)"	11.2	5.8	3.3	11.2	3.1	46.1	9.0	4.6	4.1	14.2	3.3	11.0	12.0	9.5	13.3	33.2	9.5	8.7	6.7	5.0	3.6	6.7	9.4	12.9	11.9	3.4	3.5	9.0	7.9	10.4	5.2	20.8	3.6	8.8	11.1	6.3	10.2	5.8	11.8	16.6	12.6	8.8	3.5	8.6	13.4	13.7	4.3	14.5	6.3	10.6	14.7	10.2	19.1	4.2	21.3	19.5	17.2	19.0	13.5	18.6	36.1	21.5	15.2	19.7	18.7	18.0	25.2	23.8	17.1	18.7	9.9	32.6	26.2	15.4	29.4	10.1	9.6	44.2	17.4	17.6	18.4	44.3	38.2	13.1	23.6	17.4	26.5	21.1	21.8	22.1	35.7	17.5	20.1	34.6	27.8	29.9	8.5	23.2	33.1	70.4	17.4	10.6	24.1	25.9	22.2	13.8	48.1	21.9	13.9	21.5	30.0	34.6	23.8	13.6	10.2	43.8	14.2	12.9	16.6	25.0	16.3	32.0	14.6	3.1	1.4	2.2	0.2	1.5	0.3	0.3	0.3	0.6	1.5	0.3	0.3	0.3	3.7	0.7	1.8	0.6	0.5	0.5	3.3	3.1	4.6	4.1	5.0	3.6	3.4	3.5	3.6	3.5	4.3	4.2	15.8	48.1	40.0	32.3	27.3	57.6	27.7	12.0	30.7	8.4	25.6	20.7	16.7	10.0	19.7	3.7	2.1	31.1	39.1	31.5	5.9	6.7	5.1	55.7	36.1	15.9	21.0	32.2	39.3	7.4	20.4	20.2	32.6	58.3	24.1	18.0	11.0	11.7	15.1	10.1	33.8	16.8	10.2	38.8	65.6	4.9	24.2	43.6	24.9	52.5	33.1	9.5	12.3	22.1	23.5	16.7	15.2	21.1	14.8	25.4	18.2	8.0	16.3	5.4	0.0	18.9	19.6	22.5	18.6	46.9	117.6	43.1	26.2	20.3	22.8	72.3
RELT	"FLJ14993, TNFRSF19L"	ENSG00000054967	"RELT TNF receptor"	Q969Z4	11	73376399-73397474	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	Receptor	"Amelogenesis imperfecta, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"bone marrow: 154.7"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 43.9;Macrophages: 43.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062824, HPA071518"			Supported	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA062824: AB_2684875, HPA071518: AB_2686408"	"unprognostic (3.49e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.80e-3)"	"unprognostic (9.92e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.87e-1)"	"unprognostic (8.42e-2)"	"unprognostic (4.13e-2)"	"prognostic unfavorable (4.07e-11)"	"unprognostic (1.64e-1)"	"unprognostic (3.07e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.69e-1)"	4.9	2.2	3.4	12.9	6.5	154.7	2.5	6.7	7.7	1.4	0.4	2.3	2.3	1.4	0.5	3.9	1.9	4.5	6.2	3.6	7.0	3.7	2.1	10.9	11.9	8.9	6.8	1.8	0.8	1.1	3.5	4.6	8.1	2.1	1.4	2.2	1.9	0.4	24.3	3.2	7.1	2.6	7.0	20.8	2.2	3.2	6.9	4.6	2.2	6.4	6.9	4.8	2.3	12.6	9.1	8.9	7.0	6.8	0.8	1.0	7.5	9.6	6.2	11.1	6.7	8.5	3.9	16.4	30.9	6.4	8.8	13.1	4.4	4.7	4.3	9.9	8.3	15.4	12.4	3.1	1.8	15.6	26.3	1.1	2.0	11.9	3.5	2.6	4.1	8.4	11.8	21.0	3.1	8.5	11.5	16.5	6.1	6.9	11.0	21.9	11.7	14.2	2.3	3.9	8.9	8.5	8.3	7.5	10.0	1.7	4.1	13.9	5.4	13.8	9.7	23.1	17.6	7.5	6.1	18.2	8.5	15.5	14.8	0.7	12.5	22.2	0.9	25.4	2.0	7.6	1.0	1.7	11.8	5.8	1.3	0.6	19.9	0.4	35.3	11.7	0.5	6.3	3.4	6.5	6.7	7.7	3.6	7.0	8.9	6.8	8.1	7.0	6.9	12.6	5.7	6.4	2.2	3.6	24.2	26.5	15.4	2.8	2.8	3.5	6.1	5.5	2.7	1.5	3.4	0.0	12.5	1.6	33.0	4.7	0.0	3.6	0.9	5.4	5.2	7.2	3.5	5.7	3.1	0.9	10.7	10.1	11.2	10.8	24.8	6.8	1.8	0.2	23.0	30.3	4.5	2.8	6.1	24.2	43.9	1.2	0.0	43.9	5.4	2.8	32.8	8.9	3.1	1.5	4.8	6.7	2.4	0.0	19.2	9.9	1.0	0.5	1.4	2.8	6.6	7.2	14.5	11.7	10.5	4.6	18.3	21.1	16.1	0.6	3.1	17.8
REPS1		ENSG00000135597	"RALBP1 associated Eps domain containing 1"	Q96D71	6	138903493-138988261	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 207.3;Excitatory neurons: 114.3;Inhibitory neurons: 138.1;Oligodendrocyte precursor cells: 99.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029961, HPA029962"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Plasma membrane, Cytosol"		"HPA029961: AB_10603233, HPA029962: AB_2673269"	"unprognostic (1.72e-3)"	"unprognostic (9.61e-2)"	"unprognostic (5.82e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (9.47e-4)"	"unprognostic (3.79e-1)"	"unprognostic (2.49e-1)"	"unprognostic (9.71e-3)"	"unprognostic (4.29e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.69e-2)"	13.5	11.9	24.7	14.9	25.4	23.2	23.6	27.7	36.8	19.2	14.8	17.4	15.4	21.9	40.2	28.0	18.4	14.0	23.9	27.4	24.0	17.4	31.3	15.2	19.4	25.2	23.9	21.1	18.8	41.0	31.7	17.2	21.3	15.9	17.3	38.8	26.1	16.2	17.5	30.0	16.4	19.5	21.5	22.1	18.1	35.6	25.9	36.0	17.8	12.6	22.2	19.5	20.1	25.3	29.3	22.6	42.3	53.1	23.4	41.6	46.2	27.8	30.7	31.9	38.2	54.1	24.8	35.2	22.9	38.9	38.0	33.6	48.7	42.0	42.1	37.6	41.9	29.6	12.9	32.9	35.3	94.6	45.9	34.1	33.7	58.6	70.3	30.2	33.5	51.2	40.2	35.1	41.4	49.4	53.9	51.3	40.4	37.4	21.3	62.4	26.0	20.0	26.5	43.6	37.7	37.2	25.7	38.7	38.0	62.0	18.6	64.4	32.9	17.8	29.6	48.5	38.8	34.4	33.7	49.2	21.1	38.3	26.4	5.9	1.3	1.9	2.2	4.0	3.8	3.0	2.9	3.2	1.9	1.6	2.9	3.6	0.7	2.9	4.5	3.5	3.3	1.2	24.7	25.4	27.7	36.8	27.4	24.0	25.2	23.9	21.3	21.5	25.9	25.3	11.8	19.2	7.4	207.3	18.0	13.4	11.7	7.9	22.2	12.6	13.7	9.5	28.4	10.0	12.2	5.5	16.7	25.6	18.9	11.9	7.9	7.8	13.7	17.5	9.7	10.3	6.0	5.0	114.3	7.1	28.3	11.5	16.3	23.3	15.9	14.4	15.7	43.8	13.3	13.5	138.1	12.8	6.1	24.0	10.3	7.7	7.2	17.2	5.4	47.8	10.5	36.8	15.5	99.5	71.2	8.9	14.7	8.6	23.9	11.2	13.5	8.6	16.5	14.4	19.7	16.8	10.9	41.7	33.8	26.4	14.9	28.6	18.7	7.6	15.2	18.1
REXO4	"hPMC2, XPMC2H"	ENSG00000148300	"REX4 homolog, 3'-5' exonuclease"	Q9GZR2	9	133406059-133418096	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047006	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA047006: AB_2679900"	"unprognostic (2.69e-2)"	"unprognostic (3.76e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.77e-2)"	"unprognostic (6.52e-2)"	"prognostic unfavorable (4.76e-6)"	"unprognostic (2.15e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.55e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (2.25e-2)"	"unprognostic (2.86e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.20e-1)"	12.6	15.7	8.6	6.7	8.9	5.1	12.3	9.0	9.4	16.0	8.1	14.8	5.7	12.7	3.8	18.2	12.2	4.5	16.3	8.7	8.6	15.6	22.6	10.5	8.7	8.7	8.7	18.0	21.4	5.1	13.0	5.8	8.9	15.7	3.9	3.5	13.1	4.7	35.4	17.0	14.3	3.9	8.7	18.8	14.1	18.2	8.8	8.3	12.8	9.7	6.6	16.2	15.1	9.2	9.8	22.2	10.3	15.1	10.5	10.7	18.2	16.4	9.3	17.0	11.2	26.8	12.3	31.5	11.0	9.0	13.9	26.0	21.5	17.2	9.7	20.5	19.8	17.2	23.7	21.1	13.0	39.4	16.1	10.1	14.4	17.9	24.4	13.0	12.6	16.8	38.3	13.5	11.0	28.1	27.9	23.7	20.8	35.0	32.2	19.7	16.7	31.5	10.8	9.1	29.1	15.9	17.4	20.2	19.4	10.1	24.7	15.7	11.1	30.9	16.1	14.7	20.3	8.8	11.5	21.6	11.5	22.5	18.7	0.4	1.3	2.0	1.9	1.3	2.2	2.4	2.0	2.0	1.1	2.8	2.5	2.7	0.1	3.9	1.1	1.8	2.0	1.0	8.6	8.9	9.0	9.4	8.7	8.6	8.7	8.7	8.9	8.7	8.8	9.2	16.8	22.4	15.0	4.9	29.7	25.0	22.3	12.9	10.2	26.6	27.0	23.5	9.9	21.5	8.5	25.8	22.9	37.5	27.8	24.2	19.6	29.2	38.2	36.6	34.5	17.4	13.2	7.6	4.4	28.7	36.2	14.7	7.1	32.7	17.7	24.2	19.6	26.8	21.3	16.8	4.6	22.2	4.1	22.4	11.5	83.3	28.9	13.2	7.2	1.9	37.9	17.6	51.5	1.5	5.0	30.6	21.7	24.0	18.4	25.3	30.8	28.2	10.4	34.1	19.7	13.1	16.9	51.6	65.9	10.7	27.6	31.5	24.9	16.4	35.8	13.7
RFC1	"A1, MHCBFB, PO-GA, RFC140"	ENSG00000035928	"Replication factor C subunit 1"	P35251	4	39287456-39366375	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"	Neuropathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009520, HPA046116, HPA069306"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"CAB009520: AB_2178317, HPA046116: AB_2679544, HPA069306: AB_2686115"	"unprognostic (8.23e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (4.43e-5)"	"unprognostic (4.15e-2)"	"unprognostic (4.08e-2)"	"unprognostic (3.38e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.62e-3)"	"unprognostic (4.48e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.47e-2)"	15.6	19.0	13.7	16.7	19.2	33.1	22.2	15.4	15.6	16.9	12.0	15.3	13.3	19.2	17.4	13.8	14.6	12.2	16.5	13.5	14.9	20.8	25.5	18.2	30.2	16.5	15.6	26.1	29.0	31.4	14.7	14.6	18.0	17.8	14.8	24.3	16.6	16.1	11.6	14.9	13.8	17.1	15.4	17.0	14.9	11.8	14.8	28.0	23.1	15.9	30.2	13.5	14.1	25.5	43.5	19.4	53.7	44.1	25.4	32.0	27.5	49.1	44.6	49.2	58.2	37.8	43.1	106.5	32.4	33.2	52.8	20.7	49.8	42.6	78.5	19.5	33.9	48.0	35.6	34.7	30.6	67.5	30.7	24.6	33.8	49.9	55.3	39.1	38.8	52.1	48.0	22.1	37.9	17.5	99.7	43.4	33.0	26.8	24.2	78.1	97.8	33.7	21.4	30.1	37.6	36.4	29.1	11.3	37.6	33.4	29.8	37.5	30.0	40.3	49.6	37.8	63.1	31.0	45.8	101.3	33.1	69.3	41.2	8.2	8.6	3.8	13.7	6.9	10.1	14.6	11.7	11.9	6.9	16.1	13.8	12.2	3.9	12.6	8.9	14.3	11.5	5.5	13.7	19.2	15.4	15.6	13.5	14.9	16.5	15.6	18.0	15.4	14.8	25.5	65.5	64.1	120.6	33.0	62.9	20.6	37.9	26.5	47.3	67.8	60.5	62.4	86.1	45.8	37.0	57.0	60.5	43.1	83.8	30.6	72.4	54.8	73.0	45.9	79.1	56.1	30.0	57.9	22.0	66.0	48.5	54.9	28.1	60.0	25.9	82.2	57.8	82.0	30.7	85.8	32.1	58.2	12.2	44.3	16.6	32.3	82.0	35.1	16.0	22.5	58.1	82.7	107.1	38.7	95.7	51.1	34.2	91.7	75.0	50.0	36.1	124.2	32.6	83.3	59.2	61.6	54.6	49.0	66.5	38.2	21.3	32.2	63.7	70.8	49.1	44.5
RFC2	"A1, RFC40"	ENSG00000049541	"Replication factor C subunit 2"	P35250	7	74231499-74254458	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA replication"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 68.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029493	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	Yes			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Golgi apparatus"	"HPA029493: AB_10603991"	"unprognostic (1.25e-1)"	"prognostic favorable (9.91e-4)"	"unprognostic (1.44e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (2.08e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.09e-7)"	"unprognostic (2.22e-1)"	"unprognostic (6.65e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.59e-1)"	12.2	9.5	10.6	13.4	10.9	27.4	15.5	11.4	11.5	12.6	11.1	13.4	9.0	9.6	8.4	18.6	10.1	8.6	10.1	10.5	10.9	14.7	21.2	11.3	23.5	11.7	11.3	11.3	13.3	11.8	7.9	18.4	11.4	11.5	15.0	8.8	12.2	7.6	18.8	20.3	11.2	12.6	11.5	14.2	13.6	10.0	10.7	20.2	9.2	12.2	30.8	11.5	12.6	11.8	74.3	55.6	65.2	64.6	13.1	15.2	29.4	42.5	46.7	85.2	101.4	62.6	67.3	69.2	11.5	30.7	78.7	49.7	53.3	69.2	87.5	49.6	91.5	42.9	76.4	46.7	10.1	64.6	25.3	15.4	15.9	79.8	55.0	18.5	46.0	63.9	89.4	41.9	66.4	87.2	65.1	124.7	74.1	116.3	47.4	95.0	72.0	85.8	45.7	58.1	52.4	65.5	50.7	94.8	34.7	79.2	68.7	58.0	17.4	83.4	54.9	64.6	96.3	25.1	35.1	120.6	42.4	98.4	89.3	33.4	36.7	27.3	18.0	42.3	18.1	31.6	15.5	16.5	31.9	36.8	19.5	14.3	46.4	42.9	40.1	17.1	23.9	29.1	10.6	10.9	11.4	11.5	10.5	10.9	11.7	11.3	11.4	11.5	10.7	11.8	15.4	12.8	11.1	2.6	19.0	23.8	24.3	24.3	19.9	13.2	12.6	17.4	6.1	5.7	16.5	5.5	2.1	68.6	17.5	12.4	5.9	21.0	2.8	8.1	13.3	13.5	4.8	38.3	3.0	19.0	65.0	17.4	10.7	11.5	23.4	25.1	13.6	14.0	37.7	3.3	2.6	13.1	20.3	14.4	28.2	2.5	8.7	18.2	21.4	1.9	26.3	16.1	23.7	1.5	2.2	13.8	6.9	10.9	17.5	11.0	13.2	13.8	8.8	9.5	6.6	14.6	17.5	33.8	44.6	20.1	17.0	46.1	16.9	12.9	19.1	15.3
RFC5	RFC36	ENSG00000111445	"Replication factor C subunit 5"	P40937	12	118013588-118033130	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 45.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041037	Supported		Approved	Nucleoplasm		NA	NA		6500	"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA041037: AB_10805834"	"unprognostic (9.63e-2)"	"prognostic favorable (8.05e-5)"	"unprognostic (5.12e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.40e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (1.44e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.06e-1)"	5.9	5.8	3.7	10.5	4.4	33.8	10.7	5.9	4.9	8.6	4.2	10.3	9.8	11.1	5.4	9.3	9.5	6.7	5.4	6.0	2.9	8.7	13.0	6.8	16.4	3.3	3.2	15.6	7.6	7.1	4.7	7.3	3.2	7.9	12.6	11.5	5.8	8.0	5.6	12.9	9.1	7.7	3.8	8.0	7.2	8.3	3.7	23.4	10.3	4.7	16.1	6.3	7.1	4.3	52.8	49.3	49.1	28.1	12.2	14.7	58.3	38.4	24.0	66.6	49.9	50.2	21.4	56.4	25.9	18.1	42.0	47.2	66.9	34.0	63.2	42.1	58.1	43.9	40.7	36.5	7.6	70.7	38.1	7.8	12.2	50.0	16.8	30.4	28.6	70.3	62.6	21.6	33.3	50.3	93.2	59.2	40.5	29.8	46.1	68.1	61.2	55.3	30.7	47.7	67.5	30.7	62.2	18.2	24.1	30.4	64.4	30.0	13.7	36.9	42.5	50.4	69.5	36.2	51.7	76.9	36.4	51.7	66.1	16.6	5.0	3.6	8.6	8.4	7.6	10.7	10.3	7.4	7.2	9.1	8.0	6.9	5.6	7.9	4.9	6.0	11.4	6.5	3.7	4.4	5.9	4.9	6.0	2.9	3.3	3.2	3.2	3.8	3.7	4.3	4.0	0.0	3.3	4.6	5.6	8.4	6.9	7.1	4.0	4.2	5.2	4.7	3.1	4.3	4.6	9.2	2.1	21.0	4.7	3.6	9.8	8.9	3.0	6.0	6.3	4.3	4.2	45.7	11.8	6.3	25.2	6.4	4.1	6.5	5.7	14.0	3.3	6.0	9.1	1.7	7.3	6.9	4.1	3.2	3.1	2.7	4.1	4.9	0.0	3.7	3.8	9.5	2.1	2.5	5.5	4.1	4.0	8.2	16.4	2.3	3.2	6.6	11.0	6.0	0.0	5.3	8.4	13.4	9.1	9.5	5.4	8.9	7.9	18.7	10.6	4.2
RFWD3	"FANCW, FLJ10520, RNF201"	ENSG00000168411	"Ring finger and WD repeat domain 3"	Q6PCD5	16	74621399-74666877	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 47.7"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 48.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048258, HPA075649"	Approved		Enhanced	Nucleoplasm,Cytosol		No	No			"Cluster 42: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA048258: AB_2680332, HPA075649: AB_2686761"	"unprognostic (4.79e-2)"	"unprognostic (6.45e-3)"	"unprognostic (6.35e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.11e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.03e-3)"	"unprognostic (2.53e-3)"	"unprognostic (1.73e-3)"	"unprognostic (2.84e-1)"	"unprognostic (4.31e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.29e-1)"	5.2	3.9	2.5	9.9	3.5	47.7	7.6	4.0	3.2	6.4	4.4	8.0	6.5	6.2	5.3	9.4	6.8	6.5	2.9	2.3	2.9	6.7	5.8	6.1	15.4	3.3	3.1	7.0	10.2	6.8	3.8	8.0	3.2	4.9	9.3	6.2	5.8	5.1	3.3	12.6	6.1	6.1	2.8	8.1	6.2	25.2	3.4	27.1	6.6	2.7	16.7	7.2	6.8	4.7	46.1	57.5	42.6	31.2	8.8	11.9	47.8	40.5	30.9	63.0	54.5	75.4	46.8	63.6	32.1	31.8	31.6	53.9	70.3	42.1	76.9	20.0	42.1	56.3	46.0	43.0	7.6	57.3	56.3	8.6	13.2	79.6	48.7	16.3	27.3	53.2	86.7	27.7	48.1	72.8	84.0	52.2	84.0	26.8	27.7	128.7	28.8	55.9	22.7	47.8	31.5	33.6	65.2	22.8	28.8	38.2	41.7	48.4	26.7	46.0	43.9	26.2	51.4	37.4	75.1	188.3	32.8	43.5	57.0	12.1	4.4	6.5	5.5	4.1	6.1	4.9	4.5	5.1	4.6	5.4	6.7	4.8	4.9	6.2	7.7	3.5	7.2	4.4	2.5	3.5	4.0	3.2	2.3	2.9	3.3	3.1	3.2	2.8	3.4	4.7	6.0	0.0	5.9	4.2	13.2	10.8	6.8	4.0	10.2	6.6	8.4	8.3	3.9	2.8	5.4	1.8	10.4	12.1	15.3	7.6	11.7	6.2	5.4	6.9	5.7	7.2	9.5	22.5	8.9	7.6	8.3	5.9	5.1	6.6	4.5	13.5	11.7	7.4	8.9	3.3	7.1	9.7	2.0	12.2	6.0	6.3	3.7	7.8	16.0	15.0	7.6	3.0	10.3	6.6	15.2	10.0	2.7	4.1	11.6	12.7	4.3	4.6	5.9	6.7	6.6	6.4	5.6	48.5	31.7	9.5	9.2	7.5	10.6	3.6	9.5	11.4
RFX7	"FLJ12994, RFXDC2"	ENSG00000181827	"Regulatory factor X7"	Q2KHR2	15	56087280-56245082	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Astrocytes: 108.4;Excitatory neurons: 149.4;Inhibitory neurons: 164.0;Microglial cells: 91.8;Oligodendrocyte precursor cells: 187.0;Oligodendrocytes: 169.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035462, HPA057957"	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nuclear membrane"		"HPA035462: AB_10602152, HPA057957: "	"unprognostic (2.36e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.73e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (2.24e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.84e-1)"	3.4	5.9	3.9	5.6	3.5	8.5	5.2	11.6	4.0	5.2	1.3	4.0	5.3	5.6	5.3	4.7	5.7	4.0	3.2	3.0	4.4	3.5	4.0	4.8	8.9	3.5	3.3	6.3	3.2	5.7	2.7	5.4	3.7	4.6	5.0	11.0	3.8	5.3	8.8	9.9	4.5	5.7	3.0	7.4	4.8	8.7	3.5	15.2	5.1	9.8	9.3	5.7	2.9	4.2	7.7	15.6	31.3	22.0	11.0	13.9	7.6	6.6	9.1	8.3	13.1	8.4	6.3	24.0	9.7	9.9	7.7	20.9	18.7	14.7	11.1	13.3	6.6	31.5	19.0	17.6	11.6	24.1	4.6	12.0	21.7	9.0	19.5	12.2	14.7	24.1	14.2	12.7	11.9	9.8	21.3	6.9	13.4	5.9	4.5	23.1	20.0	19.8	9.2	24.0	16.4	18.8	8.2	8.3	9.4	21.5	7.1	15.3	11.9	21.8	11.3	5.1	13.2	10.2	11.4	27.6	7.8	22.2	9.7	2.0	0.2	0.5	0.5	0.3	0.6	0.5	0.6	0.7	0.4	0.4	0.4	0.6	0.0	0.5	0.2	0.5	1.1	0.3	3.9	3.5	11.6	4.0	3.0	4.4	3.5	3.3	3.7	3.0	3.5	4.2	8.6	6.4	13.4	108.4	9.7	13.4	4.4	9.5	20.5	16.2	9.9	7.5	6.5	2.8	6.2	7.3	10.4	4.2	7.3	5.3	3.9	3.4	19.9	7.2	10.3	9.4	4.8	17.1	149.4	4.7	1.4	6.8	4.6	6.4	12.6	14.2	7.9	8.9	5.6	16.8	164.0	5.7	10.2	9.5	8.8	15.9	6.5	8.8	5.4	91.8	8.4	5.1	2.1	187.0	169.7	3.7	6.0	10.5	7.9	6.6	4.3	4.2	8.5	9.1	0.0	13.2	7.0	6.6	6.8	16.8	17.6	1.6	9.0	10.6	6.8	5.6
RHOT1	"ARHT1, FLJ11040, MIRO-1, MIRO1"	ENSG00000126858	"Ras homolog family member T1"	Q8IXI2	17	32142454-32253374	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Muller glia cells: 128.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010687, CAB068223, CAB068224"	Supported					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"			"CAB068223: AB_2665691, CAB068224: AB_2665692, HPA010687: AB_1079813"	"unprognostic (3.28e-2)"	"unprognostic (4.02e-3)"	"unprognostic (6.85e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.57e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.59e-2)"	"unprognostic (7.02e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.05e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.90e-1)"	"unprognostic (4.08e-2)"	19.1	26.9	19.9	9.6	20.8	19.7	19.5	20.5	29.4	16.6	12.5	19.8	11.4	16.3	15.0	14.9	14.4	11.4	24.8	22.0	18.5	17.6	16.8	17.3	10.9	18.1	17.5	17.7	15.5	38.1	14.2	18.6	19.8	17.1	11.3	50.9	17.3	19.1	28.4	28.5	12.2	16.0	18.7	12.2	17.3	12.3	19.9	19.4	25.0	34.5	11.2	16.6	15.5	24.8	14.1	26.2	21.9	22.8	25.8	28.9	13.2	22.7	18.2	24.2	26.0	13.8	9.0	18.2	22.3	18.7	26.5	24.9	34.3	13.8	29.1	14.4	25.9	21.4	15.8	21.0	35.4	28.1	15.3	15.3	40.7	20.7	23.8	40.5	21.1	36.7	48.1	14.9	21.5	10.6	52.1	23.0	18.0	16.7	12.6	28.6	32.4	32.2	17.5	8.4	20.0	18.1	22.8	14.1	38.4	26.1	31.9	38.1	16.3	17.0	17.5	19.6	16.2	22.0	22.9	19.9	20.5	26.7	28.9	3.0	5.8	5.4	2.1	4.9	2.3	2.1	2.3	2.1	5.3	4.0	1.8	2.3	3.6	3.4	5.2	1.8	1.3	2.8	19.9	20.8	20.5	29.4	22.0	18.5	18.1	17.5	19.8	18.7	19.9	24.8	16.5	28.9	38.8	88.8	17.8	25.9	13.5	14.4	27.9	61.5	21.4	18.0	38.1	14.3	18.7	16.5	70.9	28.4	14.1	12.3	33.2	17.0	19.6	14.5	15.5	17.9	16.9	31.5	97.3	13.1	20.3	19.3	15.3	13.9	27.3	24.8	18.9	18.3	33.7	57.2	89.9	9.3	22.4	46.4	29.1	20.6	30.1	33.2	16.0	76.8	45.1	128.9	29.9	68.3	65.9	13.5	14.4	24.0	11.6	13.7	22.8	21.3	15.1	58.7	26.3	24.8	21.9	63.0	40.3	24.3	53.0	22.7	18.9	24.5	13.9	11.4
RINT1	"FLJ11785, RINT-1"	ENSG00000135249	"RAD50 interactor 1"	Q6NUQ1	7	105532169-105567677	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, ER-Golgi transport, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019875, HPA031646"	Approved		Approved	"Golgi apparatus"		Yes	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA019875: AB_1856283, HPA031646: AB_2673975"	"unprognostic (1.58e-2)"	"unprognostic (3.94e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.68e-3)"	"unprognostic (1.33e-2)"	"unprognostic (4.96e-3)"	"unprognostic (2.41e-1)"	"unprognostic (8.72e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.75e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (2.39e-5)"	"unprognostic (1.76e-1)"	7.3	6.1	2.8	9.0	3.1	15.2	10.0	6.9	3.7	8.2	5.6	8.1	9.4	8.6	7.2	11.3	8.0	6.7	8.2	3.1	3.1	9.3	10.5	6.7	13.4	2.8	2.7	8.0	11.6	9.7	5.4	8.8	3.1	7.8	9.3	10.3	11.3	6.1	16.7	8.7	7.1	6.4	3.2	8.8	9.7	11.1	2.7	9.9	8.8	13.3	13.7	8.4	5.7	4.1	28.8	23.5	12.1	27.8	18.8	24.9	15.9	27.2	19.2	26.4	29.6	27.4	18.4	31.6	31.3	24.1	29.4	19.0	22.5	21.0	34.7	17.0	25.9	18.3	26.1	18.5	14.5	38.9	17.8	17.9	16.4	28.1	16.3	20.3	29.1	16.3	39.5	23.2	30.3	46.9	29.3	28.6	26.1	23.8	23.1	17.5	20.5	45.4	14.2	23.6	20.5	22.4	28.9	47.7	20.6	20.9	19.4	12.5	20.3	30.2	24.0	83.1	34.8	46.6	59.7	61.4	20.0	31.8	34.6	4.4	3.9	4.4	6.7	5.8	11.6	9.0	9.8	9.2	6.0	7.8	8.6	9.4	0.7	9.1	4.8	4.0	10.5	6.2	2.8	3.1	6.9	3.7	3.1	3.1	2.8	2.7	3.1	3.2	2.7	4.1	6.7	3.2	9.8	10.4	12.4	6.6	9.6	7.7	8.6	5.8	5.9	5.3	10.5	1.5	9.4	3.7	8.4	11.2	13.4	6.0	9.8	8.1	10.8	9.0	6.4	6.8	5.4	4.6	25.6	6.3	10.3	9.4	12.2	5.5	10.1	7.5	4.2	5.1	7.3	6.7	26.0	5.8	10.2	5.6	3.4	6.2	8.7	5.2	5.4	9.4	5.7	7.8	7.2	9.0	18.2	6.7	4.0	9.8	17.9	6.5	5.5	6.8	18.1	8.9	6.6	8.3	8.0	29.2	12.4	8.3	7.7	12.0	10.8	7.5	6.4	8.3
RIOK1	"AD034, bA288G3.1, FLJ30006, RRP10"	ENSG00000124784	"RIO kinase 1"	Q9BRS2	6	7389793-7418037	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ribosome biogenesis"	"Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017866, HPA051446"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA017866: AB_2669670, HPA051446: AB_2681488"	"unprognostic (2.33e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (3.41e-5)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (3.45e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (5.85e-5)"	"unprognostic (2.33e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.12e-3)"	"unprognostic (2.59e-2)"	12.1	9.3	4.1	10.8	4.1	20.6	11.0	5.0	5.3	10.0	3.7	7.9	6.5	10.5	5.2	11.4	8.2	7.5	8.0	4.2	5.1	6.4	7.9	7.1	14.0	4.7	5.1	10.9	10.2	7.3	4.7	11.4	4.6	8.0	8.6	7.3	7.0	8.1	11.5	9.1	6.3	10.8	4.2	9.4	7.0	19.9	4.5	15.7	7.3	10.3	15.9	14.9	7.6	4.7	20.4	11.7	18.3	45.8	27.0	22.6	28.7	25.6	16.6	22.1	18.5	33.1	10.0	51.8	43.3	19.7	19.4	20.3	45.7	19.5	29.0	35.8	49.6	28.3	18.3	39.4	23.0	81.5	37.5	17.2	27.2	24.1	50.4	11.5	20.1	38.6	72.1	12.3	21.0	26.7	56.8	50.2	39.6	36.3	26.1	42.9	23.3	56.6	13.8	19.9	60.8	30.4	20.8	13.3	41.6	48.4	18.9	28.4	19.9	24.4	18.9	17.5	38.3	17.1	33.0	75.7	7.7	44.0	38.7	12.0	11.5	9.0	14.9	15.6	18.0	21.5	15.4	15.9	20.5	23.0	17.8	19.2	2.3	26.7	14.0	17.3	16.2	11.3	4.1	4.1	5.0	5.3	4.2	5.1	4.7	5.1	4.6	4.2	4.5	4.7	22.2	6.4	26.4	5.5	27.5	52.8	32.3	29.5	38.1	10.0	18.9	22.0	22.8	4.3	35.2	7.3	10.4	34.1	25.3	9.9	3.9	15.9	74.8	14.9	28.4	24.8	7.2	17.9	10.2	11.7	34.7	29.8	16.8	19.1	33.6	13.4	19.2	10.2	22.6	5.0	12.0	17.4	20.3	11.2	25.1	12.5	19.9	19.7	17.8	11.2	15.1	8.9	6.2	13.0	8.4	12.2	8.2	19.9	27.0	33.7	7.1	9.3	20.9	13.7	19.7	33.8	23.9	58.9	75.4	33.7	64.8	27.9	29.0	23.9	16.9	23.8
RITA1	"C12orf52, FLJ14827, RITA"	ENSG00000139405	"RBPJ interacting and tubulin associated 1"	Q96K30	12	113185526-113192368	"Predicted intracellular proteins"	"Neurogenesis, Notch signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 49.0;Proximal enterocytes: 62.0;Proximal tubular cells: 51.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039094, HPA039095, HPA061531"	Supported		Supported	Nucleoplasm		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA039094: AB_10671037, HPA039095: AB_2676345, HPA061531: AB_2684554"	"unprognostic (7.10e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.56e-2)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (9.79e-4)"	"unprognostic (3.47e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.01e-1)"	6.8	25.4	17.0	7.1	17.4	7.1	7.7	16.0	20.2	8.7	14.6	9.7	13.1	8.1	6.4	14.3	14.0	5.9	15.0	17.5	15.7	15.9	29.6	6.9	11.1	15.1	15.3	10.6	10.6	9.5	12.6	4.7	15.2	10.1	5.9	4.4	13.7	8.3	31.7	10.8	14.2	4.6	12.6	9.5	8.8	7.4	16.9	9.7	10.4	27.2	8.2	8.5	8.1	15.3	27.0	34.3	8.7	23.0	11.5	8.8	15.6	17.2	35.3	24.9	19.8	40.7	13.0	50.8	26.0	14.6	21.4	20.0	20.0	22.3	14.4	31.3	28.4	17.4	16.6	26.6	18.7	23.4	14.0	13.6	20.2	24.6	13.8	34.5	20.7	24.7	34.0	9.2	14.9	38.6	26.1	63.1	29.2	22.9	41.8	23.2	9.3	43.2	20.3	37.8	28.9	16.6	21.7	45.2	38.2	10.6	38.2	35.5	13.7	15.7	22.3	18.2	24.7	31.6	28.6	56.0	23.4	19.4	22.5	43.7	14.6	9.9	15.3	6.6	15.3	11.0	13.5	13.9	16.5	11.8	13.2	14.6	0.3	20.7	8.6	22.5	16.1	13.5	17.0	17.4	16.0	20.2	17.5	15.7	15.1	15.3	15.2	12.6	16.9	15.3	8.1	0.0	11.3	2.9	11.1	6.4	7.1	14.0	7.4	7.4	14.7	14.7	6.6	12.8	9.1	14.7	4.2	19.3	9.8	17.0	49.0	19.2	10.8	16.7	7.3	9.3	11.4	8.8	6.5	16.4	16.9	7.0	8.2	7.3	0.0	8.7	8.6	37.5	14.2	15.2	6.7	12.5	8.2	7.8	2.4	29.6	9.9	6.3	5.4	2.8	5.9	11.0	19.6	2.0	3.7	15.2	12.9	8.2	14.7	10.1	62.0	51.9	17.1	6.0	6.6	7.7	7.5	4.5	7.8	13.8	6.5	10.1	9.0	17.2	12.7	7.5
RLIM	"MGC15161, NY-REN-43, RNF12"	ENSG00000131263	"Ring finger protein, LIM domain interacting"	Q9NVW2	X	74582976-74614624	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018895	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA018895: AB_1856323"	"unprognostic (1.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.98e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (1.20e-1)"	11.3	11.8	10.6	10.4	11.7	41.2	10.5	5.9	9.9	10.0	10.0	6.8	5.9	9.5	5.6	8.7	8.4	9.6	8.8	11.2	15.1	10.0	8.3	12.1	8.9	8.5	10.3	10.6	7.5	11.7	10.3	9.8	10.3	9.8	6.6	10.7	7.4	7.1	9.6	9.4	6.1	9.3	7.3	9.3	7.4	6.5	12.6	11.0	11.7	8.6	9.5	8.5	8.0	8.2	23.7	24.2	22.8	18.7	20.1	22.5	22.4	22.4	26.0	19.9	24.4	18.9	24.4	12.8	25.4	28.6	26.7	19.9	45.9	26.7	30.1	11.7	23.9	22.7	43.2	10.7	17.4	34.6	38.6	21.7	14.4	28.2	46.5	15.6	23.3	20.9	19.9	22.9	24.6	18.1	26.0	16.8	35.0	12.9	22.5	24.3	48.0	21.5	16.1	28.6	16.4	19.5	42.3	19.0	24.5	20.4	11.2	24.9	31.0	23.4	23.1	24.8	19.6	12.0	24.6	20.3	25.5	33.1	23.2	22.8	6.0	5.9	3.1	7.5	3.1	3.0	3.9	3.8	4.9	3.3	4.2	3.8	11.5	5.3	5.6	2.6	4.8	3.2	10.6	11.7	5.9	9.9	11.2	15.1	8.5	10.3	10.3	7.3	12.6	8.2	44.8	16.0	17.0	13.4	22.4	35.8	29.6	16.1	23.3	13.8	18.3	13.5	30.5	18.6	20.4	25.8	14.6	16.3	27.6	10.3	11.7	13.7	7.9	32.3	35.3	30.1	23.2	12.8	19.2	10.7	21.5	27.7	27.0	41.0	38.0	24.6	21.0	14.8	18.2	21.9	18.9	10.6	10.2	20.7	34.1	4.4	9.9	29.1	17.8	15.9	12.7	13.2	12.3	11.1	16.4	14.8	8.5	18.8	16.3	25.5	6.8	12.0	25.2	14.6	6.6	31.1	24.1	9.7	18.2	21.6	38.8	26.3	22.0	19.0	11.4	37.2
RMI1	"BLAP75, C9orf76, FLJ12888"	ENSG00000178966	"RecQ mediated genome instability 1"	Q9H9A7	9	83980798-84004074	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 70.0;Late spermatids: 62.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021661			Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nuclear bodies"		"HPA021661: "	"unprognostic (9.59e-2)"	"unprognostic (7.96e-2)"	"unprognostic (6.72e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.90e-2)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (2.65e-1)"	"unprognostic (3.39e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.68e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.24e-2)"	2.5	8.3	2.9	6.0	3.2	3.9	4.5	4.6	3.4	3.2	6.0	6.6	6.2	3.5	5.6	4.9	5.8	2.8	3.4	2.4	5.8	4.4	5.8	3.3	10.2	3.3	3.3	4.4	5.8	7.7	3.7	3.6	3.5	4.8	7.4	7.0	6.0	3.1	3.7	5.1	6.8	3.3	3.2	6.4	6.2	8.9	3.8	10.2	6.0	3.9	9.6	3.6	2.4	3.8	25.2	14.9	33.6	12.4	5.5	7.7	33.9	24.1	13.6	20.7	19.4	7.5	17.0	55.4	8.5	12.4	21.7	36.9	22.0	12.3	25.3	29.2	6.1	23.0	12.1	11.8	7.7	42.6	23.1	7.4	7.8	17.6	12.6	6.7	11.1	28.2	16.7	26.3	23.2	18.1	54.4	17.4	31.3	31.6	15.7	47.8	33.9	21.0	10.8	10.4	30.4	19.3	21.3	18.6	9.8	15.4	19.4	20.8	6.6	22.9	14.7	23.2	20.1	11.6	25.6	20.2	14.6	19.7	26.4	14.2	4.5	8.8	1.8	5.5	2.2	2.8	2.1	1.9	7.2	2.6	2.2	2.5	7.8	2.8	6.5	2.2	3.0	2.6	2.9	3.2	4.6	3.4	2.4	5.8	3.3	3.3	3.5	3.2	3.8	3.8	5.4	9.6	5.1	10.1	5.9	2.7	3.2	4.3	4.0	4.1	4.3	3.3	8.5	2.8	9.0	1.8	4.2	7.9	2.1	6.1	5.9	5.5	70.0	13.9	6.5	3.8	6.7	24.4	7.1	3.0	16.2	3.3	8.2	10.2	4.5	9.0	5.0	13.3	8.1	10.1	11.2	9.8	0.0	10.7	4.3	62.1	2.1	7.4	12.4	8.4	8.5	7.7	5.2	26.2	12.6	2.7	5.6	2.2	7.8	4.2	8.9	4.9	11.1	5.2	0.0	3.3	3.4	34.0	22.6	6.9	4.8	4.2	4.4	7.7	10.1	2.4
RMI2	"BLAP18, C16orf75, MGC24665"	ENSG00000175643	"RecQ mediated genome instability 2"	Q96E14	16	11249619-11381662	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 36.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 123.8;Erythroid cells: 38.5;Extravillous trophoblasts: 34.1;Peritubular cells: 42.5;Spermatocytes: 36.6;Spermatogonia: 51.8;Syncytiotrophoblasts: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 4.2"	"Group enriched"	"Detected in many"	6	"B-cells: 4.2;T-cells: 1.4"	"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA040995	Uncertain		Supported	"Nuclear speckles,Cytosol"		NA	Yes			"Cluster 37: B-cells - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear speckles"	Cytosol	"HPA040995: AB_10795531"	"unprognostic (2.76e-1)"	"prognostic favorable (5.69e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.80e-3)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (3.98e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.44e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.50e-2)"	"unprognostic (3.68e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.03e-1)"	1.4	1.5	2.2	12.3	2.0	9.9	5.1	1.0	2.2	4.8	0.9	12.5	7.5	2.9	3.9	10.8	2.1	2.2	1.6	2.3	1.3	3.4	4.3	1.9	31.4	1.2	1.3	3.0	1.8	1.3	0.6	19.3	1.2	3.2	14.4	0.5	2.4	2.1	0.9	10.2	8.8	2.3	1.0	3.5	7.0	14.0	1.4	36.8	1.5	0.6	34.9	4.5	4.4	1.8	60.3	39.5	75.2	32.6	3.3	15.8	33.0	35.9	26.8	31.6	51.8	15.4	69.2	83.8	29.1	15.8	35.3	34.4	32.4	32.5	50.5	16.6	30.5	45.3	22.6	102.5	1.3	17.6	19.5	3.7	6.1	14.5	13.3	12.3	17.4	36.2	65.3	63.2	16.5	70.3	60.9	83.1	64.1	82.6	15.7	73.1	81.1	89.3	18.7	38.0	44.1	35.0	28.5	47.4	26.1	43.5	80.4	25.8	5.6	25.1	23.3	49.3	5.0	18.1	30.9	99.3	23.3	57.4	47.2	0.0	0.0	0.4	0.3	0.0	0.0	4.2	0.1	0.0	0.2	1.1	0.8	0.3	0.1	0.1	0.0	0.2	1.4	0.1	2.2	2.0	1.0	2.2	2.3	1.3	1.2	1.3	1.2	1.0	1.4	1.8	1.3	0.0	0.5	0.0	4.5	6.8	5.4	1.4	6.2	0.2	3.4	3.2	1.0	4.3	1.6	7.3	0.0	123.8	0.5	3.3	5.9	2.6	3.0	0.8	2.1	2.8	2.4	38.5	0.0	0.5	34.1	6.4	4.1	2.2	0.0	19.7	1.1	1.1	18.5	0.0	0.0	7.7	0.0	0.8	6.5	5.9	15.8	3.7	3.6	0.0	1.1	0.2	1.0	0.0	0.0	1.0	4.0	42.5	2.4	2.1	1.3	0.4	0.1	0.6	32.9	0.0	2.2	36.6	51.8	11.3	5.4	47.7	1.9	6.5	10.3	7.5
RMND1	"bA351K16.3, C6orf96, FLJ20627, RMD1"	ENSG00000155906	"Required for meiotic nuclear division 1 homolog"	Q9NWS8	6	151404762-151452158	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031397, HPA031398, HPA031399"	Approved		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"HPA031397: AB_2673861, HPA031398: AB_2673862, HPA031399: AB_10601156"	"unprognostic (1.12e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.70e-3)"	"unprognostic (6.67e-2)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (1.50e-3)"	"unprognostic (6.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.80e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.04e-1)"	12.6	13.9	7.7	6.4	8.1	4.4	13.6	7.8	8.9	9.9	8.2	10.3	13.4	8.9	11.7	7.5	11.9	8.0	12.1	7.8	8.6	36.9	30.5	7.5	9.2	8.2	8.1	14.6	9.5	8.9	6.3	9.6	8.4	6.8	11.3	7.1	7.1	7.7	10.9	7.7	12.1	7.5	8.0	7.3	8.0	9.1	8.6	8.1	18.6	10.0	10.1	9.2	8.1	8.2	16.0	7.2	15.1	32.3	20.6	46.7	21.3	24.6	23.4	18.6	25.4	21.5	11.7	14.9	17.4	16.1	23.1	13.5	29.3	14.9	32.1	17.7	23.8	24.1	11.0	44.5	43.4	53.9	7.2	33.4	19.5	26.9	39.7	22.8	25.0	22.6	26.3	11.5	29.0	54.1	18.6	18.1	11.1	16.8	14.3	21.0	19.7	18.2	26.7	7.2	26.1	25.5	17.9	22.2	29.5	18.6	36.6	34.8	13.8	14.6	19.0	30.6	20.0	12.1	17.5	17.6	36.7	42.3	17.5	1.9	5.6	7.1	6.4	8.2	10.4	11.6	7.6	9.1	7.0	8.9	10.1	9.3	2.8	13.3	13.3	3.2	11.8	4.5	7.7	8.1	7.8	8.9	7.8	8.6	8.2	8.1	8.4	8.0	8.6	8.2	11.6	0.0	11.2	12.1	6.9	3.8	6.4	10.2	9.1	8.9	15.4	13.7	11.9	5.7	11.9	12.9	12.5	27.0	7.4	7.6	17.6	15.6	9.4	10.9	18.4	7.8	3.0	8.0	22.4	10.7	21.7	8.8	4.1	12.4	9.5	25.0	10.8	16.7	13.7	5.0	20.6	9.7	6.1	12.5	5.7	6.4	6.8	9.8	3.6	8.4	12.3	7.7	10.3	15.6	21.7	9.9	11.2	6.4	5.8	3.6	33.8	45.1	9.3	6.9	0.0	6.7	14.9	13.0	16.8	8.3	2.7	16.8	8.4	27.3	15.3	5.3
RMND5A	"FLJ13910, GID2, GID2A, p44CTLH, RMD5"	ENSG00000153561	"Required for meiotic nuclear division 5 homolog A"	Q9H871	2	86720291-86778041	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046795, HPA060843"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA046795: AB_10963573, HPA060843: AB_2684378"	"unprognostic (4.54e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.45e-2)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (2.32e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.29e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.56e-1)"	17.8	11.2	19.4	9.3	24.3	31.2	16.2	54.5	25.2	13.4	20.0	19.7	16.4	13.0	13.3	31.3	12.9	6.8	38.2	21.6	17.5	18.2	42.9	10.5	11.6	18.4	20.6	11.1	11.6	20.8	7.9	11.6	18.3	12.4	21.2	18.9	11.4	11.1	63.6	22.4	15.5	13.7	20.4	14.3	12.1	7.8	18.7	31.4	13.0	37.0	14.0	10.0	17.0	28.8	19.4	10.2	17.6	10.5	22.9	10.1	36.3	7.5	6.1	9.7	11.0	37.6	20.3	66.7	22.4	6.9	11.3	22.6	45.1	15.8	15.0	19.4	34.4	58.7	21.8	34.2	23.1	43.2	18.6	15.4	30.5	10.2	35.2	11.0	17.0	48.7	37.7	37.3	7.9	12.6	40.1	36.9	29.8	23.1	13.0	47.3	54.2	42.3	20.1	22.8	32.6	25.1	16.9	33.5	27.9	24.8	16.8	36.8	16.3	6.7	12.9	12.2	11.7	16.7	18.8	45.0	5.6	51.3	7.8	37.5	11.9	8.1	8.1	10.1	9.7	4.7	6.2	9.1	9.4	6.4	8.4	11.6	27.5	8.8	12.5	7.4	4.7	8.6	19.4	24.3	54.5	25.2	21.6	17.5	18.4	20.6	18.3	20.4	18.7	28.8	32.8	12.8	15.9	15.3	27.0	41.9	23.4	10.4	46.7	26.3	25.5	15.6	93.2	24.3	10.5	11.0	6.2	21.0	36.2	73.3	23.5	13.1	13.7	33.8	28.7	26.0	39.5	105.2	27.3	14.1	18.6	20.1	24.5	35.3	8.2	16.3	25.0	76.7	15.1	23.5	27.2	57.4	14.2	34.4	42.7	5.6	19.3	26.3	32.0	14.0	23.7	15.3	30.9	10.6	42.3	21.9	30.9	17.3	30.1	34.8	38.1	34.4	26.6	16.3	6.6	22.7	20.1	17.9	27.8	50.0	54.8	24.6	31.4	24.6	28.7	34.0
RNF123	"FLJ12565, KPC1"	ENSG00000164068	"Ring finger protein 123"	Q5XPI4	3	49689538-49721529	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 156.1;tongue: 112.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065983, HPA071879"	Supported		Approved	Cytosol		NA	NA		140000	"Cluster 37: B-cells - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol		"HPA065983: AB_2685592, HPA071879: AB_2686468"	"unprognostic (2.68e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.51e-2)"	"unprognostic (5.03e-3)"	"prognostic favorable (1.33e-8)"	"unprognostic (5.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.83e-1)"	13.0	19.0	18.9	9.0	19.2	34.6	12.5	18.5	23.9	13.1	21.0	17.8	19.5	14.7	10.5	13.4	12.5	9.7	27.8	19.6	16.5	22.0	57.7	12.3	10.4	17.5	16.9	11.6	13.5	16.3	17.4	9.4	17.2	14.6	6.8	6.0	14.4	9.2	156.1	14.5	18.2	9.3	14.7	17.9	17.9	23.7	18.0	13.7	14.6	112.0	7.3	14.2	12.0	17.9	9.7	12.6	15.5	16.2	23.2	13.9	17.1	12.1	15.9	15.0	16.0	14.1	16.1	23.2	10.9	17.6	13.3	11.8	11.6	18.1	10.0	15.8	15.0	19.7	27.8	31.6	23.1	19.3	19.8	17.6	17.9	14.4	16.5	14.8	16.2	23.0	20.0	20.0	13.2	14.1	19.8	30.7	8.2	11.5	21.0	9.3	9.7	24.4	21.5	16.4	10.6	20.8	16.4	14.4	18.7	8.7	15.4	33.0	16.2	13.4	16.3	11.9	14.9	26.4	28.4	9.5	19.2	23.6	20.5	8.9	6.9	5.6	6.7	6.2	4.0	7.1	4.5	4.1	5.5	7.0	5.3	5.0	4.0	5.5	6.8	7.9	3.6	3.8	18.9	19.2	18.5	23.9	19.6	16.5	17.5	16.9	17.2	14.7	18.0	17.9	7.1	9.6	5.3	16.3	6.5	2.3	3.1	4.7	1.8	8.6	7.1	6.1	1.1	11.5	5.8	3.7	4.2	6.8	9.3	10.4	5.9	5.3	13.3	8.1	5.8	5.9	6.7	52.4	18.0	5.5	4.6	5.9	11.2	7.5	7.0	9.5	10.0	29.8	5.6	6.7	14.6	6.1	10.2	9.6	1.4	16.5	7.5	6.0	3.6	5.6	6.3	5.4	7.2	7.5	7.2	7.2	6.3	5.7	7.0	5.0	19.2	10.2	5.4	8.9	0.0	7.6	5.6	10.7	8.9	4.6	3.0	8.5	6.0	7.5	6.9	4.1
RNF138	"NARF, STRIN"	ENSG00000134758	"Ring finger protein 138"	Q8WVD3	18	32091874-32131561	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway, Wnt signaling pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 96.0;testis: 119.3"	"Group enriched"	"Detected in many"	15	"Early spermatids: 982.8;Late spermatids: 3827.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041101			Approved	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"HPA041101: AB_10805837"	"unprognostic (2.37e-2)"	"unprognostic (4.63e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.90e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.15e-2)"	"unprognostic (9.52e-3)"	"unprognostic (2.77e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.90e-1)"	13.7	7.3	7.6	17.4	9.3	96.0	14.5	13.8	11.9	12.4	10.7	23.5	16.7	14.3	8.5	14.9	19.4	13.6	5.9	6.9	8.7	9.7	21.6	13.3	24.2	8.0	8.6	14.9	16.4	11.2	7.5	15.3	8.5	10.5	20.2	8.9	9.9	7.9	6.9	8.8	17.3	11.6	8.3	21.6	14.2	119.3	8.2	28.9	11.8	6.8	19.8	13.3	8.6	12.4	28.3	16.4	66.4	33.2	8.5	17.5	37.6	28.3	15.8	34.7	39.8	19.4	19.3	67.9	34.3	18.6	22.3	28.9	35.1	31.9	47.1	37.7	58.8	53.5	19.2	24.1	33.3	149.3	45.3	17.1	31.3	38.3	53.8	19.9	35.9	59.3	74.7	27.0	22.7	26.6	101.1	66.5	74.4	48.4	22.6	102.5	41.7	39.3	31.9	20.7	75.0	37.5	37.7	21.7	30.1	30.2	14.0	62.2	27.8	41.5	30.5	10.3	32.2	44.4	64.5	117.9	22.6	81.6	41.5	25.0	64.4	63.3	25.0	48.7	32.2	34.6	54.5	35.9	62.5	39.2	102.8	66.9	64.7	42.8	42.0	26.6	44.3	68.3	7.6	9.3	13.8	11.9	6.9	8.7	8.0	8.6	8.5	8.3	8.2	12.4	27.9	16.0	19.7	15.3	65.9	69.3	33.7	11.8	71.2	6.7	32.4	18.0	8.3	24.3	16.8	16.5	0.0	28.3	51.6	43.0	17.6	17.6	982.8	35.6	20.4	29.4	29.9	48.8	25.9	18.4	21.6	21.3	26.0	28.7	22.8	8.4	22.5	16.8	24.8	8.4	28.0	20.8	20.3	25.5	52.3	3827.9	29.5	34.7	26.6	23.4	27.1	9.9	20.6	22.6	36.4	12.9	23.9	22.2	32.4	32.7	16.4	14.5	23.0	5.2	32.9	23.1	26.0	158.1	128.3	51.4	52.1	8.9	59.3	9.9	29.9	37.5
RNF169	KIAA1991	ENSG00000166439	"Ring finger protein 169"	Q8NCN4	11	74748849-74842413	"Enzymes, Predicted intracellular proteins"	"DNA damage, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038505, HPA046138, HPA047952"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"	"Nucleoli, Nucleoli rim, Cytosol"	"HPA038505: , HPA046138: AB_2679553, HPA047952: "	"unprognostic (1.71e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.68e-1)"	"unprognostic (6.47e-2)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (2.76e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.34e-1)"	"unprognostic (9.55e-3)"	"unprognostic (1.21e-1)"	4.2	2.8	3.8	6.7	6.2	14.4	5.6	6.2	4.4	5.5	5.4	4.4	4.0	7.6	4.2	10.1	5.6	4.8	3.2	4.0	4.4	4.6	5.0	5.9	6.3	5.4	5.0	7.6	4.4	5.6	2.1	4.7	5.4	5.2	5.3	6.1	4.5	4.3	6.8	5.5	4.4	7.6	4.4	7.3	4.6	2.9	4.6	7.7	5.8	5.8	6.7	5.2	5.4	9.2	10.2	7.7	9.1	9.0	5.8	7.7	3.7	7.9	7.4	8.6	7.4	13.0	7.5	18.2	7.9	9.5	5.8	9.6	12.4	9.3	11.2	9.1	8.0	12.6	15.3	5.1	6.6	6.8	10.1	7.1	7.2	9.8	22.1	9.6	14.0	12.2	11.4	14.1	8.7	8.6	11.6	12.0	3.6	12.9	5.0	10.7	21.7	9.9	5.5	10.6	4.1	7.4	10.6	8.0	16.6	7.3	9.9	8.6	9.4	14.2	11.8	9.0	7.1	10.2	5.8	21.1	2.8	7.3	8.4	1.2	0.5	0.4	0.4	0.3	0.3	0.0	0.4	0.2	0.2	0.1	0.3	0.2	1.4	0.3	0.3	0.2	0.3	0.2	3.8	6.2	6.2	4.4	4.0	4.4	5.4	5.0	5.4	4.4	4.6	9.2	18.8	9.6	11.4	51.6	18.4	19.9	30.6	7.1	20.5	58.2	12.6	9.8	3.0	17.2	8.3	3.7	52.1	5.5	24.6	9.8	5.9	10.2	2.8	30.5	26.7	17.2	12.0	18.3	40.8	11.1	6.4	16.0	14.8	30.1	7.0	24.4	10.8	12.3	8.5	37.0	43.2	8.7	2.0	15.6	19.9	3.1	7.5	16.6	10.6	25.3	12.6	22.9	26.8	42.7	68.7	10.1	6.8	10.5	18.5	49.7	6.3	12.1	8.9	33.7	26.3	31.9	18.7	9.4	11.7	16.4	18.6	8.1	22.2	14.0	10.4	42.2
RNMT	RG7MT1	ENSG00000101654	"RNA guanine-7 methyltransferase"	O43148	18	13726660-13764556	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"mRNA capping, mRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039409	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA039409: AB_10795289"	"unprognostic (3.02e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.71e-3)"	"unprognostic (3.57e-1)"	"unprognostic (3.04e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.42e-3)"	"unprognostic (9.45e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.78e-1)"	10.9	9.6	11.8	12.6	12.1	43.3	15.3	12.2	13.0	11.3	17.2	11.6	8.5	14.0	11.5	11.3	11.2	9.0	20.3	12.1	14.2	11.6	11.2	9.5	14.4	13.6	15.2	17.2	12.1	13.0	13.9	15.2	14.8	11.6	10.4	27.4	12.1	10.5	18.4	14.2	10.5	12.5	10.9	12.1	10.6	16.7	11.7	14.9	17.5	15.6	15.2	11.4	10.7	12.6	24.9	14.4	27.4	20.9	20.0	25.1	19.2	19.9	24.7	20.3	27.4	17.3	11.7	27.7	23.9	20.6	31.6	9.8	32.7	28.6	34.0	15.4	17.6	21.0	14.8	16.4	21.9	54.9	17.1	19.4	30.5	21.4	59.9	26.6	15.9	31.1	31.8	26.9	23.3	15.4	35.2	19.7	21.0	50.1	11.2	22.7	29.0	37.9	18.6	19.2	21.1	31.7	22.5	16.4	38.1	27.8	14.3	22.6	16.5	40.6	56.8	33.3	21.5	53.8	63.6	56.9	29.9	20.8	20.6	45.1	17.6	12.8	16.7	14.6	13.6	23.9	15.8	14.2	11.8	25.7	20.5	16.2	9.8	14.1	17.3	29.5	19.0	5.6	11.8	12.1	12.2	13.0	12.1	14.2	13.6	15.2	14.8	10.9	11.7	12.6	62.5	73.7	29.9	48.6	148.5	70.4	67.3	97.9	75.1	115.6	50.7	56.1	56.5	35.8	56.5	46.0	123.0	66.3	143.4	46.5	68.4	51.0	75.4	85.2	88.3	43.7	74.8	37.4	75.3	48.0	59.2	71.6	66.3	113.9	34.9	85.6	40.7	38.5	39.8	106.0	83.9	56.3	85.5	59.4	63.6	21.1	72.7	78.8	49.8	45.0	68.0	51.0	60.8	56.8	78.9	56.1	47.0	60.9	99.7	72.3	49.0	64.8	48.0	148.3	39.5	85.6	60.0	111.4	115.1	50.7	68.3	126.4	113.1	48.8	50.0	50.3
RNPS1		ENSG00000205937	"RNA binding protein with serine rich domain 1"	Q15287	16	2253116-2268397	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, Nonsense-mediated mRNA decay"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044014	Approved		Supported	Nucleoplasm		NA	NA		13000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA044014: AB_10966286"	"unprognostic (3.50e-2)"	"unprognostic (2.74e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.13e-3)"	"unprognostic (2.38e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.27e-1)"	82.8	78.7	91.9	55.1	96.1	144.9	83.4	82.6	112.6	89.0	60.5	108.8	51.3	98.8	51.1	98.0	84.6	39.9	101.0	99.1	93.0	81.4	63.8	73.5	76.5	96.0	84.5	92.6	71.8	52.5	101.4	53.5	94.9	95.0	43.9	47.4	70.0	54.9	229.7	97.3	84.0	52.4	72.5	94.9	76.8	88.4	88.5	69.8	74.2	105.2	71.3	94.1	83.6	90.7	119.6	154.5	167.7	163.9	89.0	78.6	194.2	125.2	88.4	170.6	147.0	306.1	142.8	251.1	124.0	103.2	108.6	160.0	217.3	152.5	128.9	175.2	283.2	172.8	133.9	198.3	150.2	185.5	159.0	99.3	168.3	149.1	207.1	80.8	134.8	144.6	302.1	195.3	143.3	259.7	296.2	363.6	340.1	135.2	128.4	441.4	196.6	322.3	122.5	66.6	354.8	218.3	172.3	157.6	166.4	77.1	152.7	187.7	102.2	155.4	155.2	143.0	182.1	199.7	282.5	582.9	63.3	168.0	185.6	48.1	144.0	123.2	169.5	170.5	167.7	177.9	162.2	172.9	153.8	205.5	153.3	162.0	43.4	182.9	187.8	131.6	196.1	290.2	91.9	96.1	82.6	112.6	99.1	93.0	96.0	84.5	94.9	72.5	88.5	90.7	90.6	44.8	62.7	29.7	148.2	206.6	208.7	148.9	119.5	119.7	99.5	95.9	36.3	65.8	85.5	51.5	139.7	182.3	138.5	90.8	70.5	115.5	16.3	76.5	88.9	102.1	122.0	130.4	72.1	93.2	237.4	90.7	79.0	108.4	103.4	114.9	77.1	37.5	104.7	97.6	61.1	100.6	124.1	71.3	117.0	21.4	94.1	80.1	97.8	23.4	123.9	98.0	180.2	31.7	37.3	121.7	76.5	68.8	117.2	209.5	81.1	64.3	50.2	132.8	85.5	103.9	102.3	132.9	267.4	117.6	212.4	162.0	131.7	101.7	125.7	203.5
ROGDI	FLJ22386	ENSG00000067836	"Rogdi atypical leucine zipper"	Q9GZN7	16	4796968-4802880	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Amelogenesis imperfecta, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 105.6"	"Cell type enhanced"	"Detected in all"		"Bipolar cells: 179.2;Rod photoreceptor cells: 149.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 74.6;intermediate monocyte: 62.7;myeloid DC: 61.5;non-classical monocyte: 61.8;plasmacytoid DC: 34.5"	"Group enriched"	"Detected in all"	6	"dendritic cells: 61.5;monocytes: 74.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041000	Uncertain					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 56: Bipolar cells - Visual perception"			"HPA041000: AB_10794077"	"unprognostic (1.74e-3)"	"unprognostic (1.98e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.79e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (9.71e-4)"	"unprognostic (5.24e-2)"	"prognostic favorable (2.67e-5)"	"unprognostic (1.71e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.08e-2)"	7.5	24.1	82.9	11.6	84.5	78.0	7.3	81.3	105.6	8.8	64.3	17.6	24.8	7.5	6.6	18.1	14.5	14.4	44.2	91.4	83.9	19.3	19.7	15.5	8.6	84.0	84.9	5.9	22.9	26.4	18.2	7.9	80.9	19.0	7.6	61.9	25.3	16.6	63.1	6.5	21.4	11.3	79.4	15.6	21.1	8.2	96.8	10.1	4.6	32.9	8.7	11.2	6.4	97.6	13.5	18.8	9.5	42.4	12.2	6.2	36.4	9.4	4.6	8.2	3.6	12.5	15.3	5.9	15.1	19.9	5.3	26.7	9.9	28.7	3.2	4.8	13.3	8.0	28.9	28.1	19.8	10.4	6.5	8.3	11.7	12.4	8.3	21.6	14.5	11.5	5.7	3.5	14.1	74.9	9.4	51.0	15.3	15.4	14.2	30.1	26.1	30.1	19.8	18.1	55.3	24.5	38.6	42.4	9.9	11.9	50.9	40.8	22.3	7.3	17.0	52.5	6.5	14.2	17.0	5.2	8.6	40.0	6.5	10.5	74.6	8.1	2.1	62.7	6.6	2.5	5.4	4.9	61.5	2.8	4.7	5.5	6.7	6.7	61.8	34.5	6.1	38.0	82.9	84.5	81.3	105.6	91.4	83.9	84.0	84.9	80.9	79.4	96.8	97.6	7.0	19.2	7.8	17.3	6.7	5.1	28.0	84.4	32.5	179.2	23.0	22.5	58.1	21.5	36.7	27.6	110.5	46.9	11.5	23.4	39.2	22.2	30.3	17.6	8.5	12.0	52.0	38.7	33.2	16.0	73.4	15.9	11.7	7.2	5.7	9.8	24.3	19.7	64.8	25.2	19.2	29.7	69.2	28.7	29.0	57.0	6.8	31.0	12.4	10.3	77.0	102.5	6.2	7.5	90.2	13.5	23.7	19.2	4.6	12.7	65.7	80.8	21.3	149.7	6.6	8.2	15.3	6.5	20.7	24.8	5.8	30.6	9.5	64.7	23.1	22.3
RP9	PAP-1	ENSG00000164610	"RP9 pre-mRNA splicing factor"	Q8TA86	7	33094797-33109404	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031523, HPA050778"	Uncertain		Enhanced	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 47: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	"Vesicles, Cytosol"	"HPA031523: AB_10603235, HPA050778: AB_2681233"	"unprognostic (1.12e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (6.71e-2)"	"unprognostic (6.22e-2)"	"unprognostic (7.53e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (2.65e-5)"	"unprognostic (4.19e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.61e-1)"	12.6	15.0	26.3	8.7	26.1	21.6	12.6	28.0	51.2	17.0	26.7	16.7	9.0	14.4	15.5	10.1	14.0	6.2	29.2	25.8	26.3	17.2	13.8	12.0	15.6	26.6	26.3	16.2	20.2	10.5	10.3	10.2	26.7	14.4	9.8	16.7	11.5	11.7	36.3	13.8	15.9	8.4	25.8	20.8	13.5	18.1	26.9	13.8	16.0	34.3	16.7	14.3	13.1	27.4	20.9	28.8	29.7	34.1	18.5	17.2	14.3	26.4	21.6	28.9	23.0	25.6	14.6	26.2	17.0	21.1	35.4	20.4	36.4	22.0	36.8	11.9	25.1	19.2	22.8	24.4	32.4	26.0	13.0	17.5	20.2	32.8	64.5	23.3	24.0	27.1	35.2	23.0	29.1	42.6	27.7	69.6	25.4	27.2	21.9	28.2	26.4	17.1	21.1	19.3	28.7	39.5	18.7	39.6	46.2	35.1	20.8	35.0	19.4	28.4	40.9	25.6	42.8	38.1	37.2	51.7	20.0	36.3	56.1	21.9	12.0	21.6	15.2	9.8	14.1	57.8	16.3	17.4	13.2	77.3	19.1	18.0	2.0	15.7	12.5	28.4	15.8	8.8	26.3	26.1	28.0	51.2	25.8	26.3	26.6	26.3	26.7	25.8	26.9	27.4	21.3	12.8	10.1	4.9	35.6	21.0	15.1	11.3	29.0	15.8	17.7	27.9	41.7	17.2	10.9	14.7	14.6	20.2	16.8	12.6	21.5	16.0	5.6	14.6	28.2	24.1	10.2	19.4	6.5	15.8	20.0	20.4	20.4	16.6	3.8	26.8	15.4	16.4	18.4	8.4	7.5	19.3	24.4	10.1	14.9	3.2	18.0	12.0	23.2	5.6	10.1	21.9	21.6	3.0	8.7	14.6	8.0	16.1	24.4	22.9	16.1	18.6	8.5	16.4	26.3	19.4	30.3	31.6	54.3	24.4	18.0	10.4	19.9	22.9	18.4	12.0
RPA1	"HSSB, REPA1, RF-A, RP-A, RPA70"	ENSG00000132383	"Replication protein A1"	P27694	17	1829702-1900082	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004563, HPA006914, HPA046497"	Supported		Enhanced	Nucleoplasm		NA	NA		82000	"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"CAB004563: AB_628224, HPA006914: AB_1856410, HPA046497: AB_2679675"	"unprognostic (1.84e-1)"	"unprognostic (1.47e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.53e-2)"	"unprognostic (6.58e-3)"	"prognostic unfavorable (9.00e-9)"	"unprognostic (9.59e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.03e-3)"	"unprognostic (1.75e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.52e-2)"	21.1	17.7	14.1	22.5	15.7	22.0	20.6	18.1	16.3	21.8	15.6	21.8	20.8	22.8	17.5	23.4	25.4	15.5	26.7	14.4	17.1	14.6	17.1	17.1	35.8	15.0	15.2	31.8	15.3	18.9	14.8	16.9	17.2	22.2	17.2	22.4	21.8	21.8	52.4	25.9	20.6	21.9	16.6	21.8	17.0	14.4	16.3	37.6	23.2	34.3	37.8	22.1	19.7	19.0	93.5	90.7	77.9	76.2	35.3	35.9	88.1	73.5	40.7	85.1	87.7	132.0	41.2	128.4	68.1	41.3	34.9	83.4	93.4	58.3	93.5	86.3	116.3	77.8	113.6	51.0	23.4	57.7	65.5	29.9	37.0	84.1	36.2	30.1	62.9	77.0	75.8	72.4	60.2	47.8	127.3	33.7	63.5	58.2	53.2	173.8	44.0	72.1	37.3	62.3	34.9	54.7	103.9	35.1	63.8	52.0	75.1	43.4	56.2	66.5	56.7	75.3	113.9	19.8	56.5	76.0	46.5	88.6	82.2	43.2	25.0	54.5	53.1	36.4	54.2	51.2	55.1	53.0	30.2	35.8	53.0	48.4	11.9	80.8	47.8	31.7	56.7	60.5	14.1	15.7	18.1	16.3	14.4	17.1	15.0	15.2	17.2	16.6	16.3	19.0	14.9	9.6	14.7	12.4	24.3	29.6	16.3	22.4	17.6	19.2	25.1	21.0	23.7	22.8	14.4	40.5	4.2	69.4	27.0	13.5	5.9	20.6	18.9	13.4	16.6	21.7	15.6	67.6	12.2	19.8	68.9	23.2	7.7	14.2	33.7	25.0	25.4	24.2	46.1	37.0	14.0	19.3	26.4	49.1	14.6	42.4	32.3	35.1	28.4	14.0	37.6	39.7	35.0	12.1	18.2	15.0	7.2	34.6	23.0	14.1	24.6	11.7	19.4	19.5	0.0	19.2	21.5	14.7	21.8	24.3	29.1	43.5	30.3	15.6	23.1	11.7
RPA2		ENSG00000117748	"Replication protein A2"	P15927	1	27891524-27914746	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, DNA replication"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 162.3;Spermatogonia: 183.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016538, HPA026306, HPA026309"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"CAB016538: AB_670974, HPA026306: AB_10598913, HPA026309: AB_10601572"	"unprognostic (2.59e-1)"	"prognostic favorable (4.33e-4)"	"unprognostic (8.98e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.12e-4)"	"unprognostic (4.29e-3)"	"unprognostic (2.03e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.59e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.82e-2)"	28.4	25.0	33.3	39.7	35.1	40.7	43.8	33.4	42.4	32.0	37.4	26.6	18.5	33.7	43.4	32.3	49.1	30.6	39.2	34.5	36.1	32.4	31.8	28.7	75.1	33.7	33.2	52.0	21.0	40.7	31.3	30.2	33.9	28.7	30.2	43.8	24.0	31.3	72.3	40.3	26.1	30.7	36.7	42.3	25.6	63.7	34.0	53.4	52.9	63.2	67.6	30.3	24.9	36.7	60.9	57.4	86.4	68.5	59.3	52.8	57.2	106.1	70.3	130.0	113.5	80.2	72.7	148.9	69.4	41.1	48.4	55.8	126.5	60.3	122.4	121.0	126.0	174.3	73.0	71.3	30.9	229.7	115.1	24.6	33.2	123.8	62.3	40.3	59.1	133.1	196.2	127.1	75.7	63.6	163.9	105.1	181.7	115.1	122.0	115.0	128.7	74.2	49.1	65.2	78.3	75.8	123.3	47.3	100.7	68.1	50.9	71.8	36.6	32.2	73.0	186.2	76.3	105.8	251.0	135.8	81.4	213.5	64.3	322.3	97.4	290.0	279.7	80.0	304.4	272.5	252.9	257.4	112.1	232.0	287.4	282.7	100.1	294.1	106.5	172.3	255.5	435.5	33.3	35.1	33.4	42.4	34.5	36.1	33.7	33.2	33.9	36.7	34.0	36.7	26.5	22.4	15.7	10.4	64.0	21.0	28.5	47.1	16.5	28.4	25.7	27.8	29.0	24.3	30.4	22.0	2.1	95.2	77.8	10.1	35.2	35.0	49.0	14.6	18.8	27.9	13.8	39.1	8.8	20.6	67.3	34.8	7.1	15.1	60.9	33.3	26.4	16.6	51.9	8.4	8.4	14.0	71.2	31.5	27.6	22.6	41.3	34.1	37.4	7.5	86.7	100.0	95.8	9.5	14.3	29.5	10.4	46.3	32.6	19.3	11.2	23.6	28.8	34.5	32.9	48.0	24.7	162.3	183.5	20.6	22.4	55.7	59.9	33.9	19.3	20.1
RPA3	REPA3	ENSG00000106399	"Replication protein A3"	P35244	7	7636518-7718607	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, DNA replication"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 428.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005708	Approved					NA	NA		17000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA005708: AB_1856411"	"unprognostic (2.06e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.20e-3)"	"unprognostic (3.75e-2)"	"prognostic unfavorable (5.16e-5)"	"unprognostic (5.31e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.24e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.83e-2)"	16.4	25.7	12.4	22.9	14.4	46.2	24.4	14.3	19.7	12.5	19.9	25.2	15.8	10.5	37.1	19.6	25.5	10.6	20.5	12.3	15.7	35.7	40.5	14.6	37.9	13.9	13.1	12.7	15.4	46.4	27.2	16.4	15.3	11.5	19.9	34.1	14.5	13.6	18.7	13.3	18.4	9.6	14.7	23.4	20.8	22.5	13.8	51.8	19.3	12.5	35.6	16.3	12.5	15.7	174.1	95.9	94.8	102.3	35.2	31.9	67.2	47.6	44.3	73.0	116.2	92.3	153.1	88.4	45.2	36.0	235.9	129.2	64.5	85.9	106.4	41.1	112.0	48.1	111.9	189.2	15.3	102.5	38.9	23.4	29.9	85.0	59.6	36.0	41.9	168.6	119.5	132.6	70.8	257.0	83.9	198.1	149.9	104.9	125.1	98.3	154.9	141.6	52.3	84.0	70.5	86.8	88.2	91.6	51.0	137.9	122.0	107.4	19.3	60.5	169.1	99.8	113.7	102.7	199.9	167.7	89.7	119.3	118.5	17.9	25.3	27.2	34.1	40.8	40.9	75.4	55.7	44.0	31.9	76.9	45.6	46.3	22.2	29.7	49.0	61.6	68.5	35.7	12.4	14.4	14.3	19.7	12.3	15.7	13.9	13.1	15.3	14.7	13.8	15.7	35.6	38.5	39.5	2.9	93.2	40.5	65.0	160.8	41.5	24.1	54.7	73.9	39.0	60.1	89.5	71.7	10.4	152.2	53.2	61.9	273.9	84.8	96.9	144.8	34.9	35.7	25.3	218.2	5.2	105.4	257.5	43.3	39.8	61.8	53.9	43.2	36.0	154.5	131.4	16.8	5.6	75.1	83.4	48.7	54.2	24.4	39.1	49.9	56.9	1.9	68.2	63.7	56.7	6.0	5.8	64.1	70.4	24.5	75.8	25.9	74.3	428.6	269.9	44.7	6.6	34.7	46.9	112.7	65.9	59.6	34.4	66.2	68.7	46.1	90.5	66.2
RPA4	HSU24186	ENSG00000204086	"Replication protein A4"	Q13156	X	96883908-96885467	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 1.8;testis: 1.6"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 20.6;Syncytiotrophoblasts: 9.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HeLa: 1.0"									HPA066010	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA066010: AB_2685596"	"unprognostic (6.23e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.66e-6)"	"unprognostic (1.33e-1)"	"unprognostic (6.33e-2)"	"unprognostic (9.75e-4)"	"unprognostic (3.15e-1)"	"unprognostic (7.61e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.47e-12)"	"unprognostic (8.95e-3)"	"unprognostic (6.05e-3)"	"unprognostic (8.17e-2)"	"unprognostic (4.59e-2)"	0.4	0.1	0.3	0.0	0.5	0.2	0.2	0.0	0.4	0.5	1.8	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.3	0.6	0.2	0.1	0.4	0.3	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.1	1.6	0.2	0.0	0.1	0.0	0.0	0.2	0.3	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.4	0.1	0.4	0.0	0.1	0.7	0.0	0.7	0.0	0.2	0.0	0.3	0.0	1.0	0.0	0.0	0.9	0.2	0.0	0.0	0.5	0.2	0.0	0.0	0.3	0.0	0.7	0.6	0.1	0.3	0.4	0.3	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.4	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.5	0.3	0.0	0.5	0.7	0.4	0.2	0.4	0.2	0.1	0.0	0.1	0.2	0.0	0.1	0.3	0.0	0.4	0.3	0.3	0.0	0.3	0.5	0.0	0.4	0.6	0.2	0.1	0.0	0.1	0.1	0.2	0.2	3.3	0.0	3.3	0.0	0.7	0.8	0.3	0.7	0.6	0.3	0.4	0.5	0.1	2.8	0.8	0.0	0.0	4.6	1.6	2.1	0.0	0.8	1.1	0.9	1.5	2.0	3.6	0.0	0.0	0.6	1.1	1.3	2.6	1.7	0.0	3.4	0.4	1.9	1.9	0.0	0.0	2.5	4.1	2.2	1.1	1.0	1.5	2.0	0.0	0.0	2.4	0.3	0.0	0.0	0.0	1.4	2.9	1.5	0.3	0.4	1.1	0.1	0.1	1.6	6.6	3.5	1.0	20.6	6.7	1.1	1.3	9.9	0.8	1.1	1.7	0.2
RPF1	BXDC5	ENSG00000117133	"Ribosome production factor 1 homolog"	Q9H9Y2	1	84479259-84498352	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024642	Supported		Supported	Nucleoli		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoli		"HPA024642: AB_1856428"	"unprognostic (1.56e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.63e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.16e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (1.60e-5)"	"unprognostic (2.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.71e-1)"	24.4	21.6	13.7	19.0	17.4	44.9	24.7	14.7	19.4	23.5	15.8	28.1	17.7	26.0	23.0	27.0	23.2	14.1	34.2	13.5	15.4	28.0	26.1	20.5	26.8	13.7	14.0	20.7	22.8	18.8	21.0	14.9	13.8	20.8	20.9	16.8	21.9	15.5	42.7	26.1	23.2	18.1	13.4	26.2	25.6	25.3	13.9	29.4	23.3	23.9	28.1	24.9	23.3	14.8	43.1	29.2	36.6	30.2	27.1	35.5	40.5	46.8	36.5	53.2	47.0	21.4	17.6	31.9	50.1	33.9	89.0	31.7	54.3	43.2	57.7	51.0	57.6	85.2	30.7	37.8	37.2	80.0	25.4	29.0	63.0	56.0	39.2	30.7	42.6	60.7	79.9	40.7	46.9	21.8	76.3	53.0	91.5	43.0	62.5	48.3	58.5	25.7	51.3	47.6	45.2	42.2	27.7	52.7	107.3	32.8	29.6	53.4	30.3	40.1	41.3	64.8	90.4	29.5	39.0	73.0	19.2	71.0	37.0	64.0	35.2	34.6	41.4	41.0	45.4	65.4	46.0	42.0	37.4	58.6	51.3	50.7	14.7	52.6	46.3	39.5	52.9	47.4	13.7	17.4	14.7	19.4	13.5	15.4	13.7	14.0	13.8	13.4	13.9	14.8	28.2	38.5	39.5	7.2	35.8	34.7	41.5	71.6	12.0	15.7	20.4	19.6	39.3	30.0	43.0	16.5	16.7	35.5	51.7	18.0	74.3	60.3	72.7	34.9	27.6	35.0	33.5	17.2	10.1	64.1	33.1	25.0	16.8	26.5	65.2	18.6	28.9	36.6	44.0	8.4	9.8	29.6	28.5	31.7	30.2	13.2	32.6	28.4	28.4	9.4	37.0	30.1	60.8	8.5	10.4	53.0	23.6	35.0	16.2	26.8	21.7	67.4	53.8	25.6	46.0	23.4	43.3	94.7	63.7	18.0	32.7	27.5	40.3	21.4	36.0	39.7
RPL35A	"eL33, GIG33, L35A"	ENSG00000182899	"Ribosomal protein L35a"	P18077	3	197950190-197956610	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, tRNA-binding"	"Diamond-Blackfan anemia, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		11000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"				"unprognostic (9.48e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.01e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.89e-3)"	"prognostic unfavorable (9.89e-4)"	"unprognostic (2.51e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (1.37e-6)"	"unprognostic (1.03e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.85e-2)"	"unprognostic (7.72e-2)"	1060.9	919.0	554.5	548.3	560.9	1161.6	1209.1	556.6	875.5	1438.4	549.5	971.4	520.6	971.4	599.3	1071.3	1200.8	252.4	966.5	543.8	571.1	753.4	643.4	725.7	776.3	560.9	550.3	2394.5	1789.9	502.8	697.1	374.5	562.3	950.7	463.3	326.6	899.8	418.6	879.5	1311.5	830.6	379.1	574.1	927.0	1025.4	358.9	568.7	907.9	754.4	616.9	736.3	892.3	1148.1	574.3	2272.2	669.9	1091.7	982.0	737.1	1529.0	1215.9	1067.3	916.3	1121.8	841.4	2189.3	934.5	1922.7	3792.9	680.8	669.3	1163.5	924.8	990.5	1121.2	439.8	1629.0	1117.0	1082.0	1513.0	1173.4	1973.2	899.3	1383.4	1121.0	605.3	1672.3	1389.3	1085.5	810.5	1049.2	2182.5	1071.6	3132.8	1295.6	2533.4	1729.9	1681.6	1618.3	1221.8	942.7	2976.8	1286.5	1394.9	1052.5	969.8	676.7	2283.5	3031.5	1176.3	3953.6	3116.9	1031.2	652.8	872.6	979.3	2042.8	1709.4	2192.8	2579.9	934.9	3009.7	1045.6	461.7	737.7	233.9	705.6	543.2	1155.3	1223.1	1275.3	970.1	796.3	1105.2	1645.4	1249.0	118.2	741.6	513.4	929.9	878.3	2092.3	554.5	560.9	556.6	875.5	543.8	571.1	560.9	550.3	562.3	574.1	568.7	574.3	1882.9	1060.9	1722.6	24.5	4121.3	5337.3	4473.1	3629.9	3843.2	320.9	5257.9	6722.9	541.7	2116.1	2284.9	941.7	100.1	2684.9	2686.7	1217.3	3470.9	2107.4	1845.9	1520.8	2914.9	2334.0	1638.9	2465.7	23.1	4595.8	4411.0	2262.0	1398.1	1765.7	2045.0	2514.8	3040.2	1877.8	2449.5	156.5	25.7	3361.4	1184.0	3417.8	4894.1	1595.8	4527.5	2304.4	2968.6	28.1	3705.1	1155.2	2747.7	13.6	30.9	3218.5	2744.3	2315.1	2374.0	4080.9	2776.5	3992.3	1300.9	435.6	1610.6	4280.8	2712.8	850.7	723.4	3869.4	6022.9	2692.1	3610.9	2182.6	3544.4	4170.3
RPL39L	RPL39L1	ENSG00000163923	"Ribosomal protein L39 like"	Q96EH5	3	187120948-187180908	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"testis: 210.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 545.6;Late spermatids: 245.5;Spermatocytes: 785.0;Spermatogonia: 161.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA047105	Approved					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA047105: AB_2679933"	"unprognostic (1.01e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (6.05e-4)"	"prognostic unfavorable (1.30e-6)"	"unprognostic (6.94e-2)"	"unprognostic (9.75e-3)"	"unprognostic (1.66e-3)"	"unprognostic (8.02e-2)"	"prognostic favorable (1.94e-4)"	"unprognostic (1.19e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.27e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.21e-3)"	"unprognostic (2.60e-1)"	7.8	3.0	9.6	7.9	10.4	19.4	12.8	12.8	12.0	11.2	8.5	12.5	3.4	8.7	4.6	8.9	12.0	3.6	11.6	9.5	12.7	6.9	4.5	5.4	13.2	8.4	8.9	4.7	20.2	5.9	4.8	6.0	8.6	9.9	4.5	6.8	8.3	7.1	2.1	12.0	6.2	8.2	6.6	7.0	6.8	210.5	10.0	16.5	4.0	2.3	14.1	8.5	10.7	12.5	213.2	67.3	22.4	35.9	10.2	15.3	20.9	56.6	44.0	51.0	54.8	5.6	33.3	78.7	203.7	32.7	98.2	64.7	56.4	10.8	77.5	136.5	9.1	1.5	69.7	1.3	19.3	18.7	20.3	12.7	8.2	42.2	35.9	38.9	52.6	95.4	42.8	90.3	19.4	62.7	2.1	66.0	162.8	65.0	122.7	69.5	31.0	58.9	17.0	4.8	54.6	56.8	47.3	120.2	138.0	94.1	118.8	55.4	24.8	1.4	59.6	48.5	59.2	118.6	138.1	153.4	30.8	69.9	117.0	6.1	10.7	2.6	25.1	10.4	12.3	33.1	25.1	22.5	10.8	22.7	17.2	26.1	2.2	16.5	7.3	12.2	47.5	30.9	9.6	10.4	12.8	12.0	9.5	12.7	8.4	8.9	8.6	6.6	10.0	12.5	3.0	3.2	7.1	2.3	21.0	25.0	37.0	32.5	19.4	3.4	30.4	35.9	48.4	14.3	10.7	3.7	0.0	26.0	9.1	3.3	7.9	13.0	545.6	16.4	14.7	8.1	0.0	8.8	1.8	2.6	95.7	16.8	5.1	9.2	7.0	21.1	23.6	50.4	40.3	6.7	1.6	4.5	16.2	19.1	25.5	245.5	21.8	9.9	23.2	1.0	4.3	16.6	34.0	3.0	1.3	10.5	2.2	11.7	27.2	31.6	0.7	2.3	10.2	2.2	6.6	8.5	26.4	785.0	161.7	12.7	21.2	14.9	16.0	14.5	8.4	30.4
RPP14	P14	ENSG00000163684	"Ribonuclease P/MRP subunit p14"	O95059	3	58306245-58324695	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 40.8;tongue: 39.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA036194	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA036194: AB_10672082"	"unprognostic (6.05e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.95e-3)"	"unprognostic (3.76e-2)"	"prognostic favorable (3.07e-10)"	"unprognostic (5.19e-3)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (5.78e-2)"	5.1	5.7	3.1	4.6	3.2	4.8	5.0	5.9	4.1	4.6	2.0	6.8	6.8	5.5	3.7	5.9	4.9	4.2	10.9	3.2	2.9	9.1	11.5	4.1	4.0	3.0	2.2	5.5	6.1	7.7	5.9	4.0	3.1	4.7	6.4	5.1	4.9	4.4	40.8	5.3	6.9	7.1	1.7	5.8	5.4	5.1	3.1	6.5	5.5	39.0	6.0	5.2	5.0	3.4	12.3	10.4	11.5	8.2	6.6	9.0	12.3	9.9	11.7	14.5	17.1	15.9	8.0	13.8	2.4	14.4	13.7	7.2	17.6	15.8	14.8	10.6	8.5	12.0	11.9	8.4	7.8	24.4	10.7	8.4	12.1	18.6	16.3	5.2	12.1	18.2	12.0	7.8	14.3	6.5	16.2	7.9	11.9	10.5	17.9	6.8	8.4	14.0	9.6	18.9	6.9	11.8	10.2	9.8	11.9	7.3	11.0	8.6	11.1	10.4	11.7	10.5	20.4	13.0	28.3	22.3	11.2	17.1	6.7	2.1	3.4	2.6	2.1	2.8	3.0	2.1	2.7	3.2	3.9	3.0	3.2	3.5	4.0	5.5	6.0	3.9	1.8	2.1	3.1	3.2	5.9	4.1	3.2	2.9	3.0	2.2	3.1	1.7	3.1	3.4	9.0	9.6	11.9	6.2	8.2	31.2	8.1	21.1	17.1	26.3	8.2	7.6	28.4	7.2	11.8	3.7	25.0	8.4	9.4	14.9	11.7	5.7	0.8	8.2	12.4	10.6	9.6	7.6	18.4	6.2	5.9	11.5	13.3	8.2	3.8	11.5	11.4	21.3	6.2	18.5	18.2	11.8	16.2	11.0	20.0	1.7	12.5	9.7	23.2	13.1	9.2	13.2	7.2	10.6	11.2	7.8	7.6	9.8	14.2	8.1	16.2	11.4	9.7	28.3	0.0	14.1	13.7	11.9	15.3	20.4	43.0	10.3	9.2	15.0	13.7	6.5
RPP30	TSG15	ENSG00000148688	"Ribonuclease P/MRP subunit p30"	P78346	10	90871952-90908553	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037578	Approved		Approved	"Nucleoplasm,Nucleoli,Microtubule ends,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli"	"Microtubule ends, Cytosol"	"HPA037578: AB_10696939"	"unprognostic (1.55e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.08e-1)"	"unprognostic (5.64e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (1.01e-6)"	"unprognostic (1.98e-1)"	"unprognostic (9.84e-3)"	"unprognostic (3.43e-2)"	"unprognostic (2.10e-2)"	19.2	13.9	7.8	12.9	8.8	25.9	17.3	8.2	10.6	14.1	7.3	15.3	9.3	15.8	14.1	18.0	14.9	12.7	22.6	8.8	8.4	16.3	15.1	13.1	21.0	7.1	7.3	18.1	11.0	23.0	8.0	18.5	7.6	12.1	15.1	13.2	14.5	12.2	31.1	17.9	12.4	16.4	8.3	15.0	14.3	28.6	7.7	21.7	12.2	22.2	22.4	17.0	14.2	10.6	82.2	53.2	55.0	66.5	34.4	37.6	19.4	57.0	51.1	93.3	98.3	90.6	64.1	48.1	42.6	36.4	60.9	56.0	73.9	50.5	95.3	77.2	51.3	32.7	31.1	73.0	33.0	66.7	39.1	30.9	32.4	70.5	79.1	39.6	54.1	43.5	65.7	42.6	62.6	50.8	77.4	89.8	33.9	46.4	59.8	42.9	46.7	50.4	35.6	38.2	29.9	29.9	33.1	23.8	68.2	50.0	64.8	41.3	31.2	46.3	46.3	26.5	119.6	28.7	79.4	104.4	57.9	35.4	36.4	9.2	30.0	27.1	25.2	30.7	27.5	31.7	28.7	28.0	35.1	28.1	24.6	27.0	3.5	25.4	26.2	32.8	33.0	27.6	7.8	8.8	8.2	10.6	8.8	8.4	7.1	7.3	7.6	8.3	7.7	10.6	31.4	32.1	16.9	14.0	28.7	34.4	27.5	51.8	23.9	19.2	16.7	28.2	45.7	27.1	31.4	14.7	18.8	60.6	33.7	9.4	31.3	41.9	95.9	18.9	26.1	25.2	19.8	38.5	18.0	35.0	68.1	28.0	13.3	17.9	23.5	33.3	21.4	14.3	58.1	16.8	19.4	21.0	30.5	23.9	29.3	49.9	28.9	24.7	23.2	11.2	32.2	23.3	15.5	17.6	19.6	31.3	12.5	29.3	20.6	18.8	12.5	36.5	21.6	24.3	39.5	30.1	36.9	77.9	54.2	20.2	34.0	33.8	23.7	28.6	17.6	27.6
RPP38		ENSG00000152464	"Ribonuclease P/MRP subunit p38"	P78345	10	15097180-15139818	"Enzymes, Predicted intracellular proteins, Ribosomal proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 555.3;Late spermatids: 231.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045128, HPA050398"	Approved		Supported	Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoli		"HPA045128: AB_2797230, HPA050398: AB_2732560"	"unprognostic (1.75e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (1.41e-2)"	"unprognostic (4.86e-1)"	"unprognostic (1.57e-3)"	"unprognostic (3.42e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (6.13e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.11e-2)"	"prognostic favorable (2.89e-6)"	14.0	12.9	9.1	12.3	9.4	12.4	19.8	12.4	11.7	14.0	15.1	16.3	15.8	15.0	16.7	16.2	19.3	11.2	13.0	9.4	9.5	17.2	19.4	13.8	20.1	8.9	9.0	14.6	15.2	14.2	13.4	11.5	8.9	13.9	16.7	13.4	14.4	12.1	19.0	17.2	16.6	12.5	8.8	17.7	15.4	48.1	9.3	15.6	16.2	14.8	18.0	17.6	13.3	10.1	40.6	29.4	15.6	20.3	20.7	21.2	27.9	18.7	14.0	29.0	29.3	29.6	40.3	33.2	19.3	17.6	23.7	36.2	31.8	32.4	26.2	26.0	28.6	34.3	17.3	26.2	44.4	19.5	27.5	25.3	43.8	23.4	20.5	21.9	23.2	33.0	40.1	22.7	22.0	32.6	34.9	20.9	18.0	49.0	14.0	28.3	15.9	41.5	37.0	15.3	14.7	18.5	25.7	44.4	53.6	25.6	39.7	30.8	18.8	13.1	22.8	28.3	25.2	31.6	36.5	44.9	25.8	23.3	12.6	21.9	48.5	49.7	49.1	49.0	48.6	58.7	49.7	60.8	51.9	66.0	57.2	52.4	16.2	41.5	40.8	52.3	47.3	43.4	9.1	9.4	12.4	11.7	9.4	9.5	8.9	9.0	8.9	8.8	9.3	10.1	15.5	16.0	22.0	4.2	24.0	31.5	41.9	34.7	14.2	14.2	22.5	26.0	7.1	11.5	40.3	9.2	6.2	30.2	18.6	18.6	27.4	34.2	555.3	54.4	18.7	19.2	13.2	15.2	3.3	33.2	42.1	15.7	16.8	16.0	12.7	15.5	19.6	32.4	24.7	8.4	3.5	25.4	36.7	18.8	12.6	231.1	23.6	13.4	8.8	5.6	21.6	17.7	33.0	4.5	5.5	29.6	16.8	19.9	14.5	46.8	26.9	33.9	89.2	31.0	13.1	14.9	14.6	68.0	34.6	17.2	36.1	32.2	21.5	23.6	24.0	43.8
RPS6KB2	"KLS, P70-BETA, p70S6Kb, S6Kβ, S6KB, S6Kbeta, STK14B"	ENSG00000175634	"Ribosomal protein S6 kinase B2"	Q9UBS0	11	67428460-67435401	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010010, CAB019404"	Approved		Supported	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"CAB019404: AB_331355, HPA010010: AB_1856469"	"unprognostic (1.38e-1)"	"unprognostic (2.36e-3)"	"unprognostic (8.50e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.01e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.49e-3)"	"unprognostic (7.66e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.03e-7)"	"unprognostic (1.28e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.66e-1)"	16.2	28.0	9.7	13.8	10.8	28.2	17.0	9.9	12.4	23.5	13.2	22.8	26.5	17.7	6.0	71.9	20.0	10.6	22.1	9.1	9.3	21.3	50.2	19.5	18.4	10.9	10.3	16.2	35.4	17.5	20.6	13.6	10.6	31.6	12.8	4.2	31.5	9.9	37.9	81.6	25.4	10.1	10.2	33.7	35.2	9.6	9.9	24.0	20.1	26.0	20.1	19.3	31.4	11.3	58.2	42.7	22.8	39.0	10.4	20.0	30.0	27.4	33.9	49.7	34.2	67.2	37.5	21.1	46.3	26.9	31.0	41.8	25.9	41.4	19.9	36.9	70.0	34.5	54.2	55.5	35.2	43.7	40.4	25.5	42.8	26.3	26.9	12.5	37.5	54.8	55.8	54.8	25.4	88.5	68.1	68.4	24.9	83.7	54.6	50.0	31.8	100.5	23.0	32.6	34.4	37.1	28.0	76.8	59.8	13.2	90.4	35.7	15.8	25.8	27.6	63.1	31.1	48.8	43.9	34.4	42.4	27.3	33.1	18.8	37.2	28.5	23.8	42.6	24.5	23.4	22.9	23.9	44.1	21.9	16.1	17.9	24.7	29.6	49.9	30.4	34.5	37.3	9.7	10.8	9.9	12.4	9.1	9.3	10.9	10.3	10.6	10.2	9.9	11.3	22.0	9.6	20.5	6.8	48.1	49.8	28.0	48.9	19.9	25.3	32.6	27.8	1.3	28.6	31.2	7.3	10.4	71.8	45.0	66.9	43.0	44.5	14.9	16.0	16.9	17.9	46.2	65.0	7.7	64.8	89.1	21.9	48.9	19.3	27.9	23.2	18.2	57.4	61.3	33.7	7.1	67.7	34.6	45.8	29.1	29.4	20.2	36.9	19.6	3.7	56.6	28.5	73.2	5.0	12.1	46.6	70.4	17.3	82.1	43.7	115.0	42.2	16.0	27.6	19.7	16.7	26.9	15.8	16.0	52.5	63.6	103.6	41.7	27.5	58.3	39.4
RPTOR	"KIAA1303, KOG1, Mip1, raptor"	ENSG00000141564	"Regulatory associated protein of MTOR complex 1"	Q8N122	17	80544819-80966371	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Astrocytes: 46.0;Excitatory neurons: 70.1;Inhibitory neurons: 66.3;Microglial cells: 32.8;Oligodendrocyte precursor cells: 50.8;Oligodendrocytes: 66.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013514, HPA064306"	Approved		Enhanced	Vesicles,Lysosomes		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Vesicles, Lysosomes"		"CAB013514: AB_2533523, HPA064306: AB_2685240"	"unprognostic (5.09e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.75e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.17e-2)"	"unprognostic (9.63e-2)"	"unprognostic (8.80e-2)"	"unprognostic (4.40e-3)"	"unprognostic (8.46e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.77e-2)"	5.9	4.6	3.5	4.4	3.3	4.1	3.6	2.0	4.4	4.3	0.1	5.7	4.8	5.6	1.8	4.5	4.5	2.9	6.1	3.8	2.6	3.1	3.4	4.2	3.3	3.3	2.8	4.8	5.5	5.3	4.0	3.6	3.3	4.5	2.4	2.6	4.6	5.0	14.1	5.1	4.5	4.6	2.0	3.8	4.4	4.0	3.5	4.4	3.6	7.0	2.7	5.4	3.6	3.2	16.2	34.7	6.8	12.9	9.5	7.0	15.5	12.7	9.5	17.9	12.4	21.5	13.8	13.3	10.1	12.9	13.8	11.6	10.5	15.7	8.9	5.6	19.6	20.8	16.8	21.2	8.9	19.8	15.3	12.3	9.9	17.3	9.1	5.9	16.6	15.7	24.9	4.6	8.6	8.8	12.4	7.8	7.4	9.2	24.0	10.2	12.9	11.2	4.6	17.8	13.4	17.4	14.4	22.9	14.9	6.6	16.3	14.5	9.6	37.1	17.8	11.6	15.7	8.9	3.9	12.6	22.4	10.1	23.6	0.0	0.1	0.0	0.5	0.3	0.3	0.2	0.2	0.3	0.4	0.1	0.2	0.2	0.0	0.1	0.2	0.0	1.0	0.4	3.5	3.3	2.0	4.4	3.8	2.6	3.3	2.8	3.3	2.0	3.5	3.2	4.3	0.0	3.9	46.0	8.5	3.2	3.0	2.4	4.6	6.8	4.2	3.3	4.5	5.7	1.6	5.5	4.2	4.4	7.2	3.8	1.9	3.6	6.7	3.9	5.4	4.3	6.0	4.8	70.1	3.8	5.9	4.8	8.2	4.9	2.5	7.5	2.2	7.5	4.7	11.8	66.3	3.1	6.1	5.7	3.2	10.9	3.1	6.7	1.8	32.8	1.7	4.3	2.1	50.8	66.2	4.7	3.5	5.3	9.4	4.5	4.6	2.7	2.0	7.0	0.0	5.5	4.1	4.5	3.5	5.1	3.0	4.4	9.3	6.0	5.6	3.8
RRM1		ENSG00000167325	"Ribonucleotide reductase catalytic subunit M1"	P23921	11	4094707-4138932	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA replication"	"Allosteric enzyme, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 102.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022093, HPA057265, HPA064297"	Enhanced		Supported	Cytosol		NA	Yes		140000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"CAB022093: , HPA057265: AB_2683386, HPA064297: AB_2685236"	"unprognostic (4.47e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.99e-3)"	"unprognostic (3.65e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (1.31e-2)"	"unprognostic (3.43e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.06e-3)"	"unprognostic (4.21e-2)"	"unprognostic (6.88e-3)"	"unprognostic (9.20e-3)"	"unprognostic (6.16e-2)"	"unprognostic (8.41e-2)"	"unprognostic (9.93e-3)"	16.6	21.2	5.1	24.8	5.3	32.8	22.7	7.1	6.1	16.9	4.7	25.7	19.3	16.2	10.1	26.5	15.5	11.8	16.4	5.1	5.7	13.4	18.4	12.8	34.4	6.1	5.5	16.4	14.6	24.7	7.1	20.4	6.6	18.5	29.4	23.6	14.7	16.0	30.3	36.1	20.2	20.1	6.2	13.0	17.6	17.9	5.1	56.7	15.6	30.0	45.2	15.6	18.9	6.2	221.6	117.8	188.4	110.0	28.4	56.2	73.0	198.0	98.2	220.7	225.9	106.8	163.8	237.4	47.0	100.1	95.9	173.0	176.9	143.2	259.3	117.3	187.9	121.0	159.8	83.1	11.2	208.9	84.6	26.6	37.8	121.7	86.4	48.3	107.8	140.1	161.1	107.3	186.8	99.6	246.7	41.9	118.2	152.2	119.2	196.1	147.0	84.3	59.4	61.8	159.8	88.1	175.1	104.8	30.0	75.8	102.8	71.4	62.3	203.4	106.0	206.9	147.4	70.3	103.5	252.5	114.1	137.6	130.3	8.3	4.0	4.5	11.3	11.2	21.1	9.2	22.3	16.6	7.3	5.2	17.2	15.0	0.0	10.5	15.6	4.4	41.7	10.3	5.1	5.3	7.1	6.1	5.1	5.7	6.1	5.5	6.6	6.2	5.1	6.2	12.4	19.2	14.4	4.9	17.0	33.4	26.8	31.0	17.6	15.6	15.1	14.4	33.5	14.3	24.7	18.4	6.2	62.8	14.9	13.3	7.9	25.6	69.9	11.5	14.5	15.7	18.0	81.2	11.2	22.2	62.5	22.0	20.4	13.9	7.0	27.3	10.8	15.0	28.3	18.5	12.0	25.0	16.2	11.7	10.3	83.9	13.1	13.9	10.6	6.5	10.7	24.0	5.2	12.1	11.9	15.8	10.4	16.6	31.3	10.1	12.5	8.4	15.5	22.7	13.1	19.5	27.1	102.8	63.1	36.5	29.0	39.7	23.2	18.1	34.3	20.6
RRM2	"C2orf48, FLJ25102"	ENSG00000171848	"Ribonucleotide reductase regulatory subunit M2"	P31350	2	10120698-10211725	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"DNA replication"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 44.2;esophagus: 18.4;intestine: 19.7;lymphoid tissue: 58.1"	"Group enriched"	"Detected in many"	4	"Erythroid cells: 214.0;Extravillous trophoblasts: 254.1;Plasma cells: 248.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056994	Enhanced		Supported	Cytosol		Yes	Yes		13000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA056994: AB_2683304"	"unprognostic (2.10e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.40e-3)"	"unprognostic (4.42e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (1.04e-3)"	"unprognostic (6.67e-3)"	"unprognostic (4.53e-2)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (5.11e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.05e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.09e-2)"	1.5	1.3	0.3	12.4	0.3	44.2	2.9	0.5	0.4	3.0	1.9	14.2	9.4	2.2	0.7	18.4	0.8	1.1	0.5	0.3	0.3	0.9	3.2	2.4	35.5	0.4	0.4	0.3	1.1	0.3	0.2	4.6	0.4	0.9	19.7	0.2	2.1	0.5	0.1	3.7	7.5	6.1	0.3	11.1	6.0	2.9	0.8	58.1	0.9	0.1	37.6	6.0	4.6	0.5	110.2	25.0	127.1	49.9	7.4	22.5	116.8	209.2	128.6	170.2	187.9	70.8	59.1	114.4	9.5	88.6	151.1	55.0	188.0	136.6	198.0	210.7	41.8	146.3	52.1	105.1	0.8	146.7	87.4	8.1	3.4	234.6	16.2	27.7	103.3	110.4	63.4	328.6	214.3	57.1	167.3	90.9	83.0	133.3	103.6	87.6	187.0	67.8	87.1	62.7	67.7	56.2	198.0	116.6	17.3	51.8	69.2	31.4	57.6	93.1	125.1	66.9	289.6	212.1	184.9	195.9	51.0	134.4	107.7	0.3	0.1	0.1	1.2	0.0	0.0	0.1	0.3	0.8	0.1	0.1	0.1	0.4	0.4	0.8	0.0	0.1	0.2	0.2	0.3	0.3	0.5	0.4	0.3	0.3	0.4	0.4	0.4	0.3	0.8	0.5	0.2	3.2	1.5	0.0	25.0	10.5	3.0	9.2	1.2	0.0	3.9	4.4	1.4	1.5	2.3	0.0	0.0	42.3	5.6	12.9	1.9	1.2	3.9	2.2	3.5	4.2	0.0	214.0	0.1	0.0	254.1	11.2	11.7	3.6	5.7	12.2	3.9	3.7	47.9	0.0	0.0	26.9	2.0	7.2	8.8	6.8	0.3	5.0	0.0	1.0	0.0	0.0	7.2	0.0	0.0	0.5	0.3	0.4	248.0	1.5	2.4	2.1	4.6	0.0	0.0	0.2	14.6	22.9	34.0	51.5	1.6	48.7	11.9	1.2	36.7	5.6
RRP1	"D21S2056E, NNP-1, Nop52, RRP1A"	ENSG00000160214	"Ribosomal RNA processing 1"	P56182	21	43789513-43805293	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016818, HPA018166"	Approved		Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Mitotic chromosome"		"HPA016818: AB_1854561, HPA018166: AB_1854562"	"unprognostic (5.38e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.53e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.69e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.63e-3)"	"unprognostic (9.42e-2)"	"unprognostic (6.94e-2)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (6.29e-5)"	"unprognostic (1.13e-1)"	"unprognostic (9.21e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.88e-1)"	8.0	8.2	8.0	6.5	8.7	5.3	7.3	7.4	10.2	6.9	4.8	6.4	5.0	7.1	3.3	16.0	6.4	4.0	7.0	9.2	7.2	7.6	13.0	5.3	8.1	8.9	8.1	8.0	9.7	4.8	5.5	4.9	8.0	7.2	3.0	1.7	8.1	4.2	12.9	11.9	5.9	3.4	6.6	8.2	7.5	7.9	7.6	5.0	6.0	5.3	6.1	7.3	7.9	10.8	37.6	19.6	13.5	22.6	7.3	8.2	25.6	18.5	10.9	25.7	18.1	52.1	21.6	35.5	14.9	10.4	23.8	18.8	25.2	18.5	11.7	17.7	47.9	50.4	18.8	32.1	14.9	32.6	17.5	11.0	17.0	26.0	20.6	6.7	13.7	32.9	67.3	26.9	12.2	43.2	28.7	44.7	44.8	26.1	28.7	52.0	10.7	66.4	13.4	20.5	31.6	18.8	19.3	21.0	25.3	3.8	21.5	22.1	15.6	17.2	19.1	18.2	33.0	32.1	29.8	37.1	25.7	53.7	22.6	0.1	5.0	1.7	10.7	4.8	13.4	11.0	11.0	11.1	10.2	13.0	11.9	8.0	1.1	13.1	2.3	8.8	6.8	7.0	8.0	8.7	7.4	10.2	9.2	7.2	8.9	8.1	8.0	6.6	7.6	10.8	12.9	16.0	19.4	9.4	17.3	72.3	40.2	55.9	23.3	18.7	14.4	12.7	6.1	18.6	45.3	7.3	20.9	31.4	12.7	18.6	7.9	40.0	4.2	14.9	15.5	18.8	20.9	19.0	6.2	33.1	39.0	24.5	18.8	16.1	20.3	20.1	9.3	16.0	32.7	8.4	6.3	19.3	32.6	8.4	35.0	2.7	19.3	13.6	42.7	2.8	15.3	12.3	13.4	2.5	11.6	41.4	9.1	20.7	19.2	59.4	10.5	21.0	24.3	17.6	32.9	23.8	20.6	21.4	30.0	32.2	70.2	30.4	15.0	21.4	29.5	46.1
RRP12	KIAA0690	ENSG00000052749	"Ribosomal RNA processing 12 homolog"	Q5JTH9	10	97356358-97426076	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 90.9;skeletal muscle: 38.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 26.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049945, HPA074403"			Supported	"Nucleoli,Vesicles,Plasma membrane,Cytosol"		No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	Nucleoli	"Vesicles, Plasma membrane, Cytosol"	"HPA049945: AB_2680965, HPA074403: "	"unprognostic (2.79e-1)"	"unprognostic (7.65e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.12e-8)"	"unprognostic (2.64e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (2.54e-5)"	"unprognostic (2.58e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.81e-2)"	"unprognostic (6.99e-3)"	8.1	10.2	2.6	9.2	3.4	90.9	5.6	1.1	7.6	5.6	2.4	4.9	6.0	7.4	3.6	8.5	7.3	7.2	11.4	3.2	2.7	6.8	5.7	6.7	6.7	4.3	4.4	6.1	16.0	9.3	10.2	4.3	4.1	6.3	3.8	3.4	8.3	4.0	38.5	10.3	4.7	6.0	0.2	7.6	6.3	10.9	3.7	4.7	5.5	9.7	6.1	9.3	5.7	4.6	38.9	50.8	13.2	28.6	10.0	11.6	28.9	24.2	14.4	24.2	18.7	55.6	35.0	42.3	30.4	15.1	21.6	48.7	36.3	28.0	16.3	23.1	44.2	32.8	19.5	43.6	16.5	51.7	41.5	12.2	38.6	59.9	54.6	27.0	13.7	23.5	47.7	27.4	14.0	50.8	35.0	33.0	57.0	20.4	34.0	38.1	18.0	42.1	16.8	21.4	17.7	37.9	19.2	18.1	24.1	10.4	43.7	26.5	18.2	16.1	27.9	36.5	76.4	55.7	52.7	48.6	23.2	64.9	17.9	0.4	11.2	6.9	2.7	13.6	3.3	3.9	1.6	2.2	6.2	4.2	2.5	2.8	26.7	1.9	16.9	5.0	1.2	6.0	2.6	3.4	1.1	7.6	3.2	2.7	4.3	4.4	4.1	0.2	3.7	4.6	8.8	35.3	31.1	5.9	18.5	23.5	14.2	5.1	25.0	5.8	12.7	9.9	11.6	7.2	21.5	14.7	41.7	5.2	7.7	10.6	0.0	8.7	7.2	17.1	10.6	10.6	21.5	7.2	15.1	8.7	7.5	13.5	27.0	20.1	41.7	12.9	3.9	8.9	11.5	5.0	9.5	13.8	4.1	12.5	7.1	4.8	3.7	30.3	7.2	2.8	12.3	1.9	3.1	5.0	4.4	8.5	6.4	2.6	31.8	17.1	3.7	6.8	24.6	12.7	0.0	19.4	6.7	10.6	20.6	22.7	19.6	9.2	11.0	13.5	11.5	13.6
RRP15	"CGI-115, KIAA0507"	ENSG00000067533	"Ribosomal RNA processing 15 homolog"	Q9Y3B9	1	218285293-218337983	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024639	Approved		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome,Mitochondria"		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli rim, Mitotic chromosome"	"Nucleoplasm, Mitochondria"	"HPA024639: AB_1844368"	"unprognostic (2.68e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (4.26e-5)"	"unprognostic (7.87e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.65e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.76e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.77e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.23e-2)"	4.0	2.6	1.7	3.3	1.7	4.1	4.7	2.5	2.4	3.0	1.4	3.0	2.1	3.7	2.7	3.0	2.9	1.9	4.9	1.8	1.9	3.4	3.5	2.8	3.7	1.4	2.0	3.8	2.9	4.5	1.8	3.6	1.6	3.1	2.9	2.2	2.6	2.4	9.6	3.5	2.4	3.4	1.5	2.9	2.6	2.4	1.8	2.6	3.5	7.7	3.5	3.9	2.8	1.9	9.8	7.2	7.9	5.7	5.6	7.8	6.7	9.8	7.3	10.0	7.2	14.1	8.8	14.0	13.1	7.6	6.7	8.7	13.5	13.0	16.6	5.7	10.1	10.9	6.6	7.8	11.6	17.0	5.6	5.4	7.8	13.1	17.4	4.4	6.6	6.5	22.7	4.4	11.4	8.9	11.3	8.3	15.7	7.8	14.8	7.8	4.9	13.8	8.0	8.9	9.0	13.1	8.3	15.3	15.0	9.3	11.0	12.1	9.3	8.0	7.6	14.3	18.3	5.4	8.9	14.4	9.1	8.1	13.1	0.3	0.8	0.1	1.6	1.3	2.3	2.4	2.0	1.4	1.2	2.3	2.6	2.6	0.2	1.6	1.1	1.7	1.3	0.7	1.7	1.7	2.5	2.4	1.8	1.9	1.4	2.0	1.6	1.5	1.8	1.9	33.7	32.1	28.1	7.5	36.0	65.3	33.6	28.7	24.5	31.1	32.6	31.0	68.4	22.8	25.0	36.8	10.4	38.1	32.7	13.5	27.4	39.7	17.0	22.6	47.3	27.9	12.1	41.0	18.4	52.2	59.1	32.2	19.9	28.5	31.0	18.6	21.8	44.2	33.6	26.9	16.1	20.8	6.1	17.3	18.5	4.6	37.6	17.4	21.4	7.5	20.8	21.2	24.7	7.5	9.0	36.8	9.0	24.8	13.0	34.9	5.2	37.2	11.7	23.6	26.3	72.1	33.0	59.7	69.1	24.3	47.6	18.1	26.4	20.4	32.1	23.0
RRP1B	"KIAA0179, Nnp1, PPP1R136, RRP1"	ENSG00000160208	"Ribosomal RNA processing 1B"	Q14684	21	43659560-43696079	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 131.3;Early spermatids: 213.2;Late spermatids: 222.8;Rod photoreceptor cells: 143.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA017893, HPA020324"	Supported		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA017893: AB_1852274, HPA020324: AB_1852276"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.03e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.08e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.95e-9)"	"unprognostic (1.45e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.24e-2)"	8.8	5.9	7.9	12.2	8.9	6.2	9.1	7.0	7.8	7.2	5.9	7.2	6.7	9.1	5.5	8.6	9.1	6.1	4.9	7.4	7.2	4.9	8.7	6.7	17.4	7.8	7.9	13.1	10.2	7.2	4.3	5.8	7.2	7.5	7.3	28.4	10.2	6.8	12.1	8.8	6.4	8.8	7.4	11.0	7.8	12.0	7.8	16.1	6.5	8.8	14.8	9.8	6.5	8.6	52.5	30.4	31.8	48.1	20.2	21.5	26.0	27.0	19.3	29.3	24.0	69.4	22.2	101.9	17.2	21.5	33.9	22.8	78.9	46.5	34.6	34.6	62.8	60.3	34.8	43.9	27.9	95.0	22.9	22.4	29.2	35.1	40.3	18.1	33.1	43.2	96.0	29.1	26.1	27.4	76.1	28.9	108.4	33.7	33.4	98.7	32.1	71.2	21.2	24.8	62.7	33.6	50.6	36.9	37.9	11.7	24.2	29.4	29.7	9.0	28.3	24.0	49.8	39.1	53.8	119.3	28.5	100.7	30.1	2.0	2.5	0.7	6.2	2.5	7.3	5.6	7.9	7.5	3.0	4.3	7.2	8.6	0.1	5.8	2.2	2.4	6.6	5.5	7.9	8.9	7.0	7.8	7.4	7.2	7.8	7.9	7.2	7.4	7.8	8.6	15.5	32.1	16.4	8.8	32.7	22.8	17.7	15.0	28.5	30.3	13.8	11.0	13.4	17.2	21.0	5.5	131.3	8.6	27.1	5.7	1.9	17.0	213.2	10.5	28.8	19.1	5.4	23.7	19.0	15.6	17.0	18.9	14.8	10.8	36.0	25.5	12.8	18.4	18.7	25.2	20.0	9.2	6.1	13.9	12.7	222.8	22.4	13.4	8.8	21.5	17.0	17.9	35.0	18.6	22.2	20.9	3.7	26.7	48.5	23.6	6.8	9.9	16.7	143.5	0.0	29.9	18.1	26.3	33.6	32.0	31.7	4.4	35.7	32.6	16.5	17.4
RRP7A	"CGI-96, Rrp7"	ENSG00000189306	"Ribosomal RNA processing 7 homolog A"	Q9Y3A4	22	42508344-42519796	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001586, HPA046768"	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Nucleoli"	"Cell Junctions"	"HPA001586: AB_1078506, HPA046768: AB_2679796"	"unprognostic (8.46e-2)"	"unprognostic (3.30e-3)"	"unprognostic (5.96e-2)"	"unprognostic (3.21e-3)"	"unprognostic (9.71e-3)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (6.73e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.22e-2)"	"unprognostic (9.53e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.71e-2)"	14.0	16.5	15.8	9.8	18.0	12.3	15.4	14.3	17.0	13.9	11.6	13.9	6.2	13.7	28.2	18.7	13.9	4.7	15.6	16.4	14.1	22.3	18.4	13.0	14.2	15.0	15.3	17.3	14.5	11.1	11.2	6.6	15.5	22.3	6.1	5.2	15.6	7.5	13.8	15.7	13.8	6.4	13.1	18.4	15.0	12.8	14.6	10.3	13.6	5.2	10.2	14.8	14.0	15.7	23.9	34.6	21.1	24.7	13.7	8.8	35.9	21.0	13.7	27.0	22.8	47.4	14.3	41.4	10.6	15.5	13.4	29.3	25.4	28.1	11.1	11.2	50.3	21.8	26.4	23.6	11.2	57.1	19.4	12.1	16.4	35.6	17.7	10.5	15.6	21.6	30.7	12.1	15.9	51.5	54.8	23.0	17.9	20.5	25.5	88.9	19.9	17.6	13.7	31.5	9.8	8.4	14.8	50.5	20.7	8.9	18.2	23.9	12.4	22.9	25.1	16.4	21.1	18.5	16.0	48.8	18.2	20.3	31.2	16.1	28.0	22.4	21.2	33.2	20.4	26.1	18.4	19.7	21.8	32.5	20.0	18.8	5.7	20.4	37.2	37.6	17.1	26.2	15.8	18.0	14.3	17.0	16.4	14.1	15.0	15.3	15.5	13.1	14.6	15.7	32.2	22.4	36.6	5.9	48.6	43.8	95.1	41.4	12.5	26.6	28.6	28.3	16.0	31.5	37.2	22.0	16.7	93.0	50.3	48.4	17.6	71.3	55.8	24.2	25.4	38.6	26.4	64.6	7.5	27.2	133.8	31.0	34.7	28.8	47.5	46.3	37.5	32.6	94.8	26.9	6.8	39.8	28.5	43.3	47.4	118.3	22.1	39.5	33.8	6.5	116.5	24.8	68.0	1.0	7.9	52.1	46.0	18.4	51.4	94.3	38.5	42.1	34.4	28.5	6.6	30.2	37.0	33.5	24.7	27.3	37.8	120.4	40.2	45.2	59.4	106.3
RRP8	"KIAA0409, NML"	ENSG00000132275	"Ribosomal RNA processing 8"	O43159	11	6595072-6603616	"Metabolic proteins, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038487, HPA057562"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Nucleoli, Cytosol"		"HPA038487: AB_10672518, HPA057562: AB_2683468"	"unprognostic (9.01e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (3.10e-7)"	"unprognostic (4.64e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.23e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.87e-2)"	10.8	10.2	10.9	5.8	10.6	18.4	10.5	10.6	14.9	12.7	9.3	21.8	6.7	11.0	9.8	11.4	10.5	3.4	15.4	10.0	9.9	13.3	21.5	9.2	8.6	10.3	10.7	9.3	10.0	5.3	8.2	6.1	10.4	15.8	6.5	7.6	7.4	8.8	9.5	12.6	10.3	6.2	10.9	14.2	12.1	10.7	10.6	6.8	10.6	4.1	8.4	16.8	11.1	12.1	12.3	12.0	4.7	6.1	9.6	8.3	6.7	6.2	7.7	14.0	13.1	12.4	14.1	17.1	6.0	5.9	10.3	12.1	13.6	10.9	14.7	8.3	19.5	8.1	14.0	14.3	11.0	14.8	10.8	7.1	14.0	6.7	12.1	9.2	14.7	8.0	16.3	9.7	11.2	15.2	14.5	22.0	11.6	21.4	10.7	12.8	3.8	3.9	13.4	9.7	7.2	8.4	8.9	18.0	10.7	7.7	9.8	12.9	7.6	13.2	6.1	13.0	12.2	10.8	10.5	16.7	11.2	14.8	8.7	26.3	10.0	10.4	11.5	10.7	11.2	9.1	11.3	10.7	13.0	11.9	11.0	11.7	3.9	13.6	11.8	9.9	11.9	9.0	10.9	10.6	10.6	14.9	10.0	9.9	10.3	10.7	10.4	10.9	10.6	12.1	17.0	22.4	15.0	37.2	19.6	23.2	18.5	13.3	14.2	17.3	14.1	11.7	20.7	8.6	14.7	9.2	14.6	23.5	20.7	12.2	11.7	19.0	7.4	13.7	22.8	16.4	7.2	37.7	45.0	15.9	21.2	15.5	21.4	14.0	17.7	14.7	12.5	23.5	18.9	3.3	32.6	16.2	12.2	9.4	13.4	13.6	13.1	13.1	8.8	21.5	18.4	14.2	22.6	27.2	34.6	22.7	18.2	9.8	15.2	15.8	13.7	29.8	10.3	30.5	0.0	15.3	20.0	23.7	18.0	18.3	27.1	20.0	17.7	25.2	17.3	15.0
RRP9	"RNU3IP2, U3-55K"	ENSG00000114767	"Ribosomal RNA processing 9, U3 small nucleolar RNA binding protein"	O43818	3	51933429-51941904	"Predicted intracellular proteins"	"rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 66.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038798	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA038798: AB_10672653"	"unprognostic (5.57e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (1.24e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.82e-2)"	"unprognostic (8.25e-3)"	"unprognostic (2.60e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.15e-2)"	"unprognostic (5.92e-2)"	20.5	20.1	9.8	13.7	10.7	12.4	17.3	9.9	12.1	17.1	8.2	13.2	10.9	16.4	5.3	17.7	15.8	6.8	14.5	10.4	9.8	17.7	16.2	13.9	15.7	10.1	10.0	15.8	14.2	10.4	10.5	9.1	9.5	14.6	7.6	5.6	11.6	9.0	28.9	17.8	12.5	9.1	9.3	14.6	13.1	10.8	10.5	9.2	12.6	13.2	10.5	19.1	15.5	10.6	35.8	50.0	23.5	56.2	33.8	18.8	59.5	38.4	20.9	63.7	40.3	85.5	39.6	102.7	15.9	27.3	86.5	32.3	81.9	59.4	25.5	47.1	35.8	69.5	30.6	77.5	67.9	76.6	55.6	39.0	43.0	80.1	75.3	15.5	24.9	35.8	67.0	25.2	28.5	56.7	65.3	76.2	92.6	54.7	126.9	39.7	26.7	78.6	31.4	52.1	28.9	34.1	34.8	38.5	38.8	20.0	20.1	49.2	24.1	44.3	59.4	111.0	160.8	43.0	75.6	96.2	39.5	94.2	71.4	2.1	9.1	0.5	16.4	13.2	17.5	16.4	14.1	14.5	17.0	13.5	10.9	13.2	0.6	18.8	6.5	18.0	12.5	10.0	9.8	10.7	9.9	12.1	10.4	9.8	10.1	10.0	9.5	9.3	10.5	10.6	9.2	0.0	10.5	3.6	15.2	66.8	27.1	29.7	13.1	12.9	11.2	10.3	4.1	10.0	14.0	5.5	4.2	26.8	14.8	8.3	15.6	24.3	8.1	11.2	12.7	12.7	8.4	7.2	1.9	13.4	40.5	12.6	9.7	9.3	15.2	14.4	5.0	7.0	23.4	16.8	1.3	7.2	22.4	5.3	13.4	6.6	8.7	8.7	21.4	1.0	12.9	10.6	16.5	2.0	1.6	20.0	10.3	9.1	11.6	34.2	6.2	22.2	11.9	10.7	6.6	15.6	36.7	8.0	23.8	15.0	50.4	16.7	12.5	16.4	18.9	14.6
RSBN1L	"FLJ42526, FLJ45813, MGC71764"	ENSG00000187257	"Round spermatid basic protein 1 like"	Q6PCB5	7	77696459-77783022	"Cancer-related genes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 349.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 60.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 60.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020406, HPA020413"	Approved		Supported	"Nuclear speckles,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	"Plasma membrane"	"HPA020406: AB_1856488, HPA020413: AB_2253910"	"unprognostic (2.02e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (3.74e-4)"	"unprognostic (1.27e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.02e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.53e-3)"	7.3	6.4	8.7	11.5	9.1	8.2	12.1	19.0	12.1	10.3	10.2	11.3	9.0	12.5	10.3	10.8	9.5	7.3	5.6	8.5	10.5	9.1	11.3	10.5	16.1	8.2	9.0	14.5	11.2	10.3	6.9	9.9	8.6	10.3	11.7	30.2	9.6	11.4	8.2	7.8	10.4	11.0	9.0	15.0	11.0	26.3	8.6	18.3	16.5	7.6	15.0	9.6	8.2	11.6	15.8	11.9	19.6	34.5	13.4	17.0	9.5	11.5	12.4	16.0	18.2	14.9	27.6	32.4	4.4	12.0	20.2	13.4	26.8	15.0	22.8	17.7	14.4	25.8	18.4	14.7	11.3	32.1	23.3	12.2	10.7	14.7	16.0	12.1	13.5	21.2	35.7	33.0	16.8	18.2	27.7	32.1	14.0	20.3	10.6	28.3	19.6	34.2	10.0	20.5	22.9	24.0	17.5	31.4	12.6	19.9	19.2	16.9	12.9	23.9	21.9	14.5	17.7	14.7	16.7	51.6	11.4	29.2	16.0	21.6	7.4	13.5	9.5	5.8	7.3	11.0	8.4	7.1	4.4	13.5	7.8	8.6	60.6	6.4	6.7	13.9	9.3	2.6	8.7	9.1	19.0	12.1	8.5	10.5	8.2	9.0	8.6	9.0	8.6	11.6	53.6	57.7	60.3	27.1	85.0	78.8	102.1	76.1	88.8	246.8	52.1	57.3	22.1	61.5	84.4	55.2	235.6	52.7	101.5	77.1	39.2	38.1	271.3	55.5	63.3	60.8	77.5	47.7	44.3	50.4	34.1	55.6	51.5	45.6	70.3	51.3	49.2	56.5	43.7	158.2	47.5	104.6	57.0	48.1	69.0	85.2	101.5	46.4	64.0	34.7	59.0	83.2	132.8	53.8	50.1	35.1	62.7	119.6	74.6	56.7	49.6	28.4	72.0	349.9	72.3	44.2	73.0	108.0	156.7	56.2	75.3	38.7	90.2	61.7	79.1	84.0
RSF1	"HBXAP, p325, RSF-1, XAP8"	ENSG00000048649	"Remodeling and spacing factor 1"	Q96T23	11	77659996-77821017	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022626, HPA046129, HPA057547, HPA064567"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"CAB022626: , HPA046129: AB_2679550, HPA057547: AB_2683462, HPA064567: AB_2685289"	"unprognostic (2.67e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.35e-3)"	"unprognostic (5.00e-3)"	"unprognostic (5.57e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.33e-3)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (6.19e-2)"	"prognostic favorable (5.94e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.15e-1)"	12.5	17.9	10.8	16.5	12.9	25.7	15.4	43.9	13.7	17.1	1.5	12.8	9.4	20.0	8.9	14.1	14.5	16.6	14.0	8.7	15.4	14.3	11.7	13.2	15.3	8.3	8.5	26.3	16.9	17.3	6.5	18.5	8.5	15.4	12.6	25.9	10.2	13.4	11.7	9.3	10.8	17.5	8.0	16.3	13.5	23.8	12.0	22.6	22.3	13.4	13.5	17.0	8.4	15.5	27.7	18.2	62.0	33.3	20.6	25.9	23.3	31.7	31.0	25.5	31.4	48.0	37.5	46.7	33.2	22.3	39.4	28.1	36.8	23.8	47.7	33.4	16.3	43.9	25.1	13.0	19.6	42.2	30.0	21.8	17.5	35.0	55.8	29.7	32.7	15.2	72.8	43.0	29.7	18.7	29.7	23.4	36.1	32.9	24.8	49.1	107.5	30.6	13.5	35.5	37.3	37.6	48.8	19.1	18.5	32.2	34.3	20.6	41.2	45.0	38.8	71.0	23.1	25.7	35.7	106.3	11.9	28.1	34.5	49.3	17.8	32.8	27.4	16.9	18.8	34.3	16.6	17.6	14.2	35.0	22.7	22.9	46.4	23.7	30.1	32.0	17.0	7.5	10.8	12.9	43.9	13.7	8.7	15.4	8.3	8.5	8.5	8.0	12.0	15.5	100.3	118.6	113.5	99.6	98.0	90.5	69.3	89.7	93.9	123.0	68.8	85.1	97.1	54.3	84.3	73.5	75.0	57.8	85.1	53.0	46.9	79.2	112.4	72.9	95.2	96.5	85.6	71.8	129.4	55.3	50.6	90.5	51.0	86.0	95.5	132.5	79.9	46.2	45.6	146.4	129.3	64.7	71.2	62.9	68.5	40.3	126.8	66.5	56.9	98.4	93.9	124.6	120.5	157.8	144.7	73.1	63.4	118.1	74.8	97.6	44.1	38.2	69.7	97.6	105.2	99.3	100.4	114.8	109.4	57.2	84.0	67.5	99.9	141.7	58.1	91.6
RSL1D1	"CSIG, DKFZP564M182, L12, PBK1, UTP30"	ENSG00000171490	"Ribosomal L1 domain containing 1"	O76021	16	11833850-11851580	"Predicted intracellular proteins, Ribosomal proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043483	Supported		Enhanced	"Nucleoli rim,Mitotic chromosome"		Yes	No		18000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	"Nucleoli rim, Mitotic chromosome"		"HPA043483: AB_2678504"	"unprognostic (4.46e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.88e-2)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (2.95e-4)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (6.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.68e-2)"	39.3	32.2	11.1	36.9	11.7	46.7	78.8	13.4	14.1	47.6	12.2	35.7	32.6	44.0	28.8	38.2	44.5	30.5	33.7	11.9	12.5	33.0	39.1	26.4	48.2	11.6	11.4	118.5	43.6	28.8	13.2	30.0	12.2	33.3	37.9	15.1	42.0	34.0	87.3	34.1	29.2	36.6	13.3	26.9	25.1	22.4	13.3	41.8	34.8	51.7	65.1	48.0	26.4	15.4	90.7	84.3	69.1	87.1	88.6	157.9	81.9	82.1	91.4	104.0	105.9	82.6	83.1	225.6	133.1	68.6	72.1	62.5	186.7	124.4	168.4	88.8	100.7	111.6	75.9	188.0	165.4	159.5	71.3	116.6	173.2	107.6	248.2	77.8	102.4	87.0	198.6	101.5	129.3	100.8	125.7	92.6	177.7	108.1	86.1	129.2	127.3	240.1	92.9	78.0	96.4	79.2	155.0	116.6	110.0	70.9	100.5	122.2	63.2	69.0	77.3	66.0	120.0	81.3	126.2	261.7	75.0	164.9	94.1	14.1	123.2	12.6	69.7	119.1	129.6	132.6	129.5	91.7	130.8	117.3	185.4	136.8	7.1	124.6	120.7	80.2	100.9	253.0	11.1	11.7	13.4	14.1	11.9	12.5	11.6	11.4	12.2	13.3	13.3	15.4	111.2	141.1	156.6	5.5	198.1	330.9	338.6	251.0	299.3	39.9	241.1	344.4	188.4	74.4	198.1	49.7	22.9	186.4	118.7	41.2	135.0	134.5	22.8	76.0	181.1	118.1	94.5	104.5	11.0	186.2	286.8	180.9	88.2	100.0	152.6	106.6	64.2	78.5	147.6	38.7	11.6	126.4	107.8	153.0	177.3	18.5	199.4	141.0	92.5	3.7	276.5	52.8	113.3	3.5	7.3	135.4	75.1	126.0	104.6	226.5	110.5	155.0	81.3	30.8	59.2	245.4	151.5	111.2	136.0	203.5	290.2	160.6	166.5	162.8	184.3	225.1
RSPRY1	KIAA1972	ENSG00000159579	"Ring finger and SPRY domain containing 1"	Q96DX4	16	57186137-57240469	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003729	Approved				"Secreted to blood"	NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA003729: AB_10964215"	"unprognostic (2.73e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.32e-3)"	"unprognostic (5.32e-2)"	"unprognostic (1.63e-3)"	"prognostic unfavorable (8.21e-5)"	"unprognostic (6.84e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.89e-2)"	"unprognostic (4.68e-2)"	"unprognostic (3.35e-1)"	"unprognostic (6.47e-2)"	"unprognostic (4.81e-3)"	10.1	8.9	8.8	10.1	10.1	7.0	13.2	9.4	9.5	15.1	19.0	14.4	16.0	13.1	12.6	11.7	11.6	16.0	8.6	8.2	9.1	16.1	19.7	9.5	13.4	10.0	9.7	14.4	18.5	15.3	8.3	15.1	9.3	13.8	16.2	8.5	11.5	14.0	9.1	9.7	16.2	15.3	8.6	9.7	13.4	21.8	10.6	17.5	17.3	10.6	17.3	16.1	9.2	11.7	17.0	25.7	39.5	20.4	24.6	30.8	23.5	29.7	30.5	39.1	31.0	27.4	21.8	23.8	37.6	39.7	27.0	21.6	34.7	28.6	44.4	16.2	14.4	12.7	18.9	39.5	32.1	22.7	33.5	37.3	27.7	38.4	53.6	29.6	53.5	27.2	21.3	9.6	34.3	9.9	38.7	15.3	25.6	28.4	29.1	48.9	27.2	22.0	46.6	17.1	13.4	29.8	47.8	17.8	12.3	22.4	17.5	22.9	37.8	27.9	27.2	17.6	24.6	25.0	24.7	38.6	24.5	22.0	30.3	27.6	22.5	30.1	24.8	24.7	22.6	26.1	22.7	22.9	26.0	24.0	26.2	25.2	24.5	26.4	36.3	16.5	30.0	18.2	8.8	10.1	9.4	9.5	8.2	9.1	10.0	9.7	9.3	8.6	10.6	11.7	18.6	32.1	13.1	22.5	24.0	34.0	21.0	27.5	38.7	17.1	28.5	17.3	17.5	42.9	23.2	18.4	10.4	26.9	18.9	27.4	25.4	25.2	107.2	22.2	36.7	23.8	21.5	24.8	22.0	23.4	37.7	29.2	25.5	28.9	10.8	31.1	22.5	41.8	17.3	15.2	25.6	32.9	28.5	22.9	23.8	65.9	20.2	19.8	14.2	19.7	25.1	19.7	15.5	36.2	35.8	25.5	15.5	21.4	21.2	29.1	29.5	28.1	23.3	18.2	6.6	25.5	25.2	60.9	52.3	27.9	37.1	27.9	21.8	37.7	23.5	23.0
RSRC2	FLJ11021	ENSG00000111011	"Arginine and serine rich coiled-coil 2"	Q7L4I2	12	122503454-122527000	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 65.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040070, HPA048183"	Approved		Approved	"Nucleoli fibrillar center,Nuclear speckles,Cytosol"		No	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nuclear speckles"	"Nucleoli fibrillar center, Cytosol"	"HPA040070: AB_10673430, HPA048183: AB_2680302"	"unprognostic (4.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.42e-3)"	"unprognostic (6.90e-2)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.74e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.23e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.53e-2)"	12.6	12.2	11.5	11.0	11.4	65.7	13.2	17.6	18.4	14.6	11.3	13.9	8.6	14.1	12.5	17.4	12.3	13.6	13.1	11.3	15.3	16.3	11.4	13.8	16.8	12.1	13.7	16.4	13.8	8.0	14.5	13.3	11.7	12.7	12.0	17.1	12.6	9.5	28.5	12.7	12.5	8.8	7.7	11.6	10.8	14.0	11.8	13.2	15.4	16.1	10.7	14.0	15.0	14.0	21.4	24.8	23.2	9.5	18.4	11.2	16.9	38.8	12.0	16.0	8.7	35.5	8.6	24.4	32.0	13.3	9.7	13.3	25.9	10.8	15.7	22.8	23.9	42.1	32.0	38.3	10.1	37.0	24.8	14.5	12.3	13.6	23.2	20.1	11.6	10.7	27.8	14.6	14.1	16.3	26.8	27.8	19.6	17.8	19.6	19.6	20.9	15.9	21.1	39.8	18.4	16.7	29.6	10.0	22.0	23.1	15.9	13.4	18.1	16.5	20.3	18.4	21.7	16.7	42.8	39.5	9.8	21.6	9.4	27.5	17.7	25.4	17.2	14.7	14.3	28.3	15.3	13.9	18.0	33.4	19.3	15.4	18.7	18.3	22.2	17.0	22.4	12.3	11.5	11.4	17.6	18.4	11.3	15.3	12.1	13.7	11.7	7.7	11.8	14.0	176.8	86.6	102.0	44.7	208.7	202.3	376.1	94.0	118.4	114.3	155.6	146.0	103.3	104.4	107.1	93.8	79.2	149.1	219.3	193.5	195.6	109.3	247.3	223.6	218.6	141.7	156.3	143.1	39.1	97.2	183.8	169.3	89.7	238.0	216.5	127.5	84.9	113.7	94.3	149.7	39.9	185.7	101.7	87.6	184.9	107.1	119.9	139.0	126.3	35.6	107.0	132.9	133.9	34.2	49.6	107.3	171.0	105.7	134.2	219.0	110.1	132.7	128.5	131.0	124.9	194.8	176.7	229.2	165.3	116.0	187.0	280.1	210.3	107.6	154.8	287.1
RTF1	KIAA0252	ENSG00000137815	"RTF1 homolog, Paf1/RNA polymerase II complex component"	Q92541	15	41408408-41483563	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006714, CAB079946, CAB079947"	Supported		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB079946: , CAB079947: , HPA006714: AB_1079855"	"unprognostic (1.10e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.87e-2)"	"unprognostic (5.36e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.69e-2)"	"unprognostic (8.22e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.50e-2)"	17.8	23.2	24.7	18.8	26.3	45.1	22.4	26.8	42.7	24.3	19.2	21.6	19.2	25.1	19.5	21.4	17.1	20.3	24.6	27.1	24.0	19.0	19.9	19.4	28.2	21.0	21.3	29.4	16.6	36.9	11.4	24.5	20.9	23.4	22.4	26.4	16.7	22.8	49.4	25.9	19.8	26.3	20.0	23.8	20.8	29.8	23.9	28.8	29.5	34.8	25.0	23.1	17.5	24.6	32.0	20.6	66.5	54.2	37.0	43.4	31.2	41.8	46.8	56.0	46.5	40.4	19.8	30.2	33.0	43.9	24.9	55.3	38.9	34.8	47.6	46.2	36.1	63.5	45.2	30.4	25.8	57.2	35.5	31.4	34.3	30.0	30.1	41.6	45.8	54.0	49.2	34.0	46.5	24.2	55.1	35.1	35.9	39.6	28.0	59.0	51.8	28.9	36.5	67.5	34.0	44.9	37.6	47.4	19.0	35.9	38.9	54.5	37.9	54.6	34.4	54.8	46.5	38.9	65.0	49.6	39.4	53.5	34.1	5.4	3.1	6.9	3.4	2.1	3.1	6.9	3.3	2.9	2.2	5.3	4.0	3.2	8.5	6.2	2.7	5.5	4.3	1.1	24.7	26.3	26.8	42.7	27.1	24.0	21.0	21.3	20.9	20.0	23.9	24.6	118.0	128.2	80.1	23.8	109.0	145.0	98.7	120.4	102.4	213.5	152.6	129.7	94.3	111.5	89.7	123.2	93.8	168.3	117.1	129.6	164.4	103.0	333.7	103.9	162.6	116.4	87.8	85.0	40.3	110.5	119.1	103.5	71.9	126.2	91.2	127.9	129.5	193.2	95.5	148.0	43.6	145.4	109.9	86.7	94.4	348.5	145.1	83.0	108.5	15.9	116.1	106.2	128.8	16.6	23.5	127.0	105.1	159.9	104.1	141.9	112.6	186.4	70.7	188.2	85.5	115.4	146.9	198.3	59.9	83.4	163.0	219.3	113.0	126.1	133.2	99.2
RTN4IP1	NIMP	ENSG00000130347	"Reticulon 4 interacting protein 1"	Q8WWV3	6	106570771-106629498	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Neurogenesis		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036357	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA036357: AB_10673128"	"prognostic unfavorable (9.18e-6)"	"unprognostic (5.87e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.88e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.71e-2)"	"unprognostic (7.37e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.72e-2)"	"prognostic favorable (8.55e-6)"	"unprognostic (1.62e-1)"	"unprognostic (9.82e-2)"	"unprognostic (3.71e-1)"	"unprognostic (5.76e-2)"	2.5	6.8	2.8	3.1	3.0	1.8	3.2	3.3	3.9	2.6	3.3	6.3	4.8	2.7	5.5	4.2	2.7	1.6	14.7	2.7	2.7	6.4	7.4	2.0	4.6	2.5	2.5	2.2	3.2	5.2	4.5	2.2	2.8	2.7	6.0	6.0	4.6	2.7	15.6	2.9	4.5	2.9	2.5	4.2	5.9	5.5	2.8	3.0	4.0	15.4	6.1	2.9	2.8	3.4	7.6	10.8	7.3	12.6	5.9	3.5	8.6	5.0	7.0	7.7	7.4	17.4	4.1	11.6	7.6	6.5	15.1	10.8	13.0	10.7	12.1	8.1	7.4	12.1	8.4	14.0	6.1	12.5	8.1	5.2	8.3	10.3	6.7	4.7	6.9	16.3	21.7	4.7	8.5	11.3	4.7	14.4	9.1	10.7	7.9	16.1	13.3	8.8	12.4	8.1	7.1	5.7	4.7	12.3	11.2	7.5	15.5	8.0	3.6	4.4	6.1	8.8	8.9	3.5	5.7	24.8	11.5	18.1	9.6	0.1	4.6	2.2	3.2	5.1	3.3	11.4	4.4	3.4	10.7	16.0	4.0	3.9	0.8	6.5	3.7	5.6	8.2	3.3	2.8	3.0	3.3	3.9	2.7	2.7	2.5	2.5	2.8	2.5	2.8	3.4	1.6	0.0	2.8	7.8	8.1	0.8	1.9	6.4	0.6	5.5	2.8	1.7	18.4	4.3	3.1	1.8	8.4	12.5	1.3	5.2	27.4	6.7	8.5	7.6	2.0	2.1	4.2	1.3	15.6	8.6	15.0	2.1	4.1	4.2	2.5	3.6	2.5	5.5	7.3	0.0	17.2	3.0	10.2	5.4	1.8	3.4	0.6	3.6	0.0	8.4	0.9	3.7	1.0	6.6	17.5	4.9	3.0	1.9	4.2	1.2	3.3	14.5	5.4	6.2	13.1	2.1	2.5	11.9	16.7	4.1	1.0	5.6	2.8	5.6	6.4	2.0
RTRAF	"C14orf166, CGI-99, CLE, CLE7, hCLE1, LCRP369, RLLM1"	ENSG00000087302	"RNA transcription, translation and transport factor"	Q9Y224	14	51989514-52010694	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 316.0;Distal tubular cells: 309.1;Exocrine glandular cells: 289.7;Extravillous trophoblasts: 349.6;Proximal tubular cells: 303.7;Syncytiotrophoblasts: 261.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039824	Supported		Supported	Nucleoplasm		NA	NA		48000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA039824: AB_10793922"	"unprognostic (2.99e-2)"	"unprognostic (2.90e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.31e-2)"	"unprognostic (3.34e-1)"	"unprognostic (5.03e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.99e-1)"	92.9	92.7	47.2	73.7	48.9	138.9	87.2	50.8	60.3	69.3	52.5	93.5	61.3	71.1	87.0	79.1	64.5	67.8	151.6	46.6	50.9	77.3	78.9	64.0	105.5	50.4	48.6	96.5	114.0	74.1	65.6	68.2	49.4	66.6	88.7	56.3	76.8	58.7	155.8	79.6	67.3	76.9	51.4	61.2	98.9	142.2	49.0	107.0	81.2	102.2	105.3	87.9	62.8	54.6	214.6	142.1	239.8	233.7	157.7	208.3	228.8	166.9	183.6	180.9	203.1	153.2	184.0	290.8	174.0	139.5	142.2	167.1	226.2	152.6	234.7	158.0	126.5	113.3	287.8	206.7	252.1	243.8	125.0	158.5	155.6	136.6	223.5	210.1	207.2	269.6	118.8	135.1	177.3	237.6	310.8	306.3	187.1	247.8	238.1	278.6	228.0	138.0	176.1	245.2	169.0	171.6	211.0	376.7	274.7	301.3	252.8	190.4	146.0	196.6	216.4	167.2	212.7	50.5	76.2	295.7	96.9	189.3	228.7	54.8	93.3	58.7	73.5	104.7	91.1	108.8	102.0	88.6	117.6	90.9	93.2	95.2	19.2	96.1	112.5	107.9	144.0	126.6	47.2	48.9	50.8	60.3	46.6	50.9	50.4	48.6	49.4	51.4	49.0	54.6	168.6	44.8	67.2	0.0	39.2	0.0	0.0	0.0	0.0	0.0	181.7	232.8	0.0	0.0	39.0	73.5	0.0	316.0	83.1	0.0	309.1	226.6	0.0	164.3	108.1	77.5	0.0	0.0	0.0	289.7	349.6	77.4	0.0	103.6	61.8	242.8	0.0	0.0	240.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.5	0.0	0.0	154.5	0.0	0.0	0.0	0.0	232.4	0.0	0.0	13.0	0.0	0.0	303.7	49.6	0.0	0.0	0.0	95.2	0.0	0.0	0.0	0.0	261.6	53.6	233.9	0.0	0.0
RUNDC1	DKFZp761H0421	ENSG00000198863	"RUN domain containing 1"	Q96C34	17	42980565-42993690	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023726	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear speckles"	Cytosol	"HPA023726: AB_2184078"	"unprognostic (4.24e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.39e-2)"	"prognostic favorable (6.93e-5)"	"unprognostic (9.78e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.53e-3)"	"unprognostic (2.87e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.77e-3)"	5.5	8.0	8.7	6.6	11.0	6.8	10.0	6.5	11.0	8.6	9.7	9.4	6.5	8.7	12.1	6.6	14.5	6.1	7.3	9.6	8.8	8.4	5.0	6.9	7.2	6.3	6.8	5.0	7.9	12.0	9.4	4.8	6.2	12.1	7.6	8.5	7.5	8.5	11.6	7.1	7.8	8.6	5.8	8.1	10.1	6.8	7.9	6.7	10.2	9.0	7.7	8.4	6.2	8.2	12.9	22.1	8.8	11.9	14.7	8.8	9.3	12.2	12.6	17.1	12.7	14.0	7.2	8.6	10.7	12.1	11.6	15.8	11.3	12.3	18.9	9.7	17.7	5.8	12.8	13.5	9.4	12.6	11.9	6.6	14.7	15.1	10.0	13.6	9.2	9.3	11.2	5.3	9.9	9.3	15.6	8.9	9.9	18.3	13.8	11.2	12.3	8.6	14.3	17.0	12.8	11.8	9.6	9.0	10.2	12.9	17.5	13.9	7.6	15.4	9.6	9.2	14.7	12.6	13.1	7.5	11.0	6.6	9.8	4.7	2.3	7.9	1.3	3.8	1.7	3.7	1.6	1.1	1.8	3.7	1.6	1.7	5.4	1.1	2.8	5.6	2.0	1.0	8.7	11.0	6.5	11.0	9.6	8.8	6.3	6.8	6.2	5.8	7.9	8.2	5.3	44.8	38.4	6.5	18.7	15.0	11.0	5.8	9.1	18.9	19.2	9.8	13.7	22.8	17.2	5.5	22.9	9.8	19.1	28.7	21.5	11.8	8.1	26.4	9.6	10.3	19.2	5.7	13.8	9.8	7.3	8.6	20.4	19.5	11.4	8.4	10.4	6.1	8.4	38.7	11.0	16.9	6.1	10.5	14.7	4.5	9.9	9.5	3.6	7.5	14.3	14.3	12.3	5.0	6.2	10.1	16.4	14.3	11.7	16.6	15.1	12.8	24.7	33.2	19.7	8.5	9.6	22.9	14.9	7.2	14.6	5.5	13.9	10.4	17.8	17.0
RUVBL1	"ECP54, INO80H, NMP238, Pontin52, RVB1, TIH1, TIP49, TIP49a"	ENSG00000175792	"RuvB like AAA ATPase 1"	Q9Y265	3	128064778-128153914	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Growth regulation, Mitosis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 147.0;Respiratory ciliated cells: 221.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019947, HPA019948"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		81000	"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"		"HPA019947: AB_1856516, HPA019948: AB_1856514"	"unprognostic (7.40e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (1.21e-8)"	"unprognostic (2.43e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.27e-2)"	20.2	18.7	6.4	10.1	6.3	8.6	18.5	6.1	7.0	17.7	9.8	16.2	5.1	23.1	5.8	26.0	27.5	5.0	25.8	6.2	6.3	24.6	17.2	17.2	13.1	7.3	8.7	15.3	13.9	14.6	17.3	12.7	7.5	13.1	8.5	7.4	14.0	6.9	19.1	17.7	15.2	10.0	6.4	22.3	14.8	29.4	6.5	15.7	15.4	6.0	16.1	19.2	18.5	6.8	75.1	66.2	40.1	65.6	30.5	29.4	52.2	35.8	30.5	67.3	45.9	69.7	43.2	105.0	34.8	34.2	52.2	58.4	107.2	75.6	77.6	43.4	52.3	87.8	36.3	47.4	31.4	82.9	27.0	30.2	39.1	56.5	72.1	25.6	45.6	39.4	72.9	24.4	38.7	105.9	89.7	64.6	101.1	83.5	55.8	72.4	48.4	73.4	40.7	27.6	66.8	60.1	39.6	32.4	55.9	36.8	58.5	61.8	29.8	30.5	37.2	46.4	55.2	24.3	41.6	103.0	37.4	50.2	39.2	1.3	7.3	2.5	15.6	11.9	20.1	15.6	18.7	19.6	11.3	15.7	15.6	17.6	0.3	15.9	11.9	12.6	30.5	11.0	6.4	6.3	6.1	7.0	6.2	6.3	7.3	8.7	7.5	6.4	6.5	6.8	26.1	22.4	15.3	12.7	22.7	20.0	23.7	61.6	25.0	17.4	17.4	21.8	20.9	21.5	37.3	22.0	2.1	53.7	31.3	7.8	46.9	40.9	21.2	147.0	50.8	27.4	16.9	20.4	12.6	30.1	65.4	22.9	17.3	23.8	26.0	35.7	12.8	14.6	29.9	23.5	14.6	14.0	28.5	8.8	8.2	67.1	15.2	14.6	10.6	4.7	13.3	28.1	11.3	9.0	10.0	27.1	11.1	18.4	27.3	34.5	4.6	59.2	221.3	19.7	13.1	16.1	32.3	94.8	75.0	27.9	16.9	24.1	29.1	84.7	23.4	15.6
RUVBL2	"ECP51, INO80J, Reptin52, RVB2, TIH2, TIP48, TIP49b"	ENSG00000183207	"RuvB like AAA ATPase 2"	Q9Y230	19	48993562-49015970	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 614.5;Late spermatids: 945.1;Respiratory ciliated cells: 253.6;Spermatocytes: 394.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012432, HPA042880, HPA067966"	Enhanced		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA		53000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	Centrosome	"CAB012432: , HPA042880: AB_2678210, HPA067966: AB_2685933"	"unprognostic (1.71e-1)"	"unprognostic (9.06e-3)"	"unprognostic (3.51e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (9.28e-4)"	"unprognostic (7.06e-3)"	"unprognostic (6.25e-2)"	"unprognostic (3.28e-1)"	"unprognostic (8.13e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.61e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.58e-1)"	23.4	21.7	41.4	26.7	42.9	51.4	22.6	44.6	54.6	23.5	48.9	29.8	27.9	19.3	15.3	36.7	72.2	15.8	37.0	44.7	42.6	19.4	24.0	19.6	30.8	42.4	45.8	25.8	34.5	28.2	6.5	24.0	44.2	20.2	17.4	14.9	32.5	25.4	60.3	30.7	24.7	19.0	41.4	20.6	22.6	110.7	43.8	38.9	23.8	39.1	21.3	22.6	7.2	52.3	236.5	346.0	63.3	250.2	45.0	50.9	88.8	105.4	86.3	214.9	162.5	267.4	148.7	219.9	78.5	106.8	93.7	134.6	99.9	210.3	68.5	99.2	323.7	158.8	196.7	241.0	119.1	318.8	96.8	78.0	68.0	145.0	113.5	59.2	114.1	232.8	266.6	121.3	90.5	195.2	234.1	218.5	122.6	162.4	152.4	227.4	156.9	155.8	110.5	182.7	155.7	169.9	132.2	164.2	66.2	30.4	125.9	179.4	104.8	100.8	135.1	63.8	318.1	171.4	177.1	223.6	76.2	174.6	156.4	51.1	54.9	18.9	42.6	52.4	46.8	54.5	45.2	42.3	65.9	52.6	42.9	40.0	3.7	47.4	48.5	48.9	49.2	55.4	41.4	42.9	44.6	54.6	44.7	42.6	42.4	45.8	44.2	41.4	43.8	52.3	16.5	12.8	20.7	4.2	25.3	27.8	52.0	89.8	37.5	17.5	30.4	33.7	48.5	24.3	55.7	33.1	33.3	104.6	15.0	33.8	46.9	78.3	614.5	131.7	29.6	27.3	17.5	58.1	6.1	71.8	81.8	36.6	28.5	25.4	13.3	32.8	23.2	34.2	51.1	18.5	5.2	38.5	52.9	22.9	25.5	945.1	36.1	18.9	26.6	1.9	35.5	31.2	27.8	4.5	5.6	56.0	30.6	42.9	41.3	43.5	33.1	70.4	253.6	31.4	19.7	28.9	65.4	394.2	43.9	49.2	27.6	115.9	20.8	37.1	61.0	38.8
RWDD1	PTD013	ENSG00000111832	"RWD domain containing 1"	Q9H446	6	116571409-116597675	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028712, HPA028713"	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA028712: AB_10602793, HPA028713: AB_10601485"	"unprognostic (1.44e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (3.65e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.30e-2)"	"unprognostic (9.24e-2)"	"unprognostic (9.58e-2)"	"unprognostic (9.60e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.63e-1)"	58.9	47.4	39.7	31.0	45.0	59.9	51.5	47.0	51.5	51.0	36.7	70.1	36.2	47.3	37.3	41.0	47.3	34.8	67.2	38.3	46.2	50.8	45.2	41.3	40.8	44.4	42.7	54.0	72.0	47.1	32.3	31.4	44.2	45.5	33.7	60.5	59.1	37.1	128.5	34.8	35.5	36.0	46.7	33.0	49.9	23.9	43.9	35.0	36.1	96.6	38.8	55.3	45.3	49.9	48.4	30.1	65.5	142.2	102.8	127.3	41.4	111.7	69.8	66.3	74.5	53.8	27.9	70.5	68.2	74.7	78.6	37.7	52.6	70.1	90.7	84.6	81.5	62.4	45.8	77.7	81.4	102.7	51.2	79.3	81.3	44.8	77.0	95.4	78.1	69.9	99.8	96.9	101.2	44.1	97.9	136.0	32.9	82.2	58.4	82.0	43.0	63.3	84.9	38.2	57.1	56.5	35.1	70.1	133.7	64.5	46.6	93.3	57.9	78.1	42.1	74.6	120.9	70.3	86.6	133.3	69.9	79.4	84.7	63.9	42.2	44.7	64.7	55.0	83.2	69.7	85.3	74.6	51.0	57.7	78.0	78.3	16.7	89.0	73.4	75.5	118.0	51.9	39.7	45.0	47.0	51.5	38.3	46.2	44.4	42.7	44.2	46.7	43.9	49.9	139.4	70.5	75.9	14.4	118.0	206.5	166.2	212.3	135.5	133.5	153.3	211.5	205.0	134.4	120.1	130.6	116.7	106.5	130.5	105.1	440.3	130.2	191.5	68.0	120.8	148.5	90.3	108.2	15.5	184.4	147.0	151.9	67.2	76.3	107.2	100.8	172.1	209.3	162.1	106.0	17.6	131.2	150.5	194.0	173.3	149.3	220.3	121.0	209.9	2.8	146.9	169.7	196.7	7.5	19.4	145.4	114.1	222.3	145.1	226.5	183.5	479.7	75.9	179.2	170.9	176.9	188.4	164.4	119.5	164.1	213.5	97.4	144.8	166.2	138.5	159.3
RWDD2A	"dJ747H23.2, MGC13523, RWDD2"	ENSG00000013392	"RWD domain containing 2A"	Q9UIY3	6	83193357-83198935	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 52.3;Spermatocytes: 65.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 11.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030105, HPA030106, HPA030107"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA030105: AB_10599826, HPA030106: AB_10600896, HPA030107: AB_10601009"	"unprognostic (2.51e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.19e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"prognostic favorable (3.82e-5)"	"prognostic favorable (1.38e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.59e-2)"	2.9	6.9	7.1	2.1	7.0	0.5	3.2	6.1	8.1	3.4	6.3	2.9	2.5	3.3	9.4	1.7	3.8	4.6	4.4	6.9	7.9	4.5	5.9	2.8	2.5	5.6	6.0	4.0	9.6	4.0	5.6	2.5	5.9	11.5	2.5	4.7	6.0	4.7	2.3	1.9	2.7	3.2	5.7	2.9	3.9	8.9	8.4	1.8	6.2	4.0	2.6	2.6	1.8	6.1	2.1	1.9	4.4	8.3	5.2	3.7	3.0	4.8	10.1	3.5	4.2	2.8	1.1	1.6	3.8	5.8	8.0	2.1	3.7	2.8	5.4	2.0	3.8	1.9	3.0	6.2	8.0	0.5	1.5	4.9	4.6	4.4	9.2	11.5	6.6	4.5	3.1	2.8	4.3	3.1	0.7	1.5	1.5	1.9	1.9	2.4	9.1	1.0	7.4	2.4	1.5	5.3	2.9	4.5	4.4	6.3	2.8	2.9	7.1	2.4	1.5	3.5	2.1	6.2	2.7	0.9	2.8	0.8	2.9	0.3	0.9	0.0	1.2	0.8	1.8	1.9	1.7	1.7	1.0	1.0	2.2	2.1	0.3	0.4	2.2	3.5	2.2	1.0	7.1	7.0	6.1	8.1	6.9	7.9	5.6	6.0	5.9	5.7	8.4	6.1	2.4	0.0	6.7	9.8	4.2	3.7	3.6	5.3	3.4	5.6	3.7	3.2	5.4	2.8	3.3	1.8	0.0	7.7	3.9	2.4	5.9	8.9	52.3	4.8	4.5	3.5	5.4	0.4	10.8	9.1	3.3	6.5	3.6	4.0	0.0	7.0	5.0	6.8	5.0	1.7	11.2	6.1	8.2	1.6	2.5	14.8	9.0	2.2	8.8	3.7	3.8	11.0	0.0	13.6	4.5	5.8	2.5	6.0	11.2	8.7	4.1	13.3	4.9	5.0	6.6	7.0	5.2	65.2	10.5	1.2	2.4	5.7	2.9	6.3	3.4	2.8
SAAL1	FLJ41463	ENSG00000166788	"Serum amyloid A like 1"	Q96ER3	11	18069935-18106087	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039003, HPA039004"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA039003: AB_2676303, HPA039004: AB_10673602"	"unprognostic (1.13e-1)"	"unprognostic (3.00e-1)"	"unprognostic (4.35e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.76e-2)"	"unprognostic (4.10e-3)"	"unprognostic (1.53e-2)"	"unprognostic (4.75e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.78e-5)"	"unprognostic (2.86e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.87e-1)"	6.0	5.3	4.9	8.2	4.8	19.1	10.0	5.6	6.1	6.2	4.3	9.6	8.0	7.5	7.7	6.6	5.6	4.8	6.5	4.6	5.0	5.4	8.3	4.9	14.6	4.8	5.3	8.2	8.1	5.4	5.2	7.0	4.9	6.0	11.9	8.2	5.6	5.8	5.8	5.7	6.7	9.6	4.8	7.5	6.7	12.8	5.1	13.7	6.1	7.2	15.6	7.8	6.1	5.7	27.1	41.5	29.5	40.5	19.5	21.8	24.6	29.9	20.4	44.8	52.8	57.8	10.1	73.0	15.5	16.9	62.3	34.9	56.9	48.5	62.6	32.5	57.4	33.6	24.9	35.0	15.9	57.1	28.6	15.2	22.2	28.7	42.9	16.8	38.5	62.8	50.5	23.9	37.2	36.2	66.7	54.2	38.5	41.7	39.0	65.7	51.8	25.4	25.7	31.4	36.4	34.3	26.9	28.4	36.4	37.1	18.2	25.9	15.8	51.0	35.0	29.4	43.2	11.6	37.7	80.6	21.2	45.2	47.5	11.1	12.9	4.3	14.0	15.4	13.5	16.5	16.2	12.3	22.3	11.7	12.3	13.3	0.6	10.4	14.6	11.4	20.9	10.8	4.9	4.8	5.6	6.1	4.6	5.0	4.8	5.3	4.9	4.8	5.1	5.7	7.6	0.0	10.8	7.5	15.9	4.6	7.8	16.0	9.6	9.0	7.2	6.9	8.5	2.8	7.4	1.8	2.1	22.0	13.6	6.3	5.9	9.6	21.9	4.4	8.0	8.7	28.1	11.1	8.5	10.2	23.1	8.0	4.6	4.2	14.0	15.3	5.7	4.6	16.1	0.0	9.5	10.7	8.2	10.9	7.3	3.5	8.1	7.7	5.4	6.5	10.7	6.5	4.1	15.1	11.7	6.6	7.5	7.9	17.3	3.8	6.9	7.7	6.0	8.5	6.6	6.1	10.5	41.5	24.9	8.3	5.4	10.4	9.9	10.1	15.1	6.1
SAFB	"HET, SAFB1"	ENSG00000160633	"Scaffold attachment factor B"	Q15424	19	5623035-5668478	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001969, HPA016832, HPA020076"	Supported		Enhanced	Nucleoplasm,Midbody		Yes	NA		67000	"Cluster 14: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Midbody	"CAB001969: , HPA016832: AB_1850622, HPA020076: AB_1850624"	"unprognostic (2.41e-2)"	"unprognostic (8.18e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.81e-3)"	"unprognostic (6.50e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.62e-3)"	"unprognostic (9.31e-2)"	"unprognostic (5.76e-2)"	"unprognostic (4.85e-2)"	"prognostic favorable (9.75e-5)"	"unprognostic (3.25e-2)"	"unprognostic (3.53e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.07e-1)"	"prognostic favorable (1.70e-4)"	43.4	40.1	27.9	34.5	31.6	55.6	44.2	37.1	33.8	52.5	24.0	50.4	28.8	49.7	14.0	45.2	45.2	17.3	46.0	27.6	31.4	39.3	42.6	45.8	39.0	32.0	29.2	54.4	44.3	22.7	43.4	27.7	31.0	46.4	17.7	32.1	42.8	19.6	85.3	60.9	48.4	20.6	23.9	58.9	43.2	43.4	32.4	43.4	42.6	30.2	29.4	43.4	47.6	44.6	94.1	81.8	95.3	62.0	41.6	36.4	111.5	68.0	43.7	56.8	47.4	124.2	52.0	149.7	52.9	33.8	48.3	86.4	92.7	55.7	58.1	101.6	94.6	109.9	75.1	118.0	39.4	136.7	93.6	33.6	50.9	50.8	53.2	40.4	45.5	65.9	156.7	75.0	43.5	84.7	146.2	109.9	128.3	63.7	81.1	144.4	105.1	104.8	44.4	76.6	88.2	76.4	76.3	61.2	76.2	54.3	56.3	74.4	71.4	57.6	71.6	72.2	106.2	121.5	112.0	133.3	55.4	112.6	77.7	65.4	47.4	84.1	55.9	47.8	57.1	53.1	55.1	54.9	53.2	47.6	56.8	55.1	53.1	54.6	79.8	44.6	58.6	55.4	27.9	31.6	37.1	33.8	27.6	31.4	32.0	29.2	31.0	23.9	32.4	44.6	34.8	32.1	21.0	33.3	59.1	65.6	50.2	41.0	51.2	41.3	28.9	30.2	43.4	17.2	47.6	16.5	35.5	53.6	47.7	41.0	25.4	44.0	10.0	56.6	55.6	38.9	29.8	29.6	28.6	35.0	55.2	42.6	33.1	46.4	50.6	52.6	23.2	28.1	38.0	50.5	29.8	43.4	32.6	23.0	52.6	8.2	35.8	37.0	30.2	30.9	55.6	30.0	50.4	34.2	41.5	32.3	29.9	25.9	50.9	44.8	33.7	28.1	72.9	47.2	19.7	44.5	45.1	89.7	94.3	37.2	65.4	62.5	52.2	44.0	40.5	38.9
SAFB2	KIAA0138	ENSG00000130254	"Scaffold attachment factor B2"	Q14151	19	5586999-5624046	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050894	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA		48000	"Cluster 38: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies, Vesicles"	"HPA050894: AB_2681266"	"unprognostic (7.46e-2)"	"unprognostic (3.09e-1)"	"unprognostic (7.69e-3)"	"prognostic favorable (7.10e-4)"	"unprognostic (7.95e-2)"	"unprognostic (6.76e-3)"	"unprognostic (4.19e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.14e-2)"	"prognostic favorable (2.53e-4)"	"unprognostic (2.23e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.11e-2)"	"prognostic favorable (2.12e-4)"	26.8	35.8	23.3	22.4	23.8	35.2	25.8	28.0	30.3	48.4	21.0	35.3	22.2	38.2	21.0	23.1	44.0	15.6	30.8	21.7	29.6	40.6	30.7	27.8	24.4	24.2	23.9	56.2	30.5	18.0	48.6	14.2	23.1	43.0	16.1	34.7	27.6	18.6	41.5	25.8	34.3	19.3	17.5	39.9	27.8	32.5	23.9	22.3	38.9	20.4	21.2	31.5	35.0	27.5	44.9	54.8	38.8	30.4	36.7	23.7	47.6	40.9	21.3	24.4	23.3	69.9	31.4	84.9	36.9	19.9	19.6	39.9	47.2	24.9	39.2	59.8	53.5	64.4	59.5	54.6	21.2	53.0	58.2	23.5	25.4	35.2	26.9	23.9	24.6	29.3	63.6	40.6	28.7	48.9	65.7	53.1	69.9	33.1	59.9	82.2	34.2	47.6	27.7	70.5	37.6	35.3	54.7	25.3	35.3	24.4	36.5	33.0	40.5	30.7	32.7	39.3	57.6	55.2	52.2	58.6	31.2	47.1	52.2	42.8	12.6	22.0	14.6	10.8	16.8	13.9	13.2	11.7	11.3	14.9	14.5	11.7	23.4	9.4	12.3	12.5	13.4	7.9	23.3	23.8	28.0	30.3	21.7	29.6	24.2	23.9	23.1	17.5	23.9	27.5	40.6	41.7	45.1	79.7	69.7	46.7	58.1	41.4	47.3	70.2	39.1	30.6	28.7	20.0	39.3	33.1	75.0	46.8	63.0	46.4	23.5	49.7	7.6	44.5	92.6	49.0	43.0	45.8	36.2	44.4	44.7	47.3	44.4	58.3	42.3	45.4	26.7	23.3	30.6	43.7	42.7	46.5	57.0	27.6	49.5	13.3	72.4	46.6	26.6	32.8	52.2	77.5	52.5	29.7	34.6	42.2	48.6	65.8	70.0	50.3	54.1	61.5	55.3	78.4	46.0	75.4	47.9	68.3	78.8	37.3	41.9	32.3	79.1	59.7	44.8	54.2
SAMM50	"CGI-51, OMP85, SAM50, TOB55, TRG-3, YNL026W"	ENSG00000100347	"SAMM50 sorting and assembly machinery component"	Q9Y512	22	43955442-44010531	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 240.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034537	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA034537: AB_10602794"	"unprognostic (2.92e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.95e-3)"	"prognostic favorable (2.63e-7)"	"unprognostic (2.43e-3)"	"unprognostic (2.28e-1)"	"unprognostic (5.28e-3)"	"unprognostic (1.70e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.52e-1)"	"prognostic favorable (4.43e-8)"	"unprognostic (1.08e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.60e-1)"	41.7	50.6	26.1	27.0	27.0	32.5	35.8	29.8	30.6	43.4	31.1	35.6	50.8	27.0	29.3	31.7	41.9	29.3	65.5	27.1	29.2	48.8	37.2	22.2	34.6	29.8	28.5	40.0	33.3	114.4	24.4	20.1	30.4	26.5	35.5	25.5	35.2	25.1	240.4	35.9	38.3	27.7	27.0	24.4	43.8	26.1	28.5	34.4	28.1	177.0	37.0	27.9	24.0	28.0	64.6	59.8	57.1	69.5	72.2	75.9	79.8	61.7	65.7	89.1	76.4	86.1	46.0	105.9	44.3	70.8	51.4	75.6	85.4	82.6	79.7	29.4	105.3	57.5	73.9	102.6	50.4	184.0	83.1	88.3	64.7	77.0	35.5	62.3	93.1	49.9	49.9	34.0	80.9	91.7	72.6	72.0	56.0	77.4	70.9	83.8	61.8	85.9	74.4	81.0	34.1	55.4	68.3	72.2	104.1	60.4	67.7	59.8	57.7	57.3	68.8	53.6	51.2	50.1	74.4	82.1	72.0	66.3	58.7	47.5	39.2	46.9	39.8	39.0	55.4	55.1	36.6	40.5	67.7	51.0	37.8	36.0	6.1	39.1	31.8	26.7	45.7	40.2	26.1	27.0	29.8	30.6	27.1	29.2	29.8	28.5	30.4	27.0	28.5	28.0	52.9	35.3	18.9	10.4	31.6	20.6	27.0	72.0	30.7	20.1	32.1	40.9	68.6	18.6	39.5	9.2	8.4	41.6	31.7	36.1	60.7	47.2	40.3	47.3	24.9	35.1	18.6	51.4	12.0	55.5	54.1	24.6	42.3	32.7	27.3	43.9	30.0	41.8	51.1	32.0	12.7	35.2	46.8	28.6	20.5	50.1	26.1	25.0	16.0	12.2	41.4	32.8	33.0	9.5	9.1	43.7	34.5	30.5	31.0	16.2	82.4	116.8	39.9	30.1	19.7	23.2	33.4	45.8	31.2	34.3	22.6	20.5	28.5	69.9	59.8	19.3
SAP130	FLJ12761	ENSG00000136715	"Sin3A associated protein 130"	Q9H0E3	2	127941217-128028120	"Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 47.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 71.5;Late spermatids: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034664			Supported	"Nuclear speckles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA034664: AB_10603238"	"unprognostic (2.17e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (7.89e-4)"	"unprognostic (2.75e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.92e-2)"	"unprognostic (6.77e-2)"	"unprognostic (3.75e-2)"	"unprognostic (5.26e-2)"	"unprognostic (4.41e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.13e-1)"	9.1	8.6	8.8	8.7	8.5	21.7	8.2	8.5	10.2	10.5	5.1	10.3	8.3	10.4	9.2	10.4	9.6	7.2	8.5	8.1	10.8	7.2	8.3	8.0	10.0	6.4	7.9	11.2	8.7	12.4	14.5	9.0	7.1	8.7	9.7	8.6	9.1	7.9	11.9	12.9	9.8	10.2	6.1	8.5	9.7	47.3	8.0	14.8	8.8	13.0	12.6	9.5	10.3	8.8	35.3	18.9	35.3	28.6	22.9	15.7	38.5	22.0	21.4	33.4	26.2	45.1	14.4	29.4	19.3	25.0	17.4	24.0	39.3	22.7	34.5	16.3	25.2	29.2	16.7	35.9	27.5	25.5	22.2	14.8	16.7	44.1	27.5	17.6	27.0	24.4	35.9	21.1	28.2	39.3	35.6	20.0	36.6	20.7	21.1	24.3	29.0	19.6	17.9	30.7	18.5	22.3	23.2	21.7	13.6	22.1	16.4	17.3	23.2	32.1	34.5	30.1	23.6	29.3	31.2	34.3	26.4	17.0	21.0	2.3	4.2	4.6	5.3	2.7	4.0	2.0	3.8	3.5	3.4	5.0	2.7	3.1	14.0	3.6	8.6	6.2	2.7	3.8	8.8	8.5	8.5	10.2	8.1	10.8	6.4	7.9	7.1	6.1	8.0	8.8	5.4	0.0	10.9	29.0	7.9	7.9	2.3	3.2	5.7	5.2	6.5	5.3	15.2	2.8	3.1	1.8	8.4	11.9	9.4	13.1	0.0	4.9	71.5	4.6	8.6	6.2	6.7	11.6	25.4	4.7	12.8	5.2	8.6	8.7	1.3	5.3	5.3	5.8	7.8	8.4	28.9	7.0	4.1	8.4	6.3	44.2	8.4	7.0	5.4	16.9	4.9	5.0	6.2	26.2	31.0	6.1	7.8	8.2	13.2	4.9	6.5	3.4	4.0	5.8	6.6	4.4	5.5	31.0	17.9	9.2	10.4	19.3	7.6	3.7	7.8	4.3
SAPCD2	"C9orf140, p42.3"	ENSG00000186193	"Suppressor APC domain containing 2"	Q86UD0	9	137062127-137070557	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.1;esophagus: 8.5;skin 1: 6.2"	"Cell type enhanced"	"Detected in many"		"Intestinal goblet cells: 10.8;Oligodendrocyte precursor cells: 29.7;Undifferentiated cells: 12.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 122.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA044154	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	Yes				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA044154: AB_10959464"	"unprognostic (3.68e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.42e-8)"	"prognostic unfavorable (5.88e-4)"	"unprognostic (8.33e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.83e-7)"	"unprognostic (4.37e-3)"	"unprognostic (4.62e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.35e-2)"	0.5	0.3	6.9	2.4	5.1	2.0	1.3	4.7	5.4	1.2	1.3	3.7	4.3	0.4	0.0	8.5	0.3	0.2	0.2	5.4	4.5	1.2	0.2	0.5	2.7	7.1	6.8	0.1	0.4	0.0	0.5	0.9	5.7	3.1	1.8	0.1	4.1	0.1	0.1	6.2	4.3	0.4	5.0	2.2	2.4	0.5	6.8	2.3	0.3	0.0	2.5	0.4	2.3	7.0	52.1	27.5	10.7	32.0	0.3	0.7	57.1	8.4	5.7	8.8	4.1	52.5	23.2	53.8	26.5	4.1	8.2	72.3	33.6	9.7	2.0	37.4	38.9	23.6	32.7	59.6	0.2	27.0	39.2	0.1	1.5	3.0	5.8	2.3	14.4	27.1	33.1	23.7	2.6	122.1	7.8	72.7	19.9	119.2	61.9	82.9	40.7	60.1	10.9	14.8	55.2	32.7	32.2	89.1	12.2	2.4	71.9	51.1	9.4	7.9	26.6	24.0	41.9	8.2	25.5	26.3	18.4	31.8	25.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.9	5.1	4.7	5.4	5.4	4.5	7.1	6.8	5.7	5.0	6.8	7.0	0.5	0.0	0.0	0.7	1.9	4.2	0.7	0.5	0.6	0.2	5.0	5.2	1.3	0.0	1.1	0.0	0.0	2.8	1.6	5.4	1.9	0.3	0.0	1.6	0.8	0.9	0.0	3.6	0.2	0.0	3.5	1.1	6.1	6.0	0.0	3.3	1.4	0.0	3.1	0.0	0.2	10.8	0.0	2.8	1.5	0.1	0.0	2.2	0.0	0.0	1.5	0.5	0.0	29.7	5.6	0.6	4.0	0.0	1.8	2.1	0.5	0.0	0.1	0.6	0.0	0.2	1.0	0.0	1.4	5.8	2.7	0.5	1.3	0.6	12.1	1.1
SARNP	"CIP29, Hcc-1, THO1"	ENSG00000205323	"SAP domain containing ribonucleoprotein"	P82979	12	55752463-55817724	"Plasma proteins, Predicted intracellular proteins"	"mRNA transport, Transcription, Transcription regulation, Translation regulation, Transport"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030902, HPA030903"	Supported		Supported	"Nuclear speckles"		NA	NA		150000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA030902: AB_10669872, HPA030903: AB_10964180"	"unprognostic (1.83e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.36e-4)"	"unprognostic (2.02e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.03e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.31e-6)"	"unprognostic (8.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.19e-1)"	48.0	59.1	52.9	45.8	53.7	88.8	58.0	56.4	88.2	52.6	55.0	53.7	31.1	48.2	57.2	61.9	42.3	34.8	81.5	53.4	60.8	62.5	49.4	46.4	67.2	54.8	56.8	48.5	31.6	45.7	43.7	55.1	55.3	48.0	53.6	31.6	39.4	47.7	98.9	43.3	38.5	53.4	53.5	47.9	44.1	55.4	55.8	83.0	41.6	84.0	84.5	59.8	48.3	56.2	118.8	106.6	251.5	107.9	114.9	162.9	119.7	160.5	126.2	196.7	163.6	151.4	129.1	191.3	108.7	131.8	77.2	66.5	223.7	158.2	209.8	151.2	140.5	192.5	181.6	132.9	166.9	162.0	142.4	121.1	115.7	129.0	99.7	206.0	210.4	169.1	141.3	137.9	198.0	100.5	204.1	257.8	221.4	107.0	97.8	186.5	131.6	159.3	265.9	133.0	108.2	87.8	138.1	88.1	144.8	143.3	134.1	216.3	146.1	79.0	79.3	101.3	128.3	87.0	122.8	258.5	94.9	163.8	101.9	246.1	137.9	218.7	110.5	156.2	101.1	125.3	115.8	119.0	153.7	114.0	91.7	103.0	107.2	134.2	138.8	146.8	170.6	153.9	52.9	53.7	56.4	88.2	53.4	60.8	54.8	56.8	55.3	53.5	55.8	56.2	14.7	32.1	35.6	27.7	26.6	25.2	24.5	24.0	46.1	11.2	12.9	9.9	0.2	10.0	41.0	22.0	16.7	16.1	17.9	11.8	25.4	28.8	16.3	9.1	8.8	16.5	14.9	34.1	32.8	29.8	19.8	30.5	33.6	11.4	27.8	8.9	8.9	7.4	14.6	8.4	33.8	13.3	24.4	19.2	36.3	35.9	18.0	25.1	21.4	27.2	32.4	10.6	16.5	37.7	46.6	32.1	13.1	17.3	37.0	14.8	14.8	19.1	45.2	10.0	6.6	12.6	23.3	36.4	32.8	50.9	26.6	16.8	29.9	12.2	11.5	20.4
SART3	"KIAA0156, p110, RP11-13G14, TIP110"	ENSG00000075856	"Spliceosome associated factor 3, U4/U6 recycling protein"	Q15020	12	108522214-108561400	"Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028840, HPA044322"	Approved		Supported	Nucleoplasm		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA028840: , HPA044322: AB_2678895"	"unprognostic (1.72e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (6.32e-6)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (1.38e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-3)"	"unprognostic (7.91e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.36e-2)"	14.6	15.1	14.0	18.5	14.0	25.5	14.8	17.6	15.1	18.8	12.2	15.9	12.6	19.3	13.7	19.2	17.4	11.9	13.9	13.7	14.6	13.9	16.1	14.5	26.3	12.5	12.9	23.8	13.2	18.3	18.9	15.4	13.0	16.5	15.2	20.3	14.1	14.5	17.8	19.0	17.2	13.9	13.5	19.8	15.1	16.8	14.5	25.7	18.8	15.1	23.2	15.5	16.0	16.8	34.5	61.5	45.4	53.8	24.2	18.9	43.6	29.3	35.8	50.1	37.2	51.5	23.4	51.3	20.1	26.4	32.2	32.0	68.2	33.9	44.1	61.8	43.0	74.1	40.9	47.9	39.2	74.0	44.4	26.4	31.4	31.9	46.8	38.1	30.8	42.1	85.7	33.7	30.9	34.6	69.9	57.5	90.2	27.6	59.9	67.3	44.7	59.3	26.1	57.5	56.8	40.3	45.0	17.0	30.7	38.7	49.0	51.1	26.0	39.0	21.0	30.1	30.7	42.6	68.3	75.6	34.1	42.2	46.2	6.9	6.2	6.4	8.3	5.1	9.9	7.7	6.3	8.3	9.0	7.1	9.4	6.0	1.6	8.6	7.6	6.1	10.5	7.9	14.0	14.0	17.6	15.1	13.7	14.6	12.5	12.9	13.0	13.5	14.5	16.8	14.7	19.2	24.5	16.0	25.9	14.7	16.3	15.4	16.5	42.0	11.5	11.4	19.9	10.0	23.4	18.4	35.5	21.4	21.1	12.0	7.9	14.7	53.6	15.1	21.6	20.0	12.5	23.1	22.1	12.7	14.0	17.1	15.3	15.9	17.7	21.9	11.7	12.5	13.2	35.3	22.2	9.3	24.4	14.1	13.8	30.8	10.2	17.0	16.0	16.9	18.6	23.4	14.4	19.1	24.9	13.5	7.7	17.7	29.6	16.1	9.5	8.2	27.4	39.1	32.9	22.0	18.0	27.2	31.1	19.6	18.0	23.7	24.2	19.1	14.0	17.0
SASS6	"DKFZp761A078, FLJ22097, SAS-6, SAS6"	ENSG00000156876	"SAS-6 centriolar assembly protein"	Q6UVJ0	1	100083563-100132955	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028187	Uncertain					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA028187: AB_10602220"	"unprognostic (1.57e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.02e-3)"	"unprognostic (1.21e-4)"	"unprognostic (1.27e-1)"	"unprognostic (8.43e-3)"	"unprognostic (4.73e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.71e-2)"	"unprognostic (7.76e-8)"	"unprognostic (1.19e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.54e-1)"	1.3	1.2	1.0	2.9	1.2	6.0	2.8	1.6	1.5	1.6	0.8	2.2	2.8	2.0	2.2	2.1	1.4	1.0	1.0	0.8	1.0	1.0	1.4	1.3	4.2	1.1	1.2	1.8	1.4	3.9	1.6	2.0	1.1	2.1	3.0	5.7	1.8	1.5	1.3	2.1	2.2	1.8	1.1	2.1	2.1	6.7	1.0	4.3	1.5	0.9	3.6	1.4	1.6	1.3	17.0	5.2	13.1	11.5	1.5	2.6	19.3	10.7	4.7	13.5	15.6	9.0	8.5	18.5	8.0	3.7	8.0	14.8	18.0	6.5	18.6	8.9	17.8	16.2	10.9	11.3	0.9	26.8	14.5	1.3	2.8	11.4	9.0	2.7	7.3	12.2	25.8	17.6	6.7	4.8	22.2	12.9	17.5	11.1	10.7	16.1	25.9	9.4	6.5	8.1	9.5	14.0	9.9	17.0	8.7	9.4	8.6	15.9	3.8	9.5	11.6	10.9	14.9	7.4	18.5	24.6	7.7	17.7	5.3	3.9	0.1	1.0	0.7	0.6	0.9	1.6	0.8	0.7	0.5	0.7	0.7	0.6	0.7	0.6	0.5	0.2	0.9	0.3	1.0	1.2	1.6	1.5	0.8	1.0	1.1	1.2	1.1	1.1	1.0	1.3	7.2	0.0	2.3	8.5	12.8	4.0	2.8	7.1	6.8	19.4	8.4	9.4	2.9	7.2	5.9	1.8	16.7	13.6	13.5	2.4	1.9	7.5	15.7	7.4	5.8	5.8	4.2	33.2	7.6	5.6	17.3	7.0	7.1	5.4	5.7	15.0	6.8	3.1	9.1	8.4	9.6	4.8	14.2	8.4	4.7	6.2	8.1	5.8	1.8	5.6	6.1	13.3	20.6	5.0	16.1	6.2	2.7	10.9	19.7	4.5	2.2	4.3	4.9	23.0	0.0	12.6	5.9	77.4	36.0	11.9	4.1	5.1	7.9	4.0	8.8	2.1
SBDS	"CGI-97, FLJ10917, SDS, SWDS"	ENSG00000126524	"SBDS ribosome maturation factor"	Q9Y3A5	7	66987680-66995587	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 2042.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028891	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		190000	"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA028891: AB_10601500"	"prognostic unfavorable (1.49e-4)"	"unprognostic (1.87e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.71e-3)"	"unprognostic (8.06e-3)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.99e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.59e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.06e-3)"	139.1	107.5	136.1	57.9	152.1	157.2	113.7	151.2	168.3	97.3	115.8	143.6	127.8	117.2	83.3	128.6	99.2	84.9	238.0	133.1	148.4	117.8	126.8	113.8	43.8	156.2	142.3	90.1	89.3	145.0	87.4	106.2	155.0	107.9	111.6	90.3	80.7	122.6	374.0	92.0	114.2	128.2	152.6	57.3	104.6	60.9	143.4	38.8	107.0	263.3	52.5	113.9	90.7	169.7	168.3	68.9	59.9	54.6	212.7	157.9	67.0	281.4	225.4	206.1	157.1	143.1	83.0	62.2	209.7	253.5	136.3	80.1	101.7	164.3	219.4	59.8	136.4	31.1	125.9	86.6	188.9	78.1	40.8	144.0	215.1	157.0	269.8	105.9	129.2	39.7	227.2	65.0	324.2	100.0	41.8	112.4	67.2	227.3	165.9	31.3	132.6	129.3	218.1	73.6	91.7	63.7	142.3	235.5	194.3	131.0	176.2	64.8	176.4	276.5	96.7	142.5	205.4	40.6	51.4	141.0	95.7	125.5	157.4	75.5	33.2	61.4	64.7	37.7	81.7	62.8	82.7	75.2	33.4	59.9	104.4	85.7	13.0	51.8	35.1	45.4	80.2	62.2	136.1	152.1	151.2	168.3	133.1	148.4	156.2	142.3	155.0	152.6	143.4	169.7	169.9	304.5	128.0	10.7	101.6	464.2	466.2	213.2	145.7	73.7	118.5	154.0	286.6	108.7	160.3	92.0	12.5	130.5	98.0	270.9	262.2	177.4	583.0	93.0	131.2	153.2	101.9	51.3	12.5	165.7	232.1	197.7	96.8	128.2	150.0	29.7	138.5	102.1	107.0	58.9	15.3	221.9	142.4	47.2	238.1	2042.9	127.1	74.8	256.1	11.2	66.5	161.9	30.9	7.5	36.0	300.0	242.2	168.5	117.5	267.2	359.3	264.6	75.6	56.8	164.3	512.9	266.2	86.3	47.9	129.9	430.0	398.5	144.5	132.2	165.4	318.5
SCAF4	"DKFZp434E098, KIAA1172, SFRS15, SRA4"	ENSG00000156304	"SR-related CTD associated factor 4"	O95104	21	31671000-31732118	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018319, HPA018668, HPA021504, HPA028807"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA018319: AB_1856784, HPA018668: AB_1856783, HPA021504: AB_1856785, HPA028807: AB_10602927"	"unprognostic (9.18e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.85e-2)"	"unprognostic (3.99e-3)"	"unprognostic (4.31e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.28e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.87e-1)"	"unprognostic (7.65e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.16e-3)"	14.1	10.6	6.8	12.7	7.3	13.7	13.2	9.3	9.0	14.9	5.5	14.1	12.3	14.6	9.1	16.1	12.8	8.5	11.3	7.1	9.7	9.6	17.1	14.2	18.4	7.8	7.4	16.1	11.8	11.4	11.2	12.7	7.1	12.5	10.1	10.6	13.0	9.0	17.9	18.5	16.3	9.5	5.4	16.3	13.4	17.5	7.3	18.9	11.4	10.8	17.2	13.3	15.1	8.6	31.4	20.5	40.3	29.4	21.4	16.1	27.4	22.6	23.8	23.7	22.0	39.5	22.2	63.9	13.4	22.3	25.9	18.9	44.3	22.1	25.8	28.6	25.8	50.9	16.8	33.4	24.5	54.8	20.5	18.2	24.6	31.6	27.1	15.1	20.9	25.0	68.4	32.4	19.9	41.7	58.4	39.7	51.7	30.5	17.3	57.1	44.8	21.1	16.5	24.3	27.5	29.7	34.9	26.8	19.7	22.1	20.7	36.7	24.4	24.5	23.6	23.5	23.5	20.6	20.7	72.0	17.6	43.4	23.3	6.6	7.9	10.9	9.7	10.6	9.6	10.9	5.6	9.3	9.7	9.7	6.5	7.2	4.0	7.6	9.6	6.8	5.2	8.1	6.8	7.3	9.3	9.0	7.1	9.7	7.8	7.4	7.1	5.4	7.3	8.6	16.5	6.4	14.5	25.8	46.5	46.7	35.5	15.2	53.5	22.8	23.0	13.8	9.4	18.6	13.8	11.0	25.0	16.6	31.2	39.4	3.9	16.4	9.9	14.9	26.7	19.9	19.8	48.4	34.9	14.0	17.8	21.6	19.4	22.9	11.4	21.9	18.9	24.4	15.7	21.9	34.5	18.7	22.4	23.1	37.8	3.8	22.1	22.7	33.8	36.5	24.5	12.5	32.0	34.7	45.5	17.9	23.4	14.3	23.9	31.2	31.6	6.7	18.2	24.6	13.1	29.9	18.3	25.6	23.9	41.7	41.1	18.9	33.1	12.5	22.2	33.5
SCAF8	"KIAA1116, RBM16"	ENSG00000213079	"SR-related CTD associated factor 8"	Q9UPN6	6	154733378-154834244	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 105.4;Inhibitory neurons: 114.2;Microglial cells: 119.9;Oligodendrocyte precursor cells: 121.2;Oligodendrocytes: 145.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035601, HPA035602"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA035601: AB_2674698, HPA035602: AB_10673220"	"unprognostic (4.60e-3)"	"unprognostic (3.67e-2)"	"unprognostic (7.90e-3)"	"unprognostic (2.50e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (6.61e-4)"	"unprognostic (3.65e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.11e-1)"	19.2	11.8	7.9	15.6	10.3	37.2	18.9	17.8	9.9	18.2	2.7	14.9	12.7	22.1	16.4	13.2	17.4	13.6	14.8	6.9	8.5	16.6	15.4	16.2	22.6	7.3	8.5	27.0	14.9	21.3	10.2	18.9	6.2	16.9	17.6	23.2	15.6	15.6	18.7	18.3	14.3	20.3	6.8	19.1	15.2	23.5	8.7	26.8	21.3	19.1	20.8	15.3	14.7	10.4	16.2	15.3	44.6	27.1	29.3	29.8	27.2	25.7	35.8	33.1	33.4	24.2	16.0	49.7	20.4	29.6	29.4	21.1	39.5	33.8	44.2	21.7	19.7	44.6	16.0	29.8	33.8	41.7	28.8	32.3	35.0	29.0	45.0	25.7	28.6	21.6	52.6	29.4	30.8	29.1	44.6	28.2	31.0	24.4	11.3	42.3	24.4	27.1	28.1	29.0	27.4	32.3	26.7	34.7	19.9	32.1	22.8	47.8	26.3	18.8	23.0	24.6	26.2	27.2	21.7	54.0	23.4	25.6	30.0	0.6	1.5	1.8	2.8	2.0	2.8	2.4	3.0	2.9	1.7	2.6	3.0	2.7	1.9	3.1	3.8	1.6	4.0	1.4	7.9	10.3	17.8	9.9	6.9	8.5	7.3	8.5	6.2	6.8	8.7	10.4	23.1	25.6	18.1	89.8	22.6	12.6	12.2	11.9	17.6	19.5	14.6	12.4	33.9	7.2	11.7	12.9	25.0	11.1	23.2	15.8	1.9	11.3	3.6	18.8	25.4	16.6	13.1	18.7	105.4	11.8	8.8	17.5	23.0	25.0	34.2	29.3	18.5	11.6	13.3	13.5	114.2	14.1	6.1	20.8	9.7	5.4	16.4	16.6	10.6	119.9	13.5	16.1	8.2	121.2	145.8	13.6	11.8	12.4	13.7	13.7	11.7	6.5	15.8	21.4	26.3	24.5	16.3	21.4	21.2	14.8	10.7	10.7	19.2	19.5	16.1	15.4
SCLY	SCL	ENSG00000132330	"Selenocysteine lyase"	Q96I15	2	238060924-238099413	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 39.1"	"Group enriched"	"Detected in many"	13	"Early spermatids: 90.6;Late spermatids: 156.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020190, HPA055760"	Uncertain		Enhanced	"Golgi apparatus"		NA	NA		300000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus"		"HPA020190: , HPA055760: AB_2682910"	"unprognostic (7.39e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.29e-2)"	"unprognostic (8.65e-5)"	"unprognostic (8.96e-2)"	"unprognostic (9.85e-3)"	"unprognostic (1.14e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.02e-3)"	"unprognostic (3.73e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.98e-1)"	5.1	4.3	7.2	5.3	9.4	5.0	4.9	9.4	9.3	6.8	6.4	7.3	8.5	8.1	5.6	5.9	6.3	3.8	8.1	6.8	8.2	12.9	39.1	4.7	5.7	9.2	8.8	6.3	22.8	6.1	5.0	2.0	9.4	5.9	3.2	4.6	4.4	4.1	6.4	3.5	8.6	3.9	7.3	7.2	5.8	16.8	8.3	5.9	7.2	3.5	4.3	7.8	5.1	10.4	11.1	19.1	11.9	31.1	9.0	6.4	23.2	11.2	5.6	11.3	14.3	11.6	8.0	18.9	3.3	5.9	35.4	16.4	44.1	21.5	10.9	21.2	41.8	21.1	24.0	37.6	16.7	17.6	18.2	7.1	11.6	21.3	22.0	5.1	21.0	26.1	38.0	5.1	11.7	16.9	17.9	33.0	36.4	16.0	15.6	22.0	23.3	18.2	11.3	3.6	13.1	28.9	12.0	19.4	20.6	8.2	6.3	26.5	8.5	16.3	11.8	24.2	23.7	14.2	13.3	9.3	11.3	37.0	14.4	1.1	3.2	4.0	2.6	2.3	2.0	2.6	3.1	4.4	3.3	1.6	2.3	2.6	0.5	2.9	3.5	0.6	3.2	2.8	7.2	9.4	9.4	9.3	6.8	8.2	9.2	8.8	9.4	7.3	8.3	10.4	2.2	0.0	0.0	0.0	4.6	1.7	2.4	1.9	5.7	5.4	1.7	1.9	2.6	1.5	1.2	0.0	8.4	1.4	3.4	1.9	3.9	5.3	90.6	1.7	3.4	2.4	2.4	9.4	0.0	3.7	2.1	1.9	5.1	2.6	0.0	3.5	1.8	3.3	4.0	6.7	0.0	3.3	8.2	0.9	3.2	156.3	3.1	2.1	1.8	0.0	2.7	2.6	2.1	0.0	0.0	3.0	5.0	0.0	4.9	1.9	3.9	2.7	1.9	6.9	0.0	1.9	3.2	6.2	5.6	3.4	1.6	0.7	4.4	2.2	4.8	1.8
SCO1	SCOD1	ENSG00000133028	"Synthesis of cytochrome C oxidase 1"	O75880	17	10672474-10698375	"Disease related genes, Human disease related genes, Predicted membrane proteins"		Chaperone	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 102.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021565, HPA021579"	Enhanced					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA021565: AB_1856631, HPA021579: AB_1856632"	"unprognostic (6.11e-3)"	"unprognostic (2.88e-1)"	"unprognostic (5.12e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.52e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.02e-2)"	"unprognostic (7.09e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.84e-2)"	"prognostic favorable (9.69e-7)"	"unprognostic (4.94e-3)"	"unprognostic (3.54e-2)"	"prognostic unfavorable (7.44e-4)"	"unprognostic (3.12e-2)"	16.4	18.5	9.2	12.2	9.4	8.9	14.2	9.7	9.5	12.5	14.5	18.8	19.9	13.6	8.0	16.5	10.6	8.0	24.2	9.2	10.1	20.0	30.1	10.2	12.0	9.7	9.4	10.4	9.6	15.7	12.5	11.3	9.7	12.8	14.6	9.2	11.9	9.7	24.9	12.1	16.8	9.2	9.6	12.0	13.2	12.0	10.0	9.6	13.1	17.2	9.9	13.5	12.3	10.2	32.6	46.9	19.0	25.5	22.8	19.4	40.7	35.2	18.3	31.1	29.9	24.0	18.5	56.8	37.4	31.6	19.1	35.0	38.0	33.4	34.7	30.1	48.4	29.3	28.8	34.0	32.5	20.5	20.8	24.7	21.4	29.3	46.3	16.2	22.5	36.9	30.3	9.8	32.4	18.4	28.7	21.1	42.0	36.6	23.9	33.8	23.6	25.4	40.3	23.2	10.1	29.2	41.6	25.4	37.2	24.4	32.1	14.4	26.9	23.7	20.2	25.6	37.1	15.5	16.5	21.6	19.3	25.5	26.3	6.6	15.5	14.8	11.5	18.5	12.2	13.2	10.0	12.0	15.2	9.8	12.2	12.8	5.1	11.1	20.5	10.9	14.3	12.2	9.2	9.4	9.7	9.5	9.2	10.1	9.7	9.4	9.7	9.6	10.0	10.2	18.1	22.4	19.8	5.9	24.3	11.5	23.3	32.2	13.1	20.4	14.0	13.2	39.5	18.6	23.4	18.4	66.7	61.0	15.5	34.6	41.1	26.1	4.0	13.7	25.2	19.1	15.7	22.1	4.2	20.4	102.6	19.7	24.5	15.9	8.8	22.4	19.6	38.2	29.8	16.8	4.7	25.3	26.4	18.9	9.5	5.4	18.6	15.9	10.6	6.5	28.4	20.7	22.6	2.5	5.4	24.1	19.3	19.2	18.4	33.1	31.6	49.8	16.1	37.7	6.6	23.8	19.1	28.4	37.0	21.5	11.8	60.5	17.5	43.0	35.6	23.0
SDAD1	FLJ10498	ENSG00000198301	"SDA1 domain containing 1"	Q9NVU7	4	75940950-75990962	"Human disease related genes, Predicted intracellular proteins"	"Protein transport, Ribosome biogenesis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035949	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoli	Nucleoplasm	"HPA035949: AB_10673225"	"unprognostic (8.82e-3)"	"unprognostic (3.39e-3)"	"unprognostic (7.62e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.98e-2)"	"prognostic favorable (2.13e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.62e-1)"	14.6	13.5	10.5	14.8	10.8	7.2	17.9	8.4	12.3	13.6	8.5	14.3	11.9	17.6	19.0	15.3	12.7	8.7	14.3	10.9	11.0	15.0	15.8	12.6	21.2	9.6	8.9	13.7	17.7	17.7	8.9	12.9	9.3	14.2	15.1	6.8	15.0	16.2	22.9	14.8	11.1	17.1	8.5	15.5	14.0	21.3	11.1	16.4	21.2	16.4	20.2	18.8	11.7	10.2	29.8	11.8	28.5	38.9	33.1	29.8	30.6	41.3	35.9	34.0	29.1	36.6	42.0	46.7	30.2	38.1	32.4	29.7	44.5	40.5	42.3	41.2	23.0	39.9	24.4	30.6	32.7	68.5	43.9	26.4	45.0	36.3	40.4	21.1	30.0	31.2	72.7	37.8	36.4	33.1	69.6	25.1	47.4	48.3	18.1	41.8	53.5	39.3	32.7	32.6	43.3	35.6	28.1	57.0	48.9	31.1	26.4	39.6	29.1	36.6	36.7	44.4	34.8	33.9	37.6	62.0	40.7	31.1	46.0	10.4	14.5	4.1	19.1	19.1	23.8	17.8	23.0	21.1	15.3	20.1	23.0	19.5	2.3	23.4	27.5	13.0	21.5	15.9	10.5	10.8	8.4	12.3	10.9	11.0	9.6	8.9	9.3	8.5	11.1	10.2	36.2	19.2	34.7	15.0	45.7	27.5	26.8	45.1	35.3	21.1	21.3	29.1	12.3	14.3	46.0	22.0	6.2	30.6	35.7	14.5	35.2	37.7	109.0	12.1	29.9	25.2	22.8	35.3	34.0	24.9	32.2	27.4	20.9	18.7	49.4	26.3	18.9	22.1	37.9	13.5	31.8	22.6	36.7	24.3	16.3	106.7	25.4	30.0	24.9	30.9	40.3	23.7	42.2	23.6	29.9	33.4	18.3	33.1	49.0	37.1	17.1	46.6	26.1	20.0	19.7	33.2	38.7	75.6	100.7	47.5	33.1	25.0	38.1	33.2	27.9	22.4
SDE2	"C1orf55, FLJ35382"	ENSG00000143751	"SDE2 telomere maintenance homolog"	Q6IQ49	1	225982702-225999343	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 72.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028467, HPA031255, HPA031256"	Approved		Supported	"Nuclear speckles,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA028467: AB_10599192, HPA031255: AB_10601462, HPA031256: AB_10603568"	"unprognostic (9.69e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (9.59e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.90e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.84e-2)"	17.4	8.5	5.5	11.3	7.0	32.9	11.8	6.4	6.6	9.0	4.8	8.3	9.0	11.8	7.8	9.6	7.4	10.5	7.7	4.9	6.0	9.2	14.6	9.2	12.4	6.9	6.6	10.2	9.6	11.1	4.4	11.8	6.6	9.8	9.1	5.1	6.7	7.3	12.7	10.8	9.0	9.8	6.6	10.4	7.7	8.3	6.1	22.8	12.5	9.6	10.6	11.6	7.8	8.4	13.1	9.3	14.9	15.9	10.2	11.3	18.5	13.7	12.9	18.4	14.0	13.7	14.7	19.2	20.9	11.6	7.2	16.5	18.9	11.9	22.2	14.7	15.3	21.1	7.9	12.7	18.6	21.0	24.6	12.5	16.9	19.6	24.6	10.3	12.8	22.6	39.3	22.6	13.7	3.8	29.5	16.6	20.8	20.2	9.8	24.4	19.1	24.9	11.1	9.2	13.3	22.0	15.6	16.9	26.3	11.9	16.6	25.4	12.7	15.6	11.0	20.3	30.4	13.4	10.3	23.4	16.1	12.9	31.5	21.8	6.3	5.9	8.0	6.4	10.8	8.0	8.1	7.8	7.1	7.0	8.1	7.7	18.5	13.5	7.9	8.1	6.7	6.9	5.5	7.0	6.4	6.6	4.9	6.0	6.9	6.6	6.6	6.6	6.1	8.4	36.0	28.9	22.6	4.2	39.9	43.6	17.2	11.2	29.0	6.2	19.8	13.6	9.4	2.8	20.1	9.2	0.0	9.6	29.3	14.3	15.6	6.5	72.8	24.8	15.1	24.8	17.4	56.2	4.7	7.1	10.2	17.8	13.3	35.9	35.5	9.7	12.8	20.6	11.1	15.2	5.0	10.8	16.2	16.4	28.8	20.4	9.9	27.0	19.6	1.9	7.4	12.6	10.3	4.5	8.6	9.7	9.4	6.4	26.6	14.2	9.5	12.7	12.7	8.9	6.6	28.8	23.9	23.9	14.4	26.5	59.1	14.2	23.2	21.0	9.9	18.2
SDHAF3	"ACN9, DC11, LYRM10, Sdh7"	ENSG00000196636	"Succinate dehydrogenase complex assembly factor 3"	Q9NRP4	7	97117698-97181763	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 148.7;Early spermatids: 136.0;Proximal tubular cells: 150.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA020515, HPA020523"	Approved		Approved	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA020515: , HPA020523: AB_2670464"	"unprognostic (3.94e-2)"	"unprognostic (9.11e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.61e-2)"	"unprognostic (9.60e-3)"	"unprognostic (3.21e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.07e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.67e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.34e-1)"	"unprognostic (8.45e-2)"	12.4	17.5	9.3	12.4	9.8	16.7	18.7	10.5	13.3	15.0	13.5	20.7	19.9	12.4	22.2	15.0	14.6	13.0	27.0	9.4	11.2	33.5	32.1	8.4	18.5	10.6	10.4	10.7	18.4	12.2	3.6	9.6	11.0	14.8	20.3	16.4	22.0	12.0	29.0	14.1	17.4	12.2	11.6	11.2	18.3	14.5	10.2	24.5	19.0	25.6	14.5	12.8	3.7	12.1	36.6	27.6	24.5	82.3	15.8	12.8	14.8	15.8	7.6	15.6	22.8	5.0	30.7	57.4	40.1	14.1	20.7	13.4	49.6	38.8	33.7	44.2	59.6	34.6	24.8	54.8	23.8	89.4	16.0	24.3	30.3	25.7	32.0	11.6	14.5	57.2	99.5	1.6	34.8	0.0	94.5	126.7	37.3	74.1	34.6	21.0	14.0	83.7	26.0	24.9	63.8	40.7	38.5	47.9	55.5	33.9	0.4	31.6	16.0	4.2	53.2	88.6	10.7	41.4	87.0	139.5	14.6	144.7	51.9	30.0	21.4	8.0	26.5	26.3	36.3	36.3	33.3	39.1	27.9	32.1	45.9	44.4	20.2	23.9	26.7	82.6	33.2	37.9	9.3	9.8	10.5	13.3	9.4	11.2	10.6	10.4	11.0	11.6	10.2	12.1	24.4	19.2	12.5	8.5	34.4	0.0	23.1	0.0	29.0	13.8	38.6	44.4	37.9	18.6	6.8	25.8	4.2	35.2	31.3	7.2	148.7	30.6	136.0	31.3	20.6	17.3	13.3	32.6	16.6	39.1	30.0	20.1	29.0	21.4	5.1	22.2	16.4	55.9	31.1	10.1	14.3	24.2	0.0	20.1	0.0	20.7	22.7	20.2	0.0	9.4	13.9	44.8	36.0	14.6	18.5	24.0	29.1	24.8	30.9	17.0	35.1	150.9	16.0	19.5	32.9	19.5	20.4	32.7	49.3	53.5	0.0	9.6	26.3	45.6	39.8	25.0
SDHB	"SDH, SDH1"	ENSG00000117118	"Succinate dehydrogenase complex iron sulfur subunit B"	P21912	1	17018722-17054032	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Electron transport, Transport, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 491.5;tongue: 580.6"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 405.5;Proximal tubular cells: 449.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002868, CAB009822, CAB068233, CAB068234, CAB068235"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Mitochondria"	"Intracellular and membrane"	NA	NA		7900	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Nucleoplasm, Plasma membrane"	"CAB009822: AB_2183458, CAB068233: AB_2665638, CAB068234: AB_2665639, CAB068235: AB_2665640, HPA002868: AB_1079889"	"unprognostic (1.06e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.79e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.93e-2)"	"prognostic favorable (2.93e-7)"	"unprognostic (1.46e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.82e-2)"	"unprognostic (3.82e-2)"	85.8	95.7	68.0	59.0	72.2	94.6	68.7	80.6	84.3	56.8	81.1	134.3	163.0	56.0	71.0	77.4	59.8	48.0	302.8	69.9	76.9	228.0	336.1	56.1	75.3	74.8	71.4	44.4	80.3	144.3	42.8	57.6	73.8	55.7	132.4	62.9	74.0	60.5	491.5	55.6	121.9	70.4	73.9	60.5	92.8	64.4	74.9	62.7	64.3	580.6	84.2	71.3	52.0	78.9	157.3	152.7	72.2	107.8	141.6	135.2	95.9	122.4	145.2	254.3	227.7	216.8	183.1	206.8	159.3	156.4	176.1	180.1	290.7	226.8	284.8	128.7	280.6	183.4	149.2	168.2	172.8	276.0	135.6	140.4	154.9	224.5	370.1	138.7	183.6	176.5	165.2	236.9	179.6	129.5	182.4	175.1	70.4	224.6	302.6	146.1	142.5	265.4	252.4	88.7	157.5	86.0	172.3	216.3	392.3	76.4	131.1	169.1	94.9	115.8	131.0	206.4	176.0	98.9	133.3	198.6	170.4	438.5	128.3	68.7	149.8	149.5	71.4	206.5	70.7	89.9	81.0	77.5	186.8	81.1	73.5	74.8	174.3	85.3	185.7	89.3	113.8	116.1	68.0	72.2	80.6	84.3	69.9	76.9	74.8	71.4	73.8	73.9	74.9	78.9	48.2	64.1	47.4	20.9	57.4	52.1	93.3	199.8	40.5	31.5	45.2	49.4	405.5	101.5	97.0	47.8	14.6	107.1	48.3	176.1	354.1	134.3	220.3	48.7	38.2	54.7	48.6	77.3	27.7	149.2	142.2	62.0	46.9	45.5	66.6	39.9	46.8	226.0	177.4	37.0	32.1	103.1	116.0	88.7	67.9	30.5	57.8	78.4	64.0	29.0	123.1	78.3	48.4	15.6	24.6	111.5	218.3	67.7	62.2	74.4	300.5	449.0	79.8	53.8	39.5	57.1	191.6	148.9	71.5	72.9	54.6	121.8	46.8	69.3	162.0	110.9
SEC23IP	p125	ENSG00000107651	"SEC23 interacting protein"	Q9Y6Y8	10	119892730-119944657	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038403, HPA043305"	Approved		Enhanced	Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Vesicles		"HPA038403: AB_10675796, HPA043305: AB_2678416"	"unprognostic (4.05e-2)"	"unprognostic (5.01e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.52e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.23e-1)"	"unprognostic (6.81e-3)"	"unprognostic (3.43e-2)"	10.3	9.7	3.5	12.0	3.9	14.1	11.8	6.2	4.6	11.2	6.4	12.6	10.4	11.9	12.1	9.4	8.8	9.6	7.7	4.0	4.0	10.3	12.6	10.2	13.7	4.2	4.3	10.0	11.1	9.8	8.5	12.4	4.0	13.1	13.0	9.0	10.3	9.9	9.8	10.4	9.5	16.4	3.1	11.7	17.5	11.5	4.6	11.1	12.5	8.4	13.4	12.0	8.3	6.3	32.4	30.2	24.3	31.9	22.4	25.3	19.0	27.2	39.5	26.1	31.6	31.0	22.9	30.2	14.7	36.2	32.5	23.9	27.9	29.2	39.5	27.2	28.7	25.1	16.3	34.0	31.0	29.6	29.9	31.4	18.4	30.8	30.5	28.3	36.3	15.5	19.1	21.4	28.7	19.2	25.9	28.2	29.5	28.6	20.9	23.7	44.7	17.3	26.1	25.6	9.6	25.5	25.0	19.9	24.1	24.9	17.5	21.7	29.6	15.8	18.5	23.8	35.1	33.5	32.6	38.7	27.6	37.4	14.1	14.3	10.5	10.3	10.7	16.3	13.9	11.3	10.5	12.4	11.9	9.1	11.1	10.7	3.8	13.0	18.1	7.2	11.9	9.6	3.5	3.9	6.2	4.6	4.0	4.0	4.2	4.3	4.0	3.1	4.6	6.3	15.1	12.8	28.3	21.9	20.9	8.4	19.3	18.1	13.1	17.3	19.1	12.1	17.4	27.1	24.5	18.4	6.2	17.8	18.7	19.7	5.9	16.8	26.1	15.1	22.1	19.9	19.9	21.2	28.3	14.4	18.9	21.4	44.9	15.5	22.1	21.0	14.3	25.5	23.3	11.8	30.2	24.3	26.4	24.6	12.2	24.9	14.0	23.3	8.8	39.4	21.3	14.6	16.5	31.7	37.5	20.2	19.8	15.1	23.7	23.4	16.0	19.2	25.4	23.7	0.0	16.8	17.9	25.0	19.8	19.1	13.9	23.1	18.2	24.2	20.8	21.1
SEC24B		ENSG00000138802	"SEC24 homolog B, COPII coat complex component"	O95487	4	109433772-109540896	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 88.1;Oligodendrocytes: 91.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038181	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		14000	"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Vesicles"		"HPA038181: AB_10672472"	"unprognostic (1.19e-1)"	"unprognostic (4.31e-3)"	"unprognostic (8.58e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.67e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.85e-3)"	"unprognostic (2.51e-3)"	"unprognostic (7.47e-2)"	"prognostic favorable (2.33e-6)"	"unprognostic (2.67e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.73e-1)"	19.3	13.7	7.2	13.2	7.5	28.0	17.4	14.7	9.9	16.3	15.0	15.7	14.1	16.9	12.9	17.2	15.0	13.8	15.6	6.8	7.6	16.7	46.2	14.8	13.9	7.5	6.9	21.4	18.6	21.9	11.2	20.6	7.8	15.6	16.1	32.6	14.3	16.1	28.1	19.8	12.7	17.9	7.3	14.7	13.3	11.3	7.4	27.2	18.5	22.9	16.7	17.5	16.0	9.6	21.1	18.9	29.3	22.1	34.9	34.7	16.8	27.0	32.8	22.5	19.8	17.4	23.8	19.4	13.8	41.1	19.3	17.4	33.2	26.9	33.0	24.0	16.6	20.3	16.6	19.2	23.4	27.0	22.9	34.4	33.7	25.8	30.8	31.8	33.7	19.7	31.5	17.3	33.6	17.1	39.2	12.5	11.2	26.1	15.0	25.1	25.9	11.3	27.1	25.8	20.6	16.5	20.8	43.8	16.0	30.0	12.9	10.3	31.3	26.2	17.6	23.1	19.5	16.6	22.3	18.1	23.3	10.7	21.5	6.1	9.5	11.5	8.6	10.4	9.5	10.3	9.5	9.0	11.8	8.9	10.8	9.3	9.2	11.5	10.5	4.6	9.1	9.0	7.2	7.5	14.7	9.9	6.8	7.6	7.5	6.9	7.8	7.3	7.4	9.6	25.1	25.6	15.4	63.0	23.0	35.4	20.1	11.8	28.5	27.0	12.9	10.8	30.5	14.3	17.4	5.5	6.2	13.3	13.2	22.7	5.9	10.4	4.4	18.7	14.6	22.5	15.6	11.6	71.1	13.1	9.2	16.4	19.9	21.9	11.4	15.9	16.8	29.9	12.3	16.8	84.1	15.6	4.1	17.6	16.8	7.9	20.5	18.7	17.8	88.1	14.5	20.3	13.4	76.9	91.6	12.6	18.7	21.8	21.3	22.5	16.5	9.6	19.6	22.0	13.1	16.3	16.8	14.7	13.6	22.2	36.7	16.1	17.0	9.9	14.4	30.3
SEC62	"Dtrp1, HTP1, TLOC1"	ENSG00000008952	"SEC62 homolog, preprotein translocation factor"	Q99442	3	169966635-169998373	"Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014059, HPA061450"	Approved		Approved	"Endoplasmic reticulum,Intermediate filaments"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Endoplasmic reticulum"	"Intermediate filaments"	"HPA014059: AB_1858029, HPA061450: AB_2684524"	"unprognostic (8.15e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.93e-3)"	"unprognostic (5.13e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.04e-1)"	"unprognostic (6.78e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.02e-1)"	104.9	86.5	82.9	58.6	94.3	94.4	64.5	88.1	120.6	74.4	74.6	60.9	58.5	74.7	131.9	44.4	52.3	58.5	49.1	81.8	108.1	118.6	193.7	67.6	63.3	94.9	97.7	75.9	116.5	109.7	41.5	71.0	97.9	82.5	56.6	128.9	130.4	83.5	55.3	27.4	59.4	68.3	95.5	83.5	91.1	34.6	92.3	51.1	120.9	60.2	67.0	63.7	31.7	99.9	140.4	96.6	74.2	66.3	217.9	114.7	46.7	175.5	128.3	80.0	82.5	104.0	143.9	156.8	190.7	125.9	132.5	130.3	92.3	84.8	124.7	123.1	89.2	108.6	57.2	105.6	157.9	111.6	68.5	115.0	79.7	88.0	85.3	108.8	80.1	47.3	68.0	147.2	96.3	117.2	58.9	59.0	76.4	110.8	62.5	77.6	107.6	212.8	115.1	88.5	76.1	71.9	143.7	155.8	125.3	71.3	233.5	101.0	107.8	113.1	51.0	95.6	143.1	168.8	134.9	240.8	118.5	85.1	108.0	17.2	34.8	62.3	44.2	37.1	49.2	77.6	40.6	43.5	30.9	82.1	50.9	46.6	52.0	31.8	29.0	35.1	39.1	27.6	82.9	94.3	88.1	120.6	81.8	108.1	94.9	97.7	97.9	95.5	92.3	99.9	419.0	237.2	291.5	64.6	362.7	254.4	252.8	511.1	144.0	362.0	223.3	278.5	582.1	320.3	431.7	680.5	277.3	218.7	209.5	144.7	195.6	256.4	31.6	302.9	424.8	363.7	261.1	874.1	79.3	347.6	215.0	396.3	104.5	455.3	293.5	105.2	463.7	1081.6	214.7	452.6	86.8	285.4	364.2	237.2	268.0	43.4	560.1	208.4	279.3	48.7	280.0	486.8	183.4	47.3	103.1	283.4	217.4	435.6	469.8	223.5	233.7	416.9	385.8	418.4	295.9	358.9	423.4	206.5	142.2	90.2	172.3	434.1	205.5	175.9	182.2	176.8
SELENOI	"EPT1, KIAA1724, SELI, SEPI"	ENSG00000138018	"Selenoprotein I"	Q9C0D9	2	26308547-26395891	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 22.0;Endometrial ciliated cells: 16.3;Glandular and luminal cells: 15.3;Pancreatic endocrine cells: 13.6;Syncytiotrophoblasts: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064125	Approved					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"			"HPA064125: "	"unprognostic (6.29e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.05e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.39e-2)"	"unprognostic (7.44e-3)"	"unprognostic (5.00e-3)"	"unprognostic (7.79e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.65e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.87e-3)"	"unprognostic (1.42e-2)"	3.6	6.4	7.9	5.5	8.4	12.1	8.1	11.2	10.6	5.4	5.0	8.6	12.3	4.1	5.4	11.1	3.5	4.0	3.9	10.3	9.3	7.9	23.2	4.4	5.7	6.8	7.3	3.5	9.0	17.2	4.5	4.7	8.6	6.2	8.7	9.3	6.2	4.2	7.0	18.3	18.4	3.7	9.7	4.3	7.1	4.4	7.2	6.3	7.1	6.6	6.1	7.5	7.1	10.0	42.7	25.7	20.9	21.0	12.8	10.2	32.0	20.3	9.2	10.0	10.2	54.5	26.6	49.5	24.2	9.5	21.4	34.1	32.4	17.9	14.4	13.7	15.4	31.3	17.5	32.3	12.2	41.9	9.7	8.1	15.6	22.3	21.9	6.1	9.4	17.6	35.9	16.6	13.5	18.4	25.1	20.7	26.8	21.6	17.4	22.6	49.2	25.0	19.3	32.4	45.7	19.4	17.3	36.2	16.4	17.3	17.4	12.4	15.1	17.1	22.0	22.7	31.7	22.6	60.8	65.8	17.5	25.4	15.6	0.0	0.7	0.0	0.9	1.0	0.9	2.5	0.9	1.2	0.7	1.0	1.2	2.0	0.2	0.9	0.9	1.3	1.8	0.4	7.9	8.4	11.2	10.6	10.3	9.3	6.8	7.3	8.6	9.7	7.2	10.0	9.1	12.8	8.7	0.0	3.0	0.0	0.0	0.0	0.0	0.0	12.2	7.1	0.0	0.0	3.1	22.0	0.0	6.1	11.7	0.0	0.0	10.4	0.0	16.3	12.8	3.7	0.0	0.0	0.0	10.4	6.2	2.9	0.0	15.3	1.3	8.6	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	13.6	0.0	0.0	3.9	0.0	0.0	5.6	2.2	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	16.6	4.7	11.5	0.0	0.0
SEM1	"C7orf76, DSS1, ECD, FLJ42280, SHFD1, Shfdg1, SHFM1, SHSF1"	ENSG00000127922	"SEM1 26S proteasome complex subunit"	"P60896, Q6ZVN7"	7	96481626-96709891	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 636.7;Endometrial ciliated cells: 571.3;Exocrine glandular cells: 537.4;Extravillous trophoblasts: 712.8;Pancreatic endocrine cells: 543.9;Proximal tubular cells: 533.4;Syncytiotrophoblasts: 872.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA020429, HPA072648"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA020429: AB_1859527, HPA072648: AB_2686543"	"unprognostic (5.41e-3)"	"unprognostic (6.25e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.24e-3)"	"unprognostic (6.16e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (2.52e-4)"	"unprognostic (4.55e-1)"	"unprognostic (6.92e-2)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.64e-1)"	"prognostic favorable (8.00e-5)"	137.1	178.9	100.5	118.2	101.2	77.8	124.2	101.7	161.4	135.9	100.3	146.0	121.8	132.5	118.5	193.9	114.9	34.8	193.2	98.4	108.9	130.0	262.8	102.7	87.9	102.6	107.5	167.3	103.7	105.5	122.2	106.7	103.0	118.2	77.8	85.0	131.4	69.0	360.5	144.8	116.1	64.2	98.6	96.9	126.7	183.7	101.2	136.8	106.6	150.2	84.7	113.4	144.8	104.0	570.7	327.0	448.1	468.1	187.4	162.3	241.7	453.4	220.0	186.9	232.5	298.3	459.4	373.6	1096.4	222.8	575.9	288.2	379.5	306.5	263.6	437.4	285.9	448.3	505.7	472.5	171.2	670.0	321.4	208.4	233.7	279.8	283.7	291.4	253.8	438.4	592.4	444.7	193.0	716.9	760.9	942.6	607.0	572.4	297.3	291.6	576.4	441.1	273.2	555.6	367.8	463.6	845.0	701.6	497.9	681.4	200.6	502.2	525.6	365.3	641.2	683.1	575.0	278.3	818.9	1080.9	399.4	574.3	515.8	292.6	385.3	109.0	279.9	443.1	268.4	336.4	363.1	332.7	570.6	312.5	282.4	284.0	27.0	300.4	392.8	622.8	546.6	375.7	100.5	101.2	101.7	161.4	98.4	108.9	102.6	107.5	103.0	98.6	101.2	104.0	288.2	173.1	224.5	0.0	47.2	0.0	0.0	0.0	0.0	0.0	212.6	325.2	0.0	0.0	103.4	244.6	0.0	636.7	93.1	0.0	412.8	382.5	0.0	571.3	314.1	127.6	0.0	0.0	0.0	537.4	712.8	129.5	0.0	450.0	102.2	258.9	0.0	0.0	393.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	123.0	0.0	0.0	241.3	0.0	0.0	0.0	0.0	543.9	0.0	0.0	19.6	0.0	0.0	533.4	149.4	0.0	0.0	0.0	140.3	0.0	0.0	0.0	0.0	872.3	65.9	187.2	0.0	0.0
SENP3	"DKFZP586K0919, DKFZp762A152, SMT3IP1, SSP3, Ulp1"	ENSG00000161956	"SUMO specific peptidase 3"	Q9H4L4	17	7561919-7571969	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"											HPA060290	Supported		Supported	Nucleoplasm,Nucleoli		Yes	No				"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nucleoli"		"HPA060290: AB_2684244"	"unprognostic (5.68e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.82e-1)"	"unprognostic (7.37e-2)"	"unprognostic (3.72e-2)"	"prognostic favorable (6.22e-5)"	"unprognostic (2.71e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.56e-2)"	24.2	24.0	43.7	21.0	42.6	25.4	23.7	38.5	47.9	23.7	38.5	32.4	21.2	26.7	27.4	25.4	25.9	19.3	25.2	42.6	39.8	34.1	20.5	28.6	26.5	40.4	42.2	26.8	26.4	38.1	26.4	22.5	41.1	23.0	25.4	24.7	24.8	26.0	33.5	28.6	25.2	28.9	39.5	28.3	27.0	29.0	44.0	33.8	23.9	30.9	31.2	29.7	21.8	42.0	76.4	90.8	52.7	82.5	58.6	42.8	54.8	54.8	56.0	93.4	87.2	54.9	32.5	90.3	52.6	72.7	62.3	72.0	114.4	85.8	78.0	63.7	105.0	46.7	74.8	56.9	79.1	44.0	57.9	55.1	86.5	107.1	103.5	53.3	76.0	102.1	61.5	24.7	73.0	51.4	107.9	33.6	64.2	70.9	54.5	97.1	48.8	52.4	62.9	44.0	52.5	67.6	55.3	52.7	60.0	66.6	44.1	28.5	40.5	53.0	45.9	51.3	119.0	36.3	40.4	57.3	53.9	45.7	80.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	43.7	42.6	38.5	47.9	42.6	39.8	40.4	42.2	41.1	39.5	44.0	42.0	4.5	3.2	5.4	0.0	4.9	8.5	6.4	1.6	10.2	6.1	6.7	11.0	7.1	7.2	3.6	1.8	22.9	3.0	4.8	2.6	0.0	2.3	1.4	4.0	4.2	4.7	6.6	1.3	0.0	2.4	2.3	3.8	3.6	4.7	1.3	5.2	8.2	2.7	1.5	6.7	0.0	3.0	2.0	6.0	6.4	0.7	4.1	4.9	3.6	0.0	4.7	5.5	4.1	0.0	0.0	2.1	0.8	2.2	6.4	6.1	4.0	1.1	2.1	7.3	0.0	5.2	4.4	3.7	4.0	7.4	11.6	4.1	4.9	3.0	3.7	6.4
SENP8	"DEN1, HsT17512, NEDP1, PRSC2"	ENSG00000166192	"SUMO peptidase family member, NEDD8 specific"	Q96LD8	15	72114258-72143692	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 15.6"	"Group enriched"	"Detected in many"	11	"Early spermatids: 86.5;Late spermatids: 222.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036273	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"		"HPA036273: AB_10669985"	"unprognostic (1.83e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.85e-4)"	"unprognostic (5.43e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.06e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.46e-12)"	"unprognostic (1.24e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.54e-2)"	1.1	1.7	2.7	1.1	2.4	2.8	2.0	1.1	3.1	1.7	0.0	1.9	1.8	1.7	3.3	2.3	2.5	1.9	4.0	2.2	2.1	4.4	2.5	1.5	1.5	1.4	1.7	2.4	1.5	2.4	2.1	1.7	1.9	2.1	1.9	4.6	1.6	1.7	6.3	1.6	1.5	1.6	0.4	1.5	2.0	15.6	1.7	1.5	5.0	5.7	1.2	1.7	1.0	2.6	1.5	2.7	4.7	3.8	5.6	6.9	2.7	4.1	2.5	2.2	2.0	2.1	3.4	1.5	5.7	2.4	4.0	3.4	7.4	5.9	3.3	1.6	4.0	2.5	3.7	1.9	3.9	2.8	1.3	3.3	5.8	1.4	6.2	2.9	2.1	4.4	3.7	2.7	5.4	3.8	2.9	3.7	4.0	3.4	2.5	1.9	4.2	3.3	6.0	2.6	5.8	2.0	4.4	3.3	4.2	5.6	5.1	2.1	2.2	4.5	1.7	7.8	2.0	2.2	2.9	1.8	2.1	4.0	3.3	1.1	0.9	0.7	0.8	2.2	1.1	1.9	1.3	1.2	2.9	0.6	1.5	1.8	0.3	3.5	3.2	0.8	1.1	1.0	2.7	2.4	1.1	3.1	2.2	2.1	1.4	1.7	1.9	0.4	1.7	2.6	1.2	6.4	5.3	3.9	0.4	0.3	1.4	2.5	1.2	4.5	2.4	2.4	5.4	1.5	4.5	1.8	4.2	6.7	0.3	1.5	13.7	3.3	86.5	2.5	2.7	1.8	1.2	3.2	4.6	1.7	3.4	2.6	4.1	2.6	0.0	3.4	1.8	1.5	2.1	1.7	6.1	1.5	2.0	2.6	0.6	222.9	1.8	1.7	0.0	2.8	3.8	10.6	0.0	6.0	4.0	1.4	3.2	1.2	0.2	1.7	2.3	8.1	6.0	4.0	0.0	2.3	1.3	10.7	12.6	1.4	0.4	7.8	1.0	3.0	2.2	1.0
SEPTIN7	"CDC10, CDC3, SEPT7, SEPT7A"	ENSG00000122545	"Septin 7"	Q16181	7	35800932-35907105	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 570.9"	"Group enriched"	"Detected in some"	4	"Adipocytes: 192.1;Cardiomyocytes: 227.0;Cytotrophoblasts: 171.4;dendritic cells: 196.6;Extravillous trophoblasts: 198.2;Fibroblasts: 153.5;Hofbauer cells: 191.0;Smooth muscle cells: 190.0;Syncytiotrophoblasts: 124.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023309, HPA029524"	Enhanced		Approved	"Nucleoli,Plasma membrane,Actin filaments,Midbody,Cytosol"		Yes	No		4300000	"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Actin filaments"	"Nucleoli, Plasma membrane, Midbody, Cytosol"	"HPA023309: AB_10600093, HPA029524: AB_10601573"	"unprognostic (7.91e-3)"	"unprognostic (6.89e-3)"	"unprognostic (9.49e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (2.37e-4)"	"unprognostic (2.00e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.56e-2)"	"unprognostic (7.66e-2)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.43e-3)"	127.1	95.1	352.6	98.8	386.1	131.0	99.5	334.3	570.9	111.5	289.5	116.4	55.7	126.5	121.5	106.6	84.1	117.5	172.1	344.1	341.6	82.9	76.9	98.6	150.9	337.4	355.9	138.2	37.0	81.1	62.6	143.5	339.1	93.9	94.8	119.5	50.3	95.5	82.9	105.0	74.9	145.2	345.1	108.3	59.4	70.3	367.7	159.0	78.2	104.3	149.7	125.0	86.9	411.9	198.1	94.3	232.0	153.2	256.7	263.1	119.3	248.6	228.6	206.7	177.0	147.7	148.9	186.2	164.2	254.9	274.9	146.3	166.3	166.4	294.0	127.8	88.4	149.8	123.4	80.8	149.4	182.7	157.7	171.7	127.1	163.8	159.4	215.6	221.0	143.3	120.1	141.9	341.6	92.8	185.6	304.3	249.7	183.1	132.6	188.3	220.9	107.6	202.6	146.1	124.3	217.4	173.5	220.1	151.8	377.1	163.1	198.7	187.3	207.2	246.7	129.9	278.5	165.9	163.4	470.2	132.4	301.2	449.3	266.8	86.0	150.1	214.8	100.1	220.7	165.6	151.5	199.6	100.8	155.5	134.4	171.2	160.9	298.7	110.5	71.0	147.4	241.7	352.6	386.1	334.3	570.9	344.1	341.6	337.4	355.9	339.1	345.1	367.7	411.9	192.1	0.0	0.0	0.0	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	227.0	0.0	0.0	0.0	0.0	171.4	196.6	0.0	0.0	0.0	0.0	0.0	0.0	40.1	0.0	0.0	0.0	0.0	198.2	153.5	0.0	0.0	0.0	0.0	0.0	0.0	191.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	190.0	0.0	0.0	0.0	0.0	124.2	30.4	0.0	0.0	0.0
SERAC1	FLJ14917	ENSG00000122335	"Serine active site containing 1"	Q96JX3	6	158109519-158168280	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"		"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 95.8;Late spermatids: 111.7;Oligodendrocytes: 47.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025715, HPA025716"	Enhanced					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"			"HPA025715: AB_1856697, HPA025716: AB_2185128"	"unprognostic (1.14e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.46e-1)"	"unprognostic (5.98e-2)"	"unprognostic (6.11e-3)"	"unprognostic (4.21e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.03e-2)"	2.8	7.1	3.7	1.6	3.9	0.6	3.1	3.7	5.3	3.2	4.1	3.7	3.1	3.6	3.5	6.2	2.2	3.7	3.0	4.1	3.7	4.7	2.9	2.7	2.0	3.9	3.9	2.5	7.8	3.4	2.5	2.4	4.6	3.9	3.2	6.3	4.4	3.8	5.7	4.6	3.1	6.0	3.6	2.5	3.8	6.2	3.7	1.9	5.2	4.5	2.5	3.6	3.8	4.3	4.0	5.9	9.4	11.3	6.7	4.8	4.1	5.0	5.2	8.6	11.2	3.1	1.5	1.9	3.6	10.3	6.1	3.5	9.1	3.8	7.2	2.1	5.2	6.2	2.1	5.3	6.9	2.7	2.8	3.0	6.5	6.7	6.8	13.3	5.6	4.4	5.5	1.3	7.5	1.8	2.6	3.1	4.1	6.3	3.0	1.7	6.5	2.5	9.4	3.3	6.4	4.9	5.4	6.3	4.6	7.7	2.9	4.4	6.6	5.8	4.4	13.4	10.8	1.5	2.9	1.7	4.0	3.3	5.8	1.2	2.2	0.6	1.0	2.5	1.1	0.3	0.7	0.9	2.4	0.3	0.7	0.8	1.1	1.1	1.7	0.6	0.8	1.1	3.7	3.9	3.7	5.3	4.1	3.7	3.9	3.9	4.6	3.6	3.7	4.3	4.3	3.2	14.1	9.4	3.2	6.9	4.3	4.7	4.0	9.5	5.6	2.8	5.8	7.2	10.7	1.8	4.2	2.7	6.5	7.2	1.9	11.7	95.8	18.0	3.1	5.3	5.4	3.8	22.4	5.8	1.1	4.6	5.1	11.1	12.0	14.7	4.6	4.6	4.9	5.0	19.1	4.4	10.2	7.6	17.7	111.7	5.0	6.8	10.6	7.5	6.4	5.0	4.1	10.6	47.5	6.3	8.3	6.4	4.0	8.0	7.4	5.5	9.8	10.7	0.0	4.5	4.8	16.8	9.7	5.8	11.5	5.7	6.3	7.3	5.0	8.1
SERBP1	"CGI-55, CHD3IP, DKFZP564M2423, HABP4L, PAI-RBP1, PAIRBP1"	ENSG00000142864	"SERPINE1 mRNA binding protein 1"	Q8NC51	1	67407810-67430415	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020559, CAB026297"	Supported		Enhanced	Cytosol		NA	NA		810000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB026297: AB_425924, HPA020559: AB_1856701"	"unprognostic (1.58e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.45e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.71e-3)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.32e-3)"	"unprognostic (5.97e-2)"	"unprognostic (8.25e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.76e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.34e-3)"	116.2	79.6	45.9	110.1	48.9	130.5	106.9	45.7	48.5	98.3	44.4	91.2	99.6	89.9	65.7	188.2	81.5	66.5	93.4	42.5	46.5	85.9	131.4	76.6	123.8	51.6	47.5	86.8	121.1	131.5	48.0	92.9	52.4	77.3	84.5	47.6	119.0	66.2	336.9	149.6	92.7	82.1	50.3	81.4	94.1	82.9	49.3	125.7	91.1	159.0	118.1	101.4	118.4	52.8	444.4	272.4	274.9	280.4	236.9	214.0	420.9	452.9	163.8	294.7	241.6	524.8	195.4	828.9	341.1	236.0	294.6	337.4	435.2	411.2	309.5	375.7	535.8	764.1	488.7	460.7	207.0	614.9	290.8	221.3	272.1	384.6	356.0	205.9	319.7	276.0	867.4	293.0	236.2	314.9	494.9	412.9	978.1	298.1	355.2	566.3	600.4	429.8	231.0	349.8	468.8	330.8	351.0	385.6	442.4	231.1	212.0	386.4	345.9	283.4	351.5	421.2	618.3	273.6	369.2	747.9	233.0	603.3	326.9	37.8	84.1	53.7	100.4	92.5	125.4	101.3	99.0	100.9	107.5	102.1	114.6	105.6	27.1	147.4	90.1	98.2	131.5	119.2	45.9	48.9	45.7	48.5	42.5	46.5	51.6	47.5	52.4	50.3	49.3	52.8	251.3	250.0	225.5	17.6	262.6	686.4	437.3	363.8	536.7	146.7	262.1	251.8	144.8	214.4	311.4	117.7	91.8	271.5	343.7	200.0	242.6	324.4	555.9	368.1	411.9	314.9	230.1	398.8	24.1	361.5	531.0	231.0	169.7	400.5	219.2	215.6	179.2	331.5	297.9	143.0	24.6	338.7	183.1	247.7	281.2	240.9	221.2	214.2	192.1	27.2	298.4	153.6	325.4	26.7	33.2	349.3	192.0	278.7	277.4	540.5	168.4	323.0	206.3	139.7	138.1	301.6	516.0	569.8	281.6	597.9	719.7	229.3	271.4	318.8	405.0	470.2
SET	"2PP2A, IGAAD, IPP2A2, PHAPII, TAF-I, TAF-IBETA"	ENSG00000119335	"SET nuclear proto-oncogene"	Q01105	9	128683424-128696400	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Chaperone, DNA-binding"	"Cancer-related genes, Disease variant, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005232, HPA063683"	Supported		Enhanced	"Nucleoplasm,Lipid droplets"		NA	NA		880000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Lipid droplets"	"CAB005232: AB_2185634, HPA063683: AB_2685088"	"unprognostic (1.92e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.77e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.37e-3)"	"prognostic unfavorable (9.41e-7)"	"unprognostic (2.00e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.62e-1)"	"unprognostic (3.78e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.54e-2)"	124.9	122.7	125.2	195.6	134.6	261.8	174.2	115.9	137.6	147.7	111.0	160.1	125.5	174.7	88.0	196.3	154.9	149.1	152.7	109.1	115.3	155.5	159.8	129.3	308.5	120.3	126.1	190.6	175.3	143.3	78.6	206.2	126.9	135.8	169.7	142.4	139.4	134.9	182.5	154.1	132.2	164.6	141.1	170.4	139.8	105.3	124.2	286.8	211.2	134.5	300.4	220.8	122.9	147.6	579.4	644.4	908.7	723.6	265.2	412.2	835.7	465.8	511.8	656.9	449.9	892.0	688.8	1483.4	383.1	482.8	513.6	1053.0	1358.8	700.1	745.2	681.2	577.8	855.2	968.5	734.5	591.3	1581.1	535.5	346.7	535.7	561.6	1114.6	526.1	626.1	781.8	1692.1	583.3	545.4	974.2	1333.9	580.0	1521.8	876.7	678.6	1198.7	1128.2	1198.7	506.5	640.5	921.0	576.5	1024.4	679.0	560.5	641.6	847.6	483.9	604.4	770.6	576.9	481.4	784.1	455.0	1417.0	1737.1	367.1	824.8	753.1	165.1	207.3	182.0	224.0	235.4	277.6	287.4	253.0	240.4	215.1	258.0	241.0	286.1	141.4	329.2	199.5	271.6	223.1	335.1	125.2	134.6	115.9	137.6	109.1	115.3	120.3	126.1	126.9	141.1	124.2	147.6	249.9	121.8	145.0	25.1	337.1	673.6	507.5	134.0	352.8	187.6	372.3	250.6	204.2	238.8	134.0	196.8	43.8	316.7	365.9	136.8	389.4	254.6	43.5	318.3	502.1	266.9	256.1	355.6	41.7	218.7	504.0	194.8	126.9	438.5	132.3	308.3	193.1	198.5	239.4	124.5	40.2	261.8	93.6	264.0	436.5	33.6	164.1	249.0	327.3	22.5	274.3	240.6	211.2	38.2	36.6	294.5	132.5	173.4	356.2	647.6	106.7	338.6	87.0	132.5	131.5	323.9	297.0	124.6	259.7	448.0	702.1	314.5	292.3	238.9	342.8	580.9
SETD2	"FLJ23184, HIF-1, HYPB, KIAA1732, KMT3A"	ENSG00000181555	"SET domain containing 2, histone lysine methyltransferase"	Q9BYW2	3	47016429-47164113	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Differentiation, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Methyltransferase, Transferase"	"Autism spectrum disorder, Cancer-related genes, Disease variant, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042451	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	Cytosol	"HPA042451: AB_10806239"	"unprognostic (2.78e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (8.19e-4)"	"unprognostic (6.19e-2)"	"unprognostic (2.45e-1)"	"unprognostic (7.84e-2)"	"prognostic favorable (7.99e-6)"	"unprognostic (1.03e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.79e-2)"	"unprognostic (5.43e-2)"	9.9	6.5	8.2	10.7	10.5	23.8	10.3	24.1	8.3	12.6	10.8	9.7	9.1	13.3	6.1	9.8	11.0	8.5	7.2	6.2	6.7	10.8	10.0	9.4	13.5	8.3	8.5	15.3	13.3	16.2	2.2	11.4	8.4	10.2	11.0	10.6	9.6	9.7	11.1	9.0	10.3	11.9	8.1	11.4	10.7	13.1	7.9	19.2	15.5	14.5	13.3	9.8	4.0	12.8	21.1	13.2	25.4	14.5	15.3	18.9	11.3	17.9	17.0	20.8	19.9	15.4	13.8	43.5	11.6	25.5	20.0	12.4	29.5	17.6	27.6	27.5	12.2	47.3	24.8	12.4	11.7	34.1	26.5	15.2	17.3	20.7	24.6	15.3	20.1	22.8	29.9	16.6	17.8	9.5	26.7	8.5	20.6	9.4	15.4	17.5	25.6	23.2	12.4	26.6	10.9	17.6	29.5	11.8	12.0	17.2	12.9	27.5	26.7	24.6	18.1	21.5	29.9	22.0	25.4	43.7	14.2	19.6	14.6	1.3	1.2	2.9	2.0	1.1	1.1	2.2	1.2	1.6	1.4	2.5	1.7	1.6	3.3	3.6	1.1	1.5	0.6	0.6	8.2	10.5	24.1	8.3	6.2	6.7	8.3	8.5	8.4	8.1	7.9	12.8	50.5	48.1	58.8	115.9	58.3	33.3	22.6	15.6	54.1	40.5	31.0	29.1	67.2	27.1	53.2	11.0	41.7	20.3	58.2	32.6	11.7	20.9	26.1	62.8	63.0	41.2	22.1	38.9	131.4	22.4	12.7	39.2	56.6	66.2	58.8	68.9	23.6	29.8	16.8	26.9	129.4	28.2	14.2	28.8	26.5	35.1	30.4	42.7	17.8	148.9	37.9	22.7	43.3	113.1	143.2	23.7	22.3	33.1	54.0	31.2	24.6	11.5	49.7	39.9	13.1	56.1	42.6	71.0	29.3	60.2	35.7	18.5	65.3	57.1	29.5	34.7
SETD9	"C5orf35, MGC33648"	ENSG00000155542	"SET domain containing 9"	Q8NE22	5	56909260-56925532	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 18.8"	"Group enriched"	"Detected in many"	7	"Early spermatids: 691.8;Late spermatids: 372.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 5.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 5.2;monocytes: 3.2"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA049936			Approved	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA049936: "	"unprognostic (1.13e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.29e-1)"	"unprognostic (7.37e-2)"	"unprognostic (8.75e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.06e-1)"	5.1	2.8	0.9	1.0	1.1	2.6	5.1	1.1	1.4	1.6	0.9	5.9	5.2	3.0	3.9	3.0	2.3	2.6	5.9	0.8	1.1	6.2	9.9	2.1	2.7	1.3	1.0	3.1	4.4	3.5	0.6	2.4	1.2	2.3	4.6	1.1	6.3	1.2	3.7	1.4	6.7	2.8	1.1	1.8	3.1	18.8	1.0	1.2	4.9	7.2	2.9	2.9	0.9	1.5	6.8	1.6	5.9	3.3	5.1	3.7	3.9	4.8	3.1	5.2	7.2	4.9	5.1	4.5	10.3	5.1	8.1	6.4	3.9	2.6	7.3	4.1	6.9	0.7	1.7	6.6	5.1	3.6	4.7	3.6	3.8	8.7	7.3	4.8	7.8	2.3	5.1	3.1	8.0	11.0	0.5	3.5	7.0	0.0	8.1	5.9	2.2	8.0	5.8	3.0	4.5	6.7	1.1	3.4	10.3	3.7	8.3	4.1	6.1	2.9	9.2	5.0	6.0	4.0	12.8	9.1	3.5	2.5	0.7	5.2	1.0	1.9	0.4	0.9	0.7	0.2	0.8	0.2	0.6	0.3	0.3	0.6	1.8	0.6	3.2	0.2	0.9	0.4	0.9	1.1	1.1	1.4	0.8	1.1	1.3	1.0	1.2	1.1	1.0	1.5	10.7	3.2	2.7	1.0	7.8	17.5	15.6	17.9	1.8	2.8	32.2	30.5	14.7	12.8	9.0	7.3	0.0	15.5	7.6	24.5	56.7	14.6	691.8	10.4	7.7	9.6	18.5	5.2	0.7	17.4	21.4	12.2	9.2	7.6	14.7	7.1	8.2	27.4	14.8	0.0	1.4	10.4	14.2	13.5	35.4	372.2	10.2	11.9	28.4	2.8	13.6	6.9	8.2	2.0	8.6	9.8	20.7	5.7	9.0	28.4	24.7	52.7	9.9	3.1	0.0	14.5	12.7	67.0	13.5	4.8	15.3	14.4	6.8	10.3	14.3	19.2
SETX	"ALS4, AOA2, KIAA0625, SCAR1, Sen1"	ENSG00000107290	Senataxin	Q7Z333	9	132261356-132354986	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Differentiation, DNA damage, DNA recombination, DNA repair, Neurogenesis, Spermatogenesis"	"Helicase, Hydrolase"	"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024105, HPA057269"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Cytokinetic bridge"	"HPA024105: AB_2671437, HPA057269: AB_2683389"	"unprognostic (2.16e-1)"	"unprognostic (5.77e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.14e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.32e-1)"	"unprognostic (6.76e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.64e-3)"	"unprognostic (6.42e-2)"	13.7	9.5	6.2	19.9	8.8	16.8	13.9	9.8	6.3	13.2	7.7	13.1	10.6	12.7	11.1	10.6	10.9	12.7	10.5	5.1	7.8	11.9	16.7	15.4	27.4	8.7	7.0	13.0	9.2	18.3	6.0	14.3	9.6	13.0	12.8	13.2	9.0	12.7	12.9	12.3	13.2	12.8	8.0	27.6	12.9	31.9	7.7	25.4	33.0	12.8	26.3	15.7	8.5	13.2	15.1	19.9	22.5	24.4	28.3	34.1	13.5	19.6	21.9	15.6	14.6	21.1	16.8	25.6	9.4	36.9	38.3	30.2	22.8	17.0	17.0	24.6	9.9	26.9	22.7	18.4	26.5	41.8	31.2	24.0	26.2	26.6	23.6	19.1	25.4	17.8	31.7	20.0	18.3	21.8	25.9	15.8	24.2	25.4	15.4	24.2	32.6	17.2	17.1	19.5	14.0	21.4	32.4	14.2	18.2	29.7	19.7	21.2	29.3	32.5	14.0	22.1	19.0	12.2	22.0	38.6	14.9	16.3	17.8	10.5	4.4	4.7	5.3	4.1	5.6	5.5	3.9	4.1	3.3	6.9	4.2	3.7	15.1	5.2	4.9	5.0	3.2	2.3	6.2	8.8	9.8	6.3	5.1	7.8	8.7	7.0	9.6	8.0	7.7	13.2	76.2	60.9	45.7	75.1	85.6	30.2	34.6	26.6	38.7	31.2	24.1	22.7	61.3	17.2	43.9	20.2	29.2	13.7	96.8	37.6	3.9	20.0	7.6	62.7	68.0	58.7	14.5	25.5	73.7	14.7	10.6	52.9	44.4	89.7	58.2	38.3	51.4	33.0	28.8	67.3	64.8	30.6	16.2	73.1	37.6	13.8	30.7	75.5	12.4	131.2	75.8	20.7	87.6	65.9	113.0	23.2	31.9	36.1	61.8	49.3	25.6	18.5	54.4	28.7	13.1	44.9	42.5	145.2	38.5	35.1	33.5	9.4	65.9	53.7	26.9	46.4
SF3A1	"Prp21, PRPF21, SAP114, SF3a120"	ENSG00000099995	"Splicing factor 3a subunit 1"	Q15459	22	30331988-30356919	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000690, HPA030083"	Enhanced		Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA		87000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Nuclear speckles"		"HPA000690: AB_1079933, HPA030083: AB_10602183"	"unprognostic (8.61e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.54e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.79e-1)"	"unprognostic (5.54e-3)"	"unprognostic (3.30e-1)"	"unprognostic (3.83e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.26e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.00e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.13e-1)"	36.2	29.7	14.1	45.4	19.0	58.0	35.0	19.2	20.5	33.4	12.6	31.2	29.8	36.3	20.5	34.0	31.8	21.3	28.0	15.3	12.7	25.5	27.5	31.0	44.1	16.6	14.8	46.4	32.9	42.8	24.3	29.0	14.1	29.4	27.0	36.4	33.3	28.1	51.1	40.5	32.8	29.9	13.3	42.0	31.8	49.2	15.9	42.6	31.6	25.8	41.4	33.2	32.8	20.7	86.2	58.9	79.4	77.6	46.4	41.3	94.8	66.5	42.7	71.4	52.8	78.8	55.9	106.4	44.6	47.7	55.9	80.4	101.6	70.8	77.7	97.4	88.4	99.3	69.1	65.3	41.8	202.1	106.3	41.7	49.6	89.5	72.4	40.1	52.1	56.6	112.5	108.0	52.8	49.1	99.4	46.2	132.0	65.7	48.4	139.5	99.4	86.8	40.9	93.6	82.2	74.9	84.4	50.8	78.4	52.5	62.3	65.4	72.9	90.2	80.0	65.1	124.4	83.2	108.2	106.9	69.4	73.8	95.0	6.7	8.9	14.1	10.9	9.8	11.2	10.4	11.0	11.8	9.2	11.0	12.0	11.2	14.1	11.0	13.0	5.6	14.5	8.0	14.1	19.0	19.2	20.5	15.3	12.7	16.6	14.8	14.1	13.3	15.9	20.7	32.4	57.7	66.5	12.1	60.8	26.1	25.4	19.0	37.0	17.6	25.7	24.4	27.6	34.3	30.5	31.3	16.7	32.5	49.2	30.8	17.6	25.7	106.1	30.5	23.1	32.6	25.1	36.1	7.5	29.4	39.7	29.1	35.2	29.1	52.6	76.3	28.2	28.4	40.6	26.9	9.4	30.7	16.2	37.2	28.3	116.8	35.1	39.8	17.8	5.6	58.5	27.1	46.4	6.0	7.1	28.8	31.3	37.6	45.5	26.4	31.8	17.0	39.4	20.3	46.0	29.0	27.3	64.3	41.6	37.8	27.3	34.6	55.8	26.7	33.9	25.8
SF3A3	"PRP9, PRPF9, SAP61, SF3a60"	ENSG00000183431	"Splicing factor 3a subunit 3"	Q12874	1	37956975-37990075	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032054, HPA032055"	Supported		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA		57000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"	Nucleoplasm	"HPA032054: AB_10602184, HPA032055: AB_2674130"	"unprognostic (1.56e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.08e-3)"	"unprognostic (6.19e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.68e-2)"	"prognostic unfavorable (2.11e-8)"	"unprognostic (1.34e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.74e-3)"	"unprognostic (9.18e-2)"	"unprognostic (4.79e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.39e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.68e-2)"	24.6	23.4	22.3	29.2	22.6	57.9	31.7	24.1	29.0	25.6	23.2	25.1	20.4	30.5	33.7	23.3	27.5	19.1	18.6	22.0	22.8	26.0	27.4	22.9	39.0	22.6	22.6	32.1	20.3	30.6	16.2	25.4	22.9	24.9	30.0	29.9	23.5	28.8	49.6	29.2	21.4	31.7	22.3	27.4	20.0	27.5	23.4	43.4	26.9	27.4	44.6	28.1	18.8	24.0	84.4	57.0	108.1	90.8	63.3	57.7	129.6	82.2	69.1	131.9	106.4	97.2	84.4	165.8	68.1	73.6	51.6	71.5	136.7	108.6	162.3	74.9	125.7	206.3	92.3	86.7	57.9	261.1	93.5	54.9	75.4	135.5	88.4	58.6	89.9	112.6	176.1	60.0	95.2	53.2	131.4	123.0	268.0	80.4	89.9	156.8	197.0	110.7	59.4	83.5	95.8	69.4	104.2	47.1	83.9	95.1	54.0	90.3	82.0	70.3	79.6	64.9	157.2	57.6	89.5	166.4	65.6	215.6	92.1	37.2	41.3	28.4	56.1	53.3	55.0	54.9	65.3	56.7	53.1	68.9	69.4	58.9	4.6	56.2	61.8	32.5	75.5	61.7	22.3	22.6	24.1	29.0	22.0	22.8	22.6	22.6	22.9	22.3	23.4	24.0	37.3	51.3	35.0	11.4	42.2	47.3	38.6	46.6	55.2	37.0	21.3	27.7	22.7	20.0	42.3	22.0	22.9	59.1	40.7	12.1	39.2	44.4	37.9	23.7	42.4	35.8	15.6	53.6	15.7	38.1	69.2	41.6	15.3	25.3	42.4	43.0	25.0	23.6	51.5	26.9	14.9	23.9	34.6	28.0	39.8	14.0	39.7	34.2	39.2	6.5	82.9	45.6	44.3	11.1	11.5	35.4	13.1	54.2	41.5	28.5	19.0	29.2	27.8	38.6	39.5	47.2	68.3	120.8	55.2	36.5	41.8	33.0	42.9	53.5	31.4	24.0
SF3B1	"Hsh155, Prp10, PRPF10, SAP155, SF3b155"	ENSG00000115524	"Splicing factor 3b subunit 1"	O75533	2	197388515-197435079	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050275	Approved		Enhanced	"Nuclear speckles"		NA	NA		94000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"HPA050275: AB_2681071"	"unprognostic (6.86e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.51e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.44e-3)"	"unprognostic (3.31e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.41e-2)"	183.8	173.9	101.7	132.7	112.4	304.8	180.7	120.5	126.1	222.8	136.8	170.9	110.4	195.8	200.0	136.8	183.8	123.2	135.7	98.2	100.8	135.4	168.5	162.8	203.0	105.7	101.9	226.5	200.7	154.9	147.8	165.3	111.0	163.2	147.3	138.4	180.4	133.2	172.4	156.5	231.6	116.5	107.5	287.8	169.2	91.4	104.9	221.9	167.8	144.8	199.3	154.4	167.1	135.8	134.9	105.4	288.6	155.9	222.8	219.2	237.8	172.6	196.7	163.2	205.9	233.0	147.2	247.5	116.6	193.1	165.8	133.7	273.4	151.2	271.8	196.5	154.8	237.5	257.4	294.3	155.4	270.1	198.6	232.1	163.0	175.9	209.3	278.6	205.9	171.0	210.2	174.0	192.3	134.2	251.1	285.6	231.4	167.5	163.8	234.4	197.9	182.9	245.8	286.4	154.2	186.7	174.7	118.2	139.2	345.1	115.2	242.5	186.8	126.9	109.4	123.3	145.8	168.7	238.8	342.0	123.7	174.8	146.5	49.8	50.4	57.5	54.5	51.7	55.4	46.1	46.2	50.9	60.5	44.1	48.7	49.2	60.8	56.7	52.5	37.5	71.3	56.2	101.7	112.4	120.5	126.1	98.2	100.8	105.7	101.9	111.0	107.5	104.9	135.8	175.6	179.5	222.9	92.4	187.4	119.0	172.0	127.1	125.7	103.4	96.4	83.3	129.2	72.9	194.0	92.0	73.0	116.8	224.1	90.1	56.7	104.8	9.2	123.9	191.0	143.1	110.5	109.0	55.5	94.8	102.3	151.6	132.0	179.0	246.9	171.1	107.1	74.4	100.6	94.2	59.7	108.1	89.5	124.7	144.1	20.6	120.2	166.1	76.5	75.9	163.9	111.1	116.4	87.0	121.1	112.0	68.3	104.6	195.6	103.8	84.2	70.5	221.5	98.5	118.3	159.5	227.9	104.6	100.5	94.3	118.8	142.7	216.2	119.4	91.4	156.1
SF3B3	"KIAA0017, RSE1, SAP130, SF3b130"	ENSG00000189091	"Splicing factor 3b subunit 3"	Q15393	16	70523791-70577670	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041134, HPA042986"	Supported		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No		50000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA041134: AB_2677317, HPA042986: AB_10960386"	"unprognostic (3.39e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.67e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.76e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.73e-1)"	15.7	11.2	7.9	19.2	8.2	22.2	13.8	15.9	9.6	16.3	11.4	17.1	13.6	17.0	10.2	19.9	16.4	11.6	12.1	8.8	9.7	12.5	12.3	11.7	24.3	7.0	6.9	22.3	13.8	16.8	7.9	14.1	7.5	11.6	13.2	16.3	12.6	10.7	23.6	19.9	12.9	16.0	6.5	13.9	13.2	10.2	10.4	23.7	14.5	11.7	26.6	14.2	14.4	12.0	72.4	72.6	93.4	65.3	45.5	41.6	74.0	66.3	55.5	84.5	67.3	75.6	55.8	97.1	52.6	51.8	49.9	81.4	98.0	55.7	133.0	31.5	71.1	75.1	56.7	81.0	30.6	106.1	83.9	39.8	40.1	93.9	68.8	54.1	50.9	55.3	104.6	34.2	67.4	87.5	92.9	51.6	85.2	44.8	41.9	163.2	73.3	109.7	26.9	96.4	81.4	59.8	217.7	33.8	33.8	39.2	73.9	53.0	52.7	61.9	67.8	49.2	71.6	37.4	90.4	260.7	40.9	66.9	61.3	23.4	26.1	28.1	35.8	30.8	39.3	28.4	33.1	37.5	35.3	34.3	38.8	33.7	8.3	35.5	31.2	19.1	40.2	37.4	7.9	8.2	15.9	9.6	8.8	9.7	7.0	6.9	7.5	6.5	10.4	12.0	18.9	25.6	25.7	16.6	33.0	22.4	23.2	23.4	13.1	35.5	20.5	18.3	29.3	14.3	25.4	23.9	14.6	33.6	21.6	19.7	7.9	20.7	6.3	17.8	31.9	25.4	21.1	36.8	23.2	23.2	34.7	24.2	20.4	17.5	17.7	52.3	17.5	23.6	23.6	40.4	26.5	21.8	24.4	20.6	12.8	10.3	33.8	19.2	17.8	24.4	22.7	19.4	25.7	26.2	26.7	24.9	14.0	33.1	25.1	30.2	18.1	15.7	18.8	26.7	6.6	30.2	18.8	28.7	33.3	37.6	26.1	25.4	28.3	48.2	31.6	24.7
SF3B5	"MGC3133, SF3b10, Ysf3"	ENSG00000169976	"Splicing factor 3b subunit 5"	Q9BWJ5	6	144094884-144095573	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA054408	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA054408: AB_2682479"	"unprognostic (1.22e-1)"	"unprognostic (7.12e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.47e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.49e-1)"	105.8	180.4	121.2	79.5	125.6	251.9	110.1	130.7	140.7	99.1	128.0	121.8	93.1	101.8	100.8	152.3	127.8	86.0	149.3	126.2	124.8	159.8	191.1	94.3	129.7	128.0	122.9	107.2	146.9	132.5	149.6	75.6	126.8	104.3	111.0	32.3	112.4	83.8	158.5	133.0	104.6	91.7	125.9	119.3	113.6	93.7	126.2	147.1	114.2	161.2	125.5	116.8	97.7	129.2	124.1	164.2	184.6	343.4	211.9	239.3	109.8	125.5	209.6	252.3	286.8	175.0	110.2	204.7	219.7	205.3	244.5	143.6	214.0	288.5	177.2	213.0	302.5	223.8	136.0	391.3	203.4	441.2	138.0	246.0	382.5	277.7	275.3	162.8	310.0	278.0	292.3	290.1	229.7	436.5	287.1	396.2	119.3	192.9	196.8	176.5	241.7	208.0	276.0	109.8	252.6	159.6	175.1	211.5	242.2	93.0	154.1	266.9	169.0	129.0	175.5	233.6	276.7	216.3	284.6	197.3	208.8	366.8	162.5	181.9	377.9	191.8	171.5	277.7	213.0	211.2	192.2	203.6	326.2	197.2	190.3	189.1	101.0	199.0	256.3	364.0	241.3	364.1	121.2	125.6	130.7	140.7	126.2	124.8	128.0	122.9	126.8	125.9	126.2	129.2	97.8	89.8	137.8	5.2	151.9	271.1	168.4	282.5	97.3	45.5	178.4	238.9	87.2	170.1	171.2	123.2	12.5	224.5	180.9	244.9	457.8	253.7	240.9	149.3	159.3	136.6	267.7	157.8	3.8	315.5	221.8	151.6	100.4	138.5	178.7	156.6	163.9	265.6	328.1	43.7	4.9	423.3	201.4	224.0	239.5	109.8	134.8	165.3	252.5	7.5	258.0	132.2	176.1	6.6	13.2	259.8	259.6	108.7	214.7	233.7	304.2	625.7	153.3	58.4	105.2	119.8	135.6	169.6	59.1	164.7	324.2	206.5	168.9	203.9	342.4	222.7
SFPQ	"PPP1R140, PSF"	ENSG00000116560	"Splicing factor proline and glutamine rich"	P23246	1	35176378-35193145	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009886, HPA047513, HPA054689"	Enhanced		Enhanced	Nucleoplasm		NA	NA		640000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB009886: AB_2186937, HPA047513: AB_2680073, HPA054689: AB_2682574"	"prognostic favorable (9.56e-5)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.99e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (7.91e-13)"	"unprognostic (3.10e-1)"	"unprognostic (4.00e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.07e-1)"	"unprognostic (3.77e-3)"	62.9	46.7	25.1	62.1	26.0	215.1	53.2	38.5	32.3	54.0	23.4	46.9	44.6	60.2	51.0	59.8	54.6	39.9	43.8	24.8	30.7	48.8	50.6	40.8	76.4	30.2	27.2	74.4	52.8	44.9	34.4	51.8	25.2	49.8	54.4	47.4	52.8	35.6	63.9	60.0	47.6	52.9	23.0	54.1	48.0	45.8	24.9	85.5	44.8	27.4	94.5	58.1	52.5	44.6	180.5	147.3	251.1	142.9	60.5	90.0	234.7	96.1	97.1	160.4	116.3	161.5	126.4	325.6	130.1	111.8	100.6	160.4	276.1	188.3	217.0	175.2	183.0	245.5	156.2	193.6	81.5	258.2	140.1	72.4	71.7	139.4	67.3	70.9	142.3	169.1	282.6	150.9	158.3	156.8	304.2	220.1	299.7	107.8	140.7	304.5	170.4	213.6	156.2	214.4	180.1	200.3	138.6	106.3	147.1	174.4	125.0	181.7	152.3	127.7	188.3	84.7	208.9	171.2	156.5	327.6	91.1	168.6	185.9	2.6	4.1	3.0	4.7	5.8	5.4	4.1	4.6	3.8	3.8	4.5	4.3	4.8	2.1	3.4	4.7	7.3	5.6	2.3	25.1	26.0	38.5	32.3	24.8	30.7	30.2	27.2	25.2	23.0	24.9	44.6	286.7	169.9	237.7	149.8	317.4	357.5	239.3	80.6	234.5	230.0	231.6	191.0	149.6	82.9	146.2	110.3	191.8	206.5	339.0	149.7	82.2	120.1	126.8	230.1	318.9	222.2	219.6	198.9	127.3	138.4	222.9	255.8	267.6	333.1	155.8	450.5	123.5	109.1	141.4	171.6	143.4	189.5	59.0	129.4	216.9	361.9	142.9	258.5	140.5	104.9	146.2	152.6	127.7	248.8	183.1	162.0	126.7	116.6	291.8	159.9	94.8	87.6	114.8	223.6	52.6	530.6	259.2	199.1	171.9	287.9	327.3	305.5	313.7	223.7	220.0	167.7
SFXN4	SLC56A4	ENSG00000183605	"Sideroflexin 4"	Q6P4A7	10	119140767-119165714	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018028, HPA020872"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria"	Vesicles	"HPA018028: AB_1856792, HPA020872: AB_1856793"	"unprognostic (8.13e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.84e-2)"	"unprognostic (4.56e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.70e-3)"	"unprognostic (4.22e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.21e-3)"	"unprognostic (3.07e-3)"	13.3	35.9	9.9	10.1	12.5	16.4	14.1	12.8	13.6	14.2	17.0	21.9	20.4	11.1	13.5	19.1	14.3	8.6	33.1	10.2	12.4	24.5	36.4	8.5	14.4	11.3	12.5	16.0	33.7	23.1	21.5	8.8	11.6	18.8	22.7	5.7	27.8	13.2	51.4	11.5	17.3	12.2	10.6	20.9	17.3	11.9	11.3	11.0	24.7	59.3	17.8	16.4	13.8	12.5	26.2	27.6	8.7	41.8	10.4	19.7	33.0	16.3	19.8	21.0	21.8	45.9	43.2	62.6	15.6	14.9	22.4	48.2	57.5	36.3	24.3	33.1	65.7	28.7	18.4	47.3	37.1	49.7	28.8	21.1	34.4	22.0	63.8	19.5	25.0	46.5	45.2	17.5	13.6	29.6	53.8	60.4	11.8	50.2	32.5	51.7	27.1	49.0	24.3	17.3	25.2	13.9	10.8	42.2	61.9	11.1	26.0	28.4	11.5	10.6	21.9	19.8	37.6	42.6	53.0	56.3	16.2	72.6	7.2	2.5	18.1	1.9	6.5	19.5	10.8	12.5	7.9	7.1	21.2	7.0	12.1	9.8	2.2	7.3	15.9	10.6	6.0	11.1	9.9	12.5	12.8	13.6	10.2	12.4	11.3	12.5	11.6	10.6	11.3	12.5	8.0	6.4	5.6	29.0	16.9	12.0	25.8	39.9	23.3	7.9	17.8	18.2	36.2	12.8	19.1	14.7	2.1	37.6	6.2	13.2	58.7	28.4	27.4	7.6	8.9	8.4	18.0	33.6	22.3	23.8	25.8	12.4	14.3	7.9	5.7	28.5	7.1	31.5	29.2	6.7	29.1	24.7	30.5	17.6	5.0	69.3	8.7	13.1	12.4	8.4	11.3	7.7	10.3	22.1	19.5	17.6	12.1	13.5	31.9	28.0	29.8	65.6	13.5	11.3	6.6	22.3	10.6	27.7	15.2	26.9	9.1	21.9	9.2	44.5	45.8	20.5
SGO1	"NY-BR-85, SGOL1"	ENSG00000129810	"Shugoshin 1"	Q5FBB7	3	20160593-20186206	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.7;lymphoid tissue: 13.0;testis: 6.7"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 16.5;Extravillous trophoblasts: 42.6;Granulosa cells: 20.3;Hofbauer cells: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"basophil: 10.0;memory B-cell: 8.8;naive B-cell: 8.9;plasmacytoid DC: 4.1;T-reg: 2.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035501, HPA069302, HPA069857"	Enhanced		Enhanced	Nucleoplasm,Kinetochore,Cytosol		Yes	Yes			"Cluster 37: B-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Kinetochore, Cytosol"	"HPA035501: AB_2732469, HPA069302: , HPA069857: AB_2686214"	"unprognostic (6.87e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.93e-3)"	"unprognostic (2.51e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.55e-6)"	"unprognostic (9.49e-3)"	"unprognostic (2.45e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.65e-4)"	"unprognostic (1.52e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.29e-2)"	"unprognostic (4.95e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.64e-1)"	0.3	0.1	0.3	3.3	0.7	8.7	0.5	0.9	0.5	0.4	0.0	2.1	2.3	0.4	0.0	1.9	0.1	0.4	0.1	0.3	0.4	0.3	0.6	0.3	6.2	0.8	0.6	0.2	0.1	0.2	0.0	1.7	0.6	0.2	2.8	0.1	0.4	0.1	0.1	1.1	2.5	1.0	0.3	1.4	1.5	6.7	0.6	13.0	0.2	0.0	6.6	0.9	0.7	1.2	20.3	23.9	29.9	18.5	1.4	2.6	20.2	21.3	10.1	31.2	33.6	16.5	24.0	30.7	10.6	8.6	21.2	11.4	28.7	11.3	37.6	40.9	19.6	34.6	15.6	12.8	0.2	32.0	28.8	0.3	0.9	33.3	13.1	4.0	18.5	34.9	31.3	52.2	24.6	19.4	52.4	15.4	30.0	20.3	17.0	31.8	38.4	17.7	7.5	14.9	14.2	15.4	23.6	27.2	13.1	22.7	18.2	21.3	4.7	22.5	27.3	20.5	43.3	22.8	57.4	35.2	12.5	31.1	35.0	10.0	0.1	1.4	0.2	0.2	0.1	8.8	0.6	0.7	0.3	8.9	0.2	0.3	1.4	0.3	0.2	4.1	2.6	0.6	0.3	0.7	0.9	0.5	0.3	0.4	0.8	0.6	0.6	0.3	0.6	1.2	0.1	0.0	0.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.0	3.4	0.0	0.0	0.0	1.8	0.0	16.5	1.5	0.0	0.0	1.1	0.0	2.3	1.6	1.2	0.0	0.0	0.0	1.8	42.6	3.3	0.0	2.9	1.3	20.3	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	4.9	1.0	4.3	0.0	0.0
SGO2	"FLJ25211, SGOL2, TRIPIN"	ENSG00000163535	"Shugoshin 2"	Q562F6	2	200510008-200584096	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.9;testis: 32.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 11.6;Endometrial ciliated cells: 12.1;Extravillous trophoblasts: 31.0;granulocytes: 11.4;Granulosa cells: 23.4;Hofbauer cells: 13.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"basophil: 16.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 16.7"	"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA035163, HPA040817"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"HPA035163: AB_10602397, HPA040817: AB_2677149"	"unprognostic (3.43e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.06e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.55e-6)"	"unprognostic (1.12e-2)"	"unprognostic (1.98e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.37e-4)"	"unprognostic (9.49e-2)"	"unprognostic (8.07e-9)"	"unprognostic (5.21e-2)"	"unprognostic (5.43e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.02e-1)"	3.3	0.9	0.6	4.4	0.9	6.8	1.9	0.8	0.9	0.9	0.3	3.1	2.5	1.8	0.7	2.4	1.4	1.2	1.0	0.5	0.9	0.9	0.8	1.5	7.9	0.9	0.9	1.9	0.5	1.1	0.3	2.6	0.9	1.4	3.2	0.9	0.7	0.7	0.4	2.3	2.6	2.0	0.7	2.0	1.8	32.6	0.9	14.9	1.2	0.6	8.1	1.5	0.9	1.2	34.6	16.2	37.0	17.4	5.2	7.9	23.7	38.7	16.6	32.0	33.1	24.3	23.5	22.5	18.6	18.1	34.4	25.3	33.6	20.1	54.5	48.0	16.9	43.5	21.6	17.5	1.6	43.9	33.1	3.4	2.5	32.9	17.3	8.0	29.4	31.3	33.1	31.6	61.4	15.4	35.9	17.9	26.7	24.9	41.2	28.8	49.1	21.3	13.3	13.6	22.2	15.4	28.6	13.3	16.3	29.2	14.1	25.2	18.1	33.9	34.0	31.6	34.0	14.3	33.5	49.8	21.4	28.9	49.4	16.7	1.4	4.5	2.2	1.4	1.4	2.7	2.4	2.2	0.8	3.2	1.8	2.2	1.0	2.0	1.7	1.7	3.6	1.2	0.6	0.9	0.8	0.9	0.5	0.9	0.9	0.9	0.9	0.7	0.9	1.2	9.4	3.2	3.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	5.8	7.1	0.0	0.0	6.2	0.0	0.0	11.6	7.8	0.0	3.9	3.9	0.0	12.1	5.3	3.3	0.0	0.0	0.0	2.7	31.0	6.7	0.0	3.6	11.4	23.4	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	3.2	0.0	0.0	1.7	0.0	0.0	2.5	8.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	3.4	3.8	4.0	0.0	0.0
SHCBP1	"FLJ22009, PAL"	ENSG00000171241	"SHC binding and spindle associated 1"	Q8NEM2	16	46578591-46621379	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.4;lymphoid tissue: 10.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 36.2;Extravillous trophoblasts: 28.7;Plasma cells: 38.3;Spermatocytes: 33.7;Spermatogonia: 23.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA048876	Uncertain		Approved	"Nuclear bodies,Microtubules,Midbody,Mitotic spindle"		Yes	Yes			"Cluster 19: B-cells - Humoral immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear bodies"	"Microtubules, Midbody, Mitotic spindle"	"HPA048876: AB_2680542"	"unprognostic (2.44e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.96e-4)"	"unprognostic (2.26e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (4.47e-5)"	"unprognostic (4.81e-2)"	"unprognostic (2.22e-16)"	"unprognostic (3.59e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.66e-1)"	0.7	0.5	0.5	5.1	0.5	17.4	0.9	1.2	0.6	0.6	0.4	1.9	1.2	0.6	0.6	3.5	0.2	0.6	1.0	0.4	0.2	5.4	0.2	1.0	9.8	0.4	0.3	0.3	0.2	0.2	0.2	2.4	0.4	0.3	2.2	0.2	0.8	0.2	1.5	3.3	1.5	1.7	0.1	4.4	0.9	5.2	0.5	8.8	0.3	0.2	10.6	1.2	1.2	0.7	33.8	30.8	11.9	15.3	3.1	6.2	16.2	60.7	24.6	59.2	26.8	14.6	20.8	28.0	30.2	28.8	26.8	21.0	29.3	21.7	73.8	17.7	17.2	28.2	25.8	30.3	0.1	28.5	35.4	1.2	1.6	45.9	18.1	5.9	33.0	14.9	12.7	28.3	69.7	21.5	24.0	23.7	10.0	17.2	31.6	45.4	89.9	44.8	13.7	9.4	5.0	7.2	46.0	23.7	11.1	11.4	13.0	23.4	16.1	43.9	28.7	43.5	54.0	24.9	36.7	46.7	21.4	31.3	45.8	0.2	0.3	0.6	0.2	0.5	0.0	1.7	0.3	0.1	0.3	1.2	0.0	0.1	0.4	0.1	2.4	0.7	1.2	1.1	0.5	0.5	1.2	0.6	0.4	0.2	0.4	0.3	0.4	0.1	0.5	0.7	0.2	0.0	1.1	1.3	7.1	1.7	0.7	1.2	0.0	0.3	0.6	1.1	1.9	1.5	1.4	0.0	0.0	11.3	0.8	1.9	0.0	0.2	8.4	0.7	1.7	1.7	0.0	36.2	2.1	0.0	28.7	3.7	4.1	1.5	0.0	7.6	1.8	0.3	12.6	0.0	0.7	2.2	2.0	4.5	3.3	2.3	0.6	4.0	1.8	2.8	2.8	0.8	0.0	1.0	0.5	0.1	0.1	0.4	38.3	0.5	0.4	0.1	0.1	0.3	0.0	0.5	6.3	33.7	23.7	3.6	0.6	3.7	2.2	0.8	3.4	1.1
SHLD2	"bA163M19.1, FAM35A, FAM35A1, MGC5560, RINN2"	ENSG00000122376	"Shieldin complex subunit 2"	Q86V20	10	87094161-87191465	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 31.3;Endometrial stromal cells: 28.6;Glandular and luminal cells: 29.0;Proximal tubular cells: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036582	Uncertain		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Actin filaments"	"HPA036582: AB_10670233"	"unprognostic (1.08e-1)"	"unprognostic (2.72e-1)"	"prognostic favorable (6.06e-4)"	"unprognostic (1.77e-1)"	"prognostic favorable (3.09e-4)"	"unprognostic (5.34e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.53e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.44e-3)"	"unprognostic (3.61e-2)"	15.6	20.1	10.8	12.6	8.4	9.6	17.3	7.3	10.0	11.9	10.2	15.7	22.3	11.4	7.0	12.8	11.2	10.7	10.3	8.6	10.5	32.1	37.2	11.6	13.1	27.5	10.9	12.7	12.4	6.1	10.9	9.7	8.8	14.9	16.5	15.6	14.3	9.5	10.6	12.0	24.8	12.2	9.3	11.9	12.0	8.0	10.1	10.4	23.3	11.7	14.4	13.3	11.2	8.7	33.6	26.7	14.9	34.4	16.4	15.8	21.7	22.1	31.0	29.0	31.8	30.8	25.2	24.4	12.1	30.2	17.0	21.9	37.2	16.9	29.8	35.1	24.6	33.9	24.3	29.1	25.4	53.4	28.5	14.5	30.4	26.6	45.4	25.6	19.6	26.3	43.7	42.7	27.2	19.2	43.7	37.8	17.2	24.2	18.4	26.8	29.6	27.0	26.6	27.7	7.4	30.6	17.1	19.9	29.8	13.7	44.0	29.6	19.4	16.5	15.0	24.8	44.7	23.9	55.8	58.5	27.8	65.4	9.1	7.1	7.3	2.8	6.7	11.8	13.7	9.2	10.0	10.0	11.3	8.8	10.0	10.1	0.1	12.5	9.5	3.9	10.4	8.7	10.8	8.4	7.3	10.0	8.6	10.5	27.5	10.9	8.8	9.3	10.1	8.7	21.2	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	20.9	13.2	0.0	0.0	0.0	5.5	0.0	7.2	17.4	0.0	31.3	12.6	0.0	16.7	28.6	4.2	0.0	0.0	0.0	13.7	15.1	7.9	0.0	29.0	0.0	20.2	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	8.8	0.0	0.0	0.0	0.0	14.7	0.0	0.0	7.6	0.0	0.0	48.2	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	2.2	7.8	19.1	0.0	0.0
SHTN1	"KIAA1598, shootin-1, shootin1"	ENSG00000187164	"Shootin 1"	A0MZ66	10	116881477-117126586	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 128.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	31	"classical monocyte: 19.7;intermediate monocyte: 12.9;myeloid DC: 19.3;non-classical monocyte: 6.6;plasmacytoid DC: 12.9"	"Group enriched"	"Detected in many"	42	"dendritic cells: 19.3;monocytes: 19.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037942, HPA037943"	Enhanced	Approved	Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA037942: AB_2675748, HPA037943: AB_10671637"	"unprognostic (1.00e-1)"	"unprognostic (2.50e-2)"	"unprognostic (6.77e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (2.17e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (5.08e-6)"	1.9	4.0	63.2	4.5	94.5	0.7	4.9	42.7	54.1	2.9	10.0	4.3	4.1	2.4	4.6	3.1	2.9	3.8	1.6	46.9	73.9	4.7	7.6	6.2	2.9	77.5	70.1	3.9	12.2	8.0	6.2	3.1	69.5	4.2	5.2	10.6	6.7	1.4	0.3	5.6	4.8	2.0	48.6	4.5	5.7	6.4	79.5	2.7	7.5	0.8	2.3	2.1	2.1	128.1	24.2	13.4	1.3	2.8	0.0	0.0	12.8	2.0	5.3	4.0	7.6	15.1	15.5	0.0	4.0	7.4	11.8	12.2	10.6	8.9	4.1	0.0	11.0	0.0	14.5	8.9	1.7	4.3	3.7	0.5	7.5	4.0	7.5	10.3	9.7	6.4	6.7	0.1	2.8	9.6	0.0	0.1	5.0	4.8	8.9	0.0	17.5	5.4	10.3	3.3	14.5	5.7	16.0	23.3	13.8	15.7	18.4	3.8	17.0	1.4	9.4	0.1	11.7	2.4	0.1	0.0	7.1	0.0	7.2	0.0	19.7	0.2	0.0	12.9	0.0	0.0	0.1	0.0	19.3	0.0	0.1	0.0	0.4	0.0	6.6	12.9	0.4	5.6	63.2	94.5	42.7	54.1	46.9	73.9	77.5	70.1	69.5	48.6	79.5	128.1	1.4	76.9	35.7	0.0	2.0	0.0	18.9	0.0	15.4	92.3	31.8	15.9	4.9	35.8	23.5	23.9	62.6	42.1	24.7	10.6	21.5	46.4	7.5	43.4	10.6	5.1	17.0	1.7	0.0	53.2	30.9	11.2	36.7	81.1	2.5	23.6	1.8	50.5	37.3	48.8	0.0	15.5	0.0	83.6	0.0	11.7	11.1	77.2	0.0	0.0	90.3	13.8	1.0	0.0	0.0	46.2	42.5	5.3	0.8	25.2	21.2	58.4	18.2	59.4	13.1	18.2	5.0	22.0	39.6	20.5	0.0	20.0	3.1	28.4	15.7	15.4
SKA2	"FAM33A, FLJ12758"	ENSG00000182628	"Spindle and kinetochore associated complex subunit 2"	Q8WVK7	17	59109857-59155260	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059235	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA059235: AB_2683953"	"unprognostic (2.67e-1)"	"unprognostic (6.42e-3)"	"unprognostic (9.69e-3)"	"unprognostic (5.93e-3)"	"unprognostic (2.07e-1)"	"unprognostic (4.44e-2)"	"unprognostic (7.70e-3)"	"unprognostic (9.81e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (2.90e-7)"	"unprognostic (2.59e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.75e-3)"	"unprognostic (1.05e-1)"	19.9	12.6	30.8	20.1	33.4	24.2	11.8	43.3	39.5	18.4	29.1	22.1	18.8	20.3	12.5	24.4	18.1	13.0	34.5	27.8	36.3	21.9	22.4	16.1	33.6	34.3	37.6	16.7	11.5	26.1	14.9	22.9	34.3	16.3	20.0	44.4	10.9	19.9	12.6	13.9	16.8	24.6	37.2	15.8	18.3	12.5	34.4	53.7	25.5	20.4	28.5	20.3	18.1	38.3	217.6	78.6	249.4	85.6	32.4	24.5	76.8	107.1	102.8	163.1	182.5	120.2	122.6	114.1	118.8	87.0	124.3	90.9	162.9	149.3	231.0	197.8	127.4	179.4	142.2	75.1	36.8	142.3	112.5	35.6	63.1	104.8	84.5	64.4	77.2	127.3	114.3	164.5	117.1	297.7	215.4	71.9	66.6	238.3	145.1	114.0	281.3	81.0	121.4	93.2	112.3	96.2	119.1	53.8	66.9	165.4	179.2	112.0	68.0	160.5	153.4	130.5	244.8	111.7	255.6	135.9	85.4	105.3	117.6	26.7	13.1	17.2	18.7	23.5	14.4	18.4	25.6	24.1	15.4	13.7	19.8	22.4	2.4	22.9	38.3	18.3	48.3	12.8	30.8	33.4	43.3	39.5	27.8	36.3	34.3	37.6	34.3	37.2	34.4	38.3	24.8	25.6	18.2	23.2	24.6	21.4	21.6	49.2	25.6	36.1	10.8	17.1	46.3	12.8	26.7	9.2	25.0	62.6	25.8	16.1	39.2	38.3	20.8	22.4	30.2	26.9	10.3	96.8	10.9	25.2	61.7	26.9	30.5	21.0	18.3	26.6	25.4	33.0	46.3	50.5	20.1	23.0	14.2	37.0	22.6	9.4	27.1	28.2	23.2	15.0	42.9	49.3	39.1	15.1	26.3	31.9	24.7	25.6	52.0	8.9	12.8	32.1	26.8	39.4	0.0	13.8	41.5	38.8	30.7	34.1	13.5	30.9	35.0	33.8	35.2	18.9
SKA3	"C13orf3, MGC4832, RAMA1"	ENSG00000165480	"Spindle and kinetochore associated complex subunit 3"	Q8IX90	13	21153595-21176552	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.7;lymphoid tissue: 12.1;testis: 6.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 12.8;Extravillous trophoblasts: 21.0;Spermatocytes: 21.7;Spermatogonia: 18.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA039272, HPA039356, HPA061534"	Approved		Supported	"Mitotic spindle,Centrosome,Cytosol"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Mitotic spindle"	"Centrosome, Cytosol"	"HPA039272: AB_10805359, HPA039356: AB_10805475, HPA061534: "	"unprognostic (3.46e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (9.73e-6)"	"unprognostic (2.03e-3)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.39e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.24e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.32e-1)"	0.2	0.1	0.2	2.5	0.2	4.7	0.8	0.1	0.3	0.2	0.0	1.7	1.0	0.5	0.0	1.9	0.2	0.4	0.0	0.5	0.2	0.1	0.2	0.2	4.3	0.2	0.2	0.0	0.0	0.0	0.0	1.6	0.2	0.0	3.0	0.0	0.2	0.0	0.0	1.8	2.1	1.1	0.2	0.7	1.0	6.3	0.3	12.1	0.1	0.1	3.7	0.4	0.5	0.2	26.1	13.0	25.8	20.5	0.9	5.1	19.1	35.0	14.8	42.1	28.7	23.4	27.8	35.6	10.0	19.3	18.5	24.4	34.4	15.2	54.7	30.3	15.9	47.3	7.7	12.7	0.0	39.5	17.7	1.5	1.0	34.9	15.4	4.2	20.7	30.6	26.3	14.2	33.9	21.0	60.7	37.8	27.9	42.8	23.8	36.5	50.3	15.8	12.2	9.9	30.1	11.1	11.8	17.1	8.1	17.9	15.3	33.5	8.7	16.0	23.8	17.0	43.9	9.0	19.7	34.5	4.4	31.1	51.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.5	0.1	0.2	0.2	0.1	0.3	0.5	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.4	0.0	0.0	0.0	2.6	2.0	0.7	2.4	0.0	0.1	0.9	0.8	0.8	0.0	1.8	0.0	0.0	8.7	1.0	2.1	0.0	1.2	6.3	2.8	0.9	1.4	0.0	12.8	0.8	1.3	21.0	2.1	1.5	1.6	0.0	5.8	1.8	0.4	5.5	0.0	0.6	1.8	2.0	1.9	2.9	7.7	1.5	1.6	0.0	1.9	0.8	0.3	3.1	0.0	0.2	1.0	1.6	1.2	8.5	0.3	0.4	0.6	2.0	0.4	0.0	0.3	2.3	21.7	18.2	5.8	2.8	2.2	1.2	0.5	5.0	0.7
SLC19A1	"FOLT, RFC1"	ENSG00000173638	"Solute carrier family 19 member 1"	P41440	21	45493572-45573365	"Cancer-related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 82.6"	"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 158.0;Syncytiotrophoblasts: 362.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 102.9"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 102.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024802	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"		"HPA024802: AB_10602892"	"unprognostic (4.31e-3)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (5.23e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.04e-2)"	"unprognostic (7.34e-2)"	"unprognostic (2.87e-3)"	"unprognostic (4.04e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (1.07e-10)"	"unprognostic (1.44e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.97e-5)"	"unprognostic (3.10e-1)"	7.7	9.4	8.2	5.7	4.0	8.1	5.9	5.6	12.4	10.0	82.6	6.8	22.5	6.4	0.9	3.2	6.9	1.9	4.2	11.8	2.7	8.0	20.9	15.7	4.2	5.3	5.2	11.8	6.9	0.8	5.4	13.6	6.0	5.8	0.8	2.3	3.3	0.8	2.6	3.9	7.9	1.1	3.0	15.1	7.4	4.6	6.6	2.2	13.8	0.5	0.7	4.3	5.2	4.1	28.9	23.7	4.9	19.4	1.5	2.1	40.2	12.5	1.9	11.1	7.0	55.1	26.1	26.8	24.9	2.8	9.1	14.1	9.0	8.5	2.7	25.2	51.2	54.7	12.4	38.8	6.1	37.2	8.5	2.7	6.3	11.6	3.3	3.3	9.1	27.3	67.6	11.8	3.5	29.3	49.6	29.9	28.5	11.2	30.0	66.5	5.4	79.2	4.6	16.9	29.7	26.7	14.9	23.5	11.2	6.7	18.4	41.4	10.7	14.6	18.8	4.3	21.1	4.8	18.5	23.5	6.7	56.4	11.9	1.6	18.5	24.1	0.9	16.3	2.8	2.5	1.4	2.0	13.4	0.8	2.0	1.5	102.9	1.1	10.8	4.1	3.2	7.9	8.2	4.0	5.6	12.4	11.8	2.7	5.3	5.2	6.0	3.0	6.6	4.1	1.4	48.1	6.3	13.7	2.9	2.4	2.0	2.6	1.8	23.6	3.9	3.4	2.5	1.5	6.2	0.0	0.0	158.0	0.5	8.2	0.0	8.0	3.7	2.2	5.8	3.4	0.0	6.7	3.4	4.9	21.5	3.7	4.1	4.5	1.3	12.7	1.1	16.2	27.3	8.4	4.0	4.1	8.2	11.1	5.0	6.6	6.5	8.6	3.6	23.4	8.3	5.7	0.0	2.0	1.7	7.6	5.4	11.3	9.4	4.6	20.5	2.4	0.9	3.6	0.0	3.3	4.1	1.5	4.8	1.8	1.6	362.4	2.6	5.1	8.5	0.9
SLC25A11	"OGC, SLC20A4"	ENSG00000108528	"Solute carrier family 25 member 11"	Q02978	17	4937130-4940053	"Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"heart muscle: 233.6;skeletal muscle: 314.5;tongue: 450.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021167	Approved					NA	NA		25000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA021167: AB_1857021"	"unprognostic (8.58e-2)"	"unprognostic (4.06e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.86e-1)"	"unprognostic (9.48e-2)"	"prognostic favorable (6.41e-6)"	"unprognostic (2.84e-1)"	"prognostic favorable (2.84e-9)"	"unprognostic (1.26e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.09e-1)"	35.6	52.5	69.2	33.8	70.7	31.7	32.0	77.7	79.8	35.3	70.8	46.7	47.5	36.7	22.1	50.5	41.6	30.7	233.6	76.8	73.6	66.6	66.7	30.0	40.7	69.2	72.7	30.7	27.9	70.8	36.4	27.6	69.6	34.0	36.1	23.2	41.6	38.4	314.5	48.7	40.2	33.4	70.2	37.5	39.9	10.9	77.0	45.1	38.5	450.4	33.9	38.5	33.3	71.5	51.1	134.6	67.3	66.3	64.7	39.9	47.3	56.2	57.2	96.2	79.3	85.1	24.7	78.3	74.5	55.3	46.8	99.6	88.1	101.5	37.8	99.6	113.8	86.4	70.9	74.5	66.0	37.6	100.7	57.7	65.1	85.4	71.7	46.7	67.8	83.2	38.7	74.1	82.7	91.2	121.6	38.3	35.6	56.1	89.6	108.6	41.4	71.0	74.8	52.6	59.9	62.1	70.9	79.0	65.2	33.6	73.3	58.7	46.0	43.0	28.1	58.8	109.7	39.3	25.4	30.7	84.8	62.6	108.4	126.0	170.3	132.3	98.8	176.8	90.8	87.5	75.1	87.8	160.4	74.3	74.1	81.2	111.8	151.6	165.1	107.0	97.3	186.2	69.2	70.7	77.7	79.8	76.8	73.6	69.2	72.7	69.6	70.2	77.0	71.5	39.7	25.6	23.3	12.7	32.9	38.1	47.1	92.7	25.6	60.3	47.5	51.3	150.6	51.5	40.0	66.2	16.7	132.2	39.0	67.0	185.9	60.7	15.2	30.3	29.7	41.0	27.6	50.3	8.0	53.6	138.7	40.2	30.5	28.2	39.3	45.6	33.5	61.5	109.1	47.1	10.5	51.6	99.7	45.3	44.4	19.6	30.4	56.2	51.6	9.4	106.9	59.2	47.4	9.5	10.4	47.4	58.7	38.4	45.8	43.1	99.9	202.5	26.5	56.0	52.6	43.1	48.4	15.1	31.3	46.9	44.3	102.5	38.4	57.5	88.3	42.1
SLC25A13	"ARALAR2, CITRIN, CTLN2"	ENSG00000004864	"Solute carrier family 25 member 13"	Q9UJS0	7	96120220-96322147	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 150.1"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 153.4;Oligodendrocytes: 439.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018997	Enhanced		Supported	Mitochondria		NA	NA		21000	"Cluster 14: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA018997: AB_1857023"	"unprognostic (3.61e-2)"	"unprognostic (7.99e-2)"	"unprognostic (6.99e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.99e-2)"	"prognostic favorable (9.14e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.32e-1)"	"unprognostic (7.09e-2)"	9.2	14.3	7.0	8.9	13.7	8.0	10.3	13.7	10.0	8.0	15.1	16.3	16.0	7.6	10.2	9.6	9.5	9.9	6.6	6.7	9.9	32.3	150.1	7.9	7.1	13.6	12.2	7.8	9.6	13.8	8.3	16.1	13.0	8.2	17.8	19.4	7.7	12.5	7.0	12.3	13.4	6.7	10.1	10.0	14.4	7.4	11.3	3.9	13.7	3.3	8.7	11.0	7.6	20.2	45.3	39.2	44.2	15.5	7.5	6.0	61.8	11.2	8.5	26.5	26.7	70.7	41.2	20.2	51.9	7.2	57.8	26.3	50.1	16.2	31.0	8.0	33.0	23.0	34.4	55.4	17.4	29.5	17.4	15.8	16.9	22.7	20.4	10.1	31.0	3.0	65.9	7.6	13.0	49.6	0.1	27.6	78.0	47.8	24.0	11.6	26.3	46.8	63.7	42.1	21.1	69.0	38.8	81.1	67.3	72.9	24.2	22.4	18.2	19.6	43.6	46.8	34.5	15.2	40.8	12.7	24.1	28.0	32.9	0.4	3.1	2.2	1.4	4.5	1.5	2.4	1.1	1.3	6.1	1.2	0.7	0.9	0.6	2.0	5.1	3.1	1.2	1.4	7.0	13.7	13.7	10.0	6.7	9.9	13.6	12.2	13.0	10.1	11.3	20.2	31.5	9.6	12.6	60.7	19.7	7.4	8.5	8.6	16.5	36.5	13.6	17.1	8.3	27.1	9.2	18.4	54.2	29.2	8.9	32.1	27.4	19.8	11.0	44.0	23.2	20.7	37.8	15.3	26.6	19.1	26.5	18.8	44.4	34.2	14.5	30.4	11.7	153.4	23.2	10.1	43.7	22.3	12.2	23.8	10.0	11.1	13.1	21.5	21.4	82.4	13.2	17.6	8.2	53.3	439.6	22.6	23.7	15.8	12.7	14.9	27.1	74.9	14.2	47.3	13.1	19.0	16.9	7.0	14.5	25.4	8.0	20.0	7.9	21.6	25.5	15.4
SLC25A15	"D13S327, HHH, ORC1, ORNT1"	ENSG00000102743	"Solute carrier family 25 member 15"	Q9Y619	13	40789412-40812460	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 37.6;liver: 88.3;pancreas: 52.1"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 44.5;Hepatocytes: 39.8;Proximal enterocytes: 19.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA042146	Approved					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA042146: AB_2677874"	"unprognostic (4.17e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.86e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.85e-1)"	"prognostic favorable (2.16e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.37e-2)"	"prognostic favorable (1.74e-4)"	"unprognostic (4.04e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (5.46e-4)"	2.3	1.4	2.0	4.1	2.2	5.6	4.6	2.3	2.5	2.1	2.3	5.9	37.6	3.1	1.1	3.2	2.6	5.0	2.8	1.9	2.6	5.6	88.3	2.3	4.8	2.6	2.3	2.9	52.1	3.4	1.3	2.8	2.5	2.8	6.5	2.8	3.4	1.8	5.9	3.7	26.7	3.4	2.1	2.5	5.5	9.4	2.4	5.3	17.3	6.0	5.3	2.6	1.6	2.9	7.4	14.7	16.5	21.3	6.5	8.2	17.3	5.6	2.9	6.8	3.9	17.6	15.2	48.0	6.4	10.3	12.7	12.6	26.6	15.5	7.0	11.9	12.4	37.0	8.6	26.6	12.7	15.0	5.3	9.0	8.6	9.6	21.9	4.6	11.2	23.8	18.1	7.8	11.8	28.2	10.2	9.9	33.2	32.7	7.9	25.5	12.0	10.6	11.7	7.0	7.7	20.1	10.2	18.4	10.1	11.5	13.6	23.2	8.4	8.4	12.1	12.7	17.0	8.9	9.6	27.9	8.4	11.4	16.4	1.3	0.5	0.1	1.6	0.9	1.0	0.6	1.0	1.1	1.1	0.7	1.0	2.0	0.7	1.4	0.5	0.5	0.9	0.5	2.0	2.2	2.3	2.5	1.9	2.6	2.6	2.3	2.5	2.1	2.4	2.9	0.3	3.2	0.5	3.9	1.3	0.3	1.0	0.8	2.2	1.4	2.1	1.4	1.1	1.5	0.2	0.0	0.0	2.2	1.3	0.6	7.9	2.1	4.6	1.2	2.1	0.9	1.2	9.0	2.4	4.3	44.5	1.0	1.5	2.1	0.0	1.5	0.7	39.8	1.7	0.0	4.3	0.6	2.0	1.6	0.3	6.8	0.6	1.0	1.8	1.0	0.0	0.4	2.1	5.0	1.4	1.7	2.7	0.0	6.2	1.6	19.0	4.3	0.1	1.9	0.0	1.0	1.1	5.4	9.3	2.1	0.1	1.5	3.2	4.3	3.5	0.8
SLC25A17	PMP34	ENSG00000100372	"Solute carrier family 25 member 17"	O43808	22	40769630-40819399	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052708, HPA060972"	Approved		Supported	Peroxisomes		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Peroxisomes		"HPA052708: AB_2681924, HPA060972: AB_2684400"	"unprognostic (2.75e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.91e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.85e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.63e-3)"	"unprognostic (8.44e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.59e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.18e-1)"	7.4	12.3	9.4	5.3	9.2	3.3	14.3	9.9	10.7	9.3	11.5	6.3	5.4	13.2	19.6	7.1	11.4	5.7	4.3	9.2	10.2	13.6	16.9	6.6	9.4	9.9	9.6	20.6	8.8	13.6	9.2	10.0	9.7	10.7	7.3	9.2	9.8	5.9	3.9	9.6	6.0	10.5	10.1	7.3	7.8	10.0	10.0	9.3	12.7	3.6	9.7	8.1	7.2	11.2	23.5	13.5	21.0	18.5	12.8	15.9	16.8	20.7	22.7	32.5	35.7	16.5	8.8	26.7	12.2	20.4	17.7	18.6	30.6	16.6	33.4	27.0	41.3	31.1	18.4	21.1	18.3	35.8	16.2	15.3	22.8	28.6	18.4	14.7	19.4	21.4	46.5	12.9	26.5	19.2	22.0	24.2	17.7	33.2	20.6	23.8	32.4	40.3	27.6	19.7	14.2	12.5	42.8	26.6	26.7	20.3	22.0	10.7	11.8	18.5	24.4	16.1	19.2	13.9	29.6	25.7	19.7	18.4	20.4	7.0	3.3	4.2	4.9	3.9	6.9	8.4	5.8	5.5	4.2	7.6	8.2	6.7	1.5	8.3	3.3	5.4	8.6	4.7	9.4	9.2	9.9	10.7	9.2	10.2	9.9	9.6	9.7	10.1	10.0	11.2	8.4	19.2	9.5	23.2	10.9	16.6	16.8	29.8	10.8	12.1	13.6	9.3	4.0	7.2	20.7	12.9	8.4	39.8	8.0	5.8	21.5	17.9	9.6	17.9	16.5	10.4	6.1	11.6	17.3	17.7	31.9	15.9	8.2	14.2	5.1	15.5	8.2	24.8	12.9	11.8	21.5	6.5	26.4	7.9	6.0	16.0	27.1	7.4	16.0	7.5	17.6	7.9	10.3	18.1	28.0	18.1	4.4	26.7	11.9	18.1	8.2	21.1	15.0	7.0	32.9	9.3	11.6	51.0	38.0	11.7	17.2	28.6	9.7	16.4	7.5	14.9
SLC25A26		ENSG00000144741	"Solute carrier family 25 member 26"	Q70HW3	3	66133610-66388116	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026887	Supported		Supported	Mitochondria		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA026887: AB_2189921"	"unprognostic (1.93e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.83e-2)"	"unprognostic (7.94e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.54e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.43e-2)"	"prognostic favorable (1.73e-5)"	"unprognostic (4.73e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.07e-1)"	15.8	16.0	9.6	5.6	9.9	12.9	15.0	8.7	11.0	12.7	6.8	18.1	7.8	13.3	9.4	15.9	12.7	7.8	28.3	10.1	8.7	18.5	25.9	11.6	10.7	9.1	9.3	16.5	15.5	14.9	10.2	7.7	9.2	13.5	9.5	8.5	16.1	9.0	42.4	22.0	13.3	7.8	9.3	13.5	17.4	14.3	11.1	8.6	15.8	21.0	9.6	17.5	14.1	11.3	10.7	10.4	6.5	12.4	13.9	13.1	13.9	9.0	15.7	10.7	10.2	13.5	13.9	12.3	5.5	15.1	14.3	7.6	7.3	15.8	11.7	11.5	16.8	16.3	8.1	19.2	14.7	22.5	13.4	17.7	29.6	8.4	21.3	11.2	8.9	21.5	9.2	12.8	12.9	12.5	9.9	28.3	20.8	23.2	6.8	10.0	11.7	19.4	10.1	8.3	5.4	14.6	12.4	11.8	21.4	10.9	9.8	19.7	10.4	12.7	11.0	15.9	16.6	21.1	30.6	15.1	17.4	21.1	14.7	1.8	9.9	6.1	15.4	10.8	14.5	19.3	16.9	16.4	18.3	16.2	20.5	17.5	0.9	18.1	6.7	17.5	17.7	13.4	9.6	9.9	8.7	11.0	10.1	8.7	9.1	9.3	9.2	9.3	11.1	11.3	11.6	32.1	22.2	22.9	29.5	35.8	38.6	45.7	28.5	17.7	36.1	34.0	106.9	30.0	25.0	18.4	12.5	36.8	27.3	14.1	35.2	28.8	33.3	17.2	13.6	20.5	18.6	9.2	55.5	45.1	44.6	26.1	17.3	19.1	19.6	21.1	13.2	39.1	30.3	11.8	51.4	29.2	28.5	22.3	26.5	28.6	16.1	15.8	37.4	31.9	21.4	26.5	32.0	32.2	63.9	27.6	20.8	21.8	18.7	49.1	30.8	57.7	16.2	24.5	19.7	31.7	22.1	29.4	32.9	28.2	36.8	32.7	39.6	22.3	33.3	37.8
SLC25A28	"MRS3/4, MRS4L"	ENSG00000155287	"Solute carrier family 25 member 28"	Q96A46	10	99610522-99620609	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 148.9;Late spermatids: 390.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (2.87e-3)"	"prognostic favorable (2.18e-6)"	"unprognostic (8.59e-3)"	"unprognostic (6.86e-2)"	"unprognostic (4.29e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.39e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.40e-2)"	"unprognostic (9.80e-3)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (7.28e-5)"	"unprognostic (1.12e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.62e-3)"	55.6	74.0	107.1	32.8	110.6	86.0	51.1	104.4	125.4	60.1	98.7	82.0	22.9	46.9	46.4	70.5	59.0	24.9	69.2	106.6	108.9	53.6	96.7	73.4	41.6	108.5	112.8	60.9	66.0	32.4	55.7	28.2	109.0	78.6	33.7	54.4	51.7	45.7	100.3	58.8	56.3	35.8	105.8	80.4	58.5	90.2	107.8	30.9	48.6	45.4	37.8	89.8	62.9	111.9	28.7	28.5	17.8	42.8	32.3	40.1	18.1	33.8	40.4	45.2	37.0	22.4	35.2	36.9	19.9	30.8	20.5	47.6	22.1	31.6	27.8	27.5	28.3	16.3	46.4	23.9	31.8	29.3	21.6	33.9	46.0	29.4	58.1	58.9	32.4	32.1	11.7	27.9	23.5	39.6	25.4	66.1	4.2	23.1	21.9	31.9	21.2	20.6	30.0	31.1	11.9	14.9	19.2	20.7	25.4	23.1	37.3	28.8	19.9	27.6	19.0	36.9	41.0	22.8	15.5	18.3	26.5	55.8	11.7	0.0	1.4	4.0	2.7	1.3	1.2	1.7	1.9	1.6	2.1	1.6	1.4	1.2	1.2	1.6	1.3	5.8	2.4	0.7	107.1	110.6	104.4	125.4	106.6	108.9	108.5	112.8	109.0	105.8	107.8	111.9	30.4	12.8	11.0	37.2	11.8	25.4	16.4	17.5	4.6	30.7	12.5	14.1	19.7	15.7	7.3	5.5	20.9	21.0	18.3	9.2	7.9	3.8	148.9	11.1	13.6	17.1	4.2	4.8	34.1	8.0	8.7	15.8	4.1	13.2	6.3	36.2	9.7	19.1	9.8	43.7	34.0	11.9	6.1	9.2	20.0	390.1	12.8	16.2	19.6	20.6	10.6	29.0	8.2	28.6	36.3	6.3	9.6	18.0	10.6	31.1	7.2	8.3	4.0	29.2	13.1	20.5	15.6	63.4	9.2	13.6	27.4	14.5	12.2	58.2	11.4	20.6
SLC25A33	"BMSC-MCP, MGC4399, PNC1"	ENSG00000171612	"Solute carrier family 25 member 33"	Q9BSK2	1	9539465-9585173	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 27.5"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 422.0;Late spermatids: 559.8;Spermatocytes: 358.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.8"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049982	Uncertain					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA049982: AB_2680981"	"unprognostic (1.61e-1)"	"prognostic favorable (4.86e-4)"	"unprognostic (2.94e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.75e-2)"	"unprognostic (5.18e-2)"	"prognostic favorable (7.02e-4)"	"unprognostic (1.88e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.77e-1)"	"unprognostic (4.55e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.25e-2)"	"unprognostic (3.77e-2)"	11.3	3.4	12.4	2.6	13.6	9.0	6.0	15.1	13.8	2.5	11.9	4.6	2.2	3.0	12.6	2.9	3.0	3.7	5.2	12.2	14.5	10.0	12.6	2.7	3.3	14.1	14.7	2.7	3.7	3.9	5.6	1.4	13.7	4.1	3.7	11.2	5.4	2.0	18.1	2.5	2.6	2.7	14.5	2.3	4.4	13.4	15.8	3.5	5.1	27.5	3.5	4.0	2.3	14.5	6.9	3.1	8.7	13.4	7.0	4.0	5.6	6.5	6.1	10.8	9.5	6.9	5.2	19.8	7.8	5.4	11.3	2.8	22.2	4.3	13.3	15.3	13.9	19.5	4.2	27.5	15.1	19.6	14.8	4.8	7.5	10.8	5.2	2.6	6.4	14.5	19.2	10.0	6.1	7.2	12.5	13.4	10.7	12.5	7.3	16.5	9.2	12.8	6.9	3.8	15.1	9.7	7.3	22.2	20.0	7.5	8.2	14.2	2.8	6.8	9.0	9.2	8.4	11.8	23.6	33.5	4.9	21.6	8.4	2.8	0.3	0.1	0.5	0.4	0.3	0.8	0.4	0.3	0.6	0.3	0.6	0.7	0.4	0.5	0.4	0.5	0.0	0.1	12.4	13.6	15.1	13.8	12.2	14.5	14.1	14.7	13.7	14.5	15.8	14.5	25.7	3.2	13.1	59.1	34.4	51.5	107.3	4.2	69.4	15.1	60.0	39.5	9.3	37.1	6.8	9.2	52.1	14.0	32.9	22.5	199.6	11.5	422.0	38.1	19.0	19.9	66.3	8.2	12.3	15.1	38.6	27.2	30.1	39.8	23.6	9.5	11.4	55.8	21.3	10.1	18.2	27.5	6.1	9.2	66.8	559.8	9.9	30.7	32.0	5.6	11.7	195.3	9.2	13.6	13.7	11.5	14.4	10.1	20.4	94.7	6.6	29.5	8.0	53.3	6.6	41.5	37.0	358.5	115.1	42.6	35.8	39.3	22.7	16.7	32.4	96.2
SLC25A38	FLJ20551	ENSG00000144659	"Solute carrier family 25 member 38"	Q96DW6	3	39383370-39397351	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 73.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041027	Approved					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA041027: AB_10794403"	"unprognostic (3.82e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.26e-2)"	"unprognostic (5.54e-2)"	"prognostic favorable (1.58e-5)"	"unprognostic (1.73e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.06e-1)"	"prognostic favorable (7.29e-4)"	19.1	35.4	22.2	18.8	23.3	70.0	21.0	25.9	26.8	23.8	33.6	28.1	25.3	27.3	27.6	14.5	27.3	19.4	20.7	22.9	26.3	28.7	58.0	21.0	36.2	24.2	24.1	44.1	45.6	38.7	30.7	15.4	25.3	29.2	36.9	23.0	22.5	23.9	48.2	16.7	25.2	20.3	22.6	27.2	33.8	18.7	26.0	33.6	52.0	35.7	35.4	27.8	19.1	23.3	24.3	38.3	24.3	41.2	56.4	46.4	30.8	33.6	46.1	48.3	43.7	26.3	5.6	67.8	19.6	31.6	40.7	18.4	55.2	40.1	36.0	43.6	45.0	52.0	33.5	40.2	75.6	37.7	33.9	58.8	46.1	46.2	93.2	44.6	31.5	52.8	47.7	40.6	36.4	35.2	44.7	67.0	66.2	35.9	44.3	16.2	26.4	47.7	37.5	45.4	24.3	31.1	11.9	65.9	34.0	44.5	33.5	35.0	26.9	38.3	26.4	56.2	48.9	54.7	93.1	41.9	29.3	48.3	24.7	30.7	9.6	18.1	38.8	5.7	44.7	50.8	39.1	43.3	14.9	37.8	41.7	40.5	1.0	57.0	8.4	18.5	55.3	29.2	22.2	23.3	25.9	26.8	22.9	26.3	24.2	24.1	25.3	22.6	26.0	23.3	10.4	22.4	27.4	8.5	35.6	11.5	13.0	12.5	28.5	13.2	26.1	22.6	16.8	22.8	9.6	27.6	6.2	35.2	33.1	21.9	21.5	15.7	6.5	26.6	16.3	11.1	12.6	73.7	8.9	16.9	32.6	13.7	16.8	38.5	22.2	24.0	9.7	27.0	15.2	5.0	10.1	25.6	12.2	7.0	13.7	12.9	15.5	9.8	12.4	1.9	11.2	18.9	29.9	7.1	6.2	13.4	22.2	13.5	23.3	17.7	23.1	31.3	12.3	12.6	6.6	15.2	14.9	11.0	7.8	19.4	10.2	19.4	36.6	32.8	26.7	8.4
SLC25A40	MCFP	ENSG00000075303	"Solute carrier family 25 member 40"	Q8TBP6	7	87833568-87876360	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055197	Uncertain					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA055197: AB_2682735"	"unprognostic (4.19e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.15e-1)"	"unprognostic (8.80e-2)"	"unprognostic (4.03e-2)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (3.73e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.78e-2)"	"prognostic favorable (1.52e-5)"	"unprognostic (8.42e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.85e-2)"	4.8	7.0	4.0	8.5	4.3	7.6	8.0	6.4	6.5	5.9	2.6	7.8	6.6	6.8	6.1	5.8	6.2	5.5	9.7	4.6	4.6	8.2	6.7	5.9	10.6	4.7	4.9	8.6	4.3	9.4	3.6	3.8	4.9	8.6	9.6	8.7	6.0	5.1	6.3	8.1	7.1	5.3	2.9	8.9	7.1	4.8	6.0	9.6	7.1	5.2	9.9	5.2	4.2	5.0	20.3	5.3	16.3	6.3	6.5	10.4	4.8	14.3	12.6	10.1	14.7	4.6	28.2	23.8	9.1	7.1	16.3	8.7	8.0	8.2	14.5	15.1	4.0	12.6	12.3	5.7	6.2	30.8	16.2	6.3	5.8	9.2	7.2	8.5	11.0	18.9	13.9	34.0	17.5	8.6	35.7	25.6	7.6	16.6	5.9	17.6	20.6	21.0	14.7	10.8	8.0	19.2	18.4	17.8	14.1	13.1	8.7	24.0	7.7	17.3	12.8	27.2	13.8	18.7	21.6	30.6	12.0	37.0	36.1	9.1	3.5	5.0	1.1	3.7	1.8	1.5	1.6	1.6	3.9	1.7	1.7	1.6	1.9	4.0	4.0	1.0	1.9	1.5	4.0	4.3	6.4	6.5	4.6	4.6	4.7	4.9	4.9	2.9	6.0	5.0	5.8	3.2	5.3	33.0	12.3	7.5	6.1	4.0	12.0	5.7	8.3	5.2	16.6	12.8	7.7	7.3	10.4	8.6	10.5	9.6	15.6	3.8	10.0	5.7	5.0	5.9	3.0	17.9	35.2	3.9	8.4	5.7	9.2	6.4	5.1	9.1	6.1	8.1	11.1	3.3	37.0	8.9	6.1	28.6	4.1	3.9	7.8	19.4	21.4	19.7	17.5	4.5	5.2	32.2	30.8	6.5	13.8	10.9	18.8	3.5	7.2	8.6	5.2	4.9	13.1	4.6	4.4	9.0	5.0	10.4	8.0	3.7	9.4	9.1	10.0	5.5
SLC27A4	"ACSVL4, FATP4"	ENSG00000167114	"Solute carrier family 27 member 4"	Q6P1M0	9	128340527-128361470	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport"	Ligase	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 53.7;Proximal enterocytes: 100.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007293, CAB009771"	Approved		Approved	Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"CAB009771: AB_2270540, HPA007293: AB_1857062"	"unprognostic (7.25e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.92e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.31e-3)"	"unprognostic (4.51e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.72e-2)"	"unprognostic (5.07e-2)"	"prognostic favorable (2.61e-5)"	"unprognostic (7.29e-3)"	"unprognostic (2.11e-1)"	"unprognostic (3.45e-2)"	"unprognostic (8.01e-3)"	11.4	14.7	22.5	8.5	23.7	2.7	11.6	25.4	30.3	17.2	12.4	22.8	66.9	14.4	6.3	61.8	10.4	7.3	20.4	22.7	25.9	28.8	40.0	11.8	6.4	29.4	23.9	8.3	21.6	15.5	12.1	5.6	28.8	13.1	9.4	6.8	16.4	7.5	16.1	41.8	41.1	9.3	19.7	11.6	16.4	25.8	27.1	5.8	15.5	6.2	9.6	15.5	23.5	24.1	20.8	41.8	21.1	28.1	31.5	9.8	23.3	16.7	11.7	20.3	14.5	30.1	20.7	19.1	13.5	19.8	24.8	70.6	25.5	20.7	6.7	19.5	37.2	11.4	35.6	28.5	17.1	21.0	17.8	12.7	29.6	21.2	17.0	9.4	23.1	26.3	27.5	13.7	20.2	56.2	26.0	22.7	9.2	51.6	63.0	30.4	19.6	36.4	38.1	32.0	34.8	19.2	27.6	57.0	20.3	11.3	26.7	8.8	32.4	23.7	22.9	26.6	22.0	11.4	17.4	6.5	24.3	13.0	27.7	0.0	2.5	1.7	4.7	3.3	3.4	2.1	2.9	3.6	4.4	0.9	2.3	2.4	1.0	1.4	4.3	3.9	2.2	2.4	22.5	23.7	25.4	30.3	22.7	25.9	29.4	23.9	28.8	19.7	27.1	24.1	4.7	0.0	1.1	12.7	2.0	2.8	1.4	4.0	1.2	9.6	5.8	3.0	5.2	7.2	2.8	9.2	12.5	6.1	2.1	53.7	1.9	13.1	4.8	3.6	5.2	5.3	13.1	4.0	27.7	16.0	6.8	3.5	14.3	9.3	8.9	5.9	3.6	20.1	11.3	8.4	29.2	18.6	8.2	6.1	1.9	5.4	1.2	5.4	1.8	15.9	10.0	5.0	6.2	8.5	26.4	26.4	30.0	4.1	3.2	3.2	100.6	9.7	1.8	7.8	6.6	4.4	4.4	11.8	7.9	11.9	6.1	5.2	2.4	7.9	25.7	2.8
SLC2A4RG	"GEF, HDBP1, Si-1-2, Si-1-2-19"	ENSG00000125520	"SLC2A4 regulator"	Q9NR83	20	63739776-63744050	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 150.6"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 116.2;Proximal tubular cells: 160.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA063050			Approved	"Nuclear speckles"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles"		"HPA063050: AB_2684930"	"unprognostic (2.89e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.07e-3)"	"unprognostic (6.48e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.50e-3)"	"unprognostic (3.22e-1)"	59.4	37.9	8.8	3.1	8.6	10.2	45.0	7.3	12.8	42.0	7.7	55.5	1.6	39.2	4.2	47.7	35.0	3.3	60.5	8.3	8.4	67.8	150.6	30.9	5.0	8.4	8.2	45.8	28.4	5.6	23.0	2.8	7.6	50.1	1.5	2.3	27.3	10.5	88.2	60.8	25.6	3.3	8.6	35.5	33.4	24.2	8.2	6.3	32.1	18.7	3.0	50.2	40.6	8.6	20.5	26.4	12.2	11.0	7.6	14.9	11.9	16.6	16.4	43.8	15.2	49.0	34.0	4.3	23.1	12.1	18.9	24.1	6.1	20.0	7.6	13.5	11.0	4.3	19.4	25.8	16.2	10.5	8.9	17.4	29.0	11.8	9.5	8.7	12.8	3.9	15.8	4.7	21.3	37.0	5.9	29.8	5.3	21.9	59.6	29.4	21.8	10.5	17.3	7.8	10.8	19.0	35.4	16.0	4.5	4.6	37.9	33.7	11.0	43.4	22.7	25.2	13.1	12.8	27.0	7.3	18.1	12.4	11.8	0.0	0.0	0.2	0.9	0.0	0.4	0.1	0.9	0.5	0.1	0.0	0.7	0.7	0.0	0.3	0.1	0.2	1.1	0.1	8.8	8.6	7.3	12.8	8.3	8.4	8.4	8.2	7.6	8.6	8.2	8.6	35.9	9.6	21.2	21.5	16.0	24.5	25.0	19.3	19.4	10.1	44.7	61.5	21.3	37.1	11.2	42.3	10.4	30.7	60.1	18.3	78.2	8.2	9.2	16.3	57.1	22.2	2.4	55.4	5.5	10.3	16.6	49.7	12.8	32.4	3.8	52.6	19.6	116.2	14.7	10.1	4.5	17.5	14.2	13.5	12.7	4.3	28.9	14.6	3.6	5.6	11.7	33.5	13.4	8.0	7.1	20.3	7.8	34.6	16.9	14.9	10.5	160.8	6.1	6.5	32.9	26.1	32.9	1.1	6.4	29.3	37.8	8.6	46.3	77.0	15.0	18.3
SLC35G1	"C10orf60, FLJ33990, TMEM20"	ENSG00000176273	"Solute carrier family 35 member G1"	Q2M3R5	10	93893973-93956062	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"intestine: 68.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 26.9;Peritubular cells: 36.5;Proximal enterocytes: 47.4;Theca cells: 59.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"				"unprognostic (1.94e-2)"	"unprognostic (1.90e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.90e-4)"	"unprognostic (8.89e-2)"	"unprognostic (9.01e-3)"	"unprognostic (1.15e-2)"	"unprognostic (9.47e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.29e-3)"	"unprognostic (3.28e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.30e-1)"	0.8	0.8	0.1	1.0	0.1	0.3	0.7	0.2	0.1	0.4	1.0	6.0	68.4	0.8	0.8	1.1	0.4	0.6	1.4	0.1	0.2	0.5	3.7	0.8	0.8	0.3	0.2	1.0	9.5	2.1	1.1	0.8	0.4	0.7	5.8	0.2	1.4	0.8	0.6	1.5	33.4	0.9	0.1	0.6	2.0	3.4	0.2	0.4	1.4	0.2	0.6	1.1	0.7	0.1	6.2	6.1	2.9	3.3	0.9	2.5	3.8	5.4	6.2	5.2	6.5	4.8	4.2	3.9	2.1	3.6	3.4	11.1	6.7	2.1	7.9	4.8	7.0	3.2	3.7	3.6	1.3	6.1	6.1	2.4	2.1	3.9	2.3	1.7	2.3	3.5	3.0	2.2	3.1	2.2	2.9	1.3	3.7	2.2	7.1	0.0	4.6	1.5	2.5	5.3	3.7	3.4	7.2	3.5	4.6	2.4	3.7	2.0	2.9	3.8	6.1	6.8	5.6	2.5	2.4	1.3	2.8	0.0	2.7	0.0	0.1	0.7	0.1	0.1	0.4	0.1	0.8	0.5	0.1	0.1	0.8	0.5	0.0	0.0	0.0	0.1	1.1	0.2	0.1	0.1	0.2	0.1	0.1	0.2	0.3	0.2	0.4	0.1	0.2	0.1	3.2	3.2	3.9	1.0	2.4	3.1	2.1	2.2	2.2	4.3	1.5	2.7	4.7	5.7	1.6	7.3	4.2	3.0	0.6	26.9	3.9	2.3	20.3	1.8	5.0	4.7	4.2	3.0	2.6	9.7	6.1	4.4	3.1	1.3	0.0	19.9	5.0	5.8	2.3	1.7	6.4	5.0	2.0	3.3	1.2	9.2	17.1	0.9	5.4	1.0	3.1	4.8	0.0	5.0	0.9	3.1	18.3	36.5	2.2	1.3	47.4	1.2	1.3	2.7	0.0	3.6	2.4	19.1	9.2	4.1	1.8	0.8	3.6	59.2	8.3	2.3
SLC38A7	FLJ10815	ENSG00000103042	"Solute carrier family 38 member 7"	Q9NVC3	16	58665109-58684770	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 32.8"	"Group enriched"	"Detected in all"	13	"Early spermatids: 271.8;Late spermatids: 753.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041777, HPA049428"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041777: AB_10796782, HPA049428: "	"unprognostic (2.16e-3)"	"unprognostic (2.30e-2)"	"unprognostic (6.23e-3)"	"prognostic favorable (6.87e-4)"	"unprognostic (3.49e-1)"	"unprognostic (8.08e-3)"	"unprognostic (9.76e-3)"	"unprognostic (6.34e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.90e-2)"	"prognostic favorable (2.87e-4)"	"unprognostic (1.85e-1)"	"unprognostic (4.38e-2)"	"unprognostic (7.50e-2)"	"unprognostic (4.93e-3)"	6.0	11.4	7.5	6.0	7.8	2.6	5.3	6.0	8.9	5.1	6.1	5.1	4.3	5.5	6.2	6.5	4.0	5.6	15.9	7.9	7.4	7.3	13.6	5.4	4.3	7.7	7.6	4.6	4.8	14.1	7.2	7.5	8.1	5.5	5.9	4.7	6.2	4.6	9.4	5.3	5.5	7.4	5.8	10.3	5.4	32.8	9.8	3.6	7.8	8.3	4.6	5.4	4.9	7.0	6.9	10.9	10.8	16.5	22.0	12.9	19.3	16.2	18.7	22.7	15.6	9.9	11.0	4.5	8.9	22.9	17.9	15.9	10.2	11.7	13.3	2.8	9.4	5.1	9.3	16.5	32.9	10.6	14.0	25.9	23.6	16.1	10.3	12.3	23.5	10.4	14.9	6.3	16.7	8.0	4.3	6.3	11.7	7.5	16.0	15.2	11.6	12.1	10.0	15.4	7.9	11.3	25.7	17.0	7.0	14.4	7.6	4.2	18.7	12.3	9.3	21.8	5.0	9.7	6.7	5.2	16.8	6.3	9.3	0.1	6.8	2.0	4.0	6.6	2.2	1.3	2.4	2.9	4.5	2.5	1.9	2.1	0.5	1.8	6.4	1.7	1.8	5.5	7.5	7.8	6.0	8.9	7.9	7.4	7.7	7.6	8.1	5.8	9.8	7.0	3.3	3.2	4.4	7.8	2.0	3.8	4.0	4.4	1.2	9.8	4.7	3.2	12.8	4.3	4.8	11.0	12.5	8.4	5.0	3.7	3.9	14.0	271.8	3.5	6.8	6.2	13.1	2.1	13.3	8.5	9.5	5.1	9.7	6.0	1.3	10.7	8.2	9.3	38.6	16.8	15.5	3.1	12.2	10.1	8.2	753.3	9.6	11.6	8.8	9.4	4.0	7.1	8.2	5.0	7.6	12.8	2.7	8.6	1.8	3.7	4.8	5.9	3.8	7.1	6.6	4.8	5.1	6.9	7.6	4.6	4.3	15.3	2.7	8.6	4.9	3.2
SLC43A1	"PB39, POV1, R00504"	ENSG00000149150	"Solute carrier family 43 member 1"	O75387	11	57484534-57515780	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"liver: 128.6;pancreas: 233.2"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 47.1;Erythroid cells: 82.9;Exocrine glandular cells: 35.4;Hepatocytes: 138.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 45.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 62.7;NB-4: 74.3;U-937: 70.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018813, HPA018826"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus, Vesicles, Plasma membrane"		"HPA018813: AB_1857164, HPA018826: AB_1857165"	"unprognostic (3.04e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.19e-2)"	"prognostic favorable (3.19e-4)"	"unprognostic (2.51e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (2.97e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (5.27e-4)"	"unprognostic (7.30e-2)"	13.9	10.7	3.6	4.7	4.2	35.7	11.1	2.7	5.0	13.1	2.7	15.7	8.7	12.6	10.3	4.4	13.5	18.2	8.6	3.6	2.8	7.3	128.6	9.9	7.4	3.8	3.2	20.3	233.2	1.8	4.4	6.3	3.5	12.8	9.4	1.3	13.8	6.2	17.1	18.8	9.2	8.7	2.7	8.5	30.4	3.4	3.4	2.1	12.7	9.1	6.6	16.2	9.9	3.9	1.1	1.7	1.8	20.3	25.7	18.8	0.2	10.4	13.8	3.0	7.6	6.5	2.8	59.5	2.7	7.9	3.9	1.0	18.1	1.2	3.7	2.8	4.6	30.9	0.5	62.7	33.7	54.3	7.2	23.8	4.4	5.2	23.2	7.3	13.4	34.7	43.9	10.7	3.8	2.3	0.5	74.3	6.6	27.0	13.6	51.0	9.8	27.2	0.5	0.1	23.5	3.6	1.9	0.3	23.8	0.5	1.6	27.3	5.5	3.1	7.1	26.2	1.7	12.1	4.3	35.3	1.5	70.6	4.2	11.1	6.2	0.7	10.9	2.4	9.2	2.9	4.9	7.7	8.4	1.5	4.9	6.9	0.5	7.5	0.2	1.9	9.5	5.5	3.6	4.2	2.7	5.0	3.6	2.8	3.8	3.2	3.5	2.7	3.4	3.9	4.4	0.0	7.3	1.6	3.3	7.0	1.6	0.0	3.4	5.7	1.8	2.4	6.8	47.1	0.6	0.0	0.0	0.2	3.6	3.1	3.9	3.4	21.5	5.3	6.0	4.7	6.0	82.9	3.5	35.4	0.4	10.9	4.6	13.4	3.8	1.3	15.4	138.2	7.4	0.0	1.4	8.8	0.0	8.1	2.9	14.8	15.5	3.2	5.4	5.6	1.3	0.2	5.2	4.0	0.6	11.1	2.9	7.9	6.2	3.2	0.3	0.1	0.7	0.4	6.6	6.4	7.7	0.7	1.5	0.3	3.7	0.1	6.4	2.9	9.0	0.9
SLC7A6OS	"FLJ13291, Iwr1"	ENSG00000103061	"Solute carrier family 7 member 6 opposite strand"	Q96CW6	16	68284503-68310946	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041533	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA041533: AB_10794298"	"unprognostic (1.43e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.59e-2)"	"unprognostic (3.09e-1)"	"unprognostic (5.51e-2)"	"unprognostic (4.62e-4)"	"unprognostic (2.44e-4)"	"unprognostic (2.05e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.03e-2)"	"prognostic favorable (2.35e-4)"	"unprognostic (1.84e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.68e-1)"	13.9	8.8	9.6	10.1	11.2	13.9	12.0	11.7	10.8	10.1	9.1	9.8	8.2	9.0	10.1	8.3	9.6	6.1	13.4	9.1	9.6	9.1	6.1	8.5	16.0	11.1	10.7	9.5	8.9	8.1	6.7	9.4	11.2	9.0	7.7	8.8	9.2	6.9	17.0	9.0	11.3	6.8	10.2	13.2	9.5	6.7	10.4	13.0	10.2	8.7	12.3	9.3	8.9	12.5	11.3	11.4	16.4	12.3	9.4	12.8	18.2	14.4	8.1	16.7	14.4	29.3	15.9	19.4	12.6	9.3	10.4	20.0	15.6	12.1	14.5	7.4	10.0	13.1	20.1	24.2	12.1	18.7	13.8	9.9	13.5	13.9	21.7	14.6	12.5	16.6	20.7	8.6	15.2	16.9	24.3	19.1	11.8	13.0	9.7	28.4	10.1	24.3	10.4	14.8	17.3	12.6	27.4	6.1	15.7	12.7	16.5	17.2	18.5	13.0	11.2	12.7	11.3	21.0	18.6	29.2	13.4	22.4	13.8	28.5	12.8	26.3	14.3	15.1	16.6	14.2	14.4	13.3	10.3	15.1	15.5	12.1	11.6	14.8	14.2	12.7	16.2	12.7	9.6	11.2	11.7	10.8	9.1	9.6	11.1	10.7	11.2	10.2	10.4	12.5	15.8	9.6	6.3	2.9	20.6	9.2	13.0	12.4	9.6	22.9	8.3	11.0	1.4	12.8	9.3	12.9	35.5	24.1	24.7	7.0	17.6	13.0	3.0	10.8	16.2	13.6	13.8	8.0	4.8	11.2	12.4	12.7	11.2	10.5	14.0	20.5	13.9	6.2	21.5	16.8	5.2	7.8	12.2	14.1	7.4	2.5	15.8	11.9	12.4	1.0	20.2	25.5	30.9	5.0	4.8	17.0	7.3	16.1	15.7	16.9	10.0	9.8	13.9	23.5	0.0	11.4	11.0	16.7	18.5	10.2	6.7	22.0	21.6	19.7	9.5	14.2
SLITRK2	"CXorf1, CXorf2, KIAA1854, SLITL1, TMEM257"	ENSG00000185985	"SLIT and NTRK like family member 2"	Q9H156	X	145817829-145829856	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 12.5;retina: 32.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 33.3;Melanocytes: 26.6;Muller glia cells: 188.6;Oligodendrocyte precursor cells: 48.7;Oligodendrocytes: 25.7"	"Cancer enhanced"	"Detected in some"		"glioma: 5.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	36	"HAP1: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		150000		"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"				"unprognostic (2.13e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.73e-3)"	"unprognostic (6.79e-6)"	"unprognostic (3.39e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.89e-4)"	"unprognostic (6.23e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.53e-2)"	"unprognostic (4.13e-8)"	"unprognostic (3.12e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.14e-2)"	1.6	0.2	9.7	0.1	12.3	0.0	0.3	8.4	12.5	0.8	0.0	0.8	0.1	0.2	0.0	0.1	1.8	0.1	1.1	9.7	9.6	0.9	0.1	0.9	0.4	12.1	11.0	0.3	0.7	0.0	0.8	0.0	10.8	0.6	0.2	32.8	0.5	3.3	0.1	2.4	0.4	0.3	9.6	6.0	0.3	0.1	9.5	0.2	0.6	0.1	0.0	0.8	0.7	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	12.3	8.4	12.5	9.7	9.6	12.1	11.0	10.8	9.6	9.5	12.1	0.2	0.0	0.0	33.3	0.0	1.1	0.0	0.0	0.0	4.8	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.7	1.8	0.0	9.1	0.0	0.0	2.2	0.0	0.0	0.0	0.3	1.4	0.0	0.0	6.7	17.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	26.6	5.6	0.0	188.6	0.0	48.7	25.7	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	10.8	0.0	1.3	0.4	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0
SLMAP	"KIAA1601, SLAP"	ENSG00000163681	"Sarcolemma associated protein"	Q14BN4	3	57755450-57930003	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 295.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002357, HPA002358"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA		9200	"Cluster 49: Eosinophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Endoplasmic reticulum"		"HPA002357: AB_1080023, HPA002358: AB_1080021"	"unprognostic (3.70e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.82e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (7.98e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (1.58e-6)"	"unprognostic (8.18e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.92e-2)"	"unprognostic (6.08e-2)"	25.9	28.1	8.3	35.2	14.7	15.5	21.9	13.4	9.2	25.6	11.3	126.5	34.0	93.5	14.2	116.8	48.6	31.6	134.7	7.5	7.3	24.9	16.4	17.6	16.4	7.8	7.4	37.5	16.1	36.6	11.5	23.5	8.3	65.6	38.2	20.4	20.1	100.3	64.0	21.5	37.7	137.6	6.5	14.9	52.3	31.8	9.2	19.8	28.7	42.0	18.3	87.5	29.0	8.7	43.3	23.1	23.0	25.7	31.8	28.9	24.2	40.8	41.9	27.0	25.5	59.4	54.6	25.1	17.9	30.4	48.4	23.5	38.5	54.5	36.8	32.2	20.6	49.9	31.1	47.6	29.1	47.8	26.5	20.0	39.1	33.6	60.8	38.1	31.8	25.0	39.7	23.7	28.5	11.7	28.0	20.4	29.7	29.3	38.7	12.4	21.0	28.0	47.7	44.3	10.0	12.8	49.9	37.4	23.7	26.7	19.9	27.4	38.1	33.0	23.1	28.2	52.8	28.9	57.1	36.7	25.5	45.4	27.9	3.3	3.8	10.9	3.6	2.7	3.2	3.7	2.8	3.2	3.2	2.5	3.2	3.4	9.5	5.2	2.4	1.4	4.1	3.6	8.3	14.7	13.4	9.2	7.5	7.3	7.8	7.4	8.3	6.5	9.2	8.7	17.3	38.5	39.6	90.1	25.6	92.0	45.4	49.3	54.1	28.0	25.0	23.7	295.9	40.0	40.0	33.1	50.1	19.0	34.4	53.9	19.6	45.8	40.2	45.9	24.6	22.8	14.4	28.6	113.3	34.3	12.2	28.6	41.3	72.4	3.8	34.8	18.2	22.7	15.6	32.0	121.5	26.8	20.3	20.3	25.9	26.2	32.6	27.8	28.4	76.8	25.1	86.8	34.0	101.0	97.7	64.1	36.6	71.8	39.0	93.3	36.4	24.8	46.5	32.4	52.6	26.8	82.2	87.4	47.0	54.5	73.3	16.3	26.1	52.0	28.7	126.9
SLTM	"FLJ13213, Met"	ENSG00000137776	"SAFB like transcription modulator"	Q9NWH9	15	58879050-58933679	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040256, HPA040381"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA040256: AB_10674990, HPA040381: AB_2676953"	"unprognostic (2.36e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.52e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.44e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.10e-3)"	"unprognostic (8.03e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.69e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.24e-3)"	31.2	21.5	27.3	31.5	30.6	57.7	29.5	35.6	34.6	29.9	26.3	30.0	30.0	27.6	20.8	38.5	27.8	23.8	28.4	25.6	28.6	33.6	34.9	28.2	42.7	28.3	29.1	29.6	24.9	36.1	28.4	21.0	28.6	29.2	32.1	44.9	30.6	24.2	46.1	35.1	33.4	25.8	27.5	38.1	38.9	27.8	28.7	57.3	34.1	43.6	44.1	33.8	31.3	31.3	77.8	84.1	72.0	36.6	48.1	36.2	60.6	55.1	64.3	49.9	48.2	58.4	45.7	144.6	50.5	50.8	54.4	67.9	72.3	62.9	68.7	93.7	46.4	105.4	91.8	44.7	42.0	83.8	78.1	34.1	61.0	52.8	44.1	30.4	46.9	66.0	95.5	81.7	58.2	56.1	84.1	64.6	80.9	46.3	40.5	63.6	65.4	70.1	60.2	99.8	58.9	50.8	57.0	55.1	57.8	79.3	44.0	90.1	48.6	60.2	88.5	66.3	74.6	57.3	123.1	105.5	47.6	101.7	61.5	67.9	30.3	44.4	45.2	29.5	46.1	53.5	36.0	39.3	31.2	47.3	39.2	35.6	42.8	47.0	37.7	53.6	36.5	22.7	27.3	30.6	35.6	34.6	25.6	28.6	28.3	29.1	28.6	27.5	28.7	31.3	92.5	153.8	161.2	61.4	125.8	96.9	100.2	85.6	107.0	116.3	77.3	66.0	107.8	64.3	122.8	106.7	98.0	73.5	155.9	88.4	78.2	98.4	100.8	110.5	99.0	94.7	73.4	115.7	67.7	115.7	160.1	94.3	99.4	119.1	118.9	75.3	63.9	104.1	63.9	119.5	67.3	94.4	59.0	88.6	73.0	120.8	86.3	108.8	78.2	72.1	121.0	84.9	126.7	74.4	141.8	131.1	76.5	88.4	140.0	92.4	57.4	90.6	103.9	145.3	72.3	106.6	95.6	215.1	85.2	100.0	104.6	112.5	134.9	78.0	94.0	125.6
SLX4	"BTBD12, FANCP, KIAA1784, KIAA1987"	ENSG00000188827	"SLX4 structure-specific endonuclease subunit"	Q8IY92	16	3581181-3611606	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"		"Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 10.6"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049421, HPA066238"	Approved		Supported	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cell Junctions, Cytosol"	"HPA049421: AB_2680759, HPA066238: AB_2685642"	"unprognostic (1.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.62e-1)"	"unprognostic (6.08e-3)"	"unprognostic (8.28e-5)"	"unprognostic (6.52e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.32e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.74e-2)"	1.8	2.1	2.1	2.9	1.9	3.0	1.6	7.1	2.7	2.1	0.4	2.3	2.2	2.1	1.3	2.4	2.0	1.1	1.9	2.3	2.1	1.9	1.9	2.1	4.1	2.3	2.0	1.6	1.7	1.1	3.9	1.1	1.8	2.3	0.9	1.7	1.6	1.0	2.7	1.8	2.8	1.2	1.1	3.4	2.2	10.6	1.9	2.7	1.8	1.3	2.9	2.1	2.0	2.1	2.7	8.4	5.3	6.7	2.0	2.1	5.6	4.3	2.2	4.9	5.4	4.2	3.3	10.0	4.2	2.2	3.8	6.0	3.6	3.0	2.9	8.4	4.6	6.8	6.5	2.7	1.8	6.7	9.3	1.5	2.2	4.6	2.6	1.2	3.6	5.6	6.7	5.3	3.9	4.7	4.2	5.9	4.5	1.7	3.1	8.2	8.9	2.8	1.9	1.9	4.5	4.1	3.8	2.6	1.3	2.8	6.5	5.2	4.3	5.6	7.8	4.9	5.1	4.8	4.0	11.4	1.8	6.7	5.7	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	2.1	1.9	7.1	2.7	2.3	2.1	2.3	2.0	1.8	1.1	1.9	2.1	2.7	0.0	2.3	4.6	4.5	0.8	0.8	1.1	4.0	8.7	2.0	1.4	1.7	1.5	3.2	0.0	2.1	1.7	3.4	2.0	0.0	1.5	6.5	5.5	4.2	1.8	0.0	6.5	9.5	2.4	1.6	2.4	3.6	4.6	0.0	4.8	1.1	1.4	2.9	0.0	9.3	2.4	2.0	2.9	1.6	2.3	2.1	5.1	0.0	4.7	2.2	2.7	4.1	7.1	5.5	2.0	0.3	1.9	4.0	0.4	2.3	0.6	2.3	10.1	0.0	4.9	2.5	20.0	9.1	2.3	0.6	1.0	4.4	3.0	2.1	0.6
SMARCA5	"hISWI, hSNF2H, ISWI"	ENSG00000153147	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5"	O60264	4	143513702-143557486	"Predicted intracellular proteins, Transcription factors"		"Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 307.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005227, HPA008751"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Nucleoli fibrillar center"		"CAB005227: AB_2191863, HPA008751: AB_1857268"	"unprognostic (9.21e-3)"	"unprognostic (7.99e-2)"	"unprognostic (4.99e-3)"	"unprognostic (8.03e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.47e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (3.85e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.82e-1)"	16.9	26.0	15.1	21.1	20.1	32.7	17.6	17.6	17.3	18.1	13.5	17.2	14.9	20.4	20.5	14.1	14.6	19.3	17.1	13.0	16.6	16.7	16.8	27.9	27.0	17.9	16.8	21.2	16.4	22.6	13.5	22.8	19.1	18.1	17.9	26.4	12.4	17.0	15.3	11.1	16.4	18.4	18.3	22.8	16.2	32.6	16.0	29.9	23.1	15.3	25.7	22.7	11.0	26.0	33.4	25.8	92.5	58.5	53.4	38.4	55.5	41.5	49.4	59.5	50.0	44.3	45.8	90.0	27.9	35.7	23.7	26.0	85.9	38.9	57.1	60.2	30.2	67.7	36.9	36.7	39.3	84.2	38.3	34.0	27.8	42.1	36.0	34.5	46.9	45.1	62.0	55.4	39.2	30.1	98.7	29.4	75.7	55.6	36.6	108.2	59.1	29.4	46.6	40.4	73.6	62.2	54.0	37.9	49.5	69.2	27.4	39.1	50.0	38.9	29.7	41.0	41.2	60.0	77.4	106.8	30.6	69.5	40.3	5.8	10.7	16.0	12.7	12.8	15.3	11.4	13.1	14.2	13.3	11.2	13.4	13.6	9.4	15.8	21.5	10.0	16.7	11.5	15.1	20.1	17.6	17.3	13.0	16.6	17.9	16.8	19.1	18.3	16.0	26.0	77.3	307.7	291.0	30.7	95.7	46.4	78.9	50.6	55.2	93.9	56.4	49.0	104.1	31.5	96.9	44.1	64.6	70.6	125.6	39.8	39.2	77.9	63.2	104.5	127.1	74.3	79.9	85.4	42.5	61.4	66.4	73.8	46.4	94.2	103.1	97.3	39.3	25.4	44.8	85.8	41.7	41.3	69.2	51.9	49.4	27.9	60.3	79.2	30.2	27.2	98.6	84.7	55.6	37.7	85.2	66.0	35.3	62.1	93.9	57.7	36.6	36.8	109.6	116.4	52.6	113.9	88.3	144.4	130.8	47.4	40.9	102.1	107.9	118.7	46.2	71.2
SMARCC1	"BAF155, CRACC1, Rsc8, SRG3"	ENSG00000173473	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1"	Q92922	3	47585269-47782106	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011576, CAB016336, HPA024352, HPA026853"	Supported		Enhanced	Nucleoplasm		NA	NA		31000	"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB011576: AB_2191988, CAB016336: AB_671095, HPA024352: AB_1857274, HPA026853: AB_10603030"	"unprognostic (3.47e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (3.34e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.83e-2)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (1.33e-2)"	"unprognostic (4.28e-3)"	"unprognostic (6.92e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.66e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.84e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.45e-1)"	12.2	8.1	19.6	18.6	21.1	21.2	23.5	16.2	19.6	19.3	17.0	23.0	14.7	18.3	15.6	20.1	13.1	11.8	9.4	15.9	17.7	20.0	13.8	13.1	22.2	18.3	19.8	17.8	19.5	14.3	8.3	22.2	18.8	22.4	21.9	9.6	17.0	17.1	19.0	24.1	16.9	16.3	19.7	16.3	16.9	16.7	18.9	34.8	17.7	10.3	30.3	21.0	15.9	20.9	45.1	23.4	95.7	74.9	21.0	35.7	64.3	35.1	32.7	44.5	45.1	42.3	46.6	104.3	27.7	44.4	25.8	37.7	91.2	54.3	64.6	50.3	54.1	102.4	38.4	57.7	31.4	94.8	45.3	30.1	47.0	50.1	55.2	33.1	52.8	68.7	87.5	34.4	48.4	33.4	124.4	48.9	126.8	43.2	35.4	55.1	55.5	92.0	47.2	58.0	42.6	85.5	54.5	52.7	38.9	66.5	45.8	87.1	42.7	29.6	41.7	33.9	58.0	41.9	57.1	122.0	21.6	88.1	42.5	1.9	1.6	1.7	2.7	2.6	2.4	3.9	3.0	3.7	2.1	2.6	2.8	3.3	1.9	2.0	1.9	2.2	3.1	1.9	19.6	21.1	16.2	19.6	15.9	17.7	18.3	19.8	18.8	19.7	18.9	20.9	30.4	41.7	45.9	56.5	61.7	53.0	60.5	37.4	71.7	29.3	60.3	45.5	31.5	34.3	58.9	57.0	37.5	79.7	43.7	30.1	13.7	67.9	88.9	60.2	72.3	38.3	91.6	76.9	47.3	46.7	113.0	32.7	49.5	115.7	24.6	103.8	22.1	37.8	30.2	20.2	52.2	64.5	34.6	32.3	36.9	113.1	25.4	41.6	23.2	42.2	57.7	18.9	52.5	98.0	104.9	58.8	29.0	28.6	65.3	83.7	24.1	38.0	34.0	33.0	39.5	44.7	60.1	59.4	108.3	86.0	66.8	72.5	52.4	77.6	61.8	62.4
SMC1A	"DXS423E, KIAA0178, SB1.8, SMC1L1, Smcb"	ENSG00000072501	"Structural maintenance of chromosomes 1A"	Q14683	X	53374149-53422728	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"		"Cancer-related genes, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005499, CAB025404"	Supported		Enhanced	Nucleoplasm		NA	NA		33000	"Cluster 27: Non-specific - Gene expression"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB025404: , HPA005499: AB_1080028"	"unprognostic (2.00e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.00e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.89e-1)"	"unprognostic (9.80e-3)"	"unprognostic (9.49e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.18e-3)"	"unprognostic (6.28e-2)"	"unprognostic (2.89e-1)"	"unprognostic (9.39e-2)"	16.6	11.8	8.7	28.4	11.7	30.3	17.2	15.0	9.5	13.8	9.6	20.0	18.6	21.0	8.0	17.1	16.7	11.5	15.6	7.8	9.5	16.3	18.8	16.0	34.4	10.2	10.7	19.1	14.4	25.8	6.3	18.2	10.7	14.0	18.4	21.0	15.1	13.0	17.9	18.1	15.9	22.9	8.7	20.1	15.7	7.8	11.3	58.1	16.8	18.8	29.9	15.5	12.4	13.9	110.0	115.1	92.4	76.1	32.4	35.4	51.5	68.0	37.0	76.4	59.4	71.6	60.5	115.8	54.1	40.7	105.2	78.9	162.9	92.6	85.1	91.7	176.0	94.3	133.9	51.1	15.4	134.9	120.9	20.6	23.3	86.0	52.8	19.4	67.5	68.7	144.7	64.7	58.6	69.2	122.0	40.8	139.9	47.8	55.6	117.2	165.5	100.1	34.4	69.4	92.8	83.5	176.9	84.4	33.5	122.8	87.9	54.0	45.7	63.3	68.0	65.1	62.2	45.8	77.9	91.9	39.1	152.1	64.1	2.7	6.8	4.5	7.3	8.5	7.6	5.4	5.8	6.7	8.4	5.8	5.2	6.3	2.7	4.6	12.4	4.6	5.7	6.7	8.7	11.7	15.0	9.5	7.8	9.5	10.2	10.7	10.7	8.7	11.3	13.9	40.7	44.8	39.9	16.0	45.6	24.1	37.0	27.7	28.5	46.6	30.7	27.4	63.5	27.1	47.4	20.2	27.1	43.2	57.7	49.6	7.9	31.6	10.5	46.5	62.6	41.7	19.9	70.7	12.0	27.1	61.4	37.2	29.0	44.0	35.4	42.7	18.9	54.1	47.6	60.6	14.2	43.5	22.4	41.1	27.6	7.6	37.9	51.5	23.2	24.4	55.2	38.1	59.8	16.6	30.2	33.1	23.6	36.1	61.2	40.7	29.0	24.6	47.1	48.4	39.5	49.5	71.0	54.5	51.2	39.8	24.4	48.4	47.9	34.0	51.4	32.0
SMC2	"CAP-E, hCAP-E, SMC2L1"	ENSG00000136824	"Structural maintenance of chromosomes 2"	O95347	9	104094260-104141419	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 25.7"	"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 114.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071309	Approved		Supported	Nucleoplasm,Nucleoli		Yes	No		26000	"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"HPA071309: AB_2686385"	"unprognostic (1.51e-1)"	"unprognostic (2.01e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.57e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.47e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.56e-3)"	"unprognostic (8.02e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.32e-2)"	5.2	4.1	2.8	11.3	4.0	18.4	6.6	4.4	3.3	7.5	1.3	8.2	7.5	6.0	2.6	7.3	4.7	4.0	7.9	2.2	4.0	6.3	4.7	4.5	16.0	4.9	3.7	4.7	3.5	5.7	1.5	6.9	4.1	4.2	8.8	5.6	3.1	4.7	2.2	7.4	7.6	5.4	3.5	7.2	6.1	12.0	3.5	25.7	7.6	5.4	15.9	4.9	3.2	5.0	59.3	45.0	49.4	45.9	10.3	14.9	46.2	53.5	25.4	46.9	39.4	39.3	44.9	112.6	25.2	27.7	40.5	97.6	72.3	34.8	63.2	71.6	30.3	67.9	68.8	25.5	2.7	41.5	65.6	9.8	7.0	63.7	25.7	15.9	33.7	71.2	55.8	89.8	43.0	28.9	109.1	21.3	42.9	47.6	34.8	72.0	141.3	42.2	20.1	21.1	46.5	35.9	63.8	29.6	15.5	20.5	59.5	28.0	27.1	56.8	59.1	79.3	67.9	32.6	118.2	64.6	36.8	59.8	70.3	15.0	2.2	2.5	4.8	5.9	5.4	7.3	4.4	4.8	2.6	7.9	5.0	5.8	0.3	7.0	7.4	4.4	6.0	2.4	2.8	4.0	4.4	3.3	2.2	4.0	4.9	3.7	4.1	3.5	3.5	5.0	19.6	25.6	11.9	6.5	19.9	27.3	16.4	27.6	11.4	39.7	16.6	19.3	45.1	7.2	17.8	16.5	8.4	54.3	15.2	13.7	35.2	18.9	40.0	114.6	21.6	21.4	4.9	95.3	10.2	20.4	93.8	20.2	13.3	16.0	22.2	40.4	21.0	7.6	44.3	28.6	15.5	14.6	26.4	19.8	19.8	24.7	18.6	22.9	7.2	7.5	19.8	15.6	22.6	5.5	18.4	15.6	6.3	12.4	40.9	7.3	10.3	15.0	12.0	19.1	13.1	25.1	37.7	84.5	93.5	27.4	23.2	25.9	18.1	28.1	35.0	14.2
SMC3	"BAM, bamacan, CSPG6, HCAP, SMC3L1"	ENSG00000108055	"Structural maintenance of chromosomes 3"	Q9UQE7	10	110567695-110606048	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"		"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Spermatocytes: 994.2;Spermatogonia: 799.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043206	Approved		Supported	Nucleoplasm		NA	NA		630000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA043206: AB_2678362"	"unprognostic (3.40e-1)"	"unprognostic (1.73e-2)"	"unprognostic (9.05e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.89e-3)"	"unprognostic (9.74e-3)"	"unprognostic (8.06e-2)"	"unprognostic (5.31e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.17e-2)"	"unprognostic (8.73e-3)"	"unprognostic (7.22e-2)"	"unprognostic (5.18e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.32e-1)"	19.5	13.3	9.0	18.7	10.9	43.9	19.1	18.5	11.7	18.5	11.7	18.3	15.5	20.3	15.7	19.2	16.5	11.1	12.9	8.6	10.2	14.0	15.3	14.5	25.2	10.2	9.4	25.7	19.6	20.0	14.2	20.7	10.4	14.0	16.7	27.6	16.2	15.2	21.1	20.6	19.4	16.9	9.6	18.6	14.7	38.1	9.5	39.2	16.5	14.1	24.3	15.5	17.8	12.7	73.1	44.5	95.4	67.8	30.7	26.3	40.9	57.7	56.7	51.9	50.7	56.4	59.7	94.2	24.5	38.6	40.0	56.5	68.7	35.0	78.6	77.3	60.1	76.5	56.2	51.2	30.8	109.8	56.6	21.1	28.0	57.4	89.5	48.5	38.8	31.7	61.7	70.4	45.4	38.1	85.2	58.3	66.1	38.6	35.1	71.1	171.5	51.4	32.4	31.7	53.7	61.8	62.0	17.7	48.6	61.8	28.5	53.1	40.1	41.6	65.5	47.6	84.4	40.9	38.8	99.6	37.5	103.9	34.8	20.7	6.1	15.8	9.6	8.4	12.1	11.0	11.3	10.6	6.8	11.0	11.3	11.2	6.5	12.6	7.6	8.7	14.5	6.2	9.0	10.9	18.5	11.7	8.6	10.2	10.2	9.4	10.4	9.6	9.5	12.7	74.9	80.1	62.0	16.6	73.5	60.5	53.2	64.1	34.7	81.3	44.3	49.9	64.5	47.1	64.4	55.2	75.0	119.6	94.3	29.8	25.4	96.9	56.9	52.0	65.0	74.9	40.7	104.6	26.2	45.6	111.4	66.0	20.9	49.0	56.3	124.9	40.4	31.9	59.1	60.6	29.2	40.7	54.9	37.9	42.5	34.6	115.2	49.8	37.4	19.7	96.1	54.9	98.9	33.2	43.4	53.0	70.1	114.0	65.0	44.7	70.7	30.3	68.3	78.9	184.1	102.0	110.6	994.2	799.1	48.1	64.5	49.1	80.9	112.7	51.9	37.5
SMC4	"CAP-C, hCAP-C, SMC4L1"	ENSG00000113810	"Structural maintenance of chromosomes 4"	Q9NTJ3	3	160399274-160434954	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 60.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 305.8;Spermatocytes: 339.8;Spermatogonia: 239.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"basophil: 74.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029449, CAB055509"	Approved		Supported	"Nuclear speckles,Cytosol"		NA	Yes		25000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear speckles, Cytosol"		"CAB055509: , HPA029449: AB_10603891"	"unprognostic (2.63e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.28e-2)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (9.54e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.47e-2)"	"prognostic unfavorable (4.20e-5)"	"prognostic unfavorable (9.00e-4)"	"prognostic unfavorable (8.05e-7)"	"unprognostic (3.03e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.98e-2)"	6.8	6.5	1.0	21.2	2.0	36.3	6.8	1.2	1.7	6.3	1.5	13.2	14.0	7.4	2.3	23.5	4.5	7.6	7.3	0.9	1.9	5.9	7.8	11.8	37.1	1.7	1.4	5.9	7.8	3.8	2.0	16.2	1.6	5.8	14.9	7.7	4.6	5.0	3.6	11.0	15.4	10.1	1.3	14.7	11.8	32.5	1.9	60.6	9.0	6.8	31.6	9.6	4.3	3.2	386.3	72.8	155.0	73.0	31.5	30.9	72.1	181.2	88.8	206.0	176.8	94.4	209.7	236.6	101.9	81.1	140.0	212.5	183.0	95.0	332.4	297.9	113.8	234.7	123.3	33.6	17.3	158.3	182.6	14.6	13.3	114.4	96.5	78.5	94.8	103.2	130.3	272.2	133.9	78.3	183.2	44.4	91.8	106.7	149.3	180.1	238.8	177.3	43.4	54.8	93.7	94.0	141.4	135.1	65.5	76.6	156.9	128.6	84.8	132.2	105.2	119.9	349.8	181.1	192.2	412.0	96.7	166.9	151.9	74.4	6.0	23.6	11.5	8.9	11.4	17.2	18.2	14.3	6.6	15.0	11.4	10.2	10.8	15.3	15.9	11.7	30.3	9.5	1.0	2.0	1.2	1.7	0.9	1.9	1.7	1.4	1.6	1.3	1.9	3.2	24.6	105.8	174.0	3.9	43.7	40.8	18.2	33.1	30.7	14.9	21.5	21.0	41.3	25.8	35.0	35.0	8.4	74.6	54.4	41.4	3.9	20.9	48.6	35.2	27.0	44.8	30.1	305.8	3.5	14.7	138.1	50.7	32.6	36.1	79.1	77.3	38.2	20.4	61.3	0.0	2.9	44.5	24.4	29.7	43.5	28.3	25.1	36.4	17.8	17.8	39.3	9.3	46.4	3.5	30.1	13.5	26.5	48.2	95.9	14.1	25.9	8.6	25.4	25.8	131.5	21.7	73.2	339.8	239.4	58.1	35.7	34.1	58.4	34.6	69.7	19.1
SMC5	"KIAA0594, SMC5L1"	ENSG00000198887	"Structural maintenance of chromosomes 5"	Q8IY18	9	70258978-70354873	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA054900	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA054900: AB_2682634"	"unprognostic (2.55e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.72e-1)"	"unprognostic (8.04e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.36e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.80e-1)"	10.2	7.7	4.3	15.0	4.8	26.0	16.6	10.4	5.0	12.2	9.0	15.0	13.5	15.2	12.8	10.8	12.3	12.9	9.9	4.2	6.1	8.0	14.8	12.8	18.5	5.2	5.7	25.2	19.4	10.4	9.6	14.8	5.7	11.4	16.9	8.3	17.1	8.7	13.8	9.0	13.9	10.7	4.2	12.0	14.5	13.5	4.9	18.2	14.3	8.2	16.1	16.4	11.3	7.8	43.9	10.8	26.6	16.2	15.1	28.3	20.9	29.8	25.8	15.9	17.3	4.1	23.3	43.7	9.5	22.5	13.9	39.3	28.9	19.8	31.7	19.9	10.3	25.5	18.3	13.1	19.2	41.8	25.3	19.9	13.5	21.5	24.5	25.4	16.9	25.8	19.1	17.1	29.9	6.7	55.4	14.7	20.4	33.5	14.9	32.4	43.6	13.7	16.1	21.3	18.9	14.2	29.5	18.7	8.3	19.2	11.2	17.6	18.6	21.3	22.4	29.2	41.2	20.9	29.9	29.9	17.9	21.6	25.9	14.1	5.6	10.4	8.5	6.3	8.0	8.4	7.3	8.1	4.6	8.2	8.0	7.4	3.7	8.1	7.6	8.7	8.4	4.0	4.3	4.8	10.4	5.0	4.2	6.1	5.2	5.7	5.7	4.2	4.9	7.8	48.9	57.7	70.3	61.7	54.6	45.6	102.0	30.3	59.7	26.8	39.2	34.0	34.6	41.5	62.0	20.2	29.2	32.1	65.2	38.8	9.8	61.3	47.9	65.3	58.9	37.6	28.1	29.0	72.2	54.8	37.5	62.1	40.8	89.1	51.8	52.5	16.1	25.9	16.4	38.7	66.4	34.8	20.3	22.9	30.8	15.9	53.4	37.9	24.9	74.0	65.4	17.2	54.6	85.5	94.6	68.3	37.9	59.5	40.6	105.5	23.6	11.7	51.0	35.7	26.3	66.2	52.2	80.0	55.0	52.5	41.9	35.6	56.7	58.4	45.0	105.8
SMC6	"FLJ22116, SMC6L1"	ENSG00000163029	"Structural maintenance of chromosomes 6"	Q96SB8	2	17663812-17800242	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 153.4;Spermatocytes: 150.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035057, CAB037186, HPA042733"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB037186: AB_1080031, HPA035057: AB_2674435, HPA042733: AB_2678134"	"unprognostic (1.75e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.70e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.38e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.94e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (3.15e-4)"	"unprognostic (7.02e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.25e-2)"	8.4	5.2	6.8	14.7	7.6	13.3	8.5	11.4	7.7	9.5	31.9	11.9	9.0	9.4	17.4	13.2	8.7	9.4	8.6	8.0	8.4	8.9	17.2	9.0	21.6	6.2	6.9	6.9	6.1	6.0	11.6	14.2	7.4	6.7	13.3	6.8	12.4	10.8	9.4	14.7	11.4	8.7	5.3	14.9	9.8	35.2	8.4	14.3	7.7	8.8	22.6	8.6	11.4	10.6	50.6	24.8	31.9	26.6	33.6	32.2	32.2	26.4	18.6	16.7	16.2	27.9	19.4	43.9	16.6	24.2	27.9	34.4	38.5	31.0	25.7	52.3	25.2	60.3	16.2	42.1	31.3	42.3	31.2	24.3	21.4	27.0	35.1	20.5	38.9	26.4	67.5	35.4	31.9	20.8	32.8	21.7	43.3	25.3	19.7	38.7	90.0	29.9	16.2	27.7	28.0	29.9	38.4	20.0	30.0	35.1	12.7	18.7	42.7	41.3	16.5	32.5	47.2	25.0	43.5	87.9	21.0	45.7	30.0	2.2	3.8	8.2	7.8	4.2	6.6	24.8	6.0	7.1	5.1	26.4	4.3	6.0	3.1	7.5	6.7	27.7	14.4	4.1	6.8	7.6	11.4	7.7	8.0	8.4	6.2	6.9	7.4	5.3	8.4	10.6	25.6	48.1	12.5	34.9	63.7	18.2	21.6	41.5	68.3	15.2	8.4	9.3	36.5	14.3	30.8	5.5	12.5	15.2	51.5	18.9	11.7	17.0	153.4	33.0	26.3	21.9	11.3	36.6	51.1	11.7	27.5	21.0	32.1	18.2	20.8	38.6	15.7	19.3	17.6	6.7	47.9	15.7	16.2	10.0	9.1	123.7	22.4	20.1	26.6	30.0	22.0	12.5	25.7	56.3	60.5	19.7	17.2	27.4	25.3	25.1	16.0	14.5	27.2	17.4	46.0	41.2	67.8	150.0	87.9	37.4	14.2	12.4	22.2	28.9	21.2	14.9
SMCHD1	"FSHD2, KIAA0650"	ENSG00000101596	"Structural maintenance of chromosomes flexible hinge domain containing 1"	A6NHR9	18	2655726-2805017	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator, DNA-binding, Hydrolase"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"B-cells: 363.7;Plasma cells: 391.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	8	"neutrophil: 58.7"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 58.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039441	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 2: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nuclear bodies"	"HPA039441: AB_10671042"	"unprognostic (2.99e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.03e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (5.39e-4)"	"unprognostic (1.32e-1)"	"unprognostic (4.14e-2)"	"unprognostic (3.11e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.63e-2)"	13.6	6.9	5.4	24.6	6.6	41.1	12.4	11.4	8.3	16.5	6.8	14.4	13.7	14.9	9.2	8.7	14.1	12.4	10.1	5.0	6.6	6.5	8.4	19.0	33.9	7.2	6.1	15.4	16.3	11.9	7.9	16.3	7.4	13.4	14.7	16.3	10.1	11.2	11.0	9.1	20.3	12.8	6.4	28.6	12.4	14.1	6.3	25.6	9.6	11.5	22.4	15.0	14.2	8.7	24.1	10.7	35.8	22.6	15.0	21.8	25.7	23.7	16.8	22.0	27.7	20.3	7.7	51.6	10.2	21.2	24.7	13.0	29.1	13.6	34.4	10.7	15.1	32.3	21.7	19.5	16.8	93.9	24.3	14.4	12.2	27.9	22.8	16.8	18.3	25.5	38.3	31.1	21.3	8.6	39.4	23.9	14.4	13.0	12.4	31.7	29.1	22.9	13.6	36.5	29.2	18.4	32.0	10.6	18.8	19.8	7.9	39.3	17.5	27.1	37.4	37.1	44.0	18.8	30.4	46.5	17.4	17.1	24.0	5.1	2.5	6.6	3.6	1.7	2.6	5.8	4.8	4.3	0.9	7.5	5.9	3.8	58.7	2.3	2.3	2.6	5.4	1.3	5.4	6.6	11.4	8.3	5.0	6.6	7.2	6.1	7.4	6.4	6.3	8.7	96.5	44.8	44.7	71.5	363.7	27.1	35.3	14.5	48.9	112.1	33.3	32.8	53.0	15.7	27.7	18.4	100.1	36.5	232.7	102.7	5.9	23.4	117.2	43.6	83.3	53.0	22.7	69.0	98.4	19.4	22.3	52.8	68.3	75.9	40.4	54.2	30.7	16.4	19.4	99.3	127.2	35.5	10.2	65.4	69.7	38.6	42.0	116.3	30.2	121.8	142.5	32.3	120.5	111.1	130.4	23.6	60.1	38.0	391.1	52.0	46.5	6.1	22.5	88.5	39.5	59.7	69.8	166.7	115.3	41.3	24.9	46.9	257.9	45.9	30.4	57.8
SMG1	"ATX, KIAA0421, LIP"	ENSG00000157106	"SMG1 nonsense mediated mRNA decay associated PI3K related kinase"	Q96Q15	16	18804860-18926408	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Nonsense-mediated mRNA decay"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 31.7"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 31.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006870, HPA031623, HPA073972"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA006870: AB_1079725, HPA031623: AB_2673962, HPA073972: AB_2686648"	"unprognostic (6.34e-2)"	"unprognostic (5.88e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.32e-3)"	"unprognostic (7.28e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.45e-2)"	12.9	8.4	11.0	16.1	11.0	39.0	19.5	42.6	12.6	13.4	11.9	14.4	11.6	14.1	15.8	14.2	12.1	10.8	13.5	12.0	7.5	14.6	17.8	11.4	21.6	7.5	6.7	18.6	13.0	15.2	10.2	11.5	9.9	12.1	15.9	20.9	12.0	10.9	53.1	42.0	13.6	13.2	1.9	15.9	12.8	14.5	12.6	29.9	18.1	35.4	19.1	15.4	13.2	16.6	42.2	27.5	25.5	18.1	28.6	29.9	18.8	19.1	18.8	20.4	22.7	24.4	15.1	57.5	26.8	26.8	21.5	23.3	29.6	16.7	32.3	37.2	18.4	26.2	25.8	31.4	23.1	35.7	19.9	17.7	27.5	42.4	50.5	20.1	29.1	30.7	41.0	31.0	22.8	22.0	24.8	20.9	27.2	15.3	15.7	28.4	34.2	19.8	17.6	32.1	23.0	17.6	29.9	19.9	20.8	20.8	15.9	22.3	37.0	30.2	20.4	19.0	28.7	15.8	21.8	37.0	20.2	27.1	18.6	31.7	2.7	4.2	6.6	3.2	3.2	4.0	4.4	4.8	2.9	7.6	5.7	5.1	8.4	2.6	7.2	5.3	4.5	1.4	11.0	11.0	42.6	12.6	12.0	7.5	7.5	6.7	9.9	1.9	12.6	16.6	83.2	76.9	85.4	58.4	98.8	193.2	73.0	26.9	112.1	52.0	71.3	40.5	48.1	32.9	67.1	27.6	75.0	21.3	97.4	65.5	3.9	21.7	20.3	88.1	81.1	66.5	39.4	44.8	81.5	23.6	19.0	57.3	90.7	140.0	39.3	66.1	37.9	46.1	24.1	42.1	75.2	41.8	36.7	48.0	112.8	24.9	29.8	82.5	39.2	68.4	61.4	20.5	72.1	48.7	87.5	34.6	76.9	26.4	82.2	94.2	43.0	15.6	45.9	44.8	46.0	118.2	63.1	49.6	32.2	107.1	204.4	30.0	97.6	37.6	46.4	95.4
SMG7	"C1orf16, EST1C, KIAA0250, SGA56M, SMG-7"	ENSG00000116698	"SMG7 nonsense mediated mRNA decay factor"	Q92540	1	183472216-183598246	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029350	Supported		Supported	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Intermediate filaments, Cytosol"		"HPA029350: AB_10603031"	"unprognostic (6.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.44e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.01e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.47e-3)"	"unprognostic (7.82e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.40e-3)"	17.4	16.2	19.2	21.9	20.8	43.1	17.0	28.1	24.4	19.6	21.4	20.0	20.5	19.6	15.4	22.9	25.9	15.3	22.0	20.4	18.1	21.8	22.7	18.7	25.8	16.5	17.8	25.9	21.8	24.8	20.4	18.9	16.0	17.0	23.8	32.0	21.6	16.1	25.8	25.3	20.5	17.9	16.0	21.5	22.4	67.5	19.5	35.7	23.5	27.9	30.2	18.1	19.3	20.0	56.4	33.6	47.5	37.3	31.8	29.8	78.9	33.8	61.8	36.9	28.0	50.1	42.8	78.9	37.9	42.1	33.5	59.4	64.5	50.1	43.4	35.2	28.1	63.8	36.3	41.0	32.1	84.4	39.1	27.3	45.0	50.6	116.1	30.0	41.0	42.9	80.6	54.0	38.8	56.9	59.7	37.1	82.4	66.9	19.1	37.2	53.0	61.9	28.3	51.7	63.7	49.7	52.2	73.1	40.5	80.4	72.9	34.0	39.3	41.5	42.9	41.7	48.5	58.6	74.3	63.5	33.8	46.9	45.3	2.0	5.8	6.2	5.6	5.7	5.1	5.5	5.0	5.5	6.6	4.7	5.5	5.9	6.8	5.9	3.2	7.0	4.9	5.1	19.2	20.8	28.1	24.4	20.4	18.1	16.5	17.8	16.0	16.0	19.5	20.0	31.3	22.4	20.6	66.3	26.8	27.0	11.6	13.9	23.3	22.6	21.4	15.6	31.8	20.0	20.5	27.6	31.3	11.4	23.9	38.5	9.8	12.1	58.1	39.8	23.6	26.8	34.6	28.8	63.0	15.8	16.5	14.9	31.1	48.0	22.1	19.4	25.4	45.2	13.2	30.3	63.0	23.0	6.1	38.6	48.6	49.5	15.2	25.2	10.6	52.5	20.0	9.6	15.5	70.9	99.1	17.6	19.9	12.4	36.2	16.7	30.4	12.9	30.5	19.0	39.5	14.5	23.8	35.2	23.8	30.8	26.9	10.8	24.2	13.0	18.8	23.2
SMG8	"C17orf71, FLJ10587, FLJ23205"	ENSG00000167447	"SMG8 nonsense mediated mRNA decay factor"	Q8ND04	17	59209400-59215239	"Predicted intracellular proteins, Predicted membrane proteins"	"Nonsense-mediated mRNA decay"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA024841	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA024841: AB_10600790"	"unprognostic (2.68e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.51e-3)"	"unprognostic (9.91e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (3.72e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.18e-3)"	"unprognostic (4.65e-2)"	"unprognostic (9.37e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.75e-1)"	5.9	7.0	5.0	6.4	5.3	10.9	8.5	5.7	6.8	7.4	5.5	6.0	5.9	7.4	6.9	6.5	8.5	5.1	7.5	5.3	6.4	7.1	7.7	6.3	9.5	5.2	5.7	11.2	5.2	9.4	4.1	9.2	5.8	6.6	6.0	4.6	6.3	6.9	8.3	7.3	5.4	7.2	5.7	7.4	5.9	7.5	6.2	10.2	8.1	8.4	10.1	6.7	3.9	6.3	16.2	22.6	17.4	17.5	21.4	18.0	23.5	23.1	23.5	31.7	27.3	15.5	14.1	23.8	35.2	22.1	24.6	19.2	28.3	21.4	30.6	31.5	27.0	27.3	12.2	22.2	24.6	26.8	22.6	23.6	26.2	23.2	17.2	21.0	21.1	14.7	33.5	12.2	22.0	36.2	25.9	12.4	17.1	23.3	22.0	17.3	26.0	22.5	14.9	11.5	15.4	24.9	16.2	8.9	19.3	21.7	26.9	18.7	20.5	11.9	27.0	13.0	20.8	23.7	36.3	27.3	15.2	14.0	19.8	26.7	18.6	9.6	8.7	24.2	10.2	10.0	8.1	8.3	15.0	6.2	8.0	7.3	4.7	10.2	26.4	5.0	8.3	9.0	5.0	5.3	5.7	6.8	5.3	6.4	5.2	5.7	5.8	5.7	6.2	6.3	1.0	3.2	2.6	4.6	3.8	0.6	0.3	0.9	1.8	0.8	0.7	0.4	0.9	0.0	1.8	0.0	0.0	1.0	1.2	2.4	0.0	2.7	0.3	1.6	1.9	1.8	1.8	1.3	3.4	2.8	1.0	1.6	3.1	1.6	5.7	1.5	1.1	1.0	0.8	3.3	3.7	0.5	0.0	2.4	0.0	0.0	0.9	2.4	0.0	0.0	2.3	0.6	1.0	4.5	5.0	2.9	6.3	0.7	3.6	0.2	0.8	0.6	3.5	1.1	0.0	1.6	3.0	1.2	1.3	3.1	0.6	1.4	2.3	2.1	1.5	0.3
SMIM10L2A	"LED, LINC00086, LINC0086, MGC39606, NCRNA00086"	ENSG00000178947	"Small integral membrane protein 10 like 2A"	P0DMW4	X	135421944-135428075	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 30.3;brain: 28.2;epididymis: 14.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 6.5;Distal tubular cells: 7.9;Granulosa cells: 8.4;Proximal tubular cells: 12.4;Rod photoreceptor cells: 6.6;Theca cells: 16.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 15.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.1;CACO-2: 2.6;HAP1: 10.3;hTCEpi: 5.4"															NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (4.22e-2)"	"unprognostic (4.72e-2)"	"unprognostic (4.50e-2)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (8.62e-3)"	"unprognostic (5.83e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.55e-3)"	"unprognostic (1.36e-1)"	"prognostic favorable (8.28e-8)"	"unprognostic (5.29e-2)"	"unprognostic (3.26e-1)"	"unprognostic (7.37e-3)"	"unprognostic (2.28e-2)"	0.8	30.3	17.7	0.4	20.1	0.1	1.9	8.9	24.4	2.0	3.9	0.9	0.2	1.5	14.4	1.4	2.3	0.6	3.4	19.3	28.2	5.8	0.2	2.1	0.5	14.5	16.2	4.7	3.1	4.6	3.9	0.3	21.1	2.1	0.3	5.1	2.8	1.8	0.3	2.3	0.6	0.8	10.5	3.1	1.4	5.4	18.4	0.4	3.6	0.5	0.5	0.8	1.4	14.6	0.0	0.1	0.2	5.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.8	0.1	1.9	0.0	10.3	1.3	0.0	0.0	0.9	0.1	0.0	0.0	0.1	0.0	0.4	0.4	5.4	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.1	0.0	1.0	0.5	2.4	0.0	0.0	0.0	1.5	0.1	0.3	0.9	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	20.1	8.9	24.4	19.3	28.2	14.5	16.2	21.1	10.5	18.4	14.6	0.9	0.0	3.3	0.0	0.0	0.0	1.0	0.0	4.6	6.5	1.6	5.7	3.8	2.8	0.0	5.5	0.0	0.0	0.0	0.0	7.9	0.7	0.4	0.8	0.6	1.8	1.2	0.0	0.0	0.4	0.0	0.7	0.0	1.0	1.3	8.4	3.3	0.0	0.0	3.3	0.0	0.2	0.0	0.0	0.0	0.5	0.9	0.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.8	0.0	0.7	0.0	0.4	0.1	12.4	0.0	6.6	0.0	1.2	0.6	1.1	0.4	1.3	0.0	0.3	0.3	16.3	0.1	0.7
SMIM12	"C1orf212, FLJ90372"	ENSG00000163866	"Small integral membrane protein 12"	Q96EX1	1	34712737-34859755	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA065331	Approved		Approved	Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA065331: AB_2685470"	"unprognostic (2.21e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (2.64e-1)"	"unprognostic (2.05e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.93e-1)"	"prognostic favorable (1.15e-5)"	"unprognostic (7.33e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.52e-2)"	40.2	56.6	31.7	26.5	32.1	24.8	33.5	29.5	35.3	20.9	29.2	34.0	30.1	26.0	17.7	41.3	23.5	17.3	53.8	31.5	35.7	42.3	87.9	31.6	25.0	32.6	32.7	17.1	26.4	31.8	26.9	24.8	33.1	19.9	28.0	12.8	24.1	20.5	56.2	29.7	30.8	31.5	29.6	31.9	30.4	28.0	31.9	30.3	24.9	51.1	27.3	29.2	25.7	33.3	52.9	39.8	43.3	31.6	55.2	43.3	30.1	55.8	48.1	70.2	60.3	40.0	65.0	55.1	49.2	57.6	55.5	51.7	55.5	74.7	53.5	67.3	41.6	98.1	65.6	49.1	51.3	107.9	55.4	66.2	71.9	76.5	61.3	25.3	72.9	47.0	71.0	72.3	63.0	38.6	52.6	55.4	70.1	40.8	52.7	44.1	42.7	71.7	62.2	54.6	41.5	32.9	52.0	48.1	81.5	53.9	32.8	29.9	69.9	47.8	49.3	74.3	66.7	40.4	60.2	56.9	45.2	63.7	32.1	104.2	76.0	126.4	65.8	82.0	77.9	57.7	60.4	72.0	86.0	59.2	50.1	64.3	50.2	62.6	67.5	62.4	76.2	87.5	31.7	32.1	29.5	35.3	31.5	35.7	32.6	32.7	33.1	29.6	31.9	33.3	51.2	25.6	13.1	4.9	37.0	68.2	26.3	49.8	23.3	14.4	36.4	30.1	33.9	42.9	30.4	22.0	10.4	50.7	38.5	46.7	86.1	78.7	58.3	17.1	19.0	56.2	21.8	53.9	10.4	83.7	60.2	24.9	20.9	20.6	23.5	18.9	48.2	89.3	83.8	20.2	9.5	23.4	46.8	41.7	61.6	32.7	14.9	41.0	39.2	7.5	89.8	24.9	54.6	6.6	7.0	87.5	41.0	23.3	27.5	40.8	62.9	90.6	26.8	17.3	13.1	21.8	52.3	37.6	23.0	41.4	75.6	58.0	40.8	33.7	39.6	41.7
SMIM13	C6orf228	ENSG00000224531	"Small integral membrane protein 13"	P0DJ93	6	11093834-11138733	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 75.1;Syncytiotrophoblasts: 65.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA065706	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Nuclear membrane, Golgi apparatus"		"HPA065706: AB_2685539"	"unprognostic (6.89e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.11e-3)"	"unprognostic (4.01e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (1.04e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.22e-2)"	"unprognostic (3.45e-2)"	4.7	4.6	15.4	3.4	16.1	2.9	3.4	21.4	23.8	4.3	5.6	4.1	3.6	5.0	3.4	4.8	2.9	4.1	6.6	16.7	18.0	4.3	9.7	3.5	3.0	17.6	16.7	4.1	3.0	6.4	4.1	12.7	19.3	4.6	3.6	17.1	3.7	4.8	11.5	4.9	3.1	5.2	15.8	2.9	3.1	3.4	20.0	3.4	3.0	14.2	3.0	4.9	3.7	19.4	9.9	8.3	12.6	10.6	12.7	14.4	13.2	26.7	11.3	13.4	14.9	11.1	3.1	12.1	35.9	8.6	13.3	8.6	26.3	9.3	24.0	7.1	19.1	12.7	9.1	8.8	16.9	23.8	2.9	17.4	25.5	13.7	18.0	10.6	14.4	11.0	18.3	5.0	25.7	5.4	10.1	14.0	5.9	6.5	7.1	13.5	23.1	17.2	8.2	7.6	29.4	16.3	5.6	18.2	32.4	17.2	4.6	9.9	20.7	20.3	15.0	8.6	18.1	9.5	33.0	17.1	4.8	9.9	31.8	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.1	0.0	15.4	16.1	21.4	23.8	16.7	18.0	17.6	16.7	19.3	15.8	20.0	19.4	14.3	12.8	1.5	12.4	9.1	75.1	17.1	13.7	10.8	16.4	10.6	10.3	12.7	12.8	5.2	11.0	20.9	29.3	14.4	5.7	3.9	5.2	10.3	11.8	15.6	11.4	3.6	11.8	26.8	7.4	36.6	11.9	6.1	12.0	10.8	4.2	7.9	25.6	13.5	30.3	31.4	8.1	10.2	8.1	29.4	4.3	2.8	12.0	16.0	10.3	6.3	7.6	7.2	18.6	28.0	10.5	3.1	4.1	14.6	18.8	5.8	7.8	4.6	15.2	0.0	7.7	9.8	16.8	24.8	12.7	39.5	65.1	12.9	10.4	8.7	16.2
SMIM30	LINC00998	ENSG00000214194	"Small integral membrane protein 30"	A4D0T7	7	113116718-113118560	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 126.9;Distal tubular cells: 414.8;Hofbauer cells: 243.9;Proximal tubular cells: 396.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"													NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 38: Heart - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"				"unprognostic (1.25e-1)"	"unprognostic (1.73e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.44e-3)"	"unprognostic (3.89e-3)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (7.25e-2)"	"unprognostic (5.00e-3)"	"unprognostic (7.07e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (7.21e-4)"	"unprognostic (2.46e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.35e-1)"	44.6	53.2	40.8	26.8	41.5	12.2	47.2	41.4	57.8	37.2	40.8	33.3	32.3	30.6	70.9	39.5	30.5	37.4	205.3	40.7	42.7	83.7	57.6	40.0	38.5	42.8	40.0	26.9	41.6	83.9	26.3	29.4	42.5	37.6	35.6	43.5	47.8	30.0	142.5	20.8	27.6	39.0	42.5	41.4	39.4	19.7	41.0	30.2	60.0	149.6	31.8	50.6	21.5	44.8	48.0	24.1	56.3	49.6	100.8	159.8	0.2	57.3	95.0	60.5	94.0	25.1	82.7	57.4	69.5	72.0	104.5	29.9	55.8	126.5	146.8	37.9	113.3	130.3	32.7	42.9	66.8	179.2	0.4	120.8	120.1	91.6	46.8	111.0	95.7	60.6	176.1	52.4	199.6	24.7	76.3	196.4	58.6	72.6	66.0	47.7	136.2	156.9	118.8	63.9	85.1	61.8	43.1	85.6	140.2	97.5	57.5	117.4	55.1	96.8	49.6	110.9	86.2	77.6	102.6	205.3	126.9	161.0	138.0	2.0	15.8	12.5	16.1	17.6	17.9	19.6	18.3	16.9	25.2	17.0	17.2	17.5	0.6	19.7	14.1	36.5	23.2	16.7	40.8	41.5	41.4	57.8	40.7	42.7	42.8	40.0	42.5	42.5	41.0	44.8	32.6	51.3	68.9	0.0	10.4	0.0	0.0	0.0	0.0	0.0	77.4	42.7	0.0	0.0	32.8	126.9	0.0	76.2	8.2	0.0	414.8	102.3	0.0	51.5	37.8	27.7	0.0	0.0	0.0	69.8	61.8	20.7	0.0	43.5	32.8	27.0	0.0	0.0	243.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.9	0.0	0.0	44.5	0.0	0.0	0.0	0.0	83.7	0.0	0.0	1.3	0.0	0.0	396.3	32.8	0.0	0.0	0.0	24.2	0.0	0.0	0.0	0.0	41.6	11.0	70.8	0.0	0.0
SMNDC1	"SMNR, SPF30, TDRD16C"	ENSG00000119953	"Survival motor neuron domain containing 1"	O75940	10	110290730-110304938	"Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061214, HPA070666"			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA061214: AB_2684451, HPA070666: "	"unprognostic (4.65e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.63e-3)"	"unprognostic (5.03e-3)"	"prognostic unfavorable (8.08e-6)"	"unprognostic (3.16e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (7.20e-4)"	"unprognostic (2.68e-3)"	"unprognostic (6.88e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.00e-1)"	16.3	12.0	7.0	15.1	7.5	31.8	13.7	10.8	11.1	13.8	7.7	13.4	9.9	14.4	8.7	16.2	13.3	11.6	12.4	6.5	7.2	13.6	14.9	14.2	16.9	7.1	6.9	13.5	10.2	13.1	8.9	18.4	7.0	10.0	11.1	16.6	11.5	10.2	24.8	13.2	11.5	14.6	7.5	14.7	11.5	13.1	7.1	20.4	12.1	17.9	18.3	17.3	13.7	9.4	36.2	27.0	38.9	44.9	29.6	35.1	28.9	41.0	42.6	53.3	54.6	35.1	43.7	51.2	25.7	25.9	30.5	38.5	57.8	28.2	59.9	29.0	30.6	51.1	21.9	41.2	35.3	56.9	47.2	27.4	29.7	42.2	71.1	39.5	30.0	29.0	46.8	46.5	41.9	17.1	61.0	55.0	43.5	27.8	18.4	52.0	77.9	26.8	30.0	25.7	19.4	26.0	26.6	22.4	48.9	33.3	27.7	32.3	33.0	31.2	35.2	28.9	52.9	37.8	42.4	76.7	31.4	77.9	24.6	5.7	8.9	14.5	5.2	9.2	6.4	5.4	6.8	6.7	8.6	4.8	5.9	5.9	16.6	6.3	9.8	5.2	8.1	4.3	7.0	7.5	10.8	11.1	6.5	7.2	7.1	6.9	7.0	7.5	7.1	9.4	57.7	28.9	37.1	6.8	53.4	69.6	42.5	27.2	89.4	27.3	31.7	26.7	23.4	14.3	27.9	11.0	20.9	33.0	55.7	23.9	33.2	22.8	10.7	34.2	52.0	41.5	18.6	37.0	7.8	18.0	32.0	39.1	37.8	58.8	58.3	27.3	27.1	26.5	32.4	33.7	8.0	21.4	38.7	40.9	79.7	4.4	29.2	47.7	35.6	6.5	45.8	23.0	22.6	5.0	11.2	21.7	21.0	22.2	45.7	53.3	20.6	40.9	28.6	33.0	19.7	30.8	39.7	46.2	37.7	72.4	83.4	46.1	57.4	33.5	24.1	65.8
SMYD4	"KIAA1936, ZMYND21"	ENSG00000186532	"SET and MYND domain containing 4"	Q8IYR2	17	1779485-1830634	"Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030059	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Vesicles"	"Nucleoplasm, Cytosol"	"HPA030059: AB_2191728"	"unprognostic (1.45e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.66e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.83e-3)"	"unprognostic (9.26e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.18e-1)"	7.4	6.6	4.1	6.0	3.6	3.4	7.3	8.0	4.5	7.9	3.7	7.5	7.0	6.5	5.0	3.9	7.3	3.6	7.0	3.5	3.5	3.7	4.9	5.6	6.8	3.7	3.2	9.5	6.7	3.6	6.6	4.7	4.0	6.5	4.8	7.6	7.3	5.6	13.7	6.6	7.4	5.9	2.2	6.3	4.9	5.8	4.3	6.2	5.7	10.2	6.5	7.2	6.2	5.6	7.4	13.7	13.5	9.6	9.0	6.1	15.7	11.9	6.7	12.3	12.5	22.0	6.2	19.7	7.8	4.8	8.3	14.2	12.9	7.7	15.3	5.7	13.1	7.2	15.9	6.0	4.5	7.4	6.8	4.4	6.8	12.7	11.1	6.3	6.2	16.6	7.6	7.5	9.7	4.6	13.6	5.3	6.2	8.7	6.6	16.7	6.9	5.0	4.9	8.8	5.5	7.6	11.0	4.5	11.1	10.9	6.7	4.5	5.9	12.0	6.1	10.0	10.4	5.2	7.5	7.1	6.8	6.4	11.9	12.0	2.4	2.3	5.1	3.0	4.3	4.0	3.0	3.3	1.5	2.7	3.4	5.0	1.3	3.1	2.4	4.5	3.5	2.1	4.1	3.6	8.0	4.5	3.5	3.5	3.7	3.2	4.0	2.2	4.3	5.6	22.9	6.4	27.8	6.5	12.9	5.0	9.3	11.9	14.8	19.3	6.9	8.4	6.3	14.3	14.0	7.3	33.3	9.7	16.5	6.9	1.9	5.7	20.2	3.7	8.9	10.9	3.6	9.7	11.7	3.3	10.9	14.2	4.1	3.5	7.6	14.7	17.2	6.7	12.9	26.9	12.1	5.2	12.2	23.3	9.2	5.9	27.1	17.4	5.4	13.1	16.4	7.9	43.3	4.5	7.1	4.2	2.0	24.8	10.1	7.2	23.3	2.9	17.8	19.9	46.0	43.6	23.9	12.6	14.8	5.1	6.7	8.1	12.1	6.1	6.4	3.5
SMYD5	"NN8-4AG, RAI15, RRG1, ZMYND23"	ENSG00000135632	"SMYD family member 5"	Q6GMV2	2	73214222-73227221	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015514, HPA049002"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA015514: AB_2669205, HPA049002: AB_2680595"	"unprognostic (1.75e-1)"	"unprognostic (3.39e-1)"	"unprognostic (5.22e-2)"	"unprognostic (6.66e-3)"	"unprognostic (3.86e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (6.58e-7)"	"unprognostic (1.28e-1)"	"unprognostic (1.60e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.84e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.40e-1)"	13.3	19.1	27.2	12.1	27.8	11.6	14.8	24.3	30.5	15.5	22.0	12.5	7.3	14.4	19.4	14.1	19.5	7.3	17.9	28.2	28.0	18.8	15.2	9.8	13.1	28.9	26.5	28.3	18.4	17.9	15.4	13.1	28.8	15.4	11.3	13.0	12.2	13.4	17.7	14.5	12.4	14.5	25.9	16.2	11.4	17.4	26.9	8.2	14.3	13.0	16.0	17.5	13.1	26.9	24.3	45.2	27.0	25.9	19.3	28.4	45.7	22.8	23.0	43.4	26.6	59.4	24.4	43.1	20.9	38.6	52.1	24.4	42.2	49.4	39.1	26.3	29.7	41.8	19.5	65.9	26.0	41.5	16.5	24.0	31.4	39.7	47.3	19.2	26.7	33.9	44.9	20.2	27.9	34.1	38.8	27.1	42.2	50.8	36.3	25.6	50.6	35.5	28.6	34.6	17.4	25.9	20.7	30.7	26.4	24.4	25.0	14.7	18.5	29.7	46.3	36.5	38.1	22.0	17.7	38.2	33.5	35.2	24.3	0.0	1.4	0.0	5.1	3.9	11.1	6.0	7.0	6.8	3.2	6.2	7.0	7.7	0.0	4.5	4.3	3.0	3.1	4.5	27.2	27.8	24.3	30.5	28.2	28.0	28.9	26.5	28.8	25.9	26.9	26.9	4.1	3.2	5.6	5.2	5.6	5.1	3.9	2.3	1.8	10.2	5.4	6.7	7.2	2.8	4.4	5.5	4.2	9.0	3.4	2.4	1.9	8.5	0.5	2.8	4.2	4.9	0.0	9.5	5.0	8.8	10.4	4.5	2.6	3.7	7.0	9.5	2.9	4.8	5.9	5.0	5.2	4.4	4.1	2.4	2.5	2.9	2.8	2.7	5.4	2.8	3.7	4.0	4.1	1.5	3.5	5.6	1.5	3.0	3.1	5.0	1.3	8.1	1.3	5.3	6.6	4.0	4.6	6.7	11.1	5.7	3.4	4.8	4.5	4.6	5.6	3.6
SNAPC4	"FLJ13451, PTFalpha, SNAP190"	ENSG00000165684	"Small nuclear RNA activating complex polypeptide 4"	Q5SXM2	9	136375577-136400168	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028939, HPA046627, HPA073243"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA028939: , HPA046627: AB_10961152, HPA073243: AB_2686585"	"unprognostic (3.34e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.40e-1)"	"prognostic favorable (4.52e-5)"	"unprognostic (3.15e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (6.41e-2)"	6.3	5.3	3.5	6.0	2.9	8.5	6.6	2.0	6.3	8.0	2.7	6.2	5.7	6.7	3.0	5.8	9.8	3.9	5.8	2.9	0.5	7.6	10.8	6.5	6.9	1.7	1.1	8.0	11.3	5.9	11.2	3.7	0.9	8.0	4.1	5.4	6.6	4.6	6.3	8.2	7.2	4.5	0.1	10.1	6.0	19.7	0.9	5.2	8.6	2.4	6.0	6.7	6.4	2.2	9.2	10.5	10.6	14.8	6.7	12.9	19.4	11.7	7.8	12.0	9.5	24.3	8.2	14.0	8.2	9.3	8.3	29.0	12.9	15.0	7.1	19.9	20.3	9.5	30.3	11.6	5.9	20.2	10.8	10.3	12.4	10.4	9.8	10.4	10.8	11.3	19.8	10.1	8.4	20.6	11.7	22.7	21.9	14.5	13.7	19.0	10.7	19.9	6.9	16.4	30.4	21.2	11.7	19.1	6.2	9.1	19.7	11.6	15.4	12.3	11.2	22.3	16.9	6.3	7.9	11.2	8.6	9.3	7.3	0.0	0.5	0.4	0.7	0.3	0.3	0.5	0.3	0.3	0.1	1.5	0.2	0.1	1.0	0.7	0.1	0.5	0.2	0.1	3.5	2.9	2.0	6.3	2.9	0.5	1.7	1.1	0.9	0.1	0.9	2.2	3.6	6.4	9.0	12.1	4.8	5.4	2.8	3.9	5.7	8.2	6.0	5.0	5.9	5.7	3.8	3.7	2.1	2.6	5.9	5.4	0.0	6.2	4.1	15.1	5.6	4.1	5.3	7.0	12.2	4.5	2.0	4.1	4.6	7.1	1.3	7.0	5.7	8.1	3.2	3.3	8.5	5.0	10.2	4.2	7.7	2.5	5.0	3.4	0.0	5.6	3.2	4.4	3.1	7.1	5.5	6.8	5.8	4.9	4.6	3.7	3.6	4.3	20.3	12.2	0.0	4.2	4.4	9.5	10.0	3.0	6.8	1.4	5.7	6.2	6.1	2.9
SNRNP200	"ASCC3L1, BRR2, HELIC2, KIAA0788, RP33, U5-200KD"	ENSG00000144028	"Small nuclear ribonucleoprotein U5 subunit 200"	O75643	2	96274338-96321271	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029321	Approved		Supported	Nucleoplasm		NA	NA		78000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA029321: AB_10604096"	"unprognostic (2.63e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (3.89e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.10e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.03e-1)"	26.5	21.8	11.2	38.1	11.3	58.8	38.6	16.9	12.1	31.9	25.5	29.6	29.4	41.0	20.2	29.5	39.8	25.8	26.9	9.9	11.1	28.8	29.3	29.3	43.2	13.1	10.3	53.2	34.3	52.4	19.7	39.2	12.0	31.6	34.6	67.6	35.1	33.0	47.4	30.8	30.3	38.5	12.2	36.5	30.6	40.4	9.8	73.5	37.4	38.7	52.3	30.1	21.6	14.6	97.8	107.7	144.1	106.1	63.1	57.1	131.5	67.3	80.6	119.5	112.9	197.3	69.3	169.3	101.3	83.3	178.9	74.9	264.4	88.8	130.8	94.3	139.4	221.6	169.8	106.7	40.9	171.2	92.4	58.1	53.7	133.2	112.0	61.3	97.3	98.3	198.2	112.3	68.3	82.3	158.8	49.4	182.8	77.9	102.4	185.0	139.3	107.4	43.8	145.4	159.8	150.5	107.7	88.7	65.4	165.0	86.4	100.5	86.2	98.3	117.2	101.3	96.2	101.0	134.0	207.6	66.2	109.0	106.2	16.7	4.7	6.0	7.9	5.0	8.9	5.7	6.0	9.5	5.6	6.1	5.2	7.1	4.7	7.3	6.1	5.8	6.8	5.5	11.2	11.3	16.9	12.1	9.9	11.1	13.1	10.3	12.0	12.2	9.8	14.6	47.3	44.8	53.9	21.9	57.4	29.6	27.2	35.5	38.1	79.3	40.2	42.4	35.2	54.3	46.2	51.5	104.3	43.2	64.2	43.4	5.9	42.6	29.3	42.4	48.7	44.8	46.7	54.1	21.2	46.7	36.1	37.9	52.0	48.8	25.3	79.0	40.4	49.4	35.1	87.5	21.1	40.6	34.6	31.9	33.2	18.2	57.5	35.2	17.8	16.9	45.2	79.1	73.2	17.1	16.7	46.1	30.7	55.3	68.3	34.8	47.3	17.9	50.7	135.2	65.7	54.7	45.5	77.6	56.0	38.7	33.0	44.6	71.6	53.3	49.4	30.3
SNRNP25	"C16orf33, U11/U12-25K"	ENSG00000161981	"Small nuclear ribonucleoprotein U11/U12 subunit 25"	Q9BV90	16	53828-57669	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 131.6"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 156.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 219.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041183, HPA044248"	Uncertain		Supported	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA041183: AB_2677353, HPA044248: AB_2678873"	"unprognostic (7.87e-2)"	"prognostic favorable (1.95e-4)"	"unprognostic (6.04e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.99e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.16e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.03e-3)"	15.2	29.3	80.7	20.6	81.4	32.7	16.1	95.2	98.3	14.0	74.4	27.2	12.9	15.9	16.3	20.1	16.0	10.4	85.3	81.7	81.0	25.0	39.2	10.8	32.6	86.3	82.7	19.8	19.7	24.6	30.7	8.7	87.0	19.8	17.5	12.4	22.9	13.8	131.6	10.9	16.5	15.1	81.8	19.0	27.6	11.0	88.0	22.5	17.7	84.5	31.2	17.2	11.9	80.1	50.1	111.2	60.7	70.8	21.2	24.9	29.5	41.4	26.5	90.7	76.1	150.4	47.5	157.3	48.3	34.2	48.6	50.4	111.8	76.2	69.2	57.3	87.8	91.6	155.3	152.9	22.4	168.9	103.9	32.1	27.0	80.8	22.4	19.6	49.6	93.5	139.2	36.5	52.2	236.5	89.5	70.0	72.8	88.4	54.5	141.9	64.6	186.9	48.6	34.7	66.2	42.9	93.4	119.8	20.7	59.0	77.5	80.8	39.3	40.0	49.6	51.8	67.2	37.6	96.9	248.2	21.3	89.5	62.3	15.1	25.5	93.3	14.9	40.3	17.9	74.3	15.1	17.9	49.6	75.1	15.9	16.3	17.2	22.5	35.9	219.7	26.1	23.2	80.7	81.4	95.2	98.3	81.7	81.0	86.3	82.7	87.0	81.8	88.0	80.1	16.5	12.8	14.3	6.8	53.4	18.6	27.2	39.5	14.8	17.9	48.1	51.9	113.0	18.6	29.3	33.1	4.2	54.6	62.3	30.9	156.5	41.6	3.0	27.3	23.8	18.9	44.0	58.5	9.9	51.4	63.3	29.3	30.1	36.9	4.5	62.3	16.4	67.5	114.5	11.8	9.8	34.5	69.2	26.4	59.8	6.5	21.5	36.2	62.2	5.6	94.3	89.0	32.0	4.5	6.5	31.0	44.8	29.7	65.9	31.5	24.0	87.6	53.2	14.5	6.6	29.4	35.7	33.7	44.8	35.8	21.9	26.1	22.4	105.0	53.5	27.7
SNRNP40	"HPRP8BP, PRP8BP, PRPF8BP, SPF38, WDR57"	ENSG00000060688	"Small nuclear ribonucleoprotein U5 subunit 40"	Q96DI7	1	31259568-31296788	"Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026527, HPA027345"	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear speckles"		"HPA026527: AB_1858814, HPA027345: AB_2239703"	"unprognostic (2.31e-3)"	"unprognostic (5.63e-2)"	"unprognostic (5.24e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.28e-2)"	"prognostic unfavorable (4.73e-6)"	"unprognostic (2.14e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.57e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.78e-2)"	"unprognostic (5.93e-2)"	"unprognostic (4.31e-2)"	"unprognostic (6.24e-2)"	17.9	18.9	10.7	21.2	14.6	30.0	20.7	15.5	12.6	17.7	10.3	20.6	16.4	20.1	21.7	19.1	22.5	13.1	14.2	10.4	12.5	17.6	19.3	15.8	35.4	14.5	13.3	20.8	13.0	18.0	15.9	22.3	15.4	20.1	22.1	19.1	15.0	20.8	20.9	18.5	17.6	21.7	13.7	21.3	16.6	21.2	12.8	40.3	18.0	18.1	40.2	24.0	16.7	20.1	71.6	53.6	95.5	78.6	46.7	38.4	66.2	58.8	57.4	104.7	101.9	76.7	69.8	91.8	56.4	46.1	53.9	66.4	145.7	69.8	105.9	99.2	109.3	135.2	72.1	83.9	58.4	150.0	59.3	36.2	54.7	102.1	75.6	34.4	86.1	80.2	129.0	52.9	60.5	51.6	111.3	87.9	171.6	71.1	76.5	87.3	134.5	71.1	44.2	57.7	65.1	63.6	92.3	47.4	116.2	88.0	47.2	94.9	59.5	57.9	85.2	81.5	112.9	43.5	57.1	126.1	47.1	139.3	96.4	102.8	75.8	82.3	98.6	97.3	113.1	93.8	95.1	98.2	93.0	82.6	101.1	115.1	16.4	110.5	92.0	78.4	110.2	161.1	10.7	14.6	15.5	12.6	10.4	12.5	14.5	13.3	15.4	13.7	12.8	20.1	44.1	3.2	6.1	14.7	51.5	53.0	50.2	90.8	41.5	15.6	24.4	30.6	16.5	21.5	32.5	16.5	18.8	108.7	35.7	11.9	43.0	42.5	7.1	21.0	27.5	39.4	34.8	80.8	23.7	35.9	91.3	38.1	28.5	13.9	34.3	36.2	28.9	22.3	56.2	10.1	24.3	18.6	69.2	20.7	48.6	5.4	26.8	31.5	42.7	15.0	44.7	23.8	44.3	23.6	49.0	36.4	20.2	34.3	40.6	55.0	17.0	45.0	27.6	22.2	32.9	31.0	35.1	105.5	89.7	39.6	54.8	61.3	52.4	45.9	36.9	40.6
SNRNP48	"C6orf151, dJ336K20B.1, dJ512B11.2, FLJ32234"	ENSG00000168566	"Small nuclear ribonucleoprotein U11/U12 subunit 48"	Q6IEG0	6	7590198-7611967	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029234	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA029234: AB_10604097"	"prognostic unfavorable (8.30e-4)"	"unprognostic (3.46e-2)"	"unprognostic (2.65e-1)"	"unprognostic (9.65e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.46e-3)"	"unprognostic (2.55e-1)"	"unprognostic (9.87e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (4.16e-4)"	"unprognostic (1.55e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.03e-1)"	5.4	3.8	4.8	5.5	5.1	10.4	6.9	8.5	6.7	7.0	4.4	5.4	5.7	6.4	4.6	4.7	5.7	4.0	7.2	4.6	5.0	6.0	7.3	4.5	7.3	5.7	4.9	7.7	5.7	3.7	3.6	5.3	5.9	5.8	5.5	7.3	5.3	4.4	9.7	6.3	6.7	5.4	4.7	6.1	5.4	2.7	5.1	7.1	5.8	7.1	5.9	5.6	5.8	5.9	10.0	7.9	16.2	30.3	8.5	12.5	10.9	11.2	10.4	12.0	13.1	16.9	8.1	23.6	11.8	9.4	11.5	12.6	20.2	12.1	18.2	18.2	19.8	17.0	24.1	32.7	8.9	20.5	10.9	8.8	18.3	13.5	10.2	14.2	10.5	20.8	24.1	3.6	16.8	5.7	33.7	29.6	21.9	17.1	8.8	35.8	13.9	31.6	10.8	8.7	25.0	6.8	21.8	5.6	19.6	29.7	10.9	7.2	11.8	15.8	7.1	9.5	19.6	5.8	34.6	14.5	5.3	16.1	28.9	0.1	0.7	0.4	0.7	0.5	1.2	0.6	0.8	0.9	0.9	1.1	0.7	1.3	2.3	1.1	0.3	1.0	0.7	0.6	4.8	5.1	8.5	6.7	4.6	5.0	5.7	4.9	5.9	4.7	5.1	5.9	18.6	19.2	10.3	8.1	15.7	35.7	20.2	13.6	12.0	18.7	12.6	14.6	32.1	15.7	17.3	9.2	20.9	16.3	22.7	19.2	11.7	18.0	2.5	18.0	14.8	20.5	11.4	17.7	20.4	20.1	15.6	18.0	8.2	19.6	24.1	16.8	20.3	23.4	15.9	5.0	18.8	18.2	0.0	15.1	22.1	2.5	17.7	14.9	8.8	13.1	21.7	15.5	19.6	14.6	23.8	12.1	17.9	16.6	11.5	21.4	27.1	20.1	8.5	17.8	6.6	20.9	23.2	16.1	17.0	11.5	34.0	16.3	18.5	11.2	17.1	20.1
SNRPC	"U1-C, Yhc1"	ENSG00000124562	"Small nuclear ribonucleoprotein polypeptide C"	P09234	6	34757505-34773857	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 384.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034338, HPA042419, HPA055490"	Supported		Enhanced	Nucleoplasm		NA	NA		320000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB034338: AB_2295245, HPA042419: AB_2677989, HPA055490: AB_2682833"	"unprognostic (1.84e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (5.65e-4)"	"unprognostic (1.48e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.16e-3)"	"unprognostic (7.71e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (8.20e-5)"	"unprognostic (4.39e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.62e-2)"	71.7	73.9	68.4	67.7	73.7	176.7	74.2	73.1	84.5	67.0	75.3	78.5	73.1	83.5	63.1	85.5	84.8	48.9	195.7	70.5	71.8	91.7	92.0	62.6	101.6	72.2	70.5	75.0	87.0	78.2	57.6	73.5	73.1	65.8	65.6	39.7	75.2	55.3	162.0	67.4	75.6	65.3	75.4	84.7	81.8	124.4	72.6	115.5	75.3	125.0	95.3	73.9	66.6	78.4	332.8	203.2	260.7	331.6	137.7	134.7	199.0	186.6	204.9	367.9	308.6	349.6	128.4	373.9	239.1	235.0	255.6	156.0	398.7	279.1	297.8	247.6	420.0	287.7	158.7	493.4	240.1	371.2	171.0	167.3	266.4	372.5	264.1	144.9	237.0	354.4	471.2	205.0	270.4	280.8	443.8	592.0	282.4	493.9	245.8	295.2	219.4	350.5	242.0	140.9	316.9	229.9	167.3	167.0	422.3	167.7	256.0	541.5	157.4	219.8	258.3	181.0	460.4	228.5	645.6	522.4	101.2	629.7	381.1	122.8	165.7	133.4	127.2	200.4	149.4	233.5	156.2	148.4	196.1	210.7	168.3	153.9	30.3	163.3	238.6	207.6	235.7	245.6	68.4	73.7	73.1	84.5	70.5	71.8	72.2	70.5	73.1	75.4	72.6	78.4	43.6	121.8	107.9	5.2	70.5	44.0	76.0	178.6	72.8	25.9	47.4	64.4	229.3	82.9	131.3	68.0	25.0	239.8	69.0	49.1	189.8	148.4	185.6	74.2	58.0	74.3	90.7	73.2	11.1	156.8	213.9	72.3	51.5	63.7	80.4	83.6	71.4	101.1	232.2	28.6	10.1	92.6	118.0	77.3	55.1	83.8	55.3	75.4	64.0	1.9	158.2	96.6	123.6	8.5	14.6	149.3	66.7	41.8	116.6	70.0	96.0	214.6	127.4	41.4	65.7	49.0	82.8	384.6	99.7	83.8	44.8	113.3	70.7	86.3	109.6	67.8
SNRPD2	"Sm-D2, SNRPD1"	ENSG00000125743	"Small nuclear ribonucleoprotein D2 polypeptide"	P62316	19	45687460-45692569	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041437	Supported		Supported	Cytosol		NA	NA		76000	"Cluster 30: Non-specific - Translation"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA041437: AB_10795119"	"unprognostic (1.48e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.63e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.08e-1)"	"unprognostic (7.71e-2)"	"unprognostic (3.50e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (8.58e-5)"	"unprognostic (1.95e-1)"	"unprognostic (6.57e-3)"	"unprognostic (1.53e-1)"	"unprognostic (7.12e-2)"	201.0	215.1	305.0	237.7	317.2	478.3	390.9	309.5	374.8	267.3	297.8	253.3	170.1	228.8	331.5	244.5	318.1	195.9	265.5	312.2	321.0	215.6	200.1	157.1	442.7	312.2	308.3	440.0	184.9	263.5	202.9	215.3	310.8	201.9	253.5	120.8	197.4	209.7	306.0	245.1	168.1	235.2	311.1	202.2	189.1	167.5	315.5	501.0	214.7	305.6	406.4	312.2	216.4	312.6	970.0	1429.6	863.8	905.4	843.8	797.5	475.5	630.8	777.8	933.3	974.0	814.6	582.4	1119.3	493.9	788.2	624.9	543.7	1180.4	1184.6	888.6	721.6	1428.6	1066.5	756.6	1040.6	585.1	1287.9	646.4	894.2	862.7	798.3	759.9	639.5	960.3	1111.6	996.6	713.1	765.9	1329.7	1274.7	1129.0	780.8	1758.5	776.2	848.1	890.0	896.5	782.0	1249.4	792.7	880.4	828.1	842.8	808.7	705.9	500.2	1378.5	614.2	422.3	694.7	397.5	1198.8	717.5	1949.8	1775.2	601.5	1087.8	691.3	306.6	525.1	275.0	810.3	500.5	1045.6	1309.4	1076.4	964.5	789.1	1155.8	1244.5	1083.7	62.7	885.6	393.8	876.0	1144.9	1776.3	305.0	317.2	309.5	374.8	312.2	321.0	312.2	308.3	310.8	311.1	315.5	312.6	150.6	147.4	211.1	8.1	407.6	470.5	564.5	724.2	463.9	43.1	361.2	650.5	443.3	233.1	372.3	329.2	22.9	607.0	294.3	318.8	665.2	368.8	563.3	190.9	310.2	225.3	310.2	315.9	7.9	350.7	787.7	305.2	199.8	198.2	266.0	284.4	232.3	265.4	475.4	37.0	8.3	492.0	376.4	269.9	470.6	1325.8	347.9	232.5	434.0	9.4	373.9	162.6	373.9	3.5	12.2	318.2	348.5	231.7	341.2	553.5	356.9	768.7	309.3	65.2	164.3	279.4	382.1	286.3	274.7	562.6	422.7	482.8	426.5	216.2	556.9	534.0
SNRPD3	"Sm-D3, SMD3"	ENSG00000100028	"Small nuclear ribonucleoprotein D3 polypeptide"	P62318	22	24555958-24582052	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA001170	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		290000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA001170: AB_1080042"	"unprognostic (3.30e-1)"	"unprognostic (1.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.28e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.20e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.65e-2)"	30.5	31.1	24.7	35.2	25.7	39.2	37.5	29.6	34.8	31.8	25.7	50.5	33.2	35.5	35.5	43.5	36.7	20.2	35.3	25.0	25.8	48.0	64.9	26.9	47.7	23.7	23.9	34.3	23.7	51.2	27.0	24.7	25.5	33.8	40.7	54.1	29.7	31.9	103.7	28.8	35.7	29.5	23.6	34.3	36.5	24.7	25.0	74.4	38.9	86.2	53.3	39.5	32.3	30.7	182.5	45.7	188.6	58.5	70.1	57.7	56.1	173.1	74.8	166.1	148.1	61.4	65.8	158.7	70.1	109.2	83.0	130.7	252.1	219.3	175.5	107.9	188.8	152.4	95.4	113.9	66.2	408.0	95.7	66.5	93.8	186.3	86.6	81.8	120.6	139.8	116.2	60.5	61.5	56.8	187.0	82.6	98.9	237.8	61.9	179.5	190.7	66.6	154.5	130.0	82.2	95.6	83.4	62.7	87.7	162.7	102.3	97.5	135.5	127.0	126.3	74.3	126.2	74.3	168.2	283.7	70.1	127.1	91.4	18.5	42.9	53.9	35.6	50.2	37.6	60.5	38.4	39.2	54.2	50.7	36.6	41.3	18.6	51.1	51.1	49.7	41.1	47.4	24.7	25.7	29.6	34.8	25.0	25.8	23.7	23.9	25.5	23.6	25.0	30.7	120.0	96.1	81.8	7.5	118.2	108.6	115.3	293.1	133.1	61.1	94.2	138.8	95.9	101.5	162.9	130.6	35.5	239.5	123.1	112.6	291.6	161.9	91.0	176.6	157.7	96.8	111.0	139.4	8.1	114.8	228.8	121.0	92.2	147.9	86.2	145.3	66.0	203.3	176.4	38.7	8.7	134.2	168.9	74.5	84.8	85.1	116.2	98.1	67.6	10.3	151.0	134.3	86.5	8.0	13.4	129.4	118.2	118.5	120.7	96.8	191.7	310.5	135.2	68.9	65.7	102.8	209.6	111.1	131.4	164.9	113.7	180.3	111.9	176.2	139.0	113.3
SNRPE	Sm-E	ENSG00000182004	"Small nuclear ribonucleoprotein polypeptide E"	P62304	1	203861599-203871152	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"	"Disease variant, Hypotrichosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		34000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"				"unprognostic (1.13e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.32e-3)"	"unprognostic (4.87e-1)"	"unprognostic (3.01e-3)"	"unprognostic (2.86e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.59e-2)"	"prognostic favorable (3.95e-4)"	"unprognostic (1.34e-2)"	"unprognostic (7.00e-2)"	"prognostic unfavorable (4.38e-5)"	"unprognostic (3.54e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.47e-3)"	36.5	50.0	37.5	50.4	39.6	87.2	65.7	43.3	61.3	41.4	43.9	52.5	31.8	42.4	59.5	39.1	38.5	24.1	34.5	38.2	41.2	47.3	46.1	25.6	50.0	38.0	39.8	64.7	38.0	37.6	24.9	39.3	40.5	29.6	41.5	37.8	33.0	29.2	39.9	31.0	33.9	27.2	41.1	33.3	35.7	22.4	38.0	100.4	27.8	22.3	58.2	51.4	33.9	43.4	262.9	85.4	307.0	157.4	64.6	131.4	179.1	187.1	111.6	159.9	147.5	103.1	200.6	258.4	154.3	111.9	164.0	185.7	258.1	206.8	205.2	105.1	120.4	166.4	169.8	144.5	106.8	375.6	168.1	113.7	55.7	190.1	176.1	151.4	146.4	288.3	310.0	155.7	138.9	150.7	372.6	360.0	413.1	175.6	91.4	242.9	295.0	303.9	201.5	96.1	160.9	210.2	130.5	275.7	347.6	271.2	203.7	261.7	98.4	127.6	216.4	115.9	341.7	130.7	184.3	574.1	125.6	198.3	146.9	14.6	22.6	13.7	19.7	21.1	30.2	24.0	26.7	20.9	34.1	21.5	26.7	26.3	7.4	37.0	25.4	46.0	23.1	19.1	37.5	39.6	43.3	61.3	38.2	41.2	38.0	39.8	40.5	41.1	38.0	43.4	125.2	128.2	116.4	5.5	153.6	244.1	284.5	442.3	101.3	48.5	190.2	204.1	73.3	204.5	226.4	128.8	14.6	454.6	146.1	92.2	424.6	408.6	23.1	179.9	197.6	173.5	163.4	176.9	8.1	473.8	612.3	159.3	72.4	188.6	112.7	190.0	138.5	278.7	300.7	57.2	7.7	241.2	341.8	172.9	177.6	34.8	237.0	117.6	172.5	5.6	304.5	149.7	212.1	7.5	8.8	421.8	136.7	164.0	97.7	351.2	113.4	434.3	162.7	48.3	98.6	272.0	240.4	217.7	239.5	128.8	256.0	225.1	126.2	178.5	313.8	294.1
SNRPG	Sm-G	ENSG00000143977	"Small nuclear ribonucleoprotein polypeptide G"	P62308	2	70281362-70293740	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA064152, HPA067814"	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA064152: AB_2685199, HPA067814: AB_2685903"	"unprognostic (6.42e-2)"	"unprognostic (7.89e-2)"	"unprognostic (6.10e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.75e-3)"	"unprognostic (2.28e-2)"	"unprognostic (3.60e-3)"	"unprognostic (6.19e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.14e-2)"	"prognostic unfavorable (1.08e-6)"	"unprognostic (4.37e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.41e-2)"	66.9	92.0	55.9	85.9	58.0	118.0	85.1	58.4	85.7	50.4	60.2	87.9	62.1	55.2	103.0	95.5	45.6	40.5	102.2	55.3	58.3	97.1	95.5	59.8	100.7	58.9	58.0	49.2	53.1	69.5	60.4	83.8	59.5	53.7	80.3	92.7	59.2	46.0	88.3	43.5	63.2	51.6	59.1	76.6	61.1	60.1	58.4	139.9	61.2	83.8	96.9	91.4	56.3	63.1	398.0	414.3	412.2	240.0	146.5	157.1	369.0	255.4	230.5	332.8	307.2	718.7	258.1	355.1	180.6	202.2	404.9	253.9	415.1	355.7	356.7	333.2	404.5	474.0	256.6	875.4	194.0	602.3	313.6	140.2	198.1	312.8	308.8	135.0	341.5	301.1	645.3	254.8	266.9	479.0	541.5	961.8	430.4	489.9	340.2	350.4	507.9	419.0	483.9	367.1	238.1	204.4	235.9	201.1	295.8	250.7	202.1	470.1	232.9	235.3	440.2	246.3	520.4	188.1	228.3	731.8	211.1	510.0	260.9	163.1	168.5	181.1	144.2	219.2	147.4	209.1	193.4	168.8	202.5	166.0	157.8	188.9	88.1	135.8	222.4	273.0	230.1	264.8	55.9	58.0	58.4	85.7	55.3	58.3	58.9	58.0	59.5	59.1	58.4	63.1	191.7	201.9	198.9	7.2	237.0	299.1	340.3	625.6	143.4	88.8	192.3	239.1	145.7	178.7	314.8	202.3	33.3	655.3	175.7	249.1	534.1	389.6	51.0	253.2	184.7	209.1	186.6	319.4	7.4	391.5	818.7	173.3	119.3	188.4	213.3	140.7	175.3	391.8	390.8	65.6	8.7	301.5	370.2	186.6	270.8	45.4	175.8	194.0	224.1	5.6	329.1	446.1	208.1	4.5	13.8	434.1	271.6	159.1	251.9	366.1	226.5	676.1	401.8	91.4	184.1	181.3	244.4	340.7	367.4	236.6	318.2	521.5	220.2	125.9	324.1	375.1
SNX4	ATG24B	ENSG00000114520	"Sorting nexin 4"	O95219	3	125446650-125520202	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 163.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005709	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA005709: AB_1080049"	"unprognostic (1.11e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.91e-2)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (1.97e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.33e-2)"	"unprognostic (4.93e-2)"	"unprognostic (4.06e-1)"	"unprognostic (3.42e-1)"	"unprognostic (6.99e-2)"	"prognostic favorable (5.01e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.13e-3)"	"unprognostic (1.05e-1)"	16.7	22.1	11.0	12.7	11.2	16.3	25.3	11.5	16.7	19.9	12.4	24.9	35.8	14.1	13.7	14.9	14.2	19.8	16.5	11.1	12.3	53.8	56.5	18.1	16.3	11.9	11.1	14.9	19.5	18.0	14.4	31.7	12.0	22.7	27.7	9.1	22.4	11.4	18.9	10.2	34.2	13.4	11.8	13.0	21.6	16.1	10.8	21.1	44.9	23.3	17.1	16.8	11.3	14.0	34.8	10.9	34.5	21.8	20.9	17.4	39.1	18.5	17.5	35.9	32.1	23.7	15.5	22.0	21.4	22.5	15.5	18.0	32.4	15.6	42.9	20.6	23.8	35.6	14.5	36.0	24.5	37.8	22.1	22.7	17.0	18.2	14.5	20.0	34.1	31.8	38.6	10.9	27.6	26.2	41.8	25.4	20.2	37.6	13.0	38.2	42.0	40.3	33.0	30.6	36.1	50.9	29.8	38.3	47.4	32.0	37.7	61.3	22.3	18.0	22.9	23.4	21.9	22.1	20.1	60.2	22.0	23.8	27.8	12.4	14.0	25.8	9.7	18.8	13.0	13.8	12.4	11.2	18.3	10.3	15.8	13.8	2.6	17.4	19.1	16.1	15.1	12.0	11.0	11.2	11.5	16.7	11.1	12.3	11.9	11.1	12.0	11.8	10.8	14.0	27.1	28.9	39.4	33.6	24.5	12.1	17.9	21.3	12.5	13.4	27.2	17.1	17.7	37.1	34.1	22.0	0.0	87.2	20.6	39.9	60.7	45.4	21.6	23.8	22.1	24.7	30.0	22.7	46.7	36.6	57.8	26.9	26.0	20.9	31.0	30.9	24.7	75.8	50.9	18.5	44.9	37.0	46.8	27.0	22.6	31.5	22.1	28.3	30.2	31.9	45.7	21.3	34.0	37.7	47.8	42.9	37.9	18.0	26.2	22.5	48.8	163.4	37.1	12.0	13.1	27.8	30.3	33.0	29.8	23.0	11.8	41.2	22.9	27.2	29.6	15.7
SOCS4	SOCS7	ENSG00000180008	"Suppressor of cytokine signaling 4"	Q8WXH5	14	55027230-55049489	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"testis cancer: 17.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013478, HPA057961"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"CAB013478: , HPA057961: AB_2683564"	"unprognostic (7.18e-3)"	"unprognostic (1.49e-1)"	"unprognostic (9.74e-3)"	"unprognostic (4.57e-2)"	"unprognostic (3.36e-3)"	"unprognostic (3.82e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.70e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.56e-2)"	"unprognostic (7.61e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.13e-1)"	6.6	4.9	6.1	7.9	6.7	6.8	5.7	6.7	6.7	4.7	5.6	5.2	5.3	5.8	4.2	5.1	5.2	6.6	5.6	5.9	8.7	6.3	4.9	6.7	8.9	8.1	7.1	3.8	4.1	5.5	4.5	5.7	8.2	4.8	5.6	10.8	4.5	4.5	4.9	5.1	5.3	6.0	8.1	7.6	7.0	4.3	7.0	8.0	6.9	5.1	7.6	6.5	4.2	8.8	14.2	11.0	16.2	18.9	11.0	12.2	12.0	16.4	12.1	9.9	16.0	9.6	15.2	20.8	11.3	12.4	9.7	19.1	21.4	13.5	23.1	20.8	8.8	12.8	16.3	6.1	11.1	14.3	20.9	9.9	14.4	17.6	13.0	11.5	18.5	22.0	7.4	19.2	19.3	14.6	21.9	11.6	12.7	11.7	12.0	20.3	24.5	8.5	15.2	15.0	21.1	18.5	16.6	9.8	16.8	14.8	14.0	11.2	19.3	25.5	23.9	13.1	14.0	7.4	8.3	19.6	17.2	11.8	20.2	0.9	1.2	1.2	0.8	1.3	1.3	0.8	1.0	0.8	0.9	1.1	0.6	0.6	0.7	1.8	1.8	1.2	1.0	0.5	6.1	6.7	6.7	6.7	5.9	8.7	8.1	7.1	8.2	8.1	7.0	8.8	30.7	6.4	12.4	9.8	22.3	24.0	10.8	10.7	14.8	13.6	14.7	12.3	20.2	11.5	15.8	14.7	20.9	5.2	27.5	14.7	13.7	9.4	7.4	36.8	22.5	20.9	20.4	16.8	14.3	8.7	6.2	14.8	29.0	20.6	32.9	11.8	15.0	9.4	7.4	37.0	13.6	8.3	8.2	13.3	21.8	2.6	7.2	15.6	3.6	11.2	17.3	21.0	13.4	4.5	20.4	15.6	9.6	10.1	19.4	8.1	6.7	14.6	19.7	17.4	0.0	15.8	21.5	20.7	10.9	14.7	23.2	4.9	21.7	13.7	8.1	11.5
SPAG5	"DEEPEST, hMAP126, MAP126"	ENSG00000076382	"Sperm associated antigen 5"	Q96R06	17	28577565-28599025	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.9;kidney: 37.8;testis: 74.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 126.0;Erythroid cells: 37.2;Spermatocytes: 72.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 11.7;T-reg: 4.9"	"Group enriched"	"Detected in many"	6	"granulocytes: 11.7;T-cells: 4.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA022008, HPA022479, HPA024418"	Approved		Supported	"Nuclear bodies,Mitotic spindle,Cytosol"		Yes	Yes			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear bodies, Mitotic spindle"	Cytosol	"HPA022008: AB_1853519, HPA022479: AB_1853521, HPA024418: "	"unprognostic (4.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.32e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (5.43e-5)"	"unprognostic (3.37e-3)"	"unprognostic (4.84e-3)"	"unprognostic (5.97e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (3.49e-2)"	"prognostic unfavorable (5.43e-13)"	"unprognostic (2.64e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.01e-1)"	2.2	3.3	7.8	7.8	7.6	37.9	2.4	5.8	9.1	2.6	3.4	8.3	7.9	1.9	2.4	8.3	1.7	1.8	1.4	7.6	7.7	37.8	14.8	3.4	14.5	6.7	6.8	2.7	1.5	1.1	4.3	5.7	6.7	2.2	10.7	10.8	2.4	0.8	1.0	5.5	9.1	3.4	5.0	7.4	3.6	74.0	7.7	22.4	8.7	0.7	17.3	2.6	3.6	7.5	84.7	87.7	103.3	78.4	5.2	8.6	42.4	65.9	42.4	98.1	78.3	69.2	25.5	59.8	34.2	46.8	91.7	70.2	114.5	42.7	103.8	108.6	72.9	62.9	87.9	80.2	0.6	83.1	76.1	2.9	3.8	78.6	40.4	14.5	52.1	90.6	69.7	101.5	80.7	52.6	109.4	92.9	54.2	68.3	44.5	72.1	144.4	70.9	29.0	43.0	78.6	45.8	96.4	114.9	31.6	84.9	82.2	70.6	25.7	56.4	91.3	46.6	114.6	46.7	72.9	87.3	37.8	60.6	91.8	11.7	0.0	0.0	0.4	0.4	0.7	0.6	1.2	0.9	0.1	1.4	1.1	0.9	0.2	0.8	0.3	0.3	4.9	0.9	7.8	7.6	5.8	9.1	7.6	7.7	6.7	6.8	6.7	5.0	7.7	7.5	0.5	3.2	1.7	0.7	3.3	2.0	0.9	1.3	1.2	5.0	1.1	1.0	0.7	0.0	1.9	0.0	0.0	9.0	1.3	4.7	1.9	0.5	126.0	6.0	1.1	1.5	13.1	37.2	5.2	0.4	12.2	2.6	5.1	1.8	1.3	12.6	3.3	6.3	6.5	3.3	6.0	4.6	4.1	2.7	4.0	25.2	0.9	6.1	0.0	1.9	0.9	0.7	0.0	2.0	1.7	0.4	4.7	0.0	13.1	0.8	8.1	12.5	7.7	3.9	6.6	2.0	2.2	72.6	21.0	5.2	1.0	3.8	2.8	0.9	5.1	1.1
SPART	"KIAA0610, SPG20, TAHCCP1"	ENSG00000133104	Spartin	Q8N0X7	13	36301638-36370180	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 75.0;Proximal tubular cells: 90.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"basophil: 172.7"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 172.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039053, HPA039054"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	"Plasma membrane"	"HPA039053: AB_10672769, HPA039054: AB_2676323"	"unprognostic (3.73e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.10e-2)"	"unprognostic (9.18e-3)"	"unprognostic (9.58e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.62e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.79e-2)"	42.3	48.4	36.9	18.0	42.8	23.6	32.5	43.4	50.6	49.2	42.3	37.8	12.7	42.4	67.1	24.5	44.5	37.4	25.7	35.3	39.4	48.4	19.9	27.0	15.7	42.4	40.5	63.6	14.6	29.5	29.6	39.8	42.1	34.7	13.3	43.3	17.3	36.4	33.5	18.4	15.4	52.8	41.2	30.7	21.1	27.6	38.3	16.7	35.6	33.7	11.2	35.5	29.9	51.0	0.1	22.4	59.5	0.0	127.9	106.6	42.4	54.1	81.3	53.7	52.8	0.1	0.0	0.0	32.9	65.9	98.2	31.2	81.4	38.0	57.5	4.4	46.9	69.4	28.3	14.6	128.0	72.8	134.3	106.2	59.5	44.4	61.9	131.7	79.6	18.7	30.6	11.9	97.5	5.2	21.7	120.8	30.0	0.0	7.8	0.0	99.4	2.5	62.5	28.2	6.2	14.5	46.3	18.3	58.9	85.3	10.5	84.7	66.8	40.0	20.1	55.9	32.2	14.2	0.2	0.1	44.6	61.8	71.0	172.7	22.1	30.1	13.5	21.7	13.1	10.1	18.6	5.4	15.7	9.7	24.5	13.1	35.0	14.2	23.8	19.3	4.8	18.1	36.9	42.8	43.4	50.6	35.3	39.4	42.4	40.5	42.1	41.2	38.3	51.0	43.5	35.3	51.5	0.0	6.1	0.0	0.0	0.0	0.0	0.0	30.8	30.1	0.0	0.0	40.2	27.6	0.0	52.7	18.6	0.0	66.5	26.2	0.0	59.4	62.6	15.9	0.0	0.0	0.0	15.0	59.7	39.8	0.0	38.1	58.0	75.0	0.0	0.0	42.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	24.3	0.0	0.0	0.0	0.0	16.8	0.0	0.0	3.5	0.0	0.0	90.4	65.6	0.0	0.0	0.0	27.8	0.0	0.0	0.0	0.0	64.3	10.8	59.2	0.0	0.0
SPATA33	"C16orf55, FLJ31606"	ENSG00000167523	"Spermatogenesis associated 33"	Q96N06	16	89657740-89671272	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"testis: 114.0"	"Group enriched"	"Detected in all"	8	"Early spermatids: 1778.0;Late spermatids: 4200.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA045648, HPA073096"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Vesicles	"HPA045648: AB_2679405, HPA073096: AB_2686570"	"unprognostic (1.05e-2)"	"prognostic favorable (1.06e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.03e-3)"	"unprognostic (8.82e-2)"	"unprognostic (4.02e-2)"	"unprognostic (4.52e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.60e-1)"	3.6	4.2	7.0	2.8	7.0	3.4	4.3	6.1	8.9	5.1	9.1	5.2	5.0	4.5	8.9	5.3	12.6	2.8	4.0	7.6	6.6	11.8	6.2	5.9	2.4	6.7	7.1	3.2	5.1	3.6	9.7	1.8	6.7	6.4	2.9	6.7	4.3	2.5	2.0	4.3	9.2	2.4	5.5	5.8	5.0	114.0	6.8	3.6	8.3	1.2	2.9	4.3	4.8	6.7	11.1	11.8	13.4	5.5	3.5	3.1	4.9	7.8	2.5	10.6	4.7	11.5	10.6	1.2	3.8	5.0	8.0	15.1	6.2	3.7	8.5	2.2	9.7	2.0	17.4	16.1	1.5	2.3	4.5	3.1	5.1	7.9	3.2	4.0	2.3	11.0	12.6	1.9	7.1	14.7	7.4	6.6	7.3	7.3	9.3	14.3	7.4	4.0	6.2	3.9	13.2	7.0	17.9	3.0	4.4	6.3	13.5	3.3	2.8	7.8	10.7	6.9	5.9	4.4	7.1	4.4	8.1	14.5	3.5	2.4	1.1	2.1	1.6	1.3	2.2	2.3	1.7	2.2	0.9	0.9	1.8	1.4	1.4	3.2	1.0	2.0	1.2	1.4	7.0	7.0	6.1	8.9	7.6	6.6	6.7	7.1	6.7	5.5	6.8	6.7	14.7	6.4	9.7	4.6	10.3	7.1	8.6	16.4	8.0	18.2	14.9	14.7	6.6	15.7	13.5	29.5	64.6	4.1	10.2	16.0	23.5	15.9	1778.0	94.9	13.3	13.3	17.5	22.7	7.0	17.7	5.6	13.0	32.1	11.9	1.3	11.4	8.9	14.6	9.0	23.5	4.4	9.9	12.2	2.9	8.0	4200.3	30.4	9.5	17.8	3.7	5.8	17.0	16.5	1.0	5.1	14.2	18.9	23.7	11.1	6.7	35.6	33.4	97.8	82.5	13.1	11.8	11.4	348.5	101.2	13.5	7.1	1.4	12.8	13.9	17.1	5.5
SPATA5	"AFG2, SPAF"	ENSG00000145375	"Spermatogenesis associated 5"	Q8NB90	4	122923070-123319433	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Chaperone, Developmental protein, Hydrolase"	"Deafness, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 207.9;Inhibitory neurons: 59.0;Microglial cells: 104.0;Oligodendrocyte precursor cells: 79.9;Oligodendrocytes: 91.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036450, HPA036451"	Approved		Approved	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol		"HPA036450: AB_2675131, HPA036451: AB_10670107"	"unprognostic (4.28e-1)"	"unprognostic (7.54e-2)"	"unprognostic (7.37e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.65e-4)"	"unprognostic (1.95e-3)"	"unprognostic (9.00e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.43e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.68e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.79e-1)"	1.3	0.8	0.8	0.9	1.1	1.4	1.6	2.3	1.0	1.3	1.2	1.0	0.6	1.3	0.8	1.0	1.0	0.8	0.9	0.6	1.2	1.1	1.1	0.9	1.2	1.2	1.1	1.2	0.8	1.5	0.7	1.4	1.2	1.1	1.2	2.2	1.0	1.1	1.3	1.2	0.7	1.3	1.0	1.3	2.3	3.6	1.0	2.0	1.5	1.2	1.2	1.0	1.1	1.3	2.3	3.2	2.9	7.1	2.4	1.7	1.9	4.0	1.6	3.3	3.3	1.5	3.2	3.7	2.4	2.4	2.4	2.0	5.0	2.2	5.6	6.2	0.9	3.8	5.7	2.5	1.1	5.2	4.0	1.2	1.1	3.8	3.3	1.7	3.4	2.4	7.7	6.2	4.6	2.4	10.1	3.2	2.1	3.6	1.3	3.3	7.2	2.4	1.9	1.9	4.8	3.1	3.2	2.3	1.7	4.2	2.2	2.0	2.6	6.9	5.2	4.6	4.2	3.9	5.0	3.3	3.3	4.4	6.2	0.5	0.2	0.2	0.6	0.6	0.4	0.5	0.5	0.5	0.1	0.5	0.5	0.5	0.3	0.5	0.2	0.7	0.3	0.2	0.8	1.1	2.3	1.0	0.6	1.2	1.2	1.1	1.2	1.0	1.0	1.3	10.7	16.0	5.0	34.6	9.1	5.1	5.6	2.6	6.2	6.2	4.2	3.2	4.3	11.5	7.4	1.8	14.6	5.1	6.7	2.9	0.0	3.1	207.9	4.5	9.6	8.5	2.4	11.2	48.8	3.6	4.3	5.1	14.3	5.2	5.1	8.6	4.2	3.2	3.5	3.3	59.0	2.6	0.0	4.1	5.3	25.0	7.2	5.3	0.0	104.0	1.8	4.0	4.1	79.9	91.4	4.2	2.1	4.5	10.6	3.9	1.5	3.1	6.4	11.3	0.0	12.5	6.6	14.7	10.6	5.0	5.4	2.2	9.9	4.7	4.1	3.0
SPC24	"FLJ90806, SPBC24"	ENSG00000161888	"SPC24 component of NDC80 kinetochore complex"	Q8NBT2	19	11131520-11155808	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 26.0;lymphoid tissue: 14.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 35.0;Extravillous trophoblasts: 15.5;Hofbauer cells: 14.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA051234	Approved		Supported	Nucleoplasm,Nucleoli		NA	Yes			"Cluster 40: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"HPA051234: AB_2681397"	"unprognostic (1.57e-1)"	"prognostic favorable (3.59e-4)"	"unprognostic (6.79e-2)"	"unprognostic (1.07e-3)"	"unprognostic (4.04e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (1.21e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (6.12e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.62e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.82e-2)"	1.9	1.7	1.3	4.8	1.5	26.0	1.2	3.9	2.1	2.1	1.7	4.7	4.5	2.7	0.8	5.0	1.3	2.3	2.7	1.6	1.5	0.8	1.6	1.6	6.3	1.1	0.8	1.3	1.1	0.4	0.4	3.2	1.3	1.6	4.3	1.2	1.3	2.0	4.0	3.9	4.1	8.1	0.5	3.1	2.9	4.3	1.4	14.7	0.9	1.1	6.5	2.5	2.0	2.4	73.6	26.9	36.9	30.1	5.0	9.7	16.6	42.3	15.7	38.6	43.6	28.4	24.6	58.2	46.0	18.5	22.8	38.8	29.0	30.3	28.7	30.9	24.9	78.5	68.9	43.2	1.1	55.5	33.7	1.9	1.1	27.8	12.8	10.0	34.7	62.3	42.8	118.3	27.6	48.7	76.4	32.9	25.5	19.8	43.9	59.8	56.7	18.6	11.2	23.8	38.4	27.2	37.0	22.4	9.6	17.5	22.0	19.8	33.2	36.8	38.3	49.6	51.2	70.5	39.8	55.6	26.9	53.9	30.5	1.9	0.4	0.4	0.5	0.5	0.4	0.8	0.9	1.5	0.2	0.7	0.9	0.6	2.2	2.0	0.5	0.5	1.7	0.3	1.3	1.5	3.9	2.1	1.6	1.5	1.1	0.8	1.3	0.5	1.4	2.4	0.2	0.0	0.5	0.3	1.5	1.1	1.2	1.3	0.0	0.0	1.0	0.4	9.0	1.5	0.8	5.5	6.2	10.0	0.9	2.8	0.0	0.2	0.3	1.0	2.2	2.2	2.4	35.0	0.3	0.0	15.5	3.5	3.6	1.8	5.7	6.5	4.6	0.7	14.0	0.0	0.3	2.6	0.0	3.0	2.5	3.0	0.6	1.0	0.0	1.0	0.0	2.1	2.1	0.5	0.3	0.3	0.0	0.4	6.3	0.3	0.7	0.6	0.2	0.6	0.0	1.3	2.4	6.9	10.8	2.1	0.3	2.1	2.2	0.5	6.6	1.2
SPEN	"KIAA0929, MINT, RBM15C, SHARP"	ENSG00000065526	"Spen family transcriptional repressor"	Q96T58	1	15836095-15940456	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015825, HPA050257"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA015825: AB_1856823, HPA050257: AB_2681065"	"unprognostic (3.91e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.06e-2)"	"unprognostic (6.93e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.26e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.71e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.83e-1)"	15.3	8.6	11.3	11.5	14.6	23.2	14.0	22.6	12.9	13.3	4.8	12.0	8.8	14.4	8.5	13.3	15.5	8.0	10.8	10.4	14.6	9.6	11.0	14.8	12.9	14.2	12.4	21.3	17.5	16.4	10.7	11.8	11.4	11.1	9.1	15.1	12.8	9.9	20.5	17.3	13.4	9.8	8.0	12.7	11.0	10.3	12.6	16.6	15.6	19.8	13.3	13.0	13.6	20.7	25.4	20.9	26.1	19.6	25.0	15.2	13.8	12.9	16.6	13.5	11.4	19.3	19.5	35.6	15.0	25.1	15.9	36.0	24.0	22.6	21.4	32.1	68.5	44.6	20.5	12.4	11.3	37.1	20.8	11.2	15.9	20.2	28.9	12.9	15.5	26.5	47.1	35.9	11.1	14.0	30.7	14.7	11.6	14.4	15.9	29.5	25.1	21.9	7.5	22.4	20.5	19.9	36.2	17.4	14.8	11.6	6.5	18.4	28.9	12.8	15.5	24.4	18.5	21.5	15.0	39.6	12.2	29.2	17.9	7.4	1.9	1.6	1.4	1.7	0.9	1.3	1.1	1.0	0.5	3.0	0.9	1.0	8.5	1.1	1.3	2.8	0.9	0.5	11.3	14.6	22.6	12.9	10.4	14.6	14.2	12.4	11.4	8.0	12.6	20.7	55.7	80.1	85.3	68.9	69.4	104.6	44.9	18.3	90.5	67.1	35.0	27.9	52.6	30.0	43.2	5.5	52.1	12.2	52.8	44.4	3.9	18.5	7.0	90.4	67.4	51.6	31.7	47.1	57.2	17.6	15.0	45.9	41.8	146.5	62.6	34.3	20.0	32.6	15.2	95.9	66.0	27.4	8.2	34.6	69.6	4.9	27.4	53.2	21.4	64.6	56.3	28.3	68.0	51.8	88.7	23.6	34.6	35.7	74.5	46.7	16.8	7.5	29.4	53.2	19.7	85.7	56.6	59.5	45.9	89.8	101.6	15.7	52.3	33.1	32.8	56.3
SPICE1	"CCDC52, SPICE"	ENSG00000163611	"Spindle and centriole associated protein 1"	Q8N0Z3	3	113442718-113515187	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA064843	Approved		Supported	Centrosome		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Centrosome		"HPA064843: AB_2685367"	"unprognostic (2.66e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.99e-3)"	"unprognostic (1.17e-1)"	"unprognostic (6.30e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.89e-2)"	"unprognostic (4.75e-3)"	"unprognostic (6.53e-2)"	"unprognostic (4.47e-1)"	"unprognostic (3.64e-3)"	"unprognostic (2.95e-2)"	4.4	3.8	2.1	4.6	2.3	4.1	7.4	3.2	2.9	8.5	3.4	6.7	4.1	8.6	4.9	6.9	8.0	7.7	4.3	2.4	2.4	4.6	4.1	4.7	4.1	2.2	2.1	7.8	6.3	6.4	8.9	5.5	2.1	6.4	6.6	7.7	8.6	4.9	2.6	6.0	5.3	6.7	1.4	4.2	6.8	7.1	1.9	8.3	6.8	2.3	5.5	6.1	7.2	3.1	17.0	10.4	12.1	10.6	7.5	9.2	7.6	8.2	6.3	10.9	13.6	9.2	9.4	9.9	11.6	7.2	10.7	16.0	6.3	8.0	14.7	5.9	2.8	9.0	9.3	6.1	4.5	18.0	6.8	7.5	7.9	11.3	4.6	9.6	8.0	18.0	5.8	8.2	3.8	17.7	15.6	7.0	13.0	13.4	11.5	10.8	10.3	8.8	4.0	10.7	6.2	10.8	8.7	10.3	4.8	13.4	10.2	7.2	8.0	5.5	8.8	5.1	7.5	7.9	5.8	16.7	11.0	10.5	8.2	3.6	4.1	1.5	3.2	3.0	5.2	5.6	5.0	4.0	3.1	6.1	7.0	5.2	2.1	2.7	2.9	9.7	2.6	2.0	2.1	2.3	3.2	2.9	2.4	2.4	2.2	2.1	2.1	1.4	1.9	3.1	6.7	0.0	4.2	14.4	12.0	6.8	7.9	5.4	9.1	6.4	9.4	5.8	2.5	5.7	5.6	5.5	8.4	4.7	3.5	8.0	0.0	5.4	6.5	22.8	11.9	4.7	3.6	9.9	20.2	4.5	5.9	7.4	16.3	12.7	1.3	10.1	3.3	5.2	4.4	3.3	6.8	10.6	6.1	2.5	3.9	3.5	9.9	4.1	0.0	15.9	2.3	7.9	1.0	16.1	14.4	5.6	3.6	3.4	13.9	4.1	3.9	4.2	15.3	25.0	6.6	6.2	5.4	20.9	16.9	7.7	7.7	3.4	7.5	6.2	7.4	8.5
SPIN4	"FLJ44984, TDRD28"	ENSG00000186767	"Spindlin family member 4"	Q56A73	X	63347228-63351332	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 2.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA044559	Uncertain		Approved	Nucleoli,Cytosol		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol	Nucleoli	"HPA044559: AB_10794171"	"unprognostic (9.66e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.22e-4)"	"unprognostic (3.30e-3)"	"unprognostic (9.44e-3)"	"unprognostic (8.62e-2)"	"unprognostic (3.65e-3)"	"unprognostic (9.39e-2)"	"prognostic unfavorable (3.56e-6)"	"unprognostic (1.74e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.09e-2)"	1.8	1.7	1.4	2.7	1.3	10.2	3.3	0.9	1.7	2.4	1.7	3.6	2.2	3.4	2.3	5.9	2.7	2.1	1.3	1.3	3.1	1.5	1.3	3.1	3.5	1.6	2.0	2.9	1.7	1.7	2.3	4.4	1.6	3.3	4.1	2.0	7.2	1.7	0.5	2.0	2.2	3.5	1.2	2.8	2.2	0.7	2.5	3.1	2.5	0.5	5.6	2.1	2.7	1.8	31.7	8.0	18.2	14.9	3.9	5.5	13.1	15.6	6.5	8.9	10.6	5.4	30.7	0.0	6.7	7.3	10.2	10.3	23.7	11.2	16.2	13.7	7.5	40.5	10.3	4.9	1.7	35.5	30.3	2.6	3.9	14.9	8.0	4.3	9.9	7.0	12.5	38.2	20.4	10.7	11.9	19.0	18.8	5.2	11.5	16.4	39.2	8.7	6.5	8.3	0.1	10.0	27.9	8.1	3.0	37.4	17.4	16.9	4.3	17.9	19.9	29.8	9.8	8.4	10.4	20.5	9.5	28.8	10.7	0.7	0.8	1.6	0.5	0.9	0.2	0.4	0.3	0.3	0.6	0.4	0.1	0.4	0.0	2.6	0.8	0.0	0.2	0.4	1.4	1.3	0.9	1.7	1.3	3.1	1.6	2.0	1.6	1.2	2.5	1.8	3.0	0.0	2.0	2.3	2.9	3.3	1.4	3.5	6.2	5.7	6.0	4.3	1.5	1.5	5.8	3.7	2.1	6.1	3.9	3.6	1.9	0.6	0.0	3.4	3.2	5.1	6.7	11.1	2.4	1.4	6.8	3.4	2.0	2.1	9.5	3.5	8.6	1.3	2.6	1.7	3.3	6.7	4.1	1.0	2.1	0.4	3.1	2.2	5.4	1.9	1.1	1.3	5.2	3.0	4.5	1.3	6.3	3.4	0.7	2.3	0.6	1.3	5.7	2.8	0.0	2.5	2.6	0.1	0.5	9.8	6.3	3.3	3.1	4.3	5.7	5.7
SPOUT1	"C9orf114, CENP-32, HSPC109"	ENSG00000198917	"SPOUT domain containing methyltransferase 1"	Q5T280	9	128819651-128829794	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 34.0;Extravillous trophoblasts: 25.2;Granulosa cells: 32.5;Hofbauer cells: 21.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076946	Approved					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"			"HPA076946: "	"unprognostic (1.85e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.76e-2)"	"unprognostic (3.32e-3)"	"unprognostic (8.01e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.41e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (4.09e-4)"	"unprognostic (1.44e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.70e-2)"	17.0	19.0	20.8	14.3	21.4	13.5	18.3	20.2	25.6	20.0	19.1	18.3	11.2	17.6	5.7	25.7	19.9	9.1	21.2	20.0	20.8	26.0	45.1	16.8	18.9	20.6	20.9	20.0	22.9	9.1	20.6	9.5	19.9	32.7	5.5	6.5	18.7	8.6	20.6	23.7	20.6	8.1	19.4	30.8	22.9	13.2	21.4	13.4	22.8	6.0	10.3	22.8	19.8	21.6	13.7	31.2	25.2	37.2	14.1	14.2	44.5	14.5	8.7	26.3	14.2	44.1	24.1	27.5	15.6	14.9	26.8	56.3	23.3	22.6	8.7	26.3	24.2	21.8	51.6	36.6	15.4	32.6	39.2	14.8	18.9	18.2	18.9	11.2	19.6	40.3	44.7	24.0	14.9	88.1	40.8	66.5	33.2	63.5	39.5	44.0	24.1	48.7	17.5	25.4	29.6	28.7	27.7	40.7	19.0	14.0	40.3	36.5	20.0	37.3	16.6	25.6	38.2	26.1	47.0	28.9	23.7	28.3	30.8	5.5	11.7	6.1	24.7	12.6	25.5	19.1	19.9	22.8	13.9	19.3	19.5	19.7	2.9	25.2	10.3	15.7	19.8	17.4	20.8	21.4	20.2	25.6	20.0	20.8	20.6	20.9	19.9	19.4	21.4	21.6	9.3	3.2	10.2	0.0	4.8	0.0	0.0	0.0	0.0	0.0	19.2	12.2	0.0	0.0	8.1	9.2	0.0	34.0	10.8	0.0	11.7	15.7	0.0	6.4	10.2	6.1	0.0	0.0	0.0	17.6	25.2	4.3	0.0	7.7	13.9	32.5	0.0	0.0	21.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	15.5	0.0	0.0	0.0	0.0	15.7	0.0	0.0	1.8	0.0	0.0	19.3	4.4	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	10.4	5.4	12.1	0.0	0.0
SPRED2	"FLJ21897, FLJ31917, Spred-2"	ENSG00000198369	"Sprouty related EVH1 domain containing 2"	Q7Z698	2	65310851-65432637	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 108.7;Excitatory neurons: 138.5;Inhibitory neurons: 122.4;Oligodendrocyte precursor cells: 124.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"NK-cell: 1.9;plasmacytoid DC: 4.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 4.2;NK-cells: 1.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038256, HPA064394"	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA038256: , HPA064394: AB_2732712"	"unprognostic (1.49e-1)"	"unprognostic (5.95e-3)"	"unprognostic (3.46e-2)"	"unprognostic (4.40e-3)"	"unprognostic (8.94e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.90e-2)"	"unprognostic (9.94e-2)"	"unprognostic (9.07e-2)"	"unprognostic (4.25e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.21e-3)"	"unprognostic (5.43e-2)"	23.9	11.4	12.0	9.7	15.3	7.0	21.7	11.8	22.8	13.5	5.6	16.5	14.9	16.5	8.6	10.9	13.3	13.2	14.7	14.4	11.4	13.7	24.8	18.4	14.0	14.4	12.5	14.0	18.0	16.7	11.5	15.8	11.2	12.3	16.1	10.9	15.9	10.8	8.0	11.3	13.7	11.5	11.1	8.5	19.8	7.4	13.3	28.7	17.9	13.9	15.4	15.5	14.0	12.7	60.4	32.9	32.2	32.4	41.1	40.9	22.2	16.1	25.2	10.9	14.5	43.4	16.4	41.2	9.2	20.8	29.2	18.7	18.2	37.2	21.9	52.3	11.6	9.7	9.1	45.2	21.0	25.7	18.8	33.1	22.2	37.2	36.9	22.9	6.9	24.9	39.1	16.9	17.7	40.9	22.6	26.7	16.1	43.4	35.4	17.1	28.6	24.2	34.1	52.3	13.1	45.1	18.1	14.8	44.2	20.1	15.1	23.7	11.4	27.6	35.8	23.8	27.4	33.2	13.8	73.7	44.7	27.1	54.2	0.0	0.2	0.0	0.6	0.7	0.0	0.0	0.1	0.5	0.4	0.0	0.1	0.1	0.6	1.9	0.3	4.2	0.0	0.7	12.0	15.3	11.8	22.8	14.4	11.4	14.4	12.5	11.2	11.1	13.3	12.7	49.7	19.2	16.0	108.7	1.8	39.9	29.0	12.0	41.5	17.8	22.7	17.7	7.5	14.3	6.6	9.2	6.2	11.0	3.3	32.0	13.7	11.0	1.5	16.8	11.4	18.6	11.4	1.7	138.5	8.6	8.4	21.0	14.8	35.0	1.3	2.8	13.9	14.1	6.7	25.2	122.4	24.1	8.2	7.5	67.6	4.1	17.1	10.2	19.6	68.4	26.0	7.9	0.0	124.1	23.2	13.9	21.5	12.4	0.5	23.4	17.1	7.4	7.2	9.8	26.3	17.0	17.4	3.9	10.4	16.6	16.8	3.0	3.8	4.7	10.9	24.0
SPRTN	"C1orf124, DKFZP547N043, DVC1, Spartan"	ENSG00000010072	"SprT-like N-terminal domain"	Q9H040	1	231337104-231355023	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 85.5;Rod photoreceptor cells: 73.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025073	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA025073: AB_1847695"	"unprognostic (2.63e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.69e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.75e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.25e-1)"	"unprognostic (7.51e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.35e-2)"	4.4	3.6	2.9	5.0	3.7	11.8	5.4	3.9	3.5	4.2	3.6	3.7	4.0	4.9	4.1	5.7	3.4	4.4	4.4	2.6	3.3	4.6	5.1	3.7	6.3	3.1	3.2	3.1	2.7	4.8	2.7	7.8	3.6	3.9	3.8	4.9	3.5	3.6	8.5	5.9	3.6	4.9	3.2	5.0	4.1	14.5	3.0	7.2	5.1	5.3	6.2	4.8	3.3	4.5	13.7	11.4	10.5	11.5	9.6	6.8	12.7	12.1	10.5	13.6	11.8	13.2	11.4	12.4	12.8	10.1	5.4	19.6	15.2	12.2	14.7	10.6	26.1	7.8	11.1	9.1	10.2	13.3	11.0	9.3	12.7	15.0	12.2	6.2	13.8	11.1	19.0	11.8	13.9	7.5	14.1	7.5	10.4	15.6	10.0	12.3	13.6	14.7	12.0	10.2	13.2	12.8	13.0	9.8	13.9	4.7	17.9	19.3	10.5	11.7	11.8	17.1	19.9	9.1	10.0	17.0	9.1	11.2	20.4	8.6	4.6	9.8	5.1	6.6	5.7	4.9	5.1	5.8	4.6	3.2	6.1	6.8	9.5	6.6	4.8	4.3	5.9	3.6	2.9	3.7	3.9	3.5	2.6	3.3	3.1	3.2	3.6	3.2	3.0	4.5	14.5	16.0	4.2	8.8	19.9	32.0	11.4	9.3	27.3	22.6	11.6	13.1	5.2	10.0	11.4	3.7	85.5	12.0	25.2	10.3	9.8	8.7	20.5	16.6	13.2	16.1	12.0	12.4	12.5	9.3	10.6	12.3	12.2	9.8	26.1	11.4	13.6	7.0	9.6	15.2	11.9	7.0	12.2	9.5	12.5	8.4	9.0	10.1	7.2	8.4	15.8	13.6	34.0	10.6	21.3	12.1	7.1	7.9	10.2	10.5	11.0	8.1	16.8	73.7	13.1	14.4	13.7	51.8	21.4	20.5	28.4	15.2	20.9	11.6	8.5	14.5
SRBD1	FLJ10379	ENSG00000068784	"S1 RNA binding domain 1"	Q8N5C6	2	45388680-45612165	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030567, HPA030568"	Approved		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Mitochondria, Cytosol"		"HPA030567: AB_10611244, HPA030568: AB_10601856"	"unprognostic (1.16e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.97e-3)"	"unprognostic (2.46e-1)"	"unprognostic (8.20e-3)"	"unprognostic (4.14e-1)"	"unprognostic (8.69e-3)"	"unprognostic (9.74e-2)"	"unprognostic (7.11e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.42e-3)"	"unprognostic (3.99e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.29e-1)"	6.8	5.6	1.9	7.2	2.5	6.5	7.6	2.1	1.9	9.8	3.5	7.1	5.7	7.2	11.8	4.7	5.4	5.6	5.8	1.7	2.5	7.6	8.7	6.5	7.5	2.5	2.3	5.4	7.3	12.2	3.7	6.8	2.8	7.4	8.0	3.7	5.2	5.7	3.1	3.8	5.4	6.8	2.4	8.6	8.1	9.0	2.5	11.5	10.2	4.9	7.5	5.3	3.9	2.8	18.7	9.5	19.1	12.9	6.9	15.0	15.1	14.1	12.2	13.2	12.1	8.0	7.8	16.1	10.2	10.1	9.8	8.7	19.0	17.9	24.3	22.1	10.6	21.4	7.4	17.3	8.1	17.9	12.1	9.3	7.2	15.7	18.2	5.8	16.2	5.8	15.6	11.9	19.8	17.0	24.3	13.8	21.9	12.0	10.3	16.5	27.5	14.7	15.0	12.1	16.8	13.7	12.3	13.1	14.0	9.9	8.2	6.4	14.9	18.4	14.7	9.0	12.3	12.5	4.9	9.6	10.4	17.6	13.5	3.9	6.2	13.1	5.4	7.0	4.8	5.3	4.0	6.3	6.1	4.6	5.4	5.0	2.3	8.3	12.3	5.7	4.5	4.3	1.9	2.5	2.1	1.9	1.7	2.5	2.5	2.3	2.8	2.4	2.5	2.8	10.9	19.2	7.7	28.7	13.0	3.6	3.5	6.2	8.6	7.9	8.7	8.0	8.8	8.6	10.6	3.7	4.2	8.4	15.7	5.9	9.8	8.3	3.5	11.5	20.7	9.3	7.2	15.8	22.0	9.1	7.1	10.9	20.9	9.9	8.2	11.0	7.9	13.8	9.6	13.5	32.7	9.7	0.0	22.5	3.9	2.5	7.5	13.8	7.2	46.9	13.7	12.9	13.4	48.2	51.8	4.6	6.3	6.4	19.8	2.9	5.9	10.8	7.8	14.7	13.1	12.9	10.2	37.5	28.4	9.5	3.8	5.6	12.8	16.6	5.1	2.2
SRFBP1	"BUD22, FLJ25286, p49, Rlb1, STRAP"	ENSG00000151304	"Serum response factor binding protein 1"	Q8NEF9	5	121961975-122075570	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042737	Approved		Approved	"Nucleoli rim"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli rim"		"HPA042737: AB_10796583"	"unprognostic (8.94e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.61e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.07e-3)"	"unprognostic (2.03e-1)"	"unprognostic (8.96e-3)"	"unprognostic (6.31e-3)"	"prognostic unfavorable (5.31e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.45e-2)"	6.8	4.3	2.3	6.3	3.0	6.2	9.1	3.6	2.6	6.3	2.3	5.3	4.9	6.2	4.3	6.9	5.2	5.1	4.6	1.9	2.3	7.2	6.9	4.7	7.4	2.9	3.2	4.8	4.3	7.4	1.7	6.3	3.1	5.4	5.7	4.2	5.0	4.7	6.3	3.8	4.1	5.8	2.8	6.1	4.6	4.5	3.2	5.4	8.3	6.9	6.5	7.7	3.5	4.1	14.7	10.6	9.5	15.2	10.7	9.9	15.9	13.8	10.0	14.8	17.3	8.7	14.2	18.4	15.6	8.6	25.5	10.5	15.7	18.8	27.5	26.4	8.9	17.7	7.0	9.0	11.5	20.6	14.0	12.0	14.2	18.7	18.3	7.1	16.3	9.3	16.5	14.5	15.7	6.8	14.4	6.6	14.1	11.6	6.9	14.6	22.6	19.4	16.5	14.9	9.9	9.2	12.7	12.5	24.2	11.8	12.7	12.2	11.9	22.8	13.8	16.4	20.3	7.7	15.5	20.8	13.0	16.4	20.4	0.6	7.0	2.8	6.0	12.7	7.8	10.3	6.7	6.8	9.6	8.8	7.8	10.7	0.9	7.8	10.4	9.0	6.8	4.3	2.3	3.0	3.6	2.6	1.9	2.3	2.9	3.2	3.1	2.8	3.2	4.1	45.5	16.0	15.2	15.7	32.4	19.2	36.7	27.8	12.0	38.7	19.7	26.3	14.3	18.6	26.2	14.7	25.0	20.6	21.2	8.0	41.1	33.0	35.2	29.5	37.5	25.2	16.2	22.9	26.2	20.2	19.7	24.2	16.3	27.8	44.4	24.9	8.6	9.4	20.0	47.1	24.3	11.2	12.2	8.1	11.7	7.5	24.2	22.9	19.6	23.4	16.6	29.8	21.6	35.7	34.0	20.2	9.7	26.7	10.7	35.1	4.4	34.8	17.8	28.6	13.1	41.3	28.3	29.6	27.4	18.3	19.0	12.9	19.0	30.5	19.6	27.8
SRP19		ENSG00000153037	"Signal recognition particle 19"	P09132	5	112861188-112898371	"Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029272, HPA057315"	Approved		Supported	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Nuclear bodies"	"HPA029272: AB_10600910, HPA057315: "	"unprognostic (4.77e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.60e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.98e-3)"	"unprognostic (5.55e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.62e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (3.72e-10)"	"unprognostic (1.82e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.69e-3)"	30.2	32.5	18.9	29.0	19.8	79.2	29.0	19.2	25.8	21.6	17.7	25.1	24.6	25.2	38.2	29.3	22.0	23.1	25.4	20.0	21.4	27.7	48.1	24.4	38.4	18.4	19.1	17.9	41.7	25.4	40.5	28.6	19.0	32.6	27.2	14.5	29.6	18.0	33.9	23.8	23.4	30.2	17.5	30.0	25.8	20.2	20.4	36.0	39.9	23.9	39.9	28.7	22.3	20.6	60.1	40.7	49.3	78.6	45.2	52.4	118.7	82.0	51.8	69.2	82.3	68.0	45.8	62.3	55.0	53.2	110.0	39.0	54.6	84.5	82.2	66.0	88.8	55.1	80.5	80.6	72.4	44.7	58.5	61.2	80.5	64.9	95.6	45.5	64.7	67.1	41.9	72.3	59.5	70.1	72.6	79.0	51.1	60.5	61.6	45.6	44.3	94.4	68.6	75.5	56.1	49.6	66.4	42.4	40.3	56.5	64.7	63.2	52.1	57.1	48.6	57.3	98.3	85.2	111.4	107.9	55.4	75.4	60.3	66.7	34.1	43.6	49.3	37.3	60.9	54.9	55.0	52.7	39.9	45.8	46.3	52.4	48.1	50.9	41.3	86.8	72.2	36.3	18.9	19.8	19.2	25.8	20.0	21.4	18.4	19.1	19.0	17.5	20.4	20.6	64.7	80.1	49.9	17.9	60.6	86.4	74.8	102.2	9.1	15.6	75.1	85.9	52.0	41.5	87.8	44.1	20.9	80.0	120.2	29.6	103.7	96.4	38.9	76.0	85.0	53.4	119.0	52.2	26.7	103.2	125.0	55.9	16.3	80.4	73.5	54.6	35.7	65.3	84.5	13.5	24.6	67.6	79.3	53.3	53.8	24.0	38.8	56.6	51.6	21.5	87.8	30.7	90.6	21.6	41.1	130.4	38.9	39.5	65.7	107.5	33.5	117.1	74.1	24.6	26.3	40.8	58.3	157.4	44.7	22.6	87.8	148.2	71.3	54.2	41.2	112.7
SRP68		ENSG00000167881	"Signal recognition particle 68"	Q9UHB9	17	76038775-76072517	"Plasma proteins, Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 314.6"	"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 162.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"medulla oblongata: 314.6"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023303, HPA055617"	Approved		Supported	Cytosol		NA	NA		23000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA023303: AB_1857477, HPA055617: AB_2682863"	"unprognostic (1.25e-1)"	"unprognostic (8.97e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (2.18e-4)"	"prognostic unfavorable (4.28e-5)"	"unprognostic (3.31e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.10e-2)"	"unprognostic (4.42e-2)"	"unprognostic (8.73e-2)"	"unprognostic (4.75e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (4.02e-3)"	37.5	34.6	23.7	24.8	25.2	21.9	36.3	25.5	76.6	39.4	24.6	47.2	21.3	39.7	35.1	49.8	37.4	17.3	42.8	34.8	27.7	31.6	37.0	34.0	29.0	314.6	25.1	39.8	65.7	37.7	37.7	33.1	49.6	30.6	27.4	28.0	38.5	26.1	103.1	43.7	32.2	34.5	30.5	31.5	41.5	22.2	25.9	30.8	32.8	47.0	36.7	41.9	37.9	26.4	98.0	89.8	51.0	54.9	71.5	57.2	94.3	72.4	50.7	80.7	62.9	75.5	45.5	81.6	36.8	70.5	69.2	66.2	98.2	74.2	119.2	34.3	118.1	72.6	63.4	102.8	86.3	83.9	54.7	48.5	81.3	70.7	61.1	60.0	95.1	47.4	109.0	70.9	67.2	60.1	84.6	43.5	50.3	81.2	91.0	70.1	137.1	79.9	59.2	80.6	63.2	64.9	61.9	103.8	81.8	85.2	91.5	76.4	62.3	89.2	70.7	42.7	99.4	70.5	34.7	87.1	64.0	62.2	66.4	7.6	28.6	37.3	24.5	26.3	26.4	30.5	34.8	37.9	34.3	25.3	39.2	29.4	4.3	45.4	27.1	27.1	34.6	19.4	23.7	25.2	25.5	76.6	34.8	27.7	314.6	25.1	49.6	30.5	25.9	26.4	20.9	28.9	22.9	12.1	27.9	31.4	49.3	30.2	22.2	24.2	18.2	19.2	27.2	28.6	25.9	12.9	37.5	86.9	21.2	18.3	37.2	43.6	15.0	24.3	26.1	28.1	14.4	41.3	11.1	41.4	63.2	26.8	16.8	28.5	17.1	25.6	21.8	23.2	37.9	37.0	10.8	22.8	20.3	18.5	17.4	20.0	24.2	17.8	24.9	11.2	31.8	36.8	29.9	7.1	11.5	39.0	15.8	28.2	37.9	46.5	20.7	30.4	23.7	26.7	0.0	28.5	31.7	47.2	24.4	26.6	31.7	162.3	25.2	30.2	24.1	48.9
SRP72		ENSG00000174780	"Signal recognition particle 72"	O76094	4	56467617-56503681	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Ribonucleoprotein	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034621	Approved					NA	NA		23000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA034621: AB_10601593"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-2)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.75e-1)"	"unprognostic (1.76e-2)"	"unprognostic (9.40e-2)"	"prognostic unfavorable (3.25e-6)"	"unprognostic (7.76e-3)"	"unprognostic (2.88e-2)"	"unprognostic (4.09e-3)"	"unprognostic (4.60e-3)"	"unprognostic (9.63e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.35e-1)"	37.7	31.6	13.9	41.2	15.0	73.5	49.8	15.1	18.1	41.4	20.5	39.1	29.3	40.8	29.5	42.3	33.0	33.5	25.2	14.2	19.1	33.4	45.4	32.1	49.5	14.9	18.8	45.0	47.7	43.4	16.4	48.3	16.8	31.1	41.1	27.3	43.8	32.7	33.3	34.3	31.6	44.6	15.9	39.1	33.6	27.2	14.9	52.8	54.3	35.7	55.6	46.6	23.7	18.6	109.1	82.0	101.6	98.7	63.2	90.0	98.0	157.2	125.0	129.3	102.7	91.2	120.5	167.6	105.6	132.2	68.2	61.1	126.9	133.4	152.3	44.3	74.0	146.4	90.3	86.0	115.7	284.4	116.3	85.8	175.9	138.0	243.3	112.1	117.1	126.4	216.1	157.0	124.9	84.2	168.6	73.9	88.2	135.1	86.1	149.2	81.9	127.0	88.5	101.7	62.9	104.5	99.8	193.4	88.5	81.3	77.0	102.3	142.7	106.8	143.3	110.4	165.2	111.8	56.9	181.2	114.9	148.3	132.2	43.0	64.3	38.7	50.4	70.8	65.1	52.8	50.9	51.1	82.1	48.5	49.4	49.9	8.4	59.5	57.5	61.4	60.8	58.7	13.9	15.0	15.1	18.1	14.2	19.1	14.9	18.8	16.8	15.9	14.9	18.6	78.5	73.7	72.5	17.0	84.7	97.3	93.7	103.5	47.3	61.6	65.8	80.4	45.2	54.3	87.9	27.6	18.8	120.8	97.0	30.5	66.5	121.1	86.3	38.9	87.2	83.7	53.2	113.8	30.2	131.2	197.3	84.0	39.3	73.3	101.9	94.5	63.9	80.1	100.4	57.2	32.4	94.8	69.2	109.4	78.9	116.1	65.3	83.4	58.7	28.1	122.4	54.5	72.1	29.1	35.6	111.8	48.7	66.5	156.6	131.7	43.5	71.1	54.6	37.7	39.5	92.9	106.7	48.2	86.5	73.2	100.9	166.5	71.1	111.0	89.0	115.2
SRPK1	SFRSK1	ENSG00000096063	"SRSF protein kinase 1"	Q96SB4	6	35832966-35921342	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Chromosome partition, Differentiation, Host-virus interaction, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 379.9;Late spermatids: 599.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 61.0"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 61.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016431, HPA056486"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA016431: AB_1857478, HPA056486: AB_2683148"	"unprognostic (4.65e-3)"	"unprognostic (6.82e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.01e-3)"	"unprognostic (7.74e-2)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (7.90e-6)"	"unprognostic (1.23e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (6.53e-5)"	"unprognostic (7.28e-2)"	"unprognostic (2.21e-3)"	"unprognostic (9.24e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.55e-3)"	8.7	6.0	6.4	18.1	8.2	41.7	14.5	10.0	14.8	12.5	6.8	31.2	25.2	12.7	9.3	23.9	8.6	11.9	8.3	8.9	3.7	16.7	16.0	12.9	19.7	4.0	4.1	8.7	23.3	14.5	9.0	14.5	4.3	9.6	35.6	25.8	16.1	10.9	20.0	26.7	23.6	14.2	2.4	17.8	18.0	44.7	5.2	19.9	8.7	12.6	24.3	31.0	16.2	11.6	104.1	39.2	54.9	82.4	30.2	39.3	69.0	62.1	60.1	57.3	60.2	109.0	34.1	139.0	51.8	39.1	65.5	51.3	110.3	74.2	100.6	96.2	79.9	73.5	42.6	93.8	26.7	111.3	34.0	25.6	39.3	66.0	84.7	44.6	72.3	76.4	157.7	55.6	48.2	36.8	111.1	80.8	45.9	62.9	42.7	77.8	67.3	84.1	56.8	169.5	117.5	42.9	65.4	59.3	42.5	55.2	33.3	70.3	54.8	52.4	41.3	37.2	78.6	33.1	78.6	128.5	20.9	124.3	48.1	61.0	4.4	30.6	8.5	5.3	12.1	8.6	11.2	11.5	5.9	6.9	9.2	10.0	50.9	11.2	7.6	3.3	14.9	6.3	6.4	8.2	10.0	14.8	8.9	3.7	4.0	4.1	4.3	2.4	5.2	11.6	26.6	9.6	25.8	18.6	40.0	42.3	119.3	91.0	67.7	36.8	25.8	22.7	28.7	14.3	51.4	22.0	37.5	54.3	33.1	51.6	29.4	55.4	379.9	29.9	40.2	29.2	46.2	46.7	74.2	68.2	53.2	25.1	46.9	54.0	7.6	44.1	13.2	41.8	21.6	10.1	50.0	50.8	32.6	16.3	19.9	599.1	22.1	20.0	16.0	24.4	31.5	16.8	32.0	30.2	29.7	100.4	47.9	24.8	68.0	117.9	50.8	59.4	33.8	92.9	6.6	17.8	48.9	197.3	100.4	126.8	41.8	39.7	43.6	33.7	90.7	162.6
SRRD	"HC/HCC, SRR1L"	ENSG00000100104	"SRR1 domain containing"	Q9UH36	22	26483877-26494658	"Predicted intracellular proteins"	"Biological rhythms, Heme biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 49.0;Late spermatids: 54.9;Pancreatic endocrine cells: 48.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002945	Uncertain		Approved	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol		"HPA002945: AB_1079265"	"unprognostic (3.25e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (2.16e-6)"	"unprognostic (9.00e-2)"	"unprognostic (8.51e-3)"	"unprognostic (2.49e-2)"	"unprognostic (4.50e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.96e-1)"	5.0	3.5	8.4	4.1	8.8	6.2	6.2	10.4	9.7	5.5	6.2	6.0	3.6	6.3	6.1	5.3	5.5	3.7	7.6	8.7	8.0	6.4	6.9	5.3	5.6	8.2	8.2	7.1	5.5	6.7	5.1	5.3	7.7	6.8	5.2	5.8	4.9	7.2	19.6	6.0	3.9	7.0	8.1	5.4	4.9	4.8	8.6	5.7	10.5	17.1	7.3	5.5	4.2	8.6	10.7	6.3	10.6	10.9	10.8	6.5	6.1	7.4	10.4	14.7	13.5	6.2	4.6	23.6	5.1	9.7	7.4	9.5	16.6	15.6	14.3	12.2	16.5	10.4	5.5	10.1	7.6	23.1	7.8	6.2	13.4	10.5	16.4	9.7	12.9	13.8	17.2	14.5	9.7	9.2	10.4	7.3	6.6	11.7	7.9	23.3	13.2	17.0	9.7	7.6	11.2	7.6	8.5	7.6	19.7	8.8	9.1	9.0	9.9	11.3	37.2	6.4	13.1	9.5	8.3	19.4	7.7	9.4	15.0	0.3	0.5	0.2	0.7	0.4	1.0	1.1	0.8	1.0	0.5	0.6	1.1	1.2	0.4	0.9	0.4	0.4	0.2	0.3	8.4	8.8	10.4	9.7	8.7	8.0	8.2	8.2	7.7	8.1	8.6	8.6	12.1	0.0	6.4	3.6	10.6	29.7	16.2	7.5	3.4	13.0	10.0	10.5	3.0	12.8	5.9	1.8	2.1	13.3	5.9	3.7	9.8	24.9	22.4	5.8	10.6	11.2	4.8	46.9	3.1	49.0	22.9	8.9	7.7	8.9	11.4	15.1	11.0	15.4	14.1	13.5	3.0	4.5	2.0	3.8	8.6	54.9	7.2	8.6	8.8	1.0	6.1	9.8	10.3	3.5	1.9	48.9	2.4	9.1	10.4	12.1	3.4	19.9	3.2	9.3	6.6	12.6	10.3	17.8	12.9	7.7	31.8	16.7	9.1	21.7	5.9	14.7
SRRM1	"MGC39488, POP101, SRM160"	ENSG00000133226	"Serine and arginine repetitive matrix 1"	Q8IYB3	1	24631716-24673281	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049941, HPA058612"	Supported		Enhanced	"Nuclear speckles"		NA	NA		20000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 51: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA049941: AB_2680962, HPA058612: AB_2683778"	"unprognostic (3.31e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.71e-3)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (3.83e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.38e-1)"	"unprognostic (9.27e-2)"	"unprognostic (5.08e-3)"	"unprognostic (4.52e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.46e-1)"	43.2	32.8	28.5	30.7	32.9	68.9	45.3	37.2	35.8	62.6	33.8	48.8	27.7	50.7	83.8	37.5	58.4	22.9	40.5	28.3	29.4	31.2	32.1	40.2	40.3	32.6	31.1	79.2	35.7	26.2	37.6	33.3	33.7	53.5	26.9	52.4	40.6	31.9	52.0	54.8	43.2	30.6	27.4	45.7	36.8	39.3	30.7	31.4	39.8	21.5	37.0	41.6	50.3	46.0	52.4	40.4	79.2	74.2	44.4	46.0	78.0	57.7	40.5	59.1	67.4	45.2	88.1	115.0	36.6	50.4	39.2	66.0	82.1	58.2	78.4	39.2	54.3	89.9	83.3	53.0	30.7	101.3	58.5	30.6	34.9	48.4	68.1	66.4	53.7	55.2	92.8	65.5	61.5	44.1	96.3	69.6	139.4	42.9	29.0	89.4	63.3	58.0	52.4	51.6	49.3	43.0	63.5	54.5	45.5	59.8	49.3	50.7	56.7	54.2	53.2	71.4	62.5	54.7	46.0	138.3	58.4	122.4	61.0	32.3	18.1	20.9	21.6	23.3	26.7	19.9	20.4	21.3	20.7	20.0	18.6	21.6	23.2	29.7	27.5	16.8	16.5	16.9	28.5	32.9	37.2	35.8	28.3	29.4	32.6	31.1	33.7	27.4	30.7	46.0	231.5	157.0	165.3	67.9	266.8	302.3	280.8	194.6	271.5	178.4	164.6	188.0	154.8	128.7	172.7	121.4	118.9	152.1	315.1	146.5	199.6	174.1	330.2	211.3	247.6	170.7	118.4	230.1	53.6	147.2	170.0	177.2	142.2	260.0	241.0	148.6	140.7	225.6	149.5	124.5	56.7	174.4	120.1	178.7	311.3	134.1	167.7	205.3	154.7	45.9	286.6	187.1	256.4	58.8	173.2	147.5	149.1	150.8	236.8	329.8	141.8	198.4	145.5	186.9	138.1	252.3	220.3	219.4	223.3	282.5	295.4	241.2	288.6	135.9	194.3	308.9
SRRT	"ARS2, Asr2, serrate"	ENSG00000087087	"Serrate, RNA effector molecule"	Q9BXP5	7	100875103-100888664	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 251.1;Late spermatids: 329.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042858, HPA058379"	Supported		Enhanced	Nucleoplasm		NA	NA		32000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA042858: AB_2678201, HPA058379: AB_2683697"	"unprognostic (5.83e-2)"	"unprognostic (3.72e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (1.90e-5)"	"unprognostic (4.36e-2)"	"unprognostic (4.99e-3)"	"unprognostic (2.35e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (1.01e-6)"	"unprognostic (6.30e-3)"	"unprognostic (2.77e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.10e-3)"	50.1	64.6	38.8	47.2	43.2	115.2	52.4	44.1	43.8	69.9	41.8	54.7	37.7	56.8	30.3	63.4	56.5	28.7	46.3	38.8	43.2	63.0	74.7	49.4	62.3	43.2	40.1	71.3	63.0	33.0	64.1	33.2	40.7	73.6	25.2	30.8	59.3	30.6	51.1	69.6	60.4	26.8	37.7	75.0	55.3	159.9	42.0	51.0	64.2	23.6	40.6	49.6	60.0	44.7	104.3	122.5	123.6	121.2	51.6	36.8	115.2	112.9	56.6	113.0	96.7	161.3	114.5	172.7	75.6	82.0	84.6	96.1	149.6	101.0	56.0	154.0	128.3	163.3	150.3	134.7	46.4	213.6	270.4	55.2	39.0	100.8	28.8	51.3	62.1	103.8	147.1	135.6	79.4	180.9	198.7	235.6	127.5	89.0	107.4	183.1	94.9	103.4	73.6	113.0	97.6	94.4	111.0	136.5	75.4	62.9	85.9	130.7	95.2	127.1	122.7	109.4	154.8	85.5	132.8	185.2	70.6	141.4	122.6	7.7	14.6	22.2	28.3	23.0	18.3	12.2	18.7	38.8	15.7	15.5	16.0	23.0	10.9	10.4	18.1	14.2	9.7	20.9	38.8	43.2	44.1	43.8	38.8	43.2	43.2	40.1	40.7	37.7	42.0	44.7	22.7	25.6	49.2	17.3	37.6	38.5	27.8	24.1	63.7	23.3	22.4	21.8	21.5	14.3	39.2	16.5	14.6	42.7	43.2	24.4	7.9	31.7	251.1	25.6	36.2	25.9	32.9	51.9	8.6	32.0	50.4	29.2	51.5	41.7	27.1	31.3	12.8	13.1	26.5	26.9	8.5	29.1	18.3	15.0	35.9	329.5	33.8	28.4	16.0	9.4	25.1	29.4	26.8	12.5	12.7	26.3	17.9	27.8	67.2	22.8	16.0	12.2	30.5	46.0	19.7	31.7	41.7	133.3	65.8	52.4	43.5	54.2	62.8	33.9	32.3	21.4
SRSF1	"ASF, MGC5228, SF2, SF2p33, SFRS1, SRp30a"	ENSG00000136450	"Serine and arginine rich splicing factor 1"	Q07955	17	58000919-58007346	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013073, HPA061301"	Supported		Supported	Nucleoplasm		NA	NA		980000	"Cluster 27: Non-specific - Gene expression"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB013073: AB_2533079, HPA061301: AB_2684474"	"unprognostic (9.86e-2)"	"prognostic favorable (7.00e-4)"	"prognostic favorable (4.56e-5)"	"unprognostic (8.11e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.88e-3)"	"prognostic unfavorable (1.64e-6)"	"unprognostic (8.28e-2)"	"unprognostic (2.60e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.48e-2)"	"prognostic unfavorable (2.95e-5)"	"unprognostic (1.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.50e-1)"	"unprognostic (1.59e-2)"	71.1	81.1	44.0	84.0	47.5	54.7	62.8	52.1	50.0	78.6	53.8	76.1	69.7	79.1	70.0	84.0	73.5	42.5	61.8	43.0	45.9	71.0	71.4	60.8	107.1	44.1	45.7	78.4	58.6	73.0	69.2	64.8	45.0	70.2	77.1	60.5	67.5	57.4	71.2	57.2	73.4	59.6	47.4	72.6	69.0	38.9	46.3	104.5	72.7	51.5	119.7	69.3	73.6	50.7	211.4	157.1	264.9	153.3	72.3	67.3	164.6	187.0	102.9	177.9	167.8	195.9	180.6	352.0	121.1	129.8	134.3	178.9	298.4	192.6	325.5	196.8	176.1	263.0	202.2	220.9	83.2	292.4	169.9	56.3	90.5	164.6	168.3	84.3	145.1	131.9	291.0	166.9	181.2	162.6	370.2	258.4	246.5	191.7	160.9	349.4	216.1	217.1	176.6	177.5	192.4	206.8	142.5	128.6	139.5	142.0	180.8	220.5	139.3	158.6	197.0	122.7	258.8	149.7	217.3	333.3	150.1	272.2	193.8	23.9	48.3	32.5	38.9	64.4	38.6	35.7	30.7	37.1	71.1	24.9	32.8	33.3	22.0	48.1	45.1	40.5	36.9	45.2	44.0	47.5	52.1	50.0	43.0	45.9	44.1	45.7	45.0	47.4	46.3	50.7	74.1	35.3	48.3	66.0	89.1	133.7	130.0	53.1	96.2	62.9	73.1	58.0	31.3	41.5	48.6	44.1	31.3	70.3	68.1	57.5	70.5	68.2	57.8	44.9	59.2	66.2	65.8	93.2	33.0	60.1	116.6	74.7	53.5	59.3	59.6	92.2	44.6	46.3	59.1	52.2	51.8	76.2	52.9	54.0	73.5	34.0	84.2	52.3	55.2	36.5	60.7	43.5	80.3	56.3	59.2	61.4	84.9	60.2	73.3	102.8	76.3	56.4	43.4	83.1	105.2	87.7	89.5	74.6	58.0	86.6	137.5	60.9	69.4	57.3	93.3	120.6
SRSF10	"FUSIP1, FUSIP2, PPP1R149, SFRS13, SFRS13A, SRp38, SRrp40, TASR1, TASR2"	ENSG00000188529	"Serine and arginine rich splicing factor 10"	O75494	1	23964347-23980927	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053805, HPA053831"	Uncertain		Supported	Nucleoplasm		NA	Yes		49000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA053805: AB_2682269, HPA053831: AB_2682275"	"unprognostic (2.49e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (1.18e-6)"	"unprognostic (2.05e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.74e-4)"	"prognostic unfavorable (1.01e-5)"	"unprognostic (2.69e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.40e-2)"	57.0	59.9	22.5	46.3	23.3	119.6	46.9	26.5	30.1	51.7	29.9	48.8	38.0	49.6	40.7	43.8	56.3	29.2	40.0	23.2	24.4	56.3	56.7	49.6	61.0	23.3	23.5	61.1	50.1	37.2	43.6	42.2	24.3	47.9	45.0	46.5	45.4	32.1	37.7	40.1	50.2	41.3	25.0	49.0	47.9	34.7	23.1	55.8	61.3	24.4	57.1	43.0	45.0	28.6	110.7	89.6	142.9	92.9	88.6	68.2	98.0	133.4	53.5	116.8	102.3	83.5	112.8	239.5	82.7	63.5	73.8	99.7	163.4	89.7	140.7	140.9	122.7	134.5	160.3	115.1	62.2	164.3	107.9	44.2	68.5	74.3	72.9	66.8	89.1	92.1	187.2	83.4	99.3	77.2	167.9	118.1	196.2	139.6	84.4	162.9	99.7	127.6	102.1	86.4	104.9	85.5	98.7	88.2	100.1	97.4	94.2	129.5	89.2	94.7	99.5	89.2	126.4	94.6	134.6	189.1	83.4	185.9	112.8	112.8	67.7	74.0	51.3	84.1	65.1	80.2	58.5	60.3	58.1	68.8	62.9	55.8	43.9	74.5	82.0	69.6	75.9	72.3	22.5	23.3	26.5	30.1	23.2	24.4	23.3	23.5	24.3	25.0	23.1	28.6	115.8	112.2	112.1	39.2	188.4	42.6	115.5	23.2	183.2	159.1	104.4	103.4	59.1	97.2	85.5	79.1	160.6	116.8	150.5	85.6	78.2	94.2	115.4	96.7	138.3	109.8	122.0	154.2	54.7	89.2	164.1	111.3	93.8	106.7	93.6	181.0	86.0	63.8	82.0	99.3	50.9	92.4	36.7	51.2	41.3	118.5	127.7	83.4	26.6	44.0	101.5	131.6	111.2	54.8	67.2	78.6	85.9	110.6	169.4	122.6	67.4	74.6	94.6	287.5	105.2	121.8	125.8	188.1	150.5	140.0	45.5	63.3	142.6	335.7	106.3	100.1
SRSF11	"NET2, p54, SFRS11"	ENSG00000116754	"Serine and arginine rich splicing factor 11"	Q05519	1	70205682-70253052	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008762	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA008762: AB_1856782"	"unprognostic (7.82e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.30e-3)"	"prognostic unfavorable (3.91e-4)"	"unprognostic (2.23e-3)"	"unprognostic (5.65e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.25e-3)"	"prognostic unfavorable (6.53e-6)"	"unprognostic (7.79e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.43e-2)"	76.4	67.0	39.4	51.4	42.6	136.8	76.9	48.1	64.6	86.6	40.0	73.7	44.7	75.9	70.0	62.1	83.7	45.1	51.9	39.4	46.5	68.8	94.1	70.1	75.8	42.0	40.7	96.3	85.7	43.0	79.8	56.1	43.7	73.7	45.0	57.7	69.5	40.8	66.3	75.9	84.9	39.3	39.7	89.8	72.9	58.4	41.4	75.4	86.2	32.9	64.7	68.5	75.0	47.9	92.8	46.2	118.4	76.2	59.5	79.7	162.4	111.6	57.5	89.0	80.3	81.6	68.0	156.6	74.7	56.5	58.4	77.4	151.5	61.4	120.7	105.9	118.1	159.0	112.4	98.5	71.1	221.0	63.3	64.2	76.0	82.5	83.5	111.3	80.4	79.0	159.1	96.1	88.7	36.4	133.3	163.1	190.9	72.3	76.9	156.1	130.9	99.9	104.3	65.7	99.3	82.1	94.5	101.1	139.8	109.1	80.9	98.1	96.0	97.8	70.4	71.3	102.3	110.4	94.5	169.9	70.2	161.3	87.7	111.7	63.5	103.6	65.7	51.6	74.9	76.3	67.0	65.2	66.1	70.7	72.2	67.8	31.7	85.8	64.6	91.7	80.4	52.7	39.4	42.6	48.1	64.6	39.4	46.5	42.0	40.7	43.7	39.7	41.4	47.9	198.6	211.5	224.9	90.4	208.6	354.0	295.5	229.6	222.5	164.8	166.9	171.7	119.6	115.8	184.5	195.0	118.9	242.0	243.4	123.8	115.4	151.0	64.4	160.0	267.9	186.8	173.8	218.5	219.0	135.3	253.1	228.9	165.6	231.0	194.1	218.1	146.3	152.6	150.4	159.9	183.0	158.3	150.5	124.9	244.4	56.9	255.7	155.4	168.9	126.5	183.1	115.5	145.2	168.9	219.8	144.9	104.7	264.4	234.9	317.8	122.1	101.4	157.8	158.1	170.9	199.1	218.3	270.0	138.0	181.4	353.6	303.7	226.2	195.5	172.9	315.0
SRSF2	"PR264, SC-35, SC35, SFRS2, SFRS2A"	ENSG00000161547	"Serine and arginine rich splicing factor 2"	Q01130	17	76734115-76737333	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA049905	Supported		Approved	Nucleoplasm,Cytosol		NA	NA		180000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA049905: AB_2680945"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.73e-3)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.75e-2)"	"unprognostic (4.19e-2)"	"prognostic unfavorable (3.53e-8)"	"unprognostic (1.19e-1)"	"unprognostic (7.79e-3)"	"unprognostic (7.03e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.07e-3)"	"prognostic unfavorable (1.05e-7)"	"unprognostic (3.85e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.95e-1)"	"prognostic favorable (9.87e-4)"	106.0	106.8	27.8	95.5	29.6	184.7	92.1	29.9	34.0	83.6	37.7	100.3	86.2	88.9	64.0	129.5	89.5	42.1	78.5	29.2	32.9	83.0	115.2	95.4	111.6	30.8	28.5	85.6	88.3	48.4	81.9	66.0	30.3	78.0	71.6	53.4	90.6	52.3	91.7	96.5	113.2	49.0	31.3	121.6	94.4	49.5	30.0	94.2	102.1	36.0	100.2	80.0	94.3	36.0	318.7	239.8	289.5	207.5	70.9	58.5	300.5	197.3	146.8	225.4	207.0	257.2	216.8	478.0	143.3	188.7	164.3	279.9	293.3	229.0	230.2	202.3	489.3	357.9	246.6	311.9	79.3	404.4	210.6	65.2	51.1	186.2	54.0	91.1	179.9	212.0	373.4	209.6	183.7	251.0	460.0	440.9	339.5	186.4	340.2	455.0	310.6	360.5	156.5	225.2	247.7	350.8	227.1	196.3	120.4	154.0	238.8	301.6	187.9	206.9	271.3	139.4	330.0	278.2	219.2	552.9	187.3	318.9	177.1	2.5	40.9	10.0	26.0	53.3	26.0	23.5	17.7	26.7	67.0	19.6	20.1	19.4	4.4	35.6	33.6	49.2	24.0	33.0	27.8	29.6	29.9	34.0	29.2	32.9	30.8	28.5	30.3	31.3	30.0	36.0	271.3	118.6	105.6	57.5	396.7	460.8	439.7	205.9	540.1	151.9	291.7	277.9	86.2	148.7	141.5	88.3	91.8	339.4	548.0	233.1	156.5	199.1	203.6	176.8	181.9	204.3	266.3	366.6	51.1	157.3	579.7	233.9	196.7	257.4	218.4	241.7	116.7	125.1	251.3	99.3	55.4	246.9	132.2	143.7	480.4	162.0	159.1	273.5	282.8	63.7	226.9	153.3	196.7	55.8	87.9	189.0	288.7	127.5	492.0	384.8	250.5	128.7	97.4	188.9	118.3	286.8	242.1	272.3	296.8	489.5	443.4	316.0	469.1	185.4	329.4	459.4
SRSF3	"SFRS3, SRp20"	ENSG00000112081	"Serine and arginine rich splicing factor 3"	P84103	6	36594353-36605600	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012986, HPA056981"	Supported		Supported	Nucleoplasm		NA	NA		1600000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB012986: AB_2533150, HPA056981: AB_2683299"	"unprognostic (3.25e-1)"	"unprognostic (1.08e-3)"	"prognostic favorable (2.56e-4)"	"unprognostic (8.19e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (6.22e-5)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (1.95e-4)"	"prognostic favorable (1.37e-4)"	"unprognostic (9.61e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (9.88e-2)"	"unprognostic (3.33e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.06e-2)"	97.2	62.5	39.2	93.5	40.9	172.3	90.2	43.6	44.0	72.6	42.4	89.6	54.0	76.1	62.5	97.8	78.0	40.5	70.2	40.1	43.8	83.3	75.3	68.8	118.9	40.0	40.6	84.0	58.0	62.3	49.2	74.6	41.6	58.6	95.2	45.2	57.8	64.6	76.0	66.4	73.2	89.9	43.1	67.2	74.9	59.9	44.0	164.3	60.7	48.5	147.9	97.7	72.0	45.5	357.2	232.3	401.4	308.9	151.9	117.9	247.2	248.4	206.5	408.6	312.2	275.1	248.2	593.4	174.3	273.3	266.8	275.1	533.1	395.4	433.2	279.3	327.3	357.0	175.5	312.3	184.9	485.2	289.6	105.8	131.6	267.4	295.6	130.3	315.2	354.4	438.7	244.1	300.8	277.4	601.0	457.0	424.5	414.5	241.5	527.3	384.2	355.9	292.2	291.1	308.7	291.8	276.1	267.4	385.4	284.9	271.2	513.1	207.9	208.1	303.9	211.0	380.1	238.6	381.4	822.9	178.4	443.7	295.5	85.6	179.0	57.9	145.8	176.6	166.0	129.0	136.8	154.7	350.7	113.5	136.1	140.8	17.1	190.5	125.1	206.8	184.2	305.6	39.2	40.9	43.6	44.0	40.1	43.8	40.0	40.6	41.6	43.1	44.0	45.5	648.3	201.9	238.6	47.3	337.6	469.6	425.1	308.4	225.9	146.2	371.3	388.4	227.9	198.8	258.0	125.0	54.2	495.6	574.3	245.3	363.9	357.3	176.1	216.0	295.7	346.9	332.9	345.9	24.0	324.9	816.9	373.6	226.8	251.1	396.8	275.2	243.8	182.7	359.3	99.3	23.8	409.9	191.2	262.9	559.3	321.2	211.9	356.5	334.4	45.9	366.3	368.8	334.8	38.2	51.1	290.1	301.9	172.3	256.3	401.7	259.2	274.7	164.8	154.5	203.8	497.3	448.2	374.2	290.8	312.2	445.8	526.1	415.2	184.1	427.4	285.1
SSBP1	"mtSSB, SSBP"	ENSG00000106028	"Single stranded DNA binding protein 1"	Q04837	7	141738334-141787922	"Human disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002866	Supported		Supported	Mitochondria		NA	NA		150000	"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria		"HPA002866: AB_1080092"	"unprognostic (2.95e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.62e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.86e-2)"	"prognostic unfavorable (4.42e-4)"	"unprognostic (3.68e-2)"	"unprognostic (6.03e-2)"	"prognostic favorable (3.40e-4)"	"unprognostic (9.23e-3)"	"unprognostic (4.02e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.62e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.25e-2)"	"unprognostic (9.58e-2)"	86.1	105.0	70.5	80.9	72.6	89.9	97.0	72.3	101.1	75.1	65.8	94.1	70.4	83.6	107.7	125.9	74.0	54.0	135.0	71.5	74.5	105.4	120.4	62.9	97.0	72.5	74.4	85.3	87.8	93.6	64.8	78.4	72.8	64.9	85.3	58.2	77.4	70.4	141.2	88.4	77.5	76.1	72.5	80.8	93.1	80.8	70.8	96.6	82.7	94.1	112.8	91.8	82.1	74.4	280.6	333.6	281.6	369.2	125.5	193.2	262.2	208.7	193.0	256.4	287.9	353.7	330.5	414.0	267.6	173.5	421.8	210.2	349.5	347.4	369.6	220.8	339.1	226.1	253.6	322.3	242.6	644.9	166.8	179.9	230.9	257.4	373.0	177.7	316.2	279.9	552.8	184.0	343.4	430.9	477.3	837.2	634.1	476.8	403.0	262.6	258.2	578.5	340.9	286.7	256.4	352.5	236.8	323.7	319.8	213.7	210.7	267.2	239.6	183.0	171.6	282.1	533.8	328.6	465.9	796.1	369.9	577.6	395.8	136.1	69.9	76.8	71.7	96.1	107.7	106.3	113.8	98.9	90.6	92.0	101.1	113.7	20.6	98.8	99.8	104.0	123.8	116.3	70.5	72.6	72.3	101.1	71.5	74.5	72.5	74.4	72.8	72.5	70.8	74.4	151.0	102.5	104.7	13.7	135.7	116.0	199.6	477.7	98.4	58.6	114.3	178.8	279.1	148.7	242.7	150.8	41.7	311.0	139.2	92.7	350.2	310.3	187.0	160.6	162.3	136.5	96.3	111.7	17.0	353.3	313.7	140.5	92.2	169.8	151.9	163.3	105.3	221.9	251.9	43.7	16.0	163.7	244.1	122.0	126.3	62.2	137.3	131.0	104.9	15.0	221.2	152.1	157.6	16.6	29.1	314.0	130.0	123.8	101.3	166.6	141.9	445.2	178.0	79.1	98.6	170.6	223.5	253.5	190.0	136.3	129.4	261.7	145.2	254.1	188.1	200.2
SSNA1	"N14, NA14"	ENSG00000176101	"SS nuclear autoantigen 1"	O43805	9	137188660-137190370	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (6.70e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.36e-2)"	"prognostic favorable (8.94e-4)"	"unprognostic (1.73e-1)"	"unprognostic (4.44e-1)"	"unprognostic (1.12e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.63e-2)"	"unprognostic (9.07e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.67e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.66e-1)"	46.3	48.2	64.5	41.7	67.8	61.6	45.3	66.5	89.0	38.8	62.4	52.7	42.1	39.5	18.4	77.6	38.8	24.4	81.5	64.2	66.4	60.8	66.5	38.7	54.6	67.0	66.8	30.3	75.9	30.2	27.9	29.1	66.8	48.6	19.2	10.1	61.5	27.8	78.7	62.0	45.9	26.0	65.4	52.2	68.3	124.8	67.4	48.5	37.4	41.9	34.9	48.8	43.8	72.3	79.1	167.4	54.9	86.6	52.0	45.8	56.8	71.8	63.9	96.9	53.5	82.6	108.2	77.0	89.3	60.8	84.2	128.2	65.6	99.2	14.7	140.7	44.9	62.7	128.8	89.0	70.8	104.6	64.5	46.2	86.2	64.5	56.3	45.7	87.8	112.5	69.4	141.9	66.7	225.2	138.8	107.0	86.5	167.7	73.6	91.6	75.2	223.0	83.1	67.5	96.7	54.8	56.9	156.0	82.3	21.3	167.2	122.3	63.8	94.3	53.5	141.6	98.2	34.9	140.3	76.7	103.6	103.3	79.0	117.4	96.7	161.1	99.6	143.8	90.3	118.0	91.6	100.9	90.6	117.9	84.0	85.1	85.0	107.7	136.9	146.1	140.6	93.7	64.5	67.8	66.5	89.0	64.2	66.4	67.0	66.8	66.8	65.4	67.4	72.3	72.4	41.7	44.2	7.5	83.7	63.7	58.0	78.3	63.2	39.1	96.1	115.6	49.9	94.4	59.4	62.5	16.7	150.7	109.9	200.5	113.5	144.6	76.3	80.3	54.4	64.8	77.7	97.4	14.2	233.1	170.5	51.5	65.2	75.0	57.2	57.8	49.6	84.0	156.3	40.4	13.6	131.0	71.2	78.0	82.8	56.6	60.3	82.6	119.2	7.5	186.1	86.7	107.1	8.0	39.7	207.0	166.2	50.8	83.4	88.6	210.2	194.3	52.7	40.3	32.9	27.8	67.1	320.6	114.2	113.5	84.0	111.1	89.9	67.0	130.2	72.7
SSRP1	FACT80	ENSG00000149136	"Structure specific recognition protein 1"	Q08945	11	57325986-57335892	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002697	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		42000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	Nucleoplasm	"HPA002697: AB_1857509"	"unprognostic (1.67e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (4.03e-7)"	"unprognostic (3.22e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (5.63e-4)"	"unprognostic (5.92e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.52e-2)"	52.3	42.7	37.6	62.9	39.1	78.9	53.7	37.9	46.4	61.0	37.2	64.7	48.3	64.9	47.7	67.7	68.3	37.0	47.0	39.3	41.2	48.8	43.3	51.7	76.1	38.2	38.9	74.1	74.0	60.9	57.4	57.5	37.1	46.6	66.1	36.0	55.0	49.6	140.6	67.0	55.1	58.4	38.5	52.6	59.8	45.8	42.4	87.8	54.0	63.9	91.9	58.6	56.4	40.2	353.0	332.0	308.3	226.9	95.1	105.1	150.7	188.9	181.1	321.8	229.2	230.0	255.2	424.4	196.7	166.7	204.5	264.8	493.7	293.9	402.2	297.7	276.9	271.5	233.1	250.5	149.3	455.4	195.3	106.7	175.7	331.8	456.8	149.1	213.3	320.7	376.0	207.9	222.6	237.1	463.3	400.3	406.1	186.1	201.7	386.1	520.4	412.0	151.7	249.3	321.4	271.6	267.6	226.2	286.7	157.0	275.3	177.0	162.7	218.2	287.1	298.3	328.9	240.9	259.9	431.9	185.0	251.6	294.6	0.8	4.1	4.6	8.6	5.1	8.2	8.4	7.4	9.5	6.0	10.5	8.2	11.0	1.0	7.2	5.2	10.0	9.9	5.0	37.6	39.1	37.9	46.4	39.3	41.2	38.2	38.9	37.1	38.5	42.4	40.2	31.2	76.9	91.2	4.6	51.0	74.9	78.1	52.0	55.8	27.3	38.3	39.8	26.4	44.3	78.1	29.5	25.0	115.6	31.7	29.9	13.7	92.5	83.0	40.8	47.2	52.0	28.8	106.8	10.5	99.4	116.9	45.3	32.1	33.2	41.0	55.6	33.2	39.7	57.5	25.2	9.1	45.2	32.6	37.9	45.5	158.0	42.6	34.9	28.4	8.4	42.5	26.3	40.2	6.0	8.4	69.0	32.9	44.4	72.2	80.0	32.3	25.7	101.0	18.9	19.7	53.1	66.1	58.4	108.0	75.3	76.3	67.6	43.5	46.7	78.4	70.7
SSX2IP	hMsd1	ENSG00000117155	"SSX family member 2 interacting protein"	Q9Y2D8	1	84643706-84690803	"Predicted intracellular proteins"	"Cell adhesion, Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 118.7;testis: 105.7"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 260.6;Early spermatids: 774.9;Late spermatids: 1095.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075946	Supported		Approved	"Cell Junctions"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Cell Junctions"		"HPA075946: "	"unprognostic (5.18e-3)"	"unprognostic (2.13e-1)"	"prognostic favorable (1.45e-4)"	"unprognostic (2.83e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.73e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.37e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.23e-3)"	"unprognostic (2.08e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.46e-2)"	1.9	3.1	8.2	5.8	13.1	14.9	5.1	12.9	23.4	6.8	4.4	8.1	43.2	9.3	22.6	6.4	7.2	8.7	9.4	13.8	3.6	16.5	14.5	3.9	6.4	1.1	1.4	2.0	7.1	9.2	9.6	6.3	1.4	12.7	7.8	118.7	6.9	11.8	3.5	6.5	26.8	10.7	0.0	5.4	7.1	105.7	1.5	12.1	8.2	2.6	6.3	5.7	3.5	11.9	39.1	19.0	15.1	27.7	5.0	15.7	18.4	65.6	33.2	28.3	22.7	13.7	8.4	38.6	11.3	55.8	36.5	21.4	27.0	21.2	39.5	7.7	23.0	36.4	22.2	11.9	10.3	32.1	2.9	6.7	34.1	31.9	20.1	18.9	9.7	14.7	76.5	14.1	18.1	15.0	22.5	12.7	22.3	7.4	29.6	15.1	66.0	17.0	29.5	22.3	29.4	36.7	18.4	29.6	32.9	9.5	17.2	16.4	2.9	26.8	39.2	36.9	65.9	14.7	18.7	42.0	22.4	28.2	16.9	0.8	0.8	3.9	8.2	1.9	4.5	1.2	2.6	3.3	3.5	1.2	3.3	5.1	1.1	4.6	2.6	4.5	1.5	3.9	8.2	13.1	12.9	23.4	13.8	3.6	1.1	1.4	1.4	0.0	1.5	11.9	4.4	3.2	3.0	38.2	3.7	10.5	8.6	8.7	12.5	45.6	10.5	7.0	36.8	21.5	7.3	11.0	260.6	5.3	23.9	3.9	7.9	7.3	774.9	14.9	8.9	5.0	8.4	46.7	108.5	12.0	1.9	15.7	5.6	11.6	4.5	4.2	3.6	14.9	2.7	20.2	70.2	9.3	2.0	1.9	5.6	1095.3	15.8	24.1	5.4	18.7	3.5	187.4	15.5	16.6	23.9	9.4	4.6	11.3	12.7	4.3	19.7	44.9	13.3	158.0	0.0	4.2	7.3	71.7	53.6	13.6	9.8	0.5	8.4	2.0	10.7	4.2
ST13	"FAM10A1, HIP, HSPABP1, P48, SNC6"	ENSG00000100380	"ST13 Hsp70 interacting protein"	P50502	22	40824535-40856639	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 1091.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043233, HPA046412, HPA047114, HPA047116"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA043233: AB_2678377, HPA046412: AB_2679658, HPA047114: AB_2679937, HPA047116: AB_2679939"	"unprognostic (1.19e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.69e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.68e-2)"	"prognostic unfavorable (5.23e-4)"	"unprognostic (2.73e-3)"	"unprognostic (1.74e-2)"	"unprognostic (3.63e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.54e-2)"	"prognostic favorable (3.10e-4)"	"unprognostic (8.41e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.04e-1)"	"unprognostic (8.40e-2)"	163.2	157.5	131.9	84.2	148.3	99.0	161.6	149.9	171.9	163.0	140.4	135.6	96.7	197.5	137.2	116.6	180.6	122.8	121.9	123.8	156.8	254.2	296.7	97.0	111.7	147.3	140.5	542.6	126.2	150.8	92.3	135.3	154.8	145.0	108.0	146.4	111.3	142.6	341.2	98.4	108.3	165.0	147.2	89.0	111.1	107.7	136.1	131.6	176.6	217.9	126.2	131.5	113.5	191.9	249.0	195.1	290.6	255.4	265.7	407.1	263.7	229.0	293.2	279.6	242.3	353.7	144.3	356.8	193.2	232.9	253.7	177.3	387.7	226.3	331.2	228.4	250.3	255.0	379.1	406.4	241.2	374.6	198.5	365.5	235.7	252.6	169.7	351.2	293.6	219.3	313.2	151.2	271.3	187.1	329.5	200.1	166.4	302.0	130.7	375.7	246.4	281.9	284.2	369.8	96.4	97.1	265.0	211.7	337.7	334.1	205.5	233.2	220.8	232.1	223.0	197.0	188.2	173.5	367.9	333.4	317.4	172.0	228.2	108.9	79.5	85.7	84.7	108.7	129.1	146.2	133.0	101.9	107.1	131.6	206.6	160.7	26.3	110.6	146.3	75.5	122.3	162.6	131.9	148.3	149.9	171.9	123.8	156.8	147.3	140.5	154.8	147.2	136.1	191.9	187.0	141.1	220.5	28.1	217.5	311.6	384.6	267.7	279.4	89.5	364.6	359.2	140.1	334.6	232.5	171.0	16.7	382.8	141.7	192.9	563.4	284.8	513.2	431.6	349.8	204.1	262.0	296.3	37.4	205.1	381.2	239.7	107.0	289.6	207.1	305.0	227.7	539.2	328.6	38.7	41.5	263.7	183.1	270.6	374.5	1010.4	510.4	210.3	211.7	15.0	286.7	265.1	157.6	27.2	53.7	193.7	210.8	413.3	129.0	312.2	369.6	1091.8	281.8	73.0	223.5	212.0	268.7	306.9	191.2	193.5	274.5	500.9	200.6	227.3	333.2	325.8
STARD7	GTT1	ENSG00000084090	"StAR related lipid transfer domain containing 7"	Q9NQZ5	2	96184859-96208827	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033965, HPA064958, HPA064978"	Supported		Approved	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"CAB033965: AB_2302780, HPA064958: AB_2685391, HPA064978: AB_2685397"	"unprognostic (3.75e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (8.56e-5)"	"prognostic favorable (3.89e-6)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (2.72e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (4.38e-6)"	"unprognostic (1.02e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.42e-2)"	44.7	54.3	57.8	46.7	62.4	34.3	43.9	61.9	53.2	33.9	60.6	57.6	55.7	29.8	30.5	36.8	44.0	29.1	98.5	49.8	61.4	80.3	62.8	61.1	70.6	56.4	55.5	29.4	42.2	69.7	23.6	29.3	54.9	39.0	56.2	54.4	65.2	45.7	202.5	35.2	45.4	37.6	60.5	53.1	44.6	21.1	66.9	56.2	56.6	174.0	86.9	42.1	27.0	74.4	128.8	79.1	102.3	106.2	134.9	66.9	150.1	122.6	107.0	121.2	129.6	188.8	117.7	228.7	129.0	98.6	95.8	102.3	183.3	106.4	157.3	147.2	131.9	204.1	74.3	218.3	62.2	158.1	106.9	65.4	77.9	101.0	99.1	77.2	123.2	92.6	211.1	89.2	108.8	113.0	175.9	161.0	173.3	110.3	115.2	171.6	156.4	227.1	73.2	162.2	191.6	90.5	62.5	201.8	115.8	126.0	60.5	171.6	103.8	100.1	100.4	112.0	125.8	113.9	114.0	201.7	92.8	174.9	112.6	35.6	25.4	22.7	25.6	30.2	26.1	42.6	21.5	26.6	36.2	37.8	23.6	23.4	3.0	30.8	19.9	42.2	41.5	26.0	57.8	62.4	61.9	53.2	49.8	61.4	56.4	55.5	54.9	60.5	66.9	74.4	32.0	134.6	44.2	21.5	71.2	63.7	43.2	34.3	101.9	39.5	58.1	50.2	176.9	55.8	47.1	46.0	108.4	35.8	83.8	63.3	74.3	32.4	2.5	34.5	43.2	49.9	44.4	48.6	25.6	38.0	40.3	31.3	37.8	48.6	15.8	45.4	41.7	114.7	71.0	40.4	23.8	58.4	24.4	122.4	102.3	6.9	23.3	54.4	42.7	20.6	95.8	38.4	30.9	19.1	42.6	35.8	26.6	25.2	120.6	68.4	50.1	65.7	31.8	58.1	26.3	43.5	43.0	22.7	35.1	75.4	57.4	35.4	62.9	36.8	81.9	38.8
STIL	"MCPH7, SIL"	ENSG00000123473	"STIL centriolar assembly protein"	Q15468	1	47250139-47314147	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Cancer-related genes, Disease variant, Mental retardation, Primary microcephaly, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.8;lymphoid tissue: 9.9"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 12.8;Glandular and luminal cells: 12.4;Spermatocytes: 17.8;Spermatogonia: 14.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA046543			Approved	"Plasma membrane,Cytosol"		NA	Yes			"Cluster 40: NK-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Cytosol"		"HPA046543: AB_2679692"	"unprognostic (2.07e-1)"	"unprognostic (6.29e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.67e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.90e-5)"	"unprognostic (7.35e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (5.81e-2)"	"unprognostic (3.36e-14)"	"unprognostic (5.76e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.28e-1)"	1.0	0.5	0.8	3.0	0.8	10.8	2.9	0.7	1.2	1.1	0.2	4.1	2.9	1.4	1.4	2.5	0.9	1.4	0.6	0.8	0.6	0.7	1.0	0.9	4.9	0.7	0.6	0.8	0.7	0.9	0.4	1.9	0.8	1.3	5.6	1.2	1.7	0.5	0.6	3.1	2.7	1.4	0.4	1.4	1.8	6.6	0.8	9.9	0.9	0.7	5.7	1.1	1.0	1.0	33.7	17.4	24.7	22.1	1.8	3.8	15.7	29.3	14.0	32.0	33.2	18.5	16.1	39.4	13.3	14.4	32.7	21.4	29.4	15.3	33.7	29.6	12.9	44.5	20.9	16.6	0.8	35.7	21.5	1.6	2.1	27.2	17.5	3.8	21.5	29.5	31.7	35.9	24.1	14.3	35.6	10.9	30.0	18.6	14.2	23.0	40.3	19.0	9.0	20.0	22.0	13.2	31.4	22.2	14.6	29.6	14.5	20.6	12.2	29.6	29.9	21.2	40.0	11.9	26.4	38.1	13.8	27.0	28.0	0.3	0.1	0.2	0.2	0.0	0.0	0.4	0.2	0.2	0.1	0.2	0.0	0.1	0.3	0.7	0.0	0.3	0.3	0.1	0.8	0.8	0.7	1.2	0.8	0.6	0.7	0.6	0.8	0.4	0.8	1.0	1.6	3.2	0.5	2.0	2.4	0.9	0.6	2.0	1.2	1.1	2.8	3.0	0.5	0.0	2.3	0.0	4.2	2.5	1.6	5.4	0.0	1.6	1.6	7.8	3.2	2.2	1.8	12.8	5.1	0.4	4.4	1.6	3.1	12.4	2.5	8.2	1.4	0.5	2.9	0.0	3.9	6.1	0.0	2.4	1.2	1.1	0.3	2.7	0.0	0.0	3.0	0.8	1.0	2.0	4.8	1.9	1.8	0.7	10.2	1.1	1.4	0.4	7.6	0.6	0.0	1.7	2.0	17.8	14.4	5.3	2.4	0.8	3.3	2.6	5.5	1.4
STIP1	"HOP, STI1"	ENSG00000168439	"Stress induced phosphoprotein 1"	P31948	11	64185272-64204543	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 340.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017448, HPA039291, HPA044062"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		3600000	"Cluster 27: Non-specific - Gene expression"	"Cluster 47: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Plasma membrane"	Cytosol	"CAB017448: AB_10618972, HPA039291: AB_2676428, HPA044062: AB_2678795"	"unprognostic (2.49e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.23e-4)"	"prognostic unfavorable (6.18e-8)"	"unprognostic (2.16e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.04e-3)"	"unprognostic (1.70e-1)"	"unprognostic (6.72e-2)"	"unprognostic (8.23e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.99e-2)"	68.0	128.0	114.5	70.2	119.9	61.3	49.7	124.6	340.6	69.5	122.1	72.9	40.4	74.1	49.0	79.5	72.4	43.5	98.5	120.2	133.4	86.7	68.9	70.8	72.9	124.0	131.3	87.6	53.3	61.4	71.7	77.5	139.2	60.7	56.0	62.9	56.1	56.1	140.3	60.5	53.9	66.7	123.6	69.0	66.1	126.3	134.2	66.2	57.6	92.2	88.2	81.2	63.8	159.4	321.0	486.3	298.1	251.7	161.8	108.1	271.5	277.2	150.1	393.9	228.1	361.3	265.2	371.1	322.9	220.3	475.4	329.7	745.4	280.3	427.6	302.1	311.7	521.5	302.6	336.7	142.8	278.7	325.1	109.4	174.5	327.1	242.7	162.4	284.2	276.1	537.2	209.5	232.1	468.8	432.0	388.6	366.4	306.0	407.2	418.3	279.1	385.6	282.8	271.8	242.7	217.3	314.4	338.9	266.7	310.3	357.1	194.0	253.8	252.0	310.9	333.1	389.0	189.8	434.0	388.0	328.8	282.6	374.1	61.0	66.8	57.4	87.6	95.1	88.2	85.9	65.5	79.5	69.9	68.5	72.7	81.6	20.0	108.2	114.6	58.1	66.1	119.1	114.5	119.9	124.6	340.6	120.2	133.4	124.0	131.3	139.2	123.6	134.2	159.4	31.3	44.8	32.9	7.8	40.0	80.4	184.1	61.5	40.9	37.5	32.5	29.8	46.1	31.5	59.1	20.2	41.7	124.8	39.8	38.3	49.0	76.3	31.0	65.8	48.6	45.9	67.3	69.0	9.5	55.2	146.1	49.6	24.5	51.1	79.3	47.8	14.3	27.4	91.5	63.9	14.9	39.9	97.6	21.9	90.3	77.5	27.4	46.7	62.2	12.2	51.8	36.9	53.5	11.1	17.2	69.5	32.7	39.9	56.4	75.7	22.3	39.6	85.8	36.7	26.3	36.1	65.4	96.3	118.6	47.6	72.0	211.0	67.0	62.8	48.6	95.3
STK39	"DCHT, SPAK"	ENSG00000198648	"Serine/threonine kinase 39"	Q9UEW8	2	167954020-168247595	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 159.9;Inhibitory neurons: 142.9;Oligodendrocyte precursor cells: 153.3;Oligodendrocytes: 359.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046022, HPA061803, HPA062802"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		80000	"Cluster 35: T-regs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Vesicles, Cytosol"	"CAB046022: AB_2196960, HPA061803: AB_2684616, HPA062802: AB_2684870"	"prognostic favorable (3.96e-4)"	"unprognostic (2.97e-2)"	"unprognostic (4.40e-2)"	"unprognostic (4.22e-2)"	"unprognostic (4.36e-1)"	"unprognostic (6.14e-2)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (3.04e-2)"	"unprognostic (8.86e-2)"	"unprognostic (9.43e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.45e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.20e-3)"	19.4	6.7	20.1	14.0	25.8	5.1	8.4	25.3	25.1	12.0	52.9	26.3	32.0	7.3	14.5	36.3	6.4	18.1	15.8	16.0	18.6	9.0	1.9	7.6	22.2	28.8	25.8	6.6	25.6	13.7	8.2	2.3	31.9	28.7	32.4	27.8	67.9	11.5	2.7	6.3	18.6	11.7	20.8	8.6	31.8	48.5	25.6	29.1	6.9	7.6	23.5	24.8	9.5	37.0	19.1	10.9	40.9	12.9	28.1	37.5	4.0	45.0	33.8	29.6	27.8	0.2	59.9	51.1	12.2	30.5	25.5	46.6	26.7	34.4	37.1	16.2	16.4	21.2	11.8	42.9	52.3	30.5	2.1	29.1	52.8	35.1	36.5	38.5	21.2	41.3	0.5	0.0	67.0	11.4	51.6	13.0	30.3	41.0	24.3	72.1	16.0	4.8	27.9	47.6	65.7	27.0	15.7	2.6	21.8	20.3	8.0	25.9	20.2	36.6	11.1	26.5	32.2	0.1	0.0	41.5	29.7	28.5	25.1	0.0	0.3	0.0	1.1	0.2	0.6	0.2	0.9	1.6	0.5	0.5	0.2	0.8	0.0	1.0	0.1	0.1	1.8	0.2	20.1	25.8	25.3	25.1	16.0	18.6	28.8	25.8	31.9	20.8	25.6	37.0	6.1	3.2	14.0	64.6	6.4	3.8	34.4	6.5	5.7	14.8	5.5	6.5	26.2	18.6	15.2	5.5	16.7	0.1	30.0	47.7	21.5	10.9	29.4	11.9	11.6	5.6	22.8	5.7	159.9	23.1	0.1	9.2	28.1	18.9	0.0	5.8	2.9	0.4	3.5	20.2	142.9	17.3	14.2	6.7	6.7	16.2	10.2	6.7	17.8	64.6	5.5	28.9	12.3	153.3	359.4	36.0	20.1	11.3	9.5	74.8	14.5	7.9	17.5	30.0	6.6	7.7	18.2	25.4	8.1	7.5	4.4	0.3	19.4	15.8	22.4	50.6
STMN1	"C1orf215, FLJ32206, Lag, LAP18, OP18, PP17, PP19, PR22, SMN"	ENSG00000117632	"Stathmin 1"	P16949	1	25884181-25906991	"Cancer-related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 951.6;lymphoid tissue: 1343.2"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 2537.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 424.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 424.6;T-cells: 143.3"	"Cell line enhanced"	"Detected in all"		"MOLT-4: 3270.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010107, HPA068438"	Enhanced		Approved	Cytosol		NA	NA		320000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"CAB010107: AB_628297, HPA068438: "	"unprognostic (6.30e-2)"	"unprognostic (2.40e-3)"	"unprognostic (5.31e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.02e-2)"	"prognostic unfavorable (9.90e-7)"	"unprognostic (9.45e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.00e-2)"	56.4	69.1	526.8	103.8	568.0	260.5	60.6	514.2	951.6	57.7	333.6	93.2	70.5	129.8	40.7	115.9	45.2	51.1	56.0	573.2	568.2	77.7	35.8	60.7	253.2	560.1	516.8	172.4	23.2	43.8	103.5	120.1	552.4	31.7	110.6	304.7	43.4	32.7	29.5	56.3	89.1	100.0	537.1	72.8	54.5	387.0	531.7	1343.2	33.6	29.9	246.0	58.9	76.0	791.9	1026.8	226.1	2191.0	882.5	128.9	126.0	225.7	776.3	609.7	1081.9	1037.9	157.2	1018.3	1260.3	426.3	572.0	425.8	304.6	618.6	450.9	1616.1	390.4	310.9	786.0	363.3	547.6	51.9	994.6	529.3	77.0	65.6	439.6	496.8	405.5	833.6	1594.4	1074.4	1203.0	1429.6	268.0	3270.7	1441.5	1350.8	615.1	302.8	1907.9	1709.2	740.7	536.9	91.7	1479.2	1282.3	710.0	348.3	638.4	695.8	500.7	1240.1	406.2	721.8	853.6	634.3	664.8	702.5	1212.0	1535.8	357.7	1904.8	798.2	13.4	4.1	23.5	53.9	8.6	32.2	37.0	47.8	68.2	23.2	45.6	77.8	71.6	1.9	56.3	4.5	424.6	143.3	57.2	526.8	568.0	514.2	951.6	573.2	568.2	560.1	516.8	552.4	537.1	531.7	791.9	257.3	41.7	31.6	32.7	125.1	201.6	148.9	350.0	577.7	454.6	91.0	175.1	77.2	31.5	100.0	174.7	64.6	439.3	261.7	35.1	226.9	148.9	917.2	92.8	100.3	196.3	250.8	505.7	109.5	20.1	604.1	134.9	121.3	141.1	262.0	712.4	109.2	15.4	530.1	195.2	73.0	100.9	567.6	87.3	287.0	2537.2	44.7	130.0	268.6	32.8	32.1	252.4	84.5	38.2	217.4	59.0	69.3	47.0	261.7	63.5	21.0	221.4	59.1	183.6	39.5	68.0	267.6	873.0	260.8	423.9	90.4	130.4	224.9	66.5	177.1	95.7
STOML2	"HSPC108, SLP-2"	ENSG00000165283	"Stomatin like 2"	Q9UJZ1	9	35099776-35103195	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015944, HPA062016"	Supported		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		44000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane, Cytosol"		"CAB015944: , HPA062016: AB_2684659"	"unprognostic (2.49e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.20e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.13e-2)"	"prognostic unfavorable (4.77e-4)"	"unprognostic (5.14e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (3.00e-5)"	"unprognostic (2.74e-2)"	"unprognostic (5.26e-1)"	"unprognostic (2.67e-1)"	"unprognostic (5.47e-2)"	63.6	93.3	45.4	39.1	46.2	66.7	62.0	47.5	49.0	58.4	61.3	75.3	55.6	64.2	49.4	84.7	57.3	33.2	123.4	46.2	46.6	75.4	99.2	43.7	46.6	44.7	45.9	59.4	69.5	71.9	42.3	46.2	45.3	49.0	67.2	23.5	59.3	48.4	171.2	71.0	61.2	54.0	45.9	53.1	75.8	42.8	48.2	55.1	48.6	111.7	59.5	64.5	56.5	45.4	219.6	248.1	130.3	195.7	93.3	111.1	139.5	105.9	153.5	292.6	212.5	283.2	99.6	183.2	72.9	135.2	210.6	91.4	201.3	235.8	193.7	158.1	185.0	112.7	202.6	269.7	272.1	215.8	124.0	141.9	181.1	238.6	283.2	92.2	193.8	183.6	186.5	109.1	144.8	176.0	193.5	377.6	205.3	162.4	155.2	166.6	110.3	197.0	159.5	128.9	120.4	146.3	60.0	158.0	141.7	92.5	109.7	139.1	106.2	99.7	141.1	84.4	190.4	76.1	140.3	173.8	132.7	134.3	137.1	67.8	73.0	42.5	64.7	65.8	77.8	91.4	73.1	74.1	98.0	87.0	69.2	63.8	12.9	98.1	49.3	121.8	115.5	114.4	45.4	46.2	47.5	49.0	46.2	46.6	44.7	45.9	45.3	45.9	48.2	45.4	63.9	41.7	33.1	6.5	66.8	96.4	123.8	172.9	83.6	36.6	104.5	118.7	83.4	108.7	92.5	49.7	8.4	233.6	48.3	116.1	250.5	144.3	77.2	72.7	76.3	66.4	98.8	106.2	7.8	153.4	245.2	74.9	66.3	47.3	84.3	111.3	61.4	111.3	132.7	18.5	8.1	145.9	73.2	41.0	68.3	22.9	75.2	47.9	99.6	5.6	84.5	83.9	56.7	2.5	8.8	137.2	117.5	69.6	126.1	177.6	197.7	290.1	85.8	37.1	52.6	66.5	95.6	73.1	110.0	119.2	114.5	166.4	51.2	153.2	222.2	148.7
STRADB	"ALS2CR2, CALS-21, ILPIP, ILPIPA, PAPK"	ENSG00000082146	"STE20 related adaptor beta"	Q9C0K7	2	201387858-201480846	"Enzymes, Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 412.8;Proximal enterocytes: 124.0;Proximal tubular cells: 217.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 188.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026549, HPA028520"	Approved		Uncertain	Aggresome,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol	Aggresome	"HPA026549: AB_1844779, HPA028520: AB_10604100"	"unprognostic (6.34e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.56e-3)"	"unprognostic (4.04e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.63e-3)"	"unprognostic (2.65e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (1.08e-1)"	"unprognostic (7.83e-2)"	"prognostic favorable (4.45e-4)"	"unprognostic (4.93e-2)"	29.9	53.2	24.1	8.9	26.3	80.9	16.8	26.2	30.8	10.6	22.4	27.6	37.0	13.2	17.4	17.0	10.4	14.3	38.0	25.3	26.2	73.3	104.9	10.6	14.5	27.7	25.9	14.1	17.6	6.2	17.4	19.7	27.3	11.1	30.3	40.5	13.9	7.7	109.0	8.4	42.9	10.2	26.7	13.7	9.1	15.8	25.6	11.4	17.9	69.5	11.6	9.7	9.3	30.2	12.6	21.5	36.2	47.0	58.5	73.8	25.6	25.6	43.4	34.9	51.6	29.6	11.9	0.1	16.0	40.7	42.4	12.6	35.8	23.9	62.7	14.9	30.1	15.2	9.6	62.9	43.9	18.4	16.7	62.5	21.6	43.7	39.0	63.5	26.5	28.5	33.4	5.3	188.5	6.8	17.2	31.1	49.2	11.7	22.6	22.8	14.5	9.6	29.2	9.9	6.0	29.3	17.6	13.1	76.8	66.0	6.7	34.4	25.7	20.6	16.1	26.6	19.3	21.1	39.0	5.8	35.8	8.2	20.5	5.5	12.9	16.3	9.2	14.4	8.3	28.8	12.2	13.4	17.2	35.8	15.5	15.6	2.6	29.0	13.1	7.7	16.4	15.8	24.1	26.3	26.2	30.8	25.3	26.2	27.7	25.9	27.3	26.7	25.6	30.2	5.0	9.6	4.2	17.0	20.2	2.2	6.8	6.5	11.4	13.8	24.9	10.8	27.8	28.6	6.1	14.7	83.4	51.0	6.3	40.9	39.2	12.4	3.9	7.5	7.4	5.6	16.9	412.8	20.8	15.4	27.6	13.6	6.6	10.2	5.7	12.0	7.9	94.6	19.2	11.8	19.8	22.6	8.2	16.9	5.2	8.1	10.8	13.5	16.0	15.0	14.8	19.6	7.2	26.7	26.0	9.0	35.2	3.8	10.9	10.2	124.0	217.8	5.3	19.1	6.6	21.7	6.6	45.0	46.7	15.2	1.4	27.9	8.9	26.8	25.0	9.1
STRN	"PPP2R6A, STRN1"	ENSG00000115808	Striatin	O43815	2	36837698-36966536	"Cancer-related genes, Predicted intracellular proteins"		Calmodulin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 294.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017286	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	Nucleoplasm	"HPA017286: AB_1857618"	"unprognostic (1.65e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.57e-3)"	"unprognostic (2.23e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.63e-3)"	"unprognostic (7.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.27e-4)"	"unprognostic (1.13e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.43e-2)"	8.4	4.7	5.3	9.4	16.7	14.9	8.6	11.9	9.0	8.6	0.6	9.1	8.1	6.2	3.8	21.2	5.3	6.8	21.2	5.5	10.2	8.4	7.5	7.8	7.7	13.0	11.6	7.7	5.6	7.3	2.4	10.1	13.1	5.5	10.7	10.1	10.7	5.0	11.6	11.2	8.6	7.7	9.8	8.1	9.0	8.0	14.2	13.3	6.2	11.5	12.6	8.4	10.1	24.7	38.3	19.0	25.2	10.4	13.3	18.0	24.6	14.8	14.2	14.5	13.3	19.4	12.2	24.7	11.8	19.7	20.6	17.6	21.4	17.0	17.9	27.9	16.0	40.2	16.4	10.3	12.1	24.9	21.8	11.4	12.9	23.2	18.3	10.7	18.6	10.0	30.4	19.2	18.2	11.1	24.7	7.4	19.8	15.7	9.4	15.9	38.5	11.2	9.7	31.0	4.5	15.1	22.4	16.9	13.6	13.7	12.2	9.2	24.9	25.4	25.4	16.0	20.1	19.5	31.0	21.6	13.2	23.2	18.2	1.3	0.2	0.4	0.5	0.4	0.2	0.4	0.4	0.3	0.1	0.2	0.2	0.2	1.0	0.2	0.4	0.2	0.1	0.1	5.3	16.7	11.9	9.0	5.5	10.2	13.0	11.6	13.1	9.8	14.2	24.7	26.5	9.6	10.0	38.8	18.8	20.6	12.3	11.3	21.6	12.7	16.0	9.4	55.4	8.6	17.4	23.9	20.9	8.0	22.8	25.0	9.8	10.5	1.9	14.2	14.3	19.4	11.4	26.5	65.3	8.4	10.3	13.6	20.4	26.2	5.1	16.0	16.4	7.9	8.8	18.5	55.2	17.8	10.2	20.7	10.0	2.1	9.6	18.0	8.8	47.8	20.3	10.1	35.0	55.3	294.0	16.8	14.1	12.4	14.3	19.3	13.0	8.5	8.2	16.9	0.0	13.6	16.5	15.2	19.2	31.4	33.2	16.3	19.4	17.7	16.0	39.4
SUMO1	"GMP1, OFC10, PIC1, SMT3C, SMT3H3, SUMO-1, UBL1"	ENSG00000116030	"Small ubiquitin like modifier 1"	P63165	2	202206182-202238599	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"cerebellum: 7.6"	"CAB004269, HPA056956"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli,Nuclear bodies"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear membrane"	"Nucleoli, Nuclear bodies"	"CAB004269: AB_628300, HPA056956: AB_2683285"	"unprognostic (7.15e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.89e-1)"	"unprognostic (9.56e-3)"	"unprognostic (1.76e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.78e-3)"	"prognostic favorable (7.93e-4)"	"unprognostic (7.06e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.31e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.19e-1)"	77.5	99.1	79.4	62.7	84.9	133.7	83.6	89.0	99.9	68.9	84.4	82.7	72.0	65.1	86.3	71.6	65.7	71.7	79.8	85.6	85.3	118.1	174.1	66.5	86.4	79.9	80.1	54.5	55.8	91.6	56.7	75.6	81.1	75.3	82.8	80.2	66.8	61.9	107.5	57.1	80.5	71.5	78.9	68.1	73.8	54.7	81.4	112.1	102.3	103.3	95.4	77.9	54.9	86.6	164.1	82.4	291.4	155.8	159.3	168.5	129.7	171.0	214.6	209.0	274.6	178.1	203.7	111.6	153.5	199.0	193.5	117.1	242.2	237.9	325.0	104.8	185.7	207.6	159.0	211.2	114.9	237.2	188.5	130.9	225.2	164.0	123.9	195.1	197.3	219.0	194.2	176.0	226.4	141.1	298.3	391.6	351.7	168.5	172.2	190.9	163.2	197.9	255.5	134.3	201.7	219.3	140.3	133.6	236.4	313.9	120.0	223.2	139.9	152.5	153.0	141.4	152.8	151.7	322.9	285.8	170.2	165.4	137.2	242.2	220.0	284.2	169.2	226.5	179.6	276.3	206.8	200.0	223.6	231.6	193.8	202.3	256.5	246.5	239.7	187.8	329.0	394.7	79.4	84.9	89.0	99.9	85.6	85.3	79.9	80.1	81.1	78.9	81.4	86.6	182.7	112.2	61.1	10.7	143.1	422.1	204.4	448.6	177.6	99.6	196.8	170.2	58.1	130.1	215.3	189.4	64.6	259.4	162.3	136.6	481.3	250.4	91.3	148.3	115.1	170.7	142.4	140.1	31.4	173.3	297.8	161.8	89.7	115.2	92.6	114.7	142.8	202.1	205.3	87.5	27.8	156.4	319.4	140.7	330.2	28.0	129.8	137.7	211.7	15.9	241.3	182.3	176.1	16.6	21.2	208.1	191.1	127.9	130.5	258.5	272.2	534.4	185.5	87.8	111.7	92.5	221.9	212.0	141.5	183.9	424.5	209.7	174.5	134.9	157.5	254.1
SUMO3	"SMT3A, SMT3H1"	ENSG00000184900	"Small ubiquitin like modifier 3"	P55854	21	44805617-44818779	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB012180, HPA042123, HPA048064"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Nuclear bodies"		"CAB012180: AB_304041, HPA042123: AB_2677860, HPA048064: AB_2680244"	"unprognostic (2.77e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.79e-2)"	"prognostic unfavorable (7.88e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.81e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.80e-2)"	68.6	58.1	58.5	56.7	64.6	118.8	63.6	50.6	75.5	55.5	55.9	55.2	55.1	52.9	50.3	57.2	52.1	44.6	74.3	64.4	71.8	64.0	59.3	61.7	68.8	53.3	59.0	57.6	49.4	44.7	38.3	49.1	58.3	46.2	45.8	72.0	66.5	47.4	106.6	51.0	58.0	39.8	54.5	61.6	56.3	28.8	68.5	63.7	54.8	73.9	57.5	50.0	53.6	50.9	226.4	88.8	131.7	80.2	105.1	147.9	86.5	152.0	177.2	211.5	173.6	133.6	137.2	78.4	234.6	165.4	122.4	53.0	96.8	123.0	166.3	110.0	106.3	322.7	78.8	123.1	113.3	184.5	172.1	126.0	139.5	123.9	89.9	87.8	109.8	164.6	188.7	215.2	173.8	293.1	220.0	127.7	254.4	223.1	174.9	239.0	8.0	217.1	120.2	111.9	98.8	153.4	136.5	196.2	126.3	48.1	190.6	218.6	172.4	99.1	151.4	151.6	172.8	155.4	234.8	198.7	77.9	265.2	138.6	2.8	123.1	52.0	78.9	130.0	79.7	84.6	74.9	76.5	133.3	77.7	88.7	81.0	14.0	70.6	122.3	162.8	91.2	157.8	58.5	64.6	50.6	75.5	64.4	71.8	53.3	59.0	58.3	54.5	68.5	50.9	83.4	64.1	50.4	5.5	76.5	96.0	121.7	127.9	74.6	72.2	99.4	88.5	59.5	67.2	66.5	95.6	20.9	122.9	98.1	95.6	166.3	121.7	63.1	36.4	51.7	101.4	59.2	113.8	14.3	112.4	107.8	76.7	52.0	37.9	29.8	63.8	92.8	116.6	200.5	62.2	13.3	91.5	81.4	143.4	172.3	114.2	72.1	137.9	97.8	10.3	280.0	132.4	111.2	3.5	6.5	148.7	112.6	72.6	58.2	150.7	129.2	130.2	33.0	60.5	59.2	43.8	68.7	90.7	77.5	82.7	77.9	136.3	78.2	43.2	99.9	145.1
SUPT16H	"CDC68, FACT, FACTP140, FLJ10857, FLJ14010, SPT16/CDC68"	ENSG00000092201	"SPT16 homolog, facilitates chromatin remodeling subunit"	Q9Y5B9	14	21351476-21384019	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022551, HPA049787"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA		27000	"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center"	"CAB022551: , HPA049787: AB_2680881"	"unprognostic (1.65e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.52e-2)"	"unprognostic (7.12e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.86e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.58e-3)"	"unprognostic (9.05e-2)"	"unprognostic (5.87e-3)"	29.3	24.8	9.7	36.6	11.1	42.3	35.9	18.8	13.9	34.2	8.2	30.6	23.1	41.1	19.5	29.0	32.0	24.1	24.1	9.7	15.6	28.6	22.4	26.3	51.2	11.3	12.0	43.6	22.6	46.2	13.5	32.1	12.0	29.9	35.1	44.4	20.9	32.6	21.8	28.9	25.9	36.6	10.7	32.9	26.3	43.3	12.1	56.8	33.3	24.6	51.8	35.6	20.1	12.3	147.8	136.9	185.5	136.6	85.5	81.7	131.4	130.3	103.2	155.5	145.4	133.9	129.5	311.3	48.5	96.5	99.7	153.9	237.2	118.9	234.0	99.8	100.9	188.7	121.9	195.1	87.0	270.1	134.7	73.4	72.6	131.0	146.3	75.4	107.7	174.2	158.1	129.4	131.3	99.9	253.6	85.8	207.1	136.2	134.1	270.3	210.6	168.0	63.9	160.8	183.8	157.2	209.8	125.3	81.1	118.7	69.2	127.9	91.1	135.0	113.4	85.0	143.3	128.8	230.2	306.7	49.9	158.0	104.9	35.6	18.3	28.2	29.6	23.9	34.7	31.2	27.9	33.2	23.7	27.4	31.3	32.2	15.0	34.0	31.1	22.2	28.4	25.2	9.7	11.1	18.8	13.9	9.7	15.6	11.3	12.0	12.0	10.7	12.1	12.3	41.5	64.1	55.9	24.2	51.6	35.6	44.3	51.5	45.5	48.9	46.3	49.7	64.2	22.8	50.3	53.3	47.9	65.1	73.6	28.4	25.4	71.0	142.5	52.0	124.3	46.9	23.4	74.6	27.4	61.1	63.9	61.1	29.6	61.7	84.2	73.4	29.3	32.0	41.9	55.5	30.1	31.2	40.7	34.9	25.2	96.1	59.7	40.7	17.8	20.6	90.9	53.3	64.9	16.1	25.2	68.9	15.2	59.8	39.5	46.1	16.5	30.4	40.2	41.1	19.7	78.5	69.5	128.9	152.8	45.1	41.5	45.6	56.3	61.6	43.0	35.7
SUPT5H	"FLJ34157, SPT5, SPT5H"	ENSG00000196235	"SPT5 homolog, DSIF elongation factor subunit"	O00267	19	39436156-39476670	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029273, CAB034370"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"CAB034370: AB_2196394, HPA029273: AB_10603896"	"unprognostic (3.96e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.53e-3)"	"unprognostic (4.19e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (7.00e-5)"	"unprognostic (7.30e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.94e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.38e-1)"	43.3	46.2	44.7	44.9	46.6	106.1	41.7	38.2	48.3	45.3	35.3	48.1	40.3	49.7	29.6	42.7	46.2	34.6	41.2	42.7	42.6	38.8	52.1	45.4	51.6	40.4	40.6	55.9	49.5	49.3	72.6	38.2	40.7	48.5	30.0	33.0	54.7	36.1	87.2	50.0	51.3	33.7	37.5	46.7	46.9	102.1	45.1	40.2	51.1	35.6	41.4	45.0	40.2	49.1	134.1	209.5	75.2	76.4	70.7	50.4	64.8	115.4	70.5	66.0	73.2	137.9	80.1	159.7	106.4	104.7	55.0	50.8	101.9	73.5	51.6	161.6	100.3	179.2	99.7	84.5	64.0	148.5	117.4	78.9	54.6	83.9	86.2	72.2	64.0	137.3	137.9	80.4	66.2	132.5	108.5	44.5	94.0	109.8	52.3	108.8	111.0	80.5	68.3	214.1	72.7	98.1	134.0	104.6	71.7	63.3	63.6	80.1	137.6	67.1	77.8	84.1	145.5	130.9	240.8	196.0	81.8	84.1	84.7	49.0	22.1	19.0	13.7	11.5	13.9	23.0	9.6	11.5	11.1	16.2	10.6	9.0	46.3	15.3	17.2	42.6	11.4	15.6	44.7	46.6	38.2	48.3	42.7	42.6	40.4	40.6	40.7	37.5	45.1	49.1	45.1	44.8	82.7	26.4	51.9	51.6	26.8	34.1	43.3	47.4	40.2	51.9	58.8	30.0	51.6	44.1	85.5	36.5	79.6	62.6	13.7	37.4	69.9	73.2	57.2	43.8	89.2	40.4	16.6	35.1	45.3	39.1	72.9	92.2	46.2	36.0	32.5	62.5	36.7	48.8	17.6	62.4	26.4	32.2	68.9	79.1	45.1	51.4	40.9	15.0	41.2	28.4	47.4	15.1	23.1	53.5	46.3	41.3	86.5	32.8	58.1	22.9	67.9	57.6	19.7	57.3	38.1	84.4	80.4	41.0	49.6	54.0	72.6	31.0	50.4	31.2
SUPV3L1	SUV3	ENSG00000156502	"Suv3 like RNA helicase"	Q8IYB8	10	69180234-69209099	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038380, HPA038405"	Supported		Supported	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria		"HPA038380: AB_2675983, HPA038405: AB_10675797"	"unprognostic (4.70e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.57e-1)"	"unprognostic (9.47e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.48e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.33e-1)"	10.1	10.9	7.9	8.7	8.2	24.2	11.5	10.2	10.3	7.7	7.6	11.6	8.9	9.3	7.9	8.8	8.3	6.0	15.8	8.5	8.2	12.9	17.9	6.1	12.0	7.9	7.4	10.6	9.3	16.5	7.5	8.7	7.9	8.0	12.7	11.1	8.9	8.6	25.9	10.6	8.6	9.3	7.2	9.9	8.9	15.8	7.8	11.0	10.9	29.1	12.2	9.5	7.7	8.5	28.9	19.9	17.4	53.5	19.1	16.1	22.7	17.5	27.1	34.7	32.6	51.4	23.8	51.5	14.0	17.6	24.8	32.3	42.2	27.4	33.1	21.5	33.1	22.6	14.9	27.2	48.1	54.3	16.5	20.5	33.7	31.9	72.6	23.6	20.3	32.2	59.6	26.1	19.2	18.7	33.1	33.5	20.8	27.2	106.7	30.1	24.7	22.6	15.6	13.9	24.7	18.7	24.2	49.7	46.7	19.1	15.5	23.5	12.7	13.7	24.7	21.1	34.3	20.5	25.4	47.5	22.6	56.4	8.9	8.9	5.1	4.7	11.1	7.3	12.5	9.0	7.9	9.5	7.1	7.3	8.7	9.6	0.9	7.7	5.4	3.9	8.8	6.2	7.9	8.2	10.2	10.3	8.5	8.2	7.9	7.4	7.9	7.2	7.8	8.5	11.2	6.4	7.4	15.3	21.7	23.8	11.6	16.6	21.6	21.6	10.8	9.5	22.5	5.7	15.1	7.3	4.2	17.8	49.3	11.7	11.7	11.6	13.4	17.2	17.6	10.1	9.0	10.3	29.6	8.6	11.4	12.6	14.8	28.8	7.6	15.1	5.7	12.0	9.6	11.8	28.2	9.0	16.2	6.0	10.0	4.5	6.8	9.4	5.4	15.0	7.2	11.3	19.6	14.1	17.6	8.5	8.1	9.1	37.0	10.8	8.5	14.3	12.6	12.5	6.6	17.2	14.6	38.6	26.6	23.6	22.3	22.4	28.8	16.1	14.1	10.7
SURF6	"FLJ30322, RRP14"	ENSG00000148296	"Surfeit 6"	O75683	9	133328776-133336188	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 91.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023608, HPA074622"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA023608: AB_1857671, HPA074622: AB_2686703"	"unprognostic (5.27e-3)"	"unprognostic (8.67e-3)"	"unprognostic (5.41e-3)"	"unprognostic (3.69e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.18e-3)"	"unprognostic (9.32e-3)"	"prognostic favorable (7.31e-5)"	"unprognostic (1.50e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.66e-1)"	10.4	11.7	8.1	4.1	7.8	4.9	10.3	8.7	7.5	12.4	5.9	13.6	6.2	11.9	2.6	12.5	11.2	2.5	10.5	7.2	7.5	11.7	12.3	8.5	5.5	7.7	7.8	13.1	11.2	3.9	8.1	3.3	7.8	11.5	3.4	3.3	9.7	4.0	17.9	13.2	12.1	2.7	7.5	11.4	9.9	7.9	7.9	4.6	10.6	3.9	3.7	12.2	11.1	8.1	5.6	8.7	6.5	9.8	4.0	3.7	10.8	8.8	5.1	7.7	4.8	13.8	9.2	16.2	6.7	4.9	5.6	16.7	8.4	9.3	2.8	10.8	9.6	11.2	10.5	8.3	7.2	19.1	9.3	5.3	8.0	8.0	7.4	6.8	4.0	15.6	25.1	8.4	6.8	14.7	15.5	15.7	19.1	22.7	15.6	16.1	9.1	16.7	6.7	5.3	13.7	11.6	8.6	13.7	7.8	3.9	12.2	10.6	8.4	17.3	9.3	8.9	12.0	6.2	9.6	21.0	6.5	12.9	10.4	3.3	3.0	1.4	4.3	2.9	4.5	4.6	3.9	3.9	3.3	5.1	5.2	4.4	0.8	3.2	2.7	6.0	3.6	2.5	8.1	7.8	8.7	7.5	7.2	7.5	7.7	7.8	7.8	7.5	7.9	8.1	25.7	44.8	27.3	4.6	20.9	23.7	15.7	11.0	24.5	26.5	33.4	32.3	30.0	28.6	24.5	22.0	6.2	32.2	20.3	36.8	21.5	29.2	1.3	21.1	42.2	23.6	33.6	14.1	4.3	19.6	25.2	21.2	18.8	25.1	25.3	25.4	16.4	35.2	21.2	21.9	4.8	40.3	6.1	14.7	10.2	4.1	27.7	13.7	7.2	5.6	18.6	15.2	29.9	5.0	4.1	29.0	33.3	27.8	14.4	24.8	50.6	26.1	13.2	19.6	0.0	15.8	20.3	19.2	23.6	26.3	27.6	19.0	18.1	91.1	57.7	13.3
SUV39H1	"KMT1A, SUV39H"	ENSG00000101945	"Suppressor of variegation 3-9 homolog 1"	O43463	X	48695554-48709016	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Differentiation, Host-virus interaction, rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"				"unprognostic (4.92e-2)"	"prognostic favorable (8.93e-5)"	"unprognostic (9.51e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.91e-7)"	"unprognostic (2.29e-3)"	"unprognostic (6.47e-3)"	"unprognostic (2.01e-1)"	"unprognostic (5.67e-2)"	4.0	2.2	4.7	4.2	4.4	13.7	3.5	4.9	5.1	2.9	2.0	3.4	3.1	3.2	12.5	5.0	3.3	1.7	3.6	4.3	5.1	2.6	6.6	2.7	7.5	5.2	5.6	3.8	2.9	2.3	3.0	3.3	4.8	3.0	3.2	3.3	2.6	3.0	4.9	4.4	4.2	2.6	3.9	6.0	3.6	4.9	5.0	9.7	2.6	3.8	7.0	3.4	2.4	4.3	28.7	34.3	13.3	14.0	3.4	4.0	27.0	13.5	10.2	25.8	21.0	21.0	18.7	31.4	8.0	9.9	26.1	19.8	33.0	19.3	15.4	24.2	33.8	12.3	31.8	17.4	2.0	30.7	6.6	3.6	3.7	22.8	11.6	4.2	18.6	20.2	31.9	21.6	14.2	33.1	26.8	32.0	15.7	14.0	32.8	19.3	24.5	33.1	8.6	15.7	17.4	11.4	18.3	17.4	9.8	14.8	26.0	25.5	10.0	15.8	27.0	22.1	23.3	14.6	23.9	26.4	11.8	43.6	17.7	4.9	2.8	6.8	8.5	4.0	6.2	4.6	5.5	9.1	2.2	5.4	6.8	6.6	2.0	10.6	6.5	2.6	11.0	6.5	4.7	4.4	4.9	5.1	4.3	5.1	5.2	5.6	4.8	3.9	5.0	4.3	1.2	6.4	0.0	0.3	3.5	1.8	0.9	2.0	2.8	5.3	2.2	2.5	2.5	2.8	1.3	1.8	0.0	6.5	6.6	2.1	3.9	2.9	0.2	1.3	0.9	1.7	3.0	6.9	0.7	2.9	28.3	1.9	3.1	1.0	1.3	2.9	1.8	6.7	5.2	0.0	1.0	2.6	0.0	2.9	1.6	0.2	1.2	2.4	5.4	1.0	3.0	0.9	6.2	1.0	0.8	2.3	1.7	1.5	7.1	0.6	1.6	2.4	2.6	3.8	0.0	1.8	2.5	3.7	0.8	2.5	1.1	6.2	3.6	1.7	3.2	0.6
SUV39H2	"FLJ23414, KMT1B"	ENSG00000152455	"Suppressor of variegation 3-9 homolog 2"	Q9H5I1	10	14878820-14904315	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 39.3"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 421.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045901, HPA057554"	Enhanced		Uncertain	Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Mitochondria		"HPA045901: AB_10960702, HPA057554: AB_2683466"	"prognostic unfavorable (5.55e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.78e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.23e-3)"	"prognostic unfavorable (2.01e-6)"	"unprognostic (1.06e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.42e-1)"	"unprognostic (4.13e-3)"	"prognostic unfavorable (5.71e-5)"	"unprognostic (2.71e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.39e-1)"	2.1	1.5	1.4	2.4	1.8	4.7	3.8	8.3	3.5	1.6	1.4	2.9	2.0	2.0	1.5	3.1	2.1	1.7	1.0	1.5	1.2	2.4	3.1	1.3	2.5	1.2	1.4	2.5	1.8	1.9	1.3	3.8	1.2	2.7	3.4	3.4	1.7	2.3	1.4	1.9	2.6	2.3	1.2	1.5	1.8	39.3	1.3	6.1	1.4	1.2	3.1	3.1	1.4	3.1	28.6	20.8	40.8	24.1	7.5	10.7	16.9	14.8	8.1	24.1	34.6	29.5	15.2	22.4	13.4	5.8	22.6	21.3	27.7	16.4	31.6	22.9	15.1	29.4	14.0	21.5	4.3	14.8	16.2	4.1	5.3	24.2	5.4	6.4	19.0	37.4	41.9	15.2	20.3	19.3	31.3	4.4	28.8	26.6	5.9	38.4	28.1	20.7	10.9	11.0	13.8	16.8	23.9	16.6	11.1	23.8	24.6	11.0	11.6	21.4	31.7	22.9	23.1	9.5	36.1	47.9	12.1	14.8	13.5	0.2	0.3	0.2	1.5	1.1	1.9	0.4	1.1	1.7	1.1	0.3	1.8	1.8	0.3	3.0	0.4	1.8	2.0	0.5	1.4	1.8	8.3	3.5	1.5	1.2	1.2	1.4	1.2	1.2	1.3	3.1	2.0	0.0	1.5	4.2	2.6	8.3	10.2	6.7	9.1	7.5	4.0	3.7	2.9	2.8	7.5	1.8	10.4	13.9	1.7	1.1	5.9	4.4	421.0	3.4	5.1	4.3	3.5	16.2	8.0	2.2	25.6	5.1	4.1	4.0	2.5	7.8	1.8	3.0	5.0	11.8	7.9	3.1	6.1	1.6	2.8	104.4	4.7	1.8	1.8	2.8	0.7	4.2	3.1	4.5	4.5	2.1	1.7	2.6	7.1	14.5	1.0	7.4	3.5	10.2	6.6	5.8	6.6	47.5	46.6	8.3	8.8	8.9	3.4	8.7	4.5	10.9
SUZ12	"CHET9, JJAZ1, KIAA0160"	ENSG00000178691	"SUZ12 polycomb repressive complex 2 subunit"	Q15022	17	31937007-32001038	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Disease variant, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057436	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli, Nucleoli rim, Nuclear bodies"		"HPA057436: AB_2683439"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.65e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.66e-3)"	"unprognostic (8.05e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.29e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.31e-1)"	12.3	11.8	6.3	18.8	6.3	45.4	15.0	11.1	8.5	11.6	6.8	14.9	16.0	15.2	12.0	14.0	11.0	12.0	10.3	5.4	5.8	16.4	18.1	12.6	33.0	5.4	5.9	11.4	11.5	19.8	6.6	18.7	5.6	13.3	16.4	26.5	10.5	12.2	8.1	13.0	15.3	14.7	5.2	18.4	15.2	27.4	6.1	38.5	18.3	11.0	30.0	15.6	9.0	7.1	46.5	40.4	37.2	42.9	21.1	26.8	38.2	44.2	38.8	53.0	63.7	30.9	25.5	100.7	33.2	27.7	45.4	40.1	56.0	25.5	85.7	35.8	54.0	69.9	32.9	22.3	24.8	111.5	68.7	18.7	28.1	53.1	40.4	32.1	33.1	47.3	68.8	135.6	46.2	16.2	133.3	64.4	21.3	32.4	24.4	78.5	95.3	81.9	31.1	44.6	47.5	37.1	71.3	22.7	43.3	25.8	66.0	91.5	24.7	41.9	38.0	50.8	69.3	73.5	98.4	122.5	30.7	67.4	38.7	0.6	0.7	1.6	1.4	1.1	1.1	2.4	1.6	1.6	0.6	1.8	1.5	2.1	1.6	1.8	0.7	1.9	1.8	0.4	6.3	6.3	11.1	8.5	5.4	5.8	5.4	5.9	5.6	5.2	6.1	7.1	44.5	41.7	45.8	43.1	50.1	58.5	50.2	21.8	31.9	77.6	54.2	36.8	32.3	27.1	32.6	35.0	108.4	61.5	65.2	24.0	17.6	28.3	16.2	52.8	55.8	45.1	29.4	93.6	71.6	21.9	53.1	35.1	31.1	54.2	15.8	41.4	38.2	42.3	32.9	62.2	69.5	31.8	10.2	42.1	58.2	13.9	26.8	47.3	24.9	45.0	73.1	45.7	38.1	75.4	71.3	27.8	15.4	25.6	66.2	62.8	21.5	26.6	29.6	80.9	13.1	47.2	38.4	121.7	128.9	48.6	71.7	69.5	52.5	52.8	35.6	66.7
SYNJ1	"INPP5G, PARK20"	ENSG00000159082	"Synaptojanin 1"	O43426	21	32628759-32728040	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Endocytosis	"Hydrolase, RNA-binding"	"Disease variant, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.9;retina: 48.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 110.9;Inhibitory neurons: 91.5;Oligodendrocytes: 61.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011916	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"	Centrosome	"HPA011916: AB_1857692"	"unprognostic (6.84e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.76e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (4.43e-4)"	"unprognostic (1.45e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.63e-1)"	"unprognostic (6.22e-3)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (1.28e-1)"	"unprognostic (6.36e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.92e-1)"	7.6	6.9	15.0	5.3	22.8	23.8	6.5	1.1	45.9	6.2	3.5	5.6	4.0	5.1	5.1	4.6	5.0	5.2	6.4	22.1	9.8	7.4	5.7	8.0	6.3	19.5	5.6	4.8	4.8	8.4	13.8	9.8	14.8	4.5	5.4	48.4	4.7	3.7	7.7	5.1	6.3	4.9	0.0	7.9	5.0	10.2	8.7	7.1	7.3	6.4	4.8	5.5	5.4	25.9	5.5	2.9	5.0	5.7	8.9	7.1	10.3	11.3	6.2	6.8	5.7	6.1	2.6	2.0	3.8	6.9	8.9	5.0	8.9	6.8	8.4	6.8	8.1	13.8	8.7	3.5	4.8	5.6	11.7	4.1	4.9	12.0	6.1	5.8	10.8	7.3	10.6	11.6	9.0	5.5	5.5	5.1	3.4	6.4	6.0	6.1	11.1	7.4	7.5	4.3	5.6	4.5	14.0	8.4	5.6	6.9	7.8	7.2	11.2	10.0	5.3	8.2	6.4	6.0	7.8	4.4	8.0	10.7	8.7	3.4	2.9	6.9	1.2	5.2	2.0	0.1	1.9	2.0	2.5	0.3	2.2	2.2	9.1	0.5	4.7	1.4	2.6	1.1	15.0	22.8	1.1	45.9	22.1	9.8	19.5	5.6	14.8	0.0	8.7	25.9	10.2	6.4	5.4	22.9	3.9	4.8	1.9	3.1	8.0	24.8	3.8	2.5	10.0	2.8	4.0	1.8	45.9	17.7	7.0	4.8	5.9	2.0	19.9	2.4	4.7	11.9	3.0	5.0	110.9	1.3	9.8	5.3	4.1	3.6	3.8	2.2	11.0	4.2	10.1	10.1	91.5	2.0	0.0	18.6	5.7	11.3	2.8	15.7	1.8	31.9	6.5	21.8	4.1	49.3	61.0	2.8	5.3	4.5	8.6	2.7	6.2	6.5	4.6	45.4	6.6	6.1	5.8	22.1	13.3	6.7	3.3	38.0	9.9	2.8	5.4	4.3
TACC3	"ERIC-1, ERIC1, maskin, Tacc4"	ENSG00000013810	"Transforming acidic coiled-coil containing protein 3"	Q9Y6A5	4	1712891-1745171	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 58.9;lymphoid tissue: 52.4;testis: 50.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 70.4;Hofbauer cells: 43.9;Late spermatids: 69.9;Spermatocytes: 94.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005781, HPA006050, CAB010111, HPA022039"	Enhanced		Enhanced	"Vesicles,Mitotic spindle,Centriolar satellite,Cytosol"		Yes	Yes		11000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Mitotic spindle, Centriolar satellite, Cytosol"	Vesicles	"CAB010111: AB_628323, HPA005781: AB_1857724, HPA006050: AB_2667505, HPA022039: AB_1857725"	"unprognostic (2.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.71e-2)"	"unprognostic (4.35e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (1.10e-3)"	"unprognostic (4.61e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.26e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.44e-3)"	"unprognostic (9.75e-2)"	5.3	3.9	4.2	24.9	4.3	58.9	3.5	5.2	5.3	3.6	5.2	10.3	6.6	3.3	4.8	14.9	2.8	4.2	3.3	4.5	4.4	2.7	3.5	6.5	43.2	4.8	5.3	2.2	1.4	2.3	2.6	8.7	4.8	2.4	10.6	1.9	3.9	2.5	2.0	6.4	12.9	6.4	4.2	22.1	6.4	50.6	5.1	52.4	2.8	3.4	39.3	5.0	5.4	4.7	106.7	88.7	129.5	72.2	6.7	15.2	72.9	114.6	62.1	135.4	87.6	93.5	122.8	133.8	48.0	65.4	149.9	71.4	142.5	86.8	131.1	59.8	77.0	113.8	67.2	85.8	5.9	146.6	85.5	5.2	5.7	85.6	46.0	26.0	102.2	110.3	106.3	90.8	123.8	87.1	207.5	204.0	139.3	89.2	111.6	139.1	90.5	55.0	73.8	125.5	99.8	62.8	70.1	42.3	33.1	95.2	83.3	90.5	56.4	75.4	90.0	65.4	176.7	69.5	102.5	207.1	43.2	141.1	109.1	45.5	30.0	37.9	8.5	12.5	11.1	7.8	16.5	11.5	15.3	10.8	28.3	13.1	91.8	12.2	9.6	8.3	42.5	32.5	4.2	4.3	5.2	5.3	4.5	4.4	4.8	5.3	4.8	4.2	5.1	4.7	6.0	0.0	6.7	2.0	16.5	2.2	1.2	3.2	1.2	1.7	2.4	3.0	2.6	2.8	3.4	9.2	8.4	19.5	6.4	11.2	0.0	2.2	70.4	4.2	2.8	5.2	1.2	37.2	2.3	0.7	20.4	6.0	12.8	4.3	5.1	24.5	8.9	5.1	43.9	5.0	3.2	9.5	4.1	23.2	10.8	69.9	2.8	34.1	0.0	4.7	24.4	1.4	6.2	0.5	0.8	2.9	4.2	2.6	18.0	1.3	2.6	2.8	0.9	2.7	6.6	2.0	4.8	94.3	37.7	12.8	1.4	4.0	23.2	2.2	16.1	2.7
TACO1	CCDC44	ENSG00000136463	"Translational activator of cytochrome c oxidase I"	Q9BSH4	17	63600882-63608365	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Translation regulation"	Activator	"Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.2"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 87.9;Proximal enterocytes: 81.2;Proximal tubular cells: 109.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021626, HPA021643, HPA024294"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA021626: AB_1846148, HPA021643: AB_1846149, HPA024294: AB_1846150"	"unprognostic (1.26e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.55e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.30e-3)"	"unprognostic (2.83e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.38e-2)"	"prognostic favorable (3.73e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.12e-3)"	"unprognostic (5.21e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.60e-2)"	12.8	18.6	16.6	8.2	17.4	8.3	10.9	18.9	18.4	8.8	17.7	17.8	18.9	11.1	9.7	13.4	9.3	5.5	42.3	16.5	17.5	30.1	69.2	7.7	10.4	17.4	17.4	8.3	12.0	18.2	9.5	8.3	17.3	9.5	16.1	9.4	11.4	9.2	61.5	11.3	16.7	9.7	16.9	11.5	15.1	12.1	17.6	9.9	9.4	55.9	12.2	11.8	9.2	16.7	39.6	61.2	19.4	20.2	16.5	23.5	25.7	28.5	26.8	56.2	44.4	40.5	23.2	32.6	21.2	33.1	38.9	35.8	43.0	41.5	52.6	17.3	58.1	32.0	29.8	72.3	45.5	38.3	21.7	29.0	28.6	48.5	51.1	20.9	29.6	24.2	44.4	24.1	26.6	71.6	44.7	28.7	16.8	42.5	62.9	28.1	47.7	40.8	33.2	27.6	29.5	32.4	19.6	64.0	55.3	25.3	53.3	29.1	26.4	39.9	29.9	27.5	50.7	25.9	27.2	38.7	30.4	26.0	29.6	2.2	9.4	9.0	9.8	8.5	10.7	7.5	13.7	9.7	10.6	9.9	12.4	10.3	1.4	17.8	7.4	7.0	10.2	9.4	16.6	17.4	18.9	18.4	16.5	17.5	17.4	17.4	17.3	16.9	17.6	16.7	9.8	3.2	6.3	2.6	12.0	2.5	8.0	21.1	8.6	8.2	7.8	10.9	54.0	17.2	11.5	14.7	2.1	32.1	8.2	32.9	54.8	29.1	15.3	8.0	11.4	14.2	13.8	17.4	4.0	27.4	28.9	14.1	16.8	6.4	9.5	16.2	8.6	87.9	26.3	6.7	3.9	21.7	12.2	10.7	3.9	46.0	11.8	9.2	10.6	2.8	22.0	15.5	14.4	1.5	3.2	30.0	25.8	11.3	10.7	11.6	81.2	109.7	9.1	13.4	19.7	10.7	14.6	26.8	13.9	18.6	4.3	19.8	10.1	40.7	32.8	7.1
TAF11	"TAF2I, TAFII28"	ENSG00000064995	"TATA-box binding protein associated factor 11"	Q15544	6	34877462-34888071	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029326, HPA049127"			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Golgi apparatus"	"HPA029326: AB_2672999, HPA049127: AB_2680645"	"unprognostic (4.02e-2)"	"unprognostic (5.36e-3)"	"unprognostic (7.41e-2)"	"unprognostic (5.18e-3)"	"unprognostic (6.65e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.68e-3)"	"prognostic favorable (5.87e-4)"	"unprognostic (2.91e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.87e-2)"	"unprognostic (4.92e-1)"	"unprognostic (3.32e-1)"	23.2	27.9	21.3	19.5	22.4	47.1	23.0	24.8	26.5	23.9	22.0	27.8	19.3	22.6	18.4	25.8	25.1	15.5	29.5	21.4	21.0	27.5	28.5	25.5	27.1	22.0	21.7	27.9	27.2	16.7	19.8	22.6	22.0	26.2	20.6	24.8	20.9	16.9	32.6	29.0	26.5	20.7	21.1	33.8	25.1	33.4	22.3	23.7	24.4	21.6	25.4	24.9	23.1	25.6	37.2	15.4	50.2	91.4	29.5	30.8	44.5	29.5	23.1	47.2	44.8	35.9	23.0	49.5	37.8	27.3	23.1	23.4	61.5	25.1	37.7	30.3	49.6	55.7	30.7	58.8	41.3	74.9	38.6	35.8	41.2	32.2	25.2	28.8	57.6	55.0	89.0	38.1	22.6	65.6	48.1	63.4	45.9	74.3	26.0	51.6	44.9	39.7	34.4	23.0	60.6	55.3	33.9	37.9	68.6	41.5	59.4	88.6	34.6	33.3	44.6	20.1	36.9	35.2	90.5	72.4	12.2	86.3	49.9	43.6	27.8	24.5	14.3	25.8	13.8	13.8	14.9	15.4	24.1	17.1	17.4	15.6	17.5	17.6	21.7	21.5	21.4	15.9	21.3	22.4	24.8	26.5	21.4	21.0	22.0	21.7	22.0	21.1	22.3	25.6	49.9	28.9	19.5	18.3	44.9	46.0	31.4	36.1	24.5	29.0	55.1	44.3	24.0	25.8	31.3	42.3	12.5	71.9	50.4	33.5	64.6	47.9	6.6	37.4	49.7	43.8	39.5	39.5	20.8	63.2	68.9	33.5	29.6	47.7	22.2	57.8	61.1	58.8	44.2	32.0	23.7	38.4	50.8	52.2	32.2	10.6	33.8	36.5	24.9	13.1	48.5	37.8	48.4	16.6	33.6	50.8	51.2	37.2	44.0	32.9	43.5	48.9	17.1	32.9	32.9	34.0	35.5	130.9	71.2	36.3	58.4	76.8	44.3	38.2	40.6	31.2
TAF15	"hTAFII68, Npl3, RBP56, TAF2N"	ENSG00000270647	"TATA-box binding protein associated factor 15"	Q92804	17	35713791-35864615	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"DNA-binding, RNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052059, HPA063647"	Supported		Enhanced	Nucleoplasm		NA	NA		44000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA052059: AB_2681711, HPA063647: AB_2685072"	"unprognostic (1.26e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.48e-3)"	"unprognostic (4.75e-2)"	"unprognostic (8.06e-3)"	"unprognostic (2.08e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.99e-1)"	62.0	74.8	56.2	74.5	54.4	69.2	57.3	52.9	68.4	74.3	55.2	71.9	56.4	69.9	40.9	102.7	61.6	33.4	80.2	52.0	61.1	63.8	82.1	57.2	90.0	56.3	56.9	66.0	74.0	54.4	71.3	48.2	55.8	63.0	48.6	54.2	65.8	38.2	130.2	80.0	78.6	38.0	54.3	76.4	76.6	87.8	56.1	95.5	58.5	38.3	75.2	74.6	72.1	57.0	216.8	347.3	190.2	191.2	149.6	88.5	108.3	247.9	79.1	109.7	107.0	244.5	151.1	440.1	166.9	145.2	122.2	239.6	254.0	232.8	166.0	112.9	187.1	250.6	264.3	261.1	145.3	401.1	168.4	135.7	143.6	155.3	266.0	137.0	140.1	238.5	233.3	188.9	148.1	270.4	442.0	96.0	117.0	205.9	40.2	255.7	279.6	164.7	149.3	399.1	130.1	136.6	299.6	97.8	98.3	231.0	224.5	144.9	214.1	86.1	178.3	115.8	310.1	165.6	198.4	303.4	173.7	190.1	134.1	1.4	1.0	1.2	1.7	1.4	2.0	1.0	1.0	1.2	0.7	1.2	0.9	1.2	0.9	2.0	1.5	1.0	1.5	0.9	56.2	54.4	52.9	68.4	52.0	61.1	56.3	56.9	55.8	54.3	56.1	57.0	38.1	16.0	55.1	90.4	71.4	36.1	59.7	57.9	93.9	57.8	29.3	31.0	41.6	40.0	57.0	60.7	41.7	82.1	63.1	38.4	3.9	42.7	7.5	51.4	55.0	52.6	49.1	75.3	108.4	29.6	50.8	36.9	66.3	53.8	55.8	32.4	36.8	60.7	43.1	60.6	111.7	52.2	46.8	44.0	32.9	10.4	30.7	49.0	33.8	78.7	56.0	75.1	54.6	100.0	124.2	29.2	29.4	40.6	53.2	43.4	50.3	31.6	47.2	45.4	46.0	48.0	51.7	84.9	74.7	115.3	37.2	78.0	78.8	55.6	58.5	44.8
TAF3	"TAF140, TAFII140"	ENSG00000165632	"TATA-box binding protein associated factor 3"	Q5VWG9	10	7818505-8016631	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066184			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Nuclear membrane"	"HPA066184: AB_2685631"	"unprognostic (3.82e-2)"	"unprognostic (2.87e-3)"	"unprognostic (6.60e-2)"	"unprognostic (4.23e-1)"	"unprognostic (6.88e-2)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (2.14e-7)"	"unprognostic (2.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.71e-2)"	"unprognostic (9.71e-2)"	"unprognostic (6.30e-3)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (8.59e-2)"	"unprognostic (3.44e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.74e-1)"	5.4	4.9	7.1	4.8	7.9	6.9	4.5	9.9	9.0	4.7	4.8	5.1	2.8	5.2	2.2	3.0	4.3	3.3	5.9	6.1	7.6	4.0	3.7	3.9	6.1	7.9	9.0	7.0	4.3	5.2	3.1	4.5	7.9	3.5	3.5	5.3	3.6	4.4	10.7	5.2	3.8	4.2	7.2	5.5	3.7	7.5	8.2	7.0	4.3	7.6	4.6	5.0	4.2	7.2	7.9	7.2	8.0	4.3	9.0	6.2	11.1	9.2	3.5	6.8	7.7	15.6	5.8	13.4	6.9	5.4	2.8	8.4	8.9	7.9	8.5	10.9	9.8	11.5	5.0	10.0	7.7	7.8	10.1	4.2	7.8	9.5	4.6	4.3	6.5	14.5	13.0	13.5	7.8	14.9	17.7	5.5	6.1	11.5	4.2	14.2	7.6	9.0	3.9	4.9	4.3	6.1	10.0	7.2	9.4	7.8	13.1	8.1	8.1	6.1	10.7	16.3	9.1	8.0	10.3	14.4	5.9	8.8	5.6	5.8	3.9	5.7	6.0	3.4	7.1	5.2	5.4	5.9	3.2	5.6	6.7	5.8	1.5	6.2	6.6	3.1	4.9	3.9	7.1	7.9	9.9	9.0	6.1	7.6	7.9	9.0	7.9	7.2	8.2	7.2	26.2	28.9	29.5	41.1	45.2	32.0	20.7	13.3	23.3	28.6	15.3	16.5	40.1	14.3	10.5	27.6	35.5	26.6	32.0	18.0	0.0	17.0	39.6	16.7	22.9	29.9	18.7	25.2	45.1	14.7	36.8	23.2	19.9	16.7	22.1	18.0	19.6	14.5	19.8	26.9	54.4	14.6	8.2	21.3	24.2	22.0	27.4	25.3	24.9	71.2	25.7	27.0	53.5	43.2	63.9	15.0	5.9	28.6	37.7	14.1	20.5	4.5	16.3	47.8	26.3	39.3	31.0	58.9	46.2	16.4	43.0	20.0	48.6	16.4	16.5	17.6
TAMM41	"C3orf31, DKFZp434E0519, MGC16471"	ENSG00000144559	"TAM41 mitochondrial translocator assembly and maintenance homolog"	Q96BW9	3	11790442-11846919	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036834, HPA044861"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA036834: AB_10672270, HPA044861: AB_2679116"	"unprognostic (2.40e-2)"	"unprognostic (4.41e-2)"	"prognostic favorable (1.23e-4)"	"unprognostic (4.45e-2)"	"unprognostic (1.44e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.03e-5)"	"unprognostic (1.57e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.33e-3)"	"unprognostic (3.78e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.34e-2)"	"unprognostic (3.59e-3)"	8.3	7.4	5.8	5.6	6.2	4.3	8.0	6.4	8.5	8.0	2.6	6.5	4.9	7.2	9.7	9.0	6.9	4.1	8.0	5.3	6.9	6.7	5.5	5.0	7.1	3.9	4.1	11.0	5.6	5.8	5.6	4.1	4.0	5.2	4.9	6.3	6.8	4.5	9.2	10.1	6.2	6.2	2.8	6.5	6.0	5.7	5.4	6.5	6.0	5.2	7.8	8.4	8.2	6.2	6.2	11.3	13.5	9.4	14.3	18.0	24.9	9.3	6.6	13.9	13.8	13.6	9.9	23.4	13.3	9.8	6.2	7.4	22.9	13.9	17.9	8.8	21.6	14.0	10.6	15.9	16.7	25.8	7.1	10.3	20.3	13.1	14.6	9.1	21.8	18.3	20.8	7.0	18.0	17.8	14.6	19.2	10.9	9.6	23.8	14.4	7.7	20.7	21.6	14.8	6.2	5.4	8.1	10.3	16.6	15.1	13.5	11.6	5.7	7.2	8.3	21.8	13.5	5.4	14.2	12.1	8.8	21.8	6.7	1.9	4.5	7.1	5.7	3.2	7.6	7.5	9.1	5.8	7.8	7.1	8.4	8.8	0.2	6.9	6.7	5.8	7.7	4.8	5.8	6.2	6.4	8.5	5.3	6.9	3.9	4.1	4.0	2.8	5.4	6.2	9.4	6.4	7.0	24.5	11.4	4.2	8.1	15.7	5.7	11.5	5.5	8.3	8.9	0.0	8.7	3.7	12.5	12.2	8.6	3.3	9.8	10.1	2.2	5.4	9.2	7.6	3.0	9.4	34.5	9.3	11.0	7.2	6.6	4.4	2.5	10.5	5.7	5.8	9.2	10.1	34.7	8.1	12.2	6.4	6.4	1.5	7.8	6.8	3.6	14.0	5.9	11.0	10.3	34.7	32.0	7.9	3.4	6.4	7.1	6.7	4.2	10.3	11.8	14.7	0.0	8.6	8.7	7.4	12.4	6.6	4.1	7.0	9.5	10.8	7.3	5.9
TANGO6	"FLJ12688, KIAA1746, TMCO7"	ENSG00000103047	"Transport and golgi organization 6 homolog"	Q9C0B7	16	68843531-69085182	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 110.2;Excitatory neurons: 45.4;Inhibitory neurons: 57.4;Late spermatids: 50.5;Oligodendrocyte precursor cells: 38.7;Oligodendrocytes: 51.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041312	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus"	Cytosol	"HPA041312: AB_10796342"	"unprognostic (8.55e-2)"	"unprognostic (6.64e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (3.20e-4)"	"unprognostic (1.55e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.45e-3)"	"unprognostic (6.02e-2)"	5.1	3.0	2.8	4.5	3.8	3.4	4.6	3.5	3.4	4.8	4.9	3.9	2.4	4.3	1.9	3.6	3.8	2.8	3.2	2.6	3.6	5.7	12.9	3.6	4.9	2.7	3.1	4.2	3.2	6.0	2.5	3.4	2.8	4.0	3.1	4.2	3.2	4.2	8.8	4.2	3.1	4.8	2.4	4.5	4.1	4.3	3.5	4.7	3.3	5.7	4.6	5.5	4.2	3.9	7.1	14.3	4.6	9.9	7.6	8.6	3.3	9.5	7.7	11.5	9.3	9.1	5.7	15.8	5.1	13.2	6.0	5.8	10.6	12.8	14.0	3.8	6.3	3.0	5.4	8.5	6.3	8.0	7.2	6.6	6.7	16.3	14.7	4.7	11.2	7.6	10.6	2.7	10.7	7.1	8.3	6.4	10.2	6.9	7.6	8.9	6.8	17.8	8.4	3.9	4.8	5.6	23.3	1.3	6.3	5.5	4.6	8.9	6.5	10.9	3.9	11.2	6.8	4.9	4.5	10.7	6.9	3.0	7.4	0.0	3.8	2.0	3.4	6.6	3.5	2.7	3.3	3.5	4.8	2.4	2.0	3.3	0.2	2.0	6.2	1.3	4.9	3.1	2.8	3.8	3.5	3.4	2.6	3.6	2.7	3.1	2.8	2.4	3.5	3.9	5.1	0.0	4.2	23.5	5.4	5.2	9.5	5.0	2.8	8.8	1.5	1.8	3.8	5.7	2.2	7.3	10.4	5.6	3.1	2.1	0.0	2.2	110.2	1.5	3.5	4.8	0.0	7.8	45.4	3.3	2.7	4.0	6.1	3.0	1.3	3.7	3.9	12.3	4.7	5.0	57.4	1.8	4.1	7.6	3.5	50.5	5.6	4.2	5.4	25.3	3.5	3.3	4.1	38.7	51.3	2.7	4.4	3.4	2.9	3.7	1.1	6.0	0.5	10.5	0.0	3.9	3.4	5.7	4.7	4.0	3.0	2.5	7.0	3.2	2.2	9.2
TAOK1	"FLJ14314, KIAA1361, MAP3K16, MARKK, PSK2, TAO1"	ENSG00000160551	"TAO kinase 1"	Q7L7X3	17	29390363-29551903	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, DNA damage, DNA repair"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 220.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007669	Approved		Uncertain	Vesicles		NA	NA		1600000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Vesicles		"HPA007669: AB_1080201"	"unprognostic (1.46e-1)"	"unprognostic (7.15e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.81e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.85e-2)"	"unprognostic (5.53e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.62e-1)"	13.7	9.1	12.0	9.8	16.0	10.5	10.3	13.8	13.1	11.8	1.2	9.5	5.2	10.8	8.5	10.3	7.9	9.6	13.2	13.3	12.8	10.2	8.6	9.8	9.9	16.4	14.5	10.3	7.8	19.4	8.0	11.7	14.9	9.0	8.5	20.9	7.8	10.0	11.4	10.4	7.3	11.7	13.2	10.4	8.1	11.7	13.9	13.2	14.5	15.2	9.5	12.1	8.7	20.4	19.3	35.0	32.1	13.4	24.1	29.8	11.3	20.0	23.9	20.3	21.1	20.7	7.9	13.8	15.8	35.9	20.7	16.3	30.4	15.7	36.4	20.7	18.2	21.0	21.3	12.2	16.6	26.5	16.7	19.4	19.6	29.0	30.6	21.3	27.3	14.0	20.7	12.0	26.7	14.2	18.5	9.5	12.0	12.9	8.6	15.1	41.2	8.8	19.1	31.5	16.1	18.7	34.6	34.4	21.1	32.6	23.6	21.6	33.6	28.0	19.7	23.7	27.5	9.3	18.6	14.0	20.3	14.8	24.3	0.6	0.5	0.5	0.6	0.6	0.5	0.5	0.6	0.7	0.5	0.6	0.7	0.7	1.7	0.5	0.6	1.4	0.4	0.3	12.0	16.0	13.8	13.1	13.3	12.8	16.4	14.5	14.9	13.2	13.9	20.4	96.9	48.1	45.8	105.8	35.9	44.5	27.4	27.0	52.9	56.6	35.5	23.2	90.2	30.0	37.7	46.0	98.0	18.7	40.5	29.3	15.6	27.3	11.8	45.0	72.0	55.4	37.7	18.7	162.3	24.3	16.0	58.0	31.6	80.1	28.5	44.3	52.1	29.5	30.1	52.2	160.5	23.7	24.4	65.6	60.4	19.8	39.7	67.3	40.9	92.8	55.8	37.1	29.9	142.2	220.8	38.9	24.0	54.2	34.2	40.4	17.6	22.1	31.0	54.7	26.3	66.1	52.1	59.1	33.2	49.5	45.9	37.6	43.1	43.0	21.1	41.6
TARDBP	"ALS10, TDP-43"	ENSG00000120948	"TAR DNA binding protein"	Q13148	1	11012344-11030528	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"	"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003703, HPA017284"	Supported		Enhanced	Nucleoplasm		NA	NA		29000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB003703: AB_425904, HPA017284: AB_1857775"	"unprognostic (3.72e-3)"	"prognostic favorable (1.15e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.52e-2)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (1.20e-7)"	"unprognostic (1.06e-1)"	"unprognostic (3.41e-3)"	"unprognostic (4.75e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.27e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.71e-2)"	83.4	80.1	71.9	87.1	80.6	69.7	83.3	84.7	79.0	93.9	78.1	94.5	77.4	90.9	78.8	111.1	84.1	58.7	93.0	69.4	78.5	93.8	105.5	91.6	106.5	75.5	77.2	103.5	77.2	86.7	89.1	82.7	76.4	90.1	94.5	119.9	86.6	78.8	138.9	96.1	94.5	81.2	74.8	97.4	82.4	68.2	74.7	115.1	96.6	102.9	122.9	87.6	95.8	86.0	244.7	164.4	270.4	143.5	143.9	118.2	160.3	164.7	142.3	263.6	195.5	187.9	175.6	316.3	118.1	180.6	154.3	169.2	333.1	187.6	336.0	175.1	153.8	241.2	275.2	257.9	119.4	290.5	158.9	99.5	211.4	184.5	147.9	143.8	188.6	126.7	319.0	176.4	221.7	195.0	215.6	228.6	221.0	232.2	141.7	256.9	214.4	206.2	186.0	179.1	187.9	150.8	221.3	173.7	128.8	197.1	173.8	200.9	174.8	173.8	207.8	146.3	236.9	133.3	176.2	336.3	116.2	288.2	192.0	38.0	38.0	33.7	46.7	48.6	57.4	55.2	46.9	45.4	61.7	39.6	46.3	50.5	15.4	67.2	50.0	43.1	54.3	36.4	71.9	80.6	84.7	79.0	69.4	78.5	75.5	77.2	76.4	74.8	74.7	86.0	35.5	32.1	74.4	29.4	57.6	114.6	89.9	40.8	52.3	37.6	52.0	38.6	68.0	31.5	57.0	29.5	29.2	63.2	46.3	54.2	33.2	50.8	9.7	50.7	50.0	54.9	66.3	63.5	29.5	54.2	84.5	45.2	34.7	61.7	42.3	45.8	40.0	51.7	50.1	37.0	29.8	50.1	38.7	45.9	46.3	12.3	47.2	37.8	35.6	23.4	54.3	36.2	35.0	37.2	57.2	52.9	36.1	51.6	48.8	71.7	43.2	43.9	54.4	38.8	32.9	42.8	56.9	64.9	32.8	52.4	114.5	73.5	41.3	23.6	52.6	71.3
TATDN3		ENSG00000203705	"TatD DNase domain containing 3"	Q17R31	1	212791828-212816830	"Predicted intracellular proteins"		"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032092	Approved		Approved	"Nucleoplasm,Golgi apparatus,Focal adhesion sites"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Golgi apparatus, Focal adhesion sites"	"HPA032092: AB_10671086"	"unprognostic (9.81e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.34e-3)"	"unprognostic (5.02e-3)"	"prognostic favorable (1.59e-4)"	"unprognostic (1.93e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.96e-3)"	13.0	11.3	10.1	10.4	12.4	12.2	10.0	10.1	12.7	6.5	9.3	8.3	6.1	7.1	13.3	7.3	7.7	7.4	19.3	10.6	12.4	16.6	10.3	8.0	12.2	12.2	10.5	8.6	9.4	18.2	8.2	7.3	12.4	6.9	7.7	17.7	8.5	6.9	29.9	6.3	7.2	7.7	10.5	11.1	11.1	10.0	10.4	11.2	11.7	24.1	10.3	8.2	5.5	15.8	12.2	11.9	10.3	15.1	16.7	26.0	23.5	12.9	14.3	10.8	13.1	3.1	17.2	27.4	12.3	12.4	6.0	7.6	13.0	18.2	11.5	17.1	17.0	13.4	10.3	6.3	19.0	33.3	16.3	20.6	12.8	14.3	37.3	11.2	16.1	37.7	28.2	21.7	11.7	5.9	28.4	10.9	13.9	14.9	7.6	16.0	19.3	49.4	11.3	6.3	21.6	18.5	14.5	25.1	30.6	19.2	26.6	19.6	10.1	7.9	10.3	16.4	13.0	19.4	32.9	44.9	20.6	26.8	12.0	26.1	37.2	60.2	12.7	59.3	11.5	39.7	15.8	15.4	45.6	31.0	12.5	14.9	42.8	13.8	64.4	74.6	16.1	22.9	10.1	12.4	10.1	12.7	10.6	12.4	12.2	10.5	12.4	10.5	10.4	15.8	9.1	6.4	16.2	17.3	18.5	4.5	8.1	14.2	3.4	16.1	8.5	8.3	36.6	8.6	8.0	3.7	18.8	14.3	39.7	3.4	41.1	18.1	12.2	10.8	7.6	8.9	10.2	6.5	35.1	16.5	17.5	10.0	6.1	7.8	7.0	10.8	5.3	7.0	18.8	15.2	43.9	5.1	12.2	27.6	8.3	4.0	5.3	20.4	14.2	17.8	31.0	17.8	8.2	23.1	53.6	12.0	6.2	4.9	9.3	6.2	7.3	26.4	12.5	29.6	6.6	8.8	9.2	24.2	17.9	6.6	4.4	9.3	11.1	11.0	5.2	7.0
TBC1D13	FLJ10743	ENSG00000107021	"TBC1 domain family member 13"	Q9NVG8	9	128787253-128810430	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 55.5;Oligodendrocytes: 36.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 23.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045865	Approved		Approved	Nucleoli		No	No		9300	"Cluster 34: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoli		"HPA045865: AB_10965700"	"unprognostic (1.22e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.16e-2)"	"unprognostic (4.23e-2)"	"unprognostic (4.29e-2)"	"prognostic favorable (3.14e-6)"	"unprognostic (1.82e-2)"	"prognostic favorable (1.58e-7)"	"unprognostic (1.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.68e-1)"	13.5	21.6	32.3	9.1	30.8	14.7	13.4	23.2	32.3	13.8	19.9	15.3	12.3	13.9	14.0	11.8	14.5	8.6	18.7	30.9	28.1	27.8	16.6	11.2	10.8	29.8	28.9	18.7	17.5	28.4	15.4	9.9	29.6	17.3	8.3	7.1	18.6	13.8	20.7	12.2	15.9	12.9	25.6	19.3	17.0	7.2	29.9	10.9	17.8	13.6	10.9	14.1	10.9	30.0	9.5	22.5	23.1	23.2	29.3	14.1	22.5	22.4	19.0	22.7	14.7	24.6	12.5	15.9	15.2	26.6	22.6	25.1	14.2	17.8	13.3	12.6	16.1	17.0	27.4	22.7	18.1	25.9	33.3	19.8	20.7	19.7	11.8	20.1	29.6	16.6	26.7	10.5	27.4	20.5	15.8	15.2	22.0	26.3	33.5	17.7	21.4	36.1	16.7	12.3	23.2	16.3	31.1	19.7	13.4	22.3	21.0	24.1	23.7	28.3	17.7	23.2	18.4	13.3	18.5	15.5	20.7	15.4	20.8	23.0	2.7	4.8	4.2	2.7	4.4	4.7	3.3	4.2	3.0	3.2	2.9	5.0	2.0	3.4	2.1	8.3	2.6	3.6	32.3	30.8	23.2	32.3	30.9	28.1	29.8	28.9	29.6	25.6	29.9	30.0	6.9	3.2	9.0	9.4	7.2	2.3	2.6	3.4	4.6	10.1	9.6	9.1	12.1	2.8	4.2	16.5	10.4	5.2	6.6	8.8	9.8	6.1	1.5	4.2	6.7	9.4	5.4	7.8	11.2	9.9	4.7	6.4	9.7	5.9	8.2	10.9	16.1	14.8	17.6	6.7	10.5	4.7	4.1	8.5	2.5	2.9	9.3	6.7	0.0	5.6	55.5	6.5	9.2	11.1	36.6	8.5	5.2	7.5	5.4	3.5	15.9	26.0	4.8	5.8	6.6	5.6	4.9	5.1	8.6	5.7	3.1	2.5	6.5	9.7	6.8	2.1
TBCCD1	FLJ10560	ENSG00000113838	"TBCC domain containing 1"	Q9NVR7	3	186546067-186570543	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 42.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"				"unprognostic (1.15e-1)"	"unprognostic (7.41e-3)"	"unprognostic (6.36e-2)"	"unprognostic (2.62e-2)"	"unprognostic (8.79e-2)"	"unprognostic (7.14e-2)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (2.10e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.27e-1)"	6.7	5.9	4.7	7.5	5.6	7.5	6.7	6.4	5.3	6.4	6.8	6.5	6.4	7.1	7.5	7.7	5.7	6.2	5.4	4.5	5.6	6.2	9.5	5.4	9.4	5.3	5.3	6.3	7.5	8.5	4.2	7.6	5.8	5.2	7.3	12.5	6.4	5.3	6.1	6.9	6.1	6.3	5.3	6.6	6.1	19.2	5.3	10.9	8.4	7.4	9.2	6.6	6.5	6.8	12.5	8.7	13.8	13.7	11.6	12.4	9.8	9.5	6.9	12.2	12.9	15.3	9.6	15.3	24.5	6.9	9.5	13.2	21.3	9.0	15.6	22.2	10.9	19.5	7.7	9.5	6.6	18.4	12.7	7.4	9.5	10.8	12.5	8.0	17.3	19.9	15.9	14.3	10.8	15.0	17.9	10.6	8.6	28.4	15.1	20.3	13.8	17.1	8.0	7.7	16.2	10.4	17.0	18.9	10.1	10.8	24.7	11.6	10.7	8.4	10.7	10.5	15.0	19.8	36.9	37.0	9.0	16.4	16.5	17.3	9.7	11.7	11.7	9.7	15.3	11.8	12.9	13.2	12.8	11.3	10.2	13.0	4.2	14.6	11.3	7.5	18.0	9.1	4.7	5.6	6.4	5.3	4.5	5.6	5.3	5.3	5.8	5.3	5.3	6.8	5.6	16.0	3.7	8.5	8.8	6.4	2.8	2.6	9.1	6.5	3.2	2.4	2.6	4.3	1.9	1.8	2.1	4.0	2.9	4.1	11.7	7.1	3.0	3.7	4.9	5.3	3.6	5.9	11.5	6.5	6.0	4.7	12.2	3.5	12.0	4.2	6.8	5.2	4.7	0.0	13.2	6.6	0.0	3.8	6.4	2.8	5.9	4.2	5.4	7.5	4.6	5.2	9.2	12.5	14.1	4.8	5.0	3.8	11.5	2.2	5.4	3.5	7.0	6.7	6.6	4.2	4.8	42.1	20.8	9.7	4.1	4.1	7.2	3.3	5.5	1.9
TBK1	NAK	ENSG00000183735	"TANK binding kinase 1"	Q9UHD2	12	64452090-64502114	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Amyotrophic lateral sclerosis, Disease variant, Glaucoma, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045797, HPA060211"	Uncertain		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA045797: AB_2679457, HPA060211: AB_2684222"	"unprognostic (4.73e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.48e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (4.20e-6)"	"unprognostic (4.35e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.26e-2)"	"unprognostic (9.56e-3)"	11.6	15.3	6.0	10.1	6.1	16.9	11.4	5.6	6.9	10.6	5.3	10.5	15.1	11.0	6.7	11.3	9.5	10.1	9.4	5.8	5.6	11.8	17.4	12.9	14.6	6.5	6.9	9.6	7.5	11.6	9.8	13.7	6.1	10.6	8.5	6.3	10.2	9.0	18.4	8.6	11.4	10.8	5.3	13.4	10.2	23.5	6.7	6.8	8.5	14.9	12.9	16.0	10.2	7.1	23.3	24.2	11.1	10.6	24.7	26.1	29.0	22.9	37.6	22.5	21.1	14.9	12.4	31.5	21.4	26.8	34.4	19.0	19.4	20.0	26.4	29.5	17.1	33.0	15.3	19.1	30.2	35.2	36.4	18.5	19.1	23.1	23.6	42.3	32.4	11.0	27.9	38.7	31.6	27.0	0.9	17.0	29.9	22.9	13.8	14.9	15.3	31.8	25.1	36.9	9.8	14.7	33.3	36.0	23.5	23.5	33.1	24.9	25.9	20.2	18.1	14.9	24.0	25.4	54.3	30.3	28.1	18.6	26.1	41.8	10.1	24.3	13.9	17.7	16.3	12.8	10.1	15.2	12.2	10.1	2.8	8.7	17.8	26.6	15.5	2.1	13.6	10.0	6.0	6.1	5.6	6.9	5.8	5.6	6.5	6.9	6.1	5.3	6.7	7.1	23.7	19.2	20.5	28.4	21.6	11.0	25.7	20.1	15.4	17.0	14.9	9.1	10.9	8.6	23.4	22.0	10.4	28.8	30.0	14.1	11.7	19.3	34.5	19.2	17.9	28.6	17.3	18.3	50.5	23.6	32.6	21.3	15.3	30.2	43.1	17.5	16.8	17.1	20.2	18.5	42.2	10.5	12.2	23.0	30.2	29.2	19.3	31.1	14.2	46.9	31.4	12.7	33.0	39.2	52.3	16.9	10.9	20.7	25.6	43.7	13.6	12.3	20.8	16.3	26.3	22.4	18.7	68.9	12.7	14.0	14.9	92.6	27.1	11.5	10.1	41.6
TBL3	"SAZD, UTP13"	ENSG00000183751	"Transducin beta like 3"	Q12788	16	1972053-1982929	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 113.8;Late spermatids: 72.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042562, HPA055695"	Enhanced	Supported	Enhanced	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoli		"HPA042562: AB_10964911, HPA055695: AB_2682888"	"unprognostic (1.96e-1)"	"unprognostic (5.49e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.67e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.78e-2)"	"unprognostic (8.03e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.32e-2)"	"prognostic favorable (7.33e-4)"	"unprognostic (3.65e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.77e-1)"	3.6	3.5	1.8	3.2	2.2	2.1	3.9	4.5	2.7	3.4	1.0	3.4	2.4	3.8	0.6	4.9	3.0	1.4	4.7	2.3	2.3	3.3	3.1	2.8	2.3	3.3	2.0	3.7	5.9	2.8	2.4	1.2	3.4	2.8	1.0	1.5	4.8	1.1	10.6	5.4	3.5	1.4	1.7	3.0	3.7	6.8	1.8	2.0	3.1	3.1	1.5	3.3	3.5	2.7	7.1	13.4	3.6	7.2	3.5	2.8	11.8	6.4	4.2	5.4	4.4	17.3	13.3	9.4	14.6	4.9	4.9	18.8	5.9	7.5	2.8	6.9	8.5	5.9	7.1	6.6	4.0	10.3	5.4	2.8	5.5	6.7	3.9	4.3	6.8	5.6	12.1	6.7	3.2	11.3	13.2	5.8	8.6	6.2	5.4	23.1	6.7	15.7	2.6	2.7	8.4	6.5	5.8	14.6	6.0	3.5	11.1	6.9	10.8	7.4	8.8	6.6	12.6	12.1	5.6	15.0	4.5	6.5	8.7	4.5	9.4	5.5	10.6	11.0	9.3	6.4	7.6	10.4	10.4	6.9	9.7	7.4	2.2	14.5	11.8	5.3	9.2	8.5	1.8	2.2	4.5	2.7	2.3	2.3	3.3	2.0	3.4	1.7	1.8	2.7	9.1	3.2	12.2	2.3	11.9	13.0	15.8	21.9	12.0	13.0	12.6	10.4	16.4	7.2	16.4	18.4	8.4	26.4	10.7	23.4	7.9	25.4	113.8	7.4	8.5	11.2	13.8	18.5	2.0	22.5	26.0	10.5	20.4	9.7	14.7	14.5	7.1	12.7	19.6	10.1	2.1	16.1	18.3	8.9	6.6	72.1	14.9	8.5	7.2	0.0	24.1	13.6	9.2	2.0	2.0	24.0	22.0	10.9	13.5	15.6	31.9	16.9	8.8	9.8	26.3	11.1	24.7	21.8	20.8	13.7	18.3	22.4	11.1	11.6	24.2	14.4
TBRG4	"Cpr2, FASTKD4, H_TD2522F11.8, KIAA0948"	ENSG00000136270	"Transforming growth factor beta regulator 4"	Q969Z0	7	45100100-45112047	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020582, HPA050430"	Approved		Enhanced	Mitochondria		NA	NA		23000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA020582: AB_1857804, HPA050430: AB_2681125"	"unprognostic (2.22e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.41e-2)"	"unprognostic (9.29e-3)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (3.15e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.53e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.66e-3)"	"unprognostic (3.91e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.52e-1)"	24.5	29.5	19.3	23.0	21.8	23.0	24.0	22.8	21.4	22.9	23.5	36.1	29.4	23.1	7.9	35.8	21.2	11.9	56.5	19.7	21.6	29.6	43.3	19.0	25.5	22.4	21.1	24.0	21.3	21.9	17.4	19.5	23.0	24.5	18.7	6.6	24.1	15.6	83.0	32.4	28.6	15.6	21.4	28.5	26.2	34.4	22.0	21.9	18.9	66.2	17.9	29.3	25.5	23.2	49.4	113.1	35.7	77.3	31.5	28.9	70.2	39.2	35.9	74.6	61.5	123.8	67.5	93.8	58.7	39.9	103.3	125.6	82.6	89.3	37.6	49.0	77.8	64.5	73.6	84.4	51.6	74.5	63.4	39.7	81.7	71.2	50.7	26.7	46.6	79.3	181.1	46.0	46.2	84.5	75.9	168.0	111.0	110.6	88.6	65.9	45.3	136.2	44.1	50.4	69.9	65.6	40.4	218.8	77.6	45.6	97.7	120.4	36.4	54.6	65.7	33.9	64.8	81.0	87.6	137.5	50.1	104.9	125.7	17.3	23.8	20.6	31.1	44.3	29.5	27.9	25.6	30.0	35.9	20.9	34.5	33.3	1.9	18.1	39.5	13.6	27.2	33.0	19.3	21.8	22.8	21.4	19.7	21.6	22.4	21.1	23.0	21.4	22.0	23.2	13.3	3.2	16.3	9.4	21.0	35.1	33.2	39.8	15.4	15.1	17.0	15.0	28.0	15.7	24.1	20.2	0.0	61.5	18.4	32.9	43.0	31.1	24.6	12.5	13.8	14.2	22.2	14.3	6.5	18.3	72.5	17.9	24.5	16.9	14.0	25.4	10.4	31.8	34.5	11.8	7.1	32.5	36.7	12.3	17.8	19.6	16.4	18.0	17.8	3.7	34.6	14.7	14.4	4.5	8.4	29.5	28.0	11.7	17.9	33.8	33.5	47.4	11.2	14.2	13.1	17.1	25.5	72.4	33.0	17.0	29.3	47.9	19.2	44.7	53.3	30.2
TCEAL8	"MGC45400, WEX3"	ENSG00000180964	"Transcription elongation factor A like 8"	Q8IYN2	X	103252995-103255192	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059115	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA059115: AB_2683909"	"unprognostic (1.51e-2)"	"unprognostic (4.56e-2)"	"unprognostic (9.24e-2)"	"unprognostic (7.13e-3)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (8.53e-6)"	"unprognostic (3.71e-3)"	"unprognostic (1.88e-2)"	"unprognostic (5.52e-2)"	"unprognostic (4.80e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.26e-2)"	"unprognostic (7.22e-2)"	"unprognostic (9.12e-2)"	"unprognostic (9.32e-2)"	42.9	62.6	51.9	36.3	53.1	29.3	60.0	55.0	69.6	67.2	53.8	47.9	30.5	58.3	131.1	38.8	45.3	57.1	93.1	53.1	54.6	69.4	42.7	43.9	47.6	53.4	52.2	69.4	40.9	71.0	56.5	62.2	53.9	59.2	49.5	33.2	61.5	56.1	18.8	39.3	40.4	63.2	55.1	45.8	42.0	42.9	53.4	71.9	71.3	32.0	45.7	57.3	36.5	55.9	49.2	26.4	110.9	51.8	161.9	269.3	53.2	104.9	154.7	90.6	141.0	20.6	94.5	25.8	68.2	120.7	157.7	32.1	19.6	120.0	116.5	0.4	61.5	111.2	34.5	30.8	98.8	114.4	105.6	184.9	68.0	79.5	0.0	190.3	123.9	75.3	135.0	23.8	223.6	0.0	98.2	43.9	123.2	4.4	52.7	37.1	152.8	7.6	124.7	36.4	57.7	75.4	58.3	18.1	130.8	105.7	33.9	38.0	83.1	53.5	71.0	164.4	35.2	26.2	49.8	1.1	86.7	61.0	87.6	73.7	31.9	20.0	66.3	29.3	76.6	62.4	78.1	71.4	58.2	52.6	84.5	73.5	3.0	120.6	23.2	101.3	109.5	54.5	51.9	53.1	55.0	69.6	53.1	54.6	53.4	52.2	53.9	55.1	53.4	55.9	72.3	51.3	66.7	6.8	32.7	60.8	83.9	169.4	68.9	52.3	70.5	69.2	76.6	104.4	89.4	97.5	10.4	188.8	48.5	27.5	273.9	137.8	6.8	46.2	71.8	85.0	78.5	33.2	10.3	109.4	176.3	93.9	29.6	49.7	69.6	76.2	169.6	102.5	98.7	50.5	10.0	133.7	81.4	90.6	81.1	17.2	125.9	52.4	120.9	10.3	71.4	110.4	104.0	7.1	11.3	68.2	49.2	121.9	27.2	51.3	73.5	276.2	60.1	37.5	85.5	80.6	77.4	5.6	4.0	47.6	59.5	134.9	45.1	68.1	78.7	79.5
TCP1	"CCT1, Ccta, D6S230E"	ENSG00000120438	"T-complex 1"	P17987	6	159778498-159789703	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 586.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017460, HPA027337, HPA031082"	Approved					NA	NA		2300000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"			"CAB017460: AB_10618875, HPA027337: AB_10600774, HPA031082: AB_10600990"	"prognostic unfavorable (8.88e-5)"	"unprognostic (1.34e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.67e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.39e-3)"	"prognostic unfavorable (1.49e-5)"	"unprognostic (1.54e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.64e-2)"	"unprognostic (9.34e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.54e-1)"	114.1	92.9	110.5	90.8	117.0	181.5	106.0	119.2	179.4	88.3	118.1	103.6	71.7	97.8	84.9	103.8	93.2	69.2	114.8	117.4	120.5	105.8	98.0	89.5	105.7	117.3	118.1	122.8	96.0	98.2	57.0	83.5	120.9	81.0	108.1	76.8	92.2	72.6	171.8	101.3	84.7	99.7	122.2	82.2	92.3	174.0	118.0	98.2	77.1	125.4	128.3	101.9	84.8	141.4	236.3	284.1	296.9	405.2	260.5	209.0	456.5	344.6	170.4	423.3	320.9	571.4	170.9	579.5	233.4	275.2	494.7	339.0	793.5	350.2	601.5	301.8	380.6	606.7	292.7	545.9	199.1	496.7	308.9	204.3	215.0	417.5	392.0	241.8	381.7	498.8	856.1	262.8	399.4	201.5	620.2	590.4	321.6	305.0	310.3	447.8	219.7	474.7	345.1	170.7	365.8	237.7	323.3	452.3	161.3	386.2	212.6	464.2	264.0	203.9	310.0	467.0	717.6	238.5	531.7	638.4	293.8	571.8	329.1	92.0	73.8	93.6	84.3	99.1	110.1	95.8	92.6	91.7	90.4	74.2	94.4	92.4	34.4	101.1	131.5	55.4	105.0	114.2	110.5	117.0	119.2	179.4	117.4	120.5	117.3	118.1	120.9	122.2	118.0	141.4	122.4	51.3	38.8	12.4	95.4	171.7	304.4	153.2	75.7	39.1	95.2	75.2	68.2	81.5	108.6	27.6	29.2	161.7	80.7	93.8	115.4	191.9	427.4	113.4	140.1	106.4	104.4	119.5	22.8	134.6	288.7	98.6	64.2	122.2	104.6	109.8	51.0	43.8	118.7	30.3	24.3	84.6	120.1	65.7	134.4	586.4	86.0	91.5	108.5	22.5	99.9	73.3	77.2	18.1	25.3	151.1	75.7	92.2	93.0	235.2	84.0	152.3	127.1	53.1	72.3	111.9	247.2	307.3	237.1	93.4	148.0	240.4	116.6	100.6	133.8	249.3
TCTN3	"C10orf61, DKFZP564D116, JBTS18, TECT3"	ENSG00000119977	"Tectonic family member 3"	Q6NUS6	10	95659823-95694143	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026987	Approved		Approved	Microtubules	"Intracellular and membrane"	NA	NA		4400000	"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	Microtubules		"HPA026987: AB_10600911"	"unprognostic (1.58e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.78e-2)"	"prognostic favorable (5.77e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.50e-2)"	"unprognostic (8.88e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.03e-2)"	"unprognostic (9.25e-3)"	"unprognostic (3.78e-3)"	"unprognostic (7.29e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.30e-3)"	"unprognostic (1.59e-1)"	21.3	25.3	8.6	15.7	9.0	5.1	25.2	9.1	11.3	26.3	24.0	22.1	17.6	24.8	65.0	17.0	35.4	22.7	18.4	8.8	9.8	32.5	26.8	19.4	14.3	9.7	9.5	30.6	27.1	69.9	22.8	26.9	9.5	25.6	25.6	22.2	25.4	27.7	9.5	20.5	15.4	26.8	9.2	17.3	19.1	19.4	9.6	14.0	70.6	11.5	18.0	23.9	18.6	9.2	34.0	54.1	44.1	89.3	93.6	74.6	25.7	45.3	94.8	46.9	55.3	35.4	57.3	31.3	40.1	60.4	49.8	46.7	43.9	54.5	56.5	33.6	36.4	10.9	21.6	49.2	46.9	37.4	22.8	65.2	49.2	46.6	72.4	88.0	80.7	27.7	21.0	40.3	63.4	32.5	23.4	27.9	12.1	49.7	38.1	25.3	33.9	38.3	67.8	23.3	11.5	24.5	37.7	18.5	52.6	40.8	71.0	35.1	37.9	35.6	24.9	23.9	49.5	18.9	37.9	20.7	57.5	47.1	19.0	6.8	14.2	4.9	25.8	21.9	32.0	28.3	23.1	25.2	45.2	19.4	24.2	20.0	1.6	26.8	24.3	23.6	22.2	21.3	8.6	9.0	9.1	11.3	8.8	9.8	9.7	9.5	9.5	9.2	9.6	9.2	14.8	19.2	16.2	16.6	29.3	14.4	23.7	33.8	31.3	24.0	18.2	15.0	8.5	27.1	20.3	31.3	37.5	50.3	18.8	20.2	7.9	27.2	18.6	25.5	25.7	20.4	13.8	11.6	17.3	20.3	44.2	27.3	11.7	18.3	8.2	29.8	21.4	16.8	28.5	25.2	17.7	12.5	26.4	14.1	59.1	14.1	20.8	18.7	16.0	16.9	14.8	36.7	15.5	20.6	13.7	14.1	12.7	25.2	35.9	19.8	16.2	16.1	27.5	44.4	13.1	23.9	19.8	39.8	34.1	15.3	11.5	31.5	23.0	34.2	23.7	14.6
TDG		ENSG00000139372	"Thymine DNA glycosylase"	Q13569	12	103965822-103988874	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052263	Supported		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Plasma membrane"	"HPA052263: AB_2681777"	"unprognostic (3.15e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.89e-3)"	"unprognostic (6.93e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (6.27e-5)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (6.90e-5)"	"unprognostic (5.37e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (1.90e-10)"	"unprognostic (3.68e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.16e-1)"	10.8	13.6	5.8	15.9	6.4	18.1	12.0	6.7	7.2	10.0	7.2	13.2	11.4	11.6	9.5	17.8	8.7	12.2	9.8	6.3	6.0	8.5	12.1	9.6	21.0	5.3	5.5	9.7	9.5	10.4	9.5	17.5	5.5	9.6	15.6	10.5	9.2	7.3	9.5	12.8	13.4	10.9	4.6	11.9	11.2	4.9	5.5	25.7	10.6	9.6	19.1	17.1	11.2	7.3	42.6	21.4	64.4	37.2	15.5	13.7	69.4	32.4	12.3	42.6	23.6	39.1	18.2	99.4	18.8	26.3	6.9	27.9	76.8	36.5	32.6	42.8	66.8	76.4	31.8	17.5	14.8	95.4	55.8	16.3	48.0	31.5	24.6	25.9	42.3	58.4	91.1	15.8	20.6	45.2	107.6	53.6	76.7	33.0	34.0	107.9	32.8	35.0	46.4	61.4	84.2	58.0	38.9	42.7	28.4	37.7	70.7	52.2	26.5	13.3	21.5	14.3	37.5	34.5	49.5	81.8	14.2	52.0	25.3	55.0	53.0	45.8	28.9	39.2	22.0	43.4	28.1	24.3	34.6	39.8	28.5	25.5	35.5	33.6	40.1	92.5	30.5	17.6	5.8	6.4	6.7	7.2	6.3	6.0	5.3	5.5	5.5	4.6	5.5	7.3	35.4	38.5	23.8	12.1	54.6	79.0	49.1	63.0	38.7	51.3	61.2	54.9	25.9	37.1	49.4	33.1	27.1	66.7	68.7	35.2	37.2	68.6	6.2	44.7	44.7	45.2	81.7	69.4	30.3	53.9	82.6	38.5	47.4	45.7	40.4	27.0	39.3	36.4	44.1	35.3	30.0	55.7	87.5	44.8	42.1	3.8	27.4	42.4	16.0	23.4	41.1	24.4	43.3	20.6	20.9	79.7	39.0	30.1	52.6	52.4	28.4	30.5	40.8	39.0	46.0	37.4	38.0	11.0	23.1	52.8	102.9	156.7	49.8	25.0	42.6	61.8
TDP1	"FLJ11090, SCAN1"	ENSG00000042088	"Tyrosyl-DNA phosphodiesterase 1"	Q9NUW8	14	89954939-90044764	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 123.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071317	Approved		Supported	"Nucleoplasm,Plasma membrane"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Plasma membrane"	"HPA071317: AB_2686388"	"unprognostic (5.60e-3)"	"unprognostic (3.53e-1)"	"unprognostic (7.03e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.45e-2)"	"unprognostic (7.22e-2)"	"prognostic unfavorable (8.99e-5)"	"unprognostic (2.61e-1)"	"unprognostic (1.46e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.26e-1)"	5.5	3.9	4.8	11.8	4.5	13.9	8.9	6.6	4.9	6.6	7.1	7.8	6.5	5.9	5.8	8.2	9.2	6.6	2.6	4.1	5.3	7.0	6.5	4.7	19.0	3.8	3.6	6.4	4.8	5.1	4.6	8.2	3.9	5.0	10.1	4.9	5.5	4.3	2.1	6.4	7.0	6.3	2.8	10.6	7.9	22.3	4.6	28.3	4.9	1.7	23.7	8.1	5.0	4.2	33.8	18.6	40.9	37.5	10.1	14.0	32.7	31.7	25.9	38.4	34.6	13.6	35.5	42.9	23.3	21.7	12.9	33.9	18.2	29.5	55.2	44.1	19.6	43.9	16.7	16.6	8.7	73.2	24.1	10.1	12.9	26.9	24.9	21.9	49.5	57.3	30.6	43.5	45.9	35.0	56.3	39.2	10.0	39.8	43.7	42.3	77.3	34.0	24.6	27.3	30.7	20.9	26.9	77.6	10.1	27.0	31.0	30.8	39.9	16.5	15.7	23.0	28.7	31.8	60.4	52.3	35.5	32.3	24.6	28.7	8.9	15.1	18.8	14.6	18.3	21.1	19.8	20.8	14.2	20.0	21.7	23.1	5.7	23.8	14.1	15.0	32.2	14.8	4.8	4.5	6.6	4.9	4.1	5.3	3.8	3.6	3.9	2.8	4.6	4.2	2.9	0.0	1.1	4.2	15.2	4.7	4.9	7.4	4.0	3.0	6.4	7.1	1.4	1.5	5.0	14.7	8.4	11.4	14.6	3.8	5.9	9.2	123.5	13.2	6.1	3.6	3.6	12.8	13.4	5.6	14.9	4.3	7.7	9.2	2.5	8.9	3.9	4.2	8.8	3.3	13.9	4.9	0.0	6.8	10.2	36.7	2.8	7.8	1.8	1.9	8.0	1.5	8.2	8.0	24.2	6.4	4.8	3.0	16.9	5.7	2.9	7.8	11.0	2.7	0.0	3.4	5.4	33.7	22.8	8.7	4.5	10.1	15.0	10.3	7.9	4.0
TDP2	TTRAP	ENSG00000111802	"Tyrosyl-DNA phosphodiesterase 2"	O95551	6	24649979-24666930	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	"Hydrolase, Nuclease"	"Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 183.2"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 530.9;Paneth cells: 428.1;Proximal enterocytes: 637.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 75.6;neutrophil: 228.9"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 228.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB073398, HPA074011"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	No	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nuclear bodies"		"CAB073398: , HPA074011: AB_2686651"	"unprognostic (2.46e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.66e-3)"	"unprognostic (4.13e-3)"	"unprognostic (3.24e-1)"	"unprognostic (5.78e-3)"	"prognostic favorable (2.53e-7)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.47e-5)"	24.4	23.7	27.4	34.3	28.4	21.8	27.3	30.4	36.4	20.6	30.4	141.6	120.1	19.7	25.3	18.6	22.6	28.6	28.2	28.0	28.9	77.9	51.2	24.5	38.9	28.2	29.5	21.3	29.5	25.7	20.3	20.1	28.7	56.5	127.4	18.9	21.9	21.7	21.9	21.1	183.2	24.6	28.3	27.9	26.2	25.3	32.1	37.5	21.7	26.3	37.7	27.2	16.5	28.3	47.7	37.1	41.5	48.1	63.0	64.0	32.4	41.4	53.1	38.9	51.9	50.8	26.3	57.0	70.1	43.8	90.0	34.2	51.2	47.3	52.9	73.6	53.1	53.4	37.7	84.2	40.1	82.8	49.5	43.1	43.7	40.7	36.5	46.0	63.9	54.1	48.8	23.7	59.2	34.1	64.7	52.8	37.1	54.7	31.8	55.5	43.7	61.6	67.0	66.5	52.2	29.8	33.6	84.5	71.0	42.2	38.9	47.4	48.0	37.6	31.3	28.3	61.4	33.7	107.9	77.1	26.0	107.5	61.3	75.6	13.9	29.4	25.0	14.8	30.8	20.0	28.8	27.9	13.2	14.5	24.0	26.2	228.9	29.0	16.5	12.4	31.9	22.7	27.4	28.4	30.4	36.4	28.0	28.9	28.2	29.5	28.7	28.3	32.1	28.3	24.0	6.4	16.7	23.5	24.1	14.1	25.1	37.0	18.8	12.7	19.8	20.2	23.4	37.1	29.6	22.0	6.2	18.4	23.0	530.9	49.0	35.4	140.6	19.4	16.6	22.5	52.7	20.8	25.9	36.0	23.6	18.3	14.3	19.7	24.1	15.7	27.5	31.4	68.4	6.7	25.8	168.9	30.5	28.9	20.0	80.2	18.0	33.5	12.4	15.0	61.7	19.5	38.1	11.6	21.2	21.4	428.1	23.3	10.7	37.0	637.5	175.8	30.5	15.8	32.9	19.1	20.4	9.0	32.7	10.4	16.6	44.3	28.5	15.7	119.3	31.9
TEFM	"C17orf42, FLJ22729"	ENSG00000172171	"Transcription elongation factor, mitochondrial"	Q96QE5	17	30897336-30906238	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023788, HPA053044"	Approved		Enhanced	Mitochondria		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"HPA023788: AB_1848818, HPA053044: AB_2682023"	"unprognostic (1.22e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.31e-2)"	"unprognostic (7.89e-2)"	"unprognostic (3.75e-1)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (2.11e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.39e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.37e-3)"	4.9	6.0	4.4	5.9	4.6	2.2	6.7	5.7	6.0	4.0	5.5	5.7	5.6	4.9	4.1	5.2	4.8	4.1	8.9	4.6	4.4	9.6	8.8	4.0	7.3	4.5	4.4	4.8	3.3	6.6	3.2	6.8	4.6	5.0	6.6	6.9	5.4	4.8	6.8	5.3	4.6	5.1	4.3	5.7	5.1	4.2	4.6	5.4	5.4	11.7	6.7	5.4	2.9	5.1	12.8	19.2	10.7	14.9	12.7	12.4	10.1	13.1	9.5	23.7	21.4	15.6	7.2	17.4	12.7	8.1	15.5	21.6	18.6	9.1	22.4	5.5	23.9	8.8	15.1	15.5	8.5	18.7	11.2	7.9	11.7	13.4	6.9	7.2	11.9	12.4	19.1	14.3	13.9	11.7	16.0	24.3	8.9	19.6	12.1	10.5	22.9	17.6	19.2	14.4	16.3	7.5	9.8	11.7	15.4	10.9	23.7	14.1	7.8	10.9	14.7	11.2	13.8	7.9	14.0	16.2	7.3	13.8	13.2	2.6	7.7	6.5	6.4	12.2	8.8	9.8	8.2	6.5	8.1	6.3	9.9	9.2	2.3	8.6	9.9	7.0	10.0	7.1	4.4	4.6	5.7	6.0	4.6	4.4	4.5	4.4	4.6	4.3	4.6	5.1	10.1	16.0	10.6	13.7	11.3	4.1	8.0	22.6	9.1	17.8	6.8	6.9	5.8	11.5	13.6	9.2	8.4	26.0	11.5	5.4	25.4	13.4	10.4	12.6	15.3	9.6	5.4	6.9	27.1	8.5	17.3	10.2	5.1	7.8	5.1	17.2	10.4	10.1	20.4	16.8	27.3	7.4	22.4	7.8	3.0	6.3	8.1	9.6	7.2	21.5	14.0	15.0	16.5	27.2	32.2	12.5	5.6	7.5	7.1	5.2	9.4	17.7	17.8	19.4	19.7	11.0	11.6	27.7	17.8	8.7	4.3	17.8	10.0	18.9	7.9	4.7
TENT4B	"PAPD5, TRF4-2, TUT3"	ENSG00000121274	"Terminal nucleotidyltransferase 4B"	Q8NDF8	16	50152911-50235310	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, mRNA processing, rRNA processing"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 82.8;Endometrial ciliated cells: 44.3;Glandular and luminal cells: 31.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA042968, HPA048225"	Uncertain		Supported	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Nucleoli, Plasma membrane"	"HPA042968: AB_2678244, HPA048225: AB_2680319"	"unprognostic (1.05e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.30e-2)"	"prognostic favorable (1.85e-4)"	"unprognostic (4.24e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.00e-2)"	6.1	6.4	2.4	1.7	2.3	7.1	4.6	3.9	2.6	7.3	3.0	6.9	4.6	6.9	2.3	5.4	6.5	2.0	3.7	2.7	3.0	4.2	8.9	5.0	2.3	2.2	2.4	6.8	4.3	3.9	4.8	2.8	2.2	5.3	1.9	1.4	4.7	1.7	5.4	5.5	5.9	2.5	2.2	4.6	5.5	5.7	3.1	1.7	4.7	2.1	1.9	7.2	6.4	2.7	5.5	1.9	0.6	3.3	3.8	2.0	4.3	3.9	2.3	3.5	1.6	3.4	2.3	6.5	5.6	2.7	1.4	3.6	3.9	2.0	3.1	3.8	4.5	3.6	1.6	5.4	3.8	2.4	4.9	1.9	2.6	2.3	3.3	2.3	1.8	2.1	4.2	1.5	4.1	1.5	3.5	4.6	4.2	1.5	4.5	4.9	4.8	6.9	1.7	0.5	4.0	2.2	4.9	2.7	2.3	1.5	1.5	0.9	3.0	2.1	4.1	4.0	1.9	4.9	3.7	6.9	1.7	2.7	2.7	0.0	0.4	0.0	0.4	0.2	0.1	0.3	0.2	0.5	0.2	0.2	0.3	0.5	0.7	0.2	0.2	0.4	0.1	0.1	2.4	2.3	3.9	2.6	2.7	3.0	2.2	2.4	2.2	2.2	3.1	2.7	17.9	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	17.8	16.3	0.0	0.0	0.0	14.7	0.0	18.1	82.8	0.0	3.9	10.9	0.0	44.3	24.4	6.1	0.0	0.0	0.0	14.9	11.5	6.7	0.0	31.5	0.0	13.5	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	3.6	0.0	0.0	0.0	0.0	15.2	0.0	0.0	22.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	18.3	14.9	17.3	0.0	0.0
TERF2	"TRBF2, TRF2"	ENSG00000132604	"Telomeric repeat binding factor 2"	Q15554	16	69355567-69408571	"Predicted intracellular proteins"	"Cell cycle"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001907, HPA002735, CAB010451"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"CAB010451: AB_2201333, HPA001907: AB_1080246, HPA002735: AB_1857898"	"unprognostic (2.61e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.04e-1)"	15.2	14.4	19.8	17.2	20.6	18.5	14.1	22.7	29.1	15.3	9.1	15.5	13.4	17.9	15.1	15.0	15.4	13.7	15.1	21.8	21.0	13.0	14.8	12.6	35.6	17.6	19.9	19.2	16.7	18.3	12.4	16.1	16.8	13.3	14.4	21.0	11.9	14.1	31.9	15.9	14.0	19.1	14.5	15.8	12.6	16.4	18.4	21.0	16.6	22.1	44.7	15.6	13.4	23.3	21.6	34.4	30.5	30.8	28.5	20.9	26.0	21.5	26.9	50.1	38.7	31.7	28.6	98.2	28.6	26.7	17.9	34.0	37.8	26.4	46.7	18.6	29.3	28.8	18.2	29.1	24.2	28.6	23.0	21.5	26.2	40.2	48.7	22.2	35.0	38.4	54.8	14.2	32.8	29.2	57.0	36.4	35.1	23.6	16.7	78.5	20.2	56.8	21.6	15.8	34.4	27.0	71.4	16.1	19.6	27.5	30.6	32.8	21.5	31.3	27.4	21.9	25.9	36.8	42.1	124.9	27.1	25.5	30.8	14.9	3.5	4.3	5.9	3.3	4.3	13.0	5.6	5.0	3.7	8.4	6.3	6.2	4.2	4.6	3.5	5.0	5.0	2.8	19.8	20.6	22.7	29.1	21.8	21.0	17.6	19.9	16.8	14.5	18.4	23.3	16.2	16.0	10.2	15.0	20.9	12.5	12.8	5.0	5.7	25.3	13.4	8.5	17.2	5.7	5.1	9.2	18.8	8.3	13.0	15.5	1.9	5.3	33.4	15.5	20.8	17.9	10.2	8.6	18.3	7.5	7.7	13.5	8.6	20.5	14.0	14.9	14.3	18.2	12.5	45.4	19.9	11.6	2.0	15.4	12.3	19.5	9.3	11.0	3.6	16.9	8.9	19.3	16.5	18.6	26.5	7.9	7.3	14.3	11.2	14.8	9.5	8.4	8.3	13.9	19.7	18.8	12.1	8.8	13.1	9.6	12.9	8.3	12.1	17.0	11.1	12.8
TEX10	"bA208F1.2, FLJ20287, Ipi1"	ENSG00000136891	"Testis expressed 10"	Q9NXF1	9	100302077-100352942	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 53.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045434			Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Mitochondria	"HPA045434: AB_10965650"	"unprognostic (2.88e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.28e-2)"	"unprognostic (5.26e-2)"	"prognostic unfavorable (4.46e-5)"	"unprognostic (2.43e-2)"	"unprognostic (3.74e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.07e-1)"	"unprognostic (7.39e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.66e-3)"	"unprognostic (9.63e-3)"	9.3	7.0	4.0	8.7	4.3	12.2	9.9	7.2	4.8	9.7	5.2	7.4	5.3	11.2	8.2	9.1	10.2	8.6	6.5	4.3	4.4	6.3	6.9	6.4	14.3	3.9	4.1	11.4	5.7	8.1	5.4	18.8	4.1	7.5	6.8	5.5	6.9	7.4	16.0	12.2	6.5	8.8	4.1	7.9	6.5	22.3	4.9	22.3	8.4	11.6	13.6	10.8	8.7	5.5	26.5	28.5	36.6	41.3	13.2	23.1	56.6	32.7	33.7	41.8	38.7	29.5	30.4	74.6	17.2	21.4	38.3	35.2	52.9	42.1	48.6	30.2	23.3	40.6	17.5	25.8	28.2	59.6	29.1	20.3	23.3	42.5	44.6	20.3	23.1	26.0	46.3	23.8	54.5	41.5	44.0	38.1	75.4	51.1	33.9	42.1	62.2	22.8	30.8	17.0	32.3	27.4	17.9	29.3	29.4	22.4	12.2	17.3	23.6	27.5	24.5	37.3	30.9	16.7	30.6	29.9	28.1	26.3	29.4	18.1	7.4	2.6	9.1	8.9	9.7	12.2	9.0	9.1	9.1	12.9	9.7	11.5	1.8	10.7	6.9	5.3	11.4	7.0	4.0	4.3	7.2	4.8	4.3	4.4	3.9	4.1	4.1	4.1	4.9	5.5	8.6	3.2	9.3	10.7	14.7	22.2	10.6	8.4	20.5	7.8	10.8	8.1	15.4	0.0	13.0	9.2	12.5	53.5	9.6	3.8	3.9	7.7	13.9	11.0	15.8	10.9	5.3	11.1	24.1	8.8	15.7	14.7	5.1	21.9	17.1	13.9	5.0	7.9	9.8	8.4	23.3	5.7	2.0	4.1	8.1	11.4	8.7	8.1	17.8	18.7	7.8	3.4	7.2	21.1	23.9	7.5	5.6	7.9	7.1	9.7	3.0	4.5	5.6	6.5	0.0	14.5	14.7	33.0	33.4	12.9	22.6	46.1	10.3	12.0	6.9	9.5
TFAM	"TCF6, TCF6L2"	ENSG00000108064	"Transcription factor A, mitochondrial"	Q00059	10	58385345-58399220	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"Early spermatids: 631.4;Late spermatids: 933.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040648, HPA063684"	Supported		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Mitochondria		"HPA040648: AB_10795635, HPA063684: AB_2685089"	"unprognostic (5.30e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.34e-3)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.10e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.24e-2)"	"prognostic favorable (2.74e-4)"	"unprognostic (1.99e-2)"	"unprognostic (5.39e-2)"	"prognostic favorable (2.22e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.76e-2)"	16.5	20.1	5.7	21.6	6.1	38.1	17.3	10.8	8.4	11.4	6.8	20.0	21.0	13.7	9.5	14.7	12.6	10.7	18.5	5.5	7.3	21.5	22.6	10.9	27.7	5.8	6.1	17.8	13.9	16.2	6.3	20.4	6.5	14.5	17.3	9.8	17.3	11.4	17.7	9.0	17.8	11.6	7.0	17.3	16.1	33.0	6.4	24.9	19.6	16.1	23.0	16.7	7.5	8.8	85.7	47.7	52.8	54.7	15.3	19.4	59.8	37.9	37.3	46.8	51.1	170.0	88.6	170.1	53.9	17.6	34.8	65.2	97.6	53.5	73.4	73.4	85.7	64.1	33.4	64.5	23.3	164.7	49.4	19.2	24.4	57.0	51.6	22.2	41.1	49.9	153.4	74.8	33.2	46.4	130.2	65.1	100.0	39.2	49.9	102.9	113.0	76.0	28.3	57.0	69.8	48.1	75.1	103.7	97.0	42.9	112.8	47.9	32.0	34.4	109.5	39.5	102.5	75.6	125.8	214.2	44.1	125.1	26.4	1.0	9.5	4.0	8.3	9.5	10.8	12.8	10.0	8.8	12.1	12.5	12.4	10.1	7.1	15.0	8.3	14.7	9.0	6.9	5.7	6.1	10.8	8.4	5.5	7.3	5.8	6.1	6.5	7.0	6.4	8.8	46.4	54.5	27.9	6.2	52.5	50.1	44.0	52.4	59.2	25.1	48.6	62.9	35.0	38.6	51.0	20.2	16.7	98.1	56.8	17.1	88.0	41.0	631.4	36.8	44.5	39.5	15.5	46.7	10.1	44.7	77.4	38.8	25.0	41.2	29.7	34.1	26.0	64.1	44.0	38.7	11.5	37.5	18.3	21.9	19.3	933.1	41.3	32.3	23.2	2.8	36.3	38.2	48.4	10.6	11.7	35.2	23.0	30.9	35.8	47.3	14.1	72.0	31.4	21.4	26.3	74.8	40.5	55.3	63.9	48.6	54.7	52.5	38.3	69.1	48.1	31.8
TFAP2D	TFAP2BL1	ENSG00000008197	"Transcription factor AP-2 delta"	Q7Z6R9	6	50713526-50773033	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	18	"brain: 6.3"	"Cell type enhanced"	"Detected in single"		"Horizontal cells: 1.7"	"Cancer enriched"	"Detected in single"	10	"lung cancer: 0.5"	"Region enriched"	"Detected in some"	5	"midbrain: 6.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HAP1: 1.0"	"Region enriched"	"Detected in many"	4	"midbrain: 11.8"	"Region enriched"	"Detected in some"	6	"midbrain: 9.4"	HPA048962			Uncertain	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA048962: AB_2680573"																		0.0	0.0	0.6	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.1	0.0	0.3	0.2	0.0	0.0	6.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TFB2M	"FLJ22661, FLJ23182, Hkp1"	ENSG00000162851	"Transcription factor B2, mitochondrial"	Q9H5Q4	1	246540561-246566261	"Metabolic proteins, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028482, HPA028554, HPA030265"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA028482: AB_2672633, HPA028554: AB_2732441, HPA030265: AB_10696209"	"unprognostic (4.38e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.79e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.13e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.81e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.44e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.53e-2)"	11.6	23.5	3.6	9.4	3.7	24.2	12.1	6.2	5.0	8.5	6.3	12.6	11.4	7.2	9.5	10.9	8.6	7.1	14.0	3.4	3.9	21.2	37.8	6.3	13.3	3.4	3.5	6.9	15.6	10.8	6.3	9.1	3.5	8.8	12.9	5.0	11.3	7.5	22.7	9.3	9.1	8.0	3.8	7.0	10.1	8.7	3.9	9.3	13.6	24.3	13.2	13.3	6.1	4.1	33.9	31.9	12.1	21.5	14.8	21.1	42.2	24.2	24.8	26.9	24.6	39.0	31.6	59.8	36.9	24.7	17.4	28.5	29.3	25.7	36.8	23.4	11.3	30.3	18.1	34.5	24.2	54.1	26.3	21.0	30.2	23.1	25.8	14.8	21.2	20.9	89.2	19.8	23.4	15.7	27.5	24.1	53.8	58.6	32.1	27.2	23.9	72.9	24.5	36.7	26.7	53.8	23.4	41.9	82.2	13.3	30.6	51.3	15.6	18.7	22.7	26.6	63.8	57.1	102.9	47.6	23.0	52.6	23.9	0.3	5.4	1.5	9.1	5.7	11.5	11.9	8.0	9.7	12.9	12.0	10.3	8.9	1.2	14.8	9.8	11.1	12.3	5.3	3.6	3.7	6.2	5.0	3.4	3.9	3.4	3.5	3.5	3.8	3.9	4.1	11.9	6.4	9.4	4.2	17.2	53.3	13.7	27.9	31.9	3.2	12.4	11.9	16.5	14.3	18.4	16.5	10.4	24.4	13.1	7.6	29.4	13.8	1.5	17.6	12.9	13.2	11.4	8.6	8.1	15.5	28.1	10.2	18.8	22.4	14.0	7.5	5.7	33.9	11.9	0.0	7.2	14.3	6.1	9.3	7.7	3.4	6.5	7.3	5.4	1.9	6.9	6.6	7.2	6.0	5.5	11.0	10.3	4.5	12.7	17.2	7.8	39.2	15.4	3.4	13.1	14.4	12.2	13.2	21.6	21.3	44.9	21.1	10.9	17.7	19.8	10.4
TGFBRAP1	"TRAP-1, TRAP1, VPS3"	ENSG00000135966	"Transforming growth factor beta receptor associated protein 1"	Q8WUH2	2	105264391-105329735	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037672, HPA038397"	Approved		Approved	Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"HPA037672: AB_2675597, HPA038397: AB_10669782"	"unprognostic (1.66e-1)"	"unprognostic (1.58e-2)"	"unprognostic (8.99e-2)"	"unprognostic (4.49e-3)"	"unprognostic (3.02e-2)"	"unprognostic (6.77e-2)"	"unprognostic (5.63e-3)"	"unprognostic (9.15e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.62e-2)"	9.6	8.1	6.5	8.0	6.3	22.7	8.1	6.1	7.2	6.6	7.7	8.1	7.2	7.8	5.4	8.3	7.0	5.9	6.6	6.8	5.4	6.7	5.0	7.4	9.4	5.8	6.4	7.6	9.9	11.4	5.1	10.4	5.9	8.3	8.2	6.2	8.3	9.3	11.8	11.1	8.0	8.9	5.6	8.5	13.5	2.5	6.5	9.1	10.9	7.7	8.3	7.8	6.6	7.2	22.5	17.5	12.5	15.5	13.3	10.5	25.4	16.0	21.8	26.6	25.3	25.9	13.6	22.7	16.9	18.2	27.1	13.5	22.4	38.1	21.9	24.3	23.8	30.7	13.8	20.7	12.1	28.6	22.4	12.7	22.5	22.2	19.6	14.1	28.7	19.5	28.0	10.9	32.6	14.9	20.4	18.3	15.9	15.4	14.5	22.9	19.8	33.0	16.4	27.3	24.7	16.5	13.2	26.1	25.8	9.0	13.1	17.5	20.8	16.7	25.4	14.1	16.4	11.3	14.8	24.7	11.9	19.6	35.3	0.4	0.8	1.1	1.8	0.7	1.5	0.6	1.2	1.0	0.6	1.0	0.7	1.1	0.3	0.9	0.5	1.0	0.9	0.7	6.5	6.3	6.1	7.2	6.8	5.4	5.8	6.4	5.9	5.6	6.5	7.2	13.7	6.4	9.5	10.4	8.1	8.0	3.5	5.6	9.1	12.4	8.8	9.3	5.9	5.7	7.1	5.5	16.7	12.4	8.9	7.5	1.9	5.4	0.1	5.2	7.0	10.6	11.3	11.3	17.0	10.8	4.8	8.5	9.7	8.3	2.5	10.8	13.9	6.7	12.9	15.2	14.8	8.2	8.2	13.8	4.4	0.5	7.5	9.9	3.6	17.8	9.5	9.0	11.3	8.5	13.5	8.3	5.2	8.2	7.6	7.7	5.8	7.3	2.7	7.2	26.3	15.8	8.1	0.4	1.2	11.5	13.1	7.4	8.8	11.1	9.2	3.1
TGS1	"NCOA6IP, PIMT"	ENSG00000137574	"Trimethylguanosine synthase 1"	Q96RS0	8	55773446-55826445	"Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025024, HPA029824"	Supported		Supported	Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA025024: AB_1854330, HPA029824: AB_2673212"	"unprognostic (4.13e-2)"	"unprognostic (7.46e-2)"	"unprognostic (6.64e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (2.11e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.94e-2)"	"unprognostic (9.32e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.62e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.85e-2)"	5.9	4.0	1.8	5.0	1.4	7.2	5.5	3.8	2.3	5.0	2.5	4.9	3.1	5.9	4.1	5.7	5.8	4.1	3.5	1.5	1.5	5.5	4.0	4.5	8.5	1.2	1.3	6.0	4.0	6.8	4.0	4.2	1.3	4.5	4.6	2.5	4.9	5.7	7.4	6.4	5.5	4.6	1.1	5.7	4.5	4.9	1.6	9.5	5.4	2.6	8.5	7.3	5.1	1.9	12.0	9.0	10.2	12.7	9.7	8.2	10.3	10.9	11.6	11.9	12.3	8.5	10.7	27.7	7.0	8.5	8.5	10.8	24.3	14.7	16.3	17.2	8.7	31.6	10.6	5.1	13.1	16.8	9.4	9.7	10.1	11.4	22.7	5.2	9.5	16.0	24.8	9.9	9.6	9.4	36.0	10.6	35.0	16.8	3.6	26.4	7.1	8.2	10.6	12.0	10.6	13.3	19.4	8.0	10.4	10.5	10.9	9.7	9.7	8.4	10.6	9.8	10.4	8.5	6.3	32.1	8.5	13.6	11.3	5.0	2.7	4.3	5.1	2.8	6.0	4.6	4.8	4.7	2.4	4.8	5.2	5.2	3.4	3.3	3.9	5.2	4.2	2.6	1.8	1.4	3.8	2.3	1.5	1.5	1.2	1.3	1.3	1.1	1.6	1.9	29.8	48.1	35.2	15.7	41.6	37.0	36.8	25.7	35.3	30.6	21.8	34.7	15.5	20.0	37.9	51.5	22.9	29.6	30.4	10.8	3.9	20.3	3.7	28.2	42.6	27.2	10.7	49.2	28.9	25.2	26.7	32.4	23.4	27.6	50.0	24.3	20.7	17.2	20.3	21.9	30.0	23.3	16.2	16.8	12.2	4.6	29.5	22.2	7.2	12.2	26.1	27.7	29.9	34.7	19.9	22.2	12.1	23.0	32.7	42.3	10.9	17.7	25.5	29.5	26.3	40.5	25.7	88.2	78.3	33.5	26.1	22.4	41.2	35.2	22.5	31.9
THAP11	"CTG-B43a, CTG-B45d, HRIHFB2206, RONIN"	ENSG00000168286	"THAP domain containing 11"	Q96EK4	16	67842320-67844195	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041434, HPA042189, HPA072537"	Supported		Supported	Nucleoplasm,Cytosol		NA	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	Cytosol	"HPA041434: AB_10960385, HPA042189: AB_10964636, HPA072537: "	"unprognostic (1.43e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.93e-3)"	"unprognostic (1.40e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.59e-2)"	"unprognostic (5.87e-2)"	16.6	14.4	20.5	14.9	21.1	10.2	16.3	21.4	21.3	21.9	19.2	26.7	12.3	24.5	13.0	19.5	22.4	10.1	25.1	20.7	21.7	16.1	14.9	15.4	20.8	22.1	20.8	20.9	19.3	16.9	16.4	12.3	20.6	16.1	11.1	10.9	15.7	19.6	48.1	26.1	22.1	17.2	22.5	24.8	20.8	12.6	21.1	23.5	14.9	26.4	19.0	23.9	18.4	23.1	31.3	40.2	27.4	25.9	37.5	25.7	28.7	15.5	27.0	37.1	31.9	51.9	23.6	68.0	31.7	15.9	22.3	35.6	48.6	29.0	21.1	25.4	55.3	27.1	22.5	64.1	34.2	34.9	29.4	23.6	28.4	25.6	22.4	26.8	27.7	45.9	39.5	15.4	22.9	49.1	37.7	62.6	55.1	36.9	34.7	73.6	32.7	61.4	19.0	20.2	38.2	43.1	45.4	16.4	33.2	19.6	40.1	35.2	22.3	23.4	28.4	21.3	19.2	60.9	65.9	67.5	18.3	38.2	25.8	7.6	13.6	14.7	26.3	18.4	20.7	13.8	23.6	24.2	14.3	18.8	29.9	24.0	4.1	21.3	17.5	11.3	31.5	17.9	20.5	21.1	21.4	21.3	20.7	21.7	22.1	20.8	20.6	22.5	21.1	23.1	20.4	22.4	13.1	3.3	24.4	29.2	25.0	6.6	22.8	25.6	27.4	23.6	15.1	12.8	5.3	11.0	4.2	19.6	32.8	12.5	52.8	7.6	1.2	18.6	18.0	21.3	13.2	23.8	4.6	9.5	25.9	17.4	7.1	14.3	7.6	20.3	24.3	14.0	22.4	8.4	4.6	16.2	6.1	19.6	20.0	2.2	23.6	19.1	10.6	4.7	24.5	29.8	43.3	7.1	6.1	6.5	5.9	31.2	18.9	25.0	13.5	19.8	6.1	16.9	19.7	24.2	22.2	16.1	27.4	20.9	39.1	13.5	32.5	28.6	16.5	20.2
THAP4	"CGI-36, Nb(III)"	ENSG00000176946	"THAP domain containing 4"	Q8WY91	2	241584405-241637158	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"		"DNA-binding, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 223.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044982, HPA053448"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nuclear speckles"		"HPA044982: AB_10959786, HPA053448: AB_2682154"	"unprognostic (3.17e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.16e-3)"	"unprognostic (3.61e-2)"	"unprognostic (7.56e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (1.46e-4)"	"unprognostic (2.57e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.06e-1)"	"unprognostic (1.07e-1)"	34.3	31.8	60.3	19.0	60.4	28.1	35.6	57.7	78.5	34.5	60.2	51.1	42.1	30.9	28.7	53.1	29.0	25.0	106.5	58.9	60.7	96.7	54.0	29.3	22.0	60.0	61.4	33.2	48.4	107.0	37.7	16.1	60.3	43.7	27.1	9.0	42.1	24.1	118.8	46.8	34.9	17.3	56.3	26.5	52.0	40.8	62.7	23.4	31.9	91.6	19.0	41.5	38.9	59.8	47.6	53.4	31.5	58.9	41.5	43.1	53.7	32.1	42.5	46.6	41.4	48.6	41.1	40.5	16.4	50.1	53.8	53.4	63.8	71.4	17.6	33.3	76.9	42.5	35.7	138.7	55.0	48.6	28.5	44.8	55.4	50.2	69.2	32.5	43.9	62.4	76.9	13.1	36.4	84.5	51.1	110.1	57.1	43.9	45.2	55.9	44.1	52.6	100.2	57.0	76.4	50.1	24.7	76.9	65.1	19.4	38.7	52.3	40.0	55.5	36.6	50.7	58.3	32.4	19.9	42.6	40.2	40.4	40.9	31.0	15.7	40.3	27.4	18.0	29.4	21.6	30.3	25.5	16.4	25.0	28.6	23.3	10.2	22.7	24.1	23.2	53.6	16.1	60.3	60.4	57.7	78.5	58.9	60.7	60.0	61.4	60.3	56.3	62.7	59.8	16.6	19.2	21.7	15.7	16.4	20.0	42.1	31.9	21.1	9.9	21.2	17.1	55.9	35.8	28.3	40.5	4.2	23.4	13.2	64.6	223.0	48.0	17.7	37.5	19.6	17.7	28.8	21.5	12.2	27.8	24.6	19.9	35.2	58.9	7.0	16.6	13.6	38.0	17.7	8.4	12.8	52.3	32.6	11.4	10.6	7.7	18.0	14.2	12.4	7.5	15.3	11.1	22.6	11.1	11.5	27.6	44.2	19.5	21.3	38.1	79.0	90.0	21.3	6.8	32.9	16.3	23.3	25.3	29.1	40.0	25.9	27.5	15.1	17.5	60.2	53.4
THAP5	DKFZp313O1132	ENSG00000177683	"THAP domain containing 5"	Q7Z6K1	7	108554543-108569750	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	9	"Early spermatids: 398.3;Late spermatids: 537.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA043170, HPA051488"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA043170: AB_10964500, HPA051488: AB_2681504"	"unprognostic (2.53e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.33e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.20e-1)"	"prognostic favorable (8.99e-4)"	"unprognostic (6.00e-2)"	"unprognostic (3.39e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.79e-2)"	8.9	13.2	9.8	11.3	11.2	4.7	12.8	13.1	14.3	12.1	9.2	9.2	9.8	12.8	12.6	7.7	9.9	7.8	13.8	9.4	10.8	15.9	19.7	10.3	14.6	11.2	10.4	17.4	9.9	18.0	10.6	10.0	10.5	13.1	8.2	17.8	9.9	11.4	13.0	8.3	9.8	8.6	10.8	12.7	10.2	26.7	10.8	13.1	22.3	15.3	13.3	7.8	5.9	14.9	19.4	14.8	18.6	42.3	11.8	16.7	9.7	17.5	19.8	19.0	20.1	7.5	15.9	23.4	31.0	12.1	24.8	8.0	19.3	13.8	24.5	30.5	15.2	17.6	14.4	7.1	25.1	31.7	22.4	10.4	26.1	11.6	27.4	20.2	11.8	26.3	27.9	49.3	19.4	19.5	48.6	13.7	21.9	11.5	14.4	15.0	26.6	54.8	11.6	11.2	21.8	38.2	25.0	29.2	35.1	14.5	12.2	11.9	11.8	35.7	19.7	28.3	21.8	57.0	52.6	43.0	19.8	19.1	33.0	19.2	8.0	15.0	11.7	10.6	15.2	17.8	13.2	11.1	8.0	19.5	17.2	14.6	25.7	11.2	15.5	12.7	11.9	8.3	9.8	11.2	13.1	14.3	9.4	10.8	11.2	10.4	10.5	10.8	10.8	14.9	30.6	16.0	20.9	9.4	31.0	12.2	12.0	9.0	9.1	40.9	23.6	20.4	30.1	32.9	12.6	25.8	8.4	13.2	26.6	14.7	46.9	15.5	398.3	14.9	18.9	20.7	15.7	39.5	12.9	16.9	9.3	21.3	7.7	12.1	32.2	18.6	21.8	26.5	9.6	47.1	15.1	16.3	12.2	15.2	19.8	537.3	28.3	15.0	35.6	6.5	16.1	49.5	15.5	12.5	21.6	13.6	15.6	28.2	20.8	14.9	16.6	32.8	23.7	40.7	26.3	24.4	21.8	44.6	25.9	8.4	18.0	14.4	22.5	18.0	12.4	8.1
THG1L	"FLJ11601, FLJ20546, hTHG1, ICF45, IHG-1"	ENSG00000113272	"TRNA-histidine guanylyltransferase 1 like"	Q9NWX6	5	157731420-157741449	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Nucleotidyltransferase, Transferase"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035877, HPA035878"	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"			"HPA035877: AB_10669979, HPA035878: AB_10672993"	"unprognostic (4.30e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.37e-2)"	"unprognostic (5.74e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.05e-1)"	"prognostic unfavorable (3.93e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.69e-1)"	3.8	4.9	2.3	4.0	2.5	5.9	5.3	2.7	2.7	5.2	2.2	6.9	5.5	6.8	5.9	5.0	6.4	4.7	3.4	2.2	2.7	3.5	5.1	3.0	5.4	2.6	2.4	7.6	4.7	3.1	3.2	4.3	2.6	4.0	7.7	3.4	3.1	5.3	3.9	5.4	4.9	5.7	2.1	4.1	5.4	4.9	2.6	5.3	6.7	2.8	6.0	6.4	4.6	3.0	8.8	15.4	7.2	13.8	6.7	19.6	5.5	6.8	12.6	13.7	18.1	21.4	8.7	21.8	5.7	6.0	8.3	9.1	9.0	13.1	15.2	8.9	12.0	7.7	10.2	9.1	7.6	16.6	8.0	17.8	15.4	12.1	16.6	13.0	5.1	3.4	13.8	6.9	8.2	12.1	2.0	11.3	6.9	3.9	14.8	3.3	13.8	12.6	8.5	11.0	9.1	12.8	5.5	8.2	11.3	5.2	13.9	9.5	5.8	10.9	7.2	9.2	18.5	6.0	7.1	14.0	4.8	15.9	6.9	3.9	7.8	0.1	3.3	8.7	3.9	5.7	4.3	3.4	7.0	4.6	6.3	5.3	0.7	6.7	8.7	4.5	5.0	3.9	2.3	2.5	2.7	2.7	2.2	2.7	2.6	2.4	2.6	2.1	2.6	3.0	6.0	3.2	8.6	1.3	14.7	20.6	27.7	27.1	27.9	2.6	14.2	15.4	6.2	11.5	11.5	3.7	4.2	17.6	10.2	6.9	9.8	17.1	19.2	8.8	20.8	9.0	7.2	23.5	1.8	26.4	12.8	15.4	12.2	7.2	2.5	17.3	6.8	8.6	19.1	0.0	1.4	14.3	8.2	15.7	17.9	8.6	14.3	16.2	5.4	1.9	21.2	2.0	7.2	0.5	1.9	12.1	19.6	15.4	13.7	21.2	9.7	14.7	5.8	4.6	6.6	17.1	12.4	19.8	8.9	24.0	15.3	13.8	11.2	38.0	24.1	28.4
THOC1	"HPR1, P84"	ENSG00000079134	"THO complex 1"	Q96FV9	18	214520-268050	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019096, HPA019687"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nuclear speckles"		"HPA019096: AB_1857979, HPA019687: AB_1857980"	"prognostic favorable (8.43e-4)"	"unprognostic (2.06e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.83e-5)"	"unprognostic (6.74e-3)"	"unprognostic (2.49e-3)"	"prognostic favorable (2.89e-5)"	"unprognostic (3.60e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (1.80e-6)"	"unprognostic (2.03e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.42e-1)"	"prognostic favorable (9.62e-4)"	6.0	5.2	8.7	8.1	9.7	7.5	5.8	10.0	12.2	5.5	9.8	6.6	6.3	4.7	4.5	6.5	4.1	4.6	4.6	8.8	8.8	7.5	9.9	4.6	12.3	9.4	9.0	4.7	3.9	6.7	3.7	6.4	9.9	5.1	5.5	5.8	6.9	4.1	6.2	6.3	5.9	5.7	8.8	6.3	5.3	16.8	9.5	12.8	4.7	6.2	11.6	9.5	3.8	10.7	27.0	15.8	32.4	26.1	20.8	15.4	40.2	15.4	14.5	29.8	31.1	30.8	16.1	37.2	11.9	20.0	46.0	17.1	43.0	24.4	36.9	12.3	19.1	22.2	18.4	21.0	16.0	50.5	20.2	10.6	14.4	33.3	21.8	13.6	33.3	34.5	52.3	17.4	27.3	20.5	38.1	29.6	31.5	34.2	21.1	53.3	30.3	33.4	17.2	26.1	21.2	16.6	39.0	19.9	25.3	36.7	14.0	37.1	16.6	26.6	29.9	21.8	48.3	15.9	26.4	54.7	22.2	36.0	22.8	13.4	7.3	6.4	9.8	10.7	14.8	13.3	11.7	12.4	11.9	11.5	13.5	13.4	0.7	11.2	9.4	7.2	12.8	6.6	8.7	9.7	10.0	12.2	8.8	8.8	9.4	9.0	9.9	8.8	9.5	10.7	20.4	19.2	11.7	48.3	21.0	12.9	15.6	16.8	23.9	30.8	13.1	14.1	9.6	2.8	17.9	11.0	20.9	24.7	23.2	6.0	15.6	16.5	67.1	15.0	23.6	16.7	9.5	21.0	45.3	8.2	16.7	19.9	9.2	21.9	27.3	32.4	8.2	10.3	16.1	28.6	51.6	8.7	10.2	6.9	11.1	11.6	19.3	15.0	3.6	32.8	14.3	12.9	10.3	41.7	74.6	12.7	7.0	17.0	15.6	16.7	9.2	10.2	10.5	27.6	6.6	21.6	22.9	73.4	30.5	13.8	9.1	18.7	22.3	17.7	13.4	12.9
THOC6	"fSAP35, MGC2655, WDR58"	ENSG00000131652	"THO complex 6"	Q86W42	16	3024027-3027755	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing, mRNA transport, Transport"	"Developmental protein, RNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 107.8;Extravillous trophoblasts: 121.1;Prostatic glandular cells: 109.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052953	Uncertain		Supported	"Nucleoplasm,Nuclear speckles"		No	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Nuclear speckles"		"HPA052953: AB_2681997"	"unprognostic (2.07e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.91e-1)"	"unprognostic (7.82e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (4.40e-4)"	"unprognostic (3.59e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.17e-2)"	"unprognostic (9.43e-2)"	17.0	16.9	8.6	16.1	9.1	23.5	15.3	9.6	11.2	16.1	9.7	17.9	18.8	20.3	6.0	19.3	13.9	10.5	15.8	8.6	9.2	22.2	21.3	17.5	20.8	11.6	9.1	11.6	12.9	10.8	17.4	18.2	11.8	21.1	10.1	2.1	15.2	12.2	25.9	24.9	19.2	12.5	9.2	22.7	15.6	10.4	10.2	19.6	15.7	8.4	16.1	17.1	16.5	9.5	37.3	59.6	42.0	45.0	21.1	23.9	74.4	11.3	25.7	25.7	37.8	39.6	42.8	70.0	36.0	18.9	19.1	49.9	46.3	35.6	14.0	62.3	59.9	38.0	58.6	58.7	35.9	56.2	80.0	24.3	42.6	31.4	76.9	32.4	24.1	39.7	56.1	36.5	12.8	87.0	32.0	103.3	76.2	21.4	25.3	84.7	31.6	82.4	27.1	18.6	86.4	41.0	31.8	49.9	21.7	18.1	35.9	60.0	20.1	26.8	61.1	30.6	41.3	26.3	24.3	85.5	7.0	38.1	27.3	2.4	61.3	13.6	35.2	62.2	36.2	37.8	32.6	34.7	88.6	43.2	37.1	39.1	4.4	38.8	35.7	74.3	38.0	45.4	8.6	9.1	9.6	11.2	8.6	9.2	11.6	9.1	11.8	9.2	10.2	9.5	11.0	19.2	7.4	1.6	24.7	68.2	84.9	59.0	30.7	3.7	22.1	20.8	3.3	14.3	18.9	18.4	2.1	107.8	23.3	23.2	35.2	33.1	5.4	17.9	19.0	17.9	25.8	30.3	1.9	23.5	121.1	24.6	15.3	25.8	12.0	15.6	6.4	10.3	51.8	3.3	1.7	32.3	44.7	19.4	37.3	3.2	14.9	23.4	24.9	2.8	39.6	3.2	15.5	0.5	4.2	21.5	28.0	12.0	19.7	109.4	32.1	32.0	8.7	2.4	6.6	23.4	31.9	5.3	23.3	23.3	44.9	77.2	20.4	20.9	42.2	46.8
THRAP3	"BCLAF2, TRAP150"	ENSG00000054118	"Thyroid hormone receptor associated protein 3"	Q9Y2W1	1	36224432-36305357	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA012041, CAB017472, HPA063765"	Supported		Enhanced	"Nuclear speckles"		NA	NA		59000	"Cluster 6: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"CAB017472: AB_2271759, HPA012041: AB_1857983, HPA063765: AB_2685117"	"unprognostic (8.53e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.29e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.67e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.08e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.34e-2)"	"prognostic favorable (5.36e-4)"	"unprognostic (7.56e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.23e-1)"	41.9	40.6	24.0	45.9	24.7	44.6	43.7	28.5	26.3	36.6	31.2	40.2	33.9	39.5	34.9	40.6	39.3	29.6	47.2	24.3	26.2	32.3	45.8	37.4	57.1	25.6	24.6	45.3	35.6	52.0	30.0	40.1	26.7	50.4	38.7	40.9	38.8	31.3	115.3	38.2	35.1	42.1	24.1	48.0	37.8	34.3	25.0	63.1	46.0	64.0	60.8	37.1	36.2	28.1	100.7	63.9	110.1	94.9	88.0	69.7	90.9	104.6	107.4	107.2	109.8	74.7	91.5	187.5	38.5	113.8	73.8	89.1	125.2	106.9	131.3	97.4	70.1	157.7	94.3	85.6	94.6	157.2	102.5	105.7	65.7	107.1	86.7	75.2	118.4	107.5	127.8	93.5	77.6	57.8	180.4	92.7	130.5	64.2	50.4	163.6	133.4	99.4	77.0	125.4	69.6	83.9	117.5	77.0	92.7	108.7	73.1	69.3	122.4	89.2	100.4	82.5	111.6	56.7	80.7	162.4	82.2	109.2	92.7	85.8	36.9	64.7	51.5	43.9	46.0	53.6	43.9	46.5	42.4	61.0	46.4	43.1	80.8	51.2	48.6	46.7	40.7	47.3	24.0	24.7	28.5	26.3	24.3	26.2	25.6	24.6	26.7	24.1	25.0	28.1	101.0	115.4	101.7	32.3	136.1	56.7	94.5	126.9	78.0	98.0	76.4	65.5	113.7	75.8	106.2	47.8	31.3	150.7	151.9	64.3	97.8	155.7	9.7	92.1	114.7	96.2	72.4	114.9	65.6	104.1	147.2	98.3	58.6	106.0	92.9	120.5	80.7	78.8	101.6	87.5	63.2	70.1	89.5	77.1	71.7	12.0	80.2	89.9	72.9	53.4	155.5	129.4	196.7	47.7	53.4	111.5	61.9	83.5	119.7	125.2	51.6	76.0	87.6	93.2	92.1	114.6	116.5	145.9	118.4	89.6	68.5	144.1	129.0	141.0	87.1	86.4
TICRR	"C15orf42, FLJ41618, MGC45866, SLD3, Treslin"	ENSG00000140534	"TOPBP1 interacting checkpoint and replication regulator"	Q7Z2Z1	15	89575469-89631056	"Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 3.4;esophagus: 4.2;lymphoid tissue: 4.2"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 6.5;Extravillous trophoblasts: 6.0;Granulosa cells: 5.1;Spermatocytes: 5.4;Spermatogonia: 5.3;Squamous epithelial cells: 8.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046746, HPA049454"			Supported	Nucleoplasm		NA	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA046746: AB_2732533, HPA049454: AB_2680773"	"unprognostic (3.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (4.44e-4)"	"unprognostic (3.41e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.22e-5)"	"unprognostic (7.73e-3)"	"prognostic unfavorable (2.87e-6)"	"unprognostic (1.64e-1)"	"unprognostic (1.31e-4)"	"unprognostic (5.87e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.54e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.59e-2)"	0.3	0.1	0.1	1.0	0.1	3.4	0.3	0.0	0.0	0.5	0.0	0.8	1.0	0.4	0.0	4.2	0.3	0.1	0.1	0.0	0.0	0.1	0.1	0.2	1.4	0.1	0.0	0.3	0.0	0.0	0.1	0.9	0.0	0.2	1.1	0.1	0.5	0.0	0.0	0.5	0.9	0.2	0.1	0.5	0.4	1.5	0.2	4.2	0.1	0.0	1.8	0.3	1.1	0.0	11.0	15.0	19.0	11.0	0.7	1.5	10.7	8.0	3.7	11.0	11.4	16.4	8.4	14.7	4.2	2.6	9.2	21.5	26.3	7.0	10.0	7.4	25.4	21.9	15.5	8.7	0.1	15.8	7.6	0.4	0.5	9.0	6.6	1.6	5.5	12.8	21.3	16.6	6.4	10.4	13.9	13.3	12.7	11.0	7.6	19.6	17.1	11.8	2.6	15.5	8.1	8.0	19.0	10.6	3.1	13.9	7.9	10.5	3.3	11.9	14.8	24.4	16.5	3.9	8.0	12.3	4.1	13.2	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.2	1.2	0.0	0.3	0.8	1.4	0.0	0.0	0.0	0.0	2.0	0.0	1.4	0.0	0.0	1.7	0.1	0.3	0.3	0.0	6.5	0.4	0.0	6.0	0.5	2.0	0.3	0.0	5.1	0.0	0.0	1.3	0.0	0.6	1.6	0.0	0.0	0.7	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.2	0.1	0.0	2.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.5	5.4	5.3	8.6	0.1	1.0	0.1	0.1	1.6	0.1
TIMELESS	"hTIM, TIM, TIM1"	ENSG00000111602	"Timeless circadian regulator"	Q9UNS1	12	56416363-56449426	"Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 57.5;Spermatogonia: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA060655	Enhanced		Supported	Nucleoplasm		No	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA060655: AB_2684338"	"unprognostic (3.94e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.06e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (7.03e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (2.61e-5)"	"unprognostic (9.47e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.92e-2)"	"unprognostic (5.01e-2)"	3.4	3.4	1.6	11.0	2.1	22.0	4.5	2.1	2.1	4.1	2.7	6.7	6.0	4.4	2.5	6.8	3.1	3.3	1.8	1.5	2.1	3.8	9.8	4.1	15.3	2.4	2.4	1.9	5.0	5.9	5.4	8.7	2.5	3.2	8.5	13.7	3.9	3.4	3.4	5.5	6.2	5.6	2.1	6.8	5.5	6.2	2.6	19.8	4.7	1.6	17.9	4.7	3.9	2.5	39.4	89.1	111.4	51.9	9.9	9.9	62.8	41.9	25.3	58.3	46.0	45.6	56.5	113.3	41.5	24.5	29.4	32.8	82.0	32.7	53.5	54.2	45.7	86.9	47.6	33.6	5.1	66.2	62.2	6.9	10.3	41.9	25.2	16.0	31.5	67.3	82.7	99.5	49.8	77.2	94.7	51.2	79.2	49.5	36.8	93.5	56.7	55.5	22.7	49.5	85.4	58.9	78.2	43.9	12.2	45.6	77.4	51.8	18.9	45.3	45.1	41.8	35.0	37.3	50.9	62.8	21.1	39.9	55.5	0.1	0.6	0.4	1.8	1.5	0.3	3.3	1.1	1.2	1.0	4.9	0.8	0.3	0.2	1.5	1.1	1.2	1.5	1.1	1.6	2.1	2.1	2.1	1.5	2.1	2.4	2.4	2.5	2.1	2.6	2.5	2.6	0.0	5.0	2.3	8.2	3.3	3.0	3.0	6.8	57.5	3.1	3.4	2.1	2.8	6.8	7.3	2.1	15.9	1.8	2.7	0.0	4.8	6.9	2.5	3.9	5.0	1.8	16.6	0.9	5.7	20.9	3.7	6.6	4.8	5.7	15.5	4.6	10.6	8.5	6.7	1.3	5.2	4.1	2.6	3.7	2.9	1.2	4.6	0.0	1.9	4.2	4.8	4.1	0.5	3.2	3.7	0.6	1.2	18.2	4.2	1.1	2.0	3.4	17.8	0.0	2.7	7.0	1.6	24.5	12.1	1.4	9.2	6.1	3.2	8.5	3.0
TIMM10B	"FXC1, TIM10B, Tim9b"	ENSG00000132286	"Translocase of inner mitochondrial membrane 10B"	Q9Y5J6	11	6481501-6484681	"Predicted intracellular proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA052265	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA052265: AB_2681778"	"unprognostic (1.70e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.15e-3)"	"unprognostic (1.10e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.65e-1)"	"prognostic favorable (3.19e-10)"	"unprognostic (9.92e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.61e-1)"	"unprognostic (2.42e-1)"	16.5	24.0	12.1	14.2	13.3	16.9	18.1	14.4	16.8	18.5	11.4	22.6	17.0	21.6	21.9	17.0	19.4	14.8	16.1	11.5	15.6	27.5	20.3	17.7	17.2	18.7	18.2	21.6	24.5	28.9	19.2	17.3	18.4	21.9	18.6	18.2	18.2	20.1	12.4	15.5	17.6	18.8	13.3	18.4	22.7	12.9	14.6	13.9	26.6	11.3	16.8	20.6	15.8	16.9	21.7	11.8	25.6	24.4	30.6	31.1	17.8	21.2	29.4	26.3	30.1	21.7	43.5	21.8	14.8	24.7	32.7	28.5	23.8	32.3	25.4	22.0	23.3	28.6	23.8	25.0	34.3	39.6	31.1	30.9	36.0	16.8	26.4	16.9	19.7	29.1	51.5	40.2	25.3	17.2	38.7	20.9	39.5	33.8	21.1	28.8	17.2	21.4	32.8	30.4	27.2	29.5	25.0	36.1	35.9	16.7	23.1	28.4	20.7	28.4	20.2	22.9	14.8	36.3	39.9	33.3	27.4	29.2	31.0	17.2	28.9	25.8	36.5	29.8	38.5	36.0	32.6	34.8	26.7	37.9	45.2	39.6	6.5	36.0	25.2	32.9	28.6	39.6	12.1	13.3	14.4	16.8	11.5	15.6	18.7	18.2	18.4	13.3	14.6	16.9	18.7	19.2	24.1	3.9	28.5	29.1	44.8	32.2	19.4	26.2	24.1	19.3	21.0	0.0	28.2	18.4	25.0	29.5	28.0	23.3	58.7	24.4	19.8	17.1	17.7	16.9	31.0	12.6	8.6	29.7	29.5	22.6	10.2	20.6	31.1	21.1	0.0	0.0	29.3	11.8	9.9	34.5	30.5	0.0	18.9	10.9	18.3	19.1	23.2	5.6	28.7	21.8	44.3	7.5	11.7	29.3	26.9	21.1	21.6	41.7	25.0	34.0	35.8	31.2	26.3	14.9	24.1	49.0	35.2	24.0	31.1	40.2	22.5	33.3	27.2	63.7
TIMM17A	"TIM17, TIM17A"	ENSG00000134375	"Translocase of inner mitochondrial membrane 17A"	Q99595	1	201955503-201970664	"Cancer-related genes, Predicted membrane proteins"	"Protein transport, Translocation, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 265.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010083	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Mitochondria"		"HPA010083: AB_10602899"	"prognostic unfavorable (1.98e-5)"	"unprognostic (3.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-3)"	"unprognostic (7.58e-2)"	"unprognostic (4.15e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.64e-2)"	"unprognostic (8.54e-3)"	"unprognostic (2.02e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.81e-1)"	31.4	48.3	29.3	35.4	30.6	36.8	29.3	31.2	35.8	27.4	34.9	35.2	31.4	25.7	41.1	31.9	20.9	19.0	72.2	31.3	32.5	42.2	80.6	23.7	30.9	30.2	30.6	18.5	23.4	55.8	24.8	31.3	31.0	25.0	38.0	33.3	23.0	28.4	86.1	20.9	23.9	35.3	30.5	24.9	29.1	19.7	30.7	30.3	38.2	94.9	35.8	42.8	23.2	29.4	89.1	88.9	78.5	94.9	64.5	67.2	132.5	138.4	98.0	110.5	98.4	104.8	89.7	122.5	49.7	118.6	81.1	69.2	145.3	82.4	118.3	90.4	90.7	67.7	119.1	99.7	66.7	145.5	69.5	78.0	89.8	113.2	93.9	79.5	117.4	75.4	173.1	66.7	131.7	56.9	78.9	78.3	99.6	88.3	47.0	76.5	91.4	152.6	136.2	83.1	118.0	83.2	84.6	213.5	130.7	98.7	118.5	97.0	95.2	73.6	78.7	86.7	146.4	99.9	115.9	102.3	78.4	109.2	84.2	18.5	32.0	29.2	21.7	44.5	28.6	30.3	23.5	28.1	50.1	23.6	22.4	26.2	7.7	29.7	46.7	33.6	37.0	32.2	29.3	30.6	31.2	35.8	31.3	32.5	30.2	30.6	31.0	30.5	30.7	29.4	31.7	38.5	37.2	9.4	54.7	92.2	100.2	123.3	34.1	24.1	43.2	36.2	129.5	37.1	73.0	38.6	35.5	115.2	44.2	38.8	137.0	94.5	69.7	40.1	55.2	46.0	34.0	36.6	18.1	86.0	187.0	55.9	40.2	48.1	55.2	37.9	32.9	168.0	114.8	35.3	17.4	58.1	81.4	44.0	177.7	32.0	33.5	52.8	53.4	4.7	80.4	49.4	26.8	6.6	14.9	109.4	30.4	38.4	98.6	85.0	37.2	131.8	55.8	31.7	26.3	46.6	75.3	42.6	61.5	60.6	98.9	265.6	46.2	62.9	58.3	118.1
TIMM23	TIM23	ENSG00000265354	"Translocase of inner mitochondrial membrane 23"	O14925	10	45972489-46003742	"Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 148.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA031408	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA031408: AB_10600828"	"unprognostic (4.09e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (1.74e-1)"	"unprognostic (3.90e-2)"	"prognostic favorable (6.79e-4)"	"unprognostic (4.41e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.24e-1)"	"unprognostic (7.78e-2)"	"unprognostic (5.54e-2)"	"unprognostic (7.20e-2)"	"unprognostic (2.21e-1)"	39.0	50.1	47.1	35.5	48.7	66.4	38.3	50.3	62.9	28.2	55.6	40.1	56.5	26.8	61.9	43.1	28.0	31.7	84.9	49.1	51.6	59.5	74.2	26.6	36.4	50.7	51.5	20.6	32.2	50.5	35.0	35.2	52.3	34.6	39.9	42.9	32.5	36.9	128.5	35.7	37.7	37.6	49.9	25.6	32.8	80.6	50.5	40.0	43.3	134.5	45.4	53.0	27.1	49.0	162.6	167.5	108.7	110.3	88.5	82.4	106.1	130.6	156.1	155.6	164.0	212.8	125.4	144.1	105.7	138.6	111.3	136.1	168.0	139.9	153.3	108.0	165.6	92.1	120.8	231.7	142.2	173.1	98.7	99.4	122.3	133.4	188.0	64.7	146.1	123.0	166.0	78.8	138.7	162.7	155.5	239.0	131.7	119.0	51.8	118.6	105.0	105.5	177.6	111.8	127.3	117.0	72.8	159.4	132.8	83.8	168.7	102.1	108.1	74.8	130.6	96.8	188.9	83.6	148.9	203.2	139.3	246.7	63.9	54.8	98.1	54.3	73.1	131.1	75.7	82.1	70.0	79.1	111.2	79.8	62.5	69.5	22.8	79.1	118.6	92.2	85.8	129.5	47.1	48.7	50.3	62.9	49.1	51.6	50.7	51.5	52.3	49.9	50.5	49.0	13.3	9.6	22.2	10.7	19.4	21.9	18.1	32.7	15.9	14.3	16.0	11.9	97.5	30.0	24.4	12.9	8.4	42.1	17.0	16.1	45.0	40.4	101.5	26.6	20.8	18.3	10.2	43.3	19.1	30.1	47.7	24.8	20.9	23.8	27.8	14.2	13.2	27.3	34.5	0.0	18.6	16.5	36.7	16.0	15.8	35.0	17.7	18.9	23.2	12.2	29.3	23.0	20.6	14.6	19.6	36.7	14.7	11.7	36.0	20.3	22.3	61.0	26.9	10.4	6.6	13.1	26.0	148.7	48.4	38.7	21.6	35.6	16.6	17.0	25.6	22.4
TIMM50	"TIM50, TIM50L"	ENSG00000105197	"Translocase of inner mitochondrial membrane 50"	Q3ZCQ8	19	39480412-39493785	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Translocation, Transport"	RNA-binding	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 185.5;Late spermatids: 662.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048843, HPA056448"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		12000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Mitochondria"		"HPA048843: , HPA056448: AB_2683137"	"unprognostic (1.49e-1)"	"unprognostic (6.97e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.80e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.11e-2)"	"unprognostic (7.91e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.11e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.14e-3)"	"unprognostic (3.04e-2)"	"unprognostic (9.87e-2)"	"unprognostic (3.82e-2)"	"unprognostic (4.04e-2)"	37.3	37.2	31.2	30.4	33.7	45.4	29.7	34.3	44.2	27.7	31.5	32.2	30.4	33.2	11.2	35.8	27.9	18.5	75.7	35.0	35.0	32.9	43.9	25.7	27.7	35.0	32.8	27.4	35.3	36.2	22.7	25.2	33.0	27.4	15.4	8.9	32.0	17.5	127.0	26.6	29.6	23.0	30.6	26.2	31.8	80.5	32.9	21.6	31.7	76.6	18.2	30.9	26.1	33.1	147.2	365.3	59.6	155.1	43.8	33.4	116.8	115.8	54.2	119.6	97.4	262.6	96.6	156.5	126.0	67.9	71.9	81.6	100.9	114.8	56.4	148.7	170.8	140.3	94.5	197.3	81.5	282.8	106.6	51.9	73.2	97.2	78.7	33.9	76.4	184.5	237.8	91.3	77.2	202.9	178.4	110.5	113.7	159.2	123.3	190.8	112.5	119.3	88.1	195.5	166.3	99.4	133.6	190.0	251.8	35.7	89.1	168.0	86.4	154.7	165.6	140.1	262.7	96.1	181.1	232.8	117.9	146.7	179.2	42.5	53.7	13.4	36.3	58.5	34.9	41.8	34.1	40.0	60.5	46.4	41.4	35.7	5.9	45.2	58.1	47.0	47.8	62.1	31.2	33.7	34.3	44.2	35.0	35.0	35.0	32.8	33.0	30.6	32.9	33.1	20.0	22.4	26.0	4.6	19.3	26.0	43.6	57.4	18.8	10.4	23.8	28.7	47.6	24.3	37.6	25.8	12.5	83.8	14.7	27.4	66.5	56.3	185.5	19.8	24.2	28.6	23.4	29.6	8.7	51.8	84.4	30.9	25.0	21.5	39.3	29.5	19.2	31.3	67.1	28.6	9.3	27.5	48.8	18.8	27.7	662.8	23.3	22.3	30.2	3.7	22.1	17.4	21.6	6.6	4.9	50.9	22.2	21.1	34.6	68.0	35.7	66.0	22.1	11.4	6.6	27.2	55.7	111.5	46.5	32.3	26.7	94.5	19.9	34.1	48.1	47.6
TIPIN	FLJ20516	ENSG00000075131	"TIMELESS interacting protein"	Q9BVW5	15	66336191-66386746	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 98.0;Langerhans cells: 93.7;Spermatocytes: 120.6;Suprabasal keratinocytes: 108.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039704, HPA058799"	Enhanced					NA	Yes			"Cluster 24: B-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA039704: AB_10795258, HPA058799: AB_2683824"	"unprognostic (3.47e-1)"	"prognostic favorable (4.15e-4)"	"unprognostic (3.49e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.14e-2)"	"prognostic unfavorable (2.47e-4)"	"unprognostic (3.75e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (9.35e-4)"	"unprognostic (2.18e-3)"	"unprognostic (9.47e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.91e-1)"	"unprognostic (2.89e-3)"	4.2	4.4	3.3	7.1	3.3	12.6	5.9	5.4	4.6	3.9	2.0	4.8	2.8	4.7	1.8	4.9	5.5	2.6	3.1	3.2	3.1	4.0	4.9	3.5	9.5	3.2	3.9	6.4	4.7	5.2	3.2	3.8	3.1	3.5	5.3	8.1	3.3	3.2	4.0	3.9	3.0	4.4	2.9	3.7	3.8	20.5	3.2	7.8	4.4	4.8	10.8	3.6	3.3	3.7	28.6	33.9	36.9	17.7	6.4	13.6	30.2	39.1	16.0	54.8	48.0	49.9	32.1	58.5	27.8	14.9	31.9	44.8	94.2	34.1	51.7	39.0	52.4	51.7	33.0	28.0	12.9	54.4	17.1	17.5	11.1	51.2	41.2	7.8	23.0	47.6	43.6	27.4	47.8	32.7	50.3	35.2	37.7	66.7	26.7	50.1	54.9	58.0	19.0	32.5	35.0	21.9	27.5	17.4	25.3	26.8	26.6	32.9	15.3	38.9	42.6	33.7	73.4	16.4	91.2	92.7	26.0	98.8	40.3	0.4	2.1	1.4	2.7	4.3	3.2	2.3	2.0	2.4	3.8	4.3	3.0	3.4	0.4	4.5	2.7	2.9	1.9	1.9	3.3	3.3	5.4	4.6	3.2	3.1	3.2	3.9	3.1	2.9	3.2	3.7	7.8	6.4	7.0	14.0	15.7	98.0	72.4	24.3	5.7	11.8	7.1	9.0	2.7	28.6	11.5	9.2	10.4	35.9	7.8	5.4	86.1	11.8	63.3	8.3	8.6	18.4	4.8	15.6	7.8	8.6	41.2	16.5	5.1	4.8	8.2	11.8	14.6	13.7	21.4	8.4	11.1	7.1	14.2	27.4	93.7	31.4	19.0	13.2	56.9	1.0	12.3	9.2	15.5	10.1	9.6	7.3	7.0	18.0	8.7	41.2	3.8	63.5	6.8	14.7	32.9	51.9	29.0	120.6	62.5	6.6	108.8	19.4	21.0	9.3	10.1	34.1
TIPRL	"dJ69E11.3, MGC3794, TIP41, TIPRL1"	ENSG00000143155	"TOR signaling pathway regulator"	O75663	1	168178962-168202109	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027995, HPA054282"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Vesicles, Cytosol"		"HPA027995: AB_10602900, HPA054282: AB_2682435"	"unprognostic (3.18e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.80e-1)"	"unprognostic (2.35e-3)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (5.82e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (1.45e-8)"	"unprognostic (3.23e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.55e-2)"	"unprognostic (8.61e-2)"	16.3	14.9	15.5	19.6	16.3	33.8	21.0	15.0	20.1	17.7	12.8	22.2	19.0	23.2	16.8	20.1	14.3	16.8	23.7	16.8	17.0	17.8	22.5	14.9	22.2	14.0	13.4	17.4	15.9	27.4	13.6	17.5	14.4	18.4	22.0	14.7	12.0	17.3	24.4	16.3	18.5	22.7	13.4	16.3	15.4	18.2	15.1	30.1	17.4	23.0	19.9	18.7	13.6	15.7	69.4	31.0	45.9	41.6	36.7	53.1	27.5	50.5	53.0	54.6	48.4	48.3	50.1	49.0	68.2	48.7	40.1	81.8	34.5	49.3	52.6	47.2	36.4	47.3	29.2	22.9	64.5	94.7	62.0	43.2	62.8	47.4	62.7	36.0	58.1	75.4	69.0	66.3	47.7	25.4	84.9	49.0	37.0	96.7	54.2	41.1	47.0	66.4	49.7	33.9	29.6	66.1	39.3	54.6	102.2	51.6	59.9	96.3	53.4	45.6	52.4	43.6	69.7	72.2	80.5	108.1	29.8	61.4	53.4	71.6	26.7	36.8	22.0	32.1	22.1	27.3	25.7	23.8	31.6	27.6	22.8	22.4	34.5	29.6	33.9	23.4	36.0	28.2	15.5	16.3	15.0	20.1	16.8	17.0	14.0	13.4	14.4	13.4	15.1	15.7	52.1	25.6	20.4	9.4	39.7	48.2	42.1	70.4	50.1	27.3	31.3	36.2	46.3	22.8	40.7	22.0	16.7	44.2	49.0	37.1	29.4	68.5	53.4	36.0	50.1	43.4	24.0	32.6	41.6	88.9	62.8	47.3	24.5	30.8	40.0	35.2	36.0	33.5	65.1	52.2	37.9	33.9	44.7	26.6	41.1	15.4	37.6	42.6	30.2	19.7	61.0	43.9	51.5	22.1	21.3	69.7	27.7	38.0	37.1	43.3	35.9	77.2	36.1	20.8	26.3	35.4	51.1	151.5	51.6	56.0	41.8	29.0	48.0	84.5	38.5	37.5
TK1		ENSG00000167900	"Thymidine kinase 1"	P04183	17	78174091-78187233	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA synthesis"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 77.9"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 92.8;Erythroid cells: 108.6;Extravillous trophoblasts: 210.4;Hofbauer cells: 65.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 34.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Region enhanced"	"Detected in some"		"white matter: 3.6"	"Low region specificity"	"Detected in many"			CAB004683	Enhanced					NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"			"CAB004683: AB_437067"	"unprognostic (7.09e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.14e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (6.87e-4)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (4.05e-2)"	"unprognostic (3.18e-3)"	"unprognostic (6.64e-3)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (6.50e-11)"	"unprognostic (5.55e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.94e-2)"	3.7	2.7	2.5	20.4	3.4	77.9	5.9	3.6	3.4	5.9	1.3	24.4	18.0	3.0	0.2	27.2	4.9	3.4	2.8	2.7	2.4	11.0	9.2	9.1	34.8	3.4	3.3	1.3	5.6	0.6	0.6	14.8	3.3	3.4	15.7	0.1	6.3	1.5	5.5	14.2	18.3	10.1	2.6	12.4	17.9	3.1	3.8	25.1	2.0	1.6	30.6	5.5	9.0	4.4	443.9	357.7	68.2	92.5	7.6	28.0	47.3	207.6	113.2	323.1	442.3	324.2	178.7	144.1	72.9	131.7	133.9	204.2	63.4	187.1	158.0	51.2	230.4	252.5	119.9	213.3	2.2	107.1	162.9	13.8	7.1	166.1	22.5	22.3	137.9	49.4	156.7	311.9	130.8	352.0	56.0	68.6	36.7	259.1	240.9	152.6	276.4	324.1	90.6	138.5	33.6	94.2	162.0	481.2	59.7	59.4	303.9	156.1	57.8	302.3	305.7	219.9	292.1	132.5	71.4	181.9	149.0	71.9	142.1	0.0	1.1	0.0	1.8	2.1	0.7	5.8	7.9	4.0	3.4	1.7	0.4	2.2	1.8	10.8	1.7	1.1	34.0	5.5	2.5	3.4	3.6	3.4	2.7	2.4	3.4	3.3	3.3	2.6	3.8	4.4	1.6	0.0	2.7	0.0	17.1	28.4	13.3	17.8	2.2	0.0	10.6	9.4	0.9	2.8	8.3	12.9	0.0	92.8	3.6	35.0	7.9	7.7	3.0	9.2	3.3	10.6	5.4	108.6	0.3	11.2	210.4	15.7	19.4	7.0	0.0	15.9	7.5	10.5	65.2	0.0	0.2	32.7	8.2	15.5	19.1	6.8	0.6	10.9	3.6	0.0	5.7	0.0	3.1	0.0	1.0	9.6	7.5	0.7	53.6	4.9	3.1	17.5	5.8	0.0	0.0	1.7	20.1	3.8	16.8	24.7	11.2	51.0	8.7	1.7	60.8	24.0
TLCD3A	"CT120, FAM57A, FLJ22282"	ENSG00000167695	"TLC domain containing 3A"	Q8TBR7	17	732412-742968	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 71.7"	"Group enriched"	"Detected in some"	5	"Extravillous trophoblasts: 20.1;Hofbauer cells: 10.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 1.5"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"				"unprognostic (1.46e-1)"	"unprognostic (6.16e-2)"	"unprognostic (5.64e-2)"	"prognostic favorable (3.53e-6)"	"unprognostic (1.11e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (4.88e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.39e-2)"	7.7	3.5	4.5	6.1	4.9	2.4	8.2	9.7	5.8	10.2	9.5	10.7	12.5	7.3	2.6	23.6	7.1	12.3	4.9	4.7	5.7	5.7	3.7	7.1	3.2	4.2	4.6	7.4	9.7	6.1	8.3	8.2	4.9	9.6	10.0	3.8	11.6	10.9	2.8	71.7	8.6	8.5	4.5	2.9	18.4	12.1	5.5	4.7	8.0	2.9	9.2	18.5	15.9	5.2	63.8	39.4	27.5	36.6	35.5	47.1	27.3	53.9	46.1	53.2	59.4	19.2	9.8	14.4	28.3	51.7	17.1	61.3	57.3	44.3	58.9	38.3	53.1	14.8	26.8	46.6	28.1	12.4	20.7	39.6	38.8	24.2	63.5	24.5	37.3	19.6	13.6	1.7	31.2	22.1	5.3	3.7	12.2	40.7	13.7	25.6	10.8	1.4	38.1	48.9	13.2	25.0	25.7	2.5	16.7	18.0	10.3	13.7	29.1	51.9	23.6	60.8	65.3	4.6	13.3	15.2	47.2	23.9	32.1	0.0	0.0	0.0	1.2	0.0	1.1	0.1	0.2	0.5	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.1	1.5	0.1	4.5	4.9	9.7	5.8	4.7	5.7	4.2	4.6	4.9	4.5	5.5	5.2	2.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	20.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0
TLE5	"AES, GRG5"	ENSG00000104964	"TLE family member 5, transcriptional modulator"	Q08117	19	3052910-3063107	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 92.3;dendritic cells: 167.1;Extravillous trophoblasts: 372.2;Hofbauer cells: 84.2;Plasma cells: 57.5;Syncytiotrophoblasts: 94.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049499			Supported	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA049499: AB_2680795"	"unprognostic (1.08e-1)"	"unprognostic (3.32e-3)"	"unprognostic (7.15e-2)"	"prognostic favorable (3.89e-4)"	"unprognostic (1.45e-1)"	"unprognostic (4.07e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.58e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.15e-1)"	"prognostic favorable (7.74e-4)"	"unprognostic (7.17e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.78e-3)"	237.7	357.9	325.2	93.8	320.4	99.7	214.8	341.0	435.0	304.3	209.5	466.7	82.0	336.6	80.8	282.1	315.9	90.6	504.4	319.4	327.4	266.5	239.6	283.8	145.2	341.8	301.7	284.0	234.4	174.5	276.9	94.7	349.4	314.8	90.9	82.9	287.9	197.1	550.0	231.4	233.2	109.9	279.3	325.2	274.2	109.0	345.5	210.0	315.9	313.7	120.0	361.8	285.4	326.0	120.8	138.7	101.8	180.7	122.1	140.8	78.9	155.1	211.9	192.6	173.0	57.2	120.3	195.9	169.1	200.7	69.5	100.6	122.9	226.7	112.6	292.8	56.5	68.8	141.9	109.6	217.1	99.4	85.1	152.3	182.1	93.2	89.7	226.9	191.8	100.8	245.5	80.0	169.0	120.0	221.7	119.5	89.4	85.3	140.3	251.3	123.4	135.1	241.7	247.7	258.1	283.3	152.2	174.1	163.9	55.8	138.3	134.2	266.5	161.1	106.6	152.8	143.5	4.7	0.9	265.0	151.1	165.7	151.7	38.9	6.6	18.1	130.8	10.7	100.8	62.0	169.3	134.9	12.5	74.3	220.8	149.5	4.6	41.6	9.2	28.8	242.0	89.2	325.2	320.4	341.0	435.0	319.4	327.4	341.8	301.7	349.4	279.3	345.5	326.0	92.3	0.0	0.0	0.0	34.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	24.5	167.1	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	372.2	27.7	0.0	0.0	0.0	0.0	0.0	0.0	84.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	94.0	27.8	0.0	0.0	0.0
TLK1	"KIAA0137, PKU-BETA"	ENSG00000198586	"Tousled like kinase 1"	Q9UKI8	2	170990823-171231314	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016043	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA016043: AB_1858027"	"unprognostic (2.13e-2)"	"unprognostic (3.87e-1)"	"unprognostic (7.36e-2)"	"unprognostic (6.00e-3)"	"unprognostic (2.00e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.47e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.53e-1)"	7.7	10.2	5.9	10.7	8.3	11.1	12.3	4.1	10.5	12.7	5.1	13.0	9.4	10.6	5.4	9.4	9.5	9.6	7.0	10.1	4.6	13.0	14.8	8.4	15.0	3.5	7.3	14.0	10.4	18.0	6.2	15.2	3.4	11.8	12.3	15.8	9.2	14.6	16.3	8.5	11.8	11.7	4.4	13.2	13.5	17.7	10.6	13.8	17.6	5.5	15.7	11.7	8.3	7.6	16.6	15.6	22.0	17.3	15.4	15.3	24.7	22.5	31.9	21.8	18.2	21.8	25.9	34.2	18.7	33.4	23.6	13.7	28.5	24.6	23.8	42.1	14.9	39.1	18.5	28.0	16.5	50.3	19.0	16.7	24.6	43.4	28.4	23.0	24.3	21.2	42.3	27.4	13.2	20.3	43.8	15.5	20.6	15.5	8.9	31.9	26.9	34.7	17.7	30.9	25.0	19.7	24.7	16.7	16.1	14.9	13.8	17.0	33.2	19.3	24.0	12.7	17.8	24.5	43.0	59.7	23.9	20.1	19.9	11.1	3.1	5.7	5.2	2.6	7.3	8.3	8.3	5.7	3.0	8.3	9.3	6.2	4.2	8.1	5.3	4.4	8.5	5.2	5.9	8.3	4.1	10.5	10.1	4.6	3.5	7.3	3.4	4.4	10.6	7.6	34.2	51.3	27.8	135.8	76.7	41.3	33.2	27.1	30.7	34.8	45.9	28.4	32.1	37.1	29.2	51.5	60.5	82.7	42.6	55.8	88.0	29.2	58.1	29.5	33.9	34.5	23.9	33.7	196.2	32.7	52.7	30.3	37.8	38.4	27.3	39.5	27.5	40.0	27.4	45.4	161.0	36.7	36.7	29.0	30.4	32.0	43.2	54.7	37.4	74.0	29.1	26.6	49.4	84.9	92.0	35.6	36.5	44.8	66.3	51.0	33.4	58.0	30.7	77.5	0.0	41.6	29.6	31.1	54.9	24.5	39.1	174.9	66.4	59.2	33.9	43.0
TMEM14B	MGC1223	ENSG00000137210	"Transmembrane protein 14B"	Q9NUH8	6	10747759-10852753	"Predicted membrane proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"				"unprognostic (5.45e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (6.51e-4)"	"unprognostic (5.45e-1)"	"unprognostic (2.58e-3)"	"prognostic unfavorable (9.35e-5)"	"unprognostic (1.63e-1)"	"unprognostic (3.75e-3)"	"prognostic favorable (7.41e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.24e-2)"	"unprognostic (4.77e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.07e-1)"	78.4	101.1	58.2	45.0	60.6	186.3	74.8	62.9	81.2	51.8	77.6	60.3	53.7	46.5	78.0	47.4	72.0	48.7	132.8	59.8	60.6	81.9	91.0	45.2	70.9	61.1	59.3	50.1	64.3	77.3	40.3	41.5	60.5	65.5	58.8	151.6	86.1	44.1	146.5	46.0	59.2	42.6	61.0	42.2	64.4	27.5	60.4	78.6	128.1	141.5	57.5	52.2	41.4	63.6	376.2	155.9	72.9	106.7	80.0	102.8	106.4	77.9	136.6	163.8	193.2	153.8	171.8	130.8	187.1	93.1	375.9	81.8	65.5	135.1	253.4	89.3	89.6	107.9	123.1	235.2	120.0	163.2	102.1	83.6	76.7	174.6	174.9	92.3	91.6	120.1	267.2	54.1	135.0	134.7	144.4	182.0	110.1	198.6	118.9	120.1	97.1	304.9	198.7	91.7	117.9	88.0	95.7	188.6	251.3	139.0	132.3	145.0	91.7	120.0	150.0	82.3	268.6	128.4	289.4	175.7	98.5	92.4	190.1	178.1	112.1	161.2	86.1	109.8	121.5	121.7	120.7	100.1	136.3	114.7	130.3	111.5	64.4	117.0	122.3	168.6	141.0	154.9	58.2	60.6	62.9	81.2	59.8	60.6	61.1	59.3	60.5	61.0	60.4	63.6	103.2	80.1	77.2	21.5	95.4	82.0	92.1	169.9	90.5	85.5	157.9	206.8	141.4	144.4	113.8	88.3	60.5	177.1	89.7	94.1	365.9	183.3	18.9	190.4	73.2	83.5	80.5	399.9	19.9	220.9	183.0	97.0	68.3	101.9	82.4	90.2	70.6	156.3	210.0	107.7	21.2	143.2	130.2	121.0	132.6	53.5	96.3	110.1	120.9	9.4	265.8	239.0	52.5	17.1	18.1	261.3	102.5	75.2	102.5	145.8	142.0	309.5	247.6	196.1	26.3	95.6	92.8	46.5	129.9	103.9	100.7	105.9	99.4	133.3	164.3	109.0
TMEM14C	"bA421M1.6, C6orf53, HSPC194, NET26"	ENSG00000111843	"Transmembrane protein 14C"	Q9P0S9	6	10722915-10731129	"Predicted membrane proteins"	"Heme biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"				"unprognostic (4.08e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.82e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.77e-1)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (2.83e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.93e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.34e-1)"	95.8	124.6	30.4	22.6	31.5	59.8	87.2	33.8	37.5	90.5	41.6	91.1	42.5	94.0	42.7	64.0	84.7	40.3	104.8	28.1	33.8	93.5	70.3	67.0	29.7	32.0	31.4	88.0	66.7	60.3	52.5	37.3	32.7	86.8	37.6	25.8	80.4	41.8	123.8	60.3	63.3	34.2	33.3	51.3	81.3	32.6	33.1	33.7	79.2	70.6	26.5	80.2	73.4	35.0	123.7	70.1	53.7	80.4	103.4	115.5	52.4	70.8	114.5	80.5	89.5	71.6	88.2	81.8	151.8	81.6	159.5	57.3	30.1	85.1	62.4	53.7	51.0	52.4	67.8	109.4	127.3	41.0	36.6	103.5	91.1	60.6	98.7	88.6	42.8	21.4	130.4	29.8	110.3	67.2	27.8	114.4	64.4	59.0	73.6	51.4	71.5	132.7	113.0	51.3	44.8	58.5	70.3	109.8	134.4	105.7	68.3	49.0	102.3	106.6	64.7	44.4	109.5	69.3	132.7	38.6	61.4	52.8	114.2	48.2	39.2	68.2	10.9	39.4	32.1	31.2	27.0	16.3	70.5	23.7	26.2	22.2	4.0	32.0	35.6	66.1	32.2	31.6	30.4	31.5	33.8	37.5	28.1	33.8	32.0	31.4	32.7	33.3	33.1	35.0	163.2	115.4	77.3	15.7	59.1	99.4	135.2	318.8	99.6	41.0	167.4	219.2	129.3	151.5	171.0	156.3	8.4	239.7	60.3	148.4	270.1	200.0	4.8	132.3	159.6	122.7	122.4	472.5	10.0	138.6	275.2	158.9	66.3	128.2	137.1	104.4	124.2	142.5	390.8	16.8	14.6	177.6	189.2	151.5	228.0	15.0	179.3	146.3	193.9	9.4	288.6	199.5	8.2	7.1	18.0	206.3	192.6	190.7	90.8	163.9	274.4	310.4	128.3	51.5	177.5	114.3	160.3	41.5	99.0	134.2	115.5	195.2	56.7	176.2	204.5	141.8
TMEM170A	"FLJ37611, TMEM170"	ENSG00000166822	"Transmembrane protein 170A"	Q8WVE7	16	75443054-75465497	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (3.49e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.52e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.62e-2)"	"unprognostic (7.97e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.15e-2)"	"prognostic favorable (2.36e-9)"	"unprognostic (4.37e-2)"	"unprognostic (3.41e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.53e-3)"	8.2	9.8	7.7	10.6	10.6	36.6	6.0	9.2	9.0	7.7	7.9	12.1	14.5	8.0	6.0	8.4	7.6	7.8	7.2	7.4	9.3	9.2	12.7	8.0	11.9	11.3	10.2	10.2	10.2	3.9	8.7	10.2	9.9	7.6	10.1	14.9	6.5	3.2	3.7	7.8	13.7	6.3	9.3	9.2	7.3	17.4	8.5	6.8	9.7	4.9	9.7	8.1	7.8	16.9	14.2	17.1	21.8	22.3	9.5	7.7	38.9	9.2	5.2	7.4	11.3	35.3	30.7	19.6	17.0	4.4	16.4	25.9	18.3	8.9	13.0	12.0	11.4	10.6	16.4	22.4	6.3	25.3	27.3	6.7	6.8	12.5	9.4	8.7	6.5	22.7	21.8	15.2	3.9	28.8	22.3	16.8	26.1	17.2	9.2	43.5	8.5	15.7	5.1	18.3	12.8	14.9	22.4	7.0	12.6	25.6	9.4	11.6	9.6	12.6	21.4	10.1	10.2	13.7	17.3	60.3	9.8	14.7	14.4	14.5	26.6	38.2	27.9	29.1	36.6	28.9	29.1	31.8	24.0	28.8	30.9	27.3	33.3	25.4	26.9	26.8	23.1	21.6	7.7	10.6	9.2	9.0	7.4	9.3	11.3	10.2	9.9	9.3	8.5	16.9	39.7	19.2	15.0	20.5	49.0	19.9	45.7	37.8	26.7	25.6	37.7	27.1	9.3	40.0	25.3	20.2	37.5	73.0	65.0	86.2	25.4	26.8	40.5	62.5	23.6	37.2	34.1	17.1	17.6	19.3	51.5	24.3	16.8	67.7	28.6	57.3	35.3	24.2	37.2	37.0	15.9	37.6	22.4	31.8	29.7	8.7	24.2	38.3	21.4	11.2	41.2	43.7	42.2	24.1	29.8	23.3	67.6	21.4	29.2	57.5	53.5	30.2	32.4	38.3	32.9	19.9	20.1	88.5	61.8	19.7	20.0	53.4	49.0	36.7	56.0	67.8
TMEM183A	C1orf37	ENSG00000163444	"Transmembrane protein 183A"	Q8IXX5	1	203007374-203024848	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072607			Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA072607: AB_2686539"	"unprognostic (2.94e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (2.62e-4)"	"unprognostic (6.46e-2)"	"unprognostic (3.21e-2)"	"unprognostic (4.82e-3)"	"unprognostic (5.28e-2)"	"unprognostic (7.84e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.01e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.32e-1)"	21.6	19.1	27.6	17.0	28.8	76.6	22.1	28.2	35.1	22.9	23.8	30.9	26.6	19.8	18.8	30.3	19.4	14.1	17.0	30.1	30.1	22.8	23.9	21.0	21.7	26.7	25.8	20.1	28.7	17.8	12.2	14.4	27.7	21.2	30.2	21.8	25.4	16.4	14.8	27.5	26.1	19.9	23.7	22.2	25.2	34.1	26.7	30.0	22.2	12.7	24.1	23.4	22.9	27.0	32.7	31.2	39.2	64.6	50.6	37.7	64.4	32.2	31.7	36.4	31.7	38.1	33.6	81.1	22.6	41.7	14.6	40.4	53.1	45.1	30.1	26.6	64.5	40.2	33.8	42.3	36.6	72.6	33.9	37.3	49.3	30.1	60.2	36.8	46.6	64.4	83.8	28.7	34.5	73.3	59.7	74.4	107.7	44.0	49.2	45.4	66.7	65.7	57.0	31.6	50.2	62.7	48.0	79.0	48.1	61.9	56.6	56.6	34.8	24.4	34.2	42.3	35.7	28.8	49.7	62.4	27.0	55.7	26.3	33.3	33.6	51.2	23.5	29.2	23.1	23.8	26.3	26.6	37.4	26.2	29.8	24.7	28.7	36.6	27.8	26.8	30.6	37.4	27.6	28.8	28.2	35.1	30.1	30.1	26.7	25.8	27.7	23.7	26.7	27.0	39.7	16.0	20.5	3.6	40.4	73.4	61.5	62.2	41.5	22.8	62.2	48.6	14.9	54.3	52.1	35.0	10.4	53.2	57.3	70.4	70.5	88.6	161.1	31.1	34.9	36.2	52.7	103.7	13.2	76.1	86.0	34.8	42.3	34.4	17.7	34.6	40.7	53.6	60.4	18.5	11.8	87.5	63.1	63.1	52.0	113.7	27.1	49.7	39.2	6.5	71.1	26.6	50.4	3.5	7.2	52.7	57.6	29.3	62.1	100.2	102.3	100.4	44.5	28.0	19.7	38.3	46.7	95.0	80.9	72.9	82.1	51.6	48.3	39.6	88.6	105.2
TMEM186	"C16orf51, DKFZP564K2062"	ENSG00000184857	"Transmembrane protein 186"	Q96B77	16	8780384-8797642	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 44.8;Late spermatids: 106.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018226, HPA063559"	Uncertain		Approved	"Cell Junctions"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Cell Junctions"		"HPA018226: AB_1845579, HPA063559: AB_2685041"	"unprognostic (3.49e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.06e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.99e-2)"	"prognostic favorable (1.93e-8)"	"unprognostic (1.06e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.89e-2)"	7.0	11.2	8.6	6.2	9.0	2.2	10.0	8.8	10.5	6.5	9.2	10.8	9.6	7.5	12.5	9.6	9.3	4.6	13.2	8.5	8.9	12.3	16.3	5.8	8.6	8.6	8.7	8.5	8.9	12.4	9.5	7.2	8.8	7.5	11.2	5.0	8.3	7.2	18.5	8.3	9.7	7.5	8.6	9.9	9.5	7.8	8.9	7.9	7.6	21.3	10.7	7.5	6.5	9.2	10.4	16.1	11.8	15.1	19.8	10.5	11.2	11.8	12.1	15.2	12.5	15.9	17.1	31.9	9.8	8.7	10.4	19.8	21.2	16.8	17.3	18.7	20.4	13.4	22.3	34.1	22.0	15.1	10.3	12.7	27.8	16.7	24.4	12.5	14.0	25.9	23.3	17.1	9.0	28.3	11.7	14.7	15.0	22.0	13.9	24.4	15.5	35.3	16.3	8.8	18.1	17.3	16.2	22.7	14.3	12.0	27.1	12.0	8.9	10.8	15.1	27.0	9.9	15.6	17.6	15.5	16.8	27.1	8.8	9.9	8.7	6.8	7.5	8.6	10.0	13.1	8.1	8.8	9.1	11.5	13.7	10.9	4.1	9.1	13.3	7.0	11.7	7.4	8.6	9.0	8.8	10.5	8.5	8.9	8.6	8.7	8.8	8.6	8.9	9.2	3.4	6.4	6.7	2.6	6.7	8.2	7.1	16.1	5.7	6.9	7.3	6.6	2.7	10.0	13.1	11.0	0.0	23.4	4.4	7.8	21.5	15.1	44.8	4.8	6.0	5.6	13.8	8.2	1.9	11.2	13.3	5.7	6.1	5.0	7.0	9.6	6.1	12.8	13.2	13.5	1.5	9.4	12.2	4.9	4.7	106.9	9.3	2.5	7.2	1.0	9.9	10.8	11.3	1.5	1.9	9.9	6.7	6.4	5.1	9.8	14.8	21.9	9.3	5.6	13.1	6.6	5.3	21.3	11.9	9.5	9.5	15.1	5.0	11.0	16.0	5.8
TMEM192	FLJ38482	ENSG00000170088	"Transmembrane protein 192"	Q8IY95	4	165070608-165208549	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014717, HPA024110"	Enhanced		Supported	Nucleoplasm,Endosomes,Lysosomes		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Endosomes, Lysosomes"	Nucleoplasm	"HPA014717: AB_1844373, HPA024110: AB_2204898"	"prognostic unfavorable (9.52e-4)"	"unprognostic (5.38e-3)"	"unprognostic (9.16e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.91e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.27e-2)"	"unprognostic (5.06e-2)"	"prognostic favorable (2.33e-14)"	"unprognostic (2.09e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.76e-2)"	"unprognostic (9.30e-2)"	12.0	15.2	4.9	7.2	5.9	6.6	13.2	7.5	7.0	9.9	7.1	11.5	9.7	10.5	9.0	8.8	11.2	10.3	12.6	4.8	5.2	48.3	45.2	10.6	8.9	4.7	5.5	24.5	22.3	24.6	5.1	10.8	5.0	22.1	13.3	10.7	14.5	8.4	15.0	5.4	9.3	8.6	4.6	9.1	10.5	9.8	4.8	6.6	26.8	17.0	7.7	8.5	5.4	6.2	13.5	19.9	7.1	18.0	18.1	6.4	16.5	20.1	29.4	20.5	22.8	11.7	21.6	29.5	11.7	13.0	33.4	11.8	26.8	20.6	23.6	19.2	13.8	16.4	14.1	13.4	46.1	41.0	21.2	23.3	42.8	18.4	37.4	17.8	17.0	15.6	28.4	48.1	25.4	29.4	7.1	12.0	14.8	28.1	16.9	16.0	6.2	27.1	16.4	19.6	15.2	15.9	31.4	49.1	31.9	10.4	23.9	18.5	12.6	9.0	11.1	28.6	23.0	46.9	67.0	40.8	21.6	22.2	36.6	2.9	16.6	4.8	12.1	14.9	16.3	26.7	9.4	12.6	15.7	20.2	10.4	12.6	1.7	18.7	8.3	16.3	8.5	10.7	4.9	5.9	7.5	7.0	4.8	5.2	4.7	5.5	5.0	4.6	4.8	6.2	12.3	32.1	36.2	18.9	24.0	9.7	18.4	10.5	10.2	33.0	21.5	15.7	35.0	42.9	19.1	55.2	16.7	31.4	15.4	17.0	11.7	21.0	26.4	11.2	17.0	19.0	21.7	10.1	16.4	25.8	20.5	18.9	7.7	15.5	40.4	26.1	27.8	77.7	38.2	37.0	16.5	18.2	6.1	27.4	17.7	11.1	39.7	22.3	28.4	11.2	21.3	35.8	28.8	14.6	20.9	11.5	14.3	33.4	11.8	33.7	26.3	63.4	10.9	27.1	6.6	30.7	20.7	17.8	18.3	12.0	12.9	33.7	15.9	27.1	24.0	14.2
TMEM201	"Ima1, NET5, RP13-15M17.2, SAMP1"	ENSG00000188807	"Transmembrane protein 201"	Q5SNT2	1	9588911-9614877	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 43.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB039039	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nuclear membrane"	Nucleoplasm	"CAB039039: "	"unprognostic (1.75e-2)"	"prognostic favorable (5.36e-4)"	"unprognostic (1.89e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.88e-1)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (9.61e-8)"	"unprognostic (2.22e-1)"	"unprognostic (3.60e-1)"	"unprognostic (3.87e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.38e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.25e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.45e-1)"	5.8	6.1	8.6	3.6	8.9	7.7	5.2	7.9	9.7	7.5	6.8	5.7	3.2	7.3	2.0	7.0	6.3	2.2	14.5	9.4	8.4	9.5	3.4	4.0	3.2	10.8	9.7	9.4	6.1	4.4	16.0	2.5	9.5	6.4	1.3	6.1	5.5	2.9	43.2	6.4	4.7	2.7	7.9	5.4	4.6	10.4	9.6	3.2	5.5	24.3	2.0	5.2	5.5	8.3	13.6	18.2	11.1	26.3	4.6	3.1	9.9	15.7	4.8	18.3	12.9	33.1	12.0	23.5	19.4	5.5	9.0	27.9	12.4	12.4	6.2	15.7	31.2	16.7	17.4	17.0	8.4	20.4	16.6	5.7	5.5	24.6	3.9	3.9	7.3	10.9	21.7	6.6	7.5	16.0	17.8	14.8	11.2	10.3	16.4	37.1	19.0	19.3	6.6	7.3	26.6	19.9	12.3	29.9	13.5	3.8	9.1	12.7	6.7	21.7	18.8	24.0	30.0	11.0	9.9	21.0	15.0	33.0	19.6	0.0	0.2	0.0	0.3	0.2	0.1	0.5	0.3	0.5	0.3	0.2	0.2	0.2	0.0	0.1	0.1	1.3	0.5	0.3	8.6	8.9	7.9	9.7	9.4	8.4	10.8	9.7	9.5	7.9	9.6	8.3	5.2	3.2	2.0	4.9	2.2	7.0	2.5	1.8	4.6	16.0	5.3	4.7	12.1	2.8	2.1	0.0	27.1	4.1	0.8	2.6	1.9	2.3	2.0	4.2	4.9	4.9	6.7	5.2	4.1	1.0	2.5	4.0	2.6	4.4	4.5	11.7	3.6	1.6	3.6	10.1	6.0	3.7	2.0	2.5	3.5	1.8	4.1	2.4	3.6	0.0	0.9	5.0	1.0	7.1	5.9	1.7	0.9	4.5	2.8	3.2	0.6	1.9	2.4	16.9	0.0	7.3	4.2	6.8	5.4	7.9	5.5	0.8	2.8	4.6	4.3	2.3
TMEM203	"HBEBP1, MGC14327"	ENSG00000187713	"Transmembrane protein 203"	Q969S6	9	137204082-137205648	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"				"unprognostic (1.31e-1)"	"unprognostic (2.65e-2)"	"unprognostic (4.53e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.16e-2)"	"prognostic favorable (4.78e-6)"	"unprognostic (2.94e-1)"	"prognostic favorable (1.50e-5)"	"unprognostic (3.50e-3)"	"unprognostic (1.57e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.19e-1)"	25.7	32.6	32.8	17.2	33.6	10.9	25.5	33.8	36.8	28.1	33.1	30.2	22.2	29.9	26.4	31.4	24.2	16.4	45.9	32.9	33.4	33.2	49.2	20.5	27.0	33.6	33.6	27.7	26.2	30.7	25.6	15.9	33.4	27.1	18.2	16.4	26.8	21.8	49.7	43.6	28.5	16.9	32.8	30.4	30.1	19.1	34.9	20.3	25.1	45.9	22.7	27.8	27.6	33.0	38.0	39.3	36.5	60.7	53.1	41.1	43.6	48.4	46.6	55.1	41.1	32.6	33.3	39.0	45.7	42.2	53.0	72.6	45.3	48.1	32.1	71.0	43.5	27.0	45.5	37.4	44.3	63.1	26.8	39.6	75.4	36.0	47.4	36.8	35.8	50.5	64.2	44.4	43.2	65.2	50.5	54.6	60.8	72.4	63.2	54.2	51.1	78.2	46.5	27.2	48.3	47.3	38.6	48.8	39.2	25.0	68.8	50.6	32.0	56.3	30.1	63.6	55.1	23.8	80.0	49.5	43.5	46.3	47.3	4.7	3.8	4.1	5.2	4.3	6.4	8.3	5.8	6.5	4.6	4.5	8.7	6.0	1.9	7.5	3.9	4.8	4.0	2.6	32.8	33.6	33.8	36.8	32.9	33.4	33.6	33.6	33.4	32.8	34.9	33.0	23.2	9.6	6.8	4.6	21.4	17.6	22.7	7.0	23.9	33.6	29.6	33.8	13.5	40.0	7.9	31.3	4.2	30.5	23.7	15.9	52.8	49.4	3.5	15.3	24.2	20.7	16.3	29.8	5.7	42.0	26.3	22.3	14.8	13.3	5.7	31.7	21.4	41.1	29.3	32.0	6.2	13.4	10.2	27.1	13.2	9.4	22.1	20.8	24.9	5.6	54.2	58.8	24.7	2.5	6.1	41.7	10.8	20.7	13.3	37.2	18.5	59.2	4.9	25.7	13.1	19.5	32.5	18.6	15.9	28.5	27.3	19.4	24.4	36.2	18.6	17.9
TMEM208	HSPC171	ENSG00000168701	"Transmembrane protein 208"	Q9BTX3	16	67227103-67229278	"Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041868, HPA041949"	Supported					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA041868: AB_10962347, HPA041949: AB_10959903"	"unprognostic (9.42e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (9.63e-5)"	"unprognostic (2.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.53e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.18e-2)"	"unprognostic (7.73e-2)"	"unprognostic (9.42e-2)"	35.5	83.8	41.8	31.7	41.9	22.5	40.3	44.0	50.1	34.7	50.3	42.9	45.8	29.2	57.5	41.0	32.7	27.8	26.6	41.8	44.8	52.9	124.7	34.9	28.0	43.8	44.6	25.2	65.3	67.6	62.6	32.7	43.9	34.1	41.7	13.8	44.9	31.1	26.5	32.9	39.1	28.1	43.4	38.2	47.4	30.4	43.8	26.5	41.3	19.0	32.1	36.9	28.7	44.9	64.6	82.1	40.0	48.6	124.3	59.3	73.4	66.3	83.3	72.1	61.4	106.4	80.1	63.4	76.1	93.8	64.6	86.2	64.4	89.8	45.6	27.9	90.1	34.9	64.0	110.1	128.6	56.2	91.6	79.9	112.7	95.1	82.1	51.5	54.3	57.6	61.2	81.4	85.7	128.0	56.2	82.5	67.2	105.5	56.1	61.0	48.7	186.2	97.4	42.9	66.2	67.6	119.1	50.2	54.8	27.2	65.0	70.7	33.8	54.5	35.9	78.3	74.0	122.7	127.9	131.8	96.0	54.1	79.8	79.2	108.5	59.4	74.0	102.7	66.5	70.7	68.7	63.9	85.1	58.5	56.1	61.6	69.7	53.3	81.3	168.5	74.2	93.9	41.8	41.9	44.0	50.1	41.8	44.8	43.8	44.6	43.9	43.4	43.8	44.9	51.7	25.6	36.9	8.1	71.8	51.7	79.5	131.0	48.9	44.7	92.1	96.9	29.8	102.9	111.1	57.0	33.3	98.9	69.2	81.8	60.7	158.8	19.8	57.6	54.3	49.5	76.8	31.6	7.8	202.0	142.9	66.7	50.0	64.1	53.3	47.1	43.5	209.6	120.5	26.9	9.3	119.0	140.4	54.7	53.6	7.4	62.1	59.4	88.9	6.5	90.2	102.6	55.6	9.0	12.3	129.7	107.8	41.8	197.3	137.6	145.4	162.7	109.7	55.5	26.3	43.6	100.6	68.4	58.4	62.7	51.9	143.7	52.4	65.9	95.4	128.0
TMEM209	"FLJ14803, NET31"	ENSG00000146842	"Transmembrane protein 209"	Q96SK2	7	130164713-130207770	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031678	Uncertain		Approved	"Nuclear membrane,Nuclear speckles,Vesicles"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nuclear membrane, Nuclear speckles, Vesicles"		"HPA031678: AB_10603135"	"unprognostic (3.03e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.50e-3)"	"unprognostic (5.98e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.19e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.34e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.24e-1)"	8.9	15.3	4.1	8.4	6.2	9.6	10.6	7.2	6.5	7.4	13.0	11.0	8.8	10.8	9.5	5.5	9.6	6.4	6.2	4.0	5.2	8.6	10.4	9.2	11.9	6.1	6.1	10.2	8.5	15.1	4.4	9.5	6.4	8.3	11.2	13.3	7.9	8.4	5.2	7.2	10.7	9.0	5.9	10.5	7.6	15.0	5.4	14.2	16.2	7.7	12.1	7.6	4.3	9.6	23.4	21.8	29.3	36.7	16.8	17.2	21.4	20.8	20.9	18.3	24.7	23.0	39.2	34.6	15.1	13.3	34.5	34.2	34.7	24.2	33.0	42.7	20.0	17.9	34.0	16.5	29.6	38.2	17.2	18.9	24.6	37.0	36.8	11.4	14.5	35.1	58.9	38.2	23.2	30.2	73.2	23.6	44.1	20.9	19.4	38.9	33.1	57.4	19.1	29.3	26.2	40.0	47.5	75.8	31.3	22.7	23.7	25.6	11.4	33.0	13.1	35.4	50.6	51.7	81.6	70.4	54.7	43.4	53.0	16.1	12.2	13.8	22.0	18.3	23.0	18.3	22.3	20.2	12.0	17.3	25.6	22.3	1.8	19.5	16.8	14.9	24.6	15.1	4.1	6.2	7.2	6.5	4.0	5.2	6.1	6.1	6.4	5.9	5.4	9.6	12.3	3.2	12.3	11.4	15.3	4.7	4.0	8.2	6.8	13.6	8.8	5.2	8.6	10.0	9.8	9.2	4.2	8.9	15.2	7.2	1.9	6.4	33.5	9.6	8.0	9.5	13.8	25.9	10.4	9.1	9.3	7.5	7.7	10.4	10.1	10.0	9.7	9.4	7.9	5.0	13.0	11.9	8.2	13.1	4.4	8.5	6.5	7.8	7.2	15.0	7.7	18.1	8.2	10.6	20.9	7.6	11.6	5.3	11.0	5.3	13.4	4.9	9.8	14.6	0.0	9.0	5.9	16.6	16.0	6.4	5.4	6.6	13.1	12.1	9.5	3.7
TMEM242	"BM033, C6orf35"	ENSG00000215712	"Transmembrane protein 242"	Q9NWH2	6	157289025-157323601	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025764	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA025764: AB_1845742"	"unprognostic (5.42e-3)"	"unprognostic (6.02e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.28e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.06e-1)"	6.7	9.2	9.2	5.0	9.9	11.0	6.4	9.6	10.6	7.5	8.4	7.3	5.9	7.6	8.0	6.0	5.8	5.0	14.1	10.0	9.1	8.2	10.2	5.4	5.4	8.8	8.4	6.5	5.5	10.7	6.2	6.1	9.0	6.5	6.2	9.5	6.8	5.4	12.1	6.1	5.7	7.9	8.3	5.2	6.5	4.7	9.4	6.0	7.4	11.9	5.8	7.2	6.9	9.3	5.1	4.0	8.3	8.8	15.4	10.0	6.2	9.7	9.1	9.7	10.7	5.3	4.9	7.7	12.5	10.6	13.3	9.0	8.7	8.7	9.9	11.1	14.3	10.9	9.1	10.8	16.0	11.3	8.3	10.2	9.3	6.9	14.1	13.4	11.8	10.3	17.1	10.1	8.7	5.2	6.6	14.9	5.6	3.2	7.8	3.8	5.4	11.1	13.9	4.5	10.9	5.7	8.7	5.8	11.8	7.6	5.9	11.9	9.9	6.7	7.6	14.5	13.0	9.7	10.5	7.3	13.7	13.0	11.2	15.0	19.5	12.4	13.9	16.8	13.4	18.5	14.0	13.9	18.6	19.5	12.1	13.8	3.0	17.1	11.6	29.8	16.7	12.1	9.2	9.9	9.6	10.6	10.0	9.1	8.8	8.4	9.0	8.3	9.4	9.3	28.8	12.8	10.0	7.5	21.6	27.5	18.8	62.2	25.6	25.1	20.3	25.4	51.8	20.0	27.1	22.0	4.2	51.2	28.0	19.6	33.2	49.1	11.7	25.8	32.8	28.0	9.6	40.0	23.0	39.1	53.2	27.5	13.3	28.6	15.8	16.9	25.4	28.5	36.5	38.7	28.3	21.8	32.6	17.3	26.7	6.8	21.1	17.7	42.7	14.0	21.7	26.9	27.8	15.1	22.0	39.6	26.9	26.7	23.7	17.9	32.0	38.2	29.7	30.5	59.2	22.8	36.0	34.7	37.1	24.4	24.3	41.6	24.8	24.6	24.6	16.8
TMEM248	"C7orf42, FLJ10099, FLJ13090"	ENSG00000106609	"Transmembrane protein 248"	Q9NWD8	7	66921225-66958551	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016495	Uncertain		Approved	Vesicles		NA	NA		1600000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA016495: AB_1848643"	"unprognostic (6.74e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.86e-2)"	"unprognostic (4.64e-2)"	"unprognostic (6.67e-3)"	"unprognostic (9.36e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.54e-2)"	"unprognostic (9.18e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.96e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.28e-2)"	"unprognostic (5.57e-2)"	31.8	39.7	29.2	27.5	30.8	17.8	34.8	25.3	29.0	46.6	57.5	40.8	42.4	44.3	40.6	26.6	45.0	38.6	32.4	32.2	36.1	36.3	49.4	38.7	36.5	27.3	31.0	50.0	40.3	50.0	31.7	34.5	31.0	43.1	41.1	39.0	39.6	40.9	23.1	29.5	37.4	39.2	26.3	34.2	43.6	32.6	40.1	29.5	46.1	21.4	35.0	34.0	32.4	28.0	46.4	53.3	44.2	63.4	98.2	75.0	38.7	55.7	95.1	51.8	55.9	38.9	59.2	46.7	66.3	75.5	70.8	40.8	38.3	45.9	64.0	43.1	28.2	34.2	36.9	45.4	63.5	57.6	45.5	68.0	52.4	43.6	36.1	75.4	68.5	36.1	66.6	30.6	83.4	28.1	54.3	70.5	65.9	47.5	36.1	39.3	51.4	79.3	70.3	35.1	30.7	65.6	49.1	89.0	50.6	65.6	44.8	52.1	63.9	72.4	35.4	48.0	61.9	37.2	45.4	52.1	60.6	62.9	70.5	2.3	4.0	7.7	6.0	4.3	7.2	8.3	6.5	6.4	3.2	8.1	6.3	6.8	5.8	7.3	2.7	8.3	4.7	1.9	29.2	30.8	25.3	29.0	32.2	36.1	27.3	31.0	31.0	26.3	40.1	28.0	55.1	51.3	42.7	14.7	66.2	64.5	53.5	23.6	46.7	18.5	60.6	44.2	25.0	51.5	25.2	53.3	6.2	48.3	75.2	100.8	11.7	37.0	106.2	37.8	34.5	51.7	27.6	45.9	25.8	47.2	81.2	60.9	55.5	35.0	28.5	44.8	58.2	109.9	52.7	18.5	26.4	82.6	16.2	65.7	76.5	172.3	63.6	53.0	49.8	20.6	46.2	96.7	62.8	24.1	27.7	60.2	62.3	65.8	76.5	108.8	64.4	34.3	36.9	12.7	32.9	40.3	47.7	111.5	57.9	42.2	73.9	88.1	64.4	46.4	60.3	98.7
TMEM250	"bA83N9.1, C9orf69"	ENSG00000238227	"Transmembrane protein 250"	H0YL14	9	136114581-136118875	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 17.1;Extravillous trophoblasts: 21.3;Pancreatic endocrine cells: 15.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA066070	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 47: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA066070: AB_2685608"	"unprognostic (2.79e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.34e-2)"	"prognostic favorable (1.09e-4)"	"unprognostic (4.99e-2)"	"unprognostic (2.34e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.27e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.99e-2)"	"unprognostic (9.33e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.64e-1)"	14.9	14.0	18.6	11.6	18.6	4.3	13.5	14.1	20.2	12.8	10.0	20.0	16.7	14.3	7.3	29.1	12.2	6.9	17.4	19.5	12.0	16.3	21.7	13.1	11.4	15.6	13.8	13.2	13.2	8.2	11.9	10.4	16.4	14.7	8.0	2.9	14.0	8.5	28.5	20.8	17.1	7.7	13.3	16.8	15.6	13.0	16.7	8.7	11.0	10.4	8.9	19.5	15.0	16.0	24.9	46.2	17.7	26.5	24.7	22.4	54.9	29.2	20.7	17.3	12.3	26.4	35.5	18.3	33.3	31.5	27.6	62.2	12.6	20.6	5.4	78.8	24.1	15.4	48.3	18.7	34.2	28.2	19.2	20.2	38.8	18.8	19.6	22.3	27.9	18.0	35.1	18.9	15.3	57.3	34.6	22.7	39.2	43.4	49.6	14.0	24.5	30.5	19.0	17.9	30.4	23.1	31.5	21.6	26.4	10.4	19.7	42.1	31.6	30.2	13.3	39.8	32.9	11.0	11.3	10.9	30.4	19.9	29.0	4.3	2.9	1.8	6.2	4.2	4.5	1.8	4.7	5.2	3.0	1.3	2.2	4.1	3.4	3.5	4.2	1.9	2.6	2.1	18.6	18.6	14.1	20.2	19.5	12.0	15.6	13.8	16.4	13.3	16.7	16.0	11.9	6.4	7.3	0.0	1.9	0.0	0.0	0.0	0.0	0.0	12.9	11.9	0.0	0.0	1.3	14.7	0.0	17.1	15.2	0.0	3.9	13.1	0.0	9.8	12.6	6.0	0.0	0.0	0.0	10.6	21.3	5.1	0.0	7.0	2.5	14.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	3.6	0.0	0.0	0.0	0.0	15.8	0.0	0.0	1.3	0.0	0.0	13.2	1.5	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	7.8	5.5	11.5	0.0	0.0
TMEM33	"FLJ10525, Pom33"	ENSG00000109133	"Transmembrane protein 33"	P57088	4	41935129-41960803	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075863	Approved					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA075863: "	"unprognostic (7.14e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.94e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.75e-1)"	"prognostic favorable (1.35e-5)"	"unprognostic (7.70e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.35e-3)"	"unprognostic (2.36e-2)"	12.4	16.1	8.0	19.4	10.5	14.9	16.0	13.1	11.4	11.4	16.0	18.7	21.1	11.1	25.5	21.2	12.3	17.2	10.5	9.6	12.8	24.2	39.9	15.1	17.0	15.5	13.5	10.5	18.2	30.1	11.0	20.0	14.7	17.2	21.3	13.0	17.9	11.8	8.4	11.9	16.9	11.3	14.1	13.9	19.1	9.9	12.1	14.9	23.8	12.4	20.1	21.8	10.8	18.8	36.9	42.4	36.7	51.3	46.7	31.8	44.9	49.5	53.9	41.5	47.5	52.4	123.4	64.8	74.7	41.5	85.5	57.4	124.4	65.0	56.1	17.1	26.2	80.7	49.7	45.9	54.4	108.7	67.6	33.4	69.0	52.5	78.3	26.5	32.7	37.3	86.8	24.7	57.4	32.6	96.5	67.9	67.2	58.1	50.0	42.7	57.8	51.6	58.2	53.5	40.8	58.4	40.5	38.0	62.4	35.3	42.9	37.4	53.0	48.3	65.0	48.9	89.5	44.5	76.9	77.4	51.7	88.4	71.2	41.2	32.1	21.7	14.9	31.0	17.6	13.0	15.3	14.2	22.9	12.0	13.6	15.0	43.2	16.5	35.2	17.9	19.0	16.4	8.0	10.5	13.1	11.4	9.6	12.8	15.5	13.5	14.7	14.1	12.1	18.8	25.1	60.9	34.3	20.9	25.0	73.3	35.7	42.4	24.5	19.2	36.9	16.4	18.0	27.1	40.5	55.2	16.7	56.3	35.2	58.9	23.5	44.6	2.9	26.9	31.2	25.9	35.0	25.0	33.6	38.1	49.3	30.5	36.2	33.4	38.7	23.1	24.7	84.4	57.3	28.6	32.8	40.4	34.6	67.5	51.0	4.7	20.2	55.7	56.9	11.2	55.9	33.9	16.5	32.6	40.3	54.1	47.4	23.3	32.5	73.7	41.6	41.1	29.7	20.4	26.3	26.5	55.6	31.0	28.7	47.5	66.9	133.1	28.3	39.7	43.0	64.5
TMX1	"PDIA11, TMX, TXNDC, TXNDC1"	ENSG00000139921	"Thioredoxin related transmembrane protein 1"	Q9H3N1	14	51240162-51257655	"Predicted membrane proteins, Transporters"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003085	Approved		Supported	"Nucleoli,Endoplasmic reticulum"		NA	NA		26000	"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Endoplasmic reticulum"	Nucleoli	"HPA003085: AB_1080424"	"unprognostic (1.83e-1)"	"unprognostic (7.42e-2)"	"unprognostic (6.97e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.29e-6)"	"unprognostic (3.70e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.44e-3)"	"unprognostic (5.07e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.21e-3)"	11.0	8.8	5.8	10.8	6.3	10.7	11.3	6.7	8.7	7.8	7.4	12.3	10.6	8.1	10.8	9.1	6.6	8.5	4.8	5.4	6.6	10.2	12.6	9.3	12.4	6.5	6.8	6.6	9.1	9.4	5.5	13.2	7.0	7.9	12.2	6.8	8.3	9.2	5.2	9.8	9.3	9.9	6.9	10.7	10.4	5.0	7.0	11.6	11.4	4.4	10.5	13.0	6.6	7.0	27.0	23.8	33.8	18.4	26.0	20.3	35.5	33.5	26.8	33.2	42.2	24.9	49.0	38.8	30.0	22.6	15.6	26.1	60.3	21.5	60.4	38.6	19.6	28.4	19.4	24.7	22.4	66.2	27.4	24.4	19.5	22.2	16.3	24.0	29.7	31.2	23.6	25.9	32.1	32.6	29.7	35.5	38.3	42.2	28.5	30.9	60.9	23.4	32.2	34.8	21.1	15.5	26.6	17.8	24.6	22.2	25.8	28.6	19.0	34.9	32.2	24.8	30.9	22.4	23.9	31.4	15.4	36.6	33.5	10.5	12.2	6.2	8.6	14.7	10.6	7.7	8.8	9.0	13.6	6.3	8.5	10.1	4.3	11.5	11.0	15.7	11.0	12.4	5.8	6.3	6.7	8.7	5.4	6.6	6.5	6.8	7.0	6.9	7.0	7.0	43.0	38.5	29.1	24.5	55.9	108.6	63.1	80.5	71.2	13.7	40.7	20.8	9.2	44.3	55.7	35.0	12.5	73.9	82.6	38.2	9.8	62.1	2.5	22.0	42.2	47.5	17.4	81.2	8.9	67.6	149.3	48.4	32.1	28.0	43.6	24.4	43.2	44.0	73.2	10.1	11.2	29.2	63.1	61.1	84.3	4.3	24.8	65.7	55.2	18.7	70.0	27.0	46.4	22.1	25.2	50.3	44.0	28.6	79.2	58.4	29.3	32.4	42.2	32.6	59.2	37.3	49.4	59.5	68.7	79.0	97.3	57.7	62.5	58.7	46.5	59.5
TMX2	"PDIA12, TXNDC14"	ENSG00000213593	"Thioredoxin related transmembrane protein 2"	Q9Y320	11	57712593-57740973	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Lissencephaly, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040282, HPA063763"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cytosol"		"HPA040282: AB_10697715, HPA063763: AB_2685116"	"unprognostic (3.66e-3)"	"unprognostic (6.96e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.73e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (3.64e-4)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (4.48e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.26e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.22e-1)"	"prognostic favorable (1.55e-5)"	"unprognostic (5.88e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (3.37e-4)"	52.9	75.1	77.7	37.3	83.0	27.0	50.5	87.4	101.9	43.6	103.3	70.0	56.4	39.4	58.2	62.8	42.7	33.2	71.5	75.0	84.1	78.7	83.4	45.0	31.5	81.7	81.5	40.9	57.7	84.9	43.1	44.0	83.5	50.1	80.8	64.7	49.6	53.8	44.7	45.1	58.3	43.1	84.3	44.9	60.9	30.6	85.5	34.9	57.1	41.3	47.6	48.2	43.8	90.6	122.7	141.4	78.5	143.4	144.8	77.2	86.6	144.2	111.8	140.0	117.9	135.3	205.6	115.1	156.6	116.3	207.1	220.0	203.5	115.4	146.3	83.3	88.9	110.2	105.7	136.8	119.3	156.6	145.5	94.8	166.5	154.8	243.2	76.3	80.6	95.3	194.4	130.9	157.7	62.7	93.0	177.1	153.8	227.7	191.5	124.7	97.9	242.5	174.4	136.4	90.3	129.3	110.2	255.7	168.3	76.7	228.5	102.2	66.7	130.5	84.8	176.1	152.1	127.9	269.5	115.3	146.6	109.3	198.3	37.8	41.5	40.0	34.6	72.4	44.0	36.8	34.4	40.9	40.6	34.9	43.1	43.8	11.2	37.8	86.0	49.7	32.0	45.0	77.7	83.0	87.4	101.9	75.0	84.1	81.7	81.5	83.5	84.3	85.5	90.6	37.9	38.5	34.0	0.0	32.0	32.1	44.9	108.2	19.9	43.4	35.8	28.1	42.6	30.0	60.8	49.7	31.3	108.0	29.9	39.5	43.0	72.4	2.0	19.6	27.4	36.8	28.8	37.6	0.0	43.5	85.6	38.6	23.0	20.7	43.1	29.9	31.8	48.7	62.0	30.3	0.0	49.6	81.4	30.8	21.4	3.6	48.7	31.9	48.0	0.0	37.8	91.1	19.6	0.0	0.0	54.5	32.0	43.6	32.5	49.0	51.4	41.1	37.4	66.7	39.5	36.3	34.5	60.7	62.2	33.6	32.7	99.6	26.6	46.6	75.2	43.6
TNPO3	"IPO12, LGMD1F, MTR10A, TRN-SR, TRN-SR2"	ENSG00000064419	"Transportin 3"	Q9Y5L0	7	128954180-129055173	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039555, HPA041537"	Approved		Enhanced	Vesicles		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA039555: AB_10672000, HPA041537: AB_2677539"	"unprognostic (5.76e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (3.29e-5)"	"unprognostic (1.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.26e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.24e-2)"	16.1	16.9	17.1	19.3	17.7	34.3	15.7	19.0	18.7	14.1	16.3	18.4	16.4	15.6	17.8	21.1	16.2	13.0	15.6	17.3	19.9	19.1	22.9	16.0	23.4	17.0	17.6	20.5	15.1	21.1	10.0	14.8	19.3	16.6	20.1	16.5	15.5	18.0	32.6	18.1	16.6	19.5	17.2	17.7	19.7	26.4	19.0	30.1	22.8	27.0	28.8	18.6	15.1	17.6	59.1	65.3	49.7	84.3	47.3	40.5	42.3	51.8	45.0	47.4	55.5	53.7	52.9	73.3	23.6	55.7	89.7	42.3	101.6	49.8	67.6	61.3	45.0	54.0	52.2	42.2	45.0	99.8	44.2	38.1	49.7	57.9	51.4	41.4	59.9	59.5	124.7	51.3	61.2	43.7	86.9	73.4	142.6	64.4	59.7	61.0	46.3	60.0	48.0	54.6	61.5	48.7	55.2	25.7	58.3	71.4	29.0	61.3	45.2	59.7	29.4	71.1	71.5	65.3	54.6	99.3	86.3	100.5	106.1	26.7	14.1	22.0	16.4	17.3	14.6	16.1	13.3	14.8	16.1	15.5	13.0	15.2	15.5	14.5	23.9	7.7	15.1	11.7	17.1	17.7	19.0	18.7	17.3	19.9	17.0	17.6	19.3	17.2	19.0	17.6	20.4	16.0	16.7	30.7	31.4	6.8	15.6	5.7	27.3	23.4	20.3	13.8	21.4	20.0	11.6	18.4	22.9	24.7	26.9	20.4	7.9	23.2	41.4	19.1	17.7	18.8	11.5	38.5	45.8	24.8	37.2	17.4	22.4	27.7	10.8	30.5	19.6	27.9	27.8	37.0	46.8	22.2	2.0	25.7	9.5	25.4	16.8	24.9	8.8	31.9	44.4	13.6	17.5	37.7	47.5	30.3	17.7	17.7	28.5	17.6	21.7	18.7	13.1	21.7	13.1	18.5	19.4	76.3	31.8	32.5	8.2	35.0	23.5	33.1	24.8	30.4
TNRC6B	KIAA1093	ENSG00000100354	"Trinucleotide repeat containing adaptor 6B"	Q9UPQ9	22	40044817-40335808	"Metabolic proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing, Translation regulation"	RNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 484.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003180	Approved					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 6: Brain - Smell perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"			"HPA003180: AB_1079196"	"unprognostic (1.45e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.48e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.42e-2)"	"unprognostic (1.84e-3)"	"unprognostic (8.85e-2)"	"unprognostic (7.24e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.81e-1)"	4.0	3.6	4.5	4.9	6.2	19.5	3.9	22.0	7.6	4.4	13.2	4.2	3.2	4.0	5.8	3.5	3.7	4.4	4.7	3.6	1.1	3.9	5.4	4.9	5.3	3.7	3.5	4.2	3.9	4.7	5.5	3.6	4.2	3.7	3.5	12.7	4.0	2.8	6.4	5.5	5.2	3.7	1.1	5.6	4.3	14.9	3.9	9.2	5.0	5.1	5.9	3.6	4.2	15.7	6.3	9.3	9.4	9.8	6.1	4.3	5.1	4.2	7.7	6.5	7.9	4.2	4.3	11.9	7.4	5.1	7.6	4.3	11.8	8.6	6.8	13.0	9.3	8.8	9.3	5.3	3.0	10.2	12.5	4.8	4.0	10.2	5.1	3.1	9.0	6.7	7.4	10.8	6.1	6.8	6.3	3.2	12.2	4.8	6.7	7.7	9.0	6.0	6.1	10.6	11.4	2.7	10.2	3.6	5.2	8.5	5.1	3.7	10.3	5.7	20.7	5.8	4.0	8.5	8.2	7.8	3.7	5.1	6.8	228.9	32.8	66.2	48.0	19.2	42.4	100.7	50.5	44.5	16.3	134.6	52.8	53.6	484.5	34.7	29.6	104.9	29.5	12.5	4.5	6.2	22.0	7.6	3.6	1.1	3.7	3.5	4.2	1.1	3.9	15.7	114.0	38.5	54.9	260.8	178.8	74.8	70.2	60.8	92.8	248.7	103.4	85.9	153.6	125.8	56.0	69.9	458.7	36.4	171.1	77.8	70.5	59.8	82.5	142.2	91.0	104.4	141.0	203.1	334.1	59.3	20.7	108.4	61.2	85.0	65.9	78.1	120.7	109.7	39.0	341.6	371.8	76.7	65.1	115.9	80.1	72.4	111.9	71.4	65.8	235.2	117.2	127.2	168.9	255.9	304.0	54.4	76.4	127.9	117.8	79.8	93.0	69.0	91.3	356.9	52.6	175.5	95.1	87.7	88.3	56.6	82.1	7.5	149.0	82.6	83.7	59.1
TOE1	hCaf1z	ENSG00000132773	"Target of EGR1, exonuclease"	Q96GM8	1	45340052-45343973	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 36.6;Spermatocytes: 51.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053775, HPA069119"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear bodies"	Nucleoplasm	"HPA053775: AB_2682259, HPA069119: AB_2686090"	"unprognostic (7.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.33e-1)"	"prognostic favorable (9.05e-4)"	"prognostic unfavorable (6.12e-9)"	"unprognostic (4.67e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.03e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (2.71e-4)"	"prognostic favorable (9.98e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.08e-1)"	4.8	5.1	4.9	5.9	4.9	8.0	5.5	4.8	6.1	3.7	4.8	6.8	6.7	6.7	8.4	3.7	5.4	3.5	3.7	4.7	5.4	4.7	5.5	5.1	7.9	5.1	5.0	6.2	4.8	7.5	3.2	6.8	5.1	5.0	8.2	4.1	5.3	5.0	3.0	3.9	5.0	6.5	5.0	5.8	5.6	11.8	5.4	9.0	7.1	2.4	8.3	5.5	3.3	5.1	15.8	9.1	16.5	15.7	7.6	5.9	23.9	15.6	12.9	26.6	24.7	16.7	9.6	29.9	12.1	16.2	23.4	15.9	21.0	22.5	21.3	19.6	17.3	36.0	21.9	15.6	7.3	23.7	17.2	8.8	4.8	28.4	17.8	9.4	19.5	22.5	28.4	19.6	18.9	14.6	34.8	18.4	31.1	20.6	14.2	24.9	24.5	13.6	11.5	28.7	13.9	13.4	14.5	36.3	27.5	25.7	9.8	33.2	14.6	12.6	23.3	19.1	29.7	15.0	19.4	19.9	14.8	26.5	14.7	20.0	5.8	6.2	7.3	6.9	8.4	5.9	6.3	7.3	6.0	8.4	6.4	7.0	0.6	4.1	6.1	5.2	8.6	5.1	4.9	4.9	4.8	6.1	4.7	5.4	5.1	5.0	5.1	5.0	5.4	5.1	6.5	6.4	4.8	2.3	12.4	1.8	6.3	8.8	4.6	10.7	4.5	5.0	1.8	7.2	8.1	7.3	12.5	36.6	9.2	9.2	7.9	5.4	13.9	2.1	6.2	9.0	3.0	14.1	2.5	6.2	13.8	6.6	4.6	3.4	11.4	10.5	8.6	5.0	9.3	8.4	2.7	7.3	8.2	3.5	2.6	9.4	6.8	6.2	3.6	1.9	12.3	13.1	9.2	2.0	2.1	3.4	10.7	6.4	7.0	6.5	8.8	7.9	4.7	18.3	13.1	8.0	7.1	51.7	18.9	3.8	1.4	22.7	9.0	10.2	6.9	4.6
TOMM20	"KIAA0016, MAS20, MOM19, TOM20"	ENSG00000173726	"Translocase of outer mitochondrial membrane 20"	Q15388	1	235109341-235128837	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005585, HPA011562"	Supported		Enhanced	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Mitochondria		"CAB005585: AB_628381, HPA011562: AB_1080326"	"unprognostic (1.30e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.66e-2)"	"unprognostic (4.49e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.16e-3)"	"unprognostic (5.05e-2)"	"unprognostic (7.08e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.97e-1)"	71.5	83.5	80.0	39.2	89.0	96.6	130.8	63.0	111.9	82.9	63.4	64.3	61.0	83.5	91.6	67.8	95.6	48.3	86.4	91.7	79.9	100.4	88.3	60.2	53.7	76.9	71.5	119.5	103.1	111.6	54.3	68.2	81.2	80.5	67.9	51.3	125.1	70.1	83.0	82.5	54.5	59.3	81.7	47.2	69.4	32.8	84.1	57.1	142.9	82.4	56.6	66.4	56.7	83.3	198.7	102.4	131.6	111.6	101.4	202.6	203.5	138.8	119.3	127.9	92.5	133.1	135.6	239.3	180.1	121.0	36.1	154.0	147.8	135.0	166.9	57.9	314.8	146.2	126.2	253.9	169.2	331.3	84.2	182.3	180.8	128.6	175.4	173.0	140.7	92.2	312.1	85.9	141.9	58.2	141.9	149.4	296.6	131.2	54.9	170.9	100.3	312.6	144.5	140.2	172.5	402.8	108.0	149.2	306.7	53.6	230.9	358.6	125.6	111.5	67.5	143.0	299.6	201.2	203.1	172.4	131.2	155.4	193.1	37.7	18.8	6.5	19.4	19.7	23.6	23.0	24.8	24.3	22.7	18.2	30.1	24.2	5.6	15.8	22.9	30.6	23.7	21.5	80.0	89.0	63.0	111.9	91.7	79.9	76.9	71.5	81.2	81.7	84.1	83.3	167.2	137.8	163.5	25.1	201.9	267.4	254.9	158.5	251.6	49.9	299.2	307.0	137.8	160.2	151.3	49.7	29.2	171.3	195.5	98.3	160.4	161.6	318.4	180.2	254.3	156.8	160.5	127.0	69.0	211.2	462.5	139.9	121.3	216.9	157.7	146.4	129.9	160.1	159.9	50.5	61.1	273.4	99.7	197.7	164.6	354.0	155.0	175.7	149.4	28.1	187.5	145.4	116.4	26.2	55.8	220.1	172.3	153.4	176.7	340.4	247.0	223.5	99.7	60.9	105.2	201.4	207.5	186.5	71.1	273.3	286.1	199.5	179.5	196.1	272.6	333.4
TOMM40	"C19orf1, D19S1177E, PER-EC1, PEREC1, TOM40"	ENSG00000130204	"Translocase of outer mitochondrial membrane 40"	O96008	19	44890569-44903689	"Predicted intracellular proteins, Transporters"	"Ion transport, Protein transport, Transport"	Porin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036231, HPA036232"	Supported		Enhanced	Mitochondria,Cytosol		NA	NA		45000	"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Cytosol	"HPA036231: AB_2675010, HPA036232: AB_2675011"	"unprognostic (2.14e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.13e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.86e-3)"	"unprognostic (5.30e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.87e-1)"	34.6	59.7	31.3	25.1	30.1	32.9	29.0	33.6	37.2	25.2	28.0	34.7	28.4	25.0	14.1	51.8	25.3	10.8	46.1	30.7	33.5	33.5	50.8	28.4	23.6	32.6	33.5	24.9	26.6	31.4	25.3	20.0	33.6	24.7	23.0	18.0	24.1	17.4	64.0	34.4	26.1	16.4	30.2	26.4	29.3	22.0	35.0	25.2	22.3	34.4	22.6	29.9	29.5	32.2	147.6	244.6	87.6	121.3	32.2	28.4	110.3	103.3	57.1	192.1	136.6	268.8	99.5	215.3	107.7	68.8	108.7	155.2	228.9	149.1	87.0	84.0	206.1	145.3	93.5	214.7	68.0	187.6	125.1	45.2	83.4	149.3	94.1	36.0	67.3	102.4	232.6	73.3	76.4	184.2	205.4	137.1	153.6	209.6	149.1	206.1	99.2	125.3	89.6	201.8	135.2	86.4	109.9	229.4	75.2	48.4	77.1	188.2	55.9	132.0	133.6	93.1	273.7	78.3	176.0	212.9	98.2	197.0	142.1	0.7	3.6	3.7	2.8	4.6	3.2	5.8	2.8	4.1	4.6	2.4	4.9	5.4	0.7	3.2	4.3	4.6	3.5	1.4	31.3	30.1	33.6	37.2	30.7	33.5	32.6	33.5	33.6	30.2	35.0	32.2	26.2	16.0	7.3	8.8	34.9	87.4	73.7	17.1	35.9	68.2	32.7	30.9	15.7	25.8	14.3	31.3	29.2	104.5	28.9	78.8	39.2	48.1	11.3	22.7	41.0	31.0	29.3	52.4	11.3	38.6	169.9	38.6	40.2	29.5	19.1	57.8	12.5	24.2	100.1	70.7	16.9	59.4	28.5	21.0	44.9	7.2	26.8	35.0	39.2	4.7	31.9	46.6	27.8	5.5	12.8	53.6	32.4	24.5	47.9	139.0	34.5	39.5	4.9	60.2	19.7	49.1	47.8	46.2	64.5	60.5	89.4	72.9	26.7	105.9	132.1	75.5
TOMM5	"bA613M10.3, C9orf105, Tom5"	ENSG00000175768	"Translocase of outer mitochondrial membrane 5"	Q8N4H5	9	37582646-37592604	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA048712	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA048712: AB_2680499"	"unprognostic (1.81e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.37e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (9.89e-3)"	"prognostic unfavorable (5.49e-4)"	"prognostic favorable (2.37e-4)"	"unprognostic (7.80e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.09e-2)"	90.0	92.6	69.9	62.8	72.2	66.4	71.9	71.1	84.8	62.2	68.9	84.2	74.0	64.9	62.0	89.1	58.7	47.2	83.9	71.3	75.9	114.5	87.5	57.0	83.0	70.7	73.5	63.7	90.3	52.4	66.3	39.2	77.0	58.9	60.2	40.2	70.1	46.0	129.4	63.3	62.2	55.9	72.9	75.5	72.7	65.2	70.7	72.0	65.2	89.6	78.8	79.8	65.2	70.7	353.2	400.4	234.3	211.2	265.7	258.9	128.9	262.5	169.4	252.1	268.6	431.4	142.2	240.3	208.4	253.7	254.4	119.0	212.0	316.2	262.6	338.5	329.0	212.1	535.7	630.0	216.1	350.6	133.7	224.9	170.4	277.4	273.5	118.7	293.5	264.1	524.9	261.5	261.1	282.3	297.2	306.9	407.7	296.2	249.0	247.9	195.2	353.3	294.0	218.7	202.4	184.7	134.9	181.6	201.5	198.2	127.0	405.4	198.8	173.3	369.7	273.9	411.8	97.5	312.3	407.8	211.4	300.9	272.0	77.3	155.2	74.5	202.0	177.4	252.1	309.9	246.7	227.8	196.8	260.6	251.9	232.8	17.8	216.5	154.3	218.4	221.2	279.7	69.9	72.2	71.1	84.8	71.3	75.9	70.7	73.5	77.0	72.9	70.7	70.7	31.7	28.9	33.4	16.0	95.5	112.3	49.9	72.8	138.3	5.0	51.2	66.5	20.8	47.1	54.3	46.0	12.5	24.5	41.6	36.5	80.3	55.6	218.3	43.3	49.1	49.8	18.1	120.5	14.2	127.2	55.6	45.9	122.9	46.2	46.2	22.1	50.0	159.2	66.6	1.7	14.9	50.8	52.9	52.7	48.6	181.2	35.1	55.0	62.2	6.5	58.3	10.5	32.0	6.6	11.0	109.2	32.6	31.2	178.3	67.7	75.3	215.0	51.7	8.8	0.0	40.5	42.2	87.4	24.2	235.4	146.3	25.2	73.3	20.8	53.6	55.9
TOMM70	"KIAA0719, Tom70, TOMM70A"	ENSG00000154174	"Translocase of outer mitochondrial membrane 70"	O94826	3	100363431-100401089	"Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 34.9;Extravillous trophoblasts: 33.2;Proximal tubular cells: 48.6;Theca cells: 32.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014589, CAB017156, HPA048020"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"CAB017156: , HPA014589: AB_1858185, HPA048020: AB_2680234"	"unprognostic (2.74e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.69e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.01e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.73e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.53e-1)"	"unprognostic (3.34e-2)"	"unprognostic (6.98e-3)"	29.7	23.1	21.8	19.5	38.7	16.6	31.5	20.6	24.4	19.8	19.1	27.7	29.3	24.5	21.3	28.9	20.4	16.1	38.8	23.6	23.0	36.8	61.7	15.9	22.2	21.3	18.6	30.8	26.8	27.2	14.8	23.4	21.9	26.4	29.8	45.4	21.9	26.9	66.4	19.8	24.4	26.7	17.9	19.2	21.5	19.6	22.9	29.6	30.1	76.1	25.9	27.3	17.8	19.5	70.2	48.3	39.8	57.9	55.4	60.0	52.0	57.9	49.6	52.2	53.8	68.7	39.0	83.2	49.9	49.7	46.6	67.4	73.1	53.4	76.7	31.6	33.7	95.2	30.3	67.3	34.6	117.2	41.8	53.7	48.6	46.5	75.6	46.5	38.8	40.1	69.2	65.6	63.3	51.9	79.6	47.5	55.2	107.4	101.2	72.0	80.9	89.0	42.6	52.2	72.2	60.1	42.3	67.0	77.9	38.2	87.1	65.8	35.2	45.5	60.3	25.8	44.0	71.1	108.8	139.1	44.1	70.0	35.2	1.1	1.0	1.2	1.9	1.1	2.3	2.0	2.3	2.0	1.4	1.4	2.3	2.5	0.2	2.7	1.3	1.4	1.0	0.8	21.8	38.7	20.6	24.4	23.6	23.0	21.3	18.6	21.9	17.9	22.9	19.5	24.2	6.4	25.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	30.0	20.2	0.0	0.0	11.2	14.7	0.0	26.8	11.5	0.0	11.7	19.0	0.0	13.8	34.9	10.0	0.0	0.0	0.0	20.1	33.2	12.9	0.0	25.4	7.6	27.1	0.0	0.0	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	5.7	0.0	0.0	0.0	0.0	22.5	0.0	0.0	2.3	0.0	0.0	48.6	10.2	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	16.3	6.3	32.9	0.0	0.0
TOP2A	TOP2	ENSG00000131747	"DNA topoisomerase II alpha"	P11388	17	40388525-40417896	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 127.8;testis: 65.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 216.8;Granulosa cells: 117.5;Spermatocytes: 621.2;Spermatogonia: 269.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basal ganglia: 4.2;white matter: 8.0"	"Low region specificity"	"Detected in some"			"CAB002448, HPA006458, HPA026773"	Enhanced	Approved	Supported	Nucleoplasm,Nucleoli		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"CAB002448: AB_564035, HPA006458: AB_1858189, HPA026773: AB_1858190"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.28e-3)"	"unprognostic (9.42e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.92e-6)"	"prognostic unfavorable (4.99e-4)"	"unprognostic (6.21e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (3.83e-5)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.46e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.29e-1)"	2.2	2.5	0.2	20.0	0.2	42.0	5.4	0.1	0.7	5.0	1.1	17.8	18.1	3.9	0.3	29.0	1.5	2.6	1.2	0.2	0.2	1.2	2.8	4.1	40.3	0.2	0.8	1.0	0.9	0.3	0.3	15.9	0.5	1.4	19.8	0.1	4.3	0.5	0.3	15.3	17.0	7.6	0.2	9.9	8.9	65.7	1.1	127.8	1.9	0.2	42.5	6.0	9.6	0.4	212.6	275.6	343.1	158.0	16.8	33.9	76.3	283.3	151.5	255.0	224.2	130.5	157.6	339.4	140.1	96.7	152.7	326.5	266.8	113.5	339.5	182.7	177.8	224.8	167.9	216.7	1.6	318.4	228.6	7.4	9.2	179.8	181.4	55.1	136.3	216.5	247.5	225.8	279.2	72.6	372.3	209.6	143.0	152.4	108.3	310.7	531.9	141.3	61.6	133.3	201.6	144.6	229.3	281.4	89.4	198.2	236.9	143.2	90.3	167.0	233.2	195.5	276.7	128.4	154.9	290.7	94.3	214.9	285.0	0.2	0.0	0.0	0.2	0.0	0.0	0.6	0.3	0.3	0.1	0.1	0.0	0.0	0.1	1.4	0.1	0.0	2.4	0.4	0.2	0.2	0.1	0.7	0.2	0.2	0.2	0.8	0.5	0.2	1.1	0.4	1.0	0.0	2.0	0.3	17.4	11.7	3.7	15.0	2.2	0.0	18.7	17.1	1.3	2.8	5.8	0.0	0.0	72.9	6.1	19.8	0.0	0.8	20.3	12.7	15.8	9.3	0.0	216.8	0.2	0.0	92.4	23.3	23.0	10.0	0.0	117.5	20.7	5.4	83.5	0.0	0.1	34.2	18.3	33.9	13.2	19.1	4.7	14.1	1.8	0.0	2.6	0.0	3.1	0.0	0.1	0.3	3.5	1.9	31.3	3.1	3.4	0.1	1.8	0.0	72.3	0.5	19.5	621.2	269.6	45.1	6.1	8.9	14.8	4.3	61.0	6.9
TOP3A	"TOP3, ZGRF7"	ENSG00000177302	"DNA topoisomerase III alpha"	Q13472	17	18271428-18315007	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, Disease variant, Dwarfism, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002449	Approved					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"			"CAB002449: AB_564037"	"unprognostic (5.49e-2)"	"unprognostic (9.04e-2)"	"unprognostic (8.99e-2)"	"unprognostic (7.24e-3)"	"unprognostic (4.01e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.33e-3)"	"unprognostic (6.54e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.39e-4)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (5.58e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.53e-2)"	"unprognostic (5.05e-2)"	"unprognostic (6.05e-2)"	9.4	8.0	1.9	3.3	1.8	5.7	8.6	3.1	2.6	8.6	2.1	7.8	2.3	8.4	1.6	8.6	8.5	2.1	6.0	1.8	1.8	7.0	11.2	7.7	3.6	1.7	1.6	7.5	7.7	2.6	8.9	2.5	1.7	7.7	2.4	2.1	8.1	1.7	10.0	11.3	8.2	2.6	1.4	11.4	7.6	11.7	2.0	4.2	6.7	2.5	3.3	8.5	7.8	2.0	9.3	14.2	9.4	11.1	3.8	4.6	10.9	9.4	4.9	14.2	12.8	22.4	3.4	13.7	6.0	6.5	6.6	11.7	12.6	6.7	11.5	11.6	11.4	13.1	15.2	7.9	4.3	5.8	11.9	2.9	4.6	15.0	8.7	2.9	7.3	11.5	11.3	5.7	6.1	6.4	15.2	5.9	8.7	13.8	6.8	17.4	22.6	14.8	3.2	8.1	7.7	13.6	12.6	8.3	8.4	24.5	16.1	6.5	6.5	10.6	8.1	18.2	15.4	5.8	13.7	10.4	6.6	8.0	10.5	1.1	3.1	3.4	1.8	2.7	1.3	0.7	1.3	1.6	1.3	0.8	1.1	1.2	4.2	2.2	1.5	1.2	1.2	2.0	1.9	1.8	3.1	2.6	1.8	1.8	1.7	1.6	1.7	1.4	2.0	2.0	5.3	6.4	4.8	6.5	9.7	2.0	4.5	4.5	6.8	20.8	6.2	3.9	3.1	5.7	7.4	11.0	39.6	7.4	11.8	4.6	3.9	4.2	7.2	5.0	8.7	6.2	0.0	9.9	16.4	3.7	6.9	6.3	6.6	6.3	5.1	12.1	6.4	7.0	5.4	21.9	17.2	4.2	4.1	12.4	6.3	7.9	8.1	11.6	1.8	12.2	13.9	6.4	15.5	11.6	11.2	3.6	2.8	6.4	12.0	5.8	3.8	2.1	6.5	22.2	13.1	9.3	6.6	26.7	25.5	5.2	3.4	4.4	9.0	13.1	5.9	5.0
TOR1B	"DQ1, MGC4386"	ENSG00000136816	"Torsin family 1 member B"	O14657	9	129803157-129811281	"Predicted intracellular proteins"		"Chaperone, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA013403, HPA013697, CAB022709"	Approved		Uncertain	"Nuclear speckles,Cytosol"	"Intracellular and membrane"	NA	NA		140000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"	Cytosol	"CAB022709: , HPA013403: AB_1858195, HPA013697: AB_1858196"	"unprognostic (2.91e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.55e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.95e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.07e-3)"	"unprognostic (4.09e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.69e-3)"	11.1	10.0	8.6	13.1	8.4	14.3	8.7	12.0	8.7	8.4	9.5	20.3	11.3	9.1	7.0	10.3	7.7	13.3	8.9	8.2	9.2	8.6	18.5	11.7	11.0	8.8	8.6	7.5	12.6	11.7	7.3	14.2	8.7	11.0	22.6	5.9	10.3	9.2	10.6	11.8	14.1	12.6	8.6	9.3	11.9	10.2	9.5	10.7	10.7	9.9	9.4	15.8	8.5	8.4	11.7	26.5	10.9	29.0	53.2	39.4	25.0	40.8	26.7	27.6	27.2	22.0	26.1	8.3	25.2	40.7	43.0	46.4	11.9	16.9	28.2	30.4	12.3	7.2	21.5	15.8	22.8	13.8	31.1	22.6	29.3	39.6	19.4	20.4	24.9	21.5	25.6	18.8	26.2	32.9	19.2	21.8	22.9	54.8	20.1	7.8	18.9	25.3	21.3	12.1	15.0	17.2	26.0	30.4	16.6	19.5	43.7	13.5	22.7	51.9	24.5	62.4	35.7	13.6	53.9	7.0	28.6	17.9	36.0	8.7	13.3	20.2	12.6	16.0	13.0	4.0	10.0	11.2	6.9	4.7	7.3	7.3	16.4	8.8	10.1	4.2	10.5	9.9	8.6	8.4	12.0	8.7	8.2	9.2	8.8	8.6	8.7	8.6	9.5	8.4	9.5	9.6	2.4	6.5	11.7	6.5	5.9	7.3	12.5	2.7	6.9	5.6	5.5	5.7	6.1	5.5	4.2	10.8	16.1	15.3	0.0	9.7	13.3	5.0	6.7	8.2	19.2	3.4	13.9	13.7	17.7	10.5	17.9	5.7	4.5	4.0	9.7	13.3	12.0	6.7	15.6	16.2	4.1	5.4	5.0	15.1	4.4	12.1	3.6	4.7	12.3	4.7	16.5	14.6	10.5	12.6	6.7	5.7	14.5	10.1	10.7	3.7	9.4	2.7	19.7	6.8	13.0	22.7	5.4	10.4	5.4	15.2	12.2	4.6	10.5	11.2
TPR		ENSG00000047410	"Translocated promoter region, nuclear basket protein"	P12270	1	186311652-186375693	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 772.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019661, HPA019663, HPA024336"	Enhanced		Enhanced	"Nuclear membrane"		NA	NA		30000000	"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear membrane"		"HPA019661: AB_1858215, HPA019663: AB_1858216, HPA024336: AB_1858217"	"unprognostic (4.51e-2)"	"unprognostic (9.87e-3)"	"unprognostic (2.48e-1)"	"unprognostic (7.56e-2)"	"unprognostic (9.88e-3)"	"prognostic favorable (4.71e-4)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (1.71e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.31e-3)"	"unprognostic (3.75e-1)"	"unprognostic (4.19e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.98e-2)"	19.8	14.5	12.2	23.4	14.1	28.9	19.7	14.4	10.9	17.6	18.4	17.6	15.5	20.3	19.7	14.8	15.0	16.1	17.1	9.5	12.9	16.0	15.4	18.0	26.0	13.6	12.0	23.1	15.5	34.2	13.4	26.7	13.8	17.2	20.0	19.8	15.8	17.6	20.4	24.2	19.3	17.6	12.2	22.9	19.1	43.8	13.3	31.0	22.7	22.3	26.0	19.6	14.5	15.1	55.9	46.7	68.2	39.8	53.4	47.4	73.2	62.0	41.2	42.8	40.4	70.5	45.9	64.0	47.1	42.1	29.4	70.9	51.9	42.4	52.1	51.8	58.6	86.8	78.3	49.7	28.7	93.1	53.5	36.4	25.0	64.4	49.4	39.3	51.3	36.5	106.0	57.3	45.8	47.5	46.2	24.5	76.1	49.9	16.0	54.3	54.3	56.5	34.8	65.0	37.7	59.5	72.9	47.1	37.6	92.5	53.1	58.0	73.0	42.5	40.6	47.7	76.6	63.2	77.6	57.0	27.5	45.8	38.7	121.4	34.1	69.0	43.8	30.0	37.7	48.9	38.6	36.8	20.6	55.4	47.3	32.8	145.7	33.0	50.4	58.7	49.1	17.3	12.2	14.1	14.4	10.9	9.5	12.9	13.6	12.0	13.8	12.2	13.3	15.1	126.4	218.0	119.6	43.1	122.9	101.2	105.5	98.6	114.9	89.8	65.8	79.8	180.0	54.3	110.0	58.8	79.2	136.9	136.8	51.2	23.5	107.1	199.3	129.1	151.7	123.8	67.7	102.4	42.5	74.7	99.9	126.5	80.5	134.4	81.0	134.2	74.6	40.8	72.8	99.3	42.6	61.9	93.6	64.2	79.3	50.4	125.6	92.6	55.2	39.4	137.3	101.1	139.0	48.2	62.8	90.1	56.7	117.4	113.7	95.1	52.4	27.7	120.9	111.4	131.5	172.5	152.1	772.9	250.4	85.6	99.2	150.8	145.8	160.0	77.7	96.0
TPX2	"C20orf1, C20orf2, DIL-2, p100"	ENSG00000088325	"TPX2 microtubule nucleation factor"	Q9ULW0	20	31739271-31801805	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 48.0;lymphoid tissue: 70.3;testis: 30.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 90.7;Extravillous trophoblasts: 68.5;Granulosa cells: 46.6;Spermatocytes: 114.5;Spermatogonia: 63.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"T-reg: 8.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 5.1;NK-cells: 3.6;T-cells: 8.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005487	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"		Yes	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cytokinetic bridge, Mitotic spindle"	"HPA005487: AB_1858223"	"unprognostic (2.18e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.43e-6)"	"unprognostic (2.99e-1)"	"unprognostic (7.56e-2)"	"prognostic unfavorable (8.07e-7)"	"prognostic unfavorable (6.46e-4)"	"unprognostic (3.70e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.68e-5)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.56e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.39e-1)"	1.9	1.4	0.9	13.0	0.9	48.0	2.7	0.8	1.0	2.3	0.5	11.6	9.4	2.4	0.2	13.2	0.9	1.8	0.8	1.1	0.6	0.7	4.2	1.9	26.6	0.6	1.0	0.5	0.4	0.4	0.2	8.3	0.7	0.7	14.2	0.5	2.0	0.5	1.4	9.8	9.4	6.8	0.6	5.2	6.2	30.7	1.3	70.3	1.0	0.8	32.3	3.4	4.1	0.9	455.1	149.1	176.4	139.1	13.8	25.2	169.8	186.1	104.5	264.0	197.7	319.1	190.4	212.4	106.7	104.5	196.8	232.7	203.7	169.0	298.8	92.3	78.8	416.3	139.7	219.6	4.2	161.9	102.8	8.7	9.1	166.0	120.0	37.9	144.6	157.1	313.8	187.8	209.7	186.2	272.2	125.3	197.1	174.0	159.3	152.5	475.5	128.2	71.2	72.8	127.5	85.7	284.6	106.3	82.0	120.9	185.1	97.3	98.3	294.1	179.7	136.5	290.0	74.4	138.6	187.3	92.2	565.1	195.8	5.1	0.0	0.4	0.4	0.0	0.2	0.6	1.4	1.7	0.5	0.2	0.3	0.5	0.2	3.6	0.1	1.0	8.1	1.0	0.9	0.9	0.8	1.0	1.1	0.6	0.6	1.0	0.7	0.6	1.3	0.9	1.0	0.0	4.2	0.0	5.9	6.9	1.5	4.3	1.2	0.9	3.0	3.4	0.9	4.3	3.8	0.0	0.0	23.3	3.8	6.4	0.0	1.2	9.3	7.3	6.6	3.9	1.2	90.7	2.9	0.4	68.5	9.2	16.3	8.4	0.0	46.6	8.9	3.0	19.5	1.7	0.9	9.8	10.2	8.0	5.5	13.1	0.9	7.6	0.0	1.0	2.1	0.4	3.1	0.5	0.5	1.8	1.4	0.0	30.8	2.5	0.9	0.0	0.7	0.4	0.0	1.1	15.4	114.5	63.1	31.2	6.1	4.7	8.2	4.2	18.4	2.9
TRAIP	"RNF206, TRIP"	ENSG00000183763	"TRAF interacting protein"	Q9BWF2	3	49828601-49856574	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 8.2;Spermatocytes: 15.6;Spermatogonia: 9.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 10.8"	"HPA036261, HPA036262"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Cytosol"		"HPA036261: AB_10673348, HPA036262: AB_2675029"	"unprognostic (5.30e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.50e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.68e-3)"	"prognostic unfavorable (8.77e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.24e-2)"	"unprognostic (7.97e-2)"	"unprognostic (9.01e-5)"	"unprognostic (5.84e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-1)"	1.5	1.0	1.6	1.8	2.5	6.8	1.9	0.7	1.8	2.0	0.4	2.3	1.5	1.7	1.4	2.9	1.8	1.0	0.9	1.6	0.9	0.8	0.8	0.9	4.6	0.6	0.6	2.1	1.0	0.8	1.2	1.6	0.7	1.4	2.9	2.3	1.2	0.9	2.0	4.2	2.0	2.1	0.6	1.9	1.2	7.9	1.3	5.3	1.4	1.2	4.4	1.3	1.9	0.9	10.4	12.4	17.4	17.6	1.6	2.4	14.4	12.4	5.8	25.3	24.0	15.2	11.6	25.5	8.5	7.1	17.7	13.4	18.5	14.0	18.8	14.7	12.2	19.2	16.3	13.6	0.7	15.8	15.4	1.6	2.0	20.4	10.7	3.0	6.7	22.3	14.0	17.8	11.4	15.1	26.5	20.1	14.0	12.3	20.3	14.4	11.7	14.8	4.6	14.2	8.4	14.4	13.6	11.3	8.8	12.4	10.2	22.4	5.2	16.1	19.0	22.5	24.4	13.0	33.7	27.3	8.1	21.2	14.6	0.0	0.6	0.3	0.9	0.3	0.9	2.9	0.5	2.1	0.6	1.5	0.7	1.1	0.1	1.2	1.3	0.7	0.3	0.6	1.6	2.5	0.7	1.8	1.6	0.9	0.6	0.6	0.7	0.6	1.3	0.9	0.6	3.2	0.6	1.0	1.8	1.1	0.6	1.5	2.2	2.8	1.2	1.4	2.6	0.0	0.3	3.7	0.0	4.2	1.2	1.8	0.0	2.0	4.3	0.6	0.9	0.8	0.0	3.8	1.4	1.0	8.2	2.0	1.5	0.9	0.0	5.7	1.1	0.7	3.5	0.0	0.9	2.0	0.0	0.8	0.4	4.8	2.5	0.7	1.8	1.0	1.8	1.7	0.0	0.5	0.6	1.1	0.3	1.2	4.3	0.8	0.9	0.3	0.5	3.3	0.0	1.4	1.7	15.6	9.1	2.3	0.3	1.0	1.2	1.2	4.6	0.2
TRAP1	"HSP75, HSP90L"	ENSG00000126602	"TNF receptor associated protein 1"	Q12931	16	3651639-3717553	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 140.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041082, HPA044227"	Enhanced		Enhanced	Mitochondria		NA	NA		1700000	"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA041082: AB_2677291, HPA044227: AB_2678864"	"unprognostic (1.18e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.80e-4)"	"unprognostic (7.10e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.52e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.58e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.54e-1)"	"unprognostic (7.69e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.68e-2)"	"unprognostic (9.90e-2)"	"unprognostic (3.82e-2)"	46.4	50.6	32.5	32.7	35.6	35.6	45.7	28.9	37.6	54.0	22.7	50.0	39.7	42.5	18.5	72.2	59.0	33.3	88.1	34.5	34.2	59.9	121.5	33.3	47.6	33.1	32.2	58.8	76.2	39.9	35.3	33.3	33.5	41.6	36.9	22.3	46.1	26.5	193.9	67.7	36.7	30.3	26.8	39.9	49.5	40.1	36.7	27.5	33.3	138.9	36.4	48.9	50.4	32.5	113.4	277.6	56.7	150.2	61.1	62.1	167.6	67.6	60.7	152.2	95.3	347.9	156.5	361.1	123.7	65.1	41.1	207.3	223.0	167.7	67.1	139.3	241.8	105.9	225.1	246.0	105.3	192.0	69.4	74.2	114.6	121.1	188.2	55.0	106.1	122.5	338.4	120.8	50.5	367.8	138.6	141.5	106.0	133.8	140.1	314.1	118.9	500.6	112.8	83.0	268.4	102.2	70.0	254.5	135.8	46.5	184.5	137.2	60.2	63.7	112.9	112.5	99.5	135.5	161.1	289.2	39.7	152.1	88.8	0.1	24.0	0.8	24.7	38.9	47.3	42.1	36.0	31.5	54.9	30.7	42.1	35.9	2.6	31.9	29.8	8.4	33.4	33.0	32.5	35.6	28.9	37.6	34.5	34.2	33.1	32.2	33.5	26.8	36.7	32.5	20.4	22.4	17.5	16.3	21.3	25.4	44.3	63.2	38.1	29.3	32.4	36.8	2.1	45.8	39.8	31.3	10.4	112.6	5.9	28.7	88.0	67.7	24.1	30.6	21.1	21.3	35.5	42.1	31.6	53.8	56.2	23.7	36.2	28.1	16.5	41.5	12.8	48.8	46.1	47.1	31.1	37.5	59.0	14.5	14.8	13.0	16.4	14.7	12.4	12.2	26.3	20.2	12.3	11.6	16.2	31.9	14.5	21.4	37.9	45.9	14.1	140.9	30.1	22.2	19.7	29.9	29.4	37.2	70.9	70.7	28.1	67.2	15.1	58.9	74.9	42.8
TRAPPC10	"EHOC-1, TMEM1, TRS130"	ENSG00000160218	"Trafficking protein particle complex 10"	P48553	21	44012309-44106552	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 81.2;Oligodendrocytes: 132.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	11	"basophil: 9.7"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 9.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050423	Supported					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA050423: AB_2681123"	"unprognostic (1.82e-2)"	"unprognostic (4.89e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.95e-3)"	"unprognostic (1.93e-1)"	"unprognostic (4.00e-1)"	"unprognostic (9.70e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.80e-2)"	"unprognostic (2.76e-1)"	5.6	4.3	2.8	7.3	5.7	17.4	4.6	4.1	4.7	4.9	3.5	7.0	5.3	5.1	7.8	5.6	5.3	5.4	4.8	3.1	4.2	7.0	6.1	5.8	10.0	4.6	4.8	3.6	5.0	7.5	3.4	6.0	5.5	3.8	7.4	6.1	5.3	4.1	6.2	5.5	6.7	5.3	3.5	7.5	6.8	7.6	4.8	10.1	7.0	5.6	11.9	5.3	4.2	10.5	12.1	5.8	8.7	6.0	15.7	8.0	8.7	10.8	10.7	10.9	11.5	12.8	6.8	15.1	3.6	10.5	20.7	5.6	8.5	11.7	16.0	9.8	8.2	20.7	6.2	4.8	7.2	14.0	12.1	6.3	12.4	14.0	11.0	8.3	12.3	9.3	15.4	15.7	18.4	8.6	8.0	6.7	10.1	8.8	8.8	8.9	5.7	12.4	6.1	8.2	12.4	7.2	9.8	10.8	10.1	4.5	5.9	11.9	12.9	11.2	7.6	12.8	10.5	14.8	14.3	10.8	6.9	13.2	8.7	9.7	0.4	0.9	0.6	0.6	0.1	0.3	0.7	0.6	0.3	0.5	0.3	0.5	0.8	0.4	0.7	0.7	0.0	0.2	2.8	5.7	4.1	4.7	3.1	4.2	4.6	4.8	5.5	3.5	4.8	10.5	17.1	0.0	3.6	26.1	28.9	16.6	12.5	6.9	4.6	29.2	12.0	9.4	10.0	4.3	5.5	12.9	39.6	4.2	81.2	25.1	9.8	1.8	14.3	19.7	20.2	10.6	8.3	4.2	35.8	2.2	4.3	9.5	10.2	29.8	8.2	11.7	10.4	11.1	7.5	18.5	33.3	11.0	10.2	9.4	19.1	33.8	7.8	17.6	12.4	32.8	10.3	11.3	65.9	24.6	132.9	4.8	15.7	7.2	28.0	13.1	7.9	12.4	12.0	39.4	0.0	17.4	13.1	25.4	20.6	5.5	23.3	7.7	37.0	23.1	11.5	19.5
TRAPPC13	"C5orf44, FLJ13611, MGC48585"	ENSG00000113597	"Trafficking protein particle complex 13"	A5PLN9	5	65625004-65666233	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 66.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037777	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Plasma membrane"		"HPA037777: AB_10672464"	"unprognostic (3.66e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.54e-2)"	"unprognostic (7.22e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.49e-2)"	"unprognostic (5.70e-2)"	"unprognostic (5.75e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (8.66e-4)"	"unprognostic (2.89e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.53e-2)"	"unprognostic (6.25e-2)"	10.0	11.5	7.8	8.9	8.4	8.0	12.8	9.1	9.9	10.6	7.0	10.8	9.3	10.8	9.1	12.4	8.9	9.3	16.8	8.3	9.4	20.0	14.7	10.5	10.8	8.7	8.8	7.6	7.3	22.7	8.8	10.4	8.8	18.7	13.3	16.6	9.1	10.9	13.4	5.8	9.1	12.9	9.1	9.9	10.0	10.6	8.7	16.6	17.3	16.8	10.8	12.1	7.0	10.4	20.7	13.6	21.0	38.2	15.8	20.2	20.7	23.8	21.2	29.1	31.2	11.8	28.7	21.3	25.5	19.5	31.0	18.8	24.0	25.0	33.9	14.6	17.8	13.4	15.3	11.1	21.7	16.6	19.3	14.5	19.2	22.7	28.8	17.5	25.8	30.0	16.2	19.1	26.3	21.9	27.3	6.4	9.5	11.9	7.4	23.7	26.9	24.0	20.8	23.2	25.4	19.2	29.3	17.4	22.2	11.6	25.7	20.8	17.8	10.2	14.0	22.6	24.4	12.6	26.3	34.0	21.3	28.9	19.8	17.6	8.3	3.6	8.4	9.3	11.0	5.8	8.1	7.0	9.0	4.7	7.9	7.9	3.1	8.9	13.4	6.7	9.3	9.1	7.8	8.4	9.1	9.9	8.3	9.4	8.7	8.8	8.8	9.1	8.7	10.4	10.4	19.2	10.5	27.1	7.4	5.7	6.8	17.3	6.2	13.3	8.5	5.5	7.1	12.8	13.1	7.3	10.4	12.1	13.0	7.6	15.6	12.9	24.6	7.9	7.6	11.9	15.5	12.0	54.7	10.8	9.6	9.1	11.2	7.6	3.8	9.8	8.2	11.2	12.4	13.5	44.2	8.9	26.4	13.9	7.7	10.2	7.5	9.6	7.2	28.1	11.1	14.8	11.3	46.3	66.5	10.3	6.3	13.2	8.9	11.8	11.0	25.2	13.4	16.2	6.6	8.7	8.3	16.4	8.6	9.1	6.8	15.2	12.0	10.2	8.7	11.9
TRAPPC2L	HSPC176	ENSG00000167515	"Trafficking protein particle complex 2 like"	Q9UL33	16	88856220-88862686	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"ER-Golgi transport, Transport"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 403.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041714	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Vesicles, Cytosol"		"HPA041714: AB_10793930"	"unprognostic (1.27e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.46e-1)"	"prognostic favorable (3.75e-4)"	"unprognostic (2.77e-1)"	"unprognostic (2.69e-1)"	"unprognostic (5.24e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.53e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.94e-2)"	55.4	134.3	55.1	30.9	56.7	36.9	51.5	57.4	69.8	49.1	55.2	46.0	25.3	46.7	60.3	53.8	44.1	19.9	66.4	57.8	61.9	53.5	46.5	42.7	31.1	57.5	57.9	55.8	48.8	58.1	45.3	20.4	59.1	39.2	23.8	25.6	48.0	20.5	96.8	58.5	39.1	18.1	60.0	52.7	62.8	122.0	56.9	50.0	41.8	70.7	27.2	48.5	47.3	65.4	69.9	47.9	79.6	60.8	58.5	73.9	81.5	61.5	69.4	92.6	35.4	133.6	89.6	53.4	105.8	78.6	97.7	73.3	109.5	88.5	67.0	46.9	65.7	35.3	46.1	172.7	86.3	101.4	27.5	72.2	54.7	125.4	63.1	52.4	75.7	118.7	108.2	41.4	64.3	216.2	136.1	311.7	80.3	133.4	88.6	128.9	65.9	55.4	73.1	79.6	85.8	42.2	207.6	63.5	59.0	43.6	162.5	106.3	60.3	61.1	66.7	81.1	71.2	57.9	106.6	254.5	73.3	148.0	74.5	39.2	136.3	40.8	113.0	114.5	115.0	154.2	129.8	124.1	135.1	137.9	120.8	103.5	23.9	94.6	114.8	162.5	178.0	162.9	55.1	56.7	57.4	69.8	57.8	61.9	57.5	57.9	59.1	60.0	56.9	65.4	66.2	57.7	82.0	2.3	58.7	51.9	57.4	115.4	43.3	34.9	80.1	106.3	121.1	92.9	81.1	53.3	10.4	93.8	58.2	75.3	240.7	134.7	219.1	60.9	53.4	60.7	62.1	42.1	4.0	154.8	141.5	79.2	72.9	50.5	36.1	55.9	62.8	123.9	226.7	15.2	5.1	78.5	75.3	91.0	69.6	403.2	74.0	68.4	81.8	1.9	134.4	87.3	79.3	2.5	13.0	137.4	76.3	58.3	92.6	45.3	122.5	271.7	93.5	39.5	59.2	44.1	94.7	210.7	123.1	86.0	64.9	77.6	61.2	64.6	86.8	62.5
TRIAP1	"HSPC132, MDM35, P53CSV, WF-1"	ENSG00000170855	"TP53 regulated inhibitor of apoptosis 1"	O43715	12	120443964-120446384	"Predicted intracellular proteins, Transporters"	"Apoptosis, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 128.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA053640	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Mitochondria"		"HPA053640: AB_2682213"	"unprognostic (8.74e-3)"	"unprognostic (9.44e-2)"	"unprognostic (5.24e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (9.87e-3)"	"unprognostic (4.39e-2)"	"unprognostic (9.93e-2)"	"prognostic unfavorable (8.77e-4)"	"unprognostic (8.81e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.44e-2)"	"unprognostic (4.97e-2)"	21.8	24.6	16.6	18.9	16.8	32.9	28.4	17.1	23.0	16.6	18.0	24.6	19.2	14.1	20.8	22.9	17.2	15.4	19.4	16.8	17.5	21.1	66.4	16.8	24.8	16.9	16.7	12.1	52.5	14.7	12.3	29.1	17.1	20.1	30.5	8.8	25.3	15.3	60.4	27.0	18.5	20.9	17.2	16.3	19.6	13.2	16.9	25.7	15.7	39.1	27.5	24.1	15.6	18.2	56.2	75.1	67.4	46.3	57.5	88.1	161.0	71.8	51.2	62.5	51.6	63.2	30.4	110.0	59.6	59.2	25.0	37.4	79.3	118.6	65.8	49.1	88.5	66.9	48.7	167.9	85.4	113.6	49.6	91.6	146.7	61.4	87.0	62.3	131.1	59.8	109.3	27.7	92.1	70.3	86.0	152.7	96.5	67.9	60.4	70.4	63.5	114.4	81.1	62.0	66.3	43.2	82.7	28.1	64.6	105.7	93.9	65.6	74.8	40.0	60.7	40.7	44.1	70.6	120.6	118.5	61.5	86.9	71.2	26.7	47.1	18.2	41.0	52.7	48.8	35.1	39.2	39.0	59.1	31.8	48.3	43.1	4.0	49.6	36.5	53.1	37.3	45.0	16.6	16.8	17.1	23.0	16.8	17.5	16.9	16.7	17.1	17.2	16.9	18.2	25.8	3.2	15.2	3.6	30.5	51.2	28.5	108.2	44.3	10.6	35.9	44.1	12.1	45.8	36.0	7.3	6.2	128.5	29.4	16.9	66.5	48.4	8.3	22.4	27.7	34.3	22.1	23.7	3.9	50.4	91.2	23.1	15.3	16.4	17.2	34.9	24.3	63.3	52.0	3.3	2.9	22.6	40.7	23.3	27.6	5.7	16.4	19.1	39.2	1.0	48.0	15.4	44.3	3.0	4.7	43.2	20.7	18.4	19.8	37.7	30.1	49.4	25.4	9.5	19.7	18.9	27.3	34.5	31.4	45.6	71.3	75.4	28.3	47.0	39.5	28.9
TRIM14	KIAA0129	ENSG00000106785	"Tripartite motif containing 14"	Q14142	9	98069275-98119222	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 75.0;Kupffer cells: 80.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA053217	Uncertain					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 4: Macrophages - Innate immune response"			"HPA053217: AB_2682082"	"unprognostic (1.62e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.80e-2)"	"unprognostic (9.00e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.69e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.61e-3)"	"unprognostic (3.55e-3)"	"unprognostic (4.57e-2)"	6.4	5.3	9.0	18.4	7.6	12.1	10.0	4.7	7.7	5.8	4.7	18.9	29.5	4.3	1.8	19.5	6.3	9.6	1.6	7.7	7.3	11.4	22.3	14.9	25.6	14.1	8.1	2.9	3.1	13.5	5.1	5.0	8.4	9.4	16.8	2.7	10.6	5.6	1.0	9.9	30.4	8.8	9.4	26.8	11.6	7.8	9.7	32.7	2.9	1.0	21.8	12.7	9.1	8.9	25.5	12.9	0.6	11.3	0.0	3.9	8.3	14.8	28.1	79.3	67.8	24.8	14.9	33.5	11.8	16.1	47.2	28.6	24.9	16.5	24.1	43.3	20.0	9.9	20.3	24.6	17.1	53.1	10.7	2.4	8.0	11.6	14.8	10.6	10.1	37.4	39.6	15.5	7.3	32.6	42.2	16.7	14.2	56.3	39.5	27.4	1.4	17.2	6.3	15.6	4.0	3.3	20.8	43.2	14.3	2.8	11.4	30.4	7.1	3.3	8.5	1.2	20.5	6.7	8.3	11.1	9.1	41.1	11.4	1.0	14.4	2.1	15.1	28.4	16.1	8.3	17.1	15.7	15.8	5.6	13.1	11.4	4.0	13.0	59.0	15.3	23.1	17.2	9.0	7.6	4.7	7.7	7.7	7.3	14.1	8.1	8.4	9.4	9.7	8.9	2.1	3.2	8.8	3.3	15.3	2.8	14.3	11.8	15.4	35.1	8.7	8.3	1.0	7.2	14.2	5.5	75.0	5.0	28.8	40.0	3.9	4.9	8.8	4.8	8.9	4.1	12.6	5.9	7.0	13.6	16.9	3.2	13.3	5.4	1.3	12.0	7.5	22.4	15.4	3.3	5.4	15.3	10.2	80.6	2.4	9.9	0.3	32.6	1.8	2.8	16.5	1.9	30.9	12.1	0.9	15.0	13.5	1.5	8.5	19.1	38.1	21.1	17.0	4.4	0.0	1.4	2.0	16.3	3.8	17.3	3.3	3.3	21.3	5.8	19.4	21.1
TRIM32	"BBS11, HT2A, LGMD2H, TATIP"	ENSG00000119401	"Tripartite motif containing 32"	Q13049	9	116687305-116701300	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Limb-girdle muscular dystrophy, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050060	Approved		Approved	"Intermediate filaments"		No	No			"Cluster 35: T-regs - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Intermediate filaments"		"HPA050060: AB_2681000"	"unprognostic (2.47e-2)"	"unprognostic (7.06e-3)"	"unprognostic (5.50e-2)"	"unprognostic (3.63e-1)"	"unprognostic (5.08e-2)"	"prognostic unfavorable (4.53e-4)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (2.41e-3)"	"unprognostic (2.92e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.79e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.03e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.64e-3)"	"unprognostic (9.77e-2)"	6.7	7.2	4.6	5.4	4.5	1.0	6.8	16.4	5.4	10.1	15.2	6.0	5.9	10.6	6.5	7.4	13.1	6.4	7.9	4.7	6.1	5.2	3.8	5.5	8.1	3.6	2.8	10.1	6.2	8.6	3.5	6.1	3.9	6.9	6.2	7.2	5.2	7.3	18.6	4.6	7.2	10.7	2.1	6.2	5.4	5.2	4.5	7.5	6.3	12.5	7.4	7.6	5.7	3.4	10.9	24.5	14.3	15.7	28.3	20.1	10.8	19.9	21.7	22.1	18.4	16.4	11.7	11.3	8.6	30.7	16.5	22.8	17.5	22.4	20.0	9.9	8.5	6.1	15.4	10.2	14.7	4.1	19.1	17.4	19.7	21.0	12.3	24.4	14.6	12.4	8.6	9.3	26.3	13.9	11.0	0.1	13.0	26.2	14.6	12.7	38.2	7.4	9.0	25.1	14.2	7.2	15.7	10.8	11.4	14.3	29.8	4.0	18.2	20.4	16.2	15.3	15.2	15.1	4.3	17.7	17.0	2.7	20.5	0.0	1.7	0.0	10.9	3.3	8.4	7.3	9.5	8.7	2.3	5.1	9.6	9.8	0.3	7.0	3.0	4.3	20.9	6.0	4.6	4.5	16.4	5.4	4.7	6.1	3.6	2.8	3.9	2.1	4.5	3.4	2.5	6.4	0.6	5.5	4.3	4.2	6.3	9.3	5.7	11.7	3.1	3.7	7.6	7.2	7.3	9.2	0.0	6.7	2.1	1.7	1.9	8.5	3.5	7.1	10.7	3.6	4.2	0.4	7.6	8.0	3.6	6.1	3.6	2.3	2.5	4.5	2.9	4.1	7.2	1.7	10.1	4.0	8.2	2.4	4.7	2.1	5.3	2.2	1.8	1.9	0.8	4.0	3.1	6.6	5.1	5.0	2.6	12.0	3.1	2.8	10.6	3.1	10.8	4.8	0.0	6.0	6.6	17.7	13.1	5.6	3.7	7.4	4.7	5.0	5.3	4.8
TRIM59	"Mrf1, RNF104, TRIM57, TSBF1"	ENSG00000213186	"Tripartite motif containing 59"	Q8IWR1	3	160432445-160485773	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 68.4"	"Cell type enriched"	"Detected in many"	12	"Oligodendrocytes: 391.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017750	Uncertain		Approved	"Rods & Rings"		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Rods & Rings"		"HPA017750: AB_1858312"	"unprognostic (3.74e-1)"	"prognostic favorable (4.36e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.02e-1)"	"unprognostic (8.00e-4)"	"unprognostic (1.88e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (1.15e-5)"	"unprognostic (1.02e-3)"	"unprognostic (2.44e-11)"	"unprognostic (7.92e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.03e-2)"	"unprognostic (5.91e-3)"	0.7	0.8	9.0	5.1	38.8	17.6	2.1	18.0	20.4	1.4	0.0	2.7	2.8	3.0	0.9	4.9	2.0	2.7	0.8	12.3	15.2	1.2	1.0	2.0	12.1	19.4	23.6	1.3	1.5	1.8	1.2	2.0	19.9	2.0	2.6	1.4	1.7	1.0	1.2	5.4	2.9	2.8	9.3	5.1	2.5	8.7	24.6	13.6	2.0	0.1	12.1	3.1	2.2	68.4	20.4	15.8	19.8	1.3	7.8	10.6	26.0	31.5	27.3	38.5	36.9	1.9	34.8	54.5	22.9	23.7	12.1	34.1	0.0	12.9	50.7	49.1	19.2	2.0	5.4	2.4	10.9	24.3	3.2	9.0	3.8	18.7	13.4	23.6	27.1	8.0	25.8	22.6	36.7	21.9	15.0	1.9	52.5	13.2	26.1	20.7	17.2	24.6	13.8	6.6	13.0	2.8	9.0	26.3	0.7	26.5	31.2	22.4	20.9	2.8	8.9	4.5	3.1	37.0	14.5	13.4	3.4	31.0	3.1	29.1	2.8	5.4	10.9	3.1	12.7	10.4	17.9	15.0	4.5	9.3	12.0	14.5	2.2	12.4	1.5	6.7	22.0	3.7	9.0	38.8	18.0	20.4	12.3	15.2	19.4	23.6	19.9	9.3	24.6	68.4	0.6	0.0	6.5	0.3	7.8	4.8	4.7	2.1	3.4	0.4	2.8	1.8	2.5	2.8	1.4	1.8	6.2	7.2	6.1	1.2	0.0	2.0	31.2	1.9	2.1	2.5	10.8	29.5	0.4	2.0	11.7	2.1	5.1	2.9	1.3	10.1	2.2	0.1	2.9	0.0	0.5	2.9	2.0	2.2	2.3	12.5	0.3	1.8	3.6	0.0	2.1	0.5	3.1	0.0	391.8	1.9	2.8	0.7	6.4	3.3	1.2	2.3	2.1	1.7	0.0	2.4	2.7	14.0	15.1	5.6	4.4	2.5	10.9	2.7	4.8	3.6
TRIP11	"CEV14, GMAP-210, GMAP210, Trip230"	ENSG00000100815	"Thyroid hormone receptor interactor 11"	Q15643	14	91965991-92040896	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002570, HPA070684"	Supported		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	Nucleoplasm	"HPA002570: AB_1078995, HPA070684: AB_2686295"	"unprognostic (1.65e-1)"	"unprognostic (2.81e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.33e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (1.78e-6)"	"unprognostic (1.78e-1)"	"unprognostic (5.08e-1)"	"unprognostic (7.74e-2)"	"unprognostic (5.55e-2)"	10.4	10.5	4.7	8.6	8.8	7.6	10.5	10.8	7.4	11.6	13.5	10.1	10.4	9.7	6.7	12.1	7.7	10.1	10.6	3.5	5.4	13.5	12.9	8.0	9.4	6.2	7.3	11.0	25.5	19.2	4.8	11.6	6.8	9.6	9.8	10.6	11.0	8.5	11.8	8.9	7.9	10.2	6.2	8.6	15.3	13.6	6.5	11.2	16.7	15.6	11.4	10.4	5.8	10.7	22.8	22.5	14.4	15.2	24.8	38.1	21.8	35.3	27.0	17.1	19.5	13.8	36.0	15.8	25.3	31.3	13.3	29.1	19.1	17.1	37.0	24.1	5.8	17.9	20.4	13.1	18.9	21.2	17.1	14.7	20.4	30.3	25.8	18.9	27.8	8.7	11.9	17.8	27.0	31.7	12.2	5.2	6.6	22.1	16.0	14.8	27.5	8.0	15.3	36.5	10.5	9.5	28.5	16.6	11.0	14.5	36.2	10.5	36.9	19.8	13.8	20.8	16.1	15.7	25.9	14.2	23.2	11.7	25.3	9.3	9.7	20.2	13.9	9.0	13.6	13.0	14.7	13.1	7.9	23.7	14.2	14.9	9.6	14.8	16.1	14.3	14.5	4.3	4.7	8.8	10.8	7.4	3.5	5.4	6.2	7.3	6.8	6.2	6.5	10.7	66.8	54.5	79.8	57.5	32.5	16.6	30.7	31.7	21.6	61.1	39.9	40.0	115.7	34.3	54.0	38.6	73.0	44.2	41.4	29.8	17.6	72.5	13.6	58.2	81.2	53.9	32.2	30.7	58.1	46.2	32.0	51.7	39.8	56.5	37.9	68.7	32.9	37.5	24.4	43.7	74.7	40.4	32.6	25.7	11.2	14.7	62.1	30.4	7.2	51.5	41.6	56.5	47.4	66.9	92.4	44.7	29.5	54.2	26.3	39.0	31.6	23.4	56.4	70.4	59.2	76.6	50.4	105.0	65.8	19.5	17.0	72.5	30.2	79.8	32.9	35.1
TRIP13	16E1BP	ENSG00000071539	"Thyroid hormone receptor interactor 13"	Q15645	5	892884-919357	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Meiosis, Oogenesis, Spermatogenesis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 29.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 115.4;Late spermatids: 206.9;Respiratory ciliated cells: 79.9;Spermatocytes: 86.4;Spermatogonia: 70.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA005727, HPA053093"	Enhanced		Approved	Nucleoplasm		NA	NA		78000	"Cluster 40: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA005727: AB_10603220, HPA053093: AB_2682042"	"unprognostic (1.65e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.59e-2)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (2.34e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (1.30e-6)"	"unprognostic (4.44e-3)"	"unprognostic (1.73e-3)"	"prognostic favorable (1.39e-4)"	"unprognostic (4.25e-2)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.04e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.34e-1)"	1.4	0.7	2.0	4.4	2.1	6.0	2.7	0.9	1.8	1.5	1.0	3.8	3.5	1.8	0.6	4.6	6.7	0.7	0.4	1.6	1.5	1.1	0.8	1.3	7.1	1.3	2.0	2.0	1.3	0.2	1.6	3.3	1.4	0.8	5.7	0.5	1.0	0.4	0.6	2.3	3.6	3.5	1.1	1.9	1.7	29.9	1.9	9.3	0.5	0.3	8.4	1.9	1.7	1.2	67.5	73.9	46.6	69.6	4.3	10.1	51.8	68.6	33.1	103.4	96.7	72.2	43.4	59.1	48.7	39.5	90.1	48.7	100.3	47.6	129.1	91.0	83.7	40.6	136.4	52.3	1.1	67.3	23.9	4.7	3.6	87.0	37.3	10.7	51.5	45.9	61.7	50.2	71.7	45.7	67.6	60.6	53.0	37.7	69.4	38.8	87.3	113.0	29.3	34.2	47.9	49.0	103.1	38.2	20.8	40.2	71.3	32.0	26.4	55.6	70.4	46.5	79.0	31.9	68.9	64.6	34.2	79.3	63.1	0.0	0.0	0.0	0.4	0.0	0.2	1.1	0.6	0.7	0.1	1.2	0.2	0.1	0.0	1.6	0.1	1.0	2.1	0.4	2.0	2.1	0.9	1.8	1.6	1.5	1.3	2.0	1.4	1.1	1.9	1.2	0.7	0.0	1.1	0.3	4.3	3.4	3.5	7.3	4.0	0.9	2.2	1.8	0.3	0.0	5.0	0.0	0.0	8.6	0.7	2.2	0.0	3.0	115.4	29.3	2.1	2.5	4.2	14.3	1.3	2.0	25.2	3.4	1.5	3.8	5.7	9.8	2.2	0.4	7.3	3.3	0.5	3.0	4.1	1.3	4.2	206.9	2.1	1.7	0.0	0.0	1.1	0.7	0.0	0.0	0.4	2.2	1.8	2.2	18.1	2.8	0.5	1.2	79.9	0.9	6.6	2.5	5.2	86.4	70.1	7.6	1.4	3.4	3.2	2.7	5.1	3.3
TRMT1	"FLJ20244, TRM1"	ENSG00000104907	"TRNA methyltransferase 1"	Q9NXH9	19	13104902-13117567	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Kupffer cells: 80.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041130, HPA041380"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041130: AB_10803995, HPA041380: AB_10793873"	"unprognostic (2.10e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.91e-2)"	"unprognostic (8.74e-3)"	"prognostic unfavorable (9.87e-7)"	"unprognostic (1.19e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.49e-2)"	22.0	19.8	16.5	16.2	15.3	21.1	21.0	14.7	22.1	24.3	14.8	20.0	11.8	22.9	6.3	22.3	23.6	8.9	17.3	15.5	14.7	18.0	22.1	17.3	23.2	16.0	14.8	28.7	25.4	10.0	17.2	11.3	16.8	23.0	10.9	6.5	17.0	11.4	28.8	23.4	21.7	12.5	14.2	30.6	18.9	16.8	16.2	11.6	19.2	10.5	15.9	22.3	22.2	17.6	38.6	25.3	26.9	46.0	26.7	34.1	38.7	42.1	20.9	45.3	39.1	27.4	30.8	47.7	53.6	22.9	23.7	34.8	45.2	37.3	20.9	31.3	62.8	38.0	68.7	46.5	48.7	77.2	43.1	48.4	48.4	47.3	44.1	28.9	33.8	35.2	83.7	14.9	28.6	42.6	31.7	83.3	64.0	24.2	57.5	52.5	34.6	65.8	28.3	38.2	63.5	28.9	26.2	53.7	44.8	19.4	21.0	42.8	38.2	65.1	25.5	39.8	75.1	25.6	53.4	44.1	30.3	80.7	34.7	1.8	18.9	0.6	8.9	15.0	8.6	12.4	9.6	8.6	18.2	12.9	11.1	8.5	3.7	5.6	9.9	10.6	6.9	10.7	16.5	15.3	14.7	22.1	15.5	14.7	16.0	14.8	16.8	14.2	16.2	17.6	15.5	12.8	13.1	8.5	47.5	24.0	27.0	16.8	22.8	8.9	16.6	20.2	8.3	11.5	9.6	12.9	2.1	21.7	19.6	16.6	5.9	17.3	22.4	7.9	11.7	17.6	7.2	13.0	12.0	14.9	22.6	14.3	17.9	9.8	29.8	19.7	6.1	10.8	47.7	8.4	9.1	14.1	4.1	80.0	51.0	47.9	14.0	57.4	17.8	10.3	64.8	6.1	12.3	2.5	7.5	12.8	6.8	12.8	24.2	29.0	7.8	14.2	9.2	12.6	13.1	17.5	16.1	21.1	20.0	20.7	20.6	15.5	24.4	14.6	22.5	20.3
TRMT10C	"FLJ20432, MRPP1, RG9MTD1"	ENSG00000174173	"TRNA methyltransferase 10C, mitochondrial RNase P subunit"	Q7L0Y3	3	101561868-101566446	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036671	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Mitochondria	Nucleoplasm	"HPA036671: AB_10602085"	"unprognostic (7.42e-2)"	"unprognostic (2.68e-1)"	"unprognostic (9.08e-3)"	"unprognostic (4.47e-3)"	"unprognostic (5.01e-2)"	"unprognostic (5.55e-2)"	"prognostic unfavorable (6.56e-5)"	"unprognostic (1.67e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.42e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (3.32e-5)"	"unprognostic (2.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-2)"	16.6	17.4	6.9	14.8	7.9	18.2	20.8	9.1	9.7	12.2	8.5	15.4	12.7	14.1	13.4	18.9	14.5	11.4	21.6	7.8	7.9	19.2	25.2	10.3	20.5	7.4	7.4	15.7	10.4	15.6	6.4	14.0	7.9	11.9	14.7	7.8	13.0	9.9	27.6	12.7	13.1	16.0	7.4	12.5	12.1	11.8	7.5	17.5	15.4	30.2	20.7	26.6	8.6	7.5	58.9	28.2	36.6	37.1	33.0	28.0	34.1	34.2	33.3	43.6	48.5	43.2	38.6	121.3	43.4	21.6	35.4	57.9	71.5	52.5	59.7	43.8	35.3	81.6	20.5	31.6	25.4	72.5	33.1	32.9	53.3	38.3	35.4	23.2	43.1	45.4	70.3	26.3	47.6	40.4	58.2	52.9	68.2	75.9	60.4	42.9	29.8	54.3	56.2	49.0	90.9	51.8	26.7	56.0	78.1	31.9	74.0	78.9	28.7	23.6	45.0	15.8	36.5	30.4	59.4	117.5	40.0	51.5	36.2	56.6	18.2	12.8	21.1	24.7	29.8	35.7	26.2	25.1	22.7	34.2	35.0	33.2	8.1	21.4	27.4	25.8	26.2	19.5	6.9	7.9	9.1	9.7	7.8	7.9	7.4	7.4	7.9	7.4	7.5	7.5	33.3	22.4	24.0	4.9	47.9	94.3	153.4	106.8	63.7	30.6	39.9	52.7	51.5	21.5	69.2	29.5	14.6	65.7	50.3	21.5	52.8	48.5	49.7	54.7	54.0	39.5	35.8	65.0	8.8	33.8	47.0	38.8	28.1	63.5	46.3	47.3	31.4	56.9	31.1	21.9	8.5	31.5	69.2	27.3	31.9	13.7	37.3	23.7	14.2	1.9	42.1	29.8	37.0	6.6	7.6	37.2	17.9	37.6	21.5	85.3	17.3	72.0	53.3	33.9	32.9	58.1	41.3	77.7	55.0	55.2	105.0	65.5	46.4	57.1	47.0	127.4
TRMT13	"CCDC76, FLJ10287, FLJ11219"	ENSG00000122435	"TRNA methyltransferase 13 homolog"	Q9NUP7	1	100133150-100150498	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 97.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028494	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Plasma membrane"	"Nuclear bodies, Cytosol"	"HPA028494: AB_10601254"	"unprognostic (1.12e-1)"	"unprognostic (3.33e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.17e-3)"	"unprognostic (4.97e-2)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (1.16e-3)"	"unprognostic (3.28e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.02e-3)"	"prognostic unfavorable (6.89e-6)"	"unprognostic (3.12e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.70e-3)"	8.8	8.7	6.9	12.2	9.8	5.2	14.5	9.6	9.6	11.2	6.7	9.3	11.2	13.9	11.8	8.5	9.2	7.2	8.0	6.5	9.7	8.8	8.7	7.8	18.2	8.5	9.0	13.5	11.5	12.9	6.8	10.7	8.7	10.4	11.3	21.7	9.1	8.1	13.1	14.7	10.7	10.1	7.0	14.1	10.0	9.4	8.5	11.3	12.0	6.2	14.6	9.5	10.3	14.9	17.5	10.0	16.5	11.5	8.7	16.9	18.0	18.0	7.1	13.4	11.1	11.9	7.0	28.7	21.8	14.4	8.9	15.4	30.6	14.0	23.1	29.0	24.2	17.2	23.1	11.6	15.7	30.0	15.4	11.9	15.5	25.5	33.3	8.4	12.4	21.0	36.6	17.9	13.6	6.7	24.6	15.6	23.0	16.7	19.9	26.0	25.0	15.7	11.1	13.6	10.7	17.9	16.6	15.8	21.6	16.1	9.3	26.1	13.0	17.8	11.9	15.1	24.3	22.8	20.0	34.0	20.1	23.5	7.0	0.2	5.8	3.1	10.5	6.1	13.0	19.9	11.3	10.6	7.0	18.7	16.8	14.0	2.5	7.9	5.1	12.8	8.6	5.6	6.9	9.8	9.6	9.6	6.5	9.7	8.5	9.0	8.7	7.0	8.5	14.9	13.1	25.6	17.0	34.0	29.0	9.7	14.2	14.2	19.9	38.9	10.7	7.9	11.1	12.8	22.2	14.7	29.2	14.2	18.9	8.0	13.7	10.5	20.9	14.3	21.0	15.7	20.4	11.3	23.1	6.1	10.2	13.7	11.7	8.0	21.5	18.7	17.9	11.4	7.6	28.6	32.1	9.9	18.3	10.1	7.0	6.0	24.8	10.3	10.6	25.3	14.7	16.6	41.2	33.7	97.4	8.5	9.6	18.4	9.0	12.6	13.0	10.7	20.4	44.7	19.7	16.0	13.4	47.6	21.9	12.2	11.9	7.3	21.5	15.8	13.6	10.0
TRMT6	"CGI-09, GCD10, Gcd10p, MGC5029"	ENSG00000089195	"TRNA methyltransferase 6"	Q9UJA5	20	5937228-5950558	"Predicted intracellular proteins"	"tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatogonia: 103.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047032, HPA050408"	Approved		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Cell Junctions"	"HPA047032: AB_2679911, HPA050408: AB_2681117"	"unprognostic (1.78e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.26e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (4.70e-12)"	"unprognostic (5.37e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.65e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.87e-3)"	"unprognostic (4.96e-2)"	7.4	9.7	5.1	7.3	5.3	13.8	5.9	5.9	6.3	5.9	4.5	5.8	3.4	6.6	6.0	9.1	5.7	3.5	7.7	5.4	5.2	8.0	5.5	4.9	9.3	5.8	5.1	5.6	7.3	6.8	8.4	5.1	5.8	5.2	5.5	3.7	6.1	9.9	20.2	7.8	5.9	5.6	4.9	6.6	5.8	11.5	4.8	8.8	5.9	7.3	9.0	11.0	6.4	5.1	55.5	27.8	17.1	25.9	10.4	11.8	21.4	24.7	12.5	24.5	20.6	36.5	22.2	62.1	13.1	15.1	33.8	39.9	36.3	41.8	40.3	13.3	25.5	50.6	12.0	32.2	19.8	47.8	13.3	13.6	21.8	44.4	33.4	8.6	10.0	25.6	32.3	18.0	28.8	14.4	50.6	26.2	39.5	36.9	33.9	33.4	33.6	36.1	18.3	31.3	33.9	51.1	29.2	39.3	45.0	16.2	20.2	24.4	8.8	28.5	27.1	26.8	52.1	31.6	64.1	74.6	13.3	37.9	29.3	2.1	7.8	6.3	9.1	9.1	10.9	8.6	9.9	11.5	18.0	8.1	10.1	11.1	0.7	15.6	8.3	7.5	12.5	7.2	5.1	5.3	5.9	6.3	5.4	5.2	5.8	5.1	5.8	4.9	4.8	5.1	11.7	6.4	20.3	2.0	20.0	21.4	26.1	35.8	25.0	19.8	12.6	14.9	25.9	15.7	31.3	29.5	10.4	26.2	12.4	6.3	35.2	26.3	3.9	18.2	14.8	17.8	13.8	10.7	6.4	30.7	26.8	19.7	12.8	16.2	34.9	25.5	5.0	19.1	17.6	26.9	4.9	8.6	26.4	15.0	47.5	6.5	11.5	35.0	17.8	11.2	13.6	13.2	20.6	4.5	4.0	22.4	7.3	7.2	17.5	33.8	3.8	22.7	30.8	11.0	13.1	26.7	28.7	70.4	103.6	17.4	24.0	29.3	21.0	18.7	12.6	20.6
TRMT61B	FLJ20628	ENSG00000171103	"TRNA methyltransferase 61B"	Q9BVS5	2	28849821-28870309	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA026747, HPA026751"	Enhanced		Uncertain	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA026747: AB_1848782, HPA026751: AB_1848784"	"unprognostic (1.01e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.05e-2)"	"unprognostic (3.32e-2)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (2.36e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.52e-2)"	"prognostic favorable (9.61e-5)"	"unprognostic (2.19e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.34e-1)"	8.8	13.1	9.8	8.5	9.9	9.2	13.1	12.1	17.0	9.4	12.0	8.4	14.1	10.1	14.0	8.6	8.1	7.2	15.2	9.8	9.9	14.4	12.6	6.6	11.0	9.7	9.8	9.4	7.0	15.1	9.0	8.9	10.0	10.6	9.3	9.4	8.7	7.9	13.8	8.7	14.1	10.3	9.8	8.7	9.2	7.4	9.7	10.2	9.1	16.6	9.1	10.7	7.5	10.6	28.5	16.7	16.7	29.6	22.3	19.0	20.1	16.5	20.3	20.6	19.2	19.3	15.0	29.9	14.8	14.5	24.7	21.7	23.5	20.1	21.3	22.6	15.8	9.1	13.6	25.7	25.2	19.4	10.0	19.5	22.0	16.4	22.2	15.2	20.0	19.1	18.9	11.2	17.2	11.3	17.3	29.6	31.0	33.6	26.7	12.7	26.9	26.1	18.2	18.2	28.1	29.8	17.8	27.8	28.5	13.9	14.2	6.7	15.8	13.7	23.1	13.6	21.0	13.7	24.2	46.6	18.1	28.9	18.8	0.0	8.0	3.5	11.2	8.5	13.8	14.5	12.4	12.0	7.8	14.1	13.7	9.9	1.1	17.7	7.1	8.3	14.7	7.4	9.8	9.9	12.1	17.0	9.8	9.9	9.7	9.8	10.0	9.8	9.7	10.6	10.2	16.0	8.7	18.3	17.7	18.1	11.0	23.7	17.1	10.8	9.9	10.2	2.8	11.5	14.7	9.2	6.2	22.1	11.8	4.5	15.6	14.5	9.3	9.4	11.8	8.5	4.8	10.9	38.0	10.2	13.8	10.8	21.4	7.7	9.5	15.8	7.5	11.5	9.2	6.7	34.8	9.8	20.3	7.3	8.2	3.6	8.7	7.0	7.2	7.5	11.0	10.3	8.2	36.2	32.2	10.3	8.5	10.5	13.5	7.6	23.6	30.3	15.0	21.6	6.6	12.2	10.6	24.1	9.7	15.3	15.8	8.8	12.4	15.9	12.1	7.3
TRNT1	"CCA1, CGI-47, MtCCA"	ENSG00000072756	"TRNA nucleotidyl transferase 1"	Q96Q11	3	3126933-3150879	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Nucleotidyltransferase, RNA-binding, Transferase"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036938	Uncertain		Supported	Mitochondria		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA036938: AB_10670566"	"unprognostic (6.39e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.68e-1)"	"unprognostic (6.22e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.02e-1)"	9.7	10.0	7.2	8.9	7.2	3.5	8.5	7.9	8.0	7.8	7.0	8.1	4.4	8.8	5.5	9.4	7.6	8.3	8.4	7.4	7.2	17.2	10.0	8.4	9.7	7.1	7.3	8.3	8.4	8.3	10.3	10.5	7.1	11.3	7.6	4.0	7.7	6.3	9.3	6.4	7.9	8.3	7.3	10.7	9.1	6.5	7.4	9.8	11.3	7.6	10.9	13.1	7.9	8.0	20.0	29.6	18.2	9.8	24.1	21.5	20.5	19.9	17.4	21.6	20.9	25.0	20.9	35.6	12.8	22.4	32.0	12.6	24.6	18.6	26.5	24.6	13.3	28.7	25.3	24.9	31.4	32.2	20.8	17.9	25.0	20.2	6.8	15.0	21.0	24.1	25.1	9.8	35.9	37.2	22.0	21.4	15.2	29.2	19.0	20.5	28.1	32.5	26.1	25.8	10.8	15.9	31.6	20.6	18.5	26.3	18.7	16.3	14.8	22.8	18.7	23.6	25.7	12.6	31.4	43.4	17.2	27.6	25.0	49.4	12.4	36.4	16.4	18.1	16.0	25.8	20.8	18.1	16.8	15.7	22.7	20.1	16.6	19.8	19.0	15.6	18.6	11.2	7.2	7.2	7.9	8.0	7.4	7.2	7.1	7.3	7.1	7.3	7.4	8.0	20.7	16.0	13.4	15.3	30.2	14.8	29.0	19.9	24.5	13.5	12.1	11.0	14.3	2.8	16.3	18.4	14.6	25.8	23.5	10.6	45.0	19.1	2.3	15.8	19.0	21.1	8.4	16.6	23.8	9.9	17.8	19.9	23.4	12.0	22.8	20.7	12.5	9.2	13.3	10.1	27.0	10.7	16.2	11.0	13.3	2.9	10.8	13.3	7.2	23.4	20.3	17.1	18.6	23.6	34.7	10.6	9.2	8.6	30.7	30.9	11.0	32.7	11.4	15.7	0.0	14.9	17.4	20.8	17.9	23.4	13.1	28.3	22.0	24.7	13.5	23.9
TRPM3	"GON-2, KIAA1616, LTRPC3"	ENSG00000083067	"Transient receptor potential cation channel subfamily M member 3"	Q9HCF6	9	70529060-71446904	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"choroid plexus: 801.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 905.0;Excitatory neurons: 390.3;Inhibitory neurons: 186.9;Muller glia cells: 184.5"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HAP1: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA072650, HPA074393"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA072650: , HPA074393: "	"unprognostic (3.74e-1)"	"unprognostic (6.30e-2)"	"unprognostic (4.79e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.82e-7)"	"unprognostic (3.51e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.50e-2)"	0.7	0.6	22.0	0.1	30.4	0.2	0.1	40.5	9.6	1.0	801.0	0.2	0.8	1.1	1.3	0.1	0.4	0.4	0.8	39.3	27.8	16.5	0.2	0.1	0.1	36.7	46.8	3.6	0.5	0.0	2.9	0.1	20.8	0.5	0.1	23.0	0.1	2.5	0.3	0.1	0.0	0.2	25.2	0.3	0.6	5.1	41.6	0.2	0.9	0.1	0.0	0.1	0.4	15.4	0.0	0.0	0.9	0.0	1.1	2.6	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	17.2	0.0	0.1	0.0	0.1	0.1	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.2	0.0	0.0	1.0	4.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.2	0.0	0.9	0.0	1.1	0.0	0.2	0.0	0.3	0.2	0.0	0.0	3.1	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	22.0	30.4	40.5	9.6	39.3	27.8	36.7	46.8	20.8	25.2	41.6	15.4	0.3	3.2	3.0	905.0	0.5	0.4	0.9	0.0	0.6	16.4	0.3	0.5	5.3	5.7	2.5	16.5	66.7	0.1	0.2	0.1	5.9	0.1	4.8	1.4	1.0	1.3	15.4	0.0	390.3	0.2	0.1	3.0	0.0	3.2	0.0	1.4	0.7	0.3	0.2	1.7	186.9	0.1	0.0	0.9	1.4	2.3	5.6	0.8	0.0	56.2	0.2	184.5	1.0	105.6	8.3	0.1	0.1	9.1	0.0	0.5	0.1	33.3	0.8	10.1	0.0	3.5	1.3	1.3	0.6	0.0	0.9	0.3	0.9	0.6	0.0	0.3
TRUB1	PUS4	ENSG00000165832	"TruB pseudouridine synthase family member 1"	Q8WWH5	10	114938195-114977676	"Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 62.2;Theca cells: 74.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037914, HPA057552"	Approved		Approved	Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles		"HPA037914: AB_10672399, HPA057552: AB_2683465"	"unprognostic (1.98e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.20e-3)"	"unprognostic (9.79e-2)"	"unprognostic (9.26e-2)"	"unprognostic (4.89e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.50e-3)"	"unprognostic (7.54e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-1)"	7.4	29.3	6.3	7.5	7.4	4.2	11.3	5.1	9.0	9.8	7.3	9.5	8.9	12.8	9.3	8.3	9.7	7.7	21.5	7.6	7.1	16.0	12.9	6.6	10.0	5.8	6.0	16.8	6.8	15.8	4.9	7.5	6.1	11.7	10.4	6.7	9.3	9.9	7.5	6.5	8.2	11.1	5.6	9.3	8.7	17.9	7.0	11.5	12.3	9.7	10.1	7.8	4.8	6.4	25.5	19.6	18.8	47.0	13.3	17.7	25.3	21.4	24.1	28.4	32.0	16.1	25.5	31.4	24.2	16.9	12.4	21.3	25.6	26.5	41.8	23.9	27.5	14.4	9.2	28.8	22.8	27.2	20.7	18.2	35.8	20.2	39.6	30.1	16.2	24.9	15.1	12.5	34.1	12.3	25.7	21.6	17.8	17.0	19.1	25.4	47.5	19.2	37.4	12.7	17.5	19.3	18.0	26.4	47.7	20.0	21.1	16.6	14.5	13.0	13.0	20.8	26.5	23.6	20.4	26.3	18.3	34.2	11.9	4.0	2.6	0.9	4.4	4.0	6.5	7.3	4.7	4.7	4.8	5.9	6.2	5.8	0.2	8.1	7.3	4.3	6.2	4.6	6.3	7.4	5.1	9.0	7.6	7.1	5.8	6.0	6.1	5.6	7.0	6.4	6.9	12.8	8.4	8.8	11.2	5.6	4.7	15.3	6.2	13.9	11.9	8.1	13.6	4.3	12.0	9.2	2.1	9.1	10.5	7.1	21.5	7.6	62.2	11.1	12.8	6.6	7.7	9.0	23.0	4.9	6.6	11.2	6.6	12.0	10.2	26.7	12.1	20.2	7.6	25.2	22.0	8.2	6.1	7.3	4.2	9.6	8.4	5.0	3.6	8.4	5.4	10.4	9.2	31.2	16.7	7.0	3.6	10.1	12.7	4.2	6.2	27.9	9.8	5.6	6.6	8.4	9.3	14.5	23.3	15.9	7.0	6.2	8.0	74.1	12.9	5.8
TRUB2	CLONE24922	ENSG00000167112	"TruB pseudouridine synthase family member 2"	O95900	9	128305159-128322447	"Predicted intracellular proteins"	"mRNA processing"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021211	Uncertain					NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA021211: AB_1858375"	"unprognostic (2.40e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.72e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.49e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.81e-3)"	"prognostic favorable (5.57e-10)"	"unprognostic (8.74e-3)"	"unprognostic (8.81e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.08e-1)"	3.7	8.5	8.7	3.6	9.0	4.2	4.7	8.9	9.3	3.3	8.7	4.5	5.0	3.3	2.9	6.3	4.1	2.7	8.7	8.5	8.1	6.5	12.9	2.4	4.5	9.3	9.3	3.8	5.2	7.2	6.8	2.7	9.8	3.6	4.2	3.6	4.8	3.4	7.2	5.4	4.3	3.2	7.7	3.6	4.6	3.1	9.5	3.5	4.7	9.8	4.3	4.0	3.5	9.9	6.6	14.9	6.7	9.2	10.7	7.9	7.1	7.1	8.5	11.6	9.5	11.1	8.3	14.7	6.0	9.7	11.0	17.5	15.4	12.4	7.8	7.1	10.2	6.9	12.8	10.4	8.2	12.7	8.9	10.0	13.7	11.4	10.7	7.2	12.0	12.8	26.2	6.4	9.3	19.7	17.1	14.7	9.2	22.2	19.0	13.3	10.9	21.0	10.7	5.9	14.4	10.6	13.2	14.6	9.5	5.2	19.1	8.7	8.1	9.4	7.5	11.2	8.6	7.5	16.4	11.9	9.9	9.9	10.5	3.6	3.6	1.1	5.0	3.8	5.7	6.3	4.8	5.7	5.5	5.3	5.5	5.7	1.8	6.5	2.0	3.8	6.2	3.8	8.7	9.0	8.9	9.3	8.5	8.1	9.3	9.3	9.8	7.7	9.5	9.9	10.9	25.6	10.3	1.6	17.1	9.6	13.7	43.0	15.4	21.3	14.6	15.7	49.9	24.3	27.0	35.0	16.7	51.6	10.9	19.8	64.6	39.0	12.9	15.1	20.7	16.4	19.1	16.2	5.0	35.4	45.9	15.4	27.0	15.9	8.2	22.0	17.2	50.7	31.0	3.3	5.2	26.4	34.6	9.0	4.1	16.4	20.8	12.4	12.4	3.7	16.8	15.4	18.6	3.0	10.5	27.2	19.1	18.0	17.8	14.9	34.0	78.6	16.9	16.7	0.0	17.2	16.3	15.8	19.2	22.1	10.5	28.0	13.9	46.1	35.3	11.1
TSC1	"hamartin, KIAA0243, LAM, TSC"	ENSG00000165699	"TSC complex subunit 1"	Q92574	9	132891348-132946874	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Chaperone	"Cancer-related genes, Disease variant, Epilepsy, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 133.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011568, CAB012481, HPA074132"	Supported		Enhanced	Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"CAB011568: AB_732752, CAB012481: , HPA074132: AB_2686666"	"unprognostic (1.88e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.67e-2)"	"unprognostic (4.23e-3)"	"prognostic unfavorable (6.03e-6)"	"unprognostic (1.96e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (8.01e-4)"	"unprognostic (1.84e-2)"	"prognostic favorable (7.91e-4)"	"unprognostic (9.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.16e-1)"	11.8	14.5	6.1	5.2	6.0	9.0	12.2	8.3	6.8	13.7	3.6	13.4	5.1	12.0	6.5	10.1	11.8	5.4	14.0	6.0	5.1	13.1	10.9	11.4	6.3	4.5	5.2	18.2	12.8	7.4	16.2	9.3	4.9	13.1	7.1	8.3	11.4	5.4	14.9	15.8	12.6	7.9	1.1	14.9	12.2	22.8	4.5	6.7	17.3	14.6	8.6	11.4	12.7	4.4	8.3	9.7	13.0	10.7	13.0	12.2	24.2	10.3	17.6	11.5	11.0	16.5	9.5	19.4	4.7	20.9	17.0	21.0	15.4	11.0	11.3	9.4	8.2	6.1	19.9	13.6	15.6	9.4	8.0	13.6	8.2	14.3	17.4	11.1	13.0	16.9	11.1	10.2	12.9	15.4	8.3	7.8	17.8	12.1	7.8	9.9	24.5	11.0	5.0	10.7	6.4	10.0	12.7	7.9	6.2	15.2	14.4	5.5	13.8	18.1	10.8	11.4	7.7	5.7	13.8	18.5	10.3	5.2	8.2	2.1	2.3	2.8	3.2	3.8	3.5	0.9	1.7	2.9	1.7	1.2	2.9	2.6	0.9	3.0	1.8	0.9	3.1	1.5	6.1	6.0	8.3	6.8	6.0	5.1	4.5	5.2	4.9	1.1	4.5	4.4	14.7	22.4	27.2	35.3	10.8	7.5	6.2	5.1	9.6	26.6	11.2	9.5	29.2	7.2	10.3	11.0	37.5	15.1	13.5	7.1	13.7	11.7	45.9	18.0	22.2	12.7	16.8	15.8	53.6	7.2	24.0	14.0	14.3	25.8	8.8	27.4	9.7	5.9	9.2	25.2	59.0	10.0	10.2	7.7	7.9	133.1	15.5	12.8	12.4	19.7	10.8	9.7	7.2	30.7	47.8	12.5	7.9	11.3	12.4	9.0	8.9	7.3	16.2	24.4	19.7	19.5	15.4	22.4	20.0	11.8	8.7	21.1	11.9	23.2	10.6	11.0
TSEN2	"MGC2776, SEN2, SEN2L"	ENSG00000154743	"TRNA splicing endonuclease subunit 2"	Q8NCE0	3	12484421-12541549	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, tRNA processing"	Lyase	"Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 43.8;Excitatory neurons: 42.8;Inhibitory neurons: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027120, HPA027125, HPA027268"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Centrosome, Cytosol"	"HPA027120: AB_10600197, HPA027125: AB_10601896, HPA027268: AB_10601347"	"unprognostic (5.58e-2)"	"unprognostic (4.49e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.71e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (1.13e-5)"	"unprognostic (1.42e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.99e-2)"	"unprognostic (4.90e-2)"	"unprognostic (6.06e-2)"	"prognostic favorable (3.49e-4)"	8.9	9.4	3.4	1.1	3.9	0.3	8.9	4.4	4.8	11.5	3.7	11.5	1.4	10.9	2.6	8.6	12.0	1.8	15.5	3.5	3.7	10.2	8.5	6.0	2.2	3.6	3.5	14.2	12.1	3.2	10.9	0.9	3.6	10.0	2.3	3.4	6.7	3.2	15.9	8.3	6.9	3.2	3.3	6.6	9.7	6.7	3.9	2.6	9.0	3.8	2.2	11.5	9.7	3.8	6.2	11.8	5.5	7.4	6.3	7.7	7.6	5.8	4.3	6.6	5.1	4.2	5.2	5.5	3.3	4.0	5.8	5.8	7.8	9.4	5.4	5.5	9.8	5.1	9.1	5.7	5.4	9.3	2.1	4.9	11.2	10.1	9.7	3.3	4.7	8.8	10.7	3.4	6.5	11.9	9.6	6.1	6.5	10.5	13.5	4.6	2.3	13.5	9.9	4.8	1.5	4.5	6.7	5.0	4.8	3.1	10.1	5.1	4.5	4.2	3.9	4.7	9.7	3.1	8.6	6.2	5.6	11.8	5.4	0.6	1.9	0.0	2.7	1.6	4.4	3.7	4.6	3.8	2.3	3.2	6.2	5.1	0.4	2.5	1.7	3.4	1.6	2.6	3.4	3.9	4.4	4.8	3.5	3.7	3.6	3.5	3.6	3.3	3.9	3.8	5.5	3.2	3.3	26.1	8.9	2.9	11.2	5.6	13.1	28.1	3.7	4.3	7.0	10.0	3.8	11.0	43.8	8.8	2.6	9.2	1.9	6.2	1.6	7.1	7.4	6.2	4.2	8.4	42.8	4.2	4.3	5.7	13.7	3.7	5.1	17.7	3.6	5.0	4.6	10.1	46.4	5.2	4.1	3.5	1.7	2.8	9.0	3.6	3.6	16.9	2.4	8.0	6.2	19.1	31.8	4.5	5.0	10.1	3.8	6.2	2.3	6.9	11.1	34.1	6.6	7.9	6.3	14.0	23.0	7.1	4.8	1.9	4.6	15.3	8.4	8.0
TSN	"BCLF-1, REHF-1, TRSLN"	ENSG00000211460	Translin	Q15631	2	121737103-121767853	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"DNA-binding, Endonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059561	Uncertain		Supported	"Nucleoplasm,Endoplasmic reticulum"		NA	NA		280000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Endoplasmic reticulum"		"HPA059561: AB_2684063"	"unprognostic (3.15e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.53e-1)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (7.13e-3)"	"unprognostic (3.12e-2)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (2.32e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.18e-1)"	16.2	16.9	20.9	13.5	21.9	47.8	25.4	22.7	28.4	17.4	18.9	23.3	16.9	15.8	17.9	16.6	14.2	13.2	19.5	21.0	23.6	24.4	22.9	14.3	19.1	21.3	22.4	16.7	18.4	21.7	13.1	10.8	22.3	14.5	18.8	16.6	14.9	17.2	31.6	19.3	14.6	14.2	21.4	14.7	15.0	26.2	22.0	24.1	17.2	31.0	18.2	15.6	12.8	23.8	56.2	24.8	38.4	34.1	35.0	27.8	21.1	45.6	43.2	50.3	48.4	71.1	32.3	81.7	51.9	45.4	30.1	27.0	55.0	46.6	69.8	43.2	44.3	48.0	33.0	68.3	40.0	69.3	32.5	24.2	51.3	56.3	38.7	23.0	43.2	40.0	72.9	39.4	47.4	30.5	38.2	77.5	46.6	32.8	47.2	67.6	43.1	59.3	63.7	36.0	48.9	30.6	31.4	46.6	61.2	29.2	29.3	54.1	30.8	36.2	56.4	22.9	45.1	33.8	97.0	85.4	40.3	46.8	45.6	27.6	29.8	28.6	22.5	27.9	26.9	27.4	23.4	19.8	27.4	21.0	26.5	22.9	9.3	26.9	24.3	20.1	25.6	28.8	20.9	21.9	22.7	28.4	21.0	23.6	21.3	22.4	22.3	21.4	22.0	23.8	34.7	32.1	24.4	15.0	37.5	39.1	34.4	49.1	23.3	32.1	38.2	27.6	34.7	42.9	36.9	42.3	22.9	34.9	34.3	22.3	43.0	64.4	80.0	24.9	29.7	42.7	19.9	34.7	19.8	60.0	33.3	32.5	15.8	23.9	40.0	36.0	58.5	44.4	35.2	16.8	19.8	27.7	57.0	35.6	34.9	19.8	36.4	29.8	67.6	15.0	45.4	88.7	44.3	29.1	33.5	45.4	22.2	31.2	25.4	34.7	24.4	58.7	33.0	29.5	26.3	39.9	81.8	152.8	96.6	36.7	43.9	28.5	36.8	38.5	37.9	28.8
TSNAX	"C3PO, TRAX"	ENSG00000116918	"Translin associated factor X"	Q99598	1	231528541-231566524	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 194.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA024613, HPA031054, HPA031055, CAB034263"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		36000	"Cluster 10: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB034263: AB_2272293, HPA024613: , HPA031054: AB_10600415, HPA031055: AB_10602314"	"unprognostic (6.28e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.52e-3)"	"unprognostic (2.70e-2)"	22.7	31.9	12.2	20.2	12.8	15.1	25.4	11.5	15.1	19.5	17.8	18.4	17.7	21.5	22.8	19.4	18.0	18.7	26.2	13.2	15.2	31.7	26.0	20.8	26.4	11.9	12.7	18.3	16.3	40.0	17.0	20.4	12.3	22.8	19.6	19.9	18.1	20.5	50.5	21.8	17.3	20.7	13.4	28.5	17.7	20.9	13.2	26.6	29.8	40.7	25.7	19.9	14.9	13.7	30.3	24.1	36.7	29.7	27.1	32.6	41.4	33.1	50.9	42.2	36.0	21.4	40.8	42.3	55.0	38.0	15.7	31.9	29.3	31.4	53.9	38.4	51.7	40.7	23.9	28.6	35.8	67.8	82.1	40.4	32.4	40.9	32.3	26.4	30.7	31.6	66.6	28.8	58.0	12.9	44.0	32.9	53.4	26.5	28.3	42.8	39.8	56.8	46.9	33.9	34.1	65.7	35.3	43.3	116.8	14.5	63.2	113.0	28.9	28.3	26.3	57.6	61.0	48.2	68.9	46.4	46.8	52.0	79.7	194.4	34.8	85.6	30.6	40.2	30.3	28.5	33.5	30.6	33.2	28.3	34.6	34.0	37.7	51.9	55.7	22.3	39.4	33.6	12.2	12.8	11.5	15.1	13.2	15.2	11.9	12.7	12.3	13.4	13.2	13.7	48.3	28.9	41.3	0.0	25.5	43.8	21.4	42.4	8.6	59.2	27.2	20.1	24.1	40.0	25.3	42.3	29.2	44.4	36.9	21.8	54.8	30.6	12.6	23.6	20.5	46.1	28.9	59.5	0.0	31.1	51.5	28.1	11.7	19.3	77.3	26.2	31.8	32.8	49.5	65.6	0.0	28.2	38.7	62.2	35.0	9.4	33.5	40.5	26.6	0.0	51.7	72.0	37.0	0.0	0.0	26.5	21.8	36.1	13.4	17.3	22.4	45.8	31.9	47.1	39.5	34.4	30.2	40.8	65.4	13.0	51.4	36.3	30.5	46.8	25.6	14.9
TSR1	FLJ10534	ENSG00000167721	"TSR1 ribosome maturation factor"	Q2NL82	17	2322396-2336657	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024434, HPA053087"	Approved		Approved	Nucleoplasm		NA	NA		13000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA024434: AB_1858413, HPA053087: AB_2682040"	"unprognostic (1.45e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.95e-3)"	"unprognostic (9.80e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.60e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.46e-3)"	18.2	10.9	11.7	17.2	12.1	15.5	17.3	11.2	12.2	10.5	11.5	13.0	9.4	14.8	12.2	20.1	12.3	10.8	17.2	11.5	11.4	12.3	14.8	10.1	15.9	11.7	11.8	15.2	19.9	16.1	8.3	14.6	11.9	13.4	14.6	14.0	12.8	13.9	49.4	19.6	9.4	18.4	12.6	11.0	11.8	18.1	12.4	15.3	11.8	30.7	19.2	22.2	11.8	12.1	80.2	85.1	39.6	77.6	31.6	36.9	80.4	65.5	36.3	39.8	30.6	138.2	33.4	85.5	54.6	52.2	36.4	70.3	86.5	76.8	50.7	39.1	97.3	63.9	66.4	65.5	44.0	59.4	42.3	37.4	48.1	76.6	87.2	43.5	39.5	45.5	84.1	46.5	49.1	49.8	56.6	29.3	94.0	60.0	50.6	59.6	55.1	57.6	49.1	52.5	27.7	61.7	57.6	43.4	45.7	37.6	40.4	26.0	43.9	54.6	43.3	65.7	122.8	33.3	45.7	49.7	53.5	67.3	67.3	1.9	7.1	1.5	8.3	10.5	11.0	7.1	6.8	7.7	11.5	8.7	7.4	9.0	1.3	6.5	11.5	4.8	9.1	6.3	11.7	12.1	11.2	12.2	11.5	11.4	11.7	11.8	11.9	12.6	12.4	12.1	13.5	32.1	29.3	7.2	21.5	34.4	42.8	18.1	31.3	16.2	18.3	13.7	17.6	12.8	30.7	14.7	18.8	29.9	17.3	7.8	3.9	27.7	68.2	18.0	32.6	20.8	10.3	30.5	7.7	16.5	39.7	24.0	18.3	24.8	43.1	24.4	12.5	13.2	16.0	18.5	6.7	12.0	10.2	12.4	10.2	73.6	13.1	14.4	16.0	3.7	18.2	12.6	10.3	3.0	6.4	23.3	5.8	12.0	23.2	35.8	4.8	11.4	21.9	19.7	19.7	36.4	27.7	29.7	47.7	42.2	41.2	24.2	16.1	25.4	15.7	33.1
TSR2	"DT1P1A10, RP1-112K5.2, WGG1"	ENSG00000158526	"TSR2 ribosome maturation factor"	Q969E8	X	54440404-54448032	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"rRNA processing"		"Diamond-Blackfan anemia, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030514	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nucleoli"	"Cell Junctions, Cytosol"	"HPA030514: AB_10603457"	"unprognostic (1.05e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.91e-2)"	"unprognostic (7.15e-3)"	"unprognostic (8.29e-2)"	"unprognostic (4.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.94e-2)"	"unprognostic (6.19e-2)"	"prognostic favorable (1.21e-6)"	"unprognostic (2.27e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.80e-3)"	35.2	45.1	50.9	11.2	49.9	11.9	35.6	43.4	59.4	36.8	39.3	42.2	10.2	34.9	23.0	34.6	32.2	7.7	45.5	46.2	52.9	43.8	36.7	30.4	12.6	48.9	48.0	34.6	30.2	25.0	47.1	14.6	47.3	33.3	13.3	27.4	32.6	16.9	51.7	40.7	31.3	13.2	50.3	32.4	38.8	16.5	50.6	14.9	41.1	18.6	15.8	36.3	35.0	47.8	24.1	26.6	23.9	20.6	19.9	13.0	18.7	22.4	17.5	19.6	17.3	26.2	24.1	23.5	15.8	18.2	35.7	24.9	47.9	28.3	24.8	29.8	26.8	19.3	20.8	19.6	12.5	32.7	19.4	12.9	18.0	26.4	27.1	19.7	13.8	22.9	20.5	16.9	19.3	37.9	27.4	29.9	34.6	23.6	33.0	26.5	38.2	19.6	20.6	18.3	25.9	20.5	42.1	19.9	28.0	38.0	45.4	14.7	21.0	16.2	27.1	38.0	19.9	19.8	32.3	29.7	24.4	27.5	23.2	29.7	16.6	32.0	36.3	23.1	30.0	44.8	34.0	33.6	15.1	46.3	42.6	32.3	10.4	29.7	26.0	16.7	40.8	24.9	50.9	49.9	43.4	59.4	46.2	52.9	48.9	48.0	47.3	50.3	50.6	47.8	39.1	25.6	30.2	1.6	39.8	32.8	43.0	42.7	26.7	61.6	27.4	28.6	49.0	28.6	38.6	35.0	27.1	98.5	36.0	26.3	125.2	43.9	1.2	17.7	23.7	35.6	18.1	18.1	5.7	32.9	71.5	33.8	16.8	22.9	45.0	20.3	31.8	25.2	46.6	57.2	5.6	35.5	61.1	18.2	31.4	2.8	34.8	24.6	40.9	6.5	48.6	85.6	44.3	2.5	6.5	38.1	29.5	45.1	22.3	36.7	32.6	64.6	33.8	67.0	46.0	29.8	38.0	20.5	43.3	25.4	31.7	75.9	37.8	36.2	30.9	33.9
TTC1	TPR1	ENSG00000113312	"Tetratricopeptide repeat domain 1"	Q99614	5	160009113-160065543	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036557, HPA057502"	Approved		Enhanced	Cytosol		NA	NA		17000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA036557: AB_10670112, HPA057502: AB_2683450"	"unprognostic (4.34e-3)"	"unprognostic (2.26e-2)"	"unprognostic (3.05e-2)"	"unprognostic (7.38e-2)"	"unprognostic (6.62e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (8.29e-2)"	"unprognostic (2.38e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.08e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.05e-2)"	"unprognostic (6.16e-2)"	37.0	46.5	77.6	35.6	79.7	26.2	39.4	84.2	111.7	31.5	71.2	44.5	27.3	32.2	58.1	37.4	32.2	26.2	59.9	79.4	83.1	49.5	45.5	33.0	47.8	90.6	85.4	32.6	27.4	45.1	29.8	35.5	88.7	33.4	45.4	42.9	39.4	37.2	91.2	34.8	30.9	41.8	80.3	36.6	34.6	33.8	83.8	48.7	35.7	77.0	55.9	35.7	27.6	84.1	83.2	85.1	62.2	104.4	71.9	51.6	70.5	90.8	80.4	97.7	115.6	120.2	94.0	84.5	172.7	78.2	132.9	63.9	83.5	124.7	156.6	157.7	88.4	75.9	63.0	87.3	102.0	127.2	61.2	48.7	81.0	86.5	71.8	71.8	118.8	74.2	73.6	81.7	112.3	65.0	92.8	99.8	70.7	67.3	85.8	88.4	87.0	93.6	124.2	76.8	51.2	57.7	63.1	74.4	175.1	58.3	117.6	121.5	84.4	64.8	55.8	58.5	141.9	58.4	114.8	82.3	89.6	143.3	85.9	109.8	72.8	105.7	57.6	80.9	73.4	92.6	68.3	68.0	73.5	86.0	62.5	69.1	103.0	87.7	80.6	65.4	90.2	113.1	77.6	79.7	84.2	111.7	79.4	83.1	90.6	85.4	88.7	80.3	83.8	84.1	48.6	67.3	50.8	20.9	55.0	47.0	33.6	89.2	28.5	38.4	40.4	47.0	237.0	40.0	67.4	46.0	20.9	108.7	36.0	58.0	162.4	114.2	115.3	62.8	46.5	61.3	35.3	89.2	54.0	106.5	77.9	57.4	23.4	54.8	83.4	41.3	52.1	72.8	90.0	35.3	47.6	51.4	83.4	48.1	34.7	39.9	46.9	52.4	28.4	23.4	70.1	99.1	68.0	43.7	57.0	98.5	54.7	63.9	42.9	37.6	53.7	144.9	89.4	50.2	59.2	55.7	59.2	142.9	101.5	37.8	47.3	99.9	50.8	53.6	53.7	21.9
TTC4	"CNS1, FLJ41930, MGC5097"	ENSG00000243725	"Tetratricopeptide repeat domain 4"	O95801	1	54715861-54742657	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041608, HPA042459"	Approved		Enhanced	"Intermediate filaments,Cytoplasmic bodies"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Intermediate filaments"	"Cytoplasmic bodies"	"HPA041608: AB_10794485, HPA042459: AB_10797496"	"unprognostic (4.89e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.62e-4)"	"unprognostic (8.91e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.21e-5)"	"unprognostic (1.39e-4)"	"unprognostic (1.51e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.79e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.76e-3)"	8.9	8.8	21.2	5.3	21.8	2.0	10.4	22.0	24.7	10.4	20.4	9.7	5.6	8.5	8.1	10.6	9.1	3.9	16.5	21.7	22.2	11.0	10.2	5.6	7.2	22.2	22.2	12.5	11.7	11.7	12.8	7.7	22.3	8.8	6.3	9.0	9.1	8.3	33.7	10.3	8.0	7.6	22.5	6.6	10.8	8.6	22.0	12.8	8.0	22.2	8.9	11.0	10.1	23.9	24.3	18.2	20.1	10.9	29.2	16.6	17.9	32.6	16.0	39.8	26.6	20.5	6.9	40.1	17.4	22.4	42.2	13.1	43.7	31.1	41.6	38.2	31.7	38.4	7.7	11.9	27.4	32.4	10.6	16.1	30.4	58.2	34.9	17.8	17.3	31.3	45.5	6.3	22.7	11.3	30.0	18.3	41.0	29.1	30.9	27.1	43.0	22.5	19.9	6.5	13.5	9.7	28.4	13.8	27.2	33.0	13.2	16.5	17.4	19.5	21.2	20.5	44.9	16.1	29.9	34.0	25.9	36.5	20.8	7.3	12.3	10.3	13.9	14.0	14.8	12.6	11.1	13.3	13.5	12.6	15.9	14.3	0.2	18.9	15.1	11.2	11.8	13.0	21.2	21.8	22.0	24.7	21.7	22.2	22.2	22.2	22.3	22.5	22.0	23.9	3.7	9.6	2.6	0.0	6.2	1.1	3.4	2.1	7.4	4.5	3.1	3.3	3.2	1.5	5.2	0.0	0.0	3.9	2.4	1.5	0.0	3.5	0.5	4.7	8.8	3.4	1.2	3.0	0.0	4.2	2.4	5.4	3.6	4.5	7.0	3.0	3.9	2.4	1.4	5.0	0.0	1.3	0.0	0.6	1.5	0.7	4.1	2.7	1.8	0.0	5.9	2.3	6.2	0.0	0.0	3.9	1.7	2.6	6.1	3.0	2.0	6.4	2.6	3.8	0.0	3.8	3.5	9.2	8.2	5.7	1.6	1.4	4.6	1.9	2.5	1.8
TTC5	Strap	ENSG00000136319	"Tetratricopeptide repeat domain 5"	Q8N0Z6	14	20256558-20305960	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045008, HPA054198"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA045008: AB_10960209, HPA054198: AB_2682414"	"unprognostic (2.19e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.15e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.32e-2)"	"unprognostic (3.29e-1)"	"prognostic favorable (8.54e-4)"	"unprognostic (3.01e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.07e-2)"	2.1	2.8	2.8	1.8	2.8	2.9	3.8	2.2	3.1	3.1	4.8	2.2	2.1	3.1	3.2	2.2	5.7	2.2	1.8	2.6	3.1	3.5	1.4	2.5	3.2	2.1	2.7	3.0	1.9	6.1	2.1	2.4	2.1	3.8	2.3	2.6	2.3	3.0	0.7	3.4	1.6	2.9	2.1	2.4	2.4	2.5	4.3	2.6	4.9	2.3	3.1	2.3	1.7	2.2	3.4	5.4	6.5	0.7	4.7	6.8	3.5	4.3	5.0	6.4	6.6	2.4	7.6	7.2	2.7	4.5	3.3	2.8	6.4	3.0	9.8	6.3	2.4	5.9	2.2	4.3	4.8	11.0	3.5	4.2	6.7	5.6	7.2	5.8	6.3	5.1	4.3	3.5	6.3	4.6	6.5	4.6	5.5	5.6	5.2	3.4	4.8	5.2	5.6	3.5	2.2	4.3	4.9	5.1	3.0	2.6	4.0	5.3	6.6	2.5	4.1	3.4	2.3	5.0	4.7	8.9	2.0	4.6	6.0	1.3	2.0	2.9	2.7	2.0	2.3	2.7	2.0	2.2	2.2	3.0	2.1	2.5	0.8	3.0	2.9	1.6	2.7	2.0	2.8	2.8	2.2	3.1	2.6	3.1	2.1	2.7	2.1	2.1	4.3	2.2	13.9	12.8	7.2	6.5	15.2	6.4	9.4	21.5	13.6	15.5	9.4	12.8	4.3	12.8	9.8	18.4	16.7	20.4	12.2	2.3	11.7	10.6	1.6	27.7	13.4	12.3	9.0	6.7	18.2	6.5	12.4	12.5	8.6	7.9	12.0	16.0	10.8	6.4	15.4	5.0	12.4	6.9	18.3	11.2	6.8	3.4	10.2	10.5	7.2	6.5	11.5	12.4	19.6	11.6	8.7	6.4	5.0	9.8	7.8	4.6	8.6	13.1	32.8	19.4	6.6	14.1	11.6	26.6	36.1	8.8	8.7	4.7	12.7	14.6	8.3	5.3
TTF2	"HuF2, ZGRF6"	ENSG00000116830	"Transcription termination factor 2"	Q9UNY4	1	117060326-117107453	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation, Transcription termination"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA005776, HPA070762"	Approved		Supported	Cytosol		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA005776: AB_1080416, HPA070762: AB_2686307"	"unprognostic (1.82e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.29e-3)"	"unprognostic (2.01e-3)"	"unprognostic (4.90e-2)"	"unprognostic (3.41e-3)"	"unprognostic (5.27e-4)"	"unprognostic (7.96e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.33e-1)"	"unprognostic (4.64e-2)"	"unprognostic (9.52e-3)"	"unprognostic (7.34e-3)"	"unprognostic (1.48e-3)"	"unprognostic (7.73e-2)"	"unprognostic (3.50e-1)"	"unprognostic (3.65e-2)"	3.8	4.7	2.6	6.4	3.9	5.4	4.2	2.8	3.7	3.3	3.6	5.0	4.3	3.0	1.7	5.2	2.6	2.8	3.1	2.4	2.8	2.6	1.4	2.6	7.3	5.4	3.5	2.7	3.5	3.9	2.3	2.7	3.6	2.5	5.4	2.5	3.3	2.5	4.7	4.9	4.0	4.0	3.0	4.3	3.9	4.2	3.8	8.9	3.6	2.3	7.9	3.3	3.6	4.7	27.7	10.0	19.8	28.0	7.7	6.7	24.6	14.5	6.7	20.8	18.3	14.1	4.8	33.4	21.8	9.6	23.2	28.1	35.2	18.7	32.0	25.9	24.8	28.5	19.5	18.2	5.5	42.1	31.5	7.7	7.0	15.4	28.4	5.2	14.4	26.0	22.3	29.6	15.9	42.4	28.1	26.0	30.9	26.3	20.0	40.0	72.7	14.6	12.7	12.4	16.8	7.0	21.7	21.4	8.4	14.9	11.7	17.0	14.6	13.1	27.6	31.0	31.8	13.5	12.5	40.6	8.8	31.2	53.7	0.9	2.3	1.5	1.2	2.8	1.2	1.5	1.4	2.0	2.6	1.5	1.4	1.7	0.4	2.6	1.6	1.4	2.7	1.0	2.6	3.9	2.8	3.7	2.4	2.8	5.4	3.5	3.6	3.0	3.8	4.7	4.4	6.4	6.4	6.8	13.4	13.3	17.1	8.5	12.0	5.7	7.6	6.3	7.3	5.7	7.3	12.9	8.4	9.7	8.9	10.6	5.9	6.6	6.9	8.9	15.6	6.9	4.9	30.3	8.1	8.0	7.6	11.0	8.6	12.3	9.5	24.7	5.7	3.0	11.4	11.8	4.7	8.3	0.0	8.6	12.1	7.0	6.5	14.5	7.2	10.3	22.1	3.3	14.4	2.5	13.5	9.3	5.1	4.1	16.0	22.7	6.2	3.8	5.1	7.2	0.0	18.4	8.5	9.2	12.4	19.4	14.3	3.8	12.3	12.2	13.5	17.9
TTK	"CT96, MPH1, MPS1, MPS1L1"	ENSG00000112742	"TTK protein kinase"	P33981	6	80003887-80042527	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 25.3;lymphoid tissue: 46.6;testis: 34.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 43.3;Erythroid cells: 23.1;Late spermatids: 21.4;Spermatocytes: 130.5;Spermatogonia: 33.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.2"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB010166, CAB013229"	Enhanced		Approved	Nucleoli,Cytosol		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli, Cytosol"		"CAB010166: AB_632567, CAB013229: AB_2533230"	"unprognostic (4.27e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (7.97e-2)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (3.84e-10)"	"unprognostic (1.56e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.02e-3)"	"prognostic unfavorable (2.54e-4)"	"unprognostic (1.54e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.51e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	0.7	0.8	0.0	4.2	0.1	25.3	2.2	0.1	0.3	0.7	0.0	4.8	4.0	1.0	0.1	4.8	0.6	0.5	0.1	0.1	0.1	0.2	0.5	0.8	8.1	0.2	0.1	0.2	0.2	0.3	0.0	3.9	0.2	0.8	5.9	1.8	0.7	0.1	0.0	3.6	4.1	1.7	0.1	1.4	3.3	34.3	0.2	46.6	0.4	0.1	9.0	1.2	1.4	0.2	39.9	23.4	68.2	56.4	3.1	9.5	38.5	44.9	27.4	64.2	77.8	32.1	29.6	58.5	34.1	19.5	66.9	50.0	60.7	27.6	88.6	53.4	49.3	54.1	29.4	26.5	0.2	64.4	33.9	1.2	2.8	45.0	28.6	9.6	36.9	80.6	60.2	58.5	55.2	29.5	37.0	46.4	40.4	35.4	27.9	32.7	124.4	24.4	16.3	25.2	46.8	27.4	26.6	28.3	16.3	36.6	26.6	48.3	15.4	28.8	28.5	18.8	72.9	13.1	47.1	32.4	10.3	58.9	25.1	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.2	0.4	0.0	0.7	0.0	0.1	0.0	0.3	0.0	0.0	1.2	0.2	0.0	0.1	0.1	0.3	0.1	0.1	0.2	0.1	0.2	0.1	0.2	0.2	0.3	3.2	1.1	0.0	1.4	1.3	0.6	2.6	0.0	0.2	0.9	0.5	0.6	0.0	2.3	0.0	2.1	9.8	0.8	2.2	3.9	0.4	43.3	3.1	1.6	1.1	1.8	23.1	0.2	0.2	15.0	2.1	2.6	2.3	1.3	13.9	0.7	0.2	6.5	0.0	0.2	3.0	4.1	2.6	1.2	21.4	0.9	1.9	0.0	0.0	5.2	0.2	1.0	0.0	0.1	0.6	0.2	0.7	5.1	0.4	0.3	0.1	3.0	1.6	6.6	0.1	1.7	130.5	33.0	8.5	0.3	3.7	1.1	0.5	5.6	1.6
TTLL12	KIAA0153	ENSG00000100304	"Tubulin tyrosine ligase like 12"	Q14166	22	43166622-43187134	"Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 104.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 56.3;Paneth cells: 56.9;Squamous epithelial cells: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003054, CAB046029"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		140000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 37: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol	"Plasma membrane"	"CAB046029: AB_11128395, HPA003054: AB_2666770"	"unprognostic (2.45e-2)"	"unprognostic (3.47e-2)"	"unprognostic (7.37e-3)"	"unprognostic (5.40e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (5.81e-3)"	"unprognostic (2.24e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.81e-2)"	13.9	28.1	8.7	16.6	8.5	26.2	13.0	10.0	15.1	25.8	1.8	35.6	24.4	13.9	3.6	104.5	13.9	18.5	10.2	9.5	9.7	9.0	21.0	9.3	11.2	16.2	8.7	23.7	19.2	9.4	14.7	7.2	15.8	15.2	19.5	4.7	21.9	6.8	12.6	36.8	22.9	7.1	6.5	10.7	33.4	25.7	8.1	8.0	9.1	7.9	12.9	15.5	37.0	9.1	113.2	46.7	18.5	45.9	27.8	19.0	59.7	36.3	12.8	34.1	17.8	76.2	62.7	107.9	43.0	30.3	16.7	78.8	77.3	66.5	8.7	13.6	123.3	26.5	73.6	66.4	43.5	120.2	26.4	30.2	79.3	40.8	43.4	18.3	36.5	52.1	166.1	24.8	16.1	104.4	84.1	65.2	67.4	78.9	46.1	84.4	63.5	155.6	28.7	36.6	56.2	23.2	77.1	111.2	41.6	8.4	44.0	52.9	35.2	22.7	31.7	44.1	51.4	41.6	55.4	81.0	25.7	60.8	31.4	0.0	2.3	0.3	2.6	1.2	2.5	1.8	2.5	1.9	1.8	1.1	2.4	1.7	0.6	2.3	1.7	1.6	1.8	1.9	8.7	8.5	10.0	15.1	9.5	9.7	16.2	8.7	15.8	6.5	8.1	9.1	3.7	6.4	6.7	3.6	6.4	11.2	11.4	11.0	17.1	8.5	13.5	9.9	4.5	17.2	7.6	7.3	4.2	8.8	3.2	56.3	5.9	14.2	1.0	5.0	9.5	5.8	9.1	39.1	8.0	8.6	19.0	6.0	34.1	14.7	0.0	14.3	8.2	35.0	9.8	0.0	8.5	30.6	10.2	14.2	2.9	2.6	8.7	7.5	10.6	1.9	7.7	4.2	4.1	3.0	2.2	25.8	56.9	17.0	9.4	28.7	32.1	8.3	5.0	5.6	0.0	5.2	7.2	2.0	12.2	60.2	18.2	4.1	5.9	13.4	39.9	13.7
TUBA1B	K-ALPHA-1	ENSG00000123416	"Tubulin alpha 1b"	P68363	12	49127782-49131397	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 2143.3;Extravillous trophoblasts: 2555.5;Hofbauer cells: 2114.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011513, HPA039247, HPA043684, HPA063394"	Enhanced		Supported	Microtubules		NA	Yes			"Cluster 51: Monocytes - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Microtubules		"CAB011513: AB_2210057, HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003"	"prognostic unfavorable (5.49e-4)"	"unprognostic (4.19e-2)"	"unprognostic (3.84e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.91e-1)"	"unprognostic (7.10e-2)"	"prognostic unfavorable (1.68e-7)"	"unprognostic (2.98e-3)"	"unprognostic (9.28e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.69e-2)"	"unprognostic (9.46e-2)"	"prognostic unfavorable (2.85e-12)"	"unprognostic (1.60e-1)"	"unprognostic (3.52e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.55e-3)"	531.9	319.3	1071.9	650.0	1115.9	1491.9	453.7	941.8	1318.4	306.5	841.2	598.4	279.4	460.5	403.7	550.9	369.1	305.6	509.3	1108.8	1139.4	310.3	233.9	511.3	750.8	1176.0	1108.8	325.9	179.9	262.6	322.2	582.9	1162.2	247.8	665.1	652.9	304.6	394.1	243.9	404.3	352.5	1004.6	993.4	435.8	355.7	322.7	1127.4	1557.3	267.3	242.0	882.3	639.5	339.4	1076.7	3063.5	3381.9	3587.5	2051.4	910.0	1321.7	1939.2	2635.0	2642.5	5018.6	4034.6	4300.0	3144.6	3430.1	1854.8	3732.5	2047.5	1864.3	3993.2	3609.1	4586.7	1938.3	2103.5	2445.9	1822.2	2219.9	251.5	3705.8	1863.3	793.6	540.2	3930.9	1298.9	1697.4	4353.5	3121.3	2788.0	2182.3	4142.7	3362.1	4985.5	2943.8	2504.9	7570.8	3944.4	3980.1	3023.6	2137.4	2377.1	2008.1	2250.7	1921.9	2211.7	1697.3	803.9	1804.3	2403.1	3624.8	2321.3	2393.9	2752.4	2404.5	3470.2	1196.5	1876.2	3685.5	1668.2	2924.3	2303.6	197.9	240.0	411.5	241.8	1022.1	266.7	268.9	230.1	225.3	632.4	239.6	241.0	192.4	271.6	230.9	1107.4	632.0	293.2	731.1	1071.9	1115.9	941.8	1318.4	1108.8	1139.4	1176.0	1108.8	1162.2	993.4	1127.4	1076.7	702.9	198.7	231.8	36.6	445.8	584.0	653.7	875.4	288.5	426.4	267.9	391.8	0.8	90.1	373.4	187.6	492.1	1143.1	514.2	482.6	361.9	814.5	272.5	189.3	218.3	643.9	303.7	2143.3	201.8	630.1	2555.5	603.4	237.0	203.9	542.8	1069.6	353.4	106.3	2114.8	498.0	99.1	508.1	512.7	361.8	1353.1	204.8	326.8	729.8	473.2	68.4	1248.5	455.7	228.6	34.7	82.7	703.3	298.4	236.6	595.9	373.5	240.0	245.1	287.7	970.8	263.0	321.5	957.4	161.6	488.9	560.6	449.8	304.4	480.3	172.4	551.2	539.1
TUBB	"M40, MGC16435, OK/SW-cl.56, Tubb5"	ENSG00000196230	"Tubulin beta class I"	P07437	6	30717435-30725538	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 2296.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005417, CAB012406, HPA043640, HPA046280"	Enhanced		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	Yes		170000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB005417: AB_2241191, CAB012406: AB_2210370, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (1.01e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (5.97e-4)"	"unprognostic (2.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (2.62e-8)"	"unprognostic (8.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.50e-1)"	229.5	164.8	74.6	243.5	81.8	541.0	186.9	46.2	367.7	228.7	87.0	250.3	87.6	333.0	174.5	246.3	227.0	158.5	245.3	73.5	119.7	137.8	236.6	205.3	369.2	80.5	74.8	467.5	138.1	74.4	97.0	194.4	99.2	145.2	194.4	82.4	160.2	194.6	185.7	211.9	159.4	371.0	57.5	195.0	172.8	77.8	94.0	620.4	142.4	98.6	487.6	222.3	213.8	63.5	2281.7	1027.3	2650.0	1458.4	733.2	1265.2	568.2	396.9	469.5	943.3	863.5	1329.2	703.9	1494.1	1105.1	1408.1	1877.8	805.3	2160.6	1968.0	160.3	892.5	1321.1	461.4	207.3	1306.7	345.8	2550.0	1223.9	943.6	455.9	416.0	443.6	967.1	1493.3	2058.1	1270.4	294.1	1844.8	1398.2	2719.0	249.3	377.3	604.1	948.6	102.6	708.5	911.6	1564.5	1071.4	940.8	1516.7	969.0	911.2	354.7	1625.5	1148.3	422.4	880.6	2712.0	1526.0	614.5	917.7	835.3	1735.4	2101.3	538.8	2494.6	3548.7	119.8	115.6	122.8	187.3	182.5	218.8	166.1	152.3	188.8	111.7	113.0	143.2	163.3	46.8	165.1	222.4	227.7	180.8	342.5	74.6	81.8	46.2	367.7	73.5	119.7	80.5	74.8	99.2	57.5	94.0	63.5	215.8	131.4	47.3	21.5	214.9	576.2	358.4	698.6	434.2	72.7	234.2	312.8	114.9	244.5	238.7	171.0	39.6	811.9	198.7	133.4	311.0	1091.0	9.1	69.1	261.6	370.8	163.6	1322.1	28.2	1061.1	2296.1	471.5	95.3	140.2	207.3	643.6	298.4	267.8	955.2	109.4	25.0	185.3	376.4	454.5	689.6	24.4	402.6	295.8	321.9	30.9	774.0	192.6	246.1	20.1	23.0	1087.0	90.7	237.3	304.6	199.5	117.9	245.9	66.6	65.4	118.3	124.0	838.6	58.0	126.5	447.0	430.6	220.4	244.0	224.9	253.2	229.0
TUBGCP4	"76P, FLJ14797"	ENSG00000137822	"Tubulin gamma complex associated protein 4"	Q9UGJ1	15	43369221-43409771	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Horizontal cells: 55.5;Rod photoreceptor cells: 57.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 13.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043212	Approved		Supported	Centrosome		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 62: Horizontal cells - Visual perception"	Centrosome		"HPA043212: AB_10796690"	"unprognostic (1.34e-2)"	"unprognostic (3.57e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.90e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.91e-2)"	"unprognostic (5.65e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.28e-1)"	3.9	4.3	5.1	3.7	6.9	4.8	5.1	8.4	8.4	5.3	6.4	5.0	4.8	4.5	3.5	5.8	4.5	2.9	4.9	5.6	5.6	4.7	5.9	3.9	4.6	5.6	5.7	5.2	6.1	8.3	5.2	3.7	5.9	5.1	5.2	11.1	5.1	3.7	9.7	4.6	5.2	4.9	5.4	4.4	4.9	4.1	5.7	6.1	4.5	9.8	5.5	4.6	5.1	6.4	18.2	5.6	13.3	13.7	12.9	13.9	10.3	10.2	7.3	13.9	14.0	18.0	11.1	11.3	15.2	8.8	19.5	29.4	28.3	18.2	16.3	19.0	26.9	29.5	30.2	15.9	10.7	20.4	17.6	7.6	17.9	14.4	20.0	11.0	11.5	18.5	28.4	9.6	10.4	6.3	16.4	15.7	6.3	29.6	22.1	22.0	17.5	15.9	9.2	17.1	35.5	12.1	12.4	23.8	4.1	8.4	14.1	15.8	9.5	13.2	13.5	18.3	22.7	9.9	12.5	19.6	12.1	29.0	15.1	0.1	2.5	13.8	3.7	2.9	2.7	3.6	2.8	2.6	5.3	3.2	2.0	2.9	0.3	5.3	1.6	2.8	3.2	2.4	5.1	6.9	8.4	8.4	5.6	5.6	5.6	5.7	5.9	5.4	5.7	6.4	6.5	19.2	14.5	12.1	14.9	11.0	16.3	4.5	5.2	30.9	8.8	7.4	1.7	18.6	10.8	16.5	22.9	16.1	6.5	8.5	7.9	12.2	28.7	9.4	15.3	8.8	14.4	15.4	17.3	9.9	14.7	10.4	5.6	10.4	11.4	15.9	10.0	11.4	6.9	55.5	13.8	10.6	8.2	7.6	5.6	43.6	15.2	6.1	3.6	4.7	7.7	13.1	22.6	17.1	9.2	11.0	9.4	12.4	5.8	20.1	12.7	6.1	9.5	57.1	6.6	19.1	10.2	25.0	14.5	9.2	8.9	11.5	9.8	11.2	17.7	16.9
TUBGCP5	"GCP5, KIAA1899"	ENSG00000275835	"Tubulin gamma complex associated protein 5"	Q96RT8	15	22983192-23039572	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039366, HPA040366"	Supported		Supported	Centrosome,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Centrosome, Cytosol"		"HPA039366: AB_10673243, HPA040366: AB_2676942"	"unprognostic (1.17e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.27e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.45e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.53e-3)"	8.4	9.1	3.5	6.5	4.2	9.0	9.7	3.8	6.6	9.7	1.8	7.3	6.3	9.7	5.7	8.0	6.7	6.0	9.1	3.3	4.7	8.2	9.3	7.0	8.4	4.8	4.1	7.4	10.6	8.4	8.0	6.9	5.1	9.6	7.3	9.8	6.7	7.7	10.7	10.0	6.3	8.7	3.3	7.2	7.8	13.4	4.3	8.9	11.2	10.2	8.7	7.6	7.6	6.5	20.3	20.8	23.9	14.4	18.3	11.9	13.8	24.3	26.6	26.2	22.7	16.1	9.3	16.0	10.3	22.3	13.8	19.8	16.0	18.8	21.8	23.6	6.6	26.9	21.2	8.8	6.4	27.7	11.6	19.4	7.2	17.5	16.2	8.6	16.1	26.4	19.8	23.6	16.9	13.1	18.8	12.1	14.2	19.8	18.8	22.9	26.1	3.2	15.3	30.6	8.3	14.0	19.7	14.2	12.7	11.8	22.2	13.4	13.9	18.4	11.7	14.0	36.6	18.3	19.8	40.0	23.8	18.3	17.3	0.2	1.4	0.6	2.6	2.1	2.7	2.2	4.0	4.4	2.3	4.2	3.5	4.7	1.5	3.9	2.1	2.5	3.7	1.7	3.5	4.2	3.8	6.6	3.3	4.7	4.8	4.1	5.1	3.3	4.3	6.5	7.4	16.0	17.7	16.0	11.0	3.3	3.2	4.2	9.1	27.6	5.2	5.0	13.2	7.2	6.3	5.5	14.6	8.3	11.6	3.0	5.9	6.5	7.8	12.5	13.4	6.4	4.2	3.8	21.4	4.6	7.2	10.4	6.1	6.2	6.3	31.4	5.7	10.2	7.9	10.1	29.7	4.7	4.1	5.2	2.9	13.4	11.1	6.2	3.6	12.2	5.1	11.6	7.2	15.6	26.2	6.6	5.0	12.8	7.9	2.3	2.9	7.1	9.0	18.9	0.0	13.6	10.6	35.0	36.7	8.6	2.7	3.4	9.6	14.1	4.6	2.0
TUT4	"KIAA0191, PAPD3, TENT3A, ZCCHC11"	ENSG00000134744	"Terminal uridylyl transferase 4"	Q5TAX3	1	52408282-52553487	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 52.2;Cytotrophoblasts: 53.6;dendritic cells: 64.9;Endometrial ciliated cells: 59.5;Endometrial stromal cells: 96.1;Granulosa cells: 70.7;Theca cells: 57.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027412, HPA027973"	Supported		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	Nucleoli	"HPA027412: AB_1852281, HPA027973: AB_10603242"	"unprognostic (2.74e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.85e-3)"	"prognostic unfavorable (9.00e-4)"	"unprognostic (2.64e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.84e-1)"	"unprognostic (6.57e-3)"	"unprognostic (3.11e-2)"	"unprognostic (5.35e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.33e-1)"	22.5	34.4	28.4	18.3	28.6	26.6	21.4	44.7	36.2	34.1	28.6	26.3	8.7	27.4	23.7	19.3	30.8	15.4	27.1	26.8	35.3	22.9	31.3	22.1	34.2	28.5	29.4	46.3	31.2	29.5	41.5	21.2	28.5	26.1	11.2	84.9	20.7	16.5	60.0	35.1	30.9	15.9	26.4	35.0	22.3	46.9	33.4	32.5	31.4	30.0	29.4	23.1	26.5	33.5	24.4	22.7	55.3	37.3	21.1	27.1	36.4	20.0	31.0	30.3	34.9	23.6	12.5	50.6	23.0	30.0	49.1	19.7	41.6	22.6	38.7	39.7	36.5	53.7	30.0	49.7	35.0	59.4	29.1	31.9	49.4	32.6	40.0	38.6	21.4	35.7	44.7	25.6	25.7	0.3	60.1	42.7	39.8	12.5	27.5	51.3	55.3	39.3	33.4	20.0	28.7	26.8	31.8	14.1	32.9	62.3	19.4	31.5	18.1	23.2	30.6	21.1	26.2	52.7	74.0	71.8	15.5	32.0	17.0	83.7	9.7	34.8	26.1	4.0	19.3	49.0	27.3	21.6	5.1	50.2	33.1	22.0	37.6	25.3	3.7	61.9	23.3	5.1	28.4	28.6	44.7	36.2	26.8	35.3	28.5	29.4	28.5	26.4	33.4	33.5	52.2	0.0	0.0	0.0	36.0	0.0	0.0	0.0	0.0	0.0	36.1	41.4	0.0	0.0	0.0	47.8	0.0	53.6	64.9	0.0	15.6	28.5	0.0	59.5	96.1	14.3	0.0	0.0	0.0	17.0	19.1	18.8	0.0	46.7	0.0	70.7	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	9.8	0.0	0.0	0.0	0.0	19.6	0.0	0.0	30.2	0.0	0.0	22.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	0.0	0.0	36.9	28.2	57.3	0.0	0.0
TUT7	"FLJ13409, KIAA1711, PAPD6, TENT3B, ZCCHC6"	ENSG00000083223	"Terminal uridylyl transferase 7"	Q5VYS8	9	86287733-86354454	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 80.3;Endometrial stromal cells: 61.1;Glandular and luminal cells: 206.7;Syncytiotrophoblasts: 92.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 114.6"	"Group enriched"	"Detected in all"	5	"granulocytes: 114.6;monocytes: 47.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020615, HPA020620"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Cytosol	Nucleoplasm	"HPA020615: AB_1858983, HPA020620: AB_1858984"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.43e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.40e-1)"	12.5	9.4	4.8	16.0	6.4	22.6	18.7	5.9	10.0	12.8	10.9	12.1	11.0	9.1	8.9	24.7	8.8	11.3	8.2	5.1	7.9	7.5	38.4	16.5	19.1	9.0	6.3	8.7	13.1	8.7	8.2	14.3	7.8	20.8	11.8	7.7	14.2	7.2	13.6	33.7	12.3	7.8	5.1	20.6	13.6	11.6	9.2	15.1	8.6	9.3	19.2	13.4	16.0	9.0	16.2	17.2	9.8	14.3	22.4	36.0	12.2	21.6	20.5	9.1	10.6	7.8	13.7	22.8	18.9	14.0	9.5	27.3	11.8	12.0	13.5	27.1	6.0	16.5	18.4	13.7	19.3	19.1	21.8	23.5	22.7	14.5	16.2	13.7	15.0	12.3	15.9	24.0	24.6	14.9	16.0	11.0	7.5	25.1	11.1	8.0	17.5	10.1	15.3	31.4	7.2	5.7	13.1	15.5	7.4	11.6	6.4	7.8	24.8	8.7	10.5	15.7	14.8	27.4	23.3	16.5	20.7	10.8	11.8	35.4	19.4	20.5	15.0	24.7	12.5	11.6	8.2	10.7	11.9	12.2	9.5	10.1	114.6	12.8	47.8	5.5	8.8	8.9	4.8	6.4	5.9	10.0	5.1	7.9	9.0	6.3	7.8	5.1	9.2	9.0	28.1	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	34.2	16.4	0.0	0.0	0.0	9.2	0.0	22.4	36.6	0.0	5.9	29.6	0.0	80.3	61.1	7.2	0.0	0.0	0.0	17.9	17.4	5.6	0.0	206.7	0.0	36.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.1	0.0	0.0	12.4	0.0	0.0	0.0	0.0	27.8	0.0	0.0	13.8	0.0	0.0	6.7	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	92.5	14.8	30.9	0.0	0.0
TWNK	"C10orf2, FLJ21832, IOSCA, PEO, PEO1, TWINKLE, TWINL"	ENSG00000107815	"Twinkle mtDNA helicase"	Q96RR1	10	100987367-100994403	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA replication"	"Helicase, Hydrolase"	"Deafness, Disease variant, Neurodegeneration, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 6.8;Breast myoepithelial cells: 6.6;Ductal cells: 5.4;Endometrial stromal cells: 7.2;Granulosa cells: 7.1;Theca cells: 9.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002532	Uncertain					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"			"HPA002532: AB_1078311"	"unprognostic (8.10e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.82e-3)"	"unprognostic (7.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.95e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.46e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.45e-1)"	4.9	7.0	3.7	5.5	3.7	3.0	7.5	3.6	3.5	3.8	3.2	4.4	3.3	4.6	5.3	5.5	6.6	2.6	5.0	3.4	3.6	5.9	6.0	2.1	6.1	3.9	4.0	5.1	5.2	4.8	2.4	3.8	3.8	4.0	4.8	1.6	4.0	3.4	11.6	5.5	3.8	4.5	3.7	4.6	3.9	8.3	4.0	8.1	4.1	12.6	8.3	6.6	3.5	3.5	15.5	32.0	12.5	39.7	11.1	7.2	14.7	11.4	14.8	17.3	16.6	52.6	13.1	55.4	21.1	7.0	10.4	25.0	52.2	27.7	21.1	25.5	31.0	42.1	17.4	40.2	19.1	54.8	16.7	14.9	30.7	25.5	77.6	15.8	10.6	26.3	45.9	15.0	12.3	21.2	37.0	18.8	35.8	28.2	25.9	35.5	27.5	33.2	10.7	15.4	20.1	38.5	12.0	16.0	37.8	13.8	20.9	16.0	12.4	8.6	17.4	10.6	32.5	28.0	31.3	46.0	10.6	47.8	9.8	1.2	0.6	0.1	1.2	0.5	3.7	2.4	1.8	2.7	1.2	2.1	2.0	2.2	0.0	2.5	0.8	1.3	0.4	1.4	3.7	3.7	3.6	3.5	3.4	3.6	3.9	4.0	3.8	3.7	4.0	3.5	3.5	0.0	2.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	6.8	6.6	0.0	0.0	3.1	1.8	0.0	4.2	1.9	0.0	3.9	5.4	0.0	2.3	7.2	2.0	0.0	0.0	0.0	3.0	3.7	1.3	0.0	2.8	1.3	7.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.6	1.1	9.1	0.0	0.0
TXLNG	"CXorf15, FIAT, FLJ11209, LSR5, MGC126621, MGC126625, TXLNGX"	ENSG00000086712	"Taxilin gamma"	Q9NUQ3	X	16786432-16844519	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000297, HPA000841"	Approved		Approved	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA000297: AB_1078590, HPA000841: AB_1078589"	"unprognostic (2.48e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.78e-2)"	"unprognostic (4.15e-2)"	"prognostic unfavorable (6.33e-6)"	"unprognostic (2.61e-2)"	"unprognostic (5.27e-3)"	"unprognostic (6.96e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.58e-3)"	"unprognostic (2.04e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.62e-2)"	"unprognostic (6.00e-3)"	14.4	15.9	4.6	8.0	5.3	14.0	10.1	7.8	6.3	6.9	6.7	6.3	8.3	9.8	6.6	6.1	9.1	6.3	5.7	4.1	5.6	7.5	8.0	7.7	12.6	3.9	4.6	16.5	8.5	11.6	6.9	5.8	4.1	6.5	6.0	14.6	7.0	8.7	5.9	6.1	6.5	7.5	4.0	7.7	6.8	6.0	4.6	9.2	10.4	6.0	11.5	7.9	4.6	6.4	27.7	16.9	15.9	28.3	28.4	15.5	8.4	10.8	10.4	12.1	11.8	23.7	16.1	57.6	26.7	6.1	34.8	17.5	54.9	35.4	21.6	17.7	66.7	20.7	23.5	15.3	12.1	31.1	14.2	9.2	17.1	28.2	50.6	16.4	15.5	23.4	40.3	16.6	9.5	16.5	28.6	17.9	47.6	18.3	19.4	19.5	21.7	47.7	9.7	13.6	25.8	18.7	25.0	23.6	19.8	27.1	28.7	12.7	7.6	7.6	10.0	26.9	18.9	17.4	28.4	57.6	9.6	20.1	7.8	0.6	1.9	1.0	3.1	1.5	4.0	3.7	3.4	3.7	2.1	4.0	4.0	4.4	0.7	2.9	1.7	2.1	3.8	2.1	4.6	5.3	7.8	6.3	4.1	5.6	3.9	4.6	4.1	4.0	4.6	6.4	26.3	16.0	24.8	17.6	32.0	41.0	60.2	13.6	23.3	35.9	27.0	29.1	13.3	17.2	23.3	9.2	6.2	14.2	37.7	9.0	21.5	19.3	4.4	33.5	27.3	15.6	14.4	19.8	32.5	16.7	13.2	35.8	9.7	27.2	13.3	13.1	13.2	16.1	9.0	28.6	39.7	15.0	8.2	7.7	11.1	2.2	27.1	12.2	17.8	11.2	9.0	17.7	12.3	16.1	28.3	15.6	7.7	21.1	17.0	43.6	12.3	20.5	16.3	23.0	6.6	42.3	25.8	17.1	37.7	19.1	34.8	21.9	32.9	16.3	16.2	33.0
TXN2	MT-TRX	ENSG00000100348	"Thioredoxin 2"	Q99757	22	36467046-36481640	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Transport"		"Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000994, CAB008681"	Approved		Enhanced	Mitochondria		No	No		84000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB008681: AB_1623682, HPA000994: AB_1080267"	"unprognostic (5.11e-2)"	"unprognostic (4.40e-3)"	"unprognostic (4.40e-3)"	"unprognostic (1.07e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.17e-2)"	"prognostic favorable (2.04e-4)"	"prognostic favorable (1.17e-6)"	"unprognostic (1.49e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.05e-1)"	60.3	182.3	89.8	45.5	92.4	64.7	58.0	94.6	98.2	57.4	92.4	65.3	84.0	50.0	51.7	79.8	64.1	49.4	122.3	87.9	90.7	91.5	149.5	44.7	59.2	92.9	91.3	75.8	59.2	99.1	43.4	47.3	91.9	59.3	63.6	43.0	59.5	52.5	159.4	60.5	64.3	48.3	91.2	65.7	76.1	48.8	97.0	50.9	67.7	180.1	59.9	59.0	54.0	91.7	52.8	80.4	75.4	126.8	115.2	125.0	81.3	70.8	108.1	114.8	128.7	87.9	52.1	133.3	64.2	116.8	54.5	76.1	151.7	127.4	66.1	93.6	131.8	147.7	91.7	125.4	94.6	189.6	125.8	162.3	98.9	101.9	79.3	99.5	118.2	78.4	157.7	104.1	106.1	80.3	87.5	128.2	60.0	170.3	95.3	75.3	79.5	92.6	116.4	84.8	99.9	98.3	70.2	148.1	125.3	61.3	103.6	165.9	83.7	120.5	95.0	69.8	65.9	81.4	64.2	128.6	111.0	109.5	74.1	30.2	173.5	32.3	102.5	194.3	108.9	140.4	101.2	109.0	223.4	133.8	116.4	108.6	59.3	145.4	170.1	167.1	110.9	224.3	89.8	92.4	94.6	98.2	87.9	90.7	92.9	91.3	91.9	91.2	97.0	91.7	68.9	60.9	53.0	12.1	66.4	83.5	87.7	154.0	108.1	105.6	124.3	137.7	105.4	88.6	82.5	69.9	39.6	213.2	62.8	128.5	303.3	93.0	19.6	45.7	70.6	73.7	89.5	114.0	8.3	106.2	275.8	74.0	75.4	57.2	69.1	148.0	81.0	122.7	173.4	116.1	10.3	132.4	95.6	100.5	80.7	36.8	56.5	80.7	78.2	8.4	91.9	168.9	77.2	9.0	13.5	82.5	104.3	50.8	79.5	52.7	252.2	213.7	49.0	59.4	19.7	61.1	67.1	49.1	42.4	124.5	89.8	207.1	62.4	287.0	179.6	87.1
TXNDC12	"AGR1, ERP18, ERP19, hAG-1, PDIA16, TLP19"	ENSG00000117862	"Thioredoxin domain containing 12"	O95881	1	52020131-52055191	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		160000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (6.54e-2)"	"unprognostic (5.46e-2)"	"prognostic favorable (4.44e-4)"	"unprognostic (2.33e-3)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (2.61e-4)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (1.25e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (1.40e-12)"	"unprognostic (2.13e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.17e-1)"	49.6	47.7	39.7	45.7	40.7	51.3	50.8	41.2	48.0	49.2	44.2	60.8	47.0	40.8	62.9	31.2	56.8	46.5	36.6	40.1	47.0	54.0	74.1	46.9	50.1	42.5	41.6	47.8	56.5	46.7	21.9	54.5	43.1	40.8	66.1	28.6	57.6	36.5	18.2	29.9	48.4	40.8	44.1	46.4	56.4	38.9	42.8	52.3	52.6	30.2	54.4	57.5	18.0	46.1	97.1	88.9	96.0	135.4	160.1	83.9	76.4	143.5	143.8	132.7	150.7	99.8	78.2	73.0	93.8	118.1	141.1	127.3	134.5	112.9	178.2	94.1	124.2	93.1	73.3	163.2	165.7	176.8	181.8	120.5	132.0	134.0	203.3	99.0	135.4	89.1	87.1	48.2	111.9	91.4	89.3	233.6	208.0	138.8	85.9	94.2	143.3	207.1	178.6	85.3	68.3	97.3	143.9	123.5	138.7	187.7	69.6	228.1	86.5	93.9	100.1	106.7	166.1	107.2	183.6	84.2	131.0	164.9	108.2	355.3	224.0	356.5	135.3	215.0	170.8	160.1	164.3	145.3	169.2	146.0	156.7	151.1	393.2	150.0	234.2	180.6	220.0	273.3	39.7	40.7	41.2	48.0	40.1	47.0	42.5	41.6	43.1	44.1	42.8	46.1	89.8	9.6	12.3	9.4	50.4	44.1	63.1	78.9	35.3	18.3	53.6	57.0	13.6	62.9	30.4	44.1	14.6	115.5	58.9	35.3	17.6	75.4	13.3	42.5	54.7	62.3	48.5	25.7	15.0	89.4	170.9	52.1	23.4	49.2	33.0	106.3	55.6	31.0	120.8	21.9	14.7	70.5	50.8	59.1	55.7	7.2	55.9	66.0	51.6	19.7	66.6	39.2	50.4	10.1	15.9	73.0	57.0	30.9	68.7	68.7	65.4	36.1	32.3	17.0	32.9	40.7	47.1	60.4	9.7	36.0	45.5	118.5	52.3	75.4	71.2	60.4
TXNL1	"TRP32, Txl, TXNL"	ENSG00000091164	"Thioredoxin like 1"	O43396	18	56597209-56651600	"Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002828, HPA002829, CAB016446"	Supported	Supported	Enhanced	Cytosol		NA	Yes		1100000	"Cluster 34: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB016446: , HPA002828: AB_1858358, HPA002829: AB_1858359"	"unprognostic (2.05e-1)"	"unprognostic (2.97e-1)"	"unprognostic (3.38e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (9.62e-6)"	"unprognostic (1.83e-1)"	"unprognostic (1.03e-2)"	"prognostic favorable (6.26e-5)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.51e-1)"	38.3	55.9	45.4	38.6	47.5	83.0	49.1	49.1	63.6	42.5	40.1	41.7	42.1	38.3	66.9	54.2	35.2	40.0	80.0	50.0	50.9	51.7	80.7	30.6	41.2	47.7	47.2	47.1	62.2	51.4	38.2	48.1	49.5	40.5	43.4	77.9	48.5	39.3	149.0	36.5	40.6	43.4	46.2	32.2	46.7	41.9	47.5	48.0	197.9	146.8	49.9	51.8	35.1	54.0	77.7	74.8	99.2	102.8	83.2	121.6	70.2	90.2	91.8	113.4	95.4	67.0	74.2	83.4	78.1	98.4	82.3	93.7	94.4	81.3	116.9	85.7	43.1	114.9	58.3	127.1	98.3	168.9	71.7	92.9	82.4	107.4	97.4	118.8	93.0	62.9	85.5	136.0	116.0	74.4	98.1	109.8	71.9	53.5	79.6	78.2	66.8	145.9	133.0	118.6	81.6	74.5	51.3	70.9	88.1	78.3	77.5	89.1	74.3	118.7	62.9	41.9	89.5	130.8	151.1	130.5	77.2	127.0	89.1	98.5	63.1	48.3	26.9	55.8	37.2	38.9	33.0	35.8	54.8	35.4	32.0	32.9	48.3	43.3	54.9	47.0	42.9	61.5	45.4	47.5	49.1	63.6	50.0	50.9	47.7	47.2	49.5	46.2	47.5	54.0	89.7	57.7	45.9	25.5	80.0	134.3	123.1	177.1	75.7	82.7	89.3	110.4	110.1	67.2	108.3	29.5	139.7	242.3	82.7	72.2	109.5	150.5	246.9	88.0	90.0	84.2	75.9	153.8	43.8	128.3	130.9	86.1	52.0	90.3	53.2	167.5	52.8	78.0	150.1	57.2	43.6	111.6	77.3	97.3	97.0	294.1	77.6	90.5	65.8	15.9	121.8	86.0	78.2	26.2	55.6	139.5	83.7	83.8	88.9	121.2	110.0	144.7	75.1	97.1	65.7	73.0	167.1	204.1	108.0	93.9	126.0	358.6	72.4	171.0	109.7	123.1
TXNL4A	"DIB1, DIM1, HsT161, SNRNP15, TXNL4, U5-15kD"	ENSG00000141759	"Thioredoxin like 4A"	P83876	18	79970813-80033949	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, mRNA processing, mRNA splicing"		Deafness	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 360.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041324			Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA041324: AB_2677410"	"unprognostic (7.56e-2)"	"unprognostic (1.06e-3)"	"unprognostic (5.94e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.99e-3)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (1.45e-1)"	"unprognostic (9.39e-2)"	"unprognostic (3.31e-3)"	"unprognostic (7.61e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.18e-1)"	61.1	79.1	88.1	39.9	92.5	59.6	52.1	96.0	98.7	37.2	94.9	53.5	32.8	35.7	50.3	69.4	38.1	24.1	88.6	95.0	98.4	87.7	97.1	48.2	53.4	89.4	95.8	32.6	86.0	42.2	95.5	31.6	94.1	53.9	33.2	36.5	55.0	25.3	88.5	59.3	48.0	25.6	93.1	67.8	60.5	88.0	91.6	52.4	51.1	61.3	45.6	46.1	45.5	99.3	98.5	129.3	113.0	108.1	90.3	94.7	99.8	104.3	83.5	138.7	124.9	121.2	68.0	118.8	37.8	100.3	94.1	81.4	137.1	121.5	91.2	139.7	173.7	85.6	196.1	288.7	115.4	247.6	134.1	88.6	105.5	98.7	125.6	87.9	132.4	145.0	76.2	168.0	97.8	177.1	177.0	166.3	88.6	74.3	276.9	106.2	75.7	245.4	137.7	152.7	172.1	125.0	51.6	151.8	200.5	96.9	74.6	145.0	62.9	121.3	149.5	55.7	129.4	74.0	302.3	198.6	113.4	185.7	113.9	10.6	10.3	9.0	14.7	12.7	9.9	15.8	11.8	11.6	14.5	17.6	11.7	14.0	8.2	15.6	13.1	31.3	17.3	6.1	88.1	92.5	96.0	98.7	95.0	98.4	89.4	95.8	94.1	93.1	91.6	99.3	81.0	19.2	42.6	14.0	89.2	87.2	76.9	73.6	64.3	35.7	131.9	139.7	80.3	65.8	62.3	66.2	35.5	107.8	104.8	53.6	360.0	123.4	259.3	98.5	66.0	65.2	56.3	94.1	25.3	125.2	156.9	69.8	71.4	88.1	11.4	84.1	47.2	97.4	126.0	45.4	22.5	88.4	59.0	66.4	76.9	245.5	42.0	89.5	94.3	14.0	87.2	81.5	60.8	21.1	34.8	144.5	54.9	45.1	177.9	177.2	48.6	271.8	41.9	51.3	46.0	61.2	100.8	84.6	74.2	147.6	109.8	96.7	78.7	112.6	71.1	119.4
TXNL4B	"Dim2, DLP, FLJ20511"	ENSG00000140830	"Thioredoxin like 4B"	Q9NX01	16	72044289-72094431	"Predicted intracellular proteins"	"Cell cycle, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 86.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065865			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA065865: AB_2685571"	"unprognostic (1.45e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.78e-2)"	"unprognostic (8.72e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.91e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.62e-1)"	9.5	7.2	8.8	9.5	11.1	14.3	9.6	10.7	12.2	8.1	9.9	7.4	10.1	7.7	7.6	9.1	10.1	8.7	8.6	9.5	10.1	8.3	16.2	6.7	11.3	10.7	10.1	20.9	9.1	7.6	8.4	7.5	10.8	7.3	8.2	6.7	8.7	7.4	9.0	8.0	8.5	6.4	10.4	7.4	7.9	15.6	10.5	11.7	8.1	8.3	9.7	7.3	6.9	15.5	14.3	20.8	11.2	15.9	8.2	9.7	25.0	18.1	14.7	31.0	23.3	21.4	12.7	20.6	12.8	9.4	14.5	19.3	20.1	10.9	24.0	10.3	18.9	19.0	16.8	32.7	17.4	22.8	15.9	10.1	7.3	27.5	26.1	12.0	13.5	22.6	46.5	12.2	14.8	26.7	27.6	20.5	20.9	9.0	19.1	28.3	14.2	28.3	11.5	10.6	25.9	22.2	17.0	8.0	24.6	8.6	18.7	14.5	12.9	14.9	21.6	12.5	17.2	23.9	41.8	86.0	16.7	15.4	15.2	25.4	8.8	12.3	7.6	9.8	11.9	9.7	7.9	6.7	7.8	7.1	10.8	10.8	12.6	4.9	14.0	8.5	9.9	9.1	8.8	11.1	10.7	12.2	9.5	10.1	10.7	10.1	10.8	10.4	10.5	15.5	7.1	3.2	8.3	7.5	13.1	8.5	7.7	5.4	9.6	3.7	9.8	10.4	2.0	7.2	5.5	5.5	2.1	13.5	8.9	7.4	5.9	10.7	1.6	10.5	9.7	10.1	9.0	10.8	3.3	10.1	17.5	7.9	7.7	12.5	9.5	16.0	10.8	13.3	12.0	10.1	3.3	9.5	0.0	9.2	4.6	4.5	11.8	9.3	7.2	2.8	10.8	4.5	8.2	7.5	5.8	7.6	3.3	9.1	7.9	7.7	11.6	16.2	7.2	5.1	0.0	8.2	6.7	8.2	8.8	9.6	8.2	19.4	9.7	10.2	9.1	7.2
TYMS	"HsT422, TMS, TS, Tsase"	ENSG00000176890	"Thymidylate synthetase"	P04818	18	657653-673578	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Methyltransferase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 88.5;lymphoid tissue: 113.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 105.8;Erythroid cells: 189.3;Extravillous trophoblasts: 115.3;Plasma cells: 112.7;Spermatocytes: 180.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 14.1"	"Group enriched"	"Detected in many"	6	"NK-cells: 6.7;T-cells: 14.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB002784, HPA074922"	Enhanced					NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"			"CAB002784: , HPA074922: "	"unprognostic (7.58e-2)"	"unprognostic (2.06e-3)"	"unprognostic (9.31e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (5.10e-6)"	"unprognostic (1.62e-3)"	"unprognostic (1.68e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.65e-3)"	"unprognostic (2.47e-1)"	4.5	3.1	4.3	24.2	7.5	88.5	6.7	4.1	6.5	4.8	2.7	22.9	10.5	5.1	1.3	14.8	5.6	3.8	2.2	5.0	4.9	6.5	11.8	4.9	36.1	4.9	5.2	2.1	3.6	1.8	1.6	22.3	4.4	3.1	27.1	4.2	3.9	2.0	0.4	6.2	14.8	12.7	4.8	10.6	8.8	34.3	6.1	113.6	2.1	0.4	44.5	8.4	5.5	10.3	102.7	156.6	320.4	154.9	35.1	57.9	159.9	238.9	141.1	251.7	299.9	132.8	80.1	160.0	91.5	129.9	143.2	45.1	225.3	89.7	216.1	152.3	244.9	273.1	135.8	229.4	8.2	564.8	286.5	51.5	20.7	159.6	49.6	48.4	214.4	334.0	222.0	249.6	321.8	118.1	687.7	311.4	114.7	124.3	114.0	446.8	287.0	191.3	95.6	88.9	106.0	175.7	201.4	91.6	61.1	197.3	63.5	253.5	85.0	289.7	569.5	267.3	474.2	305.9	405.2	367.3	75.2	240.6	339.2	0.0	0.0	1.3	1.1	0.1	0.0	1.1	2.8	2.2	1.8	0.0	0.0	0.6	0.7	6.7	0.1	0.3	14.1	2.9	4.3	7.5	4.1	6.5	5.0	4.9	4.9	5.2	4.4	4.8	6.1	10.3	2.1	0.0	2.3	1.6	15.7	14.4	15.9	13.0	27.9	0.5	7.8	11.7	3.6	2.8	6.7	0.0	0.0	105.8	14.5	15.5	1.9	2.3	34.4	5.6	8.4	12.5	1.2	189.3	0.4	0.8	115.3	28.3	14.3	7.4	7.0	76.2	6.8	4.3	71.4	0.0	0.6	20.9	10.2	15.6	19.4	31.9	6.2	10.7	10.6	1.0	3.9	45.0	5.2	0.5	15.6	1.5	8.9	3.8	112.7	5.0	13.8	36.6	1.0	2.4	13.1	1.3	32.6	180.8	30.7	48.0	7.2	27.0	21.3	10.5	54.9	18.7
TYW1	"FLJ10900, MGC23001, MGC60291, RSAFD1, TYW1A, YPL207W"	ENSG00000198874	"TRNA-yW synthesizing protein 1 homolog"	Q9NV66	7	66995173-67239519	"Enzymes, Predicted membrane proteins"	"tRNA processing"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 57.8;Oligodendrocytes: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA013568, HPA014118, HPA015535, HPA043136, HPA047029, HPA047052, HPA052097"	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA013568: AB_2668852, HPA014118: AB_2668941, HPA015535: AB_1856487, HPA043136: AB_2678333, HPA047029: AB_2679909, HPA047052: AB_2679918, HPA052097: AB_2681723"	"unprognostic (1.53e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (4.86e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.79e-2)"	7.7	10.8	5.5	8.1	5.9	9.1	10.0	6.6	7.6	13.0	8.8	9.0	9.5	9.2	9.7	6.6	10.1	7.1	7.9	5.6	6.4	8.8	12.0	7.2	9.8	6.4	5.8	12.2	7.3	13.1	6.9	8.4	6.1	9.8	10.7	9.0	7.1	9.5	15.6	7.9	7.8	9.2	5.6	7.7	7.7	8.1	5.7	10.4	12.8	8.4	9.4	8.5	8.7	7.3	16.3	20.5	12.1	24.9	17.4	12.0	13.8	16.8	12.9	12.9	12.0	23.3	20.2	28.1	25.2	15.4	18.6	18.4	24.9	20.3	18.4	22.1	24.1	11.9	17.1	15.6	17.7	27.7	15.1	12.4	20.3	17.5	27.0	10.6	13.0	20.9	32.3	16.0	15.6	15.7	18.1	23.4	21.1	27.2	18.8	19.7	16.6	34.8	17.4	16.4	18.2	18.3	20.4	38.4	17.6	22.7	26.6	19.6	14.0	15.0	10.8	11.8	23.3	16.1	25.7	33.2	12.1	25.9	20.8	2.4	7.4	3.9	8.5	7.7	11.2	8.3	8.8	9.5	8.8	9.8	10.8	11.7	1.8	11.1	10.0	6.7	6.8	6.2	5.5	5.9	6.6	7.6	5.6	6.4	6.4	5.8	6.1	5.6	5.7	7.3	10.0	6.4	15.3	39.2	18.2	10.5	5.3	10.0	17.1	12.0	11.4	11.7	9.5	10.0	7.6	11.0	4.2	18.6	11.7	7.8	0.0	7.8	7.3	10.9	18.0	8.8	4.8	12.6	57.8	6.9	13.1	11.0	12.8	10.9	34.2	9.1	6.1	14.2	7.7	3.3	53.4	12.3	12.2	7.1	11.2	4.5	8.4	10.3	8.8	43.1	10.0	6.8	10.3	50.3	58.7	7.1	4.0	8.2	18.0	6.2	4.9	2.4	9.6	11.5	19.7	11.2	10.4	23.9	23.4	15.6	16.9	15.2	17.1	10.2	11.4	3.3
TYW3	"C1orf171, FLJ40918"	ENSG00000162623	"TRNA-yW synthesizing protein 3 homolog"	Q6IPR3	1	74733152-74766678	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029641	Approved		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Plasma membrane"	"HPA029641: AB_2272535"	"unprognostic (6.89e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (3.79e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.96e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.05e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.98e-3)"	12.9	15.4	10.8	11.7	11.8	13.1	17.0	11.3	12.7	13.4	10.2	15.2	8.9	16.0	12.2	11.6	14.7	9.2	20.3	10.5	12.5	17.4	13.8	10.6	14.6	11.2	12.1	26.6	11.7	21.5	11.7	12.7	11.8	15.1	11.1	14.6	14.0	13.6	10.6	9.9	8.9	17.9	11.5	11.0	11.5	11.9	11.6	12.7	19.2	14.4	16.4	15.2	11.1	13.2	19.6	16.1	27.3	19.5	30.3	32.9	41.4	32.9	30.0	30.7	26.9	34.3	16.2	51.0	29.4	28.6	45.1	15.6	31.5	37.9	38.3	31.9	27.1	40.2	49.4	67.0	19.9	81.2	24.9	25.1	37.7	39.2	37.6	24.7	27.7	34.8	70.8	38.0	39.9	16.6	39.8	27.1	72.8	29.2	37.2	37.2	56.8	23.0	26.6	25.2	21.1	18.0	15.7	42.4	53.7	29.5	23.2	29.3	18.2	13.6	37.0	37.0	40.2	21.9	42.7	35.4	30.3	29.0	39.9	9.1	6.4	1.8	10.6	8.8	10.0	10.7	9.2	9.7	9.9	9.8	13.2	14.2	0.5	15.4	6.9	9.6	9.4	5.8	10.8	11.8	11.3	12.7	10.5	12.5	11.2	12.1	11.8	11.5	11.6	13.2	30.6	16.0	23.9	17.6	34.1	25.6	40.5	32.7	58.1	34.5	32.4	42.3	29.9	20.0	28.6	16.5	4.2	44.5	21.2	7.4	78.2	36.2	19.8	28.9	38.8	31.7	13.8	18.5	28.0	59.4	51.1	34.7	15.8	29.0	21.0	32.8	21.8	29.2	33.1	50.5	22.7	19.5	22.4	30.9	22.6	19.6	43.5	26.2	21.4	14.0	39.5	27.6	37.0	30.2	24.5	32.5	8.4	61.3	35.6	45.7	12.2	64.4	18.4	22.5	13.1	44.2	36.0	34.3	45.3	44.1	22.7	22.3	29.2	55.7	25.9	31.2
U2AF2	U2AF65	ENSG00000063244	"U2 small nuclear RNA auxiliary factor 2"	P26368	19	55654146-55674716	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010910, HPA041943, HPA043562"	Supported	Supported	Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA		73000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"	Nucleoplasm	"CAB010910: AB_262122, HPA041943: AB_2677760, HPA043562: AB_2678555"	"unprognostic (2.37e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.12e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.94e-2)"	"unprognostic (4.01e-2)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (9.46e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.00e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.19e-2)"	"unprognostic (4.80e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.08e-2)"	74.2	80.9	70.3	101.9	73.0	147.7	70.2	74.6	82.4	92.1	75.4	83.7	85.1	87.4	56.7	98.2	82.8	54.0	69.3	70.3	70.8	79.4	80.2	74.2	119.3	76.2	71.5	98.3	75.0	70.1	93.7	63.6	73.0	74.9	54.0	46.0	72.0	65.9	67.3	80.0	92.3	62.1	72.0	115.7	75.4	81.8	72.1	132.5	78.9	45.9	93.7	78.2	80.7	82.4	244.5	394.0	235.9	191.1	108.3	109.8	249.3	191.9	174.1	314.2	305.3	231.3	222.3	284.5	149.5	164.9	160.5	193.0	299.3	268.3	149.1	218.0	501.9	245.2	176.1	221.5	176.7	287.4	263.5	148.8	161.0	239.5	166.8	120.0	190.8	195.9	293.1	181.3	169.9	239.2	388.0	261.1	260.4	217.1	307.2	414.5	149.7	233.0	189.7	290.0	270.6	211.0	208.6	197.1	125.7	134.6	190.5	296.9	161.5	279.7	203.7	130.0	415.9	165.0	239.3	344.5	124.3	279.5	245.2	0.1	1.1	0.8	1.3	1.5	1.0	0.8	1.1	0.9	1.0	1.1	0.8	0.8	2.1	0.6	1.2	1.8	1.1	0.9	70.3	73.0	74.6	82.4	70.3	70.8	76.2	71.5	73.0	72.0	72.1	82.4	31.0	3.2	9.1	10.4	46.0	45.4	41.4	34.8	57.5	41.8	29.7	21.3	2.7	24.3	20.6	27.6	31.3	58.5	34.1	44.0	19.6	33.0	6.4	33.8	36.0	31.4	45.5	32.6	6.8	23.8	63.0	29.4	51.0	40.9	34.3	30.4	27.5	26.8	37.6	35.3	7.6	42.4	30.5	22.0	32.3	8.4	44.4	31.6	19.6	11.2	37.4	25.3	30.9	4.0	12.0	31.8	29.3	34.3	62.4	41.9	31.9	21.3	15.3	52.0	0.0	26.1	46.6	22.5	32.0	53.5	39.2	71.8	42.7	30.8	43.6	44.9
UBA1	"A1S9T, CFAP124, GXP1, POC20, UBE1, UBE1X"	ENSG00000130985	"Ubiquitin like modifier activating enzyme 1"	P22314	X	47190861-47215128	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Ligase	"Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000289, HPA001506, CAB019435, CAB073410"	Approved		Supported	Nucleoplasm		NA	NA		14000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB019435: AB_2211440, CAB073410: , HPA000289: AB_1080443, HPA001506: AB_2756305"	"unprognostic (7.18e-3)"	"unprognostic (1.52e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.40e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (6.10e-5)"	"unprognostic (7.22e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.43e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.17e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.38e-2)"	"prognostic favorable (1.78e-4)"	"unprognostic (1.21e-2)"	98.4	157.9	102.9	98.3	113.2	94.3	98.6	103.4	115.5	127.9	133.9	101.1	71.3	127.1	64.3	155.3	119.3	64.9	117.4	106.2	102.0	131.2	114.7	109.5	105.0	106.9	104.2	136.5	89.0	107.5	135.2	67.4	109.3	103.2	68.5	95.6	119.5	78.9	201.1	119.5	100.4	117.4	94.4	131.9	98.6	98.7	110.0	119.7	160.1	114.1	110.8	101.1	124.8	121.3	269.1	273.2	307.7	471.9	207.4	186.8	135.0	175.1	187.1	248.6	200.5	219.3	201.3	201.6	111.8	357.0	361.5	254.9	392.9	375.7	180.9	163.4	391.7	126.1	295.2	180.0	145.1	215.2	258.8	177.4	193.2	362.7	279.4	176.7	330.2	236.1	138.9	173.7	250.4	343.4	203.3	188.5	329.6	163.2	417.1	233.1	215.3	343.7	198.7	287.0	197.4	148.1	520.8	250.9	116.9	329.9	349.5	130.3	241.6	183.1	210.7	266.4	166.1	117.6	132.8	286.3	189.4	150.8	224.9	31.0	39.7	40.7	39.4	51.1	34.0	39.8	31.8	35.0	43.2	29.9	24.7	31.1	44.8	38.1	49.7	29.3	40.3	39.9	102.9	113.2	103.4	115.5	106.2	102.0	106.9	104.2	109.3	94.4	110.0	121.3	37.2	51.3	34.7	45.1	37.1	33.6	38.6	55.7	26.2	24.9	48.3	39.6	51.4	51.5	50.0	82.8	16.7	46.3	34.2	133.1	35.2	77.5	29.6	84.9	56.3	40.9	57.5	33.2	27.1	90.8	68.7	45.0	74.9	97.5	18.3	60.3	43.5	51.2	60.0	11.8	35.5	78.6	30.5	49.0	37.8	61.6	42.3	51.4	19.6	31.9	57.7	20.7	13.4	32.2	46.5	147.9	74.7	65.8	44.0	55.2	82.2	61.6	56.4	25.1	39.5	38.8	56.6	10.5	34.0	51.3	42.1	71.1	34.6	56.8	68.2	55.4
UBA2	"FLJ13058, HRIHFB2115, SAE2"	ENSG00000126261	"Ubiquitin like modifier activating enzyme 2"	Q9UBT2	19	34428352-34471251	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Sertoli cells: 269.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA041436	Supported		Supported	Nucleoplasm		NA	NA		130000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA041436: AB_2677479"	"unprognostic (2.37e-1)"	"unprognostic (3.17e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.36e-3)"	"unprognostic (6.39e-3)"	"unprognostic (8.72e-3)"	"prognostic unfavorable (3.76e-4)"	"unprognostic (1.96e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.88e-1)"	91.3	36.8	35.9	37.1	37.1	54.9	67.7	44.6	53.1	52.4	35.1	41.6	27.4	55.3	34.8	43.6	47.9	35.7	43.3	36.4	39.3	36.5	36.0	45.3	57.2	36.9	39.1	51.7	40.4	40.8	38.5	60.6	36.5	33.6	35.1	47.2	34.4	34.3	109.4	54.5	37.0	43.0	36.9	32.4	38.6	91.8	38.3	68.5	41.8	57.8	54.8	45.7	46.1	40.7	122.9	175.7	176.2	73.4	93.5	75.8	72.0	93.5	80.0	118.2	130.9	151.7	72.7	227.4	140.3	76.7	73.4	48.8	188.8	72.9	165.4	164.0	126.7	241.6	84.6	152.9	120.3	194.6	100.7	55.3	90.8	83.8	146.2	79.2	94.2	96.2	244.0	125.4	105.0	122.7	151.1	107.4	132.3	190.4	59.9	118.1	121.3	101.9	83.9	126.1	149.0	146.1	85.8	77.3	133.2	113.9	55.7	234.4	61.2	131.9	92.1	85.3	169.6	130.7	200.8	223.1	83.5	146.4	118.8	8.8	4.8	8.1	7.3	4.9	9.9	8.5	9.5	11.1	5.8	8.2	11.5	9.3	0.6	8.0	6.4	10.2	8.0	3.8	35.9	37.1	44.6	53.1	36.4	39.3	36.9	39.1	36.5	36.9	38.3	40.7	58.9	25.6	35.3	25.5	62.1	87.1	72.5	36.4	59.7	90.6	36.3	33.1	36.2	31.5	32.7	18.4	41.7	75.4	53.3	15.9	33.2	49.8	22.1	29.7	47.8	55.9	46.0	60.3	50.8	42.0	95.9	56.4	44.4	36.2	38.7	52.5	25.0	25.0	46.7	47.1	48.9	32.8	24.4	34.9	45.4	23.9	43.5	40.4	76.5	33.7	51.9	50.2	41.2	41.7	56.7	39.6	23.9	53.0	74.5	93.5	19.0	32.0	29.7	42.0	269.5	69.0	206.5	223.9	198.3	57.9	92.9	92.8	58.6	49.9	45.4	73.6
UBAP2L	"KIAA0144, NICE-4"	ENSG00000143569	"Ubiquitin associated protein 2 like"	Q14157	1	154220179-154271510	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 147.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035068	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA		67000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles, Cytosol"		"HPA035068: AB_10696366"	"unprognostic (3.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.93e-3)"	"unprognostic (3.98e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (4.65e-5)"	"unprognostic (1.97e-2)"	"unprognostic (5.10e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.96e-2)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (7.40e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.72e-1)"	54.1	49.3	30.7	60.9	31.3	62.8	50.0	29.2	40.4	52.2	32.5	53.2	34.2	59.8	48.6	55.0	54.6	44.8	62.7	32.0	31.2	39.8	36.6	54.5	60.7	26.3	27.6	60.5	37.9	60.4	49.4	70.6	26.3	45.7	40.8	46.0	48.0	47.1	83.1	60.2	40.6	55.2	20.4	53.6	45.9	64.5	27.2	59.5	53.6	49.1	65.9	54.0	50.9	35.0	189.3	184.8	167.4	136.5	121.0	138.0	148.1	212.1	154.9	187.6	131.6	197.9	143.6	235.3	213.2	178.9	94.6	160.8	224.3	158.4	167.7	208.1	199.7	255.7	184.6	162.7	113.7	269.6	144.0	130.5	68.3	173.8	114.8	117.9	153.1	92.0	235.0	111.5	152.6	212.6	207.8	101.1	320.4	140.1	170.9	148.9	135.5	207.8	120.7	220.5	173.1	209.3	245.1	227.2	91.4	186.8	226.6	180.6	245.9	117.0	123.8	145.1	205.7	239.1	278.4	313.2	125.7	144.8	179.0	15.1	28.2	20.4	23.1	35.9	25.4	20.9	21.8	21.2	34.9	26.4	24.6	27.7	24.5	36.4	41.3	16.3	21.5	29.6	30.7	31.3	29.2	40.4	32.0	31.2	26.3	27.6	26.3	20.4	27.2	35.0	29.2	25.6	38.5	22.9	31.7	18.4	18.7	21.5	22.2	18.4	21.5	21.5	39.0	17.2	32.3	18.4	8.4	51.3	32.7	16.7	17.6	28.4	80.6	34.3	43.8	26.8	23.4	34.9	26.7	27.1	39.5	29.0	21.9	35.7	24.7	32.3	23.2	19.1	36.1	15.2	25.3	21.7	26.4	22.6	30.2	147.1	21.5	32.4	19.6	26.2	24.5	13.7	24.7	29.1	29.1	30.9	10.4	22.6	20.6	25.1	12.5	15.9	29.7	20.4	13.1	31.1	51.6	42.2	48.8	31.7	20.5	77.8	23.5	35.6	22.0	21.9
UBE2C	UBCH10	ENSG00000175063	"Ubiquitin conjugating enzyme E2 C"	O00762	20	45812576-45816957	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 78.5;lymphoid tissue: 113.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 129.6;Erythroid cells: 182.1;Extravillous trophoblasts: 449.1;Granulosa cells: 119.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"T-reg: 8.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.1;NK-cells: 2.1;T-cells: 8.2"	"Low cell line specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basal ganglia: 4.3;white matter: 11.4"	"Low region specificity"	"Detected in some"			"CAB011464, HPA034569, CAB035990, HPA054975"	Approved		Approved	"Plasma membrane,Cytosol"		Yes	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Cytosol"		"CAB011464: AB_442965, CAB035990: , HPA034569: AB_2674226, HPA054975: AB_2682658"	"unprognostic (1.45e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (6.24e-6)"	"unprognostic (2.27e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (6.91e-4)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.09e-1)"	"unprognostic (3.61e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.68e-1)"	2.6	2.9	0.3	21.5	0.3	78.5	4.3	0.9	0.6	6.1	0.7	26.7	21.4	5.7	0.6	37.2	1.9	2.7	1.4	0.2	0.3	1.9	2.9	5.4	45.3	0.3	0.7	1.3	1.0	0.4	0.4	20.4	0.7	1.5	30.9	0.2	5.0	0.9	0.9	18.5	20.6	10.5	0.2	15.8	13.0	16.4	1.6	113.5	1.1	0.2	69.5	6.9	12.3	0.4	312.8	223.9	390.9	188.3	10.4	24.0	225.2	238.5	121.6	390.7	278.4	743.8	345.4	327.6	233.2	115.5	475.6	294.9	2.2	260.5	395.8	141.7	213.7	101.5	168.5	196.0	3.0	145.4	241.6	7.6	27.8	265.7	257.3	57.4	193.4	206.4	1.8	261.6	325.4	516.2	243.5	41.1	237.1	350.8	529.4	256.0	354.8	1.4	134.9	105.9	226.1	188.7	378.3	271.7	154.4	196.2	276.6	209.4	70.1	341.2	298.4	236.2	473.4	84.3	2.9	369.4	208.0	103.4	328.6	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.8	1.7	0.6	0.1	0.1	0.1	2.1	2.1	0.5	0.3	8.2	3.2	0.3	0.3	0.9	0.6	0.2	0.3	0.3	0.7	0.7	0.2	1.6	0.4	0.9	0.0	3.7	0.0	17.9	17.3	7.8	39.0	5.7	0.0	8.6	14.6	0.0	1.5	9.3	0.0	0.0	129.6	3.6	27.4	0.0	1.3	12.0	5.8	5.9	9.5	1.2	182.1	0.0	0.5	449.1	28.5	25.5	9.6	5.7	119.0	18.2	3.6	92.6	0.0	0.1	41.1	50.8	20.8	18.1	6.4	0.9	24.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.5	7.2	0.0	37.0	12.6	6.2	0.6	1.8	0.0	0.0	0.5	19.2	52.2	50.7	83.2	11.6	31.2	13.7	2.5	68.4	18.4
UBE2D1	"E2(17)KB1, SFT, UBC4/5, UBCH5, UbcH5A"	ENSG00000072401	"Ubiquitin conjugating enzyme E2 D1"	P51668	10	58334979-58370751	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 138.7;tongue: 65.3"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 194.4;Suprabasal keratinocytes: 190.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 112.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (1.12e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (5.58e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.37e-3)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (8.04e-6)"	"unprognostic (9.71e-3)"	"unprognostic (4.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.66e-2)"	13.0	11.8	5.3	16.7	5.7	32.4	7.8	6.6	8.1	8.9	4.4	11.4	7.0	12.6	7.5	11.6	7.1	9.5	33.3	6.1	6.2	8.1	8.3	8.9	13.8	6.6	6.4	8.4	5.5	8.9	3.9	8.9	6.6	9.5	12.0	5.4	5.5	6.7	138.7	5.9	8.3	13.6	6.4	13.4	6.4	4.5	6.3	7.8	8.4	65.3	11.4	15.1	5.6	6.7	19.1	10.2	18.8	24.4	37.5	30.0	12.1	12.4	21.2	13.9	20.3	20.9	16.4	0.0	19.0	18.6	10.3	17.1	36.6	18.0	19.5	19.8	21.2	4.9	3.7	12.2	24.4	15.3	11.8	34.8	19.9	14.4	26.8	18.7	28.1	13.1	10.0	7.8	19.1	6.1	16.5	17.1	23.0	11.7	15.7	13.8	16.9	10.6	21.2	11.2	14.0	18.8	24.2	40.3	20.6	28.5	14.8	10.2	22.8	5.3	18.6	18.2	13.7	19.7	16.4	16.8	16.7	31.3	6.2	10.1	38.5	17.8	6.2	27.1	7.2	8.9	7.3	7.9	20.0	9.8	7.5	6.2	112.3	8.2	23.4	8.3	9.8	23.4	5.3	5.7	6.6	8.1	6.1	6.2	6.6	6.4	6.6	6.4	6.3	6.7	41.6	12.8	11.2	5.5	54.3	194.4	94.1	60.6	46.1	23.7	45.6	45.5	92.4	17.2	39.0	27.6	18.8	29.9	41.7	27.4	76.3	62.3	5.0	32.6	46.9	42.5	41.7	12.0	18.5	42.0	50.4	51.9	38.7	51.2	22.9	19.6	27.5	15.6	73.7	16.8	17.1	40.1	69.2	90.6	104.0	3.0	33.2	147.7	53.4	4.7	94.6	17.9	22.6	12.5	21.2	81.2	52.7	32.4	26.4	108.4	16.1	54.3	33.6	16.1	6.6	51.4	59.1	33.5	19.9	47.1	190.2	149.0	42.8	14.9	28.5	118.2
UBE2K	"HIP2, HYPG, UBC1"	ENSG00000078140	"Ubiquitin conjugating enzyme E2 K"	P61086	4	39698109-39782792	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028869, CAB033212, CAB033515"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		390000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Plasma membrane"	"CAB033212: AB_2272506, CAB033515: AB_2304024, HPA028869: AB_10602487"	"unprognostic (1.14e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.06e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.05e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (8.60e-4)"	"unprognostic (1.08e-1)"	"unprognostic (3.67e-1)"	"unprognostic (4.83e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.10e-3)"	29.9	19.4	13.5	23.4	17.5	21.4	21.7	20.9	24.5	16.0	9.2	35.8	31.2	17.8	17.7	26.2	12.7	12.9	18.4	18.3	14.9	26.7	45.4	16.4	20.1	12.9	14.0	13.6	13.2	20.4	15.8	24.4	13.1	19.8	24.2	21.0	16.9	14.9	37.3	22.6	24.8	17.2	7.8	18.0	31.8	16.5	14.2	22.4	23.8	25.6	18.0	20.2	17.2	16.0	91.3	90.7	49.3	45.6	29.8	28.7	82.8	122.8	26.4	32.8	34.0	138.0	91.1	114.3	105.2	35.0	79.8	39.0	95.4	54.7	51.9	76.1	70.0	145.7	88.9	121.6	38.4	159.0	79.6	27.1	60.2	46.0	49.0	35.2	43.3	49.3	152.9	39.6	33.9	86.6	111.5	89.9	67.7	54.4	69.8	66.3	144.0	44.2	46.0	123.9	103.9	47.4	91.7	34.5	58.9	54.1	44.4	58.2	116.9	49.9	105.7	60.0	114.5	55.3	174.0	121.4	26.9	101.4	59.5	19.6	18.1	24.8	14.4	16.9	13.4	20.7	15.0	13.8	19.7	14.7	11.2	12.6	15.1	14.0	25.4	27.6	16.0	10.5	13.5	17.5	20.9	24.5	18.3	14.9	12.9	14.0	13.1	7.8	14.2	16.0	63.2	57.7	63.1	69.2	53.0	122.9	65.5	74.3	59.7	62.2	65.3	52.5	72.3	52.9	66.7	49.7	29.2	84.5	76.5	143.7	66.5	83.5	144.9	72.0	82.3	65.6	59.7	85.8	115.9	89.4	168.7	59.2	68.3	90.9	34.8	40.1	63.5	113.6	80.2	104.3	113.8	74.5	65.1	77.1	91.8	202.4	65.3	76.5	56.9	89.0	104.0	87.1	56.7	87.0	118.2	139.6	94.3	56.4	55.5	111.4	75.3	98.0	60.7	42.9	39.5	61.8	121.1	145.2	55.1	74.3	137.9	147.5	61.3	54.8	74.1	107.0
UBE2N	"MGC8489, UBC13, UbcH-ben"	ENSG00000177889	"Ubiquitin conjugating enzyme E2 N"	P61088	12	93405673-93441947	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	15	"Early spermatids: 2532.0;Late spermatids: 8141.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044976	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA		1800000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA044976: AB_2679163"	"unprognostic (1.74e-2)"	"unprognostic (5.53e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.09e-2)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (8.49e-3)"	"unprognostic (2.72e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.07e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.30e-3)"	52.4	48.6	46.4	62.1	49.9	69.9	41.6	40.3	51.6	35.8	26.8	55.9	42.5	44.0	38.3	60.4	37.3	33.5	57.6	50.8	53.2	54.4	45.5	38.2	80.0	45.2	43.9	31.3	30.6	40.4	32.6	49.5	52.2	46.0	44.0	50.3	36.0	34.5	83.0	41.3	42.3	42.7	44.3	42.9	41.0	186.9	44.3	79.4	29.0	70.3	73.8	76.4	38.6	44.4	190.3	133.2	221.1	142.6	82.9	81.4	154.5	259.4	135.6	201.0	167.3	239.8	80.0	380.2	57.3	151.1	133.8	147.7	245.2	188.7	189.7	323.3	128.4	258.0	66.6	214.2	106.4	311.9	165.1	86.3	75.2	120.8	148.9	143.1	157.3	146.9	292.8	58.0	210.9	155.3	310.4	286.2	288.9	165.9	189.4	237.3	179.9	186.6	170.1	280.9	214.9	195.6	136.1	158.5	130.0	118.7	207.5	188.0	165.8	135.7	114.6	124.1	189.9	99.5	289.4	324.0	53.5	162.5	170.2	133.7	89.5	101.3	99.3	123.3	116.8	174.0	124.8	124.1	119.6	144.7	109.3	104.9	27.7	106.0	141.7	89.6	198.6	202.5	46.4	49.9	40.3	51.6	50.8	53.2	45.2	43.9	52.2	44.3	44.3	44.4	87.5	38.5	45.8	24.8	151.4	322.2	231.3	219.1	92.2	72.1	84.3	60.5	74.6	60.1	112.2	90.1	27.1	236.0	104.3	76.3	191.7	141.4	2532.0	79.7	79.0	95.3	74.7	75.9	44.6	99.0	226.0	100.9	49.5	96.5	93.8	68.3	55.3	55.3	165.6	87.5	49.0	78.6	187.2	67.8	216.3	8141.3	93.8	97.0	147.7	33.7	152.9	111.9	79.3	38.7	42.1	135.5	83.8	86.1	113.3	218.2	61.2	171.3	88.9	57.6	46.0	101.9	146.2	338.4	227.6	142.2	322.5	284.7	128.2	86.4	94.9	260.3
UBE2T	"FANCT, HSPC150"	ENSG00000077152	"Ubiquitin conjugating enzyme E2 T"	Q9NPD8	1	202331657-202341980	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 47.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 74.5;Erythroid cells: 134.3;Extravillous trophoblasts: 103.4;Spermatocytes: 114.1;Spermatogonia: 113.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA002831			Approved	Nucleoplasm,Nucleoli		NA	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoli	Nucleoplasm	"HPA002831: AB_1080445"	"unprognostic (2.38e-3)"	"unprognostic (6.37e-2)"	"unprognostic (5.27e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.13e-3)"	"prognostic unfavorable (4.79e-6)"	"unprognostic (1.71e-2)"	"unprognostic (2.32e-2)"	"prognostic favorable (6.90e-6)"	"unprognostic (6.28e-3)"	"unprognostic (2.85e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (5.37e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.86e-2)"	2.3	3.7	6.6	10.4	6.5	28.7	4.5	5.8	13.7	4.1	5.0	13.1	8.7	4.5	4.4	10.6	3.3	2.5	11.3	6.8	7.4	3.5	3.2	3.0	19.0	6.5	6.6	1.0	0.7	4.4	3.0	10.1	6.9	2.1	15.5	2.5	2.7	3.1	17.2	5.3	8.2	9.4	6.0	6.2	4.7	19.3	6.7	47.1	2.9	13.0	18.6	6.3	5.0	6.1	123.3	111.6	167.1	79.8	15.4	27.9	94.2	130.2	72.8	146.0	102.6	79.9	147.1	140.4	50.0	47.0	108.4	98.6	154.1	76.7	131.2	128.1	87.2	85.6	54.0	93.8	6.9	105.2	102.0	9.8	18.1	114.0	47.2	34.3	85.8	157.4	111.0	114.0	116.4	113.3	190.8	135.1	65.4	126.9	57.4	145.0	176.2	122.9	57.1	58.1	131.3	132.8	90.2	112.1	44.8	49.8	117.1	64.6	41.8	65.7	104.6	116.1	159.6	57.8	120.1	182.9	64.5	107.0	139.1	0.0	0.7	1.7	3.3	2.3	2.5	8.5	4.5	3.3	1.7	6.6	6.4	7.1	0.0	1.2	8.9	3.4	10.8	2.4	6.6	6.5	5.8	13.7	6.8	7.4	6.5	6.6	6.9	6.0	6.7	6.1	1.9	0.0	2.2	1.3	13.3	14.3	10.4	29.9	2.8	6.4	6.3	8.6	12.8	0.0	12.1	5.5	0.0	74.5	5.4	10.1	5.9	10.9	24.4	15.7	7.6	5.3	1.2	134.3	8.3	7.5	103.4	11.8	10.7	6.7	8.8	32.2	3.9	2.4	27.7	10.1	6.1	14.4	32.6	1.9	5.4	8.2	3.1	5.8	3.6	1.9	2.6	1.6	0.0	1.0	1.4	10.3	2.9	4.1	32.1	5.2	3.3	12.2	16.2	1.2	6.6	0.8	11.3	114.1	113.1	15.5	10.9	22.4	9.3	12.1	30.5	11.3
UBE2V2	"DDVit-1, DDVIT1, EDAF-1, EDPF-1, EDPF1, MMS2, UEV-2, UEV2"	ENSG00000169139	"Ubiquitin conjugating enzyme E2 V2"	Q15819	8	48008415-48064708	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052535, HPA053186"			Supported	Nucleoplasm		NA	NA		800000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA052535: AB_2681863, HPA053186: AB_2682073"	"unprognostic (3.50e-3)"	"unprognostic (3.27e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.65e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (4.96e-6)"	"unprognostic (1.42e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.45e-1)"	"unprognostic (9.62e-2)"	36.6	42.9	40.0	32.1	44.0	23.0	35.5	38.3	50.3	28.2	33.5	43.7	35.1	32.9	26.7	49.0	26.2	27.5	25.3	45.7	47.0	35.8	60.8	23.3	39.2	44.4	42.2	24.4	21.4	36.9	36.0	31.4	45.2	34.0	36.1	52.1	23.2	30.8	56.3	25.4	33.0	38.3	39.6	23.7	32.8	34.3	46.4	52.1	37.2	56.0	39.7	41.7	31.7	38.6	112.7	63.9	140.0	78.0	75.4	83.6	49.4	114.8	80.1	113.8	99.2	80.9	85.3	136.9	65.7	110.5	97.4	66.1	128.6	107.8	152.1	47.2	89.8	123.6	74.4	68.8	94.0	68.2	35.7	79.5	109.9	91.7	145.6	86.1	97.6	115.8	154.0	83.0	145.3	85.7	218.3	131.6	130.3	166.7	42.2	108.3	61.8	67.6	122.7	90.0	152.9	99.4	96.7	85.1	107.5	103.8	143.0	89.7	54.1	95.8	87.8	86.6	108.7	82.3	151.5	175.8	124.3	118.7	104.0	73.9	70.5	74.4	58.9	84.9	71.6	77.4	72.6	72.8	87.2	76.1	72.2	81.7	45.1	110.6	85.0	73.3	104.6	94.2	40.0	44.0	38.3	50.3	45.7	47.0	44.4	42.2	45.2	39.6	46.4	38.6	52.4	48.1	34.7	20.2	53.1	45.2	75.5	172.5	36.5	87.1	40.9	51.8	58.9	35.8	89.0	51.5	16.7	93.3	39.9	29.9	129.1	81.9	51.6	46.7	58.3	45.4	32.3	57.0	41.6	88.3	149.6	67.9	30.5	36.9	50.8	55.5	32.2	50.8	90.4	80.8	38.1	49.2	109.9	35.4	53.1	34.6	56.2	51.6	37.4	20.6	76.0	110.8	56.7	21.1	28.4	83.6	56.0	73.4	46.7	95.9	51.9	130.2	71.4	65.2	59.2	48.3	122.1	134.7	82.2	46.8	57.1	149.7	47.2	76.2	59.3	75.0
UBE3A	"ANCR, AS, E6-AP, EPVE6AP, FLJ26981, HPVE6A"	ENSG00000114062	"Ubiquitin protein ligase E3A"	Q05086	15	25333728-25439051	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009723, HPA039410, HPA040380"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"CAB009723: AB_639982, HPA039410: AB_10671997, HPA040380: AB_2676952"	"unprognostic (7.95e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.05e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.17e-2)"	29.1	29.0	28.0	27.6	30.3	32.4	32.6	42.8	41.7	33.5	14.0	33.5	22.9	32.9	29.5	32.9	29.9	24.5	40.6	31.0	28.2	32.6	42.2	24.9	33.3	22.3	23.6	37.1	27.2	38.4	15.3	28.4	24.0	31.8	28.9	32.8	23.3	28.4	109.2	26.8	29.5	30.9	19.9	26.9	26.1	45.6	28.1	41.7	41.5	92.0	34.2	32.8	20.0	29.2	55.9	33.6	77.7	46.1	45.0	56.4	38.4	84.8	54.8	59.9	55.6	76.0	27.6	103.4	61.2	68.2	57.8	51.2	106.8	62.2	75.2	54.1	32.7	85.8	49.0	43.1	65.5	107.0	60.2	60.6	56.2	58.3	71.6	60.0	47.6	87.0	89.0	71.1	95.1	32.3	84.0	29.1	50.3	62.1	46.6	88.6	117.8	45.6	51.7	91.1	80.0	59.6	72.1	72.1	102.1	51.3	57.9	56.7	59.2	102.1	84.7	52.1	64.5	77.5	103.4	139.5	60.4	56.6	55.3	14.4	12.7	17.2	17.0	11.2	19.9	17.3	18.5	20.8	16.7	22.8	20.8	18.7	2.2	29.6	22.3	15.2	15.8	9.7	28.0	30.3	42.8	41.7	31.0	28.2	22.3	23.6	24.0	19.9	28.1	29.2	56.6	96.1	80.5	112.6	74.7	71.1	83.8	40.6	84.2	82.7	59.5	42.3	175.3	42.9	58.7	38.6	56.3	52.3	74.3	43.3	19.6	51.6	139.4	53.6	75.2	58.7	68.7	64.3	187.7	49.6	49.6	64.1	52.5	63.8	62.8	84.1	44.3	58.6	46.0	80.8	196.3	55.0	12.2	60.9	41.1	61.6	56.8	64.4	53.4	87.1	53.3	54.5	54.6	126.2	124.4	59.8	41.5	64.7	95.7	102.8	51.4	50.3	59.4	59.2	78.9	119.0	80.5	146.1	88.3	78.3	90.6	74.0	63.3	65.7	52.6	98.6
UBE4B	"E4, KIAA0684, UBOX3, UFD2"	ENSG00000130939	"Ubiquitination factor E4B"	O95155	1	10032832-10181239	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 99.9;Inhibitory neurons: 101.1;Oligodendrocytes: 185.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019219	Approved					NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA019219: AB_1858554"	"unprognostic (5.32e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.46e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.39e-2)"	"prognostic unfavorable (3.69e-5)"	"unprognostic (2.53e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.26e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.76e-3)"	13.5	22.2	13.0	12.9	18.4	20.1	13.4	19.6	16.7	15.8	9.3	24.3	16.2	19.4	12.6	22.8	14.6	12.3	23.2	13.6	13.9	13.6	13.9	11.2	12.4	19.1	15.1	23.3	26.9	21.1	15.2	20.0	20.7	14.1	13.4	19.3	15.0	12.8	41.8	25.3	15.9	17.4	10.4	12.2	20.4	9.5	16.6	17.1	21.0	27.5	14.2	17.3	16.7	28.7	37.9	24.5	28.8	31.6	37.5	49.0	22.5	24.4	31.1	24.0	24.3	26.6	43.2	32.4	29.2	43.6	18.6	27.5	37.2	28.2	28.1	33.8	20.8	35.1	41.5	30.2	27.4	36.6	23.9	40.4	24.7	32.1	26.8	43.9	35.0	23.3	61.7	42.4	22.0	19.6	24.1	16.7	38.2	24.2	19.9	23.6	28.1	34.8	23.0	17.0	35.0	26.7	38.8	26.8	49.5	30.4	21.1	26.0	30.4	21.1	32.0	26.5	20.2	18.8	27.7	37.1	30.9	41.4	28.4	3.4	4.9	2.4	3.0	3.7	5.1	3.6	5.0	5.0	4.1	3.2	4.5	3.6	5.5	1.8	2.8	1.8	6.4	3.6	13.0	18.4	19.6	16.7	13.6	13.9	19.1	15.1	20.7	10.4	16.6	28.7	13.5	22.4	24.0	65.6	17.7	17.6	14.6	13.0	21.6	14.7	18.6	13.2	42.2	15.7	12.9	9.2	25.0	33.1	12.3	12.0	9.8	12.8	3.0	22.4	23.3	15.4	16.3	33.4	99.9	14.8	13.5	18.5	14.8	24.6	6.3	27.9	17.2	16.4	16.5	16.8	101.1	16.2	16.2	22.1	10.9	4.8	11.1	16.1	5.4	46.9	22.9	10.5	19.6	82.4	185.2	19.5	19.5	8.6	24.3	19.3	25.5	10.3	12.9	33.5	19.7	15.2	16.4	8.5	15.0	35.8	22.4	20.5	18.3	21.1	18.6	18.5
UBIAD1	"SCCD, TERE1"	ENSG00000120942	"UbiA prenyltransferase domain containing 1"	Q9Y5Z9	1	11273198-11296049	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Menaquinone biosynthesis, Ubiquinone biosynthesis"	"Prenyltransferase, Transferase"	"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044862			Approved	Vesicles		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA044862: AB_2679117"	"unprognostic (1.79e-2)"	"unprognostic (2.26e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.95e-3)"	"unprognostic (7.55e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.63e-1)"	"prognostic favorable (6.80e-5)"	"unprognostic (3.00e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.25e-1)"	7.3	7.5	5.5	7.6	7.5	7.6	8.3	6.9	7.0	6.8	2.3	7.0	5.5	8.4	6.1	5.9	9.6	4.6	8.2	5.2	6.1	6.5	10.1	6.1	10.2	7.5	7.5	11.5	10.8	10.0	5.8	6.4	6.8	7.1	6.8	8.0	7.0	6.6	17.7	8.1	6.4	7.9	6.6	7.1	7.2	9.2	7.1	11.9	7.7	13.8	10.5	8.1	5.6	10.1	14.5	14.1	11.0	21.3	8.0	7.4	14.8	15.6	12.7	16.4	14.9	16.4	13.1	28.5	15.6	11.1	15.4	19.5	28.1	18.7	19.9	20.0	24.1	19.1	14.5	22.0	14.5	29.5	15.9	11.2	24.9	22.2	26.3	8.7	12.2	25.8	23.1	22.9	11.2	14.8	19.1	14.7	13.3	27.1	20.7	18.0	24.6	34.6	12.7	9.5	13.6	14.5	16.6	16.3	21.5	4.5	12.1	15.3	10.2	14.4	15.5	15.1	20.5	18.6	27.9	52.4	9.2	38.3	18.3	11.5	12.8	19.5	24.3	17.5	27.3	45.3	32.5	24.8	16.9	42.1	48.5	33.3	3.9	20.5	15.6	21.1	33.8	22.2	5.5	7.5	6.9	7.0	5.2	6.1	7.5	7.5	6.8	6.6	7.1	10.1	9.4	9.6	14.6	4.2	19.6	15.4	16.7	11.2	22.2	11.9	13.3	13.7	8.3	11.5	18.1	5.5	8.4	10.6	17.5	7.4	11.7	10.8	34.1	6.3	9.6	9.5	4.9	13.3	4.2	13.3	14.7	11.4	13.3	9.6	7.0	11.3	7.9	19.7	8.7	13.5	6.5	11.1	14.2	8.2	14.1	23.1	12.5	9.5	5.4	4.7	7.1	9.5	14.4	9.0	11.1	11.0	5.3	10.9	14.2	15.0	5.8	8.6	8.9	15.8	0.0	20.2	10.4	24.7	15.7	15.7	12.6	18.9	14.4	12.0	14.1	10.3
UBN1		ENSG00000118900	"Ubinuclein 1"	Q9NPG3	16	4846665-4882401	"Predicted intracellular proteins"	"Host-virus interaction"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 153.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	8	"neutrophil: 14.2"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 14.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061029, HPA069036, HPA069045"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA061029: AB_2684420, HPA069036: , HPA069045: AB_2686072"	"unprognostic (8.20e-2)"	"unprognostic (1.01e-1)"	"unprognostic (8.99e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.47e-3)"	"unprognostic (6.53e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.89e-2)"	14.7	12.3	8.3	14.5	7.9	48.9	12.9	10.5	8.3	14.9	12.4	13.9	14.7	12.4	6.5	25.0	11.9	11.8	20.8	9.1	5.9	10.5	13.6	13.5	15.4	6.6	6.9	13.3	14.1	12.2	10.1	11.5	5.8	11.6	14.3	20.1	15.7	9.6	22.9	15.8	14.6	13.8	6.2	21.5	12.7	37.4	8.0	22.5	11.4	19.5	15.5	11.6	16.5	8.0	21.0	26.0	29.5	29.3	25.3	23.6	23.7	25.7	24.5	29.6	28.4	21.7	24.4	39.2	23.1	25.3	32.1	27.2	38.2	23.6	25.0	38.4	19.0	32.2	35.0	17.1	24.3	39.4	33.6	15.8	30.6	34.4	36.7	22.5	39.3	38.3	53.6	32.5	22.0	30.1	43.6	18.0	25.1	21.8	19.3	67.5	36.6	37.5	15.5	24.0	39.9	22.0	44.7	36.4	22.3	21.8	36.0	34.6	39.7	31.3	29.5	102.5	32.4	30.4	34.7	77.5	18.5	24.5	53.9	1.7	1.2	0.9	1.4	1.1	1.0	0.9	1.0	1.3	0.8	1.0	1.1	0.7	14.2	1.0	0.9	1.7	0.9	0.9	8.3	7.9	10.5	8.3	9.1	5.9	6.6	6.9	5.8	6.2	8.0	8.0	31.2	9.6	15.9	17.3	31.9	18.0	22.0	7.5	30.1	59.9	23.6	20.3	25.5	22.8	9.8	9.2	110.5	28.1	51.3	41.1	7.9	16.7	46.2	39.2	36.8	36.4	30.9	32.4	17.9	18.2	23.3	22.9	29.6	29.8	7.6	27.9	28.5	31.0	23.2	50.5	16.8	27.4	8.2	33.2	21.5	57.8	29.2	37.0	26.6	30.0	28.9	27.9	61.8	19.6	20.3	27.7	33.4	22.6	44.0	33.4	27.4	13.3	16.4	100.8	13.1	26.8	21.8	153.8	128.4	30.9	22.3	29.1	40.4	35.2	26.8	27.3
UBP1	LBP-1a	ENSG00000153560	"Upstream binding protein 1"	Q9NZI7	3	33388336-33441371	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003967			Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA003967: AB_10601829"	"unprognostic (3.11e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (1.81e-4)"	"unprognostic (4.64e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.92e-2)"	"prognostic unfavorable (9.45e-4)"	"unprognostic (6.67e-3)"	"unprognostic (3.92e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.48e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.88e-2)"	23.6	21.4	18.6	31.2	20.8	24.5	24.4	24.3	22.9	23.9	14.2	34.7	29.7	28.7	26.8	29.6	23.2	24.4	31.3	21.2	19.9	23.4	32.4	30.5	44.1	15.0	16.6	29.2	31.0	24.6	22.9	22.2	15.5	25.7	34.6	28.5	23.5	39.5	23.0	26.5	28.7	37.0	17.0	32.6	27.0	16.9	20.0	43.6	26.5	27.6	43.8	35.6	23.0	18.4	48.9	58.6	44.3	74.0	66.1	48.0	21.6	57.7	64.0	67.8	68.4	57.1	42.5	91.2	33.1	85.2	48.6	33.1	133.3	67.6	82.9	50.2	40.7	97.9	57.0	68.7	46.2	71.8	40.5	40.0	54.4	65.7	66.3	55.5	82.5	49.6	90.7	49.0	66.1	46.5	57.5	42.5	105.4	38.6	59.7	59.8	32.4	84.7	47.9	72.8	30.5	36.3	45.9	78.8	50.3	58.5	59.6	86.2	68.8	59.4	45.7	67.8	81.1	38.8	74.9	92.4	51.4	82.7	45.0	3.5	1.6	1.7	2.1	1.7	2.0	1.1	2.1	2.1	2.5	0.8	2.4	2.0	0.4	2.2	2.4	2.0	1.4	1.6	18.6	20.8	24.3	22.9	21.2	19.9	15.0	16.6	15.5	17.0	20.0	18.4	18.0	6.4	20.9	29.7	15.4	25.5	9.7	13.6	19.9	24.6	35.3	17.8	29.3	18.6	10.0	11.0	14.6	7.9	22.2	30.0	3.9	11.8	1.6	12.8	23.5	23.5	12.1	21.7	58.3	14.5	9.4	15.8	17.9	18.4	2.5	27.2	21.4	41.6	14.8	23.5	50.9	27.8	10.2	27.3	27.6	3.5	9.9	25.5	26.6	29.0	27.3	7.7	20.6	34.2	35.5	14.3	17.1	17.7	15.7	17.1	17.3	10.9	8.1	17.8	13.1	15.6	19.7	14.3	13.8	26.8	31.1	5.5	20.5	24.9	28.4	13.2
UBR1		ENSG00000159459	"Ubiquitin protein ligase E3 component n-recognin 1"	Q8IWV7	15	42942897-43106113	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 48.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 108.9;Inhibitory neurons: 108.8;Oligodendrocyte precursor cells: 102.1;Oligodendrocytes: 127.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038838, HPA038839"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Vesicles	"Nucleoplasm, Cytosol"	"HPA038838: AB_10673120, HPA038839: "	"unprognostic (1.07e-2)"	"unprognostic (5.02e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.79e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.89e-1)"	9.1	7.9	12.5	8.8	29.4	24.9	9.3	11.7	17.4	9.9	4.8	8.6	7.8	10.7	7.4	5.8	8.0	8.6	13.7	11.6	31.5	9.2	7.1	8.6	10.9	24.2	18.3	7.7	9.5	14.3	6.6	10.5	21.6	10.0	8.0	14.3	6.3	10.5	12.0	5.6	7.8	9.6	8.5	9.5	7.2	10.1	21.2	13.3	12.6	14.0	8.7	9.1	5.8	48.6	7.4	10.2	11.6	9.6	17.1	14.7	10.7	17.6	19.4	15.9	19.2	13.3	5.5	8.6	10.1	18.4	18.9	12.4	17.1	15.5	18.1	18.0	8.4	33.1	20.4	6.3	12.3	23.0	14.4	15.3	8.4	18.8	14.8	14.6	17.0	16.7	19.6	12.3	18.7	4.5	12.7	6.8	6.5	18.9	10.6	16.4	15.7	6.4	14.9	16.6	12.0	10.3	22.7	12.0	7.7	13.1	10.9	12.2	24.3	17.9	11.1	16.7	18.0	14.6	26.4	23.6	12.2	14.6	16.6	3.7	1.5	2.5	2.4	1.8	2.9	1.9	2.6	2.9	1.4	2.3	2.6	3.2	2.9	3.2	1.7	2.2	1.9	0.9	12.5	29.4	11.7	17.4	11.6	31.5	24.2	18.3	21.6	8.5	21.2	48.6	46.4	48.1	30.7	73.1	28.9	10.6	11.6	9.3	17.1	27.5	15.4	10.8	28.0	12.8	19.1	9.2	27.1	14.7	35.8	12.8	0.0	10.8	16.8	13.4	27.4	24.5	14.4	23.8	108.9	14.4	7.7	25.6	20.9	18.2	28.5	22.8	17.2	9.9	8.1	32.0	108.8	10.9	14.2	16.4	10.6	16.9	16.1	17.1	8.8	73.1	15.6	13.5	23.7	102.1	127.6	10.3	8.2	20.7	33.2	7.7	12.3	9.2	15.7	38.8	13.1	34.7	36.5	27.0	17.8	8.6	7.2	36.9	31.4	16.5	10.6	9.8
UBR7	C14orf130	ENSG00000012963	"Ubiquitin protein ligase E3 component n-recognin 7"	Q8N806	14	93207241-93229215	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"Early spermatids: 300.9;Late spermatids: 372.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000861	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA000861: AB_1078321"	"unprognostic (9.60e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.11e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (8.12e-5)"	"unprognostic (1.14e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.94e-2)"	"prognostic favorable (9.76e-5)"	"unprognostic (3.61e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.78e-1)"	12.7	10.4	16.9	13.2	19.1	21.1	19.1	16.3	20.2	17.6	17.7	16.9	11.8	14.4	14.0	13.0	14.4	13.1	22.0	18.8	15.9	16.6	15.1	12.7	22.2	15.3	16.1	17.6	22.9	25.7	8.9	10.3	16.0	14.6	18.3	24.3	12.7	15.3	17.5	15.7	13.2	15.3	17.1	14.1	14.2	19.0	17.3	34.0	16.8	25.9	27.3	13.6	10.9	18.8	26.1	33.0	52.2	44.2	24.2	24.0	18.6	54.0	38.6	57.1	43.9	23.5	28.2	60.9	42.6	28.3	26.0	30.7	55.8	30.1	60.7	46.4	29.2	45.7	33.1	23.7	11.2	65.7	47.5	15.5	20.7	33.8	21.2	21.7	33.1	54.8	41.5	60.5	57.7	77.3	104.5	35.7	24.1	69.4	61.9	81.9	92.9	33.6	20.6	42.0	65.3	45.4	39.5	32.1	16.3	31.1	58.4	44.6	24.0	43.1	23.0	37.0	56.3	69.0	103.4	61.1	37.0	49.8	38.7	34.5	11.3	18.2	17.8	14.2	19.5	26.4	16.4	16.4	11.4	20.4	13.6	15.1	16.6	18.1	18.3	15.0	26.7	13.4	16.9	19.1	16.3	20.2	18.8	15.9	15.3	16.1	16.0	17.1	17.3	18.8	13.8	16.0	6.4	9.4	16.1	19.9	8.3	8.0	6.8	6.1	11.6	11.0	19.7	11.5	8.5	11.0	10.4	12.3	15.1	15.6	11.7	9.9	300.9	8.2	8.5	11.0	5.4	20.2	16.3	12.9	15.2	12.0	9.7	9.1	5.1	8.8	12.8	11.3	14.0	3.3	12.7	8.4	12.2	10.7	10.9	372.2	9.3	9.0	14.2	7.5	9.3	13.5	13.4	10.6	13.9	8.9	5.4	12.4	26.0	4.7	10.3	9.3	5.5	13.9	6.6	11.2	10.1	38.7	23.2	10.7	13.5	6.6	12.4	6.2	12.4	6.0
UBTF	"NOR-90, UBF, UBF1, UBF2"	ENSG00000108312	"Upstream binding transcription factor"	P17480	17	44205033-44221626	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004611, HPA006385"	Supported	Supported	Enhanced	"Nucleoli fibrillar center"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli fibrillar center"		"CAB004611: AB_671403, HPA006385: AB_1080447"	"unprognostic (1.37e-3)"	"unprognostic (1.12e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.15e-1)"	"unprognostic (8.54e-3)"	"unprognostic (1.35e-3)"	"unprognostic (4.10e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.96e-3)"	"unprognostic (5.44e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.00e-1)"	34.8	36.5	36.2	44.8	33.7	54.9	35.4	38.2	37.1	50.6	30.1	49.4	33.6	50.8	27.5	41.8	41.9	32.5	38.8	35.5	32.7	38.1	36.1	32.3	67.6	34.0	34.5	41.6	41.4	38.2	33.8	29.2	32.2	41.6	28.2	23.1	37.7	40.8	63.7	47.4	42.5	36.3	31.6	49.8	34.7	20.8	34.9	73.6	46.4	36.6	51.7	45.1	41.8	35.0	69.1	104.3	77.3	93.2	49.6	56.5	72.3	70.6	46.7	70.1	52.0	50.7	54.8	250.0	69.3	65.3	51.9	63.6	99.1	59.2	57.9	145.3	109.5	100.5	73.8	83.7	32.5	192.1	85.7	56.9	52.2	44.6	65.6	67.2	58.9	108.8	117.4	75.9	58.9	113.7	188.3	75.0	73.7	46.6	81.6	184.0	104.3	112.0	40.4	54.5	119.5	90.3	70.4	62.2	54.2	47.9	89.9	120.8	75.5	109.9	133.1	65.1	95.0	66.6	61.7	151.1	64.8	86.0	100.1	9.6	5.7	6.1	15.5	6.3	16.7	11.7	10.8	16.2	6.7	14.1	12.2	13.1	9.7	15.7	11.6	12.7	10.0	11.3	36.2	33.7	38.2	37.1	35.5	32.7	34.0	34.5	32.2	31.6	34.9	35.0	41.4	41.7	42.1	14.7	57.5	20.5	19.6	17.9	57.5	88.8	31.0	29.6	44.5	35.8	32.2	38.6	79.2	30.9	60.3	41.7	35.2	27.2	2.3	39.3	57.7	42.7	47.3	61.2	8.5	40.8	40.7	38.9	23.9	48.1	31.7	43.1	32.5	26.5	25.9	26.9	8.2	32.5	12.2	18.4	13.3	3.6	36.7	27.4	23.2	8.4	38.1	33.9	54.6	3.5	10.6	28.1	30.7	50.8	42.2	17.4	26.7	25.4	26.5	57.6	52.6	48.5	45.9	5.3	44.0	52.1	24.3	32.7	53.1	40.2	32.8	11.8
UBXN7	"KIAA0794, UBXD7"	ENSG00000163960	"UBX domain protein 7"	O94888	3	196347662-196432430	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA048441, HPA049442"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA048441: AB_2680394, HPA049442: AB_2680769"	"unprognostic (8.36e-3)"	"unprognostic (4.89e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.05e-1)"	"unprognostic (6.64e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.49e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.40e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.32e-1)"	6.5	7.5	5.3	7.5	7.5	21.7	8.2	17.5	7.1	8.3	7.4	6.9	5.5	10.1	8.1	6.6	8.4	5.7	4.9	5.4	9.3	6.8	6.4	6.7	9.0	6.3	7.3	12.8	7.4	10.8	7.3	9.5	6.9	7.3	6.8	18.1	6.6	6.7	5.0	10.7	6.3	7.9	5.8	8.9	6.6	11.9	7.6	13.9	8.1	7.0	8.7	6.2	7.0	10.9	25.2	7.7	29.8	15.8	15.2	26.6	13.0	20.3	13.4	11.4	10.4	19.9	10.5	23.0	41.6	13.7	15.4	20.0	22.5	12.0	21.2	9.5	13.8	36.9	16.5	11.3	11.6	18.8	11.5	16.0	13.5	16.0	20.0	20.4	18.7	17.2	17.8	15.5	13.5	10.8	19.6	9.9	17.3	10.2	9.7	22.7	22.3	15.8	9.4	10.9	20.0	15.4	32.6	9.0	15.7	23.7	24.2	15.7	23.5	13.0	11.6	11.8	21.7	21.6	31.3	33.5	12.0	21.0	9.9	9.9	4.7	7.0	4.4	3.7	4.0	6.9	3.8	2.9	5.0	5.9	6.5	5.9	8.4	6.2	5.4	2.2	6.6	2.5	5.3	7.5	17.5	7.1	5.4	9.3	6.3	7.3	6.9	5.8	7.6	10.9	27.1	44.8	18.8	29.7	31.4	47.3	14.3	16.2	40.5	38.0	22.2	16.0	16.8	12.8	21.1	20.2	70.9	18.0	32.9	14.8	5.9	10.8	38.3	47.8	46.3	27.8	46.5	34.0	35.3	10.0	10.5	30.7	18.8	35.1	8.8	46.0	21.8	12.0	12.5	32.0	41.3	15.9	12.2	25.4	41.0	24.7	29.8	24.7	23.2	27.2	28.4	21.5	33.0	36.7	47.8	12.2	11.8	28.2	34.3	31.7	13.3	11.7	30.5	46.5	32.9	37.3	25.6	34.7	23.8	38.6	54.7	18.9	29.8	33.2	15.8	25.3
UCK2	UMPK	ENSG00000143179	"Uridine-cytidine kinase 2"	Q9BZX2	1	165827614-165911618	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 110.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057128			Approved	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA057128: AB_2683346"	"unprognostic (5.37e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.83e-3)"	"prognostic unfavorable (9.22e-8)"	"prognostic unfavorable (4.98e-4)"	"prognostic unfavorable (6.70e-4)"	"unprognostic (3.04e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.13e-2)"	"prognostic unfavorable (5.12e-13)"	"unprognostic (2.49e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.83e-1)"	12.8	6.0	5.9	9.2	6.0	11.8	15.3	8.9	7.7	8.3	2.5	14.5	13.9	8.0	15.2	17.4	7.5	5.0	9.2	7.2	7.1	7.0	10.6	9.9	8.5	8.0	8.9	5.5	16.0	4.8	7.4	28.0	9.9	6.8	14.1	3.7	13.1	8.4	17.0	13.9	13.2	8.5	5.7	5.9	11.2	6.0	6.2	17.7	5.2	10.8	10.6	14.2	9.9	6.0	66.1	67.7	36.6	34.4	20.2	32.9	49.3	63.4	59.7	86.7	92.2	70.6	75.3	32.3	43.5	57.6	35.2	46.3	88.6	106.2	72.3	51.3	40.8	40.2	52.3	81.8	56.2	72.1	29.2	35.0	52.1	176.6	111.7	21.5	60.8	73.6	95.3	43.0	78.1	54.1	63.6	49.4	103.4	104.7	54.5	27.8	37.6	112.5	43.5	37.6	51.5	58.3	47.2	104.4	48.8	83.3	62.5	65.9	32.9	41.4	52.1	50.3	71.9	49.8	84.9	116.0	36.7	50.1	33.3	0.8	5.9	0.1	1.5	3.7	3.6	3.3	1.6	2.5	15.1	4.4	0.1	1.4	0.1	3.8	4.2	13.9	2.2	1.9	5.9	6.0	8.9	7.7	7.2	7.1	8.0	8.9	9.9	5.7	6.2	6.0	10.2	0.0	1.1	10.7	6.6	22.9	29.6	18.3	19.9	4.2	22.4	26.2	5.7	8.6	8.8	9.2	0.0	4.4	12.9	41.5	7.9	14.7	110.4	8.7	12.1	22.3	6.7	10.7	32.8	22.2	60.1	12.4	17.3	11.4	0.0	15.4	5.0	5.8	13.0	0.0	33.1	16.1	14.2	4.1	10.2	56.2	6.5	7.9	10.6	30.0	13.5	4.5	9.2	19.6	23.3	54.8	16.1	3.4	25.8	33.0	31.4	6.7	4.5	4.6	0.0	23.0	15.3	5.6	12.0	26.9	29.7	26.4	4.1	5.4	20.4	22.3
UHRF1BP1	"C6orf107, dJ349A12.1, FLJ20302, ICBP90"	ENSG00000065060	"UHRF1 binding protein 1"	Q6BDS2	6	34792015-34883138	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032099, HPA032100"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA032099: AB_10696057, HPA032100: AB_10671087"	"unprognostic (2.30e-2)"	"unprognostic (9.52e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (3.58e-2)"	"unprognostic (4.39e-3)"	"unprognostic (9.82e-2)"	"unprognostic (4.68e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.90e-1)"	"unprognostic (4.24e-2)"	4.3	4.4	2.8	4.3	2.8	14.2	3.6	7.1	3.2	2.7	4.6	3.1	3.2	3.3	2.4	3.2	2.8	2.5	6.8	2.4	3.4	3.7	3.9	4.2	4.9	3.5	3.7	3.3	8.0	8.5	3.0	5.3	3.9	3.6	3.9	7.5	5.9	2.9	14.3	3.1	3.6	3.9	3.5	4.4	4.0	12.0	3.5	5.8	6.0	7.5	4.2	3.5	2.4	3.8	12.9	9.1	7.9	25.9	4.1	3.0	14.3	7.4	5.0	7.1	10.0	18.2	3.4	19.4	7.9	7.7	12.3	9.6	29.2	4.2	9.6	10.0	9.4	17.2	8.7	15.2	16.7	15.7	10.3	6.8	12.0	5.7	12.0	6.6	9.1	16.6	29.3	7.5	3.1	12.3	12.2	10.2	3.6	9.3	6.3	7.3	12.7	11.8	9.6	11.8	9.5	9.7	18.7	9.7	24.7	8.1	18.5	20.3	5.6	3.5	12.7	5.5	8.2	11.1	18.6	12.0	1.9	21.5	8.8	0.1	0.3	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.2	0.1	0.4	1.3	0.1	0.1	0.2	2.8	2.8	7.1	3.2	2.4	3.4	3.5	3.7	3.9	3.5	3.5	3.8	5.1	16.0	6.3	16.0	5.0	1.0	3.0	3.9	5.7	10.1	5.2	2.9	16.8	4.3	9.1	0.0	20.9	6.9	3.7	3.0	1.9	5.4	10.0	5.8	4.9	6.3	9.5	6.7	20.8	5.8	3.8	4.9	10.2	11.5	1.3	14.3	15.0	6.0	15.6	5.0	39.3	4.9	10.2	19.0	6.0	18.2	5.6	11.9	0.0	22.5	9.4	4.6	4.1	25.6	14.1	7.2	3.3	2.6	11.4	9.9	4.1	3.9	5.1	10.8	13.1	7.5	5.4	16.4	10.8	8.3	2.8	4.9	3.9	4.0	3.8	8.5
UIMC1	RAP80	ENSG00000087206	"Ubiquitin interaction motif containing 1"	Q96RL1	5	176905005-177022633	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 132.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 64.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 64.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037503, HPA037504"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear bodies"	Nucleoplasm	"HPA037503: AB_10671373, HPA037504: AB_10671760"	"unprognostic (2.96e-1)"	"unprognostic (9.57e-2)"	"unprognostic (2.48e-3)"	"unprognostic (4.40e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.88e-3)"	"prognostic unfavorable (7.67e-6)"	"unprognostic (1.85e-1)"	"unprognostic (1.12e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.33e-3)"	"unprognostic (8.51e-2)"	"unprognostic (5.52e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.44e-1)"	28.2	24.6	15.8	14.0	15.9	60.2	27.2	22.3	19.1	31.1	19.1	32.5	9.5	29.4	11.2	18.8	26.6	10.8	27.1	15.1	15.4	21.9	18.6	26.4	22.8	14.0	14.4	35.8	27.2	9.1	19.6	12.7	14.4	23.0	12.4	15.0	17.1	13.3	32.6	23.8	23.3	18.9	12.6	31.4	22.5	62.3	14.9	27.6	23.5	12.0	22.0	29.2	23.8	17.6	27.6	26.6	26.9	33.1	25.8	22.7	38.3	28.1	31.4	35.5	37.0	30.6	30.7	79.1	33.8	23.3	37.8	21.1	27.9	62.7	41.8	91.4	25.4	35.4	30.9	25.7	28.5	43.8	22.7	15.9	29.0	27.0	74.0	26.9	41.6	47.1	30.9	26.1	26.6	25.7	43.1	29.4	19.6	22.2	16.2	39.5	38.8	46.1	38.0	17.4	29.1	23.2	62.3	20.1	30.4	28.3	17.5	24.2	31.6	20.1	20.3	17.7	37.6	39.1	49.8	50.8	19.6	43.2	22.1	15.8	11.8	33.0	9.0	7.0	9.4	11.8	10.3	8.9	7.4	13.9	10.0	8.3	64.5	14.5	4.5	9.5	14.7	6.5	15.8	15.9	22.3	19.1	15.1	15.4	14.0	14.4	14.4	12.6	14.9	17.6	24.8	12.8	21.0	36.9	31.3	10.5	18.0	11.8	23.3	19.3	10.9	11.8	20.6	8.6	17.3	9.2	14.6	13.9	22.5	7.8	7.9	13.7	27.4	19.4	23.1	17.0	13.1	47.8	59.5	12.9	12.7	17.1	12.2	22.8	18.3	20.6	13.2	8.8	9.9	16.8	53.3	7.9	8.2	14.8	14.1	13.2	15.5	19.8	1.8	44.0	18.0	8.9	19.6	43.7	51.1	17.0	9.1	12.4	24.2	12.9	8.1	8.9	19.2	33.7	13.1	17.7	18.8	132.1	73.8	13.2	11.9	6.8	23.0	35.4	8.7	13.9
UMPS		ENSG00000114491	"Uridine monophosphate synthetase"	P11172	3	124730433-124749273	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Decarboxylase, Glycosyltransferase, Lyase, Multifunctional enzyme, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 109.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036178, HPA036179"	Uncertain		Approved	Cytosol		NA	NA		9200	"Cluster 26: Non-specific - Mitochondria"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA036178: AB_10673002, HPA036179: AB_10673615"	"unprognostic (6.41e-2)"	"unprognostic (6.70e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.15e-3)"	"unprognostic (5.51e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (2.18e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.31e-1)"	1.3	1.4	2.5	1.2	2.5	1.3	1.8	2.8	2.9	1.0	1.1	2.3	2.0	1.3	1.0	2.0	1.8	0.7	0.8	2.6	1.8	1.8	2.6	0.9	1.4	2.8	2.1	1.9	2.1	1.5	0.8	0.7	2.3	1.4	1.6	1.8	1.3	0.7	3.1	2.3	2.1	1.1	2.0	2.6	1.8	0.9	2.3	1.8	1.1	0.7	1.7	0.8	1.0	3.5	1.4	4.4	5.1	2.1	2.9	3.4	5.4	7.9	2.4	3.1	2.6	3.8	2.1	4.0	8.2	3.0	7.9	9.0	7.1	2.4	5.0	4.4	4.2	8.2	3.0	2.7	2.6	8.7	6.0	3.8	2.3	1.8	3.9	1.9	1.2	8.2	3.7	1.9	2.3	3.5	10.8	1.7	12.1	3.9	2.7	7.4	6.0	3.3	2.4	2.5	4.0	2.6	11.3	4.2	4.3	3.7	4.1	3.1	15.4	2.5	5.2	7.4	3.2	8.0	12.5	12.1	2.8	3.4	2.6	5.9	10.3	5.5	14.0	11.3	12.4	17.0	9.2	12.1	14.6	24.3	13.9	10.8	0.7	12.8	9.3	11.0	12.4	11.9	2.5	2.5	2.8	2.9	2.6	1.8	2.8	2.1	2.3	2.0	2.3	3.5	9.6	6.4	11.5	6.5	11.2	15.8	24.5	41.3	18.8	8.3	8.9	12.3	6.2	20.0	22.8	9.2	4.2	66.8	13.2	9.0	29.4	29.8	3.2	10.9	18.2	15.2	9.6	16.2	11.0	30.5	35.0	12.7	14.3	12.1	12.0	22.8	7.9	31.4	22.0	5.0	12.0	10.3	20.3	7.0	5.9	4.4	13.7	8.3	3.6	10.3	18.0	11.0	13.4	15.6	12.2	23.4	8.6	13.9	10.4	14.6	14.0	25.9	22.1	9.1	13.1	13.3	17.1	23.2	32.1	20.6	19.0	109.2	11.0	29.5	17.8	21.1
UNG	"DGU, HIGM4, UDG, UNG1, UNG2"	ENSG00000076248	"Uracil DNA glycosylase"	P13051	12	109097597-109110992	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 64.9;Spermatogonia: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011605	Uncertain		Approved	Cytosol		NA	Yes			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"CAB011605: AB_778737"	"unprognostic (4.38e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.64e-1)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (6.40e-4)"	"unprognostic (5.68e-3)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (4.66e-2)"	"unprognostic (8.78e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.35e-3)"	"unprognostic (2.57e-2)"	"unprognostic (4.50e-1)"	"unprognostic (1.40e-2)"	"unprognostic (6.89e-2)"	19.8	56.7	32.4	14.7	32.4	16.0	23.1	30.1	34.8	16.6	27.7	28.0	17.1	14.5	12.7	29.7	15.6	10.4	21.1	29.2	34.9	27.5	32.2	9.6	18.0	32.2	31.4	15.7	12.4	33.2	10.9	17.8	34.1	13.6	29.3	6.8	17.7	17.6	43.0	32.7	18.8	14.5	31.6	16.1	17.7	24.3	33.5	22.8	22.2	33.5	27.0	13.5	20.1	30.8	77.1	77.5	72.8	66.6	118.6	33.8	69.5	44.4	30.1	68.6	52.3	61.7	51.6	100.3	65.1	40.2	35.9	47.6	81.4	46.0	66.4	85.6	150.9	98.1	41.1	105.5	17.7	147.6	58.2	30.7	41.6	33.0	18.3	54.6	50.4	117.8	80.9	32.5	47.0	96.2	136.8	173.6	130.0	124.2	117.7	123.9	109.8	85.9	43.4	95.6	103.3	57.4	79.6	67.8	39.5	94.2	126.2	68.2	26.0	59.1	52.7	39.3	62.5	62.6	145.0	190.5	44.8	97.7	73.8	12.9	2.7	5.0	22.4	5.3	31.6	16.0	25.5	25.6	6.8	17.2	16.4	18.4	0.0	16.5	5.5	4.9	25.5	14.4	32.4	32.4	30.1	34.8	29.2	34.9	32.2	31.4	34.1	31.6	33.5	30.8	26.6	0.0	4.8	16.0	9.2	18.0	11.0	13.2	25.0	2.6	21.7	14.1	12.4	7.2	5.0	42.3	4.2	64.9	12.5	14.7	19.6	14.4	3.4	7.6	15.0	17.7	8.4	32.4	7.0	6.2	38.1	12.6	14.3	9.9	7.6	24.8	20.3	20.8	18.3	5.0	6.2	21.4	10.2	3.8	5.4	4.2	14.0	5.5	14.2	6.5	3.8	15.8	7.2	6.6	4.0	5.0	10.3	14.7	16.7	6.8	9.3	20.2	3.2	3.5	6.6	10.2	11.5	21.9	74.6	37.8	20.9	20.4	15.3	25.7	40.4	9.7
UPF3A	"HUPF3A, RENT3A, UPF3"	ENSG00000169062	"UPF3A regulator of nonsense mediated mRNA decay"	Q9H1J1	13	114281601-114305817	"Predicted intracellular proteins"	"mRNA transport, Nonsense-mediated mRNA decay, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 480.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018325, HPA061316"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Vesicles, Cytosol"	"HPA018325: AB_1858638, HPA061316: AB_2684477"	"unprognostic (9.08e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.80e-3)"	"unprognostic (1.44e-1)"	"prognostic favorable (7.09e-5)"	"unprognostic (1.39e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.34e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.76e-1)"	"prognostic favorable (3.71e-4)"	17.5	20.0	13.7	15.1	14.6	18.0	16.4	19.6	19.7	17.6	10.2	17.4	18.1	18.7	8.3	13.3	18.4	11.7	12.9	12.9	16.9	14.5	10.3	12.1	17.0	16.4	14.6	15.5	19.7	13.7	17.1	11.2	17.3	16.4	11.1	11.6	16.5	14.5	23.8	15.6	15.9	11.3	13.2	16.3	16.7	46.3	14.3	17.9	30.2	7.5	10.8	15.4	14.3	17.5	55.9	15.9	35.3	31.7	16.4	28.1	22.3	42.0	30.0	26.4	29.1	24.4	19.4	54.0	11.9	19.6	17.8	29.3	17.2	14.1	32.6	39.8	33.7	47.0	50.9	27.1	28.3	81.7	20.3	19.1	28.1	17.8	20.5	27.7	21.2	14.0	29.0	24.7	26.6	16.7	33.8	22.1	46.7	36.8	15.9	43.2	19.8	31.7	23.4	17.5	39.1	43.3	33.6	51.3	31.3	23.6	37.6	72.7	27.5	27.8	46.0	15.5	26.6	53.4	39.3	74.5	51.7	46.7	23.3	3.0	5.6	4.8	6.8	4.7	5.2	13.2	7.0	7.2	6.5	9.7	7.1	6.7	0.9	11.9	6.1	16.9	10.8	4.3	13.7	14.6	19.6	19.7	12.9	16.9	16.4	14.6	17.3	13.2	14.3	17.5	104.8	67.3	61.5	88.5	64.2	68.7	57.8	57.2	76.8	85.3	80.6	84.3	22.8	52.9	60.8	58.8	83.4	65.0	75.3	32.1	103.7	54.3	205.8	148.7	101.2	78.1	57.5	51.9	84.7	71.2	45.2	69.7	42.8	65.4	55.6	57.7	63.9	72.6	45.7	79.1	114.7	50.5	79.3	44.9	46.1	96.8	100.6	53.8	55.2	59.0	51.1	74.2	83.4	188.5	130.9	52.6	34.0	87.6	81.1	59.1	36.0	69.8	96.0	72.3	85.5	77.5	56.4	480.3	172.4	82.4	71.9	40.5	64.3	111.8	62.2	46.7
UPF3B	"HUPF3B, MRX62, MRX82, RENT3B, UPF3BP1, UPF3BP2, UPF3BP3, UPF3X"	ENSG00000125351	"UPF3B regulator of nonsense mediated mRNA decay"	Q9BZI7	X	119805311-119852998	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA transport, Nonsense-mediated mRNA decay, Transport"	RNA-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 157.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001592, HPA001800, HPA001882"	Approved		Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 6: Non-specific - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA001592: AB_2666373, HPA001800: AB_1080476, HPA001882: AB_1080474"	"unprognostic (1.79e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.64e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.52e-6)"	"unprognostic (6.61e-2)"	"prognostic unfavorable (5.39e-4)"	"unprognostic (5.74e-2)"	"unprognostic (4.51e-2)"	"unprognostic (8.63e-3)"	"prognostic unfavorable (1.44e-7)"	"unprognostic (8.67e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.95e-2)"	9.9	8.1	17.0	10.2	17.2	13.6	9.5	21.1	30.0	11.9	16.3	11.8	11.8	11.7	10.5	12.7	9.9	6.9	7.5	16.5	20.0	11.4	12.4	9.0	15.4	17.5	17.3	13.3	8.1	11.3	12.9	8.8	17.4	10.8	10.5	22.0	8.8	9.0	12.9	15.5	10.0	9.3	16.0	11.3	8.6	15.7	17.8	14.7	11.5	10.9	15.6	10.5	11.7	18.6	29.2	17.3	35.1	28.8	15.7	10.3	22.5	27.4	15.3	20.9	18.3	32.7	20.4	51.9	22.6	11.5	29.9	27.1	45.9	16.6	26.5	29.9	33.9	48.3	57.9	17.2	17.9	52.7	23.0	8.7	12.4	35.8	43.3	19.0	19.7	30.5	47.4	41.8	17.6	35.9	36.8	65.6	67.7	37.1	46.8	35.9	40.2	38.2	17.3	14.5	46.7	32.1	55.6	22.4	42.4	36.2	11.9	30.4	17.3	21.6	16.6	34.9	58.6	23.1	27.5	69.5	17.5	76.1	25.7	8.1	4.4	6.5	5.9	4.8	4.8	12.5	5.6	4.8	3.3	13.7	6.3	6.4	4.9	7.7	5.6	8.7	7.4	2.2	17.0	17.2	21.1	30.0	16.5	20.0	17.5	17.3	17.4	16.0	17.8	18.6	26.3	32.1	25.7	31.6	47.4	37.7	31.1	31.6	47.8	50.7	26.4	28.2	19.0	17.2	38.7	25.8	56.3	39.0	46.1	33.5	5.9	31.6	157.3	26.1	23.5	31.1	27.6	52.2	30.6	26.4	48.2	25.5	23.0	33.8	58.9	32.8	23.2	22.9	28.5	28.6	39.5	35.5	26.4	19.1	43.3	31.7	30.4	28.2	24.9	27.2	44.9	32.6	56.7	33.7	45.4	21.5	33.6	32.7	32.5	33.8	30.4	16.5	35.2	99.0	13.1	34.4	42.0	65.8	41.4	38.8	38.1	64.3	39.9	28.1	37.6	25.0
UQCR10	"HSPC051, QCR9, UCCR7.2, UCRC"	ENSG00000184076	"Ubiquinol-cytochrome c reductase, complex III subunit X"	Q9UDW1	22	29767369-29770413	"Metabolic proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 4406.3;Distal tubular cells: 2296.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"				"unprognostic (1.09e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.05e-2)"	"unprognostic (9.24e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.12e-2)"	"prognostic favorable (5.45e-5)"	"unprognostic (1.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.80e-3)"	87.8	167.6	175.5	59.0	182.2	72.2	70.8	186.9	221.3	58.7	180.2	124.6	111.7	54.0	72.1	111.0	70.4	52.4	433.7	181.4	186.4	169.9	170.0	75.4	68.4	177.2	175.8	61.9	73.4	142.8	98.8	53.7	177.0	94.6	87.6	90.4	85.4	64.0	509.1	73.7	98.2	52.9	179.6	89.8	121.7	101.7	182.0	81.0	86.3	463.5	65.8	79.5	71.0	178.1	173.3	177.3	167.7	131.3	154.0	100.8	93.1	93.8	116.2	164.1	170.8	230.4	96.8	129.6	99.6	149.7	120.5	168.2	200.6	219.9	101.8	162.6	423.2	162.2	200.9	512.2	110.1	210.7	170.0	169.8	132.0	171.6	115.1	137.4	124.1	137.3	112.6	169.8	163.8	434.9	159.4	246.5	96.6	413.1	232.4	171.3	134.6	235.1	289.7	324.3	184.6	92.9	109.3	231.7	156.2	105.7	164.5	198.9	98.2	168.4	204.8	104.8	141.3	127.2	140.2	176.0	152.2	161.4	108.7	982.0	782.2	1009.7	455.0	820.3	503.6	1000.7	620.1	587.4	842.3	830.2	670.6	571.5	552.9	554.9	762.4	864.6	890.3	1160.1	175.5	182.2	186.9	221.3	181.4	186.4	177.2	175.8	177.0	179.6	182.0	178.1	138.4	246.8	290.2	42.7	231.0	181.8	205.4	1090.3	149.1	167.6	354.1	421.9	4406.3	443.2	563.5	627.1	77.2	680.2	215.8	819.5	2296.9	438.5	356.7	361.2	190.9	200.9	380.1	380.7	26.0	553.2	549.2	291.0	423.5	345.2	150.1	279.1	180.2	1306.4	737.2	114.4	33.8	791.0	783.3	390.7	254.0	652.3	234.6	337.1	311.3	15.9	424.2	455.0	310.0	16.1	32.4	499.6	771.6	206.5	293.4	335.2	1114.8	1872.1	522.9	307.1	210.4	150.2	327.7	577.2	165.7	490.0	281.7	582.0	226.2	346.5	782.7	389.6
UQCRH	"QCR6, UQCR8"	ENSG00000173660	"Ubiquinol-cytochrome c reductase hinge protein"	P07919	1	46303698-46316776	"Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 2099.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042574	Supported					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA042574: AB_10960998"	"unprognostic (2.24e-2)"	"unprognostic (6.48e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.34e-2)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (4.63e-5)"	"unprognostic (1.31e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.56e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.07e-2)"	"unprognostic (3.77e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.04e-1)"	216.1	159.7	403.2	200.3	408.4	414.5	241.5	420.6	533.0	176.6	423.5	433.1	396.6	153.6	215.7	292.8	121.1	134.9	1012.8	410.2	421.1	363.4	261.5	121.6	257.5	417.7	404.1	227.8	215.9	403.4	144.7	142.4	411.3	147.8	418.4	436.6	278.5	177.2	932.8	172.0	291.0	146.8	408.8	143.2	256.0	77.7	420.4	312.4	138.0	1033.3	349.6	237.6	188.9	408.4	766.7	456.4	514.3	945.2	529.0	720.3	1070.8	501.7	311.3	435.2	372.5	883.1	416.1	750.2	653.2	474.0	777.9	537.8	742.2	778.7	650.8	563.1	1262.1	1854.5	1320.9	1215.3	313.6	1832.0	508.1	810.8	466.3	706.7	363.4	643.0	622.6	907.5	1803.3	814.1	675.1	613.9	830.6	1884.9	3043.4	950.6	917.8	858.9	840.5	2386.6	974.1	1679.4	1008.3	1180.4	806.7	1519.3	1628.1	1346.7	507.4	2232.3	541.3	410.8	528.9	589.2	935.7	546.9	1230.5	1185.4	593.1	1432.2	625.9	171.5	372.6	249.0	214.4	332.7	281.9	544.6	307.8	283.6	481.5	433.1	346.2	313.0	69.3	221.4	297.8	318.2	340.7	620.8	403.2	408.4	420.6	533.0	410.2	421.1	417.7	404.1	411.3	408.8	420.4	408.4	249.6	105.8	148.5	26.4	523.3	457.8	703.8	1298.7	544.7	269.7	669.2	942.3	1897.2	479.0	505.3	393.6	166.8	651.5	273.8	761.5	2099.3	479.4	65.2	239.0	321.1	293.0	502.5	453.8	49.7	350.6	816.2	285.8	452.1	341.1	283.6	432.7	355.6	612.9	724.5	102.6	53.9	1148.6	612.3	711.1	410.1	69.1	308.8	516.2	489.2	12.2	606.2	408.1	365.6	22.1	22.2	419.9	789.0	284.4	703.3	710.0	944.4	1521.9	213.3	454.0	328.7	358.3	372.6	184.3	337.8	935.4	526.9	650.2	318.0	396.5	1298.2	866.4
URB2	"KIAA0133, NET10, NPA2"	ENSG00000135763	"URB2 ribosome biogenesis homolog"	Q14146	1	229626247-229660200	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008902, HPA046788"	Uncertain		Enhanced	Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoli		"HPA008902: AB_2213805, HPA046788: AB_2679807"	"unprognostic (1.26e-1)"	"unprognostic (4.03e-3)"	"unprognostic (2.16e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.62e-3)"	"unprognostic (7.81e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.45e-1)"	4.9	2.8	2.2	3.9	2.6	4.5	3.2	2.6	2.4	2.1	1.9	2.6	2.2	3.2	1.8	3.7	2.8	2.6	2.6	2.0	2.3	2.2	2.8	2.1	4.5	2.6	2.7	2.9	4.7	2.5	4.3	3.3	2.5	2.0	2.4	2.6	2.3	1.8	6.9	3.0	2.5	3.3	2.6	3.0	2.7	5.7	2.5	4.6	2.2	4.5	4.7	4.9	2.2	3.1	13.6	20.1	12.8	17.2	7.9	6.5	39.1	10.6	6.6	16.1	12.1	20.1	10.4	28.0	11.9	7.6	8.6	18.3	32.0	13.0	14.6	13.8	30.4	17.5	16.8	11.9	7.5	25.8	14.5	6.4	9.3	16.0	12.4	4.1	7.8	16.2	37.7	12.7	10.1	10.7	29.0	12.6	43.1	24.1	13.2	32.0	18.2	27.9	7.1	17.0	19.1	23.4	12.5	12.9	10.6	4.4	14.6	14.6	8.6	13.1	16.6	16.8	30.8	13.9	14.4	41.6	7.0	19.0	24.4	0.1	0.9	0.2	1.2	1.7	2.2	0.8	1.1	1.4	1.1	1.0	1.6	1.3	0.1	0.8	0.6	0.7	1.4	1.4	2.2	2.6	2.6	2.4	2.0	2.3	2.6	2.7	2.5	2.6	2.5	3.1	5.4	0.0	1.1	3.6	6.0	10.1	8.6	1.8	4.0	6.4	5.1	4.3	2.7	1.5	2.6	5.5	29.2	5.3	4.5	2.0	0.0	2.4	0.4	2.8	5.0	4.6	6.6	6.9	7.1	2.7	11.7	3.6	4.1	3.2	0.0	3.5	3.9	3.7	2.8	3.3	7.2	2.5	4.1	1.3	2.7	0.9	2.1	2.8	5.4	6.5	2.7	2.6	2.1	10.1	7.0	2.7	0.8	3.4	4.4	8.7	0.6	2.3	1.3	16.7	0.0	11.6	4.0	8.0	4.0	5.5	9.1	3.3	4.2	3.1	3.1	5.5
URI1	"C19orf2, FLJ10575, NNX3, PPP1R19, RMP, URI"	ENSG00000105176	"URI1 prefoldin like chaperone"	O94763	19	29923644-30016612	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Protein phosphatase inhibitor, Repressor"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 499.7;Late spermatids: 514.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071709	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 24: B-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA071709: AB_2686434"	"unprognostic (4.22e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (2.96e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.40e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.42e-3)"	"unprognostic (1.57e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.47e-2)"	25.0	30.6	29.7	24.8	39.6	36.4	36.7	57.8	40.7	27.9	21.0	26.1	23.5	34.2	32.3	28.5	30.2	25.1	28.1	25.0	36.8	25.6	30.5	22.9	39.9	35.9	32.3	44.1	21.9	31.4	11.0	24.1	34.5	37.7	32.1	32.4	27.2	30.4	52.8	44.9	23.4	22.8	28.4	30.0	25.0	51.6	30.9	31.7	55.4	36.2	37.3	24.8	10.7	45.6	64.8	85.9	39.5	61.7	27.5	39.8	66.5	41.3	34.4	29.5	33.7	45.4	41.5	99.7	79.4	48.2	23.4	44.6	84.8	52.7	66.5	69.7	48.5	90.8	44.3	59.7	39.7	88.5	37.3	35.1	70.6	25.7	95.7	31.7	22.1	58.2	109.7	27.2	37.4	55.3	58.0	37.1	37.1	83.4	26.2	56.7	73.2	40.5	19.4	75.3	63.4	49.7	47.1	56.3	62.2	41.7	23.5	54.8	29.1	72.1	63.9	35.6	63.3	74.4	86.2	67.7	35.5	76.5	44.4	3.4	1.3	1.8	2.9	1.4	2.5	1.9	2.6	3.0	1.1	4.5	3.1	3.1	0.1	2.2	1.4	1.6	2.2	0.8	29.7	39.6	57.8	40.7	25.0	36.8	35.9	32.3	34.5	28.4	30.9	45.6	51.6	44.8	38.8	59.1	48.6	57.0	95.3	19.4	40.5	60.6	67.6	68.1	52.8	48.6	28.2	40.5	25.0	19.2	84.4	21.7	105.7	16.9	499.7	48.5	82.8	32.5	28.9	38.5	79.9	27.8	28.7	45.6	41.3	41.8	30.9	54.5	31.8	50.9	15.4	52.2	122.3	36.5	18.3	33.6	24.0	514.0	43.8	32.9	32.0	74.9	25.0	58.5	70.0	137.7	178.4	19.4	23.7	41.3	53.3	123.9	19.4	85.2	38.8	59.8	13.1	82.3	48.5	72.2	52.2	44.8	73.6	13.1	74.2	91.6	37.0	94.3
URM1	"C9orf74, MGC2668"	ENSG00000167118	"Ubiquitin related modifier 1"	Q9BTM9	9	128371361-128392016	"Predicted intracellular proteins"	"tRNA processing, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053645, HPA065160"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles	Nucleoplasm	"HPA053645: AB_2682215, HPA065160: AB_2685423"	"unprognostic (7.42e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.94e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (6.91e-4)"	"unprognostic (3.04e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.39e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (7.43e-6)"	"unprognostic (1.77e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.17e-2)"	20.1	23.8	35.5	16.3	40.3	26.2	20.0	37.7	37.8	21.2	28.1	22.0	20.2	21.2	15.1	22.0	18.8	11.2	31.1	33.8	35.9	26.8	24.6	17.6	21.7	40.3	41.2	19.5	30.0	18.9	17.9	14.7	38.0	22.7	16.5	12.4	17.2	14.1	25.2	20.9	20.8	16.8	35.7	28.0	23.2	12.5	38.6	23.6	19.3	25.5	20.7	21.9	18.7	42.4	17.9	36.6	34.5	21.6	31.2	29.9	29.9	17.8	27.8	40.1	27.4	28.5	32.7	41.6	14.2	37.8	26.0	63.8	40.3	38.7	20.7	27.7	27.5	37.2	53.4	32.9	28.7	40.8	30.9	40.5	33.3	31.4	28.2	30.6	49.0	44.7	43.9	26.2	29.5	39.9	54.7	54.9	39.5	71.5	41.0	44.5	41.8	48.6	33.5	16.3	27.6	37.6	31.5	51.3	41.4	18.5	50.7	32.2	32.1	31.6	30.0	30.3	30.0	25.2	54.2	39.8	31.4	33.6	38.7	6.1	14.1	10.0	14.5	18.3	12.2	11.7	12.7	13.6	16.8	12.3	12.4	13.5	3.5	12.2	17.6	12.2	15.7	12.6	35.5	40.3	37.7	37.8	33.8	35.9	40.3	41.2	38.0	35.7	38.6	42.4	49.9	16.0	24.5	13.7	36.8	22.7	32.9	60.0	16.5	19.2	37.1	32.9	22.4	25.8	26.1	27.6	14.6	84.1	37.1	57.3	70.5	69.2	2.5	21.5	31.6	47.4	22.2	53.0	12.6	112.2	85.1	32.1	35.7	19.8	37.4	34.6	38.9	23.1	81.6	10.1	13.3	53.3	28.5	42.6	27.7	4.2	31.1	31.6	53.4	4.7	70.5	32.2	59.8	15.1	38.7	89.5	49.3	31.2	29.4	38.4	90.4	51.4	17.4	14.4	19.7	26.3	32.6	24.1	27.1	29.4	23.9	71.7	37.4	48.1	66.7	31.7
USP1		ENSG00000162607	"Ubiquitin specific peptidase 1"	O94782	1	62436297-62451804	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 302.7;Spermatogonia: 206.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028387, HPA028440"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA028387: AB_2672578, HPA028440: AB_10603000"	"unprognostic (1.22e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.78e-3)"	"unprognostic (4.05e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (6.72e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.33e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.61e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-1)"	13.8	10.6	12.4	21.0	14.7	53.2	23.9	20.2	15.4	16.2	11.8	19.0	17.1	20.7	16.8	17.9	16.7	11.9	12.2	11.5	13.4	14.1	13.5	16.0	32.3	12.8	13.0	26.0	16.0	18.2	10.0	14.4	13.7	16.7	20.7	34.5	14.7	15.9	11.9	19.3	17.2	17.0	14.2	19.4	16.9	51.5	12.9	48.1	20.2	16.0	31.7	13.9	11.9	17.3	85.6	25.5	96.8	53.2	21.3	25.5	57.0	79.7	52.1	93.3	101.2	41.4	39.3	151.3	57.0	43.1	83.6	48.0	80.3	53.0	128.5	79.5	63.5	124.5	82.1	42.7	23.2	132.5	60.9	13.7	33.8	84.1	62.8	25.1	44.9	100.1	92.7	125.3	66.2	38.0	136.9	50.9	88.2	48.5	52.4	131.9	166.3	93.9	34.9	60.1	103.4	58.6	89.3	70.1	86.8	64.2	41.3	79.7	32.1	72.7	80.7	109.3	112.9	52.2	78.1	171.1	49.5	104.0	67.0	22.6	9.9	26.0	12.7	10.5	16.9	15.6	15.3	13.5	12.3	11.2	14.4	12.2	17.4	17.9	14.9	12.4	15.3	10.3	12.4	14.7	20.2	15.4	11.5	13.4	12.8	13.0	13.7	14.2	12.9	17.3	35.8	48.1	31.8	6.2	58.7	62.2	34.7	32.9	75.7	49.6	41.5	46.2	34.9	24.3	34.9	16.5	22.9	43.7	52.4	22.7	19.6	34.1	173.9	37.2	32.3	39.7	8.4	85.2	10.3	34.1	59.2	43.9	15.8	33.2	27.8	41.4	30.0	18.4	31.0	35.3	11.2	33.3	30.5	27.2	38.8	81.1	50.1	34.7	26.6	7.5	56.0	49.5	62.8	10.6	17.2	27.5	12.7	41.0	63.7	56.8	22.7	17.3	41.9	86.6	52.6	59.7	42.0	302.7	206.7	73.8	64.4	33.0	59.7	21.2	39.5	35.8
USP10	"KIAA0190, UBPO"	ENSG00000103194	"Ubiquitin specific peptidase 10"	Q14694	16	84699986-84779922	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Autophagy, DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 742.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 742.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006731, HPA006749"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Nucleoplasm	"HPA006731: AB_1080495, HPA006749: AB_1080492"	"unprognostic (4.14e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.91e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.82e-3)"	"prognostic favorable (1.00e-4)"	"unprognostic (5.91e-2)"	"unprognostic (4.57e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.38e-1)"	24.8	21.7	19.6	29.4	20.3	29.5	23.4	22.1	22.9	21.0	17.8	31.2	29.5	25.9	23.9	29.1	27.0	18.5	25.4	20.8	20.7	28.8	33.8	18.7	36.7	18.8	18.7	27.1	23.0	41.5	6.0	40.3	19.0	28.3	26.4	52.5	21.0	25.9	46.6	25.7	27.4	31.0	19.8	32.6	23.8	22.0	20.4	29.1	27.4	39.5	37.7	32.1	10.1	21.6	63.6	72.9	78.5	104.7	31.4	50.2	111.5	58.0	60.1	96.9	51.5	106.9	54.9	102.9	65.2	61.1	47.7	69.8	108.2	89.7	139.0	41.3	63.3	63.2	37.3	92.2	39.4	95.0	37.9	30.0	74.8	95.6	112.3	57.5	76.4	68.5	153.4	22.7	73.1	129.4	92.4	96.8	102.5	71.8	56.7	119.9	44.5	55.0	81.9	48.4	73.0	48.6	130.5	48.7	54.0	72.3	108.4	76.8	55.7	66.9	60.2	39.4	62.2	38.8	53.7	272.3	44.5	64.6	73.2	29.0	77.3	15.6	46.1	61.9	58.0	60.6	148.0	53.9	92.6	59.7	82.9	49.6	742.4	65.9	58.6	30.7	57.3	97.3	19.6	20.3	22.1	22.9	20.8	20.7	18.8	18.7	19.0	19.8	20.4	21.6	21.3	54.5	50.0	26.4	51.5	51.5	46.1	25.8	54.1	25.1	27.6	28.6	66.6	25.8	45.2	27.6	29.2	106.9	38.1	25.8	31.3	29.0	63.3	31.0	35.8	30.4	28.9	42.5	39.3	25.1	73.4	40.1	35.7	42.1	58.0	38.7	21.0	37.2	31.4	20.2	38.9	28.1	16.2	34.8	33.4	116.6	23.6	40.6	24.9	41.2	52.6	23.7	32.0	49.8	35.8	23.6	23.9	22.6	50.8	48.6	30.4	45.0	90.7	52.7	26.3	58.4	34.3	35.0	29.5	54.5	49.6	60.9	42.5	33.6	40.6	45.2
USP14	TGT	ENSG00000101557	"Ubiquitin specific peptidase 14"	P54578	18	158383-214629	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001308	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		2700000	"Cluster 15: NK-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane, Cytosol"		"HPA001308: AB_1080499"	"unprognostic (2.21e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.59e-3)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (7.81e-5)"	"prognostic unfavorable (4.30e-5)"	"unprognostic (5.14e-2)"	"unprognostic (5.00e-2)"	"prognostic favorable (7.91e-4)"	"unprognostic (1.64e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.76e-2)"	26.0	21.5	19.9	22.7	21.3	23.9	17.0	20.1	22.9	15.5	13.9	17.8	13.9	17.0	23.8	24.0	14.6	14.6	24.8	21.0	24.5	23.4	25.3	15.1	21.6	25.4	21.7	13.3	13.0	21.2	14.3	26.5	25.7	29.7	19.3	15.5	15.2	19.6	55.6	15.4	12.4	24.7	20.3	13.8	15.1	17.9	26.0	21.8	20.4	36.4	31.3	22.6	15.3	23.3	91.6	75.4	62.7	64.5	60.7	60.0	109.6	115.5	64.9	118.9	110.5	98.9	48.7	133.1	86.6	99.1	114.4	50.9	125.1	91.7	134.9	38.7	59.0	72.5	46.0	78.1	60.5	184.1	70.8	48.4	69.1	122.3	69.5	55.0	93.5	65.9	106.2	99.3	119.1	76.2	105.2	52.4	59.4	56.0	83.5	87.8	78.6	98.0	88.7	79.9	71.8	60.1	120.7	59.2	52.5	68.0	58.2	51.5	103.9	138.7	104.3	128.8	170.6	62.3	125.7	130.9	80.0	77.3	88.4	10.7	18.1	13.8	27.9	25.8	33.6	21.1	27.5	29.5	25.6	16.4	26.7	26.2	1.5	39.3	20.5	18.7	28.6	19.4	19.9	21.3	20.1	22.9	21.0	24.5	25.4	21.7	25.7	20.3	26.0	23.3	40.0	22.4	40.4	27.7	52.7	58.6	53.3	42.0	51.8	58.0	33.4	23.5	44.9	31.5	48.3	44.1	31.3	92.3	58.1	22.5	45.0	60.6	70.9	44.9	56.3	43.1	22.1	102.0	58.8	54.0	71.8	49.0	43.8	80.8	34.8	47.1	28.2	45.4	50.9	116.1	54.4	22.5	46.8	31.5	53.4	21.6	31.7	45.5	35.6	33.7	48.8	39.4	46.4	35.2	74.8	75.8	16.9	45.9	72.7	71.4	15.2	56.0	40.2	50.3	0.0	49.6	51.4	34.1	68.1	57.9	52.4	135.6	55.0	58.9	33.5	51.8
USP37	KIAA1594	ENSG00000135913	"Ubiquitin specific peptidase 37"	Q86T82	2	218450251-218568351	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 119.4;Late spermatids: 145.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045160	Approved		Approved	Nucleoplasm,Nucleoli		NA	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA045160: AB_10795620"	"unprognostic (7.00e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.83e-2)"	"unprognostic (9.19e-4)"	"unprognostic (1.83e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (2.18e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.66e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.87e-1)"	"unprognostic (6.69e-2)"	"unprognostic (6.41e-3)"	2.7	4.1	3.5	4.4	4.7	11.8	4.7	8.5	4.9	3.6	1.9	3.0	2.9	4.2	7.5	3.9	3.3	3.5	2.3	3.3	4.0	2.9	3.8	3.0	6.0	3.8	4.0	5.9	3.0	4.0	1.4	4.0	4.0	3.6	3.5	9.1	3.9	3.0	2.9	3.9	3.3	3.2	2.5	3.8	3.4	12.7	3.4	6.3	5.0	4.2	4.9	3.6	2.2	8.3	9.6	6.9	14.2	11.0	3.6	4.4	12.1	7.1	5.1	12.2	13.6	13.1	7.4	8.7	7.5	5.6	9.3	8.9	15.7	8.0	13.4	12.0	8.3	23.5	13.6	8.7	4.1	15.6	11.3	2.4	4.7	12.9	9.2	4.5	5.3	15.0	17.3	16.2	7.8	7.2	20.1	10.6	12.2	6.2	5.9	16.0	21.3	8.0	4.2	11.2	15.5	8.4	11.5	5.6	7.2	13.6	6.4	10.8	6.8	13.7	12.0	7.7	9.5	11.0	10.4	17.6	7.4	11.2	9.5	4.2	2.0	3.8	3.1	2.3	3.2	2.5	2.6	2.7	2.1	3.2	4.0	2.6	1.6	3.2	2.2	2.9	3.6	1.2	3.5	4.7	8.5	4.9	3.3	4.0	3.8	4.0	4.0	2.5	3.4	8.3	12.8	0.0	11.0	34.3	16.5	19.5	7.0	7.1	22.2	14.7	14.4	10.2	4.9	4.3	9.6	7.3	27.1	8.4	13.4	5.5	0.0	5.8	119.4	13.3	11.8	14.2	10.3	16.6	47.4	2.3	6.6	13.2	9.2	16.4	5.1	16.2	12.5	11.0	7.8	15.2	40.0	8.9	4.1	8.5	22.9	145.5	9.9	17.2	21.4	27.2	10.2	9.1	10.3	35.2	60.5	4.9	7.4	9.8	14.6	12.1	7.1	4.2	11.1	19.9	6.6	12.7	21.6	60.8	31.4	13.6	20.6	7.3	19.7	10.9	7.6	7.1
USP39	"CGI-21, SAD1, SNRNP65"	ENSG00000168883	"Ubiquitin specific peptidase 39"	Q53GS9	2	85602856-85649283	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034823, HPA077350"	Supported	Supported	Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA034823: AB_10602488, HPA077350: "	"unprognostic (1.10e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (8.46e-3)"	"unprognostic (3.67e-2)"	"prognostic unfavorable (2.84e-6)"	"unprognostic (1.10e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.17e-3)"	"unprognostic (3.14e-2)"	"prognostic unfavorable (4.05e-7)"	"unprognostic (3.95e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.52e-1)"	22.6	16.1	18.1	19.8	18.7	40.8	21.3	19.0	20.6	22.2	22.7	24.2	17.1	23.5	26.1	22.7	19.5	12.7	22.7	17.9	19.5	21.7	18.5	21.4	26.5	18.9	18.4	20.1	17.2	21.8	14.3	26.9	18.9	18.7	22.7	22.0	19.0	21.2	55.2	23.8	19.5	21.3	18.9	20.9	20.6	15.6	18.8	41.0	19.8	42.6	32.2	24.7	20.6	19.8	71.0	70.0	70.0	77.5	49.7	38.7	79.5	59.2	54.6	84.1	74.5	113.9	49.8	83.0	53.4	54.6	62.3	50.6	135.7	62.5	105.8	83.9	86.4	103.4	39.1	100.6	49.0	127.4	67.5	27.9	49.3	65.1	57.8	39.3	68.1	85.3	129.8	47.2	62.8	81.4	125.2	94.8	92.8	84.9	64.2	114.1	150.0	63.1	45.0	53.8	65.1	53.7	36.4	58.9	51.4	56.7	39.5	60.5	43.9	51.7	65.0	62.7	97.2	42.0	83.0	87.7	44.9	130.5	63.6	51.1	35.8	44.5	40.2	42.4	46.6	34.7	41.8	41.7	40.6	37.0	40.4	37.0	23.1	40.4	41.6	32.0	53.4	43.6	18.1	18.7	19.0	20.6	17.9	19.5	18.9	18.4	18.9	18.9	18.8	19.8	18.4	19.2	25.2	19.9	17.5	20.5	16.7	17.9	22.2	8.5	14.1	14.0	17.3	11.5	19.9	12.9	8.4	54.1	17.8	14.8	21.5	21.1	26.1	9.8	15.4	17.1	12.1	18.3	13.9	18.8	31.8	17.1	9.7	11.7	17.1	16.3	17.5	14.2	25.6	5.0	18.2	13.4	24.4	11.9	14.7	13.0	19.3	17.6	19.6	17.8	26.4	15.3	12.3	16.1	33.1	19.2	8.5	18.8	14.0	16.0	11.2	14.6	15.6	11.6	0.0	13.0	17.7	19.5	17.1	15.5	16.2	35.7	21.3	12.7	15.7	16.3
USP47		ENSG00000170242	"Ubiquitin specific peptidase 47"	Q96K76	11	11841423-11961887	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 315.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029286, HPA029289"	Supported		Approved	"Vesicles,Intermediate filaments"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Intermediate filaments"	Vesicles	"HPA029286: AB_10599852, HPA029289: AB_10601675"	"unprognostic (2.02e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.27e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.54e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.85e-1)"	15.7	14.3	11.9	11.4	15.8	19.0	15.1	17.3	12.8	14.3	10.2	19.8	10.3	17.2	15.6	16.1	13.5	12.3	23.5	12.5	14.1	13.2	23.3	16.2	13.3	14.1	12.8	15.9	16.9	22.2	13.8	16.7	15.0	16.6	12.3	25.7	14.1	15.4	59.8	18.0	14.1	17.8	14.1	11.8	16.6	15.0	12.7	19.1	14.9	33.6	13.8	16.7	14.2	20.6	26.8	15.7	30.3	13.1	21.8	23.2	12.6	31.6	22.3	20.1	22.1	16.5	22.2	29.6	13.3	28.0	23.7	17.8	23.7	15.3	30.3	27.5	20.4	18.6	30.3	12.6	21.5	25.0	23.9	22.3	22.5	12.3	29.0	26.1	21.8	21.7	35.8	23.7	25.4	10.6	21.7	14.3	7.9	28.1	12.7	21.4	30.3	9.4	24.6	29.1	9.8	21.0	25.8	19.6	19.3	18.4	14.4	20.6	24.9	27.8	16.2	22.3	19.6	7.9	18.1	25.9	19.9	15.2	20.3	14.7	5.9	11.9	11.0	7.4	14.5	7.4	10.3	11.4	7.9	6.7	13.1	11.4	2.8	18.5	11.5	4.8	8.3	7.9	11.9	15.8	17.3	12.8	12.5	14.1	14.1	12.8	15.0	14.1	12.7	20.6	41.1	70.5	63.1	116.5	46.9	71.0	68.8	28.8	45.5	67.5	41.1	30.9	222.5	40.0	56.0	23.9	47.9	69.6	57.2	30.4	25.4	39.5	40.1	49.8	63.0	44.8	59.3	34.3	122.7	38.9	33.2	69.7	44.4	134.5	54.3	52.6	32.5	53.9	28.0	63.9	136.5	32.9	24.4	27.7	39.7	30.0	44.1	41.8	24.9	96.5	40.5	79.7	68.0	171.4	315.9	44.8	31.5	50.0	55.2	65.5	29.7	21.9	48.2	52.4	52.6	85.0	68.2	92.8	55.1	46.6	87.9	125.7	65.0	41.8	35.0	58.9
USP6NL	"KIAA0019, RN-tre, RNTRE, TRE2NL, USP6NL-IT1"	ENSG00000148429	"USP6 N-terminal like"	Q92738	10	11453946-11611754	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 145.2;Oligodendrocyte precursor cells: 68.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 4.0;naive B-cell: 3.4"	"Lineage enriched"	"Detected in single"	4	"B-cells: 4.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039196	Approved					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"			"HPA039196: AB_10795031"	"unprognostic (1.64e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.35e-3)"	"prognostic favorable (8.06e-4)"	"unprognostic (2.39e-1)"	"unprognostic (2.44e-2)"	"unprognostic (4.22e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.49e-1)"	"unprognostic (8.54e-2)"	5.4	6.8	4.8	7.3	5.2	8.6	5.5	6.5	4.3	6.5	6.0	5.8	5.5	5.9	7.7	22.9	8.9	5.7	4.5	4.8	6.0	5.6	16.3	6.5	14.9	7.5	6.3	7.5	5.1	5.4	4.6	6.8	7.5	4.7	7.4	13.0	6.9	5.2	1.7	8.1	5.8	5.7	6.9	13.6	7.3	24.6	6.4	7.4	5.2	2.2	18.5	5.6	9.7	7.5	26.9	11.6	24.5	10.7	6.1	7.4	11.9	7.3	6.3	8.2	11.3	14.3	24.8	33.5	7.0	6.3	6.7	14.6	11.2	7.9	12.0	0.1	8.7	14.3	6.6	25.5	7.3	4.2	2.0	4.2	11.6	9.5	5.6	9.5	19.8	11.5	22.6	0.8	7.0	18.6	11.6	3.1	12.5	25.0	6.0	22.2	6.4	4.3	11.6	7.9	7.8	13.7	7.9	24.0	25.3	10.2	17.8	4.4	10.8	4.2	15.4	10.9	7.1	0.0	0.9	22.0	7.1	5.1	11.5	0.8	0.5	0.8	0.0	0.9	0.1	4.0	0.1	0.1	0.7	3.4	0.1	0.1	0.3	0.5	0.6	0.6	0.0	0.3	4.8	5.2	6.5	4.3	4.8	6.0	7.5	6.3	7.5	6.9	6.4	7.5	12.0	3.2	17.5	23.2	37.7	6.8	20.6	7.8	13.6	6.0	9.6	6.6	7.8	2.8	12.4	1.8	29.2	7.6	0.5	8.2	7.9	10.8	17.4	32.5	9.7	11.1	13.8	14.3	16.0	10.6	7.5	6.8	20.4	33.2	0.0	11.8	5.7	14.1	8.6	6.7	24.3	14.0	8.2	16.3	8.7	15.4	4.7	12.7	12.4	145.2	7.5	11.2	3.1	68.3	29.4	16.1	6.8	4.9	20.0	20.8	4.2	9.0	15.6	14.6	0.0	5.2	9.1	21.5	7.2	20.1	9.9	7.3	3.9	7.7	7.1	48.3
USP9X	"DFFRX, FAF, MRX99"	ENSG00000124486	"Ubiquitin specific peptidase 9 X-linked"	Q93008	X	41085445-41236579	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Cell division, Chromosome partition, Mitosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011618, HPA047417, CAB070164"	Approved		Uncertain	Vesicles		NA	NA		24000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Vesicles		"CAB011618: AB_470860, CAB070164: AB_10011071, HPA047417: "	"unprognostic (5.42e-3)"	"unprognostic (6.42e-2)"	"unprognostic (3.19e-3)"	"unprognostic (2.94e-2)"	"unprognostic (5.99e-2)"	"unprognostic (4.76e-1)"	"unprognostic (1.82e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.33e-1)"	16.4	16.8	11.9	14.3	13.9	18.2	14.2	12.7	12.8	15.3	14.3	14.8	13.6	15.4	14.9	14.1	16.0	13.0	15.3	14.3	13.2	17.8	33.9	14.4	15.8	12.2	13.1	13.4	16.0	30.0	10.2	18.4	13.8	12.3	13.7	22.0	11.5	15.3	39.1	13.8	14.3	16.3	12.5	13.3	13.8	17.5	12.8	18.8	19.5	28.4	16.2	15.0	12.6	16.4	38.6	44.2	39.1	40.2	33.0	32.7	8.8	21.5	28.8	23.8	27.5	21.1	16.9	25.7	11.5	48.5	71.3	25.3	67.1	39.7	39.7	32.0	50.5	29.3	41.3	19.9	27.6	26.4	21.0	29.3	17.9	56.4	53.4	35.5	37.2	17.1	36.0	20.3	38.6	29.1	18.8	12.7	42.6	14.1	24.7	20.3	51.8	16.9	24.7	30.7	22.2	20.8	89.0	26.7	26.0	69.8	24.3	16.2	40.2	36.6	27.6	34.6	24.0	19.1	22.3	30.9	26.4	12.1	18.5	1.7	2.3	3.0	2.5	1.9	3.6	2.8	3.0	2.7	2.6	2.1	3.0	2.8	6.4	2.5	2.5	2.1	2.8	1.5	11.9	13.9	12.7	12.8	14.3	13.2	12.2	13.1	13.8	12.5	12.8	16.4	38.1	41.7	35.1	48.0	42.6	48.3	30.8	29.6	55.2	38.1	41.3	29.5	83.5	54.3	37.9	27.6	37.5	39.6	46.3	58.5	7.9	28.4	14.9	85.5	56.9	43.6	26.9	41.0	84.9	26.5	25.4	41.4	41.8	136.9	25.9	58.3	45.7	62.8	32.6	37.0	86.0	39.1	18.3	47.8	42.1	15.4	33.2	55.5	33.8	67.5	44.6	31.3	30.9	74.9	108.0	32.6	40.1	49.2	38.8	35.6	47.7	21.5	35.8	31.2	32.9	70.6	48.3	86.4	82.9	55.2	55.3	46.7	42.4	45.8	38.0	40.2
UTP11	"CGI-94, UTP11L"	ENSG00000183520	"UTP11 small subunit processome component"	Q9Y3A2	1	38009258-38024820	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 111.4;tongue: 85.5"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 60.2;Exocrine glandular cells: 67.4;Pancreatic endocrine cells: 72.6;Syncytiotrophoblasts: 77.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045830	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA045830: AB_10969917"	"unprognostic (1.95e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.18e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (7.44e-8)"	"unprognostic (3.51e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.40e-1)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (1.42e-8)"	"unprognostic (1.39e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.57e-1)"	15.4	18.7	11.0	15.4	11.9	16.7	13.6	11.9	15.9	11.4	10.6	18.4	11.3	15.9	13.4	18.4	12.3	12.9	19.9	11.7	11.6	12.3	17.0	11.4	14.9	12.9	12.3	11.0	15.6	12.0	7.3	14.8	12.4	13.7	13.3	7.0	14.1	12.8	111.4	14.6	9.9	19.7	12.0	10.7	14.0	15.1	11.9	13.5	11.0	85.5	17.5	19.7	11.0	14.7	37.6	22.9	38.5	36.8	27.8	37.8	34.6	41.5	39.4	55.4	50.4	32.8	44.9	62.6	37.9	34.2	27.2	31.6	44.2	37.2	68.8	47.3	39.9	72.6	27.9	28.8	37.9	72.7	45.3	35.3	23.7	61.4	53.3	34.1	44.6	47.6	84.1	32.5	63.5	26.6	56.9	75.4	92.1	41.9	29.1	49.7	80.8	57.3	36.5	36.2	49.8	41.5	36.1	30.7	67.8	40.1	28.1	44.5	33.2	36.8	45.0	40.8	80.0	31.0	65.8	52.6	49.3	79.3	46.5	18.1	27.6	15.2	23.1	30.6	24.3	15.0	18.3	19.3	27.6	17.5	16.3	20.3	8.3	32.2	36.5	26.3	23.4	20.5	11.0	11.9	11.9	15.9	11.7	11.6	12.9	12.3	12.4	12.0	11.9	14.7	37.9	35.3	43.6	0.0	5.7	0.0	0.0	0.0	0.0	0.0	29.8	27.6	0.0	0.0	21.1	25.8	0.0	54.2	23.6	0.0	39.2	60.2	0.0	23.6	43.5	31.4	0.0	0.0	0.0	67.4	51.7	23.4	0.0	24.8	25.2	19.0	0.0	0.0	52.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	19.1	0.0	0.0	0.0	0.0	72.6	0.0	0.0	3.5	0.0	0.0	49.4	25.5	0.0	0.0	0.0	25.1	0.0	0.0	0.0	0.0	77.8	10.5	39.1	0.0	0.0
UTP14A	"NY-CO-16, SDCCAG16, Utp14"	ENSG00000156697	"UTP14A small subunit processome component"	Q9BVJ6	X	129906121-129929761	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA047217, HPA054023, CAB079950"	Uncertain		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Cytosol	"CAB079950: , HPA047217: AB_2679987, HPA054023: AB_2682346"	"unprognostic (6.75e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.84e-3)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (7.67e-4)"	"unprognostic (3.00e-3)"	"unprognostic (8.24e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.28e-2)"	"unprognostic (6.99e-3)"	"prognostic unfavorable (8.12e-8)"	"unprognostic (4.77e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.06e-2)"	"unprognostic (9.99e-2)"	11.5	7.8	5.9	11.9	7.7	9.8	13.2	6.2	8.1	10.5	5.6	10.1	7.2	11.2	11.1	11.6	10.7	7.6	7.8	5.9	7.6	9.0	8.2	7.5	13.7	6.7	7.0	12.7	16.1	9.5	5.2	10.1	6.6	8.2	11.9	5.1	8.6	8.3	12.5	10.0	8.2	11.7	5.8	9.5	10.1	2.2	7.0	12.7	9.2	6.3	17.1	14.2	9.8	7.1	34.7	38.0	19.9	52.9	32.7	33.2	33.5	37.6	28.5	37.0	29.4	39.0	33.5	81.6	73.7	27.3	40.2	43.4	80.6	40.8	45.1	27.2	40.1	46.6	32.9	29.8	36.9	66.7	34.5	40.9	35.1	50.2	52.6	23.7	29.5	29.9	47.3	25.0	32.1	57.1	48.4	50.6	41.6	65.5	42.1	37.5	30.1	56.0	25.4	26.1	20.8	54.7	21.3	38.9	45.2	26.1	21.0	38.4	25.8	16.2	21.2	45.8	73.2	30.8	38.4	71.1	24.4	81.2	37.4	29.2	9.4	5.0	13.9	16.8	16.1	12.3	11.5	13.1	13.8	14.1	14.4	13.5	1.1	18.5	15.4	11.0	17.6	8.8	5.9	7.7	6.2	8.1	5.9	7.6	6.7	7.0	6.6	5.8	7.0	7.1	10.1	12.8	15.6	3.6	11.2	8.4	17.0	11.1	17.6	5.3	10.2	13.2	10.5	11.5	20.6	0.0	4.2	24.1	16.8	7.2	13.7	16.8	0.2	12.7	24.0	10.1	7.7	12.2	7.8	12.6	20.0	11.9	9.7	15.7	14.0	10.6	6.8	5.1	13.6	1.7	7.2	10.4	12.2	9.5	5.5	0.5	6.2	11.1	5.4	3.7	17.8	6.5	16.5	3.5	8.4	13.0	9.7	7.2	14.7	12.2	4.9	9.1	8.1	5.2	13.1	17.9	13.2	1.3	2.2	18.9	8.0	40.6	13.1	13.1	13.8	11.4
UTP15	"FLJ12787, FLJ23637, NET21"	ENSG00000164338	"UTP15 small subunit processome component"	Q8TED0	5	73565443-73583380	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 36.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044697			Approved	"Nucleoli,Endoplasmic reticulum"		No	No			"Cluster 32: T-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Endoplasmic reticulum"		"HPA044697: AB_2679050"	"unprognostic (8.96e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.87e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.27e-2)"	"unprognostic (9.66e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.22e-1)"	8.7	6.5	2.0	8.0	2.4	36.9	9.7	3.2	3.2	4.6	1.2	6.8	5.5	7.2	6.4	9.2	5.0	5.1	4.8	2.2	2.5	5.1	7.5	5.9	10.8	2.1	2.3	4.9	7.4	7.5	3.1	6.0	2.7	5.9	8.3	5.5	4.9	4.7	7.2	9.5	5.2	7.6	1.6	7.8	5.7	6.1	2.1	7.6	8.1	7.5	10.7	9.3	4.5	3.6	21.2	22.3	15.8	44.6	12.6	14.9	27.9	24.8	14.1	27.1	29.8	25.0	29.6	47.5	24.9	16.6	34.2	17.3	25.5	45.5	41.6	23.9	19.2	21.7	23.7	20.2	15.5	20.2	18.1	15.2	20.0	30.8	34.3	8.3	19.1	21.2	33.8	25.3	23.2	26.4	31.7	14.0	20.6	7.5	12.7	24.5	24.7	45.9	16.1	28.5	15.8	16.9	22.7	17.6	27.4	13.4	22.8	14.4	15.4	15.9	22.5	19.4	49.3	19.0	27.6	60.5	26.0	34.3	23.8	4.9	6.8	4.6	8.2	7.0	7.6	7.9	8.1	9.1	7.4	7.0	9.6	9.4	5.1	8.2	7.2	7.0	7.3	4.9	2.0	2.4	3.2	3.2	2.2	2.5	2.1	2.3	2.7	1.6	2.1	3.6	8.4	0.0	7.3	2.3	7.7	14.7	13.1	5.0	11.4	3.8	6.7	6.5	6.8	4.3	5.2	5.5	6.2	8.0	6.0	2.7	3.9	8.9	4.3	4.9	6.8	6.9	2.4	9.4	6.4	7.8	9.5	8.0	5.6	6.8	7.0	6.7	2.9	8.1	6.8	1.7	5.4	4.1	2.0	5.8	2.1	2.8	3.1	3.9	7.2	1.9	3.6	3.0	2.1	3.5	6.9	6.5	3.6	5.3	9.1	10.0	2.2	6.3	1.7	4.7	6.6	9.5	8.8	10.0	12.4	11.7	17.0	6.6	6.1	7.6	6.7	9.8
UTP18	"CGI-48, WDR50"	ENSG00000011260	"UTP18 small subunit processome component"	Q9Y5J1	17	51260546-51297936	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 190.6;Late spermatids: 182.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052378	Approved		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Nuclear membrane"	"HPA052378: AB_2681805"	"unprognostic (1.36e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (3.33e-4)"	"unprognostic (2.62e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (2.47e-2)"	"unprognostic (8.37e-3)"	"unprognostic (1.10e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.75e-2)"	"unprognostic (3.11e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.72e-3)"	"unprognostic (1.93e-2)"	17.9	20.1	12.6	24.9	13.7	40.0	25.8	19.1	15.7	18.8	14.2	17.5	17.8	15.7	15.8	21.0	17.5	12.8	10.2	13.2	13.8	21.8	22.3	17.3	33.1	13.0	12.3	23.8	21.3	23.3	20.4	26.3	13.6	16.2	18.7	17.5	17.4	14.2	24.4	32.3	16.5	12.9	13.0	24.5	18.1	58.7	13.2	27.7	24.4	16.2	34.4	24.8	18.0	15.6	90.5	87.7	54.6	50.3	35.1	52.2	142.2	48.9	40.2	83.5	79.7	55.4	49.3	113.5	67.8	36.6	89.0	48.1	89.7	52.0	123.3	74.8	117.0	119.4	52.6	97.3	48.0	127.9	56.4	33.9	39.5	71.1	57.0	42.1	50.7	55.6	98.7	50.6	63.5	56.1	115.6	86.9	78.5	127.5	91.8	103.2	124.2	89.4	61.3	59.1	60.7	76.9	56.7	66.6	114.7	67.4	82.3	64.4	44.7	85.3	71.8	71.1	102.9	97.4	192.5	131.5	53.0	87.6	62.4	19.0	48.2	27.9	40.2	46.9	49.9	54.1	50.7	49.2	55.9	52.4	53.6	51.1	8.2	40.0	49.0	35.0	56.8	56.2	12.6	13.7	19.1	15.7	13.2	13.8	13.0	12.3	13.6	13.0	13.2	15.6	20.6	16.0	23.4	11.8	37.4	60.2	62.9	40.6	33.0	15.6	19.6	17.9	4.4	20.0	25.2	14.7	14.6	66.7	27.4	11.4	39.2	38.4	190.6	26.3	27.3	25.1	16.1	20.8	18.5	46.9	71.2	24.5	14.3	24.1	31.7	19.6	8.9	17.1	62.8	10.1	18.0	20.7	34.6	37.7	26.1	182.0	26.8	33.3	23.2	15.0	42.2	21.3	25.7	17.6	24.6	34.2	16.3	22.2	24.2	50.2	13.8	37.5	38.8	11.8	13.1	24.8	35.7	140.2	104.5	27.7	52.7	79.6	30.4	30.8	25.3	48.1
UTP20	"1A6/DRIM, DRIM"	ENSG00000120800	"UTP20 small subunit processome component"	O75691	12	101280105-101386618	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049341			Supported	"Nucleoli,Plasma membrane"		No	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoli	"Plasma membrane"	"HPA049341: AB_2680720"	"unprognostic (3.04e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.15e-5)"	"unprognostic (8.34e-2)"	"unprognostic (4.30e-2)"	"unprognostic (8.15e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.22e-2)"	"prognostic favorable (8.87e-4)"	"unprognostic (2.88e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.30e-2)"	"unprognostic (6.92e-3)"	4.3	4.2	2.2	5.0	3.7	4.2	5.7	2.9	2.7	5.7	2.5	3.2	2.1	4.6	2.6	4.0	3.8	2.4	3.0	2.3	2.5	3.3	3.0	3.0	5.0	2.8	2.8	6.4	4.8	5.3	2.2	4.3	2.9	3.5	4.2	3.5	5.6	3.3	5.2	4.6	3.1	4.0	2.4	3.6	3.2	5.6	3.3	4.3	4.2	3.9	4.8	5.1	3.5	5.0	8.1	19.9	14.8	6.9	13.0	15.1	18.2	13.8	10.8	21.5	11.8	23.1	5.7	21.6	7.1	15.4	16.2	16.6	33.0	14.2	27.8	9.8	13.4	22.8	10.0	17.3	7.3	38.4	10.2	9.9	7.3	29.9	10.3	8.2	15.0	10.9	36.7	4.3	15.8	10.6	16.8	10.9	38.9	11.3	20.6	18.8	24.2	16.8	9.1	24.4	17.0	11.5	25.8	16.1	15.7	12.2	17.0	8.5	17.1	25.3	12.5	17.8	27.1	7.8	12.6	35.1	13.8	17.2	39.6	0.0	0.2	0.0	0.5	0.3	0.5	0.9	0.5	0.7	0.4	0.6	0.6	0.7	0.0	0.6	0.2	0.8	0.5	0.2	2.2	3.7	2.9	2.7	2.3	2.5	2.8	2.8	2.9	2.4	3.3	5.0	14.3	9.6	9.9	16.0	16.7	10.1	9.7	7.7	11.4	9.9	8.7	8.4	10.3	7.2	13.6	3.7	10.4	7.8	4.4	3.4	5.9	7.6	1.5	11.4	24.5	12.6	6.6	14.9	17.0	11.6	8.8	13.0	7.7	10.1	13.3	18.6	7.1	7.6	5.8	21.9	17.0	6.3	4.1	6.3	3.5	1.2	9.6	8.6	3.6	8.4	3.3	3.3	4.1	16.1	34.2	5.9	1.9	8.2	13.2	14.5	1.1	3.0	9.0	9.4	6.6	24.9	11.0	22.6	22.3	17.3	11.1	2.9	10.0	23.7	9.8	7.2
UTP25	"C1orf107, DEF, DIEXF, MGC29875"	ENSG00000117597	"UTP25 small subunit processor component"	Q68CQ4	1	209827972-209857565	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 11.0;Endometrial stromal cells: 11.4;Glandular and luminal cells: 13.1;Granulosa cells: 10.7;Pancreatic endocrine cells: 11.2;Proximal tubular cells: 10.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026640	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"			"HPA026640: AB_2067139"	"unprognostic (3.11e-3)"	"unprognostic (1.14e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.75e-2)"	"unprognostic (6.96e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.86e-3)"	"unprognostic (4.44e-2)"	"unprognostic (8.49e-2)"	"unprognostic (7.01e-2)"	3.6	2.9	2.9	4.0	3.1	2.9	6.5	1.2	3.2	3.6	1.5	3.4	2.8	4.2	3.4	3.2	4.5	2.6	2.4	2.9	2.5	3.5	4.4	2.5	4.9	1.5	2.3	7.1	3.5	3.6	1.5	3.2	2.2	3.0	3.8	2.3	3.0	3.2	2.6	4.6	3.0	3.9	1.8	3.9	3.3	2.0	2.4	3.5	4.2	2.8	4.7	4.1	3.2	3.0	9.5	9.6	3.5	6.3	7.4	6.9	10.2	11.9	14.4	8.4	7.7	6.1	10.3	11.5	6.9	12.7	10.2	10.2	10.6	7.3	11.5	8.3	10.3	6.1	6.6	4.2	5.2	9.0	6.1	6.8	10.2	13.8	12.8	7.3	7.0	6.1	15.6	7.3	8.8	4.8	8.1	5.1	15.3	8.7	7.0	6.4	11.2	14.7	6.1	8.7	8.2	10.0	6.1	15.5	12.3	9.3	6.4	7.1	8.3	17.7	8.2	11.5	13.1	8.0	9.4	11.0	7.7	6.7	7.2	4.1	2.3	0.7	3.7	3.0	5.1	5.3	4.0	3.6	3.1	4.5	5.0	4.5	0.2	4.9	4.1	2.1	3.2	2.5	2.9	3.1	1.2	3.2	2.9	2.5	1.5	2.3	2.2	1.8	2.4	3.0	8.6	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	9.9	10.0	0.0	0.0	0.0	11.0	0.0	6.8	6.7	0.0	7.9	10.2	0.0	10.6	11.4	4.0	0.0	0.0	0.0	9.1	7.8	3.1	0.0	13.1	0.0	10.7	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	5.7	0.0	0.0	0.0	0.0	11.2	0.0	0.0	1.4	0.0	0.0	10.8	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	4.0	3.2	6.6	0.0	0.0
UTP4	"CIRH1A, CIRHIN, FLJ14728, KIAA1988, NAIC, TEX292"	ENSG00000141076	"UTP4 small subunit processome component"	Q969X6	16	69131291-69231130	"Human disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 100.0;Spermatogonia: 49.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 398.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041139, HPA043542"	Approved		Supported	"Nucleoli fibrillar center"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoli fibrillar center"		"HPA041139: AB_10961278, HPA043542: AB_2678542"	"unprognostic (1.82e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.16e-3)"	"prognostic unfavorable (9.05e-5)"	"prognostic unfavorable (8.18e-7)"	"unprognostic (1.31e-1)"	"unprognostic (4.76e-2)"	"prognostic favorable (2.88e-5)"	"unprognostic (2.12e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.32e-3)"	"unprognostic (9.57e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.20e-2)"	25.4	17.4	7.7	17.5	8.6	27.1	21.0	7.3	10.1	16.3	7.3	21.1	10.8	20.6	9.9	23.0	19.5	12.7	19.2	10.3	7.5	31.7	19.1	16.3	19.1	6.1	6.9	18.3	24.1	16.6	14.2	15.5	6.6	16.1	17.6	11.4	15.7	14.4	61.7	20.2	13.9	22.7	5.9	14.0	19.1	31.4	8.0	17.6	23.2	26.3	23.3	28.8	16.8	7.3	79.6	95.6	56.9	79.8	48.5	42.9	94.5	83.7	57.2	152.1	112.8	188.1	68.8	166.4	68.0	57.7	63.1	106.0	130.8	102.7	167.4	33.2	74.6	82.2	58.6	99.7	58.6	96.5	52.7	41.0	55.2	143.0	129.5	40.7	68.6	88.8	169.4	22.9	90.0	96.2	105.4	50.5	139.1	80.3	66.7	174.3	85.3	163.4	63.6	77.7	96.4	67.1	178.3	45.3	48.3	63.3	80.2	53.4	48.2	83.3	83.6	73.4	119.2	59.5	116.1	398.1	56.5	76.5	87.4	4.5	18.6	3.5	26.7	26.1	38.5	30.6	30.0	26.9	25.6	20.1	34.7	31.6	1.7	35.0	19.4	21.6	31.5	30.2	7.7	8.6	7.3	10.1	10.3	7.5	6.1	6.9	6.6	5.9	8.0	7.3	12.1	6.4	11.4	0.0	14.6	0.0	30.0	0.0	28.5	5.7	12.4	11.6	0.0	5.7	9.9	5.5	8.4	18.9	7.4	1.7	9.8	27.4	17.9	7.0	13.2	12.1	0.0	12.4	0.0	25.4	22.1	14.8	10.2	9.0	2.5	12.0	9.3	7.9	16.7	6.7	0.0	6.4	0.0	8.9	0.0	7.6	15.8	9.8	0.0	0.0	8.2	7.6	11.3	0.0	0.0	24.4	5.4	14.7	13.4	26.7	4.5	100.0	5.8	5.7	6.6	26.7	12.8	30.1	49.5	25.1	0.0	12.9	11.0	16.5	10.0	22.6
VAC14	"ArPIKfyve, FLJ10305, TAX1BP2"	ENSG00000103043	"VAC14 component of PIKFYVE complex"	Q08AM6	16	70687439-70801160	"Disease related genes, Predicted intracellular proteins"	"Host-virus interaction"		"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 74.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027766, HPA075382"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles	Cytosol	"HPA027766: AB_1848651, HPA075382: "	"unprognostic (9.25e-2)"	"prognostic favorable (8.33e-5)"	"unprognostic (2.83e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.94e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.21e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.26e-1)"	"prognostic favorable (1.56e-6)"	"unprognostic (1.61e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.80e-1)"	17.3	25.0	20.6	14.5	19.3	11.3	17.1	19.5	24.7	16.2	18.0	16.7	12.1	16.9	8.6	19.0	15.1	10.2	20.3	20.8	20.5	26.3	27.1	16.9	24.7	21.5	20.0	14.3	23.7	17.5	16.6	10.9	21.4	17.5	8.3	6.8	17.4	10.7	24.3	23.0	17.9	11.5	19.2	22.5	20.7	16.2	21.6	15.5	21.4	12.0	13.9	18.1	14.9	21.6	25.9	25.3	21.0	23.6	29.9	20.3	32.0	18.5	29.0	34.6	15.5	31.6	41.0	33.3	23.3	22.5	39.9	32.3	27.8	30.1	16.3	10.0	28.2	16.9	18.6	39.5	76.8	29.1	33.7	36.0	30.9	50.7	45.1	20.7	33.0	29.2	30.1	14.6	30.1	37.3	27.1	48.5	36.9	20.4	22.7	32.3	14.9	48.6	16.7	17.4	24.9	26.7	60.9	18.5	43.0	15.2	27.4	27.0	26.7	45.7	25.9	29.2	20.4	20.4	27.5	62.9	76.1	25.1	21.3	0.8	2.7	4.4	1.5	3.6	1.4	2.5	2.2	3.1	5.6	3.9	2.0	1.8	1.0	2.4	3.6	3.1	1.3	1.1	20.6	19.3	19.5	24.7	20.8	20.5	21.5	20.0	21.4	19.2	21.6	21.6	5.1	3.2	4.2	15.0	10.1	4.2	7.8	7.0	9.6	8.4	8.4	7.4	12.6	12.8	8.0	3.7	2.1	16.7	4.0	11.5	5.9	19.2	20.4	14.2	5.4	8.2	9.1	5.7	11.7	22.5	29.2	5.9	11.7	6.7	5.7	11.6	16.4	15.9	42.9	10.1	13.8	10.0	14.2	18.3	13.5	74.4	6.2	15.6	10.6	10.3	19.2	6.8	8.2	8.5	16.3	20.8	10.8	3.4	15.8	8.9	13.7	15.0	14.6	7.7	6.6	5.9	7.9	4.8	13.5	10.3	9.1	19.6	6.5	8.7	12.6	7.1
VDAC1	"MGC111064, PORIN"	ENSG00000213585	"Voltage dependent anion channel 1"	P21796	5	133971871-134004975	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Ion transport, Transport"	Porin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1045.7;tongue: 812.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005885, HPA030780, CAB072343"	Supported					NA	NA		1300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"CAB005885: AB_2214787, CAB072343: , HPA030780: AB_2673608"	"prognostic unfavorable (5.30e-4)"	"unprognostic (7.63e-3)"	"unprognostic (3.07e-3)"	"unprognostic (2.01e-1)"	"unprognostic (5.11e-3)"	"prognostic unfavorable (4.90e-4)"	"prognostic unfavorable (8.49e-4)"	"prognostic unfavorable (2.87e-5)"	"unprognostic (1.81e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.19e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-1)"	96.3	129.8	104.8	96.2	113.5	53.9	106.2	112.8	137.4	62.8	149.0	154.1	265.7	54.4	196.9	172.3	61.5	90.3	403.5	116.7	122.3	200.9	206.2	79.3	89.6	113.4	105.1	60.8	99.7	181.8	63.4	104.5	118.3	82.4	166.4	316.0	132.9	72.5	1045.7	113.9	179.1	90.7	101.1	60.2	163.6	37.5	117.3	90.9	68.5	812.0	129.3	108.3	91.0	106.4	364.5	315.8	282.8	295.3	277.5	385.0	398.0	398.1	292.2	386.5	395.2	650.0	282.9	497.4	291.5	418.0	515.1	278.2	403.4	701.2	480.7	296.1	331.7	287.3	308.9	526.0	282.2	266.5	272.9	353.3	368.5	301.1	333.0	385.3	381.2	248.0	260.1	197.8	511.8	404.5	326.3	264.1	198.5	555.2	264.3	296.5	282.6	474.3	608.6	450.0	315.0	177.7	253.7	305.2	416.0	385.9	147.0	257.6	311.6	361.4	241.6	335.9	530.2	262.9	278.3	309.4	537.1	351.9	420.7	24.9	83.2	30.3	54.5	118.4	60.0	58.3	55.6	57.3	140.7	40.5	38.8	43.8	6.9	87.7	105.1	41.1	74.5	72.9	104.8	113.5	112.8	137.4	116.7	122.3	113.4	105.1	118.3	101.1	117.3	106.4	89.9	105.8	63.1	21.2	101.9	204.8	246.6	250.8	128.7	463.6	163.7	98.3	276.0	198.8	133.2	126.9	81.3	372.4	94.9	333.1	729.8	303.4	68.7	140.8	161.1	120.7	104.1	96.7	41.5	302.6	471.4	136.9	225.8	184.6	121.8	163.9	57.1	203.9	332.7	519.9	40.6	202.7	189.2	130.6	243.5	50.3	95.7	165.7	249.1	31.9	315.8	277.0	60.8	24.1	23.8	300.7	227.7	112.1	162.0	353.6	415.8	585.3	121.2	257.2	85.5	132.8	171.4	10.9	32.7	275.5	232.9	325.6	111.0	229.1	326.7	265.1
VDAC3	HD-VDAC3	ENSG00000078668	"Voltage dependent anion channel 3"	Q9Y277	8	42391624-42405937	"Plasma proteins, Predicted intracellular proteins"	"Ion transport, Transport"	Porin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 385.2;skeletal muscle: 914.4;tongue: 942.7"	"Cell type enhanced"	"Detected in all"		"Spermatocytes: 403.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026864	Uncertain		Supported	Mitochondria		NA	NA		1200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA026864: AB_1858733"	"unprognostic (2.55e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.88e-3)"	"unprognostic (4.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.78e-3)"	"unprognostic (6.94e-3)"	67.5	76.2	117.3	59.1	119.4	92.1	70.3	116.8	150.6	53.7	115.4	106.9	79.8	63.5	68.6	99.9	85.8	56.0	385.2	121.1	130.8	108.8	92.9	51.9	66.3	122.7	119.3	61.6	64.6	92.4	58.9	63.9	139.2	69.5	106.4	123.1	61.6	81.3	914.4	54.1	73.0	92.8	114.1	67.3	72.1	114.5	118.6	80.1	83.3	942.7	79.3	78.9	59.8	113.8	226.3	225.7	174.5	185.9	146.3	126.6	84.8	180.0	151.1	225.4	205.2	173.4	190.4	235.8	165.0	153.7	196.3	142.5	238.4	194.1	244.7	117.2	196.6	352.9	138.4	250.2	105.2	172.0	190.1	98.6	143.3	171.6	80.9	149.6	279.8	201.3	284.4	158.6	235.7	126.4	373.3	197.1	205.2	285.6	144.5	193.6	322.1	165.3	245.7	198.8	156.8	133.3	112.1	132.8	116.1	126.4	279.9	129.9	149.8	86.6	150.0	217.7	174.0	145.2	264.1	266.9	117.5	238.0	150.9	142.8	165.3	183.4	145.8	167.2	148.7	126.5	155.6	146.5	222.7	96.6	152.7	147.7	82.8	125.8	155.6	163.0	202.5	360.5	117.3	119.4	116.8	150.6	121.1	130.8	122.7	119.3	139.2	114.1	118.6	113.8	78.1	44.8	24.4	50.6	59.8	64.5	81.1	197.8	58.1	85.9	53.0	73.9	321.2	55.8	82.8	66.2	35.5	145.5	91.9	65.7	307.2	116.3	151.1	112.8	56.7	70.5	47.8	186.4	63.2	90.0	112.1	81.5	41.3	47.1	55.2	100.6	68.2	60.4	139.7	138.0	78.9	86.1	177.0	58.5	77.8	146.4	69.3	107.7	72.9	26.2	130.1	72.9	83.4	38.2	34.7	84.9	86.7	97.4	75.9	48.9	125.3	177.5	142.1	94.5	65.7	146.4	123.8	403.7	156.3	82.3	70.8	58.3	79.7	94.2	124.8	70.4
VIRMA	"DKFZP434I116, fSAP121, KIAA1429"	ENSG00000164944	"Vir like m6A methyltransferase associated"	Q69YN4	8	94487689-94553529	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 26.4;Endometrial stromal cells: 32.2;Granulosa cells: 28.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031530	Approved		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear bodies"	Nucleoplasm	"HPA031530: AB_10600818"	"unprognostic (2.51e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.43e-1)"	"unprognostic (3.83e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.83e-2)"	"unprognostic (7.54e-3)"	"unprognostic (1.98e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (7.90e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.82e-2)"	"unprognostic (9.87e-2)"	12.5	7.8	6.9	11.6	8.5	27.3	17.5	11.5	7.2	13.1	7.1	9.9	8.1	13.7	8.6	9.7	11.4	8.9	9.9	6.1	7.4	10.8	12.5	10.7	14.4	7.1	7.2	16.7	10.3	14.8	6.3	13.2	7.2	10.7	11.7	12.3	9.5	10.3	8.7	9.7	9.1	13.9	7.2	11.4	11.6	16.5	7.3	20.0	13.3	9.3	15.2	10.5	8.0	9.2	40.5	25.2	26.8	14.9	32.4	42.5	17.1	27.5	27.9	29.4	29.9	17.9	33.2	43.6	25.5	36.1	23.0	25.9	36.2	33.5	42.9	38.7	20.0	52.0	19.6	17.6	23.6	25.9	17.9	32.8	13.4	35.4	33.7	30.1	37.5	28.2	54.0	26.6	30.0	23.8	50.7	14.6	17.5	41.4	19.1	29.9	24.4	24.3	19.1	27.6	20.9	28.9	21.6	5.5	23.8	26.3	31.2	20.7	37.3	26.9	15.9	23.1	25.7	20.8	27.8	51.0	26.4	33.7	26.2	14.2	5.0	8.7	6.7	6.4	10.7	6.6	7.4	9.1	5.2	5.0	9.0	7.9	6.0	9.5	13.8	3.3	6.9	5.8	6.9	8.5	11.5	7.2	6.1	7.4	7.1	7.2	7.2	7.2	7.3	9.2	24.2	25.6	21.5	0.0	6.3	0.0	0.0	0.0	0.0	0.0	16.9	16.4	0.0	0.0	14.9	7.3	0.0	26.4	20.0	0.0	7.9	14.4	0.0	23.8	32.2	9.8	0.0	0.0	0.0	12.2	23.7	10.6	0.0	22.4	5.1	28.5	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	14.7	0.0	0.0	5.2	0.0	0.0	6.9	8.7	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	16.8	9.9	25.0	0.0	0.0
VKORC1L1		ENSG00000196715	"Vitamin K epoxide reductase complex subunit 1 like 1"	Q8N0U8	7	65873074-65959563	"Enzymes, FDA approved drug targets, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053954	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Endoplasmic reticulum"		"HPA053954: AB_2682319"	"unprognostic (3.01e-1)"	"unprognostic (1.76e-3)"	"unprognostic (4.64e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.00e-3)"	"unprognostic (7.15e-3)"	"unprognostic (1.30e-3)"	"unprognostic (8.84e-3)"	"unprognostic (5.12e-2)"	"unprognostic (5.59e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.03e-3)"	"unprognostic (4.30e-1)"	"unprognostic (5.06e-2)"	54.0	11.1	8.1	11.2	9.0	4.3	23.7	8.3	12.1	12.0	3.7	12.4	11.1	12.3	10.6	12.5	10.0	10.0	12.1	10.1	9.2	10.0	22.9	18.4	8.7	18.1	10.5	17.3	9.7	33.6	6.7	12.0	10.5	12.0	12.5	11.5	10.9	12.4	21.6	12.8	11.6	11.6	8.9	7.4	12.8	9.1	8.5	9.7	13.9	15.3	8.7	11.9	9.6	9.6	46.8	29.5	23.4	29.5	72.6	28.6	42.3	49.5	31.8	29.0	29.1	28.7	44.9	40.4	39.0	35.7	43.9	31.2	33.6	20.1	47.9	25.5	33.1	27.6	25.4	24.7	35.4	38.7	20.3	23.2	25.3	29.5	40.7	22.5	29.2	22.6	59.0	30.0	34.9	18.3	31.8	44.8	56.1	43.8	22.0	34.5	34.0	50.5	28.0	18.5	28.0	39.8	38.3	68.5	21.8	32.8	34.5	29.5	33.3	46.6	32.0	29.5	51.0	26.9	47.1	46.1	28.6	43.0	41.6	2.0	1.1	2.7	1.2	1.1	1.0	1.3	1.5	1.4	1.3	1.1	0.9	0.9	1.3	2.9	2.2	3.5	1.5	0.7	8.1	9.0	8.3	12.1	10.1	9.2	18.1	10.5	10.5	8.9	8.5	9.6	19.5	73.7	41.7	16.6	5.5	24.9	18.6	16.2	9.6	21.8	18.6	15.9	21.5	27.1	24.2	16.5	12.5	12.5	10.0	27.1	5.9	18.1	39.0	13.7	23.8	17.1	13.8	26.1	42.7	24.8	21.2	22.6	19.4	25.3	5.1	24.1	10.8	46.9	16.0	30.3	36.6	26.4	20.3	6.6	10.2	9.1	17.7	12.9	7.2	28.1	10.0	11.6	7.2	26.7	34.6	31.6	8.2	18.4	15.6	36.3	14.4	11.4	11.7	20.2	6.6	24.9	26.4	18.5	7.2	17.9	32.0	8.8	6.6	10.8	20.3	22.6
VPS13A	"CHAC, KIAA0986"	ENSG00000197969	"Vacuolar protein sorting 13 homolog A"	Q96RL7	9	77177445-77421537	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 228.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021652, HPA021662"	Supported					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA021652: AB_1858759, HPA021662: AB_1858760"	"unprognostic (1.52e-1)"	"unprognostic (4.19e-2)"	"unprognostic (5.49e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.68e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.69e-3)"	"unprognostic (9.67e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.96e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.70e-2)"	5.1	7.6	2.6	7.1	4.8	17.6	7.3	11.2	9.6	4.4	3.6	9.4	16.3	6.0	8.0	7.6	4.7	9.0	9.5	6.0	0.1	9.9	7.4	6.3	8.8	0.5	0.1	3.6	8.8	9.3	6.5	3.6	0.3	6.7	11.4	7.2	8.0	6.6	14.6	15.6	13.8	7.2	0.0	10.6	12.3	16.8	0.2	10.3	8.5	9.8	7.6	6.4	6.2	3.1	21.0	10.4	9.1	7.9	8.5	7.4	13.7	11.4	10.3	9.8	11.1	4.2	9.3	16.4	5.2	10.6	11.9	27.9	13.7	11.3	17.4	15.5	11.0	21.7	21.3	10.3	8.3	28.3	13.9	4.7	16.6	14.5	17.7	17.3	14.1	15.7	14.3	17.4	6.0	9.8	21.7	9.7	10.2	11.9	8.3	15.7	17.4	6.8	14.1	20.2	13.3	13.3	14.3	9.2	6.3	16.6	6.3	6.3	18.6	10.4	11.3	14.4	14.6	9.7	9.6	8.4	10.8	13.2	4.2	3.8	0.2	2.0	1.2	0.1	1.2	0.9	0.9	0.9	0.1	1.2	0.7	0.8	0.2	1.2	0.1	2.2	0.7	0.2	2.6	4.8	11.2	9.6	6.0	0.1	0.5	0.1	0.3	0.0	0.2	3.1	29.7	64.1	46.5	48.3	32.2	33.0	26.6	28.0	27.3	29.1	25.4	22.1	87.2	27.1	41.2	29.5	58.4	15.2	42.3	78.9	3.9	18.2	90.5	33.8	28.2	38.6	87.8	48.4	228.3	18.4	4.8	18.9	86.6	42.6	19.0	32.4	37.5	34.1	8.6	11.8	101.1	47.4	30.5	10.6	14.4	55.0	13.7	13.3	23.2	43.1	11.9	16.4	41.2	72.4	23.0	46.2	42.9	15.8	42.7	31.0	98.5	21.7	38.9	18.2	32.9	33.1	30.5	74.3	64.5	36.6	31.3	8.9	43.2	38.0	39.8	25.7
VPS13D	"FLJ10619, KIAA0453"	ENSG00000048707	"Vacuolar protein sorting 13 homolog D"	Q5THJ4	1	12230030-12512047	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 181.4;Inhibitory neurons: 149.2;Late spermatids: 208.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027332, HPA051621"	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Vesicles"	Cytosol	"HPA027332: AB_2672223, HPA051621: AB_2681555"	"unprognostic (2.97e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.84e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.53e-3)"	"unprognostic (3.33e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.77e-2)"	"prognostic favorable (7.42e-12)"	"unprognostic (5.13e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.31e-2)"	10.9	6.9	14.3	4.4	17.2	5.0	10.3	14.5	17.9	13.7	18.1	12.2	3.8	8.1	8.7	12.6	8.9	5.3	21.9	15.8	14.5	10.5	10.4	8.8	6.4	14.6	16.5	8.9	10.9	13.4	7.7	5.3	14.3	17.4	6.4	14.1	10.8	9.3	18.1	24.7	8.7	6.0	13.4	9.3	11.1	6.1	17.8	6.6	15.5	15.3	6.2	9.6	10.6	16.6	9.3	5.2	5.8	4.4	15.1	11.9	2.7	4.4	7.7	7.4	7.0	3.5	6.4	8.7	5.4	12.6	6.2	8.3	10.1	8.7	10.3	4.7	3.4	7.4	8.1	2.8	6.3	10.8	3.7	10.1	11.9	9.5	9.3	9.2	12.0	8.2	15.5	4.3	6.9	4.3	6.4	4.2	2.3	5.0	6.5	5.5	6.9	2.6	5.3	5.4	2.8	3.8	12.9	9.4	9.0	5.4	8.1	3.6	13.1	4.6	4.7	12.0	3.7	3.8	3.3	13.4	5.2	7.5	7.1	3.2	0.7	0.5	1.1	0.7	1.2	0.9	1.2	0.8	0.6	1.6	1.1	0.9	0.9	0.7	0.5	1.5	0.6	0.3	14.3	17.2	14.5	17.9	15.8	14.5	14.6	16.5	14.3	13.4	17.8	16.6	28.9	19.2	23.4	111.0	19.8	21.7	45.1	23.2	19.9	38.1	18.8	12.8	68.0	14.3	35.7	18.4	73.0	8.4	20.3	24.7	3.9	9.1	83.1	20.6	23.5	23.0	14.4	9.4	181.4	14.4	7.2	19.4	28.1	48.1	12.6	26.3	17.9	21.2	11.5	47.1	149.2	15.1	18.3	17.3	15.5	208.7	23.0	17.5	12.4	79.6	16.7	23.0	17.5	78.4	107.4	17.0	11.2	21.8	11.8	32.0	18.2	9.8	32.0	34.1	46.0	23.4	46.5	18.8	12.3	38.2	31.4	14.8	21.4	20.3	15.5	37.3
VPS26A	"Hbeta58, PEP8A, VPS26"	ENSG00000122958	"VPS26, retromer complex component A"	O75436	10	69123512-69174412	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 243.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011602, HPA057498, CAB075733"	Supported		Enhanced	Endosomes,Lysosomes		NA	NA		41000	"Cluster 7: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Endosomes, Lysosomes"		"CAB011602: AB_2215043, CAB075733: AB_2665739, HPA057498: AB_2683448"	"unprognostic (1.17e-2)"	"unprognostic (6.94e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.35e-2)"	"unprognostic (5.95e-2)"	"prognostic unfavorable (1.72e-4)"	"prognostic unfavorable (1.70e-6)"	"unprognostic (1.17e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.88e-2)"	"prognostic unfavorable (9.18e-6)"	"unprognostic (4.63e-2)"	"unprognostic (2.15e-2)"	"unprognostic (7.14e-2)"	"unprognostic (6.68e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.72e-1)"	37.0	27.1	23.6	24.4	25.9	36.2	32.9	27.6	32.3	26.9	23.7	32.1	24.8	26.8	22.1	41.7	22.7	22.7	22.0	24.3	25.9	34.0	30.4	27.5	23.3	26.0	25.9	25.8	23.8	38.1	12.0	39.9	25.6	24.6	32.3	19.6	26.1	20.9	33.4	37.3	25.5	25.7	26.7	23.1	24.1	42.7	24.9	27.8	29.9	31.3	27.9	33.0	29.9	29.0	113.1	42.5	51.7	87.1	80.8	73.8	46.1	66.3	106.0	79.7	90.1	91.8	110.9	34.3	53.1	72.3	78.2	75.9	73.1	63.5	108.5	31.3	38.7	54.0	36.7	52.2	104.9	80.6	39.4	66.3	90.8	79.8	161.5	99.8	81.9	40.8	104.7	46.0	119.2	35.8	35.8	86.4	34.0	51.9	97.9	44.2	85.0	40.4	86.6	68.3	30.5	45.5	89.3	119.5	117.6	44.5	50.3	62.9	97.9	53.0	69.7	91.7	83.8	28.0	74.4	57.4	71.2	123.6	27.8	54.6	39.6	38.6	40.8	46.6	37.4	26.3	30.7	42.2	44.8	20.0	26.7	37.7	38.1	54.6	40.9	17.7	38.3	44.4	23.6	25.9	27.6	32.3	24.3	25.9	26.0	25.9	25.6	26.7	24.9	29.0	49.0	73.7	56.6	21.5	40.6	120.7	83.4	79.6	60.3	24.4	43.0	34.8	44.2	40.0	75.2	40.5	14.6	117.1	59.2	47.3	80.3	69.3	59.4	29.8	42.2	52.7	16.2	58.3	29.4	53.4	87.8	57.4	30.5	42.0	45.5	32.4	35.3	29.4	85.8	20.2	30.3	38.3	85.5	53.2	108.7	29.6	42.3	66.0	62.2	28.1	62.4	63.2	52.5	21.6	39.8	65.7	43.3	44.8	28.2	65.2	30.5	80.6	45.5	27.4	13.1	48.0	61.9	89.3	73.7	57.5	107.0	243.7	59.5	38.2	44.4	77.6
VPS4A	"FLJ22197, SKD1, SKD1A, SKD2, VPS4, VPS4-1"	ENSG00000132612	"Vacuolar protein sorting 4 homolog A"	Q9UN37	16	69311350-69326939	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB018751, CAB034411, HPA060092"	Approved		Supported	Midbody		Yes	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Midbody		"CAB018751: AB_2215497, CAB034411: AB_2304400, HPA060092: AB_2684203"	"unprognostic (2.60e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.26e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.63e-2)"	"unprognostic (8.61e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.79e-2)"	13.2	15.3	15.7	8.9	16.9	8.8	12.8	16.1	17.1	10.4	11.0	13.5	13.5	11.7	8.1	16.0	10.3	9.4	20.6	15.5	14.9	18.0	11.6	9.9	11.8	16.4	16.8	12.2	27.8	20.6	7.6	10.0	16.7	10.4	7.6	10.2	19.9	8.4	54.0	15.3	12.8	8.4	15.4	9.2	17.6	6.8	16.7	6.2	16.7	33.6	7.3	11.4	11.3	18.2	21.1	34.9	23.2	30.7	21.2	18.8	20.5	27.9	25.2	36.4	24.3	33.4	19.0	35.0	27.3	28.0	17.5	30.3	23.9	28.2	21.8	14.8	30.8	22.0	20.7	26.3	32.6	27.5	19.6	21.7	36.3	31.6	28.7	21.4	27.4	27.3	37.0	10.3	27.2	46.8	36.4	20.5	26.7	20.6	24.5	47.8	19.0	41.3	18.5	16.8	39.1	24.7	59.3	18.1	21.4	15.4	31.4	20.6	32.8	33.2	20.8	30.4	22.1	36.9	31.3	62.6	30.4	18.2	37.1	8.8	9.9	13.3	11.2	8.7	10.0	8.5	9.3	13.9	9.4	7.4	10.5	9.9	7.5	8.0	11.5	5.5	11.8	13.8	15.7	16.9	16.1	17.1	15.5	14.9	16.4	16.8	16.7	15.4	16.7	18.2	39.8	25.6	19.0	14.7	33.8	30.7	37.3	22.2	22.8	51.4	30.2	28.2	31.0	22.8	16.7	23.9	22.9	59.8	48.4	48.9	74.3	51.7	11.2	14.9	27.0	34.9	31.3	43.6	14.5	82.5	66.5	32.9	29.0	25.6	29.2	36.3	31.8	21.6	45.1	74.0	14.9	34.2	20.3	33.7	24.6	11.9	29.5	30.2	44.4	5.6	40.9	66.0	38.1	4.5	16.8	67.4	42.2	30.5	31.9	67.6	76.4	57.7	6.4	41.8	52.6	36.0	38.9	28.7	38.3	27.1	31.3	70.1	35.6	26.0	41.4	41.2
VRK1		ENSG00000100749	"VRK serine/threonine kinase 1"	Q99986	14	96797304-96954846	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 50.4;testis: 37.1"	"Cell type enhanced"	"Detected in all"		"Spermatocytes: 198.9;Spermatogonia: 110.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000660, HPA017929"	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA000660: AB_1080579, HPA017929: AB_1858770"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.24e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (4.20e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.58e-1)"	5.9	5.2	5.9	12.8	7.1	50.4	11.5	6.0	7.9	5.2	4.3	10.8	6.5	6.5	6.9	8.9	9.2	4.4	5.2	5.9	5.1	4.9	5.5	4.9	27.1	5.3	5.5	6.0	3.2	5.4	3.1	7.6	5.4	5.0	12.3	4.4	4.3	5.0	4.7	7.4	7.2	6.7	4.8	11.3	6.5	37.1	5.9	35.5	5.9	4.6	27.9	7.7	5.4	7.0	52.4	27.0	78.5	30.2	9.2	14.9	44.8	42.8	34.4	67.1	65.4	36.0	54.7	139.2	22.4	24.3	39.2	56.5	75.5	54.4	90.5	73.4	36.4	90.5	18.7	39.3	10.2	168.5	49.2	8.5	9.7	50.4	32.6	12.8	47.0	104.8	76.6	79.0	56.9	65.5	137.1	76.5	47.8	39.9	59.3	124.5	134.2	48.6	32.3	59.3	53.2	28.0	34.2	36.4	30.8	36.0	39.3	66.6	24.4	27.9	22.8	47.7	37.3	37.7	53.5	124.8	44.7	74.6	34.8	42.7	12.3	26.2	21.5	15.5	29.0	31.3	24.9	26.4	15.7	32.7	27.1	27.3	6.5	45.6	15.2	21.4	34.9	19.4	5.9	7.1	6.0	7.9	5.9	5.1	5.3	5.5	5.4	4.8	5.9	7.0	15.3	3.2	4.6	6.8	30.6	16.8	13.8	23.3	6.2	12.4	9.3	11.3	11.8	12.8	16.7	14.7	8.4	34.8	24.8	6.3	11.7	13.5	21.3	21.1	8.3	12.4	3.0	76.2	42.0	19.4	48.3	11.4	14.8	10.8	28.5	20.0	7.1	3.3	19.2	10.1	36.2	10.4	20.3	11.8	14.9	11.5	5.6	12.0	12.4	19.7	14.2	6.2	27.8	12.1	19.8	10.3	2.2	9.8	25.4	6.1	3.0	11.2	37.6	9.6	19.7	14.3	15.1	198.9	110.9	14.1	13.9	15.1	26.8	9.2	18.1	10.4
VTA1	"C6orf55, HSPC228, My012"	ENSG00000009844	"Vesicle trafficking 1"	Q9NP79	6	142147162-142224685	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030968, HPA030969"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		220000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Vesicles, Cytosol"		"HPA030968: AB_10602585, HPA030969: AB_2673679"	"prognostic unfavorable (7.02e-4)"	"unprognostic (1.84e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (6.58e-6)"	"unprognostic (2.83e-2)"	"unprognostic (3.61e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.24e-1)"	22.2	20.9	16.6	25.7	19.0	30.6	31.6	20.2	20.3	23.2	12.5	34.9	38.2	23.4	25.4	39.1	27.3	23.0	33.9	18.9	18.9	34.5	45.4	21.5	33.4	17.4	18.1	21.0	19.3	28.3	9.9	32.1	17.8	22.5	39.9	29.2	18.2	19.6	55.7	30.7	37.0	26.3	21.1	23.1	23.5	18.3	18.2	45.4	27.6	58.3	39.1	35.8	20.3	22.2	56.5	47.5	75.8	116.8	65.3	71.4	52.3	124.7	74.0	111.6	105.8	80.9	43.0	91.2	82.1	112.6	84.6	70.2	81.5	85.1	153.4	62.3	71.7	99.2	46.2	97.0	48.2	155.6	55.2	59.4	97.7	111.8	71.7	59.8	72.4	69.7	93.7	44.5	94.5	82.1	101.8	80.7	57.0	72.1	53.8	92.1	60.8	55.8	86.4	61.5	79.0	61.5	70.1	53.3	63.7	62.9	57.8	104.4	53.0	50.0	69.6	84.7	90.8	43.5	80.9	103.8	32.7	85.5	77.8	222.4	90.0	151.9	64.3	114.5	83.5	85.6	72.8	76.0	90.9	84.8	79.8	80.4	56.0	97.5	120.3	55.9	79.0	121.5	16.6	19.0	20.2	20.3	18.9	18.9	17.4	18.1	17.8	21.1	18.2	22.2	16.7	22.4	20.3	22.5	25.8	25.2	19.2	25.5	25.6	9.7	16.5	18.3	47.8	12.8	24.5	16.5	0.0	32.7	23.9	40.2	17.6	31.5	4.5	30.7	30.4	17.5	21.6	23.1	40.1	28.0	36.4	25.4	16.8	28.0	12.6	18.1	11.4	24.7	27.9	11.8	38.7	24.7	14.2	20.9	14.3	2.2	11.8	20.0	8.8	40.3	28.0	23.9	35.0	25.6	48.7	30.1	18.3	12.4	16.4	17.2	30.0	31.6	36.6	12.6	6.6	16.8	18.4	23.6	24.9	28.8	31.0	31.7	23.8	25.3	25.9	18.8
WAPL	"FOE, KIAA0261, WAPAL"	ENSG00000062650	"WAPL cohesin release factor"	Q7Z5K2	10	86435256-86521792	"Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037874, HPA037875, HPA066141"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA037874: AB_10697086, HPA037875: AB_10672396, HPA066141: "	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.91e-2)"	"unprognostic (6.63e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.25e-1)"	"unprognostic (5.78e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.79e-1)"	15.4	13.2	8.4	19.6	9.9	27.1	16.6	11.9	9.2	12.8	7.8	15.4	15.2	14.8	8.7	15.9	11.7	13.1	10.3	7.5	8.3	16.8	22.6	16.5	25.0	8.2	8.5	13.7	14.4	16.9	4.9	18.4	8.3	13.0	15.2	36.0	11.2	11.7	20.9	17.9	16.0	14.8	8.9	19.0	16.5	35.1	9.0	33.7	17.9	22.5	27.7	17.9	9.2	10.4	42.6	19.6	33.5	44.4	26.1	27.6	29.6	36.4	44.2	30.3	32.4	42.9	36.6	64.3	24.1	32.5	26.7	39.1	38.3	31.3	46.3	42.1	25.3	38.9	30.9	47.4	29.7	79.8	43.1	21.9	35.7	38.9	64.9	34.5	34.6	36.8	41.7	37.6	35.2	36.3	49.9	29.6	29.9	26.4	19.5	35.2	27.1	25.6	26.3	37.2	13.1	25.2	32.3	21.4	40.9	33.2	47.1	41.9	33.5	29.1	34.4	25.8	48.6	36.8	54.9	66.9	26.7	55.8	20.9	15.0	3.5	7.7	3.4	4.1	4.9	3.9	4.5	4.7	4.8	4.0	5.1	4.0	5.5	3.2	7.4	3.6	6.1	2.4	8.4	9.9	11.9	9.2	7.5	8.3	8.2	8.5	8.3	8.9	9.0	10.4	38.3	83.3	54.8	0.0	48.3	0.0	57.4	0.0	35.3	49.1	41.3	27.9	0.0	20.0	21.1	16.5	20.9	42.8	62.4	17.4	21.5	60.8	86.8	36.7	44.4	33.9	18.2	94.1	0.0	52.5	28.3	30.0	37.8	52.2	25.2	40.3	32.5	47.6	40.4	55.5	0.0	21.5	0.0	56.5	0.0	42.0	32.0	58.3	0.0	0.0	81.0	48.7	55.6	0.0	0.0	52.1	27.5	32.4	50.5	56.6	25.0	35.5	13.8	113.4	65.7	70.3	33.6	153.4	90.2	48.4	0.0	76.1	51.4	35.2	24.8	74.1
WDCP	"C2orf44, FLJ21945, MMAP"	ENSG00000163026	"WD repeat and coiled coil containing"	Q9H6R7	2	24029347-24049575	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 9.2;Distal tubular cells: 7.9;Granulosa cells: 4.3;Theca cells: 4.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041054	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoli	Cytosol	"HPA041054: AB_10796566"	"unprognostic (1.07e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.36e-1)"	"prognostic unfavorable (6.53e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (5.14e-8)"	"unprognostic (7.69e-2)"	"unprognostic (9.01e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.76e-2)"	"unprognostic (3.00e-1)"	2.6	3.7	3.9	3.8	4.1	1.4	4.4	4.7	4.0	3.5	4.6	4.2	2.5	4.2	3.7	3.2	3.2	2.7	3.4	3.8	4.0	3.5	4.1	2.6	6.6	3.9	4.1	5.4	2.6	5.0	2.3	4.2	4.0	3.6	2.9	6.3	2.9	4.5	6.1	2.9	3.3	3.5	3.9	4.2	3.0	4.9	4.3	7.7	3.1	8.7	7.0	3.6	2.7	4.6	12.3	18.8	20.1	14.0	13.6	10.7	7.2	14.6	7.8	15.1	14.1	17.2	5.6	32.0	6.2	7.5	12.6	8.8	28.7	10.0	15.6	19.4	16.4	19.7	8.5	17.8	9.3	18.0	13.0	6.5	7.6	15.6	7.7	7.8	14.3	18.4	27.5	8.7	15.9	5.6	23.8	10.8	24.3	12.2	14.3	25.7	33.8	12.9	7.1	6.1	15.4	21.3	7.2	7.0	9.1	14.0	5.4	7.9	13.9	12.0	13.1	7.2	13.6	14.4	19.2	45.2	7.7	19.0	9.5	0.0	1.8	1.1	5.2	2.7	5.3	3.3	3.3	3.8	3.1	2.9	4.6	5.0	0.4	3.9	2.0	1.1	5.4	3.3	3.9	4.1	4.7	4.0	3.8	4.0	3.9	4.1	4.0	3.9	4.3	4.6	3.1	3.2	3.7	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.7	2.7	0.0	0.0	0.6	9.2	0.0	2.9	1.8	0.0	7.9	2.3	0.0	1.5	3.2	1.6	0.0	0.0	0.0	2.0	2.5	1.4	0.0	1.0	0.0	4.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	1.4	0.7	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.1	1.0	4.5	0.0	0.0
WDHD1	"AND-1, CHTF4, CTF4"	ENSG00000198554	"WD repeat and HMG-box DNA binding protein 1"	O75717	14	54938949-55027105	"Predicted intracellular proteins, Predicted membrane proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 8.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 15.5;Spermatocytes: 15.0;Spermatogonia: 19.3"	"Cancer enhanced"	"Detected in all"		"testis cancer: 23.5"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000632, HPA001122"	Enhanced		Enhanced	Nucleoplasm		NA	Yes			"Cluster 40: NK-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA000632: , HPA001122: AB_1080589"	"unprognostic (1.88e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.85e-3)"	"unprognostic (2.33e-4)"	"unprognostic (5.52e-3)"	"unprognostic (7.28e-3)"	"unprognostic (8.05e-3)"	"prognostic unfavorable (9.24e-4)"	"unprognostic (5.11e-2)"	"unprognostic (2.67e-4)"	"unprognostic (8.31e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.36e-2)"	1.3	0.8	0.5	3.8	1.0	7.2	2.2	0.9	0.9	1.2	0.1	2.8	1.8	2.1	0.6	2.4	1.6	1.3	0.9	0.7	0.2	1.1	1.2	1.3	5.5	0.2	0.2	1.4	0.9	1.5	0.3	2.8	0.2	1.0	4.0	1.8	0.7	0.8	0.6	2.0	1.7	2.6	0.3	1.7	1.6	5.3	0.4	8.0	0.9	0.8	6.7	1.7	1.1	0.9	39.6	24.7	48.4	21.4	4.6	11.2	28.1	37.5	16.1	29.6	36.0	16.6	25.9	44.9	18.6	10.8	21.4	32.8	72.9	21.5	61.7	30.0	12.7	29.8	23.7	16.2	1.9	56.7	21.8	5.9	3.8	36.6	14.3	7.1	19.6	28.8	37.8	22.0	28.7	21.7	53.5	11.1	38.6	21.1	25.7	49.5	69.7	17.3	8.4	26.0	28.1	19.8	39.8	10.0	12.8	35.1	26.8	11.3	12.8	37.3	43.9	27.5	32.1	6.5	14.4	58.8	17.1	27.4	30.0	1.7	0.3	0.6	0.9	0.2	1.2	1.2	1.0	1.3	0.5	1.8	1.3	1.8	0.4	2.0	0.4	0.7	1.6	0.6	0.5	1.0	0.9	0.9	0.7	0.2	0.2	0.2	0.2	0.3	0.4	0.9	2.3	0.0	2.0	3.9	5.1	3.8	2.2	3.5	3.4	2.9	1.8	1.9	1.7	0.0	4.0	3.7	0.0	8.7	3.6	1.8	0.0	1.8	0.8	1.9	3.1	2.0	0.0	15.5	10.3	1.0	8.4	3.4	2.6	2.5	0.0	12.4	0.7	0.9	4.1	3.3	6.5	2.4	6.1	2.1	1.2	1.1	0.0	2.4	1.8	5.6	1.4	1.4	2.1	4.5	10.1	1.1	0.3	3.0	7.8	0.6	0.5	6.2	3.5	3.1	0.0	2.4	3.0	15.0	19.3	6.1	2.4	2.6	3.6	2.8	5.2	1.7
WDR11	"BRWD2, DR11, FLJ10506, HH14, KIAA1351, SRI1, WDR15"	ENSG00000120008	"WD repeat domain 11"	Q9BZH6	10	120851305-120909524	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038980	Approved		Approved	Microtubules,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Microtubules, Cytosol"		"HPA038980: AB_10675955"	"unprognostic (8.98e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.07e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.84e-1)"	"unprognostic (3.84e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.80e-3)"	"prognostic favorable (5.04e-4)"	"unprognostic (5.09e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.38e-2)"	15.2	12.3	5.9	16.9	5.7	6.6	15.3	6.7	5.1	15.4	10.8	15.2	14.2	15.3	10.8	14.8	17.7	15.0	7.8	6.0	7.1	24.4	20.2	15.2	18.6	10.1	6.5	16.0	13.6	38.6	5.3	16.8	10.9	15.6	16.6	15.1	14.4	14.2	3.5	9.7	14.9	16.9	10.3	18.5	16.1	11.5	6.6	17.9	22.5	6.5	20.2	15.7	8.6	14.7	28.5	25.1	24.8	43.4	35.4	42.2	18.0	26.0	52.4	28.3	34.9	14.7	29.1	19.9	13.1	37.5	22.5	26.5	29.1	35.8	35.4	26.5	24.2	20.8	19.9	15.3	33.6	29.6	23.6	36.7	28.5	26.2	42.2	51.7	53.1	14.0	16.9	23.3	30.1	12.1	18.7	12.9	12.8	24.8	16.1	7.7	43.3	17.4	33.7	21.8	12.2	21.8	22.6	24.9	68.8	43.3	18.4	18.7	40.0	18.6	11.6	2.8	25.1	12.9	8.6	24.3	26.4	24.8	9.9	27.4	8.5	3.8	4.5	11.2	3.6	8.5	3.0	4.1	9.7	4.6	3.1	3.3	0.6	5.9	25.3	2.3	4.3	5.2	5.9	5.7	6.7	5.1	6.0	7.1	10.1	6.5	10.9	10.3	6.6	14.7	23.7	6.4	16.4	77.7	42.3	12.0	13.5	15.5	10.8	42.8	16.6	13.6	8.3	27.1	20.1	25.8	98.0	19.3	30.5	24.3	11.7	18.3	3.8	31.7	33.1	24.4	27.1	16.6	57.0	10.5	12.1	21.8	29.6	32.7	9.5	34.2	33.9	33.9	32.2	25.2	54.2	24.5	12.2	43.2	16.5	4.4	43.5	34.9	3.6	30.9	42.4	21.0	20.6	112.1	84.7	25.3	23.4	38.7	25.6	17.9	34.8	19.9	30.1	85.3	19.7	28.9	17.9	25.8	16.3	15.6	14.2	15.2	18.9	41.7	20.6	19.3
WDR12	"FLJ10881, YTM1"	ENSG00000138442	"WD repeat domain 12"	Q9GZL7	2	202874261-203014798	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036389	Uncertain		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"	Nucleoli	"HPA036389: AB_10670716"	"unprognostic (1.08e-2)"	"unprognostic (3.59e-1)"	"unprognostic (8.17e-2)"	"unprognostic (3.59e-3)"	"unprognostic (1.24e-2)"	"unprognostic (9.40e-3)"	"prognostic unfavorable (2.57e-6)"	"unprognostic (1.52e-1)"	"unprognostic (6.14e-2)"	"unprognostic (4.78e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.69e-3)"	"unprognostic (4.48e-2)"	2.6	3.6	2.1	2.7	2.3	3.6	3.6	2.3	3.2	2.5	1.4	3.0	4.1	3.2	3.2	3.2	3.1	2.3	4.0	2.2	2.9	5.2	4.2	1.7	3.3	2.5	2.1	3.2	2.2	3.5	1.9	2.7	2.7	2.2	4.0	2.6	1.9	2.3	4.8	3.6	2.9	3.4	1.5	2.1	2.3	3.5	2.8	3.2	3.2	6.0	3.7	4.1	2.3	2.5	5.3	5.8	6.4	12.5	12.3	10.4	11.4	7.6	6.6	10.1	9.8	14.8	7.5	10.2	7.2	6.6	8.5	6.6	18.2	13.3	16.0	4.6	11.1	17.0	9.0	17.7	8.0	22.1	9.9	9.5	9.4	12.0	23.6	6.4	10.8	10.2	26.7	5.9	11.3	6.5	14.8	13.3	14.9	7.3	14.3	11.1	9.7	16.1	11.2	6.5	11.4	9.8	6.5	8.2	9.8	11.0	4.7	14.1	8.3	8.3	6.9	7.4	8.4	8.0	12.8	16.3	8.7	15.3	8.8	1.3	1.6	0.6	1.4	1.7	2.0	1.9	1.3	1.4	2.1	1.9	1.7	1.7	0.6	1.3	1.7	2.4	1.6	1.1	2.1	2.3	2.3	3.2	2.2	2.9	2.5	2.1	2.7	1.5	2.8	2.5	10.1	9.6	16.9	12.1	13.6	20.5	21.4	24.4	13.1	10.2	8.4	9.1	27.9	7.2	19.1	5.5	2.1	25.3	7.9	7.8	15.6	18.0	14.3	14.7	25.3	12.6	5.4	22.1	19.2	10.6	34.9	16.5	9.7	13.3	15.2	15.8	8.2	15.0	18.0	15.2	20.3	10.6	24.4	7.2	6.0	8.9	17.1	9.2	1.8	12.2	13.7	6.4	5.2	10.6	9.9	14.2	6.6	15.4	9.3	17.3	13.9	38.1	15.7	8.3	13.1	20.1	41.9	43.0	32.3	18.2	17.3	21.5	10.7	21.0	19.2	17.0
WDR3	"DIP2, FLJ12796, UTP12"	ENSG00000065183	"WD repeat domain 3"	Q9UNX4	1	117929720-117966543	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027509, HPA054354, HPA072915"			Enhanced	Nucleoplasm,Nucleoli		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoli	Nucleoplasm	"HPA027509: AB_10601808, HPA054354: AB_2682459, HPA072915: "	"unprognostic (6.77e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.91e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (1.29e-1)"	"unprognostic (9.52e-2)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (8.90e-3)"	"unprognostic (7.47e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.65e-2)"	9.1	6.3	2.2	8.4	2.8	2.9	9.3	2.8	2.6	7.3	7.4	5.9	5.4	6.7	4.2	6.6	7.4	3.1	4.4	2.6	3.1	5.9	11.2	4.5	7.1	2.2	2.7	7.6	5.1	9.2	3.0	6.2	2.2	5.8	7.7	4.3	4.4	4.9	10.3	5.0	4.9	8.0	2.3	6.2	6.6	11.7	2.7	8.5	6.0	7.4	11.8	9.4	4.3	2.7	35.6	22.2	21.7	33.5	23.0	18.8	24.9	24.1	15.9	27.8	24.3	23.8	11.6	42.4	32.4	18.2	17.7	23.1	55.0	28.4	44.4	34.3	28.1	39.7	22.7	19.0	19.1	74.8	20.0	18.5	19.8	35.4	53.3	16.3	27.2	29.1	49.7	20.2	24.2	20.4	35.9	15.5	78.7	30.7	34.7	33.9	75.5	32.5	13.8	23.4	33.4	30.1	27.8	33.6	39.6	29.6	13.5	29.9	24.0	20.9	33.1	38.4	54.9	29.3	36.8	64.5	30.5	47.2	55.0	0.1	6.8	0.6	9.3	7.1	12.0	9.3	8.4	11.0	13.5	8.6	12.9	11.9	0.6	9.6	8.1	7.4	12.4	7.4	2.2	2.8	2.8	2.6	2.6	3.1	2.2	2.7	2.2	2.3	2.7	2.7	11.4	9.6	14.3	5.9	13.1	20.9	21.9	13.1	15.4	11.3	11.2	9.7	14.9	8.6	23.4	7.3	6.2	10.7	8.6	4.6	9.8	12.8	33.2	11.7	20.4	13.2	3.6	10.7	12.4	13.8	9.9	14.9	8.2	7.5	16.4	11.9	8.9	27.4	7.9	15.2	12.5	6.4	14.2	7.3	5.7	43.6	12.5	7.1	10.6	5.6	8.2	7.4	10.3	13.0	7.5	12.3	4.1	11.7	10.9	31.4	3.0	7.4	17.6	7.3	13.1	23.0	13.8	52.3	50.8	21.7	22.4	5.1	10.6	31.1	9.8	15.4
WDR4	"TRM82, TRMT82"	ENSG00000160193	"WD repeat domain 4"	P57081	21	42843094-42879568	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, tRNA processing"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 25.8;Prostatic glandular cells: 24.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017381	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA017381: AB_1858807"	"unprognostic (3.47e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (5.48e-7)"	"unprognostic (2.85e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.25e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.46e-2)"	5.1	4.7	4.0	7.2	3.9	6.7	3.9	3.8	4.8	4.3	3.4	3.8	5.0	5.1	1.9	9.1	4.1	1.8	3.5	3.8	3.4	4.8	6.0	3.8	9.3	4.3	3.9	4.3	5.6	2.9	2.3	4.1	4.4	3.4	3.1	1.6	3.6	2.6	6.7	5.0	4.0	3.3	3.9	5.4	3.6	4.7	4.0	5.3	4.1	3.2	7.3	5.7	5.0	4.5	35.7	48.5	12.9	18.5	6.9	8.2	30.7	20.2	7.3	16.9	10.7	48.9	18.1	58.8	11.5	14.5	24.5	19.3	44.7	25.5	11.8	19.2	42.0	59.7	52.0	41.9	13.3	36.8	14.5	4.7	11.2	22.9	16.4	6.3	22.1	20.9	72.6	22.0	14.8	29.4	38.5	20.9	32.3	26.4	47.0	41.6	7.8	58.4	12.8	21.2	30.4	19.5	21.2	31.1	10.2	4.1	20.4	28.2	16.4	25.9	17.3	12.1	41.0	28.9	21.6	48.1	12.5	57.2	31.1	0.0	3.9	0.2	2.4	6.8	3.6	5.4	3.4	3.1	7.1	4.9	3.4	3.5	0.0	3.6	4.2	3.5	4.4	3.5	4.0	3.9	3.8	4.8	3.8	3.4	4.3	3.9	4.4	3.9	4.0	4.5	3.6	0.0	4.8	5.5	10.3	8.5	12.7	7.3	4.0	4.1	5.3	4.6	2.5	0.0	3.2	0.0	2.1	16.3	5.5	5.9	0.0	7.4	4.8	2.8	5.8	5.2	5.4	8.4	4.8	6.7	25.8	4.7	6.1	3.4	10.2	5.4	3.6	7.0	12.5	3.3	4.5	6.0	4.1	3.5	4.0	3.8	2.8	4.7	7.2	2.8	1.9	3.8	2.1	1.5	5.1	6.9	1.0	3.0	15.3	24.6	3.5	6.8	2.1	4.6	6.6	2.7	6.1	10.4	8.4	7.5	10.9	11.5	3.6	8.2	7.7	10.7
WDR5	"CFAP89, SWD3"	ENSG00000196363	"WD repeat domain 5"	P61964	9	134135365-134159968	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 152.7;Spermatocytes: 99.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047182			Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA047182: AB_2679971"	"unprognostic (9.28e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.26e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.31e-3)"	"unprognostic (4.63e-2)"	"unprognostic (7.06e-2)"	"unprognostic (5.91e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.88e-2)"	17.5	18.4	17.4	13.9	18.2	20.3	16.7	20.1	21.0	17.1	17.3	19.3	17.6	18.7	8.9	24.9	18.9	8.3	19.5	17.8	18.0	18.6	34.0	15.4	16.2	15.9	16.9	21.9	27.7	13.5	25.4	14.7	16.5	18.9	13.7	9.1	18.1	12.7	33.9	22.2	19.4	13.5	15.0	20.0	20.6	38.7	18.4	17.8	17.7	18.2	18.0	18.4	16.3	17.9	43.6	52.4	49.0	56.1	26.1	28.7	77.4	43.0	28.3	57.5	39.1	61.3	34.9	68.8	26.7	35.2	50.5	105.9	66.9	44.1	46.6	46.4	45.6	39.7	85.6	49.9	27.9	90.0	40.2	27.7	41.0	43.1	52.6	23.7	38.7	67.5	75.3	37.6	40.5	116.1	77.4	73.6	62.3	98.3	65.2	83.4	99.2	65.2	28.3	42.0	81.7	42.5	64.8	50.2	29.7	32.5	69.1	78.3	33.9	58.7	53.8	54.5	70.5	19.6	40.0	74.0	34.1	60.4	48.2	0.9	9.3	1.6	6.7	6.0	6.6	4.6	6.6	6.9	10.0	5.8	6.8	5.4	0.8	4.9	5.1	8.3	6.4	7.1	17.4	18.2	20.1	21.0	17.8	18.0	15.9	16.9	16.5	15.0	18.4	17.9	8.2	9.6	8.6	10.7	11.8	11.9	14.9	7.0	16.5	9.6	13.6	12.8	9.5	11.5	5.0	5.5	22.9	27.4	8.9	9.1	9.8	14.7	152.7	8.6	14.4	9.6	6.6	17.5	16.4	20.9	42.5	12.2	15.3	10.0	8.9	17.6	5.3	21.9	19.1	8.4	16.6	13.7	8.2	6.3	9.8	41.4	11.5	10.9	5.4	11.2	10.0	6.8	10.3	10.1	14.3	16.7	9.7	11.7	26.6	30.4	17.6	10.2	3.9	7.4	6.6	9.7	10.9	99.9	42.3	25.6	16.3	17.8	9.7	32.5	22.2	18.0
WDR53	"MGC12928, MGC64882"	ENSG00000185798	"WD repeat domain 53"	Q7Z5U6	3	196554177-196568674	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 74.2"	"Group enriched"	"Detected in many"	9	"Early spermatids: 313.9;Late spermatids: 118.8;Spermatocytes: 135.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016420	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA016420: AB_1858812"	"unprognostic (3.29e-2)"	"unprognostic (4.24e-3)"	"unprognostic (9.89e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (1.57e-6)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (2.57e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.48e-3)"	"unprognostic (8.01e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.97e-1)"	7.8	7.4	9.4	6.9	10.3	14.7	9.0	10.3	12.1	7.7	9.7	8.1	4.3	8.1	11.0	9.0	7.1	6.3	8.1	9.5	10.0	8.8	10.0	6.9	10.6	9.6	9.7	7.0	5.9	10.0	6.7	6.3	11.2	7.2	7.1	8.9	7.0	6.1	13.0	11.9	7.9	7.4	9.4	10.8	7.2	74.2	9.8	12.1	7.1	12.6	11.9	7.2	7.6	11.3	39.4	8.5	14.6	13.6	15.0	13.2	23.8	20.1	16.2	23.0	21.7	22.8	20.2	18.9	66.4	13.0	21.2	22.3	18.9	18.4	28.8	30.0	16.3	19.4	21.2	14.6	18.5	26.9	14.3	10.7	25.9	20.6	22.2	11.4	18.7	23.6	18.8	34.5	17.7	36.4	22.5	27.5	19.5	25.7	24.4	26.5	25.3	40.5	12.8	13.4	15.0	15.2	15.0	20.8	32.2	19.8	53.0	24.2	17.2	18.9	18.0	21.5	40.6	29.5	63.8	56.6	12.7	34.2	19.4	13.1	5.5	15.7	8.8	4.7	14.1	7.8	12.2	8.5	4.7	7.5	10.2	6.1	4.7	7.4	7.8	6.2	16.5	5.0	9.4	10.3	10.3	12.1	9.5	10.0	9.6	9.7	11.2	9.4	9.8	11.3	3.9	0.0	2.8	6.8	3.8	4.2	3.2	8.1	2.8	3.7	3.4	3.4	5.6	2.8	5.8	3.7	0.0	5.7	3.5	1.7	5.9	5.0	313.9	3.3	3.5	4.7	0.0	7.4	5.5	4.2	6.1	3.9	0.5	2.7	9.5	3.2	3.9	2.5	4.3	3.3	4.8	1.6	10.2	3.8	3.0	118.8	5.0	3.9	5.4	10.3	7.3	4.0	4.1	6.0	7.1	3.7	1.9	3.4	3.7	2.9	1.5	5.0	3.1	2.8	19.7	4.0	5.5	135.6	13.9	3.5	4.7	4.7	6.3	4.1	2.7	2.6
WDR59	FLJ12270	ENSG00000103091	"WD repeat domain 59"	Q6PJI9	16	74871362-75000173	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041084, HPA048218"	Approved		Approved	Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol		"HPA041084: AB_10793867, HPA048218: AB_2680318"	"unprognostic (3.68e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.16e-2)"	"unprognostic (6.14e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.28e-2)"	"unprognostic (8.83e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.37e-2)"	"unprognostic (4.21e-3)"	"unprognostic (3.25e-3)"	"unprognostic (2.05e-2)"	"unprognostic (9.08e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.61e-2)"	11.6	19.0	18.2	13.8	22.1	16.1	14.2	18.2	21.3	19.2	15.5	15.3	13.1	16.1	21.1	17.3	14.9	9.7	17.0	17.9	20.0	17.3	35.7	11.1	12.7	19.0	19.3	22.4	16.9	22.6	22.9	14.1	19.8	15.8	14.0	37.9	14.1	11.6	24.8	21.1	16.4	13.2	17.2	15.3	14.2	13.9	20.6	22.3	22.9	17.4	16.0	14.5	17.3	28.5	15.6	23.8	27.1	25.8	20.8	18.7	22.9	9.8	17.0	20.7	23.5	32.3	27.1	21.8	10.6	18.3	19.3	24.6	21.7	23.4	29.3	13.2	23.1	27.9	16.3	52.5	12.6	20.4	32.7	21.8	18.7	25.1	23.7	26.7	21.7	52.5	42.0	10.6	9.9	46.1	31.4	36.4	21.6	34.0	9.7	31.3	11.9	18.3	22.2	13.9	16.5	18.2	28.0	16.2	12.6	28.5	24.5	17.8	19.0	12.9	19.6	14.8	8.5	20.1	29.3	47.2	22.8	14.1	14.3	0.7	0.7	0.7	1.0	0.4	3.4	1.9	1.9	1.5	0.4	1.1	1.2	1.4	0.7	1.0	0.8	0.7	1.0	0.4	18.2	22.1	18.2	21.3	17.9	20.0	19.0	19.3	19.8	17.2	20.6	28.5	9.8	16.0	16.5	77.1	15.0	22.4	20.0	12.7	21.6	38.8	15.0	16.3	17.6	21.5	15.0	22.0	62.6	34.4	9.6	13.1	9.8	13.0	37.4	13.1	14.6	11.8	22.1	21.0	41.5	9.6	16.5	13.6	17.3	20.1	13.3	22.4	17.9	24.6	10.8	20.2	53.8	11.9	12.2	13.2	17.1	79.2	13.4	12.7	8.8	29.0	15.3	11.9	14.4	65.9	88.8	11.9	14.0	11.7	5.9	24.1	17.0	19.6	16.7	55.5	19.7	17.1	9.7	17.7	19.1	16.5	24.2	47.3	15.3	13.8	16.8	23.4
WDR62	"C19orf14, DKFZP434J046, FLJ33298, MCPH2"	ENSG00000075702	"WD repeat domain 62"	O43379	19	36054649-36105108	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Neurogenesis		"Disease variant, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 110.3;testis: 63.7;tongue: 63.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 43.4;Cone photoreceptor cells: 85.5;Early spermatids: 42.5;Late spermatids: 46.2;Rod photoreceptor cells: 41.7;Spermatocytes: 67.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.1"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 2.7"	"Lineage enriched"	"Detected in single"	4	"monocytes: 2.7"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA043255, HPA043639"	Enhanced		Enhanced	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	"Centriolar satellite"	"HPA043255: AB_2678393, HPA043639: AB_2678593"	"unprognostic (1.77e-1)"	"unprognostic (2.79e-3)"	"unprognostic (3.16e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.78e-4)"	"unprognostic (2.00e-1)"	"unprognostic (4.00e-2)"	"unprognostic (5.82e-3)"	"unprognostic (4.72e-2)"	"unprognostic (4.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.73e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.67e-1)"	0.4	0.4	0.3	2.1	0.5	5.4	0.4	0.9	0.7	0.9	0.2	0.9	1.1	0.6	0.2	3.7	0.7	0.2	22.1	0.4	0.2	0.4	0.7	0.7	2.9	0.5	0.5	0.3	0.2	0.1	0.4	0.5	0.5	0.7	0.5	6.7	1.3	0.2	110.3	2.7	1.2	0.7	0.2	2.0	0.9	63.7	0.4	5.0	0.4	63.1	1.8	0.3	1.4	0.8	19.9	37.8	12.3	12.6	1.1	0.3	7.8	18.0	7.6	24.1	20.8	20.0	6.7	24.7	10.9	9.3	11.3	6.1	18.6	6.8	13.5	16.1	8.8	16.9	20.5	13.5	0.8	16.8	19.6	0.3	0.7	17.7	5.2	1.7	6.0	17.3	21.7	26.8	11.3	20.6	33.1	9.0	7.3	16.0	7.4	23.3	12.5	11.7	3.3	7.5	15.3	8.6	12.1	16.7	2.8	7.6	9.6	14.3	4.1	20.8	19.9	16.7	29.6	14.0	22.1	32.0	9.1	13.0	24.6	0.5	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.6	0.2	2.7	0.1	0.5	0.1	0.3	0.5	0.9	0.7	0.4	0.2	0.5	0.5	0.5	0.2	0.4	0.8	1.8	0.0	5.5	0.3	1.0	2.2	1.3	0.5	0.6	1.6	0.9	0.6	43.4	0.0	0.8	0.0	85.5	1.9	1.2	2.5	1.9	0.4	42.5	0.8	0.8	2.0	0.0	11.0	1.4	0.9	1.9	1.8	5.6	0.8	0.0	4.3	1.1	0.8	2.2	3.3	1.0	2.2	2.0	1.3	1.6	46.2	1.2	1.9	1.8	1.0	0.8	2.1	0.0	1.0	1.0	0.5	0.2	0.4	7.1	0.8	0.3	0.3	0.2	41.7	6.6	2.8	1.9	67.6	15.4	2.0	3.7	0.3	2.2	1.2	3.0	0.7
WDR75	"FLJ12519, NET16, UTP17"	ENSG00000115368	"WD repeat domain 75"	Q8IWA0	2	189441446-189475552	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"				"unprognostic (1.23e-1)"	"unprognostic (7.34e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (6.50e-8)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.93e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.15e-11)"	"unprognostic (1.34e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-2)"	18.0	21.1	16.5	18.7	16.6	20.5	24.3	17.9	20.5	23.5	14.7	16.3	13.8	23.4	23.8	18.0	21.2	14.9	13.7	16.3	17.3	15.5	17.7	12.3	26.3	17.5	16.1	23.4	19.8	17.3	13.5	16.9	17.5	15.1	18.2	15.8	13.6	13.1	15.9	21.9	16.0	19.5	17.9	21.6	16.3	16.1	17.6	20.6	14.7	13.8	24.1	23.1	17.9	19.4	36.0	34.3	43.7	55.2	46.7	49.5	49.2	73.3	34.1	82.0	62.7	71.5	39.7	76.1	41.0	24.1	31.6	48.3	81.9	49.0	79.7	49.9	39.1	99.5	60.3	55.4	44.4	111.2	48.7	41.1	41.3	59.4	80.6	34.7	55.9	43.5	99.9	45.3	56.3	35.7	54.8	77.4	101.6	41.5	92.6	51.0	65.4	64.0	41.3	42.5	41.2	41.9	46.1	44.1	38.1	70.2	40.7	45.9	48.3	48.7	52.4	37.4	55.3	48.7	81.2	95.1	34.5	47.5	40.3	0.7	4.3	2.5	5.7	7.4	11.3	5.9	6.3	7.4	8.0	4.3	7.7	7.5	0.0	7.6	4.6	4.5	8.4	4.7	16.5	16.6	17.9	20.5	16.3	17.3	17.5	16.1	17.5	17.9	17.6	19.4	19.8	28.9	16.4	20.5	20.4	17.0	21.0	16.6	26.7	6.4	8.3	9.7	18.3	2.8	13.1	1.8	8.4	19.0	13.3	4.2	11.7	15.0	2.1	10.6	27.3	18.0	9.0	15.8	32.8	16.9	16.0	17.8	15.3	12.0	5.1	13.7	9.7	8.5	10.7	16.8	41.2	12.1	20.3	44.5	8.5	3.8	18.0	11.9	14.2	12.2	11.4	4.8	9.2	28.6	29.7	16.3	6.7	15.8	14.9	16.6	6.1	14.6	11.3	9.6	19.7	20.4	19.6	30.5	31.4	18.1	11.2	17.2	19.5	17.0	11.4	15.2
WDR76	FLJ12973	ENSG00000092470	"WD repeat domain 76"	Q9H967	15	43826980-43868412	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.1;lymphoid tissue: 21.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 35.3;Spermatocytes: 23.5;Spermatogonia: 35.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039804, HPA040626"	Uncertain		Approved	"Nucleoli fibrillar center,Nuclear bodies"		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear bodies"	"Nucleoli fibrillar center"	"HPA039804: AB_10795297, HPA040626: AB_10795527"	"unprognostic (2.26e-1)"	"unprognostic (7.56e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.85e-2)"	"unprognostic (3.12e-2)"	"prognostic unfavorable (6.98e-4)"	"prognostic unfavorable (8.02e-5)"	"unprognostic (4.24e-3)"	"unprognostic (6.25e-2)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (1.91e-2)"	"prognostic unfavorable (1.35e-8)"	"unprognostic (7.71e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.28e-2)"	2.6	1.2	1.0	8.4	1.1	19.1	3.5	4.8	1.7	3.0	0.8	4.8	3.2	3.3	0.9	4.5	1.7	1.9	1.1	0.7	1.1	1.5	2.2	2.4	19.8	1.3	1.1	2.2	3.1	2.7	1.1	3.9	1.3	1.9	6.0	6.3	2.4	2.0	0.8	4.1	3.3	3.9	1.0	3.6	2.9	5.3	1.3	19.5	2.5	1.3	21.3	2.8	2.8	1.2	35.1	17.5	40.7	31.3	4.5	10.7	11.1	57.3	33.9	61.5	76.8	22.1	17.8	51.4	24.8	26.9	31.0	49.4	42.4	20.5	53.1	80.4	25.2	63.3	52.1	7.3	2.5	65.0	27.0	3.4	3.3	33.8	7.7	8.9	19.9	54.7	48.6	86.9	42.6	12.2	63.4	15.4	14.6	11.0	18.1	66.9	70.1	32.4	11.4	35.5	31.3	30.9	36.1	22.5	7.0	12.6	35.0	31.0	9.1	56.3	26.5	63.5	58.9	42.7	114.6	129.1	40.4	56.7	31.5	0.0	0.6	0.3	3.8	0.5	4.1	1.8	4.6	3.4	1.0	2.2	3.8	2.9	0.0	4.8	0.2	1.2	6.6	2.0	1.0	1.1	4.8	1.7	0.7	1.1	1.3	1.1	1.3	1.0	1.3	1.2	4.1	3.2	1.3	2.6	8.2	7.4	3.2	2.4	4.6	3.7	3.7	2.8	1.2	1.5	2.3	1.8	10.4	12.8	6.2	3.5	1.9	2.9	1.7	1.8	3.9	4.8	0.0	35.3	2.5	4.2	13.0	3.9	4.6	3.3	5.7	12.2	2.9	0.9	8.9	1.7	3.3	3.7	0.0	3.5	5.3	0.9	1.8	3.9	3.6	2.8	3.3	8.0	10.3	0.5	1.9	1.1	3.1	2.2	16.1	1.5	1.4	0.9	0.4	16.2	6.6	5.8	5.7	23.5	35.9	7.4	5.8	3.6	11.6	1.5	9.0	1.8
WDR77	"MEP50, p44"	ENSG00000116455	"WD repeat domain 77"	Q9BQA1	1	111439890-111449256	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 104.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026437, HPA026448, HPA027271"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		18000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA026437: AB_10600199, HPA026448: AB_10600993, HPA027271: AB_10602004"	"unprognostic (1.84e-1)"	"unprognostic (7.01e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.19e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (2.06e-6)"	"unprognostic (5.14e-1)"	"unprognostic (3.88e-3)"	"prognostic favorable (7.88e-4)"	"unprognostic (6.16e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.63e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.23e-2)"	16.5	23.5	13.5	18.2	13.6	10.3	14.1	13.0	13.5	14.2	13.3	17.0	14.9	20.1	17.7	27.3	104.9	12.4	29.6	15.1	14.6	19.5	22.7	13.8	28.4	14.1	15.2	12.6	17.5	18.2	14.2	18.5	14.2	17.4	24.1	11.4	19.4	14.7	42.2	13.6	16.3	19.2	13.4	22.5	21.2	14.1	15.1	20.5	13.6	32.9	36.2	24.6	16.7	14.1	70.0	58.6	56.0	46.2	32.5	19.6	76.6	51.8	27.6	76.4	50.1	86.0	25.5	118.8	48.6	44.0	49.1	49.4	101.2	96.9	91.1	46.9	80.0	70.9	67.4	125.2	36.9	71.7	114.6	23.8	68.6	75.4	47.6	20.5	51.7	51.9	96.3	30.1	74.5	86.0	94.0	38.8	109.7	64.5	99.4	92.2	88.2	44.9	68.9	118.7	45.6	33.4	45.5	54.7	42.3	70.6	45.1	50.5	38.7	42.3	86.4	82.6	111.1	25.4	34.1	106.3	54.6	81.1	126.5	17.6	24.6	6.6	27.5	38.2	31.2	53.6	30.0	31.5	54.5	42.3	31.2	29.4	3.6	58.5	35.6	34.1	27.8	27.1	13.5	13.6	13.0	13.5	15.1	14.6	14.1	15.2	14.2	13.4	15.1	14.1	11.1	12.8	11.4	8.1	29.6	20.8	27.9	34.8	10.8	11.5	13.2	11.7	22.2	10.0	17.7	18.4	25.0	56.1	19.4	7.0	25.4	30.6	4.8	42.1	18.2	15.3	15.7	18.1	6.0	13.6	57.0	12.9	26.5	40.9	15.8	21.2	8.2	15.6	47.4	8.4	7.2	14.4	20.3	20.3	8.0	4.1	7.5	18.9	5.4	7.5	16.0	9.7	13.4	7.1	5.8	22.1	7.8	9.1	20.1	28.2	8.8	29.3	34.2	9.2	13.1	10.6	18.3	22.3	24.8	26.1	18.5	45.6	15.3	36.0	22.5	23.5
WDR82	"MST107, MSTP107, PRO2730, PRO34047, SWD2, TMEM113, WDR82A"	ENSG00000164091	"WD repeat domain 82"	Q6UXN9	3	52254434-52288020	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 185.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040427			Supported	"Nucleoli rim"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli rim"		"HPA040427: AB_2676979"	"unprognostic (7.43e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.15e-3)"	"unprognostic (2.92e-3)"	"unprognostic (9.32e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.26e-1)"	40.3	37.8	36.5	46.8	37.0	55.6	33.9	38.1	36.5	48.6	35.9	37.5	33.8	56.2	30.1	46.7	43.8	35.3	48.0	37.9	40.2	28.7	32.6	36.0	57.8	31.4	34.1	54.6	28.1	35.4	22.0	43.3	33.4	41.2	39.1	35.5	31.2	48.7	65.5	37.0	33.6	52.2	34.3	49.1	31.4	33.3	42.7	73.1	40.4	67.0	60.8	47.4	36.1	34.6	46.0	54.3	100.4	75.5	93.7	77.3	50.3	76.6	63.3	74.0	61.1	63.9	44.9	121.4	29.2	82.4	64.8	40.7	139.3	82.2	86.2	88.5	53.3	155.9	67.3	65.8	64.9	148.2	78.6	78.1	79.6	87.3	79.3	68.8	79.0	97.7	70.8	84.8	72.4	46.3	115.6	58.1	91.1	60.0	104.2	58.7	67.0	90.8	77.2	83.1	23.9	100.3	82.1	24.5	47.8	67.4	46.4	58.8	81.6	69.0	78.2	72.9	89.3	82.3	129.1	120.6	59.0	110.6	77.3	9.4	7.4	10.1	15.3	7.5	18.5	8.8	13.9	15.0	6.5	7.0	15.8	16.2	14.2	8.9	12.0	6.1	12.9	9.8	36.5	37.0	38.1	36.5	37.9	40.2	31.4	34.1	33.4	34.3	42.7	34.6	45.9	28.9	42.8	12.1	43.0	51.5	33.9	23.5	34.1	54.6	40.7	41.4	53.1	32.9	26.3	14.7	20.9	28.8	66.2	45.4	13.7	17.4	45.3	62.6	71.0	42.7	44.3	41.2	20.4	18.9	31.2	38.3	31.1	91.5	15.2	51.0	40.0	42.9	32.5	62.2	22.0	35.2	12.2	61.9	40.2	185.1	58.4	43.2	37.4	21.5	50.2	36.5	63.8	15.1	18.1	30.4	30.8	62.8	33.4	40.8	26.0	21.7	21.4	35.0	52.6	53.3	36.6	21.5	30.7	41.5	56.8	30.8	62.5	42.9	40.5	40.3
WDR89	"C14orf150, MGC9907"	ENSG00000140006	"WD repeat domain 89"	Q96FK6	14	63597039-63641871	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000813	Uncertain		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 58: T-cells - T-cell receptor"	"Intermediate filaments, Cytosol"		"HPA000813: AB_1078324"	"prognostic favorable (3.37e-4)"	"unprognostic (6.46e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.08e-2)"	"unprognostic (8.66e-3)"	"unprognostic (3.63e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.63e-2)"	"unprognostic (3.29e-1)"	4.9	5.8	4.4	7.6	4.9	3.0	8.1	7.0	5.9	6.8	3.3	6.1	5.1	6.9	6.8	5.3	6.4	4.8	4.4	4.5	4.6	8.8	8.8	5.4	11.2	4.5	4.4	8.2	5.9	7.4	3.0	6.6	4.2	5.8	6.8	11.4	4.1	4.5	5.8	6.1	4.0	5.3	3.9	8.6	5.4	5.3	5.1	10.1	9.2	7.3	10.3	6.6	4.4	5.7	35.4	16.2	18.2	10.2	10.7	11.2	27.2	14.0	7.6	14.4	16.2	11.6	17.0	33.7	11.4	4.2	9.7	16.7	22.8	13.2	24.3	21.8	13.1	22.7	10.5	14.4	13.8	29.9	15.5	10.1	17.1	16.0	22.7	8.1	12.8	24.0	19.7	17.8	10.5	19.5	24.0	17.3	17.5	23.9	29.2	18.2	18.3	19.2	15.5	14.6	16.5	12.4	15.0	16.8	11.1	18.1	19.2	16.0	9.2	16.8	16.4	11.0	16.6	10.4	8.8	20.9	7.2	20.9	11.9	0.1	2.8	0.5	8.4	2.7	10.5	8.0	8.8	7.8	4.8	7.3	14.3	12.4	0.6	9.4	4.6	3.1	10.1	5.3	4.4	4.9	7.0	5.9	4.5	4.6	4.5	4.4	4.2	3.9	5.1	5.7	5.6	9.6	6.7	4.9	14.5	9.7	13.9	4.6	8.0	6.7	6.3	5.3	4.8	8.6	7.0	5.5	4.2	9.9	7.0	3.8	13.7	6.8	2.8	3.4	7.7	7.0	3.6	11.6	11.3	5.5	13.6	6.5	2.6	4.1	1.3	7.5	5.3	8.0	6.3	1.7	13.2	5.1	4.1	6.3	4.2	4.6	4.4	5.1	3.6	6.5	5.6	7.0	8.2	8.5	14.5	3.6	2.4	6.4	6.1	11.2	2.7	7.9	3.1	9.3	13.1	6.9	4.9	6.1	11.6	6.3	10.9	7.0	11.2	8.7	5.5	7.3
WIPI2	"ATG18B, ATG21, CGI-50, DKFZP434J154, DKFZp686P02188, FLJ12979, FLJ14217, FLJ42984"	ENSG00000157954	"WD repeat domain, phosphoinositide interacting 2"	Q9Y4P8	7	5190196-5233840	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Autophagy		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 255.9;Spermatocytes: 233.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019852, HPA021488"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA019852: AB_1846589, HPA021488: AB_1846591"	"unprognostic (5.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (7.69e-5)"	"unprognostic (1.96e-3)"	"unprognostic (9.27e-3)"	"unprognostic (4.60e-3)"	"unprognostic (4.96e-2)"	"unprognostic (6.60e-2)"	"unprognostic (4.23e-1)"	"prognostic favorable (9.78e-4)"	"unprognostic (1.20e-1)"	"prognostic favorable (2.05e-6)"	"unprognostic (2.61e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.41e-2)"	"unprognostic (6.98e-2)"	31.1	30.9	38.8	22.9	40.7	47.0	30.8	35.2	41.8	27.3	37.1	33.9	24.7	32.1	26.3	35.8	29.0	23.2	38.0	42.8	38.6	32.2	35.7	26.4	30.2	36.3	39.1	28.2	37.1	38.2	30.6	32.8	38.7	28.7	20.2	19.1	43.5	28.2	41.3	47.1	26.7	26.8	37.0	29.6	33.6	53.8	38.7	36.8	27.4	45.0	29.2	27.1	30.0	39.8	67.5	42.1	40.4	69.4	60.7	63.3	62.0	58.7	66.9	61.2	64.2	41.2	60.9	47.7	43.9	73.8	76.0	48.2	41.2	47.8	47.4	24.9	64.1	32.7	39.7	45.8	59.9	51.8	34.4	66.9	56.4	69.7	38.3	60.9	86.3	64.3	94.2	41.9	56.2	69.9	39.6	90.0	84.3	35.9	61.1	64.3	57.7	79.5	40.4	32.3	50.3	75.4	43.0	72.8	52.4	67.3	44.8	97.2	69.2	38.9	80.9	65.6	44.4	75.0	75.2	54.7	63.4	59.3	58.8	0.4	4.7	13.6	4.4	6.0	2.8	5.7	5.8	8.0	4.2	6.2	7.5	4.7	9.1	2.6	4.2	6.4	9.0	2.2	38.8	40.7	35.2	41.8	42.8	38.6	36.3	39.1	38.7	37.0	38.7	39.8	40.2	38.5	31.5	16.3	51.6	54.9	39.5	13.9	39.3	71.5	49.4	50.5	37.0	42.9	17.6	18.4	62.6	89.4	62.7	42.6	72.4	43.0	195.8	50.0	38.1	37.9	39.5	125.0	19.7	41.8	96.6	43.1	34.7	48.0	31.1	54.8	54.7	60.4	69.1	47.1	19.6	42.6	18.3	61.4	44.8	255.9	42.6	55.9	44.4	20.6	64.5	89.5	44.3	13.6	23.5	55.6	37.0	56.1	67.7	97.7	48.7	80.6	26.4	52.8	52.6	39.7	39.4	233.0	117.3	49.8	71.0	150.8	46.8	44.1	43.0	69.8
WNK1	"HSAN2, HSN2, PPP1R167, PRKWNK1"	ENSG00000060237	"WNK lysine deficient protein kinase 1"	Q9H4A3	12	752579-911452	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Protein kinase inhibitor, Serine/threonine-protein kinase, Transferase"	"Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 293.0"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 336.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046541, HPA059157"	Enhanced		Supported	Cytosol		NA	NA		92000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA046541: AB_2679690, HPA059157: AB_2683935"	"unprognostic (1.40e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.67e-4)"	"unprognostic (1.84e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.30e-2)"	56.7	20.6	190.8	36.4	236.8	54.2	33.5	179.4	166.1	32.8	110.8	22.8	14.4	26.7	30.4	72.1	29.4	27.1	63.8	132.3	161.1	84.0	31.6	44.6	39.2	232.3	238.4	30.1	22.5	51.1	17.0	36.0	217.0	29.7	24.2	87.4	24.0	33.4	79.7	52.0	17.4	36.1	225.4	30.2	27.6	48.3	238.0	61.3	27.7	79.8	46.9	35.8	43.8	293.0	53.9	97.5	131.8	11.3	88.1	80.0	52.2	48.3	61.6	58.2	51.3	59.4	55.7	71.0	16.8	107.8	73.5	39.8	93.8	56.7	84.3	124.7	51.4	169.4	122.2	46.1	66.7	86.9	68.2	64.0	82.1	97.6	164.4	61.6	73.4	68.0	76.4	158.2	77.8	54.1	154.6	15.6	105.8	47.8	24.3	78.0	138.8	20.8	80.6	96.8	35.1	40.7	121.8	82.9	33.6	183.3	86.8	97.2	78.3	67.1	77.3	86.2	70.8	23.8	43.1	103.8	59.4	44.6	53.2	0.7	1.8	1.6	1.9	2.1	1.9	1.7	1.9	2.1	1.4	1.2	1.2	1.9	5.6	1.4	4.7	1.2	3.4	1.6	190.8	236.8	179.4	166.1	132.3	161.1	232.3	238.4	217.0	225.4	238.0	293.0	261.1	102.5	141.6	77.1	65.3	112.8	42.3	38.3	85.4	87.9	50.6	39.5	241.6	50.1	47.1	90.1	150.1	32.5	83.0	27.8	86.1	28.0	29.7	63.0	68.6	106.7	58.7	304.2	182.3	24.4	32.9	58.3	37.2	70.2	52.6	46.2	52.5	71.7	57.3	84.1	165.0	26.3	16.2	121.4	80.8	21.2	61.8	96.7	37.4	114.3	95.7	64.0	61.8	126.7	336.4	41.7	34.8	55.7	76.5	59.0	24.2	21.8	64.6	96.1	13.1	69.6	63.8	186.5	74.6	147.2	136.0	28.5	112.9	33.2	25.8	55.2
WRAP53	"FLJ10385, TCAB1, WDR79"	ENSG00000141499	"WD repeat containing antisense to TP53"	Q9BUR4	17	7686071-7703502	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	"Chaperone, RNA-binding"	"Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Respiratory ciliated cells: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 29.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023026, HPA028130, HPA029928"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA023026: AB_10963931, HPA028130: AB_10961728, HPA029928: AB_2673257"	"unprognostic (1.45e-1)"	"unprognostic (3.50e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.86e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (4.70e-4)"	"unprognostic (8.69e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (8.26e-4)"	"unprognostic (2.68e-2)"	"unprognostic (5.67e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.93e-2)"	"unprognostic (4.04e-1)"	4.1	3.7	3.4	4.5	3.5	7.6	4.0	3.4	3.5	4.3	5.0	4.2	2.7	4.5	2.3	4.5	14.5	3.0	4.2	3.4	3.5	4.0	3.6	4.1	6.9	3.9	5.0	3.3	4.5	3.1	4.1	3.4	3.8	3.0	3.5	3.4	3.6	3.0	6.2	4.4	4.7	3.9	4.0	6.9	4.3	5.2	3.5	8.0	3.5	4.5	6.5	3.8	3.6	4.0	22.7	40.6	28.9	29.5	9.2	8.0	16.5	14.3	14.9	45.6	42.1	24.2	13.2	23.3	15.0	13.1	18.7	24.0	33.8	24.5	35.2	14.4	41.4	12.0	22.6	20.5	7.9	8.1	14.7	6.8	9.3	39.9	8.9	6.8	28.8	27.4	12.0	7.7	18.7	21.1	27.0	22.2	15.4	16.7	20.5	35.0	19.3	14.0	17.2	7.7	13.3	19.4	23.1	11.9	12.1	14.0	16.7	10.3	10.1	17.4	19.0	0.1	36.6	5.3	15.9	13.1	16.8	15.2	21.4	29.4	5.8	5.0	5.3	6.3	6.1	3.0	4.2	6.2	5.3	4.2	3.8	4.2	2.5	5.0	2.8	7.4	8.9	3.8	3.4	3.5	3.4	3.5	3.4	3.5	3.9	5.0	3.8	4.0	3.5	4.0	4.6	3.2	3.4	2.3	7.0	3.8	5.2	12.9	2.8	5.6	4.1	4.6	3.6	2.8	7.0	11.0	6.2	12.3	9.2	4.5	3.9	10.1	3.9	22.4	3.4	5.8	3.0	10.8	2.0	10.4	17.0	4.4	4.1	4.1	1.3	7.3	5.3	4.6	7.7	1.7	2.1	5.6	18.3	7.2	3.1	1.9	2.5	5.4	3.6	1.0	8.7	7.2	12.3	5.0	2.8	6.9	3.7	2.2	8.8	2.2	5.2	6.5	51.0	6.3	0.0	6.4	6.3	13.3	6.7	3.5	4.5	4.1	5.7	5.8	7.2	2.9
WRAP73	WDR8	ENSG00000116213	"WD repeat containing, antisense to TP73"	Q9P2S5	1	3630767-3652761	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026893	Uncertain					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA026893: AB_10603459"	"unprognostic (3.34e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.12e-1)"	"unprognostic (9.44e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.40e-3)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (2.35e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.19e-2)"	"prognostic favorable (3.49e-4)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.00e-3)"	13.8	14.3	12.0	10.7	12.9	23.8	13.4	13.3	16.1	14.2	12.5	14.7	13.9	14.2	7.9	15.7	13.4	9.0	14.2	11.7	11.5	13.6	13.5	13.3	17.6	12.1	12.4	14.0	18.1	10.1	17.5	9.6	12.4	13.6	9.0	8.4	13.5	7.8	16.3	12.9	18.1	8.8	11.9	21.5	16.7	15.9	12.8	14.3	14.6	9.6	14.1	13.9	13.5	14.0	30.5	17.4	17.0	33.1	22.4	14.3	16.8	14.9	14.6	24.8	21.5	27.5	39.4	33.5	27.5	19.0	20.2	22.6	50.0	29.8	12.8	59.3	75.8	19.1	23.7	31.3	24.0	22.5	29.2	13.2	20.7	20.1	25.6	13.8	22.2	39.7	31.8	19.9	18.1	27.2	47.6	33.7	23.5	30.4	36.7	29.3	24.5	17.9	13.1	12.6	43.7	61.1	17.3	23.5	43.1	14.4	23.3	35.9	17.9	19.1	19.1	32.6	21.7	27.0	34.7	68.7	9.8	45.8	8.6	57.3	23.4	70.3	21.7	22.5	21.6	22.2	22.7	21.1	24.3	22.4	19.9	21.0	28.8	24.2	33.3	20.5	27.3	19.3	12.0	12.9	13.3	16.1	11.7	11.5	12.1	12.4	12.4	11.9	12.8	14.0	15.4	3.2	13.4	12.1	18.3	7.0	10.8	22.3	12.0	23.5	8.7	9.4	7.9	10.0	12.9	14.7	35.5	21.3	21.0	15.4	13.7	13.1	12.1	11.3	9.4	11.2	10.3	5.9	9.0	14.2	12.5	12.0	14.3	8.7	4.5	14.8	10.0	7.0	18.3	42.1	7.9	13.8	16.2	11.9	6.8	25.7	12.5	13.5	12.4	9.4	14.8	17.6	15.5	6.0	10.3	16.6	7.8	9.8	16.5	14.2	30.3	9.4	14.2	26.9	6.6	9.8	15.3	38.1	15.8	12.3	6.8	14.5	20.3	15.4	13.0	9.6
WWP2	AIP2	ENSG00000198373	"WW domain containing E3 ubiquitin protein ligase 2"	O00308	16	69762328-69941741	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 68: Oligodendrocytes - Mixed function"				"unprognostic (1.63e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.08e-2)"	"unprognostic (9.81e-2)"	"prognostic favorable (5.87e-11)"	"unprognostic (4.26e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.62e-1)"	27.3	31.2	22.4	18.2	23.5	34.1	22.8	19.7	22.3	23.5	23.8	23.2	23.4	22.6	10.1	26.2	23.5	15.1	16.7	20.0	20.9	31.7	18.4	23.4	22.0	22.9	21.5	23.4	29.6	25.9	17.7	16.2	22.2	20.5	19.8	15.5	31.9	17.2	21.6	30.7	23.5	14.3	19.7	30.2	26.3	16.1	22.0	19.7	22.6	9.3	19.3	18.8	20.9	26.6	25.0	24.8	15.7	16.3	12.9	10.7	24.1	16.3	18.6	27.4	28.3	23.1	18.5	28.4	17.4	29.2	14.9	28.6	20.8	24.7	20.4	13.4	17.9	15.9	15.1	39.4	24.1	28.3	22.4	15.7	17.9	37.4	25.9	15.4	25.6	24.1	24.5	15.5	17.6	43.2	15.5	30.9	22.1	20.6	10.5	34.6	13.1	49.5	26.6	23.6	19.3	21.3	69.1	19.8	15.4	10.2	30.9	34.6	25.6	21.3	30.8	29.9	19.8	36.3	26.0	42.7	22.9	23.6	38.2	35.9	19.0	29.8	16.3	23.5	12.2	10.8	12.1	13.0	14.9	12.4	12.3	8.7	49.7	8.5	30.8	7.0	11.7	17.1	22.4	23.5	19.7	22.3	20.0	20.9	22.9	21.5	22.2	19.7	22.0	26.6	11.9	9.6	31.0	16.0	18.7	7.4	7.0	5.4	9.1	9.0	10.0	8.3	8.7	21.5	12.8	14.7	10.4	10.0	13.1	47.2	1.9	12.3	22.6	13.9	7.5	13.1	16.8	13.9	20.3	20.0	9.2	8.2	31.1	14.4	21.5	12.7	13.2	13.3	12.8	10.1	26.0	16.1	6.1	22.7	13.6	38.5	10.2	18.8	10.6	42.2	18.8	12.3	19.6	79.4	56.4	16.8	23.6	8.6	12.4	6.1	22.6	10.0	24.1	6.5	13.1	6.9	17.7	8.1	6.0	9.6	6.0	20.0	14.6	7.0	20.4	9.9
XPO1	"CRM-1, CRM1, emb"	ENSG00000082898	"Exportin 1"	O14980	2	61476032-61538741	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Transport"	RNA-binding	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010184, HPA042933"	Supported		Enhanced	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA		410000	"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"CAB010184: AB_2215817, HPA042933: AB_2678229"	"unprognostic (7.34e-2)"	"unprognostic (7.04e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.84e-1)"	"unprognostic (1.99e-3)"	"unprognostic (4.43e-1)"	"unprognostic (3.53e-3)"	"unprognostic (4.90e-2)"	"prognostic unfavorable (3.74e-4)"	"unprognostic (5.69e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.55e-2)"	33.2	29.8	30.1	48.7	31.4	25.8	39.2	35.7	44.3	37.9	31.6	34.9	24.7	52.5	37.0	35.1	45.9	32.0	36.0	27.9	33.7	30.8	41.7	31.9	65.3	28.9	30.5	58.9	26.2	38.5	22.0	52.1	30.4	34.2	42.0	52.0	19.9	34.9	37.5	34.2	33.2	48.6	30.9	43.4	31.9	54.5	32.8	73.6	38.8	47.2	60.9	38.6	22.4	38.9	169.1	152.9	194.1	135.8	91.4	107.9	145.5	166.6	109.2	192.9	151.8	217.3	114.7	256.0	117.4	127.1	186.3	125.0	307.9	126.5	268.6	151.6	110.7	242.8	136.2	148.4	55.4	234.6	145.4	62.9	103.8	149.4	145.9	126.0	149.5	108.7	285.5	127.7	164.9	97.8	212.6	100.4	213.1	189.9	111.5	175.6	208.0	148.1	103.0	124.9	152.8	77.5	174.2	142.8	87.1	185.6	108.6	110.8	98.9	153.7	178.7	137.2	175.0	102.8	203.2	347.0	96.8	214.0	151.0	3.3	1.4	2.2	1.8	2.2	1.9	1.1	1.0	1.8	2.1	0.7	1.0	1.0	0.6	2.7	1.2	1.6	1.2	1.2	30.1	31.4	35.7	44.3	27.9	33.7	28.9	30.5	30.4	30.9	32.8	38.9	42.0	41.7	43.2	114.3	55.3	52.1	32.1	45.5	78.6	67.5	40.2	38.6	64.5	38.6	38.7	31.3	95.9	54.1	56.6	27.3	13.7	29.7	4.2	58.6	79.7	47.7	45.1	73.2	87.9	26.1	49.3	49.9	42.3	68.6	41.8	100.4	41.4	55.8	57.2	72.3	101.3	34.2	40.7	55.3	58.4	11.9	33.5	63.9	37.4	68.4	64.2	33.4	61.8	83.4	102.5	32.3	20.9	30.9	57.2	55.6	21.0	22.2	56.9	101.7	19.7	50.5	55.7	65.9	91.6	83.3	56.8	30.1	54.5	54.4	46.2	47.7
XPO6	"FLJ22519, KIAA0370, RANBP20"	ENSG00000169180	"Exportin 6"	Q96QU8	16	28097976-28211965	"Metabolic proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 90.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	6	"neutrophil: 202.1"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 202.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038246	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		No	No			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli"	"Plasma membrane, Cytosol"	"HPA038246: AB_10674550"	"unprognostic (1.17e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.48e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.01e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.36e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (8.80e-4)"	48.0	48.3	70.0	55.9	73.7	92.0	39.9	61.7	87.0	43.7	63.9	47.0	21.8	42.3	18.8	57.0	44.8	24.5	36.2	72.2	72.0	47.2	62.1	70.9	62.9	76.1	69.2	36.6	43.2	26.9	56.6	25.7	73.6	48.6	27.4	35.2	44.9	20.1	29.9	52.9	63.0	26.8	67.8	160.6	42.8	100.3	72.9	51.1	50.5	13.7	44.9	44.9	46.0	77.8	82.9	63.3	54.8	58.8	37.2	58.8	57.9	97.0	98.0	124.8	124.8	89.1	61.7	59.8	78.6	99.8	63.3	53.8	131.6	83.9	151.5	115.3	72.1	67.6	90.0	101.6	87.9	95.4	70.8	46.3	61.2	111.1	108.9	53.5	73.1	63.4	118.0	31.0	86.0	101.1	116.2	116.1	88.1	43.6	55.4	101.0	64.3	101.2	46.8	45.2	103.3	55.0	52.9	88.3	47.8	60.8	62.7	63.3	75.4	104.1	64.4	87.2	84.8	63.0	83.8	89.8	78.7	98.4	89.1	21.1	9.9	32.9	14.2	11.4	15.4	20.7	16.5	15.8	7.3	15.7	18.1	22.6	202.1	10.7	17.6	9.5	14.7	8.4	70.0	73.7	61.7	87.0	72.2	72.0	76.1	69.2	73.6	67.8	72.9	77.8	9.6	9.6	14.2	27.4	20.2	18.6	11.4	12.6	5.2	20.8	15.0	14.6	8.0	5.7	12.6	23.9	31.3	11.5	30.2	28.5	7.9	14.1	39.2	12.7	21.5	11.6	23.5	10.3	51.2	19.2	17.3	13.3	12.2	32.8	2.5	34.6	9.3	16.7	23.4	21.9	55.4	20.6	10.2	27.9	15.8	44.8	10.8	22.6	7.2	43.1	28.6	8.3	23.7	59.3	90.3	23.4	13.5	8.6	16.5	22.4	13.3	7.1	10.3	28.1	6.6	13.5	12.2	31.6	26.5	18.0	21.3	8.3	27.0	9.5	21.2	15.4
XPO7	"KIAA0745, RANBP16"	ENSG00000130227	"Exportin 7"	Q9UIA9	8	21919662-22006585	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 169.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043727, HPA048153"	Uncertain					NA	NA		53000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA043727: AB_2678638, HPA048153: AB_2680289"	"unprognostic (6.30e-2)"	"unprognostic (1.95e-2)"	"prognostic favorable (2.29e-4)"	"unprognostic (6.61e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.81e-3)"	"unprognostic (9.66e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.76e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.19e-1)"	20.0	21.8	25.1	21.9	27.2	61.9	26.6	24.5	25.7	26.5	24.7	24.7	15.9	30.7	28.5	26.5	30.5	20.3	31.3	27.9	23.2	40.3	19.2	22.5	26.8	19.7	20.7	39.7	21.7	43.4	19.9	31.8	20.3	21.3	28.3	45.0	20.6	24.7	33.2	28.0	17.7	28.6	22.4	23.2	23.6	41.0	24.3	33.4	35.5	40.5	31.2	23.9	21.6	28.4	47.8	83.2	60.7	43.9	49.9	43.3	47.9	46.2	54.3	67.2	60.4	63.6	29.1	78.0	51.5	57.6	61.0	45.5	87.9	66.2	117.8	23.7	44.7	87.5	67.9	46.9	34.0	42.3	63.9	34.0	45.9	67.1	64.0	48.8	65.5	69.1	106.0	61.0	49.9	36.8	105.6	39.4	78.3	81.2	33.0	60.5	78.3	40.9	44.3	98.0	36.7	57.9	43.8	45.3	46.4	61.2	41.2	34.7	42.9	35.0	44.5	50.3	47.0	21.4	25.9	83.0	53.5	50.9	63.1	6.4	3.4	2.6	5.1	4.6	4.3	4.5	4.5	3.9	5.1	3.2	3.4	4.3	1.6	3.4	4.3	1.8	4.9	3.9	25.1	27.2	24.5	25.7	27.9	23.2	19.7	20.7	20.3	22.4	24.3	28.4	14.8	22.4	11.4	37.5	14.6	14.3	6.3	9.0	10.2	31.8	11.8	10.7	38.1	15.7	13.5	18.4	14.6	11.5	12.0	11.2	3.9	10.3	70.5	12.0	12.0	12.4	20.9	169.5	65.8	11.2	13.4	13.1	19.9	11.3	7.6	32.1	13.6	14.1	14.4	50.5	68.8	12.0	8.2	23.9	11.3	39.7	15.5	16.8	10.6	37.5	17.3	15.3	11.3	70.4	70.9	10.7	6.5	17.7	15.7	10.3	7.8	15.3	9.8	23.5	13.1	14.9	13.2	21.6	21.4	16.0	12.1	5.6	9.4	13.2	12.8	8.5
XRCC1	RCC	ENSG00000073050	"X-ray repair cross complementing 1"	P18887	19	43543311-43580473	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005427, HPA006717"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"CAB005427: AB_2215661, HPA006717: AB_1858896"	"unprognostic (1.10e-2)"	"unprognostic (3.51e-3)"	"unprognostic (4.59e-1)"	"unprognostic (2.81e-2)"	"unprognostic (4.08e-1)"	"unprognostic (2.68e-2)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (5.07e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.00e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.34e-3)"	"unprognostic (2.20e-2)"	"unprognostic (5.69e-2)"	18.5	16.4	15.3	18.0	15.6	24.4	17.9	18.5	17.1	23.6	13.5	20.4	14.6	23.5	16.2	16.1	23.2	14.4	15.5	14.6	15.6	15.7	10.8	16.2	22.9	15.7	15.2	32.0	19.6	17.6	32.3	16.6	14.0	16.2	11.4	16.7	16.3	15.6	19.5	21.0	15.7	17.3	13.5	20.1	18.5	23.9	16.6	29.0	20.6	15.7	20.9	18.6	18.0	15.6	57.4	51.4	54.4	48.2	23.6	24.6	27.0	28.4	36.0	42.5	46.3	32.0	40.4	44.1	39.1	28.9	39.1	30.0	33.2	36.8	24.7	46.4	33.9	57.5	49.4	36.1	23.2	34.5	42.9	27.3	24.8	53.5	26.4	48.8	37.2	49.1	35.9	42.5	37.3	48.9	57.5	52.5	18.5	44.2	21.3	57.0	35.4	25.8	34.3	44.1	44.5	26.5	41.6	35.3	20.7	26.8	33.9	67.4	23.3	55.7	40.4	16.3	39.9	44.2	44.2	32.0	42.8	28.0	58.7	18.6	13.1	15.6	10.8	11.9	12.3	11.7	13.8	14.6	11.6	10.5	11.3	10.9	15.1	10.4	7.9	9.1	14.5	11.7	15.3	15.6	18.5	17.1	14.6	15.6	15.7	15.2	14.0	13.5	16.6	15.6	10.2	16.0	9.8	5.9	13.4	6.1	7.1	17.5	12.5	12.6	10.2	9.0	7.6	7.2	14.7	7.3	6.2	29.8	12.5	9.1	19.6	15.4	32.2	18.7	13.3	12.2	13.7	15.4	8.2	11.6	19.2	13.3	8.2	13.7	19.7	22.0	11.4	7.1	21.0	5.0	9.2	15.3	10.2	18.0	10.1	19.5	10.2	12.6	14.2	3.7	14.3	8.6	8.2	4.5	8.1	12.2	9.7	12.8	17.7	4.1	9.2	16.9	39.0	12.7	6.6	9.6	17.7	21.4	14.1	10.8	7.1	20.0	14.6	16.4	13.7	4.7
XRCC2	FANCU	ENSG00000196584	"X-ray repair cross complementing 2"	O43543	7	152644776-152676141	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Fanconi anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 5.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 14.1;Extravillous trophoblasts: 21.2;Granulosa cells: 20.2;Spermatocytes: 31.3;Spermatogonia: 19.1;Syncytiotrophoblasts: 12.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065153			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Vesicles"		"HPA065153: AB_2685422"	"unprognostic (9.31e-3)"	"unprognostic (8.25e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.53e-3)"	"unprognostic (9.10e-2)"	"unprognostic (2.52e-2)"	"unprognostic (3.36e-5)"	"unprognostic (9.98e-3)"	"unprognostic (5.82e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.55e-15)"	"unprognostic (4.52e-3)"	"unprognostic (3.01e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.73e-2)"	0.2	0.2	0.9	2.3	0.6	5.3	1.5	1.6	2.8	0.3	0.0	1.1	1.7	1.1	0.9	1.0	0.5	0.4	1.0	0.6	1.9	0.4	0.4	0.5	2.9	0.6	0.6	1.0	0.0	0.6	0.0	2.1	1.4	0.7	1.7	1.9	0.2	0.4	0.1	1.9	1.5	0.5	1.1	1.0	1.0	3.0	1.0	3.6	0.6	0.0	2.5	0.5	0.1	1.9	16.5	10.4	18.3	15.8	1.1	1.8	15.0	11.8	3.9	8.2	10.3	14.7	12.8	24.8	9.5	3.5	13.7	13.7	12.8	7.1	19.3	8.9	17.3	16.8	15.5	10.0	0.3	27.3	9.3	0.9	1.1	15.6	3.6	2.0	3.8	15.5	34.2	22.8	8.3	12.6	32.4	21.2	21.6	10.8	12.9	22.8	19.3	15.3	3.1	10.3	16.7	18.1	11.7	7.6	5.0	11.3	5.4	8.3	4.2	17.2	6.9	13.3	23.0	8.8	14.5	19.0	11.0	20.9	20.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.9	0.6	1.6	2.8	0.6	1.9	0.6	0.6	1.4	1.1	1.0	1.9	0.2	0.0	1.1	1.6	1.9	1.3	1.0	1.0	0.0	4.9	0.8	0.4	2.9	0.0	1.4	1.8	0.0	11.2	0.4	0.9	0.0	1.1	11.7	0.9	1.9	1.1	0.0	14.1	2.3	0.2	21.2	2.5	3.1	1.4	0.0	20.2	1.1	0.2	2.4	0.0	2.0	1.7	2.0	0.6	0.8	4.9	0.9	0.8	0.0	0.0	0.6	1.1	3.1	4.5	2.0	0.5	0.1	1.2	6.1	0.6	0.3	0.3	0.1	2.3	0.0	1.9	1.8	31.3	19.1	2.7	1.4	12.6	2.2	1.2	2.3	1.0
XRCC5	"KARP-1, KU80, Ku86, KUB2"	ENSG00000079246	"X-ray repair cross complementing 5"	P13010	2	216107464-216206303	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004468, HPA025813, HPA064685"	Supported		Enhanced	Nucleoplasm		NA	NA		940000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB004468: AB_672929, HPA025813: AB_1858901, HPA064685: AB_2685322"	"unprognostic (4.23e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.07e-3)"	"unprognostic (3.44e-3)"	"unprognostic (2.44e-2)"	"unprognostic (7.00e-2)"	"prognostic unfavorable (2.10e-7)"	"unprognostic (4.42e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.58e-2)"	"unprognostic (6.01e-2)"	79.6	74.0	52.8	102.4	58.4	112.0	114.6	56.0	69.9	96.4	38.1	91.0	82.2	103.3	85.3	96.8	95.8	83.2	77.1	58.1	56.4	100.2	140.6	76.6	127.8	52.4	50.7	104.0	71.7	118.4	61.4	87.1	54.4	84.7	106.6	102.0	71.6	91.3	103.1	91.6	82.3	100.1	59.1	83.9	77.0	69.5	51.0	176.8	129.2	92.7	140.9	131.7	72.7	65.6	234.4	194.9	427.0	230.5	185.5	210.9	256.6	269.9	279.2	307.1	328.5	421.0	225.7	225.6	214.8	239.1	269.2	203.5	425.2	329.5	469.7	215.0	291.0	488.5	282.9	398.0	229.2	437.1	230.0	193.5	172.1	361.2	156.6	218.4	368.0	272.1	314.4	199.7	405.9	225.9	496.7	221.7	498.0	236.0	170.6	429.8	376.7	186.5	331.9	262.6	372.6	314.6	217.8	159.9	201.1	428.5	196.7	325.8	264.2	287.3	241.5	190.6	312.3	240.0	311.4	493.6	223.4	339.5	290.0	253.2	172.7	175.0	153.6	177.1	165.3	121.2	148.1	157.0	168.0	121.6	147.6	149.1	192.7	172.9	217.4	102.1	167.5	330.4	52.8	58.4	56.0	69.9	58.1	56.4	52.4	50.7	54.4	59.1	51.0	65.6	129.0	105.8	126.3	65.6	131.0	113.7	174.0	242.4	90.5	136.7	93.6	87.1	163.0	105.8	190.0	101.2	45.9	210.5	141.6	79.8	97.8	304.3	103.0	147.4	175.4	142.4	133.3	159.4	73.9	235.8	238.8	134.1	74.5	159.1	146.7	140.2	82.8	222.5	157.3	89.2	82.4	90.7	173.0	100.5	85.3	30.0	101.5	130.7	69.4	108.7	310.9	142.0	138.0	93.0	111.4	247.9	70.3	129.4	132.5	137.4	82.8	139.9	160.1	114.0	111.7	142.9	161.3	252.2	179.2	114.7	120.3	165.5	149.7	165.3	112.0	161.2
YIF1A	"54TM, FinGER7, YIF1, YIF1P"	ENSG00000174851	"Yip1 interacting factor homolog A, membrane trafficking protein"	O95070	11	66284580-66289145	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014840, HPA076194"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus, Vesicles"		"HPA014840: AB_2217189, HPA076194: "	"unprognostic (9.35e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.23e-1)"	"unprognostic (4.38e-3)"	"unprognostic (2.25e-3)"	"unprognostic (2.51e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.53e-2)"	"prognostic unfavorable (8.70e-4)"	49.2	54.7	33.4	28.4	36.0	16.7	47.5	38.5	41.4	42.7	42.4	50.8	56.5	53.5	34.5	50.9	45.7	25.5	57.8	33.5	35.6	50.9	149.5	44.9	22.9	38.9	36.1	42.1	86.0	40.6	74.1	34.5	38.2	47.3	37.7	12.3	51.1	29.6	96.2	43.0	47.4	41.1	38.5	35.9	56.1	36.4	35.6	21.6	49.9	59.3	24.7	45.4	40.6	41.9	80.7	131.3	39.4	72.6	130.0	138.7	73.8	114.4	122.3	95.5	94.3	126.0	95.5	67.9	111.5	161.4	107.8	119.9	60.7	107.9	75.6	77.7	72.0	42.5	93.3	158.7	147.4	59.3	61.5	97.4	144.4	98.6	158.9	76.6	91.3	67.0	80.7	114.8	84.3	199.3	71.3	64.4	40.3	147.4	136.6	54.9	61.2	203.9	81.9	70.9	58.5	57.9	62.5	106.7	103.4	49.6	155.5	43.5	81.0	80.8	69.0	165.3	54.1	78.1	86.0	63.0	125.4	56.2	90.2	19.4	95.6	20.6	71.3	141.4	78.4	95.9	60.6	67.2	116.4	82.4	48.0	55.3	9.4	51.2	140.0	141.6	54.9	99.8	33.4	36.0	38.5	41.4	33.5	35.6	38.9	36.1	38.2	38.5	35.6	41.9	63.4	38.5	48.0	6.2	52.2	36.1	88.1	170.4	38.1	27.1	84.4	92.7	34.5	82.9	115.5	46.0	22.9	114.3	42.6	66.8	64.6	137.9	28.1	42.1	84.8	53.6	87.4	21.0	1.9	149.4	248.5	90.4	55.0	42.8	29.9	38.8	49.2	172.0	105.4	26.9	3.9	140.9	116.0	38.4	44.9	48.6	75.5	45.0	72.9	8.4	40.8	73.7	28.8	10.1	10.4	132.1	93.3	82.4	92.4	195.2	202.2	135.2	101.4	34.0	39.5	60.8	150.0	61.0	56.8	63.3	46.3	154.3	36.5	88.1	107.2	112.1
YLPM1	"C14orf170, PPP1R169, ZAP"	ENSG00000119596	"YLP motif containing 1"	P49750	14	74763316-74859435	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048070, HPA061123"	Uncertain		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear speckles"		"HPA048070: AB_2680247, HPA061123: AB_2684435"	"unprognostic (2.17e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.95e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.79e-2)"	"unprognostic (7.64e-2)"	"unprognostic (3.22e-3)"	"unprognostic (8.74e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.83e-3)"	"unprognostic (6.63e-2)"	"prognostic favorable (6.08e-7)"	"unprognostic (1.09e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.60e-1)"	13.3	13.0	12.5	10.4	12.8	17.6	13.8	18.1	15.6	18.0	2.8	12.9	7.0	16.1	12.9	12.7	15.9	8.5	11.4	10.9	16.4	10.6	8.5	11.2	13.1	9.5	10.0	22.1	13.1	12.1	15.6	11.2	9.3	14.0	9.2	17.6	15.0	10.3	15.0	15.3	13.4	9.4	4.8	13.4	11.9	18.5	12.3	14.9	16.8	7.4	11.9	14.0	15.0	12.8	28.3	28.9	31.8	7.1	25.2	20.8	18.0	18.3	18.7	18.9	18.9	25.8	19.6	40.9	13.4	20.8	13.7	26.1	28.6	19.6	30.2	24.6	17.3	29.4	19.8	20.0	12.2	22.3	21.9	19.0	13.5	20.9	16.5	23.3	25.3	22.9	24.1	18.9	23.5	29.9	26.4	24.4	20.0	19.2	26.1	40.5	31.8	14.3	16.5	37.2	24.2	23.8	29.4	20.2	8.3	21.8	22.9	17.4	37.0	22.6	28.3	15.6	23.9	23.3	24.8	43.6	19.3	17.3	17.2	0.3	1.4	1.5	1.5	1.6	1.7	1.9	1.3	1.3	1.1	1.9	1.8	1.8	1.0	2.3	1.5	3.4	1.1	1.4	12.5	12.8	18.1	15.6	10.9	16.4	9.5	10.0	9.3	4.8	12.3	12.8	26.8	25.6	34.3	54.2	32.7	19.9	11.2	13.3	27.9	42.0	27.7	25.3	45.9	14.3	25.0	9.2	41.7	19.7	32.4	15.7	1.9	15.7	35.4	26.8	36.0	29.7	20.4	23.5	86.7	15.5	13.5	24.4	23.0	28.6	17.7	54.1	21.8	16.8	19.1	52.2	84.3	18.9	12.2	22.6	12.3	17.7	33.8	19.5	5.4	51.5	28.6	24.6	32.0	68.9	76.5	18.0	13.3	48.5	30.3	18.9	14.0	14.7	33.0	30.8	19.7	35.5	24.8	62.8	49.0	29.2	23.3	15.7	29.3	32.5	21.6	13.2
YME1L1	YME1L	ENSG00000136758	"YME1 like 1 ATPase"	Q96TA2	10	27110111-27155266	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA066953	Approved		Supported	"Nuclear bodies,Mitochondria"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	"Nuclear bodies"	"HPA066953: AB_2685753"	"unprognostic (2.28e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.12e-2)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (8.25e-6)"	"unprognostic (7.08e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.24e-2)"	"unprognostic (9.43e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.09e-2)"	48.8	52.6	17.7	51.7	18.4	95.1	47.5	23.3	21.7	52.4	36.4	52.2	46.0	50.3	53.3	59.1	43.7	46.0	61.4	17.8	22.7	54.0	65.5	39.8	56.6	18.2	22.1	50.8	52.0	54.5	33.3	61.1	19.9	48.4	52.4	42.0	44.7	44.5	111.4	40.1	46.3	49.2	16.6	46.4	48.8	51.2	19.7	65.9	62.2	97.7	62.5	56.8	35.0	24.4	146.6	105.3	125.5	62.0	118.3	123.9	100.7	143.3	79.7	139.7	157.6	143.3	171.9	152.1	90.8	154.8	100.5	135.6	152.8	122.6	152.9	143.4	89.0	144.4	91.0	98.3	124.6	100.4	114.5	104.7	143.3	123.4	121.6	122.5	146.7	138.8	173.8	150.5	154.4	95.1	189.1	53.7	97.4	119.3	49.4	160.4	199.7	143.0	107.7	68.2	95.6	121.9	138.4	105.2	138.9	102.8	101.5	115.1	146.9	83.4	117.3	140.8	126.7	75.1	121.9	196.1	119.4	178.8	65.8	195.0	146.4	165.4	147.5	128.5	149.4	143.0	142.4	138.8	121.9	149.7	129.3	136.8	204.0	135.6	143.1	222.6	156.7	155.5	17.7	18.4	23.3	21.7	17.8	22.7	18.2	22.1	19.9	16.6	19.7	24.4	105.4	67.3	81.8	40.5	108.3	70.1	96.7	55.6	92.2	53.1	76.8	90.9	103.6	32.9	66.4	29.5	83.4	61.2	121.0	179.4	15.6	52.2	62.3	141.4	152.5	86.1	50.3	63.1	67.0	48.6	74.4	101.1	136.6	224.3	110.8	75.0	58.5	70.0	73.2	50.5	68.1	121.2	32.6	98.9	133.2	27.0	57.8	125.4	56.9	41.2	63.7	63.8	47.4	66.9	75.2	66.8	109.3	43.2	93.8	83.7	156.5	47.3	70.1	65.7	72.3	156.6	94.5	143.4	57.4	92.5	64.9	94.8	122.1	102.2	104.4	75.0
YRDC	"FLJ23476, IRIP, SUA5"	ENSG00000196449	"YrdC N6-threonylcarbamoyltransferase domain containing"	Q86U90	1	37802945-37808208	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 50.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 77.8;Prostatic glandular cells: 87.8;Urothelial cells: 92.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	8	"basophil: 8.8"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 8.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030147	Approved		Approved	Mitochondria		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Mitochondria		"HPA030147: AB_10603327"	"unprognostic (2.98e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (1.83e-6)"	"unprognostic (5.43e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.10e-1)"	"unprognostic (4.34e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.46e-2)"	12.4	11.1	8.2	9.8	8.2	50.1	11.2	9.5	9.8	6.6	7.9	9.8	8.2	7.5	8.0	16.1	8.0	8.6	7.8	8.2	8.8	10.5	14.1	8.9	10.5	8.3	8.3	7.2	14.1	10.8	10.6	13.3	8.8	8.6	11.9	8.1	9.7	6.0	8.6	16.0	8.6	9.4	7.9	9.2	10.6	16.9	8.8	8.3	9.1	5.7	10.9	16.4	9.7	8.0	25.2	17.6	18.7	23.9	12.7	14.6	53.6	20.3	16.5	31.5	19.9	23.7	23.3	60.3	32.6	20.4	36.1	20.0	35.6	32.8	29.2	36.3	35.1	42.1	21.3	24.9	27.9	55.5	41.7	15.2	48.1	35.0	50.3	20.6	22.5	45.7	66.5	26.4	25.4	17.6	32.7	32.4	70.2	36.3	37.1	32.3	30.1	39.3	26.1	25.2	48.5	49.7	22.0	28.0	72.8	33.2	15.3	24.2	20.9	26.8	28.3	29.6	67.8	53.2	81.2	50.3	23.6	35.4	43.8	8.8	0.6	0.5	0.6	0.6	0.6	0.5	0.9	0.5	0.5	0.8	1.0	1.0	0.7	0.5	0.4	0.9	1.0	0.4	8.2	8.2	9.5	9.8	8.2	8.8	8.3	8.3	8.8	7.9	8.8	8.0	31.3	0.0	9.2	3.9	21.0	50.6	77.8	6.3	29.6	10.8	28.3	25.9	3.6	10.0	5.5	5.5	6.2	24.3	23.6	7.6	23.5	7.7	3.5	16.2	15.7	22.5	15.6	17.2	3.5	9.2	48.5	14.4	10.2	25.4	7.0	13.0	10.8	12.5	12.7	21.9	3.8	10.2	4.1	9.4	19.1	1.8	4.1	15.3	5.4	3.7	6.3	10.9	4.1	3.0	5.0	15.9	7.1	4.1	25.6	87.8	6.1	16.8	4.9	8.8	6.6	12.5	22.0	19.4	37.4	28.6	49.3	40.6	20.2	14.2	11.7	92.7
YTHDC1	"KIAA1966, YT521, YT521-B"	ENSG00000083896	"YTH domain containing 1"	Q96MU7	4	68310387-68350090	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036462	Supported		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Plasma membrane"	"HPA036462: AB_10669793"	"unprognostic (1.02e-1)"	"unprognostic (8.44e-3)"	"unprognostic (5.74e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.52e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.05e-1)"	"prognostic favorable (7.29e-5)"	43.0	27.0	22.4	19.5	26.5	116.6	43.8	31.9	25.0	52.6	18.6	40.0	15.6	43.6	22.7	48.0	42.3	15.3	34.1	20.9	26.0	38.2	33.1	40.6	28.4	23.6	23.6	68.6	44.5	20.3	41.2	23.8	24.8	37.9	19.6	38.5	42.1	17.6	47.2	51.3	40.5	17.2	23.2	41.9	36.3	31.3	23.1	30.3	42.1	16.7	26.7	37.3	50.5	32.7	31.8	18.4	37.1	22.2	21.7	18.8	30.4	33.8	21.3	20.6	21.5	22.9	27.9	50.8	27.0	17.2	16.7	23.3	35.1	29.4	33.1	38.2	21.3	38.8	27.3	25.6	22.1	41.5	29.0	17.8	31.3	18.5	44.0	26.6	22.6	24.7	37.5	29.0	30.7	23.9	48.9	37.1	27.6	30.4	18.0	42.4	41.6	22.8	32.6	35.6	31.9	24.8	29.5	31.5	25.9	34.3	24.6	28.8	24.1	23.5	24.9	16.4	22.5	30.1	21.8	53.7	15.9	26.6	22.0	69.3	20.3	40.4	24.1	12.7	19.0	36.1	19.6	19.8	12.2	44.8	26.9	22.9	105.4	20.8	27.0	39.3	20.3	9.7	22.4	26.5	31.9	25.0	20.9	26.0	23.6	23.6	24.8	23.2	23.1	32.7	104.6	112.2	129.5	54.9	104.7	119.9	103.6	76.2	88.8	105.8	112.8	107.2	92.6	85.8	125.1	73.5	70.9	73.6	136.8	58.1	52.8	70.2	98.5	131.9	135.3	92.2	85.8	74.7	43.8	57.2	124.8	81.3	54.0	254.8	94.7	86.2	63.5	85.6	43.2	90.9	49.4	77.9	63.1	61.0	75.9	22.0	74.6	84.5	64.0	56.2	67.0	99.2	96.8	59.3	110.1	81.6	56.0	67.7	103.2	121.6	42.0	44.0	113.2	138.4	52.6	122.0	98.8	139.2	95.9	127.1	134.5	119.0	122.0	59.5	66.9	119.8
YTHDC2	"DKFZp564A186, FLJ10053, FLJ2194"	ENSG00000047188	"YTH domain containing 2"	Q9H6S0	5	113513694-113595285	"Enzymes, Predicted intracellular proteins"	"Differentiation, Meiosis, Oogenesis, Spermatogenesis"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 129.8;Inhibitory neurons: 146.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037364, HPA072678"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytoplasmic bodies"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytoplasmic bodies"	"HPA037364: AB_10672788, HPA072678: AB_2686548"	"unprognostic (2.09e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (1.82e-5)"	"unprognostic (4.33e-3)"	"unprognostic (1.45e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.96e-1)"	"unprognostic (7.82e-3)"	"unprognostic (3.55e-2)"	"unprognostic (8.56e-3)"	"unprognostic (4.61e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.15e-2)"	"unprognostic (3.05e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.56e-2)"	8.4	9.7	5.2	11.3	5.8	9.9	10.1	8.8	6.6	8.9	7.8	8.7	9.3	9.2	8.6	9.4	8.3	8.0	7.6	6.1	5.1	8.5	12.6	7.4	13.8	5.3	5.8	11.0	8.7	15.5	8.7	6.9	5.3	8.1	10.0	18.3	8.9	7.4	11.5	11.3	10.1	7.9	5.1	11.4	9.2	14.8	4.7	10.2	9.2	10.9	12.9	9.8	8.9	7.1	16.0	14.2	18.1	30.7	9.8	12.9	19.7	12.1	13.4	15.2	23.6	10.0	8.8	29.1	8.5	10.2	19.5	15.3	22.0	27.2	19.8	12.6	19.9	15.8	25.8	13.6	14.5	12.8	13.4	10.6	10.3	9.6	17.4	14.3	21.5	13.0	15.8	13.0	13.6	5.3	17.8	9.1	8.4	4.7	9.2	7.4	15.6	22.7	12.7	20.9	14.4	12.0	16.3	11.7	12.7	11.3	16.6	11.4	18.8	23.2	8.1	12.1	16.7	13.3	18.0	18.0	13.3	14.4	10.1	0.0	2.8	2.9	2.8	1.9	3.3	7.3	3.2	3.0	2.4	5.1	3.4	2.9	1.0	4.3	3.3	3.6	2.6	1.2	5.2	5.8	8.8	6.6	6.1	5.1	5.3	5.8	5.3	5.1	4.7	7.1	27.4	28.9	32.8	61.0	39.6	13.3	21.8	14.7	15.9	59.9	17.6	17.7	17.7	14.3	25.3	12.9	83.4	13.7	34.0	12.3	0.0	17.8	47.5	15.5	24.5	24.0	7.2	16.6	129.8	18.6	8.3	22.4	34.1	17.2	12.6	69.0	20.0	25.7	17.3	52.2	146.3	14.2	20.3	30.0	13.2	44.2	19.9	26.8	12.4	95.5	23.9	21.4	16.5	94.5	97.6	18.0	7.8	14.7	20.0	14.4	16.0	17.8	24.9	88.9	26.3	34.0	26.6	93.8	37.8	19.2	14.3	18.1	33.0	33.4	16.7	18.5
YTHDF2	"CAHL, HGRG8, NY-REN-2"	ENSG00000198492	"YTH N6-methyladenosine RNA binding protein 2"	Q9Y5A9	1	28736621-28769775	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Host-virus interaction, Immunity, Innate immunity, Mitosis, Oogenesis, Spermatogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030063, HPA054080, HPA059621"	Approved		Enhanced	"Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Cytoplasmic bodies"	"HPA030063: AB_2732453, HPA054080: AB_2682371, HPA059621: AB_2684084"	"unprognostic (8.75e-2)"	"unprognostic (1.90e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (6.14e-9)"	"unprognostic (1.75e-2)"	"unprognostic (4.82e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.38e-2)"	"unprognostic (9.29e-2)"	"unprognostic (6.97e-3)"	33.5	33.0	20.0	26.7	21.0	63.9	38.3	22.1	24.8	27.5	29.5	32.0	29.4	27.8	43.6	37.5	27.7	27.0	27.0	21.3	22.5	31.8	42.2	35.6	35.6	20.2	19.6	29.3	27.4	37.1	18.0	34.4	20.6	22.9	33.8	20.2	39.8	23.9	43.9	41.9	26.2	32.9	21.4	32.1	27.6	29.3	21.2	44.1	28.0	33.7	43.8	32.8	26.1	23.1	68.8	46.3	99.6	96.8	75.5	58.1	117.8	66.1	80.7	80.0	80.4	42.8	78.1	117.8	64.4	84.4	47.8	62.2	117.3	105.7	94.0	76.0	91.9	98.7	60.7	78.4	90.0	105.1	74.4	78.5	106.4	86.1	121.1	70.0	99.0	70.0	101.9	55.6	89.7	53.3	112.1	80.8	161.8	61.1	61.1	95.4	74.2	96.8	111.3	95.8	85.7	91.2	68.6	102.1	181.7	82.6	67.8	95.8	69.4	55.4	57.8	52.5	93.5	68.2	47.7	133.3	63.3	81.2	89.9	108.3	78.4	78.7	66.1	91.1	88.3	80.3	72.7	80.3	96.7	59.0	77.9	73.2	26.5	92.4	94.4	62.6	92.3	109.5	20.0	21.0	22.1	24.8	21.3	22.5	20.2	19.6	20.6	21.4	21.2	23.1	70.8	51.3	61.2	13.7	70.8	152.7	104.9	111.0	109.8	45.4	110.2	101.3	52.8	77.2	85.3	44.1	31.3	149.6	79.5	46.4	66.5	102.0	16.3	65.8	78.2	78.5	75.7	52.8	22.5	69.6	108.3	64.5	49.5	76.6	72.3	63.6	77.4	102.3	77.3	58.9	20.4	76.0	105.8	65.4	75.4	19.3	71.1	56.7	37.4	21.5	74.1	66.4	73.2	14.1	23.5	80.7	43.8	75.2	71.0	78.6	42.4	96.0	53.8	45.9	92.1	61.5	83.0	142.2	115.5	95.3	161.7	260.2	69.2	69.5	65.9	118.7
YWHAE	FLJ45465	ENSG00000108953	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon"	P62258	17	1344275-1400222	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA008445, CAB016200, CAB021109, CAB047350"	Approved		Supported	Cytosol		NA	NA		83000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB016200: AB_626619, CAB021109: AB_10060396, CAB047350: , HPA008445: AB_1844336"	"unprognostic (1.29e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.99e-2)"	"prognostic favorable (6.48e-6)"	"unprognostic (1.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.73e-2)"	"unprognostic (4.77e-3)"	"unprognostic (4.53e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.92e-3)"	"unprognostic (8.33e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.24e-2)"	"unprognostic (8.94e-2)"	221.9	198.9	251.8	122.8	264.2	121.3	198.7	266.3	272.8	168.8	195.7	161.1	136.8	155.6	192.7	239.1	188.1	103.7	242.3	260.7	275.4	229.3	211.7	176.9	113.7	271.1	246.8	170.8	154.9	236.9	178.8	198.2	267.1	150.0	168.1	220.8	184.8	121.6	656.7	193.3	129.3	137.3	279.2	101.5	136.9	165.4	262.2	211.0	208.5	441.8	164.5	186.9	179.7	302.7	615.3	565.8	700.2	563.4	376.9	454.7	589.8	382.1	481.5	724.5	571.3	907.5	305.5	524.7	411.9	621.9	439.7	463.1	859.2	745.6	798.7	294.2	930.9	334.1	366.2	409.4	483.4	277.1	311.1	421.6	458.6	619.3	897.0	520.6	729.2	458.5	402.8	337.9	719.7	368.5	445.8	264.1	566.6	596.9	332.7	477.3	255.9	380.4	547.7	365.7	354.2	497.2	531.1	240.3	364.3	439.9	442.3	290.9	467.4	411.9	293.8	453.7	731.4	190.5	329.9	346.6	478.4	387.5	585.4	78.6	137.2	41.2	47.3	153.6	57.8	78.1	67.3	55.1	180.3	59.1	55.7	51.2	49.9	64.1	144.8	133.8	99.7	151.0	251.8	264.2	266.3	272.8	260.7	275.4	271.1	246.8	267.1	279.2	262.2	302.7	363.6	298.1	194.4	83.2	161.1	573.9	457.5	468.4	281.7	153.6	313.6	219.1	473.4	265.9	310.9	371.5	50.1	463.2	128.7	300.7	745.4	460.8	258.0	573.6	414.3	352.6	352.6	244.7	73.4	421.4	709.5	319.4	194.7	502.7	211.5	328.1	262.3	309.0	384.9	111.0	72.4	346.3	376.4	260.9	434.9	434.3	280.8	227.5	425.2	60.0	320.5	357.8	55.6	56.8	112.1	464.8	289.8	294.9	279.5	487.9	272.1	707.8	504.6	173.3	243.3	361.2	524.6	508.7	573.3	333.8	586.6	519.5	130.7	287.2	361.1	474.4
YWHAG	"14-3-3γ, 14-3-3GAMMA, PPP1R170"	ENSG00000170027	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma"	P61981	7	76326799-76358991	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 337.4;skeletal muscle: 349.8"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 408.8;Suprabasal keratinocytes: 425.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013274, CAB018389, HPA026918"	Approved	Approved	Approved	Cytosol		NA	NA		66000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 28: Keratinocytes - Keratinization"	Cytosol		"CAB013274: , CAB018389: AB_2217962, HPA026918: AB_10610566"	"unprognostic (3.71e-2)"	"prognostic unfavorable (4.53e-4)"	"unprognostic (3.88e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.40e-3)"	"unprognostic (8.98e-3)"	"prognostic unfavorable (5.34e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (7.44e-4)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (9.31e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.70e-1)"	188.1	99.2	165.6	60.6	185.3	27.3	61.0	80.2	337.4	41.1	8.5	48.4	47.8	50.9	20.8	64.5	37.9	54.5	111.4	206.5	206.1	50.8	72.4	47.1	43.2	204.5	120.7	40.7	59.7	50.1	32.6	55.4	192.9	46.1	44.0	87.2	39.9	40.0	349.8	43.7	41.6	66.4	81.5	44.2	38.2	28.9	135.1	40.2	29.7	238.4	48.6	78.8	46.3	199.1	189.0	231.9	200.5	256.7	200.5	114.9	90.5	213.3	105.0	129.6	139.5	147.0	196.7	263.5	71.7	190.8	215.2	171.6	254.3	235.8	180.5	179.9	110.9	250.2	150.0	164.5	182.6	309.0	234.0	127.1	221.0	151.5	310.8	137.3	208.9	140.2	349.9	289.0	195.8	177.6	222.3	227.1	223.0	150.7	160.4	256.3	203.0	291.7	204.5	126.3	107.0	297.1	236.7	299.2	156.0	256.9	208.5	184.2	222.6	250.7	145.7	225.4	290.1	95.1	191.6	399.5	225.5	285.3	273.8	1.5	2.3	0.5	0.8	2.0	1.4	1.3	1.0	1.1	2.4	0.7	0.7	0.9	0.5	0.5	1.8	2.6	0.9	0.9	165.6	185.3	80.2	337.4	206.5	206.1	204.5	120.7	192.9	81.5	135.1	199.1	73.7	32.1	26.4	23.2	51.8	408.8	128.3	87.9	126.9	102.9	107.0	70.1	234.0	40.0	55.1	38.6	12.5	36.5	39.3	49.9	37.2	52.4	91.2	96.0	82.9	92.0	85.4	72.8	99.9	38.2	84.1	97.4	61.2	127.9	67.3	38.7	50.0	93.1	83.5	124.5	78.5	35.7	44.7	90.3	229.0	25.2	46.3	87.8	94.3	40.3	64.2	27.1	20.6	23.1	57.1	71.1	29.9	43.2	56.6	129.8	34.1	61.3	47.2	35.3	32.9	92.5	91.5	13.4	19.0	160.1	425.4	67.2	41.5	46.4	45.1	177.1
YY1	"DELTA, INO80S, NF-E1, UCRBP, YIN-YANG-1"	ENSG00000100811	"YY1 transcription factor"	P25490	14	100238298-100282788	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, DNA damage, DNA recombination, DNA repair, Spermatogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001119, CAB009392"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center, Vesicles"	"CAB009392: AB_2218501, HPA001119: AB_1858930"	"unprognostic (7.67e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (6.75e-3)"	"unprognostic (8.31e-3)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.68e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.72e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.30e-1)"	27.2	26.2	20.9	28.9	22.1	56.4	27.0	27.0	24.2	24.6	18.5	30.7	27.9	24.8	34.0	28.9	21.7	22.7	22.8	22.7	20.2	32.9	46.8	24.0	36.0	20.4	20.4	21.6	24.4	32.5	17.4	34.2	20.3	25.2	28.7	20.1	25.1	23.6	36.8	29.0	29.7	24.8	20.1	31.9	26.2	23.8	21.5	52.3	37.2	27.2	38.2	31.9	21.0	26.2	62.0	30.7	64.2	51.5	51.8	65.9	68.1	60.0	55.1	64.7	66.0	38.6	97.7	94.0	82.3	54.5	37.1	64.0	72.6	64.1	88.3	70.8	60.9	86.8	34.6	50.0	48.4	103.8	73.2	38.7	76.4	45.4	61.4	58.6	63.9	67.3	69.9	61.8	63.7	74.5	113.5	61.8	68.7	98.0	56.0	93.9	88.9	50.7	75.8	58.3	68.2	53.3	79.2	57.8	85.1	54.0	86.6	100.1	57.4	39.4	48.3	97.6	53.8	68.3	72.0	126.6	56.4	68.6	52.5	4.8	5.7	11.9	4.3	4.8	5.6	5.3	5.7	5.9	4.9	8.3	5.4	5.4	9.8	9.5	3.8	5.3	7.7	2.7	20.9	22.1	27.0	24.2	22.7	20.2	20.4	20.4	20.3	20.1	21.5	26.2	116.0	54.5	66.8	23.8	102.4	238.0	101.1	49.9	211.7	80.5	129.8	98.2	91.5	92.9	50.0	68.0	81.3	118.6	147.4	122.8	72.4	68.7	10.3	118.7	133.8	115.7	110.1	125.4	28.2	82.0	123.6	106.7	58.1	153.6	71.7	99.4	103.5	119.4	81.3	127.9	26.5	108.8	48.8	111.8	225.8	15.7	94.8	121.6	76.5	30.0	117.8	82.0	114.4	20.6	40.7	80.0	95.5	100.8	125.0	168.9	90.0	104.6	47.6	74.9	92.1	106.5	124.3	86.0	67.0	192.1	243.1	175.5	124.8	124.1	118.7	153.5
ZBED4	KIAA0637	ENSG00000100426	"Zinc finger BED-type containing 4"	O75132	22	49853844-49890080	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045341	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA045341: AB_2679295"	"unprognostic (3.82e-2)"	"unprognostic (6.39e-2)"	"unprognostic (7.22e-3)"	"unprognostic (4.43e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.74e-3)"	"unprognostic (9.44e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.53e-2)"	"unprognostic (5.20e-2)"	3.6	2.6	2.3	5.3	2.1	11.0	3.4	5.6	2.3	3.1	1.3	5.7	5.3	3.5	2.7	6.5	3.3	3.5	3.3	2.2	1.6	3.7	4.7	4.2	6.6	2.2	1.9	3.6	5.3	3.0	3.3	3.9	2.1	3.4	4.8	4.7	3.8	2.1	4.5	5.0	5.3	3.2	1.2	5.1	4.5	3.8	2.2	10.9	3.3	3.2	5.5	4.0	3.5	4.0	14.9	13.1	24.5	19.5	7.4	8.1	15.2	8.6	7.1	9.3	8.6	13.5	6.5	29.3	5.9	9.2	9.7	16.7	17.4	11.1	9.9	11.6	21.2	16.8	13.2	12.8	10.7	36.0	23.2	7.6	16.5	10.2	15.4	9.3	12.6	28.0	18.2	13.7	11.1	11.9	30.0	17.1	13.4	12.9	9.1	35.5	22.1	17.8	9.9	14.9	12.9	25.7	8.5	24.9	17.3	15.2	11.8	20.3	14.7	12.7	19.9	7.5	12.3	13.5	9.0	26.5	7.7	15.9	15.2	0.4	0.4	0.7	0.8	0.6	1.6	0.6	0.8	0.9	1.0	0.4	1.0	0.8	0.2	2.9	0.6	1.0	0.6	0.6	2.3	2.1	5.6	2.3	2.2	1.6	2.2	1.9	2.1	1.2	2.2	4.0	4.9	0.0	6.5	11.4	7.2	5.1	5.1	5.0	4.0	7.9	6.3	6.1	7.2	7.2	8.6	5.5	14.6	3.6	23.5	8.7	3.9	9.2	4.8	10.0	10.1	6.6	12.6	12.8	14.7	7.1	6.4	5.1	7.7	10.1	0.0	10.1	5.3	6.9	6.8	13.5	14.7	9.5	4.1	12.6	5.2	4.6	3.1	7.3	0.0	16.9	8.5	2.5	16.5	12.1	16.6	13.3	8.5	4.1	12.5	9.2	3.8	2.9	6.2	9.9	6.6	5.8	7.1	4.8	6.4	6.7	3.8	3.3	17.2	7.4	11.0	6.8
ZBTB2	"bA351K16.2, KIAA1483, ZNF437"	ENSG00000181472	"Zinc finger and BTB domain containing 2"	Q8N680	6	151364115-151391559	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 42.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023136, HPA023137, HPA023458, HPA023487"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"HPA023136: AB_1858941, HPA023137: AB_1858942, HPA023458: AB_1858944, HPA023487: AB_1858945"	"unprognostic (1.13e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.42e-2)"	"unprognostic (8.36e-3)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (6.36e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.72e-2)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (9.36e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.44e-3)"	"unprognostic (7.73e-2)"	8.4	4.8	4.8	8.5	5.1	16.1	8.5	6.0	6.3	6.9	4.5	8.0	7.5	8.5	6.9	5.9	7.7	7.9	6.0	5.2	5.1	6.9	9.4	9.7	14.4	5.4	5.3	13.3	8.3	7.1	3.0	8.7	5.4	6.1	9.0	3.2	7.1	5.9	9.1	6.9	8.2	9.4	5.0	9.3	7.4	6.7	5.2	20.8	29.7	9.7	12.6	11.0	5.4	6.6	15.3	10.9	16.3	12.4	17.1	17.9	17.4	23.6	33.9	29.2	27.7	21.1	12.2	38.9	12.8	23.9	29.5	17.8	26.5	28.7	36.1	17.7	19.7	17.5	12.6	32.2	25.3	47.9	20.8	19.0	16.9	26.8	32.6	16.6	17.4	18.1	32.5	22.2	20.8	34.2	26.1	22.3	19.8	18.8	16.4	24.6	15.4	15.6	22.2	22.7	18.1	12.6	18.6	24.2	18.8	16.3	16.3	28.4	14.4	24.5	26.8	11.3	31.8	29.4	32.9	43.2	10.1	25.7	17.8	18.7	6.5	16.8	11.3	7.1	14.2	6.3	10.2	13.5	7.1	4.5	8.4	10.4	7.3	8.9	12.9	2.9	9.2	7.1	4.8	5.1	6.0	6.3	5.2	5.1	5.4	5.3	5.4	5.0	5.2	6.6	13.3	9.6	4.6	4.6	13.2	15.7	11.4	5.8	42.7	3.0	14.4	7.4	8.8	5.7	9.1	0.0	0.0	5.9	18.0	4.6	13.7	4.8	9.4	18.7	14.2	12.7	9.0	8.2	5.6	2.9	19.6	9.9	6.6	29.5	9.5	4.9	5.7	3.3	7.5	1.7	4.4	6.3	18.3	8.8	17.4	10.5	8.7	10.8	10.6	1.0	4.4	3.1	12.3	5.5	11.1	5.0	2.0	4.1	11.1	14.8	5.8	5.3	7.1	2.3	6.6	6.2	10.8	4.1	6.7	23.8	18.3	12.4	16.3	3.7	7.3	9.6
ZBTB37	"MGC2629, ZNF908"	ENSG00000185278	"Zinc finger and BTB domain containing 37"	Q5TC79	1	173868082-173903549	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 12.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 60.2;Late spermatids: 67.0;Rod photoreceptor cells: 60.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023438	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA023438: AB_1858954"	"unprognostic (1.18e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.66e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.57e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.72e-2)"	"unprognostic (9.53e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.96e-2)"	3.0	1.6	4.6	2.6	7.5	5.7	2.6	6.3	4.6	2.8	2.1	1.9	1.8	2.1	2.3	1.4	2.1	1.6	2.0	4.4	4.6	2.2	2.1	2.7	3.8	8.6	6.3	3.3	2.0	1.8	2.6	2.1	9.2	2.3	1.6	10.8	2.0	1.4	1.8	3.2	2.3	1.8	4.4	3.8	2.3	9.3	6.4	3.2	2.7	2.2	3.0	2.0	2.3	12.7	1.7	2.5	3.8	1.6	2.3	1.8	4.2	1.5	1.1	2.7	1.9	3.2	2.1	4.6	3.1	2.4	1.4	2.1	3.2	1.7	2.2	2.6	2.0	6.4	3.0	1.6	1.3	3.8	3.9	1.7	1.1	4.0	2.6	1.6	1.4	3.2	5.7	3.0	2.8	1.2	2.6	0.9	3.6	1.3	0.6	1.7	3.3	1.5	1.5	4.2	2.8	3.5	2.1	2.9	2.8	4.0	4.2	3.9	2.5	3.5	3.7	1.7	2.4	5.3	4.2	7.3	2.3	2.1	2.1	0.1	0.4	1.4	1.1	0.4	0.4	0.2	0.5	0.7	0.2	0.6	0.2	0.6	2.3	0.9	0.4	0.9	0.4	0.3	4.6	7.5	6.3	4.6	4.4	4.6	8.6	6.3	9.2	4.4	6.4	12.7	8.5	6.4	6.3	2.0	9.7	2.9	3.7	3.6	4.0	27.2	5.7	2.8	9.2	12.8	4.2	11.0	33.3	8.3	11.9	4.6	7.9	3.6	60.2	9.1	8.8	6.8	3.5	5.7	1.6	3.8	3.9	7.4	5.1	7.6	2.5	16.9	11.0	4.7	5.0	18.5	2.1	3.9	0.0	15.4	5.5	67.0	8.7	10.0	10.6	2.8	10.6	10.3	18.6	3.5	5.3	2.8	2.7	13.2	5.7	4.3	4.7	5.4	10.6	60.1	6.6	9.5	10.8	23.2	13.2	3.2	5.8	9.2	9.3	11.6	3.6	3.4
ZBTB4	"KAISO-L1, KIAA1538, ZNF903"	ENSG00000174282	"Zinc finger and BTB domain containing 4"	Q9P1Z0	17	7459366-7484263	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008980, HPA064763"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 56: Bipolar cells - Visual perception"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"CAB008980: , HPA064763: AB_2685347"	"unprognostic (2.23e-1)"	"unprognostic (3.95e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.92e-2)"	"unprognostic (5.32e-2)"	"unprognostic (7.62e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.63e-3)"	"prognostic favorable (2.53e-4)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.65e-9)"	"unprognostic (1.10e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.04e-3)"	34.8	36.1	22.1	7.4	20.6	3.0	31.4	19.9	23.1	41.9	11.7	47.2	6.3	40.3	16.2	26.4	40.5	9.6	38.8	21.2	21.0	24.1	7.8	30.0	8.3	27.1	21.7	48.4	23.1	36.1	28.6	10.8	27.0	33.1	6.6	23.1	28.0	21.4	32.4	27.2	23.0	16.4	19.7	22.1	27.3	15.9	23.3	9.5	43.9	14.8	9.0	42.3	33.9	21.5	10.7	14.4	3.6	6.9	37.1	19.1	6.5	14.7	21.0	13.0	12.9	4.8	5.1	1.1	11.4	28.0	9.5	16.7	3.6	20.6	9.5	17.0	6.2	5.3	12.3	3.4	10.4	1.0	12.2	13.4	21.1	12.5	15.9	30.6	11.5	4.0	1.8	3.4	14.5	7.1	3.7	2.2	1.5	4.3	6.8	6.8	6.2	1.6	15.9	8.9	2.1	5.3	6.5	4.6	6.9	6.3	8.6	2.4	16.1	14.6	5.7	13.9	12.3	6.1	4.5	0.7	15.7	3.3	7.7	0.4	0.3	0.5	1.0	0.5	1.0	0.5	0.8	0.8	0.2	0.5	1.0	1.0	0.2	0.6	1.7	0.4	0.4	0.6	22.1	20.6	19.9	23.1	21.2	21.0	27.1	21.7	27.0	19.7	23.3	21.5	27.4	51.3	53.1	33.6	14.6	30.7	16.3	18.4	18.8	86.6	23.6	20.6	92.6	20.0	24.8	20.2	68.8	10.3	24.5	4.6	3.9	14.4	40.8	21.1	25.2	26.1	17.4	9.5	36.9	14.4	2.2	24.8	7.1	26.0	13.9	25.7	23.9	8.1	13.5	74.0	37.3	10.1	14.2	30.0	34.6	57.0	51.9	18.6	17.8	15.9	12.0	27.0	24.7	21.6	26.7	19.0	5.3	70.0	9.5	16.2	8.2	11.2	32.2	39.9	32.9	37.8	27.4	7.3	4.3	17.3	23.4	5.2	21.1	16.3	9.0	14.7
ZBTB5	KIAA0354	ENSG00000168795	"Zinc finger and BTB domain containing 5"	O15062	9	37438102-37465450	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021521	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Nuclear bodies"	"Golgi apparatus"	"HPA021521: AB_2670736"	"unprognostic (2.36e-2)"	"unprognostic (2.78e-2)"	"unprognostic (5.22e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.96e-3)"	"unprognostic (5.81e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.27e-3)"	"unprognostic (5.73e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.80e-1)"	4.9	6.2	4.9	5.6	5.8	13.6	7.4	5.9	5.0	6.3	5.0	6.1	6.3	6.3	7.7	17.8	5.9	5.4	5.5	4.7	5.0	7.4	12.9	7.9	9.0	5.7	5.3	8.4	8.4	7.6	4.7	6.2	5.5	7.2	5.8	9.2	7.8	6.7	5.2	11.9	7.2	5.3	5.0	7.2	7.2	8.8	5.2	9.5	10.3	7.2	12.1	5.6	9.3	7.8	9.3	10.5	26.6	16.6	6.7	4.7	11.4	7.5	5.8	9.0	7.4	7.8	6.7	18.8	7.9	5.6	6.6	11.1	17.5	6.2	6.9	13.9	9.1	6.9	28.7	9.1	6.5	8.6	5.8	4.5	15.5	4.5	9.5	10.2	10.2	14.8	16.6	15.6	6.8	5.9	18.2	6.3	6.8	10.0	5.3	16.3	12.8	7.2	8.7	8.2	12.2	21.9	7.3	11.7	5.8	13.3	18.7	8.3	7.0	6.3	17.3	3.7	7.2	8.3	9.8	16.3	5.8	7.3	6.8	0.1	0.4	0.0	0.6	0.2	0.7	0.9	0.5	0.5	0.8	0.7	0.8	0.9	0.0	0.3	0.0	0.2	0.5	0.3	4.9	5.8	5.9	5.0	4.7	5.0	5.7	5.3	5.5	5.0	5.2	7.8	4.0	16.0	6.5	12.7	5.1	14.3	8.8	5.0	11.4	2.0	8.4	6.6	3.2	7.2	9.3	1.8	6.2	3.9	3.7	6.5	0.0	4.0	2.2	7.3	4.2	5.6	8.4	2.1	8.9	3.2	2.2	4.2	5.1	7.3	1.3	6.6	3.6	8.6	2.4	13.5	9.1	5.2	4.1	1.9	4.8	5.3	4.1	3.4	3.6	10.3	3.7	3.3	1.0	13.6	15.5	4.1	3.7	3.8	4.2	12.6	3.1	3.5	6.0	5.1	0.0	5.4	4.0	7.5	7.9	17.9	18.2	5.7	2.7	4.4	5.1	8.2
ZC3H10	"FLJ14451, ZC3HDC10"	ENSG00000135482	"Zinc finger CCCH-type containing 10"	Q96K80	12	56118260-56127514	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 47.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039236, HPA062265"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Vesicles		"HPA039236: AB_10795463, HPA062265: AB_2684730"	"unprognostic (1.19e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.97e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.31e-5)"	"unprognostic (4.42e-2)"	"unprognostic (2.69e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.21e-1)"	2.8	3.1	1.9	3.0	2.8	1.4	2.5	3.4	2.4	3.8	1.1	3.6	1.6	3.9	2.2	1.9	3.3	1.7	2.5	1.9	2.1	2.3	2.9	2.4	2.9	2.9	2.5	4.1	3.6	2.5	2.4	2.0	2.7	2.6	1.3	4.0	2.8	2.4	5.0	2.4	2.3	2.0	2.1	3.9	2.4	8.7	2.7	2.9	2.6	3.1	2.2	3.3	2.6	4.0	3.3	5.8	4.6	3.6	5.5	3.7	3.5	3.9	2.6	2.3	1.8	1.6	1.9	3.7	6.3	2.8	1.3	4.4	2.4	1.4	1.5	6.3	6.1	5.5	5.8	1.7	3.4	5.4	3.3	2.4	3.1	2.7	3.1	4.3	3.5	4.2	2.9	6.5	3.1	2.4	5.6	2.1	3.1	1.9	4.7	5.5	5.0	3.4	1.9	1.6	4.4	4.3	2.3	3.4	3.5	3.4	5.6	4.5	5.0	2.2	5.1	4.3	2.9	5.4	3.7	2.0	2.9	2.4	5.4	3.6	5.0	5.9	4.7	6.0	4.9	3.6	3.7	4.1	5.3	3.9	3.7	3.6	3.6	8.0	10.5	2.4	2.0	3.7	1.9	2.8	3.4	2.4	1.9	2.1	2.9	2.5	2.7	2.1	2.7	4.0	4.2	0.0	4.2	1.3	5.6	0.8	2.5	1.3	1.8	9.0	3.2	2.2	3.0	5.7	0.8	7.3	20.9	6.3	5.9	7.1	15.6	5.3	47.6	2.2	4.3	5.1	1.2	5.2	0.6	3.0	2.7	3.3	1.1	2.6	2.5	5.9	6.8	3.0	5.3	13.5	0.9	3.8	2.0	7.4	1.6	9.5	5.3	4.0	3.6	1.0	10.6	9.2	9.2	0.0	1.5	3.3	2.3	5.3	1.6	2.3	6.0	4.7	2.7	17.3	0.0	6.2	5.3	16.2	15.5	1.9	1.7	6.4	3.2	5.1	3.9	1.4
ZC3H15	LEREPO4	ENSG00000065548	"Zinc finger CCCH-type containing 15"	Q8WU90	2	186486253-186509361	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031099, HPA031100, HPA031101"	Enhanced		Enhanced	Cytosol		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA031099: AB_10599418, HPA031100: AB_2257403, HPA031101: AB_10611669"	"unprognostic (1.51e-1)"	"prognostic unfavorable (6.45e-5)"	"unprognostic (2.24e-1)"	"unprognostic (3.11e-3)"	"unprognostic (5.92e-2)"	"unprognostic (8.15e-2)"	"prognostic unfavorable (1.48e-7)"	"unprognostic (9.08e-3)"	"unprognostic (4.95e-2)"	"prognostic favorable (3.98e-4)"	"prognostic unfavorable (9.75e-4)"	"unprognostic (5.72e-3)"	"unprognostic (5.69e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.89e-2)"	"unprognostic (3.45e-2)"	42.6	47.5	39.2	44.3	42.0	128.8	45.9	43.4	52.5	35.1	38.6	40.8	48.3	39.8	47.0	40.2	26.3	36.5	37.0	42.6	44.5	53.8	67.3	28.4	53.9	42.2	40.9	32.6	47.9	41.2	27.2	48.8	41.7	37.0	46.0	53.0	45.3	32.4	50.3	44.3	46.1	36.9	39.4	38.6	36.8	40.6	41.7	50.2	49.3	44.9	51.4	54.0	29.2	42.4	103.5	68.9	83.3	107.8	93.0	93.4	124.9	112.7	76.7	102.3	91.5	202.9	81.8	140.3	100.2	80.9	130.9	73.6	155.8	137.5	144.0	128.7	118.1	201.9	101.1	221.9	124.9	208.7	118.6	77.2	149.6	111.4	157.2	89.9	111.9	86.0	197.0	106.8	108.4	93.5	133.7	146.5	157.6	135.7	171.8	105.2	113.0	131.6	127.6	124.0	100.3	73.6	71.5	96.4	167.3	124.3	68.1	149.7	95.7	114.7	99.1	70.9	136.4	92.0	167.0	199.8	101.7	145.7	102.3	59.9	47.9	49.1	44.7	61.6	55.8	55.0	54.8	57.4	54.7	42.2	50.5	53.9	28.8	60.4	75.1	48.0	66.6	41.5	39.2	42.0	43.4	52.5	42.6	44.5	42.2	40.9	41.7	39.4	41.7	42.4	107.1	73.7	83.6	26.4	137.0	212.2	169.1	116.6	99.6	75.0	101.9	118.9	95.8	57.2	104.8	115.8	60.5	131.3	116.1	131.4	256.3	112.0	153.1	110.1	125.5	106.4	101.7	98.7	38.0	104.3	167.0	107.4	67.8	127.1	112.2	220.1	62.4	137.0	124.3	57.2	39.8	136.1	87.5	107.4	104.8	307.1	78.6	113.2	64.0	33.7	142.5	82.6	126.7	19.6	32.8	111.6	106.2	87.3	128.0	179.5	164.1	330.2	68.3	130.2	32.9	156.2	127.6	215.6	174.4	116.1	209.1	177.6	117.3	319.6	151.2	163.5
ZC3H18	NHN1	ENSG00000158545	"Zinc finger CCCH-type containing 18"	Q86VM9	16	88570403-88631964	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040847, HPA041327"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA040847: AB_10794865, HPA041327: AB_10795005"	"unprognostic (3.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (1.10e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.07e-3)"	"prognostic favorable (3.68e-4)"	"unprognostic (5.83e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.29e-2)"	"unprognostic (4.01e-1)"	14.1	11.0	10.7	18.7	11.3	25.5	13.6	14.4	14.2	14.3	5.7	16.1	14.9	17.4	4.3	14.5	14.2	8.8	14.3	10.6	11.4	10.9	12.0	13.1	18.4	10.1	9.6	14.1	13.7	12.3	10.1	11.9	9.2	11.5	8.1	9.0	13.6	8.2	22.8	15.3	15.6	10.1	7.5	17.4	14.5	25.3	10.2	19.1	13.1	10.1	12.3	15.3	13.7	12.1	45.3	59.6	42.6	42.8	20.7	17.7	68.3	44.5	24.1	40.8	18.5	58.8	38.3	55.1	36.9	21.1	27.3	53.0	40.3	33.7	25.6	32.5	51.2	36.6	29.2	50.6	26.2	28.5	30.7	16.1	25.2	43.3	20.8	16.9	25.5	37.8	101.4	17.8	20.4	87.4	91.6	50.5	66.7	35.3	35.5	111.0	29.3	40.4	18.5	28.3	44.9	38.7	85.2	23.5	25.2	24.8	53.3	38.1	35.1	43.6	45.2	32.0	45.5	39.5	67.2	130.8	38.6	65.7	47.0	2.3	2.0	2.0	2.5	2.3	2.8	2.3	2.4	2.7	1.9	1.9	2.1	1.7	3.4	3.1	5.4	2.8	3.3	2.1	10.7	11.3	14.4	14.2	10.6	11.4	10.1	9.6	9.2	7.5	10.2	12.1	24.9	28.9	24.2	11.1	29.6	16.8	17.0	11.1	13.1	26.6	13.8	14.4	10.2	20.0	23.9	16.5	35.5	24.1	45.6	30.1	7.9	16.5	76.2	21.9	28.7	21.3	25.0	28.6	12.0	16.6	22.1	18.7	22.4	32.1	20.8	26.6	16.4	12.9	18.2	28.6	11.9	18.5	10.2	20.1	21.1	10.0	21.8	30.5	14.2	12.2	23.9	18.1	46.4	7.1	15.7	17.5	21.7	17.0	35.5	20.5	20.3	8.4	13.1	44.0	6.6	28.8	19.5	41.4	37.5	19.6	22.3	25.2	39.2	25.1	24.7	16.6
ZC3H8	"Fliz1, ZC3HDC8"	ENSG00000144161	"Zinc finger CCCH-type containing 8"	Q8N5P1	2	112211529-112255136	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034803, HPA034804"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies"	"HPA034803: AB_2674338, HPA034804: AB_10670284"	"unprognostic (2.45e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.12e-6)"	"unprognostic (4.93e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.29e-3)"	"unprognostic (8.76e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.04e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (2.74e-2)"	"unprognostic (3.49e-2)"	"unprognostic (8.02e-3)"	"unprognostic (4.88e-3)"	3.6	3.9	4.7	5.7	4.8	6.2	8.0	6.5	6.2	5.4	3.1	4.6	5.2	4.6	4.4	8.6	5.1	2.6	8.6	5.0	4.7	5.7	5.9	2.9	8.5	4.5	4.1	6.0	9.0	11.2	6.6	3.7	4.5	5.6	6.0	5.9	7.1	3.9	11.0	7.6	4.6	4.4	4.0	6.1	4.4	9.0	4.1	9.1	7.2	11.0	8.6	4.9	6.1	4.8	22.1	10.5	13.2	13.7	7.4	8.0	20.6	6.8	5.8	9.5	7.9	25.3	8.3	45.6	12.4	4.8	13.3	13.1	19.4	13.7	12.5	16.2	9.0	30.3	11.8	12.9	11.7	28.6	13.4	10.0	27.0	18.4	28.4	7.0	7.2	27.3	39.2	12.2	7.5	14.6	31.0	25.7	12.2	23.1	29.2	21.2	22.5	18.8	8.7	9.7	19.8	15.4	12.9	13.7	29.9	11.5	10.9	15.1	9.6	12.3	15.9	8.8	17.4	21.9	27.9	44.4	8.8	23.4	4.9	2.7	2.5	0.8	4.0	2.0	8.4	5.9	4.2	4.3	2.5	6.1	7.1	5.9	1.4	7.2	2.6	4.1	4.7	2.4	4.7	4.8	6.5	6.2	5.0	4.7	4.5	4.1	4.5	4.0	4.1	4.8	15.5	9.6	15.2	17.0	35.6	12.6	18.2	16.6	30.7	50.2	28.7	28.6	35.4	12.8	22.8	7.3	41.7	18.1	38.7	13.4	27.4	15.2	30.9	25.5	28.0	15.4	14.9	19.8	35.8	18.6	16.8	16.4	12.2	15.1	35.4	20.2	13.6	11.3	11.4	38.7	46.2	27.4	22.4	15.7	7.8	40.6	22.1	13.7	1.8	12.2	18.1	16.1	43.3	41.2	27.8	19.5	11.3	20.3	14.3	21.2	12.7	24.3	17.4	53.5	13.1	20.9	16.2	60.9	39.0	34.3	17.8	14.2	31.6	24.4	24.0	12.5
ZC3HC1	NIPA	ENSG00000091732	"Zinc finger C3HC-type containing 1"	Q86WB0	7	130018287-130051451	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019089, HPA024023"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA019089: AB_1858976, HPA024023: AB_1858977"	"unprognostic (7.14e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (1.89e-1)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (1.02e-6)"	"unprognostic (2.11e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.53e-1)"	8.4	12.4	11.2	7.3	11.3	4.7	8.4	10.9	11.4	9.1	11.9	9.5	5.4	9.3	8.6	7.4	8.3	5.7	16.5	11.1	12.1	11.8	14.1	6.3	10.6	11.4	11.5	9.3	7.5	11.6	7.5	8.4	11.4	8.3	7.2	5.8	7.1	7.0	32.7	6.3	7.6	11.5	11.4	12.5	8.7	15.6	12.1	10.4	7.4	29.1	10.6	9.1	7.6	11.8	15.2	24.8	30.3	35.1	17.2	15.5	20.6	19.5	23.5	36.5	36.3	29.7	25.5	34.2	13.7	24.4	48.5	13.4	40.1	29.2	35.0	22.7	34.2	24.1	21.4	29.1	27.7	27.4	22.9	18.4	21.2	38.1	24.2	20.1	39.5	28.9	73.7	11.7	35.5	26.5	33.2	51.9	62.5	26.0	28.0	31.0	23.6	29.5	37.0	10.7	19.3	34.3	27.5	39.4	30.7	42.9	17.3	28.6	17.6	24.2	11.5	20.5	32.8	22.9	36.8	44.7	37.8	34.9	41.2	34.5	24.6	23.8	26.0	29.4	29.5	39.3	26.6	27.5	31.2	37.1	35.2	27.7	2.0	29.5	28.3	18.6	30.8	24.6	11.2	11.3	10.9	11.4	11.1	12.1	11.4	11.5	11.4	11.4	12.1	11.8	5.2	6.4	2.3	12.4	8.8	1.5	5.4	16.0	11.4	6.1	4.3	5.8	13.5	4.3	7.5	7.3	0.0	19.2	4.8	2.3	17.6	12.8	3.3	3.1	5.5	8.6	3.6	5.2	13.8	9.7	16.9	8.1	4.1	2.6	4.5	12.4	11.4	9.1	9.0	6.7	15.7	4.2	16.2	5.0	3.0	5.2	8.7	4.3	1.8	9.4	11.6	6.9	9.2	11.6	12.4	8.9	7.7	6.4	9.1	2.3	2.6	22.1	8.9	5.9	0.0	7.4	8.3	42.0	22.9	5.0	1.7	7.4	7.0	9.4	4.9	2.2
ZCCHC3	"C20orf99, dJ1103G7.7"	ENSG00000247315	"Zinc finger CCHC-type containing 3"	Q9NUD5	20	297570-300321	"Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA042972			Approved	Vesicles		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Vesicles		"HPA042972: AB_10959663"	"unprognostic (5.98e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.29e-1)"	"unprognostic (6.55e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (4.30e-1)"	"unprognostic (3.34e-3)"	"unprognostic (6.33e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.74e-2)"	9.9	11.3	14.5	11.7	14.1	17.8	8.4	15.8	16.8	10.8	15.9	8.9	9.8	11.2	12.5	6.8	13.0	8.3	9.8	13.5	19.5	10.9	10.0	8.6	17.7	14.8	15.7	18.2	10.8	11.7	10.9	20.1	15.1	9.2	7.5	8.5	8.8	10.7	9.8	6.1	11.4	8.1	13.2	15.4	10.3	9.6	17.7	23.1	8.9	12.6	15.7	9.8	6.3	14.2	24.0	18.4	56.7	28.4	18.3	18.6	33.6	14.7	16.2	16.2	16.7	28.4	14.0	21.8	9.6	9.5	16.7	32.6	29.2	16.5	15.3	11.8	26.8	44.1	9.3	90.0	21.2	50.9	11.7	18.2	19.2	9.9	11.7	16.8	26.2	24.4	55.7	21.5	12.7	10.6	38.8	62.1	50.7	23.3	19.6	56.5	27.1	27.7	14.4	15.2	23.5	34.7	17.5	34.9	46.8	24.2	16.0	93.8	11.4	16.6	16.3	6.8	17.8	39.1	53.9	42.3	6.0	32.4	16.3	2.5	1.2	2.2	1.6	0.7	1.5	1.7	1.4	1.3	0.9	2.1	1.6	1.6	0.4	1.1	0.5	2.1	1.4	0.8	14.5	14.1	15.8	16.8	13.5	19.5	14.8	15.7	15.1	13.2	17.7	14.2	17.3	0.0	9.1	8.8	12.6	15.8	22.7	3.5	11.4	26.9	16.1	12.8	7.6	17.2	4.9	9.2	8.4	22.4	22.3	13.0	3.9	5.9	0.7	22.6	28.0	16.4	21.0	17.9	6.8	5.4	13.4	14.5	8.2	14.9	0.0	16.1	19.2	10.2	11.0	37.0	8.0	16.2	4.1	9.8	9.7	2.1	17.4	11.5	12.4	8.4	11.0	19.6	8.2	7.1	12.3	5.2	10.3	10.5	8.9	16.3	12.2	6.8	8.9	22.1	6.6	14.2	12.3	5.8	7.6	7.2	5.7	20.7	11.1	21.2	13.3	16.0
ZCCHC7	"AIR1, FLJ22611"	ENSG00000147905	"Zinc finger CCHC-type containing 7"	Q8N3Z6	9	37120574-37358149	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 225.6;Inhibitory neurons: 229.6;Oligodendrocyte precursor cells: 196.1;Oligodendrocytes: 250.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 124.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020600, HPA021088, HPA029522"	Uncertain		Enhanced	Nucleoli,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	"Nucleoli, Cytosol"		"HPA020600: AB_1858985, HPA021088: AB_1858986, HPA029522: AB_10601029"	"unprognostic (1.19e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.21e-3)"	"unprognostic (2.78e-1)"	"unprognostic (4.27e-3)"	"unprognostic (3.18e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.29e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.58e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.49e-2)"	8.3	7.4	5.8	12.7	5.5	13.7	13.2	18.7	8.8	9.3	5.1	8.2	7.9	11.6	11.3	7.5	9.6	7.9	6.4	5.3	5.4	7.4	8.1	6.5	23.2	5.6	6.2	16.6	11.2	7.1	9.4	7.9	6.6	7.0	10.9	9.9	7.8	7.1	5.9	8.2	8.2	9.5	4.4	10.6	7.7	12.1	7.4	12.9	12.3	6.0	24.8	9.5	7.5	9.2	17.2	9.4	17.5	18.4	17.4	27.0	15.5	17.4	21.3	14.0	19.2	11.8	8.6	54.8	8.1	14.0	15.9	7.2	16.6	17.1	19.9	26.3	8.8	19.1	19.3	10.7	27.3	32.5	17.5	18.6	26.3	14.2	56.7	26.0	16.0	24.4	53.3	21.8	12.7	8.2	24.9	18.2	18.3	20.3	17.3	124.7	11.0	16.2	17.6	7.1	17.5	12.9	12.6	15.3	17.1	16.9	10.2	21.4	12.7	9.9	11.8	14.1	10.3	5.0	13.2	76.4	14.9	20.8	18.7	8.4	7.6	20.6	12.9	9.0	12.8	32.6	14.9	15.0	7.2	48.9	18.6	17.3	15.3	18.4	17.2	13.2	13.4	9.3	5.8	5.5	18.7	8.8	5.3	5.4	5.6	6.2	6.6	4.4	7.4	9.2	27.7	35.3	18.5	126.3	110.3	28.3	29.5	28.2	32.5	15.5	21.7	23.7	10.7	15.7	21.7	5.5	10.4	15.3	32.8	7.7	27.4	16.3	52.2	17.6	37.6	18.7	19.1	38.5	225.6	15.8	25.4	31.0	30.1	24.2	23.5	18.0	16.4	11.6	15.2	11.8	229.6	22.5	40.7	17.9	22.8	20.8	27.1	20.3	16.0	121.8	19.8	18.2	28.8	196.1	250.0	12.8	13.6	19.5	44.7	34.9	17.7	22.5	19.1	24.9	6.6	33.9	25.4	60.1	44.8	29.3	32.7	18.6	42.2	32.4	20.3	26.0
ZCCHC8	DKFZp434E2220	ENSG00000033030	"Zinc finger CCHC-type containing 8"	Q6NZY4	12	122471599-122501073	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 43.7"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 125.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037483, HPA037484"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA037483: AB_10671502, HPA037484: AB_10672485"	"unprognostic (1.96e-3)"	"unprognostic (8.48e-2)"	"unprognostic (5.55e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.30e-3)"	"unprognostic (1.33e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (7.40e-4)"	"unprognostic (1.03e-1)"	"unprognostic (6.95e-2)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (5.36e-4)"	"unprognostic (8.86e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.48e-2)"	10.2	8.2	3.6	8.9	4.0	43.7	9.9	7.5	4.8	10.8	5.5	9.3	9.0	9.8	8.8	9.8	10.2	6.5	6.3	3.4	3.5	7.9	10.3	8.5	10.5	4.2	3.6	11.5	9.4	8.9	8.9	8.1	3.9	7.9	8.1	10.8	9.7	6.6	16.8	11.8	10.4	7.5	3.0	11.0	10.7	12.1	3.9	10.7	10.8	8.7	11.8	8.9	9.6	5.5	14.8	14.4	21.7	21.0	8.4	10.8	25.2	18.0	11.3	21.5	16.1	13.9	13.0	26.6	10.9	7.6	12.5	17.4	23.1	9.8	19.6	20.9	14.0	17.5	21.0	11.5	19.8	30.5	16.9	9.4	15.7	12.9	18.2	19.2	10.9	26.8	24.3	17.0	11.3	8.4	20.7	23.9	18.5	10.0	15.3	24.2	17.8	21.4	10.5	9.3	15.6	17.2	20.5	9.5	23.0	21.1	20.0	20.3	12.2	14.3	15.3	14.2	17.7	18.2	11.6	36.6	7.8	19.6	8.6	5.5	3.4	2.2	3.5	3.6	3.6	4.5	4.1	4.3	2.8	4.0	4.6	3.8	2.9	4.3	4.3	2.9	5.7	2.5	3.6	4.0	7.5	4.8	3.4	3.5	4.2	3.6	3.9	3.0	3.9	5.5	21.6	32.1	22.6	20.5	26.8	20.5	27.2	13.5	27.3	30.5	23.1	21.5	9.4	21.5	27.0	9.2	125.1	17.4	32.6	13.3	1.9	11.8	78.5	30.7	40.6	21.0	19.6	48.2	21.7	9.5	17.6	22.8	26.0	41.4	19.0	22.5	10.4	17.9	12.8	15.2	24.6	15.5	14.2	15.6	20.2	48.1	14.9	22.4	16.0	26.2	23.5	12.4	21.6	27.6	25.3	14.1	12.2	14.7	29.6	21.3	18.8	6.6	20.4	72.7	6.6	33.6	21.0	34.4	17.1	24.0	25.7	32.3	26.2	19.0	17.3	22.9
ZDHHC12	"FLJ14524, ZNF400"	ENSG00000160446	"Zinc finger DHHC-type palmitoyltransferase 12"	Q96GR4	9	128720870-128724127	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 224.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA059339	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Intermediate filaments"	"HPA059339: AB_2683985"	"unprognostic (2.05e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.53e-3)"	"unprognostic (5.34e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.50e-3)"	"unprognostic (6.56e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.42e-2)"	"unprognostic (9.97e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.82e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.23e-1)"	18.8	23.9	7.8	15.5	7.7	41.3	19.3	7.5	9.9	16.8	8.4	40.5	26.3	12.9	7.1	67.8	12.0	14.1	13.7	7.4	8.8	30.6	52.3	23.3	20.0	9.6	7.8	7.4	67.1	9.8	11.3	16.3	8.4	26.6	13.7	0.5	43.2	12.5	15.6	42.4	36.8	6.3	8.4	31.7	49.2	24.7	10.5	12.4	16.2	4.1	13.7	18.7	30.5	9.7	53.5	127.6	6.0	31.3	17.6	12.1	59.4	32.8	28.8	34.5	22.9	109.6	61.5	37.3	29.6	25.5	62.9	139.8	13.0	65.0	3.8	65.0	31.7	20.1	92.7	49.1	34.7	33.1	87.1	19.9	44.7	29.6	11.0	17.7	25.6	65.6	18.8	93.6	7.1	187.3	45.9	66.2	26.8	118.8	107.6	21.0	21.0	108.4	28.7	43.4	42.1	30.4	46.2	64.1	18.3	9.6	98.9	35.6	27.5	0.1	36.9	25.9	45.8	58.1	106.8	17.3	61.3	38.4	41.4	231.1	122.3	385.6	105.1	123.9	91.2	94.6	95.9	101.5	100.1	111.0	99.2	91.4	269.5	90.5	150.0	244.7	130.9	101.0	7.8	7.7	7.5	9.9	7.4	8.8	9.6	7.8	8.4	8.4	10.5	9.7	10.0	16.0	12.0	1.3	31.8	16.2	43.3	94.0	10.8	1.2	55.5	30.4	14.8	77.2	59.0	46.0	0.0	183.9	39.1	171.0	13.7	106.8	73.2	20.7	11.5	21.1	51.2	51.1	0.6	200.0	224.0	14.2	38.7	52.5	18.4	13.7	35.7	55.3	137.0	0.0	0.5	108.5	67.1	62.2	20.9	30.0	9.6	46.5	42.7	6.5	115.3	18.4	81.4	0.5	2.0	133.8	167.7	7.2	43.3	56.5	186.0	48.5	20.1	2.0	6.6	5.4	16.3	36.0	18.6	55.2	28.1	134.1	34.1	22.0	110.0	77.5
ZDHHC16	APH2	ENSG00000171307	"Zinc finger DHHC-type palmitoyltransferase 16"	Q969W1	10	97446170-97457370	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Apoptosis, DNA damage"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 67.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039893, HPA040214"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA039893: AB_10794757, HPA040214: AB_2676886"	"unprognostic (4.44e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.75e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.27e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.31e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.48e-1)"	15.6	14.9	17.8	10.2	18.5	6.8	16.3	20.3	21.9	15.0	16.4	17.1	14.3	16.4	18.5	19.9	12.2	9.9	22.1	18.1	16.5	25.1	30.3	20.8	11.3	17.2	17.8	15.9	22.8	25.5	16.7	21.6	16.4	18.3	17.3	17.4	24.2	12.1	25.8	13.1	14.7	16.6	16.1	14.5	24.1	17.3	18.8	12.6	16.0	27.9	15.1	17.1	15.3	16.7	50.7	57.4	37.9	47.1	58.7	40.4	38.7	54.6	72.1	61.2	58.4	45.7	43.6	44.4	60.1	79.8	53.4	58.0	48.2	76.7	54.2	43.7	56.0	28.5	39.8	44.3	47.4	34.0	39.7	45.7	49.8	71.6	51.3	66.3	63.9	40.4	23.1	32.8	79.0	48.4	51.8	46.0	29.9	45.8	49.5	34.0	38.6	40.9	51.9	23.2	18.4	25.9	33.2	33.7	30.6	37.7	44.6	32.9	39.6	38.2	35.0	25.0	64.7	29.2	53.0	26.9	44.1	51.7	20.7	0.3	11.1	11.1	7.2	11.9	8.1	9.0	12.5	11.5	15.7	10.6	10.0	10.1	0.5	14.5	11.8	12.0	11.1	6.8	17.8	18.5	20.3	21.9	18.1	16.5	17.2	17.8	16.4	16.1	18.8	16.7	6.2	19.2	23.1	3.9	9.0	5.2	18.9	31.8	14.8	15.8	13.6	9.3	10.1	14.3	27.6	12.9	4.2	39.8	10.3	11.5	25.4	35.5	24.8	7.0	13.3	11.3	7.2	11.6	8.2	32.3	67.2	13.7	10.2	10.9	7.0	13.3	7.5	19.5	24.6	13.5	9.2	18.9	28.5	7.3	5.9	7.6	8.7	9.3	3.6	9.4	18.4	14.9	15.5	11.1	8.4	31.5	12.1	3.8	17.1	20.0	18.9	22.2	8.3	13.0	6.6	5.2	12.2	20.1	12.9	13.8	4.3	37.9	7.2	10.9	20.9	19.3
ZDHHC4	"FLJ10479, ZNF374"	ENSG00000136247	"Zinc finger DHHC-type palmitoyltransferase 4"	Q9NPG8	7	6577434-6589374	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032124	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA032124: AB_10610699"	"unprognostic (1.07e-1)"	"prognostic unfavorable (9.35e-4)"	"unprognostic (6.82e-2)"	"unprognostic (8.36e-2)"	"unprognostic (3.66e-1)"	"prognostic unfavorable (3.95e-6)"	"unprognostic (9.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (1.18e-7)"	"unprognostic (8.75e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (8.94e-4)"	25.9	31.0	17.5	16.2	19.4	18.8	24.3	19.4	18.8	24.4	21.1	38.2	19.1	28.0	34.2	19.5	31.0	23.3	26.5	17.8	21.1	33.6	35.7	21.9	20.6	19.5	20.9	27.6	37.9	33.0	23.9	18.5	20.5	25.3	20.8	19.3	32.2	25.5	54.5	13.5	22.5	24.6	19.1	17.9	32.9	33.8	20.9	18.6	36.8	43.7	19.4	29.2	18.7	19.6	50.7	35.0	11.7	68.8	60.8	41.4	52.4	26.2	6.5	31.2	44.3	44.3	69.7	29.9	40.1	51.3	66.2	44.2	40.8	25.7	33.2	16.8	24.0	31.4	37.8	48.6	47.8	39.8	36.6	45.2	37.6	24.1	0.0	40.8	27.9	51.8	72.4	40.3	43.5	59.2	22.1	39.6	59.4	45.0	28.1	29.4	57.5	40.3	25.9	43.7	26.9	68.7	35.5	11.8	51.7	60.4	43.1	45.8	18.7	40.6	54.9	39.2	39.3	62.1	58.7	66.7	21.6	50.0	56.5	56.3	25.0	44.8	24.1	31.9	24.8	38.8	25.1	27.3	28.1	36.0	31.4	31.1	2.9	28.7	26.5	113.9	24.5	29.3	17.5	19.4	19.4	18.8	17.8	21.1	19.5	20.9	20.5	19.1	20.9	19.6	11.7	38.5	20.1	2.9	23.3	11.3	46.5	63.4	24.5	30.2	42.1	34.7	4.4	57.2	42.4	35.0	10.4	69.0	46.1	12.1	86.1	60.5	3.0	24.1	22.1	14.3	32.4	26.5	4.6	66.4	69.4	26.0	20.9	20.3	10.2	25.9	25.0	47.3	55.3	21.9	5.4	21.2	42.7	36.5	18.2	3.5	18.0	24.8	21.4	2.8	35.3	71.8	28.8	5.0	6.7	54.6	21.4	32.7	34.2	39.5	27.2	71.9	32.5	24.6	13.1	20.9	25.6	70.2	69.7	19.2	9.2	48.8	19.0	40.6	27.5	39.5
ZFC3H1	"CCDC131, CSRC2, KIAA0546, MGC23401, PSRC2"	ENSG00000133858	"Zinc finger C3H1-type containing"	O60293	12	71609599-71667725	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007072, HPA007151"	Enhanced		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Intermediate filaments"	"HPA007072: AB_1846134, HPA007151: AB_1846133"	"unprognostic (3.90e-3)"	"unprognostic (3.69e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.15e-2)"	"unprognostic (9.44e-2)"	"unprognostic (6.14e-2)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.56e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.53e-3)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (1.46e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.07e-3)"	9.6	12.3	4.1	10.1	5.1	18.5	8.1	8.1	6.2	9.5	5.3	10.6	6.2	8.7	10.5	10.4	9.2	7.3	7.8	4.2	6.0	7.9	5.5	12.1	14.5	4.5	4.2	11.0	8.0	7.6	8.0	8.0	4.5	8.3	8.9	13.4	8.1	8.2	7.7	9.1	11.1	6.3	2.9	10.9	10.1	12.4	5.0	13.2	9.0	5.6	12.0	9.8	9.5	6.2	16.1	15.7	12.6	8.6	14.4	26.5	7.6	12.9	18.6	17.8	17.7	15.1	9.2	21.2	7.3	15.0	7.9	19.2	15.3	7.4	23.8	20.8	13.0	21.6	27.6	7.3	8.6	22.0	10.5	15.2	14.6	13.1	6.1	25.4	18.2	17.1	19.6	9.8	17.0	5.0	15.5	8.2	11.5	7.2	9.6	14.0	13.7	15.9	13.5	12.4	8.3	8.3	13.4	8.1	8.0	12.0	21.0	14.4	16.7	12.2	7.4	6.9	6.9	17.3	10.5	15.2	12.6	15.8	7.7	60.5	20.9	27.1	15.0	10.7	12.1	21.7	13.3	10.4	9.3	29.9	13.1	11.2	60.7	11.7	20.3	27.1	11.9	3.5	4.1	5.1	8.1	6.2	4.2	6.0	4.5	4.2	4.5	2.9	5.0	6.2	33.5	35.3	25.5	37.2	50.1	47.9	85.8	20.6	46.7	32.8	28.4	17.1	18.4	7.2	30.5	14.7	22.9	14.6	60.2	35.7	1.9	20.5	97.6	33.2	46.0	35.8	20.9	24.8	56.9	16.9	14.5	40.2	52.0	66.5	48.8	32.7	23.9	12.0	17.5	58.9	58.1	32.1	18.3	17.8	47.0	65.2	32.0	49.7	10.6	55.3	39.3	14.7	37.0	62.4	68.6	28.5	36.4	23.0	54.0	45.1	32.1	8.4	22.9	33.0	26.3	39.9	37.5	51.7	30.8	79.3	40.9	11.5	44.9	29.2	28.7	93.4
ZFP69B	"FLJ34293, ZKSCAN23B, ZNF643, ZSCAN54B"	ENSG00000187801	"ZFP69 zinc finger protein B"	Q9UJL9	1	40450102-40463718	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 10.2;Inhibitory neurons: 7.9;Oligodendrocyte precursor cells: 11.1;Spermatogonia: 5.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA044289	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"HPA044289: AB_10962717"	"unprognostic (2.01e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.36e-2)"	"unprognostic (6.44e-9)"	"unprognostic (2.05e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.23e-5)"	"unprognostic (1.64e-1)"	"unprognostic (8.05e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.89e-1)"	0.4	0.5	1.7	1.7	1.4	0.4	0.9	0.0	2.9	0.9	0.0	0.9	0.9	1.4	0.7	0.7	0.5	1.1	0.6	1.3	0.5	0.4	0.8	0.5	1.4	0.2	0.5	0.6	1.0	0.7	0.5	0.4	1.0	0.6	1.0	1.5	0.4	0.6	0.4	0.5	0.6	1.0	0.0	0.8	0.9	1.4	1.0	1.9	0.9	0.3	1.9	1.2	0.3	1.2	3.6	1.5	6.1	14.8	2.2	5.8	1.7	3.5	3.2	1.5	2.9	1.6	2.3	6.9	3.3	3.0	3.0	1.3	3.1	3.0	3.4	6.0	1.3	2.8	3.5	5.2	1.5	0.4	4.4	1.3	4.9	5.4	7.1	1.5	2.1	9.0	7.5	6.9	4.6	2.5	9.4	0.6	8.1	1.3	1.5	5.3	5.9	3.3	3.0	3.5	8.0	8.4	5.6	4.6	2.4	3.4	2.4	8.0	4.6	4.9	10.4	4.6	5.0	10.4	10.6	14.8	6.5	0.9	5.2	0.0	0.1	0.3	0.9	0.7	1.2	0.6	0.6	0.5	0.4	0.6	1.2	1.0	0.0	0.6	0.2	0.1	1.4	0.3	1.7	1.4	0.0	2.9	1.3	0.5	0.2	0.5	1.0	0.0	1.0	1.2	1.1	0.0	0.0	1.3	2.4	0.3	0.6	0.3	0.0	3.4	0.8	0.6	0.7	0.0	0.2	1.8	0.0	0.6	1.0	0.1	0.0	1.2	0.0	0.8	1.6	1.3	0.0	0.4	10.2	0.2	1.4	0.7	1.1	0.5	0.0	3.2	1.1	0.1	1.1	0.0	7.9	0.5	0.0	0.0	0.8	0.0	0.0	0.8	0.0	1.0	1.1	0.9	3.1	11.1	1.8	1.1	0.3	0.4	2.4	0.3	0.2	0.2	0.1	2.2	0.0	0.9	1.3	1.8	5.7	0.3	0.1	0.0	1.5	0.9	0.4	0.2
ZFR	"SPG71, ZFR1"	ENSG00000056097	"Zinc finger RNA binding protein"	Q96KR1	5	32354350-32444740	"Predicted intracellular proteins"		"Developmental protein, DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016666	Supported		Approved	Nucleoplasm		NA	NA		8100	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA016666: AB_1859060"	"unprognostic (7.45e-3)"	"unprognostic (8.46e-2)"	"unprognostic (4.07e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.47e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.07e-1)"	26.6	28.3	32.2	21.8	36.4	30.9	26.8	32.5	37.6	26.6	23.9	22.1	18.5	27.9	21.7	26.0	27.9	23.6	34.4	34.4	32.2	29.5	24.9	19.5	26.7	31.8	32.2	38.4	26.0	31.3	14.2	35.5	32.2	26.2	22.5	36.7	27.7	24.7	42.4	16.1	21.0	27.4	33.0	22.6	21.2	30.2	32.6	31.6	34.1	41.3	26.3	28.7	17.3	36.8	45.1	65.8	75.4	47.2	81.4	59.3	65.8	68.0	57.3	70.5	50.3	65.9	39.0	65.7	43.2	66.8	92.0	34.4	99.0	48.1	98.4	62.4	55.3	80.5	66.9	65.3	71.2	83.7	63.6	56.7	59.1	74.7	135.8	63.9	53.9	31.9	82.0	53.9	73.1	34.0	73.7	35.4	55.5	47.3	48.7	59.2	101.3	36.1	52.7	73.1	41.9	44.2	101.1	58.2	60.8	53.1	36.1	102.0	61.4	69.5	65.0	51.9	57.4	26.7	50.3	72.6	51.4	66.2	86.2	35.3	15.5	19.8	15.6	24.2	18.1	16.6	14.9	16.1	17.3	13.1	14.2	14.3	10.1	22.9	24.9	9.1	15.1	13.2	32.2	36.4	32.5	37.6	34.4	32.2	31.8	32.2	32.2	33.0	32.6	36.8	48.0	51.3	55.4	80.0	55.1	26.0	70.6	47.0	61.5	61.2	39.4	34.9	108.7	34.3	63.7	31.3	22.9	40.1	51.4	28.3	49.0	51.7	53.1	47.7	62.1	51.6	39.5	36.6	109.5	35.9	31.3	66.0	34.1	48.6	76.5	50.4	40.4	35.8	32.7	77.4	98.5	26.1	52.9	35.8	31.3	35.6	53.1	47.3	30.2	74.0	53.9	70.8	52.5	117.6	171.4	44.9	39.6	60.9	52.3	69.8	28.7	45.6	56.3	55.4	39.5	81.2	70.9	118.5	71.8	53.1	24.6	55.5	50.1	65.3	34.1	55.7
ZGRF1	"C4orf21, FLJ11331"	ENSG00000138658	"Zinc finger GRF-type containing 1"	Q86YA3	4	112539333-112636995	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 7.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 18.0;Microglial cells: 17.8;Oligodendrocytes: 27.5;Spermatocytes: 22.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			"HPA030704, HPA030706"	Uncertain		Approved	Cytosol		NA	Yes			"Cluster 7: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA030704: AB_2673577, HPA030706: AB_10601784"	"unprognostic (8.48e-2)"	"unprognostic (6.17e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.83e-3)"	"unprognostic (1.45e-1)"	"unprognostic (5.89e-4)"	"unprognostic (4.74e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.72e-3)"	"unprognostic (7.60e-10)"	"unprognostic (3.45e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.02e-4)"	1.0	0.7	0.9	2.0	1.4	7.8	1.3	2.2	1.5	0.9	0.1	1.1	1.2	1.2	0.3	1.0	0.8	0.5	0.7	0.8	0.7	0.5	0.6	0.9	2.5	1.3	0.9	1.1	0.7	0.3	1.3	1.7	1.3	0.9	1.4	4.3	0.9	0.4	1.2	1.4	1.5	0.9	1.0	1.8	0.9	3.6	1.0	5.2	0.8	0.6	2.9	0.7	0.8	2.1	5.0	3.6	12.1	8.6	0.9	1.6	4.7	8.8	3.7	8.7	7.8	6.9	7.3	13.2	2.5	2.7	3.6	4.0	12.7	4.7	10.0	7.3	3.1	8.3	5.8	2.1	0.4	18.5	5.3	0.8	0.6	11.0	3.0	1.2	3.5	13.6	12.0	14.3	6.0	8.2	25.0	6.7	6.3	5.2	4.2	13.8	18.1	4.5	1.5	4.4	5.6	9.5	3.9	5.3	1.7	8.8	2.5	5.4	4.2	10.9	10.6	5.9	7.1	5.5	10.1	17.0	4.9	6.3	6.3	0.0	0.1	0.3	0.2	0.7	0.1	0.3	0.1	0.0	0.0	0.5	0.4	0.4	0.2	0.2	0.1	0.7	0.2	0.1	0.9	1.4	2.2	1.5	0.8	0.7	1.3	0.9	1.3	1.0	1.0	2.1	3.3	0.0	1.3	10.4	5.4	0.0	1.3	0.0	0.6	10.4	2.1	1.7	2.4	0.0	3.7	1.8	8.4	3.5	10.4	2.1	0.0	1.0	2.9	1.8	3.5	1.9	1.2	11.1	18.0	0.5	2.7	2.3	4.6	2.8	2.5	12.2	1.1	0.6	1.8	5.0	14.5	1.8	0.0	1.6	0.0	2.8	0.6	4.1	0.0	17.8	1.3	1.6	6.2	17.6	27.5	0.6	1.4	2.2	10.5	0.8	0.7	0.3	0.7	17.6	0.0	3.1	2.7	22.1	15.6	3.6	0.0	0.8	5.0	2.2	2.5	0.9
ZKSCAN5	"ZFP95, ZNF914, ZSCAN37"	ENSG00000196652	"Zinc finger with KRAB and SCAN domains 5"	Q9Y2L8	7	99504662-99534700	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003201	Uncertain		Approved	"Intermediate filaments"		No	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Intermediate filaments"		"HPA003201: AB_10610701"	"unprognostic (2.47e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (7.59e-6)"	"unprognostic (1.12e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.35e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (3.42e-1)"	2.7	3.2	4.8	2.9	5.1	3.1	3.4	6.0	5.7	3.1	4.1	3.0	1.6	3.3	3.5	2.3	3.0	2.6	3.2	4.8	4.8	3.2	3.1	2.9	3.4	4.5	4.8	3.6	1.5	3.8	2.9	3.3	5.0	3.3	2.7	5.4	2.0	3.5	4.7	2.4	2.4	4.1	4.3	3.1	2.5	8.4	4.9	6.0	3.7	6.8	3.8	3.1	2.6	5.2	6.6	10.6	12.4	16.5	8.5	6.4	5.3	11.1	10.6	12.7	12.4	7.6	5.9	11.3	9.9	8.3	15.5	5.2	11.1	7.2	12.7	6.5	6.6	7.2	6.9	7.1	8.9	10.8	11.4	5.7	10.2	10.9	16.7	8.1	9.1	9.9	14.8	15.0	13.7	8.5	15.0	11.8	10.9	5.9	8.6	9.4	10.6	9.4	8.1	6.5	8.8	14.0	10.0	9.4	7.4	9.8	5.7	7.5	8.7	16.2	11.7	13.1	9.5	9.6	14.6	16.9	7.5	7.5	14.6	0.8	0.8	2.4	2.0	1.2	1.6	0.7	0.7	1.0	1.6	0.6	1.6	1.6	0.7	1.7	0.8	1.1	1.4	1.0	4.8	5.1	6.0	5.7	4.8	4.8	4.5	4.8	5.0	4.3	4.9	5.2	6.9	6.4	3.2	7.8	5.8	2.7	1.9	2.3	4.6	5.8	4.7	4.4	6.1	0.0	4.8	3.7	14.6	3.8	5.6	4.3	0.0	3.3	6.2	3.8	5.8	6.4	6.0	6.5	8.5	3.5	3.4	3.7	5.6	4.4	5.7	7.5	4.6	4.2	3.4	10.1	8.6	3.0	8.2	3.9	4.0	2.9	4.1	4.9	0.0	9.4	3.5	8.7	2.1	6.0	8.4	4.3	0.8	5.7	4.4	2.4	4.1	2.5	3.0	6.3	6.6	6.5	4.1	18.0	6.6	5.9	2.8	2.6	4.4	5.9	3.3	1.8
ZMYND19	MIZIP	ENSG00000165724	"Zinc finger MYND-type containing 19"	Q96E35	9	137582081-137590512	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"retina: 287.8"	"Group enriched"	"Detected in many"	14	"Cone photoreceptor cells: 244.0;Rod photoreceptor cells: 680.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020642, HPA050761"	Supported		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus, Vesicles"		"HPA020642: AB_1859078, HPA050761: AB_2681228"	"unprognostic (2.30e-2)"	"unprognostic (9.62e-3)"	"unprognostic (3.45e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.67e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.72e-1)"	11.9	16.5	19.6	9.4	19.9	9.1	11.9	18.8	23.9	14.2	18.6	12.4	8.8	11.2	5.0	26.5	11.4	7.2	14.1	20.0	19.5	12.9	21.1	12.0	11.9	18.7	19.2	12.9	16.1	8.0	16.9	8.5	19.7	16.5	5.7	287.8	15.9	7.1	14.2	27.7	12.4	6.8	18.9	15.1	22.2	49.5	19.4	9.5	10.8	8.8	9.4	13.3	16.6	19.8	28.9	44.7	41.8	45.5	22.1	21.3	42.1	38.8	25.8	41.7	31.8	53.1	28.7	51.7	43.6	25.8	40.2	71.7	51.3	38.9	13.2	33.8	49.7	26.9	86.1	41.8	34.4	58.4	33.9	16.8	58.7	38.0	37.1	18.4	22.3	40.5	66.3	22.2	25.6	97.2	68.4	88.7	60.7	86.4	61.9	73.8	36.8	79.6	25.7	24.2	60.1	39.4	37.4	79.4	35.4	18.5	53.7	89.9	21.3	51.1	38.9	76.8	63.8	21.4	54.9	56.8	31.6	44.8	35.9	0.0	0.3	0.3	0.5	1.6	1.2	0.8	0.3	0.2	0.3	0.3	0.5	0.4	0.0	0.1	0.2	0.9	1.0	0.1	19.6	19.9	18.8	23.9	20.0	19.5	18.7	19.2	19.7	18.9	19.4	19.8	6.1	9.6	7.2	3.6	4.0	17.5	5.6	3.2	5.2	23.6	14.9	19.2	6.2	2.8	2.4	1.8	244.0	5.2	6.8	5.3	0.0	3.2	4.5	6.5	12.8	5.6	2.4	6.9	4.1	3.6	6.8	6.3	10.7	8.1	1.3	10.6	3.9	7.6	4.4	11.8	4.0	8.8	6.1	3.2	5.7	4.4	2.8	3.6	5.4	1.9	2.2	31.6	5.2	2.0	2.1	4.2	4.6	3.0	10.9	10.2	1.9	3.1	1.3	680.0	0.0	6.9	6.7	27.8	28.7	4.5	22.9	4.5	4.6	8.5	7.8	7.1
ZNF143	"pHZ-1, SBF, STAF"	ENSG00000166478	"Zinc finger protein 143"	P52747	11	9460319-9528524	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Sertoli cells: 59.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003263, HPA003264, HPA074818"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Vesicles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear bodies, Golgi apparatus, Vesicles"	"HPA003263: AB_1080672, HPA003264: , HPA074818: AB_2686715"	"unprognostic (2.30e-2)"	"unprognostic (2.12e-2)"	"unprognostic (5.51e-2)"	"unprognostic (9.72e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.76e-5)"	"unprognostic (4.87e-3)"	"unprognostic (2.57e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (1.20e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.55e-2)"	9.0	6.1	8.6	11.4	10.1	18.6	9.6	17.3	9.9	10.0	10.8	9.7	9.5	10.5	14.4	9.8	10.1	8.4	9.3	7.9	9.3	8.6	9.6	9.1	15.7	9.9	8.8	13.7	7.7	7.9	7.1	10.4	11.2	8.7	9.9	16.1	8.9	8.0	17.3	10.2	8.2	9.5	9.8	11.1	7.7	16.9	9.0	18.9	14.6	11.5	14.1	11.2	8.4	14.9	20.0	18.8	23.4	15.2	18.9	17.4	21.5	21.8	17.3	16.4	17.9	26.7	24.3	19.6	9.7	17.7	14.0	22.5	23.1	17.3	24.5	20.0	27.7	18.5	27.7	18.7	15.6	25.9	17.8	15.3	20.4	22.2	19.4	21.4	16.3	17.9	20.5	23.3	18.3	17.1	24.1	10.6	26.3	23.0	19.9	21.4	21.2	12.3	14.7	24.0	16.1	15.8	24.0	16.0	14.3	20.6	14.9	14.6	15.6	21.4	15.3	15.1	19.6	11.5	21.6	33.4	13.8	14.8	12.5	39.1	24.6	57.3	28.0	24.9	25.0	23.0	24.6	22.9	20.9	18.2	22.8	19.6	45.1	19.4	28.2	10.1	29.7	19.6	8.6	10.1	17.3	9.9	7.9	9.3	9.9	8.8	11.2	9.8	9.0	14.9	17.9	6.4	12.1	6.2	14.7	26.6	34.1	12.1	17.6	9.3	8.7	13.2	15.5	7.2	10.3	5.5	8.4	10.0	17.1	10.1	3.9	12.5	20.3	18.7	14.9	13.0	6.6	25.4	8.1	11.5	16.2	14.5	9.7	16.3	14.0	7.7	6.8	7.6	9.9	5.0	7.4	6.9	14.2	8.3	22.0	10.0	11.8	15.8	10.6	12.2	16.3	15.5	17.5	7.5	9.8	14.1	7.7	6.8	15.4	20.1	6.3	7.7	15.0	14.3	59.2	18.3	16.7	50.5	21.3	12.8	23.4	18.3	18.1	7.3	7.9	26.9
ZNF146	OZF	ENSG00000167635	"Zinc finger protein 146"	Q15072	19	36214602-36238771	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 121.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003358	Supported		Supported	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Nucleoli		"HPA003358: AB_1080674"	"unprognostic (1.01e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.35e-3)"	"unprognostic (2.11e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.42e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.92e-1)"	25.9	21.1	22.6	25.6	30.4	12.5	41.6	26.6	33.9	33.7	20.5	26.8	23.1	37.0	21.9	24.7	28.1	22.4	23.7	21.5	26.4	29.2	32.4	23.4	35.3	28.4	30.7	40.5	22.8	33.4	28.2	32.4	30.9	30.5	31.5	31.2	24.4	26.4	46.3	27.0	21.8	32.6	24.0	27.0	25.2	12.1	27.9	39.6	33.9	46.4	37.5	34.4	23.2	36.2	70.2	96.0	79.8	77.1	57.8	64.5	42.5	60.2	55.4	57.1	56.2	43.5	49.6	67.7	94.6	56.0	37.4	31.8	102.6	70.5	102.3	105.5	57.2	113.0	37.4	52.7	67.4	180.1	74.9	52.8	106.5	55.1	156.0	60.0	71.7	72.6	122.2	72.3	69.4	45.9	84.1	42.2	108.1	122.2	57.7	96.1	80.3	58.2	69.4	67.7	100.7	63.5	74.7	93.0	66.1	81.6	41.5	90.9	55.0	64.0	76.8	50.6	107.1	50.2	63.7	95.2	44.9	88.0	83.1	7.9	11.2	8.7	15.8	13.8	22.7	19.1	18.1	16.0	13.6	17.4	23.2	21.4	2.6	14.9	22.4	6.9	16.8	14.9	22.6	30.4	26.6	33.9	21.5	26.4	28.4	30.7	30.9	24.0	27.9	36.2	21.4	44.8	29.0	21.5	29.7	23.6	30.8	20.5	22.8	10.8	26.7	22.1	45.4	21.5	28.4	20.2	10.4	34.3	26.3	11.6	35.2	27.7	18.3	16.7	35.5	22.8	14.5	25.0	29.2	18.0	48.7	26.9	16.3	23.6	20.8	28.5	20.3	20.8	18.9	11.8	33.4	24.6	14.2	17.8	14.0	20.9	25.1	15.5	10.6	19.7	18.8	9.0	28.8	37.2	121.1	25.0	13.7	19.2	18.6	38.1	9.0	21.2	23.7	10.3	6.6	30.2	29.6	13.0	10.7	24.5	29.8	23.5	29.9	20.0	26.4	29.6
ZNF174	ZSCAN8	ENSG00000103343	"Zinc finger protein 174"	Q15697	16	3401215-3409364	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009656, HPA070692"	Approved		Supported	"Nucleoli fibrillar center,Nuclear bodies"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli fibrillar center"	"Nuclear bodies"	"HPA009656: AB_1080679, HPA070692: "	"unprognostic (4.33e-2)"	"unprognostic (6.81e-3)"	"unprognostic (2.08e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.94e-3)"	"unprognostic (5.19e-2)"	"unprognostic (2.03e-3)"	"unprognostic (6.39e-3)"	"unprognostic (2.41e-1)"	"unprognostic (4.25e-3)"	"unprognostic (2.06e-3)"	"unprognostic (4.35e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.83e-1)"	6.7	7.0	7.8	5.5	8.3	4.0	6.8	8.0	9.1	8.1	7.1	10.4	6.1	9.5	11.5	6.1	10.8	5.6	10.0	7.4	9.0	6.6	6.6	5.4	8.2	8.0	8.1	12.6	5.8	14.1	9.3	5.0	8.3	8.8	7.1	9.9	7.9	10.9	9.9	7.4	6.4	10.3	7.8	7.3	6.8	9.5	8.3	9.5	7.5	10.6	8.4	9.0	6.8	9.4	7.1	11.6	13.1	14.9	15.8	11.3	8.4	6.1	16.2	14.2	12.7	8.8	12.3	23.0	9.3	11.9	12.7	10.1	12.4	11.0	13.1	14.0	11.7	12.2	11.2	11.4	11.3	14.5	13.9	13.3	12.6	11.9	11.9	13.6	11.7	16.8	18.9	10.8	14.7	12.2	14.7	12.4	13.9	10.5	14.2	19.8	14.3	19.3	10.0	3.6	12.0	9.1	12.7	14.1	11.0	12.2	13.7	15.4	9.1	10.4	10.8	8.3	8.5	12.9	14.9	19.5	5.6	9.1	10.1	17.4	6.4	27.0	9.6	7.5	9.1	10.3	10.0	11.0	7.9	8.0	12.0	8.9	7.8	8.5	5.1	4.2	10.2	7.6	7.8	8.3	8.0	9.1	7.4	9.0	8.0	8.1	8.3	7.8	8.3	9.4	4.3	3.2	2.0	4.9	4.1	1.9	1.4	2.6	6.2	6.4	3.3	4.3	5.3	4.3	1.8	0.0	6.2	6.1	5.6	3.0	3.9	5.0	7.1	5.4	4.4	5.2	3.6	5.5	3.4	4.3	3.8	4.7	1.5	2.5	1.3	4.9	2.9	3.5	4.5	3.3	4.3	2.2	8.2	2.5	0.9	4.0	8.7	2.6	3.6	1.0	2.4	7.7	8.2	3.5	10.6	4.0	5.0	9.8	4.6	2.2	4.7	4.7	1.6	8.8	0.0	4.7	4.0	15.1	10.3	4.7	1.8	2.9	4.0	5.8	3.4	0.8
ZNF180	HHZ168	ENSG00000167384	"Zinc finger protein 180"	Q9UJW8	19	44474428-44500524	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028979, HPA028980"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA028979: AB_10600328, HPA028980: AB_10611524"	"unprognostic (2.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.13e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.16e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.37e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.38e-3)"	2.8	2.8	1.7	2.4	1.8	2.7	4.5	2.3	2.2	3.2	2.4	2.9	2.4	3.5	2.6	2.7	4.1	1.6	2.4	1.8	1.8	2.9	3.3	3.0	3.2	1.8	2.0	4.7	3.3	8.1	2.4	2.7	1.9	5.2	3.4	4.7	2.4	3.0	2.6	3.0	3.0	3.2	1.8	3.2	3.1	2.8	1.8	3.9	4.5	2.2	4.0	2.7	2.8	2.2	7.0	2.0	9.1	6.5	2.1	3.9	5.5	4.0	4.3	6.3	7.4	3.6	0.9	0.6	3.1	5.5	4.5	2.2	5.5	8.0	7.8	8.0	3.3	7.7	1.6	2.7	2.0	11.7	4.8	3.8	3.3	3.8	4.8	5.8	4.4	3.4	3.7	5.6	4.4	1.3	6.2	4.1	6.0	6.5	4.4	3.7	4.9	5.2	6.1	11.4	7.5	6.4	7.1	6.8	3.3	5.8	3.6	9.8	3.5	10.8	4.3	1.4	5.7	1.5	5.7	3.2	2.4	5.0	5.6	2.1	1.1	2.3	1.1	0.6	1.6	1.8	1.7	2.0	1.7	1.7	1.9	1.8	0.3	1.7	1.2	0.4	4.6	1.3	1.7	1.8	2.3	2.2	1.8	1.8	1.8	2.0	1.9	1.8	1.8	2.2	3.4	6.4	1.5	4.2	4.3	2.5	2.2	2.4	4.0	6.7	3.2	2.4	4.5	2.8	4.1	1.8	4.2	5.5	4.2	3.5	7.9	4.2	5.8	3.0	4.7	2.8	4.2	8.2	5.7	4.2	4.0	3.5	4.1	2.9	1.3	5.7	5.3	3.7	3.4	1.7	5.8	4.9	6.1	4.6	1.1	1.3	2.8	2.6	5.4	8.4	5.4	6.0	7.2	6.6	9.0	3.9	5.7	4.5	1.7	2.2	4.3	3.5	4.3	4.4	6.6	4.3	3.5	2.7	4.6	2.5	1.3	3.1	4.0	3.5	4.0	1.7
ZNF213	"CR53, ZKSCAN21, ZSCAN53"	ENSG00000085644	"Zinc finger protein 213"	O14771	16	3129777-3142804	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 22.7;Late spermatids: 58.3;Sertoli cells: 19.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035000, HPA056750"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"HPA035000: AB_10669997, HPA056750: AB_2683225"	"unprognostic (1.94e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.05e-3)"	"prognostic unfavorable (6.74e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.73e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.57e-1)"	4.3	6.7	5.0	3.6	4.9	3.9	4.6	5.7	6.2	5.1	0.9	5.7	5.5	6.5	1.7	6.9	5.1	3.2	5.6	4.9	3.3	4.6	2.5	3.5	5.7	7.1	4.6	6.5	7.2	4.9	6.7	2.1	4.7	5.7	1.2	4.3	10.4	3.0	11.5	10.0	6.8	2.3	3.4	4.9	5.7	17.9	5.1	2.5	5.2	1.2	0.9	5.7	5.2	5.4	3.6	11.1	4.9	11.3	4.7	3.8	6.0	6.4	2.6	3.3	3.9	3.6	7.2	4.3	6.2	4.2	4.9	8.4	2.2	7.1	1.3	9.2	8.3	2.4	13.4	7.0	8.8	7.5	7.8	3.7	8.7	4.4	1.8	2.5	2.5	8.2	8.0	9.4	2.2	15.1	7.0	9.1	8.3	3.8	8.4	9.4	5.7	8.1	2.6	2.4	10.0	8.5	9.7	5.7	4.7	3.1	7.5	12.8	6.3	6.8	6.2	7.7	4.5	5.2	5.4	6.4	2.7	9.9	5.3	0.0	0.5	1.3	1.2	0.9	1.1	0.9	1.2	0.8	0.5	1.5	1.5	1.1	1.3	1.6	0.7	1.2	0.7	0.8	5.0	4.9	5.7	6.2	4.9	3.3	7.1	4.6	4.7	3.4	5.1	5.4	4.1	0.0	1.1	3.6	1.9	1.9	1.5	2.1	2.8	5.3	4.8	4.2	4.4	1.5	1.7	0.0	2.1	1.8	3.4	10.2	1.9	4.0	22.7	3.0	3.1	3.4	2.4	2.1	3.2	4.9	2.0	3.9	4.6	4.4	4.5	4.8	4.6	1.4	3.2	8.4	3.5	6.0	0.0	5.1	1.7	58.3	6.5	3.6	0.0	1.0	4.4	5.6	5.2	0.5	4.6	5.2	4.2	7.2	1.3	2.1	14.6	2.5	1.5	5.2	19.7	3.9	4.1	9.5	4.5	4.8	2.0	1.4	2.3	3.5	6.6	1.8
ZNF250	"MGC9718, ZFP647, ZNF647"	ENSG00000196150	"Zinc finger protein 250"	P15622	8	144876497-144902168	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020853	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"	Cytosol	"HPA020853: AB_1859152"	"unprognostic (1.16e-3)"	"unprognostic (9.56e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.60e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.95e-3)"	"unprognostic (3.73e-3)"	"unprognostic (2.72e-2)"	"unprognostic (6.27e-2)"	"unprognostic (7.37e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (2.43e-7)"	"unprognostic (2.23e-1)"	"unprognostic (6.79e-2)"	"unprognostic (5.82e-2)"	"prognostic favorable (8.26e-4)"	4.7	3.9	3.2	3.3	3.2	2.9	5.6	10.5	4.7	9.7	2.3	6.9	4.8	7.4	2.8	6.4	7.6	3.3	4.9	2.4	4.5	7.6	4.0	5.1	3.0	3.0	3.2	9.7	4.9	6.0	7.3	5.5	3.3	7.5	3.6	7.9	6.0	5.2	4.8	10.9	5.2	4.2	1.5	5.5	4.9	4.5	3.3	4.5	10.0	5.8	3.3	6.3	8.6	3.4	5.1	2.9	13.4	11.1	6.8	5.9	4.3	5.6	6.4	9.4	7.7	2.4	3.9	12.0	9.8	6.5	3.8	6.6	5.3	4.8	6.0	3.8	7.8	10.8	14.9	3.5	2.0	1.8	3.6	3.9	6.5	5.6	4.5	7.2	3.9	7.1	8.6	11.5	7.9	6.8	12.6	4.1	4.0	6.0	12.5	14.4	5.9	5.0	7.8	3.7	13.2	10.1	11.8	4.4	5.3	5.3	6.3	6.1	5.1	9.2	8.8	7.3	5.3	5.6	5.1	8.0	4.7	6.2	4.1	3.2	5.1	5.8	10.5	2.7	8.1	10.3	7.7	5.8	6.6	9.7	8.9	7.3	2.9	6.0	3.7	2.6	11.7	4.5	3.2	3.2	10.5	4.7	2.4	4.5	3.0	3.2	3.3	1.5	3.3	3.4	5.8	12.8	3.0	10.7	10.7	5.5	3.2	7.5	10.2	8.4	4.3	6.6	4.3	1.5	3.9	5.5	0.0	2.3	18.6	2.4	3.9	7.5	7.4	5.1	6.0	5.5	4.2	1.7	11.9	1.9	1.3	5.2	2.6	4.9	2.5	6.3	5.0	2.1	1.7	8.4	17.5	1.9	12.2	2.2	8.0	3.0	4.1	3.0	5.4	4.7	2.0	3.3	5.2	11.1	7.8	2.6	1.0	5.3	8.2	3.3	3.7	3.4	5.0	9.9	13.1	4.1	6.1	14.3	8.7	4.4	5.5	1.9	10.9	4.9	3.4	2.3
ZNF3	"A8-51, FLJ20216, HF.12, KOX25, PP838, Zfp113"	ENSG00000166526	"Zinc finger protein 3"	P17036	7	100064033-100082548	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA003719	Supported	Supported	Approved	Nucleoplasm		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA003719: AB_1080701"	"unprognostic (5.92e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (5.73e-4)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (2.65e-1)"	"unprognostic (2.50e-3)"	"unprognostic (7.54e-2)"	"unprognostic (3.71e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.41e-2)"	"prognostic favorable (2.20e-4)"	13.3	11.1	18.5	9.9	21.1	27.1	19.8	20.4	20.6	17.7	20.0	16.9	20.3	21.3	22.2	13.5	36.5	11.9	11.8	18.7	19.0	15.1	18.6	12.3	12.9	21.3	21.0	21.7	16.0	19.2	13.0	11.7	21.4	14.9	18.4	14.9	14.3	15.7	18.3	13.9	21.0	14.2	20.3	13.9	16.6	8.8	19.9	18.6	18.5	19.5	15.5	14.3	13.8	26.1	13.2	14.1	39.1	54.9	18.8	14.5	23.1	16.8	18.5	23.8	20.4	18.4	19.0	19.2	28.8	15.7	19.6	17.2	29.3	18.2	19.8	20.1	23.7	15.5	20.8	26.6	22.4	28.7	13.6	18.5	21.5	16.8	37.3	26.4	21.4	27.6	44.9	29.3	22.0	36.1	67.3	28.9	54.9	24.2	25.7	27.7	31.4	49.0	22.8	25.9	40.9	60.5	20.1	57.2	26.1	37.1	16.5	27.1	17.5	29.5	21.8	22.0	22.0	39.9	47.3	38.1	14.8	24.6	29.3	13.1	10.2	19.5	14.2	9.8	16.6	13.4	11.8	14.7	10.5	15.5	13.6	14.9	3.9	18.6	14.5	11.8	12.7	10.1	18.5	21.1	20.4	20.6	18.7	19.0	21.3	21.0	21.4	20.3	19.9	26.1	13.5	12.8	31.9	8.1	16.9	7.6	10.0	8.1	12.0	18.7	15.1	12.2	10.5	14.3	13.2	3.7	16.7	12.5	12.6	17.0	7.9	19.3	2.7	42.3	16.1	17.4	26.3	26.1	5.8	11.1	7.6	16.4	15.8	13.0	15.2	28.5	14.6	14.5	6.6	18.5	6.2	20.0	10.2	12.6	5.9	1.8	15.2	7.8	3.6	2.8	11.5	16.5	30.9	9.0	20.4	16.1	18.1	15.1	11.6	12.7	32.5	13.5	32.1	19.5	6.6	9.3	12.1	16.2	17.0	9.9	8.9	10.4	11.1	14.0	20.1	8.2
ZNF330	"HSA6591, NOA36"	ENSG00000109445	"Zinc finger protein 330"	Q9Y3S2	4	141220887-141234697	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 154.0;Early spermatids: 197.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015705, HPA056325"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 38: Heart - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoli	Nucleoplasm	"HPA015705: AB_1859199, HPA056325: AB_2683101"	"unprognostic (1.90e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.12e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.32e-3)"	"unprognostic (4.49e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (3.66e-6)"	"prognostic favorable (7.27e-6)"	"unprognostic (3.24e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.30e-2)"	29.1	26.8	11.9	20.3	12.6	35.5	22.8	14.3	15.7	23.1	15.0	30.9	18.5	26.0	17.6	25.2	25.6	19.8	100.3	11.0	12.8	26.0	51.7	25.1	28.6	13.3	12.6	25.1	26.9	23.9	15.5	20.2	13.2	21.0	22.7	25.0	48.1	20.1	67.1	19.0	21.2	32.1	12.9	23.2	22.8	26.3	13.1	21.5	37.4	43.4	26.7	23.4	18.7	14.6	20.7	24.8	29.5	23.4	51.7	46.1	41.3	54.0	31.1	34.1	32.1	33.5	38.6	87.6	32.4	34.3	19.3	16.1	52.6	35.0	51.7	40.8	34.4	40.7	39.2	47.6	55.2	103.8	31.6	46.6	40.3	32.0	46.4	41.4	36.1	53.1	84.3	57.9	43.8	46.4	80.9	48.6	26.3	63.2	46.7	65.0	42.2	55.9	36.7	22.6	51.1	23.8	19.0	42.9	55.7	33.0	21.5	28.1	38.7	43.3	29.4	26.3	39.1	96.1	74.7	83.2	36.2	63.8	31.6	16.3	27.4	16.7	15.9	22.7	22.3	21.6	20.1	20.7	28.9	17.7	21.6	20.0	4.1	20.1	18.8	19.6	25.9	16.3	11.9	12.6	14.3	15.7	11.0	12.8	13.3	12.6	13.2	12.9	13.1	14.6	32.5	54.5	32.4	8.1	31.9	49.2	53.9	22.3	35.3	63.0	21.5	29.1	154.0	27.1	26.2	9.2	14.6	38.2	29.8	21.2	58.7	32.7	197.7	34.9	58.2	31.5	16.8	29.6	13.0	51.0	37.9	35.3	18.8	26.9	22.9	25.7	32.5	70.6	73.5	16.8	13.4	25.7	20.3	56.2	36.0	50.5	39.1	48.2	46.2	20.6	38.1	38.4	14.4	11.6	17.3	43.5	27.8	28.6	27.4	43.6	26.0	78.3	20.3	26.1	13.1	42.4	34.9	46.2	17.7	33.6	51.6	34.3	29.7	38.4	26.9	56.6
ZNF343	MGC10715	ENSG00000088876	"Zinc finger protein 343"	Q6P1L6	20	2481817-2524702	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 14.0;Inhibitory neurons: 14.2;Oligodendrocyte precursor cells: 13.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA030587, HPA052438"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA030587: AB_10603246, HPA052438: AB_2681833"	"unprognostic (5.77e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.75e-3)"	"unprognostic (3.83e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.38e-6)"	"unprognostic (9.26e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.88e-1)"	"unprognostic (5.60e-2)"	"prognostic unfavorable (4.53e-5)"	"unprognostic (1.65e-1)"	"unprognostic (3.71e-1)"	"unprognostic (3.41e-2)"	"unprognostic (9.53e-2)"	6.8	4.4	4.3	5.2	3.9	1.9	8.1	6.6	6.8	7.4	3.9	7.5	4.1	8.0	10.3	5.6	6.6	4.3	4.2	4.6	4.8	5.5	4.7	5.2	5.3	3.2	3.4	7.9	4.5	8.7	4.7	6.2	3.5	5.8	5.9	6.2	5.5	6.1	7.9	8.0	4.2	7.7	2.3	5.8	4.9	4.4	4.4	5.6	6.4	8.9	6.2	6.7	6.2	5.8	11.7	14.5	8.7	10.5	10.1	10.0	3.4	8.7	9.3	10.2	10.1	8.2	6.8	18.1	3.6	8.3	10.7	12.4	13.8	15.7	13.0	4.4	7.6	9.9	6.9	18.0	9.2	6.8	4.0	10.3	15.0	13.2	20.6	11.2	10.1	11.5	13.9	7.6	10.0	4.7	13.1	5.8	9.0	10.5	13.8	11.1	12.3	10.1	6.3	5.8	10.7	16.6	10.5	17.1	10.6	7.1	6.1	6.1	7.5	13.6	6.7	10.8	10.1	15.4	28.3	8.1	3.2	8.7	8.7	0.5	2.2	2.7	2.9	2.3	3.5	4.0	3.9	2.4	2.3	4.8	4.0	4.7	1.7	1.3	2.1	3.6	3.4	2.1	4.3	3.9	6.6	6.8	4.6	4.8	3.2	3.4	3.5	2.3	4.4	5.8	2.0	3.2	1.5	6.2	4.0	2.0	1.6	0.9	5.2	4.1	1.8	1.5	1.9	1.5	2.3	1.8	0.0	2.4	2.2	1.6	1.9	2.2	0.9	0.9	3.3	2.2	3.0	0.8	14.0	0.9	1.3	3.6	2.0	1.2	1.3	2.2	1.8	3.6	1.4	8.4	14.2	2.2	4.1	1.3	1.2	0.2	4.1	1.4	1.8	2.8	1.4	2.6	1.0	13.6	8.9	2.5	0.8	3.0	2.3	2.1	1.8	3.4	1.0	2.9	0.0	2.2	3.9	4.2	3.5	4.5	2.3	0.8	1.9	2.0	2.5	1.7
ZNF367	FLJ33970	ENSG00000165244	"Zinc finger protein 367"	Q7RTV3	9	96385941-96418370	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 26.1"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA015319, HPA015785"	Uncertain		Supported	Nucleoplasm		NA	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA015319: AB_2669185, HPA015785: AB_2217750"	"unprognostic (5.91e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.17e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.57e-3)"	"unprognostic (7.76e-3)"	"unprognostic (1.60e-3)"	"unprognostic (4.35e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.71e-2)"	"unprognostic (4.88e-3)"	"unprognostic (3.23e-3)"	"unprognostic (1.72e-1)"	"prognostic favorable (2.34e-4)"	"unprognostic (2.28e-1)"	1.4	0.6	0.7	3.7	1.3	26.1	1.7	1.4	1.3	1.1	0.2	3.0	2.9	1.1	0.1	2.4	0.7	1.0	2.1	0.7	1.0	3.0	10.8	1.1	4.6	1.5	1.4	1.0	1.4	1.6	0.3	1.9	1.4	1.2	3.3	1.3	0.7	0.4	1.5	3.5	3.0	2.4	0.9	1.3	2.1	6.1	1.3	8.7	1.1	2.7	4.7	1.5	1.2	2.7	25.4	10.3	9.9	8.9	3.8	5.3	13.4	34.6	20.4	16.9	20.0	6.4	17.5	19.2	14.4	16.5	12.6	30.5	11.6	12.6	19.9	21.2	10.0	14.0	19.1	5.3	0.0	19.8	16.5	0.9	0.8	13.7	6.9	3.7	6.3	13.3	13.0	45.4	21.7	16.9	30.4	16.1	6.7	27.9	16.7	15.3	49.9	11.7	4.9	16.8	17.4	12.0	15.3	18.1	10.6	8.0	9.4	17.3	5.7	27.6	15.8	25.6	26.6	17.6	32.0	7.8	16.7	17.0	23.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.7	1.3	1.4	1.3	0.7	1.0	1.5	1.4	1.4	0.9	1.3	2.7	1.1	0.0	0.0	2.9	3.8	9.9	1.3	0.4	10.8	0.7	2.2	2.3	2.6	0.0	0.9	0.0	0.0	3.2	2.5	2.4	0.0	0.5	0.7	0.6	1.1	2.0	0.0	22.3	5.1	1.2	4.2	1.7	2.6	1.8	0.0	4.7	1.1	3.8	1.9	0.0	5.3	3.6	0.0	2.1	2.6	0.8	0.6	8.3	3.6	2.8	0.1	0.6	1.0	3.0	7.9	0.7	0.5	0.7	9.6	0.6	0.9	2.5	0.0	1.5	6.6	2.0	3.6	10.3	1.7	10.9	6.5	0.8	5.0	0.3	5.6	1.1
ZNF407	"FLJ13839, FLJ20307, KIAA1703"	ENSG00000215421	"Zinc finger protein 407"	Q9C0G0	18	74597870-75065671	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Astrocytes: 96.9;Excitatory neurons: 111.0;Inhibitory neurons: 100.2;Microglial cells: 113.4;Oligodendrocyte precursor cells: 122.6;Oligodendrocytes: 130.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028255, HPA041673"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Plasma membrane"		"HPA028255: AB_10603466, HPA041673: AB_2677610"	"unprognostic (3.96e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.48e-1)"	"unprognostic (8.62e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.31e-1)"	"unprognostic (1.19e-3)"	"unprognostic (4.04e-4)"	"unprognostic (3.47e-2)"	"unprognostic (2.22e-1)"	"prognostic favorable (9.79e-5)"	"unprognostic (8.87e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.11e-2)"	2.4	1.9	2.9	3.1	3.5	5.3	2.9	8.0	2.8	2.7	8.6	2.8	2.2	3.7	1.9	2.5	2.7	2.1	3.2	2.3	2.9	2.4	2.2	2.4	3.3	3.6	3.0	4.8	2.2	3.9	1.5	2.7	4.1	2.8	2.2	2.9	2.4	2.8	3.9	2.3	2.4	3.1	2.9	3.4	2.3	4.0	3.2	5.5	3.6	3.6	3.0	2.4	2.0	4.1	3.9	4.0	4.4	4.1	3.2	4.7	3.2	5.1	4.4	3.7	4.0	1.7	2.2	5.6	1.5	7.1	2.5	4.5	4.2	5.5	5.4	9.3	2.6	7.1	5.5	3.2	2.9	10.9	6.0	4.3	2.4	5.9	5.1	3.5	5.6	3.9	4.1	8.0	5.7	3.1	5.3	1.5	2.6	1.4	3.6	5.4	5.8	4.4	2.6	7.2	4.2	4.0	4.7	2.9	3.6	3.2	3.4	4.6	7.9	8.3	3.5	2.3	4.1	2.8	6.2	5.7	3.0	4.6	5.0	1.6	0.7	0.9	1.0	0.9	1.0	0.8	0.8	0.6	0.3	0.8	0.9	1.1	2.2	1.1	0.6	1.3	0.2	0.4	2.9	3.5	8.0	2.8	2.3	2.9	3.6	3.0	4.1	2.9	3.2	4.1	16.5	6.4	6.3	96.9	10.6	3.2	5.0	3.0	2.8	11.2	6.3	6.0	19.4	2.8	4.9	5.5	6.2	4.2	11.4	6.9	0.0	4.3	4.6	8.6	15.3	10.0	4.2	3.4	111.0	2.9	2.7	7.6	17.3	14.4	1.3	10.2	3.3	5.5	3.2	5.0	100.2	5.7	2.0	5.3	2.8	3.3	5.3	7.6	5.4	113.4	6.1	6.2	8.2	122.6	130.5	4.8	6.0	4.5	11.1	4.4	4.3	2.6	6.2	13.2	6.6	10.8	8.1	9.0	12.8	5.6	4.1	5.2	10.1	12.1	6.0	3.9
ZNF555	MGC26707	ENSG00000186300	"Zinc finger protein 555"	Q8NEP9	19	2841437-2860471	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 81.6;Late spermatids: 62.6;Spermatocytes: 27.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA053956, HPA055430"	Uncertain					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA053956: AB_2682321, HPA055430: AB_2682814"	"unprognostic (9.64e-3)"	"unprognostic (4.39e-3)"	"unprognostic (7.98e-2)"	"unprognostic (2.08e-3)"	"unprognostic (4.30e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.11e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.99e-3)"	"unprognostic (5.73e-2)"	"unprognostic (1.06e-7)"	"unprognostic (2.44e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.66e-2)"	2.3	1.9	1.3	1.5	2.0	2.8	4.0	3.1	2.4	3.0	1.0	2.5	1.4	3.7	3.0	3.3	3.2	1.3	3.0	1.4	1.7	3.0	2.3	2.2	2.4	2.4	1.8	5.9	2.7	3.3	1.9	3.9	2.3	2.9	1.8	5.5	2.3	3.4	2.7	2.0	1.7	2.2	1.7	2.8	2.2	5.7	1.9	2.5	4.0	4.7	3.0	2.7	2.4	2.9	2.5	1.2	5.7	4.9	4.6	7.6	2.9	2.2	6.0	5.6	5.6	3.1	2.0	3.1	1.8	3.9	4.3	2.0	4.9	3.1	5.2	0.0	2.3	2.3	1.5	4.0	5.5	0.0	4.0	5.0	4.7	3.0	7.4	6.2	5.6	4.0	5.0	1.7	6.4	0.9	1.9	2.4	3.4	1.5	2.9	4.1	6.0	1.3	6.7	2.5	1.3	4.5	3.2	3.4	5.6	6.6	2.5	4.2	3.8	3.2	1.8	4.7	3.0	1.0	4.7	0.0	3.3	6.4	3.1	5.2	4.7	8.0	3.2	5.6	4.7	3.0	3.6	4.4	6.9	2.1	3.2	2.6	0.5	2.6	9.6	9.6	4.0	3.3	1.3	2.0	3.1	2.4	1.4	1.7	2.4	1.8	2.3	1.7	1.9	2.9	2.4	0.0	1.1	13.1	2.0	0.6	1.7	1.4	1.8	13.2	2.8	2.5	5.7	1.5	1.0	1.8	18.8	1.9	2.6	0.4	3.9	2.8	81.6	2.4	4.1	2.2	1.2	3.4	8.9	2.0	1.2	3.2	1.5	3.3	0.0	6.2	3.9	0.9	2.1	11.8	11.7	1.3	0.0	1.9	3.8	62.6	5.9	2.7	0.0	1.9	2.9	6.8	1.0	8.5	11.5	1.8	1.5	3.8	5.8	1.7	0.5	2.3	2.3	13.0	0.0	4.7	2.5	27.2	11.3	1.6	1.7	1.6	1.8	4.3	1.0	1.1
ZNF562	FLJ20079	ENSG00000171466	"Zinc finger protein 562"	Q6V9R5	19	9641807-9675100	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA055332, HPA062397"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA055332: AB_2682786, HPA062397: AB_2684751"	"unprognostic (2.14e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.02e-2)"	"prognostic favorable (4.17e-4)"	"unprognostic (4.44e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.88e-2)"	"unprognostic (2.96e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.62e-3)"	"unprognostic (9.44e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.13e-3)"	5.9	4.6	6.1	6.4	6.7	7.5	11.6	12.6	6.3	6.1	5.2	8.3	5.0	7.9	4.3	14.0	5.4	6.4	5.6	4.5	6.3	5.5	6.9	5.7	5.9	5.9	5.3	6.1	6.0	5.8	4.7	6.2	5.6	6.3	7.5	5.7	6.7	6.4	3.0	6.0	5.3	8.0	5.5	7.2	5.8	3.5	6.7	5.4	5.9	5.2	7.4	9.0	7.1	10.2	12.7	10.5	15.2	29.0	7.9	7.3	0.7	13.6	9.4	14.1	15.4	8.2	7.2	12.9	13.1	10.4	11.4	10.1	19.7	15.2	17.5	14.4	12.1	46.3	10.9	8.2	9.2	16.6	33.1	12.9	10.5	17.5	28.1	7.8	15.4	10.3	22.8	22.0	14.0	6.2	16.7	4.1	19.8	8.9	6.8	6.5	17.5	6.3	6.6	34.8	16.0	10.0	20.1	7.7	9.3	12.0	11.3	13.6	13.5	24.9	9.7	11.4	17.7	17.7	45.3	21.1	3.5	1.1	13.2	3.3	2.7	3.1	2.4	3.9	3.6	3.1	2.1	1.7	3.5	2.3	2.4	3.0	1.2	3.0	4.5	2.1	2.3	1.3	6.1	6.7	12.6	6.3	4.5	6.3	5.9	5.3	5.6	5.5	6.7	10.2	14.7	9.6	18.5	8.5	11.3	6.4	40.0	11.6	12.0	30.6	23.9	14.4	9.4	30.0	17.7	25.8	73.0	14.9	11.9	32.2	19.6	19.6	7.5	20.1	17.6	18.1	23.9	23.8	19.4	8.6	18.5	12.7	19.4	29.7	12.7	22.1	23.2	13.6	11.9	28.6	18.0	16.9	12.2	31.5	8.9	12.2	12.2	16.7	7.2	18.7	21.3	12.4	20.6	24.6	22.2	24.7	20.9	13.5	6.1	45.1	9.6	9.1	15.6	31.2	0.0	17.4	12.8	13.5	11.4	14.6	10.1	19.4	11.9	13.7	18.1	67.1
ZNF594	KIAA1871	ENSG00000180626	"Zinc finger protein 594"	Q96JF6	17	5179535-5191868	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 17.8;Horizontal cells: 15.2;Inhibitory neurons: 15.7;Oligodendrocytes: 20.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA060283, HPA067178, HPA069360, HPA074493, HPA077596"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA060283: AB_2732645, HPA067178: AB_2685796, HPA069360: AB_2732131, HPA074493: , HPA077596: "	"unprognostic (6.67e-2)"	"unprognostic (1.07e-2)"	"unprognostic (6.93e-2)"	"unprognostic (7.92e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.24e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.33e-5)"	"unprognostic (4.09e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.99e-1)"	"unprognostic (5.21e-2)"	"unprognostic (6.59e-2)"	1.8	3.3	2.8	4.2	3.9	0.7	4.9	6.0	3.8	4.4	4.5	3.9	1.6	5.1	4.2	1.9	4.4	2.2	2.9	3.0	2.7	4.2	2.2	2.2	6.2	3.8	2.8	10.7	3.3	5.4	6.2	3.2	3.1	5.1	2.7	11.7	3.8	4.3	4.0	2.1	4.0	3.0	2.0	5.1	2.9	4.5	3.4	5.1	5.6	2.9	5.9	3.6	2.9	6.8	5.8	2.5	10.5	8.3	1.6	1.8	8.9	3.8	1.9	6.6	6.2	7.3	2.1	13.1	5.9	3.0	4.9	6.2	6.8	0.2	8.3	7.0	6.9	4.2	10.2	3.7	2.4	0.0	4.0	1.4	1.1	4.0	0.0	1.7	0.7	7.5	1.7	3.2	2.2	5.7	3.6	1.8	4.9	0.9	3.5	7.6	8.9	1.7	1.9	1.5	6.2	8.4	2.8	1.5	5.8	4.6	3.4	3.1	0.1	0.1	3.7	3.4	2.7	2.0	4.5	3.0	0.6	0.0	4.1	0.2	0.4	0.5	1.4	0.5	1.0	1.6	1.5	1.4	0.4	2.5	2.3	1.6	0.2	1.3	0.5	2.2	2.4	0.6	2.8	3.9	6.0	3.8	3.0	2.7	3.8	2.8	3.1	2.0	3.4	6.8	1.8	6.4	3.9	14.0	3.6	1.1	1.3	0.4	1.2	9.5	2.5	2.2	5.5	4.3	2.8	5.5	6.2	1.4	1.3	0.7	7.9	1.6	0.8	0.8	3.1	2.1	1.2	2.5	17.8	1.1	0.7	2.7	1.5	0.8	3.8	9.9	3.9	0.7	1.1	15.2	15.7	1.5	0.0	1.4	0.6	4.3	3.4	1.2	0.0	8.4	1.5	7.7	3.1	14.6	20.3	0.7	1.5	2.6	0.8	0.9	0.6	1.0	5.0	9.2	0.0	3.3	2.4	2.5	4.1	0.9	0.3	0.3	1.8	5.2	1.3	0.5
ZNF644	"BM-005, KIAA1221, MGC60165, MGC70410"	ENSG00000122482	"Zinc finger protein 644"	Q9H582	1	90915298-91022272	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 262.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057795	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Vesicles		"HPA057795: AB_2683529"	"unprognostic (8.20e-2)"	"unprognostic (5.86e-3)"	"prognostic favorable (4.27e-4)"	"prognostic unfavorable (8.39e-4)"	"unprognostic (3.19e-3)"	"unprognostic (4.62e-3)"	"unprognostic (8.04e-2)"	"unprognostic (7.01e-2)"	"unprognostic (2.44e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.03e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.07e-1)"	12.4	9.8	17.4	11.7	23.4	17.3	17.1	24.5	22.3	15.7	13.3	13.3	8.5	17.2	11.4	10.3	10.9	10.2	10.0	15.3	18.0	11.0	19.8	10.3	15.9	19.0	20.8	14.7	9.6	12.6	7.9	13.2	19.4	11.6	13.4	11.2	15.4	10.4	14.5	10.4	10.5	12.2	18.8	13.2	10.5	13.1	18.6	19.7	18.7	17.4	15.3	13.5	12.1	28.4	24.1	11.2	32.0	17.1	14.9	17.1	19.4	21.0	21.1	22.1	24.1	15.4	8.3	29.0	23.2	15.6	29.3	19.1	31.6	23.7	33.4	21.5	19.8	38.3	21.8	21.1	20.6	34.6	11.9	16.3	27.0	22.4	30.1	20.8	23.8	21.6	26.8	32.0	23.6	9.5	27.9	30.0	30.3	12.5	22.7	28.7	52.3	16.6	23.5	21.5	25.8	20.6	24.5	19.1	55.2	21.7	12.4	33.7	19.0	24.5	21.3	20.4	31.9	24.5	17.8	39.7	10.3	25.8	12.9	5.4	3.5	4.0	4.6	3.6	5.3	6.8	5.0	5.3	4.4	5.2	6.4	5.5	1.1	9.9	3.8	5.4	4.4	2.6	17.4	23.4	24.5	22.3	15.3	18.0	19.0	20.8	19.4	18.8	18.6	28.4	72.6	70.5	30.0	98.9	85.9	54.2	98.9	45.0	48.3	37.3	49.8	45.0	51.2	28.6	47.0	11.0	25.0	25.6	85.2	34.3	31.3	31.1	11.4	87.3	68.7	44.9	55.0	30.9	96.0	22.6	19.6	51.8	43.8	107.9	43.2	51.9	27.1	26.1	22.5	55.5	106.2	30.4	36.7	29.2	38.6	13.3	46.6	49.7	35.6	124.6	30.7	40.2	38.1	144.3	262.3	29.6	29.2	34.6	79.6	58.8	22.2	29.2	41.7	36.8	52.6	83.5	67.4	51.5	49.2	39.8	47.5	12.0	72.9	44.5	34.0	75.2
ZNF655	"VIK, VIK-1"	ENSG00000197343	"Zinc finger protein 655"	Q8N720	7	99558406-99576453	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029534, HPA050750"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane"	"HPA029534: AB_10603008, HPA050750: AB_2681225"	"prognostic favorable (7.12e-4)"	"unprognostic (3.03e-2)"	"unprognostic (9.62e-2)"	"unprognostic (5.00e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.31e-2)"	"unprognostic (3.93e-3)"	"prognostic unfavorable (7.24e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.12e-1)"	11.6	11.9	7.0	14.3	6.2	8.9	12.8	8.3	7.8	13.2	5.9	15.5	15.9	10.1	11.0	26.9	11.5	10.2	8.4	6.3	6.1	13.8	14.9	15.3	19.7	5.0	5.5	13.9	21.1	14.4	8.2	12.5	6.4	11.4	11.8	8.5	16.7	11.3	12.7	18.4	13.8	11.7	5.1	14.2	18.0	7.4	6.3	22.6	11.8	13.5	17.3	18.8	14.9	9.6	40.5	35.9	16.5	23.9	15.8	25.4	12.4	24.0	45.8	40.7	37.8	20.1	37.0	31.8	0.4	33.2	52.0	25.2	18.0	29.6	40.6	34.5	23.6	18.9	16.0	27.8	24.1	38.1	35.9	21.1	32.8	35.8	50.6	21.4	17.3	26.4	54.4	39.7	24.4	0.1	53.9	36.6	21.1	0.1	0.0	19.9	14.0	52.9	25.9	42.8	17.4	37.6	25.1	0.7	27.2	24.0	12.2	20.2	13.3	24.3	60.2	43.4	43.6	47.3	72.7	63.4	23.5	18.2	39.9	147.8	43.2	74.4	47.8	47.2	45.1	32.7	44.1	55.7	40.3	31.3	35.0	43.8	50.3	37.0	55.2	23.3	61.3	55.4	7.0	6.2	8.3	7.8	6.3	6.1	5.0	5.5	6.4	5.1	6.3	9.6	19.5	96.1	82.8	51.2	53.2	44.7	46.5	36.5	42.1	48.8	34.4	25.1	36.1	31.5	44.3	23.9	41.7	31.6	76.3	46.3	33.2	31.6	12.8	25.8	33.9	20.4	41.5	12.8	53.4	36.2	42.7	32.7	37.2	33.0	18.9	70.8	19.2	24.6	37.4	50.5	57.4	40.4	18.3	63.4	31.6	9.7	25.4	56.0	23.2	44.0	59.2	24.9	106.1	61.3	75.3	48.2	55.2	25.2	55.4	44.5	48.1	41.1	26.0	45.8	13.1	39.9	31.7	39.0	29.8	55.6	48.9	73.6	62.5	30.0	28.1	64.0
ZNF718	FLJ90036	ENSG00000250312	"Zinc finger protein 718"	Q3SXZ3	4	124501-202303	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 37.5;Excitatory neurons: 40.1;Inhibitory neurons: 58.2;Microglial cells: 47.8;Oligodendrocyte precursor cells: 62.8;Oligodendrocytes: 85.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 19.3"															NA	Yes			"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"				"unprognostic (1.96e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.62e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.60e-1)"	"unprognostic (8.97e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (7.67e-6)"	"unprognostic (1.39e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.92e-1)"	1.9	3.0	1.8	2.2	1.8	3.0	2.6	3.4	2.5	3.3	0.5	2.5	1.7	2.2	2.1	1.8	2.9	2.0	1.9	1.3	2.3	2.5	1.4	2.0	3.8	2.0	2.5	3.5	2.5	2.7	2.0	2.8	2.4	3.0	2.2	2.7	2.2	2.2	0.9	3.0	1.9	1.9	1.5	2.9	1.9	2.0	2.4	4.6	4.7	1.8	3.4	2.0	2.3	2.7	0.0	0.9	5.4	0.0	3.3	6.2	1.3	6.9	0.9	4.3	3.3	5.9	7.7	8.5	4.0	2.5	7.6	2.0	4.4	3.2	5.8	0.0	1.6	0.0	1.5	0.0	4.1	0.1	0.1	3.2	2.8	4.3	0.6	3.9	2.9	2.4	4.1	0.1	7.6	4.4	0.8	5.3	6.6	0.0	2.4	19.3	2.1	4.7	3.5	2.1	7.3	1.7	3.5	1.2	4.2	4.3	12.5	1.6	2.1	3.2	4.0	4.1	5.1	0.0	0.0	13.3	0.0	0.0	4.0	2.6	1.3	5.7	2.2	1.8	2.1	2.0	1.9	1.4	2.4	2.2	2.2	2.1	1.6	5.4	1.1	2.4	1.6	1.2	1.8	1.8	3.4	2.5	1.3	2.3	2.0	2.5	2.4	1.5	2.4	2.7	4.0	3.2	3.6	37.5	6.5	2.0	2.2	1.4	4.6	8.4	3.5	3.0	2.4	0.0	5.1	0.0	2.1	1.9	7.6	1.2	0.0	3.1	0.3	1.0	3.7	3.4	1.2	9.7	40.1	1.4	1.4	3.6	4.1	1.6	5.7	6.6	6.1	0.9	1.4	8.4	58.2	0.7	0.0	1.6	1.9	0.7	3.7	2.9	3.6	47.8	1.7	2.6	15.5	62.8	85.0	1.6	0.1	4.5	4.6	0.9	0.5	1.4	2.6	5.1	0.0	4.4	3.8	2.4	4.1	3.0	0.9	1.4	5.5	4.0	0.8	1.4
ZNF75D	"D8C6, ZKSCAN24, ZNF75, ZNF82, ZSCAN28"	ENSG00000186376	"Zinc finger protein 75D"	P51815	X	135248920-135344109	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"Early spermatids: 202.9;Late spermatids: 378.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA004705	Supported		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA004705: AB_1080749"	"unprognostic (1.56e-3)"	"unprognostic (7.96e-3)"	"unprognostic (3.07e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.00e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.32e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.13e-2)"	"prognostic favorable (1.31e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (7.42e-5)"	6.3	14.5	4.8	5.6	4.9	6.9	6.3	4.7	5.3	7.1	5.6	6.7	4.8	6.2	7.5	5.2	7.0	4.7	5.5	4.6	5.6	8.4	11.0	6.7	8.4	5.2	4.9	6.8	9.8	7.1	6.9	5.0	5.4	10.2	5.5	6.7	6.4	5.9	5.1	6.8	8.2	4.9	4.9	13.9	7.5	2.2	5.2	8.6	9.3	3.9	7.2	6.0	5.8	5.3	3.3	4.3	4.6	7.4	7.7	9.3	7.0	5.5	7.5	4.4	9.4	2.6	4.1	3.5	7.9	4.7	8.5	4.5	15.2	2.5	4.2	3.3	4.0	2.4	8.6	3.5	3.3	4.1	6.6	4.6	5.9	2.7	3.4	5.5	4.6	4.4	2.1	5.4	3.9	8.0	5.0	7.5	2.2	6.7	5.8	4.7	4.6	3.1	5.0	4.5	1.5	5.2	3.1	5.2	0.9	4.9	1.8	5.9	4.8	4.2	1.0	7.1	5.3	2.7	4.1	2.5	2.6	4.5	2.7	2.7	1.0	2.0	2.3	0.8	2.1	1.4	2.5	2.7	0.9	1.6	3.1	2.8	1.1	2.8	0.8	0.8	3.4	1.5	4.8	4.9	4.7	5.3	4.6	5.6	5.2	4.9	5.4	4.9	5.2	5.3	6.4	6.4	12.9	23.5	7.5	1.8	1.3	1.4	2.8	4.9	3.9	2.0	4.7	1.5	5.0	0.0	6.2	2.4	8.4	3.7	1.9	2.0	202.9	9.2	4.8	7.1	1.8	0.8	18.5	4.0	1.5	4.2	6.1	4.9	6.3	4.9	5.7	5.3	2.4	5.0	21.8	5.0	6.1	2.9	1.6	378.3	6.5	3.8	0.0	28.1	3.9	4.1	6.2	18.6	21.4	3.1	2.8	3.4	5.0	2.3	3.3	3.7	5.1	5.1	0.0	3.4	3.5	7.6	3.1	3.4	1.4	1.8	7.1	10.2	3.6	2.3
ZNF77	pT1	ENSG00000175691	"Zinc finger protein 77"	Q15935	19	2933218-2944971	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 14.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA023397	Uncertain		Approved	Nucleoplasm,Nucleoli		No	No			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoli	Nucleoplasm	"HPA023397: AB_1859447"	"unprognostic (1.17e-2)"	"prognostic favorable (8.49e-4)"	"unprognostic (2.18e-1)"	"prognostic favorable (6.65e-5)"	"unprognostic (2.01e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (6.79e-6)"	"unprognostic (2.06e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.93e-3)"	"unprognostic (2.65e-3)"	"unprognostic (3.20e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.79e-3)"	2.7	2.7	2.3	1.2	2.3	2.2	4.6	4.6	2.6	3.5	2.0	2.5	1.4	3.0	2.8	3.1	2.9	1.4	2.6	2.1	2.2	3.4	2.7	2.8	2.5	2.2	2.2	3.4	3.0	3.3	3.1	2.9	2.3	2.8	2.1	4.0	2.6	2.1	2.6	3.2	2.1	2.9	2.1	2.6	3.2	3.6	2.2	3.4	3.0	4.1	3.4	2.6	2.9	2.7	4.3	2.1	9.4	5.5	1.9	2.5	4.2	2.5	3.8	5.0	5.9	6.5	1.7	4.8	2.1	2.8	2.7	3.4	6.1	4.1	8.3	0.7	4.7	5.9	3.4	7.3	4.8	0.2	4.6	3.9	5.6	3.9	5.7	6.2	7.0	9.2	7.7	0.0	3.4	4.7	7.2	4.2	2.1	3.7	2.8	8.1	7.3	3.3	4.1	6.5	3.8	7.2	3.9	3.6	4.6	4.5	3.5	10.0	3.5	2.1	2.7	6.0	4.7	4.8	4.9	2.2	5.4	0.1	3.9	0.0	1.6	0.8	3.0	1.7	3.5	3.7	3.1	3.2	2.2	3.5	2.3	3.4	0.1	2.4	1.8	1.7	1.6	1.9	2.3	2.3	4.6	2.6	2.1	2.2	2.2	2.2	2.3	2.1	2.2	2.7	4.2	3.2	3.9	3.6	2.2	11.6	4.7	3.3	14.2	2.8	4.6	5.3	2.2	1.5	3.4	1.8	2.1	3.6	5.7	1.9	0.0	2.1	2.1	3.3	3.6	3.7	7.2	1.3	2.9	1.8	3.0	2.9	4.6	4.0	2.5	4.0	4.2	2.2	1.7	0.0	3.2	2.5	2.0	1.6	2.8	0.3	2.8	1.7	1.8	0.0	0.7	3.3	4.1	1.0	2.6	2.4	1.9	1.5	2.0	2.8	1.5	1.4	2.0	5.6	0.0	2.5	2.3	9.7	8.1	6.8	10.9	6.2	3.3	5.4	3.4	1.8
ZNF777	KIAA1285	ENSG00000196453	"Zinc finger protein 777"	Q9ULD5	7	149431363-149461062	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003252	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA003252: AB_1080755"	"unprognostic (7.19e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (4.78e-2)"	"unprognostic (6.64e-2)"	"unprognostic (5.87e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.15e-2)"	"unprognostic (5.17e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.00e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.23e-2)"	"unprognostic (5.72e-2)"	7.5	6.6	5.9	4.4	5.4	7.9	7.7	5.8	7.0	8.7	2.3	9.0	4.5	10.4	3.3	6.2	8.4	3.6	7.1	6.0	6.3	6.2	7.3	5.3	5.1	5.9	5.3	10.0	7.5	6.4	8.5	4.9	5.1	8.9	3.3	3.4	7.5	5.2	13.9	11.7	6.3	5.2	4.7	6.7	7.3	6.7	5.9	5.7	7.3	7.0	3.9	9.0	7.9	5.5	14.9	18.0	11.9	17.3	8.7	7.0	15.3	9.4	9.9	12.5	10.8	11.3	9.3	9.4	18.5	10.7	7.7	9.7	11.7	14.3	6.8	15.3	17.8	9.2	5.0	11.4	14.7	13.2	12.9	8.3	16.1	10.1	14.6	6.6	6.8	12.4	30.2	0.0	7.2	19.2	27.9	18.0	14.5	6.6	10.5	22.7	6.1	19.8	7.7	11.4	12.9	18.1	16.2	16.5	15.7	4.3	7.8	21.7	10.7	10.4	4.1	20.8	15.5	8.6	8.2	4.4	7.8	9.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.9	5.4	5.8	7.0	6.0	6.3	5.9	5.3	5.1	4.7	5.9	5.5	4.0	0.0	1.7	5.9	3.8	1.1	1.4	0.3	2.8	6.5	3.9	5.5	2.9	2.8	0.1	1.8	6.2	2.0	4.2	3.1	0.0	1.2	2.6	2.9	4.8	2.9	1.8	6.6	6.9	1.0	3.8	2.8	2.0	4.5	0.0	8.2	2.9	5.7	1.6	1.7	6.7	3.1	0.0	2.2	1.3	3.8	2.8	2.0	0.0	4.7	0.2	5.5	2.1	3.0	3.5	1.1	3.1	3.4	1.6	2.4	1.4	1.6	0.8	5.5	0.0	5.2	3.7	1.5	4.6	2.5	1.8	3.8	3.5	6.6	2.8	1.0
ZNHIT3	"Hit1, TRIP3"	ENSG00000273611	"Zinc finger HIT-type containing 3"	Q15649	17	36486629-36499310	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Epilepsy, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 222.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060019, HPA078211"	Approved		Approved	Mitochondria		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Mitochondria		"HPA060019: AB_2684188, HPA078211: "	"unprognostic (5.47e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.75e-3)"	"unprognostic (6.03e-2)"	"unprognostic (6.48e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.19e-2)"	27.4	32.4	33.4	17.6	34.9	31.2	32.7	33.6	43.1	26.2	31.3	30.9	24.1	24.6	39.9	30.4	24.0	20.1	27.2	33.9	35.1	35.1	35.9	19.4	39.1	33.5	34.0	31.1	33.1	27.4	24.0	21.0	33.9	26.3	30.5	19.5	26.3	20.0	58.0	30.9	24.1	18.9	35.2	25.5	28.2	50.4	33.4	29.4	28.7	32.4	39.7	30.0	26.5	35.6	39.6	39.0	70.4	55.1	38.6	49.4	38.8	35.8	56.0	53.6	55.2	6.9	55.7	67.3	38.8	18.0	66.8	37.1	25.7	30.8	66.5	35.3	25.7	27.2	41.1	54.3	28.2	73.0	37.7	34.4	69.0	22.1	53.6	60.3	37.1	79.6	48.5	39.8	58.3	36.0	98.3	92.5	50.1	38.0	38.0	33.0	71.2	56.1	67.7	35.2	57.6	42.7	42.7	26.3	73.0	59.5	76.3	72.7	36.4	25.2	42.6	50.9	54.3	41.3	57.6	68.8	54.6	44.3	50.5	15.7	14.5	10.3	15.5	11.3	32.4	22.6	27.1	21.5	20.0	21.6	33.9	27.6	7.9	23.8	26.5	20.0	27.2	17.2	33.4	34.9	33.6	43.1	33.9	35.1	33.5	34.0	33.9	35.2	33.4	35.6	29.0	25.6	27.0	7.5	48.3	46.4	34.1	99.9	38.1	25.4	51.2	75.2	11.8	30.0	47.5	33.1	12.5	93.2	58.1	24.4	88.0	61.1	222.2	37.9	29.9	32.3	43.5	33.9	10.9	51.2	98.5	30.9	21.4	32.3	34.2	48.5	25.4	30.4	67.4	15.2	12.7	33.8	42.7	49.4	36.7	79.1	37.0	34.6	53.4	10.3	66.6	42.5	47.4	12.1	14.7	60.9	36.8	44.4	32.4	47.3	50.6	88.1	33.8	28.3	46.0	36.6	37.5	179.1	71.2	37.2	43.8	77.2	58.3	55.9	44.6	34.0
ZNHIT6	"BCD1, C1orf181, FLJ20729, NY-BR-75"	ENSG00000117174	"Zinc finger HIT-type containing 6"	Q9NWK9	1	85649417-85708433	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018132	Uncertain		Approved	"Nuclear speckles,Vesicles"		No	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles, Vesicles"		"HPA018132: AB_1848789"	"unprognostic (1.37e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (6.08e-6)"	"unprognostic (1.11e-1)"	"unprognostic (3.89e-2)"	"unprognostic (8.48e-2)"	"unprognostic (9.91e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.27e-3)"	"unprognostic (5.91e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.37e-2)"	10.3	6.6	7.2	5.2	8.2	5.2	10.1	6.8	7.7	14.6	5.3	9.7	2.9	11.0	4.4	11.8	9.6	3.6	7.7	6.8	7.9	9.0	6.7	6.9	6.4	7.7	7.4	10.4	7.2	4.2	7.5	4.7	7.6	8.9	4.2	3.3	9.5	4.4	7.8	11.1	7.9	5.5	8.1	8.1	6.9	6.1	7.6	5.5	8.5	3.9	6.0	11.6	11.3	9.1	13.5	9.1	8.9	8.1	19.2	17.4	11.3	17.0	16.3	11.5	11.0	9.2	6.8	10.4	19.7	10.4	24.7	11.2	15.9	10.9	18.6	14.3	13.7	21.6	10.3	10.7	16.2	35.4	8.3	17.2	10.0	15.3	13.4	11.4	13.7	16.4	20.2	13.3	17.6	5.1	20.9	9.2	13.5	11.0	16.5	16.6	19.7	12.0	18.7	25.2	8.6	5.6	13.3	20.3	19.3	9.3	9.0	8.9	15.6	14.8	10.0	12.5	24.7	8.5	9.3	28.2	3.4	22.0	13.1	0.6	0.7	0.1	1.8	0.7	2.0	1.9	1.6	2.0	1.2	2.4	2.0	2.0	0.1	1.8	0.7	2.1	1.8	0.8	7.2	8.2	6.8	7.7	6.8	7.9	7.7	7.4	7.6	8.1	7.6	9.1	22.0	16.0	22.5	22.5	20.3	16.2	14.4	12.5	13.1	31.8	10.6	9.9	17.6	11.5	38.0	31.3	33.3	9.0	21.0	25.6	3.9	11.9	4.2	15.5	47.4	20.9	9.5	8.4	40.4	8.8	13.7	22.2	6.1	16.1	27.8	22.4	14.3	10.6	7.5	15.2	30.0	20.9	16.2	13.5	7.4	3.8	13.4	9.1	7.2	22.5	11.0	17.6	27.8	34.2	45.3	12.2	11.6	12.8	11.1	11.1	15.5	6.3	18.0	38.8	19.7	22.4	20.7	35.8	21.6	14.0	16.3	2.7	20.1	25.8	20.5	10.8
ZRANB2	"ZIS, ZIS1, ZIS2, ZNF265"	ENSG00000132485	"Zinc finger RANBP2-type containing 2"	O95218	1	71063291-71081289	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053960, HPA061949, HPA063298"	Supported		Enhanced	Nucleoplasm		NA	Yes		13000	"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA053960: AB_2682323, HPA061949: AB_2684645, HPA063298: AB_2684979"	"unprognostic (2.10e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.15e-3)"	"unprognostic (8.11e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (7.29e-5)"	"unprognostic (4.25e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.79e-2)"	"unprognostic (4.54e-2)"	"prognostic unfavorable (5.70e-4)"	"prognostic unfavorable (1.57e-8)"	"unprognostic (3.96e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.84e-3)"	41.0	39.4	29.7	45.3	31.1	60.0	52.6	36.9	47.0	45.0	36.8	40.8	35.5	70.7	67.6	29.3	45.4	29.6	42.7	30.7	29.1	35.3	30.2	40.4	62.5	32.0	27.7	56.7	33.8	33.2	64.5	36.3	31.6	44.2	42.9	62.1	39.5	38.0	58.9	43.4	37.9	50.1	29.3	42.6	35.6	50.4	30.3	47.6	48.5	38.9	49.3	37.9	35.2	38.8	86.8	31.1	122.3	73.0	46.5	79.8	71.0	103.2	55.6	89.2	113.2	58.7	55.5	177.6	89.0	64.2	82.7	53.5	111.1	63.9	133.4	127.5	79.9	154.5	127.3	50.0	70.8	171.5	62.7	61.7	80.3	86.1	73.5	98.1	76.3	90.3	165.1	93.6	69.6	29.3	145.0	58.4	128.7	52.9	59.6	159.8	92.3	108.4	60.5	72.6	93.8	58.3	88.7	58.8	91.4	63.7	74.7	76.8	102.5	65.9	62.1	51.9	103.8	75.7	100.6	193.8	96.4	160.3	94.6	99.1	33.4	32.1	44.5	32.3	51.2	68.8	47.5	44.0	26.8	63.1	61.2	48.7	30.7	48.2	33.8	73.4	49.6	31.2	29.7	31.1	36.9	47.0	30.7	29.1	32.0	27.7	31.6	29.3	30.3	38.8	86.9	99.3	154.5	83.6	109.8	50.6	94.4	66.1	59.7	166.5	61.4	66.5	99.9	50.1	68.4	49.7	129.3	55.1	136.9	85.8	49.0	60.2	190.3	79.9	123.5	63.5	73.0	87.1	135.3	68.2	50.4	92.6	62.7	85.7	87.4	132.8	50.7	41.8	45.4	213.7	114.7	64.5	54.9	34.5	39.7	46.2	185.4	55.7	48.0	73.1	74.8	116.6	139.0	90.5	131.9	69.2	76.5	115.5	127.5	54.8	41.2	41.1	76.5	202.2	118.3	88.1	99.2	218.7	113.0	55.3	46.5	63.5	89.6	96.4	55.1	68.5
ZRANB3	"AH2, DKFZP434B1727"	ENSG00000121988	"Zinc finger RANBP2-type containing 3"	Q5FWF4	2	135136916-135531218	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Endonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 34.9;Excitatory neurons: 69.4;Inhibitory neurons: 46.2;Oligodendrocytes: 67.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA035234			Supported	Nucleoplasm		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA035234: AB_2674530"	"unprognostic (6.98e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.52e-3)"	"unprognostic (4.09e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.74e-1)"	"unprognostic (3.58e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.77e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.00e-2)"	"unprognostic (9.88e-2)"	0.8	1.4	0.5	0.9	0.7	1.1	0.8	0.2	0.8	1.0	0.2	0.7	0.5	0.9	0.5	0.7	0.9	0.7	0.9	0.6	0.3	0.7	1.1	0.6	0.6	0.1	0.1	1.5	1.3	0.6	1.4	0.5	0.2	0.9	0.4	1.5	0.7	0.5	2.0	0.8	0.6	0.4	0.1	0.8	0.7	3.2	0.3	0.8	1.0	0.6	0.4	0.8	0.8	0.7	0.9	0.9	1.7	1.1	0.8	1.5	1.5	1.3	0.9	0.9	1.1	1.5	0.7	2.8	1.3	1.0	0.6	0.9	2.4	1.1	1.6	2.5	1.8	3.2	0.4	3.5	0.6	2.5	0.6	1.3	1.0	1.3	3.2	1.5	1.3	1.6	3.1	1.3	0.7	1.3	1.5	1.4	1.1	0.8	1.1	1.8	1.3	1.0	1.3	0.6	1.8	2.3	1.1	0.5	0.9	1.6	0.9	1.1	1.0	0.7	0.6	0.4	0.8	1.1	1.4	2.6	1.0	1.7	1.0	0.1	0.1	0.1	0.1	0.0	0.2	0.3	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.5	0.7	0.2	0.8	0.6	0.3	0.1	0.1	0.2	0.1	0.3	0.7	1.7	3.2	1.5	34.9	7.3	1.3	4.5	4.5	8.0	5.8	2.8	2.3	3.3	2.8	4.3	0.0	8.4	5.7	2.0	0.5	0.0	2.0	16.9	3.2	5.0	1.9	1.8	10.1	69.4	0.9	8.3	4.7	1.5	3.5	0.0	9.1	1.8	8.9	2.5	5.0	46.2	1.2	4.1	0.8	1.5	4.5	3.1	2.3	0.0	26.2	2.9	2.7	2.1	24.6	67.0	1.4	1.7	2.2	4.7	2.1	0.4	4.5	1.6	7.5	0.0	8.3	3.4	14.1	10.3	4.8	2.3	3.8	3.9	10.8	2.6	3.0
ZRSR2	"U2AF1-RS2, U2AF1L2, URP, ZC3H22"	ENSG00000169249	"Zinc finger CCCH-type, RNA binding motif and serine/arginine rich 2"	Q15696	X	15790472-15823260	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"				"prognostic favorable (7.96e-4)"	"unprognostic (1.54e-2)"	"unprognostic (7.31e-2)"	"prognostic favorable (8.50e-5)"	"unprognostic (8.08e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.14e-3)"	"unprognostic (5.72e-3)"	"unprognostic (8.46e-2)"	"unprognostic (3.47e-3)"	"unprognostic (6.90e-2)"	"unprognostic (2.85e-2)"	"prognostic unfavorable (4.87e-5)"	"unprognostic (8.14e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.65e-2)"	"prognostic favorable (2.97e-4)"	15.2	12.1	25.7	17.3	25.1	42.7	16.2	28.8	36.1	24.3	26.5	22.9	11.0	21.3	20.2	13.4	20.2	10.2	17.2	24.4	27.5	16.2	13.3	20.1	29.0	25.9	24.9	22.2	14.3	13.0	24.1	10.8	24.9	18.1	12.5	22.2	13.9	11.9	20.4	15.4	19.8	17.0	23.2	31.8	14.8	5.6	26.0	21.9	17.4	13.1	20.2	18.1	20.1	26.3	14.3	8.9	15.6	14.7	21.9	18.4	6.1	11.4	10.5	10.8	11.0	11.3	11.3	16.1	19.2	10.6	28.3	13.7	15.6	19.9	11.0	12.3	20.0	10.4	22.8	10.1	14.8	24.4	23.9	9.2	17.7	20.0	32.4	21.3	18.9	15.5	17.0	15.3	12.9	17.5	13.0	25.4	20.1	7.5	12.7	15.1	22.0	16.4	12.9	11.0	10.6	11.8	26.7	23.5	17.7	21.4	18.4	13.6	13.2	10.7	7.8	28.7	11.0	12.9	11.7	15.0	8.2	17.0	14.2	38.7	25.7	24.0	17.3	22.6	17.2	34.9	21.6	23.2	15.1	37.2	26.1	18.5	26.9	14.3	22.9	24.6	24.3	10.5	25.7	25.1	28.8	36.1	24.4	27.5	25.9	24.9	24.9	23.2	26.0	26.3	16.7	9.6	17.4	12.1	35.6	11.3	10.2	16.6	12.0	15.3	13.8	12.1	23.9	5.7	17.2	16.5	14.6	6.8	42.3	14.0	23.5	12.8	1.1	27.7	14.3	14.2	16.8	9.9	15.5	14.9	10.2	11.5	4.6	14.1	32.3	9.7	11.0	13.8	19.1	8.4	17.9	16.9	22.4	33.5	19.6	1.6	13.7	25.6	12.4	14.0	30.5	9.6	37.0	10.1	13.7	13.1	8.2	16.6	18.8	7.0	17.3	17.7	23.7	19.5	19.7	13.8	16.2	6.4	8.3	7.8	10.5	7.3	32.2	9.3	13.4	8.0
ZSCAN25	"FLJ32468, ZNF498"	ENSG00000197037	"Zinc finger and SCAN domain containing 25"	Q6NSZ9	7	99616946-99632408	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Astrocytes: 34.6;Excitatory neurons: 48.1;Inhibitory neurons: 44.9;Microglial cells: 32.8;Oligodendrocyte precursor cells: 47.7;Oligodendrocytes: 44.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055127, HPA057173"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA055127: AB_2682706, HPA057173: AB_2683360"	"unprognostic (2.21e-3)"	"unprognostic (3.96e-2)"	"unprognostic (4.45e-1)"	"unprognostic (3.92e-2)"	"unprognostic (5.89e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.97e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.82e-3)"	"unprognostic (9.98e-2)"	"unprognostic (1.10e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.19e-3)"	4.2	4.0	2.8	4.8	2.7	6.4	5.0	3.3	3.1	4.9	3.1	4.4	3.3	5.1	2.3	4.7	5.1	3.3	3.0	2.6	2.5	3.9	3.3	3.8	6.0	2.8	2.3	7.7	4.5	5.7	3.1	4.1	2.5	4.7	3.6	2.7	4.5	5.4	4.5	6.1	4.1	4.8	2.2	5.1	3.9	5.3	2.8	9.5	4.6	3.9	5.3	4.3	4.3	3.1	7.6	3.5	10.0	11.5	4.3	3.3	9.8	8.2	6.9	9.3	9.6	9.3	6.1	10.6	9.3	6.9	8.5	9.7	11.0	9.5	11.5	6.1	9.4	7.1	5.8	8.1	7.4	16.6	6.3	5.2	11.7	7.4	7.7	3.7	6.0	11.7	20.4	8.3	6.6	8.4	24.0	23.4	18.4	4.2	8.3	10.0	10.3	11.4	4.0	10.3	6.8	16.8	10.8	16.2	11.7	11.8	4.5	11.2	4.3	14.4	11.6	8.3	14.0	7.4	12.8	18.2	7.8	10.2	21.6	3.5	2.4	3.2	4.3	2.6	5.3	1.9	3.0	4.2	1.9	1.6	5.0	5.1	2.9	2.8	2.4	1.6	4.7	3.3	2.8	2.7	3.3	3.1	2.6	2.5	2.8	2.3	2.5	2.2	2.8	3.1	3.9	0.0	6.2	34.6	4.6	3.4	1.8	2.6	2.8	4.9	4.0	4.4	4.2	2.8	1.5	1.8	8.4	4.3	5.1	5.2	1.9	2.9	5.2	2.3	4.6	3.9	2.4	5.5	48.1	2.8	3.4	3.3	3.6	3.5	5.1	4.5	4.2	3.6	3.6	5.0	44.9	4.4	6.1	6.0	1.4	2.7	3.7	2.0	1.8	32.8	3.9	2.3	4.1	47.7	44.4	2.1	3.1	6.0	5.5	3.0	3.7	2.4	2.5	4.7	6.6	4.0	3.9	10.0	7.6	4.0	2.3	1.9	6.2	4.7	3.7	1.7
ZSCAN32	"FLJ20417, ZNF434"	ENSG00000140987	"Zinc finger and SCAN domain containing 32"	Q9NX65	16	3382081-3401065	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA005758	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	Cytosol	"HPA005758: AB_1080720"	"unprognostic (5.05e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.38e-3)"	"unprognostic (7.72e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.13e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.18e-3)"	"unprognostic (9.71e-2)"	4.8	5.9	8.9	5.6	9.4	3.6	5.9	8.6	10.9	6.2	10.0	6.6	7.8	6.0	4.4	4.9	6.9	5.0	5.3	8.6	10.1	5.9	5.5	6.0	8.6	9.6	9.6	8.2	7.4	7.6	8.4	5.4	9.5	6.5	5.7	11.6	4.9	7.0	4.6	6.1	5.4	5.5	8.8	6.9	5.9	7.4	9.6	10.1	7.2	3.3	9.1	6.1	5.2	11.4	6.0	10.1	12.7	15.3	10.1	10.0	9.5	7.1	12.6	10.3	9.9	5.2	8.8	19.4	7.5	10.6	6.8	6.4	10.6	10.6	12.0	13.0	7.6	16.7	9.1	7.1	12.7	11.9	12.1	10.0	17.1	10.2	17.3	11.2	10.6	21.3	16.5	7.5	13.5	7.5	16.4	8.1	13.8	10.6	5.1	16.0	13.1	18.6	8.9	6.4	11.2	8.6	14.4	8.8	7.8	8.1	10.1	14.7	12.8	8.9	8.4	7.3	8.6	12.4	14.8	25.1	2.5	9.4	13.6	4.1	5.4	7.3	9.7	4.2	8.3	8.3	6.7	6.2	4.9	6.7	9.3	9.0	6.0	15.0	13.1	5.0	9.5	6.2	8.9	9.4	8.6	10.9	8.6	10.1	9.6	9.6	9.5	8.8	9.6	11.4	3.9	19.2	5.3	3.3	5.1	2.3	2.2	1.7	1.8	4.6	3.0	3.4	0.9	5.7	6.2	1.8	8.4	4.9	3.6	2.7	11.7	5.6	1.6	3.5	3.8	3.9	0.0	6.1	4.8	6.2	2.7	2.8	1.5	2.2	5.1	4.6	2.5	3.4	3.0	8.4	4.4	3.3	2.0	5.1	1.8	1.4	4.4	5.1	1.8	9.4	6.2	6.0	9.2	8.0	7.7	5.8	3.2	5.3	3.6	3.9	3.1	3.7	1.7	4.2	0.0	4.1	2.9	15.9	15.9	2.9	2.8	2.6	5.6	6.5	3.1	1.5
ZW10	KNTC1AP	ENSG00000086827	"Zw10 kinetochore protein"	O43264	11	113733187-113773735	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, ER-Golgi transport, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 44.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011565, HPA051253, HPA055410"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Endoplasmic reticulum, Cytosol"		"CAB011565: AB_779030, HPA051253: AB_2681408, HPA055410: AB_2682809"	"unprognostic (4.33e-3)"	"unprognostic (6.65e-2)"	"prognostic favorable (2.70e-4)"	"unprognostic (3.12e-1)"	"unprognostic (5.51e-2)"	"unprognostic (6.52e-2)"	"prognostic unfavorable (8.57e-4)"	"unprognostic (7.44e-2)"	"unprognostic (8.01e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.78e-2)"	"unprognostic (8.57e-3)"	"unprognostic (6.00e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.17e-3)"	6.9	6.0	3.5	8.1	4.1	9.2	10.9	5.0	4.8	8.1	3.7	8.3	7.2	7.6	7.3	9.6	6.1	5.9	5.6	3.8	3.8	8.8	13.0	6.4	9.4	4.2	4.7	6.9	9.1	7.2	5.1	7.7	4.6	7.9	10.0	6.8	8.3	7.3	13.4	13.7	7.1	8.7	3.8	7.0	7.3	13.5	4.2	12.1	6.7	12.0	12.0	8.5	7.5	5.7	25.0	14.4	30.2	22.1	18.4	20.0	17.4	26.1	21.4	32.2	32.5	38.1	46.1	29.0	34.5	25.8	28.1	34.2	36.7	31.6	46.0	19.1	15.1	30.9	12.0	23.5	20.6	31.7	18.8	16.5	20.8	34.1	27.4	14.2	33.5	31.7	36.3	11.8	33.8	12.2	29.3	20.9	21.7	29.8	29.0	27.0	34.4	32.7	21.2	22.2	13.3	15.7	29.1	24.2	11.8	24.2	44.9	17.4	21.1	28.8	44.2	14.4	28.8	6.1	10.6	30.6	9.9	38.1	33.0	8.5	7.4	7.4	6.3	10.4	8.5	5.9	5.9	5.6	9.5	5.1	5.4	6.8	1.9	6.2	9.2	3.0	5.6	5.6	3.5	4.1	5.0	4.8	3.8	3.8	4.2	4.7	4.6	3.8	4.2	5.7	5.6	0.0	4.8	11.1	5.8	12.1	7.6	7.5	8.0	2.9	5.9	5.0	6.8	7.2	7.3	0.0	0.0	9.2	3.9	3.9	9.8	10.1	10.7	7.7	7.1	6.9	3.6	10.7	12.5	11.8	10.0	6.5	8.2	12.7	3.8	7.8	3.9	8.1	9.2	3.3	11.1	4.6	4.1	6.0	5.4	7.3	5.0	6.1	3.6	10.3	8.0	7.6	3.1	12.1	18.7	8.4	3.8	5.7	10.4	5.6	5.3	7.2	4.8	4.9	19.7	7.0	7.0	44.4	17.5	9.4	12.5	10.5	5.9	6.9	6.4	5.8
ZWILCH	"FLJ10036, KNTC1AP"	ENSG00000174442	"Zwilch kinetochore protein"	Q9H900	15	66504959-66550130	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 53.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 97.3;Late spermatids: 74.5;Spermatocytes: 167.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"				"unprognostic (1.10e-1)"	"unprognostic (9.99e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.83e-3)"	"unprognostic (3.32e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (2.90e-5)"	"prognostic unfavorable (7.34e-4)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (2.81e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.42e-1)"	3.8	2.2	2.9	8.4	2.7	10.3	6.7	2.3	2.8	4.9	4.1	8.7	5.5	6.2	6.3	6.7	4.0	5.9	2.6	3.0	2.7	4.7	5.4	5.2	11.6	3.3	2.1	6.0	3.2	2.6	2.4	7.3	2.9	4.6	9.9	3.8	3.4	3.7	3.3	7.9	5.5	6.2	3.0	5.5	5.5	53.9	3.1	14.1	3.9	3.1	14.1	5.5	4.1	3.8	38.1	48.5	58.0	51.5	13.6	24.0	31.3	58.8	35.6	69.4	76.5	39.4	32.2	81.6	26.3	38.6	57.7	92.6	156.4	42.2	83.9	41.7	31.9	59.5	63.9	31.3	4.9	41.4	32.0	9.9	10.7	71.2	51.8	21.4	44.8	34.3	57.4	43.2	54.7	38.2	36.7	25.2	111.7	75.2	31.0	41.9	72.1	59.6	24.9	42.6	34.5	37.5	32.1	41.4	50.6	66.1	32.9	27.6	30.0	63.2	68.7	37.6	87.2	21.6	92.6	85.0	42.9	94.5	53.5	4.0	2.1	3.6	4.3	4.2	3.7	4.3	4.3	4.1	2.1	4.1	2.8	4.0	2.5	5.0	5.4	2.2	4.5	2.2	2.9	2.7	2.3	2.8	3.0	2.7	3.3	2.1	2.9	3.0	3.1	3.8	6.1	3.2	4.6	1.3	7.5	11.1	6.4	8.4	4.0	5.1	5.8	4.2	1.5	5.7	8.7	1.8	0.0	14.1	7.0	5.3	3.9	8.2	97.3	5.9	6.6	6.5	4.8	31.5	5.2	6.5	25.1	6.7	10.7	7.8	15.2	9.6	3.9	4.7	12.5	0.0	4.3	10.3	12.2	4.1	8.4	74.5	7.5	7.4	5.4	2.8	7.4	1.5	7.2	2.5	2.7	8.1	2.1	5.3	15.0	4.6	2.0	2.8	5.2	3.7	26.3	3.1	6.4	167.9	43.1	11.2	8.5	12.9	8.3	4.8	10.1	6.9
ZWINT	"KNTC2AP, SIP30, Zwint1"	ENSG00000122952	"ZW10 interacting kinetochore protein"	O95229	10	56357227-56361273	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 41.6;lymphoid tissue: 43.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 133.0;Extravillous trophoblasts: 108.6;Late spermatids: 208.8;Spermatocytes: 121.0;Spermatogonia: 100.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 17.0"	"Lineage enriched"	"Detected in many"	5	"T-cells: 17.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA005757, HPA022264"			Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		No	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA005757: AB_10600224, HPA022264: AB_10600995"	"unprognostic (5.59e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-2)"	"unprognostic (9.38e-2)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (1.77e-8)"	"unprognostic (6.36e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (3.72e-12)"	"unprognostic (1.40e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.46e-1)"	2.6	2.5	1.2	15.7	1.3	41.6	6.5	1.1	1.8	3.9	1.0	18.8	13.7	3.2	1.7	12.4	2.8	2.4	1.5	1.5	1.2	4.4	4.8	2.9	26.5	1.2	1.3	1.5	2.4	5.4	0.8	10.8	1.2	2.5	22.4	0.5	3.3	1.4	0.3	10.8	14.8	6.8	1.2	5.0	12.5	26.1	1.6	43.5	3.9	0.7	33.0	5.0	4.3	1.4	199.8	154.8	107.9	120.9	7.5	10.8	88.1	143.1	108.0	169.6	153.4	275.4	116.1	102.0	53.2	49.6	79.1	99.9	153.2	108.3	156.7	259.9	80.2	101.6	120.8	129.4	0.7	169.6	131.0	5.1	6.8	157.7	64.9	20.8	86.8	134.2	140.2	121.4	151.1	160.1	150.7	108.3	77.0	135.9	188.7	151.7	209.5	54.0	53.5	87.5	99.8	61.2	135.2	304.2	35.3	62.2	197.3	163.4	47.4	73.6	189.4	76.9	223.2	105.8	55.3	176.0	103.8	210.0	94.7	0.0	0.8	0.7	2.4	3.0	0.3	1.6	5.3	3.6	1.4	0.3	6.3	3.6	0.0	3.5	2.3	1.1	17.0	3.1	1.2	1.3	1.1	1.8	1.5	1.2	1.2	1.3	1.2	1.2	1.6	1.4	0.9	3.2	1.7	0.3	11.1	18.4	6.0	20.2	4.6	2.0	9.4	5.5	1.4	2.8	7.3	5.5	0.0	73.7	3.3	17.9	0.0	9.7	74.0	7.0	4.3	5.7	0.0	133.0	1.3	13.3	108.6	10.3	16.8	8.0	0.0	27.6	7.9	3.5	49.4	0.0	0.3	22.8	14.2	8.5	8.8	208.8	5.0	9.2	7.2	0.0	2.6	1.3	0.0	0.0	0.6	8.6	16.4	2.6	42.4	1.9	8.7	6.0	2.5	0.9	0.0	1.4	10.6	121.0	100.3	24.5	8.2	23.1	7.9	6.5	39.4	8.4
ZYG11B	"FLJ13456, ZYG11"	ENSG00000162378	"Zyg-11 family member B, cell cycle regulator"	Q9C0D3	1	52726453-52827336	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 78.9;tongue: 62.0"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 107.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028156	Uncertain		Approved	"Golgi apparatus,Intermediate filaments"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Golgi apparatus, Intermediate filaments"		"HPA028156: AB_10602360"	"unprognostic (2.54e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (5.42e-6)"	"unprognostic (1.58e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.04e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.84e-3)"	"unprognostic (5.06e-2)"	"unprognostic (2.76e-1)"	"unprognostic (6.08e-2)"	"prognostic favorable (9.80e-7)"	"unprognostic (2.22e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.57e-2)"	9.4	8.4	13.5	5.5	14.5	7.6	7.2	15.9	14.0	9.1	3.5	9.9	4.3	10.8	5.9	9.5	6.8	6.6	17.1	13.7	16.0	12.9	18.6	7.6	5.1	8.5	9.7	10.8	5.1	10.0	4.6	7.1	11.1	9.4	7.5	13.4	6.3	8.6	78.9	6.3	4.6	12.5	8.0	5.6	5.0	8.6	16.3	6.9	12.8	62.0	5.4	7.7	5.7	10.3	10.8	9.9	12.1	15.1	21.7	18.5	10.0	11.7	15.3	9.4	8.7	8.4	3.5	10.2	11.1	23.6	12.6	5.5	14.1	10.6	14.9	7.9	8.6	13.1	10.4	5.3	11.5	9.9	7.7	13.5	11.2	13.4	9.4	13.1	16.6	2.3	12.0	2.1	17.2	4.4	3.9	6.4	12.3	5.4	10.0	6.7	22.4	9.3	9.6	17.2	5.5	10.9	20.6	12.8	10.6	15.2	7.7	7.8	19.1	14.4	8.2	14.3	7.4	8.6	10.8	7.4	9.8	6.6	9.5	0.3	0.7	0.9	0.5	0.3	0.6	0.6	0.7	0.4	0.7	0.5	1.1	0.8	1.7	0.6	0.6	0.4	1.0	0.3	13.5	14.5	15.9	14.0	13.7	16.0	8.5	9.7	11.1	8.0	16.3	10.3	26.8	25.6	28.8	29.0	13.4	11.3	10.5	12.1	10.2	49.5	13.6	11.9	88.3	20.0	14.0	14.7	20.9	24.6	6.9	37.2	7.9	12.2	5.7	13.2	40.9	22.1	10.2	9.0	72.4	11.1	12.0	26.3	12.2	18.6	8.2	32.0	32.5	107.7	20.6	97.6	82.6	11.4	14.2	37.5	11.8	7.9	24.5	21.5	21.4	36.5	21.9	21.6	4.1	46.3	52.0	16.3	17.9	30.9	11.6	26.0	14.0	30.0	11.1	24.4	26.3	35.7	25.9	11.4	23.7	17.3	14.6	34.8	9.7	19.5	15.5	19.0
ZZEF1	"FLJ10821, KIAA0399, ZZZ4"	ENSG00000074755	"Zinc finger ZZ-type and EF-hand domain containing 1"	O43149	17	4004445-4143030	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 115.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031778, HPA031790"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA		1100000	"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Mitochondria	"HPA031778: AB_10599831, HPA031790: AB_10600999"	"unprognostic (4.48e-2)"	"unprognostic (7.59e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (2.80e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.21e-2)"	"prognostic favorable (6.08e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.38e-3)"	"unprognostic (6.09e-3)"	"unprognostic (1.80e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.46e-2)"	10.2	10.6	6.4	10.1	6.7	20.8	9.7	7.4	7.3	8.4	18.3	19.2	15.5	9.9	5.7	11.1	9.1	6.4	11.0	7.1	6.0	7.6	9.0	11.3	10.1	8.0	6.9	10.1	14.2	12.1	11.2	6.0	7.8	10.1	14.6	11.2	9.1	7.4	22.2	12.1	27.5	8.8	5.8	14.2	12.0	8.0	8.5	15.1	10.7	13.3	9.7	10.9	8.1	7.5	13.1	20.1	7.1	9.7	17.4	9.8	8.5	11.1	13.9	12.7	12.3	10.0	4.5	12.4	7.3	15.0	8.4	14.6	14.4	7.6	12.9	14.5	15.0	12.0	16.4	6.5	11.8	10.2	22.6	12.6	10.0	12.5	14.7	6.6	16.6	12.3	8.8	12.2	8.0	8.9	12.7	6.0	4.3	12.5	7.6	14.0	8.6	5.4	7.1	13.2	5.6	8.2	12.6	7.7	10.8	7.0	7.6	7.7	19.7	11.1	5.6	14.1	14.7	5.4	3.0	6.3	11.1	8.9	10.5	0.7	0.6	0.6	0.8	0.9	1.0	0.4	0.5	0.5	0.5	0.3	0.3	0.6	1.0	0.2	1.0	0.4	0.4	0.4	6.4	6.7	7.4	7.3	7.1	6.0	8.0	6.9	7.8	5.8	8.5	7.5	19.3	57.7	54.8	39.8	23.5	7.1	5.4	6.6	13.1	30.6	12.6	10.3	22.8	18.6	30.0	9.2	98.0	8.3	23.7	93.4	0.0	7.3	48.9	18.8	17.4	19.2	13.2	12.4	50.3	11.2	6.4	21.6	46.4	25.6	26.5	21.8	23.2	15.2	11.9	40.4	55.3	38.5	12.2	30.5	10.6	26.8	14.9	29.0	12.4	22.5	20.4	15.8	19.6	35.2	53.6	14.9	34.3	9.8	27.8	9.5	115.2	4.8	22.7	50.3	6.6	23.7	15.2	12.0	11.8	16.4	10.1	8.9	31.1	18.0	28.6	9.3
ZZZ3	"ATAC1, DKFZP564I052"	ENSG00000036549	"Zinc finger ZZ-type containing 3"	Q8IYH5	1	77562416-77683419	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Astrocytes: 73.8;Excitatory neurons: 102.1;Inhibitory neurons: 100.7;Microglial cells: 77.8;Oligodendrocyte precursor cells: 141.8;Oligodendrocytes: 280.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053663, HPA054913, HPA066197"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA053663: AB_2682222, HPA054913: AB_2682640, HPA066197: AB_2685635"	"unprognostic (1.30e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.13e-3)"	"unprognostic (5.38e-3)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (6.96e-5)"	"unprognostic (2.91e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.43e-1)"	8.9	12.2	6.3	10.2	10.8	9.7	17.1	5.6	6.9	13.0	2.6	9.6	9.0	13.0	9.2	9.8	11.2	8.6	11.1	5.3	7.5	14.5	16.7	8.2	12.8	5.7	7.2	16.9	9.7	13.9	6.0	10.5	8.0	11.9	9.5	11.3	10.4	12.2	8.7	10.8	8.1	12.0	7.1	9.8	10.4	6.5	7.9	14.3	19.8	10.2	12.4	10.4	6.5	16.0	27.9	12.4	22.4	17.9	21.3	30.3	26.0	32.6	27.9	27.7	31.3	15.5	12.9	34.8	29.3	27.2	32.3	24.3	29.3	22.2	44.4	25.9	26.9	41.1	26.9	19.8	33.2	45.5	12.0	26.0	34.2	31.0	63.4	30.1	31.2	24.2	41.4	24.0	27.3	13.1	22.0	13.7	35.1	15.9	29.5	25.9	40.3	17.1	22.5	26.1	30.0	26.5	19.2	23.0	60.6	16.4	13.0	25.7	24.9	23.7	29.9	40.2	44.6	20.3	30.8	36.7	27.2	39.2	19.3	0.1	4.3	5.3	6.1	4.5	9.6	7.3	7.6	7.7	7.4	9.0	9.5	8.6	0.8	7.8	5.0	4.9	10.4	5.1	6.3	10.8	5.6	6.9	5.3	7.5	5.7	7.2	8.0	7.1	7.9	16.0	11.3	0.0	0.0	73.8	22.2	17.2	13.6	10.9	27.9	18.1	0.0	0.0	0.0	15.7	5.6	0.0	8.4	13.3	14.3	6.9	0.0	0.0	5.1	0.0	0.0	10.5	19.8	17.4	102.1	0.0	12.3	11.0	16.3	0.0	0.0	0.0	15.0	15.1	14.1	16.8	100.7	14.1	6.1	13.2	11.8	3.9	16.8	8.2	12.4	77.8	7.5	16.1	17.5	141.8	280.3	0.0	14.0	19.5	14.9	18.7	10.1	0.0	4.2	19.7	6.6	29.6	11.4	7.8	9.7	28.1	19.6	8.5	14.2	0.0	14.2	14.2